Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.8" "Cell line enhanced" "Detected in all" "CACO-2: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 18.8 42.2 7.5 7.5 11.4 5.2 16.2 10.9 8.6 13.8 15.8 9.5 16.9 10.1 18.0 9.5 12.4 13.4 11.8 35.0 7.5 6.4 12.8 15.5 11.8 3.5 13.0 6.8 14.3 18.1 6.9 11.1 7.9 9.9 12.6 8.3 10.0 16.7 14.5 155.8 13.0 13.6 21.0 15.3 7.4 14.2 14.4 13.1 6.5 14.1 15.7 5.0 14.4 17.0 8.1 13.2 43.3 11.9 13.7 18.0 6.4 7.6 6.3 9.8 7.0 28.7 20.0 2.7 12.7 8.7 11.6 14.5 72.2 11.6 5.2 12.4 21.4 4.3 14.7 8.5 13.9 11.9 11.9 5.0 10.9 13.2 14.2 2.8 4.5 26.6 5.9 12.2 6.5 34.3 5.7 8.4 24.4 9.1 5.9 11.1 4.6 10.7 5.7 16.8 5.0 15.3 4.6 3.5 13.1 16.2 7.0 9.0 10.9 5.6 35.7 12.3 6.7 23.2 4.2 9.1 14.2 9.5 4.7 4.6 6.8 43.3 11.9 12.3 6.1 6.6 7.8 7.0 11.9 10.0 12.7 8.1 10.4 7.8 6.9 13.7 6.4 13.2 18.0 6.4 7.5 11.4 10.9 8.6 7.5 6.4 13.0 6.8 9.9 13.1 AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948875-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavourable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavourable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 8.2 6.8 5.7 11.4 9.8 14.4 7.1 7.5 6.9 7.5 8.8 9.2 7.5 6.2 9.7 6.3 7.6 8.2 7.5 9.8 5.9 7.6 8.7 6.8 11.0 10.1 4.5 11.1 8.8 8.5 5.2 11.1 8.3 7.1 8.6 4.6 6.7 9.2 13.0 8.3 8.5 8.5 7.9 11.2 7.0 8.7 10.2 18.5 9.5 7.2 13.1 10.4 13.5 19.4 18.8 32.1 27.3 20.5 27.2 19.0 20.4 33.1 7.2 14.4 9.7 11.3 13.3 13.2 9.7 15.0 13.3 22.7 14.3 37.0 16.8 11.4 18.1 27.2 15.2 20.3 18.8 20.3 17.2 13.1 15.9 11.9 27.7 14.6 9.9 27.3 19.4 17.3 10.8 23.8 11.2 12.9 15.0 30.3 20.9 9.1 12.7 19.7 21.7 19.9 12.5 18.1 15.7 6.8 19.4 8.0 17.7 13.9 14.3 12.1 11.6 19.7 24.5 41.3 12.6 17.9 27.9 14.5 20.7 20.5 14.2 20.2 32.1 23.9 27.3 23.5 18.0 21.5 25.0 18.8 19.4 19.6 19.6 26.1 20.5 25.9 17.4 27.2 19.0 ABCA1 "ABC1, HDLDT1, TGD" ENSG00000165029 "ATP binding cassette subfamily A member 1" O95477 9 104781002-104928237 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" "Atherosclerosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 16.9;U-87 MG: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.6;neutrophil: 10.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057283, CAB069889" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB069889: AB_10002789, HPA057283: " "unprognostic (1.58e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (2.80e-1)" "unprognostic (7.47e-3)" "unprognostic (1.85e-1)" "unprognostic (9.22e-2)" "unprognostic (9.80e-2)" "unprognostic (2.04e-1)" "unprognostic (7.28e-3)" "unprognostic (2.14e-1)" "unprognostic (4.78e-2)" "unprognostic (1.04e-2)" "unprognostic (2.00e-3)" "unprognostic (2.51e-2)" "unprognostic (6.71e-2)" "unprognostic (2.57e-1)" 25.7 38.1 6.3 9.8 13.1 15.8 23.0 2.3 8.5 8.2 14.8 8.0 6.5 4.4 7.8 9.6 7.0 7.9 13.6 10.7 7.5 3.7 7.1 33.3 12.7 29.4 18.9 2.3 8.7 5.4 1.8 3.3 20.1 10.2 9.4 9.4 7.7 6.3 8.7 21.3 12.1 8.1 25.2 16.1 12.8 7.3 8.8 8.0 16.9 5.8 2.2 5.0 16.4 20.0 1.8 0.2 11.6 1.5 0.1 0.6 0.1 0.0 2.6 2.2 0.0 6.5 2.4 2.0 2.8 10.8 0.9 1.0 0.4 0.3 3.8 3.1 2.8 0.0 1.2 0.1 0.8 0.0 0.0 0.4 0.9 9.4 11.7 0.0 6.7 16.9 0.7 11.0 0.2 1.0 0.0 9.7 0.2 0.3 2.3 5.1 3.1 0.8 0.0 0.0 0.2 1.8 1.8 0.3 0.1 2.9 0.5 0.6 0.0 1.9 0.9 2.9 0.2 3.8 3.1 3.8 1.8 2.3 38.7 0.0 0.0 2.2 0.8 11.6 0.2 1.0 0.2 1.2 0.3 0.0 0.2 1.8 0.6 0.0 10.6 0.1 1.5 0.1 0.1 0.1 6.3 13.1 2.3 4.0 7.5 3.7 18.9 2.3 10.2 8.0 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 20.8;T-47d: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.5 1.8 14.8 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.1 0.2 8.5 0.1 0.3 14.9 5.7 0.9 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 14.4 10.2 0.0 0.0 12.7 0.0 1.0 2.0 4.6 2.3 0.3 1.6 8.5 0.3 20.8 14.9 1.8 10.5 0.2 34.2 0.9 4.1 0.1 0.5 4.0 4.2 2.8 1.2 0.0 2.1 5.1 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Cell line enhanced" "Detected in many" "SiHa: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm Nucleoplasm "HPA022032: AB_1844427, HPA062904: " "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favourable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.4 7.7 5.6 0.5 4.4 4.8 4.6 6.9 0.6 1.6 0.0 2.4 3.8 6.3 1.0 3.7 5.2 0.1 2.9 0.0 4.7 2.9 10.3 0.0 2.7 5.5 4.5 1.9 5.3 10.0 0.0 1.7 0.4 3.6 2.6 0.0 1.6 2.9 0.3 0.1 0.4 0.9 7.0 8.8 1.4 15.8 7.3 4.5 7.5 2.7 7.3 5.3 1.5 4.8 0.9 9.0 0.2 0.3 2.1 0.0 4.7 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 ABCA8 KIAA0822 ENSG00000141338 "ATP binding cassette subfamily A member 8" O94911 17 68867292-68955392 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 16.2;ASC TERT1: 36.1;HSkMC: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044914 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044914: AB_10964859" "unprognostic (2.58e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.04e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (5.22e-2)" "unprognostic (6.68e-2)" "unprognostic (8.76e-2)" "unprognostic (1.42e-3)" "unprognostic (3.52e-3)" "unprognostic (1.88e-1)" "unprognostic (3.29e-1)" "unprognostic (6.14e-3)" 29.1 25.2 10.0 3.4 27.2 0.5 15.1 3.2 15.4 7.3 12.8 29.9 3.9 5.4 10.2 13.0 12.4 17.6 14.3 30.0 12.5 5.5 8.1 26.6 15.2 1.3 37.8 9.2 44.7 5.1 4.5 14.8 7.6 22.2 10.3 14.3 16.4 9.8 7.9 8.9 4.9 9.9 7.1 28.2 9.9 11.5 15.8 42.7 0.0 13.0 14.2 2.8 13.6 20.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 16.2 36.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.0 0.0 0.0 27.3 0.0 0.4 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.0 27.2 3.2 15.4 12.5 5.5 37.8 9.2 22.2 42.7 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell line enhanced" "Detected in some" "CACO-2: 29.4;HEK 293: 9.0;HEL: 16.3;Hep G2: 8.1;RPTEC TERT1: 11.3;SH-SY5Y: 36.0" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "CAB001716, HPA002199" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "CAB001716: , HPA002199: AB_1844428" "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favourable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favourable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 9.0 16.3 1.9 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 11.3 0.0 0.4 36.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401697-87480435 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 93.2" "Group enriched" "Detected in some" 5 "SH-SY5Y: 11.7;WM-115: 22.3" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.9;naive B-cell: 11.4" "Lineage enriched" "Detected in many" 8 "B-cells: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: , HPA053288: " "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.5 4.1 0.2 4.3 0.2 0.2 0.3 0.1 1.1 0.2 0.6 0.4 0.0 0.0 0.1 0.2 0.6 0.1 0.3 4.0 0.3 0.2 0.4 93.2 0.1 4.1 0.3 0.2 0.3 0.1 0.0 0.5 0.0 0.3 0.3 0.4 0.8 0.4 0.1 2.9 0.6 1.2 1.6 0.5 5.2 0.2 0.5 0.4 0.1 0.4 4.2 3.2 0.6 0.5 11.4 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 11.7 0.0 0.5 2.2 0.2 0.5 0.0 0.2 1.6 0.1 0.0 0.0 0.0 2.7 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 1.4 11.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.1 1.1 0.3 0.2 0.3 0.2 0.3 0.4 ABCB8 "EST328128, M-ABC1, MABC1" ENSG00000197150 "ATP binding cassette subfamily B member 8" Q9NUT2 7 151028422-151047782 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045187 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA045187: AB_10964281" "unprognostic (5.29e-2)" "unprognostic (9.17e-3)" "unprognostic (8.28e-2)" "unprognostic (8.32e-2)" "unprognostic (8.63e-3)" "prognostic favourable (5.91e-4)" "unprognostic (4.76e-2)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "prognostic favourable (3.34e-4)" "unprognostic (2.26e-1)" "prognostic favourable (5.88e-4)" "unprognostic (7.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.64e-2)" "unprognostic (1.23e-1)" 12.6 22.8 14.4 13.8 22.0 12.2 8.5 24.9 24.8 16.3 12.3 22.2 10.4 19.3 16.5 14.9 17.6 12.9 11.5 13.0 14.5 12.8 14.5 33.5 11.7 13.3 19.1 17.9 13.3 12.6 15.4 20.1 23.6 15.9 12.3 9.5 12.5 11.1 12.8 11.2 13.7 14.7 12.7 13.3 11.5 13.1 13.6 19.5 14.0 18.4 11.7 10.6 9.6 10.4 4.4 10.4 10.3 6.7 4.0 7.5 3.6 12.4 19.6 5.0 15.9 8.0 4.7 10.1 6.6 6.8 10.5 11.1 7.8 20.8 6.5 8.8 6.9 13.2 7.3 13.6 4.7 8.1 8.0 5.2 7.8 9.3 5.2 4.0 12.9 8.0 10.3 12.4 5.2 10.4 27.1 9.0 7.8 27.8 15.1 7.5 3.4 22.3 7.2 3.2 23.2 7.0 5.3 4.9 9.8 7.0 20.0 6.3 7.9 5.2 6.4 9.8 2.6 7.0 9.8 9.1 4.5 4.7 13.8 9.6 9.9 10.3 4.5 3.4 7.5 6.7 5.2 4.4 5.3 6.1 6.3 3.5 4.9 6.9 1.1 4.0 4.7 10.4 5.6 3.6 14.4 22.0 24.9 24.8 14.5 12.8 19.1 17.9 15.9 19.5 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184018015 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: , HPA052295: " "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavourable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 7.9 11.2 24.7 9.6 26.2 12.0 6.7 42.8 28.6 7.7 11.4 12.0 13.4 6.8 14.1 7.0 17.1 6.1 11.6 16.0 19.1 13.7 12.8 3.6 9.4 7.3 20.5 18.5 11.8 4.9 22.4 20.5 10.8 21.7 10.6 14.4 31.1 7.4 9.3 41.0 14.5 8.5 10.5 12.9 16.3 48.5 9.4 20.9 9.3 5.5 7.3 7.4 18.1 12.7 4.2 3.5 15.8 4.5 5.0 7.0 4.5 7.3 4.0 9.3 11.1 9.3 10.6 14.4 5.9 4.7 5.3 5.8 6.3 5.6 7.9 14.0 5.6 29.5 11.4 6.5 7.0 8.6 11.1 16.7 10.1 5.7 3.8 5.1 13.1 16.9 6.6 5.7 3.8 6.2 15.5 11.0 9.1 19.3 13.9 5.8 9.6 7.8 9.7 3.1 4.7 19.4 47.5 17.0 10.1 6.1 33.6 10.0 20.2 1.6 7.1 6.2 6.1 7.9 8.1 4.2 8.2 7.3 4.6 10.2 6.3 10.7 4.5 7.7 7.0 2.1 4.5 3.2 4.0 3.1 3.5 4.2 4.6 6.3 15.8 5.0 3.5 1.3 5.0 4.5 24.7 26.2 42.8 28.6 19.1 13.7 20.5 18.5 21.7 20.9 ABCC9 "CMD1O, SUR2" ENSG00000069431 "ATP binding cassette subfamily C member 9" O60706 12 21797401-21942529 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 17.2;BJ hTERT+: 9.9;CACO-2: 15.7;HSkMC: 20.5;U-138 MG: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007279 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007279: AB_1844435" "unprognostic (4.82e-2)" "unprognostic (3.62e-2)" "unprognostic (5.51e-4)" "unprognostic (1.09e-1)" "unprognostic (1.09e-1)" "unprognostic (8.30e-2)" "unprognostic (3.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.47e-2)" "unprognostic (8.72e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-1)" "prognostic unfavourable (1.85e-5)" "unprognostic (2.66e-2)" "unprognostic (1.21e-2)" "unprognostic (3.10e-3)" "unprognostic (8.22e-5)" 21.6 4.7 5.5 2.6 5.4 1.2 25.8 1.5 8.6 12.4 6.8 4.8 5.1 3.0 15.3 6.3 9.1 9.5 9.6 26.2 5.7 2.6 5.6 31.1 6.2 2.7 2.9 4.2 11.8 5.8 1.7 2.7 2.8 5.5 7.0 1.6 10.8 4.8 8.4 33.2 3.3 4.1 17.1 4.9 3.5 9.1 3.4 4.2 0.1 6.3 14.5 1.2 9.5 8.4 1.6 0.9 1.8 0.8 0.5 0.9 0.0 0.6 0.1 7.3 0.2 17.2 7.8 0.2 4.0 9.9 4.4 2.2 15.7 0.6 0.3 0.8 0.4 0.2 0.0 0.0 4.6 0.2 0.1 0.3 0.5 0.2 0.0 0.3 0.4 20.5 0.0 4.4 1.6 0.0 0.2 0.9 0.2 0.9 0.1 0.2 1.0 0.4 0.3 0.2 0.2 0.0 0.8 0.3 1.2 0.2 0.3 0.1 0.8 0.2 0.2 17.1 1.2 1.4 5.2 0.7 0.8 0.3 4.2 0.2 0.3 0.9 0.5 0.4 0.9 0.4 0.6 0.7 0.7 0.7 0.2 1.6 0.6 0.8 1.8 0.5 0.8 0.9 0.4 0.0 5.5 5.4 1.5 8.6 5.7 2.6 2.9 4.2 5.5 4.2 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell line enhanced" "Detected in many" "A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.7 19.9 5.9 0.0 0.2 0.0 34.7 0.7 0.6 1.0 1.7 4.4 0.2 0.0 0.2 0.1 5.8 0.2 0.6 1.5 5.6 0.9 0.2 0.1 5.9 0.0 0.3 0.0 0.1 2.4 2.3 0.1 1.8 0.4 0.0 0.6 11.5 2.7 0.1 2.0 0.0 1.3 0.0 17.4 0.0 4.2 0.1 0.2 4.1 0.4 0.5 0.1 0.0 0.0 0.8 0.7 0.2 0.0 5.5 2.1 0.0 1.5 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 ABHD15 ENSG00000168792 "Abhydrolase domain containing 15" Q6UXT9 17 29560547-29567137 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 11.1;MAIT T-cell: 5.0;NK-cell: 7.2;plasmacytoid DC: 17.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA014470 Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" "Nucleoplasm, Cytosol" "HPA014470: AB_1852993" "unprognostic (1.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.38e-1)" "unprognostic (8.60e-3)" "unprognostic (1.91e-1)" "unprognostic (1.62e-1)" "unprognostic (4.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.85e-1)" "unprognostic (9.76e-2)" "unprognostic (1.76e-3)" "unprognostic (3.00e-2)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (3.46e-1)" "unprognostic (5.45e-2)" 22.6 3.5 4.9 6.0 3.2 5.4 21.6 2.9 4.1 3.8 8.8 4.2 4.4 8.5 4.2 3.1 4.1 4.3 7.8 6.6 2.1 1.9 8.4 21.2 5.6 12.7 2.7 3.9 2.8 10.9 8.8 8.5 3.2 4.3 4.0 5.0 3.6 4.5 4.6 2.1 3.4 12.7 5.5 3.3 9.1 6.3 1.4 4.6 1.6 5.2 2.7 6.0 5.6 9.1 2.0 17.0 11.1 0.4 7.2 5.0 0.7 3.8 14.9 1.9 5.3 20.6 9.0 7.9 5.3 5.9 5.3 4.8 3.4 2.0 5.7 3.9 5.6 10.6 6.6 2.2 2.9 17.6 5.0 2.3 7.4 4.3 6.3 5.9 10.7 6.7 6.1 5.1 0.9 3.8 3.0 5.5 2.8 5.2 5.6 6.9 0.4 4.5 13.1 7.3 13.2 9.4 5.9 1.3 2.2 7.9 3.6 2.0 9.1 13.7 4.7 3.0 3.9 7.6 4.6 9.3 6.2 3.0 6.1 3.7 6.5 11.1 0.4 1.8 1.9 0.2 5.0 1.0 1.0 1.7 1.0 2.0 0.3 1.0 0.5 7.2 0.2 17.0 0.9 0.7 4.9 3.2 2.9 4.1 2.1 1.9 2.7 3.9 4.3 4.6 ABHD16B "C20orf135, dJ591C20.1" ENSG00000183260 "Abhydrolase domain containing 16B" Q9H3Z7 20 63861498-63862988 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 13.3;PC-3: 16.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059272 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059272: " 4.3 3.6 3.0 5.3 3.8 2.0 1.1 0.6 3.0 1.3 1.9 4.1 2.3 0.0 2.9 2.2 0.9 2.2 1.9 2.0 2.6 2.0 2.2 3.4 1.5 2.3 4.8 0.0 3.2 1.3 2.9 0.0 3.6 0.0 3.1 2.4 3.4 0.0 1.2 7.4 5.0 9.0 2.0 0.0 1.4 1.5 1.8 1.6 6.3 1.8 0.4 2.0 1.6 4.0 2.7 0.5 1.1 0.0 0.0 6.2 4.8 0.0 0.0 0.0 13.3 5.3 3.7 4.0 0.0 10.5 0.0 0.0 0.0 2.5 3.2 2.4 4.6 9.6 0.0 1.4 6.8 0.0 0.0 0.0 0.0 0.0 4.5 4.4 0.0 6.9 2.2 3.9 1.1 16.0 4.7 0.6 1.4 0.0 2.8 1.9 1.6 4.5 2.6 0.6 5.3 0.6 1.6 2.9 5.0 1.5 2.0 3.6 2.1 2.5 2.1 1.5 2.0 0.3 1.8 6.3 1.9 1.2 1.2 0.8 0.7 1.5 1.5 1.8 1.5 1.1 0.8 0.4 0.8 1.6 2.0 1.6 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2" P08910 15 89087459-89202360 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEL: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 29.0;neutrophil: 22.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favourable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 13.2 24.8 14.8 9.5 19.3 15.6 11.7 25.2 23.4 10.7 16.1 12.0 6.5 23.4 18.2 34.7 9.0 12.1 32.2 24.5 12.2 11.3 11.8 76.4 22.2 11.2 11.1 14.8 13.1 28.3 11.2 18.1 5.6 19.8 22.9 9.6 22.6 11.8 10.0 19.3 7.5 18.5 11.4 8.3 14.2 35.8 42.9 7.6 7.7 8.6 8.1 12.1 13.5 10.4 1.1 3.0 29.0 7.0 4.7 3.5 2.5 8.0 15.5 3.8 4.1 7.5 10.2 2.1 5.4 16.2 5.2 4.9 3.9 14.0 2.3 6.3 6.7 10.7 8.4 6.6 7.3 12.0 3.8 83.5 3.6 2.9 3.9 5.7 19.7 5.2 4.7 18.5 11.9 6.3 7.4 7.2 14.2 3.3 3.5 1.4 1.7 4.6 5.1 8.0 17.4 6.9 12.6 6.6 9.9 10.3 4.9 8.6 5.4 4.5 9.6 18.3 6.2 6.6 13.6 5.9 11.7 2.7 14.9 5.3 14.2 3.1 5.6 29.0 1.6 4.8 0.9 1.1 1.5 1.5 3.0 1.1 1.4 1.5 22.7 4.7 7.0 2.4 3.5 2.5 14.8 19.3 25.2 23.4 12.2 11.3 11.1 14.8 19.8 7.6 ABHD3 LABH3 ENSG00000158201 "Abhydrolase domain containing 3" Q8WU67 18 21650897-21704805 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 54.1;RPMI-8226: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010729 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles" "Plasma membrane" "HPA010729: AB_1844449" "unprognostic (1.46e-1)" "unprognostic (4.61e-2)" "unprognostic (2.37e-2)" "unprognostic (3.52e-1)" "unprognostic (8.46e-2)" "unprognostic (3.14e-3)" "unprognostic (3.54e-3)" "unprognostic (1.52e-1)" "prognostic unfavourable (8.52e-4)" "unprognostic (6.21e-2)" "unprognostic (1.98e-1)" "unprognostic (6.37e-2)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (3.98e-2)" "unprognostic (4.58e-2)" 9.2 5.4 12.0 14.2 10.7 8.6 20.7 19.5 11.1 6.4 34.2 4.8 5.1 23.8 6.0 5.4 12.7 7.8 13.5 7.1 8.8 8.5 8.7 21.7 12.8 21.3 11.5 5.0 9.4 8.8 10.7 11.8 10.8 16.6 6.9 37.1 14.7 10.3 4.1 10.1 3.8 45.3 5.5 12.3 17.9 19.0 4.4 10.8 20.9 12.9 6.7 13.7 9.2 25.5 7.1 6.1 33.0 23.3 7.1 17.6 9.1 7.4 5.4 5.3 3.4 3.4 2.2 0.0 4.9 2.0 3.5 4.8 5.6 7.7 21.4 9.0 1.6 24.8 8.6 4.0 4.9 13.4 6.0 2.3 9.1 9.6 5.2 10.1 7.8 2.0 4.8 5.2 2.4 2.3 5.9 12.8 3.1 3.0 9.7 11.3 2.6 12.8 54.1 4.0 60.2 9.7 7.2 4.5 2.0 11.2 10.0 2.8 3.1 17.9 1.8 3.4 4.9 6.0 7.5 14.4 9.3 22.1 4.4 13.3 7.8 29.1 10.2 11.4 11.1 17.9 8.5 7.1 10.0 10.6 6.1 5.1 8.2 10.3 33.0 7.1 23.3 4.2 17.6 9.1 12.0 10.7 19.5 11.1 8.8 8.5 11.5 5.0 16.6 10.8 ABHD4 FLJ12816 ENSG00000100439 "Abhydrolase domain containing 4" Q8TB40 14 22598237-22613215 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000600 Uncertain Approved Nucleoplasm Nucleoplasm "HPA000600: AB_1078081" "unprognostic (5.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.68e-3)" "unprognostic (8.17e-2)" "unprognostic (1.17e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-3)" "unprognostic (3.69e-2)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.56e-2)" "unprognostic (5.18e-2)" "unprognostic (1.37e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" 17.2 24.9 12.8 6.4 14.5 10.0 20.5 12.3 13.9 19.4 14.7 21.4 37.5 13.4 26.0 26.2 28.6 14.4 22.4 16.4 14.1 10.4 23.9 17.0 13.6 8.7 18.9 12.9 15.4 11.4 14.8 12.2 15.9 15.5 19.3 12.8 22.2 13.9 35.5 17.9 14.2 26.3 22.8 18.5 11.9 18.5 45.0 16.4 5.1 25.1 11.1 14.7 23.2 20.7 3.8 2.8 18.6 4.2 4.4 6.0 3.4 8.0 13.5 5.5 5.0 44.8 16.3 5.3 3.6 18.5 9.1 17.0 8.1 12.9 0.7 9.6 15.8 15.7 3.5 9.4 7.5 5.9 1.2 3.0 9.4 26.8 20.5 0.4 10.9 20.6 7.4 11.9 10.2 9.3 2.2 14.7 8.3 4.4 0.2 0.4 6.7 9.8 2.2 4.9 3.3 10.6 8.6 0.3 1.1 24.3 8.7 9.3 3.4 0.9 6.6 4.0 5.5 6.4 1.4 15.9 8.2 0.2 3.0 0.6 3.1 18.6 4.2 6.6 6.0 3.2 5.0 3.8 3.9 3.9 2.8 2.4 1.3 2.6 17.4 4.4 2.9 0.4 2.3 3.4 12.8 14.5 12.3 13.0 14.1 10.4 18.9 12.9 15.5 16.4 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: " "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favourable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.1 8.0 1.2 5.3 15.1 2.7 14.0 5.6 5.1 5.9 8.1 4.2 2.9 4.0 0.5 3.1 6.3 5.4 2.5 5.3 6.9 2.7 3.4 5.4 5.8 5.1 1.0 18.4 2.6 11.6 5.4 2.7 3.3 4.1 9.4 4.8 1.6 7.0 0.4 3.9 17.7 2.6 2.4 9.1 9.1 2.9 7.0 2.8 6.2 3.4 11.6 2.3 2.8 3.5 4.3 4.7 10.6 6.6 2.8 8.0 0.2 11.0 10.3 5.8 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell line enhanced" "Detected in many" "PC-3: 27.9;U-266/70: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: " "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavourable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favourable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 5.4 14.7 24.7 6.0 23.6 6.4 3.7 20.3 34.0 4.6 5.4 4.1 6.1 4.6 5.9 3.7 3.9 6.2 5.4 6.8 22.0 17.5 6.1 12.4 7.3 6.5 12.3 17.1 9.3 11.0 11.4 9.1 8.9 9.0 7.9 1.6 8.5 12.6 11.6 11.4 6.8 3.6 4.6 4.6 7.7 6.5 19.6 6.9 4.8 6.6 3.2 3.8 4.8 4.6 1.3 6.0 5.6 4.8 3.2 3.6 1.7 11.2 3.2 1.7 6.5 2.2 0.7 17.7 2.3 3.1 2.5 3.2 2.8 7.7 0.8 3.2 1.8 1.5 1.6 4.0 0.5 13.2 10.9 3.7 4.9 4.8 7.2 0.2 5.2 2.0 2.4 4.2 0.5 1.8 3.2 6.5 1.0 0.5 4.4 0.6 3.1 27.9 6.7 5.2 3.2 2.2 1.1 2.0 11.1 5.1 1.7 7.0 7.1 6.4 1.1 2.3 5.1 11.8 4.0 21.3 16.0 4.0 7.9 4.4 2.1 0.1 4.8 5.6 2.5 3.7 1.7 0.7 3.6 2.1 6.0 1.3 2.9 2.6 3.0 3.2 4.0 2.9 2.5 1.7 24.7 23.6 20.3 34.0 22.0 17.5 12.3 17.1 9.0 6.9 ABI2 "ABI-2, ABI2B, AblBP3, AIP-1, argBPIA, SSH3BP2" ENSG00000138443 "Abl interactor 2" Q9NYB9 2 203328219-203447723 "Predicted intracellular proteins" "Host-virus interaction, Neurogenesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070567 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA070567: " "unprognostic (5.26e-3)" "unprognostic (5.26e-3)" "unprognostic (1.86e-1)" "unprognostic (4.11e-3)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (1.81e-3)" "unprognostic (7.05e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-3)" "unprognostic (6.19e-3)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.24e-2)" "unprognostic (2.94e-1)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" 8.6 11.6 28.8 7.7 41.8 2.8 12.8 24.4 50.7 17.2 11.5 18.7 8.4 5.1 23.3 16.1 10.5 19.4 11.4 25.1 26.0 24.0 17.8 6.3 13.4 6.4 19.1 30.2 24.3 6.5 18.6 21.5 15.9 17.6 16.4 9.5 11.7 7.1 20.3 5.9 6.4 6.9 21.2 18.8 10.2 6.9 22.2 16.8 11.6 22.2 3.2 7.3 10.2 8.4 1.7 13.8 0.4 3.7 3.9 5.3 3.4 7.4 11.6 41.7 26.2 9.9 17.0 9.1 13.1 11.7 11.4 13.2 10.7 14.2 0.0 9.0 15.3 8.3 18.9 13.8 22.8 3.7 10.8 18.9 12.5 8.3 15.1 8.1 8.6 12.0 6.6 20.8 16.2 21.1 13.3 16.9 20.0 13.6 20.3 7.7 21.6 26.0 13.4 21.1 1.3 11.7 7.8 16.8 22.0 2.5 7.7 14.6 10.1 9.4 15.6 21.0 17.8 11.3 14.2 12.0 10.9 10.4 22.6 3.4 13.3 0.2 1.5 0.0 3.8 1.7 4.1 1.7 4.3 4.4 4.3 1.7 5.3 4.5 0.4 3.9 3.7 13.8 4.6 3.4 28.8 41.8 24.4 45.2 26.0 24.0 19.1 30.2 17.6 16.8 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.2;HHSteC: 25.8;HSkMC: 29.7;hTERT-HME1: 29.7;TIME: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavourable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.3 1.5 0.0 0.0 13.1 25.2 0.0 5.1 14.3 2.9 5.2 0.0 5.1 0.0 0.8 6.4 0.1 0.0 6.0 5.8 0.0 0.0 0.0 0.3 0.1 25.8 0.0 0.0 29.7 1.6 10.5 29.7 13.1 0.0 2.3 17.1 2.8 0.0 0.0 0.0 20.2 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.8 0.4 0.0 32.9 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell line enhanced" "Detected in some" "Daudi: 19.2;HEK 293: 10.4;LHCN-M2: 12.9;RPMI-8226: 11.0;TIME: 21.3;U-251 MG: 21.5;U-698: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA053618: , HPA054824: " "unprognostic (1.69e-1)" "prognostic favourable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favourable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 19.2 0.3 0.1 0.1 2.1 0.0 0.4 5.9 10.4 0.0 0.2 0.0 0.4 2.3 6.8 0.2 0.0 0.1 6.8 0.0 0.0 0.0 12.9 0.8 0.0 2.6 0.1 0.1 0.1 0.0 11.0 0.1 0.2 0.2 0.3 0.1 0.0 1.0 6.0 3.0 21.3 0.1 0.2 2.1 21.5 0.0 0.2 15.7 1.0 4.2 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028682-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.9" "Cell line enhanced" "Detected in many" "HL-60: 71.8;NB-4: 76.3;U-937: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol 7400000 Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favourable (1.65e-6)" 12.2 4.2 12.0 25.5 10.1 23.1 22.1 1.8 19.0 6.5 28.4 2.4 10.6 22.6 10.3 43.8 23.5 6.0 10.9 7.9 15.1 7.1 29.0 26.8 14.0 39.0 5.5 10.3 5.1 9.5 10.3 9.3 12.9 4.8 8.2 26.9 4.3 19.9 9.7 2.3 12.8 35.5 7.1 5.1 45.6 13.7 20.1 5.0 60.2 13.2 19.2 26.0 23.0 9.0 17.1 37.2 30.5 82.9 24.6 48.8 51.8 11.0 5.9 15.2 14.2 6.0 9.5 16.6 8.8 6.3 6.6 13.7 13.1 12.9 0.0 16.1 8.7 16.8 13.3 19.0 7.8 29.3 24.6 43.1 3.3 4.5 8.8 71.8 19.8 8.5 16.0 8.9 7.4 34.8 5.4 15.1 19.0 23.2 44.7 76.3 18.2 11.6 28.9 9.4 3.4 17.9 32.7 34.0 3.7 6.0 16.8 27.5 6.7 53.9 25.8 4.3 3.6 8.8 15.6 8.2 23.4 3.0 5.4 74.2 12.5 30.5 31.7 18.9 29.8 55.8 46.1 15.3 48.8 38.1 33.8 17.1 47.7 44.3 8.6 24.6 82.9 37.2 43.5 51.8 12.0 10.1 1.8 19.0 15.1 7.1 5.5 10.3 4.8 5.0 AC003006.1 ENSG00000269026 19 57682045-57753575 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ: 2.0;HEK 293: 2.8;HL-60: 3.4;RT4: 2.7;U-266/84: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA068553 Approved Nucleoplasm Nucleoplasm "HPA068553: " "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (3.50e-1)" "unprognostic (1.43e-2)" "unprognostic (3.61e-1)" "unprognostic (4.82e-2)" "unprognostic (1.46e-1)" 2.4 1.3 1.3 3.2 1.9 1.7 2.3 7.7 1.6 1.8 2.0 2.4 3.4 3.0 3.0 2.0 1.4 2.3 2.1 2.0 1.5 1.2 1.3 1.9 1.5 4.4 1.3 0.7 5.2 4.4 1.2 2.3 1.7 1.5 1.6 1.2 2.2 4.5 3.5 3.4 2.0 1.4 2.5 1.9 2.8 3.4 8.1 1.9 5.6 2.5 1.6 4.2 2.8 2.0 1.6 1.1 1.7 1.3 4.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.7 0.0 1.6 0.0 0.4 0.6 0.0 0.0 0.7 0.7 0.0 0.8 2.8 0.7 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.7 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.3 0.0 5.3 2.0 0.0 0.0 0.0 0.3 1.3 0.6 0.4 0.0 1.3 1.6 0.7 1.5 0.5 1.0 1.1 0.5 1.7 4.0 0.2 1.1 0.6 0.2 1.3 1.9 7.7 1.6 1.5 1.2 1.3 0.7 1.5 1.9 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Cell line enhanced" "Detected in some" "A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.4 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 3.4 0.0 0.5 0.0 0.9 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.6 3.4 0.0 0.8 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 AC023509.3 ENSG00000267281 12 53506688-53625979 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA003384 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (1.14e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (1.38e-2)" "unprognostic (1.94e-1)" "unprognostic (8.37e-4)" "unprognostic (6.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.08e-5)" "unprognostic (1.91e-2)" "unprognostic (2.26e-7)" "unprognostic (9.21e-2)" "unprognostic (2.50e-1)" "unprognostic (3.72e-1)" "unprognostic (9.77e-3)" 4.5 2.4 3.9 2.0 6.0 4.5 4.6 14.9 5.2 3.3 2.7 7.8 2.1 1.4 4.5 1.8 3.2 3.6 3.8 3.7 4.4 2.8 2.4 3.8 7.0 3.6 6.8 2.3 5.1 3.5 1.4 3.6 2.9 5.1 3.3 3.5 3.1 3.0 4.3 4.5 3.4 2.4 5.7 4.7 2.9 3.1 4.7 6.6 1.9 2.4 1.7 4.1 5.9 2.5 0.7 1.4 2.9 2.2 0.2 2.5 0.5 0.6 4.4 0.0 0.5 1.8 2.3 0.0 0.0 1.4 1.6 0.3 0.5 0.7 1.7 0.4 0.0 1.4 0.3 1.2 1.3 1.8 0.9 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.5 0.9 0.0 1.9 0.0 1.8 0.0 0.0 0.0 0.2 0.8 0.7 0.3 0.0 0.5 0.0 0.2 0.0 1.4 0.0 0.0 0.3 2.3 1.8 0.0 0.6 0.6 0.0 0.3 0.0 0.6 1.5 0.8 0.9 0.0 2.9 1.7 0.5 2.5 2.2 0.5 0.2 0.2 0.4 0.9 0.7 0.0 0.4 2.4 0.2 0.0 1.4 0.3 0.5 3.9 6.0 14.9 5.2 4.4 2.8 6.8 2.3 5.1 6.6 AC073610.3 ENSG00000272822 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 27.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA068942 Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA068942: " "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 6.8 3.4 10.5 2.2 20.7 3.6 4.6 7.7 27.5 6.4 4.9 6.3 2.6 2.2 9.7 7.3 5.1 4.7 7.6 7.2 8.8 7.2 5.0 4.1 5.5 5.5 5.7 13.7 6.1 7.4 2.2 5.3 3.3 10.6 5.4 4.6 3.5 4.8 4.5 3.4 4.4 4.2 10.6 4.6 4.7 4.0 8.4 4.3 3.3 5.0 2.3 4.4 4.9 3.9 0.8 1.8 1.1 1.1 1.3 3.2 2.0 1.1 0.4 4.0 3.1 4.3 1.7 0.0 1.7 8.3 2.4 1.1 0.0 1.2 1.2 2.5 1.5 0.4 1.5 0.0 2.3 5.4 0.7 1.1 0.7 0.0 3.0 0.0 1.1 0.5 2.1 0.7 1.4 1.1 0.1 1.5 1.4 0.5 0.2 0.6 0.0 1.2 2.3 0.7 0.2 0.2 0.3 2.0 0.6 1.0 0.8 0.9 0.2 0.6 4.6 0.8 0.5 0.2 0.5 2.1 0.3 0.8 1.9 1.2 0.4 0.9 1.1 0.3 2.7 0.4 3.2 0.6 0.9 1.8 0.9 0.8 2.3 2.6 1.1 1.3 0.4 1.8 0.5 2.0 10.5 20.7 7.7 27.5 8.8 7.2 5.7 13.7 10.6 4.3 AC073896.1 ENSG00000144785 12 56285916-56316059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA038466, HPA068007" Uncertain Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA038466: AB_10672646, HPA068007: " "unprognostic (3.07e-2)" "unprognostic (9.89e-3)" "unprognostic (8.23e-2)" "unprognostic (3.45e-2)" "unprognostic (8.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.13e-1)" "unprognostic (1.38e-1)" "unprognostic (3.74e-3)" "unprognostic (2.83e-1)" "unprognostic (1.04e-1)" "unprognostic (9.26e-4)" "unprognostic (2.22e-1)" "unprognostic (3.01e-1)" "unprognostic (1.93e-1)" 6.4 12.2 6.7 7.8 7.4 4.5 5.4 12.4 13.6 7.2 20.3 7.2 13.3 15.3 6.5 10.9 6.9 5.7 5.9 8.3 5.0 5.5 8.5 18.1 5.3 5.1 6.4 6.6 8.5 20.5 6.9 12.5 13.2 6.6 7.1 4.8 5.6 15.5 10.9 8.6 5.9 8.3 2.9 7.5 10.6 10.0 5.8 6.1 3.4 12.5 4.3 4.6 5.4 4.8 22.5 19.3 7.9 13.2 9.7 12.5 18.8 6.4 3.7 4.8 6.6 2.9 1.9 5.1 9.6 3.0 3.2 1.8 0.8 5.5 3.0 22.4 2.3 14.2 6.2 1.0 2.0 7.7 4.3 1.0 4.4 2.8 0.2 7.4 11.6 3.4 0.4 2.4 0.2 3.9 2.7 3.3 1.6 1.8 4.0 4.0 14.1 11.1 18.3 6.9 4.7 0.6 1.7 8.3 11.1 2.8 9.5 9.3 5.0 15.2 0.0 8.8 5.7 4.9 14.1 10.9 25.3 7.6 15.0 6.4 10.9 7.9 7.6 4.1 12.4 13.2 10.0 22.5 7.7 12.5 15.1 19.0 9.0 11.8 1.6 9.7 6.6 19.3 11.4 18.8 6.7 7.4 12.4 8.3 5.0 5.5 6.4 6.6 6.6 6.1 AC116366.3 ENSG00000283782 5 132410832-132646079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA052291 Approved Approved Nucleoplasm Nucleoplasm "HPA052291: " 4.8 4.8 2.6 11.9 4.4 1.9 5.3 4.2 6.0 6.3 6.3 4.0 6.0 5.6 4.2 7.0 3.2 4.9 7.4 4.0 3.2 5.8 6.5 10.4 9.8 4.1 2.8 8.6 3.4 5.7 6.3 3.5 3.9 5.6 4.7 6.2 4.3 5.8 4.7 1.7 8.0 6.1 4.4 9.3 4.6 1.9 4.7 7.6 5.7 2.4 9.6 4.4 8.3 5.0 3.5 7.4 3.1 5.1 9.0 3.7 3.4 0.2 1.0 1.5 8.4 8.8 4.5 3.5 3.4 6.4 6.1 0.2 7.3 2.9 2.0 4.2 2.3 4.8 0.9 5.7 6.2 0.7 4.1 0.9 0.7 12.4 2.5 2.6 4.9 1.8 4.4 9.3 4.5 0.7 7.9 7.4 0.1 7.7 3.0 2.1 1.2 7.3 3.6 9.9 1.8 0.6 1.5 1.5 2.2 1.7 3.0 0.2 3.4 5.7 2.9 1.8 2.0 1.9 11.0 5.7 3.6 3.5 8.1 1.6 3.8 1.9 7.4 9.0 3.1 5.0 5.0 4.9 6.4 1.1 5.0 5.4 6.2 4.9 5.1 2.8 3.5 5.7 3.7 AC131097.2 ENSG00000216921 2 241893985-241902551 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "pancreas: 27.6;tongue: 59.2" "Cell line enhanced" "Detected in some" "MCF7: 1.9;REH: 6.5;SCLC-21H: 4.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA073342 Approved Nucleoplasm Nucleoplasm "HPA073342: " "unprognostic (9.31e-2)" "unprognostic (4.59e-2)" "unprognostic (1.61e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (3.12e-1)" "unprognostic (2.93e-2)" "unprognostic (4.75e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (5.12e-2)" "unprognostic (5.44e-2)" "unprognostic (8.45e-2)" "unprognostic (2.44e-1)" "unprognostic (3.29e-1)" 2.7 0.3 4.9 0.6 4.4 0.2 1.6 1.7 2.4 0.8 0.6 0.6 0.6 0.1 0.6 0.6 3.8 0.5 0.9 0.6 2.1 2.3 0.6 0.6 0.6 0.6 3.9 0.6 1.4 27.6 0.0 0.6 0.6 0.6 2.6 0.0 0.6 4.4 4.0 3.7 2.6 0.6 0.6 0.6 0.6 0.1 0.8 0.6 1.1 6.4 59.2 2.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.9 1.5 0.2 0.5 0.0 6.5 0.0 0.6 0.0 0.0 4.2 0.2 0.0 0.6 0.0 0.0 1.0 1.2 0.0 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.4 1.7 2.4 2.1 2.3 3.9 0.6 0.6 0.6 AC138696.1 ENSG00000264668 8 143247110-143276403 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: " "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 3.6 4.8 6.2 2.5 4.4 1.5 2.5 5.8 7.3 3.3 3.8 4.7 2.5 2.6 5.7 2.7 2.8 7.8 2.0 2.7 6.2 4.8 2.6 1.9 2.7 2.5 4.8 3.0 5.8 6.8 4.6 4.5 2.2 4.2 3.0 2.2 3.8 3.6 3.9 4.7 1.8 3.1 3.2 3.7 2.7 2.7 3.5 3.6 1.5 2.7 1.5 2.6 3.6 4.4 0.6 0.6 0.0 0.2 0.9 2.1 0.1 1.3 0.0 0.0 0.8 4.7 0.3 0.5 1.3 3.0 1.5 0.6 0.0 1.8 0.2 0.8 0.3 0.7 0.0 0.6 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.3 0.6 2.8 1.2 0.0 1.0 0.9 0.0 0.1 0.0 0.0 3.2 0.0 3.0 0.9 1.6 2.8 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.9 0.9 0.0 0.0 0.7 2.9 0.1 2.2 0.7 1.6 1.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.9 0.2 0.6 0.3 0.1 6.2 4.4 5.8 7.3 6.2 4.8 4.8 3.0 4.2 3.6 AC138894.1 ENSG00000261832 16 28456371-28492098 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;BEWO: 1.2;hTCEpi: 3.3;NB-4: 1.4;REH: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA053611 Uncertain Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.93e-3)" "unprognostic (8.88e-3)" "unprognostic (4.33e-3)" "unprognostic (2.66e-1)" "unprognostic (3.59e-1)" "unprognostic (9.85e-2)" "unprognostic (3.82e-4)" "unprognostic (3.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (6.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.37e-1)" "unprognostic (3.74e-1)" 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.3 0.5 0.0 0.1 0.0 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.4 0.4 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.3 0.3 0.0 0.0 0.2 0.0 AC138969.1 ENSG00000183889 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 16317444-16350590 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 63.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.3;T-cells: 2.7" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.91e-1)" "unprognostic (3.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (8.96e-2)" "unprognostic (2.31e-2)" "unprognostic (3.69e-3)" "unprognostic (1.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.45e-7)" "unprognostic (1.22e-2)" "unprognostic (5.04e-6)" "unprognostic (6.04e-2)" "unprognostic (9.80e-2)" "unprognostic (1.79e-1)" "unprognostic (2.22e-3)" 5.2 6.4 9.8 2.9 7.1 6.5 5.5 35.6 12.6 4.6 9.3 2.7 11.3 17.9 7.0 10.9 9.9 5.5 11.0 9.0 4.6 4.5 6.3 5.3 5.9 16.4 5.6 12.2 17.9 3.3 7.4 11.0 5.4 8.5 10.1 19.0 5.0 12.5 4.4 6.2 5.0 7.4 6.6 7.3 4.4 4.9 4.3 0.8 0.4 0.7 0.2 2.7 0.7 7.8 5.6 15.4 14.5 22.1 20.9 10.8 15.9 7.9 8.5 11.3 3.9 4.7 6.4 15.3 17.5 13.8 9.7 6.6 12.8 2.5 9.2 14.8 38.4 25.4 22.7 9.3 63.0 19.4 42.3 13.3 22.3 5.4 5.4 21.5 12.4 13.2 15.0 34.7 7.1 3.8 18.3 6.3 6.4 13.4 26.1 9.7 10.1 7.8 11.8 25.5 12.5 28.6 3.7 13.3 7.9 8.2 6.0 9.9 17.8 12.1 7.5 10.1 6.8 0.0 0.7 0.4 2.7 0.1 0.8 4.3 2.0 2.3 0.1 1.1 1.5 0.6 0.0 0.2 0.6 0.8 1.1 0.7 AC240274.1 ENSG00000271254 Unmapped 4612-29626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " 1.1 5.4 0.7 0.5 1.0 1.0 1.6 3.1 2.3 2.6 1.7 0.8 2.9 1.4 0.3 2.0 0.4 1.4 0.0 5.4 0.0 7.0 1.8 1.3 3.5 1.0 0.8 0.7 1.1 3.9 2.3 1.2 0.5 6.9 1.3 0.2 0.7 2.1 1.4 2.7 2.1 6.4 3.1 0.9 10.9 14.6 16.5 11.7 5.5 6.1 3.7 16.6 10.1 15.5 13.1 5.3 4.3 8.6 1.3 15.2 6.2 6.3 3.1 21.1 5.7 13.0 2.3 8.0 7.2 7.5 7.4 5.1 4.0 4.5 8.8 7.1 4.3 10.3 3.0 6.0 15.0 9.1 3.2 2.6 35.4 16.5 10.6 1.2 3.7 6.1 12.3 20.0 16.4 13.9 6.8 12.5 2.2 5.8 9.6 9.9 23.8 7.4 3.5 11.9 7.3 2.3 11.5 3.4 2.7 1.7 2.7 1.7 2.1 3.1 1.5 1.0 1.1 0.7 2.1 1.8 1.9 2.0 6.4 1.5 1.4 0.1 0.9 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell line enhanced" "Detected in many" "HMC-1: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Mitochondria 15000 Mitochondria Nucleoplasm "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favourable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favourable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favourable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.3 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 3.3 4.3 1.3 0.5 10.5 5.3 5.2 2.2 12.0 6.2 0.4 23.7 10.3 2.0 1.7 0.1 4.0 4.2 0.0 1.7 4.2 7.2 12.0 1.3 3.0 5.4 2.7 1.4 7.3 11.6 0.7 4.0 6.2 0.0 9.9 5.0 8.2 4.4 0.1 3.1 3.0 0.6 10.1 5.7 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol 19000000 "Nucleoli, Mitochondria" "Nucleoplasm, Cytosol" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favourable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.2 31.9 13.1 18.0 56.6 20.8 24.8 24.5 34.1 28.0 17.4 12.9 30.2 17.8 20.5 51.4 25.7 8.8 26.8 24.8 56.5 9.0 9.5 22.7 19.6 27.2 9.0 24.8 23.2 24.6 23.4 36.9 25.1 12.2 21.8 44.9 12.6 9.4 10.9 6.2 12.6 13.1 14.5 42.4 62.2 30.4 3.5 8.6 34.6 44.0 20.1 20.2 13.9 25.0 24.8 18.6 12.5 23.9 20.4 9.5 0.9 45.6 16.0 18.0 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292376-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA049317: , HPA058381: " "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 8.7 7.8 16.4 4.2 24.5 10.4 7.3 42.0 23.6 6.4 6.4 11.5 4.3 7.9 5.9 4.2 10.6 3.7 5.1 7.9 19.5 8.7 4.8 4.9 4.7 4.0 13.0 15.4 5.5 8.2 5.1 11.2 4.3 10.4 5.8 3.4 5.6 14.6 7.7 14.2 26.5 7.7 11.8 8.1 6.0 8.0 3.1 12.8 3.1 2.7 4.5 3.5 5.6 6.4 0.9 1.2 1.5 2.0 0.0 1.4 0.7 5.2 5.9 2.7 4.7 7.0 4.8 2.9 13.3 4.3 3.8 3.0 7.5 4.6 5.8 6.9 7.4 12.1 2.7 3.6 0.9 6.4 11.8 2.4 21.9 14.0 4.8 4.9 6.1 3.3 2.9 3.2 2.0 1.8 6.7 8.0 4.3 7.3 10.3 7.1 2.9 13.8 10.0 6.3 22.3 2.3 2.9 21.0 14.8 7.9 5.0 12.5 5.3 3.8 5.8 7.1 5.0 5.7 4.6 6.5 4.7 5.0 9.9 13.1 3.1 0.0 1.4 1.5 1.3 2.0 0.0 0.9 1.0 0.6 1.2 0.8 1.4 1.2 0.2 0.0 1.4 1.0 0.5 0.7 16.4 24.5 42.0 22.1 19.5 8.7 13.0 15.4 10.4 12.8 ACAT2 ENSG00000120437 "Acetyl-CoA acetyltransferase 2" Q9BWD1 6 159760328-159779055 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 20.4;liver: 31.0" "Cell line enhanced" "Detected in all" "HBEC3-KT: 48.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021106, HPA025736, HPA025765, HPA025811" Enhanced Supported Nucleoplasm,Cytosol 16000000 Cytosol Nucleoplasm "CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488" "unprognostic (3.31e-1)" "unprognostic (2.44e-2)" "prognostic favourable (1.12e-4)" "prognostic unfavourable (7.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" "unprognostic (9.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (7.38e-4)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (8.56e-2)" "unprognostic (2.54e-2)" 1.6 2.6 2.7 1.5 1.7 1.6 2.2 2.2 6.3 2.1 4.3 3.2 1.4 4.8 5.7 1.0 0.7 0.7 2.9 3.6 3.0 31.0 1.8 2.5 2.9 2.1 0.7 1.3 1.2 0.9 4.2 3.9 2.3 0.5 0.1 2.4 1.6 1.4 5.1 1.1 1.7 6.6 0.9 4.2 1.1 2.6 13.3 9.5 12.3 8.4 10.0 20.4 12.2 6.9 6.5 44.3 16.9 6.3 11.8 1.5 6.2 7.3 14.7 25.4 25.4 8.9 5.9 3.1 4.8 6.7 18.3 48.0 17.4 3.5 18.8 13.6 10.6 42.2 6.4 7.8 3.7 6.4 3.5 24.2 10.4 7.1 14.6 9.9 8.9 12.4 13.5 12.5 14.9 4.8 8.4 9.9 18.0 34.2 9.1 11.9 6.7 7.1 4.6 2.4 8.9 15.7 4.4 5.4 4.7 7.6 15.8 4.7 8.7 14.4 1.6 15.5 8.1 6.1 7.1 12.3 13.9 8.4 13.7 13.3 15.9 13.8 9.5 13.3 16.0 12.3 3.2 10.0 5.6 8.7 20.4 12.2 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA051772: " "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favourable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favourable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favourable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.7 1.5 3.3 2.7 5.2 4.1 2.2 4.8 3.7 7.3 4.5 8.4 6.4 5.8 3.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 3.6 2.0 10.2 1.8 4.0 4.4 1.6 0.2 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 15.7 2.3 1.3 0.9 2.9 1.4 1.4 16.1 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 6.5 7.5 7.3 9.7 7.7 9.1 7.1 17.4 8.1 8.0 5.2 6.5 9.6 5.8 8.6 7.6 5.4 6.0 7.1 8.9 6.6 6.8 5.5 6.8 11.2 6.1 7.9 10.5 9.7 6.8 10.5 11.3 5.8 6.8 5.0 6.5 7.2 7.6 9.5 6.3 5.2 7.8 4.0 6.8 6.1 18.2 7.3 8.1 8.1 7.7 7.1 7.6 6.9 11.5 14.5 2.7 13.3 16.4 10.9 7.7 20.9 15.6 13.5 9.9 9.4 16.4 28.1 9.7 19.5 16.8 15.3 22.0 15.4 18.5 20.1 9.5 15.1 9.9 17.9 10.7 14.0 19.2 14.6 14.1 12.5 24.2 24.9 13.2 14.8 25.5 10.5 16.5 18.8 22.8 15.1 13.5 19.0 21.3 23.6 14.8 7.4 21.5 11.2 35.5 14.3 10.9 21.2 27.0 12.9 21.7 12.9 22.8 18.7 15.1 12.6 15.1 15.4 20.8 31.9 16.5 42.1 13.8 15.4 14.9 1.9 8.4 2.7 9.3 13.3 10.7 11.5 8.0 7.9 14.5 8.8 10.0 10.9 0.6 16.4 10.0 11.8 7.4 7.7 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Cell line enhanced" "Detected in some" "BEWO: 31.4;HEL: 10.0;SK-BR-3: 16.8;U-937: 6.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Low region specificity" "Detected in all" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: " "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.4 0.1 31.4 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.0 0.2 1.7 0.0 0.1 1.1 0.3 0.3 0.0 0.0 0.0 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 4.4 0.1 0.1 0.7 16.8 0.0 1.6 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 6.4 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81330005-81394179 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 49.6" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;CACO-2: 2.4;Karpas-707: 1.8;SK-MEL-30: 4.1" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037723, HPA037724" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037723: AB_10672606, HPA037724: " "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favourable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.2 49.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.4 0.1 0.0 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavourable (2.31e-5)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.4 20.4 20.2 21.7 4.6 7.7 7.6 20.2 10.5 30.0 18.0 70.5 7.6 28.7 14.9 16.4 23.2 32.5 54.0 11.3 25.2 28.4 15.1 16.2 24.9 19.0 17.6 12.6 6.8 10.3 24.8 29.4 16.8 12.3 6.2 15.8 27.3 36.8 18.7 10.1 47.4 44.1 23.2 19.4 16.8 9.0 11.0 31.3 18.2 28.0 64.4 9.9 8.3 27.2 27.3 16.0 27.1 31.9 5.2 21.4 40.4 17.3 30.9 16.6 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 ACOT9 "ACATE2, CGI-16, MT-ACT48" ENSG00000123130 "Acyl-CoA thioesterase 9" Q9Y305 X 23702253-23766475 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035533 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA035533: AB_10696506" "unprognostic (5.69e-2)" "unprognostic (6.34e-2)" "unprognostic (1.59e-1)" "unprognostic (2.09e-1)" "unprognostic (1.53e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (1.12e-1)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (9.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.15e-3)" "unprognostic (6.53e-2)" "unprognostic (1.68e-1)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" 19.1 15.9 6.3 14.1 7.7 10.5 29.2 6.5 13.6 15.4 16.3 5.4 17.6 11.5 21.2 16.1 12.0 14.5 15.5 35.7 5.7 7.7 12.8 15.5 23.6 36.0 7.3 8.6 13.4 16.6 9.1 7.8 13.3 12.7 12.8 12.7 13.9 16.3 23.0 28.8 10.4 12.5 35.7 13.8 15.8 15.0 7.1 4.5 3.8 15.1 11.4 9.7 15.9 14.4 5.5 16.4 11.1 26.5 6.0 10.0 8.4 26.4 18.1 7.9 17.4 13.0 14.8 4.0 21.0 18.3 20.9 20.3 16.0 24.0 1.3 13.5 23.4 16.2 9.9 26.8 29.1 6.2 15.1 9.0 19.0 11.6 17.5 3.5 11.4 13.1 18.3 24.4 27.8 30.4 5.7 9.1 22.5 9.2 4.8 8.5 11.5 22.1 5.1 30.1 11.2 24.7 9.9 1.5 7.6 22.8 9.6 13.5 10.8 4.6 28.2 17.4 11.6 25.2 11.4 2.2 5.2 0.1 12.9 3.5 14.7 9.1 16.1 11.1 5.6 22.2 7.6 5.5 7.0 6.3 16.4 4.6 2.3 5.3 8.4 6.0 26.5 2.8 10.0 8.4 6.3 7.7 6.5 13.6 5.7 7.7 7.3 8.6 12.7 4.5 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol 3700000 Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 22.3 59.7 38.0 20.8 40.3 38.0 33.0 27.9 43.7 23.1 29.7 27.4 24.4 31.1 25.2 36.2 24.8 29.5 26.9 27.4 34.6 33.7 42.1 54.8 24.7 29.4 31.5 34.6 33.7 53.0 28.4 43.9 39.7 39.7 27.0 32.8 28.5 46.0 23.8 35.4 21.6 34.5 24.2 28.6 28.1 34.2 38.3 21.2 33.0 32.5 32.8 29.8 22.7 20.3 33.9 20.3 17.3 23.0 35.3 41.0 33.1 17.6 26.4 41.1 22.6 18.7 18.7 33.5 21.5 22.9 21.5 19.1 36.1 17.8 11.1 16.8 20.1 17.4 39.9 23.3 19.4 27.0 40.7 32.5 23.9 79.1 25.9 36.9 18.7 19.0 21.3 20.1 24.9 24.4 32.8 21.7 25.4 24.0 39.7 35.7 49.7 29.8 26.3 41.8 25.4 33.6 25.3 44.9 44.5 13.4 31.7 43.0 18.8 19.8 20.1 23.7 15.8 19.5 32.4 29.5 58.6 34.7 28.1 32.0 27.9 17.3 19.8 17.1 30.1 22.7 39.7 33.9 34.3 34.4 17.7 31.1 41.0 39.7 3.5 35.3 23.0 20.3 35.6 33.1 38.0 40.3 27.9 43.7 34.6 33.7 31.5 34.6 39.7 21.2 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Cell line enhanced" "Detected in some" "HEL: 5.4;HMC-1: 7.2;U-266/70: 16.0;U-266/84: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.8 2.7 0.9 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.0 0.5 0.0 0.2 0.6 0.0 5.4 0.6 0.0 2.0 0.1 7.2 0.1 3.6 1.0 0.1 0.6 3.6 0.0 0.1 0.4 0.2 1.9 1.6 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.1 0.0 0.7 1.2 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.0 10.5 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell line enhanced" "Detected in many" "RT4: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Cytosol" Microtubules "HPA024693: " "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favourable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.4 5.0 15.3 2.3 3.4 5.0 9.8 12.2 18.4 6.0 5.1 2.8 5.8 1.8 11.3 6.0 7.5 4.4 10.3 1.5 21.7 4.6 1.3 9.6 22.1 17.4 6.4 0.8 6.8 1.2 3.4 5.4 11.6 3.1 4.1 0.4 4.6 7.8 1.9 15.1 1.6 37.5 8.5 4.6 4.5 6.8 4.7 6.0 8.8 5.1 9.1 2.8 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: , HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favourable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.4 0.2 0.2 0.0 0.8 0.1 1.0 0.3 2.2 0.0 0.1 10.4 42.4 14.0 2.6 0.5 0.1 0.0 0.0 0.2 11.6 0.0 10.9 0.4 18.1 2.8 16.9 18.5 1.9 0.0 0.2 0.0 0.8 0.0 6.3 0.0 0.0 0.0 7.8 0.0 0.4 3.8 0.0 8.5 1.1 43.4 0.0 0.2 16.9 6.5 0.0 0.0 9.5 12.3 0.1 0.1 0.7 0.7 4.6 0.0 6.8 0.3 21.2 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 57.4" "Cell line enhanced" "Detected in many" "ASC diff: 15.6;HSkMC: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 1.2;T-cells: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035817, HPA035818" Approved Approved Nucleoplasm Nucleoplasm "HPA035817: AB_10671938, HPA035818: " "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavourable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.0 0.7 0.9 0.4 1.1 0.5 1.5 2.4 1.3 1.0 0.5 0.5 1.3 0.7 0.7 1.4 0.6 1.4 0.5 0.7 0.7 0.9 1.8 1.7 0.7 0.6 1.0 0.4 1.1 0.3 0.8 1.0 0.7 1.1 1.0 0.4 0.6 0.5 1.3 0.7 0.3 0.5 1.0 0.6 0.1 0.8 57.4 0.7 0.2 1.0 0.1 0.5 1.5 3.1 1.2 0.5 0.0 0.0 0.0 3.4 0.4 3.5 2.1 0.1 1.1 15.6 5.0 0.0 4.3 2.5 2.7 2.3 0.0 4.5 0.0 6.0 4.8 2.3 1.2 2.0 2.8 2.6 1.5 8.2 1.8 0.4 2.6 0.9 0.7 10.1 0.5 3.3 0.6 4.8 0.0 0.0 4.7 1.8 0.3 0.1 3.8 4.5 0.6 0.0 0.1 2.8 0.9 2.8 2.0 5.1 1.3 0.1 2.2 3.6 2.1 0.0 0.0 2.2 0.0 0.5 0.2 0.2 1.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 3.4 1.2 0.0 1.1 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.9 1.1 2.4 1.3 0.7 0.9 1.0 0.4 1.1 0.7 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453851-38493142 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 16.6;NTERA-2: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007398, CAB025115, HPA040384" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "CAB025115: , HPA007398: , HPA040384: " "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 2.8 7.4 5.5 4.6 7.9 1.1 5.5 13.2 7.5 5.2 3.4 7.2 4.5 2.8 4.7 5.1 2.5 5.6 3.3 3.9 5.9 5.4 5.3 5.4 6.9 2.2 5.9 5.4 8.3 6.1 11.3 5.1 16.0 6.5 3.9 3.6 5.0 4.6 4.2 15.9 2.4 2.8 4.6 4.7 3.1 4.0 9.1 9.1 12.8 4.8 1.7 2.2 4.2 10.3 0.3 0.3 0.5 0.2 0.5 1.6 0.3 0.8 1.4 16.6 1.4 0.6 0.4 8.9 0.3 0.5 0.3 0.7 2.4 1.1 0.1 1.3 0.4 1.0 6.3 1.0 0.9 2.4 4.1 4.2 2.6 3.5 0.8 3.0 1.6 0.7 0.9 0.5 1.8 1.1 7.0 1.4 0.3 1.3 5.1 1.9 20.5 0.7 1.7 5.5 1.0 1.1 2.0 3.9 6.8 0.5 2.5 2.2 1.4 4.0 0.9 0.6 2.7 0.4 1.4 4.0 5.4 0.9 0.6 2.5 1.1 0.5 0.1 0.1 0.4 0.2 0.6 0.2 1.0 0.5 0.0 0.3 1.6 1.5 0.3 0.5 0.2 0.3 0.7 0.3 5.5 7.9 13.2 7.0 5.9 5.4 5.9 5.4 6.5 9.1 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053221-75069483 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol 92000 Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favourable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 8.7 27.4 23.0 13.9 20.4 12.7 16.2 24.0 25.2 10.6 14.9 14.8 14.3 11.3 10.2 26.9 11.6 21.4 7.1 10.8 19.9 30.2 12.2 5.2 10.9 17.6 28.7 19.3 9.1 7.0 8.9 38.2 10.4 24.4 10.0 19.8 9.4 9.7 12.9 22.3 24.4 11.3 11.4 27.5 10.9 14.0 16.7 22.9 8.3 20.2 10.3 19.0 7.5 12.0 10.6 7.6 12.3 6.6 10.0 17.8 5.1 24.6 13.6 19.6 12.0 8.0 9.3 10.9 14.2 5.5 14.4 20.6 13.7 27.8 27.3 8.7 5.9 22.3 12.9 6.3 23.7 39.6 15.9 17.7 35.8 9.7 4.7 11.1 18.5 5.1 9.1 20.0 10.3 19.0 13.9 33.0 19.0 16.9 24.9 20.8 6.0 13.7 20.0 25.9 12.7 20.4 13.1 36.0 14.6 9.7 6.6 22.0 14.7 11.0 8.9 9.9 18.4 19.9 15.2 7.9 15.9 28.6 15.1 13.1 10.6 3.9 2.2 12.3 8.6 4.3 9.7 10.0 14.5 9.9 3.8 10.6 12.2 11.3 0.9 10.0 6.6 7.6 17.8 5.1 23.0 20.4 24.0 25.2 19.9 30.2 28.7 19.3 24.4 22.9 ACYP2 ENSG00000170634 "Acylphosphatase 2" P14621 2 53970838-54305300 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 116.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035301 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA035301: AB_10670291" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (6.90e-3)" "unprognostic (6.21e-2)" "unprognostic (2.03e-3)" "unprognostic (3.17e-1)" "unprognostic (5.22e-2)" "unprognostic (7.83e-3)" "unprognostic (3.64e-3)" "unprognostic (1.16e-1)" "unprognostic (6.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (3.24e-1)" "unprognostic (2.24e-2)" 12.9 24.0 31.0 4.6 33.9 5.6 10.1 15.5 29.3 6.7 6.2 19.4 4.4 6.2 6.7 10.5 6.6 7.1 7.3 39.6 29.1 28.4 8.8 18.7 7.2 7.5 35.7 18.2 5.7 10.3 9.1 9.7 5.9 28.1 10.4 4.8 6.3 11.5 8.4 116.4 6.6 5.6 6.9 35.7 7.8 7.5 6.5 22.7 3.5 8.2 22.9 6.4 8.2 4.1 20.9 23.7 24.1 10.2 12.6 15.9 8.9 7.6 4.3 4.5 3.7 16.6 13.1 4.1 9.2 6.9 5.7 5.0 1.0 5.6 14.9 24.4 9.1 6.6 2.4 7.7 5.3 12.9 10.2 11.5 4.6 11.4 6.8 9.6 5.6 9.5 14.5 4.1 6.8 2.6 4.7 8.0 12.1 4.9 5.9 11.9 5.2 5.3 4.7 4.3 8.4 13.5 7.0 13.2 8.7 11.1 7.0 4.1 2.6 8.8 9.2 8.1 7.8 3.5 8.5 16.9 9.3 8.3 11.7 16.4 8.9 24.1 10.2 19.8 13.4 9.0 11.9 20.9 13.4 12.7 14.7 19.7 15.9 13.4 8.5 12.6 8.8 23.7 11.6 8.9 31.0 33.9 15.5 29.3 29.1 28.4 35.7 18.2 28.1 22.7 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell line enhanced" "Detected in some" "MCF7: 2.7;U-2 OS: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: " "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.3 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 0.1 0.2 0.5 1.3 2.7 0.4 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.3 0.9 0.4 0.2 0.3 0.0 1.1 0.0 0.0 2.6 3.7 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favourable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.6 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.2 3.3 0.0 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.9 0.1 0.0 0.3 0.1 0.0 0.0 6.2 0.2 0.0 0.8 0.4 1.2 0.1 0.1 0.3 1.7 2.5 0.5 3.3 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 3.3 4.9 9.1 2.1 0.5 0.2 0.1 4.7 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971589-100342005 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1" "Cell line enhanced" "Detected in some" "HEK 293: 12.0;RPMI-8226: 4.5;SK-BR-3: 4.6;SK-MEL-30: 5.9;WM-115: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" Nucleoplasm "HPA062487: " "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 1.2 2.0 3.6 2.7 3.1 1.5 1.9 0.7 4.5 1.9 2.1 2.9 6.4 2.5 4.9 1.9 5.1 2.9 1.9 2.2 3.4 1.6 2.2 15.7 10.5 2.0 1.6 1.0 3.0 12.2 0.3 3.5 1.6 1.7 1.9 2.1 2.7 8.3 4.7 13.5 5.0 2.8 6.6 2.1 2.5 3.6 4.0 2.0 20.1 1.9 2.7 2.1 2.7 2.1 0.1 0.0 1.4 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.2 2.2 0.4 0.0 0.0 12.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 1.0 3.6 0.7 0.4 1.8 0.0 1.1 4.5 0.0 0.4 3.8 0.8 0.5 4.6 5.9 0.0 0.6 0.7 0.0 1.6 1.1 0.1 0.7 0.0 0.0 0.0 0.9 5.5 1.4 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.0 0.1 0.5 0.5 0.4 0.2 0.1 0.0 0.0 0.1 3.6 3.1 0.7 4.5 3.4 1.6 1.6 1.0 1.7 2.0 ADAT2 "DEADC1, dJ20N2.1, TAD2" ENSG00000189007 "Adenosine deaminase, tRNA specific 2" Q7Z6V5 6 143422832-143450673 "Enzymes, Predicted intracellular proteins" "tRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035479 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA035479: AB_10611672" "unprognostic (2.24e-1)" "unprognostic (3.07e-3)" "unprognostic (1.55e-1)" "unprognostic (8.20e-2)" "unprognostic (3.05e-2)" "unprognostic (8.58e-2)" "unprognostic (1.07e-3)" "unprognostic (3.31e-2)" "unprognostic (1.34e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-2)" "unprognostic (9.28e-5)" "unprognostic (4.88e-2)" "unprognostic (6.96e-2)" "unprognostic (7.29e-2)" "unprognostic (4.08e-2)" 7.3 9.5 6.6 15.1 9.4 17.1 8.6 7.7 8.8 6.6 9.5 4.9 4.7 9.9 8.3 5.3 12.0 7.9 7.6 4.2 5.2 3.8 7.5 13.2 11.3 17.6 4.9 8.0 7.5 13.3 7.1 9.6 4.0 7.3 8.6 13.3 6.0 10.1 6.2 13.3 17.1 10.0 6.5 6.7 13.1 10.8 4.1 5.3 8.6 10.8 10.1 13.5 6.6 8.7 2.8 3.2 0.4 1.4 1.9 6.6 2.3 2.9 2.5 3.1 10.5 2.6 8.4 4.7 4.1 1.9 2.9 4.0 6.6 7.5 10.4 4.5 2.8 8.5 5.8 5.8 5.7 5.5 12.9 14.7 10.4 13.5 3.3 20.6 7.4 2.8 8.7 5.6 9.0 6.2 16.0 9.0 4.4 4.2 8.0 11.7 3.9 4.7 9.8 9.1 8.5 4.4 3.3 6.9 4.7 3.5 9.4 2.8 4.0 7.6 4.8 4.2 3.6 8.7 8.0 9.3 6.6 7.9 4.0 17.4 4.9 0.0 0.9 0.0 3.2 1.4 4.7 2.8 3.0 2.9 3.2 2.0 3.4 5.1 0.4 1.9 0.2 3.0 6.6 2.3 6.6 9.4 7.7 8.8 5.2 3.8 4.9 8.0 7.3 5.3 ADAT3 TAD3 ENSG00000213638 "Adenosine deaminase, tRNA specific 3" 19 1905378-1913447 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058899 Uncertain Approved Nucleoplasm Nucleoplasm "HPA058899: " "unprognostic (1.79e-1)" "unprognostic (7.99e-2)" "unprognostic (1.57e-1)" "unprognostic (3.61e-3)" "unprognostic (4.43e-2)" "prognostic favourable (6.13e-4)" "unprognostic (1.48e-4)" "unprognostic (2.18e-1)" "unprognostic (1.63e-1)" "unprognostic (1.38e-1)" "unprognostic (4.78e-3)" "unprognostic (5.27e-2)" "unprognostic (2.21e-2)" "prognostic favourable (6.98e-4)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "unprognostic (9.55e-3)" 6.5 7.4 4.7 5.6 7.9 5.0 6.5 7.3 10.6 4.5 12.4 18.2 7.7 31.0 6.0 7.4 12.1 7.3 7.1 4.4 4.8 3.7 9.4 7.8 6.2 4.4 8.1 4.9 8.7 7.5 3.4 8.6 9.0 10.4 8.3 5.3 7.8 16.1 7.0 5.4 18.3 20.5 3.0 12.5 8.9 15.6 5.5 7.3 3.1 8.8 3.3 6.5 3.2 7.7 2.2 14.0 0.3 1.3 4.9 2.6 0.7 4.8 1.3 0.7 1.0 0.4 0.0 6.1 1.8 0.3 0.7 1.0 2.0 1.5 2.8 0.7 0.2 3.2 0.2 0.2 0.0 6.9 12.7 0.7 2.8 2.5 0.3 1.2 9.1 0.0 0.2 0.8 0.0 0.6 7.9 1.6 0.4 1.0 2.3 4.1 6.7 8.7 7.7 1.2 4.6 0.8 1.2 2.8 6.6 2.1 5.1 2.3 4.0 1.0 1.5 0.7 2.9 2.5 3.7 2.8 2.5 2.5 0.6 1.3 1.6 0.3 1.3 0.0 1.6 0.6 1.6 1.0 2.3 2.5 1.8 2.2 1.7 2.6 0.3 4.9 1.1 14.0 2.3 0.7 4.7 7.9 7.3 10.6 4.8 3.7 8.1 4.9 10.4 7.3 ADCK1 FLJ39600 ENSG00000063761 "AarF domain containing kinase 1" Q86TW2 14 77800083-77935012 "Enzymes, Predicted secreted proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051012, HPA055014" Uncertain Approved Nucleoplasm "Secreted - unknown location" Nucleoplasm "HPA051012: , HPA055014: " "unprognostic (6.36e-2)" "unprognostic (7.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.76e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavourable (1.70e-4)" "prognostic favourable (4.11e-5)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (1.38e-1)" "prognostic favourable (5.82e-6)" "unprognostic (6.30e-3)" "unprognostic (2.06e-1)" "unprognostic (9.57e-2)" "unprognostic (4.06e-1)" 7.2 11.0 11.0 7.0 15.2 7.4 6.9 6.8 20.5 5.6 10.3 19.0 7.7 11.2 7.7 10.3 7.7 7.1 9.1 11.1 12.4 10.4 8.8 10.5 6.2 6.0 13.5 9.4 6.6 9.8 11.3 11.3 7.8 15.0 8.2 10.3 13.8 10.6 8.9 13.7 8.5 8.5 10.5 10.6 9.7 7.5 5.5 11.5 10.8 9.1 7.8 7.5 6.9 5.0 4.0 8.9 1.4 7.2 3.4 5.3 3.1 3.3 5.4 3.2 10.8 8.1 4.6 4.3 3.4 5.7 3.1 3.7 2.9 8.0 7.3 5.5 6.0 6.4 17.8 5.4 2.0 4.2 5.6 1.9 3.4 4.8 8.3 2.8 4.1 5.7 10.1 1.2 3.9 4.4 6.9 4.5 4.0 16.8 3.4 5.6 6.4 6.4 5.6 0.5 5.8 4.4 8.5 7.2 4.0 6.6 9.2 4.0 13.3 6.2 3.9 2.9 2.3 5.9 3.0 4.6 5.0 4.1 4.4 4.9 3.7 1.4 4.7 1.3 5.3 7.2 3.5 1.7 2.2 3.1 8.9 4.0 2.5 4.6 0.4 3.4 2.8 7.0 3.7 3.1 11.0 15.2 6.8 20.5 12.4 10.4 13.5 9.4 15.0 11.5 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell line enhanced" "Detected in some" "BJ: 5.0;fHDF/TERT166: 5.7;HeLa: 10.3;HHSteC: 6.6;HMC-1: 14.2;U-2 OS: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" HPA042395 Uncertain Approved Nucleoplasm,Cytosol 600000 "Nucleoplasm, Cytosol" "HPA042395: AB_10796906" "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.5 0.0 0.0 0.1 5.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.3 0.0 6.6 0.0 14.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.5 7.0 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell line enriched" "Detected in some" 6 "HMC-1: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "thalamus: 0.4" "Low region specificity" "Detected in single" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favourable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 ADNP "ADNP1, KIAA0784" ENSG00000101126 "Activity dependent neuroprotector homeobox" Q9H2P0 20 50888916-50931421 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006371 Supported Approved Nucleoplasm Nucleoplasm "HPA006371: AB_1078105" "unprognostic (3.40e-2)" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.68e-2)" "prognostic unfavourable (1.65e-5)" "unprognostic (1.73e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (3.63e-1)" "unprognostic (1.90e-2)" "unprognostic (1.08e-1)" 23.7 26.5 32.2 28.1 29.3 21.3 32.4 46.0 35.4 26.3 24.2 23.0 34.2 18.4 32.6 38.7 27.8 28.4 25.5 19.9 27.2 21.1 23.7 22.7 27.9 29.0 29.0 28.5 38.8 21.7 49.2 32.4 23.5 25.6 27.4 22.4 26.1 25.3 30.6 31.8 28.6 25.6 28.6 23.9 28.6 24.9 33.4 28.2 50.2 28.4 17.4 31.1 32.1 33.1 16.4 28.7 15.0 24.6 15.1 30.9 8.1 20.5 19.5 37.0 19.4 18.4 18.2 15.9 15.4 17.4 30.3 22.3 27.9 16.3 26.9 20.2 18.4 23.7 31.1 29.4 35.8 12.9 11.1 19.2 21.8 21.5 17.9 30.6 16.7 17.2 36.6 18.5 33.5 20.1 25.4 19.1 19.0 20.8 30.1 20.3 18.5 15.6 28.1 20.5 19.7 17.7 27.8 30.8 23.2 35.2 50.7 25.9 24.1 28.7 17.1 27.0 29.1 20.4 16.6 13.9 16.1 45.8 15.2 18.0 18.4 15.0 12.3 10.6 20.8 18.5 22.5 13.6 23.4 19.0 13.9 16.4 23.4 30.9 6.3 15.1 24.6 28.7 15.4 8.1 32.2 29.3 46.0 35.4 27.2 21.1 29.0 28.5 25.6 28.2 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 15.7;HEL: 11.3;HMC-1: 12.7;Karpas-707: 17.3;U-266/70: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB001701: , HPA036961: " "prognostic favourable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 14.3 8.5 2.3 10.9 4.6 2.5 14.8 1.2 2.4 7.1 6.2 4.7 14.6 1.9 7.9 6.2 5.0 5.4 6.6 8.4 2.3 2.4 5.1 5.5 17.4 18.9 3.7 2.7 3.6 11.9 8.1 2.8 23.0 4.0 6.3 3.9 6.8 6.5 14.5 19.7 3.1 6.4 8.8 4.7 13.6 5.1 4.1 3.6 5.3 7.4 5.8 12.0 7.1 6.9 8.2 8.0 13.3 13.0 3.4 9.6 4.9 1.5 2.0 0.4 0.0 1.7 1.9 0.0 1.4 0.3 1.2 1.6 0.6 1.3 0.4 0.6 2.1 0.1 1.4 0.0 1.1 15.7 0.1 11.3 0.2 0.0 2.7 0.0 12.7 2.8 0.0 0.6 0.0 4.9 1.0 17.3 7.4 0.5 0.0 2.7 4.7 3.9 0.0 5.6 0.7 0.7 0.6 0.3 0.0 0.0 0.1 4.2 3.0 7.0 4.0 0.0 0.8 3.1 0.3 16.9 3.7 0.0 2.1 0.0 3.1 7.8 13.0 13.3 0.6 12.0 0.6 8.2 1.4 1.3 8.0 4.9 0.2 0.6 0.4 3.4 9.2 7.0 9.6 4.9 2.3 4.6 1.2 2.4 2.3 2.4 3.7 2.7 4.0 3.6 ADPRHL1 ARH2 ENSG00000153531 "ADP-ribosylhydrolase like 1" Q8NDY3 13 113399610-113453524 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 89.6;skeletal muscle: 68.1" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.6;T-47d: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebellum: 2.6" "Low region specificity" "Detected in some" HPA066478 Enhanced Approved Nucleoplasm Nucleoplasm "HPA066478: " "unprognostic (3.03e-1)" "unprognostic (1.38e-2)" "unprognostic (2.31e-1)" "unprognostic (8.88e-3)" "unprognostic (1.50e-1)" "prognostic unfavourable (4.88e-4)" "prognostic unfavourable (2.55e-5)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.35e-1)" "unprognostic (2.56e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-2)" "unprognostic (1.53e-2)" "unprognostic (4.99e-3)" "unprognostic (1.02e-1)" 1.8 1.0 0.6 0.2 1.1 0.0 0.8 0.5 3.0 0.4 1.4 0.3 0.0 0.9 0.4 4.0 2.2 1.9 0.7 89.6 0.5 0.8 0.2 0.4 0.5 0.1 0.7 1.1 0.5 1.5 0.0 1.8 1.4 0.3 0.9 0.5 0.0 1.9 0.1 68.1 0.9 3.0 0.2 0.5 0.3 1.0 1.3 0.0 0.1 0.7 21.8 0.6 0.3 0.5 1.9 2.8 1.7 1.6 1.1 2.5 1.0 3.9 9.5 0.9 3.0 3.1 5.0 2.7 1.5 0.7 0.5 0.4 2.6 9.8 1.4 5.7 1.7 2.2 3.7 0.2 0.4 1.4 1.6 4.1 2.3 0.7 1.0 0.3 1.7 1.7 2.3 3.1 0.4 0.1 1.1 0.4 3.9 8.6 0.6 2.4 2.1 5.0 6.3 2.5 3.6 1.0 0.4 14.6 3.3 1.0 4.7 1.2 26.2 0.5 0.3 0.1 1.8 4.4 0.5 1.4 1.1 4.6 2.9 0.8 2.1 0.4 1.2 0.1 0.1 1.6 1.8 1.9 0.8 2.5 2.8 0.8 1.4 1.5 1.7 1.1 1.3 0.5 1.3 1.0 0.6 1.1 0.5 3.0 0.5 0.8 0.7 1.1 0.3 0.0 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;BJ: 46.1;BJ hTERT+: 30.4;fHDF/TERT166: 49.4;WM-115: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: , HPA063595: , HPA064970: " "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 35.0 12.4 0.2 46.1 30.4 5.2 1.1 0.0 0.0 1.2 5.1 49.4 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 2.3 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 16.6 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.2 0.1 3.3 8.1 0.0 21.4 0.1 0.0 0.2 0.2 24.3 0.1 0.0 28.3 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 121.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA069947: " "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.7 16.6 8.0 11.8 9.5 19.5 26.5 6.5 12.2 20.2 21.0 10.5 18.9 11.1 27.4 16.6 15.8 18.6 15.3 22.4 10.3 5.3 27.6 15.5 18.4 12.9 9.3 5.5 24.7 19.0 28.6 18.5 121.7 9.5 16.8 14.3 27.0 16.0 25.6 58.8 18.6 16.2 20.3 11.5 13.9 15.0 6.7 10.3 17.0 38.8 21.1 13.9 19.5 26.5 11.3 14.6 21.1 5.4 5.1 8.8 2.8 7.8 7.2 6.0 6.3 9.9 11.8 8.5 7.9 11.6 6.0 9.0 7.6 14.5 8.9 10.8 9.6 3.6 9.4 11.9 8.4 15.1 3.7 18.4 18.7 6.3 7.7 17.6 14.6 9.6 8.6 10.3 9.1 22.1 11.3 25.1 2.5 2.1 15.9 5.1 7.9 2.5 12.6 3.5 11.3 17.7 7.5 13.6 2.5 12.0 7.9 3.8 4.7 14.8 11.0 11.2 10.2 6.8 4.3 21.8 12.1 15.3 9.2 20.4 4.0 3.5 5.4 11.7 6.7 4.1 7.4 8.0 8.8 6.6 6.0 11.3 4.7 4.4 21.1 5.1 2.2 14.6 7.5 2.8 8.0 9.5 6.5 12.2 10.3 5.3 9.3 5.5 9.5 10.3 AGO3 "EIF2C3, FLJ12765, hAGO3" ENSG00000126070 "Argonaute 3, RISC catalytic component" Q9H9G7 1 35930718-36072500 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048342, HPA075436" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "HPA048342: , HPA075436: " "unprognostic (4.10e-2)" "unprognostic (7.10e-2)" "unprognostic (4.94e-2)" "prognostic unfavourable (5.70e-4)" "unprognostic (1.89e-2)" "unprognostic (2.12e-2)" "unprognostic (4.39e-4)" "unprognostic (5.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-1)" "unprognostic (4.97e-2)" "unprognostic (2.96e-2)" "unprognostic (9.28e-3)" "unprognostic (1.61e-1)" "unprognostic (4.45e-2)" "unprognostic (9.06e-2)" "unprognostic (1.81e-1)" 9.8 8.1 8.8 16.2 11.7 20.6 9.6 12.8 9.6 9.4 7.4 13.8 10.4 4.6 9.5 10.9 7.8 7.4 8.8 9.5 8.0 7.4 8.2 11.3 9.6 9.3 11.5 6.1 10.8 9.7 13.3 28.0 11.0 9.1 9.8 7.1 8.7 7.7 14.1 8.3 12.5 7.3 12.0 10.9 8.3 8.0 21.4 13.5 14.4 9.7 4.7 10.1 8.4 13.9 6.5 5.1 14.0 6.0 6.0 5.5 2.3 6.6 4.6 5.9 4.6 8.2 5.0 7.0 5.5 5.7 8.5 9.1 5.0 7.5 7.3 6.8 5.6 5.6 6.2 4.0 11.3 10.2 3.9 9.0 8.0 3.8 4.4 8.7 7.6 2.4 3.6 12.2 7.7 7.2 9.7 10.8 7.4 2.5 6.3 4.7 10.1 8.1 7.7 7.9 7.3 2.7 6.5 7.2 4.5 9.7 2.4 3.4 3.7 3.6 5.6 5.9 15.1 5.2 5.9 5.9 10.2 10.3 3.0 5.6 5.6 8.5 4.7 13.2 5.5 4.2 3.5 6.2 3.6 3.9 5.1 6.5 5.0 5.0 14.0 6.0 6.0 4.5 3.4 2.3 8.8 11.7 12.8 9.6 8.0 7.4 11.5 6.1 9.1 13.5 AHCYL2 KIAA0828 ENSG00000158467 "Adenosylhomocysteinase like 2" Q96HN2 7 129225023-129430211 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 72.4" "Cell line enriched" "Detected in all" 8 "HDLM-2: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053128 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA053128: AB_2682050" "unprognostic (1.57e-1)" "unprognostic (2.91e-1)" "unprognostic (8.52e-3)" "unprognostic (1.71e-3)" "unprognostic (7.44e-3)" "prognostic favourable (4.17e-4)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (3.35e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-1)" "unprognostic (6.79e-3)" "prognostic favourable (1.08e-7)" "unprognostic (4.70e-3)" "unprognostic (2.46e-1)" "unprognostic (7.21e-2)" "unprognostic (2.62e-1)" 4.3 6.6 12.8 5.9 20.3 1.5 4.3 7.2 16.9 7.1 61.8 13.3 5.1 23.1 6.1 3.3 5.7 4.4 22.7 3.4 16.5 9.6 11.9 3.4 26.1 4.2 10.7 14.9 5.7 5.8 9.1 12.8 5.1 19.8 5.0 72.4 24.3 15.0 3.3 20.7 9.8 15.0 5.3 11.4 2.9 16.5 8.1 9.6 4.6 24.1 4.0 4.0 5.4 4.7 0.9 1.3 2.0 2.5 3.3 5.0 0.5 2.6 4.2 8.1 4.8 2.2 3.2 1.7 2.1 2.9 2.4 2.1 2.4 1.8 1.6 2.2 2.3 1.8 4.0 3.3 2.7 71.8 5.0 3.8 4.6 1.9 1.3 2.8 4.9 3.0 4.3 1.9 2.9 4.7 1.7 9.1 3.1 2.5 4.1 3.6 4.0 3.0 2.7 2.2 4.3 4.8 3.5 3.7 2.3 4.8 2.0 2.8 1.9 2.0 2.7 2.0 1.2 5.4 2.2 3.8 4.3 2.2 5.3 3.0 3.1 0.1 1.2 2.0 0.9 2.5 1.2 0.9 1.5 0.7 1.3 0.5 1.3 0.5 0.4 3.3 1.2 0.4 5.0 0.5 12.8 20.3 7.2 16.9 16.5 9.6 10.7 14.9 19.8 9.6 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971174-22982642 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 49.0;hTCEpi: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 2.9 2.0 1.1 2.4 1.8 0.0 4.1 1.1 1.6 11.1 2.0 1.6 4.9 0.5 8.8 4.4 12.3 4.7 7.9 3.2 2.3 0.6 15.6 55.0 8.5 2.2 1.5 1.3 8.2 5.6 5.5 1.4 12.5 2.6 9.2 1.1 7.1 5.5 11.0 1.5 31.3 1.7 4.3 0.5 2.9 2.6 4.1 1.3 7.1 15.4 5.3 6.6 3.7 10.0 1.3 1.0 2.6 1.2 2.9 2.5 0.6 10.2 12.2 16.3 6.2 1.6 2.9 13.1 10.1 13.4 23.7 21.3 26.0 10.7 0.2 10.6 20.8 33.4 12.4 49.0 29.0 0.9 1.1 0.7 19.8 29.2 18.6 1.0 0.7 9.1 51.3 9.9 38.3 9.1 0.4 0.6 21.9 8.2 1.0 1.2 1.0 16.8 2.8 13.6 0.2 23.8 16.0 0.0 1.4 30.5 9.0 1.9 12.6 1.0 8.1 10.3 20.8 1.6 9.6 0.1 0.3 0.1 1.6 0.9 4.6 2.2 1.2 0.5 1.4 0.5 0.5 0.4 1.2 2.5 0.4 1.3 1.5 0.9 2.6 2.9 0.8 1.0 0.2 0.6 1.1 1.8 1.1 1.6 2.3 0.6 1.5 1.3 2.6 1.3 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Cell line enhanced" "Detected in many" "CACO-2: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Group enriched" "Detected in many" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm Nucleoplasm "CAB004308: AB_626655, HPA053891: " "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.0 4.3 1.3 2.7 1.0 0.6 3.7 0.3 1.6 2.6 3.1 4.2 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 0.6 0.5 1.0 1.0 1.0 3.3 0.3 1.3 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.3 1.3 0.3 0.8 1.9 5.8 0.2 2.1 2.9 3.2 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 AKR1A1 "ALR, DD3" ENSG00000117448 "Aldo-keto reductase family 1 member A1" P14550 1 45550543-45570049 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006246, HPA017919, HPA019649, HPA027734" Approved Supported Nucleoplasm,Cytosol 8100000 Cytosol Nucleoplasm "CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976" "unprognostic (1.73e-1)" "prognostic favourable (2.66e-6)" "unprognostic (4.03e-1)" "prognostic favourable (2.92e-4)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (6.54e-3)" "unprognostic (1.31e-3)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (8.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.56e-2)" "unprognostic (2.46e-1)" "unprognostic (2.89e-2)" "unprognostic (4.57e-2)" 20.0 20.4 12.0 27.9 13.9 9.7 31.8 11.5 23.6 21.7 39.6 18.7 20.0 43.6 18.5 31.7 39.0 21.8 31.7 18.5 11.2 12.0 79.6 80.4 26.0 33.8 15.0 13.9 18.3 44.2 11.3 27.5 20.2 13.1 19.4 28.9 16.7 59.8 24.1 13.4 18.2 69.7 19.4 16.3 25.6 27.7 10.5 13.1 24.8 24.6 31.3 33.2 17.4 18.6 23.3 46.8 26.8 56.3 13.8 18.7 38.4 16.4 23.8 21.8 16.8 47.4 34.5 15.4 19.6 45.7 17.1 34.5 9.9 12.7 40.7 15.7 22.3 21.1 22.9 28.5 16.1 16.4 20.6 23.5 20.2 43.4 39.6 30.3 26.4 38.0 25.8 21.6 40.2 39.5 12.0 32.6 20.0 11.9 32.4 13.2 23.7 16.4 37.4 26.2 47.1 48.6 22.5 26.0 15.0 16.9 67.6 24.7 18.9 17.4 24.0 7.9 17.6 27.4 11.6 22.5 29.9 19.1 15.5 39.6 6.8 26.8 56.3 10.5 16.3 51.8 17.8 23.3 15.3 16.0 46.8 22.7 13.1 13.5 2.6 13.8 38.1 40.8 18.7 38.4 12.0 13.9 11.5 23.6 11.2 12.0 15.0 13.9 13.1 13.1 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Group enriched" "Detected in some" 4 "A549: 134.6;ASC diff: 167.1;Hep G2: 251.2;RT4: 76.9" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: " "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 134.6 0.1 14.2 167.1 5.7 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 3.8 0.0 0.7 0.0 0.0 0.0 0.0 38.0 251.2 0.3 0.0 0.0 14.9 8.4 0.7 0.7 0.0 5.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.2 76.9 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.9 0.0 0.0 0.0 0.0 1.7 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell line enhanced" "Detected in many" "A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: " "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavourable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 149.2 0.1 43.6 85.8 30.9 0.0 0.0 2.1 0.0 0.1 4.4 2.5 0.0 8.1 2.0 1.2 0.1 2.9 0.0 0.3 0.0 0.2 46.2 62.6 0.4 0.0 0.0 17.1 6.1 2.0 0.0 2.8 0.9 0.0 3.9 0.3 1.0 0.2 0.0 0.4 0.3 0.9 4.4 14.7 58.9 0.0 0.3 21.4 0.0 0.0 0.0 0.0 20.8 0.5 0.4 9.0 0.3 0.0 0.0 0.0 5.0 5.9 0.4 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell line enriched" "Detected in some" 6 "HDLM-2: 11.8" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: , HPA068265: " "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138117986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 103.2" "Cell line enriched" "Detected in single" 20 "Hep G2: 16.5" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA057002 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057002: " "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favourable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 2.7 0.5 0.7 0.7 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.8 0.2 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.3 16.5 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.4 0.0 0.3 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.2 0.3 2.7 0.5 0.6 0.4 0.4 0.3 0.6 0.4 0.4 0.3 1.1 0.5 0.7 1.8 0.7 0.5 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0;THP-1: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.4 0.8 0.0 0.8 0.2 6.6 1.0 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 0.5 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 AL139260.3 ENSG00000274944 1 38864501-38881617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.3;testis: 15.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.3" "Low lineage specificity" "Detected in many" "HPA041188, HPA078331" Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: " "unprognostic (8.00e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (2.00e-1)" "unprognostic (9.72e-3)" "unprognostic (4.27e-4)" "unprognostic (4.64e-7)" "unprognostic (2.59e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (9.54e-3)" "unprognostic (6.09e-6)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.32e-3)" 1.2 0.0 0.4 1.3 0.9 0.0 0.4 0.4 1.0 0.4 3.3 0.6 0.4 2.0 0.4 0.4 3.0 0.0 0.4 0.4 0.4 0.5 1.5 0.4 2.7 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.6 0.4 2.3 1.8 2.3 0.4 0.4 1.5 2.1 0.4 0.4 0.4 2.4 15.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 7.3 2.8 4.0 0.0 1.7 0.0 12.3 1.3 3.2 0.0 0.6 0.0 3.6 0.4 0.0 0.0 0.5 6.6 13.1 2.4 11.2 0.2 9.1 0.0 0.9 0.0 7.8 2.1 2.7 2.5 2.2 0.0 16.8 4.9 0.0 0.0 1.6 1.1 2.0 6.3 4.5 1.6 3.2 6.8 15.9 6.5 7.7 7.8 7.9 12.5 0.0 6.9 6.2 3.3 7.6 7.2 1.5 4.1 5.2 5.8 2.3 6.4 6.2 11.4 1.5 11.6 9.3 5.6 7.3 2.6 0.0 1.3 0.2 0.5 1.9 1.1 3.0 0.2 0.5 4.2 2.0 0.4 0.4 2.8 0.0 4.0 7.3 1.7 0.0 AL358113.1 ENSG00000285130 9 69035750-69255187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;HUVEC TERT2: 2.1;REH: 9.6;U-2 OS: 2.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6" "HPA001813, HPA068304, HPA070714" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA001813: AB_1080764, HPA068304: , HPA070714: " 1.6 4.3 2.5 1.9 2.1 2.6 2.8 3.6 2.5 1.6 2.8 3.0 2.7 1.6 2.2 1.6 1.6 3.4 1.6 5.8 1.3 2.1 8.8 2.1 3.2 2.8 1.7 3.7 9.4 1.6 1.7 1.6 2.4 4.0 1.6 2.9 2.8 3.2 7.5 1.6 3.0 4.5 1.6 3.1 3.1 3.4 2.1 0.0 2.6 2.0 2.1 2.4 1.3 0.1 1.3 0.1 2.8 0.0 2.6 0.4 0.4 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.7 0.3 2.8 0.2 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 1.2 0.2 0.8 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.6 0.2 0.1 1.3 0.1 1.0 0.1 0.6 0.3 0.1 0.0 2.8 1.3 2.6 0.4 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell line enriched" "Detected in some" 20 "A549: 321.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: , HPA063783: " "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favourable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 321.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 16.1 0.0 0.1 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 5.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 62.2;U-266/70: 42.9" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavourable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.4 0.5 3.5 14.4 7.2 7.4 0.7 3.8 8.6 2.9 18.1 4.3 0.7 3.5 4.6 3.4 9.7 2.3 23.6 5.5 3.0 2.2 6.7 2.7 7.4 6.8 2.4 7.8 6.8 3.3 0.3 5.9 1.3 4.6 18.8 2.5 3.5 2.8 8.1 5.4 3.9 2.4 0.4 62.2 0.4 1.0 9.2 16.4 2.2 17.7 0.1 9.6 5.5 0.9 0.3 1.4 0.5 0.6 42.9 12.3 2.6 28.1 7.0 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 ALG14 MGC19780 ENSG00000172339 "ALG14, UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974407-95072945 "Disease related genes, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA031829: " "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 5.8 13.2 6.8 4.1 8.5 4.6 6.8 5.6 8.0 5.5 7.5 8.5 7.0 8.5 5.4 11.3 5.7 4.8 6.1 6.3 7.0 7.2 8.9 15.1 5.3 7.5 8.2 4.7 5.3 12.6 5.8 6.6 6.3 8.4 5.1 8.7 6.9 14.5 9.8 7.2 5.0 9.2 4.4 9.4 5.8 6.0 10.0 4.2 3.7 8.5 6.2 5.3 4.8 4.2 4.9 5.8 3.1 3.9 2.8 3.8 1.9 5.1 3.3 2.8 2.5 2.2 3.7 2.5 3.7 4.0 3.9 3.3 3.8 1.8 2.7 3.9 4.6 3.6 3.2 3.6 4.7 5.7 5.4 1.5 3.6 5.8 3.5 3.6 1.0 4.1 3.6 2.9 2.9 3.3 2.8 3.5 3.7 2.5 3.8 2.3 1.7 4.7 2.4 5.6 2.9 4.3 3.0 2.5 3.2 2.1 7.1 6.2 3.1 3.1 2.5 2.5 2.7 4.4 7.8 2.2 2.1 2.4 1.8 1.8 2.0 3.1 3.2 1.1 2.5 3.9 2.4 4.9 3.1 3.1 4.5 4.4 2.9 3.0 2.7 2.8 1.9 5.8 3.8 1.9 6.8 8.5 5.6 8.0 7.0 7.2 8.2 4.7 8.4 4.2 ALG8 MGC2840 ENSG00000159063 "ALG8, alpha-1,3-glucosyltransferase" Q9BVK2 11 78100936-78139660 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051898 Approved Approved Nucleoplasm Nucleoplasm "HPA051898: " "unprognostic (1.37e-1)" "unprognostic (9.24e-2)" "unprognostic (4.60e-2)" "unprognostic (2.69e-2)" "unprognostic (2.65e-1)" "unprognostic (6.49e-2)" "unprognostic (5.38e-3)" "unprognostic (5.91e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (5.29e-2)" "unprognostic (1.20e-1)" "unprognostic (1.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.34e-1)" "unprognostic (3.78e-2)" "unprognostic (6.37e-2)" 20.2 24.5 18.0 11.2 22.3 9.7 23.7 13.8 17.9 16.5 15.0 20.7 23.9 10.3 14.5 30.9 13.3 18.4 12.3 13.0 15.9 16.0 24.9 40.8 12.8 15.7 16.0 11.6 22.9 23.4 24.2 23.6 21.7 17.1 15.5 19.0 17.6 23.2 19.5 8.2 13.3 13.3 14.8 17.6 13.8 13.1 38.9 16.5 18.2 29.7 13.1 17.4 13.2 11.2 21.9 19.4 3.0 20.3 18.2 19.0 14.9 9.3 25.9 24.9 21.2 21.5 15.2 13.4 13.8 20.7 23.7 23.0 49.0 34.4 22.0 25.6 16.5 27.1 28.9 19.9 38.3 15.8 17.4 26.5 22.8 22.0 14.0 25.3 17.6 12.1 12.8 27.6 13.8 17.2 32.8 22.7 31.6 13.7 21.1 28.5 27.6 13.6 22.5 11.4 52.3 23.8 14.5 7.3 18.3 19.9 32.3 10.0 36.0 20.0 10.5 16.1 18.7 36.2 11.9 16.3 31.6 32.5 8.9 24.8 27.8 0.3 17.5 3.0 15.7 19.5 17.5 21.9 16.0 16.1 19.4 16.6 19.0 17.2 1.1 18.2 20.3 18.7 13.0 14.9 18.0 22.3 13.8 17.9 15.9 16.0 16.0 11.6 17.1 16.5 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favourable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavourable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.5 32.4 13.2 23.7 19.4 13.4 11.5 16.2 20.1 26.7 24.9 36.6 8.9 21.3 24.0 17.8 22.2 19.8 17.1 13.7 24.3 27.0 15.6 18.4 20.4 18.1 11.2 20.9 12.8 11.7 20.0 11.9 15.4 16.9 9.7 14.8 24.9 24.2 12.6 11.1 16.6 22.0 26.0 37.3 7.8 11.6 13.6 17.9 20.2 14.1 18.5 14.2 9.7 15.6 25.7 18.0 37.7 31.7 11.4 8.6 12.8 46.7 18.5 16.8 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 ALPK3 "KIAA1330, MAK, Midori" ENSG00000136383 "Alpha kinase 3" Q96L96 15 84816680-84873482 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.4;skeletal muscle: 47.6" "Cell line enhanced" "Detected in some" "BEWO: 9.2;HDLM-2: 6.9;HUVEC TERT2: 9.9;LHCN-M2: 13.6;NTERA-2: 8.3;RH-30: 24.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026558 Uncertain Approved Nucleoplasm Nucleoplasm "HPA026558: AB_1844774" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (4.61e-2)" "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.74e-3)" "unprognostic (1.23e-1)" "prognostic favourable (3.95e-7)" "unprognostic (1.76e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (4.87e-2)" 3.7 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.5 1.4 0.0 0.1 1.7 0.8 0.2 0.3 18.4 0.0 0.6 1.6 1.3 1.0 0.0 0.1 0.0 2.1 8.8 6.9 0.6 0.4 0.0 0.4 0.2 47.6 0.0 0.2 0.8 0.0 0.0 1.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.1 0.1 0.2 0.0 9.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 6.9 1.1 1.1 0.2 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 9.9 0.0 0.0 13.6 0.5 0.0 0.1 8.3 0.0 0.0 24.4 0.1 0.0 2.5 0.0 0.1 0.0 1.3 0.0 0.0 6.0 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.1" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 AMD1 SAMDC ENSG00000123505 "Adenosylmethionine decarboxylase 1" P17707 6 110874770-110895713 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 104.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029281, HPA029282" Approved Approved Nucleoplasm Nucleoplasm "HPA029281: AB_10600101, HPA029282: AB_10599965" "prognostic unfavourable (3.87e-4)" "unprognostic (4.68e-2)" "unprognostic (1.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (1.91e-6)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (6.50e-2)" "unprognostic (2.25e-1)" "unprognostic (4.20e-1)" "prognostic favourable (4.28e-4)" "unprognostic (8.62e-3)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (7.71e-2)" 16.7 15.2 29.7 16.9 35.6 38.1 17.8 27.3 34.2 18.6 18.6 45.7 12.5 14.9 18.9 14.2 28.9 14.7 17.5 18.5 32.5 21.5 25.2 16.9 16.9 18.5 39.0 22.0 16.9 20.2 21.8 26.2 33.8 32.7 104.7 19.4 12.8 17.5 19.2 15.3 14.5 13.5 18.4 38.3 16.7 18.4 15.8 46.0 19.4 25.5 20.1 24.6 12.6 16.8 6.6 12.9 42.0 14.0 6.1 9.2 6.5 20.6 14.1 17.3 32.7 26.2 16.6 22.6 29.7 32.9 23.2 27.4 22.4 13.0 36.4 14.4 18.8 14.2 40.8 26.9 32.0 21.3 23.6 37.7 12.9 23.5 15.6 32.5 22.6 11.2 24.9 16.0 32.4 20.2 28.1 31.8 39.0 12.5 43.2 25.0 21.2 12.9 23.8 17.4 21.6 26.3 27.7 22.2 15.8 18.1 23.0 26.2 14.8 27.9 13.2 15.4 11.6 82.0 32.0 8.7 14.1 37.3 17.7 26.0 19.7 15.0 9.8 14.7 7.6 11.6 8.9 6.3 7.6 8.7 12.9 6.6 9.2 9.0 42.0 6.1 14.0 5.8 8.8 6.5 29.7 35.6 27.3 34.2 32.5 21.5 39.0 22.0 32.7 46.0 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell line enhanced" "Detected in many" "A-431: 19.1;HMC-1: 21.1;Karpas-707: 26.1;SiHa: 17.5;SK-BR-3: 19.6;U-266/70: 21.1;U-266/84: 24.7" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.1 4.2 0.3 2.8 0.1 0.0 4.3 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 3.6 0.1 0.0 0.1 6.6 0.7 1.8 2.9 3.7 0.0 2.5 21.1 0.0 0.1 0.3 0.0 0.1 1.3 26.1 0.0 2.9 1.6 4.7 2.0 1.0 3.5 0.1 2.1 0.0 1.8 2.2 3.1 17.5 19.6 2.2 2.0 3.6 0.0 2.7 9.5 3.4 2.4 21.1 24.7 2.6 1.9 5.1 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: " "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 15.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 18 "HEL: 27.6;K-562: 15.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved "Nucleoplasm,Vesicles,Centriolar satellite,Cytosol" Vesicles "Nucleoplasm, Centriolar satellite, Cytosol" "HPA060228: , HPA069636: " "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 27.6 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell line enhanced" "Detected in many" "SK-BR-3: 12.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA046152: " "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.5 1.2 2.7 9.3 3.5 1.5 3.3 4.3 2.2 5.0 2.4 0.5 0.1 0.2 1.2 2.7 1.4 7.2 0.3 4.2 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.3 0.7 3.2 1.7 0.0 1.2 2.0 0.0 0.1 4.3 0.4 4.3 1.6 2.9 0.7 0.0 0.3 5.8 1.2 9.4 3.1 1.0 12.3 3.5 3.6 3.0 1.1 0.1 5.8 3.4 1.8 0.2 0.0 0.0 1.8 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 45.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000590: , HPA057234: " "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavourable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 7.8 6.4 5.2 5.2 5.2 5.0 7.1 5.7 5.2 7.6 5.5 5.2 5.2 4.6 8.7 5.2 6.4 6.9 5.9 5.2 5.2 3.3 5.2 7.7 5.6 5.2 5.2 5.2 7.6 8.8 7.6 5.2 7.3 5.2 6.4 5.7 45.9 5.9 5.2 5.2 7.2 5.8 7.5 5.2 6.8 6.1 7.9 5.2 5.2 6.1 5.2 5.4 5.8 7.3 4.2 5.4 9.0 3.7 3.5 6.1 3.2 12.2 8.2 16.9 13.8 16.1 13.1 16.0 14.5 13.2 16.0 14.5 18.2 9.2 11.9 9.7 14.3 12.2 16.4 12.1 17.6 14.1 12.0 15.1 12.2 10.3 19.2 14.9 15.5 14.4 26.5 19.6 26.5 16.7 13.8 12.0 12.8 8.7 13.9 14.5 13.4 15.2 14.6 13.6 6.8 12.7 10.7 11.2 12.6 12.0 18.8 29.1 8.7 10.4 16.6 19.8 18.6 9.2 10.9 10.1 14.8 12.3 9.5 9.6 13.1 1.6 3.2 9.0 4.7 3.7 6.1 3.6 4.5 4.1 4.8 4.2 4.1 3.8 4.3 3.5 3.7 5.4 4.2 3.2 5.2 5.2 5.7 5.2 5.2 3.3 5.2 5.2 5.2 5.2 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416775-49422753 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 10.2;Hep G2: 29.5;NTERA-2: 5.3;SH-SY5Y: 7.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005566 Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favourable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 10.9 6.6 8.0 8.8 6.0 6.6 16.7 10.4 8.4 10.0 7.4 21.3 10.9 9.2 11.1 3.4 9.7 13.0 16.6 7.4 2.0 21.4 41.2 5.6 2.3 7.6 8.3 14.5 18.5 16.3 10.4 2.5 10.7 9.1 10.1 12.2 9.8 20.0 3.8 5.4 11.0 7.1 5.8 7.9 8.1 2.6 7.4 1.7 8.7 0.4 1.8 6.2 8.1 0.7 5.4 4.7 3.2 8.9 1.6 2.3 0.1 0.5 0.7 0.1 0.4 0.0 10.2 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.2 0.2 0.1 0.4 0.1 0.2 0.1 0.0 0.3 29.5 1.1 0.0 0.1 0.3 0.7 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.2 0.2 5.3 0.1 0.0 0.1 0.2 0.7 0.2 0.0 7.8 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 3.2 4.7 0.0 1.9 0.1 0.6 0.0 0.0 5.4 0.7 1.6 1.5 0.3 8.9 0.7 0.5 0.0 2.3 6.6 8.8 16.7 10.4 7.4 2.0 7.6 8.3 10.7 7.4 ANAPC10 "APC10, DKFZP564L0562, DOC1" ENSG00000164162 "Anaphase promoting complex subunit 10" Q9UM13 4 144831908-145098541 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044547 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA044547: " "unprognostic (2.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.04e-1)" "unprognostic (5.88e-2)" "unprognostic (2.66e-3)" "unprognostic (1.02e-2)" "unprognostic (6.69e-2)" "prognostic unfavourable (8.22e-4)" "unprognostic (2.80e-2)" "unprognostic (1.46e-1)" "unprognostic (4.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (7.81e-2)" "unprognostic (1.70e-1)" "unprognostic (5.55e-2)" 19.0 15.6 16.4 11.9 22.1 14.0 23.4 29.8 24.6 19.3 14.4 16.6 10.6 7.1 19.3 21.3 13.8 17.5 12.5 21.4 17.2 17.6 21.2 21.0 15.8 15.0 18.1 16.2 19.9 14.2 15.1 28.6 19.6 25.9 15.4 16.7 15.9 14.5 15.5 23.8 13.7 11.7 19.4 20.2 14.8 13.1 27.3 20.5 20.4 19.2 13.3 16.7 15.4 15.5 13.5 13.9 18.2 8.4 14.1 15.1 6.7 9.0 5.1 13.8 5.1 13.0 14.1 8.9 10.9 11.6 14.7 10.6 11.3 12.4 14.1 7.2 8.2 5.6 11.5 15.4 15.0 12.0 9.1 7.6 3.9 9.3 16.6 15.5 8.9 11.6 10.7 11.7 18.7 11.7 20.7 18.5 14.7 6.7 26.5 18.6 9.0 11.5 12.5 11.4 8.2 15.9 5.9 9.3 7.6 7.9 6.3 14.0 6.0 12.9 9.4 9.2 6.0 8.9 14.6 15.4 16.9 21.4 12.8 19.7 12.4 18.2 6.8 8.6 11.9 8.4 12.0 13.5 12.8 12.2 9.4 10.9 13.0 12.9 2.0 14.1 8.2 13.9 15.1 6.7 16.4 22.1 29.8 24.6 17.2 17.6 18.1 16.2 25.9 20.5 ANAPC15 "APC15, C11orf51, DKFZP564M082, HSPC020" ENSG00000110200 "Anaphase promoting complex subunit 15" P60006 11 72106378-72112780 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036596 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA036596: AB_10671961" "unprognostic (1.17e-1)" "unprognostic (5.83e-2)" "unprognostic (4.23e-2)" "unprognostic (3.05e-2)" "unprognostic (1.86e-2)" "unprognostic (2.09e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (9.18e-2)" "unprognostic (3.35e-2)" "prognostic favourable (2.55e-4)" "unprognostic (9.34e-3)" "unprognostic (1.76e-1)" "unprognostic (1.26e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.77e-1)" "unprognostic (9.08e-2)" 10.7 14.9 29.5 13.8 30.1 40.3 14.0 9.1 32.5 9.9 20.0 13.7 13.2 14.9 15.3 19.9 17.2 13.4 13.3 22.2 23.6 19.8 16.0 16.9 12.2 19.5 25.2 20.6 8.0 16.6 9.4 11.7 12.7 19.3 17.4 20.5 11.6 18.2 20.6 41.5 14.1 14.8 21.8 17.7 14.4 15.1 22.1 12.6 22.5 21.6 23.1 20.9 12.8 9.4 27.0 45.6 39.9 52.7 20.5 44.0 35.5 19.7 29.9 24.5 15.5 7.3 11.9 11.6 21.1 19.4 34.1 22.7 34.9 21.6 26.7 20.6 30.0 33.7 36.9 39.5 32.3 17.1 17.5 30.4 34.2 22.6 8.7 29.5 28.5 12.4 15.7 19.3 25.9 22.3 22.0 18.6 22.1 34.0 56.6 27.5 19.8 17.3 24.0 60.9 18.1 29.3 13.8 17.4 15.2 21.7 21.3 33.5 24.9 15.8 20.2 15.7 20.7 31.0 22.3 19.1 18.5 34.1 9.6 23.7 8.7 7.5 52.7 39.9 24.0 33.4 25.4 27.0 30.9 27.9 45.6 19.9 37.1 33.9 21.7 20.5 30.4 36.6 44.0 35.5 29.5 30.1 9.1 32.5 23.6 19.8 25.2 20.6 19.3 12.6 ANAPC5 APC5 ENSG00000089053 "Anaphase promoting complex subunit 5" Q9UJX4 12 121308245-121399896 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039457, HPA039801" Supported Approved Nucleoplasm Nucleoplasm "HPA039457: AB_10795676, HPA039801: " "unprognostic (3.41e-1)" "unprognostic (1.16e-3)" "unprognostic (5.37e-2)" "unprognostic (7.24e-3)" "unprognostic (5.35e-3)" "unprognostic (1.18e-2)" "prognostic unfavourable (2.31e-5)" "unprognostic (1.63e-1)" "unprognostic (6.91e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-3)" "unprognostic (4.94e-2)" "prognostic unfavourable (2.01e-9)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (6.87e-2)" "unprognostic (3.28e-1)" 28.9 26.9 23.2 24.1 37.3 29.3 31.3 34.1 38.1 28.2 26.3 57.0 21.8 22.3 33.7 28.4 26.0 34.2 20.8 24.8 25.4 21.6 23.6 33.5 22.2 31.6 53.8 25.1 30.0 40.1 27.4 34.1 22.3 34.3 22.9 29.6 24.9 47.3 24.7 48.6 29.2 23.9 26.1 36.5 30.0 27.6 18.2 45.5 36.5 27.5 32.1 37.7 26.3 25.9 30.7 36.4 27.0 32.1 34.9 38.7 42.0 27.6 39.2 17.6 12.6 31.1 34.4 31.1 26.9 30.7 31.4 28.2 31.2 14.3 37.7 27.8 39.2 23.8 40.8 26.5 25.1 32.4 45.5 34.4 25.5 35.7 34.1 49.7 34.3 34.4 25.3 32.1 25.7 39.6 43.3 22.9 25.2 39.7 42.9 48.8 27.9 43.1 38.3 25.8 48.7 22.8 28.8 22.4 22.5 40.0 16.7 27.3 40.1 47.6 24.8 21.3 15.3 14.4 22.0 29.6 29.8 44.3 27.9 37.5 26.1 18.6 30.7 27.0 26.6 32.1 32.4 30.7 30.3 32.5 36.4 23.9 30.6 29.0 7.5 34.9 27.3 24.2 38.7 42.0 23.2 37.3 34.1 38.1 25.4 21.6 53.8 25.1 34.3 45.5 ANAPC7 APC7 ENSG00000196510 "Anaphase promoting complex subunit 7" Q9UJX3 12 110372900-110403730 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009567 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009567: AB_2227137" "unprognostic (2.49e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.36e-2)" "unprognostic (2.02e-2)" "unprognostic (4.35e-2)" "prognostic unfavourable (1.54e-6)" "unprognostic (3.20e-1)" "unprognostic (7.08e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (4.36e-10)" "unprognostic (1.45e-1)" "unprognostic (9.92e-2)" "unprognostic (3.08e-2)" "unprognostic (1.58e-2)" 15.6 20.3 17.8 14.7 25.1 12.2 19.9 24.8 25.1 20.6 16.2 16.8 12.2 11.9 21.4 19.8 34.2 20.9 15.6 18.8 19.1 18.5 21.4 16.8 16.6 20.8 16.2 22.1 18.1 16.7 26.6 14.9 9.6 17.6 21.8 18.9 16.4 19.7 21.3 29.7 16.0 13.3 24.0 17.1 16.8 14.9 36.3 16.3 25.8 23.2 24.5 22.2 19.2 22.5 14.9 17.7 17.6 15.1 20.1 22.4 12.5 18.3 25.3 18.6 15.8 19.5 9.9 10.6 12.9 11.8 23.9 16.6 25.8 11.8 29.4 13.2 17.3 18.7 27.6 17.7 24.4 15.6 22.3 26.0 18.8 21.3 14.2 23.2 12.3 10.7 12.8 20.7 13.8 23.1 40.7 6.0 18.7 19.7 35.1 17.3 16.1 22.1 27.2 18.4 35.0 16.2 23.6 24.2 13.9 20.2 15.9 21.2 33.7 21.1 14.5 14.3 13.4 12.7 15.2 10.6 21.7 39.6 15.9 19.9 16.5 14.3 10.5 17.6 17.2 15.1 20.2 13.3 18.5 16.5 17.7 14.9 15.5 16.5 8.3 20.1 13.1 9.7 22.4 12.5 17.8 25.1 24.8 25.1 19.1 18.5 16.2 22.1 17.6 16.3 ANGEL1 "Ccr4e, KIAA0759" ENSG00000013523 "Angel homolog 1" Q9UNK9 14 76786178-76826246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000948 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA000948: AB_2227189" "unprognostic (4.81e-2)" "unprognostic (2.37e-2)" "unprognostic (2.67e-1)" "unprognostic (2.46e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-1)" "unprognostic (7.33e-2)" "prognostic favourable (3.43e-4)" "unprognostic (9.24e-2)" "unprognostic (1.01e-1)" "prognostic favourable (5.46e-4)" "unprognostic (3.03e-1)" "unprognostic (6.92e-3)" "unprognostic (1.42e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-1)" "unprognostic (6.32e-2)" 7.2 13.0 14.7 8.1 16.4 4.3 9.0 10.0 16.6 7.2 7.1 17.9 3.3 6.6 11.0 18.8 5.1 9.1 8.0 11.6 15.1 10.8 7.0 11.3 10.5 8.6 22.5 11.7 15.2 35.8 13.1 18.9 7.7 14.5 6.7 8.2 11.7 10.7 6.7 8.1 4.7 6.3 9.2 16.5 18.6 11.5 27.5 14.9 6.1 9.3 4.6 7.8 7.2 5.3 9.0 9.3 1.9 8.3 6.6 10.2 6.7 9.6 10.5 11.7 10.4 9.6 8.8 10.9 5.8 8.4 6.1 7.8 10.0 13.7 17.6 8.6 5.0 12.2 11.1 10.4 10.2 7.4 10.0 10.6 6.6 7.6 6.2 5.7 6.7 9.3 13.0 5.6 11.2 15.2 10.5 4.7 6.2 18.7 10.2 8.5 13.4 14.1 12.5 8.0 10.4 9.2 13.7 16.7 7.4 8.8 12.1 5.4 23.7 5.9 7.2 7.0 6.3 5.3 4.8 12.1 9.1 10.9 6.0 10.0 8.8 0.7 5.9 1.9 7.9 6.7 9.6 9.0 7.1 7.4 9.3 7.7 10.2 7.5 1.8 6.6 8.3 6.2 5.7 6.7 14.7 16.4 10.0 15.0 15.1 10.8 22.5 11.7 14.5 14.9 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374373 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 55.5;liver: 68.4;pancreas: 51.7" "Cell line enhanced" "Detected in some" "ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0" "Cancer enhanced" "Detected in all" "renal cancer: 212.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 5.8;neutrophil: 2.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" 7750000 1500000 "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavourable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavourable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavourable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 55.5 9.6 23.3 13.5 24.7 2.3 33.0 5.1 37.6 3.3 11.8 9.2 0.3 10.6 5.9 1.5 11.8 3.2 8.8 11.4 17.1 5.5 9.4 68.4 9.0 2.7 21.4 3.1 2.9 51.7 2.3 3.3 21.4 36.8 6.7 2.1 2.5 3.9 3.7 5.9 6.5 23.5 6.0 20.6 2.5 4.4 3.7 27.7 0.0 7.1 2.5 3.5 10.7 6.0 0.5 0.3 5.8 0.4 0.8 0.6 0.2 0.0 0.6 0.3 0.9 16.1 3.5 0.1 1.2 0.1 0.2 0.0 0.0 5.9 0.0 8.8 2.4 0.8 0.0 64.0 0.1 0.5 0.1 0.1 0.2 0.1 0.3 0.0 0.0 1.6 0.2 9.8 0.2 4.9 0.3 0.2 17.3 0.5 0.0 0.5 0.1 0.5 0.3 0.0 0.2 3.2 1.1 0.0 0.1 7.4 0.7 1.1 1.9 0.1 32.2 19.0 0.1 9.5 0.0 0.0 0.0 0.0 13.0 0.0 3.5 5.8 0.4 0.9 0.4 0.2 0.3 0.5 0.5 0.4 0.2 0.4 0.3 0.3 2.3 0.8 0.2 0.3 0.6 0.2 23.3 24.7 5.1 37.6 17.1 5.5 21.4 3.1 36.8 27.7 ANKAR FLJ25415 ENSG00000151687 "Ankyrin and armadillo repeat containing" Q7Z5J8 2 189674290-189761193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.3;testis: 9.0" "Cell line enhanced" "Detected in some" "TIME: 2.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036168 Uncertain Approved "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "HPA036168: AB_10673345" "unprognostic (2.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.06e-2)" "unprognostic (5.41e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (5.03e-3)" "unprognostic (2.89e-1)" "unprognostic (2.65e-2)" "unprognostic (6.34e-4)" "unprognostic (2.43e-1)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" 0.2 0.4 0.2 0.0 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.0 0.3 0.7 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 0.2 1.2 0.3 0.1 0.5 0.3 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.2 0.6 9.0 0.6 0.1 0.2 0.2 2.3 0.3 0.5 0.4 0.0 0.6 0.1 0.6 0.5 0.4 0.5 0.4 1.0 0.0 0.0 0.7 0.2 0.5 0.9 1.1 0.3 0.3 1.0 0.8 0.7 0.0 0.3 0.9 0.6 0.6 0.4 1.3 0.0 1.8 0.2 1.3 0.2 0.3 1.4 0.0 0.1 0.9 0.3 0.4 0.0 0.5 0.0 0.7 0.3 0.4 0.0 0.6 2.2 0.0 0.0 0.5 0.3 0.8 2.4 1.8 2.7 0.8 1.1 0.0 0.0 1.0 0.4 0.1 0.4 0.1 0.2 0.0 0.0 0.5 0.6 0.4 0.1 0.6 0.3 0.1 0.1 2.3 0.2 0.5 0.0 0.0 0.3 0.3 0.0 0.1 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958700 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 18.7;RT4: 14.1;U-266/84: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 29.1" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.9 12.4 7.9 3.7 9.5 3.2 2.3 7.9 9.4 4.3 2.2 0.6 3.5 1.9 4.7 7.6 5.1 5.9 3.9 3.6 8.3 3.9 2.0 1.3 4.4 6.3 4.2 9.8 5.8 7.6 3.5 4.4 5.4 3.5 3.3 0.5 2.4 3.3 4.2 1.5 4.9 2.4 6.5 3.0 14.2 2.6 8.6 1.1 0.0 3.8 0.9 1.6 5.1 4.0 1.0 1.5 1.4 1.9 6.8 4.0 0.8 1.0 2.8 1.4 1.3 2.2 1.6 5.5 1.3 3.4 1.3 1.9 1.6 1.4 1.2 1.5 2.8 1.4 2.8 0.2 1.0 0.7 0.8 1.4 3.0 1.1 1.6 1.1 2.3 1.3 0.4 0.8 0.5 0.9 0.2 18.7 0.4 2.7 0.4 2.0 1.7 1.3 0.8 0.8 8.9 0.1 14.1 2.8 3.5 0.7 0.9 1.3 1.1 1.1 1.4 2.6 2.7 2.3 1.3 5.2 18.2 1.0 2.8 2.5 0.8 1.0 0.9 0.1 2.1 1.9 0.8 1.0 1.1 3.2 1.5 0.7 0.8 0.8 1.4 6.8 1.8 0.0 4.0 0.8 7.9 9.5 7.9 9.4 8.3 3.9 4.2 9.8 3.5 1.1 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell line enhanced" "Detected in some" "HeLa: 7.9;MOLT-4: 16.4;T-47d: 5.7;U-2197: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.8 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.1 0.1 0.4 16.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.3 5.7 0.0 0.0 0.0 0.4 5.5 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Cell line enhanced" "Detected in many" "Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Low region specificity" "Detected in many" "HPA026789, HPA073498" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: " "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavourable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.7 0.0 0.3 1.4 0.5 0.1 0.3 0.2 6.9 0.4 30.2 0.3 0.1 0.6 11.7 0.1 0.2 9.1 1.5 12.3 4.8 0.0 0.1 13.3 5.1 0.1 0.4 1.2 0.0 0.2 1.6 3.6 0.1 0.2 9.1 17.0 3.7 1.0 7.3 0.0 3.1 0.1 0.1 0.4 2.7 2.9 0.2 0.2 0.0 8.7 0.5 0.1 0.5 0.5 0.3 0.3 0.3 10.7 0.1 23.7 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favourable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.2 11.5 2.5 4.6 2.3 3.3 10.4 2.5 3.8 2.1 2.8 3.7 10.8 5.2 0.4 2.8 5.8 4.8 5.9 2.5 9.6 3.9 10.3 5.6 9.6 1.9 5.7 10.0 5.2 14.5 1.9 13.8 2.1 9.6 6.7 3.5 5.0 5.3 9.4 2.1 6.9 14.9 7.6 8.2 3.2 11.3 5.9 4.4 2.0 5.5 7.6 4.8 8.9 2.7 7.8 2.7 3.1 4.4 15.6 3.9 5.0 4.4 8.8 6.0 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 ANKMY2 "DKFZP564O043, ZMYND20" ENSG00000106524 "Ankyrin repeat and MYND domain containing 2" Q8IV38 7 16599776-16645817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050447, HPA067100" Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA050447: , HPA067100: " "unprognostic (3.07e-1)" "unprognostic (4.20e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (1.99e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.11e-2)" "unprognostic (3.00e-2)" "prognostic favourable (1.05e-7)" "unprognostic (5.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.85e-2)" 9.6 10.3 14.5 6.6 30.1 10.0 11.8 14.6 28.7 12.4 13.6 9.0 13.3 12.2 10.8 10.4 9.4 13.1 11.1 30.2 18.5 12.7 13.3 8.9 9.4 6.7 12.7 21.2 21.5 9.6 13.2 14.9 7.3 20.4 11.3 14.1 11.8 11.4 16.3 17.3 8.5 13.5 14.4 11.9 8.8 19.1 8.0 7.8 8.9 17.7 7.5 7.1 14.6 11.6 6.7 4.9 18.5 8.9 10.6 10.2 5.2 11.5 9.9 13.5 13.4 12.8 13.5 7.3 14.2 17.4 10.9 17.0 16.4 17.8 2.3 16.6 14.8 12.1 9.1 5.4 16.4 5.2 6.3 21.0 11.9 7.4 8.4 15.6 8.2 11.7 2.9 11.0 11.1 9.8 21.5 3.9 15.5 3.1 6.6 10.9 9.0 11.8 10.9 12.2 5.6 17.1 10.1 8.5 5.1 9.6 7.1 5.7 8.3 14.1 6.1 8.5 7.6 18.9 9.6 14.2 10.3 3.6 13.1 12.9 13.5 18.5 3.2 14.3 10.0 4.3 9.6 6.7 8.2 10.2 4.9 6.7 6.9 8.2 2.7 10.6 8.9 4.7 8.3 5.2 14.5 30.1 14.6 28.7 18.5 12.7 12.7 21.2 20.4 7.8 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67288547-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.8" "Cell line enhanced" "Detected in many" "NB-4: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavourable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 9.1 9.1 18.2 18.1 17.6 80.8 18.9 20.2 18.7 9.0 7.6 7.7 13.7 8.0 9.0 10.4 14.6 10.2 11.9 8.8 20.2 14.0 8.3 4.5 12.4 20.8 12.4 11.4 9.4 7.7 6.0 17.0 9.2 10.7 12.7 4.5 10.9 17.5 12.0 4.2 28.1 8.6 9.9 9.6 24.1 8.9 6.8 12.0 9.6 6.4 6.2 14.4 14.3 13.4 2.6 8.1 11.4 4.6 3.8 6.7 1.9 6.2 4.4 3.4 7.9 5.1 5.0 6.3 3.8 3.8 4.5 2.8 5.2 6.9 6.7 6.4 4.3 10.4 2.4 4.9 0.7 9.5 2.9 5.7 6.6 2.9 7.9 6.3 23.0 5.4 7.7 4.0 5.1 4.2 4.0 8.3 4.0 10.0 8.4 48.7 3.8 5.6 21.2 3.6 4.7 6.4 8.5 3.9 6.7 3.3 10.0 26.6 10.3 17.9 5.4 7.1 4.6 7.2 5.0 8.4 5.9 4.0 9.4 17.6 4.6 7.2 3.3 11.4 6.7 4.6 4.4 2.6 3.8 5.4 1.9 2.4 2.4 5.8 10.8 3.8 3.8 8.1 2.8 1.9 18.2 17.6 20.2 18.7 20.2 14.0 12.4 11.4 10.7 12.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88822132-88851818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.2;stomach 1: 27.6;tongue: 29.0" "Cell line enhanced" "Detected in some" "A-431: 8.8;CAPAN-2: 28.2;HaCaT: 6.9;HL-60: 8.3;RT4: 19.0;T-47d: 12.9;U-937: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 15.4" "Group enriched" "Detected in many" 13 "granulocytes: 15.4;monocytes: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favourable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavourable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.4 0.5 2.3 8.4 3.6 5.3 2.3 0.3 3.2 6.7 6.7 0.5 0.0 2.0 0.3 0.2 21.9 0.3 4.3 1.1 4.0 0.6 6.0 1.6 1.3 6.1 3.6 0.2 0.3 40.2 0.1 1.6 0.2 2.7 2.0 7.2 0.1 3.7 0.0 0.3 18.5 2.1 1.3 7.4 8.8 27.6 0.3 1.4 7.9 0.3 29.0 14.6 4.4 8.6 0.1 0.4 15.4 6.8 0.5 0.8 1.2 8.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.1 0.1 0.0 6.9 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 6.6 0.1 0.1 0.0 0.0 0.0 0.1 19.0 0.0 0.0 0.0 1.4 0.0 12.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.6 0.1 0.1 4.8 2.5 0.1 6.8 0.0 0.0 0.4 0.1 0.4 0.1 0.8 0.2 15.4 0.5 1.2 0.4 0.0 1.2 2.3 3.6 0.3 3.2 4.0 0.6 3.6 0.2 2.7 1.4 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.6;BJ hTERT+: 12.0;hTCEpi: 11.9;PC-3: 11.4;U-2197: 14.9;U-87 MG: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 1.1;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 14 "dendritic cells: 1.6;T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favourable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favourable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favourable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 11.8 6.1 8.9 6.6 6.6 0.2 9.9 1.9 15.1 8.4 3.0 3.7 3.0 1.2 13.1 6.4 6.5 9.6 4.4 4.9 9.8 5.3 2.5 1.6 25.2 14.6 8.7 6.2 12.4 0.8 18.4 6.0 0.3 17.9 7.0 1.8 4.3 5.1 7.5 3.2 3.2 4.5 9.8 3.2 2.0 11.7 2.9 3.1 1.6 2.3 5.5 11.1 4.8 9.1 0.0 1.6 0.0 0.0 0.0 1.1 0.0 1.6 4.8 0.0 0.0 1.2 12.6 0.1 4.7 12.0 1.9 2.4 2.1 0.4 0.0 0.7 2.2 2.4 0.0 6.2 0.4 0.1 4.3 0.0 3.1 0.1 0.2 0.0 0.3 3.3 11.9 1.9 3.2 1.2 0.0 0.2 3.2 0.5 0.0 0.0 0.8 11.4 0.0 0.3 1.1 3.0 1.7 0.7 5.9 1.2 0.2 0.1 1.4 0.0 2.8 0.3 1.7 14.9 4.2 0.0 0.0 0.0 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 8.9 6.6 1.9 15.1 9.8 5.3 8.7 6.2 17.9 3.1 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 45.8" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 45.8 0.0 0.1 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.8;THP-1: 7.2;TIME: 9.2;U-87 MG: 9.2;U-937: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favourable (9.35e-4)" "prognostic favourable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 10.8 0.3 1.5 3.9 0.5 1.3 0.4 0.0 0.0 0.3 1.2 0.2 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.0 1.2 3.0 0.1 3.7 0.5 0.3 0.1 0.4 0.0 0.0 2.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 7.2 9.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.1 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 ANKRD36 UNQ2430 ENSG00000135976 "Ankyrin repeat domain 36" A6QL64 2 97113496-97264521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051757: , HPA057661: " "unprognostic (4.24e-3)" "unprognostic (7.59e-2)" "unprognostic (6.15e-3)" "unprognostic (9.86e-2)" "unprognostic (9.83e-3)" "unprognostic (5.25e-3)" "unprognostic (5.65e-2)" "unprognostic (1.49e-2)" "unprognostic (4.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-2)" "unprognostic (9.14e-7)" "unprognostic (1.67e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.75e-1)" 5.1 3.3 8.8 6.0 14.5 22.0 6.8 20.5 10.2 5.6 4.6 4.8 2.2 3.0 8.5 7.7 2.4 6.0 3.8 3.9 7.6 3.3 3.2 1.8 5.0 5.0 4.0 11.3 8.9 5.1 5.3 9.2 2.3 6.8 4.8 5.2 4.7 4.3 3.1 2.2 5.9 4.3 4.7 3.7 5.9 5.1 13.3 8.2 5.6 5.4 2.1 3.7 4.0 4.9 9.9 11.7 9.3 3.3 4.9 9.2 1.7 6.3 1.6 5.3 3.3 1.2 2.7 2.4 2.5 1.7 1.9 2.0 1.6 3.3 8.2 1.7 2.3 3.2 1.9 2.2 1.6 3.9 2.9 6.2 7.0 3.0 0.5 4.5 2.7 1.8 1.4 1.4 2.5 3.5 4.2 14.3 0.9 1.1 5.7 5.9 1.2 2.9 5.5 2.2 2.3 1.5 3.1 3.7 2.7 2.6 1.5 0.8 1.6 2.6 5.3 5.5 5.4 6.3 2.9 8.4 3.6 6.7 3.2 6.5 1.8 9.3 2.6 3.5 9.2 1.2 9.1 9.9 8.4 7.3 1.2 9.9 8.6 9.2 3.9 4.9 3.3 11.7 7.0 1.7 8.8 14.5 20.5 10.2 7.6 3.3 4.0 11.3 6.8 8.2 ANKRD36B "FLJ21281, KIAA1641" ENSG00000196912 "Ankyrin repeat domain 36B" Q8N2N9 2 97492663-97589965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051757: , HPA057661: " "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "unprognostic (2.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-1)" "unprognostic (8.72e-3)" "unprognostic (5.03e-2)" "unprognostic (7.17e-3)" "unprognostic (4.20e-2)" "unprognostic (4.00e-2)" "unprognostic (2.13e-6)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (7.71e-3)" "unprognostic (6.98e-2)" 1.0 1.5 2.0 2.8 7.0 16.4 3.3 6.8 6.7 1.4 1.7 1.6 0.2 1.3 3.8 2.0 0.5 2.0 2.1 0.8 3.1 1.1 0.4 2.2 2.3 4.3 6.2 3.8 1.7 1.8 3.3 0.7 3.9 1.8 2.7 1.0 2.6 3.0 0.7 3.6 2.1 1.9 1.9 1.7 1.7 7.5 4.0 4.2 1.3 2.8 2.1 1.2 0.8 3.5 2.6 3.4 0.7 2.6 3.0 0.3 4.0 2.5 2.9 2.5 1.7 3.9 1.9 2.8 1.8 1.8 2.1 2.4 4.9 5.6 1.5 2.3 1.8 1.8 1.3 1.9 1.6 4.5 4.4 5.1 1.8 1.3 3.5 2.6 2.6 2.3 2.3 3.8 2.4 6.0 4.8 2.2 1.0 4.4 6.3 1.4 3.0 5.4 1.4 1.9 2.0 2.5 3.3 4.7 2.1 1.8 1.5 2.8 3.3 3.5 3.3 3.8 3.8 3.7 6.6 8.4 5.3 2.0 4.7 1.7 3.4 0.7 0.9 2.2 0.3 2.0 2.2 2.6 1.8 0.3 3.5 3.0 2.3 0.5 2.6 0.2 2.6 1.3 0.3 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.6" "Cell line enhanced" "Detected in many" "PC-3: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA051757: , HPA057661: " "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 2.2 1.0 4.2 1.8 4.1 13.2 5.3 8.0 5.8 3.1 3.1 0.5 2.8 0.7 3.2 1.9 1.8 2.6 4.0 1.5 3.3 1.8 1.2 0.8 2.0 2.7 1.6 1.7 5.6 3.1 1.2 3.9 0.9 3.1 1.6 2.1 2.1 9.2 1.5 0.9 2.9 2.6 1.5 1.9 2.4 4.5 10.1 1.1 2.8 1.6 2.4 4.0 2.5 2.2 11.1 19.6 18.1 2.0 7.2 12.5 0.7 6.6 1.3 2.7 1.9 1.8 4.9 1.0 1.6 1.1 2.1 2.7 1.5 1.5 6.6 2.1 1.1 1.5 2.4 1.2 2.6 3.7 3.3 2.7 3.2 1.9 0.4 7.8 2.0 1.4 0.9 1.6 0.8 3.5 2.5 8.4 2.3 0.9 5.9 2.9 0.6 25.4 3.2 2.0 2.6 1.0 1.3 2.5 2.2 1.0 1.7 1.1 0.8 1.9 3.8 2.6 2.8 2.0 1.9 3.2 2.6 7.1 0.7 5.4 1.0 18.1 2.0 1.5 12.5 0.3 8.1 9.2 10.0 8.1 1.4 11.1 8.7 8.5 0.1 7.2 0.5 19.6 8.3 0.7 4.2 4.1 8.0 5.8 3.3 1.8 1.6 1.7 3.1 1.1 ANKRD39 MGC41816 ENSG00000213337 "Ankyrin repeat domain 39" Q53RE8 2 96836611-96858095 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042678 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042678: AB_10794532" "unprognostic (6.26e-2)" "unprognostic (1.32e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (9.53e-2)" "unprognostic (2.28e-2)" "unprognostic (2.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.68e-1)" "unprognostic (9.25e-2)" "unprognostic (3.12e-3)" "prognostic favourable (6.12e-5)" "unprognostic (6.15e-2)" "prognostic unfavourable (6.78e-9)" "unprognostic (3.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.03e-2)" "prognostic favourable (5.21e-4)" 8.9 16.2 17.1 9.2 19.2 12.0 6.9 29.4 20.8 7.4 8.3 15.0 7.2 11.2 11.7 5.9 7.6 10.9 7.9 17.6 14.8 14.7 6.5 12.6 7.6 13.0 13.5 14.0 7.3 11.2 11.7 14.2 7.4 13.4 10.4 5.6 10.3 9.5 10.1 6.3 10.9 8.4 9.5 10.7 8.9 7.9 3.7 13.0 5.4 6.3 4.3 8.7 9.0 5.8 15.5 29.0 7.1 9.0 14.4 27.8 8.7 6.2 4.1 2.4 5.2 0.8 1.6 5.7 4.9 2.3 6.1 4.7 10.2 2.6 4.0 7.3 3.5 2.7 3.0 4.6 1.3 4.6 9.1 2.8 3.7 13.8 4.1 6.5 7.1 3.0 2.7 5.6 2.1 4.4 6.0 71.9 2.2 9.9 6.0 5.0 3.0 9.6 4.6 1.7 22.5 3.1 3.2 5.5 3.6 3.5 8.3 6.2 2.5 3.5 2.1 3.8 3.8 4.3 8.6 3.7 4.0 6.5 3.9 7.5 4.0 7.1 6.9 5.3 19.6 8.3 16.4 15.5 19.4 17.2 6.8 13.6 10.8 13.3 3.5 14.4 9.0 29.0 27.8 8.7 17.1 19.2 29.4 20.8 14.8 14.7 13.5 14.0 13.4 13.0 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell line enhanced" "Detected in all" "U-2197: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.8 3.2 6.7 10.6 11.1 3.0 8.0 6.2 4.7 2.9 4.1 4.7 1.6 10.3 7.1 8.4 3.4 5.4 3.9 2.1 2.7 2.7 9.2 2.7 7.2 7.7 6.5 6.5 6.5 11.9 6.4 4.9 8.0 1.5 6.8 5.7 1.1 8.5 2.8 4.3 1.8 4.9 2.0 15.8 4.7 2.6 3.5 10.3 6.5 2.0 9.8 4.3 7.0 7.4 5.1 26.8 3.7 2.0 4.6 3.3 5.8 4.8 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: " "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavourable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favourable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.5 6.5 7.4 9.5 9.1 10.1 9.0 10.6 12.5 14.0 12.6 16.9 15.5 7.1 14.0 9.1 6.9 8.5 13.1 7.4 14.5 11.3 4.7 8.5 12.7 11.6 6.6 17.2 8.2 11.4 8.3 13.7 10.0 7.0 4.4 13.5 23.2 4.3 7.2 11.0 8.4 8.4 10.0 6.8 7.5 7.7 6.9 6.9 6.3 14.1 8.6 5.1 9.6 6.8 10.5 5.0 5.8 13.5 17.9 3.2 15.4 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 ANKRD50 KIAA1223 ENSG00000151458 "Ankyrin repeat domain 50" Q9ULJ7 4 124664052-124712732 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 21.7;HUVEC TERT2: 21.6;TIME: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.4;monocytes: 3.8" "Low region specificity" "Detected in all" HPA044008 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044008: AB_10961996" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (6.85e-3)" "unprognostic (5.90e-1)" "unprognostic (9.77e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (7.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.02e-1)" "prognostic unfavourable (3.28e-4)" "unprognostic (1.67e-1)" "unprognostic (8.25e-2)" "unprognostic (5.55e-3)" "unprognostic (4.82e-2)" "unprognostic (8.23e-2)" "unprognostic (8.16e-3)" 10.1 4.8 6.6 8.2 6.8 4.7 7.6 4.0 8.3 17.1 10.0 4.3 8.7 3.7 17.5 7.4 11.4 5.9 10.2 7.3 6.2 6.5 9.8 6.9 13.4 5.4 5.5 6.5 9.0 5.2 12.5 3.9 17.1 6.2 19.1 6.9 6.7 7.7 7.9 3.2 12.9 7.9 14.2 4.8 7.1 8.2 16.8 4.8 15.4 9.2 5.8 4.4 16.5 10.9 0.1 2.4 0.5 3.8 0.4 0.1 0.4 2.2 4.2 12.0 5.5 9.6 6.1 1.2 5.8 5.0 3.0 1.9 1.8 3.0 0.0 1.8 8.3 2.1 7.9 4.5 5.4 0.0 1.7 1.9 5.5 1.8 6.9 3.1 2.5 6.2 6.2 4.8 21.7 21.6 3.4 4.1 5.7 5.1 3.9 1.1 2.5 6.3 3.2 3.7 0.5 3.8 9.4 3.5 4.3 4.0 2.6 4.7 2.7 2.7 54.4 6.5 5.0 3.2 5.0 3.0 0.0 0.8 2.9 1.3 7.4 0.0 1.5 0.5 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.4 2.3 0.9 0.0 0.4 6.6 6.8 4.0 8.3 6.2 6.5 5.5 6.5 6.2 4.8 ANKRD52 "FLJ34236, PP6-ARS-C" ENSG00000139645 "Ankyrin repeat domain 52" Q8NB46 12 56237807-56258391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043815 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA043815: AB_10961762" "unprognostic (6.25e-3)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (3.33e-4)" "unprognostic (9.84e-2)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (6.31e-2)" 10.7 23.2 12.3 13.2 19.6 12.1 10.8 23.1 23.5 10.8 11.6 15.6 9.1 11.9 13.8 8.9 10.9 11.5 12.7 12.0 12.7 13.4 13.2 8.3 9.8 12.3 13.3 14.7 14.6 14.1 28.4 14.5 12.6 22.8 11.9 12.1 14.8 11.6 13.6 30.8 15.8 13.0 15.8 8.8 11.9 10.9 8.5 13.5 10.5 12.4 11.4 13.4 12.3 11.8 1.1 1.1 2.4 0.6 0.3 1.2 0.5 11.6 28.8 12.9 23.2 10.5 8.3 9.0 23.3 10.4 20.9 9.5 18.6 6.5 12.4 14.9 22.7 15.2 14.1 10.1 12.1 12.0 14.3 22.3 18.8 7.1 7.2 17.5 13.0 8.5 11.5 19.4 9.9 12.1 9.1 6.8 19.6 16.2 14.0 5.8 5.4 13.4 11.1 8.9 4.9 13.8 14.9 9.7 8.8 25.4 16.2 9.3 13.1 6.8 16.7 21.9 19.3 12.2 14.5 6.3 8.3 6.2 22.5 5.8 14.2 2.4 0.6 0.9 1.2 0.1 1.0 0.8 0.4 0.7 0.3 1.1 0.6 0.7 0.3 0.3 0.4 1.1 0.3 0.5 12.3 19.6 23.1 23.5 12.7 13.4 13.3 14.7 22.8 13.5 ANKRD54 LIAR ENSG00000100124 "Ankyrin repeat domain 54" Q6NXT1 22 37830855-37849327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071287 Approved Approved Nucleoplasm,Microtubules,Midbody "Microtubules, Midbody" Nucleoplasm "HPA071287: " "unprognostic (5.36e-2)" "prognostic favourable (2.06e-4)" "unprognostic (1.02e-1)" "prognostic favourable (7.38e-5)" "unprognostic (1.14e-1)" "unprognostic (1.50e-1)" "unprognostic (1.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.41e-2)" "prognostic favourable (6.16e-4)" "unprognostic (2.53e-1)" "unprognostic (6.33e-2)" "unprognostic (1.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-3)" 7.8 14.8 18.4 7.9 15.8 7.5 9.1 20.0 19.5 13.5 11.9 14.1 17.4 9.8 11.2 14.9 13.6 33.5 11.4 8.9 17.1 20.6 13.0 11.9 9.3 8.1 14.2 12.1 19.0 24.6 15.3 16.4 7.9 14.8 13.1 9.4 13.4 19.1 16.3 9.3 11.8 9.5 13.5 11.7 7.5 8.9 23.7 11.0 12.3 18.2 8.7 9.8 11.6 13.9 6.2 6.7 3.5 10.0 12.8 6.9 3.8 10.8 11.1 9.3 13.7 12.6 7.1 5.0 15.1 11.7 25.7 15.8 7.0 4.3 10.6 6.3 9.9 9.8 11.9 8.4 12.5 8.4 24.1 5.2 10.0 16.6 11.3 10.5 12.7 6.4 8.7 13.9 8.1 15.7 6.9 7.4 11.7 11.4 10.1 12.0 2.7 10.1 11.9 11.4 6.6 14.1 3.6 16.3 8.7 12.6 11.2 17.9 11.5 16.6 9.1 14.9 16.1 7.8 11.0 8.3 6.6 8.4 12.4 8.9 10.8 2.6 5.4 2.4 6.8 6.4 6.8 4.5 6.6 5.2 6.7 6.2 6.9 3.4 3.5 12.8 10.0 6.7 2.8 3.8 18.4 15.8 20.0 19.5 17.1 20.6 14.2 12.1 14.8 11.0 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 6 "HEL: 23.9;HMC-1: 12.4;NB-4: 15.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: , HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.1 0.9 0.0 1.1 12.4 0.0 0.0 0.0 0.0 3.0 1.9 0.8 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;fallopian tube: 33.6" "Group enriched" "Detected in some" 7 "Hep G2: 19.9;RT4: 19.5;SCLC-21H: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "myeloid DC: 4.8;plasmacytoid DC: 10.4" "Lineage enriched" "Detected in single" 20 "dendritic cells: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065720 Enhanced Approved Nucleoplasm Nucleoplasm "HPA065720: " "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favourable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 4.6 1.1 12.4 2.8 20.8 0.4 4.2 8.0 13.3 6.7 4.8 21.0 3.7 2.2 4.0 5.6 6.7 33.6 2.7 2.2 12.0 8.6 1.9 0.9 9.9 7.1 37.8 8.2 6.9 13.3 1.1 0.6 6.3 13.7 8.9 1.8 2.1 14.0 21.2 2.8 4.8 2.1 3.8 16.7 1.4 4.3 3.1 28.0 4.2 1.8 1.0 6.3 13.2 3.3 0.5 10.4 0.3 0.3 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.5 2.6 0.2 2.5 0.0 0.3 0.2 0.0 0.0 19.9 0.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 2.6 0.0 0.0 19.5 27.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 4.8 0.5 0.1 0.4 0.0 0.0 0.0 10.4 0.0 0.2 12.4 20.8 8.0 13.3 12.0 8.6 37.8 8.2 13.7 28.0 ANKS1A "ANKS1, KIAA0229" ENSG00000064999 "Ankyrin repeat and sterile alpha motif domain containing 1A" Q92625 6 34889265-35091413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036768, HPA036769" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036768: AB_10670923, HPA036769: AB_10672473" "unprognostic (3.75e-2)" "unprognostic (2.67e-1)" "unprognostic (2.59e-2)" "unprognostic (7.79e-3)" "unprognostic (5.73e-2)" "prognostic favourable (7.48e-4)" "unprognostic (1.18e-3)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (2.18e-1)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "prognostic favourable (8.05e-5)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.23e-2)" "unprognostic (7.80e-2)" 13.6 15.6 11.8 10.5 20.7 5.0 11.5 19.2 19.9 8.8 20.3 11.6 33.9 9.8 10.2 11.0 15.4 19.8 9.9 14.8 11.7 8.0 10.3 11.6 14.5 8.0 15.0 8.8 14.6 11.0 13.9 12.8 27.3 12.8 9.3 8.7 19.7 8.5 30.4 14.8 11.6 10.9 13.9 10.6 18.6 12.3 23.6 13.9 9.5 11.3 4.2 9.1 22.7 9.9 1.3 3.4 2.4 4.3 0.5 1.5 1.1 7.9 3.5 8.2 7.9 3.7 3.4 12.6 3.3 3.7 3.8 4.9 9.9 4.8 5.3 5.3 3.2 8.1 9.5 9.0 4.1 4.2 11.2 3.8 4.6 7.5 2.3 6.1 3.8 4.2 8.3 4.8 6.1 9.0 6.6 2.5 3.5 5.3 3.6 6.9 6.0 4.3 4.7 4.3 5.7 8.1 15.4 32.2 8.1 4.8 7.8 24.5 6.0 7.1 7.7 4.1 5.1 4.2 4.8 3.7 5.7 2.6 3.2 9.2 11.2 0.0 2.0 1.2 0.9 2.9 1.2 1.3 0.8 1.5 1.5 0.5 1.0 0.8 2.4 0.5 4.3 3.4 1.0 1.1 11.8 20.7 19.2 19.9 11.7 8.0 15.0 8.8 12.8 13.9 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233665-21253845 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 64.5;kidney: 16.2;liver: 15.0" "Group enriched" "Detected in some" 4 "HDLM-2: 5.3;Hep G2: 12.7" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.0" HPA043523 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043523: AB_10966687" "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.1 0.1 0.1 4.3 0.2 0.0 0.1 0.9 0.1 0.1 26.9 0.0 0.0 9.3 0.1 1.5 0.1 0.1 9.2 0.1 0.1 0.1 16.2 15.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.5 0.1 64.5 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.6 2.0 0.4 1.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.1 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.5 0.4 0.4 0.3 0.3 0.2 0.5 0.3 0.2 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.6 0.3 0.1 0.1 0.2 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favourable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.4 8.3 7.7 13.4 6.4 5.2 5.2 4.0 6.9 4.5 5.4 4.6 4.0 10.2 3.1 5.7 16.5 5.6 6.8 2.4 14.2 5.8 2.5 5.0 1.9 6.3 1.3 1.7 6.4 8.5 6.2 6.3 5.1 17.2 2.4 3.4 9.1 0.5 2.6 12.1 9.1 6.8 19.1 0.8 8.2 3.4 5.0 5.7 1.7 9.9 4.5 0.0 2.8 5.2 4.8 5.2 12.9 3.9 4.8 8.0 1.7 6.7 4.6 6.8 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 ANKZF1 "FLJ10415, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger domain containing 1" Q9H8Y5 2 219229757-219236669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavourable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavourable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 10.1 11.1 14.8 19.0 19.8 13.7 12.9 38.4 25.9 13.8 15.4 17.5 21.7 17.5 14.3 14.7 17.1 21.1 11.7 13.8 12.7 9.6 15.2 15.8 13.2 23.2 19.6 13.5 19.6 19.0 12.3 22.7 11.3 16.4 16.6 10.4 13.6 18.2 22.7 18.9 21.7 19.5 9.5 18.5 21.0 15.1 8.7 18.8 18.7 14.0 8.8 19.8 16.8 16.2 11.7 8.3 10.7 10.6 20.6 17.8 11.0 19.2 3.9 5.1 7.5 7.1 5.9 20.2 6.4 6.4 8.9 11.3 9.4 8.2 4.1 11.5 2.7 14.2 6.8 10.9 6.5 8.5 7.0 9.0 11.5 8.7 7.0 5.5 8.9 5.9 21.7 6.6 10.5 6.0 15.1 9.4 4.5 8.5 8.5 14.5 8.4 7.0 8.8 6.1 13.1 4.8 4.9 6.6 6.2 6.5 15.4 12.3 4.0 13.6 6.5 7.3 5.6 5.9 8.0 20.6 11.7 7.3 12.4 8.4 3.2 8.4 7.7 8.8 14.6 7.5 15.4 11.0 14.7 14.4 7.8 11.7 17.8 16.3 10.7 20.6 10.6 8.3 14.0 11.0 14.8 19.8 38.4 25.9 12.7 9.6 19.6 13.5 16.4 18.8 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.4;HUVEC TERT2: 8.3;U-2 OS: 22.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: " "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.1 0.0 3.9 0.0 0.0 0.2 1.8 0.0 8.4 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.3 0.0 1.6 0.0 0.8 0.0 0.0 4.0 0.0 1.6 0.0 0.9 0.1 0.1 0.0 0.0 2.0 1.4 0.0 1.1 0.0 0.2 0.0 22.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 6 "PC-3: 41.0;RT4: 55.4" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005469 Enhanced Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849" "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favourable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6" "Group enriched" "Detected in some" 13 "A549: 23.3;HDLM-2: 12.0" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Region enhanced" "Detected in single" "midbrain: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.1 0.3 0.7 0.5 0.0 0.4 0.1 0.4 0.2 30.3 0.4 41.9 66.5 1.1 2.6 0.2 13.3 38.7 0.1 0.5 0.6 2.1 4.3 0.1 0.1 3.0 0.1 0.9 0.3 0.0 0.1 0.1 0.7 1.1 8.1 0.2 0.2 20.7 0.1 0.1 108.6 0.4 8.0 0.1 0.7 2.3 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.4 0.5 0.6 3.0 0.1 0.7 0.3 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039081-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 25.1" "Cell line enhanced" "Detected in many" "HSkMC: 10.0;MOLT-4: 10.7;REH: 11.2;U-937: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: " "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavourable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 5.5 1.6 1.3 8.8 4.1 13.1 8.6 1.0 1.5 5.7 4.1 2.0 1.8 2.5 3.6 3.9 4.6 3.7 2.9 2.2 1.7 1.3 2.4 1.4 7.2 19.0 2.6 0.5 2.0 1.1 0.7 1.8 2.6 1.4 5.7 2.2 2.1 2.9 1.9 4.4 2.2 7.5 3.2 1.9 14.9 2.4 2.3 2.0 25.1 3.1 1.8 13.4 5.2 5.6 8.9 1.4 1.5 2.1 6.5 28.9 7.7 0.7 0.7 0.6 0.4 1.1 2.9 0.2 0.2 0.1 0.1 0.3 1.4 0.9 2.7 2.4 0.5 0.3 1.8 0.2 0.1 4.5 1.4 0.9 1.9 0.6 1.5 1.0 0.4 10.0 0.1 0.8 0.1 5.6 0.5 3.6 0.7 1.0 10.7 1.4 0.0 5.4 11.2 1.4 1.6 0.3 0.4 2.2 0.0 1.0 0.2 0.2 0.3 1.9 3.5 0.2 0.0 0.3 0.9 1.6 2.3 1.1 1.3 41.5 0.5 1.5 1.1 0.5 16.0 0.7 18.6 8.7 16.6 17.5 1.0 8.9 28.9 21.2 0.9 6.5 2.1 1.4 17.7 7.7 1.3 4.1 1.0 1.5 1.7 1.3 2.6 0.5 1.4 2.0 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Approved Nucleoplasm,Cytosol 540000 Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: " "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favourable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 27.4 27.1 28.0 18.5 28.7 24.1 29.3 23.5 33.1 25.2 21.1 25.0 15.5 13.0 25.1 28.2 24.7 19.7 20.7 36.6 27.2 26.8 39.4 40.8 21.5 33.0 26.0 28.8 26.2 24.2 103.3 28.1 23.3 24.9 24.1 25.4 22.8 26.0 25.3 75.4 21.5 17.3 32.3 25.4 21.3 18.0 11.7 15.5 17.1 30.2 28.2 26.7 27.6 20.5 35.3 36.4 53.0 34.9 33.0 44.4 42.5 24.2 17.6 6.9 16.8 27.0 26.6 15.0 16.2 42.9 21.3 18.0 25.6 28.8 9.7 16.5 30.6 20.4 12.8 19.2 21.2 23.9 9.5 13.7 8.8 22.8 23.8 19.5 6.3 16.5 18.7 26.6 47.7 18.9 17.8 27.6 27.0 19.4 11.0 12.6 7.7 122.1 9.1 19.6 17.6 36.9 14.9 5.5 7.6 18.3 42.3 15.3 26.4 10.4 17.6 8.7 15.8 26.3 20.9 17.9 25.4 13.7 20.6 25.3 6.7 53.0 34.9 45.1 22.2 26.2 30.1 35.3 34.4 27.7 36.4 24.0 31.5 27.7 35.4 33.0 25.6 15.6 44.4 42.5 28.0 28.7 23.5 33.1 27.2 26.8 26.0 28.8 24.9 15.5 ANXA8 ANX8 ENSG00000265190 "Annexin A8" P13928 10 47460162-47484158 "Predicted intracellular proteins" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 41.6;skin 1: 60.7" "Cell line enhanced" "Detected in some" "HaCaT: 72.1;HBEC3-KT: 105.1;hTCEpi: 59.4;RT4: 26.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "HPA045246, HPA047451" Approved Nucleoplasm Nucleoplasm "HPA045246: , HPA047451: " "unprognostic (8.32e-4)" "unprognostic (2.52e-1)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (5.94e-2)" "unprognostic (2.88e-2)" "unprognostic (2.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavourable (2.68e-4)" "unprognostic (1.19e-1)" "unprognostic (7.55e-15)" "unprognostic (1.04e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" 0.1 0.0 0.1 3.7 0.1 0.0 2.3 0.1 0.1 2.9 0.4 0.1 0.1 0.0 0.1 1.3 41.6 0.2 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.4 0.1 0.0 0.1 7.7 0.1 1.2 0.0 0.3 0.1 1.8 0.1 60.7 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 2.5 9.5 10.2 0.1 0.0 5.5 1.1 2.1 0.7 0.0 0.5 20.1 2.5 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 1.3 5.8 0.0 0.4 0.1 72.1 0.0 105.1 0.0 4.6 0.0 0.0 6.5 0.0 4.3 0.0 0.2 0.0 59.4 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 10.4 3.0 0.0 0.0 0.5 0.0 0.0 6.2 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 75.4;tongue: 34.2" "Cell line enhanced" "Detected in some" "HaCaT: 71.2;HBEC3-KT: 108.3;hTCEpi: 28.7;SiHa: 25.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;myeloid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;monocytes: 3.2" "HPA045246, HPA047451" Approved Nucleoplasm Nucleoplasm "HPA045246: , HPA047451: " "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.7 1.2 35.9 1.2 0.0 0.9 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.9 0.0 0.0 1.1 0.7 0.0 75.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 34.2 13.3 6.9 0.6 0.0 5.0 0.8 3.2 0.5 0.0 0.5 14.2 3.7 0.0 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.3 2.5 0.0 0.1 0.0 71.2 0.0 108.3 0.0 6.1 0.0 0.0 6.9 0.0 2.5 0.0 0.1 0.0 28.7 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.0 0.0 16.6 0.0 0.0 25.6 2.2 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 AP2A2 "ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899" ENSG00000183020 "Adaptor related protein complex 2 alpha 2 subunit" O94973 11 924894-1012245 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017514, HPA043040" Supported Supported Nucleoplasm,Vesicles 93000 Vesicles Nucleoplasm "CAB017514: AB_2056344, HPA043040: " "unprognostic (1.90e-1)" "unprognostic (1.54e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (1.28e-2)" "unprognostic (5.72e-2)" "prognostic unfavourable (9.27e-5)" "unprognostic (1.34e-2)" "unprognostic (4.09e-1)" "unprognostic (1.70e-1)" "prognostic favourable (4.57e-4)" "unprognostic (2.41e-1)" "unprognostic (2.86e-3)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (1.40e-1)" "unprognostic (2.08e-2)" 21.9 11.1 20.2 8.7 20.7 18.4 23.2 50.9 32.4 17.5 13.9 9.5 10.4 16.8 16.3 8.5 12.2 21.5 10.1 14.7 22.6 20.0 19.4 16.3 13.3 18.1 16.1 21.1 11.2 14.7 7.8 15.5 16.3 16.9 15.5 16.3 11.5 21.7 14.7 13.3 16.5 12.0 18.5 18.1 34.5 17.0 16.4 6.7 12.4 12.1 5.0 9.1 10.5 10.5 3.4 3.7 6.8 4.6 3.4 5.4 1.7 5.5 2.5 3.0 8.7 11.3 11.6 7.3 7.9 2.7 4.9 4.0 0.9 6.0 5.8 6.9 9.4 7.3 7.0 4.4 3.1 4.2 18.1 1.7 7.7 3.0 4.4 2.2 4.1 13.7 4.8 2.4 4.9 6.7 5.8 4.5 4.9 0.5 2.0 2.5 1.7 14.1 3.5 2.0 6.3 7.4 5.0 9.4 8.0 8.9 7.3 1.1 4.2 0.8 10.5 1.6 1.9 2.2 4.0 3.6 2.9 4.3 3.0 2.8 2.4 3.3 4.6 3.8 3.1 4.6 1.8 1.7 3.2 1.8 3.7 3.4 3.4 3.5 6.8 3.4 3.8 3.7 5.4 1.7 20.2 20.7 50.9 32.4 22.6 20.0 16.1 21.1 16.9 6.7 AP3B1 "ADTB3A, HPS2" ENSG00000132842 "Adaptor related protein complex 3 beta 1 subunit" O00203 5 78000525-78294755 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038737, HPA045458" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA038737: AB_10670788, HPA045458: " "unprognostic (9.14e-2)" "unprognostic (2.02e-1)" "prognostic favourable (1.37e-5)" "unprognostic (8.17e-2)" "unprognostic (2.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-3)" "unprognostic (7.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.97e-2)" "prognostic favourable (7.97e-6)" "unprognostic (1.65e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (3.39e-2)" 30.1 19.9 16.5 23.1 20.7 16.5 19.0 15.2 16.6 21.7 20.8 17.4 21.1 17.0 21.2 50.3 26.5 14.6 14.2 16.6 15.6 15.1 28.3 13.7 16.1 27.1 22.2 11.4 18.3 22.0 29.4 36.1 20.1 17.4 18.8 25.6 15.0 23.3 18.8 12.9 18.9 24.8 18.1 20.2 25.5 19.1 13.0 20.9 38.0 24.0 18.6 22.9 19.4 18.2 26.2 10.1 9.0 9.2 5.2 6.7 4.5 20.0 16.2 18.8 25.7 22.5 27.2 16.4 22.7 26.6 20.5 27.9 12.4 17.8 21.2 13.4 27.9 14.8 18.1 38.1 26.4 24.1 12.8 14.8 14.8 22.5 13.2 13.0 19.4 19.7 14.2 17.3 17.6 26.0 10.4 13.9 35.6 12.4 16.8 21.2 9.9 9.7 17.6 32.9 29.3 30.5 19.2 6.5 10.6 20.9 13.7 19.5 16.6 22.3 26.1 15.5 12.2 18.6 22.8 10.8 16.6 14.5 20.1 19.4 19.5 8.5 7.3 6.3 6.0 7.5 6.7 18.5 5.1 6.2 10.1 26.2 4.4 5.6 9.0 5.2 9.2 8.6 6.0 4.5 16.5 20.7 15.2 16.6 15.6 15.1 22.2 11.4 17.4 20.9 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell line enhanced" "Detected in some" "RT4: 11.5;SCLC-21H: 18.8;SH-SY5Y: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.1 1.9 0.5 0.1 4.5 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.4 0.1 0.7 0.5 0.0 0.1 1.5 0.5 0.3 0.4 0.2 0.3 0.3 1.2 0.5 0.6 0.1 0.2 0.1 0.6 0.5 0.1 0.8 0.3 0.3 5.9 0.1 0.3 0.1 0.1 0.0 11.5 18.8 14.6 2.8 0.7 1.3 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.6 0.5 1.4 0.2 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 beta 1 subunit" Q2VPB7 11 65775893-65780802 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "neutrophil: 22.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: , HPA067880: " "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favourable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 11.2 6.8 5.3 10.2 8.2 48.6 10.3 10.7 9.1 6.3 6.7 4.0 6.9 9.6 9.8 6.8 13.2 7.2 8.2 6.6 5.7 3.5 7.7 9.3 11.3 13.3 6.0 5.5 4.5 16.1 9.9 5.5 14.8 5.3 6.4 4.2 8.0 10.9 10.7 11.9 10.3 9.5 5.1 5.6 13.0 7.9 3.1 6.2 9.2 7.9 7.4 7.8 11.0 6.5 0.2 0.3 22.5 1.3 0.3 0.4 0.5 10.0 7.8 1.8 10.2 4.9 2.5 14.7 4.3 4.1 4.5 3.6 6.7 4.7 5.7 8.3 3.7 12.0 5.0 3.2 1.4 9.1 8.7 5.2 8.8 3.3 3.9 6.8 11.1 4.8 6.2 3.1 1.6 3.5 11.8 7.6 2.3 7.0 4.3 6.7 3.6 8.9 13.8 0.3 12.6 3.3 11.4 2.4 4.2 3.1 2.0 19.2 3.9 9.9 5.5 8.3 7.5 10.5 4.3 7.8 7.8 5.8 5.8 5.8 7.9 0.6 1.3 0.5 0.4 0.8 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 22.5 0.3 1.0 0.2 0.1 0.5 5.3 8.2 10.7 9.1 5.7 3.5 6.0 5.5 5.3 6.2 APAF1 "APAF-1, CED4" ENSG00000120868 "Apoptotic peptidase activating factor 1" O14727 12 98645141-98735433 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031373, CAB069399" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "CAB069399: AB_1611908, HPA031373: AB_10602230" "unprognostic (1.32e-1)" "unprognostic (5.12e-2)" "prognostic favourable (5.90e-4)" "unprognostic (2.21e-1)" "unprognostic (3.94e-1)" "unprognostic (8.21e-3)" "unprognostic (2.03e-3)" "unprognostic (1.35e-1)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (5.63e-2)" "unprognostic (6.04e-2)" "unprognostic (9.93e-3)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.07e-2)" 10.5 4.7 10.3 11.0 11.0 36.1 8.8 13.4 11.5 10.8 11.6 8.2 5.5 7.0 10.6 7.5 6.2 6.3 11.6 5.8 10.2 8.6 5.8 6.8 11.8 11.2 8.8 6.7 10.8 7.4 5.7 6.2 10.1 8.2 9.1 12.9 8.5 8.2 6.4 6.0 7.5 14.9 7.2 10.9 15.9 8.6 6.1 9.3 15.7 7.0 3.9 14.2 9.5 9.0 2.8 6.3 33.0 8.7 1.1 1.9 1.5 4.3 6.6 20.2 7.7 6.9 12.2 5.6 11.0 8.3 8.4 8.5 4.2 3.2 6.6 3.1 9.2 7.3 14.1 8.0 10.6 4.6 5.7 12.0 6.3 5.2 2.4 11.7 15.5 5.0 2.5 8.5 4.4 14.4 5.6 3.4 12.3 1.2 6.2 12.3 5.5 3.8 7.8 16.1 2.1 4.9 7.8 2.9 5.0 8.6 3.6 3.2 6.3 17.6 11.1 5.7 4.5 6.5 3.5 2.3 4.3 7.3 2.2 16.5 7.5 6.2 8.7 7.2 1.9 3.6 1.5 2.4 1.4 1.1 6.3 2.8 1.4 0.9 33.0 1.1 3.6 4.6 0.9 1.5 10.3 11.0 13.4 11.5 10.2 8.6 8.8 6.7 8.2 9.3 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916499 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol 77000 Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 23.2 29.8 12.0 13.7 18.7 9.6 15.8 7.6 12.6 12.7 13.8 17.9 16.8 10.5 15.3 10.8 12.2 13.9 12.1 15.4 14.5 11.7 24.8 21.8 16.2 14.4 21.5 11.7 13.2 19.7 13.4 10.3 12.5 21.1 14.1 12.6 10.4 18.5 20.4 48.7 6.8 13.9 16.0 27.8 13.9 19.1 9.7 21.1 23.9 19.0 12.9 11.5 19.0 16.1 14.2 25.6 14.9 19.8 17.5 15.8 10.6 8.5 9.1 10.9 2.5 8.9 8.8 4.9 12.6 12.2 12.4 14.2 5.4 7.5 26.2 7.7 4.6 10.2 19.8 8.5 16.1 16.1 18.8 13.5 9.7 13.7 13.7 37.4 10.4 8.6 6.3 7.9 13.0 10.2 31.7 16.1 8.6 8.2 17.9 17.3 8.6 21.7 11.5 31.8 8.9 12.8 12.3 9.2 4.4 15.8 12.7 15.5 13.3 11.6 8.5 9.4 9.4 24.0 3.0 15.8 11.9 29.5 11.7 8.0 11.9 4.7 16.9 14.9 11.0 17.5 13.6 14.2 13.4 11.9 25.6 13.4 13.8 11.7 4.1 17.5 19.8 16.5 15.8 10.6 12.0 18.7 7.6 12.6 14.5 11.7 21.5 11.7 21.1 21.1 APOBEC3B "FLJ21201, PHRBNL" ENSG00000179750 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3B" Q9UH17 22 38982347-38992804 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.1" "Cell line enhanced" "Detected in many" "A-431: 59.6;Karpas-707: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 10.2" "Low lineage specificity" "Detected in many" "HPA056980, HPA066719" Approved Nucleoplasm Nucleoplasm "HPA056980: , HPA066719: " "unprognostic (2.92e-2)" "prognostic favourable (2.58e-5)" "unprognostic (4.29e-2)" "unprognostic (1.19e-1)" "unprognostic (2.50e-1)" "unprognostic (1.35e-1)" "unprognostic (1.69e-2)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (6.36e-2)" "unprognostic (1.08e-2)" "unprognostic (5.88e-2)" "prognostic unfavourable (2.78e-4)" "unprognostic (8.47e-2)" "unprognostic (2.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.04e-1)" 1.6 2.3 0.3 4.4 2.2 20.1 1.4 0.3 1.2 2.3 9.9 0.7 0.3 5.8 2.0 2.4 4.6 1.2 2.2 1.6 0.6 0.2 3.6 0.9 2.5 4.3 0.3 0.3 1.7 5.7 0.4 0.3 6.4 0.8 2.1 10.0 1.3 4.8 0.3 4.1 1.9 8.8 1.0 0.7 10.4 3.8 2.0 0.3 5.9 3.3 0.3 12.0 2.0 2.4 10.2 0.8 1.7 5.8 2.2 3.8 5.9 59.6 6.7 2.6 16.1 0.3 1.5 4.5 5.5 4.8 10.6 13.9 12.8 10.9 0.6 5.0 5.5 25.6 0.3 1.1 10.7 21.6 0.6 17.2 1.4 3.3 0.1 14.2 10.4 0.5 0.1 11.0 0.5 4.1 9.6 67.6 16.4 1.6 0.0 8.0 0.0 6.0 0.4 25.8 21.5 2.1 10.1 0.4 0.0 0.0 0.0 3.7 7.9 4.1 2.5 11.7 20.4 1.8 0.1 15.0 4.1 0.0 8.3 15.9 23.7 0.5 1.3 0.0 0.3 5.8 0.0 10.2 0.8 0.5 0.8 3.2 0.0 0.4 1.7 2.2 1.8 0.1 3.8 5.9 0.3 2.2 0.3 1.2 0.6 0.2 0.3 0.3 0.8 0.3 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Group enriched" "Detected in some" 19 "CACO-2: 27.8;Hep G2: 75.2" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" 88520000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: , HPA073918: " "prognostic favourable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 27.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 75.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 APOL2 APOL-II ENSG00000128335 "Apolipoprotein L2" Q9BQE5 22 36226203-36239954 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001078 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" 10000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA001078: AB_10602432" "unprognostic (4.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.50e-2)" "unprognostic (4.26e-3)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.38e-2)" "unprognostic (7.39e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.22e-7)" "unprognostic (1.80e-1)" "unprognostic (6.79e-2)" "unprognostic (2.66e-2)" "prognostic favourable (5.06e-6)" 21.5 14.2 17.4 25.3 12.0 6.9 20.3 26.5 30.1 16.7 15.6 11.1 11.1 25.0 20.3 17.9 10.2 15.3 25.6 17.3 15.1 19.3 18.2 39.7 23.6 22.0 20.2 11.9 12.6 10.1 11.2 57.1 14.6 28.7 19.0 16.1 15.9 15.2 18.8 16.5 9.6 21.7 22.2 16.2 26.2 22.7 7.2 12.0 14.9 23.0 12.7 17.0 25.8 19.4 6.2 6.0 43.0 17.0 9.9 15.5 4.6 7.4 5.5 5.4 4.1 21.2 16.5 10.3 10.1 23.7 27.6 37.5 2.2 6.1 9.0 17.2 18.2 3.5 5.9 8.1 13.7 30.4 6.7 4.2 11.7 10.4 35.8 9.0 8.2 20.8 5.5 19.3 5.1 17.9 7.5 25.6 17.2 2.7 9.1 4.0 2.0 5.1 9.4 7.0 5.3 27.8 19.7 9.8 2.8 6.9 13.2 5.4 4.1 1.3 17.3 16.7 8.3 3.4 5.6 15.5 7.7 2.8 14.4 4.7 6.3 8.9 8.6 5.8 15.5 17.0 14.1 6.2 11.2 12.7 6.0 4.1 6.5 10.9 43.0 9.9 11.4 3.7 10.5 4.6 17.4 12.0 26.5 30.1 15.1 19.3 20.2 11.9 28.7 12.0 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811944 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Supported Nucleoplasm,Cytosol 1200000 "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 22.9 37.1 10.9 33.6 13.2 32.9 31.6 10.1 15.3 22.7 31.1 10.7 33.6 27.1 19.9 28.3 50.7 21.0 30.4 22.5 9.1 8.2 27.7 60.4 30.6 94.2 14.8 10.7 17.9 58.2 19.4 15.6 19.3 11.0 25.1 15.1 13.9 48.2 37.4 26.2 49.8 24.3 18.4 12.1 30.4 27.5 16.0 12.2 37.9 29.5 49.7 35.8 18.5 32.8 65.4 92.1 24.2 70.2 58.2 83.7 104.7 25.4 37.4 7.3 33.0 9.0 17.9 39.1 19.3 17.2 22.8 8.9 38.5 30.9 23.7 37.8 10.9 27.3 12.0 31.7 4.6 16.7 71.6 20.2 17.7 40.2 28.6 13.8 16.5 19.1 34.3 18.1 23.0 28.4 42.4 17.8 11.5 93.8 39.0 40.8 28.2 49.0 42.0 11.4 56.1 25.1 17.3 36.5 22.4 36.8 21.5 20.8 71.0 27.5 18.3 20.6 18.0 16.6 18.9 35.0 29.3 65.2 30.3 36.8 18.1 8.5 70.2 24.2 63.0 57.7 83.7 63.2 81.9 67.5 71.6 65.4 75.9 64.3 4.3 58.2 37.1 92.1 66.1 104.7 10.9 13.2 10.1 15.3 9.1 8.2 14.8 10.7 11.0 12.2 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell line enhanced" "Detected in many" "CACO-2: 8.7;Hep G2: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favourable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.1 3.6 1.5 2.4 3.5 0.9 1.6 1.9 0.8 1.8 0.8 8.7 1.7 1.8 0.9 0.8 1.1 0.6 0.1 0.9 5.3 1.5 1.4 1.2 14.4 1.1 3.0 1.7 0.9 0.3 1.0 0.2 0.3 0.9 1.1 2.0 1.8 1.1 2.0 1.6 3.4 1.6 3.9 0.6 1.0 1.4 1.5 1.1 2.4 0.5 0.9 1.8 0.4 1.0 1.4 4.6 2.8 1.2 1.2 0.8 1.4 0.5 0.2 2.0 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 ARAF ARAF1 ENSG00000078061 "A-Raf proto-oncogene, serine/threonine kinase" P10398 X 47561100-47571920 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046188, HPA066326" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA046188: AB_2679578, HPA066326: AB_2685659" "unprognostic (1.21e-1)" "unprognostic (5.69e-3)" "unprognostic (2.47e-2)" "unprognostic (2.10e-2)" "unprognostic (7.63e-2)" "unprognostic (9.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "unprognostic (6.75e-2)" "unprognostic (8.65e-2)" "prognostic favourable (1.45e-6)" "unprognostic (1.97e-1)" "unprognostic (2.01e-1)" "unprognostic (6.37e-2)" "unprognostic (4.71e-2)" 22.2 24.2 10.9 16.5 15.5 41.9 19.5 16.0 13.7 18.0 23.2 21.1 24.1 17.8 21.3 18.4 19.4 18.7 21.0 28.6 12.8 7.3 28.0 49.6 21.8 20.2 16.4 9.5 23.4 35.1 28.1 16.9 25.3 13.5 23.5 15.8 25.4 22.1 18.5 60.8 18.9 23.8 18.6 11.2 27.4 24.2 10.2 16.3 27.7 23.1 23.9 27.3 20.2 16.9 23.9 34.3 36.1 38.4 22.4 29.1 27.5 19.9 28.8 12.3 19.9 18.8 15.0 16.7 16.8 17.8 25.2 23.3 23.4 24.5 11.9 13.9 22.6 28.2 21.8 23.3 14.5 21.8 25.6 11.9 30.5 12.1 26.5 23.6 36.5 19.7 23.7 24.0 21.1 19.4 22.0 23.5 17.0 33.8 17.1 25.4 17.7 32.2 15.9 16.1 26.8 14.4 19.1 14.0 10.8 18.2 16.8 9.9 31.6 17.8 18.4 16.4 18.4 32.7 17.0 30.5 19.5 9.2 21.8 26.7 13.0 23.9 29.0 36.1 29.1 35.4 26.9 21.4 25.5 26.7 34.3 23.9 22.7 26.7 23.6 22.4 38.4 24.7 25.1 27.5 10.9 15.5 16.0 13.7 12.8 7.3 16.4 9.5 13.5 16.3 ARAP1 CENTD2 ENSG00000186635 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1" Q96P48 11 72685069-72793599 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020703, HPA070383" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" 39000 "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "CAB020703: , HPA070383: " "unprognostic (3.60e-2)" "unprognostic (7.68e-2)" "unprognostic (6.19e-2)" "unprognostic (5.98e-2)" "unprognostic (5.76e-2)" "unprognostic (1.64e-2)" "prognostic unfavourable (6.45e-4)" "unprognostic (4.01e-2)" "unprognostic (4.07e-1)" "unprognostic (5.95e-2)" "prognostic favourable (2.04e-5)" "unprognostic (1.84e-1)" "unprognostic (1.05e-3)" "unprognostic (6.93e-2)" "unprognostic (2.57e-2)" "prognostic favourable (6.41e-4)" "unprognostic (7.56e-3)" 19.2 29.6 28.8 32.9 29.1 51.1 17.9 34.0 37.5 19.6 16.8 26.6 20.0 17.4 23.7 20.0 21.1 30.3 26.1 20.3 27.7 14.4 20.9 16.6 35.5 27.8 27.5 17.8 28.8 18.9 14.3 31.0 20.9 23.0 21.3 11.2 18.1 19.9 19.0 12.9 27.5 23.6 17.1 25.6 53.8 16.2 23.5 32.3 18.8 24.7 14.0 18.6 28.4 19.6 3.3 7.4 24.0 22.5 6.1 4.4 6.4 7.1 15.1 5.8 7.0 24.8 16.8 8.7 9.8 17.7 11.2 11.1 20.7 19.0 15.8 19.8 16.5 24.1 8.8 23.4 4.8 18.6 10.3 13.4 14.3 28.5 17.2 9.1 37.7 17.9 24.9 18.3 8.8 11.8 11.2 6.4 5.2 14.7 13.8 31.8 3.6 9.8 13.5 8.8 7.7 10.4 22.8 6.0 12.3 7.1 10.6 31.6 9.3 20.8 14.0 15.9 11.0 16.1 6.0 10.3 5.0 8.3 8.4 13.7 8.4 7.5 11.0 13.3 4.4 18.7 2.6 3.3 2.9 3.3 7.4 2.6 2.3 2.7 24.0 6.1 22.5 2.5 3.1 6.4 28.8 29.1 34.0 37.5 27.7 14.4 27.5 17.8 23.0 32.3 ARFIP1 HSU52521 ENSG00000164144 "ADP ribosylation factor interacting protein 1" P53367 4 152779937-152918463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005080, HPA037375, HPA063759" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB005080: AB_2058797, HPA037375: , HPA063759: " "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "prognostic favourable (5.75e-5)" "unprognostic (1.49e-3)" "unprognostic (4.32e-1)" "unprognostic (1.24e-1)" "unprognostic (3.54e-2)" "unprognostic (5.34e-1)" "unprognostic (1.03e-2)" "unprognostic (3.56e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-2)" "prognostic favourable (2.83e-10)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (7.02e-2)" "unprognostic (4.22e-3)" 17.8 15.6 12.2 22.6 13.2 2.8 22.3 15.7 12.3 22.8 25.3 17.5 25.6 20.9 21.1 23.8 23.4 17.6 20.8 11.9 12.6 13.2 23.6 15.3 20.3 14.9 16.1 9.5 22.9 18.8 20.4 22.5 29.0 13.5 23.8 26.4 19.1 19.6 23.9 12.7 19.1 29.9 18.5 18.3 18.5 20.2 12.7 13.9 14.7 23.9 10.2 17.9 24.3 20.4 8.4 10.9 35.7 13.8 12.3 7.6 7.7 13.0 9.8 13.7 13.4 21.6 22.1 16.9 15.8 22.3 15.9 15.2 11.4 27.5 10.5 5.3 21.9 9.4 14.1 15.9 19.9 8.8 8.8 10.4 10.0 11.2 15.3 19.5 22.0 15.5 17.8 13.5 13.4 14.6 12.1 22.8 22.3 15.2 10.9 10.9 11.5 10.0 6.3 7.7 9.7 28.8 17.6 17.3 14.3 11.9 22.4 15.7 20.1 10.5 9.1 15.5 11.0 14.9 11.1 25.1 20.6 14.4 19.6 19.5 21.3 12.1 12.0 17.9 6.7 13.8 6.7 8.4 5.3 5.5 10.9 7.7 4.1 5.5 35.7 12.3 12.6 1.3 7.6 7.7 12.2 13.2 15.7 12.3 12.6 13.2 16.1 9.5 13.5 13.9 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favourable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favourable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 13.3 20.5 19.7 15.2 19.4 12.6 33.0 24.0 32.0 24.5 22.9 16.4 29.5 20.2 17.5 23.1 22.0 25.5 21.5 13.2 16.5 17.2 21.3 32.7 17.5 13.0 15.5 22.0 20.3 36.0 36.1 29.9 27.3 16.8 30.9 31.2 18.6 46.6 29.4 12.1 21.6 23.5 17.8 14.9 15.0 31.2 14.9 16.0 12.3 28.4 16.3 24.2 16.0 19.8 11.5 17.4 7.8 12.7 15.6 15.5 10.8 14.0 18.8 11.5 11.7 18.1 16.9 16.4 11.4 31.2 25.7 30.7 17.8 23.7 11.4 4.9 23.0 20.1 14.5 24.3 21.5 8.8 25.7 6.1 25.0 16.9 21.8 9.9 12.7 17.9 19.5 12.3 30.1 16.3 9.8 13.5 16.7 27.8 11.7 11.3 19.4 21.4 9.0 6.5 10.8 17.9 14.7 15.3 18.6 13.9 62.0 7.1 25.5 9.2 10.3 11.0 10.6 11.4 8.4 20.2 9.0 6.9 19.7 6.2 12.5 7.4 12.7 7.8 15.5 8.8 15.2 10.7 14.6 12.7 17.4 11.5 14.5 14.8 5.3 15.6 5.4 13.6 14.7 10.8 19.7 19.4 24.0 32.0 16.5 17.2 15.5 22.0 16.8 16.0 ARHGAP10 "FLJ20896, FLJ41791, GRAF2" ENSG00000071205 "Rho GTPase activating protein 10" A1A4S6 4 147732063-148072780 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 9 "cerebellum: 154.3" HPA039589 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA039589: " "unprognostic (8.57e-3)" "unprognostic (1.34e-1)" "unprognostic (3.45e-2)" "unprognostic (1.38e-2)" "unprognostic (2.79e-1)" "unprognostic (3.41e-3)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.23e-4)" "unprognostic (2.40e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-2)" "prognostic favourable (8.15e-5)" "prognostic unfavourable (6.26e-4)" "unprognostic (1.54e-1)" "unprognostic (1.02e-3)" "unprognostic (1.09e-2)" 31.2 7.9 2.3 11.3 3.2 2.0 27.8 1.8 3.7 20.1 23.9 1.9 13.2 3.4 15.4 17.6 25.2 17.6 20.3 20.0 2.8 1.6 9.6 4.8 11.8 8.3 3.8 1.9 19.9 7.8 20.8 4.7 7.5 9.9 19.8 6.0 16.0 6.7 17.0 37.5 12.3 8.9 58.0 5.2 9.7 15.9 11.2 2.5 8.7 9.9 12.4 7.9 28.7 24.9 0.0 2.6 14.0 1.5 4.1 9.7 2.1 9.6 3.9 2.1 4.4 16.4 22.4 22.3 13.4 11.2 8.6 6.7 10.1 5.6 0.0 2.3 11.4 4.8 7.8 11.0 10.5 5.3 5.2 3.3 3.1 0.3 25.3 3.2 3.9 11.5 8.6 10.7 9.2 10.4 0.4 18.3 15.4 11.8 2.0 0.0 1.9 1.9 3.7 6.1 11.3 5.9 8.9 5.2 2.4 3.5 14.1 3.7 1.7 0.3 10.4 8.2 6.3 4.9 6.4 6.8 0.8 0.0 12.4 0.4 7.2 0.0 1.5 14.0 5.2 0.0 9.7 0.0 3.9 5.7 2.6 0.0 1.1 5.7 0.2 4.1 0.0 0.0 4.6 2.1 2.3 3.2 1.8 3.7 2.8 1.6 3.8 1.9 9.9 2.5 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell line enhanced" "Detected in many" "HaCaT: 75.4;RT4: 29.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: " "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavourable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavourable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavourable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.1 4.3 3.9 1.3 2.5 8.3 4.9 11.1 12.5 9.8 5.7 14.3 14.2 0.1 9.2 25.7 75.4 0.4 15.7 7.0 0.8 0.8 0.0 13.8 0.1 12.5 0.8 0.0 4.8 3.0 7.1 4.5 10.0 0.1 2.1 5.5 0.0 2.4 1.5 2.3 1.6 4.2 8.5 2.6 4.1 29.3 0.9 2.2 6.7 0.0 0.0 1.7 1.9 14.5 16.5 5.8 3.3 2.9 1.7 1.7 0.4 4.1 2.0 14.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 94.2;lymphoid tissue: 48.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 73.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 94.2" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4" "Low region specificity" "Detected in all" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favourable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 7.4 3.5 2.6 33.1 3.6 14.6 5.7 0.9 3.2 3.1 4.9 6.7 1.6 2.5 4.0 10.5 3.5 3.5 7.2 4.3 2.8 2.3 5.7 4.6 12.9 39.0 5.9 1.9 8.1 2.2 0.6 3.1 4.5 4.2 3.7 4.2 3.1 5.7 1.5 2.0 3.3 14.3 3.5 6.3 48.7 3.4 2.2 3.3 20.9 4.0 2.3 40.6 6.1 4.7 23.6 7.5 94.2 12.5 22.8 26.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.1 0.0 0.7 0.0 5.7 0.0 0.6 0.0 18.3 0.0 0.0 0.2 4.0 73.6 0.0 0.7 0.1 2.3 0.0 0.1 6.7 0.0 0.0 4.6 12.9 0.3 0.0 5.1 1.2 0.2 0.0 1.5 1.1 0.1 0.0 0.0 0.4 0.0 3.4 0.9 0.0 0.2 0.0 0.1 14.5 7.7 4.6 0.0 9.1 0.1 27.5 8.7 72.8 26.3 10.9 16.4 23.6 11.8 22.7 5.3 14.5 8.5 15.0 94.2 22.8 12.5 7.5 14.2 15.7 2.6 3.6 0.9 3.2 2.8 2.3 5.9 1.9 4.2 3.3 ARHGAP29 PARG1 ENSG00000137962 "Rho GTPase activating protein 29" Q52LW3 1 94148988-94275068 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 47.6;hTERT-HME1: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 38 "monocytes: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026534 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Nucleoplasm, Centrosome" "Plasma membrane, Cytosol" "HPA026534: AB_1844998" "unprognostic (2.49e-1)" "unprognostic (1.52e-3)" "unprognostic (3.16e-2)" "prognostic unfavourable (6.26e-5)" "unprognostic (8.53e-2)" "unprognostic (2.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "prognostic unfavourable (9.63e-4)" "unprognostic (4.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.81e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (4.61e-3)" 28.1 3.2 7.2 6.8 10.6 0.3 24.4 34.9 11.5 11.9 7.4 2.3 9.0 2.8 10.3 8.1 6.9 8.2 9.1 15.9 7.8 5.2 27.7 21.1 23.0 8.2 6.7 3.6 11.5 6.5 12.8 7.4 22.9 10.0 12.2 4.7 11.7 20.7 10.4 10.3 13.5 5.4 8.0 6.4 26.0 8.8 7.7 7.0 2.2 22.7 8.9 3.8 10.6 14.8 0.0 0.0 0.0 3.7 0.0 0.0 0.3 47.6 2.0 2.9 0.0 10.4 24.7 10.6 16.0 26.1 13.6 19.8 5.7 2.4 0.0 36.1 32.1 10.2 0.1 10.9 28.0 0.0 1.5 0.2 2.7 2.5 1.0 0.0 0.0 4.8 2.0 10.3 43.0 36.5 0.0 0.0 13.4 1.6 0.9 0.0 3.9 32.9 0.6 2.4 0.0 28.6 4.2 0.0 0.6 9.8 7.7 0.7 2.3 0.1 32.8 8.2 11.3 12.6 12.3 0.0 0.0 0.0 1.6 0.0 0.4 0.0 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 7.2 10.6 34.9 11.5 7.8 5.2 6.7 3.6 10.0 7.0 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 62.9" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.1 1.9 3.6 1.0 3.5 0.0 1.2 6.2 7.0 2.0 2.0 2.4 1.7 1.2 1.4 7.0 0.9 0.4 5.3 4.4 1.8 0.2 1.5 0.3 3.3 0.9 2.9 2.0 4.0 0.9 2.1 0.9 3.5 2.3 0.6 2.6 2.4 0.6 7.2 0.9 1.2 12.8 2.8 0.1 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 7.5 7.5 3.5 5.5 0.7 0.6 6.8 1.9 0.6 2.4 1.6 4.8 4.5 0.7 5.1 0.8 6.4 1.7 1.9 0.5 0.0 6.7 0.1 4.9 3.0 1.2 0.0 0.7 0.5 3.1 3.2 1.3 0.8 6.9 0.0 1.0 12.1 4.1 0.0 3.7 10.7 3.8 2.8 2.8 1.9 3.8 10.3 7.3 5.7 2.0 3.4 8.4 1.1 1.9 1.8 0.1 6.2 4.1 0.0 0.1 0.3 3.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 18.6;epididymis: 38.0;skin 1: 26.7" "Cell line enhanced" "Detected in some" "BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.3 0.3 0.3 0.0 18.6 0.3 0.5 1.6 0.3 0.4 5.2 0.8 0.6 38.0 15.8 0.0 0.9 0.3 0.3 0.1 4.1 0.3 1.8 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 3.0 0.0 0.3 1.9 5.1 0.3 26.7 0.3 0.7 0.3 0.3 2.6 1.2 0.6 0.3 0.3 5.2 6.6 3.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.8 0.0 3.3 0.0 0.0 0.0 12.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 11.3 0.0 13.7 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.3 0.3 0.6 ARHGAP8 "BPGAP1, FLJ20185" ENSG00000241484 "Rho GTPase activating protein 8" P85298 22 44752558-44862788 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.3" "Cell line enhanced" "Detected in some" "A-431: 12.2;BEWO: 23.0;CACO-2: 14.6;HEK 293: 19.9;MCF7: 20.6;SK-BR-3: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 2.2" "Low lineage specificity" "Detected in single" HPA069694 Approved Approved Nucleoplasm Nucleoplasm "HPA069694: " "unprognostic (4.14e-1)" "unprognostic (1.21e-2)" "unprognostic (6.88e-2)" "unprognostic (8.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-2)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-1)" "unprognostic (8.78e-3)" "unprognostic (9.58e-2)" "unprognostic (7.65e-6)" "unprognostic (8.59e-2)" "unprognostic (3.29e-1)" "unprognostic (2.32e-2)" "unprognostic (2.22e-2)" 0.5 0.1 1.7 5.6 0.4 0.2 7.5 0.3 0.4 2.2 10.6 0.6 29.3 1.2 2.6 13.0 5.7 6.1 11.5 0.3 0.3 0.4 18.2 0.9 3.9 0.3 0.3 0.3 0.9 14.6 4.5 5.2 22.4 1.2 10.0 5.7 1.9 28.4 24.8 0.3 1.4 3.6 1.2 0.3 6.7 4.3 3.0 0.3 0.7 15.2 2.4 4.9 2.0 1.8 0.2 0.7 0.2 0.4 0.1 2.2 0.3 12.2 0.1 0.2 0.1 0.0 0.2 23.0 0.1 1.5 0.0 0.1 14.6 6.6 0.1 0.7 0.0 9.2 4.3 10.5 0.1 0.0 19.9 0.0 0.3 0.1 0.0 0.0 0.2 0.1 4.6 0.1 0.2 0.0 0.4 0.3 0.0 20.6 0.0 0.0 3.1 0.0 0.0 0.0 0.2 5.6 8.4 1.3 0.0 0.0 19.9 0.4 8.6 0.1 0.1 0.0 0.7 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 0.7 2.2 0.3 1.7 0.4 0.3 0.4 0.3 0.4 0.3 0.3 1.2 0.3 ARHGEF10 "Gef10, KIAA0294" ENSG00000104728 "Rho guanine nucleotide exchange factor 10" O15013 8 1823976-1958641 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024649 Approved Approved Nucleoplasm Nucleoplasm "HPA024649: AB_1845002" "unprognostic (2.51e-1)" "unprognostic (3.60e-2)" "unprognostic (2.39e-1)" "unprognostic (1.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (7.27e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-2)" "unprognostic (9.29e-2)" "unprognostic (3.37e-2)" "unprognostic (1.81e-2)" "unprognostic (4.42e-1)" "unprognostic (3.18e-2)" "unprognostic (4.46e-2)" 13.5 8.2 11.1 6.9 18.4 1.8 9.7 3.5 14.2 11.6 10.8 20.4 9.3 3.2 19.5 7.1 7.2 8.9 8.0 19.0 13.5 7.9 6.5 2.3 17.7 5.4 17.0 8.6 9.6 5.8 4.9 4.6 9.9 13.4 9.3 5.7 10.2 7.5 10.4 3.8 14.2 5.3 15.0 18.0 5.7 8.4 19.1 21.0 1.6 8.4 4.4 4.1 10.2 19.9 0.0 0.0 0.0 0.0 1.4 0.7 0.1 6.5 8.3 7.9 3.3 6.6 9.9 1.7 8.5 7.2 6.7 7.3 2.6 3.0 0.0 1.3 11.9 5.0 7.1 10.7 8.5 0.0 2.9 2.8 7.3 0.0 6.3 0.0 1.9 7.1 6.2 6.8 6.2 12.8 3.1 0.0 7.6 3.5 4.1 0.8 6.0 4.4 0.3 7.5 0.0 4.9 2.3 1.4 1.8 6.7 0.2 4.2 3.4 1.6 15.3 6.7 3.8 0.1 8.2 0.0 2.7 0.0 5.2 6.2 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.2 0.1 11.1 18.4 3.5 14.2 13.5 7.9 17.0 8.6 13.4 21.0 ARHGEF11 "GTRAP48, KIAA0380, PDZ-RHOGEF" ENSG00000132694 "Rho guanine nucleotide exchange factor 11" O15085 1 156934840-157045370 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011026, HPA012037, HPA014658" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428" "unprognostic (2.19e-1)" "unprognostic (9.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.17e-1)" "unprognostic (2.00e-1)" "unprognostic (4.94e-3)" "unprognostic (3.30e-2)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favourable (1.72e-4)" "unprognostic (3.38e-1)" "unprognostic (2.41e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-1)" "unprognostic (1.08e-1)" "unprognostic (4.73e-2)" 11.9 13.0 17.5 11.6 13.4 4.3 12.3 28.8 22.4 12.3 13.2 9.2 22.0 14.4 14.7 11.9 13.1 12.2 14.3 13.2 13.6 16.0 10.9 7.6 12.7 8.0 13.9 13.7 15.6 11.0 31.7 15.4 12.3 13.1 11.4 12.9 14.5 9.3 25.1 14.7 11.2 23.3 15.2 9.1 9.8 11.9 20.9 9.9 1.0 14.9 5.3 6.3 13.2 12.6 0.4 0.9 3.3 2.8 0.0 1.0 0.7 6.9 13.7 11.8 8.9 15.7 8.1 13.4 6.9 10.3 10.8 7.9 9.2 7.4 0.9 12.1 12.0 7.5 8.0 7.2 6.0 9.9 4.9 3.4 8.2 6.0 9.1 6.9 12.3 12.5 7.9 9.9 7.7 7.7 5.6 0.6 7.2 9.0 1.7 3.8 14.6 8.4 0.2 5.8 3.8 5.3 11.4 2.2 13.5 14.8 12.0 12.5 10.7 15.9 11.6 11.1 7.1 9.7 7.1 10.0 6.1 0.6 7.0 0.9 36.7 0.0 1.4 0.0 0.0 2.8 0.0 0.4 0.6 0.0 0.9 0.0 0.6 1.0 3.3 0.0 1.5 0.0 0.3 0.7 17.5 13.4 28.8 22.4 13.6 16.0 13.9 13.7 13.1 9.9 ARHGEF12 "KIAA0382, LARG" ENSG00000196914 "Rho guanine nucleotide exchange factor 12" Q9NZN5 11 120336914-120489936 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.2;NK-cells: 1.5;T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018911, CAB025581" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "CAB025581: , HPA018911: AB_1845003" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (6.91e-3)" "unprognostic (1.28e-1)" "unprognostic (7.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.56e-1)" "unprognostic (5.55e-2)" "unprognostic (4.79e-2)" "unprognostic (7.77e-2)" "unprognostic (4.34e-3)" "unprognostic (4.78e-2)" "prognostic favourable (5.43e-6)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" 17.6 19.2 27.6 8.3 32.5 5.9 19.6 40.4 41.5 21.7 16.4 12.4 15.7 14.9 17.5 15.9 17.8 18.6 17.3 23.4 21.8 17.7 41.2 38.8 24.1 6.5 15.8 26.3 16.3 16.9 55.8 17.2 25.4 21.1 16.8 17.8 20.7 16.7 20.0 24.1 29.0 14.8 18.6 10.8 12.4 19.0 6.7 13.0 3.0 31.3 15.0 10.9 19.4 22.9 0.3 0.3 2.2 0.1 1.5 1.0 0.4 12.9 10.9 14.7 14.0 19.9 19.9 6.1 15.3 17.3 9.3 11.9 12.7 9.5 1.1 18.8 27.3 9.8 18.8 19.4 18.2 10.7 9.2 21.1 11.7 9.8 17.8 0.0 15.7 18.9 14.1 20.4 22.7 28.2 17.8 43.3 23.5 9.0 0.0 0.0 4.0 9.4 4.6 16.8 4.1 22.9 22.6 10.8 13.3 21.4 18.0 5.6 15.3 1.7 27.8 20.7 8.9 13.4 11.1 12.7 5.1 7.2 8.5 2.7 15.6 2.2 0.0 0.0 1.0 0.1 0.2 0.3 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.5 0.1 0.3 0.7 0.4 27.6 32.5 40.4 41.5 21.8 17.7 15.8 26.3 21.1 13.0 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 9.8;U-251 MG: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: " "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favourable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 11.2 4.0 9.1 5.8 8.7 1.0 9.8 5.6 17.8 9.2 20.0 6.5 3.3 10.3 5.9 3.1 12.0 8.3 17.6 4.1 8.7 4.6 3.1 22.0 18.6 1.0 5.4 6.3 5.3 27.1 13.9 2.9 4.7 12.2 5.3 3.7 4.4 4.1 5.5 1.5 7.0 11.5 12.7 9.7 1.6 12.3 7.4 5.5 0.0 4.1 2.5 2.0 7.4 11.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 5.2 3.0 6.0 4.1 2.7 0.4 0.1 0.3 0.0 1.5 1.7 2.4 0.4 2.4 0.4 0.1 6.2 3.0 1.5 2.8 0.0 7.9 0.0 2.2 0.8 2.5 0.8 0.1 0.9 0.1 1.9 0.3 0.1 0.0 0.0 1.0 6.0 1.0 0.1 3.8 2.6 0.0 9.8 0.0 0.5 3.5 2.2 0.7 0.7 8.6 1.3 5.2 0.4 0.0 0.9 3.9 0.0 17.7 2.5 0.4 0.0 1.6 0.0 6.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.1 8.7 5.6 10.1 8.7 4.6 5.4 6.3 12.2 5.5 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 35.5" "Group enriched" "Detected in some" 8 "RPTEC TERT1: 16.0;SK-BR-3: 8.9;T-47d: 9.1" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA036510: AB_10672357, HPA045484: " "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.2 0.2 0.2 3.2 0.2 0.0 10.8 0.2 0.2 3.5 7.6 0.0 1.6 2.3 1.4 15.7 0.4 1.1 11.7 0.2 0.2 0.2 13.8 0.4 16.1 0.0 0.2 0.0 1.3 12.9 0.0 35.5 0.4 0.0 14.6 5.6 0.2 13.9 0.5 0.2 1.0 9.6 0.0 0.2 0.2 4.1 0.6 0.0 0.0 8.0 0.7 2.0 0.5 0.4 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 16.0 0.0 0.0 0.0 0.0 8.9 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070270-21090240 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.4;ASC TERT1: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 2.8;neutrophil: 9.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 15.7 32.9 9.3 7.4 9.2 1.7 12.4 16.5 8.2 16.2 8.2 11.4 30.9 3.5 13.6 12.6 5.9 9.3 20.2 7.8 10.2 4.6 7.2 16.9 9.3 4.2 12.6 4.5 15.7 16.6 17.7 6.6 6.3 9.1 9.8 6.3 10.3 20.1 30.0 6.5 4.9 5.2 11.2 10.5 19.5 6.4 4.7 10.8 1.3 11.0 4.9 2.5 8.6 9.6 0.0 1.0 9.2 1.3 0.1 0.0 0.5 1.6 1.5 17.4 3.1 14.7 22.2 0.6 5.8 15.7 6.8 5.3 0.7 4.1 0.0 0.9 11.4 2.5 1.5 2.0 2.6 3.2 0.6 2.3 1.7 4.7 2.0 1.5 8.6 9.0 1.4 5.9 1.8 0.0 0.7 0.7 5.5 0.2 0.0 4.8 3.9 0.3 0.5 11.5 0.7 4.4 2.1 0.4 6.0 3.2 0.3 4.7 1.5 5.1 2.8 14.1 9.2 6.2 2.7 1.4 0.0 0.0 4.8 2.1 3.8 0.0 1.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 0.5 9.3 9.2 16.5 8.2 10.2 4.6 12.6 4.5 9.1 10.8 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027333, HPA053692" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027333: AB_1845013, HPA053692: " "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.3 9.3 16.3 12.6 12.0 12.6 13.4 14.1 12.4 9.8 9.6 9.5 13.2 14.5 16.4 10.6 11.0 13.2 5.9 14.2 18.7 14.3 11.7 11.1 8.0 9.2 12.5 17.2 8.4 8.0 12.0 10.3 13.2 15.1 20.9 9.1 5.6 18.6 11.4 15.0 6.1 7.0 11.5 12.1 10.7 10.4 13.3 18.4 18.0 14.9 13.9 15.8 20.3 18.2 12.1 9.2 14.7 13.7 20.4 16.1 14.5 8.3 9.2 16.1 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901300-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 43.3 5.6 7.8 13.8 9.9 4.2 22.6 3.3 11.5 27.5 14.0 9.5 4.4 6.8 29.4 10.4 14.0 15.6 27.2 16.0 5.9 5.1 14.6 5.7 14.6 14.4 11.8 6.5 18.6 4.3 14.7 11.4 22.4 9.4 16.6 8.2 6.9 14.5 7.3 88.6 15.0 12.1 29.4 10.4 12.7 9.4 7.7 10.5 8.6 7.5 11.7 18.0 22.5 17.1 21.2 1.0 4.3 3.6 5.7 14.7 2.6 0.8 0.3 2.3 5.7 5.1 13.7 0.4 16.6 44.8 11.8 9.3 20.1 0.9 1.4 4.0 15.9 5.5 8.0 2.5 14.3 5.2 2.4 0.7 4.1 5.0 9.5 0.2 9.9 17.3 1.3 7.0 8.0 1.4 0.7 2.2 3.8 2.8 5.4 0.4 0.4 5.2 6.6 3.8 0.4 7.8 9.0 1.3 1.7 7.4 4.1 4.8 3.4 0.2 1.2 6.6 8.9 9.9 4.2 0.1 0.0 4.3 5.7 0.3 2.1 4.3 0.6 0.4 7.3 1.4 0.9 19.0 10.5 6.3 1.0 21.2 6.9 4.5 1.2 5.7 3.6 0.5 14.7 2.6 7.8 9.9 3.3 11.5 5.9 5.1 11.8 6.5 9.4 10.5 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014113-65022184 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favourable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 39.6 32.0 37.3 17.7 78.7 19.8 26.8 16.1 46.5 21.2 23.5 34.7 13.4 23.9 26.8 20.2 23.7 35.2 22.4 52.6 34.8 32.7 33.8 6.6 23.1 14.8 36.1 38.2 27.2 29.9 22.5 15.4 25.5 32.7 25.3 15.5 30.3 26.9 33.1 78.3 19.6 23.4 28.2 44.9 16.7 18.9 31.4 28.7 7.9 26.3 23.6 12.9 24.7 22.8 43.7 37.8 18.7 21.8 21.0 40.7 34.7 35.8 57.1 17.7 26.2 48.1 36.6 16.1 17.7 40.9 25.4 25.1 16.1 24.8 13.8 33.8 24.9 23.0 18.6 31.1 12.1 14.5 29.2 13.9 25.8 24.3 36.9 16.9 12.7 28.8 26.1 21.1 47.4 33.7 32.9 25.9 17.0 42.4 14.0 38.1 27.7 46.7 7.4 19.4 33.3 27.3 15.6 33.0 18.6 15.1 15.7 49.7 16.5 20.8 25.3 47.8 16.1 38.0 18.2 8.9 12.5 8.5 22.6 24.5 38.8 10.2 21.8 18.7 34.8 21.2 37.6 43.7 32.2 33.6 27.6 37.3 36.8 40.7 2.8 21.0 12.4 37.8 20.6 34.7 37.3 78.7 16.1 46.5 34.8 32.7 36.1 38.2 32.7 28.7 ARL3 ARFL3 ENSG00000138175 "ADP ribosylation factor like GTPase 3" P36405 10 102673731-102714407 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036292, HPA063596" Approved Supported Nucleoplasm,Centrosome 17000 Centrosome Nucleoplasm "HPA036292: AB_10673618, HPA063596: " "unprognostic (1.36e-1)" "unprognostic (2.89e-3)" "unprognostic (4.19e-2)" "unprognostic (7.58e-2)" "unprognostic (2.98e-2)" "unprognostic (3.24e-2)" "unprognostic (2.45e-2)" "unprognostic (7.69e-2)" "unprognostic (4.00e-2)" "unprognostic (3.21e-1)" "unprognostic (3.99e-3)" "unprognostic (5.58e-2)" "prognostic favourable (1.71e-6)" "unprognostic (5.62e-2)" "unprognostic (3.09e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-1)" 8.8 13.8 24.8 6.6 29.4 2.9 11.4 24.1 32.9 14.1 8.9 9.6 8.2 6.8 17.1 16.7 10.2 23.0 8.3 29.9 19.9 21.4 22.7 8.1 9.6 5.5 20.2 16.0 25.2 9.9 18.9 21.0 7.7 17.6 12.1 7.7 21.5 8.8 14.5 7.9 7.9 6.4 13.4 14.2 5.3 9.0 13.6 9.3 4.1 17.3 5.5 7.2 16.0 13.8 5.0 7.8 14.9 8.1 4.5 11.1 5.8 8.5 14.8 20.4 14.9 9.5 14.2 3.6 6.8 10.4 8.3 9.1 5.1 4.4 3.6 6.6 11.0 6.4 7.7 9.1 10.4 9.3 8.0 5.8 10.6 4.8 10.3 2.7 5.8 7.2 7.7 11.5 6.8 9.5 2.6 3.6 13.8 8.8 5.4 4.3 7.8 5.9 4.6 15.1 3.1 11.0 4.6 7.2 15.7 5.2 1.1 8.0 27.2 2.7 5.4 5.7 8.0 11.5 9.3 2.6 5.1 6.6 15.0 8.0 4.9 2.3 8.1 2.7 4.5 6.5 11.1 5.0 7.8 6.5 7.8 3.5 4.8 5.7 14.9 4.5 5.5 5.7 5.2 5.8 24.8 29.4 24.1 25.6 19.9 21.4 20.2 16.0 17.6 9.3 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801242 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favourable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 5.5 9.2 8.8 3.6 18.6 1.6 6.0 10.0 17.7 6.5 4.9 5.0 7.3 2.7 7.9 7.3 5.3 11.9 6.2 5.9 17.1 11.0 13.2 4.4 8.4 3.9 8.9 14.1 6.4 5.6 22.6 22.3 5.0 12.9 7.1 4.6 7.3 9.1 6.5 2.9 5.2 3.2 7.2 8.0 4.7 5.0 10.9 9.0 4.2 9.1 2.0 3.8 5.6 5.1 2.7 1.0 0.5 1.0 4.1 4.8 1.6 7.6 4.3 3.9 3.3 9.9 7.0 1.0 5.0 4.7 4.4 5.7 1.6 3.1 4.2 4.8 2.4 3.7 5.0 5.7 9.0 5.1 3.0 1.2 3.2 1.7 4.8 5.2 2.7 3.6 4.1 5.9 1.5 4.3 1.4 0.8 7.1 2.7 2.9 2.5 4.9 4.9 1.5 4.1 2.5 5.0 2.2 21.6 11.5 4.3 3.0 9.0 3.5 2.0 3.2 4.4 3.9 3.8 6.6 3.4 4.1 4.8 8.1 2.9 5.3 0.5 0.5 0.2 2.4 0.7 4.8 1.9 2.1 2.5 0.9 2.7 3.6 3.0 0.0 4.1 1.0 1.0 3.6 1.6 8.8 18.6 10.0 17.7 17.1 11.0 8.9 14.1 12.9 9.0 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Cell line enhanced" "Detected in some" "ASC diff: 7.2;HSkMC: 9.5;MOLT-4: 6.5;U-698: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.1 3.8 7.2 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.7 0.0 0.0 9.5 2.3 0.1 1.3 0.7 0.1 4.4 1.1 0.4 6.5 0.8 0.5 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.1 0.0 0.0 0.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.1 0.3 3.9 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974472 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm Nucleoplasm "HPA025809: AB_1845032, HPA053696: " "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 6.0 5.2 13.3 5.6 19.6 7.8 7.3 9.6 14.7 7.4 4.2 7.9 2.1 2.0 8.2 11.9 3.7 21.5 5.4 9.4 12.2 7.0 4.6 2.8 8.8 4.0 4.0 11.8 6.1 3.3 9.9 20.0 7.0 16.7 4.4 4.9 5.7 3.8 5.2 3.7 5.3 3.5 4.4 6.3 5.8 4.9 31.8 7.1 2.4 11.0 2.8 4.3 4.0 5.0 2.7 4.6 9.5 4.7 4.8 7.0 1.6 3.7 2.2 11.0 7.0 5.4 6.8 2.5 2.2 3.2 5.7 7.7 3.4 3.3 5.7 2.9 3.6 3.2 6.0 4.5 10.0 1.6 5.1 5.4 5.0 3.5 3.0 8.3 2.4 7.8 6.3 6.6 1.9 5.4 2.2 8.9 5.9 2.8 7.2 7.6 3.4 2.8 8.2 9.0 4.7 5.2 4.4 15.3 5.7 7.8 2.0 5.4 4.0 4.3 2.7 4.9 2.5 4.1 3.0 4.2 5.6 5.0 8.3 5.8 6.0 4.3 3.5 0.9 3.4 4.7 3.2 1.4 2.7 3.7 2.8 2.7 1.6 3.9 9.5 4.8 3.7 4.6 7.0 1.6 13.3 19.6 9.6 14.7 12.2 7.0 4.0 11.8 16.7 7.1 ARMC5 FLJ13063 ENSG00000140691 "Armadillo repeat containing 5" Q96C12 16 31458080-31467166 "Disease related genes, Predicted intracellular proteins" "Cushing syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041524, HPA063706" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Intracellular and membrane" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA041524: AB_10796676, HPA063706: " "unprognostic (1.37e-1)" "unprognostic (1.68e-3)" "unprognostic (8.22e-3)" "unprognostic (9.96e-2)" "unprognostic (2.59e-1)" "unprognostic (2.94e-3)" "unprognostic (4.09e-2)" "unprognostic (6.14e-3)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favourable (1.97e-6)" "unprognostic (4.70e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 8.3 8.1 6.6 8.1 11.6 35.3 8.4 13.1 13.6 5.3 5.7 7.8 5.5 9.7 9.1 6.0 8.4 7.1 4.9 6.6 8.4 7.5 6.7 16.1 8.4 7.3 8.9 5.4 8.6 9.3 9.2 9.4 7.3 9.1 7.2 2.9 6.5 10.4 5.8 14.2 13.2 8.3 4.5 5.9 8.6 8.0 6.0 8.9 6.8 9.9 6.8 5.3 5.1 16.8 4.0 10.0 2.8 3.1 9.8 4.9 3.2 2.9 4.6 2.0 2.9 1.3 1.0 5.2 3.8 1.7 2.3 1.9 4.3 3.0 2.8 8.1 2.1 4.4 2.3 3.5 0.4 4.0 5.9 1.2 7.0 9.9 2.5 8.6 8.8 2.3 4.0 2.2 0.6 3.4 6.3 7.0 1.5 7.3 3.3 34.7 3.3 2.9 5.8 2.9 10.6 1.7 3.4 6.6 5.8 3.5 4.8 2.6 3.1 10.3 6.4 4.9 3.6 2.0 3.1 6.4 5.5 1.8 3.2 7.3 3.4 2.8 3.1 0.9 4.9 1.6 4.1 4.0 3.8 3.8 4.1 3.5 3.4 3.8 1.8 9.8 1.7 10.0 4.6 3.2 6.6 11.6 13.1 13.6 8.4 7.5 8.9 5.4 9.1 8.9 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: " "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavourable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 19.4 13.5 16.9 14.3 21.9 43.5 14.5 52.6 26.4 17.1 14.4 16.8 9.4 9.9 15.2 10.8 18.0 13.7 13.0 14.4 16.9 20.9 16.6 13.8 13.9 16.3 17.6 16.1 14.3 11.9 20.5 26.1 16.3 26.3 14.5 15.9 12.5 11.9 15.8 34.6 11.8 13.1 20.6 18.7 16.7 14.2 14.7 19.1 21.3 18.2 12.1 18.4 16.9 12.9 25.6 25.4 40.1 23.8 25.3 26.5 19.3 20.2 9.9 13.1 10.6 16.5 14.6 17.6 15.7 15.2 21.5 21.1 15.5 10.7 19.1 16.2 13.5 10.6 16.8 15.3 26.7 12.8 11.8 34.0 6.6 10.5 20.9 26.3 38.2 21.7 9.8 13.8 19.9 16.7 12.7 10.9 26.6 17.7 18.4 12.4 18.1 8.7 14.5 21.0 15.2 14.1 18.9 15.2 11.1 22.5 7.8 13.0 15.5 14.0 18.1 11.5 9.4 15.2 11.5 20.9 15.9 29.3 10.4 12.6 11.4 32.3 22.1 40.1 22.8 23.8 26.0 25.6 21.0 24.0 25.4 22.0 24.6 24.4 15.6 25.3 23.5 11.2 26.5 19.3 16.9 21.9 52.6 26.4 16.9 20.9 17.6 16.1 26.3 19.1 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;ASC TERT1: 23.8;BJ hTERT+ SV40 Large T+ RasG12V: 27.3;LHCN-M2: 24.0;RH-30: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005685, CAB020695" Supported Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "CAB020695: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favourable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.5 0.0 26.4 23.8 0.0 8.6 16.9 10.8 27.3 0.0 0.1 0.0 7.4 13.2 0.7 0.0 1.2 6.1 0.0 0.0 4.9 1.6 0.0 14.0 0.0 0.0 19.9 1.6 8.2 0.0 6.5 0.1 0.1 24.0 0.3 0.0 0.0 7.9 0.0 0.0 30.3 0.0 7.4 0.0 5.4 4.5 0.0 0.1 14.8 0.8 3.6 8.6 6.6 3.5 19.1 0.1 0.0 0.1 0.0 6.4 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.4;NTERA-2: 34.8;RH-30: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favourable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 15.0 0.1 13.4 12.2 0.1 16.4 20.6 0.4 0.4 0.0 6.3 0.0 0.0 21.5 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.6 0.0 14.1 0.1 0.0 19.2 5.2 12.8 0.1 17.4 0.0 0.1 48.4 0.0 0.0 0.2 34.8 0.1 4.1 26.7 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 7.6 0.0 3.8 18.5 19.7 11.5 0.1 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing, X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: " "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favourable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 21.0 39.2 26.6 14.8 32.9 8.5 20.5 20.5 36.9 30.6 18.8 21.0 37.1 13.3 26.9 67.8 12.7 17.1 22.0 31.7 28.0 26.6 24.0 17.8 19.1 12.7 27.8 29.6 26.7 38.2 62.0 37.9 28.5 35.4 29.1 14.8 13.6 34.8 31.6 25.5 7.9 13.8 24.6 25.7 24.1 19.0 9.2 22.8 8.2 31.9 17.1 13.7 21.4 21.3 11.6 18.8 25.2 11.8 10.2 14.8 9.4 8.7 6.0 16.2 9.0 37.5 41.8 3.6 19.3 18.7 8.5 24.7 7.1 8.2 3.4 11.1 22.5 1.7 12.2 7.1 10.4 6.7 7.7 6.2 20.2 10.1 29.7 6.0 14.9 23.1 9.5 10.2 11.0 16.1 4.8 30.0 23.1 3.9 5.0 0.2 8.3 1.3 6.4 21.2 3.0 11.9 3.6 7.6 6.4 9.3 0.6 20.0 7.1 6.2 22.5 11.3 7.4 25.5 3.7 24.3 6.5 0.0 17.2 4.9 9.5 25.2 11.2 9.5 10.9 11.3 14.8 11.6 10.8 9.5 11.3 7.9 12.2 8.5 4.1 10.2 11.8 18.8 6.6 9.4 26.6 32.9 20.5 36.9 28.0 26.6 27.8 29.6 35.4 22.8 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing, X-linked 4" X 101418287-101533459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 10.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: " "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favourable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 1.5 4.6 1.9 0.8 2.7 0.3 2.9 3.2 5.7 2.4 1.7 0.6 4.0 2.8 0.7 2.8 1.1 1.2 2.0 2.9 1.2 0.5 1.5 0.5 1.9 8.5 1.4 10.8 4.3 1.6 4.1 1.6 1.2 5.7 1.6 2.1 1.5 2.8 1.4 1.3 1.3 0.4 2.4 0.5 2.1 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.3 0.6 8.1 0.0 3.9 4.1 0.8 5.5 4.4 4.5 8.9 1.9 0.8 0.0 2.2 8.1 0.9 0.0 0.1 7.5 0.0 0.9 0.6 2.3 0.0 2.3 0.0 3.1 2.6 0.4 9.8 0.0 7.9 0.0 0.7 2.0 0.0 0.3 0.3 6.0 0.0 0.4 6.7 0.0 1.2 1.4 5.5 5.1 0.8 0.0 3.0 0.6 1.2 2.9 2.1 1.3 6.3 0.0 0.0 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 ARMCX6 "FLJ20811, GASP10" ENSG00000198960 "Armadillo repeat containing, X-linked 6" Q7L4S7 X 101615118-101618001 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043030, HPA048125" Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" Cytosol "Nucleoplasm, Nuclear membrane" "HPA043030: , HPA048125: " "unprognostic (1.20e-1)" "unprognostic (2.80e-1)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.80e-2)" "unprognostic (1.73e-3)" "unprognostic (1.92e-3)" "unprognostic (4.13e-2)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (3.31e-1)" "unprognostic (3.74e-1)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (7.82e-3)" "unprognostic (2.38e-2)" 15.1 17.2 11.7 12.1 12.1 7.6 12.7 10.9 12.1 18.7 12.0 15.4 22.6 6.7 17.3 25.9 17.3 14.1 12.4 15.6 11.3 12.6 14.1 12.2 11.2 12.1 13.1 10.3 21.3 27.2 23.4 21.0 16.3 13.1 17.7 9.0 11.8 39.2 23.5 6.5 11.3 10.4 17.1 16.7 22.6 10.6 9.0 11.4 17.9 17.3 9.7 19.3 18.8 13.7 12.8 14.1 10.0 7.0 8.1 8.7 6.4 6.6 7.8 12.3 7.0 25.2 15.0 2.4 13.9 13.6 12.5 24.5 4.7 6.4 7.1 14.3 13.0 6.9 11.9 5.6 9.8 6.1 7.3 6.6 10.9 6.2 11.6 6.4 8.4 9.3 5.8 7.7 4.0 12.7 5.4 9.1 18.7 16.3 9.4 0.0 8.8 1.6 9.7 16.5 2.6 9.0 0.9 6.8 6.4 8.2 0.0 10.4 5.7 3.1 9.8 15.3 6.9 21.2 3.2 11.3 6.0 0.0 4.5 1.7 5.0 10.0 3.8 6.3 6.5 7.0 8.7 12.8 7.0 7.3 8.1 9.1 8.4 7.8 0.5 8.1 5.0 14.1 3.9 6.4 11.7 12.1 10.9 12.1 11.3 12.6 13.1 10.3 13.1 11.4 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" 3200000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavourable (7.09e-4)" "prognostic favourable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 15.5 15.8 10.7 11.5 16.2 3.9 20.5 17.5 18.2 13.7 12.8 7.5 9.9 14.7 13.0 13.4 11.5 10.6 9.0 13.4 11.4 13.0 34.7 33.2 15.4 15.0 10.9 8.6 15.3 7.7 7.7 13.8 26.7 18.6 11.6 14.2 9.2 8.8 10.6 14.9 7.0 16.2 11.8 10.6 16.2 10.9 10.8 9.4 13.2 26.5 11.9 14.0 14.1 10.6 9.6 12.3 26.9 18.6 10.8 13.2 10.8 8.1 6.3 13.2 11.8 10.8 17.0 21.2 15.3 13.4 12.9 17.1 16.2 6.7 12.2 10.3 10.8 8.3 38.8 11.4 21.8 13.4 12.2 8.8 7.5 18.8 13.4 16.5 11.1 13.7 8.1 17.2 10.2 18.2 12.6 15.7 16.0 33.9 10.3 15.8 22.4 5.3 13.6 11.4 9.6 39.4 10.4 5.5 3.5 12.8 12.1 7.8 34.2 13.0 15.0 6.3 8.8 23.3 12.1 7.3 9.2 14.5 11.2 20.4 7.4 22.8 14.7 26.9 7.8 18.6 10.3 9.6 10.2 8.3 12.3 7.1 9.5 8.7 12.2 10.8 16.6 4.6 13.2 10.8 10.7 16.2 17.5 18.2 11.4 13.0 10.9 8.6 18.6 9.4 ARRDC2 "CLONE24945, PP2703" ENSG00000105643 "Arrestin domain containing 2" Q8TBH0 19 18001132-18014102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.7" "Cell line enhanced" "Detected in many" "REH: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053788, HPA074216" Uncertain Approved Nucleoplasm Nucleoplasm "HPA053788: , HPA074216: " "unprognostic (8.10e-2)" "prognostic favourable (5.93e-4)" "unprognostic (2.20e-3)" "unprognostic (8.67e-2)" "unprognostic (4.81e-3)" "unprognostic (4.26e-3)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (4.40e-2)" "prognostic unfavourable (5.84e-4)" "unprognostic (1.16e-1)" "unprognostic (8.37e-2)" "unprognostic (4.87e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-1)" "prognostic favourable (6.91e-4)" "prognostic favourable (2.92e-4)" 26.7 5.3 10.4 12.5 34.6 39.3 27.7 3.2 19.5 10.9 9.6 28.3 7.3 6.9 7.6 4.7 8.1 8.5 13.1 8.5 14.1 8.2 10.7 9.8 22.6 19.0 47.5 9.0 4.9 6.2 18.7 5.7 8.1 20.1 10.1 7.2 6.0 15.3 11.6 60.7 9.4 13.3 6.7 16.8 18.7 12.1 3.2 32.9 10.5 14.3 4.9 19.1 9.3 11.3 5.9 3.1 3.7 6.3 7.2 16.0 4.7 5.8 10.5 0.2 5.4 4.4 4.1 4.2 3.4 9.7 2.8 2.8 2.3 11.4 10.9 9.7 2.8 3.9 4.2 3.1 2.3 7.0 6.2 8.2 8.2 3.2 4.1 6.2 12.3 4.4 4.9 3.3 5.1 4.8 9.4 0.3 2.7 8.9 4.7 17.3 1.3 17.4 28.0 0.1 8.1 4.1 5.4 2.5 2.6 5.5 5.6 5.6 3.3 16.1 10.3 5.0 3.9 16.7 4.2 0.8 0.0 12.2 8.0 23.8 3.8 3.7 6.3 3.7 4.0 5.2 2.8 3.9 6.7 5.1 3.1 5.9 16.0 8.4 2.4 7.2 5.4 2.0 5.0 4.7 10.4 34.6 3.2 19.5 14.1 8.2 47.5 9.0 20.1 32.9 ARSK "DKFZp313G1735, TSULF" ENSG00000164291 "Arylsulfatase family member K" Q6UWY0 5 95555074-95605064 "Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042384 Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA042384: AB_10795703" "unprognostic (9.50e-2)" "unprognostic (1.37e-1)" "unprognostic (2.03e-3)" "unprognostic (2.39e-1)" "unprognostic (3.33e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.59e-4)" "unprognostic (3.39e-1)" "unprognostic (1.37e-1)" "unprognostic (5.19e-2)" "unprognostic (7.61e-2)" "unprognostic (2.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.91e-2)" "unprognostic (2.32e-1)" "unprognostic (8.20e-2)" "unprognostic (1.06e-2)" 8.5 10.2 6.9 4.8 7.6 4.7 7.6 14.2 12.3 8.9 8.6 4.3 9.6 5.1 8.5 9.6 6.7 7.4 6.9 8.5 7.9 7.1 11.5 9.7 7.4 5.6 8.4 9.9 12.8 11.7 29.3 14.5 11.2 7.2 10.7 5.9 7.3 6.7 11.2 5.5 8.4 5.4 6.7 8.8 5.5 9.7 4.5 7.5 10.6 15.8 2.8 4.5 9.2 14.0 6.7 2.7 10.0 1.6 3.9 9.2 2.3 3.3 2.1 4.6 4.6 22.8 11.9 6.6 10.7 6.2 4.2 8.7 2.7 5.3 4.6 5.6 3.6 3.2 4.0 6.8 9.3 4.9 5.8 3.7 5.5 4.4 6.6 2.0 3.0 8.7 6.1 6.4 4.1 6.8 3.7 5.0 9.3 1.6 5.5 3.9 5.9 10.4 3.4 7.3 7.2 9.7 0.8 3.2 3.3 6.6 2.2 6.4 6.1 2.1 12.2 6.7 5.4 10.3 6.5 4.3 7.3 5.5 6.6 5.4 24.8 10.0 1.6 2.5 5.3 1.5 6.1 5.3 6.0 6.7 0.8 6.7 9.2 6.9 1.5 3.9 1.0 2.7 4.5 2.3 6.9 7.6 14.2 12.3 7.9 7.1 8.4 9.9 7.2 7.5 ASB1 ASB-1 ENSG00000065802 "Ankyrin repeat and SOCS box containing 1" Q9Y576 2 238426742-238452250 "Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003508 Uncertain Approved Nucleoplasm Nucleoplasm "HPA003508: AB_1845065" "unprognostic (1.02e-1)" "unprognostic (5.30e-2)" "unprognostic (9.58e-2)" "prognostic unfavourable (4.89e-5)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "prognostic unfavourable (5.37e-4)" "unprognostic (3.49e-2)" "unprognostic (5.81e-2)" "unprognostic (1.50e-2)" "prognostic favourable (1.56e-4)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.19e-1)" 9.2 8.4 17.0 10.9 19.7 3.8 7.7 9.3 18.4 7.1 8.7 16.2 7.8 5.8 12.0 5.9 7.5 9.3 7.8 22.0 16.1 14.7 8.0 6.2 7.6 10.5 18.0 12.7 15.3 6.6 15.1 8.8 4.9 15.6 9.8 7.2 9.3 5.4 12.1 26.2 8.3 7.8 11.8 18.8 7.8 7.6 14.0 11.3 9.0 8.2 9.3 11.7 7.1 6.5 5.5 4.2 1.4 1.1 3.0 6.7 1.9 4.9 7.0 9.7 7.7 6.2 6.5 7.9 13.4 8.9 8.1 9.1 3.3 3.5 4.2 1.9 12.5 5.3 9.5 21.3 12.9 10.6 7.8 5.3 6.3 8.4 14.5 7.3 7.1 6.9 9.8 23.6 32.1 3.4 11.2 2.9 14.8 3.3 3.9 7.7 10.3 6.0 5.8 19.7 2.8 5.9 6.6 7.8 10.6 4.2 3.1 7.0 2.3 7.8 7.4 14.7 9.6 11.5 26.6 10.5 6.4 7.4 23.2 2.3 7.3 0.0 0.8 1.4 6.7 1.1 3.5 5.5 4.7 6.5 0.9 3.3 4.1 4.9 0.3 3.0 0.6 4.2 5.5 1.9 17.0 19.7 9.3 18.4 16.1 14.7 18.0 12.7 15.6 11.3 ASB13 "FLJ13134, MGC19879" ENSG00000196372 "Ankyrin repeat and SOCS box containing 13" Q8WXK3 10 5638867-5666595 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.7;RPMI-8226: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048293, HPA061742" Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA048293: , HPA061742: " "unprognostic (3.64e-2)" "unprognostic (3.60e-1)" "unprognostic (7.39e-2)" "unprognostic (2.21e-2)" "unprognostic (4.83e-2)" "unprognostic (2.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.87e-1)" "unprognostic (6.93e-2)" "unprognostic (3.42e-2)" "unprognostic (4.58e-3)" "unprognostic (1.16e-2)" "unprognostic (3.03e-1)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" 7.7 14.0 5.8 5.8 7.3 2.7 10.8 12.2 18.2 7.4 23.7 7.3 6.9 21.6 6.5 11.0 7.5 11.8 9.6 7.9 5.3 5.8 18.4 28.5 5.4 14.7 5.8 5.5 13.6 8.4 2.8 5.9 3.3 8.7 6.7 5.9 41.1 6.1 6.3 8.1 8.1 26.4 5.1 5.1 7.0 6.9 4.7 4.9 2.1 4.6 7.0 11.7 9.3 8.6 2.3 10.8 0.4 9.5 0.8 3.5 5.2 4.6 6.1 2.7 11.7 11.4 3.1 4.6 0.8 2.2 2.7 3.5 5.1 9.1 29.7 7.3 1.8 7.4 6.1 6.1 0.5 1.4 10.4 4.2 3.7 4.0 7.3 3.8 0.4 5.0 9.9 1.6 2.3 2.4 5.2 0.6 0.8 3.4 4.6 3.5 5.6 3.7 1.9 0.2 31.6 3.8 7.6 5.3 12.3 5.8 3.8 9.3 12.2 5.0 0.6 1.6 2.9 7.0 2.4 1.4 3.6 19.9 5.2 10.0 1.3 0.0 9.5 0.2 1.2 6.7 2.1 1.5 3.5 1.5 10.8 2.3 3.5 1.6 0.4 0.8 5.0 0.3 0.9 5.2 5.8 7.3 12.2 18.2 5.3 5.8 5.8 5.5 8.7 4.9 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934153-93976791 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.9" "Cell line enhanced" "Detected in some" "Karpas-707: 8.6;RPMI-8226: 7.8;U-266/70: 23.4;U-266/84: 5.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 8 "eosinophil: 23.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favourable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 3.1 0.5 0.2 7.9 0.8 0.4 0.5 0.2 1.7 7.4 14.0 0.0 4.6 2.2 11.9 5.7 7.2 6.5 7.7 17.2 0.2 0.2 0.3 0.3 0.8 2.3 0.3 0.6 2.3 0.3 0.3 0.2 0.3 0.5 8.5 1.5 1.5 1.6 5.8 96.9 0.5 4.4 24.4 0.3 1.5 5.0 0.3 0.0 0.0 0.7 25.7 4.7 14.3 4.5 0.9 2.6 23.1 3.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 7.8 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 1.7 0.0 0.0 0.0 0.1 0.0 23.4 5.2 0.8 0.2 2.4 0.5 0.0 0.0 23.1 0.8 1.0 0.1 0.9 0.8 1.7 2.6 0.2 0.1 0.2 0.0 0.0 3.0 0.1 1.1 0.5 0.2 0.8 0.2 1.7 0.2 0.2 0.3 0.6 0.5 0.0 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602534-100651705 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 8.6 8.9 8.9 15.5 11.9 20.2 10.2 12.7 10.2 10.3 12.1 8.1 13.5 8.3 11.6 12.5 10.0 10.9 9.5 7.0 10.4 8.3 12.5 12.1 8.8 12.9 10.6 6.7 11.2 11.0 13.7 11.8 14.0 9.4 10.1 11.8 7.6 10.3 11.3 8.0 9.5 15.5 11.2 9.7 10.4 8.3 13.8 9.2 21.2 11.5 9.6 11.1 11.6 9.2 6.6 7.0 13.6 8.0 5.5 9.4 6.3 6.2 13.9 6.4 7.6 8.5 9.2 7.4 6.9 12.5 11.6 12.1 8.3 12.7 10.2 6.4 8.8 13.9 8.9 9.0 12.1 7.2 9.5 13.6 9.2 8.2 12.9 7.9 12.0 8.8 10.1 9.4 15.6 10.6 8.0 8.6 6.5 6.7 6.1 8.0 6.1 6.8 8.5 13.9 8.5 11.4 14.1 6.4 9.1 10.6 10.4 14.3 7.3 10.0 8.0 10.2 9.5 7.0 9.6 10.4 21.4 9.8 7.8 7.3 8.0 1.7 8.0 13.6 7.6 6.5 6.1 6.3 6.7 9.3 7.0 6.6 9.4 6.7 7.3 5.5 4.1 4.5 7.7 6.3 8.9 11.9 12.7 10.2 10.4 8.3 10.6 6.7 9.4 9.2 ASCC1 "ASC1p50, CGI-18, Em:AC022392.3" ENSG00000138303 "Activating signal cointegrator 1 complex subunit 1" Q8N9N2 10 72096032-72217134 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038038, HPA057567" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038038: AB_10674544, HPA057567: " "unprognostic (1.96e-1)" "unprognostic (2.79e-2)" "unprognostic (5.36e-2)" "unprognostic (1.03e-2)" "unprognostic (2.92e-3)" "unprognostic (2.34e-2)" "prognostic unfavourable (3.52e-4)" "unprognostic (1.22e-2)" "unprognostic (8.30e-3)" "unprognostic (3.22e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.66e-1)" "unprognostic (6.64e-2)" 17.2 23.3 23.2 13.3 25.9 10.9 20.9 27.4 23.8 21.2 12.4 25.7 19.6 9.5 16.9 21.3 16.4 17.2 16.0 26.4 24.7 21.6 18.6 24.3 12.7 19.8 35.2 14.9 21.9 24.8 19.3 22.0 14.5 28.2 15.4 12.9 13.1 11.9 19.5 25.7 14.8 12.5 18.0 35.4 16.9 13.7 20.9 34.5 20.8 17.8 9.4 20.9 18.0 15.7 24.9 22.9 25.4 14.9 19.7 24.2 14.6 13.2 17.4 13.3 25.1 18.4 19.3 10.2 8.1 17.3 13.8 17.0 18.9 47.8 17.9 16.6 11.7 17.2 10.6 16.2 14.9 12.6 9.4 11.3 14.4 17.4 16.6 12.3 11.9 18.1 35.6 14.8 20.8 16.8 15.5 22.4 14.7 12.6 16.1 17.0 7.0 4.2 9.1 10.7 13.1 23.7 8.9 12.6 9.0 11.2 28.9 21.8 9.9 8.4 16.0 7.0 13.3 5.5 8.5 13.9 17.9 21.7 11.3 28.1 5.4 16.5 14.9 25.4 14.5 14.7 14.4 24.3 17.2 15.2 15.1 24.9 24.2 21.9 9.4 19.7 11.5 22.9 21.6 14.6 23.2 25.9 27.4 23.8 24.7 21.6 35.2 14.9 28.2 34.5 ASCC2 "ASC1p100, DKFZp586O0223, FLJ21588" ENSG00000100325 "Activating signal cointegrator 1 complex subunit 2" Q9H1I8 22 29788608-29838304 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001439, HPA052879" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Focal adhesion sites, Cytosol" Nucleoplasm "HPA001439: AB_1078229, HPA052879: " "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (8.58e-2)" "unprognostic (3.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.45e-3)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (5.39e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.97e-3)" "unprognostic (5.19e-2)" "unprognostic (7.53e-2)" "unprognostic (3.81e-1)" "unprognostic (2.05e-3)" 19.5 24.2 13.1 22.1 15.1 32.3 23.1 13.4 14.0 16.8 16.9 17.9 22.5 16.5 17.1 17.7 31.1 14.6 19.0 17.7 10.8 8.2 15.8 35.3 19.2 20.2 15.4 9.1 16.2 18.4 17.5 20.6 23.2 12.5 20.1 17.8 17.6 22.2 30.9 50.0 21.7 22.3 14.2 12.9 22.7 25.8 41.0 13.0 28.9 21.9 25.0 26.6 19.1 21.2 11.3 21.1 28.5 27.6 17.3 18.8 10.9 19.6 11.5 12.5 16.9 18.7 16.7 17.9 20.5 15.8 21.4 21.4 13.3 10.7 19.7 14.8 19.8 24.0 16.0 23.3 18.1 25.1 27.9 16.9 14.6 15.9 23.6 30.2 51.3 17.9 21.2 24.3 22.3 18.7 17.3 19.1 19.3 24.3 18.5 15.9 9.1 15.7 22.3 15.3 20.6 13.1 32.6 19.4 17.0 19.1 21.1 15.3 14.9 15.9 18.4 29.9 5.0 18.1 20.3 22.9 17.5 23.3 17.4 17.0 21.5 18.2 16.7 28.5 18.8 27.6 16.8 11.3 14.2 15.8 21.1 8.9 14.7 14.8 5.1 17.3 22.5 12.0 16.4 10.9 13.1 15.1 13.4 14.0 10.8 8.2 15.4 9.1 12.5 13.0 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957686-102960516 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;liver: 23.0;pituitary gland: 29.4" "Group enriched" "Detected in some" 22 "SCLC-21H: 32.6;SH-SY5Y: 17.6" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.9 2.8 11.1 0.7 6.9 0.7 0.7 3.3 19.3 1.3 0.9 6.6 0.0 0.9 1.0 0.8 0.7 2.2 0.8 0.7 8.5 5.8 0.8 23.0 1.7 1.4 7.6 4.7 1.6 0.9 0.7 29.4 0.8 13.9 1.1 1.0 0.0 0.7 0.8 0.8 0.7 0.8 0.9 18.7 0.7 3.2 0.9 7.3 6.0 1.0 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.9 3.3 10.7 8.5 5.8 7.6 4.7 13.9 7.3 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell line enhanced" "Detected in many" "U-266/70: 16.9;U-266/84: 8.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049155: , HPA054805: " "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.5 1.6 2.4 3.3 0.0 7.2 0.4 0.0 0.3 0.4 0.7 1.6 0.8 0.4 0.2 2.2 0.9 0.0 0.7 7.7 4.1 1.6 2.6 0.0 0.0 0.1 3.8 0.5 0.5 0.2 0.0 0.1 3.8 6.3 0.5 5.9 0.3 0.4 1.7 2.8 2.9 1.6 0.5 0.3 1.3 2.1 8.4 0.6 0.4 4.1 1.7 0.4 0.1 1.5 2.2 4.0 1.0 16.9 8.9 0.1 2.0 5.6 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 20.6" "Group enriched" "Detected in some" 30 "HEL: 18.7;HMC-1: 5.6;K-562: 10.7;SH-SY5Y: 5.1" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 65.5" "Low region specificity" "Detected in many" "HPA036042, HPA057078" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite" "Golgi apparatus, Centriolar satellite" "Nucleoplasm, Plasma membrane" "HPA036042: AB_10672998, HPA057078: " "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.8 3.3 4.9 0.6 4.7 0.5 0.6 6.9 17.7 1.0 0.5 1.6 0.0 0.5 0.8 0.6 0.5 0.6 0.6 0.6 3.9 4.5 0.5 0.6 0.9 0.6 4.8 2.9 0.5 0.5 0.5 20.6 0.6 3.0 0.6 0.5 4.9 0.6 0.8 0.5 0.6 0.5 0.7 1.9 0.6 0.7 1.6 3.1 0.0 0.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.7 6.9 4.9 3.9 4.5 4.8 2.9 3.0 3.1 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Cell line enhanced" "Detected in some" "HEK 293: 13.3;MOLT-4: 15.5;SH-SY5Y: 9.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042631, HPA042654" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" 51000 Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.3 0.0 0.5 3.7 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 1.6 15.5 0.1 0.0 0.3 0.3 0.3 1.0 0.0 0.2 1.7 9.2 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 1.9 0.2 2.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase like 1" Q7L266 11 62337448-62393412 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.4;cervix, uterine: 68.7;testis: 57.6" "Cell line enhanced" "Detected in many" "EFO-21: 30.0;HAP1: 28.9;RPTEC TERT1: 25.6;SCLC-21H: 39.5" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 51.4;eosinophil: 52.4" "Group enriched" "Detected in many" 4 "granulocytes: 52.4;monocytes: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "CAB070192: , HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favourable (6.14e-4)" "prognostic favourable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavourable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favourable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 3.6 2.6 27.8 3.8 37.0 7.1 4.6 12.3 22.3 68.7 7.9 9.9 2.0 4.1 15.3 7.9 1.4 36.8 9.5 1.7 19.5 19.0 23.8 2.4 6.6 3.3 30.8 11.8 1.6 5.1 1.5 5.7 2.3 16.4 8.6 9.9 4.9 6.4 4.8 2.3 1.2 3.1 3.0 9.6 2.4 5.6 57.6 11.3 2.8 3.7 0.0 3.0 2.9 1.0 0.5 8.2 52.4 14.2 2.5 0.7 4.9 0.8 6.6 7.3 9.4 0.0 0.0 5.8 0.8 0.2 1.3 1.2 10.8 2.9 0.6 30.0 0.1 0.6 28.9 0.3 1.5 1.1 11.9 0.4 9.0 7.8 0.2 8.0 10.8 0.3 0.1 0.6 0.1 13.6 8.0 7.5 0.3 12.6 21.5 5.3 9.9 5.2 8.7 4.4 4.0 25.6 2.0 39.5 5.6 5.6 9.8 4.8 5.2 4.1 0.7 0.1 5.5 0.4 3.2 11.5 10.9 1.0 0.3 4.1 3.3 51.4 14.2 52.4 0.6 10.3 0.4 0.5 0.2 0.7 8.2 0.4 0.5 0.7 3.3 2.5 7.2 1.4 0.1 4.9 27.8 37.0 12.3 22.3 19.5 19.0 30.8 11.8 16.4 11.3 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavourable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.6 1.1 1.3 2.2 8.8 22.5 4.2 13.9 86.6 2.7 8.4 4.9 3.2 0.0 9.4 28.6 82.0 5.7 0.5 1.9 2.0 2.6 0.0 1.8 12.7 30.7 1.7 0.1 14.8 79.7 4.4 8.0 0.1 0.4 51.7 2.7 57.6 0.6 24.3 1.8 2.5 0.1 1.5 132.8 7.6 5.8 33.4 0.5 49.5 52.2 3.9 35.8 99.5 0.0 1.1 6.9 0.2 1.2 8.6 8.2 2.9 21.8 12.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 ASTN2 KIAA0634 ENSG00000148219 "Astrotactin 2" O75129 9 116425225-117415070 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 24.5" "Cancer enhanced" "Detected in all" "prostate cancer: 15.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027035 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027035: AB_1845122" "unprognostic (3.25e-2)" "unprognostic (2.70e-2)" "unprognostic (7.41e-3)" "unprognostic (5.42e-3)" "unprognostic (1.89e-1)" "unprognostic (2.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-2)" "unprognostic (2.94e-1)" "unprognostic (2.80e-1)" "unprognostic (3.40e-2)" "unprognostic (2.93e-1)" "prognostic favourable (6.66e-16)" "unprognostic (3.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" 4.1 11.9 13.0 3.3 14.9 4.4 5.3 17.2 25.5 5.6 4.6 20.0 5.5 4.6 3.8 5.3 3.2 9.6 3.4 18.6 13.5 16.3 5.5 5.2 3.0 3.0 15.4 19.4 4.0 7.4 5.6 10.7 2.6 16.1 29.2 4.2 6.7 6.1 13.6 7.7 3.5 5.2 3.6 11.3 3.1 4.1 16.7 16.9 1.9 2.4 0.9 2.4 3.6 3.0 2.3 1.3 2.5 0.7 7.8 10.3 1.3 2.5 7.7 3.1 4.7 5.1 4.7 10.2 3.8 1.5 1.7 1.8 5.3 3.0 5.7 4.4 2.5 0.9 7.5 0.4 2.0 3.1 1.9 2.1 3.6 10.9 2.0 1.4 4.1 6.4 0.7 5.1 0.4 1.2 2.6 4.3 5.1 2.6 2.6 1.1 8.9 4.6 3.3 18.1 1.7 5.3 8.2 4.2 24.5 4.5 1.5 3.2 10.2 0.9 2.3 3.9 6.4 3.8 3.2 6.2 3.5 5.4 7.0 1.4 16.7 2.5 0.6 0.6 3.9 0.4 4.8 2.0 4.2 3.2 0.3 2.3 4.0 3.3 2.4 7.8 0.7 1.3 10.3 1.3 13.0 14.9 17.2 23.2 13.5 16.3 15.4 19.4 16.1 16.9 ASXL1 KIAA0978 ENSG00000171456 "Additional sex combs like 1, transcriptional regulator" Q8IXJ9 20 32358330-32439319 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor" "Cancer-related genes, Craniosynostosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064156 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA064156: " "unprognostic (1.49e-1)" "unprognostic (5.97e-2)" "unprognostic (8.36e-2)" "prognostic unfavourable (2.86e-4)" "unprognostic (6.69e-2)" "prognostic favourable (9.16e-4)" "unprognostic (2.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-1)" "unprognostic (4.32e-2)" "unprognostic (3.21e-2)" "unprognostic (1.84e-3)" "unprognostic (5.47e-2)" "unprognostic (1.90e-1)" "unprognostic (4.82e-2)" "unprognostic (1.06e-1)" 24.3 19.6 19.0 35.0 18.2 39.0 24.7 28.3 23.8 32.4 22.7 17.7 16.9 15.6 32.4 22.2 14.3 20.5 21.6 17.9 19.7 10.7 21.2 25.2 27.3 26.7 20.3 14.7 28.1 27.1 21.2 16.3 19.8 18.2 20.6 16.4 16.6 17.4 23.3 25.5 18.2 21.8 21.8 12.2 28.2 19.7 32.1 23.0 47.4 26.8 15.8 29.0 23.2 35.3 9.8 3.1 1.3 0.8 1.7 14.6 1.9 22.6 13.2 20.7 11.4 9.5 11.8 18.0 15.2 13.0 26.6 19.7 39.1 14.6 21.4 9.8 18.7 15.8 17.4 14.6 21.7 32.0 9.4 34.2 20.9 21.4 8.5 14.2 14.2 13.1 9.8 18.5 13.9 14.6 16.5 11.6 12.3 6.9 19.4 11.5 5.0 15.2 11.3 24.7 9.2 10.9 10.9 9.5 14.9 27.6 9.2 12.1 13.1 10.1 15.1 28.3 24.7 13.0 16.9 13.6 14.5 15.8 14.3 37.9 10.8 0.0 0.8 1.3 4.4 0.7 3.5 9.8 5.2 5.6 0.7 5.8 5.8 5.9 0.9 1.7 0.7 3.1 14.6 1.9 19.0 18.2 28.3 23.8 19.7 10.7 20.3 14.7 18.2 23.0 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Group enriched" "Detected in some" 24 "Daudi: 3.9;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA020558 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family, AAA domain containing 5" Q96QE3 17 30831970-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;lymphoid tissue: 29.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 2.0 1.2 1.1 8.1 3.8 19.0 2.4 9.6 3.2 2.7 3.3 1.2 0.7 2.8 2.1 2.5 4.0 2.0 1.7 1.4 1.8 1.3 1.9 1.4 2.3 6.4 1.9 2.7 3.0 1.7 1.3 3.1 5.3 2.3 1.8 3.1 0.6 2.1 1.2 1.3 4.5 3.4 1.5 1.5 6.3 2.2 4.0 2.6 29.9 1.8 2.7 5.3 1.8 2.7 2.3 2.1 3.1 1.3 3.0 1.6 0.3 4.8 4.0 9.5 9.0 0.2 1.0 3.8 4.2 2.1 4.7 6.8 4.4 3.4 12.9 4.1 1.9 8.8 6.1 3.2 8.6 2.9 5.3 7.8 5.2 3.0 0.1 15.1 6.3 0.4 0.4 6.9 2.4 2.4 12.1 10.8 3.1 2.8 16.8 7.5 5.6 1.9 11.6 18.1 6.1 1.2 5.1 5.6 5.0 4.7 2.7 2.5 5.1 6.7 1.9 5.9 7.9 8.2 7.5 3.6 3.7 16.2 2.5 7.2 5.7 1.2 1.0 1.4 1.6 1.3 0.9 1.2 0.9 1.2 0.7 2.3 1.1 1.2 3.1 3.0 0.6 2.1 1.4 0.3 1.1 3.8 9.6 3.2 1.8 1.3 1.9 2.7 2.3 2.6 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli 31000000 Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 11.7 19.4 23.1 13.7 29.4 24.9 14.3 20.2 19.1 17.8 20.2 15.4 9.8 11.2 19.2 32.7 20.0 27.7 15.4 11.0 19.4 11.4 13.5 14.0 15.6 17.0 20.6 16.5 22.6 18.4 38.1 16.1 21.1 16.9 16.8 18.8 14.1 16.2 14.0 7.1 17.8 15.9 9.4 12.8 22.8 20.2 19.5 17.0 21.7 21.2 11.8 21.0 18.0 16.4 4.4 5.7 6.6 4.1 5.6 4.9 4.4 0.8 2.9 8.1 3.0 6.1 6.9 3.0 3.3 3.2 7.3 9.2 9.5 15.9 14.5 11.7 29.4 4.7 11.0 22.1 5.4 2.9 12.1 1.1 15.3 10.1 20.1 1.1 17.6 11.5 9.8 1.3 20.4 19.9 19.1 19.3 18.7 7.5 10.1 7.1 2.4 0.5 0.7 3.5 6.4 6.6 1.4 0.5 0.8 14.3 7.8 19.4 24.4 1.8 8.6 4.0 4.5 6.5 9.9 19.3 8.3 6.8 9.3 6.7 9.9 6.6 2.2 1.9 4.9 4.1 4.7 4.4 2.8 2.3 5.7 3.4 1.8 3.5 2.5 5.6 3.7 3.8 4.5 4.4 23.1 29.4 20.2 19.1 19.4 11.4 20.6 16.5 16.9 17.0 ATF7 ATFA ENSG00000170653 "Activating transcription factor 7" P17544 12 53507856-53626410 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003384 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003384: AB_1078234" "unprognostic (2.20e-2)" "unprognostic (3.10e-2)" "unprognostic (2.48e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (4.73e-2)" "unprognostic (1.54e-2)" "unprognostic (9.16e-3)" "unprognostic (3.59e-3)" "unprognostic (8.03e-2)" "unprognostic (1.76e-3)" "unprognostic (2.59e-1)" "unprognostic (3.28e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (2.51e-1)" "unprognostic (3.37e-1)" "unprognostic (1.17e-1)" 22.6 12.2 18.3 14.6 25.3 11.4 21.5 56.1 22.9 17.8 17.7 31.6 12.1 10.5 21.5 13.0 19.7 14.6 15.6 18.8 20.1 9.5 15.1 12.3 18.0 10.3 28.2 12.9 23.5 15.6 15.3 17.3 15.4 22.2 17.1 18.6 15.6 21.9 13.4 23.1 20.9 12.2 24.5 22.3 11.4 16.1 12.4 27.5 11.4 15.2 10.8 13.1 18.1 18.4 11.5 11.4 14.2 19.5 15.5 11.5 9.3 10.2 19.8 10.5 11.6 20.3 26.0 7.0 12.3 12.8 13.7 9.1 14.2 16.0 16.0 16.4 15.1 12.8 8.2 13.7 12.6 15.5 10.4 13.8 22.8 15.2 13.6 17.7 10.4 20.2 17.9 17.0 19.4 26.8 15.7 14.9 20.4 18.9 10.6 12.4 10.5 10.7 14.1 12.7 15.4 20.6 13.2 8.9 9.5 18.8 13.9 19.5 18.6 11.0 19.7 16.4 11.6 13.0 11.1 7.3 8.7 10.3 13.4 16.8 14.9 12.9 14.8 14.2 8.6 19.5 8.7 10.8 11.5 8.4 11.4 11.5 8.5 9.9 9.3 15.5 14.3 7.8 10.8 9.3 18.3 25.3 56.1 22.9 20.1 9.5 28.2 12.9 22.2 27.5 ATG10 "APG10L, DKFZP586I0418, FLJ13954" ENSG00000152348 "Autophagy related 10" Q9H0Y0 5 81972025-82276857 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044163 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA044163: " "unprognostic (1.20e-1)" "unprognostic (7.96e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (3.18e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (3.22e-5)" "unprognostic (5.60e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.21e-1)" "unprognostic (9.62e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-3)" "unprognostic (4.43e-1)" 8.2 9.2 8.4 6.3 13.6 8.4 11.7 11.3 15.4 7.2 8.9 14.7 7.5 5.5 12.0 13.7 10.9 7.2 7.3 8.0 8.4 7.9 9.3 10.4 7.1 8.3 10.3 13.5 5.8 9.9 23.0 9.5 7.9 11.3 9.6 10.2 12.4 8.6 9.6 10.3 10.9 6.0 9.1 10.4 6.7 7.1 27.0 8.9 22.8 11.7 4.6 9.9 9.2 8.2 7.6 11.4 12.2 9.3 9.2 8.9 6.0 3.7 9.9 6.5 18.4 4.3 8.3 16.5 4.3 3.5 3.2 4.9 2.9 13.5 6.5 3.6 6.9 2.2 4.7 9.6 4.2 11.0 3.4 7.2 9.4 3.1 4.2 3.7 5.9 7.6 6.6 4.6 3.9 5.9 8.5 5.6 11.5 7.4 8.4 4.3 9.2 6.5 6.4 9.3 15.6 8.1 5.2 9.6 13.8 7.0 3.9 7.9 7.6 7.0 4.7 6.0 5.7 3.0 9.0 7.6 12.6 9.0 8.0 9.0 9.6 3.3 9.3 12.2 8.4 8.8 7.9 5.9 7.5 7.7 11.4 7.6 7.2 8.9 12.1 9.2 6.5 8.8 7.4 6.0 8.4 13.6 11.3 15.4 8.4 7.9 10.3 13.5 11.3 8.9 ATG13 KIAA0652 ENSG00000175224 "Autophagy related 13" O75143 11 46617527-46674818 "Cancer-related genes, Predicted intracellular proteins, Transporters" Autophagy "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039350 Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA039350: AB_10673142" "unprognostic (3.66e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (5.36e-2)" "unprognostic (2.31e-1)" "prognostic unfavourable (8.59e-5)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (7.57e-2)" "unprognostic (2.44e-2)" "unprognostic (2.41e-1)" "unprognostic (2.14e-1)" "unprognostic (7.68e-2)" "unprognostic (3.47e-1)" 13.8 15.8 20.2 11.9 27.3 25.8 12.5 32.8 37.0 13.2 12.6 39.5 9.2 14.3 12.9 16.8 14.9 16.6 14.5 17.8 19.5 16.3 14.3 21.1 11.5 13.6 31.8 18.2 15.6 19.7 24.4 23.1 13.5 27.2 12.8 12.0 21.3 17.0 13.5 20.9 16.3 12.4 12.3 15.7 16.2 16.5 60.6 34.9 14.8 18.6 8.8 15.8 12.5 13.0 15.8 20.0 38.9 24.0 17.0 24.7 20.3 13.7 25.2 19.4 11.4 27.1 31.8 19.6 16.0 28.4 19.8 25.4 17.2 13.7 12.9 11.4 24.1 16.8 18.6 21.7 20.1 24.4 35.5 13.8 17.6 30.0 30.4 18.4 24.1 38.2 25.9 13.6 30.2 19.5 24.1 29.5 17.7 20.6 18.3 27.3 24.2 21.9 17.5 25.1 22.5 13.3 15.1 18.5 18.6 22.1 17.8 23.6 25.4 38.1 19.1 24.4 15.0 22.5 17.5 26.9 29.8 16.3 30.3 16.7 17.9 21.2 20.7 26.9 21.3 24.0 17.2 15.8 19.2 16.8 20.0 12.7 16.6 18.3 38.9 17.0 18.7 14.9 24.7 20.3 20.2 27.3 32.8 37.0 19.5 16.3 31.8 18.2 27.2 34.9 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917248 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" Cytosol "Nucleoplasm, Vesicles" "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favourable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 8.4 8.3 6.0 8.4 10.4 63.7 7.1 12.2 14.3 7.2 9.2 11.6 8.2 10.0 9.5 5.5 6.1 7.7 8.9 6.4 7.0 6.4 9.0 33.2 9.3 7.7 7.5 7.5 11.8 11.7 7.6 8.7 8.9 9.0 8.5 4.3 12.1 9.3 8.4 12.4 15.9 11.4 9.7 6.7 11.1 9.2 8.0 8.2 13.2 8.4 7.8 9.4 7.9 6.2 1.0 2.3 16.5 2.0 1.5 2.6 0.9 9.9 9.6 3.6 9.6 4.7 3.3 9.5 5.5 8.3 7.6 5.6 8.6 7.9 7.1 11.7 4.7 8.6 3.6 6.6 2.0 6.6 12.4 6.4 14.4 7.7 6.6 5.0 14.9 9.1 5.8 9.5 5.1 6.3 12.0 5.8 3.3 16.2 6.0 17.0 4.1 10.8 6.7 5.6 10.4 4.1 8.5 13.0 5.1 8.0 11.7 10.1 11.3 6.4 7.9 7.2 7.1 14.2 4.1 11.5 4.0 5.1 10.6 4.0 4.5 2.8 2.0 2.0 2.6 1.9 2.2 0.8 1.7 2.2 1.3 1.0 1.4 2.5 16.5 1.5 1.5 2.3 0.9 0.9 6.0 10.4 12.2 14.3 7.0 6.4 7.5 7.5 9.0 8.2 ATG4B "Apg4B, AUTL1, DKFZp586D1822, KIAA0943" ENSG00000168397 "Autophagy related 4B cysteine peptidase" Q9Y4P1 2 241637213-241673857 "Enzymes, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037195, HPA069803" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB037195: AB_1078237, HPA069803: " "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "unprognostic (2.67e-3)" "unprognostic (1.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.02e-2)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.60e-1)" "unprognostic (6.63e-2)" "unprognostic (1.66e-1)" "prognostic favourable (9.64e-4)" 10.9 16.5 19.6 16.6 21.3 31.3 15.1 34.8 25.7 13.5 18.7 21.7 23.2 14.6 33.5 24.0 26.7 17.7 18.8 19.5 20.5 21.5 17.2 15.5 15.8 19.4 29.2 19.7 17.3 19.2 18.7 27.4 15.4 20.3 20.5 18.9 20.8 22.8 14.2 17.2 26.6 21.1 18.9 23.1 18.7 15.5 28.0 21.4 21.2 18.2 7.3 21.9 15.3 14.4 16.5 20.3 18.9 18.6 11.4 19.6 16.8 8.6 13.4 19.2 14.9 19.3 14.1 19.1 12.7 13.8 16.4 13.6 14.7 15.3 6.6 5.7 22.7 12.7 18.3 24.1 16.0 14.1 18.6 19.5 21.7 31.8 25.1 11.2 11.0 13.9 16.8 18.4 17.8 16.9 16.6 10.2 18.6 21.1 20.2 19.9 22.4 14.4 34.8 17.7 10.0 12.9 28.0 19.3 13.4 10.8 14.4 15.1 15.9 16.6 18.4 15.7 10.7 10.4 13.6 11.5 12.0 25.4 19.0 14.1 14.6 4.6 18.6 18.9 18.7 15.5 15.5 15.7 15.2 16.5 20.3 16.5 19.6 14.7 14.8 11.4 16.2 16.3 19.3 16.8 19.6 21.3 34.8 25.7 20.5 21.5 29.2 19.7 20.3 21.4 ATG4C "APG4C, AUTL1, AUTL3, FLJ14867" ENSG00000125703 "Autophagy related 4C cysteine peptidase" Q96DT6 1 62784135-62865513 "Enzymes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007049 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007049: AB_1845159" "unprognostic (1.28e-1)" "unprognostic (2.69e-1)" "prognostic favourable (9.83e-4)" "unprognostic (7.43e-2)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (3.76e-2)" "unprognostic (8.36e-2)" "unprognostic (1.83e-2)" "unprognostic (1.30e-1)" "unprognostic (3.77e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-2)" "unprognostic (1.81e-1)" "unprognostic (4.17e-2)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" 8.8 9.8 19.4 11.3 32.8 6.0 9.2 16.7 23.4 10.6 9.5 29.8 7.2 7.7 9.6 7.2 8.6 8.0 10.4 7.2 23.7 15.5 13.5 12.6 9.2 13.7 42.6 16.5 10.3 11.2 15.5 11.3 15.0 22.4 8.0 10.6 4.9 10.8 8.0 6.4 6.3 7.8 11.2 26.5 13.3 8.6 8.9 40.4 11.0 12.0 3.7 12.4 13.4 6.8 20.6 19.4 16.0 10.9 7.0 9.4 6.7 7.6 6.1 9.5 8.3 12.5 13.5 9.5 11.5 7.8 11.1 12.5 4.5 6.1 16.3 8.9 5.8 5.9 11.3 8.7 16.1 12.2 10.4 18.3 6.5 5.8 8.9 14.8 12.3 11.1 6.2 11.8 5.6 13.3 15.5 13.3 9.3 3.6 14.9 5.7 13.9 10.1 17.9 22.8 11.5 8.0 5.6 12.9 6.5 7.6 14.4 14.8 7.0 7.0 5.2 8.9 8.7 15.0 12.6 11.6 15.6 13.3 10.2 14.7 10.7 16.0 10.9 8.5 4.8 8.8 6.6 20.6 6.6 5.6 19.4 19.1 9.4 7.7 1.6 7.0 5.0 11.6 5.7 6.7 19.4 32.8 16.7 23.4 23.7 15.5 42.6 16.5 22.4 40.4 ATG4D "APG4-D, APG4D, AUTL4" ENSG00000130734 "Autophagy related 4D cysteine peptidase" Q86TL0 19 10543895-10553418 "Enzymes, Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067683 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA067683: " "unprognostic (2.85e-1)" "prognostic favourable (3.18e-5)" "unprognostic (2.73e-1)" "unprognostic (3.67e-1)" "unprognostic (2.18e-1)" "unprognostic (1.15e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (4.28e-2)" "unprognostic (7.30e-2)" "prognostic favourable (9.95e-4)" "unprognostic (1.52e-1)" "prognostic favourable (2.39e-7)" "prognostic favourable (5.03e-4)" "unprognostic (3.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.18e-3)" 6.4 10.8 5.1 9.2 7.8 35.0 6.3 15.6 14.9 6.2 18.4 9.8 8.1 26.0 6.1 7.2 18.4 5.5 7.6 15.4 4.6 4.9 14.5 8.8 7.3 9.8 9.6 6.4 7.0 16.1 8.2 12.1 6.9 7.3 9.7 7.3 7.8 11.5 8.5 31.5 17.7 27.3 4.0 4.5 12.0 10.5 29.0 8.8 19.9 9.8 16.4 10.5 7.5 9.6 2.0 7.6 5.7 1.6 2.2 3.6 1.4 6.9 4.7 6.5 8.8 1.2 1.0 5.1 4.3 4.3 6.1 6.8 7.8 2.3 4.5 8.2 0.5 11.0 4.0 3.7 0.8 4.4 10.6 11.9 11.4 4.3 4.1 4.7 12.2 1.0 7.7 5.3 1.9 1.8 8.8 10.9 1.9 11.2 14.0 29.1 9.9 12.8 10.3 4.0 8.0 3.5 9.4 24.6 9.5 6.3 12.4 4.9 7.6 11.7 3.4 9.4 5.9 18.9 9.5 9.7 6.6 5.3 8.0 9.3 10.6 3.0 1.6 5.7 2.1 1.5 3.1 2.0 2.5 2.3 1.1 1.0 2.5 3.4 0.5 2.2 0.7 7.6 3.6 1.4 5.1 7.8 15.6 14.9 4.6 4.9 9.6 6.4 7.3 8.8 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" 13000 Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favourable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavourable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favourable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 27.0 18.6 14.8 21.1 21.9 37.5 16.6 14.1 29.2 16.4 15.2 26.2 13.4 11.6 28.9 15.9 18.9 17.4 15.1 12.3 14.0 13.1 13.1 11.8 18.4 18.8 14.8 17.1 15.5 13.1 18.7 23.0 18.7 21.6 12.9 17.8 19.3 16.6 11.6 15.8 22.2 16.9 18.3 16.6 19.7 13.1 19.7 13.9 17.7 12.7 12.2 21.6 16.5 15.2 4.0 23.8 31.3 39.7 5.9 4.8 14.2 18.2 14.4 6.5 3.4 11.3 15.0 32.0 17.2 22.4 17.2 20.1 6.1 16.6 8.4 10.4 15.2 5.6 7.2 24.1 29.6 7.4 9.0 6.0 13.9 7.3 15.0 17.4 20.1 15.4 11.2 33.3 21.0 23.7 8.9 6.9 23.8 11.9 4.9 8.2 5.0 18.7 6.2 7.7 7.4 13.0 13.2 5.7 5.7 12.2 10.4 6.6 11.3 17.0 16.1 14.2 10.3 9.2 24.0 4.4 11.5 14.1 22.9 16.4 19.0 13.1 39.7 24.5 4.8 22.9 3.7 4.0 4.0 4.5 23.8 3.7 3.5 4.2 31.3 5.9 16.3 4.2 3.4 14.2 14.8 21.9 14.1 29.2 14.0 13.1 14.8 17.1 21.6 13.9 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" 27000 Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favourable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 27.0 37.2 43.1 25.6 40.4 23.4 39.1 22.8 38.5 29.0 23.9 29.7 32.3 30.2 21.4 37.6 28.4 24.5 33.4 27.7 37.5 45.7 50.5 96.1 21.3 48.9 54.3 37.0 16.2 29.0 31.5 23.0 25.6 35.2 25.7 24.4 25.0 34.7 29.8 12.8 26.3 31.6 28.1 46.5 34.1 21.0 28.7 33.8 24.5 36.3 29.7 44.8 27.2 22.1 22.5 49.9 43.3 54.8 20.1 22.8 24.2 13.9 23.0 13.5 9.3 36.1 29.6 17.9 25.2 28.6 25.4 34.7 31.1 30.2 28.1 30.8 43.2 13.1 16.4 63.3 20.9 18.0 28.0 12.3 15.0 31.6 33.7 17.0 14.1 38.3 13.3 31.9 21.1 37.2 10.1 83.2 38.5 34.2 12.5 37.7 7.7 48.3 7.7 15.6 43.5 24.4 12.2 17.7 10.4 21.6 61.8 94.2 30.2 20.8 41.6 26.4 21.1 32.2 43.8 68.7 60.4 16.8 35.8 11.5 108.8 27.5 48.7 43.3 18.3 54.8 16.7 22.5 16.6 15.8 39.1 16.2 13.2 14.3 36.4 20.1 37.4 49.9 22.8 24.2 43.1 40.4 22.8 38.5 37.5 45.7 54.3 37.0 35.2 33.8 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell line enhanced" "Detected in many" "HAP1: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA050808: " "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favourable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.5 1.0 2.4 1.6 6.8 7.4 0.4 10.5 12.7 5.0 9.1 5.4 9.0 4.7 3.9 16.9 2.7 24.5 8.8 7.8 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.6 8.5 0.0 2.5 13.7 0.5 2.5 0.7 0.8 1.3 2.8 5.3 0.0 9.1 1.8 1.6 2.9 4.9 1.2 3.1 2.2 1.2 12.8 12.5 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 4.0 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193402077-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 9.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051932 Approved Nucleoplasm Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favourable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.6 0.7 11.2 0.6 11.1 0.6 17.8 2.6 10.1 1.8 2.2 8.4 9.0 0.9 0.6 46.4 11.8 2.7 4.3 0.6 11.1 5.1 0.8 0.7 22.0 0.8 7.5 7.7 0.8 3.9 52.5 3.5 0.6 9.0 0.6 3.2 0.5 4.5 16.7 0.6 11.2 0.6 0.7 6.1 0.7 7.6 0.8 7.5 0.0 51.2 7.8 9.5 0.6 3.7 0.4 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.2 0.2 0.1 1.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.9 1.4 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 11.2 11.1 2.6 10.1 11.1 5.1 7.5 7.7 9.0 7.5 ATP5S "ATPW, HSU79253" ENSG00000125375 "ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)" Q99766 14 50312326-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046967, HPA062690" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA046967: , HPA062690: " "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favourable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favourable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 5.5 5.0 8.4 6.0 12.5 10.0 7.0 5.6 11.0 5.9 5.2 13.9 7.9 9.4 7.0 7.6 7.9 6.0 5.7 9.0 8.8 9.0 6.8 5.0 5.4 6.6 10.0 10.5 6.3 7.3 3.3 11.2 3.5 10.1 5.6 4.6 8.3 5.6 4.7 11.6 11.7 6.5 3.6 12.4 5.4 5.4 19.8 10.3 5.1 10.1 8.0 6.1 5.1 5.1 17.0 14.2 15.4 14.1 9.2 12.9 9.6 7.8 2.0 3.8 2.1 4.7 8.4 11.8 2.9 3.6 4.9 7.2 3.3 5.9 8.9 2.6 4.6 4.8 1.3 2.7 3.1 5.1 2.4 4.8 4.1 13.8 1.1 7.0 7.3 7.5 6.7 0.7 1.4 3.6 1.5 15.9 3.3 7.1 1.7 5.3 2.4 4.2 5.1 5.6 4.7 2.4 11.2 5.4 3.5 2.3 7.5 5.3 8.0 3.6 2.2 6.3 9.0 3.8 2.9 8.0 5.2 5.2 1.0 5.3 5.0 9.8 10.4 15.4 11.4 11.4 10.0 17.0 9.4 11.0 7.7 14.1 11.9 12.9 1.1 9.2 14.1 14.2 10.8 9.6 8.4 12.5 5.6 11.0 8.8 9.0 10.0 10.5 10.1 10.3 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Group enriched" "Detected in some" 9 "BEWO: 13.5;HaCaT: 12.4;SK-BR-3: 30.6" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: " "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.3 0.8 1.6 1.9 13.5 0.2 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.7 12.4 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 30.6 0.0 0.3 0.0 0.2 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favourable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 18.2 51.9 43.9 13.8 47.7 9.9 15.9 23.6 54.1 13.1 19.9 13.5 20.9 16.2 13.8 30.2 33.6 17.9 14.8 52.6 39.8 45.2 52.0 19.9 14.5 11.8 39.7 44.9 10.4 12.4 21.8 28.8 17.2 39.6 21.4 20.3 10.8 15.7 18.1 31.8 14.7 16.8 16.1 29.4 9.7 17.8 14.0 23.0 14.7 34.1 25.2 15.3 16.6 17.0 14.7 35.0 39.2 34.5 17.9 28.5 23.9 60.9 12.7 26.0 16.4 17.4 18.5 18.4 47.1 21.7 28.9 24.2 14.5 21.6 5.0 19.8 28.2 23.0 14.1 22.0 39.1 21.7 9.8 5.3 17.6 11.8 31.9 5.2 19.5 13.2 16.1 20.2 15.3 18.1 11.7 15.5 41.5 14.8 15.2 11.8 18.8 15.3 11.7 21.6 7.9 38.5 24.2 32.6 14.3 30.4 19.7 40.6 28.0 15.4 29.1 43.4 31.7 20.8 30.2 16.5 11.8 7.1 43.5 10.6 24.1 32.2 34.5 37.3 18.6 33.6 15.7 14.7 20.1 20.0 35.0 14.5 15.1 16.8 39.2 17.9 33.3 26.7 28.5 23.9 43.9 47.7 23.6 54.1 39.8 45.2 39.7 44.9 39.6 23.0 ATP6V1E1 "ATP6E, ATP6E2, ATP6V1E, P31, Vma4" ENSG00000131100 "ATPase H+ transporting V1 subunit E1" P36543 22 17592136-17628818 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009528, CAB018699, HPA029196" Enhanced Approved Nucleoplasm 61000 Nucleoplasm "CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: " "unprognostic (1.53e-3)" "unprognostic (5.78e-3)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.24e-3)" "prognostic unfavourable (1.56e-5)" "unprognostic (2.17e-1)" "unprognostic (2.09e-1)" "unprognostic (3.37e-2)" "unprognostic (7.72e-3)" "prognostic favourable (4.18e-4)" "prognostic favourable (7.66e-8)" "unprognostic (3.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (2.75e-1)" 32.8 45.9 59.5 20.4 69.0 24.9 31.5 48.9 90.3 30.2 26.7 34.5 25.2 17.6 27.7 44.4 37.5 26.7 26.7 67.4 58.9 55.4 71.7 26.1 31.7 24.5 54.5 52.3 27.0 15.8 48.3 29.6 46.2 69.8 31.1 32.0 24.1 21.5 42.1 48.5 26.9 19.1 38.1 53.7 23.9 23.8 20.2 32.4 17.5 31.9 26.1 32.5 32.1 22.0 24.2 26.3 55.3 34.8 22.6 29.4 30.1 21.5 19.7 17.8 17.3 59.5 32.2 19.6 28.9 38.6 36.8 42.7 24.4 17.9 13.5 24.9 38.6 34.3 27.8 25.3 32.9 25.9 31.5 24.4 19.7 32.7 87.1 28.0 42.3 40.3 49.7 35.4 25.9 31.0 30.4 27.8 62.6 22.5 24.2 20.3 13.1 27.8 14.2 26.1 8.0 61.0 34.2 13.1 22.8 26.5 18.8 62.2 18.2 32.5 26.4 25.9 13.7 32.3 21.4 27.3 47.8 17.1 41.7 13.7 34.7 45.2 32.9 55.3 21.4 30.8 20.8 24.2 21.9 20.5 26.3 19.0 20.8 21.5 44.3 22.6 34.8 25.4 29.4 30.1 59.5 69.0 48.9 90.3 58.9 55.4 54.5 52.3 69.8 32.4 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587746-114598373 "Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli 150000 Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: " "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favourable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 34.8 66.4 41.5 36.7 38.0 56.6 56.6 37.5 49.4 45.2 34.2 23.4 42.3 26.7 43.7 91.0 57.5 32.3 39.2 45.4 40.8 52.5 84.9 65.9 45.3 50.0 52.2 39.5 49.2 55.9 39.5 79.4 77.8 44.7 65.3 33.2 49.2 63.2 45.1 54.9 40.8 33.2 31.7 35.6 66.5 52.7 58.3 25.6 51.7 65.2 53.5 53.4 45.8 40.1 99.9 81.6 96.6 67.9 50.0 85.1 121.6 17.9 17.3 35.7 8.7 29.6 21.5 33.1 28.1 22.3 23.3 16.7 23.2 21.7 17.4 24.6 20.0 40.8 26.6 21.2 19.6 13.8 18.3 16.7 21.9 33.7 41.5 37.2 31.0 27.4 57.1 18.6 23.2 22.0 32.0 37.0 31.8 39.0 35.9 23.5 42.2 32.7 34.9 22.9 27.9 47.6 30.9 26.9 34.4 37.8 66.1 99.7 53.6 44.2 29.3 19.0 15.1 29.5 31.4 49.9 97.9 30.4 24.5 22.4 26.0 78.3 67.9 96.6 46.7 63.9 57.9 99.9 65.6 56.0 50.9 94.2 85.1 67.1 87.3 50.0 65.8 81.6 76.5 121.6 41.5 38.0 37.5 49.4 40.8 52.5 52.2 39.5 44.7 25.6 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Cell line enhanced" "Detected in some" "HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.1 0.0 3.0 0.6 0.0 0.0 5.2 18.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 12.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 37.6 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;LHCN-M2: 9.3;RH-30: 13.7;SH-SY5Y: 9.8;U-266/70: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.4 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 6.9 9.3 0.2 8.0 0.0 6.6 0.1 5.9 13.7 8.8 3.1 0.0 3.4 9.8 0.0 0.0 0.2 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: " "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.0 9.3 14.6 14.3 19.6 6.4 10.4 8.2 11.4 8.0 15.7 11.5 12.8 10.5 9.8 7.7 14.0 18.1 13.1 2.3 4.9 5.4 11.7 12.1 8.6 8.8 11.6 12.5 14.3 15.0 12.6 6.5 8.6 12.4 21.9 9.0 7.8 7.1 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.5 6.6 8.8 12.3 6.0 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000163635 "Ataxin 7" O15265 3 63898399-64003453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.1" "Low lineage specificity" "Detected in many" HPA034989 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favourable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 8.8 6.4 4.9 14.5 7.4 19.7 8.9 10.2 6.5 9.5 10.7 4.9 6.7 8.0 10.9 9.2 9.2 7.5 11.4 7.5 5.0 4.3 6.3 8.2 10.2 19.9 6.1 3.1 12.4 21.7 15.3 10.9 15.1 6.0 8.2 8.1 15.1 12.2 7.8 9.6 10.6 12.5 9.2 5.7 11.1 7.2 14.6 6.7 55.4 8.8 8.5 24.2 8.4 10.2 0.9 0.5 11.1 0.5 2.6 5.9 1.1 5.9 4.8 5.0 4.0 5.7 6.5 6.5 3.5 6.4 7.4 6.0 6.8 5.8 5.7 2.1 6.7 3.9 6.3 6.5 7.9 15.0 2.6 10.0 5.7 2.0 2.9 4.2 12.1 6.2 3.5 11.0 12.2 5.5 3.7 17.5 4.6 14.2 8.8 3.4 3.4 2.2 3.8 4.5 6.9 3.6 7.1 2.0 3.7 7.7 5.2 7.0 3.6 6.0 7.6 6.4 8.7 9.3 8.0 7.9 7.9 6.4 7.6 7.0 6.1 11.1 0.3 0.9 3.2 0.5 2.6 0.0 5.9 3.4 0.1 0.9 5.7 3.7 1.2 2.6 0.1 0.5 4.7 1.1 4.9 7.4 10.2 6.5 5.0 4.3 6.1 3.1 6.0 6.7 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000285258 "Ataxin 7" O15265 3 63864557-64003462 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.9" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034989: AB_10602596" 0.4 0.0 1.5 2.8 1.3 0.0 2.0 0.7 0.0 2.0 2.0 0.0 0.9 0.8 0.0 1.0 0.9 0.9 2.1 0.5 1.0 3.0 1.9 0.9 0.9 0.5 0.6 0.3 3.1 0.8 0.3 1.5 1.0 0.0 0.8 1.8 0.1 4.9 3.6 8.9 1.9 2.5 4.3 0.7 2.4 0.1 3.4 3.2 3.2 6.0 3.3 3.0 2.5 4.0 5.5 1.4 3.2 6.8 1.1 2.0 2.7 3.3 2.3 4.8 6.5 2.5 6.2 4.2 2.4 4.5 4.5 5.7 1.8 6.8 5.1 6.7 2.9 2.3 9.7 2.8 13.0 2.9 3.9 2.2 0.8 5.7 2.9 2.4 2.5 3.3 1.1 1.7 5.9 4.8 3.8 1.4 6.6 4.0 6.0 3.3 3.6 4.6 5.3 4.7 4.2 2.3 4.7 3.5 5.7 1.9 2.7 2.5 1.2 2.9 4.9 2.9 2.4 1.6 4.3 3.5 2.5 8.9 2.5 1.4 3.6 4.3 0.7 ATXN7L1 "ATXN7L4, KIAA1218, MGC33190" ENSG00000146776 "Ataxin 7 like 1" Q9ULK2 7 105605067-105876604 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021448 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021448: AB_1845213" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (4.36e-2)" "unprognostic (1.01e-2)" "unprognostic (2.84e-1)" "unprognostic (8.20e-3)" "unprognostic (3.69e-1)" "unprognostic (2.51e-2)" "unprognostic (8.71e-2)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-2)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 10.8 10.7 10.3 12.1 16.6 7.7 10.6 24.7 13.4 13.3 11.7 9.7 12.3 7.9 9.2 9.1 9.6 11.7 8.4 6.4 8.5 6.2 14.1 12.3 7.8 15.6 7.1 7.3 13.3 7.2 11.2 17.8 10.8 6.9 10.1 11.6 8.3 11.4 12.1 5.2 12.2 10.9 9.7 6.9 10.4 9.8 20.8 9.9 12.4 11.8 4.6 17.9 11.3 11.7 3.9 3.1 4.3 4.8 4.2 14.5 3.4 2.8 3.8 8.3 3.9 5.1 6.0 2.6 5.1 5.1 4.6 4.3 3.7 5.5 1.1 4.0 5.4 2.7 4.6 5.3 3.4 15.9 3.1 3.8 2.8 3.6 3.0 6.2 12.8 4.1 4.3 3.1 3.1 4.1 4.5 2.6 3.8 6.8 3.4 3.5 15.3 3.9 3.4 2.8 0.8 3.5 2.9 5.2 3.4 3.6 7.3 7.2 3.8 6.4 10.4 7.3 3.3 5.9 2.0 0.5 0.0 0.1 4.5 9.7 7.2 2.3 4.2 4.3 2.9 4.8 2.1 3.9 7.5 6.4 3.1 3.6 8.2 4.7 1.4 4.2 2.8 2.1 14.5 3.4 10.3 16.6 24.7 13.4 8.5 6.2 7.1 7.3 6.9 9.9 ATXN7L3B lnc-SCA7 ENSG00000253719 "Ataxin 7 like 3B" Q96GX2 12 74537827-74545430 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056612 Approved Nucleoplasm Nucleoplasm "HPA056612: " "unprognostic (3.43e-3)" "unprognostic (1.07e-1)" "unprognostic (4.76e-2)" "unprognostic (3.20e-2)" "unprognostic (3.68e-1)" "unprognostic (9.26e-2)" "unprognostic (1.81e-3)" "unprognostic (7.12e-2)" "unprognostic (9.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.49e-1)" "prognostic favourable (2.25e-6)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 12.4 17.9 29.7 13.1 34.2 15.6 20.9 44.1 52.1 18.2 15.8 20.6 12.9 18.5 19.9 24.3 14.8 31.6 14.7 16.1 27.6 35.0 22.2 18.6 15.3 17.6 26.0 32.2 31.5 20.9 23.3 18.3 20.8 31.2 21.6 18.1 22.3 20.4 21.0 18.1 16.4 16.9 17.0 20.0 17.2 34.2 8.1 18.5 27.8 23.1 9.5 20.2 14.8 13.2 5.6 9.1 13.7 11.5 8.2 14.8 8.4 9.3 7.4 24.7 15.6 15.6 14.8 10.6 8.9 9.0 10.7 8.4 8.5 5.2 13.6 7.1 8.8 9.4 12.8 8.7 8.9 12.5 10.0 18.2 7.5 12.8 15.0 17.9 3.8 17.0 20.3 8.1 13.5 12.3 22.3 6.9 8.7 13.5 19.8 12.8 14.0 7.1 15.6 13.4 12.2 9.8 15.4 38.9 24.6 10.1 12.0 14.1 28.4 11.8 10.5 10.3 9.1 6.0 5.5 8.2 7.6 17.8 4.4 6.6 10.2 13.7 9.5 12.5 5.6 9.0 6.7 4.4 8.5 6.2 9.1 5.6 14.8 8.0 2.7 8.2 11.5 5.1 6.1 8.4 29.7 34.2 44.1 52.1 27.6 35.0 26.0 32.2 31.2 18.5 AUP1 ENSG00000115307 "AUP1, lipid droplet regulating VLDL assembly factor" Q9Y679 2 74526645-74529939 "Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007674 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007674: AB_1078251" "unprognostic (1.09e-1)" "unprognostic (2.95e-2)" "unprognostic (1.97e-2)" "unprognostic (2.11e-2)" "unprognostic (5.97e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (2.29e-4)" "unprognostic (2.00e-1)" "unprognostic (2.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-1)" "prognostic unfavourable (2.97e-9)" "unprognostic (9.68e-2)" "unprognostic (1.59e-1)" "unprognostic (3.35e-1)" "unprognostic (3.96e-2)" 18.8 21.7 13.9 15.5 16.9 9.4 24.2 18.0 16.7 25.7 28.2 14.6 18.4 14.0 14.6 17.8 25.6 15.4 12.5 14.1 11.8 11.2 19.2 44.5 14.4 21.1 18.4 8.0 11.8 44.2 26.4 14.1 20.6 15.1 13.6 25.9 13.5 29.8 17.6 34.6 25.2 31.3 18.0 12.2 18.2 26.0 10.6 14.4 13.5 19.0 11.7 19.9 16.7 13.5 26.3 38.0 30.6 46.3 20.7 31.6 36.4 16.0 24.2 6.2 10.5 36.8 18.4 17.0 11.7 26.8 21.7 11.4 37.6 11.6 16.5 8.3 22.7 19.8 26.6 20.5 15.4 14.2 25.3 24.4 12.3 31.3 38.9 12.7 12.7 24.3 45.3 32.7 30.3 22.7 32.2 22.8 23.1 23.1 13.2 15.3 16.0 20.7 17.1 25.5 48.4 24.2 13.7 9.9 11.1 11.6 35.8 27.7 15.7 20.3 8.6 17.6 10.9 4.2 18.5 5.8 9.2 20.2 21.0 17.3 31.0 28.4 39.3 30.6 25.0 46.3 30.2 24.3 26.4 27.3 38.0 26.3 22.1 24.7 19.1 20.7 40.4 35.8 31.6 36.4 13.9 16.9 18.0 16.7 11.8 11.2 18.4 8.0 15.1 14.4 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavourable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 32.5 24.0 16.1 11.3 0.9 2.1 20.4 26.7 12.5 64.7 27.3 67.2 22.8 10.7 18.4 10.9 26.3 28.5 17.9 69.0 9.6 10.9 19.0 24.6 41.8 0.5 25.4 26.8 1.0 1.9 22.4 20.1 15.1 21.5 8.5 27.5 33.2 15.2 19.7 14.7 24.8 11.6 31.1 11.8 10.3 8.6 13.9 7.5 37.3 43.0 17.9 25.5 15.9 8.6 28.1 27.9 15.5 37.6 11.9 13.8 18.5 15.2 14.8 23.2 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 AUTS2 "FBRSL2, KIAA0442" ENSG00000158321 "AUTS2, activator of transcription and developmental regulator" Q8WXX7 7 69598296-70793495 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Autism, Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 27.5;REH: 26.9;SCLC-21H: 37.8;T-47d: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.6;naive B-cell: 11.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000390 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000390: AB_1845218" "unprognostic (8.73e-3)" "unprognostic (2.24e-1)" "unprognostic (4.62e-2)" "unprognostic (8.78e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.07e-3)" "unprognostic (3.33e-2)" "unprognostic (3.52e-2)" "unprognostic (8.46e-2)" "unprognostic (3.29e-3)" "unprognostic (1.76e-2)" "unprognostic (2.47e-1)" "unprognostic (3.04e-1)" "unprognostic (7.33e-2)" 10.3 7.3 29.3 11.6 30.3 9.3 20.3 14.3 19.1 10.5 14.0 17.3 4.1 8.9 10.5 12.4 13.7 8.0 16.6 5.6 22.2 12.9 14.6 19.7 14.7 6.1 14.8 12.3 17.2 6.0 9.9 17.4 5.7 18.9 14.6 13.1 9.9 52.1 8.3 14.9 23.3 18.8 13.6 10.2 8.2 11.3 10.0 20.6 10.5 6.7 7.9 8.9 13.0 10.8 11.6 3.2 0.8 0.2 1.5 2.2 0.7 0.1 2.4 27.5 1.4 1.8 1.1 0.3 1.7 0.0 0.1 0.1 9.3 0.1 4.0 0.6 1.6 8.9 3.3 3.7 0.7 18.3 7.4 2.0 2.6 0.1 0.8 0.0 0.1 2.9 5.1 4.1 1.0 0.0 0.1 2.2 2.3 1.5 0.4 0.7 19.6 0.0 26.9 13.4 11.4 0.0 4.1 37.8 20.6 1.7 3.0 0.0 25.9 0.0 0.0 0.1 9.3 2.9 16.9 0.0 0.0 13.9 0.0 0.0 0.0 0.8 0.2 0.2 1.6 0.1 2.2 8.6 1.1 1.5 0.7 11.6 0.2 0.9 0.5 1.5 0.1 3.2 0.2 0.7 29.3 30.3 14.3 19.1 22.2 12.9 14.8 12.3 18.9 20.6 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687323 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 28.4;HHSteC: 29.3;hTCEpi: 55.3;SK-MEL-30: 44.6;U-2197: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 21.5 27.4 5.1 4.7 8.5 3.3 11.0 6.3 17.7 13.0 18.6 3.6 4.8 10.7 5.8 8.2 16.3 6.5 19.9 8.5 5.5 5.8 5.6 29.9 17.1 1.7 7.3 5.6 43.3 10.8 4.1 7.2 19.3 8.0 15.3 15.0 13.6 10.7 13.8 8.3 35.5 15.3 8.5 12.6 11.9 12.7 8.4 2.5 1.3 8.2 9.7 7.6 22.0 16.6 3.5 12.4 2.3 7.1 2.0 5.0 3.0 8.9 23.4 0.1 3.4 4.9 2.2 4.8 4.4 23.9 6.0 9.1 4.3 11.2 0.2 3.1 2.4 9.4 1.8 7.6 2.2 0.2 2.1 0.6 28.4 12.0 29.3 0.5 0.7 3.6 55.3 4.5 11.9 0.8 1.3 0.4 3.3 7.6 0.4 0.7 0.8 2.2 0.3 2.7 0.3 5.8 4.8 0.4 0.9 15.1 5.4 44.6 4.1 0.7 1.3 1.4 2.8 32.3 1.0 1.0 0.7 0.1 5.4 1.8 0.9 0.0 7.1 2.3 5.0 6.1 2.3 3.5 3.3 3.7 12.4 2.2 3.6 4.4 0.7 2.0 0.5 2.4 2.9 3.0 5.1 8.5 6.3 17.7 5.5 5.8 7.3 5.6 8.0 2.5 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235449923-235504481 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 35.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012502, HPA050662" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA012502: AB_1845228, HPA050662: " "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 5.0 6.3 3.9 4.3 5.1 1.3 8.4 4.7 4.5 5.4 7.6 3.5 5.1 3.3 8.0 8.7 10.3 6.1 9.7 7.9 2.8 2.9 3.7 4.6 3.7 3.1 3.0 3.2 5.9 35.7 9.8 8.9 4.5 4.7 8.3 5.8 8.5 8.7 7.3 21.6 6.1 6.9 16.9 2.5 3.3 9.2 5.8 3.9 4.7 7.1 7.0 5.0 9.7 5.9 1.5 5.7 2.4 2.7 1.9 1.9 1.3 10.0 6.6 7.3 10.8 11.8 10.0 17.6 8.8 8.0 6.7 6.2 5.1 9.0 5.3 11.7 10.0 12.7 14.2 10.3 8.2 10.4 9.8 3.3 8.4 5.8 7.5 10.8 3.7 7.2 6.7 6.9 16.6 10.2 8.1 7.1 6.2 4.8 6.8 3.9 10.4 3.8 7.5 12.2 13.4 4.3 12.0 9.4 12.0 15.3 5.8 7.6 11.1 11.0 10.0 5.9 9.7 9.9 11.8 10.4 8.5 3.2 3.8 7.8 13.6 2.4 2.3 1.1 1.1 2.7 1.7 1.5 0.8 1.9 5.7 1.1 1.0 1.3 0.2 1.9 2.5 3.1 0.5 1.3 3.9 5.1 4.7 4.5 2.8 2.9 3.0 3.2 4.7 3.9 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell line enhanced" "Detected in many" "AF22: 19.7;NTERA-2: 17.6;SCLC-21H: 21.9;SH-SY5Y: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053126 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" "Intracellular and membrane" "Nucleoplasm, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA053126: " "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 19.7 11.3 0.0 0.0 4.6 3.5 0.9 1.6 0.5 2.0 0.0 0.0 2.6 0.4 0.7 2.6 4.7 0.5 0.0 6.7 0.0 6.2 6.1 0.2 0.0 4.8 0.3 2.8 0.1 2.1 0.2 6.0 0.0 0.0 5.8 0.2 0.0 17.6 7.7 0.0 0.0 2.6 0.2 0.0 21.9 26.7 1.3 0.9 0.2 7.7 0.0 4.8 1.1 6.3 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell line enhanced" "Detected in some" "AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: " "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.4 0.2 0.2 7.3 0.0 1.2 8.5 0.0 0.1 0.2 0.0 0.1 0.2 4.6 0.4 0.4 0.0 0.0 0.0 1.4 0.2 0.3 0.0 0.5 0.0 0.5 1.4 1.4 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.4 0.1 0.1 0.5 0.0 0.0 13.3 9.8 0.2 0.0 0.0 0.1 0.1 1.4 7.7 0.5 0.2 0.5 0.0 0.1 0.1 36.2 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 BACH1 "BACH-1, BTBD24" ENSG00000156273 "BTB domain and CNC homolog 1" O14867 21 29194071-29630751 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 47.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.7" "Group enriched" "Detected in all" 4 "granulocytes: 46.7;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034949 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034949: " "unprognostic (1.57e-1)" "unprognostic (8.08e-3)" "unprognostic (2.64e-1)" "unprognostic (2.33e-2)" "unprognostic (6.00e-2)" "unprognostic (2.99e-1)" "unprognostic (9.84e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "unprognostic (5.79e-3)" "prognostic unfavourable (3.11e-5)" "unprognostic (5.63e-2)" "prognostic unfavourable (7.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.60e-1)" "unprognostic (4.19e-2)" "unprognostic (8.70e-2)" 23.3 7.8 7.9 15.5 13.1 44.7 10.3 4.7 8.8 13.5 12.8 9.6 6.7 9.9 16.0 10.0 18.6 8.9 15.6 10.7 8.0 5.8 11.7 17.6 25.2 21.9 10.8 5.5 9.5 12.5 5.3 9.2 28.8 11.1 14.9 7.8 9.2 12.2 5.3 30.7 22.9 17.9 15.9 16.0 22.9 9.5 20.6 11.1 14.3 11.3 12.6 14.0 19.4 15.8 4.0 7.6 46.7 15.2 2.1 4.4 4.0 7.4 3.0 9.5 2.4 7.5 21.8 5.9 8.2 19.7 8.0 9.0 6.3 10.4 8.9 6.6 7.5 3.9 5.7 11.0 14.2 7.4 4.7 27.5 6.4 6.5 10.0 7.9 10.3 11.2 16.9 15.6 23.3 4.2 13.9 47.2 10.9 2.6 6.7 4.6 14.7 3.1 6.9 22.6 11.5 4.2 5.9 3.9 4.6 4.5 8.5 10.4 6.2 9.6 10.5 7.8 10.9 8.5 4.1 27.4 17.5 9.6 6.4 9.8 23.4 17.9 15.2 11.3 1.6 12.4 1.3 3.2 2.7 1.4 7.6 4.0 3.9 1.9 46.7 2.1 13.3 1.8 4.4 4.0 7.9 13.1 4.7 8.8 8.0 5.8 10.8 5.5 11.1 11.1 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell line enhanced" "Detected in some" "Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.2 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.5 10.2 1.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.0 2.1 0.0 0.1 7.1 0.0 0.5 0.3 0.0 0.0 0.1 0.0 3.1 0.4 0.4 0.0 0.4 0.0 4.3 0.1 0.4 0.0 0.3 4.7 2.0 0.0 0.2 0.1 0.0 0.4 1.8 1.0 0.0 0.4 0.0 0.0 24.5 0.0 1.6 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951622-93955372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 59.7" "Group enriched" "Detected in some" 7 "AN3-CA: 15.2;HMC-1: 36.4;NTERA-2: 10.8;THP-1: 14.4" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA055858: " "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 4.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.4 1.5 0.0 0.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 59.7 5.6 0.0 0.0 0.5 12.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 10.8 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.0 BAZ2B WALp4 ENSG00000123636 "Bromodomain adjacent to zinc finger domain 2B" Q9UIF8 2 159318979-159616692 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 24.1;neutrophil: 54.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 54.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019819, HPA059292" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019819: AB_1845282, HPA059292: " "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-2)" "unprognostic (4.94e-3)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" "unprognostic (5.49e-3)" "unprognostic (9.01e-2)" "unprognostic (2.29e-1)" "unprognostic (1.44e-1)" "unprognostic (1.27e-1)" "unprognostic (2.14e-1)" "unprognostic (3.30e-1)" "unprognostic (1.06e-2)" "unprognostic (2.14e-2)" 16.7 20.7 22.1 12.7 37.7 23.5 16.5 30.3 28.5 25.8 18.3 30.0 19.4 12.4 25.4 17.7 16.6 19.2 19.3 13.4 26.1 13.1 13.3 12.3 18.1 9.8 37.2 20.4 33.4 16.4 27.1 45.4 14.9 29.5 17.1 12.4 13.0 19.0 24.6 19.2 12.7 14.5 20.0 42.3 14.4 14.4 18.6 48.9 6.5 19.0 9.1 9.6 18.6 19.2 2.4 5.9 54.6 7.0 4.7 2.7 1.4 3.6 7.3 25.2 15.2 7.6 12.2 4.4 7.8 9.6 4.3 5.1 11.1 10.2 6.3 13.4 7.6 8.5 10.0 10.6 6.8 2.1 5.7 11.5 12.7 1.5 5.0 7.8 8.0 9.5 11.7 10.7 11.8 22.1 12.5 1.2 6.8 4.3 2.7 4.8 8.3 6.4 6.4 8.1 4.3 8.7 13.3 16.7 14.6 15.4 1.9 9.2 2.9 21.6 21.8 7.8 15.8 3.2 5.2 4.7 0.4 7.0 7.2 8.5 4.9 24.1 7.0 8.8 2.7 3.0 2.2 1.5 1.6 2.7 4.4 2.4 1.1 1.7 54.6 4.7 2.6 5.9 1.7 1.4 22.1 37.7 30.3 28.5 26.1 13.1 37.2 20.4 29.5 48.9 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favourable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 1.5 2.5 0.9 3.1 3.8 7.4 1.2 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 BCL10 "c-E10, CARMEN, CIPER, CLAP, mE10" ENSG00000142867 "B cell CLL/lymphoma 10" O95999 1 85266248-85277090 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Immunity" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001944, HPA017925" Approved Approved Nucleoplasm Nucleoplasm "CAB001944: , HPA017925: AB_1845312" "unprognostic (3.78e-3)" "unprognostic (2.53e-1)" "prognostic favourable (2.51e-4)" "unprognostic (1.61e-1)" "unprognostic (3.47e-1)" "unprognostic (2.61e-2)" "prognostic unfavourable (7.21e-7)" "unprognostic (7.06e-2)" "unprognostic (2.36e-1)" "unprognostic (9.46e-2)" "unprognostic (1.27e-2)" "unprognostic (1.73e-1)" "unprognostic (4.92e-3)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.63e-1)" "unprognostic (1.07e-1)" 17.2 10.7 5.8 16.4 6.0 19.6 20.7 5.8 8.6 14.7 21.5 7.5 9.5 12.2 14.8 10.0 29.0 8.5 16.7 7.5 5.9 5.4 11.9 11.4 20.4 21.5 6.5 5.2 11.6 9.1 5.4 6.3 11.8 5.9 11.6 20.4 6.4 11.8 12.4 5.0 14.6 27.6 9.9 6.1 18.5 13.0 8.5 5.1 18.3 11.3 12.7 22.1 14.3 17.6 22.4 14.2 37.5 18.2 10.4 13.3 9.0 15.7 3.3 4.6 4.9 6.6 9.8 7.8 12.1 11.0 8.8 12.2 4.0 6.4 7.1 8.6 9.5 8.6 5.2 12.9 12.8 6.0 4.0 7.4 3.3 5.5 10.3 7.3 7.0 7.8 14.3 13.1 11.7 40.0 5.3 6.4 14.7 3.0 7.0 6.0 8.0 11.2 5.0 10.5 4.5 30.6 12.2 3.1 4.1 3.7 12.5 11.5 4.2 5.0 19.9 9.1 6.4 11.1 12.0 5.2 2.8 6.9 4.5 6.4 6.2 25.2 15.1 20.1 10.0 18.2 11.1 22.4 13.1 11.3 14.2 20.3 12.4 11.4 37.5 10.4 13.5 12.0 13.3 9.0 5.8 6.0 5.8 8.6 5.9 5.4 6.5 5.2 5.9 5.1 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "B cell CLL/lymphoma 11B" Q9C0K0 14 99169287-99271524 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6" "Cell line enriched" "Detected in some" 6 "MOLT-4: 32.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 13.7" "Group enriched" "Detected in many" 8 "gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 14 "T-cells: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favourable (7.48e-4)" 0.3 0.4 4.4 6.6 13.7 5.2 1.3 0.3 3.8 0.8 1.3 0.1 0.0 2.3 1.9 0.8 3.9 0.3 3.0 0.8 4.8 1.0 0.3 0.5 1.1 10.8 0.8 2.6 0.2 0.1 0.0 0.1 0.0 0.6 0.6 1.7 0.3 5.0 0.7 0.1 17.6 3.0 0.2 0.7 4.9 2.1 0.4 1.6 25.4 0.9 1.5 8.8 2.0 2.3 0.0 0.0 0.1 0.0 0.5 7.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 3.0 0.0 1.8 32.6 0.5 0.3 0.0 5.1 0.0 0.0 0.0 1.8 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 3.3 0.0 3.0 0.0 4.5 3.7 0.0 0.0 7.4 4.9 0.0 0.5 0.0 0.0 3.0 1.1 4.4 13.7 0.3 3.8 4.8 1.0 0.8 2.6 0.6 1.6 BCL2 "Bcl-2, PPP1R50" ENSG00000171791 "BCL2, apoptosis regulator" P10415 18 63123346-63320128 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 22.3;U-266/70: 77.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7" "Group enriched" "Detected in many" 8 "B-cells: 5.2;T-cells: 7.6" "Low region specificity" "Detected in all" "CAB000003, HPA055295" Enhanced Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "CAB000003: AB_2064429, HPA055295: " "unprognostic (1.11e-3)" "prognostic favourable (5.13e-5)" "unprognostic (5.49e-2)" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (3.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.93e-3)" "unprognostic (4.78e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-2)" "unprognostic (8.51e-2)" "prognostic favourable (1.29e-8)" "unprognostic (6.67e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.47e-4)" "unprognostic (2.63e-1)" 12.9 3.0 10.1 15.7 9.4 5.3 24.6 4.7 8.4 14.8 7.8 7.4 9.1 5.0 17.1 9.3 4.7 12.2 9.2 6.5 10.0 8.1 8.5 2.3 5.0 14.6 10.8 5.6 18.2 2.9 19.6 7.0 22.4 9.2 8.4 5.9 10.8 5.4 15.7 20.0 6.3 10.5 8.6 9.3 17.8 5.4 3.5 10.5 21.0 35.6 2.9 13.4 7.9 16.4 5.2 0.3 0.7 0.2 0.7 7.6 1.9 0.4 0.1 2.3 1.8 2.7 0.4 0.8 0.2 0.2 0.7 0.5 1.1 0.1 0.0 0.4 0.2 0.1 2.0 0.3 0.4 13.3 0.4 0.0 0.6 0.2 0.5 12.1 1.8 0.5 0.2 0.9 1.9 0.2 0.2 22.3 0.4 0.4 2.5 5.2 0.5 0.4 11.4 0.5 8.6 3.8 1.8 1.9 1.8 0.0 0.0 2.7 0.1 10.2 0.1 3.0 1.0 0.3 1.5 77.6 10.2 0.8 0.5 8.6 1.7 0.7 0.0 0.0 2.3 0.0 7.6 5.2 6.3 3.8 0.1 4.1 5.1 4.5 0.1 0.7 0.2 0.3 6.7 1.9 10.1 9.4 4.7 8.4 10.0 8.1 10.8 5.6 9.2 10.5 BCL7A BCL7 ENSG00000110987 "BCL tumor suppressor 7A" Q4VC05 12 122019422-122062044 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.9;MOLT-4: 19.0;U-698: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 8.4;plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 10 "B-cells: 8.4;dendritic cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019762 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA019762: AB_10962489" "unprognostic (3.27e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (6.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.46e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (5.18e-1)" "unprognostic (5.13e-2)" "unprognostic (1.06e-2)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "prognostic favourable (1.54e-6)" "unprognostic (4.86e-2)" "unprognostic (8.56e-2)" "unprognostic (6.16e-3)" "unprognostic (1.51e-2)" 3.8 3.7 13.0 9.8 14.5 9.9 6.5 19.8 18.2 6.7 4.2 6.8 3.3 3.6 6.0 7.4 3.3 10.3 4.3 9.4 9.5 7.5 10.7 5.3 5.1 19.4 6.6 15.9 4.9 11.7 8.3 6.1 2.8 6.8 6.3 3.8 3.8 8.2 7.2 12.8 8.2 3.4 4.1 5.1 6.5 4.4 3.1 7.9 26.4 11.1 3.5 15.8 6.9 5.4 8.4 9.7 0.1 0.1 0.5 0.9 0.6 1.7 2.4 7.9 5.6 0.5 0.3 1.7 1.0 1.0 1.7 1.5 1.0 0.7 25.9 2.9 0.8 2.3 5.7 5.5 1.4 0.0 9.4 1.3 0.2 1.4 1.7 4.0 2.3 1.2 5.2 1.2 7.1 2.1 5.8 0.0 1.0 3.6 19.0 0.3 2.8 4.0 10.5 2.7 0.3 3.1 4.4 7.9 8.9 1.3 0.3 3.3 5.3 3.3 1.9 0.3 1.7 2.9 1.7 2.7 1.8 29.9 0.5 2.5 1.8 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.2 0.2 2.2 8.4 0.9 0.6 0.1 0.5 0.1 9.7 0.0 0.6 13.0 14.5 19.8 18.0 9.5 7.5 6.6 15.9 6.8 7.9 BCL7B ENSG00000106635 "BCL tumor suppressor 7B" Q9BQE9 7 73536356-73558002 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Wnt signaling pathway" "Allergen, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049943, HPA058069" Approved Approved Nucleoplasm Nucleoplasm "HPA049943: , HPA058069: " "unprognostic (2.79e-2)" "unprognostic (2.87e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-1)" "unprognostic (3.54e-3)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" "unprognostic (4.84e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (5.37e-2)" "unprognostic (9.43e-2)" "prognostic favourable (4.38e-4)" "unprognostic (4.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.41e-2)" "unprognostic (1.32e-1)" 24.3 13.6 19.2 10.3 21.7 44.1 21.2 10.2 24.2 10.8 21.4 10.3 12.5 11.2 12.1 12.2 13.1 9.7 12.2 28.7 17.6 14.0 15.2 16.6 15.9 11.5 12.8 13.7 7.9 9.9 13.9 16.1 15.3 13.1 11.7 10.7 14.9 10.4 14.9 43.2 7.7 16.5 20.8 9.3 14.2 15.2 15.8 10.6 11.9 13.7 9.3 11.6 16.4 12.5 13.2 14.6 14.4 15.4 17.1 12.8 5.7 18.6 9.4 5.4 11.0 4.4 6.0 9.7 20.6 14.8 14.7 11.8 10.4 16.5 19.4 4.3 13.1 7.7 4.9 9.4 12.4 19.3 9.5 10.0 5.9 5.5 11.1 14.4 25.8 4.5 8.1 13.2 13.2 9.1 14.9 13.8 8.2 15.5 26.2 15.8 12.9 24.0 13.6 7.1 17.4 9.8 12.9 15.4 16.1 16.3 15.9 13.0 11.1 15.1 12.6 17.7 14.6 10.3 21.2 12.8 10.7 29.0 16.3 19.7 18.5 10.3 12.0 14.4 10.1 13.6 12.0 10.2 11.5 12.8 11.8 13.2 12.0 10.6 7.0 17.1 15.4 14.6 9.1 5.7 19.2 21.7 10.2 24.2 17.6 14.0 12.8 13.7 13.1 10.6 BCL7C ENSG00000099385 "BCL tumor suppressor 7C" Q8WUZ0 16 30833626-30894960 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018676, HPA052654" Uncertain Approved Nucleoplasm Nucleoplasm "HPA018676: AB_1845322, HPA052654: " "unprognostic (2.27e-2)" "prognostic favourable (4.23e-4)" "unprognostic (2.95e-1)" "unprognostic (1.49e-1)" "unprognostic (1.21e-1)" "unprognostic (3.60e-1)" "unprognostic (3.18e-3)" "unprognostic (4.91e-3)" "unprognostic (2.44e-1)" "unprognostic (3.41e-2)" "unprognostic (3.84e-2)" "unprognostic (9.22e-2)" "unprognostic (2.05e-2)" "unprognostic (2.45e-1)" "unprognostic (2.97e-1)" "unprognostic (2.07e-2)" "unprognostic (2.85e-1)" 18.5 13.5 14.2 19.1 16.2 21.3 24.8 16.1 12.4 24.1 22.1 13.3 21.6 14.3 21.2 18.9 23.2 19.0 27.5 24.4 13.1 14.4 22.3 12.6 13.2 19.6 17.1 9.3 28.2 14.1 11.1 15.9 17.1 17.1 25.4 10.7 19.3 20.3 22.3 23.4 21.7 20.2 31.3 13.7 15.0 16.8 24.9 13.6 10.5 26.5 17.7 20.5 20.5 32.0 7.2 6.6 7.0 5.2 5.7 10.2 3.7 20.9 12.3 14.0 32.4 10.6 17.0 8.4 16.5 14.0 16.5 12.2 10.5 13.7 1.4 19.6 20.7 11.3 7.1 14.5 11.2 14.7 24.9 4.9 10.2 17.5 15.9 8.9 11.2 18.4 19.2 12.3 6.8 16.4 11.7 8.8 15.6 27.7 9.2 23.0 7.2 20.0 20.3 14.2 18.9 8.8 7.7 9.1 14.6 15.4 13.0 10.2 21.2 13.6 11.2 22.9 22.7 14.3 13.5 8.2 7.4 9.6 15.3 15.1 16.8 6.2 5.2 7.0 9.2 3.5 10.2 7.2 7.9 10.1 4.5 7.1 7.1 8.4 4.2 5.7 3.7 6.6 8.2 3.7 14.2 16.2 16.1 12.4 13.1 14.4 17.1 9.3 17.1 13.6 BCL9 ENSG00000116128 "B cell CLL/lymphoma 9" O00512 1 147541412-147626216 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020274 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA020274: " "unprognostic (2.31e-1)" "unprognostic (1.52e-2)" "unprognostic (5.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (6.74e-4)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.29e-1)" "unprognostic (4.78e-3)" "unprognostic (3.92e-2)" "unprognostic (1.64e-3)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" 4.5 7.8 10.2 5.9 9.2 3.1 4.8 22.3 12.6 18.2 9.4 8.1 10.9 5.3 23.9 15.9 6.8 18.9 5.2 8.3 8.0 7.4 9.6 4.3 5.0 4.0 5.9 8.7 17.0 6.1 14.6 10.6 4.5 6.8 10.5 7.9 11.8 8.1 13.2 7.9 7.8 5.5 15.7 5.4 3.8 7.6 6.1 6.5 22.4 7.8 8.0 6.0 9.6 8.0 0.4 0.0 0.6 0.3 0.1 2.6 1.0 3.0 2.9 20.9 15.5 2.4 2.8 4.1 2.5 3.9 2.7 2.6 3.8 4.5 2.9 5.5 2.3 2.4 13.2 4.5 2.6 6.8 3.7 1.4 3.2 2.5 2.0 0.8 4.1 2.8 3.8 3.2 2.3 4.2 2.7 4.7 2.4 6.8 7.1 0.7 24.6 6.5 7.6 5.2 5.5 10.6 3.4 5.7 12.3 2.8 5.1 4.8 6.5 1.4 3.0 1.9 9.1 5.4 3.9 21.1 5.3 5.4 4.8 0.8 9.2 0.0 0.3 0.6 1.0 0.0 0.9 0.2 1.2 1.2 0.0 0.4 2.6 1.6 0.2 0.1 0.1 0.0 0.9 1.0 10.2 9.2 22.3 12.6 8.0 7.4 5.9 8.7 6.8 6.5 BCLAF3 CXorf23 ENSG00000173681 "BCLAF1 and THRAP3 family member 3" A2AJT9 X 19912860-19970298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027215 Approved Approved Nucleoplasm Nucleoplasm "HPA027215: AB_1847358" "unprognostic (2.46e-1)" "unprognostic (1.96e-1)" "unprognostic (3.15e-1)" "unprognostic (2.24e-1)" "unprognostic (2.27e-2)" "unprognostic (2.48e-2)" "unprognostic (3.72e-2)" "prognostic favourable (5.42e-4)" "unprognostic (1.82e-2)" "unprognostic (1.10e-1)" "unprognostic (1.43e-1)" "unprognostic (4.83e-2)" "unprognostic (2.03e-2)" "unprognostic (2.21e-1)" "unprognostic (9.38e-2)" "unprognostic (2.30e-2)" "prognostic favourable (5.56e-4)" 4.3 2.4 3.7 2.8 3.4 2.5 4.6 8.1 3.4 3.4 4.5 2.6 5.0 8.1 2.8 3.6 3.6 2.7 4.0 3.2 3.8 2.0 3.8 3.2 3.7 5.1 3.2 7.1 3.3 2.5 4.6 5.4 3.1 4.9 3.9 5.3 4.1 3.4 4.2 4.1 3.1 1.8 4.2 3.3 4.2 3.9 2.8 2.3 4.8 1.4 1.4 1.6 0.3 5.7 4.6 6.4 10.7 5.7 8.1 3.5 5.3 4.5 3.5 4.9 4.1 6.2 5.9 3.2 6.3 4.2 5.6 4.0 6.7 3.8 4.6 3.8 4.8 4.0 8.1 5.2 6.6 7.2 6.2 3.9 5.3 4.0 2.7 14.1 4.0 4.4 3.6 3.4 5.6 5.9 1.6 6.4 7.9 9.2 5.8 3.9 6.0 6.7 5.7 5.3 6.8 4.7 7.3 5.9 2.9 14.1 3.9 4.5 3.4 4.9 5.1 2.9 5.0 4.1 0.9 1.8 1.5 1.2 1.6 1.2 1.2 1.5 0.7 2.8 1.2 1.4 4.8 1.4 1.4 2.3 0.5 0.3 BCR "ALL, BCR1, CML, D22S11, D22S662, PHL" ENSG00000186716 "BCR, RhoGEF and GTPase activating protein" P11274 22 23179704-23318037 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010421, CAB018545, HPA038337" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795" "unprognostic (7.46e-3)" "unprognostic (2.43e-2)" "unprognostic (2.15e-3)" "unprognostic (1.16e-1)" "unprognostic (5.35e-2)" "unprognostic (1.45e-1)" "unprognostic (5.08e-2)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (1.81e-1)" "unprognostic (9.46e-2)" "unprognostic (2.39e-2)" "prognostic favourable (9.15e-10)" "unprognostic (1.47e-1)" "unprognostic (7.10e-2)" "unprognostic (4.10e-2)" "unprognostic (7.43e-2)" 14.5 8.4 24.0 9.1 41.2 26.7 10.5 14.2 26.5 13.6 9.7 10.3 10.6 8.7 9.2 13.9 19.3 10.8 8.3 7.8 20.9 13.0 16.3 8.3 11.3 10.9 16.0 15.6 8.8 12.9 14.5 14.9 15.7 14.2 7.0 6.8 8.3 15.5 9.7 3.4 12.8 8.7 9.0 9.5 9.1 14.0 9.6 15.4 11.8 16.6 5.5 9.2 9.2 8.8 1.5 0.8 1.2 1.0 2.8 6.6 2.5 18.6 8.1 12.4 12.7 7.4 5.1 18.8 6.8 6.3 6.3 5.1 14.1 7.5 13.0 12.6 5.7 19.2 1.3 18.8 1.8 24.9 12.9 11.4 11.1 11.2 9.7 10.5 6.0 4.3 12.7 9.4 8.2 21.8 43.5 6.1 2.8 12.3 9.8 8.2 10.5 7.9 12.9 5.0 8.6 9.7 11.8 11.4 10.8 12.4 10.7 5.1 6.7 8.6 24.6 3.8 0.4 6.1 5.5 1.4 5.6 4.6 9.7 8.0 5.8 0.0 1.0 0.0 6.6 0.4 2.3 1.4 3.3 3.3 0.8 1.5 2.6 3.6 1.2 2.8 1.0 0.8 1.6 2.5 24.0 41.2 14.2 24.9 20.9 13.0 16.0 15.6 14.2 15.4 BEND3 KIAA1553 ENSG00000178409 "BEN domain containing 3" Q5T5X7 6 107065182-107115269 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 12.6" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "testis cancer: 12.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017891, HPA062067" Uncertain Approved Nucleoplasm Nucleoplasm "HPA017891: AB_2064595, HPA062067: " "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (9.47e-3)" "unprognostic (4.25e-3)" "unprognostic (1.04e-1)" "unprognostic (2.43e-2)" "unprognostic (8.37e-8)" "unprognostic (1.59e-1)" "unprognostic (9.71e-2)" "unprognostic (3.99e-2)" "unprognostic (2.71e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (8.65e-2)" "unprognostic (3.49e-1)" "unprognostic (1.09e-1)" "unprognostic (4.37e-1)" 1.8 1.9 1.4 1.8 2.5 1.8 5.6 4.0 2.2 1.6 3.6 1.3 0.8 3.0 2.4 4.2 2.5 2.3 3.6 3.8 1.1 1.3 3.1 4.4 2.0 1.5 1.8 0.8 1.9 12.6 1.8 2.3 1.5 3.3 2.6 3.9 1.3 3.4 1.0 5.0 1.4 4.1 2.5 1.8 2.8 5.0 4.6 1.5 2.4 1.9 3.9 3.6 2.2 1.2 1.5 1.3 2.0 1.0 0.8 1.7 0.4 2.8 4.0 11.2 6.3 1.3 1.0 9.2 1.1 1.4 1.5 1.7 4.6 2.1 8.3 2.8 2.9 2.8 12.0 6.2 2.5 3.3 6.0 2.2 2.9 5.0 1.1 5.9 3.0 2.4 2.6 2.2 3.1 1.8 6.2 3.5 1.9 5.6 5.0 4.5 15.6 2.6 6.9 3.3 5.5 2.4 8.3 11.4 5.6 3.5 6.0 2.2 3.6 4.8 2.2 4.1 3.8 1.8 5.3 2.4 3.2 8.5 1.4 4.6 3.1 2.0 0.8 1.5 1.2 1.0 0.9 1.5 1.1 1.1 0.5 1.1 0.8 1.7 1.6 0.8 1.0 1.3 1.2 0.4 1.4 2.5 4.0 1.8 1.1 1.3 1.8 0.8 3.3 1.5 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Cell line enhanced" "Detected in some" "HAP1: 24.1;HEK 293: 5.8;HEL: 14.7;MOLT-4: 9.0;U-698: 9.6" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 24.1 0.0 0.0 0.0 5.8 14.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 4.4 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.0;fHDF/TERT166: 18.2" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: " "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.3 1.4 0.8 0.4 12.0 20.0 3.2 10.2 10.0 4.6 5.3 0.1 1.6 0.0 3.3 18.2 0.4 1.1 0.5 5.8 1.5 0.6 2.2 4.9 0.2 3.2 6.2 0.1 8.6 2.9 6.4 2.9 3.0 2.8 5.9 9.3 3.4 3.7 1.6 2.9 0.8 0.0 0.1 1.6 1.7 3.4 4.0 4.0 6.8 0.8 0.8 0.2 3.8 3.9 14.0 0.4 9.4 2.2 8.2 9.0 2.6 8.2 4.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 BEND7 "C10orf30, FLJ40283" ENSG00000165626 "BEN domain containing 7" Q8N7W2 10 13438484-13528974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.6" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037835 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA037835: AB_10669722" "unprognostic (6.22e-2)" "unprognostic (1.80e-1)" "unprognostic (1.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.18e-2)" "unprognostic (4.62e-3)" "unprognostic (3.24e-3)" "unprognostic (3.52e-2)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.06e-1)" "unprognostic (4.19e-3)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (5.20e-3)" 2.3 1.7 1.1 0.3 1.3 0.0 3.0 5.4 0.8 3.0 3.6 7.4 2.9 6.2 0.5 5.7 2.6 1.5 0.8 1.4 8.4 3.6 3.3 0.0 1.2 3.3 5.4 9.8 4.4 1.5 2.1 2.6 5.3 2.6 4.5 0.8 8.7 2.4 0.6 0.9 3.5 8.1 11.2 0.0 2.1 1.4 0.0 0.0 2.7 0.0 0.1 0.0 0.0 7.7 4.4 5.7 2.5 0.1 0.0 7.4 3.0 0.1 8.7 5.1 3.6 14.6 0.0 4.2 6.5 0.4 8.1 2.2 7.4 0.0 7.3 0.1 0.0 11.0 3.3 0.0 0.0 0.2 5.1 1.3 0.0 8.2 4.5 0.0 7.5 5.8 0.1 0.0 2.5 1.0 0.0 4.1 0.0 6.1 1.3 0.5 4.4 8.9 0.0 0.2 0.2 3.7 6.8 1.7 11.4 10.5 4.0 0.0 0.0 0.0 2.7 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavourable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 18.6 20.3 11.4 23.4 15.2 9.2 19.2 14.4 19.8 22.3 18.0 21.0 34.1 17.0 23.4 28.6 16.2 21.7 25.3 18.7 11.6 12.6 21.4 30.3 20.4 20.4 14.9 13.7 33.8 62.2 29.3 31.4 17.3 15.8 27.3 18.0 24.4 35.1 28.0 11.6 18.6 22.4 26.1 13.4 22.3 21.8 27.4 10.5 18.4 27.0 15.6 22.4 25.8 21.0 18.1 12.3 34.3 15.1 15.1 22.5 15.9 18.4 15.4 9.2 11.3 28.5 25.2 13.3 19.7 26.0 21.2 21.8 19.1 17.9 16.3 9.6 35.7 17.2 10.6 18.0 16.3 12.6 11.4 15.1 8.1 19.3 26.4 17.1 29.5 28.3 24.3 12.5 33.7 14.3 21.9 17.1 13.5 10.0 12.5 10.9 14.0 17.5 13.0 13.6 11.0 17.4 8.3 10.0 12.2 17.6 28.5 19.2 14.6 13.5 15.8 16.5 7.7 6.7 9.7 30.3 13.8 14.4 22.3 14.4 15.0 27.0 10.4 34.3 16.7 15.1 20.0 18.1 19.3 17.0 10.5 15.1 22.5 17.3 24.5 15.1 13.2 12.3 14.6 15.9 11.4 15.2 14.4 19.8 11.6 12.6 14.9 13.7 15.8 10.5 BHLHA15 "bHLHa15, BHLHB8, MIST1" ENSG00000180535 "Basic helix-loop-helix family member a15" Q7RTS1 7 98211427-98212979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "pancreas: 145.8;salivary gland: 95.2" "Group enriched" "Detected in some" 8 "Karpas-707: 16.7;RPMI-8226: 31.0;U-266/70: 37.1" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 7 "B-cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034083, HPA047834" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "CAB034083: AB_2065216, HPA047834: AB_2680172" "unprognostic (2.80e-2)" "unprognostic (9.45e-3)" "unprognostic (8.10e-2)" "unprognostic (6.66e-2)" "unprognostic (4.33e-3)" "unprognostic (1.10e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (3.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (3.70e-4)" "unprognostic (3.36e-1)" "unprognostic (1.94e-1)" "unprognostic (2.95e-1)" "unprognostic (8.25e-3)" 0.1 0.1 0.2 0.8 0.2 0.0 0.1 0.1 0.2 0.3 1.2 0.0 3.5 0.9 0.1 0.1 0.4 0.1 0.8 0.1 0.3 0.2 0.3 4.7 0.5 1.8 0.1 0.0 0.0 145.8 0.0 0.4 0.0 0.0 1.6 0.1 0.0 95.2 6.8 0.4 0.2 0.8 0.0 0.1 1.9 6.2 0.1 0.0 0.0 0.2 1.2 2.7 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 1.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 16.7 0.0 0.3 0.0 0.0 0.5 0.5 0.2 0.0 31.0 0.0 0.0 1.8 0.7 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 37.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 BHMG1 HMGDC ENSG00000237452 "Basic helix-loop-helix and HMG-box containing 1" C9JSJ3 19 45733251-45764534 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 33 "testis: 17.8" "Group enriched" "Detected in some" 5 "Daudi: 3.4;K-562: 8.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049521 Uncertain Approved Nucleoplasm Nucleoplasm "HPA049521: " "unprognostic (4.15e-2)" "unprognostic (2.97e-2)" "unprognostic (2.64e-1)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-3)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (1.15e-2)" "unprognostic (1.08e-1)" "unprognostic (6.53e-12)" "unprognostic (2.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 3.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 8.1 0.3 0.0 1.2 0.0 0.4 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.9 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58513140-58831437 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell line enhanced" "Detected in many" "A549: 19.6;BJ hTERT+: 20.8;CACO-2: 30.8;RPTEC TERT1: 48.7" "Cancer enhanced" "Detected in all" "renal cancer: 25.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "basophil: 8.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045212 Approved Nucleoplasm Nucleoplasm "HPA045212: AB_10959667" "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 11.8 5.7 1.1 5.7 1.5 0.2 9.4 0.5 2.5 9.8 5.1 1.1 4.8 1.0 7.8 12.3 8.1 7.1 11.6 12.1 1.1 1.4 43.0 2.5 5.8 5.2 0.9 2.2 19.0 24.2 0.8 4.6 3.2 2.1 7.8 3.9 18.7 4.8 4.1 22.4 6.5 2.8 6.0 3.9 2.7 3.2 4.9 0.8 0.8 5.1 7.5 3.2 8.6 10.4 0.1 1.1 8.7 0.3 1.0 0.2 0.1 0.0 19.6 0.2 0.0 6.3 8.1 0.0 12.9 20.8 11.8 14.0 30.8 4.1 0.0 13.6 13.1 0.2 2.0 2.3 16.4 0.0 2.0 0.0 2.5 0.0 4.0 0.0 0.0 12.7 0.7 9.2 9.9 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 1.2 0.0 4.9 0.0 48.7 2.3 0.0 2.5 0.0 0.1 1.1 0.0 0.2 0.0 2.8 2.6 0.4 1.6 0.0 0.0 0.0 8.3 0.0 2.6 8.7 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.2 1.0 0.3 0.9 0.1 0.1 1.1 1.5 0.5 2.5 1.1 1.4 0.9 2.2 2.1 0.8 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Cell line enhanced" "Detected in many" "hTCEpi: 27.3;MCF7: 14.7;SCLC-21H: 17.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA061116: " "unprognostic (2.17e-1)" "prognostic favourable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favourable (3.15e-4)" "prognostic unfavourable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favourable (3.93e-5)" "prognostic favourable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.7 0.0 1.1 9.5 0.0 27.3 0.0 0.3 0.0 0.3 1.1 0.0 14.7 6.4 0.1 11.7 2.7 0.7 0.5 2.4 3.5 4.5 17.2 1.2 2.0 5.4 1.4 12.3 4.4 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 BICRA GLTSCR1 ENSG00000063169 "BRD4 interacting chromatin remodeling complex associated protein" Q9NZM4 19 47608196-47703277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056211 Approved Approved Nucleoplasm Nucleoplasm "HPA056211: " "unprognostic (2.36e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-2)" "unprognostic (9.58e-2)" "unprognostic (7.75e-2)" "prognostic favourable (1.34e-4)" "unprognostic (8.38e-2)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-2)" "unprognostic (1.56e-3)" "unprognostic (2.21e-3)" "prognostic unfavourable (1.82e-4)" "unprognostic (9.72e-2)" "unprognostic (7.98e-2)" "unprognostic (1.61e-1)" "prognostic favourable (9.34e-4)" 12.6 8.5 11.3 14.0 12.4 12.0 10.8 19.6 13.1 13.7 12.5 16.7 8.2 15.2 17.0 7.9 10.8 14.4 10.1 9.9 11.4 5.9 7.2 7.6 10.6 11.5 13.8 12.4 16.5 7.6 17.4 9.5 12.7 9.3 13.0 10.4 8.7 11.0 12.8 30.4 14.0 12.1 15.4 11.5 10.5 9.9 7.1 12.7 12.4 11.9 4.2 9.6 14.9 13.8 0.6 1.6 1.8 0.6 0.1 0.9 0.1 7.4 8.0 16.1 11.8 8.5 8.8 8.0 6.8 6.8 9.0 6.3 8.7 4.7 8.4 3.5 9.4 7.6 10.6 5.3 9.6 8.0 6.8 5.2 5.8 4.2 10.8 6.2 8.7 7.1 7.9 9.9 8.9 9.1 7.7 10.9 5.5 5.9 9.8 15.0 10.5 6.3 10.3 5.5 2.3 3.6 5.4 9.0 11.2 17.3 10.1 4.5 4.2 4.7 9.8 7.0 12.7 5.2 9.3 7.4 14.0 8.8 1.3 4.1 9.5 0.2 0.6 1.6 0.3 0.0 0.1 0.1 0.2 0.2 0.6 0.6 0.9 0.2 1.8 0.1 0.2 1.6 0.2 0.1 11.3 12.4 19.6 13.1 11.4 5.9 13.8 12.4 9.3 12.7 BIVM FLJ20159 ENSG00000134897 "Basic, immunoglobulin-like variable motif containing" Q86UB2 13 102799049-102841535 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.6;NK-cells: 6.3;T-cells: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050126 Approved Approved Nucleoplasm Nucleoplasm "HPA050126: " "unprognostic (8.86e-2)" "unprognostic (1.02e-1)" "unprognostic (3.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.19e-2)" "unprognostic (1.83e-3)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (6.89e-3)" "unprognostic (6.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.79e-2)" "unprognostic (2.73e-1)" "unprognostic (7.29e-2)" "unprognostic (3.33e-2)" 6.8 7.6 10.8 3.3 15.6 3.4 9.6 32.3 16.9 9.2 6.9 6.9 10.5 6.8 10.1 14.3 5.6 7.7 6.9 18.7 10.9 8.4 17.7 17.6 6.4 4.5 9.3 10.8 10.1 10.3 6.4 10.7 7.4 10.4 8.7 8.2 6.3 6.7 9.8 16.9 8.3 6.7 8.8 7.1 7.0 8.9 2.2 9.8 4.3 8.4 7.4 3.6 6.7 6.3 0.6 1.2 3.6 0.4 6.3 4.9 0.9 7.5 2.4 8.9 10.3 11.6 17.7 2.1 9.0 9.1 5.7 6.3 2.7 3.4 0.0 4.0 8.7 5.2 7.3 7.1 8.0 6.9 9.0 6.4 6.7 4.5 10.3 7.2 11.1 14.3 9.1 3.1 10.1 8.5 6.9 0.0 11.6 1.6 8.1 9.4 2.1 6.3 0.0 4.3 3.2 26.1 3.1 13.9 12.0 3.7 4.3 5.9 6.8 9.9 6.1 7.3 1.8 5.3 5.5 6.0 2.6 0.0 9.2 0.0 12.6 3.6 0.4 0.8 2.4 0.2 4.9 0.5 1.4 3.1 1.2 0.6 0.9 2.1 0.4 6.3 0.1 0.5 1.2 0.9 10.8 15.6 32.3 16.9 10.9 8.4 9.3 10.8 10.4 9.8 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564604 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8" "Cell line enhanced" "Detected in some" "Daudi: 43.0;REH: 11.6;RPMI-8226: 14.2;U-698: 21.0;U-87 MG: 8.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 47.8;naive B-cell: 33.9" "Lineage enriched" "Detected in many" 5 "B-cells: 47.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005093, HPA069571" Approved Approved Nucleoplasm Nucleoplasm "CAB005093: AB_2274756, HPA069571: " "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.5 0.2 0.1 32.3 0.1 1.7 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.3 0.1 0.0 1.9 0.2 0.4 0.3 0.1 0.1 1.3 0.5 0.6 27.6 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.3 2.4 0.0 0.1 0.1 23.5 0.0 0.1 31.9 1.4 0.2 0.0 3.9 0.7 0.4 39.8 2.5 0.4 47.8 4.3 0.1 0.0 0.0 9.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.6 0.0 14.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.2 3.7 21.0 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.8 47.8 0.3 1.1 0.0 33.9 0.2 0.1 0.1 0.0 0.0 4.3 0.4 1.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.1 16.1 15.6 10.8 10.7 11.5 7.5 9.5 5.9 15.0 13.0 23.6 3.0 30.3 17.0 7.6 7.1 33.7 13.0 12.7 8.0 26.5 18.6 14.5 20.0 15.6 33.8 11.5 13.5 0.9 11.7 6.8 22.0 39.6 12.4 6.2 7.7 41.8 24.7 14.9 7.5 36.3 40.5 20.0 12.0 9.1 36.0 12.9 8.4 16.4 10.3 11.2 17.5 14.0 9.3 18.7 4.1 16.8 15.0 30.8 40.9 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 81.0" "Cell line enhanced" "Detected in many" "HeLa: 21.4;HMC-1: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favourable (1.83e-4)" "prognostic unfavourable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 5.3 2.9 1.3 13.5 1.9 15.8 6.1 2.3 2.0 10.9 9.9 2.1 13.0 11.9 12.4 4.7 2.8 8.3 6.7 3.4 1.3 1.6 6.5 3.9 7.7 18.4 2.8 0.9 8.9 8.1 1.8 2.8 5.7 2.5 7.0 4.5 7.2 9.2 10.8 4.6 4.0 23.2 5.8 3.0 18.1 6.7 4.1 2.1 81.0 18.6 3.1 15.0 7.5 3.7 5.1 3.3 5.2 6.0 0.0 1.4 0.9 0.5 0.7 12.5 2.7 0.3 0.5 8.5 0.0 1.9 0.2 0.6 12.5 0.9 3.6 4.0 0.5 2.6 3.0 0.1 0.0 8.6 2.5 1.8 21.4 2.8 1.2 0.3 24.3 6.3 0.7 0.2 0.2 3.2 0.9 1.6 1.1 0.6 1.2 9.2 3.3 0.4 2.3 2.8 10.4 0.5 2.9 6.6 5.4 2.4 6.3 5.6 3.7 7.3 2.5 0.4 1.8 0.4 0.1 15.5 14.4 2.2 0.9 1.7 1.5 0.1 4.2 3.6 0.2 4.9 0.4 5.1 0.4 1.4 2.7 1.8 0.7 0.1 5.2 0.0 6.0 3.3 1.2 0.9 1.3 1.9 2.3 2.0 1.3 1.6 2.8 0.9 2.5 2.1 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321211-22331484 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 87.1;U-937: 102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: , HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavourable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 19.7 23.5 28.0 17.0 35.0 13.3 26.5 26.1 33.7 21.6 22.3 26.3 11.6 14.1 23.9 22.8 16.0 17.0 17.4 15.1 28.3 24.2 19.2 25.5 16.7 17.9 42.3 27.7 18.8 18.6 40.0 37.6 20.6 24.8 25.5 16.0 16.5 15.7 20.3 28.5 10.3 14.6 26.3 34.8 24.6 16.5 24.3 40.7 12.9 17.6 10.6 18.8 21.5 25.9 5.0 1.8 13.0 3.4 6.2 8.4 2.4 12.7 6.2 7.1 2.2 12.5 10.1 7.2 8.6 3.9 6.6 7.8 6.5 16.0 6.5 5.9 7.8 4.5 10.3 6.1 8.2 87.1 12.8 18.0 5.3 7.3 7.5 6.6 10.0 6.5 10.6 7.2 8.0 4.6 17.8 11.1 8.7 5.1 17.8 1.9 1.6 14.8 13.3 10.2 6.2 6.2 4.2 6.0 11.9 5.7 7.5 9.6 6.7 26.7 9.8 7.4 22.2 17.7 11.6 13.7 17.8 14.4 10.5 102.3 4.8 13.0 1.5 2.5 6.1 3.4 8.4 5.0 6.4 5.8 1.0 2.6 5.5 5.2 0.6 6.2 2.1 1.8 4.3 2.4 28.0 35.0 26.1 33.7 28.3 24.2 42.3 27.7 24.8 40.7 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell line enhanced" "Detected in some" "Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" 247500 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: " "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 1.6 41.5 10.6 0.0 12.0 1.2 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 3.0 0.0 0.0 0.0 18.4 0.0 0.0 0.1 4.5 1.3 31.3 0.1 0.2 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 56.7 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 57.1" "Cell line enriched" "Detected in single" 121 "HUVEC TERT2: 88.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 8.2 0.3 0.1 1.0 0.7 3.6 5.4 0.1 0.3 2.2 5.5 0.1 4.6 2.4 2.6 57.1 1.5 2.5 2.6 10.5 0.5 0.0 0.2 0.9 3.7 6.5 0.4 0.0 1.4 0.9 0.2 0.6 2.6 0.7 2.2 1.4 0.5 1.5 0.6 4.2 1.6 5.5 2.2 0.4 2.4 1.5 1.9 0.1 0.2 2.2 1.1 0.8 2.8 2.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.7 0.1 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.6 3.9 12.9 8.7 1.6 1.6 9.1 7.6 6.8 12.0 13.1 10.4 13.1 14.8 4.3 4.3 9.7 11.6 7.5 15.9 13.7 6.4 18.2 6.3 8.5 1.5 34.4 11.8 1.3 1.9 5.3 11.7 9.9 8.3 6.4 8.6 5.3 15.4 10.0 5.7 4.7 11.3 7.6 6.5 4.0 5.9 3.4 4.1 7.6 7.4 5.5 5.0 12.6 3.6 3.3 7.6 5.8 9.7 5.5 5.0 10.6 9.4 16.3 8.3 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 BORCS8 MEF2BNB ENSG00000254901 "BLOC-1 related complex subunit 8" Q96FH0 19 19176903-19192591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045700 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA045700: AB_10968570" "unprognostic (4.23e-3)" "unprognostic (1.61e-2)" "unprognostic (2.75e-1)" "unprognostic (3.58e-2)" "unprognostic (2.28e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (6.82e-2)" "prognostic favourable (4.05e-5)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (3.16e-1)" "unprognostic (1.38e-2)" "unprognostic (3.00e-2)" 11.3 17.0 25.0 12.9 26.8 12.2 13.3 19.3 31.0 10.1 13.5 17.3 14.5 15.5 12.9 15.8 13.8 14.0 14.8 17.9 23.9 30.0 16.0 14.1 12.0 14.0 26.3 12.2 10.5 10.1 11.7 20.1 11.3 15.6 10.9 15.3 13.6 12.4 15.5 12.0 9.6 9.5 13.0 13.9 11.9 11.2 11.1 12.9 12.4 13.0 11.1 13.8 10.9 8.5 8.7 9.8 25.6 14.6 5.0 7.1 6.7 9.6 5.4 8.9 7.3 9.8 5.3 8.9 10.1 8.5 16.0 14.8 9.4 9.4 7.1 14.1 11.7 6.4 9.7 12.4 7.6 3.9 12.3 5.4 12.3 10.1 8.0 3.9 7.6 6.4 9.3 12.2 6.1 14.0 9.5 10.3 16.9 17.4 14.6 9.0 4.8 11.9 6.9 3.6 8.1 13.8 5.9 18.3 10.1 9.2 6.1 7.5 6.7 7.5 7.1 5.5 8.1 18.7 15.3 6.5 7.7 8.2 10.9 6.6 11.2 10.6 9.6 16.0 4.9 13.7 4.8 8.7 5.7 5.6 7.4 6.3 4.7 5.2 25.6 5.0 14.6 9.8 7.1 6.7 25.0 26.8 19.3 31.0 23.9 30.0 26.3 12.2 15.6 12.9 BORCS8-MEF2B MEF2BNB-MEF2B ENSG00000064489 "BORCS8-MEF2B readthrough" 19 19145567-19192158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 10.9;U-266/70: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA004734 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (2.74e-1)" "unprognostic (5.77e-3)" "unprognostic (8.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.46e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.75e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (6.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "unprognostic (5.29e-2)" 4.8 3.5 7.0 5.8 7.4 7.4 4.6 5.6 8.6 5.4 5.4 8.1 6.7 3.2 6.7 7.4 5.4 10.5 7.2 3.4 6.8 6.2 7.5 5.9 4.8 7.1 8.0 5.5 9.8 7.8 5.5 4.9 5.0 7.3 5.7 5.5 6.2 5.6 7.2 5.3 8.8 4.0 8.9 5.9 5.8 5.0 5.5 5.8 5.6 5.9 4.9 7.5 5.8 5.8 0.0 0.4 0.6 0.1 0.0 0.3 0.0 1.6 0.0 0.7 1.2 1.0 2.4 1.3 1.1 1.0 1.5 1.5 0.0 3.1 3.3 0.5 0.0 0.6 0.6 0.6 0.3 0.4 2.4 1.1 0.1 0.3 2.2 0.0 0.2 0.0 2.3 0.7 3.7 0.4 0.2 1.9 0.6 3.1 0.7 0.4 0.0 10.9 3.3 0.9 0.9 0.0 0.2 0.0 1.1 1.9 0.0 0.9 0.3 0.5 0.3 0.7 1.2 5.6 0.4 11.1 1.7 5.5 2.3 2.6 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 7.0 7.4 5.6 8.6 6.8 6.2 8.0 5.5 7.3 5.8 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Cell line enhanced" "Detected in all" "HDLM-2: 37.1;RT4: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved Nucleoplasm,Nucleoli 69000000 Nucleoli Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favourable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favourable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.4 5.4 7.2 9.7 8.3 4.9 7.2 13.4 16.2 5.2 7.8 2.1 6.0 5.4 4.0 7.5 3.6 7.6 7.4 9.2 37.1 6.7 3.1 5.0 2.5 5.7 5.9 4.1 4.8 6.7 9.8 5.3 18.9 9.0 6.8 12.3 2.1 9.6 8.2 7.4 5.2 7.3 5.1 3.9 11.8 59.6 6.2 10.4 6.2 7.5 6.7 4.9 3.8 14.3 8.3 2.0 11.1 10.8 11.3 12.9 6.8 14.4 5.7 14.2 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2, DNA repair associated" P51587 13 32315474-32400266 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.2;testis: 16.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026815 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 2.4 1.0 0.6 13.8 0.6 11.6 3.2 0.6 0.6 1.8 4.0 0.2 0.2 1.4 1.5 2.7 3.0 1.0 0.7 2.1 0.6 0.7 1.0 1.4 3.5 5.3 0.7 0.5 1.4 3.3 0.4 0.7 7.0 0.8 0.9 2.0 0.1 1.8 0.3 3.3 1.8 3.2 0.8 2.1 6.6 1.5 16.9 0.1 23.2 0.9 4.8 4.2 1.3 1.7 1.3 1.9 0.4 0.2 1.5 0.8 0.0 3.9 3.5 6.0 4.5 0.6 1.6 6.2 4.3 2.7 5.0 4.6 8.2 5.3 14.0 2.8 2.1 5.4 4.9 2.5 9.6 9.1 2.6 8.9 2.2 3.2 0.2 12.7 4.4 0.3 0.3 9.1 6.3 4.0 5.8 4.9 5.7 4.5 10.1 7.5 7.2 1.9 10.0 15.5 2.7 1.3 4.3 2.3 4.3 5.2 2.2 2.1 2.6 6.3 3.1 5.7 6.1 6.3 5.9 1.9 2.9 7.2 2.9 5.1 5.4 0.1 0.2 0.2 0.3 0.2 0.1 0.9 0.4 0.2 0.2 1.3 0.6 0.8 0.4 1.5 0.2 1.9 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.5 0.8 0.1 BRD9 FLJ13441 ENSG00000028310 "Bromodomain containing 9" Q9H8M2 5 850291-892824 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021465, HPA023197" Uncertain Approved Nucleoplasm Nucleoplasm "HPA021465: AB_1845441, HPA023197: " "unprognostic (3.10e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-3)" "unprognostic (4.61e-2)" "unprognostic (5.89e-2)" "unprognostic (2.59e-2)" "prognostic unfavourable (5.88e-7)" "unprognostic (6.28e-2)" "unprognostic (7.53e-3)" "unprognostic (3.84e-2)" "unprognostic (8.82e-2)" "unprognostic (2.28e-2)" "prognostic unfavourable (2.37e-6)" "unprognostic (6.64e-2)" "unprognostic (1.07e-1)" "unprognostic (6.62e-3)" "unprognostic (1.02e-2)" 13.7 12.3 14.5 15.2 23.8 12.7 12.9 31.8 22.0 13.0 13.0 16.1 10.9 11.7 17.9 10.0 12.8 14.9 9.1 15.3 16.2 10.9 9.1 8.5 11.9 14.3 15.1 15.0 16.3 14.6 13.2 18.2 10.9 14.4 11.2 11.1 11.1 14.7 14.7 25.8 13.1 12.5 12.7 13.9 12.5 13.6 18.5 21.1 16.8 13.3 12.0 15.9 15.6 14.4 6.5 3.1 6.2 4.7 2.7 4.8 1.1 6.1 3.7 11.8 11.7 4.2 8.7 13.5 12.3 7.2 12.3 9.0 7.8 8.3 7.9 19.0 11.6 5.7 8.0 11.1 10.3 43.2 5.4 10.2 13.6 3.9 9.2 14.7 8.8 6.5 3.2 8.6 7.5 12.0 12.5 5.6 9.2 6.3 17.0 8.4 7.0 6.4 10.8 7.1 6.7 6.2 8.1 6.9 12.4 23.4 8.2 4.3 7.4 13.0 11.9 11.1 7.3 5.7 11.9 9.0 4.1 14.0 9.3 14.2 13.4 6.2 4.7 5.4 3.5 2.4 4.6 6.5 4.2 4.8 3.1 4.9 4.8 3.0 4.1 2.7 3.1 1.8 4.5 1.1 14.5 23.8 31.8 22.0 16.2 10.9 15.1 15.0 14.4 21.1 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1, RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA051918: , HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favourable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favourable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 12.1 11.8 15.2 11.0 15.9 9.2 8.2 21.7 25.9 10.4 9.6 24.7 11.0 11.8 11.0 7.0 9.1 15.4 10.5 10.6 16.4 19.1 10.0 9.8 11.3 11.2 19.1 14.5 14.4 20.8 18.0 16.6 9.3 18.3 12.1 6.9 13.2 15.8 11.0 21.8 12.4 12.3 12.5 21.2 12.0 10.5 11.1 14.8 9.9 9.7 6.1 9.5 8.9 7.6 3.3 6.4 4.0 7.4 4.9 3.6 2.8 7.2 16.5 7.0 15.5 6.4 7.2 7.4 11.1 6.8 9.4 7.6 11.6 11.2 5.7 10.8 7.1 14.9 8.5 7.0 5.1 15.6 9.4 6.7 8.6 5.3 7.1 8.0 14.9 6.8 5.9 5.6 6.9 6.7 8.1 4.3 4.5 22.8 9.5 10.2 5.3 17.8 17.0 4.9 5.7 4.7 17.8 23.0 17.1 11.0 8.7 9.3 20.1 11.2 10.0 7.3 6.4 13.8 8.5 8.9 6.6 5.3 8.8 6.6 9.9 0.7 2.3 4.0 3.6 2.2 2.5 3.2 2.5 3.5 2.5 3.3 3.4 2.9 1.0 4.9 7.4 6.4 3.1 2.8 15.2 15.9 21.7 25.9 16.4 19.1 19.1 14.5 18.3 14.8 BRI3BP "BNAS1, HCCR-2, HCCRBP-3, KG19" ENSG00000184992 "BRI3 binding protein" Q8WY22 12 124993700-125031231 "Predicted membrane proteins, Transporters" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.6;U-698: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014957 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA014957: AB_1845447" "unprognostic (1.62e-2)" "unprognostic (6.82e-2)" "unprognostic (1.53e-2)" "unprognostic (9.95e-2)" "unprognostic (4.66e-2)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.87e-4)" "unprognostic (7.65e-3)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (7.40e-2)" "unprognostic (4.82e-2)" "unprognostic (2.72e-3)" "unprognostic (1.44e-3)" "unprognostic (2.20e-1)" "unprognostic (9.20e-2)" "unprognostic (1.55e-1)" 3.8 3.2 10.8 12.6 13.7 4.7 6.8 13.4 16.0 3.8 16.8 8.8 2.4 22.5 2.9 3.0 10.7 5.0 9.8 3.0 11.0 10.8 8.3 7.5 3.4 14.2 10.9 10.3 2.2 11.2 9.8 4.0 2.6 10.5 3.8 17.8 4.7 4.1 3.1 2.0 8.0 21.8 3.3 12.6 7.3 9.0 2.6 7.7 11.1 5.4 4.5 17.8 3.6 4.3 2.4 5.7 9.5 2.5 1.5 1.2 0.7 9.3 12.3 4.6 4.2 3.9 2.0 5.0 6.6 1.4 4.0 1.9 7.8 6.4 37.6 7.8 1.7 11.5 10.7 6.0 3.9 6.9 5.8 17.2 5.5 7.0 0.7 25.0 21.6 0.9 3.5 4.6 2.5 1.7 5.9 2.2 4.2 10.0 12.8 11.2 2.5 4.8 8.1 7.6 8.2 6.1 14.3 6.1 4.0 8.1 8.9 2.9 15.7 20.7 2.0 3.5 3.8 3.7 6.6 7.3 13.1 46.1 3.8 9.4 9.6 4.5 2.5 9.5 1.2 1.7 1.1 1.8 0.9 0.9 2.4 2.4 0.8 1.2 3.8 1.5 1.6 5.7 0.8 0.7 10.8 13.7 13.4 16.0 11.0 10.8 10.9 10.3 10.5 7.7 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA063522 Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA063522: " "prognostic favourable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favourable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favourable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.7 5.5 7.6 4.3 1.2 1.3 13.9 2.7 0.5 1.5 2.3 7.0 6.9 1.5 1.8 0.5 7.4 1.0 1.0 1.1 5.1 3.3 1.7 13.2 1.8 0.7 0.7 4.3 1.5 2.0 2.2 0.5 0.9 1.8 3.9 0.6 7.4 4.7 10.7 7.4 3.1 14.6 5.7 4.9 1.7 2.2 5.3 4.8 2.7 3.3 2.6 3.4 3.9 2.2 7.3 5.9 6.3 2.3 11.9 5.1 3.9 1.3 4.4 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 BRIX1 "BRIX, BXDC2, FLJ11100" ENSG00000113460 "BRX1, biogenesis of ribosomes" Q8TDN6 5 34915376-34925996 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039614 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039614: AB_10963698" "prognostic unfavourable (2.18e-4)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (1.10e-5)" "unprognostic (1.82e-1)" "unprognostic (5.85e-3)" "prognostic unfavourable (4.11e-8)" "unprognostic (3.37e-2)" "unprognostic (3.84e-3)" "prognostic favourable (6.34e-4)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "prognostic unfavourable (3.07e-9)" "unprognostic (1.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (2.09e-2)" 18.9 18.4 20.4 15.6 24.0 30.6 23.7 24.9 24.1 16.4 14.4 10.7 18.9 11.9 18.1 18.2 23.4 17.6 11.9 16.4 15.8 15.2 17.0 18.6 14.0 22.2 21.1 15.6 19.4 13.4 15.6 19.1 24.5 20.9 15.9 16.5 7.7 15.7 14.5 19.7 15.9 13.3 22.9 18.6 17.0 14.7 13.4 21.9 17.0 16.6 14.2 23.1 21.6 21.7 22.9 14.0 4.1 10.4 15.0 22.1 16.2 14.7 14.5 14.9 20.5 6.5 9.2 29.4 18.2 12.9 24.6 15.7 19.8 19.5 32.5 9.4 10.8 12.3 26.0 18.8 28.0 17.4 25.7 21.7 34.9 17.7 17.8 34.5 15.0 11.1 12.2 22.7 20.5 11.3 37.9 10.0 16.0 16.0 23.9 37.8 24.0 21.4 21.5 27.0 13.9 14.1 17.2 18.0 16.1 37.7 26.4 16.9 16.5 21.3 6.7 18.9 20.7 13.6 34.8 9.0 19.2 41.3 16.4 39.7 23.5 4.1 8.5 4.0 14.4 7.9 20.4 22.9 17.7 18.1 10.7 18.0 22.1 19.6 0.5 15.0 10.4 14.0 16.4 16.2 20.4 24.0 24.9 24.1 15.8 15.2 21.1 15.6 20.9 21.9 BROX "C1orf58, FLJ32421" ENSG00000162819 "BRO1 domain and CAAX motif containing" Q5VW32 1 222712553-222735196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031445 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" 190000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA031445: AB_10602697" "unprognostic (1.27e-1)" "unprognostic (4.32e-1)" "unprognostic (3.43e-2)" "unprognostic (4.60e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-1)" "unprognostic (3.31e-2)" "unprognostic (2.83e-2)" "unprognostic (2.52e-2)" "unprognostic (6.72e-2)" "unprognostic (4.27e-2)" "unprognostic (2.53e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.56e-2)" "unprognostic (1.83e-2)" "unprognostic (2.50e-2)" 24.0 21.1 22.7 15.7 25.3 33.0 22.2 21.6 24.9 17.8 23.6 22.0 13.8 19.8 18.2 15.6 30.1 17.7 18.3 14.9 22.5 20.2 22.6 21.0 18.5 22.7 30.2 22.7 21.4 16.2 28.3 21.8 28.1 29.6 17.0 23.7 11.8 21.3 17.9 23.7 23.5 33.0 16.8 27.5 22.9 23.2 12.6 30.1 24.4 25.0 22.5 19.7 21.1 19.8 8.8 13.4 30.9 21.7 14.2 15.3 8.5 25.6 15.4 9.6 8.3 13.9 14.8 18.5 17.6 22.2 14.6 16.8 8.6 33.7 8.6 21.3 21.8 22.7 10.7 16.9 22.2 10.6 9.5 12.7 17.3 8.5 15.7 14.5 12.2 13.0 16.7 18.1 21.6 13.1 19.2 11.8 17.9 7.7 6.1 7.6 12.0 18.4 6.5 29.0 19.1 17.2 25.6 10.8 17.0 19.4 22.2 13.1 27.0 14.9 18.9 20.1 11.6 20.7 19.9 8.8 14.8 7.7 16.3 12.3 18.3 30.9 15.8 18.3 12.0 21.7 13.3 8.8 15.3 12.0 13.4 8.3 10.3 13.0 27.3 14.2 21.0 7.5 13.8 8.5 22.7 25.3 21.6 24.9 22.5 20.2 30.2 22.7 29.6 30.1 BRPF3 KIAA1286 ENSG00000096070 "Bromodomain and PHD finger containing 3" Q9ULD4 6 36196744-36232790 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022787 Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA022787: AB_1845454" "unprognostic (1.44e-1)" "unprognostic (2.24e-1)" "unprognostic (5.52e-2)" "unprognostic (2.15e-2)" "unprognostic (2.98e-1)" "unprognostic (9.51e-2)" "unprognostic (5.33e-2)" "unprognostic (3.78e-1)" "unprognostic (3.02e-2)" "unprognostic (1.07e-1)" "unprognostic (7.98e-2)" "unprognostic (3.74e-1)" "unprognostic (3.59e-2)" "unprognostic (3.29e-2)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.28e-1)" 9.6 21.8 11.9 12.3 11.7 12.3 25.8 22.4 16.7 11.9 15.2 10.9 28.3 13.5 16.0 13.4 9.5 10.8 10.6 10.9 10.3 9.1 15.9 16.5 9.6 7.7 10.4 11.7 15.2 20.8 18.1 18.8 8.7 7.4 15.2 15.3 8.0 16.5 31.0 22.9 14.5 17.0 12.2 9.8 9.8 12.4 22.9 11.8 11.8 18.3 4.4 7.1 13.9 22.3 0.8 0.5 3.0 0.2 0.1 2.0 0.6 6.7 6.5 16.3 12.8 9.0 7.7 14.0 10.2 10.8 14.4 11.4 19.0 6.4 10.5 11.0 9.9 6.6 14.3 7.3 12.6 9.9 8.9 7.4 6.0 11.2 9.6 5.7 10.3 9.8 6.3 17.1 8.6 10.7 15.3 9.6 7.8 9.6 6.5 2.5 8.2 5.6 19.0 6.7 3.2 4.7 13.9 23.4 7.3 8.3 9.1 8.7 10.2 15.8 11.2 15.0 12.9 4.1 11.7 8.0 10.3 7.9 2.5 9.1 17.7 3.0 0.2 1.4 1.9 0.2 2.0 0.8 0.5 0.6 0.2 0.4 0.9 0.6 1.5 0.1 0.1 0.5 1.2 0.6 11.9 11.7 22.4 16.7 10.3 9.1 10.4 11.7 7.4 11.8 BRWD3 "FLJ38568, MRX93" ENSG00000165288 "Bromodomain and WD repeat domain containing 3" Q6RI45 X 80670854-80809688 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012802 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA012802: AB_2066662" "unprognostic (1.13e-2)" "unprognostic (2.14e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-3)" "unprognostic (7.04e-3)" "unprognostic (2.00e-1)" "unprognostic (1.50e-1)" "unprognostic (7.18e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-1)" "unprognostic (7.18e-2)" "unprognostic (1.62e-2)" "unprognostic (1.41e-2)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.01e-1)" "unprognostic (3.35e-1)" 7.7 5.7 7.5 9.1 7.7 10.5 13.0 20.9 8.5 9.3 8.2 5.6 8.6 8.5 8.0 6.2 10.8 8.1 6.3 5.0 7.4 4.6 5.6 7.5 12.7 9.3 5.3 5.5 11.9 7.8 7.3 12.5 8.6 6.5 6.7 8.1 7.7 8.2 11.3 3.7 14.0 10.3 5.8 12.7 8.9 7.3 9.3 7.1 10.1 9.0 6.0 9.1 10.7 12.7 1.1 0.7 2.8 1.1 0.5 1.2 0.5 4.7 5.2 7.9 5.2 3.2 4.0 5.8 2.8 2.4 3.6 4.9 2.3 6.6 5.1 6.5 2.6 8.5 12.0 4.7 4.8 4.4 4.9 10.4 8.4 3.6 2.3 6.0 7.1 2.7 3.2 4.1 5.7 5.4 7.6 13.0 4.1 0.8 3.4 5.5 12.1 2.2 3.1 13.8 3.0 4.1 4.1 1.8 4.5 6.8 3.7 3.0 1.7 5.9 4.9 4.2 5.3 3.9 3.0 5.8 6.0 6.1 3.4 12.1 2.8 0.5 1.1 0.7 0.8 0.9 0.8 0.7 0.8 0.7 0.6 1.1 0.6 1.2 2.8 0.5 0.8 0.7 0.6 0.5 7.5 7.7 20.9 8.5 7.4 4.6 5.3 5.5 6.5 7.1 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell line enhanced" "Detected in some" "A-431: 19.7;CAPAN-2: 12.7;MCF7: 29.4;RPMI-8226: 15.4;SK-BR-3: 14.8;T-47d: 14.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favourable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 19.7 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 4.1 12.7 0.0 0.2 0.0 1.8 0.2 0.0 0.0 2.1 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 29.4 0.3 0.0 0.5 0.0 0.4 0.0 15.4 1.9 4.3 6.8 0.0 0.0 14.8 0.0 14.9 2.1 0.0 0.0 0.0 0.0 0.0 4.8 6.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm Nucleoplasm "HPA031355: AB_10611812" "prognostic favourable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favourable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favourable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 25.9 9.4 19.9 9.4 17.7 11.8 53.4 18.1 27.0 13.6 14.6 5.4 15.2 14.1 9.9 14.7 17.4 11.4 13.6 19.8 17.9 12.9 9.7 12.3 17.7 11.3 11.3 15.9 13.1 5.6 7.7 12.4 7.7 9.5 13.1 11.7 11.6 20.5 12.6 73.0 19.4 14.3 14.4 6.1 9.3 13.7 24.7 6.2 8.2 9.3 31.3 10.6 11.5 22.3 2.4 2.7 4.6 1.6 0.6 8.1 1.1 17.5 14.1 7.7 20.5 24.9 17.3 0.0 16.3 14.8 25.3 17.3 11.0 16.2 5.6 10.0 23.7 23.7 14.8 15.7 12.6 14.3 12.0 4.1 20.5 0.0 17.0 12.3 7.9 18.0 21.7 11.6 9.5 20.1 0.0 0.1 13.4 25.0 12.9 5.0 3.3 24.4 14.0 0.0 5.2 9.6 19.5 12.7 5.4 15.3 12.4 12.0 25.3 15.9 13.5 20.4 0.5 29.8 20.1 3.7 4.9 2.7 21.0 5.7 15.8 0.6 1.1 4.6 4.1 1.6 4.0 2.4 4.3 4.2 1.1 1.3 3.3 2.3 0.7 0.6 1.2 2.7 8.1 1.1 19.9 17.7 18.1 27.0 17.9 12.9 11.3 15.9 9.5 6.2 BTBD9 "dJ322I12.1, KIAA1880" ENSG00000183826 "BTB domain containing 9" Q96Q07 6 38168451-38640148 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041930 Uncertain Approved Nucleoplasm Nucleoplasm "HPA041930: AB_10795270" "unprognostic (4.40e-1)" "unprognostic (1.74e-1)" "unprognostic (1.75e-3)" "unprognostic (1.64e-2)" "unprognostic (6.59e-2)" "unprognostic (3.94e-2)" "unprognostic (1.48e-1)" "unprognostic (1.76e-3)" "unprognostic (5.44e-2)" "unprognostic (6.13e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-1)" "prognostic favourable (4.20e-13)" "unprognostic (1.35e-1)" "unprognostic (6.56e-2)" "unprognostic (8.67e-2)" "unprognostic (1.15e-2)" 5.3 6.6 17.9 5.4 23.9 9.1 5.1 9.8 20.4 5.7 6.6 7.8 7.1 6.3 7.2 5.4 7.8 13.0 7.5 9.2 15.6 11.5 8.4 3.8 12.5 7.4 8.9 13.7 11.5 4.8 28.6 12.9 5.6 10.5 6.8 7.8 7.0 5.3 6.4 7.8 7.4 8.7 6.8 6.1 5.3 5.7 10.2 7.7 4.1 8.5 3.0 7.6 7.5 5.2 5.2 3.9 12.7 5.5 5.0 5.6 2.6 5.8 5.0 7.9 9.9 5.9 8.3 5.7 6.2 8.3 6.9 7.3 5.9 3.4 3.6 4.2 9.4 4.2 4.3 8.9 8.2 10.1 8.5 7.6 5.1 2.5 4.6 7.7 15.9 6.3 6.8 9.3 8.8 11.8 3.7 6.0 6.9 3.6 5.5 2.8 2.1 4.4 3.3 5.6 6.8 6.6 14.8 10.1 7.2 5.8 5.8 5.7 6.1 5.3 7.7 6.7 4.2 7.4 6.5 3.5 2.9 4.2 5.3 4.8 7.3 12.7 2.7 4.5 3.8 3.8 5.3 3.9 3.8 3.4 2.5 5.2 4.8 4.3 6.7 5.0 5.5 3.9 5.6 2.6 17.9 23.9 9.8 20.4 15.6 11.5 8.9 13.7 10.5 7.7 BTF3L4 MGC23908 ENSG00000134717 "Basic transcription factor 3 like 4" Q96K17 1 52056125-52090716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067026 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA067026: " "unprognostic (6.12e-2)" "unprognostic (6.33e-2)" "unprognostic (5.09e-2)" "unprognostic (8.83e-3)" "unprognostic (1.42e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (6.73e-8)" "unprognostic (8.85e-2)" "unprognostic (5.59e-2)" "unprognostic (1.71e-3)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.43e-6)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (8.56e-2)" 22.3 29.1 20.6 14.8 22.1 26.7 26.2 25.5 52.3 17.5 12.8 17.2 8.4 7.1 19.5 16.7 20.3 19.6 12.5 28.4 23.7 22.4 18.5 20.8 19.6 38.8 20.4 23.8 29.2 47.6 21.0 24.3 19.1 16.7 15.7 12.6 16.5 26.4 13.5 36.9 19.3 9.8 22.4 23.1 14.1 14.2 19.2 14.6 20.7 22.9 13.6 20.4 19.0 16.2 23.2 34.1 32.2 36.0 21.3 28.2 27.9 27.7 6.8 33.1 17.3 17.9 23.1 34.3 27.5 27.7 31.6 34.0 12.3 14.6 25.9 27.6 19.3 16.2 31.9 21.4 40.5 17.9 22.4 29.7 12.4 18.3 49.1 32.8 20.5 23.7 29.7 29.2 41.2 25.0 22.4 16.6 28.3 11.9 22.7 19.5 59.0 14.8 15.0 38.6 30.4 30.5 22.3 26.1 29.6 32.2 29.8 39.5 26.9 35.2 18.2 17.8 19.3 22.9 32.3 29.0 47.8 25.3 15.4 25.6 22.4 24.1 35.4 32.2 15.0 36.0 20.1 23.2 21.7 15.4 34.1 22.1 25.4 19.4 15.1 21.3 31.0 16.1 28.2 27.9 20.6 22.1 25.5 52.3 23.7 22.4 20.4 23.8 16.7 14.6 BTG1 APRO2 ENSG00000133639 "BTG anti-proliferation factor 1" P62324 12 92140278-92145897 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 190.7" "Cell line enhanced" "Detected in all" "ASC TERT1: 49.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005972 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005972: AB_1078303" "prognostic favourable (4.36e-5)" "unprognostic (1.43e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-3)" "unprognostic (1.10e-1)" "unprognostic (5.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.50e-1)" "unprognostic (4.94e-2)" "prognostic unfavourable (1.95e-7)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (5.79e-2)" "unprognostic (9.81e-2)" 52.0 22.1 11.5 58.3 13.4 126.9 114.4 66.8 10.4 41.7 40.1 5.5 21.9 15.5 30.1 22.0 28.7 27.9 39.9 49.2 11.9 8.1 22.2 58.1 85.6 190.7 10.4 8.2 29.1 64.2 17.6 17.1 23.4 13.3 28.7 18.1 21.0 19.0 25.9 31.6 70.6 34.3 26.0 24.6 77.1 26.4 19.0 8.9 148.9 15.7 14.3 58.2 54.2 35.2 58.3 6.6 94.3 14.0 47.1 95.2 26.1 6.8 8.6 9.5 1.1 35.7 49.6 4.1 7.7 17.1 5.2 5.2 5.1 2.4 7.4 1.6 8.2 4.7 3.1 8.7 9.7 8.9 6.7 1.4 6.0 2.6 36.2 5.4 2.5 42.3 26.2 11.9 36.9 10.4 5.1 9.8 5.9 7.1 3.8 17.4 2.3 9.9 13.1 5.3 2.3 16.0 14.3 5.3 10.6 9.7 7.5 25.0 31.4 12.6 3.3 5.9 1.8 4.5 4.7 13.6 7.2 12.3 4.6 4.3 6.6 22.3 13.6 94.3 17.0 10.6 20.1 44.5 34.3 29.8 6.6 58.3 95.2 39.1 52.3 47.1 14.0 6.2 39.2 26.1 11.5 13.4 66.8 10.4 11.9 8.1 10.4 8.2 13.3 8.9 BTG2 "APRO1, MGC126063, MGC126064, PC3, TIS21" ENSG00000159388 "BTG anti-proliferation factor 2" P78543 1 203305491-203309602 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.9;HMC-1: 38.6;U-266/70: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002355 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA002355: AB_1078304" "prognostic favourable (8.53e-4)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" "unprognostic (4.81e-3)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (2.47e-1)" "unprognostic (7.87e-3)" "unprognostic (4.72e-1)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.18e-2)" "unprognostic (4.46e-2)" "unprognostic (6.22e-2)" "unprognostic (4.34e-1)" "unprognostic (1.17e-1)" "unprognostic (2.86e-3)" 61.6 45.9 10.1 61.4 20.6 46.9 27.8 13.0 10.4 23.0 53.3 27.8 27.0 15.2 27.1 24.6 55.7 103.7 76.1 65.3 10.4 10.0 22.3 4.3 40.7 20.0 12.2 5.5 102.0 117.6 7.0 52.2 42.7 28.3 61.0 38.5 30.4 18.1 104.1 98.9 30.5 36.6 50.8 22.7 32.7 67.1 11.5 9.9 82.9 36.7 45.2 49.0 64.7 21.5 14.1 17.3 34.5 14.2 5.7 8.5 7.1 0.9 1.4 2.6 1.0 3.3 2.4 21.7 2.5 5.0 0.6 2.5 1.9 0.4 36.9 1.8 0.8 16.2 9.4 9.9 1.2 2.4 4.6 19.3 2.7 4.2 7.2 0.1 38.6 2.4 18.4 2.4 4.5 13.5 8.9 25.6 6.7 0.8 4.0 1.2 1.1 0.2 2.5 8.7 18.5 1.2 30.1 0.4 2.7 2.0 0.8 0.3 2.1 2.3 3.3 0.0 4.3 0.6 0.1 59.8 30.2 23.6 0.5 0.9 1.5 3.2 8.1 9.9 4.7 12.1 7.1 14.1 5.3 4.8 5.1 13.1 8.5 5.9 34.5 5.7 14.2 17.3 4.9 7.1 10.1 20.6 13.0 10.4 10.4 10.0 12.2 5.5 28.3 9.9 BTRC "beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1" ENSG00000166167 "Beta-transducin repeat containing E3 ubiquitin protein ligase" Q9Y297 10 101354033-101557321 "Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031156, CAB032986" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB032986: AB_2243598, HPA031156: " "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (8.88e-2)" "unprognostic (2.09e-1)" "unprognostic (3.55e-1)" "unprognostic (2.73e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.22e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-3)" "unprognostic (5.05e-1)" "unprognostic (2.81e-3)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (3.07e-2)" "unprognostic (2.23e-1)" 6.6 11.2 16.0 7.3 23.1 3.6 11.8 16.2 28.0 10.2 6.6 10.7 13.7 5.4 8.8 14.5 11.5 10.8 8.1 18.6 15.7 18.3 11.6 7.1 6.8 5.3 14.3 15.3 15.5 8.6 21.5 17.3 10.4 13.5 12.2 7.0 11.9 9.0 8.7 14.1 9.0 5.4 9.7 10.2 7.5 6.4 17.9 9.0 6.3 11.4 7.1 7.5 7.3 9.8 5.2 4.8 3.9 3.7 5.1 8.1 3.4 6.5 10.1 14.2 16.3 13.9 12.1 5.1 9.5 15.3 9.9 8.3 7.0 5.2 10.7 9.6 8.0 10.2 11.6 10.3 10.8 7.0 9.2 7.8 6.3 9.1 7.4 11.3 4.2 7.4 12.0 8.5 15.2 12.2 8.4 3.6 9.5 5.6 7.6 5.7 6.6 7.9 9.6 19.9 2.2 9.1 4.3 10.5 9.0 6.2 2.8 8.8 7.7 4.0 10.3 5.2 8.3 6.8 6.6 6.0 13.0 6.8 5.2 5.7 3.5 3.8 3.7 3.9 6.1 3.1 6.1 5.2 6.5 5.5 4.8 4.4 8.1 6.5 2.4 5.1 3.1 2.4 5.6 3.4 16.0 23.1 16.2 23.3 15.7 18.3 14.3 15.3 13.5 9.0 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 26.4 31.9 43.6 26.1 44.8 66.6 29.5 28.3 36.4 25.6 31.3 25.6 31.6 27.0 25.1 32.2 35.2 35.7 28.1 30.8 39.2 36.3 37.9 33.2 26.2 34.5 39.5 27.4 28.8 31.4 21.0 35.2 33.7 32.3 27.3 22.7 22.0 31.5 28.9 20.7 23.5 31.2 25.4 34.5 29.1 26.7 51.2 27.0 24.1 40.1 29.0 31.6 35.3 26.5 39.1 32.2 91.2 42.7 34.1 37.6 56.6 25.0 29.6 16.6 37.1 16.6 18.7 16.1 24.1 23.1 27.7 30.4 34.5 25.0 19.2 29.5 23.2 15.0 18.2 22.0 23.2 23.2 24.7 14.0 21.1 22.6 34.7 23.8 18.5 18.3 27.3 25.2 47.6 21.5 34.3 44.1 25.4 65.8 31.2 64.6 36.4 37.1 16.4 16.7 33.2 24.1 20.0 29.1 35.0 23.8 27.5 50.0 17.3 30.1 17.5 26.4 33.6 52.2 37.6 27.7 46.5 51.3 23.3 35.6 47.7 59.1 39.3 91.2 34.1 40.5 31.9 39.1 32.8 33.0 32.2 36.6 27.9 29.2 83.0 34.1 42.7 31.1 37.6 56.6 43.6 44.8 28.3 36.4 39.2 36.3 39.5 27.4 32.3 27.0 C10orf55 bA417O11.3 ENSG00000222047 "Chromosome 10 open reading frame 55" Q5SWW7 10 73909969-73922777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 14.0" "Cell line enhanced" "Detected in some" "A-431: 5.0;CAPAN-2: 4.8;HaCaT: 4.8;RPTEC TERT1: 7.6;U-251 MG: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA045739 Approved Approved Nucleoplasm Nucleoplasm "HPA045739: AB_10961861" "unprognostic (5.50e-2)" "unprognostic (1.82e-1)" "unprognostic (1.84e-2)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (9.68e-3)" "unprognostic (5.61e-3)" "unprognostic (4.99e-2)" "unprognostic (8.84e-2)" "unprognostic (3.62e-3)" "unprognostic (1.30e-1)" "unprognostic (2.15e-3)" "unprognostic (1.27e-1)" "unprognostic (3.90e-2)" "unprognostic (5.94e-3)" "unprognostic (3.13e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 14.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.4 0.3 0.0 4.8 0.0 0.3 0.2 4.8 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.4 0.6 1.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.7 0.0 2.1 0.0 7.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;SiHa: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "HPA038130, HPA038131" Approved Approved "Nucleoplasm,Nucleoli,Nuclear speckles" Nucleoplasm "Nucleoli, Nuclear speckles" "HPA038130: , HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.6 0.1 2.4 0.2 0.2 1.5 5.2 0.2 0.7 1.6 0.5 0.4 0.1 0.7 0.3 1.0 0.1 0.0 0.6 1.7 0.6 1.0 0.0 0.2 0.7 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.2 0.4 1.7 0.3 0.9 0.4 8.4 0.3 0.1 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.0 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299193-49327487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 104.2;tongue: 35.0" "Group enriched" "Detected in some" 21 "K-562: 8.9;RH-30: 13.6" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA057556: " "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 2.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.0 1.7 0.1 0.0 13.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 3.3 15.3 0.1 0.0 0.0 0.3 0.0 0.0 1.1 0.0 104.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.5 35.0 3.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Cell line enhanced" "Detected in some" "SK-MEL-30: 48.4;U-2197: 14.8;U-266/84: 10.4;U-87 MG: 15.4;WM-115: 12.1" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 48.4 0.0 0.1 0.0 1.9 0.0 14.8 0.2 0.0 10.4 0.0 15.4 0.0 12.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295645-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0" "Cell line enhanced" "Detected in some" "HEL: 30.1;HL-60: 11.4;NB-4: 10.4;THP-1: 7.3;U-937: 12.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA037607 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.5 0.4 0.7 8.7 0.5 30.4 0.7 0.2 0.7 1.5 0.8 1.7 0.8 0.2 1.6 1.3 0.7 1.0 5.4 15.6 0.4 0.4 1.0 1.3 5.2 8.5 2.2 0.9 0.7 0.6 0.0 0.8 0.8 1.0 0.8 0.8 1.4 9.3 0.1 0.4 0.8 3.3 0.6 1.4 16.0 2.0 0.9 1.0 6.4 1.1 2.7 11.5 1.0 0.9 2.6 7.3 29.5 23.2 9.5 10.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 30.1 0.0 0.1 0.3 11.4 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 12.8 0.0 29.5 6.3 18.7 10.6 13.1 7.3 2.0 3.6 8.4 7.3 2.6 5.4 7.5 5.5 9.5 23.2 0.7 2.6 6.4 0.7 0.5 0.2 0.7 0.4 0.4 2.2 0.9 1.0 1.0 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 123.3;liver: 55.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" 640000 "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favourable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 6.0 10.2 5.0 4.3 7.6 1.8 7.2 6.7 6.0 5.9 12.0 7.7 7.8 12.2 6.4 7.3 6.8 7.5 10.6 8.5 5.3 5.0 123.3 55.9 8.0 4.6 8.4 5.1 8.5 13.9 5.6 11.6 5.7 7.3 9.7 10.0 8.9 8.3 6.5 14.2 5.2 20.0 6.7 9.3 5.2 8.4 5.1 7.8 8.9 11.3 5.3 5.3 6.9 4.9 10.6 12.4 37.6 11.7 9.3 11.9 7.2 3.8 5.5 12.7 7.8 10.0 11.4 14.8 5.3 8.8 5.4 7.5 2.1 21.6 15.7 35.4 10.2 9.0 14.6 3.9 7.5 15.8 5.0 8.6 12.8 10.1 11.3 7.2 4.6 10.6 7.5 10.0 7.2 8.7 11.3 11.0 5.5 3.0 13.1 10.0 4.7 8.8 12.6 16.5 24.8 30.9 7.4 6.5 8.3 9.7 12.2 11.7 27.1 5.7 5.7 5.5 4.4 9.6 2.8 4.9 14.4 15.5 4.2 12.0 9.4 23.7 11.7 27.3 9.0 8.5 9.3 10.6 9.3 10.2 8.9 9.5 11.5 10.1 37.6 9.3 7.4 12.4 11.9 7.2 5.0 7.6 6.7 6.0 5.3 5.0 8.4 5.1 7.3 7.8 C11orf58 SMAP ENSG00000110696 "Chromosome 11 open reading frame 58" O00193 11 16613132-16756881 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036591, HPA076406" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA036591: AB_10669909, HPA076406: " "unprognostic (8.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "prognostic unfavourable (5.84e-5)" "unprognostic (1.30e-1)" "unprognostic (7.84e-2)" "unprognostic (9.45e-3)" "unprognostic (1.76e-1)" "unprognostic (2.06e-1)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (9.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.50e-1)" 44.5 47.1 34.7 37.8 49.0 34.7 40.5 59.7 43.0 40.3 42.1 32.3 29.7 27.3 54.1 35.3 51.6 36.3 34.0 55.1 32.4 33.3 42.6 56.4 41.6 43.0 36.5 38.9 54.2 39.6 35.8 53.7 58.9 35.7 42.0 23.6 30.6 40.1 36.3 69.5 36.4 28.4 43.0 38.9 41.1 35.1 27.5 33.9 50.6 47.6 32.6 36.5 52.0 39.2 97.7 91.8 87.4 74.8 67.4 91.1 123.2 65.4 52.8 63.1 31.1 35.2 32.1 44.4 65.2 33.9 43.4 39.8 49.9 62.2 56.6 52.4 39.5 38.3 42.4 30.7 47.1 74.3 45.4 50.0 45.6 45.0 43.6 71.5 45.0 31.7 43.1 25.8 57.0 30.3 62.5 39.5 37.3 38.3 76.6 34.8 46.7 30.1 62.5 63.7 29.8 33.7 37.6 43.4 44.4 57.0 43.3 77.5 38.5 49.7 56.5 54.6 44.6 65.2 61.5 26.5 97.8 78.7 47.5 41.7 49.8 78.3 65.8 87.4 72.2 72.9 83.0 97.7 80.2 75.8 71.4 89.3 91.1 78.9 31.3 67.4 74.8 91.8 81.5 123.2 34.7 49.0 59.7 43.0 32.4 33.3 36.5 38.9 35.7 33.9 C11orf68 "BLES03, P5326" ENSG00000175573 "Chromosome 11 open reading frame 68" Q9H3H3 11 65916808-65919117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045938 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045938: AB_10961633" "unprognostic (3.18e-1)" "unprognostic (3.35e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (1.23e-1)" "unprognostic (9.25e-2)" "unprognostic (1.15e-2)" "unprognostic (9.88e-2)" "unprognostic (5.98e-2)" "unprognostic (9.88e-2)" "unprognostic (2.73e-1)" "unprognostic (1.50e-3)" "prognostic favourable (5.02e-6)" "unprognostic (2.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (1.18e-1)" 20.1 13.1 23.5 11.0 23.5 6.9 15.4 44.0 42.9 24.5 19.7 20.0 16.6 13.6 26.3 33.0 19.0 25.3 16.4 24.5 22.9 18.8 13.7 12.1 15.4 17.3 18.3 23.7 32.9 17.6 20.6 11.0 19.5 18.6 23.3 12.9 14.8 24.2 27.5 37.0 19.6 13.1 22.2 15.5 19.0 14.1 21.5 18.5 23.0 21.5 13.1 16.4 22.3 23.1 6.6 3.6 12.6 5.2 4.9 7.5 2.8 20.4 9.2 5.7 6.2 20.3 19.7 4.9 16.4 25.2 21.1 12.9 3.4 23.4 4.2 11.5 24.7 6.7 4.4 10.1 11.4 6.5 4.4 5.0 6.2 8.9 16.2 4.0 6.7 18.1 15.2 15.2 16.9 15.7 6.6 10.6 38.1 9.3 5.2 9.6 5.7 46.4 7.8 6.5 11.8 11.1 4.0 3.9 6.1 6.3 8.4 15.9 10.9 3.8 16.9 33.7 16.5 45.7 8.3 7.1 3.1 3.5 19.9 3.0 26.2 8.7 3.5 4.9 7.4 5.2 5.2 4.2 4.8 6.1 2.6 6.6 7.4 7.5 12.6 4.9 2.6 3.6 5.6 2.8 23.5 23.5 44.0 42.9 22.9 18.8 18.3 23.7 18.6 18.5 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" 11 43942505-43944338 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 152.0" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavourable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 68.2 81.2 4.9 23.4 17.4 3.4 42.6 2.6 10.5 39.7 32.2 3.3 6.6 12.4 35.1 41.5 16.3 69.3 70.0 34.3 8.8 7.9 17.9 67.7 61.9 4.9 7.6 4.7 152.0 18.1 3.8 14.2 14.6 32.8 28.6 6.2 7.6 2.3 12.8 38.2 10.1 17.2 22.9 15.3 12.7 31.3 41.7 4.2 0.0 16.7 14.0 2.3 62.9 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.4 0.7 0.0 0.0 0.0 0.7 0.8 0.5 0.3 3.2 0.2 1.4 0.0 0.0 0.7 63.8 0.0 0.0 5.9 0.0 0.6 0.8 3.1 1.2 0.7 0.0 7.4 0.0 0.9 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 17.4 2.6 7.1 8.8 7.9 7.6 4.7 32.8 4.2 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986310-105074197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 82.3" "Lineage enriched" "Detected in all" 13 "dendritic cells: 82.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavourable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 12.1 11.4 14.1 14.4 14.4 15.9 10.8 6.5 15.4 9.0 13.6 9.4 12.4 14.9 9.6 10.0 11.1 7.3 7.1 9.2 12.3 11.5 8.0 18.8 7.7 14.6 11.4 11.0 10.2 35.3 2.7 10.8 7.9 16.0 10.3 11.7 7.5 21.6 13.8 7.7 10.6 10.6 9.7 9.6 12.3 14.1 8.1 9.7 11.0 12.1 8.5 15.4 9.0 11.1 5.9 82.3 1.2 6.2 4.7 5.5 3.5 9.2 13.2 6.4 16.3 5.4 5.5 29.6 8.4 2.1 5.1 2.8 13.3 4.7 17.7 8.4 3.7 6.2 5.3 12.7 5.7 5.0 9.5 11.7 6.7 18.1 7.9 17.5 9.3 8.1 5.4 7.7 8.3 8.2 9.7 4.6 4.9 15.5 11.5 30.0 12.4 19.1 15.6 7.7 39.9 6.8 12.1 8.2 6.0 8.1 17.4 12.4 14.4 7.1 3.9 12.8 8.4 10.9 12.6 9.7 11.0 18.7 5.9 12.4 12.0 1.2 6.2 0.1 2.6 5.2 3.2 5.9 3.5 3.2 18.7 4.4 3.6 3.4 0.7 4.7 2.9 82.3 5.5 3.5 14.1 14.4 6.5 15.4 12.3 11.5 11.4 11.0 16.0 9.7 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803572-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 1.7 8.9 2.6 2.3 9.9 1.7 1.8 1.9 4.7 1.5 1.3 4.8 1.6 0.7 1.1 2.9 1.3 2.9 1.8 5.4 3.7 2.0 4.8 8.7 2.0 3.2 6.3 4.7 1.5 2.1 1.7 3.8 1.6 7.2 2.1 1.2 5.1 1.9 1.4 2.5 1.3 1.4 0.8 9.2 5.5 1.9 22.5 4.9 1.7 3.3 1.0 2.0 1.5 1.7 3.9 1.1 3.6 1.4 3.3 4.5 1.2 2.6 2.8 2.8 8.2 3.1 2.2 2.6 1.9 1.0 2.0 2.4 1.2 2.9 2.3 2.3 0.7 3.0 3.2 6.3 2.7 5.1 3.2 1.8 0.8 1.9 2.6 2.6 1.0 1.2 3.9 2.1 4.3 3.9 2.9 0.5 2.7 0.8 1.0 1.6 9.8 1.6 3.1 4.9 3.3 3.7 0.8 2.1 2.5 4.2 1.0 3.7 3.2 1.2 3.0 1.8 2.0 1.4 2.1 1.4 1.0 7.5 2.3 2.4 2.6 0.3 1.3 3.6 2.3 1.4 3.7 3.9 1.9 3.3 1.1 2.6 4.5 3.8 0.3 3.3 0.8 1.0 3.6 1.2 2.6 9.9 1.9 4.7 3.7 2.0 6.3 4.7 7.2 4.9 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavourable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favourable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.5 10.0 11.4 22.3 5.7 6.1 6.9 12.1 7.7 12.3 9.1 10.8 8.6 18.1 10.5 3.9 10.7 12.3 6.6 11.8 13.6 11.0 21.3 9.9 9.4 12.8 9.9 10.8 6.4 16.1 8.9 18.5 8.0 22.5 7.5 8.2 6.3 23.7 18.3 8.7 15.5 17.7 13.6 16.8 11.5 8.3 24.3 10.5 13.5 6.9 12.6 11.0 11.6 9.0 13.4 16.1 12.1 12.2 12.4 14.3 16.6 8.7 13.1 17.5 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell line enhanced" "Detected in some" "HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059518: " "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.4 0.0 0.0 0.0 0.0 0.3 4.2 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.0 20.4 0.2 2.7 1.3 0.0 5.6 0.0 0.3 1.5 0.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985908-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted - unknown location" "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favourable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 10.4 6.1 10.2 11.8 7.3 12.4 9.8 14.3 7.9 12.0 12.2 8.3 16.7 8.1 10.8 13.5 10.3 11.1 10.3 7.2 9.6 4.6 10.3 9.7 8.7 10.3 6.8 5.9 12.2 15.9 12.9 18.9 5.4 7.4 11.0 10.9 9.1 9.8 10.2 7.3 20.3 9.4 8.4 11.0 12.9 9.5 5.8 9.0 22.7 16.3 7.8 14.6 11.6 9.5 9.7 8.8 21.3 11.3 8.8 12.4 6.6 3.8 7.3 6.2 8.7 10.1 22.5 8.7 4.6 7.1 3.7 4.8 4.5 11.5 10.9 4.4 4.2 8.3 3.8 11.5 3.5 4.2 2.6 6.9 8.8 10.4 8.8 5.0 5.9 16.3 9.0 5.4 6.9 6.7 7.4 2.4 3.7 11.0 6.3 9.3 2.1 5.1 10.3 6.0 6.6 4.8 6.0 22.7 9.9 6.1 5.9 6.2 9.1 8.8 3.8 6.9 9.2 3.1 4.5 8.5 2.3 7.5 4.8 6.2 7.0 11.7 7.5 21.3 8.3 6.9 7.3 9.7 6.8 8.6 8.8 9.4 10.2 9.8 10.7 8.8 11.3 6.2 12.4 6.6 10.2 7.3 14.3 7.9 9.6 4.6 6.8 5.9 7.4 9.0 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042980 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favourable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 13.5 16.3 14.3 11.1 15.4 15.1 13.5 15.9 15.8 10.9 13.9 15.0 16.3 16.3 9.6 24.2 10.8 10.6 10.1 9.0 13.1 9.1 17.2 16.3 9.2 16.0 13.2 13.8 13.9 16.7 12.3 14.1 9.0 12.7 10.3 10.0 11.9 13.8 12.1 13.4 18.2 16.8 10.6 10.5 13.8 11.3 14.3 10.3 14.3 16.0 11.9 12.5 9.9 10.4 27.9 18.8 27.0 14.1 26.5 24.7 12.2 9.3 11.9 7.8 10.7 9.9 9.2 7.5 6.2 10.0 6.1 6.9 8.6 16.7 10.2 8.5 4.8 18.2 17.2 12.8 6.9 19.4 12.0 9.7 15.9 9.8 9.8 15.9 10.2 8.1 18.0 10.2 11.6 10.6 13.1 17.0 5.8 9.6 13.6 8.7 13.7 8.1 18.3 11.0 13.6 10.4 14.7 19.1 11.7 16.4 11.8 23.1 14.8 9.5 6.7 13.2 18.5 9.9 11.0 15.8 23.9 19.3 16.6 16.4 14.4 27.0 14.1 18.8 19.3 13.6 21.1 27.9 20.5 19.9 13.2 24.4 24.1 20.7 15.1 26.5 12.6 18.8 24.7 12.2 14.3 15.4 15.9 15.8 13.1 9.1 13.2 13.8 12.7 10.3 C15orf41 "FLJ22851, HH114, MGC11326" ENSG00000186073 "Chromosome 15 open reading frame 41" Q9Y2V0 15 36579611-36810248 "Disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 79.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm Nucleoplasm "HPA061023: " "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.3 4.1 3.4 4.1 8.9 0.8 2.4 4.2 4.1 5.5 4.0 2.8 3.5 4.9 8.8 2.7 7.0 3.3 4.7 79.9 2.5 2.4 2.3 2.8 2.9 1.9 3.1 2.3 3.6 1.9 2.7 3.5 1.8 2.8 5.4 2.7 2.7 3.5 5.3 7.9 4.2 3.0 16.0 3.4 2.0 2.8 4.9 3.7 2.8 2.2 7.2 3.9 7.7 6.2 3.6 2.4 0.4 2.1 4.9 7.8 2.0 12.8 7.0 8.8 3.3 9.7 11.8 3.6 6.3 3.1 7.9 6.5 9.6 5.2 2.0 6.4 15.2 23.8 9.1 5.3 9.1 1.0 6.3 6.8 6.4 7.0 8.8 5.9 5.0 8.8 5.9 6.7 3.7 7.5 8.6 2.2 10.8 5.9 1.7 3.3 4.8 3.6 5.4 2.5 1.4 5.1 17.8 5.1 3.2 4.2 4.2 3.3 3.9 9.0 5.3 7.8 4.3 5.2 1.7 5.3 7.2 9.5 9.9 10.3 7.2 0.0 0.8 0.4 4.3 2.1 3.9 3.6 3.4 4.2 2.4 3.5 4.1 3.5 0.1 4.9 0.8 1.8 7.8 2.0 3.4 8.9 4.2 4.1 2.5 2.4 3.1 2.3 2.8 3.7 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Cell line enhanced" "Detected in some" "ASC diff: 11.3;fHDF/TERT166: 7.5;HEK 293: 7.8;NTERA-2: 4.8;SK-BR-3: 6.7;U-2 OS: 6.6" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favourable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.8 1.8 11.3 0.2 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.1 0.9 7.5 2.9 2.4 0.0 0.0 0.0 7.8 0.4 0.0 0.0 0.8 0.0 0.2 0.8 0.1 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.7 0.7 3.1 0.2 0.1 1.8 6.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408548-55418764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.6" "Cell line enhanced" "Detected in many" "hTCEpi: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067189 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA067189: " "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favourable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 3.4 3.1 6.5 0.9 7.4 0.8 5.4 2.4 6.7 7.7 5.2 3.7 5.4 2.9 3.7 11.2 3.4 13.7 5.3 7.0 6.0 7.6 11.2 1.9 3.8 2.2 5.2 6.8 4.6 11.0 6.2 17.2 1.2 12.0 5.8 6.2 2.8 27.6 5.3 8.7 2.4 2.5 3.7 3.4 1.9 7.8 11.3 4.6 1.7 7.1 0.6 1.8 3.6 1.5 2.3 0.6 6.5 1.6 0.0 0.7 0.4 0.8 1.7 2.9 1.8 4.5 6.6 0.5 1.6 2.2 1.4 2.8 0.0 1.5 1.3 4.4 5.1 1.3 0.0 2.7 0.5 2.4 2.0 1.2 10.0 0.4 8.7 2.8 1.6 2.8 14.7 4.1 1.2 2.6 2.3 4.3 6.1 2.2 0.1 9.2 0.9 3.3 0.5 0.0 11.1 7.6 0.0 7.8 4.7 2.0 3.3 12.7 6.8 2.7 1.9 2.4 0.9 2.5 0.9 1.9 4.9 1.2 6.1 7.2 1.1 6.5 1.1 3.9 0.5 1.6 0.0 1.9 0.1 0.7 0.6 2.3 0.1 0.0 2.1 0.0 0.8 0.2 0.0 0.4 6.5 7.4 2.4 6.7 6.0 7.6 5.2 6.8 12.0 4.6 C16orf45 FLJ32618 ENSG00000166780 "Chromosome 16 open reading frame 45" Q96MC5 16 15434295-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 32.5;U-2197: 23.6;U-87 MG: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 11.1" "Lineage enriched" "Detected in many" 4 "T-cells: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favourable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 11.5 10.2 38.8 6.8 27.6 1.3 8.4 30.6 72.3 28.4 10.4 10.1 3.8 5.9 21.3 12.7 14.2 12.3 14.6 28.7 39.2 30.4 9.4 12.9 6.0 4.1 21.8 33.8 26.1 5.6 2.2 11.3 1.4 61.3 15.0 6.2 8.5 6.5 17.8 25.5 4.9 4.4 21.5 12.5 5.3 7.6 13.8 12.0 0.0 5.7 4.4 3.0 14.2 10.7 2.7 0.5 0.6 0.1 0.2 11.1 1.5 0.4 10.5 4.4 0.4 19.8 16.9 0.0 5.7 19.7 5.1 2.8 0.0 0.2 0.0 1.3 32.5 0.0 1.2 1.6 2.7 0.2 0.2 2.5 4.1 0.3 6.5 0.0 4.3 8.2 1.7 11.4 0.1 7.8 0.1 0.1 7.6 6.3 1.4 0.1 5.6 4.0 0.3 6.0 0.0 2.8 1.8 8.7 8.6 0.3 2.9 1.7 0.1 0.1 4.5 11.5 5.9 23.6 2.8 1.9 4.5 0.0 40.5 0.0 2.8 0.1 0.1 0.2 11.1 0.0 2.0 2.7 2.1 6.2 0.5 1.6 2.0 3.3 0.6 0.2 0.1 0.3 2.7 1.5 38.8 27.6 30.6 52.4 39.2 30.4 21.8 33.8 61.3 12.0 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 2.0 2.5 5.2 1.8 6.8 2.2 3.1 3.3 8.6 2.8 1.4 3.5 1.3 1.3 2.8 4.4 1.7 8.6 2.0 1.4 5.8 5.8 2.4 3.0 2.2 1.1 5.9 6.0 1.7 2.6 2.9 14.4 3.2 8.6 3.0 1.4 3.5 2.0 2.4 2.5 1.0 1.0 1.9 4.2 1.1 1.1 25.2 2.5 1.5 8.9 0.5 1.3 1.9 1.3 0.2 0.4 1.1 0.4 0.0 2.0 0.0 2.8 0.4 1.1 0.5 5.1 1.0 2.6 0.5 3.5 1.9 1.1 0.6 4.0 0.7 1.8 0.7 1.0 1.1 1.9 3.5 0.6 0.7 0.8 2.3 2.7 3.0 1.0 2.1 2.1 1.5 4.6 2.8 1.7 1.7 1.4 1.5 1.9 0.3 5.4 1.2 0.6 2.1 0.3 0.4 3.4 1.6 1.5 1.3 3.9 1.3 0.7 1.2 1.4 1.3 0.9 0.4 0.8 0.7 1.5 2.1 1.6 1.8 1.4 0.9 0.0 0.4 1.1 0.2 0.0 2.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 5.2 6.8 3.3 8.6 5.8 5.8 5.9 6.0 8.6 2.5 C16orf58 FLJ13868 ENSG00000140688 "Chromosome 16 open reading frame 58" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 13.5 17.7 15.9 15.3 22.3 11.0 15.7 17.9 30.8 22.6 17.5 16.6 34.2 18.6 24.2 21.4 16.8 21.0 20.0 16.7 12.9 15.3 19.1 51.0 13.9 15.7 13.8 16.4 29.5 49.1 30.7 27.6 23.1 13.1 22.0 11.6 22.9 36.9 26.7 4.8 14.1 22.2 15.6 9.1 12.9 19.7 11.9 14.3 15.1 26.4 14.2 19.3 15.9 17.4 8.9 12.0 8.8 9.8 10.8 11.3 8.4 11.4 15.2 9.5 16.5 22.1 14.8 17.6 13.7 23.5 10.7 12.8 4.6 20.2 9.8 29.2 20.2 16.0 9.5 12.7 5.0 14.3 9.4 10.0 8.6 11.4 32.1 11.7 12.0 17.8 13.8 14.1 29.0 10.3 14.7 17.0 10.4 21.6 5.4 7.8 7.4 10.0 12.4 14.3 29.7 12.2 7.1 10.4 16.0 10.3 27.2 21.4 23.5 17.3 8.9 18.7 10.5 12.0 8.9 24.8 14.4 7.4 23.9 18.0 25.7 3.8 6.9 8.8 10.3 9.8 9.6 8.9 10.7 10.2 12.0 8.5 10.8 9.3 1.2 10.8 9.6 11.0 11.3 8.4 15.9 22.3 17.9 30.8 12.9 15.3 13.8 16.4 13.1 14.3 C16orf72 "FLJ41272, PRO0149" ENSG00000182831 "Chromosome 16 open reading frame 72" Q14CZ0 16 9091648-9121640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041568, HPA067492" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041568: AB_10796677, HPA067492: " "unprognostic (3.98e-2)" "unprognostic (4.74e-2)" "unprognostic (5.87e-3)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (1.37e-1)" "unprognostic (3.17e-2)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (6.74e-2)" "unprognostic (8.64e-2)" "unprognostic (7.92e-3)" "unprognostic (2.03e-1)" "unprognostic (1.29e-2)" "unprognostic (6.64e-3)" "unprognostic (6.51e-2)" 20.1 16.5 15.4 15.8 22.5 80.1 17.7 15.2 25.5 20.1 19.5 18.3 17.4 13.5 17.3 16.7 24.0 14.9 22.6 24.9 13.6 14.4 17.2 23.7 19.3 20.1 14.3 19.3 17.3 16.8 31.3 14.0 20.5 19.0 16.5 14.3 17.8 16.6 16.3 34.5 19.2 17.3 16.7 14.1 19.4 16.6 20.2 12.6 20.1 17.5 20.6 21.2 17.7 21.5 4.1 3.8 14.3 4.1 3.0 5.8 1.9 9.0 10.1 16.2 14.7 19.4 15.1 8.5 17.9 14.9 10.3 10.7 8.4 11.8 16.2 10.3 20.6 10.7 14.9 15.8 21.8 10.6 8.3 10.9 14.0 17.7 25.0 13.7 12.8 22.9 24.9 17.3 24.9 17.9 16.4 24.9 18.3 13.1 12.1 12.2 19.7 8.9 20.8 19.8 17.4 13.5 16.7 10.5 11.8 21.4 15.2 18.0 17.5 14.0 20.5 20.3 13.4 26.0 11.4 28.4 24.4 23.1 18.1 12.3 16.4 5.5 3.8 4.0 5.1 4.0 5.8 3.5 4.4 3.6 2.8 4.1 5.1 4.5 14.3 3.0 4.1 3.8 3.4 1.9 15.4 22.5 15.2 25.5 13.6 14.4 14.3 19.3 19.0 12.6 C16orf87 ENSG00000155330 "Chromosome 16 open reading frame 87" Q6PH81 16 46796607-46831411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041179 Uncertain Approved Nucleoplasm Nucleoplasm "HPA041179: AB_10795002" "unprognostic (2.44e-1)" "unprognostic (4.21e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-1)" "unprognostic (1.63e-2)" "prognostic unfavourable (7.95e-5)" "unprognostic (1.74e-1)" "unprognostic (3.13e-2)" "unprognostic (3.21e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (6.57e-4)" "unprognostic (9.90e-2)" "unprognostic (1.35e-2)" "unprognostic (2.08e-2)" "unprognostic (2.66e-1)" "unprognostic (6.61e-3)" "unprognostic (1.84e-2)" 5.4 7.7 10.9 7.7 22.1 23.3 8.2 6.3 13.9 5.8 6.7 3.9 5.9 5.1 6.9 5.2 7.2 5.0 6.4 10.3 7.4 6.2 14.2 19.7 6.1 12.7 5.5 10.6 5.3 4.2 22.0 9.6 8.7 6.5 6.2 5.0 4.3 5.5 4.4 18.2 5.6 11.8 7.6 6.5 7.8 4.6 28.5 8.0 10.6 5.0 6.1 9.0 8.7 6.4 13.6 10.9 9.1 9.8 3.8 15.4 4.8 8.9 3.9 14.1 7.7 3.9 3.6 13.2 10.3 6.3 7.1 4.3 6.1 6.5 13.6 11.7 5.6 7.0 13.3 4.9 9.4 11.0 9.0 8.3 6.1 7.6 8.7 9.6 12.0 5.5 5.7 9.0 8.8 6.0 9.3 2.5 7.5 5.3 13.9 14.4 13.1 7.2 21.1 21.8 9.1 11.5 5.7 8.6 9.7 12.9 12.5 4.8 5.3 11.1 6.9 8.4 6.9 8.6 5.2 11.8 12.5 36.5 3.8 8.4 7.9 3.0 7.8 9.1 5.5 9.8 3.0 13.6 7.8 6.8 10.9 8.1 7.4 5.3 1.1 3.8 9.0 6.0 15.4 4.8 10.9 22.1 6.3 13.9 7.4 6.2 5.5 10.6 6.5 8.0 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell line enhanced" "Detected in many" "Hep G2: 11.7;SH-SY5Y: 11.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: " "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.6 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.9 1.1 2.6 2.5 6.6 7.6 1.4 2.6 11.7 2.0 0.2 3.9 2.3 2.5 0.8 1.8 1.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.6 3.4 0.4 3.9 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 C17orf107 ENSG00000205710 "Chromosome 17 open reading frame 107" Q6ZR85 17 4899418-4902932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.7;salivary gland: 26.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.4;HMC-1: 7.2;hTCEpi: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Not detected" "Not detected" HPA069713 Uncertain Approved Nucleoplasm Nucleoplasm "HPA069713: " "prognostic favourable (5.06e-5)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "unprognostic (1.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-3)" "unprognostic (9.61e-2)" "unprognostic (5.03e-2)" "unprognostic (4.15e-1)" "unprognostic (2.05e-1)" "prognostic favourable (8.61e-4)" "unprognostic (1.17e-1)" "prognostic favourable (2.68e-4)" "unprognostic (9.29e-2)" "unprognostic (2.65e-1)" "unprognostic (2.71e-1)" "unprognostic (3.12e-1)" 2.4 3.7 5.0 2.3 5.1 4.2 3.0 7.7 8.7 3.9 1.4 0.2 5.9 2.1 1.9 5.9 1.3 1.8 3.3 15.3 3.8 4.3 2.2 8.8 2.9 1.0 1.6 4.2 6.4 7.7 6.2 25.7 1.5 1.7 4.5 0.9 2.1 26.0 6.4 0.6 3.3 1.6 1.2 2.2 2.1 4.6 4.7 0.6 0.1 1.9 0.6 2.7 3.3 1.9 0.0 0.0 6.7 0.2 0.0 0.9 0.1 0.6 0.8 1.0 0.3 2.1 1.7 1.5 3.8 0.5 0.2 0.5 0.7 0.7 0.4 0.6 5.4 1.4 0.1 0.5 0.3 0.1 0.8 2.0 0.6 0.7 3.0 0.0 7.2 1.7 6.5 0.1 0.4 0.2 0.0 0.1 0.1 0.7 0.1 0.6 0.3 0.7 0.3 0.2 2.8 0.3 0.3 0.1 0.5 0.6 2.3 0.3 0.6 1.0 0.5 0.3 0.7 0.6 0.5 0.6 0.6 0.1 0.4 0.1 0.3 0.0 0.2 0.8 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.8 6.7 0.0 0.1 0.0 0.0 0.1 5.0 5.1 7.7 8.7 3.8 4.3 1.6 4.2 1.7 0.6 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: " "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.1 2.3 7.9 7.3 6.9 2.1 7.1 3.5 5.2 5.9 12.1 0.4 3.5 4.0 3.9 0.3 9.8 3.7 8.6 11.0 15.2 0.7 5.6 5.0 13.6 0.9 3.9 6.5 3.4 10.5 11.4 3.7 1.9 0.8 4.4 0.0 7.6 0.3 4.3 5.2 7.4 4.8 0.5 1.9 0.5 5.1 0.9 6.6 0.2 5.2 0.1 0.3 6.6 6.1 6.3 14.5 8.5 2.3 2.8 13.5 7.3 1.3 7.1 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 C17orf53 MGC3130 ENSG00000125319 "Chromosome 17 open reading frame 53" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavourable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavourable (3.46e-4)" "prognostic unfavourable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 2.0 0.7 0.5 3.5 0.4 13.4 2.0 2.8 1.4 1.2 1.5 0.6 0.5 1.4 1.3 1.1 4.0 0.9 1.4 1.9 0.8 0.7 0.8 0.8 1.3 2.4 0.5 0.2 1.3 1.2 0.7 0.7 2.3 1.0 1.0 1.7 0.6 1.1 1.1 1.8 2.4 2.2 1.1 0.5 1.9 1.0 32.1 0.4 8.2 0.5 1.5 4.8 0.8 1.7 1.4 3.7 0.9 1.1 0.3 2.0 0.6 7.5 9.5 7.5 6.7 0.6 2.1 8.9 6.0 5.2 11.5 12.7 9.7 4.7 8.1 5.3 5.2 6.6 9.7 9.4 10.2 9.1 12.3 5.2 8.7 6.5 0.3 5.7 6.6 1.8 1.4 14.3 7.1 4.8 11.8 10.7 5.6 5.6 13.5 8.5 5.1 9.4 8.6 12.0 10.0 2.7 6.1 4.7 2.8 3.6 3.6 2.9 7.2 6.6 2.2 11.2 8.8 7.5 8.6 6.1 10.3 7.0 5.2 4.4 6.3 0.0 1.1 0.9 1.1 0.8 0.4 0.8 0.8 0.2 0.4 1.4 0.6 0.4 0.0 0.3 0.4 3.7 2.0 0.6 0.5 0.4 2.8 1.4 0.8 0.7 0.5 0.2 1.0 0.4 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell line enhanced" "Detected in some" "MCF7: 10.8;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.0 0.0 0.6 0.7 1.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 10.8 0.3 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 2.7 0.3 0.0 0.1 0.0 0.0 1.7 1.3 0.2 0.0 1.4 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 C17orf80 "FLJ20721, HLC-8, MIG3, SPEP1" ENSG00000141219 "Chromosome 17 open reading frame 80" Q9BSJ5 17 73232233-73248947 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012896 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA012896: AB_1850766" "unprognostic (9.22e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.43e-4)" "unprognostic (5.55e-3)" "unprognostic (8.58e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (9.02e-6)" "unprognostic (1.08e-1)" "unprognostic (1.00e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.52e-1)" "unprognostic (2.36e-3)" "unprognostic (1.37e-1)" 8.0 10.5 12.8 8.5 13.2 2.4 10.6 27.8 15.4 11.3 11.7 8.4 5.3 9.1 13.1 9.0 10.8 11.2 7.8 13.5 13.8 10.0 11.5 8.6 10.2 11.0 11.8 12.7 16.0 10.1 17.2 24.9 10.9 11.8 11.6 9.0 9.4 9.0 11.2 22.2 7.5 10.4 12.4 14.4 9.9 9.7 32.5 11.3 16.1 14.6 8.3 10.3 10.3 13.3 6.5 7.1 14.6 5.0 5.2 8.7 3.9 9.8 10.4 14.5 8.8 10.7 9.2 14.1 13.0 11.3 18.5 17.6 9.9 8.2 18.8 9.3 6.6 9.9 20.1 7.5 21.7 6.8 13.7 17.3 11.0 11.5 9.3 18.1 10.2 7.1 9.4 12.3 10.2 15.8 18.6 11.3 12.3 5.6 21.0 8.6 11.5 11.3 12.7 39.9 9.6 9.6 7.5 17.8 16.0 6.9 12.7 15.1 13.9 11.5 8.6 19.4 17.9 6.2 12.3 12.8 15.2 18.1 7.8 8.3 12.3 14.6 4.0 5.7 8.5 5.0 8.7 6.5 6.3 7.5 4.6 5.8 6.0 8.6 1.9 5.2 4.7 7.1 8.6 3.9 12.8 13.2 27.8 15.4 13.8 10.0 11.8 12.7 11.8 11.3 C18orf25 "ARKL1, MGC12909, RNF111L1" ENSG00000152242 "Chromosome 18 open reading frame 25" Q96B23 18 46173553-46266991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051314, HPA051899" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051314: , HPA051899: " "unprognostic (1.44e-2)" "unprognostic (2.32e-1)" "unprognostic (2.08e-2)" "unprognostic (5.77e-3)" "unprognostic (4.46e-1)" "unprognostic (7.78e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (3.97e-1)" "unprognostic (7.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.43e-1)" "unprognostic (5.80e-2)" "unprognostic (3.27e-2)" "unprognostic (1.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" 5.3 4.9 5.8 6.4 8.2 18.6 6.5 10.1 10.1 6.1 4.9 5.5 6.5 4.4 7.7 5.3 54.0 6.2 3.8 11.4 4.8 4.9 5.4 6.2 5.9 6.8 5.3 6.5 5.9 5.0 15.3 6.3 7.3 8.3 5.2 5.7 9.5 11.3 4.8 13.1 6.2 5.5 5.7 4.7 6.3 5.1 7.8 5.7 8.2 7.4 10.2 11.8 7.2 12.7 8.1 11.0 19.0 11.0 2.8 11.1 5.5 11.2 11.3 9.5 10.7 6.8 6.2 12.2 16.4 8.7 17.6 15.0 8.6 13.0 8.7 15.6 11.0 25.7 17.5 11.1 19.1 14.4 5.6 7.6 9.6 6.5 11.8 14.2 10.3 5.7 13.0 20.4 17.0 6.9 8.5 10.4 9.7 8.5 10.8 7.3 8.4 4.4 9.8 11.3 12.7 16.8 20.3 13.3 6.9 12.0 8.5 8.5 5.6 8.8 10.0 16.0 11.5 3.9 15.0 13.7 11.6 14.0 8.3 15.1 17.1 4.2 7.5 15.4 5.7 8.4 9.9 5.9 11.1 8.6 7.4 8.1 8.0 6.3 19.0 2.8 11.0 11.0 7.1 5.5 5.8 8.2 10.1 10.1 4.8 4.9 5.3 6.5 8.3 5.7 C18orf32 FLJ23458 ENSG00000177576 "Chromosome 18 open reading frame 32" Q8TCD1 18 49477250-49487252 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040921 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA040921: AB_10795423" "unprognostic (5.83e-2)" "unprognostic (5.48e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-2)" "unprognostic (4.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.72e-1)" "unprognostic (2.80e-2)" "unprognostic (6.36e-2)" "unprognostic (4.36e-3)" "unprognostic (2.58e-3)" "unprognostic (2.76e-2)" "prognostic favourable (8.89e-9)" "unprognostic (1.02e-1)" "unprognostic (7.42e-2)" "unprognostic (1.28e-2)" "unprognostic (4.36e-2)" 17.1 16.5 67.0 7.1 59.0 19.1 25.5 27.4 48.4 22.2 24.2 29.5 16.1 10.7 12.7 35.0 13.6 17.2 19.4 25.1 57.5 49.8 42.2 38.6 19.6 14.8 67.8 28.3 16.5 20.1 23.8 20.5 15.7 47.0 21.3 22.4 17.0 21.6 18.9 10.8 10.2 14.2 14.9 78.5 13.6 23.4 15.5 25.2 8.3 28.8 8.0 12.7 19.4 9.6 16.1 21.4 57.2 22.1 9.8 15.4 21.0 7.6 8.8 16.7 10.4 15.2 13.5 19.2 11.6 12.8 11.3 9.6 1.6 3.5 6.9 29.3 9.8 8.9 3.8 13.1 9.7 22.1 7.8 6.2 5.9 10.6 24.2 12.2 13.3 11.7 29.1 7.6 11.3 15.1 7.1 13.3 23.4 4.8 7.7 6.3 4.6 8.8 7.3 5.8 13.9 30.1 15.0 19.2 33.1 7.6 6.0 15.7 8.6 4.5 16.1 11.7 9.9 3.3 12.5 40.6 24.1 7.5 9.2 8.2 10.9 36.3 17.1 43.2 13.9 19.3 15.4 16.1 13.7 14.3 14.1 12.8 11.7 15.4 57.2 9.8 22.1 21.4 14.6 21.0 67.0 59.0 27.4 48.4 57.5 49.8 67.8 28.3 47.0 25.2 C18orf54 "LAS2, MGC33382" ENSG00000166845 "Chromosome 18 open reading frame 54" Q8IYD9 18 54357917-54385218 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 21.4;testis: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040704 Approved Nucleoplasm "Secreted in male reproductive system" Nucleoplasm "HPA040704: AB_10959454" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (5.29e-2)" "unprognostic (8.63e-3)" "unprognostic (2.40e-1)" "unprognostic (1.05e-1)" "unprognostic (5.60e-6)" "unprognostic (1.11e-2)" "unprognostic (7.85e-3)" "unprognostic (2.55e-2)" "unprognostic (5.91e-3)" "unprognostic (1.13e-2)" "unprognostic (3.06e-5)" "unprognostic (2.29e-1)" "unprognostic (4.21e-1)" "unprognostic (1.28e-2)" "unprognostic (7.05e-2)" 2.9 1.3 2.8 4.8 7.7 2.0 2.1 4.5 4.3 4.1 2.4 3.8 1.0 1.3 3.6 1.1 2.0 1.9 2.1 2.0 3.3 2.2 1.6 0.9 2.5 4.0 10.0 3.4 2.5 1.1 1.9 1.0 21.4 5.7 1.8 2.3 0.7 1.4 1.6 1.0 1.8 2.0 2.7 5.8 4.3 1.5 25.2 6.7 9.3 1.9 1.2 4.0 2.1 3.2 1.4 0.6 1.9 4.1 0.8 2.1 0.6 5.8 3.4 14.4 6.8 3.6 6.2 4.8 9.6 4.1 9.7 12.4 2.1 3.1 4.3 2.7 3.1 6.2 10.0 5.3 12.7 14.2 3.1 4.2 3.6 3.7 0.8 4.7 4.5 2.1 1.1 13.1 6.1 11.5 4.3 9.3 13.8 1.8 5.2 2.9 7.1 6.6 3.9 10.6 2.9 4.7 4.0 8.0 4.5 3.9 1.7 2.1 2.5 4.1 10.4 18.0 7.9 3.0 5.2 5.6 6.3 6.3 4.7 8.1 12.6 1.9 0.7 0.3 1.3 0.8 1.2 0.9 1.1 0.9 0.6 1.4 1.0 1.2 0.0 0.8 4.1 0.3 2.1 0.6 2.8 7.7 4.5 4.3 3.3 2.2 10.0 3.4 5.7 6.7 C19orf44 FLJ21742 ENSG00000105072 "Chromosome 19 open reading frame 44" Q9H6X5 19 16496311-16521352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041683, HPA049414" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA041683: AB_10793929, HPA049414: " "unprognostic (2.16e-1)" "unprognostic (2.16e-2)" "unprognostic (1.25e-1)" "unprognostic (8.52e-2)" "unprognostic (2.05e-1)" "unprognostic (8.38e-3)" "unprognostic (1.83e-1)" "unprognostic (4.19e-2)" "unprognostic (6.45e-2)" "unprognostic (1.36e-1)" "unprognostic (2.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.04e-1)" "unprognostic (7.02e-2)" "unprognostic (7.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.90e-1)" 5.0 4.6 8.1 3.6 8.1 6.1 5.6 11.2 8.8 9.9 7.7 7.4 10.2 3.9 12.7 5.8 5.1 11.5 7.6 5.9 6.3 5.1 6.9 4.3 4.5 3.8 4.0 3.8 13.2 8.1 14.9 19.7 4.1 5.9 11.0 2.9 11.2 10.6 9.9 6.9 7.7 3.8 8.2 5.9 3.9 5.3 19.7 5.8 4.1 9.1 3.1 4.3 6.4 6.1 3.5 1.6 5.7 1.7 1.5 2.7 1.0 5.5 6.3 5.4 7.7 3.6 8.8 7.3 4.7 4.5 5.9 8.6 3.8 6.9 4.8 8.5 3.7 3.9 4.6 4.1 4.7 2.8 11.3 2.3 9.0 4.9 6.3 2.6 2.5 4.5 4.1 7.9 5.8 3.2 6.7 1.5 3.2 7.6 4.2 6.8 3.5 8.3 3.1 2.7 6.6 6.2 2.5 6.4 3.9 4.6 6.8 4.1 5.9 2.8 6.4 8.0 3.8 5.6 6.4 4.8 3.4 2.7 5.7 2.5 6.7 5.7 1.5 0.5 1.6 0.7 0.4 3.5 1.5 0.7 0.6 3.4 1.7 2.7 3.3 1.5 1.7 1.6 0.6 1.0 8.1 8.1 11.2 8.8 6.3 5.1 4.0 3.8 5.9 5.8 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774168-13778462 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA059928: , HPA061291: " "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 37.3 41.5 55.6 31.1 53.7 42.1 33.1 22.0 41.7 40.4 35.7 27.0 34.2 28.0 33.9 55.6 43.1 44.0 39.3 67.0 46.2 44.8 42.8 68.4 35.5 42.4 47.2 34.7 49.9 46.9 27.4 41.8 27.2 37.3 39.2 26.4 30.1 45.9 35.7 90.7 31.5 29.2 39.6 37.0 34.8 31.3 34.1 30.0 59.6 53.5 47.7 41.6 43.1 43.1 67.9 63.0 57.3 49.6 36.3 75.8 92.4 34.8 49.7 24.8 20.6 35.2 39.9 16.4 32.9 29.2 40.9 40.8 46.1 17.1 18.6 41.0 39.7 18.7 22.9 49.6 21.2 22.2 72.3 17.4 53.8 50.0 36.4 27.2 23.1 48.6 35.9 37.8 21.4 35.0 26.9 32.1 31.8 78.5 38.4 28.3 31.6 88.2 21.1 18.9 32.1 36.3 43.2 22.6 27.3 23.0 27.3 33.3 24.8 28.0 23.3 46.5 18.6 49.7 45.0 35.9 45.6 27.8 28.3 31.0 25.1 48.1 48.8 57.3 49.0 49.6 55.5 67.9 63.4 57.0 44.2 63.3 75.8 68.0 23.7 36.3 43.1 63.0 69.4 92.4 55.6 53.7 22.0 41.7 46.2 44.8 47.2 34.7 37.3 30.0 C19orf57 MGC11271 ENSG00000132016 "Chromosome 19 open reading frame 57" Q0VDD7 19 13882348-13906452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;T-cells: 4.9" "HPA044012, HPA054615" Enhanced Approved Nucleoplasm Nucleoplasm "HPA044012: AB_10964782, HPA054615: " "unprognostic (1.71e-1)" "unprognostic (3.48e-3)" "unprognostic (1.84e-1)" "prognostic unfavourable (3.38e-4)" "unprognostic (2.12e-1)" "prognostic favourable (5.14e-4)" "unprognostic (5.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.06e-1)" "unprognostic (1.36e-1)" "unprognostic (7.60e-2)" "unprognostic (4.43e-2)" "unprognostic (1.57e-4)" "unprognostic (1.21e-3)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (5.73e-2)" 2.5 0.9 4.6 1.9 5.5 4.0 4.2 12.8 9.1 2.6 6.9 5.8 0.8 7.7 1.8 3.7 6.2 5.6 1.9 1.1 5.4 3.1 1.3 2.2 1.6 1.9 7.2 3.7 2.8 10.8 3.3 1.6 0.9 6.3 2.4 3.0 1.4 4.4 1.9 1.3 14.2 5.6 1.2 5.9 1.8 2.9 22.9 4.1 2.3 1.4 0.5 1.8 2.1 4.5 0.1 2.6 0.0 0.2 0.6 4.9 1.1 9.3 0.3 7.1 4.0 2.0 0.4 4.7 2.6 1.1 3.2 3.1 5.9 1.4 10.4 14.6 1.1 4.7 2.1 0.9 1.1 1.5 4.5 4.4 3.8 0.1 0.6 2.2 9.7 0.4 0.6 2.0 0.3 0.7 2.9 4.2 1.0 3.0 8.3 4.8 1.0 7.1 9.1 2.6 0.6 1.2 2.2 6.2 2.4 10.2 1.9 2.9 2.0 2.1 0.0 5.8 3.2 13.2 0.7 7.5 1.6 5.2 3.5 7.1 8.9 0.0 0.1 0.0 4.9 0.0 0.5 0.0 0.2 1.1 0.0 0.1 0.4 2.5 0.0 0.6 0.2 2.6 0.0 1.1 4.6 5.5 12.8 9.1 5.4 3.1 7.2 3.7 6.3 4.1 C19orf73 FLJ10490 ENSG00000221916 "Chromosome 19 open reading frame 73" Q9NVV2 19 49118397-49119140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA062719 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA062719: " "unprognostic (3.02e-1)" "unprognostic (3.75e-2)" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (2.04e-2)" "unprognostic (4.39e-3)" "unprognostic (2.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.92e-1)" "unprognostic (1.97e-3)" "prognostic favourable (1.58e-4)" "unprognostic (3.05e-1)" "unprognostic (9.00e-5)" "unprognostic (1.19e-1)" "unprognostic (6.70e-2)" "unprognostic (1.91e-1)" "unprognostic (5.13e-3)" 2.5 3.4 5.0 2.3 6.7 1.0 3.7 10.2 8.7 1.4 3.9 4.1 3.1 7.7 1.3 5.6 2.6 1.4 2.1 3.5 4.9 4.5 2.5 4.8 1.5 2.3 9.2 4.9 0.7 12.9 3.3 5.4 1.4 5.0 2.5 2.9 1.8 6.3 2.1 3.6 4.1 4.4 1.3 4.7 3.6 2.9 2.1 5.6 1.1 3.1 1.2 1.7 1.5 1.4 6.2 5.5 0.7 4.1 7.9 4.6 2.3 2.4 3.1 1.2 6.0 2.0 0.4 1.3 0.7 0.4 1.3 0.9 0.2 1.4 1.8 0.7 0.5 1.6 1.6 0.2 0.2 3.5 12.7 1.5 1.9 2.0 2.0 0.0 0.7 0.2 4.1 0.9 3.4 0.4 2.8 2.9 0.6 2.5 1.9 1.8 0.9 0.6 1.8 2.4 2.3 2.3 1.0 6.3 2.9 1.1 1.5 2.3 1.5 0.6 1.2 1.6 2.7 0.5 0.6 1.8 3.4 2.0 1.1 2.1 1.8 0.0 3.3 0.7 2.9 1.9 4.6 2.7 2.2 2.6 5.5 6.2 4.3 3.2 0.1 7.9 4.1 4.2 1.9 2.3 5.0 6.7 10.2 8.7 4.9 4.5 9.2 4.9 5.0 5.6 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Cell line enriched" "Detected in single" 51 "K-562: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C1orf21 PIG13 ENSG00000116667 "Chromosome 1 open reading frame 21" Q9H246 1 184387058-184629020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.9;Karpas-707: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 11.4;memory CD8 T-cell: 5.9;naive CD8 T-cell: 5.9;NK-cell: 7.5" "Group enriched" "Detected in many" 12 "NK-cells: 7.5;T-cells: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026831 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA026831: AB_1845636" "unprognostic (8.27e-2)" "unprognostic (7.45e-2)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (5.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (3.35e-8)" "unprognostic (1.81e-2)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (3.60e-2)" 12.0 15.9 16.8 7.5 9.5 2.1 25.2 17.5 18.8 20.2 18.5 4.4 16.7 8.7 17.3 14.2 14.1 10.1 9.2 20.0 12.5 8.8 4.1 7.5 12.2 3.5 8.3 13.3 13.9 4.7 12.6 7.6 5.7 11.8 17.8 13.1 10.7 5.1 18.9 51.7 30.1 15.8 25.2 7.6 8.2 10.7 4.1 5.4 1.5 4.4 13.6 3.9 22.0 23.5 0.0 0.7 0.2 0.1 7.5 11.4 2.1 0.6 0.1 3.6 0.3 11.2 9.2 6.0 3.1 3.1 2.0 1.8 0.0 0.3 0.0 0.0 3.5 2.0 2.3 2.6 1.9 22.9 3.6 0.1 1.0 0.0 4.4 1.9 1.0 11.1 7.6 2.3 2.0 2.3 0.0 17.4 3.0 2.4 2.3 0.5 5.3 0.6 3.0 3.7 3.4 0.0 1.2 2.0 5.3 1.6 1.4 6.5 0.2 0.2 2.3 4.0 2.1 6.1 3.8 10.8 5.0 0.0 4.0 3.3 4.6 0.0 0.1 0.0 11.4 0.0 1.1 0.0 1.9 5.9 0.7 0.0 0.6 5.9 0.2 7.5 0.0 0.2 0.0 2.1 16.8 9.5 17.5 15.9 12.5 8.8 8.3 13.3 11.8 5.4 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713875-35719472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: " "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavourable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 4.3 4.4 12.5 2.1 10.5 1.1 2.4 5.0 22.1 4.7 3.5 1.0 4.1 5.0 2.1 2.5 3.0 4.0 12.1 9.7 0.7 1.8 3.1 2.4 7.0 3.5 1.2 2.0 1.8 1.6 3.1 2.0 1.1 4.4 5.1 2.9 1.2 7.0 5.2 2.2 1.2 3.4 1.4 2.5 2.4 1.4 2.5 3.2 0.1 3.7 0.8 7.3 3.0 3.3 7.9 4.4 5.7 19.9 14.6 2.9 9.7 11.4 14.4 13.8 4.7 7.2 4.3 7.0 14.2 3.2 10.8 6.4 12.4 13.9 5.1 25.5 11.6 1.3 7.6 12.6 16.8 15.0 8.1 10.3 3.3 9.4 10.1 11.5 15.4 5.5 5.1 10.8 6.3 6.7 3.4 5.8 3.5 4.9 4.0 5.9 5.8 9.2 1.9 18.9 3.6 5.7 11.1 11.7 9.3 8.7 10.1 3.5 8.7 3.2 11.7 12.2 18.2 0.0 3.2 0.1 5.9 3.7 1.9 2.5 4.7 7.3 3.2 1.4 1.1 4.4 0.1 0.8 2.7 0.7 1.6 3.0 C1orf226 FLJ13137 ENSG00000239887 "Chromosome 1 open reading frame 226" A1L170 1 162366908-162386818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.6" "Cell line enhanced" "Detected in many" "A-431: 13.2;HEL: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052251 Approved Approved Nucleoplasm Nucleoplasm "HPA052251: " "prognostic favourable (2.60e-4)" "unprognostic (1.30e-1)" "unprognostic (2.69e-2)" "unprognostic (1.59e-2)" "unprognostic (6.71e-3)" "unprognostic (9.80e-2)" "unprognostic (8.55e-2)" "unprognostic (1.65e-1)" "unprognostic (2.05e-1)" "unprognostic (4.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-3)" "prognostic favourable (4.44e-5)" "unprognostic (9.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "prognostic favourable (1.13e-4)" 1.5 8.2 1.5 3.4 1.5 1.2 7.1 4.8 2.0 3.7 18.0 1.5 1.5 4.9 1.9 1.6 4.4 2.5 3.2 1.5 1.6 2.4 5.2 15.2 3.0 1.5 1.8 1.5 2.0 3.5 1.4 6.9 18.9 1.5 3.2 8.3 2.0 8.2 7.6 1.5 3.3 28.6 2.4 2.3 2.2 5.8 2.7 1.5 1.5 1.5 7.4 5.1 2.2 1.5 0.0 0.0 0.8 0.7 0.0 0.0 0.2 13.2 0.7 10.9 8.3 0.3 0.0 0.2 1.2 1.1 0.8 0.4 1.5 6.1 0.0 9.1 0.2 9.7 3.1 0.7 0.5 0.2 4.4 16.9 0.5 7.4 0.2 0.0 0.1 1.2 0.8 0.0 0.6 3.3 1.4 0.1 0.2 4.3 0.6 0.0 6.8 6.1 0.2 1.7 0.0 9.3 5.4 4.7 3.2 4.5 1.2 2.6 4.9 0.7 2.3 0.0 1.4 0.2 3.3 6.3 0.0 0.0 1.6 0.2 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 1.5 1.5 4.8 2.0 1.6 2.4 1.8 1.5 1.5 1.5 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 24.6" "Group enriched" "Detected in some" 7 "NTERA-2: 11.2;U-87 MG: 32.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045805 Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.6 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.2 1.8 0.5 0.7 0.5 0.0 3.2 0.0 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.5" "Cell line enhanced" "Detected in many" "ASC diff: 82.7;BJ hTERT+: 19.4;HHSteC: 31.3;HSkMC: 16.6;U-87 MG: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" 313900000 30000 Nucleoplasm Cytosol "CAB025429: , HPA051101: " "unprognostic (2.58e-1)" "prognostic unfavourable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavourable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 62.4 18.3 1.7 7.4 4.3 0.4 60.5 1.3 5.1 14.3 10.3 5.2 30.8 2.5 11.0 14.2 10.2 14.4 19.1 77.5 2.0 4.1 9.5 19.4 9.7 16.6 4.8 2.5 25.2 7.5 10.1 4.2 34.0 7.6 13.3 3.3 19.6 13.8 51.8 11.9 8.6 6.1 6.9 2.5 14.3 6.1 8.8 2.8 1.3 26.9 13.3 5.0 14.8 27.5 0.5 0.3 1.9 0.3 1.2 0.4 0.0 0.0 8.0 0.0 0.0 82.7 7.4 0.0 4.1 19.4 1.7 3.4 0.6 3.9 0.0 0.4 1.2 0.2 0.2 0.1 1.3 0.0 0.9 0.0 3.0 0.3 31.3 0.0 0.0 16.6 0.0 3.7 0.2 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.8 8.4 0.0 5.4 0.0 0.0 0.1 0.3 1.5 2.6 0.4 7.7 0.0 0.0 0.3 8.8 0.2 0.9 1.2 0.0 0.0 0.0 19.5 0.0 0.7 1.9 0.3 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.1 0.5 0.2 0.4 0.4 1.2 0.2 0.3 0.0 0.0 1.7 4.3 1.3 4.2 2.0 4.1 4.8 2.5 7.6 2.8 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180167-37199385 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 23.7;placenta: 79.5" "Cell line enhanced" "Detected in many" "MCF7: 44.0;RT4: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" 354300000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavourable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 3.3 4.4 1.2 4.2 1.6 0.8 2.5 1.2 1.8 7.8 2.5 1.3 1.6 1.0 23.7 7.2 1.6 5.2 6.2 3.1 1.4 0.7 3.9 7.9 9.2 3.1 1.2 1.3 5.9 2.3 1.4 1.4 79.5 1.7 4.3 2.5 4.4 2.2 3.4 1.5 3.1 3.2 5.7 1.8 4.6 1.8 3.5 1.2 1.6 2.4 1.7 1.8 5.1 2.7 2.4 1.1 1.8 0.5 4.0 3.8 1.0 6.6 8.2 4.3 1.5 0.7 8.7 13.1 1.4 2.7 1.1 0.8 1.5 9.7 0.0 5.6 2.3 13.7 0.1 3.3 0.5 1.9 1.0 1.0 3.1 1.5 3.0 0.0 0.9 12.0 1.9 0.9 0.2 10.3 0.0 3.1 0.4 44.0 0.0 0.2 2.7 0.1 0.1 0.0 1.1 10.0 20.4 0.7 5.6 0.4 7.9 1.1 2.8 0.2 3.5 0.4 2.2 0.1 0.0 6.4 0.1 0.0 0.8 0.8 1.2 1.0 0.5 1.5 0.7 0.5 0.8 0.8 1.3 1.0 0.5 2.4 2.9 2.2 1.8 4.0 0.3 1.1 3.8 1.0 1.2 1.6 1.2 1.8 1.4 0.7 1.2 1.3 1.7 1.2 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 351.6" "Cell line enhanced" "Detected in some" "ASC diff: 97.0;ASC TERT1: 129.2;BJ hTERT+: 41.1;HSkMC: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 17 "granulocytes: 6.2" "Low region specificity" "Detected in all" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" 93000000000 13000000000 Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favourable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavourable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 48.7 16.6 3.3 18.7 4.1 0.0 55.7 1.9 3.1 35.3 31.1 2.9 12.7 6.8 32.2 50.0 38.3 46.4 47.2 34.4 2.5 1.1 18.0 351.6 31.4 21.1 6.3 3.2 98.8 15.5 1.9 6.0 8.5 6.5 52.1 18.6 26.1 14.6 12.4 18.2 14.7 19.2 47.6 8.8 32.5 24.6 37.2 2.3 3.2 30.5 22.7 18.8 48.6 73.0 0.2 0.1 6.2 0.3 0.2 0.1 0.0 0.0 2.2 0.1 1.2 97.0 129.2 0.4 17.5 41.1 9.3 17.0 0.0 0.2 0.0 2.4 21.7 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.6 4.6 29.2 0.2 0.1 68.6 0.3 7.5 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 10.6 0.2 0.2 0.0 0.0 0.0 4.3 0.3 16.5 0.0 0.0 0.0 0.1 9.3 0.1 0.2 0.6 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 6.2 0.2 0.1 0.1 0.0 0.0 3.3 4.1 1.9 3.1 2.5 1.1 6.3 3.2 6.5 2.3 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3768387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 64.7" "Group enriched" "Detected in many" 5 "classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 38.5;monocytes: 46.6" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol 87000 "Nucleoplasm, Cytosol" "HPA047483: " "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavourable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavourable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 23.1 9.7 10.2 11.8 64.7 51.9 17.2 4.9 15.8 12.0 22.6 7.7 3.7 10.3 16.9 10.9 14.4 18.7 26.6 7.3 9.2 14.4 5.0 5.4 8.4 13.5 14.5 6.1 20.9 8.5 3.9 5.3 6.7 13.7 18.3 4.9 5.0 9.0 7.1 11.2 9.6 9.4 22.3 5.7 13.4 21.2 6.0 13.2 6.0 5.4 7.9 6.1 27.4 10.3 7.8 38.5 1.1 46.6 5.8 8.5 13.8 34.0 36.1 5.7 24.0 11.7 6.5 8.9 8.8 5.8 16.3 12.0 24.7 13.0 21.4 8.6 10.3 29.4 15.1 22.1 6.2 4.9 27.1 12.1 7.3 44.0 8.4 17.3 5.3 9.1 9.3 20.8 10.4 11.0 21.4 13.5 8.4 48.2 22.9 41.3 24.4 48.9 17.7 13.9 25.3 10.2 12.4 25.4 11.6 8.0 35.8 17.6 7.9 21.8 6.7 22.9 15.8 36.2 26.9 10.4 17.3 15.9 6.8 32.9 11.1 0.2 28.1 0.4 5.9 46.6 8.5 7.8 7.0 7.8 38.5 7.3 8.0 7.8 1.1 5.8 42.2 7.3 6.4 13.8 10.2 64.7 4.9 15.8 9.2 14.4 14.5 6.1 13.7 13.2 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 189.0" "Cell line enhanced" "Detected in many" "HaCaT: 16.8;U-138 MG: 17.4;U-87 MG: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm Nucleoplasm "HPA000650: " "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 0.9 0.9 1.3 2.0 1.8 0.7 0.8 1.7 3.3 1.2 4.1 2.8 0.8 0.8 3.7 2.8 6.1 6.0 2.5 1.8 1.7 1.7 1.2 1.1 2.7 1.0 1.9 2.0 2.2 3.4 0.1 2.2 2.0 5.5 1.8 0.0 2.0 4.1 1.4 1.8 11.3 1.2 1.2 3.2 0.8 3.8 189.0 1.2 0.8 3.4 0.9 0.9 5.2 1.6 0.7 0.3 0.9 0.2 0.1 1.4 0.2 3.5 2.8 6.1 5.6 0.1 0.2 7.5 9.7 0.3 0.3 0.4 3.3 3.1 1.8 2.9 0.2 16.8 0.2 0.1 0.3 3.5 7.2 1.0 2.2 2.3 0.2 2.8 2.4 0.2 0.1 1.1 0.1 0.0 1.2 1.1 0.0 2.1 0.1 1.6 0.9 2.4 3.3 8.7 0.7 0.1 15.4 3.1 2.3 4.5 1.7 5.5 2.0 3.8 14.7 17.4 5.8 13.5 5.2 2.5 1.1 0.9 26.1 1.3 9.8 0.9 0.1 0.0 1.3 0.2 1.4 0.7 0.3 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 1.3 1.8 1.7 1.8 1.7 1.7 1.9 2.0 5.5 1.2 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" Nucleoplasm Nucleoli "HPA052741: " "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favourable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.7 4.5 11.0 6.7 8.1 8.6 9.9 7.4 8.0 6.3 8.5 4.5 5.7 5.5 5.4 6.1 4.1 5.6 5.7 7.6 19.5 5.3 6.0 9.3 3.7 4.7 4.4 11.9 6.8 7.7 10.5 7.5 1.6 9.8 8.1 5.5 14.4 3.5 5.4 4.5 3.5 5.1 9.1 6.0 5.4 6.0 2.7 4.2 8.6 7.8 11.1 9.0 5.5 4.3 8.3 14.2 4.4 3.9 17.3 17.6 5.1 5.0 5.4 11.2 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41953890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 56.9" "Cell line enhanced" "Detected in many" "ASC diff: 38.0;SK-BR-3: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA030922: , HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavourable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 23.9 56.9 5.4 6.1 8.0 1.1 21.0 2.7 7.0 5.8 5.8 7.6 10.9 3.5 6.3 6.1 5.4 4.9 7.8 3.6 5.9 5.1 5.3 4.2 9.6 9.1 12.8 4.5 11.7 10.7 19.4 3.8 4.2 10.9 8.8 4.3 11.8 8.1 9.4 2.7 10.1 4.4 5.6 11.7 20.7 5.7 2.7 9.1 5.7 4.8 3.9 5.3 7.0 23.9 1.1 1.4 0.9 1.3 1.9 2.8 0.7 6.0 2.5 1.8 4.1 38.0 10.5 7.1 4.2 6.7 2.6 2.5 3.9 6.9 0.1 2.4 8.2 0.7 6.4 4.4 3.4 0.4 2.9 1.0 3.2 3.2 5.1 0.4 0.0 6.7 4.2 14.2 5.5 12.5 3.7 0.0 7.1 0.5 0.8 1.2 10.0 8.7 0.6 2.6 3.6 4.0 12.7 3.0 1.3 4.6 20.9 3.7 5.4 2.7 4.3 6.4 0.9 2.1 3.4 2.4 3.4 0.5 18.6 3.5 1.3 0.0 1.3 0.0 1.3 0.8 0.5 0.5 1.2 0.5 1.4 1.1 2.8 1.6 0.9 1.9 0.7 0.2 1.5 0.7 5.4 8.0 2.7 7.0 5.9 5.1 12.8 4.5 10.9 9.1 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell line enhanced" "Detected in all" "HMC-1: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: " "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favourable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.3 2.5 3.5 7.1 4.5 1.9 2.2 5.1 4.5 5.1 4.3 4.0 3.5 5.1 13.4 3.5 7.6 4.3 2.2 2.0 8.0 3.6 20.0 3.2 2.9 6.0 5.7 29.2 2.2 4.5 9.5 3.5 3.2 8.3 9.1 4.7 8.9 6.4 13.8 1.3 6.8 4.1 3.1 5.8 5.0 2.1 10.7 6.1 2.1 11.5 3.2 20.2 7.7 3.8 4.7 1.6 5.6 8.9 4.0 2.4 2.0 2.9 9.9 5.2 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 C2CD3 DKFZP586P0123 ENSG00000168014 "C2 calcium dependent domain containing 3" Q4AC94 11 74012714-74171210 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 14.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038552, HPA038553, HPA040433" Approved Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA038552: AB_10669542, HPA038553: , HPA040433: " "unprognostic (3.94e-1)" "unprognostic (7.89e-2)" "unprognostic (3.68e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (8.48e-5)" "unprognostic (1.99e-1)" "unprognostic (4.96e-3)" "unprognostic (2.20e-1)" "unprognostic (1.74e-1)" "unprognostic (5.86e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-1)" "unprognostic (3.11e-1)" "unprognostic (1.18e-1)" "unprognostic (2.92e-1)" 7.4 11.9 10.5 13.5 11.2 17.3 8.4 14.9 11.8 8.1 6.8 14.3 4.4 6.3 10.9 10.3 7.8 12.5 6.4 8.3 9.6 6.5 8.5 8.4 9.7 8.5 12.0 8.1 10.2 6.9 17.5 15.0 13.5 11.4 8.6 9.0 10.4 8.5 7.9 6.9 9.7 7.3 7.2 11.3 10.0 7.7 19.9 13.2 16.7 13.1 4.2 12.1 8.1 9.7 5.3 2.0 14.8 3.2 3.3 2.6 0.5 5.6 11.1 8.2 9.9 4.8 4.3 3.8 8.2 5.9 10.8 9.4 15.5 4.5 5.8 6.1 5.0 10.0 9.1 3.9 12.7 9.6 4.6 8.4 12.5 6.1 5.2 9.5 13.2 3.1 3.7 11.3 6.6 6.7 8.4 11.4 9.5 5.4 10.2 5.1 5.7 5.4 8.7 38.6 6.3 3.2 9.0 9.9 6.4 15.6 5.5 12.3 9.6 5.2 7.3 7.7 11.9 8.1 7.3 8.9 6.1 18.0 2.7 5.6 8.5 14.8 1.9 2.2 2.6 2.2 2.2 2.3 1.5 2.1 1.0 5.3 2.0 1.9 13.1 3.3 3.2 2.0 1.0 0.5 10.5 11.2 14.9 11.8 9.6 6.5 12.0 8.1 11.4 13.2 C2orf54 FLJ22671 ENSG00000172478 "Chromosome 2 open reading frame 54" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5" "Group enriched" "Detected in some" 6 "CACO-2: 21.1;HaCaT: 15.8;SK-BR-3: 56.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.4" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.3 0.0 0.3 1.5 0.3 0.0 0.9 0.3 0.3 8.9 3.9 0.3 0.3 6.3 0.7 0.4 63.8 0.3 0.3 0.3 0.3 0.0 2.8 2.8 5.5 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.7 0.3 0.5 1.1 0.3 7.6 0.3 0.3 18.6 3.6 0.3 0.3 0.3 1.0 0.3 0.3 1.0 0.3 35.5 28.6 0.8 19.1 0.8 0.1 0.7 0.2 3.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.1 1.3 0.1 0.1 0.0 15.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 3.1 1.0 0.0 0.0 56.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.8 0.1 0.2 0.1 3.4 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 C2orf68 ENSG00000168887 "Chromosome 2 open reading frame 68" Q2NKX9 2 85606654-85612066 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051143 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" "Nucleoplasm, Nuclear membrane, Mitochondria" Nucleoli "HPA051143: " "unprognostic (1.71e-2)" "unprognostic (3.65e-2)" "unprognostic (1.07e-2)" "prognostic unfavourable (1.12e-6)" "unprognostic (9.34e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (6.76e-6)" "unprognostic (4.24e-3)" "unprognostic (8.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (1.11e-6)" "unprognostic (1.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.70e-2)" "unprognostic (8.81e-3)" 10.7 9.8 7.0 17.4 12.3 11.5 16.5 16.6 9.9 16.5 15.2 17.2 17.7 13.1 17.1 15.0 13.6 14.3 16.2 13.7 7.7 6.6 13.5 16.8 17.5 15.6 16.1 7.2 22.2 25.4 13.3 14.6 21.8 11.4 16.5 14.1 10.8 20.6 20.6 23.3 18.6 18.5 14.8 10.9 17.5 13.4 15.1 12.3 37.1 17.2 20.4 17.6 15.2 17.0 15.4 16.5 36.1 22.7 19.2 20.1 9.5 8.5 8.0 13.1 9.9 13.5 6.7 8.9 3.9 5.2 6.5 8.8 7.1 10.4 11.6 6.0 7.2 9.5 7.2 7.9 7.1 6.1 15.0 19.9 11.7 7.4 11.1 10.7 10.5 10.2 9.1 4.9 13.1 10.7 10.0 13.1 6.3 9.7 12.1 10.4 6.2 6.9 13.6 25.0 11.4 8.4 9.1 16.8 12.1 6.1 8.1 7.9 9.2 5.4 6.3 4.7 13.1 5.3 3.7 16.9 11.8 10.8 7.0 10.8 5.7 18.0 22.7 36.1 15.4 15.0 14.5 10.9 14.7 14.5 16.5 15.4 20.1 18.7 36.1 19.2 16.9 10.6 11.9 9.5 7.0 12.3 16.6 9.9 7.7 6.6 16.1 7.2 11.4 12.3 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;SH-SY5Y: 2.2" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favourable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavourable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.9;testis: 20.0" "Cell line enhanced" "Detected in many" "MCF7: 11.9;RPMI-8226: 11.3;SCLC-21H: 14.8;SH-SY5Y: 16.2" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.2" "Low lineage specificity" "Detected in many" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: " 0.4 0.9 2.2 1.2 5.5 0.5 0.9 1.2 3.4 1.3 0.8 2.6 8.2 0.9 2.2 4.9 1.6 17.9 2.0 0.7 2.1 1.9 0.0 2.5 3.0 0.0 2.8 3.2 1.6 4.9 13.7 1.0 1.9 1.8 0.2 3.2 1.3 3.5 0.8 0.3 1.1 0.7 0.0 2.1 1.7 20.0 0.8 5.3 2.1 0.7 1.9 1.9 0.0 6.5 13.2 0.2 1.8 3.1 3.4 1.3 3.5 6.5 2.0 7.2 2.2 1.9 0.7 0.6 2.1 0.6 0.7 0.4 4.0 8.4 1.6 1.0 1.3 0.1 1.7 0.7 4.7 0.5 0.9 0.5 0.1 1.1 1.7 1.9 1.1 4.3 0.8 0.8 0.0 0.3 1.3 1.1 11.9 2.2 4.4 3.9 1.4 1.1 0.7 11.3 2.6 1.5 14.8 16.2 2.0 3.2 0.9 3.0 1.6 0.1 0.7 3.2 2.2 1.8 3.1 5.5 2.7 4.5 1.7 1.5 0.1 1.8 0.0 0.6 1.8 0.3 5.7 0.7 0.8 6.2 6.5 3.4 1.5 0.2 3.1 1.4 13.2 0.6 1.3 C3orf33 "AC3-33, FLJ31139" ENSG00000174928 "Chromosome 3 open reading frame 33" Q6P1S2 3 155762617-155806351 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037663 Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA037663: AB_10672610" "unprognostic (1.18e-1)" "unprognostic (9.39e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-3)" "unprognostic (1.31e-1)" "unprognostic (7.27e-2)" "unprognostic (6.31e-3)" "unprognostic (3.28e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic favourable (6.48e-7)" "unprognostic (3.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (1.56e-1)" 4.3 16.9 6.7 3.1 7.9 2.3 6.8 9.2 9.5 5.0 3.6 6.5 5.0 4.1 6.1 9.7 2.5 5.4 3.5 9.3 7.6 7.9 9.4 4.1 5.2 2.8 5.6 11.0 6.9 19.4 11.7 8.6 2.1 7.9 7.2 3.4 5.5 4.5 6.6 5.6 1.6 2.8 11.1 5.0 2.8 4.3 6.2 6.9 1.7 13.4 2.4 1.7 4.0 6.3 2.3 3.0 3.0 1.8 6.1 7.7 3.4 5.9 8.4 4.0 5.5 0.3 5.0 1.7 2.5 3.9 2.5 6.0 2.9 7.6 1.1 6.1 2.5 0.9 4.0 0.1 4.5 2.9 5.9 3.6 1.3 7.6 7.0 4.9 1.2 3.9 4.4 2.6 5.2 4.2 5.7 2.8 4.3 4.3 5.2 4.4 5.3 1.8 5.3 2.1 5.8 13.9 2.8 3.0 4.1 5.7 7.6 5.1 10.5 6.4 2.7 2.8 2.1 6.0 6.3 4.8 4.5 0.0 2.0 4.6 2.9 3.0 1.8 0.2 6.2 1.6 7.7 2.3 4.9 5.5 3.0 2.2 6.2 6.4 0.1 6.1 1.1 2.4 3.2 3.4 6.7 7.9 9.2 9.5 7.6 7.9 5.6 11.0 7.9 6.9 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Group enriched" "Detected in some" 5 "EFO-21: 6.4;HeLa: 1.6;TIME: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA046432 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: " "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149743-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: , HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favourable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavourable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 12.2 11.7 13.7 12.8 16.1 35.2 12.3 12.9 12.8 11.6 11.9 13.6 8.4 9.5 11.5 10.7 14.6 10.7 9.4 9.7 11.3 11.1 10.2 13.5 10.6 19.2 15.1 9.4 12.1 9.3 7.1 15.8 12.5 11.4 11.2 11.2 9.0 10.6 10.2 9.7 11.6 11.4 10.9 11.3 17.0 10.1 33.2 13.5 29.5 11.6 9.0 17.1 12.4 11.6 20.0 17.7 25.8 24.2 17.1 17.4 15.3 6.3 6.6 12.9 6.9 8.6 7.8 5.9 10.3 12.3 15.3 20.8 7.5 8.7 8.5 9.2 9.4 4.6 9.3 7.5 13.2 15.2 4.4 10.4 5.1 6.4 12.3 14.2 9.0 11.2 7.6 10.3 8.8 8.8 6.6 9.7 16.6 7.3 14.3 6.0 15.6 7.4 9.0 4.5 8.0 10.1 8.6 3.9 5.7 9.4 5.1 15.4 9.9 10.8 8.0 9.6 10.4 58.0 11.3 9.0 13.3 12.6 7.4 11.3 8.9 25.8 16.8 17.5 13.5 24.2 17.4 20.0 12.6 13.8 17.7 15.9 12.6 12.8 7.5 17.1 19.7 12.3 15.1 15.3 13.7 16.1 12.9 12.8 11.3 11.1 15.1 9.4 11.4 13.5 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666679-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047287: , HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 4.5 4.6 4.2 5.4 5.6 16.7 4.3 6.4 5.5 5.4 4.5 10.7 2.4 4.2 7.2 5.1 5.5 4.2 4.0 5.1 4.5 3.7 3.9 2.7 4.8 7.7 7.3 3.5 6.4 5.8 2.2 3.1 6.3 5.3 4.1 6.1 7.2 4.1 3.4 2.8 4.1 4.4 5.7 6.6 5.4 4.3 25.5 7.3 26.3 6.1 5.8 7.2 5.3 5.0 4.0 5.1 4.9 4.9 8.6 5.8 3.4 6.8 4.2 10.2 15.1 4.5 4.7 5.1 11.7 8.1 13.6 11.9 3.7 6.2 12.3 1.8 5.9 3.8 8.9 6.0 17.8 16.8 4.5 18.5 4.7 4.9 1.5 14.1 10.2 2.8 2.2 11.0 4.8 9.9 8.0 31.0 18.6 3.6 26.8 12.7 7.0 5.5 19.5 5.8 5.4 4.1 3.4 5.6 17.0 5.1 4.7 4.2 4.0 11.3 5.2 21.1 9.7 11.7 9.7 7.1 8.9 15.4 5.3 12.6 8.1 4.9 4.7 4.5 4.9 3.9 3.7 4.0 4.0 4.8 5.1 3.9 5.5 5.8 1.6 8.6 4.9 4.4 4.1 3.4 4.2 5.6 6.4 5.5 4.5 3.7 7.3 3.5 5.3 7.3 C7orf26 MGC2718 ENSG00000146576 "Chromosome 7 open reading frame 26" Q96N11 7 6590017-6608726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042899, HPA052175" Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol" Nucleoplasm "Nucleoli, Intermediate filaments, Cytosol" "HPA042899: , HPA052175: " "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (4.51e-2)" "unprognostic (2.50e-2)" "unprognostic (2.18e-2)" "unprognostic (5.22e-2)" "unprognostic (4.28e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "prognostic favourable (6.95e-5)" "unprognostic (4.72e-2)" "unprognostic (2.26e-3)" "unprognostic (4.41e-1)" "unprognostic (1.03e-2)" "unprognostic (3.40e-3)" "unprognostic (1.55e-1)" 19.8 17.1 13.4 21.7 17.7 29.2 20.0 20.6 26.9 19.0 17.9 21.1 21.5 19.4 23.0 15.4 14.7 19.9 15.6 12.8 14.4 14.1 15.4 18.4 19.3 24.1 18.8 20.2 20.6 23.9 17.2 16.6 14.0 15.4 21.1 11.5 16.4 21.2 16.6 18.7 21.9 16.4 19.6 13.1 27.3 18.6 16.8 16.1 31.7 18.3 18.5 20.6 17.6 19.6 4.2 6.4 4.6 3.4 3.3 6.1 1.9 11.1 9.3 6.5 15.4 10.7 6.0 8.6 6.7 5.9 9.7 6.0 8.7 4.7 13.2 8.8 4.9 12.4 8.7 6.1 4.4 5.1 12.5 4.9 5.8 9.1 12.6 11.7 15.9 6.9 9.3 5.8 6.1 10.5 12.9 10.1 5.7 18.7 10.2 24.3 13.0 12.5 20.9 5.2 11.2 6.3 9.8 8.6 15.9 6.5 21.6 9.0 9.8 17.7 7.5 8.1 26.5 8.8 14.6 12.3 12.0 12.2 5.4 13.1 23.8 1.1 3.4 4.6 4.7 3.3 6.1 4.1 5.7 6.0 2.6 4.2 5.9 4.9 3.4 3.3 3.3 6.4 5.4 1.9 13.4 17.7 20.6 26.9 14.4 14.1 18.8 20.2 15.4 16.1 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Cell line enhanced" "Detected in many" "U-266/70: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020346 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavourable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.9 2.1 4.7 5.3 1.8 1.0 2.6 1.2 5.1 3.8 5.8 4.0 2.8 7.4 1.9 2.3 1.2 5.2 1.4 4.1 3.5 5.0 3.5 0.2 5.4 4.4 5.6 8.5 3.2 4.0 3.1 0.7 0.7 5.2 4.1 1.0 0.0 5.7 7.2 1.9 1.9 7.2 5.4 1.1 2.6 3.7 1.4 3.9 1.2 5.0 4.8 0.8 9.5 1.0 2.4 6.4 0.0 1.8 18.5 5.9 10.6 0.7 5.4 10.8 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 C7orf50 "MGC11257, YCR016W" ENSG00000146540 "Chromosome 7 open reading frame 50" Q9BRJ6 7 996986-1138260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052281 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA052281: " "unprognostic (1.64e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (1.79e-2)" "unprognostic (1.28e-3)" "unprognostic (2.57e-3)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "prognostic favourable (6.20e-6)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (3.37e-2)" "unprognostic (8.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 22.5 14.2 37.7 14.9 29.4 9.7 14.9 16.4 32.8 17.0 17.5 15.5 19.4 12.8 20.1 18.8 14.8 21.0 20.3 28.7 28.1 21.4 21.7 14.2 16.1 21.2 22.4 23.0 21.6 79.5 12.3 39.3 13.9 17.3 21.7 7.9 25.9 25.1 28.8 68.4 8.2 13.8 34.5 19.1 19.5 25.1 19.5 9.8 6.0 20.8 18.0 16.6 17.2 10.9 32.3 41.5 76.3 27.0 8.1 20.6 22.7 41.1 26.4 8.8 26.8 4.8 6.8 18.6 18.5 9.1 16.5 14.0 18.6 17.7 12.3 12.2 11.9 26.1 10.6 22.3 3.3 11.7 21.3 11.3 18.7 25.2 19.5 14.4 7.8 9.7 17.9 15.3 14.1 11.2 20.0 11.9 7.3 59.4 6.6 38.4 21.6 39.2 19.6 3.3 20.4 7.7 11.4 20.3 29.2 15.2 18.0 24.9 43.3 26.4 12.9 9.6 42.7 28.5 24.2 10.1 13.6 11.2 19.3 23.9 30.2 3.2 27.0 76.3 20.6 26.2 14.6 23.6 16.9 17.4 41.5 32.3 13.2 15.3 3.0 8.1 25.0 12.0 19.7 22.7 37.7 29.4 16.4 32.8 28.1 21.4 22.4 23.0 17.3 9.8 C7orf55-LUC7L2 ENSG00000269955 "C7orf55-LUC7L2 readthrough" 7 139341360-139422599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045663, HPA051631" Approved Approved Nucleoplasm Nucleoplasm "HPA045663: , HPA051631: " "unprognostic (2.54e-1)" "unprognostic (5.27e-2)" "unprognostic (3.21e-2)" "unprognostic (1.33e-3)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (1.68e-2)" "unprognostic (4.48e-2)" "unprognostic (2.26e-1)" "unprognostic (1.76e-3)" "unprognostic (1.10e-1)" "unprognostic (3.12e-2)" "unprognostic (6.42e-3)" 14.4 17.5 10.1 9.7 19.2 7.6 11.7 11.2 21.2 9.8 10.6 8.3 17.2 13.4 13.8 14.3 8.1 10.5 11.1 30.3 8.7 6.7 13.3 14.8 8.9 9.1 14.7 11.7 16.5 25.1 6.9 9.1 8.5 13.9 10.9 6.1 8.2 13.9 15.1 57.2 7.8 11.6 9.3 9.5 10.4 13.5 7.4 13.6 6.1 17.5 21.2 6.2 10.7 12.4 18.6 18.3 17.0 14.8 18.8 21.1 12.6 13.2 19.2 23.8 13.7 10.1 7.2 9.1 10.5 7.0 13.2 10.6 15.1 15.0 15.3 19.0 8.0 10.5 25.2 9.0 4.3 10.2 5.1 19.9 19.5 12.3 10.0 24.2 16.6 6.3 6.7 12.3 8.1 9.2 24.9 20.6 8.2 19.6 35.7 4.0 19.3 4.9 23.3 17.9 20.4 3.0 9.4 20.1 20.7 14.4 11.3 13.8 8.5 10.4 10.2 9.4 8.8 9.6 15.8 19.2 16.3 28.2 17.6 15.9 16.9 9.7 12.9 17.0 19.0 12.6 17.8 18.6 18.4 19.5 18.3 18.5 21.1 18.8 4.3 18.8 14.8 15.0 19.8 12.6 10.1 19.2 11.2 21.2 8.7 6.7 14.7 11.7 13.9 13.6 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566843-13568287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;testis: 17.3" "Cell line enhanced" "Detected in many" "U-87 MG: 11.7;WM-115: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 2.7 0.7 3.6 1.2 11.7 0.1 3.7 0.8 2.9 3.0 1.3 0.9 0.2 0.9 2.3 6.0 1.4 3.9 2.5 4.0 2.8 1.6 4.1 1.7 2.4 1.2 1.7 3.0 2.1 1.2 0.5 1.5 2.8 2.8 2.2 1.0 2.4 2.2 1.0 0.9 2.7 0.9 1.9 1.1 1.1 1.9 17.3 1.5 0.0 8.9 0.3 0.5 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 1.8 0.0 6.2 6.2 0.0 5.4 6.0 2.9 5.0 0.0 0.0 0.0 0.0 2.8 0.6 0.2 1.0 5.7 0.0 0.6 0.5 0.0 0.0 2.2 0.0 0.9 1.9 3.7 3.9 1.0 3.7 0.1 0.0 7.3 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.2 0.0 3.2 0.0 0.2 6.0 0.0 0.0 1.7 5.1 5.0 6.0 4.8 0.0 0.0 0.0 11.7 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 11.7 0.8 2.9 2.8 1.6 1.7 3.0 2.8 1.5 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA044805: , HPA071903: " "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 43.6 22.3 33.1 21.5 20.6 39.9 25.9 29.0 27.9 34.0 33.6 25.9 37.8 10.9 24.1 19.2 30.4 23.0 31.9 38.4 30.7 25.1 64.4 21.1 38.3 24.4 24.2 29.2 33.8 37.9 21.9 27.8 28.8 28.9 26.8 28.2 34.4 53.3 45.5 9.5 38.9 22.8 27.7 49.5 33.0 28.0 11.2 24.0 22.0 36.2 40.0 41.8 36.1 22.0 21.7 45.5 24.0 27.5 31.3 36.6 51.2 43.3 31.0 24.1 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 C8orf82 MGC70857 ENSG00000213563 "Chromosome 8 open reading frame 82" Q6P1X6 8 144525733-144529132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034331 Uncertain Approved Nucleoplasm Nucleoplasm "CAB034331: AB_1565393" "unprognostic (3.56e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (8.60e-2)" "unprognostic (6.31e-3)" "unprognostic (1.95e-1)" "unprognostic (4.57e-2)" "unprognostic (3.82e-1)" "unprognostic (1.22e-1)" "unprognostic (3.61e-1)" "unprognostic (4.09e-2)" "prognostic favourable (1.70e-5)" "unprognostic (5.72e-3)" "unprognostic (3.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-3)" 11.1 11.4 7.9 10.6 8.1 4.2 16.1 8.6 11.6 14.2 19.4 7.8 8.1 16.8 10.2 10.4 13.3 9.3 14.7 16.3 8.1 6.1 12.7 29.1 7.9 8.9 8.8 7.8 13.4 17.5 19.7 10.2 7.1 6.3 32.8 6.4 8.2 18.0 11.4 12.2 8.9 17.7 7.4 5.1 11.0 12.2 12.7 8.0 8.5 14.8 10.3 7.0 12.4 9.6 1.7 1.5 1.7 2.1 0.9 1.2 0.3 3.6 9.2 5.5 4.4 2.3 1.9 4.6 3.9 2.2 2.2 2.2 4.5 6.1 6.4 6.4 2.4 4.4 1.2 1.3 0.8 4.8 14.4 12.4 5.3 8.4 2.4 1.9 6.0 2.9 3.1 1.4 1.4 1.5 10.1 3.2 1.6 19.1 4.6 7.6 2.9 26.1 5.3 1.8 3.1 3.3 5.5 18.8 15.3 6.0 4.3 3.8 7.9 3.8 8.0 4.2 16.4 4.6 2.8 2.3 1.4 5.0 5.6 2.3 4.0 0.8 2.1 1.7 0.6 0.8 0.7 1.4 0.2 0.6 0.9 1.7 0.6 0.7 0.0 0.9 1.7 1.5 1.2 0.3 7.9 8.1 8.6 11.6 8.1 6.1 8.8 7.8 6.3 8.0 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 63.3;testis: 47.8" "Cell line enhanced" "Detected in many" "MCF7: 22.2;T-47d: 23.0;U-2197: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: " "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favourable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 1.5 7.2 8.0 1.0 9.2 1.0 2.2 1.5 6.2 4.1 1.1 6.2 8.2 1.1 3.3 22.1 1.0 63.3 2.7 1.5 9.6 9.3 7.8 1.5 9.8 0.9 4.9 4.9 9.3 4.5 3.3 7.6 1.5 19.9 2.0 1.3 1.7 2.0 5.0 1.4 1.2 1.0 1.3 2.6 1.0 1.8 47.8 2.6 0.1 6.7 0.2 1.2 2.2 0.3 1.7 0.9 0.1 2.6 1.8 4.2 1.1 5.8 10.1 4.5 6.9 1.9 4.2 0.9 4.0 2.8 4.8 3.3 3.8 5.9 1.0 5.3 2.6 4.0 4.9 2.2 4.1 0.3 4.5 0.0 11.2 11.6 5.4 0.8 2.8 2.9 1.7 2.4 0.7 2.3 5.4 0.8 2.3 22.2 3.0 1.0 9.4 11.9 4.6 2.2 3.6 11.4 4.2 4.3 4.6 5.5 2.4 0.6 23.0 0.9 1.1 2.7 3.7 23.7 1.5 2.6 6.4 0.9 8.2 0.3 0.8 0.1 2.6 0.0 1.9 1.6 4.2 0.7 1.3 1.4 0.9 1.7 2.4 1.8 0.0 1.8 0.4 0.4 1.6 1.1 8.0 9.2 1.5 6.2 9.6 9.3 4.9 4.9 19.9 2.6 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavourable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.7 3.7 9.6 3.9 3.9 5.0 17.9 13.4 4.2 9.3 10.1 1.0 5.2 15.1 4.0 3.3 5.0 7.5 0.7 15.0 20.4 11.6 8.0 6.7 6.4 3.1 9.6 12.8 2.4 5.1 5.2 3.7 2.8 11.3 10.3 12.1 4.7 16.9 11.3 11.3 11.3 15.9 7.6 3.6 3.9 4.1 10.5 4.6 5.8 5.0 4.0 6.0 7.4 3.7 8.5 9.5 11.5 11.6 19.8 14.8 9.6 6.4 10.8 9.0 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: , HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.6 5.1 9.0 7.3 9.4 17.1 9.1 9.9 15.3 7.9 7.8 1.1 4.6 12.5 5.0 8.5 14.0 9.4 9.3 11.0 8.8 4.6 7.6 7.4 6.3 10.1 11.2 6.3 13.8 12.8 8.0 17.5 9.7 9.0 8.4 10.1 3.9 13.5 7.9 8.4 12.4 8.0 15.5 0.3 11.3 11.1 7.4 9.8 4.9 12.5 16.2 4.4 6.5 8.5 7.3 9.4 16.7 7.2 8.5 13.9 5.7 10.0 8.6 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell line enhanced" "Detected in many" "A549: 38.2;ASC TERT1: 40.3;RT4: 40.5;SK-BR-3: 32.5;T-47d: 52.3;U-138 MG: 55.8;U-87 MG: 67.0" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008773, CAB025181, CAB062549, CAB068179, HPA073203" Enhanced Approved Nucleoplasm,Vesicles 29000 Nucleoplasm Vesicles "CAB025181: , CAB062549: , CAB068179: , HPA008773: AB_1078394, HPA073203: " "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 38.2 0.6 0.0 5.1 40.3 2.0 2.7 2.5 0.4 0.7 0.2 0.0 0.0 9.4 2.2 0.2 0.0 1.8 1.1 0.0 1.3 0.0 2.6 0.0 0.1 0.0 0.0 15.2 2.1 11.6 3.7 0.4 0.0 0.0 0.5 22.0 0.0 0.0 0.6 6.0 0.0 0.0 0.0 0.0 40.5 0.3 0.0 0.1 32.5 0.0 52.3 0.0 0.0 55.8 3.0 1.8 0.0 0.0 0.0 0.0 67.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell line enriched" "Detected in some" 4 "MOLT-4: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favourable (1.79e-4)" "prognostic unfavourable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 CACFD1 "C9orf7, D9S2135, flower" ENSG00000160325 "Calcium channel flower domain containing 1" Q9UGQ2 9 133459965-133470848 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 15.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015280 Approved Nucleoplasm Nucleoplasm "HPA015280: AB_1845833" "unprognostic (3.15e-2)" "unprognostic (4.25e-1)" "unprognostic (1.96e-3)" "unprognostic (4.48e-1)" "unprognostic (2.77e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-2)" "unprognostic (5.49e-2)" "unprognostic (3.97e-1)" "unprognostic (3.17e-1)" "unprognostic (1.67e-3)" "unprognostic (3.91e-2)" "prognostic favourable (2.83e-8)" "unprognostic (5.10e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (3.99e-3)" 2.8 7.0 7.2 7.4 6.9 3.5 11.4 8.5 9.4 5.7 14.0 9.4 5.9 18.9 6.7 16.9 8.4 7.3 15.8 9.1 6.5 5.5 19.1 33.7 9.8 8.6 12.3 6.7 7.7 16.6 10.6 12.6 5.3 8.4 8.3 8.3 6.9 9.9 10.3 5.2 3.3 17.9 6.3 8.7 5.0 22.1 13.7 8.6 4.4 13.7 3.7 3.8 8.7 12.6 4.2 1.3 7.6 1.4 2.7 1.0 1.1 0.8 3.6 8.0 5.0 1.7 0.8 5.0 2.5 3.3 2.3 0.7 8.0 6.6 0.9 8.0 3.3 1.6 2.5 2.0 0.1 1.4 2.9 0.6 5.2 5.5 4.2 0.0 0.9 1.8 5.4 1.7 1.3 3.0 1.4 2.6 2.5 9.3 1.0 1.3 4.8 3.1 2.1 2.1 7.0 4.7 3.5 10.0 11.3 3.2 13.6 2.0 15.7 1.8 1.3 5.4 5.2 1.4 0.3 4.5 5.5 2.9 2.1 0.6 1.9 3.7 1.4 7.6 0.8 1.1 0.6 3.5 0.7 1.0 1.3 4.2 0.4 0.7 0.2 2.7 0.9 0.5 0.5 1.1 7.2 6.9 8.5 9.4 6.5 5.5 12.3 6.7 8.4 8.6 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153121-1221772 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 49.5" "Cell line enhanced" "Detected in some" "A549: 10.8;AN3-CA: 15.6;MCF7: 28.6;T-47d: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favourable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 5.0 6.8 5.1 4.2 12.0 0.3 3.3 0.3 4.3 17.5 28.1 1.6 10.2 5.4 25.7 5.9 16.3 11.7 26.0 2.2 2.5 2.1 4.7 5.5 3.5 0.7 1.0 2.8 31.8 2.1 6.6 14.8 1.9 2.0 21.0 2.2 4.2 1.7 24.9 2.9 4.8 8.5 49.5 1.1 0.5 9.7 11.7 2.1 0.0 5.2 1.4 0.5 34.6 20.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.8 1.8 15.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 6.4 0.0 0.0 6.5 1.9 0.0 2.8 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 28.6 0.0 0.0 5.8 2.2 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.5 8.5 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.0 0.3 4.3 2.5 2.1 1.0 2.8 2.0 2.1 CACUL1 "C10orf46, CAC1, FLJ40409, MGC33215" ENSG00000151893 "CDK2 associated cullin domain 1" Q86Y37 10 118674167-118755249 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050611 Approved Nucleoplasm Nucleoplasm "HPA050611: " "unprognostic (1.48e-1)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.34e-5)" "unprognostic (3.44e-2)" "unprognostic (1.84e-1)" "unprognostic (9.35e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" "unprognostic (1.68e-1)" "unprognostic (9.75e-2)" "unprognostic (8.48e-2)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" 19.7 20.0 18.4 13.4 19.3 28.8 23.0 13.2 19.9 20.7 20.2 14.9 22.8 13.7 27.2 21.6 20.7 14.6 14.1 17.9 15.6 16.6 15.2 19.0 19.7 11.2 15.3 17.1 14.8 16.1 23.9 18.7 25.3 15.4 22.5 16.4 13.0 15.7 23.1 26.9 17.0 13.5 26.2 15.0 16.7 17.2 23.8 13.0 20.2 15.9 14.2 15.0 25.1 20.4 3.2 6.1 15.7 11.8 3.1 5.2 3.3 11.4 6.8 5.2 9.5 12.4 8.6 5.4 5.0 13.7 7.2 9.1 7.5 9.8 8.1 3.8 8.1 10.2 10.3 8.8 9.7 3.2 5.8 7.5 7.1 9.4 8.2 6.9 5.0 6.8 9.9 9.3 14.1 8.1 3.7 8.5 8.4 8.8 6.5 11.0 5.0 3.7 3.7 21.6 5.0 10.5 8.8 2.7 8.9 4.8 12.1 15.6 6.8 5.6 7.7 5.0 5.7 6.2 8.4 7.4 7.9 5.8 6.5 13.6 3.1 15.7 6.8 12.1 4.1 11.2 4.0 3.0 3.9 4.1 6.1 3.2 4.4 5.2 15.2 3.1 11.8 2.9 2.9 3.3 18.4 19.3 13.2 19.9 15.6 16.6 15.3 17.1 15.4 13.0 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell line enriched" "Detected in many" 5 "WM-115: 109.8" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favourable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.5 2.5 13.4 17.5 0.0 0.2 0.7 0.4 0.7 1.2 1.8 3.7 1.5 0.0 3.2 0.1 2.0 2.9 1.7 1.5 0.1 2.3 0.0 0.5 5.4 1.6 0.0 1.3 0.5 3.9 6.4 0.2 0.8 0.8 0.1 0.1 1.2 1.2 0.1 1.4 0.8 6.9 0.1 0.8 1.7 1.8 1.5 8.6 0.9 2.7 3.4 2.0 0.4 0.3 0.1 20.7 0.1 0.8 1.2 0.8 0.0 0.9 0.1 109.8 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.4;BJ: 18.5;BJ hTERT+: 18.8;fHDF/TERT166: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.2 3.7 0.9 1.2 14.1 23.4 4.5 18.5 18.8 5.7 8.1 1.6 2.6 1.6 2.1 21.2 2.5 1.9 0.0 1.1 0.2 10.7 3.8 1.1 0.3 6.4 0.6 0.3 8.0 0.0 1.7 0.0 6.7 0.8 9.9 3.7 12.1 1.4 1.7 2.3 3.4 4.4 1.5 3.5 0.5 0.4 2.6 1.1 0.7 3.1 1.0 0.6 1.2 11.9 1.8 2.2 6.3 1.3 1.5 3.5 1.9 15.7 11.6 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.8;testis: 2.0" "Cell line enriched" "Detected in some" 5 "U-266/84: 17.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;myeloid DC: 1.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.1 0.8 0.3 0.9 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.4 2.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 2.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 1.8 0.0 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.3 3.2 0.4 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 17.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: " "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.7 5.7 3.4 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.0 2.5 2.0 1.1 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.2 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.9 3.8 2.9 0.6 7.2 5.6 7.7 4.9 2.3 8.4 5.6 5.1 0.9 4.3 2.9 3.3 2.5 2.3 6.7 1.7 3.4 2.4 3.8 3.5 6.6 6.3 10.6 6.2 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 CAMK1D CKLiK ENSG00000183049 "Calcium/calmodulin dependent protein kinase ID" Q8IU85 10 12349482-12835545 "Enzymes, Plasma proteins, Predicted membrane proteins" "Inflammatory response, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 46.7;U-266/70: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 31.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007266 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007266: AB_1078389" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (2.77e-1)" "unprognostic (3.65e-3)" "unprognostic (4.23e-1)" "unprognostic (2.32e-2)" "unprognostic (6.90e-3)" "prognostic favourable (1.67e-4)" "unprognostic (1.06e-1)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (7.40e-2)" "unprognostic (1.35e-2)" "unprognostic (6.55e-2)" "unprognostic (1.65e-1)" "unprognostic (4.66e-2)" "unprognostic (2.56e-3)" 5.1 5.3 20.9 10.5 22.1 6.6 4.0 23.4 33.5 8.3 11.5 4.6 10.0 3.8 3.3 3.3 8.7 4.3 6.8 13.8 18.6 7.2 2.2 11.5 7.6 9.3 5.8 17.8 2.6 17.0 1.3 2.5 3.2 5.0 4.9 12.9 11.9 4.5 15.4 1.7 18.5 5.5 5.6 4.9 10.5 3.4 6.2 6.8 20.8 13.6 2.9 12.5 8.1 7.0 7.1 4.2 31.8 3.7 1.4 2.3 1.3 0.1 2.5 2.9 0.1 1.8 0.6 0.2 0.4 0.9 0.6 0.9 3.5 2.0 1.4 0.3 0.2 1.3 3.5 0.5 0.5 46.7 1.8 5.6 8.3 0.2 0.5 0.1 5.1 0.1 2.3 1.2 0.1 0.3 0.1 0.2 0.7 2.9 10.9 2.2 1.9 1.1 8.3 1.6 2.6 0.1 2.7 4.5 2.0 5.5 2.0 0.0 1.5 1.3 0.1 2.4 3.6 7.7 1.6 21.5 6.7 4.7 3.6 3.6 0.0 8.3 2.2 31.8 1.8 3.1 1.9 5.6 1.6 2.3 4.2 7.1 1.9 1.3 13.9 1.4 3.7 1.4 0.5 1.3 20.9 22.1 23.4 33.5 18.6 7.2 5.8 17.8 5.0 6.8 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell line enhanced" "Detected in some" "AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.1 24.6 0.1 0.7 0.0 4.7 0.0 0.0 8.4 5.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA052636: , HPA056472: " "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.5 7.4 12.8 23.7 28.4 44.0 5.7 13.6 19.8 10.2 19.3 13.6 14.6 39.1 20.0 9.5 12.4 10.5 16.6 14.5 18.2 19.4 10.4 13.6 11.1 20.9 5.5 32.9 35.6 18.1 12.5 21.6 19.2 6.5 18.2 15.1 10.7 14.5 23.2 6.5 7.5 16.3 16.9 15.1 17.5 9.4 18.9 13.3 9.8 6.2 32.6 17.2 11.5 18.4 9.9 6.1 15.1 12.3 17.2 18.5 15.0 16.7 17.3 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051147 Approved "Nucleoplasm,Actin filaments,Mitochondria" Nucleoplasm "Actin filaments, Mitochondria" "HPA051147: " "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favourable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 7.8 14.1 2.6 3.7 17.7 12.4 5.4 7.7 8.5 7.2 6.4 3.5 2.1 9.3 7.5 11.9 8.0 10.0 11.9 4.1 13.0 12.9 5.9 7.6 3.9 10.2 3.4 25.2 8.5 15.0 6.8 10.8 12.1 9.5 8.5 6.8 5.2 6.0 2.2 0.4 5.8 5.3 3.0 3.6 8.2 8.3 3.7 3.2 4.8 8.8 2.3 7.8 3.4 16.0 5.8 3.4 6.0 12.4 4.3 4.6 3.3 14.1 6.9 5.6 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell line enhanced" "Detected in many" "LHCN-M2: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.4 8.4 16.3 19.6 0.1 0.0 3.5 19.3 14.1 15.9 14.5 2.8 2.4 0.0 18.2 20.7 2.8 7.2 7.2 23.0 0.0 2.7 0.0 5.4 9.2 1.5 0.0 0.0 1.2 3.5 8.0 3.5 0.7 0.0 0.0 33.5 8.7 0.0 0.0 6.2 4.8 1.8 21.7 0.3 8.3 2.2 2.1 4.1 6.5 21.0 11.4 23.2 3.9 0.0 12.9 12.3 0.3 16.9 0.0 0.0 0.0 4.2 0.0 17.5 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 CAPN10 ENSG00000142330 "Calpain 10" Q9HC96 2 240586716-240617705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004170, HPA056098" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA004170: AB_1078381, HPA056098: " "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (9.29e-3)" "unprognostic (6.09e-2)" "unprognostic (5.44e-3)" "prognostic favourable (8.47e-5)" "prognostic unfavourable (4.78e-6)" "unprognostic (7.48e-3)" "unprognostic (7.94e-2)" "unprognostic (1.31e-2)" "prognostic favourable (7.94e-5)" "unprognostic (1.46e-1)" "unprognostic (1.11e-2)" "unprognostic (1.19e-1)" "unprognostic (6.88e-2)" "unprognostic (5.76e-2)" "unprognostic (5.58e-3)" 9.2 11.8 16.8 12.9 15.1 10.9 6.6 20.5 15.7 8.3 13.6 12.8 10.0 20.8 11.3 8.0 9.7 9.8 10.2 11.5 15.9 10.7 14.2 9.3 8.4 15.3 11.2 18.1 10.0 13.0 8.6 13.2 7.3 11.1 10.6 12.2 12.4 14.6 10.7 6.5 19.5 16.2 8.3 8.1 21.0 15.0 10.7 13.7 15.1 9.3 5.6 13.2 8.3 7.0 1.5 2.0 7.7 1.8 5.8 2.2 0.8 5.1 7.8 7.7 6.0 3.0 2.5 13.4 6.6 2.8 4.4 4.3 5.7 12.4 3.9 2.3 2.3 8.8 1.9 4.4 2.3 14.9 13.6 7.2 12.9 10.0 4.9 4.6 10.2 2.2 3.1 4.6 1.9 3.3 8.0 4.9 1.8 4.5 10.3 17.7 11.5 5.5 9.8 5.4 8.3 6.9 6.2 19.4 15.2 4.2 6.0 8.3 3.0 5.7 5.7 7.6 6.5 6.1 7.9 12.2 2.7 7.0 7.2 8.5 7.1 1.7 1.8 3.3 2.0 1.0 0.5 1.5 1.3 2.0 0.8 1.5 1.2 1.8 7.7 5.8 1.1 2.0 2.2 0.8 16.8 15.1 20.5 15.7 15.9 10.7 11.2 18.1 11.1 13.7 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3" "Cell line enriched" "Detected in some" 5 "HMC-1: 17.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Group enriched" "Detected in many" 7 "basophil: 24.5;NK-cell: 12.7" "Group enriched" "Detected in many" 7 "granulocytes: 24.5;NK-cells: 12.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "hippocampal formation: 3.6" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" "Focal adhesion sites" Nucleoplasm "HPA053322: " "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavourable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.6 0.4 0.2 4.7 0.2 0.2 0.7 0.2 0.3 4.2 4.1 0.1 5.6 1.2 1.1 1.0 1.2 3.6 21.0 0.7 1.0 0.4 7.1 21.8 2.0 1.8 0.2 0.1 0.4 5.0 0.2 0.7 0.5 2.4 2.2 0.7 0.4 34.3 3.0 0.3 4.5 1.9 0.5 0.4 4.9 1.6 0.6 0.1 0.4 0.4 1.6 5.2 1.5 1.0 1.7 0.0 24.5 0.0 12.7 2.6 0.7 0.2 1.8 0.1 0.0 0.3 0.1 2.2 0.1 0.0 0.0 0.1 3.2 0.1 0.7 0.1 0.0 1.3 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.9 0.0 0.0 17.2 0.8 2.5 0.3 0.0 0.0 0.4 0.5 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 1.8 0.0 0.1 0.0 0.1 0.4 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.4 0.9 0.7 0.0 0.1 0.0 0.6 24.5 0.0 1.8 2.6 0.0 2.5 1.5 0.7 1.3 0.0 1.7 0.0 0.6 0.4 12.7 0.0 0.0 0.5 0.7 0.2 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.4 0.1 CAPN13 FLJ23523 ENSG00000162949 "Calpain 13" Q6MZZ7 2 30722771-30820542 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.3;pancreas: 20.4;stomach 1: 17.6" "Group enriched" "Detected in some" 5 "RT4: 8.8;SK-BR-3: 21.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029496, HPA029497, HPA030034" Uncertain Approved Nucleoplasm Nucleoplasm "HPA029496: , HPA029497: , HPA030034: " "unprognostic (7.42e-2)" "unprognostic (1.19e-1)" "unprognostic (7.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.56e-2)" "unprognostic (1.51e-1)" "unprognostic (1.68e-1)" "unprognostic (1.32e-3)" "unprognostic (2.17e-1)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.96e-2)" "unprognostic (3.64e-1)" "unprognostic (3.32e-2)" "unprognostic (5.03e-2)" "unprognostic (4.28e-3)" 0.2 0.0 0.5 0.5 0.4 0.0 4.8 0.2 0.2 6.2 39.6 0.3 0.2 13.0 1.1 0.6 1.1 0.5 7.4 0.2 0.8 0.4 2.0 0.2 9.4 0.2 0.7 0.3 0.4 20.4 0.6 1.2 0.2 0.2 5.2 16.0 0.2 1.0 0.2 0.2 0.1 67.3 1.6 1.0 0.2 17.6 0.2 0.2 0.2 0.2 0.5 1.0 3.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 8.8 0.1 0.4 0.0 21.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.2 0.8 0.4 0.7 0.3 0.2 0.2 CAPN15 SOLH ENSG00000103326 "Calpain 15" O75808 16 527717-554636 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 15.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011960 Uncertain Approved Nucleoplasm Nucleoplasm "HPA011960: AB_10610556" "unprognostic (4.11e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.18e-2)" "unprognostic (1.12e-2)" "unprognostic (1.54e-3)" "unprognostic (8.31e-3)" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.86e-1)" "unprognostic (4.02e-2)" "unprognostic (2.53e-3)" "unprognostic (2.54e-3)" "unprognostic (5.91e-2)" "unprognostic (1.83e-1)" "unprognostic (9.23e-3)" 9.2 7.7 7.1 13.1 6.8 12.0 12.0 20.4 10.9 5.6 15.7 5.7 8.6 26.1 7.9 5.4 10.7 7.5 13.4 5.9 9.8 2.9 9.7 14.1 8.6 8.2 5.8 4.7 8.2 20.5 4.3 9.1 6.1 5.0 7.2 4.7 3.7 11.7 6.9 11.4 14.3 24.7 7.0 3.4 16.8 21.9 10.8 4.1 9.7 6.9 6.6 11.8 6.4 11.8 2.7 0.5 15.8 1.1 1.1 0.4 0.2 8.4 11.0 1.6 4.8 0.9 1.8 24.3 9.0 2.4 2.6 1.7 14.3 6.2 12.2 8.7 1.6 11.2 1.0 3.5 0.9 12.6 19.3 10.1 11.2 8.8 3.9 11.8 14.3 2.0 2.1 2.5 1.2 2.7 18.5 3.6 0.8 13.0 13.1 13.0 14.1 10.4 23.1 4.5 12.0 1.7 5.5 10.2 9.3 5.9 8.3 5.1 6.8 12.4 13.3 8.0 11.3 8.1 11.2 9.8 5.3 10.4 3.5 6.9 5.0 3.0 1.1 0.7 0.2 0.8 0.1 0.3 0.1 0.4 0.3 2.7 0.1 0.2 15.8 1.1 1.0 0.5 0.2 0.2 7.1 6.8 20.4 10.9 9.8 2.9 5.8 4.7 5.0 4.1 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066932-77126155 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.5;intestine: 47.8" "Cell line enhanced" "Detected in many" "U-2197: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.8" "Lineage enriched" "Detected in single" 5 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: " "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavourable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 3.9 7.1 5.6 19.5 5.4 1.5 3.9 6.3 10.8 7.4 34.1 6.0 4.8 32.7 6.3 8.3 18.3 6.6 49.5 4.4 5.4 4.6 8.7 26.8 2.8 1.2 3.7 7.0 15.4 3.2 0.7 3.3 2.6 10.2 9.3 27.9 7.4 4.7 7.5 1.8 1.9 47.8 9.3 4.1 2.2 29.3 22.0 2.3 0.6 3.1 4.6 7.3 9.8 6.3 0.2 0.7 0.0 0.9 0.0 4.8 2.1 0.4 6.7 4.5 4.4 17.0 16.4 0.4 6.8 11.8 7.0 5.1 3.9 2.0 0.2 4.9 11.7 0.3 1.8 0.5 3.0 0.4 0.4 1.3 0.2 0.4 4.2 0.1 0.4 8.1 0.7 11.2 2.7 8.1 0.1 0.1 12.9 9.4 1.1 0.2 3.8 5.3 1.0 15.2 0.2 2.3 8.5 0.3 8.1 1.6 1.3 3.0 1.0 0.0 16.7 13.6 8.0 18.7 0.8 0.4 0.9 0.0 7.0 0.2 3.1 0.0 0.7 0.0 4.8 0.9 0.4 0.0 0.5 1.6 0.7 0.2 2.4 2.5 0.0 0.0 0.2 0.3 0.0 2.1 5.6 5.4 6.3 10.8 5.4 4.6 3.7 7.0 10.2 2.3 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell line enriched" "Detected in some" 9 "RT4: 41.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: " "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 2.4 0.0 0.0 0.0 4.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.9 41.1 0.6 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 CAPNS1 "30K, CANP, CANPS, CAPN4, CDPS" ENSG00000126247 "Calpain small subunit 1" P04632 19 36139575-36150353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006872 Approved Approved Nucleoplasm,Cytosol 50000000 "Nucleoplasm, Cytosol" "HPA006872: AB_1078382" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.03e-1)" "unprognostic (2.82e-3)" "unprognostic (1.25e-3)" "unprognostic (2.04e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-1)" "unprognostic (5.53e-2)" "unprognostic (7.10e-3)" "unprognostic (1.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-2)" 67.8 59.4 58.7 49.6 53.1 47.1 54.4 29.9 92.0 74.8 87.8 50.8 45.3 61.3 50.1 48.8 111.9 74.9 70.6 137.2 55.7 61.0 104.0 67.5 70.7 74.0 56.6 52.0 63.0 45.1 72.3 48.6 48.1 71.5 59.8 69.6 62.8 61.4 71.8 95.7 30.9 95.6 69.2 47.4 63.6 50.4 49.2 27.8 45.4 71.4 65.9 87.3 56.7 57.9 13.4 25.7 11.3 33.2 9.6 20.3 8.1 40.5 101.8 25.5 36.4 61.6 75.5 5.1 33.2 71.0 67.8 52.6 23.0 60.3 14.6 49.3 110.6 21.7 30.5 81.4 57.6 61.4 15.0 16.9 30.7 38.8 71.6 16.8 42.8 80.7 50.8 43.8 62.3 73.6 20.4 58.9 103.0 53.3 30.0 30.5 14.7 51.6 15.9 20.7 27.0 127.2 40.9 17.3 21.8 40.0 56.8 15.8 33.1 27.6 47.5 60.2 45.8 20.1 33.3 21.0 27.9 13.0 68.3 23.0 51.5 8.8 22.5 9.3 20.3 31.4 13.0 12.9 14.3 16.2 19.8 13.4 8.8 11.8 11.3 9.6 33.2 25.7 14.0 8.1 58.7 53.1 29.9 92.0 55.7 61.0 56.6 52.0 71.5 27.8 CAPRIN2 "C1QDC1, caprin-2, EEG1, FLJ11391, FLJ22569, RNG140" ENSG00000110888 "Caprin family member 2" Q6IMN6 12 30709552-30754951 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039746 Supported Supported Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA039746: AB_10672902" "unprognostic (7.45e-2)" "unprognostic (6.38e-2)" "unprognostic (2.83e-3)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-1)" "unprognostic (8.91e-2)" "unprognostic (9.90e-2)" "unprognostic (3.09e-1)" "unprognostic (3.30e-2)" "prognostic unfavourable (3.50e-5)" "unprognostic (1.91e-1)" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "prognostic favourable (8.36e-4)" 5.5 7.8 12.5 5.3 20.6 9.3 5.0 19.9 15.7 7.3 5.3 4.4 9.5 4.0 8.6 10.5 3.6 4.9 6.1 17.4 11.8 19.0 6.5 5.3 6.5 5.4 11.2 11.6 8.3 5.5 22.4 11.0 4.2 18.2 7.4 5.7 6.1 3.1 10.0 5.6 10.6 4.6 8.4 11.5 6.7 6.5 22.3 9.4 4.3 5.7 3.9 5.0 6.1 8.1 4.1 4.2 7.5 1.5 2.6 5.4 0.9 4.6 3.2 6.1 5.2 6.1 6.5 3.7 8.6 7.3 3.7 5.1 1.7 3.0 2.7 7.6 9.0 3.7 3.2 14.0 6.8 4.0 3.6 11.3 5.3 6.5 3.4 1.7 1.1 7.4 5.6 12.0 9.7 8.4 0.7 2.7 8.8 0.9 2.2 2.9 7.2 9.9 1.0 9.2 1.3 1.6 16.7 7.7 4.7 3.2 2.3 3.7 2.1 0.5 11.4 7.2 4.0 22.0 15.8 5.3 3.7 2.4 8.8 0.5 4.7 7.5 1.5 1.2 4.4 0.6 5.4 3.7 2.8 4.6 0.6 4.1 3.1 2.8 0.3 2.6 0.7 4.2 1.8 0.9 12.5 20.6 19.9 13.7 11.8 19.0 11.2 11.6 18.2 9.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.0;U-266/70: 10.0" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favourable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favourable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.0 1.1 0.7 3.4 1.3 1.8 2.1 0.5 0.4 0.2 0.3 0.8 7.4 0.8 2.2 0.9 1.3 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.2 2.1 0.2 0.5 0.5 0.5 2.9 0.4 2.1 1.4 2.0 0.6 5.6 1.7 0.3 2.3 1.0 3.1 0.7 2.5 0.5 36.0 3.6 2.2 2.3 1.0 0.6 0.4 2.6 9.5 10.0 3.4 0.6 4.2 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell line enhanced" "Detected in many" "A549: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040004 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome Centrosome "Nucleoplasm, Nucleoli" "HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.8 5.0 1.4 0.4 2.5 1.9 0.2 1.0 0.2 2.7 2.9 0.0 2.3 0.5 4.4 0.7 1.1 0.0 2.2 1.9 1.7 0.8 2.1 0.8 0.0 0.0 0.3 0.0 0.8 1.3 2.3 0.5 0.3 0.4 0.8 3.5 0.1 2.4 2.0 0.7 0.7 0.0 0.0 0.2 3.5 0.0 2.9 1.4 0.2 0.1 1.6 1.7 0.7 1.1 2.5 1.1 0.6 0.4 0.2 0.0 0.0 2.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904295-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.9;epididymis: 18.3;fallopian tube: 59.4" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.8;REH: 7.6;U-698: 18.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 14.1;ovarian cancer: 3.4" "Region enriched" "Detected in many" 7 "pons and medulla: 34.9" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.1 0.2 3.6 0.1 4.4 0.2 0.2 0.0 0.5 2.4 0.1 4.3 0.4 0.1 1.3 18.3 0.2 59.4 0.2 0.2 5.2 5.3 0.7 0.1 11.8 0.1 0.3 0.0 6.7 0.4 0.1 17.0 0.2 34.9 0.2 0.1 0.0 0.4 0.4 0.2 0.2 0.1 0.2 0.8 0.1 0.2 5.4 0.5 0.5 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.3 6.2 0.0 0.0 2.1 0.0 0.9 0.0 0.1 0.0 4.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 1.3 0.0 0.0 1.2 2.2 0.0 0.5 0.0 0.0 18.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 4.4 0.0 0.3 5.2 5.3 0.3 0.0 34.9 0.5 CAPZB ENSG00000077549 "Capping actin protein of muscle Z-line beta subunit" P47756 1 19338776-19485539 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031531 Approved Approved Nucleoplasm,Vesicles,Cytosol 35000000 "Nucleoplasm, Cytosol" Vesicles "HPA031531: AB_10603556" "unprognostic (7.52e-2)" "unprognostic (2.13e-1)" "unprognostic (5.25e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.18e-1)" "prognostic unfavourable (1.85e-4)" "unprognostic (4.55e-2)" "unprognostic (7.70e-2)" "unprognostic (3.08e-1)" "unprognostic (4.15e-2)" "unprognostic (2.55e-1)" "prognostic unfavourable (3.57e-4)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (4.00e-1)" "unprognostic (3.78e-1)" 29.6 24.8 57.1 38.4 47.3 27.9 28.1 23.0 39.7 34.8 84.1 34.3 19.3 29.2 40.3 28.2 41.8 29.2 29.3 80.3 53.8 40.7 29.3 37.5 29.7 50.4 53.5 33.6 38.6 24.9 23.7 18.1 36.9 29.5 42.2 43.5 30.4 23.7 35.9 160.5 27.0 43.7 49.5 72.0 42.1 32.6 70.5 22.3 51.2 34.2 35.3 54.3 56.9 32.3 39.8 55.6 155.9 96.3 27.1 57.2 78.0 47.7 28.4 51.2 36.8 70.3 90.5 36.0 81.3 84.9 72.1 74.2 35.4 67.4 33.0 35.5 101.6 40.6 43.9 56.1 81.2 51.9 31.1 64.6 38.1 55.2 72.1 42.8 106.8 83.4 46.7 61.7 58.4 65.6 22.9 47.2 72.0 33.9 47.4 49.8 38.4 30.8 42.9 36.0 43.3 90.9 27.5 31.1 24.1 47.8 40.0 53.8 43.9 37.5 67.6 48.6 39.9 79.5 38.7 29.2 35.1 41.6 63.7 56.4 52.3 53.8 54.4 155.9 49.1 79.4 41.8 39.8 51.1 52.3 55.6 29.1 43.1 46.1 87.8 27.1 96.3 30.2 57.2 78.0 57.1 47.3 23.0 39.7 53.8 40.7 53.5 33.6 29.5 22.3 CARS2 FLJ12118 ENSG00000134905 "Cysteinyl-tRNA synthetase 2, mitochondrial" Q9HA77 13 110641412-110713603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041776 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA041776: " "unprognostic (2.34e-3)" "unprognostic (9.50e-2)" "unprognostic (6.62e-2)" "prognostic favourable (1.84e-4)" "unprognostic (1.98e-1)" "unprognostic (3.54e-3)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (7.82e-2)" "unprognostic (2.11e-3)" "unprognostic (5.75e-2)" "prognostic unfavourable (2.49e-5)" "unprognostic (4.73e-2)" "unprognostic (3.42e-1)" "unprognostic (3.21e-1)" "unprognostic (1.71e-2)" 19.6 28.1 11.9 24.8 13.0 25.6 37.1 18.2 14.5 21.8 20.2 17.6 21.2 17.8 18.5 23.0 20.2 16.8 26.9 26.0 9.9 10.3 17.0 21.4 19.9 26.7 11.3 14.1 17.6 31.7 11.5 19.7 12.5 11.7 17.5 15.0 16.6 19.0 21.3 39.7 16.1 20.1 22.1 11.7 19.7 17.9 11.2 11.4 21.8 19.2 18.5 21.9 16.9 16.7 3.4 4.0 3.1 6.8 0.6 2.2 1.7 35.1 11.7 6.7 16.4 18.0 16.9 9.1 15.7 14.3 15.9 19.6 16.4 15.9 16.4 22.0 17.1 18.7 11.5 19.6 13.0 15.0 19.2 10.2 24.8 18.7 18.4 25.0 12.5 21.0 15.7 13.8 16.7 11.3 7.0 5.2 22.4 8.2 11.1 8.1 5.7 11.6 16.4 4.9 6.7 17.0 10.3 12.0 9.1 12.6 19.5 18.1 9.4 27.8 10.1 13.3 5.0 16.7 15.7 9.3 10.6 9.5 65.0 15.0 13.1 0.0 4.7 0.7 2.0 5.1 2.2 3.4 0.6 0.8 4.0 1.4 2.0 1.0 3.1 0.6 6.8 3.4 0.7 1.7 11.9 13.0 18.2 14.5 9.9 10.3 11.3 14.1 11.7 11.4 CASC10 "bA418C1.3, C10orf114" ENSG00000204682 "Cancer susceptibility 10" Q5T4H9 10 21492658-21497262 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;liver: 13.6" "Cell line enhanced" "Detected in many" "A549: 10.1;AF22: 10.2;AN3-CA: 14.1;BEWO: 13.6;SK-BR-3: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" HPA064131 Uncertain Approved Nucleoplasm Nucleoplasm "HPA064131: " "unprognostic (2.69e-2)" "unprognostic (1.46e-2)" "unprognostic (5.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavourable (8.87e-4)" "unprognostic (3.22e-2)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.00e-1)" "unprognostic (8.55e-2)" "unprognostic (1.85e-1)" "unprognostic (4.04e-3)" "unprognostic (1.09e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "prognostic unfavourable (5.86e-4)" 1.8 2.6 8.9 0.9 6.2 0.9 0.9 2.0 8.0 2.5 0.8 6.1 0.1 1.0 1.3 1.1 1.2 2.4 1.7 3.8 11.8 3.8 6.3 13.6 1.5 1.3 3.3 4.2 2.6 1.3 3.7 3.3 7.2 2.7 1.9 0.7 2.0 1.0 1.8 5.0 3.3 0.9 1.5 2.2 0.8 0.9 2.6 5.3 0.1 5.6 0.0 0.8 2.3 1.6 0.6 0.4 2.2 0.3 1.0 0.4 0.2 1.7 10.1 10.2 14.1 1.9 1.0 13.6 0.9 0.4 0.1 0.2 1.5 3.5 0.5 1.5 0.8 2.2 1.8 0.5 0.1 0.3 1.9 0.1 1.4 2.3 0.5 0.0 0.1 1.3 1.8 0.1 0.1 0.9 0.6 0.1 0.1 1.6 0.6 0.6 1.4 0.9 0.7 0.1 0.0 2.0 1.4 1.3 5.0 4.7 8.9 0.6 1.6 7.7 2.4 0.8 8.0 0.2 1.0 0.1 0.2 0.1 4.4 0.0 4.4 1.5 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.1 0.0 0.6 0.2 0.4 2.2 1.0 0.3 0.4 0.2 0.2 8.9 6.2 2.0 8.0 11.8 3.8 3.3 4.2 2.7 5.3 CASD1 "C7orf12, FLJ21213, FLJ21879" ENSG00000127995 "CAS1 domain containing 1" Q96PB1 7 94509219-94557019 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044404 Uncertain Approved Nucleoplasm Nucleoplasm "HPA044404: AB_10964353" "unprognostic (4.02e-2)" "unprognostic (4.16e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (7.04e-2)" "unprognostic (7.90e-2)" "unprognostic (3.66e-2)" "unprognostic (2.18e-2)" "unprognostic (9.83e-2)" "unprognostic (4.74e-2)" "unprognostic (4.95e-3)" "unprognostic (2.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (1.93e-1)" "unprognostic (7.07e-2)" "unprognostic (2.59e-3)" 8.6 21.6 16.6 7.1 24.2 4.1 13.2 20.5 24.8 10.0 13.2 10.9 7.5 5.0 11.7 12.5 5.1 9.2 8.1 13.6 25.9 22.2 10.2 7.1 9.0 9.2 13.1 16.6 14.1 7.8 12.7 22.8 9.8 20.0 11.8 15.9 8.4 22.6 8.2 11.3 3.7 6.3 9.7 13.7 8.0 6.0 10.1 11.5 7.3 13.2 2.9 8.3 9.0 6.3 1.8 1.1 0.2 0.7 1.8 4.7 0.7 3.0 5.8 20.1 7.4 6.1 7.4 3.4 4.1 7.3 4.6 6.0 3.7 7.5 7.7 10.8 5.5 1.7 5.0 1.4 9.1 12.3 4.0 6.9 5.0 6.6 5.2 11.3 0.0 6.7 5.3 4.2 6.0 7.2 3.7 17.0 11.2 4.4 15.6 6.4 10.2 4.7 10.8 16.3 6.0 9.2 8.4 7.6 26.0 6.4 12.0 4.0 3.1 7.1 3.8 11.5 9.1 9.4 5.9 16.3 15.2 16.1 6.3 2.6 7.4 0.0 0.6 0.2 1.9 0.7 4.7 1.8 2.8 2.3 1.1 1.7 2.9 2.2 0.0 1.8 0.6 1.0 1.7 0.7 16.6 24.2 20.5 24.8 25.9 22.2 13.1 16.6 20.0 11.5 CASK "CAGH39, FGS4, LIN2, TNRC8" ENSG00000147044 "Calcium/calmodulin dependent serine protein kinase" O14936 X 41514934-41923645 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.3" "Lineage enriched" "Detected in many" 11 "granulocytes: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001949, HPA023857" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB001949: , HPA023857: AB_1846035" "unprognostic (6.30e-2)" "unprognostic (3.78e-2)" "unprognostic (1.48e-1)" "unprognostic (2.48e-3)" "unprognostic (1.56e-1)" "unprognostic (1.29e-1)" "unprognostic (1.42e-3)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (5.85e-3)" "prognostic unfavourable (6.11e-5)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (8.72e-2)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "unprognostic (2.85e-2)" 9.1 15.9 13.9 18.8 12.7 9.8 13.2 14.2 15.7 11.1 22.1 20.0 7.1 27.1 12.2 13.7 17.2 9.9 16.0 7.0 12.1 12.8 14.6 10.8 10.3 13.6 16.3 8.5 13.9 14.2 11.1 9.8 13.4 11.9 10.7 23.8 10.4 15.9 7.7 5.8 12.8 32.9 12.1 10.1 9.6 16.2 2.9 14.3 30.9 9.3 8.1 14.0 11.8 13.1 0.6 0.3 26.3 0.8 2.4 2.3 0.3 10.8 13.9 13.3 7.9 9.0 7.4 4.3 9.5 7.9 5.6 5.1 29.9 17.7 0.1 4.9 11.8 21.8 14.7 9.7 9.4 9.6 8.2 0.0 12.5 10.6 9.3 1.7 1.4 8.4 26.7 10.6 13.6 4.5 0.8 8.5 12.1 12.7 3.1 0.7 12.2 9.1 5.1 32.8 5.2 12.6 23.7 12.2 6.5 17.9 7.1 5.4 7.7 0.3 5.3 10.5 10.6 8.9 5.2 3.3 2.0 3.6 10.3 1.2 6.7 26.3 0.8 4.8 0.5 0.7 0.5 0.4 0.6 0.8 0.2 0.6 0.7 0.7 1.1 2.4 0.4 0.3 2.3 0.3 13.9 12.7 14.2 14.2 12.1 12.8 16.3 8.5 11.9 14.3 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB079050: , HPA055990: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.5 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 1.2 0.3 0.0 16.6 3.7 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.3 0.0 0.9 0.7 0.0 0.9 0.0 0.4 0.2 0.0 7.7 3.7 0.1 0.2 0.2 1.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell line enriched" "Detected in some" 7 "hTCEpi: 32.4" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: " "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavourable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavourable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 CASP2 "ICH1, MGC2181, NEDD2, PPP1R57" ENSG00000106144 "Caspase 2" P42575 7 143288215-143307696 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 45.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012175, HPA050678" Approved Approved Nucleoplasm Nucleoplasm "CAB012175: , HPA050678: " "unprognostic (6.96e-2)" "prognostic favourable (7.38e-4)" "unprognostic (2.74e-2)" "unprognostic (7.51e-2)" "unprognostic (4.24e-2)" "unprognostic (2.39e-2)" "prognostic unfavourable (2.34e-4)" "unprognostic (1.74e-2)" "unprognostic (1.34e-2)" "prognostic favourable (2.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.64e-1)" "prognostic unfavourable (5.01e-6)" "unprognostic (2.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.64e-1)" 10.5 6.5 6.6 10.7 6.7 26.8 10.2 9.6 10.9 9.6 8.5 9.0 8.2 8.2 10.8 7.8 14.1 8.4 5.7 6.1 5.7 4.1 7.3 5.8 9.8 15.8 6.9 6.1 8.7 8.1 12.1 6.6 11.3 7.3 7.6 10.2 10.1 11.6 5.8 4.3 14.2 14.0 7.4 6.3 18.6 7.5 8.6 6.9 45.7 8.9 8.0 23.0 7.4 10.2 18.5 11.8 33.2 17.7 13.4 21.4 7.6 10.7 10.1 11.4 20.2 6.4 7.6 6.1 11.1 5.0 10.2 11.2 10.1 12.3 20.5 10.5 7.0 10.6 11.4 8.7 13.6 17.9 8.8 12.1 16.0 6.9 3.4 23.6 15.2 5.2 7.2 12.3 4.4 8.7 10.1 13.1 10.8 10.6 41.0 24.9 14.3 10.3 30.2 5.9 12.5 6.0 9.2 12.5 14.1 22.0 9.6 7.0 10.5 9.0 9.7 9.0 6.3 16.2 11.0 10.9 10.7 23.8 10.2 28.1 16.4 33.2 10.8 9.3 14.9 11.9 14.6 15.8 20.6 15.4 9.8 18.5 15.4 17.8 12.3 13.4 17.7 11.8 21.4 7.6 6.6 6.7 9.6 10.9 5.7 4.1 6.9 6.1 7.3 6.9 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.8" "Cell line enhanced" "Detected in all" "Karpas-707: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favourable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favourable (9.93e-4)" 8.1 6.1 3.6 6.7 4.3 5.3 14.3 2.8 3.8 6.9 25.5 2.8 4.5 23.4 5.9 4.3 8.7 5.3 11.7 4.9 4.0 2.0 11.0 14.3 5.6 8.5 5.0 1.6 7.0 13.0 2.3 6.4 4.3 4.5 8.1 19.5 3.4 8.0 10.3 3.4 6.5 42.8 14.0 6.6 9.1 9.2 2.7 4.3 14.5 11.2 3.3 8.4 8.2 12.7 4.4 8.0 8.5 7.0 5.6 21.3 8.0 12.4 4.0 8.3 7.5 6.1 6.0 12.3 7.0 4.8 6.2 6.8 6.7 25.6 1.3 8.1 7.1 5.8 9.9 11.0 5.0 19.7 6.5 10.9 3.6 5.9 4.9 10.9 7.7 6.6 8.2 6.0 1.5 11.8 14.1 38.8 10.1 7.0 28.1 6.9 6.3 7.3 9.8 5.3 6.8 20.6 11.8 8.8 6.6 7.4 13.3 4.1 5.7 4.0 10.0 6.9 7.4 3.3 7.9 5.7 10.3 1.4 9.0 13.1 3.5 8.5 5.3 6.3 4.9 4.8 5.3 4.1 17.8 9.3 6.0 4.4 21.3 11.8 1.1 5.6 7.0 8.0 16.4 8.0 3.6 4.3 2.8 3.8 4.0 2.0 5.0 1.6 4.5 4.3 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: " "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favourable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavourable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 14.1 10.6 2.0 31.6 2.6 27.1 10.2 1.4 1.8 7.9 18.5 3.9 7.0 9.6 9.6 12.0 11.7 9.1 12.1 4.4 2.1 2.3 16.4 14.8 17.1 28.3 3.9 1.1 8.2 7.6 1.8 5.9 12.3 3.2 9.8 8.7 4.4 9.6 8.4 2.7 7.4 34.7 5.1 5.0 37.7 7.4 3.8 2.7 43.7 6.7 10.7 43.4 9.6 7.3 13.8 13.7 52.5 17.0 22.2 26.4 12.0 14.3 12.2 3.6 9.9 10.0 14.6 5.5 6.3 6.2 7.5 12.4 16.4 25.0 1.6 13.9 4.9 7.3 7.8 7.5 14.8 9.3 7.1 14.0 9.9 15.6 8.1 10.8 15.2 12.7 18.5 14.2 11.1 7.1 12.5 31.2 6.8 5.9 14.1 11.5 5.8 10.9 10.6 7.4 25.5 14.1 16.0 1.0 0.5 8.2 13.6 8.1 3.6 8.5 8.8 8.1 8.4 4.2 4.9 28.3 12.6 9.7 12.2 14.6 7.6 20.7 13.0 24.9 25.0 17.0 23.1 13.8 20.5 26.4 13.7 7.8 13.3 16.9 52.5 22.2 15.6 6.1 24.0 12.0 2.0 2.6 1.4 1.8 2.1 2.3 3.9 1.1 3.2 2.7 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.4 0.2 1.8 0.8 0.0 4.1 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.2 0.0 0.8 0.0 0.5 0.1 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.8 1.9 0.1 0.4 0.5 0.4 0.9 0.2 0.4 0.0 0.3 0.0 1.0 0.6 0.0 0.7 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300391-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "testis: 139.5" "Cell line enhanced" "Detected in some" "BEWO: 5.6;CACO-2: 15.3;PC-3: 9.1;T-47d: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052822 Approved Nucleoplasm Nucleoplasm "HPA052822: " "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.1 0.0 0.5 0.0 0.4 0.0 0.8 0.1 0.9 0.2 0.1 0.1 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 139.5 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.5 0.4 0.6 0.6 0.0 0.3 0.0 0.0 4.1 0.3 0.0 0.5 1.0 5.6 0.0 0.3 0.0 0.0 15.3 3.2 0.1 0.2 0.1 3.4 3.1 0.5 0.1 0.0 0.0 1.5 0.1 1.0 0.1 0.0 0.0 0.1 0.3 0.9 0.0 0.2 1.6 0.7 0.2 0.7 0.0 0.7 1.1 9.1 1.7 0.0 2.0 4.5 1.4 0.1 0.9 1.7 0.5 0.2 7.5 0.4 0.2 0.2 0.1 2.1 0.0 0.4 0.1 0.5 0.2 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.1 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100587906 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 83.8;tongue: 52.4" "Cell line enhanced" "Detected in many" "AF22: 7.2;NTERA-2: 10.1;SCLC-21H: 15.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 3.5 0.0 0.3 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.2 2.7 1.9 0.0 0.1 16.4 0.5 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.8 0.0 83.8 0.1 0.0 0.1 0.7 0.0 0.1 1.4 0.0 0.1 0.2 52.4 1.6 0.0 0.0 0.4 0.3 1.4 0.4 0.7 0.7 0.0 0.5 0.4 7.2 2.7 1.6 2.4 5.2 1.3 1.0 1.0 1.2 0.0 0.5 0.3 0.3 0.6 0.3 3.4 0.1 2.1 1.7 2.4 0.0 1.1 0.0 0.5 0.3 0.4 5.8 0.3 1.0 0.6 1.2 0.2 0.3 4.5 0.1 2.0 0.3 10.1 0.8 2.9 6.8 0.0 0.8 0.4 15.5 4.1 0.2 0.3 1.4 0.2 0.2 1.3 1.8 1.4 1.3 1.1 0.4 1.3 0.7 1.9 0.1 1.3 0.6 0.3 0.2 0.5 0.4 0.2 0.2 0.7 0.5 0.1 0.4 0.5 0.5 1.4 0.7 0.3 0.3 0.2 0.0 0.3 0.6 0.5 0.3 0.5 0.3 0.5 0.1 0.0 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.6" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA012777 Approved Nucleoplasm Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.2 0.2 0.6 1.5 4.4 1.3 0.9 0.9 2.3 0.2 0.0 4.9 0.9 2.3 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.2 0.1 1.8 1.2 0.5 1.1 0.3 0.6 2.7 0.1 0.6 3.9 0.0 1.3 3.6 2.1 4.3 0.8 0.3 0.2 0.5 3.2 8.6 0.0 0.1 4.5 0.6 0.9 1.7 1.8 5.5 5.1 1.6 0.5 0.5 0.0 1.4 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 CBFB PEBP2B ENSG00000067955 "Core-binding factor beta subunit" Q13951 16 67029116-67101058 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038852 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038852: AB_10795358" "unprognostic (1.05e-1)" "unprognostic (1.18e-2)" "unprognostic (1.30e-1)" "unprognostic (3.22e-2)" "unprognostic (4.66e-2)" "unprognostic (3.80e-3)" "prognostic unfavourable (2.83e-4)" "unprognostic (1.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-3)" "unprognostic (1.88e-2)" "prognostic unfavourable (2.89e-8)" "unprognostic (1.03e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" 15.9 10.9 15.9 26.4 25.1 20.5 15.0 9.5 14.3 15.4 10.6 23.3 11.8 8.8 15.3 10.2 20.5 14.3 16.3 21.5 16.2 13.2 12.1 14.4 16.1 32.6 23.6 12.4 17.3 13.6 40.4 18.8 13.2 17.5 14.6 11.1 13.7 19.6 10.3 33.3 14.8 12.2 11.7 22.4 18.2 17.1 7.3 24.2 42.2 17.0 14.8 31.0 15.9 18.8 6.5 9.1 20.5 9.2 14.8 7.0 5.1 15.4 10.3 9.0 14.7 6.6 8.5 14.5 17.9 10.7 16.9 15.0 20.7 17.7 34.2 17.1 15.2 15.4 16.1 10.1 22.8 11.7 9.2 23.7 8.8 16.4 9.4 30.9 51.1 8.5 6.9 18.9 14.6 13.7 25.2 12.2 17.5 11.7 31.8 16.6 8.8 14.6 64.5 39.1 29.0 11.9 13.8 13.3 11.9 45.9 7.0 18.3 6.3 22.2 18.9 26.3 18.0 14.9 24.0 16.7 29.7 99.9 20.0 21.2 23.6 20.5 7.4 7.4 6.7 9.2 7.0 6.5 6.6 7.0 9.1 6.4 6.3 5.3 4.6 14.8 6.1 3.3 7.0 5.1 15.9 25.1 9.5 14.3 16.2 13.2 23.6 12.4 17.5 24.2 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 38.4 9.0 3.7 19.5 4.9 15.5 16.3 24.4 3.8 13.7 18.7 5.9 7.7 9.3 13.8 12.2 8.3 12.5 13.4 27.5 3.8 4.8 7.4 6.7 16.3 19.1 4.4 1.9 17.7 6.8 3.4 13.5 25.4 7.9 12.9 8.0 11.6 9.1 6.3 10.3 8.5 13.8 25.6 5.7 16.4 12.4 9.2 5.2 11.6 13.5 7.0 18.0 24.9 24.1 5.1 3.1 2.8 2.1 10.3 9.9 1.6 1.6 2.2 7.6 3.7 8.7 8.8 4.9 5.6 2.8 1.6 2.7 2.9 1.9 3.6 4.0 3.0 2.8 1.0 1.0 2.0 2.7 2.9 1.9 11.7 1.8 12.8 1.3 1.4 8.4 3.0 4.4 12.0 5.5 2.0 11.5 3.5 2.0 1.9 0.9 2.7 3.2 4.1 2.3 0.6 4.0 7.2 5.8 6.4 6.7 0.8 8.8 1.6 2.9 3.1 23.4 2.0 3.2 1.3 6.5 0.5 5.6 6.2 1.2 1.5 0.7 1.5 2.8 9.9 0.9 8.8 2.2 5.1 5.6 1.3 5.1 4.4 8.0 1.0 10.3 2.1 3.1 5.6 1.6 3.7 4.9 24.4 3.8 3.8 4.8 4.4 1.9 7.9 5.2 CBLC "CBL-3, CBL-SL, RNF57" ENSG00000142273 "Cbl proto-oncogene C" Q9ULV8 19 44777869-44800634 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.8" "Cell line enhanced" "Detected in some" "A-431: 19.0;BEWO: 13.1;CACO-2: 12.8;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.2;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB008087, HPA035266" Approved Approved Nucleoplasm Nucleoplasm "CAB008087: AB_2228531, HPA035266: " "unprognostic (1.58e-1)" "unprognostic (2.25e-1)" "unprognostic (8.21e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (3.91e-2)" "unprognostic (1.67e-1)" "unprognostic (2.13e-2)" "unprognostic (3.82e-1)" "unprognostic (7.39e-2)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "prognostic favourable (3.11e-6)" "unprognostic (3.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.90e-2)" "unprognostic (2.21e-3)" 0.1 0.0 0.5 8.5 0.2 0.0 4.8 0.1 0.4 4.4 39.5 0.1 3.2 29.5 1.7 1.7 22.0 1.4 18.8 0.1 0.6 0.0 4.9 15.1 1.3 0.1 0.1 0.3 0.8 18.1 0.9 0.7 4.1 0.2 6.9 6.9 0.5 11.4 5.2 0.1 20.8 66.8 0.4 0.1 0.1 10.2 1.6 0.1 0.5 1.9 13.2 15.7 7.6 8.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 19.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 12.8 26.3 0.0 0.0 0.0 18.4 0.0 16.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.0 14.6 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.4 0.6 0.0 0.1 0.3 0.2 0.1 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.8;HDLM-2: 12.5;HSkMC: 18.6;Karpas-707: 14.0;U-266/70: 9.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 48 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavourable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavourable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 4.9 10.8 0.3 4.1 8.5 1.6 2.1 0.5 2.0 1.8 0.9 2.6 0.3 0.6 2.2 1.1 12.5 0.4 0.0 3.4 0.8 2.7 0.3 0.7 18.6 1.0 2.1 1.7 1.4 0.5 14.0 2.1 0.6 0.0 0.5 0.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.5 0.6 0.4 6.5 6.0 1.2 2.4 0.2 9.8 2.3 1.9 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 CBR1 "CBR, SDR21C1" ENSG00000159228 "Carbonyl reductase 1" P16152 21 36069941-36073166 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 176.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA018433 Enhanced Approved Nucleoplasm,Cytosol 12000000 Nucleoplasm Cytosol "HPA018433: AB_1846109" "prognostic favourable (2.18e-4)" "unprognostic (9.78e-2)" "unprognostic (3.25e-2)" "unprognostic (2.14e-1)" "unprognostic (6.47e-3)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (6.37e-2)" "unprognostic (4.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (4.00e-1)" "prognostic favourable (4.75e-4)" "unprognostic (2.37e-1)" "unprognostic (2.47e-1)" "unprognostic (6.13e-3)" "unprognostic (2.47e-2)" 9.6 22.9 31.7 8.4 41.6 3.7 8.5 12.0 35.8 14.6 63.4 75.9 6.5 176.1 9.3 17.1 40.2 9.6 15.1 7.8 37.7 24.7 35.2 77.2 11.7 8.5 57.3 25.2 10.4 8.0 8.9 7.9 11.7 51.6 16.7 16.8 10.4 23.1 15.0 8.7 34.4 118.1 11.6 48.1 10.0 41.4 5.7 41.9 3.6 11.3 29.8 14.3 12.4 17.1 17.0 29.9 17.1 51.4 19.1 29.2 37.0 25.4 39.2 4.8 12.4 25.2 25.5 0.2 28.5 20.5 15.6 18.7 14.4 15.0 6.4 18.8 26.6 18.7 9.8 28.0 12.0 31.6 23.2 19.2 22.8 9.8 14.4 10.6 17.7 12.4 35.3 15.1 6.6 16.6 0.0 4.7 14.3 25.2 5.3 11.1 0.0 28.6 0.0 0.1 17.7 41.5 12.7 14.0 12.6 27.6 40.1 32.4 19.0 14.8 16.7 17.5 7.4 44.5 20.6 32.1 58.1 0.1 32.2 10.6 25.4 1.8 36.6 17.1 18.1 51.4 15.3 17.0 22.7 16.9 29.9 15.6 29.2 21.4 2.5 19.1 38.6 10.4 22.7 37.0 31.7 41.6 12.0 35.8 37.7 24.7 57.3 25.2 51.6 41.9 CBX6 ENSG00000183741 "Chromobox 6" O95503 22 38861450-38872314 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048653 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA048653: " "unprognostic (1.65e-2)" "unprognostic (8.66e-2)" "unprognostic (6.20e-3)" "unprognostic (3.14e-3)" "unprognostic (1.56e-1)" "unprognostic (2.62e-1)" "prognostic unfavourable (8.30e-4)" "unprognostic (2.90e-2)" "unprognostic (3.72e-3)" "unprognostic (5.97e-2)" "prognostic favourable (2.46e-6)" "unprognostic (2.75e-1)" "unprognostic (1.27e-3)" "unprognostic (7.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (2.26e-2)" 15.0 15.0 44.7 14.5 35.1 21.7 7.4 27.8 53.8 14.0 19.5 15.3 9.8 6.5 19.3 14.2 12.9 18.8 10.9 14.0 40.6 18.3 12.1 5.9 13.0 12.0 15.8 21.8 23.4 13.1 62.2 15.5 4.7 19.3 16.1 7.4 17.0 12.5 25.4 5.5 7.7 9.2 23.8 12.1 11.2 12.0 5.0 12.0 11.3 13.4 4.5 13.8 16.6 9.5 4.7 26.9 2.6 7.4 5.2 11.7 9.2 16.5 17.5 3.9 13.4 30.2 17.0 1.2 18.1 10.5 9.4 8.8 8.7 15.5 27.2 13.6 12.3 19.8 7.2 7.7 5.2 26.1 22.7 2.7 7.6 3.0 16.5 13.3 13.5 25.2 3.9 21.5 10.3 10.6 6.1 13.8 6.4 18.7 8.2 3.9 3.5 13.6 12.4 13.1 10.7 13.4 15.7 19.2 4.2 11.6 15.5 9.7 10.6 8.0 13.8 8.2 25.4 14.2 12.3 14.2 13.6 9.9 16.1 14.0 17.0 1.1 5.5 2.6 11.7 7.4 9.7 4.2 8.1 8.2 5.4 4.7 6.7 8.2 2.3 5.2 6.8 26.9 4.6 9.2 44.7 35.1 27.8 53.8 40.6 18.3 15.8 21.8 19.3 12.0 CCDC102A MGC10992 ENSG00000135736 "Coiled-coil domain containing 102A" Q96A19 16 57512178-57536599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040598, HPA040958" Supported Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA040598: AB_10794035, HPA040958: AB_10794156" "unprognostic (3.46e-2)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.01e-3)" "unprognostic (7.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.38e-1)" "unprognostic (5.24e-3)" "unprognostic (8.40e-3)" "unprognostic (4.08e-1)" "unprognostic (2.75e-1)" "unprognostic (2.37e-1)" "unprognostic (8.42e-3)" 5.0 3.7 1.9 7.4 2.1 0.8 12.1 2.0 2.4 12.1 9.7 1.8 8.1 4.5 11.1 7.2 5.5 7.9 8.4 6.4 1.6 1.5 5.6 2.2 9.9 6.2 2.0 2.8 8.2 4.6 3.6 2.4 5.0 4.2 13.5 0.9 5.5 4.6 8.6 2.6 4.3 4.3 17.2 2.9 5.8 4.7 2.9 2.2 7.7 7.2 3.9 5.2 10.6 21.2 2.4 1.0 0.3 0.0 1.6 3.5 0.7 5.6 6.9 2.7 3.8 0.9 1.3 5.6 3.7 2.1 2.1 1.1 2.8 6.7 5.2 15.0 1.1 4.3 1.4 2.0 0.8 4.2 6.1 0.7 3.2 1.1 3.5 0.4 7.0 3.2 1.3 1.8 0.4 1.7 3.9 0.0 0.7 2.2 4.6 4.6 6.4 13.1 4.2 3.1 2.1 2.8 0.8 0.5 7.1 5.8 1.9 2.6 4.0 2.5 4.6 4.0 13.4 0.3 3.3 6.3 2.3 2.0 2.3 1.9 6.6 0.0 0.0 0.0 3.1 0.0 2.6 2.4 0.8 3.5 0.0 1.3 1.4 2.4 0.3 1.6 0.0 1.0 0.1 0.7 1.9 2.1 2.0 2.4 1.6 1.5 2.0 2.8 4.2 2.2 CCDC107 MGC31967 ENSG00000159884 "Coiled-coil domain containing 107" Q8WV48 9 35658290-35661511 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016857, HPA050442" Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA016857: AB_10669751, HPA050442: " "unprognostic (3.70e-3)" "unprognostic (7.07e-3)" "unprognostic (3.60e-2)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.09e-2)" "unprognostic (4.13e-1)" "unprognostic (1.72e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-1)" "unprognostic (8.33e-2)" "unprognostic (1.89e-1)" "unprognostic (5.15e-1)" "unprognostic (1.96e-1)" "unprognostic (5.75e-2)" 42.1 23.4 11.1 15.4 10.3 5.4 50.3 17.2 12.9 17.5 35.2 8.5 18.1 15.0 24.9 28.6 22.4 18.2 31.5 31.3 10.2 11.0 13.0 15.0 14.0 14.1 9.7 7.9 15.3 80.2 7.6 10.5 10.8 8.4 22.8 13.7 11.5 14.6 24.5 29.3 9.6 16.0 44.8 9.7 13.5 24.2 9.2 8.8 19.3 14.0 8.8 10.9 38.9 24.1 20.7 32.5 7.6 11.0 16.4 46.9 18.3 7.9 7.2 6.0 7.5 30.3 19.5 3.5 13.5 12.2 8.7 8.1 3.3 2.4 5.2 6.0 17.7 2.7 4.4 6.5 6.4 15.3 7.1 2.4 11.0 8.1 7.2 3.8 9.5 11.5 7.8 9.2 7.2 6.0 3.2 10.1 10.8 5.1 4.2 5.6 4.4 22.3 6.1 1.4 4.1 28.7 4.3 3.9 6.6 7.0 9.8 6.6 5.1 4.7 7.5 13.9 7.7 10.0 12.3 4.5 6.7 10.4 25.7 6.1 12.1 7.6 10.6 5.1 36.1 11.0 46.9 20.7 31.7 31.4 11.8 20.1 15.5 21.3 2.1 16.4 6.4 32.5 35.2 18.3 11.1 10.3 17.2 12.9 10.2 11.0 9.7 7.9 8.4 8.8 CCDC117 FLJ33814 ENSG00000159873 "Coiled-coil domain containing 117" Q8IWD4 22 28772674-28789301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000826 Uncertain Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA000826: AB_1078417" "unprognostic (1.71e-1)" "unprognostic (2.04e-2)" "unprognostic (1.61e-3)" "unprognostic (9.07e-2)" "unprognostic (3.84e-2)" "unprognostic (1.26e-1)" "unprognostic (1.62e-1)" "unprognostic (1.35e-2)" "unprognostic (8.43e-2)" "unprognostic (7.74e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-3)" "unprognostic (8.25e-2)" 10.7 14.2 12.3 13.6 13.6 19.2 25.2 19.3 12.7 15.9 13.1 9.6 16.6 12.1 15.3 8.9 11.5 10.7 10.0 9.0 12.2 10.6 10.3 26.1 12.5 17.0 14.6 8.3 14.9 13.3 12.4 14.1 20.7 11.9 13.0 11.9 9.5 21.0 16.5 20.2 9.1 10.9 15.2 13.1 13.8 12.3 35.9 15.4 24.2 18.1 7.4 20.1 12.3 31.3 13.4 13.9 14.0 13.9 23.3 15.2 12.6 8.6 7.2 14.8 14.3 9.6 8.4 11.6 8.8 10.8 15.3 13.5 10.9 4.2 27.1 3.9 8.0 9.1 21.5 3.5 14.6 14.7 14.2 11.0 8.2 16.0 6.6 17.7 14.2 5.7 7.6 8.8 5.5 10.5 15.4 12.1 6.8 11.1 10.3 14.4 12.0 3.5 21.0 23.2 11.8 6.8 3.4 5.6 7.5 13.5 12.7 5.4 15.8 7.6 6.1 19.2 13.2 6.0 6.7 28.3 29.3 22.8 6.7 9.6 8.1 10.7 13.9 14.0 10.2 12.3 10.5 10.0 8.6 9.9 13.9 13.4 15.2 12.2 6.7 23.3 11.7 12.2 10.7 12.6 12.3 13.6 19.3 12.7 12.2 10.6 14.6 8.3 11.9 15.4 CCDC122 FLJ31846 ENSG00000151773 "Coiled-coil domain containing 122" Q5T0U0 13 43823909-43879727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 11.2;hTERT-HME1: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034233, HPA054995, HPA061456" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB034233: AB_2228702, HPA054995: , HPA061456: " "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (1.07e-1)" "unprognostic (1.67e-2)" "unprognostic (1.39e-2)" "unprognostic (1.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (5.28e-2)" "unprognostic (2.79e-2)" "unprognostic (1.30e-3)" "unprognostic (2.74e-1)" "unprognostic (1.16e-2)" "unprognostic (2.14e-2)" "unprognostic (3.79e-2)" "unprognostic (1.32e-1)" "unprognostic (6.75e-2)" 4.3 6.7 5.0 8.5 9.5 1.8 7.5 2.4 5.6 5.5 5.5 7.2 8.8 3.3 8.0 10.7 4.5 8.6 5.9 8.3 6.1 5.0 10.4 5.7 5.5 4.6 9.8 5.8 12.2 6.9 8.4 15.6 8.2 6.0 9.8 6.9 3.6 5.7 4.8 3.3 7.8 7.3 9.8 6.4 7.7 5.8 9.7 11.0 5.2 10.9 4.5 4.7 6.2 11.8 3.6 3.0 6.4 2.6 3.6 1.9 1.0 2.1 1.8 0.8 0.0 0.7 4.5 2.3 5.8 6.4 3.0 3.4 3.1 7.9 3.6 3.3 3.5 3.5 0.8 0.9 4.3 5.7 2.7 1.5 1.0 1.7 8.4 0.8 0.4 11.2 7.1 4.4 11.6 1.5 0.0 1.1 4.1 2.6 0.5 0.5 1.0 1.8 0.8 0.0 1.9 4.7 1.2 2.1 3.1 3.9 0.1 3.5 0.7 0.6 6.8 0.2 0.8 5.2 0.0 0.0 0.0 1.6 2.9 0.1 3.0 6.4 1.6 2.4 1.3 1.4 1.6 2.4 1.9 1.4 1.2 3.6 1.3 1.4 3.9 3.6 2.6 3.0 1.7 1.0 5.0 9.5 2.4 5.6 6.1 5.0 9.8 5.8 6.0 11.0 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597379-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 75.4" "Lineage enriched" "Detected in all" 18 "granulocytes: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026883 Uncertain Approved Nucleoplasm "Secreted to blood" 31000000 Nucleoplasm "HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.7 8.1 8.7 4.4 9.2 6.9 19.5 11.6 13.2 7.4 6.5 5.6 5.8 8.7 8.0 5.3 6.6 6.7 6.2 5.7 13.8 8.9 7.6 11.7 6.5 9.3 10.5 3.9 7.4 9.8 12.2 12.6 4.6 11.1 6.0 6.5 5.8 7.5 6.5 10.0 6.6 9.4 6.7 12.9 6.1 6.8 41.3 8.1 5.4 9.9 5.0 8.6 7.0 7.7 3.8 3.0 75.4 3.6 2.9 4.1 2.9 4.8 3.4 7.5 9.5 12.6 7.0 17.2 6.1 6.0 5.2 7.7 3.5 1.6 10.4 9.6 5.1 2.8 3.2 2.9 6.9 2.1 4.3 1.8 1.4 4.5 5.1 4.7 9.2 7.5 8.5 1.7 1.6 7.0 4.1 2.9 6.3 2.2 3.2 5.7 3.5 4.2 2.2 11.8 3.1 5.5 2.2 4.6 8.6 6.3 6.1 4.5 5.1 4.4 8.4 3.1 5.6 7.1 4.8 8.4 8.3 7.4 3.4 6.9 16.8 75.4 3.6 16.4 3.0 3.3 3.7 3.8 3.3 3.5 3.0 3.2 4.1 3.2 6.9 2.9 3.1 0.6 3.6 2.9 8.7 9.2 11.6 13.2 13.8 8.9 10.5 3.9 11.1 8.1 CCDC127 FLJ25701 ENSG00000164366 "Coiled-coil domain containing 127" Q96BQ5 5 196871-218215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045052 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA045052: AB_10960630" "prognostic unfavourable (7.01e-4)" "unprognostic (4.26e-2)" "unprognostic (1.93e-2)" "unprognostic (9.18e-2)" "unprognostic (2.78e-3)" "unprognostic (2.65e-2)" "prognostic unfavourable (4.04e-6)" "unprognostic (2.41e-1)" "unprognostic (1.57e-1)" "unprognostic (9.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "prognostic unfavourable (5.95e-5)" "unprognostic (2.42e-1)" "unprognostic (9.06e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-1)" 10.3 14.3 10.3 7.3 13.0 3.8 9.7 14.0 16.2 10.7 10.0 10.6 8.2 8.7 11.6 7.7 13.4 10.5 12.7 16.3 9.8 11.8 8.1 6.8 6.9 12.4 12.0 9.8 15.3 8.6 5.0 14.9 10.2 13.9 10.5 4.1 10.5 8.1 6.1 18.4 12.4 10.1 8.1 9.5 7.2 9.4 11.1 12.2 9.6 23.5 7.4 5.2 9.9 7.9 9.0 8.1 7.2 5.3 8.6 11.0 5.3 4.0 5.2 5.9 10.7 7.2 5.5 5.8 7.7 4.0 3.5 3.4 5.5 8.4 8.4 11.2 3.5 5.3 3.7 3.0 3.3 21.2 6.5 2.9 24.6 4.8 4.2 2.3 5.4 4.5 4.8 3.2 2.3 2.8 4.8 2.9 3.7 3.2 4.2 4.7 5.0 6.8 4.9 4.3 6.8 6.5 4.0 6.5 10.3 10.7 7.4 7.0 9.7 4.4 6.5 8.8 5.2 3.5 3.1 4.9 4.1 5.7 5.7 4.1 5.5 4.6 4.5 7.2 8.1 5.3 8.7 9.0 8.3 9.6 4.5 8.8 9.8 11.0 2.9 8.6 4.7 8.1 6.2 5.3 10.3 13.0 14.0 14.7 9.8 11.8 12.0 9.8 13.9 12.2 CCDC138 FLJ32745 ENSG00000163006 "Coiled-coil domain containing 138" Q96M89 2 108786757-108885477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049899, HPA054223" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049899: , HPA054223: " "unprognostic (2.34e-1)" "unprognostic (3.74e-2)" "unprognostic (3.22e-2)" "unprognostic (3.04e-1)" "unprognostic (2.83e-2)" "unprognostic (1.64e-2)" "unprognostic (2.24e-5)" "unprognostic (2.89e-1)" "unprognostic (1.01e-4)" "unprognostic (2.56e-1)" "unprognostic (1.64e-1)" "unprognostic (5.77e-2)" "unprognostic (7.06e-4)" "unprognostic (7.88e-2)" "unprognostic (4.73e-2)" "unprognostic (2.69e-1)" "unprognostic (8.93e-2)" 2.6 2.5 5.7 5.0 7.0 6.1 4.8 13.5 8.2 3.1 3.9 4.9 1.6 2.1 6.0 2.8 5.5 8.6 3.8 2.3 6.8 5.0 3.6 5.5 2.8 8.1 4.3 5.1 3.7 3.5 2.3 7.4 2.8 8.0 3.1 4.8 1.9 3.3 2.1 2.1 4.8 3.4 3.3 6.4 3.2 3.7 19.4 6.5 19.5 2.3 2.9 7.2 4.3 6.1 5.4 8.1 3.1 2.1 3.2 4.8 2.4 8.1 3.8 13.0 6.7 1.0 1.2 8.3 3.6 1.1 8.5 6.3 12.3 4.8 19.7 5.4 1.1 7.0 9.4 4.9 7.7 4.5 12.1 9.1 7.1 10.1 1.3 12.4 1.3 0.8 1.4 10.0 3.0 4.4 17.2 9.1 4.3 4.6 17.7 8.4 19.3 3.9 11.7 12.3 12.1 4.7 6.5 9.2 9.0 7.8 4.2 6.2 4.5 6.0 2.8 5.4 9.5 3.4 7.5 2.9 6.6 20.6 2.2 9.7 5.3 3.1 0.9 1.3 2.1 2.1 3.9 5.1 2.8 4.0 0.9 5.4 4.1 4.8 0.5 3.2 0.8 8.1 4.1 2.4 5.7 7.0 13.5 8.2 6.8 5.0 4.3 5.1 8.0 6.5 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell line enhanced" "Detected in some" "CACO-2: 6.2;Daudi: 4.1;HEL: 9.3;RH-30: 5.0;U-266/70: 6.0;U-698: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" HPA012718 Approved Nucleoplasm Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 1.9 0.0 0.1 0.0 0.2 6.2 0.5 4.1 0.1 0.0 0.2 0.1 0.0 0.0 3.4 0.2 9.3 0.3 0.0 0.0 1.6 0.5 0.4 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.1 0.1 0.3 3.3 0.7 0.2 5.0 1.5 0.0 0.1 0.2 0.2 0.1 0.3 0.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.0 0.1 8.3 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;TIME: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA022996, HPA047220, HPA047851" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: , HPA047851: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.5 3.8 0.9 2.4 3.4 10.9 0.4 0.2 0.0 0.2 0.2 4.8 0.1 0.5 3.3 6.7 5.9 4.9 0.3 0.3 3.4 0.3 0.5 0.5 0.3 0.2 0.7 3.1 2.0 0.1 2.3 0.2 0.1 0.5 0.3 2.2 0.2 0.1 1.2 0.8 0.4 1.5 0.2 0.1 0.1 4.6 1.2 1.3 0.7 0.2 1.4 4.0 0.2 9.3 0.8 0.5 5.2 1.5 6.6 6.8 0.2 0.4 6.8 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 2.3 0.0 0.0 26.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 CCDC150 FLJ39660 ENSG00000144395 "Coiled-coil domain containing 150" Q8NCX0 2 196639554-196763490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.7;testis: 11.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 7.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048104 Uncertain Approved Nucleoplasm Nucleoplasm "HPA048104: " "unprognostic (1.92e-1)" "unprognostic (3.75e-1)" "unprognostic (2.95e-1)" "unprognostic (2.58e-4)" "unprognostic (9.88e-2)" "unprognostic (1.42e-3)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (5.91e-4)" "unprognostic (2.01e-2)" "unprognostic (3.16e-2)" "unprognostic (9.17e-3)" "unprognostic (5.66e-4)" "unprognostic (7.29e-2)" "unprognostic (1.99e-2)" "unprognostic (4.35e-2)" "unprognostic (2.69e-5)" 0.5 0.4 1.0 2.9 5.2 1.5 0.5 2.6 3.1 0.4 1.0 2.4 0.0 0.6 0.5 0.6 1.6 0.6 0.6 0.5 1.3 0.5 6.7 3.4 0.5 0.8 3.1 0.3 0.5 0.5 0.5 1.0 0.7 2.9 0.4 0.9 0.1 0.4 0.2 0.6 0.6 0.8 1.2 3.1 0.6 0.6 11.9 3.9 3.9 0.4 2.9 2.1 0.6 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.6 7.1 4.6 0.2 0.4 3.2 1.6 0.8 1.3 3.3 2.4 1.5 1.2 0.9 1.3 2.1 2.8 1.2 3.3 6.6 4.1 2.5 3.5 3.9 0.0 1.3 1.1 0.0 0.2 1.5 0.9 0.8 3.2 3.0 0.9 0.7 1.2 2.1 4.0 1.6 2.7 1.1 0.9 0.5 0.6 7.8 1.4 1.1 0.7 0.3 1.1 0.8 1.4 2.5 2.1 2.3 1.4 1.3 1.3 2.1 1.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 5.2 2.6 3.1 1.3 0.5 3.1 0.3 2.9 3.9 CCDC151 MGC20983 ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;fallopian tube: 18.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.0;T-47d: 9.2;U-87 MG: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;memory B-cell: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044184, HPA054626" Enhanced Approved Nucleoplasm Nucleoplasm "HPA044184: AB_10959331, HPA054626: " "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.8 3.1 5.7 0.6 9.9 0.6 0.6 4.4 7.7 1.6 0.6 4.0 1.4 0.6 1.0 2.8 0.6 18.2 0.6 1.2 7.7 4.3 2.0 0.8 2.7 0.6 2.3 4.6 2.5 0.6 9.8 10.4 1.4 12.7 0.8 0.6 0.7 4.0 1.8 0.5 0.5 0.6 0.6 1.7 1.9 0.9 8.5 5.4 0.0 2.1 0.0 0.7 0.6 0.4 1.5 0.7 0.1 2.3 0.0 0.0 0.1 0.5 0.1 1.2 0.1 0.1 0.4 1.0 0.5 0.1 0.6 0.7 0.1 0.0 0.3 0.5 0.2 0.2 0.9 0.4 0.0 1.0 1.0 0.4 0.6 0.0 0.5 0.0 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.9 0.2 0.8 0.0 0.1 0.4 2.1 0.4 0.1 1.4 0.7 0.0 4.0 2.7 1.2 0.2 0.1 9.2 0.4 0.0 1.4 0.3 3.4 0.1 3.4 2.7 0.2 3.6 0.6 0.1 0.0 0.6 0.0 0.0 2.3 0.0 1.5 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 5.7 9.9 4.4 7.7 7.7 4.3 2.3 4.6 12.7 5.4 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756801-42802360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.8;pituitary gland: 24.3" "Cell line enhanced" "Detected in some" "HeLa: 10.8;U-2 OS: 19.5;U-266/84: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 4.0 6.0 7.5 2.5 10.2 1.6 3.0 1.0 8.4 2.1 2.3 4.1 0.5 5.0 2.7 1.9 2.0 1.6 6.1 4.6 7.1 3.2 3.6 52.8 3.2 8.6 4.9 5.5 8.2 2.1 0.0 24.3 2.8 20.9 2.1 0.3 1.9 2.1 0.3 1.5 3.1 12.4 0.6 8.8 6.9 1.9 5.7 8.5 8.5 1.7 0.5 3.0 2.9 3.1 3.6 10.0 0.3 0.7 6.2 6.1 1.3 0.3 0.1 0.9 0.1 2.8 3.5 0.0 4.7 0.1 0.0 0.3 0.0 0.2 0.0 0.3 2.1 3.7 0.0 0.0 0.4 0.0 0.3 0.2 10.8 4.5 2.8 0.1 0.0 4.5 0.0 1.9 0.0 1.4 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.3 5.4 0.0 0.1 0.0 0.4 0.1 0.1 0.2 19.5 4.5 0.1 0.1 13.0 0.1 5.7 0.1 0.1 0.1 0.1 0.1 4.0 0.7 4.9 2.2 3.0 5.0 0.7 3.6 4.0 6.1 0.3 6.2 0.3 10.0 1.9 1.3 7.5 10.2 1.0 8.4 7.1 3.2 4.9 5.5 20.9 8.5 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: " "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favourable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favourable (9.46e-4)" "prognostic favourable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favourable (8.62e-4)" 7.9 24.6 21.0 13.4 35.1 22.2 10.9 15.5 28.6 14.8 12.9 30.6 28.3 17.8 13.9 21.1 11.8 14.2 19.0 13.6 22.8 11.9 13.4 18.9 12.8 14.7 38.5 22.9 19.2 15.1 34.3 20.8 7.3 28.0 24.7 9.5 17.7 14.5 17.4 6.3 14.6 14.3 12.5 24.2 24.1 16.1 28.2 43.5 7.5 17.8 8.5 11.2 13.7 12.6 9.9 16.5 21.2 28.0 15.7 15.2 11.8 2.2 1.9 1.6 5.1 6.7 9.7 1.7 3.6 3.8 4.3 5.8 0.6 2.4 1.8 9.4 6.8 1.8 1.0 5.8 2.7 9.0 1.4 4.4 1.6 2.3 11.7 1.7 6.6 11.6 15.4 3.1 4.2 12.1 3.9 21.4 2.1 2.7 2.6 3.5 0.9 7.3 3.0 0.0 12.0 3.9 3.2 0.7 2.7 3.7 4.2 6.7 6.2 7.4 8.0 3.4 1.0 5.9 3.3 19.7 4.7 3.8 4.6 9.0 4.9 21.2 28.0 19.1 12.1 23.6 11.7 8.1 8.2 11.0 16.5 9.9 7.5 5.9 13.2 15.7 16.4 4.3 15.2 11.8 21.0 35.1 15.5 28.6 22.8 11.9 38.5 22.9 28.0 43.5 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;SCLC-21H: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 CCDC18 NY-SAR-41 ENSG00000122483 "Coiled-coil domain containing 18" Q5T9S5 1 93179919-93278730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028035 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028035: AB_10601795" "unprognostic (8.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (1.49e-4)" "unprognostic (4.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.44e-2)" "unprognostic (3.41e-2)" "unprognostic (1.63e-2)" "unprognostic (3.50e-2)" "unprognostic (3.64e-13)" "unprognostic (4.94e-2)" "unprognostic (9.19e-2)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" 3.8 2.3 2.7 20.0 4.3 13.4 4.6 3.7 2.7 2.2 3.2 0.4 2.9 2.5 1.8 4.0 3.2 1.8 1.7 2.6 3.4 1.9 2.0 3.0 3.8 11.9 1.7 1.8 2.8 1.5 0.7 4.8 1.9 2.6 1.9 4.1 1.3 2.0 3.1 6.2 3.1 3.4 2.3 3.8 6.0 2.3 12.6 2.5 15.8 2.1 2.8 8.2 2.9 3.3 12.2 11.9 6.0 3.9 1.1 2.7 0.5 15.5 5.2 12.2 3.8 3.0 3.1 6.4 9.7 5.1 10.0 10.1 2.7 5.4 20.2 5.4 5.2 7.4 5.3 7.6 14.5 9.9 7.0 13.8 11.1 4.7 1.1 14.3 6.4 2.1 0.6 7.5 7.4 6.4 14.7 15.6 13.2 2.2 6.8 5.8 11.2 6.5 8.8 14.6 5.9 4.9 7.0 5.4 3.4 13.7 7.0 4.0 3.3 8.4 4.9 11.7 8.3 7.5 11.0 6.7 8.7 12.1 2.4 12.8 3.1 3.4 3.8 5.3 2.4 3.9 2.7 8.8 2.2 2.1 1.6 12.2 1.7 2.0 6.0 1.1 3.5 11.9 2.2 0.5 2.7 4.3 3.7 2.7 3.4 1.9 1.7 1.8 2.6 2.5 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148427-20151065 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.1;testis: 23.1" "Cell line enhanced" "Detected in some" "AF22: 5.7;SCLC-21H: 7.8;SH-SY5Y: 10.2;U-2 OS: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 47 "dendritic cells: 4.7" "Low region specificity" "Detected in single" HPA049901 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA049901: " "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.1 0.9 0.4 0.5 0.6 0.5 0.5 1.4 1.2 0.4 0.4 0.4 0.4 1.0 0.6 0.4 0.4 0.4 0.4 0.4 0.4 1.9 0.4 0.4 0.6 0.7 0.5 0.4 0.4 0.4 0.0 6.1 0.8 0.4 0.4 0.0 0.4 0.4 0.4 0.7 1.5 0.5 0.4 0.4 1.8 0.8 23.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.7 0.3 0.0 0.7 0.0 1.6 0.8 1.3 0.9 0.1 0.1 0.0 0.2 0.8 0.3 0.0 0.0 0.1 0.2 0.0 1.4 0.2 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.5 0.1 0.2 3.7 1.2 0.5 0.0 0.3 0.0 0.0 1.1 0.2 0.0 0.0 0.1 7.8 10.2 0.5 0.0 0.6 0.0 0.1 4.1 2.4 4.4 3.0 0.2 0.6 0.1 0.2 3.8 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.6 1.4 0.6 0.4 1.9 0.5 0.4 0.4 0.4 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235467-49250526 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport, Ubl conjugation pathway" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888" Uncertain Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000229: , HPA000888: AB_1078420" "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 11.5 15.4 12.1 18.2 14.9 26.0 16.3 20.7 16.5 12.5 11.8 13.7 17.2 16.3 14.8 12.3 15.8 13.7 11.9 12.9 12.2 9.8 13.9 14.2 19.8 24.7 12.2 15.9 13.7 20.3 12.1 13.5 11.0 11.8 15.2 8.6 12.8 19.2 21.3 23.0 15.1 15.3 14.6 12.4 23.9 14.2 4.5 14.1 25.0 13.0 15.5 17.9 12.6 12.3 12.4 23.5 13.9 22.1 6.1 13.9 15.1 10.5 9.2 5.6 19.5 5.2 5.4 12.0 6.3 4.6 7.0 8.1 9.2 9.2 3.9 9.3 5.5 8.6 6.1 10.3 2.9 10.1 13.6 4.1 8.7 8.7 8.8 11.6 7.3 5.0 8.9 9.3 5.1 6.9 8.1 6.9 5.0 32.7 8.4 13.6 6.5 13.5 12.3 9.1 16.9 5.5 5.4 6.7 5.1 9.6 11.3 8.4 17.6 11.4 7.6 9.1 9.9 11.2 6.5 12.5 6.8 7.0 9.9 21.7 7.1 5.1 22.1 13.9 12.0 19.2 13.1 12.4 12.5 13.9 23.5 11.6 11.4 12.9 1.8 6.1 15.7 9.3 12.9 15.1 12.1 14.9 20.7 16.5 12.2 9.8 12.2 15.9 11.8 14.1 CCDC25 FLJ10853 ENSG00000147419 "Coiled-coil domain containing 25" Q86WR0 8 27733311-27772653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023256 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA023256: AB_2072067" "unprognostic (1.43e-1)" "unprognostic (5.48e-2)" "unprognostic (3.10e-3)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (6.62e-3)" "unprognostic (2.34e-1)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (8.49e-3)" "unprognostic (3.50e-1)" "unprognostic (2.69e-2)" "prognostic favourable (1.11e-7)" "unprognostic (3.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-1)" 12.7 25.4 16.8 10.6 22.4 4.0 16.7 14.2 26.1 10.3 26.0 13.1 12.0 32.5 13.2 14.2 13.7 14.6 11.3 11.1 16.5 14.0 21.5 30.4 8.5 12.8 19.9 15.8 10.9 16.0 15.6 12.7 9.9 29.4 11.4 15.1 9.8 14.1 12.4 23.3 10.9 39.7 10.5 19.0 12.1 18.0 12.0 17.2 9.7 17.8 13.8 12.8 13.2 10.5 19.2 18.9 14.9 13.2 13.8 21.8 9.1 23.8 12.9 13.1 12.2 11.7 17.0 8.8 20.1 19.5 12.4 12.1 5.3 8.6 25.8 13.9 10.1 11.3 11.6 19.5 17.9 9.6 7.8 32.1 12.2 9.3 19.7 11.2 10.4 18.9 13.0 13.3 18.8 26.6 15.1 12.4 13.8 8.7 27.3 9.5 18.8 7.2 8.9 22.2 13.6 16.2 14.0 7.5 21.0 13.5 10.4 20.4 11.9 6.3 21.4 11.4 18.0 19.4 10.5 13.5 15.7 9.4 17.7 15.0 11.7 14.9 10.4 7.3 14.6 13.2 19.8 19.2 21.2 17.8 12.1 14.0 18.8 20.9 4.0 13.8 12.5 18.9 21.8 9.1 16.8 22.4 14.2 26.1 16.5 14.0 19.9 15.8 29.4 17.2 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" Q8IWP9 6 138773509-138793319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA055125: " "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favourable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 12.9 30.8 25.4 19.8 28.7 20.9 17.9 22.6 27.9 15.6 17.4 13.3 18.7 18.5 11.5 24.8 12.4 22.6 16.8 11.0 31.4 32.2 36.5 40.5 17.4 19.2 22.2 21.7 14.2 22.2 25.5 19.2 19.3 28.3 16.1 15.4 16.4 31.6 20.8 17.4 11.0 21.3 13.9 16.1 18.3 16.5 15.0 13.4 18.2 33.9 9.3 19.8 19.3 12.5 30.0 29.3 73.5 27.3 30.6 44.5 24.5 3.3 6.2 4.7 8.5 8.9 12.4 9.6 5.7 10.0 7.4 12.3 5.3 6.8 14.7 11.0 5.6 6.0 7.6 7.9 12.2 16.9 17.1 11.9 7.6 10.5 14.0 20.6 12.6 8.0 10.0 5.4 16.0 12.2 12.0 20.7 8.4 7.5 16.8 27.2 4.3 6.4 10.2 4.7 13.6 8.9 5.1 5.8 9.0 7.5 6.8 16.3 3.3 22.8 9.3 5.9 6.8 10.9 8.5 27.7 24.5 10.8 6.3 12.8 5.2 33.2 27.3 33.7 26.0 27.0 23.2 30.0 27.6 28.3 29.3 29.7 32.1 29.5 73.5 30.6 22.9 25.8 44.5 24.5 25.4 28.7 22.6 27.9 31.4 32.2 22.2 21.7 28.3 13.4 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell line enhanced" "Detected in some" "AN3-CA: 6.7;HAP1: 13.7;HDLM-2: 22.5;U-2 OS: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" Nucleoplasm Cytosol "HPA062425: " "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavourable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.5 0.0 1.3 13.7 2.5 0.4 22.5 5.8 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.7 0.3 0.0 0.7 0.0 0.1 0.7 0.1 0.0 3.8 1.1 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 0.0 0.0 0.0 0.0 14.9 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 CCDC36 "CT74, FLJ25320" ENSG00000173421 "Coiled-coil domain containing 36" Q8IYA8 3 49198428-49258104 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.8;hTEC/SVTERT24-B: 13.0;LHCN-M2: 5.4;U-2197: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA045690, HPA069534" Approved Approved Nucleoplasm Nucleoplasm "HPA045690: AB_10964634, HPA069534: " "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 6.5 1.7 0.8 1.8 0.8 0.4 3.6 0.8 0.7 3.7 2.2 0.7 2.1 0.4 6.3 1.2 1.1 1.3 1.4 1.9 0.9 0.4 0.5 0.4 1.4 0.5 1.1 0.1 5.0 0.4 0.2 0.4 1.4 2.0 0.6 0.4 2.6 2.0 0.8 1.6 0.8 0.6 3.9 0.4 0.7 0.6 35.4 0.3 0.0 1.3 0.3 0.6 1.2 0.9 0.9 0.6 3.6 0.3 0.8 0.5 0.2 0.0 0.1 0.1 0.2 2.8 3.0 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.4 0.0 0.2 2.4 0.0 13.0 0.0 1.6 0.0 0.3 5.4 0.0 0.0 0.2 3.4 0.1 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 2.4 7.0 0.1 0.1 0.1 0.1 0.0 0.2 3.6 2.1 0.3 0.6 0.4 0.2 0.3 0.8 0.4 0.3 0.1 0.9 0.4 0.5 3.6 0.8 0.2 0.6 0.3 0.2 0.8 0.8 0.8 0.7 0.9 0.4 1.1 0.1 2.0 0.3 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 17.9 10.2 11.3 14.2 16.3 54.9 18.9 14.9 14.7 17.6 16.9 8.9 7.7 7.5 14.8 17.4 17.0 17.2 11.2 14.5 11.5 12.5 16.0 15.4 12.6 13.7 14.8 12.4 18.8 12.5 2.6 18.2 18.7 13.5 18.7 12.5 6.5 12.7 13.3 23.5 12.7 18.9 14.5 16.5 17.3 12.1 18.4 14.9 15.3 19.9 17.9 18.1 21.4 20.9 18.9 18.6 17.9 14.0 13.1 23.6 6.7 11.4 10.8 9.0 6.4 10.0 8.7 14.0 10.4 12.0 18.3 15.0 21.8 6.5 13.4 5.3 10.3 7.3 40.9 19.8 15.6 14.1 21.8 13.2 6.4 14.4 29.5 17.4 7.6 15.1 16.8 19.3 24.4 15.0 24.9 6.9 11.2 20.7 16.0 23.8 14.2 25.2 12.1 13.4 10.9 9.7 11.4 15.3 7.4 11.9 6.4 15.1 13.8 23.1 7.0 9.1 7.0 6.5 19.0 11.0 12.3 25.7 6.5 13.9 12.3 12.7 9.3 16.8 11.6 9.6 19.8 15.2 18.6 16.9 9.6 18.9 22.1 17.6 17.9 13.1 14.0 18.6 23.6 6.7 11.3 16.3 14.9 14.7 11.5 12.5 14.8 12.4 13.5 14.9 CCDC61 ENSG00000104983 "Coiled-coil domain containing 61" Q9Y6R9 19 45995461-46021318 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040325, HPA061548" Uncertain Approved Nucleoplasm Nucleoplasm "HPA040325: AB_10672970, HPA061548: " "unprognostic (1.30e-1)" "unprognostic (1.51e-3)" "unprognostic (2.56e-1)" "unprognostic (6.23e-3)" "unprognostic (7.27e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" "unprognostic (2.93e-2)" "unprognostic (2.73e-2)" "unprognostic (1.34e-1)" "unprognostic (2.13e-3)" "unprognostic (2.58e-1)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (1.09e-1)" 9.0 10.7 7.8 16.9 8.0 6.3 8.5 10.5 9.3 9.2 12.4 13.1 9.3 9.4 15.2 9.5 9.4 18.3 10.7 7.5 6.0 5.0 10.1 10.6 8.8 11.7 6.6 12.4 12.0 10.2 11.2 12.7 7.3 6.3 11.1 6.0 11.8 10.2 11.3 5.5 15.1 10.2 14.5 6.6 12.6 10.6 22.6 10.1 17.8 13.8 7.0 13.0 11.0 9.4 1.9 0.6 7.8 1.0 0.6 2.0 0.4 8.4 6.2 3.3 5.6 6.2 4.6 5.0 6.1 3.1 3.6 6.2 3.8 7.5 5.3 3.0 4.2 7.2 3.6 8.1 2.7 10.0 3.3 5.6 4.9 6.1 6.9 5.3 7.8 4.9 11.2 3.2 6.6 7.3 6.2 11.0 4.7 2.7 12.2 34.7 1.2 2.7 8.3 1.1 8.6 6.0 7.0 3.6 3.2 6.0 7.9 4.7 3.3 7.7 6.2 2.6 1.1 1.3 6.8 6.7 3.2 5.3 6.0 6.0 4.4 7.8 0.9 0.8 2.0 0.8 1.1 1.4 1.0 1.2 0.4 1.9 1.5 1.2 2.8 0.6 1.0 0.6 1.0 0.4 7.8 8.0 10.5 9.3 6.0 5.0 6.6 12.4 6.3 10.1 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Cell line enhanced" "Detected in some" "U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: " "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 0.9 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.1 0.9 0.8 1.1 0.3 0.2 3.3 0.4 1.9 2.0 0.8 0.3 0.5 0.3 1.5 0.0 0.3 0.9 1.2 0.1 1.6 0.4 0.9 7.6 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Cell line enriched" "Detected in single" 18 "MCF7: 9.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: " "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell line enhanced" "Detected in many" "AF22: 11.9;AN3-CA: 14.2;HSkMC: 13.0;K-562: 12.4;RH-30: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favourable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.1 0.1 11.9 14.2 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.1 4.8 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.6 0.0 0.1 13.0 0.0 3.3 9.9 0.0 12.4 0.0 4.3 0.0 0.0 0.8 8.6 0.0 0.4 16.1 0.0 10.4 0.0 1.9 0.1 0.0 0.0 0.0 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96352769-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 19.4 12.5 22.8 14.6 32.7 12.1 15.3 34.5 29.6 13.6 12.7 18.3 6.7 9.8 18.4 12.2 9.0 14.9 13.9 10.4 23.7 9.0 13.7 17.8 15.7 17.4 31.9 20.3 16.5 13.5 11.7 22.3 14.3 25.6 12.2 11.6 8.1 11.9 13.7 10.8 10.5 15.5 14.1 26.0 16.5 13.6 19.4 35.5 7.5 15.9 6.2 15.8 15.4 16.9 14.3 12.2 28.6 10.8 22.7 19.2 11.0 5.3 8.1 25.1 9.7 16.7 14.3 9.3 21.0 12.9 13.8 20.2 13.3 18.9 11.2 19.8 10.9 12.7 8.9 7.6 20.5 19.1 5.4 22.9 17.4 11.3 12.0 17.9 15.3 8.8 4.1 27.8 10.4 16.4 13.7 12.2 18.5 0.2 15.1 17.5 5.0 5.9 10.4 21.4 9.9 10.5 14.1 4.0 10.7 11.6 1.2 10.3 1.9 8.9 19.0 24.5 13.5 20.4 11.1 4.1 12.5 16.3 7.3 14.1 17.4 28.6 8.3 15.5 16.5 10.2 17.2 14.3 17.6 16.1 8.9 12.1 19.2 18.2 11.6 22.7 10.8 12.2 18.4 11.0 22.8 32.7 34.5 29.6 23.7 9.0 31.9 20.3 25.6 35.5 CCDC84 DLNB14 ENSG00000186166 "Coiled-coil domain containing 84" Q86UT8 11 118998142-119015791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039906, HPA071715" Uncertain Approved Nucleoplasm Nucleoplasm "HPA039906: AB_2676740, HPA071715: " "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (1.54e-1)" "unprognostic (4.06e-2)" "unprognostic (1.15e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-3)" "unprognostic (3.45e-2)" "unprognostic (4.64e-3)" "unprognostic (1.20e-2)" "prognostic unfavourable (2.93e-5)" "unprognostic (8.14e-2)" "unprognostic (8.24e-2)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 9.3 10.7 10.5 11.0 15.3 15.2 12.5 18.9 17.5 9.8 10.6 19.4 12.1 10.7 16.2 16.6 9.3 8.7 10.4 9.4 11.4 9.0 12.6 15.0 13.2 13.6 15.8 11.7 10.0 10.1 14.1 14.1 9.9 16.7 13.7 9.8 18.7 13.0 16.6 16.7 19.1 11.7 12.8 8.7 18.8 10.8 6.8 12.3 7.6 14.0 9.4 15.1 8.5 10.1 5.8 3.8 4.0 2.1 5.5 8.8 2.5 3.6 3.1 2.6 3.6 2.8 0.8 2.7 3.1 3.4 2.7 1.8 17.8 2.2 1.3 10.4 3.5 9.4 1.2 1.6 2.9 4.9 2.0 6.0 5.3 4.9 2.6 2.5 3.3 1.1 1.9 2.8 3.2 1.5 1.2 4.7 2.7 5.5 6.3 4.5 3.5 8.2 8.8 5.4 6.0 4.3 5.0 3.7 2.4 8.1 2.4 0.6 7.4 2.3 1.7 2.8 13.2 3.7 2.1 3.6 3.5 5.5 2.2 4.8 5.0 0.0 2.1 4.0 4.4 1.2 5.2 5.0 5.4 4.7 3.3 5.8 5.0 3.6 3.6 5.5 1.2 3.8 8.8 2.5 10.5 15.3 18.9 17.5 11.4 9.0 15.8 11.7 16.7 12.3 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Cell line enhanced" "Detected in some" "HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favourable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavourable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.5 9.0 1.4 0.5 0.7 0.0 0.2 0.0 9.8 0.0 6.8 1.8 0.5 0.4 4.2 39.8 0.0 0.0 0.1 0.0 0.2 0.2 10.4 0.3 0.4 5.7 3.5 0.3 0.2 5.4 0.1 8.4 0.1 0.1 2.2 0.0 0.0 0.2 0.4 1.2 15.8 0.0 0.0 0.3 0.0 0.1 2.2 0.7 7.3 0.5 11.5 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 23.9;U-266/70: 21.0;U-266/84: 29.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 18.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favourable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favourable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 3.6 0.9 2.7 31.1 18.7 15.0 6.9 0.9 2.3 3.0 8.9 1.8 15.5 9.6 4.7 4.0 8.9 9.7 11.8 2.2 2.0 2.4 5.0 2.6 11.1 34.5 2.0 0.3 2.0 14.8 6.7 4.0 1.8 1.6 6.4 4.7 4.1 12.1 11.7 1.5 4.5 9.6 6.0 2.9 14.5 8.1 4.8 3.7 18.5 2.5 6.0 27.6 7.1 5.3 2.3 1.8 5.2 3.2 3.1 11.0 2.8 3.1 2.9 3.4 3.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 3.0 4.7 13.5 2.5 0.0 0.1 4.8 2.7 0.0 11.4 1.8 3.6 2.0 4.2 0.3 7.0 3.0 0.0 4.0 0.0 0.0 3.7 4.1 17.0 0.0 10.3 7.1 9.3 3.3 4.4 5.9 0.1 4.5 0.8 4.5 23.9 5.3 2.0 6.9 1.6 3.8 6.5 1.1 0.0 0.0 0.0 0.0 21.0 29.5 6.9 0.0 6.4 0.0 5.2 3.2 1.3 9.0 1.8 8.7 2.3 6.1 9.3 1.8 1.9 3.9 5.8 2.6 3.1 2.5 1.5 11.0 2.8 2.7 18.7 0.9 2.3 2.0 2.4 2.0 0.3 1.6 3.7 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85684866-85686277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.6" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040628 Enhanced Approved Nucleoplasm Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.7 0.9 0.9 0.1 1.8 0.0 1.3 6.4 1.3 1.5 0.6 2.0 0.9 0.1 2.8 0.9 0.3 10.5 1.1 1.0 1.2 1.2 1.4 0.3 1.2 0.6 0.9 1.2 5.9 0.2 2.7 5.2 0.7 3.7 1.7 0.7 0.9 0.4 1.9 0.7 0.5 0.5 2.6 1.2 0.4 1.1 40.6 0.9 0.1 0.4 0.2 0.0 0.7 0.7 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.1 3.7 5.0 0.2 1.4 0.0 0.0 0.1 0.2 0.0 0.1 5.4 4.2 1.9 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 2.5 0.0 0.0 2.8 0.1 4.0 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.3 2.8 7.3 1.8 0.0 0.9 0.0 0.6 0.0 0.0 3.7 0.0 8.3 3.4 0.0 3.7 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 6.4 1.3 1.2 1.2 0.9 1.2 3.7 0.9 CCDC91 "DKFZp779L1558, FLJ11088, p56" ENSG00000123106 "Coiled-coil domain containing 91" Q7Z6B0 12 28133249-28581511 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038169 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038169: AB_10672506" "unprognostic (6.25e-2)" "unprognostic (4.25e-2)" "unprognostic (3.67e-2)" "unprognostic (1.91e-2)" "unprognostic (6.71e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (1.05e-4)" "unprognostic (4.98e-2)" "unprognostic (2.44e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (7.69e-4)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "unprognostic (5.85e-2)" "unprognostic (2.38e-1)" 14.3 16.8 16.3 14.5 20.6 9.4 14.6 14.8 22.5 11.3 12.9 10.8 14.4 10.5 16.3 16.6 14.5 11.3 13.4 26.5 16.1 19.8 18.2 13.4 11.3 13.1 18.2 17.1 16.8 22.9 23.3 26.2 10.6 32.3 14.0 11.5 11.5 14.2 15.6 32.7 9.1 11.9 21.2 21.6 13.9 14.8 36.3 15.3 23.3 22.3 9.7 11.6 21.0 16.1 6.5 4.2 16.0 5.4 7.1 8.5 3.6 10.2 7.4 6.8 0.3 7.1 6.6 12.8 8.8 9.3 7.7 9.9 5.1 13.9 5.4 7.6 10.4 11.9 6.3 14.1 11.7 15.7 5.1 17.8 14.2 4.1 11.0 16.9 8.9 6.5 14.2 7.7 22.6 6.1 16.1 18.1 7.3 3.7 16.7 14.5 14.0 7.0 10.3 19.8 9.2 12.5 7.1 5.8 10.5 16.6 5.6 26.4 10.8 13.5 4.6 16.5 11.4 16.2 5.0 22.8 24.7 14.8 14.2 13.9 9.3 16.0 2.4 3.4 5.5 4.6 7.3 6.5 7.1 7.9 3.4 5.5 8.5 7.7 0.8 7.1 5.4 4.2 8.1 3.6 16.3 20.6 14.8 22.5 16.1 19.8 18.2 17.1 32.3 15.3 CCDC92 FLJ22471 ENSG00000119242 "Coiled-coil domain containing 92" Q53HC0 12 123918660-123972831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038560, HPA057580" Approved Supported Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA038560: AB_10672717, HPA057580: " "unprognostic (4.77e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "prognostic favourable (7.15e-4)" "unprognostic (4.82e-2)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (5.01e-2)" "unprognostic (5.69e-2)" "unprognostic (7.14e-2)" "prognostic favourable (4.59e-5)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (3.08e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" 19.3 11.1 35.2 9.4 24.6 3.8 16.3 17.0 34.5 11.4 11.7 16.4 6.0 14.4 11.8 18.6 8.9 12.6 10.6 23.6 33.6 26.5 11.5 11.0 20.1 8.2 27.2 23.0 13.0 11.8 18.3 14.9 17.3 34.2 11.2 7.8 13.6 9.0 12.9 22.3 7.7 14.2 14.2 22.4 9.4 11.1 24.0 13.0 8.0 15.3 4.9 6.6 10.7 12.7 1.7 1.3 4.6 1.3 1.3 3.7 1.8 4.0 4.5 2.3 4.0 15.2 8.4 4.1 6.8 12.9 3.8 4.1 2.4 1.2 1.9 2.4 8.5 2.8 2.5 1.7 2.6 12.6 5.9 2.5 1.6 1.5 8.1 0.4 9.7 4.7 7.8 4.8 3.0 10.6 2.5 0.9 3.4 2.7 2.4 4.4 1.0 10.1 3.1 1.3 0.5 5.2 4.2 4.4 6.3 3.3 1.7 4.6 4.8 2.2 10.5 7.7 1.7 4.9 2.3 3.2 1.7 0.6 6.1 3.4 3.2 4.6 1.3 1.9 2.3 0.7 3.7 1.6 3.0 3.5 1.0 1.7 2.3 2.8 1.2 1.3 0.1 1.3 0.5 1.8 35.2 24.6 17.0 34.5 33.6 26.5 27.2 23.0 34.2 13.0 CCDC94 FLJ10374 ENSG00000105248 "Coiled-coil domain containing 94" Q9BW85 19 4247079-4269090 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043606, HPA055675" Approved Supported Nucleoplasm Nucleoplasm "HPA043606: AB_10963431, HPA055675: AB_2682880" "unprognostic (1.75e-2)" "unprognostic (2.11e-3)" "unprognostic (1.81e-2)" "unprognostic (6.91e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (7.53e-2)" "unprognostic (1.01e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.32e-4)" "prognostic favourable (8.04e-4)" "unprognostic (7.61e-2)" "unprognostic (3.12e-2)" "unprognostic (9.46e-3)" 18.1 14.8 16.1 14.5 17.3 50.5 14.3 22.0 20.3 15.5 16.2 18.4 15.6 17.9 17.2 14.6 16.9 16.8 12.5 12.2 16.2 13.6 18.1 16.7 14.7 20.8 20.4 17.1 23.3 24.7 12.2 10.4 23.2 15.6 15.4 10.9 16.0 19.7 14.5 21.5 19.7 15.2 13.6 17.3 18.7 16.1 16.6 20.0 18.8 20.0 26.3 18.8 14.0 12.5 24.8 19.3 22.6 19.3 16.8 25.0 13.9 17.1 16.7 9.4 7.5 5.6 7.4 9.6 7.0 8.9 13.1 14.5 14.9 10.6 20.1 8.0 10.5 13.1 15.2 16.6 9.2 11.5 15.0 12.9 10.9 17.3 8.3 16.8 18.1 7.9 10.0 11.5 17.1 10.5 18.2 23.4 5.4 23.7 17.7 10.4 22.4 12.8 10.4 7.9 17.8 12.2 17.0 13.6 14.1 6.2 13.6 12.5 9.8 15.8 11.8 9.3 9.8 18.6 17.3 25.5 18.1 19.9 13.0 17.9 9.9 15.2 15.2 22.6 21.2 19.3 18.9 23.3 20.5 19.5 18.5 24.8 24.5 20.2 9.4 16.8 13.8 19.3 25.0 13.9 16.1 17.3 22.0 20.3 16.2 13.6 20.4 17.1 15.6 20.0 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 39.2;WM-115: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 2.8 4.8 3.6 9.4 5.8 1.5 4.5 3.4 6.2 9.4 29.6 6.3 38.1 5.7 11.5 14.1 19.8 5.0 12.3 30.5 5.8 3.2 5.1 2.1 6.8 1.7 6.7 4.7 2.6 12.0 9.7 4.8 2.3 5.7 10.3 7.6 12.9 13.9 40.6 35.0 7.7 8.3 16.2 3.6 2.5 11.0 5.3 6.3 0.3 21.3 16.1 6.1 13.0 7.2 0.5 0.5 6.7 0.6 0.9 0.3 0.4 15.4 2.2 0.0 0.1 0.3 1.5 0.8 4.7 4.7 5.2 5.1 0.1 14.3 0.1 6.6 15.1 39.2 0.0 12.8 4.9 0.0 0.1 4.6 18.3 1.5 2.8 0.0 0.9 1.9 2.9 2.2 6.7 3.7 0.0 0.2 8.9 0.0 0.1 0.0 0.1 4.1 0.0 1.3 0.0 15.8 0.8 0.0 1.1 2.8 6.2 2.7 0.6 0.7 19.7 9.8 15.8 2.6 12.3 0.0 0.0 0.1 11.9 0.8 44.6 6.7 0.6 0.6 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.3 0.2 1.2 0.9 0.2 0.5 0.0 0.4 3.6 5.8 3.4 5.3 5.8 3.2 6.7 4.7 5.7 6.3 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffolding protein" Q9NUG4 20 32010450-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.0" "Cell line enhanced" "Detected in some" "EFO-21: 10.4;HUVEC TERT2: 12.2;NTERA-2: 6.6;RH-30: 4.6;SCLC-21H: 11.3;TIME: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Approved Nucleoplasm Nucleoplasm "HPA008434: AB_1845671, HPA071063: " "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 7.2 1.8 2.1 1.8 2.0 0.2 15.0 2.1 2.2 4.4 1.4 1.7 2.1 1.2 7.1 2.3 1.9 2.6 2.4 5.4 2.0 1.7 3.1 1.0 15.1 1.3 2.3 1.5 1.8 1.0 1.4 1.4 6.7 2.5 1.9 1.2 4.9 1.4 2.0 3.5 1.5 1.6 3.2 1.4 53.0 1.4 1.6 1.6 0.2 3.0 5.2 1.0 2.0 4.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 3.5 0.0 0.0 6.6 0.0 0.8 4.6 0.2 0.0 0.0 11.3 1.3 0.3 0.0 0.0 3.6 0.0 6.2 0.1 2.0 0.0 0.0 0.2 0.0 0.2 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 2.0 2.1 2.2 2.0 1.7 2.3 1.5 2.5 1.6 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442882 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;parathyroid gland: 24.2;testis: 50.4" "Cell line enriched" "Detected in some" 4 "HMC-1: 85.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 20.7;ovarian cancer: 18.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 108 "basophil: 24.5" "Lineage enriched" "Detected in single" 233 "granulocytes: 24.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA060646: , HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.8 7.3 0.4 6.2 1.3 0.6 0.2 4.7 4.0 0.3 1.6 0.0 0.4 2.6 4.7 0.3 11.1 0.6 0.3 4.5 5.9 0.3 0.2 1.0 1.0 1.9 5.5 1.2 0.5 24.2 4.8 0.2 3.1 0.3 0.3 0.1 0.4 0.2 1.3 0.2 0.3 5.1 1.0 0.3 0.4 50.4 0.4 0.2 0.4 0.0 0.5 0.4 0.6 0.1 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 3.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.7 85.1 0.0 8.3 0.1 0.7 0.2 0.0 0.1 0.0 1.0 0.1 16.6 0.5 2.1 0.0 2.0 0.0 0.5 0.0 0.6 1.4 0.0 2.0 0.0 0.0 16.6 1.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 21.0 0.1 24.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 6.2 0.2 4.7 4.5 5.9 1.9 5.5 3.1 0.4 CCNG2 ENSG00000138764 "Cyclin G2" Q16589 4 77157151-77433388 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 16.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 99.1" HPA034684 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA034684: AB_10669894" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (1.46e-2)" "unprognostic (2.29e-1)" "unprognostic (5.73e-2)" "unprognostic (8.15e-2)" "unprognostic (8.40e-3)" "unprognostic (1.72e-2)" "unprognostic (1.20e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (8.57e-4)" "unprognostic (2.04e-1)" "prognostic favourable (2.47e-5)" "unprognostic (7.98e-2)" "unprognostic (2.20e-1)" "unprognostic (2.28e-1)" "unprognostic (1.05e-3)" 18.4 8.1 11.3 13.5 15.1 25.9 26.7 53.0 17.2 15.1 12.3 8.9 9.6 8.6 16.4 10.7 45.2 8.0 10.4 6.3 9.6 5.4 23.0 3.4 12.8 21.4 7.3 10.6 12.5 7.2 8.8 7.7 20.0 7.3 26.1 11.0 12.2 18.4 10.5 7.5 12.8 9.8 13.5 7.4 14.2 7.7 8.0 7.8 25.3 17.3 7.2 22.6 20.3 18.6 4.8 2.2 16.0 2.3 1.6 4.6 0.6 10.2 1.3 23.1 12.2 15.3 19.7 15.7 8.6 24.9 6.7 12.6 1.5 14.9 20.7 14.0 8.0 7.4 6.0 28.5 13.1 14.3 4.0 1.7 6.0 3.0 8.0 3.0 21.6 16.6 14.2 3.1 7.0 10.1 0.9 12.7 12.4 4.0 14.0 6.5 2.3 1.4 8.1 22.5 1.3 42.5 28.5 6.1 19.6 10.2 16.2 6.0 12.0 4.6 9.3 9.2 9.4 6.6 1.4 9.3 7.1 14.6 6.4 4.8 4.6 11.4 1.5 16.0 0.8 2.0 1.9 2.7 1.2 0.8 1.5 4.8 0.9 0.5 6.5 1.6 2.3 2.2 4.6 0.6 11.3 15.1 53.0 17.2 9.6 5.4 7.3 10.6 7.3 7.8 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047158-77076005 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 248.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: , HPA061470: " "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favourable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 49.0 26.6 48.1 47.1 45.8 50.3 121.1 101.3 248.9 66.3 56.8 21.6 36.9 25.6 56.7 69.0 56.2 50.7 45.2 87.7 44.8 34.1 48.2 34.5 64.7 70.1 55.8 33.5 94.9 65.4 36.5 33.1 35.4 46.7 61.4 34.9 32.7 45.5 62.9 64.3 38.5 45.8 61.6 58.1 41.3 42.4 53.0 20.3 55.4 81.2 28.2 60.0 82.7 62.6 49.2 42.9 70.5 39.8 33.6 56.2 24.3 25.1 15.1 49.3 43.1 74.2 67.9 18.9 19.4 47.7 30.8 29.7 18.5 38.3 46.5 29.9 48.7 13.2 33.7 68.1 49.2 33.0 13.2 27.8 17.6 17.6 72.9 47.7 56.3 53.1 81.5 28.4 69.7 43.1 23.8 50.7 43.7 29.0 62.0 45.1 21.6 9.4 38.9 46.6 19.6 45.8 28.8 62.6 34.2 25.8 39.7 31.4 22.5 20.4 29.1 37.8 22.6 40.1 26.5 28.1 12.7 49.1 32.0 33.0 24.4 43.1 32.9 70.5 31.7 33.4 44.9 46.6 52.4 47.2 37.3 49.2 56.2 47.4 47.0 33.6 39.8 42.9 44.8 24.3 48.1 45.8 101.3 248.9 44.8 34.1 55.8 33.5 46.7 20.3 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell line enriched" "Detected in some" 6 "MOLT-4: 23.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: " "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favourable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 23.7 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 1.7 3.6 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 CCNJ "bA690P14.1, FLJ10895" ENSG00000107443 "Cyclin J" Q5T5M9 10 96043394-96060870 "Predicted intracellular proteins" Cyclin "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036531, HPA058151" Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA036531: AB_10696656, HPA058151: " "unprognostic (1.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-2)" "unprognostic (4.37e-2)" "unprognostic (1.14e-1)" "unprognostic (8.61e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (6.65e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-3)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.08e-2)" 7.1 10.5 5.0 8.9 9.2 18.1 7.7 11.4 8.2 6.9 8.6 6.4 9.3 8.1 10.8 8.3 6.7 8.7 8.0 5.3 4.9 5.5 11.4 6.4 8.2 8.2 5.0 3.7 8.7 9.3 11.3 11.0 7.4 6.6 7.1 7.1 9.2 7.6 7.3 7.3 5.3 11.7 7.7 5.0 13.4 7.4 9.9 5.7 16.3 7.2 5.8 8.3 6.8 5.0 1.9 6.9 1.1 4.0 1.2 3.1 2.1 5.0 4.1 25.1 24.9 2.5 2.0 3.6 3.2 3.8 4.9 4.4 10.4 2.2 7.0 3.7 3.1 3.1 16.6 3.5 6.3 3.4 6.7 6.8 3.0 14.7 6.0 6.8 3.3 3.8 4.7 4.5 10.8 11.2 9.9 0.1 2.9 4.9 11.5 7.7 13.9 3.4 13.8 1.1 0.5 5.5 4.8 3.8 13.3 3.7 0.9 6.9 5.8 7.5 5.6 3.1 6.7 3.4 7.5 1.4 0.5 6.5 3.5 12.0 2.0 0.3 4.0 1.1 2.3 3.3 3.1 1.8 2.0 1.2 6.9 1.9 2.9 2.6 0.5 1.2 3.2 1.4 1.5 2.1 5.0 9.2 11.4 8.2 4.9 5.5 5.0 3.7 6.6 5.7 CCNQ FAM58A ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587919-153600045 "Disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA050137: , HPA059843: " "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 3.1 5.7 4.2 6.1 12.8 4.2 9.7 3.7 11.1 4.5 5.2 6.4 4.2 6.1 3.7 10.5 5.1 5.1 4.0 14.7 7.9 6.5 6.3 5.0 10.9 9.5 6.1 4.1 9.5 3.0 6.4 6.4 7.3 5.7 6.1 3.5 8.0 6.8 10.3 4.0 5.0 4.9 6.7 7.3 5.4 2.7 7.4 3.9 4.9 4.2 8.7 5.2 4.5 7.4 1.9 6.8 2.3 1.1 4.8 1.4 19.9 15.6 6.0 21.4 11.1 5.7 9.5 12.0 10.5 11.5 11.8 14.9 7.1 16.2 23.3 12.8 12.9 19.9 11.4 11.9 9.9 20.2 3.9 9.4 11.4 9.8 13.6 9.4 7.5 10.3 7.8 8.6 9.7 4.8 7.8 9.8 23.2 9.6 16.7 7.6 26.3 10.9 9.7 8.4 8.7 8.6 8.0 10.5 6.2 9.8 14.1 3.6 12.5 7.0 10.2 14.3 22.4 18.2 11.3 10.7 20.5 9.1 21.3 7.5 0.0 2.3 6.8 4.0 2.1 1.8 7.4 3.7 2.8 1.9 6.2 4.0 2.8 1.4 1.1 1.0 1.9 4.8 1.4 CCNT2 ENSG00000082258 "Cyclin T2" O60583 2 134918235-134959342 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005559 Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA005559: AB_1078608" "unprognostic (2.49e-2)" "unprognostic (1.19e-1)" "unprognostic (9.57e-2)" "unprognostic (1.25e-1)" "unprognostic (4.92e-2)" "unprognostic (2.65e-3)" "unprognostic (1.85e-2)" "unprognostic (1.00e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.44e-4)" "prognostic unfavourable (1.25e-5)" "unprognostic (2.33e-1)" "unprognostic (8.51e-2)" "unprognostic (9.94e-2)" "prognostic favourable (3.28e-4)" 15.8 14.1 21.0 15.2 19.9 32.5 21.1 30.5 22.2 16.4 14.2 16.9 17.8 17.6 22.6 20.9 15.4 16.1 12.9 14.2 16.1 14.3 12.9 20.8 17.5 18.9 18.6 16.2 22.8 24.0 25.1 29.6 17.9 20.0 18.0 16.7 11.5 16.9 19.4 14.5 20.3 17.2 18.0 17.1 19.8 18.9 15.8 19.1 23.0 18.7 9.4 18.2 18.9 19.5 3.8 4.9 6.9 4.5 6.2 8.4 3.4 6.8 3.4 22.3 8.3 11.1 11.3 17.0 9.4 7.8 8.9 11.2 9.1 7.9 11.2 7.1 7.7 8.9 13.3 7.1 13.1 6.0 9.0 12.0 8.7 12.9 10.8 10.8 10.7 10.3 14.1 8.8 10.9 13.1 10.0 11.5 10.3 4.6 11.9 16.2 18.1 7.1 11.6 8.0 8.9 13.9 18.9 15.3 12.6 6.9 8.1 10.7 8.5 13.2 11.9 11.6 12.8 4.9 6.9 8.1 5.0 11.7 7.2 8.6 9.8 6.9 3.7 4.5 4.3 4.5 5.3 3.8 4.8 5.1 4.9 3.1 8.4 6.4 4.8 6.2 2.3 4.5 5.9 3.4 21.0 19.9 30.5 22.2 16.1 14.3 18.6 16.2 20.0 19.1 CCSER2 "FAM190B, KIAA1128" ENSG00000107771 "Coiled-coil serine rich protein 2" Q9H7U1 10 84328558-84518521 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037481, HPA037482" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037481: AB_10672385, HPA037482: AB_10671501" "unprognostic (4.06e-3)" "unprognostic (4.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.71e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-1)" "unprognostic (5.60e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-1)" "unprognostic (3.02e-2)" "unprognostic (1.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.83e-2)" "unprognostic (8.56e-2)" "unprognostic (1.33e-1)" "unprognostic (5.74e-2)" 14.9 8.7 18.5 7.9 18.2 7.3 16.7 22.1 21.8 16.4 18.3 17.9 11.4 9.4 15.7 13.1 22.7 9.2 10.3 42.9 19.6 18.2 9.9 10.5 13.3 9.0 21.7 15.9 11.8 9.9 11.8 8.8 15.3 28.3 12.6 10.4 9.4 10.3 13.5 46.2 13.0 15.5 24.2 22.2 8.2 10.6 45.7 15.2 11.8 19.9 14.6 9.1 17.1 11.9 5.2 4.4 5.2 3.0 14.6 15.0 5.4 8.0 6.2 7.4 16.4 11.0 17.9 5.3 9.7 16.1 6.0 11.8 3.5 8.6 5.3 6.3 17.9 6.9 5.5 6.2 9.1 17.7 3.4 1.9 3.0 4.3 10.1 2.8 4.1 8.7 8.9 9.8 31.5 16.5 2.5 16.4 10.9 5.0 4.9 2.0 3.2 5.0 5.0 3.8 1.9 5.4 8.5 2.3 4.1 5.3 3.5 16.6 6.5 1.4 14.7 18.2 8.3 8.9 10.2 16.6 5.5 4.3 11.7 3.7 7.8 2.7 3.0 5.2 14.9 2.8 15.0 5.2 11.1 13.7 2.9 5.0 10.0 10.5 4.2 14.6 2.2 4.4 6.7 5.4 18.5 18.2 22.1 21.8 19.6 18.2 21.7 15.9 28.3 15.2 CCT4 Cctd ENSG00000115484 "Chaperonin containing TCP1 subunit 4" P50991 2 61868089-61888804 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029349 Supported Supported Nucleoplasm,Cytosol 3400000 Cytosol Nucleoplasm "HPA029349: AB_10600800" "prognostic unfavourable (2.03e-4)" "unprognostic (2.80e-2)" "unprognostic (6.46e-2)" "unprognostic (1.74e-3)" "unprognostic (5.03e-2)" "unprognostic (1.40e-2)" "prognostic unfavourable (9.37e-12)" "unprognostic (1.28e-3)" "unprognostic (2.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-2)" "unprognostic (5.18e-2)" "unprognostic (2.00e-1)" "unprognostic (3.96e-1)" "unprognostic (2.14e-2)" 35.1 42.3 34.8 33.3 38.7 32.4 63.3 41.2 40.6 37.7 36.2 26.0 34.4 26.7 43.1 32.6 47.9 44.6 25.3 49.0 31.4 33.7 43.1 37.6 28.7 54.1 42.1 33.9 66.4 65.9 39.7 32.8 37.7 40.0 37.6 35.4 21.5 32.1 35.9 52.5 37.5 28.1 42.5 39.7 36.2 38.1 49.4 37.7 55.6 50.0 40.8 50.9 39.3 93.4 30.3 31.4 13.7 29.8 31.6 39.1 34.6 41.7 48.7 32.6 30.1 27.1 41.3 54.7 38.2 27.4 55.3 37.1 84.8 30.4 67.3 38.9 27.3 30.2 63.8 49.0 58.4 33.0 62.7 43.0 25.2 53.2 24.4 52.8 28.8 35.0 34.2 44.5 46.3 46.1 61.0 21.8 47.0 37.5 45.5 72.6 58.5 43.5 51.7 50.9 45.5 38.4 28.8 28.4 23.9 27.7 35.4 49.3 25.6 39.1 28.9 30.7 44.7 22.8 61.9 33.3 44.5 114.2 30.4 61.1 40.2 13.7 19.0 7.5 27.8 27.2 35.7 30.3 29.6 33.3 31.4 27.5 39.1 38.0 2.7 31.6 29.8 20.3 30.7 34.6 34.8 38.7 41.2 40.6 31.4 33.7 42.1 33.9 40.0 37.7 CCT8 "C21orf112, Cctq, PRED71" ENSG00000156261 "Chaperonin containing TCP1 subunit 8" P50990 21 29055805-29073797 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018520, HPA021051, HPA029426" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" 2700000 "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (1.25e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.56e-5)" "unprognostic (8.78e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" "unprognostic (1.02e-2)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (8.26e-2)" "unprognostic (3.50e-2)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" 33.5 62.5 28.9 36.1 43.8 28.2 39.7 47.9 46.4 34.5 33.7 15.7 41.9 29.6 37.4 36.4 47.6 33.6 23.6 43.9 33.0 36.0 43.6 42.1 33.2 48.8 28.8 39.2 39.3 47.2 35.4 42.6 41.0 39.6 30.9 38.3 17.0 34.7 38.6 68.4 35.5 30.1 38.3 29.5 39.8 35.2 30.2 30.2 66.6 36.1 52.0 57.6 38.5 47.8 25.6 41.7 17.5 38.1 22.8 27.2 33.9 49.0 27.9 35.7 25.7 26.4 36.4 39.8 39.4 25.1 44.7 37.4 59.1 30.4 97.1 26.5 27.2 19.9 73.6 45.5 50.9 41.0 38.3 134.3 33.6 26.4 27.4 66.3 37.6 27.7 28.1 52.6 43.8 42.7 103.5 56.8 45.6 25.5 49.9 26.0 64.3 34.8 44.9 70.3 60.3 45.7 25.8 35.8 25.8 38.6 40.8 33.8 36.5 58.1 30.8 25.4 71.9 23.9 49.0 36.9 71.3 76.5 29.8 75.5 38.8 17.5 33.7 16.7 18.5 36.9 25.5 25.6 24.0 24.3 41.7 19.2 27.2 24.5 3.7 22.8 38.1 24.6 26.6 33.9 28.9 43.8 47.9 46.4 33.0 36.0 28.8 39.2 39.6 30.2 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 8.8 0.1 4.7 5.2 0.0 0.0 6.5 0.2 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.5 4.3 6.8 0.0 0.0 5.4 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell line enhanced" "Detected in some" "ASC diff: 66.6;ASC TERT1: 65.7;BJ hTERT+: 43.3;fHDF/TERT166: 58.0;HSkMC: 70.0;U-2197: 104.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" 27000000 "Plasma membrane" Nucleoplasm "HPA051856: " "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavourable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 66.6 65.7 0.0 28.8 43.3 2.1 2.0 0.0 0.0 0.0 0.7 58.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.2 0.0 0.0 70.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Cell line enhanced" "Detected in some" "HEL: 27.9;HL-60: 37.1;HMC-1: 27.8;NB-4: 17.7;RPMI-8226: 20.0;THP-1: 21.8;U-937: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "CAB011442, HPA035832, HPA064807" Approved Supported "Nucleoplasm,Plasma membrane" 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: , HPA064807: " "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.0 37.1 27.8 0.0 0.0 0.0 0.0 0.0 5.1 7.0 0.0 0.0 0.0 17.7 0.0 8.5 0.0 1.4 20.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.2 4.8 0.4 0.6 0.0 0.1 2.4 0.0 3.2 27.4 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 CD34 ENSG00000174059 "CD34 molecule" P28906 1 207880972-207911402 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 31.8;MOLT-4: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000018, HPA036722, HPA036723" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" 69000000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB000018: AB_2063006, HPA036722: , HPA036723: " "unprognostic (3.82e-1)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (5.93e-5)" "unprognostic (1.25e-2)" "unprognostic (7.74e-2)" "unprognostic (7.65e-2)" "unprognostic (3.53e-1)" "unprognostic (1.37e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (8.47e-4)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (1.60e-1)" "unprognostic (1.01e-2)" 61.9 8.8 4.6 12.8 7.6 1.9 37.5 3.1 6.7 38.3 15.9 5.2 20.5 5.0 41.4 40.3 33.8 22.3 20.6 51.2 5.4 4.9 18.8 2.2 25.0 11.9 8.1 6.7 20.7 8.6 7.8 3.6 78.9 6.3 21.0 7.4 12.8 12.4 20.5 39.7 21.2 12.1 42.3 4.7 9.2 11.3 23.1 4.7 3.5 25.8 35.9 11.0 33.6 33.1 0.6 1.7 1.6 0.3 0.6 0.5 1.5 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 1.1 0.3 0.9 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 31.8 0.0 0.0 0.8 0.0 31.4 0.1 0.2 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 4.8 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.2 0.3 0.5 0.2 0.5 0.3 0.3 0.2 0.2 0.6 0.3 0.3 1.1 0.6 0.3 1.7 0.2 1.5 4.6 7.6 3.1 6.7 5.4 4.9 8.1 6.7 6.3 4.7 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell line enhanced" "Detected in some" "Daudi: 12.4;Karpas-707: 8.0;REH: 5.2;U-698: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in all" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: " "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.8 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.4 0.0 0.2 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.0 0.0 8.0 0.7 0.0 0.2 1.6 0.1 0.1 5.2 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.0 0.1 0.2 27.7 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20588948-20618908 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.5;bone marrow: 68.0" "Cell line enhanced" "Detected in many" "A-431: 41.9;CAPAN-2: 28.0;HeLa: 39.7;PC-3: 20.0;SiHa: 49.8;U-937: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 126.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 126.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA064202 Enhanced Approved Nucleoplasm 3700000 Nucleoplasm "HPA064202: " "unprognostic (2.38e-1)" "prognostic unfavourable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavourable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 4.0 1.4 1.5 4.0 1.5 68.0 2.2 1.1 2.4 19.0 8.6 1.7 2.0 2.6 6.7 3.5 38.3 2.9 1.8 5.9 1.7 1.6 12.5 42.1 8.4 9.1 2.0 1.3 2.9 0.8 1.2 0.7 30.8 3.5 4.2 10.2 4.5 6.9 1.5 3.2 7.0 24.7 4.3 1.9 11.8 1.2 2.9 0.9 0.9 3.0 23.3 10.5 3.1 16.5 0.0 1.3 126.5 21.7 0.0 0.1 7.1 41.9 4.1 0.0 0.0 0.0 1.2 0.0 3.2 0.8 0.8 3.3 0.2 28.0 0.0 1.6 6.7 14.7 0.8 11.0 2.2 0.0 0.8 0.0 39.7 5.3 0.3 0.0 0.0 1.8 1.8 7.9 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 20.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 49.8 0.0 0.0 0.0 1.2 0.7 0.0 1.7 3.8 0.2 0.0 0.0 0.0 0.5 17.6 0.0 16.3 21.7 43.3 0.0 11.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 126.5 0.0 9.3 0.2 0.0 7.1 1.5 1.5 1.1 2.4 1.7 1.6 2.0 1.3 3.5 0.9 CDADC1 NYD-SP15 ENSG00000102543 "Cytidine and dCMP deaminase domain containing 1" Q9BWV3 13 49247925-49293485 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047615, HPA058314" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047615: , HPA058314: " "unprognostic (2.81e-1)" "unprognostic (2.64e-1)" "unprognostic (2.20e-1)" "unprognostic (2.86e-1)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-3)" "prognostic favourable (6.03e-4)" "unprognostic (7.68e-2)" "unprognostic (6.06e-2)" "unprognostic (2.35e-3)" "unprognostic (1.89e-1)" "prognostic favourable (1.19e-5)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (5.40e-2)" "unprognostic (8.27e-3)" 9.3 13.8 11.6 6.5 10.4 11.0 8.6 14.1 12.9 8.4 8.6 7.1 8.4 6.3 9.7 12.5 6.7 7.6 6.7 8.5 9.5 9.7 18.6 15.4 7.0 5.7 9.8 11.2 9.5 5.6 8.8 12.5 4.3 10.7 8.2 6.7 7.6 6.8 9.5 7.9 4.7 6.0 8.4 14.2 8.7 8.0 23.5 8.8 5.5 18.5 7.2 5.2 6.5 7.4 1.0 1.3 10.3 2.7 1.8 3.3 1.4 2.5 3.2 2.8 3.4 13.8 7.6 1.4 6.1 3.8 3.1 3.3 3.2 2.1 3.5 1.3 2.7 4.4 5.6 2.7 4.0 7.5 4.5 4.0 3.0 3.2 6.1 7.4 2.1 5.2 6.8 2.9 3.7 4.5 2.5 2.6 3.9 0.9 7.0 6.1 1.0 2.7 4.7 3.0 3.4 4.5 0.8 1.6 1.4 4.1 2.7 3.5 1.9 6.5 3.4 1.7 3.1 4.3 2.8 0.8 2.8 2.2 1.4 8.6 4.6 10.3 1.9 1.5 2.4 1.5 2.6 0.7 1.8 3.3 1.3 1.0 1.6 2.3 2.0 1.8 2.7 1.3 2.5 1.4 11.6 10.4 14.1 12.9 9.5 9.7 9.8 11.2 10.7 8.8 CDC123 "C10orf7, D123" ENSG00000151465 "Cell division cycle 123" O75794 10 12195965-12250589 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037830, HPA057540" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA037830: AB_10671368, HPA057540: " "unprognostic (5.35e-3)" "unprognostic (9.06e-2)" "unprognostic (2.42e-1)" "unprognostic (5.09e-3)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "prognostic unfavourable (3.16e-7)" "unprognostic (2.63e-1)" "unprognostic (2.22e-1)" "unprognostic (3.20e-2)" "unprognostic (2.74e-2)" "unprognostic (8.54e-2)" "prognostic unfavourable (2.42e-6)" "unprognostic (5.35e-2)" "unprognostic (1.40e-1)" "unprognostic (3.88e-2)" "unprognostic (6.19e-2)" 26.1 28.0 30.8 28.8 50.8 35.7 25.5 24.6 35.0 25.8 32.0 24.2 16.3 21.5 26.1 27.2 34.1 25.3 18.4 36.5 28.5 25.1 33.2 45.1 21.5 34.7 25.9 27.6 19.5 26.0 18.4 26.9 28.8 36.6 20.7 31.8 16.1 22.4 22.9 29.2 29.8 24.7 30.2 24.9 36.2 21.8 22.5 24.6 39.0 24.4 20.5 41.9 29.2 23.4 43.7 40.7 66.4 34.0 32.3 38.8 40.6 32.0 43.0 30.7 37.2 29.5 29.2 25.2 27.9 19.4 40.3 43.4 59.4 41.1 55.4 29.4 35.2 36.2 55.8 51.1 33.7 38.8 43.9 43.2 34.7 54.4 36.4 33.7 37.5 31.1 26.6 50.9 30.2 44.0 44.5 26.7 35.1 29.7 43.0 28.3 54.0 16.1 44.7 25.7 49.2 36.9 18.7 15.8 31.2 29.8 38.8 34.6 40.5 38.0 47.2 24.8 30.5 37.8 35.2 26.2 48.1 67.9 31.1 32.2 16.1 28.6 28.7 66.4 31.4 32.4 32.4 43.7 35.3 34.6 40.7 42.1 29.0 30.9 64.6 32.3 34.0 33.2 38.8 40.6 30.8 50.8 24.6 35.0 28.5 25.1 25.9 27.6 36.6 24.6 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188402 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005855 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA005855: AB_1846364" "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.8 1.2 1.1 5.5 1.1 13.0 0.8 0.7 1.2 1.1 3.3 0.6 1.0 1.8 0.6 0.9 3.9 0.4 2.2 0.7 1.3 2.4 1.2 0.9 0.7 4.1 1.4 0.2 2.1 3.6 0.4 2.3 4.2 1.2 1.0 4.0 1.5 1.8 0.5 0.7 0.8 2.1 0.8 0.7 3.6 1.3 19.4 0.2 23.0 1.6 8.8 7.4 0.8 1.3 1.7 0.9 0.5 0.1 0.0 1.0 0.1 7.5 3.7 17.8 9.6 0.6 1.2 12.3 10.5 4.0 13.2 10.7 16.1 3.9 22.4 4.1 2.7 5.7 30.5 7.2 13.9 7.3 16.0 28.7 6.8 7.9 0.6 20.2 8.3 0.6 1.1 16.4 7.1 5.0 22.8 11.9 7.1 4.0 25.2 15.7 26.0 8.5 11.3 11.7 12.2 3.3 7.1 8.4 10.4 6.5 7.6 3.3 4.0 14.3 2.5 6.5 10.0 7.2 14.2 6.0 17.9 35.2 4.8 22.5 5.4 0.0 0.0 0.5 0.4 0.0 0.0 1.7 0.6 0.2 0.9 0.0 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.1 1.1 1.1 0.7 1.2 1.3 2.4 1.4 0.2 1.2 0.2 CDC26 "ANAPC12, APC12, C9orf17" ENSG00000176386 "Cell division cycle 26" Q8NHZ8 9 113255835-113275589 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044130 Approved Approved Nucleoplasm Nucleoplasm "HPA044130: AB_10963690" "unprognostic (9.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.47e-2)" "unprognostic (2.60e-1)" "unprognostic (1.48e-1)" "unprognostic (2.59e-2)" "prognostic unfavourable (1.72e-4)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (7.27e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (7.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.27e-1)" "unprognostic (6.26e-2)" "unprognostic (3.79e-2)" 24.2 21.8 19.1 21.0 25.3 15.8 27.4 20.8 19.8 24.2 27.4 18.0 30.9 19.7 20.1 29.4 22.2 18.6 16.6 37.5 18.1 15.9 27.6 34.9 21.7 24.7 24.9 15.2 23.2 24.2 27.4 23.3 26.7 20.7 23.4 23.2 15.6 31.7 24.6 28.1 21.7 37.1 36.3 29.1 27.7 21.8 13.3 25.7 22.7 34.5 20.1 29.7 31.5 44.6 54.8 30.1 65.2 30.3 44.9 68.5 38.2 16.0 26.2 23.0 11.6 39.5 34.0 10.5 23.4 36.8 25.2 24.9 27.5 19.5 29.9 20.9 20.9 31.7 19.4 35.8 25.1 27.1 14.1 19.6 26.4 25.5 19.3 34.4 19.8 23.5 25.1 23.2 34.0 33.6 29.3 22.5 18.9 33.0 29.2 22.2 37.9 23.4 25.7 49.3 14.7 26.3 28.1 17.7 16.9 31.5 22.8 17.5 20.8 14.9 22.1 15.1 14.0 22.3 30.2 15.2 26.1 23.6 21.2 20.4 14.7 48.1 30.0 65.2 46.7 30.3 57.2 54.8 59.4 51.5 30.1 45.3 68.5 53.1 46.0 44.9 28.0 25.5 56.7 38.2 19.1 25.3 20.8 19.8 18.1 15.9 24.9 15.2 20.7 25.7 CDH24 CDH11L ENSG00000139880 "Cadherin 24" Q86UP0 14 23047062-23057538 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065233 Approved "Nucleoplasm,Cell Junctions,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite" "Cell Junctions, Cytosol" "HPA065233: " "unprognostic (2.30e-1)" "unprognostic (3.06e-2)" "unprognostic (4.15e-3)" "unprognostic (6.21e-2)" "unprognostic (1.27e-1)" "unprognostic (9.18e-2)" "unprognostic (6.68e-3)" "unprognostic (2.71e-2)" "unprognostic (5.97e-3)" "unprognostic (3.55e-1)" "unprognostic (4.18e-2)" "unprognostic (5.97e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.37e-2)" "unprognostic (8.85e-2)" 5.8 4.7 8.0 4.3 9.3 2.9 5.0 13.0 12.6 6.2 4.5 4.0 6.1 3.0 13.4 3.2 5.8 5.8 10.1 3.8 10.5 5.1 4.6 1.1 4.7 3.4 4.4 4.8 3.8 3.5 8.3 3.1 5.7 5.3 4.6 4.5 7.9 4.7 4.5 1.8 7.2 5.0 10.2 4.0 5.2 4.1 3.4 6.6 7.8 6.8 3.8 4.1 7.3 6.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.5 2.5 10.6 12.0 2.6 1.3 5.9 4.8 3.1 4.0 5.2 3.2 3.5 0.2 3.9 5.2 14.6 4.5 4.0 3.3 3.9 3.8 0.5 6.5 1.0 2.9 7.3 0.2 10.2 1.3 4.4 2.9 6.6 1.5 6.3 3.5 7.2 0.5 4.9 2.6 5.9 12.7 3.5 4.7 1.1 2.1 30.8 8.2 11.2 6.0 0.6 5.3 1.0 6.1 4.0 15.5 1.6 3.5 2.0 0.6 0.1 4.2 2.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 9.3 13.0 12.6 10.5 5.1 4.4 4.8 5.3 6.6 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 111.2;TIME: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavourable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.6 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 111.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 95.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 CDIPT "PIS, PIS1" ENSG00000103502 "CDP-diacylglycerol--inositol 3-phosphatidyltransferase" O14735 16 29858357-29863736 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056597 Approved Approved "Nucleoplasm,Nuclear membrane,Plasma membrane" "Nucleoplasm, Nuclear membrane, Plasma membrane" "HPA056597: " "unprognostic (7.81e-2)" "prognostic favourable (9.40e-4)" "unprognostic (1.93e-3)" "unprognostic (8.08e-3)" "unprognostic (1.50e-2)" "unprognostic (2.84e-2)" "unprognostic (7.60e-2)" "unprognostic (1.09e-2)" "unprognostic (7.03e-2)" "unprognostic (8.75e-2)" "unprognostic (5.56e-3)" "unprognostic (1.61e-1)" "unprognostic (6.17e-2)" "unprognostic (3.36e-2)" "unprognostic (6.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.48e-1)" 40.4 40.8 24.3 20.2 28.1 15.3 42.9 50.7 39.5 37.1 37.2 21.5 33.9 24.8 33.4 23.0 39.4 30.1 34.5 44.4 23.1 27.9 34.8 66.3 27.1 22.4 24.1 26.4 52.7 40.0 47.1 24.9 43.7 21.8 36.8 16.1 29.3 42.2 38.8 21.0 29.6 32.6 31.8 21.0 25.6 29.5 20.2 16.4 30.4 47.1 19.9 17.3 41.8 42.8 4.8 6.1 20.6 6.5 8.2 8.4 2.7 12.3 26.8 7.5 15.1 41.3 28.6 22.4 21.7 24.3 15.4 15.4 15.6 23.8 8.3 41.1 25.0 19.5 12.2 14.0 7.1 20.7 24.5 5.9 20.0 22.8 28.8 8.8 15.4 48.3 24.8 20.7 9.5 19.3 8.8 21.5 13.9 39.4 11.9 17.4 18.0 20.0 23.3 9.4 24.1 20.3 11.9 31.2 17.5 11.5 24.5 17.1 18.3 23.9 16.7 22.9 7.2 18.6 11.1 16.0 18.1 5.9 25.0 14.2 13.8 7.5 6.5 20.6 6.9 4.6 4.6 4.7 6.4 7.3 3.0 4.8 6.3 5.9 16.4 8.2 5.7 6.1 8.4 2.7 24.3 28.1 50.7 39.5 23.1 27.9 24.1 26.4 21.8 16.4 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.2;ovary: 9.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HBF TERT88: 18.2;HMC-1: 34.4;LHCN-M2: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "basophil: 3.5;eosinophil: 6.9" "Lineage enriched" "Detected in single" 69 "granulocytes: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 1.3 0.2 0.1 5.2 0.1 0.0 3.7 0.3 0.1 3.4 2.3 0.1 0.1 0.3 4.1 20.2 1.1 1.0 4.2 0.3 0.1 0.0 0.4 0.1 3.3 0.1 0.1 0.1 9.8 0.2 0.0 0.5 0.1 0.1 2.0 0.7 1.4 0.6 0.3 0.7 1.1 3.0 3.9 0.1 0.1 1.1 2.5 0.1 0.1 0.2 1.2 1.2 1.6 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.7 0.0 3.1 14.6 5.5 11.9 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.2 0.0 34.4 2.0 0.0 1.5 0.7 0.0 0.0 0.0 10.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CDK17 "PCTAIRE2, PCTK2" ENSG00000059758 "Cyclin dependent kinase 17" Q00537 12 96278261-96400560 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 43.7;TIME: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015325 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015325: AB_1855090" "unprognostic (4.35e-1)" "unprognostic (2.79e-1)" "unprognostic (2.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.50e-1)" "unprognostic (4.96e-3)" "unprognostic (5.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.23e-2)" "unprognostic (2.75e-2)" "unprognostic (2.44e-1)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.09e-6)" "unprognostic (4.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.92e-2)" "unprognostic (1.70e-2)" 16.3 9.1 20.6 13.9 47.0 31.5 14.7 17.8 35.7 11.8 12.9 23.6 3.4 9.2 20.7 7.5 11.7 10.9 12.9 9.4 25.3 17.3 9.2 12.4 15.9 15.2 23.8 21.0 12.9 8.0 9.9 7.3 24.3 14.8 11.4 9.8 5.7 7.5 9.3 7.3 9.1 9.3 23.4 19.6 15.8 7.9 19.9 28.0 29.6 9.4 6.1 16.6 11.0 10.7 9.6 5.3 29.1 4.7 16.5 14.8 8.6 4.8 4.1 10.8 2.9 5.3 14.0 7.7 10.9 15.4 9.6 9.1 2.4 2.8 7.2 7.6 7.9 4.4 6.4 6.7 13.2 7.6 4.9 10.4 2.8 3.4 11.5 5.5 6.0 10.2 7.0 14.2 25.7 43.7 7.6 5.9 21.7 3.0 5.2 8.7 4.7 7.2 9.1 5.8 6.2 11.4 4.1 5.6 3.8 6.4 6.0 7.9 4.6 5.0 52.4 8.6 3.3 4.6 5.9 8.3 6.3 7.8 3.2 2.4 6.3 29.1 3.4 8.9 12.7 4.7 13.7 9.6 10.4 14.4 5.3 8.8 14.8 12.6 12.8 16.5 4.6 3.9 8.1 8.6 20.6 47.0 17.8 24.6 25.3 17.3 23.8 21.0 14.8 28.0 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007053 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA007053: AB_1846369" "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavourable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 5.3 3.3 18.1 6.1 29.4 9.7 6.0 13.8 21.3 6.6 6.3 31.1 2.4 4.8 9.6 3.7 7.8 5.3 7.8 4.1 20.8 10.1 6.3 4.6 6.2 8.0 22.1 12.9 9.7 3.1 8.0 4.1 10.5 14.4 25.8 6.1 3.4 4.5 5.9 3.2 7.9 5.9 7.1 20.8 7.0 6.5 16.4 26.3 6.1 5.8 1.3 8.4 5.9 6.4 1.3 1.8 8.5 2.2 1.3 0.8 0.6 3.6 3.8 13.4 16.2 7.3 10.5 7.0 11.6 12.4 4.4 5.8 4.8 4.0 9.1 4.2 8.2 2.1 5.1 2.5 10.1 11.3 3.0 15.6 5.7 5.6 4.4 6.3 11.7 7.2 5.5 6.0 9.3 4.3 4.7 12.8 9.4 5.8 8.4 9.4 1.3 2.6 9.1 6.9 3.5 5.1 6.6 6.9 12.8 8.9 7.2 10.4 2.4 23.2 4.8 9.2 4.9 18.6 7.1 1.4 1.8 7.9 9.7 8.5 9.5 3.3 2.2 1.5 0.8 1.2 0.8 1.1 0.7 0.7 1.8 1.3 0.5 0.7 8.5 1.3 0.7 0.9 0.8 0.6 18.1 29.4 13.8 21.3 20.8 10.1 22.1 12.9 14.4 26.3 CDK2AP2 "DOC-1R, p14" ENSG00000167797 "Cyclin dependent kinase 2 associated protein 2" O75956 11 67506497-67508649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047599 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047599: AB_10963069" "unprognostic (2.44e-1)" "unprognostic (5.01e-2)" "unprognostic (1.42e-1)" "prognostic favourable (8.80e-4)" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (8.85e-3)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (3.85e-3)" "unprognostic (4.91e-3)" "unprognostic (2.06e-1)" "prognostic unfavourable (5.20e-4)" "unprognostic (7.58e-2)" "unprognostic (3.11e-1)" "unprognostic (6.96e-2)" "unprognostic (1.73e-3)" 16.2 28.0 16.8 20.4 22.4 17.0 26.2 13.5 15.6 20.5 22.4 13.1 32.3 23.4 16.6 44.8 17.8 16.6 18.6 28.6 16.2 14.8 43.3 45.5 19.6 23.8 21.9 9.2 12.3 41.6 9.0 18.1 19.5 21.3 16.0 14.4 8.1 55.1 24.9 9.6 10.1 20.0 13.8 21.1 19.0 19.7 6.8 21.4 28.3 80.3 10.6 22.9 17.4 35.8 25.9 91.6 27.8 30.0 32.5 37.6 23.3 17.0 11.1 6.0 10.5 8.1 2.5 9.5 6.5 3.2 7.7 7.2 14.0 19.9 12.6 22.3 4.3 12.2 8.8 11.7 2.2 23.8 8.1 6.8 8.5 9.7 18.6 6.6 10.5 3.0 12.7 5.9 13.6 8.5 7.1 26.8 4.0 26.4 33.1 22.5 5.4 18.6 15.1 3.5 40.7 18.2 4.2 4.5 10.4 8.1 16.5 26.6 11.8 13.0 7.1 4.9 9.0 12.2 4.8 11.3 6.8 10.8 14.6 8.7 5.6 23.9 17.2 27.8 37.6 27.0 32.5 25.9 29.1 34.0 23.0 24.0 17.1 24.6 11.3 32.5 30.0 91.6 32.6 23.3 16.8 22.4 13.5 15.6 16.2 14.8 21.9 9.2 21.3 21.4 CDK8 K35 ENSG00000132964 "Cyclin dependent kinase 8" P49336 13 26254104-26405238 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044721 Approved Nucleoplasm Nucleoplasm "HPA044721: " "unprognostic (3.28e-3)" "unprognostic (2.25e-3)" "unprognostic (2.08e-1)" "unprognostic (3.88e-3)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (5.00e-2)" "unprognostic (8.57e-2)" "unprognostic (2.52e-1)" "unprognostic (3.18e-3)" "unprognostic (2.12e-1)" "prognostic favourable (9.23e-4)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (6.37e-2)" 7.6 8.8 10.1 10.4 8.5 5.2 5.6 26.9 11.3 5.9 24.0 6.0 13.8 13.8 11.2 6.5 10.0 7.0 11.2 7.6 8.3 7.3 9.4 10.4 6.7 5.2 7.8 7.9 6.1 12.7 8.4 10.2 10.6 8.2 7.8 11.2 4.6 9.0 19.2 9.7 6.1 15.0 12.7 6.0 6.4 11.7 16.3 9.9 12.8 6.4 6.9 7.2 15.5 11.0 1.9 1.7 3.4 1.6 1.0 2.1 1.3 6.8 5.6 11.4 11.6 6.0 7.5 7.0 13.2 9.1 9.8 7.1 16.3 9.6 7.3 5.8 6.8 8.4 13.1 8.9 12.4 16.8 7.2 13.8 4.6 5.6 4.2 21.6 7.9 5.4 8.5 7.4 12.4 7.1 21.4 0.0 8.8 7.3 16.5 10.2 9.1 7.0 10.4 11.3 5.0 5.7 6.4 9.7 5.7 5.6 10.7 9.7 3.8 9.9 7.3 6.3 8.0 11.5 7.1 5.6 9.9 13.4 3.9 9.1 7.4 0.4 0.9 3.4 1.1 1.6 1.9 1.0 1.5 2.1 1.7 1.9 2.1 1.7 0.0 1.0 1.2 1.0 0.6 1.3 10.1 8.5 26.9 11.3 8.3 7.3 7.8 7.9 8.2 9.9 CDK9 "C-2k, CDC2L4, PITALRE, TAK" ENSG00000136807 "Cyclin dependent kinase 9" P50750 9 127785679-127790787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004216, HPA006738" Supported Approved "Nucleoplasm,Cytoplasmic bodies" Nucleoplasm "Cytoplasmic bodies" "CAB004216: AB_627245, HPA006738: AB_1078493" "unprognostic (3.60e-1)" "unprognostic (1.71e-1)" "unprognostic (5.44e-3)" "unprognostic (1.04e-3)" "unprognostic (1.93e-1)" "unprognostic (3.97e-2)" "unprognostic (2.07e-1)" "unprognostic (5.84e-2)" "unprognostic (2.66e-1)" "unprognostic (8.36e-2)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (1.37e-1)" "unprognostic (1.00e-1)" "unprognostic (3.52e-2)" "unprognostic (8.78e-3)" 26.2 27.0 22.8 18.9 22.4 33.9 17.4 31.0 26.8 23.1 21.9 22.9 24.7 16.6 22.5 20.1 22.7 29.1 21.5 22.9 26.3 23.4 18.5 48.7 23.3 26.6 23.4 18.8 43.7 29.1 15.5 28.4 19.8 20.6 20.7 10.8 18.7 20.6 21.6 14.6 26.6 21.4 21.0 17.9 29.0 17.7 22.3 16.1 29.3 25.8 18.3 24.2 17.0 17.6 6.0 8.9 5.1 6.4 18.6 9.9 2.9 8.8 16.1 10.1 11.1 11.5 9.0 13.2 9.1 13.4 9.5 8.6 11.9 10.0 15.5 10.7 10.3 17.9 6.6 14.9 3.6 13.9 8.0 14.5 17.4 9.8 16.8 14.0 23.3 15.8 18.2 10.1 11.4 19.6 12.5 20.9 8.5 23.3 15.3 21.1 22.3 17.2 44.3 8.6 22.3 13.8 9.9 10.0 11.9 13.7 14.5 8.2 18.2 13.3 22.4 11.4 12.9 9.8 8.8 38.1 29.2 13.9 10.7 9.6 10.4 3.7 3.4 4.9 9.9 4.5 9.9 3.5 5.6 7.9 4.4 6.0 6.3 7.7 5.1 18.6 6.4 8.9 3.8 2.9 22.8 22.4 31.0 26.8 26.3 23.4 23.4 18.8 20.6 16.1 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Cell line enhanced" "Detected in many" "EFO-21: 8.3;HeLa: 8.5;RPMI-8226: 11.2;SH-SY5Y: 22.8;SiHa: 15.9;SK-MEL-30: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.3 0.1 0.3 0.2 0.2 0.1 3.7 0.8 0.1 8.5 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.2 1.8 0.6 0.3 0.0 0.0 3.9 7.4 2.7 1.4 0.0 11.2 0.4 0.0 2.4 22.8 15.9 0.2 8.7 0.1 1.8 0.3 0.0 1.5 0.0 0.0 4.8 0.0 0.0 0.0 1.2 4.5 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 CDKN2B "CDK4I, INK4B, MTS2, P15, p15INK4b, TP15" ENSG00000147883 "Cyclin dependent kinase inhibitor 2B" P42772 9 22002903-22009363 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell line enhanced" "Detected in many" "ASC diff: 14.6;ASC TERT1: 20.1;HaCaT: 17.4;HeLa: 16.4;SiHa: 22.0;SK-MEL-30: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9" "Lineage enriched" "Detected in single" 16 "monocytes: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000349, HPA052838, HPA063327" Uncertain Approved Nucleoplasm Nucleoplasm "CAB000349: , HPA052838: , HPA063327: " "unprognostic (2.30e-1)" "unprognostic (9.23e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (4.47e-6)" "unprognostic (2.10e-1)" "unprognostic (7.40e-2)" "prognostic unfavourable (1.49e-4)" "unprognostic (2.01e-1)" "unprognostic (3.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (1.03e-4)" "unprognostic (9.14e-3)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.28e-2)" 22.4 1.4 1.4 7.3 1.1 0.0 25.1 0.8 1.2 6.6 35.4 1.4 1.5 14.1 2.6 0.8 27.0 1.2 1.4 1.4 1.6 0.8 0.5 0.6 9.9 2.3 2.0 0.8 0.8 1.0 3.9 7.8 3.7 3.4 3.1 13.4 0.7 5.1 3.2 6.5 8.6 47.0 3.2 1.0 4.4 3.9 3.3 1.3 1.1 0.8 9.8 12.5 2.8 16.6 0.0 0.6 0.0 10.9 0.0 0.4 1.3 0.0 0.0 0.1 1.0 14.6 20.1 0.3 0.7 0.0 2.3 6.4 1.6 4.4 0.0 1.8 1.0 17.4 0.4 3.4 2.7 1.1 5.4 0.0 16.4 0.7 7.4 0.5 2.9 4.1 0.0 2.9 12.9 2.2 0.0 7.8 3.6 1.3 0.0 0.0 0.8 10.1 0.0 1.0 0.3 4.9 0.0 2.8 0.0 22.0 5.7 15.8 1.2 0.0 5.6 0.0 0.4 0.0 0.0 7.4 4.2 0.1 0.0 0.5 0.0 0.0 4.6 0.0 0.1 3.9 0.0 0.0 0.4 0.3 0.6 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.1 1.3 1.4 1.1 0.8 1.2 1.6 0.8 2.0 0.8 3.4 1.3 CDKN2C "INK4C, p18" ENSG00000123080 "Cyclin dependent kinase inhibitor 2C" P42773 1 50960745-50974633 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005303, CAB018398, HPA019057, HPA019764" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866" "unprognostic (4.07e-2)" "unprognostic (1.47e-3)" "unprognostic (2.89e-1)" "unprognostic (4.86e-2)" "unprognostic (6.70e-2)" "unprognostic (4.76e-3)" "prognostic unfavourable (1.58e-4)" "unprognostic (1.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.38e-1)" "prognostic unfavourable (1.70e-10)" "unprognostic (2.55e-2)" "unprognostic (2.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.24e-1)" 42.1 12.6 5.9 10.7 7.9 14.9 31.7 4.3 5.7 13.1 13.0 8.7 7.7 6.6 17.1 13.9 11.5 8.4 13.7 20.1 5.7 3.1 7.4 3.3 7.9 11.0 13.7 5.3 22.5 9.4 23.1 5.7 3.1 3.9 10.3 5.7 6.0 5.4 12.2 9.2 8.5 7.9 15.1 7.5 8.5 5.3 5.3 8.9 54.2 8.0 4.9 9.8 17.4 21.7 3.4 7.4 12.2 2.5 6.0 14.1 3.8 13.8 5.7 1.0 19.1 19.7 2.8 0.2 13.2 13.4 22.2 19.5 0.3 4.7 27.2 11.9 11.2 1.7 12.9 1.7 10.9 16.4 17.3 20.6 43.6 3.5 1.0 14.3 9.4 1.0 0.3 6.0 2.6 5.8 9.2 0.0 12.9 3.4 18.4 6.9 0.0 14.0 22.0 18.0 0.0 7.0 5.8 9.7 22.7 18.0 12.7 4.2 6.3 48.6 4.6 25.5 9.8 15.4 0.2 27.9 26.5 22.4 0.0 52.3 22.4 12.2 2.5 11.0 5.2 1.4 6.0 3.4 7.7 6.8 6.1 1.9 4.3 4.1 0.2 6.0 0.6 7.4 14.1 3.8 5.9 7.9 4.3 5.7 5.7 3.1 13.7 5.3 3.9 8.9 CDO1 ENSG00000129596 "Cysteine dioxygenase type 1" Q16878 5 115804733-115816954 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 142.1;seminal vesicle: 53.7" "Cell line enhanced" "Detected in some" "AF22: 22.6;ASC diff: 27.9;ASC TERT1: 10.8;HAP1: 8.0;NTERA-2: 8.4" "Group enriched" "Detected in many" 6 "glioma: 33.6;liver cancer: 74.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 20 "memory CD4 T-cell: 4.1;T-reg: 1.2" "Lineage enriched" "Detected in single" 41 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036573, HPA057503" Enhanced Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036573: AB_10696658, HPA057503: AB_2683451" "unprognostic (2.34e-2)" "unprognostic (3.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.32e-1)" "prognostic favourable (1.91e-5)" "unprognostic (1.14e-3)" "unprognostic (2.63e-1)" "unprognostic (7.23e-2)" "unprognostic (9.28e-3)" "unprognostic (6.69e-2)" "unprognostic (1.58e-1)" "unprognostic (2.74e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-1)" "unprognostic (2.06e-2)" 31.9 6.2 9.3 1.7 11.2 0.8 9.9 7.6 9.4 3.4 1.5 3.7 36.4 1.0 3.1 42.6 1.8 4.9 3.7 7.6 7.3 9.0 1.7 142.1 3.9 2.3 6.5 5.5 8.7 4.7 1.0 6.5 17.7 14.5 4.0 1.3 19.2 2.8 53.7 3.5 1.1 1.1 2.6 5.3 1.8 1.2 5.0 4.3 0.0 2.8 2.5 1.6 2.4 2.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 22.6 0.0 27.9 10.8 0.1 0.6 0.2 2.2 2.1 0.0 0.0 0.0 0.0 0.2 0.0 8.0 0.0 3.1 0.0 3.9 0.7 0.0 0.6 0.1 0.0 0.0 4.1 0.0 0.3 0.0 2.9 0.0 0.0 2.5 0.0 0.5 0.1 8.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 9.3 11.2 7.6 9.4 7.3 9.0 6.5 5.5 14.5 4.3 CDPF1 "C22orf40, LOC150383" ENSG00000205643 "Cysteine rich DPF motif domain containing 1" Q6NVV7 22 46244011-46250679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018823 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018823: AB_1853018" "unprognostic (1.98e-2)" "unprognostic (5.06e-3)" "unprognostic (1.42e-2)" "prognostic favourable (3.13e-5)" "unprognostic (2.20e-1)" "unprognostic (1.51e-1)" "unprognostic (1.85e-3)" "unprognostic (1.83e-3)" "unprognostic (2.09e-1)" "unprognostic (2.56e-3)" "unprognostic (4.69e-3)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" 7.3 12.7 10.4 9.4 10.9 5.3 7.8 10.6 12.4 10.1 11.4 11.4 5.3 7.0 12.4 11.8 6.0 11.9 8.3 14.1 10.4 6.8 9.4 8.5 9.4 9.0 10.7 9.5 11.2 8.5 8.0 11.1 7.9 10.9 11.0 6.0 10.3 15.5 11.8 12.3 7.7 9.4 8.2 8.7 11.6 9.9 4.0 10.9 12.9 11.2 5.2 9.6 8.1 12.2 8.9 11.6 11.0 8.5 8.3 11.6 7.3 5.5 4.1 6.6 9.6 4.2 7.4 5.5 3.0 4.4 6.1 5.7 0.7 5.7 5.7 3.2 2.2 6.5 3.0 1.0 3.7 5.3 10.5 3.0 6.2 6.2 7.7 8.1 4.6 7.9 5.9 4.5 5.6 4.5 5.8 7.1 4.3 4.0 10.0 5.8 5.1 4.0 6.4 2.7 12.1 4.6 1.8 3.3 8.0 3.7 6.6 6.3 7.1 3.4 3.5 11.5 7.3 6.4 3.7 7.0 3.3 4.4 5.3 5.9 11.3 1.5 6.5 11.0 10.1 8.0 9.5 7.3 9.9 8.9 5.5 8.9 11.6 8.4 1.7 8.3 8.5 11.6 7.4 7.3 10.4 10.9 10.6 12.4 10.4 6.8 10.7 9.5 10.9 10.9 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell line enhanced" "Detected in some" "AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: " "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDR2 "CDR62, Yo" ENSG00000140743 "Cerebellar degeneration related protein 2" Q01850 16 22345936-22437165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018151, HPA023870" Uncertain Approved Nucleoplasm Nucleoplasm "HPA018151: AB_1846457, HPA023870: AB_1846459" "unprognostic (7.89e-2)" "unprognostic (1.55e-1)" "unprognostic (5.23e-2)" "unprognostic (3.09e-1)" "unprognostic (6.59e-2)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.06e-1)" "unprognostic (9.86e-2)" "unprognostic (3.04e-1)" "unprognostic (2.04e-2)" "unprognostic (3.34e-3)" "unprognostic (1.38e-2)" "unprognostic (5.78e-2)" "unprognostic (1.67e-3)" 10.6 7.2 6.9 14.3 14.2 12.0 13.3 12.0 9.1 16.6 24.6 2.2 14.2 15.9 10.4 11.7 13.2 8.9 13.4 13.1 5.6 8.0 14.7 14.1 20.1 20.3 5.4 4.9 18.3 11.3 9.0 27.4 9.0 9.2 22.9 11.6 37.1 16.9 15.2 5.3 6.5 24.5 40.5 4.2 13.7 11.7 42.9 3.4 17.9 38.2 5.8 14.7 39.8 43.4 1.4 1.5 5.9 1.1 3.1 8.4 2.0 15.2 10.7 9.5 10.2 24.2 20.9 10.0 15.2 23.9 15.7 20.9 14.0 10.9 13.5 7.8 25.9 15.0 20.6 8.8 18.6 10.2 10.7 10.0 11.8 44.4 28.2 11.1 20.5 15.4 8.1 15.6 17.4 19.5 9.9 21.8 14.9 11.2 10.6 8.1 13.4 9.2 15.8 12.5 19.8 19.7 9.7 7.4 5.2 10.2 21.8 15.1 6.5 5.4 12.2 15.3 9.7 14.4 13.0 11.8 18.4 18.1 10.0 11.1 13.0 5.9 1.1 1.5 2.4 0.9 5.1 1.4 7.6 4.8 1.1 0.9 6.0 5.0 1.0 3.1 1.1 1.5 8.4 2.0 6.9 14.2 12.0 9.1 5.6 8.0 5.4 4.9 9.2 3.4 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.3;HaCaT: 28.1;HeLa: 9.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.3 6.7 0.2 1.9 0.2 0.7 0.1 0.5 1.5 0.2 0.7 5.0 15.3 0.1 0.4 1.3 28.1 0.4 0.3 0.4 2.3 0.3 0.1 9.5 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.0 1.2 0.8 0.1 0.4 0.2 0.2 0.8 0.0 0.4 0.0 1.8 3.7 0.1 0.2 2.2 2.0 0.1 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.6;hTCEpi: 25.8;SK-BR-3: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: " "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favourable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favourable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.5 0.2 0.6 0.1 0.0 0.0 12.1 0.0 0.1 0.3 0.2 4.9 20.6 0.0 0.9 0.0 12.1 3.8 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.8 0.0 3.7 0.0 0.0 0.0 0.0 8.1 0.1 0.0 1.7 0.8 0.0 0.0 2.4 5.8 8.8 4.8 0.1 1.3 28.0 0.0 8.5 0.2 0.0 0.0 0.7 1.3 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.8;TIME: 17.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: , HPA052865: " "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.3 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.3 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.7 1.4 3.2 0.2 0.8 1.1 8.8 2.2 5.4 2.1 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.0 0.0 1.6 0.2 13.8 1.0 1.7 0.4 0.9 0.9 0.8 1.2 0.3 17.8 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 CEBPZOS CEBPZ-AS1 ENSG00000218739 "CEBPZ opposite strand" A8MTT3 2 37196488-37216193 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053866 Uncertain Approved Nucleoplasm Nucleoplasm "HPA053866: " "unprognostic (2.13e-1)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" "unprognostic (8.05e-3)" "prognostic unfavourable (1.72e-6)" "unprognostic (2.34e-2)" "unprognostic (2.40e-2)" "unprognostic (5.93e-2)" "unprognostic (3.14e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (3.46e-7)" "unprognostic (3.69e-2)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" 16.5 31.3 29.5 16.2 25.4 17.9 18.5 21.0 30.2 16.9 19.8 16.3 19.1 19.0 25.9 33.0 19.3 19.5 14.4 24.5 43.8 23.8 21.5 18.2 13.8 16.5 23.6 31.3 22.8 14.9 18.6 30.2 22.1 25.4 22.3 18.9 16.1 23.9 16.7 38.4 19.0 22.0 17.1 19.4 13.8 15.3 20.3 12.7 12.9 23.7 19.8 15.1 19.4 14.0 20.9 29.4 15.3 15.3 13.1 25.2 13.7 25.9 8.7 18.6 15.1 19.9 21.6 18.1 19.3 17.4 12.5 9.2 8.1 11.8 9.0 10.4 19.1 15.3 10.1 14.6 15.4 24.3 21.1 24.2 10.1 12.7 17.2 30.1 13.6 22.9 20.2 16.8 18.9 20.0 18.2 13.6 20.3 5.2 7.5 29.6 27.5 13.4 22.6 25.7 20.6 22.0 7.1 20.0 19.7 14.7 24.6 18.8 11.0 18.3 17.5 13.6 16.7 19.8 16.6 24.3 0.2 19.6 25.2 18.2 19.2 15.3 14.1 12.1 17.7 15.3 20.4 20.9 20.1 18.5 13.5 18.0 25.2 22.4 5.7 13.1 11.5 29.4 13.7 13.7 29.5 25.4 21.0 30.2 43.8 23.8 23.6 31.3 25.4 12.7 CECR2 KIAA1740 ENSG00000099954 "CECR2, histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1;skeletal muscle: 30.6" "Cell line enhanced" "Detected in some" "AF22: 12.6;HAP1: 11.6;HEK 293: 5.8;K-562: 6.4;NTERA-2: 18.5;SCLC-21H: 8.3" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 1.8 1.3 4.6 1.0 8.8 1.5 2.0 25.1 8.4 1.1 1.2 10.6 0.8 1.0 4.3 1.7 1.4 2.5 1.0 4.4 6.1 2.8 1.9 6.5 4.1 0.9 8.0 4.0 5.4 5.6 0.8 8.4 4.7 5.8 2.3 1.1 4.9 1.9 1.1 30.6 1.6 1.2 2.2 5.7 1.4 1.1 6.0 8.0 0.0 2.7 2.2 0.9 2.3 2.5 0.2 0.1 0.9 0.8 0.5 0.1 0.0 0.1 0.0 12.6 4.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 11.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.1 0.0 0.4 18.5 0.0 1.4 0.8 0.0 0.0 4.0 8.3 0.0 0.0 0.1 0.7 1.3 1.9 0.1 0.1 2.8 0.0 0.0 4.7 1.1 1.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.1 0.0 0.0 0.0 4.6 8.8 25.1 5.0 6.1 2.8 8.0 4.0 5.8 8.0 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151702404-151716814 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2" "Group enriched" "Detected in some" 7 "SCLC-21H: 27.9;SH-SY5Y: 19.5" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 1.1 16.8 21.4 1.4 28.9 1.1 1.0 29.2 44.0 1.0 2.1 2.0 0.0 5.0 1.0 1.0 1.1 2.1 1.0 1.0 19.5 16.2 1.1 1.0 1.1 1.0 5.3 15.3 1.0 8.8 1.0 31.2 1.2 3.7 1.1 2.1 3.7 1.0 1.0 1.0 1.0 3.8 1.2 1.5 1.0 8.5 2.0 4.4 0.0 1.1 0.0 1.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 27.9 19.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 28.9 29.2 29.1 19.5 16.2 5.3 15.3 3.7 4.4 CEMP1 CP-23 ENSG00000205923 "Cementum protein 1" Q6PRD7 16 2530035-2531417 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 8.6;REH: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "HPA057658, HPA075926" Approved Approved Nucleoplasm Nucleoplasm "HPA057658: , HPA075926: " 0.7 4.1 5.8 1.6 3.3 0.6 0.5 3.6 3.7 1.2 0.7 1.7 1.1 0.0 3.3 0.6 2.6 3.3 4.5 2.4 3.6 2.5 1.6 5.4 3.0 2.1 0.8 0.8 0.9 1.3 1.0 0.0 5.5 0.6 1.9 8.0 4.6 0.0 2.4 3.4 0.9 1.0 2.4 0.0 4.6 0.6 0.6 1.2 4.2 0.0 0.7 1.8 0.0 1.2 0.9 1.1 5.9 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.9 5.2 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.7 8.6 0.7 0.0 2.9 0.0 0.7 4.1 0.0 0.0 0.0 0.0 0.0 2.1 2.0 0.0 3.6 1.0 2.9 2.3 1.7 9.1 0.6 0.1 0.0 1.8 4.9 1.7 1.4 6.4 6.3 7.2 0.7 0.4 2.3 1.9 2.8 1.3 1.0 1.6 2.0 2.8 4.3 1.2 4.2 0.0 3.5 0.3 0.0 0.6 0.6 0.6 1.1 0.0 0.4 0.2 0.9 0.0 0.7 0.0 1.2 1.8 0.0 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.6 5.9 21.6 10.4 1.5 3.3 4.2 18.8 9.4 14.0 9.4 9.3 11.2 14.0 4.8 6.9 9.2 15.4 7.6 22.2 17.5 5.7 16.5 12.4 6.7 0.2 19.5 9.6 1.0 0.5 11.3 9.5 11.8 17.0 16.8 18.1 7.5 15.3 8.8 6.9 9.3 10.3 20.2 4.6 3.9 4.1 10.0 5.9 16.7 11.6 4.5 6.6 6.9 12.8 13.6 14.3 14.1 19.2 8.2 14.0 14.5 7.5 10.9 14.4 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 CEP112 "CCDC46, MGC33887" ENSG00000154240 "Centrosomal protein 112" Q8N8E3 17 65635538-66192084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell line enhanced" "Detected in many" "LHCN-M2: 16.7;RH-30: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024481 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA024481: AB_1846153" "unprognostic (9.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.11e-3)" "unprognostic (1.43e-2)" "unprognostic (7.99e-2)" "unprognostic (4.48e-3)" "unprognostic (3.37e-2)" "unprognostic (1.39e-3)" "unprognostic (3.50e-2)" "unprognostic (4.46e-3)" "unprognostic (1.02e-2)" "unprognostic (1.26e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" 10.0 3.8 6.0 9.0 8.3 1.7 9.6 2.9 6.5 11.5 6.7 1.9 14.9 1.9 8.8 10.2 4.3 6.9 6.6 7.4 5.9 4.3 5.2 2.9 6.9 2.2 4.3 3.4 7.7 4.3 8.4 28.3 6.6 6.8 8.6 3.2 7.2 2.9 13.9 9.5 3.1 2.9 9.8 7.4 7.9 4.5 39.5 4.3 4.2 6.8 6.9 1.8 6.6 13.6 3.0 4.1 4.3 1.3 2.9 2.7 0.5 2.5 5.2 6.9 2.0 3.7 7.7 0.2 2.3 4.0 2.9 2.6 0.7 1.1 0.9 2.2 5.0 0.3 1.5 1.5 4.2 1.3 2.4 0.1 2.3 0.9 1.7 0.3 0.1 4.5 2.5 2.7 0.8 8.8 0.1 2.6 16.7 0.3 2.6 0.2 0.7 2.2 0.7 39.5 0.2 3.1 0.1 1.9 3.9 2.4 0.2 1.8 1.9 0.2 3.9 7.7 4.3 2.0 3.4 1.2 1.0 0.1 2.3 0.1 2.8 2.9 1.3 1.1 1.1 0.6 1.9 1.0 2.7 1.2 0.7 3.0 1.7 1.4 4.3 2.9 0.8 4.1 1.7 0.5 6.0 8.3 2.9 6.5 5.9 4.3 4.3 3.4 6.8 4.3 CEP63 FLJ13386 ENSG00000182923 "Centrosomal protein 63" Q96MT8 3 134485743-134575017 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058154, HPA058313" Approved Approved Nucleoplasm Nucleoplasm "HPA058154: , HPA058313: " "unprognostic (1.80e-1)" "unprognostic (1.03e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-2)" "unprognostic (2.23e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (3.08e-2)" "unprognostic (5.24e-2)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 21.6 15.4 17.7 17.1 18.1 25.3 16.5 19.7 22.6 13.8 15.4 14.5 18.8 9.1 13.7 17.6 15.1 12.2 12.3 25.6 17.2 15.0 15.2 20.5 12.4 15.7 20.4 15.7 16.7 17.8 21.8 23.1 13.5 20.0 16.7 14.5 11.1 15.5 17.4 38.1 15.0 11.3 20.2 20.2 15.3 13.9 37.2 21.5 21.7 18.3 14.9 16.3 17.3 19.9 6.1 7.2 54.1 8.2 5.9 5.6 3.5 17.2 7.7 14.6 9.5 21.3 18.0 13.7 18.7 15.4 15.0 12.7 6.1 7.4 19.6 12.0 13.5 10.3 7.5 10.4 18.2 21.8 4.0 25.3 8.3 8.6 14.7 16.0 11.8 15.7 13.8 8.0 26.7 14.8 7.5 17.1 17.6 11.6 19.0 19.1 10.4 9.1 12.4 21.6 28.0 12.7 10.8 8.6 8.2 16.8 6.6 25.2 13.5 21.8 16.8 17.0 10.1 16.1 13.8 15.8 10.9 25.1 18.2 17.1 21.5 18.1 6.0 9.9 4.0 6.2 5.4 4.8 3.9 5.1 7.2 6.1 5.6 4.2 54.1 5.9 8.2 4.8 4.8 3.5 17.7 18.1 19.7 22.6 17.2 15.0 20.4 15.7 20.0 21.5 CEP68 KIAA0582 ENSG00000011523 "Centrosomal protein 68" Q76N32 2 65056366-65087004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040493, HPA040620" Enhanced Supported "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA040493: AB_10673411, HPA040620: AB_10794144" "unprognostic (7.99e-2)" "unprognostic (6.15e-2)" "unprognostic (5.09e-2)" "unprognostic (4.90e-3)" "unprognostic (1.31e-2)" "unprognostic (1.75e-2)" "unprognostic (4.84e-3)" "unprognostic (8.25e-3)" "unprognostic (9.94e-2)" "unprognostic (5.09e-2)" "unprognostic (9.22e-2)" "unprognostic (1.77e-1)" "prognostic favourable (3.93e-4)" "unprognostic (2.25e-1)" "unprognostic (2.50e-1)" "unprognostic (8.45e-2)" "unprognostic (1.71e-1)" 18.4 7.3 12.7 9.2 17.0 5.0 16.2 24.8 22.2 19.2 13.2 11.9 8.5 6.6 20.0 10.4 11.7 16.9 12.7 15.7 12.5 11.9 8.4 3.3 9.2 10.6 11.3 17.6 26.4 10.6 13.2 7.5 11.8 15.0 14.2 8.6 11.6 12.0 15.4 28.2 13.6 8.7 17.3 10.3 10.2 9.7 7.6 7.8 10.3 11.6 12.9 9.9 13.4 13.0 5.1 8.7 1.5 5.5 5.2 11.1 3.0 2.7 5.0 9.7 7.1 8.8 9.9 17.9 2.6 4.8 4.1 3.6 3.8 2.5 4.7 3.4 4.8 3.9 6.3 4.1 4.4 5.7 5.4 6.4 1.8 4.6 2.4 3.6 4.6 9.3 5.8 3.8 5.3 11.7 5.8 15.2 5.2 3.2 6.0 6.6 9.8 4.0 6.3 11.8 5.5 3.7 3.7 17.2 11.7 5.3 3.9 5.6 2.3 2.3 4.6 3.9 5.4 6.1 2.6 16.6 4.6 11.1 2.1 2.8 4.7 1.0 1.7 0.4 3.0 3.1 3.4 3.4 7.0 5.6 4.3 5.1 11.1 6.6 1.5 5.2 5.5 8.7 5.1 3.0 12.7 17.0 24.8 22.2 12.5 11.9 11.3 17.6 15.0 7.8 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0" "Group enriched" "Detected in many" 8 "B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favourable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavourable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 5.5 8.3 11.0 5.7 15.8 3.5 9.0 14.7 15.6 20.8 12.2 7.1 22.8 35.7 14.0 14.8 10.2 20.3 8.9 11.3 10.9 15.9 17.0 18.8 11.5 4.2 12.6 10.2 14.4 17.4 16.6 27.8 2.7 14.4 14.3 12.1 12.6 6.1 28.7 10.6 4.6 11.5 14.0 19.1 3.9 8.6 41.5 15.3 24.2 26.2 6.7 4.5 13.3 9.1 2.9 0.2 0.5 0.1 3.6 6.4 2.0 21.5 4.5 10.6 13.0 6.6 7.5 10.0 4.2 8.1 5.9 8.8 6.3 11.7 5.1 10.2 8.0 9.5 9.7 8.5 13.5 8.9 6.3 14.6 10.5 8.2 10.5 0.7 5.4 40.2 5.0 4.5 11.2 8.6 10.6 17.1 9.7 8.1 15.3 0.8 6.3 10.2 16.9 13.8 13.1 11.4 9.6 13.0 8.4 22.5 5.4 25.4 27.0 7.0 5.0 4.4 8.4 9.0 5.2 15.9 8.7 17.3 9.8 1.4 14.9 0.4 0.1 0.2 4.2 0.1 5.0 2.9 3.4 3.7 0.1 2.0 5.9 6.4 0.5 3.6 0.0 0.2 2.0 2.0 11.0 15.8 14.7 15.6 10.9 15.9 12.6 10.2 14.4 15.3 CEP83 "CCDC41, NPHP18, NY-REN-58" ENSG00000173588 "Centrosomal protein 83" 12 94306449-94459988 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038161 Approved Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038161: AB_10674547" "unprognostic (4.98e-2)" "unprognostic (1.64e-2)" "unprognostic (7.22e-2)" "unprognostic (1.75e-2)" "unprognostic (4.76e-3)" "unprognostic (3.59e-2)" "unprognostic (5.44e-3)" "unprognostic (1.70e-1)" "unprognostic (2.24e-2)" "unprognostic (1.92e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (4.98e-4)" "prognostic unfavourable (5.00e-10)" "unprognostic (1.29e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-2)" 6.8 9.8 10.1 11.3 10.5 8.4 9.7 11.8 10.1 8.7 7.4 7.6 7.0 5.5 12.3 12.7 6.7 16.2 6.1 19.0 9.0 6.6 8.2 6.3 7.1 7.7 6.2 7.7 11.0 12.2 9.3 12.1 6.3 8.9 6.8 10.3 7.8 10.0 8.5 7.3 6.3 5.4 11.0 6.3 6.9 6.3 22.3 7.3 10.6 9.7 9.4 8.0 6.7 9.2 7.6 8.5 1.9 3.5 5.7 6.6 2.0 5.6 6.3 10.8 10.2 4.8 6.4 9.3 10.0 3.2 7.2 7.5 7.8 4.7 14.8 2.2 3.0 8.0 12.9 7.6 11.3 8.5 9.4 8.7 6.7 7.9 4.8 14.2 6.0 4.1 6.4 6.0 18.6 6.8 11.2 6.1 7.5 5.7 9.7 23.7 12.3 11.7 13.3 10.2 14.8 6.6 7.1 11.2 4.7 8.4 10.0 6.8 6.7 9.0 4.0 8.6 5.3 4.2 7.8 8.0 8.9 13.5 3.6 15.1 8.1 0.6 3.5 1.9 5.8 3.5 5.2 6.6 5.8 4.4 7.7 7.6 6.1 5.4 1.4 5.7 1.5 8.5 6.6 2.0 10.1 10.5 11.8 10.1 9.0 6.6 6.2 7.7 8.9 7.3 CEP95 "CCDC45, DKFZp667E1824" ENSG00000258890 "Centrosomal protein 95" Q96GE4 17 64506588-64542461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023654, HPA052426, HPA052428, HPA061371" Approved Approved "Nucleoplasm,Vesicles,Mitotic spindle,Centrosome" Nucleoplasm "Vesicles, Mitotic spindle, Centrosome" "HPA023654: AB_2072077, HPA052426: , HPA052428: , HPA061371: " "unprognostic (1.28e-2)" "unprognostic (9.12e-2)" "unprognostic (3.66e-3)" "unprognostic (4.09e-2)" "unprognostic (3.30e-2)" "prognostic favourable (5.78e-4)" "prognostic unfavourable (2.52e-5)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (1.54e-1)" "unprognostic (1.64e-2)" "unprognostic (3.57e-3)" "prognostic unfavourable (5.76e-5)" "unprognostic (3.48e-1)" "unprognostic (1.84e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" 13.0 8.6 10.9 17.1 13.1 37.9 15.5 27.9 15.6 16.7 14.2 16.2 11.6 11.9 26.5 16.6 10.7 17.1 12.3 10.6 11.5 7.8 14.1 11.7 13.0 20.7 13.6 7.9 27.3 15.5 11.8 20.4 8.5 13.0 15.2 13.5 15.6 13.8 19.8 14.6 21.7 14.2 15.0 17.4 13.2 13.3 16.9 13.9 26.4 21.0 8.6 14.7 14.3 14.0 5.9 3.7 2.2 3.6 2.1 10.8 2.4 10.0 6.4 13.1 11.3 3.5 9.0 13.1 5.1 5.2 6.4 9.7 7.7 5.8 16.1 3.4 7.2 12.8 11.2 9.9 13.2 4.2 8.6 14.3 12.4 14.8 11.6 15.5 7.7 10.2 10.4 7.1 15.9 5.4 16.4 11.8 7.0 11.8 19.6 9.9 8.1 8.0 14.1 23.7 11.9 7.4 16.1 8.3 15.0 7.0 10.3 13.3 11.4 10.4 8.0 14.6 11.4 6.7 6.9 12.0 9.6 17.1 6.3 11.9 8.9 2.2 3.6 2.2 4.5 2.9 10.8 4.5 5.2 4.5 3.4 5.9 8.0 5.4 1.4 2.1 3.4 3.7 4.2 2.4 10.9 13.1 27.9 15.6 11.5 7.8 13.6 7.9 13.0 13.9 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 59.0;fHDF/TERT166: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: " "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavourable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.4 6.1 6.8 7.3 55.3 59.0 5.9 30.7 29.0 8.0 6.0 2.2 0.4 0.0 12.6 50.1 6.5 3.0 4.0 3.1 2.4 4.8 0.5 5.5 3.3 16.9 1.1 17.2 32.7 2.1 8.7 2.1 9.1 2.7 7.5 10.4 18.0 0.4 11.6 0.4 4.6 0.9 4.8 1.3 3.7 3.6 1.0 1.9 6.9 8.4 3.5 6.8 2.3 10.0 21.4 5.8 29.4 4.7 8.8 6.9 0.1 20.3 3.3 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 CERS5 "FLJ25304, LASS5, MGC45411, Trh4" ENSG00000139624 "Ceramide synthase 5" Q8N5B7 12 50129306-50167533 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026589 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA026589: AB_1852727" "unprognostic (1.59e-2)" "unprognostic (9.83e-2)" "unprognostic (5.17e-2)" "unprognostic (3.64e-2)" "unprognostic (3.02e-1)" "unprognostic (2.49e-3)" "prognostic unfavourable (4.63e-5)" "unprognostic (5.56e-2)" "unprognostic (1.65e-2)" "unprognostic (9.26e-2)" "unprognostic (1.88e-3)" "unprognostic (5.67e-2)" "prognostic unfavourable (9.33e-11)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "prognostic favourable (5.76e-5)" "unprognostic (3.26e-1)" 18.0 13.2 18.3 13.3 21.6 10.9 18.0 38.3 19.6 21.1 15.0 17.5 8.9 6.3 22.6 20.9 14.1 17.7 14.9 9.9 16.7 11.6 16.0 7.8 14.7 15.1 13.9 19.1 22.5 13.8 23.9 22.4 19.7 14.3 15.6 11.5 14.9 14.6 16.2 5.0 21.5 12.2 21.8 10.3 15.7 13.3 11.6 14.4 12.7 15.5 7.0 14.9 18.4 18.3 21.0 26.1 33.5 35.1 29.0 26.3 22.3 9.3 10.4 23.0 6.5 12.9 10.8 19.5 20.6 17.8 19.8 18.8 24.5 14.7 14.1 17.2 29.1 8.7 10.1 7.9 19.6 22.1 10.3 11.8 8.8 14.8 25.6 11.9 16.0 18.6 12.0 16.3 15.2 18.0 8.8 13.1 24.8 16.2 10.4 32.5 14.8 10.1 13.6 15.1 10.0 25.6 12.0 7.0 11.4 17.4 8.2 27.5 11.2 13.8 17.1 17.0 11.4 12.8 8.9 12.8 12.1 11.3 13.5 8.3 7.8 24.8 19.0 28.1 26.0 25.5 22.9 17.9 22.9 22.4 18.2 21.0 17.9 24.3 33.5 29.0 35.1 26.1 26.3 22.3 18.3 21.6 38.3 19.6 16.7 11.6 13.9 19.1 14.3 14.4 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407983-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 17.7;testis: 60.5" "Cell line enhanced" "Detected in some" "MCF7: 4.4;RPTEC TERT1: 5.3;T-47d: 9.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: " "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.2 0.5 1.3 0.3 3.0 0.2 0.5 0.3 2.2 0.9 0.3 3.0 0.2 0.3 0.7 3.4 0.2 17.7 0.4 0.3 2.1 2.0 1.5 0.3 2.4 0.2 0.7 1.4 2.7 0.3 0.8 2.6 0.4 8.1 0.5 0.2 0.3 0.3 0.5 0.2 0.3 0.2 0.3 0.5 0.2 0.2 60.5 0.6 0.0 1.4 0.0 0.2 0.4 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.9 0.5 2.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.2 1.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.9 0.0 0.2 0.0 0.1 0.8 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 1.2 1.1 0.6 0.4 0.5 0.3 9.0 0.2 0.0 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 3.0 0.3 2.2 2.1 2.0 0.7 1.4 8.1 0.6 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Cell line enhanced" "Detected in some" "Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: " "unprognostic (2.42e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favourable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.0 6.3 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.1 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.3 1.1 0.4 0.2 3.2 0.0 0.5 0.8 0.7 0.6 0.1 0.0 0.9 0.0 3.8 0.0 0.1 0.1 1.0 0.3 0.2 0.6 0.2 12.7 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433485 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: " "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavourable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 21.3 33.0 38.3 23.3 32.9 18.7 28.5 31.8 35.4 35.6 24.3 19.5 24.6 18.9 37.4 40.9 21.3 36.1 18.8 19.2 33.7 40.5 40.2 26.6 20.6 16.9 33.6 28.4 54.5 26.9 20.9 53.0 38.5 32.7 28.4 25.8 21.1 23.8 25.6 25.9 20.8 22.2 33.8 38.6 18.0 19.1 38.5 29.7 27.2 28.7 12.6 21.4 26.0 41.1 20.1 28.2 33.7 27.6 15.1 37.8 15.0 16.4 12.2 41.7 15.4 38.0 42.5 12.5 16.5 19.2 21.9 31.7 21.0 22.5 15.8 24.5 20.3 18.5 32.0 26.2 44.0 6.8 15.2 16.5 11.8 44.7 26.2 17.3 14.4 26.4 22.5 26.4 32.3 23.8 22.9 7.4 24.4 37.4 25.4 38.3 20.4 6.4 46.1 17.1 27.3 24.3 9.1 25.0 21.1 27.6 5.8 22.6 24.0 30.8 14.1 15.7 17.0 16.5 10.4 14.4 22.4 59.4 15.7 23.0 13.8 28.7 27.3 33.7 19.4 27.6 27.3 19.8 26.7 21.3 28.2 20.1 24.5 23.1 22.4 15.1 25.0 28.1 37.8 15.0 38.3 32.9 31.8 35.4 33.7 40.5 33.6 28.4 32.7 29.7 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: " "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.6 15.9 10.2 6.6 10.4 39.0 5.8 30.8 35.5 29.5 31.5 11.9 7.6 6.3 12.6 49.1 3.5 21.8 6.5 52.0 0.8 9.0 1.3 18.8 28.2 17.0 1.6 1.0 29.5 2.3 25.1 13.9 29.2 1.9 5.0 36.2 5.0 1.2 0.8 3.3 24.4 1.1 32.5 0.9 10.7 3.6 2.1 8.8 20.1 4.3 10.4 9.6 1.5 25.6 29.4 19.6 13.8 14.7 7.0 4.5 2.4 10.8 2.3 6.9 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 CHD1 ENSG00000153922 "Chromodomain helicase DNA binding protein 1" O14646 5 98853985-98928957 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022236 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA022236: " "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (1.09e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (7.15e-2)" "unprognostic (6.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-1)" "unprognostic (4.94e-2)" "unprognostic (3.15e-1)" "prognostic unfavourable (7.25e-6)" "unprognostic (2.69e-1)" "unprognostic (3.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.17e-1)" 13.0 7.4 5.5 15.8 7.5 41.7 10.2 14.9 5.5 9.4 9.3 4.7 7.9 6.6 11.3 7.5 7.6 10.8 10.6 6.8 4.9 3.1 7.3 10.1 12.1 8.8 8.8 3.2 18.1 8.3 9.3 12.0 11.1 6.4 7.7 7.4 5.6 8.1 11.5 13.2 8.2 12.3 8.3 7.2 17.2 8.6 12.0 7.4 70.1 8.1 5.5 9.3 10.4 11.3 10.1 7.1 16.7 8.2 8.1 8.4 2.2 11.4 10.5 24.8 16.8 8.4 8.7 21.7 11.9 7.8 9.7 12.6 13.1 8.9 9.7 11.6 6.9 9.6 19.4 13.1 20.3 15.2 14.6 17.2 12.6 9.9 9.3 16.5 13.4 7.5 5.4 16.8 17.0 11.7 20.7 15.0 9.7 9.2 32.8 7.2 16.7 12.8 27.9 17.4 14.6 8.5 11.0 11.6 9.9 15.3 8.0 19.3 7.7 11.4 13.1 20.8 11.2 13.0 21.0 10.5 11.0 20.7 11.4 16.6 12.5 11.4 8.2 10.7 6.5 7.5 8.2 10.1 6.1 6.1 7.1 9.4 8.4 6.6 16.7 8.1 7.1 5.2 6.3 2.2 5.5 7.5 14.9 5.5 4.9 3.1 8.8 3.2 6.4 7.4 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: , HPA076524: " "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavourable (2.43e-4)" "prognostic favourable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favourable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.1 30.4 17.8 23.6 21.7 18.2 9.5 14.2 19.1 12.1 12.9 5.9 10.3 34.3 10.8 20.9 16.5 33.4 15.0 15.2 17.4 19.4 16.6 39.4 0.7 11.6 4.7 32.7 24.0 8.0 16.2 10.9 22.3 11.1 0.5 11.2 12.0 13.1 5.5 2.8 11.2 38.4 21.7 5.2 12.0 29.7 12.1 16.4 35.3 13.8 6.9 15.8 7.8 27.9 26.2 20.6 6.3 20.4 2.5 0.4 19.4 13.3 13.5 22.3 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 CHD6 "CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB" ENSG00000124177 "Chromodomain helicase DNA binding protein 6" Q8TD26 20 41402101-41618494 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015543 Approved Nucleoplasm Nucleoplasm "HPA015543: " "unprognostic (5.13e-3)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.27e-1)" "unprognostic (6.66e-2)" "unprognostic (1.36e-1)" "unprognostic (4.72e-3)" "prognostic favourable (3.42e-4)" "unprognostic (1.17e-1)" "unprognostic (3.17e-1)" "unprognostic (4.75e-2)" "unprognostic (1.14e-1)" "unprognostic (2.12e-3)" "unprognostic (6.66e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-1)" "unprognostic (1.14e-2)" 12.1 12.6 16.5 12.7 16.2 18.1 19.4 34.1 24.9 17.4 11.3 16.6 15.4 6.5 20.4 19.9 11.0 16.3 11.7 12.1 15.8 13.9 11.8 10.7 11.7 12.1 14.7 16.8 26.1 12.5 31.4 30.3 12.9 24.3 19.7 10.0 14.2 14.5 17.0 9.4 14.4 10.5 14.4 17.3 12.0 12.3 11.1 18.2 21.4 21.4 6.7 15.3 16.9 15.0 12.0 11.5 15.1 9.3 10.4 10.4 2.3 6.4 7.6 16.4 7.2 9.3 9.6 10.9 5.6 11.6 10.0 12.3 10.4 5.3 7.7 10.2 9.5 9.5 10.2 9.6 11.5 2.4 4.9 10.5 6.9 10.0 5.2 8.2 5.2 9.6 9.0 7.3 8.1 8.6 8.2 8.7 7.7 17.6 12.9 8.9 5.3 12.7 10.0 19.4 5.4 6.2 14.8 14.8 10.2 17.1 4.6 11.4 7.8 6.2 9.9 15.8 7.8 8.4 4.8 7.9 6.3 9.9 7.1 4.0 4.9 15.1 6.5 7.1 8.9 6.2 8.9 8.8 7.7 7.3 5.1 12.0 10.4 8.7 0.9 10.4 9.3 11.5 5.9 2.3 16.5 16.2 34.1 24.9 15.8 13.9 14.7 16.8 24.3 18.2 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody "Nucleoplasm, Midbody" "HPA061997: , HPA062896: " "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favourable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.8 12.6 16.4 13.8 21.5 15.1 23.8 13.8 23.3 9.4 12.6 16.3 13.0 8.0 20.7 14.9 11.0 7.4 19.2 8.4 7.4 9.2 5.8 19.2 13.4 15.9 22.1 10.0 21.9 41.6 10.5 24.5 13.6 9.8 10.4 14.8 15.9 15.3 17.0 6.8 6.3 7.9 8.4 13.7 25.2 17.7 16.0 16.0 23.4 11.0 21.1 9.0 20.4 19.8 21.2 11.2 16.7 14.7 12.5 14.3 10.2 19.6 10.3 10.0 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 CHN2 "ARHGAP3, RhoGAP3" ENSG00000106069 "Chimerin 2" P52757 7 29146569-29514328 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.2;intestine: 44.3" "Cell line enhanced" "Detected in many" "HEL: 18.2;HMC-1: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA018989 Approved Approved Nucleoplasm Nucleoplasm "HPA018989: AB_1846681" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (6.87e-2)" "unprognostic (2.56e-1)" "unprognostic (1.52e-1)" "unprognostic (8.12e-2)" "unprognostic (6.87e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "unprognostic (4.71e-2)" "unprognostic (7.54e-2)" "unprognostic (7.85e-2)" "unprognostic (1.61e-2)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (1.15e-2)" "unprognostic (1.58e-3)" 2.7 4.4 7.9 3.3 21.8 1.4 2.1 89.2 14.7 6.6 14.1 19.2 0.3 44.3 2.7 2.1 1.9 5.0 4.8 6.9 10.5 7.0 8.2 22.0 3.7 2.0 34.7 6.9 13.4 13.9 0.5 1.9 6.4 16.5 5.3 5.9 4.6 1.6 2.9 2.7 1.5 36.3 3.0 16.5 5.1 4.2 2.3 29.2 0.8 4.7 0.0 1.7 3.5 4.0 0.3 8.5 3.9 11.2 9.3 2.5 2.6 0.1 0.4 1.6 0.0 0.0 0.0 9.4 0.0 0.0 0.4 0.0 5.0 1.5 0.5 3.1 0.1 2.6 5.0 0.0 0.0 8.9 1.6 18.2 0.8 9.7 0.1 0.0 35.5 0.0 3.3 0.0 0.7 1.9 0.7 0.2 0.1 0.2 4.9 0.2 0.6 1.7 0.4 0.0 0.9 9.2 6.2 9.5 0.7 2.2 3.3 5.8 0.3 1.0 0.2 0.5 0.1 0.0 0.2 1.8 7.0 0.0 0.1 1.1 0.7 3.9 10.5 0.1 2.5 11.2 1.8 0.3 0.4 2.2 8.5 0.2 0.5 1.0 0.6 9.3 6.4 1.0 0.0 2.6 7.9 21.8 89.2 14.7 10.5 7.0 34.7 6.9 16.5 29.2 CHPF2 "ChSy-3, CSGlcA-T, KIAA1402" ENSG00000033100 "Chondroitin polymerizing factor 2" Q9P2E5 7 151232489-151238827 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020992 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA020992: AB_1847267" "unprognostic (8.31e-2)" "unprognostic (2.14e-3)" "unprognostic (1.02e-3)" "unprognostic (1.14e-1)" "unprognostic (4.79e-3)" "unprognostic (5.25e-2)" "prognostic unfavourable (9.47e-4)" "unprognostic (4.07e-1)" "unprognostic (1.71e-1)" "unprognostic (4.54e-2)" "prognostic favourable (2.51e-4)" "unprognostic (1.04e-1)" "unprognostic (2.68e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-2)" "unprognostic (8.59e-3)" 13.5 29.3 13.4 19.0 12.9 22.6 19.1 13.1 20.2 15.3 14.4 11.4 20.7 14.9 19.5 16.9 13.3 14.9 17.6 18.8 13.7 12.5 14.9 20.7 17.4 23.4 11.4 17.4 14.4 23.7 16.7 41.5 18.6 11.8 18.5 10.8 12.2 25.4 19.8 7.9 14.2 17.1 17.3 9.4 28.1 20.1 12.9 11.1 16.2 17.5 7.4 13.7 18.9 12.8 2.7 9.5 9.9 5.6 2.6 5.7 3.7 8.9 7.3 4.9 14.4 17.2 17.1 7.5 18.9 29.6 10.3 12.6 4.8 15.3 2.7 33.5 30.0 11.3 2.2 13.5 4.5 10.3 6.7 2.8 8.0 6.7 16.2 5.8 24.0 26.2 7.6 9.7 3.5 16.2 2.7 7.9 16.3 14.7 5.4 22.7 6.6 8.5 5.1 2.9 9.0 10.0 7.1 5.4 9.5 10.1 10.0 4.8 3.8 9.6 22.0 11.5 1.9 15.2 16.0 14.6 2.1 3.9 41.7 7.8 15.5 1.2 5.6 7.9 5.7 5.1 5.4 2.7 3.1 5.1 6.3 2.7 2.2 2.3 9.9 2.6 5.0 9.5 3.4 3.7 13.4 12.9 13.1 20.2 13.7 12.5 11.4 17.4 11.8 11.1 CHRAC1 "CHRAC15, YCL1" ENSG00000104472 "Chromatin accessibility complex 1" Q9NRG0 8 140511298-140517137 "Predicted intracellular proteins" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059008 Approved Nucleoplasm Nucleoplasm "HPA059008: " "unprognostic (6.34e-2)" "unprognostic (7.32e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (2.28e-4)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (4.88e-5)" "unprognostic (8.79e-3)" "unprognostic (1.86e-1)" "prognostic favourable (9.72e-4)" "prognostic unfavourable (5.43e-4)" "unprognostic (4.19e-1)" "unprognostic (6.22e-3)" "unprognostic (7.61e-2)" "unprognostic (1.01e-1)" "unprognostic (6.92e-2)" "unprognostic (1.49e-1)" 24.3 14.7 12.1 15.9 16.0 23.3 18.0 10.1 14.2 17.3 20.9 23.8 11.9 15.5 20.4 12.7 24.1 16.1 19.8 18.7 13.7 10.4 21.4 24.3 16.5 21.6 19.2 7.7 18.2 17.7 15.5 13.1 21.0 13.6 17.8 16.2 17.2 17.6 20.1 28.4 19.1 24.3 21.2 20.8 22.2 18.2 26.1 21.6 36.4 27.5 19.3 24.9 19.3 15.8 19.6 19.5 21.4 23.5 16.1 16.0 12.5 22.3 10.9 10.2 9.6 10.2 17.4 7.8 9.6 14.0 14.1 17.1 13.9 16.2 23.2 14.3 11.8 14.0 12.2 9.8 19.5 17.7 12.8 32.8 15.1 15.6 9.7 10.8 17.4 8.6 14.4 10.4 20.2 13.4 24.2 22.2 12.4 26.3 38.0 11.7 7.5 18.3 23.0 10.8 18.5 14.0 9.4 14.0 11.6 13.4 9.2 16.9 17.7 12.6 12.7 16.7 29.2 20.5 20.2 10.7 13.9 28.1 20.1 26.0 12.9 8.7 17.0 20.3 16.0 22.4 15.7 17.3 14.4 15.8 18.7 19.6 15.2 12.6 21.4 16.1 23.5 19.5 12.7 12.5 12.1 16.0 10.1 14.2 13.7 10.4 19.2 7.7 13.6 21.6 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Cell line enhanced" "Detected in some" "MCF7: 8.0;SK-BR-3: 4.0;T-47d: 2.6;WM-115: 1.4" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.7 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell line enriched" "Detected in single" 72 "RH-30: 42.8" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: , HPA065404: " "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573784-46598408 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 17.8;HHSteC: 13.2;NTERA-2: 15.8;PC-3: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 15.4" "Group enriched" "Detected in many" 10 "granulocytes: 9.4;monocytes: 8.0;T-cells: 15.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favourable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.1 7.5 4.9 3.8 6.6 4.7 12.1 4.7 10.3 10.5 4.4 3.6 2.5 2.2 5.0 4.1 4.2 3.2 10.7 25.6 4.1 4.0 3.6 11.0 5.4 3.7 4.5 4.7 27.0 3.4 2.4 3.4 5.9 3.6 3.9 2.2 1.4 2.7 3.7 4.3 5.4 3.3 3.5 1.9 17.1 3.4 3.6 1.8 2.4 4.2 1.4 2.0 4.1 8.7 1.0 1.0 9.4 8.0 0.4 15.4 1.6 4.1 3.4 2.9 2.7 8.5 6.0 0.1 5.7 4.1 1.5 2.0 0.9 1.6 0.0 17.8 2.3 3.1 2.8 1.0 1.3 2.4 6.2 0.8 0.3 3.0 13.2 1.4 0.1 2.0 0.8 2.9 2.4 4.7 0.0 3.6 1.1 1.9 0.5 1.8 15.8 13.2 2.7 2.5 7.4 4.2 0.1 6.8 2.6 0.8 0.2 0.6 1.0 0.3 1.1 4.8 0.5 2.5 2.6 8.5 1.7 1.2 5.3 0.0 0.3 1.2 1.9 0.6 1.4 5.9 1.3 1.0 5.3 2.5 1.0 0.6 1.1 1.0 9.4 0.4 8.0 0.6 15.4 1.6 4.9 6.6 4.7 10.3 4.1 4.0 4.5 4.7 3.6 1.8 CIAO1 "CIA1, WDR39" ENSG00000144021 "Cytosolic iron-sulfur assembly component 1" O76071 2 96266132-96273349 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017882 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017882: AB_1846738" "unprognostic (2.34e-1)" "unprognostic (4.68e-2)" "unprognostic (5.32e-2)" "prognostic unfavourable (4.13e-5)" "unprognostic (1.55e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (1.14e-4)" "unprognostic (9.86e-2)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.26e-2)" "unprognostic (2.15e-2)" 19.8 39.7 23.6 22.2 27.6 11.1 21.4 17.9 31.9 22.1 18.4 19.9 22.3 20.4 19.4 16.5 24.0 22.3 18.3 26.1 18.3 18.2 25.4 32.5 17.7 17.7 19.2 22.7 20.4 22.2 30.6 17.8 22.2 24.5 16.4 21.1 19.2 22.0 23.5 26.1 16.3 18.5 21.5 19.7 21.8 19.3 19.1 19.0 21.6 19.4 12.2 26.0 19.9 16.9 29.6 39.8 33.1 39.7 25.9 35.2 38.5 20.5 20.6 15.7 14.6 20.2 16.4 25.6 15.8 16.8 25.6 25.3 35.1 15.2 21.7 33.6 19.5 15.7 24.2 23.4 18.4 11.5 39.9 16.7 15.3 37.9 13.1 19.4 15.2 16.4 18.8 21.3 26.7 28.5 21.3 14.9 17.2 32.6 19.3 18.2 22.0 41.8 19.4 13.9 25.2 16.8 19.3 16.9 19.4 9.9 26.9 18.9 13.5 14.2 14.7 16.0 22.8 19.0 20.9 20.3 21.4 19.3 20.8 18.9 15.7 30.6 35.3 33.1 32.7 29.3 35.2 25.3 28.7 34.9 39.8 29.6 28.5 34.2 32.4 25.9 39.7 24.0 27.6 38.5 23.6 27.6 17.9 31.9 18.3 18.2 19.2 22.7 24.5 19.0 CIART "BC017397, C1orf51" ENSG00000159208 "Circadian associated repressor of transcription" Q8N365 1 150282543-150287093 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.0;Karpas-707: 23.3;U-266/84: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.4;memory CD4 T-cell: 3.8;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027515, HPA054349" Enhanced Approved Nucleoplasm Nucleoplasm "HPA027515: AB_10600757, HPA054349: " "unprognostic (1.77e-1)" "unprognostic (5.63e-2)" "unprognostic (4.15e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (4.42e-1)" "unprognostic (5.99e-3)" "unprognostic (2.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (1.89e-1)" "unprognostic (4.54e-2)" "unprognostic (1.01e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.34e-2)" 4.8 10.0 6.9 2.9 18.4 0.6 6.7 14.2 26.5 9.1 11.8 6.3 11.1 3.0 7.4 8.2 7.3 6.2 4.0 23.5 5.4 7.1 8.3 11.5 3.0 2.1 4.9 5.8 11.5 4.4 7.5 10.6 2.6 8.4 7.2 2.8 20.5 14.2 21.1 40.2 19.7 4.9 12.9 3.1 2.4 7.3 6.3 4.2 0.8 16.1 19.6 6.5 10.3 5.2 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.1 0.6 4.7 2.2 1.8 0.8 4.0 2.8 7.0 3.7 5.0 1.0 16.0 0.0 5.0 6.1 2.8 0.1 2.8 5.7 0.0 0.4 0.1 0.2 0.0 6.4 0.9 2.4 2.4 4.3 9.5 1.9 0.6 0.1 23.3 2.1 12.4 0.0 0.5 5.2 11.8 0.6 0.0 0.1 3.8 0.6 2.5 0.9 4.8 0.4 8.5 4.0 0.4 1.2 10.7 0.1 0.4 6.2 5.0 16.6 0.1 9.6 0.0 6.4 0.0 0.0 0.0 0.5 0.0 3.4 0.0 3.8 0.0 0.0 0.0 2.4 1.2 0.0 0.0 0.0 0.0 0.3 0.3 6.9 18.4 14.2 26.5 5.4 7.1 4.9 5.8 8.4 4.2 CKS1B "CKS1, ckshs1" ENSG00000173207 "CDC28 protein kinase regulatory subunit 1B" P61024 1 154974653-154979249 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: , HPA030762: AB_10670044" "unprognostic (1.06e-2)" "unprognostic (1.62e-1)" "unprognostic (2.84e-1)" "prognostic unfavourable (7.89e-4)" "unprognostic (1.34e-1)" "unprognostic (2.59e-2)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.01e-3)" "prognostic unfavourable (3.12e-5)" "unprognostic (3.63e-2)" "prognostic unfavourable (6.13e-4)" "unprognostic (3.19e-1)" "prognostic unfavourable (6.03e-7)" "unprognostic (3.12e-2)" "unprognostic (1.44e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.37e-1)" 25.3 14.5 13.5 13.4 19.0 36.4 24.8 4.2 14.6 15.6 17.4 12.4 19.8 14.7 14.7 13.8 28.2 15.2 14.1 16.5 15.3 8.0 16.6 29.5 12.9 23.8 29.5 8.8 14.2 12.8 8.3 9.4 35.6 15.9 11.7 18.8 7.5 12.8 13.1 5.9 22.6 22.9 12.5 19.8 18.0 14.7 22.8 21.5 30.2 15.5 19.3 25.5 11.1 23.3 23.9 30.4 2.2 32.8 9.0 12.2 8.7 59.4 82.1 61.5 33.3 8.9 9.1 49.2 27.7 21.5 60.1 48.2 79.3 88.0 56.7 47.4 18.3 55.2 61.0 39.7 56.5 50.9 39.5 38.3 36.5 55.7 2.7 46.1 35.3 5.3 17.2 51.4 71.3 30.1 62.2 77.1 45.2 59.2 43.2 35.6 78.0 74.1 43.5 50.7 72.6 21.4 21.8 25.1 63.4 41.9 39.7 45.8 53.1 64.6 16.8 39.1 40.5 32.2 65.9 47.6 92.3 80.0 24.8 39.3 53.9 0.7 4.4 2.2 7.0 26.0 8.4 23.9 9.9 9.5 7.2 22.6 12.2 11.5 0.6 9.0 32.8 30.4 10.6 8.7 13.5 19.0 4.2 14.6 15.3 8.0 29.5 8.8 15.9 21.5 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: , HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavourable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavourable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 86.6 74.3 45.5 30.4 13.4 12.2 33.2 51.6 27.9 57.2 45.8 30.5 43.0 64.9 30.6 19.3 61.0 54.5 39.7 65.8 50.6 44.1 32.9 54.4 80.9 5.8 67.0 37.5 4.4 9.2 40.9 36.2 52.9 39.2 56.9 73.2 65.0 52.6 118.1 66.4 68.6 45.6 50.0 38.7 44.9 19.9 38.5 22.9 42.8 41.6 41.6 50.1 39.0 30.0 24.7 47.0 59.7 75.0 46.1 93.5 52.4 36.5 38.8 35.2 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: , HPA061117: " "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 2.1 5.3 5.4 2.6 12.5 2.0 6.6 3.5 13.5 7.6 3.4 5.2 11.8 2.3 6.8 15.1 5.1 18.9 6.5 2.4 6.2 6.5 8.9 6.1 7.4 1.8 3.3 5.9 6.8 11.3 13.2 15.3 2.4 5.3 7.6 3.5 7.6 6.3 8.3 1.3 9.2 2.2 4.4 2.1 2.4 5.9 23.9 1.8 1.8 17.6 1.0 2.3 4.2 3.3 1.8 2.3 2.4 1.1 1.0 1.4 0.5 4.0 7.2 2.2 6.7 2.2 3.3 3.4 3.3 3.0 3.9 1.7 0.7 7.1 0.4 6.9 3.2 8.6 0.8 4.8 2.5 3.3 2.5 0.2 6.1 0.3 7.7 1.7 1.8 2.0 11.2 4.2 8.3 2.2 2.3 1.1 2.3 13.6 0.7 5.2 2.8 6.9 2.5 1.2 2.2 8.4 2.3 14.1 7.4 4.6 2.1 3.8 14.7 2.5 2.4 4.9 2.3 9.9 2.5 1.4 0.9 0.3 6.3 0.5 3.4 1.8 1.1 0.4 1.4 1.1 0.3 1.2 1.4 0.3 0.5 1.8 0.6 1.3 2.4 1.0 1.0 2.3 0.6 0.5 5.4 12.5 3.5 13.5 6.2 6.5 3.3 5.9 5.3 1.8 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell line enriched" "Detected in some" 5 "hTCEpi: 67.0" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: " "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 12.3 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 67.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell line enriched" "Detected in single" 964 "RT4: 96.4" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favourable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favourable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Group enriched" "Detected in some" 20 "A549: 16.6;CACO-2: 13.4;RPTEC TERT1: 29.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: " "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favourable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 23.0 14.1 27.8 21.7 12.5 14.3 19.6 20.1 27.8 14.8 18.4 9.0 19.3 13.7 24.4 17.6 10.8 35.2 21.2 7.5 18.8 5.2 13.3 22.2 16.9 18.7 25.3 58.5 15.7 16.8 21.8 9.3 27.8 28.2 9.4 12.4 11.2 20.0 15.6 8.4 30.9 11.5 18.7 8.2 8.3 22.9 19.7 6.6 28.2 6.6 14.3 20.1 26.2 24.2 17.8 18.5 36.8 15.7 14.5 43.8 16.3 33.4 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 31.4" "Cell line enhanced" "Detected in many" "Hep G2: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA056971 Uncertain Approved Nucleoplasm Nucleoplasm "HPA056971: " "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 7.7 7.8 6.8 3.2 11.1 13.3 3.3 10.9 16.5 2.6 3.6 1.4 8.4 7.7 3.0 2.5 2.9 2.8 4.5 2.5 9.9 4.7 2.8 3.5 4.0 3.2 19.6 5.2 6.7 9.1 1.5 2.9 1.8 7.4 3.8 2.4 1.7 7.5 6.0 11.9 1.5 7.1 3.8 10.2 7.3 3.3 31.4 10.6 0.0 2.9 2.2 1.2 3.2 3.0 1.7 3.0 5.8 2.0 5.3 4.5 0.7 2.0 5.9 2.2 3.0 3.2 2.9 1.2 1.0 0.5 1.0 1.3 0.7 7.0 5.5 1.2 0.6 2.7 0.7 0.3 0.2 3.9 9.5 4.8 9.2 11.5 1.2 1.4 1.4 2.2 0.9 0.2 0.6 0.6 3.1 4.1 0.9 1.3 1.1 8.0 0.9 7.5 1.1 5.0 2.2 1.6 1.6 1.3 1.5 2.5 0.5 2.1 1.5 0.4 1.4 2.2 4.4 2.3 0.9 3.8 4.0 2.0 5.3 5.5 1.3 5.8 0.9 4.1 3.5 2.0 2.0 1.7 0.8 4.5 1.4 1.1 0.6 1.5 0.5 5.3 0.7 3.0 1.2 0.7 6.8 11.1 10.9 16.5 9.9 4.7 19.6 5.2 7.4 10.6 CLEC16A "Gop-1, KIAA0350" ENSG00000038532 "C-type lectin domain containing 16A" Q2KHT3 16 10944488-11182189 "Disease related genes, Predicted intracellular proteins" Autophagy "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035814, HPA035815, HPA061385" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035814: AB_10600801, HPA035815: AB_10671937, HPA061385: " "unprognostic (3.41e-1)" "unprognostic (4.58e-2)" "unprognostic (7.36e-2)" "unprognostic (1.56e-2)" "unprognostic (3.44e-1)" "unprognostic (1.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.22e-3)" "unprognostic (4.54e-2)" "unprognostic (7.78e-3)" "unprognostic (2.08e-1)" "unprognostic (3.49e-1)" "prognostic favourable (2.92e-6)" "unprognostic (2.69e-1)" "unprognostic (1.79e-1)" "unprognostic (8.22e-2)" "unprognostic (3.03e-1)" 9.2 9.7 11.1 12.7 13.7 15.8 8.3 17.2 19.5 8.7 9.4 14.2 9.5 11.0 9.4 10.8 11.5 9.7 6.9 10.7 11.0 10.7 11.2 12.9 12.0 11.4 12.4 10.1 7.7 7.3 22.5 21.8 9.6 13.6 8.6 8.6 12.2 9.4 9.2 14.0 15.9 10.8 9.7 14.4 9.5 8.5 43.1 11.6 15.4 11.5 5.2 12.9 8.3 8.7 7.7 5.0 6.6 6.7 4.0 5.6 2.4 5.2 5.5 4.3 5.6 7.2 5.1 3.8 5.4 5.4 4.6 6.1 6.1 9.9 10.4 12.8 6.7 4.7 5.5 10.2 6.0 50.7 5.8 4.7 7.6 6.5 5.1 5.1 10.3 6.0 5.0 7.6 6.5 6.3 7.8 6.5 5.5 8.6 8.1 4.1 3.4 4.4 11.1 3.6 6.1 9.6 3.9 5.5 7.3 7.8 8.1 4.2 5.7 8.2 6.6 5.9 7.8 8.7 4.8 4.6 4.0 8.7 7.5 7.6 6.1 5.5 4.5 3.2 5.5 3.7 3.4 4.4 4.7 3.7 3.6 7.7 5.6 4.8 6.6 4.0 6.7 5.0 3.3 2.4 11.1 13.7 17.2 19.5 11.0 10.7 12.4 10.1 13.6 11.6 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Group enriched" "Detected in some" 5 "HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane" 290000 "Plasma membrane" Nucleoplasm "HPA047381: , HPA060101: " "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavourable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 36.5 0.2 5.1 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 19.7 18.2 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 31.1 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.4 0.0 1.7 0.5 0.7 0.3 1.1 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: " "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favourable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.2 9.0 7.8 9.9 8.4 10.8 8.5 6.0 6.8 6.6 7.0 8.9 7.4 16.3 5.1 8.1 11.3 28.7 8.0 7.1 6.4 5.2 12.2 8.7 11.3 12.0 15.6 7.1 12.8 11.0 6.1 11.7 8.4 11.2 5.8 7.7 6.6 7.3 13.8 8.8 4.0 14.5 9.4 16.8 12.5 12.2 6.8 5.5 8.1 13.1 8.8 5.9 13.2 7.4 6.7 5.9 5.4 5.6 6.2 9.4 8.6 6.6 19.8 5.2 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog (yeast)" Q9BQ75 3 99817834-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavourable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavourable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavourable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 21.4 34.1 23.7 15.1 24.5 17.7 20.6 24.1 27.4 13.4 12.9 9.4 8.2 8.3 19.6 10.7 12.0 13.3 10.5 16.6 24.0 22.2 17.1 17.5 10.8 15.8 15.3 22.3 21.1 26.4 20.7 25.9 11.7 19.2 15.1 12.4 9.3 12.4 14.5 58.2 11.5 9.3 13.8 15.7 12.9 11.0 28.1 13.5 13.6 14.9 14.4 14.7 18.8 15.7 23.5 26.1 1.6 10.9 11.2 19.0 7.9 28.5 12.9 12.8 18.4 9.1 10.7 13.2 13.3 7.2 24.0 20.0 16.0 9.6 30.9 23.4 7.1 17.3 17.7 15.1 31.7 16.0 16.9 24.4 9.2 13.0 16.3 33.3 13.4 7.3 14.7 17.9 29.9 16.5 15.0 20.1 17.3 19.7 26.6 31.1 18.7 32.5 12.0 20.7 33.1 14.8 7.0 36.1 15.2 13.3 10.9 30.3 13.1 20.8 4.7 19.0 54.0 11.0 27.0 14.4 28.6 60.1 12.3 36.9 31.7 0.3 4.7 0.8 10.0 10.9 14.2 23.2 14.8 13.5 9.9 23.5 18.7 19.0 1.6 11.2 9.7 26.1 13.7 7.9 23.7 24.5 24.1 27.4 24.0 22.2 15.3 22.3 19.2 13.5 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Cell line enhanced" "Detected in many" "REH: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.6 4.5 4.6 1.3 2.8 1.9 2.9 1.6 3.3 1.9 0.3 2.4 7.3 1.3 0.7 2.9 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 2.3 3.4 2.7 1.9 1.6 7.3 3.7 1.0 2.4 16.6 14.3 4.6 4.0 1.9 3.2 4.2 7.7 0.6 2.0 2.0 2.8 5.6 7.9 12.6 4.7 2.4 2.7 6.6 7.2 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 CMTM3 "BNAS2, CKLFSF3, FLJ31762" ENSG00000140931 "CKLF like MARVEL transmembrane domain containing 3" Q96MX0 16 66603874-66613892 "Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA013870, HPA072695" Approved Approved Nucleoplasm Nucleoplasm "HPA013870: AB_1847003, HPA072695: " "unprognostic (1.59e-1)" "unprognostic (2.83e-2)" "unprognostic (7.63e-2)" "unprognostic (1.49e-1)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (1.80e-3)" "unprognostic (6.65e-3)" "unprognostic (7.75e-2)" "unprognostic (1.60e-2)" "unprognostic (1.22e-2)" "unprognostic (7.38e-2)" "prognostic unfavourable (4.42e-6)" "prognostic unfavourable (1.85e-4)" "unprognostic (7.56e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" 24.3 8.5 5.4 11.5 6.1 8.0 29.5 1.2 4.6 19.1 7.8 10.0 7.7 3.2 18.0 19.1 10.0 12.2 16.3 15.9 5.9 4.9 8.9 6.1 21.7 34.1 6.7 2.6 25.4 6.5 22.9 5.6 30.8 8.4 16.4 6.0 15.5 9.3 8.7 7.9 11.5 9.1 14.0 8.4 19.0 6.2 61.7 6.9 35.6 8.6 10.4 14.6 13.6 21.1 1.4 19.9 7.0 11.3 6.5 12.0 4.4 1.9 9.9 28.0 19.5 21.0 13.2 17.3 5.0 23.3 10.3 10.3 5.4 6.2 0.0 14.1 14.3 2.2 18.8 16.9 8.4 9.6 6.7 6.2 1.3 15.3 28.3 18.4 22.8 26.2 1.3 10.9 2.3 23.4 9.4 0.2 12.8 2.4 14.9 30.8 13.4 9.3 46.5 19.6 0.9 4.9 0.2 2.9 10.0 2.5 0.1 16.3 0.2 17.1 15.5 14.8 17.6 3.5 6.0 1.3 0.2 6.2 9.2 14.3 15.7 6.1 11.3 7.0 7.8 10.9 10.9 1.4 8.8 8.9 9.7 0.8 6.8 8.2 6.6 6.5 6.5 19.9 12.0 4.4 5.4 6.1 1.2 4.6 5.9 4.9 6.7 2.6 8.4 6.9 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370325 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8" "Group enriched" "Detected in many" 4 "BEWO: 66.8;SK-BR-3: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.2;memory CD4 T-cell: 2.8" "Group enriched" "Detected in many" 7 "granulocytes: 4.2;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055077, HPA073258" Approved Approved Nucleoplasm Nucleoplasm "HPA055077: , HPA073258: " "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favourable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 9.7 9.9 4.3 4.1 3.5 0.9 27.0 1.5 3.4 4.7 6.8 1.3 10.8 5.2 3.4 13.4 4.2 6.3 5.7 8.2 3.6 3.2 8.8 40.0 19.9 12.6 3.9 3.3 2.1 79.8 2.8 3.1 12.4 2.5 8.8 5.5 4.4 13.5 19.2 4.3 6.2 8.1 2.0 3.1 1.5 10.0 1.1 1.6 5.5 20.7 6.0 11.2 4.7 5.6 0.1 0.0 4.2 0.1 0.4 2.8 0.3 3.2 3.4 0.6 4.2 3.1 4.8 66.8 0.0 0.1 0.3 0.4 4.6 4.7 0.0 7.0 0.0 1.8 5.4 1.0 0.2 0.0 9.8 2.1 0.6 7.7 0.1 0.8 1.7 9.4 3.4 0.4 3.3 2.6 0.0 0.0 3.4 2.3 2.7 0.3 1.4 3.1 3.8 0.8 0.6 4.1 3.7 1.1 0.9 0.5 18.9 1.7 5.4 0.4 2.3 0.0 5.0 0.0 1.0 0.1 0.1 0.0 0.0 1.4 1.1 0.0 0.1 4.2 0.3 0.0 0.4 0.0 2.8 0.8 0.0 0.1 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.3 4.3 3.5 1.5 3.4 3.6 3.2 3.9 3.3 2.5 1.6 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;RT4: 10.5;U-2 OS: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: " "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.1 0.1 0.7 0.0 2.0 0.3 0.4 0.1 0.0 0.8 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 0.0 0.8 0.7 0.2 1.3 0.1 0.2 0.6 3.0 0.1 0.0 0.1 0.6 10.5 0.3 0.1 0.2 0.6 0.2 1.1 0.0 0.6 0.3 4.1 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.3 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 CNN2 ENSG00000064666 "Calponin 2" Q99439 19 1026581-1039068 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049095 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" 39000000 Cytosol "Nucleoplasm, Actin filaments" "HPA049095: " "unprognostic (2.52e-2)" "unprognostic (2.69e-1)" "unprognostic (1.74e-1)" "unprognostic (4.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.31e-2)" "unprognostic (1.33e-1)" "unprognostic (2.56e-1)" "unprognostic (4.58e-2)" "unprognostic (6.56e-2)" "unprognostic (3.60e-2)" "unprognostic (3.33e-2)" "prognostic unfavourable (4.70e-7)" "unprognostic (1.28e-2)" "unprognostic (1.87e-1)" "unprognostic (2.50e-1)" "unprognostic (1.54e-1)" 36.6 6.5 1.3 46.2 2.5 44.2 29.2 2.0 3.0 38.2 16.9 5.4 22.2 5.5 35.5 24.5 39.4 25.0 40.1 18.7 1.5 1.5 24.6 15.8 54.7 61.5 3.5 1.5 81.1 26.8 1.9 6.9 21.5 4.8 35.6 7.8 26.3 40.9 34.4 6.1 21.3 17.7 28.2 2.9 59.4 21.1 15.9 2.1 37.0 68.1 27.3 78.6 37.9 51.2 33.6 29.3 115.7 26.3 27.1 57.0 43.1 37.2 12.6 35.1 43.7 18.1 34.5 27.3 33.7 37.4 42.6 33.1 43.3 32.2 24.5 34.6 60.9 36.7 20.8 53.9 28.4 17.0 1.7 17.0 20.2 33.8 72.6 15.9 39.2 58.7 25.7 26.9 20.4 23.9 10.1 38.2 34.6 7.1 1.4 14.6 43.3 5.5 8.4 12.4 27.7 41.8 44.8 0.0 2.5 42.7 5.8 4.8 42.4 26.8 58.7 23.3 24.2 35.6 34.3 17.8 13.5 48.9 13.7 19.1 37.2 61.3 18.6 81.0 34.8 24.2 57.0 33.6 43.7 46.4 29.3 30.8 37.3 36.3 115.7 27.1 26.3 13.0 45.6 43.1 1.3 2.5 2.0 3.0 1.5 1.5 3.5 1.5 4.8 2.1 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: " "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavourable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 12.3 12.6 11.3 15.2 12.4 16.6 14.0 14.2 13.4 13.4 14.0 12.5 12.8 10.8 19.8 13.5 14.8 16.1 9.8 13.0 10.5 9.4 13.1 13.5 11.4 14.7 9.7 11.9 14.7 14.0 16.0 23.0 11.3 13.3 13.1 15.7 12.2 12.0 10.9 13.5 14.9 14.7 12.8 10.5 15.1 12.2 40.5 10.9 30.2 13.8 11.9 17.4 13.0 12.6 15.0 14.1 16.0 21.0 9.0 18.5 11.2 8.2 9.3 9.7 9.1 4.7 5.4 64.7 7.0 7.0 10.0 11.3 7.0 7.2 13.6 4.7 4.9 7.3 11.4 9.2 10.0 11.7 11.7 17.4 8.4 6.8 13.7 14.3 6.7 4.0 8.3 11.0 14.6 8.1 18.1 10.6 5.8 6.8 12.7 6.9 14.6 8.9 12.9 6.6 13.6 6.4 9.7 5.5 10.7 10.3 14.5 8.4 14.1 16.2 5.0 6.2 8.8 8.1 11.5 11.0 22.5 13.6 6.3 10.9 7.5 12.8 11.2 16.0 11.4 15.7 12.3 14.8 18.5 13.6 14.1 15.0 18.5 16.2 8.8 9.0 21.0 7.8 14.4 11.2 11.3 12.4 14.2 13.4 10.5 9.4 9.7 11.9 13.3 10.9 CNOT11 "C2orf29, C40" ENSG00000158435 "CCR4-NOT transcription complex subunit 11" Q9UKZ1 2 101252802-101270316 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069823, HPA074943" Enhanced Approved Nucleoplasm Nucleoplasm "HPA069823: , HPA074943: " "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (5.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.02e-2)" "unprognostic (1.13e-3)" "prognostic unfavourable (1.05e-4)" "unprognostic (3.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "prognostic unfavourable (8.33e-6)" "unprognostic (4.19e-2)" "unprognostic (2.35e-1)" "unprognostic (3.62e-3)" "unprognostic (2.72e-3)" 13.2 19.0 13.9 19.7 15.1 20.9 14.4 13.3 18.6 17.0 21.5 15.0 19.7 23.0 19.2 18.2 31.9 17.7 23.7 25.6 12.5 12.5 23.9 28.9 14.9 24.1 15.0 13.8 14.3 27.9 16.8 17.6 36.7 16.9 20.6 26.0 16.9 22.5 15.8 27.3 17.5 25.5 15.3 11.1 27.2 25.0 32.5 13.2 39.8 19.4 23.6 30.7 20.7 17.0 4.0 3.6 11.1 3.9 1.6 5.9 1.7 15.9 11.0 18.1 25.2 15.3 18.5 54.0 16.6 20.9 20.5 21.8 24.3 18.4 28.2 19.7 14.8 19.4 21.6 19.7 25.0 19.2 18.5 23.5 12.0 36.2 16.9 28.2 23.4 14.5 18.2 14.7 15.7 23.0 26.2 17.2 18.5 16.5 27.5 30.7 22.6 15.7 17.7 19.8 21.6 28.1 30.4 27.4 17.4 10.0 29.9 26.6 18.9 26.2 15.3 16.2 18.7 13.9 13.8 24.8 23.1 22.2 17.8 32.0 18.7 9.1 2.8 4.9 4.5 3.9 3.1 2.9 4.7 5.5 2.2 4.0 4.4 5.9 11.1 1.6 3.6 3.6 5.7 1.7 13.9 15.1 13.3 18.6 12.5 12.5 15.0 13.8 16.9 13.2 CNOT2 "CDC36, NOT2, NOT2H" ENSG00000111596 "CCR4-NOT transcription complex subunit 2" Q9NZN8 12 70242994-70354993 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067711 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA067711: " "unprognostic (5.00e-2)" "unprognostic (2.12e-1)" "unprognostic (6.95e-2)" "unprognostic (3.60e-2)" "unprognostic (3.48e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (2.21e-4)" "unprognostic (7.36e-2)" "prognostic unfavourable (6.86e-4)" "unprognostic (1.32e-1)" "unprognostic (9.70e-2)" "unprognostic (2.99e-2)" "prognostic unfavourable (8.63e-5)" "unprognostic (1.28e-1)" "unprognostic (5.58e-2)" "unprognostic (5.97e-2)" "unprognostic (6.23e-2)" 27.8 19.9 18.9 24.6 23.8 44.5 24.9 53.3 24.7 24.0 21.7 21.9 21.6 20.1 37.5 25.8 22.5 20.6 18.8 20.1 18.7 16.2 21.8 24.1 25.9 24.8 23.8 21.2 26.8 20.5 25.0 41.2 30.1 19.8 24.3 24.9 20.5 21.6 21.9 27.6 36.7 24.4 25.5 23.4 26.8 18.8 16.3 24.8 46.1 22.7 20.9 28.8 24.8 24.5 28.8 33.1 37.1 36.5 32.2 41.3 27.2 19.9 19.0 32.3 20.4 17.8 20.2 26.9 22.2 26.8 24.6 21.2 24.4 19.5 42.9 20.5 25.3 19.8 22.4 21.8 27.7 20.5 20.3 28.2 17.6 22.8 19.0 36.4 25.2 22.0 24.5 23.2 28.2 26.1 25.6 24.9 21.4 21.6 41.5 26.0 27.5 20.3 32.3 26.7 26.0 22.8 40.3 21.6 25.5 26.1 21.1 18.7 27.0 30.2 19.0 23.0 15.9 21.0 17.9 22.7 26.0 34.0 23.6 17.9 18.0 37.1 26.0 28.3 29.4 36.5 32.8 28.8 31.9 32.9 33.1 27.6 38.0 41.3 15.1 32.2 29.3 23.0 29.7 27.2 18.9 23.8 53.3 24.7 18.7 16.2 23.8 21.2 19.8 24.8 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell line enhanced" "Detected in many" "TIME: 29.6;U-138 MG: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.7 2.6 5.7 1.9 8.9 18.2 0.3 10.8 18.8 8.0 7.2 0.3 0.4 0.0 0.6 11.8 2.1 2.8 0.8 6.3 4.2 0.9 0.0 10.6 2.6 4.4 0.0 0.1 17.7 0.0 7.6 1.5 10.0 0.5 3.3 3.0 0.3 0.0 1.5 2.0 2.5 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.0 2.0 0.9 29.6 34.3 5.8 7.9 2.9 4.0 2.4 0.1 9.5 0.7 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell line enhanced" "Detected in some" "AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: , HPA069356: " "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876988 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favourable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 19.0 46.2 18.9 17.0 17.3 10.8 18.1 12.2 20.2 17.5 23.9 25.7 27.0 24.7 18.0 22.4 24.9 20.1 31.5 35.3 17.7 17.0 33.2 74.7 14.7 20.2 20.5 16.3 23.2 37.1 17.6 17.2 18.3 19.4 21.5 21.1 17.6 21.2 28.0 33.2 14.4 31.2 16.2 21.5 20.1 19.2 13.5 19.4 16.3 38.7 27.6 18.2 21.5 18.9 23.4 32.3 5.3 20.6 16.7 21.2 15.0 22.9 42.8 17.7 25.7 15.7 19.6 17.8 23.4 16.3 27.9 23.6 31.2 28.6 19.6 47.5 19.3 23.1 27.0 31.4 21.7 25.5 24.6 32.8 26.7 29.3 29.8 22.2 25.7 24.7 30.1 46.5 30.3 25.5 28.2 19.3 24.9 43.7 17.5 34.8 23.2 44.4 20.5 38.0 51.7 29.4 21.3 16.0 26.9 21.7 24.9 63.0 34.9 22.6 17.4 23.0 20.5 46.3 30.6 23.9 25.9 66.3 12.6 27.8 26.0 5.3 20.5 4.7 15.9 20.6 20.2 23.4 18.7 16.5 24.6 20.4 20.1 21.2 1.4 16.7 19.1 32.3 19.0 15.0 18.9 17.3 12.2 20.2 17.7 17.0 20.5 16.3 19.4 19.4 COA6 C1orf31 ENSG00000168275 "Cytochrome c oxidase assembly factor 6" Q5JTJ3 1 234373456-234384049 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA028588 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA028588: AB_10601123" "unprognostic (6.26e-2)" "unprognostic (1.92e-1)" "unprognostic (3.05e-1)" "unprognostic (1.01e-1)" "unprognostic (7.87e-2)" "unprognostic (1.20e-3)" "unprognostic (4.04e-3)" "unprognostic (4.89e-2)" "unprognostic (2.79e-2)" "unprognostic (6.25e-3)" "unprognostic (9.24e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (2.19e-1)" "prognostic favourable (7.12e-4)" 11.0 17.8 26.4 14.4 33.9 9.4 16.6 14.3 27.5 9.7 17.7 5.7 12.9 26.4 8.4 20.3 15.5 9.4 14.2 19.1 19.3 15.7 21.4 21.4 13.6 16.2 16.3 16.1 9.1 16.7 7.6 9.5 8.7 13.4 13.3 15.6 6.0 13.6 11.6 52.7 8.7 19.7 10.6 11.4 12.5 14.4 5.8 13.3 13.1 13.6 20.2 12.0 11.6 14.6 27.5 33.3 19.7 31.3 18.3 36.6 20.2 17.8 22.9 8.3 9.4 8.8 17.3 26.5 13.1 8.0 13.8 13.0 17.6 23.9 17.9 24.4 7.5 22.8 12.9 16.2 11.0 22.1 55.2 8.0 26.1 46.6 33.7 19.7 15.6 11.4 21.8 18.1 14.0 17.0 38.9 16.1 15.0 9.5 18.6 38.1 20.4 10.9 11.1 10.0 35.1 17.2 17.0 14.8 10.8 12.8 22.6 40.4 20.1 34.0 12.8 16.4 13.6 22.0 39.2 19.2 37.2 21.8 12.5 31.2 29.2 19.7 31.3 9.7 18.5 28.5 18.2 27.5 29.9 23.0 33.3 18.0 31.3 23.1 8.1 18.3 23.8 22.5 36.6 20.2 26.4 33.9 14.3 27.5 19.3 15.7 16.3 16.1 13.4 13.3 COA7 "C1orf163, FLJ12439, RESA1, SELRC1" ENSG00000162377 "Cytochrome c oxidase assembly factor 7 (putative)" Q96BR5 1 52684451-52698366 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028154, HPA029926" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA028154: AB_10600656, HPA029926: AB_10602173" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.29e-2)" "prognostic unfavourable (8.55e-4)" "unprognostic (2.30e-2)" "unprognostic (5.12e-2)" "prognostic unfavourable (7.01e-5)" "unprognostic (1.14e-1)" "unprognostic (2.27e-2)" "unprognostic (1.24e-1)" "unprognostic (4.07e-2)" "unprognostic (7.42e-2)" "unprognostic (2.49e-1)" "prognostic favourable (4.35e-4)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 8.8 8.5 9.0 6.9 10.6 4.6 9.7 7.9 16.6 6.6 10.1 7.0 4.1 10.1 8.5 6.0 9.5 6.6 5.2 8.6 7.6 9.2 12.8 15.7 5.5 4.9 8.4 12.4 6.7 19.1 7.2 7.7 7.4 10.0 4.9 10.3 4.2 6.7 5.2 26.3 8.6 7.2 8.0 7.6 6.1 7.0 4.3 7.8 2.3 9.6 9.9 5.8 6.9 7.9 3.7 5.9 3.3 8.4 2.3 3.4 2.7 12.2 7.0 6.4 10.5 10.4 9.1 14.2 9.3 7.7 11.5 9.7 8.6 4.4 28.2 6.3 5.4 9.4 15.5 13.0 15.1 8.6 15.5 23.7 11.0 9.9 12.9 23.2 8.1 10.0 11.6 13.1 16.5 7.9 21.5 5.0 8.7 8.1 7.8 12.0 28.3 19.9 15.5 22.0 20.4 10.2 12.4 14.4 7.6 13.4 17.3 17.1 10.1 15.9 8.7 9.1 12.0 12.5 12.7 10.5 26.2 13.1 4.2 16.9 7.4 3.1 5.9 1.8 2.5 8.4 3.4 3.7 2.6 2.5 5.9 1.8 2.4 2.6 3.3 2.3 4.0 2.8 1.5 2.7 9.0 10.6 7.9 16.6 7.6 9.2 8.4 12.4 10.0 7.8 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536630 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: " "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavourable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 12.5 17.4 8.7 17.1 14.0 10.9 17.0 19.7 14.5 16.9 17.1 13.0 22.4 13.2 16.9 20.6 14.4 14.0 12.8 12.5 8.9 9.4 16.5 46.2 12.1 11.7 9.3 10.0 17.9 29.4 10.9 22.6 32.9 11.5 20.9 20.7 12.9 28.3 25.2 12.5 14.7 18.8 13.3 10.1 14.8 15.6 9.9 11.2 17.4 18.5 8.7 18.5 14.8 14.8 5.1 7.2 7.4 4.6 4.9 8.0 3.8 5.8 5.3 10.2 9.1 13.4 15.4 9.7 9.7 13.8 11.4 9.5 7.7 10.8 8.0 4.3 11.5 12.8 8.4 9.8 17.3 6.2 6.8 9.0 6.4 13.5 16.6 13.1 8.6 11.5 14.9 7.5 26.8 11.0 5.8 4.9 13.5 9.0 7.2 12.4 8.3 6.4 8.5 5.9 7.4 10.6 9.5 5.1 9.2 6.3 12.4 12.9 8.5 13.6 10.3 5.5 4.3 10.2 6.1 6.9 3.7 8.3 10.5 6.7 9.7 7.4 4.1 7.3 7.5 4.6 8.0 5.1 5.8 6.4 3.1 4.9 6.6 6.1 3.7 4.9 2.9 7.2 6.2 3.8 8.7 14.0 19.7 14.5 8.9 9.4 9.3 10.0 11.5 11.2 COL12A1 COL12A1L ENSG00000111799 "Collagen type XII alpha 1 chain" Q99715 6 75084326-75206051 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 136.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 161.0;SiHa: 95.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA009143, HPA070695" Uncertain Approved Nucleoplasm "Secreted to extracellular matrix" 4300000 Nucleoplasm "HPA009143: AB_1847095, HPA070695: " "unprognostic (2.60e-2)" "unprognostic (2.80e-3)" "unprognostic (7.92e-2)" "unprognostic (8.27e-3)" "unprognostic (1.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (3.47e-3)" "unprognostic (1.38e-1)" "unprognostic (4.30e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "prognostic unfavourable (1.69e-9)" "unprognostic (1.03e-3)" "unprognostic (1.81e-1)" "unprognostic (3.16e-3)" "unprognostic (1.92e-2)" 53.1 5.6 0.9 33.1 1.3 0.0 136.8 0.4 2.0 65.0 23.0 0.5 14.8 4.2 64.6 18.1 29.2 14.9 16.3 17.1 1.1 1.1 7.6 1.5 22.2 23.5 2.0 1.5 52.0 4.1 1.5 1.9 2.6 1.6 12.3 8.7 2.4 5.9 21.4 21.6 16.8 14.1 32.4 1.4 5.0 6.9 10.6 0.4 1.0 8.2 15.0 4.4 24.8 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 34.5 19.3 3.2 31.3 26.1 21.6 30.1 3.1 0.0 0.0 3.2 161.0 6.9 0.0 3.3 20.4 0.0 0.1 0.0 11.6 0.0 12.9 0.0 0.0 28.9 0.5 4.8 5.9 3.6 0.0 0.0 3.5 0.0 0.0 0.0 0.8 1.7 0.0 2.7 0.0 1.1 1.6 0.0 0.0 95.7 2.5 0.0 15.2 0.0 0.0 9.3 11.5 4.9 10.4 0.0 0.0 0.0 3.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.4 2.0 1.1 1.1 2.0 1.5 1.6 0.4 COL28A1 ENSG00000215018 "Collagen type XXVIII alpha 1 chain" Q2UY09 7 7356203-7535853 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 3.2;U-266/70: 13.9;U-266/84: 3.7;WM-115: 6.7" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 8 "olfactory region: 4.5" "Not detected" "Not detected" "HPA043844, HPA060468" Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" "Nucleoplasm, Cytosol" "HPA043844: , HPA060468: " "unprognostic (6.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.28e-1)" "unprognostic (8.71e-3)" "unprognostic (1.89e-2)" "unprognostic (5.63e-3)" "unprognostic (2.61e-2)" "unprognostic (7.58e-2)" "unprognostic (2.72e-2)" "unprognostic (7.69e-2)" "unprognostic (3.90e-3)" "unprognostic (2.33e-2)" "unprognostic (3.45e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (2.48e-3)" "unprognostic (3.09e-2)" 2.7 3.7 1.0 7.0 1.1 0.3 3.1 2.4 1.6 10.2 11.8 0.6 11.5 1.3 2.9 16.2 14.7 5.5 5.7 7.0 1.3 2.2 2.8 1.9 1.3 1.0 9.8 0.2 2.9 5.8 0.1 12.2 0.5 6.1 5.8 4.7 12.8 19.3 6.2 5.6 2.1 6.6 16.0 7.9 0.3 5.7 3.2 0.2 0.2 1.4 10.2 0.9 8.4 14.2 0.6 0.3 1.6 0.2 2.1 1.0 0.0 2.0 0.0 0.0 0.0 0.2 1.1 0.3 0.1 0.6 0.0 0.0 1.6 0.6 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.3 2.0 0.2 0.3 0.0 0.9 0.5 0.0 0.1 0.0 3.2 0.1 0.2 0.0 0.1 1.0 0.0 0.1 0.8 1.0 0.0 0.7 1.8 0.0 13.9 3.7 0.0 0.2 0.8 6.7 0.5 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.6 0.4 1.0 1.6 2.1 0.1 0.3 0.0 0.0 1.0 1.1 2.4 1.3 1.3 2.2 9.8 0.2 6.1 0.2 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972965-48004554 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3" "Cell line enhanced" "Detected in some" "AF22: 54.0;HAP1: 33.8;HEK 293: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB002214, HPA055753" Supported Approved Nucleoplasm "Secreted to extracellular matrix" Nucleoplasm "CAB002214: AB_563666, HPA055753: " "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 2.2 0.3 0.0 0.7 0.9 0.9 0.0 0.2 0.3 0.0 0.0 0.3 22.7 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.7 1.3 0.0 0.0 11.0 0.4 1.9 2.6 0.4 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 11.3 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 33.8 0.0 0.0 0.0 12.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.9 0.5 1.3 0.0 0.7 1.9 0.0 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell line enhanced" "Detected in some" "HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA056316: , HPA075286: " "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.2 0.1 0.6 0.3 0.9 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.4 1.2 3.7 0.1 0.7 0.0 0.0 0.1 34.6 0.5 0.7 0.3 9.7 0.6 0.3 33.4 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.9 0.4 0.7 0.8 0.4 0.8 0.0 2.4 0.0 5.1 0.5 0.8 0.0 4.3 0.4 5.4 37.4 0.0 0.0 4.4 0.0 0.1 0.5 0.0 1.1 0.3 4.4 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in some" 6 "BEWO: 52.5;Hep G2: 20.7;SK-MEL-30: 17.2;WM-115: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: " "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 52.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.4 20.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 2.3 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.2 0.0 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell line enhanced" "Detected in many" "Hep G2: 12.7;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 17.0" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "basophil: 8.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 2.1 9.4 10.8 1.7 16.6 1.9 2.8 10.6 39.0 2.0 3.0 31.3 0.0 1.4 3.0 5.2 1.7 3.5 3.7 11.7 15.3 7.9 1.8 1.0 4.5 1.1 20.2 12.9 2.3 3.5 1.0 1.9 0.8 17.4 8.1 2.0 3.5 4.4 3.7 11.0 1.1 1.4 3.0 21.8 1.3 3.4 5.0 22.5 0.0 5.1 1.8 1.5 2.4 1.4 0.0 0.0 8.1 0.0 0.7 0.6 0.1 0.1 0.0 4.4 0.2 2.3 3.4 0.1 1.2 0.5 0.6 0.7 2.1 0.2 0.0 0.3 3.3 0.0 4.2 0.0 1.1 4.6 2.3 0.3 0.0 12.7 0.1 4.1 0.0 2.0 0.0 0.6 0.1 0.0 4.1 5.4 4.6 0.1 0.2 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.9 1.7 2.7 0.2 0.0 13.7 0.0 0.2 0.0 0.5 0.4 0.0 13.1 8.0 0.0 0.0 0.4 2.0 17.0 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 10.8 16.6 10.6 17.2 15.3 7.9 20.2 12.9 17.4 22.5 COMMD2 HSPC042 ENSG00000114744 "COMM domain containing 2" Q86X83 3 149738470-149752499 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044190 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044190: AB_10966289" "unprognostic (2.17e-1)" "unprognostic (8.34e-3)" "unprognostic (6.28e-2)" "unprognostic (1.55e-3)" "unprognostic (1.53e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" "unprognostic (4.93e-2)" "prognostic unfavourable (3.69e-6)" "unprognostic (1.31e-1)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.89e-1)" "unprognostic (6.25e-2)" "unprognostic (4.86e-2)" 14.1 11.2 13.3 9.6 16.1 10.3 20.9 22.0 18.3 17.2 10.9 21.1 4.8 10.6 18.8 10.5 14.6 13.2 10.6 11.2 13.4 12.3 21.9 17.2 17.0 13.2 16.0 12.5 18.1 11.3 14.4 14.2 22.3 18.7 14.0 11.7 14.1 14.6 12.2 9.4 13.3 15.8 17.0 19.6 15.2 10.4 9.6 14.4 20.5 19.3 9.6 14.6 12.4 12.8 8.7 10.0 16.4 14.2 11.7 11.4 9.4 16.6 4.9 15.9 9.2 14.0 16.1 10.6 10.4 11.0 16.3 16.5 8.5 10.4 13.4 12.0 10.2 10.7 15.2 12.8 19.0 9.9 14.5 12.0 6.7 5.7 15.0 17.3 5.5 12.1 14.1 8.0 14.4 11.4 5.9 7.6 11.6 5.2 11.9 8.5 17.6 6.6 11.1 16.1 17.9 15.4 4.4 7.3 11.3 12.2 9.8 22.5 18.2 11.5 9.9 9.6 3.9 9.5 12.4 13.8 5.4 22.1 9.3 15.6 3.9 16.4 8.2 13.9 8.0 12.0 11.4 8.7 9.8 9.5 10.0 8.0 10.4 10.9 6.4 11.7 14.2 6.2 7.8 9.4 13.3 16.1 22.0 18.3 13.4 12.3 16.0 12.5 18.7 14.4 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: , HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 8.5 12.4 4.5 6.6 9.1 2.8 6.9 5.1 8.5 9.7 11.9 4.7 8.3 4.9 4.0 5.9 9.4 8.3 4.3 14.3 4.7 4.1 5.5 6.9 8.0 5.0 6.6 4.7 4.3 11.4 5.7 8.7 4.7 5.7 5.0 2.8 4.2 8.3 14.6 22.8 4.8 7.6 7.0 7.3 7.3 7.6 23.4 6.6 12.3 3.7 7.6 6.4 12.0 5.4 25.0 30.3 25.7 25.8 18.8 21.6 26.6 3.8 13.8 4.8 0.5 5.6 3.8 0.7 3.9 4.3 2.1 5.5 7.6 1.5 1.9 5.7 13.0 1.8 5.1 8.4 0.7 15.2 1.7 5.2 2.9 3.3 17.1 0.4 2.4 6.7 4.8 7.6 4.0 5.3 1.0 5.4 0.6 3.7 15.6 0.5 0.5 4.3 4.4 5.3 4.2 2.1 4.7 0.5 1.7 7.4 1.8 1.6 3.4 3.8 7.0 1.7 5.4 0.3 1.0 11.6 14.0 6.1 2.6 11.6 1.7 25.7 25.8 17.2 15.1 23.5 16.6 25.0 16.1 14.7 30.3 21.9 11.0 12.2 3.8 18.8 17.8 29.2 21.6 26.6 4.5 9.1 5.1 8.5 4.7 4.1 6.6 4.7 5.7 6.6 COPA HEP-COP ENSG00000122218 "Coatomer protein complex subunit alpha" P53621 1 160289273-160343400 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028024 Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" 260000 "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA028024: AB_10603787" "unprognostic (1.59e-2)" "prognostic unfavourable (6.54e-4)" "unprognostic (2.77e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-2)" "unprognostic (5.41e-3)" "prognostic unfavourable (1.08e-4)" "unprognostic (8.42e-2)" "unprognostic (3.14e-1)" "unprognostic (2.21e-1)" "unprognostic (5.03e-2)" "unprognostic (3.10e-1)" "unprognostic (2.05e-2)" "unprognostic (8.70e-2)" "unprognostic (2.03e-1)" "unprognostic (4.94e-2)" "unprognostic (1.39e-1)" 38.3 32.7 29.2 28.9 41.0 22.9 32.4 43.1 48.4 46.3 34.3 53.2 24.5 38.4 37.0 33.1 28.4 31.5 28.6 38.4 33.3 35.2 36.3 64.3 33.8 26.6 42.7 29.3 36.8 47.8 49.1 57.4 45.1 56.2 35.3 39.9 28.8 42.1 33.9 40.5 28.7 50.3 40.4 42.8 36.6 32.8 21.2 35.8 36.0 42.8 21.0 34.1 30.3 27.5 15.4 31.4 25.1 29.1 18.1 21.2 25.3 28.1 22.1 23.4 22.7 60.4 49.8 27.5 38.7 46.0 33.0 39.0 28.8 19.2 20.7 25.1 58.7 28.3 27.1 27.9 38.0 23.5 18.3 23.8 30.4 30.2 45.4 28.9 24.9 46.5 17.0 44.0 41.1 38.6 21.9 23.2 39.3 20.6 18.6 12.6 25.7 25.8 16.7 27.0 31.8 27.0 26.6 19.5 24.6 43.7 38.4 40.9 42.8 39.1 45.5 24.9 19.4 33.3 25.4 38.2 26.5 31.8 32.4 15.1 37.0 25.1 29.1 20.1 17.1 27.3 21.2 15.4 14.3 18.3 31.4 12.1 13.2 15.2 10.8 18.1 27.9 13.3 17.5 25.3 29.2 41.0 43.1 48.4 33.3 35.2 42.7 29.3 56.2 35.8 COPG1 COPG ENSG00000181789 "Coatomer protein complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" 110000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: " "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 25.2 39.4 21.1 22.2 28.0 20.1 37.3 23.6 50.3 43.3 42.1 24.3 50.6 34.2 27.6 66.5 29.5 24.4 34.5 33.4 24.2 26.7 32.4 72.1 36.5 39.4 23.0 21.6 28.6 75.6 47.6 49.7 49.3 34.9 45.1 45.1 22.4 59.9 45.5 24.1 24.3 32.4 29.1 20.7 29.0 36.3 23.6 16.2 26.9 33.0 22.0 27.7 19.9 24.1 15.7 31.9 34.9 33.0 31.1 31.8 26.0 32.4 16.5 24.1 20.9 56.6 45.9 25.8 52.9 50.6 36.5 46.2 30.3 20.2 17.8 30.8 75.2 19.6 19.9 31.2 39.8 21.7 8.2 29.6 21.8 48.9 51.6 22.4 31.8 47.9 27.5 29.2 48.2 32.8 10.3 43.1 43.9 49.3 13.1 22.8 14.4 20.2 14.2 22.7 34.5 45.5 27.0 15.1 17.6 40.6 30.4 48.5 33.6 32.8 44.4 19.9 18.9 42.0 20.4 33.7 16.1 31.2 48.6 17.1 38.1 34.9 26.8 20.2 26.2 33.0 31.8 15.0 23.7 25.7 31.9 15.7 18.5 21.6 21.3 31.1 29.7 29.4 23.6 26.0 21.1 28.0 23.6 50.3 24.2 26.7 23.0 21.6 34.9 16.2 COPS9 "CSNAP, MYEOV2" ENSG00000172428 "COP9 signalosome subunit 9" Q8WXC6 2 240126563-240136807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044845 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044845: AB_10962975" "unprognostic (6.05e-3)" "unprognostic (1.44e-1)" "unprognostic (7.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (3.72e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (1.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.25e-3)" "unprognostic (9.02e-2)" "unprognostic (3.02e-1)" "unprognostic (3.71e-1)" "unprognostic (2.26e-2)" "unprognostic (3.03e-1)" "unprognostic (4.37e-2)" 31.9 29.1 81.6 20.6 73.2 24.0 40.9 22.6 61.6 29.1 27.6 22.7 20.5 25.6 17.2 53.2 34.5 23.5 25.4 62.3 75.8 44.7 30.5 23.5 17.8 26.7 64.3 24.3 23.2 64.3 8.9 27.6 17.6 32.9 25.9 18.9 19.0 43.3 26.5 86.9 20.6 24.5 21.1 52.6 22.6 25.8 18.8 25.9 26.5 34.7 41.6 19.8 23.5 20.9 68.2 79.9 90.7 67.7 52.4 82.0 79.9 26.6 36.2 28.6 29.8 39.5 32.3 26.3 38.6 27.0 25.4 32.5 26.2 24.0 7.4 11.7 35.2 21.5 25.2 35.8 17.6 31.3 93.1 22.2 37.3 81.1 31.5 22.2 20.9 37.9 29.6 18.9 23.6 37.2 25.5 16.0 36.8 57.7 35.5 69.3 43.4 79.1 28.0 38.3 23.0 31.4 46.1 33.1 33.2 20.3 27.7 41.3 25.5 43.4 30.0 33.6 37.6 42.7 36.7 32.9 27.9 37.3 41.9 26.4 33.0 90.7 67.2 87.6 68.6 66.6 68.0 68.2 71.2 70.1 62.6 52.8 62.6 70.5 24.1 52.4 67.7 79.9 82.0 79.9 81.6 73.2 22.6 61.6 75.8 44.7 64.3 24.3 32.9 25.9 COQ3 bA9819.1 ENSG00000132423 "Coenzyme Q3, methyltransferase" Q9NZJ6 6 99369400-99394204 "Enzymes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031273, HPA031274" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA031273: AB_10611107, HPA031274: AB_10602176" "unprognostic (1.81e-2)" "unprognostic (2.69e-2)" "unprognostic (1.45e-2)" "unprognostic (4.62e-2)" "unprognostic (2.41e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-3)" "unprognostic (1.76e-1)" "unprognostic (3.40e-1)" "unprognostic (8.77e-2)" "unprognostic (9.78e-2)" "unprognostic (1.09e-1)" "prognostic favourable (6.86e-5)" "unprognostic (4.61e-2)" "unprognostic (1.81e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" 5.2 7.8 8.6 4.2 10.8 3.2 7.5 13.6 16.3 4.5 8.9 4.5 4.3 6.9 4.3 6.8 8.2 4.5 3.0 21.7 8.2 7.5 10.2 12.4 2.9 7.1 6.9 12.0 6.0 5.7 11.6 7.4 2.5 9.8 6.8 11.0 7.3 11.7 7.6 28.0 5.8 6.3 6.6 4.6 4.8 5.2 2.3 6.0 4.1 4.3 16.8 7.0 7.5 4.6 6.6 8.0 9.4 7.4 9.7 12.5 5.3 11.9 6.9 8.4 11.8 5.4 6.1 11.5 10.4 6.4 15.7 18.2 9.6 5.2 11.8 6.9 7.7 11.2 13.9 16.2 19.2 12.4 17.8 14.3 9.4 10.2 7.2 20.6 5.6 3.9 9.9 9.2 9.4 9.5 21.7 8.9 8.3 11.9 9.0 17.3 10.1 13.3 4.4 8.6 15.6 12.3 10.5 13.1 7.0 7.2 11.1 13.5 13.6 13.7 3.4 6.9 10.1 10.5 15.7 3.1 5.8 18.4 8.8 20.1 10.1 9.4 3.3 2.4 6.0 7.4 6.8 6.6 7.6 9.5 8.0 3.1 12.5 9.5 0.5 9.7 6.3 5.2 5.5 5.3 8.6 10.8 13.6 16.3 8.2 7.5 6.9 12.0 9.8 6.0 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA067252: , HPA071922: " "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favourable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.4 13.4 11.6 6.8 6.6 7.0 9.8 7.3 6.0 10.0 10.4 8.5 10.4 9.5 35.6 5.6 13.2 16.2 9.1 7.2 8.0 16.3 5.0 12.3 26.0 8.1 12.0 11.2 5.8 8.1 9.3 6.8 8.1 13.8 8.9 7.0 22.4 12.5 9.7 8.8 7.2 15.3 12.9 12.1 8.7 8.4 16.9 9.7 6.8 15.1 8.5 13.8 16.4 8.8 10.7 6.2 7.7 10.5 8.3 13.4 10.4 11.4 7.0 6.8 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.1;SCLC-21H: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavourable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.1 0.1 0.2 0.2 1.7 0.7 0.2 0.2 0.8 0.6 0.0 1.7 0.1 0.3 0.1 1.7 0.2 2.4 0.4 0.5 0.0 0.4 0.2 0.0 0.4 0.1 0.2 0.6 0.5 0.1 0.0 0.2 0.0 0.4 9.5 0.3 0.3 0.1 0.0 0.4 0.0 0.3 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865256-148897196 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 111.7" "Cell line enriched" "Detected in some" 43 "HEL: 79.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1118 "basophil: 111.7" "Lineage enriched" "Detected in single" 1118 "granulocytes: 111.7" "Low region specificity" "Detected in single" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 12.4 0.6 0.4 12.0 0.4 5.6 6.2 0.4 0.5 25.4 14.1 0.8 4.4 7.1 14.1 21.2 16.5 3.7 50.9 4.5 0.4 0.2 5.8 2.8 37.3 15.2 0.4 0.4 2.0 7.2 0.7 0.8 1.3 0.5 37.3 16.4 8.5 8.8 5.8 1.4 12.7 20.2 24.3 0.4 1.0 13.7 7.1 0.4 3.6 1.4 9.9 7.1 14.0 8.9 0.0 0.0 111.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 79.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.5 0.4 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavourable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 20.2 1.1 0.0 0.0 0.1 0.3 0.0 16.2 30.8 16.6 4.1 0.1 1.7 0.0 3.2 6.9 1.2 0.0 8.9 17.2 0.1 0.0 0.0 6.5 0.4 0.4 0.0 0.0 0.2 14.5 1.5 2.1 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.1 2.4 0.0 16.7 0.0 7.8 0.8 0.0 0.0 10.7 5.1 0.1 0.1 0.0 12.4 4.0 34.2 1.3 1.6 0.0 0.0 0.0 61.4 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 CPA5 ENSG00000158525 "Carboxypeptidase A5" Q8WXQ8 7 130344816-130368730 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "blood: 25.2;testis: 30.4" "Cell line enhanced" "Detected in some" "RH-30: 10.9;RT4: 4.9;U-266/84: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2" "Lineage enriched" "Detected in single" 114 "T-cells: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020322 Approved Nucleoplasm "Secreted in male reproductive system" Nucleoplasm "HPA020322: AB_10960562" "unprognostic (2.44e-1)" "unprognostic (3.76e-1)" "unprognostic (1.50e-1)" "unprognostic (5.94e-2)" "unprognostic (4.96e-2)" "unprognostic (7.10e-3)" "unprognostic (1.64e-2)" "unprognostic (1.41e-2)" "unprognostic (3.26e-1)" "unprognostic (5.02e-2)" "unprognostic (5.83e-4)" "unprognostic (1.43e-1)" "unprognostic (8.88e-13)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (8.81e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.4 0.0 1.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 1.6 0.0 30.4 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.0 0.0 0.2 0.0 0.0 25.2 3.1 0.8 0.0 0.1 0.6 0.0 0.0 0.0 0.4 3.2 0.2 0.4 2.4 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 1.8 0.7 0.7 1.2 0.5 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.8 0.0 0.0 10.9 0.3 1.4 4.9 1.4 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 8.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 8.0 4.1 0.0 0.0 2.1 20.3 0.0 0.0 0.0 0.0 25.2 3.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 CPD GP180 ENSG00000108582 "Carboxypeptidase D" O75976 17 30378905-30469989 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HSkMC: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052796, HPA055465" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear speckles" 930000 "Nucleoplasm, Nuclear speckles" "Nuclear membrane" "HPA052796: , HPA055465: " "unprognostic (1.05e-1)" "unprognostic (1.31e-1)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (6.13e-2)" "unprognostic (1.65e-1)" "unprognostic (7.97e-3)" "unprognostic (4.45e-2)" "unprognostic (2.07e-2)" "unprognostic (2.96e-1)" "unprognostic (1.62e-1)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.25e-2)" "unprognostic (3.36e-1)" "unprognostic (1.08e-1)" 16.4 8.0 9.8 12.3 12.4 18.1 17.9 9.1 13.3 28.6 16.2 18.5 10.1 12.9 12.6 10.1 10.0 15.2 33.6 10.5 12.8 10.4 13.4 26.8 20.0 14.2 22.1 11.4 7.8 14.7 21.2 14.9 22.3 13.9 11.4 13.3 7.5 59.7 7.9 10.0 7.8 22.0 15.1 25.9 7.9 24.6 25.0 13.5 5.8 37.2 7.7 10.0 11.5 11.6 0.4 3.4 19.3 5.5 2.1 3.8 2.5 12.1 18.5 16.1 16.5 16.8 32.0 5.8 16.8 24.6 11.7 14.4 21.7 7.9 1.5 21.4 19.2 8.7 10.4 21.2 19.7 5.7 14.9 3.4 11.4 13.4 20.4 22.6 9.1 57.0 9.5 14.9 14.5 23.6 6.7 18.0 9.3 2.3 7.2 6.2 4.5 4.2 7.0 18.7 4.7 21.8 13.9 4.0 10.2 20.0 17.3 8.7 16.4 15.7 28.1 11.7 7.7 18.1 16.0 7.2 15.1 5.1 14.9 14.8 9.8 2.8 5.5 6.4 3.4 2.8 3.8 0.2 1.7 2.8 3.4 0.4 1.4 1.7 19.3 2.1 2.3 0.4 1.1 2.5 9.8 12.4 9.1 13.3 12.8 10.4 22.1 11.4 13.9 13.5 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Cell line enhanced" "Detected in many" "Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: " "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavourable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavourable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 9.0 1.7 7.2 0.8 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.2 3.4 0.7 0.8 0.0 13.2 0.0 3.7 49.9 0.5 0.0 0.0 17.6 3.7 0.0 0.0 0.0 0.0 0.3 1.8 2.5 0.0 0.4 5.7 2.0 0.0 0.0 0.1 0.1 0.5 70.2 23.2 103.0 12.9 0.0 7.7 0.3 0.0 2.8 7.2 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Cell line enhanced" "Detected in many" "Karpas-707: 15.8;U-266/70: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059056 Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA059056: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favourable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favourable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.1 0.3 0.4 2.6 0.7 0.7 1.1 1.1 0.8 1.6 1.3 0.8 2.6 1.4 1.3 0.5 3.3 1.1 0.9 0.9 1.6 1.4 1.8 1.8 0.9 2.0 0.9 1.9 0.6 2.0 1.0 3.1 1.5 1.3 15.8 0.6 0.9 1.2 1.0 0.2 1.2 1.5 2.3 2.7 1.6 0.5 2.0 0.6 1.0 3.0 1.9 3.8 2.0 1.2 0.8 0.8 0.6 1.0 8.8 2.3 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888280-173961976 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell line enhanced" "Detected in many" "U-266/70: 38.3;U-266/84: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favourable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 11.9 42.2 25.9 10.3 21.0 39.7 11.5 29.7 30.9 11.3 7.5 10.5 9.8 8.1 8.6 6.0 18.6 6.4 12.1 26.4 22.3 14.7 30.3 44.6 12.5 6.9 15.1 20.7 6.6 21.1 45.7 20.5 17.8 33.3 7.7 8.0 14.4 17.3 13.5 106.1 10.8 8.8 12.5 38.4 9.7 11.3 8.4 18.9 1.5 20.0 16.9 9.3 11.6 15.8 1.6 0.8 9.6 2.3 0.8 1.3 0.6 3.9 5.4 2.7 1.5 4.9 2.8 5.4 7.1 6.6 2.4 2.9 5.1 2.6 4.9 5.0 3.9 0.3 2.4 3.7 4.0 9.8 2.7 3.3 13.0 3.0 10.5 1.1 6.4 4.4 8.5 6.3 9.8 2.3 10.7 12.0 5.6 2.8 0.9 1.0 1.5 5.4 0.8 2.2 16.3 3.5 7.1 3.0 3.4 0.8 9.9 12.7 6.9 2.2 7.0 4.1 2.0 2.0 4.5 38.3 55.0 2.5 9.9 2.3 5.1 0.5 1.8 2.0 1.0 1.7 1.0 1.6 1.1 0.8 0.6 1.2 1.3 0.7 9.6 0.8 2.3 0.8 1.0 0.6 25.9 21.0 29.7 30.9 22.3 14.7 15.1 20.7 33.3 18.9 CPED1 "C7orf58, FLJ21986" ENSG00000106034 "Cadherin like and PC-esterase domain containing 1" A4D0V7 7 120988677-121297444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 28.0;K-562: 54.5;LHCN-M2: 19.3;U-138 MG: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 7.6;intermediate monocyte: 7.8;myeloid DC: 17.2;non-classical monocyte: 4.8;plasmacytoid DC: 10.3" "Group enriched" "Detected in many" 9 "dendritic cells: 17.2;monocytes: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA012058 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012058: AB_1845761" "unprognostic (7.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (4.48e-4)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.52e-3)" "prognostic favourable (3.00e-4)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.48e-1)" "unprognostic (8.69e-2)" "prognostic unfavourable (4.87e-4)" "unprognostic (6.28e-3)" "unprognostic (5.05e-2)" "unprognostic (3.78e-1)" "unprognostic (6.54e-4)" 21.6 8.3 3.2 8.0 3.7 0.1 7.8 1.1 2.7 19.4 16.3 4.1 15.0 3.7 21.8 15.7 10.5 12.2 14.4 10.3 2.9 1.7 3.9 19.4 9.0 1.5 5.1 1.9 36.8 2.0 0.4 4.5 10.6 3.1 20.7 6.7 18.5 2.8 17.1 24.4 2.9 10.6 48.9 8.7 9.9 8.6 7.1 3.8 0.2 4.9 15.9 1.4 34.3 14.6 1.0 17.2 1.4 7.8 0.0 0.1 2.1 1.9 0.0 0.1 0.0 4.6 13.5 0.1 7.9 28.0 2.7 7.6 0.2 0.1 0.2 0.1 4.3 0.1 0.1 0.0 7.3 0.1 0.2 2.2 0.1 16.1 8.1 0.0 0.0 5.5 0.0 6.4 0.1 1.3 54.5 4.1 19.3 0.0 0.0 0.0 0.0 0.3 0.0 11.0 5.4 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.8 16.4 0.4 13.7 7.6 1.7 0.0 0.2 1.9 0.0 0.8 1.4 7.6 0.0 0.0 7.8 0.1 1.0 0.0 0.0 17.2 0.3 0.0 0.0 0.3 0.0 4.8 10.3 0.0 2.1 3.2 3.7 1.1 2.7 2.9 1.7 5.1 1.9 3.1 3.8 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: " "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.2 16.0 24.8 13.7 4.5 4.3 4.1 9.1 14.3 20.8 14.6 4.5 9.7 5.0 8.3 13.7 13.1 9.7 5.4 11.3 6.1 5.7 2.0 6.4 3.7 8.1 1.6 0.2 4.1 6.1 8.1 4.0 30.5 5.5 0.1 5.2 3.8 2.4 24.3 5.6 3.4 31.0 7.8 4.1 13.8 3.2 0.5 10.1 11.5 2.5 6.9 2.7 33.2 21.5 19.0 10.4 4.7 11.7 1.2 1.0 11.1 12.3 7.2 13.3 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;prostate: 35.7" "Cell line enhanced" "Detected in some" "A549: 9.7;AF22: 9.1;Karpas-707: 2.7;RT4: 3.1" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.2" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: " "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 1.4 1.4 7.0 0.8 11.6 0.8 0.7 0.4 27.2 1.0 1.1 2.5 0.7 1.6 0.9 1.6 1.1 1.2 0.7 1.9 17.5 5.3 2.1 0.8 1.2 0.7 1.3 11.8 0.7 0.8 3.8 9.5 0.7 3.1 35.7 1.0 0.1 1.1 6.0 0.6 1.0 1.4 1.2 4.6 1.8 1.4 2.3 3.6 0.0 1.1 0.0 0.7 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 9.7 9.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 2.7 1.3 0.6 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.6 3.1 1.3 0.6 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.3 0.3 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 7.0 11.6 0.4 27.2 17.5 5.3 1.3 11.8 3.1 3.6 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121937-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavourable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 20.5 24.0 14.6 24.1 16.3 10.6 16.7 14.5 16.5 18.3 16.4 19.3 21.5 15.1 19.3 16.5 25.7 15.4 15.9 16.3 14.9 13.6 16.8 22.2 17.3 20.1 20.8 11.8 21.5 16.5 24.9 28.9 19.6 16.0 17.1 18.1 14.7 18.5 25.3 36.6 14.9 19.0 18.8 19.7 23.8 17.8 25.7 18.1 44.0 22.6 19.4 25.0 19.7 17.7 9.3 13.0 15.0 14.4 12.8 13.4 9.7 18.4 18.4 18.8 19.4 9.8 8.7 28.0 23.9 23.4 22.2 22.1 15.9 25.7 19.8 15.7 25.4 27.4 25.9 21.7 32.2 32.0 8.9 29.0 19.0 15.3 29.1 29.1 24.5 14.2 18.6 21.1 38.1 20.7 26.0 25.1 24.7 26.9 33.5 10.3 21.3 16.8 33.1 29.2 17.8 15.1 26.2 20.8 14.0 28.1 15.9 20.3 33.0 18.3 22.1 17.9 11.3 13.4 20.3 15.2 24.7 40.4 21.5 23.0 27.7 15.0 14.4 10.4 9.6 13.6 12.9 9.3 8.6 10.2 13.0 5.3 7.8 10.5 5.2 12.8 10.7 8.4 13.4 9.7 14.6 16.3 14.5 16.5 14.9 13.6 20.8 11.8 16.0 18.1 CRADD RAIDD ENSG00000169372 "CASP2 and RIPK1 domain containing adaptor with death domain" P78560 12 93677375-93894840 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005337 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB005337: AB_2085481" "unprognostic (1.07e-2)" "prognostic favourable (9.06e-5)" "unprognostic (9.65e-3)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (3.10e-1)" "unprognostic (3.79e-2)" "unprognostic (8.99e-2)" "unprognostic (1.54e-1)" "unprognostic (7.89e-2)" "unprognostic (6.06e-2)" "unprognostic (3.18e-2)" "prognostic favourable (4.04e-9)" "unprognostic (2.57e-2)" "unprognostic (6.86e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" 7.8 15.9 11.0 4.4 14.2 7.1 10.4 12.5 10.4 8.8 9.3 11.5 16.7 14.8 10.6 11.9 9.9 8.3 9.6 35.7 12.3 8.9 14.8 31.4 7.5 7.1 9.8 9.7 8.5 9.7 18.7 21.2 6.5 13.3 9.4 7.5 11.3 10.3 8.8 22.1 8.0 15.4 12.2 11.5 8.3 9.5 15.0 13.2 9.7 8.6 15.5 5.5 10.2 8.4 8.6 7.6 25.3 12.2 10.8 15.0 6.8 6.1 13.9 6.9 7.8 10.0 18.1 8.7 7.0 8.7 6.2 7.3 13.0 2.5 10.9 4.4 8.1 6.3 7.4 9.3 8.1 11.5 10.0 5.8 5.9 9.5 10.3 5.3 5.6 16.4 14.2 10.0 7.9 7.5 16.4 5.2 7.3 9.8 7.7 9.5 8.8 10.7 13.1 3.5 15.1 6.0 4.5 10.6 10.2 9.5 9.4 16.8 16.6 10.4 7.9 14.5 7.2 6.9 7.1 12.3 6.7 10.1 6.8 7.9 6.8 24.9 6.9 25.3 14.7 8.3 13.0 8.6 10.3 15.0 5.6 7.2 11.1 8.2 19.4 10.8 12.2 7.6 11.5 6.8 11.0 14.2 12.5 10.4 12.3 8.9 9.8 9.7 13.3 13.2 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favourable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.2 8.6 10.9 10.3 7.3 7.3 12.6 6.2 5.4 8.4 6.0 7.9 9.0 5.3 5.9 7.1 8.9 13.0 6.3 7.7 6.4 13.5 8.3 9.9 4.9 5.3 11.7 13.5 6.3 8.6 10.0 8.1 8.3 11.1 4.1 4.6 8.7 7.7 7.2 8.7 5.3 30.0 5.2 9.2 5.5 5.4 11.4 8.1 9.2 7.6 4.9 6.1 16.2 9.4 8.0 7.8 6.8 7.8 7.0 10.1 13.5 2.7 7.8 7.1 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094810-129111189 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6;testis: 71.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" 13000 "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_1847209" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favourable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favourable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 11.6 13.4 8.4 4.6 9.2 5.9 10.7 7.5 15.9 8.3 15.4 8.6 6.2 24.3 6.5 9.5 9.4 5.4 10.0 17.3 7.7 7.9 12.9 50.0 4.2 3.1 8.3 9.1 7.3 33.1 16.8 3.2 7.9 9.3 10.5 4.4 8.1 14.7 7.9 98.6 7.0 22.8 8.3 5.2 4.6 8.1 71.7 4.4 2.4 8.0 20.2 4.4 9.3 6.8 2.6 11.3 6.0 11.3 6.0 10.0 8.1 0.1 18.3 6.4 13.2 12.0 16.1 9.4 7.8 8.7 9.5 6.0 3.8 7.4 0.7 4.7 13.1 3.3 1.7 2.8 3.4 11.8 0.4 3.6 9.2 14.8 17.1 0.1 14.0 14.7 0.0 8.0 0.2 12.4 1.7 3.8 9.8 3.7 0.3 8.1 1.5 8.2 9.1 12.3 6.1 9.2 0.3 2.1 6.6 0.0 4.2 2.7 26.7 4.0 11.2 14.3 1.0 17.9 7.7 13.0 11.0 0.0 16.9 2.2 9.1 2.5 11.3 6.0 5.0 7.4 10.0 2.4 6.9 6.6 11.3 2.6 4.3 4.7 2.9 6.0 7.3 5.3 6.4 8.1 8.4 9.2 7.5 15.9 7.7 7.9 8.3 9.1 9.3 4.4 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Group enriched" "Detected in many" 4 "MCF7: 24.8;SK-BR-3: 54.8;T-47d: 44.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favourable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.2 3.3 3.1 3.4 2.2 3.2 7.8 1.9 2.2 2.6 2.3 1.5 9.6 4.2 10.1 0.8 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.5 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.3 2.4 5.3 1.2 24.8 2.7 1.1 2.1 4.0 6.1 3.2 7.8 2.8 1.6 5.8 6.3 2.0 54.8 5.2 44.0 4.5 1.4 0.8 2.4 1.6 1.5 9.9 5.1 3.1 1.7 2.5 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell line enhanced" "Detected in many" "HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Plasma membrane" Vesicles "HPA050020: , HPA061622: " "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.6 0.1 0.3 0.8 2.3 3.5 2.2 1.4 9.7 0.7 0.9 0.4 0.1 3.3 7.4 0.0 2.6 10.5 2.0 0.2 0.2 31.6 0.4 0.7 0.7 10.0 10.8 1.5 1.2 13.2 0.8 0.0 0.0 0.0 4.8 3.9 0.2 3.6 0.2 4.8 1.0 0.4 2.8 0.1 0.2 1.1 0.1 0.7 0.4 4.6 13.9 15.2 4.4 0.8 2.2 0.1 5.1 0.2 7.8 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favourable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.8 7.6 6.7 7.6 23.7 24.0 12.9 11.6 19.6 8.5 11.8 5.5 8.7 5.1 4.5 14.0 5.0 10.1 8.9 14.6 28.5 6.1 4.0 7.7 6.7 15.5 5.7 7.5 15.5 15.9 10.0 16.5 12.5 4.0 8.1 14.3 9.5 2.9 4.7 20.0 7.0 4.1 11.6 3.2 16.4 17.1 7.9 9.0 11.7 5.7 20.2 3.2 6.5 10.0 11.8 7.6 11.6 11.4 6.8 9.0 1.3 14.0 4.9 12.1 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 CREBZF ZF ENSG00000137504 "CREB/ATF bZIP transcription factor" Q9NS37 11 85659708-85682908 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021526, HPA063652" Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA021526: , HPA063652: " "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (6.46e-2)" "unprognostic (2.23e-3)" "unprognostic (2.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.19e-2)" "unprognostic (4.51e-2)" "unprognostic (1.04e-3)" "unprognostic (2.23e-3)" "unprognostic (1.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.34e-2)" "unprognostic (2.38e-3)" 15.4 18.7 16.6 19.5 23.3 13.2 19.8 31.4 21.7 23.1 18.1 23.7 18.5 22.0 29.0 19.9 15.0 22.3 18.2 13.3 16.9 10.5 14.9 16.2 17.5 25.0 34.0 18.7 31.5 27.2 30.0 23.8 18.3 20.2 21.2 20.6 20.0 19.3 17.0 13.1 18.2 24.4 20.0 21.3 26.1 20.2 12.7 24.8 21.6 27.1 11.7 21.3 19.1 21.3 3.1 2.4 2.3 2.8 1.9 3.8 0.8 3.6 11.2 9.4 3.1 3.9 4.3 11.4 5.8 3.4 5.0 6.6 11.2 17.9 9.3 5.9 3.3 13.4 7.5 3.9 7.5 7.5 9.3 9.6 32.2 3.4 3.1 9.7 5.6 4.5 9.3 5.5 8.2 2.9 8.3 15.8 4.5 5.9 8.6 13.9 3.7 5.8 17.6 10.8 6.8 4.4 7.0 9.8 9.3 9.3 13.1 2.3 15.6 15.7 4.3 10.7 8.7 17.3 8.0 6.0 5.2 12.9 3.0 7.0 8.7 1.9 1.6 1.4 2.3 1.4 3.8 3.1 1.5 1.9 2.0 2.9 2.5 2.3 2.3 1.9 2.8 2.4 1.1 0.8 16.6 23.3 31.4 21.7 16.9 10.5 34.0 18.7 20.2 24.8 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell line enhanced" "Detected in many" "A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 37.7 5.5 15.0 0.9 3.9 1.6 1.7 0.4 0.5 0.1 1.1 7.0 0.0 38.6 12.3 21.6 0.7 9.2 0.0 0.2 0.2 0.0 23.7 14.3 4.0 0.0 3.2 1.9 0.8 0.9 5.1 36.1 0.0 0.3 5.4 55.4 0.1 0.1 1.5 22.7 0.0 0.7 1.6 25.4 0.1 8.4 20.9 2.4 43.4 0.3 37.2 0.0 14.0 12.5 5.9 0.3 7.0 0.1 0.1 0.1 3.6 0.0 25.2 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 CRIPT HSPC139 ENSG00000119878 "CXXC repeat containing interactor of PDZ3 domain" Q9P021 2 46616416-46625742 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046080 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA046080: " "unprognostic (3.38e-2)" "unprognostic (4.08e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.19e-4)" "unprognostic (1.10e-1)" "unprognostic (6.07e-2)" "unprognostic (1.54e-2)" "unprognostic (3.38e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (5.54e-4)" "unprognostic (4.18e-2)" "unprognostic (1.43e-1)" "unprognostic (1.12e-2)" "unprognostic (4.42e-2)" 13.8 17.1 29.3 9.4 26.2 10.0 18.9 24.3 23.9 12.2 11.4 28.7 10.8 15.5 18.2 17.5 12.6 14.6 10.5 22.1 26.5 23.1 19.8 18.8 9.3 11.9 27.6 18.1 17.5 9.8 12.7 21.9 14.3 23.2 14.9 13.4 13.6 16.8 12.5 18.4 13.6 14.2 12.1 36.6 10.1 11.3 12.3 26.2 13.4 14.0 8.8 13.2 14.4 10.8 13.3 14.0 20.9 9.4 11.5 15.5 9.0 15.8 9.4 10.0 8.7 12.3 13.2 12.7 11.1 8.4 9.6 10.1 12.1 12.1 8.6 30.4 12.4 8.5 10.1 10.8 14.9 18.5 11.9 9.1 11.9 15.6 14.2 8.7 8.7 10.2 14.3 12.4 8.8 14.4 13.2 12.9 11.3 8.5 9.0 17.5 10.3 13.1 8.3 19.2 16.7 13.5 10.3 14.3 20.8 11.6 9.7 16.0 7.3 8.2 10.0 13.8 12.0 11.2 14.8 10.0 10.7 11.0 18.1 10.4 12.4 20.9 9.4 17.8 8.8 8.4 8.6 13.3 9.8 8.5 9.9 11.2 9.9 9.0 19.1 11.5 6.8 14.0 15.5 9.0 29.3 26.2 24.3 23.3 26.5 23.1 27.6 18.1 23.2 26.2 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 14.9;BEWO: 23.2;HHSteC: 55.4;HSkMC: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" 219300000000 "Nucleoplasm, Nucleoli" "HPA030054: , HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavourable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 14.9 5.6 23.2 11.3 10.0 9.1 6.4 1.5 0.9 0.0 1.0 9.9 0.3 0.0 0.0 9.2 0.0 0.0 0.1 0.2 0.0 55.4 0.0 0.1 23.3 0.0 2.6 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 0.6 0.0 0.1 0.1 0.1 1.7 2.2 0.1 2.6 1.2 0.2 4.5 0.3 1.3 0.1 0.6 9.5 0.3 0.1 0.0 1.9 0.0 0.2 1.3 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" 1832500000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 0.0 0.0 0.0 7.6 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.1 0.9 0.0 12.8 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA037737: , HPA038430: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 CRYBB2 "CCA2, CRYB2, CRYB2A" ENSG00000244752 "Crystallin beta B2" P43320 22 25219522-25231869 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 26.9" "Cell line enhanced" "Detected in some" "HeLa: 5.1;THP-1: 1.7;U-138 MG: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA043749 Supported Approved Nucleoplasm Nucleoplasm "HPA043749: " "unprognostic (1.28e-1)" "unprognostic (2.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.95e-1)" "unprognostic (5.06e-2)" "unprognostic (7.04e-2)" "unprognostic (8.57e-3)" "unprognostic (9.51e-3)" "unprognostic (8.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-3)" 0.8 0.7 2.0 0.5 3.7 0.1 1.7 0.5 1.8 1.0 1.3 0.5 0.5 0.8 0.5 1.8 1.1 0.4 0.5 0.6 2.9 1.5 0.5 0.5 1.4 0.5 0.8 0.5 0.5 0.5 0.0 2.6 0.5 0.9 0.9 1.5 26.9 1.2 0.5 0.6 0.4 1.0 1.0 0.5 0.5 0.2 4.0 0.5 0.5 1.7 0.5 0.5 0.5 0.5 1.4 1.3 0.5 1.1 1.7 1.4 0.7 0.2 0.5 0.1 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.6 0.0 0.8 0.0 0.0 0.2 0.0 1.1 0.6 5.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 1.2 0.3 0.6 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.8 1.7 0.0 2.9 0.7 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.5 0.8 0.4 1.4 0.6 0.6 1.4 1.2 0.7 1.1 1.0 1.1 1.2 0.1 1.7 1.1 1.3 0.4 0.7 2.0 3.7 0.5 1.8 2.9 1.5 0.8 0.5 0.9 0.5 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.7;HBEC3-KT: 39.6;hTERT-HME1: 30.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Not detected" "Not detected" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: , HPA030949: " "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.4 0.0 0.0 0.0 8.8 31.7 3.2 1.5 11.6 3.4 3.2 0.7 3.7 16.4 0.7 7.2 16.9 0.1 39.6 1.6 22.3 0.7 0.0 0.4 5.1 4.2 10.0 0.0 15.8 23.1 6.4 30.7 14.4 0.5 2.3 9.1 1.2 2.8 4.0 0.1 6.9 4.9 0.1 0.1 5.3 24.9 0.7 0.0 6.4 11.0 0.1 5.4 7.6 4.2 3.8 0.5 0.0 10.5 1.8 1.4 17.9 18.1 12.6 8.2 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell line enhanced" "Detected in some" "A-431: 7.0;BEWO: 15.1;CACO-2: 24.6;CAPAN-2: 16.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 24.6 16.5 0.1 5.0 0.0 6.1 0.0 4.4 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 2.9 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYBG3 DKFZp667G2110 ENSG00000080200 "Crystallin beta-gamma domain containing 3" Q68DQ2 3 97822040-97944963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.9;classical monocyte: 3.0;intermediate monocyte: 1.8;myeloid DC: 2.6;non-classical monocyte: 1.9;plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 6 "dendritic cells: 7.1;granulocytes: 1.9;monocytes: 3.0" "Low region specificity" "Detected in all" HPA044122 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044122: AB_10960490" "unprognostic (1.88e-1)" "unprognostic (7.62e-3)" "unprognostic (2.54e-1)" "unprognostic (4.56e-2)" "unprognostic (7.60e-2)" "unprognostic (2.70e-2)" "unprognostic (2.45e-2)" "unprognostic (7.10e-2)" "unprognostic (3.41e-3)" "unprognostic (6.59e-2)" "unprognostic (2.80e-2)" "unprognostic (7.86e-2)" "prognostic favourable (7.07e-4)" "unprognostic (1.78e-2)" "unprognostic (1.58e-1)" "unprognostic (1.14e-2)" "unprognostic (6.38e-3)" 19.9 5.1 6.4 13.4 20.9 1.9 13.1 1.6 13.0 14.6 19.2 8.2 12.1 6.0 10.4 7.4 13.9 9.0 8.6 14.9 9.1 5.3 8.2 5.3 11.3 6.5 28.4 5.1 8.7 8.5 10.2 7.4 15.8 15.0 12.9 11.9 4.7 10.6 9.0 21.5 19.5 8.4 10.1 20.3 7.8 11.1 19.2 20.5 2.0 39.7 12.3 7.0 11.2 16.9 0.5 7.1 1.9 3.0 0.1 0.6 0.5 11.1 4.2 2.5 3.0 7.8 8.5 4.4 4.0 3.6 2.9 4.4 0.3 3.7 0.1 1.3 6.8 7.3 4.8 3.3 5.6 13.7 2.6 2.8 1.8 1.3 4.1 4.1 0.7 5.5 3.4 3.6 4.1 5.6 0.2 2.1 5.0 0.1 1.4 0.4 2.1 3.9 0.0 8.7 1.4 4.3 7.4 27.7 2.0 8.4 3.2 2.8 3.0 4.6 7.6 6.4 4.9 3.6 4.8 3.5 0.1 2.6 6.7 2.5 4.1 1.9 3.0 0.1 0.3 1.8 0.5 0.2 0.6 0.4 2.6 0.5 0.2 0.4 0.0 0.1 1.9 7.1 0.1 0.5 6.4 20.9 1.6 13.0 9.1 5.3 28.4 5.1 15.0 20.5 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favourable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favourable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.4 3.0 2.6 19.0 14.5 16.8 2.6 4.9 8.8 2.1 1.7 1.1 3.2 0.0 9.3 6.7 0.8 2.5 4.4 2.2 8.3 2.1 6.1 0.3 23.7 8.3 1.9 5.5 9.9 2.8 1.6 10.0 23.0 0.4 2.4 5.6 12.5 5.2 3.1 0.1 4.6 2.7 1.7 0.4 18.3 7.4 1.8 2.2 2.9 1.4 21.8 9.4 7.8 22.0 2.7 1.2 6.5 3.0 3.4 0.7 0.0 5.1 3.4 10.9 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 CRYZL1 "4P11, QOH-1" ENSG00000205758 "Crystallin zeta like 1" O95825 21 33589341-33643926 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019120, HPA029399, CAB034129" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865" "unprognostic (1.54e-1)" "unprognostic (4.69e-2)" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.55e-1)" "unprognostic (9.19e-2)" "unprognostic (2.73e-1)" "unprognostic (2.57e-3)" "unprognostic (2.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-2)" "unprognostic (8.16e-3)" "unprognostic (1.59e-1)" "unprognostic (1.28e-3)" 18.9 17.6 32.6 14.1 27.6 18.4 19.4 36.6 32.4 20.5 21.5 24.8 13.2 13.4 26.9 18.0 17.6 17.2 15.1 17.9 26.4 23.0 21.6 16.0 14.5 14.7 30.8 19.4 20.4 13.6 18.5 27.7 19.3 25.2 17.3 18.8 17.2 15.2 21.7 15.5 20.9 13.3 19.8 29.9 13.2 15.6 28.9 27.0 18.2 22.6 9.7 13.4 20.8 15.6 27.5 30.7 24.8 26.1 31.5 33.8 18.2 21.0 9.4 26.7 19.6 14.4 20.9 13.5 15.0 21.6 19.3 17.3 13.6 16.7 14.9 13.6 18.4 11.7 14.0 15.5 17.6 13.7 14.8 27.3 19.9 12.4 22.7 17.1 17.5 19.6 13.6 20.3 16.0 24.2 20.2 15.4 17.9 10.7 16.5 17.7 18.6 12.7 15.9 21.4 20.4 27.1 18.9 11.6 18.4 19.7 10.0 21.4 19.7 12.7 25.4 15.6 14.9 12.8 11.6 25.4 34.9 16.1 20.3 12.8 17.4 21.7 25.2 24.8 24.2 26.1 25.9 26.5 25.9 22.5 30.7 27.5 33.8 27.4 14.4 31.5 23.7 24.2 20.3 18.2 32.6 27.6 36.6 32.4 26.4 23.0 30.8 19.4 25.2 27.0 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41560763-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 84.8;ovary: 48.5" "Group enriched" "Detected in some" 6 "HeLa: 7.9;U-2 OS: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: " "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favourable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 2.5 39.0 4.7 2.1 9.6 1.1 1.2 30.5 15.3 16.8 2.6 2.7 5.5 1.6 18.4 2.0 2.2 4.1 2.6 84.8 6.0 8.5 9.9 1.2 2.8 1.1 9.0 6.0 48.5 25.5 1.1 4.1 1.3 17.7 5.3 1.4 5.6 1.4 11.7 1.5 1.1 1.5 9.1 10.5 1.2 1.6 11.1 3.4 0.0 1.1 0.3 1.0 5.8 6.2 1.0 1.0 1.7 1.1 0.4 1.6 0.7 0.0 0.1 1.0 0.1 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 3.1 0.1 0.0 0.0 0.0 0.0 2.0 0.0 7.9 0.9 2.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.7 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 29.0 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 1.0 1.0 1.7 1.3 1.1 0.5 1.0 0.8 0.7 1.0 1.0 1.5 0.7 1.0 0.4 0.9 0.2 1.6 0.7 4.7 9.6 30.5 14.7 6.0 8.5 9.0 6.0 17.7 3.4 CSNK1E "CKIE, CKIepsilon, HCKIE" ENSG00000213923 "Casein kinase 1 epsilon" P49674 22 38290691-38318084 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in all" "CAB009626, HPA026288" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB009626: AB_2084517, HPA026288: AB_1847276" "unprognostic (2.32e-1)" "unprognostic (8.41e-2)" "unprognostic (5.14e-2)" "unprognostic (5.01e-3)" "unprognostic (1.95e-2)" "unprognostic (4.50e-3)" "prognostic unfavourable (8.20e-5)" "unprognostic (2.08e-3)" "unprognostic (3.69e-1)" "unprognostic (1.22e-1)" "unprognostic (9.63e-2)" "unprognostic (4.16e-3)" "prognostic unfavourable (4.67e-6)" "unprognostic (1.91e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-1)" "unprognostic (3.25e-3)" 28.5 22.9 30.7 18.3 32.5 21.4 28.6 40.1 42.6 26.4 21.5 32.3 15.7 19.0 37.3 27.3 23.4 28.0 22.1 28.8 31.7 22.3 17.3 11.8 28.4 17.3 28.6 30.1 38.1 25.4 56.2 29.2 33.1 28.7 26.2 17.4 30.5 23.9 23.1 26.3 35.3 17.1 24.0 23.2 20.9 21.8 13.0 33.9 13.3 21.4 14.2 17.4 25.5 28.8 3.7 15.7 4.8 1.8 5.9 4.0 1.2 23.3 11.4 31.0 29.7 15.5 23.8 23.3 30.5 39.1 27.8 27.0 14.6 18.3 17.6 13.3 28.8 20.0 23.5 42.2 20.2 28.1 51.1 5.6 37.7 11.2 32.0 12.3 15.0 22.7 35.8 42.3 57.3 29.5 12.4 36.4 26.8 15.6 17.1 15.1 22.7 16.5 32.0 22.2 27.6 25.5 19.6 45.9 18.0 26.0 27.0 30.5 13.8 17.9 33.5 25.2 27.5 14.5 24.3 16.3 23.3 24.8 37.4 13.9 42.2 3.8 1.8 3.4 3.4 0.8 4.0 2.5 3.8 3.4 1.8 3.7 2.1 3.1 4.8 5.9 0.6 15.7 1.7 1.2 30.7 32.5 40.1 38.8 31.7 22.3 28.6 30.1 28.7 33.9 CSNK2A3 CSNK2A1P ENSG00000254598 "Casein kinase 2 alpha 3" Q8NEV1 11 11351942-11353357 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 5.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA059206, HPA061698" Uncertain Approved Nucleoplasm Nucleoplasm "HPA059206: , HPA061698: " "unprognostic (3.10e-2)" "unprognostic (3.39e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.82e-2)" "unprognostic (1.60e-1)" "unprognostic (6.25e-4)" "unprognostic (4.36e-2)" "unprognostic (5.42e-2)" "unprognostic (1.88e-1)" "unprognostic (5.46e-3)" "unprognostic (1.07e-1)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (3.38e-2)" 4.6 1.6 1.3 2.8 1.3 0.6 1.9 1.6 5.5 2.8 3.8 0.5 2.1 3.4 1.8 3.8 3.4 1.1 1.6 2.3 1.5 1.2 5.4 3.0 3.7 1.0 1.1 0.7 2.0 1.4 0.6 1.7 2.9 2.0 2.2 0.7 2.1 1.7 3.6 5.3 1.9 2.9 2.9 1.2 0.9 1.3 3.5 0.3 3.6 1.6 1.8 2.7 1.8 1.3 0.7 0.9 1.1 0.6 0.8 1.0 1.2 5.5 1.1 0.2 2.1 0.0 0.0 0.7 0.5 0.3 0.3 0.3 0.0 0.3 0.0 0.4 0.0 1.8 0.9 0.8 0.0 0.2 0.3 0.0 0.2 0.5 0.0 0.2 0.3 0.6 0.4 0.0 0.6 0.0 0.4 0.8 0.7 0.6 1.3 0.7 1.7 3.0 0.9 0.2 1.0 0.6 1.0 0.4 1.2 1.6 3.1 0.6 1.2 0.4 0.7 0.9 1.1 0.4 0.6 0.4 0.9 0.8 2.6 0.2 2.5 0.7 0.5 1.1 0.6 0.6 0.9 0.7 0.4 0.7 0.9 0.7 1.0 0.3 0.1 0.8 0.6 0.7 0.7 1.2 1.3 1.3 1.6 5.5 1.5 1.2 1.1 0.7 2.0 0.3 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell line enhanced" "Detected in many" "AF22: 26.2;HEK 293: 7.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049529: , HPA067818: , HPA071779: " "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favourable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.2 4.6 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.0 0.0 0.4 2.2 0.2 0.2 0.0 7.2 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.0 5.1 0.2 0.1 1.2 0.2 0.3 2.5 2.7 0.4 0.2 0.5 1.1 0.9 2.8 1.3 1.6 3.3 0.1 1.2 2.4 0.2 0.0 5.4 0.0 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325244-122341972 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 312.4;tongue: 421.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 33.1;hTCEpi: 146.6;THP-1: 91.6;U-698: 58.3;U-937: 29.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 405.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6" "Group enriched" "Detected in many" 193 "dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol 39000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favourable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 2.0 0.2 0.3 4.4 0.8 19.8 4.5 0.2 0.5 55.4 0.4 0.2 1.1 0.0 4.7 1.7 312.4 0.2 0.7 1.0 0.3 0.0 0.4 3.4 6.8 4.8 1.1 0.2 1.8 0.2 0.0 0.3 1.3 0.5 1.3 0.1 0.3 57.4 0.7 0.7 28.2 0.3 0.4 0.7 2.0 2.2 0.3 0.6 2.2 0.3 421.9 99.0 1.5 93.5 0.1 54.6 36.0 74.6 0.2 0.2 32.0 1.6 0.1 0.0 0.3 3.8 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.6 10.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.7 0.8 13.3 0.2 3.7 146.6 0.3 14.4 0.0 0.0 3.5 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 1.6 0.8 1.1 0.1 91.6 0.0 0.2 2.4 0.0 0.1 0.0 0.1 58.3 3.2 29.1 0.0 0.7 74.6 2.2 0.0 37.5 0.2 0.1 0.1 0.1 54.6 0.0 0.0 0.1 36.0 0.2 21.6 1.0 0.1 32.0 0.3 0.8 0.2 0.5 0.3 0.0 1.1 0.2 0.5 0.6 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Group enriched" "Detected in some" 7 "HMC-1: 68.4;Karpas-707: 31.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.5 31.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.4 0.0 0.0 0.5 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell line enhanced" "Detected in some" "AN3-CA: 32.5;K-562: 9.7;Karpas-707: 36.1;U-266/84: 30.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 9.7 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 7.1 30.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 15.6" "Cell line enhanced" "Detected in some" "HMC-1: 29.2;T-47d: 17.1;U-266/84: 88.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 0.6 0.0 0.0 0.1 88.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Cell line enhanced" "Detected in some" "HMC-1: 17.9;Karpas-707: 12.5;U-266/84: 64.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 1.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.9 64.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Cell line enriched" "Detected in some" 9 "U-266/84: 46.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 4.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.0;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846499-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 16 "testis: 3.9" "Group enriched" "Detected in some" 5 "AN3-CA: 13.8;HMC-1: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863776-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 54.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA044735: , HPA044757: , HPA046872: , HPA046987: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 33 "HMC-1: 32.5;K-562: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 32.5 0.0 0.0 0.0 0.0 0.0 44.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.1 0.1 0.1 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 CTDSP2 "OS4, PSR2, SCP2" ENSG00000175215 "CTD small phosphatase 2" O14595 12 57819927-57846739 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "RH-30: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052607 Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA052607: " "unprognostic (7.09e-2)" "unprognostic (2.45e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-2)" "unprognostic (4.39e-1)" "unprognostic (5.57e-2)" "unprognostic (1.05e-3)" "unprognostic (2.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.06e-2)" "unprognostic (1.12e-1)" "unprognostic (4.15e-1)" "unprognostic (7.38e-3)" "unprognostic (5.50e-2)" "unprognostic (6.50e-2)" "unprognostic (2.18e-1)" "unprognostic (3.11e-1)" 44.5 43.6 28.2 31.6 34.8 17.6 39.6 57.1 33.4 49.0 48.4 36.7 47.7 24.4 50.4 32.9 38.0 41.9 37.7 34.6 31.2 16.5 32.8 32.6 51.3 31.3 37.1 19.9 52.5 53.9 33.7 25.4 42.9 31.0 40.5 38.6 29.3 45.8 60.9 48.8 39.9 36.1 44.1 25.7 38.1 43.1 21.0 40.9 62.9 40.1 32.8 33.9 46.1 63.0 7.3 9.3 18.7 9.7 8.2 11.5 7.1 10.8 4.7 22.6 14.4 20.4 35.2 7.5 11.7 22.3 11.7 10.4 6.0 17.7 13.3 13.5 25.0 8.7 9.4 11.4 12.3 4.5 4.0 18.4 7.2 4.8 19.0 8.3 10.7 33.6 12.2 10.6 9.0 18.2 9.6 23.6 5.8 5.0 8.9 5.0 11.5 6.0 11.9 165.7 17.4 9.1 15.8 4.2 9.4 16.4 9.4 14.1 17.1 14.6 14.6 10.4 11.4 11.7 4.1 7.0 7.5 16.0 11.7 7.7 8.0 11.5 9.7 14.7 6.9 9.0 8.2 7.3 9.9 8.0 9.3 6.5 11.5 8.7 18.7 8.2 7.7 7.7 6.4 7.1 28.2 34.8 57.1 33.4 31.2 16.5 37.1 19.9 31.0 40.9 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861960-37984469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles 10000 Vesicles Nucleoplasm "HPA048325: " "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favourable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 12.8 6.3 11.1 7.8 12.4 5.6 22.0 30.2 14.1 15.5 19.9 8.0 25.7 9.3 14.5 18.3 16.8 12.2 37.2 18.9 13.1 5.9 26.7 13.3 19.0 4.9 7.8 9.9 13.7 10.2 8.3 9.4 20.6 6.9 17.5 20.3 15.6 45.5 22.4 12.5 34.8 11.2 21.3 8.1 11.3 19.7 8.1 8.3 2.9 10.0 13.9 6.9 19.6 21.7 0.0 0.2 1.1 0.5 0.0 0.5 5.6 15.5 6.8 2.8 8.8 11.0 15.9 20.9 10.7 13.5 7.4 8.8 9.8 12.8 0.0 6.6 13.2 13.0 6.9 20.3 6.0 0.0 5.4 9.5 7.2 22.1 10.1 0.0 2.3 8.2 49.9 7.8 9.4 10.4 3.0 0.0 12.3 4.9 3.9 0.0 11.5 1.0 4.3 5.4 0.1 23.8 10.4 2.3 7.4 5.9 10.6 11.9 10.2 2.6 8.2 5.4 7.5 10.0 6.7 0.2 0.0 0.0 6.0 5.3 9.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.1 1.1 0.0 0.0 0.0 0.0 5.6 11.1 12.4 30.2 14.1 13.1 5.9 7.8 9.9 6.9 8.3 CTHRC1 ENSG00000164932 "Collagen triple helix repeat containing 1" Q96CG8 8 103371515-103382997 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 55.0;HHSteC: 36.6;HSkMC: 75.4;WM-115: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.3;NK-cell: 5.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;NK-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059806, HPA061896" Approved Approved Nucleoplasm "Secreted in other tissues" 320000 Nucleoplasm "HPA059806: , HPA061896: " "unprognostic (2.04e-2)" "unprognostic (4.58e-1)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "prognostic unfavourable (1.67e-4)" "unprognostic (4.17e-2)" "unprognostic (3.64e-2)" "unprognostic (8.63e-2)" "unprognostic (1.12e-2)" "unprognostic (3.73e-2)" "prognostic unfavourable (1.22e-14)" "unprognostic (2.33e-3)" "unprognostic (3.21e-2)" "unprognostic (7.96e-3)" "unprognostic (2.37e-3)" 35.1 1.4 1.1 5.2 1.1 0.0 32.3 0.8 2.3 5.3 3.8 0.5 3.0 2.0 6.9 11.2 3.5 3.0 33.0 4.2 1.1 1.6 2.0 0.7 4.5 7.6 1.6 1.3 3.7 2.1 0.3 2.1 32.2 1.9 4.0 2.1 2.6 23.0 4.2 9.2 17.4 2.1 8.4 2.6 1.4 1.8 8.4 0.8 2.2 4.8 3.7 5.4 31.3 3.6 0.2 0.7 2.3 0.0 5.2 0.4 0.3 2.0 0.1 0.6 0.1 16.6 55.0 0.0 6.1 1.6 0.6 0.9 0.2 1.4 0.2 6.6 24.2 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.1 3.3 36.6 0.1 0.1 75.4 0.1 5.6 0.0 10.8 0.0 16.7 3.4 0.3 2.9 7.1 1.9 10.4 6.3 5.6 0.1 0.5 0.0 1.0 0.7 0.0 0.0 18.5 0.0 0.0 8.7 0.8 0.3 0.8 0.0 0.5 0.1 0.1 0.4 0.0 69.3 0.0 0.0 2.3 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.2 0.3 0.1 5.2 0.0 0.7 0.0 0.3 1.1 1.1 0.8 2.3 1.1 1.6 1.6 1.3 1.9 0.8 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell line enhanced" "Detected in some" "AF22: 17.7;MCF7: 8.0;SK-BR-3: 5.3;U-266/84: 15.1" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Nucleoplasm, Golgi apparatus, Cell Junctions" "CAB037339: , HPA015077: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 CTPS2 ENSG00000047230 "CTP synthase 2" Q9NRF8 X 16588003-16712936 "Enzymes, Predicted intracellular proteins" "Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017437 Uncertain Approved Nucleoplasm,Cytosol 14000 "Nucleoplasm, Cytosol" "HPA017437: AB_1847326" "unprognostic (1.40e-1)" "unprognostic (6.69e-2)" "unprognostic (3.37e-2)" "unprognostic (7.38e-2)" "unprognostic (1.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavourable (2.37e-5)" "unprognostic (6.57e-3)" "unprognostic (8.52e-2)" "unprognostic (4.31e-3)" "unprognostic (4.43e-1)" "unprognostic (1.89e-2)" "unprognostic (7.22e-2)" "unprognostic (6.04e-2)" "unprognostic (8.93e-2)" "unprognostic (5.04e-2)" "prognostic favourable (4.56e-4)" 10.0 12.0 7.8 11.5 11.9 7.8 13.5 14.3 9.9 17.5 13.3 14.8 10.8 15.6 22.0 10.2 9.6 12.1 11.9 7.2 8.6 7.1 8.1 13.4 8.3 7.9 9.1 6.1 17.9 14.9 22.9 8.5 8.3 9.3 12.8 12.6 14.1 11.8 9.7 5.5 9.2 12.8 14.0 12.3 7.1 11.3 4.4 10.8 11.5 11.8 8.4 10.6 11.8 11.2 1.6 3.3 1.1 6.1 3.8 2.4 1.4 7.5 6.9 11.3 9.4 5.8 4.4 0.1 4.2 3.5 6.8 6.2 7.0 7.9 0.2 13.3 4.3 6.1 15.9 7.6 8.1 0.0 10.5 4.3 9.7 10.1 3.0 3.0 0.1 4.8 2.6 6.3 5.4 9.0 6.1 0.3 6.1 10.0 0.1 2.4 19.4 8.1 0.1 6.5 2.3 7.2 8.5 7.1 13.0 13.2 1.0 7.6 18.3 8.8 5.8 3.5 1.9 9.3 3.6 0.2 0.1 25.1 2.8 2.7 3.9 0.4 1.5 1.1 1.3 0.8 2.4 1.6 2.2 1.4 3.3 1.4 1.7 1.7 0.1 3.8 6.1 2.2 2.0 1.4 7.8 11.9 14.3 9.9 8.6 7.1 9.1 6.1 9.3 10.8 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell line enriched" "Detected in many" 8 "BEWO: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favourable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavourable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavourable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavourable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 7.3 2.2 2.5 6.5 0.1 0.0 113.4 0.0 0.0 1.6 1.3 14.9 7.3 0.1 0.6 0.1 14.0 12.1 8.9 2.3 0.0 1.6 0.3 0.7 2.3 0.0 0.0 1.0 0.0 3.0 0.4 0.3 0.5 0.2 0.0 2.9 2.7 0.2 0.1 15.0 2.1 0.0 5.4 0.1 2.2 0.9 0.6 1.1 7.4 2.6 2.6 4.6 0.8 0.0 0.4 7.4 0.1 0.8 1.5 4.0 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell line enhanced" "Detected in many" "AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 2.7 7.1 33.2 0.0 0.1 1.6 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.6 0.7 12.1 1.6 0.3 0.0 1.0 23.1 0.2 1.9 0.5 0.3 0.5 0.6 0.0 0.9 0.5 0.3 1.8 7.0 0.1 0.1 13.4 6.1 4.5 25.2 11.7 19.1 0.0 2.1 5.1 0.5 19.6 32.9 1.7 0.9 3.0 7.3 0.2 2.8 0.7 11.7 1.3 1.6 0.2 0.3 1.5 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 CUL4A ENSG00000139842 "Cullin 4A" Q13619 13 113208193-113267108 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058979 Approved Nucleoplasm Nucleoplasm "HPA058979: " "unprognostic (3.01e-1)" "unprognostic (5.93e-3)" "unprognostic (6.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (2.53e-2)" "unprognostic (6.41e-3)" "unprognostic (6.77e-2)" "unprognostic (1.45e-1)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "unprognostic (5.16e-3)" "unprognostic (3.57e-3)" "prognostic favourable (2.84e-4)" "unprognostic (2.95e-1)" "unprognostic (3.91e-2)" "unprognostic (3.48e-1)" 14.6 13.5 9.7 13.9 12.0 20.7 16.5 13.2 10.0 12.0 13.6 12.6 16.1 10.5 13.5 14.4 14.7 11.9 15.0 36.8 8.6 8.4 14.1 23.6 13.3 15.8 10.1 7.0 12.6 23.8 11.2 13.4 13.3 10.6 13.7 11.8 11.2 15.8 15.6 70.5 16.8 12.8 21.7 10.7 13.8 14.0 18.0 9.7 12.8 13.3 25.7 17.4 14.3 15.7 11.7 11.9 11.8 19.3 10.8 22.8 15.4 35.6 18.4 17.0 15.1 20.7 23.2 22.8 36.7 26.4 30.7 23.6 31.7 29.3 43.6 15.9 30.5 22.9 25.9 19.4 27.8 19.4 26.2 29.5 38.5 24.0 24.7 44.9 19.9 16.6 23.5 18.0 27.7 20.1 29.1 8.5 29.7 16.6 23.1 39.3 16.2 18.5 23.8 18.3 20.2 20.6 16.3 25.9 15.2 18.6 39.7 17.2 29.2 46.5 28.8 15.1 31.8 16.7 20.2 22.8 17.1 38.4 33.4 36.5 23.5 8.4 13.2 11.8 20.1 19.1 18.6 11.7 20.3 22.8 11.9 10.6 17.1 20.4 4.8 10.8 19.3 9.1 13.2 15.4 9.7 12.0 13.2 10.0 8.6 8.4 10.1 7.0 10.6 9.7 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like 1, cell cycle control (S. pombe)" Q69YN2 10 100232298-100267680 "Disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavourable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 13.8 9.8 8.6 13.6 12.5 20.5 15.8 18.3 18.6 11.8 9.9 15.4 6.1 7.9 13.8 9.0 11.0 12.9 8.7 10.6 9.0 10.3 11.2 14.8 11.6 19.1 11.5 8.6 14.3 14.1 12.4 12.4 12.2 12.4 10.5 11.5 12.3 11.0 10.6 14.1 14.7 11.8 14.4 11.2 19.1 10.1 19.7 10.8 22.3 13.8 11.2 22.6 12.5 10.1 12.2 12.2 18.6 13.9 13.9 15.4 11.1 14.2 10.8 9.7 14.1 4.8 6.5 10.1 9.4 14.0 22.2 19.0 10.7 11.1 16.6 9.8 8.4 13.2 22.5 12.9 23.6 11.5 9.1 9.4 9.6 8.7 8.0 23.3 9.0 8.1 5.4 16.1 15.2 14.6 10.9 13.7 11.8 8.4 18.1 7.7 6.9 9.6 6.2 18.4 9.7 6.8 7.9 4.4 8.4 12.3 4.8 12.2 19.2 6.4 11.7 7.8 10.3 8.7 15.6 11.3 15.1 10.0 10.3 18.3 5.0 9.8 13.9 18.6 12.1 13.2 15.4 12.2 12.7 13.0 12.2 12.0 14.1 13.8 7.2 13.9 11.7 4.8 15.2 11.1 8.6 12.5 18.3 18.6 9.0 10.3 11.5 8.6 12.4 10.8 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 14.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.2 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 12.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 CXorf21 FLJ11577 ENSG00000120280 "Chromosome X open reading frame 21" Q9HAI6 X 30558824-30577844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7" "Cell line enriched" "Detected in some" 7 "THP-1: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001185 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 6.5 2.1 4.6 9.8 4.0 16.0 2.0 0.8 4.4 1.4 3.0 2.3 0.2 4.3 1.2 2.4 1.4 1.5 3.6 1.5 5.0 2.1 1.9 2.8 6.1 12.9 6.3 0.0 1.0 2.0 0.7 1.5 2.7 5.1 1.5 3.1 1.1 3.3 0.5 0.8 1.1 5.3 1.8 9.9 16.7 3.1 0.8 5.2 9.1 1.4 1.2 9.3 4.8 1.4 11.1 21.9 14.9 18.9 3.2 1.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 7.4 0.0 0.0 7.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 0.0 5.4 0.5 2.6 0.0 8.3 0.0 3.4 10.3 11.4 0.8 9.6 0.1 11.1 1.0 0.5 12.0 10.8 1.0 0.7 14.9 3.2 18.9 21.9 1.6 3.5 4.6 4.0 0.8 4.4 5.0 2.1 6.3 0.0 5.1 5.2 CXorf56 FLJ22965 ENSG00000018610 "Chromosome X open reading frame 56" Q9H5V9 X 119538149-119565408 "Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038245, HPA038617, HPA064831" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA038245: AB_10672407, HPA038617: AB_10674691, HPA064831: " "prognostic unfavourable (3.45e-4)" "unprognostic (3.88e-3)" "unprognostic (7.82e-2)" "unprognostic (1.03e-3)" "unprognostic (8.92e-2)" "unprognostic (7.74e-3)" "unprognostic (6.38e-3)" "unprognostic (3.89e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-2)" "unprognostic (9.63e-3)" "unprognostic (1.68e-3)" "unprognostic (9.26e-3)" "unprognostic (4.68e-3)" "unprognostic (1.45e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-1)" 15.9 14.5 18.7 12.7 29.1 19.1 21.1 21.0 24.2 15.0 15.6 18.3 15.1 12.3 17.6 14.5 13.6 17.6 12.4 16.3 16.0 20.5 18.2 14.3 14.6 15.7 18.0 21.3 24.0 16.3 20.5 12.6 29.0 20.2 15.3 15.0 18.6 14.6 16.1 16.4 17.4 12.5 16.2 17.8 15.0 13.0 12.7 17.6 12.8 20.2 13.2 19.0 14.4 13.1 19.4 12.0 16.8 15.4 7.7 12.9 10.9 17.0 20.0 12.1 13.8 13.8 10.1 15.5 11.8 12.1 18.5 16.7 17.3 17.3 27.0 29.6 13.7 11.4 30.5 15.6 26.0 16.2 23.0 9.6 18.2 11.6 11.0 26.6 15.5 11.1 13.5 22.6 19.4 12.9 21.6 17.3 9.0 29.9 16.7 14.0 18.1 20.8 16.3 12.5 20.3 11.1 13.4 8.3 14.6 22.8 12.7 15.8 10.5 11.6 12.4 11.2 7.8 20.6 24.8 15.0 26.5 27.5 10.1 26.1 14.2 5.7 12.8 16.8 12.4 15.4 11.4 13.5 10.8 12.9 12.0 19.4 11.1 10.5 6.5 7.7 14.1 11.3 12.4 10.9 18.7 29.1 21.0 24.2 16.0 20.5 18.0 21.3 20.2 17.6 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol "Nucleoli, Vesicles" "Nucleoplasm, Cytosol" "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.0 30.5 4.9 14.1 23.2 15.4 4.1 9.1 13.9 11.0 11.0 8.3 20.2 35.2 16.4 16.0 25.3 4.6 25.4 6.7 23.5 10.4 6.0 20.6 5.6 10.9 8.3 15.8 21.6 35.9 23.9 11.0 16.3 19.8 21.1 18.5 19.4 15.7 3.6 9.1 17.5 19.0 4.7 26.3 12.7 17.9 6.0 10.0 18.6 26.9 21.0 21.8 9.7 10.9 13.0 6.7 12.6 13.1 13.2 17.4 19.7 17.8 14.6 16.3 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 58.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 41.6;BJ hTERT+ SV40 Large T+: 22.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.2;HBF TERT88: 17.8;NTERA-2: 23.4;WM-115: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 5.9;memory B-cell: 12.2" "Group enriched" "Detected in many" 9 "B-cells: 12.2;granulocytes: 5.9" "Low region specificity" "Detected in many" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: " "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 3.3 1.9 9.3 2.8 12.1 1.9 7.7 3.1 12.3 6.6 2.3 26.1 4.2 1.3 10.0 13.1 8.0 5.2 3.4 2.0 11.2 5.3 2.4 2.5 4.6 3.8 22.3 7.3 14.9 2.2 23.1 0.6 6.7 11.6 7.8 2.7 12.2 12.8 11.6 0.8 23.4 1.7 6.8 12.4 2.0 2.2 58.8 14.5 0.2 2.6 6.7 4.9 5.9 7.1 12.2 0.0 5.9 1.0 0.0 0.2 0.7 2.2 1.1 0.5 0.0 0.1 0.6 7.7 14.5 41.6 22.3 20.2 0.2 3.1 0.0 3.5 7.4 0.2 0.0 0.1 17.8 0.0 0.0 0.0 1.2 0.3 12.1 0.1 2.2 6.1 0.4 0.0 1.2 1.8 2.2 0.0 0.1 0.0 0.0 0.0 23.4 1.1 11.0 0.0 0.0 0.0 1.5 0.0 0.2 0.1 9.3 0.6 1.6 3.0 0.0 2.1 0.0 0.1 1.1 0.0 0.0 3.4 0.1 0.0 32.0 0.0 1.0 5.9 0.0 0.5 0.0 12.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.7 9.3 12.1 3.1 12.3 11.2 5.3 22.3 7.3 11.6 14.5 CYLD "CYLD1, KIAA0849, USPL2" ENSG00000083799 "CYLD lysine 63 deubiquitinase" Q9NQC7 16 50742050-50801935 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011713, HPA050095" Approved Supported "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "CAB011713: AB_731794, HPA050095: " "unprognostic (9.83e-2)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" "unprognostic (2.83e-2)" "unprognostic (3.84e-1)" "unprognostic (5.06e-2)" "unprognostic (3.87e-2)" "unprognostic (3.24e-2)" "unprognostic (9.46e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (3.43e-2)" "unprognostic (6.83e-2)" "unprognostic (8.42e-2)" 9.3 16.2 13.9 22.9 26.4 51.1 9.1 14.2 20.9 9.2 10.3 18.8 12.8 10.2 16.1 8.1 15.3 8.5 13.3 12.7 15.7 17.0 9.4 13.2 15.6 30.7 16.3 14.3 11.5 12.2 20.3 27.8 9.8 20.0 11.0 12.7 13.3 12.6 10.9 31.7 12.4 14.2 12.5 16.3 23.4 12.4 22.6 13.7 16.9 16.2 8.0 29.3 14.1 12.6 9.2 10.2 31.4 9.8 13.6 19.1 10.2 9.1 2.9 3.3 3.7 5.3 7.7 3.0 13.6 19.9 14.2 8.4 2.4 4.3 10.6 4.9 13.2 3.6 3.9 8.2 21.1 46.4 6.0 5.3 5.1 1.9 10.6 5.2 24.9 8.4 6.7 17.1 17.9 5.7 2.2 9.2 19.8 1.3 5.1 7.6 3.5 4.8 4.6 6.8 10.1 4.6 3.2 4.3 3.3 11.5 3.9 3.3 3.9 6.6 6.4 24.3 5.5 8.5 5.5 24.3 23.1 11.8 17.8 5.9 5.1 31.4 8.6 20.8 10.7 9.8 12.9 9.2 15.8 14.4 10.2 6.2 14.7 11.4 19.4 13.6 9.5 6.2 19.1 10.2 13.9 26.4 14.2 20.9 15.7 17.0 16.3 14.3 20.0 13.7 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Group enriched" "Detected in some" 16 "A549: 92.9;Hep G2: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: " "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 92.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.4;lymphoid tissue: 92.9" "Cell line enhanced" "Detected in some" "Daudi: 14.3;Karpas-707: 39.0;RPMI-8226: 11.9;U-266/70: 66.4;U-266/84: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Low region specificity" "Detected in single" HPA007191 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favourable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 9.4 1.4 1.4 33.3 1.6 32.3 3.9 0.8 1.0 4.4 9.7 1.6 0.8 9.3 3.1 4.2 6.6 2.8 5.8 3.8 1.5 1.5 4.1 3.9 26.8 92.9 3.1 0.6 2.9 3.1 0.0 1.5 1.3 2.0 2.4 5.0 3.1 11.5 3.1 1.4 2.1 17.4 2.1 4.3 48.3 14.4 3.3 1.3 40.5 3.2 3.8 61.8 24.1 3.2 21.9 13.0 48.5 53.3 19.9 53.4 31.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.1 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 11.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 66.4 24.9 6.4 0.6 1.7 0.0 48.5 8.4 24.5 30.6 27.8 30.9 21.9 32.4 28.9 13.0 21.1 53.4 40.7 48.2 19.9 53.3 6.7 31.3 31.6 1.4 1.6 0.8 1.0 1.5 1.5 3.1 0.6 2.0 1.3 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Cell line enhanced" "Detected in some" "AF22: 8.8;NTERA-2: 24.7;PC-3: 6.8;RH-30: 10.4;SCLC-21H: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm Nucleoplasm "CAB034921: AB_2089315, HPA067685: " "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.2 3.4 0.0 0.0 1.6 0.0 0.0 0.0 24.7 6.8 0.0 10.4 0.0 1.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148458-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;epididymis: 9.3;fallopian tube: 8.0" "Cell line enriched" "Detected in some" 7 "HAP1: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA000258, HPA001367" Approved Approved Nucleoplasm Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.9 0.9 7.9 0.6 29.5 0.6 0.6 0.2 17.8 1.0 0.8 0.3 0.0 1.2 1.2 9.3 0.7 8.0 0.6 0.6 13.5 10.8 2.4 0.6 0.9 0.6 3.4 10.4 1.4 1.1 0.7 1.3 0.6 11.8 1.5 0.7 1.6 0.7 0.8 0.6 0.7 1.3 0.8 0.7 0.6 1.4 0.7 1.7 0.0 0.7 0.0 0.6 1.4 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 29.5 0.2 16.8 13.5 10.8 3.4 10.4 11.8 1.7 DACT3 "DAPPER3, MGC15476, RRR1" ENSG00000197380 "Dishevelled binding antagonist of beta catenin 3" Q96B18 19 46647612-46661138 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 9.3;SH-SY5Y: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043053 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043053: AB_10794769" "unprognostic (2.35e-1)" "unprognostic (3.08e-1)" "unprognostic (5.30e-3)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.66e-1)" "unprognostic (2.03e-2)" "unprognostic (3.27e-2)" "unprognostic (2.03e-4)" "unprognostic (1.70e-1)" "unprognostic (2.67e-1)" "prognostic unfavourable (7.97e-8)" "unprognostic (1.59e-2)" "unprognostic (4.03e-2)" "unprognostic (3.54e-3)" "prognostic unfavourable (6.66e-4)" 5.2 3.8 21.0 5.8 15.9 1.7 1.6 3.7 32.3 10.7 17.3 24.6 3.5 4.2 21.6 14.8 7.8 10.9 7.4 10.5 21.7 13.9 3.9 2.2 5.6 1.5 17.4 13.6 8.8 1.5 1.4 1.2 2.1 14.1 11.7 7.2 13.7 1.7 25.1 1.7 2.8 4.7 30.3 17.0 4.8 7.4 5.7 9.4 0.0 1.6 1.5 1.3 13.2 6.0 1.6 1.2 5.9 0.9 2.0 0.7 0.3 0.2 0.3 5.1 4.8 1.7 1.4 0.5 2.8 4.7 0.9 1.4 0.3 0.3 0.4 1.9 9.3 0.3 3.2 0.1 1.0 0.4 1.7 1.2 0.7 0.2 2.6 0.2 2.1 4.6 0.1 1.2 0.0 0.4 1.6 1.7 0.8 0.4 0.2 1.2 2.0 0.7 4.1 1.4 0.3 0.3 0.4 2.0 22.7 0.5 0.2 0.4 0.4 0.4 0.5 2.4 2.9 2.5 0.5 1.5 0.5 0.7 0.6 0.8 1.8 5.9 0.9 1.0 0.7 0.5 0.5 0.7 0.7 0.5 0.2 1.6 0.7 0.7 4.6 2.0 0.7 1.2 0.5 0.3 21.0 15.9 3.7 32.3 21.7 13.9 17.4 13.6 14.1 9.4 DAGLB "DAGLBETA, KCCR13L" ENSG00000164535 "Diacylglycerol lipase beta" Q8NCG7 7 6409126-6484190 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069377 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA069377: " "unprognostic (2.39e-1)" "unprognostic (4.61e-2)" "unprognostic (2.13e-3)" "unprognostic (1.42e-1)" "unprognostic (9.04e-3)" "unprognostic (3.68e-2)" "unprognostic (1.78e-3)" "unprognostic (2.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavourable (7.18e-5)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.54e-4)" "unprognostic (2.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.81e-2)" 20.1 28.2 12.6 12.7 20.3 25.8 29.8 18.4 26.1 19.1 18.0 11.4 19.4 15.1 14.3 17.5 16.2 12.5 26.6 18.9 12.4 13.8 24.0 88.0 18.4 25.2 11.6 5.8 22.5 47.0 14.2 19.0 45.7 7.5 14.6 10.6 14.6 34.1 22.3 22.0 22.1 31.3 16.0 13.2 15.1 14.0 27.1 7.9 7.2 23.1 15.1 16.8 15.6 20.8 5.6 18.9 13.6 14.7 2.4 8.4 7.5 11.5 13.3 5.7 7.5 8.7 6.8 4.6 16.3 11.1 14.1 15.3 7.0 12.7 6.2 7.1 7.9 17.1 9.3 8.6 8.1 2.8 6.5 3.3 15.2 4.8 9.4 9.4 5.3 6.0 14.3 9.4 9.3 6.0 9.4 3.1 8.3 8.1 3.3 13.4 20.8 10.1 29.0 6.6 13.5 8.8 4.3 7.4 4.4 9.2 14.1 2.7 9.9 17.7 7.4 12.2 23.2 15.2 7.6 3.3 5.9 5.3 6.0 14.8 14.7 6.2 14.7 13.6 4.4 13.9 3.9 5.6 3.5 2.9 18.9 3.6 8.4 4.8 7.3 2.4 12.2 3.2 2.9 7.5 12.6 20.3 18.4 23.4 12.4 13.8 11.6 5.8 7.5 7.9 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favourable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favourable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 9.4 14.1 9.3 13.9 9.0 4.4 21.6 10.2 11.9 11.3 9.5 7.7 14.9 7.2 7.7 14.7 13.1 34.3 14.2 8.6 8.6 7.3 16.0 9.3 10.8 9.1 7.2 9.4 13.5 29.3 12.6 11.1 8.7 6.3 8.4 7.5 8.4 13.2 18.5 7.5 13.0 10.2 6.5 5.1 8.5 9.9 32.0 6.8 21.1 21.1 13.5 12.7 9.5 14.1 17.7 8.2 7.3 9.3 14.5 19.2 9.3 6.2 8.6 5.4 10.6 15.4 20.6 6.6 5.3 14.3 8.8 8.5 6.0 7.8 2.5 7.6 14.0 4.2 7.0 13.5 6.2 3.8 4.7 2.7 7.9 11.2 10.1 7.6 5.4 13.9 14.1 11.1 24.6 13.6 2.1 6.2 8.6 10.6 3.4 5.1 8.9 8.1 1.7 0.7 18.0 23.4 9.8 3.4 11.4 5.8 15.9 11.9 11.2 8.4 8.4 3.4 5.5 12.2 4.7 20.0 10.9 1.3 13.0 3.5 6.8 7.1 7.7 3.7 10.2 9.3 18.8 17.7 17.0 12.7 8.2 15.5 14.4 9.3 7.3 14.5 8.6 5.6 19.2 9.3 9.3 9.0 10.2 11.9 8.6 7.3 7.2 9.4 6.3 6.8 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 18.9 13.8 17.2 15.8 32.2 39.0 19.1 46.6 72.4 35.3 41.0 9.8 16.2 8.3 30.6 57.5 3.7 10.7 27.6 39.3 43.5 7.8 11.1 26.8 24.1 30.4 20.7 8.3 20.0 9.6 23.1 41.9 65.7 12.8 28.1 34.5 15.0 11.1 13.2 6.2 31.8 15.3 7.6 13.6 46.5 35.3 11.7 15.7 47.5 19.4 12.4 15.3 30.5 32.2 21.9 23.8 14.4 24.6 15.8 20.4 12.2 21.7 40.5 32.8 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 DAP3 "bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29" ENSG00000132676 "Death associated protein 3" P51398 1 155687960-155739010 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Apoptosis "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023687 Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA023687: AB_1847472" "unprognostic (2.60e-1)" "unprognostic (2.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.20e-4)" "unprognostic (1.80e-1)" "unprognostic (5.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.87e-2)" "unprognostic (3.16e-1)" "prognostic unfavourable (4.14e-6)" "unprognostic (1.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" 27.8 36.5 22.9 26.3 25.9 28.9 34.2 19.5 23.6 23.5 33.4 19.5 22.8 29.4 28.7 28.1 31.3 21.8 23.2 56.3 27.0 26.4 32.8 52.2 23.9 49.0 24.9 23.0 23.3 38.5 20.7 27.1 20.5 23.0 27.9 32.1 24.5 28.0 27.1 64.0 30.9 26.5 36.0 23.2 30.8 30.3 31.6 21.1 44.4 27.6 28.4 38.0 38.0 24.1 39.0 41.1 15.9 35.2 34.0 56.5 39.6 32.3 21.0 17.2 27.2 25.4 32.1 42.3 27.3 28.9 28.1 24.6 38.7 39.8 46.2 55.7 22.2 33.1 25.5 23.8 30.7 28.9 18.6 28.1 18.8 35.1 34.8 38.4 25.1 26.9 34.2 35.8 47.4 27.6 60.7 32.9 29.2 43.0 33.7 45.0 30.4 34.4 27.9 21.6 49.0 33.4 31.0 20.0 35.5 26.2 77.4 47.1 48.0 63.3 23.6 23.9 25.2 29.5 45.8 36.0 53.7 53.2 23.8 34.5 30.7 13.9 30.1 15.9 31.3 35.2 51.4 39.0 45.1 38.0 41.1 32.2 56.5 48.4 13.0 34.0 31.9 26.8 45.0 39.6 22.9 25.9 19.5 23.6 27.0 26.4 24.9 23.0 23.0 21.1 DAPK3 "ZIP, ZIPK" ENSG00000167657 "Death associated protein kinase 3" O43293 19 3958453-3971123 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation, Translation regulation" "Activator, Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028569, HPA064809" Approved Approved Nucleoplasm Nucleoplasm "HPA028569: AB_10794319, HPA064809: " "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.34e-3)" "prognostic favourable (2.01e-5)" "unprognostic (1.83e-1)" "unprognostic (2.37e-1)" "unprognostic (7.72e-3)" "unprognostic (2.16e-1)" "unprognostic (2.46e-2)" "unprognostic (4.95e-2)" "unprognostic (1.84e-3)" "unprognostic (7.64e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (9.92e-2)" "unprognostic (1.41e-1)" "unprognostic (5.48e-2)" "unprognostic (2.14e-1)" 18.8 10.2 12.6 16.6 16.4 10.0 17.2 14.5 29.5 22.5 30.1 13.6 11.5 18.5 33.1 11.5 20.2 18.5 21.9 49.2 12.4 11.0 10.9 11.0 24.5 11.6 11.9 16.8 18.8 21.7 11.1 14.6 26.0 19.7 21.3 6.9 18.2 15.3 25.8 45.2 17.8 17.0 38.8 10.6 14.7 23.3 15.7 12.7 11.8 11.4 11.6 12.9 26.7 17.8 15.0 14.7 23.9 15.6 17.3 19.5 11.0 25.5 20.3 12.7 16.0 9.5 10.8 19.6 35.3 28.5 28.9 19.1 37.4 7.7 14.2 17.3 30.9 20.4 12.4 20.0 10.5 20.7 20.6 5.7 24.9 21.4 30.3 13.7 21.5 24.5 25.0 26.1 15.1 23.9 18.0 24.7 17.5 16.6 13.5 10.3 19.7 16.3 17.0 18.8 13.2 17.4 20.1 20.1 14.0 23.7 28.7 20.2 20.6 10.8 44.6 37.1 16.8 33.2 44.0 27.6 22.6 16.4 29.6 14.4 19.8 22.1 14.2 23.9 19.5 15.6 14.0 13.5 14.8 17.9 12.6 15.0 11.3 10.8 23.9 17.3 10.6 14.7 17.6 11.0 12.6 16.4 14.5 29.5 12.4 11.0 11.9 16.8 19.7 12.7 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;hTCEpi: 21.6;SCLC-21H: 5.5;U-87 MG: 7.9" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: , HPA058635: " "unprognostic (3.95e-5)" "prognostic favourable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.8 0.0 0.0 0.3 5.5 0.0 0.0 0.0 0.6 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 DARS2 FLJ10514 ENSG00000117593 "Aspartyl-tRNA synthetase 2, mitochondrial" Q6PI48 1 173824503-173858546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026506, HPA026528" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA026506: AB_1847482, HPA026528: AB_1847483" "unprognostic (3.14e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-3)" "unprognostic (4.10e-3)" "unprognostic (2.20e-1)" "unprognostic (1.42e-1)" "unprognostic (6.17e-2)" "unprognostic (1.15e-1)" "prognostic favourable (1.74e-4)" "unprognostic (3.30e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (4.73e-3)" 17.0 22.2 6.3 10.1 8.1 5.4 9.0 7.5 8.6 7.8 15.1 6.7 8.3 11.7 10.4 6.1 13.4 6.4 5.9 11.2 5.5 6.0 21.9 14.8 8.2 11.0 6.4 4.2 9.5 14.9 18.1 15.3 10.9 10.0 8.5 16.6 10.2 10.2 6.2 10.6 6.0 16.1 6.2 9.0 11.4 11.3 8.4 6.9 26.1 12.2 6.3 12.5 9.7 8.1 9.3 9.0 4.8 10.7 5.0 9.3 5.2 29.2 19.6 12.2 7.6 9.3 13.3 15.6 12.9 10.7 18.7 14.3 18.3 26.4 15.9 17.7 10.3 30.1 33.7 21.8 25.6 18.1 16.5 13.7 9.8 12.8 9.1 11.6 12.5 9.6 10.0 18.9 19.3 18.6 27.7 12.5 15.5 8.1 14.7 6.5 23.6 17.6 17.4 15.6 29.2 17.0 9.8 16.0 14.7 14.2 31.6 20.3 33.1 15.3 8.2 9.6 15.2 13.2 20.6 9.8 24.8 18.4 5.6 12.9 20.7 4.4 7.0 4.8 6.6 10.7 9.3 9.3 7.2 5.8 9.0 7.3 7.7 4.8 0.7 5.0 7.4 3.7 5.1 5.2 6.3 8.1 7.5 8.6 5.5 6.0 6.4 4.2 10.0 6.9 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 14.9;U-2197: 28.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.5 0.3 0.6 0.4 3.6 0.3 0.2 0.0 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 14.9 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.3 1.5 0.1 1.4 28.1 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 160.5;skeletal muscle: 84.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 12.2 7.8 56.5 9.9 64.9 2.1 15.3 21.3 88.8 11.0 26.4 132.3 5.0 16.6 14.9 13.6 18.3 17.7 10.2 68.4 85.1 47.3 5.9 2.5 13.9 5.8 98.2 31.5 6.5 6.7 18.4 5.0 13.2 51.8 14.2 28.4 3.1 9.0 29.1 84.2 10.4 19.4 31.0 160.5 5.0 13.3 3.0 70.7 2.7 4.8 10.5 8.2 16.8 8.2 0.3 15.0 0.3 9.3 0.6 7.9 3.5 21.4 3.8 3.1 21.7 2.0 0.9 4.3 12.6 13.8 10.6 7.2 10.4 29.4 0.3 2.2 12.4 31.8 21.2 1.1 6.5 0.1 12.5 17.9 16.6 9.4 12.7 0.9 27.3 0.3 3.6 4.0 3.7 7.2 1.2 0.4 0.8 27.2 1.5 1.3 4.0 22.9 0.0 0.3 0.2 30.2 0.4 7.1 3.6 4.4 2.4 27.2 29.8 5.5 11.6 0.4 21.1 14.0 13.8 0.3 0.4 0.1 1.5 0.1 3.1 0.0 8.4 0.0 7.9 9.3 2.9 0.1 6.9 5.8 6.0 0.3 6.4 6.0 0.3 0.6 5.0 15.0 5.8 3.5 56.5 64.9 21.3 62.5 85.1 47.3 98.2 31.5 51.8 70.7 DCAF4 "DKFZp434K114, WDR21, WDR21A" ENSG00000119599 "DDB1 and CUL4 associated factor 4" Q8WV16 14 72926332-72959703 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA047276 Approved Approved Nucleoplasm Nucleoplasm "HPA047276: AB_10959615" "unprognostic (6.01e-2)" "unprognostic (1.96e-1)" "unprognostic (9.31e-2)" "unprognostic (1.78e-2)" "unprognostic (1.78e-2)" "unprognostic (2.36e-1)" "prognostic unfavourable (6.77e-4)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.38e-2)" "unprognostic (2.86e-1)" "unprognostic (7.56e-2)" "prognostic favourable (4.90e-4)" "unprognostic (6.80e-2)" "unprognostic (1.87e-1)" "unprognostic (9.96e-3)" "unprognostic (2.11e-2)" 9.0 10.4 6.7 10.2 11.4 7.3 10.8 6.1 19.2 8.4 10.5 12.0 7.5 6.7 14.5 9.8 10.0 8.9 9.9 6.6 7.4 9.2 12.3 9.6 6.3 9.4 9.4 10.9 15.0 17.9 9.4 6.5 14.5 15.4 9.3 10.6 9.0 13.4 8.6 18.2 18.5 8.8 9.6 6.6 9.2 10.7 14.5 6.6 7.9 17.7 7.5 12.1 9.9 9.6 12.0 3.5 1.0 4.5 9.0 7.1 3.1 12.5 6.1 1.5 6.6 6.4 8.5 11.9 7.2 7.3 9.4 10.9 6.7 5.5 16.1 5.5 13.7 9.5 10.3 11.1 16.6 8.0 5.7 6.8 2.6 8.8 9.3 4.5 11.0 15.0 11.2 10.1 19.0 3.3 9.7 10.5 7.6 20.7 7.9 11.5 3.7 12.6 5.5 7.9 9.2 14.1 7.4 7.7 3.1 4.3 22.9 9.0 7.7 6.1 4.9 5.1 12.1 14.0 3.6 14.6 14.0 10.7 7.2 3.8 3.1 0.3 1.7 0.3 4.5 2.7 6.7 12.0 5.5 5.1 3.5 10.3 6.4 6.7 1.0 9.0 4.5 2.7 7.1 3.1 6.7 11.4 6.1 19.2 7.4 9.2 9.4 10.9 15.4 6.6 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262531 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favourable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavourable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 26.6 28.7 26.3 21.6 29.5 21.2 26.4 37.6 38.3 22.2 28.0 39.6 31.6 25.0 28.7 38.2 24.6 27.6 29.0 35.8 25.9 20.0 25.6 42.2 23.0 25.5 30.1 29.2 29.8 34.6 45.3 33.1 21.5 31.7 23.8 19.0 29.3 29.0 44.9 86.4 28.8 26.1 26.8 23.8 28.6 28.6 20.8 32.5 25.7 36.9 27.2 22.7 28.0 21.6 26.6 17.8 22.4 21.6 24.9 26.6 14.4 16.8 21.2 24.0 21.6 30.2 22.9 20.9 20.0 28.4 16.8 15.1 22.2 29.3 18.6 37.7 22.7 20.9 11.6 18.9 10.6 42.7 22.8 20.7 29.6 17.5 24.6 17.4 26.6 27.1 20.0 15.0 21.8 25.9 18.7 34.4 15.5 16.0 22.3 17.3 17.2 21.1 21.9 14.2 36.5 19.3 30.1 16.3 15.7 33.6 37.6 22.5 35.3 26.3 31.1 20.7 10.7 12.7 18.5 56.6 38.6 30.4 23.1 16.3 16.9 22.4 17.5 18.1 26.6 16.9 26.1 23.7 23.6 25.0 14.8 26.6 26.2 23.8 19.9 24.9 21.6 17.8 24.3 14.4 26.3 29.5 37.6 38.3 25.9 20.0 30.1 29.2 31.7 32.5 DCAKD FLJ22955 ENSG00000172992 "Dephospho-CoA kinase domain containing" Q8WVC6 17 45023340-45061109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060997 Approved Nucleoplasm Nucleoplasm "HPA060997: " "unprognostic (1.32e-2)" "unprognostic (4.79e-3)" "unprognostic (9.71e-2)" "prognostic favourable (7.16e-6)" "unprognostic (1.13e-1)" "unprognostic (8.24e-3)" "unprognostic (7.57e-2)" "unprognostic (6.05e-3)" "unprognostic (4.10e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-3)" "unprognostic (4.00e-2)" "unprognostic (6.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "unprognostic (1.82e-2)" 14.6 26.9 25.1 10.3 28.1 6.5 14.9 20.3 32.6 18.8 11.8 31.2 17.8 10.0 18.7 23.7 19.6 28.2 13.6 29.0 28.0 30.0 13.6 15.9 9.9 11.3 28.7 22.9 26.5 16.5 21.1 25.0 11.8 28.6 21.3 10.5 23.7 38.1 22.5 12.7 21.5 10.2 15.6 24.6 11.2 9.8 11.6 23.6 21.8 27.0 8.7 14.8 17.9 15.6 5.7 13.2 2.2 6.5 4.7 9.4 3.9 7.6 14.6 14.1 21.6 12.1 12.9 7.8 6.8 4.6 8.7 8.8 3.5 8.2 13.8 14.9 6.6 9.8 9.8 6.6 7.5 43.1 18.8 14.1 7.0 17.4 14.7 6.0 8.2 15.9 15.6 9.7 2.9 7.4 13.1 9.6 10.2 17.1 18.5 6.7 7.6 12.6 11.2 11.6 11.2 7.9 10.1 17.6 22.5 4.6 3.7 8.1 11.0 8.7 11.1 11.3 7.7 16.2 7.1 12.1 5.7 6.2 19.9 6.1 13.3 1.0 4.5 2.2 7.5 6.5 9.4 5.7 7.6 6.6 7.0 5.1 7.0 7.3 0.8 4.7 4.6 13.2 6.9 3.9 25.1 28.1 20.3 28.1 28.0 30.0 28.7 22.9 28.6 23.6 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell line enhanced" "Detected in some" "ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: , HPA015655: " "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.0 17.3 16.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 13.3 0.0 10.3 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 15.1 7.5 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 21.4 0.2 0.0 1.2 0.0 0.6 0.0 4.3 2.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.5 4.4 0.7 0.1 0.0 0.0 1.4 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: " "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavourable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavourable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 4.5 16.2 4.5 5.1 5.1 7.1 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 7.1 13.2 7.5 3.8 4.6 16.0 11.6 12.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 DCTD ENSG00000129187 "DCMP deaminase" P32321 4 182890060-182917936 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035894 Approved Approved Nucleoplasm,Cytosol 13000 "Nucleoplasm, Cytosol" "HPA035894: AB_10673488" "unprognostic (1.26e-1)" "unprognostic (9.80e-3)" "unprognostic (3.15e-2)" "unprognostic (3.78e-3)" "unprognostic (3.13e-3)" "unprognostic (2.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.59e-3)" "unprognostic (2.62e-2)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.20e-1)" "prognostic favourable (1.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-1)" 24.8 46.2 24.7 19.9 23.8 12.9 27.3 11.6 28.3 27.1 20.4 17.3 22.6 16.4 26.0 20.1 30.9 25.9 40.9 25.8 22.5 22.2 25.7 47.6 25.8 29.4 21.1 20.3 35.9 51.7 28.3 25.3 18.9 21.3 23.7 21.5 30.0 26.4 22.8 24.8 19.4 19.1 27.4 25.6 24.9 27.2 11.8 16.7 15.0 52.9 21.3 26.0 24.5 25.1 31.9 24.8 23.7 25.7 30.8 36.8 22.7 22.4 20.7 21.2 19.5 32.0 43.7 27.7 43.3 38.7 31.1 19.3 21.0 43.7 7.8 10.7 42.2 11.2 15.4 27.0 28.6 37.8 11.7 36.1 12.0 25.0 34.3 35.1 22.6 36.3 28.9 27.3 28.5 26.6 35.8 78.2 41.3 16.3 22.7 21.5 16.8 18.1 24.8 15.1 15.1 25.0 27.0 20.9 13.0 20.5 17.7 20.2 13.6 18.4 30.9 25.9 19.9 12.5 33.0 30.1 16.2 10.0 28.6 23.0 30.4 23.7 22.0 19.7 29.2 25.7 36.8 31.9 25.6 29.7 24.8 21.7 25.5 26.7 1.6 30.8 24.9 19.1 21.9 22.7 24.7 23.8 11.6 28.3 22.5 22.2 21.1 20.3 21.3 16.7 DCTN4 ENSG00000132912 "Dynactin subunit 4" Q9UJW0 5 150708440-150759109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017532, HPA038026" Uncertain Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "CAB017532: AB_1122152, HPA038026: " "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.87e-3)" "unprognostic (7.82e-3)" "unprognostic (1.37e-2)" "unprognostic (2.08e-1)" "unprognostic (8.41e-2)" "unprognostic (1.38e-1)" "unprognostic (5.86e-2)" "unprognostic (9.68e-3)" "unprognostic (1.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.83e-1)" 26.1 27.9 27.9 13.3 27.3 41.0 25.7 30.3 36.5 19.8 15.9 32.4 17.7 15.9 20.6 27.6 20.0 18.4 16.5 20.6 27.3 29.0 20.0 22.0 17.8 13.3 30.8 24.0 26.3 32.5 23.9 27.7 25.9 33.2 24.1 18.6 21.3 15.7 22.4 42.0 19.0 15.4 21.3 34.7 13.9 18.0 22.9 25.4 18.8 24.8 15.3 14.5 23.3 16.2 5.0 10.9 16.4 10.7 3.0 6.9 5.2 9.4 11.3 20.5 34.2 25.1 24.3 16.9 16.7 16.8 20.2 20.4 21.1 11.9 9.2 23.4 19.8 11.5 25.2 19.6 24.8 18.5 19.8 11.9 13.1 13.2 22.9 14.3 17.0 24.5 17.5 18.1 31.8 14.3 18.1 11.9 26.1 9.9 8.8 7.7 10.3 17.8 7.8 12.4 10.2 15.0 16.2 46.6 19.6 17.7 24.2 24.8 23.4 19.2 15.9 22.6 12.7 14.7 17.6 10.6 13.5 5.5 26.0 19.3 18.4 3.2 10.7 10.5 5.5 7.8 5.6 5.0 6.2 5.4 10.9 4.4 5.9 6.9 16.4 3.0 6.4 5.1 4.3 5.2 27.9 27.3 30.3 33.3 27.3 29.0 30.8 24.0 33.2 25.4 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641392-23677455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: " "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavourable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favourable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 16.9 16.4 26.6 17.5 38.8 36.9 15.9 19.0 47.1 15.3 19.3 26.9 13.3 20.9 19.2 13.1 30.4 14.6 14.7 17.3 19.4 17.2 22.0 15.4 17.4 20.7 19.1 23.8 14.7 18.6 23.2 17.6 21.1 29.0 18.4 26.1 17.4 19.7 15.5 21.0 23.8 22.2 22.3 19.7 21.5 19.4 20.1 19.9 16.2 19.6 10.5 31.6 20.9 18.7 14.5 17.0 19.0 19.3 20.2 17.9 16.0 11.7 23.5 23.0 19.2 16.4 12.3 16.2 20.9 13.1 13.6 16.4 26.3 16.3 16.6 17.1 21.9 12.4 38.0 20.2 16.9 18.9 15.0 20.5 28.2 37.0 11.2 24.9 15.9 10.2 14.6 16.7 17.8 21.3 39.0 12.9 21.7 32.6 19.1 7.2 27.2 10.4 23.5 19.9 18.1 11.0 25.0 19.3 20.0 18.4 15.0 12.4 20.9 21.2 28.8 18.3 8.4 14.3 14.6 17.6 26.2 26.7 17.5 12.5 19.8 11.2 16.1 19.0 16.2 13.5 17.9 14.5 15.0 17.5 17.0 11.2 12.8 15.1 7.0 20.2 19.3 11.8 17.3 16.0 26.6 38.8 19.0 47.1 19.4 17.2 19.1 23.8 29.0 19.9 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423619-30430075 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Approved Nucleoplasm,Cytosol 270000 "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavourable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavourable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favourable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 15.3 15.8 14.8 25.0 13.2 12.5 20.7 15.5 19.2 12.1 37.4 10.3 11.3 20.7 14.1 14.4 19.7 18.9 28.1 23.3 12.1 12.6 27.0 25.3 11.2 27.6 13.3 16.6 16.6 25.2 16.4 7.7 16.3 11.4 15.4 40.3 10.6 20.5 21.1 28.3 16.1 22.9 13.9 11.3 22.5 16.4 9.9 7.8 21.3 22.6 26.0 25.0 13.2 13.0 47.3 30.9 19.0 24.5 23.1 26.2 25.3 26.3 32.4 14.8 19.0 4.2 5.7 13.7 12.7 7.6 19.2 19.6 24.3 22.5 35.7 26.7 7.9 20.7 30.6 24.9 24.0 18.8 48.3 20.8 14.9 31.6 5.4 37.1 32.4 6.5 14.2 21.4 12.3 19.7 26.1 12.6 13.6 46.0 44.1 41.6 19.5 26.2 62.6 16.4 46.5 22.2 17.2 31.5 17.8 8.4 30.2 11.9 26.1 16.0 9.9 14.9 13.3 19.1 22.8 8.3 24.7 45.5 9.8 30.8 17.3 19.0 12.4 11.7 18.8 22.1 26.2 47.3 24.2 21.3 28.7 40.2 21.8 21.0 1.5 23.1 24.5 30.9 24.1 25.3 14.8 13.2 15.5 19.2 12.1 12.6 13.3 16.6 11.4 7.8 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 95.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol 70000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 5.0 5.2 7.9 5.0 7.1 6.9 4.8 9.3 8.3 4.5 4.9 4.1 2.7 4.9 5.4 4.9 6.7 4.3 4.6 5.5 7.4 5.0 7.2 11.2 4.3 5.0 9.3 6.8 4.7 3.6 4.6 14.6 4.5 8.0 6.1 4.8 2.8 4.9 5.4 14.7 5.2 6.5 8.1 9.2 5.2 4.2 95.0 7.6 7.2 6.7 5.2 6.0 8.4 4.9 7.4 10.7 17.3 9.8 11.2 8.0 5.7 23.0 10.2 13.7 5.9 14.6 14.3 11.6 14.8 16.7 16.7 16.4 15.1 17.2 27.0 32.6 13.8 13.0 11.5 11.9 22.2 22.1 6.2 26.0 8.0 6.3 9.2 15.3 19.7 10.2 14.5 9.3 8.8 11.4 8.7 14.2 12.2 12.4 15.0 8.2 11.2 9.4 11.8 14.5 17.9 12.0 16.3 10.0 9.9 25.9 18.7 13.9 38.2 12.4 11.1 10.4 10.0 14.1 17.4 11.7 21.8 27.5 13.0 14.5 14.9 9.4 9.1 17.3 7.8 9.8 7.5 7.4 6.4 7.7 10.7 4.7 7.5 7.9 15.0 11.2 6.3 8.2 8.0 5.7 7.9 7.1 9.3 8.3 7.4 5.0 9.3 6.8 8.0 7.6 DCUN1D3 "DKFZp686O0290, FLJ41725, MGC48972, SCCRO3" ENSG00000188215 "Defective in cullin neddylation 1 domain containing 3" Q8IWE4 16 20854925-20900384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 38.4" "Cell line enhanced" "Detected in all" "ASC diff: 30.1;ASC TERT1: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041983, HPA043511" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041983: , HPA043511: " "unprognostic (9.34e-2)" "unprognostic (4.56e-2)" "unprognostic (3.47e-2)" "unprognostic (1.33e-2)" "unprognostic (4.24e-2)" "unprognostic (8.71e-2)" "unprognostic (5.90e-2)" "unprognostic (1.73e-1)" "unprognostic (1.81e-1)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.31e-2)" "prognostic unfavourable (5.41e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (5.31e-2)" "unprognostic (2.42e-1)" 19.2 9.9 4.3 6.0 4.6 2.7 17.2 7.9 5.6 7.5 6.0 5.5 3.2 3.4 7.7 5.9 8.5 6.6 9.6 8.9 2.5 2.8 10.0 17.4 9.7 3.1 5.2 3.0 5.3 6.6 6.4 9.5 9.4 6.7 6.6 4.1 6.3 3.9 4.5 38.4 7.1 4.9 11.9 3.9 4.5 6.4 7.9 3.8 1.5 4.8 11.5 4.5 6.7 15.8 1.4 1.6 4.8 2.5 2.6 2.7 1.0 2.6 4.7 2.4 5.1 30.1 22.7 3.2 8.9 7.7 4.5 6.1 5.9 5.1 1.7 7.3 8.7 3.7 2.7 3.7 6.0 2.3 1.9 1.4 3.7 8.5 7.9 2.2 13.7 14.9 5.1 8.6 4.9 12.3 1.6 4.6 9.2 3.6 2.0 3.1 5.6 1.6 3.4 2.7 1.6 4.0 2.8 2.2 2.9 3.5 3.9 2.0 2.6 1.0 6.0 9.6 3.4 4.0 2.4 3.9 2.3 1.2 10.2 2.3 4.9 4.8 1.4 1.2 1.7 2.5 1.7 1.0 1.2 2.7 1.6 1.4 1.5 2.7 1.9 2.6 2.2 1.2 1.0 1.0 4.3 4.6 7.9 5.6 2.5 2.8 5.2 3.0 6.7 3.8 DCUN1D4 KIAA0276 ENSG00000109184 "Defective in cullin neddylation 1 domain containing 4" Q92564 4 51843000-51916837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036483, HPA036484" Uncertain Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036483: AB_10670719, HPA036484: AB_10671843" "unprognostic (3.16e-2)" "unprognostic (2.65e-1)" "unprognostic (2.77e-3)" "unprognostic (1.41e-1)" "unprognostic (5.61e-2)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (1.37e-1)" "unprognostic (8.47e-3)" "unprognostic (1.61e-3)" "unprognostic (3.88e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-3)" "unprognostic (2.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.10e-3)" "unprognostic (1.40e-1)" 16.9 22.9 15.9 9.9 26.1 3.5 13.5 15.4 24.8 15.9 14.3 12.8 15.5 7.6 17.8 17.3 13.4 13.6 14.2 14.9 29.8 22.3 19.4 36.5 10.4 10.7 17.7 22.0 20.8 9.8 9.9 19.8 9.3 24.6 16.6 12.0 9.4 15.9 22.9 14.3 10.2 9.8 31.4 24.0 11.4 14.6 20.4 13.4 3.9 16.8 8.6 8.2 20.3 13.7 4.6 2.9 10.2 4.2 4.4 10.7 5.3 5.6 10.2 13.8 19.9 14.1 14.2 5.3 17.6 13.1 10.1 9.1 6.5 6.1 4.2 11.4 19.9 5.7 17.5 11.0 13.9 2.7 5.1 7.5 7.9 15.7 29.8 10.4 10.1 14.6 13.1 11.5 10.1 10.1 8.3 3.1 17.4 8.3 12.7 7.3 8.1 8.3 6.1 7.1 2.4 13.1 6.7 8.1 8.8 7.6 9.4 14.6 9.7 6.6 16.4 13.4 11.0 10.7 14.0 5.8 8.2 3.9 9.4 9.9 7.6 5.5 4.2 10.2 7.2 3.7 10.7 4.6 8.1 8.0 2.9 3.3 7.8 8.5 1.7 4.4 2.6 1.9 3.7 5.3 15.9 26.1 15.4 24.8 29.8 22.3 17.7 22.0 24.6 13.4 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103062076-103092215 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA050863: " "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavourable (4.62e-4)" "prognostic unfavourable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favourable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavourable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 20.9 18.3 18.9 17.2 24.5 13.4 19.1 22.5 28.8 12.9 13.5 15.9 11.5 11.4 15.9 13.7 26.5 12.9 10.6 24.2 20.3 16.6 14.4 19.0 13.9 21.5 15.6 21.0 12.2 17.7 14.5 17.0 17.3 23.6 15.4 13.9 9.9 15.6 13.5 38.7 14.0 11.3 18.4 17.5 15.7 16.0 24.0 21.0 19.4 13.2 24.2 21.3 14.4 14.7 14.4 17.3 11.8 13.1 20.5 17.0 13.4 22.0 12.2 13.5 20.7 11.0 14.0 15.0 21.9 11.9 18.1 18.6 46.9 25.8 10.6 38.7 15.5 21.0 28.4 27.7 18.6 18.7 19.1 28.5 10.5 18.2 18.7 40.8 14.8 12.2 24.6 24.2 25.1 22.3 46.5 0.0 17.1 19.9 26.9 31.9 26.3 31.3 11.5 21.6 27.0 13.7 22.7 18.3 19.5 20.4 20.9 18.2 24.5 17.1 18.1 14.7 17.8 26.0 19.5 9.0 14.2 35.5 10.4 40.1 15.2 11.8 11.1 10.2 13.8 13.1 16.3 14.4 16.3 14.2 13.7 14.1 14.0 16.3 4.0 20.5 10.0 17.3 17.0 13.4 18.9 24.5 22.5 28.8 20.3 16.6 15.6 21.0 23.6 21.0 DDA1 "C19orf58, MGC2594, PCIA1" ENSG00000130311 "DET1 and DDB1 associated 1" Q9BW61 19 17309518-17323301 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042134, HPA055272" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA042134: AB_10794169, HPA055272: " "unprognostic (1.30e-1)" "unprognostic (6.35e-3)" "unprognostic (3.13e-2)" "unprognostic (1.49e-3)" "unprognostic (5.38e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-2)" "unprognostic (4.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (8.55e-2)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 11.6 15.5 24.5 12.7 26.6 16.1 9.9 14.6 36.2 10.8 14.6 13.5 9.6 15.4 11.6 9.9 13.4 13.5 11.8 16.4 18.9 19.8 12.9 17.9 14.6 14.7 19.0 24.4 12.9 13.4 10.9 10.9 26.4 23.0 12.9 13.1 10.8 13.6 15.9 17.8 20.8 16.9 11.5 13.2 13.4 17.4 29.6 12.0 15.9 10.5 10.9 13.7 12.4 9.9 7.1 12.7 11.5 8.0 6.5 8.8 5.7 12.4 11.1 8.4 6.7 8.8 6.3 13.1 8.5 10.8 13.0 12.0 9.8 11.0 4.9 11.8 8.7 10.6 6.2 12.3 6.3 8.1 16.4 6.0 8.8 9.2 10.7 6.8 11.8 9.7 14.2 7.8 7.2 7.5 7.1 8.6 6.8 6.2 13.6 10.1 9.6 19.0 8.7 6.6 8.2 10.2 9.3 8.6 12.9 6.2 14.3 7.4 7.2 9.1 11.3 8.7 7.3 22.4 11.7 10.7 14.4 6.9 19.2 11.7 8.6 5.0 7.3 11.5 8.6 8.0 7.4 7.1 7.2 8.5 5.9 6.6 8.3 8.0 8.2 6.5 6.9 12.7 8.8 5.7 24.5 26.6 14.6 36.2 18.9 19.8 19.0 24.4 23.0 12.0 DDR1 "CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6" ENSG00000204580 "Discoidin domain receptor tyrosine kinase 1" Q08345 6 30876421-30900156 "CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lactation, Pregnancy" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 31.2;HBEC3-KT: 24.0;RT4: 31.9;T-47d: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010162, CAB025656, HPA057194" Approved Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" 2100000 "Nucleoplasm, Cell Junctions" "CAB010162: AB_2092090, CAB025656: , HPA057194: " "unprognostic (2.11e-2)" "unprognostic (9.31e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.75e-3)" "unprognostic (6.43e-2)" "unprognostic (1.92e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (4.41e-2)" "prognostic favourable (3.31e-10)" "unprognostic (1.42e-1)" "unprognostic (2.53e-1)" "unprognostic (5.49e-3)" "unprognostic (4.09e-2)" 6.7 11.3 23.5 7.9 36.2 2.2 12.5 6.8 42.2 9.7 25.2 57.4 17.6 16.8 7.7 10.5 30.5 31.7 18.9 8.7 27.8 20.8 19.8 3.5 13.2 3.1 55.7 19.8 11.3 20.9 28.2 14.6 13.3 34.7 17.7 14.9 4.0 28.3 20.5 9.1 41.3 32.1 3.1 43.2 5.1 52.2 5.1 37.0 8.7 20.9 10.5 7.6 16.3 16.6 1.8 0.4 0.0 0.2 0.0 1.8 0.9 19.3 6.4 9.1 1.9 0.6 0.8 5.6 0.5 0.1 0.2 0.0 8.6 10.3 0.1 10.8 1.7 31.2 1.9 24.0 0.1 10.7 3.4 0.0 5.8 2.2 1.8 0.0 0.4 1.2 12.4 0.1 0.2 0.7 5.6 0.2 1.3 12.2 0.6 0.0 1.5 1.3 1.3 6.8 0.7 4.6 31.9 1.6 0.8 1.8 14.4 7.0 35.8 0.2 1.4 4.5 4.2 0.4 4.5 0.2 0.0 0.8 2.9 0.0 3.9 0.0 0.2 0.0 1.1 0.0 0.8 0.4 0.2 0.7 0.4 1.8 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.9 23.5 36.2 6.8 25.0 27.8 20.8 55.7 19.8 34.7 37.0 DDX3X "DBX, DDX14, DDX3, HLP2" ENSG00000215301 "DEAD-box helicase 3, X-linked" O00571 X 41333284-41364472 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation" "DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001648, HPA005631, HPA059585" Supported Supported Approved Nucleoplasm,Cytosol 110000 Cytosol Nucleoplasm "HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: " "unprognostic (2.42e-2)" "unprognostic (1.11e-1)" "unprognostic (8.01e-3)" "unprognostic (1.66e-1)" "unprognostic (8.12e-2)" "unprognostic (6.43e-2)" "unprognostic (1.17e-3)" "unprognostic (1.88e-1)" "unprognostic (9.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.25e-2)" "unprognostic (2.05e-1)" "unprognostic (1.51e-1)" "unprognostic (2.95e-1)" "unprognostic (4.77e-1)" "unprognostic (9.44e-2)" "unprognostic (2.93e-2)" 80.9 49.3 26.1 40.0 34.5 49.3 46.5 31.1 36.2 52.4 43.3 35.1 21.3 29.5 56.4 25.9 53.5 56.3 42.6 47.6 30.8 24.5 55.6 77.9 45.3 40.4 41.4 29.0 60.1 30.9 68.7 60.2 79.9 37.9 30.0 29.2 30.8 37.4 26.5 63.4 42.2 54.0 57.2 53.9 46.1 43.0 27.0 39.0 49.2 45.6 44.0 42.6 55.8 50.2 13.1 20.5 32.0 21.6 17.3 21.5 17.9 45.4 50.5 47.2 25.9 55.6 47.2 28.8 33.1 46.6 34.0 27.4 51.9 30.6 0.5 23.7 37.1 30.7 57.7 46.6 56.7 26.9 45.0 28.9 50.3 31.2 28.9 54.1 52.0 34.1 33.1 57.3 55.4 53.3 53.0 28.6 31.6 34.4 34.1 16.9 45.4 20.4 40.0 50.3 37.0 32.0 61.2 32.3 48.9 75.0 38.5 39.7 34.6 36.8 48.1 35.1 37.6 37.5 39.3 33.4 39.6 44.9 35.4 32.8 33.2 22.5 20.2 17.5 14.8 21.1 21.5 13.1 14.5 16.3 20.5 9.0 16.3 15.1 32.0 17.3 21.6 6.9 14.3 17.9 26.1 34.5 31.1 36.2 30.8 24.5 41.4 29.0 37.9 39.0 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.1 3.0 6.2 3.1 10.9 4.2 2.9 6.6 10.4 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.8 9.0 7.5 3.4 5.7 4.0 3.6 3.8 9.5 3.6 2.1 6.1 10.9 18.4 7.4 17.3 13.0 5.7 12.1 4.8 4.9 10.3 5.4 5.2 7.5 5.3 6.6 8.3 6.6 2.7 8.2 6.6 11.0 10.1 5.9 12.7 5.6 6.8 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643464 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA056173: " "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favourable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavourable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 6.4 4.5 4.3 5.3 5.5 9.1 4.6 8.1 6.5 6.9 6.1 4.8 5.0 5.9 7.8 10.7 6.7 3.5 5.0 3.0 4.5 9.4 7.1 4.2 5.1 5.4 3.1 6.3 4.4 6.2 8.8 5.8 6.5 6.1 6.0 4.0 4.1 4.8 6.7 6.0 10.6 4.8 6.2 5.7 4.8 4.8 4.9 8.7 5.7 5.8 6.1 6.0 6.9 4.0 5.7 3.5 4.2 3.5 4.7 1.5 4.7 9.8 1.0 9.7 5.5 4.9 4.2 6.5 5.8 8.5 8.3 5.0 1.8 2.7 4.5 4.3 4.4 10.8 7.1 11.4 6.5 12.2 6.0 6.2 4.0 5.4 7.7 3.2 5.1 7.2 5.5 6.9 9.8 0.8 1.8 5.0 1.5 11.7 4.0 5.5 0.4 7.5 8.5 5.0 9.7 5.4 7.2 5.8 7.7 1.8 4.7 3.4 6.0 6.5 7.0 4.3 3.5 7.3 2.3 3.8 5.4 5.7 4.9 5.5 3.4 3.2 3.5 4.2 4.2 3.3 3.6 4.0 3.5 2.3 4.0 3.4 4.7 2.8 3.5 2.4 5.7 3.1 1.5 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: " "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavourable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.4 27.7 10.3 19.0 6.9 8.3 26.7 14.4 13.4 19.7 10.8 28.5 12.9 34.3 16.9 12.0 19.7 18.3 18.7 7.5 19.7 22.5 20.6 14.9 19.4 12.2 34.3 24.4 13.7 14.8 19.0 11.8 16.1 29.8 12.3 10.1 24.5 29.5 49.0 24.1 19.7 21.9 15.3 35.0 10.7 27.7 13.4 12.2 20.4 31.3 13.0 26.8 26.9 11.9 16.7 18.7 19.8 30.0 18.0 20.5 38.6 14.7 19.2 17.5 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 DDX59 "DKFZP564B1023, ZNHIT5" ENSG00000118197 "DEAD-box helicase 59" Q5T1V6 1 200623896-200669969 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047166 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA047166: AB_2679966" "unprognostic (1.99e-1)" "unprognostic (1.60e-1)" "unprognostic (3.44e-2)" "unprognostic (4.87e-2)" "unprognostic (1.18e-2)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" "unprognostic (4.83e-2)" "unprognostic (3.40e-3)" "unprognostic (2.43e-3)" "unprognostic (4.16e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (9.02e-4)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (6.66e-2)" "unprognostic (5.98e-2)" 14.0 14.4 12.1 16.4 14.8 23.7 22.7 16.7 11.2 14.5 11.6 10.8 12.6 8.1 15.8 17.6 12.0 13.8 11.4 18.0 12.0 9.9 13.6 15.1 11.8 15.1 15.1 6.7 17.1 21.6 13.9 10.7 46.5 12.8 14.1 12.5 15.0 19.4 12.9 28.6 21.5 12.4 14.0 17.2 20.9 10.4 9.9 14.5 18.5 15.1 10.1 13.2 12.8 12.7 12.2 9.5 23.1 16.2 12.4 15.6 7.9 9.2 10.8 12.5 10.5 5.7 9.8 28.0 10.5 9.4 11.2 9.1 3.4 11.0 9.5 5.3 8.3 8.9 7.0 10.7 8.0 29.9 7.2 7.2 13.8 10.0 11.4 10.4 13.4 10.6 16.2 8.5 23.2 8.6 9.1 14.1 10.9 10.7 6.2 15.6 13.2 8.8 5.3 8.7 18.2 12.0 10.9 7.6 19.8 16.6 17.3 18.4 14.9 14.6 7.7 9.5 5.4 9.3 10.8 10.8 14.0 12.6 9.1 6.6 16.2 23.1 10.3 19.0 13.0 8.9 10.6 12.2 10.9 11.7 8.5 11.5 11.3 10.3 18.2 12.4 16.2 9.5 15.6 7.9 12.1 14.8 16.7 11.2 12.0 9.9 15.1 6.7 12.8 14.5 DEDD "CASP8IP1, DEDD1, DEFT, FLDED1, KE05" ENSG00000158796 "Death effector domain containing" O75618 1 161120974-161132688 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030681, HPA073628" Approved Approved Nucleoplasm Nucleoplasm "HPA030681: , HPA073628: " "unprognostic (2.24e-1)" "unprognostic (2.38e-1)" "unprognostic (4.81e-2)" "unprognostic (5.09e-2)" "unprognostic (4.20e-3)" "unprognostic (5.94e-2)" "prognostic unfavourable (8.48e-4)" "unprognostic (2.52e-1)" "unprognostic (8.70e-2)" "unprognostic (7.66e-3)" "unprognostic (2.33e-2)" "unprognostic (1.47e-2)" "prognostic unfavourable (4.98e-7)" "unprognostic (1.53e-1)" "unprognostic (1.34e-1)" "unprognostic (4.06e-2)" "unprognostic (1.43e-2)" 24.4 15.7 15.8 17.3 16.4 24.2 20.8 19.3 24.0 16.6 20.4 19.3 16.4 19.4 19.6 14.8 24.0 18.4 20.1 18.5 14.3 12.8 16.5 26.3 20.3 17.8 12.9 11.8 22.1 18.7 14.5 14.0 36.7 18.2 17.2 13.1 17.5 18.1 16.0 39.0 21.5 17.9 20.0 13.8 21.2 16.6 35.8 14.7 19.2 18.7 24.2 19.5 20.1 18.5 16.3 21.3 33.6 23.8 16.5 24.0 18.7 13.2 13.2 15.6 13.5 12.0 12.2 10.8 11.5 16.3 13.3 14.9 9.1 23.0 14.2 11.5 17.1 12.2 11.8 17.9 8.6 14.1 12.8 13.2 15.8 12.2 21.3 9.2 20.1 15.4 19.2 14.2 22.8 21.4 11.2 21.4 15.4 20.9 22.4 10.2 26.0 13.6 18.4 10.7 18.9 13.2 16.2 16.5 25.0 11.6 30.9 19.9 18.4 18.9 14.9 14.5 15.5 16.8 16.5 29.5 18.6 25.2 17.4 10.0 10.3 33.6 23.8 32.1 19.0 21.9 16.2 16.3 19.0 18.9 21.3 15.4 21.5 17.5 26.6 16.5 22.5 18.8 24.0 18.7 15.8 16.4 19.3 24.0 14.3 12.8 12.9 11.8 18.2 14.7 DEDD2 FLAME-3 ENSG00000160570 "Death effector domain containing 2" Q8WXF8 19 42198598-42220140 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 58.6" "Cell line enhanced" "Detected in many" "A549: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043419 Approved Nucleoplasm Nucleoplasm "HPA043419: AB_10960747" "unprognostic (1.59e-1)" "unprognostic (5.90e-2)" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (5.57e-2)" "unprognostic (6.48e-2)" "unprognostic (1.03e-1)" "unprognostic (7.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (6.39e-2)" "unprognostic (2.46e-1)" "unprognostic (3.59e-2)" "unprognostic (1.24e-1)" "unprognostic (5.80e-2)" "unprognostic (3.70e-2)" "prognostic favourable (3.26e-6)" 8.7 12.5 9.9 13.5 13.1 22.2 12.3 17.6 14.9 7.8 13.8 6.0 11.5 14.5 7.2 7.9 11.6 9.6 6.4 6.3 9.4 15.4 11.5 11.1 12.9 12.7 14.5 5.7 9.7 11.6 7.1 17.0 10.5 10.4 13.8 5.7 6.3 11.6 8.2 13.6 11.4 13.2 5.8 8.2 17.8 19.7 9.6 10.5 17.2 24.1 6.3 13.2 10.4 58.6 16.9 19.0 49.2 29.1 14.3 21.9 24.2 9.9 22.5 1.5 1.8 3.4 0.8 6.7 4.0 3.5 3.2 2.2 6.3 6.5 6.5 7.9 1.2 4.0 6.8 1.5 1.5 5.4 18.0 3.1 5.3 9.6 4.3 3.7 6.7 0.5 3.8 2.5 3.4 1.9 15.6 7.3 0.9 4.3 3.8 11.6 3.6 13.6 4.5 2.8 5.6 2.6 3.6 11.6 4.5 3.6 10.7 2.1 1.9 4.2 3.3 2.5 7.7 1.0 7.3 13.6 6.2 2.0 3.7 5.7 2.6 27.5 21.5 34.5 20.1 27.0 21.9 16.9 18.6 19.2 13.5 16.4 16.8 17.3 49.2 14.3 29.1 19.0 17.4 24.2 9.9 13.1 17.6 14.9 9.4 15.4 14.5 5.7 10.4 10.5 DEF8 FLJ20186 ENSG00000140995 "Differentially expressed in FDCP 8 homolog" Q6ZN54 16 89947925-89968060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041745, HPA049434" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041745: , HPA049434: " "unprognostic (4.99e-2)" "unprognostic (1.01e-1)" "unprognostic (9.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" "unprognostic (8.24e-2)" "unprognostic (1.91e-3)" "unprognostic (9.96e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-2)" "prognostic favourable (1.35e-7)" "unprognostic (1.39e-2)" "prognostic favourable (1.95e-8)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.09e-1)" 18.0 15.9 25.4 22.4 23.0 25.3 15.6 42.4 30.6 12.6 16.4 15.4 19.4 12.0 17.1 14.1 22.5 14.3 16.3 23.7 23.7 24.8 14.9 12.2 15.4 42.8 28.0 29.0 18.2 22.5 19.0 18.0 11.5 20.5 14.5 9.2 13.9 21.4 18.9 19.5 27.4 13.6 17.6 23.6 16.6 15.2 8.8 15.0 4.8 14.5 13.6 32.4 15.5 23.8 23.0 27.4 32.0 16.7 5.3 11.5 11.1 15.0 30.9 14.0 19.0 14.5 15.4 16.0 23.5 20.0 34.8 16.2 32.7 18.3 18.3 17.7 16.0 10.0 16.6 27.9 15.5 4.4 47.2 8.2 16.5 46.8 15.7 5.9 13.1 17.3 23.1 24.9 14.7 25.9 26.9 6.2 20.6 55.2 11.6 18.0 17.8 31.6 24.2 10.3 15.7 18.6 14.6 20.8 21.4 37.8 14.1 13.2 13.1 19.3 26.0 20.1 22.0 10.7 24.9 12.2 8.6 23.0 21.5 15.4 23.5 2.3 16.7 32.0 11.5 13.4 10.5 19.6 9.6 8.4 10.7 23.0 6.6 6.4 22.5 5.3 7.6 27.4 11.4 11.1 25.4 23.0 42.4 30.6 23.7 24.8 28.0 29.0 20.5 15.0 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell line enriched" "Detected in some" 20 "T-47d: 48.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA046644: " "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favourable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favourable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.0 1.6 0.0 0.7 2.4 0.0 0.0 1.4 0.0 48.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 DENND1A "FAM31A, FLJ21129, KIAA1608" ENSG00000119522 "DENN domain containing 1A" Q8TEH3 9 123379654-123930152 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020481 Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA020481: AB_2092106" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "unprognostic (2.00e-1)" "unprognostic (4.25e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.19e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (2.48e-3)" "unprognostic (5.63e-2)" "prognostic favourable (4.11e-5)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (9.66e-2)" "unprognostic (4.31e-2)" 11.4 12.2 17.4 13.9 19.8 32.5 10.0 18.6 21.2 10.9 14.8 12.8 10.3 15.8 13.3 9.0 11.3 13.0 10.5 10.3 15.9 12.8 16.4 14.5 9.4 11.6 11.8 14.9 12.0 8.9 20.1 19.0 23.9 13.9 11.0 14.1 14.5 8.5 11.8 11.0 9.3 17.2 14.4 10.1 20.2 9.9 12.1 13.2 10.6 15.5 5.6 9.5 10.6 17.4 1.5 8.4 11.2 15.2 0.5 1.3 3.2 14.7 8.7 7.9 14.9 5.4 8.5 36.6 14.4 21.7 12.3 10.6 11.9 6.6 11.9 3.0 11.6 8.4 6.7 10.4 12.0 5.0 5.1 5.6 21.2 8.7 7.2 6.7 3.8 7.8 9.4 10.1 17.4 10.9 15.3 9.1 9.9 8.4 8.0 9.7 15.7 13.3 12.4 7.7 10.1 6.1 5.2 16.8 13.6 11.6 7.7 8.9 10.5 17.0 5.0 13.3 5.1 15.4 7.5 14.0 10.8 8.2 11.1 13.4 8.7 11.2 15.2 2.8 1.3 10.1 0.7 1.1 0.9 0.6 8.4 1.5 0.6 0.7 9.3 0.5 8.2 1.3 0.4 3.2 17.4 19.8 18.6 21.2 15.9 12.8 11.8 14.9 13.9 13.2 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell line enhanced" "Detected in some" "Daudi: 12.9;HEL: 8.6;HMC-1: 26.9;MOLT-4: 8.3;THP-1: 7.9;U-937: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favourable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavourable (8.95e-4)" "prognostic favourable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favourable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 12.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.6 0.0 0.8 0.0 4.2 26.9 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 8.3 6.5 0.0 0.0 0.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.0 0.0 17.9 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.7;skeletal muscle: 31.1" "Cell line enhanced" "Detected in many" "U-2197: 10.1;U-266/70: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 6.1;eosinophil: 2.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA054955 Uncertain Approved Nucleoplasm Nucleoplasm "HPA054955: " "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 1.9 0.7 1.5 0.7 1.5 0.8 1.7 1.4 1.1 8.6 1.1 0.5 0.8 0.6 4.2 1.7 28.7 1.0 1.1 1.5 1.3 0.5 0.8 2.1 1.7 1.7 0.6 0.3 1.1 4.0 2.4 3.6 0.3 1.9 2.5 0.6 1.6 3.0 1.4 31.1 10.6 0.6 2.4 0.6 0.5 0.8 4.5 0.2 0.0 1.3 16.0 10.4 6.2 6.6 0.6 0.1 6.1 0.2 0.3 0.5 0.3 1.7 0.0 0.1 1.2 1.5 1.6 0.3 0.5 0.9 0.6 0.9 0.2 0.0 0.0 0.8 3.4 6.3 1.1 3.9 0.6 0.0 1.5 1.0 0.3 0.1 0.5 0.0 1.6 1.6 3.8 2.3 2.0 0.2 0.1 0.3 2.0 5.0 0.2 0.1 0.8 0.9 0.0 5.4 0.1 0.1 4.8 0.0 0.0 3.9 0.1 0.4 0.8 0.3 0.2 0.9 1.3 10.1 0.1 22.1 3.9 0.0 0.9 0.0 0.7 6.1 0.2 2.1 0.5 0.0 0.5 0.6 0.1 0.4 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.1 0.2 0.3 1.5 1.5 1.4 1.1 1.3 0.5 0.6 0.3 1.9 0.2 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA065343: " "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 13.7 15.7 9.5 13.9 11.3 32.9 9.5 26.7 12.6 10.0 9.6 12.2 6.8 6.9 11.5 6.6 8.0 9.3 13.2 8.2 10.7 8.5 9.8 19.1 12.8 20.8 12.1 9.7 16.3 19.9 17.9 21.2 9.9 11.6 8.1 8.2 14.6 9.5 7.2 15.3 7.6 10.2 12.5 16.6 13.6 10.2 9.0 11.9 16.9 12.7 5.6 20.1 13.4 10.1 9.3 3.1 6.8 3.6 4.4 8.0 1.9 4.8 4.6 2.4 2.4 7.2 8.0 3.0 5.0 6.7 3.3 5.0 2.6 3.8 24.8 3.5 7.3 9.0 4.7 4.4 5.9 27.5 5.4 23.6 5.9 4.9 4.2 8.0 8.4 5.3 5.0 4.6 9.8 9.0 7.1 15.4 3.8 2.6 3.7 4.3 0.7 3.4 1.8 8.5 21.4 3.9 9.3 3.9 3.6 4.9 3.4 4.4 3.3 20.4 9.6 4.7 5.2 8.4 6.9 8.4 9.3 9.3 6.6 17.4 3.8 3.1 3.6 6.8 5.3 1.5 8.0 7.8 4.6 6.7 3.1 9.3 4.9 4.7 1.9 4.4 1.2 1.2 4.2 1.9 9.5 11.3 26.7 12.6 10.7 8.5 12.1 9.7 11.6 11.9 DENND4B KIAA0476 ENSG00000198837 "DENN domain containing 4B" O75064 1 153929501-153946696 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040188, HPA071133" Approved Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA040188: AB_10671168, HPA071133: " "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (1.59e-2)" "unprognostic (9.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-3)" "prognostic unfavourable (4.14e-4)" "unprognostic (1.58e-1)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "prognostic favourable (3.18e-5)" "unprognostic (2.21e-1)" "prognostic unfavourable (9.27e-9)" "unprognostic (4.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.56e-3)" 14.5 9.6 14.4 21.5 13.6 30.7 9.9 23.5 19.7 8.6 8.3 11.9 3.1 9.2 10.3 7.9 7.7 8.8 9.9 12.4 10.5 9.8 8.6 7.9 14.2 25.8 12.5 8.5 12.4 11.0 8.5 8.3 10.1 12.6 7.9 6.3 8.0 10.2 7.6 40.6 8.6 12.7 8.8 9.3 25.9 9.2 5.5 12.9 15.7 9.4 5.9 21.1 10.7 7.7 3.0 4.8 3.9 6.2 2.0 3.9 3.0 5.8 11.3 8.8 8.8 5.3 5.1 9.1 5.8 6.3 9.2 8.6 6.8 6.8 14.8 9.9 3.9 10.5 7.9 5.3 4.1 13.4 7.1 13.0 11.8 6.5 7.3 13.6 26.5 4.6 9.4 8.5 9.2 6.5 13.8 8.3 5.2 12.1 16.5 12.6 12.2 11.1 17.7 5.9 8.4 4.4 8.8 10.4 12.8 6.1 14.5 8.2 10.4 33.7 6.7 9.9 9.7 8.2 9.2 25.3 17.8 19.5 6.8 10.8 11.8 2.5 3.8 1.1 3.3 6.2 3.9 2.9 2.6 1.9 3.7 3.0 1.3 2.8 3.9 2.0 4.9 4.8 1.7 3.0 14.4 13.6 23.5 19.7 10.5 9.8 12.5 8.5 12.6 12.9 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: " "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favourable (2.42e-4)" "prognostic unfavourable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavourable (3.08e-4)" "prognostic unfavourable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 23.7 8.1 24.7 15.1 0.5 0.8 27.1 6.4 4.4 11.4 14.8 13.4 15.1 13.6 15.9 1.9 8.0 19.8 14.5 15.3 19.3 14.3 16.9 9.3 16.7 0.4 14.2 16.6 0.5 1.5 3.7 5.3 10.5 12.1 18.6 10.0 14.9 23.0 12.4 18.2 13.2 25.6 20.1 11.6 9.2 11.9 13.8 6.3 15.1 5.4 7.1 10.1 11.3 4.8 4.8 14.3 3.9 16.3 9.4 16.5 26.8 6.0 21.0 13.4 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favourable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 1.9 1.9 2.4 8.0 2.7 4.9 6.6 6.5 0.4 0.0 1.8 7.9 4.6 5.3 1.9 5.8 0.0 7.4 1.2 7.8 9.2 1.6 4.3 5.5 2.3 2.9 2.8 2.1 0.0 2.9 0.0 26.7 0.5 0.0 7.0 2.4 0.0 0.0 20.2 0.0 1.6 0.6 0.8 2.1 18.4 3.3 15.9 0.8 2.3 0.0 3.2 5.3 17.1 5.1 0.0 0.0 0.0 1.1 0.0 15.6 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 DET1 FLJ10103 ENSG00000140543 "DET1, COP1 ubiquitin ligase partner" Q7L5Y6 15 88494440-88546675 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" "Nucleoplasm, Microtubules" "Cytokinetic bridge, Cytosol" "HPA048873: " "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 6.0 9.3 5.5 4.3 7.0 1.9 6.4 5.5 6.8 9.5 6.3 8.2 7.0 5.5 15.9 9.1 3.8 9.6 7.8 8.8 4.3 4.2 5.4 4.5 4.3 4.2 5.0 6.1 17.9 10.1 7.1 6.4 5.6 5.9 8.5 5.6 12.6 6.7 7.4 13.8 4.4 5.9 11.4 5.1 4.4 5.5 3.6 4.6 10.7 6.8 4.1 6.4 7.7 6.0 5.3 7.6 2.9 7.4 3.4 6.6 3.8 2.0 6.7 9.5 6.9 4.7 7.1 1.8 6.5 7.0 5.7 6.0 1.4 6.3 3.9 5.0 8.3 3.1 10.7 2.0 4.9 0.3 6.9 7.4 3.7 2.3 7.4 2.8 1.5 6.1 7.2 2.7 7.8 4.4 9.4 4.7 7.1 3.2 4.0 3.1 4.3 2.1 4.7 7.8 4.8 3.0 5.9 3.7 5.8 7.3 2.5 16.2 3.6 5.9 3.6 5.8 4.5 5.9 6.0 2.7 1.9 2.6 6.5 4.8 5.1 0.0 4.8 2.9 5.3 7.4 3.9 4.8 4.6 4.7 7.6 5.3 6.6 5.4 0.7 3.4 4.6 4.1 5.1 3.8 5.5 7.0 5.5 6.8 4.3 4.2 5.0 6.1 5.9 4.6 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: " "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favourable (6.29e-5)" 4.7 4.1 6.0 5.0 7.8 3.8 4.0 13.2 7.8 3.8 4.3 4.2 2.0 12.5 5.9 1.5 3.1 4.9 4.2 4.1 4.1 1.8 2.9 2.0 3.5 2.9 5.4 4.1 6.7 9.3 1.3 8.7 4.8 2.9 3.0 1.6 4.3 3.3 3.3 1.9 2.3 5.6 2.6 3.0 5.6 4.1 1.7 6.3 2.8 3.2 1.0 5.6 4.7 3.4 3.1 6.3 6.9 8.2 2.7 6.4 3.7 3.1 2.8 1.3 3.9 0.9 1.0 0.9 2.7 0.8 2.9 2.9 1.7 1.3 1.2 1.7 0.6 0.9 0.4 1.7 0.2 7.3 7.4 11.0 1.2 1.6 2.6 6.0 8.5 0.5 0.3 2.7 0.1 3.3 6.0 1.3 0.6 0.9 6.6 3.5 2.2 6.3 5.4 2.3 2.4 0.6 0.4 2.8 5.0 2.0 3.0 8.3 0.7 3.6 4.9 1.2 1.0 5.7 2.3 2.4 3.5 3.4 1.4 9.3 1.7 5.3 5.5 6.9 4.7 5.1 2.9 3.1 3.0 3.8 6.3 1.2 2.8 4.5 1.7 2.7 8.2 0.1 6.4 3.7 6.0 7.8 13.2 7.8 4.1 1.8 5.4 4.1 2.9 6.3 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria Vesicles "Nucleoplasm, Mitochondria" "HPA041645: , HPA045462: " "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavourable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.7 8.3 44.8 12.2 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933682-48944969 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 32.4;kidney: 18.0" "Cell line enhanced" "Detected in many" "U-266/70: 6.7;U-266/84: 5.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.8;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 31 "granulocytes: 5.8;T-cells: 4.8" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favourable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.3 0.5 1.5 0.1 2.1 0.1 0.2 1.8 1.5 0.1 8.2 0.2 0.1 10.6 0.2 0.4 0.8 0.3 0.8 0.1 2.7 2.0 18.0 0.7 1.9 0.2 0.4 0.4 0.5 0.4 0.2 2.1 1.3 0.6 3.5 0.1 1.2 0.8 0.2 0.3 0.2 32.4 0.1 0.9 1.8 0.7 2.8 0.1 0.4 0.1 0.5 0.7 1.1 0.3 0.1 0.0 5.8 0.0 0.0 4.8 0.5 2.9 0.0 0.2 1.5 0.8 0.7 1.2 0.0 0.4 0.5 1.4 2.8 2.3 0.0 0.6 0.0 0.8 1.0 2.1 1.0 1.1 2.3 4.1 0.9 1.1 0.0 0.0 1.0 0.6 0.2 1.1 0.0 0.0 1.3 0.4 0.0 0.6 0.0 0.3 0.6 1.9 1.5 0.2 2.1 0.4 0.9 4.5 2.4 0.5 0.3 0.9 2.0 0.1 0.0 0.0 1.8 0.7 0.1 6.7 5.3 1.7 1.4 0.0 0.4 5.8 0.0 0.9 1.6 0.0 0.8 0.0 1.6 0.7 0.0 0.1 4.8 3.1 0.1 0.0 0.0 0.0 1.2 0.5 1.5 2.1 1.8 1.5 2.7 2.0 0.4 0.4 0.6 0.1 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.3 15.4 4.5 7.4 2.4 3.2 8.5 6.3 2.5 9.6 7.4 12.1 6.8 16.6 8.6 3.4 7.8 8.8 6.8 11.3 3.7 8.3 9.1 7.5 11.8 6.8 12.6 6.7 3.1 7.0 11.6 12.2 6.9 13.9 3.0 5.8 19.6 11.9 12.1 10.1 6.0 15.1 5.9 17.5 5.8 4.9 5.3 6.3 8.5 9.1 4.1 8.1 6.4 3.0 8.8 5.5 8.3 9.2 5.8 10.8 28.1 4.6 13.8 8.0 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 DHPS MIG13 ENSG00000095059 "Deoxyhypusine synthase" P49366 19 12675717-12681902 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hypusine biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014461, HPA029413" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA014461: AB_1847651, HPA029413: AB_10602217" "unprognostic (4.17e-2)" "unprognostic (2.55e-2)" "unprognostic (2.05e-2)" "unprognostic (2.61e-1)" "unprognostic (3.10e-1)" "unprognostic (1.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.59e-2)" "unprognostic (1.20e-2)" "unprognostic (4.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (1.56e-1)" "unprognostic (8.83e-2)" 16.4 30.3 26.9 18.6 31.2 17.0 24.8 43.3 38.8 20.7 25.7 27.5 25.3 23.1 20.9 16.9 21.3 32.3 18.2 26.0 26.3 28.0 23.4 30.3 18.9 24.2 27.5 28.0 34.8 32.0 28.8 32.6 23.2 22.4 24.1 24.5 20.2 24.8 24.6 65.1 25.6 21.5 24.5 29.1 19.5 24.2 13.3 26.3 31.9 24.9 22.9 26.9 23.5 19.2 39.6 29.5 35.8 30.5 27.8 38.1 29.7 20.7 15.3 24.9 13.2 11.2 18.5 5.8 13.3 19.6 25.5 25.7 10.9 10.1 21.5 15.1 14.5 12.6 17.0 18.9 17.6 18.8 12.0 14.3 16.7 14.3 13.8 17.1 22.9 14.9 23.3 15.4 26.6 17.8 13.0 15.3 18.6 41.2 30.5 24.8 19.5 26.1 20.3 9.3 31.0 19.6 11.2 32.4 44.0 13.4 19.5 22.6 18.1 28.7 8.9 30.0 12.2 29.3 20.2 48.9 52.7 14.6 18.4 21.1 28.3 14.5 27.0 35.8 24.7 24.2 25.9 39.6 28.9 25.6 29.0 36.9 38.1 28.1 9.7 27.8 30.5 29.5 34.3 29.7 26.9 31.2 43.3 38.8 26.3 28.0 27.5 28.0 22.4 26.3 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000599 Approved Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655" "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favourable (1.18e-5)" "prognostic favourable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.0 2.6 2.9 1.1 6.7 7.1 0.7 3.9 8.7 9.4 10.2 1.0 10.7 5.2 1.7 6.1 9.0 2.1 18.3 4.5 3.5 2.3 1.5 6.4 17.4 3.1 3.1 1.2 6.4 10.7 2.3 1.7 7.0 3.2 4.9 7.6 4.4 1.1 1.1 0.5 4.0 3.9 2.0 7.1 7.2 4.1 2.5 1.8 5.6 7.6 1.9 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.3 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031121 Approved Approved Nucleoplasm,Mitochondria 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803" "prognostic favourable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavourable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favourable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 51.8 15.7 9.1 19.9 47.0 18.4 11.5 16.7 43.2 6.1 13.6 8.6 35.1 5.4 10.1 15.6 22.4 11.8 23.6 8.9 37.7 11.0 13.3 7.7 14.2 24.7 15.8 0.4 13.6 28.3 9.7 32.8 11.7 4.0 11.7 15.3 15.6 9.2 15.1 4.3 15.9 9.5 12.2 6.3 27.3 17.7 19.5 24.4 17.0 25.7 37.1 18.0 7.0 8.2 30.5 10.3 8.3 9.6 4.2 1.9 9.6 16.6 15.3 20.8 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: , HPA062700: " "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavourable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavourable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 10.4 7.3 9.7 6.9 14.6 13.9 9.8 9.7 14.3 12.2 23.2 14.8 10.7 9.9 19.7 13.9 13.9 12.5 9.2 16.9 9.0 5.8 10.4 7.5 8.7 12.6 8.2 6.7 13.9 6.5 12.1 13.5 8.4 10.9 13.3 14.3 12.4 10.4 12.6 12.5 11.1 12.4 14.7 9.9 8.4 13.4 12.5 9.4 12.1 8.5 7.6 11.2 15.9 11.8 4.6 6.7 2.0 4.9 5.8 8.2 4.4 7.3 4.4 11.9 4.9 4.6 6.0 8.4 4.4 7.8 10.1 7.8 21.0 7.2 8.4 7.8 8.4 11.7 8.2 12.9 10.1 2.1 4.0 11.2 10.0 11.9 5.5 13.0 5.9 7.0 8.3 8.9 8.4 4.5 11.3 4.8 5.4 6.0 21.3 10.0 6.8 9.9 10.4 17.4 6.8 3.7 8.4 10.5 8.2 12.1 7.3 11.1 9.9 10.8 4.4 14.6 8.0 5.7 9.1 4.8 6.4 8.8 8.6 5.9 7.6 0.0 4.9 2.0 5.3 4.5 5.2 4.6 4.5 5.6 6.7 4.3 8.2 4.3 1.0 5.8 3.8 2.4 2.8 4.4 9.7 14.6 9.7 14.3 9.0 5.8 8.2 6.7 10.9 9.4 DHX58 "D11LGP2, LGP2" ENSG00000108771 "DExH-box helicase 58" Q96C10 17 42101404-42112733 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.5;SK-MEL-30: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018670, HPA019570" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA018670: AB_1847665, HPA019570: AB_1847666" "prognostic favourable (3.45e-4)" "unprognostic (1.03e-2)" "unprognostic (3.56e-3)" "unprognostic (1.54e-2)" "unprognostic (2.45e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-3)" "unprognostic (5.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.15e-1)" "unprognostic (6.02e-2)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (8.65e-2)" "unprognostic (8.01e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 12.7 16.3 6.7 15.3 7.8 11.1 9.8 2.8 8.4 7.9 9.8 9.6 15.0 8.2 9.6 16.2 8.7 12.0 12.6 5.3 6.5 5.3 11.0 20.9 21.7 14.4 5.9 9.0 12.9 7.4 4.3 9.6 7.0 8.2 10.6 5.0 13.4 18.0 17.1 6.9 7.8 10.5 9.2 7.9 17.1 9.1 10.7 5.1 17.2 7.5 5.6 12.9 10.9 7.6 6.4 7.6 8.6 12.0 7.6 7.1 5.9 1.2 0.0 0.0 0.7 6.2 5.3 0.2 1.7 11.8 24.4 28.5 0.1 7.6 0.1 1.8 2.8 1.0 0.1 1.9 0.9 4.7 0.1 2.0 1.1 0.4 6.9 1.8 4.6 8.6 3.2 2.1 2.1 2.9 0.0 6.7 1.3 0.0 10.9 2.2 0.2 0.0 3.9 0.0 0.5 2.7 4.4 0.2 0.0 0.7 3.1 13.9 4.2 1.9 1.2 1.2 0.0 0.4 0.6 2.3 1.9 0.1 2.4 1.7 1.3 3.1 9.9 8.6 4.5 12.0 6.5 6.4 6.4 4.0 7.6 4.9 7.1 5.3 4.0 7.6 10.5 2.5 5.5 5.9 6.7 7.8 2.8 8.4 6.5 5.3 5.9 9.0 8.2 5.1 DIDO1 "BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333" ENSG00000101191 "Death inducer-obliterator 1" Q9BTC0 20 62877738-62937952 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004374, HPA049904" Supported Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "CAB004374: AB_2093108, HPA049904: " "unprognostic (9.56e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-1)" "unprognostic (7.47e-2)" "unprognostic (2.68e-1)" "prognostic favourable (5.13e-4)" "unprognostic (9.92e-3)" "unprognostic (4.57e-3)" "unprognostic (2.54e-2)" "unprognostic (2.06e-1)" "prognostic favourable (3.88e-4)" "unprognostic (2.20e-2)" "unprognostic (1.50e-3)" "unprognostic (1.06e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-2)" "unprognostic (9.82e-2)" 25.1 15.9 19.7 21.5 21.3 22.8 26.9 38.1 23.2 29.7 24.0 27.0 26.7 18.4 33.2 26.9 20.7 29.2 27.0 23.2 17.9 14.7 18.2 18.3 22.9 27.5 22.9 18.8 37.4 21.4 28.0 25.1 30.6 17.6 24.3 19.2 27.0 26.3 25.5 27.6 34.0 25.2 27.5 17.5 25.8 21.2 24.1 23.1 35.1 25.1 20.5 29.6 26.1 35.6 9.7 8.6 20.9 7.6 10.1 15.3 7.1 11.6 9.0 15.2 8.6 7.8 9.6 8.1 8.8 7.5 32.9 9.5 38.6 12.1 11.5 12.2 10.8 18.3 13.8 17.1 21.4 6.3 9.3 16.6 14.9 27.5 9.9 14.8 17.2 9.8 23.6 11.4 6.4 9.0 16.2 10.6 8.3 11.3 30.0 13.1 12.1 13.2 21.3 19.4 7.3 5.4 10.4 18.7 11.1 17.7 17.2 11.6 17.1 17.0 11.2 26.9 18.8 8.9 12.5 7.1 4.6 15.4 12.2 7.5 9.7 20.9 5.6 15.1 12.9 7.6 13.3 9.7 11.3 12.3 4.1 8.2 15.3 14.1 8.6 10.1 5.8 8.6 9.0 7.1 19.7 21.3 38.1 23.2 17.9 14.7 22.9 18.8 17.6 23.1 DIP2A "C21orf106, Dip2, KIAA0184" ENSG00000160305 "Disco interacting protein 2 homolog A" Q14689 21 46458899-46569852 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052516 Uncertain Approved Nucleoplasm Nucleoplasm "HPA052516: " "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (6.52e-2)" "unprognostic (3.88e-2)" "unprognostic (7.30e-2)" "prognostic favourable (9.35e-5)" "unprognostic (1.37e-1)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.09e-1)" "unprognostic (3.86e-2)" "unprognostic (1.70e-2)" "unprognostic (6.05e-3)" "unprognostic (1.05e-1)" "unprognostic (8.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-3)" 10.8 12.6 9.8 18.1 15.0 16.7 13.1 17.1 14.6 10.5 10.3 20.6 8.6 12.5 11.8 7.6 14.3 11.7 9.0 15.4 11.0 7.5 7.5 5.9 10.5 12.5 14.1 10.7 12.1 13.0 10.8 12.6 10.9 14.7 13.7 7.8 15.1 14.1 9.1 18.3 12.9 13.6 9.5 11.4 15.8 13.8 16.9 13.3 16.0 10.2 7.4 11.3 14.9 11.4 4.0 10.4 11.5 6.5 9.3 15.7 4.0 12.3 8.1 15.8 7.4 7.5 7.0 9.8 8.7 6.8 8.6 7.1 14.2 9.6 5.3 8.2 9.0 6.5 6.9 11.5 5.0 20.2 10.0 17.8 13.3 8.7 5.0 6.5 9.3 6.1 7.9 9.0 9.7 12.5 11.4 12.1 7.1 11.2 9.8 9.8 8.6 8.6 10.1 6.5 10.5 5.2 11.2 8.5 5.4 13.2 8.7 7.6 9.3 6.4 16.9 7.1 5.1 9.9 6.5 12.5 6.3 4.9 7.6 10.8 11.8 8.1 5.4 11.5 15.7 6.3 9.9 3.2 6.9 10.4 2.9 4.0 5.0 9.7 10.4 9.3 6.5 10.4 5.6 4.0 9.8 15.0 17.1 14.6 11.0 7.5 14.1 10.7 14.7 13.3 DIP2C KIAA0934 ENSG00000151240 "Disco interacting protein 2 homolog C" Q9Y2E4 10 274190-689668 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030264, HPA059325" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA030264: AB_10600903, HPA059325: " "unprognostic (1.72e-2)" "unprognostic (3.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (8.92e-4)" "unprognostic (8.32e-2)" "unprognostic (1.50e-1)" "unprognostic (2.16e-2)" "unprognostic (1.58e-1)" "unprognostic (2.00e-1)" "unprognostic (6.28e-3)" "unprognostic (5.94e-2)" "unprognostic (3.65e-2)" "prognostic favourable (2.46e-6)" "unprognostic (8.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.09e-3)" "unprognostic (9.10e-3)" 15.4 8.1 19.9 5.0 25.0 0.9 9.9 23.0 24.7 12.6 20.8 21.2 6.4 6.2 14.1 7.8 12.2 9.1 11.3 17.3 16.3 10.1 19.2 11.5 6.7 3.4 21.7 14.4 18.1 10.4 10.4 7.4 6.3 16.5 11.5 6.3 13.0 5.6 12.7 38.2 5.5 7.3 16.1 14.9 4.5 8.3 9.4 23.1 0.0 7.3 2.9 2.5 11.6 13.0 3.8 0.5 0.1 0.3 0.3 1.3 0.4 0.4 4.0 7.4 3.9 12.6 13.7 6.1 8.8 5.5 6.8 5.6 1.1 1.2 0.3 2.4 14.1 0.1 4.5 0.7 4.2 0.2 4.0 0.1 2.7 1.2 6.1 0.0 5.5 11.1 3.6 4.3 0.0 1.5 0.0 0.7 5.1 10.8 0.4 0.0 1.9 1.6 6.1 3.1 1.2 4.8 4.5 3.7 5.3 1.5 3.2 12.7 4.2 0.0 0.1 7.2 1.9 21.5 2.9 0.5 8.5 4.6 9.1 0.2 4.1 0.0 0.3 0.0 0.4 0.0 0.4 2.6 0.8 1.0 0.0 3.8 1.2 1.3 0.1 0.3 0.0 0.5 0.5 0.4 19.9 25.0 23.0 24.7 16.3 10.1 21.7 14.4 16.5 23.1 DIRC1 ENSG00000174325 "Disrupted in renal carcinoma 1" Q969H9 2 188734155-188790104 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 5.9;gallbladder: 2.1" "Group enriched" "Detected in some" 5 "ASC TERT1: 24.1;HSkMC: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA068508 Approved Nucleoplasm Nucleoplasm "HPA068508: " "unprognostic (3.11e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (2.77e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (7.39e-4)" "unprognostic (6.95e-2)" 1.4 0.0 0.0 0.4 0.0 0.0 5.9 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 24.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Group enriched" "Detected in some" 5 "HaCaT: 8.0;SCLC-21H: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059903: " "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 8.0 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.4 0.4 1.1 0.2 0.4 0.5 0.3 2.1 16.6 2.4 0.3 0.2 0.2 0.4 0.2 0.5 1.1 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 DLC1 "ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12" ENSG00000164741 "DLC1 Rho GTPase activating protein" Q96QB1 8 13083361-13604610 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.7;hTERT-HME1: 13.8;HUVEC TERT2: 18.8;U-2197: 18.6;WM-115: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017753 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA017753: AB_10600805" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.29e-1)" "prognostic favourable (1.11e-4)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (8.46e-3)" "unprognostic (6.49e-2)" "unprognostic (2.02e-2)" "unprognostic (3.56e-3)" "unprognostic (2.79e-2)" "unprognostic (7.33e-2)" "unprognostic (1.67e-1)" 33.9 8.0 8.5 8.8 15.4 4.9 31.9 3.1 11.4 13.6 13.1 16.0 2.0 6.1 12.4 7.4 8.6 10.4 13.1 15.1 10.0 7.3 9.2 24.1 32.4 5.6 18.0 6.8 8.0 6.3 6.3 4.4 22.3 16.2 5.7 4.5 13.6 4.9 4.1 7.6 5.4 8.5 18.7 15.0 16.6 11.1 5.5 16.5 0.0 12.0 6.1 2.9 17.1 17.2 0.0 0.2 6.5 1.3 0.0 0.1 0.0 0.0 0.1 1.6 0.0 12.3 7.0 5.9 0.6 0.1 0.2 0.5 3.9 2.4 0.0 0.2 11.7 2.0 1.0 1.6 1.1 0.0 0.9 0.3 0.0 4.1 6.4 0.0 3.5 5.4 0.1 18.7 13.8 18.8 1.0 0.0 5.6 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 5.9 0.0 0.8 0.0 0.2 6.2 0.0 0.0 1.9 13.5 7.3 18.6 4.4 0.0 0.0 0.0 10.4 0.0 13.7 6.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.5 15.4 3.1 11.0 10.0 7.3 18.0 6.8 16.2 16.5 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444861-70505490 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 20.6;SK-BR-3: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: " "prognostic unfavourable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favourable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 2.7 3.3 12.5 6.5 17.6 0.7 10.8 16.4 25.2 9.2 16.0 4.3 14.7 11.7 7.6 23.7 14.5 17.4 16.3 6.0 15.2 10.0 10.8 1.4 7.8 3.1 6.5 10.2 11.2 27.1 21.2 8.9 5.5 8.0 9.6 17.1 10.2 21.0 10.4 1.1 8.4 20.8 11.3 3.4 14.6 13.8 1.9 3.5 3.2 13.8 2.6 8.0 11.2 9.9 0.4 0.0 0.0 0.0 1.7 2.4 0.3 3.6 1.7 10.6 4.5 2.7 3.4 7.4 2.2 2.5 1.2 1.2 10.5 8.7 0.0 5.1 2.2 8.0 20.6 4.8 0.8 4.3 6.2 0.0 9.4 5.7 5.4 0.1 1.4 3.5 3.2 1.5 3.4 0.4 2.0 14.7 1.1 12.9 8.3 0.0 17.8 12.4 7.8 5.2 1.6 7.2 11.3 5.0 0.3 1.7 20.6 3.9 10.8 0.0 0.8 1.4 1.4 1.3 1.6 9.7 7.3 4.6 2.1 0.0 2.0 0.0 0.0 0.0 2.1 0.0 1.8 0.4 1.7 2.4 0.0 0.0 1.1 1.8 0.0 1.7 0.0 0.0 2.4 0.3 12.5 17.6 16.4 25.2 15.2 10.0 6.5 10.2 8.0 3.5 DLGAP4 "DAP4, KIAA0964, SAPAP4" ENSG00000080845 "DLG associated protein 4" Q9Y2H0 20 36306336-36528637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-138 MG: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054105, HPA056378" Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA054105: , HPA056378: " "unprognostic (1.11e-1)" "unprognostic (1.42e-1)" "unprognostic (9.00e-2)" "prognostic unfavourable (2.24e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (3.73e-6)" "unprognostic (1.23e-1)" "prognostic favourable (9.88e-5)" "unprognostic (1.28e-1)" "unprognostic (2.18e-2)" "unprognostic (8.45e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" 18.8 16.6 25.7 14.3 32.9 4.5 18.0 16.2 31.9 19.0 20.1 9.0 14.9 13.5 23.1 13.1 16.8 18.5 17.0 25.9 23.7 12.7 10.2 11.0 21.6 9.8 9.5 20.7 18.9 30.2 7.7 10.2 16.9 8.8 15.7 10.1 15.4 19.3 21.2 58.0 27.1 13.6 27.2 6.8 14.5 12.2 12.6 10.9 8.3 13.8 16.8 10.8 29.0 15.0 16.1 13.5 19.5 13.1 6.9 12.5 9.1 13.9 12.6 15.5 12.8 14.7 24.1 15.6 21.0 19.3 20.6 14.3 19.1 8.9 3.9 11.3 29.4 13.4 4.1 21.5 15.4 6.3 1.5 8.9 6.5 12.9 21.3 3.6 7.8 15.8 16.7 24.3 17.0 20.2 6.2 10.8 15.5 10.4 7.2 13.7 6.7 27.1 7.3 4.1 5.4 9.6 6.9 10.2 14.1 13.7 28.0 17.3 16.0 6.3 20.3 62.8 19.2 27.0 11.5 3.7 2.7 4.2 25.1 4.5 24.6 2.1 12.8 19.5 12.5 13.1 9.8 16.1 11.3 8.7 11.3 14.9 8.8 7.0 18.5 6.9 12.6 13.5 8.7 9.1 25.7 32.9 16.2 31.9 23.7 12.7 9.5 20.7 8.8 10.9 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA061223: , HPA068672: , HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.1 1.8 0.5 7.7 0.0 0.4 1.7 1.9 2.1 2.1 1.0 1.8 0.2 0.9 1.2 0.3 16.2 5.4 8.8 0.4 1.0 2.0 0.4 0.9 2.7 0.5 0.3 1.1 0.9 26.6 0.6 5.0 0.0 0.4 0.7 0.8 1.9 0.4 0.4 0.7 1.9 1.0 0.9 0.5 0.3 1.8 5.7 0.5 0.6 0.2 0.3 0.5 1.6 0.5 0.8 2.5 0.6 3.7 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 41.1" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA056533 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 1.9 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 1.9 0.0 0.0 1.2 0.5 0.1 0.5 3.0 0.1 0.0 0.1 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.4 3.1 0.3 0.1 0.1 0.1 0.1 7.3 7.4 1.4 0.0 41.1 0.0 0.1 0.0 0.0 1.3 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 DLX5 ENSG00000105880 "Distal-less homeobox 5" P56178 7 97020392-97024950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6" "Group enriched" "Detected in some" 5 "BEWO: 32.5;HAP1: 16.3" "Cancer enriched" "Detected in many" 11 "endometrial cancer: 81.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 13.5;olfactory region: 36.5" "Region enhanced" "Detected in many" "olfactory region: 24.3" HPA005670 Approved Approved Nucleoplasm Nucleoplasm "HPA005670: AB_1078681" "unprognostic (3.99e-1)" "unprognostic (1.05e-1)" "unprognostic (2.96e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (5.89e-2)" "unprognostic (6.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-2)" "unprognostic (7.43e-8)" "unprognostic (1.39e-2)" "unprognostic (3.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" 1.5 0.6 2.7 0.5 11.5 0.3 1.5 0.1 3.9 10.0 0.6 0.3 1.4 0.7 17.7 1.7 5.8 2.0 0.8 1.2 2.2 4.5 0.4 0.2 0.4 1.9 0.5 2.5 2.1 0.2 0.4 1.9 44.5 0.0 1.8 0.3 0.1 3.6 3.9 0.6 20.6 0.3 1.4 0.2 0.3 0.3 1.2 3.1 2.5 1.6 6.5 2.7 1.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.7 16.3 0.0 0.0 0.0 2.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.1 0.9 1.3 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 1.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.5 0.1 3.9 2.2 4.5 0.5 2.5 0.0 3.1 DMC1 LIM15 ENSG00000100206 "DNA meiotic recombinase 1" Q14565 22 38518949-38570286 "Predicted intracellular proteins" "Cell cycle, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.1" "Cell line enhanced" "Detected in many" "HDLM-2: 17.4;hTEC/SVTERT24-B: 12.5;U-266/84: 14.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001232, CAB015397" Enhanced Approved Nucleoplasm Nucleoplasm "CAB015397: AB_629406, HPA001232: AB_1078683" "unprognostic (1.29e-2)" "unprognostic (3.11e-3)" "unprognostic (4.48e-3)" "unprognostic (5.71e-2)" "unprognostic (6.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.22e-2)" "unprognostic (2.61e-2)" "unprognostic (4.23e-2)" "unprognostic (3.99e-3)" "unprognostic (7.40e-3)" "unprognostic (1.00e-2)" "unprognostic (2.16e-4)" "unprognostic (3.94e-1)" "unprognostic (2.79e-1)" "unprognostic (7.27e-2)" "unprognostic (2.99e-1)" 1.7 0.6 1.6 4.7 2.0 3.1 4.4 2.2 2.0 2.5 1.3 0.7 1.2 0.4 3.7 2.6 1.5 1.6 1.8 3.3 2.5 1.1 1.0 0.5 1.1 3.9 2.8 1.5 1.8 0.8 0.8 1.1 1.0 3.2 2.9 1.6 2.7 1.0 1.3 1.8 2.5 1.1 3.4 4.4 0.9 1.0 24.1 2.3 8.2 0.8 3.2 4.5 2.0 3.8 1.2 0.8 3.3 1.0 2.5 1.5 0.4 4.9 1.8 3.6 0.1 0.3 1.5 0.2 5.2 0.7 8.4 5.9 0.2 0.6 2.4 0.2 1.4 0.9 1.4 0.2 9.6 17.4 0.3 9.4 1.4 0.1 0.1 0.8 2.1 0.4 0.0 12.5 0.0 0.6 7.1 2.6 2.9 2.7 1.8 7.1 6.4 0.1 4.1 0.0 3.5 1.1 0.7 7.1 0.4 8.8 0.8 0.1 1.6 2.1 0.2 0.1 0.5 0.1 0.1 7.0 14.5 4.5 1.5 2.0 0.7 2.2 1.0 0.5 1.5 0.3 0.3 0.5 1.3 0.6 0.8 1.2 1.2 0.5 3.3 2.5 0.6 0.7 0.7 0.4 1.6 2.0 2.2 2.0 2.5 1.1 2.8 1.5 3.2 2.3 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell line enhanced" "Detected in many" "A-431: 31.5;CACO-2: 39.0;CAPAN-2: 33.5;HBEC3-KT: 51.1;RPTEC TERT1: 50.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favourable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 31.5 5.1 0.0 0.0 1.2 1.9 8.9 0.1 4.2 0.2 0.3 39.0 33.5 0.0 12.8 0.3 17.7 9.6 51.1 0.4 0.1 9.3 0.0 0.0 8.7 1.5 0.0 0.1 17.5 13.8 0.9 29.7 0.0 0.1 0.0 0.1 27.6 0.0 0.0 28.3 2.1 0.0 0.0 1.2 50.5 20.9 0.1 0.0 7.7 0.0 3.1 12.8 0.0 0.0 4.9 15.0 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HBEC3-KT: 4.2;RH-30: 15.3;SH-SY5Y: 3.2;SiHa: 3.1" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: " "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 1.2 4.2 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 3.2 3.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 DNAAF5 "CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2" ENSG00000164818 "Dynein axonemal assembly factor 5" Q86Y56 7 726701-786475 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020243 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA020243: AB_1848750" "unprognostic (9.77e-2)" "unprognostic (9.53e-3)" "unprognostic (2.55e-1)" "unprognostic (2.57e-1)" "unprognostic (8.22e-3)" "prognostic unfavourable (8.42e-4)" "prognostic unfavourable (3.83e-4)" "unprognostic (8.07e-3)" "unprognostic (2.02e-1)" "unprognostic (7.59e-2)" "unprognostic (8.26e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-3)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-1)" "unprognostic (8.70e-3)" 11.5 13.0 9.3 13.5 11.4 10.7 12.3 17.4 14.2 15.5 16.3 14.7 10.3 12.0 18.4 13.9 16.7 23.4 15.4 18.8 11.6 8.6 15.0 18.2 9.9 11.8 9.5 7.6 20.6 22.5 14.4 21.1 12.1 10.4 16.1 9.9 14.0 17.6 14.3 33.9 12.0 13.6 13.9 9.2 12.5 13.0 14.8 9.4 20.7 15.9 11.2 14.2 15.6 12.4 3.3 4.6 1.4 2.8 3.0 4.7 1.9 30.3 24.0 7.2 16.7 4.7 5.2 18.1 6.3 6.1 7.9 7.5 23.9 16.1 18.6 9.2 6.6 18.5 13.3 15.8 6.1 3.1 22.5 4.6 14.3 17.3 6.5 13.8 8.3 6.3 6.8 9.9 7.3 10.7 28.9 3.9 5.7 29.8 8.2 12.4 26.4 19.1 15.2 2.3 12.8 9.2 12.9 15.1 25.1 10.3 25.5 7.3 22.5 11.6 8.8 4.4 15.7 15.0 14.1 7.6 9.1 10.8 9.7 14.6 23.0 0.0 1.9 1.4 2.2 2.8 3.3 1.6 3.5 4.7 2.7 3.3 3.3 2.5 0.0 3.0 2.0 4.6 0.8 1.9 9.3 11.4 17.4 14.2 11.6 8.6 9.5 7.6 10.4 9.4 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Group enriched" "Detected in some" 5 "HeLa: 9.8;MOLT-4: 4.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: " "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 9.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 DNAJB5 Hsc40 ENSG00000137094 "DnaJ heat shock protein family (Hsp40) member B5" O75953 9 34989641-34998900 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 99.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 7.7;neutrophil: 7.6" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023818, HPA050794" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023818: AB_1847793, HPA050794: " "unprognostic (1.41e-2)" "unprognostic (3.87e-1)" "unprognostic (2.53e-3)" "unprognostic (5.21e-2)" "unprognostic (1.86e-1)" "unprognostic (3.54e-2)" "unprognostic (7.31e-2)" "unprognostic (2.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-1)" "unprognostic (4.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.00e-3)" 7.2 6.3 5.9 5.1 7.2 0.9 2.6 8.6 13.0 6.5 19.1 6.2 9.2 3.8 18.5 9.7 15.7 9.6 8.7 29.3 6.6 6.3 3.7 2.0 3.7 2.2 4.7 3.4 6.5 3.1 2.2 8.6 1.4 6.0 13.8 6.2 5.7 3.7 26.2 99.4 1.5 6.1 29.9 4.5 5.6 11.3 8.1 3.5 1.6 4.4 38.0 2.9 23.0 3.6 0.7 7.7 7.6 1.5 0.5 1.3 0.7 2.6 2.1 13.6 7.2 8.0 6.2 1.5 11.3 8.3 17.5 15.6 1.6 0.6 2.5 2.8 12.4 0.3 5.2 8.9 14.9 3.5 1.6 0.9 3.1 0.7 9.2 0.3 8.2 9.0 0.6 10.3 5.2 11.1 0.2 5.3 14.1 1.8 4.2 3.6 6.4 4.6 3.3 14.1 1.4 2.5 0.2 5.8 9.5 6.1 0.3 1.3 2.2 0.8 4.9 8.4 18.5 4.3 3.5 2.0 1.3 1.8 9.6 1.0 9.0 0.1 1.5 0.0 0.4 0.4 1.3 0.7 0.3 0.1 7.7 0.3 0.5 1.1 7.6 0.5 0.1 0.2 1.3 0.7 5.9 7.2 8.6 8.5 6.6 6.3 4.7 3.4 6.0 3.5 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765155-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavourable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 17.0 15.7 19.5 13.0 18.5 7.5 19.8 38.0 22.1 18.3 17.8 20.5 12.7 11.0 20.1 15.4 19.7 19.7 15.2 12.6 14.0 10.3 16.7 23.6 14.7 16.6 16.0 17.3 23.7 16.2 19.4 12.6 18.4 17.2 15.9 15.6 16.2 19.1 16.0 13.6 18.2 15.1 17.2 13.9 19.1 14.1 7.7 19.0 12.1 17.3 11.8 21.2 13.7 17.9 14.8 17.1 19.5 20.0 8.5 26.1 9.2 5.8 5.4 13.6 13.1 6.1 15.5 5.8 11.2 11.1 18.8 15.5 4.3 8.5 9.2 12.4 13.3 12.5 13.8 18.3 16.7 16.9 8.6 15.5 10.9 4.1 17.5 7.9 13.9 15.3 11.8 14.8 26.8 17.3 10.8 4.9 14.3 7.5 11.7 10.8 4.9 7.9 8.6 11.3 4.7 19.0 10.9 8.6 5.5 8.1 7.6 5.9 9.6 16.2 16.8 10.7 9.2 12.1 9.4 5.5 16.2 20.1 6.9 20.8 9.0 17.6 15.8 19.5 18.6 20.0 13.1 14.0 15.9 17.3 17.1 14.8 17.3 16.5 5.7 8.5 11.3 13.9 26.1 9.2 19.5 18.5 38.0 22.1 14.0 10.3 16.0 17.3 17.2 19.0 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favourable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.3 14.5 6.5 5.3 10.1 4.8 4.0 3.9 3.8 1.6 2.2 4.0 6.9 8.4 1.5 2.9 3.8 1.9 2.0 2.2 0.0 7.8 4.7 4.2 3.3 5.6 8.2 3.0 5.8 3.3 4.6 2.0 5.0 2.8 1.3 0.2 2.5 4.7 2.2 7.4 2.1 8.2 2.9 2.3 1.2 5.6 7.9 3.5 4.1 1.1 6.3 4.9 2.2 12.8 5.7 3.6 5.5 1.3 8.2 2.1 4.2 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell line enhanced" "Detected in many" "HDLM-2: 20.9;HEL: 55.8;K-562: 21.7" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: " "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favourable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 0.9 0.0 1.6 0.7 0.2 8.3 7.0 11.4 11.5 11.3 0.9 0.1 3.3 0.6 2.9 0.8 5.0 1.1 9.1 20.9 2.4 55.8 1.9 0.2 0.0 1.8 1.4 1.0 0.8 1.1 4.9 0.2 21.7 0.4 2.3 0.6 0.7 0.0 2.3 0.7 0.0 1.7 0.1 8.7 0.0 13.9 9.6 4.1 5.5 1.9 2.6 0.1 2.1 1.7 1.2 0.2 2.0 2.1 1.3 1.0 4.7 1.4 2.8 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA053129: , HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favourable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 6.2 6.3 9.9 5.2 15.0 5.2 4.7 9.2 15.6 5.6 4.7 10.6 7.2 2.4 9.8 11.2 4.1 20.2 8.6 7.6 16.0 9.6 9.9 3.9 6.7 4.3 7.3 14.2 7.1 5.7 11.8 15.0 4.2 18.8 5.5 5.0 7.6 5.5 7.7 4.4 2.9 3.1 8.2 8.5 4.1 5.0 42.4 7.6 3.5 14.2 2.9 3.9 4.8 4.4 6.8 10.9 6.3 4.7 3.8 7.5 2.4 9.0 6.7 8.2 7.5 5.9 7.4 6.8 9.1 7.0 12.1 12.4 6.9 14.4 3.6 6.9 9.6 5.5 7.7 7.0 17.4 5.4 3.2 3.0 9.8 2.5 6.1 3.4 3.7 5.6 5.6 13.1 9.4 7.6 3.3 8.3 14.4 14.8 8.8 4.2 3.8 6.6 6.4 12.4 1.5 9.9 9.6 12.8 6.0 15.2 2.9 7.1 16.3 2.3 7.2 15.0 27.1 11.1 8.4 4.9 10.2 7.8 12.3 1.8 10.4 6.3 4.3 4.5 5.2 4.7 7.5 4.9 5.1 5.3 3.9 6.8 4.8 5.2 4.1 3.8 3.7 10.9 4.3 2.4 9.9 15.0 9.2 15.6 16.0 9.6 7.3 14.2 18.8 7.6 DNAL4 "dJ327J16, PIG27" ENSG00000100246 "Dynein axonemal light chain 4" O96015 22 38778508-38794198 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003647 Approved Approved Nucleoplasm,Nucleoli,Centrosome,Cytosol Centrosome "Nucleoplasm, Nucleoli, Cytosol" "HPA003647: AB_1078712" "unprognostic (8.45e-2)" "unprognostic (8.15e-3)" "unprognostic (2.35e-1)" "unprognostic (3.14e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (6.46e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-1)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.07e-1)" "prognostic favourable (1.20e-6)" "unprognostic (1.60e-1)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.83e-2)" 8.2 11.4 24.1 9.6 21.9 3.9 13.7 8.6 19.8 17.8 10.1 8.5 19.7 7.3 9.8 15.0 12.3 33.5 12.7 9.9 17.7 15.2 16.0 7.1 12.8 7.5 9.5 15.7 15.8 14.9 19.2 19.3 11.9 7.9 13.2 9.2 13.1 16.4 16.3 4.4 11.4 8.0 7.7 6.4 7.5 11.1 36.5 9.7 13.2 26.1 6.6 8.6 8.4 9.1 12.6 14.8 17.5 11.2 15.7 16.6 8.1 8.8 4.5 9.1 8.1 11.6 11.7 0.0 3.7 7.3 5.8 6.4 2.8 10.5 2.2 8.2 5.5 4.3 5.7 10.1 4.1 5.5 7.4 1.2 1.3 3.1 18.5 7.1 1.9 9.4 33.0 7.8 14.1 8.4 2.6 4.5 7.2 11.0 6.6 7.0 3.5 3.6 6.4 3.9 2.9 12.3 5.3 12.8 6.9 7.8 6.0 15.3 10.9 6.8 5.1 5.3 5.4 8.1 3.8 2.8 0.8 1.0 16.0 2.4 5.1 15.6 9.6 12.8 13.5 9.5 16.6 8.7 11.2 12.1 9.8 12.6 13.3 11.0 17.5 15.7 11.2 14.8 10.2 8.1 24.1 21.9 8.6 19.8 17.7 15.2 9.5 15.7 7.9 9.7 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: , HPA057639: " "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.2 4.0 3.5 5.0 4.2 2.0 1.9 2.3 1.5 3.5 3.8 3.7 0.9 1.6 7.3 2.1 1.7 2.6 2.3 3.8 3.0 5.9 2.7 2.2 4.2 1.9 3.4 2.9 4.2 6.2 1.0 3.7 4.4 1.6 0.9 1.4 4.7 4.2 3.4 2.2 1.8 2.7 2.3 2.5 2.3 4.4 1.3 4.1 3.1 2.2 4.5 1.8 2.3 2.4 5.0 2.9 10.6 8.3 5.6 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363789 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA062738: " "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.6 11.3 13.8 13.0 11.9 13.4 10.4 8.1 13.9 9.7 8.9 9.2 4.0 12.8 10.0 6.2 13.4 7.4 7.1 29.9 11.2 9.1 13.7 14.0 8.0 14.9 11.4 3.5 13.6 25.3 5.0 6.5 7.1 8.5 11.2 2.8 6.2 9.2 7.0 29.6 7.0 7.2 9.9 8.0 13.7 8.3 6.3 6.8 11.6 11.2 7.4 8.9 8.0 9.2 8.6 4.2 8.0 3.1 0.9 6.9 1.2 4.1 7.5 2.6 7.6 1.3 2.7 6.7 6.8 3.7 5.5 2.4 9.0 4.4 9.7 25.0 4.9 9.0 1.6 3.9 0.6 39.6 9.9 3.5 3.7 3.7 5.1 7.8 6.6 3.4 4.0 4.0 2.5 2.9 5.6 7.0 3.5 31.1 9.2 13.0 11.4 19.8 28.2 3.7 11.2 6.7 4.3 11.5 16.7 6.9 6.4 6.1 7.9 7.2 6.3 9.2 8.4 6.4 10.3 6.1 8.7 8.6 6.8 3.8 8.5 8.0 1.8 0.3 3.8 3.1 4.8 8.6 5.3 5.6 2.4 5.7 5.4 4.5 1.4 0.9 1.7 4.2 6.9 1.2 13.8 11.9 8.1 11.7 11.2 9.1 11.4 3.5 8.5 6.8 DNPH1 "C6orf108, dJ330M21.3, rcl" ENSG00000112667 "2'-deoxynucleoside 5'-phosphate N-hydrolase 1" O43598 6 43225629-43229484 "Predicted intracellular proteins" "Nucleotide metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029675, HPA029676" Enhanced Approved Nucleoplasm,Cytosol 370000 Nucleoplasm Cytosol "HPA029675: AB_10599998, HPA029676: AB_10599424" "unprognostic (1.12e-2)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (8.24e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (2.61e-1)" "unprognostic (7.72e-2)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (2.25e-2)" "unprognostic (1.49e-1)" "unprognostic (1.74e-1)" "unprognostic (5.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (5.10e-2)" 17.4 25.5 24.1 16.2 27.5 10.1 8.4 7.0 18.7 11.9 39.3 15.0 10.2 53.1 12.3 13.2 19.3 19.5 18.5 12.0 17.3 16.7 48.7 34.7 10.0 14.8 17.2 14.0 13.7 38.8 17.2 9.3 7.3 13.4 13.1 9.7 16.9 22.4 11.8 40.8 10.7 51.0 10.4 10.4 18.8 22.2 5.4 10.8 14.6 14.2 19.2 19.3 12.2 8.9 44.1 36.2 0.9 46.7 7.5 52.6 19.5 35.6 26.2 4.1 16.9 2.9 9.0 12.7 8.7 3.1 5.9 7.7 10.7 13.0 25.7 13.8 2.9 18.3 3.1 6.9 1.7 13.6 62.2 12.1 24.0 30.3 6.9 10.2 7.9 5.6 8.8 1.7 5.3 7.7 27.3 45.6 4.7 59.0 9.7 25.5 8.1 15.9 16.5 5.4 65.0 10.1 12.2 15.8 19.0 8.0 21.3 17.5 29.2 33.9 9.6 4.5 7.8 10.2 17.1 31.9 14.6 20.0 2.8 13.6 7.0 0.1 23.3 0.9 9.2 46.7 16.7 44.1 30.4 16.2 36.2 38.2 27.2 18.3 0.8 7.5 33.2 27.4 52.6 19.5 24.1 27.5 7.0 18.7 17.3 16.7 17.2 14.0 13.4 10.8 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.5;lymphoid tissue: 61.0" "Cell line enhanced" "Detected in some" "Daudi: 17.0;HL-60: 16.8;MOLT-4: 15.7;NB-4: 26.6;REH: 19.8;RT4: 17.5;THP-1: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003218 Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695" "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favourable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favourable (6.89e-6)" 6.7 12.9 5.6 27.4 8.4 20.8 6.1 1.2 4.1 3.1 3.9 9.2 0.9 3.9 3.0 4.3 6.0 4.1 8.2 2.9 6.3 3.3 7.5 3.9 16.8 35.3 10.2 2.3 2.5 6.4 7.6 3.5 10.4 8.1 4.9 4.1 4.4 10.5 2.4 1.7 3.3 15.0 3.4 13.6 43.5 4.9 7.2 8.9 61.0 5.1 3.0 27.1 10.5 4.0 7.3 15.4 40.5 21.5 6.6 5.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.5 0.4 17.0 1.2 0.0 0.7 0.2 0.1 0.0 5.8 0.6 0.0 0.0 0.0 0.0 16.8 2.3 0.0 3.1 0.0 0.0 0.0 3.7 8.6 0.0 1.0 15.7 26.6 0.0 0.2 19.8 0.0 6.5 0.0 17.5 0.0 0.0 0.0 0.2 1.1 0.4 50.6 3.3 0.0 0.1 0.2 0.0 3.4 0.0 0.0 0.0 10.6 0.3 14.2 14.7 16.7 4.6 15.1 3.8 7.3 5.5 4.8 15.4 6.8 4.4 4.2 40.5 6.6 21.5 4.4 5.3 6.4 5.6 8.4 1.2 4.1 6.3 3.3 10.2 2.3 8.1 8.9 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favourable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favourable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.1 11.0 1.7 3.6 0.9 1.0 7.3 8.7 1.8 4.3 3.4 15.2 3.8 7.2 6.8 1.3 9.5 2.7 3.0 0.9 10.5 12.3 7.5 6.2 18.1 3.5 9.9 10.4 1.2 3.0 4.1 1.8 2.2 16.2 8.5 1.7 10.4 10.8 11.3 9.7 14.8 12.2 4.0 10.3 2.6 5.1 10.4 7.7 6.1 5.4 8.7 7.5 5.5 5.0 5.4 7.4 14.2 15.9 11.3 8.1 9.5 6.4 22.6 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 DONSON "B17, C21orf60, C2TA, DKFZP434M035" ENSG00000159147 "Downstream neighbor of SON" Q9NYP3 21 33559542-33588708 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039558, HPA049033" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cell Junctions" Cytosol "HPA039558: , HPA049033: " "unprognostic (9.90e-3)" "unprognostic (1.01e-3)" "unprognostic (6.58e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.93e-2)" "prognostic unfavourable (8.22e-4)" "unprognostic (4.00e-2)" "unprognostic (5.93e-3)" "prognostic favourable (2.17e-4)" "unprognostic (1.25e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.77e-2)" "unprognostic (1.66e-1)" "unprognostic (2.07e-1)" "unprognostic (8.83e-2)" 6.4 3.5 4.1 9.2 8.0 9.4 10.2 7.8 5.6 6.8 7.1 3.3 3.5 6.1 6.7 5.8 8.3 6.3 5.9 7.5 5.5 4.4 5.6 16.2 5.2 11.1 4.7 4.0 13.5 5.7 11.7 6.9 12.2 8.1 5.7 7.4 4.4 4.8 4.3 5.9 9.1 9.3 5.4 5.2 8.2 5.8 24.0 3.0 26.4 5.0 8.1 10.7 4.5 9.7 0.7 0.5 0.1 0.9 0.4 1.4 0.3 27.0 6.3 13.3 11.6 4.2 7.7 10.4 21.6 9.3 16.6 18.8 17.8 7.4 14.7 5.6 10.7 8.1 17.9 7.7 18.2 14.7 15.5 27.6 13.9 16.1 3.0 14.6 6.7 5.5 2.5 18.7 4.6 10.6 26.3 25.7 14.2 5.5 13.3 5.2 13.8 7.8 12.0 27.6 15.7 7.4 7.3 14.5 6.0 32.4 10.4 9.5 13.6 7.4 6.1 15.8 11.0 11.5 15.2 23.3 22.9 24.2 8.8 19.5 17.8 0.0 0.3 0.1 1.4 0.9 0.7 0.2 1.4 0.6 0.2 0.7 0.8 0.1 0.0 0.4 0.0 0.5 0.6 0.3 4.1 8.0 7.8 5.6 5.5 4.4 4.7 4.0 8.1 3.0 DOPEY1 "dJ202D23.2, KIAA1117" ENSG00000083097 "Dopey family member 1" Q5JWR5 6 83067666-83171350 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027902, HPA027904" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA027902: AB_10600003, HPA027904: AB_10600877" "unprognostic (7.18e-2)" "unprognostic (3.91e-1)" "unprognostic (6.11e-2)" "unprognostic (6.05e-3)" "unprognostic (8.21e-3)" "unprognostic (1.36e-2)" "unprognostic (3.32e-1)" "unprognostic (1.02e-2)" "unprognostic (2.84e-1)" "unprognostic (2.47e-1)" "prognostic favourable (7.36e-4)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" 9.7 8.7 15.7 11.3 19.5 5.5 13.3 25.2 21.2 11.9 9.5 10.1 10.1 9.5 13.9 9.5 9.5 12.0 8.9 10.6 15.2 7.0 8.9 7.5 9.1 8.3 10.9 12.9 17.7 12.1 20.3 21.7 7.3 17.3 12.4 11.0 9.0 13.8 14.9 12.7 16.6 11.7 9.5 13.1 9.5 9.5 14.9 12.8 10.7 16.9 8.5 8.9 12.2 10.7 2.3 2.8 1.4 1.4 1.2 4.1 1.3 3.7 2.7 9.0 8.1 8.2 8.6 4.3 6.3 5.3 4.3 6.3 5.7 0.9 7.2 4.5 6.8 5.0 9.1 6.9 5.5 6.3 10.2 6.0 3.7 2.1 4.4 8.8 6.3 6.8 9.7 6.0 15.8 6.4 12.5 5.4 4.7 3.5 2.6 4.0 1.8 5.5 7.2 6.8 2.6 5.8 10.4 16.2 3.0 4.7 3.0 1.2 4.8 5.0 10.6 5.5 2.0 5.5 4.9 6.7 4.7 4.2 2.9 4.1 4.3 0.1 1.3 1.4 1.9 1.4 1.6 2.3 1.6 4.1 2.8 1.9 3.0 1.4 0.2 1.2 1.2 1.2 1.5 1.3 15.7 19.5 25.2 21.2 15.2 7.0 10.9 12.9 17.3 12.8 DOPEY2 "C21orf5, KIAA0933" ENSG00000142197 "Dopey family member 2" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.1" "Cell line enhanced" "Detected in many" "BEWO: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034922, HPA072065" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "CAB034922: AB_2277578, HPA072065: " "prognostic unfavourable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 4.6 2.3 5.5 7.5 9.5 17.1 4.9 28.7 11.6 5.1 11.8 3.8 6.8 9.7 2.8 3.3 13.5 3.6 6.5 4.3 4.6 4.0 3.5 7.2 7.2 5.8 3.1 5.8 2.3 3.8 43.1 3.1 4.7 9.5 9.8 12.0 2.8 15.2 9.1 11.1 7.4 13.9 3.8 3.7 5.2 15.8 3.3 3.3 9.3 3.6 7.5 10.6 5.4 6.5 12.0 6.4 6.3 3.2 1.1 3.1 1.3 15.0 3.2 2.4 4.1 2.7 5.3 23.3 7.2 8.5 10.2 6.4 2.2 1.2 2.8 1.1 5.3 3.1 4.6 1.6 8.3 5.1 4.2 6.4 0.7 0.8 2.4 6.2 3.3 1.8 3.4 6.6 1.7 4.2 2.0 4.6 3.0 16.8 5.0 6.4 2.0 3.3 8.9 1.4 13.7 5.4 6.0 6.5 3.7 4.8 21.6 6.1 7.8 7.7 7.2 3.9 1.1 5.1 5.7 3.5 8.4 1.3 5.6 13.5 2.2 1.0 3.2 6.3 3.1 3.1 1.7 8.6 2.0 1.8 2.1 12.0 1.3 1.1 5.5 1.1 2.6 6.4 1.5 1.3 5.5 9.5 28.7 11.6 4.6 4.0 3.1 5.8 9.5 3.3 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SCLC-21H: 18.2" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Cytosol" Mitochondria "HPA049148: " "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.4 2.9 12.5 9.1 0.9 0.6 1.2 3.7 2.1 6.3 5.4 2.1 0.3 5.7 2.5 2.8 2.2 15.4 2.1 2.8 5.4 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 1.1 4.2 0.3 6.0 4.8 3.0 0.3 2.2 3.5 5.7 6.3 1.2 0.6 1.0 18.2 6.3 4.2 0.4 0.8 1.9 0.3 1.4 9.2 2.9 2.2 3.3 2.3 7.5 7.6 4.8 2.0 3.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 DPH2 DPH2L2 ENSG00000132768 "DPH2 homolog" Q9BQC3 1 43970000-43973369 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045796 Uncertain Approved Nucleoplasm Nucleoplasm "HPA045796: " "unprognostic (2.41e-1)" "unprognostic (1.15e-1)" "unprognostic (4.20e-3)" "unprognostic (9.13e-3)" "unprognostic (3.83e-2)" "unprognostic (1.30e-1)" "prognostic unfavourable (1.17e-8)" "unprognostic (1.38e-1)" "unprognostic (1.81e-1)" "unprognostic (3.72e-1)" "unprognostic (2.49e-1)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "prognostic favourable (1.37e-4)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (6.37e-2)" 9.6 12.7 13.5 12.4 14.1 7.5 9.8 7.9 18.8 8.3 12.0 12.4 5.9 8.9 9.4 7.5 15.2 10.8 11.5 11.6 11.6 6.3 11.5 21.7 8.5 14.1 13.6 9.3 9.1 21.1 10.4 10.6 8.3 9.7 9.8 11.9 5.8 11.6 9.2 33.4 13.1 9.9 11.2 7.6 13.7 10.6 14.7 12.3 10.8 8.9 14.6 13.5 10.3 7.8 9.0 10.2 0.5 9.2 9.8 10.1 5.8 9.8 11.4 5.1 10.9 3.9 4.1 17.4 5.3 5.7 13.8 11.2 14.5 9.7 16.6 9.0 5.4 11.4 17.2 15.0 7.4 11.4 15.0 17.1 14.2 14.9 10.2 19.7 9.7 6.3 16.7 16.2 9.0 9.5 21.6 9.4 6.8 11.5 17.4 10.9 35.5 13.1 15.0 11.8 27.0 8.6 7.9 17.7 20.5 7.0 17.6 12.8 7.4 13.7 6.2 6.6 15.2 11.7 20.9 23.0 38.1 17.1 5.9 22.0 9.7 0.0 6.6 0.3 6.7 9.2 9.9 9.0 6.8 6.9 10.2 8.8 7.0 10.1 0.5 9.8 4.7 8.5 6.6 5.8 13.5 14.1 7.9 18.8 11.6 6.3 13.6 9.3 9.7 12.3 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 4.9;testis: 9.0" "Group enriched" "Detected in some" 5 "BEWO: 7.9;EFO-21: 15.0" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" HPA036134 Uncertain Approved Nucleoplasm Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.1 0.1 2.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 5 "HAP1: 22.7;NTERA-2: 83.5" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB020678: , HPA035249: , HPA035250: " "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA071264: , HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 0.8 2.2 3.4 4.7 2.1 0.2 1.6 2.5 2.5 0.1 2.2 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: " "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 34.1 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 48.9 28.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087886-18107971 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favourable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavourable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.9 19.9 16.1 17.5 21.8 17.4 19.3 14.7 30.8 19.3 19.3 22.9 16.6 19.2 23.5 22.8 21.6 25.2 18.2 22.4 15.7 17.0 19.1 31.9 15.7 21.2 17.6 16.1 27.6 23.9 20.6 18.8 22.4 17.9 21.1 13.4 18.4 21.7 21.7 33.3 19.4 17.9 18.3 17.1 20.7 17.6 14.6 17.2 21.6 23.6 21.2 25.6 20.5 18.0 12.6 18.4 17.0 20.9 20.0 19.8 14.0 16.8 24.1 8.2 8.1 15.3 16.3 15.7 11.9 11.8 19.3 18.0 25.5 10.1 16.3 15.5 13.7 17.8 13.5 16.5 13.1 14.4 36.9 7.1 12.8 14.2 16.6 6.5 11.4 18.1 14.7 19.3 16.3 18.4 12.5 6.4 11.2 19.0 17.3 11.0 6.1 17.7 18.6 19.9 30.2 11.5 9.9 4.7 13.3 11.8 7.0 14.6 13.9 9.9 13.8 9.3 8.9 10.9 19.5 7.3 8.9 9.2 13.4 11.9 17.1 11.6 15.9 17.0 19.8 17.2 16.4 12.2 14.7 15.8 18.4 12.6 14.0 15.3 2.1 20.0 20.9 10.3 18.3 14.0 16.1 21.8 14.7 30.8 15.7 17.0 17.6 16.1 17.9 17.2 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell line enhanced" "Detected in some" "RH-30: 8.1;SH-SY5Y: 36.6;U-2197: 13.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 68.5" "Cell line enriched" "Detected in many" 5 "CACO-2: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" HPA020446 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.5 0.5 0.5 0.5 0.5 1.3 0.8 1.0 0.5 0.5 0.5 0.5 0.5 0.1 1.3 9.7 0.5 0.6 0.5 0.5 0.5 0.3 1.2 0.5 0.5 0.7 0.5 0.5 1.3 0.9 8.3 0.8 0.5 0.5 0.7 0.2 0.5 0.5 0.6 0.5 1.3 0.6 0.5 0.5 0.8 0.4 68.5 0.5 0.5 1.0 0.5 0.5 0.5 0.5 0.0 0.0 0.4 0.6 0.0 1.0 0.0 0.7 0.8 2.1 0.6 2.6 0.6 1.9 0.0 0.0 0.1 0.1 15.3 0.6 1.0 0.1 0.6 1.5 3.0 0.1 0.4 0.2 1.4 0.5 1.2 0.6 0.9 0.3 2.3 1.2 1.3 0.4 0.0 0.4 1.2 0.3 0.2 0.7 0.2 0.7 0.2 0.8 1.6 0.1 0.0 0.4 1.6 0.9 0.7 0.0 1.3 1.1 0.2 0.1 0.4 0.0 2.7 2.4 0.2 1.0 1.4 0.1 2.5 0.6 0.2 0.0 0.3 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.5 0.3 0.5 0.5 0.5 0.5 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847139 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.2;pituitary gland: 9.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019324 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA019324: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.9 1.1 12.7 0.9 10.3 0.9 1.2 3.0 22.2 0.9 1.0 8.2 0.0 1.0 0.9 2.8 0.9 1.1 1.0 0.9 10.1 8.6 0.9 1.4 1.0 0.9 6.8 10.1 0.9 1.2 0.9 9.1 2.9 9.5 1.0 1.0 0.7 0.9 1.0 0.9 0.9 1.0 0.9 3.7 2.9 0.9 2.0 6.9 0.0 0.9 0.0 0.9 1.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 10.3 3.0 14.7 10.1 8.6 6.8 10.1 9.5 6.9 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119856010 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm Nucleoplasm "HPA023780: , HPA024401: " "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavourable (3.92e-6)" "prognostic unfavourable (3.93e-4)" "prognostic unfavourable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 4.3 4.7 3.6 8.5 3.9 9.2 5.4 9.4 5.0 5.1 4.6 3.3 3.5 4.1 6.2 2.4 5.8 3.0 4.7 3.4 3.9 2.6 2.1 2.5 3.3 11.5 4.0 2.0 4.1 7.0 1.3 1.6 4.0 5.3 4.1 6.4 2.1 11.4 4.3 3.9 4.5 4.0 4.9 4.2 4.1 4.0 4.8 5.1 34.2 2.4 5.7 9.5 3.4 5.1 1.4 0.8 0.2 0.2 2.4 3.3 0.9 12.1 6.0 11.9 10.8 1.7 3.2 5.1 8.4 1.7 6.1 6.4 5.4 7.5 22.1 7.4 2.5 9.0 13.5 5.2 6.6 15.0 12.2 28.2 6.1 6.3 0.5 11.0 9.9 1.4 0.8 7.5 3.6 1.7 9.5 9.9 7.3 12.0 28.9 6.8 17.5 15.0 10.4 11.3 10.6 4.7 7.7 10.7 6.6 4.5 35.9 5.6 6.7 6.1 1.1 6.6 18.1 6.4 12.2 13.6 20.3 23.5 3.4 17.7 9.6 0.0 0.2 0.2 3.3 0.0 2.5 1.4 0.7 1.6 0.2 0.6 0.4 1.4 0.0 2.4 0.0 0.8 1.1 0.9 3.6 3.9 9.4 5.0 3.9 2.6 4.0 2.0 5.3 5.1 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 19.5;BJ hTERT+: 11.3;LHCN-M2: 24.3;U-138 MG: 25.3" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060942 Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA060942: " "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.3 0.0 4.6 6.8 0.3 19.5 11.3 5.0 2.1 0.0 0.0 0.0 0.0 9.8 0.1 0.4 0.8 4.8 0.0 0.0 0.0 2.2 0.0 3.9 0.0 0.0 6.9 1.3 3.0 7.2 0.9 0.0 0.2 24.3 0.0 0.0 0.0 0.3 2.0 0.2 5.1 0.0 2.2 0.0 0.9 1.1 1.8 0.0 0.0 0.0 0.0 1.7 25.3 0.7 1.8 2.2 0.1 0.0 0.0 5.3 0.0 2.1 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 DST "BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2" ENSG00000151914 Dystonin Q03001 6 56457987-56954628 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 92.5;hTERT-HME1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030200 Uncertain Approved Nucleoplasm,Microtubules,Cytosol "Nucleoplasm, Microtubules" Cytosol "HPA030200: AB_10601901" "unprognostic (4.87e-3)" "unprognostic (1.29e-1)" "unprognostic (3.40e-1)" "unprognostic (1.54e-1)" "unprognostic (1.25e-2)" "unprognostic (3.60e-2)" "unprognostic (5.78e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-2)" "unprognostic (1.13e-1)" "unprognostic (3.69e-1)" "unprognostic (4.39e-2)" "unprognostic (5.13e-3)" "unprognostic (1.46e-1)" "unprognostic (2.66e-1)" "unprognostic (7.62e-2)" 26.5 29.2 43.4 11.7 57.1 2.5 59.2 43.6 52.4 53.8 31.5 32.1 11.5 15.1 53.6 21.7 37.1 19.4 16.8 28.1 41.2 36.2 18.0 26.6 29.4 5.4 56.5 28.9 30.3 14.0 32.1 28.2 15.1 53.9 22.6 17.4 8.4 23.6 25.3 57.5 81.8 16.9 53.6 54.9 12.8 14.8 11.7 66.5 6.1 7.6 33.6 7.7 19.7 23.7 0.6 5.3 0.3 1.7 2.1 0.4 0.3 11.9 5.7 7.7 4.4 12.8 20.2 4.4 16.1 15.4 6.7 7.5 3.3 3.2 1.8 6.7 36.4 8.4 6.5 28.4 13.2 11.4 9.7 3.4 10.4 6.1 11.5 3.2 0.0 8.9 92.5 16.2 68.5 12.6 2.7 7.9 17.3 3.3 0.9 1.3 5.9 4.2 0.0 6.0 2.7 20.2 15.4 10.3 7.7 6.9 2.4 11.0 3.7 5.2 33.8 14.8 12.4 7.0 13.3 8.9 6.3 0.9 10.5 1.7 7.0 0.3 1.7 0.0 0.3 1.3 0.1 0.2 0.4 0.0 3.2 0.6 0.1 0.2 0.1 2.1 1.0 5.3 0.0 0.3 43.4 57.1 43.6 52.4 41.2 36.2 56.5 28.9 53.9 66.5 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49620980-49656232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA042214: " "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 12.6 15.7 11.3 27.5 4.2 17.5 16.7 16.0 24.5 20.1 10.9 9.4 6.9 25.2 15.8 11.7 17.0 19.9 12.0 11.5 9.3 10.3 9.9 11.6 10.4 12.9 12.2 21.6 28.5 8.7 22.1 11.2 11.9 19.2 11.2 11.6 18.0 14.2 10.7 10.8 8.9 22.4 11.7 9.4 15.6 8.2 13.1 12.1 15.5 11.8 8.7 21.5 17.2 8.6 21.6 5.4 11.9 11.1 11.5 5.2 4.4 5.2 9.6 5.1 19.1 37.4 7.6 12.9 12.9 17.2 12.7 1.6 3.6 7.0 9.7 16.1 8.0 6.8 6.8 16.7 4.7 4.8 6.1 10.6 6.2 12.8 7.9 5.3 18.0 9.1 10.7 13.2 7.0 11.3 7.5 18.0 8.9 5.3 6.4 6.0 7.1 7.7 19.8 27.7 5.5 3.1 8.6 6.5 15.6 5.3 12.0 5.3 11.5 4.6 20.4 8.1 11.4 14.3 6.0 9.1 4.2 17.9 22.7 12.6 5.4 8.6 4.2 6.5 9.8 8.9 8.6 9.6 10.4 10.8 8.6 11.5 10.6 2.1 11.1 11.9 21.6 7.5 5.2 15.7 27.5 16.7 16.0 11.5 9.3 12.9 12.2 11.9 13.1 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: " "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favourable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favourable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.4 25.0 0.0 0.0 0.0 0.1 5.1 13.3 11.3 11.5 4.3 13.6 4.5 7.9 11.1 5.2 0.0 0.6 8.0 11.3 1.5 2.6 13.0 4.5 19.3 0.0 0.0 9.5 6.3 8.6 0.1 12.6 0.0 15.4 8.6 7.0 13.7 0.1 19.7 0.7 0.0 20.9 0.2 1.0 8.4 18.2 28.8 4.0 1.2 2.4 14.4 6.9 0.0 14.8 5.9 6.8 7.3 25.2 18.9 0.0 9.5 0.0 7.7 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 DUS3L "DUS3, FLJ13896" ENSG00000141994 "Dihydrouridine synthase 3 like" Q96G46 19 5784832-5791238 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041854, HPA041944, HPA062846" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: " "unprognostic (1.25e-2)" "unprognostic (7.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.64e-3)" "unprognostic (6.08e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.87e-1)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (7.35e-3)" "unprognostic (4.25e-3)" "unprognostic (7.73e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" 9.1 9.4 7.4 11.4 9.4 25.4 9.5 7.1 13.2 8.9 12.4 13.7 8.7 16.6 13.1 7.7 12.3 11.1 11.1 7.8 6.0 5.0 9.9 17.5 7.9 12.6 8.3 6.7 11.8 17.6 4.7 8.6 11.1 7.8 11.8 4.6 12.4 12.4 10.1 14.3 17.5 14.4 7.6 7.5 12.5 12.3 42.5 8.1 15.6 11.7 10.3 11.1 8.8 9.7 13.5 19.2 4.3 18.6 15.8 16.6 9.9 10.8 10.7 3.1 10.9 0.8 1.4 10.2 3.6 2.1 3.8 2.9 16.7 5.1 11.1 13.9 1.4 7.1 2.6 3.5 0.6 8.1 24.6 7.3 5.6 6.3 5.5 16.2 21.3 3.3 3.8 4.3 3.0 2.5 19.4 0.0 2.0 14.2 13.6 16.5 11.1 29.2 7.1 6.4 13.6 1.6 7.8 10.8 10.9 3.8 6.4 7.1 4.4 13.3 3.3 5.4 9.6 16.1 15.6 31.9 23.4 10.6 5.3 16.8 6.1 4.3 13.2 3.4 14.8 18.6 16.6 10.2 11.0 13.5 18.7 13.5 15.1 14.4 1.5 15.8 14.4 19.2 12.5 9.9 7.4 9.4 7.1 13.2 6.0 5.0 8.3 6.7 7.8 8.1 DUSP14 "MKP-L, MKP6" ENSG00000276023 "Dual specificity phosphatase 14" O95147 17 37489831-37513501 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 12.5;HBF TERT88: 17.9;WM-115: 10.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019911 Approved Approved Nucleoplasm,Cytosol 44000 "Nucleoplasm, Cytosol" "HPA019911: AB_1847888" "unprognostic (1.32e-1)" "unprognostic (3.06e-1)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (4.60e-1)" "unprognostic (3.22e-2)" "unprognostic (3.43e-3)" "unprognostic (2.02e-3)" "unprognostic (2.18e-1)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (3.81e-1)" "prognostic unfavourable (6.97e-9)" "unprognostic (7.93e-2)" "unprognostic (1.97e-1)" "unprognostic (1.73e-1)" "unprognostic (1.41e-3)" 4.7 3.7 3.3 2.1 6.6 1.1 3.9 1.8 8.0 3.3 1.0 1.5 0.1 0.7 2.7 1.2 7.2 11.7 5.1 2.6 2.3 2.1 6.5 2.4 1.0 1.9 2.5 3.0 2.9 1.7 3.3 11.6 2.6 1.4 1.4 1.6 2.8 1.1 1.7 8.4 0.9 3.5 2.7 1.7 1.0 3.5 0.8 2.3 8.3 6.1 4.3 1.9 1.0 0.5 0.0 3.2 0.0 0.4 0.4 0.5 1.7 0.1 0.4 0.8 0.0 0.5 1.5 8.0 6.1 10.7 12.5 0.9 1.8 0.1 0.7 5.8 1.3 0.1 4.7 17.9 0.1 0.5 0.0 1.0 2.0 0.8 0.4 1.2 4.7 2.9 3.8 2.0 0.2 0.4 0.0 7.9 0.3 0.8 0.2 0.2 0.0 0.7 0.5 0.2 2.6 0.7 1.3 0.1 0.4 0.7 1.1 0.6 1.0 0.7 8.6 2.0 0.1 4.0 0.0 0.2 0.1 0.0 0.0 10.3 0.0 0.0 0.9 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.3 0.2 3.2 0.4 0.0 0.0 0.0 0.5 DUSP19 "DUSP17, SKRP1" ENSG00000162999 "Dual specificity phosphatase 19" Q8WTR2 2 183078559-183100005 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021501 Approved Approved Nucleoplasm Nucleoplasm "HPA021501: AB_1847892" "unprognostic (1.24e-1)" "unprognostic (2.13e-2)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (5.18e-2)" "unprognostic (2.44e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (8.30e-2)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (6.53e-2)" "unprognostic (5.80e-3)" "unprognostic (6.97e-2)" "unprognostic (2.91e-2)" "unprognostic (2.16e-2)" "unprognostic (2.75e-2)" 2.8 4.6 9.2 2.0 16.3 1.0 3.0 2.9 9.6 3.4 4.7 2.2 3.8 3.5 6.8 9.2 4.2 8.4 3.5 7.4 17.4 3.4 4.7 3.0 3.4 2.3 3.3 6.8 4.4 4.3 7.7 10.6 2.7 3.7 4.2 3.0 3.0 2.8 5.4 3.8 3.4 3.0 8.6 2.9 4.0 9.1 10.4 4.7 6.2 4.6 1.1 1.9 4.0 2.7 4.1 1.5 2.0 0.8 2.2 3.2 1.3 0.1 2.4 2.8 1.4 3.9 2.2 0.0 1.1 1.8 4.5 1.6 2.2 2.9 1.0 5.9 1.2 0.3 5.7 0.8 3.5 5.7 3.1 10.5 1.8 1.6 1.7 2.6 6.5 1.7 0.5 2.3 1.1 2.6 3.1 1.6 2.7 1.0 4.9 2.5 2.4 2.0 4.9 4.5 0.3 1.0 1.1 3.6 1.5 3.9 1.6 2.8 0.8 1.0 2.0 2.4 2.1 1.6 0.9 2.0 2.4 0.1 3.1 0.4 3.7 2.0 0.5 1.9 2.3 0.8 2.3 4.1 2.1 3.1 0.6 2.2 2.7 2.7 1.3 2.2 0.4 1.5 3.2 1.3 9.2 16.3 2.9 9.6 17.4 3.4 3.3 6.8 3.7 4.7 DUSP22 "JKAP, JSP1, MKPX, VHX" ENSG00000112679 "Dual specificity phosphatase 22" Q9NRW4 6 291630-351355 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 70.3;U-266/70: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031394 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031394: AB_10604114" "unprognostic (7.34e-3)" "unprognostic (7.94e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (9.08e-3)" "unprognostic (2.48e-1)" "unprognostic (9.06e-2)" "unprognostic (5.56e-3)" "unprognostic (3.10e-2)" "unprognostic (3.04e-1)" "unprognostic (1.77e-1)" "unprognostic (3.97e-2)" "unprognostic (3.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" 24.8 13.1 22.0 24.6 31.3 19.4 28.7 12.1 27.5 18.1 29.0 29.8 18.8 21.2 20.6 25.2 29.8 15.0 20.4 31.0 22.6 17.4 16.0 20.3 24.6 27.4 33.5 16.1 13.9 27.9 10.8 14.8 25.9 25.5 16.1 15.9 16.9 20.9 15.5 32.0 30.6 21.8 23.4 29.2 30.0 21.4 41.3 30.0 9.2 19.9 19.0 27.9 22.8 27.4 21.6 18.0 16.3 17.5 2.9 8.2 9.8 3.5 2.2 4.7 7.0 5.4 6.1 6.2 2.6 2.1 2.3 2.8 2.3 4.0 7.5 6.4 2.7 2.5 5.9 4.9 1.7 17.9 6.8 5.1 1.7 6.4 2.8 1.8 6.7 4.5 14.8 1.7 3.1 6.7 4.7 25.2 1.9 2.1 2.6 6.5 2.8 5.1 5.3 3.2 70.3 4.4 1.5 8.1 3.2 2.2 0.9 7.7 4.7 2.3 9.1 2.1 2.8 2.1 1.6 35.8 25.2 10.4 0.8 5.0 4.7 16.3 17.5 6.9 5.0 14.0 3.5 21.6 3.9 5.1 18.0 17.5 3.6 5.1 12.0 2.9 12.6 15.4 8.2 9.8 22.0 31.3 12.1 27.5 22.6 17.4 33.5 16.1 25.5 30.0 DUSP27 ENSG00000198842 "Dual specificity phosphatase 27, atypical" Q5VZP5 1 167094045-167129165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2" "Cell line enriched" "Detected in some" 10 "RH-30: 17.7" "Group enriched" "Detected in many" 6 "colorectal cancer: 12.8;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA012912 Approved Nucleoplasm Nucleoplasm "HPA012912: " "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.44e-3)" "unprognostic (1.22e-1)" "unprognostic (2.10e-3)" "unprognostic (4.65e-2)" "unprognostic (1.53e-1)" "unprognostic (8.19e-2)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.72e-1)" "unprognostic (7.65e-2)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 2.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 46.8 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.0 0.0 0.9 0.0 64.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.5 18.2 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 DUSP6 "MKP-3, PYST1" ENSG00000139318 "Dual specificity phosphatase 6" Q16828 12 89347232-89353271 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.0" "Cell line enhanced" "Detected in many" "AN3-CA: 80.6;NB-4: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 125.0" "Group enriched" "Detected in many" 11 "granulocytes: 125.0;monocytes: 79.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017566, HPA053188, HPA064692" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB017566: AB_647991, HPA053188: , HPA064692: " "unprognostic (7.35e-2)" "unprognostic (1.50e-2)" "unprognostic (5.77e-2)" "prognostic favourable (7.21e-4)" "unprognostic (2.35e-3)" "unprognostic (2.10e-3)" "unprognostic (3.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.63e-2)" "unprognostic (1.67e-2)" "unprognostic (3.15e-3)" "unprognostic (2.09e-1)" "unprognostic (5.91e-3)" "unprognostic (1.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-2)" "unprognostic (2.84e-1)" 37.7 7.5 7.2 15.9 11.7 41.3 24.1 3.4 14.7 11.6 12.4 6.2 5.8 6.1 9.8 8.7 12.0 15.4 25.1 16.2 10.5 6.5 17.1 38.4 28.2 13.3 6.9 7.4 7.5 12.2 15.0 13.7 19.7 7.9 17.4 15.3 44.4 64.3 6.3 12.0 8.5 14.6 11.3 7.1 28.4 10.3 4.8 6.4 6.1 21.0 13.3 17.8 15.2 6.9 1.2 9.2 125.0 79.7 1.2 0.9 32.4 1.1 1.1 24.0 80.6 20.8 17.7 0.0 8.7 11.1 1.7 1.3 7.0 1.2 0.0 2.0 3.7 9.3 0.1 21.6 2.5 0.1 0.1 3.6 0.2 11.2 14.7 15.5 39.5 3.4 7.6 15.3 14.3 40.1 0.0 3.8 5.5 0.5 0.5 57.8 14.6 19.7 39.3 3.0 1.5 24.8 23.3 0.4 17.1 0.2 0.1 45.9 1.2 8.6 10.7 5.9 0.1 1.1 4.1 0.6 3.1 0.0 24.5 10.9 37.4 125.0 49.5 22.4 0.9 79.7 0.4 0.2 0.2 0.3 9.2 1.2 0.1 0.3 22.5 1.2 74.4 1.2 0.6 32.4 7.2 11.7 3.4 14.7 10.5 6.5 6.9 7.4 7.9 6.4 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" 650000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: " "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavourable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavourable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 45.5 48.5 128.5 34.4 97.8 21.9 54.3 48.4 120.5 50.6 61.8 61.9 31.1 31.6 47.2 64.9 113.7 107.1 46.7 44.2 124.1 105.2 49.7 40.7 40.3 41.2 92.9 90.7 49.0 45.7 30.4 46.4 49.8 67.4 39.9 64.5 24.8 34.0 54.9 15.0 117.3 38.9 75.2 93.6 30.4 45.1 59.4 56.8 35.4 37.1 84.3 65.6 59.0 63.0 55.0 80.6 73.6 55.0 46.7 63.4 50.8 78.4 89.7 89.0 68.2 78.2 83.0 28.6 108.6 50.2 88.7 53.2 84.5 52.9 44.0 58.7 103.7 70.8 105.7 90.8 88.7 58.3 69.2 43.0 64.3 114.3 79.0 44.8 71.5 50.4 97.2 66.5 54.6 92.1 53.9 50.7 117.0 103.9 58.5 97.6 73.0 104.7 59.8 46.1 54.6 126.7 72.7 61.2 45.2 88.5 76.9 98.6 76.2 65.6 70.8 68.3 58.3 60.2 93.5 30.6 58.7 43.7 75.7 70.1 87.4 73.6 49.5 63.6 37.7 51.4 28.7 55.0 39.0 39.0 49.1 36.5 25.2 31.5 9.1 46.7 55.0 80.6 63.4 50.8 128.5 97.8 48.4 120.5 124.1 105.2 92.9 90.7 67.4 56.8 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Cell line enhanced" "Detected in all" "BEWO: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge" "Nucleoplasm, Nuclear bodies, Vesicles" "Cytokinetic bridge" "HPA059516: , HPA060569: , HPA069538: " "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 3.9 6.4 6.8 7.0 4.0 3.4 55.0 5.8 4.1 6.7 6.5 8.8 4.4 11.0 3.7 4.2 3.3 8.9 5.1 7.7 9.0 6.4 9.5 5.8 8.0 9.0 8.9 7.7 4.5 9.1 9.6 6.5 6.6 10.1 8.2 5.5 8.1 8.8 5.0 12.2 6.7 8.1 5.6 6.1 5.8 6.9 7.0 12.3 7.1 6.6 6.7 9.9 7.1 6.4 7.0 5.2 6.2 8.3 10.8 21.6 11.6 6.8 10.7 8.3 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 EARS2 "KIAA1970, MSE1" ENSG00000103356 "Glutamyl-tRNA synthetase 2, mitochondrial" Q5JPH6 16 23522014-23557731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043289, HPA043633" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA043289: AB_10963932, HPA043633: AB_10959901" "unprognostic (3.10e-2)" "unprognostic (1.60e-1)" "unprognostic (3.65e-3)" "unprognostic (4.20e-1)" "unprognostic (3.57e-1)" "unprognostic (4.64e-2)" "unprognostic (2.73e-1)" "unprognostic (2.91e-2)" "unprognostic (1.16e-1)" "unprognostic (2.99e-2)" "prognostic unfavourable (7.20e-4)" "unprognostic (8.09e-2)" "prognostic favourable (3.16e-6)" "unprognostic (2.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (4.29e-2)" 8.4 19.0 11.0 8.5 19.0 2.7 13.6 13.4 16.8 11.1 10.0 10.8 12.7 6.4 11.4 10.2 10.5 13.1 7.8 14.9 10.9 11.9 14.5 18.3 7.3 8.1 9.9 14.0 12.0 18.9 32.7 10.9 12.4 10.3 11.3 11.0 8.8 16.4 11.7 17.3 11.1 6.9 8.3 9.3 7.6 9.2 12.6 10.4 6.3 14.5 9.0 11.0 8.6 16.9 3.0 6.2 0.5 5.5 10.6 7.9 3.3 8.1 16.4 7.7 12.4 5.4 7.8 9.4 9.0 6.9 11.2 9.4 11.9 8.2 11.3 9.3 8.3 9.1 29.1 16.6 10.7 4.5 14.1 6.5 10.1 20.2 8.7 7.2 8.2 8.3 9.9 10.0 14.2 5.0 20.3 6.0 7.9 17.1 7.2 5.2 20.4 5.7 12.9 8.9 21.7 14.1 7.0 13.8 10.1 7.1 13.4 7.2 18.1 8.2 4.0 8.8 7.8 9.7 11.4 11.0 10.4 9.1 9.0 10.1 13.0 0.0 2.8 0.3 4.2 3.6 7.9 3.0 4.7 4.3 6.2 3.0 4.6 4.5 0.5 10.6 5.5 4.5 3.4 3.3 11.0 19.0 13.4 16.8 10.9 11.9 9.9 14.0 10.3 10.4 EBF1 "EBF, OLF1" ENSG00000164330 "Early B cell factor 1" Q9UH73 5 158695916-159099761 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;HSkMC: 14.8;REH: 39.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 23.6" "Group enriched" "Detected in some" 62 "memory B-cell: 11.8;naive B-cell: 10.4" "Lineage enriched" "Detected in single" 66 "B-cells: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061169 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061169: " "unprognostic (7.86e-2)" "unprognostic (3.08e-2)" "unprognostic (7.29e-2)" "unprognostic (4.70e-2)" "unprognostic (2.63e-1)" "unprognostic (1.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.60e-1)" "unprognostic (5.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (9.62e-7)" "prognostic unfavourable (7.80e-4)" "unprognostic (5.75e-2)" "unprognostic (5.81e-2)" "unprognostic (4.37e-3)" 33.7 3.3 1.9 9.7 2.5 3.1 25.0 23.6 2.0 15.9 5.8 1.1 9.0 1.2 19.7 13.0 5.0 8.5 9.4 15.5 2.0 2.4 3.3 0.9 5.2 12.7 3.2 1.2 7.4 3.7 1.8 2.6 10.7 4.7 8.5 3.4 10.4 4.7 10.8 15.5 4.8 4.5 25.7 6.6 5.4 3.4 8.4 1.0 0.1 6.8 13.2 9.1 11.7 12.5 11.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 6.1 0.0 19.0 8.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 5.4 0.0 2.2 0.0 0.2 0.0 0.1 1.2 0.0 0.0 1.6 0.0 0.3 0.0 0.0 14.8 0.0 5.8 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 39.7 0.2 0.0 0.0 0.0 3.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 7.3 0.8 8.3 0.1 0.0 0.0 5.5 4.8 0.4 6.6 0.1 0.0 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 2.5 23.6 1.6 2.0 2.4 3.2 1.2 4.7 1.0 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "Early B cell factor 3" Q9H4W6 10 129835283-129963841 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 25.8;lymphoid tissue: 29.9" "Cell line enhanced" "Detected in some" "ASC diff: 9.9;HAP1: 11.6;LHCN-M2: 18.5;NB-4: 23.3;RH-30: 10.1;SCLC-21H: 23.9;THP-1: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061169: " "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 20.0 0.9 0.3 3.4 0.4 0.1 25.8 0.7 0.5 7.3 3.6 0.2 2.5 0.2 5.4 4.9 4.3 3.8 4.3 10.5 0.3 2.5 0.6 0.4 1.0 29.9 5.0 0.3 1.0 1.2 3.6 0.9 3.8 4.8 4.6 0.8 2.0 3.6 2.2 10.9 2.8 1.0 6.3 9.3 0.2 1.6 4.6 0.1 0.5 6.7 6.3 2.4 4.7 16.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 9.9 7.6 0.1 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 11.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 2.3 0.0 0.0 0.0 0.0 18.5 0.1 0.0 23.3 0.1 0.0 0.3 10.1 0.0 0.0 0.1 23.9 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 1.2 6.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.5 0.3 2.5 5.0 0.3 4.8 0.1 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA062510: , HPA068795: " "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.2 1.2 0.0 2.1 0.0 15.3 2.6 0.5 0.3 2.4 1.5 1.0 2.6 2.5 1.8 3.1 1.1 2.1 0.1 0.0 0.8 1.8 3.1 1.7 0.1 5.1 2.6 1.2 1.2 1.9 1.6 2.4 3.1 0.5 1.3 2.2 2.1 1.4 1.0 2.1 1.8 0.9 2.4 1.5 2.4 2.9 2.6 2.2 6.3 1.5 1.1 3.8 0.2 1.3 0.9 5.2 4.6 1.4 2.9 3.9 2.1 0.4 1.3 1.0 2.6 4.3 3.2 0.8 2.7 1.8 2.0 2.2 2.6 1.3 1.2 2.2 5.0 2.2 0.8 4.1 4.8 2.9 1.6 2.6 2.6 1.8 1.6 5.0 1.4 2.8 2.0 5.8 3.3 1.4 5.2 1.3 2.0 1.4 5.4 1.2 2.5 1.3 2.3 0.7 3.5 1.6 3.4 1.5 2.9 4.0 3.1 5.0 2.4 2.6 1.5 4.6 2.5 0.3 1.5 6.3 3.6 0.5 3.0 1.5 3.2 3.1 0.5 2.6 2.7 3.8 3.3 1.1 0.6 2.2 3.7 0.2 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 6 "AN3-CA: 29.4;HeLa: 15.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA027241 Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976" "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavourable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavourable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavourable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.1 0.6 2.3 0.0 13.8 76.4 2.1 22.4 53.2 14.0 18.3 0.3 3.4 0.1 0.2 50.1 12.9 0.0 2.6 14.7 0.1 0.1 0.9 0.7 0.1 3.8 0.0 23.2 6.7 0.1 36.0 1.3 3.9 4.8 0.1 39.0 0.0 0.0 0.7 0.2 0.7 0.3 16.8 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.1 0.0 5.9 1.0 29.7 4.4 3.3 4.8 0.1 0.1 0.2 15.6 2.0 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 ECSCR "ARIA, ECSM2" ENSG00000249751 "Endothelial cell surface expressed chemotaxis and apoptosis regulator" Q19T08 5 139448556-139462743 "Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 121 "EFO-21: 48.5;HUVEC TERT2: 122.6;TIME: 90.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" HPA063337 Supported "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA063337: " "unprognostic (5.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.69e-2)" "unprognostic (2.15e-3)" "unprognostic (3.95e-2)" "unprognostic (1.12e-1)" "unprognostic (2.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.78e-2)" "unprognostic (1.91e-1)" "unprognostic (1.83e-3)" "unprognostic (2.41e-3)" "unprognostic (1.36e-1)" "unprognostic (9.90e-2)" "unprognostic (2.91e-1)" 14.8 1.9 0.8 5.7 1.6 0.0 17.5 0.4 0.7 13.7 6.1 1.0 5.1 1.9 14.3 14.4 11.0 7.9 8.6 26.9 0.8 5.6 4.3 23.4 26.9 1.4 0.7 7.9 1.0 1.3 0.4 19.6 2.9 9.3 4.3 6.8 3.6 5.5 13.4 2.9 3.4 14.3 4.3 12.1 1.1 6.8 1.1 0.1 11.5 14.5 4.6 13.2 13.1 0.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 122.6 0.0 0.0 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 90.6 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.6 1.1 1.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 EDARADD ENSG00000186197 "EDAR associated death domain" Q8WWZ3 1 236348257-236502915 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.6" "Group enriched" "Detected in some" 4 "HMC-1: 36.7;RT4: 29.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 24.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 24.6" "Group enriched" "Detected in some" 5 "olfactory region: 0.7;thalamus: 0.8" "Low region specificity" "Detected in many" HPA018836 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018836: AB_1847984" "unprognostic (3.74e-1)" "unprognostic (3.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.12e-2)" "unprognostic (2.06e-3)" "unprognostic (3.12e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (2.57e-2)" "unprognostic (5.72e-2)" "unprognostic (3.00e-1)" "unprognostic (2.47e-1)" "unprognostic (1.90e-2)" "unprognostic (9.62e-3)" 0.9 0.4 0.5 2.4 0.5 0.2 5.8 0.3 0.4 1.1 1.1 0.1 13.7 0.2 0.9 13.0 7.2 1.0 1.3 2.2 0.4 0.4 2.5 0.6 1.7 1.2 0.5 0.0 0.7 5.5 0.0 0.4 6.4 0.1 11.3 0.2 1.7 3.6 16.6 0.3 5.7 0.7 3.6 0.4 2.9 6.4 4.0 0.2 4.5 6.4 5.3 6.8 15.6 9.9 0.1 0.3 24.6 0.2 2.9 4.0 1.1 0.0 1.7 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.7 0.4 0.4 0.0 0.0 0.0 0.1 4.1 3.0 4.4 0.7 5.9 3.5 0.0 0.0 0.6 0.0 0.1 36.7 0.0 1.3 0.5 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.8 0.0 1.5 0.0 0.0 0.0 29.7 0.2 0.1 0.0 0.6 0.1 7.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.6 0.2 0.0 2.1 0.2 2.7 0.1 3.2 4.0 0.3 0.1 0.3 2.1 0.2 2.9 0.1 0.0 2.9 1.1 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.0 0.1 0.2 EDRF1 "C10orf137, DKFZp586F1019, FLJ21617" ENSG00000107938 "Erythroid differentiation regulatory factor 1" Q3B7T1 10 125719515-125764143 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031820 Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA031820: AB_10600753" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (1.53e-1)" "unprognostic (3.64e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-2)" "unprognostic (8.84e-4)" "unprognostic (4.76e-3)" "unprognostic (8.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.63e-3)" "unprognostic (4.62e-2)" "prognostic unfavourable (3.16e-5)" "unprognostic (3.44e-3)" "unprognostic (5.51e-2)" "unprognostic (1.38e-1)" "unprognostic (7.68e-3)" 9.2 6.7 6.3 16.6 9.7 27.9 9.0 20.3 10.0 10.5 8.1 7.7 6.8 7.1 12.2 8.3 7.5 9.8 6.4 7.5 7.4 5.4 5.9 5.0 7.2 12.5 8.8 7.3 13.4 14.0 6.3 18.1 8.2 8.0 10.0 7.3 5.2 19.7 12.7 12.7 8.3 9.0 9.5 7.8 9.3 8.4 21.2 9.0 20.2 7.7 4.5 10.7 10.1 8.7 9.6 9.9 9.1 7.0 6.9 9.7 3.5 8.9 8.7 10.9 11.9 5.1 8.5 5.7 11.2 11.0 13.0 14.8 11.0 7.6 12.0 5.6 7.1 11.3 17.2 2.7 14.8 7.9 13.7 8.4 7.4 6.4 8.6 12.6 8.7 5.2 4.3 12.4 5.6 6.1 7.9 9.2 7.3 3.6 12.5 8.7 16.1 7.9 10.0 10.5 7.8 4.5 4.1 5.9 11.6 8.3 4.2 7.6 7.7 4.8 3.9 6.9 7.1 9.0 12.7 12.0 8.0 18.9 7.4 6.2 3.8 9.1 7.0 6.5 7.8 5.8 9.7 9.6 6.9 7.1 6.8 8.1 7.3 7.5 8.4 6.9 4.2 9.9 7.4 3.5 6.3 9.7 20.3 10.0 7.4 5.4 8.8 7.3 8.0 9.0 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791870 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA050138 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA050138: " "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavourable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavourable (2.53e-4)" "unprognostic (9.09e-2)" 11.5 11.8 17.6 13.2 19.0 13.0 17.3 25.2 18.0 11.1 12.0 12.5 17.3 6.2 11.8 18.3 10.1 11.7 10.7 14.0 13.8 12.6 16.5 17.8 9.0 9.8 12.3 14.2 16.4 11.3 15.7 15.4 10.2 12.1 12.5 13.3 9.6 15.0 12.2 28.4 10.5 11.2 13.0 14.8 9.6 12.5 28.6 13.3 8.3 17.7 12.1 12.0 9.3 12.5 9.8 6.7 6.0 5.2 10.4 10.8 5.7 18.6 4.9 7.8 10.4 4.9 12.1 6.0 8.7 15.0 12.2 11.4 5.5 13.5 11.3 5.0 7.7 6.2 7.1 5.7 18.0 11.7 3.8 7.3 5.8 5.8 10.4 11.4 5.4 6.7 7.3 6.1 14.2 8.2 11.3 14.2 14.7 6.8 7.1 11.4 7.9 7.7 3.2 7.6 4.3 5.8 3.7 2.1 7.7 4.7 6.1 14.4 8.0 12.4 8.3 5.1 6.4 5.7 14.0 6.7 5.9 11.7 7.0 5.3 6.3 6.0 5.0 3.5 8.1 5.0 10.5 9.8 8.8 8.5 6.2 6.6 10.8 8.5 1.5 10.4 5.2 6.7 9.9 5.7 17.6 19.0 25.2 18.0 13.8 12.6 12.3 14.2 12.1 13.3 EEF2K eEF-2K ENSG00000103319 "Eukaryotic elongation factor 2 kinase" O00418 16 22206282-22288732 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 3.9;HMC-1: 4.7;NB-4: 4.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007818, HPA056061" Approved Approved Nucleoplasm Nucleoplasm "CAB007818: AB_598150, HPA056061: " "unprognostic (4.79e-2)" "unprognostic (6.10e-1)" "unprognostic (3.89e-2)" "unprognostic (3.49e-1)" "unprognostic (1.94e-2)" "unprognostic (5.09e-3)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (1.74e-1)" "unprognostic (8.50e-2)" "unprognostic (2.01e-2)" "unprognostic (9.07e-3)" "prognostic unfavourable (2.38e-4)" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 16.8 5.5 5.3 8.6 3.7 7.6 12.4 17.5 4.8 14.3 10.7 1.3 9.4 5.6 13.2 8.3 6.1 8.2 12.5 9.0 3.2 3.3 3.7 5.5 9.2 6.7 2.4 4.9 6.4 8.1 3.3 3.0 6.4 4.9 12.5 4.6 4.4 12.4 20.5 16.2 37.5 5.1 15.5 1.6 6.1 6.4 4.6 3.1 4.0 4.4 11.5 6.7 13.3 14.2 0.7 2.3 2.2 0.9 1.3 1.6 0.1 0.1 0.0 0.0 0.0 1.0 1.3 1.0 0.0 0.0 0.2 0.0 0.7 0.0 0.9 0.4 0.0 3.9 0.6 0.0 0.0 0.3 0.0 1.6 0.7 2.7 0.0 3.7 4.7 0.0 1.0 0.2 0.3 0.2 0.5 3.3 0.0 0.0 0.2 4.0 0.4 0.0 1.0 2.6 0.7 1.1 0.0 1.0 1.5 0.0 0.0 0.4 0.5 1.2 1.3 2.4 0.9 3.6 0.1 0.7 0.3 1.1 2.7 2.7 0.4 1.5 0.8 0.6 0.5 0.9 0.7 0.4 0.3 0.2 0.2 0.7 0.7 0.3 2.2 1.3 0.5 2.3 1.6 0.1 5.3 3.7 17.5 4.8 3.2 3.3 2.4 4.9 4.9 3.1 EEFSEC "eEFSec, EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153454-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.5;SH-SY5Y: 8.8;SK-BR-3: 14.8;SK-MEL-30: 12.7;T-47d: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favourable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 8.2 6.8 5.6 7.9 7.9 3.1 7.9 8.4 9.8 11.6 8.6 9.3 7.3 2.5 10.8 5.4 8.0 9.4 7.1 18.7 7.6 6.4 9.4 18.1 7.1 15.5 5.4 4.2 11.5 8.4 23.9 9.2 9.7 6.9 9.0 4.9 7.2 10.7 11.2 20.3 15.9 15.7 10.0 5.0 9.2 6.9 11.5 6.2 17.2 8.4 6.7 10.5 7.7 7.9 7.1 10.9 7.3 7.8 9.7 7.0 3.8 0.4 0.1 3.4 1.4 0.1 0.2 0.4 0.0 0.2 0.2 0.2 0.3 5.7 12.5 0.1 3.1 0.9 0.3 0.1 0.1 0.3 0.3 0.0 0.1 0.1 4.9 0.2 0.3 0.1 0.1 3.4 0.1 0.2 0.0 0.2 2.9 0.1 6.2 0.3 0.4 0.1 0.2 0.2 0.8 0.0 0.0 0.3 8.8 0.0 14.8 12.7 8.0 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.6 0.3 0.1 0.4 0.2 0.5 7.5 7.3 6.7 7.8 5.6 7.1 5.9 5.8 10.9 5.8 5.6 6.5 0.0 9.7 6.2 4.6 7.0 3.8 5.6 7.9 8.4 9.8 7.6 6.4 5.4 4.2 6.9 6.2 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Cell line enhanced" "Detected in some" "A-431: 8.9;ASC diff: 3.9;ASC TERT1: 9.1;CAPAN-2: 4.4;hTEC/SVTERT24-B: 3.7;SCLC-21H: 7.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: " "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 8.9 0.0 1.1 0.0 3.9 9.1 0.0 0.1 0.9 0.0 0.3 0.0 4.4 0.0 0.0 0.2 2.4 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.2 0.3 3.7 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.3 0.1 0.0 0.0 0.0 2.1 7.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;fallopian tube: 29.9;testis: 24.8" "Cell line enhanced" "Detected in some" "Hep G2: 4.6;RPTEC TERT1: 3.7;SCLC-21H: 2.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 14.9;pons and medulla: 24.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 14.2" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.7 0.6 2.2 0.7 14.9 1.5 0.9 1.7 3.0 2.0 0.6 7.8 0.0 0.5 1.8 10.1 0.6 29.9 1.5 0.7 4.2 4.3 1.2 2.1 3.6 0.8 0.5 3.5 6.1 1.0 3.1 15.2 0.7 24.4 4.1 0.6 1.5 0.6 0.9 0.5 0.5 0.5 0.6 1.0 0.7 1.0 24.8 1.6 0.0 2.4 0.0 0.9 0.5 0.1 1.4 0.0 1.3 0.4 0.3 0.6 0.0 0.4 2.2 0.7 2.2 0.4 0.1 0.4 0.0 0.2 0.3 0.1 0.8 1.2 0.4 0.4 0.0 0.3 0.0 0.4 0.3 0.6 0.5 0.5 0.6 4.6 0.3 0.3 0.9 0.5 0.0 0.5 0.0 0.0 1.3 0.9 0.0 0.3 0.1 1.6 0.3 0.1 0.8 0.0 0.5 3.7 0.0 2.9 0.1 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.5 1.0 0.2 1.4 1.8 2.1 0.5 0.7 0.2 0.0 0.4 0.8 0.1 0.0 0.3 0.3 0.0 0.6 0.0 1.4 0.3 0.2 1.3 0.3 0.0 0.0 0.2 0.0 2.2 14.9 1.7 3.0 4.2 4.3 0.5 3.5 24.4 1.6 EFCAB7 "KIAA1799, RP4-534K7.1" ENSG00000203965 "EF-hand calcium binding domain 7" A8K855 1 63523372-63572693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029611, HPA029612, HPA029613" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004" "unprognostic (8.81e-2)" "unprognostic (5.24e-2)" "unprognostic (5.13e-2)" "unprognostic (1.64e-1)" "prognostic favourable (3.65e-4)" "unprognostic (1.70e-2)" "unprognostic (6.53e-4)" "unprognostic (2.99e-1)" "unprognostic (5.81e-3)" "unprognostic (1.69e-1)" "unprognostic (6.28e-2)" "unprognostic (1.66e-1)" "unprognostic (3.78e-2)" "unprognostic (2.18e-1)" "unprognostic (6.97e-2)" "unprognostic (9.90e-2)" "unprognostic (2.73e-1)" 4.3 8.4 12.7 3.5 16.7 3.1 9.3 24.5 19.5 9.4 5.1 3.7 6.4 3.2 9.6 9.8 5.7 12.6 7.2 9.7 11.4 11.8 8.8 2.8 6.2 5.2 8.1 10.8 12.8 4.9 16.3 31.6 5.1 13.7 8.7 5.0 3.5 5.3 8.2 10.8 4.9 3.4 7.5 9.4 4.2 5.0 20.0 10.2 11.5 9.1 2.4 5.2 7.3 12.9 3.3 1.7 9.8 3.3 1.8 2.9 1.1 6.2 5.2 6.9 4.4 7.3 10.9 3.5 4.1 4.4 7.0 8.7 1.7 4.9 4.4 9.7 2.3 5.8 5.9 3.9 8.4 8.1 4.1 3.5 9.8 3.6 4.7 4.9 3.2 5.9 9.5 8.2 5.6 5.9 4.4 7.2 4.6 1.3 9.3 3.3 3.0 5.3 6.0 10.4 4.3 10.8 3.4 14.8 5.7 7.7 4.4 9.9 4.5 3.5 1.6 3.9 3.5 11.7 3.8 4.8 8.3 5.1 7.3 3.5 5.8 9.8 0.7 0.2 2.1 0.4 2.9 3.3 2.4 2.5 1.3 2.8 2.5 2.4 0.1 1.8 3.3 1.7 2.7 1.1 12.7 16.7 24.5 19.5 11.4 11.8 8.1 10.8 13.7 10.2 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.1;HEL: 5.3;HMC-1: 17.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034492, HPA057359" Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227, HPA057359: " "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 5.3 0.0 0.0 0.0 0.0 17.6 0.3 0.3 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.3 0.0 0.0 1.4 0.0 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 EIF2B2 "EIF-2Bbeta, EIF2B" ENSG00000119718 "Eukaryotic translation initiation factor 2B subunit beta" P49770 14 75002911-75012366 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005841, CAB037105, HPA048028" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB037105: AB_1840834, HPA005841: AB_1078725, HPA048028: " "unprognostic (1.10e-1)" "unprognostic (4.41e-2)" "unprognostic (5.70e-2)" "unprognostic (6.71e-2)" "unprognostic (7.64e-2)" "unprognostic (3.45e-3)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "prognostic favourable (2.95e-4)" "unprognostic (4.15e-2)" "unprognostic (2.74e-1)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" 11.8 20.1 11.6 9.2 12.3 9.1 11.6 11.0 16.4 13.2 13.9 13.2 9.2 9.8 11.6 15.8 14.3 10.4 12.6 15.0 11.5 12.0 19.6 18.8 10.3 11.6 13.6 11.4 12.3 12.9 32.3 11.9 20.4 15.7 13.6 12.2 11.7 11.1 14.8 29.0 12.5 13.1 11.0 14.8 12.1 10.9 20.1 11.0 17.7 33.4 11.2 12.7 14.9 9.7 4.2 5.1 7.7 3.9 6.5 8.1 4.8 5.0 6.1 5.0 5.7 5.8 4.8 6.6 3.3 5.4 6.4 7.4 7.7 5.2 4.5 2.1 5.1 3.9 7.7 7.6 9.6 2.7 5.8 3.9 5.4 5.3 7.5 2.9 4.7 4.4 7.3 8.1 8.4 21.8 3.5 4.4 13.6 14.9 4.6 3.6 3.6 9.1 2.9 5.9 3.7 9.0 6.1 5.4 4.3 3.4 4.9 7.2 7.9 2.8 5.6 4.9 4.8 2.2 4.1 7.6 6.2 5.3 5.4 3.7 3.7 7.7 3.9 2.8 6.7 3.9 5.6 4.2 5.9 5.4 5.1 4.1 4.4 4.6 2.2 6.5 3.7 4.2 8.1 4.8 11.6 12.3 11.0 16.4 11.5 12.0 13.6 11.4 15.7 11.0 EIF3A "EIF3, eIF3-p170, eIF3-theta, eIF3a, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 36.7 27.4 19.6 29.4 20.2 41.4 42.4 22.4 22.3 27.8 29.2 21.7 32.3 26.0 33.4 26.0 35.7 22.7 25.0 36.7 19.9 18.6 28.2 41.5 24.6 39.0 24.2 20.1 29.2 61.9 35.8 33.2 33.7 25.5 26.9 26.4 14.4 31.4 31.6 92.3 36.0 29.2 49.3 29.8 29.8 34.1 18.6 22.6 45.8 28.6 33.6 28.7 40.5 38.9 15.0 20.2 21.6 29.7 14.2 27.6 13.9 50.8 38.5 31.8 43.4 34.6 50.2 24.7 46.4 48.2 29.9 30.1 36.2 33.7 59.7 17.3 38.2 51.2 41.3 35.6 42.6 32.8 34.0 51.3 29.8 40.2 39.5 75.0 38.2 43.3 40.1 44.0 75.9 33.8 52.5 39.4 38.6 30.1 31.0 35.5 30.4 19.7 32.1 68.7 28.5 28.6 43.0 14.8 31.5 36.5 34.3 48.0 22.0 48.0 49.6 29.0 26.8 30.3 67.0 34.2 37.5 58.8 30.8 74.0 19.9 21.6 21.2 12.6 16.5 23.9 19.1 15.0 19.9 14.9 20.2 13.3 13.9 15.0 5.7 14.2 29.7 11.6 27.6 13.9 19.6 20.2 22.4 22.3 19.9 18.6 24.2 20.1 25.5 22.6 EIF3B "eIF3b, EIF3S9, PRT1" ENSG00000106263 "Eukaryotic translation initiation factor 3 subunit B" P55884 7 2354086-2380745 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017562, HPA048983" Approved Approved Nucleoplasm,Cytosol 22000 Nucleoplasm Cytosol "CAB017562: AB_2246341, HPA048983: " "unprognostic (1.50e-3)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (3.92e-2)" "unprognostic (9.45e-3)" "prognostic unfavourable (2.20e-4)" "prognostic unfavourable (4.41e-9)" "unprognostic (4.64e-3)" "unprognostic (3.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (3.47e-1)" "prognostic unfavourable (9.66e-6)" "unprognostic (2.38e-1)" "unprognostic (7.54e-2)" "unprognostic (9.00e-2)" "unprognostic (6.18e-3)" 27.5 27.3 16.5 28.9 21.8 38.7 28.8 20.0 26.2 23.5 33.3 22.4 25.7 20.3 29.6 24.1 38.8 28.6 26.2 32.1 15.8 16.5 24.3 51.4 21.7 29.6 22.2 19.4 31.2 66.6 24.2 20.3 34.6 21.1 26.0 24.0 18.0 34.1 24.2 72.3 39.8 23.9 33.0 16.5 31.6 29.7 45.2 19.0 44.9 23.1 34.3 35.9 32.9 29.7 6.5 8.0 3.7 7.3 16.5 9.5 4.4 85.0 43.5 18.0 48.8 20.4 18.5 44.7 29.9 22.5 34.1 32.0 56.8 33.3 49.7 24.7 31.7 46.4 49.6 39.4 37.7 14.8 58.2 37.8 42.2 38.3 28.8 46.0 28.1 23.0 26.0 36.9 38.9 27.4 96.1 23.2 31.1 60.4 22.2 51.8 56.3 39.2 27.4 36.5 51.2 21.8 39.0 41.2 30.8 31.6 70.5 17.1 46.9 51.1 28.9 26.4 58.3 40.4 54.0 25.6 34.4 50.4 29.9 51.7 64.4 1.8 7.3 3.7 7.6 6.8 9.5 6.3 7.4 8.4 7.8 6.5 8.8 8.9 0.6 16.5 5.8 8.0 8.7 4.4 16.5 21.8 20.0 26.2 15.8 16.5 22.2 19.4 21.1 19.0 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli 22000000 Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favourable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 30.9 18.4 17.4 17.5 19.8 26.4 55.1 34.4 19.3 40.7 29.1 16.1 16.7 20.8 36.1 18.9 33.4 24.2 14.0 15.5 15.0 15.6 23.7 36.1 18.4 31.3 14.0 13.4 63.4 78.8 20.2 26.8 27.9 17.7 38.7 23.8 21.5 39.6 31.0 40.3 30.6 25.2 35.8 15.6 24.7 22.7 19.6 11.4 44.0 54.8 32.3 31.0 38.6 22.0 33.6 58.1 9.8 35.9 25.0 42.5 55.2 16.8 9.6 27.1 19.6 26.2 58.7 19.5 16.2 39.0 26.1 35.8 15.9 12.5 58.1 4.5 18.9 10.8 29.8 22.4 30.8 7.6 49.7 20.5 14.0 7.5 16.4 54.3 17.6 31.6 25.6 19.3 29.2 32.4 17.0 15.9 30.2 6.6 14.4 25.2 15.4 25.3 16.6 37.2 17.0 19.9 10.2 19.7 30.6 16.0 18.8 21.8 14.3 21.9 15.6 16.3 19.8 9.9 12.9 9.5 15.5 23.7 15.3 24.1 13.3 9.8 35.9 9.6 20.7 35.4 34.6 33.6 30.0 25.0 58.1 27.5 42.5 31.8 4.8 25.0 29.1 28.4 29.1 55.2 17.4 19.8 34.4 19.3 15.0 15.6 14.0 13.4 17.7 11.4 EIF4EBP2 ENSG00000148730 "Eukaryotic translation initiation factor 4E binding protein 2" Q13542 10 70404379-70428618 "Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019415, HPA037410, HPA061665" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "CAB019415: AB_10699019, HPA037410: , HPA061665: " "unprognostic (9.57e-2)" "unprognostic (3.22e-2)" "unprognostic (2.27e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-1)" "unprognostic (3.51e-1)" "unprognostic (3.84e-1)" "unprognostic (7.24e-2)" "unprognostic (8.24e-2)" "unprognostic (8.19e-2)" "unprognostic (2.87e-1)" "unprognostic (1.46e-1)" "prognostic favourable (6.69e-6)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.53e-1)" "unprognostic (4.61e-2)" 57.3 27.2 22.1 28.2 21.8 20.2 77.1 22.7 23.0 28.7 47.9 16.7 25.9 30.8 24.8 18.3 28.3 22.7 37.9 52.4 18.0 15.8 44.4 40.1 31.8 21.6 19.0 14.7 33.4 28.4 23.2 13.3 36.2 18.6 33.2 31.6 34.8 25.5 50.2 54.5 27.6 51.2 32.4 17.8 30.5 28.7 17.9 16.2 34.8 23.5 29.2 22.1 39.8 64.3 7.0 14.0 20.6 17.5 9.3 14.2 14.2 16.8 5.6 30.1 29.4 58.4 22.2 16.3 10.3 12.9 7.7 8.4 24.1 15.2 17.6 6.3 15.2 11.0 14.7 9.6 8.8 18.7 7.6 12.7 6.7 9.5 13.7 22.5 9.0 24.7 9.9 9.4 8.6 11.7 20.6 16.2 11.9 9.7 19.1 23.2 25.3 10.1 19.8 12.1 11.4 9.9 17.6 16.4 24.7 14.3 32.9 13.6 15.0 20.1 12.7 5.0 6.3 8.2 9.2 10.8 21.2 20.8 5.8 33.7 5.1 13.8 15.5 20.6 14.2 13.8 11.6 7.0 11.5 11.7 14.0 6.1 9.8 10.1 17.0 9.3 17.5 4.7 12.5 14.2 22.1 21.8 22.7 23.0 18.0 15.8 19.0 14.7 18.6 16.2 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174245-74197101 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 520000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavourable (3.89e-4)" "prognostic unfavourable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 46.8 42.7 47.6 37.6 52.8 82.3 42.8 56.0 89.5 39.8 44.5 46.6 36.2 43.1 48.1 37.9 58.6 44.4 40.7 47.4 45.6 41.4 34.5 50.7 37.4 42.8 45.4 54.6 54.2 74.3 54.3 30.1 72.2 47.6 44.8 35.1 35.6 60.3 45.4 89.6 53.0 41.5 43.4 59.9 34.6 45.4 52.5 32.1 46.8 43.5 57.9 44.2 43.4 41.4 38.4 57.6 60.2 64.2 46.7 52.0 80.6 86.2 57.5 43.9 53.2 39.1 41.7 49.9 61.7 46.9 51.1 50.3 70.4 66.5 74.1 16.9 56.9 45.8 48.3 82.0 48.4 49.8 56.6 41.3 54.0 56.5 44.8 69.6 41.7 48.7 52.1 56.7 80.8 55.9 72.5 32.2 52.3 73.6 54.9 82.6 58.5 56.9 64.4 58.8 66.9 42.5 55.2 44.6 56.4 57.5 72.7 48.9 82.2 45.1 58.2 73.3 49.8 61.2 77.5 38.3 45.7 126.5 57.3 73.1 75.2 45.7 58.4 60.2 43.5 64.2 44.9 38.4 44.7 43.0 57.6 35.3 52.0 42.4 39.0 46.7 63.6 24.4 47.6 80.6 47.6 52.8 56.0 89.5 45.6 41.4 45.4 54.6 47.6 32.1 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 30.7;testis: 45.3" "Cell line enhanced" "Detected in some" "A-431: 9.9;AF22: 15.2;SCLC-21H: 51.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB022222: , HPA063001: " "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 1.0 2.4 8.7 1.0 13.4 1.4 1.1 18.3 27.5 1.0 1.3 0.7 0.0 1.0 1.5 1.4 1.1 1.0 1.1 1.0 8.1 19.2 1.4 0.8 1.1 1.0 16.3 18.9 2.1 0.8 1.2 2.5 0.9 30.7 1.2 1.5 0.5 1.0 1.0 1.0 1.5 1.1 1.1 5.0 1.0 1.0 45.3 1.1 0.0 1.2 0.0 1.0 1.6 0.3 1.8 1.1 5.1 0.9 1.4 1.3 0.1 9.9 0.1 15.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 4.1 6.4 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.9 0.0 4.6 0.1 0.3 0.5 2.1 0.0 0.0 0.0 4.0 4.8 0.0 5.5 0.0 0.0 0.0 51.0 4.8 0.1 0.1 0.1 0.2 0.7 0.0 0.1 3.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 2.7 0.9 1.6 0.5 0.6 0.6 1.0 0.5 0.4 0.4 1.8 1.1 1.3 5.1 1.4 0.5 1.1 0.6 0.1 8.7 13.4 18.3 27.5 8.1 19.2 16.3 18.9 30.7 1.1 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50048014-50203786 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1" "Cell line enriched" "Detected in some" 19 "SH-SY5Y: 52.5" "Group enriched" "Detected in some" 10 "glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 5 "monocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: " "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.9 11.4 11.5 3.3 12.8 0.8 1.0 11.6 43.1 0.9 3.0 0.9 0.0 2.3 0.9 0.8 1.1 0.9 1.0 1.0 12.3 16.5 0.9 1.0 1.0 0.9 10.6 30.7 0.8 2.8 0.8 7.1 0.9 37.0 1.0 3.8 0.0 0.9 0.9 0.8 1.2 3.1 2.0 8.5 1.0 1.9 7.8 1.4 0.1 0.8 0.0 1.0 0.9 0.5 0.0 0.6 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.6 0.0 0.0 11.5 12.8 11.6 40.4 12.3 16.5 10.6 30.7 37.0 1.4 ELF4 "ELFR, MEF" ENSG00000102034 "E74 like ETS transcription factor 4" Q99607 X 130064874-130110716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058595, HPA060277" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA058595: , HPA060277: " "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (3.83e-1)" "unprognostic (2.13e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (4.43e-3)" "unprognostic (7.86e-3)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.29e-2)" "unprognostic (3.95e-1)" "prognostic unfavourable (6.49e-6)" "unprognostic (1.43e-1)" "unprognostic (5.46e-2)" "unprognostic (2.51e-1)" "prognostic favourable (1.42e-4)" 16.9 3.6 2.0 18.1 2.5 27.6 16.9 0.5 3.0 7.7 10.8 3.1 7.0 8.4 10.5 8.1 10.5 9.5 11.0 7.3 3.1 1.2 5.9 2.5 21.9 33.3 3.8 0.9 12.7 4.5 3.8 4.2 23.5 3.0 6.6 10.9 3.6 5.4 7.9 5.7 9.1 16.3 6.4 4.2 18.9 12.3 3.5 2.9 18.1 3.9 7.4 11.5 11.7 14.4 3.9 6.1 9.4 10.3 8.4 10.3 5.1 22.5 8.4 1.5 0.1 3.9 8.4 22.0 10.5 13.4 12.8 14.2 11.6 16.1 11.6 21.1 14.2 14.7 8.4 12.4 12.6 12.4 7.0 22.7 11.2 5.4 8.7 19.8 29.1 8.7 13.9 20.5 20.3 12.3 8.7 3.2 6.9 13.1 3.2 11.3 1.0 8.3 7.0 2.7 4.9 7.8 26.1 5.8 2.5 9.4 9.1 2.9 4.5 19.1 11.4 9.0 7.1 16.7 19.4 1.7 0.7 9.3 10.6 18.2 2.0 1.6 5.4 7.8 10.3 10.3 8.3 3.9 6.2 8.8 6.1 3.5 6.2 7.2 9.4 8.4 7.0 3.7 6.3 5.1 2.0 2.5 0.5 3.0 3.1 1.2 3.8 0.9 3.0 2.9 ELF5 ENSG00000135374 "E74 like ETS transcription factor 5" Q9UKW6 11 34478793-34513805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9" "Group enriched" "Detected in some" 8 "RT4: 17.4;T-47d: 33.4" "Cancer enhanced" "Detected in many" "breast cancer: 8.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062706 Approved Nucleoplasm Nucleoplasm "HPA062706: " "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (7.55e-2)" "unprognostic (3.31e-2)" "unprognostic (2.41e-4)" "unprognostic (6.90e-2)" "unprognostic (3.93e-1)" "prognostic favourable (3.64e-4)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (8.15e-2)" "unprognostic (3.15e-2)" "unprognostic (1.78e-3)" "unprognostic (3.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.86e-1)" 0.1 0.0 0.0 0.0 0.1 0.0 48.8 0.0 0.0 0.5 0.0 0.0 72.2 0.6 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 6.5 0.0 2.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.8 0.0 1.4 0.0 0.0 85.1 86.9 0.0 3.5 0.0 1.0 0.0 0.3 0.1 0.1 0.0 0.2 0.0 3.5 1.0 5.8 1.2 0.5 0.5 2.0 1.8 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 17.4 0.0 0.0 0.0 3.0 0.0 33.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.0 0.3 0.2 0.5 1.8 0.3 0.2 0.3 0.4 0.3 0.5 0.4 0.4 0.9 0.7 1.8 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell line enhanced" "Detected in some" "REH: 19.1;U-138 MG: 12.0;U-2 OS: 17.6;U-2197: 20.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066382 Approved "Nucleoplasm,Cell Junctions" 11000 "Nucleoplasm, Cell Junctions" "HPA066382: " "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favourable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 2.9 6.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.5 0.0 2.8 1.2 0.7 19.1 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.0 0.2 0.0 12.0 17.6 20.5 0.0 0.0 0.2 5.1 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavourable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 3.9 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.2 7.9 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.1 0.4 0.0 18.6 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.6;RH-30: 26.5" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.4 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.3 0.4 0.0 1.8 0.1 0.0 0.0 1.2 0.1 0.0 0.4 0.1 0.0 0.0 11.6 0.0 0.1 0.8 0.0 0.0 0.1 0.5 1.7 0.0 26.5 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.6 0.1 0.0 0.0 3.5 0.0 2.0 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA047600: " "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favourable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.5 7.3 14.9 11.4 15.7 18.1 9.6 15.5 14.8 8.6 10.4 7.1 14.0 10.7 6.9 9.7 6.0 14.1 9.8 10.7 10.4 8.4 8.8 5.8 9.3 14.2 13.4 7.8 12.4 16.4 7.3 7.6 9.4 11.3 17.7 14.8 4.8 14.5 4.6 7.9 6.0 17.1 11.5 6.9 12.5 10.5 7.1 26.4 10.2 10.4 11.1 10.2 5.6 9.4 19.9 7.2 9.3 16.0 18.6 26.4 13.6 14.5 10.6 15.0 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 ELMOD3 "DFNB88, FLJ21977, RBED1, RBM29" ENSG00000115459 "ELMO domain containing 3" Q96FG2 2 85354394-85391752 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012126 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA012126: AB_1848130" "unprognostic (1.90e-1)" "unprognostic (9.80e-3)" "unprognostic (1.42e-3)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (1.60e-2)" "unprognostic (1.35e-2)" "unprognostic (1.52e-2)" "unprognostic (4.62e-2)" "unprognostic (5.63e-2)" "prognostic favourable (6.16e-6)" "unprognostic (1.34e-1)" "prognostic unfavourable (1.09e-6)" "unprognostic (5.71e-2)" "unprognostic (1.53e-1)" "unprognostic (9.51e-2)" "prognostic favourable (2.85e-5)" 18.5 14.5 11.0 10.5 17.4 4.9 15.0 15.4 14.7 13.4 12.0 18.4 18.6 9.5 12.7 11.6 8.7 13.8 11.5 9.2 13.2 8.6 10.7 14.4 8.4 9.0 20.2 8.8 12.0 11.4 14.4 15.6 11.7 14.2 13.7 9.7 13.0 11.6 14.5 18.8 9.7 10.6 13.4 11.1 11.1 12.1 12.3 17.4 7.6 13.0 6.8 10.2 11.9 10.7 4.5 4.5 10.8 6.6 6.1 7.6 3.9 4.0 5.2 6.0 8.8 18.7 8.4 3.5 7.5 5.8 11.2 10.3 4.3 2.1 3.2 5.8 6.0 4.3 8.3 10.3 10.2 11.0 5.8 5.4 2.9 3.0 9.8 4.1 7.2 8.6 9.2 10.6 12.2 7.9 5.5 3.7 10.3 3.1 6.0 2.4 2.8 5.5 4.3 12.2 2.9 5.1 2.5 5.6 2.9 4.6 6.4 6.9 3.5 3.1 4.4 8.0 4.3 6.9 6.8 4.7 8.3 4.2 8.0 4.8 8.1 9.1 3.9 10.8 7.6 2.6 4.0 4.5 4.9 3.0 4.5 4.1 4.2 7.3 3.5 6.1 6.6 1.2 7.3 3.9 11.0 17.4 15.4 14.7 13.2 8.6 20.2 8.8 14.2 17.4 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513761 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: " "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favourable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 10.8 25.9 15.6 16.3 18.5 8.8 15.3 23.2 24.6 12.8 13.3 22.7 19.0 13.3 17.5 22.1 14.2 16.0 13.3 17.0 16.3 15.7 16.4 18.7 11.6 17.5 16.7 21.8 20.8 18.8 16.6 18.8 12.9 19.9 18.1 13.0 18.5 14.8 17.5 23.6 14.7 11.7 16.4 18.6 14.9 13.9 24.9 13.6 23.7 17.8 13.7 17.8 15.5 11.9 20.4 19.5 10.4 12.0 18.4 21.3 14.2 16.7 15.9 21.3 21.5 17.1 15.8 12.1 20.3 14.1 26.0 23.6 15.5 17.8 31.6 12.7 17.5 10.4 20.6 29.6 15.9 17.6 16.0 28.6 24.6 17.2 18.8 21.6 17.8 17.1 16.0 29.6 18.9 22.3 29.9 9.9 25.8 18.5 25.8 24.5 25.5 27.3 12.9 10.3 19.3 18.2 14.9 19.0 18.5 17.3 14.0 10.5 19.1 17.5 14.5 26.6 19.0 13.8 25.3 20.9 27.4 29.0 13.8 26.4 27.1 10.4 12.0 8.4 19.5 11.0 15.1 18.7 18.3 19.5 15.0 20.4 17.3 17.4 1.7 18.4 7.6 19.5 21.3 14.2 15.6 18.5 23.2 24.6 16.3 15.7 16.7 21.8 19.9 13.6 EMC6 "MGC2963, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668815-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA062681: " "unprognostic (2.21e-1)" "prognostic unfavourable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavourable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 14.6 18.5 15.5 12.2 15.5 21.4 12.5 9.9 21.2 8.9 15.9 14.9 10.0 16.9 9.8 10.8 15.6 9.5 12.1 26.2 14.5 12.3 19.8 42.1 10.2 10.7 14.2 11.0 8.7 24.5 7.6 9.3 16.6 12.2 12.9 9.7 14.6 17.8 10.5 100.1 10.6 16.8 10.1 13.6 12.5 18.8 27.4 11.1 14.3 14.9 31.5 14.3 9.7 9.1 34.5 56.1 40.7 42.0 25.2 43.4 38.5 30.6 30.2 13.2 13.8 9.5 7.7 25.5 22.0 10.8 18.1 16.7 18.2 11.5 19.3 32.1 10.2 29.6 15.3 15.5 13.1 18.6 57.1 14.0 21.2 25.3 13.8 9.7 14.4 9.6 17.7 16.6 11.7 13.7 17.5 14.0 13.2 18.6 19.8 28.6 19.0 34.1 18.5 12.3 18.3 25.3 8.7 10.9 19.8 18.1 14.2 23.4 16.5 10.5 15.0 15.2 18.9 22.9 32.2 13.7 15.1 12.7 23.8 12.7 18.2 34.5 42.0 40.7 34.9 39.7 32.0 34.5 39.0 38.3 35.8 32.3 40.6 36.7 31.6 25.2 27.9 56.1 43.4 38.5 15.5 15.5 9.9 21.2 14.5 12.3 14.2 11.0 12.2 11.1 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101948 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010029, HPA047572" Approved Approved Nucleoplasm Nucleoplasm "HPA010029: AB_1078335, HPA047572: " "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favourable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavourable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 31.2 45.1 36.8 22.4 41.6 31.8 29.7 22.5 36.8 25.1 30.1 30.9 38.2 25.1 27.1 53.1 25.0 23.0 24.5 36.5 34.0 45.3 52.5 62.3 26.5 24.4 44.0 38.7 24.1 46.7 35.5 33.5 57.6 35.2 31.8 32.3 29.8 29.6 46.0 44.8 28.2 28.1 29.0 42.2 28.5 28.5 39.3 30.8 18.8 35.3 26.7 21.8 26.3 26.2 37.8 68.8 66.6 54.7 32.6 53.7 49.1 14.1 39.1 14.2 18.1 55.7 31.9 15.0 40.7 42.5 38.2 39.6 35.6 17.1 8.4 42.3 39.7 27.6 20.6 20.5 28.6 20.6 20.5 20.8 58.5 30.3 51.0 20.9 29.7 35.2 39.1 27.2 39.6 24.0 20.3 56.3 36.7 16.4 11.5 23.8 12.7 26.0 14.6 16.5 29.1 40.1 25.2 23.3 17.2 24.2 32.8 20.1 23.8 33.8 20.0 40.9 15.9 27.0 30.3 38.1 46.0 18.8 41.3 32.0 33.1 66.6 47.3 49.0 42.7 51.0 41.6 37.8 42.9 43.4 43.1 28.9 31.6 39.0 41.3 32.6 54.7 68.8 53.7 49.1 36.8 41.6 22.5 36.8 34.0 45.3 44.0 38.7 35.2 30.8 EMG1 ENSG00000126749 "EMG1, N1-specific pseudouridine methyltransferase" Q92979 12 6970893-6979941 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA039304, HPA039666" Supported Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA039304: , HPA039666: AB_10672891" "unprognostic (1.23e-1)" "unprognostic (1.17e-1)" "unprognostic (6.77e-2)" "unprognostic (1.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "prognostic unfavourable (3.69e-4)" "unprognostic (2.70e-1)" "unprognostic (1.03e-1)" "unprognostic (2.12e-1)" "unprognostic (9.03e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (2.83e-6)" "unprognostic (2.13e-1)" "unprognostic (2.34e-1)" "unprognostic (6.75e-2)" "unprognostic (1.62e-1)" 8.1 10.1 4.9 12.4 6.6 7.3 8.8 3.6 6.3 5.8 7.5 4.8 11.5 7.5 6.9 9.9 8.1 5.8 7.4 11.6 5.0 7.2 8.3 6.4 8.8 6.4 4.2 8.9 9.4 2.7 5.6 12.6 6.2 7.2 6.8 5.1 8.6 11.4 14.9 5.6 6.7 6.3 5.5 7.7 6.0 4.8 6.1 9.0 8.7 9.5 10.8 7.5 8.7 33.3 20.5 7.7 29.6 20.8 30.1 28.5 16.8 16.8 6.5 8.0 5.1 3.7 27.1 12.6 5.6 10.0 6.8 33.0 18.1 17.0 4.7 7.7 12.4 5.9 14.4 11.3 12.3 9.6 23.6 16.6 30.4 6.6 23.9 15.3 6.0 8.6 14.5 16.6 4.3 11.6 3.8 9.4 19.9 12.4 14.7 53.9 8.8 17.2 13.2 13.5 6.3 21.4 3.8 11.4 13.2 13.9 12.0 3.8 17.8 9.1 10.5 13.6 8.5 28.5 4.6 5.2 29.6 11.2 10.4 16.6 4.4 16.6 7.7 24.0 23.8 24.8 30.7 25.5 26.3 18.8 33.3 30.1 27.7 2.3 20.8 29.6 20.5 24.1 28.5 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196716-13219939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 240.9;lymphoid tissue: 129.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 129.3;fHDF/TERT166: 89.9;HaCaT: 80.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 28.6" "Cell type enriched" "Detected in some" 7 "myeloid DC: 7.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051931, HPA056250" Approved Nucleoplasm Nucleoplasm "HPA051931: , HPA056250: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavourable (2.26e-8)" "prognostic unfavourable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavourable (9.69e-8)" 63.3 5.0 2.7 8.0 10.4 2.1 20.8 0.8 3.9 51.3 11.6 5.5 4.0 4.6 14.0 10.4 240.9 9.9 25.2 16.1 7.3 2.8 8.9 4.4 18.1 5.9 5.3 0.9 5.7 10.2 2.9 2.8 10.6 28.6 6.3 6.9 17.8 45.4 2.8 12.0 16.8 10.7 17.6 9.7 8.5 6.0 5.2 3.0 0.6 22.5 99.1 129.3 14.1 80.6 0.0 7.0 0.0 0.5 0.1 0.1 0.0 38.1 2.0 0.9 0.2 61.8 129.3 0.1 28.3 51.9 14.6 18.7 0.2 64.6 0.2 20.2 89.9 80.4 1.1 3.7 19.8 0.7 0.0 0.1 6.7 0.0 14.9 0.2 0.2 40.5 5.4 46.4 13.6 33.3 0.2 0.6 34.3 0.1 0.0 0.8 0.7 6.5 0.1 3.9 0.3 42.6 0.4 0.0 0.0 12.6 1.8 21.0 0.3 0.2 36.5 32.8 11.5 30.8 15.2 0.1 0.4 0.2 47.8 0.2 38.5 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.7 10.4 0.8 3.9 7.3 2.8 5.3 0.9 28.6 3.0 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Cell line enhanced" "Detected in many" "MCF7: 58.3;RT4: 40.1;SK-BR-3: 57.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014711 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA014711: AB_1848147" "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavourable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavourable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.2 8.6 3.6 4.2 8.1 7.0 7.1 8.9 8.2 5.4 8.2 28.2 21.9 0.0 2.8 10.6 27.8 9.2 11.0 7.1 0.0 5.8 0.0 18.1 15.4 1.4 0.0 0.0 4.2 2.9 7.2 0.7 2.2 2.0 0.5 14.9 58.3 0.1 0.1 4.1 2.1 1.6 4.1 13.6 1.2 40.1 5.0 5.7 11.0 57.6 3.3 35.2 1.3 1.2 17.3 7.5 5.7 4.9 0.1 0.2 0.0 7.6 0.1 16.9 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542444-117549546 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3" "Cell line enhanced" "Detected in some" "EFO-21: 16.8;fHDF/TERT166: 18.6;RPTEC TERT1: 18.7;RT4: 5.9" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm Nucleoplasm "HPA003497: , HPA065294: " "unprognostic (1.53e-1)" "prognostic favourable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favourable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 4.6 0.5 11.5 0.6 10.3 0.5 1.4 0.5 12.5 23.5 0.7 7.3 46.8 0.5 40.5 53.9 0.7 25.4 1.2 0.6 14.7 2.1 25.5 0.5 0.5 0.7 1.8 10.4 5.7 0.5 0.6 1.1 0.6 2.5 1.9 0.5 3.4 1.3 76.3 5.1 4.7 0.5 22.6 0.6 0.5 0.5 3.6 6.2 0.0 0.5 1.2 0.7 4.2 2.4 0.7 0.5 2.4 0.9 1.0 0.7 0.1 0.0 0.0 0.0 1.8 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 16.8 18.6 0.1 0.4 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.1 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.1 18.7 5.9 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.4 0.7 0.6 0.5 1.1 1.0 0.9 0.5 0.6 0.1 11.5 10.3 0.5 12.5 14.7 2.1 1.8 10.4 2.5 6.2 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell line enhanced" "Detected in some" "HaCaT: 2.6;MCF7: 8.2;T-47d: 5.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: " "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.4 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.0 2.6 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.7 8.2 0.0 0.0 1.4 0.2 0.0 0.0 0.0 1.1 0.6 0.9 0.0 2.1 0.1 0.0 5.1 0.0 0.5 0.0 0.7 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430562-82461091 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" 140000 Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavourable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 10.2 15.4 43.4 12.1 37.1 14.3 16.3 22.9 38.8 13.8 12.7 34.7 5.1 12.2 10.5 23.3 13.5 10.4 9.0 11.1 44.2 34.9 20.8 13.3 11.1 16.0 47.5 26.4 12.9 14.6 17.8 11.7 17.7 31.0 17.2 15.3 8.9 11.4 11.9 9.8 13.1 11.0 11.1 66.2 12.8 13.2 6.1 29.4 14.2 18.0 8.2 18.6 10.7 9.5 13.0 14.1 4.3 10.4 14.4 20.2 12.2 18.8 12.5 22.4 13.9 13.7 13.5 24.6 22.0 14.7 20.1 18.0 22.7 21.1 37.5 23.1 16.6 10.2 29.6 27.8 36.4 22.6 13.8 22.7 12.2 30.2 22.3 37.6 19.7 13.0 29.6 21.0 24.9 20.3 29.3 20.7 26.2 24.3 41.4 22.4 20.6 10.1 29.6 34.4 20.4 32.8 18.7 31.8 19.4 12.5 37.8 27.9 17.1 18.2 14.9 25.0 18.5 24.7 28.9 23.8 20.4 46.8 16.1 23.4 33.5 3.4 8.7 4.3 14.4 10.4 18.0 13.0 17.3 16.5 12.7 11.0 20.2 16.2 0.7 14.4 8.8 14.1 18.4 12.2 43.4 37.1 22.9 38.4 44.2 34.9 47.5 26.4 31.0 29.4 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell line enhanced" "Detected in some" "AF22: 24.7;ASC diff: 33.8;ASC TERT1: 72.2;BJ hTERT+: 41.5;fHDF/TERT166: 26.8;HSkMC: 33.1" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: " "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favourable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 24.7 0.0 33.8 72.2 0.0 22.7 41.5 9.8 9.4 0.0 0.0 0.0 0.3 26.8 0.0 0.5 0.0 6.9 1.8 0.7 0.0 0.0 0.6 15.1 0.0 0.1 33.1 0.2 20.0 1.0 0.1 0.0 4.0 0.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.4 23.9 0.1 0.2 0.0 0.0 16.8 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.8;HSkMC: 7.9;T-47d: 9.3;U-266/70: 5.8;U-266/84: 8.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favourable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favourable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favourable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.8 1.9 3.9 0.3 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.5 2.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 9.3 0.0 0.0 0.0 1.4 0.0 0.1 5.8 8.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "U-698: 419.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol 22000 "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: " "unprognostic (6.27e-2)" "prognostic favourable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 30.3 26.4 48.9 26.9 48.9 46.8 33.0 33.8 69.3 31.7 31.8 28.0 26.8 34.4 29.7 45.4 66.3 26.3 28.5 30.0 42.4 37.9 31.7 32.3 28.6 30.0 42.0 39.0 27.7 30.5 33.0 25.2 37.5 34.6 23.9 30.4 28.5 29.4 22.8 67.7 49.8 34.0 27.3 38.3 23.8 28.7 12.8 27.3 25.8 35.2 42.9 35.5 31.7 36.3 34.4 39.5 49.5 33.6 33.0 33.2 38.4 14.3 7.6 10.5 10.1 6.7 5.6 11.4 6.5 6.6 9.7 8.2 8.5 10.9 12.9 10.8 5.2 11.6 8.5 14.4 7.2 22.3 11.9 18.5 10.7 6.4 4.5 14.9 23.9 4.4 8.9 10.0 12.8 9.1 14.1 27.2 6.5 31.1 14.6 12.1 21.1 9.3 14.3 8.7 16.1 12.7 12.6 15.8 10.0 9.2 19.4 10.0 26.5 21.9 9.6 7.2 13.4 8.6 16.7 15.3 22.2 419.6 10.0 17.3 9.5 28.7 30.7 49.5 32.2 33.6 28.9 34.4 27.0 33.2 39.5 31.8 22.3 32.9 29.0 33.0 31.9 30.2 29.8 38.4 48.9 48.9 33.8 69.3 42.4 37.9 42.0 39.0 34.6 27.3 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659506-99706240 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm 24000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 3.1 5.6 2.2 5.1 2.1 6.4 2.7 2.4 3.3 4.4 15.7 1.3 11.3 18.6 3.9 5.7 9.1 3.1 9.1 3.2 2.0 1.7 6.0 14.5 4.2 7.1 1.4 1.9 3.2 23.9 3.6 8.6 8.5 1.5 5.6 4.9 3.4 9.0 13.2 1.6 4.4 46.1 5.6 1.4 5.4 5.1 3.5 0.5 2.5 3.5 6.0 6.3 11.4 5.0 0.9 7.7 3.7 2.2 2.7 2.2 1.3 5.1 6.0 8.0 14.7 4.0 4.0 9.6 9.8 20.5 12.8 10.8 10.9 5.9 4.5 5.7 13.2 13.8 6.7 4.0 10.5 1.9 5.3 3.3 4.7 10.0 5.9 11.9 7.8 3.7 6.8 16.1 15.3 12.9 6.4 4.4 5.1 4.6 2.4 2.5 4.7 2.6 0.0 6.1 2.4 14.0 16.9 3.3 6.3 6.8 2.6 8.6 7.1 6.1 8.1 11.1 7.1 7.1 8.2 4.5 7.4 4.1 10.8 3.6 3.0 0.3 2.2 3.7 2.2 2.2 2.0 0.9 0.8 1.8 5.0 0.3 1.4 0.9 2.0 2.7 1.2 7.7 0.6 1.3 2.2 2.1 2.4 3.3 2.0 1.7 1.4 1.9 1.5 0.5 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favourable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.6 0.0 0.2 0.1 0.4 0.0 0.0 8.7 1.4 0.0 0.3 0.9 0.2 0.0 0.1 4.7 0.2 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2, transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345953 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavourable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 31.9 35.0 28.7 28.1 34.3 44.4 34.8 20.6 31.4 28.2 34.5 18.7 28.3 31.8 24.6 33.8 30.1 22.9 19.1 34.0 31.8 26.2 44.1 58.8 24.7 26.6 27.6 28.3 19.6 27.8 16.5 35.8 30.6 29.1 24.0 33.7 19.9 27.2 25.9 66.7 20.3 31.6 28.4 31.9 30.6 29.0 21.3 24.3 26.1 24.3 29.5 30.3 29.6 23.3 14.0 32.1 30.3 38.9 13.0 14.6 22.6 42.1 35.3 52.5 23.6 20.0 25.7 15.1 33.7 21.8 34.6 43.8 26.1 26.3 27.5 31.7 26.2 21.6 23.5 23.9 42.3 43.5 27.8 52.7 26.5 53.6 21.4 18.1 32.9 19.4 16.4 22.8 21.6 52.0 50.1 15.5 39.3 68.7 54.7 41.2 38.1 34.5 34.9 22.8 34.0 46.7 32.4 31.7 34.2 21.1 26.6 28.8 33.8 31.4 35.3 23.3 39.3 24.0 34.1 26.6 28.3 52.0 23.5 30.6 27.1 16.3 35.6 30.3 10.7 37.1 13.2 14.0 14.6 13.0 32.1 9.6 12.1 13.3 19.4 13.0 38.9 26.5 14.2 22.6 28.7 34.3 20.6 31.4 31.8 26.2 27.6 28.3 29.1 24.3 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975214-69013961 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavourable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 14.9 5.8 3.4 10.1 4.4 3.0 11.9 2.5 4.8 16.8 12.1 4.4 10.2 4.8 23.3 10.4 15.1 11.4 18.1 18.2 3.9 3.6 6.6 5.5 15.8 9.6 4.2 5.0 12.7 7.8 3.9 5.5 15.2 5.1 18.9 5.8 8.7 14.0 24.0 28.0 6.1 7.7 29.4 4.9 10.2 10.1 7.4 2.4 8.3 5.4 14.2 7.3 27.0 9.8 1.7 3.4 5.5 2.2 3.3 9.2 1.8 8.1 2.7 5.4 6.5 7.6 14.9 3.9 11.0 13.5 7.0 9.3 3.7 4.6 0.4 1.7 11.9 2.7 3.7 14.3 8.8 26.3 2.6 8.4 6.2 5.2 8.4 4.7 3.5 12.4 12.2 9.0 11.5 38.4 2.3 5.0 23.4 2.1 0.7 1.5 6.2 1.3 0.3 5.6 3.5 6.0 18.7 0.5 3.0 12.6 1.0 10.0 2.8 6.5 20.3 19.7 6.0 2.2 10.6 2.5 8.3 4.0 7.8 7.3 11.0 5.5 2.2 0.0 3.0 1.9 3.5 1.7 4.8 6.4 3.4 1.2 4.1 4.1 0.3 3.3 0.7 0.6 9.2 1.8 3.4 4.4 2.5 4.8 3.9 3.6 4.2 5.0 5.1 2.4 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 19.6;HeLa: 22.2;RT4: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favourable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 21.4 3.7 3.5 5.0 4.0 2.1 19.0 2.1 6.1 7.3 3.0 1.7 22.1 1.9 6.1 11.3 13.6 6.2 11.7 9.3 4.0 3.1 10.0 4.8 21.9 6.9 3.7 2.0 4.9 4.2 14.3 4.3 8.9 3.7 5.3 3.8 10.5 7.7 22.0 6.8 7.2 3.2 5.9 4.3 6.7 4.3 4.8 1.9 2.1 15.7 8.2 6.9 5.5 12.2 3.6 0.5 1.3 1.2 0.4 4.8 0.9 0.5 3.4 9.1 0.9 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.8 7.7 3.8 19.6 0.0 4.6 0.6 4.3 0.0 0.6 3.2 6.0 22.2 1.2 0.1 1.6 2.0 0.0 1.9 0.0 0.0 5.7 1.1 3.5 0.0 1.1 2.7 2.1 1.7 0.6 1.4 6.9 0.8 5.3 13.4 7.6 3.9 6.7 3.3 2.6 10.0 0.8 9.8 0.4 1.5 1.2 2.7 3.5 0.7 2.9 0.9 3.2 0.5 1.3 0.4 0.2 4.8 0.6 2.7 3.6 1.5 1.4 0.5 3.3 2.4 4.7 0.5 0.4 1.2 0.3 1.4 0.9 3.5 4.0 2.1 3.9 4.0 3.1 3.7 2.0 3.7 1.9 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Group enriched" "Detected in some" 6 "hTCEpi: 61.2;U-2197: 27.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavourable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.1 0.0 61.2 1.0 4.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 1.1 0.0 0.1 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Cell line enriched" "Detected in some" 6 "AF22: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavourable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 11.5 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 290000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: " "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favourable (4.98e-4)" "prognostic unfavourable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.7 2.9 3.4 15.4 5.4 0.9 2.5 1.9 8.2 3.8 23.9 16.2 4.6 21.6 2.5 3.2 1.1 5.4 4.4 5.4 5.6 6.5 3.5 1.1 3.0 5.5 12.7 3.8 17.9 5.4 6.1 5.4 12.0 8.2 3.3 25.0 2.2 6.6 4.0 0.7 1.8 22.6 4.0 12.1 3.3 2.3 2.9 9.3 0.1 8.4 1.0 2.1 5.3 3.3 0.1 0.6 0.3 2.5 0.1 0.1 0.4 16.7 7.1 6.8 10.9 0.6 0.6 0.0 3.9 0.2 11.8 2.5 2.4 6.7 0.2 8.4 1.7 15.8 4.6 22.8 3.1 0.0 1.6 0.0 0.7 0.0 7.1 0.0 1.7 2.3 7.3 21.1 0.1 31.1 0.6 0.0 2.3 2.5 0.3 0.1 1.6 4.6 2.0 7.0 0.3 5.8 1.6 7.4 7.8 6.8 0.2 0.1 0.4 0.2 30.7 4.7 12.4 11.9 26.8 0.0 0.1 0.0 8.8 0.3 0.1 0.3 2.5 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 3.4 5.4 1.9 8.2 5.6 6.5 12.7 3.8 8.2 9.3 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;NTERA-2: 5.9;SCLC-21H: 2.6" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 18 "dendritic cells: 2.8;monocytes: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favourable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.2 0.1 0.1 0.2 0.3 0.1 1.0 0.1 0.3 12.5 0.2 0.2 0.4 0.1 0.9 0.3 34.8 1.1 1.7 0.1 0.5 0.1 1.6 0.2 1.6 0.0 0.2 0.0 0.6 0.0 2.2 2.4 0.2 0.4 1.5 0.1 0.6 3.4 0.6 0.2 33.1 0.2 0.2 0.2 1.2 0.5 2.7 0.2 2.4 0.2 39.6 29.6 2.8 13.6 0.0 2.8 0.2 4.9 0.0 0.0 0.5 0.2 0.6 1.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.7 0.8 0.5 6.3 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.1 0.0 0.5 0.0 0.5 0.0 0.3 0.6 0.0 0.0 0.3 0.4 0.0 1.0 0.1 0.8 5.9 0.8 0.0 0.0 0.1 0.2 1.3 2.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.8 0.1 0.3 0.1 0.6 0.8 0.1 0.2 0.2 0.0 1.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 4.9 2.8 0.0 0.5 0.1 0.3 0.1 0.3 0.5 0.1 0.2 0.0 0.4 0.2 EPN3 "FLJ20778, MGC129899" ENSG00000049283 "Epsin 3" Q9H201 17 50532543-50543750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 12.4;HBEC3-KT: 17.2;hTCEpi: 9.7;MCF7: 27.5;RT4: 21.6;SK-BR-3: 11.2;T-47d: 24.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 6.8;pons and medulla: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2" "HPA055546, HPA063224" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA055546: , HPA063224: " "unprognostic (1.91e-2)" "unprognostic (1.99e-2)" "unprognostic (2.41e-1)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (2.06e-1)" "unprognostic (5.70e-3)" "unprognostic (7.62e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.66e-3)" "unprognostic (1.00e-2)" "prognostic favourable (1.53e-5)" "unprognostic (1.45e-1)" "unprognostic (1.16e-1)" "unprognostic (4.90e-1)" "unprognostic (3.52e-3)" 0.4 7.7 0.5 1.9 0.7 0.4 1.9 1.1 6.8 5.3 7.8 1.5 24.0 5.1 0.7 3.8 26.2 6.0 12.6 6.6 0.5 0.7 10.9 0.4 0.7 0.0 2.0 1.4 10.3 18.3 9.6 0.9 8.4 17.8 9.3 3.4 0.3 16.7 18.7 0.4 19.7 5.1 0.5 0.6 0.3 23.8 2.2 0.0 3.4 1.2 15.9 21.9 8.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 6.3 5.4 0.0 0.1 0.0 12.4 0.0 17.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 27.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 21.6 0.2 0.0 0.0 11.2 0.0 24.9 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.1 6.8 0.5 0.7 2.0 1.4 17.8 0.0 ERAP1 "A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP" ENSG00000164307 "Endoplasmic reticulum aminopeptidase 1" Q9NZ08 5 96760810-96808100 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025095, HPA042317" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 27000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB025095: , HPA042317: " "unprognostic (2.33e-3)" "unprognostic (3.45e-1)" "unprognostic (1.84e-3)" "unprognostic (1.34e-1)" "unprognostic (1.86e-1)" "unprognostic (4.38e-1)" "unprognostic (1.88e-3)" "unprognostic (5.37e-2)" "unprognostic (1.45e-1)" "unprognostic (7.94e-2)" "unprognostic (4.52e-2)" "unprognostic (3.23e-1)" "unprognostic (7.09e-2)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (5.14e-2)" 23.8 13.6 9.3 22.7 11.9 11.6 23.3 14.2 14.6 14.5 23.8 10.1 11.2 30.8 14.7 13.4 12.3 14.3 19.9 16.1 9.7 6.8 13.3 23.7 17.8 16.4 13.5 7.6 15.5 16.5 11.1 39.4 28.2 11.4 13.4 21.9 8.5 13.9 15.2 23.1 17.7 39.7 10.6 17.1 19.5 16.5 5.4 13.8 55.5 13.5 9.8 17.8 15.9 14.1 14.9 15.2 19.8 17.5 19.8 21.8 10.7 7.3 4.7 6.3 5.9 35.0 34.3 18.4 5.4 17.5 13.1 23.0 5.9 26.7 22.0 11.3 10.4 7.6 5.2 11.1 8.2 39.8 2.2 7.1 3.1 4.0 40.1 3.4 13.2 14.2 4.8 15.0 4.6 18.0 3.7 21.4 7.8 3.4 31.6 3.5 3.1 3.0 23.5 8.6 10.9 9.8 11.4 2.3 1.6 8.6 5.8 8.4 5.1 16.4 14.3 11.3 3.8 1.9 8.9 8.0 15.0 17.1 12.1 11.6 6.6 19.8 13.2 15.6 21.2 11.4 19.7 13.0 18.5 18.2 9.5 14.9 21.8 17.4 14.4 19.8 17.5 15.2 12.3 10.7 9.3 11.9 14.2 14.6 9.7 6.8 13.5 7.6 11.4 13.8 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920157-13952345 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "CAB000156: , HPA045828: " "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 8.4 12.7 8.6 7.0 11.3 5.3 6.4 8.9 9.7 8.1 6.7 9.9 6.0 4.1 8.5 6.8 6.7 8.5 6.8 7.8 7.2 7.1 6.9 7.2 6.9 6.8 10.5 8.8 9.9 7.6 13.3 13.0 5.9 9.6 8.3 5.4 7.1 6.4 7.0 31.3 6.9 5.7 8.5 10.3 7.7 6.6 14.2 8.9 13.7 9.7 5.6 6.4 9.1 7.8 8.4 7.9 8.3 6.8 8.9 7.4 2.6 5.4 7.0 6.4 9.2 10.7 10.1 5.0 7.2 7.7 6.5 8.3 2.4 5.4 9.1 10.4 6.3 6.9 9.5 4.9 10.1 12.3 5.6 4.5 7.8 6.0 9.8 6.0 5.1 7.6 6.9 8.6 7.3 8.6 7.0 10.7 9.1 4.5 8.0 4.1 4.7 3.7 9.2 13.0 11.2 4.0 3.7 5.3 6.3 8.8 7.2 6.7 9.1 4.6 9.7 9.6 7.1 8.6 6.3 9.5 11.1 6.3 9.2 7.3 9.7 8.3 6.2 5.4 6.8 6.8 7.4 6.2 6.4 5.1 5.5 8.4 6.4 6.9 7.2 8.9 5.7 7.9 5.8 2.6 8.6 11.3 8.9 9.7 7.2 7.1 10.5 8.8 9.6 8.9 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "Q03468, P0DP91, Q8N328" 10 49455368-49539538 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 34.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA071297: " "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 7.9 6.9 11.5 6.0 12.3 13.9 11.1 21.0 13.9 9.8 7.0 8.9 10.6 6.4 9.3 8.6 13.5 8.1 7.7 9.1 12.7 6.5 10.1 10.0 8.0 7.9 9.2 11.4 12.5 13.1 20.3 14.2 9.7 10.1 10.5 8.8 9.2 10.5 13.7 9.6 14.4 9.1 7.9 11.8 9.2 7.6 7.8 12.4 7.8 13.6 8.2 9.6 9.9 11.6 7.9 5.1 10.9 8.1 1.6 5.3 2.1 6.6 3.5 2.6 1.6 4.5 7.6 2.1 11.9 16.5 8.2 5.8 3.6 4.1 2.9 2.2 10.7 6.2 3.7 9.4 8.3 4.6 2.4 2.2 13.1 2.0 2.6 3.0 2.3 2.6 12.9 8.0 34.2 11.9 4.3 0.8 10.6 4.9 2.1 1.7 2.4 6.2 2.0 3.8 1.7 2.8 4.7 3.5 3.6 8.8 3.2 5.3 5.8 1.7 22.8 4.6 3.8 5.5 3.0 3.2 3.0 2.8 5.6 3.3 3.4 10.9 4.1 9.7 5.3 3.7 4.2 7.9 3.1 2.9 5.1 6.3 3.8 1.8 9.8 1.6 8.1 2.8 4.0 2.1 11.5 12.3 21.0 13.9 12.7 6.5 9.2 11.4 10.1 12.4 ERG "erg-3, p55" ENSG00000157554 "ERG, ETS transcription factor" P11308 21 38380027-38661780 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 42.7;MOLT-4: 14.0;REH: 45.3;TIME: 34.6" "Cancer enhanced" "Detected in all" "prostate cancer: 18.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "myeloid DC: 1.7;NK-cell: 1.0" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB018377, HPA046598" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB018377: AB_675518, HPA046598: " "unprognostic (2.14e-1)" "prognostic unfavourable (6.18e-6)" "unprognostic (6.44e-3)" "unprognostic (8.64e-3)" "unprognostic (5.65e-2)" "unprognostic (1.91e-1)" "unprognostic (9.03e-4)" "unprognostic (4.30e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (2.89e-1)" "prognostic unfavourable (3.94e-4)" "unprognostic (4.31e-3)" "unprognostic (3.88e-2)" "unprognostic (2.64e-2)" "unprognostic (5.63e-3)" 39.1 4.2 5.7 6.5 8.5 6.6 20.5 3.6 7.0 17.9 5.2 2.3 5.6 3.3 16.9 9.0 6.2 9.2 11.6 10.1 6.2 3.6 10.8 6.0 19.9 7.4 8.0 1.8 7.7 4.8 2.3 3.9 23.2 8.0 8.1 3.6 7.8 4.2 5.6 13.5 5.3 6.2 11.8 4.7 32.5 5.0 4.8 5.0 2.4 10.8 9.1 3.6 9.6 15.8 0.0 1.7 0.0 0.2 1.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 7.0 0.0 0.0 0.3 0.0 42.7 0.0 0.0 0.0 0.3 14.0 0.0 0.1 0.0 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 34.6 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 5.7 8.5 3.6 7.0 6.2 3.6 8.0 1.8 8.0 5.0 ERG28 "C14orf1, NET51" ENSG00000133935 "Ergosterol biosynthesis 28 homolog" Q9UKR5 14 75649791-75661189 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043172, HPA063568" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043172: AB_10793942, HPA063568: " "unprognostic (2.68e-3)" "unprognostic (2.11e-2)" "unprognostic (4.55e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-1)" "unprognostic (1.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.66e-2)" "unprognostic (4.64e-1)" "unprognostic (2.66e-2)" "unprognostic (2.47e-1)" "unprognostic (3.01e-2)" "prognostic favourable (4.30e-5)" "unprognostic (1.28e-1)" "unprognostic (2.77e-1)" "unprognostic (9.58e-3)" "unprognostic (2.20e-1)" 6.4 20.0 14.2 6.3 16.3 8.1 12.6 9.2 25.5 11.8 11.7 16.3 10.5 14.9 11.3 29.6 23.7 12.4 11.8 9.4 13.6 15.5 17.6 48.3 19.3 9.4 11.9 10.4 15.0 12.4 16.5 13.2 15.6 17.9 15.5 11.2 26.2 15.4 10.6 6.6 15.6 16.9 10.5 18.2 7.1 9.5 52.2 9.6 7.5 24.3 21.3 15.6 9.2 13.5 18.1 18.2 11.8 6.0 14.2 22.0 13.9 14.1 8.0 16.2 12.6 11.0 20.5 10.0 5.8 17.9 11.3 19.4 12.3 33.9 6.0 8.5 7.2 15.7 14.3 24.6 12.9 11.2 9.5 6.5 8.1 17.3 16.0 7.1 9.7 25.6 21.3 16.1 9.0 13.1 5.7 14.8 7.7 27.8 10.8 7.9 15.7 12.9 8.7 11.0 11.9 36.9 18.4 13.9 7.7 14.6 12.5 8.6 20.9 10.5 9.4 6.2 12.4 5.9 5.7 9.6 11.3 13.0 9.9 10.4 10.4 11.8 6.0 8.9 20.1 5.9 19.8 18.1 22.0 20.9 14.2 15.3 20.2 20.1 3.2 14.2 5.9 18.2 19.4 13.9 14.2 16.3 9.2 25.5 13.6 15.5 11.9 10.4 17.9 9.6 ERH DROER ENSG00000100632 "ERH, mRNA splicing and mitosis factor" P84090 14 69380123-69398627 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavourable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 42.6 45.4 54.9 43.9 46.7 47.0 51.3 45.1 48.4 46.6 43.5 31.1 39.4 42.1 53.3 63.3 44.8 46.4 35.9 40.6 47.6 51.1 56.1 62.2 34.5 52.5 43.5 48.5 47.8 38.7 23.9 45.5 55.2 45.4 40.4 50.3 41.3 58.5 40.3 43.3 31.0 47.3 46.9 43.6 55.2 35.6 54.6 28.4 72.2 55.2 37.5 64.4 47.7 36.8 38.7 37.3 24.2 32.4 34.1 35.3 38.8 89.6 58.2 58.3 38.8 29.3 21.6 35.3 47.0 27.1 42.5 39.8 59.3 37.3 85.1 20.7 31.4 26.3 58.9 39.1 50.6 44.4 36.0 42.7 38.6 66.1 45.2 37.1 31.0 24.6 21.0 38.0 34.2 34.7 41.1 28.6 34.7 102.5 56.1 52.9 45.4 55.2 45.4 57.8 29.1 42.8 61.4 44.8 41.8 44.9 41.2 25.7 50.6 52.0 37.0 41.6 61.7 27.6 46.8 32.2 30.5 95.1 30.9 39.5 40.1 15.3 32.4 24.2 26.1 30.1 25.7 38.7 32.5 28.6 34.0 30.6 30.7 27.2 15.4 34.1 27.1 37.3 35.3 38.8 54.9 46.7 45.1 48.4 47.6 51.1 43.5 48.5 45.4 28.4 ERI3 "FLJ22943, PINT1, PRNPIP" ENSG00000117419 "ERI1 exoribonuclease family member 3" O43414 1 44221070-44355260 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027147, HPA029895" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027147: AB_1855725, HPA029895: " "unprognostic (1.31e-1)" "unprognostic (2.39e-2)" "unprognostic (3.26e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (5.94e-2)" "unprognostic (6.21e-2)" "prognostic unfavourable (2.04e-6)" "unprognostic (6.48e-2)" "unprognostic (2.67e-1)" "unprognostic (6.70e-3)" "unprognostic (5.30e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-1)" "unprognostic (7.47e-2)" "unprognostic (1.08e-1)" "unprognostic (2.07e-3)" 12.6 15.4 30.7 8.3 32.0 12.4 15.2 19.7 43.7 15.1 13.4 23.2 10.8 12.3 14.7 22.2 13.4 23.4 12.7 21.1 28.9 25.1 25.3 15.5 11.7 10.0 23.9 26.8 18.6 15.7 24.0 17.2 13.5 22.9 16.7 14.1 14.8 14.7 16.9 35.7 13.3 8.6 17.7 17.9 9.5 10.6 24.4 21.9 9.7 17.6 11.9 11.0 12.5 12.1 18.8 25.3 9.6 22.2 14.8 18.2 15.2 28.1 21.8 27.7 30.6 18.2 22.9 17.4 18.4 24.6 32.8 30.6 14.1 30.1 20.1 31.2 22.6 16.3 24.8 31.4 23.2 22.5 47.7 22.5 36.8 19.8 26.6 22.6 12.9 23.3 29.5 24.8 34.2 22.5 21.9 16.4 21.5 18.9 25.1 21.2 32.7 34.6 24.3 25.4 29.4 25.4 14.9 47.2 22.3 20.1 27.6 32.6 18.1 18.8 13.6 21.7 22.7 23.5 27.8 15.6 18.1 21.6 26.9 19.7 27.3 9.4 16.3 9.6 16.7 22.2 18.2 18.8 14.0 16.2 25.3 18.3 16.7 17.2 1.5 14.8 21.3 18.9 18.1 15.2 30.7 32.0 19.7 43.7 28.9 25.1 23.9 26.8 22.9 21.9 ERICH1 ENSG00000104714 "Glutamate rich 1" Q86X53 8 614746-738106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003725 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA003725: AB_1853023" "unprognostic (7.19e-2)" "unprognostic (1.38e-2)" "unprognostic (7.73e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-2)" "unprognostic (1.02e-1)" "unprognostic (7.51e-3)" "unprognostic (1.55e-1)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (5.11e-2)" "unprognostic (1.27e-1)" "unprognostic (8.63e-2)" "unprognostic (3.07e-1)" "unprognostic (1.42e-1)" 20.2 11.7 12.3 35.7 16.9 30.5 18.1 9.0 15.6 13.6 16.0 13.9 13.7 13.1 21.7 25.6 15.3 13.7 17.1 14.7 15.1 11.4 17.6 15.3 19.4 29.3 14.5 14.0 16.9 12.2 13.8 16.1 16.9 16.9 15.4 11.7 14.0 13.5 19.4 17.2 17.0 15.8 16.2 17.0 22.2 14.9 11.8 14.0 21.8 18.2 13.3 25.0 17.1 15.3 11.7 10.2 18.5 20.9 7.2 6.2 6.0 9.1 13.2 7.1 8.4 7.6 9.3 14.7 8.8 4.7 8.0 8.9 8.4 5.9 20.9 4.2 7.4 15.4 12.9 13.5 5.7 9.0 16.8 14.6 8.5 12.0 8.6 8.9 13.7 10.7 8.8 6.1 7.9 8.7 14.9 12.1 8.0 7.6 17.1 15.8 11.2 5.9 15.5 4.6 14.3 8.9 16.9 3.2 9.1 6.4 8.3 11.7 3.4 10.7 13.9 5.9 2.8 0.3 9.3 7.9 20.6 22.6 12.1 14.3 6.2 11.4 20.9 7.2 5.4 19.0 4.8 9.7 6.2 5.3 10.2 11.7 5.3 4.7 18.5 7.2 16.8 7.8 4.4 6.0 12.3 16.9 9.0 15.6 15.1 11.4 14.5 14.0 16.9 14.0 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443158-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 78.1" "Group enriched" "Detected in some" 12 "CACO-2: 4.7;Hep G2: 10.8;THP-1: 3.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042632: , HPA048484: " "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.6 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.4 21.0 0.2 0.2 27.1 0.4 0.4 0.2 0.4 0.5 1.3 0.2 0.0 10.0 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.9 0.0 78.1 0.2 0.3 0.2 0.1 0.8 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.2 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell line enhanced" "Detected in some" "A549: 6.8;EFO-21: 5.2;HAP1: 6.3;HEK 293: 9.1;RPTEC TERT1: 6.1;RT4: 15.9" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favourable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favourable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.8 0.0 0.0 0.1 0.0 4.0 3.6 1.3 1.9 1.4 0.1 2.0 0.0 5.2 0.9 0.3 6.3 0.1 2.3 0.0 9.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 1.4 2.7 0.0 0.0 0.1 6.1 15.9 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Cell line enhanced" "Detected in some" "CACO-2: 27.6;hTCEpi: 19.9;RPTEC TERT1: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" 5000000 Nucleoplasm Cytosol "HPA011423: , HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavourable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.4 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 27.6 5.9 0.0 0.6 0.1 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 19.9 0.0 2.9 0.0 1.5 0.0 0.1 0.3 0.0 0.0 1.8 0.8 0.0 0.0 0.0 14.7 0.4 1.2 0.2 1.8 0.8 0.0 2.4 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784886 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047083: , HPA050396: " "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavourable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.4 10.5 13.5 9.7 19.7 7.1 11.9 17.0 17.4 10.8 8.8 6.9 9.2 7.7 11.2 11.5 11.9 9.2 9.1 9.7 17.2 11.6 10.8 14.6 7.0 10.3 16.8 17.5 14.1 8.7 12.9 20.0 11.9 17.2 12.2 10.7 4.2 8.9 8.6 29.9 11.3 7.5 12.9 28.9 10.7 8.1 14.3 17.9 9.2 11.5 12.1 10.1 11.2 9.2 13.8 14.6 2.0 10.6 11.5 12.4 3.7 13.2 12.6 11.7 5.9 9.0 10.8 6.5 14.2 8.7 10.3 8.8 13.4 12.5 17.4 7.2 6.7 20.4 17.4 14.2 18.4 4.6 8.2 22.9 5.1 31.4 12.5 27.5 6.3 8.7 10.1 17.0 13.8 7.8 31.8 7.9 11.7 11.7 20.8 16.5 11.2 7.6 13.6 29.1 12.7 7.2 11.7 11.5 7.1 11.4 18.0 17.6 9.1 12.1 10.5 15.9 11.0 11.6 26.1 8.0 19.4 21.4 6.7 12.1 14.5 1.8 6.9 2.0 8.7 8.6 10.0 13.6 10.0 9.3 6.9 13.8 12.4 11.3 0.4 11.5 10.6 14.6 7.5 3.7 13.5 19.7 17.0 17.4 17.2 11.6 16.8 17.5 17.2 17.9 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 68.9" "Group enriched" "Detected in some" 9 "MCF7: 24.3;T-47d: 31.5" "Group enriched" "Detected in many" 9 "breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: , HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favourable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 3.0 0.9 0.5 1.6 0.5 0.2 16.2 0.8 0.4 64.5 1.5 0.2 2.2 0.1 68.9 27.7 1.1 26.7 1.9 1.1 0.5 0.8 1.5 6.6 3.6 1.6 0.4 0.1 14.2 0.4 0.0 9.3 0.9 0.6 3.6 0.1 2.6 1.6 4.1 2.0 0.6 0.5 20.8 0.4 1.6 0.3 1.9 0.4 1.9 1.3 2.2 2.5 3.8 23.7 0.6 1.0 0.0 0.8 0.3 2.5 1.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.6 0.0 24.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 31.5 0.0 0.0 0.1 0.1 0.3 0.0 2.9 0.5 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.3 0.2 1.0 0.6 1.3 0.4 1.0 0.4 2.5 0.9 0.0 0.3 0.0 0.0 0.3 1.0 0.5 0.5 0.8 0.4 0.5 0.8 0.4 0.1 0.6 0.4 ESRRG NR3B3 ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;parathyroid gland: 37.2;placenta: 40.8" "Group enriched" "Detected in some" 4 "RPMI-8226: 15.1;SH-SY5Y: 28.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "pons and medulla: 49.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favourable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.5 5.1 2.8 0.4 3.3 0.2 2.9 6.9 10.3 1.4 0.7 0.7 2.2 4.0 0.5 1.5 1.4 2.1 0.8 8.3 3.2 2.6 22.0 0.8 0.7 0.4 6.8 1.7 0.8 4.4 37.2 9.9 40.8 49.5 2.6 0.4 10.7 11.0 2.4 6.3 1.5 3.7 0.9 2.6 1.0 22.2 1.0 1.5 0.0 4.6 7.2 0.4 1.0 0.7 0.4 0.2 1.5 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 15.1 2.3 1.7 5.4 28.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.0 2.8 3.3 6.9 10.3 3.2 2.6 6.8 1.7 49.5 1.5 ESS2 "bis1, DGCR13, DGCR14, DGS-H, DGSI, ES2, Es2el, ESS-2" ENSG00000100056 "Ess-2 splicing factor homolog" Q96DF8 22 19130279-19144684 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 11.5;RH-30: 10.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001221, HPA001222" Enhanced Approved Nucleoplasm Nucleoplasm "HPA001221: AB_1078645, HPA001222: AB_1078647" "unprognostic (8.31e-2)" "unprognostic (1.81e-3)" "unprognostic (2.26e-1)" "unprognostic (2.83e-1)" "unprognostic (5.75e-3)" "unprognostic (4.70e-2)" "unprognostic (2.43e-2)" "unprognostic (6.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (5.89e-2)" "unprognostic (9.36e-2)" "unprognostic (3.04e-2)" "unprognostic (1.71e-3)" 4.5 4.0 6.3 5.1 7.2 2.5 4.2 18.9 11.8 5.2 7.9 6.3 3.8 3.6 6.8 4.4 6.4 7.3 4.1 5.9 6.0 6.1 3.9 2.9 4.7 4.9 5.7 6.8 9.4 3.7 5.4 5.2 4.9 5.6 6.4 4.2 5.0 4.4 9.6 6.3 9.3 4.1 6.9 5.0 5.6 5.0 7.2 5.8 6.1 5.0 5.5 6.0 7.2 5.5 1.2 1.5 1.7 1.1 1.8 1.4 1.1 2.0 3.8 2.2 2.6 3.5 0.6 0.9 2.0 1.2 3.3 2.7 3.0 0.7 2.6 0.7 0.9 3.7 6.5 1.1 1.7 4.3 7.4 0.7 3.2 0.5 0.9 3.4 2.6 0.5 3.9 2.4 0.7 0.6 11.5 0.3 1.5 2.1 2.0 1.9 1.9 3.0 3.1 10.8 0.0 0.9 1.6 5.3 1.2 0.9 1.7 2.4 1.1 1.3 0.5 3.0 4.4 2.8 1.5 1.5 3.2 1.0 0.9 2.1 2.0 0.3 1.1 1.7 0.9 0.4 0.4 0.4 1.2 0.6 0.7 1.2 1.3 1.4 0.9 1.8 0.5 1.5 0.6 1.1 6.3 7.2 18.9 11.8 6.0 6.1 5.7 6.8 5.6 5.8 ETAA1 ETAA16 ENSG00000143971 "ETAA1, ATR kinase activator" Q9NY74 2 67397319-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 9.3 23.4 6.4 11.0 11.3 6.6 14.7 14.0 10.6 15.4 11.7 6.3 9.4 7.2 14.6 13.9 12.0 13.9 15.7 9.4 8.7 5.5 17.5 11.1 11.3 14.8 9.7 10.4 15.6 16.2 14.2 13.9 8.8 10.7 11.6 9.2 6.1 12.4 13.7 11.4 12.4 11.1 10.6 8.5 11.8 10.5 11.3 10.3 19.2 15.9 9.7 9.8 11.6 12.7 7.5 4.4 3.4 5.2 4.2 7.4 3.1 9.1 7.1 12.0 10.8 9.4 13.0 9.9 9.8 13.0 10.5 10.1 5.7 11.1 17.1 5.4 8.0 11.2 10.2 11.9 15.0 10.0 8.1 9.5 17.1 8.3 9.0 9.5 9.0 10.2 17.0 7.7 12.1 16.6 7.7 7.4 14.3 4.1 14.0 10.5 12.2 7.7 10.1 19.1 7.9 12.7 6.0 10.1 20.1 9.9 9.1 9.3 7.9 4.6 11.4 14.3 11.0 6.7 11.5 8.3 7.4 13.8 13.3 10.1 10.8 3.4 2.5 2.0 5.5 4.1 6.0 7.5 5.1 3.2 3.1 7.0 7.0 6.2 0.2 4.2 5.2 4.4 7.4 3.1 6.4 11.3 14.0 10.6 8.7 5.5 9.7 10.4 10.7 10.3 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742040-108763054 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.5;liver: 111.0" "Cell line enhanced" "Detected in some" "HeLa: 10.8;Hep G2: 4.2;NTERA-2: 2.2" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Approved Approved Nucleoplasm Nucleoplasm "HPA044546: AB_10962867, HPA072938: " "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favourable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 1.2 1.9 50.8 1.3 51.3 1.2 1.3 7.9 53.5 1.3 1.2 13.4 0.0 1.3 1.4 1.2 1.3 1.2 1.4 3.2 37.5 20.1 6.2 111.0 1.2 1.2 26.0 28.7 1.3 1.2 1.4 0.1 1.2 15.7 1.2 1.2 0.5 19.9 1.3 1.6 1.2 1.2 1.2 7.3 1.6 10.4 1.5 18.7 0.0 1.9 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 10.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 2.2 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 51.3 7.9 24.9 37.5 20.1 26.0 28.7 15.7 18.7 ETV1 ER81 ENSG00000006468 "ETS variant 1" P50549 7 13891228-13991425 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 90.0;salivary gland: 45.8" "Cell line enhanced" "Detected in many" "AN3-CA: 22.2;SCLC-21H: 26.3;U-87 MG: 51.9;WM-115: 25.6" "Cancer enhanced" "Detected in all" "glioma: 22.5" "Region enriched" "Detected in all" 8 "cerebellum: 90.0" "Cell type enriched" "Detected in single" 5 "T-reg: 3.1" "Lineage enriched" "Detected in single" 5 "T-cells: 3.1" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 418.9" "HPA068389, HPA077249" Supported Approved Nucleoplasm Nucleoplasm "HPA068389: , HPA077249: " "unprognostic (2.45e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-2)" "unprognostic (2.13e-2)" "unprognostic (1.64e-7)" "unprognostic (7.08e-3)" "unprognostic (7.21e-2)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-3)" "unprognostic (2.21e-2)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" 2.5 12.4 8.1 1.1 11.7 0.2 4.4 90.0 35.2 1.4 2.4 3.1 0.1 1.2 2.4 1.3 1.5 1.1 9.2 18.0 7.0 4.5 2.1 2.0 14.9 0.7 4.5 6.9 1.0 1.6 11.4 7.4 1.9 8.3 3.1 2.4 0.9 45.8 7.1 0.9 1.5 1.9 2.0 3.5 4.5 1.7 4.5 2.9 0.3 6.5 0.9 4.7 1.8 1.3 0.0 0.0 0.0 0.6 0.0 3.1 0.2 0.0 1.6 11.7 22.2 4.1 12.2 0.0 1.0 3.9 0.6 2.6 0.0 5.3 0.0 1.2 1.8 0.1 0.4 1.2 1.4 0.3 0.5 0.6 1.0 0.0 2.4 3.8 1.5 3.6 0.0 7.6 0.6 5.0 3.4 0.1 4.7 0.0 0.0 0.0 17.5 11.8 0.0 7.1 0.9 7.9 0.1 26.3 5.1 0.0 0.4 6.3 0.4 0.1 2.7 2.3 0.7 4.5 4.3 4.0 1.2 0.0 51.9 0.2 25.6 0.0 0.2 0.0 0.1 0.6 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 8.1 11.7 90.0 10.9 7.0 4.5 4.5 6.9 8.3 2.9 EVC DWF-1 ENSG00000072840 "EvC ciliary complex subunit 1" P57679 4 5711197-5814305 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.1;BJ hTERT+: 26.9;hTERT-HME1: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008703, HPA016046" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008703: AB_1078765, HPA016046: AB_1848299" "unprognostic (1.69e-1)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (9.37e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-2)" "unprognostic (9.63e-2)" "unprognostic (2.82e-1)" "prognostic favourable (5.60e-9)" "unprognostic (3.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "prognostic unfavourable (9.47e-5)" 5.0 2.9 2.5 4.6 2.7 0.0 4.1 1.9 2.3 13.2 4.3 1.8 8.4 0.6 17.2 10.1 6.0 8.1 16.0 3.8 2.2 2.2 26.5 3.7 6.4 1.0 2.3 1.4 20.2 9.2 14.9 2.3 1.8 2.9 10.2 1.6 12.0 9.1 5.7 2.4 4.2 2.8 15.8 2.4 2.1 3.6 5.3 1.0 1.0 6.9 3.9 3.8 7.5 9.0 0.1 0.3 1.2 0.1 0.1 0.5 0.0 3.1 4.0 2.2 5.8 14.6 21.1 0.8 7.0 26.9 8.1 10.6 0.0 0.0 0.0 2.2 11.1 3.7 2.3 5.8 6.7 5.1 1.6 0.0 2.3 1.0 10.8 0.0 0.6 10.4 8.5 10.8 26.8 5.6 0.0 0.0 18.8 0.0 0.0 0.0 2.4 3.7 4.7 6.2 0.0 2.8 0.5 1.2 3.8 0.0 0.0 2.8 1.4 0.2 9.8 7.0 1.3 4.9 6.1 4.3 3.5 0.3 20.0 0.0 6.5 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.3 0.5 0.0 2.5 2.7 1.9 2.3 2.2 2.2 2.3 1.4 2.9 1.0 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Cell line enhanced" "Detected in many" "HHSteC: 19.8;Karpas-707: 32.7;RPMI-8226: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA045033: , HPA057051: " "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavourable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavourable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.6 10.4 0.0 1.3 2.2 1.7 6.0 0.0 0.4 8.8 0.0 1.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 19.8 10.2 11.1 12.8 0.0 2.4 6.8 0.6 0.3 32.7 12.9 0.1 7.3 11.2 0.0 0.0 7.6 1.3 50.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 11.1 4.2 7.2 0.2 0.3 4.7 14.8 0.0 9.9 5.8 7.4 5.9 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377662-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.2;lymphoid tissue: 10.4" "Cell line enhanced" "Detected in some" "A-431: 1.9;HeLa: 3.2;hTCEpi: 11.3;RT4: 3.9;SiHa: 2.1;T-47d: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 3.3 0.5 0.0 0.7 0.4 0.8 0.9 22.2 0.4 0.8 0.0 0.0 0.0 0.9 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.7 0.2 0.0 2.1 3.1 0.1 7.8 0.4 1.4 0.0 0.1 1.7 2.5 0.0 0.1 2.2 9.5 10.4 3.5 7.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.0 2.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EVX1 ENSG00000106038 "Even-skipped homeobox 1" P49640 7 27242700-27250493 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9" "Cell line enriched" "Detected in some" 12 "RT4: 17.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 26 "pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "midbrain: 1.0;pons and medulla: 1.0" "Region enriched" "Detected in single" 9 "pons and medulla: 1.1" HPA055132 Approved Nucleoplasm Nucleoplasm "HPA055132: " "unprognostic (2.73e-2)" "unprognostic (3.59e-1)" "unprognostic (4.31e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-3)" "unprognostic (2.08e-2)" "unprognostic (8.48e-3)" "unprognostic (5.94e-2)" "unprognostic (1.26e-8)" "unprognostic (2.94e-1)" "unprognostic (1.39e-1)" "unprognostic (9.12e-2)" "unprognostic (1.83e-2)" 0.1 6.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.2 0.6 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 3.0 6.4 0.7 0.1 0.1 6.7 0.1 0.0 0.1 1.9 0.1 0.1 0.0 1.7 0.1 0.1 0.1 0.1 0.1 8.9 5.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.0 0.1 EXOC3 "SEC6L1, Sec6p" ENSG00000180104 "Exocyst complex component 3" O60645 5 443158-471937 "Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037880 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA037880: " "unprognostic (2.94e-1)" "unprognostic (4.74e-3)" "unprognostic (4.82e-3)" "unprognostic (4.10e-1)" "unprognostic (6.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.91e-3)" "unprognostic (1.91e-1)" "unprognostic (6.62e-2)" "unprognostic (3.26e-1)" "prognostic favourable (1.54e-4)" "unprognostic (6.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.82e-1)" "unprognostic (1.70e-1)" 18.7 15.6 22.0 20.7 22.4 19.1 16.5 20.1 28.6 18.1 22.4 22.5 22.3 18.3 22.2 14.9 26.3 19.0 20.9 20.8 22.5 17.3 15.9 14.1 15.6 18.8 23.3 29.5 21.6 23.5 20.8 18.0 17.9 22.7 17.6 13.3 14.5 23.9 20.2 47.5 24.9 17.1 26.7 16.2 18.2 20.8 40.7 21.0 13.3 19.8 20.7 17.4 20.8 17.6 3.6 3.5 31.0 6.2 9.8 6.4 4.4 12.5 21.2 7.1 15.9 12.3 10.6 17.8 11.2 11.6 11.3 13.7 10.6 18.6 10.7 17.4 14.0 14.3 5.7 9.7 8.3 39.3 9.9 11.5 44.4 8.0 11.5 17.2 29.2 10.8 7.2 12.6 11.1 12.6 8.7 7.0 8.7 14.9 12.3 20.5 5.9 12.7 10.1 8.2 13.7 9.5 15.8 7.2 9.1 27.9 15.8 10.8 21.4 19.9 9.4 11.2 13.9 8.6 9.0 11.9 8.6 7.6 11.8 20.9 10.1 5.4 5.7 31.0 6.4 6.2 5.4 3.3 5.0 5.1 3.5 3.6 6.4 5.9 7.9 9.8 4.4 2.6 6.4 4.4 22.0 22.4 20.1 28.6 22.5 17.3 23.3 29.5 22.7 21.0 EXOC3L2 "FLJ36147, XTP7" ENSG00000283632 "Exocyst complex component 3 like 2" Q2M3D2 19 45212621-45245431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 17.8;K-562: 16.4" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "HPA041595, HPA061110" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" Vesicles "Nucleoplasm, Golgi apparatus, Cytosol" "HPA041595: AB_10794521, HPA061110: " 3.2 4.3 0.0 2.0 0.0 0.9 3.0 0.0 0.3 3.6 2.1 0.1 2.4 2.3 14.5 1.2 2.3 0.6 6.9 1.9 0.0 12.7 9.4 3.4 6.3 0.0 0.0 3.4 2.8 2.4 3.5 0.4 0.0 3.7 0.2 13.7 3.3 3.6 1.0 2.4 3.9 1.6 0.0 12.6 2.4 2.1 0.0 0.0 4.6 1.5 3.2 1.6 3.3 0.5 0.3 2.5 0.4 0.2 0.4 0.2 0.1 0.3 2.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.1 0.0 1.1 0.0 0.1 0.0 0.1 0.0 17.8 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 16.4 0.3 0.0 0.2 0.0 0.0 0.2 0.5 1.2 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.3 0.4 0.8 1.6 0.3 0.1 0.2 0.1 0.0 0.1 0.2 0.1 1.6 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 2.5 0.2 0.3 0.3 0.1 0.2 EXOC6 "DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p" ENSG00000138190 "Exocyst complex component 6" Q8TAG9 10 92834713-93059493 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036285, HPA059111" Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036285: AB_10673617, HPA059111: " "unprognostic (1.41e-1)" "unprognostic (1.39e-3)" "unprognostic (5.20e-2)" "unprognostic (2.65e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (1.16e-3)" "unprognostic (7.21e-3)" "unprognostic (3.84e-1)" "unprognostic (2.70e-1)" "unprognostic (1.66e-1)" "unprognostic (8.13e-2)" "prognostic favourable (4.66e-4)" "unprognostic (2.12e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (6.41e-2)" 9.7 19.4 15.3 8.5 16.9 11.6 9.4 18.9 16.2 7.4 9.6 4.5 5.1 8.3 7.3 7.5 4.9 6.3 10.3 7.0 15.5 8.6 7.0 10.8 12.0 16.7 6.1 12.8 5.4 12.5 8.2 17.8 34.6 8.1 9.4 10.8 3.5 7.2 5.0 29.3 6.2 9.8 12.8 6.7 12.6 7.6 10.0 8.1 13.5 29.1 10.2 8.2 9.5 8.2 4.9 7.6 21.2 3.4 1.8 2.5 1.7 8.4 10.6 11.3 7.4 0.6 0.7 4.0 3.9 10.8 3.5 4.4 3.9 7.2 9.6 8.2 1.8 5.4 9.1 2.4 4.5 8.5 9.2 13.9 3.7 5.0 4.4 15.1 12.5 1.0 1.3 3.2 2.1 46.2 11.7 6.4 1.7 4.5 6.3 9.8 1.5 3.1 9.6 4.9 5.0 7.7 5.7 3.8 5.3 4.0 4.1 5.0 8.0 8.0 9.4 0.2 3.7 3.3 6.3 4.8 5.1 7.8 1.2 17.0 4.0 3.7 3.4 10.1 2.2 2.7 2.2 4.7 2.5 2.1 3.4 4.9 2.1 2.4 21.2 1.8 2.6 7.6 2.3 1.7 15.3 16.9 18.9 16.2 15.5 8.6 6.1 12.8 8.1 8.1 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: , HPA063991: " "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 12.1 14.2 17.9 5.7 23.0 1.9 9.5 19.8 23.3 10.2 7.2 18.0 6.0 8.4 11.8 7.5 16.5 8.7 7.8 51.7 18.3 14.4 8.8 4.8 7.9 3.8 18.5 17.0 17.4 6.0 18.6 11.2 34.7 19.8 9.7 7.0 7.3 7.6 10.9 11.2 27.5 10.7 11.6 15.0 6.0 8.0 7.7 20.4 3.1 11.7 7.8 7.3 9.5 12.6 3.0 1.7 3.2 2.0 1.6 3.4 1.2 10.8 8.3 7.6 9.2 22.0 9.1 13.2 8.0 11.3 6.9 4.5 11.2 1.7 2.8 5.0 13.3 18.2 6.4 13.1 10.0 2.1 5.2 8.4 5.8 6.4 11.8 1.2 2.9 7.7 19.1 7.7 12.1 11.2 0.9 0.0 9.0 3.7 3.1 1.4 7.9 4.6 1.7 13.7 1.1 6.6 25.5 3.8 3.3 13.6 4.2 5.5 2.9 1.1 12.3 8.0 6.8 6.8 4.8 2.9 2.8 0.0 9.3 0.6 6.3 3.2 1.9 0.2 2.7 1.7 2.1 2.4 2.1 1.7 1.7 3.0 2.4 3.4 0.0 1.6 2.0 0.6 2.6 1.2 17.9 23.0 19.8 22.8 18.3 14.4 18.5 17.0 19.8 20.4 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97436142-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 18.2 23.3 22.3 28.8 26.2 24.8 23.4 22.8 26.6 19.9 21.9 21.4 23.4 21.9 22.9 45.6 25.1 20.2 19.2 19.4 21.6 23.2 20.5 24.6 18.3 30.1 24.2 19.8 22.3 35.0 21.0 33.6 22.8 21.8 21.5 26.2 20.6 32.5 27.7 23.6 22.1 20.7 24.2 22.4 27.4 26.2 15.6 20.8 36.6 23.4 21.1 34.1 23.5 19.9 37.3 32.2 30.9 43.0 18.5 47.2 28.4 18.8 19.0 12.1 20.1 16.9 18.1 15.9 16.8 29.0 22.7 26.5 30.7 20.8 21.1 16.8 18.7 21.1 19.2 22.6 22.3 22.4 23.6 13.0 16.4 23.2 29.5 29.0 14.3 18.6 29.8 25.8 39.1 26.4 15.7 35.1 17.6 24.0 27.5 48.2 18.8 16.4 20.0 14.2 36.4 15.1 10.8 6.9 12.1 11.8 9.9 25.0 23.4 32.9 13.0 11.3 12.9 17.1 35.0 22.1 27.0 36.8 18.5 36.8 8.6 24.3 31.6 30.9 28.1 43.0 35.3 37.3 35.5 31.9 32.2 29.4 34.2 29.6 13.0 18.5 39.0 28.1 47.2 28.4 22.3 26.2 22.8 26.6 21.6 23.2 24.2 19.8 21.8 20.8 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397479 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA053150: , HPA055677: " "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavourable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 9.1 14.3 12.6 12.3 16.6 13.1 11.1 7.6 21.3 8.8 12.1 10.8 9.0 10.0 8.1 6.0 14.6 13.6 6.4 11.6 12.0 10.3 7.9 25.1 5.7 17.0 13.4 9.9 13.2 46.9 3.2 4.9 6.5 10.3 9.5 6.6 6.3 14.0 8.1 30.9 18.5 9.5 6.6 14.0 12.7 9.8 7.5 11.8 16.8 15.1 15.7 12.2 11.3 8.6 22.9 36.8 3.3 23.7 17.1 21.1 13.5 17.8 33.5 4.7 13.8 3.0 3.8 11.0 7.6 3.6 12.4 10.3 19.5 13.2 27.9 19.7 3.7 6.8 9.3 8.5 3.9 17.8 32.1 12.4 12.6 14.8 9.6 22.4 12.3 4.7 19.1 10.0 9.6 5.8 16.6 20.1 4.1 23.4 19.3 15.8 16.6 16.6 18.3 12.9 25.1 5.0 12.8 18.1 13.6 10.9 18.3 18.5 8.5 27.7 4.6 13.1 11.0 8.3 23.3 31.7 40.5 30.3 10.2 32.3 11.1 3.3 21.7 0.6 13.2 23.7 15.8 21.1 14.4 13.3 34.1 22.9 21.1 18.5 1.5 17.1 14.0 36.8 11.1 13.5 12.6 16.6 7.6 21.3 12.0 10.3 13.4 9.9 10.3 11.8 EXTL2 ENSG00000162694 "Exostosin like glycosyltransferase 2" Q9UBQ6 1 100872372-100895998 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020716, HPA068921" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" 83000000 Nucleoplasm Cytosol "CAB020716: , HPA068921: " "unprognostic (3.14e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-2)" "unprognostic (8.20e-2)" "unprognostic (9.07e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (6.84e-2)" "unprognostic (7.83e-2)" "unprognostic (1.24e-2)" "unprognostic (4.34e-2)" 7.5 23.0 9.8 4.1 19.9 1.7 10.4 14.7 22.8 13.4 8.7 8.1 9.9 4.5 16.7 13.1 6.0 10.1 10.3 8.2 9.5 13.3 11.2 10.0 7.6 3.4 14.0 12.0 18.8 7.7 17.5 18.7 21.8 20.1 12.3 7.1 8.6 6.0 11.4 5.3 5.9 4.6 15.4 11.4 5.4 6.2 9.7 16.3 6.4 9.3 5.0 3.4 9.0 6.2 2.1 7.4 3.3 1.1 5.3 5.6 1.9 5.1 2.7 19.8 20.7 22.0 16.2 12.6 8.9 14.6 7.0 15.7 2.5 3.9 5.7 8.6 8.1 5.0 7.2 7.6 14.2 11.6 5.0 7.0 9.6 7.1 7.2 10.9 3.7 19.2 2.7 14.0 2.7 25.5 8.8 0.7 17.6 2.6 5.7 6.0 24.9 6.0 4.2 20.4 4.7 7.5 3.9 8.2 23.3 6.8 1.7 15.9 4.3 4.9 10.7 17.5 10.3 11.2 9.3 6.1 5.4 3.5 27.9 11.3 5.7 3.3 0.8 0.0 5.6 1.1 2.8 1.9 1.9 3.7 2.5 2.1 2.1 4.8 0.2 5.3 0.9 7.4 0.0 1.9 9.8 19.9 14.7 22.8 9.5 13.3 14.0 12.0 20.1 16.3 EYA4 "CMD1J, DFNA10" ENSG00000112319 "EYA transcriptional coactivator and phosphatase 4" O95677 6 133240598-133532120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 65.6" "Cell line enhanced" "Detected in many" "A549: 12.6;HeLa: 35.3;RH-30: 12.0;U-87 MG: 12.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004805, HPA038771, HPA038772" Enhanced Approved Nucleoplasm Nucleoplasm "HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-9)" "unprognostic (1.64e-1)" "unprognostic (3.08e-2)" "unprognostic (3.44e-2)" "unprognostic (7.21e-2)" "unprognostic (9.07e-2)" "unprognostic (2.04e-2)" "unprognostic (2.80e-1)" "unprognostic (2.29e-1)" "unprognostic (8.27e-4)" "unprognostic (1.82e-3)" "unprognostic (6.67e-2)" "unprognostic (9.55e-2)" "unprognostic (2.51e-2)" 1.6 3.0 1.2 0.2 1.3 0.1 2.4 0.4 1.2 9.7 0.6 2.5 11.1 0.4 2.6 1.9 0.7 8.3 0.7 6.2 1.5 1.2 6.1 0.4 2.0 0.2 2.1 0.8 1.6 0.4 0.2 7.2 0.2 3.5 6.6 0.4 2.7 0.8 13.9 65.6 0.4 0.5 1.9 3.5 0.6 0.7 7.4 1.4 1.8 2.5 5.5 0.7 2.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 1.2 0.0 0.0 0.0 0.0 0.0 10.1 0.2 1.5 0.0 0.0 0.0 10.0 0.0 0.0 7.6 3.2 0.0 0.0 9.9 1.3 35.3 0.0 0.3 0.0 3.4 2.6 0.0 7.3 2.2 0.0 0.0 5.4 4.0 0.0 0.0 0.0 0.0 0.7 0.1 12.0 0.0 0.0 1.9 1.8 2.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 3.6 1.6 0.0 12.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.4 1.2 1.5 1.2 2.1 0.8 3.5 1.4 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Group enriched" "Detected in some" 8 "AF22: 37.8;U-251 MG: 10.2;WM-115: 22.7" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: , HPA028825: AB_10602130" "prognostic favourable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavourable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 37.8 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.2 0.0 0.0 0.0 0.4 0.0 22.7 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 FAM104A FLJ14775 ENSG00000133193 "Family with sequence similarity 104 member A" Q969W3 17 73207353-73236753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021459 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021459: AB_1848361" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-3)" "unprognostic (3.23e-2)" "unprognostic (2.28e-2)" "unprognostic (3.05e-2)" "prognostic unfavourable (2.12e-7)" "unprognostic (5.19e-2)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (4.20e-2)" "unprognostic (1.20e-2)" "prognostic unfavourable (1.26e-10)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" 9.3 7.2 8.7 9.1 9.0 23.2 12.4 10.8 7.9 9.9 9.1 6.9 7.4 7.8 8.4 8.4 10.4 6.6 8.5 11.6 8.1 7.0 6.4 10.0 8.2 10.1 6.9 8.3 8.2 11.4 8.4 11.2 14.2 6.4 9.3 8.1 8.4 8.3 8.0 11.9 11.7 10.1 7.3 7.1 11.8 13.3 74.8 6.5 14.6 9.2 7.1 11.2 9.9 11.6 21.3 19.7 34.3 20.3 26.7 49.5 29.9 22.6 18.6 9.4 17.4 14.4 13.6 30.8 18.5 19.5 20.5 21.2 15.6 14.7 13.3 15.3 17.8 14.5 12.0 13.5 22.3 15.5 16.2 19.3 16.0 23.6 19.2 16.8 33.2 14.3 18.0 18.1 13.3 23.9 14.9 22.2 24.5 15.4 29.8 11.6 12.9 23.9 16.4 26.2 12.8 15.6 18.6 15.5 20.6 10.8 15.8 19.9 22.2 17.4 16.6 24.3 28.1 16.5 21.6 22.0 21.7 16.1 21.7 18.4 17.9 24.5 20.3 34.3 24.7 17.6 23.7 21.3 30.3 28.1 19.7 20.2 22.2 26.7 33.3 26.7 18.6 12.8 49.5 29.9 8.7 9.0 10.8 7.9 8.1 7.0 6.9 8.3 6.4 6.5 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles, Cytosol" "CAB034110: AB_1562838, HPA069240: " "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavourable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.4 3.4 1.9 3.5 2.1 0.9 13.2 3.9 2.2 2.5 2.2 7.3 7.9 4.1 1.7 2.4 20.3 1.5 10.3 2.1 3.3 1.1 8.4 2.1 1.9 0.9 2.3 3.0 0.5 12.8 3.4 3.4 1.7 4.5 10.1 2.3 7.5 6.4 6.2 2.5 5.8 6.4 3.3 5.3 1.9 9.1 3.6 4.3 3.3 39.7 1.7 16.4 3.4 2.2 6.0 4.4 5.4 4.3 3.7 3.2 1.7 0.9 6.0 4.3 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, DNA replication, Host-virus interaction" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavourable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favourable (4.39e-4)" 16.3 13.7 4.8 28.1 6.7 9.9 14.5 3.3 4.8 14.7 14.2 8.3 13.2 12.8 18.1 16.8 10.2 11.3 15.9 6.7 5.5 3.9 14.5 11.7 17.5 19.6 7.4 3.8 11.2 10.7 17.8 17.4 10.8 8.1 22.5 11.7 13.2 13.4 13.0 5.6 11.0 19.3 14.0 12.3 29.5 12.9 5.9 6.5 73.4 19.5 12.9 21.3 10.9 13.2 4.6 6.5 7.7 6.3 6.9 8.6 2.4 21.0 5.5 2.7 2.5 6.0 7.3 1.8 30.2 16.4 13.0 19.2 8.2 19.8 30.9 12.7 9.7 7.4 9.0 13.1 16.4 27.5 0.4 11.6 6.9 2.5 6.2 18.5 15.8 5.1 3.3 12.1 3.9 12.0 1.4 25.5 14.0 6.0 27.8 12.4 1.2 5.9 19.2 9.7 7.2 8.7 18.8 0.0 0.7 15.5 13.0 5.9 26.6 8.3 11.6 21.2 19.1 14.4 14.0 13.1 13.6 5.0 11.6 13.2 25.5 6.2 6.3 6.7 6.6 5.4 8.6 4.2 4.5 4.8 6.5 4.6 4.4 3.7 7.7 6.9 2.6 1.8 4.6 2.4 4.8 6.7 3.3 4.8 5.5 3.9 7.4 3.8 8.1 6.5 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavourable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.0 6.2 9.3 0.1 1.0 1.8 0.1 18.3 9.2 10.9 16.2 13.1 9.6 30.0 12.4 5.3 18.7 13.5 12.3 19.5 15.6 3.3 3.2 11.8 5.7 0.0 0.1 3.9 0.4 0.4 10.5 0.8 5.8 0.9 28.3 12.8 9.1 18.9 0.2 0.1 7.3 20.0 13.8 11.7 5.8 20.8 1.8 5.9 15.1 17.5 3.0 19.4 1.7 3.2 8.5 18.5 25.5 16.6 21.8 15.7 0.2 12.3 0.1 12.1 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 FAM117A ENSG00000121104 "Family with sequence similarity 117 member A" Q9C073 17 49710332-49789180 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 34.7;U-266/84: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 24.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA022531 Approved Approved Nucleoplasm Nucleoplasm "HPA022531: AB_2101087" "prognostic favourable (5.30e-5)" "unprognostic (8.06e-3)" "unprognostic (2.82e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (3.90e-3)" "unprognostic (1.69e-1)" "prognostic favourable (8.25e-7)" "unprognostic (4.05e-1)" "unprognostic (3.58e-1)" "prognostic favourable (1.81e-4)" "unprognostic (1.99e-2)" "unprognostic (3.73e-2)" "unprognostic (9.12e-2)" "unprognostic (1.45e-1)" "unprognostic (4.07e-2)" "unprognostic (4.66e-2)" 9.9 5.7 7.6 15.5 9.4 42.9 9.6 12.4 5.7 17.4 15.8 5.6 12.2 7.2 21.2 9.6 11.3 12.4 13.3 12.5 5.6 3.7 8.3 10.0 9.0 14.2 2.8 5.4 16.0 17.6 8.6 11.9 4.4 10.8 16.4 6.0 24.3 11.9 21.3 4.0 13.6 13.7 20.7 2.1 26.7 10.3 18.4 3.6 30.0 14.2 6.5 24.1 21.8 8.5 13.9 2.1 24.3 0.9 6.7 5.5 1.8 2.9 0.7 4.8 0.0 2.1 0.4 8.7 1.0 1.7 1.8 3.0 21.3 4.9 14.1 5.3 0.6 1.7 3.8 3.6 1.4 1.0 6.0 15.5 0.0 6.8 2.4 2.3 12.4 2.1 3.0 3.0 1.6 3.2 18.9 12.0 1.7 8.0 14.9 12.5 7.2 2.4 4.7 4.1 7.4 2.8 2.6 4.8 3.2 1.0 0.4 3.5 7.1 8.9 0.3 1.8 1.5 1.9 0.8 34.7 23.9 9.3 1.5 3.4 1.4 24.3 0.9 4.9 5.0 0.6 5.5 13.9 3.3 4.2 0.7 9.3 2.7 3.7 1.9 6.7 0.1 2.1 3.2 1.8 7.6 9.4 12.4 5.7 5.6 3.7 2.8 5.4 10.8 3.6 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202635188-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: " "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 5.8 12.5 10.1 11.1 10.3 4.3 10.0 20.8 18.1 5.5 7.9 3.2 7.1 7.0 5.0 7.5 9.6 6.6 6.2 4.3 8.6 10.8 8.3 3.6 6.2 13.0 5.9 9.1 8.8 11.6 24.7 7.5 11.0 4.7 8.6 7.9 3.7 8.6 9.3 5.8 9.0 6.0 7.3 5.7 8.2 6.6 12.6 5.8 22.4 5.5 4.8 11.7 7.2 12.7 9.0 4.8 2.3 8.9 4.5 9.9 3.3 1.5 2.0 8.8 6.0 3.0 1.7 8.5 0.5 0.8 0.5 1.0 2.5 3.4 6.6 5.4 0.9 1.5 7.5 3.8 1.4 0.1 6.0 5.5 3.8 9.3 2.4 4.7 2.5 2.3 5.3 1.1 1.6 2.3 7.9 1.3 0.5 3.2 12.6 9.8 8.9 3.8 10.0 1.8 7.8 4.7 4.2 14.9 12.9 6.6 4.4 3.1 1.8 6.5 1.4 1.1 2.0 1.5 0.9 4.9 2.8 8.8 2.0 3.6 1.1 0.3 4.5 1.6 1.6 8.9 4.0 9.0 3.6 3.1 4.8 8.5 9.9 6.8 2.3 4.5 8.8 1.7 1.3 3.3 10.1 10.3 20.8 18.1 8.6 10.8 5.9 9.1 4.7 5.8 FAM120B "CCPG, KIAA1838, PGCC1" ENSG00000112584 "Family with sequence similarity 120B" Q96EK7 6 170290703-170407065 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037518, HPA037519" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037518: AB_10671626, HPA037519: AB_10696935" "unprognostic (7.99e-3)" "unprognostic (7.81e-2)" "unprognostic (2.01e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-2)" "unprognostic (6.02e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-1)" "unprognostic (9.87e-2)" "prognostic unfavourable (1.60e-4)" "prognostic favourable (2.70e-4)" "unprognostic (1.41e-1)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (2.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" 18.4 20.6 18.5 21.1 28.7 10.7 20.5 28.4 27.7 20.5 16.6 28.5 16.3 15.8 28.3 24.1 16.5 26.8 18.1 18.4 18.1 22.8 17.3 15.6 18.3 16.7 20.6 19.5 23.4 17.0 24.7 32.0 19.5 26.1 22.4 18.6 19.1 21.4 21.2 25.7 18.4 16.2 20.1 21.1 16.9 16.9 20.7 20.4 24.7 22.3 15.3 22.0 19.8 16.3 7.4 9.2 14.7 13.6 15.9 10.2 8.5 5.9 6.1 9.3 11.1 13.4 13.0 5.5 10.0 11.7 8.9 8.9 5.4 4.6 8.4 6.0 14.3 7.2 9.6 11.5 11.7 12.1 5.9 9.0 5.7 7.1 12.0 8.8 7.2 15.7 12.3 8.2 10.9 13.7 9.8 6.9 14.9 12.2 6.4 7.9 4.6 4.2 5.5 8.7 8.7 9.3 5.3 6.6 10.1 8.6 7.7 3.0 7.6 17.6 11.6 3.8 6.3 10.0 7.0 8.6 7.1 8.9 10.4 7.3 13.9 14.7 8.1 10.0 8.3 9.0 9.5 6.6 7.9 8.9 9.2 7.4 10.2 8.1 13.9 15.9 13.6 5.3 8.4 8.5 18.5 28.7 28.4 27.7 18.1 22.8 20.6 19.5 26.1 20.4 FAM122A "C9orf42, MGC17347" ENSG00000187866 "Family with sequence similarity 122A" Q96E09 9 68780034-68784608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056646 Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA056646: " "unprognostic (1.88e-2)" "unprognostic (7.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.16e-1)" "unprognostic (9.79e-2)" "unprognostic (1.45e-2)" "unprognostic (4.18e-1)" "unprognostic (8.49e-3)" "unprognostic (1.45e-2)" "unprognostic (4.58e-3)" "prognostic favourable (1.34e-5)" "unprognostic (9.35e-2)" "unprognostic (3.02e-2)" "unprognostic (2.72e-1)" "unprognostic (6.89e-2)" 21.0 21.3 13.9 12.0 20.2 9.8 21.4 22.5 24.6 23.1 15.5 17.0 12.4 10.0 20.3 15.6 17.6 19.7 14.4 24.2 13.8 14.3 21.5 21.2 14.1 14.7 16.8 14.2 24.2 17.9 25.3 20.8 21.8 18.0 20.6 14.9 22.4 17.0 19.8 20.0 15.1 15.0 17.6 13.9 17.7 15.0 16.2 14.6 18.1 19.1 14.8 15.4 15.7 16.5 5.8 6.7 4.3 5.1 4.5 9.8 2.5 5.3 3.6 5.0 4.4 17.5 11.4 6.9 7.7 7.3 6.8 5.5 1.3 2.7 11.3 3.9 8.1 10.1 5.6 5.2 8.5 12.2 6.0 6.2 6.0 4.5 10.8 11.3 4.5 9.2 11.9 6.2 4.9 6.7 6.6 12.9 7.3 2.9 6.3 3.0 6.4 6.6 7.7 7.0 3.5 6.1 4.4 8.1 3.7 5.7 4.8 3.9 2.9 5.0 8.4 6.4 4.5 11.8 5.6 15.2 6.1 4.7 6.8 7.2 7.1 4.3 5.1 3.7 4.5 4.9 4.0 3.6 4.5 4.9 5.7 5.8 9.8 5.5 2.9 4.5 4.8 6.7 4.9 2.5 13.9 20.2 22.5 24.6 13.8 14.3 16.8 14.2 18.0 14.6 FAM122B "DKFZp686L20116, RP11-308B5.5" ENSG00000156504 "Family with sequence similarity 122B" Q7Z309 X 134769566-134797232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000266 Enhanced Approved Nucleoplasm Nucleoplasm "HPA000266: AB_1078801" "unprognostic (2.10e-3)" "unprognostic (1.55e-2)" "unprognostic (4.53e-3)" "prognostic unfavourable (7.19e-5)" "unprognostic (1.67e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-2)" "unprognostic (3.07e-2)" "unprognostic (1.50e-2)" "unprognostic (2.15e-1)" "unprognostic (7.64e-2)" "unprognostic (1.53e-3)" "unprognostic (2.26e-3)" "unprognostic (2.60e-2)" "unprognostic (7.96e-2)" "unprognostic (2.11e-2)" "unprognostic (3.19e-3)" 13.4 18.5 24.5 18.4 41.5 27.1 14.8 20.9 29.6 15.7 15.4 22.3 13.4 15.5 23.0 27.7 16.2 20.3 13.6 13.9 22.5 21.8 15.2 9.8 15.5 27.2 22.9 24.7 29.3 15.9 29.0 27.8 17.4 21.3 17.3 23.6 13.3 18.8 17.4 10.3 19.4 19.5 20.3 21.8 26.1 18.5 34.5 20.5 21.4 20.7 11.1 26.5 16.3 16.3 1.6 3.8 5.9 1.2 2.7 3.3 1.1 17.5 16.2 13.0 9.3 6.7 8.8 9.2 13.9 12.3 15.9 15.1 14.3 15.7 17.3 27.7 10.1 11.8 19.2 11.5 28.9 21.3 13.3 17.3 32.4 4.6 4.1 31.7 22.2 5.7 11.4 17.4 7.6 9.2 11.3 22.2 16.7 23.7 19.7 27.6 7.1 17.5 20.0 14.2 15.0 9.7 18.3 11.9 8.4 7.4 10.1 5.1 5.4 16.4 6.5 13.2 8.6 33.6 30.2 12.3 14.1 22.3 14.2 37.0 16.4 0.1 1.2 5.9 2.1 0.5 2.8 1.6 2.0 2.8 1.2 1.5 2.4 3.3 1.3 2.7 1.1 3.8 2.0 1.1 24.5 41.5 20.9 29.6 22.5 21.8 22.9 24.7 21.3 20.5 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3" "Group enriched" "Detected in some" 4 "HAP1: 13.0;HUVEC TERT2: 7.7;NTERA-2: 25.5;SH-SY5Y: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA048182: " "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 5.3 3.5 7.7 4.7 19.6 0.7 2.6 2.6 15.0 3.3 7.2 40.3 0.3 1.4 3.8 8.4 2.4 3.6 4.3 7.1 13.5 7.4 6.7 1.5 3.3 1.5 29.1 7.7 1.3 2.7 1.2 1.5 6.2 18.8 6.5 2.6 3.8 12.4 8.1 1.8 1.9 2.1 8.9 25.3 13.2 4.1 2.3 26.7 0.3 2.8 0.6 1.1 4.1 1.8 0.8 1.0 2.7 0.9 1.2 0.8 0.3 0.0 1.2 0.9 0.8 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.0 0.0 0.1 13.0 0.1 0.1 0.0 1.9 0.0 0.3 0.0 1.0 0.6 0.8 0.3 0.1 0.4 0.0 7.7 0.1 0.0 0.0 0.2 3.1 0.2 25.5 2.0 0.7 0.0 1.8 0.0 0.1 1.8 9.8 0.4 1.6 1.5 0.2 0.7 0.1 0.0 0.9 0.6 0.9 0.2 0.0 0.0 1.2 2.2 1.0 2.7 0.8 0.8 0.8 0.6 0.8 0.6 0.5 0.6 0.4 0.8 0.7 0.7 2.4 1.2 0.9 1.0 0.6 0.3 7.7 19.6 2.6 11.8 13.5 7.4 29.1 7.7 18.8 26.7 FAM126B "HYCC2, MGC39518" ENSG00000155744 "Family with sequence similarity 126 member B" Q8IXS8 2 200973718-201071671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036166, HPA036167, HPA067307" Uncertain Supported "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA036166: AB_10696651, HPA036167: , HPA067307: " "unprognostic (7.47e-3)" "unprognostic (5.54e-2)" "unprognostic (2.52e-1)" "unprognostic (9.08e-2)" "unprognostic (8.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.11e-2)" "unprognostic (2.61e-3)" "unprognostic (1.34e-1)" "unprognostic (1.48e-2)" "unprognostic (1.79e-2)" "unprognostic (1.90e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" 10.5 6.9 9.8 8.7 17.2 22.1 7.3 28.7 21.1 5.9 10.3 6.5 5.9 9.8 6.8 6.3 12.1 5.8 6.4 6.5 9.3 9.2 12.0 10.9 9.4 7.9 7.3 11.6 7.8 7.1 9.8 16.6 7.2 15.1 5.8 9.6 8.8 7.0 4.9 5.6 10.2 9.3 5.8 8.1 10.6 11.0 6.3 6.4 8.3 10.3 2.9 8.7 5.5 8.1 2.1 1.2 20.3 1.9 2.3 3.4 1.5 3.2 1.7 2.5 2.6 2.6 3.5 5.4 3.1 1.8 2.5 2.4 4.4 3.9 3.0 3.1 3.1 4.0 5.0 1.9 3.9 4.3 3.1 8.7 4.6 4.1 2.1 10.5 7.6 1.5 2.4 3.4 2.1 2.4 8.0 11.2 2.5 2.0 6.3 6.9 1.7 2.9 3.7 3.7 2.7 2.4 3.6 4.9 2.5 3.3 3.8 2.8 2.6 4.6 4.8 4.7 3.4 2.3 2.8 8.3 34.6 6.4 2.8 4.1 3.2 1.7 1.4 5.1 3.1 1.8 3.4 2.1 2.6 2.4 1.2 2.0 2.6 3.1 20.3 2.3 1.9 0.9 1.7 1.5 9.8 17.2 28.7 21.1 9.3 9.2 7.3 11.6 15.1 6.4 FAM129C "BCNP1, FLJ39802" ENSG00000167483 "Family with sequence similarity 129 member C" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9" "Group enriched" "Detected in some" 22 "Daudi: 29.1;REH: 14.6;U-698: 18.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 226 "memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2" "Group enriched" "Detected in many" 284 "B-cells: 19.5;dendritic cells: 37.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043277 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.5 0.2 0.2 37.9 0.2 12.1 0.2 0.3 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 2.2 0.2 0.5 0.6 0.2 0.2 0.5 0.3 0.9 17.4 0.2 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.4 9.9 0.2 0.1 0.2 12.3 0.0 0.3 28.5 0.4 0.5 0.0 2.5 0.5 0.4 35.4 3.0 0.4 19.5 37.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.7 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 FAM135A "FLJ20176, KIAA1411" ENSG00000082269 "Family with sequence similarity 135 member A" Q9P2D6 6 70412941-70561174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031743, HPA031744" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA031743: AB_10600767, HPA031744: AB_10601101" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "prognostic favourable (8.00e-4)" "unprognostic (1.59e-1)" "unprognostic (1.66e-2)" "unprognostic (1.08e-1)" "unprognostic (6.69e-4)" "unprognostic (4.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "prognostic favourable (3.46e-4)" "unprognostic (3.99e-1)" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "unprognostic (2.65e-2)" 5.8 4.3 6.4 9.2 6.8 1.7 5.3 14.0 10.7 9.6 13.3 4.0 5.3 14.9 7.7 4.9 33.8 5.4 8.8 5.2 5.4 5.2 9.6 5.5 5.5 4.1 6.1 7.1 8.0 6.9 16.4 13.8 22.7 8.5 18.9 13.0 4.2 10.4 6.7 5.7 14.2 27.9 4.8 8.9 4.5 12.3 11.0 6.0 4.1 4.8 13.1 10.6 7.6 14.4 3.9 6.3 3.3 5.3 5.4 2.2 1.5 5.8 3.4 7.6 4.7 3.5 2.6 6.8 1.9 3.8 2.1 3.5 6.6 4.8 10.5 13.7 1.4 5.7 7.5 4.7 3.6 5.0 6.2 4.8 3.7 5.8 4.3 8.8 5.0 2.2 11.0 4.0 10.9 5.4 7.5 5.5 2.3 0.6 1.6 4.1 4.9 2.8 5.1 23.9 5.0 7.8 3.2 8.0 2.4 2.3 2.0 2.3 1.4 4.0 2.6 1.8 4.6 1.7 4.3 6.5 7.4 4.2 1.2 8.0 3.2 3.3 4.3 0.2 1.5 3.5 1.9 3.0 1.4 0.6 6.3 3.9 2.2 1.3 1.2 5.4 5.3 1.0 1.7 1.5 6.4 6.8 14.0 10.7 5.4 5.2 6.1 7.1 8.5 6.0 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell line enriched" "Detected in some" 11 "RH-30: 13.9" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 13.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 FAM13B "ARHGAP49, C5orf5, FAM13B1, KHCHP, N61" ENSG00000031003 "Family with sequence similarity 13 member B" Q9NYF5 5 137937960-138051961 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036525, HPA041819, HPA071936" Uncertain Approved Nucleoplasm Nucleoplasm "HPA036525: AB_10696655, HPA041819: , HPA071936: " "unprognostic (8.09e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-3)" "unprognostic (9.61e-2)" "unprognostic (1.44e-1)" "unprognostic (3.95e-2)" "unprognostic (1.44e-2)" "unprognostic (2.02e-3)" "unprognostic (6.51e-2)" "unprognostic (6.31e-2)" "unprognostic (1.69e-2)" "unprognostic (3.60e-1)" "prognostic favourable (3.55e-5)" "unprognostic (9.56e-2)" "unprognostic (4.46e-1)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" 12.8 27.1 19.7 18.3 22.0 19.1 14.6 29.4 22.6 15.2 16.4 15.8 18.4 8.9 21.1 13.7 13.3 14.6 13.8 18.3 17.0 21.9 13.1 7.9 13.5 17.8 18.5 15.5 23.7 9.3 14.9 17.7 14.6 26.3 23.4 11.6 14.2 12.3 34.4 5.8 10.1 13.5 29.6 13.4 15.3 12.4 29.4 21.5 13.5 14.1 5.7 20.5 21.2 15.2 7.9 3.7 11.9 6.6 7.6 6.2 1.8 9.4 4.8 14.3 11.7 19.1 6.0 11.2 20.9 17.1 16.1 18.7 12.7 8.6 21.4 7.0 18.2 7.4 8.7 6.6 21.0 16.1 9.5 9.6 11.6 4.0 6.5 15.6 13.3 7.6 3.9 12.2 7.2 5.5 5.5 11.0 14.7 6.9 15.6 8.6 5.6 5.7 11.3 14.2 4.2 9.7 16.9 16.2 14.3 16.3 5.0 20.6 13.7 15.9 7.2 17.2 7.5 12.7 15.7 8.9 21.1 20.4 9.7 12.8 14.7 11.9 2.9 10.5 6.2 3.9 5.2 6.5 4.4 5.4 2.1 7.9 4.6 5.9 9.1 7.6 6.6 3.7 4.1 1.8 19.7 22.0 29.4 22.6 17.0 21.9 18.5 15.5 26.3 21.5 FAM13C FAM13C1 ENSG00000148541 "Family with sequence similarity 13 member C" Q8NE31 10 59246129-59363181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.2;HSkMC: 6.8;NTERA-2: 5.7;SCLC-21H: 11.3;SH-SY5Y: 6.6" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037888 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037888: AB_10962981" "unprognostic (3.68e-1)" "unprognostic (6.10e-2)" "unprognostic (2.46e-1)" "unprognostic (6.69e-5)" "unprognostic (8.54e-2)" "unprognostic (4.56e-2)" "unprognostic (3.30e-2)" "unprognostic (1.06e-2)" "unprognostic (6.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.27e-1)" "unprognostic (4.51e-6)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (1.94e-3)" "unprognostic (4.66e-3)" 11.8 17.0 16.1 3.8 22.3 0.3 7.7 12.4 24.9 9.4 6.4 36.6 3.2 4.5 9.0 8.7 14.4 15.3 11.6 7.8 18.9 15.9 3.8 2.3 10.0 4.5 23.8 18.8 22.2 2.5 4.0 8.3 2.9 21.2 17.9 6.7 16.5 4.9 8.7 15.3 7.3 5.0 12.5 33.2 5.0 3.9 5.2 28.9 0.0 6.0 7.6 2.5 7.4 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 1.7 0.3 0.1 0.0 1.6 0.0 5.2 2.4 0.2 0.0 0.0 6.8 0.8 0.3 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 5.7 0.5 0.0 1.1 0.0 0.0 1.7 11.3 6.6 0.0 0.3 0.0 0.9 0.0 0.0 3.3 3.0 0.1 2.6 0.0 0.0 0.1 4.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 22.3 12.4 23.4 18.9 15.9 23.8 18.8 21.2 28.9 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168166-73244504 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm Nucleoplasm "HPA039189: AB_10805355, HPA039859: " "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavourable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 9.3 8.9 21.3 7.3 17.0 5.4 10.1 7.7 15.1 12.2 13.4 14.9 10.3 5.4 9.1 10.6 10.5 11.4 12.8 15.7 19.2 14.2 17.5 15.2 7.9 6.3 20.8 9.8 12.6 9.3 12.9 10.8 10.3 13.6 10.5 8.0 8.1 9.0 9.1 9.4 5.8 9.5 9.3 22.8 5.9 7.2 16.6 13.2 6.2 9.8 13.4 7.3 8.3 7.3 2.7 2.7 5.0 1.8 4.6 3.4 1.3 7.1 5.4 12.1 11.2 26.6 16.6 7.9 8.1 16.0 5.5 9.8 3.4 12.5 5.3 3.2 14.2 6.8 7.0 10.2 6.7 6.5 3.6 6.8 4.2 5.7 13.9 9.3 4.5 14.2 7.5 7.1 27.9 13.9 6.1 9.9 10.0 6.4 6.1 8.8 5.2 14.2 4.0 7.6 5.4 14.9 7.1 2.7 11.5 6.4 17.0 9.8 9.8 5.9 7.3 5.4 5.5 5.4 10.2 10.9 4.9 4.7 9.3 9.2 4.3 5.0 0.7 2.5 2.2 1.8 2.8 2.7 2.2 2.1 1.5 2.2 3.4 3.1 1.5 4.6 1.0 2.7 2.5 1.3 21.3 17.0 7.7 15.1 19.2 14.2 20.8 9.8 13.6 13.2 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 11.6;SCLC-21H: 7.1;SH-SY5Y: 16.1;U-138 MG: 5.0;U-87 MG: 10.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: " "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.0 2.4 0.1 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.2 0.0 11.6 1.9 7.1 16.1 0.0 0.0 0.0 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.2 0.0 3.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 FAM160B2 "FLJ21801, RAI16" ENSG00000158863 "Family with sequence similarity 160 member B2" Q86V87 8 22089159-22104898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025040 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA025040: AB_1856049" "unprognostic (3.45e-1)" "unprognostic (2.08e-3)" "unprognostic (1.60e-1)" "unprognostic (8.85e-3)" "unprognostic (2.28e-2)" "prognostic favourable (4.56e-4)" "unprognostic (2.35e-2)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (8.38e-3)" "unprognostic (7.67e-3)" "unprognostic (3.38e-2)" "unprognostic (6.30e-2)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" "unprognostic (2.75e-3)" 15.8 11.8 9.6 13.1 10.0 6.6 14.3 14.3 14.8 12.9 13.2 12.9 20.8 12.0 13.2 16.9 13.7 14.1 14.5 26.0 8.5 6.9 12.3 9.8 11.0 11.2 12.5 10.5 11.4 22.1 15.3 14.1 22.4 10.9 14.4 6.0 13.4 18.8 25.1 15.1 24.4 13.4 25.3 10.4 12.3 16.1 6.4 10.3 6.5 16.0 11.6 13.2 19.9 11.2 2.7 0.9 0.5 1.4 1.7 3.2 2.1 3.7 9.2 4.4 6.8 8.9 8.3 6.8 5.7 12.5 8.5 5.9 3.8 4.5 3.8 6.3 17.9 5.2 3.2 10.3 1.8 3.3 3.5 5.7 2.4 2.6 12.1 1.5 5.3 13.9 7.0 6.2 4.2 8.7 3.8 3.3 8.0 7.7 4.1 2.2 1.8 3.2 4.3 3.2 2.2 7.1 9.1 1.5 4.8 3.5 7.4 4.8 4.4 3.4 8.3 8.6 6.6 7.7 3.9 2.6 0.8 0.7 9.1 2.8 9.2 0.0 1.2 0.5 3.2 0.7 1.9 2.7 2.1 2.6 0.8 2.3 1.9 2.7 0.3 1.7 1.4 0.9 0.3 2.1 9.6 10.0 14.3 14.8 8.5 6.9 12.5 10.5 10.9 10.3 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavourable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favourable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (9.70e-4)" 12.4 10.3 32.0 9.7 28.5 9.9 12.3 29.1 54.7 15.3 10.1 28.2 7.9 7.9 14.6 16.3 9.3 14.0 13.6 11.8 30.3 22.5 11.8 7.9 9.9 7.8 30.1 29.2 16.9 10.3 34.0 9.2 9.5 34.3 12.7 9.4 9.6 11.3 16.2 16.1 8.0 9.8 17.4 35.3 8.5 8.2 6.4 22.4 5.5 14.5 4.3 7.6 9.9 8.5 1.1 2.6 7.5 4.1 0.9 1.5 0.6 8.1 9.1 19.7 11.3 14.1 16.3 3.1 11.8 13.8 13.8 13.0 9.7 10.3 8.8 10.8 21.7 7.1 12.3 12.3 16.3 6.8 8.3 10.2 9.5 4.9 5.5 5.6 19.1 15.8 7.8 14.5 7.4 8.3 2.6 6.9 12.9 11.5 13.2 4.8 7.0 11.8 18.1 33.0 4.6 7.2 7.1 13.7 20.4 14.0 10.1 21.0 17.0 6.2 10.8 15.5 13.3 19.4 9.4 15.4 10.8 15.7 7.7 6.5 13.8 7.5 2.7 1.5 1.5 4.1 0.8 1.0 0.8 1.3 2.1 1.1 1.1 1.3 6.3 0.9 2.9 2.6 1.2 0.6 32.0 28.5 29.1 42.4 30.3 22.5 30.1 29.2 34.3 22.4 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell line enhanced" "Detected in many" "Karpas-707: 24.9;U-138 MG: 17.3" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavourable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavourable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.7 4.1 12.8 12.3 9.3 0.1 2.5 4.5 3.1 4.5 7.5 12.3 0.0 0.9 7.2 0.3 5.6 2.4 4.5 0.0 3.2 2.8 1.3 0.0 1.0 0.8 1.0 11.8 1.0 2.4 1.9 6.8 0.0 24.9 5.9 1.6 1.6 0.0 5.4 2.8 0.0 8.0 0.5 4.9 8.8 12.9 7.0 1.3 0.8 3.4 1.0 0.6 4.0 17.3 2.3 0.3 1.6 6.6 6.4 0.0 5.3 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 FAM173B JS-2 ENSG00000150756 "Family with sequence similarity 173 member B" Q6P4H8 5 10226330-10249897 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074513 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA074513: " "prognostic unfavourable (1.32e-6)" "unprognostic (8.87e-3)" "unprognostic (1.23e-3)" "unprognostic (1.20e-1)" "unprognostic (9.24e-2)" "unprognostic (1.41e-2)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-2)" "unprognostic (6.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" "unprognostic (1.79e-1)" "unprognostic (9.06e-2)" "unprognostic (5.61e-2)" "unprognostic (1.03e-1)" 10.1 14.6 17.7 10.4 16.2 3.3 9.0 20.1 18.6 7.9 9.7 12.2 8.8 7.7 9.3 12.6 7.9 9.2 9.9 8.8 14.9 18.1 12.1 13.1 7.5 8.9 18.8 9.9 8.6 6.8 19.2 22.8 5.3 18.6 12.2 12.4 10.3 8.8 12.3 7.3 7.4 7.1 10.1 13.2 5.6 7.8 6.5 18.9 8.4 12.7 6.2 8.7 11.6 13.9 5.7 8.9 11.6 9.7 5.1 8.6 4.5 7.3 8.0 7.9 7.5 8.7 6.6 2.7 11.3 5.7 6.0 4.7 8.4 12.1 9.4 20.3 8.0 5.5 12.1 10.3 9.8 15.6 7.4 7.8 27.3 6.3 5.9 12.0 9.4 6.1 11.4 9.9 3.4 11.6 10.9 9.6 17.0 6.8 5.9 10.7 4.8 9.7 8.2 5.5 8.3 15.4 9.6 6.3 6.3 39.7 14.0 6.3 14.3 12.6 6.4 12.9 7.6 7.8 8.2 6.5 7.2 10.5 8.1 13.8 5.2 5.0 9.3 11.6 7.0 9.7 8.4 5.7 6.7 8.5 8.9 4.2 6.8 8.6 3.4 5.1 7.7 3.1 7.8 4.5 17.7 16.2 20.1 18.6 14.9 18.1 18.8 9.9 18.6 18.9 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" 180000 Vesicles Nucleoplasm "HPA053222: , HPA055440: " "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavourable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favourable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 20.8 25.6 29.5 17.5 29.2 24.9 20.6 14.1 25.9 27.2 45.8 29.2 19.6 32.6 16.3 17.9 22.2 12.7 22.0 44.2 31.6 35.3 35.5 49.1 36.0 10.4 41.1 24.2 14.4 21.5 14.2 43.8 17.7 39.6 37.9 41.6 13.6 19.5 22.3 33.8 17.4 34.0 25.5 45.4 15.7 24.1 42.6 22.2 13.3 31.0 19.0 12.8 27.6 18.2 14.1 16.8 56.7 15.1 9.4 18.5 9.7 20.1 16.3 12.4 10.0 21.5 21.6 16.8 32.9 17.9 17.1 18.8 16.5 26.6 8.3 23.6 31.2 21.1 15.1 18.6 21.9 23.5 11.5 6.4 20.7 56.2 26.6 9.8 15.0 19.4 24.5 20.7 16.3 19.5 15.2 25.9 32.9 28.9 12.0 9.1 10.1 23.2 7.0 17.5 11.6 30.9 21.8 17.4 15.6 38.8 30.6 25.3 28.3 7.5 22.9 22.4 19.9 24.9 16.8 20.1 24.1 9.9 13.9 6.6 21.8 20.9 15.1 24.9 10.7 11.4 12.6 14.1 14.2 12.2 10.9 11.3 11.3 11.0 56.7 9.4 9.7 16.8 18.5 9.7 29.5 29.2 14.1 25.9 31.6 35.3 41.1 24.2 39.6 22.2 FAM180A "HWKM1940, UNQ1940" ENSG00000189320 "Family with sequence similarity 180 member A" Q6UWF9 7 135728348-135748846 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.0" "Cell line enriched" "Detected in some" 4 "U-2197: 73.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA021224 Uncertain Approved Nucleoplasm "Secreted - unknown location" Nucleoplasm "HPA021224: AB_1851352" "unprognostic (3.85e-2)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.27e-1)" "unprognostic (5.05e-2)" "unprognostic (1.97e-3)" "unprognostic (5.62e-2)" "unprognostic (7.55e-2)" "unprognostic (8.88e-4)" "unprognostic (3.14e-3)" "unprognostic (1.82e-1)" "unprognostic (4.35e-4)" "unprognostic (6.62e-4)" 9.3 2.6 0.1 1.7 0.5 0.0 5.6 0.1 1.0 7.8 5.7 0.3 0.5 0.7 9.4 2.0 5.1 3.0 21.2 14.7 0.1 0.1 8.7 23.0 4.6 0.0 0.1 0.0 8.1 1.1 0.0 0.3 1.4 0.5 6.1 1.8 1.9 2.2 0.1 3.5 5.5 3.2 8.1 0.4 0.9 1.6 3.9 0.1 0.0 4.6 4.8 0.9 6.6 8.3 0.6 0.2 2.0 0.3 0.4 0.5 0.1 0.0 0.0 0.0 0.0 7.9 8.2 0.0 4.1 15.7 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 10.0 1.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 16.3 0.0 73.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.1 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.6 0.4 0.5 0.8 0.4 0.3 0.2 0.2 0.1 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.5 0.1 FAM182B ENSG00000175170 "Family with sequence similarity 182 member B" Q5T319 20 25763466-25868225 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6;testis: 9.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 17.0" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA050100 Uncertain Approved Nucleoplasm Nucleoplasm "HPA050100: " "unprognostic (8.05e-2)" "unprognostic (1.48e-2)" "unprognostic (1.29e-2)" "unprognostic (3.63e-1)" "unprognostic (2.68e-1)" "unprognostic (1.50e-2)" "unprognostic (1.88e-4)" "unprognostic (1.61e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-2)" "unprognostic (3.30e-1)" "unprognostic (2.47e-9)" "unprognostic (2.36e-1)" "unprognostic (4.40e-2)" "unprognostic (6.54e-2)" "unprognostic (3.18e-1)" 0.4 0.9 2.9 0.2 3.8 0.0 0.8 7.6 5.9 0.6 0.2 0.1 1.2 0.3 0.6 6.4 0.2 0.3 3.0 3.7 0.4 0.0 1.2 0.2 2.0 1.7 0.8 0.5 2.7 4.4 1.7 0.1 0.8 0.5 1.2 5.2 0.7 0.4 1.2 0.8 0.6 9.9 1.4 0.0 0.0 0.4 0.2 0.2 2.1 0.1 0.7 1.2 0.4 2.1 0.9 1.2 1.2 0.6 0.1 0.5 0.3 0.0 0.0 0.4 0.0 3.0 0.2 1.3 1.4 4.0 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.3 0.2 1.1 0.8 0.1 0.0 1.1 0.1 0.9 2.7 0.0 0.1 1.4 0.7 0.1 1.6 0.1 0.1 0.6 0.4 0.0 17.0 1.1 0.7 0.2 1.2 0.5 0.6 0.3 0.2 3.6 0.8 0.5 1.7 0.3 0.8 0.1 0.5 1.4 0.0 0.1 1.7 0.6 0.0 0.6 0.1 1.0 0.3 0.2 0.2 0.9 1.2 2.1 0.7 0.0 0.1 0.0 0.4 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell line enhanced" "Detected in many" "AF22: 16.4;HEK 293: 9.6;K-562: 13.4;SCLC-21H: 10.7;SH-SY5Y: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: , HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.3 16.4 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.3 1.1 0.0 0.2 0.0 5.0 0.0 0.2 1.3 9.6 0.5 1.5 7.2 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.0 13.4 0.6 0.2 0.3 0.3 0.0 5.5 1.2 0.0 0.0 0.0 0.1 0.1 10.7 7.9 0.5 0.5 1.6 2.2 1.9 0.2 0.8 0.5 0.2 4.1 4.1 4.4 0.3 1.3 0.0 2.1 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.1;ASC TERT1: 39.8;HSkMC: 45.6;HUVEC TERT2: 50.9;WM-115: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.1 39.8 3.0 0.8 0.6 0.1 1.0 3.4 1.2 0.0 0.1 1.3 0.0 18.6 4.9 0.5 0.0 0.0 0.2 0.0 9.5 14.1 0.1 0.0 45.6 1.2 6.5 0.7 50.9 3.3 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.1 0.0 0.0 7.4 2.1 1.4 0.0 2.4 4.3 4.7 2.5 1.6 0.0 0.0 11.6 0.6 0.0 19.6 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 FAM199X CXorf39 ENSG00000123575 "Family with sequence similarity 199, X-linked" Q6PEV8 X 104166620-104195902 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003093 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA003093: AB_1078597" "unprognostic (2.03e-3)" "unprognostic (4.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.18e-2)" "unprognostic (1.89e-2)" "unprognostic (6.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (1.18e-1)" "unprognostic (9.13e-2)" "unprognostic (6.07e-3)" "unprognostic (1.08e-2)" "unprognostic (4.73e-2)" "unprognostic (4.00e-2)" "unprognostic (2.39e-2)" 19.5 13.4 19.6 7.5 24.4 13.0 13.1 17.1 25.9 11.1 9.3 14.2 21.0 8.7 13.0 39.2 9.0 10.5 7.8 8.0 17.4 19.2 17.1 8.6 9.0 8.7 19.3 17.9 13.9 13.1 24.9 11.8 9.9 22.6 11.8 9.7 8.7 10.8 16.6 10.7 10.4 8.2 9.9 16.9 9.2 8.9 10.9 12.9 6.5 19.4 5.6 8.5 9.5 12.8 3.8 2.3 2.6 2.0 1.5 3.9 1.3 16.9 10.8 9.8 10.7 7.3 8.8 9.9 9.0 8.5 11.8 11.1 8.3 14.2 9.4 11.2 8.3 12.9 17.6 13.3 19.4 4.5 9.8 7.4 13.8 9.4 10.4 14.0 10.5 6.8 17.0 11.6 11.7 11.9 8.0 21.2 13.1 12.1 7.5 10.0 9.7 12.6 8.0 6.4 11.7 20.1 11.4 5.3 6.5 21.8 14.6 15.6 7.3 7.0 14.6 13.2 4.8 10.2 9.6 10.0 8.3 10.5 14.9 15.2 9.6 2.2 2.0 1.1 2.8 1.5 3.2 1.6 2.6 3.4 2.3 3.8 3.9 2.3 2.6 1.5 2.0 1.2 2.9 1.3 19.6 24.4 17.1 23.3 17.4 19.2 19.3 17.9 22.6 12.9 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C, golgi associated secretory pathway kinase" Q8IXL6 7 192969-260745 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 80.6" "Cell line enhanced" "Detected in many" "HSkMC: 52.0;U-87 MG: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" 160000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavourable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavourable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 27.5 10.2 10.8 19.3 16.6 3.3 25.6 7.4 14.9 8.3 20.1 13.5 15.1 12.9 9.5 6.9 11.1 9.7 15.0 15.0 8.8 7.2 31.8 31.6 12.7 5.1 16.9 5.6 11.8 14.8 2.6 9.2 7.2 15.8 15.0 4.6 8.8 80.6 11.8 20.4 6.8 16.5 17.0 17.0 6.9 20.0 5.9 14.8 0.4 9.6 8.4 4.4 20.5 17.5 0.0 0.6 0.0 1.6 0.2 0.0 0.0 13.8 6.7 0.2 9.6 12.3 20.4 0.0 12.3 20.9 6.7 5.4 0.8 8.5 0.0 6.8 18.4 12.0 1.0 0.6 1.7 2.9 0.6 0.0 3.2 3.7 9.3 0.0 0.9 52.0 1.5 0.2 0.7 4.6 0.0 0.1 1.7 1.8 0.0 0.7 6.5 0.4 1.5 0.4 0.0 5.0 0.0 3.2 0.1 12.8 0.0 1.9 9.1 6.3 12.9 8.4 4.2 7.1 3.7 0.0 0.0 0.0 32.0 0.8 23.8 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 16.6 7.4 14.9 8.8 7.2 16.9 5.6 15.8 14.8 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavourable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.4 7.1 5.0 4.7 5.9 6.2 7.3 8.6 8.1 9.8 11.4 9.5 6.1 13.0 10.9 6.1 6.0 9.5 10.8 16.0 8.8 4.4 9.0 5.2 7.0 7.0 15.4 8.5 5.3 8.5 9.4 33.2 6.2 12.2 7.1 11.2 8.6 9.5 9.9 5.6 7.1 7.7 11.9 15.0 8.1 7.9 3.2 5.6 7.6 11.2 20.6 5.9 7.3 6.8 25.0 24.6 15.5 10.6 8.0 10.0 14.9 13.3 8.0 10.0 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 FAM212A "C3orf54, INKA1" ENSG00000185614 "Family with sequence similarity 212 member A" Q96EL1 3 49803254-49805030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.8;skin 1: 30.0" "Cell line enhanced" "Detected in many" "HEL: 31.3;HMC-1: 21.5;NB-4: 17.4;THP-1: 19.3;U-937: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4" "Group enriched" "Detected in many" 6 "B-cells: 25.8;granulocytes: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041879 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favourable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 6.0 4.1 5.8 3.2 4.7 5.0 3.5 8.0 6.3 6.8 2.6 4.9 1.4 1.7 5.5 2.8 16.3 2.9 4.8 7.6 4.4 4.3 3.4 1.2 7.3 5.9 6.3 4.8 3.6 2.3 0.8 2.0 5.2 5.6 5.4 1.4 3.2 4.5 3.9 15.3 30.0 3.5 5.3 8.3 6.9 2.2 2.4 4.3 1.8 1.9 10.4 8.4 4.8 8.5 25.8 3.6 19.0 2.9 0.0 1.5 2.8 0.6 0.5 0.7 0.5 0.9 2.0 0.0 1.4 0.9 0.6 0.8 0.0 0.0 6.8 0.2 1.0 4.0 0.2 4.8 0.0 1.2 0.0 31.3 0.3 0.1 1.2 4.7 21.5 2.6 6.9 1.4 1.2 2.9 2.1 0.5 0.5 0.3 0.4 17.4 0.5 2.7 6.3 0.3 1.5 0.0 7.8 0.3 2.5 1.2 0.2 0.6 0.1 19.3 1.7 3.5 0.4 1.6 0.6 0.8 0.7 0.5 1.5 16.0 0.8 19.0 0.9 4.3 0.6 2.2 0.1 25.8 0.6 0.7 0.2 23.4 0.9 1.5 0.5 0.0 2.9 3.6 0.6 2.8 5.8 4.7 8.0 6.3 4.4 4.3 6.3 4.8 5.6 4.3 FAM214A "FLJ10980, KIAA1370" ENSG00000047346 "Family with sequence similarity 214 member A" Q32MH5 15 52581317-52709817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 26.7;U-698: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039369, HPA040180" Approved Approved Nucleoplasm Nucleoplasm "HPA039369: AB_10795250, HPA040180: AB_10794736" "unprognostic (1.75e-1)" "unprognostic (6.40e-2)" "unprognostic (4.54e-1)" "prognostic favourable (7.27e-6)" "unprognostic (1.08e-2)" "unprognostic (5.96e-3)" "unprognostic (1.32e-3)" "prognostic favourable (8.68e-4)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.91e-2)" "unprognostic (2.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.22e-1)" "unprognostic (3.79e-2)" "unprognostic (6.94e-3)" 21.7 17.1 11.6 15.3 16.2 12.1 18.8 41.3 18.5 11.9 12.0 8.7 32.0 8.8 12.7 6.7 21.1 10.9 8.8 10.5 11.6 5.6 7.7 24.5 9.9 14.5 14.0 14.1 10.4 16.8 24.4 26.0 6.5 11.9 10.1 10.9 9.4 17.3 27.9 47.7 11.9 14.2 13.9 7.1 11.9 12.9 14.9 16.1 12.1 16.4 13.4 18.9 16.4 17.7 7.7 10.0 6.1 0.7 5.4 5.3 1.4 2.3 3.2 3.3 5.7 10.2 6.2 3.9 5.9 10.3 3.2 4.2 1.8 2.6 16.3 7.1 5.5 4.8 2.3 5.4 2.8 13.0 3.4 4.1 7.0 1.5 3.6 2.0 2.2 14.5 8.8 3.1 3.5 10.4 2.3 17.3 4.5 9.3 3.1 5.0 0.6 3.8 7.5 3.4 12.3 5.2 11.1 3.8 6.6 5.9 11.2 4.4 17.5 4.3 7.7 3.2 1.0 3.5 1.3 26.7 15.9 29.9 5.5 2.6 1.0 0.8 0.7 6.1 4.7 0.2 5.0 7.7 3.4 3.1 0.9 6.9 3.9 3.6 4.5 5.4 0.3 10.0 5.3 1.4 11.6 16.2 41.3 18.5 11.6 5.6 14.0 14.1 11.9 16.1 FAM214B "bA182N22.6, FLJ11560, KIAA1539" ENSG00000005238 "Family with sequence similarity 214 member B" Q7L5A3 9 35104112-35116341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.8;TIME: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.6" "Group enriched" "Detected in many" 4 "dendritic cells: 4.4;granulocytes: 14.6;monocytes: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048831, HPA055751" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA048831: , HPA055751: " "unprognostic (2.91e-3)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.06e-1)" "unprognostic (7.72e-3)" "unprognostic (2.38e-2)" "unprognostic (1.70e-2)" "unprognostic (1.02e-2)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (8.15e-2)" 13.0 10.3 14.1 12.4 14.9 35.0 6.7 10.4 18.9 7.3 12.0 25.9 10.7 10.9 7.7 7.9 22.4 6.1 12.5 16.5 15.4 14.4 12.5 7.7 13.6 7.4 17.0 11.4 7.5 5.6 10.4 10.9 26.3 20.8 8.6 11.5 9.3 8.6 11.1 8.9 10.9 10.6 11.8 20.5 19.1 10.7 5.8 8.4 3.7 9.1 12.2 12.0 10.4 8.8 0.5 4.4 14.6 8.5 1.7 2.1 2.5 2.9 2.4 6.9 4.9 5.4 8.4 1.4 14.8 13.4 8.2 5.3 1.7 2.1 0.7 4.4 23.8 1.3 1.2 4.7 5.4 3.8 0.3 3.7 5.3 1.5 5.5 1.0 16.3 5.9 8.5 9.6 6.1 15.8 2.0 3.0 17.1 0.8 1.4 4.5 1.3 3.7 1.6 1.2 0.8 10.7 0.6 0.5 4.5 2.4 1.7 7.9 2.1 2.4 26.8 11.6 5.6 5.5 5.4 1.9 1.8 0.4 18.2 1.9 12.8 4.7 5.2 4.7 2.1 6.9 0.7 0.5 1.3 1.4 4.4 0.2 0.5 0.9 14.6 1.7 8.5 1.1 0.7 2.5 14.1 14.9 10.4 18.9 15.4 14.4 17.0 11.4 20.8 8.4 FAM219B "C15orf17, FLJ00005" ENSG00000178761 "Family with sequence similarity 219 member B" Q5XKK7 15 74899987-74907121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048929, HPA058064" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA048929: , HPA058064: " "unprognostic (1.12e-1)" "unprognostic (6.10e-2)" "prognostic unfavourable (1.75e-4)" "unprognostic (8.08e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "unprognostic (2.41e-2)" "unprognostic (5.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.92e-1)" "unprognostic (3.17e-2)" "unprognostic (3.11e-2)" "prognostic favourable (1.29e-4)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (4.91e-3)" 16.5 14.4 12.5 10.0 16.5 5.9 28.7 18.5 20.0 11.3 11.6 10.1 10.3 11.2 11.1 22.9 16.6 14.6 12.1 22.7 13.0 13.6 11.7 4.7 13.4 10.6 13.8 12.5 13.0 11.0 22.3 21.5 9.1 15.1 18.6 9.8 13.8 15.9 13.7 12.0 18.1 10.1 12.8 10.2 18.2 11.2 5.2 11.0 4.4 13.7 8.1 11.8 16.8 11.2 3.7 1.4 6.9 1.5 2.1 3.7 1.1 2.5 5.6 10.9 5.3 15.7 9.8 5.7 8.0 4.1 6.7 5.2 2.3 6.3 7.1 5.2 5.2 9.0 11.9 4.9 3.6 13.6 12.1 2.9 9.7 1.2 5.8 4.2 7.6 5.5 16.3 2.5 6.3 5.4 4.4 5.6 6.4 0.6 3.9 5.2 6.4 9.8 9.4 3.6 4.0 12.8 5.5 9.5 5.0 7.1 6.2 10.7 9.9 2.7 10.8 4.5 4.0 3.7 6.3 6.5 4.7 3.4 6.8 10.4 5.2 3.8 1.0 6.9 2.2 1.4 3.7 3.7 2.8 0.9 1.4 2.9 2.3 1.8 2.4 2.1 1.5 0.3 0.3 1.1 12.5 16.5 18.5 20.0 13.0 13.6 13.8 12.5 15.1 11.0 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 50.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favourable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favourable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favourable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.8 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 11.7 0.2 0.1 1.0 0.3 0.5 0.8 0.0 0.2 7.5 1.7 1.4 0.3 2.6 0.1 1.1 1.5 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.1 4.7 0.3 1.5 1.3 2.3 0.9 3.4 0.5 1.5 0.6 8.3 50.2 1.0 1.6 3.3 1.9 1.2 0.1 0.2 1.4 0.6 1.0 1.3 1.6 1.0 0.1 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favourable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.5 8.5 15.4 15.4 0.8 6.4 24.6 9.3 19.6 0.7 4.1 1.3 19.1 11.8 1.0 3.6 9.3 14.8 0.4 12.0 1.5 2.0 6.6 9.6 3.4 0.8 9.3 6.3 15.3 2.6 9.0 2.0 3.4 11.3 0.4 6.2 5.4 4.5 10.1 9.7 4.4 1.4 13.6 0.2 16.3 6.8 5.1 0.6 9.9 8.3 3.1 5.1 7.7 3.3 29.5 8.5 2.6 0.1 11.8 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell line enhanced" "Detected in many" "EFO-21: 20.5;PC-3: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavourable (8.64e-4)" "prognostic unfavourable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favourable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.6 1.8 15.0 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.1 0.0 20.5 0.3 5.5 7.8 4.5 3.4 13.3 10.7 0.0 3.2 4.0 4.0 0.0 4.8 0.0 4.4 0.1 2.3 0.0 4.9 0.0 0.2 17.9 0.1 0.0 9.0 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 9.6 2.4 0.6 0.4 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 FAM35A "bA163M19.1, FAM35A1, MGC5560" ENSG00000122376 "Family with sequence similarity 35 member A" Q86V20 10 87094161-87191468 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036582 Uncertain Approved "Nucleoplasm,Actin filaments" Nucleoplasm "Actin filaments" "HPA036582: AB_10670233" "unprognostic (1.08e-1)" "unprognostic (2.72e-1)" "prognostic favourable (6.06e-4)" "unprognostic (1.77e-1)" "prognostic favourable (3.09e-4)" "unprognostic (5.34e-2)" "unprognostic (2.68e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (8.20e-2)" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (1.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" "unprognostic (6.44e-3)" "unprognostic (3.61e-2)" 17.3 16.9 5.4 14.4 7.2 5.4 15.4 6.4 4.9 12.6 20.2 4.7 9.1 15.0 10.8 10.6 12.6 9.3 7.4 11.5 6.0 6.1 31.2 35.3 12.5 16.4 9.0 3.5 12.7 10.2 3.6 19.4 7.4 6.8 14.0 11.6 7.4 11.4 14.0 9.3 9.1 33.1 14.8 6.9 15.6 8.7 7.1 7.9 12.0 30.7 12.6 9.4 12.3 13.6 9.0 10.7 4.9 11.1 11.2 13.7 8.5 15.9 12.9 7.4 17.0 8.3 8.1 10.8 10.8 15.2 14.5 16.0 14.8 12.3 11.7 6.0 14.6 10.7 18.2 8.2 15.0 16.6 12.0 16.2 12.3 13.9 12.9 25.2 14.2 7.4 15.2 13.2 22.9 9.6 20.5 21.2 13.4 9.1 20.5 18.0 8.5 9.0 12.7 14.7 12.9 13.3 13.4 3.7 15.3 8.3 9.8 14.3 21.7 14.2 9.4 8.3 7.5 12.3 21.4 11.9 26.0 28.4 14.0 31.6 4.4 4.9 7.0 2.3 6.8 11.1 13.7 9.0 10.3 10.0 10.7 7.2 10.5 10.5 0.1 11.2 8.4 3.7 9.7 8.5 5.4 7.2 6.4 4.9 6.0 6.1 9.0 3.5 6.8 7.9 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "Family with sequence similarity 3 member A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" Nucleoli Nucleoplasm "CAB025016: , HPA035268: , HPA056991: " "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 18.9 18.9 18.9 14.7 20.9 13.7 17.3 13.4 25.7 22.3 21.2 31.1 16.3 37.0 18.2 16.2 19.3 19.1 25.3 31.4 21.3 18.7 19.8 28.5 16.1 16.7 23.0 16.4 29.1 35.5 18.2 22.1 21.0 18.5 20.6 9.9 17.3 29.4 34.7 33.4 15.3 33.7 14.4 25.4 18.4 23.6 10.7 16.8 13.5 28.8 16.1 12.2 16.9 16.9 8.0 13.3 21.2 11.5 8.5 13.3 8.9 16.3 15.8 4.0 13.3 12.0 6.1 11.2 8.4 5.8 5.8 6.9 7.2 10.0 10.7 42.8 14.0 12.0 6.2 7.4 1.4 8.7 8.4 4.2 13.8 5.1 18.9 2.8 6.7 7.5 6.7 12.0 8.4 4.0 7.9 7.9 6.6 17.1 5.1 12.1 1.7 19.9 6.4 4.0 29.3 6.3 6.8 7.9 6.0 3.8 9.4 13.8 7.1 4.3 4.5 7.8 4.7 21.1 11.3 30.3 16.6 13.0 14.4 7.3 7.9 21.2 9.9 12.5 13.3 11.5 12.9 6.2 8.2 9.3 9.9 8.0 10.2 11.9 5.0 8.5 9.5 13.3 8.5 8.9 18.9 20.9 13.4 25.7 21.3 18.7 23.0 16.4 18.5 16.8 FAM46A "C6orf37, FLJ20037" ENSG00000112773 "Family with sequence similarity 46 member A" Q96IP4 6 81491439-81752774 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 106.4" "Cell line enhanced" "Detected in many" "ASC diff: 21.8;fHDF/TERT166: 25.0;HeLa: 24.7;HL-60: 28.3;THP-1: 48.8;U-937: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051067: , HPA067140: " "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 10.0 7.1 1.4 4.9 1.4 64.7 5.6 2.8 0.9 14.4 17.7 1.3 24.2 5.1 12.8 20.0 4.2 8.8 17.1 19.4 1.2 4.4 3.2 11.8 5.8 2.3 1.4 0.9 20.1 3.5 6.5 20.4 106.4 3.5 16.2 5.6 4.9 49.8 45.6 4.5 7.0 32.6 15.3 2.5 5.8 13.2 6.8 1.4 1.2 7.7 6.7 3.7 13.4 31.1 12.0 12.4 22.4 22.2 8.3 6.2 6.1 1.0 1.5 1.0 0.0 21.8 9.6 1.9 8.2 5.9 4.9 7.5 15.4 0.8 0.1 0.3 25.0 0.9 0.7 1.3 3.6 0.0 1.9 0.0 24.7 2.4 6.8 28.3 2.2 4.2 0.7 3.8 0.6 0.6 0.4 0.0 3.2 4.4 0.0 20.1 0.2 1.1 0.0 9.0 0.0 0.6 1.9 1.0 1.4 3.7 1.6 2.4 0.3 48.8 1.3 5.6 1.2 2.4 2.2 0.1 0.1 0.1 8.0 21.9 2.4 16.1 14.9 22.4 6.2 15.1 3.7 8.0 2.4 3.0 12.4 12.0 4.7 4.4 7.3 8.3 22.2 4.3 2.7 6.1 1.4 1.4 2.8 0.9 1.2 4.4 1.4 0.9 3.5 1.4 FAM46C FLJ20202 ENSG00000183508 "Family with sequence similarity 46 member C" Q5VWP2 1 117605934-117628372 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction" "Nucleotidyltransferase, RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 114.0" "Cell line enhanced" "Detected in some" "Karpas-707: 73.1;RPMI-8226: 43.6;U-266/70: 20.3;U-266/84: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.3" "Group enriched" "Detected in many" 17 "B-cells: 9.7;granulocytes: 16.3;T-cells: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA054049 Uncertain Approved Nucleoplasm Nucleoplasm "HPA054049: " "unprognostic (3.76e-2)" "unprognostic (3.85e-3)" "unprognostic (3.24e-3)" "prognostic favourable (3.75e-5)" "unprognostic (1.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.29e-1)" "unprognostic (2.88e-2)" "unprognostic (5.75e-2)" "unprognostic (1.36e-3)" "unprognostic (9.41e-3)" "unprognostic (3.91e-2)" "prognostic favourable (2.77e-5)" "unprognostic (6.26e-2)" "unprognostic (3.16e-2)" "unprognostic (3.08e-2)" "unprognostic (1.10e-2)" 3.2 1.8 1.2 24.5 1.1 28.9 4.4 1.1 1.1 8.1 16.1 1.8 8.4 5.6 4.8 16.6 6.9 3.3 9.7 6.4 1.2 1.1 5.0 5.5 11.2 16.3 1.2 0.1 8.3 114.0 7.2 5.3 10.6 3.9 6.4 9.5 4.4 37.8 11.9 10.0 1.8 10.6 4.7 1.4 19.1 12.2 34.0 0.2 1.5 10.3 10.9 37.0 9.5 8.6 9.7 0.2 16.3 0.0 0.6 9.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 6.6 0.1 0.0 0.4 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.0 4.1 0.4 9.0 0.0 0.0 0.0 5.2 11.7 0.0 0.0 0.1 0.0 0.0 1.2 73.1 0.0 0.9 0.0 5.4 0.9 0.5 0.0 0.0 43.6 0.0 0.8 0.5 0.0 0.4 0.5 0.4 0.4 0.0 0.1 0.0 0.5 0.0 0.1 20.3 16.8 0.4 0.4 1.9 0.6 16.3 0.0 10.5 2.5 0.0 2.2 9.7 2.5 3.1 0.0 8.0 0.3 1.4 1.1 0.6 0.0 0.2 9.2 2.1 1.2 1.1 1.1 1.1 1.2 1.1 1.2 0.1 3.9 0.2 FAM49A "DKFZP566A1524, FLJ11080" ENSG00000197872 "Family with sequence similarity 49 member A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.8;brain: 39.5" "Cell line enhanced" "Detected in many" "HMC-1: 22.7;HUVEC TERT2: 18.1;RH-30: 40.8;SK-BR-3: 12.0;TIME: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm Nucleoplasm "CAB017847: , HPA060398: " "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavourable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavourable (4.46e-4)" 10.8 9.1 22.7 15.6 28.0 15.3 7.0 6.6 39.5 13.7 5.3 7.0 1.2 2.9 8.2 2.1 4.3 6.2 8.7 3.3 17.2 14.1 1.9 6.1 9.6 13.4 10.2 25.2 10.0 2.4 1.1 4.8 15.3 9.9 6.9 5.3 2.9 3.2 7.3 6.0 2.9 4.6 8.6 6.0 20.1 3.4 1.8 6.3 1.9 31.8 1.1 13.6 7.7 7.4 8.9 15.5 45.8 34.4 13.4 5.3 8.5 0.2 0.0 2.6 0.1 2.7 0.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.6 0.6 1.0 0.0 2.7 0.1 1.5 0.0 0.0 1.4 0.0 22.7 1.3 1.0 0.2 0.0 18.1 0.1 2.0 1.6 0.1 0.0 5.2 1.1 0.0 0.8 40.8 0.1 2.2 10.1 0.4 1.5 0.0 12.0 0.0 0.4 0.7 14.2 0.2 2.3 0.0 0.0 1.2 0.0 1.3 6.0 1.1 0.8 0.0 23.6 31.4 5.3 29.8 0.6 8.9 0.2 2.7 15.5 6.1 0.2 2.1 45.8 13.4 34.4 7.7 0.1 8.5 22.7 28.0 6.6 33.3 17.2 14.1 10.2 25.2 9.9 6.3 FAM49B BM-009 ENSG00000153310 "Family with sequence similarity 49 member B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.5;bone marrow: 80.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Approved Approved Nucleoplasm,Cytosol 990000 Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavourable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavourable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 19.2 14.5 23.2 42.8 33.1 80.1 20.6 28.0 36.9 7.2 14.3 18.2 5.5 14.2 8.0 10.6 17.9 7.9 14.9 9.8 25.5 25.2 11.8 12.3 19.1 49.6 28.5 19.6 6.4 10.0 7.5 16.1 19.4 21.2 7.6 17.4 7.3 12.0 7.9 16.8 9.0 19.3 13.5 38.8 41.3 12.9 13.6 21.2 28.2 13.8 9.7 46.4 20.6 8.4 21.0 47.3 93.5 42.2 30.8 29.3 43.4 31.6 17.0 18.5 10.4 1.6 2.4 24.7 9.6 9.3 13.4 14.3 9.7 21.8 31.6 21.2 6.3 15.8 15.3 25.4 20.1 66.2 10.7 31.7 9.5 10.9 6.5 20.5 27.3 3.9 11.9 9.0 18.8 11.8 22.7 36.7 14.6 14.1 69.6 15.2 15.7 23.5 30.4 12.5 53.1 27.4 13.0 12.4 16.2 19.3 12.2 28.5 14.2 26.6 7.2 4.9 31.8 10.4 20.4 12.2 36.0 52.5 7.8 44.7 12.7 45.5 35.3 65.6 29.3 42.2 22.4 21.0 16.7 23.9 47.3 15.1 15.0 24.6 93.5 30.8 36.5 30.4 22.5 43.4 23.2 33.1 28.0 36.9 25.5 25.2 28.5 19.6 21.2 21.2 FAM69A FLJ23493 ENSG00000154511 "Family with sequence similarity 69 member A" Q5T7M9 1 92832737-92961522 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015718, HPA017281" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA015718: AB_1848405, HPA017281: AB_1848406" "prognostic favourable (8.96e-4)" "unprognostic (1.00e-1)" "unprognostic (6.17e-2)" "unprognostic (1.50e-3)" "unprognostic (1.43e-1)" "unprognostic (3.77e-3)" "unprognostic (3.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.10e-1)" "unprognostic (2.19e-1)" "unprognostic (5.04e-2)" "prognostic unfavourable (1.45e-7)" "unprognostic (1.26e-2)" "unprognostic (5.99e-2)" "unprognostic (2.57e-1)" "unprognostic (1.66e-2)" 13.3 3.4 20.7 10.4 22.5 7.0 7.8 19.4 22.2 7.3 13.2 15.9 4.2 8.8 15.7 3.8 9.3 8.3 11.1 5.3 22.6 18.0 6.1 24.7 4.5 10.1 25.0 12.2 6.0 3.5 20.5 4.1 12.8 17.7 9.5 12.4 5.4 5.5 11.3 7.5 5.6 8.2 19.4 24.7 7.6 8.8 6.4 24.4 9.6 6.2 3.6 8.8 12.2 6.0 22.5 7.1 0.2 0.9 11.8 14.2 6.7 4.2 4.7 1.9 4.7 7.4 13.9 2.4 13.4 27.7 7.6 15.5 2.7 0.9 14.5 2.4 24.7 5.5 0.3 10.1 12.7 5.8 4.8 0.5 3.7 6.8 2.6 1.3 0.9 8.2 8.1 16.7 3.8 0.1 5.1 15.5 9.6 1.6 4.8 1.2 3.5 1.9 4.3 14.3 4.5 1.1 4.5 4.9 3.8 3.7 3.7 4.9 1.8 0.4 0.5 9.0 6.9 17.5 4.7 23.4 22.3 17.0 4.3 0.9 0.8 0.0 0.9 0.0 10.5 0.4 8.1 22.5 12.1 8.2 4.3 13.6 14.2 12.1 0.2 11.8 0.2 7.1 10.7 6.7 20.7 22.5 19.4 22.0 22.6 18.0 25.0 12.2 17.7 24.4 FAM69B "C9orf136, MGC20262" ENSG00000165716 "Family with sequence similarity 69 member B" Q5VUD6 9 136712570-136724050 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.1;HEK 293: 25.1;HUVEC TERT2: 31.2;REH: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive B-cell: 7.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 34 "B-cells: 7.3;dendritic cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046812, HPA054443" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA046812: , HPA054443: " "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavourable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favourable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 8.0 3.8 12.3 3.6 14.2 8.2 5.6 19.8 21.4 6.1 4.6 4.9 2.3 4.7 9.6 5.0 4.7 11.0 5.9 18.8 12.3 14.6 6.6 5.5 11.0 4.5 12.4 15.9 5.4 11.9 7.9 11.4 24.5 14.2 6.5 1.3 17.5 11.2 4.5 9.9 13.0 4.4 4.1 5.3 7.9 3.5 7.5 3.2 1.6 7.6 4.1 2.1 3.2 3.1 7.3 1.9 0.0 0.1 0.0 0.0 0.7 0.5 3.3 9.4 9.2 0.0 0.0 8.4 0.3 0.0 0.3 0.4 9.5 1.5 0.8 28.1 0.0 2.9 4.8 0.1 0.0 1.3 25.1 5.3 0.4 0.3 0.1 0.8 2.8 0.1 0.0 0.1 0.0 31.2 6.2 0.9 0.0 4.1 3.6 8.4 14.5 2.1 20.0 0.2 9.4 0.5 1.0 16.0 17.3 0.4 1.8 7.0 5.2 4.9 16.0 0.8 7.0 1.3 0.5 5.5 0.5 2.4 0.6 0.8 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.7 12.3 14.2 19.8 21.4 12.3 14.6 12.4 15.9 14.2 3.2 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 28.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm Nucleoplasm "HPA020513: AB_1853077, HPA024248: " "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 1.1 0.7 0.7 1.2 1.3 0.7 1.8 1.1 0.7 0.7 0.7 0.7 0.4 0.7 1.6 0.7 0.5 0.8 0.9 0.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.2 2.5 0.7 0.7 0.9 0.5 0.7 1.6 0.7 1.6 1.3 0.7 1.0 0.7 1.2 1.0 28.1 0.7 0.7 0.9 0.7 0.7 0.7 0.7 1.4 1.3 4.2 0.8 1.2 0.9 0.2 0.8 1.3 1.5 2.9 2.6 2.0 0.7 1.7 0.4 0.4 1.0 0.3 1.4 0.9 0.8 2.8 1.9 0.2 0.7 0.7 0.8 1.3 0.5 2.6 0.2 0.7 0.7 1.8 1.6 0.7 2.9 0.5 0.4 0.4 1.4 1.2 1.3 0.4 1.4 0.9 1.9 1.0 0.3 0.4 1.0 3.5 1.2 0.7 0.7 0.8 2.2 1.0 0.4 4.2 1.8 0.7 3.8 1.5 2.9 2.4 0.9 1.0 1.2 1.2 3.9 0.8 0.6 0.5 0.4 0.5 0.8 0.6 0.5 0.3 1.4 0.6 0.6 4.2 1.2 0.5 1.3 0.9 0.2 0.7 1.2 1.8 1.1 0.7 0.7 0.7 0.7 0.7 0.7 FAM76A MGC34648 ENSG00000009780 "Family with sequence similarity 76 member A" Q8TAV0 1 27725979-27763122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044762, HPA077897" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044762: AB_10795886, HPA077897: " "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (7.58e-2)" "unprognostic (2.07e-2)" "unprognostic (2.87e-1)" "unprognostic (2.18e-3)" "unprognostic (4.44e-3)" "unprognostic (2.18e-3)" "unprognostic (3.07e-2)" "unprognostic (1.04e-1)" "unprognostic (4.35e-3)" "unprognostic (5.22e-2)" "prognostic favourable (2.26e-4)" "unprognostic (6.32e-2)" "unprognostic (6.33e-3)" "unprognostic (2.30e-1)" "unprognostic (1.07e-2)" 22.1 8.6 10.6 12.2 17.2 14.3 14.1 17.9 18.3 14.7 12.8 17.4 8.4 10.2 15.9 16.6 13.9 13.8 15.3 13.8 11.3 11.4 13.7 13.8 13.1 11.3 9.5 16.1 14.6 14.4 11.7 19.5 12.8 14.3 12.9 16.2 15.7 12.4 16.8 39.7 15.4 12.1 17.8 11.9 12.1 13.8 28.5 10.9 13.6 18.7 17.8 13.8 14.0 14.1 13.6 14.6 13.7 12.2 12.0 16.0 6.4 8.6 7.0 8.0 8.2 10.1 8.8 14.4 8.1 8.6 12.1 11.9 8.0 11.7 15.9 5.3 9.0 11.5 10.0 9.0 9.4 8.2 7.6 4.9 9.9 9.4 8.1 7.8 7.7 9.0 9.8 13.2 13.3 6.0 9.3 15.0 8.6 8.4 18.4 7.2 12.6 7.0 11.2 9.5 9.0 9.6 12.5 11.6 5.2 9.3 10.1 9.7 7.3 3.1 6.4 14.3 6.2 16.5 5.6 13.7 14.9 13.0 8.9 10.2 6.1 10.0 12.2 13.7 14.7 12.1 15.6 12.2 15.3 14.0 10.4 13.6 14.5 16.0 8.3 12.0 12.1 14.6 11.3 6.4 10.6 17.2 17.9 18.3 11.3 11.4 9.5 16.1 14.3 10.9 FAM76B MGC33371 ENSG00000077458 "Family with sequence similarity 76 member B" Q5HYJ3 11 95768942-95790409 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036608 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA036608: " "unprognostic (8.17e-2)" "unprognostic (2.26e-1)" "unprognostic (8.21e-2)" "unprognostic (2.39e-2)" "unprognostic (3.12e-2)" "unprognostic (1.43e-2)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (1.01e-2)" "unprognostic (1.65e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-3)" "prognostic unfavourable (7.17e-5)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.43e-1)" "prognostic favourable (2.72e-4)" 10.1 6.2 5.3 12.1 9.3 35.7 9.3 12.3 9.7 8.5 10.8 6.2 6.1 9.5 8.2 7.5 7.8 7.3 10.1 4.9 6.1 4.4 5.2 13.6 8.2 16.8 10.5 5.6 8.3 6.7 6.3 9.5 8.2 7.1 9.0 5.7 6.3 9.1 8.2 5.6 8.7 9.0 9.8 8.9 8.8 6.6 28.2 10.1 12.0 8.4 4.1 17.8 8.6 7.9 3.0 7.3 8.7 3.0 4.5 7.6 2.8 4.4 3.4 12.9 7.0 2.1 2.2 10.8 7.6 3.7 5.7 6.5 12.7 8.7 16.8 9.7 3.7 8.5 7.5 2.6 6.0 9.0 5.5 19.7 6.2 6.6 5.5 13.8 11.3 2.8 4.3 6.5 5.8 5.3 11.6 9.4 3.1 3.3 15.5 16.2 7.2 3.1 16.8 9.6 9.8 4.2 5.0 5.4 15.5 9.4 5.3 5.7 7.0 6.0 5.4 7.8 8.4 9.2 6.9 5.1 10.8 25.9 1.8 13.5 11.0 0.1 2.9 5.2 5.4 3.0 4.4 3.0 4.9 5.4 2.0 2.6 4.5 6.7 8.7 4.5 2.8 7.3 7.6 2.8 5.3 9.3 12.3 9.7 6.1 4.4 10.5 5.6 7.1 10.1 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell line enriched" "Detected in many" 4 "Daudi: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001847: , HPA065797: " "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.7 8.4 0.6 0.1 0.2 0.1 3.4 0.3 0.0 0.5 1.6 1.0 1.0 36.7 0.2 0.1 4.4 4.7 1.4 1.1 0.4 2.4 0.0 5.6 0.3 0.0 3.1 0.7 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.5 1.9 0.0 0.1 0.5 3.0 0.8 8.5 0.9 1.9 2.1 1.7 0.5 3.3 0.1 5.4 1.4 1.9 0.2 1.4 4.3 1.6 6.2 0.0 0.0 0.4 1.4 1.2 3.8 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.8;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 5 "A-431: 23.7;HBEC3-KT: 37.0;hTCEpi: 19.9;K-562: 58.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052615 Approved Nucleoplasm Nucleoplasm "HPA052615: " "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavourable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavourable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavourable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.1 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.6 0.4 0.0 8.3 0.6 0.8 2.0 44.8 2.8 1.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 2.7 0.0 1.3 0.0 0.0 3.1 13.6 0.1 4.4 2.5 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.3 13.4 28.6 3.1 18.4 0.4 0.3 0.7 0.2 0.3 0.4 0.0 23.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 3.2 0.0 7.6 0.0 37.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 19.9 0.0 5.1 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 4.2 2.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.1 0.2 0.1 0.0 0.4 0.1 0.2 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994949-40043529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.4;seminal vesicle: 33.3" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 22.8;hTERT-HME1: 7.2;RT4: 10.9;SCLC-21H: 24.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: " "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favourable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favourable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.1 0.2 0.1 2.8 0.2 0.8 4.7 0.2 0.3 2.6 6.9 0.1 29.4 3.0 0.2 7.5 15.4 1.1 4.0 1.5 0.2 0.1 4.8 2.1 1.0 0.1 0.2 0.1 0.5 14.4 2.6 2.6 0.5 0.1 6.3 3.1 0.4 7.8 33.3 0.1 13.8 12.5 0.8 0.2 0.1 5.9 24.9 0.1 1.3 12.6 12.8 8.1 3.0 4.1 0.7 0.5 2.7 0.4 0.6 0.3 0.1 4.7 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 7.0 1.4 0.0 0.0 0.0 7.6 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 22.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 10.9 24.1 0.0 0.2 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.3 2.2 0.6 0.3 0.5 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 FAM84A "FLJ35392, NSE1" ENSG00000162981 "Family with sequence similarity 84 member A" Q96KN4 2 14632686-14650814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.0" "Cell line enhanced" "Detected in some" "HaCaT: 6.0;hTCEpi: 11.8;RT4: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047703 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047703: " "unprognostic (1.05e-2)" "unprognostic (9.22e-2)" "unprognostic (2.24e-3)" "unprognostic (1.13e-1)" "unprognostic (4.28e-2)" "unprognostic (7.38e-2)" "unprognostic (2.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-1)" "unprognostic (4.44e-2)" "unprognostic (1.20e-1)" "unprognostic (9.27e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-1)" "unprognostic (1.58e-1)" "unprognostic (5.57e-3)" "unprognostic (1.36e-1)" 0.9 1.8 22.0 9.1 14.8 0.6 2.7 3.1 31.8 9.9 34.0 1.7 0.9 22.4 3.0 29.0 22.6 2.8 5.6 2.1 7.7 7.7 3.3 1.8 5.6 0.8 3.6 11.2 7.9 3.3 2.0 3.0 5.9 2.4 11.1 31.9 1.6 15.9 2.5 1.3 14.4 21.3 3.0 2.5 0.8 3.0 20.0 3.9 0.6 2.2 10.4 3.8 9.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 1.6 0.4 0.3 0.0 0.2 0.0 0.0 0.2 6.0 0.6 2.6 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.4 11.8 0.0 3.9 0.0 0.0 0.0 0.8 4.8 0.0 0.1 0.5 2.5 0.0 0.0 0.1 4.5 31.2 2.8 1.3 0.0 1.2 0.0 0.0 0.0 1.8 5.4 0.4 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 14.8 3.1 31.8 7.7 7.7 3.6 11.2 2.4 3.9 FAM84B "BCMP101, NSE2" ENSG00000168672 "Family with sequence similarity 84 member B" Q96KN1 8 126552442-126558393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 23.9;AN3-CA: 34.7;HEK 293: 20.7;MCF7: 35.1;PC-3: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050782, HPA062115" Approved Approved Nucleoplasm Nucleoplasm "HPA050782: AB_2681235, HPA062115: " "unprognostic (2.46e-3)" "unprognostic (6.37e-2)" "unprognostic (7.36e-2)" "prognostic unfavourable (9.71e-4)" "unprognostic (2.75e-3)" "unprognostic (1.54e-1)" "unprognostic (1.79e-1)" "unprognostic (4.52e-2)" "unprognostic (1.32e-1)" "unprognostic (4.49e-2)" "unprognostic (2.42e-3)" "unprognostic (1.07e-2)" "prognostic favourable (1.96e-8)" "unprognostic (2.04e-3)" "unprognostic (1.58e-1)" "unprognostic (1.18e-1)" "prognostic favourable (1.75e-5)" 8.1 3.0 6.0 6.5 8.2 2.2 20.0 8.7 6.8 10.0 8.0 10.8 11.4 10.7 10.5 11.2 20.9 7.2 16.4 4.8 7.7 5.1 23.5 10.2 10.7 4.7 13.9 3.8 3.7 13.8 9.0 5.6 7.8 11.0 7.3 7.0 18.6 33.3 13.2 2.0 7.5 6.3 4.0 6.2 2.8 14.1 2.7 10.3 1.9 8.3 5.4 8.1 6.3 11.2 1.6 0.1 2.7 0.1 1.9 5.3 1.6 23.9 3.2 1.9 34.7 0.0 0.0 2.3 0.3 0.8 0.2 0.3 0.9 14.4 0.0 16.0 0.0 10.9 1.0 4.7 0.4 0.0 20.7 0.0 0.0 0.1 0.5 0.0 0.5 0.2 6.7 0.0 2.9 2.0 0.0 0.0 0.1 35.1 0.8 0.0 1.8 23.9 0.0 0.8 0.2 14.2 10.4 9.5 0.0 0.7 11.4 10.3 17.2 0.2 0.0 0.1 3.3 0.0 0.6 0.4 0.0 0.0 0.3 1.6 6.4 2.5 0.1 2.7 2.7 0.0 2.5 0.6 3.6 5.3 0.0 1.6 3.9 4.0 0.3 1.9 0.0 0.1 4.7 1.6 6.0 8.2 8.7 5.3 7.7 5.1 13.9 3.8 11.0 10.3 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell line enhanced" "Detected in many" "BEWO: 51.1;SK-MEL-30: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: , HPA059578: " "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.7 2.2 4.6 5.4 1.1 51.1 2.6 2.0 1.0 1.8 7.1 4.2 0.0 0.6 1.7 2.8 4.1 0.6 0.8 14.2 10.0 2.2 0.1 0.3 20.7 1.6 12.4 18.0 9.3 0.0 4.7 2.5 17.6 3.0 0.9 1.6 1.0 2.9 3.3 1.5 5.5 7.1 5.3 3.5 5.0 2.0 5.6 0.9 0.4 26.7 0.2 9.9 0.3 8.0 0.0 0.1 4.9 6.4 7.7 3.9 2.3 3.3 15.8 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768456-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 21.9 15.3 12.2 16.1 14.3 39.1 17.3 17.2 15.2 17.3 18.7 11.8 26.7 15.3 16.4 15.5 20.0 13.6 17.3 14.6 12.6 14.4 20.0 30.6 18.4 17.9 15.4 11.6 18.8 15.4 25.2 20.3 26.9 15.6 14.0 16.3 16.1 18.0 24.2 9.2 17.1 23.0 12.8 18.4 31.3 14.4 11.9 14.0 24.4 19.8 12.0 20.0 15.3 16.2 5.7 8.9 12.0 10.4 6.6 4.3 4.2 25.4 17.1 5.4 9.3 10.3 11.2 8.6 14.7 16.1 14.0 17.9 8.4 10.5 12.0 16.5 12.1 12.5 12.6 15.9 25.1 22.8 12.2 18.8 9.0 10.1 16.2 8.6 24.5 10.5 12.9 18.3 22.9 12.6 6.7 17.1 12.5 29.9 14.7 5.6 5.2 15.4 8.1 8.8 8.8 11.8 26.1 6.4 9.0 19.5 42.1 19.6 13.0 9.1 12.6 13.4 24.2 14.8 21.4 13.4 25.5 11.5 21.0 15.5 16.2 6.9 8.3 12.0 3.8 10.4 3.4 5.7 3.8 3.2 8.9 5.0 3.3 4.3 11.4 6.6 9.1 3.5 3.3 4.2 12.2 14.3 17.2 15.2 12.6 14.4 15.4 11.6 15.6 14.0 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavourable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favourable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 11.7 12.8 1.5 7.4 1.6 5.6 6.5 6.8 5.8 6.8 7.2 2.1 8.6 10.7 7.7 4.0 5.7 2.9 4.9 1.1 17.2 6.0 3.5 2.1 4.9 7.3 3.0 6.4 5.3 10.3 3.4 6.3 4.0 9.6 11.8 4.0 13.0 4.3 2.3 1.1 13.8 8.9 3.1 6.3 8.2 6.2 2.6 7.6 6.9 12.2 4.0 9.3 9.4 5.1 3.1 8.3 9.4 8.2 12.7 6.4 4.5 7.9 7.0 4.9 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 FASTKD1 FLJ21901 ENSG00000138399 "FAST kinase domains 1" Q53R41 2 169529749-169573875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043719 Approved Approved Nucleoplasm Nucleoplasm "HPA043719: " "unprognostic (3.08e-3)" "unprognostic (1.63e-1)" "unprognostic (6.91e-3)" "unprognostic (8.03e-3)" "unprognostic (1.99e-2)" "unprognostic (3.84e-1)" "unprognostic (5.56e-3)" "unprognostic (1.15e-1)" "unprognostic (3.83e-3)" "unprognostic (2.46e-1)" "unprognostic (1.29e-3)" "unprognostic (2.17e-1)" "unprognostic (4.26e-3)" "unprognostic (2.23e-2)" "unprognostic (1.41e-1)" "unprognostic (7.58e-2)" "unprognostic (7.62e-3)" 6.3 8.7 11.5 10.1 17.3 6.1 7.8 25.7 17.4 4.7 16.8 8.0 7.1 17.0 6.7 11.1 14.9 6.0 5.2 26.1 12.2 8.9 12.4 12.5 7.2 9.2 10.7 9.8 3.6 9.4 13.8 21.5 7.8 16.5 6.9 22.2 7.4 9.7 6.6 13.1 7.3 18.0 8.6 13.0 10.9 9.3 9.6 12.7 8.8 11.7 16.6 11.5 8.9 7.7 5.2 6.7 15.7 6.0 8.1 5.6 2.9 5.6 6.2 8.3 9.5 5.9 8.3 14.9 9.5 5.9 8.1 9.8 10.3 9.5 17.5 9.1 6.2 15.8 23.3 10.7 13.0 15.7 12.6 25.3 9.6 12.0 4.4 23.3 8.1 5.8 9.6 11.9 6.9 11.2 18.5 10.0 10.4 4.1 18.0 20.1 17.0 8.0 14.4 9.1 21.4 12.2 9.6 18.9 6.0 8.8 16.9 14.4 2.9 23.2 7.8 9.2 9.1 9.0 9.8 8.9 16.9 12.7 7.8 21.0 6.3 15.7 5.3 2.4 3.9 6.0 5.3 5.2 5.3 4.2 6.7 4.6 5.6 4.8 0.7 8.1 2.7 6.7 3.4 2.9 11.5 17.3 25.7 17.4 12.2 8.9 10.7 9.8 16.5 12.7 FASTKD3 "FLJ23274, MGC5297" ENSG00000124279 "FAST kinase domains 3" Q14CZ7 5 7859159-7869037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068525, HPA074462" Approved Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA068525: , HPA074462: " "unprognostic (5.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.41e-3)" "prognostic unfavourable (1.87e-5)" "unprognostic (6.66e-3)" "unprognostic (4.56e-3)" "unprognostic (3.19e-2)" "unprognostic (1.61e-2)" "unprognostic (5.82e-3)" "unprognostic (5.68e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "prognostic favourable (8.53e-4)" 7.1 15.5 8.6 9.7 13.3 7.6 12.3 9.1 15.0 8.3 10.7 8.6 7.9 10.4 8.8 10.2 8.9 7.5 6.5 7.2 8.7 7.3 17.8 14.5 8.3 10.0 9.2 13.7 9.3 8.4 13.0 10.8 6.4 8.0 8.6 13.5 8.1 11.1 15.8 10.2 9.0 12.1 7.8 8.8 12.0 9.1 6.0 7.4 12.2 8.9 7.4 12.2 9.1 7.0 9.6 6.7 7.4 7.3 4.8 10.3 4.7 7.0 6.2 6.1 7.9 3.8 4.9 12.0 6.0 5.1 9.3 7.2 9.3 7.6 24.6 12.0 6.2 7.5 14.9 8.3 13.3 6.7 7.7 8.5 20.3 7.3 5.2 14.0 7.1 5.5 3.6 8.7 5.4 5.1 11.6 4.3 7.0 5.1 9.4 8.2 5.6 8.8 11.0 7.5 5.6 7.6 7.6 4.3 4.0 17.8 7.9 8.7 7.1 6.5 3.5 9.3 9.4 9.6 9.7 5.0 4.7 15.7 6.2 13.0 7.5 3.8 5.4 7.4 6.1 7.3 8.2 9.6 9.4 6.5 6.7 6.8 10.3 9.7 0.2 4.8 5.7 3.8 10.2 4.7 8.6 13.3 9.1 15.0 8.7 7.3 9.2 13.7 8.0 7.4 FAXC "C6orf168, dJ273F20, MGC2817" ENSG00000146267 "Failed axon connections homolog" Q5TGI0 6 99271169-99350062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 14.7;SCLC-21H: 21.5;SH-SY5Y: 15.0;SK-MEL-30: 13.2;WM-115: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039106 Uncertain Approved Nucleoplasm Nucleoplasm "HPA039106: AB_10697546" "unprognostic (8.03e-2)" "unprognostic (4.91e-2)" "unprognostic (5.04e-3)" "unprognostic (6.44e-2)" "unprognostic (3.80e-1)" "unprognostic (5.00e-3)" "unprognostic (7.56e-2)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (2.47e-3)" "unprognostic (6.70e-4)" "unprognostic (1.13e-2)" "unprognostic (1.71e-1)" "unprognostic (4.86e-2)" "unprognostic (3.49e-3)" 0.7 3.3 9.4 2.1 12.2 0.4 4.6 11.0 19.7 1.8 13.3 1.8 5.1 2.3 4.5 15.3 8.6 2.4 3.5 1.3 7.7 10.3 2.5 0.3 2.3 0.4 9.1 9.9 3.4 2.2 9.3 10.4 1.4 7.5 10.1 4.3 1.4 5.8 15.1 0.9 0.4 2.1 19.1 4.8 0.8 5.2 2.8 1.6 0.0 2.0 0.2 0.5 13.6 1.7 1.2 0.6 1.4 0.6 0.8 0.4 0.0 2.3 1.9 6.5 8.9 0.0 0.0 2.4 3.1 1.9 5.1 4.4 1.2 0.8 0.0 0.3 0.6 0.1 14.7 2.9 4.4 0.0 7.3 0.0 1.2 0.4 0.4 0.0 0.0 0.3 4.6 0.1 2.4 0.0 0.3 0.0 1.6 4.2 0.0 0.0 7.6 3.0 0.0 0.6 0.0 2.7 0.1 21.5 15.0 2.7 2.0 13.2 6.2 0.0 0.6 1.6 2.9 0.0 9.3 0.0 0.0 0.0 0.1 0.0 12.1 0.8 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.2 1.2 0.3 0.4 1.4 0.8 0.3 0.6 0.2 0.0 9.4 12.2 11.0 17.4 7.7 10.3 9.1 9.9 7.5 1.6 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529116-168530634 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 18.9;SH-SY5Y: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049546 Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA049546: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.8 6.2 10.3 0.9 12.1 0.7 1.1 10.6 24.9 1.0 0.9 0.9 0.0 1.4 0.8 0.8 0.8 1.4 1.1 1.3 11.0 18.4 1.1 0.9 0.9 0.7 9.7 8.5 1.2 2.1 1.8 7.4 1.0 7.9 1.4 0.9 0.5 1.4 1.3 0.9 1.5 1.6 1.1 3.0 0.8 1.4 5.1 1.7 0.0 0.8 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.4 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.4 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 15.8 1.6 0.0 0.8 0.0 1.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.1 10.6 16.9 11.0 18.4 9.7 8.5 7.9 1.7 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Cell line enhanced" "Detected in many" "HHSteC: 37.3;HSkMC: 26.6;hTERT-HME1: 58.9;HUVEC TERT2: 33.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.4 16.1 0.0 2.6 4.6 3.3 17.6 0.0 15.6 11.7 0.0 0.0 0.0 0.0 23.5 2.6 10.4 2.6 14.7 0.0 4.2 0.0 7.4 0.0 37.3 2.3 0.0 26.6 1.4 6.6 58.9 33.1 0.0 0.0 9.6 0.0 0.0 0.8 6.9 5.3 5.1 5.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 4.9 0.0 6.3 12.0 17.9 0.0 0.0 0.0 0.0 1.8 0.0 6.6 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell line enhanced" "Detected in some" "BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA012513, HPA055286, HPA077371" Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA012513: AB_1848446, HPA055286: , HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.2 0.0 0.0 0.1 0.0 3.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 5.0 1.2 0.0 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 FBRS "FBS, FBS1, FLJ11618" ENSG00000156860 Fibrosin Q9HAH7 16 30658431-30670814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044117 Approved Approved Nucleoplasm Nucleoplasm "HPA044117: AB_10794394" "unprognostic (1.87e-1)" "unprognostic (8.48e-3)" "unprognostic (2.41e-2)" "unprognostic (9.52e-3)" "unprognostic (1.03e-1)" "unprognostic (4.80e-2)" "unprognostic (2.07e-3)" "unprognostic (7.01e-3)" "unprognostic (6.32e-2)" "unprognostic (7.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.01e-1)" "unprognostic (1.25e-2)" "unprognostic (2.13e-1)" "unprognostic (4.16e-1)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" 13.4 13.0 14.2 19.8 15.4 41.0 9.9 22.6 16.4 12.1 13.6 18.5 12.2 18.3 15.5 8.7 21.5 14.7 10.8 9.4 16.7 8.2 13.1 12.9 13.6 17.1 20.0 10.5 14.3 14.6 16.5 23.8 23.6 13.8 14.6 6.0 13.1 17.5 18.5 16.8 21.3 19.0 10.0 13.0 21.7 13.6 52.9 19.3 22.7 14.8 8.1 19.7 13.8 12.3 2.3 2.9 5.6 2.9 1.2 2.8 2.5 12.3 13.2 7.0 5.8 7.0 7.2 17.8 9.2 7.5 8.0 6.0 7.7 11.5 11.6 15.4 7.4 10.3 7.4 8.7 3.8 31.2 18.4 15.6 12.3 14.1 17.3 11.3 23.6 10.6 11.9 15.4 7.5 9.8 13.5 22.4 5.8 25.5 14.3 22.2 1.9 8.4 20.9 5.3 12.6 8.3 9.3 9.8 11.0 7.2 14.0 9.8 31.4 15.0 15.1 18.2 11.1 11.2 12.0 26.4 12.7 11.1 17.5 11.1 10.7 0.0 2.9 2.3 2.4 1.2 2.3 1.9 2.0 2.3 1.5 2.3 0.6 2.8 5.6 1.2 1.7 2.9 0.2 2.5 14.2 15.4 22.6 16.4 16.7 8.2 20.0 10.5 13.8 19.3 FBRSL1 KIAA1545 ENSG00000112787 "Fibrosin like 1" Q9HCM7 12 132489551-132585188 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049880 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA049880: " "unprognostic (2.02e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-2)" "unprognostic (7.75e-2)" "unprognostic (3.21e-1)" "unprognostic (2.59e-2)" "unprognostic (1.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (2.77e-3)" "prognostic unfavourable (9.82e-4)" "prognostic favourable (1.17e-4)" "unprognostic (1.13e-1)" "unprognostic (3.39e-1)" "unprognostic (1.09e-2)" "prognostic favourable (7.21e-4)" 7.6 4.7 4.3 4.9 6.6 5.2 3.2 13.0 9.9 3.4 4.9 2.9 2.9 7.0 4.8 4.6 4.5 4.7 9.6 4.4 4.8 3.1 4.3 5.2 4.2 4.5 9.8 5.5 5.1 12.7 3.9 7.9 4.5 4.5 5.4 1.8 5.0 9.7 4.4 17.9 4.7 7.3 2.9 2.9 10.9 6.1 6.1 4.5 8.0 4.0 2.9 8.6 4.5 3.2 2.8 3.6 4.1 2.0 0.7 1.9 0.9 4.5 7.3 3.4 5.9 1.4 1.7 25.7 4.3 1.1 2.8 1.7 13.4 2.6 6.9 7.6 1.3 8.6 3.6 2.2 0.9 6.0 18.2 8.8 4.2 10.1 2.9 9.2 9.7 1.6 4.1 2.8 1.8 2.6 19.2 1.5 1.1 11.7 12.0 34.2 9.2 13.0 19.0 3.8 4.8 2.2 4.3 13.7 10.6 4.1 6.5 5.2 7.1 9.6 4.2 3.1 7.8 5.8 5.4 9.3 4.8 4.5 3.4 9.3 3.9 2.3 1.5 4.1 1.2 1.3 1.3 2.8 1.2 1.2 1.2 2.6 1.1 1.6 1.7 0.7 2.0 3.6 1.9 0.9 4.3 6.6 13.0 9.9 4.8 3.1 9.8 5.5 4.5 4.5 FBXL14 "Fbl14, MGC40195" ENSG00000171823 "F-box and leucine rich repeat protein 14" Q8N1E6 12 1565993-1594165 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053889 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA053889: " "unprognostic (8.67e-2)" "unprognostic (2.89e-2)" "unprognostic (2.82e-1)" "unprognostic (4.00e-1)" "unprognostic (2.66e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.27e-1)" "unprognostic (5.90e-2)" "unprognostic (8.98e-2)" "prognostic favourable (9.04e-6)" "unprognostic (5.60e-3)" "unprognostic (1.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.12e-3)" 6.0 6.0 12.5 8.1 13.0 7.4 4.9 10.2 15.8 5.9 11.7 9.3 4.2 7.3 5.1 3.4 7.2 9.2 7.5 5.7 11.4 9.3 5.4 4.8 6.2 10.4 9.7 7.2 6.8 17.4 9.9 11.3 6.2 7.9 5.2 5.3 6.2 8.2 6.8 3.4 3.6 8.0 3.7 10.5 8.9 14.1 20.1 9.9 21.2 9.4 1.8 6.2 6.3 19.4 3.8 0.6 2.2 0.5 2.4 4.6 0.5 7.6 11.4 3.4 5.9 2.9 3.0 9.9 1.7 3.3 1.7 1.9 11.9 10.2 10.6 2.1 2.0 5.5 2.7 4.2 0.3 17.5 12.8 13.1 3.2 3.8 3.8 9.9 9.6 4.7 2.0 3.1 2.6 3.0 5.3 30.3 2.0 8.5 9.9 4.9 14.1 4.7 8.7 5.4 6.7 2.7 7.2 6.4 6.3 4.2 6.7 6.6 5.2 8.2 4.2 3.8 11.8 4.7 6.2 3.6 3.8 13.1 8.0 5.9 5.7 2.2 0.5 0.0 0.4 0.4 0.4 0.9 1.4 1.5 0.6 3.8 1.5 0.7 1.1 2.4 0.5 0.6 4.6 0.5 12.5 13.0 10.2 15.8 11.4 9.3 9.7 7.2 7.9 9.9 FBXL18 "Fbl18, FLJ11467" ENSG00000155034 "F-box and leucine rich repeat protein 18" Q96ME1 7 5431335-5513798 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036049 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036049: " "unprognostic (2.86e-3)" "prognostic unfavourable (7.88e-4)" "unprognostic (1.26e-2)" "unprognostic (8.73e-3)" "unprognostic (1.72e-2)" "unprognostic (3.70e-1)" "unprognostic (3.98e-4)" "unprognostic (1.50e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-3)" "unprognostic (1.04e-2)" "unprognostic (3.69e-1)" "unprognostic (8.28e-4)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" "unprognostic (7.30e-4)" "unprognostic (1.73e-3)" 6.4 6.2 11.0 7.2 15.0 8.5 3.7 10.8 17.7 3.0 4.6 8.1 4.3 5.6 5.1 3.4 6.1 4.4 3.3 5.0 10.2 8.0 4.3 3.6 4.4 5.7 6.6 12.3 4.3 8.0 6.2 4.8 4.2 7.6 5.0 3.2 5.6 5.3 3.8 10.8 10.2 5.0 4.3 5.4 5.4 4.6 5.7 7.7 4.3 4.8 2.8 5.6 4.8 3.2 3.4 2.5 8.9 4.0 3.9 2.7 1.8 9.2 12.2 3.5 7.4 3.2 3.4 6.0 5.5 2.9 3.4 3.7 9.2 5.9 4.2 6.7 2.7 14.6 4.0 9.7 2.6 3.2 5.1 2.2 9.2 3.0 2.3 4.7 3.6 2.8 5.2 5.3 2.5 4.1 6.7 3.8 2.3 9.7 2.5 3.0 11.2 10.1 6.2 6.7 2.3 2.2 4.8 7.5 10.5 8.6 14.6 2.9 14.3 2.9 9.3 11.3 16.2 8.3 8.4 5.0 6.2 3.2 5.8 5.8 13.4 7.9 3.5 1.3 2.7 3.2 2.7 2.1 1.7 2.5 2.5 3.4 1.9 2.4 8.9 3.9 4.0 2.5 2.0 1.8 11.0 15.0 10.8 17.7 10.2 8.0 6.6 12.3 7.6 7.7 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: " "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favourable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 4.0 1.1 1.7 1.9 2.4 4.0 0.6 3.2 2.6 2.9 4.3 0.8 4.9 0.2 1.0 2.1 1.1 1.4 3.6 2.0 0.4 2.0 0.7 3.4 0.8 2.9 0.3 0.8 1.6 2.6 1.8 1.4 5.2 1.0 0.4 9.9 0.4 0.8 0.7 1.2 1.0 0.1 1.0 0.1 7.4 1.2 2.1 2.1 1.4 0.8 2.4 2.3 1.2 4.0 1.5 1.4 1.1 1.8 0.4 0.2 0.2 1.3 0.3 1.0 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" HPA008867 Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavourable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 6.1 5.8 3.1 7.7 3.6 6.0 8.2 8.1 5.6 6.9 13.4 3.7 9.9 14.3 4.4 7.5 8.3 4.4 12.0 2.7 2.9 3.1 5.7 15.5 11.6 9.9 3.8 2.6 2.7 13.8 5.1 4.6 6.1 3.2 4.9 6.3 3.6 9.6 9.4 4.6 7.5 19.1 3.1 2.9 8.3 6.2 5.6 3.5 6.0 3.9 6.8 6.5 5.1 4.7 0.7 2.4 1.9 4.3 0.8 1.2 0.2 8.1 2.5 1.8 11.9 2.5 0.6 3.7 4.2 4.6 4.1 2.8 2.7 3.5 3.9 5.2 1.9 5.4 2.2 5.4 0.9 7.0 3.2 7.9 1.4 6.8 3.8 1.9 7.9 1.1 4.9 2.3 6.1 3.4 3.7 5.9 1.5 14.1 5.2 1.9 2.6 7.9 6.3 2.2 12.4 5.3 2.6 2.9 2.9 4.7 7.2 6.9 11.9 3.3 2.9 1.9 7.8 9.8 4.9 2.4 1.8 2.7 3.1 4.7 2.6 0.0 0.6 1.9 1.2 1.3 1.1 0.7 0.9 0.8 0.5 0.5 0.1 0.4 0.2 0.8 4.3 2.4 0.1 0.2 3.1 3.6 8.1 5.6 2.9 3.1 3.8 2.6 3.2 3.5 FBXO10 FBX10 ENSG00000147912 "F-box protein 10" Q9UK96 9 37510892-37576349 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.7;HHSteC: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.9" "Lineage enriched" "Detected in many" 5 "B-cells: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002863, HPA072721" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002863: AB_10965996, HPA072721: " "unprognostic (2.40e-1)" "unprognostic (2.43e-2)" "unprognostic (5.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.98e-1)" "unprognostic (3.44e-3)" "unprognostic (1.96e-2)" "unprognostic (1.80e-1)" "unprognostic (5.49e-2)" "unprognostic (9.84e-2)" "unprognostic (2.93e-5)" "unprognostic (1.91e-1)" "unprognostic (2.61e-2)" "unprognostic (2.08e-1)" "unprognostic (1.00e-1)" "unprognostic (2.74e-1)" "unprognostic (1.99e-1)" 3.8 7.5 4.8 7.5 8.3 1.2 3.4 4.4 12.1 3.6 6.7 4.9 6.3 2.8 5.0 16.9 4.7 2.8 4.5 4.3 6.3 5.9 3.9 4.0 3.5 7.7 4.0 6.7 3.1 7.4 6.4 20.8 3.1 3.9 4.0 2.9 5.3 15.0 5.2 27.0 2.9 4.8 5.0 3.1 10.1 3.6 12.2 3.3 2.9 11.7 6.0 7.7 4.5 2.9 5.9 0.8 0.0 0.2 0.2 1.1 0.5 1.6 4.0 17.7 4.5 8.3 3.0 1.4 3.1 5.5 3.8 5.8 2.3 1.1 10.3 1.0 3.3 0.1 6.4 1.5 2.8 5.7 5.1 2.0 3.8 1.9 25.4 5.4 0.7 6.7 1.2 3.5 2.3 5.4 7.1 2.9 6.8 1.4 2.1 1.8 8.1 1.5 4.0 7.7 1.3 2.2 1.1 3.7 9.4 2.0 2.4 2.2 1.0 5.6 4.3 2.8 4.8 2.4 2.1 3.5 2.8 1.7 2.3 2.1 2.6 0.0 0.1 0.0 0.7 0.2 0.7 5.9 1.1 0.7 0.0 3.2 0.1 0.1 0.0 0.2 0.2 0.8 0.2 0.5 4.8 8.3 4.4 12.1 6.3 5.9 4.0 6.7 3.9 3.3 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell line enhanced" "Detected in many" "AF22: 15.4;Karpas-707: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: , HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favourable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.0 2.5 15.4 6.0 0.4 0.0 0.4 0.1 0.6 2.4 4.5 2.4 3.6 4.6 5.6 0.1 4.1 1.7 2.5 2.3 1.8 2.9 2.2 0.2 1.3 0.3 2.6 1.6 0.2 8.3 0.6 2.5 0.0 0.8 17.8 1.0 4.1 0.3 3.6 3.3 3.5 0.1 3.6 7.1 3.2 2.1 10.0 4.2 0.3 2.5 6.7 10.7 4.5 0.5 1.3 4.7 2.7 2.2 3.9 3.4 3.9 5.2 0.6 2.7 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;pancreas: 52.5" "Cell line enhanced" "Detected in some" "CACO-2: 20.6;HBEC3-KT: 18.1;Hep G2: 43.2;SiHa: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 1.4;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005472: " "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favourable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 1.7 21.8 49.7 2.6 39.2 1.2 7.9 21.1 48.3 2.1 1.8 13.2 2.1 13.7 1.5 6.4 3.6 3.6 2.9 2.6 33.1 32.6 6.9 11.0 3.0 2.5 40.0 23.0 2.2 52.5 17.7 20.2 1.3 25.7 5.1 1.3 2.7 21.7 7.6 1.3 6.6 4.9 1.7 31.4 2.2 3.8 4.4 24.3 1.1 3.7 0.0 3.8 2.6 2.9 1.4 0.1 0.0 0.0 0.0 3.1 0.6 6.7 2.0 0.0 6.6 0.1 0.0 1.0 0.3 0.6 0.1 0.0 20.6 2.0 0.0 8.5 0.0 0.0 0.7 18.1 0.0 0.1 0.2 0.0 0.2 43.2 0.9 0.0 0.0 0.6 3.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.5 0.7 0.9 81.5 0.0 0.8 4.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 3.1 1.4 1.2 2.9 0.1 1.1 1.8 2.6 0.0 0.0 0.0 0.0 0.8 0.6 49.7 39.2 21.1 30.3 33.1 32.6 40.0 23.0 25.7 24.3 FBXO27 "Fbg5, Fbx27" ENSG00000161243 "F-box protein 27" Q8NI29 19 38990714-39032785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046800, HPA062242" Approved Approved Nucleoplasm Nucleoplasm "HPA046800: , HPA062242: " "prognostic favourable (2.15e-4)" "unprognostic (7.32e-2)" "unprognostic (2.03e-2)" "prognostic unfavourable (3.53e-5)" "unprognostic (1.48e-3)" "unprognostic (4.38e-3)" "unprognostic (1.02e-1)" "unprognostic (8.95e-2)" "unprognostic (1.67e-1)" "unprognostic (7.31e-3)" "unprognostic (6.80e-2)" "unprognostic (9.31e-2)" "unprognostic (2.25e-2)" "unprognostic (8.72e-3)" "unprognostic (6.04e-2)" "unprognostic (7.51e-2)" "unprognostic (3.21e-2)" 8.9 3.1 11.8 2.0 7.9 2.3 21.3 18.5 14.1 4.5 5.2 4.7 5.2 2.0 3.9 2.3 11.6 4.4 4.4 14.1 8.8 8.8 5.1 5.8 3.9 3.5 7.3 10.5 8.1 3.8 1.4 3.3 3.1 6.4 7.2 6.7 5.1 5.5 6.4 1.5 26.7 3.9 5.8 6.7 2.5 2.8 3.6 4.1 2.9 3.7 6.0 5.6 9.3 7.1 1.6 1.1 4.0 0.7 2.7 0.9 0.3 4.2 5.3 0.2 3.4 7.5 0.4 1.6 0.6 3.2 2.5 2.4 1.8 1.6 0.6 8.4 4.7 7.2 0.3 3.0 1.7 0.4 0.2 0.2 1.4 0.2 1.3 0.4 1.2 2.7 4.9 2.5 0.2 1.5 2.4 0.6 3.5 3.7 0.3 0.6 3.8 9.7 0.1 0.0 0.6 1.6 16.3 0.3 5.2 8.2 1.1 0.0 4.4 0.8 1.9 0.3 0.2 0.1 0.4 1.7 3.9 0.9 4.3 0.1 0.1 1.8 0.7 0.4 0.8 0.6 0.5 0.8 0.5 0.6 0.5 1.6 0.9 0.7 4.0 2.7 0.4 1.1 0.5 0.3 11.8 7.9 18.5 14.1 8.8 8.8 7.3 10.5 6.4 4.1 FBXO3 "FBA, FBX3" ENSG00000110429 "F-box protein 3" Q9UK99 11 33740939-33774543 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002467 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002467: " "unprognostic (1.87e-1)" "unprognostic (2.81e-1)" "unprognostic (6.07e-2)" "unprognostic (1.25e-1)" "unprognostic (3.71e-1)" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (8.53e-2)" "unprognostic (5.21e-2)" "unprognostic (2.42e-1)" "unprognostic (1.47e-1)" "unprognostic (7.36e-2)" "prognostic favourable (2.46e-9)" "unprognostic (6.96e-2)" "unprognostic (1.92e-1)" "unprognostic (1.27e-1)" "unprognostic (3.19e-2)" 18.2 16.0 18.4 8.7 33.9 14.1 17.4 27.7 30.3 16.1 13.3 17.1 11.5 11.2 16.4 15.8 21.1 15.0 13.5 28.1 17.3 19.3 29.3 25.3 12.2 10.3 15.2 15.4 18.8 16.5 35.9 21.8 15.3 27.8 16.6 15.0 16.7 17.0 16.9 67.6 18.4 16.3 19.0 12.4 12.6 14.6 15.1 15.2 18.6 21.6 24.2 16.6 15.9 16.6 11.1 8.4 13.0 9.2 15.7 22.8 10.4 11.6 10.5 14.3 15.2 17.3 13.6 8.6 14.0 14.1 11.4 14.3 11.9 11.8 7.8 9.9 15.2 20.3 19.1 18.5 19.2 7.8 26.4 4.0 16.4 9.7 11.0 9.2 9.4 13.8 18.8 7.8 12.5 15.0 13.6 15.7 12.8 7.9 6.8 5.4 7.2 16.1 5.2 32.0 11.0 16.5 14.8 20.3 11.2 19.8 13.7 10.3 19.7 7.1 13.7 14.1 12.4 19.9 11.7 8.8 11.4 13.3 12.6 7.2 13.9 13.0 7.8 11.1 15.1 7.5 16.6 10.9 17.9 17.0 8.4 11.1 22.8 15.9 8.4 15.7 9.2 4.3 21.4 10.4 18.4 33.9 27.7 30.3 17.3 19.3 15.2 15.4 27.8 15.2 FBXO31 "FBX14, Fbx31, FBXO14, MGC15419" ENSG00000103264 "F-box protein 31" Q5XUX0 16 87326987-87392142 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA030150 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA030150: AB_10670559" "unprognostic (4.85e-1)" "unprognostic (5.76e-3)" "unprognostic (1.67e-1)" "unprognostic (1.53e-2)" "unprognostic (4.04e-1)" "unprognostic (2.25e-1)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (2.36e-2)" "unprognostic (3.65e-2)" "prognostic favourable (9.16e-5)" "unprognostic (3.00e-2)" "unprognostic (1.47e-3)" "unprognostic (1.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.57e-3)" "unprognostic (2.26e-3)" 25.7 11.5 10.5 6.1 12.1 5.4 22.3 39.7 18.7 10.4 14.1 5.9 9.3 9.0 13.3 7.4 10.8 11.1 6.7 17.2 8.3 8.2 5.3 11.3 5.6 6.3 6.9 10.4 13.9 13.5 8.8 16.6 5.4 8.5 9.4 6.4 7.9 10.3 12.0 50.4 8.9 11.4 14.8 4.6 5.3 8.3 9.1 5.6 4.5 6.0 7.0 5.4 12.2 22.6 2.4 0.9 1.4 0.7 0.2 3.7 1.4 4.8 9.3 3.1 8.4 16.1 9.7 9.1 8.5 8.6 8.5 4.5 8.4 4.1 11.4 9.4 9.0 7.5 6.0 7.1 5.7 5.2 11.0 3.8 5.7 23.6 9.0 3.7 3.2 11.5 6.0 11.0 10.5 5.2 10.9 4.5 4.5 7.0 8.6 5.0 6.0 8.3 11.1 3.7 4.8 3.8 3.5 14.5 7.1 19.0 3.9 5.8 6.1 3.2 7.1 8.2 6.2 7.8 6.7 10.4 8.0 14.1 6.5 6.8 5.0 1.4 0.6 0.2 1.0 0.6 1.8 2.4 1.7 2.4 0.4 1.6 1.8 1.9 0.9 0.2 0.7 0.9 3.7 1.4 10.5 12.1 39.7 18.7 8.3 8.2 6.9 10.4 8.5 5.6 FBXO33 Fbx33 ENSG00000165355 "F-box protein 33" Q7Z6M2 14 39397669-39432500 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046657 Approved Approved Nucleoplasm Nucleoplasm "HPA046657: AB_10960398" "unprognostic (8.84e-3)" "unprognostic (6.72e-2)" "unprognostic (3.65e-2)" "unprognostic (2.79e-1)" "unprognostic (1.08e-1)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic favourable (4.94e-4)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "prognostic favourable (4.58e-4)" "unprognostic (9.61e-2)" "unprognostic (4.54e-1)" "unprognostic (4.41e-2)" "unprognostic (8.58e-3)" 8.9 13.3 8.9 8.9 12.1 49.1 8.4 12.3 19.7 10.1 7.0 7.1 10.0 8.2 8.5 12.0 7.5 8.8 8.6 6.1 10.4 11.7 8.5 8.8 9.0 12.8 9.1 11.0 9.4 7.8 18.4 19.0 8.8 9.3 9.1 6.9 9.4 10.8 12.0 4.4 6.7 8.0 7.7 7.2 10.4 8.2 12.8 7.5 16.6 14.9 5.7 10.6 8.6 8.7 2.5 1.6 7.8 2.2 5.5 4.8 1.3 9.5 6.0 5.5 8.4 19.9 9.3 9.1 9.6 13.1 5.4 6.4 3.5 8.6 10.8 12.0 15.0 5.0 14.1 9.5 9.8 10.3 9.1 4.3 8.8 9.2 5.6 16.1 16.4 8.6 10.4 9.2 3.0 4.5 3.7 9.8 10.6 10.2 14.3 10.1 5.6 9.0 12.5 8.9 9.8 10.3 12.3 9.5 4.3 8.7 9.2 10.5 6.7 10.4 5.7 9.2 8.3 13.6 7.6 13.4 15.7 17.0 7.1 7.7 6.8 1.6 1.7 3.7 3.4 2.1 3.2 2.5 3.4 3.7 1.6 2.3 4.8 4.5 7.8 5.5 2.2 1.5 3.4 1.3 8.9 12.1 12.3 19.7 10.4 11.7 9.1 11.0 9.3 7.5 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013109 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA053865: " "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favourable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 4.0 7.8 8.9 1.9 12.6 1.9 7.3 4.1 12.2 6.7 2.8 11.9 4.7 3.2 5.4 8.9 3.8 21.7 3.9 2.9 8.3 9.1 10.3 3.7 4.9 2.1 8.1 6.9 6.8 3.7 11.7 11.7 3.6 10.1 6.4 3.0 9.3 5.0 5.8 2.0 6.1 3.2 3.9 8.9 2.1 3.7 14.0 5.2 2.7 14.8 2.8 2.7 2.9 3.3 2.8 3.6 0.8 1.7 2.7 4.5 1.2 1.2 2.5 3.0 1.2 1.5 9.2 6.0 1.6 4.2 2.2 3.9 0.8 4.0 0.1 0.8 2.8 1.0 1.4 0.8 3.9 0.3 0.9 0.5 0.9 1.5 5.9 1.0 0.4 9.7 6.8 4.3 3.3 2.3 1.7 0.7 2.6 5.1 2.1 2.4 7.9 2.9 2.6 0.8 0.6 4.0 1.0 2.9 3.7 2.6 2.1 1.0 4.4 1.8 1.7 3.7 1.4 6.0 0.6 2.7 2.2 0.9 4.6 0.5 2.7 0.1 1.7 0.1 2.5 1.3 2.1 2.8 1.9 1.7 3.6 2.0 4.5 2.5 0.8 2.7 0.9 1.7 3.5 1.2 8.9 12.6 4.1 12.2 8.3 9.1 8.1 6.9 10.1 5.2 FBXO4 FBX4 ENSG00000151876 "F-box protein 4" Q9UKT5 5 41925254-41941743 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003362 Approved Nucleoplasm Nucleoplasm "HPA003362: " "unprognostic (1.43e-1)" "unprognostic (2.10e-2)" "unprognostic (9.25e-3)" "unprognostic (2.65e-2)" "unprognostic (2.50e-1)" "unprognostic (7.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.48e-2)" "unprognostic (1.62e-3)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.42e-2)" "prognostic unfavourable (1.28e-4)" "unprognostic (8.57e-2)" "unprognostic (1.51e-1)" "unprognostic (5.39e-2)" "unprognostic (8.27e-2)" 15.5 13.3 6.6 9.4 9.8 8.5 14.9 7.1 10.3 11.1 9.2 7.8 14.4 9.2 10.0 19.6 10.0 10.5 12.3 8.6 6.3 6.5 9.2 19.9 10.2 12.9 8.9 7.3 12.1 19.3 9.7 9.4 8.6 8.7 11.2 9.7 10.8 11.7 11.7 7.6 11.2 9.9 10.6 7.8 14.8 9.2 11.0 8.2 11.1 16.2 9.9 15.1 11.0 8.9 11.5 9.6 2.6 15.9 8.0 9.9 6.7 5.6 4.1 0.7 10.5 5.6 9.3 6.3 4.8 8.9 8.0 11.0 2.0 15.3 14.3 6.4 6.6 1.4 2.5 1.5 6.7 5.0 1.0 7.5 14.8 5.2 11.0 12.2 4.8 5.6 3.5 4.0 15.4 6.0 6.9 4.5 9.2 2.2 7.7 2.5 0.3 3.5 1.4 1.6 3.6 5.4 5.5 1.7 3.2 18.8 1.4 7.0 9.4 13.8 4.3 9.0 2.5 6.1 3.7 7.2 6.2 0.9 9.1 13.6 4.7 2.6 5.1 1.1 8.5 7.4 9.9 11.5 9.5 8.9 9.6 11.1 9.7 8.9 0.3 8.0 15.9 8.5 7.4 6.7 6.6 9.8 7.1 10.3 6.3 6.5 8.9 7.3 8.7 8.2 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "Daudi: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: , HPA058386: " "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavourable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavourable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.5 1.7 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.0 2.1 26.5 0.1 0.1 2.9 3.7 2.3 1.2 11.0 0.3 8.1 4.0 1.6 0.9 12.2 6.2 1.5 0.9 0.0 0.9 0.2 1.6 4.4 1.2 0.9 4.2 11.4 2.7 1.6 14.9 6.8 12.9 0.7 1.2 9.2 3.4 4.5 1.9 2.8 2.6 5.1 0.2 4.1 3.6 3.7 0.7 5.2 2.2 12.6 1.0 13.4 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 FBXO42 "Fbx42, KIAA1332" ENSG00000037637 "F-box protein 42" Q6P3S6 1 16246839-16352454 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025071 Approved Approved Nucleoplasm Nucleoplasm "HPA025071: AB_1848461" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-2)" "prognostic unfavourable (3.72e-4)" "unprognostic (3.22e-2)" "unprognostic (4.00e-2)" "unprognostic (4.22e-2)" "unprognostic (3.96e-2)" "unprognostic (4.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-1)" "unprognostic (5.78e-3)" "unprognostic (3.91e-2)" 18.2 15.0 18.2 13.0 18.7 11.3 16.1 37.3 23.9 19.1 15.8 17.1 16.1 10.4 24.3 18.5 23.0 18.5 16.3 19.7 16.2 15.9 13.4 15.7 15.2 15.3 16.1 13.4 22.2 22.6 21.2 19.6 16.2 19.5 21.6 15.0 19.0 18.2 22.0 24.3 33.6 12.5 24.9 13.1 15.9 14.3 16.5 17.7 20.1 18.2 10.4 18.9 19.9 22.1 12.2 14.4 18.5 16.8 12.4 12.9 7.9 10.5 5.7 13.9 14.1 17.0 11.1 6.1 10.9 16.6 15.8 15.6 5.3 9.8 11.2 9.8 15.1 9.6 14.0 10.4 13.0 12.8 6.6 10.5 8.7 6.0 20.2 12.3 13.7 11.8 24.0 13.9 20.2 15.8 11.1 15.8 11.2 7.2 11.8 10.8 6.0 6.5 13.5 8.5 9.9 10.5 3.0 13.2 8.6 12.4 10.4 12.9 8.4 9.7 9.8 8.1 7.1 13.1 8.5 7.8 7.8 11.4 10.7 16.2 11.0 7.1 12.3 18.5 12.9 16.8 9.7 8.2 9.8 8.2 14.4 12.2 11.3 9.6 10.9 12.4 12.5 6.4 12.2 7.9 18.2 18.7 37.3 23.9 16.2 15.9 16.1 13.4 19.5 17.7 FBXO44 "FBG3, FBX30, Fbx44, Fbxo6a, MGC14140" ENSG00000132879 "F-box protein 44" Q9H4M3 1 11654375-11663327 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 61.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003363 Approved Approved Nucleoplasm Nucleoplasm "HPA003363: AB_1078831" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (9.59e-2)" "unprognostic (5.34e-2)" "unprognostic (2.82e-1)" "unprognostic (2.97e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-2)" "unprognostic (3.32e-1)" "unprognostic (1.93e-1)" "prognostic favourable (2.63e-4)" "unprognostic (2.57e-2)" "prognostic favourable (6.29e-5)" "unprognostic (1.34e-2)" "unprognostic (5.45e-1)" "unprognostic (1.77e-1)" "unprognostic (3.02e-3)" 6.6 21.1 26.6 8.3 39.0 5.3 7.0 61.7 45.0 6.5 5.0 12.3 8.9 14.2 8.5 10.3 7.7 12.1 10.5 13.7 28.7 26.4 12.2 7.7 8.1 16.3 20.7 27.4 11.3 17.8 21.7 19.5 2.4 23.1 13.7 3.4 9.9 25.5 15.4 6.4 22.1 7.8 6.2 14.2 13.4 8.1 8.5 15.3 3.2 13.0 3.3 9.9 7.4 7.5 10.9 5.1 1.5 2.5 1.5 11.7 6.1 7.4 12.1 4.5 17.0 6.6 6.9 6.1 6.0 7.4 6.7 5.7 8.8 14.2 0.2 13.4 6.6 1.9 8.9 20.1 2.8 8.5 10.9 0.2 6.5 14.7 9.2 0.2 1.1 8.9 13.4 6.2 4.8 5.2 4.5 1.9 1.7 4.6 12.5 1.4 4.7 8.6 5.0 0.2 2.5 10.7 2.7 13.6 11.2 15.8 6.1 26.7 11.0 6.8 6.3 4.9 11.8 6.5 4.7 12.6 7.0 4.6 11.2 3.2 11.5 1.1 2.1 0.6 11.7 2.4 9.0 10.0 8.0 8.9 3.3 10.9 10.9 7.5 1.5 1.5 2.5 5.1 7.1 6.1 26.6 39.0 61.7 45.0 28.7 26.4 20.7 27.4 23.1 15.3 FBXO46 "20D7-FC4, Fbx46, FBXO34L" ENSG00000177051 "F-box protein 46" Q6PJ61 19 45710629-45730904 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049390 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA049390: " "unprognostic (9.02e-3)" "unprognostic (1.01e-2)" "unprognostic (2.82e-2)" "prognostic unfavourable (2.13e-5)" "unprognostic (9.33e-2)" "prognostic favourable (5.44e-4)" "prognostic unfavourable (1.11e-4)" "unprognostic (1.08e-1)" "unprognostic (2.06e-1)" "unprognostic (6.13e-2)" "prognostic favourable (8.11e-4)" "unprognostic (9.77e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (5.10e-2)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (5.09e-6)" 7.4 7.4 13.8 12.9 13.1 10.4 9.8 10.4 15.7 11.2 10.3 8.6 10.6 9.6 15.7 10.0 20.7 10.7 7.3 8.7 13.3 4.8 7.6 10.5 7.7 17.2 13.9 10.1 17.1 12.6 8.4 10.4 12.3 10.2 10.1 9.7 8.6 11.0 9.0 12.8 12.8 11.4 10.9 9.7 15.8 13.3 11.5 13.0 13.6 12.8 9.2 17.1 10.0 12.4 5.9 2.6 7.1 2.3 1.1 3.7 1.2 6.9 10.8 8.4 9.8 2.2 3.9 9.6 3.7 2.0 2.9 3.4 9.0 9.2 12.1 5.0 2.0 10.1 6.2 4.6 2.2 14.9 13.1 9.8 36.6 4.8 3.3 4.4 12.7 3.3 4.2 4.9 3.1 4.3 7.7 14.8 2.4 6.6 10.0 5.1 5.3 3.8 13.6 4.7 11.2 3.4 8.4 8.4 7.4 5.8 12.3 4.8 10.4 5.4 4.9 6.2 5.6 3.4 6.0 14.2 19.6 8.1 6.9 6.2 5.0 7.1 2.3 2.3 3.7 1.8 2.5 4.0 2.8 2.5 1.5 5.9 2.6 3.0 6.7 1.1 2.1 2.6 2.6 1.2 13.8 13.1 10.4 15.7 13.3 4.8 13.9 10.1 10.2 13.0 FBXO8 "FBS, FBX8" ENSG00000164117 "F-box protein 8" Q9NRD0 4 174236658-174284264 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002885 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA002885: AB_1078835" "unprognostic (8.17e-2)" "unprognostic (6.59e-2)" "unprognostic (2.46e-1)" "unprognostic (3.18e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (7.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-2)" "unprognostic (3.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.25e-1)" "prognostic favourable (1.29e-7)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" 16.8 18.5 13.5 9.2 14.1 7.3 16.4 19.4 14.0 15.6 17.3 14.0 10.7 13.4 13.1 19.5 16.4 15.1 13.1 19.1 13.3 12.0 20.2 43.5 11.8 9.5 14.6 10.1 15.7 22.6 16.5 26.9 27.1 14.3 16.8 15.3 14.7 13.3 13.1 7.4 16.0 18.9 18.8 14.7 13.9 14.7 10.0 14.0 18.2 19.9 6.5 12.4 20.6 18.2 12.6 8.6 19.2 8.9 9.8 15.5 7.8 4.7 3.2 6.5 2.2 14.6 16.0 5.1 9.7 8.9 6.4 6.5 2.5 8.4 3.6 9.2 6.3 3.0 4.3 5.6 6.8 10.8 9.8 3.2 5.3 3.9 11.1 4.3 3.5 9.2 13.9 5.9 7.8 6.4 6.7 18.8 8.4 4.7 4.5 4.5 1.8 3.4 2.6 4.3 5.7 10.0 2.0 6.0 39.3 4.3 7.6 10.7 4.3 4.7 7.3 3.8 3.6 10.7 5.4 9.7 4.6 3.1 12.7 3.1 5.2 19.2 6.2 12.7 12.3 7.8 15.5 12.6 14.2 12.1 8.5 10.7 13.5 11.8 6.2 9.8 8.9 8.6 15.0 7.8 13.5 14.1 19.4 14.0 13.3 12.0 14.6 10.1 14.3 14.0 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744024-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 15.9" "Cell line enhanced" "Detected in some" "A549: 5.7;ASC diff: 2.1;CAPAN-2: 3.0;HaCaT: 4.3;HeLa: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA047457 Approved Nucleoplasm Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.7 0.1 0.1 0.7 0.0 0.1 1.9 0.6 0.6 0.1 0.1 0.1 0.4 0.1 2.1 0.2 0.8 0.4 0.1 0.6 0.3 0.2 1.1 0.3 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.6 0.1 0.0 0.4 0.3 0.2 0.8 0.1 0.4 0.1 0.1 0.1 0.3 15.9 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.7 0.0 0.1 2.1 1.3 0.1 0.0 0.2 0.0 0.3 0.0 3.0 0.1 0.1 0.4 4.3 0.0 0.0 0.2 0.1 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.9 0.6 0.6 0.3 0.1 0.8 1.6 0.1 FBXW2 "FBW2, Fwd2, Md6" ENSG00000119402 "F-box and WD repeat domain containing 2" Q9UKT8 9 120751978-120793412 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067878 Approved Approved Nucleoplasm Nucleoplasm "HPA067878: " "unprognostic (1.08e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (6.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.57e-1)" "unprognostic (8.06e-3)" "unprognostic (1.40e-1)" "unprognostic (2.95e-1)" "unprognostic (3.88e-3)" "prognostic favourable (1.38e-6)" "unprognostic (1.66e-1)" "unprognostic (2.75e-1)" "unprognostic (2.86e-1)" "unprognostic (3.83e-2)" 26.4 31.7 17.4 22.9 25.8 35.6 29.7 27.0 30.3 26.0 22.6 22.6 17.4 18.1 28.8 25.2 25.5 22.7 24.2 25.3 18.1 16.1 20.4 25.5 27.4 25.0 15.1 19.8 20.9 27.3 30.7 23.4 18.8 18.8 22.8 22.3 23.8 25.6 23.2 20.2 27.2 20.9 29.7 16.8 30.1 24.5 23.0 16.7 32.9 22.8 15.7 26.6 25.2 23.8 10.6 11.7 17.7 13.2 15.4 19.3 9.6 13.8 17.6 13.3 22.3 25.0 20.7 12.3 18.7 21.5 20.7 20.3 13.9 16.8 20.9 9.9 24.3 30.7 19.1 18.6 25.9 28.0 8.2 13.5 29.8 20.2 14.2 30.1 18.8 15.0 23.4 22.8 24.5 24.2 17.9 22.8 17.9 22.3 21.5 9.0 19.7 16.9 16.7 21.2 20.8 14.3 15.8 10.6 16.0 26.2 19.5 13.5 31.9 8.7 18.0 17.7 14.2 28.5 23.1 16.5 33.2 18.2 18.8 13.5 18.2 13.3 12.6 17.7 19.3 12.0 14.7 10.6 14.1 18.1 11.7 6.9 11.7 15.8 13.4 15.4 13.2 10.3 13.4 9.6 17.4 25.8 27.0 30.3 18.1 16.1 15.1 19.8 18.8 16.7 FCF1 "Bka, C14orf111, CGI-35, UTP24" ENSG00000119616 "FCF1, rRNA-processing protein" Q9Y324 14 74713144-74738620 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046681 Approved Approved Nucleoplasm Nucleoplasm "HPA046681: AB_10960541" "unprognostic (1.39e-2)" "unprognostic (1.54e-1)" "unprognostic (5.74e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (7.94e-3)" "prognostic unfavourable (5.54e-6)" "unprognostic (3.17e-1)" "unprognostic (3.43e-2)" "unprognostic (7.36e-2)" "prognostic unfavourable (3.54e-4)" "unprognostic (7.79e-2)" "prognostic favourable (2.26e-4)" "unprognostic (3.30e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-1)" "unprognostic (1.47e-1)" 23.9 26.0 19.5 18.4 23.0 18.3 27.1 15.7 21.6 25.6 21.6 24.6 25.9 14.4 29.5 18.5 30.4 30.6 17.8 21.9 17.7 18.2 24.6 25.1 21.1 24.2 25.2 17.5 32.7 18.3 23.1 34.5 24.4 23.8 22.8 23.2 20.8 22.7 25.4 26.3 20.3 19.3 23.8 34.9 21.4 19.8 19.4 21.6 28.3 37.8 23.3 30.5 26.6 24.0 19.0 25.2 15.8 14.5 12.1 18.1 6.8 35.6 26.3 19.1 21.5 30.4 26.9 25.2 31.4 24.2 31.4 28.1 29.2 29.4 32.0 20.5 27.3 26.4 31.7 29.6 55.6 29.6 13.8 22.1 16.6 19.0 22.0 27.0 20.4 21.1 26.3 33.3 35.1 29.2 26.4 19.3 28.2 25.5 31.2 9.7 25.5 30.7 23.8 37.5 15.2 16.0 29.3 13.4 19.6 40.3 21.4 17.9 27.4 18.8 26.6 25.1 27.0 23.7 35.8 17.1 44.6 49.8 23.9 25.7 27.8 10.0 14.5 15.8 16.6 12.3 18.1 19.0 16.0 14.2 11.2 18.7 17.4 17.8 12.1 12.1 14.2 25.2 15.4 6.8 19.5 23.0 15.7 21.6 17.7 18.2 25.2 17.5 23.8 21.6 FCHSD1 FLJ00007 ENSG00000197948 "FCH and double SH3 domains 1" Q86WN1 5 141639302-141651419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043795 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043795: AB_10963435" "prognostic favourable (8.62e-4)" "unprognostic (4.08e-2)" "unprognostic (6.17e-2)" "unprognostic (5.28e-2)" "unprognostic (3.50e-3)" "unprognostic (8.56e-3)" "unprognostic (5.34e-2)" "unprognostic (9.61e-3)" "unprognostic (2.17e-2)" "unprognostic (2.66e-2)" "unprognostic (1.88e-3)" "unprognostic (1.50e-2)" "prognostic unfavourable (6.19e-6)" "unprognostic (2.26e-1)" "prognostic unfavourable (4.77e-4)" "unprognostic (4.12e-3)" "prognostic favourable (1.21e-4)" 7.5 6.6 9.2 16.1 14.1 15.2 8.6 3.0 12.5 11.7 9.9 11.1 4.9 9.7 12.5 8.6 8.6 8.5 13.7 5.4 8.8 6.6 6.8 2.9 9.6 18.6 18.8 4.3 17.7 7.5 23.8 12.6 7.9 14.5 10.0 4.8 5.6 10.3 6.1 2.6 18.5 15.3 8.8 14.5 18.4 10.5 7.4 15.4 7.4 10.6 8.8 23.2 12.1 13.8 5.3 1.9 9.8 3.0 2.3 7.2 2.9 7.3 4.6 6.2 13.0 5.3 6.7 11.0 15.9 8.2 14.3 22.6 8.6 15.7 3.0 8.0 12.2 4.2 2.0 8.8 6.4 12.9 3.3 6.4 6.1 3.1 4.1 2.0 21.7 8.2 7.0 11.2 3.7 8.2 3.9 5.8 1.6 6.5 1.6 3.9 1.8 4.3 0.0 0.0 2.9 4.9 11.0 0.7 7.0 0.3 6.0 9.1 7.3 6.1 16.5 0.2 4.0 5.8 6.6 7.0 2.3 1.6 12.5 7.2 6.8 6.3 1.7 5.6 7.0 2.0 5.2 5.3 3.8 7.2 1.9 3.0 3.6 4.9 9.8 2.3 3.0 1.7 5.0 2.9 9.2 14.1 3.0 12.5 8.8 6.6 18.8 4.3 14.5 15.4 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in some" 5 "RPMI-8226: 51.7;U-266/70: 26.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favourable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.3 0.0 0.1 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 7.2 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.2 51.7 0.0 0.1 0.0 0.0 1.0 0.2 4.8 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.1 1.9 7.2 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 FDPS ENSG00000160752 "Farnesyl diphosphate synthase" P14324 1 155308748-155320666 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028200 Approved Approved Nucleoplasm,Cytosol 2000000 Cytosol Nucleoplasm "HPA028200: AB_10612109" "unprognostic (1.23e-1)" "unprognostic (8.46e-3)" "unprognostic (2.47e-2)" "unprognostic (6.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (7.35e-4)" "unprognostic (4.21e-2)" "unprognostic (6.78e-3)" "unprognostic (1.64e-3)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (1.11e-2)" "unprognostic (8.25e-2)" "unprognostic (2.07e-1)" "unprognostic (5.65e-2)" "unprognostic (8.44e-2)" 21.0 57.8 19.3 17.6 26.5 16.5 19.8 12.8 32.2 19.0 25.0 22.6 14.5 45.9 18.0 21.7 41.4 16.7 18.8 19.6 18.6 23.4 23.7 100.8 25.7 19.2 19.5 24.3 15.2 27.5 15.6 12.3 20.2 47.3 16.5 29.7 20.5 29.2 12.9 15.7 29.3 32.3 18.9 23.0 17.7 23.4 15.1 16.5 25.1 19.5 41.7 27.3 13.7 20.8 41.1 39.7 49.4 37.1 45.3 45.5 48.3 35.6 19.4 71.3 25.7 16.7 61.3 25.4 17.0 33.7 27.2 44.3 31.4 84.9 27.2 41.4 14.9 39.8 42.4 147.8 25.5 14.8 30.4 15.8 34.6 37.8 27.5 25.5 18.1 43.6 23.4 43.2 21.7 47.3 28.1 73.3 28.3 38.3 32.6 24.8 42.8 28.4 28.2 30.9 75.4 71.6 23.8 27.7 23.7 17.5 31.9 29.4 23.0 69.4 34.4 15.2 18.7 9.4 31.1 31.1 23.9 48.5 14.8 27.2 23.9 30.5 36.0 49.4 39.4 37.1 35.0 41.1 34.8 39.8 39.7 34.2 31.5 39.3 16.5 45.3 27.2 31.4 45.5 48.3 19.3 26.5 12.8 32.2 18.6 23.4 19.5 24.3 47.3 16.5 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell line enhanced" "Detected in many" "HEL: 20.9;HL-60: 18.6;HMC-1: 39.8;NB-4: 24.4;THP-1: 36.6;U-937: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.5 1.0 3.1 6.0 0.9 0.0 1.7 1.0 0.8 0.0 2.2 0.1 2.0 0.5 0.6 0.1 0.5 1.1 0.3 20.9 0.0 3.7 2.0 18.6 39.8 3.0 0.0 2.6 0.0 10.5 0.6 0.0 0.0 6.8 0.5 24.4 1.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 0.0 36.6 8.3 0.0 3.6 0.1 0.0 0.0 2.6 0.8 0.1 15.8 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 FGD3 "FLJ00004, ZFYVE5" ENSG00000127084 "FYVE, RhoGEF and PH domain containing 3" Q5JSP0 9 92947451-93036236 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.2;lymphoid tissue: 48.1" "Cell line enhanced" "Detected in many" "HMC-1: 20.7;Karpas-707: 28.7;RT4: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020963, HPA021018" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA020963: , HPA021018: " "unprognostic (5.66e-3)" "prognostic favourable (5.51e-4)" "unprognostic (5.05e-3)" "unprognostic (1.75e-2)" "unprognostic (1.14e-1)" "prognostic favourable (2.23e-7)" "unprognostic (2.26e-1)" "unprognostic (1.03e-2)" "unprognostic (2.61e-2)" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.32e-1)" "unprognostic (8.56e-2)" "unprognostic (3.96e-1)" "unprognostic (1.60e-1)" "unprognostic (9.66e-2)" "unprognostic (1.22e-2)" 3.1 1.5 2.3 20.5 2.5 23.4 3.5 0.5 1.6 1.8 3.1 3.1 1.6 1.9 2.8 2.5 2.8 2.5 3.1 1.5 2.2 2.0 4.6 2.1 7.5 30.5 3.3 1.0 1.1 5.7 0.1 1.0 2.6 2.6 3.2 1.4 2.2 6.6 1.0 0.7 3.1 10.1 1.5 6.3 28.1 2.6 3.9 2.5 48.1 3.5 2.1 25.8 7.7 3.2 11.3 10.3 49.2 24.7 10.5 15.7 17.1 6.3 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 7.9 4.4 5.1 0.2 0.0 4.1 0.3 0.0 0.0 8.8 0.0 8.1 0.0 0.3 0.0 2.1 20.7 0.0 0.1 0.0 0.0 0.0 0.3 28.7 0.0 10.6 9.4 9.0 0.2 0.5 9.4 0.0 7.2 0.0 16.3 0.6 0.2 0.0 7.0 0.2 2.7 9.5 0.0 0.0 0.3 0.0 0.0 2.9 2.9 2.4 1.5 4.5 0.0 34.0 13.4 36.7 15.1 17.3 15.5 8.5 15.6 14.1 10.3 11.3 15.7 13.3 49.2 10.5 24.7 4.7 13.5 17.1 2.3 2.5 0.5 1.6 2.2 2.0 3.3 1.0 2.6 2.5 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139395-192767764 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7" "Cell line enhanced" "Detected in some" "AF22: 11.6;NTERA-2: 7.9;SCLC-21H: 18.6;U-251 MG: 11.1;WM-115: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA071557: " "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.2 21.5 8.8 0.7 15.8 0.6 1.0 17.7 31.9 0.9 0.9 1.9 0.0 1.0 1.2 0.7 1.5 1.5 0.9 75.7 6.8 4.1 2.0 0.9 1.2 0.7 5.1 15.8 1.1 4.9 0.7 2.9 0.8 22.3 1.3 0.8 1.1 3.6 4.2 1.1 0.7 0.7 1.0 2.7 6.8 0.9 1.7 2.8 0.0 1.4 0.0 0.7 0.8 0.8 1.1 0.3 1.2 0.4 0.5 0.4 0.1 0.0 0.8 11.6 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.1 0.6 5.6 0.2 0.1 0.0 0.0 1.3 0.1 0.1 2.4 4.9 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 3.2 0.0 0.0 7.9 0.2 0.0 0.1 0.0 3.6 1.3 18.6 0.0 0.0 0.4 0.0 0.8 0.1 0.3 4.8 2.5 0.0 11.1 0.1 1.8 0.0 1.0 0.0 13.4 1.2 0.2 0.5 0.2 0.3 0.4 1.1 0.2 0.2 0.1 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.1 8.8 15.8 17.7 31.9 6.8 4.1 5.1 15.8 22.3 2.8 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423096-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 23.7;ASC TERT1: 21.8;fHDF/TERT166: 9.8;HSkMC: 22.2;RH-30: 17.6;U-138 MG: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in single" 9 "cerebellum: 9.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 39.7 2.7 0.6 9.9 0.6 0.0 16.5 0.6 2.4 73.3 22.2 0.0 10.1 1.1 13.1 16.1 25.2 14.1 25.4 19.1 0.6 0.6 5.9 1.2 44.8 5.5 2.1 0.0 43.7 2.5 2.9 2.8 9.1 0.8 42.5 4.5 2.7 6.4 8.1 25.6 3.6 4.2 38.3 1.4 1.0 6.6 12.7 0.0 0.0 23.2 24.7 2.9 72.2 32.4 0.2 0.1 1.6 0.2 0.3 0.5 0.0 0.1 0.0 0.1 0.1 23.7 21.8 0.0 7.2 4.4 0.0 0.0 0.0 0.1 0.0 0.1 9.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.0 0.1 0.0 22.2 0.4 1.9 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.1 0.0 17.6 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.1 0.1 0.1 12.0 0.2 0.4 0.0 0.2 0.1 0.0 3.3 0.0 0.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.1 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.6 2.1 0.0 0.8 0.0 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell line enhanced" "Detected in some" "AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favourable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favourable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.0 57.8 0.0 0.0 19.4 0.1 0.0 0.0 0.0 15.1 0.3 0.0 4.1 0.9 17.4 18.7 4.0 0.0 0.0 4.0 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.5 0.0 0.0 0.0 2.2 5.6 4.9 0.1 0.1 0.1 10.6 0.0 15.5 0.0 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.4" "Cell line enhanced" "Detected in many" "HDLM-2: 26.2;RH-30: 18.2" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054971 Approved "Nucleoplasm,Nuclear bodies" 110000 "Nucleoplasm, Nuclear bodies" "HPA054971: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.5 10.3 5.4 6.5 5.7 1.4 4.6 23.2 5.5 4.9 5.1 4.4 10.1 4.9 9.6 26.1 4.5 7.0 8.6 7.6 3.7 5.0 13.0 45.4 7.8 5.2 6.2 3.3 3.8 8.4 9.9 7.4 2.7 4.4 5.7 4.7 6.8 7.6 8.8 26.0 3.7 7.6 6.3 3.0 3.4 3.8 2.9 3.4 4.5 5.4 4.3 6.9 6.2 3.7 8.2 3.6 3.9 4.8 4.7 8.0 3.0 2.8 0.8 6.0 2.4 3.0 10.6 0.5 2.5 4.2 1.4 2.2 0.0 2.2 3.3 8.1 6.7 1.2 1.0 7.4 3.1 26.2 0.7 2.3 1.9 5.3 7.8 1.3 1.5 14.9 6.3 3.1 4.9 2.8 1.6 2.1 9.5 3.2 1.7 1.9 3.7 3.2 4.0 18.2 1.2 8.0 5.4 4.6 2.0 3.5 2.0 7.2 1.7 1.4 2.7 2.4 1.8 2.8 1.7 4.8 1.7 2.8 8.2 5.5 2.2 2.6 2.2 2.2 5.4 2.3 5.0 8.2 2.6 6.6 3.6 6.8 4.8 8.0 3.9 4.7 4.8 1.8 4.5 3.0 5.4 5.7 23.2 5.5 3.7 5.0 6.2 3.3 4.4 3.4 FHL3 SLIM2 ENSG00000183386 "Four and a half LIM domains 3" Q13643 1 37996770-38005606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "blood: 67.9;skeletal muscle: 247.1;tongue: 100.1" "Cell line enhanced" "Detected in many" "HEL: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 9 "eosinophil: 67.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 67.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045723 Approved Nucleoplasm Nucleoplasm "HPA045723: AB_10966278" "prognostic favourable (5.62e-4)" "unprognostic (1.12e-1)" "unprognostic (3.02e-3)" "unprognostic (6.97e-2)" "unprognostic (2.26e-1)" "unprognostic (1.88e-2)" "prognostic unfavourable (8.59e-5)" "unprognostic (1.02e-3)" "unprognostic (1.80e-1)" "unprognostic (1.36e-1)" "unprognostic (9.05e-2)" "unprognostic (5.05e-2)" "prognostic unfavourable (4.20e-11)" "unprognostic (8.88e-3)" "unprognostic (2.38e-1)" "unprognostic (4.94e-2)" "unprognostic (2.77e-2)" 7.0 2.0 1.2 3.3 2.1 3.9 4.5 0.6 1.4 5.5 6.4 1.3 2.4 1.1 7.5 8.1 6.9 4.4 3.6 2.3 1.6 1.1 1.7 1.3 2.9 5.0 2.4 0.9 7.6 2.0 1.4 1.1 2.1 2.1 4.8 1.6 2.2 5.5 3.6 247.1 2.6 1.9 12.0 2.2 2.5 2.7 1.7 1.0 0.3 1.8 100.1 4.0 15.5 5.7 0.1 3.8 67.9 5.7 3.0 3.4 2.3 6.2 2.3 6.2 6.3 5.8 23.5 3.9 5.0 9.8 9.4 7.0 5.2 5.0 0.0 8.4 11.2 2.4 4.0 6.0 4.7 2.3 7.2 29.5 5.1 5.9 22.7 2.3 21.6 20.7 6.9 10.7 6.1 13.2 24.7 0.1 17.6 3.3 0.8 10.0 8.1 1.6 4.0 5.2 0.4 6.2 1.1 0.7 3.2 4.5 0.4 7.1 1.9 2.0 9.3 4.1 9.5 1.1 4.5 1.6 5.7 0.7 1.9 13.7 4.3 1.3 5.7 67.9 3.2 3.7 3.4 0.0 0.7 1.6 3.8 0.1 0.5 0.7 7.4 3.0 2.4 0.1 1.6 2.3 1.2 2.1 0.6 1.3 1.6 1.1 2.4 0.9 2.1 1.0 FICD "HIP13, HYPE" ENSG00000198855 "FIC domain containing" Q9BVA6 12 108515185-108525837 "Enzymes, Predicted intracellular proteins" "Unfolded protein response" "Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021390, HPA071134" Approved Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA021390: AB_1851340, HPA071134: " "unprognostic (1.00e-1)" "unprognostic (8.76e-2)" "unprognostic (1.76e-2)" "prognostic favourable (4.61e-5)" "unprognostic (6.92e-2)" "unprognostic (2.68e-2)" "unprognostic (5.73e-2)" "unprognostic (2.84e-2)" "unprognostic (8.68e-2)" "unprognostic (2.57e-1)" "unprognostic (3.15e-2)" "unprognostic (1.19e-1)" "unprognostic (7.66e-2)" "unprognostic (1.56e-2)" "unprognostic (6.22e-2)" "unprognostic (3.12e-2)" "unprognostic (3.65e-2)" 4.2 9.6 5.6 6.1 8.2 3.0 4.5 4.0 6.7 8.5 3.8 7.3 10.5 3.9 4.6 15.8 2.3 4.1 4.1 3.5 5.4 5.9 5.2 16.4 5.0 4.9 8.9 5.1 4.8 27.9 4.8 15.3 7.9 6.0 6.1 3.6 10.2 19.7 7.9 2.6 3.4 3.3 4.6 7.5 4.8 5.1 8.5 6.6 5.4 13.6 1.0 6.2 4.1 4.5 5.0 15.2 10.9 5.4 3.1 8.0 1.8 1.9 4.7 1.9 3.8 4.6 3.2 5.3 12.5 6.6 5.9 4.2 2.9 1.9 2.6 4.7 5.9 2.5 2.0 1.4 5.3 4.4 3.1 1.5 3.6 4.1 18.2 2.2 5.6 1.5 3.0 8.3 11.9 4.2 1.0 9.0 5.2 4.3 2.9 2.3 2.1 7.9 1.7 2.6 6.4 2.8 3.7 1.8 1.3 5.6 2.6 6.1 4.2 2.1 4.7 6.1 2.2 10.6 4.8 17.9 2.9 0.9 8.4 1.9 4.2 10.9 2.8 4.2 6.8 4.8 8.0 5.0 5.0 6.2 2.7 3.3 2.9 5.6 5.5 3.1 5.4 15.2 3.1 1.8 5.6 8.2 4.0 6.7 5.4 5.9 8.9 5.1 6.0 6.6 FIGN ENSG00000182263 "Fidgetin, microtubule severing factor" Q5HY92 2 163593396-163736012 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 54 "basophil: 5.4" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034987, HPA057919" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "Vesicles, Cell Junctions" "HPA034987: AB_10669681, HPA057919: " "unprognostic (3.93e-2)" "unprognostic (8.30e-3)" "unprognostic (1.48e-1)" "unprognostic (7.68e-5)" "unprognostic (3.45e-2)" "unprognostic (8.98e-4)" "unprognostic (5.23e-3)" "unprognostic (7.65e-3)" "unprognostic (2.33e-1)" "unprognostic (1.64e-1)" "unprognostic (2.07e-2)" "unprognostic (3.24e-2)" "unprognostic (3.85e-3)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (4.10e-2)" "unprognostic (3.78e-2)" 8.5 7.6 9.6 2.9 13.7 2.8 5.2 5.1 11.9 6.8 5.9 5.5 3.7 2.1 3.3 5.0 2.9 4.5 4.4 10.1 8.8 4.3 7.2 7.9 4.3 2.5 8.7 4.7 14.3 7.2 1.8 12.1 4.4 7.7 4.8 3.4 4.3 8.4 9.9 3.6 3.2 3.6 5.6 9.1 8.7 4.5 4.4 10.5 0.0 3.1 3.0 1.6 4.1 6.3 0.0 0.0 5.4 0.0 0.0 0.0 0.0 5.7 2.1 17.3 0.0 0.0 0.0 6.4 2.2 1.5 1.6 3.0 0.0 2.1 0.0 6.2 2.4 0.8 5.7 2.4 1.3 0.0 4.3 0.0 4.0 4.1 1.4 0.0 0.0 0.8 2.1 3.1 8.5 3.7 0.0 0.0 4.7 1.4 0.0 0.0 7.3 2.7 0.0 5.8 0.0 4.0 1.9 2.7 2.3 0.0 1.6 1.5 1.8 0.0 0.3 7.2 6.5 0.0 4.6 1.0 0.0 0.0 2.1 0.0 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 13.7 5.1 11.9 8.8 4.3 8.7 4.7 7.7 10.5 FIZ1 "FLJ14768, ZNF798" ENSG00000179943 "FLT3 interacting zinc finger 1" Q96SL8 19 55591371-55601970 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074026 Approved Nucleoplasm Nucleoplasm "HPA074026: " "unprognostic (1.97e-2)" "unprognostic (6.59e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-1)" "unprognostic (6.43e-2)" "unprognostic (8.33e-3)" "unprognostic (4.51e-3)" "unprognostic (8.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "prognostic favourable (8.42e-4)" "unprognostic (7.02e-2)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (6.92e-2)" "unprognostic (3.03e-1)" "prognostic favourable (2.02e-4)" 10.9 8.6 13.9 9.3 16.6 5.8 12.4 17.0 17.8 10.2 10.9 13.6 10.4 10.4 14.5 13.0 8.0 10.9 11.1 10.0 13.7 11.2 11.5 8.1 9.7 8.0 14.2 9.1 12.1 15.4 21.1 13.9 8.6 9.2 11.7 8.7 14.7 14.3 15.5 18.2 10.6 10.7 16.0 12.3 10.5 13.7 9.4 10.8 9.5 14.4 8.6 9.4 9.4 17.6 2.5 3.4 1.9 3.0 2.1 2.6 0.9 7.1 15.2 10.5 7.5 6.1 4.2 12.0 6.0 4.1 6.9 5.3 8.5 8.1 12.5 5.6 3.8 7.2 7.3 7.6 6.8 9.8 19.1 9.7 10.4 7.4 6.2 8.1 9.2 5.0 12.5 5.9 7.1 3.4 11.8 5.8 5.1 6.3 14.5 6.1 11.6 10.9 15.1 9.9 6.8 6.9 13.2 14.1 16.1 9.4 6.9 6.3 7.1 9.7 5.4 6.5 10.6 2.4 7.3 15.3 22.4 8.2 9.3 7.8 7.1 0.1 1.7 0.2 1.0 3.0 1.0 2.5 2.6 1.5 1.2 1.5 1.3 1.9 1.9 2.1 1.1 3.4 1.0 0.9 13.9 16.6 17.0 17.8 13.7 11.2 14.2 9.1 9.2 10.8 FKBP14 "FKBP22, FLJ20731" ENSG00000106080 "FK506 binding protein 14" Q9NWM8 7 30010587-30026684 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Deafness, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013329, HPA026829" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" Cytosol "Nucleoplasm, Golgi apparatus" "HPA013329: AB_1848613, HPA026829: AB_10601651" "prognostic unfavourable (1.60e-4)" "unprognostic (1.12e-3)" "unprognostic (6.84e-2)" "unprognostic (1.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.41e-3)" "prognostic unfavourable (6.87e-4)" "unprognostic (6.06e-2)" "unprognostic (7.00e-2)" "unprognostic (6.99e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-1)" "unprognostic (1.93e-3)" "prognostic unfavourable (4.57e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "prognostic unfavourable (4.25e-4)" 8.8 7.4 8.7 9.2 7.3 5.1 8.8 17.6 7.7 14.9 7.8 4.1 6.9 4.2 12.1 14.2 8.0 8.1 8.5 9.8 7.1 5.2 5.4 9.2 7.6 8.1 9.2 5.2 13.0 9.8 8.6 27.8 10.7 7.1 9.8 6.9 8.4 7.6 10.9 3.3 6.4 5.3 18.8 8.1 6.7 7.2 4.2 7.1 2.6 5.6 5.9 7.7 13.4 8.7 1.6 3.3 2.7 1.2 1.0 1.6 0.6 3.4 2.6 7.3 17.0 19.1 24.5 3.4 17.5 16.4 6.1 12.0 2.2 2.2 1.2 8.3 15.3 7.5 4.1 6.4 12.3 0.6 5.8 2.7 4.9 6.4 9.7 1.9 4.8 15.3 6.7 10.6 12.6 13.5 4.4 2.5 11.0 1.4 1.0 2.4 3.8 4.7 0.0 4.9 4.0 6.1 3.0 1.9 6.4 6.2 14.0 4.3 3.2 2.6 10.9 6.6 7.7 11.2 6.9 3.9 4.0 2.1 9.3 1.9 20.3 1.9 1.2 1.2 1.3 0.8 1.0 1.1 1.6 1.1 2.2 1.6 1.5 1.3 2.7 1.0 0.5 3.3 1.4 0.6 8.7 7.3 17.6 7.7 7.1 5.2 9.2 5.2 7.1 7.1 FKBPL "DIR1, NG7, WISp39" ENSG00000204315 "FK506 binding protein like" Q9UIM3 6 32128707-32130291 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043478, HPA060158" Approved Approved "Nucleoplasm,Mitotic spindle" Nucleoplasm "Mitotic spindle" "HPA043478: , HPA060158: " "unprognostic (1.80e-1)" "unprognostic (6.80e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-3)" "unprognostic (1.02e-1)" "unprognostic (7.67e-2)" "unprognostic (8.22e-3)" "unprognostic (2.25e-2)" "unprognostic (1.22e-1)" "prognostic favourable (8.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-2)" "unprognostic (7.32e-2)" "unprognostic (4.39e-2)" "unprognostic (2.70e-1)" "unprognostic (1.13e-1)" 3.6 5.6 4.1 2.7 4.7 4.6 7.1 12.1 6.2 4.4 4.5 3.9 8.9 6.0 4.1 8.7 12.7 7.0 4.5 6.0 4.1 3.5 5.9 6.7 4.5 7.7 7.1 2.4 7.0 13.2 6.2 5.0 6.9 5.8 3.8 4.9 3.7 8.0 3.6 5.1 11.5 4.4 5.1 3.6 7.8 6.6 7.6 6.8 10.5 11.6 2.8 6.8 4.7 6.3 3.4 3.7 8.3 4.8 3.3 4.6 1.5 0.0 2.0 4.4 11.9 6.6 4.7 3.8 2.9 3.3 5.5 5.3 9.5 4.0 3.3 3.4 5.0 2.2 6.2 5.7 3.8 5.9 7.6 0.0 6.6 5.3 3.7 0.0 3.6 4.6 5.8 10.7 6.7 5.8 11.1 8.2 5.6 3.2 3.6 4.1 3.3 1.7 3.0 5.8 7.2 5.7 0.7 8.4 2.0 2.9 5.3 6.3 9.2 6.4 2.5 8.0 6.6 4.1 7.0 4.4 7.7 3.0 3.1 5.4 4.9 4.9 3.4 2.3 4.6 4.8 4.4 2.8 2.6 3.3 3.7 3.4 3.0 2.9 8.3 3.3 2.5 2.9 1.1 1.5 4.1 4.7 12.1 6.2 4.1 3.5 7.1 2.4 5.8 6.8 FKRP "LGMD2I, MDC1C" ENSG00000181027 "Fukutin related protein" Q9H9S5 19 46746046-46776988 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Cardiomyopathy, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043115, HPA060454" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA043115: , HPA060454: " "unprognostic (4.44e-2)" "unprognostic (5.20e-2)" "unprognostic (2.19e-2)" "unprognostic (8.37e-3)" "unprognostic (1.83e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "unprognostic (2.99e-2)" "unprognostic (4.59e-3)" "prognostic favourable (8.98e-4)" "unprognostic (3.53e-1)" "unprognostic (2.30e-2)" "unprognostic (2.53e-1)" "unprognostic (2.46e-1)" "unprognostic (1.01e-1)" "unprognostic (2.53e-2)" 13.7 10.7 12.4 12.5 17.5 12.6 9.6 7.4 25.2 10.5 11.5 12.8 13.7 7.8 15.7 8.7 8.3 12.7 10.1 13.1 9.8 12.2 10.7 10.8 11.6 11.0 11.5 11.1 13.3 13.2 12.9 16.9 16.5 14.1 13.6 7.3 13.0 17.8 13.2 23.6 9.6 9.7 13.4 9.1 14.7 10.3 13.0 11.1 8.8 13.5 7.8 7.9 12.3 10.2 6.9 5.0 5.4 4.2 5.6 4.5 2.4 8.4 18.0 12.4 8.6 10.9 12.2 11.0 21.5 14.5 8.8 14.0 11.4 14.7 7.5 12.1 12.3 8.9 4.6 10.0 8.1 14.9 15.3 8.0 8.7 7.2 9.7 6.2 13.7 13.5 8.7 10.9 10.7 11.5 7.9 7.7 8.9 3.8 4.5 15.1 12.1 4.5 12.2 7.6 2.8 5.6 18.1 8.5 16.1 10.8 5.2 7.0 6.4 4.9 11.9 13.2 13.9 4.8 17.2 8.2 9.8 7.2 10.7 5.0 17.5 3.4 4.2 2.5 4.1 2.5 2.8 4.6 3.0 4.5 2.6 6.9 3.7 4.5 5.4 5.6 2.6 5.0 1.6 2.4 12.4 17.5 7.4 25.2 9.8 12.2 11.5 11.1 14.1 11.1 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Secreted to blood" 270000000 "Plasma membrane" "Nucleoplasm, Cell Junctions" "CAB000099: , HPA046519: , HPA067906: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.2 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.3 2.8 0.1 0.2 0.1 12.6 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 8.1 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 12.0 0.2 12.7 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911937-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 15.6 16.6 13.1 12.6 17.2 12.5 10.2 24.4 27.4 13.6 12.2 17.7 9.5 14.7 14.3 13.4 11.8 11.9 15.0 16.7 12.1 15.9 10.1 5.9 10.7 11.6 15.8 18.5 21.4 12.2 22.6 12.2 9.5 18.8 13.9 4.7 25.3 14.4 15.6 28.1 22.8 14.4 14.1 16.2 19.9 11.0 5.1 10.9 8.5 11.5 8.4 10.3 17.1 15.7 4.6 1.6 2.3 1.6 0.9 5.5 2.1 5.0 17.9 4.1 12.1 6.7 6.8 12.5 9.4 7.4 4.8 4.9 2.9 16.5 12.4 25.1 7.2 10.6 3.4 6.3 0.9 20.6 10.2 4.1 15.1 9.9 15.0 5.5 14.5 6.1 20.1 10.0 7.4 6.7 9.2 13.2 3.6 12.1 12.5 6.6 6.7 12.3 22.0 6.1 22.2 5.6 3.4 8.9 8.2 9.9 10.8 12.6 8.4 10.0 12.6 8.0 7.3 15.5 6.3 19.6 16.7 11.1 8.8 9.0 9.3 2.3 1.6 0.6 3.0 0.7 4.9 2.0 4.5 5.5 1.6 4.6 3.9 3.4 0.2 0.9 0.8 1.0 2.2 2.1 13.1 17.2 24.4 27.4 12.1 15.9 15.8 18.5 18.8 10.9 FLYWCH2 ENSG00000162076 "FLYWCH family member 2" Q96CP2 16 2883186-2899382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041354 Uncertain Approved Nucleoplasm Nucleoplasm "HPA041354: AB_10795007" "unprognostic (3.57e-2)" "prognostic favourable (9.38e-4)" "unprognostic (7.33e-2)" "unprognostic (8.53e-3)" "unprognostic (4.40e-1)" "unprognostic (3.81e-2)" "unprognostic (4.83e-3)" "unprognostic (8.35e-3)" "unprognostic (8.92e-2)" "unprognostic (1.62e-1)" "prognostic favourable (1.87e-5)" "unprognostic (5.50e-2)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" 19.7 33.9 20.8 13.0 24.6 9.3 14.9 28.5 29.5 15.7 15.0 14.7 19.4 20.8 16.8 13.7 20.8 18.3 22.0 23.8 19.8 27.1 20.2 8.3 15.7 12.6 22.8 16.4 19.5 13.9 17.6 21.7 10.3 22.9 22.4 7.4 22.9 25.4 19.6 34.6 15.9 14.6 13.2 18.2 31.4 17.6 22.3 10.4 19.8 27.0 18.6 17.0 14.2 12.6 15.3 25.3 10.1 18.4 9.8 19.3 12.7 8.6 17.3 7.3 17.0 7.3 10.4 10.6 6.7 5.2 7.3 5.0 7.9 10.9 8.4 25.8 6.3 5.5 3.9 9.4 1.3 14.2 10.9 8.9 16.9 6.2 20.5 5.3 9.1 14.4 7.2 5.8 3.0 5.6 6.4 9.3 5.0 40.3 13.7 23.3 7.9 17.8 26.7 7.7 18.3 5.1 2.6 11.3 14.6 18.7 20.3 13.5 24.0 17.8 7.7 12.5 10.2 19.4 6.8 15.3 13.4 11.7 7.3 7.9 9.1 5.6 13.0 10.1 15.1 18.4 16.5 15.3 17.5 14.5 18.4 14.3 19.3 16.5 5.6 9.8 17.8 25.3 16.3 12.7 20.8 24.6 28.5 29.5 19.8 27.1 22.8 16.4 22.9 10.4 FN3KRP "FLJ12171, FN3KL" ENSG00000141560 "Fructosamine 3 kinase related protein" Q9HA64 17 82716683-82730328 "Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056172, HPA065831" Approved Approved Nucleoplasm 14000 Nucleoplasm "HPA056172: , HPA065831: " "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (1.54e-2)" "unprognostic (2.09e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (2.31e-1)" "unprognostic (1.25e-2)" "unprognostic (8.67e-2)" "unprognostic (1.26e-1)" "unprognostic (1.99e-1)" "unprognostic (8.84e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-2)" "unprognostic (1.31e-1)" "unprognostic (2.23e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-2)" 17.6 18.3 27.9 10.8 26.3 12.3 15.7 19.5 27.3 15.3 17.4 27.4 10.0 11.8 18.4 16.7 16.4 16.6 13.0 12.7 26.1 20.8 18.8 23.1 12.8 12.9 25.7 23.0 21.9 15.3 10.8 11.4 17.1 22.2 17.1 14.4 13.2 17.2 20.0 7.3 16.1 13.6 20.3 30.7 13.7 12.6 8.8 21.6 8.2 15.1 9.8 17.5 12.1 12.9 16.5 23.2 18.5 15.5 18.5 23.0 17.1 10.7 43.6 11.9 15.7 5.8 11.1 9.9 20.2 11.3 19.6 16.0 23.0 7.6 8.9 13.6 16.3 12.4 10.8 15.3 17.7 5.9 19.2 14.9 24.3 26.5 10.4 10.3 8.3 10.2 18.2 18.6 10.2 14.0 14.3 5.6 25.0 20.4 20.2 15.4 5.4 19.0 15.2 30.3 13.8 13.9 20.7 10.0 21.1 33.4 15.1 16.3 25.2 15.1 12.4 38.1 13.1 26.9 29.8 11.5 12.6 22.0 17.7 13.1 17.5 17.0 14.2 18.5 20.4 15.5 20.0 15.7 19.9 19.5 11.7 16.5 23.0 16.7 2.1 18.5 8.4 23.2 18.6 17.1 27.9 26.3 19.5 27.3 26.1 20.8 25.7 23.0 22.2 21.6 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;EFO-21: 4.9;HaCaT: 2.7;SH-SY5Y: 5.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.4 0.5 4.9 0.1 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.9 0.7 0.0 0.0 1.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 5.9 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell line enhanced" "Detected in many" "AN3-CA: 16.9;ASC diff: 17.3;HUVEC TERT2: 20.7;SH-SY5Y: 16.2;TIME: 18.9;U-87 MG: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" Nucleoplasm "Aggresome, Cytosol" "HPA051804: , HPA063581: " "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavourable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavourable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.6 16.9 17.3 10.6 0.1 3.8 7.7 2.8 2.4 0.7 0.2 0.0 0.4 12.2 0.0 6.4 2.3 2.4 0.0 1.0 0.8 0.0 8.7 6.4 0.0 0.1 9.0 1.1 4.8 0.9 20.7 0.9 0.0 10.2 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.2 0.1 0.0 0.1 0.0 0.0 18.9 2.6 1.2 1.0 2.9 0.0 0.0 0.0 14.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712657-108742740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.0;testis: 5.2" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;PC-3: 1.1;U-87 MG: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: " "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.1 0.1 0.6 0.1 0.8 0.6 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.5 0.6 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.3 0.0 0.0 1.2 0.5 0.0 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.5 0.3 0.3 0.1 0.4 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 1.1 1.7 0.7 0.1 0.1 3.0 0.1 FOXA3 HNF3G ENSG00000170608 "Forkhead box A3" P55318 19 45863989-45873797 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 36.7;pancreas: 63.3" "Cell line enhanced" "Detected in some" "A549: 5.5;CACO-2: 7.5;HDLM-2: 8.8;Hep G2: 20.3;K-562: 16.2;NTERA-2: 8.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 10 "T-cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB015154, HPA054034" Uncertain Approved Nucleoplasm Nucleoplasm "CAB015154: AB_647545, HPA054034: " "unprognostic (2.88e-1)" "unprognostic (6.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "unprognostic (2.27e-1)" "unprognostic (2.39e-2)" "unprognostic (1.42e-1)" "unprognostic (6.87e-3)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-2)" "unprognostic (2.57e-2)" "unprognostic (1.91e-2)" "unprognostic (3.55e-1)" "unprognostic (3.75e-1)" "unprognostic (2.11e-1)" 0.3 0.0 0.2 5.9 0.2 0.0 0.1 0.1 0.3 0.5 9.7 0.3 0.7 4.7 0.2 0.1 0.2 0.1 13.7 0.5 0.1 0.0 0.9 36.7 0.6 0.1 0.1 0.1 0.1 63.3 0.7 0.1 0.1 0.2 0.3 8.0 0.1 1.0 0.8 0.1 0.1 9.0 0.1 0.1 0.1 17.1 0.7 0.3 0.2 0.1 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.5 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.8 0.8 0.1 0.0 20.3 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 16.2 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.7 3.2 0.0 0.3 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.3 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Group enriched" "Detected in some" 4 "AF22: 7.0;HDLM-2: 15.2;HEK 293: 11.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA073369: " "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 11.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;testis: 3.1" "Cell line enhanced" "Detected in many" "THP-1: 8.7" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.6 0.6 1.2 0.5 1.4 0.1 0.1 5.7 1.5 0.4 0.2 0.4 0.7 0.1 0.1 0.3 0.1 0.2 1.3 1.5 1.6 0.2 0.6 0.7 0.8 0.3 0.5 0.2 0.7 0.6 0.7 0.3 0.3 0.5 1.4 0.3 0.6 0.4 0.4 1.0 0.6 3.1 0.2 0.2 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.4 0.8 0.4 3.6 0.2 0.4 0.0 0.3 1.0 0.2 3.7 0.6 0.0 0.0 0.9 0.2 0.3 3.5 3.0 0.0 0.5 0.3 0.2 2.5 1.9 0.5 0.0 0.0 0.1 0.0 1.2 1.6 0.1 1.3 0.3 2.1 0.1 1.8 0.3 0.8 0.5 0.9 1.8 1.7 1.4 1.0 0.5 0.0 0.9 8.7 0.5 1.1 1.1 0.7 1.3 0.1 0.4 0.8 0.8 2.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L1 FOXD5 ENSG00000184492 "Forkhead box D4 like 1" Q9NU39 2 113498665-113501155 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1" "Cell line enhanced" "Detected in some" "RH-30: 5.2;THP-1: 3.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 22 "B-cells: 2.2" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "unprognostic (3.02e-2)" "unprognostic (6.61e-2)" "unprognostic (3.22e-1)" "unprognostic (6.41e-4)" "unprognostic (2.54e-1)" "unprognostic (5.77e-3)" "unprognostic (5.93e-2)" "unprognostic (4.21e-2)" "unprognostic (9.54e-4)" "unprognostic (3.98e-2)" "unprognostic (1.18e-8)" "unprognostic (1.57e-2)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (5.91e-4)" 0.2 0.5 0.4 1.2 1.2 3.0 0.1 3.3 0.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.6 0.6 0.4 0.1 0.4 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.2 3.1 0.2 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.6 1.0 0.0 1.5 0.0 0.6 0.0 0.1 0.3 0.0 2.0 0.9 0.1 0.1 0.6 0.0 0.1 1.9 1.3 0.7 1.0 0.9 0.0 2.1 1.6 0.0 0.7 0.2 0.0 0.0 1.2 1.7 0.3 0.1 0.3 0.9 0.0 0.7 0.6 5.2 0.7 0.1 0.6 0.7 0.4 0.5 0.1 0.2 0.4 3.7 0.4 1.7 1.5 0.6 1.3 1.3 1.3 0.7 0.3 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L3 FOXD6 ENSG00000187559 "Forkhead box D4 like 3" Q6VB84 9 68302867-68304905 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (7.93e-4)" "unprognostic (8.71e-2)" "unprognostic (7.04e-2)" "unprognostic (4.75e-2)" 0.0 0.1 0.7 1.4 1.3 0.0 0.0 2.1 2.3 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.4 0.0 2.6 0.7 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.0 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.2 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.6 0.1 0.8 0.5 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.4 0.6 0.3 1.0 1.2 0.0 0.2 1.5 1.3 0.7 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.4 1.0 0.7 0.2 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.0 0.4 0.1 0.2 0.5 0.1 0.5 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.5 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.2 1.0 0.0 0.5 0.2 0.2 0.0 0.2 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.2 0.2 0.7 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.7 1.0 0.4 0.0 0.2 0.7 0.0 0.1 0.5 0.0 0.4 1.0 0.5 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L5 bA15J10.2 ENSG00000204779 "Forkhead box D4 like 5" Q5VV16 9 65282101-65285209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.26e-2)" "unprognostic (6.95e-3)" "unprognostic (1.58e-1)" "unprognostic (5.76e-2)" "unprognostic (2.57e-1)" 0.7 1.1 0.3 0.1 0.5 0.0 0.7 0.6 2.2 0.3 0.1 0.1 0.1 1.1 0.4 0.7 0.1 0.2 1.0 0.5 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.3 0.0 1.2 0.1 0.5 2.0 0.3 0.0 0.2 0.2 0.4 1.0 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 1.1 0.7 2.8 0.5 0.3 3.4 0.6 0.2 0.0 0.0 0.7 0.3 1.9 0.4 0.2 0.0 1.5 0.2 0.2 2.7 1.7 1.8 0.8 0.9 0.0 1.5 2.6 0.2 0.8 0.2 0.5 0.0 2.7 1.1 0.2 0.6 0.3 1.0 0.8 0.9 0.6 2.1 0.7 0.7 1.4 1.4 2.5 0.6 0.3 0.2 0.8 3.4 0.4 0.4 2.1 1.2 1.1 0.8 1.7 0.5 0.3 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L6 ENSG00000273514 "Forkhead box D4 like 6" Q3SYB3 9 41126430-41128463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;lymphoid tissue: 1.5" "Cell line enhanced" "Detected in some" "HEK 293: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA012836 Uncertain Approved Nucleoplasm Nucleoplasm "HPA012836: AB_2105429" "unprognostic (2.41e-1)" "unprognostic (3.41e-1)" "unprognostic (3.61e-1)" 0.0 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.7 0.2 0.0 0.5 1.0 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.1 1.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.6 0.2 0.5 0.5 0.3 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.7 0.3 0.0 0.8 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXF1 "FKHL5, FREAC1" ENSG00000103241 "Forkhead box F1" Q12946 16 86510527-86515418 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 54.7;urinary bladder: 48.5" "Group enriched" "Detected in some" 4 "BJ: 9.2;BJ hTERT+: 20.2;HHSteC: 19.9;U-2197: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028886 Approved Nucleoplasm Nucleoplasm "HPA028886: AB_10601652" "unprognostic (7.91e-2)" "unprognostic (3.02e-3)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.08e-1)" "unprognostic (8.22e-2)" "unprognostic (6.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (4.89e-2)" "unprognostic (4.20e-2)" "unprognostic (7.11e-2)" "unprognostic (2.44e-1)" 2.2 0.3 2.5 15.4 2.9 0.0 0.8 2.3 4.2 7.9 34.6 1.3 1.6 7.2 2.1 0.9 17.9 1.2 39.7 0.6 3.4 1.9 1.2 2.4 33.1 2.4 3.5 1.0 0.6 0.9 1.1 0.4 18.5 3.5 35.7 9.2 0.5 0.9 4.8 0.3 0.4 18.4 54.7 3.0 0.5 18.4 0.6 3.7 0.0 3.6 2.6 3.3 48.5 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 20.2 2.8 0.9 0.0 0.1 0.0 0.0 0.8 0.0 1.6 0.0 2.4 0.0 1.1 0.0 1.4 0.0 19.9 0.0 1.7 2.1 0.0 3.3 0.4 3.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.7 0.0 0.0 0.0 0.0 1.8 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 2.9 2.3 4.2 3.4 1.9 3.5 1.0 3.5 3.7 FOXJ3 KIAA1041 ENSG00000198815 "Forkhead box J3" Q9UPW0 1 42176539-42335877 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067284 Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nucleoplasm, Nuclear speckles" Vesicles "HPA067284: " "unprognostic (5.60e-2)" "unprognostic (2.26e-2)" "unprognostic (4.24e-2)" "unprognostic (5.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.17e-6)" "unprognostic (3.65e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "prognostic unfavourable (4.51e-7)" "unprognostic (2.10e-1)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (5.43e-2)" 24.8 15.1 21.2 20.1 31.3 31.6 25.6 38.2 30.9 22.3 18.4 22.9 15.4 18.8 24.9 18.9 17.4 19.8 16.2 23.5 21.5 20.2 16.8 17.6 20.4 19.6 22.9 19.2 29.5 22.6 31.6 28.7 33.5 21.2 21.7 22.5 18.4 19.0 23.7 44.3 24.3 20.0 22.0 20.7 19.6 20.8 19.0 22.6 29.0 23.7 15.2 22.2 22.8 21.4 12.3 9.7 10.9 9.4 11.6 13.1 4.3 13.6 11.5 12.7 13.2 13.7 17.0 18.4 10.4 15.4 14.0 15.6 10.6 16.4 21.0 11.1 14.5 13.1 17.7 17.1 23.8 15.7 10.0 23.1 14.7 9.0 11.9 21.2 15.9 12.6 17.0 20.9 26.0 15.2 13.9 15.3 16.7 7.8 21.4 12.2 19.8 10.6 20.1 33.4 14.3 11.9 19.9 17.7 16.7 18.7 21.7 18.8 10.9 31.7 14.1 14.7 19.7 14.8 17.1 15.1 18.6 17.2 13.2 17.7 11.7 6.0 5.7 6.1 9.0 4.8 10.9 8.0 11.0 9.5 4.6 12.3 11.8 13.1 10.9 11.6 9.4 9.7 7.0 4.3 21.2 31.3 38.2 30.9 21.5 20.2 22.9 19.2 21.2 22.6 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA059209: " "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favourable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 26.8 14.5 12.6 23.2 11.3 33.9 35.2 46.9 10.7 17.2 28.4 15.3 12.2 18.2 19.3 11.2 21.0 17.4 11.9 20.2 12.8 7.8 7.5 15.4 14.1 20.1 11.3 7.4 28.8 15.1 35.0 10.1 11.3 13.2 15.7 11.1 17.8 13.4 12.6 44.3 29.5 31.1 25.1 14.0 13.2 15.9 12.6 13.2 34.0 8.8 18.4 19.9 25.7 31.7 9.6 19.3 21.4 14.2 17.3 24.3 15.2 0.1 2.6 7.2 4.3 29.5 9.5 4.9 5.5 5.8 5.1 8.4 2.6 2.1 8.6 2.9 8.7 1.9 12.4 8.0 7.6 36.9 2.3 2.8 5.3 8.9 9.5 5.6 5.1 22.4 4.6 0.4 3.5 10.9 3.3 24.5 8.6 3.3 11.0 5.6 7.6 4.8 17.4 24.6 7.9 0.5 8.8 3.8 12.9 8.1 8.1 2.2 4.4 16.1 19.1 8.8 11.8 8.6 8.3 21.8 37.1 15.4 3.0 9.9 5.1 21.4 13.0 18.8 24.3 14.2 19.5 7.8 16.4 20.8 19.3 9.6 21.5 20.5 5.4 17.3 8.7 4.3 19.2 15.2 12.6 11.3 46.9 10.7 12.8 7.8 11.3 7.4 13.2 13.2 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.3;SH-SY5Y: 6.5;U-266/70: 8.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA050018: " "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.5 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 8.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 FOXP4 FLJ40908 ENSG00000137166 "Forkhead box P4" Q8IVH2 6 41546426-41602384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007176 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA007176: AB_1078911" "unprognostic (8.28e-2)" "unprognostic (2.90e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.17e-6)" "unprognostic (3.20e-2)" "unprognostic (2.96e-3)" "prognostic unfavourable (9.72e-4)" "unprognostic (2.13e-2)" "unprognostic (7.86e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-3)" "unprognostic (9.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-2)" 12.1 7.8 6.3 13.7 12.6 4.4 15.5 12.3 10.0 28.2 15.8 14.0 16.4 18.7 20.7 8.4 10.5 10.1 29.5 12.9 6.6 7.3 16.4 18.9 14.4 9.1 12.9 4.9 17.1 24.8 5.9 12.6 5.5 9.4 21.7 7.2 21.2 30.1 13.0 7.9 7.1 19.3 11.7 7.9 5.8 37.0 15.4 10.9 12.0 23.9 6.3 14.0 11.7 27.6 2.0 1.0 0.3 0.9 0.6 1.5 0.4 10.1 13.9 17.6 18.8 3.4 1.1 18.0 5.6 3.0 5.0 3.4 43.4 3.2 11.7 10.5 3.4 7.8 5.1 5.3 2.1 9.2 8.1 9.3 7.7 29.1 6.4 5.9 7.7 2.8 6.6 4.4 2.7 4.8 11.5 4.8 2.3 27.4 6.9 10.1 4.4 4.9 7.5 5.6 7.9 4.3 8.4 4.9 7.1 6.0 14.3 9.9 8.1 14.4 6.8 6.3 15.7 9.8 9.4 3.8 2.4 16.3 5.2 9.9 5.9 0.3 0.7 0.3 0.7 0.9 1.2 1.0 0.6 1.5 0.6 2.0 0.1 0.3 0.3 0.6 0.3 1.0 1.1 0.4 6.3 12.6 12.3 9.2 6.6 7.3 12.9 4.9 9.4 10.9 FOXS1 "FKHL18, FREAC10" ENSG00000179772 "Forkhead box S1" O43638 20 31844301-31845619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;RH-30: 11.9;U-2 OS: 15.9;U-251 MG: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042475 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042475: AB_10964265" "unprognostic (2.28e-1)" "unprognostic (8.05e-2)" "unprognostic (1.72e-2)" "unprognostic (5.89e-2)" "unprognostic (3.24e-1)" "unprognostic (1.86e-1)" "unprognostic (3.10e-2)" "unprognostic (4.23e-1)" "unprognostic (2.65e-1)" "unprognostic (1.72e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-1)" "prognostic unfavourable (1.10e-8)" "unprognostic (1.09e-3)" "unprognostic (2.04e-2)" "unprognostic (5.02e-2)" "unprognostic (9.00e-2)" 5.9 3.1 2.7 3.0 4.7 0.3 11.7 2.7 4.9 9.7 2.6 4.8 1.8 0.9 15.5 6.2 2.8 3.6 11.7 14.0 3.2 2.6 5.5 0.9 6.5 4.6 4.1 4.8 4.0 1.1 0.8 3.2 14.4 5.2 5.0 1.6 7.0 2.0 7.0 4.5 1.8 1.8 3.7 2.6 5.5 1.6 9.7 0.6 3.0 4.9 7.0 3.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.9 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.0 15.9 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.7 2.7 4.9 3.2 2.6 4.1 4.8 5.2 0.6 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 34.2" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: , HPA061744: " "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.6 2.7 0.2 0.4 2.4 0.1 0.8 0.8 0.0 0.1 0.3 6.9 0.5 0.1 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.0 0.3 0.6 0.6 0.5 1.1 0.2 0.0 1.6 0.1 0.0 0.3 34.2 0.8 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 FRAT2 ENSG00000181274 "FRAT2, WNT signaling pathway regulator" O75474 10 97332497-97334709 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 70.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 29.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049763 Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA049763: " "unprognostic (4.93e-2)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (1.46e-1)" "unprognostic (4.04e-3)" "unprognostic (1.87e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (3.17e-3)" "unprognostic (2.60e-1)" "unprognostic (8.02e-2)" "unprognostic (4.60e-2)" "unprognostic (3.25e-2)" "prognostic favourable (2.55e-4)" "unprognostic (7.87e-3)" "unprognostic (4.83e-2)" "unprognostic (2.34e-1)" "unprognostic (9.08e-2)" 5.0 3.8 5.7 8.7 7.5 23.8 9.7 8.6 9.4 5.7 18.8 4.8 10.2 21.9 6.0 5.9 13.2 6.4 7.2 7.7 6.1 4.9 5.8 15.6 12.0 22.4 5.6 2.0 3.0 16.5 4.8 3.2 9.6 7.7 8.8 14.0 5.4 22.4 4.9 8.7 17.8 20.3 3.7 5.9 28.0 11.5 14.9 7.3 9.0 8.1 8.3 11.1 7.9 13.2 1.2 1.9 29.3 3.7 0.6 1.1 1.1 5.3 2.1 3.5 15.7 2.5 2.1 13.1 1.2 4.4 1.9 1.9 3.3 6.3 6.5 4.3 1.2 10.1 9.2 4.7 1.5 9.7 14.0 8.7 4.6 7.2 1.5 13.9 10.5 1.6 10.2 1.8 5.9 4.7 7.6 2.1 0.9 8.7 6.0 17.7 21.8 8.8 6.2 1.4 9.2 4.5 4.8 6.4 5.2 1.5 9.6 6.0 14.5 22.1 2.1 1.1 1.4 0.8 3.1 5.8 5.9 3.2 1.3 24.2 0.4 3.3 3.7 7.1 0.6 2.3 0.3 0.5 0.7 0.9 1.9 1.2 1.1 0.7 29.3 0.6 3.5 0.4 0.3 1.1 5.7 7.5 8.6 9.4 6.1 4.9 5.6 2.0 7.7 7.3 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell line enhanced" "Detected in some" "HEL: 11.6;RPMI-8226: 39.2;SCLC-21H: 14.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: " "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favourable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favourable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.2 1.9 0.1 0.4 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.6 0.4 2.4 0.9 0.1 0.1 0.0 0.0 0.1 0.1 11.6 2.5 1.4 0.1 0.0 0.1 0.5 0.0 0.0 0.1 1.3 0.0 0.0 2.5 0.3 0.0 0.0 0.2 3.6 0.0 1.5 39.2 3.2 5.1 14.5 7.0 0.7 0.1 0.4 0.8 0.4 2.2 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.8 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 FRMD4A "bA295P9.4, FLJ10210, FRMD4, KIAA1294" ENSG00000151474 "FERM domain containing 4A" Q9P2Q2 10 13643706-14462142 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 28.0;TIME: 34.1;WM-115: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038449 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038449: AB_10669539" "unprognostic (6.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.51e-3)" "unprognostic (5.68e-2)" "unprognostic (1.55e-1)" "prognostic favourable (2.63e-5)" "unprognostic (6.21e-3)" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (9.20e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (8.16e-2)" "unprognostic (1.84e-1)" 20.5 2.9 8.2 4.6 13.6 2.6 5.6 4.2 22.4 5.3 3.6 2.0 5.9 2.5 4.3 3.4 4.6 4.4 4.9 5.8 10.3 9.5 5.6 6.0 6.1 5.0 7.3 10.3 3.8 8.5 1.1 9.3 12.3 4.3 5.4 2.9 7.8 7.5 9.6 3.8 18.5 3.4 3.3 5.0 17.1 3.3 7.6 1.5 2.6 3.7 2.0 4.5 4.1 3.6 1.9 2.1 2.0 0.9 1.4 2.0 0.2 1.8 1.2 21.1 0.1 1.9 5.4 5.3 5.4 11.3 7.9 13.0 3.7 0.6 0.0 6.2 5.4 4.1 0.1 1.0 6.9 0.1 3.1 0.4 0.2 0.0 2.6 0.1 0.3 3.7 1.0 28.0 4.0 22.4 4.0 0.1 15.6 2.5 1.3 0.2 3.7 0.8 0.1 4.7 0.0 5.2 1.7 0.7 3.6 0.0 10.2 17.0 5.7 0.7 34.1 12.9 3.0 8.4 8.1 0.1 0.0 0.0 10.0 0.3 48.4 0.4 0.5 0.5 0.4 0.9 0.7 1.9 1.8 0.6 0.4 0.8 0.8 0.5 2.0 1.4 0.6 2.1 2.0 0.2 8.2 13.6 4.2 22.4 10.3 9.5 7.3 10.3 4.3 1.5 FRMD8 "FKSG44, FLJ90369" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386599-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002861, HPA005506" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA002861: AB_1078878, HPA005506: " "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 14.6 11.9 7.8 18.5 12.1 13.1 15.2 8.9 10.3 12.5 15.1 11.4 6.9 13.6 10.5 12.2 23.9 14.6 17.4 10.0 8.0 5.4 10.5 12.0 15.1 17.3 17.0 8.5 8.9 20.9 5.7 8.2 12.2 11.7 10.7 8.2 7.8 18.6 10.9 12.0 24.3 16.5 8.1 8.9 29.0 11.7 11.3 14.6 16.6 12.4 16.6 21.8 11.0 18.1 10.9 11.4 19.7 14.9 6.5 14.3 9.0 6.8 8.8 3.6 8.3 9.6 5.1 6.3 7.7 7.3 6.7 5.3 8.4 11.5 8.5 16.8 11.0 12.1 4.5 6.8 2.9 14.1 4.1 11.7 8.0 4.6 5.2 6.5 18.3 6.3 5.4 6.4 3.4 10.8 9.7 9.5 7.4 9.3 9.9 9.6 3.9 11.5 13.2 6.6 9.6 5.5 8.6 7.6 5.3 6.0 24.4 18.6 8.9 5.4 9.4 7.6 7.9 10.2 4.8 16.4 8.4 8.0 6.6 4.1 52.2 0.8 9.7 13.4 11.5 11.0 12.7 10.9 8.4 14.3 9.1 9.2 7.8 8.4 19.7 6.5 14.9 11.4 8.9 9.0 7.8 12.1 8.9 10.3 8.0 5.4 17.0 8.5 11.7 14.6 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell line enhanced" "Detected in many" "BEWO: 35.5;hTCEpi: 39.2;SiHa: 72.5;U-2197: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Approved Nucleoplasm "Secreted in other tissues" 6800000 Nucleoplasm "CAB024899: , HPA045378: " "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavourable (3.01e-4)" "prognostic unfavourable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavourable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavourable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.6 1.1 0.8 4.9 12.6 35.5 26.5 3.9 6.6 2.4 5.7 3.0 0.8 10.7 17.8 13.7 0.8 22.6 2.2 1.6 1.8 0.7 21.8 4.6 21.2 1.3 2.6 15.7 39.2 7.3 30.7 1.1 1.6 1.1 10.0 6.8 0.5 0.8 1.3 5.4 1.4 0.7 1.7 9.2 0.3 0.7 1.2 72.5 1.4 0.8 1.3 0.7 15.9 6.7 23.1 37.4 9.7 1.8 0.8 0.4 1.0 4.2 3.0 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 FUBP3 FBP3 ENSG00000107164 "Far upstream element binding protein 3" Q96I24 9 130578965-130638352 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047658, HPA058392" Uncertain Approved Nucleoplasm,Cytosol 6200 Nucleoplasm Cytosol "HPA047658: , HPA058392: " "unprognostic (1.23e-2)" "unprognostic (2.00e-2)" "unprognostic (1.91e-1)" "unprognostic (2.51e-1)" "unprognostic (5.67e-3)" "unprognostic (2.12e-2)" "unprognostic (2.29e-2)" "prognostic unfavourable (2.38e-4)" "unprognostic (3.12e-2)" "unprognostic (7.27e-2)" "unprognostic (4.66e-1)" "unprognostic (4.23e-2)" "prognostic favourable (4.39e-5)" "unprognostic (2.15e-2)" "unprognostic (3.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.23e-2)" 26.6 24.1 24.3 18.5 24.3 10.5 21.8 23.9 30.3 22.8 24.0 37.7 22.9 19.9 32.7 20.7 24.2 22.1 25.4 24.3 24.6 20.0 22.4 37.6 19.9 18.7 27.4 22.8 25.2 27.7 36.6 23.8 33.8 23.9 26.1 20.4 21.9 26.1 25.3 15.2 22.0 20.5 26.9 30.0 20.2 22.0 30.0 27.5 26.4 39.9 18.1 20.1 23.2 22.9 4.5 5.6 2.1 4.5 7.3 6.9 3.0 20.6 19.1 27.9 22.9 20.1 23.0 35.4 29.7 26.6 24.0 18.7 27.5 19.2 20.1 15.7 28.1 36.2 23.4 25.2 28.6 22.1 20.1 22.2 30.4 20.1 27.6 33.3 25.2 22.1 20.3 25.2 23.9 19.6 35.3 12.5 24.8 27.8 25.7 17.0 35.8 24.4 23.0 34.8 26.9 21.0 21.9 18.5 30.7 31.5 23.5 19.4 32.2 25.4 24.8 43.5 20.7 29.3 34.3 11.5 18.9 26.1 24.3 14.5 31.0 0.0 3.7 2.1 4.7 4.5 6.9 4.5 5.1 5.6 5.6 3.3 5.9 5.1 1.0 7.3 3.5 4.9 4.0 3.0 24.3 24.3 23.9 23.7 24.6 20.0 27.4 22.8 23.9 27.5 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009499 Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095" "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.1 8.6 1.9 8.7 14.3 9.2 22.2 17.8 13.6 7.4 5.2 12.6 15.5 0.5 45.9 12.9 25.5 3.9 9.2 1.6 40.7 10.1 24.8 15.5 16.5 7.6 3.4 40.9 10.4 10.4 8.4 3.8 23.6 18.9 2.5 4.9 9.7 1.3 11.2 6.2 2.5 2.2 7.5 3.2 11.5 10.8 3.9 2.6 15.1 8.2 12.6 2.9 9.1 34.7 8.3 17.8 12.7 26.1 4.4 25.1 1.1 15.9 11.2 16.8 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 FUT10 ENSG00000172728 "Fucosyltransferase 10" Q6P4F1 8 33370824-33473422 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053970, HPA058655" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" "Nucleoplasm, Endoplasmic reticulum, Golgi apparatus" "HPA053970: , HPA058655: " "unprognostic (6.02e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-3)" "unprognostic (6.24e-2)" "unprognostic (1.01e-1)" "unprognostic (4.80e-2)" "unprognostic (5.40e-3)" "unprognostic (6.07e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (9.10e-3)" "unprognostic (2.76e-4)" "unprognostic (3.06e-3)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-3)" "unprognostic (6.01e-3)" 5.6 7.2 7.9 3.9 10.9 2.0 8.9 18.8 8.6 10.9 6.3 6.9 5.0 6.4 10.5 5.3 5.8 8.4 4.8 5.4 7.4 4.5 8.3 5.2 6.0 4.1 5.8 7.2 13.6 10.9 14.5 11.7 8.2 6.8 6.0 6.9 12.4 6.7 5.9 2.4 9.7 6.1 7.3 5.1 3.8 5.7 4.1 4.6 5.8 6.9 2.2 6.0 6.6 7.2 2.4 3.5 1.9 1.5 3.8 4.1 2.1 2.1 4.4 7.0 8.4 11.1 11.3 3.7 4.5 7.2 4.3 5.9 6.6 3.9 2.5 5.4 5.6 6.1 10.2 4.1 4.4 5.7 3.9 8.3 3.7 7.3 5.1 1.8 3.0 7.8 7.4 1.1 5.4 8.7 7.6 3.4 4.1 1.3 6.5 2.7 9.9 2.9 4.8 5.4 1.4 6.2 5.5 2.4 2.3 2.5 3.8 4.9 3.7 1.9 7.1 3.3 1.5 8.5 3.5 1.4 2.2 1.7 2.0 5.4 3.4 1.1 1.5 1.9 3.7 0.7 4.0 2.4 2.2 3.5 3.5 1.0 2.5 2.4 1.1 3.8 0.5 2.0 4.1 2.1 7.9 10.9 18.8 8.6 7.4 4.5 5.8 7.2 6.8 4.6 FUT8 ENSG00000033170 "Fucosyltransferase 8" Q9BYC5 14 65410592-65744121 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.5;NK-cells: 12.0;T-cells: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017129, HPA040863, HPA043410" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB017129: , HPA040863: , HPA043410: " "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (3.28e-2)" "unprognostic (1.65e-3)" "unprognostic (2.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.41e-1)" "unprognostic (8.81e-2)" "unprognostic (2.00e-2)" "unprognostic (1.33e-3)" "unprognostic (8.09e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-3)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" 7.2 7.6 16.2 12.0 21.1 3.3 9.4 24.1 18.1 6.7 9.8 29.1 16.1 15.4 8.7 5.0 6.5 14.0 10.1 5.2 19.8 12.9 6.2 2.9 7.0 11.2 20.5 11.2 7.2 10.5 6.2 5.2 18.8 17.3 5.4 10.4 7.1 33.7 13.7 3.5 4.9 15.1 9.5 39.8 8.5 27.6 13.1 23.6 8.4 7.5 2.4 15.2 14.4 5.6 13.5 2.2 0.5 1.7 12.0 8.2 2.5 34.9 6.9 3.3 30.7 14.8 11.2 20.8 11.2 17.2 7.8 8.7 5.4 12.9 9.3 9.6 11.1 2.6 7.9 3.1 12.0 34.5 3.4 9.4 2.5 7.0 7.6 2.1 7.7 28.1 2.0 10.8 5.1 19.8 3.4 7.9 5.6 18.0 9.9 5.1 4.5 24.2 6.8 2.9 5.3 14.0 9.8 7.1 5.3 6.0 2.8 2.4 2.8 3.4 43.1 10.3 11.0 4.5 9.1 15.9 6.0 22.2 20.8 3.7 3.2 0.5 1.7 0.5 3.5 0.6 3.5 13.5 5.6 5.1 2.2 6.8 6.1 6.0 0.2 12.0 1.1 2.2 8.2 2.5 16.2 21.1 24.1 17.3 19.8 12.9 20.5 11.2 17.3 23.6 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell line enhanced" "Detected in some" "MCF7: 4.1;RT4: 9.4;SCLC-21H: 9.6;SK-BR-3: 5.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: " "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 9.4 9.6 0.2 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Cell line enhanced" "Detected in some" "ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavourable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 30.3 8.8 0.8 3.6 0.1 0.0 0.0 0.0 0.2 2.4 0.9 0.0 0.6 0.7 0.4 0.0 2.1 0.8 0.4 0.0 1.1 3.5 0.2 0.2 12.5 0.0 0.1 0.3 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.1 3.9 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.6 0.4 5.0 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell line enhanced" "Detected in some" "HaCaT: 88.3;hTCEpi: 160.7;RT4: 83.9;SK-BR-3: 82.6;WM-115: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavourable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 15.9 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.5 23.2 0.0 0.0 0.0 88.3 0.0 33.3 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 160.7 0.0 0.0 0.0 0.0 0.1 0.0 29.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 83.9 19.7 0.2 0.1 82.6 6.1 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 59.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Cell line enhanced" "Detected in some" "AF22: 37.1;HAP1: 24.5;RH-30: 15.4;SCLC-21H: 56.2;SH-SY5Y: 32.1" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: " "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavourable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favourable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favourable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favourable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 24.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.6 0.1 7.4 0.0 0.0 15.4 0.2 0.9 0.0 56.2 32.1 0.0 0.1 1.2 0.6 0.6 0.0 0.0 9.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105255-39274528 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 153.7;lymphoid tissue: 63.5" "Group enriched" "Detected in some" 4 "HEL: 18.4;MOLT-4: 62.6;REH: 18.4;U-937: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025336, HPA026796" Enhanced Approved "Nucleoplasm,Plasma membrane" 6600000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126" "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 7.0 3.5 6.3 36.0 18.3 22.1 3.9 1.8 10.1 3.5 4.4 8.3 0.3 4.1 2.7 6.5 4.9 4.2 7.9 3.5 6.8 6.6 5.7 6.2 13.8 35.5 15.5 2.7 2.6 2.5 1.3 3.5 8.7 11.7 3.8 5.3 3.0 5.4 1.5 1.9 2.4 11.7 5.6 29.4 41.5 5.2 3.5 12.2 63.5 4.1 1.8 28.0 10.1 3.6 0.1 11.9 153.7 41.3 8.6 28.7 30.8 0.0 1.3 0.0 0.0 0.1 0.0 7.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 18.4 0.0 0.0 0.0 6.9 5.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 62.6 3.9 0.0 0.0 18.4 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.1 1.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 24.3 0.0 11.9 33.8 32.3 7.9 38.6 5.5 0.1 22.5 13.8 11.9 0.1 28.7 17.3 153.7 8.6 41.3 3.0 21.7 30.8 6.3 18.3 1.8 10.1 6.8 6.6 15.5 2.7 11.7 12.2 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Group enriched" "Detected in some" 4 "AF22: 8.4;BEWO: 9.7;hTCEpi: 5.6;RPTEC TERT1: 2.9;RT4: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Approved Nucleoplasm Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favourable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.9 4.7 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557459-44559570 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.7;BJ hTERT+ SV40 Large T+: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 6 "dendritic cells: 5.6;monocytes: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: " "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 2.3 2.8 2.3 3.9 5.8 0.9 3.2 0.7 3.1 16.1 2.9 2.1 3.0 2.9 10.8 7.6 2.4 6.6 7.7 5.8 3.2 1.5 5.0 0.5 6.9 3.1 2.1 2.9 12.1 2.7 1.6 1.9 8.4 4.9 4.2 0.8 14.3 2.9 7.9 1.8 1.1 3.6 3.3 2.0 3.7 2.1 6.5 1.8 1.1 5.3 2.4 3.1 3.8 4.3 0.2 5.6 0.0 3.5 0.0 0.8 0.6 7.5 25.7 14.7 8.4 3.3 2.9 0.3 21.3 13.0 25.5 18.4 19.8 4.4 0.0 6.7 5.3 3.5 1.7 1.8 6.1 1.9 5.0 0.8 4.2 0.1 4.3 0.1 4.4 5.5 1.4 6.2 4.2 1.0 1.6 0.2 6.4 4.0 3.4 1.9 16.1 4.8 9.8 4.4 1.3 3.3 0.3 1.9 6.4 2.7 0.7 1.6 8.2 3.6 0.4 13.8 12.2 2.6 12.5 0.6 0.4 1.8 2.5 1.4 6.3 0.0 3.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 5.6 0.2 0.0 0.2 0.0 0.0 0.2 2.6 0.0 0.6 2.3 5.8 0.7 2.1 3.2 1.5 2.1 2.9 4.9 1.8 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;Hep G2: 31.8;HSkMC: 18.3;HUVEC TERT2: 36.0;TIME: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: " "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favourable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.0 2.0 25.4 6.6 1.4 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.0 1.2 0.5 1.0 0.1 0.8 1.0 0.8 31.8 7.5 0.0 0.0 18.3 0.2 1.1 0.2 36.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 7.2 0.0 1.9 0.0 3.5 5.2 0.2 0.3 1.3 0.3 0.5 4.6 0.0 17.6 3.0 2.0 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 GADD45B "DKFZP566B133, GADD45BETA, MYD118" ENSG00000099860 "Growth arrest and DNA damage inducible beta" O75293 19 2476122-2478259 "Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029816 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029816: AB_10601325" "unprognostic (1.32e-1)" "unprognostic (4.51e-2)" "unprognostic (3.94e-3)" "unprognostic (5.06e-2)" "unprognostic (1.53e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (2.95e-1)" "unprognostic (2.79e-1)" "unprognostic (4.37e-2)" "unprognostic (1.09e-3)" "unprognostic (3.90e-2)" "unprognostic (8.27e-3)" "unprognostic (6.00e-2)" 50.5 37.3 10.3 24.6 33.8 142.2 34.2 6.7 26.4 20.0 29.2 17.9 4.1 9.7 14.2 10.7 17.6 34.3 44.6 59.0 22.5 15.6 26.2 143.6 49.8 14.7 17.1 3.9 36.3 45.5 16.7 27.5 22.6 32.4 27.2 6.6 26.6 28.1 36.9 38.4 22.1 12.3 14.5 32.8 14.7 27.1 12.4 13.1 6.7 53.9 29.5 13.7 35.0 15.0 12.2 13.5 45.1 14.9 14.9 22.6 10.1 21.2 4.2 0.5 2.8 16.2 12.5 1.3 21.7 6.3 17.1 8.9 5.9 8.2 10.1 14.7 10.7 11.8 1.1 7.2 4.2 7.7 3.9 1.1 4.7 2.2 27.4 2.3 7.1 20.2 4.7 5.1 25.5 6.8 0.5 27.6 17.6 6.8 2.6 11.3 2.6 9.2 9.8 7.9 15.9 7.7 3.8 0.2 0.2 24.2 18.2 7.0 9.6 17.0 27.6 17.1 15.8 12.2 27.0 12.4 9.2 4.1 4.1 6.9 5.5 11.7 11.8 45.1 22.6 14.9 20.4 7.4 15.8 17.3 11.9 12.2 14.1 18.5 34.5 14.9 11.6 13.5 19.1 10.1 10.3 33.8 6.7 26.4 22.5 15.6 17.1 3.9 32.4 13.1 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell line enhanced" "Detected in many" "HaCaT: 8.5;HSkMC: 8.6;WM-115: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: " "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.0 7.5 2.1 2.2 1.3 1.7 0.4 0.2 0.7 0.5 7.3 8.5 0.2 1.2 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.6 3.3 3.9 0.4 2.5 1.1 0.1 2.3 0.2 2.7 0.1 1.3 0.9 2.1 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.5 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.6 1.4 0.4 29.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800804 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007340 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA007340: AB_1078934" "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favourable (2.68e-4)" "unprognostic (1.41e-2)" 4.4 5.5 4.8 5.6 6.1 1.8 5.0 4.3 8.7 9.1 22.3 3.2 12.4 20.0 3.0 6.0 26.2 6.4 34.7 3.7 4.0 4.1 18.2 26.1 7.7 3.9 3.7 5.2 2.4 15.9 7.7 3.5 29.4 3.5 4.8 23.8 5.5 32.1 6.9 1.7 3.9 30.4 4.1 3.6 8.6 46.7 3.4 2.6 3.7 2.3 9.8 19.6 8.1 8.4 3.1 10.6 2.0 18.6 19.4 5.2 4.7 16.2 19.5 7.8 12.4 2.9 4.1 7.6 11.1 15.0 19.7 14.7 17.8 54.5 3.8 15.6 6.5 18.0 6.9 28.4 15.0 8.2 4.5 10.9 9.9 19.3 29.8 4.7 3.2 8.8 15.0 18.1 45.5 16.9 12.1 1.0 14.0 17.3 7.7 5.0 2.2 19.0 9.2 7.6 4.9 31.9 10.9 3.0 6.9 20.1 18.3 19.7 13.4 3.9 9.2 14.4 21.4 14.8 13.6 5.0 12.1 5.0 15.2 20.0 7.7 1.1 7.7 1.7 5.1 15.5 5.2 3.1 3.1 4.1 10.6 1.0 3.6 2.5 2.0 19.4 18.6 3.0 5.1 4.7 4.8 6.1 4.3 8.7 4.0 4.1 3.7 5.2 3.5 2.6 GALK2 GK2 ENSG00000156958 "Galactokinase 2" Q01415 15 49155656-49367869 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043564, HPA048267" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043564: AB_2678557, HPA048267: " "unprognostic (2.27e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "prognostic favourable (7.31e-4)" "unprognostic (3.04e-1)" "unprognostic (9.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.95e-1)" "unprognostic (2.30e-1)" "unprognostic (8.67e-3)" "unprognostic (2.25e-2)" "unprognostic (2.43e-1)" "prognostic favourable (1.88e-5)" "unprognostic (2.33e-1)" "unprognostic (9.79e-2)" "unprognostic (2.13e-2)" "unprognostic (1.93e-1)" 12.7 24.9 10.2 9.2 15.3 6.5 12.4 15.7 15.3 14.7 16.3 15.3 25.6 21.5 16.0 9.9 11.5 13.5 9.9 14.2 11.3 10.3 32.3 28.4 12.7 8.0 16.2 9.4 11.5 18.5 19.4 34.2 10.8 15.3 11.1 17.9 13.2 12.2 16.3 12.5 11.6 17.9 11.8 13.9 12.8 13.9 9.2 14.8 14.6 16.7 10.9 11.5 10.3 11.6 9.6 10.4 24.2 11.3 12.8 23.1 8.7 6.2 7.3 3.4 4.5 8.7 13.6 9.9 6.5 8.7 6.5 7.7 9.3 6.6 2.0 5.2 6.8 9.1 13.4 9.3 9.2 11.2 3.9 11.7 7.0 7.8 9.5 8.0 3.7 7.0 17.1 6.9 17.3 13.1 11.6 11.4 7.0 6.7 5.8 6.4 1.4 7.0 7.1 4.1 30.3 12.0 5.9 4.1 2.7 7.2 15.0 12.3 7.4 7.8 7.2 6.4 4.4 25.9 6.1 9.4 32.3 3.8 9.9 30.7 8.7 24.2 10.6 18.6 12.8 11.3 13.6 9.6 13.1 12.6 10.4 6.7 10.5 10.7 5.4 12.8 10.8 9.2 23.1 8.7 10.2 15.3 15.7 15.3 11.3 10.3 16.2 9.4 15.3 14.8 GALM ENSG00000143891 "Galactose mutarotase" Q96C23 2 38665910-38741237 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 54.2" "Cell line enhanced" "Detected in many" "Karpas-707: 27.9;U-266/70: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 29.7" "Group enriched" "Detected in all" 5 "granulocytes: 13.2;T-cells: 29.7" "Low region specificity" "Detected in all" "HPA035472, HPA035473, HPA064835" Enhanced Approved Nucleoplasm 570000 Nucleoplasm "HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723" "unprognostic (5.02e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (9.20e-2)" "unprognostic (1.88e-2)" "unprognostic (9.99e-3)" "unprognostic (1.63e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (6.65e-2)" "unprognostic (6.45e-2)" "prognostic favourable (9.06e-5)" "unprognostic (1.70e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "prognostic favourable (1.32e-4)" 11.2 54.2 3.1 10.4 2.5 0.7 4.6 1.9 2.7 5.9 28.4 2.5 44.3 22.7 6.8 11.8 3.4 11.6 13.3 7.7 2.5 1.8 39.1 28.8 5.8 6.4 2.4 1.9 6.4 7.9 10.4 2.4 3.1 2.9 8.1 10.7 15.3 7.9 29.1 4.6 2.2 39.8 5.4 3.3 4.1 5.0 4.7 2.1 6.4 7.4 3.3 9.3 6.5 5.2 2.8 4.5 13.2 2.1 2.3 29.7 5.3 0.0 10.7 3.3 0.0 11.1 6.5 5.9 1.3 4.0 3.0 4.9 11.9 5.6 4.1 7.9 5.9 1.7 4.6 0.3 6.0 18.8 7.8 2.2 2.9 23.8 4.0 0.9 0.1 4.5 0.1 6.8 0.0 3.4 6.3 27.9 5.5 0.3 9.1 14.8 5.0 3.5 5.7 0.2 8.1 3.9 18.4 0.6 4.7 0.0 7.6 5.4 3.7 2.1 1.3 1.0 0.2 7.4 0.4 31.3 21.2 0.1 6.9 2.6 0.1 13.2 2.1 1.8 10.2 1.5 15.0 2.8 16.0 14.8 4.5 2.5 5.8 5.0 5.1 2.3 0.2 0.4 29.7 5.3 3.1 2.5 1.9 2.7 2.5 1.8 2.4 1.9 2.9 2.1 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell line enhanced" "Detected in many" "TIME: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favourable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavourable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 7.4 25.4 6.2 5.4 13.2 11.8 4.8 21.5 12.0 8.6 8.2 3.5 17.1 4.8 15.2 36.1 1.3 2.8 16.8 7.9 12.6 2.0 13.3 4.8 4.8 10.2 2.8 13.0 14.6 3.9 6.9 10.3 16.4 3.0 15.4 14.6 7.7 0.3 2.0 2.4 5.2 1.5 3.3 4.8 11.9 5.1 0.8 2.0 9.5 35.6 2.8 13.8 2.2 48.2 20.9 5.0 5.1 22.8 4.4 4.3 2.6 13.7 5.7 6.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell line enhanced" "Detected in many" "A549: 12.9;RPMI-8226: 14.9;RPTEC TERT1: 22.0;RT4: 16.3" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" 9400 "Golgi apparatus" Nucleoplasm "HPA030138: " "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 10.9 12.9 0.0 0.0 0.0 0.0 0.0 3.6 1.9 2.4 0.3 0.0 0.0 10.2 3.7 0.2 0.0 0.4 0.5 0.4 0.3 1.3 5.7 0.0 0.0 0.0 8.2 0.0 0.0 2.3 0.0 8.5 0.0 0.0 9.1 0.0 5.0 0.0 0.0 6.1 0.0 7.1 0.0 14.9 22.0 16.3 12.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.2 0.9 2.8 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 GALNT16 "GalNAc-T16, GALNTL1, KIAA1130" ENSG00000100626 "Polypeptide N-acetylgalactosaminyltransferase 16" Q8N428 14 69259277-69357033 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.7;ASC diff: 10.2;hTEC/SVTERT24-B: 14.4;SCLC-21H: 7.6;U-2 OS: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059136 Approved Approved Nucleoplasm 250000 Nucleoplasm "HPA059136: " "unprognostic (9.71e-3)" "unprognostic (7.47e-2)" "unprognostic (4.02e-1)" "unprognostic (2.30e-2)" "unprognostic (6.71e-2)" "unprognostic (5.72e-3)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.62e-4)" "unprognostic (1.31e-2)" "prognostic favourable (5.23e-6)" "unprognostic (5.38e-3)" "unprognostic (3.34e-2)" "unprognostic (3.93e-2)" "unprognostic (7.96e-5)" 13.6 15.5 20.0 2.9 17.9 0.8 14.5 16.1 21.7 7.8 4.1 5.0 4.0 3.2 6.4 6.0 5.1 6.5 4.8 27.6 18.3 27.2 5.6 3.0 4.2 4.2 6.6 25.2 2.8 5.6 4.0 4.1 1.2 13.0 4.6 3.4 1.7 28.9 6.6 5.3 7.0 5.0 11.3 8.7 14.3 2.4 3.3 3.3 0.0 3.5 6.3 2.2 5.0 3.8 0.5 0.2 1.3 0.5 0.3 0.3 0.2 0.0 0.7 7.7 0.2 10.2 4.6 0.0 1.1 0.0 1.4 1.9 0.4 0.0 0.0 0.2 1.2 0.0 2.5 0.0 0.2 0.1 5.3 0.0 0.1 0.3 0.1 0.0 0.5 0.5 0.0 14.4 0.0 0.8 0.0 0.0 2.4 0.4 0.0 0.0 1.4 0.1 0.0 4.0 0.0 0.5 0.0 7.6 2.5 1.7 0.3 0.0 0.2 0.0 0.1 1.6 17.3 2.0 1.6 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.5 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.5 0.3 0.2 1.3 0.3 0.1 0.2 0.1 0.2 20.0 17.9 16.1 16.2 18.3 27.2 6.6 25.2 13.0 3.3 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 35.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.6;CACO-2: 33.2;SK-BR-3: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 2900000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favourable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favourable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 3.1 1.8 4.0 4.1 9.5 4.4 10.6 1.0 5.1 19.5 13.4 15.4 0.5 11.8 0.9 14.4 2.8 3.7 6.8 0.8 7.1 3.6 2.5 0.8 4.1 4.0 14.4 3.6 1.4 6.3 0.4 1.6 9.9 5.8 1.3 3.9 0.9 23.8 6.3 0.6 5.5 16.9 0.8 8.3 5.5 35.4 0.8 9.7 6.6 1.8 2.3 6.6 2.2 2.2 2.9 3.7 23.8 6.5 10.8 3.4 2.8 11.5 1.2 0.2 0.0 0.0 0.1 18.5 19.4 33.6 8.3 5.6 33.2 6.1 0.1 1.8 10.9 11.1 0.6 8.4 5.3 2.6 1.2 7.4 0.2 0.2 0.3 3.9 26.1 0.7 7.8 7.4 7.1 20.4 1.6 0.3 0.0 22.6 12.5 2.9 1.6 21.0 0.0 0.0 3.3 6.5 0.8 0.1 7.5 0.1 33.9 0.0 18.8 1.7 23.9 0.0 4.2 0.0 0.0 0.6 0.1 1.0 2.3 8.7 0.1 4.5 4.4 23.8 3.4 3.7 1.4 0.8 1.7 2.6 3.7 2.9 2.7 2.3 0.8 10.8 6.5 3.1 1.1 2.8 4.0 9.5 1.0 5.1 7.1 3.6 14.4 3.6 5.8 9.7 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168753-173323967 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" 5000000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favourable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavourable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 3.7 4.4 8.4 7.4 8.4 5.0 12.0 27.6 8.0 13.4 23.3 9.4 2.8 14.1 9.3 5.5 12.0 4.9 9.5 3.5 6.5 5.2 4.9 1.2 4.5 5.2 10.8 7.0 7.2 14.9 5.3 5.6 6.3 11.2 20.3 26.7 6.2 20.1 4.2 1.4 3.1 16.2 8.4 16.3 5.7 32.8 6.4 8.8 67.4 6.6 4.4 9.6 9.4 4.8 5.0 9.8 16.8 11.4 5.5 6.8 4.7 20.1 10.6 10.4 3.3 5.6 8.3 14.9 5.3 6.0 5.0 6.9 3.3 32.0 11.2 3.9 4.7 17.2 4.4 9.3 6.8 43.5 8.5 13.6 21.9 0.1 3.7 20.1 9.7 5.3 8.5 11.1 5.6 32.9 9.1 17.5 25.2 6.6 14.7 11.1 10.2 7.0 14.8 9.6 2.9 36.6 9.5 8.4 6.4 2.5 14.8 7.3 5.9 6.0 39.3 3.6 15.9 0.1 11.4 5.1 0.0 6.0 14.6 12.1 12.8 9.6 11.4 14.6 4.3 6.0 6.2 5.0 4.9 4.6 9.8 3.1 3.9 3.0 16.8 5.5 6.1 4.1 6.8 4.7 8.4 8.4 27.6 8.0 6.5 5.2 10.8 7.0 11.2 8.8 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016949 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA016949: AB_1849465" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favourable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 13.3 14.0 12.5 17.3 20.7 17.6 14.4 16.6 14.2 15.8 14.3 25.6 15.4 11.7 17.9 26.0 20.7 12.9 13.0 12.4 13.4 10.4 13.5 18.0 30.5 13.8 25.0 13.7 18.8 13.1 17.4 20.5 10.8 19.8 13.1 17.8 18.3 20.4 13.7 23.9 13.9 15.4 15.9 25.1 15.5 13.1 24.5 22.6 17.4 16.8 12.3 18.3 16.2 16.3 17.6 12.2 9.3 10.1 4.0 7.4 4.7 6.1 3.2 7.9 8.5 9.6 13.5 5.0 13.6 14.7 15.0 12.6 4.7 4.4 3.4 7.4 13.7 12.9 9.4 14.5 10.4 8.4 4.3 8.4 8.5 9.1 8.1 8.1 7.3 9.1 8.7 6.1 10.4 10.1 8.7 9.5 11.8 1.3 5.4 9.0 4.8 4.1 10.5 9.2 11.7 11.3 5.8 5.9 8.4 7.6 6.7 4.8 2.5 19.3 9.2 15.8 4.2 13.0 8.1 10.3 13.6 6.9 7.4 15.0 8.7 9.3 9.3 7.4 3.7 10.1 5.0 16.2 5.7 6.9 12.2 17.6 7.4 4.4 5.0 4.0 8.1 9.6 5.5 4.7 12.5 20.7 16.6 14.2 13.4 10.4 25.0 13.7 19.8 22.6 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533412-35545316 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 154.6" "Cell line enhanced" "Detected in many" "A549: 16.2" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA042666: " "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 0.3 0.5 0.3 0.8 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.6 0.5 1.6 0.6 0.2 0.8 0.8 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 0.7 1.3 0.0 0.3 0.3 0.3 0.3 0.0 4.2 1.3 0.3 0.3 4.4 0.6 0.3 0.3 1.2 0.4 154.6 0.3 0.3 3.6 0.3 0.3 0.6 0.3 2.1 1.0 1.2 0.8 1.4 2.0 0.8 4.4 16.2 4.5 6.8 0.0 0.0 3.8 1.3 0.0 0.0 0.0 9.8 7.4 7.4 2.1 0.0 5.4 0.0 0.0 0.0 7.2 7.9 4.9 10.3 5.0 0.1 4.4 5.9 0.0 0.0 0.0 0.0 0.0 11.8 4.4 0.0 13.8 1.7 2.1 6.1 2.2 5.2 3.2 5.7 0.0 4.4 8.1 3.7 1.6 4.1 4.8 3.4 1.9 1.5 5.2 5.8 1.3 1.8 12.1 3.2 4.3 2.8 8.0 1.9 0.0 0.8 1.2 1.1 0.6 2.0 1.1 0.4 1.9 1.0 2.1 1.1 1.2 0.0 1.4 0.3 0.8 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 GAR1 NOLA1 ENSG00000109534 "GAR1 ribonucleoprotein" Q9NY12 4 109815510-109824740 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059098 Supported Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA059098: " "unprognostic (9.72e-2)" "unprognostic (6.94e-2)" "unprognostic (3.04e-2)" "unprognostic (4.47e-2)" "unprognostic (2.40e-1)" "unprognostic (1.24e-2)" "prognostic unfavourable (2.64e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (4.17e-3)" "unprognostic (2.14e-2)" "unprognostic (2.45e-3)" "unprognostic (1.17e-1)" "unprognostic (5.11e-2)" "unprognostic (1.11e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-3)" 16.6 18.9 15.2 19.5 19.9 34.7 22.4 11.0 16.5 14.6 20.9 12.4 15.5 17.0 24.3 14.8 26.6 17.2 17.8 11.6 14.2 13.3 15.6 20.0 13.7 17.2 15.5 17.1 20.2 24.1 15.7 19.1 24.8 13.8 17.3 21.0 14.5 23.3 17.5 13.8 25.4 16.3 19.0 18.1 18.8 15.1 27.7 16.3 29.5 17.3 27.6 22.4 15.5 15.5 11.3 9.3 7.4 9.3 9.5 10.7 4.3 15.6 18.2 12.5 16.9 6.7 9.6 10.9 16.3 8.8 13.5 10.9 28.4 19.9 38.3 10.7 12.3 7.5 23.0 16.2 22.5 11.3 22.6 22.8 16.4 31.0 16.3 48.8 12.1 8.7 17.0 16.7 12.0 16.3 54.4 11.7 16.6 33.5 30.1 33.7 20.4 22.1 20.4 20.5 14.2 17.8 22.1 18.5 18.9 10.3 26.8 14.5 9.5 14.5 14.1 13.5 18.9 9.9 20.8 14.9 24.2 47.3 9.6 23.9 14.6 7.4 5.9 3.3 9.7 9.3 10.3 11.3 9.2 9.8 9.3 10.0 10.7 9.9 1.0 9.5 8.0 9.2 9.6 4.3 15.2 19.9 11.0 16.5 14.2 13.3 15.5 17.1 13.8 16.3 GAREM1 "C18orf11, FAM59A, FLJ21610, GAREM" ENSG00000141441 "GRB2 associated regulator of MAPK1 subtype 1" Q9H706 18 32124877-32470484 "Predicted intracellular proteins" Mitogen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.5" "Cell line enhanced" "Detected in many" "hTCEpi: 12.0;hTERT-HME1: 20.8;RT4: 17.7;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040709, HPA042046" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040709: , HPA042046: " "unprognostic (9.52e-2)" "unprognostic (4.13e-3)" "unprognostic (2.67e-2)" "unprognostic (3.32e-3)" "unprognostic (3.62e-1)" "unprognostic (5.53e-3)" "unprognostic (1.87e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (5.59e-2)" "prognostic unfavourable (6.73e-5)" "unprognostic (1.45e-1)" "prognostic favourable (5.49e-6)" "unprognostic (2.36e-1)" "unprognostic (2.56e-3)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 11.1 8.7 9.7 2.9 10.9 8.0 6.0 17.6 11.1 6.0 7.2 19.5 0.3 6.5 4.2 3.4 11.0 4.8 4.9 8.9 11.8 5.8 15.3 12.5 5.2 1.3 16.3 10.1 4.4 43.5 1.9 5.1 4.8 13.2 4.3 6.3 3.0 11.2 5.1 7.7 13.9 7.8 4.6 12.9 3.1 12.7 6.7 16.4 0.0 3.5 3.1 2.9 9.3 9.1 1.9 5.0 2.6 1.0 3.1 1.4 0.0 1.0 1.5 1.7 0.3 4.6 3.2 4.7 0.3 0.0 0.0 0.0 0.3 2.6 3.0 2.5 0.2 3.3 2.6 4.9 0.0 0.9 1.6 0.0 3.0 1.0 2.3 0.3 0.2 3.8 12.0 0.2 20.8 0.1 0.1 0.6 1.8 2.4 0.8 0.1 1.8 0.8 1.2 6.8 5.2 6.0 17.7 5.6 14.7 3.9 5.0 0.2 1.0 2.5 0.2 1.2 1.4 0.0 0.4 2.1 0.2 0.7 1.9 0.0 1.4 0.0 1.0 0.2 0.5 0.1 0.2 0.3 0.8 0.5 0.1 1.9 1.0 1.4 2.6 3.1 0.1 5.0 0.1 0.0 9.7 10.9 17.6 11.1 11.8 5.8 16.3 10.1 13.2 16.4 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 5.9;SH-SY5Y: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: " "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.6 0.3 1.8 1.9 0.6 0.0 1.7 0.1 0.9 3.3 0.0 0.3 0.0 1.4 0.0 2.9 1.9 0.8 0.7 0.3 0.2 2.6 0.0 0.0 1.3 1.4 1.1 0.1 1.0 0.0 0.6 0.7 2.7 0.2 2.0 5.9 3.2 4.1 2.1 6.5 1.3 4.7 0.5 1.6 0.1 0.0 0.4 1.9 0.0 0.6 4.1 3.9 2.0 0.9 1.0 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Group enriched" "Detected in some" 10 "Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: " "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favourable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 40.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.2 2.0 0.0 0.5 11.7 0.6 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.4 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475970 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.1;intestine: 23.6" "Cell line enhanced" "Detected in some" "EFO-21: 2.5;HEL: 4.9;K-562: 7.7;SiHa: 3.4;T-47d: 8.2" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067583 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA067583: " "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 1.9 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.4 15.9 0.0 5.2 14.8 3.8 1.7 0.3 9.1 22.1 6.8 0.0 0.0 3.3 0.7 1.6 0.0 0.0 0.0 3.1 0.0 0.3 0.6 0.6 0.0 11.3 0.0 1.0 0.4 0.8 0.1 0.3 23.6 18.3 0.2 0.1 10.3 16.8 0.0 0.0 1.2 0.0 0.0 14.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 3.4 0.0 0.0 8.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GBA2 "AD035, DKFZp762K054, KIAA1605, SPG46" ENSG00000070610 "Glucosylceramidase beta 2" Q9HCG7 9 35736866-35749228 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024026 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024026: AB_1849530" "unprognostic (3.34e-2)" "unprognostic (2.90e-1)" "unprognostic (2.99e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (5.83e-3)" "unprognostic (2.20e-2)" "unprognostic (2.09e-2)" "unprognostic (3.99e-2)" "unprognostic (8.69e-2)" "prognostic favourable (6.00e-4)" "unprognostic (9.01e-3)" "prognostic favourable (1.24e-11)" "unprognostic (7.62e-3)" "unprognostic (2.94e-1)" "unprognostic (7.69e-2)" "prognostic favourable (6.60e-4)" 15.6 19.3 28.9 17.0 23.3 11.0 24.3 42.3 41.6 14.8 35.1 17.0 28.4 41.5 19.0 22.3 16.6 16.8 21.4 34.6 22.4 21.0 34.8 25.0 20.9 17.3 23.7 19.5 16.4 20.9 27.9 27.1 19.3 36.6 23.9 32.8 28.4 27.7 25.5 46.1 23.5 51.1 23.3 21.0 23.4 26.9 11.6 19.5 10.9 25.4 15.5 16.4 18.2 16.9 5.6 6.8 12.2 6.1 3.1 7.3 3.1 8.1 13.5 18.7 18.1 9.1 5.6 19.0 11.1 8.8 11.4 12.0 15.0 6.5 8.8 8.1 6.7 8.6 17.9 7.5 5.7 12.4 12.2 9.4 35.4 16.1 10.1 14.0 23.5 9.6 14.1 9.6 10.1 29.7 9.2 16.9 10.5 8.1 3.8 14.5 19.4 21.5 7.0 7.5 7.4 15.8 19.3 15.3 20.5 6.2 15.7 11.0 10.7 12.7 20.6 12.3 14.9 10.5 13.5 11.5 7.3 7.3 15.5 5.1 9.5 12.2 4.4 2.9 6.0 6.1 4.1 5.0 5.8 7.3 4.2 5.6 3.7 3.2 4.9 3.1 3.7 6.8 4.0 3.1 28.9 23.3 42.3 41.6 22.4 21.0 23.7 19.5 36.6 19.5 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489699-81762161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.9" "Cell line enhanced" "Detected in all" "ASC diff: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Nucleoplasm,Cytosol 5900000 "Nucleoplasm, Cytosol" "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 23.1 22.4 2.2 7.8 4.2 5.6 19.2 4.2 4.6 6.4 7.7 5.2 5.2 4.1 8.4 4.9 7.5 4.9 11.5 19.7 3.6 4.3 14.0 36.3 11.3 7.5 7.9 3.4 8.2 5.7 8.2 11.6 11.4 8.4 5.7 4.5 9.9 8.0 10.1 56.9 5.9 6.3 7.2 6.1 8.0 4.5 4.6 4.1 5.4 6.5 11.2 4.5 9.6 10.0 11.6 13.6 14.5 11.4 13.0 7.2 6.1 12.0 7.3 2.4 34.6 60.9 46.3 4.4 20.0 28.6 12.0 20.4 1.4 3.1 13.5 8.8 24.6 1.4 2.0 9.2 28.3 6.3 1.1 4.2 15.1 4.5 41.9 14.1 3.7 34.1 6.9 19.3 19.9 26.6 3.2 7.8 39.0 3.5 2.3 16.8 2.4 11.1 4.4 11.0 15.8 8.5 4.1 1.2 1.6 13.0 3.8 4.1 2.7 11.7 37.0 24.9 5.8 17.4 18.5 35.7 4.1 4.9 40.5 9.5 10.1 6.3 11.4 14.5 5.6 10.4 5.4 11.0 6.0 5.9 13.6 11.6 7.0 7.2 11.0 13.0 10.8 4.5 5.0 6.1 2.2 4.2 4.2 4.6 3.6 4.3 7.9 3.4 8.4 4.1 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell line enhanced" "Detected in some" "AF22: 31.8;BEWO: 5.5;PC-3: 9.3;TIME: 5.0" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Nucleoplasm "HPA067809: " "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 31.8 1.2 0.0 0.0 5.5 0.4 0.0 0.8 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.2 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.1 0.0 0.4 0.7 0.0 0.2 0.8 9.3 0.0 3.4 0.0 0.3 0.0 0.4 0.2 1.0 0.0 0.3 0.0 0.0 5.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell line enhanced" "Detected in all" "A549: 54.7;Hep G2: 46.7;RT4: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favourable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavourable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 8.1 54.7 4.5 10.6 5.4 2.4 6.0 4.1 6.7 3.1 3.7 8.0 19.0 15.5 7.9 3.7 11.6 13.7 30.1 4.2 12.2 8.4 10.4 10.6 46.7 6.2 13.6 6.4 3.8 12.8 3.5 15.7 4.7 5.7 4.9 1.5 8.6 11.7 5.4 8.3 5.1 3.9 2.7 13.7 10.1 50.4 13.0 6.4 6.9 11.1 7.2 7.6 6.5 6.5 2.8 9.8 7.1 6.1 6.6 10.1 9.0 7.0 9.8 4.7 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 GCLM GLCLR ENSG00000023909 "Glutamate-cysteine ligase modifier subunit" P48507 1 93885205-93909456 "Cancer-related genes, Predicted intracellular proteins" "Glutathione biosynthesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009568, HPA023696, CAB040554" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" 1000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009568: AB_2107835, CAB040554: , HPA023696: AB_1849560" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (8.85e-3)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (4.64e-2)" "prognostic unfavourable (9.83e-6)" "unprognostic (2.37e-1)" "unprognostic (1.07e-1)" "unprognostic (3.53e-1)" "unprognostic (3.51e-2)" "unprognostic (3.89e-2)" "unprognostic (2.19e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (2.34e-3)" 10.3 17.5 7.0 6.0 7.7 11.3 23.9 5.7 8.9 4.5 22.8 4.2 11.5 16.6 3.5 6.5 8.8 12.8 12.5 7.7 6.8 8.9 17.8 41.7 8.4 10.4 9.2 5.7 4.6 6.9 6.3 5.1 10.3 8.7 5.3 5.2 6.4 6.7 6.4 19.2 3.4 20.0 3.4 7.7 6.9 6.1 3.2 2.8 5.6 15.0 23.0 8.6 8.9 8.0 3.2 1.9 3.3 0.7 4.6 6.7 1.2 14.0 22.2 2.4 4.8 8.3 5.2 9.5 16.8 10.5 12.8 9.6 3.7 8.3 5.3 33.7 10.8 14.2 3.6 6.8 10.3 14.4 4.9 37.1 15.2 16.0 15.6 13.6 5.9 6.4 2.6 26.0 4.2 13.9 14.7 7.9 9.2 2.7 9.8 3.1 8.4 10.6 4.6 7.4 7.8 9.1 16.4 5.8 2.4 15.8 12.5 5.8 2.8 8.5 14.6 13.4 7.9 25.2 25.1 7.1 9.1 5.5 11.1 7.7 4.7 3.3 0.7 1.3 5.3 0.4 3.1 2.6 5.0 6.7 0.6 3.2 3.2 3.2 2.9 4.6 0.5 1.9 1.3 1.2 7.0 7.7 5.7 8.9 6.8 8.9 9.2 5.7 8.7 2.8 GCNT4 C2GNT3 ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4, core 2" Q9P109 5 75025346-75030899 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.6;intestine: 13.1;stomach 1: 10.4" "Cell line enriched" "Detected in some" 5 "RT4: 26.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Group enriched" "Detected in many" 54 "granulocytes: 13.6;T-cells: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favourable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.6 0.6 0.3 1.0 0.7 0.0 0.9 0.0 2.3 1.1 1.1 13.1 1.4 0.6 1.3 1.1 2.5 0.3 0.3 0.1 1.8 0.4 1.0 1.7 0.1 0.9 3.0 8.4 0.1 3.0 1.0 0.2 0.5 2.4 1.0 1.5 10.8 0.7 0.0 0.6 10.4 1.0 0.5 1.1 6.4 2.0 0.0 0.0 13.6 0.1 0.2 11.6 1.6 0.2 0.1 1.0 1.6 1.8 0.6 0.1 2.0 5.2 1.0 0.9 2.5 0.1 0.0 0.2 1.5 0.7 1.0 1.8 0.2 0.0 0.0 0.8 0.2 0.2 0.8 0.0 0.0 0.3 2.9 0.1 0.3 0.0 0.0 0.3 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.0 2.6 0.2 26.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 13.6 0.0 0.0 0.9 0.0 3.5 0.0 8.1 2.6 0.0 0.0 8.1 5.9 0.1 0.2 0.1 0.0 11.6 1.6 GCOM1 "FLJ30973, GRINL1A, MYZAP-POLR2M" ENSG00000137878 "GRINL1A complex locus 1" 15 57591908-57714745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 107.1;smooth muscle: 42.3" "Cell line enhanced" "Detected in some" "HEL: 24.8;RH-30: 7.0;RT4: 7.8;TIME: 10.7" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 10.4;pons and medulla: 3.9" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;naive CD4 T-cell: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 3.6;monocytes: 1.5;T-cells: 4.0" "HPA039827, HPA068141" Approved Approved Nucleoplasm Nucleoplasm "HPA039827: AB_10673364, HPA068141: " "unprognostic (1.10e-1)" "unprognostic (3.62e-4)" "unprognostic (1.10e-1)" "unprognostic (5.43e-3)" "unprognostic (1.31e-3)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (7.69e-4)" "unprognostic (1.22e-1)" "unprognostic (3.22e-3)" "unprognostic (3.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (7.44e-2)" "unprognostic (1.67e-1)" "unprognostic (5.78e-2)" 6.7 4.6 1.2 1.9 1.4 2.9 10.3 10.4 1.3 4.1 3.6 0.1 2.3 3.6 5.2 1.2 9.9 1.3 2.3 107.1 1.2 1.6 1.2 0.9 7.6 1.7 1.2 0.0 2.3 5.6 0.4 1.0 9.1 3.9 10.2 1.3 0.0 4.6 2.7 7.3 2.6 5.8 42.3 1.0 2.6 3.3 2.5 0.0 0.0 1.1 5.0 4.8 25.3 9.5 3.6 0.5 0.4 1.5 0.0 4.0 4.5 3.2 0.6 0.0 3.2 0.0 0.0 0.8 0.6 2.2 1.0 1.0 2.3 3.2 0.0 0.5 0.0 2.1 0.0 1.9 0.9 0.0 0.1 24.8 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.3 4.9 1.0 1.3 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 7.0 0.0 0.0 7.8 0.0 0.8 0.7 0.7 0.0 3.1 0.0 10.7 0.3 2.0 0.3 0.2 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 1.2 0.7 0.0 0.5 3.6 4.0 0.0 0.4 0.0 1.5 0.0 0.3 4.5 1.2 1.4 10.4 1.3 1.2 1.6 1.2 0.0 3.9 0.0 GDA ENSG00000119125 "Guanine deaminase" Q9Y2T3 9 72114595-72257193 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;intestine: 54.5;liver: 27.6" "Cell line enhanced" "Detected in some" "A-431: 12.7;BJ hTERT+: 9.2;EFO-21: 50.3;HeLa: 17.6;hTCEpi: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4" "HPA019352, HPA024099, HPA030387" Enhanced Approved Nucleoplasm 1300000 Nucleoplasm "HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351" "unprognostic (2.64e-2)" "unprognostic (7.10e-2)" "unprognostic (2.83e-2)" "unprognostic (2.92e-1)" "unprognostic (4.35e-2)" "unprognostic (8.45e-2)" "unprognostic (2.00e-1)" "unprognostic (5.60e-2)" "unprognostic (3.26e-1)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "prognostic favourable (2.66e-5)" "unprognostic (2.23e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (8.30e-4)" 0.5 1.7 26.7 1.8 27.7 0.5 0.5 0.4 33.8 1.0 20.6 0.9 7.7 47.4 2.4 0.6 0.5 4.7 13.1 0.5 25.7 15.0 21.4 27.6 0.5 0.5 2.9 27.4 0.4 1.7 10.8 1.7 10.3 0.8 0.4 5.5 0.0 0.4 4.1 1.1 1.6 54.5 0.5 0.6 0.5 2.0 1.0 0.2 0.0 0.4 1.0 2.6 3.4 0.5 1.4 0.5 3.0 0.7 1.0 1.0 0.1 12.7 1.6 0.0 0.0 0.0 0.0 0.3 0.0 9.2 0.0 0.0 1.1 7.1 0.0 50.3 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.4 2.9 0.0 0.2 0.9 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.7 0.3 1.0 0.6 0.3 0.6 0.5 0.4 0.3 1.4 0.7 0.7 1.9 1.0 0.4 0.5 0.5 0.1 26.7 27.7 0.4 33.8 25.7 15.0 2.9 27.4 0.8 0.2 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074747 Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA074747: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favourable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favourable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.6 17.6 9.7 11.5 46.8 17.4 13.9 15.1 26.0 11.8 14.7 10.0 26.2 11.0 19.5 22.0 12.7 13.5 17.8 14.4 11.9 20.8 9.2 17.3 21.6 28.4 12.1 8.6 18.3 28.9 12.6 14.8 15.8 5.1 11.4 12.8 26.4 10.5 11.2 11.3 13.7 15.2 17.8 15.9 29.2 22.5 11.3 10.3 14.7 17.6 13.9 18.0 14.5 16.6 10.0 9.0 13.2 9.2 10.7 10.1 7.6 15.4 18.0 8.9 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell line enriched" "Detected in some" 8 "LHCN-M2: 26.8" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavourable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.5 3.2 2.1 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 26.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Group enriched" "Detected in many" 6 "MCF7: 13.7;SK-BR-3: 48.5" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Not detected" "Not detected" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavourable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.8 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 2.1 0.4 0.9 0.7 13.7 0.4 0.9 1.1 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: , HPA057114: " "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.4 16.5 16.3 11.9 5.7 6.7 8.4 5.5 4.4 14.7 14.7 14.4 13.6 17.0 11.5 4.7 8.8 21.8 9.3 15.5 8.7 12.7 9.9 10.1 35.8 11.7 15.0 6.5 3.6 8.9 9.3 13.4 12.8 11.8 12.5 8.2 22.8 16.4 14.5 11.4 18.6 15.4 17.8 10.7 8.2 7.6 16.0 3.2 11.5 8.9 6.0 20.3 6.6 5.2 6.8 10.1 6.6 8.9 13.1 20.3 24.9 3.3 16.0 9.5 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 GEMIN8 "FAM51A1, FLJ20514" ENSG00000046647 "Gem nuclear organelle associated protein 8" Q9NWZ8 X 14008279-14029893 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028613 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA028613: AB_10602905" "unprognostic (7.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.83e-1)" "unprognostic (1.87e-3)" "unprognostic (2.58e-1)" "unprognostic (5.42e-2)" "prognostic unfavourable (7.78e-5)" "unprognostic (3.87e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-2)" "unprognostic (5.52e-2)" "unprognostic (2.40e-1)" "unprognostic (4.74e-2)" "unprognostic (4.23e-2)" "unprognostic (2.07e-2)" "unprognostic (7.75e-2)" "prognostic favourable (7.73e-5)" 13.4 13.5 14.5 12.9 17.0 12.0 19.9 12.3 20.0 16.5 13.9 24.0 27.3 9.0 21.5 16.9 13.2 22.8 16.4 15.5 14.8 14.0 16.7 12.9 14.5 16.0 16.6 14.7 28.9 22.2 18.7 27.4 10.3 21.0 13.1 11.9 16.8 24.7 30.2 7.6 15.7 10.0 17.1 23.3 12.5 13.6 8.2 12.7 14.6 21.3 7.9 13.2 12.7 13.0 11.3 15.4 0.8 6.9 9.9 15.2 7.5 6.3 6.3 7.5 1.8 12.2 18.7 3.7 5.9 6.6 5.2 3.6 3.3 11.0 14.8 14.2 4.8 8.5 4.6 10.4 5.0 7.9 9.5 3.8 4.7 7.4 7.1 9.0 8.0 15.0 17.2 9.0 15.7 11.2 6.6 13.1 7.8 8.5 9.0 14.1 8.1 3.7 13.8 5.2 26.3 8.7 6.2 7.4 20.5 6.3 11.9 7.0 16.3 9.0 8.5 3.8 2.2 11.1 2.4 8.9 4.4 9.3 8.8 5.5 2.2 0.6 6.7 0.2 9.4 6.4 11.6 11.3 15.2 8.9 12.2 9.8 13.1 9.8 0.8 9.9 6.9 15.4 8.4 7.5 14.5 17.0 12.3 20.0 14.8 14.0 16.6 14.7 21.0 12.7 GEN1 "FLJ40869, Gen" ENSG00000178295 "GEN1, Holliday junction 5' flap endonuclease" Q17RS7 2 17753858-17788941 "Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020078, HPA021141" Uncertain Approved Nucleoplasm Nucleoplasm "HPA020078: , HPA021141: " "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (1.52e-2)" "prognostic unfavourable (1.68e-4)" "unprognostic (8.64e-2)" "unprognostic (1.67e-3)" "unprognostic (7.90e-4)" "unprognostic (4.53e-2)" "unprognostic (1.70e-3)" "unprognostic (8.60e-3)" "unprognostic (8.04e-2)" "unprognostic (6.99e-2)" "unprognostic (1.89e-12)" "unprognostic (3.97e-3)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (1.49e-3)" 3.0 3.0 2.8 15.6 4.0 14.9 3.9 2.3 5.1 3.2 5.9 3.7 4.3 3.3 2.1 11.1 9.0 2.4 4.7 2.8 2.9 2.5 3.4 11.2 3.3 11.9 2.3 3.2 1.8 3.8 2.6 8.6 4.4 4.8 4.6 7.6 7.3 8.8 3.7 2.7 8.8 6.9 1.6 2.8 8.5 3.4 27.5 2.2 24.3 3.4 11.3 13.7 2.6 5.2 5.1 2.2 1.1 1.4 1.2 2.1 1.0 16.1 8.5 9.5 7.3 2.3 3.3 13.9 11.6 4.3 7.3 7.9 10.3 8.5 19.5 4.6 4.7 11.4 9.4 8.4 10.6 11.4 6.1 10.5 9.4 5.9 1.6 11.9 10.7 2.2 3.3 9.4 5.7 4.8 11.6 12.8 12.0 9.5 9.3 11.2 6.7 4.3 10.7 21.8 7.1 4.2 10.6 10.3 13.6 5.9 10.1 4.7 6.6 5.3 5.6 15.3 7.0 8.4 12.3 7.9 13.9 29.6 6.8 12.5 9.9 0.3 1.4 1.1 1.1 1.1 0.9 5.1 1.2 2.1 2.0 2.9 1.3 1.4 0.7 1.2 1.3 2.2 1.7 1.0 2.8 4.0 2.3 5.1 2.9 2.5 2.3 3.2 4.8 2.2 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.0 12.8 9.0 13.3 4.6 3.2 28.5 7.3 5.1 9.3 9.3 34.9 32.6 9.6 7.6 4.1 16.6 10.1 7.9 4.0 3.9 17.3 5.3 10.1 19.7 10.3 9.0 9.8 4.9 9.5 8.1 5.3 7.3 34.1 8.9 5.2 19.8 6.8 21.7 32.3 19.3 14.4 1.5 10.3 8.2 15.4 16.3 17.6 6.7 24.6 10.5 18.7 16.0 7.3 6.9 15.4 15.8 9.9 13.5 8.4 12.4 7.1 15.5 17.3 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 GFM1 "EFGM, EGF1, GFM" ENSG00000168827 "G elongation factor mitochondrial 1" Q96RP9 3 158644278-158692575 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034764, HPA034765, HPA061405" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (5.48e-3)" "unprognostic (4.48e-3)" "unprognostic (1.84e-1)" "unprognostic (3.40e-1)" "unprognostic (4.75e-2)" "unprognostic (6.05e-2)" "unprognostic (2.48e-1)" "unprognostic (8.36e-2)" "prognostic unfavourable (9.20e-4)" "unprognostic (2.79e-1)" "prognostic favourable (1.16e-7)" "unprognostic (1.62e-1)" "unprognostic (4.78e-1)" "unprognostic (3.32e-2)" "unprognostic (8.78e-2)" 20.1 23.3 17.6 14.1 18.6 14.7 19.8 32.8 23.4 11.4 20.7 17.8 19.1 18.8 15.4 17.9 16.2 14.3 12.6 27.9 18.0 17.9 34.1 42.2 13.5 13.2 18.9 19.5 13.2 17.0 30.9 16.4 17.4 22.6 15.3 23.3 13.8 16.3 15.4 46.5 15.4 16.0 16.0 18.5 14.2 17.1 19.8 17.8 14.5 21.4 17.6 13.6 15.0 13.2 13.2 16.5 10.8 19.8 16.0 21.1 11.5 30.4 17.5 8.5 10.2 13.6 8.9 11.4 15.7 13.8 22.0 17.2 23.3 18.8 26.1 19.9 11.7 18.5 19.0 14.6 24.6 14.5 12.8 21.7 11.9 12.9 15.5 27.8 11.8 12.3 17.3 14.2 13.2 14.7 22.5 16.0 20.0 16.8 16.3 11.1 19.2 11.8 15.9 10.2 42.0 17.5 12.8 15.4 14.9 24.8 33.6 26.7 41.4 22.7 10.8 14.7 7.3 23.0 24.8 30.9 19.4 47.5 13.9 23.4 16.4 10.8 13.2 9.1 16.1 19.8 21.1 13.2 15.0 16.9 16.5 11.9 17.6 18.5 1.9 16.0 14.0 8.6 11.9 11.5 17.6 18.6 32.8 23.4 18.0 17.9 18.9 19.5 22.6 17.8 GFM2 "EFG2, FLJ21661" ENSG00000164347 "G elongation factor mitochondrial 2" Q969S9 5 74721204-74767371 "Predicted intracellular proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036863, HPA069871" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036863: , HPA069871: " "unprognostic (2.58e-3)" "unprognostic (7.04e-2)" "unprognostic (8.54e-3)" "unprognostic (1.98e-1)" "unprognostic (4.49e-2)" "unprognostic (2.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.64e-1)" "unprognostic (1.40e-1)" "unprognostic (3.80e-2)" "unprognostic (2.10e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.33e-5)" "unprognostic (9.55e-2)" "unprognostic (4.15e-1)" "unprognostic (8.52e-3)" "unprognostic (9.82e-2)" 9.7 23.8 14.7 8.7 22.4 12.1 13.1 14.2 24.8 10.7 12.8 12.7 17.8 8.3 12.3 16.8 13.0 21.6 8.7 29.5 18.5 15.6 21.9 30.8 9.1 10.3 13.8 18.1 11.6 12.9 19.8 24.9 12.9 20.4 12.5 15.3 11.6 15.7 11.2 26.4 10.5 10.3 10.4 11.7 10.3 16.3 13.7 10.4 18.0 12.3 12.8 14.2 12.3 12.6 8.3 6.1 17.1 9.8 15.6 7.4 4.6 19.9 17.1 14.4 27.3 11.0 14.9 14.7 22.0 13.4 22.5 24.1 18.7 13.0 20.7 23.5 11.6 16.7 29.0 30.7 29.3 18.2 17.0 12.2 17.3 12.8 14.0 11.9 13.5 16.7 13.7 17.8 21.4 15.2 20.5 17.2 25.5 11.2 16.4 7.3 5.9 15.5 20.6 23.6 23.5 16.4 12.8 24.3 13.1 25.4 19.6 21.7 17.0 20.7 12.1 8.6 14.8 10.9 13.9 10.0 19.3 20.9 13.2 17.0 13.1 17.1 6.3 8.0 6.6 6.5 6.4 8.3 5.4 7.2 6.1 7.0 7.4 7.2 3.3 15.6 9.8 4.0 6.2 4.6 14.7 22.4 14.2 24.8 18.5 15.6 13.8 18.1 20.4 10.4 GFOD1 "ADG-90, C6orf114, FLJ20330" ENSG00000145990 "Glucose-fructose oxidoreductase domain containing 1" Q9NXC2 6 13357830-13487662 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.4;HMC-1: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 12.8;NK-cell: 11.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.8;NK-cells: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029096 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted - unknown location" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029096: AB_10602320" "unprognostic (5.00e-2)" "unprognostic (1.34e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.29e-5)" "unprognostic (8.49e-2)" "unprognostic (1.95e-3)" "unprognostic (1.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.34e-2)" "unprognostic (3.11e-2)" "unprognostic (6.49e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (6.72e-5)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (4.66e-3)" 15.7 3.8 9.4 4.6 11.5 17.5 8.7 28.5 22.3 5.4 5.0 4.0 0.5 3.5 4.0 2.6 12.1 4.3 11.8 18.5 11.9 7.1 2.1 6.6 8.2 6.6 6.3 14.2 1.7 2.3 3.9 3.3 6.8 6.6 4.4 5.2 1.5 3.4 3.0 15.5 4.7 5.6 8.3 4.2 12.0 8.2 1.5 4.1 1.9 3.9 4.5 6.9 4.7 7.6 2.3 0.2 12.8 0.8 11.4 1.4 0.8 7.2 0.7 0.6 1.3 1.1 1.1 0.8 0.6 0.3 0.4 0.2 0.2 0.5 9.9 10.4 0.7 6.5 2.0 3.1 0.4 0.7 3.7 18.4 3.8 3.8 1.5 5.2 28.5 0.6 2.5 0.9 2.7 5.6 0.5 0.9 0.8 2.3 1.2 3.2 1.0 2.1 4.0 1.3 5.1 0.3 1.4 3.4 0.6 2.4 0.4 2.3 0.6 0.5 7.5 0.9 2.0 2.1 3.3 8.3 4.7 11.9 0.8 3.1 0.2 0.1 0.4 12.8 1.4 0.7 0.2 2.3 0.2 0.6 0.2 1.9 0.1 0.5 0.3 11.4 0.8 0.0 0.1 0.8 9.4 11.5 28.5 18.7 11.9 7.1 6.3 14.2 6.6 4.1 GFPT1 "GFA, GFAT, GFAT1, GFPT" ENSG00000198380 "Glutamine--fructose-6-phosphate transaminase 1" Q06210 2 69319769-69387254 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms" "Aminotransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047240 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA047240: " "unprognostic (4.38e-3)" "unprognostic (8.20e-2)" "prognostic favourable (7.13e-5)" "unprognostic (2.97e-1)" "unprognostic (1.32e-1)" "unprognostic (2.40e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (2.99e-1)" "unprognostic (3.14e-1)" "unprognostic (4.84e-2)" "unprognostic (5.00e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.78e-1)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" 16.7 11.4 6.4 12.7 7.8 5.6 18.3 7.8 10.1 16.8 27.0 6.4 41.2 14.5 10.1 18.7 11.6 9.5 19.4 11.3 6.0 9.8 17.8 49.1 14.1 4.7 6.5 5.7 11.1 34.9 13.9 39.6 36.5 7.0 17.2 27.5 7.7 39.7 34.0 9.2 6.1 28.2 8.7 6.2 8.2 24.6 13.9 4.8 8.5 35.2 7.7 18.1 10.6 16.2 5.6 4.1 5.9 3.4 4.1 6.8 3.0 9.5 6.6 8.5 5.3 24.0 16.5 18.5 18.2 17.0 8.6 11.0 21.2 8.7 8.6 6.7 16.9 4.6 10.7 5.6 14.3 7.8 4.1 10.0 4.9 21.8 28.4 6.8 4.0 10.4 27.3 16.7 32.0 8.0 8.3 14.0 16.8 5.6 7.2 7.1 11.1 5.5 7.2 17.8 4.4 14.0 7.6 5.3 3.0 6.8 12.6 24.4 5.0 4.3 12.2 7.7 10.3 13.2 8.7 10.0 6.7 6.5 12.5 4.6 8.8 5.9 2.8 3.4 6.8 3.2 6.5 5.6 6.1 6.6 3.6 3.4 6.1 5.6 1.3 4.1 3.4 4.1 4.3 3.0 6.4 7.8 7.8 10.1 6.0 9.8 6.5 5.7 7.0 4.8 GFRA1 "GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1" ENSG00000151892 "GDNF family receptor alpha 1" P56159 10 116056925-116273467 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 16.7;BJ hTERT+ SV40 Large T+ RasG12V: 29.2;EFO-21: 17.8;fHDF/TERT166: 32.3;HBF TERT88: 24.4;MCF7: 21.3;U-251 MG: 19.9" "Cancer enriched" "Detected in many" 11 "breast cancer: 40.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043829 Uncertain Approved "Nucleoplasm,Golgi apparatus" 89000 "Golgi apparatus" Nucleoplasm "HPA043829: " "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (7.60e-2)" "unprognostic (1.06e-3)" "unprognostic (4.10e-2)" "unprognostic (6.95e-3)" "unprognostic (2.35e-3)" "unprognostic (1.48e-3)" "unprognostic (3.16e-1)" "unprognostic (2.06e-3)" "unprognostic (1.31e-2)" "unprognostic (2.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.20e-3)" "unprognostic (1.69e-1)" "unprognostic (2.27e-2)" "unprognostic (3.64e-2)" 24.0 4.3 6.3 9.5 13.8 0.3 26.8 0.8 8.4 12.5 14.9 1.8 5.9 2.2 6.7 23.4 11.1 12.7 11.5 6.4 4.8 6.7 7.0 21.9 3.2 7.4 9.5 2.7 10.0 7.3 2.2 3.9 0.3 2.9 12.1 4.8 3.4 5.4 6.6 7.5 6.8 7.2 9.8 3.4 5.8 7.8 5.3 1.9 2.6 2.6 10.7 8.1 10.5 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.7 0.0 0.0 0.0 0.0 2.9 0.1 16.7 29.2 0.0 0.0 0.0 17.8 32.3 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 4.2 0.0 0.0 0.0 0.0 2.2 21.3 2.6 0.0 1.8 0.0 0.0 0.7 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 19.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 13.8 0.8 4.6 4.8 6.7 9.5 2.7 2.9 1.9 GGT7 "D20S101, dJ18C9.2, GGTL3, GGTL5" ENSG00000131067 "Gamma-glutamyltransferase 7" Q9UJ14 20 34844720-34872860 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013204, HPA013339" Approved Approved Nucleoplasm,Vesicles 1500000 Vesicles Nucleoplasm "HPA013204: AB_1850347, HPA013339: " "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (9.31e-2)" "prognostic unfavourable (1.26e-5)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.46e-3)" "unprognostic (2.49e-2)" "unprognostic (3.49e-1)" "unprognostic (1.16e-2)" "unprognostic (3.34e-3)" "unprognostic (3.61e-2)" "unprognostic (5.00e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-1)" "unprognostic (5.50e-2)" "unprognostic (2.00e-1)" 6.8 6.7 21.6 6.7 23.7 2.9 8.5 42.6 29.1 9.5 11.5 9.7 14.3 9.8 12.3 19.5 6.4 10.5 11.4 13.8 19.7 17.0 9.9 7.2 9.0 10.3 11.2 32.1 13.4 19.5 20.8 18.3 8.5 19.2 11.4 9.6 6.9 18.8 15.3 31.6 11.1 9.0 9.6 11.0 8.3 12.9 5.0 15.6 4.9 16.3 4.3 8.2 9.3 8.5 6.1 2.6 1.5 3.0 3.2 12.8 1.8 2.2 3.3 17.0 17.4 13.4 12.0 15.1 9.4 9.6 7.8 11.6 17.4 11.1 0.0 11.2 7.3 1.5 7.3 4.1 5.1 0.7 13.1 6.7 5.9 9.1 12.0 0.3 11.1 17.4 4.7 8.7 4.0 0.6 5.0 1.2 5.3 3.8 1.7 3.4 3.9 1.7 0.0 11.6 10.7 11.3 3.3 9.9 11.6 4.8 7.7 12.1 5.9 6.1 0.2 26.8 10.7 2.5 5.3 13.1 1.7 0.8 31.5 0.6 9.8 1.5 3.0 1.4 7.4 2.0 2.1 5.6 6.3 2.8 2.6 6.1 12.8 8.9 0.3 3.2 0.7 1.4 4.8 1.8 21.6 23.7 42.6 29.1 19.7 17.0 11.2 32.1 19.2 15.6 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: " "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favourable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 6.0 9.3 5.0 5.7 9.5 1.4 8.0 15.0 9.6 9.0 7.0 6.5 6.1 4.9 7.0 5.6 7.2 6.4 3.7 12.7 5.8 5.1 7.9 8.3 5.6 6.6 14.0 4.2 11.0 6.0 8.4 17.4 5.1 9.4 8.3 6.7 3.6 6.1 7.6 14.6 4.5 5.9 5.8 11.4 6.9 6.3 9.3 10.8 8.6 9.1 6.1 6.7 9.4 9.5 4.6 3.3 4.8 7.1 3.7 8.3 2.8 5.4 5.8 7.4 5.4 3.5 9.1 6.0 7.3 5.0 5.5 4.9 3.5 7.0 3.3 6.9 2.8 6.4 6.9 10.2 7.4 4.1 5.5 4.7 5.7 3.9 7.3 4.2 3.1 3.6 11.4 5.0 10.3 4.3 4.2 4.8 8.6 3.9 5.8 2.8 6.3 9.2 5.2 8.5 8.4 7.2 4.5 6.0 4.4 4.8 4.0 6.9 11.8 6.4 3.5 5.6 3.4 6.0 5.5 5.8 4.7 4.7 7.1 6.7 4.5 0.4 2.7 4.8 3.4 3.4 3.9 4.6 4.6 5.0 3.3 3.8 5.6 5.6 3.8 3.7 7.1 3.2 8.3 2.8 5.0 9.5 15.0 9.6 5.8 5.1 14.0 4.2 9.4 10.8 GINS1 "KIAA0186, PSF1" ENSG00000101003 "GINS complex subunit 1" Q14691 20 25407727-25452628 "Predicted intracellular proteins" "DNA replication" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1;testis: 21.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051185 Uncertain Approved Nucleoplasm Nucleoplasm "HPA051185: AB_2681378" "unprognostic (6.10e-3)" "unprognostic (2.58e-1)" "unprognostic (5.37e-3)" "unprognostic (1.74e-3)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (4.61e-7)" "unprognostic (5.86e-3)" "unprognostic (1.42e-2)" "unprognostic (1.32e-2)" "prognostic unfavourable (5.62e-4)" "unprognostic (1.44e-1)" "prognostic unfavourable (5.42e-11)" "unprognostic (5.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (2.55e-1)" 1.5 1.9 4.1 11.7 4.2 4.5 2.2 7.4 4.3 2.2 4.5 1.3 0.0 4.3 2.2 1.0 8.5 1.4 2.3 1.0 2.2 2.2 2.2 2.0 1.4 7.2 1.9 2.1 1.7 1.8 1.1 0.8 5.5 2.2 1.4 5.9 1.3 2.1 0.7 0.7 5.3 4.1 2.8 1.8 3.4 2.9 21.4 0.9 20.1 1.0 6.4 10.5 2.6 3.2 2.6 2.3 1.3 1.0 1.9 3.5 0.9 17.7 16.2 19.9 12.9 1.1 1.5 20.1 7.9 3.9 15.3 16.2 14.0 17.8 22.0 9.1 3.3 20.7 17.3 14.6 17.8 5.8 6.0 15.1 5.9 16.9 0.4 19.7 6.9 0.7 0.8 14.5 3.0 8.1 14.5 14.5 9.1 19.2 30.2 14.8 13.5 8.5 21.7 22.9 14.8 5.8 12.0 8.3 8.7 8.0 19.3 6.8 18.3 9.9 3.6 12.0 13.0 7.7 14.4 5.8 16.5 17.4 3.2 19.3 13.5 0.8 0.8 0.5 1.5 1.0 0.9 2.6 1.1 0.5 2.1 1.7 0.8 1.4 1.3 1.9 1.0 2.3 3.5 0.9 4.1 4.2 7.4 4.3 2.2 2.2 1.9 2.1 2.2 0.9 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 16.4 15.1 17.4 12.0 21.0 2.0 11.2 12.1 28.8 19.4 51.0 29.7 15.3 14.2 11.9 14.9 71.2 14.4 21.2 17.9 16.9 14.8 18.7 16.9 20.5 7.9 18.3 23.0 10.2 15.1 6.5 12.4 24.0 23.0 14.0 23.9 15.2 22.1 19.6 26.8 40.4 13.3 15.8 21.8 10.8 35.7 6.5 16.6 11.1 18.2 26.0 24.7 17.1 26.3 2.0 4.0 2.4 1.2 1.5 12.1 1.9 65.4 30.4 9.3 14.6 8.6 8.7 7.4 24.6 12.4 20.3 18.4 16.3 24.8 0.9 46.3 17.3 37.6 8.0 20.6 6.9 6.8 14.2 12.8 20.8 15.8 26.5 1.3 15.8 10.0 20.6 12.3 10.8 13.6 5.9 11.3 10.2 48.8 4.2 2.6 10.1 30.5 4.3 7.8 8.7 25.0 57.4 8.7 9.7 13.7 33.9 31.5 21.3 7.1 23.5 28.7 15.8 40.0 26.2 10.6 13.4 3.3 24.0 10.4 30.1 2.4 0.8 0.1 5.8 1.2 5.4 2.0 5.9 5.9 1.2 1.0 4.9 3.9 0.3 1.5 0.5 4.0 12.1 1.9 17.4 21.0 12.1 28.8 16.9 14.8 18.3 23.0 23.0 16.6 GIPC2 "FLJ20075, SEMCAP-2" ENSG00000137960 "GIPC PDZ domain containing family member 2" Q8TF65 1 77979542-78138449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.1;HaCaT: 4.8;Hep G2: 17.9;HUVEC TERT2: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.9;naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 17 "T-cells: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051212, HPA062684" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051212: , HPA062684: " "unprognostic (1.72e-2)" "unprognostic (9.37e-2)" "prognostic favourable (5.49e-4)" "unprognostic (1.09e-2)" "unprognostic (1.43e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.35e-1)" "unprognostic (7.63e-2)" "unprognostic (2.22e-1)" "unprognostic (5.91e-2)" "unprognostic (1.44e-1)" "prognostic favourable (2.11e-6)" "unprognostic (6.55e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-2)" "unprognostic (1.29e-1)" 6.4 17.0 0.8 3.2 0.9 0.0 4.0 0.4 1.0 2.6 27.0 0.3 0.2 19.6 5.4 4.5 5.7 1.4 8.1 3.1 0.5 0.5 21.3 10.4 3.2 2.2 0.5 0.3 3.7 24.7 3.3 2.5 1.6 1.3 2.1 7.8 1.5 6.9 1.0 1.8 2.7 64.0 1.4 0.6 22.7 3.0 2.2 0.4 0.1 1.5 4.9 1.4 2.5 5.1 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 5.1 0.0 0.8 0.0 0.4 0.9 4.0 2.6 1.2 0.0 0.4 4.8 0.0 0.0 2.6 0.1 0.0 0.6 0.0 17.9 1.0 0.0 0.0 0.8 0.0 2.8 0.1 18.9 0.0 0.1 2.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 1.0 0.6 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 1.0 0.5 0.5 0.5 0.3 1.3 0.4 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585553-3593541 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 12.0;HMC-1: 7.8;THP-1: 14.5;WM-115: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Lineage enriched" "Detected in single" 9 "T-cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" 13000 Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 5.5 2.4 1.3 1.3 1.3 0.0 3.0 1.3 1.3 3.4 1.5 1.9 5.0 1.0 4.5 3.2 6.0 2.2 2.1 2.7 1.3 0.6 4.1 1.6 4.5 2.0 1.3 1.3 1.3 1.3 4.6 1.3 1.3 1.3 4.3 1.3 1.9 1.3 5.2 1.3 1.1 5.4 9.3 1.3 4.8 2.0 1.3 2.2 2.0 3.8 1.3 1.4 1.3 13.0 0.1 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 1.0 0.0 0.1 4.3 12.0 0.0 0.4 0.0 7.8 0.1 0.0 0.7 0.0 1.3 1.9 0.0 0.2 0.0 0.0 0.7 0.4 0.7 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 3.0 0.0 14.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.3 1.3 1.3 1.3 1.3 0.6 1.3 1.3 1.3 2.2 GJA1 "CX43, GJAL, ODD, ODDD, ODOD, SDTY3" ENSG00000152661 "Gap junction protein alpha 1" P17302 6 121435692-121449727 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 48.8;HUVEC TERT2: 61.6;NTERA-2: 62.7;TIME: 45.3;U-87 MG: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010753, HPA035097, HPA047551, HPA069245" Enhanced Supported Supported "Nucleoplasm,Vesicles,Cell Junctions" "Vesicles, Cell Junctions" Nucleoplasm "CAB010753: AB_476857, HPA035097: , HPA047551: , HPA069245: " "unprognostic (3.37e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-1)" "unprognostic (4.18e-2)" "unprognostic (1.48e-2)" "unprognostic (1.67e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (2.89e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.00e-1)" "unprognostic (4.88e-2)" "prognostic unfavourable (4.99e-5)" "unprognostic (2.39e-1)" "unprognostic (1.29e-1)" "unprognostic (3.00e-3)" 19.7 65.2 78.6 5.5 69.7 0.4 14.2 32.4 44.4 64.5 4.0 23.8 6.1 4.2 23.5 5.5 17.3 7.8 23.0 36.0 87.3 25.5 3.6 2.5 15.2 4.4 42.9 39.9 10.5 4.5 94.7 5.7 63.8 53.7 20.0 4.8 26.3 7.1 35.7 3.4 86.3 4.4 25.6 38.7 1.1 6.4 8.3 64.3 0.5 38.9 9.9 7.6 14.8 32.2 0.5 0.5 0.4 0.5 0.0 0.4 0.0 0.0 7.2 32.1 0.0 17.5 10.9 0.0 24.0 48.8 8.1 19.8 0.1 0.0 0.0 2.7 9.3 3.1 0.8 14.7 26.4 0.0 8.8 0.3 2.9 0.0 21.9 0.0 0.0 29.0 15.9 29.6 10.7 61.6 0.0 0.7 1.6 1.3 0.0 12.9 62.7 8.0 0.0 0.0 0.6 32.4 3.5 0.0 0.5 0.0 0.0 0.0 2.5 0.0 45.3 25.0 6.9 21.1 15.5 0.0 0.0 0.0 61.0 0.0 3.5 0.4 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.2 0.5 0.4 0.4 0.0 0.0 0.1 0.5 0.1 0.0 78.6 69.7 32.4 42.8 87.3 25.5 42.9 39.9 53.7 64.3 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5 (putative)" Q6ZS86 3 142157527-142225607 "Enzymes, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: " "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 6.1 12.2 5.6 5.7 7.2 10.8 10.9 9.0 9.4 11.5 10.9 8.4 11.5 14.4 10.9 14.8 7.9 7.2 8.3 5.4 5.5 4.1 5.7 3.1 6.2 3.5 9.3 6.0 11.5 4.8 5.4 20.3 3.7 12.6 13.5 11.8 6.7 14.8 14.7 5.0 8.8 14.0 9.4 11.6 3.5 8.1 6.2 5.3 4.6 7.4 4.2 6.1 8.5 6.7 1.3 1.1 3.6 5.3 3.8 3.8 0.5 10.9 2.7 4.0 2.7 8.3 15.8 6.9 3.6 2.5 4.0 2.5 4.2 6.1 7.9 3.3 3.5 4.7 4.5 3.5 5.3 2.8 4.4 5.1 6.6 3.1 4.5 5.8 6.9 6.5 3.1 2.6 3.5 2.3 4.5 4.8 7.3 7.0 5.1 4.9 2.6 3.2 4.9 4.2 2.9 4.2 6.9 3.9 2.9 10.1 10.7 3.2 14.9 3.9 2.5 3.2 2.7 7.0 4.0 5.1 4.8 8.1 5.8 3.7 5.4 3.6 1.1 0.7 3.8 0.9 1.9 0.5 1.3 1.4 0.8 1.3 1.0 1.7 3.2 3.8 5.3 1.1 0.6 0.5 5.6 7.2 9.0 9.4 5.5 4.1 9.3 6.0 12.6 5.3 GLI4 "HKR4, ZNF928" ENSG00000250571 "GLI family zinc finger 4" P10075 8 143267433-143276931 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023131 Uncertain Approved "Nucleoplasm,Cytokinetic bridge" "Nucleoplasm, Cytokinetic bridge" "HPA023131: " "unprognostic (4.98e-2)" "unprognostic (2.69e-1)" "unprognostic (5.64e-3)" "unprognostic (1.65e-1)" "unprognostic (9.07e-2)" "unprognostic (2.71e-2)" "unprognostic (1.00e-2)" "unprognostic (4.57e-2)" "unprognostic (2.22e-1)" "unprognostic (2.65e-1)" "unprognostic (7.45e-3)" "unprognostic (5.03e-1)" "unprognostic (6.88e-3)" "unprognostic (4.61e-2)" "unprognostic (1.23e-1)" "unprognostic (3.21e-2)" "unprognostic (3.71e-3)" 13.5 5.7 14.9 15.7 17.6 11.6 10.6 12.8 12.0 10.0 12.0 13.7 13.7 14.2 10.0 6.9 10.7 8.3 8.9 8.5 16.4 12.4 9.6 11.2 9.6 13.9 10.3 11.6 11.0 18.4 8.0 7.4 5.0 8.5 9.7 8.6 13.5 20.0 14.0 10.3 13.8 13.4 11.8 9.7 13.4 11.6 11.6 6.9 12.0 10.6 12.8 17.1 9.0 8.2 1.5 3.5 0.9 1.1 3.4 2.2 0.6 4.8 10.0 4.7 7.4 7.8 3.2 5.3 2.9 1.8 2.2 2.6 2.8 14.3 6.3 5.5 4.8 6.4 2.6 3.2 1.5 11.1 7.6 9.7 4.7 3.3 5.5 3.0 3.3 10.0 1.7 3.0 6.5 4.7 5.1 10.7 6.0 13.2 14.0 2.5 4.3 14.1 8.5 2.2 6.4 5.2 11.1 4.5 5.4 8.7 3.8 5.9 16.6 1.4 2.7 3.3 9.3 4.7 3.0 14.2 6.6 5.0 5.4 5.8 5.4 0.0 1.1 0.0 1.4 1.0 2.2 1.5 1.6 0.9 0.6 1.4 2.0 1.0 0.9 3.4 0.0 3.5 2.1 0.6 14.9 17.6 12.8 12.0 16.4 12.4 10.3 11.6 8.5 6.9 GLIS2 NPHP7 ENSG00000126603 "GLIS family zinc finger 2" Q9BZE0 16 4314761-4339597 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Ciliopathy, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 27.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056976 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA056976: " "unprognostic (2.86e-1)" "unprognostic (3.27e-2)" "unprognostic (5.96e-2)" "prognostic unfavourable (1.59e-5)" "unprognostic (3.76e-1)" "unprognostic (5.15e-2)" "unprognostic (8.13e-2)" "unprognostic (6.65e-2)" "unprognostic (3.94e-1)" "unprognostic (2.37e-3)" "unprognostic (3.59e-1)" "unprognostic (2.48e-1)" "prognostic favourable (8.06e-6)" "unprognostic (1.59e-3)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (4.40e-3)" 3.6 6.0 1.5 2.3 1.6 0.0 2.4 4.3 2.4 5.0 4.4 1.2 5.8 1.0 1.2 4.3 7.4 8.4 0.9 1.2 11.5 0.3 7.8 1.4 1.4 8.0 3.2 2.2 5.3 5.7 5.6 0.2 3.0 5.8 1.1 1.5 1.2 4.3 0.2 0.8 2.7 1.9 5.3 0.5 5.6 2.7 0.3 0.0 0.2 0.0 0.0 0.1 0.0 4.0 10.4 1.7 3.8 1.4 5.6 3.5 4.4 4.2 1.6 1.2 2.8 2.9 0.0 7.7 4.8 2.5 1.0 4.5 0.1 4.6 0.0 0.0 7.9 1.4 6.1 0.0 0.8 3.3 1.1 1.4 0.7 1.5 0.3 1.8 1.1 2.6 0.1 0.8 3.7 1.8 6.7 2.3 4.7 0.0 0.1 0.7 3.6 5.1 2.2 1.0 6.1 0.7 3.4 2.3 3.9 27.5 1.3 0.8 0.5 1.2 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GLMN "FAP48, FKBPAP, GLML, GVM, VMGLOM" ENSG00000174842 "Glomulin, FKBP associated protein" Q92990 1 92246402-92298987 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031446, HPA031448" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA031446: , HPA031448: " "unprognostic (4.20e-2)" "unprognostic (3.47e-2)" "prognostic favourable (1.71e-4)" "unprognostic (7.37e-2)" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "prognostic unfavourable (2.42e-5)" "unprognostic (7.32e-2)" "unprognostic (2.07e-3)" "unprognostic (4.59e-2)" "unprognostic (9.88e-2)" "unprognostic (1.81e-2)" "prognostic unfavourable (5.89e-8)" "unprognostic (7.33e-2)" "unprognostic (5.21e-2)" "unprognostic (1.89e-1)" "unprognostic (3.58e-1)" 4.9 6.6 12.5 8.1 14.8 9.0 10.3 21.3 19.5 7.4 6.8 6.6 5.1 5.1 11.5 8.6 10.1 6.3 5.7 7.2 9.4 6.9 6.4 5.2 5.3 10.6 6.8 13.2 8.3 4.7 8.5 13.6 7.9 8.6 7.6 7.3 13.9 4.9 6.9 7.5 13.5 6.6 6.9 8.0 7.6 5.8 11.2 5.7 13.3 9.0 4.8 12.1 7.9 6.9 2.5 2.0 1.4 1.4 9.0 5.5 1.9 12.1 4.7 15.7 8.6 5.6 8.8 14.5 8.5 7.0 10.6 9.5 9.6 4.8 12.3 13.7 5.0 9.3 8.2 7.7 15.3 8.7 11.6 16.4 9.3 9.5 5.5 20.7 8.6 6.8 4.5 12.4 5.6 11.4 13.6 7.6 13.9 2.8 12.7 15.8 23.9 8.5 11.0 21.6 8.5 12.0 11.8 14.5 7.5 14.7 14.0 8.8 6.7 20.0 7.1 7.7 7.5 13.2 12.7 6.7 9.1 15.5 2.9 21.0 4.5 0.0 0.7 1.4 3.2 1.4 5.5 2.5 3.5 3.9 2.0 1.5 3.1 3.6 0.2 9.0 0.8 1.4 2.7 1.9 12.5 14.8 21.3 19.5 9.4 6.9 6.8 13.2 8.6 5.7 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol 3800000 Cytosol "Nucleoplasm, Nucleoli" "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favourable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 21.7 29.5 31.3 16.7 35.6 10.2 19.1 26.0 36.2 17.8 37.1 21.5 16.5 43.0 22.3 23.3 23.6 24.9 20.9 19.7 26.1 38.5 41.6 40.4 16.8 22.8 23.0 34.8 22.9 32.3 13.9 19.4 28.1 28.6 21.1 26.6 21.9 29.2 20.9 21.4 27.5 42.5 24.7 18.2 23.8 43.4 17.9 18.2 22.7 26.0 19.2 24.0 25.2 17.5 27.5 17.9 17.8 24.6 22.8 36.7 26.0 40.3 36.6 42.2 23.3 18.6 18.5 25.8 32.4 19.9 26.3 20.0 29.6 29.0 48.2 35.3 14.5 29.3 36.8 20.5 27.5 35.3 31.4 23.2 20.3 38.7 18.5 23.9 30.7 12.9 28.6 26.4 23.2 24.2 37.9 31.4 27.7 24.9 41.0 18.4 30.9 12.5 41.1 17.1 22.1 25.9 27.6 19.3 32.4 25.7 18.6 41.5 23.1 25.4 31.5 25.1 20.1 35.1 40.5 17.7 32.2 29.6 29.8 26.9 26.2 9.2 19.8 17.8 27.7 24.2 30.2 27.0 33.6 33.3 17.5 27.5 28.7 31.3 2.7 22.8 24.6 17.9 36.7 26.0 31.3 35.6 26.0 36.2 26.1 38.5 23.0 34.8 28.6 18.2 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favourable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.4 12.3 24.7 18.0 26.7 33.4 18.5 31.2 23.0 22.7 28.4 14.2 27.0 28.0 14.8 30.7 11.3 24.9 21.6 36.0 10.1 8.6 14.0 13.9 13.1 22.8 19.5 12.3 25.3 20.3 19.7 19.5 20.4 10.2 9.9 35.9 15.1 11.9 7.6 15.9 13.1 12.1 29.0 8.1 29.0 29.0 14.7 22.8 21.7 18.5 23.6 20.4 15.5 16.1 33.0 25.1 16.7 19.3 3.5 6.2 17.5 27.8 12.1 20.8 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5" "Cell line enhanced" "Detected in some" "HMC-1: 77.0;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 1500000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favourable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavourable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 22.6 6.1 7.3 29.6 7.4 80.9 16.8 2.2 4.8 6.0 8.8 4.0 1.7 5.3 4.4 9.4 6.4 7.3 8.7 7.5 6.0 4.9 9.4 9.7 28.5 42.2 8.6 2.3 4.7 3.6 1.1 3.1 18.0 5.8 6.1 7.9 4.9 8.1 2.3 5.4 4.2 17.8 6.8 8.2 86.0 5.9 2.9 5.6 109.5 9.8 7.0 37.1 11.1 7.5 39.1 57.2 276.5 79.4 41.6 88.0 106.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.8 33.5 0.3 0.0 0.2 0.0 0.1 0.1 11.3 0.0 36.5 0.0 0.5 0.6 39.0 77.0 0.1 0.0 0.0 0.1 2.0 1.3 59.8 0.3 0.0 35.5 43.6 0.0 0.0 49.0 0.4 21.9 0.0 5.2 0.1 0.0 0.1 0.2 0.2 0.1 76.8 20.0 0.0 0.4 0.1 0.1 3.4 11.6 38.3 0.2 52.7 0.3 185.2 79.4 178.1 37.7 72.3 40.0 39.1 56.7 46.6 57.2 35.0 55.9 46.4 276.5 41.6 78.9 22.2 88.0 106.7 7.3 7.4 2.2 4.8 6.0 4.9 8.6 2.3 5.8 5.6 GMPPA ENSG00000144591 "GDP-mannose pyrophosphorylase A" Q96IJ6 2 219498867-219506989 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035512, HPA035513" Approved Approved Nucleoplasm 17000 Nucleoplasm "HPA035512: , HPA035513: AB_10671934" "unprognostic (3.43e-1)" "unprognostic (3.95e-2)" "unprognostic (7.75e-3)" "unprognostic (1.40e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (5.57e-1)" "unprognostic (2.39e-1)" "unprognostic (2.25e-1)" "unprognostic (1.17e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.90e-10)" "prognostic favourable (5.24e-4)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (2.28e-1)" 12.0 15.8 10.3 13.6 14.7 9.9 12.9 10.2 14.6 21.1 17.7 16.5 23.2 17.1 16.7 44.3 14.8 14.6 12.0 16.2 10.4 7.0 22.5 54.1 12.8 11.0 15.8 11.5 12.7 39.8 17.6 28.8 21.4 12.2 21.2 20.0 12.6 37.4 20.3 12.6 10.2 23.6 16.0 13.2 21.1 17.6 9.6 14.3 8.9 24.8 8.1 18.4 13.7 13.5 16.6 21.8 29.2 27.0 17.2 18.4 16.0 13.9 11.5 7.1 12.6 27.5 24.5 19.0 24.4 32.7 28.7 35.8 21.0 13.3 7.6 17.4 35.2 13.2 13.2 21.0 25.0 14.7 11.3 14.8 11.8 37.4 24.9 7.7 17.4 18.7 17.1 26.9 30.7 17.5 26.1 22.1 22.2 17.4 7.5 14.5 7.3 12.5 6.0 7.6 13.6 16.4 9.5 9.2 8.0 10.2 15.5 16.6 10.3 12.4 10.1 16.7 11.6 30.0 13.2 15.3 6.1 9.1 34.1 8.6 18.6 29.2 26.5 17.7 15.8 26.7 18.4 16.6 12.6 16.6 21.7 10.4 9.4 8.7 5.9 17.2 27.0 21.8 16.3 16.0 10.3 14.7 10.2 14.6 10.4 7.0 15.8 11.5 12.2 14.3 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Uncertain Approved Nucleoplasm,Nucleoli 160000 Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: , HPA068782: " "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 18.9 44.2 19.6 14.6 24.2 11.5 26.2 13.6 31.7 22.5 21.1 25.1 20.3 21.3 18.8 26.3 17.8 28.7 23.4 15.0 20.1 21.9 39.1 26.3 19.0 18.1 23.0 21.2 26.1 26.9 49.1 22.4 22.7 26.0 20.3 21.6 21.9 22.6 23.7 16.1 14.4 21.7 18.2 20.3 25.5 21.2 10.6 19.1 21.6 43.0 11.2 21.0 21.8 17.6 7.5 14.4 32.3 14.0 7.6 14.9 11.0 9.0 10.4 14.1 9.2 16.3 23.1 12.8 10.7 19.1 15.1 19.3 12.2 7.2 12.1 9.8 15.7 12.6 15.5 23.2 21.5 11.4 11.4 9.5 6.5 44.5 15.3 15.6 15.0 21.7 16.7 7.9 16.5 24.4 5.5 11.5 15.2 16.9 15.4 14.0 10.9 13.5 11.7 9.5 10.0 20.7 15.0 10.0 14.1 7.7 16.9 14.4 14.7 12.5 12.5 7.1 5.7 9.4 7.8 25.5 24.4 7.9 5.9 11.9 6.9 9.0 14.0 7.2 10.1 11.2 10.7 7.5 10.2 11.2 14.4 7.1 9.1 10.2 32.3 7.6 11.3 6.5 14.9 11.0 19.6 24.2 13.6 31.7 20.1 21.9 23.0 21.2 26.0 19.1 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: " "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavourable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavourable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.5 18.8 0.1 23.4 15.0 8.6 12.5 15.1 11.1 13.7 0.0 3.2 0.1 4.0 13.4 3.0 10.4 12.8 14.7 0.1 9.6 17.6 18.1 1.2 23.7 2.2 3.8 16.1 32.4 5.9 17.1 7.4 1.4 0.0 20.7 0.5 0.1 0.1 5.4 7.4 8.2 7.2 8.8 33.1 9.9 13.8 9.5 13.4 0.2 10.6 2.5 0.4 13.1 24.8 17.5 5.7 4.7 0.1 0.0 0.1 6.5 1.3 11.0 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: " "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favourable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavourable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favourable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavourable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 13.9 4.9 9.5 5.6 9.1 10.9 7.8 10.6 8.5 10.8 10.8 7.5 4.9 7.5 7.1 11.3 7.4 8.9 10.8 15.1 8.4 5.5 6.5 8.5 6.4 7.8 10.2 6.0 8.1 9.2 12.4 8.6 12.9 8.5 7.4 10.7 9.5 7.8 8.3 9.5 5.8 5.6 22.4 4.8 12.0 10.7 6.1 10.7 7.4 8.4 11.6 6.5 9.0 11.7 9.1 12.5 13.6 12.0 7.9 8.9 8.7 15.1 10.1 14.1 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell line enhanced" "Detected in many" "Daudi: 18.0;HeLa: 18.5;U-2 OS: 9.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: " "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 5.9 7.3 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.4 1.1 18.0 1.2 0.1 0.3 6.8 5.7 0.0 3.8 6.2 0.1 18.5 3.6 0.0 0.2 0.4 0.8 8.6 0.0 0.1 0.0 1.6 0.2 0.2 0.2 0.2 0.5 6.0 0.1 0.1 1.0 0.2 0.4 0.2 6.7 0.1 8.5 0.4 2.1 0.2 0.2 1.0 0.7 9.5 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favourable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.6 32.5 54.8 25.5 93.1 42.6 49.2 55.8 51.0 63.9 45.8 94.7 50.1 31.7 86.9 72.5 41.8 50.2 74.3 43.3 20.9 30.2 35.2 49.4 62.0 43.1 20.4 22.2 50.7 37.8 31.0 41.7 48.3 30.9 43.3 42.0 132.2 104.3 50.1 17.4 34.4 64.2 48.0 55.9 51.2 38.2 68.0 155.7 77.6 77.0 62.2 58.9 56.1 53.1 84.8 76.2 30.5 52.5 75.9 49.0 66.9 37.2 10.0 43.2 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.1 27.7 5.7 11.8 5.9 4.0 10.6 6.7 4.9 7.5 6.0 23.4 9.2 15.7 12.9 9.6 10.9 19.2 8.4 10.4 10.8 9.9 15.7 22.2 11.0 4.5 24.4 15.5 5.8 4.0 17.6 10.6 8.1 10.3 15.8 7.5 21.7 13.8 5.1 16.6 15.6 14.9 13.1 15.2 5.7 17.7 9.4 5.6 21.8 13.5 6.3 17.8 6.2 11.5 13.7 13.7 13.2 11.3 11.9 15.2 20.2 7.1 20.2 15.2 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 GOLGA3 "GCP170, golgin-160, MEA-2" ENSG00000090615 "Golgin A3" Q08378 12 132768909-132828858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039809, HPA040044" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039809: AB_10962348, HPA040044: AB_10981600" "unprognostic (1.93e-1)" "unprognostic (7.91e-2)" "unprognostic (6.80e-2)" "unprognostic (1.41e-1)" "unprognostic (2.56e-2)" "unprognostic (4.08e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (1.10e-1)" "unprognostic (7.69e-2)" "unprognostic (1.55e-2)" "prognostic favourable (3.87e-4)" "unprognostic (2.99e-1)" "prognostic unfavourable (6.47e-5)" "unprognostic (1.40e-2)" "unprognostic (1.45e-1)" "unprognostic (2.01e-2)" "unprognostic (1.20e-1)" 17.5 14.2 14.7 17.6 17.0 13.8 14.5 23.7 21.4 20.1 19.9 17.6 20.6 12.3 18.2 20.0 18.3 14.3 20.7 17.0 14.6 16.7 11.2 18.7 15.5 16.0 15.8 13.2 20.5 39.1 16.1 32.1 18.8 16.2 18.0 16.8 14.3 26.9 19.8 20.5 21.4 15.5 24.6 12.9 18.2 22.2 13.9 14.1 9.8 15.3 15.4 18.2 17.1 16.1 7.3 8.0 5.1 4.6 7.3 7.5 3.5 9.7 19.8 7.1 11.9 25.0 16.9 13.1 16.7 12.7 10.5 9.2 18.8 4.4 13.2 9.0 24.6 10.2 7.7 10.1 7.2 3.5 8.9 13.3 20.0 12.2 14.6 14.6 19.6 12.7 12.3 14.2 14.4 10.2 12.9 5.2 10.9 15.0 12.6 13.5 7.3 13.4 10.1 7.9 4.7 6.7 23.2 9.0 5.7 13.8 12.4 7.9 16.1 10.8 20.8 12.4 9.2 13.9 10.7 16.2 13.5 18.0 15.6 8.7 15.8 5.1 4.2 3.6 7.5 4.5 6.6 4.6 5.5 5.9 4.1 7.3 6.3 6.6 3.2 7.3 4.6 8.0 4.5 3.5 14.7 17.0 23.7 21.4 14.6 16.7 15.8 13.2 16.2 14.1 GOLGA4 "GCP2, GOLG, golgin-240, p230" ENSG00000144674 "Golgin A4" Q13439 3 37243177-37366751 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035102, HPA040675" Supported Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035102: AB_10601472, HPA040675: " "unprognostic (9.46e-2)" "unprognostic (1.55e-1)" "unprognostic (1.18e-2)" "unprognostic (5.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.54e-1)" "unprognostic (5.61e-2)" "unprognostic (1.38e-1)" "unprognostic (5.79e-3)" "unprognostic (3.90e-2)" "unprognostic (5.62e-2)" "unprognostic (8.55e-2)" "prognostic favourable (3.62e-6)" "unprognostic (7.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.92e-2)" "unprognostic (1.33e-1)" 22.3 20.6 16.7 14.0 29.0 11.4 30.6 26.9 27.1 19.1 25.1 14.5 29.1 23.9 12.8 18.4 22.0 11.3 16.7 34.3 18.1 12.3 22.1 32.7 15.2 12.2 30.5 12.8 14.8 27.7 27.1 42.8 34.5 18.9 21.1 18.1 20.2 24.8 24.4 64.6 29.8 29.1 19.0 23.9 14.8 21.2 26.0 24.9 10.3 29.9 22.6 11.8 20.5 24.8 10.0 9.9 19.8 11.0 13.0 14.9 3.2 23.4 16.2 8.4 10.6 22.2 19.2 21.4 30.2 25.3 11.9 14.4 13.9 13.1 8.1 7.9 25.6 13.8 13.3 21.4 24.8 10.3 9.8 10.9 14.4 22.1 22.3 11.5 8.0 10.2 20.5 18.8 36.6 17.2 13.3 12.7 19.1 10.0 8.8 5.0 9.1 15.5 2.0 25.5 8.5 14.8 24.7 5.4 7.1 18.7 20.2 23.1 29.7 8.4 20.7 12.2 14.2 23.5 21.5 15.7 11.0 7.1 21.7 10.1 14.3 19.8 5.5 12.0 14.9 6.4 12.5 8.1 9.2 10.3 4.5 10.0 9.6 7.2 7.7 13.0 11.0 9.9 6.0 3.2 16.7 29.0 26.9 27.1 18.1 12.3 30.5 12.8 18.9 24.9 GOLPH3L GPP34R ENSG00000143457 "Golgi phosphoprotein 3 like" Q9H4A5 1 150646225-150697144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "U-698: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028558 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA028558: AB_10601656" "unprognostic (1.21e-1)" "unprognostic (2.61e-1)" "unprognostic (3.76e-3)" "unprognostic (3.24e-1)" "unprognostic (3.24e-2)" "unprognostic (1.82e-1)" "unprognostic (3.18e-2)" "unprognostic (4.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.64e-1)" "unprognostic (9.88e-3)" "unprognostic (2.71e-1)" "unprognostic (3.36e-2)" "unprognostic (1.67e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.93e-2)" 16.5 19.4 16.0 10.2 14.6 4.9 18.6 20.7 16.7 21.6 26.5 10.5 26.2 15.7 19.3 30.0 36.6 24.6 14.8 11.7 10.6 15.5 21.3 13.0 14.5 10.5 12.2 11.0 22.7 30.4 16.8 30.8 14.1 15.9 19.2 32.6 16.5 25.4 22.4 16.1 17.3 20.2 14.9 11.0 15.0 19.5 14.9 12.1 21.1 30.7 11.7 20.8 21.6 22.2 10.6 11.7 7.1 3.1 16.2 13.1 4.9 6.9 6.8 3.8 2.2 9.7 7.0 6.3 6.4 9.9 7.1 10.2 3.0 12.5 8.8 9.3 4.6 6.1 6.3 5.5 8.6 5.9 6.9 9.8 3.7 4.0 8.5 8.0 7.8 4.7 9.4 7.4 16.0 10.4 7.9 5.7 4.1 7.1 6.7 3.4 7.2 6.7 4.7 4.4 10.0 8.2 4.7 5.9 5.5 3.3 9.4 4.6 7.1 8.9 8.2 2.4 3.9 3.1 5.4 7.2 6.2 98.2 6.8 8.3 3.1 7.1 1.5 2.7 9.7 1.3 13.1 10.6 9.8 9.5 8.1 8.8 12.9 9.6 1.3 16.2 3.1 11.7 10.3 4.9 16.0 14.6 20.7 16.7 10.6 15.5 12.2 11.0 15.9 12.1 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Group enriched" "Detected in some" 12 "HEL: 13.5;K-562: 5.8;U-2 OS: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" HPA066482 Approved Approved Nucleoplasm "Intracellular and membrane" 28000000 Nucleoplasm "HPA066482: " "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.3 0.3 0.8 0.4 1.4 4.4 0.9 4.6 1.6 1.3 0.4 0.3 0.3 0.1 1.1 0.3 2.1 0.5 0.5 5.4 0.7 0.9 0.4 1.5 1.4 0.3 0.3 0.3 0.6 0.3 0.6 0.3 2.8 0.3 0.6 0.4 2.0 0.7 3.0 0.3 3.2 0.3 0.3 0.3 8.9 0.1 4.2 1.0 0.3 0.6 0.3 0.3 0.7 1.8 0.0 0.3 1.3 0.2 0.0 0.1 4.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.6 0.2 0.0 0.2 0.2 0.5 13.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.4 0.2 0.2 0.1 3.9 0.1 0.0 0.3 0.0 0.4 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 4.0 0.8 1.4 4.6 1.6 0.7 0.9 0.3 0.3 0.3 1.0 GPALPP1 "AD029, bA245H20.2, KIAA1704, LSR7" ENSG00000133114 "GPALPP motifs containing 1" Q8IXQ4 13 44989529-45037669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038966, HPA058739" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA038966: AB_10672656, HPA058739: " "unprognostic (4.99e-2)" "unprognostic (1.71e-1)" "unprognostic (1.61e-1)" "unprognostic (8.81e-2)" "unprognostic (3.65e-2)" "unprognostic (2.63e-2)" "unprognostic (8.86e-2)" "unprognostic (6.08e-2)" "unprognostic (2.72e-2)" "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" "unprognostic (4.56e-2)" "unprognostic (1.41e-3)" "unprognostic (3.37e-2)" "unprognostic (6.38e-2)" "unprognostic (5.88e-2)" "unprognostic (3.94e-2)" 15.6 17.9 19.8 13.8 28.1 16.4 15.0 27.6 24.9 18.1 15.0 15.0 14.5 13.7 18.3 15.5 14.4 13.8 12.5 14.4 19.4 15.3 13.9 13.7 12.7 19.1 14.2 23.3 20.9 12.2 9.1 17.8 19.7 16.8 14.9 15.0 10.8 12.7 16.0 15.0 10.3 14.4 17.6 14.3 16.1 15.3 13.9 19.9 19.4 19.6 12.6 18.8 15.6 15.8 10.4 13.0 11.1 8.5 10.1 10.6 5.1 8.8 7.6 14.3 8.9 6.8 11.3 10.0 12.7 10.4 14.7 14.1 13.2 16.3 20.2 8.5 10.2 14.8 14.1 10.2 16.6 17.3 16.6 15.2 9.8 9.4 11.0 21.6 7.5 8.9 7.3 9.6 8.7 11.7 13.2 4.4 10.8 9.8 20.5 14.9 9.8 7.1 20.0 11.8 8.6 8.3 8.8 5.8 10.0 10.7 6.3 8.1 6.6 17.2 13.4 7.9 5.7 9.3 9.5 6.0 7.4 20.3 8.5 13.3 10.2 2.6 8.5 11.1 9.0 7.1 7.6 8.7 9.5 7.6 10.7 10.4 10.6 9.6 4.0 10.1 6.5 13.0 7.8 5.1 19.8 28.1 27.6 24.9 19.4 15.3 14.2 23.3 16.8 19.9 GPATCH2L "C14orf118, FLJ10033, FLJ20689" ENSG00000089916 "G-patch domain containing 2 like" Q9NWQ4 14 76151916-76254342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018856 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018856: AB_1845553" "unprognostic (5.98e-2)" "unprognostic (1.44e-2)" "unprognostic (7.07e-2)" "unprognostic (1.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.59e-2)" "unprognostic (6.63e-3)" "unprognostic (1.81e-2)" "unprognostic (2.89e-2)" "unprognostic (2.70e-1)" "unprognostic (2.05e-2)" "unprognostic (5.60e-2)" "unprognostic (5.81e-2)" "unprognostic (7.79e-2)" "unprognostic (2.14e-1)" "unprognostic (8.09e-2)" "unprognostic (1.81e-1)" 15.3 12.4 15.5 14.6 20.6 40.1 14.3 17.9 22.4 12.8 14.1 18.1 9.0 10.5 17.0 12.9 14.8 12.3 16.0 20.6 11.2 9.3 12.2 11.2 16.2 14.5 14.3 12.7 16.2 12.4 14.0 20.2 14.1 16.7 14.4 13.9 17.9 13.4 13.8 18.2 13.9 14.0 19.1 12.2 13.0 12.8 19.7 14.4 18.1 14.4 8.7 16.2 15.5 15.0 8.7 10.6 11.5 10.9 7.6 8.1 5.1 12.2 16.2 12.8 10.5 7.7 13.5 10.8 14.5 10.3 14.4 14.1 10.8 20.6 14.8 8.7 11.1 14.8 15.6 9.7 25.1 16.4 8.9 13.4 16.3 6.9 9.9 8.8 19.1 12.3 9.2 12.1 15.7 14.4 13.4 20.7 12.6 20.3 11.8 11.8 16.4 11.8 13.4 16.0 7.6 9.9 24.9 10.6 13.6 16.5 14.6 8.3 17.0 14.1 16.0 18.5 10.8 10.3 11.0 20.7 19.6 19.2 14.8 12.3 18.9 6.9 10.9 11.5 5.7 9.3 4.8 8.7 3.1 8.1 10.6 6.8 6.7 4.8 8.3 7.6 6.7 8.2 6.4 5.1 15.5 20.6 17.9 22.4 11.2 9.3 14.3 12.7 16.7 14.4 GPATCH3 "FLJ12455, GPATC3" ENSG00000198746 "G-patch domain containing 3" Q96I76 1 26890488-26900466 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032078, HPA054973" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA032078: AB_10603671, HPA054973: " "unprognostic (2.93e-2)" "unprognostic (1.33e-2)" "unprognostic (7.34e-2)" "unprognostic (9.63e-2)" "unprognostic (1.42e-1)" "unprognostic (9.44e-2)" "prognostic unfavourable (1.23e-7)" "unprognostic (4.37e-2)" "unprognostic (7.75e-2)" "unprognostic (6.46e-2)" "prognostic favourable (6.42e-4)" "unprognostic (3.77e-1)" "unprognostic (3.22e-3)" "unprognostic (2.31e-2)" "unprognostic (3.81e-2)" "unprognostic (2.59e-1)" "unprognostic (6.82e-2)" 11.7 14.5 13.1 10.2 13.6 31.8 13.0 19.5 20.9 9.4 11.7 15.8 11.8 13.0 11.8 14.5 11.6 10.3 12.0 9.6 11.6 10.9 10.9 14.8 10.5 12.4 12.6 10.8 11.8 11.8 12.0 10.1 13.3 13.6 10.3 10.1 10.1 10.4 10.5 21.5 16.0 11.7 10.4 12.1 15.4 12.0 17.2 16.2 16.9 10.1 10.5 11.7 10.5 12.2 12.4 17.4 22.4 16.8 8.1 16.0 12.8 8.8 7.3 6.9 11.0 6.7 6.4 9.4 7.0 7.9 13.9 12.2 9.7 10.6 8.2 7.7 6.8 9.3 11.4 12.7 7.3 9.2 17.2 15.8 16.0 20.6 9.3 10.9 11.1 9.9 11.8 14.0 7.4 9.0 18.6 10.8 5.7 8.1 9.3 21.3 16.1 11.0 11.8 9.8 13.1 7.0 4.8 9.1 11.2 13.4 11.9 20.7 10.5 11.5 9.2 9.0 10.4 12.1 7.8 14.0 19.2 10.9 8.1 15.8 7.8 22.4 16.8 19.7 16.0 13.7 12.9 12.4 13.3 14.0 17.4 12.1 14.0 13.2 7.1 8.1 15.8 13.3 11.4 12.8 13.1 13.6 19.5 20.9 11.6 10.9 12.6 10.8 13.6 16.2 GPBP1L1 SP192 ENSG00000159592 "GC-rich promoter binding protein 1 like 1" Q9HC44 1 45627304-45688113 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028593 Approved Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA028593: AB_10602906" "unprognostic (1.39e-1)" "unprognostic (8.41e-2)" "unprognostic (1.44e-3)" "unprognostic (6.60e-2)" "unprognostic (6.35e-2)" "unprognostic (1.97e-3)" "unprognostic (2.42e-3)" "unprognostic (9.79e-2)" "unprognostic (3.91e-2)" "unprognostic (1.94e-3)" "unprognostic (1.12e-2)" "unprognostic (4.11e-1)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (4.51e-1)" "unprognostic (7.56e-3)" "unprognostic (6.13e-2)" 29.9 20.5 16.9 21.2 23.7 24.9 25.2 24.4 18.6 27.4 36.9 33.3 29.7 31.6 26.3 23.8 34.8 22.5 19.7 23.9 17.3 17.0 30.2 38.9 28.3 29.1 33.2 12.4 24.7 46.9 24.4 36.6 25.7 22.1 26.4 37.2 29.8 33.5 35.3 29.6 31.0 58.0 25.7 28.2 30.6 26.2 33.2 27.2 40.5 37.7 30.3 35.4 32.5 27.5 13.5 17.8 29.8 22.1 20.0 20.0 15.4 15.8 9.8 17.1 18.1 20.2 19.7 23.4 12.6 21.0 18.3 23.1 9.8 17.8 22.0 16.5 17.3 16.6 18.7 19.0 23.3 25.1 13.3 28.6 11.4 15.2 27.9 28.4 26.5 14.3 41.7 14.3 41.0 23.1 24.3 19.6 20.8 8.5 25.2 25.7 24.3 11.2 16.6 22.3 16.2 21.0 15.7 21.1 14.1 20.8 30.8 32.1 14.0 33.6 19.6 13.2 13.9 14.2 19.1 19.2 17.8 16.3 13.9 23.8 13.8 16.4 16.6 29.8 17.8 21.2 18.9 13.5 17.6 17.4 17.8 11.5 19.4 18.9 17.7 20.0 22.1 10.2 20.0 15.4 16.9 23.7 24.4 18.6 17.3 17.0 33.2 12.4 22.1 27.2 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415490 "Plasma proteins, Predicted membrane proteins" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AF22: 50.7;EFO-21: 17.4;HAP1: 29.1;NTERA-2: 26.6;RPTEC TERT1: 66.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" 170000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favourable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favourable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 39.7 9.9 16.3 10.7 5.3 0.3 6.8 3.7 4.9 14.6 21.6 8.2 3.4 10.0 11.7 16.3 18.6 11.2 23.7 9.6 9.5 5.0 39.6 2.4 25.6 7.1 5.1 6.6 12.4 12.5 9.4 20.4 26.9 9.5 10.3 10.7 9.3 12.2 11.6 20.3 4.3 11.3 16.9 7.9 6.5 19.8 7.2 6.4 5.2 12.4 11.6 2.0 17.1 11.7 0.9 0.6 0.1 0.7 0.0 0.0 0.2 0.0 0.0 50.7 2.0 2.2 0.3 6.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 17.4 0.2 0.0 29.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 26.6 0.7 0.1 4.6 0.0 66.9 1.9 0.0 0.3 0.2 0.0 0.0 0.7 0.7 0.0 5.2 6.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.3 5.3 3.7 4.9 9.5 5.0 5.1 6.6 9.5 6.4 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Group enriched" "Detected in some" 11 "CACO-2: 30.6;HeLa: 17.5" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA040152: , HPA044081: " "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavourable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 17.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 GPCPD1 "GDE5, GDPD6, KIAA1434" ENSG00000125772 "Glycerophosphocholine phosphodiesterase 1" Q9NPB8 20 5544404-5611026 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042987 Approved Nucleoplasm Nucleoplasm "HPA042987: " "unprognostic (2.25e-2)" "unprognostic (2.45e-2)" "unprognostic (3.41e-1)" "prognostic favourable (1.30e-4)" "unprognostic (2.93e-2)" "unprognostic (8.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.39e-2)" "unprognostic (3.76e-2)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (3.73e-4)" "unprognostic (1.56e-1)" "unprognostic (1.22e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-2)" 12.9 12.9 10.6 21.8 17.6 56.7 12.7 29.6 28.2 12.2 8.8 9.1 36.7 7.4 12.5 10.5 10.6 12.6 13.2 12.6 12.2 10.1 8.1 8.1 43.6 30.6 13.1 8.9 18.1 8.9 4.5 10.3 13.4 19.4 9.6 10.6 11.0 34.2 31.2 31.8 9.1 15.1 21.5 14.6 24.9 8.8 8.1 4.0 12.1 13.4 17.0 17.5 13.7 9.8 4.2 4.5 16.2 7.1 3.6 4.6 3.4 3.7 7.2 4.9 3.9 3.2 3.8 5.5 5.9 4.8 3.5 2.3 3.7 2.9 8.4 1.1 3.3 1.3 6.1 11.8 3.4 1.8 1.9 11.5 0.8 4.3 15.7 7.1 5.3 8.1 15.4 2.1 25.5 3.6 6.6 4.4 3.1 2.0 6.4 3.8 2.6 4.1 4.6 5.8 3.0 4.7 3.2 1.8 2.4 2.6 11.7 5.6 2.8 19.9 4.1 2.9 2.2 8.0 3.8 4.2 7.2 9.0 0.9 8.7 3.2 2.6 7.1 9.0 4.0 5.5 3.1 4.2 3.0 3.3 4.5 3.8 4.6 3.1 16.2 3.6 5.5 2.0 2.4 3.4 10.6 17.6 29.6 28.2 12.2 10.1 13.1 8.9 19.4 4.0 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 140000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 62.1 66.6 43.4 27.6 58.2 83.3 34.8 62.6 88.7 20.6 36.6 20.8 23.7 48.2 21.1 20.6 45.3 24.2 33.5 107.2 42.0 45.6 51.3 77.9 19.6 29.6 39.3 64.3 22.5 21.4 66.9 33.7 20.4 50.2 23.7 37.2 36.2 34.6 33.9 144.7 29.4 44.3 34.2 22.8 23.1 26.7 19.7 19.0 23.8 26.1 68.5 32.6 32.5 25.2 16.2 26.3 74.8 40.9 14.5 27.5 24.6 76.1 107.4 9.4 73.5 30.9 23.0 22.5 29.4 23.2 37.1 44.8 60.5 27.0 50.2 43.7 28.8 53.1 56.8 63.9 42.2 55.8 22.9 64.5 51.8 63.6 20.0 83.5 42.0 31.5 26.4 43.9 22.8 34.6 32.8 39.8 26.1 64.6 36.3 29.2 25.4 38.0 34.0 24.9 94.8 46.5 51.3 51.4 29.9 59.3 104.6 21.4 23.7 26.6 29.8 14.0 30.9 39.8 45.3 73.5 41.7 45.5 46.8 63.5 28.4 38.5 22.9 74.8 22.5 35.2 27.5 16.2 20.7 25.5 26.3 13.3 17.5 20.7 1.6 14.5 40.9 8.7 21.6 24.6 43.4 58.2 62.6 88.7 42.0 45.6 39.3 64.3 50.2 19.0 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 4 "HHSteC: 52.5;hTCEpi: 23.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 2.9 0.2 5.4 9.3 3.3 2.8 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 52.5 0.0 0.0 2.1 23.7 4.8 7.7 0.0 0.0 0.0 6.7 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.3 1.1 0.0 0.0 0.0 0.0 0.1 4.1 1.8 4.7 0.4 0.0 0.0 0.0 1.4 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 GPR107 "FLJ20998, KIAA1624, LUSTR1, RP11-88G17" ENSG00000148358 "G protein-coupled receptor 107" Q5VW38 9 130053426-130140169 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031704 Supported Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA031704: AB_10601018" "prognostic unfavourable (3.56e-5)" "unprognostic (7.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (8.72e-2)" "unprognostic (1.10e-3)" "unprognostic (1.35e-2)" "unprognostic (2.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.59e-1)" "unprognostic (1.85e-1)" "prognostic favourable (1.87e-5)" "unprognostic (4.10e-2)" "unprognostic (5.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.34e-3)" 21.0 21.6 24.2 16.6 26.8 12.5 23.7 28.1 28.0 25.0 24.0 35.9 20.5 13.3 24.0 19.1 22.5 26.2 20.9 20.6 22.3 26.6 24.4 22.9 23.0 17.4 29.5 23.1 21.8 26.6 34.4 21.6 40.7 29.9 28.4 26.3 29.3 23.0 24.4 20.5 25.6 15.4 26.7 28.8 17.2 18.9 23.9 22.9 17.3 40.0 15.4 19.7 19.4 17.3 2.0 3.4 6.3 6.3 1.4 2.4 2.3 12.7 18.7 17.8 14.1 19.1 20.3 17.9 20.4 22.9 17.2 17.2 17.8 17.3 7.1 15.1 22.4 32.1 13.6 12.5 14.8 10.9 9.1 7.4 23.0 10.2 18.6 15.6 11.0 16.9 19.6 17.1 17.4 15.9 10.6 7.1 14.7 15.7 8.3 6.3 12.0 14.1 7.9 26.2 11.2 14.4 17.7 6.2 13.8 26.6 19.0 14.3 33.2 8.2 18.6 21.9 11.8 17.9 15.4 4.5 14.9 6.8 19.5 7.4 20.7 2.8 5.7 3.4 1.5 6.1 2.1 1.8 1.6 1.7 3.4 2.0 1.0 2.4 6.3 1.4 6.3 2.1 1.5 2.3 24.2 26.8 28.1 27.6 22.3 26.6 29.5 23.1 29.9 22.9 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: " "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favourable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 8.9 20.0 6.9 20.0 13.5 7.2 29.3 10.7 9.0 10.7 6.9 14.7 12.6 9.2 18.6 6.7 18.0 9.6 5.9 3.1 29.1 12.1 8.7 20.5 9.4 7.7 5.8 17.0 9.0 9.4 9.3 7.1 5.7 7.8 22.5 6.4 22.7 6.5 15.6 9.4 20.0 13.0 7.4 14.9 7.4 12.2 11.0 13.4 13.0 17.7 11.5 19.4 2.4 9.2 29.6 20.5 22.3 7.7 18.0 33.1 7.7 21.2 4.9 18.0 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell line enhanced" "Detected in many" "CACO-2: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: " "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.3 9.8 3.7 6.6 0.0 5.9 6.4 5.0 5.4 23.8 1.0 0.0 3.3 8.8 18.2 3.7 5.8 2.9 2.3 4.7 2.2 3.0 0.1 1.5 0.6 1.5 2.3 3.7 4.3 7.0 10.1 2.0 0.1 7.6 0.5 0.7 0.1 6.3 6.0 1.8 6.6 0.0 2.6 1.6 3.1 13.5 6.4 0.2 17.6 3.4 0.7 13.5 10.5 5.4 14.0 6.6 0.0 0.0 0.0 2.8 0.0 2.6 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell line enhanced" "Detected in some" "EFO-21: 12.8;HL-60: 12.2;MCF7: 10.5;NTERA-2: 21.1;RPTEC TERT1: 10.1;SH-SY5Y: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favourable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favourable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 12.8 0.0 0.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 12.2 0.7 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 10.5 0.8 0.2 21.1 0.0 0.0 0.0 0.0 10.1 5.7 2.2 8.0 2.8 0.0 0.0 7.4 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Cell line enriched" "Detected in some" 8 "HEK 293: 10.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in single" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA049862: , HPA054678: " "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell line enhanced" "Detected in some" "A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: " "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavourable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 11.3 0.0 0.0 0.0 24.6 0.0 32.8 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 43.8 0.0 18.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 1.7 0.0 0.0 0.0 1.1 12.9 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Predicted intracellular proteins" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favourable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavourable (6.63e-5)" 3.7 12.2 13.8 1.5 22.6 0.2 6.1 16.9 30.0 7.7 3.7 3.4 1.7 1.3 13.8 7.4 3.3 8.8 4.0 10.9 15.8 22.3 8.1 5.2 3.9 1.2 8.7 22.5 24.8 7.1 13.3 11.5 2.8 18.7 10.2 2.5 3.6 6.6 9.8 5.2 4.4 1.8 8.3 7.2 3.0 2.2 3.6 4.1 0.8 12.0 1.3 1.3 3.6 3.8 0.4 1.6 0.0 0.6 2.1 4.7 1.2 0.4 5.0 13.5 10.4 4.3 5.1 1.0 7.7 6.9 6.6 12.9 1.7 2.3 0.0 2.6 7.9 1.8 16.1 4.1 8.4 0.0 6.2 0.7 1.5 0.4 3.1 1.2 1.0 5.3 4.4 7.3 0.3 4.7 1.9 0.5 7.9 2.3 3.5 0.5 6.7 7.0 4.7 2.2 0.0 4.1 1.8 3.0 9.3 7.7 1.5 1.0 4.3 2.6 4.1 4.7 9.9 9.5 7.3 0.2 0.3 0.0 6.3 0.8 2.6 0.0 0.4 0.0 0.9 0.6 0.8 0.4 1.1 1.3 0.8 0.4 4.7 1.9 0.0 2.1 0.2 1.6 1.6 1.2 13.8 22.6 16.9 30.0 15.8 22.3 8.7 22.5 18.7 4.1 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell line enhanced" "Detected in many" "EFO-21: 38.4;HHSteC: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.3 12.3 2.2 12.7 0.8 2.2 0.1 3.1 1.2 0.8 11.3 0.4 0.0 38.4 0.4 0.6 9.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.2 0.0 0.0 1.1 0.0 2.1 0.0 6.0 2.5 0.2 2.8 0.6 0.0 0.0 13.4 5.8 3.5 0.0 0.0 0.4 5.7 9.5 0.8 1.4 0.8 11.0 0.0 0.2 1.1 0.0 1.4 6.0 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.9;lung: 10.5;skin 1: 13.8" "Cell line enhanced" "Detected in some" "A-431: 9.5;A549: 27.8;SiHa: 5.2;SK-BR-3: 15.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038129 Approved Approved Nucleoplasm Nucleoplasm "HPA038129: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavourable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favourable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.0 0.0 0.0 0.6 0.2 0.0 1.1 6.5 0.0 0.2 5.7 6.6 0.0 0.0 2.8 0.1 0.0 0.0 0.0 5.2 1.7 0.0 10.5 0.0 1.2 0.0 4.1 0.0 3.0 0.0 1.6 4.0 4.2 1.5 0.0 13.8 8.9 0.0 0.2 0.0 5.1 1.3 2.3 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.5 0.4 0.6 0.1 5.2 15.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell line enhanced" "Detected in some" "Karpas-707: 46.0;RPMI-8226: 11.8;SCLC-21H: 12.3;U-266/70: 7.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043148: , HPA057666: , HPA059092: " "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favourable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favourable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 11.8 0.1 0.0 12.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.1 5.5 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 GPSM1 "AGS3, DKFZP727I051" ENSG00000160360 "G protein signaling modulator 1" Q86YR5 9 136327476-136359605 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042199, HPA060736" Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA042199: AB_10959329, HPA060736: " "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (4.07e-3)" "unprognostic (3.44e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-2)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (5.96e-3)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (4.66e-2)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.48e-2)" 7.8 10.2 15.2 5.6 8.3 5.6 4.2 38.6 23.0 10.5 5.3 12.8 4.8 4.7 13.4 10.1 2.6 7.1 8.3 25.5 8.8 11.6 5.5 1.8 13.8 3.2 8.8 14.2 16.4 28.1 4.4 6.6 8.8 10.5 12.7 2.2 20.4 7.7 8.6 2.8 12.0 4.6 9.0 9.1 8.0 6.1 12.0 9.9 2.8 3.9 3.7 2.0 5.0 8.2 0.4 0.7 0.0 2.0 0.0 2.1 0.3 1.6 2.7 6.6 11.5 3.8 6.6 5.5 19.0 7.9 5.4 2.9 5.5 1.8 0.0 8.0 11.5 1.2 1.0 3.9 1.2 14.9 11.2 2.2 8.9 1.0 16.2 0.1 2.8 10.7 2.6 4.9 2.8 5.4 5.7 0.1 3.5 6.2 1.0 2.1 6.9 10.0 35.4 11.8 5.5 1.4 1.2 16.1 20.0 3.5 0.4 5.9 8.0 3.8 8.7 10.0 8.0 11.6 3.8 3.4 0.1 0.0 6.0 0.0 9.4 0.0 0.3 0.0 0.7 2.0 0.8 0.0 1.2 0.1 0.7 0.4 0.5 0.3 0.0 0.0 0.0 0.0 2.1 0.3 15.2 8.3 38.6 18.8 8.8 11.6 8.8 14.2 10.5 9.9 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 126.9;liver: 195.2" "Group enriched" "Detected in some" 20 "A549: 120.7;HaCaT: 33.4;Hep G2: 112.0;RT4: 79.8;SCLC-21H: 36.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.4" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Low region specificity" "Detected in single" HPA003545 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavourable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 0.1 0.0 0.1 23.8 0.2 0.0 0.8 0.2 0.1 5.5 50.4 0.5 2.0 14.4 0.3 1.0 53.0 0.6 126.9 0.2 0.1 0.2 29.4 195.2 2.0 0.1 0.1 0.1 0.9 7.0 0.0 0.2 0.1 0.2 16.8 71.6 0.1 59.7 4.1 0.3 3.9 35.4 5.6 0.2 0.1 57.8 0.4 0.1 0.5 0.2 44.0 7.4 56.3 15.0 0.2 0.0 0.5 0.8 2.4 0.1 0.0 0.0 120.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.0 0.0 0.7 0.0 33.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 112.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 79.8 36.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Group enriched" "Detected in many" 4 "A549: 21.8;HDLM-2: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008557 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" Nucleoli "Nucleoplasm, Intermediate filaments" "HPA008557: AB_1079197" "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 21.8 1.2 0.0 0.1 0.2 3.6 7.2 5.2 1.6 0.6 0.9 0.1 1.3 3.8 3.6 0.0 2.3 0.0 1.7 57.6 2.0 0.0 9.8 0.2 0.0 7.5 0.0 0.4 0.0 2.8 0.0 0.6 0.0 0.0 1.3 0.1 1.2 2.5 2.8 8.2 3.9 3.5 2.3 0.1 0.0 7.2 5.9 1.7 0.1 0.0 0.2 4.2 4.3 8.7 1.4 1.5 0.3 0.0 0.0 0.0 1.8 7.9 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 GRAMD2B "FLJ21313, GRAMD3, NS3TP2" ENSG00000155324 "GRAM domain containing 2B" Q96HH9 5 126360132-126496494 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.8;CAPAN-2: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 4.8;memory CD4 T-cell: 2.6;memory CD8 T-cell: 3.9;myeloid DC: 2.5;naive CD4 T-cell: 5.1;naive CD8 T-cell: 3.1;NK-cell: 1.7;plasmacytoid DC: 6.5;T-reg: 3.8" "Group enriched" "Detected in many" 6 "dendritic cells: 6.5;NK-cells: 1.7;T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009678, HPA010095" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Cytosol "Nucleoplasm, Golgi apparatus" "HPA009678: AB_2112580, HPA010095: AB_1849952" "unprognostic (2.34e-1)" "unprognostic (4.01e-1)" "unprognostic (4.63e-2)" "unprognostic (3.42e-2)" "unprognostic (6.82e-2)" "unprognostic (1.95e-2)" "unprognostic (6.76e-2)" "unprognostic (3.84e-2)" "unprognostic (9.90e-2)" "unprognostic (7.42e-2)" "unprognostic (2.09e-2)" "unprognostic (3.78e-1)" "unprognostic (2.20e-3)" "unprognostic (3.56e-3)" "unprognostic (2.39e-1)" "unprognostic (9.24e-2)" "unprognostic (1.12e-2)" 8.3 12.0 30.8 5.2 31.6 1.3 29.5 10.2 25.3 27.5 21.8 38.7 9.7 22.5 24.0 11.9 7.7 26.8 8.7 9.2 38.8 15.9 25.9 18.0 7.8 5.1 21.8 28.3 21.1 6.8 9.0 7.2 44.3 26.4 14.2 23.4 14.9 15.5 20.9 2.8 17.5 26.1 17.6 29.7 4.3 12.9 3.3 31.8 3.6 35.6 3.7 8.6 11.6 11.1 0.8 6.5 0.5 0.7 1.7 5.1 2.1 21.1 1.2 1.0 4.7 21.3 7.4 6.4 22.1 38.8 10.5 14.3 1.0 26.0 0.0 9.5 24.8 5.4 0.3 8.9 11.2 1.8 1.5 1.0 2.4 1.3 5.0 0.0 0.7 12.4 4.0 9.6 3.2 0.0 0.0 0.0 18.2 2.1 0.0 0.3 1.1 1.5 0.4 6.3 5.0 14.1 23.4 0.4 0.0 4.0 2.3 6.9 8.0 1.3 1.8 2.1 0.7 3.8 4.1 1.4 1.1 0.0 0.4 0.0 6.3 0.5 0.5 0.0 4.6 0.7 4.8 0.8 2.6 3.9 2.5 0.4 5.1 3.1 0.5 1.7 0.5 6.5 3.8 2.1 30.8 31.6 10.2 25.3 38.8 15.9 21.8 28.3 26.4 31.8 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492812-164621848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 17.7" "Cell line enhanced" "Detected in some" "A549: 5.5;HUVEC TERT2: 10.5;RPTEC TERT1: 8.7;TIME: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: " "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 1.6 2.9 1.0 1.2 1.5 0.0 6.0 0.7 3.6 0.8 1.2 0.0 1.1 1.2 0.6 7.5 1.7 0.5 0.3 10.8 5.7 1.1 8.3 17.7 0.7 0.1 0.9 2.0 2.4 6.0 0.0 1.8 2.2 1.4 0.8 0.4 1.2 1.0 0.5 3.2 0.5 0.8 0.6 0.6 0.6 1.1 3.1 0.4 0.0 5.5 3.0 0.1 0.6 1.1 0.0 0.0 0.4 0.1 0.0 0.0 3.0 0.9 5.5 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.6 0.0 3.4 0.0 0.4 0.9 1.6 0.3 0.0 4.8 0.0 0.3 1.3 0.1 0.0 0.0 0.4 1.0 2.0 0.0 10.5 0.0 0.1 1.7 2.2 0.0 0.0 2.1 1.4 0.0 0.0 0.1 8.7 0.4 3.3 0.4 0.0 0.3 0.0 0.6 0.0 13.2 0.2 1.4 0.0 0.1 0.5 0.1 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 1.0 1.5 0.7 3.6 5.7 1.1 0.9 2.0 1.4 0.4 GRHL3 "SOM, TFCP2L4" ENSG00000158055 "Grainyhead like transcription factor 3" Q8TE85 1 24319322-24364482 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5" "Cell line enhanced" "Detected in some" "BEWO: 21.5;HaCaT: 16.9;MCF7: 26.0;RT4: 29.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 28.9" "Region enhanced" "Detected in some" "pons and medulla: 3.6" "Group enriched" "Detected in some" 12 "eosinophil: 1.0;neutrophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059960 Enhanced Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA059960: " "unprognostic (8.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.95e-2)" "unprognostic (7.83e-3)" "unprognostic (7.58e-3)" "unprognostic (6.28e-3)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (9.01e-3)" "unprognostic (4.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.36e-2)" "unprognostic (8.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (6.97e-3)" "unprognostic (7.42e-2)" 0.1 0.1 0.1 0.1 0.9 0.0 1.0 0.2 0.9 9.0 0.1 0.2 0.0 0.2 0.6 0.8 59.0 0.2 0.6 0.1 1.1 0.3 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.9 0.1 1.1 3.6 3.6 0.1 0.0 5.9 0.9 0.2 21.7 0.1 0.5 3.0 0.0 0.2 1.1 0.1 0.5 0.1 51.5 60.1 12.3 11.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 1.2 0.4 0.0 0.0 0.0 21.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 16.9 0.0 1.5 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 1.3 0.0 0.1 0.0 0.0 26.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 2.1 29.7 0.1 0.0 0.0 2.9 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.2 0.1 1.1 0.3 0.1 0.0 3.6 0.1 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 172.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022971 Uncertain Approved Nucleoplasm,Cytosol 1400000 Cytosol Nucleoplasm "HPA022971: AB_1849975" "prognostic favourable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favourable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 12.8 33.7 16.3 13.8 17.4 9.9 12.3 9.5 22.3 12.1 17.6 27.5 11.6 17.2 14.3 18.1 17.6 12.9 18.1 29.2 15.8 14.7 41.9 172.0 9.7 13.8 20.0 16.5 17.0 15.5 9.5 8.8 13.2 15.5 14.2 10.2 13.5 21.6 14.0 40.0 14.8 14.6 14.2 19.4 10.0 13.3 13.0 18.7 9.5 15.1 25.2 13.6 13.4 11.7 30.6 33.2 17.8 30.3 28.9 25.9 22.4 31.3 45.2 25.6 23.4 23.6 26.2 26.0 25.1 33.3 34.2 37.2 17.1 13.6 30.1 14.8 29.4 14.2 14.7 32.7 20.5 40.2 18.4 17.6 42.1 30.3 37.3 16.7 18.3 31.3 28.7 19.8 25.5 29.6 32.2 12.4 30.0 24.0 16.3 17.2 15.6 19.7 16.1 18.8 16.7 45.6 17.8 10.7 19.2 21.6 41.2 23.4 23.2 21.6 32.2 18.8 30.2 13.0 21.6 9.8 7.6 20.1 26.7 9.6 27.5 17.8 30.2 15.0 19.4 30.3 16.2 28.6 20.7 22.0 33.2 30.6 20.4 17.3 7.0 28.9 24.7 29.8 25.9 22.4 16.3 17.4 9.5 22.3 15.8 14.7 20.0 16.5 15.5 18.7 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell line enhanced" "Detected in some" "HEL: 9.1;NTERA-2: 9.0;REH: 24.8;SCLC-21H: 7.1;SH-SY5Y: 15.8" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA074001: " "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favourable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavourable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.2 9.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 9.0 0.0 24.8 0.0 0.1 4.1 0.0 7.1 15.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564849-25729294 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.0" "Cell line enhanced" "Detected in many" "HDLM-2: 22.6;SH-SY5Y: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favourable (1.29e-4)" 28.0 6.0 11.9 12.4 10.8 7.0 11.3 7.9 18.9 4.7 4.0 3.1 0.7 3.0 5.7 3.1 2.7 9.1 5.0 4.6 15.7 8.3 3.0 3.4 9.4 14.1 9.7 9.8 4.1 8.4 4.4 8.2 4.5 9.6 8.2 4.3 4.8 3.7 1.9 1.4 4.1 6.1 6.2 4.9 23.2 4.0 14.8 2.7 11.6 4.5 1.3 15.2 6.7 2.5 6.2 3.7 5.6 8.0 0.0 0.4 1.6 0.0 2.1 6.5 2.1 4.5 0.6 9.4 0.7 2.0 2.0 3.5 3.4 3.7 11.8 0.2 0.1 0.1 6.4 4.8 6.1 22.6 4.2 5.4 0.7 7.4 0.2 17.5 9.2 1.1 3.3 1.4 2.5 0.3 0.5 0.0 2.4 2.9 12.5 1.2 4.6 0.0 5.6 10.3 2.0 0.0 3.5 15.1 20.5 1.1 0.0 4.9 1.8 7.0 0.2 0.0 13.3 0.1 2.5 1.4 4.6 9.2 8.7 6.2 2.0 0.6 4.8 5.6 0.0 8.0 0.3 4.9 0.0 0.3 3.7 6.2 0.1 0.2 0.3 0.0 7.4 3.2 0.4 1.6 11.9 10.8 7.9 18.9 15.7 8.3 9.7 9.8 9.6 2.7 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.3" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.8" "Low lineage specificity" "Detected in many" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: " "unprognostic (5.78e-2)" "prognostic favourable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavourable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favourable (5.91e-9)" 4.0 0.0 1.3 13.3 2.0 1.3 2.8 4.8 1.7 2.1 33.1 1.4 2.0 25.2 1.3 1.7 1.3 1.3 14.4 1.3 1.3 0.6 2.2 17.1 2.4 3.5 1.3 1.3 2.0 2.8 0.0 1.3 1.8 1.3 3.5 22.4 1.3 1.3 2.7 1.3 2.8 71.3 3.9 1.3 4.7 18.1 1.4 1.5 1.6 2.9 1.3 2.8 4.1 4.5 0.8 0.0 1.8 0.0 0.1 2.8 0.4 0.4 0.3 0.6 0.1 1.5 0.9 0.5 0.3 0.2 0.1 0.4 0.3 12.0 0.6 0.5 0.3 1.6 0.3 0.3 0.8 2.4 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.6 2.0 0.5 0.7 0.2 0.2 0.7 0.1 0.1 0.6 1.3 0.1 0.4 0.6 0.1 0.9 0.0 0.3 0.2 0.3 0.1 100.5 0.3 0.5 0.3 0.3 0.4 0.6 1.1 0.2 2.2 1.8 0.5 0.1 0.4 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.8 2.8 1.4 0.0 0.0 2.6 0.6 0.7 0.1 0.0 0.0 0.4 0.4 1.3 2.0 4.8 1.7 1.3 0.6 1.3 1.3 1.3 1.5 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.9" "Cell line enhanced" "Detected in many" "BEWO: 42.8;K-562: 47.5;T-47d: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036365 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036365: AB_10601762" "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favourable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 15.8 11.1 4.9 18.2 6.6 17.3 21.4 18.0 9.5 13.5 14.9 2.9 14.6 9.7 11.0 11.7 11.6 10.9 16.1 18.7 3.8 5.8 11.1 10.1 23.5 6.5 3.8 5.7 17.8 28.0 34.4 26.9 81.9 3.7 8.7 7.2 18.2 17.7 25.2 22.5 13.3 14.8 8.8 4.2 12.1 13.2 10.4 2.1 59.0 14.9 12.0 17.4 10.2 16.9 3.5 2.5 4.5 6.0 1.9 3.2 1.1 4.4 8.1 5.4 13.5 3.5 3.2 42.8 6.1 4.2 3.4 1.2 6.9 6.2 2.6 7.3 6.9 4.2 8.5 2.3 1.7 4.9 7.2 19.4 7.6 8.5 4.5 8.9 11.1 5.9 5.6 3.6 1.7 0.9 47.5 0.4 1.1 30.2 32.0 7.9 9.4 2.4 21.1 1.8 6.8 3.1 1.7 35.2 24.4 12.0 22.5 1.1 48.9 22.4 1.5 7.0 8.8 1.9 1.6 7.4 4.4 15.6 4.0 5.6 6.1 4.0 1.6 4.5 3.2 2.9 3.1 3.5 1.2 2.0 2.5 3.4 0.6 2.4 1.3 1.9 6.0 0.0 0.0 1.1 4.9 6.6 18.0 9.5 3.8 5.8 3.8 5.7 3.7 2.1 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced Approved Nucleoplasm,Cytosol 200000000 Cytosol Nucleoplasm "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favourable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavourable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 29.6 31.9 19.9 21.8 24.4 35.8 20.0 15.0 24.3 17.8 29.7 16.8 17.8 36.3 16.5 21.4 22.6 15.2 24.7 67.9 19.7 21.5 32.7 137.3 32.0 35.7 23.2 23.1 19.7 21.2 18.6 23.2 26.3 17.0 18.2 20.8 18.0 25.3 21.2 42.7 13.3 41.0 21.4 18.9 26.8 19.8 7.0 14.2 30.8 32.9 24.0 16.8 28.0 18.8 18.7 55.4 85.5 68.3 21.8 25.5 68.0 31.0 21.3 16.5 28.2 23.2 44.3 7.2 40.6 72.1 26.9 29.4 26.7 33.2 27.7 17.6 26.9 17.9 10.8 36.0 28.4 13.8 25.9 20.4 15.2 58.3 41.5 26.1 34.3 33.6 15.4 39.1 47.3 51.5 41.9 17.3 56.4 16.9 20.3 36.8 15.2 14.9 14.9 10.8 11.7 40.0 20.0 8.2 10.3 13.1 9.4 121.1 10.3 21.1 47.5 32.0 16.8 49.7 36.1 0.3 0.4 0.2 59.9 45.5 12.6 85.5 68.3 19.2 18.3 57.2 22.0 18.7 22.6 23.4 55.4 15.0 19.7 19.8 19.5 21.8 43.9 25.7 25.5 68.0 19.9 24.4 15.0 24.3 19.7 21.5 23.2 23.1 17.0 14.2 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell line enhanced" "Detected in many" "AN3-CA: 22.4;HHSteC: 33.0;SK-MEL-30: 22.8;T-47d: 25.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA000750 Uncertain Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favourable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.4 0.3 0.0 22.4 0.4 0.5 0.9 3.1 1.8 4.6 4.8 9.6 0.0 0.0 5.1 7.8 9.4 0.0 9.9 2.1 0.0 0.8 0.3 12.6 1.5 33.0 0.0 3.6 13.6 1.6 13.1 2.7 3.6 0.0 0.0 2.7 0.1 0.0 0.0 0.1 4.7 0.0 16.7 0.0 10.1 0.0 0.4 9.4 3.1 0.0 22.8 25.2 0.3 12.2 3.8 2.5 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320884-77331597 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 90.4" "Cell line enhanced" "Detected in all" "MCF7: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol 62000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favourable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favourable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favourable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 4.6 12.9 5.6 5.9 6.8 2.8 8.5 2.1 9.0 5.0 8.1 10.8 7.5 8.1 4.1 9.5 9.0 5.5 8.0 5.5 5.4 5.0 8.9 90.4 4.4 10.7 6.9 6.9 2.8 7.1 9.3 5.1 11.0 5.8 8.0 8.0 9.5 22.5 4.7 14.8 7.4 7.2 3.8 7.9 5.0 5.9 18.2 5.2 8.6 8.3 14.3 8.9 4.9 4.5 8.2 15.3 7.2 16.0 3.4 5.6 5.0 6.4 12.4 9.8 6.9 6.2 8.6 16.6 4.1 4.1 7.6 10.8 4.2 16.4 14.4 5.8 4.8 8.3 6.7 7.8 7.3 7.6 6.6 7.0 4.7 8.8 9.8 2.6 5.8 8.1 8.5 4.4 7.5 6.5 5.8 13.3 5.1 60.2 4.0 5.5 2.9 9.9 6.9 10.3 11.2 11.6 8.0 10.8 9.8 9.0 18.0 12.7 29.4 3.8 4.4 5.9 20.2 6.7 3.0 10.0 10.7 12.7 15.5 3.9 7.5 6.6 11.1 7.2 1.9 16.0 1.9 6.4 3.4 2.8 15.3 8.2 2.9 2.4 1.1 3.4 13.5 10.4 5.6 5.0 5.6 6.8 2.1 9.0 5.4 5.0 6.9 6.9 5.8 5.2 GTF2IRD2 "FLJ37938, GTF2IRD2A" ENSG00000196275 "GTF2I repeat domain containing 2" Q86UP8 7 74796144-74851551 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA056679, HPA056680" Approved Nucleoplasm Nucleoplasm "HPA056679: , HPA056680: " "unprognostic (7.91e-5)" "unprognostic (3.90e-3)" "unprognostic (1.43e-2)" "unprognostic (5.35e-2)" "unprognostic (2.02e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" "unprognostic (6.80e-3)" "unprognostic (1.22e-1)" "unprognostic (6.11e-2)" "unprognostic (4.43e-5)" "unprognostic (3.18e-2)" "unprognostic (8.97e-3)" "unprognostic (2.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.59e-4)" 3.9 4.3 3.1 2.1 2.0 4.0 5.6 2.1 2.1 6.0 5.6 3.2 5.6 3.1 3.1 6.0 2.5 4.6 2.8 2.7 4.6 6.4 4.3 2.8 2.8 9.3 6.6 4.3 5.6 1.9 6.5 3.8 4.9 4.3 21.6 3.2 3.8 4.5 2.7 3.4 5.3 2.6 6.0 2.9 4.5 4.2 14.9 12.4 10.4 6.8 5.0 9.8 6.6 9.5 3.3 4.4 6.5 6.3 4.1 3.9 3.3 3.3 4.0 4.3 0.7 8.0 2.6 0.8 5.3 1.9 0.1 2.1 3.3 1.2 0.8 2.5 4.9 4.5 5.9 3.3 0.4 3.9 3.2 1.0 3.1 3.8 5.9 5.2 3.5 8.9 1.3 9.6 7.1 2.3 2.5 1.5 9.0 9.1 8.4 3.2 10.1 13.3 34.4 7.3 7.2 6.4 3.7 5.8 1.5 1.0 5.3 4.0 1.7 2.6 5.0 2.3 12.4 10.4 6.8 7.2 3.4 3.9 5.0 14.9 7.6 9.8 7.0 10.0 9.2 5.9 1.1 5.0 3.3 12.4 6.5 6.6 GTF2IRD2B ENSG00000174428 "GTF2I repeat domain containing 2B" Q6EKJ0 7 75092573-75149817 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.8" "Low lineage specificity" "Detected in all" "HPA056679, HPA056680" Approved Nucleoplasm Nucleoplasm "HPA056679: , HPA056680: " "prognostic favourable (3.27e-4)" "unprognostic (1.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-2)" "unprognostic (2.19e-2)" "unprognostic (6.28e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-1)" "unprognostic (8.90e-4)" "unprognostic (1.54e-2)" "unprognostic (7.21e-3)" "unprognostic (2.31e-1)" "unprognostic (3.61e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-5)" 7.3 6.7 6.3 9.2 13.4 7.5 9.9 5.9 9.4 11.2 11.0 11.4 4.6 2.7 13.4 4.4 5.4 12.7 9.2 12.3 7.9 4.5 8.7 9.5 8.2 7.3 11.0 6.7 21.7 10.4 10.5 7.5 4.2 10.8 12.9 5.7 9.8 7.2 8.4 18.8 4.7 5.6 11.3 5.8 4.4 8.7 3.5 14.1 6.3 7.8 4.0 7.1 13.0 6.7 12.8 1.5 5.1 1.9 1.6 3.3 0.5 12.1 5.6 8.7 9.8 7.0 9.8 6.6 6.7 10.1 3.2 8.2 2.5 9.8 8.1 6.6 6.9 4.4 4.1 4.3 3.9 9.8 3.8 6.0 7.2 5.1 13.6 8.8 8.6 9.0 9.0 2.6 11.6 4.5 7.6 17.1 10.4 8.7 6.2 20.5 8.7 8.1 12.0 2.8 11.2 9.0 9.3 8.4 14.9 13.3 14.8 14.3 14.4 8.9 7.2 8.1 5.4 7.5 8.5 6.7 4.0 20.6 4.1 8.9 17.8 0.5 1.3 5.1 1.2 1.9 2.0 12.8 2.1 2.6 1.2 5.7 3.3 1.3 1.7 1.6 1.1 1.5 2.7 0.5 6.3 13.4 5.9 9.4 7.9 4.5 11.0 6.7 10.8 14.1 GTSF1 "FAM112B, FLJ32942" ENSG00000170627 "Gametocyte specific factor 1" Q8WW33 12 54455950-54473602 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 20.3;testis: 62.3" "Cell line enhanced" "Detected in some" "HL-60: 46.4;HMC-1: 34.7;K-562: 45.5;NB-4: 70.3;THP-1: 64.9;U-266/84: 52.1;U-937: 34.7" "Cancer enriched" "Detected in many" 5 "testis cancer: 23.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA038876, HPA038877" Approved Approved Nucleoplasm Nucleoplasm "HPA038876: AB_10670911, HPA038877: AB_2676251" "unprognostic (1.17e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (1.59e-1)" "unprognostic (1.11e-2)" "unprognostic (6.74e-3)" "unprognostic (2.56e-2)" "unprognostic (3.94e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (7.59e-2)" "unprognostic (3.97e-5)" "unprognostic (4.16e-3)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (9.18e-2)" 0.3 0.2 0.3 1.5 0.4 1.8 0.5 0.1 0.2 0.1 0.2 0.2 0.0 0.3 0.1 0.5 0.3 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.7 1.7 0.3 0.0 0.2 0.2 0.0 0.2 9.9 0.2 0.2 0.6 0.1 0.2 0.0 0.4 0.2 0.6 0.0 0.3 3.3 0.2 62.3 0.0 3.0 0.2 0.0 3.5 0.5 0.2 19.7 19.7 13.5 6.1 17.6 20.3 9.7 0.1 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 18.3 8.7 0.0 0.0 24.7 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 46.4 34.7 0.0 0.0 0.0 0.0 0.0 45.5 18.8 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 64.9 0.2 0.0 1.7 0.0 0.1 18.9 52.1 0.1 0.0 34.7 0.0 13.5 5.9 10.5 14.4 5.6 17.9 19.7 17.0 20.3 9.7 16.5 15.8 16.6 2.7 17.6 6.1 19.7 17.6 9.7 0.3 0.4 0.1 0.2 0.4 0.2 0.3 0.0 0.2 0.0 GUCD1 "C22orf13, LLN4, MGC1842" ENSG00000138867 "Guanylyl cyclase domain containing 1" Q96NT3 22 24540423-24555935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022786 Approved Nucleoplasm Nucleoplasm "HPA022786: AB_1845711" "unprognostic (1.58e-1)" "prognostic favourable (6.84e-4)" "unprognostic (2.83e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.89e-1)" "prognostic favourable (7.26e-4)" "unprognostic (1.28e-1)" "unprognostic (3.55e-2)" "unprognostic (1.76e-2)" "unprognostic (4.36e-2)" "unprognostic (8.63e-2)" "unprognostic (1.59e-1)" "unprognostic (3.01e-2)" 16.7 12.8 7.6 13.6 7.2 25.8 19.0 5.1 7.5 9.0 37.4 8.7 9.7 23.3 7.8 9.8 14.3 7.4 19.7 35.7 7.0 5.6 29.3 73.3 12.2 11.9 8.0 5.3 10.2 30.0 7.0 6.7 11.3 6.8 11.7 12.8 9.0 8.7 8.7 28.9 8.8 59.9 13.5 8.0 14.9 15.8 9.1 5.7 13.4 10.6 14.5 13.8 14.3 8.0 23.3 6.5 23.7 7.0 3.3 4.4 5.5 14.0 13.2 11.8 14.5 24.8 23.3 9.4 14.0 22.6 24.6 24.1 20.1 11.0 26.7 9.1 19.1 18.8 13.5 16.4 13.2 25.6 16.4 11.4 13.1 18.3 20.0 29.6 22.6 23.5 13.1 24.5 11.3 26.0 11.4 26.8 18.5 16.6 17.0 12.7 11.1 11.4 19.7 19.2 26.3 19.2 15.6 12.3 12.1 16.9 23.0 12.0 18.2 21.1 17.3 53.1 21.9 16.4 11.8 26.2 17.9 18.8 21.8 16.6 17.8 7.8 7.0 23.7 3.8 7.0 4.4 18.6 3.6 3.9 6.5 23.3 3.5 3.9 7.4 3.3 6.6 4.7 3.4 5.5 7.6 7.2 5.1 7.5 7.0 5.6 8.0 5.3 6.8 5.7 GUF1 FLJ13220 ENSG00000151806 "GUF1 homolog, GTPase" Q8N442 4 44678427-44700926 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003934, HPA024222" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA003934: AB_1079034, HPA024222: " "unprognostic (1.32e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-2)" "unprognostic (3.65e-3)" "unprognostic (7.56e-2)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.37e-2)" "unprognostic (3.03e-2)" "unprognostic (1.56e-3)" "unprognostic (7.38e-3)" "prognostic favourable (2.66e-6)" "unprognostic (4.98e-3)" "unprognostic (1.74e-1)" "prognostic unfavourable (1.65e-5)" "unprognostic (5.40e-2)" 10.0 11.3 12.7 7.5 16.6 11.4 10.8 9.7 17.7 7.6 11.5 9.4 8.7 9.4 10.2 9.1 13.2 8.9 7.9 12.3 12.6 9.9 15.1 16.0 6.6 10.8 10.4 11.6 10.6 9.3 11.5 11.3 7.8 13.0 10.6 12.4 7.4 10.4 8.0 31.1 11.5 12.5 7.6 11.8 9.7 15.4 11.7 11.1 13.9 11.2 13.1 9.3 11.7 9.2 4.8 4.7 4.6 6.1 5.2 7.0 3.9 7.6 3.9 7.2 9.2 3.1 6.3 16.1 10.4 5.5 10.9 8.4 6.8 5.5 16.6 8.3 5.1 6.1 12.4 12.1 12.5 5.6 8.0 19.8 3.3 4.7 9.8 21.5 8.5 6.2 5.5 8.1 7.1 7.8 20.0 3.3 8.8 3.7 12.0 4.5 4.7 9.1 8.7 15.0 7.0 3.2 3.0 10.0 7.5 6.7 2.8 7.4 4.5 6.3 7.7 7.5 8.6 10.0 12.5 12.0 10.9 12.2 8.1 12.9 6.3 1.1 4.6 4.6 4.7 6.1 6.1 4.8 4.7 4.2 4.3 4.4 4.5 4.6 0.1 5.2 4.0 4.7 7.0 3.9 12.7 16.6 9.7 17.7 12.6 9.9 10.4 11.6 13.0 11.1 GVQW3 ENSG00000179240 "GVQW motif containing 3" Q3ZCU0 11 76381313-76414619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057405 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Centrosome" "Nucleoplasm, Centrosome" "Endoplasmic reticulum" "HPA057405: " "unprognostic (8.90e-2)" "unprognostic (1.16e-1)" "unprognostic (8.27e-2)" "unprognostic (1.92e-1)" "unprognostic (9.04e-3)" "unprognostic (8.56e-2)" "unprognostic (8.87e-2)" "unprognostic (2.91e-2)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (4.05e-4)" "unprognostic (7.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.28e-2)" "unprognostic (2.13e-1)" 3.3 5.8 7.0 4.7 11.8 3.5 5.8 13.9 14.3 5.0 3.2 5.0 2.2 4.5 6.7 4.0 1.8 7.1 2.5 3.2 6.2 5.2 5.1 2.5 2.9 6.0 4.0 7.2 8.4 16.0 3.2 15.9 3.0 8.7 3.5 4.9 7.6 9.1 3.3 2.9 4.5 3.6 3.5 4.2 5.0 4.2 9.6 4.6 5.5 5.5 0.4 5.7 2.8 4.0 3.1 1.7 5.1 1.2 3.8 4.1 1.2 1.7 2.2 9.4 5.0 2.3 4.7 2.5 1.2 1.0 2.2 2.1 6.5 4.0 7.4 3.3 1.2 5.3 5.1 1.3 3.0 5.2 3.0 3.8 8.4 2.1 1.2 3.4 2.0 1.1 1.5 3.4 1.3 1.4 2.4 4.5 0.7 2.1 4.7 5.6 1.5 3.4 7.0 5.5 4.7 0.7 1.8 12.3 4.3 2.9 1.3 0.8 3.8 1.0 0.8 3.9 3.9 6.1 1.4 4.8 2.3 6.9 1.2 3.0 2.2 3.5 1.2 1.2 3.7 0.7 2.5 3.1 3.8 1.7 1.7 3.1 4.1 4.1 5.1 3.8 0.8 1.2 3.3 1.2 7.0 11.8 13.9 14.3 6.2 5.2 4.0 7.2 8.7 4.6 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888073-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.5;HSkMC: 12.9;MOLT-4: 23.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: " "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavourable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (2.42e-5)" 8.7 7.2 3.1 6.2 4.0 2.1 5.2 1.1 4.0 10.2 4.5 8.1 3.4 0.9 8.4 9.3 4.2 6.7 12.4 20.6 3.4 2.4 2.2 1.0 5.2 2.4 5.6 4.7 24.8 11.9 2.8 3.8 4.9 4.2 11.3 2.7 10.7 8.0 5.2 2.2 2.6 2.5 12.0 5.4 1.0 2.6 8.4 4.7 14.9 12.1 3.7 2.3 12.2 6.9 0.4 3.0 1.7 0.1 0.8 1.4 0.1 0.1 1.2 0.0 7.5 6.9 13.5 1.1 1.2 2.8 2.7 6.6 0.3 0.8 0.0 2.1 3.2 0.1 0.7 1.5 2.6 0.0 0.9 0.0 5.0 7.9 8.7 3.1 0.0 12.9 0.7 6.5 1.0 0.0 3.7 0.1 1.6 1.7 23.1 0.1 4.4 1.5 0.1 6.4 0.0 0.8 1.1 0.7 3.4 6.4 0.3 0.8 2.5 1.0 0.0 2.9 9.3 9.0 4.2 0.7 0.1 0.1 7.6 1.5 5.1 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.2 1.7 0.8 0.1 3.0 1.4 0.1 3.1 4.0 1.1 4.0 3.4 2.4 5.6 4.7 4.2 4.7 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell line enhanced" "Detected in many" "AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: " "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favourable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.4 17.7 0.0 10.6 0.0 12.8 0.5 3.1 3.1 3.9 13.1 0.3 0.0 1.4 2.2 0.0 10.0 0.2 3.0 0.1 2.8 0.0 0.2 14.2 3.1 0.0 4.3 3.8 0.1 0.3 0.0 0.0 0.1 0.0 3.2 0.8 0.0 0.4 17.4 0.1 2.9 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 37.7 1.7 10.7 0.0 0.0 3.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell line enriched" "Detected in some" 4 "HEL: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 H2BFS ENSG00000234289 "H2B histone family member S" P57053 21 43565189-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.0" "Cell line enhanced" "Detected in many" "K-562: 23.2;U-2 OS: 22.9;U-266/84: 23.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 1.1 0.9 0.2 7.4 0.3 1.8 2.6 0.3 0.8 1.8 1.7 0.4 1.1 2.3 2.4 4.3 4.9 4.2 4.2 4.9 0.5 0.5 4.0 3.3 12.2 0.1 0.5 2.2 4.2 0.0 0.0 4.5 0.4 5.3 1.8 0.8 3.0 2.1 1.0 0.4 3.0 1.8 0.7 5.7 2.0 7.9 0.0 65.0 2.6 7.1 6.1 2.1 1.3 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.0 3.2 0.6 0.9 2.2 0.8 2.3 2.5 1.3 3.2 1.9 4.5 1.0 0.5 8.6 0.8 2.4 0.2 0.7 0.9 2.1 3.5 0.5 4.9 0.2 0.3 0.9 4.4 2.4 0.4 0.6 0.0 0.3 23.2 2.7 0.8 6.0 1.0 2.2 0.3 2.6 0.8 0.5 8.5 0.6 0.7 3.4 2.4 10.2 3.1 2.0 10.9 1.4 0.9 1.7 22.9 1.1 0.6 7.4 23.3 4.9 1.1 11.6 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560704-15601852 "Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 34.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA035496: AB_10601328, HPA035497: , HPA073760: " "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favourable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 12.9 12.1 9.1 7.3 12.5 7.6 11.6 20.7 14.1 9.0 22.4 13.5 5.8 39.6 13.1 13.2 6.7 7.9 6.6 7.9 6.7 6.0 18.8 38.1 7.5 9.0 9.1 8.3 7.9 14.3 12.9 16.8 6.4 10.1 8.2 9.0 10.9 8.5 6.9 15.7 9.9 31.6 7.2 8.2 11.0 11.5 18.4 10.3 16.6 15.1 6.1 10.7 8.2 6.5 8.5 6.5 34.1 9.1 9.1 9.3 5.0 6.0 12.3 4.0 13.7 6.9 5.5 38.9 5.8 9.5 12.5 12.3 12.8 5.9 6.1 4.2 7.9 4.4 9.1 11.3 11.2 5.1 17.3 12.1 9.4 12.3 10.4 13.1 10.5 6.3 8.3 17.7 7.4 15.7 9.9 10.3 10.7 13.2 6.4 6.2 9.0 14.4 5.9 9.7 8.1 13.4 9.4 4.2 5.5 8.7 9.5 11.5 3.1 12.3 9.6 6.8 6.7 8.4 10.7 12.7 21.4 12.1 12.8 12.0 7.7 34.1 6.5 7.0 6.0 8.2 9.3 6.4 6.5 7.5 6.5 8.5 6.4 7.1 1.4 9.1 9.1 4.0 7.8 5.0 9.1 12.5 20.7 14.1 6.7 6.0 9.1 8.3 10.1 10.3 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell line enriched" "Detected in some" 4 "U-87 MG: 49.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA067602: " "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 11.7 0.0 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 49.8 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548810-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 18.7 11.3 13.1 12.1 11.5 49.9 18.6 13.3 15.4 9.9 11.9 11.1 5.6 8.9 14.0 10.4 12.8 9.7 9.3 10.8 14.1 13.6 10.3 11.0 16.8 16.6 14.6 13.9 12.1 12.1 8.4 9.9 11.6 13.1 8.8 10.8 8.5 10.5 8.5 13.5 11.8 9.5 12.3 18.7 11.2 9.7 13.7 11.7 18.4 10.1 11.8 13.0 10.8 14.0 10.3 7.2 7.5 13.5 4.4 8.7 4.3 11.3 6.0 11.0 7.0 5.6 6.3 10.7 11.5 6.9 10.9 9.1 12.2 7.2 7.3 5.7 6.3 19.0 11.7 7.4 10.9 9.4 6.8 10.0 10.6 9.5 8.0 17.5 9.1 5.5 5.6 8.6 8.9 10.9 17.3 9.0 10.5 7.1 12.8 14.1 9.6 7.9 14.4 13.4 9.4 6.9 8.1 9.0 7.4 11.5 11.1 6.8 11.1 13.0 8.6 16.7 12.2 25.8 21.3 13.7 38.3 21.9 10.4 19.2 12.7 7.3 7.7 7.5 8.4 9.0 8.3 10.3 8.3 6.0 6.5 8.9 6.1 8.3 3.8 4.4 13.5 7.2 8.7 4.3 13.1 11.5 13.3 15.4 14.1 13.6 14.6 13.9 13.1 11.7 HCFC1R1 "FLJ20568, HPIP" ENSG00000103145 "Host cell factor C1 regulator 1" Q9NWW0 16 3022620-3024286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 204.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059647 Approved Approved Nucleoplasm Nucleoplasm "HPA059647: " "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.85e-3)" "unprognostic (6.03e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (1.61e-2)" "unprognostic (2.12e-1)" "unprognostic (3.43e-3)" "unprognostic (2.23e-1)" "unprognostic (2.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.23e-1)" 19.7 28.9 49.3 10.2 61.0 7.8 23.9 25.4 37.5 30.4 17.5 13.5 17.7 14.3 20.5 18.4 20.7 19.4 28.0 27.8 37.2 38.6 24.9 11.1 19.1 10.6 40.9 23.9 24.3 10.4 19.9 19.5 16.5 23.0 22.8 10.0 11.5 15.1 42.4 204.8 25.0 13.9 28.7 23.2 9.1 11.2 11.4 14.7 7.5 13.5 37.0 9.1 24.7 17.2 14.1 26.2 8.4 21.6 13.7 20.2 9.6 13.7 36.5 7.3 8.9 30.1 39.6 7.0 4.4 27.7 13.7 37.6 7.6 16.7 9.6 15.0 25.9 18.2 7.3 27.0 6.3 13.3 17.4 4.2 29.2 12.8 24.7 7.0 8.4 49.0 17.5 14.3 15.5 19.0 5.8 19.3 15.3 12.4 4.3 11.0 16.0 7.7 15.2 6.6 27.0 48.7 2.8 12.7 10.7 10.7 17.2 17.2 11.4 6.5 5.4 22.6 63.2 19.1 11.8 11.7 11.5 8.5 9.6 4.4 5.1 2.7 21.6 8.4 12.3 15.5 11.6 14.1 15.9 13.3 26.2 13.5 11.8 14.2 4.5 13.7 13.5 13.0 20.2 9.6 49.3 61.0 25.4 37.5 37.2 38.6 40.9 23.9 23.0 14.7 HCK JTK9 ENSG00000101336 "HCK proto-oncogene, Src family tyrosine kinase" P08631 20 32052188-32101856 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 107.1;lymphoid tissue: 72.6" "Group enriched" "Detected in some" 8 "THP-1: 22.6;U-937: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1" "Group enriched" "Detected in many" 15 "dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005195, HPA063768" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB005195: AB_631619, HPA063768: " "unprognostic (6.22e-2)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "unprognostic (7.98e-2)" "unprognostic (8.83e-2)" "unprognostic (5.50e-2)" "unprognostic (4.09e-2)" "unprognostic (1.72e-2)" "unprognostic (4.34e-2)" "unprognostic (1.59e-1)" "unprognostic (4.08e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.66e-4)" "unprognostic (4.92e-2)" "unprognostic (4.42e-2)" "unprognostic (6.95e-2)" "unprognostic (1.12e-1)" 12.3 5.8 5.9 40.8 13.1 20.8 4.0 1.8 5.3 3.0 5.8 6.1 0.9 5.9 2.5 5.7 3.1 5.9 6.5 8.8 6.0 3.7 4.0 7.9 20.9 50.3 11.2 1.2 3.4 2.8 0.7 2.9 8.8 8.0 3.8 5.9 3.1 4.1 1.9 3.1 2.8 7.8 10.2 9.1 72.6 3.7 2.6 8.2 5.8 3.3 1.2 16.4 9.4 3.5 4.7 31.6 73.0 107.1 1.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 22.6 0.0 0.0 0.1 0.0 0.0 0.6 0.1 3.3 0.0 64.8 0.0 0.5 50.8 62.5 0.1 96.5 0.1 4.7 0.1 0.1 31.6 3.7 0.1 0.0 73.0 1.1 107.1 2.8 0.1 40.2 5.9 13.1 1.8 5.3 6.0 3.7 11.2 1.2 8.0 8.2 HDAC9 "HD7, HDAC, HDAC7B, KIAA0744, MITR" ENSG00000048052 "Histone deacetylase 9" Q9UKV0 7 18086949-19002416 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 54.3;hTERT-HME1: 26.0;SH-SY5Y: 21.7;U-698: 21.5;WM-115: 22.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 29.5" "Group enriched" "Detected in many" 9 "B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028926 Uncertain Approved Nucleoplasm Nucleoplasm "HPA028926: AB_10602327" "unprognostic (2.06e-2)" "unprognostic (2.67e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.74e-1)" "unprognostic (5.54e-2)" "unprognostic (2.20e-2)" "unprognostic (2.32e-1)" "unprognostic (2.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.01e-1)" "unprognostic (7.58e-2)" "unprognostic (1.29e-1)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" 10.7 13.5 12.6 10.7 16.2 5.9 8.4 19.1 16.9 11.6 7.4 11.3 7.5 3.8 17.8 6.7 4.7 10.5 7.5 14.9 13.1 12.0 3.9 3.1 5.7 18.9 13.9 14.9 3.0 2.7 3.0 17.7 6.8 11.2 12.5 6.2 9.7 6.9 16.5 15.5 3.8 8.4 14.4 17.6 17.4 9.1 8.7 18.2 2.9 5.5 5.4 19.3 7.1 9.6 21.8 29.5 0.5 9.7 2.0 2.1 4.5 12.3 0.0 2.0 0.0 0.3 2.8 0.0 0.7 7.3 3.1 5.3 0.1 4.0 5.3 13.7 8.2 1.8 54.3 1.0 8.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 1.0 1.0 9.6 26.0 0.1 0.0 8.3 4.2 0.0 0.5 1.0 6.6 1.2 1.5 0.8 3.1 1.7 3.3 3.9 21.7 0.1 0.1 3.9 0.2 4.9 0.5 11.3 3.6 0.6 7.0 9.6 4.1 21.5 2.9 0.5 22.2 0.1 9.7 0.0 1.7 6.7 1.7 21.8 0.6 0.8 29.5 16.3 0.0 0.9 0.5 2.0 3.8 6.4 2.1 4.5 12.6 16.2 19.1 16.9 13.1 12.0 13.9 14.9 11.2 18.2 HDDC2 "C6orf74, CGI-130, dJ167O5.2" ENSG00000111906 "HD domain containing 2" Q7Z4H3 6 125219962-125302078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035677 Approved Approved Nucleoplasm,Nucleoli 19000 Nucleoli Nucleoplasm "HPA035677: AB_10603768" "unprognostic (8.34e-2)" "unprognostic (5.41e-2)" "unprognostic (6.52e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (6.39e-3)" "unprognostic (1.04e-3)" "unprognostic (1.76e-1)" "unprognostic (2.18e-1)" "unprognostic (2.38e-2)" "unprognostic (8.59e-3)" "unprognostic (5.13e-2)" "unprognostic (4.56e-2)" "unprognostic (2.54e-1)" "unprognostic (3.68e-2)" "unprognostic (1.80e-2)" "unprognostic (9.54e-2)" 17.5 29.8 50.5 12.0 36.1 11.3 21.1 26.4 31.7 14.8 15.2 11.1 31.6 12.4 12.9 25.2 19.6 17.2 12.4 34.7 41.1 37.0 31.3 8.9 13.4 18.8 45.0 18.9 18.3 22.9 16.3 15.6 11.5 23.4 15.7 16.9 19.3 54.8 42.0 42.8 13.5 16.1 19.0 25.8 12.2 14.4 25.7 16.8 12.9 24.3 35.4 18.2 17.7 11.2 27.3 15.4 4.4 14.2 23.6 33.9 17.7 8.4 23.6 14.7 60.2 11.9 16.5 20.5 11.4 17.4 12.4 12.8 37.1 10.2 39.2 24.6 21.6 8.4 20.6 16.7 15.8 15.4 48.3 18.1 13.2 36.4 27.3 23.4 13.4 23.0 25.7 17.6 40.5 8.8 68.4 16.9 26.6 47.0 18.1 24.7 17.3 19.2 27.3 11.7 8.2 28.8 10.8 28.8 14.0 13.9 27.1 24.9 15.9 39.8 5.4 12.5 13.7 19.1 22.9 20.2 13.9 32.4 17.9 42.4 25.4 4.4 14.2 2.5 22.9 12.2 18.7 27.3 25.3 31.0 14.7 22.0 31.4 33.9 3.2 23.6 11.1 15.4 21.5 17.7 50.5 36.1 26.4 31.7 41.1 37.0 45.0 18.9 23.4 16.8 HDDC3 MGC45386 ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929964-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 14.3 18.8 16.3 8.9 17.1 10.7 11.3 10.3 17.6 8.2 13.1 9.3 12.6 12.4 5.4 12.8 7.7 12.7 7.1 15.2 12.9 12.3 14.7 18.3 7.8 9.0 14.6 12.5 10.3 30.3 15.1 10.4 10.4 11.0 8.7 11.1 9.7 24.8 14.0 14.2 9.3 17.1 6.1 11.4 13.1 11.2 4.5 8.2 11.8 12.0 10.1 10.7 7.5 7.5 19.9 25.3 5.6 15.6 16.4 21.5 14.3 6.9 8.5 3.0 3.6 6.9 7.0 5.0 4.6 6.4 4.4 6.5 4.3 14.4 13.0 4.9 3.9 10.8 6.3 10.9 3.7 16.5 13.2 16.5 3.3 9.6 14.1 6.2 8.1 6.1 17.2 8.0 14.4 9.6 13.1 11.8 3.9 10.1 8.5 5.4 2.4 8.8 7.2 1.1 20.8 9.0 7.3 7.6 4.9 3.9 11.0 11.7 16.6 17.0 5.5 2.7 6.1 4.6 6.0 19.4 21.7 9.0 10.1 12.3 8.1 5.6 11.8 4.7 14.0 15.6 18.4 19.9 18.4 16.2 15.9 17.5 21.5 15.7 2.8 16.4 14.2 25.3 17.4 14.3 16.3 17.1 10.3 17.6 12.9 12.3 14.6 12.5 11.0 8.2 HEATR3 FLJ20718 ENSG00000155393 "HEAT repeat containing 3" Q7Z4Q2 16 50065941-50106387 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041990, HPA058579" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041990: AB_10793940, HPA058579: " "unprognostic (7.36e-3)" "unprognostic (2.72e-1)" "unprognostic (2.01e-3)" "unprognostic (1.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "prognostic unfavourable (4.11e-5)" "unprognostic (7.68e-2)" "unprognostic (5.11e-2)" "unprognostic (8.79e-2)" "unprognostic (4.96e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (5.16e-6)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (3.17e-2)" 14.7 13.6 8.8 17.8 16.1 10.1 9.3 19.5 14.0 10.2 11.5 12.4 11.1 10.1 9.2 10.3 13.0 8.5 9.4 9.9 9.4 9.6 10.7 20.7 10.5 14.6 10.9 8.1 7.1 19.2 14.8 13.3 12.1 8.7 8.4 13.8 7.8 12.4 7.8 19.6 13.3 10.9 11.3 10.5 21.6 11.4 15.6 11.1 14.5 6.4 10.7 12.9 9.2 8.0 2.4 4.2 2.2 7.0 2.0 2.9 2.2 10.7 11.1 10.2 16.2 6.4 8.6 11.0 13.2 8.7 13.2 5.3 13.5 8.2 20.4 9.6 12.5 13.0 12.3 9.8 15.4 5.2 13.3 10.1 7.7 17.1 9.1 17.4 20.5 6.7 6.8 9.3 5.7 10.6 12.8 3.5 12.9 6.6 13.3 21.8 12.1 11.5 14.8 13.9 16.5 7.3 8.9 13.3 7.0 12.7 16.6 8.3 7.5 12.8 13.8 10.6 7.2 8.1 10.0 8.7 6.8 18.3 10.5 17.6 10.4 1.3 6.2 1.4 2.6 7.0 2.8 1.6 1.6 2.9 4.2 2.4 2.3 2.4 2.2 2.0 6.1 3.7 2.6 2.2 8.8 16.1 19.5 14.0 9.4 9.6 10.9 8.1 8.7 11.1 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA042025: AB_10959880, HPA055639: " "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 14.7 13.6 13.5 14.1 23.8 21.8 15.0 23.3 22.8 11.1 10.2 15.4 10.1 10.9 16.5 18.0 14.9 9.7 10.9 10.7 11.4 12.1 9.9 12.9 12.5 29.6 13.0 16.6 12.3 23.8 17.9 16.6 10.3 21.6 12.2 14.0 12.4 18.0 9.6 7.1 18.0 14.9 9.4 16.1 18.0 12.8 9.6 14.5 16.0 13.6 8.4 30.0 11.3 12.9 15.2 10.7 15.8 4.9 7.0 9.1 5.0 10.2 5.2 7.7 11.7 8.0 8.0 9.8 6.5 4.8 5.9 6.1 5.9 7.1 22.0 4.7 5.5 8.7 7.6 5.3 7.8 10.7 8.2 14.3 6.9 8.3 5.0 15.3 18.9 7.3 7.4 8.6 8.2 9.9 13.5 19.5 7.1 6.1 13.3 11.0 5.0 3.7 12.9 7.9 16.4 7.0 8.9 9.5 8.4 6.7 10.9 5.1 7.8 5.0 11.1 9.1 5.2 6.5 5.0 12.2 10.0 24.2 7.4 9.2 5.9 15.8 4.9 11.3 7.9 2.6 7.2 9.9 8.8 8.8 8.6 15.2 9.1 7.9 5.1 7.0 3.8 10.7 8.9 5.0 13.5 23.8 23.3 22.8 11.4 12.1 13.0 16.6 21.6 14.5 HECTD2 FLJ37306 ENSG00000165338 "HECT domain E3 ubiquitin protein ligase 2" Q5U5R9 10 91409280-91514829 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 21.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 6.7" "Lineage enriched" "Detected in many" 7 "NK-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037767 Approved Approved Nucleoplasm Nucleoplasm "HPA037767: AB_10671378" "unprognostic (6.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.26e-2)" "unprognostic (3.34e-1)" "unprognostic (6.65e-3)" "unprognostic (1.10e-2)" "unprognostic (9.37e-4)" "unprognostic (1.42e-1)" "unprognostic (1.59e-1)" "unprognostic (2.31e-1)" "unprognostic (2.54e-3)" "unprognostic (4.44e-2)" "prognostic unfavourable (1.67e-5)" "unprognostic (6.98e-3)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (5.84e-2)" 8.7 8.8 16.5 6.9 17.9 2.4 10.8 20.3 19.5 14.3 10.1 5.1 9.1 4.6 17.2 16.6 8.3 12.1 11.4 8.1 11.9 8.7 7.3 4.7 8.7 4.7 5.8 11.3 16.8 7.4 14.4 18.6 10.2 6.5 24.8 7.6 7.5 7.7 24.3 7.7 6.8 6.0 18.4 6.8 5.3 7.5 9.7 6.4 2.9 9.8 5.1 3.6 13.7 10.5 0.6 0.4 0.1 0.8 6.7 1.0 0.5 4.0 2.1 21.2 8.7 4.7 5.1 3.8 3.3 4.5 6.8 6.3 0.2 3.9 0.0 2.9 3.4 0.3 5.7 2.4 8.4 4.4 7.1 2.3 14.9 1.3 2.3 0.4 1.5 5.2 2.2 4.9 4.2 5.1 3.1 10.6 10.5 1.9 2.5 1.3 8.8 2.1 6.3 14.0 2.4 4.7 1.1 5.0 5.3 6.5 1.5 6.6 9.6 1.4 5.3 6.9 4.7 0.4 6.3 0.7 1.4 5.9 6.0 0.0 3.9 0.0 0.1 0.0 1.0 0.8 0.6 0.2 0.5 0.7 0.4 0.6 0.5 0.6 0.1 6.7 0.2 0.0 0.1 0.5 16.5 17.9 20.3 19.5 11.9 8.7 5.8 11.3 6.5 6.4 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA041062: , HPA045473: " "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favourable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.6 8.5 7.5 11.6 7.9 4.9 4.1 3.9 5.3 4.5 10.3 1.9 5.9 3.8 6.7 5.7 11.1 5.4 4.0 7.6 10.0 8.4 11.2 5.7 4.1 5.9 8.2 6.5 6.6 8.2 5.4 8.1 10.4 4.6 5.1 6.2 7.0 12.5 4.0 7.9 9.5 4.3 3.8 4.3 8.9 13.9 9.5 9.6 9.4 3.6 7.1 8.4 11.7 6.3 4.6 6.5 5.5 15.7 5.9 6.6 5.1 3.9 3.9 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: " "unprognostic (1.94e-1)" "prognostic favourable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.7 19.5 25.2 31.9 1.0 2.3 13.7 15.1 9.7 12.6 20.0 25.7 16.0 24.4 6.0 5.0 19.9 14.4 12.1 18.1 23.6 16.6 13.0 19.8 20.6 0.6 24.4 11.7 1.3 0.7 15.1 7.2 8.7 7.0 15.6 14.9 19.8 25.7 12.2 26.1 8.7 24.0 22.5 5.6 8.6 25.5 10.1 8.2 17.9 5.1 2.6 21.9 7.9 6.1 13.9 7.0 12.6 18.1 8.1 15.4 26.1 6.9 15.1 6.3 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 HELQ Hel308 ENSG00000163312 "Helicase, POLQ like" Q8TDG4 4 83407343-83455856 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036852, HPA036853" Approved Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA036852: , HPA036853: AB_10672102" "unprognostic (4.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.12e-2)" "unprognostic (1.12e-1)" "unprognostic (4.80e-2)" "unprognostic (5.56e-2)" "unprognostic (1.14e-1)" "unprognostic (5.13e-3)" "unprognostic (7.14e-2)" "unprognostic (8.62e-2)" "prognostic favourable (9.07e-4)" "unprognostic (2.03e-1)" "prognostic favourable (2.76e-4)" "unprognostic (3.54e-2)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.37e-1)" 10.5 20.8 6.3 12.2 7.8 7.2 10.4 12.6 9.2 10.7 9.8 9.3 8.2 5.6 9.9 8.7 8.2 9.1 9.0 10.5 6.2 5.7 11.9 10.0 8.0 15.3 6.8 5.7 17.4 8.1 13.3 20.7 11.7 9.0 11.4 7.2 11.0 10.0 10.4 14.6 8.7 9.8 8.0 8.4 14.4 8.4 10.7 7.4 18.5 14.3 8.3 13.4 10.2 9.2 10.1 4.6 6.8 4.7 5.5 9.7 2.9 4.2 3.2 7.0 4.5 8.5 9.0 3.6 6.3 9.5 8.3 8.2 3.1 4.4 11.9 5.1 5.5 4.3 8.4 4.7 8.7 6.9 3.7 7.1 5.3 4.1 5.5 8.6 17.6 7.0 6.3 6.6 6.8 6.6 9.3 10.5 8.4 5.0 7.8 6.2 3.6 2.4 6.1 8.0 4.2 6.8 2.7 5.7 4.7 6.2 6.8 6.9 4.2 9.3 5.0 6.2 5.5 8.0 4.9 9.6 4.1 10.1 5.2 6.5 6.9 5.4 3.7 6.8 5.7 4.0 5.4 5.8 6.3 6.4 4.6 10.1 9.7 8.7 2.3 5.5 4.7 4.5 7.8 2.9 6.3 7.8 12.6 9.2 6.2 5.7 6.8 5.7 9.0 7.4 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 61.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favourable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 HEPH "CPL, KIAA0698" ENSG00000089472 Hephaestin Q9BQS7 X 66162549-66268867 "Predicted intracellular proteins, Predicted membrane proteins" "Copper transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 68.7" "Cell line enhanced" "Detected in some" "AF22: 14.0;HEL: 12.0;HSkMC: 18.2;K-562: 33.7;LHCN-M2: 13.9" "Cancer enhanced" "Detected in all" "colorectal cancer: 37.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA000553, HPA005824" Approved Approved "Nucleoplasm,Nuclear bodies" 1200000 "Nucleoplasm, Nuclear bodies" "HPA000553: , HPA005824: AB_1850603" "unprognostic (3.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.25e-2)" "unprognostic (4.25e-2)" "unprognostic (1.29e-3)" "unprognostic (2.25e-1)" "unprognostic (4.94e-2)" "unprognostic (6.17e-2)" "unprognostic (1.40e-2)" "unprognostic (3.35e-1)" "unprognostic (2.40e-3)" "unprognostic (1.19e-1)" "prognostic unfavourable (7.00e-6)" "unprognostic (3.08e-2)" "unprognostic (4.46e-2)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" 4.0 12.2 8.3 10.9 9.3 0.0 3.9 3.7 10.1 11.6 38.4 9.7 8.9 32.9 18.3 9.0 7.5 8.7 21.4 14.8 8.1 5.0 3.7 1.4 7.1 1.3 9.2 10.2 10.2 1.0 0.9 2.5 0.9 8.5 11.0 33.5 11.4 3.0 14.5 0.5 2.8 68.7 34.8 6.7 4.4 8.6 3.2 8.8 0.0 3.2 2.7 1.1 11.2 6.4 0.0 0.2 0.0 0.0 0.0 0.6 0.5 0.0 0.0 14.0 1.1 0.0 0.0 0.4 3.5 0.1 0.0 0.0 8.3 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.9 0.0 12.0 0.0 0.0 0.1 0.1 0.0 18.2 0.0 0.0 0.0 0.0 33.7 0.3 13.9 0.0 0.0 0.3 6.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 8.1 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.3 9.3 3.7 10.1 8.1 5.0 9.2 10.2 8.5 8.8 HES3 bHLHb43 ENSG00000173673 "Hes family bHLH transcription factor 3" Q5TGS1 1 6244192-6245578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 6.8" "Cell line enriched" "Detected in some" 7 "NTERA-2: 15.7" "Cancer enriched" "Detected in single" 28 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 30 "cerebellum: 39.0" "Low region specificity" "Detected in many" "HPA047927, HPA072697" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047927: , HPA072697: " "unprognostic (7.42e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 HES4 bHLHb42 ENSG00000188290 "Hes family bHLH transcription factor 4" Q9HCC6 1 998962-1000172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEK 293: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 12.4" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.4" "Low region specificity" "Detected in all" HPA062465 Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA062465: " "unprognostic (6.23e-2)" "unprognostic (3.77e-2)" "unprognostic (7.07e-2)" "prognostic favourable (3.85e-4)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.99e-4)" "unprognostic (6.25e-3)" "unprognostic (2.34e-1)" "unprognostic (1.62e-2)" "unprognostic (3.77e-1)" "unprognostic (7.76e-2)" "prognostic unfavourable (6.27e-4)" "unprognostic (3.97e-1)" "unprognostic (3.87e-2)" "unprognostic (1.86e-1)" "unprognostic (5.08e-3)" 14.8 4.0 8.3 3.9 15.6 2.8 8.7 2.5 16.9 7.6 10.8 2.9 4.8 5.4 7.8 9.0 7.5 6.8 9.6 13.6 5.9 9.4 5.3 3.2 9.1 2.2 7.3 4.0 4.2 14.8 3.1 5.7 6.1 7.2 10.4 2.6 12.8 5.6 9.4 8.0 7.8 4.2 12.1 3.4 8.6 6.1 3.4 3.1 9.0 3.6 8.4 3.3 10.6 5.6 0.0 0.3 12.4 1.4 0.0 0.0 0.0 4.5 0.5 0.5 0.0 0.0 0.0 5.8 2.7 0.3 1.7 1.8 0.7 1.4 0.0 6.6 0.2 8.0 0.7 0.1 0.0 0.0 65.3 0.0 0.7 0.9 0.5 0.0 0.5 0.0 0.6 0.1 0.1 0.2 1.2 0.1 0.0 2.4 3.6 0.2 0.0 6.3 0.0 0.6 1.3 0.6 0.0 0.3 1.5 1.9 4.6 8.2 3.4 0.0 0.3 0.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 12.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 8.3 15.6 2.5 7.0 5.9 9.4 7.3 4.0 7.2 3.1 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell line enhanced" "Detected in some" "AF22: 2.6;HaCaT: 5.0;HAP1: 1.1;SCLC-21H: 1.0" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: , HPA076164: " "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in many" "NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 8.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061763 Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" "Nucleoli, Nuclear bodies" "Nucleoplasm, Cytosol" "HPA061763: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (2.79e-4)" "prognostic favourable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 2.1 5.2 15.4 3.4 10.6 10.5 3.0 7.3 47.4 3.7 12.2 17.1 0.8 18.1 6.3 1.5 1.6 14.3 5.7 1.7 17.5 9.1 1.9 2.5 2.2 3.3 11.4 12.3 1.3 13.9 5.3 23.6 1.7 14.3 2.0 9.6 1.5 3.8 1.7 8.2 1.7 12.9 3.3 18.8 4.6 5.2 9.4 11.7 0.4 5.5 1.7 2.8 1.3 1.0 0.3 1.4 8.0 0.3 0.1 1.0 0.2 1.2 1.4 6.4 7.2 0.4 0.2 4.1 0.4 0.4 0.6 0.9 1.1 0.8 0.0 1.0 0.1 0.8 6.5 0.4 0.2 2.8 7.8 1.4 1.0 13.1 1.0 10.5 8.8 0.6 4.0 0.9 1.3 0.4 13.3 0.1 0.4 3.2 1.6 50.4 10.2 1.1 7.1 16.2 3.0 0.8 0.6 33.4 14.6 1.9 2.9 48.2 2.5 22.4 0.6 0.6 1.3 3.5 3.7 3.0 0.5 2.2 2.2 25.7 1.1 0.1 0.3 8.0 1.0 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.3 1.4 0.7 0.2 15.4 10.6 7.3 39.3 17.5 9.1 11.4 12.3 14.3 11.7 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120590-8124092 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;salivary gland: 10.5" "Cell line enhanced" "Detected in some" "A-431: 6.6;Daudi: 7.0;HAP1: 9.0;HDLM-2: 7.1;HeLa: 13.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 0.8" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA072105: " "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.4 0.4 1.0 0.3 1.0 0.2 0.5 9.3 2.4 1.4 0.3 0.6 0.2 0.0 2.0 0.2 0.7 0.6 0.6 1.3 1.5 0.5 1.1 0.2 0.9 0.6 1.0 0.2 1.5 0.5 0.0 0.4 3.6 2.1 0.6 0.2 0.9 10.5 2.5 1.1 0.6 0.3 0.4 1.5 0.3 0.2 2.3 0.2 0.2 0.8 0.2 0.5 1.3 0.9 0.2 0.1 0.0 0.1 0.3 0.2 0.1 6.6 0.5 0.5 2.2 0.2 0.3 0.3 0.3 0.5 0.8 2.4 0.1 0.4 7.0 0.1 0.0 0.7 9.0 0.6 0.0 7.1 4.3 0.3 13.4 0.1 0.8 0.7 0.9 0.2 1.2 1.9 5.1 0.1 0.2 3.2 0.1 0.1 0.1 0.3 0.2 1.7 0.7 0.4 1.2 0.2 0.0 0.3 3.2 0.4 0.0 0.4 0.1 0.0 0.6 0.0 1.5 1.5 2.3 4.4 0.9 0.4 0.7 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 1.0 1.0 9.3 2.4 1.5 0.5 1.0 0.2 2.1 0.2 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197843-57226521 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 14.7;lymphoid tissue: 15.2" "Cell line enhanced" "Detected in many" "NTERA-2: 39.5;U-266/84: 12.2" "Cancer enhanced" "Detected in many" "testis cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.0;plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.5 2.6 2.1 1.4 2.0 4.2 3.5 1.4 2.3 1.4 1.4 1.4 14.7 1.0 1.4 5.7 1.4 1.2 2.1 1.4 2.2 2.3 2.7 4.8 1.5 15.2 3.3 2.4 2.1 2.5 3.4 2.6 3.4 1.4 1.9 0.8 2.3 1.5 7.0 1.4 5.7 1.4 1.4 5.1 4.6 2.1 8.7 2.0 3.0 3.3 1.4 1.8 1.4 1.4 1.5 4.6 0.3 4.0 1.1 0.3 0.5 0.7 0.5 1.4 2.6 0.2 1.0 0.4 0.0 0.2 0.4 0.8 0.2 2.4 1.9 0.4 0.0 0.1 0.7 0.7 0.5 1.0 1.4 2.7 0.7 0.1 1.7 1.0 0.2 2.5 0.7 0.2 1.5 0.3 0.4 2.4 0.1 0.1 1.1 4.9 39.5 0.5 0.4 0.9 1.0 1.9 0.2 0.6 1.9 0.6 0.8 1.5 0.6 4.0 0.3 1.8 0.7 0.6 0.8 7.3 12.2 5.9 0.7 1.7 1.0 0.0 2.1 0.3 0.3 4.0 0.0 1.5 0.1 0.0 1.1 1.1 0.2 0.0 0.3 1.1 0.3 4.6 0.0 0.5 2.1 2.0 1.4 2.3 2.2 2.3 3.3 2.4 1.4 2.0 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell line enhanced" "Detected in many" "HEK 293: 48.4;PC-3: 11.0;SK-MEL-30: 33.1;WM-115: 11.3" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA055599: AB_2682858, HPA063472: " "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.4 0.3 0.2 8.8 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.8 0.3 2.2 1.8 0.1 0.2 0.1 48.4 0.0 1.5 0.8 0.5 0.0 0.3 0.4 1.4 0.0 6.1 1.6 3.1 1.4 0.5 0.1 0.0 0.2 0.1 11.0 0.0 1.8 1.4 0.1 1.5 2.0 5.6 0.0 1.0 33.1 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 HFE HLA-H ENSG00000010704 Hemochromatosis Q30201 6 26087281-26098343 "Disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: " "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 7.2 13.7 2.2 4.4 2.7 0.0 6.2 1.2 2.5 6.7 7.1 3.5 10.3 4.2 6.8 13.9 7.6 5.2 13.3 8.9 2.0 1.4 5.4 12.8 9.0 16.1 2.3 2.0 8.1 16.2 14.6 2.2 7.6 4.3 12.6 5.3 13.7 7.0 8.1 3.1 3.2 5.8 10.4 3.2 14.4 6.1 4.9 1.2 2.0 7.7 3.9 5.0 8.6 5.2 3.5 4.6 1.9 10.5 0.2 2.2 3.4 8.1 18.7 0.3 9.1 13.8 10.6 0.0 5.8 14.0 7.5 11.9 1.5 16.6 0.8 15.9 9.6 5.2 0.0 6.9 9.6 2.1 0.1 0.2 4.4 1.2 2.7 0.0 0.3 11.0 2.0 8.2 0.7 5.1 0.3 0.2 6.4 3.3 0.0 0.1 0.4 0.0 1.1 0.0 0.1 6.2 5.4 0.0 0.0 3.5 0.0 5.0 26.6 0.8 3.9 5.3 0.5 5.3 5.1 0.1 0.1 0.1 7.9 0.1 11.4 1.2 10.5 0.0 1.7 10.2 1.3 3.5 1.7 2.2 4.6 1.5 0.4 1.2 1.9 0.2 8.2 0.3 0.3 3.4 2.2 2.7 1.2 2.5 2.0 1.4 2.3 2.0 4.3 1.2 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137769-144140843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: " "unprognostic (2.13e-2)" "prognostic unfavourable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavourable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 13.4 12.3 6.3 7.7 5.5 4.6 7.6 7.3 8.6 5.5 11.8 5.2 4.9 5.0 6.5 3.8 8.7 5.1 5.5 5.1 5.2 3.6 8.2 15.1 5.1 9.5 5.7 7.3 9.7 12.8 6.8 4.4 3.8 6.1 8.6 4.5 5.9 10.5 6.4 13.2 8.9 5.9 5.8 3.8 8.8 15.7 7.9 4.7 11.3 11.0 4.7 8.6 4.9 7.7 2.1 0.9 0.0 0.9 2.2 2.9 0.6 4.7 1.6 1.2 2.1 1.6 1.1 2.9 8.2 0.6 1.7 1.2 2.1 1.2 14.0 11.3 1.5 5.0 2.3 1.1 0.5 6.7 8.7 5.3 1.3 1.0 1.6 2.9 3.5 0.7 3.5 1.9 1.2 0.8 15.1 0.5 1.1 4.0 10.1 2.7 3.3 27.9 12.6 1.0 2.1 1.0 1.1 2.5 2.6 3.8 2.0 2.7 1.7 1.1 2.9 1.0 8.6 3.0 9.7 8.4 5.4 3.4 1.0 5.0 1.7 0.0 0.6 0.0 1.5 0.9 0.9 0.5 1.9 2.9 0.9 2.1 1.8 1.3 0.0 2.2 0.7 0.7 0.6 0.6 6.3 5.5 7.3 8.6 5.2 3.6 5.7 7.3 6.1 4.7 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689951-92695646 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 71.4" "Cell line enhanced" "Detected in many" "EFO-21: 25.5;HEL: 27.7;HMC-1: 30.7;HUVEC TERT2: 30.3;K-562: 42.1;NB-4: 28.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051894, HPA055460" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051894: , HPA055460: " "prognostic favourable (8.83e-4)" "prognostic favourable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavourable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavourable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 6.3 8.2 2.8 12.0 3.6 28.1 13.7 0.9 2.2 4.5 3.2 3.0 1.1 2.3 3.6 3.8 2.9 2.7 18.0 7.3 2.8 2.1 2.8 33.1 15.3 29.7 3.6 0.9 1.9 15.6 0.7 1.5 6.4 2.8 4.3 2.4 2.3 1.9 1.6 2.8 2.2 8.4 9.3 2.9 18.3 2.7 1.9 2.8 1.8 71.4 2.0 11.3 6.5 7.1 25.0 13.5 21.4 17.8 0.3 0.3 4.9 3.0 5.8 3.0 0.0 0.2 0.2 0.0 1.6 13.2 2.1 1.9 1.1 0.7 3.0 25.5 0.2 0.6 2.7 0.0 2.6 0.0 3.1 27.7 2.4 18.6 6.2 16.0 30.7 0.0 0.0 1.9 0.0 30.3 42.1 0.0 0.1 0.9 0.1 28.1 0.0 3.4 9.4 0.8 0.0 0.2 1.2 1.4 0.3 1.7 0.0 0.0 0.9 8.5 10.5 0.0 0.1 0.0 0.0 0.7 0.5 5.8 0.0 22.2 14.6 7.9 14.7 21.4 0.3 16.4 0.1 21.4 0.0 0.0 11.3 25.0 0.0 0.0 11.8 0.3 17.8 13.5 0.1 4.9 2.8 3.6 0.9 2.2 2.8 2.1 3.6 0.9 2.8 2.8 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 68.2;TIME: 78.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.6 68.2 0.0 0.0 1.0 0.0 9.6 0.0 0.9 0.6 0.1 13.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.7 0.0 0.8 0.0 0.5 0.4 0.0 2.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 HHLA3 ENSG00000197568 "HERV-H LTR-associating 3" Q9XRX5 1 70354805-70385339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA031323 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031323: AB_10601477" "unprognostic (2.31e-3)" "unprognostic (8.35e-2)" "unprognostic (3.29e-2)" "unprognostic (6.61e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (8.24e-3)" "unprognostic (9.87e-2)" "unprognostic (2.07e-1)" "unprognostic (3.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (1.75e-1)" "unprognostic (3.92e-2)" "unprognostic (5.16e-1)" "unprognostic (3.60e-2)" 6.9 20.0 18.2 4.1 19.5 7.6 8.5 6.9 19.3 8.9 6.4 20.1 7.2 4.6 8.2 25.7 8.0 15.8 6.8 5.1 15.8 16.5 16.8 17.6 4.6 9.7 17.5 14.6 18.0 15.5 15.8 14.1 6.8 13.4 11.4 6.1 13.1 14.4 8.6 2.8 11.0 4.3 7.9 17.0 7.3 5.2 8.9 15.4 5.8 13.6 3.2 9.0 7.6 13.2 13.4 8.5 4.5 3.0 5.2 11.2 3.9 7.8 3.6 14.1 8.0 12.2 9.9 2.1 2.2 5.2 3.7 4.8 1.2 9.1 7.5 9.7 9.4 4.9 13.8 6.4 6.6 21.3 7.9 5.0 7.5 3.5 11.9 2.4 4.0 12.9 7.6 8.0 9.4 1.2 9.2 21.3 5.4 5.9 5.0 8.6 13.9 4.9 10.4 1.0 3.6 17.2 1.3 5.1 4.0 16.9 5.3 9.9 3.1 5.5 3.1 4.0 2.3 8.3 2.7 10.7 8.6 20.3 8.1 7.6 7.7 4.5 2.5 1.4 6.5 3.0 6.5 10.5 6.7 7.0 3.7 13.4 11.2 9.9 0.7 5.2 2.2 8.5 10.8 3.9 18.2 19.5 6.9 19.3 15.8 16.5 17.5 14.6 13.4 15.4 HIBCH ENSG00000198130 "3-hydroxyisobutyryl-CoA hydrolase" Q6NVY1 2 190189735-190344193 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036540, HPA036541" Enhanced Approved Nucleoplasm,Mitochondria 90000 "Nucleoplasm, Mitochondria" "HPA036540: AB_10673355, HPA036541: AB_2675182" "unprognostic (3.60e-3)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.36e-3)" "unprognostic (3.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.96e-1)" "unprognostic (1.89e-1)" "unprognostic (2.88e-1)" "prognostic favourable (1.22e-4)" "unprognostic (7.32e-2)" "unprognostic (1.37e-2)" "prognostic favourable (1.04e-10)" "unprognostic (1.34e-1)" "unprognostic (3.73e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-3)" 13.7 38.6 18.1 10.1 19.5 5.0 15.8 16.4 18.7 16.3 15.8 14.5 13.0 24.7 17.0 13.0 20.2 10.2 10.0 13.7 18.5 12.7 65.7 56.8 7.6 8.2 20.1 10.8 9.5 29.5 35.8 24.7 7.8 21.0 11.7 18.7 15.0 10.6 12.2 17.5 23.7 16.5 11.3 18.2 9.0 10.4 10.6 22.2 10.5 17.4 15.4 9.3 12.5 49.2 24.2 15.1 14.6 7.6 17.3 20.0 7.3 9.8 7.5 16.2 10.2 15.2 13.5 8.9 10.6 5.7 10.0 10.9 23.3 8.7 14.8 15.1 9.1 18.7 17.1 14.5 15.1 21.3 13.3 19.8 15.8 20.4 5.2 14.1 7.4 10.9 7.9 11.7 2.1 16.2 24.0 13.0 10.9 9.0 14.3 16.2 5.1 15.4 17.9 11.6 37.7 22.6 29.7 12.3 11.6 9.2 13.1 29.9 14.8 11.0 11.5 10.6 9.9 7.1 7.4 8.3 17.7 12.4 9.7 12.3 8.3 12.9 6.7 14.6 11.9 7.6 12.8 24.2 13.3 12.5 11.1 18.7 14.2 18.2 3.5 17.3 5.7 15.1 20.0 7.3 18.1 19.5 16.4 18.7 18.5 12.7 20.1 10.8 21.0 22.2 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Hikeshi, heat shock protein nuclear import factor" Q53FT3 11 86302211-86345931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: " "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavourable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 23.4 24.1 25.7 16.0 23.3 15.5 31.1 19.1 24.0 21.1 23.5 20.1 14.5 10.2 27.4 24.9 24.6 18.2 15.5 36.1 23.9 23.8 11.7 20.0 16.9 22.0 30.2 18.9 26.2 22.6 18.7 32.0 26.6 25.9 18.1 19.2 15.7 15.4 29.2 46.9 20.2 13.0 30.0 25.1 18.1 15.9 15.3 26.6 23.8 20.8 23.6 28.1 21.6 24.0 30.0 33.3 20.6 26.7 25.9 39.5 20.7 9.8 10.6 26.0 14.3 22.0 27.5 13.7 15.2 18.4 15.9 19.0 31.6 27.4 10.0 35.1 20.0 21.1 19.2 33.4 17.0 21.3 16.9 16.1 17.6 23.4 29.7 19.7 13.2 19.3 34.0 19.0 22.6 30.4 17.3 23.0 32.4 26.8 23.5 46.9 21.2 7.2 18.1 12.8 22.4 27.2 18.6 16.1 13.9 18.9 14.2 10.3 22.7 13.3 15.4 18.9 13.3 37.8 11.2 9.9 22.4 19.3 9.6 18.7 18.5 19.6 26.7 20.6 25.2 24.7 27.7 30.0 30.9 27.3 33.3 24.9 27.2 27.6 5.5 25.9 24.3 25.9 39.5 20.7 25.7 23.3 19.1 24.0 23.9 23.8 30.2 18.9 25.9 26.6 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Cell line enhanced" "Detected in all" "MCF7: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Centrosome, Cytosol" "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.1 6.6 9.2 7.0 10.8 5.7 6.2 5.6 6.8 8.0 7.7 7.6 3.1 10.9 7.7 8.9 5.5 11.8 6.6 11.6 7.9 6.0 15.9 8.3 8.0 9.0 12.7 19.7 6.1 9.6 10.2 10.5 11.8 10.8 11.8 11.5 61.5 16.6 7.2 9.4 5.9 10.1 27.0 3.8 7.2 7.0 4.1 5.4 10.2 11.0 7.2 6.4 18.3 11.5 7.9 10.7 12.8 8.5 7.4 5.8 9.5 8.8 10.3 17.9 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 HIST1H2BB "H2B/f, H2BFF" ENSG00000276410 "Histone cluster 1 H2B family member b" P33778 6 26043277-26043657 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 104.9" "Cell line enhanced" "Detected in some" "K-562: 3.6;Karpas-707: 3.5;MOLT-4: 4.4;NB-4: 4.8;THP-1: 5.4;U-266/84: 5.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.4 0.3 1.0 6.4 0.3 6.6 0.6 0.5 1.0 0.5 1.0 0.0 0.0 1.1 0.4 0.5 4.1 0.6 0.3 1.0 0.2 0.8 0.3 1.7 3.0 0.1 0.4 0.3 0.5 0.3 0.0 0.9 1.0 0.3 0.3 0.2 0.3 0.3 1.3 1.0 0.8 0.3 0.8 5.8 0.5 15.8 0.1 104.9 0.3 4.8 7.4 0.3 0.0 2.1 10.5 4.2 1.1 0.2 3.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.1 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.6 0.0 1.4 3.6 3.5 0.0 0.0 4.4 4.8 2.1 2.0 2.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.3 5.4 0.0 0.3 0.3 0.3 0.9 0.8 5.9 0.0 0.7 1.7 1.3 4.2 1.1 0.8 1.5 0.1 3.9 2.1 3.9 1.6 3.3 1.6 2.0 0.8 3.6 0.2 0.4 10.5 2.9 0.6 HIST1H2BC "H2B.1, H2B/l, H2BFL" ENSG00000180596 "Histone cluster 1 H2B family member c" P62807 6 26114873-26123926 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 115.7;lymphoid tissue: 143.2" "Cell line enhanced" "Detected in many" "SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 20 "neutrophil: 115.7" "Lineage enriched" "Detected in all" 26 "granulocytes: 115.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (8.30e-3)" "unprognostic (2.60e-2)" "unprognostic (2.37e-2)" "unprognostic (9.26e-2)" "unprognostic (3.20e-2)" "unprognostic (5.08e-2)" "unprognostic (4.72e-1)" "unprognostic (6.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (9.01e-4)" "unprognostic (2.08e-1)" "prognostic unfavourable (1.75e-5)" "unprognostic (5.41e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (6.60e-3)" 7.8 5.8 5.5 21.3 7.1 31.3 10.7 2.1 5.9 12.9 11.5 5.9 12.8 5.2 4.1 13.1 20.9 10.8 8.1 5.8 6.5 4.6 8.4 20.2 15.3 11.4 5.4 4.1 5.6 9.6 1.7 9.9 17.5 3.8 31.7 4.1 5.9 12.4 18.6 20.0 10.0 6.0 4.3 10.4 11.7 10.6 9.4 4.5 143.2 6.4 8.7 23.4 12.9 14.3 4.3 2.8 115.7 1.3 1.2 1.8 2.7 2.9 1.7 0.9 0.9 0.9 0.5 1.1 2.9 1.1 2.0 1.6 2.4 1.8 1.1 5.6 1.0 2.2 1.2 1.2 1.0 2.6 1.0 0.9 2.7 4.1 1.1 1.4 3.7 12.3 0.7 0.8 0.5 0.7 16.6 9.3 3.8 3.3 3.1 3.0 0.9 5.4 1.4 1.3 6.9 3.4 0.7 4.2 1.3 32.9 2.5 1.1 14.0 1.3 2.4 2.4 23.0 1.5 1.2 19.0 23.3 5.5 1.0 3.6 1.6 4.5 1.1 5.8 1.2 1.3 1.6 2.3 1.8 1.7 0.8 4.3 1.4 1.0 115.7 1.2 1.2 2.8 1.1 2.7 5.5 7.1 2.1 5.9 6.5 4.6 5.4 4.1 3.8 4.5 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell line enhanced" "Detected in many" "U-266/70: 36.8;U-266/84: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavourable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.1 3.7 2.1 29.0 2.6 1.1 4.7 2.7 6.1 3.8 4.0 4.4 2.4 29.8 5.6 8.5 2.0 2.0 2.9 10.9 5.2 1.6 9.7 4.2 3.1 2.1 4.6 19.0 3.2 1.7 2.4 1.5 16.7 13.4 1.1 19.1 4.8 5.4 3.9 5.6 1.9 2.3 15.8 5.8 3.8 11.9 5.0 29.6 7.8 4.6 19.6 0.7 0.9 7.7 19.9 3.1 1.0 36.8 38.8 6.1 0.9 9.9 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 HIST1H2BE "H2B.h, H2B/h, H2BFH" ENSG00000274290 "Histone cluster 1 H2B family member e" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lymphoid tissue: 165.1" "Cell line enhanced" "Detected in many" "NB-4: 8.0;REH: 7.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.7 1.1 0.4 12.2 0.8 5.9 1.8 0.6 1.7 2.5 2.9 0.1 1.8 1.1 1.5 2.9 5.5 1.6 1.6 1.9 0.5 1.7 0.3 1.5 6.7 0.0 1.2 2.1 1.2 0.7 0.0 2.4 0.2 5.2 1.5 0.7 4.0 2.2 2.1 1.9 2.0 1.8 1.6 4.5 2.5 5.4 0.0 165.1 1.2 6.4 7.1 1.8 0.0 3.6 3.1 5.5 1.7 1.6 2.9 0.8 0.5 3.6 2.9 0.9 2.9 0.4 0.4 3.0 1.0 0.5 0.3 0.8 2.1 0.6 1.4 0.5 4.2 0.5 1.1 0.6 1.5 0.9 0.5 1.4 0.1 0.2 0.3 2.4 0.6 0.2 0.6 0.2 0.3 2.3 1.8 0.1 1.6 4.5 8.0 2.4 0.9 7.8 0.2 2.5 1.4 1.8 2.7 3.6 3.9 1.4 0.9 2.7 1.6 0.8 1.5 2.6 1.0 1.9 2.3 4.4 0.6 0.6 1.4 0.5 5.2 1.7 2.4 2.0 1.3 1.6 2.1 2.0 2.5 0.7 3.6 1.8 1.7 5.5 1.6 1.5 3.1 2.9 0.8 HIST1H2BF "H2B/g, H2BFG" ENSG00000277224 "Histone cluster 1 H2B family member f" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "lymphoid tissue: 252.2" "Group enriched" "Detected in some" 4 "U-266/70: 21.3;U-266/84: 15.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 1.2 0.0 17.3 0.1 3.8 5.7 0.3 0.7 2.7 3.3 0.4 1.0 0.5 1.6 1.3 9.9 1.3 1.2 0.6 0.0 0.5 0.4 2.5 7.0 0.0 0.2 0.8 0.6 0.4 0.0 3.2 0.2 5.4 1.1 0.5 1.4 1.3 0.2 0.4 3.0 0.3 0.9 8.3 1.3 2.2 0.1 252.2 0.4 3.3 14.6 2.4 0.0 3.0 0.7 6.2 0.7 0.4 1.5 1.2 0.4 0.2 0.2 0.4 0.2 0.0 0.2 0.1 0.1 0.6 0.1 0.5 0.0 0.5 0.9 0.0 0.8 0.4 0.1 0.3 0.6 0.2 0.3 1.4 0.1 0.1 0.1 0.7 0.2 0.0 0.1 0.1 0.1 1.6 3.8 0.0 0.1 3.2 1.3 0.5 0.5 1.2 0.6 2.4 0.1 0.1 2.1 0.3 4.1 0.8 0.0 3.7 0.2 0.1 0.3 1.9 0.0 0.5 21.3 15.0 1.2 0.1 0.9 0.4 0.0 0.2 1.4 0.7 0.3 1.5 0.7 0.7 0.8 0.4 3.0 0.6 1.2 6.2 0.4 0.7 0.7 0.6 1.2 HIST1H2BG "H2B.1A, H2B/a, H2BFA" ENSG00000273802 "Histone cluster 1 H2B family member g" P62807 6 26215159-26216692 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.2" "Cell line enhanced" "Detected in many" "SiHa: 8.8;T-47d: 17.8;U-266/70: 16.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.54e-2)" "unprognostic (6.69e-2)" "unprognostic (1.55e-1)" "unprognostic (2.36e-2)" "unprognostic (2.79e-2)" "prognostic unfavourable (1.70e-8)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.97e-2)" 0.4 1.5 0.7 16.5 1.2 8.9 20.2 5.1 3.4 4.3 2.9 0.5 5.1 1.8 2.8 4.0 6.6 2.1 1.8 1.7 0.2 1.2 0.6 2.0 7.2 0.1 2.0 1.3 1.9 0.4 0.5 1.6 0.7 10.3 3.0 1.2 5.0 5.8 0.3 1.6 2.2 2.8 4.7 3.1 2.9 6.7 0.3 75.2 1.0 6.9 8.3 4.3 0.0 5.8 14.6 12.0 1.6 1.3 6.2 2.0 2.4 0.1 1.2 0.0 3.8 0.2 0.3 3.1 0.2 2.0 0.8 0.3 2.1 0.0 3.1 0.3 2.6 1.1 1.0 1.1 2.1 1.3 0.7 1.2 1.1 0.6 0.2 2.0 1.4 0.5 0.6 0.0 0.4 7.6 0.1 0.0 1.8 2.2 1.7 1.2 1.6 1.4 0.7 4.3 1.1 0.6 7.2 1.1 8.8 3.2 1.0 17.8 0.8 0.2 0.0 1.0 0.3 0.4 16.7 0.1 0.0 0.3 1.0 0.5 12.0 1.2 2.5 2.0 0.9 6.2 3.7 3.1 3.8 4.4 5.8 1.5 1.3 5.6 1.3 1.6 14.6 2.7 2.0 HIST1H2BH "H2B/j, H2BFJ" ENSG00000275713 "Histone cluster 1 H2B family member h" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 220.5" "Cell line enhanced" "Detected in many" "U-266/70: 17.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavourable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.9 0.6 0.0 25.6 0.0 3.1 2.1 0.0 0.0 0.9 5.5 0.0 0.9 7.8 1.0 2.4 8.4 1.5 4.0 1.8 0.0 0.7 0.0 2.2 11.3 0.0 0.0 0.4 0.1 0.0 0.0 4.9 0.0 1.2 2.2 0.0 1.8 0.1 0.0 0.6 8.1 0.1 0.0 9.6 1.6 3.3 0.0 220.5 0.4 9.5 23.3 1.4 0.0 1.0 0.9 4.7 0.4 1.0 0.7 9.3 1.8 0.1 7.3 0.0 0.0 0.1 1.2 0.9 0.4 1.3 0.6 2.4 1.1 0.0 1.8 0.1 3.6 0.0 0.6 1.8 0.9 0.1 1.3 5.5 0.4 0.0 0.0 4.2 0.3 0.3 0.5 0.5 0.3 2.6 6.5 0.1 2.0 3.8 2.7 1.7 1.9 4.0 0.0 0.9 0.0 2.8 3.4 3.0 4.3 1.4 0.6 2.1 3.3 0.0 0.6 0.0 0.8 3.2 17.7 4.4 0.0 0.5 1.5 3.9 3.5 0.4 0.7 0.5 0.0 0.2 1.0 0.3 0.7 0.9 0.6 0.1 0.2 4.7 1.0 0.2 0.4 0.7 9.3 HIST1H2BI "H2B/k, H2BFK" ENSG00000278588 "Histone cluster 1 H2B family member i" P62807 6 26272976-26273356 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 150.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.5 0.1 0.0 19.0 0.0 8.9 1.2 0.4 0.1 1.3 3.1 0.0 0.5 0.1 0.7 2.1 6.6 0.4 2.0 1.3 0.0 0.3 0.1 2.0 6.3 0.0 0.0 0.7 0.1 0.1 0.0 2.8 0.0 0.1 0.3 0.0 1.3 0.3 0.1 1.2 1.9 0.1 0.1 11.1 0.4 1.9 0.0 150.8 0.4 8.2 14.5 2.2 0.0 4.7 0.7 0.9 1.3 0.4 4.6 0.2 1.8 0.8 1.2 0.0 0.0 0.0 0.2 0.7 0.7 2.0 5.3 0.8 0.0 0.9 0.4 0.4 0.9 1.8 0.5 0.8 2.6 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 3.8 0.0 0.7 14.8 2.5 2.8 0.0 4.0 0.0 4.9 0.0 0.4 0.3 0.9 1.1 1.0 0.0 0.0 6.2 0.9 0.8 0.0 0.6 3.0 3.1 0.4 0.0 1.1 0.5 2.2 0.2 0.5 0.0 3.4 1.3 2.2 2.2 3.2 4.6 0.7 4.7 1.4 0.8 0.9 0.4 0.1 0.3 1.5 0.2 HIST1H2BJ "H2B/r, H2BFR" ENSG00000124635 "Histone cluster 1 H2B family member j" P06899 6 27125897-27132750 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 124.3" "Cell line enhanced" "Detected in many" "K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.6" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (4.02e-2)" "prognostic favourable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 4.1 2.2 1.5 30.0 2.4 10.7 11.3 0.9 1.9 12.8 6.2 1.6 3.9 2.1 3.1 5.9 12.8 5.1 2.8 6.0 2.5 1.7 1.9 3.9 7.3 12.0 3.2 0.9 1.3 5.1 0.6 1.2 5.1 2.9 8.0 3.0 0.5 4.0 4.8 5.9 2.9 2.8 2.8 5.9 12.0 5.1 30.5 2.2 124.3 2.7 10.1 22.3 5.2 9.4 2.2 1.0 13.6 0.6 0.7 2.4 14.7 3.7 4.7 1.4 1.3 7.1 0.5 1.8 2.1 1.2 8.3 3.6 4.0 2.2 0.6 6.7 2.2 2.7 2.0 1.8 4.6 4.4 3.5 1.1 5.3 0.2 0.6 0.4 3.0 3.4 0.2 1.7 0.8 0.4 41.2 24.3 2.2 2.0 1.7 2.4 1.7 4.4 0.9 1.2 3.7 1.0 1.4 9.2 1.0 37.1 2.5 1.0 0.1 1.5 1.0 2.1 41.1 1.6 0.9 35.0 43.1 9.9 0.5 11.6 1.0 1.8 0.6 0.7 0.5 0.5 0.8 1.6 0.7 0.3 0.4 2.2 0.4 0.5 13.6 0.7 0.2 1.0 2.4 14.7 1.5 2.4 0.9 1.9 2.5 1.7 3.2 0.9 2.9 2.2 HIST1H2BK "H2BFAiii, H2BFT" ENSG00000197903 "Histone cluster 1 H2B family member k" O60814 6 27146418-27146798 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 243.8" "Cell line enhanced" "Detected in many" "K-562: 115.0;U-2 OS: 104.9;U-266/84: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavourable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 9.4 6.0 3.0 39.8 4.1 7.8 8.6 2.4 3.6 14.9 11.0 2.5 10.5 8.4 8.0 14.6 19.1 13.5 10.5 9.8 4.3 3.7 4.0 19.3 12.7 25.9 3.6 2.3 8.5 17.4 0.6 5.9 18.7 2.0 16.0 5.3 3.5 11.3 10.7 3.7 6.3 10.3 6.9 7.6 28.0 13.7 30.6 1.9 243.8 8.9 32.3 26.4 11.5 16.7 26.5 22.1 60.7 16.2 5.0 11.5 12.5 6.1 15.9 2.5 4.4 11.5 4.3 8.8 10.1 7.3 14.7 9.5 14.4 8.1 2.0 34.4 5.8 8.1 3.1 3.1 2.2 9.1 15.4 3.4 10.0 0.4 5.0 2.7 20.9 20.6 2.7 2.5 2.8 3.0 115.0 23.3 6.6 16.8 4.9 4.9 2.3 6.9 3.2 1.7 25.9 5.5 2.7 12.9 7.4 60.5 20.8 5.5 53.7 3.1 3.3 6.6 104.9 6.1 1.7 32.0 137.9 18.3 3.8 27.4 3.7 33.8 9.4 60.7 4.1 8.3 3.9 20.3 4.2 4.1 9.6 26.5 5.0 3.9 60.1 5.0 16.2 22.1 11.5 12.5 3.0 4.1 2.4 3.6 4.3 3.7 3.6 2.3 2.0 1.9 HIST1H2BL "dJ97D16.4, H2B/c, H2BFC" ENSG00000185130 "Histone cluster 1 H2B family member l" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 217.6" "Cell line enhanced" "Detected in many" "MOLT-4: 12.9;U-266/84: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 1.2 1.0 0.2 13.9 1.0 13.7 1.6 1.4 0.6 1.8 5.1 0.0 0.3 0.6 0.8 0.6 7.4 0.9 0.9 1.3 0.9 0.7 0.3 0.6 1.5 3.5 0.5 0.0 1.3 1.2 1.2 0.2 1.9 0.0 1.2 1.1 0.0 0.7 0.2 0.2 0.9 3.9 0.7 2.8 4.8 0.8 1.5 0.0 217.6 1.2 5.9 15.6 1.1 1.2 1.9 1.2 7.7 0.6 0.4 2.0 0.9 2.4 2.2 0.7 2.3 0.0 0.0 0.1 1.4 0.4 1.2 3.2 1.0 1.7 0.9 0.5 0.3 1.5 0.0 0.2 0.4 1.1 3.2 1.7 3.1 3.8 0.0 2.8 2.3 1.0 0.0 0.0 0.0 0.7 2.2 5.7 0.0 6.0 12.9 4.8 2.1 3.3 3.0 0.0 1.4 0.0 2.2 3.0 1.1 3.9 1.6 0.2 1.4 0.9 0.5 0.1 1.6 1.3 1.0 3.3 12.7 4.2 0.4 5.0 0.5 0.6 0.5 4.0 1.1 0.2 1.3 1.9 0.6 1.1 1.2 1.3 0.4 0.6 7.7 0.4 0.6 0.7 2.0 0.9 0.2 1.0 1.4 0.5 0.9 0.7 0.5 0.0 0.0 0.0 HIST1H2BM "dJ160A22.3, H2B/e, H2BFE" ENSG00000273703 "Histone cluster 1 H2B family member m" Q99879 6 27815044-27815424 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 232.2" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;NB-4: 11.1;REH: 7.2;U-266/70: 13.4;U-698: 6.8" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.1 0.1 0.0 19.9 0.0 11.6 0.1 0.0 0.2 1.6 3.4 0.0 0.0 0.1 0.7 0.9 8.4 0.1 1.4 0.3 0.0 0.1 0.3 1.8 7.3 0.0 0.0 0.3 0.1 0.1 0.0 1.5 0.0 0.5 1.1 0.0 0.3 0.1 0.1 0.8 3.8 0.1 0.5 13.9 0.5 3.5 0.0 232.2 0.1 9.4 27.6 0.1 0.0 2.6 0.4 0.3 0.3 1.5 1.7 0.0 1.5 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.5 2.1 0.4 0.3 2.2 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.8 0.2 0.8 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 0.2 17.3 0.0 0.5 4.5 11.1 3.3 0.8 7.2 0.0 0.4 0.0 0.0 0.1 1.9 0.7 1.1 0.0 1.0 3.3 0.0 0.0 2.0 1.2 0.1 13.4 0.5 6.8 1.1 1.2 0.9 0.0 0.1 0.1 1.5 0.3 1.7 1.9 1.7 1.5 0.4 2.6 0.1 1.2 0.3 1.5 0.0 0.2 0.6 0.0 HIST1H2BN "H2B/d, H2BFD" ENSG00000233822 "Histone cluster 1 H2B family member n" Q99877 6 27837760-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "lymphoid tissue: 193.3" "Cell line enhanced" "Detected in many" "K-562: 8.7;SCLC-21H: 9.6;U-266/84: 9.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 14.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 2.4 7.2 2.3 14.0 3.3 9.3 3.1 4.9 6.2 3.4 4.5 1.0 4.4 1.8 3.4 3.7 7.6 3.2 3.7 6.4 3.7 2.4 2.3 5.3 5.4 8.0 4.1 4.2 5.0 8.3 4.2 3.8 4.5 1.4 4.0 2.5 1.7 3.3 4.7 4.6 2.3 4.3 2.5 9.4 7.0 2.4 6.8 0.5 193.3 6.1 6.2 10.9 3.6 2.2 6.0 6.2 14.6 2.6 1.0 2.8 1.4 1.4 0.2 1.5 1.5 1.2 1.9 0.9 0.7 1.1 0.7 0.8 0.5 0.8 0.7 3.0 0.7 2.1 1.3 0.4 0.3 1.5 4.4 0.7 3.6 1.3 1.4 0.9 3.6 1.2 0.3 0.1 1.3 0.2 8.7 6.8 0.8 1.8 2.9 4.4 1.3 1.0 2.0 0.9 5.1 0.4 0.9 9.6 1.9 3.5 1.3 2.9 2.4 0.8 1.5 2.1 2.1 1.1 0.6 6.0 9.0 3.5 0.7 1.7 0.7 2.3 2.6 1.7 2.6 2.4 1.8 5.8 2.0 1.9 5.0 6.0 1.3 1.2 14.6 1.0 1.8 6.2 2.8 1.4 2.3 3.3 4.9 6.2 3.7 2.4 4.1 4.2 1.4 0.5 HIST1H2BO "H2B.2, H2B/n, H2BFN" ENSG00000274641 "Histone cluster 1 H2B family member o" P23527 6 27893463-27893843 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 164.5" "Cell line enhanced" "Detected in many" "U-266/84: 28.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favourable (4.89e-4)" 1.9 0.4 0.0 14.9 0.0 8.1 1.5 0.0 0.0 0.9 3.9 0.0 0.0 0.9 0.6 1.6 9.9 0.0 0.7 1.5 0.0 0.3 0.5 2.6 7.4 0.0 0.0 0.0 0.0 0.7 0.0 4.4 0.1 0.3 1.5 0.0 1.2 0.0 0.3 1.5 2.1 0.1 0.5 8.1 0.7 1.4 0.0 164.5 0.0 7.1 15.4 1.1 0.0 2.6 2.2 6.5 0.8 1.3 1.7 5.5 2.2 2.9 1.4 4.3 0.7 0.0 2.6 0.8 0.1 5.3 5.3 1.1 1.3 2.5 1.9 0.2 2.2 2.4 0.5 0.7 1.7 1.9 1.6 4.4 1.7 0.0 0.2 1.0 0.3 0.0 0.4 0.5 1.4 6.4 7.2 0.2 0.5 10.9 9.3 1.6 2.1 6.4 1.5 4.8 0.9 0.3 6.1 1.3 4.6 1.2 0.7 2.0 0.2 0.0 1.5 0.3 1.7 2.0 8.0 28.8 7.4 0.9 9.3 0.7 1.3 0.3 3.8 0.8 0.6 1.1 1.4 0.8 1.7 2.2 2.6 0.5 0.5 6.5 1.3 0.8 1.7 1.4 5.5 HIST2H2AB ENSG00000184270 "Histone cluster 2 H2A family member b" Q8IUE6 1 149887524-149887916 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 126.3" "Cell line enhanced" "Detected in many" "MOLT-4: 7.8;U-266/70: 4.8;U-266/84: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Approved Nucleoplasm Nucleoplasm "CAB011483: AB_732909, HPA041189: " "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 2.4 1.6 1.2 6.4 1.6 21.1 2.9 2.6 2.4 6.8 2.6 0.6 0.6 1.2 1.9 1.6 5.1 1.5 2.2 1.5 1.4 1.3 1.6 1.8 4.2 3.0 1.2 1.9 7.4 3.0 2.2 1.4 2.3 0.0 4.2 2.0 3.9 1.9 1.9 2.5 4.7 2.9 4.0 2.7 4.8 1.9 2.1 0.1 126.3 1.7 2.1 9.0 7.1 2.4 10.2 4.3 11.6 2.0 4.3 4.5 0.8 1.3 0.0 0.7 0.7 0.0 0.0 1.1 0.9 0.0 0.0 1.4 0.0 0.9 0.8 0.5 0.0 1.0 1.0 0.0 0.0 0.3 1.5 0.0 0.8 0.7 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 1.0 1.1 0.7 0.0 7.8 3.3 0.9 1.7 1.6 0.5 1.3 0.0 0.5 2.3 1.0 2.2 0.0 0.1 0.2 3.4 0.0 0.9 3.3 0.0 0.7 4.8 5.2 1.4 2.0 0.3 0.6 1.3 1.6 0.8 2.7 2.0 2.7 3.8 4.5 4.0 2.3 10.2 2.7 2.7 11.6 4.3 1.9 4.3 2.6 0.8 1.2 1.6 2.6 2.4 1.4 1.3 1.2 1.9 0.0 0.1 HIST2H2BE "H2B, H2B.1, H2B/q, H2BFQ" ENSG00000184678 "Histone cluster 2 H2B family member e" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.1" "Cell line enhanced" "Detected in many" "Karpas-707: 23.8;U-266/70: 39.7;U-266/84: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 14.3 16.2 9.8 22.2 10.0 19.4 16.9 17.2 14.0 31.3 9.0 11.2 10.5 6.4 18.5 24.9 25.5 13.3 9.6 51.1 13.1 10.1 12.5 10.2 27.5 24.5 12.4 8.7 28.0 13.4 5.8 15.4 17.2 8.5 72.8 7.6 19.4 24.1 15.3 43.1 33.5 8.6 18.8 18.2 22.0 17.5 9.3 11.6 198.1 12.1 12.4 25.3 27.2 33.8 2.3 4.5 29.9 5.5 0.7 1.2 5.1 1.1 1.1 1.9 0.4 10.1 2.7 0.9 4.0 2.7 1.7 0.5 0.4 1.8 0.2 1.1 3.5 4.5 1.5 0.7 0.9 1.4 1.2 0.3 4.5 0.8 3.2 0.3 5.3 9.2 3.3 0.7 2.8 0.5 4.8 23.8 2.1 6.8 1.2 2.0 1.2 2.4 1.4 0.7 5.4 1.6 0.9 12.8 2.0 13.8 1.9 1.0 9.8 0.9 0.7 1.3 14.4 0.9 0.3 39.7 21.2 1.0 1.7 1.4 0.7 8.4 2.1 3.8 0.7 3.2 1.2 0.8 0.9 1.1 1.6 2.3 1.2 1.1 29.9 0.7 5.5 4.5 1.0 5.1 9.8 10.0 17.2 8.5 13.1 10.1 12.4 8.7 8.5 11.6 HIST2H2BF ENSG00000203814 "Histone cluster 2 H2B family member f" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 117.6" "Cell line enhanced" "Detected in many" "U-266/70: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 21.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 21.7" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: , HPA043013: , HPA048671: " "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.6 17.7 3.9 14.9 3.5 3.7 7.1 8.5 5.6 17.4 3.8 3.7 3.2 1.5 5.6 6.2 7.1 7.9 3.6 12.1 3.4 2.4 5.0 4.2 14.6 27.5 3.2 3.8 24.2 6.2 2.6 4.4 5.1 3.2 16.7 2.5 3.5 3.7 5.5 1.2 10.9 3.4 6.0 7.7 12.7 7.9 5.9 3.1 117.6 4.4 6.3 16.7 6.1 21.5 2.0 0.8 21.7 1.1 0.6 0.8 0.2 0.4 0.6 0.5 0.6 4.5 3.0 0.3 7.7 4.0 5.9 5.2 0.3 2.2 0.4 0.6 4.4 1.3 0.1 0.5 4.6 1.2 0.9 0.4 1.5 0.0 6.6 0.2 1.7 5.4 0.0 7.6 1.9 3.3 1.2 2.3 0.8 0.9 3.1 3.7 0.4 1.0 0.3 1.1 0.7 2.8 0.4 2.6 7.2 4.1 3.5 0.3 1.3 9.6 1.4 1.5 0.0 11.2 2.0 31.4 1.0 1.3 5.2 0.3 3.3 0.0 1.0 0.2 0.6 0.8 0.7 0.6 0.8 0.3 0.8 2.0 0.4 0.3 21.7 0.6 1.1 0.8 0.2 0.2 3.9 3.5 8.5 5.6 3.4 2.4 3.2 3.8 3.2 3.1 HIST3H2BB ENSG00000196890 "Histone cluster 3 H2B family member b" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 56.0" "Cell line enriched" "Detected in some" 4 "U-266/70: 18.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042205: , HPA043013: , HPA048671: " "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 2.0 4.7 1.2 12.1 3.1 2.8 1.3 12.8 3.2 8.9 1.3 1.1 0.6 2.1 1.4 2.0 4.1 6.2 1.7 2.2 1.5 2.2 1.3 0.9 2.1 5.4 1.2 1.5 1.6 1.7 1.7 2.0 1.5 4.1 2.2 1.5 3.4 2.0 2.0 1.8 4.8 1.7 1.2 6.2 4.5 2.4 2.1 0.7 56.0 1.7 5.9 11.8 2.0 7.9 1.5 1.1 3.4 1.5 1.1 0.9 0.5 0.2 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 1.0 0.1 0.1 0.0 2.5 0.1 0.1 0.1 0.6 0.6 0.0 0.8 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.4 0.1 0.4 0.2 0.0 0.0 0.8 0.0 0.2 1.4 0.5 0.9 0.4 0.3 3.7 0.1 0.1 0.0 0.0 0.5 0.1 18.1 4.3 0.0 0.2 0.1 0.1 1.7 1.0 0.5 0.5 0.5 0.7 1.3 0.8 0.9 0.2 1.5 0.9 0.7 3.4 1.1 1.5 1.1 0.7 0.5 1.2 3.1 12.8 3.1 1.5 2.2 1.2 1.5 4.1 0.7 HKR1 ZNF875 ENSG00000181666 "HKR1, GLI-Kruppel zinc finger family member" P10072 19 37312837-37369365 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA036126, HPA044855" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA036126: AB_10670708, HPA044855: " "unprognostic (1.04e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-1)" "unprognostic (3.58e-1)" "unprognostic (2.78e-1)" "unprognostic (4.81e-2)" "unprognostic (2.29e-1)" "unprognostic (1.02e-3)" "unprognostic (4.92e-3)" "unprognostic (9.82e-2)" "prognostic favourable (4.41e-4)" "prognostic unfavourable (5.18e-5)" "unprognostic (1.34e-1)" "unprognostic (5.04e-2)" "unprognostic (2.00e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" 13.0 25.8 14.6 13.2 22.4 12.6 24.9 29.8 27.2 20.5 14.5 22.9 21.5 7.7 24.8 24.1 12.4 22.9 17.9 26.9 14.6 15.6 19.3 12.3 12.9 14.3 14.9 17.4 22.6 14.2 31.0 35.5 17.2 21.2 27.5 13.8 49.4 18.7 19.3 18.1 27.1 13.4 17.0 13.3 20.2 14.2 22.6 15.5 16.4 30.9 13.7 20.1 15.0 15.6 12.4 7.9 10.0 5.1 9.9 14.8 5.7 4.1 10.4 13.4 17.8 9.8 8.6 9.4 7.0 10.6 13.0 14.1 5.2 4.9 14.5 17.0 7.3 3.4 8.8 9.3 13.5 7.6 15.0 5.1 12.6 5.5 12.9 4.7 12.4 12.7 11.6 8.8 19.3 7.9 0.9 0.9 9.4 8.4 10.4 9.3 27.0 5.9 7.1 5.9 5.6 11.4 16.7 16.7 22.8 7.0 8.9 8.8 12.8 9.0 7.1 10.3 7.5 7.8 10.8 18.7 19.7 15.0 1.1 5.8 11.6 10.0 4.2 6.6 8.0 5.1 14.8 10.7 10.6 11.4 6.3 12.4 14.4 12.0 4.0 9.9 3.6 7.9 12.2 5.7 14.6 22.4 29.8 27.2 14.6 15.6 14.9 17.4 21.2 15.5 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075926-33087201 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 99.4" "Group enriched" "Detected in some" 6 "HDLM-2: 46.1;REH: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 90.1" "Group enriched" "Detected in all" 8 "B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6" "HPA011078, HPA058509" Approved Approved "Nucleoplasm,Cell Junctions" 730000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: " "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favourable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 29.6 31.9 9.8 52.8 15.1 6.9 22.0 6.1 7.7 15.5 11.8 14.9 6.9 14.4 15.3 23.4 9.8 11.0 26.6 29.6 9.7 10.4 25.5 12.4 79.9 99.4 23.5 6.0 10.8 10.5 4.3 11.5 6.2 19.6 19.4 6.6 22.2 25.0 15.4 6.1 14.8 33.7 8.9 35.3 88.8 15.8 4.3 16.2 51.9 14.2 20.7 69.3 35.5 11.9 57.8 90.1 1.1 40.6 2.8 7.6 23.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.2 0.0 0.0 0.0 0.0 46.1 2.1 1.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 22.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 5.8 0.1 3.8 0.0 0.0 0.0 0.2 18.7 1.1 5.3 40.6 0.7 57.8 1.9 7.6 90.1 56.9 0.7 4.2 0.4 2.8 17.0 25.7 7.2 23.5 9.8 15.1 6.1 7.7 9.7 10.4 23.5 6.0 19.6 16.2 HLX "HB24, HLX1" ENSG00000136630 "H2.0 like homeobox" Q14774 1 220879400-220885059 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.0" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.2;THP-1: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 25.8;neutrophil: 28.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 28.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA005968 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA005968: AB_1079066" "unprognostic (6.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.57e-2)" "unprognostic (9.19e-3)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (5.14e-3)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" "unprognostic (3.19e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (7.28e-6)" "unprognostic (8.44e-3)" "unprognostic (3.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" 27.7 3.0 2.7 8.8 3.0 54.0 18.4 0.9 2.3 5.7 24.3 2.0 3.8 4.5 7.4 3.6 8.7 5.0 7.5 15.2 3.3 0.9 4.0 11.5 14.3 10.5 6.2 0.3 4.9 4.9 1.8 2.0 14.0 2.5 6.9 2.4 4.2 2.3 3.8 10.4 5.7 11.1 4.2 6.4 10.9 3.1 3.9 3.1 1.4 6.3 3.0 3.2 10.4 12.9 2.2 5.5 28.5 6.3 0.2 0.1 1.8 0.0 1.8 0.0 1.4 4.2 6.8 3.5 5.1 8.5 5.8 4.9 0.4 0.1 0.0 0.1 3.2 0.0 1.1 0.0 2.4 1.3 3.7 0.0 2.1 0.2 7.4 1.7 0.3 7.8 0.2 6.6 0.3 2.5 2.2 0.0 0.8 0.0 0.0 6.1 0.2 3.5 0.1 4.0 0.0 0.6 0.0 0.0 2.0 0.7 0.1 13.2 0.0 46.4 0.7 4.0 0.0 0.6 4.0 0.0 0.0 0.0 6.4 5.3 1.6 25.8 6.3 10.7 0.0 1.8 0.0 2.2 0.0 0.0 5.5 1.1 0.0 0.0 28.5 0.2 0.3 3.5 0.1 1.8 2.7 3.0 0.9 2.3 3.3 0.9 6.2 0.3 2.5 3.1 HMCES "C3orf37, DC12, SRAPD1" ENSG00000183624 "5-hydroxymethylcytosine binding, ES cell specific" Q96FZ2 3 129278828-129306186 "Predicted intracellular proteins" "DNA damage" "DNA-binding, Endonuclease, Hydrolase, Nuclease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044968 Enhanced Approved Nucleoplasm Nucleoplasm "HPA044968: " "unprognostic (9.18e-3)" "unprognostic (1.11e-3)" "unprognostic (4.16e-2)" "unprognostic (2.80e-2)" "unprognostic (2.93e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (4.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (3.00e-1)" "unprognostic (4.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-2)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.25e-2)" "unprognostic (9.08e-3)" 16.4 10.8 15.9 29.8 23.1 15.1 15.2 19.2 22.8 13.2 16.3 9.3 18.1 13.3 13.4 11.8 19.6 12.8 13.9 27.9 13.6 16.7 13.1 24.6 12.5 42.6 14.9 18.6 14.4 7.3 62.2 11.2 10.5 14.4 12.7 14.8 12.2 13.0 13.0 24.9 16.2 13.2 15.5 10.4 14.4 11.9 17.8 9.7 36.5 14.3 14.3 57.5 12.8 15.1 33.3 14.9 32.9 19.7 13.3 24.4 15.5 33.0 15.0 17.1 19.8 21.4 8.9 15.5 11.7 9.4 17.0 13.2 23.3 15.6 64.2 12.6 10.4 24.3 21.7 25.0 19.7 12.8 11.6 13.3 12.1 16.6 9.2 11.5 9.8 8.5 13.1 14.1 13.9 10.2 13.4 56.8 9.3 43.7 16.4 10.0 11.1 9.7 14.8 14.7 11.2 17.9 19.8 17.2 10.6 26.0 16.4 15.8 28.0 11.7 8.2 8.5 15.0 20.3 14.9 31.6 18.6 64.6 10.2 9.3 9.4 14.8 13.8 32.9 17.1 14.2 17.7 19.1 20.9 20.1 13.8 33.3 20.8 22.7 27.7 13.3 19.7 14.9 24.4 15.5 15.9 23.1 19.2 22.8 13.6 16.7 14.9 18.6 14.4 9.7 HMG20A "FLJ10739, HMGX1, HMGXB1" ENSG00000140382 "High mobility group 20A" Q9NP66 15 77420412-77485607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008126 Supported Approved Nucleoplasm Nucleoplasm "HPA008126: AB_1079072" "unprognostic (2.04e-1)" "unprognostic (6.87e-2)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (9.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" 12.5 17.5 19.7 14.7 27.3 8.6 13.0 24.7 28.8 16.8 14.0 21.0 12.6 11.6 20.7 12.5 12.9 12.8 14.3 22.9 18.5 19.5 13.2 22.3 14.3 21.6 17.3 16.7 21.4 11.8 14.2 21.5 19.8 19.8 11.9 16.0 19.4 12.4 13.5 31.9 12.0 12.4 15.1 17.4 31.2 12.0 18.7 14.7 30.5 15.1 10.3 19.6 16.9 13.7 17.7 16.1 9.4 13.7 27.6 21.2 13.8 7.6 12.4 24.0 16.7 10.0 12.6 9.5 10.2 15.1 12.1 13.3 7.7 11.7 12.9 11.8 11.6 10.5 33.6 12.8 12.4 11.5 16.4 26.9 11.0 10.0 14.9 19.5 16.1 13.9 9.0 10.6 11.8 23.8 20.0 10.9 10.6 5.5 15.5 12.5 17.2 6.0 20.5 23.1 14.5 13.5 13.4 9.4 20.4 16.3 10.0 30.4 9.7 20.3 14.9 14.1 12.8 6.7 12.2 14.9 31.7 25.9 10.9 27.9 16.9 4.6 12.4 9.4 18.1 12.1 21.2 17.7 14.2 16.7 16.1 16.0 19.2 17.2 2.2 27.6 13.7 12.2 13.2 13.8 19.7 27.3 24.7 28.8 18.5 19.5 17.3 16.7 19.8 14.7 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB032200, HPA065612, HPA068442" Enhanced Approved Nucleoplasm,Nucleoli 18000 Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavourable (1.29e-6)" "prognostic unfavourable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavourable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 15.8 3.5 14.8 35.7 13.5 55.4 13.0 13.8 19.0 26.1 22.0 5.9 7.7 42.3 8.6 7.2 79.4 15.1 17.8 13.0 11.7 12.6 14.6 6.9 16.0 46.1 10.7 8.7 3.9 13.0 4.1 5.1 31.8 12.5 8.7 21.2 9.9 22.0 6.9 33.7 38.3 36.0 3.8 8.4 31.6 24.2 32.6 7.2 107.3 12.5 39.6 72.7 13.0 29.6 26.6 33.4 12.8 10.1 7.3 22.4 11.0 120.4 47.7 24.5 17.1 11.4 84.6 107.0 48.7 55.7 37.8 21.1 31.2 84.5 56.8 24.6 19.9 25.9 28.8 86.9 30.1 12.4 19.3 17.4 16.1 41.7 24.2 62.2 20.1 36.2 9.7 68.4 35.8 114.1 70.1 2.9 52.6 12.2 53.9 76.6 119.2 80.9 80.2 0.5 62.7 25.6 11.1 42.8 18.1 5.1 24.7 45.0 9.9 66.8 98.9 19.7 62.2 28.6 45.6 23.4 36.2 73.4 41.7 26.0 98.3 6.2 10.1 12.8 10.2 10.1 13.3 26.6 18.7 16.0 30.7 16.4 22.4 17.7 2.6 7.3 9.4 33.4 21.0 11.0 14.8 13.5 13.8 19.0 11.7 12.6 10.7 8.7 12.5 7.2 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990775 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 54.3" "Cell line enhanced" "Detected in all" "HBEC3-KT: 107.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA062583 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA062583: " "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favourable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favourable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 4.4 5.4 7.9 4.8 7.1 20.3 4.1 2.8 10.3 10.8 12.0 4.7 3.9 7.3 6.3 13.4 10.2 4.4 3.2 4.5 9.8 7.6 9.0 41.6 5.9 6.3 6.1 7.3 3.1 7.1 18.7 1.6 54.3 9.7 3.7 9.2 5.3 9.7 4.3 20.5 6.8 7.6 3.6 5.0 8.4 4.0 26.0 3.2 18.2 6.2 5.1 9.5 4.9 3.7 3.1 6.5 11.8 5.3 0.9 6.2 2.3 37.1 16.5 52.0 27.0 2.2 6.5 64.7 16.3 10.8 19.0 9.9 13.0 15.4 26.0 52.6 12.5 17.9 47.3 107.0 21.4 17.7 13.8 22.6 15.9 20.4 3.2 34.0 11.5 5.1 25.3 7.7 19.6 24.5 11.7 15.5 22.5 28.5 37.5 26.2 30.8 20.2 46.0 42.3 14.7 13.9 17.8 37.5 24.5 24.2 26.2 8.1 23.1 22.6 18.4 7.9 18.7 25.1 35.9 14.1 17.5 96.4 9.4 17.4 16.0 0.0 4.8 11.8 0.5 3.2 0.1 3.1 2.4 3.3 6.5 0.6 0.0 0.2 0.6 0.9 5.3 3.3 6.2 2.3 7.9 7.1 2.8 10.3 9.8 7.6 6.1 7.3 9.7 3.2 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135962-123137741 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;intestine: 5.7" "Cell line enhanced" "Detected in some" "EFO-21: 3.4;HEL: 5.4;HeLa: 5.0;K-562: 17.9;NB-4: 6.1;SiHa: 5.0" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 11 "hypothalamus: 6.8;pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Group enriched" "Detected in some" 5 "basal ganglia: 2.3;hypothalamus: 8.0" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA069659: " "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 1.9 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.9 0.0 0.4 0.2 0.0 0.0 0.9 0.7 0.0 1.3 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 2.0 0.0 0.0 0.8 0.7 5.4 5.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 6.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.0 0.0 0.0 0.0 2.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.0 0.0 2.2 0.0 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561978-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 16.6 19.5 14.9 13.3 16.2 47.3 20.0 22.1 17.5 18.2 16.4 10.8 17.0 16.2 21.9 19.4 14.4 17.6 16.5 14.3 17.8 11.8 12.5 11.6 17.6 12.1 13.2 19.2 19.9 16.8 18.8 16.4 13.8 10.9 16.8 13.0 13.5 14.0 22.8 13.1 12.0 13.6 14.2 12.8 12.0 16.3 24.8 12.4 40.0 19.2 11.5 11.5 20.8 26.4 1.0 6.9 5.3 3.6 3.6 21.7 3.5 16.4 7.7 22.7 13.3 11.0 10.4 14.1 15.6 12.8 13.6 11.5 8.7 9.6 0.2 14.0 13.9 10.5 14.2 11.7 14.1 24.5 12.4 12.0 14.5 21.9 10.4 22.4 12.4 8.2 9.3 11.3 12.6 14.2 20.4 37.3 16.0 7.7 24.4 12.2 22.8 14.2 4.8 15.9 8.1 11.7 21.7 15.5 17.4 13.7 12.1 11.4 10.1 9.7 14.7 10.2 15.4 11.2 12.7 20.5 20.4 0.1 8.8 5.5 12.4 5.3 3.6 5.1 6.2 1.8 11.0 0.2 15.1 11.6 6.9 1.0 4.6 2.9 2.5 3.6 0.7 0.1 21.7 3.5 14.9 16.2 22.1 17.5 17.8 11.8 13.2 19.2 10.9 12.4 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell line enhanced" "Detected in some" "A549: 5.6;HeLa: 4.4;hTCEpi: 19.3;SiHa: 5.9;THP-1: 11.1;U-2 OS: 3.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA028346: , HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 0.0 11.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell line enhanced" "Detected in some" "AN3-CA: 16.5;HaCaT: 6.8;RPTEC TERT1: 5.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA078220: " "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.5 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.1 4.0 0.2 1.9 0.2 6.8 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.3 1.9 0.1 0.3 1.0 0.0 3.5 3.3 2.7 0.1 0.0 0.1 0.0 0.0 0.3 0.0 1.0 1.0 0.7 0.0 5.4 0.7 1.2 0.0 0.2 0.0 1.1 0.0 0.0 2.7 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.6 2.9 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621159-48626356 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5" "Cell line enhanced" "Detected in some" "HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031463 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA031463: AB_10601577" "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavourable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavourable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.5 0.8 0.1 1.9 0.2 0.0 0.4 0.1 0.3 5.3 16.6 0.1 27.3 0.0 1.4 42.8 0.1 0.4 0.1 0.1 0.1 0.1 15.3 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.5 0.2 1.1 10.4 0.1 0.1 23.5 0.2 0.2 11.3 1.0 3.5 0.2 0.2 2.0 0.1 0.1 0.1 0.1 0.1 2.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.0 1.3 0.0 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 1.6 0.0 8.3 0.2 0.0 1.3 0.0 0.0 77.4 29.8 13.5 0.5 0.0 0.5 0.2 30.6 0.0 0.0 0.0 0.8 0.0 32.8 0.0 1.3 0.0 0.0 0.1 0.0 1.2 0.0 5.2 0.4 13.5 0.0 0.0 0.0 1.0 0.0 8.5 0.1 0.0 0.1 0.0 7.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119942 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.7;endometrium 1: 38.2" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;HEK 293: 25.4;RPTEC TERT1: 18.2;SCLC-21H: 7.1;SiHa: 10.6;U-251 MG: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: " "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 0.9 0.0 0.1 1.2 0.1 0.0 21.7 0.1 0.1 10.3 9.5 0.1 1.4 0.0 38.2 2.8 1.2 1.6 0.6 0.6 0.1 0.0 16.3 0.1 0.8 0.2 0.1 0.1 2.7 0.1 0.0 0.1 3.0 0.1 9.5 4.3 0.1 0.5 5.1 0.2 1.0 0.1 14.2 0.1 0.1 0.0 3.9 0.1 0.2 0.3 0.4 1.4 2.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 18.2 0.0 7.1 1.9 10.6 0.0 0.0 0.0 0.0 1.6 0.0 1.3 0.5 8.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 HOXD13 "HOX4I, SPD" ENSG00000128714 "Homeobox D13" P35453 2 176092891-176095938 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0" "Group enriched" "Detected in some" 4 "HAP1: 9.6;HEK 293: 27.6;HL-60: 30.7;NB-4: 18.3;SCLC-21H: 8.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA064064 Approved Nucleoplasm Nucleoplasm "HPA064064: " "unprognostic (2.04e-1)" "unprognostic (1.13e-1)" "prognostic unfavourable (6.95e-5)" "unprognostic (2.52e-3)" "unprognostic (7.25e-2)" "unprognostic (2.08e-2)" "unprognostic (4.62e-2)" "unprognostic (1.77e-1)" "unprognostic (4.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.82e-4)" "unprognostic (4.95e-2)" "unprognostic (3.70e-2)" "unprognostic (9.98e-3)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 14.0 13.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 13.8 8.8 0.1 0.1 19.0 0.6 0.0 0.1 3.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 3.8 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 1.5 0.0 27.6 4.2 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 18.3 0.9 1.5 0.0 0.1 0.0 0.0 0.2 8.0 1.9 1.9 0.0 4.4 0.0 0.0 0.0 1.0 0.0 0.4 2.5 0.0 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490177-174523154 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 193.3" "Cell line enhanced" "Detected in some" "A549: 27.3;ASC diff: 16.9;HEL: 59.7;RT4: 92.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Region enriched" "Detected in single" 4 "pons and medulla: 3.8" "Group enriched" "Detected in many" 5 "basophil: 37.7;T-reg: 15.1" "Group enriched" "Detected in many" 71 "granulocytes: 37.7;T-cells: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favourable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 5.1 2.6 0.5 7.9 0.6 0.0 24.6 0.4 0.6 23.0 73.3 0.5 2.5 22.9 13.4 7.5 32.0 4.5 10.7 1.2 0.6 0.7 8.5 63.7 22.9 7.9 0.8 0.5 2.3 0.4 0.0 0.9 193.3 3.8 20.1 8.4 4.6 3.0 1.1 1.6 15.3 64.5 9.3 0.5 2.9 36.3 1.9 0.5 5.5 0.4 5.0 7.9 61.2 31.8 0.1 0.2 37.7 0.1 0.3 15.1 1.0 0.0 27.3 0.0 0.0 16.9 1.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.5 59.7 2.0 0.0 0.0 0.3 0.1 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 2.8 0.0 0.2 5.6 92.8 0.1 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.7 0.1 5.4 3.7 0.0 5.7 0.1 1.9 1.6 0.2 0.0 0.6 1.5 0.4 0.3 0.0 0.0 15.1 1.0 0.5 0.6 0.4 0.6 0.6 0.7 0.8 0.5 3.8 0.5 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: , HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavourable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 12.3 11.4 25.2 9.1 34.5 5.0 16.2 16.1 25.3 7.9 9.5 8.1 10.8 8.9 6.2 9.2 22.3 8.3 10.9 28.7 22.2 22.4 8.2 6.5 8.9 8.0 23.2 12.9 7.7 9.7 11.7 10.3 10.1 15.0 10.0 6.2 8.2 10.1 12.7 51.8 32.0 8.2 8.4 17.0 6.5 7.2 6.1 11.0 5.9 8.1 24.5 9.3 9.9 19.8 2.1 1.1 0.7 4.6 0.1 2.0 0.3 21.8 19.4 9.3 8.3 5.8 4.1 12.0 10.9 5.8 17.1 14.6 9.8 8.7 8.4 3.4 14.8 17.4 9.9 26.5 4.8 6.9 22.1 4.3 7.8 8.5 8.8 3.4 3.3 6.2 29.6 9.2 10.0 8.5 8.8 12.3 9.6 17.9 12.7 12.1 9.4 19.3 10.2 11.8 7.5 9.6 5.4 36.3 14.4 10.1 18.1 7.8 14.8 6.7 13.5 15.3 12.1 5.6 14.0 4.6 6.1 6.5 14.4 6.3 14.3 0.0 0.6 0.7 1.4 1.2 1.6 0.8 1.4 1.3 0.7 2.1 2.0 0.6 0.0 0.1 4.6 1.1 2.0 0.3 25.2 34.5 16.1 21.1 22.2 22.4 23.2 12.9 15.0 11.0 HRCT1 "LGLL338, PRO537, UNQ338" ENSG00000196196 "Histidine rich carboxyl terminus 1" Q6UXD1 9 35906192-35907141 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.3" "Cell line enhanced" "Detected in some" "EFO-21: 13.5;HBEC3-KT: 7.4;HeLa: 11.1;Hep G2: 8.3;U-2197: 20.0;U-251 MG: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067038 Approved Nucleoplasm Nucleoplasm "HPA067038: " "unprognostic (2.48e-2)" "unprognostic (4.88e-2)" "unprognostic (2.43e-2)" "unprognostic (2.49e-1)" "unprognostic (5.69e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (6.63e-2)" "unprognostic (2.53e-2)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-1)" "unprognostic (2.00e-1)" "unprognostic (9.41e-2)" "unprognostic (2.80e-1)" "unprognostic (9.43e-2)" 25.3 1.9 1.9 3.6 2.8 0.4 21.4 0.9 3.4 5.3 16.8 1.8 1.4 11.2 4.2 3.9 6.6 3.5 2.1 7.6 2.6 1.6 17.6 1.8 5.2 5.0 2.4 2.3 2.2 1.6 0.3 0.7 4.7 3.6 3.6 14.8 5.8 4.6 4.0 6.1 4.2 14.3 6.5 1.5 0.8 2.5 5.3 1.4 0.0 3.5 1.2 1.5 4.6 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.6 4.5 0.0 0.1 0.4 0.1 0.0 0.1 1.2 0.0 13.5 0.3 0.0 0.0 7.4 0.0 0.0 0.0 0.0 11.1 8.3 1.7 0.0 0.0 4.4 3.8 1.5 0.9 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.1 1.8 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.8 0.2 4.0 20.0 9.3 0.0 0.0 0.0 2.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.9 3.4 2.6 1.6 2.4 2.3 3.6 1.4 HS6ST1 HS6ST ENSG00000136720 "Heparan sulfate 6-O-sulfotransferase 1" O60243 2 128236716-128318577 "Disease related genes, Predicted intracellular proteins" Transferase "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 38.8;HMC-1: 61.6;SCLC-21H: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044586, HPA075890" Approved "Nucleoplasm,Nuclear speckles" "Intracellular and membrane" 27000 Nucleoplasm "Nuclear speckles" "HPA044586: AB_10963057, HPA075890: " "unprognostic (9.94e-2)" "unprognostic (8.93e-3)" "unprognostic (4.94e-3)" "unprognostic (6.69e-3)" "unprognostic (1.99e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-2)" "unprognostic (3.21e-2)" "unprognostic (2.87e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" "unprognostic (1.21e-2)" "unprognostic (2.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" 13.2 32.0 22.4 8.0 16.2 4.1 9.2 17.2 33.2 16.2 9.6 13.5 23.8 8.3 8.8 6.4 19.3 17.1 20.1 8.1 17.3 13.9 22.8 29.5 9.1 7.1 17.8 18.8 16.2 24.2 8.9 7.5 11.5 16.5 13.1 6.9 10.5 12.2 23.9 20.1 14.2 11.3 6.4 14.9 18.2 6.3 14.7 15.6 10.9 7.0 6.7 8.0 19.1 11.1 2.0 5.5 5.8 3.0 0.5 2.6 1.2 3.5 5.1 13.7 7.8 5.3 10.0 7.4 4.3 5.6 4.4 2.4 2.6 2.3 3.4 38.8 5.6 9.4 5.2 8.5 1.6 5.6 5.3 3.0 1.9 25.1 6.5 5.2 61.6 13.5 10.1 3.5 1.1 2.3 1.9 3.6 1.6 7.4 13.8 23.0 16.3 3.1 4.5 3.7 17.7 4.0 10.6 33.8 8.4 3.5 8.9 1.9 3.6 2.0 2.8 3.9 8.7 14.5 3.5 2.1 2.0 0.7 2.4 3.7 2.8 5.8 1.6 1.4 2.6 1.0 0.4 1.9 1.0 1.6 1.1 2.0 1.0 1.0 0.5 0.5 3.0 5.5 0.5 1.2 22.4 16.2 17.2 33.2 17.3 13.9 17.8 18.8 16.5 15.6 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell line enriched" "Detected in some" 6 "RT4: 19.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: " "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favourable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.2 1.0 0.8 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSBP1L1 "FLJ10967, MGC189743" ENSG00000226742 "Heat shock factor binding protein 1 like 1" C9JCN9 18 79964561-79970822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 50.5;SK-MEL-30: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "granulocytes: 17.0;T-cells: 17.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA048273 Approved Approved Nucleoplasm Nucleoplasm "HPA048273: " "unprognostic (2.08e-1)" "unprognostic (2.14e-1)" "unprognostic (1.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.71e-2)" "unprognostic (3.70e-2)" "unprognostic (8.15e-3)" "unprognostic (8.86e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (2.53e-3)" "unprognostic (7.41e-2)" "unprognostic (4.70e-2)" "unprognostic (1.67e-1)" "unprognostic (2.12e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-2)" 7.2 15.4 10.7 4.8 9.9 2.9 18.2 15.2 13.3 10.9 16.3 3.0 14.2 6.9 7.0 11.5 14.4 9.3 8.3 5.8 11.4 7.8 15.2 37.9 11.1 3.8 9.4 5.9 5.7 21.2 8.3 8.2 11.0 15.5 8.9 13.0 8.9 18.5 19.9 12.4 12.1 5.6 6.3 7.1 5.3 10.5 2.1 9.7 0.7 15.2 14.3 6.4 6.6 9.7 1.8 2.0 17.0 4.2 3.1 17.4 3.9 8.9 2.2 0.0 0.1 1.3 4.4 3.8 4.4 9.3 4.3 3.7 4.5 5.8 0.0 1.0 5.2 5.1 7.9 5.0 1.9 9.1 2.1 0.0 2.2 2.1 50.5 0.0 0.0 5.0 14.1 0.4 3.1 0.1 0.0 0.0 0.2 7.2 0.0 0.0 0.0 9.6 0.0 0.0 0.0 15.2 1.9 0.1 0.4 4.6 5.7 28.5 3.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 2.4 0.1 17.0 4.2 5.2 3.8 2.7 4.6 1.5 6.6 4.1 1.7 1.8 17.4 9.3 0.2 3.1 0.9 2.0 2.9 3.9 10.7 9.9 15.2 13.3 11.4 7.8 9.4 5.9 15.5 9.7 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: " "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favourable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favourable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.2 6.3 2.6 3.4 10.5 3.3 3.8 6.6 4.8 4.5 4.9 10.0 19.4 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 7.8 5.6 9.3 4.0 13.5 3.0 6.1 6.0 14.8 5.9 7.7 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 6.0 4.0 4.1 14.1 7.3 13.3 6.2 13.1 10.6 9.1 9.8 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 HSF2BP ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529192-43659493 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 28.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 14.9;hTCEpi: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8" "Low region specificity" "Detected in some" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.7 0.8 1.3 0.6 3.1 0.5 1.1 1.4 4.1 0.9 0.6 3.5 1.8 0.6 1.1 1.1 0.8 1.2 0.7 0.7 1.3 1.5 0.8 0.6 0.6 0.7 2.3 3.0 1.4 0.6 1.2 2.3 1.6 2.7 0.8 0.6 2.6 1.2 1.4 0.5 0.8 0.7 0.7 2.0 0.5 0.7 28.5 1.6 1.0 1.0 0.0 0.6 0.8 0.8 1.5 0.2 0.0 0.1 1.5 2.8 0.8 5.2 1.1 1.4 0.6 0.3 1.4 1.3 1.8 1.1 1.9 1.7 7.1 5.2 4.0 2.9 1.1 2.1 0.7 14.9 0.6 1.0 1.3 0.7 2.2 0.4 1.8 1.7 0.5 0.9 9.8 0.8 4.6 0.5 1.5 1.3 4.6 0.9 2.3 1.6 4.6 2.2 3.4 1.4 0.5 2.3 1.0 1.5 1.1 3.9 1.9 2.1 2.1 1.9 3.0 1.0 3.6 0.2 2.7 1.4 1.0 3.2 1.0 3.5 2.6 0.0 0.1 0.0 0.2 0.0 1.6 1.2 0.5 1.4 0.2 1.5 2.7 2.8 0.0 1.5 0.1 0.2 0.0 0.8 1.3 3.1 1.4 3.6 1.3 1.5 2.3 3.0 2.7 1.6 HSPA12B "C20orf60, dJ1009E24.2" ENSG00000132622 "Heat shock protein family A (Hsp70) member 12B" Q96MM6 20 3732667-3753111 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 6.3;EFO-21: 6.6;HUVEC TERT2: 12.5;TIME: 6.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 11 "monocytes: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013659, HPA015639" Uncertain Approved Nucleoplasm Nucleoplasm "HPA013659: AB_1851195, HPA015639: AB_1851192" "unprognostic (1.00e-1)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (6.99e-2)" "unprognostic (4.53e-2)" "unprognostic (2.09e-1)" "unprognostic (1.21e-1)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.07e-2)" "unprognostic (6.45e-2)" "unprognostic (8.74e-2)" "unprognostic (2.61e-2)" "unprognostic (1.75e-2)" "unprognostic (1.47e-1)" "unprognostic (4.05e-1)" "unprognostic (1.66e-2)" 22.7 3.4 2.6 4.6 4.9 1.8 19.4 1.5 5.5 11.0 4.3 3.9 4.3 2.6 11.7 8.1 6.2 6.2 10.7 14.6 3.1 2.7 5.7 3.0 26.8 2.3 4.1 2.8 6.4 4.8 2.1 1.8 13.9 5.1 5.1 2.0 7.2 5.3 5.4 13.5 4.8 3.6 6.1 2.8 21.2 3.2 5.2 1.8 0.4 6.1 9.6 2.1 4.7 7.5 0.1 0.2 0.0 3.1 0.0 0.2 0.0 0.6 2.2 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.2 0.2 6.6 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 3.4 0.2 0.1 0.1 0.2 0.0 0.1 0.0 12.5 0.4 0.2 0.0 1.3 0.5 1.1 1.4 1.1 2.2 0.3 0.6 0.0 0.0 1.2 1.0 0.4 0.2 0.1 0.2 0.7 6.9 0.2 2.9 1.0 0.5 0.5 0.4 0.6 0.2 1.1 0.6 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 2.6 4.9 1.5 5.5 3.1 2.7 4.1 2.8 5.1 1.8 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell line enriched" "Detected in some" 10 "HEK 293: 302.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: " "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 30.5 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.7 0.0 0.0 2.3 0.0 0.2 302.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Group enriched" "Detected in some" 4 "A549: 23.9;Karpas-707: 71.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: " "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 23.9 0.1 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.5 1.3 1.0 0.0 0.0 0.0 0.5 7.4 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 71.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.4 0.0 0.0 0.1 5.0 0.0 0.1 11.6 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815065 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "testis: 29.1;vagina: 17.0" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.7;U-266/70: 2.8;U-266/84: 2.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles 49000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: " "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favourable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favourable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 0.4 0.5 1.8 0.5 2.2 0.5 1.2 1.4 3.1 0.5 0.7 1.5 0.0 0.3 0.8 3.0 0.8 1.5 0.3 0.5 2.0 1.1 0.9 0.7 1.7 0.7 4.5 0.8 1.1 1.5 0.3 0.7 1.0 2.6 1.2 0.6 0.2 0.4 1.5 3.9 0.6 0.8 0.5 4.6 1.1 0.8 29.1 3.2 0.0 2.0 0.0 0.7 0.5 17.0 0.3 0.0 0.4 0.1 0.0 1.7 1.1 0.0 1.7 0.0 0.0 1.9 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.9 0.0 0.0 6.7 0.0 0.0 0.2 0.2 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 2.8 2.4 0.0 1.7 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 1.3 0.0 0.3 1.5 1.6 0.3 0.0 0.0 0.0 1.7 1.1 1.8 2.2 1.4 3.1 2.0 1.1 4.5 0.8 2.6 3.2 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Cell line enhanced" "Detected in many" "A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: " "prognostic favourable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.6 24.6 3.8 0.0 2.7 0.2 38.4 13.9 32.8 5.6 9.2 0.9 17.4 2.4 5.6 15.1 11.0 0.0 0.7 3.4 1.3 1.9 0.0 1.4 0.0 2.7 0.0 3.3 1.2 0.5 0.8 0.0 0.3 0.0 2.0 2.7 4.3 0.1 0.1 2.8 3.0 1.9 0.0 0.0 8.6 1.5 34.1 1.9 0.6 1.2 0.0 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.5 0.0 0.0 3.1 0.0 3.7 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526910 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;vagina: 99.8" "Cell line enriched" "Detected in some" 7 "Karpas-707: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 67.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 67.6" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: " "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavourable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 6.8 11.9 9.4 10.3 12.4 3.5 43.0 3.5 6.0 1.4 1.9 2.2 1.7 1.9 2.2 1.3 3.2 1.1 9.6 4.5 4.5 9.3 3.1 14.6 13.5 2.1 13.7 1.3 9.3 5.4 0.9 5.4 20.8 5.7 3.3 1.9 1.7 2.9 5.8 1.4 4.4 1.7 4.2 13.2 11.2 3.6 1.4 5.0 1.3 5.8 1.8 2.8 3.1 99.8 0.0 2.5 67.6 9.0 1.6 1.4 2.1 0.5 0.9 0.0 0.2 0.0 0.8 0.7 0.4 0.3 0.1 0.3 0.3 0.5 0.1 1.5 0.1 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.9 0.0 0.0 0.1 2.2 0.1 0.7 0.3 0.0 0.0 0.4 33.3 0.0 0.0 0.1 0.8 0.0 3.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 1.9 0.2 0.4 0.1 0.1 0.3 0.2 2.2 4.5 0.2 0.0 0.8 0.8 1.5 0.8 7.5 2.7 1.4 9.0 0.2 0.0 0.1 0.7 2.5 0.0 0.0 0.3 67.6 1.6 7.3 0.0 0.0 2.1 9.4 12.4 3.5 6.0 4.5 9.3 13.7 1.3 5.7 5.0 HSPA8 "HSC70, HSC71, HSP73, HSPA10" ENSG00000109971 "Heat shock protein family A (Hsp70) member 8" P11142 11 123057489-123063230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation" "Chaperone, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002056, HPA052504" Uncertain Approved Nucleoplasm,Vesicles 210000000 Nucleoplasm Vesicles "CAB002056: , HPA052504: " "unprognostic (2.28e-3)" "unprognostic (1.19e-3)" "prognostic favourable (6.14e-6)" "unprognostic (1.75e-1)" "unprognostic (1.84e-2)" "unprognostic (5.70e-2)" "prognostic unfavourable (1.93e-4)" "unprognostic (9.65e-3)" "unprognostic (3.82e-1)" "unprognostic (9.64e-2)" "unprognostic (2.93e-1)" "unprognostic (3.22e-1)" "prognostic favourable (3.81e-4)" "unprognostic (2.53e-1)" "unprognostic (1.83e-1)" "unprognostic (2.74e-1)" "unprognostic (7.16e-2)" 70.0 96.8 93.7 78.1 102.8 58.1 73.8 119.5 125.1 52.8 64.1 72.0 77.3 77.7 59.9 98.3 83.4 76.2 76.7 106.4 83.1 102.4 128.6 114.2 68.9 93.3 105.7 72.4 66.7 191.1 97.2 98.3 71.6 169.2 65.3 81.0 53.1 62.4 69.9 224.6 31.2 74.4 75.4 91.8 79.7 92.7 58.3 98.1 92.9 90.9 98.3 124.4 76.1 123.2 77.4 47.5 41.1 84.2 76.1 124.3 200.0 82.8 125.6 83.4 72.0 77.2 82.8 110.5 164.7 91.3 201.5 121.3 188.4 109.0 134.9 104.0 91.6 112.9 238.2 59.7 201.2 116.6 36.2 146.4 59.0 91.8 21.1 142.2 112.5 44.1 96.6 61.9 19.3 107.8 158.4 70.2 161.4 73.8 147.8 105.6 131.9 111.9 133.4 59.5 76.3 104.4 60.6 85.6 64.9 120.0 130.3 45.4 113.6 55.7 105.9 101.2 81.3 87.0 145.9 47.4 116.9 115.8 112.8 203.3 122.1 30.3 41.5 41.1 96.5 82.9 115.9 77.4 113.4 105.2 47.5 53.7 109.6 105.1 14.9 76.1 84.2 34.4 124.3 200.0 93.7 102.8 119.5 125.1 83.1 102.4 105.7 72.4 169.2 98.1 HSPB11 "C1orf41, HSPCO34, IFT25, PP25" ENSG00000081870 "Heat shock protein family B (small) member 11" Q9Y547 1 53916574-53945929 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Stress response, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030140 Uncertain Approved Nucleoplasm,Cytosol 18000 Nucleoplasm Cytosol "HPA030140: AB_10600713" "unprognostic (5.73e-2)" "unprognostic (6.37e-3)" "unprognostic (8.81e-2)" "unprognostic (2.99e-3)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (9.58e-7)" "unprognostic (5.12e-1)" "unprognostic (6.70e-3)" "unprognostic (8.31e-3)" "unprognostic (2.22e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (1.03e-6)" "unprognostic (1.84e-2)" "unprognostic (2.74e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-2)" 12.2 19.7 21.5 20.1 19.5 22.6 19.5 13.1 18.6 17.4 15.6 9.5 19.4 11.0 19.1 30.6 19.0 31.9 11.0 12.9 15.4 16.0 16.0 20.0 19.9 24.0 15.0 18.7 20.8 13.4 9.5 31.3 18.2 16.8 15.1 14.6 22.4 13.3 25.1 5.6 16.0 13.1 17.8 17.3 16.0 15.6 19.6 10.0 27.1 40.4 15.0 24.2 23.5 14.3 28.6 35.9 37.5 20.0 31.1 35.0 16.8 20.8 8.9 27.7 6.5 9.6 12.7 11.2 18.7 16.0 26.0 30.7 20.6 11.7 25.3 14.6 12.6 17.0 11.4 17.8 31.1 20.5 16.4 31.0 19.4 27.6 10.4 15.5 21.7 13.2 13.6 24.6 6.9 13.6 18.1 6.0 32.3 4.3 34.5 23.9 11.1 19.4 23.5 35.1 13.0 21.0 23.2 14.1 11.6 26.5 12.2 16.8 76.0 22.6 10.1 18.2 22.3 20.3 19.7 10.9 16.3 25.0 28.8 14.6 15.6 35.4 14.8 37.5 28.0 19.0 25.1 28.6 27.8 33.0 16.8 22.9 21.9 28.0 10.3 31.1 20.0 35.9 35.0 16.8 21.5 19.5 13.1 18.6 15.4 16.0 15.0 18.7 16.8 10.0 HSPB7 cvHSP ENSG00000173641 "Heat shock protein family B (small) member 7" Q9UBY9 1 16014028-16019594 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 524.6;skeletal muscle: 551.1" "Cell line enriched" "Detected in some" 4 "fHDF/TERT166: 81.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA027639 Approved Approved Nucleoplasm 43000 Nucleoplasm "HPA027639: AB_10601756" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.28e-3)" "unprognostic (7.44e-3)" "unprognostic (8.35e-2)" "prognostic unfavourable (5.29e-4)" "unprognostic (1.02e-1)" "unprognostic (5.32e-2)" "unprognostic (2.47e-3)" "unprognostic (3.19e-3)" "unprognostic (6.94e-2)" "unprognostic (1.55e-1)" "unprognostic (1.20e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (9.98e-2)" "prognostic unfavourable (1.26e-4)" 32.3 9.6 0.1 3.3 0.1 0.1 9.0 0.9 0.2 7.0 8.4 0.3 1.3 0.7 12.6 8.0 15.7 4.5 8.2 524.6 0.1 0.0 4.1 0.2 1.2 2.7 0.2 0.3 4.8 1.0 1.1 0.2 0.7 0.9 4.7 0.9 1.7 4.4 2.7 551.1 1.0 2.1 20.1 0.4 0.3 6.1 1.3 0.0 0.0 9.6 70.1 7.2 12.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.1 0.8 0.3 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.0 2.9 0.0 0.0 0.3 0.0 3.8 0.1 0.4 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.0 0.2 0.3 0.9 0.0 HSPB8 "CMT2L, E2IG1, H11, HSP22, HspB8" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119178642-119221131 "Disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 152.6" "Cell line enhanced" "Detected in many" "EFO-21: 29.1;HeLa: 21.7;MCF7: 38.2;U-87 MG: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Cytosol "Nucleoplasm, Nuclear bodies" "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavourable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 12.2 4.4 19.3 8.2 22.7 0.7 6.8 2.0 18.1 15.3 52.7 34.1 13.1 2.8 18.6 7.2 42.9 9.6 12.0 107.9 17.4 17.6 16.3 1.7 13.4 3.3 27.4 14.7 5.7 7.7 73.3 3.0 64.3 24.5 40.1 11.9 21.7 11.4 79.4 152.6 10.0 7.9 65.5 35.0 13.6 20.6 3.6 19.3 5.4 8.0 42.1 26.7 55.6 18.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.4 4.9 0.2 0.0 5.7 4.5 19.1 10.7 9.5 2.2 0.1 12.0 0.2 0.0 29.1 14.8 0.8 0.1 0.0 0.3 0.0 0.4 0.0 21.7 1.0 3.9 0.0 0.0 5.0 1.7 7.2 0.7 4.4 0.0 0.0 5.3 38.2 0.0 0.1 2.2 7.0 0.0 7.9 1.0 15.7 2.0 0.1 0.3 4.1 0.5 2.2 9.9 0.0 6.1 5.3 13.4 6.9 0.5 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.7 2.0 16.0 17.4 17.6 27.4 14.7 24.5 19.3 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell line enhanced" "Detected in many" "EFO-21: 45.8;HUVEC TERT2: 101.1;TIME: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597" "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavourable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 6.8 6.4 2.1 7.5 22.1 16.8 8.5 10.4 2.7 3.0 2.8 7.7 14.1 0.5 45.8 16.1 4.3 0.5 5.1 0.7 0.1 0.7 2.3 6.8 5.6 4.6 0.0 0.6 10.1 1.5 3.1 0.9 101.1 3.1 0.9 4.1 1.9 0.0 3.1 1.9 2.9 1.0 9.0 0.9 5.8 0.9 0.2 0.6 7.9 3.3 4.6 1.3 1.1 80.7 6.0 7.8 4.6 0.3 0.0 1.0 0.3 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873315-32044633 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.4;BEWO: 12.9;RH-30: 14.2;SCLC-21H: 11.6;SiHa: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA027295: , HPA027372: " "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favourable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 1.7 1.9 2.7 2.9 3.5 0.5 2.1 3.2 6.4 1.1 5.9 0.2 12.6 2.4 9.0 3.4 1.1 3.3 1.0 1.7 3.7 3.2 6.0 1.3 1.7 0.7 1.2 2.1 1.8 15.7 0.2 4.7 7.6 1.4 4.0 6.5 9.1 1.5 11.1 0.6 5.0 4.4 4.1 0.9 0.4 2.1 1.8 0.2 0.4 1.1 2.2 1.0 3.8 7.7 1.0 0.7 1.7 0.5 0.5 0.5 0.1 0.0 3.0 10.4 0.1 0.0 0.0 12.9 1.0 0.0 0.2 0.0 4.1 0.1 0.0 0.4 4.8 0.0 6.2 0.0 0.0 0.0 3.1 0.0 2.7 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.9 7.9 0.1 0.1 14.2 0.0 1.1 0.0 11.6 7.7 10.2 0.8 0.4 4.2 1.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 4.9 0.8 0.5 0.5 0.5 0.3 0.3 0.5 0.5 0.3 0.2 1.0 0.5 0.5 1.7 0.5 0.3 0.7 0.4 0.1 2.7 3.5 3.2 6.4 3.7 3.2 1.2 2.1 1.4 0.2 HUS1B ENSG00000188996 "HUS1 checkpoint clamp component B" Q8NHY5 6 655939-656963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;U-266/84: 5.0;WM-115: 5.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA034511, HPA063449" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034511: , HPA063449: " "unprognostic (3.56e-4)" "unprognostic (3.68e-2)" "unprognostic (4.81e-2)" "unprognostic (1.95e-1)" "unprognostic (3.45e-2)" "unprognostic (1.36e-1)" "unprognostic (4.95e-2)" "unprognostic (6.53e-2)" "unprognostic (9.44e-2)" "unprognostic (8.46e-2)" "unprognostic (8.76e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-10)" "unprognostic (7.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" 0.5 0.1 0.1 0.5 0.1 3.3 0.6 0.0 0.0 1.4 0.4 1.3 0.9 0.7 0.9 0.2 0.6 0.5 0.2 0.1 0.6 0.8 1.0 0.2 0.3 0.8 0.0 0.0 0.8 1.1 1.4 0.2 0.5 0.1 0.0 0.9 0.3 1.0 0.6 1.0 0.1 4.3 0.7 0.2 0.3 1.2 1.6 1.6 0.0 0.7 0.0 1.9 0.6 0.6 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.8 0.1 0.3 0.5 0.1 0.0 0.5 0.0 0.4 1.3 4.3 0.9 0.0 0.0 0.3 0.0 1.5 0.0 0.3 0.4 0.4 0.1 1.7 1.0 0.5 0.0 0.4 2.4 2.8 1.4 0.9 0.8 2.5 0.2 0.6 1.0 0.1 0.3 0.0 0.7 0.1 0.1 0.4 0.7 0.8 1.5 0.4 2.2 5.0 1.0 0.1 0.5 5.4 0.0 0.7 0.0 0.7 0.3 0.5 1.6 1.1 0.9 0.0 0.8 1.0 1.9 0.0 0.0 0.0 1.6 0.7 0.6 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell line enhanced" "Detected in many" "Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: " "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.6 1.3 0.9 2.9 1.6 1.3 1.6 1.6 1.1 1.4 1.2 1.1 1.8 0.0 5.7 1.4 1.1 0.0 1.2 0.4 19.8 0.8 5.0 1.2 5.0 0.8 18.3 20.7 1.1 1.0 1.6 0.5 0.6 2.7 64.3 1.5 5.4 2.4 41.4 0.7 9.0 1.5 0.6 48.2 1.4 2.3 0.3 1.2 1.4 4.5 3.6 3.9 5.2 1.1 6.3 0.5 7.0 1.6 3.1 34.1 7.6 4.5 33.8 4.9 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684453 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 274.1" "Cell line enhanced" "Detected in many" "HDLM-2: 107.5;HEK 293: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 110.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favourable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 34.2 37.4 24.9 19.1 20.6 69.8 31.5 11.3 57.3 21.9 34.0 22.9 13.2 20.7 18.6 11.6 12.1 28.1 33.5 46.1 20.0 14.6 31.2 117.5 25.4 22.4 19.0 35.3 59.7 15.0 274.1 17.2 14.8 20.0 27.2 26.4 13.3 24.5 72.7 8.8 16.6 20.4 19.2 15.8 21.3 16.2 7.1 14.2 19.0 46.8 15.1 10.2 31.8 38.0 0.3 25.0 110.4 26.0 90.9 42.4 18.0 0.2 19.9 8.2 10.1 13.2 2.1 31.4 22.7 2.7 10.2 4.3 39.8 1.0 0.5 27.0 38.8 17.1 5.3 0.1 3.0 107.5 69.6 14.3 12.2 48.6 3.9 10.6 40.3 3.6 0.4 4.6 0.2 0.2 0.8 17.0 15.7 6.7 1.1 1.2 14.9 15.7 1.4 5.7 10.7 10.2 8.9 15.5 22.0 1.2 17.3 1.7 2.8 6.3 4.1 12.6 2.2 18.6 1.3 1.3 1.0 12.4 15.9 32.8 6.8 9.0 8.2 110.4 42.4 24.2 25.3 0.3 13.1 29.5 25.0 0.2 16.4 31.4 11.2 90.9 26.0 1.1 1.0 18.0 24.9 20.6 11.3 57.3 20.0 14.6 19.0 35.3 20.0 14.2 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088712-181092899 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favourable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavourable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 9.4 7.2 4.7 16.2 5.4 45.7 13.8 6.2 12.6 7.8 7.8 5.1 5.9 6.6 12.8 5.3 20.9 14.3 10.3 22.9 6.0 4.9 3.7 6.7 22.6 9.6 10.1 5.7 4.4 4.3 1.8 4.6 34.5 6.9 6.7 6.9 3.7 5.7 4.9 42.3 16.6 10.8 9.6 7.2 27.3 6.8 5.1 5.0 11.2 4.3 22.9 19.8 8.4 16.3 5.4 1.6 5.4 7.8 1.5 2.1 0.9 12.0 10.5 5.8 5.1 8.1 11.2 15.6 21.3 22.6 12.1 10.8 2.9 6.8 3.9 9.5 8.2 22.2 1.8 14.5 7.8 22.6 9.2 3.5 5.4 1.9 12.7 4.1 11.5 8.0 14.7 14.0 9.4 8.1 14.6 18.0 21.3 5.4 4.0 6.5 6.1 5.3 4.7 10.2 14.9 4.3 6.6 8.4 9.1 10.8 10.6 23.5 8.4 3.5 12.3 8.7 15.3 9.9 12.8 12.0 4.2 3.1 6.8 4.3 2.4 5.4 2.1 3.8 1.6 7.8 1.9 5.4 1.4 2.1 1.6 3.6 0.3 0.9 1.8 1.5 7.3 0.2 1.8 0.9 4.7 5.4 6.2 12.6 6.0 4.9 10.1 5.7 6.9 5.0 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 15.2;SiHa: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavourable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 12.6 11.3 6.0 6.4 9.0 3.3 31.3 2.1 15.3 29.6 8.2 3.5 14.9 5.0 17.4 10.8 13.0 11.0 14.3 14.9 6.4 5.0 14.8 15.0 9.4 8.1 5.5 3.9 35.0 5.4 3.2 8.0 9.8 7.9 15.2 3.7 6.1 8.1 30.1 8.4 8.0 5.3 10.5 11.8 5.7 11.1 6.2 4.1 1.2 9.4 4.9 3.8 20.7 25.5 0.0 0.3 2.1 1.1 0.4 0.8 0.2 5.1 15.2 4.3 8.3 3.2 5.1 13.1 7.7 0.7 1.2 1.2 0.8 8.5 0.1 3.1 1.8 11.3 0.2 0.9 0.2 0.7 1.1 0.0 3.2 1.4 2.4 0.1 0.1 5.6 1.2 0.9 0.1 0.5 0.4 2.7 0.2 13.2 0.1 0.6 0.4 8.0 0.7 0.3 2.2 4.6 0.7 1.9 2.6 21.4 7.0 8.7 2.1 1.3 3.1 7.4 4.4 5.0 11.0 1.5 1.0 0.1 9.5 1.5 3.2 0.0 1.1 0.0 0.3 0.6 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 2.1 0.4 0.2 0.1 0.0 0.2 6.0 9.0 2.1 9.0 6.4 5.0 5.5 3.9 7.9 4.1 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell line enhanced" "Detected in many" "HDLM-2: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: " "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.2 13.5 3.6 10.0 2.3 1.9 5.9 6.2 4.1 3.4 2.4 18.5 9.7 0.1 8.1 4.7 20.8 2.7 13.3 2.8 49.4 2.4 0.1 2.5 7.2 1.7 1.4 15.9 1.2 13.5 4.6 5.9 7.3 0.6 1.6 2.2 1.7 1.3 1.3 1.5 3.2 4.6 2.2 3.5 2.0 5.3 11.7 0.6 4.7 6.7 4.6 1.8 0.7 19.8 4.6 6.4 2.7 18.0 3.6 3.9 0.2 3.1 2.0 5.4 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 IFI35 IFP35 ENSG00000068079 "Interferon induced protein 35" P80217 17 43006725-43014456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.4;BJ hTERT+ SV40 Large T+ RasG12V: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045946, HPA075580" Approved Approved Nucleoplasm,Cytosol 93000 "Nucleoplasm, Cytosol" "HPA045946: , HPA075580: " "prognostic favourable (1.41e-4)" "unprognostic (1.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.16e-1)" "unprognostic (1.32e-1)" "unprognostic (3.26e-1)" "unprognostic (3.90e-3)" "unprognostic (1.14e-1)" "unprognostic (6.92e-2)" "unprognostic (9.78e-3)" "unprognostic (6.51e-3)" "unprognostic (1.22e-1)" "prognostic unfavourable (4.03e-5)" "unprognostic (3.55e-1)" "unprognostic (3.62e-2)" "unprognostic (1.34e-2)" "unprognostic (1.49e-1)" 24.9 27.9 9.3 18.1 12.4 14.6 15.1 5.0 9.3 10.7 20.5 9.4 12.8 15.9 13.6 17.4 11.3 14.0 15.5 13.2 7.7 7.0 21.8 26.2 17.7 20.2 9.4 8.1 19.2 11.0 8.3 10.1 15.8 9.5 24.2 13.6 19.5 18.7 10.8 6.4 7.3 33.6 14.1 9.2 31.5 14.9 5.7 9.7 19.5 30.3 8.3 17.8 13.2 10.1 13.2 23.3 22.2 43.2 18.6 17.6 24.9 2.9 6.9 0.0 0.3 6.0 7.3 1.4 1.9 20.5 50.4 74.4 2.5 11.1 0.9 3.9 5.9 1.6 0.3 3.1 4.0 7.8 1.4 2.1 2.5 9.2 15.0 2.4 4.7 10.1 1.2 7.1 0.8 4.5 1.2 14.8 2.0 2.9 5.1 1.9 0.0 3.1 4.2 0.0 5.4 6.2 2.5 1.3 0.0 3.9 1.4 20.2 6.4 4.7 2.2 3.7 0.0 1.1 3.1 13.2 4.9 0.2 6.6 1.9 3.5 19.1 35.9 20.5 16.6 43.2 15.2 12.9 12.9 15.4 21.7 13.2 10.4 12.8 22.2 18.6 39.3 23.3 17.6 24.9 9.3 12.4 5.0 9.3 7.7 7.0 9.4 8.1 9.5 9.7 IFI44 "MTAP44, p44, TLDC5" ENSG00000137965 "Interferon induced protein 44" Q8TCB0 1 78649796-78664078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 47.9;BJ hTERT+ SV40 Large T+ RasG12V: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA027148, HPA043858" Approved Approved Nucleoplasm Nucleoplasm "HPA027148: AB_1851411, HPA043858: " "unprognostic (1.20e-1)" "unprognostic (6.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.13e-3)" "unprognostic (1.63e-1)" "unprognostic (8.81e-2)" "unprognostic (5.52e-2)" "unprognostic (8.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-3)" "unprognostic (1.51e-1)" "prognostic unfavourable (1.37e-8)" "unprognostic (1.71e-1)" "unprognostic (2.07e-3)" "unprognostic (8.89e-2)" "unprognostic (4.90e-2)" 35.2 12.6 10.2 16.2 11.7 47.8 13.0 4.3 8.2 10.0 8.1 6.6 10.5 10.5 13.6 29.9 15.2 8.3 24.9 10.7 10.8 9.8 26.9 11.2 18.6 16.5 11.9 10.5 10.9 5.2 3.0 19.6 11.4 10.5 11.0 5.3 11.3 35.4 13.2 7.5 5.5 8.8 10.2 15.1 32.3 11.2 4.8 11.0 22.3 13.8 11.3 8.1 13.6 8.0 2.2 5.9 3.7 13.0 6.1 12.4 5.5 2.0 0.0 0.3 0.0 1.4 10.0 0.0 1.3 17.4 47.9 59.2 0.0 5.8 2.7 13.6 1.2 1.1 0.0 0.7 7.8 5.8 0.0 6.9 5.1 0.0 2.0 0.0 0.0 6.3 0.0 20.8 0.2 8.9 0.0 9.4 11.3 0.0 5.7 0.5 0.0 3.8 4.5 14.5 0.3 1.4 1.3 0.1 0.3 0.4 0.1 20.5 0.0 0.2 11.0 8.8 3.7 0.9 8.8 0.8 0.9 0.0 13.7 7.9 2.4 0.3 13.0 0.1 6.2 12.3 12.4 2.2 9.1 5.9 5.9 1.6 3.9 5.0 3.7 6.1 6.3 1.7 4.3 5.5 10.2 11.7 4.3 8.2 10.8 9.8 11.9 10.5 10.5 11.0 IFI44L "C1orf29, GS3686" ENSG00000137959 "Interferon induced protein 44 like" Q53G44 1 78619922-78646145 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 25.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.4;HSkMC: 14.7;SK-MEL-30: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053247, HPA060372" Uncertain Approved Nucleoplasm Nucleoplasm "HPA053247: , HPA060372: " "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.99e-3)" "prognostic unfavourable (2.95e-4)" "prognostic favourable (3.82e-4)" "unprognostic (1.35e-1)" "unprognostic (4.52e-3)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (3.26e-2)" "unprognostic (3.33e-3)" "unprognostic (1.61e-1)" "prognostic unfavourable (1.06e-4)" "unprognostic (7.58e-2)" "unprognostic (1.10e-3)" "unprognostic (2.24e-1)" "unprognostic (9.03e-2)" 33.6 5.3 9.4 6.2 10.6 36.2 7.6 3.3 10.4 3.8 4.0 12.3 2.7 3.5 10.6 19.7 3.8 4.9 15.0 7.4 9.2 11.0 15.7 4.9 9.5 5.1 10.6 9.4 6.6 2.2 1.9 5.6 8.6 21.6 5.4 3.1 14.4 26.3 5.2 3.5 2.7 3.8 7.0 17.2 23.1 3.7 5.0 12.2 21.6 10.0 4.9 5.2 10.4 3.2 3.6 2.2 2.3 5.6 4.4 2.2 1.5 0.0 0.0 1.0 0.0 0.5 6.8 0.0 0.2 5.3 25.3 27.4 0.0 0.3 5.6 3.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 0.0 0.6 0.1 0.1 14.7 0.1 1.8 0.3 0.2 0.0 0.8 0.5 0.0 0.3 0.1 0.0 2.5 0.0 0.0 0.0 1.3 0.1 0.0 0.0 6.8 0.0 11.5 0.0 0.1 0.2 0.2 0.3 0.5 0.7 1.1 0.2 0.0 4.2 0.0 0.0 0.1 5.0 0.3 0.5 5.6 1.6 3.6 2.2 1.7 1.6 1.6 0.8 0.8 2.3 4.4 2.1 2.2 0.5 1.5 9.4 10.6 3.3 10.4 9.2 11.0 10.6 9.4 21.6 12.2 IFNGR2 "AF-1, IFNGT1" ENSG00000159128 "Interferon gamma receptor 2" P38484 21 33402896-33479348 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 55.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001535 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA001535: AB_1078432" "unprognostic (9.58e-2)" "unprognostic (5.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.25e-4)" "unprognostic (3.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.53e-2)" "unprognostic (3.25e-2)" "unprognostic (9.49e-2)" "prognostic unfavourable (1.13e-10)" "unprognostic (6.74e-3)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (2.15e-3)" 27.2 13.4 11.9 20.8 12.6 45.1 64.4 4.6 18.0 12.5 21.6 5.7 13.0 18.5 10.6 14.1 21.9 11.5 15.2 17.7 11.1 10.1 14.6 20.2 26.3 46.3 8.7 9.4 13.0 21.7 7.1 12.6 20.5 12.2 14.9 11.7 12.1 21.9 11.7 13.1 16.7 20.0 15.3 18.1 27.4 30.3 14.1 7.2 7.9 18.1 19.4 18.9 14.8 26.8 13.2 7.7 55.1 22.8 0.3 3.3 13.8 3.0 2.6 1.3 2.7 3.7 6.4 4.3 8.6 6.3 2.0 3.3 3.0 1.7 5.2 4.8 5.2 2.3 2.7 6.0 1.1 20.0 16.9 1.5 1.1 2.7 2.5 7.5 4.7 4.8 4.0 3.4 3.5 5.1 7.9 2.5 2.7 0.9 1.8 5.1 4.9 16.4 4.4 4.1 4.3 2.2 4.1 1.8 4.6 4.3 0.5 8.2 1.6 4.8 8.6 2.5 5.4 2.1 2.1 5.5 7.5 6.7 2.2 6.7 11.8 12.9 22.2 14.8 0.1 22.0 0.1 11.5 1.3 0.1 7.7 13.2 3.3 1.4 55.1 0.3 22.8 2.4 1.4 13.8 11.9 12.6 4.6 18.0 11.1 10.1 8.7 9.4 12.2 7.2 IFT27 "BBS19, RABL4, RAYL" ENSG00000100360 "Intraflagellar transport 27" Q9BW83 22 36758202-36776256 "Disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "U-138 MG: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018418 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA018418: AB_1856029" "unprognostic (3.04e-2)" "unprognostic (7.25e-3)" "unprognostic (7.06e-2)" "prognostic favourable (1.91e-4)" "unprognostic (9.04e-2)" "unprognostic (6.05e-2)" "unprognostic (6.22e-2)" "unprognostic (1.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.75e-3)" "unprognostic (4.85e-3)" "unprognostic (2.10e-1)" "unprognostic (9.62e-3)" "unprognostic (8.08e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-1)" "prognostic favourable (5.55e-4)" 10.9 17.0 21.1 12.7 27.4 8.5 9.2 13.4 20.6 14.9 12.8 15.8 21.9 13.4 12.5 22.1 10.9 40.5 13.0 18.5 19.3 20.6 16.4 17.4 10.2 9.5 19.4 16.4 14.9 17.6 20.9 30.2 8.9 20.0 16.4 11.0 16.1 15.4 19.6 14.7 9.6 12.9 9.9 17.4 9.3 13.7 20.1 14.5 18.6 23.2 6.0 9.8 11.0 11.8 17.7 27.0 23.3 22.6 14.5 19.9 13.9 6.1 7.7 9.1 10.3 7.3 7.0 5.4 5.0 6.5 6.6 5.9 0.3 5.6 6.7 8.8 4.6 5.7 4.9 5.6 5.1 12.9 13.3 1.8 1.6 0.0 13.5 2.1 8.4 5.7 9.2 7.0 3.2 6.9 3.1 5.6 4.4 11.3 2.6 1.8 4.9 10.1 12.7 0.0 3.7 6.5 4.0 8.8 9.6 5.3 4.1 12.6 9.2 3.8 4.1 59.5 3.4 7.6 0.9 13.2 8.0 2.4 9.2 5.4 12.6 8.5 22.6 23.3 18.3 16.4 18.2 16.7 15.2 16.8 27.0 17.7 15.1 14.3 8.1 14.5 19.3 20.9 19.9 13.9 21.1 27.4 13.4 20.6 19.3 20.6 19.4 16.4 20.0 14.5 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell line enhanced" "Detected in some" "A549: 5.0;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.6" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.6 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Cell line enhanced" "Detected in some" "CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: , HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favourable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 14.9 0.1 0.4 0.0 112.8 0.0 0.0 1.1 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 77.4 19.8 0.0 0.0 24.1 0.0 0.1 0.0 0.1 0.0 0.0 44.5 0.2 0.0 0.1 0.1 0.2 0.0 55.3 0.1 0.0 0.1 4.4 67.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 412.2;U-2197: 171.0;U-87 MG: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" 3247666667 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavourable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavourable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavourable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.3 2.8 5.5 0.0 4.2 1.7 0.0 41.2 7.5 3.5 1.9 0.0 7.6 0.0 13.1 412.2 22.6 0.0 0.1 1.4 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.4 0.6 0.7 2.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.5 0.0 0.0 3.8 2.6 20.4 0.6 1.6 14.2 0.5 0.7 0.0 0.0 0.0 40.7 0.0 171.0 2.3 0.5 0.0 0.0 88.5 0.0 13.7 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "AF22: 68.0;NTERA-2: 18.7;RH-30: 19.5;SCLC-21H: 70.0;SH-SY5Y: 67.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 68.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.1 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 18.7 0.1 0.0 19.5 0.1 0.0 0.0 70.0 67.9 1.1 0.0 0.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell line enriched" "Detected in single" 42 "CACO-2: 42.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" Nucleoplasm "Plasma membrane" "HPA059137: " "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.8" "Group enriched" "Detected in some" 5 "HeLa: 25.0;HL-60: 12.1;REH: 9.0;RPMI-8226: 29.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA012921 Uncertain Approved "Nucleoplasm,Intermediate filaments" "Secreted - unknown location" 280000 "Intermediate filaments" Nucleoplasm "HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 2.5 2.9 0.6 0.1 0.4 0.0 4.5 0.0 0.2 0.3 0.5 0.0 0.7 0.8 2.0 3.4 7.3 4.1 0.7 0.8 0.0 0.0 6.7 0.5 0.3 17.8 0.1 0.7 1.5 0.0 0.0 0.6 3.7 0.0 0.0 1.2 0.7 0.7 0.3 0.2 0.4 0.3 1.3 1.6 1.5 0.1 0.2 1.5 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.2 3.9 25.0 0.0 0.9 12.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 29.0 0.0 0.0 0.5 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 3.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Cell line enhanced" "Detected in some" "A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 5.9 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 25.6 0.5 0.1 0.0 0.0 1.0 0.0 0.0 8.9 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Cell line enhanced" "Detected in some" "CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA051811: , HPA054591: " "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favourable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.6 0.0 0.6 13.7 0.4 0.0 1.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.3 2.2 0.0 0.3 0.0 2.5 0.4 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Cell line enhanced" "Detected in many" "HDLM-2: 61.2;WM-115: 59.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036305: , HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavourable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavourable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favourable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.3 9.1 7.0 1.7 1.6 3.4 18.9 0.0 0.2 0.7 0.2 5.2 3.0 0.0 2.8 0.0 14.9 3.1 7.3 0.3 61.2 2.3 2.9 3.5 0.1 0.0 0.2 5.5 0.4 5.8 0.0 1.3 0.0 0.8 0.0 0.1 18.7 0.2 0.1 4.4 0.2 2.1 8.6 0.0 5.4 6.7 4.1 12.5 2.2 21.0 13.5 7.0 0.3 0.0 1.2 4.2 0.0 5.5 0.0 0.3 0.0 0.5 0.1 59.0 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell line enhanced" "Detected in many" "MOLT-4: 19.2;RT4: 18.3;U-698: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 3.4 2.4 6.1 4.1 12.4 5.9 4.0 8.0 8.6 4.9 2.6 5.3 7.6 1.0 2.3 3.9 24.8 3.4 3.6 2.8 6.3 2.6 2.1 2.1 3.7 7.4 11.8 3.4 2.5 3.0 9.7 6.9 3.2 8.6 5.4 2.0 2.3 13.5 9.2 4.3 10.4 2.5 1.2 9.1 5.9 5.2 2.8 13.4 55.8 9.2 5.5 7.5 11.9 11.6 1.5 0.7 5.7 0.0 7.2 7.1 0.3 1.8 0.6 3.5 0.2 11.5 11.6 2.2 2.2 2.5 0.5 1.1 0.9 3.0 2.3 2.9 1.3 4.2 0.0 1.1 1.8 0.0 0.6 1.2 2.3 0.3 0.1 5.5 0.4 11.3 1.0 0.0 0.3 0.0 0.7 2.0 1.0 3.3 19.2 5.6 0.7 0.5 11.4 2.3 0.0 1.0 18.3 1.1 0.6 0.0 2.3 0.0 3.1 0.6 5.9 3.3 2.5 1.5 0.4 3.9 1.2 13.2 1.6 0.0 0.7 4.1 0.0 5.7 2.5 0.0 6.5 0.2 0.8 1.9 0.0 1.5 0.4 1.9 0.0 7.2 0.0 0.7 7.1 0.3 6.1 12.4 8.0 8.6 6.3 2.6 11.8 3.4 8.6 13.4 IL13RA1 "CD213a1, IL-13Ra, NR4" ENSG00000131724 "Interleukin 13 receptor subunit alpha 1" P78552 X 118727572-118794539 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 6.9;eosinophil: 7.1;myeloid DC: 10.9;neutrophil: 19.0" "Group enriched" "Detected in many" 6 "dendritic cells: 10.9;granulocytes: 19.0;monocytes: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001587 Approved Nucleoplasm,Vesicles "Intracellular and membrane" 4500000 Vesicles Nucleoplasm "HPA001587: AB_1079133" "unprognostic (5.14e-3)" "unprognostic (4.72e-2)" "unprognostic (7.12e-2)" "unprognostic (7.75e-2)" "unprognostic (8.81e-3)" "unprognostic (3.82e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (1.51e-1)" "unprognostic (2.44e-1)" "unprognostic (1.90e-1)" "unprognostic (8.21e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (1.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.82e-2)" "unprognostic (5.08e-2)" 31.5 17.5 9.3 15.3 13.3 2.1 19.8 3.6 10.2 16.6 23.8 12.6 7.2 18.9 16.6 18.0 33.0 15.4 17.7 17.5 11.4 9.4 22.7 73.3 27.7 33.9 15.2 6.0 25.2 12.9 9.5 16.1 15.2 13.4 15.3 25.2 14.5 21.8 13.0 22.3 10.2 37.7 16.3 24.5 17.4 18.5 9.9 11.9 4.8 24.0 20.1 20.0 16.5 15.4 1.9 10.9 19.0 6.9 0.0 0.1 1.7 8.2 10.2 4.9 13.4 11.1 33.1 8.8 17.3 24.1 8.3 10.8 5.9 15.3 0.0 30.5 23.8 7.9 5.3 7.3 9.2 45.1 4.1 1.4 9.3 15.1 6.8 0.1 3.6 30.1 6.7 11.3 13.9 17.2 4.4 0.9 11.7 12.1 0.0 2.2 4.4 9.9 0.0 12.0 0.0 12.4 9.0 1.8 1.7 27.2 10.0 6.8 6.4 7.8 21.9 16.2 7.7 27.2 13.5 0.2 4.1 0.0 35.7 4.2 6.8 0.0 6.9 7.1 0.0 1.7 0.0 1.9 0.0 0.0 10.9 1.8 0.0 0.0 19.0 0.0 0.6 1.9 0.1 1.7 9.3 13.3 3.6 10.2 11.4 9.4 15.2 6.0 13.4 11.9 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell line enhanced" "Detected in many" "HL-60: 27.0;NB-4: 23.7;THP-1: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favourable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.4 3.8 2.2 2.4 5.3 3.5 2.5 3.2 2.0 2.4 3.3 2.2 5.3 5.8 2.6 2.5 1.8 5.3 3.1 0.0 1.2 1.2 4.4 27.0 8.4 3.3 3.7 2.2 1.7 2.7 1.4 3.4 2.5 3.0 3.2 23.7 1.0 2.0 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.7 3.2 2.6 2.5 34.1 7.4 2.0 2.8 2.9 1.9 2.8 1.5 1.6 2.8 13.1 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 IL1R1 "CD121A, D2S1473, IL1R, IL1RA" ENSG00000115594 "Interleukin 1 receptor type 1" P14778 2 102064544-102179874 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 93.4;ASC TERT1: 41.7;HHSteC: 29.3;HSkMC: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001237, HPA005823, CAB007779, HPA029560" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Secreted to blood" 1000000 "Nucleoplasm, Vesicles" "Plasma membrane, Cytosol" "CAB007779: AB_562073, HPA001237: , HPA005823: , HPA029560: " "unprognostic (6.16e-3)" "unprognostic (3.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (7.10e-2)" "unprognostic (2.01e-1)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (3.16e-1)" "unprognostic (4.26e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (6.92e-6)" "unprognostic (2.48e-2)" "unprognostic (6.95e-2)" "unprognostic (4.83e-2)" "unprognostic (7.73e-2)" 48.6 25.2 2.6 18.2 5.2 4.0 92.4 2.4 3.9 47.8 21.0 2.5 34.3 5.2 15.2 30.2 18.2 17.1 25.8 27.0 4.2 2.5 23.7 74.8 40.5 28.0 5.6 1.1 25.1 17.1 16.9 7.3 66.2 10.9 26.0 8.4 8.6 12.7 36.4 15.5 13.5 13.0 15.1 10.0 19.2 15.6 13.4 2.8 3.5 33.6 9.0 9.6 32.0 36.4 0.1 0.1 4.0 0.5 0.8 1.8 0.2 0.2 1.8 0.0 1.5 93.4 41.7 0.6 3.9 17.7 2.8 4.2 0.8 0.4 0.0 2.9 7.8 0.7 0.0 0.3 2.3 7.7 0.0 0.1 0.4 4.3 29.3 0.0 0.0 115.0 0.3 3.1 0.7 1.2 0.4 0.1 4.0 0.7 0.0 0.1 0.1 0.1 0.0 0.2 0.0 2.6 1.9 0.0 0.0 1.7 1.1 0.0 1.6 0.1 0.0 8.0 0.5 13.4 0.3 0.0 0.0 0.0 3.1 0.0 0.5 0.6 0.5 0.1 0.0 0.0 0.7 0.1 1.1 0.0 0.1 0.1 0.0 0.1 4.0 0.8 0.0 0.1 1.8 0.2 2.6 5.2 2.4 3.9 4.2 2.5 5.6 1.1 10.9 2.8 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell line enhanced" "Detected in some" "A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" 421933 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavourable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavourable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavourable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.2 0.1 0.1 0.0 40.8 0.0 1.1 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.1 7.7 0.0 5.3 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 0.3 0.0 0.0 11.5 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.0 3.9 4.6 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.9;HHSteC: 7.7;hTERT-HME1: 10.8;U-2 OS: 16.0;U-87 MG: 18.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051532: , HPA068114: " "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.1 1.1 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 8.9 1.8 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 6.0 3.0 4.3 10.8 3.3 0.0 0.4 1.4 0.0 0.0 1.4 0.0 6.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.5 0.5 16.0 0.0 1.0 0.0 0.0 0.0 18.5 0.0 2.5 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.6;testis: 48.8" "Cell line enhanced" "Detected in some" "EFO-21: 17.6;HDLM-2: 30.5;Karpas-707: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 38.6" "Group enriched" "Detected in many" 6 "monocytes: 13.0;T-cells: 38.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 5.4 3.3 4.0 30.9 4.6 7.1 4.1 5.8 5.6 4.6 4.1 5.5 2.9 8.2 5.9 3.4 4.5 8.2 5.4 4.2 3.9 3.5 11.0 3.5 6.7 15.5 4.0 3.2 6.2 3.7 1.5 5.1 6.8 4.3 5.3 3.8 3.9 4.1 5.0 6.2 3.4 7.4 3.8 7.2 7.6 6.2 48.8 4.4 14.6 4.1 4.4 12.3 6.5 4.9 0.2 4.1 0.1 13.0 0.4 38.6 3.0 0.5 0.6 0.4 0.4 0.0 0.4 0.1 0.3 1.0 0.7 1.0 0.3 1.0 1.7 17.6 0.2 0.3 0.2 0.0 0.1 30.5 0.1 0.8 0.0 0.2 0.1 0.6 6.3 0.5 0.2 0.3 0.0 1.3 0.1 24.7 0.0 0.2 0.3 1.0 0.2 0.1 0.5 0.5 1.7 1.2 1.5 0.3 0.4 0.2 0.4 0.3 0.2 1.4 1.5 3.7 0.5 0.0 0.5 2.1 4.6 1.0 0.5 0.2 0.4 0.1 8.0 0.1 2.3 13.0 38.6 0.2 5.0 4.3 4.1 0.1 0.1 0.0 0.1 0.4 1.6 0.4 0.2 3.0 4.0 4.6 5.8 5.6 3.9 3.5 4.0 3.2 4.3 4.4 IL4R CD124 ENSG00000077238 "Interleukin 4 receptor" P24394 16 27313668-27364778 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 35.8;HBEC3-KT: 34.4;U-698: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 34.4" "Group enriched" "Detected in all" 6 "B-cells: 34.4;granulocytes: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004451, HPA050124, HPA070380" Enhanced Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" "Secreted to blood" 49000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "CAB004451: AB_626889, HPA050124: , HPA070380: " "unprognostic (6.80e-2)" "unprognostic (6.35e-2)" "unprognostic (2.84e-1)" "prognostic favourable (6.43e-4)" "unprognostic (1.12e-1)" "unprognostic (1.14e-1)" "unprognostic (2.33e-2)" "unprognostic (1.95e-3)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.23e-5)" "unprognostic (1.49e-2)" "unprognostic (1.73e-1)" "unprognostic (1.36e-1)" "unprognostic (9.58e-2)" 20.7 14.8 8.7 31.6 10.6 36.9 12.0 4.4 7.7 20.8 30.3 5.9 11.5 10.9 18.0 12.8 24.7 13.6 25.1 12.3 6.7 4.4 13.3 39.1 40.9 44.8 10.8 1.7 14.7 11.3 3.8 5.5 16.1 10.1 18.8 15.1 12.3 7.7 11.5 7.2 9.9 18.6 39.6 13.6 31.8 21.1 10.4 9.8 9.1 8.6 13.7 38.4 31.6 15.4 34.4 1.6 11.9 2.6 3.3 4.0 1.8 11.3 3.0 1.9 3.9 0.9 4.5 4.1 7.2 8.3 2.9 2.3 6.1 31.4 35.8 9.0 11.3 12.1 2.1 34.4 2.5 31.0 1.0 6.7 1.8 9.3 13.0 1.8 19.1 6.9 13.9 13.2 7.9 15.4 2.9 3.0 4.6 5.0 0.1 5.4 2.4 2.6 0.1 14.9 2.9 13.3 13.0 0.6 0.3 1.0 6.9 1.5 2.6 6.9 23.0 6.5 2.9 5.8 5.0 1.8 0.5 33.3 0.7 6.0 0.0 0.5 2.6 4.7 1.7 1.1 1.3 7.7 2.6 1.7 1.6 34.4 4.0 1.9 11.9 3.3 0.6 1.6 1.8 1.8 8.7 10.6 4.4 7.7 6.7 4.4 10.8 1.7 10.1 9.8 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Cell Junctions,Focal adhesion sites" 130000000 "Cell Junctions, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: " "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favourable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 20.9 17.6 11.0 22.3 11.9 7.5 37.0 9.4 14.6 40.2 75.1 14.7 41.9 13.5 75.4 25.2 35.7 33.2 41.1 35.1 11.1 9.2 21.6 15.1 21.9 18.9 11.5 14.0 24.2 22.3 20.4 10.9 22.2 11.5 39.9 24.6 19.3 19.4 89.9 18.5 12.4 22.2 103.5 10.6 20.2 33.2 14.2 11.0 8.2 17.5 14.1 13.6 60.8 25.9 19.5 45.9 76.5 49.4 45.3 25.8 63.7 23.8 18.4 29.1 10.0 44.9 31.9 13.2 35.1 69.4 41.6 50.8 19.2 28.1 9.0 9.3 57.4 19.2 16.2 29.7 41.8 15.7 14.8 12.9 17.6 14.9 30.1 10.3 14.8 30.6 14.0 28.1 21.5 39.6 11.8 10.7 54.2 17.9 9.1 17.7 18.3 21.6 9.6 15.2 9.5 30.5 19.1 5.0 11.4 16.6 23.0 19.3 16.0 11.8 45.8 52.2 23.6 21.6 17.0 7.8 4.8 12.6 38.7 15.6 24.3 48.3 49.4 76.5 25.8 47.9 25.1 19.5 23.3 24.4 45.9 17.1 14.7 18.5 31.7 45.3 44.4 18.5 25.7 63.7 11.0 11.9 9.4 14.6 11.1 9.2 11.5 14.0 11.5 11.0 IMPA1 IMPA ENSG00000133731 "Inositol monophosphatase 1" P29218 8 81657961-81686693 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037489 Approved Approved Nucleoplasm,Mitochondria 390000 Mitochondria Nucleoplasm "HPA037489: AB_10671757" "unprognostic (1.78e-1)" "unprognostic (3.59e-2)" "unprognostic (6.95e-3)" "unprognostic (2.15e-3)" "unprognostic (1.31e-1)" "unprognostic (6.27e-2)" "unprognostic (3.80e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-1)" "unprognostic (4.68e-2)" "unprognostic (7.78e-2)" "unprognostic (6.26e-2)" "unprognostic (2.52e-2)" "unprognostic (5.87e-2)" "unprognostic (1.84e-1)" "unprognostic (2.42e-1)" "unprognostic (5.41e-3)" 10.8 10.9 16.2 10.5 20.9 20.8 9.2 11.2 29.7 9.4 22.4 15.3 4.7 20.1 10.8 12.0 17.2 10.3 11.0 22.3 17.6 19.7 25.5 29.4 9.8 14.3 18.9 20.7 12.1 8.5 8.6 20.1 7.2 27.3 10.6 25.4 14.8 8.9 7.3 11.2 5.0 23.5 15.0 19.1 12.9 12.2 30.5 13.8 16.2 20.3 12.0 13.7 10.5 10.7 13.2 8.2 24.1 7.5 13.6 12.9 7.2 5.7 15.8 11.0 8.3 6.4 10.2 4.5 16.6 12.0 14.9 18.0 7.4 9.1 21.8 13.3 11.8 4.4 12.7 5.7 20.1 22.8 13.0 16.4 8.7 9.2 11.6 16.4 16.8 9.7 8.3 11.4 22.6 16.2 14.8 18.5 14.9 3.6 20.8 9.5 4.7 16.9 9.8 8.3 8.9 17.2 18.6 4.5 19.0 10.9 2.9 19.9 9.5 13.2 12.5 12.3 15.7 9.5 20.5 21.7 25.8 30.5 14.3 9.9 16.8 24.1 4.7 19.5 9.9 6.6 12.1 13.2 10.1 10.7 5.0 9.5 10.7 12.6 7.5 13.6 7.5 8.2 12.9 7.2 16.2 20.9 11.2 29.7 17.6 19.7 18.9 20.7 27.3 13.8 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030883 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 90.1" "Cell line enhanced" "Detected in many" "BEWO: 67.4;RPTEC TERT1: 32.6;SiHa: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 14.4;neutrophil: 18.7" "Group enriched" "Detected in many" 14 "dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029561 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favourable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 6.2 2.8 1.5 5.2 1.9 6.9 10.7 0.3 1.5 6.8 12.2 0.7 1.6 5.6 7.3 3.0 40.3 4.1 17.5 20.1 1.4 0.5 41.3 21.0 6.5 4.6 2.2 0.3 3.1 90.1 1.0 5.7 35.6 1.3 17.5 7.8 3.4 9.8 2.5 55.0 30.4 9.2 40.0 1.4 4.8 13.5 1.5 2.0 3.1 8.0 31.4 10.3 22.6 14.7 0.7 5.3 18.7 6.8 0.1 0.6 1.8 6.9 10.8 2.9 5.2 3.8 2.8 67.4 1.8 4.8 0.8 1.1 8.6 5.6 1.5 4.3 2.6 4.8 3.4 1.8 0.2 8.2 4.2 0.0 14.2 7.4 2.2 11.9 0.6 6.4 9.7 2.6 1.3 1.0 1.7 0.0 2.8 7.0 4.8 6.3 10.2 8.2 8.2 8.1 7.1 32.6 3.9 3.9 0.0 40.7 9.2 3.9 8.7 14.9 0.0 1.5 2.8 19.9 1.8 5.6 14.8 4.1 6.4 8.0 2.5 3.3 6.8 14.4 0.4 4.9 0.2 0.7 0.4 0.1 5.3 0.2 0.2 0.3 18.7 0.1 3.0 3.7 0.6 1.8 1.5 1.9 0.3 1.5 1.4 0.5 2.2 0.3 1.3 2.0 IMPACT RWDD5 ENSG00000154059 "Impact RWD domain protein" Q9P2X3 18 24426616-24453535 "Predicted intracellular proteins" "Differentiation, Neurogenesis, Stress response, Translation regulation" "Actin-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 28.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041045, HPA041968" Approved Approved Nucleoplasm Nucleoplasm "HPA041045: AB_10793866, HPA041968: AB_10795603" "unprognostic (1.13e-1)" "unprognostic (8.59e-2)" "unprognostic (1.15e-2)" "unprognostic (1.62e-1)" "unprognostic (5.12e-2)" "unprognostic (7.94e-2)" "unprognostic (3.29e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-2)" "unprognostic (2.15e-1)" "unprognostic (8.20e-2)" "unprognostic (1.22e-1)" "prognostic favourable (7.90e-4)" "unprognostic (5.60e-3)" "unprognostic (9.27e-2)" "unprognostic (1.99e-3)" "unprognostic (5.60e-3)" 16.2 23.9 18.7 12.0 24.4 11.5 21.1 6.1 17.0 14.0 14.5 14.4 16.8 13.3 16.1 23.9 18.7 12.2 14.7 17.7 15.6 28.8 21.0 18.5 12.9 13.5 19.9 12.0 15.9 16.9 22.8 28.5 17.1 22.8 15.6 12.6 13.8 23.6 19.1 15.0 12.2 13.5 20.4 26.9 11.9 13.0 40.3 10.7 10.9 27.7 14.1 11.7 16.3 11.8 3.2 6.7 28.4 6.7 4.9 4.4 3.2 10.2 5.9 10.1 12.6 9.9 15.2 16.7 13.8 16.4 7.8 7.8 2.0 9.0 6.2 14.0 14.6 12.1 3.4 15.2 11.6 0.0 3.1 9.2 6.2 3.2 15.0 36.3 9.0 13.0 11.7 5.1 32.0 14.7 7.7 0.0 12.6 9.5 0.0 6.3 16.9 6.6 0.0 19.9 3.1 8.4 16.2 8.5 10.5 19.5 8.7 14.1 12.2 12.3 18.1 31.5 4.1 5.9 5.8 12.0 15.3 0.1 12.7 4.6 13.5 28.4 5.3 9.7 2.5 6.7 3.3 2.2 3.2 2.4 6.7 3.2 3.4 2.9 0.8 4.9 4.7 4.7 4.4 3.2 18.7 24.4 6.1 17.0 15.6 28.8 19.9 12.0 22.8 10.7 IMPAD1 "FLJ20421, gPAPP, IMPA3" ENSG00000104331 "Inositol monophosphatase domain containing 1" Q9NX62 8 56957933-56993844 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" 560000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 30.6 33.9 17.8 13.9 23.7 9.6 17.6 23.6 33.1 24.7 17.7 30.9 17.8 11.7 23.2 15.2 17.7 15.6 18.0 25.2 19.9 21.6 21.3 32.6 16.5 10.3 23.6 21.1 16.0 25.2 30.4 20.4 23.3 27.2 28.8 16.2 25.2 28.7 22.5 41.4 13.4 12.3 23.0 21.7 13.0 14.7 19.0 19.5 12.0 24.4 18.1 13.0 17.2 14.9 1.9 2.0 6.1 4.6 6.8 2.4 0.6 17.1 14.3 11.0 11.3 33.9 23.3 15.2 26.1 25.4 18.7 16.4 7.1 12.2 10.7 20.0 27.7 14.1 13.3 17.6 27.9 14.7 9.5 20.9 10.1 12.7 21.1 13.2 14.9 18.7 17.7 16.8 27.4 24.8 9.0 19.5 20.5 9.1 16.1 8.0 8.2 5.3 11.3 9.9 12.1 19.5 10.2 4.3 12.0 14.6 18.1 14.8 16.1 9.7 20.7 25.4 14.7 25.0 18.7 20.2 16.8 11.5 34.8 11.1 15.6 2.9 1.9 1.1 2.0 1.2 1.6 1.3 1.3 1.2 1.4 1.9 1.5 2.4 6.1 6.8 4.6 2.0 0.9 0.6 17.8 23.7 23.6 33.1 19.9 21.6 23.6 21.1 27.2 19.5 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 41.6" "Cell line enhanced" "Detected in many" "Daudi: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: " "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favourable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 1.7 2.2 5.5 3.5 6.3 0.5 2.5 10.1 7.2 2.3 2.2 3.1 1.0 7.0 3.3 1.6 3.1 2.0 4.5 3.9 4.9 2.1 2.3 2.6 2.7 5.0 5.1 3.0 5.5 2.2 0.9 4.4 1.6 5.9 2.7 0.3 1.7 3.6 1.5 6.1 5.0 4.9 1.2 4.1 4.3 3.1 41.6 3.6 0.5 5.2 1.3 0.4 2.8 9.4 1.5 1.3 0.7 4.4 0.3 2.4 0.6 3.9 4.5 3.2 3.0 2.2 0.9 3.8 4.3 0.4 1.1 1.2 3.2 4.7 18.8 2.9 1.1 11.2 0.5 0.2 0.7 7.8 4.8 4.0 5.4 2.1 1.5 0.6 10.0 1.2 0.0 0.6 0.3 0.4 5.1 8.9 0.8 2.0 5.7 1.3 1.4 1.2 7.0 1.6 1.7 0.8 1.2 9.6 2.9 2.1 2.7 2.5 5.6 0.9 8.6 4.0 1.5 3.9 3.2 1.5 0.7 0.9 4.0 10.0 2.0 0.5 2.4 0.0 0.8 4.4 2.0 1.5 1.2 1.7 0.9 1.0 2.4 1.9 0.7 0.3 3.4 1.3 0.7 0.6 5.5 6.3 10.1 7.2 4.9 2.1 5.1 3.0 5.9 3.6 ING1 "p24ING1c, p33, p33ING1, p33ING1b, p47, p47ING1a" ENSG00000153487 "Inhibitor of growth family member 1" Q9UK53 13 110712736-110723339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016136, CAB017773, HPA052591" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB016136: AB_628077, CAB017773: , HPA052591: " "unprognostic (1.14e-2)" "unprognostic (3.25e-2)" "unprognostic (3.51e-2)" "prognostic favourable (5.81e-4)" "unprognostic (4.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.36e-1)" "unprognostic (1.87e-1)" "unprognostic (9.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (7.05e-3)" "unprognostic (6.78e-2)" "unprognostic (2.40e-3)" 11.8 11.1 8.9 11.7 10.2 24.9 19.8 12.8 12.1 15.7 14.9 6.9 9.5 13.9 16.3 8.3 10.7 13.7 20.0 9.5 9.4 9.0 9.3 16.7 14.1 20.5 11.6 8.0 25.8 11.8 3.8 9.5 13.3 11.7 13.3 6.6 9.5 13.6 10.9 12.2 8.5 13.6 11.1 10.2 17.6 10.0 26.0 12.0 22.0 11.5 8.3 10.6 18.3 14.8 15.5 3.0 21.4 3.7 12.3 11.6 6.1 17.4 6.9 12.5 12.0 5.9 4.1 12.5 9.0 7.6 5.9 7.1 13.2 12.4 11.2 14.7 3.5 11.0 5.0 4.4 4.9 21.1 9.6 9.9 9.5 9.8 3.3 13.0 9.6 3.7 4.7 5.1 3.1 4.1 9.1 9.5 3.8 10.0 22.5 15.1 12.3 5.8 16.4 6.4 6.3 5.1 9.0 12.3 13.3 8.9 17.9 12.3 6.0 15.5 6.1 7.2 8.9 7.5 10.0 11.5 11.5 14.3 12.1 10.8 11.8 21.4 2.9 11.1 10.8 3.6 11.1 14.8 9.1 9.7 2.8 15.5 9.4 7.8 4.0 12.3 3.7 3.0 11.6 6.1 8.9 10.2 12.8 12.1 9.4 9.0 11.6 8.0 11.7 12.0 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594390 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 9.0 15.0 11.4 13.5 23.1 12.3 7.0 24.0 28.4 7.5 8.5 8.3 3.8 7.7 8.2 5.7 8.4 6.7 11.0 10.8 12.9 7.8 8.1 7.2 13.5 17.0 6.1 19.8 8.3 8.2 12.7 7.0 8.6 17.9 6.8 8.6 16.1 9.3 7.2 13.6 7.3 12.1 10.5 10.4 24.0 8.4 6.4 6.8 17.6 8.4 2.7 13.4 16.8 6.9 0.8 5.9 3.8 5.1 5.8 6.4 1.8 6.4 5.4 10.0 8.1 5.8 6.6 10.1 5.7 5.0 6.1 6.2 7.0 5.7 4.2 6.4 8.2 6.0 7.2 5.6 4.9 13.8 6.1 4.8 4.9 3.2 5.2 9.1 17.9 5.9 5.2 5.8 5.1 8.5 4.4 34.5 4.5 7.8 13.9 8.2 9.5 5.4 6.0 7.1 26.9 2.9 20.0 6.6 8.7 6.4 5.3 5.1 2.4 7.3 8.0 7.0 9.0 5.5 3.9 24.5 14.2 2.9 5.8 8.8 6.0 2.0 1.8 3.8 5.5 3.9 6.4 0.8 3.1 3.7 1.9 0.2 4.3 4.9 2.0 5.8 5.1 5.9 1.6 1.8 11.4 23.1 24.0 28.4 12.9 7.8 6.1 19.8 17.9 6.8 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534042-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 49.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm Nucleoplasm "HPA044885: AB_10794779, HPA051925: " "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.3 2.3 1.0 0.5 2.8 0.2 0.3 0.5 5.2 0.2 0.2 1.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.8 5.0 0.2 0.2 0.3 0.2 1.9 1.2 0.2 0.2 0.2 0.1 0.2 2.7 0.2 0.2 0.7 1.6 0.2 0.2 0.4 0.2 0.2 0.4 0.2 0.2 2.9 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 49.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.5 4.6 0.8 5.0 1.9 1.2 2.7 0.2 INTS1 "DKFZp586J0619, INT1, KIAA1440, NET28" ENSG00000164880 "Integrator complex subunit 1" Q8N201 7 1470277-1504367 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021658, HPA053009" Approved Approved Nucleoplasm Nucleoplasm "HPA021658: AB_1852402, HPA053009: " "unprognostic (3.20e-2)" "unprognostic (2.85e-2)" "unprognostic (2.47e-2)" "unprognostic (2.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.66e-4)" "unprognostic (7.72e-3)" "unprognostic (3.11e-1)" "unprognostic (1.90e-2)" "prognostic favourable (4.83e-4)" "unprognostic (4.30e-1)" "unprognostic (5.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" 15.4 14.6 17.8 16.1 17.2 28.5 15.2 26.5 28.1 12.2 14.5 19.2 10.1 19.0 15.0 11.0 15.8 13.3 14.4 13.0 13.5 11.0 13.8 13.8 12.0 18.2 13.5 10.1 18.2 23.0 11.6 15.8 12.6 15.2 14.7 6.0 15.6 25.6 14.5 43.3 20.4 17.6 15.1 10.0 19.3 17.9 27.3 14.0 18.0 15.9 10.8 14.9 13.7 14.8 6.0 3.7 4.4 2.7 3.1 4.8 2.1 20.3 17.7 6.9 18.0 5.1 3.9 24.2 8.6 4.8 6.7 5.9 19.5 15.9 11.0 9.1 6.2 21.1 3.9 10.3 1.9 5.3 21.4 7.8 25.3 12.9 6.0 13.5 11.7 5.3 4.9 6.9 4.9 7.3 21.7 8.8 4.0 24.7 7.6 37.1 38.0 16.0 19.3 7.9 11.1 3.2 15.5 13.1 32.4 12.5 22.9 7.9 18.1 13.7 13.5 11.1 31.8 9.2 14.2 18.5 9.6 10.6 12.4 11.7 22.6 4.4 2.7 2.9 4.8 2.1 3.0 2.7 3.5 3.8 3.7 6.0 2.2 2.8 2.2 3.1 1.8 2.1 4.2 2.1 17.8 17.2 26.5 28.1 13.5 11.0 13.5 10.1 15.2 14.0 INTS10 "C8orf35, FLJ10569, INT10" ENSG00000104613 "Integrator complex subunit 10" Q9NVR2 8 19817140-19852083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039129, HPA050570" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA039129: AB_10794424, HPA050570: " "unprognostic (9.11e-2)" "unprognostic (8.41e-3)" "prognostic favourable (4.00e-4)" "prognostic favourable (1.22e-4)" "unprognostic (4.54e-2)" "unprognostic (9.79e-3)" "unprognostic (1.15e-1)" "unprognostic (1.14e-3)" "unprognostic (3.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-2)" "unprognostic (2.62e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (1.33e-1)" 21.9 20.9 31.4 18.9 30.2 22.8 23.5 38.5 28.4 23.7 23.2 23.2 19.9 21.3 18.8 17.4 21.8 31.4 17.0 20.9 31.1 27.1 25.0 42.7 19.2 21.9 28.3 18.4 21.6 39.1 18.1 25.5 18.0 21.2 24.5 22.2 17.3 23.2 26.0 20.7 25.7 19.5 22.0 28.7 21.4 19.4 12.0 24.3 26.9 34.9 21.1 25.0 20.8 23.7 17.8 20.0 8.8 15.0 16.9 21.2 12.6 15.2 22.3 12.3 16.0 18.4 20.6 16.8 11.1 18.9 15.6 14.8 12.4 7.7 42.9 19.6 12.1 16.4 14.5 14.3 17.6 8.5 16.3 19.9 24.9 24.0 13.7 17.1 13.7 16.4 22.5 11.6 18.1 14.9 23.9 34.5 10.6 13.3 30.9 20.4 17.4 12.2 16.7 14.8 27.8 19.3 23.7 12.5 9.9 15.7 19.7 13.8 10.2 17.6 12.1 9.9 14.2 23.3 15.5 9.7 12.4 32.5 20.2 24.2 16.3 6.6 15.0 8.8 13.9 13.8 21.2 17.8 17.8 17.5 20.0 15.1 19.9 17.6 5.4 16.9 11.5 17.0 19.9 12.6 31.4 30.2 38.5 28.4 31.1 27.1 28.3 18.4 21.2 24.3 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 16.6 20.2 12.1 14.1 14.9 13.1 20.2 12.0 19.1 20.1 20.0 20.8 17.3 12.3 25.5 25.3 19.6 22.3 18.4 12.4 11.3 12.9 22.7 23.2 14.4 17.5 14.1 10.4 20.2 22.0 16.1 23.5 23.5 13.9 18.9 21.6 19.9 27.5 21.7 11.8 17.5 19.9 17.0 11.9 23.5 17.5 19.7 9.9 32.4 26.1 16.1 24.0 17.7 16.2 13.4 13.6 12.9 8.6 14.8 20.3 10.4 12.1 22.0 22.2 17.7 12.4 15.6 14.3 13.4 17.4 22.4 20.8 19.6 28.8 19.9 18.9 16.7 24.7 47.3 22.6 19.8 17.4 28.7 17.3 16.4 21.2 24.7 17.7 22.3 15.1 22.5 17.0 26.2 24.2 23.7 11.6 15.7 19.3 20.1 17.1 16.2 12.2 17.3 18.7 22.8 17.4 22.7 16.0 12.7 16.2 16.5 22.4 15.4 20.7 11.8 15.5 16.3 13.8 21.2 11.5 21.4 26.9 15.6 32.4 18.0 12.9 7.5 3.9 14.3 8.6 16.2 13.4 14.8 16.3 13.6 10.5 15.7 14.3 0.8 14.8 6.2 12.0 20.3 10.4 12.1 14.9 12.0 19.1 11.3 12.9 14.1 10.4 13.9 9.9 INTS8 "C8orf52, FLJ20530, INT8, MGC131633" ENSG00000164941 "Integrator complex subunit 8" Q75QN2 8 94813311-94881746 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057299 Approved Approved Nucleoplasm Nucleoplasm "HPA057299: " "unprognostic (1.08e-2)" "unprognostic (3.12e-2)" "unprognostic (1.28e-1)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (4.81e-2)" "prognostic unfavourable (2.54e-6)" "unprognostic (3.07e-2)" "unprognostic (6.87e-2)" "unprognostic (9.77e-3)" "unprognostic (4.84e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.24e-1)" "unprognostic (5.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.96e-2)" 10.5 10.0 12.7 19.3 16.1 16.6 14.3 17.1 16.0 19.2 15.4 9.1 12.5 9.4 14.4 8.3 15.9 10.6 9.2 15.2 11.6 12.6 10.2 10.8 11.5 19.3 12.4 9.5 15.0 20.1 14.7 22.9 11.4 11.1 14.0 18.2 9.7 12.9 13.7 15.6 12.5 15.1 16.7 12.5 17.0 14.6 35.1 10.7 31.9 13.3 7.6 16.1 17.1 13.2 13.0 9.7 14.4 9.8 10.9 13.0 4.5 24.8 15.9 24.1 21.1 8.8 21.1 12.9 13.9 12.5 17.5 16.3 10.6 18.2 25.2 12.9 9.8 15.7 29.5 13.9 23.4 28.2 15.8 22.2 9.6 10.3 10.6 11.8 16.3 8.5 6.6 16.9 14.5 19.2 21.3 19.0 10.6 16.1 25.2 9.7 14.2 27.5 21.1 9.8 14.3 14.6 12.8 18.1 10.0 13.1 3.6 11.9 18.1 15.0 13.3 8.2 9.6 15.2 12.0 11.7 20.4 21.5 10.6 23.7 15.6 2.1 9.8 14.4 5.2 6.8 8.4 13.0 12.2 13.0 9.7 10.4 12.2 7.2 9.9 10.9 6.6 5.7 9.9 4.5 12.7 16.1 17.1 16.0 11.6 12.6 12.4 9.5 11.1 10.7 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: " "prognostic favourable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favourable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favourable (1.83e-4)" 18.3 31.1 40.4 20.0 55.9 51.7 28.2 74.1 37.3 29.5 32.5 23.7 34.0 36.9 34.6 56.1 30.0 28.1 24.0 19.0 30.7 19.2 32.4 24.3 18.4 22.5 35.4 27.6 33.9 28.1 23.5 42.3 20.7 29.4 34.9 41.9 22.2 28.3 32.1 19.1 50.0 31.6 21.1 28.3 25.5 27.6 26.0 37.4 31.7 35.7 21.6 19.5 24.1 34.0 27.3 22.8 50.7 25.7 27.9 35.1 19.0 8.7 17.2 35.7 25.1 20.1 25.2 25.8 16.8 18.9 19.3 22.4 14.2 23.6 15.6 13.8 15.6 23.0 17.8 25.1 18.0 18.3 15.7 17.8 53.2 30.4 16.3 16.8 17.4 23.9 36.6 26.1 21.6 26.6 13.3 19.6 22.3 19.5 36.0 23.1 27.4 31.9 15.1 11.8 17.0 26.2 42.2 22.3 33.7 36.3 24.7 17.8 23.9 28.5 18.9 21.0 20.9 13.1 16.5 18.1 21.4 21.9 19.1 19.7 18.3 50.7 22.5 38.5 29.7 21.6 26.5 27.3 25.8 27.7 21.7 25.7 24.2 24.9 35.3 27.9 25.7 22.8 35.1 19.0 40.4 55.9 74.1 37.3 30.7 19.2 35.4 27.6 29.4 37.4 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell line enhanced" "Detected in some" "HHSteC: 15.8;HSkMC: 5.7;LHCN-M2: 25.1;RH-30: 11.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA053644 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053644: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavourable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.1 0.2 0.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 5.7 0.8 0.1 0.4 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.1 0.0 0.0 11.1 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.4;testis: 33.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.3;CAPAN-2: 8.6;RPTEC TERT1: 11.0;U-698: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm Nucleoplasm "HPA046810: , HPA048782: " "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favourable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 1.2 1.2 2.8 1.3 6.4 0.6 1.8 2.0 3.8 2.6 1.1 6.8 1.7 0.6 2.3 6.3 1.8 22.4 1.4 1.6 3.8 3.2 3.4 0.6 3.0 1.3 4.8 1.5 2.5 1.4 5.4 8.7 1.2 11.4 1.1 1.2 1.6 1.2 1.7 0.7 0.9 0.7 1.4 2.5 0.6 1.0 33.8 6.4 0.0 4.0 1.1 3.3 1.6 1.0 0.6 3.7 3.6 2.8 0.0 0.1 0.5 2.7 3.2 1.1 0.8 1.2 1.3 0.7 0.4 22.3 1.1 1.5 0.5 8.6 3.0 2.4 0.6 0.5 0.5 0.9 1.8 0.2 0.9 1.0 1.1 0.5 0.7 0.3 0.7 0.5 0.6 3.5 1.1 0.7 0.2 0.2 0.2 3.1 0.2 5.8 0.2 0.8 0.2 0.5 0.8 11.0 3.4 2.5 1.0 0.7 1.1 3.5 4.0 1.7 0.3 0.5 1.7 1.1 0.6 0.9 0.7 12.0 1.6 0.1 1.9 3.6 2.8 0.0 0.1 0.2 0.0 0.6 0.0 0.0 2.1 0.2 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.5 2.8 6.4 2.0 3.8 3.8 3.2 4.8 1.5 11.4 6.4 IQCE KIAA1023 ENSG00000106012 "IQ motif containing E" Q6IPM2 7 2558972-2614734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019515 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA019515: AB_1851855" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (3.78e-2)" "prognostic favourable (5.91e-4)" "unprognostic (7.96e-3)" "unprognostic (3.75e-1)" "unprognostic (2.54e-3)" "unprognostic (1.31e-1)" "unprognostic (4.04e-3)" "unprognostic (1.30e-2)" "unprognostic (1.66e-2)" "unprognostic (2.84e-1)" "unprognostic (2.04e-2)" "unprognostic (2.82e-2)" "unprognostic (6.97e-2)" "unprognostic (7.56e-3)" "unprognostic (3.13e-2)" 5.5 7.6 15.1 6.8 17.0 7.0 7.4 11.1 18.7 6.9 10.2 12.8 6.7 13.1 9.6 12.3 6.6 17.1 11.2 7.1 14.3 15.6 7.1 3.6 9.1 4.7 12.0 12.1 9.7 8.4 12.9 15.4 4.1 11.3 8.1 9.9 7.3 9.8 11.2 4.5 8.1 10.9 7.9 11.1 5.1 10.6 35.3 9.6 2.8 11.9 3.0 3.9 6.0 7.4 0.7 4.3 8.3 2.1 0.3 1.3 0.3 19.7 10.3 4.5 13.6 5.5 8.4 7.7 4.2 7.0 5.5 6.0 5.3 11.4 1.4 4.8 9.7 10.3 3.0 4.8 5.8 3.4 6.4 2.7 12.5 1.7 4.1 7.0 4.0 3.5 8.0 5.3 5.6 5.9 8.5 2.6 7.3 20.1 3.1 5.4 3.8 7.6 3.0 5.1 5.1 5.9 9.2 9.4 11.0 4.7 19.7 4.3 24.1 9.6 5.8 4.6 9.3 17.5 7.0 2.9 4.8 0.3 9.1 5.1 12.9 1.1 1.4 3.6 1.3 2.1 0.5 0.5 0.7 0.6 0.6 0.7 0.5 1.1 8.3 0.3 0.7 4.3 0.3 0.3 15.1 17.0 11.1 18.7 14.3 15.6 12.0 12.1 11.3 9.6 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;intestine: 13.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavourable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 3.2 1.2 0.3 5.4 0.3 14.8 0.6 0.3 0.8 1.4 10.1 0.4 1.3 7.0 1.1 3.7 9.8 0.3 1.8 1.8 0.4 0.2 1.5 1.1 2.6 1.4 0.3 0.3 0.5 0.4 0.0 0.3 6.5 0.8 0.8 5.5 0.4 1.8 0.3 0.5 3.8 13.0 2.9 1.5 1.5 5.1 6.8 0.3 12.2 0.4 3.1 7.3 0.9 3.1 0.2 0.9 0.5 0.3 0.6 2.6 0.0 23.5 11.3 10.7 7.5 0.6 1.7 5.2 17.5 11.7 17.2 15.4 13.0 21.7 2.1 6.5 10.2 22.4 7.2 9.0 15.4 0.0 6.5 3.1 22.4 6.4 0.1 3.8 0.0 0.5 1.0 14.4 21.2 9.9 6.3 3.4 12.5 12.3 2.2 5.5 7.7 11.4 7.5 12.0 2.4 4.3 8.0 6.7 10.5 15.9 18.7 6.4 14.9 10.3 6.5 15.6 18.6 12.7 20.5 1.6 0.8 1.0 5.2 6.1 17.6 0.5 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.1 0.1 0.1 0.2 0.6 0.3 0.9 2.6 0.0 0.3 0.3 0.3 0.8 0.4 0.2 0.3 0.3 0.8 0.3 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Cell line enhanced" "Detected in some" "HEL: 9.4;U-266/70: 12.7;U-266/84: 3.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.7 3.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 IRF6 "LPS, OFC6, VWS, VWS1" ENSG00000117595 "Interferon regulatory factor 6" O14896 1 209785623-209806175 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 16.0;HaCaT: 58.3;HBEC3-KT: 21.3;hTCEpi: 47.0;hTERT-HME1: 23.5;RT4: 20.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 8.6;pons and medulla: 4.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA063121, HPA076162" Enhanced Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA063121: AB_2684942, HPA076162: AB_2686780" "unprognostic (2.59e-1)" "unprognostic (1.79e-3)" "unprognostic (1.74e-1)" "unprognostic (7.80e-2)" "unprognostic (1.33e-2)" "unprognostic (4.94e-3)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (7.82e-2)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (2.03e-1)" "prognostic favourable (0.00e+0)" "unprognostic (2.70e-1)" "unprognostic (2.66e-2)" "unprognostic (2.14e-1)" "unprognostic (4.42e-2)" 1.0 6.3 1.1 4.1 1.0 0.3 13.3 8.6 0.9 11.7 12.9 1.0 38.6 9.2 3.9 31.4 63.7 7.6 17.5 10.3 1.1 0.8 12.9 18.4 8.8 0.3 0.9 0.7 3.9 13.9 10.3 6.8 26.7 4.4 21.8 11.3 1.5 24.8 34.6 0.6 45.6 20.3 3.1 1.1 1.2 9.5 4.3 0.3 13.0 22.1 32.3 33.8 15.0 19.1 0.9 0.5 2.0 1.0 0.6 2.8 0.7 16.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.1 0.0 0.0 3.4 5.7 0.0 0.0 0.0 58.3 0.0 21.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 23.5 0.9 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 20.8 5.2 1.7 0.4 9.3 0.5 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.2 0.1 2.0 2.8 1.0 1.9 0.6 0.6 0.9 0.5 0.9 2.1 1.1 0.1 0.6 0.1 0.2 0.0 0.7 1.1 1.0 8.6 0.9 1.1 0.8 0.9 0.7 4.4 0.3 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615999 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.0;Karpas-707: 10.6;SCLC-21H: 5.2;SK-BR-3: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 12 "plasmacytoid DC: 81.1" "Lineage enriched" "Detected in all" 12 "dendritic cells: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017694, HPA052757" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: " "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavourable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 9.6 4.7 4.5 9.9 6.1 17.2 12.1 2.9 4.9 4.8 4.6 2.5 2.2 2.2 4.2 5.1 6.9 4.9 9.0 5.2 3.7 2.0 8.2 23.3 11.6 12.8 4.6 1.4 4.8 3.6 2.2 3.8 4.8 5.5 5.3 2.9 5.2 5.4 7.4 6.1 4.1 8.4 5.7 4.5 19.0 4.5 4.0 5.2 8.5 9.0 2.4 12.8 7.5 3.9 2.5 81.1 3.7 6.6 2.1 1.5 1.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.1 0.0 10.6 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 5.2 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 3.7 1.1 6.6 1.1 2.5 1.0 1.2 3.3 2.4 1.1 1.2 1.7 2.1 6.1 81.1 1.5 1.8 4.5 6.1 2.9 4.9 3.7 2.0 4.6 1.4 5.5 5.2 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3596054-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.1;breast: 36.0;salivary gland: 20.9" "Group enriched" "Detected in some" 4 "AF22: 7.0;REH: 28.3;U-251 MG: 11.5" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 5.3 0.4 2.6 0.4 2.1 1.4 36.0 6.6 1.5 0.4 0.4 2.0 6.0 0.4 0.4 1.7 0.8 0.4 0.4 1.0 3.1 3.2 13.9 0.4 8.0 0.6 4.2 1.0 0.4 0.7 0.4 0.7 0.4 16.1 0.5 0.4 2.8 20.9 1.5 0.4 6.8 0.4 0.4 5.1 0.4 0.4 0.5 1.6 3.0 0.5 0.5 0.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 28.3 0.0 0.0 2.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 6.6 0.2 3.1 3.2 4.2 1.0 16.1 1.6 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell line enhanced" "Detected in many" "AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: " "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favourable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 39.8 0.0 2.2 1.5 23.9 2.3 1.3 2.0 1.5 4.7 0.0 0.0 0.0 4.4 13.5 0.0 9.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.2 0.9 8.1 0.0 0.0 0.0 1.4 7.7 0.0 0.0 4.4 0.0 0.0 2.5 0.0 8.9 0.0 1.5 0.0 7.8 16.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55323760-55330760 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEK 293: 2.8;RPTEC TERT1: 10.4;SK-MEL-30: 6.6" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favourable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 11.1 0.0 0.2 0.2 1.4 0.0 18.9 0.2 0.5 3.3 0.2 0.2 0.2 0.0 0.6 0.2 0.5 0.0 0.2 11.1 0.2 0.4 1.5 0.2 2.3 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.0 2.0 2.5 0.2 2.7 9.3 0.2 0.2 0.2 1.6 0.0 0.6 0.2 3.5 0.7 0.2 2.3 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 10.4 0.0 0.2 0.1 0.1 1.7 6.6 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 ISG20L2 FLJ12671 ENSG00000143319 "Interferon stimulated exonuclease gene 20 like 2" Q9H9L3 1 156721891-156728799 "Predicted intracellular proteins" "Ribosome biogenesis" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028005, HPA054285" Approved Approved Nucleoplasm Nucleoplasm "HPA028005: AB_2126319, HPA054285: " "unprognostic (1.67e-2)" "unprognostic (7.87e-2)" "unprognostic (2.80e-1)" "prognostic unfavourable (4.63e-4)" "unprognostic (3.52e-1)" "unprognostic (1.65e-2)" "prognostic unfavourable (6.15e-5)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (6.05e-2)" "unprognostic (2.40e-1)" "unprognostic (8.17e-2)" "prognostic unfavourable (4.80e-5)" "unprognostic (5.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.82e-3)" "unprognostic (2.32e-1)" 8.0 7.9 8.5 9.5 10.5 12.1 9.7 15.4 11.2 8.6 8.9 10.2 8.9 7.7 10.6 8.5 13.8 9.3 7.9 8.2 7.9 6.1 8.6 10.1 7.9 11.1 8.5 7.6 11.1 9.3 8.4 10.6 10.5 8.3 8.8 11.3 7.5 8.8 9.0 7.2 10.6 10.5 11.6 7.9 10.6 9.2 98.1 9.4 14.1 8.4 7.6 14.3 9.8 9.2 9.5 8.0 20.4 10.6 11.9 9.9 5.5 13.6 10.3 9.5 10.2 9.9 7.7 14.7 9.7 9.2 13.4 9.3 14.0 10.9 25.8 12.3 7.9 18.9 22.1 16.3 10.3 13.3 13.8 13.9 7.9 7.9 9.9 33.3 15.1 7.7 16.1 12.5 13.7 12.1 22.2 12.0 8.6 18.6 15.0 8.6 30.2 17.7 18.6 10.8 17.0 9.2 10.7 18.7 23.6 11.7 32.1 9.4 20.7 21.4 7.2 7.6 11.1 8.8 18.8 16.0 24.7 33.4 6.8 16.9 9.9 20.4 8.3 15.5 8.5 10.1 9.9 7.7 7.0 8.7 8.0 9.5 6.8 8.3 16.0 11.9 10.6 5.1 6.2 5.5 8.5 10.5 15.4 11.2 7.9 6.1 8.5 7.6 8.3 9.4 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383391-51394738 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 30.3" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 80.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Group enriched" "Detected in some" 5 "basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5" "Group enriched" "Detected in some" 12 "basal ganglia: 8.5;hypothalamus: 8.6" HPA057416 Approved Approved Nucleoplasm Nucleoplasm "HPA057416: " "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 2.2 1.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 14.4 1.6 0.0 4.2 2.3 1.3 0.5 0.2 0.0 0.2 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.8 10.0 2.0 13.2 2.5 6.4 1.0 30.3 0.1 1.1 0.7 0.6 0.1 0.0 10.7 1.6 0.7 3.1 0.3 0.2 0.4 2.4 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.6 1.2 0.9 0.0 0.0 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.8 0.0 0.0 0.0 5.1 80.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.0 0.0 0.2 0.0 5.5 0.0 0.0 2.0 0.7 ISPD "hCG_1745121, IspD, Nip" ENSG00000214960 "Isoprenoid synthase domain containing" A4D126 7 16087527-16421322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 8.3;HEL: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 17 "basophil: 10.7" "Lineage enriched" "Detected in single" 22 "granulocytes: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043810, HPA053554" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA043810: AB_10964489, HPA053554: " "unprognostic (4.65e-3)" "unprognostic (5.92e-2)" "unprognostic (2.61e-1)" "unprognostic (9.41e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-2)" "unprognostic (2.07e-1)" "prognostic favourable (1.38e-11)" "unprognostic (4.01e-2)" "unprognostic (1.78e-4)" "unprognostic (6.26e-2)" "unprognostic (2.79e-1)" 3.0 3.8 4.2 1.9 4.5 2.6 3.0 7.7 7.7 3.7 2.9 3.9 3.4 1.8 4.7 2.4 2.0 2.8 3.2 7.1 4.4 4.5 7.0 10.0 2.9 1.5 4.7 3.9 2.7 3.9 3.6 5.7 8.0 4.6 3.5 3.0 5.7 5.5 10.1 4.5 2.6 1.8 3.7 4.9 1.4 10.2 3.9 2.4 1.1 2.6 2.4 1.4 3.2 3.7 0.3 0.4 10.7 0.1 0.4 0.3 0.0 0.3 2.3 1.2 1.8 1.0 1.5 8.3 1.8 1.2 1.6 1.3 2.6 2.2 0.0 4.0 2.6 3.0 1.4 0.0 2.9 1.0 1.4 11.5 1.4 0.6 1.3 0.9 1.4 2.7 1.2 1.3 0.2 1.2 2.7 0.2 4.1 0.5 1.1 1.0 2.2 0.3 0.0 1.8 0.1 2.7 0.8 2.0 1.3 1.3 2.4 2.5 1.7 2.6 1.3 2.3 2.1 0.3 2.2 0.2 0.0 0.0 1.9 2.7 2.8 10.7 0.1 0.4 0.3 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.6 0.4 0.0 0.4 0.0 0.0 4.2 4.5 7.7 7.7 4.4 4.5 4.7 3.9 4.6 2.4 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438301 "Enzymes, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.6" "Cell line enriched" "Detected in many" 4 "BEWO: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavourable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 7.9 8.4 7.1 3.0 5.7 4.5 7.1 2.7 6.7 9.9 3.5 10.0 44.2 3.4 13.9 12.3 4.5 20.0 6.5 8.0 5.7 7.4 12.7 4.1 4.7 3.8 4.1 4.1 31.6 25.5 7.7 12.6 44.2 16.2 9.5 1.3 19.3 8.8 34.4 8.2 3.4 3.9 3.0 2.3 10.5 3.7 83.6 3.5 3.0 5.6 3.8 3.3 5.9 7.8 4.0 1.9 0.9 0.2 11.9 8.5 4.9 2.7 8.4 20.1 5.9 0.1 0.0 101.5 1.3 0.2 0.1 0.0 4.8 5.1 0.0 6.9 0.6 7.2 0.6 0.0 0.0 7.5 23.1 10.1 0.5 15.5 2.1 0.1 0.2 1.6 0.1 0.5 0.1 1.2 20.6 0.4 0.0 16.2 0.7 0.7 10.5 6.8 13.9 0.0 4.7 1.7 0.0 6.2 15.5 0.3 1.9 10.2 13.7 1.1 3.9 0.1 0.2 0.1 0.3 3.2 1.4 0.6 0.6 0.4 3.5 0.9 0.1 0.0 7.6 0.2 5.9 4.0 7.4 6.7 0.7 2.3 6.1 8.5 0.8 11.9 0.1 1.9 5.2 4.9 7.1 5.7 2.7 6.7 5.7 7.4 4.1 4.1 16.2 3.5 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoplasm, Endoplasmic reticulum" "Cytokinetic bridge" "HPA038664: AB_10672722, HPA038665: " "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.2 16.1 11.1 15.4 14.0 12.0 14.3 17.8 17.2 16.2 13.2 23.2 21.3 11.8 19.6 16.6 13.2 17.2 14.7 12.0 8.7 9.8 15.0 11.4 14.4 14.0 13.3 9.9 29.0 28.4 22.7 23.0 13.8 13.3 13.8 14.7 22.1 23.0 19.5 7.8 10.9 13.9 13.5 10.6 20.3 14.8 10.6 15.2 25.4 26.2 9.3 23.0 14.4 15.3 17.7 12.9 5.4 21.2 13.8 14.4 10.0 4.7 7.0 8.2 6.5 7.0 8.1 7.5 10.6 6.0 12.8 9.5 15.0 11.8 10.9 3.0 9.9 6.1 12.4 10.5 9.6 9.6 7.4 15.4 7.9 6.0 13.0 13.9 8.3 10.9 12.5 11.7 18.0 8.8 8.2 11.8 7.3 14.3 20.1 8.1 16.6 5.4 10.2 9.0 6.3 7.7 8.1 3.9 12.4 13.1 11.6 4.7 7.1 6.4 8.9 8.6 5.2 8.2 20.1 1.5 0.9 16.6 5.6 8.1 8.5 2.8 10.9 5.4 13.7 14.3 12.8 17.7 10.5 13.4 12.9 17.1 14.4 13.5 1.3 13.8 21.2 9.8 8.5 10.0 11.1 14.0 17.8 17.2 8.7 9.8 13.3 9.9 13.3 15.2 ITGA2 CD49b ENSG00000164171 "Integrin subunit alpha 2" P17301 5 52989326-53094779 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 30.1;HaCaT: 30.4;HUVEC TERT2: 28.0;TIME: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB017690, HPA060991, HPA063556" Enhanced Approved Nucleoplasm,Cytosol 46000000 Nucleoplasm Cytosol "CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.70e-2)" "unprognostic (2.67e-3)" "unprognostic (2.38e-2)" "unprognostic (1.87e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.02e-5)" "unprognostic (4.27e-1)" "unprognostic (3.88e-2)" "unprognostic (2.87e-2)" "unprognostic (1.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.11e-1)" 1.9 14.0 2.9 4.7 13.4 0.4 7.9 1.8 6.8 7.1 6.5 22.5 12.1 7.6 5.1 10.4 16.7 2.8 9.3 2.5 5.4 3.6 15.1 1.8 17.2 1.4 18.3 4.5 1.8 2.7 16.1 2.5 4.8 10.7 8.5 6.0 0.8 15.8 16.8 1.2 16.9 17.0 2.5 8.4 9.1 7.4 1.3 13.0 1.5 2.5 7.4 10.0 7.5 11.1 0.5 1.5 1.7 0.6 0.2 0.6 0.3 19.5 5.0 0.4 0.2 1.3 2.4 1.5 19.8 30.1 0.7 1.2 9.4 13.8 0.0 3.4 8.4 30.4 1.6 22.2 2.9 0.0 1.5 1.4 1.3 5.6 4.6 0.2 0.4 1.0 3.9 19.9 3.5 28.0 0.0 0.0 0.5 3.6 0.2 0.0 1.2 10.1 0.0 0.1 0.0 6.3 10.4 0.2 1.1 1.0 1.3 2.0 3.2 0.0 23.9 3.6 2.1 0.5 3.9 0.0 0.0 0.0 21.8 0.0 15.9 1.7 0.6 0.2 0.6 0.2 0.4 0.4 0.5 0.5 0.1 0.5 0.5 0.6 0.8 0.2 0.1 1.5 0.4 0.3 2.9 13.4 1.8 6.8 5.4 3.6 18.3 4.5 10.7 13.0 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823514 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 4.6;CACO-2: 10.6;HEL: 8.5;HMC-1: 5.0;SH-SY5Y: 12.7;WM-115: 6.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" 250000 Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.5 15.5 3.1 5.3 3.7 5.8 9.6 1.6 5.7 17.9 11.1 2.9 5.8 4.6 17.3 7.5 12.3 6.9 17.8 25.0 4.5 2.0 4.6 13.6 8.3 16.8 3.4 2.7 7.5 2.1 2.4 3.0 7.3 2.6 10.0 5.3 8.4 4.7 8.7 3.7 3.5 8.7 16.2 4.0 30.5 10.9 10.2 2.7 1.0 35.4 7.2 3.6 7.4 8.4 0.0 0.7 2.1 0.2 0.0 0.0 0.4 0.2 0.0 4.6 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 10.6 0.0 3.4 1.5 0.0 0.2 4.1 0.0 0.0 0.1 0.6 8.5 0.2 0.2 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.0 0.2 0.6 12.7 0.1 0.6 0.7 0.0 3.3 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.6 2.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.1 3.7 1.6 5.7 4.5 2.0 3.4 2.7 2.6 2.7 ITPA "C20orf37, dJ794I6.3, HLC14-06-P" ENSG00000125877 "Inosine triphosphatase" Q9BY32 20 3208868-3223870 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022824, HPA073963" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" 69000 Cytosol "Nucleoplasm, Nuclear bodies" "HPA022824: AB_1851960, HPA073963: " "unprognostic (1.58e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-1)" "unprognostic (3.57e-1)" "unprognostic (4.63e-2)" "unprognostic (1.53e-2)" "prognostic unfavourable (2.54e-5)" "unprognostic (1.11e-2)" "unprognostic (1.68e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-1)" "unprognostic (1.94e-2)" "unprognostic (8.34e-2)" "unprognostic (3.63e-1)" "unprognostic (1.24e-1)" "unprognostic (1.84e-1)" 17.7 27.5 18.6 24.7 21.2 20.4 17.7 10.2 22.7 21.3 21.4 18.3 20.6 22.9 18.1 17.3 31.0 26.6 19.6 25.9 18.1 13.5 22.9 20.3 22.7 30.6 20.5 24.1 16.5 43.8 17.6 10.2 17.0 16.2 14.6 16.8 13.2 19.9 21.5 19.5 23.4 19.0 16.3 16.3 20.6 19.3 16.7 19.5 15.2 24.9 29.0 24.1 14.6 17.7 19.3 30.7 11.3 31.0 24.7 24.1 18.2 33.1 26.2 13.0 13.4 8.6 12.7 8.6 15.0 21.0 19.8 17.4 21.0 30.9 14.3 13.8 13.8 28.9 17.8 22.6 13.9 9.3 26.6 35.8 10.9 31.8 16.3 15.3 12.2 12.1 17.3 18.7 11.6 15.1 24.5 9.9 17.8 15.2 18.0 44.4 21.7 26.5 17.3 18.1 37.5 27.1 10.5 19.7 23.2 11.9 41.7 27.6 17.3 25.6 10.6 22.3 12.4 14.6 31.8 14.7 18.4 27.0 10.4 28.4 24.2 11.3 25.7 8.8 20.7 31.0 18.0 19.3 18.9 21.8 30.7 17.8 14.2 17.2 1.4 24.7 21.9 28.3 24.1 18.2 18.6 21.2 10.2 22.7 18.1 13.5 20.5 24.1 16.2 19.5 ITPKB "IP3-3KB, IP3KB" ENSG00000143772 "Inositol-trisphosphate 3-kinase B" P27987 1 226631690-226739323 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030273, HPA072923" Enhanced Approved Nucleoplasm Nucleoplasm "HPA030273: AB_10601127, HPA072923: " "unprognostic (4.54e-2)" "unprognostic (3.85e-2)" "unprognostic (8.41e-3)" "unprognostic (9.37e-3)" "unprognostic (1.53e-1)" "prognostic favourable (1.72e-5)" "unprognostic (1.24e-1)" "prognostic favourable (6.65e-4)" "unprognostic (2.29e-1)" "unprognostic (9.57e-2)" "unprognostic (1.41e-2)" "unprognostic (1.75e-2)" "unprognostic (3.23e-3)" "unprognostic (2.90e-2)" "unprognostic (7.46e-2)" "unprognostic (6.54e-3)" "unprognostic (7.87e-2)" 23.8 4.2 34.7 13.0 35.1 14.8 15.2 11.1 33.6 14.3 19.7 32.4 8.5 6.0 27.1 15.6 12.6 15.3 8.9 7.8 27.9 24.8 9.7 3.2 13.4 22.7 50.4 16.3 8.8 4.8 10.1 4.2 13.5 40.0 13.1 6.3 20.8 24.9 21.3 9.8 10.5 12.5 32.6 63.1 19.0 12.4 3.2 34.0 20.0 5.9 4.3 17.1 19.6 8.5 3.1 0.9 7.7 3.5 3.0 7.9 2.6 2.8 3.0 4.9 5.6 3.8 2.5 1.3 0.7 3.3 1.5 3.6 0.5 3.5 12.8 4.6 0.7 4.1 6.2 2.5 0.7 1.7 4.2 5.7 3.3 0.0 1.5 5.3 10.2 2.8 3.6 1.7 1.6 10.5 0.0 1.8 0.2 2.6 9.7 7.1 10.6 4.9 3.8 8.8 2.8 11.3 4.5 2.9 3.7 2.3 1.7 28.1 7.2 6.0 7.3 2.0 1.5 1.8 4.5 0.1 4.6 15.7 0.5 4.8 7.4 1.2 1.4 7.7 4.4 2.1 3.9 1.9 5.3 4.5 0.9 3.1 7.9 5.7 5.4 3.0 3.5 0.8 3.0 2.6 34.7 35.1 11.1 27.9 27.9 24.8 50.4 16.3 40.0 34.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405795-40435947 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria 66000 Mitochondria Nucleoplasm "HPA041391: , HPA044250: " "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favourable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favourable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 12.3 32.0 15.4 13.2 20.6 6.7 24.3 14.4 18.0 12.7 13.7 20.5 23.3 12.3 11.8 16.6 8.9 17.2 22.7 30.4 13.8 16.1 28.9 71.9 14.2 10.4 16.1 15.9 19.4 18.9 19.5 23.9 7.4 16.3 21.0 13.0 14.4 11.8 31.9 30.6 3.5 9.8 13.7 14.7 11.0 14.4 11.2 15.7 8.6 55.7 12.2 9.0 11.2 7.9 11.6 34.1 14.3 29.8 14.7 13.5 8.6 8.7 5.3 9.6 17.3 15.4 13.5 0.4 13.5 13.1 17.3 10.7 19.7 7.6 0.3 25.7 16.9 10.3 18.4 19.8 10.6 12.5 14.8 22.6 15.4 18.9 27.0 9.2 22.5 20.5 6.9 9.6 20.1 17.0 1.0 1.1 15.4 13.7 11.4 14.2 8.1 16.8 16.7 13.3 10.4 20.4 23.6 16.5 9.2 18.5 40.4 8.1 34.7 40.6 14.5 14.3 9.4 10.1 10.7 21.8 14.9 0.3 13.5 9.1 14.1 5.8 10.2 14.3 13.5 16.1 12.6 11.6 7.5 11.4 22.3 9.9 8.4 11.7 1.3 14.7 29.8 34.1 9.7 8.6 15.4 20.6 14.4 18.0 13.8 16.1 16.1 15.9 16.3 15.7 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 9 "B-cells: 4.8;dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: " "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 4.9 12.6 3.5 2.7 5.1 1.5 6.2 3.3 4.9 5.7 4.5 7.1 14.0 1.9 9.5 16.3 4.7 4.3 3.2 5.2 3.9 3.3 3.7 7.7 4.3 4.1 9.2 1.4 7.2 8.7 3.0 2.1 15.9 4.7 5.4 3.2 2.1 4.3 12.2 3.3 3.8 3.5 6.0 8.5 9.8 4.7 14.5 8.4 8.4 4.2 1.4 7.5 7.6 13.1 4.8 1.7 0.0 0.3 0.2 0.2 0.4 6.3 5.7 9.4 6.5 3.5 2.6 36.2 3.8 3.2 4.3 4.8 6.5 5.6 0.0 2.7 2.8 2.5 11.4 3.1 6.2 17.1 7.5 5.0 6.5 6.3 5.7 3.8 2.7 2.0 4.3 3.0 9.8 8.0 3.4 3.0 3.3 6.6 13.7 4.6 7.4 4.9 14.2 10.6 8.9 3.6 5.9 8.2 7.3 11.0 10.2 6.0 6.7 4.0 5.0 4.5 8.0 6.4 2.5 2.3 2.0 12.2 1.2 3.2 4.4 0.0 0.1 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.1 3.7 0.0 0.0 0.0 0.2 0.3 1.7 0.0 0.4 3.5 5.1 3.3 4.9 3.9 3.3 9.2 1.4 4.7 8.4 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell line enhanced" "Detected in some" "AF22: 18.9;BJ hTERT+: 12.0;HDLM-2: 11.8;U-138 MG: 13.6;U-87 MG: 10.0" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" 17000 "Plasma membrane" Nucleoplasm "HPA028789: , HPA077346: " "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.9 0.1 0.7 0.2 0.4 0.5 12.0 1.5 5.7 0.0 0.0 0.1 0.0 0.2 0.1 1.6 0.0 3.5 11.8 0.5 0.1 0.0 0.1 0.0 0.0 0.1 1.1 0.0 1.3 0.0 0.0 0.0 0.2 5.8 0.1 0.3 0.1 6.0 0.0 2.2 3.9 0.1 0.0 0.0 0.3 2.8 0.1 0.2 0.0 0.7 0.1 0.0 13.6 1.3 0.1 1.9 1.5 0.0 0.0 10.0 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 JDP2 JUNDM2 ENSG00000140044 "Jun dimerization protein 2" Q8WYK2 14 75427716-75474111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 11.0;granulocytes: 6.9;monocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059511 Supported Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA059511: " "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "prognostic unfavourable (8.58e-5)" "unprognostic (1.64e-2)" "unprognostic (2.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.99e-2)" "unprognostic (2.81e-1)" "unprognostic (5.06e-2)" "unprognostic (1.91e-1)" "unprognostic (3.25e-2)" "unprognostic (1.86e-1)" "unprognostic (8.11e-3)" "unprognostic (2.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.13e-1)" "unprognostic (9.30e-3)" 27.0 14.4 11.2 19.3 12.5 46.0 59.6 10.6 15.1 16.3 15.3 13.7 6.5 15.3 12.7 10.5 17.1 14.8 21.3 20.7 13.5 9.0 9.7 14.3 24.8 13.2 14.0 8.7 21.8 15.8 7.4 10.1 12.0 11.2 13.9 8.1 16.6 19.5 11.4 13.3 15.2 22.4 17.8 15.7 39.7 15.8 4.7 11.8 1.4 20.7 18.7 9.7 14.2 60.4 11.0 2.1 6.9 10.5 0.1 0.2 1.1 4.3 3.8 0.7 7.7 24.2 18.0 26.3 13.5 14.7 8.9 11.2 9.3 3.8 3.4 6.9 25.7 17.1 4.8 4.6 3.8 4.6 0.5 4.7 7.1 3.3 49.8 6.6 0.3 31.8 27.7 3.6 8.9 0.4 0.6 6.7 7.9 21.3 0.3 11.0 2.6 2.5 2.4 0.1 9.3 4.2 2.4 0.6 3.0 13.9 20.0 15.5 19.1 14.7 1.7 11.2 17.3 0.7 2.0 5.6 1.6 8.2 3.4 25.3 5.5 0.1 4.1 3.8 0.0 7.0 0.0 11.0 0.2 0.0 2.1 5.1 0.0 0.0 6.9 0.1 10.5 1.8 0.2 1.1 11.2 12.5 10.6 15.1 13.5 9.0 14.0 8.7 11.2 11.8 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: " "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favourable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.7 23.3 20.1 16.4 15.0 19.9 15.3 31.0 26.5 18.3 21.8 7.3 36.2 9.8 27.8 28.6 14.4 14.7 19.1 24.7 29.3 8.4 9.8 15.0 14.5 20.0 16.5 19.4 21.7 21.7 17.1 11.8 18.6 8.9 19.7 34.4 17.8 9.0 12.7 11.0 20.6 10.6 24.4 9.0 31.5 19.6 8.6 15.0 28.1 22.5 16.4 22.7 12.7 24.4 19.3 25.3 17.6 20.3 9.2 16.3 11.4 27.3 11.2 24.2 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 JMJD1C "DKFZp761F0118, FLJ14374, KDM3C, KIAA1380, TRIP8" ENSG00000171988 "Jumonji domain containing 1C" Q15652 10 63167221-63521850 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056175, HPA066195" Approved Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA056175: , HPA066195: " "unprognostic (7.72e-2)" "unprognostic (5.57e-2)" "unprognostic (9.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.87e-2)" "unprognostic (6.91e-2)" "unprognostic (3.85e-1)" "unprognostic (2.54e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-2)" "unprognostic (2.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.13e-1)" 31.7 10.9 8.7 26.0 10.9 25.9 16.2 43.0 11.1 21.8 16.6 5.4 11.8 12.2 18.1 17.4 16.4 13.1 18.5 11.7 10.8 8.1 14.1 16.7 29.9 20.9 9.6 6.5 19.2 12.6 27.1 18.6 10.3 14.1 14.1 9.2 13.8 15.3 15.6 13.4 11.0 22.2 11.7 17.6 29.1 12.9 10.9 13.3 27.2 15.6 20.1 15.3 21.9 11.8 4.8 4.2 15.2 2.8 1.7 3.1 1.1 10.9 5.5 13.1 10.0 7.0 12.8 4.6 7.6 15.8 6.9 9.5 9.4 11.7 14.9 4.7 7.1 9.0 3.7 7.3 12.3 4.0 4.7 5.6 5.7 6.8 8.5 12.0 2.1 12.7 7.6 12.2 35.7 12.3 9.9 11.2 16.2 2.9 9.2 6.5 13.9 19.5 16.0 28.4 7.0 7.0 7.9 7.1 11.6 11.5 7.2 11.0 7.1 22.0 14.8 6.4 9.1 5.6 9.5 10.1 8.0 14.1 7.8 7.2 5.7 0.6 2.8 3.1 2.0 1.9 3.1 4.7 2.2 2.1 2.4 4.8 3.1 2.6 15.2 1.7 1.6 4.2 1.9 1.1 8.7 10.9 43.0 11.1 10.8 8.1 9.6 6.5 14.1 13.3 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell line enhanced" "Detected in some" "MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA076304: " "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: " "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.4 5.9 6.9 5.6 6.7 9.9 4.3 8.5 3.6 10.5 6.0 5.3 11.4 9.4 3.7 7.0 7.4 6.1 5.3 5.3 7.2 10.4 9.4 18.8 6.1 2.8 7.2 6.6 6.3 4.7 6.7 3.8 5.9 10.0 4.2 8.8 9.4 8.3 4.0 5.9 8.4 11.0 4.4 5.2 3.6 9.4 12.8 8.5 15.7 6.4 3.7 6.3 4.5 6.9 8.2 17.6 8.0 4.7 5.5 6.1 5.6 6.2 9.1 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 JRKL HHMJG ENSG00000183340 "JRK like" Q9Y4A0 11 96389989-96507574 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046184, HPA060341" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA046184: AB_10963576, HPA060341: " "unprognostic (4.59e-3)" "unprognostic (9.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (6.90e-2)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" "unprognostic (4.94e-2)" "unprognostic (7.55e-3)" "unprognostic (6.12e-2)" "unprognostic (3.99e-3)" "unprognostic (1.31e-1)" "unprognostic (3.20e-3)" "unprognostic (6.21e-2)" "unprognostic (1.21e-1)" "unprognostic (2.97e-1)" "unprognostic (9.57e-3)" 11.5 7.8 10.4 10.2 12.3 1.4 10.3 11.1 9.8 12.5 10.1 6.2 7.9 8.2 13.0 9.1 9.7 12.3 8.7 8.4 9.2 6.8 9.1 5.9 8.0 9.7 10.0 7.8 16.4 7.0 13.4 15.6 12.0 10.0 13.5 10.7 6.0 9.7 11.7 9.9 8.9 12.4 12.8 17.9 10.4 9.9 17.9 13.1 11.6 14.0 6.3 10.3 12.4 14.8 5.3 9.0 6.0 5.7 3.9 7.6 3.4 6.7 4.3 9.0 6.6 18.0 20.1 6.5 11.5 7.9 8.4 10.9 7.2 16.5 9.3 16.9 10.6 10.7 4.4 7.8 9.7 10.0 4.1 8.6 11.1 5.4 14.5 4.8 5.5 9.5 12.5 12.0 15.1 7.5 4.5 4.1 13.4 1.4 6.2 14.0 1.3 5.9 6.4 8.6 7.5 10.2 7.1 3.6 6.5 6.7 4.7 5.0 5.6 6.6 9.1 16.0 7.1 13.9 4.6 3.5 7.7 5.5 7.4 7.9 6.9 6.0 5.7 5.5 3.8 4.5 5.3 5.3 6.0 4.7 5.7 4.1 7.6 6.8 2.1 3.9 5.2 9.0 2.8 3.4 10.4 12.3 11.1 9.8 9.2 6.8 10.0 7.8 10.0 13.1 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell line enhanced" "Detected in many" "CACO-2: 32.1;HEL: 19.6;SH-SY5Y: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.6 1.4 0.8 1.4 0.6 32.1 2.5 0.1 0.4 3.6 0.2 0.8 0.0 1.1 0.0 0.3 19.6 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.6 4.5 0.1 0.4 2.3 0.0 0.0 2.0 3.1 1.0 1.6 0.0 0.1 0.3 1.2 9.2 0.4 0.3 0.3 0.7 0.1 8.1 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 KAT6B "Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B" ENSG00000156650 "Lysine acetyltransferase 6B" Q8WYB5 10 74825582-75032622 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006104 Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA006104: AB_1079445" "unprognostic (4.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.82e-1)" "unprognostic (2.32e-2)" "unprognostic (7.83e-2)" "unprognostic (2.85e-2)" "unprognostic (3.56e-1)" "unprognostic (2.62e-1)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (9.47e-2)" "unprognostic (8.78e-2)" "prognostic favourable (4.82e-4)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (3.15e-1)" 11.6 9.5 11.1 13.2 11.9 15.1 12.4 19.0 11.6 16.7 12.2 13.3 15.3 7.2 25.1 13.0 12.0 13.2 12.0 10.0 10.6 9.5 9.0 7.3 9.2 9.0 9.0 9.9 24.6 13.3 24.8 31.1 9.4 8.9 13.5 9.6 10.1 17.9 12.0 15.3 10.6 11.3 16.2 9.3 10.4 13.0 12.8 12.1 26.6 13.0 8.9 12.5 14.3 12.7 3.2 1.9 1.6 1.1 5.3 3.7 1.5 3.9 4.1 7.4 6.2 5.8 8.6 3.6 3.5 6.9 3.0 3.3 2.7 4.6 8.4 1.9 6.4 3.1 3.9 3.0 4.9 3.5 5.7 3.1 3.3 3.8 4.4 7.3 2.1 5.6 5.0 4.1 6.6 3.4 3.3 7.3 3.8 4.2 7.0 3.4 4.1 22.7 11.0 3.8 1.8 2.2 2.0 3.7 6.1 3.6 6.5 3.2 3.7 2.9 4.2 4.2 5.0 2.8 3.3 5.4 6.2 5.6 4.6 7.8 0.9 0.7 1.1 1.6 3.2 0.9 3.4 2.4 2.4 2.7 1.2 3.2 3.7 3.4 0.9 5.3 0.8 1.9 2.4 1.5 11.1 11.9 19.0 11.6 10.6 9.5 9.0 9.9 8.9 12.1 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 30.3;testis: 33.2" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;Daudi: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" "Nucleoplasm, Intermediate filaments" "HPA040712: , HPA042029: " "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favourable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.5 2.9 8.2 4.1 9.7 2.8 7.1 4.0 7.5 2.5 2.4 11.3 2.5 1.8 2.8 7.1 2.7 8.6 5.1 4.3 8.1 7.6 9.5 5.2 4.6 3.4 9.6 6.2 3.1 3.3 30.3 7.0 2.2 9.0 3.4 3.1 6.4 3.4 3.7 6.0 8.0 1.5 2.3 8.7 3.3 2.0 33.2 6.3 2.4 15.5 1.1 3.0 2.3 2.5 3.1 0.6 2.7 1.3 0.8 1.5 0.3 1.9 4.3 2.3 14.8 4.8 5.9 1.1 1.8 1.6 1.5 1.9 0.2 5.0 19.6 1.5 2.8 0.6 4.7 0.5 1.1 2.0 2.5 0.8 1.3 0.3 2.0 1.2 1.9 12.1 1.8 2.5 0.6 0.5 0.7 1.5 8.4 1.9 1.1 2.6 5.3 2.6 5.4 1.1 0.0 4.7 0.4 5.4 5.9 1.9 0.4 0.6 11.2 10.9 1.0 5.0 0.5 1.9 1.2 1.3 1.0 13.2 2.7 12.4 9.5 1.7 0.7 0.5 1.1 1.3 0.9 2.2 0.9 0.5 0.3 3.1 1.5 1.4 2.7 0.8 0.9 0.6 0.2 0.3 8.2 9.7 4.0 7.5 8.1 7.6 9.6 6.2 9.0 6.3 KBTBD2 "BKLHD1, DKFZP566C134" ENSG00000170852 "Kelch repeat and BTB domain containing 2" Q8IY47 7 32868172-32894131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021133 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA021133: AB_1852093" "unprognostic (1.01e-1)" "prognostic unfavourable (1.89e-4)" "unprognostic (3.17e-2)" "unprognostic (9.19e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "prognostic unfavourable (5.69e-4)" "unprognostic (3.96e-3)" "unprognostic (1.05e-1)" "unprognostic (2.61e-1)" "unprognostic (2.80e-3)" "unprognostic (5.05e-1)" "unprognostic (6.79e-3)" "unprognostic (3.81e-3)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.96e-1)" 20.9 12.3 13.9 15.0 15.7 34.4 16.4 18.3 18.0 13.6 12.2 12.9 10.2 11.3 17.3 8.1 12.8 12.0 18.5 17.0 13.8 14.3 11.2 15.3 17.5 24.9 18.2 13.4 13.9 9.6 16.2 13.8 18.4 17.5 12.5 14.6 12.1 11.7 11.6 36.5 12.2 13.4 18.3 21.1 21.1 10.9 12.5 13.8 26.3 15.2 18.2 16.8 13.6 20.4 6.9 3.5 25.1 8.6 6.8 7.4 2.3 18.2 9.1 23.8 11.7 14.4 14.5 8.6 16.4 16.7 15.6 19.0 9.0 14.2 15.4 11.4 16.9 13.5 12.1 12.8 19.8 6.1 8.7 13.0 15.2 11.7 14.8 13.9 17.2 15.4 13.5 17.0 16.6 17.2 23.6 23.0 23.0 15.0 11.7 22.9 19.2 8.7 11.2 20.8 12.9 13.8 11.1 12.5 23.4 10.5 14.5 18.2 10.2 23.9 14.9 15.3 19.7 14.1 22.4 19.2 18.8 28.3 14.9 16.9 37.9 9.2 4.2 13.0 7.4 7.7 6.2 4.5 3.6 6.5 3.5 6.9 2.8 4.7 25.1 6.8 8.6 1.8 4.7 2.3 13.9 15.7 18.3 18.0 13.8 14.3 18.2 13.4 17.5 13.8 KBTBD4 "BKLHD4, FLJ10450, HSPC252" ENSG00000123444 "Kelch repeat and BTB domain containing 4" Q9NVX7 11 47572197-47579015 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037792, HPA037793" Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA037792: AB_10671633, HPA037793: " "unprognostic (5.52e-2)" "unprognostic (2.23e-1)" "unprognostic (8.36e-3)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "unprognostic (1.21e-1)" "unprognostic (2.09e-1)" "unprognostic (8.73e-3)" "unprognostic (2.78e-1)" "unprognostic (4.04e-2)" "unprognostic (7.22e-2)" "prognostic favourable (2.70e-7)" "unprognostic (4.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.07e-1)" "unprognostic (4.25e-2)" 8.4 13.4 7.9 6.7 15.9 11.7 9.0 16.2 25.8 9.0 9.7 13.6 13.3 6.5 12.3 13.7 8.0 15.5 7.6 9.5 7.5 8.7 12.0 9.4 8.6 10.7 7.0 7.1 13.2 8.4 23.0 11.9 10.0 11.7 12.1 9.2 13.6 8.6 10.5 19.1 10.8 10.3 10.0 6.2 9.9 9.0 11.6 4.6 13.5 12.4 9.4 14.2 10.9 8.1 12.4 6.6 11.8 5.3 12.3 14.7 10.4 5.0 10.5 11.3 9.5 6.9 9.4 4.0 8.5 10.1 11.1 9.6 4.4 9.4 9.3 4.9 9.7 8.4 6.3 11.2 9.5 11.9 10.1 6.7 14.6 4.9 5.1 13.9 13.6 8.5 7.8 4.4 6.0 11.2 5.3 7.2 8.6 12.6 10.2 4.4 6.2 7.5 10.2 15.3 5.9 11.8 10.6 15.7 10.4 7.3 9.8 6.4 16.5 4.5 10.2 8.0 8.9 11.0 8.4 11.2 17.2 12.8 11.1 4.0 8.2 10.7 5.3 11.8 13.7 4.3 14.7 12.4 11.0 12.6 6.6 11.0 11.7 12.5 8.0 12.3 4.1 3.1 12.8 10.4 7.9 15.9 16.2 25.8 7.5 8.7 7.0 7.1 11.7 4.6 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Cell line enhanced" "Detected in many" "HEL: 5.8;hTEC/SVTERT24-B: 9.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.8 0.8 1.2 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.6 1.7 5.8 1.0 2.6 0.0 1.6 0.5 0.0 0.0 9.1 0.0 3.6 0.2 0.5 0.4 0.2 0.5 1.0 1.8 0.4 0.9 1.2 4.6 0.0 0.4 1.3 1.4 0.5 1.1 1.1 1.4 0.9 3.7 1.5 0.9 2.4 1.9 3.2 0.7 0.7 4.5 1.9 1.6 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell line enhanced" "Detected in some" "RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: , HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 1.1 1.8 0.0 0.3 0.3 2.1 0.6 2.9 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.0 0.5 0.5 1.1 1.5 0.0 0.7 7.4 0.9 0.0 0.4 7.0 4.3 0.4 0.4 0.0 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 0.9 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell line enhanced" "Detected in some" "A549: 9.4;AN3-CA: 4.4;HMC-1: 4.5;RPTEC TERT1: 11.6;U-2 OS: 12.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051088: " "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 2.2 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.1 0.0 0.0 0.6 11.6 0.0 1.8 0.3 0.3 0.0 0.3 1.0 0.2 0.1 0.0 12.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Group enriched" "Detected in some" 5 "HeLa: 9.9;RT4: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 41.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 17.9;T-47d: 14.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059148 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059148: " "unprognostic (1.46e-1)" "prognostic favourable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavourable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favourable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favourable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.0 6.0 8.7 4.3 7.9 0.0 0.0 0.8 7.2 3.0 2.9 1.0 0.8 3.1 4.0 0.0 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 10.9;NB-4: 7.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 3.0 2.0 0.7 2.9 0.7 1.2 3.3 0.2 0.6 1.8 2.0 1.9 2.0 2.3 0.7 1.0 2.4 1.8 1.0 0.9 2.2 4.0 1.2 2.9 1.1 1.6 5.3 3.7 2.1 6.6 2.9 2.2 2.7 1.4 0.5 0.6 2.2 1.9 1.5 5.9 2.6 4.5 2.4 2.6 1.9 1.5 3.5 0.3 2.3 0.4 3.6 1.0 0.0 3.0 0.7 1.2 0.0 1.4 1.1 1.9 0.8 0.5 1.3 0.6 6.4 2.6 0.1 3.0 0.6 1.1 0.0 0.2 1.5 3.7 0.4 10.9 2.9 2.5 1.2 0.2 3.6 1.9 0.6 0.9 0.0 1.1 0.4 0.1 1.5 1.8 0.1 7.4 0.0 2.3 3.2 0.0 0.1 1.0 2.0 1.5 0.4 0.9 1.2 0.7 3.0 6.0 0.7 0.6 1.0 0.3 0.9 1.0 0.4 3.5 0.6 4.2 0.8 2.3 0.4 0.5 1.0 0.3 0.6 3.5 0.6 0.8 0.1 2.1 0.4 0.7 1.9 3.6 0.1 0.3 0.9 0.0 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell line enhanced" "Detected in some" "Daudi: 17.7;HMC-1: 12.3;Karpas-707: 30.3;RPMI-8226: 8.2;U-266/70: 29.2;U-698: 9.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm Nucleoplasm "HPA057127: " "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavourable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.2 0.0 0.1 0.0 0.4 0.0 30.3 0.3 0.0 0.1 0.0 0.3 1.1 0.0 7.5 8.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.2 3.8 9.8 0.3 0.0 2.8 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 KCTD1 C18orf5 ENSG00000134504 "Potassium channel tetramerization domain containing 1" Q719H9 18 26454910-26657401 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 35.6;HaCaT: 37.0;hTCEpi: 33.5;RPTEC TERT1: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "HPA057808, HPA062486" Approved "Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite" Nucleoplasm "Nucleoli, Cytokinetic bridge, Centriolar satellite" "HPA057808: , HPA062486: " "unprognostic (1.15e-3)" "unprognostic (5.66e-2)" "unprognostic (2.35e-4)" "prognostic unfavourable (2.22e-4)" "unprognostic (3.65e-3)" "unprognostic (7.43e-2)" "unprognostic (2.03e-3)" "unprognostic (6.77e-2)" "unprognostic (2.74e-1)" "unprognostic (1.88e-3)" "unprognostic (5.68e-3)" "unprognostic (1.77e-2)" "prognostic favourable (4.60e-8)" "unprognostic (3.87e-3)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (8.02e-2)" 3.9 11.8 15.9 2.1 37.3 0.7 22.2 13.7 29.0 12.6 5.0 6.9 6.2 3.2 10.0 15.8 32.8 33.8 5.8 12.9 16.7 6.7 20.1 2.6 4.0 2.0 6.6 18.4 11.1 5.2 7.4 6.1 17.2 6.8 15.3 7.3 8.4 12.5 16.4 2.8 39.3 2.2 8.7 6.0 2.9 7.0 4.1 10.7 5.7 13.6 20.1 11.7 8.5 18.3 0.3 0.7 0.7 0.3 0.0 1.8 0.2 5.4 19.0 35.6 3.8 20.9 3.4 4.5 4.6 7.0 7.4 7.3 1.8 6.3 1.1 17.7 9.8 37.0 6.8 10.0 6.9 1.0 3.2 1.1 4.2 3.0 3.9 0.6 1.8 5.7 33.5 2.1 13.9 6.9 0.4 0.5 5.2 7.8 5.4 1.7 3.6 8.7 2.9 2.1 0.8 32.6 8.2 3.7 14.1 6.7 9.2 3.1 8.3 1.5 3.7 8.2 2.6 1.6 5.1 1.7 1.4 0.1 3.1 3.7 12.2 0.0 0.1 0.7 0.8 0.1 1.6 0.0 1.8 0.6 0.7 0.3 0.7 0.5 0.0 0.0 0.3 0.3 0.0 0.2 15.9 37.3 13.7 29.0 16.7 6.7 6.6 18.4 6.8 10.7 KCTD11 "C17orf36, KCASH1, REN" ENSG00000213859 "Potassium channel tetramerization domain containing 11" Q693B1 17 7351889-7354944 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Ubl conjugation pathway" "Developmental protein, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.9;hTCEpi: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" HPA052035 Approved Approved Nucleoplasm Nucleoplasm "HPA052035: " "unprognostic (1.98e-1)" "unprognostic (5.67e-2)" "unprognostic (1.08e-1)" "prognostic favourable (9.55e-4)" "unprognostic (6.78e-3)" "unprognostic (1.92e-2)" "unprognostic (2.38e-2)" "unprognostic (1.59e-3)" "unprognostic (3.91e-1)" "prognostic unfavourable (5.02e-4)" "unprognostic (7.93e-2)" "unprognostic (3.62e-1)" "unprognostic (1.99e-1)" "unprognostic (2.03e-1)" "unprognostic (8.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" 7.4 5.7 4.7 5.3 6.5 0.9 16.2 5.8 5.7 20.1 6.9 7.6 5.1 5.2 8.9 7.5 32.9 8.0 9.8 4.9 3.6 3.6 5.2 5.1 8.6 9.4 10.2 3.4 8.6 10.5 8.2 5.2 15.2 6.0 10.5 5.2 6.5 11.1 9.8 4.3 23.0 6.5 7.1 5.0 8.1 7.9 4.0 5.5 1.5 17.2 23.3 17.0 19.2 22.0 1.8 2.5 8.8 6.0 1.6 2.3 2.5 10.1 4.1 3.1 2.3 13.2 7.7 3.3 6.5 10.7 7.1 6.2 3.7 4.5 1.5 3.7 11.1 17.8 0.4 28.9 6.1 6.0 1.2 0.1 2.9 0.6 6.9 0.1 5.8 6.1 21.3 7.6 4.2 2.2 1.3 1.7 5.3 4.3 0.9 1.4 1.0 2.4 1.3 2.8 1.3 7.2 4.0 0.1 1.7 4.7 4.7 0.7 6.6 0.6 4.2 5.8 5.1 3.9 3.4 1.2 0.5 0.4 7.0 3.3 4.2 8.8 3.6 2.4 2.3 6.0 0.8 1.8 1.1 1.0 2.5 1.4 0.6 1.6 0.5 1.6 4.3 0.1 0.2 2.5 4.7 6.5 5.8 5.7 3.6 3.6 10.2 3.4 6.0 5.5 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (3.96e-5)" "prognostic favourable (8.01e-4)" "prognostic unfavourable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favourable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favourable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.0 0.3 0.3 0.8 0.4 2.1 1.1 0.9 2.0 5.0 7.8 5.1 0.0 5.6 0.6 0.6 0.3 15.1 5.3 0.2 7.7 0.0 1.8 16.5 3.0 0.1 0.0 2.4 0.4 8.2 6.5 0.5 0.1 0.0 0.8 0.1 0.2 0.4 3.8 0.3 0.2 0.0 0.0 26.8 2.0 1.3 0.1 0.0 0.1 2.5 0.8 0.6 0.4 0.1 12.2 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 47.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA050822: " "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavourable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 8.7 4.0 10.5 7.1 7.9 3.4 7.7 7.7 11.0 15.5 13.6 8.6 4.6 4.7 20.3 6.2 14.6 12.7 9.4 6.8 13.0 5.1 6.2 7.1 13.3 4.1 5.8 8.4 14.3 15.6 1.6 3.4 7.3 9.4 9.0 4.2 12.4 3.7 13.7 4.8 47.3 5.8 13.8 9.3 8.3 8.1 10.6 8.9 1.0 8.9 5.1 4.6 9.4 13.0 0.0 3.4 7.7 6.3 0.0 1.2 0.9 5.7 13.3 12.0 18.2 4.0 2.1 9.5 7.6 1.4 4.3 2.2 7.4 3.9 0.0 17.3 10.6 6.8 8.7 6.0 1.6 6.2 15.3 23.8 8.2 7.1 11.1 4.6 4.3 4.1 25.2 1.6 9.7 8.3 5.8 0.1 0.7 14.6 0.1 13.1 10.9 22.5 11.1 6.5 2.2 4.8 2.6 9.3 32.0 14.9 21.3 27.7 15.7 12.2 13.5 20.0 18.0 0.4 1.3 14.8 0.7 9.4 0.0 8.0 24.4 0.6 2.5 7.7 0.0 4.6 0.1 0.0 1.2 0.2 3.4 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.7 0.9 10.5 7.9 7.7 9.2 13.0 5.1 5.8 8.4 9.4 8.9 KDELC2 MGC33424 ENSG00000178202 "KDEL motif containing 2" Q7Z4H8 11 108472105-108498432 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: " "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavourable (6.27e-5)" 20.8 7.8 4.2 12.7 4.7 2.7 19.7 3.6 3.2 27.2 11.1 4.8 9.7 4.1 21.8 21.1 16.1 17.6 18.0 13.3 4.1 4.2 11.4 13.5 12.5 10.0 4.6 2.7 25.6 9.5 19.8 5.1 65.0 4.6 20.6 8.0 13.4 13.0 14.5 8.1 6.9 7.3 24.4 5.0 9.9 8.9 9.5 4.4 10.0 9.2 8.7 6.5 19.5 20.0 0.9 2.0 0.2 1.5 4.5 4.6 1.0 3.1 3.6 14.1 14.4 23.8 27.7 13.5 14.0 13.1 20.1 21.9 17.2 23.4 0.0 8.8 18.2 2.3 10.6 0.3 21.3 5.6 8.2 5.3 4.0 7.9 9.6 13.7 0.0 15.9 4.4 10.6 0.3 16.9 11.8 0.1 30.4 2.3 8.8 7.9 6.1 10.4 0.4 22.0 0.0 3.7 8.8 2.9 9.0 26.5 1.8 3.8 12.7 5.3 16.8 39.0 7.7 3.3 14.5 0.1 0.0 0.0 10.0 14.5 30.9 0.1 0.3 0.0 4.6 1.5 3.9 0.5 2.3 3.8 1.1 0.9 2.4 3.6 0.2 4.5 0.7 2.0 1.9 1.0 4.2 4.7 3.6 3.2 4.1 4.2 4.6 2.7 4.6 4.4 KDF1 "C1orf172, FLJ34633, RP11-344H11.3" ENSG00000175707 "Keratinocyte differentiation factor 1" Q8NAX2 1 26949562-26960406 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 13.6;BEWO: 12.0;CAPAN-2: 12.9;HaCaT: 12.1;HBEC3-KT: 16.7;hTCEpi: 21.9;SK-BR-3: 14.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 36 "B-cells: 3.7;T-cells: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA028639, HPA068312" Uncertain Supported "Nucleoplasm,Cell Junctions,Mitotic spindle" "Cell Junctions" "Nucleoplasm, Mitotic spindle" "HPA028639: AB_10599191, HPA068312: " "unprognostic (2.58e-1)" "unprognostic (1.23e-1)" "unprognostic (6.46e-2)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (8.45e-2)" "unprognostic (9.09e-2)" "unprognostic (9.01e-2)" "unprognostic (2.73e-1)" "unprognostic (3.91e-1)" "prognostic favourable (3.04e-13)" "unprognostic (1.38e-3)" "unprognostic (7.83e-2)" "unprognostic (8.03e-2)" "prognostic favourable (4.40e-4)" 0.2 1.1 0.6 3.8 0.7 0.0 7.9 1.5 3.6 2.9 11.9 0.4 13.6 9.3 1.0 17.3 16.1 5.5 4.2 0.5 0.8 0.1 7.9 3.5 7.5 6.7 0.2 0.6 1.0 23.8 6.6 9.0 12.4 0.8 6.0 5.1 2.0 14.3 11.5 0.2 13.3 12.5 0.2 0.2 1.0 7.7 5.8 0.5 1.6 14.5 7.2 8.6 5.2 6.0 3.7 0.1 0.0 0.0 0.0 8.6 2.4 13.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 6.8 12.9 0.0 0.5 0.0 12.1 0.0 16.7 0.0 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 21.9 0.0 1.8 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.9 0.1 0.0 0.0 2.0 3.0 6.5 8.5 0.0 0.1 14.3 0.0 9.2 0.2 0.1 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 4.5 3.5 5.9 4.2 0.1 3.7 8.6 5.1 0.0 0.0 0.0 0.0 0.3 2.4 0.6 0.7 1.5 3.6 0.8 0.1 0.2 0.6 0.8 0.5 KDM2A "CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA" ENSG00000173120 "Lysine demethylase 2A" Q9Y2K7 11 67119269-67258087 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012272, HPA044251" Supported Approved Nucleoplasm Nucleoplasm "CAB012272: , HPA044251: " "unprognostic (7.43e-2)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (8.66e-2)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (6.05e-2)" "unprognostic (2.84e-1)" "unprognostic (4.46e-1)" "unprognostic (2.04e-3)" "unprognostic (3.27e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-2)" "unprognostic (3.30e-1)" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "unprognostic (9.45e-3)" 19.6 14.6 18.6 25.3 23.9 38.1 21.0 36.5 22.8 20.0 21.9 17.8 20.7 15.3 32.0 18.6 32.7 20.2 19.3 18.8 17.4 12.7 16.8 20.3 24.3 30.1 17.9 14.9 27.4 15.3 26.1 21.1 26.0 17.5 23.3 17.1 21.0 22.2 20.5 32.8 28.7 24.1 25.0 14.6 29.0 19.8 27.6 18.6 32.2 19.9 20.3 37.3 24.9 25.9 7.2 1.9 5.0 1.9 4.6 5.2 2.8 25.0 15.1 9.2 14.3 9.2 13.3 6.9 11.0 12.8 19.7 13.6 23.6 13.2 19.3 19.3 15.5 24.5 15.2 10.9 16.0 32.4 6.8 14.2 18.0 5.9 9.7 12.1 19.7 11.0 13.3 19.3 13.5 14.3 13.1 27.3 9.5 16.7 15.6 8.8 18.6 13.0 19.9 15.5 10.8 8.3 15.8 12.5 10.0 35.2 20.3 20.9 30.5 12.3 19.2 13.3 8.9 18.2 9.4 15.2 16.7 12.3 11.6 8.7 9.1 0.6 1.9 0.5 4.8 1.5 5.2 6.4 3.6 4.2 1.2 7.2 3.8 3.5 5.0 4.6 1.0 1.9 4.3 2.8 18.6 23.9 36.5 22.8 17.4 12.7 17.9 14.9 17.5 18.6 KDM4C "GASC1, JMJD2C, KIAA0780, TDRD14C" ENSG00000107077 "Lysine demethylase 4C" Q9H3R0 9 6720863-7175648 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069357 Approved Nucleoplasm Nucleoplasm "HPA069357: " "unprognostic (1.56e-2)" "unprognostic (1.91e-2)" "unprognostic (4.38e-2)" "unprognostic (1.38e-1)" "unprognostic (3.52e-1)" "unprognostic (4.36e-2)" "unprognostic (2.50e-2)" "unprognostic (6.89e-3)" "unprognostic (2.37e-1)" "unprognostic (2.34e-2)" "unprognostic (3.65e-2)" "unprognostic (2.03e-2)" "unprognostic (1.92e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" "unprognostic (2.23e-2)" "unprognostic (1.64e-3)" 12.1 12.1 13.3 21.5 15.0 27.5 12.7 51.2 14.3 12.4 14.9 18.0 14.6 14.2 14.7 13.9 12.5 12.0 11.9 10.0 11.1 11.9 9.9 12.2 16.1 21.1 15.1 10.5 13.5 18.9 26.0 24.0 10.6 13.7 11.5 18.5 15.3 15.1 13.9 9.7 16.9 16.6 15.4 13.8 15.2 16.2 10.4 16.0 29.0 14.9 7.9 25.7 13.5 14.2 13.8 8.4 13.0 11.1 10.8 11.8 6.9 9.3 5.6 2.4 3.5 8.1 9.0 6.7 4.3 5.8 5.1 5.0 6.5 5.3 11.0 2.6 5.9 2.9 5.1 7.4 6.6 31.6 3.7 15.3 7.9 8.8 7.7 5.8 10.5 7.8 5.1 4.0 8.6 6.1 2.4 7.5 5.4 4.9 9.5 22.8 4.0 2.1 5.7 2.0 6.7 7.5 5.5 8.1 4.8 3.9 7.7 3.7 3.7 10.0 6.5 5.0 2.3 5.8 4.0 5.6 4.1 11.0 4.9 5.6 1.8 7.2 6.4 13.0 9.8 6.9 10.8 11.9 10.9 10.7 8.4 13.8 11.8 8.8 1.5 10.8 11.1 3.4 9.2 6.9 13.3 15.0 51.2 14.3 11.1 11.9 15.1 10.5 13.7 16.0 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973681-94999518 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 37.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.1" "Low lineage specificity" "Detected in many" "HPA055854, HPA064037" Approved Approved Nucleoplasm Nucleoplasm "HPA055854: , HPA064037: " "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.6 0.8 1.2 0.4 2.0 0.1 0.8 1.4 2.1 0.6 0.3 1.2 1.7 0.2 0.6 0.9 0.4 1.0 0.5 1.0 0.7 0.7 0.6 0.4 0.4 0.7 0.6 1.3 1.3 0.4 1.4 2.1 0.5 1.1 0.6 0.4 1.2 0.7 0.7 1.0 0.7 0.5 0.6 0.9 0.7 0.4 37.5 1.0 0.3 0.8 0.6 0.6 0.6 0.4 1.3 1.2 0.0 5.1 0.1 1.4 0.2 0.9 1.4 5.8 4.2 1.2 1.5 2.7 1.9 2.1 5.4 4.8 1.5 1.8 2.1 6.3 1.6 1.7 3.7 4.1 4.1 2.3 3.8 1.9 0.7 2.2 1.1 0.9 0.6 2.8 2.2 5.3 4.8 2.0 2.1 1.0 2.0 1.8 3.2 2.1 2.5 7.0 4.4 2.5 1.6 1.3 0.6 3.4 4.1 2.3 2.0 1.6 2.2 0.6 1.5 3.7 2.1 5.7 2.9 1.4 4.2 0.3 1.3 1.1 4.0 0.0 0.3 0.0 0.3 0.2 0.2 1.3 0.6 1.0 0.0 0.2 0.8 0.1 0.0 0.1 5.1 1.2 1.4 0.2 1.2 2.0 1.4 2.1 0.7 0.7 0.6 1.3 1.1 1.0 KDM6A UTX ENSG00000147050 "Lysine demethylase 6A" O15550 X 44873177-45112602 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000568, HPA001165, HPA002111" Enhanced Approved Nucleoplasm,Nucleoli "Intracellular and membrane" Nucleoplasm Nucleoli "HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704" "unprognostic (1.73e-3)" "unprognostic (6.86e-3)" "unprognostic (1.45e-2)" "unprognostic (1.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.65e-2)" "unprognostic (2.58e-3)" "unprognostic (8.22e-3)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-1)" "unprognostic (2.24e-2)" "unprognostic (5.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.16e-2)" 12.3 12.1 16.5 17.6 24.5 47.9 21.4 26.1 22.0 16.9 11.8 16.7 12.0 13.1 22.6 11.3 15.4 16.9 15.2 9.1 18.2 6.5 11.6 13.5 19.7 15.1 28.8 11.3 23.8 14.9 21.3 20.2 13.3 18.3 10.3 11.3 10.3 16.1 12.6 15.1 21.3 17.6 13.5 14.9 18.1 15.0 17.7 26.1 19.1 14.5 6.9 13.6 14.9 22.8 5.5 7.1 15.7 7.5 6.2 7.9 3.5 8.9 7.8 11.6 11.7 8.3 8.6 24.9 7.0 5.0 8.4 8.8 18.4 7.7 5.9 3.8 6.5 19.3 14.8 12.3 7.8 8.5 15.9 7.3 9.9 6.8 5.9 3.9 20.7 4.6 10.2 13.8 14.5 6.5 10.1 14.6 5.2 5.8 8.1 11.5 9.7 9.0 9.0 11.1 1.0 4.8 16.8 10.0 5.4 22.3 11.2 9.5 10.8 0.1 5.5 8.0 6.2 8.0 3.6 9.2 11.1 8.9 5.6 4.1 4.6 15.7 3.8 3.5 5.3 7.5 6.0 5.5 7.2 7.9 7.1 3.8 7.0 6.3 7.3 6.2 7.2 3.8 5.6 3.5 16.5 24.5 26.1 22.0 18.2 6.5 28.8 11.3 18.3 26.1 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140177035 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 20.1 3.2 6.6 15.2 4.7 18.7 10.4 8.7 6.1 13.2 12.0 4.7 4.6 10.3 8.9 5.8 13.0 5.8 6.0 8.0 5.7 3.5 4.9 8.5 9.7 10.1 4.8 2.8 5.0 6.4 7.0 6.7 15.5 6.7 6.9 12.2 3.7 11.4 4.5 24.6 15.0 16.3 9.3 6.0 6.7 11.9 9.4 5.9 10.8 6.4 10.3 15.2 13.1 9.1 2.8 3.0 6.1 2.3 1.8 1.6 0.8 0.9 0.4 2.9 3.1 2.6 2.3 5.9 1.3 1.9 0.5 0.6 0.3 0.4 2.0 2.0 1.3 1.1 4.0 2.4 0.9 11.2 2.5 0.1 0.4 5.2 2.7 1.8 2.1 2.7 5.5 1.6 8.7 2.8 6.3 8.9 0.5 0.8 3.5 3.1 4.6 1.6 3.9 0.2 4.0 1.0 1.2 5.1 6.3 3.0 7.0 3.0 9.5 0.7 4.9 0.6 1.1 1.9 0.8 3.1 0.4 6.6 1.6 5.2 1.1 1.6 2.3 0.9 1.1 1.3 0.9 1.5 1.6 1.5 3.0 2.8 1.5 1.0 6.1 1.8 0.5 1.2 1.3 0.8 6.6 4.7 8.7 6.1 5.7 3.5 4.8 2.8 6.7 5.9 KDM8 "FLJ13798, JMJD5" ENSG00000155666 "Lysine demethylase 8" Q8N371 16 27203495-27221768 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026545 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA026545: AB_1852015" "unprognostic (1.39e-1)" "unprognostic (1.37e-3)" "unprognostic (2.80e-1)" "unprognostic (2.16e-2)" "unprognostic (3.21e-1)" "unprognostic (1.22e-2)" "unprognostic (2.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.95e-2)" "unprognostic (3.41e-1)" "prognostic favourable (1.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.75e-2)" "unprognostic (5.33e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (3.92e-3)" 1.9 3.2 2.7 3.6 3.5 1.4 2.1 5.9 5.9 2.2 4.2 3.7 3.2 12.0 3.1 2.2 2.1 2.5 2.5 2.0 2.7 3.2 2.3 44.9 2.0 3.3 2.3 5.1 3.0 4.5 2.8 3.3 1.7 3.7 2.9 1.9 2.1 2.6 2.5 4.0 1.9 16.8 1.9 2.2 3.7 2.3 2.2 2.2 5.9 2.9 2.0 3.7 2.8 2.2 5.6 6.5 1.3 3.4 2.2 8.2 3.5 1.6 3.7 6.3 3.2 1.6 1.8 3.4 2.1 2.3 4.7 4.2 3.1 2.9 9.5 3.6 3.5 1.9 3.6 3.2 2.8 10.9 5.4 6.0 4.1 7.2 3.4 4.2 7.2 2.5 2.5 3.1 2.0 3.6 7.6 5.8 2.9 2.8 4.2 7.6 11.0 2.2 6.2 3.9 8.4 1.8 1.9 5.9 3.8 0.9 3.0 2.2 3.2 5.6 4.1 5.7 2.9 2.0 2.2 3.6 3.8 7.6 2.3 3.9 0.5 0.4 3.2 1.3 4.2 3.4 3.6 3.2 6.2 6.0 3.0 5.6 6.0 8.2 0.1 2.2 2.9 6.5 3.6 3.5 2.7 3.5 5.9 5.9 2.7 3.2 2.3 5.1 3.7 2.2 KHDC4 "BLOM7, KIAA0907, SNORA80EHG" ENSG00000132680 "KH domain containing 4, pre-mRNA splicing factor" Q7Z7F0 1 155913043-155934400 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008796 Approved Approved Nucleoplasm Nucleoplasm "HPA008796: AB_1079369" "unprognostic (6.31e-2)" "unprognostic (1.32e-1)" "unprognostic (4.52e-2)" "unprognostic (5.22e-3)" "unprognostic (7.68e-3)" "unprognostic (1.61e-1)" "prognostic unfavourable (1.01e-6)" "unprognostic (3.79e-2)" "unprognostic (2.44e-2)" "unprognostic (7.88e-2)" "unprognostic (3.66e-2)" "prognostic unfavourable (3.87e-4)" "prognostic unfavourable (2.78e-10)" "unprognostic (1.04e-1)" "unprognostic (2.37e-1)" "unprognostic (9.10e-2)" "prognostic favourable (4.36e-5)" 15.6 17.9 22.5 18.4 24.6 9.3 20.0 42.2 26.7 23.0 19.0 19.5 25.2 20.4 24.4 42.5 16.3 17.2 17.4 15.8 22.7 11.0 20.1 16.2 19.1 23.5 25.0 13.3 29.8 18.8 19.5 39.4 20.5 20.2 23.1 25.0 18.9 22.3 19.9 21.9 25.7 20.4 23.8 21.7 22.3 24.3 15.8 24.8 21.8 20.4 7.1 25.6 21.5 20.8 6.5 3.6 7.6 6.1 5.1 7.2 2.4 12.1 9.3 19.8 12.0 10.7 15.0 12.3 10.5 8.4 16.0 16.6 9.7 27.0 15.1 11.7 5.9 22.6 18.2 7.4 15.9 12.0 37.9 13.6 28.4 11.5 7.5 15.9 11.8 9.8 19.6 11.2 8.8 11.5 16.3 17.4 14.5 5.8 15.3 15.7 21.9 13.5 18.1 10.8 13.4 14.1 6.6 13.9 13.8 7.8 8.2 11.2 17.3 26.9 9.6 15.6 10.8 5.0 14.0 28.4 12.2 13.5 11.2 15.0 11.7 7.6 3.5 6.5 5.3 4.6 6.8 6.1 5.6 6.8 3.4 6.5 7.2 6.5 4.5 5.1 6.1 3.6 4.6 2.4 22.5 24.6 42.2 26.7 22.7 11.0 25.0 13.3 20.2 24.8 KHNYN KIAA0323 ENSG00000100441 "KH and NYN domain containing" O15037 14 24429286-24441834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003402 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003402: AB_1079190" "unprognostic (2.95e-1)" "prognostic unfavourable (4.38e-4)" "unprognostic (1.03e-1)" "unprognostic (8.03e-2)" "prognostic unfavourable (5.10e-4)" "unprognostic (4.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (8.43e-2)" "unprognostic (1.41e-1)" "unprognostic (6.08e-2)" "unprognostic (2.73e-1)" 18.3 16.7 8.3 24.2 12.8 21.1 18.1 18.9 9.4 21.6 22.4 14.3 25.2 16.9 18.7 19.5 24.3 18.3 28.8 11.2 8.6 5.9 11.8 12.5 16.8 19.2 12.9 7.2 30.7 23.2 17.6 12.8 31.5 11.3 21.5 16.1 10.8 17.0 20.0 15.1 16.9 21.2 24.5 13.6 22.7 24.6 9.3 12.5 20.1 16.1 16.6 26.0 19.7 30.7 6.6 4.5 7.0 5.8 4.5 5.8 3.7 12.4 15.1 12.6 10.0 13.9 13.7 13.4 12.3 14.2 14.2 11.1 9.4 21.5 17.6 7.1 10.9 11.8 11.0 19.3 10.1 26.8 5.5 7.9 13.5 17.0 14.9 11.5 16.8 13.9 43.6 15.2 19.0 15.9 10.1 15.7 8.2 16.7 4.0 6.9 3.3 13.1 6.3 0.1 8.7 8.6 17.9 9.2 9.8 10.4 6.5 16.0 7.6 12.9 16.0 12.4 11.2 14.7 7.0 30.3 16.3 11.7 6.8 6.2 11.6 4.7 4.1 7.0 5.8 5.8 3.4 4.6 4.5 4.9 3.1 6.6 3.5 3.3 5.7 4.5 4.8 4.5 4.4 3.7 8.3 12.8 18.9 9.4 8.6 5.9 12.9 7.2 11.3 12.5 KIAA0040 ENSG00000235750 KIAA0040 Q15053 1 175156987-175192999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.2;RPMI-8226: 22.8;U-698: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016895, HPA068812" Approved Approved Nucleoplasm Nucleoplasm "HPA016895: , HPA068812: " "unprognostic (5.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (1.01e-2)" "unprognostic (8.54e-3)" "unprognostic (2.91e-1)" "unprognostic (2.87e-2)" "unprognostic (3.83e-1)" "unprognostic (1.21e-1)" "unprognostic (2.66e-2)" "unprognostic (1.63e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-1)" "unprognostic (2.28e-2)" "unprognostic (3.05e-1)" 25.7 4.0 2.7 18.4 7.4 5.1 16.0 2.0 3.9 8.0 7.7 1.8 3.5 5.2 8.6 7.9 7.0 9.2 11.0 16.3 3.2 2.9 17.8 12.1 25.3 16.1 6.9 1.0 5.0 17.9 4.6 13.6 45.6 7.6 7.9 5.6 12.2 15.2 4.1 11.1 5.1 10.2 6.0 5.4 27.6 9.8 3.4 3.5 14.8 9.6 7.2 18.6 6.6 10.7 16.5 5.4 26.4 6.1 3.3 9.6 5.4 3.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 3.8 0.0 0.0 1.6 4.5 32.2 7.7 0.0 12.9 2.2 15.1 0.0 10.9 1.8 3.4 7.1 0.2 0.4 0.2 0.4 0.0 4.1 0.0 5.7 5.0 2.8 5.4 0.0 0.7 4.0 0.0 1.0 2.7 3.4 1.6 22.8 4.9 7.7 0.2 1.2 2.3 12.7 0.3 8.1 0.7 2.0 0.0 1.5 0.0 0.3 13.3 16.2 41.4 0.6 0.0 3.4 12.8 6.1 1.0 5.9 3.3 5.3 16.2 6.5 4.9 5.4 16.5 6.9 5.9 26.4 3.3 1.2 1.2 9.6 5.4 2.7 7.4 2.0 3.9 3.2 2.9 6.9 1.0 7.6 3.5 KIAA0355 ENSG00000166398 KIAA0355 O15063 19 34254537-34355586 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014570 Uncertain Approved Nucleoplasm Nucleoplasm "HPA014570: AB_1852307" "unprognostic (1.88e-2)" "unprognostic (8.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.75e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-3)" "unprognostic (9.05e-2)" "unprognostic (8.27e-2)" "prognostic unfavourable (2.82e-4)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.34e-1)" "unprognostic (7.73e-3)" "unprognostic (2.96e-2)" "unprognostic (1.86e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" 19.8 7.2 9.3 10.8 14.7 4.4 19.5 16.3 15.0 12.3 8.5 22.1 9.3 7.5 16.6 9.4 11.3 11.8 13.1 14.0 9.0 8.9 10.2 8.8 14.9 11.7 15.6 11.1 12.5 14.5 18.9 21.8 31.0 15.7 11.2 8.1 16.6 9.4 9.7 17.4 12.2 9.8 12.3 16.2 20.7 8.2 22.2 13.5 8.4 14.1 5.4 12.7 10.7 12.1 6.3 2.0 4.4 3.4 2.6 5.8 1.4 2.3 7.0 6.3 3.2 4.4 4.2 8.3 5.2 4.3 4.0 6.1 5.5 2.8 5.2 11.7 4.8 1.6 4.6 2.5 4.5 7.5 4.1 3.2 2.7 4.2 5.5 1.4 2.6 4.8 4.4 5.3 7.9 16.5 9.6 2.6 4.3 1.2 0.9 1.3 4.8 2.6 2.3 4.4 2.7 3.4 2.6 7.3 6.0 6.0 23.8 7.7 1.9 2.6 13.6 14.0 5.2 3.5 5.5 4.6 6.3 1.6 2.7 0.5 6.7 0.0 1.2 0.0 1.8 2.7 2.7 4.7 3.8 1.6 1.5 6.3 3.2 2.0 4.4 2.6 3.4 2.0 5.8 1.4 9.3 14.7 16.3 15.0 9.0 8.9 15.6 11.1 15.7 13.5 KIAA0391 "MRPP3, PRORP" ENSG00000100890 KIAA0391 O15091 14 35121846-35277614 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA020459 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA020459: " "unprognostic (6.44e-3)" "unprognostic (8.10e-2)" "unprognostic (7.71e-3)" "unprognostic (4.90e-2)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" "unprognostic (8.67e-2)" "unprognostic (1.94e-2)" "unprognostic (3.25e-4)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (9.67e-5)" "unprognostic (2.56e-1)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (6.65e-2)" 13.9 26.1 18.8 17.6 20.1 12.5 17.5 23.1 21.9 17.4 22.4 20.6 15.6 16.6 13.0 19.4 26.1 14.7 13.2 16.7 17.6 16.3 31.1 29.5 20.9 29.5 20.2 17.7 10.8 16.5 29.8 27.4 13.4 19.2 14.1 24.9 15.8 18.0 21.8 22.2 23.0 16.5 15.0 23.0 18.7 15.8 17.1 20.9 31.2 18.9 21.3 24.8 18.2 16.0 10.0 9.7 10.9 5.4 12.1 25.5 12.4 22.7 18.1 12.6 16.7 13.9 16.4 11.1 15.3 13.8 19.6 17.0 17.2 14.1 25.0 19.9 14.5 17.6 23.2 26.5 22.1 19.6 7.2 11.2 14.0 36.7 14.3 13.8 12.3 17.5 20.4 18.5 17.1 28.4 18.1 7.3 23.9 25.7 20.9 15.2 13.5 18.0 20.0 21.0 14.5 27.5 23.3 11.8 13.3 19.8 22.0 12.7 32.0 11.4 21.5 15.1 13.6 11.7 13.1 7.9 18.5 26.2 7.7 15.0 15.8 10.9 5.4 3.4 15.4 5.2 22.4 10.0 23.8 16.6 7.2 7.0 21.2 15.6 6.3 12.1 4.3 9.7 25.5 12.4 18.8 20.1 23.1 21.9 17.6 16.3 20.2 17.7 19.2 20.9 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127440343-127459391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6;smooth muscle: 37.2" "Cell line enhanced" "Detected in many" "AF22: 12.4;SCLC-21H: 31.2;SH-SY5Y: 15.4;U-138 MG: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: " "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 22.9 3.1 9.1 3.4 6.9 0.0 2.8 12.4 21.0 7.4 12.0 0.6 1.9 1.1 2.6 4.7 16.7 1.1 2.9 2.6 10.2 9.7 0.6 0.7 15.3 0.5 11.5 0.7 3.3 0.5 0.0 6.8 1.1 0.9 20.4 5.0 0.7 1.9 1.7 38.6 0.4 6.7 37.2 13.1 2.0 3.7 3.4 1.2 0.7 1.5 15.4 0.8 25.2 11.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 2.8 12.4 0.0 1.1 2.9 0.0 0.3 2.2 1.9 4.4 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 8.1 0.0 0.0 0.0 0.3 2.3 0.0 4.3 0.0 4.2 0.0 0.0 2.1 0.0 0.7 0.0 31.2 15.4 0.0 0.0 0.3 0.0 0.8 0.0 8.5 1.4 0.0 2.0 0.0 0.0 0.0 4.9 0.2 6.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.1 6.9 12.4 11.8 10.2 9.7 11.5 0.7 0.9 1.2 KIAA0586 "JBTS23, Talpid3" ENSG00000100578 KIAA0586 Q9BVV6 14 58427385-58551289 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000846, HPA050249" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA000846: AB_2234167, HPA050249: " "unprognostic (1.90e-1)" "unprognostic (7.85e-2)" "unprognostic (2.98e-2)" "unprognostic (6.88e-2)" "unprognostic (4.99e-2)" "unprognostic (1.76e-3)" "unprognostic (4.82e-3)" "unprognostic (1.13e-1)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "prognostic favourable (7.20e-4)" "unprognostic (8.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.41e-1)" "unprognostic (1.13e-1)" 9.5 9.9 10.2 9.2 14.7 9.8 9.9 23.9 13.0 9.9 8.3 7.5 8.0 6.1 9.4 10.7 9.4 7.5 8.3 8.0 12.4 9.6 7.4 11.1 7.9 11.2 15.3 10.7 13.5 8.2 14.6 33.2 6.7 14.5 9.7 11.0 7.0 8.1 8.6 10.4 9.1 8.3 15.8 19.8 9.5 7.6 25.0 14.8 24.5 9.0 7.4 12.7 10.0 8.6 9.1 5.0 13.5 3.6 13.1 10.9 3.1 14.3 10.7 17.8 7.3 12.2 10.9 6.6 13.4 9.5 11.4 10.4 4.3 8.0 17.9 8.5 8.8 9.2 16.5 8.0 19.5 15.7 6.0 14.6 9.1 12.4 7.2 19.8 10.8 7.0 3.4 9.4 12.4 13.4 14.8 9.5 18.3 9.0 10.7 8.4 7.1 17.4 15.3 20.1 10.8 8.2 6.7 11.1 6.9 13.8 8.3 6.5 10.6 10.5 12.7 16.8 14.6 9.5 10.6 4.8 8.6 14.3 11.2 14.6 10.5 13.5 2.8 6.1 9.3 2.4 8.6 7.3 9.0 7.1 3.2 9.1 10.9 8.7 3.2 13.1 3.6 5.0 8.5 3.1 10.2 14.7 23.9 13.0 12.4 9.6 15.3 10.7 14.5 14.8 KIAA0895 ENSG00000164542 KIAA0895 Q8NCT3 7 36324221-36390125 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021036, HPA061066" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" Nucleoplasm "Plasma membrane, Cell Junctions, Cytosol" "HPA021036: , HPA061066: " "unprognostic (4.94e-2)" "unprognostic (9.59e-2)" "unprognostic (2.93e-1)" "unprognostic (1.39e-1)" "unprognostic (8.85e-2)" "unprognostic (1.15e-3)" "unprognostic (3.79e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (4.71e-3)" "unprognostic (1.46e-1)" "unprognostic (3.49e-1)" "unprognostic (4.51e-2)" "unprognostic (6.68e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-2)" "unprognostic (5.24e-2)" 1.5 9.9 8.1 1.3 11.0 2.8 5.2 28.9 13.5 3.7 3.0 5.8 6.0 3.0 4.6 9.1 3.6 8.6 4.6 2.6 6.2 8.1 13.1 10.4 4.2 0.7 4.2 8.2 12.7 12.4 18.6 14.7 2.0 8.0 4.6 2.1 6.6 4.1 4.7 2.1 7.8 1.7 4.4 4.7 1.2 14.3 27.1 4.9 2.1 5.5 1.5 0.9 2.3 2.7 0.6 0.5 1.3 0.1 0.5 1.5 0.4 7.2 4.4 9.1 8.9 0.2 0.2 2.0 1.9 2.2 4.3 5.3 1.9 3.7 0.0 2.0 0.4 4.2 11.8 3.8 3.8 0.6 7.5 0.1 6.9 1.7 1.6 1.1 0.2 1.0 7.0 3.9 4.9 0.1 2.9 0.1 0.4 2.3 3.6 2.5 0.4 1.0 1.4 0.3 0.0 9.9 0.8 27.9 9.7 3.6 8.5 2.5 8.5 1.2 0.0 0.6 2.2 1.3 2.8 4.1 9.2 0.0 1.7 0.3 2.1 0.8 0.1 0.3 0.1 0.1 1.3 0.3 0.9 0.2 0.1 0.6 1.4 0.6 1.3 0.5 0.1 0.5 1.5 0.4 8.1 11.0 28.9 13.5 6.2 8.1 4.2 8.2 8.0 4.9 KIAA0895L LOC653319 ENSG00000196123 "KIAA0895 like" Q68EN5 16 67175602-67184040 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.3;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065996 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA065996: " "unprognostic (8.71e-2)" "unprognostic (1.54e-1)" "unprognostic (8.11e-3)" "unprognostic (2.89e-2)" "unprognostic (2.15e-1)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (4.89e-3)" "unprognostic (2.90e-1)" "prognostic favourable (3.16e-4)" "unprognostic (3.74e-2)" "unprognostic (2.67e-3)" "unprognostic (3.93e-2)" "unprognostic (2.82e-1)" "unprognostic (3.61e-1)" "unprognostic (1.00e-3)" 9.5 20.7 18.1 8.1 19.8 5.2 5.9 46.3 25.0 8.8 6.8 11.5 11.5 10.7 15.4 13.4 6.6 15.0 10.0 7.7 15.1 10.6 9.8 4.6 8.7 3.6 13.0 27.7 21.8 7.6 18.0 24.1 9.5 18.5 10.5 8.8 13.2 8.4 10.3 5.9 9.8 9.5 11.7 16.2 11.0 13.7 13.5 12.4 4.4 13.2 4.3 3.2 7.2 6.8 0.0 2.8 0.0 0.8 0.2 1.1 0.3 2.3 4.0 14.6 9.1 2.7 6.4 9.7 6.3 1.6 2.8 2.6 4.0 2.4 4.4 4.2 2.4 9.1 4.1 3.5 1.7 4.2 5.7 6.4 10.4 3.7 2.1 2.7 13.2 3.6 1.5 3.5 1.3 4.6 6.5 4.3 3.5 3.7 6.6 4.9 3.3 6.6 18.4 7.1 8.2 4.8 5.6 17.3 14.6 7.1 3.6 1.8 8.0 4.7 5.3 9.9 7.0 4.6 2.6 5.6 4.6 4.5 12.5 4.2 5.1 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.9 1.1 2.3 0.0 0.1 0.2 0.0 0.2 0.4 2.8 0.0 0.3 18.1 19.8 46.3 24.1 15.1 10.6 13.0 27.7 18.5 12.4 KIAA1109 "FLJ21404, FSA, KIAA1371, Tweek" ENSG00000138688 KIAA1109 Q2LD37 4 122152333-122362758 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038076 Approved Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA038076: AB_10670652" "unprognostic (2.53e-1)" "unprognostic (2.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (6.62e-2)" "unprognostic (7.61e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.97e-2)" "prognostic favourable (4.33e-8)" "unprognostic (2.04e-1)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (2.29e-2)" 18.4 17.1 25.6 18.0 34.1 42.9 26.1 33.4 34.2 22.9 18.7 24.1 17.9 15.6 20.9 25.4 12.3 16.8 16.4 15.3 25.5 22.0 24.0 17.4 19.5 14.8 26.4 26.2 34.3 16.6 68.2 33.1 14.3 33.6 19.1 18.8 22.6 16.6 21.5 40.1 23.1 20.8 18.6 29.3 20.0 15.2 20.4 24.2 15.3 25.4 12.6 13.6 18.0 18.5 3.1 2.3 7.7 3.6 1.7 3.5 0.7 16.7 5.5 12.8 8.4 21.4 27.9 6.7 7.6 14.3 7.9 8.7 4.0 8.9 8.8 4.4 18.0 6.3 7.9 9.4 12.8 6.6 5.0 9.7 10.0 7.6 11.1 9.1 5.4 16.0 11.3 9.4 13.0 16.7 6.3 10.7 16.1 5.6 7.8 7.1 4.2 6.1 4.5 17.8 2.2 13.8 12.7 7.5 6.7 4.8 5.5 10.7 6.0 7.5 22.3 9.8 9.7 8.0 7.7 10.4 6.7 6.4 10.4 8.0 7.1 3.3 1.4 7.7 3.3 3.6 3.5 2.5 2.3 2.3 1.4 3.1 2.0 2.3 6.6 1.7 1.7 2.3 2.9 0.7 25.6 34.1 33.4 34.2 25.5 22.0 26.4 26.2 33.6 24.2 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favourable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favourable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 21.7 14.6 19.8 13.2 16.9 9.0 18.8 17.2 21.7 18.9 15.7 13.6 11.9 10.4 19.9 13.3 17.9 16.5 12.8 22.0 19.9 17.9 16.2 11.4 13.6 13.8 21.4 12.7 26.0 16.2 22.2 15.2 14.5 18.8 20.9 12.2 9.1 13.3 15.3 28.9 16.0 14.2 17.9 21.7 16.7 12.7 9.4 16.7 25.0 19.4 16.5 15.8 23.3 17.8 6.6 5.5 9.5 8.7 7.6 7.4 4.5 6.5 4.3 12.2 8.4 8.3 13.0 6.1 7.6 10.7 9.7 10.0 4.3 5.9 16.1 5.8 7.9 4.6 14.3 8.0 12.9 8.9 4.9 11.7 8.0 5.2 5.7 14.7 8.3 9.3 9.7 9.9 9.5 8.1 16.6 8.9 9.5 3.7 16.3 10.4 11.4 5.5 6.7 11.6 9.1 6.2 5.6 6.1 10.4 8.8 6.9 6.0 11.4 12.6 9.3 5.5 4.9 14.2 8.6 5.7 16.3 9.9 10.0 14.3 7.9 5.3 5.7 9.5 7.4 6.3 6.5 6.6 6.4 5.9 5.5 6.3 6.8 6.2 5.7 7.6 8.7 3.7 5.3 4.5 19.8 16.9 17.2 21.7 19.9 17.9 21.4 12.7 18.8 16.7 KIAA1191 "FLJ21022, p33MONOX, p60MONOX" ENSG00000122203 KIAA1191 Q96A73 5 176346061-176361968 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044701, HPA048145" Uncertain Approved Nucleoplasm Nucleoplasm "HPA044701: , HPA048145: " "unprognostic (7.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.46e-1)" "unprognostic (1.48e-2)" "unprognostic (4.39e-1)" "unprognostic (7.10e-2)" "unprognostic (8.93e-2)" "unprognostic (1.73e-1)" "prognostic favourable (9.94e-5)" "unprognostic (5.02e-3)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.73e-2)" 16.7 22.0 31.3 11.0 35.5 12.0 19.6 32.4 43.0 22.5 20.6 21.2 19.2 20.8 22.3 24.1 26.6 29.5 17.8 34.3 25.9 28.1 84.1 29.3 20.4 10.9 24.6 28.8 41.6 25.1 24.0 22.9 16.1 30.5 24.5 20.0 24.0 29.3 29.1 29.1 17.8 23.1 24.0 18.9 14.0 25.5 7.5 18.6 10.8 28.5 14.0 17.5 26.4 18.4 17.9 16.1 22.3 19.7 19.1 27.7 19.1 17.2 16.8 30.9 40.3 27.5 20.6 23.7 25.0 24.2 27.8 30.4 33.3 17.5 6.6 33.4 29.8 15.2 18.9 44.2 33.3 34.7 20.8 7.7 11.8 17.5 31.3 6.7 14.0 20.3 31.5 24.5 20.9 33.9 11.6 14.9 30.1 22.0 9.7 4.1 13.4 21.9 7.2 19.5 5.6 26.0 17.0 24.0 25.8 26.8 13.0 29.6 18.9 7.2 31.7 25.7 11.7 18.2 29.8 9.6 13.1 7.9 20.5 12.8 19.8 20.1 16.7 22.3 21.8 19.7 24.2 17.9 20.8 20.9 16.1 14.6 22.1 23.1 8.0 19.1 19.0 13.2 27.7 19.1 31.3 35.5 32.4 43.0 25.9 28.1 24.6 28.8 30.5 18.6 KIAA1211 ENSG00000109265 KIAA1211 Q6ZU35 4 56049073-56328625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 39.9;testis: 27.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 15.7;SH-SY5Y: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enhanced" "Detected in single" "B-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA043249: , HPA048148: " "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 1.0 2.1 4.5 4.2 3.7 3.0 0.8 4.2 6.8 2.3 12.6 3.3 3.2 11.8 3.7 3.9 1.0 2.7 14.4 1.6 5.7 7.0 1.6 1.0 1.4 1.8 5.3 3.0 2.2 1.6 7.6 1.9 2.3 13.4 1.6 7.2 4.7 0.9 5.5 0.7 0.9 39.9 4.0 4.8 2.1 2.4 27.0 1.5 0.2 0.8 0.0 1.6 1.5 2.2 1.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 1.7 6.6 0.5 0.2 0.0 2.4 0.0 0.2 0.3 0.7 1.9 0.2 5.7 0.1 0.0 0.0 5.5 0.1 0.2 0.5 3.2 3.2 2.9 0.3 0.9 2.7 0.4 0.2 0.1 0.0 0.1 3.1 0.0 5.7 0.0 0.8 3.9 0.2 3.5 4.2 3.8 3.6 0.1 0.0 1.4 15.7 33.5 0.6 0.2 4.0 1.4 0.3 1.2 0.1 1.7 0.4 1.5 5.7 3.8 0.0 1.7 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 3.7 4.2 6.8 5.7 7.0 5.3 3.0 13.4 1.5 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 91.1" "Cell line enhanced" "Detected in many" "BEWO: 33.6;Karpas-707: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavourable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 24.9 12.7 3.3 6.6 8.7 0.0 21.6 5.5 16.2 10.2 15.1 2.7 18.0 7.5 7.2 16.5 22.6 10.4 11.9 8.6 5.1 3.7 13.5 10.4 8.6 1.4 4.3 8.1 8.4 10.1 34.1 5.5 12.2 8.8 15.1 8.9 16.9 28.8 26.6 91.1 12.0 13.7 4.1 3.8 5.7 10.1 16.8 1.8 3.3 20.5 20.4 8.8 10.1 13.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 7.5 3.8 1.5 0.0 1.0 2.8 33.6 1.5 2.4 3.5 7.5 6.5 12.1 0.4 7.6 3.0 12.6 1.9 14.4 3.9 2.8 1.4 0.1 8.8 7.6 1.7 0.0 0.1 10.5 9.3 7.7 2.1 0.0 0.0 30.6 1.7 2.6 4.1 0.2 3.4 3.5 0.3 9.0 6.2 8.2 10.0 1.0 0.5 3.7 12.7 0.0 6.1 0.0 8.0 5.4 5.8 21.5 1.9 13.6 11.5 0.0 17.9 0.2 0.2 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.3 8.7 5.5 16.2 5.1 3.7 4.3 8.1 8.8 1.8 KIAA1468 "FLJ33841, HsT3308, HsT885" ENSG00000134444 KIAA1468 Q9P260 18 62187255-62310217 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039708, HPA040038" Approved Approved "Nucleoplasm,Centriolar satellite,Cytosol" "Nucleoplasm, Centriolar satellite, Cytosol" "HPA039708: AB_10794753, HPA040038: AB_10793860" "unprognostic (1.33e-1)" "unprognostic (2.22e-1)" "unprognostic (3.98e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (4.03e-2)" "unprognostic (1.98e-3)" "unprognostic (2.44e-2)" "unprognostic (6.30e-2)" "unprognostic (3.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.36e-1)" "unprognostic (4.84e-3)" "unprognostic (2.47e-2)" "unprognostic (6.86e-2)" "unprognostic (3.54e-1)" "unprognostic (1.71e-2)" 11.7 13.3 14.8 15.7 31.6 18.3 17.8 25.7 25.9 14.3 16.5 14.3 16.6 13.8 13.9 18.3 36.5 11.8 13.9 10.3 12.5 14.4 14.8 11.5 11.8 15.8 13.7 16.0 12.8 12.6 20.2 20.0 11.9 22.8 18.5 21.7 13.5 18.8 14.1 11.8 29.6 15.5 11.1 11.4 17.1 18.0 8.0 16.8 18.3 14.4 16.6 22.0 15.5 21.7 3.7 3.5 6.0 3.5 4.0 4.7 1.9 7.7 7.0 8.6 8.2 9.2 10.8 9.2 13.9 11.6 12.4 13.8 3.6 7.2 5.3 7.2 12.2 16.1 12.2 8.3 15.4 4.8 7.6 4.4 7.9 8.2 8.2 8.5 6.3 8.0 10.2 10.6 6.5 8.5 3.3 5.4 13.1 4.5 5.2 7.3 5.0 6.0 6.5 10.8 6.2 14.2 15.5 12.3 6.5 8.3 12.3 7.1 6.3 9.3 10.8 13.4 4.2 5.8 6.9 16.0 2.9 5.2 9.4 9.2 10.6 5.0 3.5 4.1 4.1 3.0 3.3 3.0 3.8 3.9 3.5 3.7 4.1 4.7 6.0 4.0 2.5 2.4 4.4 1.9 14.8 31.6 25.7 25.9 12.5 14.4 13.7 16.0 22.8 16.8 KIAA1522 ENSG00000162522 KIAA1522 Q9P206 1 32741885-32774970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 37.7;hTCEpi: 31.4;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032050, HPA032051, HPA064839" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA032050: AB_10601764, HPA032051: , HPA064839: " "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (3.63e-3)" "prognostic unfavourable (6.29e-7)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "prognostic unfavourable (8.25e-5)" "unprognostic (4.55e-2)" "prognostic favourable (1.29e-5)" "unprognostic (1.35e-2)" "unprognostic (1.35e-1)" "unprognostic (3.98e-1)" "unprognostic (2.12e-1)" 3.7 39.4 12.1 8.6 8.7 0.7 14.1 1.6 15.8 8.7 25.9 2.7 27.8 28.1 5.4 8.7 33.8 13.5 28.8 2.3 6.4 4.5 23.1 5.9 13.4 0.8 2.4 6.6 18.0 32.8 21.7 4.8 19.3 7.3 18.5 17.4 10.0 36.9 44.6 1.8 33.4 36.0 6.8 1.6 1.1 25.5 2.9 3.0 3.1 19.2 17.9 20.3 15.0 22.3 0.0 2.1 0.0 1.0 0.0 0.4 0.2 19.0 10.0 1.6 2.8 0.7 1.4 7.5 2.3 4.6 2.7 2.7 10.9 37.7 0.0 9.9 3.4 28.5 3.1 20.2 1.4 0.0 4.0 4.0 14.3 8.8 1.2 0.0 10.2 0.5 31.4 7.2 8.7 5.6 5.7 0.1 1.3 15.8 0.1 0.1 3.3 6.3 2.5 2.0 4.9 26.1 34.9 1.4 1.4 14.7 21.3 2.9 22.6 1.2 5.3 4.6 12.4 4.2 5.0 0.2 0.1 0.1 4.7 0.7 5.2 0.0 0.6 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 12.1 8.7 1.6 15.8 6.4 4.5 2.4 6.6 7.3 3.0 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell line enhanced" "Detected in many" "TIME: 22.7;U-138 MG: 30.0;WM-115: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.1 7.7 2.1 1.2 0.0 0.3 10.1 0.1 11.6 0.7 0.4 3.8 3.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.2 5.7 9.3 0.0 9.6 8.2 0.0 0.1 0.0 0.7 4.8 0.0 0.8 0.0 0.0 5.0 1.1 1.2 0.1 0.0 3.1 0.0 0.0 22.7 30.0 6.3 0.7 10.5 0.0 0.0 0.0 7.9 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 7.2 8.7 11.9 5.7 19.7 11.7 9.0 33.8 15.7 9.1 6.8 2.9 6.5 3.6 10.4 6.5 5.7 6.1 7.8 6.0 10.4 8.7 6.1 8.0 5.9 6.9 10.9 9.3 13.3 5.4 9.8 19.7 15.3 12.4 9.1 4.5 2.6 5.0 6.5 4.1 4.3 5.3 7.5 8.4 7.4 4.7 12.5 10.4 6.2 9.6 3.6 6.4 9.0 6.6 5.5 6.3 3.1 4.2 8.2 7.1 3.2 4.8 2.1 12.9 14.7 5.2 8.5 7.2 8.2 6.8 7.2 8.6 3.4 1.6 1.9 6.8 6.0 2.4 9.9 4.8 9.8 6.1 7.5 20.3 4.7 7.7 6.8 16.2 7.6 6.1 3.5 6.3 7.0 6.7 27.9 1.6 8.3 3.9 7.8 9.9 8.3 3.0 7.2 9.5 4.7 4.8 10.2 11.0 10.1 5.3 1.8 6.1 4.2 14.8 5.4 11.1 4.6 10.6 5.8 6.5 8.5 9.5 6.8 12.0 4.5 0.3 4.2 3.1 3.9 3.0 4.3 5.5 5.7 4.9 5.9 4.4 7.1 6.0 0.3 8.2 2.8 6.3 6.5 3.2 11.9 19.7 33.8 15.7 10.4 8.7 10.9 9.3 12.4 10.4 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051240: " "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 5.1 3.6 9.8 3.9 8.9 2.3 4.3 13.3 12.4 10.0 7.1 7.0 1.0 5.5 4.4 6.8 3.8 7.5 3.6 5.2 9.6 11.6 2.6 2.3 8.0 3.2 8.8 12.1 2.4 3.6 3.9 8.2 3.5 20.6 9.6 8.3 3.6 3.6 3.1 3.7 8.5 5.9 5.4 10.1 3.3 5.6 7.5 6.2 3.3 4.0 2.7 3.5 4.3 3.7 1.5 1.2 4.8 2.5 1.4 3.7 0.6 4.6 9.0 11.8 5.1 6.8 7.6 3.7 8.9 2.2 4.6 4.3 2.7 3.0 1.9 2.3 6.8 5.8 7.4 3.0 6.4 8.0 1.8 1.7 6.2 7.5 3.6 2.1 1.7 3.6 4.8 8.3 2.9 6.3 1.7 1.5 12.7 0.4 1.8 1.4 3.7 1.8 6.0 9.7 0.4 5.8 9.5 7.0 4.3 10.7 2.4 3.2 1.8 2.5 8.4 7.5 2.8 6.0 6.0 0.8 2.4 2.8 5.4 1.5 5.1 0.8 1.4 4.8 1.3 1.5 1.2 1.5 1.2 0.6 1.2 0.6 0.2 1.0 3.0 1.4 2.5 0.8 3.7 0.6 9.8 8.9 13.3 12.4 9.6 11.6 8.8 12.1 20.6 6.2 KIAA2026 FLJ20375 ENSG00000183354 KIAA2026 Q5HYC2 9 5881596-6007901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002109 Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA002109: AB_1078071" "unprognostic (7.42e-2)" "unprognostic (2.79e-1)" "unprognostic (3.67e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (8.74e-2)" "unprognostic (6.86e-2)" "unprognostic (9.19e-2)" "unprognostic (8.41e-3)" "unprognostic (6.49e-2)" "unprognostic (1.52e-1)" "prognostic favourable (8.34e-4)" "unprognostic (2.41e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (9.00e-2)" 7.0 6.3 10.3 13.7 11.1 6.6 6.7 21.4 12.4 10.2 7.5 8.6 5.7 5.5 9.7 7.0 7.2 6.7 7.4 6.2 11.7 9.0 7.5 5.4 6.4 7.0 16.7 7.1 13.0 6.0 13.9 14.5 8.1 9.9 8.0 5.9 5.9 12.8 15.6 15.3 9.4 6.7 7.7 11.2 9.1 7.8 13.3 12.9 11.0 10.3 3.7 7.5 8.0 17.8 7.0 4.1 9.4 5.9 7.0 7.5 1.2 5.8 2.9 5.9 3.8 4.5 7.2 2.9 4.0 5.6 3.6 3.4 1.8 3.2 7.3 1.5 4.8 3.0 3.4 3.0 5.5 16.8 2.8 21.9 6.4 2.9 3.5 7.7 10.1 4.4 4.1 3.1 5.3 5.6 2.3 13.1 4.6 1.6 4.1 13.3 3.4 2.5 4.6 3.8 3.7 3.9 3.8 8.1 4.8 3.7 3.3 3.0 3.3 9.9 6.7 6.9 4.2 3.5 4.3 10.2 8.0 7.3 3.5 3.6 2.0 5.2 3.4 9.4 6.4 2.6 7.3 7.0 6.2 5.7 1.3 6.1 6.8 7.5 8.8 7.0 5.9 4.1 3.6 1.2 10.3 11.1 21.4 12.4 11.7 9.0 16.7 7.1 9.9 12.9 KIDINS220 ARMS ENSG00000134313 "Kinase D interacting substrate 220" Q9ULH0 2 8721081-8837630 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014790 Supported Approved Nucleoplasm Nucleoplasm "HPA014790: AB_1852460" "unprognostic (3.58e-1)" "unprognostic (1.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-3)" "unprognostic (2.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.33e-2)" "prognostic favourable (9.64e-4)" "unprognostic (1.68e-1)" "unprognostic (9.21e-2)" "unprognostic (9.74e-2)" "unprognostic (7.39e-2)" "prognostic favourable (9.29e-6)" "unprognostic (4.12e-2)" "unprognostic (1.47e-1)" "unprognostic (9.27e-2)" "unprognostic (1.15e-1)" 16.5 16.4 21.6 9.4 26.9 14.7 14.7 35.3 30.3 16.9 17.2 21.9 7.2 7.8 23.2 11.2 13.0 15.7 12.3 14.7 16.6 8.1 16.0 10.7 16.1 8.2 25.6 15.9 27.5 12.8 45.8 20.2 14.5 25.5 14.5 11.7 11.1 14.8 13.3 17.4 12.7 11.6 17.5 30.3 11.1 14.0 7.1 24.3 11.2 14.9 6.3 8.3 19.6 16.7 3.6 5.1 10.0 8.1 5.7 7.2 3.7 7.0 11.3 22.7 14.5 28.7 19.0 11.9 14.0 11.6 9.0 8.3 11.3 7.2 13.2 14.4 20.9 12.0 20.4 8.6 13.2 18.9 13.8 11.8 8.8 11.8 20.3 12.2 16.3 19.7 13.6 14.2 18.6 13.9 23.0 16.5 15.7 7.7 12.4 6.6 12.3 10.1 11.8 16.7 6.6 11.8 13.5 19.3 32.5 11.1 11.2 12.6 7.1 14.0 18.3 19.9 10.5 19.8 15.0 12.2 10.7 18.0 11.6 16.5 15.1 7.4 6.2 7.5 7.2 7.4 5.4 3.6 5.3 6.0 5.1 3.6 5.5 6.1 10.0 5.7 8.1 3.4 4.3 3.7 21.6 26.9 35.3 30.3 16.6 8.1 25.6 15.9 25.5 24.3 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.1;kidney: 51.5;pancreas: 42.1" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020192, HPA024127" Uncertain Approved Nucleoplasm Nucleoplasm "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.4 0.0 0.8 0.8 1.2 0.0 9.1 0.8 0.6 3.3 5.8 0.4 3.3 11.8 4.7 18.0 0.5 3.8 33.1 0.4 0.4 0.2 51.5 9.8 1.0 0.4 0.4 0.5 1.1 42.1 0.0 0.6 1.3 0.4 2.4 1.7 0.8 1.8 4.2 0.4 0.4 7.3 0.4 0.4 0.4 5.5 1.5 0.4 1.0 11.6 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 3.6 0.0 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.1 0.4 0.0 0.0 0.0 30.9 0.1 4.5 0.1 0.0 0.6 0.0 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.8 0.6 0.4 0.2 0.4 0.5 0.4 0.4 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.7;hTERT-HME1: 8.2;U-2 OS: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.7 1.5 0.9 0.4 1.0 0.0 1.2 1.9 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.2 0.0 0.6 0.0 1.8 0.1 0.0 0.0 2.5 1.7 0.0 0.1 0.0 0.6 0.0 0.6 1.5 0.4 0.0 0.3 0.0 0.0 0.0 0.6 4.9 0.5 0.3 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 KIF26A "DKFZP434N178, KIAA1236" ENSG00000066735 "Kinesin family member 26A" Q9ULI4 14 104138723-104180894 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 16.8;MCF7: 14.3;NTERA-2: 12.6;REH: 10.9;SCLC-21H: 11.7;SH-SY5Y: 23.8" "Group enriched" "Detected in many" 5 "stomach cancer: 3.8;testis cancer: 14.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046882, HPA060346" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046882: , HPA060346: " "unprognostic (3.01e-1)" "unprognostic (3.20e-1)" "unprognostic (3.95e-1)" "unprognostic (1.77e-2)" "unprognostic (2.79e-1)" "unprognostic (1.12e-1)" "unprognostic (5.49e-3)" "unprognostic (1.69e-1)" "unprognostic (1.21e-2)" "unprognostic (3.31e-3)" "unprognostic (5.24e-3)" "unprognostic (7.01e-2)" "prognostic unfavourable (7.78e-4)" "unprognostic (7.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.12e-2)" "unprognostic (4.68e-3)" 12.0 6.8 1.8 4.9 2.1 5.0 15.9 1.3 3.9 8.9 3.3 1.5 4.9 1.7 5.9 3.9 2.1 3.7 4.9 10.1 1.6 2.6 3.4 2.5 8.5 2.5 1.9 2.8 23.5 9.4 1.6 4.4 6.8 2.0 2.5 1.6 6.9 2.5 4.0 9.1 3.9 2.5 2.3 1.0 9.3 2.5 4.1 0.9 1.9 2.3 5.6 0.9 2.6 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 2.3 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 3.2 0.0 1.5 1.8 0.0 0.0 0.0 2.9 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 14.3 0.0 0.0 12.6 1.2 10.9 4.8 1.1 0.0 0.0 11.7 23.8 2.6 0.4 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 1.3 3.5 1.6 2.6 1.9 2.8 2.0 0.9 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.1 8.8 7.9 14.2 5.3 5.3 6.3 6.0 4.7 5.7 8.0 8.6 5.8 19.5 8.3 6.9 4.6 6.1 11.8 11.8 5.8 7.2 2.8 4.4 3.2 5.2 3.6 7.7 4.0 6.1 8.2 9.1 7.0 2.9 11.3 6.9 5.1 22.9 2.7 3.9 3.3 6.4 6.3 2.3 5.6 6.1 24.5 7.7 8.9 2.9 9.0 9.0 1.1 7.4 7.1 12.4 5.2 7.2 8.2 11.9 11.2 8.7 2.9 7.8 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell line enhanced" "Detected in some" "HDLM-2: 20.0;K-562: 8.4;NTERA-2: 10.3;SCLC-21H: 21.3;U-87 MG: 7.9" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: " "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favourable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.7 3.2 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.6 0.1 2.0 0.0 1.0 20.0 1.4 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.2 8.4 4.4 0.0 0.0 0.3 0.0 10.3 0.0 0.0 0.0 0.0 0.2 0.0 21.3 4.8 0.0 0.2 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.8 3.4 0.3 7.9 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavourable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.2 24.8 12.1 7.2 7.3 5.9 9.4 14.3 10.3 14.7 11.4 13.5 6.1 9.1 13.8 10.6 17.1 12.4 13.9 4.9 14.6 15.6 1.8 19.6 9.1 14.2 4.0 9.7 5.9 18.4 17.2 14.1 6.8 9.8 12.4 11.7 28.5 22.9 6.1 11.9 20.6 8.8 6.3 12.4 11.5 11.4 33.0 16.0 10.4 9.4 17.1 15.5 2.8 11.2 24.2 21.7 29.2 18.8 12.9 10.8 4.9 17.1 2.8 9.7 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5;tongue: 25.3" "Cell line enhanced" "Detected in some" "A-431: 25.2;HaCaT: 11.7;HBEC3-KT: 7.6;hTCEpi: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: , HPA056508: " "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavourable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.1 0.2 0.0 0.2 1.2 1.9 1.9 0.0 0.5 4.0 0.1 0.0 0.0 0.1 0.6 2.9 10.6 0.1 0.2 0.1 0.2 0.0 1.9 0.1 0.7 0.2 0.0 0.0 0.3 4.5 1.5 1.1 0.9 0.5 1.7 0.2 4.0 7.8 2.2 0.6 39.5 0.3 0.0 0.0 0.2 0.2 2.8 0.2 0.3 1.1 25.3 9.2 0.2 7.9 1.5 1.0 3.3 0.9 1.0 1.3 0.6 25.2 0.2 0.1 0.3 0.1 0.1 2.1 0.2 0.0 0.0 0.1 2.5 4.7 0.2 2.1 0.0 11.7 1.6 7.6 0.1 0.6 3.8 0.1 0.7 0.5 0.0 0.2 1.6 0.0 9.5 0.1 1.8 0.0 0.4 0.3 0.1 3.3 0.1 0.3 0.6 0.8 4.0 0.0 0.2 0.2 0.9 3.4 0.5 0.2 5.4 0.7 4.7 0.1 0.0 0.3 2.7 0.2 0.3 0.6 0.5 0.2 0.1 0.1 0.3 3.3 0.7 0.6 0.8 0.5 0.7 0.9 1.0 0.9 0.3 1.5 1.0 1.3 2.6 1.0 0.9 1.0 0.8 0.6 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.2 KLF12 "AP-2rep, AP2REP, HSPC122" ENSG00000118922 "Kruppel like factor 12" Q9Y4X4 13 73686089-73995056 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064146, HPA075652" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064146: , HPA075652: " "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" "unprognostic (7.79e-2)" "prognostic unfavourable (5.03e-6)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (9.22e-2)" "unprognostic (8.59e-2)" "unprognostic (5.19e-2)" "unprognostic (3.70e-2)" "unprognostic (2.60e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (6.67e-3)" 2.1 0.9 0.4 2.9 0.4 0.9 1.9 0.6 3.4 2.1 1.5 0.1 1.7 7.1 0.7 1.1 1.1 3.2 0.4 0.5 2.9 5.8 2.0 6.1 0.5 2.8 0.6 0.0 3.5 0.0 1.2 1.1 0.9 1.4 1.9 1.4 1.2 1.4 1.3 3.9 1.4 1.5 2.1 5.5 1.7 2.1 1.7 0.9 0.9 0.6 2.6 5.1 1.4 0.0 1.0 10.1 0.0 5.7 12.5 0.1 3.9 1.9 4.4 4.7 0.8 2.5 7.5 1.9 5.9 2.7 2.6 3.1 11.9 4.9 3.6 0.2 4.5 0.0 1.9 4.9 1.8 10.8 0.8 6.2 5.1 8.7 0.0 1.9 13.2 0.8 9.5 0.0 1.4 2.0 5.3 3.7 0.0 2.5 0.2 2.4 10.3 2.7 1.3 4.5 0.3 0.8 0.0 8.6 2.6 3.8 1.8 5.2 6.6 2.4 15.2 0.0 4.3 0.9 0.1 0.1 4.2 0.4 5.1 1.7 3.7 4.7 0.5 1.4 2.6 4.0 0.0 2.6 0.6 0.9 1.9 1.4 KLF2 LKLF ENSG00000127528 "Kruppel like factor 2" Q9Y5W3 19 16324817-16327874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 32.6;U-266/70: 22.4;U-266/84: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055964 Approved Approved Nucleoplasm Nucleoplasm "HPA055964: " "unprognostic (3.22e-3)" "unprognostic (1.89e-2)" "unprognostic (3.13e-2)" "unprognostic (1.72e-3)" "unprognostic (1.04e-1)" "unprognostic (7.91e-3)" "prognostic favourable (8.55e-4)" "unprognostic (1.74e-1)" "unprognostic (3.09e-2)" "unprognostic (4.28e-2)" "unprognostic (4.90e-1)" "unprognostic (1.52e-1)" "unprognostic (9.76e-3)" "unprognostic (7.80e-2)" "unprognostic (1.76e-1)" "unprognostic (3.50e-1)" "unprognostic (7.56e-2)" 59.2 17.9 4.4 35.3 6.4 51.2 33.6 3.1 8.7 33.7 16.3 8.5 15.6 6.4 46.3 30.8 28.2 35.3 35.9 29.5 5.2 4.3 12.3 8.1 58.9 64.6 6.3 4.2 54.4 6.6 5.4 9.4 15.9 10.2 26.8 4.9 38.3 10.3 11.1 43.7 19.5 14.4 42.6 7.6 35.6 46.1 23.2 2.5 10.9 16.7 39.4 24.1 50.2 36.1 19.4 1.3 32.0 12.4 10.6 23.5 7.1 3.3 1.1 0.1 0.8 0.2 0.5 1.4 8.2 1.2 3.0 1.3 0.1 11.3 0.3 1.8 4.2 1.2 0.3 0.0 1.0 0.3 1.3 0.0 0.6 0.1 2.9 0.0 5.8 0.8 0.1 0.9 0.1 6.8 0.2 7.3 1.6 0.2 0.7 1.4 0.1 1.1 0.2 2.2 12.0 0.1 0.2 0.2 0.1 0.6 5.8 4.4 0.2 3.9 32.6 6.2 4.4 0.4 11.0 22.4 21.5 0.7 2.7 0.0 2.8 21.6 3.3 9.4 17.8 12.4 14.4 17.4 23.5 18.0 1.3 19.4 22.7 18.6 32.0 10.6 10.5 0.2 22.1 7.1 4.4 6.4 3.1 8.7 5.2 4.3 6.3 4.2 10.2 2.5 KLF6 "BCD1, COPEB, CPBP, GBF, PAC1, ST12, Zf9" ENSG00000067082 "Kruppel like factor 6" Q99612 10 3775996-3785281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013529, HPA069585" Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB013529: AB_2533431, HPA069585: " "unprognostic (1.23e-1)" "unprognostic (1.53e-2)" "unprognostic (1.47e-3)" "unprognostic (4.53e-2)" "unprognostic (1.47e-1)" "unprognostic (7.55e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-3)" "unprognostic (1.61e-1)" "unprognostic (2.83e-2)" "unprognostic (1.36e-2)" "unprognostic (2.35e-2)" "prognostic favourable (2.28e-4)" "unprognostic (8.07e-3)" "unprognostic (4.85e-2)" "unprognostic (6.87e-2)" "unprognostic (1.37e-2)" 69.8 10.0 8.4 26.3 10.6 80.6 101.1 7.4 10.1 28.6 31.7 10.3 9.7 11.0 24.9 28.8 38.6 28.0 38.6 18.6 7.8 5.1 32.2 32.5 46.0 35.8 13.8 4.2 20.2 23.8 7.5 4.7 26.1 11.2 20.1 21.0 13.2 26.9 16.5 57.8 60.2 44.8 42.8 17.0 20.3 26.7 14.3 10.0 12.5 41.0 28.8 21.5 44.7 30.7 15.6 29.8 77.8 18.7 13.0 30.8 23.2 13.0 3.5 6.8 2.2 39.6 39.8 4.3 22.5 11.5 24.1 16.4 9.1 17.6 3.7 5.2 24.3 7.9 4.2 20.7 20.1 18.3 2.5 0.5 4.1 8.6 17.0 2.4 12.9 13.1 39.6 17.1 32.7 24.5 4.1 29.2 30.5 0.9 4.5 3.8 2.5 6.4 3.0 7.0 13.1 23.6 13.0 3.0 2.9 5.5 16.0 33.7 7.9 2.0 31.9 32.5 4.5 19.2 10.3 5.6 18.2 6.9 8.7 3.3 10.0 50.9 17.0 43.7 27.1 14.2 23.9 15.6 30.8 26.8 13.1 12.5 9.6 14.8 77.8 13.0 18.7 29.8 22.2 23.2 8.4 10.6 7.4 10.1 7.8 5.1 13.8 4.2 11.2 10.0 KLHDC10 "KIAA0265, slim" ENSG00000128607 "Kelch domain containing 10" Q6PID8 7 130070510-130135720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020119 Approved Approved Nucleoplasm Nucleoplasm "HPA020119: AB_2249467" "unprognostic (2.83e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.16e-3)" "unprognostic (3.22e-1)" "unprognostic (1.80e-2)" "unprognostic (5.55e-2)" "unprognostic (8.70e-2)" "unprognostic (7.97e-2)" "unprognostic (1.42e-2)" "unprognostic (8.69e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-2)" "unprognostic (8.22e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (1.64e-2)" 11.7 18.6 15.5 9.1 21.1 7.2 14.8 27.1 24.1 13.4 12.6 16.9 13.6 11.0 13.4 14.4 13.0 15.5 9.7 14.9 14.2 24.8 21.3 22.8 11.8 7.9 17.0 18.6 15.2 15.3 37.4 25.1 13.6 23.4 13.4 13.0 15.0 10.7 17.1 23.2 13.1 11.7 11.9 14.1 11.0 11.9 35.3 10.2 9.8 18.3 8.9 11.6 9.6 12.3 3.3 1.9 1.8 2.5 0.6 3.4 0.6 11.0 10.4 7.2 39.2 9.5 10.6 3.3 10.6 8.1 8.1 8.4 5.6 8.4 9.4 7.5 9.7 8.7 11.4 6.7 10.2 7.6 6.9 5.5 11.7 6.6 7.5 10.1 6.8 6.6 11.7 12.4 7.8 11.3 26.6 6.0 9.0 9.3 8.7 9.8 1.2 6.8 7.1 13.5 6.8 11.0 7.7 11.6 9.3 17.1 30.5 8.6 7.4 7.6 12.8 10.4 4.5 13.8 12.6 7.9 10.2 8.8 21.7 9.8 14.0 0.0 1.8 1.8 2.4 2.5 2.0 1.7 1.7 2.8 1.9 3.3 1.5 2.8 1.6 0.6 1.9 1.6 3.4 0.6 15.5 21.1 27.1 24.1 14.2 24.8 17.0 18.6 23.4 10.2 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Cell line enhanced" "Detected in some" "EFO-21: 4.9;HDLM-2: 3.5;HEK 293: 3.6;MCF7: 3.3;T-47d: 3.2;U-266/70: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032058, HPA043197" Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA032058: AB_10601439, HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favourable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 1.0 3.7 4.0 1.0 8.4 0.9 1.4 3.1 9.5 1.8 2.4 2.3 5.6 1.6 2.4 3.9 1.1 5.7 2.4 1.7 3.3 4.9 5.9 2.6 1.7 1.0 3.6 7.4 2.5 3.6 4.1 4.8 1.0 5.6 3.2 1.6 3.5 2.9 2.4 2.5 0.8 1.6 1.1 1.6 1.1 2.4 24.3 2.2 0.0 5.0 0.0 1.1 1.5 0.6 0.9 0.1 0.0 0.2 0.0 1.1 0.1 0.4 2.7 1.0 2.9 0.0 0.2 0.3 0.0 0.7 0.1 0.0 0.0 0.2 0.0 4.9 0.0 1.6 0.0 0.0 0.0 3.5 3.6 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.5 0.0 1.4 2.4 2.6 0.0 1.9 0.6 0.0 2.5 1.0 0.0 0.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 4.0 8.4 3.1 9.5 3.3 4.9 3.6 7.4 5.6 2.2 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavourable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 9.1 9.0 11.5 9.7 12.2 21.1 7.1 16.7 15.7 7.8 8.2 10.4 11.7 6.8 9.1 8.4 13.8 7.7 8.5 9.3 8.8 9.4 7.2 5.8 9.6 9.7 7.7 13.5 6.6 8.5 13.9 9.8 8.6 10.6 8.2 7.4 16.0 7.2 10.7 23.7 20.0 8.4 10.3 6.3 13.9 7.6 9.6 9.9 7.0 11.3 9.3 11.2 9.5 10.1 3.5 6.7 4.6 14.0 1.1 3.7 4.5 7.3 9.4 7.3 10.7 8.0 5.8 5.2 10.0 5.2 10.2 8.4 10.0 4.5 14.3 5.7 8.4 4.5 21.9 10.6 10.6 11.2 7.3 21.0 13.6 9.1 8.3 11.1 9.7 6.7 8.2 14.7 13.8 11.3 25.3 6.0 8.2 6.0 8.4 6.5 13.3 19.0 5.9 4.8 8.3 9.6 13.8 5.0 6.7 7.0 8.6 5.0 5.0 6.2 11.8 9.5 9.8 10.9 12.6 6.8 13.0 12.4 6.1 13.0 9.9 4.6 10.2 3.2 1.9 9.2 2.9 3.5 1.5 3.7 6.7 2.1 1.3 1.8 4.5 1.1 14.0 1.8 1.5 4.5 11.5 12.2 16.7 15.7 8.8 9.4 7.7 13.5 10.6 9.9 KLHL23 "FLJ37812, MGC22679, MGC2610" ENSG00000213160 "Kelch like family member 23" Q8NBE8 2 169694488-169776989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.6" "Group enriched" "Detected in many" 4 "dendritic cells: 2.0;NK-cells: 6.6;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047593 Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA047593: " "unprognostic (4.77e-2)" "unprognostic (2.65e-2)" "unprognostic (7.48e-2)" "unprognostic (4.12e-3)" "unprognostic (1.66e-2)" "unprognostic (2.13e-2)" "prognostic unfavourable (2.09e-4)" "unprognostic (4.19e-2)" "unprognostic (3.64e-3)" "unprognostic (1.05e-2)" "unprognostic (4.09e-1)" "unprognostic (4.21e-2)" "prognostic unfavourable (2.43e-5)" "unprognostic (2.61e-1)" "unprognostic (1.45e-1)" "unprognostic (2.70e-1)" "unprognostic (4.87e-3)" 6.8 2.5 14.1 6.1 13.6 1.8 8.3 16.4 16.4 11.9 26.0 6.9 7.5 11.3 26.7 5.8 12.7 11.4 8.7 10.8 12.7 10.7 7.1 6.3 7.8 3.2 8.9 14.3 19.3 7.9 8.8 17.2 13.0 8.1 14.6 14.7 8.6 8.1 13.8 11.0 2.5 11.8 25.4 8.7 2.9 8.6 20.1 7.9 9.1 10.3 4.5 3.3 11.0 6.2 0.8 2.0 0.1 0.1 6.6 2.3 0.7 6.0 3.1 24.1 6.8 1.3 0.5 16.4 2.9 2.2 5.4 6.0 6.6 5.3 3.8 2.5 0.2 0.9 25.0 2.1 8.3 13.5 12.3 11.2 6.4 10.8 2.1 15.7 1.7 0.9 1.7 2.2 3.9 4.1 15.3 0.5 1.8 2.9 23.0 6.4 19.7 2.5 7.4 20.6 0.4 4.9 18.2 31.4 21.6 4.6 0.4 2.8 3.9 5.1 1.5 2.2 7.1 2.1 4.9 1.8 1.7 17.2 1.7 4.7 3.3 0.0 0.1 0.0 1.6 0.0 2.2 0.6 1.4 1.2 0.2 0.8 2.3 2.2 0.1 6.6 0.0 2.0 1.6 0.7 14.1 13.6 16.4 13.1 12.7 10.7 8.9 14.3 8.1 7.9 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759323-85795030 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 31.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 36.7;hippocampal formation: 25.8" HPA023450 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 10.6 4.2 5.2 6.8 12.1 1.5 12.7 3.9 21.5 4.7 4.8 7.5 7.7 9.9 7.9 7.2 8.2 6.2 5.2 4.2 5.7 5.9 4.3 18.3 4.8 4.0 5.3 5.8 4.4 3.6 4.4 4.6 2.8 5.4 5.7 2.9 3.8 6.2 7.6 7.8 9.7 7.0 6.2 3.0 2.6 7.5 16.3 4.3 3.7 4.7 2.5 3.9 4.1 31.5 0.6 1.2 0.5 6.1 5.1 3.5 1.0 2.3 7.0 10.3 5.0 2.1 1.1 5.3 2.9 1.4 4.2 3.2 9.4 3.9 1.4 1.5 2.4 5.8 11.1 5.6 0.9 1.4 5.1 0.4 3.0 7.1 2.4 0.4 1.8 2.1 1.9 4.0 1.4 2.2 0.6 1.3 1.7 4.3 3.6 2.2 9.3 3.7 7.4 6.2 2.4 1.5 4.9 14.4 10.0 4.3 5.0 1.8 9.1 0.6 1.9 4.4 8.1 2.8 5.3 1.5 3.0 1.5 1.9 2.6 2.4 0.0 0.2 0.5 2.0 2.3 1.1 0.1 2.1 1.5 0.5 0.6 3.5 2.2 0.0 5.1 6.1 1.2 1.8 1.0 5.2 12.1 3.9 11.1 5.7 5.9 5.3 5.8 5.4 4.3 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell line enhanced" "Detected in some" "CACO-2: 13.9;HMC-1: 9.3;PC-3: 8.0;SiHa: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favourable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.2 0.0 0.8 0.0 0.8 0.1 13.9 1.2 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.7 3.5 9.3 0.2 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.6 0.3 0.1 0.1 8.0 0.0 0.0 0.8 0.6 0.1 1.0 0.9 16.4 3.1 0.0 3.1 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.4;SK-MEL-30: 1.7;U-2197: 9.5" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.7 1.0 0.0 0.0 0.0 0.2 9.5 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35718019-35738878 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 10.2 9.3 11.4 14.2 13.1 18.4 10.4 23.9 11.4 10.0 12.0 14.2 12.9 13.8 13.0 7.1 11.4 11.6 12.6 7.5 11.0 5.3 9.9 8.9 10.6 14.7 14.7 6.8 15.3 19.6 10.8 13.3 9.3 11.2 12.1 5.6 13.8 14.7 10.0 13.3 19.9 12.3 12.2 12.4 15.8 12.1 21.5 14.9 14.1 14.9 7.0 14.2 12.4 14.2 0.4 0.7 3.2 0.7 2.1 0.7 0.2 11.3 19.2 8.9 9.7 4.6 4.5 9.3 5.5 4.0 5.6 4.3 12.8 5.8 10.1 8.7 4.6 7.5 8.0 4.7 2.5 15.0 8.9 18.2 9.0 6.4 4.5 11.1 20.9 6.1 6.4 5.7 6.3 5.5 15.2 12.7 3.6 11.6 9.4 9.6 8.2 6.8 14.8 5.8 5.5 3.1 10.1 10.1 8.1 8.4 13.6 5.8 8.3 11.8 7.6 11.3 12.2 7.5 11.7 17.5 10.7 8.1 6.1 10.3 7.8 1.0 0.7 0.6 0.7 0.4 0.4 0.3 0.2 0.3 0.2 0.4 0.3 0.4 3.2 2.1 0.3 0.7 0.2 0.2 11.4 13.1 23.9 11.4 11.0 5.3 14.7 6.8 11.2 14.9 KMT2C "HALR, KIAA1506, MLL3" ENSG00000055609 "Lysine methyltransferase 2C" Q8NEZ4 7 152134922-152436005 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074736 Approved Nucleoplasm Nucleoplasm "HPA074736: " "unprognostic (7.75e-2)" "unprognostic (3.10e-1)" "unprognostic (2.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.31e-1)" "unprognostic (5.23e-3)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.06e-1)" "prognostic favourable (8.01e-6)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (3.04e-2)" "unprognostic (2.64e-1)" 13.9 12.6 11.7 16.7 18.6 29.7 14.5 24.8 14.1 18.4 12.6 15.5 21.4 9.7 20.2 20.6 14.4 12.8 12.7 10.8 13.4 9.5 10.3 11.4 13.0 12.1 17.7 9.4 18.8 18.4 18.8 18.9 38.0 12.6 14.0 11.8 12.6 15.8 22.9 30.3 25.2 13.1 13.6 16.0 14.6 14.9 13.6 19.6 22.6 16.9 9.3 16.8 17.8 31.6 5.6 3.5 16.1 3.9 5.5 2.9 0.6 9.5 4.8 9.0 9.5 16.2 9.8 10.5 5.0 3.8 4.0 4.9 9.1 5.8 15.2 7.3 9.1 5.5 9.6 7.3 6.7 9.6 4.9 9.0 7.2 6.3 7.9 15.3 11.1 8.2 10.1 5.7 7.6 5.7 14.5 13.2 8.7 13.3 11.0 13.9 5.4 4.8 7.4 8.1 7.9 6.9 9.9 13.1 10.3 8.2 14.7 5.4 4.8 12.5 7.2 6.7 3.5 7.1 7.1 13.8 6.7 16.4 8.7 12.5 6.8 8.8 3.5 4.3 2.1 2.2 2.9 5.6 1.7 1.7 1.7 3.8 2.7 1.8 16.1 5.5 3.9 3.5 1.3 0.6 11.7 18.6 24.8 14.1 13.4 9.5 17.7 9.4 12.6 19.6 KMT2D "ALR, CAGL114, MLL2, MLL4, TNRC21" ENSG00000167548 "Lysine methyltransferase 2D" O14686 12 49018975-49059774 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035977 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA035977: AB_10670673" "unprognostic (8.33e-2)" "unprognostic (1.49e-1)" "unprognostic (9.14e-2)" "unprognostic (2.52e-1)" "unprognostic (8.07e-2)" "unprognostic (6.91e-3)" "unprognostic (7.35e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (5.14e-2)" "unprognostic (7.23e-2)" "unprognostic (3.07e-1)" "unprognostic (1.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.20e-2)" "unprognostic (7.60e-2)" 12.1 7.6 4.9 6.7 10.8 26.1 6.8 11.7 10.5 9.5 6.5 5.8 13.0 5.5 15.7 7.4 8.8 8.9 5.8 9.1 6.1 3.5 6.2 6.5 22.9 9.6 6.7 3.3 9.7 11.6 13.3 9.2 12.9 13.7 6.7 6.6 9.8 7.6 8.0 16.1 13.6 9.4 7.1 9.1 13.6 8.3 7.3 5.7 6.2 11.0 6.1 7.6 7.0 6.3 2.0 2.2 5.9 0.5 1.5 0.8 0.6 17.0 16.2 16.4 13.2 17.0 11.4 17.6 9.0 9.4 11.7 6.3 28.4 7.2 17.7 11.7 12.6 11.6 21.6 10.0 9.8 10.3 17.3 22.5 16.9 15.2 11.7 26.7 22.6 9.7 14.3 16.4 17.0 17.4 28.2 9.8 13.2 18.7 13.2 24.9 15.5 14.0 19.9 10.1 6.4 9.8 18.9 13.7 11.6 13.9 13.7 9.5 13.6 23.4 23.1 9.2 16.5 8.1 15.1 14.0 9.0 17.2 10.6 13.8 6.9 0.6 0.5 3.0 0.8 0.2 0.4 0.3 0.3 0.5 0.3 2.0 0.3 0.8 5.9 1.5 0.1 2.2 0.0 0.6 4.9 10.8 11.7 10.5 6.1 3.5 6.7 3.3 13.7 5.7 KMT5A "PR-Set7, SET07, SET8, SETD8" ENSG00000183955 "Lysine methyltransferase 5A" Q9NQR1 12 123383773-123409358 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064495 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064495: " "unprognostic (5.62e-2)" "unprognostic (4.45e-2)" "unprognostic (3.90e-1)" "unprognostic (3.04e-1)" "unprognostic (2.20e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (6.21e-7)" "unprognostic (3.88e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-2)" "unprognostic (6.13e-2)" "unprognostic (3.44e-1)" "unprognostic (4.75e-3)" "unprognostic (4.27e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.06e-1)" 7.6 5.4 8.9 14.0 7.5 20.2 7.9 9.8 14.1 13.9 9.1 9.9 21.4 7.3 15.7 9.5 22.3 12.3 8.3 10.9 8.1 5.5 6.7 7.4 8.7 8.4 7.8 10.6 7.2 13.1 6.8 7.4 9.9 12.8 18.6 9.1 7.9 19.3 12.5 13.6 15.6 9.1 11.0 10.3 13.3 9.0 5.2 8.6 42.2 17.2 8.9 19.7 12.3 14.2 3.5 3.8 7.8 3.8 4.1 5.4 0.6 12.2 7.8 9.3 14.3 6.0 10.7 12.8 18.2 8.8 10.6 9.4 8.9 7.2 28.3 10.6 12.1 11.4 13.3 6.7 11.4 11.9 13.8 23.7 8.2 4.4 9.0 18.4 6.0 4.6 8.4 11.5 10.7 8.7 42.9 13.1 8.7 8.9 18.6 27.5 4.3 8.9 22.2 8.0 7.6 7.4 14.9 12.8 10.1 18.2 9.3 8.4 12.9 23.5 11.0 12.0 8.7 14.2 13.1 7.3 7.6 25.9 8.2 9.7 10.0 4.1 2.5 7.8 2.8 3.8 5.4 3.5 3.3 4.3 2.0 2.3 1.8 2.3 3.4 4.1 3.6 3.8 2.7 0.6 8.9 7.5 9.8 14.1 8.1 5.5 7.8 10.6 12.8 8.6 KMT5C "MGC2705, SUV420H2" ENSG00000133247 "Lysine methyltransferase 5C" Q86Y97 19 55339853-55348120 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 16.4;SCLC-21H: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052294 Uncertain Approved Nucleoplasm Nucleoplasm "HPA052294: " "unprognostic (4.02e-2)" "unprognostic (3.45e-2)" "unprognostic (2.92e-3)" "unprognostic (6.77e-3)" "unprognostic (2.48e-1)" "unprognostic (8.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (8.69e-2)" "unprognostic (3.04e-1)" "unprognostic (9.48e-3)" "unprognostic (1.49e-2)" "prognostic unfavourable (1.05e-8)" "unprognostic (7.39e-2)" "unprognostic (2.96e-1)" "unprognostic (9.41e-2)" "unprognostic (2.39e-2)" 5.0 5.6 8.5 7.3 15.7 13.4 5.4 20.0 10.7 5.1 7.5 11.2 4.9 11.9 7.0 5.4 4.6 11.0 7.4 4.2 11.2 4.5 5.1 4.4 5.5 4.6 17.1 5.3 6.1 8.5 6.2 11.7 6.5 9.6 6.6 3.8 6.3 7.7 6.3 6.6 13.5 8.5 3.6 6.2 6.2 9.8 7.0 14.7 10.1 5.1 2.3 3.5 6.3 4.6 0.3 0.8 0.9 0.6 1.1 0.8 0.3 4.9 3.5 3.3 2.7 0.7 0.9 9.2 1.4 0.6 0.5 1.3 2.2 4.2 4.9 1.8 1.1 2.7 2.1 1.8 0.6 4.4 16.4 3.9 2.5 2.2 1.2 2.3 4.7 0.8 2.4 1.6 0.9 1.1 9.6 2.8 0.6 5.7 6.5 5.1 5.9 5.1 9.7 3.8 4.8 0.8 1.2 16.0 6.8 0.7 3.7 2.0 4.1 2.9 1.2 1.6 4.0 0.5 1.0 8.1 4.0 3.1 0.8 5.5 2.2 0.3 0.6 0.3 0.7 0.4 0.0 0.1 0.5 0.7 0.6 0.3 0.3 0.8 0.9 1.1 0.0 0.8 0.2 0.3 8.5 15.7 20.0 10.7 11.2 4.5 17.1 5.3 9.6 14.7 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699307-49792921 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 71.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046852 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA046852: " "unprognostic (4.20e-2)" "prognostic unfavourable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favourable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 12.4 8.0 15.2 9.1 11.8 14.1 12.4 10.9 14.4 8.5 11.4 7.5 8.1 7.0 9.5 6.8 14.5 7.3 8.4 17.2 12.3 11.4 8.0 13.6 9.6 9.4 11.1 11.4 8.1 6.3 9.1 8.1 8.3 13.0 9.4 9.7 5.9 8.3 11.4 71.8 9.0 8.5 14.3 13.2 8.1 8.3 15.1 11.8 11.4 10.9 14.6 10.8 15.0 16.3 6.0 5.0 7.6 6.8 8.1 12.1 4.1 13.8 9.6 18.5 15.4 18.9 20.9 9.3 25.3 20.9 22.2 16.2 29.1 13.0 29.9 5.2 29.3 16.4 22.0 20.3 37.1 17.9 15.4 21.9 9.5 33.9 18.5 32.7 14.2 15.3 14.7 18.6 24.6 27.4 12.1 8.1 30.6 6.3 17.5 17.8 21.3 6.8 23.0 18.2 9.1 13.6 11.5 7.8 12.4 9.2 11.6 10.0 6.8 13.2 24.8 16.5 13.4 15.0 16.8 6.6 9.2 26.4 10.0 15.1 16.3 7.6 4.6 4.3 8.6 5.5 12.1 6.0 8.8 8.4 5.0 4.0 8.8 7.9 2.8 8.1 6.8 2.9 10.1 4.1 15.2 11.8 10.9 14.4 12.3 11.4 11.1 11.4 13.0 11.8 KPNA6 "FLJ11249, IPOA7, KPNA7, MGC17918" ENSG00000025800 "Karyopherin subunit alpha 6" O60684 1 32108038-32176568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018863 Supported Approved Nucleoplasm,Cytosol 11000 Cytosol Nucleoplasm "HPA018863: AB_1852632" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.30e-2)" "unprognostic (8.35e-2)" "unprognostic (7.34e-2)" "prognostic unfavourable (9.28e-5)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.51e-2)" "unprognostic (3.18e-1)" "unprognostic (5.32e-2)" "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.80e-1)" "unprognostic (1.57e-2)" 16.1 18.7 24.6 14.6 19.0 22.9 18.1 23.9 25.2 16.3 18.8 15.7 23.0 11.5 21.3 17.5 21.4 15.9 12.1 23.4 22.7 18.2 18.3 18.0 17.3 13.2 15.4 19.8 16.9 17.1 40.9 18.0 23.5 29.7 17.6 17.3 14.1 16.2 19.8 54.0 20.5 14.2 23.1 29.2 14.8 17.4 22.2 17.6 12.6 17.8 14.5 18.3 17.9 17.8 9.1 9.3 9.5 12.5 5.0 11.2 6.4 17.4 13.8 12.3 15.9 19.0 16.8 14.5 14.1 16.7 20.6 20.0 15.3 19.1 14.6 16.8 25.3 15.1 18.9 21.6 26.4 14.7 10.4 15.1 21.3 12.4 16.9 16.4 12.4 16.9 20.6 25.6 24.5 21.5 14.5 13.5 19.5 9.6 13.2 9.4 28.7 10.4 13.4 17.8 12.0 18.0 16.1 11.9 10.0 25.6 15.4 13.7 10.9 8.8 24.9 19.2 13.3 24.9 20.2 9.7 11.0 11.6 21.0 15.4 18.3 4.0 10.2 9.5 11.2 12.5 11.0 7.8 9.7 8.7 8.3 9.1 11.2 10.8 6.0 5.0 12.5 9.3 9.6 6.4 24.6 19.0 23.9 25.2 22.7 18.2 15.4 19.8 29.7 17.6 KPTN 2E4 ENSG00000118162 "Kaptin, actin binding protein" Q9Y664 19 47475144-47484268 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041710, HPA041796" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA041710: AB_10961904, HPA041796: AB_10962832" "unprognostic (4.80e-3)" "unprognostic (2.22e-1)" "unprognostic (7.24e-2)" "unprognostic (1.53e-1)" "unprognostic (5.54e-2)" "unprognostic (3.47e-2)" "prognostic unfavourable (7.91e-6)" "unprognostic (9.30e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-2)" "unprognostic (5.51e-2)" "unprognostic (2.59e-2)" "prognostic unfavourable (7.82e-4)" "unprognostic (1.40e-1)" "unprognostic (8.72e-2)" "unprognostic (2.04e-1)" "unprognostic (2.34e-1)" 6.0 5.8 7.1 5.3 15.6 8.9 6.2 17.2 11.0 4.6 5.4 5.7 3.4 6.0 4.5 3.0 7.3 3.6 4.4 6.5 9.5 7.1 5.8 6.8 4.5 5.5 13.0 6.3 2.7 5.5 9.2 8.9 6.3 8.9 6.5 4.2 3.7 17.6 3.9 8.7 5.4 5.1 4.8 8.5 5.0 3.9 3.9 9.6 12.5 4.8 6.2 3.9 5.1 4.7 1.4 18.5 2.6 3.8 0.9 1.3 1.7 6.2 10.9 8.6 5.3 8.8 6.9 6.0 3.5 6.6 19.1 11.9 7.8 7.4 7.5 2.7 6.2 7.2 7.3 12.5 5.3 7.0 11.3 3.2 7.4 7.0 7.9 6.3 9.1 7.9 8.2 6.3 5.9 7.2 6.3 7.3 5.5 4.8 11.2 27.0 7.7 6.6 8.1 4.3 3.2 5.9 9.3 18.4 14.1 5.8 6.6 4.3 5.5 9.2 4.1 4.5 5.2 2.4 7.8 1.8 2.9 3.3 4.1 4.1 6.8 0.0 3.0 1.2 1.2 2.5 0.4 1.3 0.8 1.0 3.6 1.4 1.1 0.9 2.6 0.9 3.8 18.5 1.3 1.7 7.1 15.6 17.2 11.0 9.5 7.1 13.0 6.3 8.9 9.6 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 30.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: " "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favourable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 3.8 4.6 5.6 6.2 8.1 4.7 5.6 8.7 12.8 5.2 5.2 7.6 11.0 2.2 7.8 4.9 5.5 5.2 5.8 30.6 6.7 5.2 5.3 2.2 4.5 5.7 6.3 9.0 7.9 7.0 9.7 16.9 3.1 7.1 6.0 1.9 9.4 17.2 9.5 7.4 6.4 3.6 8.5 5.1 6.4 5.0 5.7 6.5 2.5 4.3 5.5 4.8 5.0 5.3 4.1 3.7 1.3 3.7 0.3 4.2 1.7 6.2 3.9 7.7 16.1 3.5 3.5 6.7 3.3 4.1 5.4 6.2 0.4 1.7 1.9 7.0 4.2 6.2 5.8 11.2 2.7 8.7 11.0 3.5 5.0 3.6 4.4 0.0 9.8 7.7 5.2 3.7 2.0 4.9 14.1 2.0 2.7 2.4 8.9 5.3 9.3 3.8 9.5 3.1 1.0 4.1 5.0 6.1 10.4 5.1 14.8 3.5 2.6 5.4 5.0 6.6 2.8 0.0 4.6 9.6 3.1 8.3 3.9 6.0 6.8 0.0 1.8 0.4 3.8 1.7 2.6 1.8 1.9 2.2 2.6 4.1 3.4 2.9 1.3 0.3 3.7 3.7 4.2 1.7 5.6 8.1 8.7 12.8 6.7 5.2 6.3 9.0 7.1 6.5 KRBA2 ENSG00000184619 "KRAB-A domain containing 2" Q6ZNG9 17 8368637-8376711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022849 Approved Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA022849: AB_1852996" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.92e-1)" "unprognostic (3.10e-2)" "unprognostic (2.98e-2)" "unprognostic (8.35e-3)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (2.80e-2)" "unprognostic (2.13e-1)" "unprognostic (7.61e-4)" "unprognostic (6.14e-2)" "unprognostic (5.02e-7)" "unprognostic (1.82e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (1.08e-1)" 10.2 6.5 7.2 3.9 9.7 1.6 6.1 7.8 7.6 6.4 4.5 9.9 4.1 3.7 6.6 5.1 3.9 5.0 3.9 27.5 8.2 4.4 9.6 2.7 4.0 4.0 9.9 6.4 7.1 5.0 11.2 8.8 4.7 7.6 6.9 4.0 11.0 7.7 4.9 11.0 6.4 4.2 4.6 9.1 3.9 4.5 6.2 8.7 6.3 7.5 6.0 3.4 7.5 5.7 5.0 2.8 12.7 3.8 1.8 6.0 0.7 0.6 6.2 7.1 6.6 3.8 5.7 3.8 0.8 2.6 3.1 3.8 0.1 2.4 0.6 4.5 0.9 1.5 2.6 1.0 4.1 3.1 2.2 1.0 4.0 2.7 1.4 0.4 1.8 4.5 0.0 2.6 1.3 4.8 0.0 0.8 2.3 1.0 2.7 0.3 0.7 2.2 5.0 4.5 0.6 2.0 4.3 2.4 4.9 6.2 2.1 1.6 3.1 0.4 2.9 2.2 3.8 0.9 0.9 2.6 1.5 0.4 2.8 0.0 5.1 12.7 2.3 3.5 3.4 1.8 3.2 2.9 3.4 2.6 1.2 5.0 6.0 3.3 2.2 1.8 3.8 2.8 3.2 0.7 7.2 9.7 7.8 7.6 8.2 4.4 9.9 6.4 7.6 8.7 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "placenta: 78.4;testis: 68.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.7;CAPAN-2: 23.0;EFO-21: 11.3;hTEC/SVTERT24-B: 16.2;hTERT-HME1: 10.9;U-2197: 32.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 9.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 9.0" HPA046901 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA046901: " "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 1.1 1.8 1.6 0.3 2.1 0.3 1.4 2.1 2.3 1.9 1.6 1.8 1.2 0.8 2.6 5.4 2.1 1.9 1.2 2.3 1.4 1.2 1.4 0.3 0.7 0.7 1.4 1.2 3.2 2.3 0.3 1.9 78.4 1.6 1.6 1.0 2.3 2.1 2.7 0.5 2.5 1.0 2.3 1.8 0.7 1.1 68.5 0.6 0.2 2.5 1.1 0.8 1.2 1.1 0.8 1.7 1.2 1.2 9.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 10.7 0.0 0.0 0.0 23.0 0.0 11.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 16.2 10.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 8.3 0.0 32.0 0.0 3.4 1.1 0.0 1.8 0.0 0.6 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.9 0.0 9.0 1.2 1.7 0.5 0.2 1.6 2.1 2.1 2.3 1.4 1.2 1.4 1.2 1.6 0.6 KRBOX4 "FLJ20344, ZNF673" ENSG00000147121 "KRAB box domain containing 4" Q5JUW0 X 46446857-46497422 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA065295 Approved Nucleoplasm Nucleoplasm "HPA065295: " "unprognostic (4.12e-1)" "unprognostic (6.40e-2)" "unprognostic (1.74e-2)" "unprognostic (1.64e-2)" "unprognostic (1.17e-1)" "unprognostic (2.25e-1)" "prognostic unfavourable (2.87e-6)" "prognostic favourable (4.67e-5)" "unprognostic (1.73e-2)" "unprognostic (2.61e-3)" "unprognostic (3.27e-2)" "unprognostic (4.75e-3)" "prognostic unfavourable (1.98e-7)" "unprognostic (7.94e-2)" "unprognostic (1.08e-1)" "unprognostic (1.00e-1)" "prognostic favourable (2.17e-4)" 17.8 11.3 16.9 10.5 22.3 6.8 17.0 24.9 21.0 14.4 14.2 19.9 11.7 7.9 25.6 27.9 8.5 16.0 14.1 10.6 13.6 16.6 12.0 16.4 13.5 15.5 16.1 16.8 22.4 14.0 17.3 24.5 20.3 22.2 16.8 11.1 13.2 9.8 14.6 8.7 13.4 10.5 18.1 17.2 19.7 10.3 6.4 19.0 12.6 17.0 9.3 14.5 14.3 12.9 17.4 12.5 13.7 8.8 13.8 17.8 8.2 15.7 9.0 14.5 11.0 14.3 15.0 8.8 15.4 14.1 14.3 13.2 7.9 14.5 9.0 10.2 13.2 11.3 17.9 8.6 16.9 8.8 7.6 7.4 18.7 7.6 15.4 10.9 12.2 16.8 9.5 19.6 16.3 13.3 7.9 9.9 12.8 9.1 11.2 5.5 13.0 16.5 8.0 13.4 11.1 9.2 6.6 5.3 10.2 13.2 6.5 14.8 10.7 11.0 12.0 16.1 16.0 20.8 12.5 10.9 12.3 12.9 13.8 0.5 14.4 12.2 6.7 13.7 12.7 8.2 13.3 13.2 13.7 12.2 6.6 17.4 17.8 12.7 5.1 13.8 8.8 12.5 11.6 8.2 16.9 22.3 24.9 21.0 13.6 16.6 16.1 16.8 22.2 19.0 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073078-29168333 "Disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 18.3;U-2197: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" 400000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: " 5.2 11.8 7.1 6.8 17.8 2.7 5.8 5.0 6.9 9.6 9.6 7.6 25.7 4.9 6.0 13.2 27.8 8.6 5.0 16.8 8.3 3.6 10.5 3.2 8.3 9.1 5.2 4.3 17.4 3.4 16.3 8.0 7.2 4.2 7.1 8.5 21.2 35.4 20.6 18.9 26.5 8.1 4.7 3.0 13.9 6.4 14.5 6.8 19.0 17.1 33.4 20.0 5.9 10.0 0.7 1.2 9.0 0.6 0.8 0.4 0.2 2.6 1.8 6.3 3.2 2.1 6.5 5.3 0.7 6.3 2.0 3.0 8.4 1.2 0.1 2.4 2.9 12.9 12.8 5.1 2.2 3.1 8.1 0.7 0.9 7.9 2.2 0.1 0.7 6.2 10.4 2.2 1.2 0.3 2.7 0.2 2.5 2.2 0.0 0.8 0.3 1.4 0.4 18.3 0.2 2.2 5.0 12.5 7.0 7.3 2.6 9.6 9.7 0.4 0.2 8.4 2.6 31.3 0.9 0.6 0.2 0.2 5.3 1.1 9.7 2.1 0.6 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.1 0.7 0.4 0.4 9.0 0.8 0.4 1.2 0.2 0.2 7.1 17.8 5.0 6.9 8.3 3.6 5.2 4.3 4.2 6.8 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2" "Cell line enriched" "Detected in some" 4 "BJ: 64.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles 170000000 "Nucleoplasm, Vesicles" "HPA055194: , HPA072208: " "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 64.5 2.8 7.7 15.3 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.9 8.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Cell line enriched" "Detected in some" 20 "HMC-1: 97.6" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebral cortex: 0.2;hippocampal formation: 0.3;olfactory region: 0.5" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: " "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 97.6 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell line enhanced" "Detected in some" "A-431: 27.9;CAPAN-2: 32.0;HaCaT: 10.2;SCLC-21H: 15.0;SK-BR-3: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: " "prognostic favourable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 27.9 0.2 0.7 0.5 0.0 0.0 5.8 0.0 0.0 0.0 0.1 9.0 32.0 0.2 0.2 0.0 10.2 0.2 7.2 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.0 0.3 0.1 0.0 7.5 0.3 1.9 6.0 0.1 0.1 0.2 0.7 0.0 0.0 15.0 0.5 0.4 9.3 0.6 0.2 0.2 0.0 0.3 0.7 0.2 0.2 1.6 1.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 KY FLJ33207 ENSG00000174611 "Kyphoscoliosis peptidase" Q8NBH2 3 134603138-134651636 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 19.5;tongue: 36.2" "Cell line enhanced" "Detected in some" "Karpas-707: 3.3;U-2197: 4.5;U-87 MG: 13.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 7.4" "Lineage enriched" "Detected in single" 75 "granulocytes: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036492, HPA036668" Uncertain Approved Nucleoplasm Nucleoplasm "HPA036492: AB_10672222, HPA036668: " "unprognostic (1.40e-2)" "unprognostic (2.05e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-2)" "unprognostic (2.72e-2)" "unprognostic (1.65e-2)" "unprognostic (2.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-1)" "unprognostic (3.86e-2)" "unprognostic (9.87e-2)" "unprognostic (2.83e-2)" "unprognostic (3.82e-1)" "unprognostic (4.62e-2)" "unprognostic (2.29e-1)" "unprognostic (8.98e-2)" "unprognostic (1.47e-1)" 0.3 5.7 3.5 0.4 2.3 0.5 1.4 2.5 4.6 2.2 1.7 2.1 1.7 0.9 3.9 2.3 3.1 3.7 0.9 4.8 4.9 2.1 0.7 0.2 0.3 0.2 1.7 6.9 1.7 0.2 8.5 6.8 0.2 3.2 3.6 0.6 3.3 1.7 2.8 19.5 12.6 0.5 7.4 2.0 0.3 1.7 0.7 3.6 0.5 5.2 36.2 1.1 1.3 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 13.6 0.7 0.0 7.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.5 2.3 2.5 4.6 4.9 2.1 1.7 6.9 3.2 3.6 KYNU ENSG00000115919 Kynureninase Q16719 2 142877498-143055832 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;liver: 41.1;placenta: 34.3" "Cell line enhanced" "Detected in some" "A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 21 "B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol 360000 Cytosol Nucleoplasm "HPA031686: " "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 9.0 3.7 2.2 11.0 3.7 3.9 15.4 0.6 1.7 3.0 1.2 1.3 0.8 0.2 1.1 2.6 5.6 1.5 4.4 3.8 1.4 1.1 8.4 41.1 12.7 13.7 2.9 0.4 1.7 1.0 0.2 1.6 34.3 2.7 1.9 1.2 1.5 3.0 0.8 0.7 1.5 2.7 2.0 6.3 16.0 2.4 7.0 2.6 2.7 2.2 1.7 13.0 12.4 2.6 19.7 28.4 1.3 35.9 0.4 0.1 11.1 0.0 40.1 0.1 0.1 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.7 0.5 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 44.8 27.2 0.5 0.1 0.2 3.9 3.2 23.5 0.1 0.0 0.1 0.2 0.3 20.5 0.0 2.4 0.1 0.1 0.0 0.2 0.1 0.6 20.7 0.1 0.0 22.2 3.3 0.2 11.1 5.7 0.3 1.3 0.1 19.6 0.0 0.1 0.0 0.0 70.2 4.6 0.1 0.1 28.7 0.5 0.1 35.9 0.1 19.7 0.1 0.1 28.4 12.7 0.1 0.0 1.3 0.4 29.2 19.9 0.1 11.1 2.2 3.7 0.6 1.7 1.4 1.1 2.9 0.4 2.7 2.6 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;HeLa: 52.1;RPTEC TERT1: 42.4" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" 59000000 Nucleoplasm "Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavourable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavourable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavourable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavourable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.6 1.3 5.4 0.0 0.0 0.0 2.3 25.0 72.2 24.2 39.7 7.1 0.1 0.0 23.9 0.1 0.7 0.6 0.4 12.7 0.0 0.1 0.0 52.1 1.1 0.0 0.0 4.0 0.1 0.3 3.6 2.5 0.0 0.0 0.0 0.1 23.9 0.0 0.5 1.2 0.9 0.0 31.7 0.1 42.4 0.3 15.9 10.4 14.0 12.5 10.2 1.3 0.3 0.0 0.0 10.6 1.1 11.9 0.2 0.3 0.1 0.1 0.2 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 L3MBTL2 "dJ756G23.3, DKFZP761I141, H-l(3)mbt-l" ENSG00000100395 "L3MBTL2, polycomb repressive complex 1 subunit" Q969R5 22 41205205-41231271 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000815 Approved Nucleoplasm Nucleoplasm "HPA000815: AB_1079220" "unprognostic (2.42e-1)" "prognostic favourable (6.39e-5)" "unprognostic (3.98e-2)" "prognostic favourable (4.37e-4)" "unprognostic (3.48e-1)" "unprognostic (1.19e-2)" "unprognostic (4.16e-3)" "unprognostic (1.03e-2)" "unprognostic (2.19e-1)" "unprognostic (2.26e-1)" "unprognostic (7.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" "unprognostic (2.19e-1)" 10.8 15.8 15.2 13.5 26.4 11.1 12.9 20.6 32.7 15.5 12.8 16.8 17.9 10.1 15.0 15.2 12.6 24.0 11.4 14.3 15.6 16.6 12.4 16.9 13.9 18.5 14.5 19.2 18.7 15.9 23.6 22.6 12.4 15.4 15.1 12.5 15.2 15.8 17.9 11.6 15.6 11.8 16.9 12.6 16.9 13.2 14.5 16.0 16.7 14.7 9.3 20.4 13.8 10.9 13.1 13.2 7.2 13.3 14.5 17.7 15.2 10.5 10.6 8.8 18.3 11.3 8.5 10.5 10.1 11.9 19.9 16.5 6.6 7.6 17.1 8.1 13.9 10.3 21.5 13.5 12.7 21.2 27.4 6.7 19.0 15.9 11.9 32.7 15.9 11.5 5.2 15.8 14.8 14.2 12.1 14.2 9.4 18.4 16.3 11.0 12.4 12.3 16.8 7.1 20.3 9.9 10.7 7.5 5.2 17.7 13.2 10.6 8.8 18.3 11.3 10.5 9.9 8.4 11.2 11.5 21.0 14.4 12.3 15.0 13.5 6.5 10.4 7.2 17.7 12.9 16.3 13.1 14.1 13.9 13.2 9.3 16.9 15.9 1.1 14.5 13.3 9.8 13.5 15.2 15.2 26.4 20.6 32.7 15.6 16.6 14.5 19.2 15.4 16.0 L3MBTL4 "FLJ35936, HsT1031" ENSG00000154655 "L3MBTL4, histone methyl-lysine binding protein" Q8NA19 18 5954706-6415237 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 5.8;RPMI-8226: 13.6;SCLC-21H: 6.6;SH-SY5Y: 7.2;U-2 OS: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 5.3;NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA064194, HPA069042" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA064194: , HPA069042: " "unprognostic (1.33e-3)" "unprognostic (8.98e-2)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (1.70e-2)" "unprognostic (1.73e-1)" "unprognostic (4.68e-2)" "unprognostic (1.94e-1)" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.20e-2)" "unprognostic (5.08e-2)" "unprognostic (1.00e-1)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" 6.3 6.9 8.4 3.7 12.8 2.1 6.8 0.8 8.1 6.2 3.4 12.3 4.8 4.2 4.9 5.4 5.9 6.2 4.3 8.6 9.6 3.5 9.9 12.0 5.9 2.7 13.7 5.5 12.3 14.2 18.8 8.2 1.1 4.6 3.4 3.0 6.0 5.9 9.6 1.4 9.9 4.8 2.0 3.6 4.0 4.4 17.0 13.4 0.6 8.2 2.5 2.3 3.1 7.1 5.3 1.3 0.4 2.2 6.4 1.4 0.8 0.0 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.1 0.2 2.9 2.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.3 1.8 3.7 0.0 13.6 0.0 2.4 6.6 7.2 0.0 0.1 0.3 0.0 0.0 0.1 0.1 4.4 0.1 1.7 0.2 0.0 0.1 1.7 0.1 2.1 0.4 2.2 0.1 1.4 0.6 0.1 1.1 0.2 0.2 1.3 5.3 0.3 0.4 0.3 6.4 1.4 0.3 0.1 0.8 8.4 12.8 0.8 8.1 9.6 3.5 13.7 5.5 4.6 13.4 LAMA5 ENSG00000130702 "Laminin subunit alpha 5" O15230 20 62307955-62367312 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 30.3;CACO-2: 41.8;EFO-21: 31.2;TIME: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054609, CAB078157" Enhanced Supported Nucleoplasm,Vesicles "Secreted to extracellular matrix" 1200000 Vesicles Nucleoplasm "CAB078157: , HPA054609: " "unprognostic (8.01e-2)" "unprognostic (2.47e-1)" "unprognostic (1.92e-2)" "unprognostic (3.42e-3)" "unprognostic (1.17e-1)" "unprognostic (9.90e-3)" "unprognostic (4.01e-3)" "unprognostic (5.45e-2)" "unprognostic (8.99e-2)" "unprognostic (1.34e-2)" "unprognostic (5.98e-3)" "unprognostic (2.98e-3)" "unprognostic (4.04e-2)" "unprognostic (9.86e-3)" "unprognostic (2.07e-1)" "unprognostic (9.76e-2)" "unprognostic (1.33e-2)" 22.6 5.9 5.6 8.1 5.9 2.5 16.8 24.0 6.6 16.7 28.0 3.1 18.6 7.6 23.2 13.8 18.0 14.2 27.4 13.7 4.7 2.9 17.0 7.3 19.7 4.4 3.7 2.3 6.9 13.9 8.3 6.0 33.3 5.5 17.4 2.6 18.6 12.7 25.0 9.4 45.2 9.0 25.0 4.5 8.8 13.3 4.4 3.4 2.0 18.4 11.8 10.4 19.4 24.9 0.9 1.2 0.2 0.0 0.0 0.0 0.0 3.9 30.3 0.6 4.0 0.7 8.6 23.3 1.1 0.6 0.9 0.1 41.8 15.7 0.3 31.2 0.0 28.4 0.8 12.1 0.0 0.1 1.7 0.9 27.3 11.9 2.7 0.0 4.5 0.4 8.1 2.1 2.1 4.0 1.8 0.4 0.0 5.8 0.0 0.1 1.9 17.7 0.0 0.3 3.3 7.8 18.5 0.3 12.1 16.7 16.8 0.3 16.6 0.2 36.6 0.4 11.6 0.2 4.9 0.2 0.0 0.1 8.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 5.6 5.9 24.0 6.6 4.7 2.9 3.7 2.3 5.5 3.4 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054752-156058510 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles 17000 "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavourable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 24.3 33.5 30.3 18.8 27.2 23.4 35.3 14.2 30.6 22.5 27.5 13.8 34.3 24.5 17.0 38.1 27.6 25.4 25.7 37.2 25.8 24.9 31.7 63.5 27.7 37.9 26.4 22.8 11.4 75.2 16.6 18.0 21.1 23.4 18.8 27.5 16.4 35.9 34.3 35.5 20.4 26.2 26.2 19.3 26.0 27.3 12.1 20.3 20.2 20.9 30.2 23.6 21.9 17.0 47.2 89.8 60.4 80.6 32.6 47.6 56.7 15.7 35.7 16.9 23.2 34.4 28.0 18.6 14.1 23.8 17.6 20.2 16.3 26.9 23.3 24.5 27.0 23.2 17.2 37.9 9.9 19.3 26.1 13.5 24.2 21.5 27.3 19.1 22.2 33.0 23.8 18.7 24.0 35.7 12.2 17.5 25.3 31.7 19.7 27.3 17.8 53.6 16.7 12.6 34.0 38.6 23.1 6.5 37.8 17.8 49.8 28.4 35.0 56.3 24.2 14.9 13.7 21.6 13.1 26.4 38.8 13.5 26.6 21.3 15.9 41.8 80.6 60.4 30.9 71.6 30.2 47.2 34.2 33.5 89.8 38.3 26.2 28.2 39.6 32.6 56.5 47.5 47.6 56.7 30.3 27.2 14.2 30.6 25.8 24.9 26.4 22.8 23.4 20.3 LAP3 "LAP, LAPEP, PEPS" ENSG00000002549 "Leucine aminopeptidase 3" P28838 4 17577192-17607972 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029606, HPA029607" Enhanced Supported Nucleoplasm,Midbody,Cytosol 4100000 Cytosol "Nucleoplasm, Midbody" "HPA029606: AB_10599288, HPA029607: AB_10611381" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (2.87e-1)" "unprognostic (2.16e-1)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.44e-3)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (4.29e-3)" "unprognostic (1.73e-1)" "unprognostic (3.28e-2)" "unprognostic (3.06e-1)" "unprognostic (8.79e-2)" 42.5 29.7 23.2 43.9 38.5 18.1 30.7 8.5 23.5 13.3 21.0 23.5 12.3 27.5 17.2 20.8 19.3 18.7 24.3 25.4 24.4 17.0 71.7 70.3 39.4 54.2 33.7 16.1 13.5 14.7 23.5 13.2 25.0 34.9 15.3 22.7 15.0 23.0 12.1 33.3 20.9 30.6 26.9 35.0 54.9 20.8 19.3 30.7 19.9 29.4 21.7 32.1 24.4 23.7 7.5 45.7 9.5 46.1 11.8 12.9 25.3 10.8 9.5 9.1 8.6 18.1 22.1 0.1 17.1 19.3 62.3 75.7 17.3 20.7 42.7 11.4 13.1 6.7 34.2 12.1 23.7 16.3 9.8 23.7 10.5 22.6 21.1 21.3 15.2 22.4 7.7 20.4 10.7 21.6 22.9 30.5 14.6 11.7 18.9 29.2 19.0 18.2 29.4 8.7 21.6 16.2 12.7 13.5 11.1 15.7 9.7 33.5 8.2 8.2 14.0 15.8 10.7 16.6 29.7 28.1 42.9 36.9 21.4 35.5 15.3 8.4 43.4 9.5 8.0 46.1 7.4 7.5 7.5 8.5 45.7 5.2 6.5 6.8 6.2 11.8 31.9 25.9 12.9 25.3 23.2 38.5 8.5 23.5 24.4 17.0 33.7 16.1 34.9 30.7 LARP1 "KIAA0731, LARP, MGC19556" ENSG00000155506 "La ribonucleoprotein domain family member 1" Q6PKG0 5 154712902-154817607 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: , HPA054819: " "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 24.9 30.1 30.5 21.9 31.9 18.9 20.3 25.7 46.5 21.3 20.4 27.3 23.2 21.0 26.5 23.0 29.2 25.4 18.5 28.5 27.8 29.1 25.6 22.6 19.9 23.1 26.8 29.7 28.4 81.2 55.9 23.6 25.1 29.2 18.2 21.3 18.9 38.8 21.4 41.7 24.7 22.3 23.8 22.2 21.5 24.4 27.8 27.4 26.1 33.5 16.4 25.8 22.1 28.7 5.2 6.4 2.8 7.9 10.1 5.8 2.5 26.0 36.5 28.5 32.7 24.8 20.2 31.6 26.5 27.1 31.1 30.4 57.3 31.4 68.9 37.7 33.1 26.3 51.9 48.8 36.0 22.8 29.3 49.8 38.0 26.4 31.6 66.5 23.1 24.9 28.3 38.6 49.4 27.3 40.9 47.8 28.8 25.7 39.4 26.0 30.3 18.4 44.1 27.1 32.8 19.1 32.5 51.7 27.8 36.0 57.8 31.9 34.4 31.4 36.1 39.1 24.5 29.5 47.5 42.8 30.7 58.7 26.0 36.9 27.3 2.8 4.0 1.1 4.5 4.9 5.8 4.3 5.4 5.3 4.0 5.2 4.3 4.7 2.4 10.1 7.9 6.4 3.4 2.5 30.5 31.9 25.7 46.5 27.8 29.1 26.8 29.7 29.2 27.4 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388506-45549421 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: , HPA066085: " "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favourable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favourable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 9.6 14.3 18.8 9.6 21.8 6.7 8.1 11.9 17.9 9.2 14.8 13.1 8.3 9.6 9.8 8.9 10.4 11.2 8.4 14.2 14.6 13.6 18.9 17.2 7.0 10.3 15.7 9.5 10.2 8.2 20.0 14.0 10.6 12.3 10.8 15.3 10.0 8.7 9.8 14.1 7.8 8.8 11.0 8.8 10.0 8.9 7.3 11.8 16.1 10.5 8.3 12.8 11.3 7.8 5.1 5.9 2.4 3.3 8.4 6.0 3.7 6.2 7.9 9.2 8.7 8.4 9.5 9.9 9.8 10.1 18.3 13.7 14.0 8.8 13.0 8.4 11.4 6.8 34.2 20.5 13.9 11.4 8.6 14.1 12.8 13.5 8.8 20.4 5.2 12.3 12.7 17.5 9.2 11.4 21.9 7.4 11.4 6.9 14.6 7.5 23.0 14.6 8.3 9.2 14.5 16.3 15.2 7.3 9.1 15.6 8.8 8.1 14.0 12.0 10.0 11.2 8.3 9.3 11.7 5.8 10.6 13.9 13.2 13.9 9.9 0.6 2.8 2.4 6.0 3.3 5.8 5.1 4.4 5.4 5.9 4.0 4.8 5.4 1.2 8.4 3.0 4.5 3.9 3.7 18.8 21.8 11.9 17.9 14.6 13.6 15.7 9.5 12.3 11.8 LATS1 WARTS ENSG00000131023 "Large tumor suppressor kinase 1" O95835 6 149658153-149718256 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031804 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031804: AB_10601688" "unprognostic (4.02e-3)" "unprognostic (3.80e-3)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (2.09e-1)" "unprognostic (6.15e-3)" "unprognostic (1.29e-2)" "unprognostic (9.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (5.62e-2)" "unprognostic (1.92e-1)" "unprognostic (8.43e-2)" "unprognostic (2.63e-1)" "unprognostic (2.65e-1)" 15.4 12.9 17.6 12.5 17.6 19.4 14.7 38.4 16.9 15.9 13.6 17.4 9.5 10.1 17.7 11.8 12.2 14.6 11.1 11.7 15.1 8.8 11.5 11.1 12.7 12.6 18.2 8.8 23.6 12.2 22.3 21.8 17.2 15.5 16.3 12.5 14.1 13.8 11.9 12.4 12.8 14.7 15.8 13.0 13.5 11.6 10.6 19.6 20.5 12.9 6.5 12.8 14.7 14.7 7.4 4.6 9.5 11.4 4.2 8.9 2.9 6.1 4.8 10.2 14.4 9.6 12.6 7.8 8.1 8.2 8.8 8.8 7.8 5.3 9.9 8.3 11.3 8.6 13.3 8.7 13.9 9.1 10.6 20.0 6.1 7.0 8.9 18.7 14.6 8.4 14.0 9.9 17.0 10.9 24.6 10.2 8.6 7.3 9.7 7.7 6.0 4.7 9.5 12.2 4.6 8.1 8.7 6.8 10.9 11.4 8.3 6.0 8.6 16.2 13.4 7.0 11.0 8.3 13.0 8.5 9.3 11.4 6.4 10.6 10.3 9.5 4.2 6.6 8.9 7.7 8.0 5.8 7.0 7.4 4.6 7.4 6.0 7.8 2.9 4.2 11.4 4.1 6.7 2.9 17.6 17.6 38.4 16.9 15.1 8.8 18.2 8.8 15.5 19.6 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Group enriched" "Detected in some" 5 "HEK 293: 4.9;RH-30: 6.2;SCLC-21H: 13.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 20 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA002016: , HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 13.3 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 13.8" "Cell line enhanced" "Detected in many" "CACO-2: 9.1;Hep G2: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;olfactory region: 0.9" HPA044257 Uncertain Approved Nucleoplasm,Midbody Nucleoplasm Midbody "HPA044257: " "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 4.4 0.4 1.5 1.0 0.5 0.3 1.3 0.5 0.5 1.1 6.8 0.0 1.5 8.3 2.2 2.6 0.5 0.6 3.9 1.8 0.3 0.3 1.9 13.8 3.7 0.4 0.3 0.6 0.6 3.4 0.0 0.3 2.6 0.5 0.6 0.0 0.2 1.5 0.4 0.8 1.3 7.3 0.1 0.4 1.9 4.9 1.3 0.0 0.3 1.1 1.7 2.1 0.8 0.6 0.2 2.1 1.6 4.8 2.5 1.0 1.5 3.7 1.3 0.0 0.1 1.7 1.4 6.4 0.3 0.2 0.4 0.4 9.1 5.6 0.2 1.5 0.7 1.5 0.0 0.2 0.0 7.8 1.7 4.0 0.5 18.9 1.3 0.2 2.6 1.8 1.4 1.4 0.3 1.6 2.6 2.0 0.3 1.9 0.1 0.8 0.4 0.2 0.4 0.4 0.2 0.2 1.2 0.2 1.0 2.3 0.3 8.3 0.2 0.3 3.6 1.4 6.0 7.3 0.1 2.5 1.9 0.2 1.4 0.7 4.2 0.8 4.0 0.3 0.8 1.9 0.5 0.2 0.2 1.0 2.1 0.2 0.2 0.7 1.6 2.5 4.8 0.6 0.1 1.5 1.5 0.5 0.5 0.5 0.3 0.3 0.3 0.6 0.5 0.0 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 64.4;liver: 154.2" "Cell line enhanced" "Detected in many" "BEWO: 35.1;Hep G2: 27.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 64.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044767 Approved Nucleoplasm "Secreted to blood" 6470000000 9500000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavourable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favourable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 4.4 3.6 6.3 2.2 3.7 0.9 4.3 64.4 9.6 4.5 4.4 7.3 1.4 1.3 5.3 3.0 1.8 3.5 3.5 4.5 8.4 1.8 3.9 154.2 5.6 1.9 5.5 6.3 4.7 2.5 5.9 2.7 5.5 9.2 6.4 1.3 1.8 2.4 6.2 3.4 9.9 2.4 3.8 7.5 3.9 2.3 2.2 6.1 1.4 7.6 1.6 1.4 2.6 4.5 1.8 0.8 5.0 1.1 1.3 1.4 0.1 2.4 4.0 5.9 6.7 5.2 7.3 35.1 9.8 4.2 6.6 4.7 13.1 3.0 1.3 1.8 14.1 8.7 1.4 13.4 4.1 0.6 3.6 1.7 8.7 27.3 7.1 0.3 4.7 12.6 12.8 13.7 4.8 4.8 3.7 0.5 4.7 4.0 1.6 4.2 3.9 2.2 1.7 6.5 1.4 1.8 4.3 0.2 3.0 14.8 0.7 1.6 8.4 2.6 9.2 8.6 13.4 9.4 3.5 8.1 2.1 3.7 4.1 1.1 7.4 2.4 1.1 5.0 0.9 0.1 1.3 1.2 0.7 0.8 0.2 1.8 1.4 0.4 2.8 1.3 0.5 0.8 0.0 0.1 6.3 3.7 64.4 9.6 8.4 1.8 5.5 6.3 9.2 6.1 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111729-25178231 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041559: , HPA043530: " "unprognostic (9.08e-2)" "prognostic favourable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavourable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favourable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 9.8 18.0 27.9 11.6 30.6 13.9 18.1 27.5 36.4 15.4 17.1 15.5 17.5 13.1 16.2 26.7 13.4 16.8 14.1 25.3 22.8 27.5 17.8 7.5 10.8 11.9 21.7 26.7 23.8 31.4 25.3 20.5 18.9 24.8 15.7 17.2 15.0 14.4 18.3 31.6 16.5 12.7 15.1 18.9 10.1 12.6 29.8 14.4 16.9 15.5 14.3 15.3 11.7 12.1 19.7 17.6 21.6 18.9 15.8 38.9 19.5 16.8 15.9 14.9 20.5 13.4 19.6 15.3 10.6 17.5 15.5 20.4 20.1 15.5 10.3 15.2 16.0 8.7 15.4 14.5 21.0 10.5 23.4 5.5 16.2 32.5 30.5 13.3 9.2 22.1 16.1 17.6 18.4 14.1 8.8 13.6 17.0 43.1 15.8 25.5 22.7 16.5 18.8 13.6 20.0 17.5 11.9 24.3 15.1 12.6 19.6 24.1 19.9 6.1 8.3 15.4 10.8 10.0 10.4 17.7 17.9 10.9 18.9 11.6 11.3 12.7 18.9 21.6 20.6 16.7 22.6 19.7 25.6 22.3 17.6 14.3 23.1 21.1 7.4 15.8 17.5 9.1 38.9 19.5 27.9 30.6 27.5 36.4 22.8 27.5 21.7 26.7 24.8 14.4 LCMT2 "KIAA0547, MGC9534, PPM2, TYW4" ENSG00000168806 "Leucine carboxyl methyltransferase 2" O60294 15 43323649-43330605 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039401, HPA048176" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA039401: AB_10805478, HPA048176: " "unprognostic (4.32e-2)" "unprognostic (1.44e-1)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "unprognostic (1.99e-1)" "unprognostic (2.27e-1)" "unprognostic (9.08e-2)" "unprognostic (5.14e-2)" "unprognostic (3.52e-2)" "unprognostic (2.20e-1)" "unprognostic (3.33e-3)" "unprognostic (9.57e-2)" "prognostic favourable (5.69e-9)" "unprognostic (2.28e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" 7.9 10.9 6.5 8.3 8.1 2.5 25.9 11.4 10.1 10.8 7.4 7.2 10.6 5.2 10.3 12.7 11.0 10.2 6.7 8.4 6.7 8.4 11.9 9.2 6.2 9.9 6.1 7.6 13.0 8.2 13.7 10.1 6.4 9.6 10.2 7.5 8.9 10.3 13.8 7.9 6.2 8.4 8.6 4.8 9.6 8.7 7.1 9.6 12.2 9.8 11.2 13.9 7.4 9.6 6.3 6.9 5.5 4.0 3.3 10.5 5.0 6.0 4.8 11.3 9.8 12.1 3.7 5.5 7.4 8.9 9.7 10.7 7.1 2.8 5.1 15.2 8.4 14.3 0.0 9.8 7.4 7.9 5.2 9.2 12.9 4.1 7.4 0.0 6.9 5.8 9.5 7.2 6.6 3.1 11.6 6.9 11.6 9.4 10.3 4.3 4.9 4.0 12.2 10.0 5.0 16.9 6.9 15.2 12.9 9.8 8.3 4.2 10.1 14.1 2.6 11.4 5.2 13.0 12.0 4.7 11.0 2.1 7.1 7.6 11.8 2.4 4.0 5.5 4.0 3.8 5.5 5.0 6.7 4.8 6.9 6.3 10.5 6.8 1.3 3.3 3.5 3.9 5.3 5.0 6.5 8.1 11.4 10.1 6.7 8.4 6.1 7.6 9.6 9.6 LDB1 "CLIM2, NLI" ENSG00000198728 "LIM domain binding 1" Q86U70 10 102107560-102120453 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034488 Approved Approved Nucleoplasm Nucleoplasm "HPA034488: AB_10669783" "unprognostic (8.83e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-3)" "unprognostic (4.54e-2)" "unprognostic (1.35e-1)" "unprognostic (5.01e-3)" "unprognostic (1.55e-2)" "unprognostic (1.04e-3)" "unprognostic (2.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-3)" "unprognostic (8.25e-2)" "unprognostic (2.54e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (1.26e-2)" 18.6 18.7 20.6 20.7 31.1 46.3 21.3 23.2 43.0 35.5 30.4 26.5 24.5 14.0 37.4 19.4 25.2 31.8 27.3 26.9 20.1 13.1 20.7 9.5 21.1 25.1 19.5 24.5 58.0 13.5 24.6 25.5 22.0 20.4 27.6 12.7 36.3 28.8 37.5 21.1 64.3 23.3 31.2 13.9 29.0 20.5 15.3 22.0 27.4 24.2 20.5 27.4 32.2 33.9 4.6 2.4 8.5 7.8 3.0 4.4 2.0 11.7 14.5 28.2 35.0 11.1 12.7 14.6 12.2 19.7 13.8 12.0 9.9 10.2 18.3 17.9 15.2 23.6 13.3 23.4 7.4 15.9 12.3 54.5 14.8 9.6 13.4 15.0 19.4 26.9 18.6 11.1 13.0 14.2 33.3 20.0 10.6 11.0 27.0 21.4 14.3 7.1 30.7 18.5 12.9 12.4 12.7 11.7 28.9 8.0 9.8 13.8 47.4 9.7 14.0 8.5 18.0 7.5 10.1 17.5 14.8 12.4 14.0 32.8 7.7 3.1 4.1 3.3 4.4 4.8 2.7 3.4 3.0 4.1 2.3 4.6 4.0 3.0 8.5 3.0 7.8 2.4 2.4 2.0 20.6 31.1 23.2 43.0 20.1 13.1 19.5 24.5 20.4 22.0 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668449-86736068 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3" "Cell line enhanced" "Detected in some" "HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" 450000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: " "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 6.4 0.4 0.9 1.3 1.6 0.2 0.5 0.1 1.3 2.8 2.3 0.0 4.9 0.4 4.2 9.9 9.9 1.3 1.0 213.9 1.7 1.0 0.3 0.2 0.4 0.2 2.6 0.0 1.5 0.3 0.3 0.1 0.5 0.0 4.4 0.8 4.7 7.6 3.1 329.7 0.3 1.2 3.6 6.7 0.2 0.7 0.5 0.0 0.0 2.8 110.3 10.2 1.9 0.9 0.9 0.6 1.8 0.4 0.6 0.6 0.0 0.3 0.3 0.4 3.2 0.4 0.1 0.3 0.4 0.3 0.1 0.2 0.3 0.3 0.3 0.6 0.0 0.4 0.2 0.0 0.1 0.9 0.8 0.7 0.9 0.1 0.1 0.1 1.7 6.0 0.5 0.1 0.0 0.0 0.3 1.9 0.3 1.6 0.4 0.2 0.4 0.3 0.0 2.0 0.1 0.0 1.1 9.7 1.8 0.3 0.2 4.7 0.3 0.2 0.0 0.3 0.5 0.4 0.1 0.2 0.6 0.4 0.8 0.3 0.5 1.8 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.9 0.5 0.6 1.4 0.6 0.4 0.6 0.3 0.0 0.9 1.6 0.1 0.6 1.7 1.0 2.6 0.0 0.0 0.0 LEF1 "TCF10, TCF1ALPHA, TCF7L3" ENSG00000138795 "Lymphoid enhancer binding factor 1" Q9UJU2 4 108047545-108168956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 231.5" "Group enriched" "Detected in some" 5 "MOLT-4: 103.2;REH: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 42.2" "Lineage enriched" "Detected in many" 5 "T-cells: 42.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002087, CAB019405" Enhanced Approved Nucleoplasm Nucleoplasm "CAB019405: AB_823558, HPA002087: AB_1079245" "unprognostic (1.03e-3)" "unprognostic (7.36e-3)" "unprognostic (2.97e-2)" "prognostic favourable (1.37e-5)" "unprognostic (9.08e-2)" "unprognostic (5.24e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (1.77e-1)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (2.47e-6)" "unprognostic (1.12e-1)" "unprognostic (5.22e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-2)" 0.9 13.5 3.5 9.3 5.4 7.6 2.0 1.6 3.4 3.6 1.0 2.9 0.8 0.4 6.0 3.5 3.4 5.0 2.8 0.5 4.7 5.2 2.7 0.3 2.4 25.3 4.9 1.9 1.8 0.8 0.0 1.1 7.8 3.1 2.8 1.0 1.6 3.1 0.7 0.5 2.4 3.9 2.9 4.4 7.0 0.9 8.2 2.3 231.5 2.7 1.3 20.6 4.8 3.2 0.3 0.1 0.5 0.0 8.9 42.2 9.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.8 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 3.2 1.2 0.0 0.0 0.0 4.0 0.6 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.5 0.1 103.2 0.0 0.3 0.2 79.7 1.5 0.0 0.4 0.2 0.5 0.9 0.0 0.0 15.2 0.4 0.0 0.0 2.2 1.8 0.0 2.6 6.7 2.8 18.3 1.3 0.0 8.8 0.0 0.0 0.0 2.6 0.0 0.5 0.1 19.7 8.8 0.0 0.3 42.2 29.2 0.5 8.9 0.0 0.1 25.7 9.5 3.5 5.4 1.6 3.4 4.7 5.2 4.9 1.9 3.1 2.3 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" Q6ZMV7 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 29.8" "Cell line enhanced" "Detected in many" "A-431: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 1.4 1.7 1.4 2.5 4.6 0.6 2.7 1.4 2.2 1.5 1.0 1.6 3.5 1.7 1.3 8.2 0.9 6.3 1.7 1.4 1.5 2.0 2.8 1.3 3.0 1.6 1.1 1.4 2.9 2.7 4.8 4.5 0.5 2.2 1.7 1.1 2.5 1.6 4.9 0.7 0.9 1.6 0.8 1.9 1.8 1.5 29.8 0.7 4.4 4.0 0.7 1.4 1.2 1.8 3.2 1.9 2.5 0.3 2.5 2.0 0.4 6.5 2.7 0.1 1.6 1.1 0.6 0.4 0.4 1.0 1.4 1.1 0.3 3.8 0.1 1.9 1.1 2.5 0.0 0.5 2.6 1.2 0.6 2.5 0.4 0.0 0.0 2.1 0.5 3.1 1.6 0.5 1.9 0.6 1.5 1.6 2.4 2.4 0.0 1.9 2.1 1.5 0.0 1.7 1.5 2.1 0.6 4.1 1.7 2.1 1.5 0.1 4.5 3.6 0.0 0.4 0.7 0.5 1.0 6.1 1.0 0.0 1.2 1.5 2.3 2.5 0.3 0.3 0.7 0.1 1.4 3.1 1.6 0.6 1.2 3.2 1.8 0.9 0.3 2.5 0.2 1.9 2.0 0.4 1.4 4.6 1.4 2.2 1.5 2.0 1.1 1.4 2.2 0.7 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 5.6;HaCaT: 8.1;HDLM-2: 5.0;HSkMC: 3.8;LHCN-M2: 4.7;U-87 MG: 5.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favourable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favourable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 9.6 8.0 8.2 8.0 11.1 6.1 7.3 10.1 9.5 7.5 10.8 11.5 10.8 7.6 13.4 8.7 6.1 11.9 9.6 12.7 8.2 7.9 7.6 7.2 8.9 6.3 11.2 7.6 10.3 9.7 7.3 8.5 7.3 10.3 9.3 10.7 6.6 21.6 10.4 13.1 9.9 14.8 7.5 10.8 21.8 8.8 12.3 13.1 10.1 10.8 7.6 6.8 8.2 15.8 3.8 3.2 4.1 3.3 2.8 3.8 0.8 0.1 0.4 5.6 0.2 0.5 0.2 0.4 0.8 0.1 0.5 0.3 0.2 0.0 0.0 0.2 0.0 8.1 0.3 0.2 0.2 5.0 1.2 0.0 0.5 0.1 0.0 0.0 0.5 3.8 0.6 0.2 0.4 0.1 0.1 0.0 4.7 0.6 0.4 0.5 0.0 0.5 0.0 0.1 0.7 0.5 0.5 0.2 0.1 0.3 0.0 0.3 0.2 0.1 0.7 0.4 0.4 0.2 0.4 0.1 0.2 0.0 5.5 0.1 2.6 1.0 2.7 4.1 2.5 3.3 2.8 1.6 3.7 3.8 2.2 3.8 3.7 2.9 3.7 2.8 1.6 3.2 2.7 0.8 8.2 11.1 10.1 9.5 8.2 7.9 11.2 7.6 10.3 13.1 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.6 2.5 1.9 1.7 1.5 4.2 1.4 4.6 5.5 6.6 4.0 1.0 5.4 1.7 10.8 1.0 1.5 3.8 16.5 6.9 0.8 1.5 2.0 1.9 2.4 1.8 0.3 1.9 1.2 4.6 7.0 15.0 6.9 1.7 2.7 5.8 2.8 4.9 1.2 0.4 11.6 1.7 3.1 1.0 10.8 0.6 1.6 1.5 1.5 0.3 0.5 1.6 0.8 11.8 2.0 14.6 3.7 1.1 1.7 1.0 1.3 3.2 2.1 1.5 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786167 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CACO-2: 1.0;HDLM-2: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LGALS1 GBP ENSG00000100097 "Galectin 1" P09382 22 37675608-37679806 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000646, HPA000687, HPA001130, CAB002157" Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" 19000000 Cytosol Nucleoplasm "CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311" "unprognostic (1.65e-1)" "unprognostic (8.13e-2)" "unprognostic (5.13e-2)" "prognostic favourable (2.36e-5)" "unprognostic (6.38e-2)" "unprognostic (2.67e-3)" "prognostic unfavourable (3.06e-4)" "unprognostic (3.22e-3)" "unprognostic (4.91e-3)" "unprognostic (2.51e-1)" "unprognostic (6.16e-3)" "unprognostic (8.06e-2)" "prognostic unfavourable (1.18e-10)" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.47e-2)" "prognostic unfavourable (5.10e-4)" 167.5 49.3 23.0 56.0 22.9 29.8 213.7 7.6 30.9 158.6 94.5 20.1 44.2 22.0 150.9 80.3 74.0 66.8 78.8 108.6 18.9 29.3 24.0 20.8 55.8 45.4 41.4 28.9 105.1 18.2 5.1 17.5 80.1 53.6 85.9 23.4 35.7 34.9 89.6 117.1 29.2 29.2 145.8 88.3 40.3 40.0 42.4 20.5 16.7 19.6 59.1 20.4 99.8 81.7 29.0 185.2 44.0 149.1 19.6 73.1 180.2 93.4 55.1 1.2 49.0 114.7 225.4 1.1 217.4 255.3 161.1 160.6 6.1 12.4 0.1 22.4 219.6 10.0 1.9 143.0 56.3 96.0 1.0 8.2 57.9 25.3 74.9 4.7 109.7 139.5 9.7 128.5 55.0 176.9 5.9 39.6 124.6 41.7 0.1 66.6 0.4 131.0 0.1 82.1 25.7 66.3 0.2 0.1 29.0 43.4 7.6 54.3 40.4 56.3 239.1 215.3 107.7 95.5 111.0 24.3 16.2 0.3 252.9 24.9 85.7 44.0 149.1 5.3 40.8 114.2 6.1 29.0 38.0 39.8 185.2 10.8 6.6 26.8 6.3 19.6 120.0 45.7 73.1 180.2 23.0 22.9 7.6 30.9 18.9 29.3 41.4 28.9 53.6 20.5 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570246-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3" "Group enriched" "Detected in some" 13 "CACO-2: 45.9;Hep G2: 25.8" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5" "Group enriched" "Detected in many" 51 "dendritic cells: 100.5;monocytes: 129.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.1 0.4 0.6 4.3 0.5 1.8 0.6 0.4 0.5 0.5 12.6 0.5 0.4 6.1 1.0 1.9 0.8 0.6 91.7 0.7 0.4 0.4 35.3 1.0 2.3 7.9 0.5 0.4 0.6 87.3 0.0 0.4 0.9 0.5 0.5 13.0 0.5 1.8 0.4 0.4 0.9 43.0 0.4 0.5 8.3 1.5 0.6 0.4 4.5 0.5 1.0 9.6 0.7 0.6 0.6 100.5 2.2 129.0 0.1 0.2 70.1 1.1 0.6 0.4 0.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 45.9 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 25.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.4 0.2 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.7 0.7 2.7 0.9 0.4 1.8 0.3 0.0 0.1 0.1 1.2 0.0 0.5 0.6 129.0 0.6 0.1 47.0 0.2 0.6 0.1 0.2 100.5 0.2 0.2 0.1 2.2 0.1 2.9 0.8 0.2 70.1 0.6 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.4 LGALSL "GRP, HSPC159" ENSG00000119862 "Galectin like" Q3ZCW2 2 64453969-64461381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 50.8;tongue: 90.3" "Cell line enhanced" "Detected in many" "AN3-CA: 24.4;HAP1: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 1.9" "Low region specificity" "Detected in all" HPA046079 Approved Approved Nucleoplasm 9700000 Nucleoplasm "HPA046079: AB_10967075" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "unprognostic (7.18e-2)" "unprognostic (3.77e-2)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (2.16e-4)" "unprognostic (1.25e-2)" "unprognostic (8.43e-2)" "unprognostic (3.57e-3)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (4.34e-2)" "unprognostic (6.57e-2)" "unprognostic (6.20e-2)" "unprognostic (9.19e-2)" "unprognostic (2.77e-2)" 6.5 9.2 4.8 3.4 6.2 3.5 12.0 11.0 7.2 6.9 11.5 2.7 2.4 5.0 4.2 6.4 12.7 3.5 4.9 8.1 4.6 5.0 5.6 4.8 18.0 2.9 3.8 3.9 5.7 5.5 10.0 6.3 5.3 4.3 8.2 6.1 14.7 6.4 3.9 30.7 50.8 13.4 5.2 2.8 4.0 4.4 4.0 1.2 0.8 3.1 90.3 13.6 5.1 6.2 0.3 0.1 4.1 0.3 0.0 1.9 3.8 5.7 3.6 10.4 24.4 0.3 0.1 3.1 1.6 3.9 3.1 2.9 17.0 1.2 0.0 2.4 0.8 6.8 35.6 6.6 2.5 6.4 9.3 0.1 1.8 8.3 3.1 1.6 2.4 1.5 4.2 1.3 4.7 1.9 0.0 1.7 0.0 4.4 2.3 0.3 8.1 4.3 2.6 6.4 1.8 3.6 4.1 1.7 6.9 5.1 3.5 3.0 2.4 0.2 0.8 2.0 6.2 1.3 3.0 7.3 3.4 4.8 0.0 1.0 2.6 0.0 0.3 3.7 0.0 0.0 1.9 0.3 0.4 0.4 0.1 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 3.8 4.8 6.2 11.0 7.2 4.6 5.0 3.8 3.9 4.3 1.2 LGMN "LGMN1, PRSC1" ENSG00000100600 Legumain Q99538 14 92703807-92748702 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "RPMI-8226: 127.6;U-266/70: 70.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 11 "dendritic cells: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001426 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" 1200000 Vesicles Nucleoplasm "HPA001426: AB_1079247" "unprognostic (1.19e-1)" "unprognostic (1.16e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (3.50e-2)" "unprognostic (4.70e-2)" "unprognostic (2.47e-1)" "prognostic favourable (4.70e-4)" "unprognostic (8.06e-2)" "unprognostic (3.64e-2)" "unprognostic (7.18e-3)" "unprognostic (7.24e-2)" 42.9 16.3 8.6 17.4 10.7 3.5 19.9 5.8 17.9 13.3 22.3 11.7 13.9 24.2 12.1 48.1 17.4 14.1 32.7 38.8 10.3 10.1 87.6 44.6 31.5 42.4 8.3 10.1 20.5 14.6 54.4 9.7 113.6 9.9 22.0 24.5 23.2 22.6 8.4 17.3 11.9 37.1 23.3 11.5 58.3 23.7 14.0 7.9 17.2 36.8 19.2 17.3 31.4 18.2 4.7 54.2 0.7 0.8 1.0 4.3 1.7 4.8 7.0 4.7 8.6 14.6 11.8 16.4 10.5 10.0 10.9 12.9 5.4 8.7 2.7 15.5 17.1 12.1 0.0 9.0 5.2 0.2 5.4 0.1 3.9 6.2 4.3 0.1 0.4 8.3 4.4 10.5 6.0 12.9 1.0 22.6 0.7 6.5 1.2 0.2 2.3 4.8 1.2 4.1 127.6 11.8 19.0 5.1 3.5 14.5 8.9 7.5 6.6 0.0 7.0 5.4 6.9 9.7 3.1 70.2 8.2 3.6 3.0 0.1 10.3 0.7 0.4 0.1 0.2 0.8 0.4 4.7 1.4 0.4 5.0 3.4 4.3 2.5 0.5 1.0 0.2 54.2 2.6 1.7 8.6 10.7 5.8 17.9 10.3 10.1 8.3 10.1 9.9 7.9 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.2;liver: 9.3" "Cell line enhanced" "Detected in some" "A549: 10.4;BEWO: 5.5;CACO-2: 3.3;HeLa: 3.8;Karpas-707: 2.6" "Cancer enhanced" "Detected in some" "lung cancer: 2.2" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 5.2 9.3 0.7 0.2 0.4 0.2 0.2 0.5 0.0 0.2 2.3 2.9 0.5 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 1.6 0.3 0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.0 3.4 0.7 0.3 0.5 0.1 0.1 10.4 0.1 0.1 0.0 0.0 5.5 0.1 0.1 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.1 3.8 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.1 1.8 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 1.6 0.7 0.3 0.5 0.3 0.2 0.7 0.5 0.3 0.1 0.7 0.4 0.5 3.4 0.3 0.3 1.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.2 2.9 0.2 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Cell line enhanced" "Detected in some" "NTERA-2: 4.6;SCLC-21H: 10.7;SH-SY5Y: 13.4;U-266/84: 11.2;WM-115: 4.1" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.0 0.0 11.2 0.0 0.5 0.0 4.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell line enhanced" "Detected in some" "HAP1: 6.2;HMC-1: 2.6;WM-115: 11.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: , HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 LHX2 "hLhx2, LH-2" ENSG00000106689 "LIM homeobox 2" P50458 9 124001670-124033301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 44.7;retina: 17.0" "Cell line enhanced" "Detected in many" "AN3-CA: 15.8;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.6;U-138 MG: 10.3" "Group enriched" "Detected in many" 5 "cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5" "Group enriched" "Detected in many" 6 "amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7" "Group enriched" "Detected in many" 6 "amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5" HPA000838 Supported Approved Nucleoplasm Nucleoplasm "HPA000838: " "unprognostic (3.60e-3)" "prognostic favourable (9.52e-4)" "unprognostic (3.52e-1)" "unprognostic (9.97e-2)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (6.37e-3)" "unprognostic (1.07e-1)" "unprognostic (4.59e-2)" "unprognostic (3.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.32e-2)" "unprognostic (4.66e-15)" "unprognostic (1.72e-1)" "unprognostic (2.92e-1)" "unprognostic (2.46e-2)" "unprognostic (1.77e-1)" 0.9 1.0 30.7 1.1 20.5 0.9 1.1 0.0 44.7 0.8 0.9 4.7 0.0 1.0 0.8 0.8 0.8 0.8 1.0 0.8 23.6 2.4 0.8 6.1 0.9 1.1 1.5 16.1 1.1 0.8 0.8 4.6 5.1 0.0 0.8 1.1 17.0 1.1 0.8 0.8 2.2 0.9 0.8 0.2 0.9 0.9 4.0 4.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 4.9 0.1 15.8 0.0 0.2 1.6 0.4 0.2 1.2 0.1 4.9 0.0 0.1 2.1 0.9 0.1 15.7 0.0 0.6 0.0 3.4 0.0 10.9 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 7.9 0.0 0.1 19.6 4.6 4.2 0.0 0.0 0.0 0.0 6.4 0.0 4.0 0.0 0.0 5.6 2.0 0.0 10.3 0.4 2.9 0.7 0.2 3.2 0.0 0.6 2.2 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 30.7 20.5 0.0 26.6 23.6 2.4 1.5 16.1 0.0 4.2 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.3;U-266/70: 7.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA071806: " "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 7.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 LHX9 ENSG00000143355 "LIM homeobox 9" Q9NQ69 1 197911902-197935478 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ovary: 22.1;retina: 24.3;testis: 17.5" "Cell line enriched" "Detected in some" 10 "fHDF/TERT166: 77.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3" "Group enriched" "Detected in many" 5 "midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4" HPA009695 Uncertain Approved Nucleoplasm Nucleoplasm "HPA009695: AB_1079251" "unprognostic (8.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.38e-4)" "unprognostic (1.43e-1)" "unprognostic (5.68e-3)" "unprognostic (3.55e-1)" "unprognostic (1.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.63e-2)" "unprognostic (3.26e-2)" "unprognostic (5.15e-2)" "unprognostic (2.62e-3)" "unprognostic (6.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" 0.3 0.2 1.7 0.1 1.0 0.1 0.1 0.1 0.5 1.1 0.3 0.7 0.4 0.2 0.8 4.1 0.1 0.4 0.2 1.5 0.7 2.6 0.1 1.2 2.7 0.1 0.8 0.0 22.1 0.1 0.1 1.4 0.1 3.1 0.1 0.2 24.3 0.1 0.2 0.9 0.1 0.2 0.1 0.5 0.1 0.1 17.5 0.5 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.2 2.1 0.1 0.0 0.0 0.0 0.0 77.1 0.0 1.9 0.0 0.6 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.3 2.3 0.8 0.0 0.0 0.0 1.8 0.0 0.7 0.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.1 0.5 0.7 2.6 0.8 0.0 3.1 0.5 LIAS LAS ENSG00000121897 "Lipoic acid synthetase" O43766 4 39458587-39485109 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018842, HPA019076" Approved Supported Approved Nucleoplasm,Mitochondria,Cytosol Mitochondria "Nucleoplasm, Cytosol" "HPA018842: AB_1852864, HPA019076: AB_1852866" "unprognostic (3.61e-1)" "unprognostic (1.89e-1)" "unprognostic (8.44e-2)" "unprognostic (2.33e-1)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "unprognostic (8.31e-2)" "unprognostic (1.57e-1)" "unprognostic (4.19e-2)" "unprognostic (3.68e-2)" "unprognostic (2.46e-3)" "unprognostic (3.80e-2)" "prognostic favourable (4.11e-7)" "unprognostic (9.41e-3)" "unprognostic (2.35e-1)" "unprognostic (5.45e-2)" "unprognostic (6.98e-2)" 9.8 12.9 9.9 7.0 12.7 10.2 11.3 10.2 13.3 7.0 10.7 12.9 8.1 10.4 9.1 10.7 11.6 11.9 7.4 14.0 10.6 10.6 15.7 15.5 5.7 9.0 12.3 10.5 19.2 12.4 10.0 11.5 6.8 15.7 8.2 12.4 9.0 7.8 7.0 42.7 8.8 9.9 13.6 12.4 8.9 9.9 20.1 13.2 8.7 8.8 13.5 8.3 10.0 7.9 9.6 5.8 3.7 7.1 6.9 16.7 4.3 3.9 3.0 4.0 3.7 8.3 8.1 3.4 4.6 2.5 4.3 2.9 5.0 5.5 14.4 5.3 1.7 3.5 11.1 6.3 5.7 1.6 2.8 6.0 1.6 5.0 7.6 13.1 3.9 7.8 10.4 5.0 16.0 4.9 14.3 3.6 5.2 2.5 7.3 16.8 5.2 10.0 6.4 10.7 8.7 5.1 2.1 4.3 3.7 2.6 3.5 14.8 3.9 6.0 1.8 3.4 7.6 4.5 10.6 7.0 10.6 10.1 5.3 15.3 2.9 2.0 6.2 3.7 6.1 7.1 12.6 9.6 8.3 8.0 5.8 8.5 16.7 11.5 3.3 6.9 5.1 5.4 5.2 4.3 9.9 12.7 10.2 13.3 10.6 10.6 12.3 10.5 15.7 13.2 LINS1 "LINS, WINS1" ENSG00000140471 "Lines homolog 1" Q8NG48 15 100559369-100603230 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038578, HPA038579" Approved Approved Nucleoplasm Nucleoplasm "HPA038578: , HPA038579: AB_10697393" "unprognostic (9.87e-2)" "unprognostic (3.32e-3)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (7.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.48e-2)" "unprognostic (3.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-3)" "unprognostic (1.14e-2)" "unprognostic (2.93e-1)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.28e-2)" 10.0 10.2 12.2 13.2 13.4 8.1 13.6 16.9 13.8 13.7 10.2 10.1 13.3 6.8 13.5 16.7 14.9 12.0 7.7 8.6 11.2 6.8 10.4 9.2 10.3 17.6 8.2 11.1 13.1 9.4 12.8 19.8 11.4 9.6 10.9 12.1 10.2 14.1 13.2 11.4 15.7 11.6 10.6 10.7 13.4 10.4 11.8 10.4 16.6 14.7 9.2 15.9 13.3 12.8 7.7 5.1 6.9 5.0 9.0 23.3 6.6 4.2 6.7 8.3 8.3 6.2 8.4 7.2 6.9 7.5 7.6 8.4 6.1 8.3 11.3 4.0 6.2 18.5 7.8 8.6 8.2 3.8 11.2 10.2 10.1 4.8 5.0 8.6 6.2 7.5 7.5 5.9 9.4 9.0 16.2 9.1 4.7 5.6 5.1 7.4 9.4 8.2 7.6 13.3 10.6 6.6 11.8 4.2 5.6 6.5 6.2 10.1 10.4 6.6 6.5 9.8 8.9 6.8 8.7 9.8 12.6 10.1 6.2 11.2 7.7 6.9 5.0 6.9 10.9 4.6 15.2 7.7 17.0 11.6 5.1 6.8 23.3 16.6 6.4 9.0 3.8 4.1 10.2 6.6 12.2 13.4 16.9 13.8 11.2 6.8 8.2 11.1 9.6 10.4 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.5;testis: 18.0" "Group enriched" "Detected in some" 4 "REH: 9.0;SCLC-21H: 9.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 12.5" "Lineage enriched" "Detected in many" 11 "monocytes: 12.5" "Low region specificity" "Detected in many" HPA056463 Approved Nucleoplasm Nucleoplasm "HPA056463: " "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.5 0.0 3.4 0.3 2.9 0.6 0.1 1.5 2.9 0.0 0.2 0.6 0.1 0.0 0.0 1.8 0.0 0.0 1.7 3.1 0.1 0.0 0.3 0.2 1.2 0.0 0.7 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.3 18.0 0.1 0.0 0.0 0.0 0.1 1.0 0.8 12.5 0.0 0.8 0.8 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.7 0.7 0.3 1.5 9.0 0.0 0.2 0.0 0.0 9.4 2.2 0.0 0.1 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.8 0.1 7.9 0.6 0.1 0.7 0.2 1.0 0.0 0.8 0.2 0.0 0.0 12.5 0.2 0.0 0.8 LMBRD2 DKFZp434H2226 ENSG00000164187 "LMBR1 domain containing 2" Q68DH5 5 36098412-36151961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 11.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012165 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA012165: AB_2136131" "unprognostic (9.43e-3)" "unprognostic (3.03e-1)" "unprognostic (1.80e-2)" "unprognostic (7.09e-2)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.58e-2)" "unprognostic (8.46e-3)" "unprognostic (6.45e-3)" "unprognostic (2.80e-1)" "unprognostic (8.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.30e-3)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-2)" "unprognostic (5.35e-2)" 6.2 9.7 12.1 6.6 21.4 2.2 8.8 12.8 25.5 7.3 8.7 9.5 7.6 9.6 5.3 7.2 6.8 4.8 5.8 8.2 14.2 11.4 10.5 14.2 5.7 7.6 9.9 15.6 5.0 7.7 16.9 16.9 8.4 14.1 9.7 9.1 4.8 7.6 6.8 11.1 7.7 9.6 5.5 10.5 6.7 10.1 5.2 8.6 8.4 12.8 2.9 7.4 7.6 6.1 1.5 1.2 11.0 1.2 1.0 2.3 0.8 4.8 3.6 4.4 7.3 9.2 8.1 15.6 10.1 5.3 7.4 7.5 4.5 10.6 8.7 5.1 5.3 6.7 5.8 3.5 12.3 12.4 3.5 6.8 12.4 0.8 5.9 8.2 9.0 4.8 6.3 6.4 6.4 4.0 7.9 9.2 9.0 3.2 7.0 5.4 2.4 4.6 5.3 10.3 5.3 6.4 4.3 8.3 6.4 14.5 8.6 3.5 9.8 9.9 5.3 8.9 2.3 11.3 5.3 7.6 11.1 7.7 8.4 9.3 6.1 11.0 1.2 2.0 1.6 1.2 1.1 1.5 1.4 1.4 1.0 1.3 1.9 1.9 0.8 1.0 1.2 1.2 2.3 0.8 12.1 21.4 12.8 25.5 14.2 11.4 9.9 15.6 14.1 8.6 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.4;RT4: 6.6;SH-SY5Y: 6.7;U-2197: 23.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA038640: " "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.5 2.3 3.1 5.4 1.2 0.2 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.3 0.9 0.1 0.9 0.8 1.9 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.6 0.5 0.4 0.2 0.2 0.2 6.6 0.1 6.7 0.2 0.4 3.8 0.3 1.5 0.3 0.2 0.9 23.5 0.2 0.8 1.3 1.6 0.3 1.5 2.5 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell line enhanced" "Detected in many" "HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: " "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favourable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.5 3.0 0.3 0.0 0.0 0.0 4.4 0.0 0.2 0.0 0.1 2.2 3.6 1.6 1.2 0.0 2.1 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.4 0.2 0.9 0.0 0.0 0.1 1.4 2.8 0.0 3.0 0.6 0.8 1.1 0.9 3.8 0.0 1.3 1.1 0.7 0.7 2.8 0.1 10.0 0.0 3.8 0.2 0.1 0.0 0.8 0.1 0.0 9.3 7.5 0.4 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 4.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 LMX1B NPS1 ENSG00000136944 "LIM homeobox transcription factor 1 beta" O60663 9 126614443-126701032 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 16.5;salivary gland: 35.3" "Cell line enhanced" "Detected in some" "HEK 293: 4.7;MCF7: 17.7;T-47d: 10.9" "Cancer enriched" "Detected in some" 14 "breast cancer: 12.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Region enhanced" "Detected in some" "midbrain: 7.9" HPA073716 Approved Nucleoplasm Nucleoplasm "HPA073716: " "unprognostic (4.17e-1)" "unprognostic (4.72e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.73e-1)" "unprognostic (1.50e-4)" "unprognostic (1.86e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-1)" "unprognostic (2.26e-1)" "unprognostic (1.34e-2)" "unprognostic (3.51e-3)" "unprognostic (1.63e-5)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-6)" "unprognostic (1.13e-2)" 1.3 0.1 0.0 0.1 0.0 0.1 7.5 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 1.9 0.1 0.2 1.4 0.0 0.1 0.0 0.6 0.0 0.1 0.8 0.0 0.6 0.0 2.9 0.1 0.0 16.5 35.3 0.0 0.4 1.5 0.2 0.0 2.4 0.0 0.1 3.1 0.0 0.0 0.9 0.1 0.0 0.2 0.1 0.6 0.4 1.2 0.3 0.9 0.5 0.0 2.5 1.2 0.4 3.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.3 1.3 0.0 0.5 0.0 1.2 3.9 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.5 0.0 2.1 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.3 0.0 1.6 0.4 0.1 0.4 10.9 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.5 0.4 1.2 0.9 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 2.9 0.0 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 9.3;K-562: 11.0;PC-3: 12.6;SiHa: 11.4;SK-MEL-30: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.4" "Lineage enriched" "Detected in single" 8 "T-cells: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA050422: , HPA061162: " "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavourable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.8 3.9 4.2 2.1 3.4 4.6 10.8 15.8 6.1 1.9 4.1 2.0 1.6 2.9 2.4 3.1 1.7 2.5 3.9 3.9 5.0 1.9 3.6 15.4 11.8 0.8 1.7 3.7 2.0 8.1 0.4 3.5 0.9 4.4 3.0 5.5 4.1 8.1 3.0 13.8 1.4 2.3 10.8 2.7 1.1 4.5 2.7 2.5 0.0 9.9 1.9 1.1 4.7 6.6 0.0 0.1 0.8 0.8 0.0 7.4 0.7 3.8 5.7 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.8 0.0 2.8 0.0 0.0 1.2 0.0 0.1 0.1 3.2 4.9 9.3 5.5 3.2 4.2 0.6 0.0 0.0 0.0 0.0 1.5 11.0 0.0 0.8 4.7 0.0 1.8 0.0 12.6 0.0 2.6 0.0 3.5 1.6 0.2 0.0 11.4 0.3 10.0 0.0 3.7 0.2 0.1 0.2 0.0 6.1 1.2 4.9 0.0 2.7 4.3 2.5 0.0 0.8 0.0 4.5 0.0 7.4 0.0 2.0 1.5 0.1 0.0 1.1 1.6 0.8 0.0 0.0 0.0 0.7 0.7 4.2 3.4 15.8 6.1 5.0 1.9 1.7 3.7 4.4 2.5 LRCH4 "LRN, LRRN1" ENSG00000077454 "Leucine rich repeats and calponin homology domain containing 4" O75427 7 100574011-100586153 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 44.8;NB-4: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037667, HPA037668" Enhanced Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA037667: AB_10671882, HPA037668: AB_10672910" "unprognostic (2.41e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (1.61e-7)" "unprognostic (8.32e-3)" "unprognostic (2.76e-2)" "unprognostic (3.96e-3)" "unprognostic (8.98e-3)" "unprognostic (3.72e-2)" "unprognostic (2.52e-1)" "unprognostic (5.51e-2)" "unprognostic (2.63e-3)" "unprognostic (7.81e-2)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (7.96e-2)" "unprognostic (1.26e-2)" 11.4 15.2 14.5 32.0 25.7 52.7 13.8 19.7 22.2 12.0 14.0 16.4 11.8 22.0 12.3 9.6 14.4 14.0 15.9 10.2 16.2 9.1 16.1 12.2 20.8 39.1 25.8 13.1 23.7 17.3 8.9 22.8 26.4 19.2 14.6 7.2 18.3 23.5 13.0 15.8 15.0 27.8 8.1 25.7 54.5 14.9 43.3 23.1 31.1 20.0 6.8 25.2 9.9 12.0 5.9 6.2 24.2 8.4 1.4 7.3 2.9 7.8 4.4 4.4 4.0 2.6 2.0 8.4 7.6 3.4 4.5 3.6 7.3 11.4 5.6 8.5 2.2 6.7 2.1 3.2 1.2 5.6 5.9 6.5 5.2 3.5 8.4 11.2 44.8 3.4 3.4 3.7 2.1 4.5 8.0 11.7 3.1 14.7 12.8 69.2 4.6 5.2 14.3 3.6 6.9 3.4 2.7 5.7 8.6 3.6 11.6 8.8 7.8 24.4 7.0 6.1 11.0 8.4 4.5 11.9 5.6 5.1 4.7 27.7 10.4 12.6 8.4 11.9 5.2 6.8 4.7 4.7 5.1 5.9 6.2 5.9 7.3 5.9 24.2 1.4 4.7 5.9 5.2 2.9 14.5 25.7 19.7 22.2 16.2 9.1 25.8 13.1 19.2 23.1 LRIG2 KIAA0806 ENSG00000198799 "Leucine rich repeats and immunoglobulin like domains 2" O94898 1 113073209-113132260 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015538 Uncertain Approved "Nucleoplasm,Golgi apparatus" 510000 "Golgi apparatus" Nucleoplasm "HPA015538: AB_2250170" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (9.08e-2)" "prognostic unfavourable (9.37e-4)" "unprognostic (4.72e-2)" "unprognostic (1.27e-3)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (3.27e-2)" "unprognostic (5.95e-2)" "unprognostic (1.03e-2)" "unprognostic (1.03e-2)" "unprognostic (1.27e-2)" "unprognostic (2.34e-1)" "unprognostic (8.83e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" 8.3 7.7 10.1 11.4 10.6 4.7 10.7 15.6 10.0 11.6 9.2 16.1 6.0 10.8 15.1 14.9 7.8 9.2 8.2 7.3 9.3 9.1 9.2 6.3 8.0 9.7 13.0 6.7 15.0 8.5 13.4 11.6 10.1 9.2 9.3 8.6 14.6 9.0 11.2 13.1 16.6 9.5 8.9 11.6 10.1 8.1 9.4 13.4 10.4 12.6 5.0 10.7 8.6 10.7 4.4 2.6 4.9 2.5 4.8 3.9 1.7 4.4 2.4 6.7 5.1 6.5 6.7 3.9 2.8 4.2 3.4 5.8 3.5 2.8 4.5 5.0 3.6 5.0 4.6 3.0 5.8 3.1 2.7 4.8 4.6 1.7 6.6 5.7 2.3 6.5 5.5 5.4 7.1 4.4 5.7 4.3 4.2 3.2 5.8 6.1 6.3 4.0 5.3 8.4 2.2 3.3 3.0 4.8 3.9 5.0 3.3 6.4 2.5 6.5 6.6 6.4 3.5 8.7 4.5 4.8 2.2 4.6 6.8 3.6 5.9 4.9 2.5 1.5 3.1 2.0 3.5 3.1 3.4 3.2 1.9 4.4 3.9 3.6 1.7 4.8 2.1 2.6 2.6 1.7 10.1 10.6 15.6 10.0 9.3 9.1 13.0 6.7 9.2 13.4 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.1 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871613-22881580 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavourable (3.54e-7)" "prognostic unfavourable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favourable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 33.1 20.1 12.7 26.0 13.1 23.7 37.2 5.8 10.3 32.0 52.4 16.2 41.0 31.7 39.0 46.8 66.1 27.1 65.1 27.7 13.6 6.0 46.5 63.3 34.1 30.0 14.2 8.1 30.7 36.6 31.4 11.7 32.0 14.4 36.9 19.0 22.6 36.1 41.1 21.2 32.9 65.9 32.0 11.2 26.1 37.9 19.1 12.9 20.7 46.9 34.1 36.2 43.3 42.8 3.8 2.3 29.7 2.6 2.4 6.3 3.4 15.4 18.8 4.1 10.8 56.5 32.8 14.1 24.4 46.5 15.4 21.4 5.7 54.9 8.1 12.2 55.0 22.1 2.7 27.9 6.1 13.2 2.9 2.8 10.3 4.0 25.2 6.4 25.8 35.8 32.7 23.1 12.0 28.1 3.4 31.3 20.7 17.8 1.8 1.9 0.9 25.4 4.0 4.2 8.0 16.5 27.5 0.3 4.5 13.5 26.0 10.6 13.6 4.6 29.3 23.8 6.8 12.3 10.0 14.7 8.7 3.7 12.3 2.6 10.1 5.9 2.2 15.8 5.1 2.3 5.0 3.8 6.3 6.0 2.3 2.7 5.5 3.1 29.7 2.4 2.6 1.9 6.0 3.4 12.7 13.1 5.8 10.3 13.6 6.0 14.2 8.1 14.4 12.9 LRP5L DKFZp434O0213 ENSG00000100068 "LDL receptor related protein 5 like" A4QPB2 22 25351418-25405377 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 6.3;NK-cell: 10.7" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;NK-cells: 10.7" HPA028717 Uncertain Approved Nucleoplasm Nucleoplasm "HPA028717: AB_10601767" "unprognostic (5.90e-2)" "unprognostic (2.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.34e-3)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (1.13e-1)" "unprognostic (5.98e-3)" "unprognostic (5.11e-1)" "unprognostic (9.64e-2)" "unprognostic (9.78e-2)" "unprognostic (4.38e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.44e-1)" "prognostic favourable (6.93e-6)" 6.0 4.7 4.8 8.0 3.8 17.6 18.5 1.5 6.2 10.0 7.0 4.1 11.4 4.1 8.2 8.1 3.9 6.3 8.0 5.3 3.9 2.0 9.1 17.4 5.9 8.5 8.1 1.7 7.7 8.0 6.3 3.8 2.1 4.1 8.9 4.7 6.5 11.0 12.2 2.7 6.1 5.7 7.7 3.4 8.4 4.8 5.0 3.6 3.7 15.5 4.3 6.7 6.3 7.5 1.1 0.2 6.3 0.5 10.7 1.0 0.3 2.0 3.0 1.2 6.1 2.3 1.0 2.2 1.7 2.8 2.3 2.6 2.9 1.0 0.8 2.4 1.9 4.0 2.2 3.1 1.5 2.9 6.9 3.9 5.1 7.2 2.7 7.6 8.1 4.1 3.0 2.7 11.4 1.0 2.5 2.5 1.6 6.8 1.4 7.1 2.7 4.4 6.8 2.7 3.0 2.8 4.7 4.0 4.6 1.3 2.2 2.1 2.6 2.8 1.8 2.6 11.6 1.8 2.9 6.3 1.2 1.7 1.6 4.6 1.4 6.3 0.5 2.1 1.0 0.4 0.9 0.2 0.3 0.3 0.1 1.1 0.1 0.3 0.2 10.7 0.2 0.2 0.0 0.3 4.8 3.8 1.5 6.2 3.9 2.0 8.1 1.7 4.1 3.6 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: , HPA069364: " "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavourable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavourable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.9 12.1 11.1 27.6 25.0 14.4 18.9 20.4 8.4 7.3 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.2 2.3 23.2 12.9 2.2 3.8 12.4 5.6 13.1 9.9 13.7 13.6 20.1 27.1 19.4 7.7 21.0 19.1 21.7 14.6 9.3 9.3 12.8 7.2 11.6 13.9 8.4 17.9 15.2 5.0 19.2 31.8 8.4 14.9 7.5 10.8 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Group enriched" "Detected in some" 5 "AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA047619: " "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 12.8 0.0 0.0 0.0 6.7 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favourable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 9.4 10.3 11.9 15.0 11.9 9.5 26.5 14.3 22.3 10.4 10.5 15.1 5.0 11.0 13.7 8.9 11.5 10.6 11.3 9.7 12.4 8.2 9.4 8.9 10.0 12.2 15.3 16.0 11.2 17.5 16.9 13.5 8.4 12.7 15.6 7.9 9.4 16.8 12.9 9.8 17.6 10.6 12.7 9.2 11.9 11.0 9.6 12.1 9.7 13.8 6.2 9.8 11.9 9.4 10.6 9.8 4.7 8.6 13.1 10.3 8.7 9.5 19.6 5.3 8.6 5.7 4.7 7.6 8.5 3.7 6.9 6.0 8.7 11.7 7.8 9.1 6.3 10.5 8.3 8.5 3.2 10.4 19.2 11.6 20.9 3.6 5.4 4.9 9.6 5.7 7.3 6.9 3.4 5.9 15.2 9.3 6.7 11.7 18.1 6.4 4.3 28.5 15.5 4.4 10.9 4.2 8.4 14.5 8.1 13.1 10.5 6.1 16.2 5.5 6.3 11.9 21.1 10.4 12.5 5.3 3.1 9.6 11.1 11.4 7.3 1.9 8.6 1.8 10.3 8.1 10.2 9.0 7.7 9.6 8.4 10.6 8.6 7.0 4.7 13.1 6.7 9.8 7.2 8.7 11.9 11.9 14.3 22.3 12.4 8.2 15.3 16.0 12.7 12.1 LRRC14B ENSG00000185028 "Leucine rich repeat containing 14B" A6NHZ5 5 191511-195353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3" "Cell line enriched" "Detected in some" 4 "U-266/84: 28.5" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038046, HPA038047" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA038046: AB_10672504, HPA038047: " "unprognostic (7.63e-4)" "unprognostic (4.25e-3)" "unprognostic (8.50e-3)" "unprognostic (7.63e-4)" "unprognostic (4.95e-2)" "unprognostic (3.79e-2)" "unprognostic (6.07e-3)" "unprognostic (9.68e-2)" "unprognostic (6.43e-2)" "unprognostic (6.43e-3)" "unprognostic (2.78e-2)" "unprognostic (6.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.19e-1)" 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 30.6 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.9 0.4 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 14.3 0.7 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 3.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 7.0 28.5 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.2 0.0 0.5 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515423-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.6;HEL: 6.1;LHCN-M2: 6.1;TIME: 4.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064844 Approved Nucleoplasm Nucleoplasm "HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 1.8 0.5 1.9 0.4 1.4 0.4 1.0 1.4 3.0 2.6 1.1 0.2 0.0 0.4 3.9 1.4 1.1 1.1 1.4 53.9 1.3 0.4 2.2 2.5 0.6 0.3 0.5 2.3 2.8 0.7 0.1 2.2 0.5 1.0 1.2 0.8 0.4 1.4 0.2 70.3 1.2 0.6 2.3 0.4 1.3 1.0 0.4 0.0 1.4 10.1 20.0 1.2 1.7 1.8 1.2 0.8 2.6 0.7 1.1 2.5 0.3 0.2 0.0 0.2 0.3 1.0 2.2 0.1 0.8 1.5 0.5 0.8 0.0 0.2 0.3 0.2 10.6 0.2 3.7 0.0 1.4 0.5 0.1 6.1 0.4 0.2 0.2 0.2 0.1 0.2 0.1 4.3 0.0 0.2 0.1 0.4 6.1 0.1 0.8 0.1 1.5 0.2 0.1 0.1 0.3 0.1 0.3 0.5 1.2 0.8 0.2 1.6 0.2 0.8 4.9 0.3 0.6 2.5 1.6 0.4 0.3 2.9 0.2 0.1 1.4 2.2 0.7 0.6 0.6 0.4 0.4 0.7 1.6 0.3 0.2 1.2 0.8 0.6 2.6 1.1 0.5 0.8 2.5 0.3 1.9 1.4 1.4 3.0 1.3 0.4 0.5 2.3 1.0 0.0 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 111.8" "Cell line enhanced" "Detected in many" "U-2 OS: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 1.3 2.5 5.6 1.4 7.2 1.6 1.4 5.2 11.2 3.3 3.2 2.5 0.0 1.4 2.7 3.1 7.1 2.4 2.1 15.8 5.0 3.9 1.2 8.3 2.2 1.7 3.7 6.3 2.2 1.3 2.1 3.6 1.1 4.9 2.6 2.0 1.8 1.8 2.4 111.8 1.6 1.4 3.5 2.0 1.4 1.6 3.5 1.9 1.6 2.6 14.3 3.1 2.2 4.8 0.9 2.6 0.0 1.0 1.1 4.1 1.1 14.6 11.3 7.3 15.6 4.1 3.3 0.0 1.9 6.6 5.0 4.7 9.6 15.3 2.9 7.8 1.4 5.3 7.1 10.6 3.5 8.2 2.3 1.7 2.5 22.0 4.5 4.2 1.4 1.3 3.2 6.9 2.3 9.7 2.1 4.7 4.6 2.3 16.0 3.5 2.4 25.7 13.4 4.2 8.3 6.5 1.5 18.5 8.0 1.2 1.3 5.1 1.9 4.3 5.9 4.0 34.6 5.3 4.5 7.6 13.4 4.8 6.5 17.4 0.8 0.0 0.9 0.0 1.7 1.0 1.4 0.9 1.3 1.9 2.6 0.0 4.1 1.5 0.0 1.1 0.7 0.4 0.2 1.1 5.6 7.2 5.2 11.2 5.0 3.9 3.7 6.3 4.9 1.9 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132379918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 52.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: " "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 2.1 2.8 8.1 1.5 8.4 1.0 4.1 2.2 8.9 3.6 2.1 6.1 7.5 2.0 3.8 5.6 1.6 10.5 3.5 2.2 6.6 5.4 4.4 2.4 3.1 1.9 4.3 7.3 5.4 3.1 7.5 5.8 2.1 6.5 4.1 2.1 4.8 3.1 4.0 1.2 2.1 2.6 3.4 3.5 3.3 3.0 52.9 4.5 0.7 5.1 1.0 1.2 2.5 1.8 4.7 7.8 4.4 6.8 3.1 2.8 2.7 2.7 5.0 11.2 15.7 9.8 10.1 1.1 2.7 8.8 4.5 4.1 0.8 5.7 1.5 1.6 6.3 1.9 2.5 1.3 2.9 3.2 2.2 0.3 3.5 2.6 7.0 1.2 1.8 4.4 8.7 4.6 6.1 3.2 0.9 1.1 3.5 4.6 2.3 3.4 3.1 1.7 2.1 1.8 0.8 8.1 0.7 2.0 5.7 1.3 0.9 3.5 2.5 2.8 4.2 1.8 2.3 4.1 1.6 0.8 0.3 0.8 8.3 2.3 1.1 4.4 6.8 1.1 1.7 5.7 1.3 3.4 1.1 1.0 7.3 4.7 2.8 1.6 0.5 3.1 3.6 7.8 0.7 2.7 8.1 8.4 2.2 8.9 6.6 5.4 4.3 7.3 6.5 4.5 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: " "unprognostic (4.84e-2)" "prognostic favourable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favourable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 9.1 9.5 7.5 5.3 12.7 7.4 7.3 12.7 15.4 7.7 10.4 8.1 6.1 15.8 6.9 7.6 9.9 5.0 8.8 10.8 7.5 6.5 17.7 42.3 6.2 6.3 6.9 8.4 5.8 18.1 9.1 10.8 5.9 9.8 6.3 9.5 9.3 8.6 6.9 18.0 12.1 18.2 7.8 6.7 6.3 9.1 24.1 5.2 17.7 7.4 8.2 8.6 7.9 7.3 4.8 6.0 21.8 6.9 3.4 7.0 4.2 3.1 7.5 7.5 9.7 10.8 15.3 3.2 3.3 9.2 5.7 6.7 5.8 6.7 6.3 6.1 7.8 6.9 5.4 10.5 8.3 3.9 8.0 4.2 3.5 5.9 9.6 4.1 6.9 9.0 14.5 5.3 10.7 17.8 3.7 6.3 11.7 6.0 11.3 7.0 3.1 2.7 6.9 6.4 5.7 12.0 9.9 3.4 4.4 7.8 4.2 12.1 6.6 7.8 6.4 5.6 3.9 4.2 6.4 12.9 17.7 3.9 7.1 4.1 10.4 15.6 6.9 21.8 5.5 5.5 4.3 4.8 5.2 5.7 6.0 4.1 4.8 4.1 3.6 3.4 5.3 5.0 7.0 4.2 7.5 12.7 12.7 15.4 7.5 6.5 6.9 8.4 9.8 5.2 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303608 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA051941: " "unprognostic (1.57e-2)" "prognostic unfavourable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 24.2 27.6 19.7 14.6 20.3 14.1 23.3 26.0 31.9 29.9 23.6 25.7 32.6 18.4 35.0 25.1 29.1 36.2 25.2 25.7 19.5 17.3 21.8 27.6 21.5 16.4 17.5 20.2 38.3 30.6 37.4 29.4 45.2 17.7 28.8 16.6 25.4 27.0 36.7 32.2 26.3 25.1 29.4 15.3 19.1 22.6 26.1 17.9 30.4 31.7 21.8 24.1 29.5 25.1 14.8 29.1 16.4 20.1 19.4 16.9 17.0 14.4 10.6 18.4 19.9 24.9 31.2 17.3 15.1 28.0 22.0 14.8 8.9 4.8 9.2 20.1 35.7 11.3 17.9 21.3 11.2 11.1 19.4 15.0 12.3 13.0 35.0 9.2 8.0 38.2 28.8 20.5 24.8 28.0 14.8 9.5 24.0 9.2 12.2 12.3 27.5 10.4 10.2 9.5 14.9 24.6 17.8 17.1 19.5 20.3 20.3 24.2 11.9 28.1 18.4 19.3 8.8 16.0 14.3 15.7 7.3 4.0 18.1 7.1 13.3 16.4 20.1 9.2 14.3 19.0 15.1 12.7 15.4 15.9 29.1 14.8 16.9 13.0 2.0 19.4 12.7 16.6 14.9 17.0 19.7 20.3 26.0 31.9 19.5 17.3 17.5 20.2 17.7 17.9 LRRC45 MGC20806 ENSG00000169683 "Leucine rich repeat containing 45" Q96CN5 17 82023302-82031151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023372, HPA023382, HPA024768" Enhanced Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" "Centrosome, Cytosol" "Nucleoplasm, Plasma membrane" "HPA023372: AB_1853317, HPA023382: AB_1853318, HPA024768: AB_10602348" "unprognostic (6.69e-2)" "unprognostic (6.10e-2)" "unprognostic (6.86e-2)" "unprognostic (1.38e-2)" "unprognostic (6.92e-2)" "unprognostic (4.41e-3)" "unprognostic (4.70e-3)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (1.78e-3)" "unprognostic (6.17e-3)" "unprognostic (7.46e-2)" "prognostic unfavourable (1.54e-4)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (4.79e-2)" "unprognostic (3.58e-1)" 5.1 4.9 7.1 7.0 9.3 12.0 4.5 20.3 10.8 4.6 7.0 5.7 9.5 11.1 4.4 5.0 8.0 10.5 5.8 3.1 7.7 3.9 5.9 12.9 5.6 6.5 8.3 4.7 3.7 15.5 4.5 4.8 4.9 6.5 6.6 3.6 4.9 13.6 5.0 4.3 10.2 9.4 5.2 3.3 7.6 10.4 3.1 9.9 7.1 9.8 6.8 6.5 5.0 5.1 2.3 3.3 5.0 3.2 2.8 4.6 3.1 9.7 11.1 3.4 6.9 1.4 1.9 13.2 6.8 2.8 4.1 3.5 9.9 6.7 7.3 6.2 1.3 11.4 3.2 4.1 0.9 4.4 20.9 4.6 20.2 13.3 1.1 5.4 11.6 1.8 1.7 2.4 0.6 6.0 3.2 3.2 1.0 16.5 12.1 18.1 3.5 14.9 10.0 6.6 4.0 2.6 9.0 10.5 10.2 3.1 16.3 5.7 13.3 6.3 3.5 7.2 9.1 11.4 11.5 6.3 1.6 1.1 3.9 4.7 7.5 5.0 3.2 3.6 3.9 2.4 4.0 1.5 4.5 4.6 2.2 2.3 2.4 3.1 0.2 2.8 1.0 3.3 3.8 3.1 7.1 9.3 20.3 10.8 7.7 3.9 8.3 4.7 6.5 9.9 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA057574: " "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (6.18e-4)" "unprognostic (1.06e-1)" 15.8 30.1 12.7 10.7 14.3 10.0 15.4 13.9 14.8 15.4 13.3 16.3 11.3 9.6 14.5 11.3 14.6 11.0 9.7 9.6 12.9 9.6 19.2 14.1 10.9 12.7 15.9 10.5 19.7 13.1 21.0 9.8 12.1 14.4 15.1 9.9 13.2 11.6 12.1 9.2 13.8 12.2 15.5 22.9 14.6 10.0 7.9 15.5 27.9 18.3 9.0 11.0 17.2 16.1 5.7 6.4 3.5 5.8 3.7 8.4 3.4 24.5 8.7 6.0 7.6 13.8 13.2 9.5 8.8 7.7 9.4 11.9 8.1 7.6 16.1 11.1 9.4 10.8 10.9 8.7 18.1 6.2 6.8 17.2 11.9 9.4 9.3 27.8 8.9 9.7 11.2 11.5 14.8 5.5 9.7 20.8 10.2 11.2 21.8 8.9 6.0 15.9 4.8 16.0 10.4 7.2 9.1 7.7 10.2 15.6 10.7 22.0 11.7 12.6 8.2 15.9 17.7 10.6 11.1 17.9 20.5 34.2 16.0 21.1 13.2 2.4 5.8 2.3 4.4 5.1 6.4 5.4 5.5 5.6 5.5 5.7 8.4 6.2 3.5 3.7 3.9 6.4 5.4 3.4 12.7 14.3 13.9 13.5 12.9 9.6 15.9 10.5 14.4 15.5 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150322639-150338150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 41.0" "Cell line enhanced" "Detected in many" "HDLM-2: 30.8;Hep G2: 20.5;NTERA-2: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavourable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favourable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 2.8 14.7 6.7 9.0 9.3 2.3 4.1 7.5 7.3 6.7 6.0 3.5 4.5 5.8 7.0 4.0 6.4 20.8 8.0 3.3 5.4 13.1 10.8 18.3 4.8 9.1 5.0 3.4 18.5 12.7 12.2 10.9 7.3 5.1 6.4 2.9 10.6 6.2 6.7 3.0 5.4 7.9 3.8 3.0 10.1 6.6 6.6 3.9 41.0 16.4 3.0 11.8 4.2 9.0 9.5 15.1 11.6 2.4 6.5 10.5 4.2 7.8 0.2 0.2 0.0 0.0 0.0 3.6 0.0 0.0 1.0 3.1 14.7 7.7 2.4 3.3 0.1 7.0 0.0 0.0 0.5 30.8 10.1 2.8 9.4 20.5 5.7 0.0 1.5 0.6 3.1 0.0 0.0 0.0 9.7 4.5 0.0 14.1 14.2 1.2 27.1 0.0 0.0 0.0 6.4 2.2 5.1 14.0 13.6 13.1 2.8 5.4 2.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 1.6 0.0 0.0 0.0 0.0 2.3 2.4 6.7 9.5 1.0 7.6 8.0 6.8 7.3 2.6 9.5 6.7 7.7 11.6 6.5 1.0 15.1 10.5 4.2 6.7 9.3 7.5 7.3 5.4 13.1 5.0 3.4 5.1 3.9 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Cell line enhanced" "Detected in some" "HEL: 11.8;HUVEC TERT2: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favourable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.1 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.7 2.2 1.1 0.3 0.0 0.8 0.1 0.4 0.3 0.2 0.1 0.4 0.9 11.8 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 3.8 0.5 0.2 0.0 1.9 1.9 0.8 0.2 0.1 0.6 0.7 0.1 0.5 0.2 2.3 0.6 0.0 0.2 2.8 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 LRRC75B "C22orf36, FAM211B, MGC131773" ENSG00000178026 "Leucine rich repeat containing 75B" Q2VPJ9 22 24585620-24593208 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 8.3;MCF7: 7.4;SH-SY5Y: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 2.7;NK-cell: 2.0" "Group enriched" "Detected in many" 5 "granulocytes: 2.7;NK-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002540 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002540: AB_1079263" "unprognostic (1.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.47e-1)" "unprognostic (2.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.21e-2)" "unprognostic (4.52e-2)" "unprognostic (2.48e-2)" "unprognostic (2.49e-1)" "unprognostic (2.48e-2)" "unprognostic (2.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (7.40e-2)" "unprognostic (9.69e-2)" 4.2 1.9 7.5 1.4 6.0 3.0 2.6 3.8 6.6 3.5 3.8 2.6 11.5 1.4 2.4 5.8 3.4 3.3 9.8 4.3 5.5 9.1 6.0 3.4 1.7 1.7 7.8 4.0 7.3 7.2 1.4 1.5 2.3 4.1 6.9 2.0 4.9 7.5 15.0 10.7 4.3 8.2 6.7 7.0 2.7 2.6 8.3 0.5 0.0 8.6 3.0 2.1 5.5 2.7 0.0 0.3 2.7 0.4 2.0 0.2 0.0 0.1 4.2 0.0 2.3 0.6 1.7 0.4 0.6 0.7 1.5 1.6 3.0 0.0 0.0 1.0 1.2 4.7 0.4 2.3 0.0 1.3 2.8 0.3 0.6 8.3 4.2 0.0 0.0 0.0 1.7 1.5 0.2 1.1 0.4 0.0 0.1 7.4 0.0 1.5 2.1 1.7 0.0 0.2 0.0 1.9 0.4 2.2 6.6 2.2 0.7 0.6 0.0 0.7 2.3 2.5 1.6 0.9 0.8 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.3 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 7.5 6.0 3.8 5.6 5.5 9.1 7.8 4.0 4.1 0.5 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014745 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA014745: AB_1853348" "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavourable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 4.4 26.3 15.7 11.0 24.0 9.6 9.7 8.8 21.3 9.7 13.1 46.2 4.3 14.1 7.7 8.1 6.7 5.9 6.0 5.5 24.5 16.9 19.8 17.6 7.1 17.0 34.7 20.3 4.6 9.6 6.8 16.2 7.5 24.5 4.3 14.0 7.5 17.8 4.6 7.8 5.0 13.6 8.6 38.5 16.8 8.3 7.5 31.6 11.8 12.1 4.3 14.8 8.9 3.4 5.8 7.8 3.0 8.8 10.5 14.3 8.4 24.3 15.9 6.5 15.4 11.7 9.9 22.1 16.7 25.3 9.5 12.0 6.8 6.2 19.3 19.1 27.7 32.1 14.9 20.0 12.1 15.0 8.3 22.6 14.4 14.4 22.9 25.7 7.1 6.2 16.7 8.1 17.7 16.1 12.3 6.1 10.3 7.3 10.6 16.7 11.3 14.6 14.5 9.5 13.8 24.0 8.7 12.2 8.5 20.8 21.6 46.2 5.1 25.6 7.1 10.2 3.5 20.8 12.6 7.5 12.7 11.6 3.9 32.6 9.0 0.0 7.1 1.2 6.2 8.8 10.3 5.8 14.3 7.4 6.8 5.3 13.8 10.2 3.0 10.5 6.6 7.8 13.8 8.4 15.7 24.0 8.8 21.3 24.5 16.9 34.7 20.3 24.5 31.6 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.4 1.9 0.3 0.8 2.1 0.8 1.3 1.2 0.9 1.7 1.8 0.2 2.8 2.8 2.5 0.2 0.3 4.3 4.0 2.1 6.8 0.1 2.5 0.6 1.3 0.3 4.4 1.4 1.4 2.2 2.9 1.1 0.8 2.1 3.9 2.7 0.0 1.7 0.7 2.2 1.3 2.1 1.6 2.8 2.5 0.3 2.1 1.4 0.3 0.3 6.0 1.7 2.5 0.3 0.3 1.4 1.0 2.3 4.0 1.4 2.2 3.0 0.5 2.2 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 40.4;lung: 50.4" "Cell line enhanced" "Detected in some" "A549: 9.7;ASC TERT1: 10.0;BJ hTERT+: 5.6;RPTEC TERT1: 10.7" "Group enriched" "Detected in many" 7 "lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 40.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 40.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favourable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 3.7 3.4 2.3 7.0 3.9 8.6 3.0 1.7 5.0 5.1 4.5 1.7 2.6 0.7 5.3 2.9 5.3 3.8 4.5 4.0 1.8 1.4 10.6 4.5 50.4 6.8 2.2 3.6 5.8 3.3 10.9 2.5 1.0 1.9 3.6 1.6 3.3 4.2 2.0 5.6 2.6 3.4 6.7 4.9 8.6 2.7 1.2 2.4 0.5 3.9 2.7 4.9 4.6 6.8 0.9 1.5 40.4 5.8 0.0 0.0 0.8 0.0 9.7 0.1 0.0 3.9 10.0 0.1 2.1 5.6 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.4 0.0 0.7 0.3 0.2 0.0 0.7 0.5 0.1 2.5 0.7 0.0 0.2 0.6 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.0 10.7 0.0 0.1 0.6 0.0 0.2 2.7 2.8 2.2 1.4 1.1 1.1 1.2 0.7 0.0 0.0 0.0 2.3 0.0 0.5 0.0 5.8 1.2 0.0 3.1 0.0 0.9 0.0 0.0 1.5 0.9 0.0 0.0 40.4 0.0 3.0 0.2 0.0 0.8 2.3 3.9 1.7 5.0 1.8 1.4 2.2 3.6 1.9 2.4 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell line enhanced" "Detected in some" "AF22: 14.6;BJ: 8.2;BJ hTERT+: 18.0;SH-SY5Y: 26.2;T-47d: 14.3" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA043820: , HPA046792: " "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.6 1.7 6.8 2.9 0.0 8.2 18.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 7.1 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.2 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686402-62689899 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 5.6;ASC TERT1: 18.7;HHSteC: 14.6;HSkMC: 7.9;LHCN-M2: 9.5" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 15.7 4.8 0.2 5.0 0.6 0.6 11.6 0.6 0.9 27.2 12.1 0.1 3.5 2.1 27.0 14.0 19.1 11.4 6.7 9.3 0.3 0.2 0.8 0.2 3.1 1.8 0.3 0.6 24.9 2.1 0.4 1.2 4.4 2.2 10.8 2.5 17.8 3.2 6.7 17.0 6.8 4.3 15.1 1.9 0.3 5.7 8.5 0.0 0.0 3.5 10.4 2.4 18.2 11.2 0.9 0.6 3.3 0.8 0.8 0.6 0.1 0.0 0.0 0.2 0.2 5.6 18.7 0.2 2.0 2.9 0.2 1.0 0.2 0.1 0.1 0.2 3.2 0.3 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.1 14.6 0.2 0.1 7.9 0.1 0.4 0.0 0.0 0.2 0.1 9.5 0.0 0.2 0.4 0.4 0.1 0.1 1.3 0.3 0.0 0.1 0.6 0.2 0.2 0.2 0.6 0.1 0.2 0.2 1.7 0.1 2.0 0.1 0.2 0.1 0.2 1.1 0.2 0.0 0.9 0.8 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.1 0.9 0.5 0.6 3.3 0.8 0.4 0.6 0.2 0.1 0.2 0.6 0.6 0.9 0.3 0.2 0.3 0.6 2.2 0.0 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178358-14201119 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA044966: " "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 14.1 13.6 18.2 12.5 17.1 18.9 15.5 13.2 17.3 11.5 15.6 11.8 7.6 15.0 11.6 13.4 19.1 10.3 11.3 20.1 15.1 12.5 27.6 26.7 10.1 14.2 14.2 13.5 12.4 15.6 7.3 12.4 16.5 14.4 14.2 13.9 12.3 13.3 11.0 31.9 12.1 17.6 15.8 15.0 16.3 12.5 21.5 13.9 24.4 19.7 21.4 13.9 12.9 11.1 21.3 23.1 27.2 18.3 17.1 17.7 18.7 14.4 11.7 12.6 13.0 5.9 6.9 32.2 12.0 8.0 15.3 14.7 13.2 11.4 15.9 10.0 8.2 6.8 14.2 11.6 15.2 15.0 17.6 16.9 16.9 12.6 3.0 18.8 12.3 5.1 8.4 15.3 6.6 7.8 18.1 12.8 11.3 16.6 19.9 25.7 21.8 15.9 11.0 15.6 17.5 14.3 14.9 7.1 11.5 13.7 19.2 11.1 22.1 24.0 7.1 9.8 15.7 11.9 20.4 9.1 26.4 30.0 12.5 18.5 14.0 27.2 15.9 23.3 12.8 18.3 15.0 21.3 15.0 14.9 14.6 17.1 16.5 17.3 15.2 17.1 15.3 23.1 17.7 18.7 18.2 17.1 13.2 17.3 15.1 12.5 14.2 13.5 14.4 13.9 LSM8 YJR022W ENSG00000128534 "LSM8 homolog, U6 small nuclear RNA associated" O95777 7 118184032-118192824 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020116 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA020116: AB_1853385" "unprognostic (1.02e-2)" "unprognostic (6.58e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (9.85e-4)" "unprognostic (3.33e-2)" "unprognostic (7.34e-2)" "unprognostic (1.13e-3)" "unprognostic (1.87e-2)" "unprognostic (1.79e-2)" "unprognostic (9.90e-2)" "unprognostic (5.14e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (7.46e-6)" "unprognostic (4.82e-2)" "unprognostic (1.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.00e-3)" 27.5 20.8 16.8 30.8 19.7 39.7 27.1 33.1 25.9 18.5 20.1 12.8 18.8 20.6 23.0 25.4 26.2 19.3 16.2 25.1 19.1 10.1 20.2 19.9 23.1 34.1 19.8 17.2 22.9 27.0 13.2 28.3 16.8 20.1 22.3 22.8 13.6 24.5 21.2 21.4 21.9 26.2 23.6 28.3 33.8 22.3 21.0 20.2 30.0 24.6 23.2 38.2 22.1 21.6 29.8 40.6 22.0 28.2 18.2 35.3 16.2 14.4 9.7 22.1 16.8 8.1 13.1 9.0 15.7 13.7 10.9 14.2 7.8 15.2 30.0 32.9 8.2 10.3 13.2 10.2 11.5 15.5 14.2 20.0 20.2 15.6 17.9 26.0 23.2 11.7 12.4 13.4 12.4 11.1 20.8 29.9 13.5 6.6 45.8 65.5 20.0 14.7 14.5 13.1 20.8 11.4 9.7 13.1 16.8 14.0 35.7 30.2 7.4 29.2 9.1 17.5 9.9 20.5 19.6 25.6 18.2 34.7 12.8 31.9 22.2 22.0 21.0 19.1 29.0 28.2 28.1 29.8 32.2 35.3 22.4 26.5 31.2 31.7 7.0 18.2 26.6 40.6 31.4 16.2 16.8 19.7 33.1 25.9 19.1 10.1 19.8 17.2 20.1 20.2 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.3;pancreas: 98.6" "Cell line enhanced" "Detected in many" "A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007270 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 2100000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA007270: AB_1079253" "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favourable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 5.0 11.2 2.9 20.9 4.0 0.9 12.4 2.0 4.5 8.7 32.8 4.0 24.4 29.5 6.5 21.4 20.3 10.6 58.2 2.6 3.4 3.1 15.7 106.3 21.1 17.0 4.1 2.6 4.8 98.6 6.2 13.4 36.6 7.1 11.2 15.4 40.9 26.2 33.8 1.9 16.8 39.5 1.8 3.8 9.1 46.7 21.0 1.9 3.4 24.0 20.1 20.9 9.9 9.5 5.3 0.3 5.9 0.2 6.1 7.1 3.2 89.3 1.5 0.1 0.2 0.2 0.1 16.2 0.2 0.3 0.4 0.3 39.1 41.6 3.5 13.8 0.2 37.5 8.3 13.7 0.0 5.4 15.1 0.0 1.2 17.3 0.3 0.0 0.1 0.2 15.3 0.3 4.5 0.1 14.1 3.2 0.2 31.7 0.1 0.1 12.8 0.5 0.7 0.1 9.7 8.6 36.2 7.1 0.2 7.5 24.4 6.7 20.9 0.5 0.0 0.7 8.6 0.5 0.4 5.1 9.0 8.1 0.6 0.1 2.2 5.9 0.2 0.2 3.3 0.0 3.3 5.3 7.1 6.7 0.1 4.1 5.5 6.0 0.1 6.1 0.0 0.3 4.8 3.2 2.9 4.0 2.0 4.5 3.4 3.1 4.1 2.6 7.1 1.9 LTBP2 "C14orf141, LTBP3" ENSG00000119681 "Latent transforming growth factor beta binding protein 2" Q14767 14 74498170-74612378 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Disease mutation, Dwarfism, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 43.9;HUVEC TERT2: 23.9;LHCN-M2: 23.9;TIME: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "cerebellum: 5.9;olfactory region: 3.0" "Region enriched" "Detected in many" 5 "olfactory region: 31.6" HPA003415 Approved Approved Nucleoplasm "Secreted to extracellular matrix" 13000000 Nucleoplasm "HPA003415: AB_1079284" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (5.10e-2)" "unprognostic (3.92e-3)" "unprognostic (2.08e-3)" "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (4.43e-2)" "unprognostic (1.08e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-2)" "unprognostic (3.77e-1)" "unprognostic (1.98e-3)" "unprognostic (2.22e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "prognostic unfavourable (3.94e-4)" 25.0 1.7 0.8 8.0 1.3 0.0 21.5 1.0 1.0 50.3 5.0 1.2 4.8 1.2 18.0 11.8 16.2 6.2 20.1 20.3 0.8 0.8 2.4 1.4 29.5 4.8 1.6 1.9 32.1 3.9 0.4 4.2 19.0 3.1 15.7 0.9 51.8 13.6 9.7 20.5 6.0 3.2 8.6 2.6 2.5 4.3 12.2 0.4 2.2 44.8 14.4 6.0 14.7 11.6 0.4 1.7 0.3 0.2 0.0 1.2 0.2 0.5 0.8 0.2 0.0 7.0 13.0 0.0 8.8 3.0 1.7 1.1 0.0 3.2 0.0 2.7 43.9 0.9 0.0 3.2 0.7 0.0 0.1 0.1 0.3 0.3 1.7 0.0 0.1 13.4 1.4 9.4 5.5 23.9 0.0 0.0 23.9 0.1 0.0 0.0 0.0 0.8 0.1 0.2 0.0 2.1 1.2 0.2 0.6 6.3 0.0 0.2 0.2 0.0 105.6 0.6 10.6 3.3 3.2 0.1 0.1 0.0 2.4 0.0 0.3 0.1 0.1 0.1 1.2 0.1 1.0 0.2 0.6 0.2 0.2 0.4 0.7 0.6 0.3 0.0 0.2 1.7 0.0 0.2 0.8 1.3 1.0 1.0 0.8 0.8 1.6 1.9 3.1 0.4 LTBP3 LTBP2 ENSG00000168056 "Latent transforming growth factor beta binding protein 3" Q9NS15 11 65538805-65558930 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding" "Amelogenesis imperfecta, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 28.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073170 Approved Nucleoplasm "Secreted to blood" 760000 Nucleoplasm "HPA073170: " "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (8.50e-3)" "unprognostic (4.01e-2)" "unprognostic (1.04e-1)" "unprognostic (1.59e-1)" "unprognostic (2.24e-2)" "unprognostic (9.22e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.04e-2)" "unprognostic (4.52e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" 35.3 31.6 25.2 14.9 21.5 7.3 33.4 24.3 27.2 41.8 29.4 28.7 37.5 12.2 43.5 42.7 17.1 36.0 45.0 38.7 24.6 12.7 22.9 25.7 36.7 16.1 22.1 22.7 55.1 35.7 48.1 37.1 18.2 23.4 40.2 6.8 36.1 34.4 43.5 33.9 13.9 16.9 30.3 34.4 24.4 19.8 16.8 23.7 12.5 40.6 17.2 11.8 30.7 29.6 28.6 8.0 1.3 5.4 4.6 6.7 3.6 4.6 18.9 2.5 12.6 18.3 29.5 2.5 18.6 12.7 2.4 1.6 7.2 24.8 0.5 16.0 18.4 20.8 3.4 3.5 1.1 2.6 7.7 4.5 6.8 7.3 12.2 0.6 3.9 33.2 1.4 3.6 0.4 9.3 1.4 3.7 1.7 11.0 3.0 1.6 2.2 23.7 8.4 0.3 8.9 2.0 1.5 0.8 12.4 5.0 7.3 9.5 13.4 1.6 30.7 7.4 9.9 12.5 4.9 4.1 7.3 0.3 47.0 0.7 15.2 0.0 3.3 1.2 4.3 4.9 6.7 28.6 6.1 5.0 4.0 22.7 5.2 5.4 1.3 4.6 5.4 8.0 6.2 3.6 25.2 21.5 24.3 22.9 24.6 12.7 22.1 22.7 23.4 23.7 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 50.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.1 0.0 0.2 0.2 0.3 50.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA056424: , HPA069321: " "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favourable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavourable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 23.8 24.5 30.4 26.5 30.9 25.3 24.0 42.6 30.0 21.9 20.1 29.9 25.8 21.3 29.4 37.7 15.5 19.2 24.5 12.7 34.1 26.5 26.9 19.9 18.8 31.0 33.1 24.3 29.3 24.2 31.2 40.3 23.1 25.4 35.2 18.2 24.3 25.1 25.2 20.3 28.8 23.9 24.4 29.2 32.1 22.6 29.8 33.1 23.2 40.2 15.9 21.0 16.6 26.3 6.5 11.1 3.5 11.7 3.9 6.9 5.6 5.3 23.9 25.4 9.5 9.8 7.6 11.2 9.9 7.6 16.2 11.7 24.9 6.3 9.7 13.0 5.6 6.8 30.2 9.0 16.3 17.4 20.7 11.9 16.3 29.1 11.0 13.7 13.3 6.7 10.5 13.1 5.2 12.4 14.0 6.3 13.0 25.7 22.5 23.9 37.8 11.6 19.4 11.1 10.2 23.1 5.7 15.1 17.0 10.7 7.4 9.3 9.7 7.4 10.1 11.8 17.7 4.9 11.9 6.9 9.1 10.3 3.6 9.8 10.5 0.3 9.1 3.5 6.7 10.4 5.2 6.5 6.3 6.5 9.8 3.0 3.7 2.8 1.2 3.9 11.7 11.1 6.9 5.6 30.4 30.9 42.6 30.0 34.1 26.5 33.1 24.3 25.4 33.1 LUC7L2 "CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2" ENSG00000146963 "LUC7 like 2, pre-mRNA splicing factor" Q9Y383 7 139340359-139423457 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051631 Approved Approved Nucleoplasm Nucleoplasm "HPA051631: " "unprognostic (1.07e-3)" "unprognostic (2.71e-2)" "unprognostic (8.26e-3)" "unprognostic (2.91e-1)" "unprognostic (2.84e-1)" "unprognostic (1.00e-2)" "unprognostic (4.54e-3)" "unprognostic (2.05e-2)" "unprognostic (1.12e-2)" "unprognostic (1.48e-3)" "unprognostic (3.54e-1)" "unprognostic (2.20e-2)" "prognostic unfavourable (4.92e-4)" "unprognostic (1.23e-2)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (4.28e-3)" 27.2 24.7 32.2 34.7 35.0 59.3 41.3 35.6 33.9 35.1 34.7 41.6 28.0 22.6 35.7 36.8 33.1 32.7 29.3 35.0 33.3 30.4 29.7 33.3 26.6 39.0 33.2 30.5 41.3 34.7 47.7 29.0 31.6 33.8 39.8 31.4 27.3 29.5 40.1 58.4 41.8 27.5 35.2 37.3 32.0 29.0 37.0 32.4 66.3 53.3 23.6 44.8 34.0 33.7 14.3 11.3 15.0 13.7 13.5 20.8 10.6 18.6 10.8 22.4 21.0 15.6 12.9 17.3 21.4 20.4 20.4 21.6 12.0 17.7 30.8 13.1 16.8 13.5 27.3 21.2 29.2 14.5 27.0 26.4 16.3 11.8 13.2 42.1 22.2 11.1 27.2 19.3 23.8 16.4 33.5 16.4 22.2 17.4 50.1 38.4 18.4 15.5 30.5 22.9 27.8 23.4 20.7 19.9 19.4 23.5 23.7 20.6 16.6 16.6 16.1 16.2 9.7 18.1 19.7 25.7 23.9 67.4 17.7 40.7 21.6 8.0 8.1 15.0 16.7 12.5 18.7 14.3 16.3 17.5 11.1 13.1 20.8 17.4 8.2 13.5 13.7 11.3 16.3 10.6 32.2 35.0 35.6 33.9 33.3 30.4 33.2 30.5 33.8 32.4 LURAP1L "bA3L8.2, C9orf150, FLJ38505, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775021-12822131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 48.7" "Cell line enhanced" "Detected in many" "HHSteC: 44.4;hTERT-HME1: 35.5;T-47d: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 10.6 7.2 2.9 7.9 9.2 0.1 13.0 23.4 5.5 11.5 13.7 7.1 2.9 4.0 5.0 7.9 8.5 4.1 14.7 3.5 3.5 3.3 4.1 48.7 17.8 5.3 7.7 4.0 4.5 19.9 0.2 7.3 21.0 5.9 8.0 9.6 4.7 21.6 7.3 2.4 8.8 6.6 13.2 8.1 11.0 9.9 3.7 7.9 0.9 8.6 2.8 5.3 10.3 9.4 0.0 0.1 1.2 0.0 0.0 0.0 1.6 0.9 3.1 0.0 1.0 4.8 6.7 0.0 1.6 8.9 2.2 2.4 0.0 1.1 0.0 0.6 8.5 1.3 0.0 0.1 1.6 0.0 0.3 0.4 2.9 1.6 44.4 0.0 0.0 2.6 4.2 7.9 35.5 1.4 0.0 11.6 1.2 0.7 0.0 0.0 0.0 3.4 0.0 0.6 0.0 8.7 0.5 6.8 0.6 1.9 1.2 1.5 51.0 0.1 0.5 1.9 0.3 4.9 1.2 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 9.2 23.4 5.5 3.5 3.3 7.7 4.0 5.9 7.9 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "HaCaT: 14.3;HAP1: 7.1" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: , HPA046161: " "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 14.3 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672693 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 31.8;HUVEC TERT2: 69.1;MCF7: 37.6;RT4: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Approved Approved Nucleoplasm,Cytosol 4200000 "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 32.3 31.5 2.8 13.6 3.3 9.4 35.8 11.7 3.5 11.8 20.9 1.2 12.7 12.4 9.8 17.7 14.0 15.2 17.2 24.4 5.7 3.6 13.6 4.0 16.9 17.8 3.0 2.1 37.1 15.0 7.9 20.6 15.5 4.4 34.0 18.6 11.1 29.3 11.3 7.8 4.8 24.1 22.8 2.6 10.0 7.0 8.5 1.3 12.4 15.8 6.6 7.3 29.3 31.5 5.9 4.5 22.2 3.6 5.2 17.0 4.2 0.0 9.4 0.7 0.1 4.1 14.2 0.8 7.2 18.7 1.8 3.6 0.0 21.3 0.0 6.7 2.0 3.3 1.9 2.9 2.7 0.0 9.3 4.4 8.2 0.1 4.7 1.1 0.1 31.8 0.5 3.4 0.5 69.1 0.0 0.2 0.0 37.6 0.4 0.0 0.8 2.4 1.2 0.0 9.0 6.4 26.1 1.2 0.0 0.0 10.0 2.4 0.0 0.0 9.9 0.1 0.0 10.0 0.0 0.1 0.0 0.0 3.5 0.3 0.1 13.8 3.6 5.0 3.7 3.4 3.6 5.9 7.6 5.9 4.3 4.1 8.5 4.7 22.2 5.2 2.1 4.5 17.0 4.2 2.8 3.3 11.7 3.5 5.7 3.6 3.0 2.1 4.4 1.3 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favourable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.0 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.1 1.8 0.0 0.2 1.0 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Cell line enriched" "Detected in single" 111 "HEL: 22.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA056234 Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA056234: " "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell line enhanced" "Detected in some" "A-431: 5.8;BEWO: 9.0;HaCaT: 9.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: " "unprognostic (4.27e-3)" "prognostic favourable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.8 0.0 0.3 0.0 0.1 0.0 9.0 0.4 0.0 0.8 1.0 0.6 2.0 0.3 1.1 0.7 9.3 0.0 1.0 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.8 2.6 0.4 1.1 0.3 0.1 0.3 0.0 0.3 0.2 0.1 0.6 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 LYPLA1 LPL1 ENSG00000120992 "Lysophospholipase I" O75608 8 54046367-54102017 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol 1700000 "Nucleoplasm, Cytosol" "HPA050941: , HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavourable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 14.1 17.7 7.2 12.2 8.9 13.4 16.4 10.8 15.2 10.7 14.6 6.9 4.7 15.4 8.0 11.1 30.4 8.0 11.9 27.1 6.8 6.8 31.1 37.3 13.6 23.4 7.3 4.9 12.3 24.3 9.0 7.4 51.1 12.0 15.3 15.2 17.0 23.3 7.1 26.4 22.1 17.6 10.4 6.3 14.0 14.9 64.8 4.1 21.3 13.3 19.3 19.7 24.6 17.3 29.1 37.1 42.7 40.4 27.1 29.2 35.1 30.3 17.2 22.4 20.1 8.1 13.3 28.3 18.2 10.5 16.8 15.9 12.4 29.5 53.3 21.3 11.8 20.4 31.5 30.3 23.6 19.3 17.2 37.1 11.0 19.9 13.4 22.7 50.3 11.6 26.7 13.1 29.5 43.6 37.6 16.2 23.4 8.0 34.5 17.3 33.3 7.9 20.9 11.8 24.4 26.0 41.2 11.8 20.1 12.8 23.9 27.9 34.9 20.3 20.9 10.2 14.9 17.6 16.8 22.6 34.0 48.1 13.8 24.1 19.9 31.4 33.1 42.7 19.1 31.1 19.0 29.1 18.2 18.4 37.1 23.9 18.4 17.8 19.5 27.1 40.4 23.8 29.2 35.1 7.2 8.9 10.8 15.2 6.8 6.8 7.3 4.9 12.0 4.1 LZIC MGC15436 ENSG00000162441 "Leucine zipper and CTNNBIP1 domain containing" Q8WZA0 1 9922113-9943407 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028184, HPA058614" Approved Approved Nucleoplasm,Cytosol 110000 Nucleoplasm Cytosol "HPA028184: AB_10602706, HPA058614: " "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (1.76e-2)" "unprognostic (1.62e-1)" "unprognostic (6.26e-2)" "unprognostic (8.37e-2)" "prognostic unfavourable (2.47e-5)" "unprognostic (2.89e-1)" "unprognostic (3.79e-3)" "unprognostic (7.84e-2)" "unprognostic (1.70e-3)" "unprognostic (1.23e-1)" "prognostic favourable (3.56e-5)" "unprognostic (1.19e-1)" "unprognostic (3.76e-3)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 13.6 14.2 21.4 12.8 18.0 11.4 17.7 13.6 21.6 18.2 19.2 24.5 15.1 19.5 18.3 13.5 17.6 16.9 14.1 21.0 19.8 16.5 20.0 20.4 11.5 13.6 24.3 10.3 25.5 15.3 26.1 15.9 14.9 20.5 15.8 19.4 13.0 16.6 14.6 21.7 13.9 23.7 21.3 28.2 11.0 12.2 44.3 20.1 20.2 17.2 13.2 15.6 14.9 23.1 13.9 28.1 28.3 22.7 16.8 21.0 12.9 15.8 10.5 20.3 14.3 12.6 21.0 9.0 14.4 12.3 20.4 19.8 13.1 27.9 19.3 16.5 18.2 12.1 19.1 21.0 30.8 17.8 13.0 28.1 13.7 21.5 12.2 25.6 14.5 13.7 30.1 28.6 27.1 16.0 34.7 11.0 18.8 11.2 21.0 12.5 10.2 17.2 22.5 26.9 15.4 11.0 7.2 10.1 16.0 17.7 7.8 34.0 12.9 13.2 14.6 14.2 19.5 20.2 15.1 9.0 20.6 33.1 14.6 38.3 18.9 22.0 18.8 28.3 16.0 20.7 14.0 13.9 16.3 15.5 18.1 13.8 16.3 16.9 18.9 16.8 22.7 28.1 21.0 12.9 21.4 18.0 13.6 21.6 19.8 16.5 24.3 10.3 20.5 20.1 LZTR1 "BTBD29, LZTR-1" ENSG00000099949 "Leucine zipper like transcription regulator 1" Q8N653 22 20982013-20999038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067852, HPA068772, HPA071248" Approved Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA067852: , HPA068772: , HPA071248: " "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (2.44e-2)" "prognostic unfavourable (5.15e-4)" "unprognostic (9.81e-2)" "unprognostic (3.55e-1)" "unprognostic (3.78e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.16e-3)" "unprognostic (4.29e-2)" "unprognostic (1.65e-1)" "unprognostic (6.25e-2)" "unprognostic (1.25e-2)" 21.2 16.9 17.3 15.6 17.4 10.3 17.9 20.7 24.7 18.5 18.3 25.3 20.6 18.9 24.9 14.0 16.5 18.3 21.2 15.8 15.4 10.9 17.2 13.1 16.2 12.8 19.6 16.5 21.7 16.2 24.9 26.0 18.8 19.0 16.9 12.9 18.9 17.5 18.0 17.2 15.0 15.7 21.9 14.0 19.3 14.5 10.8 19.2 10.8 19.6 12.6 12.5 18.5 16.4 1.6 2.2 0.2 3.4 1.8 3.0 1.5 6.2 5.1 7.6 9.2 17.6 12.2 6.2 12.8 9.0 7.3 10.0 3.0 2.6 6.6 4.8 14.2 8.4 5.7 10.5 2.9 12.3 13.3 7.1 6.7 4.4 9.4 3.8 9.4 11.2 5.3 9.2 6.7 14.1 29.4 11.5 8.2 3.8 6.8 3.6 2.4 5.6 8.0 11.1 2.6 5.7 8.4 7.5 11.2 6.9 12.1 7.5 5.6 7.1 12.6 17.0 8.7 7.7 6.9 5.0 4.4 2.0 7.7 3.7 8.2 0.0 2.5 0.2 3.0 3.1 1.6 1.6 1.5 2.8 2.2 1.0 2.1 1.5 0.1 1.8 3.4 1.2 0.5 1.5 17.3 17.4 20.7 24.7 15.4 10.9 19.6 16.5 19.0 19.2 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35474182-35477209 "Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 24.0;skeletal muscle: 8.5" "Cell line enhanced" "Detected in some" "BJ: 13.5;BJ hTERT+: 11.0;BJ hTERT+ SV40 Large T+: 15.5;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;HBF TERT88: 16.9;SH-SY5Y: 50.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9" "Low region specificity" "Detected in all" "HPA049324, HPA059864" Approved Nucleoplasm Nucleoplasm "HPA049324: , HPA059864: " "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.9 6.4 0.3 0.5 0.0 0.0 6.3 24.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.8 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.5 3.7 0.2 8.5 1.2 1.1 0.0 0.8 0.0 0.3 0.0 0.6 0.2 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.5 11.0 15.5 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 16.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.3 50.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.9;skin 1: 8.7" "Cell line enhanced" "Detected in some" "EFO-21: 15.3;RT4: 14.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039551, HPA046187" Uncertain Approved Nucleoplasm Nucleoplasm "HPA039551: , HPA046187: AB_10964208" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.3 0.0 0.3 2.7 0.3 0.8 0.5 0.3 0.3 2.8 2.1 0.3 0.3 0.2 0.3 0.3 9.9 0.0 0.3 0.3 0.3 0.2 2.0 3.1 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 2.2 0.3 1.1 1.8 0.3 1.3 0.7 0.6 8.7 3.4 0.3 0.3 0.3 0.4 0.7 0.3 0.3 0.3 2.5 1.7 2.1 4.2 2.6 1.3 5.5 1.2 4.4 0.7 0.0 3.4 0.1 0.7 0.6 0.1 0.0 5.2 0.6 0.2 0.0 0.0 0.3 1.2 2.0 15.3 0.1 2.8 0.1 0.1 0.1 0.7 0.1 0.9 0.4 2.7 0.0 0.9 0.5 0.0 0.4 0.0 0.3 0.0 0.9 2.4 0.0 0.3 0.5 0.5 2.2 1.0 0.8 0.8 0.4 0.6 14.8 0.5 0.8 2.3 1.9 0.6 2.4 0.4 0.5 1.0 2.4 0.7 0.6 2.2 3.9 0.9 0.5 0.3 1.0 2.6 1.2 0.3 0.6 0.6 0.5 0.8 0.4 0.5 0.3 2.6 0.7 0.7 5.5 4.4 0.7 1.3 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055608-120067074 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavourable (5.15e-5)" "prognostic unfavourable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavourable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 1.4 1.8 2.4 4.2 5.7 10.3 2.4 4.4 4.1 1.9 4.4 1.2 0.3 3.8 1.7 1.4 6.5 2.9 1.1 1.7 2.7 2.7 1.2 1.2 1.5 7.6 2.3 3.6 1.7 1.2 0.7 1.0 3.5 2.4 1.6 5.5 0.7 2.4 1.2 1.2 2.3 4.2 1.8 2.8 3.8 1.9 13.7 1.2 27.3 1.2 8.2 7.3 2.1 2.4 1.8 2.2 2.0 0.8 2.5 3.9 1.7 14.4 6.4 15.0 9.7 1.6 2.0 6.4 11.5 6.5 12.1 9.3 8.5 8.9 21.3 3.8 4.2 3.9 14.9 8.8 16.9 10.1 10.4 11.8 6.2 8.0 0.5 19.2 6.8 1.1 1.3 8.2 5.1 6.9 14.1 12.3 6.3 6.4 18.4 8.4 10.2 7.2 9.5 20.1 8.8 4.9 5.6 15.9 11.3 5.7 7.1 3.5 4.7 7.1 4.3 8.1 9.2 8.2 14.5 11.5 12.2 14.0 7.5 10.0 10.6 2.0 0.5 0.4 1.6 0.5 2.1 1.8 3.8 3.0 0.4 1.4 3.5 3.5 1.3 2.5 0.8 2.2 3.9 1.7 2.4 5.7 4.4 4.1 2.7 2.7 2.3 3.6 2.4 1.2 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell line enhanced" "Detected in some" "HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavourable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.0 0.2 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 15.8 33.3 0.1 1.1 0.2 0.0 0.0 0.0 0.5 0.1 3.8 1.4 0.0 0.0 0.0 0.0 0.3 0.2 9.1 0.7 8.2 0.8 2.0 0.8 0.1 0.2 9.0 0.1 13.1 0.0 0.0 0.0 0.0 8.7 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 9.3" "Group enriched" "Detected in some" 7 "U-266/70: 28.9;U-266/84: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045401: , HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 14.2" "Group enriched" "Detected in some" 14 "RT4: 48.6;U-266/70: 21.1;U-266/84: 26.0" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045401: , HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 21.1 26.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 44 "testis: 9.0" "Cell line enriched" "Detected in some" 5 "U-266/70: 36.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA055743: , HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Cell line enhanced" "Detected in some" "K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 15.1 28.5 0.0 20.4 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGI1 "AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3" ENSG00000151276 "Membrane associated guanylate kinase, WW and PDZ domain containing 1" Q96QZ7 3 65353525-66038834 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031851, HPA031852, HPA031853, HPA077002" Supported Supported "Nucleoplasm,Cell Junctions" "Cell Junctions" Nucleoplasm "HPA031851: AB_10599289, HPA031852: , HPA031853: AB_10602095, HPA077002: " "unprognostic (5.00e-2)" "unprognostic (9.84e-2)" "unprognostic (6.00e-3)" "unprognostic (1.73e-3)" "unprognostic (1.64e-1)" "unprognostic (2.17e-2)" "unprognostic (1.46e-3)" "unprognostic (9.46e-3)" "unprognostic (8.59e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (2.05e-3)" "prognostic favourable (4.55e-8)" "unprognostic (3.51e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-2)" "unprognostic (8.03e-2)" 18.0 6.0 10.1 6.4 9.8 1.0 16.5 38.6 16.8 6.9 11.2 10.1 25.7 10.7 11.6 7.6 9.4 12.6 19.7 11.1 9.4 11.8 14.3 17.6 13.3 2.9 8.8 10.4 4.3 16.7 18.7 13.1 11.1 9.6 9.2 9.5 7.7 17.4 37.9 7.7 13.0 11.6 7.9 8.3 13.9 19.8 10.7 7.7 0.6 23.2 5.8 4.4 6.9 13.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.8 1.5 8.7 0.9 1.7 1.3 3.9 4.8 4.1 1.8 2.8 10.3 2.4 0.0 0.7 5.7 0.8 2.4 1.6 2.9 0.0 1.3 24.5 3.0 6.9 1.1 0.0 0.8 1.9 1.4 6.3 1.3 4.2 10.3 0.0 1.9 2.1 0.0 0.0 11.6 1.5 0.0 2.4 0.6 2.2 9.3 2.8 7.6 1.9 2.3 0.0 4.5 0.0 1.1 5.9 4.3 1.5 1.9 0.0 0.0 0.0 3.4 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 9.8 38.6 15.5 9.4 11.8 8.8 10.4 9.6 7.7 MAGIX "FLJ21687, JM10, PDZX" ENSG00000269313 "MAGI family member, X-linked" X 49162564-49168483 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.6;RT4: 15.2;SK-BR-3: 6.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 7.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA007390, HPA035302" Uncertain Approved Nucleoplasm Nucleoplasm "HPA007390: , HPA035302: AB_10603015" "unprognostic (1.11e-1)" "unprognostic (1.34e-2)" "unprognostic (6.24e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-3)" "unprognostic (2.64e-6)" "unprognostic (6.75e-2)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-1)" "unprognostic (2.33e-2)" "prognostic favourable (6.91e-9)" "unprognostic (4.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.73e-1)" "prognostic favourable (2.10e-4)" 0.5 0.3 0.0 0.9 1.2 0.5 0.0 3.9 1.2 1.6 1.2 0.5 8.0 1.0 1.5 4.0 0.7 1.8 6.2 2.6 1.8 5.0 4.2 1.1 0.0 0.0 0.0 0.5 5.9 3.1 0.0 0.4 1.0 2.0 0.4 1.1 9.0 5.7 1.2 0.8 0.6 0.0 0.8 0.3 4.5 0.0 0.0 0.3 0.7 0.8 0.7 0.8 0.0 1.2 2.6 7.9 2.0 1.2 1.1 1.1 0.3 2.3 0.5 0.6 0.7 0.2 1.7 0.3 0.4 0.4 0.3 1.3 6.6 0.6 0.6 0.7 1.4 0.4 1.5 0.0 1.9 2.1 2.8 3.7 0.8 0.3 0.6 5.7 0.7 0.2 0.5 0.1 0.5 0.4 2.4 0.5 0.8 0.6 1.9 0.6 1.2 0.3 0.1 1.2 1.2 15.2 2.9 0.6 1.3 6.9 0.6 5.4 0.6 0.3 0.8 1.7 0.7 0.5 1.6 0.8 0.5 2.8 0.9 2.1 4.3 2.0 3.3 0.2 1.8 0.8 1.1 0.9 0.1 1.3 1.2 0.6 1.1 7.9 1.2 1.8 2.6 0.1 1.1 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell line enhanced" "Detected in many" "BEWO: 18.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB026377: , HPA059977: " "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favourable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.5 2.5 1.4 2.8 0.6 0.1 18.5 2.7 0.3 0.3 0.6 2.0 1.6 1.3 0.6 0.7 2.2 0.3 1.3 0.0 2.0 0.9 0.8 5.2 2.2 1.2 0.1 4.8 0.8 1.7 1.4 0.6 0.6 2.6 1.2 0.2 4.1 0.9 3.6 1.4 0.7 1.6 0.4 2.4 0.9 1.3 1.6 2.0 0.5 1.2 1.1 4.3 0.8 0.8 7.5 4.7 1.5 0.4 3.1 1.6 0.4 1.7 1.9 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 MANBAL dJ1141E15.2 ENSG00000101363 "Mannosidase beta like" Q9NQG1 20 37289638-37317260 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052348 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA052348: " "unprognostic (1.86e-2)" "unprognostic (9.15e-2)" "unprognostic (1.85e-1)" "unprognostic (2.45e-2)" "unprognostic (3.12e-1)" "unprognostic (2.21e-3)" "prognostic unfavourable (7.07e-4)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (9.61e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "prognostic favourable (3.62e-4)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (8.03e-2)" "unprognostic (2.70e-2)" 17.3 25.2 19.6 10.7 27.6 2.9 29.8 11.4 32.7 22.5 22.1 15.9 21.9 17.0 26.7 29.7 22.1 28.9 23.3 13.9 20.8 20.1 19.0 14.5 15.1 19.3 18.9 23.2 28.5 21.4 15.1 16.9 16.1 22.1 24.0 20.3 27.5 16.6 32.9 7.1 19.8 15.6 33.5 13.4 11.1 18.7 17.6 11.2 9.8 23.2 13.7 13.7 20.5 28.3 18.0 21.7 25.4 19.3 14.5 17.3 11.1 16.9 33.5 17.0 17.1 28.0 20.4 14.8 23.8 24.9 23.1 18.2 39.4 23.3 4.4 28.6 28.9 23.5 16.1 37.2 15.9 3.3 16.7 4.6 14.1 34.9 30.3 4.9 2.9 22.2 26.5 21.5 35.6 16.1 7.4 4.9 23.0 20.0 6.1 6.5 13.5 31.4 3.7 22.4 5.1 21.9 23.8 16.4 18.7 24.2 36.4 19.6 24.5 7.9 17.6 42.6 16.0 23.9 18.3 6.5 8.8 3.6 30.6 2.7 22.0 9.2 17.0 23.7 11.8 19.3 13.6 18.0 14.2 14.0 15.5 17.8 17.3 16.6 25.4 14.5 15.1 21.7 9.3 11.1 19.6 27.6 11.4 32.7 20.8 20.1 18.9 23.2 22.1 11.2 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042824: , HPA052474: , HPA052484: , HPA053767: " "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.6 0.0 0.7 2.9 0.4 1.4 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.1 3.7 0.7 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.1 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.5 1.6 4.7 0.7 0.9 1.4 2.9 1.6 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.3 1.2 1.1 11.1 1.5 0.2 0.9 4.0 1.1 3.5 2.6 3.8 2.9 4.6 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 MAP2K4 "JNKK1, MEK4, MKK4, PRKMK4, SERK1" ENSG00000065559 "Mitogen-activated protein kinase kinase 4" P45985 17 12020824-12143830 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007751, HPA060074" Enhanced Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "CAB007751: , HPA060074: " "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (4.47e-2)" "unprognostic (1.02e-2)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (2.89e-1)" "unprognostic (2.16e-1)" "unprognostic (1.93e-3)" "unprognostic (2.53e-1)" "unprognostic (2.76e-3)" "unprognostic (4.82e-2)" "unprognostic (5.32e-3)" "unprognostic (3.13e-1)" "unprognostic (2.30e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" 10.7 13.2 23.7 9.4 21.0 3.1 14.4 25.0 42.7 12.5 11.5 7.9 8.5 9.6 12.1 17.8 18.5 11.5 10.7 14.9 31.7 29.3 15.8 20.6 11.4 14.6 24.5 27.1 13.0 11.1 19.6 16.7 15.1 23.4 14.5 13.1 6.5 9.8 13.2 20.6 14.4 9.9 13.5 16.3 10.7 10.7 10.3 9.8 10.3 16.5 11.6 13.4 11.1 11.2 2.8 1.8 13.2 4.3 3.5 3.3 2.3 17.9 15.5 20.4 10.5 11.3 14.7 13.0 12.3 16.2 14.0 13.4 9.2 6.2 7.5 10.0 19.1 12.1 17.7 17.1 21.1 13.2 20.8 8.3 9.1 17.3 13.3 7.9 12.6 12.1 17.0 16.4 17.2 12.7 8.8 4.4 17.6 6.7 9.6 7.4 11.9 7.6 11.8 22.9 5.1 19.2 11.6 4.1 12.1 14.2 7.6 11.8 9.6 5.8 11.6 6.9 10.7 9.5 14.5 8.7 9.7 5.9 13.0 6.3 10.0 0.6 2.7 2.0 3.0 1.5 2.7 2.8 2.4 2.4 1.8 2.7 2.0 3.3 13.2 3.5 4.3 1.8 2.6 2.3 23.7 21.0 25.0 42.7 31.7 29.3 24.5 27.1 23.4 9.8 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favourable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favourable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.2 7.5 2.3 5.5 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.7 4.6 1.5 2.0 0.9 2.2 0.3 10.9 7.1 1.5 3.2 1.7 4.2 1.2 3.7 1.2 5.4 2.2 1.5 1.9 5.4 9.8 0.6 3.7 4.7 2.3 2.8 4.9 5.9 2.5 3.4 1.8 4.0 7.8 11.3 5.1 1.8 10.3 2.5 2.3 3.1 5.3 5.1 7.8 8.4 13.0 7.5 2.5 6.2 2.4 7.7 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell line enhanced" "Detected in many" "ASC diff: 28.4;HHSteC: 27.1;HSkMC: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA039936: AB_10795239, HPA071996: " "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favourable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavourable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.5 4.7 7.3 28.4 15.2 0.6 5.1 9.6 5.6 5.6 0.1 0.9 1.7 2.9 5.4 0.0 2.1 3.4 2.2 2.5 2.6 1.8 3.8 0.0 27.1 0.0 1.9 27.0 2.4 7.6 4.0 8.7 0.0 8.1 5.3 3.3 1.8 0.4 1.6 2.8 2.6 3.2 0.4 2.8 0.0 4.7 6.4 2.7 3.5 7.2 2.4 4.7 6.4 5.4 5.8 2.4 1.3 3.3 3.7 0.0 8.7 3.3 5.2 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489097 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favourable (1.11e-4)" "prognostic unfavourable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 9.8 24.8 21.7 8.7 22.2 9.5 15.1 16.4 26.1 12.9 16.9 18.4 10.5 16.8 12.9 42.1 15.2 14.6 13.1 8.1 19.2 18.6 21.9 20.7 15.2 7.4 23.2 17.1 16.5 24.9 20.9 24.5 9.1 21.8 14.5 18.9 18.6 26.2 11.4 3.3 9.8 23.4 12.1 26.4 8.7 16.4 12.9 15.8 4.4 18.6 8.3 10.3 12.5 11.5 23.7 21.5 21.1 13.2 11.5 17.4 7.8 29.1 5.8 11.3 0.3 10.3 12.7 6.6 6.7 4.6 10.9 13.2 11.2 11.0 0.2 23.0 12.2 16.7 0.3 15.5 19.4 32.4 15.0 0.1 7.9 9.2 11.2 15.3 8.4 11.5 13.6 9.3 11.7 12.1 0.3 23.7 9.7 9.1 1.8 7.2 13.0 13.7 0.2 13.5 16.0 19.2 7.6 18.6 12.4 11.3 17.1 23.2 25.8 8.6 8.0 9.0 11.7 16.2 14.5 12.1 15.6 9.6 13.2 7.8 14.7 6.4 13.2 5.1 10.3 12.2 15.8 23.7 12.4 12.8 21.5 19.0 17.4 16.8 21.1 11.5 8.6 9.4 4.8 7.8 21.7 22.2 16.4 26.1 19.2 18.6 23.2 17.1 21.8 15.8 MAP3K3 "MAPKKK3, MEKK3" ENSG00000198909 "Mitogen-activated protein kinase kinase kinase 3" Q99759 17 63622415-63696303 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007764, HPA035410, HPA035411" Uncertain Approved Nucleoplasm Nucleoplasm "CAB007764: AB_562314, HPA035410: , HPA035411: " "unprognostic (9.65e-3)" "unprognostic (1.33e-1)" "unprognostic (5.14e-2)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (4.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.33e-1)" "unprognostic (1.36e-1)" "unprognostic (9.37e-2)" "unprognostic (1.46e-3)" "unprognostic (5.51e-2)" "unprognostic (2.35e-1)" "unprognostic (2.79e-2)" "unprognostic (4.68e-2)" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" 23.9 11.8 10.5 20.5 15.0 24.8 19.1 26.8 14.9 22.2 21.8 15.0 14.0 8.0 24.5 13.2 16.6 18.3 20.6 37.4 11.3 8.4 17.1 12.4 23.1 21.4 14.4 9.6 21.6 11.4 16.9 12.3 21.0 11.9 18.4 8.3 21.7 12.8 18.5 19.6 15.4 14.7 20.4 13.2 30.4 16.4 26.5 12.3 12.9 15.5 12.8 15.4 19.0 26.8 1.9 3.5 18.3 8.5 1.1 2.6 2.3 10.1 7.6 9.7 9.4 18.6 15.0 4.4 10.0 11.0 12.5 10.1 3.5 2.1 10.9 7.1 19.6 3.8 6.3 7.1 7.9 9.5 13.9 8.9 10.3 4.9 9.7 6.8 9.5 10.7 4.9 15.5 8.2 30.3 5.4 14.5 9.9 7.1 12.2 7.1 6.0 8.1 6.5 24.8 7.1 4.5 4.6 5.0 11.9 6.8 8.2 8.3 8.2 6.8 27.2 32.0 8.5 17.3 12.1 14.4 14.6 4.0 6.9 5.5 8.3 8.8 8.5 10.4 2.2 8.3 2.3 1.5 2.6 2.1 3.5 1.9 2.5 2.5 18.3 1.1 8.2 1.3 1.9 2.3 10.5 15.0 26.8 14.9 11.3 8.4 14.4 9.6 11.9 12.3 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27355184-27366892 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: " "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.13e-4)" "prognostic favourable (7.26e-4)" "prognostic unfavourable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 37.5 6.3 7.4 6.9 8.6 1.3 22.1 12.6 8.3 19.9 9.0 2.7 8.9 3.3 13.1 10.3 25.7 12.8 12.4 14.9 6.2 2.6 13.6 5.0 21.7 5.5 11.4 1.9 11.7 8.3 8.2 15.8 7.3 9.8 13.9 5.9 15.7 11.5 9.7 6.3 63.9 6.2 16.0 11.7 8.7 9.0 6.7 7.0 0.6 12.0 16.1 14.3 14.3 18.3 2.7 3.3 5.1 6.9 1.1 7.6 2.4 7.4 6.9 6.2 6.9 8.7 15.3 1.6 9.3 5.4 7.0 5.3 2.0 10.0 0.1 8.3 14.1 11.8 2.1 6.5 3.5 6.2 5.1 0.5 16.0 3.1 2.7 0.5 0.6 12.2 15.9 7.3 2.6 4.7 2.3 4.1 11.1 18.4 0.3 8.4 1.9 5.7 2.7 4.1 1.7 10.5 7.8 2.3 3.4 9.8 8.6 7.3 4.6 6.4 9.8 17.6 7.4 19.7 4.8 3.3 4.1 0.1 15.6 6.1 5.1 1.8 1.5 5.1 5.3 3.3 7.6 2.7 5.5 5.9 3.3 2.3 4.4 3.6 2.4 1.1 6.9 0.0 5.6 2.4 7.4 8.6 12.6 8.3 6.2 2.6 11.4 1.9 9.8 7.0 MAP3K7CL "C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4" ENSG00000156265 "MAP3K7 C-terminal like" P57077 21 29077471-29175889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.9;skeletal muscle: 50.4;tongue: 28.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 17.0;LHCN-M2: 18.1;RH-30: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7" "HPA030079, HPA042439" Uncertain Approved Nucleoplasm Nucleoplasm "HPA030079: , HPA042439: AB_10794422" "unprognostic (2.23e-1)" "unprognostic (2.06e-1)" "unprognostic (9.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.98e-2)" "unprognostic (7.00e-3)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.28e-3)" "unprognostic (4.39e-3)" "prognostic unfavourable (8.31e-6)" "unprognostic (2.68e-3)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (8.10e-2)" 6.9 5.1 1.6 4.6 2.2 1.4 2.5 1.2 1.7 4.0 4.6 2.4 1.7 0.9 8.6 11.7 3.4 3.0 5.2 16.2 1.4 1.9 4.4 3.2 6.6 5.2 1.8 1.9 4.7 4.3 2.5 2.9 1.7 2.7 4.4 1.8 2.4 1.8 2.6 50.4 2.7 3.1 3.8 3.1 3.9 1.7 3.2 1.4 2.3 2.7 28.8 7.8 3.6 2.1 7.6 0.8 12.0 5.7 0.6 1.5 37.9 0.9 0.2 0.1 0.3 0.1 5.6 0.1 1.3 3.6 3.3 9.1 1.5 0.4 7.8 0.5 5.2 0.0 0.1 4.1 17.0 1.6 0.0 0.8 0.6 0.1 0.8 0.0 0.0 1.9 7.9 11.6 11.0 0.6 0.5 3.2 18.1 0.2 0.1 0.0 0.4 0.3 0.0 72.4 0.2 0.5 0.2 0.5 0.3 0.0 0.0 0.4 0.0 0.4 0.6 7.1 6.1 1.5 0.2 1.4 0.2 0.3 1.1 0.6 1.5 12.0 5.7 1.1 0.6 4.2 1.5 7.6 0.4 0.6 0.7 5.3 0.7 1.1 8.6 0.6 1.9 0.8 1.1 37.9 1.6 2.2 1.2 1.7 1.4 1.9 1.8 1.9 2.7 1.4 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell line enhanced" "Detected in many" "A-431: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.5 2.2 5.8 2.0 9.2 1.4 2.8 20.1 16.5 2.4 3.1 1.8 0.4 3.0 1.1 3.4 10.1 2.2 1.5 1.2 5.7 7.1 3.1 2.4 3.9 2.6 5.9 5.9 1.4 4.3 6.8 4.7 2.8 12.8 2.0 3.1 3.1 3.2 1.3 1.9 7.8 2.9 0.7 1.6 1.9 3.4 10.1 1.8 0.6 5.3 3.2 6.8 2.0 3.9 2.3 0.5 1.3 0.2 1.1 1.4 0.3 17.7 8.2 1.6 2.0 0.0 0.0 5.5 0.3 0.2 1.7 1.5 5.9 6.8 3.6 2.4 0.1 8.4 5.2 10.0 1.8 2.4 1.5 0.2 2.9 3.9 0.2 0.4 0.8 0.1 5.5 1.2 10.4 0.0 1.3 0.8 0.4 7.1 2.8 0.4 3.5 3.8 1.0 3.1 0.7 3.9 8.2 11.3 2.4 5.1 6.1 1.0 5.5 0.6 0.0 0.0 7.2 0.0 2.8 1.9 4.3 1.9 2.7 0.3 1.0 0.5 0.2 0.8 0.6 0.1 0.1 1.0 0.6 1.0 0.0 2.3 1.0 0.7 1.3 1.1 0.2 0.5 1.4 0.3 5.8 9.2 20.1 16.5 5.7 7.1 5.9 5.9 12.8 1.8 MAP4K3 "GLK, MAPKKKK3, RAB8IPL1" ENSG00000011566 "Mitogen-activated protein kinase kinase kinase kinase 3" Q8IVH8 2 39249266-39437312 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 40.8;RT4: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030380 Approved Approved "Nucleoplasm,Centriolar satellite" "Centriolar satellite" Nucleoplasm "HPA030380: AB_10601132" "unprognostic (4.82e-2)" "unprognostic (7.22e-2)" "unprognostic (5.87e-3)" "unprognostic (7.34e-3)" "unprognostic (6.77e-2)" "unprognostic (2.57e-1)" "unprognostic (1.05e-2)" "unprognostic (6.73e-2)" "unprognostic (1.66e-1)" "unprognostic (6.73e-2)" "unprognostic (4.33e-3)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (2.43e-1)" "unprognostic (5.08e-2)" 19.7 18.9 17.6 15.4 17.6 9.6 17.8 37.1 19.6 19.2 16.9 14.6 9.8 13.7 23.5 14.8 11.1 15.3 18.7 19.5 15.4 12.5 26.2 15.4 15.6 5.8 15.4 13.4 24.6 14.0 25.7 24.6 30.8 14.4 18.6 14.1 17.9 13.3 15.7 33.0 17.8 17.2 18.6 15.3 11.5 26.1 21.0 16.5 9.4 25.9 11.3 7.5 18.8 32.6 0.7 0.5 2.5 1.9 1.0 1.3 0.4 9.7 6.1 40.8 6.4 6.6 13.4 11.2 8.7 11.1 8.6 7.4 5.1 4.9 2.1 9.8 5.9 5.3 15.3 7.7 13.2 2.4 6.3 3.5 4.3 11.9 17.3 1.5 5.8 11.9 7.7 11.2 12.1 7.4 4.5 4.0 11.5 5.3 3.4 2.3 12.3 9.3 3.7 13.3 1.6 11.4 37.8 7.3 8.3 5.1 8.2 22.6 5.5 2.2 6.0 6.7 8.0 6.0 4.7 6.1 3.4 0.7 8.3 2.5 7.8 2.5 0.7 0.0 1.2 1.1 0.1 0.1 1.2 0.9 0.1 0.7 1.1 1.3 0.0 1.0 1.9 0.5 0.6 0.4 17.6 17.6 37.1 19.6 15.4 12.5 15.4 13.4 14.4 16.5 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 38.7" "Cell line enhanced" "Detected in some" "A549: 8.6;CACO-2: 12.4;HEK 293: 17.0;HeLa: 14.7;Hep G2: 7.3;SCLC-21H: 19.6;SiHa: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051508: , HPA059537: " "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavourable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.7 3.6 11.1 0.9 18.5 1.3 1.0 12.9 30.8 0.7 1.3 0.8 0.7 1.3 1.2 38.7 0.9 3.0 1.1 0.9 16.5 10.3 4.1 0.7 0.9 0.8 10.4 15.0 0.8 1.7 0.7 3.0 8.1 24.2 1.5 1.5 0.8 0.8 2.8 1.0 1.5 1.8 1.0 7.1 0.7 8.9 9.7 2.1 0.0 0.6 0.0 0.9 0.7 0.5 0.0 0.8 5.5 0.1 0.0 0.3 0.0 0.0 8.6 0.8 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 12.4 0.3 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.6 17.0 0.0 14.7 7.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.2 0.0 0.0 1.0 0.0 19.6 3.3 8.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.9 0.0 0.9 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 11.1 18.5 12.9 21.7 16.5 10.3 10.4 15.0 24.2 2.1 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 45.7;RPMI-8226: 27.6;RT4: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favourable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.3 0.1 0.3 0.2 1.1 5.6 2.7 1.5 0.2 0.2 0.5 16.2 19.1 4.6 1.2 1.5 15.1 0.0 45.7 0.4 11.8 5.1 0.1 0.5 16.0 1.9 0.1 1.2 4.8 16.2 2.9 0.6 3.0 0.3 5.2 0.5 10.2 0.1 1.2 0.1 0.3 11.4 0.2 27.6 8.8 28.6 19.3 0.3 1.7 0.3 0.1 21.7 2.5 4.0 1.4 0.2 0.5 0.3 0.3 6.9 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.1 0.0 1.3 0.0 5.3 0.0 0.2 0.0 1.1 1.6 0.0 14.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 13.6 0.0 0.0 2.0 1.1 0.0 2.9 0.3 0.9 1.3 3.9 3.9 0.0 2.8 0.0 12.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051631-55070192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favourable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 37.7 27.1 22.9 23.9 23.7 65.9 27.9 25.7 29.3 26.3 24.7 24.2 20.0 17.3 32.1 28.6 28.6 31.5 24.9 32.6 20.1 25.8 41.9 32.6 27.6 33.6 21.3 18.0 41.1 21.2 25.7 32.8 36.4 22.8 23.9 23.6 28.5 33.8 30.6 38.5 26.7 29.5 32.8 19.9 33.3 26.7 30.8 17.4 37.7 25.9 26.6 39.1 32.9 24.2 27.5 30.8 28.8 30.4 21.4 30.7 19.6 19.5 17.3 30.5 19.4 24.7 24.4 23.7 22.0 23.5 27.4 31.9 13.8 17.4 22.7 18.7 29.3 21.6 32.7 33.3 38.5 20.5 20.9 21.8 16.9 20.7 27.1 26.7 24.1 31.5 25.2 22.8 36.4 36.3 20.2 20.2 39.5 23.6 22.4 20.7 22.1 29.2 19.3 33.6 13.6 37.6 22.1 19.9 23.1 21.3 15.3 19.8 27.2 15.5 27.3 28.2 37.0 17.4 19.6 12.5 18.0 30.0 22.5 14.0 20.2 28.8 22.2 25.7 21.4 30.4 28.2 27.5 25.5 23.1 23.9 23.6 23.8 23.4 16.5 21.4 28.1 30.8 30.7 19.6 22.9 23.7 25.7 29.3 20.1 25.8 21.3 18.0 22.8 17.4 MAPK3 "ERK1, p44erk1, p44mapk, PRKM3" ENSG00000102882 "Mitogen-activated protein kinase 3" P27361 16 30114105-30123506 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 25.1;neutrophil: 11.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002683, HPA003995, HPA005700, HPA030069" Approved Approved Nucleoplasm Nucleoplasm "CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (5.03e-2)" "unprognostic (4.62e-2)" "unprognostic (3.46e-2)" "unprognostic (1.60e-1)" "unprognostic (4.70e-3)" "unprognostic (2.75e-1)" "prognostic unfavourable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.51e-2)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-2)" 24.9 18.5 63.3 15.3 43.2 15.6 21.1 24.8 52.0 21.3 45.1 30.4 6.3 39.7 24.2 11.4 44.1 28.7 25.6 21.2 37.1 34.0 13.4 8.8 23.3 13.1 33.8 27.4 32.7 13.0 26.1 15.2 27.6 27.6 20.1 36.7 26.2 17.1 18.3 13.9 18.7 49.2 24.0 27.8 15.9 33.7 11.6 19.5 8.4 20.5 18.7 26.0 18.2 22.2 1.4 1.5 25.1 2.7 0.8 3.1 1.4 13.7 7.5 16.1 9.1 40.5 53.8 9.0 10.3 25.6 16.4 19.6 9.0 27.8 13.9 10.2 28.8 5.1 13.5 12.1 16.0 26.3 15.7 4.3 8.3 15.0 40.7 3.1 11.9 33.1 7.0 18.7 8.4 41.6 5.8 17.9 21.6 36.3 14.3 5.0 4.3 6.6 17.0 9.6 31.2 14.9 8.7 14.2 10.1 5.9 20.8 6.0 13.6 7.6 29.4 10.8 9.3 12.3 3.5 20.3 9.3 7.1 21.6 6.7 7.6 2.4 2.7 25.1 0.9 1.9 1.4 1.3 2.1 1.6 1.4 1.4 1.5 1.6 11.3 0.8 1.0 1.5 3.1 1.4 63.3 43.2 24.8 52.0 37.1 34.0 33.8 27.4 27.6 19.5 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.1 15.4 3.7 0.0 1.1 2.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 MARCKS "80K-L, MACS, PKCSL" ENSG00000277443 "Myristoylated alanine rich protein kinase C substrate" P29966 6 113857362-113863471 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 74.3;TIME: 58.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 10.1;neutrophil: 15.0" "Group enriched" "Detected in many" 10 "B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022062, HPA054820, HPA067595, HPA069443" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" 17000000 "Plasma membrane" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB022062: AB_309681, HPA054820: , HPA067595: , HPA069443: " "unprognostic (4.71e-1)" "unprognostic (1.91e-2)" "unprognostic (2.46e-1)" "unprognostic (5.51e-3)" "unprognostic (8.22e-3)" "unprognostic (2.38e-2)" "prognostic unfavourable (2.78e-8)" "unprognostic (7.82e-2)" "unprognostic (2.57e-1)" "unprognostic (6.92e-2)" "unprognostic (2.27e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (4.85e-4)" "unprognostic (1.36e-3)" "unprognostic (2.77e-2)" "unprognostic (8.07e-2)" "unprognostic (2.70e-2)" 13.0 5.0 11.2 17.0 12.9 26.9 16.0 18.5 43.3 12.1 23.2 17.9 0.9 11.6 9.7 4.0 17.0 8.4 10.9 9.7 10.5 5.3 8.7 12.9 13.3 8.8 15.9 12.6 11.2 1.2 6.5 39.5 13.8 14.1 21.6 11.4 8.2 5.6 5.0 9.5 12.9 9.1 42.3 20.9 18.8 5.2 8.5 30.0 4.9 7.9 13.6 23.5 7.8 3.9 0.9 15.0 10.1 0.0 0.0 0.4 6.8 4.0 74.3 4.0 25.1 16.4 0.4 22.0 31.0 15.6 26.1 7.2 9.7 0.0 4.6 40.6 21.2 12.2 6.4 20.3 0.0 7.3 0.0 4.3 9.3 16.7 1.7 0.1 16.9 12.6 15.0 14.3 43.9 0.8 19.6 22.1 0.0 0.2 0.0 9.6 5.3 0.0 7.4 0.7 4.9 13.1 10.3 30.1 14.1 7.2 15.1 0.3 2.0 58.3 14.5 0.0 23.7 37.5 53.0 3.8 2.0 11.1 9.8 27.7 0.0 3.4 0.0 0.0 10.1 0.0 3.9 0.0 0.0 0.9 1.6 0.0 0.0 15.0 0.0 5.5 0.0 0.0 0.4 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911019 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: " "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavourable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 9.7 11.6 16.5 16.3 21.4 18.5 13.8 24.7 26.1 15.2 20.5 20.0 11.1 21.3 13.6 7.5 48.4 13.6 14.4 14.7 17.0 10.1 11.9 12.4 15.4 16.3 18.1 13.7 11.0 17.3 21.8 22.4 21.1 15.0 14.9 19.8 10.6 20.7 14.3 15.7 35.8 26.9 13.3 13.3 21.6 16.8 9.8 18.7 22.9 15.9 13.6 23.5 14.8 21.3 2.9 1.9 9.8 1.9 3.3 4.5 1.2 22.4 15.0 12.3 12.9 6.7 8.9 17.1 9.1 8.8 13.2 10.2 16.1 23.7 16.6 16.2 9.5 29.0 11.8 14.3 11.5 11.4 9.3 18.2 11.8 10.4 7.6 19.8 24.1 4.9 19.5 12.1 10.5 10.8 15.5 19.1 8.7 27.6 20.7 14.1 14.0 10.9 17.1 9.1 18.3 9.8 18.6 17.0 11.4 15.8 40.4 10.6 29.4 11.8 10.3 14.0 8.8 18.0 10.1 11.6 12.0 16.2 9.5 10.4 11.1 2.7 1.7 4.4 2.9 1.5 4.5 2.3 3.2 3.1 1.9 2.9 2.6 2.4 9.8 3.3 1.9 1.7 1.5 1.2 16.5 21.4 24.7 26.1 17.0 10.1 18.1 13.7 15.0 18.7 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell line enriched" "Detected in single" 39 "HEL: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAST4 KIAA0303 ENSG00000069020 "Microtubule associated serine/threonine kinase family member 4" O15021 5 66596361-67169595 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 17.5;HDLM-2: 22.2;HEL: 18.4;RT4: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000544 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA000544: AB_1079315" "unprognostic (1.77e-2)" "unprognostic (6.24e-2)" "unprognostic (1.80e-1)" "unprognostic (4.99e-3)" "unprognostic (2.83e-2)" "prognostic favourable (5.18e-5)" "unprognostic (9.01e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-2)" "unprognostic (9.47e-2)" "unprognostic (5.03e-2)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (1.37e-2)" "unprognostic (2.63e-1)" "unprognostic (2.63e-1)" "unprognostic (3.08e-2)" 16.2 12.9 10.2 6.9 11.8 2.5 12.6 6.2 19.4 13.9 6.9 6.3 6.3 6.3 14.4 8.9 31.2 11.6 9.7 24.5 9.9 8.1 14.2 9.5 13.1 5.0 6.5 9.2 20.2 5.9 35.6 16.7 18.4 11.1 10.1 5.3 5.7 13.7 8.7 12.7 16.9 6.8 11.4 5.6 6.0 8.2 10.7 5.0 37.5 8.1 21.8 20.6 13.6 22.3 3.4 1.1 12.1 0.9 2.4 7.5 1.4 7.4 4.1 2.0 0.1 6.8 6.1 4.9 1.7 2.6 0.6 0.5 3.8 2.0 0.5 3.5 1.4 6.7 6.3 17.5 0.7 22.2 2.0 18.4 2.3 1.6 0.5 0.0 6.5 10.1 9.7 3.8 7.7 13.9 1.7 2.1 4.7 6.5 2.6 0.1 1.3 3.3 0.6 1.8 0.4 1.6 22.5 3.0 2.4 2.2 0.9 0.1 1.5 0.1 13.2 1.6 2.2 2.4 2.8 5.4 2.4 0.1 4.2 0.0 1.3 12.1 0.4 0.8 1.2 0.5 2.9 3.4 4.7 1.2 0.4 2.1 5.0 2.1 4.1 2.4 0.9 1.1 7.5 1.4 10.2 11.8 6.2 19.4 9.9 8.1 6.5 9.2 11.1 5.0 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539165-85545280 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 205.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol 950000 Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavourable (4.87e-4)" "prognostic favourable (8.94e-4)" "prognostic unfavourable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 55.9 68.9 37.4 35.3 54.1 20.4 30.3 37.5 50.0 28.6 35.3 74.5 39.7 33.6 35.8 59.8 33.5 44.9 51.6 35.0 41.7 28.5 52.3 26.4 32.9 27.0 74.8 37.6 44.2 205.8 38.8 60.5 29.3 48.9 40.6 36.8 35.0 28.2 31.3 51.4 33.7 35.8 47.6 57.7 24.7 44.6 34.9 69.4 22.7 94.0 34.1 30.8 46.9 33.4 13.8 15.3 4.9 17.2 16.9 22.8 14.9 29.7 44.2 51.9 32.2 35.7 43.7 30.7 37.4 34.5 39.4 42.1 36.1 100.4 69.8 24.7 45.4 46.4 65.2 55.8 50.7 35.3 47.9 41.7 64.0 31.1 65.3 61.8 46.6 39.5 56.7 42.5 29.7 37.3 46.8 55.0 89.4 25.5 56.3 68.1 34.4 56.9 60.0 49.2 45.2 59.5 47.2 40.9 37.7 33.8 32.7 60.3 27.7 33.2 36.3 48.4 29.2 26.6 44.7 33.9 26.9 50.5 31.6 77.6 25.4 4.8 15.2 4.9 15.4 17.2 22.8 13.8 17.5 16.2 15.3 12.2 16.4 14.3 1.6 16.9 13.7 10.9 15.3 14.9 37.4 54.1 37.5 50.0 41.7 28.5 74.8 37.6 48.9 69.4 MATR3 "KIAA0723, MGC9105, MPD2, VCPDM" ENSG00000015479 "Matrin 3" P43243 5 139293648-139331677 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" RNA-binding "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB033552, HPA036564, HPA036565" Supported Approved Nucleoplasm "Intracellular and membrane" 140000 Nucleoplasm "CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (9.33e-2)" "unprognostic (6.57e-2)" "unprognostic (8.37e-2)" "unprognostic (7.53e-2)" "unprognostic (7.20e-2)" "unprognostic (4.32e-3)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (2.96e-2)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (7.90e-2)" 32.9 39.7 62.4 25.8 77.3 82.2 49.0 103.4 81.6 46.9 32.2 35.3 27.1 22.4 50.6 38.6 31.4 40.5 34.6 36.1 61.5 62.0 46.3 33.3 34.0 42.0 50.1 58.5 62.6 30.2 61.7 61.0 36.1 59.0 40.7 32.6 28.8 28.4 43.3 44.3 23.7 27.5 43.5 51.3 35.0 25.5 32.7 36.8 64.8 58.0 23.9 48.5 36.7 30.4 36.6 28.3 45.5 30.4 45.4 44.8 42.9 37.0 34.7 104.7 47.9 36.7 40.7 53.0 31.6 55.6 56.3 65.7 49.5 38.6 62.4 44.3 44.2 24.7 69.1 49.2 75.9 49.4 33.8 42.3 41.1 51.7 35.0 46.0 32.6 42.0 37.9 45.7 42.5 54.4 38.1 31.5 57.7 33.6 87.4 51.5 56.5 33.2 54.1 78.3 39.0 52.2 57.8 52.3 65.9 45.5 33.1 46.5 36.2 45.5 35.1 51.6 33.7 33.7 44.3 32.0 52.1 76.1 36.0 40.4 49.6 45.5 20.9 33.9 36.3 25.1 44.8 36.6 38.2 40.9 28.3 30.7 42.3 38.8 10.4 45.4 30.4 15.7 40.8 42.9 62.4 77.3 103.4 81.6 61.5 62.0 50.1 58.5 59.0 36.8 MATR3 ENSG00000280987 "Matrin 3" 5 139273752-139331671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA036564, HPA036565" Supported Approved Nucleoplasm Nucleoplasm "HPA036564: AB_10669907, HPA036565: AB_10673623" "unprognostic (3.08e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-2)" "unprognostic (2.37e-2)" "unprognostic (3.64e-1)" "unprognostic (1.10e-1)" "unprognostic (8.69e-9)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.91e-10)" "unprognostic (2.91e-2)" "unprognostic (9.21e-3)" "unprognostic (2.24e-1)" "unprognostic (9.89e-2)" 1.9 3.5 4.4 5.4 11.1 4.3 5.5 3.0 14.5 2.0 4.4 3.9 1.2 3.6 3.6 5.3 3.0 4.4 1.6 9.6 4.6 1.9 2.0 1.1 7.6 3.8 6.8 4.0 4.2 1.8 1.1 2.1 10.1 3.7 6.3 0.7 6.1 1.8 12.8 3.1 2.4 3.2 3.3 4.0 3.9 4.7 4.5 2.2 1.5 5.2 6.7 2.8 5.3 5.8 4.9 0.5 1.8 1.6 4.3 2.2 14.3 10.5 6.8 32.3 17.2 19.5 12.2 9.4 7.5 13.2 16.2 16.3 13.2 55.4 13.8 13.6 17.2 50.7 26.9 25.3 11.2 23.4 33.2 14.2 12.6 14.0 33.1 14.0 21.1 19.1 17.0 21.3 13.2 28.2 9.6 15.0 6.2 21.4 9.2 26.6 7.3 42.5 21.3 23.1 6.8 8.8 21.4 12.1 12.1 12.9 24.3 10.8 17.1 10.2 11.2 16.9 9.1 13.4 4.9 5.2 30.5 9.4 28.6 13.6 0.1 1.4 0.2 0.9 1.8 2.1 5.8 2.9 3.4 4.9 3.6 4.3 3.3 0.5 1.6 0.8 0.2 1.5 2.2 MBLAC2 "DKFZp686P15118, MGC46734" ENSG00000176055 "Metallo-beta-lactamase domain containing 2" Q68D91 5 90458203-90474768 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037757, HPA037758" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037757: AB_10670528, HPA037758: " "unprognostic (6.32e-2)" "unprognostic (2.48e-1)" "unprognostic (9.22e-3)" "unprognostic (1.21e-2)" "unprognostic (9.27e-2)" "unprognostic (1.96e-3)" "unprognostic (9.98e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.00e-3)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.44e-1)" "unprognostic (3.34e-1)" "unprognostic (6.31e-2)" "unprognostic (1.63e-2)" 5.2 7.4 11.2 5.7 16.8 2.7 9.5 16.7 14.7 8.7 5.7 7.4 7.4 6.1 9.6 6.6 7.2 7.5 5.0 5.2 12.7 14.2 9.3 11.1 5.5 11.1 10.6 9.8 16.3 7.4 21.8 10.0 5.4 9.7 8.6 6.2 4.8 7.8 7.8 4.3 9.5 5.4 7.1 10.7 6.6 4.8 6.1 7.0 8.1 9.7 3.1 7.0 6.5 6.9 5.3 2.9 1.1 3.8 3.3 4.8 2.3 5.8 2.5 4.4 5.5 5.8 7.9 5.4 4.6 4.2 4.0 4.2 1.9 4.4 13.6 2.8 4.1 6.0 5.6 7.0 6.3 7.7 3.9 6.1 4.1 4.4 6.1 6.0 2.7 6.8 9.4 2.9 11.1 5.1 9.1 7.6 6.7 3.5 5.8 8.2 2.8 12.3 6.2 7.3 18.5 6.0 2.2 7.5 8.8 4.2 6.1 11.1 5.0 4.5 6.2 5.0 3.4 6.1 5.9 5.3 6.0 6.0 4.3 12.7 6.8 0.0 1.5 1.1 3.2 3.8 3.9 3.1 3.6 3.5 2.9 5.3 4.8 3.7 0.1 3.3 1.9 1.0 1.3 2.3 11.2 16.8 16.7 14.7 12.7 14.2 10.6 9.8 9.7 7.0 MBTD1 "FLJ20055, SA49P01" ENSG00000011258 "Mbt domain containing 1" Q05BQ5 17 51177425-51260163 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021876 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021876: AB_2140367" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-2)" "unprognostic (1.81e-2)" "unprognostic (2.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-2)" "unprognostic (5.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.61e-2)" "unprognostic (7.90e-3)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-3)" 9.0 6.8 8.8 10.6 14.2 11.0 13.5 21.2 12.0 10.7 8.8 13.2 8.6 9.2 14.3 9.6 9.3 8.3 7.1 5.8 9.9 5.8 7.4 11.2 7.2 9.3 12.6 8.1 15.4 11.0 8.8 9.6 10.0 8.8 8.9 9.3 8.3 9.0 8.8 7.9 16.7 9.8 11.9 7.7 11.7 9.5 27.9 11.7 32.4 10.1 4.8 9.0 9.5 10.5 0.9 1.1 5.1 0.4 0.4 0.9 0.1 3.8 3.5 19.0 7.7 4.6 5.4 10.1 2.9 3.6 3.1 3.9 4.2 4.9 14.8 6.9 2.1 3.7 8.7 2.1 5.9 4.1 7.9 15.3 4.1 6.4 3.1 10.3 4.6 4.6 4.2 2.3 4.3 5.5 11.8 3.7 2.4 3.8 13.9 10.8 10.8 3.3 16.2 11.5 7.4 4.8 7.2 12.2 18.5 2.6 5.1 6.1 7.3 20.3 3.3 3.4 3.5 2.5 3.1 9.3 5.8 13.3 2.0 6.8 1.9 5.1 0.4 1.9 0.7 0.3 0.2 0.9 0.7 0.5 0.7 0.6 0.4 0.9 0.9 0.4 0.4 1.1 0.8 0.1 8.8 14.2 21.2 12.0 9.9 5.8 12.6 8.1 8.8 11.7 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 9.1 19.0 9.1 9.2 11.5 14.3 4.4 13.5 13.8 12.9 11.3 7.5 12.6 7.9 7.1 14.4 8.6 12.5 7.8 16.0 5.9 10.0 3.9 12.1 6.2 15.8 8.4 3.9 13.5 8.4 19.5 14.4 9.9 10.9 8.9 14.7 5.7 3.4 4.4 8.5 14.1 4.3 16.9 8.8 9.0 4.6 2.2 18.7 19.1 12.1 16.7 16.3 7.2 11.7 16.3 3.8 23.7 10.1 10.9 13.8 3.8 18.1 3.5 15.6 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 MCM9 "C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304" ENSG00000111877 "Minichromosome maintenance 9 homologous recombination repair factor" Q9NXL9 6 118813442-118935162 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031137 Approved Approved Nucleoplasm Nucleoplasm "HPA031137: AB_10602027" "unprognostic (3.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.33e-3)" "unprognostic (2.90e-1)" "unprognostic (2.78e-2)" "unprognostic (2.82e-1)" "unprognostic (3.00e-2)" "unprognostic (2.29e-1)" "unprognostic (3.61e-2)" "unprognostic (7.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (8.30e-2)" "unprognostic (2.16e-1)" "unprognostic (3.95e-1)" "unprognostic (2.26e-1)" "unprognostic (8.79e-2)" 8.6 7.2 5.9 11.9 8.4 14.5 17.7 5.2 6.9 9.4 11.2 8.2 9.8 7.3 9.0 16.0 10.2 8.6 8.2 6.6 5.9 4.0 9.3 7.6 15.6 12.1 11.5 4.7 8.7 12.2 11.9 11.2 13.8 6.3 10.5 8.4 7.0 11.8 8.7 4.2 9.8 12.6 10.9 5.7 10.2 7.3 7.9 8.1 27.0 13.1 7.1 9.9 9.6 10.5 3.1 5.2 8.0 5.3 10.2 6.4 3.9 4.6 7.4 11.8 12.7 5.3 5.3 9.1 4.4 7.8 6.5 8.3 6.0 8.3 14.0 5.5 7.5 14.0 8.2 4.7 9.1 8.2 11.3 11.1 8.7 5.9 3.1 11.9 7.5 5.8 5.6 6.6 7.7 6.2 13.4 6.5 4.2 9.7 10.5 9.6 5.8 3.3 8.4 7.4 3.7 6.6 9.3 10.2 7.4 7.7 5.7 4.0 8.4 16.9 6.3 5.1 4.6 3.6 6.4 8.6 7.2 16.6 6.6 9.8 6.0 7.2 4.5 8.0 4.9 5.3 3.8 3.1 3.0 5.0 5.2 3.0 3.6 3.5 5.4 10.2 3.2 3.7 6.4 3.9 5.9 8.4 5.2 6.9 5.9 4.0 11.5 4.7 6.3 8.1 MCPH1 "BRIT1, FLJ12847" ENSG00000147316 "Microcephalin 1" Q8NEM0 8 6406592-6648504 "Disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008238, HPA012064, CAB012177" Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: " "unprognostic (1.00e-1)" "unprognostic (2.17e-2)" "prognostic favourable (8.52e-4)" "unprognostic (6.45e-2)" "unprognostic (1.16e-2)" "unprognostic (1.19e-2)" "unprognostic (1.14e-2)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "unprognostic (4.79e-2)" "unprognostic (5.55e-3)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (4.79e-2)" "unprognostic (2.94e-1)" 13.5 10.0 11.6 10.7 14.6 35.0 14.0 19.9 16.8 13.6 11.7 12.4 15.1 9.1 17.2 10.0 12.2 12.5 9.4 11.9 12.2 10.0 11.4 11.0 10.8 15.0 11.0 11.3 14.3 13.4 13.2 19.4 14.4 13.9 13.6 10.6 10.2 14.4 15.4 24.9 11.9 11.2 12.3 14.2 15.3 11.7 17.1 12.5 21.6 14.0 10.7 17.0 14.3 17.6 6.9 4.1 11.7 4.1 6.0 6.2 3.0 4.5 4.0 7.3 5.1 3.7 6.6 6.3 6.9 6.1 8.8 6.6 5.1 3.4 8.8 1.9 5.6 5.3 9.3 6.6 10.5 3.6 5.1 11.2 4.2 6.8 6.1 5.6 8.9 6.3 6.9 6.0 8.7 6.4 13.6 8.9 6.7 2.9 15.1 6.1 12.7 4.1 9.0 7.0 5.3 5.1 8.4 5.1 6.8 5.1 5.4 7.5 4.7 8.0 5.3 6.9 3.8 2.2 6.5 4.1 5.6 13.1 6.4 6.5 9.3 2.2 3.0 11.7 4.8 3.4 6.2 6.0 4.2 5.5 3.0 6.9 5.4 5.6 0.5 6.0 4.1 4.1 4.2 3.0 11.6 14.6 19.9 16.8 12.2 10.0 11.0 11.3 13.9 12.5 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.7;Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 19.9 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.8 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 20.7 0.1 28.3 7.4 0.2 0.5 6.8 1.6 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.5 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell line enhanced" "Detected in many" "Daudi: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: " "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.3 4.4 2.4 12.6 2.7 7.3 9.5 8.9 5.4 9.8 8.7 0.2 8.3 36.1 1.8 7.6 2.9 9.3 5.4 8.6 23.0 7.3 4.4 4.9 0.6 4.8 8.8 0.1 4.6 1.5 5.9 5.1 13.0 1.2 23.0 7.4 12.6 20.1 0.1 11.4 6.4 7.7 19.1 4.0 11.4 4.6 10.2 4.4 9.5 28.5 2.9 3.5 0.4 9.2 3.9 5.0 20.3 15.4 8.9 6.2 8.7 11.8 1.9 2.6 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 MDFI I-mfa ENSG00000112559 "MyoD family inhibitor" Q99750 6 41636882-41654246 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 23.4;HBEC3-KT: 29.0;REH: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 19.0" "Low region specificity" "Detected in all" HPA049973 Approved Approved Nucleoplasm Nucleoplasm "HPA049973: " "unprognostic (9.74e-3)" "unprognostic (4.25e-2)" "unprognostic (6.82e-2)" "unprognostic (6.26e-3)" "unprognostic (9.18e-2)" "unprognostic (1.07e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (1.32e-5)" "prognostic unfavourable (9.11e-4)" "unprognostic (1.66e-1)" "unprognostic (3.27e-2)" "unprognostic (4.04e-2)" "prognostic unfavourable (2.85e-6)" "unprognostic (2.66e-2)" "unprognostic (6.06e-2)" "unprognostic (1.57e-1)" "unprognostic (8.22e-2)" 29.5 2.1 2.9 5.3 3.1 0.4 10.5 0.9 10.8 14.0 3.2 2.5 3.5 1.9 4.8 4.6 20.5 4.1 12.3 4.0 2.3 2.1 2.5 2.3 10.1 4.5 2.4 1.3 15.7 1.6 0.9 4.2 17.8 3.4 13.3 0.6 6.3 10.1 4.7 1.0 6.7 1.3 2.9 2.0 0.7 3.2 4.6 1.3 0.8 7.0 31.0 19.6 8.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 12.7 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 7.0 0.0 5.3 0.0 13.5 3.4 29.0 0.0 0.0 0.0 0.1 0.0 0.6 0.5 0.0 0.0 0.9 13.5 0.1 6.3 9.6 0.0 0.0 0.0 0.0 10.0 0.1 8.7 0.5 76.6 7.3 0.1 0.8 2.2 2.4 5.8 0.1 10.9 0.0 0.0 0.9 10.6 0.0 12.5 0.1 0.4 0.0 0.0 0.0 0.1 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.1 0.9 2.0 2.3 2.1 2.4 1.3 3.4 1.3 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213937-24216070 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm 34000 Nucleoplasm "HPA003064: AB_10602350, HPA070338: " "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favourable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 12.2 17.6 18.5 8.3 15.0 8.1 18.7 18.6 18.3 13.3 10.2 13.1 21.0 6.7 10.6 19.0 8.9 14.3 12.0 17.8 13.8 13.9 16.6 14.7 8.7 13.5 15.1 14.5 12.9 20.2 14.8 18.3 9.4 16.6 13.3 8.6 13.5 14.3 16.3 11.4 10.6 9.8 10.9 13.9 10.4 10.0 6.6 17.0 14.3 14.6 10.6 10.8 10.0 9.6 10.1 23.0 12.2 11.1 9.0 11.9 7.9 3.1 7.8 5.9 3.8 5.9 5.5 0.2 3.4 7.4 6.9 7.1 4.1 9.0 12.6 8.7 3.5 3.0 2.9 6.8 4.3 4.2 3.2 4.8 2.9 9.5 5.7 6.2 3.5 3.9 6.2 4.1 7.9 4.8 1.5 9.5 6.1 17.0 8.7 10.1 1.6 14.1 6.3 4.2 10.0 6.6 4.6 7.3 7.1 5.4 11.5 7.2 6.9 3.2 2.9 7.5 7.2 3.1 3.4 15.4 6.1 9.2 7.0 3.1 5.7 3.1 10.9 12.2 6.3 11.1 5.9 10.1 8.1 7.3 12.4 9.5 9.9 8.2 3.8 9.0 9.4 23.0 11.9 7.9 18.5 15.0 18.6 18.3 13.8 13.9 15.1 14.5 16.6 17.0 MEA1 MEA ENSG00000124733 "Male-enhanced antigen 1" Q16626 6 43011143-43016868 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017921 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017921: AB_1853708" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (1.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.74e-2)" "prognostic favourable (3.37e-4)" "unprognostic (8.56e-2)" "unprognostic (2.12e-2)" "prognostic unfavourable (1.29e-6)" "unprognostic (2.07e-1)" "unprognostic (8.62e-2)" "unprognostic (1.89e-2)" "unprognostic (5.58e-2)" 16.8 17.4 26.6 13.9 23.4 11.8 17.4 13.1 29.9 16.2 14.3 17.2 14.0 12.7 20.1 25.2 16.8 20.5 17.2 12.5 20.9 25.4 16.5 18.7 15.2 14.2 21.9 20.8 22.7 26.7 13.2 17.7 17.3 17.5 20.9 17.0 19.6 16.6 20.3 14.6 15.2 13.1 19.5 15.7 12.8 13.0 109.4 8.7 19.1 15.8 13.4 21.2 21.5 14.1 61.2 40.9 70.6 51.0 46.6 51.7 59.9 46.1 26.7 40.0 31.6 36.6 24.5 16.0 30.9 32.9 38.7 42.5 39.7 12.1 24.2 32.5 37.7 23.5 30.8 42.1 36.4 27.6 41.8 44.8 29.2 42.7 18.9 32.6 23.6 19.5 21.0 51.3 33.5 23.2 30.2 27.1 42.3 88.4 43.6 37.8 18.8 23.6 21.5 23.8 24.0 26.7 43.8 38.7 27.1 23.8 20.5 35.2 31.2 35.8 17.2 42.7 34.4 27.6 53.3 30.9 25.6 40.4 21.4 24.5 34.6 64.5 39.2 70.6 46.7 44.5 42.9 61.2 42.9 45.6 40.9 56.8 43.2 45.8 35.9 46.6 51.0 40.0 51.7 59.9 26.6 23.4 13.1 29.9 20.9 25.4 21.9 20.8 17.5 8.7 MECP2 "MRX16, MRX79, RTT" ENSG00000169057 "Methyl-CpG binding protein 2" P51608 X 154021573-154137103 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000593, HPA001341, CAB037264" Enhanced Approved Nucleoplasm Nucleoplasm "CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347" "unprognostic (1.27e-3)" "unprognostic (2.60e-3)" "unprognostic (2.16e-3)" "prognostic unfavourable (8.35e-5)" "unprognostic (2.35e-1)" "unprognostic (3.66e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-2)" "unprognostic (8.81e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-3)" "unprognostic (4.22e-1)" "prognostic favourable (7.32e-9)" "unprognostic (7.63e-2)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" "unprognostic (6.05e-2)" 18.6 21.4 29.2 17.0 27.1 33.8 17.6 39.1 33.5 20.2 19.2 17.6 15.9 13.9 20.0 15.1 18.8 21.1 19.5 23.1 22.5 14.0 17.1 16.4 22.8 19.7 22.5 26.7 29.0 21.2 24.3 22.9 13.9 25.4 23.0 8.0 20.8 18.7 23.7 31.6 14.1 15.3 16.2 21.1 23.3 15.0 9.7 24.4 13.8 19.1 8.7 14.3 18.7 28.6 5.6 4.2 22.4 4.9 2.9 6.8 1.8 19.2 11.5 9.7 12.1 8.4 6.0 8.2 9.7 10.9 11.9 19.4 8.9 9.4 23.2 23.0 8.5 9.2 14.5 11.3 6.0 17.6 17.6 8.9 10.5 5.6 10.2 11.2 18.8 6.1 6.5 11.1 13.1 9.2 9.6 19.8 7.1 11.5 13.5 12.8 7.6 12.9 11.7 10.6 7.6 8.4 8.8 13.7 7.9 7.6 8.8 18.5 5.7 14.6 9.6 9.1 17.9 18.3 19.5 23.8 17.7 26.4 13.1 22.1 15.5 22.4 3.5 13.3 6.8 3.2 4.8 5.6 4.8 5.5 2.4 4.9 4.6 4.4 16.9 2.9 4.9 4.2 5.0 1.8 29.2 27.1 39.1 33.5 22.5 14.0 22.5 26.7 25.4 24.4 MED11 "HSPC296, MGC88387" ENSG00000161920 "Mediator complex subunit 11" Q9P086 17 4731428-4733610 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056669 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA056669: " "unprognostic (4.01e-2)" "unprognostic (2.34e-2)" "unprognostic (7.91e-2)" "prognostic favourable (1.86e-5)" "unprognostic (8.24e-2)" "unprognostic (5.47e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.82e-2)" "unprognostic (3.86e-2)" "unprognostic (2.10e-3)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (4.84e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" 12.8 30.8 15.5 16.5 26.4 7.0 16.2 14.5 19.3 16.6 20.9 16.4 22.3 20.7 14.7 22.8 20.5 19.7 21.5 22.0 16.9 13.2 29.5 35.4 16.4 19.6 25.0 19.7 13.8 30.6 24.3 14.4 19.0 22.8 17.5 18.4 13.7 27.7 16.4 24.7 20.8 26.8 18.8 21.9 25.4 20.3 11.7 23.3 13.9 22.8 25.9 19.9 16.4 14.7 23.8 18.6 51.3 23.3 14.2 21.5 13.0 12.0 35.4 13.1 13.5 14.2 17.4 10.2 8.7 14.9 13.0 16.1 12.2 9.5 16.9 9.4 10.7 18.6 13.2 24.8 9.6 20.0 30.2 8.2 19.8 18.7 8.8 6.0 10.1 15.1 17.5 13.8 8.6 14.6 8.4 12.9 11.3 17.6 11.5 7.5 7.8 11.3 11.4 9.5 10.9 26.3 12.6 5.4 8.9 11.3 15.4 8.5 13.7 7.1 8.6 7.0 7.0 13.3 13.9 6.1 5.3 6.4 12.0 10.3 9.1 14.7 11.8 28.0 16.8 16.6 17.9 22.8 16.5 16.8 11.6 23.8 19.6 21.5 51.3 14.2 23.3 18.6 12.4 13.0 15.5 26.4 14.5 19.3 16.9 13.2 25.0 19.7 22.8 23.3 MED12 "CAGH45, FGS1, HOPA, KIAA0192, OKS, OPA1, TNRC11, TRAP230" ENSG00000184634 "Mediator complex subunit 12" Q93074 X 71118556-71142454 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003184, HPA003185" Enhanced Approved Nucleoplasm Nucleoplasm "HPA003184: AB_1079349, HPA003185: AB_1079350" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (5.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.89e-3)" "unprognostic (7.14e-2)" "unprognostic (1.68e-2)" "unprognostic (1.15e-2)" "unprognostic (2.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (2.50e-1)" "unprognostic (1.22e-3)" "unprognostic (1.28e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.16e-2)" 18.2 31.3 12.3 15.3 14.7 16.6 18.1 18.0 15.1 16.8 12.8 19.8 21.3 10.2 21.7 16.5 13.1 17.7 14.2 12.9 12.9 8.5 13.3 9.8 14.0 15.3 15.7 10.7 28.8 14.2 20.1 17.9 23.0 11.6 16.5 11.8 18.6 14.6 20.3 14.9 17.6 14.8 16.4 11.2 27.3 14.2 15.3 12.9 33.1 17.8 12.6 15.9 15.4 16.4 4.0 5.1 9.7 3.7 5.0 7.4 3.6 8.6 10.2 16.1 9.6 11.8 10.6 23.8 6.1 8.8 9.8 7.0 12.2 8.2 11.4 8.2 10.6 8.6 18.8 7.7 7.8 11.9 14.6 18.8 23.0 16.5 9.3 17.3 16.7 12.3 8.4 12.8 14.9 15.0 17.5 19.9 9.6 14.5 18.1 9.9 9.2 13.4 17.1 18.0 8.6 7.4 17.2 9.0 10.8 14.1 7.2 8.0 8.7 8.6 13.1 10.7 12.7 9.8 4.3 9.8 5.5 8.3 6.3 9.7 7.1 9.7 3.7 7.2 5.9 3.6 5.0 4.0 4.1 5.4 3.9 4.0 4.6 3.9 7.7 5.0 2.4 5.1 7.4 3.6 12.3 14.7 18.0 15.1 12.9 8.5 15.7 10.7 11.6 12.9 MED13L "KIAA1025, THRAP2, TRAP240L" ENSG00000123066 "Mediator complex subunit 13 like" Q71F56 12 115953872-116277338 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039445 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA039445: AB_10673532" "unprognostic (1.81e-2)" "unprognostic (1.87e-2)" "unprognostic (3.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (8.62e-3)" "unprognostic (1.54e-1)" "unprognostic (5.08e-2)" "unprognostic (1.83e-2)" "unprognostic (6.82e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (4.64e-1)" 21.3 7.9 9.8 14.7 10.6 39.1 22.0 29.7 11.1 17.3 13.6 12.1 12.3 7.8 21.6 11.1 13.2 13.9 12.2 9.4 11.0 7.0 9.0 7.3 15.2 16.7 11.5 9.1 20.5 15.6 14.3 13.6 13.4 9.6 14.6 10.9 11.7 14.2 14.2 18.1 21.9 13.1 15.3 11.9 14.3 12.8 14.9 11.2 55.9 14.0 10.8 15.4 13.8 22.7 2.5 1.9 13.1 1.1 1.4 1.1 0.7 6.3 15.2 7.1 8.0 9.6 15.8 7.6 6.7 8.9 9.3 6.6 15.1 2.3 4.4 5.6 12.1 4.7 8.1 5.3 12.3 9.9 5.2 8.9 4.5 5.6 10.6 8.0 12.0 12.7 9.2 10.2 15.6 6.7 9.8 4.3 8.0 14.3 15.7 16.8 4.0 3.6 11.1 7.7 10.5 6.0 5.8 7.3 6.3 6.0 3.2 5.9 50.1 17.7 8.3 10.6 7.0 7.7 8.0 8.3 3.8 8.0 4.9 8.8 5.6 13.1 1.1 3.6 1.0 0.9 1.1 2.5 1.0 1.1 1.5 1.3 0.8 0.9 4.1 1.4 1.1 1.9 0.7 0.7 9.8 10.6 29.7 11.1 11.0 7.0 11.5 9.1 9.6 11.2 MED14 "CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170" ENSG00000180182 "Mediator complex subunit 14" O60244 X 40648306-40735858 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064182 Approved Nucleoplasm Nucleoplasm "HPA064182: " "unprognostic (5.21e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.07e-1)" "unprognostic (2.34e-1)" "unprognostic (2.08e-3)" "unprognostic (2.16e-1)" "unprognostic (7.95e-3)" "unprognostic (4.38e-2)" "unprognostic (5.05e-2)" "unprognostic (7.78e-2)" "unprognostic (1.16e-1)" "unprognostic (4.89e-2)" "unprognostic (8.54e-2)" "unprognostic (2.32e-1)" "unprognostic (1.64e-1)" 11.0 11.4 12.0 18.5 14.7 19.6 10.5 19.2 16.8 12.9 17.7 20.5 11.4 18.1 14.4 21.9 15.0 10.0 11.1 14.6 13.8 12.5 13.0 15.5 12.4 16.2 12.4 11.5 14.9 12.9 21.5 15.9 13.5 15.1 12.0 15.6 14.7 10.6 12.2 53.8 16.7 19.8 16.2 12.8 13.5 12.8 5.7 11.7 31.7 16.2 18.4 20.9 17.5 12.8 4.0 5.7 6.0 7.3 7.7 5.2 2.4 24.2 12.0 19.4 17.1 8.7 11.3 3.9 9.6 12.1 13.9 17.8 11.0 12.1 14.1 6.6 12.2 18.5 32.9 15.3 20.9 12.8 24.8 14.2 14.7 10.0 9.3 14.9 14.7 8.1 9.4 20.3 17.8 16.7 9.6 13.8 14.5 12.5 13.6 13.3 21.4 14.1 6.9 20.8 14.0 13.3 11.3 12.5 11.1 22.8 10.4 10.6 15.3 8.9 15.1 14.3 15.0 17.9 11.7 12.9 13.1 14.0 13.8 10.2 10.3 4.3 3.6 6.0 4.5 7.3 5.2 3.9 4.3 4.4 5.7 4.0 4.9 3.8 1.9 7.7 3.9 3.1 3.9 2.4 12.0 14.7 19.2 16.8 13.8 12.5 12.4 11.5 15.1 11.7 MED18 "FLJ20045, p28b, SRB5" ENSG00000130772 "Mediator complex subunit 18" Q9BUE0 1 28329002-28335967 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027429 Uncertain Approved Nucleoplasm Nucleoplasm "HPA027429: AB_10610137" "unprognostic (2.72e-2)" "unprognostic (2.00e-1)" "unprognostic (2.78e-3)" "prognostic favourable (3.93e-4)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "prognostic unfavourable (1.52e-4)" "unprognostic (4.30e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (7.49e-2)" "unprognostic (2.13e-1)" "prognostic favourable (8.38e-5)" "prognostic favourable (6.72e-4)" "unprognostic (9.20e-2)" "unprognostic (3.08e-2)" "unprognostic (7.69e-2)" 9.8 11.2 6.2 9.2 6.7 5.9 7.9 5.5 12.1 7.7 11.4 7.1 8.9 9.7 8.1 9.1 13.3 9.9 9.5 8.4 6.6 6.7 11.6 19.2 6.7 11.8 8.5 6.6 7.0 12.3 5.7 7.1 12.4 8.6 8.6 10.3 7.8 10.2 7.3 10.9 9.1 13.0 6.9 6.0 14.3 9.9 8.5 6.9 17.0 11.0 6.1 18.5 8.4 6.6 8.3 8.3 11.6 8.3 5.4 7.5 7.1 13.0 6.5 6.5 5.5 8.8 8.5 7.3 7.8 9.3 10.2 8.8 3.7 12.3 16.3 8.1 8.0 8.2 10.4 9.7 8.0 11.0 7.3 12.5 6.0 8.1 12.1 7.5 13.4 9.0 11.9 8.0 12.3 8.8 11.9 4.3 9.5 6.3 9.4 9.6 7.7 3.8 6.9 9.4 8.6 9.0 6.6 6.6 6.7 7.9 8.0 10.8 6.8 7.2 10.6 6.2 7.1 10.2 8.1 7.5 10.0 9.1 9.2 16.0 4.4 6.2 7.5 10.4 7.5 7.4 5.5 8.3 5.9 6.2 6.2 6.7 7.4 7.3 11.6 5.4 8.3 8.3 7.5 7.1 6.2 6.7 5.5 12.1 6.6 6.7 8.5 6.6 8.6 6.9 MED20 "DKFZp586D2223, PRO0213, SRB2, TRFP" ENSG00000124641 "Mediator complex subunit 20" Q9H944 6 41905354-41921139 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040717 Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA040717: AB_10794146" "unprognostic (1.45e-1)" "unprognostic (1.99e-1)" "unprognostic (2.58e-3)" "unprognostic (8.32e-2)" "unprognostic (9.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.16e-3)" "unprognostic (1.22e-1)" "prognostic unfavourable (1.48e-5)" "unprognostic (1.58e-3)" "unprognostic (4.23e-2)" "unprognostic (5.10e-2)" "prognostic favourable (1.17e-4)" "unprognostic (1.71e-2)" "unprognostic (4.63e-1)" "unprognostic (4.13e-3)" "unprognostic (2.31e-1)" 11.8 22.1 12.4 12.1 14.2 7.0 14.2 17.0 15.4 15.3 14.0 16.4 17.4 13.1 16.1 17.8 17.0 13.2 9.9 15.3 12.7 9.5 17.5 14.7 10.4 11.4 14.8 9.3 12.8 17.6 14.5 23.5 17.4 13.8 16.3 15.4 13.2 15.3 14.0 23.0 12.1 15.4 15.3 9.6 13.3 12.9 14.6 11.5 20.9 15.5 13.1 16.4 16.0 12.9 15.0 20.0 13.6 22.1 11.6 10.8 11.5 14.8 12.6 13.6 16.2 12.9 14.2 16.8 9.5 9.1 13.5 10.8 16.0 10.2 20.2 18.8 11.1 11.3 23.2 12.7 17.1 11.6 7.4 18.1 9.7 14.1 12.3 15.4 11.5 11.1 20.0 12.9 19.3 16.7 24.5 9.7 16.1 13.3 17.1 11.0 17.7 10.2 23.8 16.4 7.3 19.3 9.6 12.6 10.0 13.5 6.4 12.7 12.9 16.1 16.3 9.6 20.8 5.8 11.7 10.1 13.5 42.7 5.3 17.1 13.5 13.0 19.6 13.6 8.7 22.1 10.8 14.2 5.8 9.8 20.0 15.0 7.9 9.3 7.3 11.6 14.8 17.8 10.2 11.5 12.4 14.2 17.0 15.4 12.7 9.5 14.8 9.3 13.8 11.5 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favourable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.8 17.7 9.4 14.9 20.9 21.2 15.6 19.2 14.4 16.2 21.2 18.6 19.1 11.1 12.2 14.7 13.9 20.0 17.8 28.0 9.7 17.8 16.0 18.4 11.4 11.7 19.5 11.5 14.9 26.0 20.1 24.1 23.5 12.9 14.9 18.3 12.6 17.0 35.9 28.8 23.4 14.7 60.2 12.5 16.9 19.3 7.1 10.5 23.4 10.1 15.1 17.8 13.0 17.0 18.1 14.1 22.5 19.3 4.6 9.4 18.2 17.3 21.7 12.2 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 MED22 "Med24, SRB6, SURF5" ENSG00000148297 "Mediator complex subunit 22" Q15528 9 133338323-133348131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020391, HPA063694" Uncertain Approved Nucleoplasm Nucleoplasm "HPA020391: AB_1857668, HPA063694: " "unprognostic (2.62e-2)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "unprognostic (7.53e-2)" "unprognostic (5.56e-1)" "unprognostic (2.98e-2)" "prognostic unfavourable (5.16e-6)" "unprognostic (4.99e-3)" "unprognostic (3.23e-2)" "unprognostic (1.66e-1)" "prognostic favourable (6.46e-4)" "unprognostic (3.99e-1)" "prognostic favourable (3.76e-11)" "unprognostic (9.25e-3)" "unprognostic (2.66e-1)" "unprognostic (1.66e-2)" "unprognostic (1.62e-1)" 12.6 14.4 15.2 15.9 16.5 11.9 11.3 19.6 26.0 19.0 16.6 15.5 12.6 14.3 18.4 12.6 13.4 16.2 14.3 15.4 13.7 14.3 14.0 10.6 13.8 15.6 14.5 16.2 19.7 15.0 19.3 13.0 16.2 15.7 18.1 8.7 14.6 14.7 21.7 14.5 14.9 14.4 20.4 15.4 16.9 12.2 8.3 12.7 11.4 20.4 7.5 13.4 14.5 12.3 4.6 4.8 6.3 4.9 1.6 2.9 2.4 6.9 8.2 12.8 9.2 2.9 4.8 14.9 8.5 5.9 10.5 7.1 17.8 6.5 14.0 5.0 6.0 13.8 9.5 8.1 4.4 10.9 5.5 7.4 17.8 4.9 4.8 9.4 7.6 3.7 6.5 9.4 6.3 5.1 10.7 6.8 5.0 9.5 13.4 7.9 17.9 9.9 18.3 10.3 12.8 4.3 5.1 10.4 8.5 9.8 12.5 7.4 14.2 3.3 6.7 13.8 9.6 9.4 11.0 4.7 6.2 13.5 7.9 7.4 11.3 2.2 3.9 6.3 2.0 3.7 2.6 3.4 2.4 2.6 3.0 4.6 2.9 2.2 6.0 1.6 4.9 4.8 2.0 2.4 15.2 16.5 19.6 26.0 13.7 14.3 14.5 16.2 15.7 12.7 MED23 "CRSP130, CRSP3, DRIP130, Sur2" ENSG00000112282 "Mediator complex subunit 23" Q9ULK4 6 131573966-131628229 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070341 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA070341: " "unprognostic (1.11e-2)" "unprognostic (4.66e-2)" "unprognostic (5.51e-3)" "unprognostic (1.80e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (6.62e-3)" "unprognostic (4.47e-1)" "unprognostic (1.64e-1)" "unprognostic (6.81e-3)" "unprognostic (1.44e-2)" "unprognostic (3.59e-1)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (2.21e-1)" "unprognostic (2.44e-2)" "unprognostic (2.53e-2)" 14.0 17.1 12.1 19.7 12.7 21.8 16.3 23.0 17.6 14.7 12.3 12.1 17.8 12.7 21.6 13.3 14.9 14.6 10.2 10.2 11.7 8.3 12.2 9.6 13.1 15.4 15.9 12.3 20.5 18.7 23.9 16.1 12.3 11.3 13.9 14.4 12.3 19.8 16.8 14.8 15.0 15.4 14.3 11.0 13.7 14.9 13.1 13.3 22.7 18.0 7.4 16.7 16.2 20.7 6.0 6.8 8.8 5.7 15.0 10.9 4.6 5.1 5.8 13.8 17.4 17.2 13.2 12.7 13.1 14.9 12.1 17.7 6.0 7.3 11.6 9.6 13.4 9.4 7.4 8.5 18.9 13.1 10.3 12.1 10.6 10.2 12.5 20.0 20.7 11.5 10.2 13.4 13.7 15.0 15.5 12.2 12.8 8.0 15.1 12.6 6.6 5.8 13.7 8.6 6.9 9.4 7.7 10.4 9.4 9.3 13.1 8.5 3.6 14.1 15.1 9.0 10.3 14.4 11.9 13.0 8.7 16.7 11.1 9.2 12.1 4.5 5.3 8.8 7.3 5.7 10.9 6.0 7.2 8.0 6.8 5.2 7.4 6.7 4.5 15.0 3.9 3.6 7.8 4.6 12.1 12.7 23.0 17.6 11.7 8.3 15.9 12.3 11.3 13.3 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA057997: , HPA071835: " "unprognostic (2.02e-2)" "prognostic favourable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavourable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.5 3.3 7.1 4.3 3.4 9.6 5.3 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 6.9 5.1 5.4 4.0 10.7 10.4 5.7 3.3 4.2 4.2 6.5 5.5 4.0 5.3 4.9 5.2 3.1 9.4 17.7 3.6 9.1 6.8 6.1 7.8 11.5 7.2 5.0 15.9 3.4 3.6 8.7 4.6 4.6 4.6 5.3 3.3 8.6 3.7 7.4 5.9 8.9 7.1 12.4 10.0 11.8 5.2 8.6 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 MED30 "THRAP6, TRAP25" ENSG00000164758 "Mediator complex subunit 30" Q96HR3 8 117520713-117540262 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045767 Approved Nucleoplasm Nucleoplasm "HPA045767: " "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (3.86e-2)" "unprognostic (1.57e-2)" "unprognostic (1.46e-1)" "unprognostic (3.20e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-2)" "unprognostic (8.41e-2)" "unprognostic (4.02e-2)" "unprognostic (1.51e-2)" "unprognostic (7.73e-2)" "prognostic unfavourable (1.70e-6)" "unprognostic (5.38e-3)" "unprognostic (2.80e-1)" "unprognostic (1.05e-1)" "unprognostic (4.62e-2)" 18.5 12.5 10.8 16.1 12.1 46.7 18.8 12.9 14.8 16.8 14.9 15.4 12.0 11.9 17.8 21.0 15.8 18.3 9.2 14.9 11.1 10.0 9.9 19.0 16.2 19.7 13.7 8.6 23.0 10.1 4.2 14.5 14.3 12.1 16.1 15.2 10.5 11.1 14.2 12.2 16.9 12.9 15.8 14.1 17.0 12.4 18.9 13.1 34.3 19.3 12.9 18.5 17.5 16.1 28.7 34.8 45.4 27.3 16.9 24.3 17.5 22.5 2.4 9.1 6.0 6.4 6.0 10.1 6.8 7.4 10.5 13.1 4.3 11.3 18.1 10.9 3.7 10.2 8.0 5.3 13.5 24.1 10.0 14.6 1.5 5.5 7.0 11.6 12.7 5.5 6.1 5.4 12.2 6.4 8.1 11.0 4.9 5.3 35.5 29.8 5.0 16.8 13.2 11.4 7.9 5.3 3.9 12.9 10.9 8.1 18.6 10.3 4.5 14.8 3.0 5.1 13.4 9.3 11.8 9.7 6.5 20.8 4.7 13.2 8.5 24.7 16.7 45.4 21.3 18.8 22.3 24.0 21.6 20.9 18.1 28.7 24.3 23.0 38.8 16.9 27.3 34.8 22.8 17.5 10.8 12.1 12.9 14.8 11.1 10.0 13.7 8.6 12.1 13.1 MED31 "CGI-125, Soh1" ENSG00000108590 "Mediator complex subunit 31" Q9Y3C7 17 6643315-6651634 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035947 Uncertain Approved Nucleoplasm Nucleoplasm "HPA035947: AB_10696646" "unprognostic (1.42e-1)" "unprognostic (4.39e-1)" "unprognostic (6.87e-2)" "unprognostic (4.40e-3)" "unprognostic (1.71e-1)" "unprognostic (3.99e-1)" "unprognostic (6.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.03e-2)" "unprognostic (1.39e-2)" "unprognostic (5.79e-2)" "unprognostic (6.46e-3)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" 9.7 19.7 18.7 9.6 21.6 9.4 16.2 25.3 25.5 12.1 10.0 10.2 8.9 9.4 11.9 30.5 20.8 14.3 13.9 16.0 19.0 21.4 15.4 15.9 10.1 14.1 16.0 15.1 14.0 9.5 9.1 22.3 12.5 19.4 11.3 9.7 10.5 14.3 10.4 11.4 21.8 11.3 13.6 13.7 14.5 10.0 17.6 11.5 17.5 16.3 13.4 15.4 16.9 11.9 12.5 13.4 33.3 12.2 11.8 15.7 11.0 17.6 19.9 17.9 11.4 16.3 13.9 6.4 13.9 14.3 21.5 28.2 9.8 9.3 2.3 17.7 6.8 19.5 14.1 17.0 18.8 12.8 23.7 4.4 18.2 15.1 12.3 4.9 9.3 7.5 18.7 19.4 6.7 15.9 7.6 4.6 15.5 6.4 9.4 12.9 6.4 11.5 7.1 7.9 6.5 17.9 8.9 7.0 7.8 7.1 5.8 15.1 6.0 5.4 7.1 10.7 9.2 13.4 13.8 4.2 5.4 5.9 14.8 5.9 7.5 28.6 12.2 19.5 14.7 8.3 13.9 12.0 13.6 14.1 10.4 12.5 12.4 13.1 33.3 11.8 10.0 13.4 15.7 11.0 18.7 21.6 25.3 25.5 19.0 21.4 16.0 15.1 19.4 11.5 MED8 "ARC32, MGC17544, MGC19641" ENSG00000159479 "Mediator complex subunit 8" Q96G25 1 43383917-43389808 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028377, HPA028438" Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA028377: AB_10600112, HPA028438: AB_10600057" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (1.49e-2)" "unprognostic (2.37e-2)" "unprognostic (8.58e-3)" "prognostic unfavourable (2.04e-7)" "unprognostic (2.60e-2)" "unprognostic (1.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.17e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.11e-7)" "unprognostic (7.08e-2)" "unprognostic (3.28e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-1)" 22.7 21.9 19.0 18.3 22.0 22.0 22.9 30.0 25.8 20.4 21.1 21.9 19.0 21.7 18.4 24.8 33.4 15.0 16.1 15.9 18.5 19.0 22.1 34.6 19.4 18.3 21.0 17.2 19.2 25.6 17.7 34.5 26.8 20.3 19.3 24.5 19.2 25.0 21.1 16.5 27.3 21.2 23.5 21.3 20.9 22.5 18.5 20.6 14.2 27.0 19.3 25.9 24.9 20.6 27.0 34.6 32.5 35.0 18.4 25.5 22.1 21.8 13.8 13.0 15.5 20.1 20.2 17.1 22.0 20.3 26.6 28.1 26.2 16.1 13.3 15.8 27.6 14.0 20.4 18.7 25.8 18.4 20.0 21.8 24.0 32.8 34.2 19.2 23.2 19.7 24.8 28.1 34.5 21.2 19.3 22.7 17.1 14.1 10.0 15.8 12.4 16.0 11.8 15.0 20.4 17.7 14.3 13.6 10.3 13.1 21.5 43.3 14.5 38.7 15.7 11.6 21.1 22.8 31.2 27.1 31.2 15.5 24.7 24.0 15.4 25.3 35.0 32.5 22.0 31.3 20.9 27.0 20.2 24.8 34.6 21.1 20.7 21.5 28.0 18.4 27.3 16.0 25.5 22.1 19.0 22.0 30.0 25.8 18.5 19.0 21.0 17.2 20.3 20.6 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476986-17493226 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Nucleoplasm Midbody "HPA056415: " "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favourable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favourable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 10.2 12.7 16.0 6.5 23.5 12.3 14.1 16.3 29.1 13.0 11.2 9.2 10.9 11.2 11.7 17.3 8.2 11.7 6.6 30.0 14.3 13.6 13.9 19.1 8.2 11.5 13.6 14.5 12.4 10.2 20.3 11.3 7.9 12.6 11.4 10.5 8.9 15.8 14.9 34.4 11.3 10.5 8.6 10.3 9.5 10.1 12.9 8.6 14.9 13.4 15.2 9.1 7.5 7.8 11.4 12.8 11.8 11.4 10.3 13.4 7.4 8.5 11.0 9.5 10.2 7.6 6.9 8.1 7.0 8.7 10.8 9.8 15.9 4.3 10.6 8.1 7.2 11.2 12.0 9.7 10.3 6.7 19.1 6.4 7.3 11.4 8.2 5.1 5.6 11.2 9.2 9.1 9.4 7.4 7.6 4.9 7.2 7.2 22.9 10.6 8.7 11.3 17.8 21.4 6.8 9.5 6.1 6.2 9.8 9.2 7.3 15.5 8.6 6.7 5.0 8.0 9.3 13.7 11.0 9.3 6.6 5.9 10.1 9.1 8.4 2.7 7.0 11.8 10.3 9.6 13.4 11.4 10.7 10.6 7.8 10.4 11.6 12.8 2.4 10.3 11.4 12.8 10.3 7.4 16.0 23.5 16.3 29.1 14.3 13.6 13.6 14.5 12.6 8.6 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Group enriched" "Detected in some" 12 "Daudi: 49.8;U-266/70: 50.0;U-698: 65.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 49.8 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.4 0.5 0.1 50.0 4.6 65.8 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;HEL: 52.3;Karpas-707: 28.8;REH: 59.6;WM-115: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 5 "B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5" "Group enriched" "Detected in many" 7 "amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3" "Group enriched" "Detected in all" 4 "amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB068196: , CAB068197: , HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 13.9 10.8 17.0 15.0 26.7 3.8 10.7 4.3 52.8 8.2 6.8 6.1 1.5 2.8 10.9 5.4 5.0 6.4 9.8 11.2 11.1 6.8 4.5 4.0 8.3 19.3 6.6 28.0 12.3 2.9 5.2 6.5 14.8 4.8 7.1 5.7 4.6 6.6 6.6 154.8 3.9 7.4 10.8 8.3 16.0 4.5 3.6 4.4 1.6 9.6 3.5 24.0 8.9 5.8 48.2 23.8 5.8 19.5 4.0 0.1 7.2 0.3 0.0 1.7 0.0 1.8 1.1 0.0 0.5 1.0 0.0 0.2 0.0 0.2 23.7 0.1 2.7 0.7 2.2 2.1 0.0 7.2 2.9 52.3 3.1 0.0 0.6 2.3 0.1 5.2 0.0 0.0 0.0 8.2 2.7 28.8 2.1 0.0 0.0 0.0 0.5 1.9 59.6 15.0 11.4 0.0 0.2 0.0 2.0 0.0 0.1 6.9 0.0 13.3 9.4 1.3 0.2 0.1 1.2 21.9 2.5 14.3 0.3 16.2 34.1 0.1 17.2 0.0 0.0 19.5 0.0 32.6 0.0 0.0 22.3 48.2 0.0 0.0 5.8 4.0 15.9 23.8 0.1 7.2 17.0 26.7 4.3 52.8 11.1 6.8 6.6 28.0 4.8 4.4 MEGF9 EGFL5 ENSG00000106780 "Multiple EGF like domains 9" Q9H1U4 9 120600813-120714470 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.1" "Group enriched" "Detected in many" 5 "granulocytes: 19.1;monocytes: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014319, HPA050238" Approved Approved Nucleoplasm,Cytosol 32000000 Nucleoplasm Cytosol "HPA014319: AB_1848035, HPA050238: " "unprognostic (1.18e-1)" "unprognostic (5.33e-2)" "unprognostic (1.84e-1)" "unprognostic (1.75e-2)" "unprognostic (3.30e-1)" "unprognostic (3.68e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-2)" "unprognostic (3.63e-2)" "unprognostic (1.13e-2)" "unprognostic (5.92e-2)" "unprognostic (4.97e-2)" "prognostic favourable (5.48e-11)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" 15.0 9.6 22.4 9.9 21.7 15.4 12.8 27.9 26.2 11.7 6.7 29.3 2.1 6.4 6.1 5.5 12.8 12.8 7.9 6.1 24.6 16.4 12.5 33.8 17.9 7.0 28.6 16.0 9.3 5.4 15.6 6.8 4.8 22.6 8.4 5.8 21.4 7.8 6.6 6.0 19.0 6.5 8.1 21.1 12.9 7.2 3.1 25.8 3.2 25.5 4.6 5.6 11.3 9.6 0.3 2.2 19.1 5.7 0.3 0.6 1.3 2.8 11.3 9.9 3.0 13.8 8.5 3.2 2.9 2.5 0.8 1.1 0.6 1.7 10.6 4.5 2.8 12.4 14.2 5.1 2.1 8.6 4.1 1.4 21.1 4.6 5.9 4.2 9.1 4.0 15.5 4.9 3.9 6.9 3.3 5.1 8.2 8.2 8.3 1.5 0.4 3.0 6.4 11.0 4.5 20.3 9.3 9.8 8.3 3.5 2.8 8.3 8.6 4.3 8.1 3.0 1.7 10.9 4.4 9.3 10.9 3.5 4.2 5.0 16.9 0.4 5.7 3.6 0.6 1.9 0.2 0.3 0.6 0.5 2.2 0.3 0.5 0.4 19.1 0.3 3.0 0.2 0.5 1.3 22.4 21.7 27.9 21.5 24.6 16.4 28.6 16.0 22.6 25.8 MEIS1 ENSG00000143995 "Meis homeobox 1" O00470 2 66433452-66573869 "Disease related genes, Predicted intracellular proteins, Transcription factors" Transcription "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.9;HHSteC: 18.6;SH-SY5Y: 15.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.3;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 2.9;granulocytes: 1.9;NK-cells: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011521, HPA056000, HPA058641" Approved Approved Nucleoplasm Nucleoplasm "CAB011521: AB_776272, HPA056000: , HPA058641: " "unprognostic (6.84e-2)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "prognostic favourable (2.70e-5)" "unprognostic (2.45e-2)" "unprognostic (7.78e-3)" "unprognostic (2.36e-2)" "unprognostic (5.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (1.69e-4)" "unprognostic (6.52e-2)" "unprognostic (9.71e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-2)" 7.9 21.2 2.5 14.1 5.1 1.1 9.0 27.5 5.1 52.6 24.0 6.8 13.1 3.0 49.3 15.6 18.2 30.5 15.5 9.0 2.0 1.5 4.7 1.8 14.7 5.3 8.9 3.6 25.4 33.8 4.4 1.4 8.0 9.4 14.8 7.0 10.8 26.4 20.2 2.6 4.8 7.7 31.9 7.7 7.2 14.1 5.9 5.6 0.7 2.7 6.6 6.2 20.6 22.7 0.1 2.9 1.9 0.4 3.3 0.6 5.3 0.1 0.9 7.4 1.5 9.6 6.3 1.0 9.6 24.9 8.3 8.7 0.8 7.0 0.0 2.4 7.4 1.2 4.3 4.3 8.3 0.0 4.2 12.1 15.6 1.7 18.6 0.0 3.3 5.7 5.0 3.3 1.5 3.8 1.0 0.0 0.3 0.4 0.9 0.2 0.2 0.9 0.0 2.0 1.8 0.7 2.2 2.3 15.9 1.7 0.5 0.7 0.7 1.4 1.2 1.8 3.0 1.3 2.7 1.9 0.6 0.1 1.5 10.7 0.5 1.9 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.6 1.4 3.3 0.0 2.9 0.2 5.3 2.5 5.1 27.5 5.1 2.0 1.5 8.9 3.6 9.4 5.6 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 41.0;SH-SY5Y: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 49 "basophil: 4.8;eosinophil: 4.9" "Lineage enriched" "Detected in single" 49 "granulocytes: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 83.2;olfactory region: 364.7" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavourable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 6.3 16.5 9.6 6.5 36.8 0.4 7.7 7.4 12.4 26.4 17.0 4.3 12.0 15.1 35.6 6.3 10.6 17.8 16.9 11.3 6.7 3.9 7.3 5.9 7.5 5.2 3.9 6.9 16.4 10.0 2.8 19.8 6.4 10.7 28.8 5.2 6.4 39.0 16.7 1.0 2.9 5.2 34.6 6.2 5.6 11.3 2.6 8.6 2.2 3.5 4.6 3.2 19.5 16.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 4.6 4.3 5.6 16.0 6.4 7.9 1.3 10.2 5.7 12.1 6.8 6.1 3.9 2.7 0.2 41.0 8.1 9.9 2.6 6.8 3.8 6.3 20.7 5.8 5.0 10.8 6.1 21.2 10.4 2.3 8.1 2.4 6.9 6.9 0.0 2.4 5.0 0.0 2.4 0.0 1.4 0.0 4.1 1.4 0.0 9.2 4.3 38.8 3.8 2.6 2.9 1.2 4.9 9.7 14.0 1.7 3.7 4.3 2.8 2.7 5.2 16.5 3.4 3.5 4.8 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 36.8 7.4 8.0 6.7 3.9 3.9 6.9 10.7 8.6 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419523 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 35.3;endometrium 1: 28.8" "Cell line enhanced" "Detected in many" "AF22: 27.9;HMC-1: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavourable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 5.6 3.9 35.3 4.7 10.6 0.0 5.0 11.0 25.3 8.4 4.7 2.4 3.8 3.5 28.8 2.2 6.0 14.2 6.0 3.7 23.2 11.6 1.5 1.1 3.1 1.2 2.6 14.6 7.4 1.7 1.1 4.9 7.4 3.8 7.0 2.1 4.1 3.6 6.4 1.4 1.6 3.8 22.5 1.7 2.4 2.6 3.3 2.0 0.5 3.4 1.6 1.4 6.1 4.7 0.0 0.2 0.5 0.7 0.0 0.1 0.4 0.3 11.9 27.9 0.1 15.2 13.1 0.4 12.4 19.1 9.7 17.2 1.0 1.9 0.0 1.4 20.4 1.4 2.9 3.4 3.3 18.6 4.2 0.0 4.3 0.1 9.8 0.2 24.2 9.6 0.7 3.8 2.0 0.0 0.2 2.8 1.1 11.3 0.0 0.1 8.1 0.7 0.0 2.0 0.3 0.6 0.8 1.1 22.6 10.7 0.9 5.1 0.6 3.5 0.0 7.5 18.9 5.4 1.6 0.0 0.0 0.0 20.9 1.1 14.9 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.4 35.3 10.6 11.0 25.3 23.2 11.6 2.6 14.6 3.8 2.0 MEOX1 MOX1 ENSG00000005102 "Mesenchyme homeobox 1" P50221 17 43640388-43661954 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "HeLa: 23.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 17.9" "Lineage enriched" "Detected in single" 66 "T-cells: 17.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA045214, HPA063788" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA045214: AB_10959299, HPA063788: " "unprognostic (1.36e-3)" "unprognostic (2.15e-4)" "unprognostic (1.25e-1)" "unprognostic (2.58e-3)" "unprognostic (2.01e-2)" "unprognostic (5.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.55e-3)" "unprognostic (6.71e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-1)" "unprognostic (9.36e-2)" "unprognostic (3.44e-6)" "unprognostic (2.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.82e-1)" "unprognostic (7.47e-3)" 24.3 0.3 0.1 7.4 0.1 0.0 17.3 0.1 0.1 12.4 3.2 0.1 2.3 1.2 11.6 5.7 10.9 6.7 6.5 17.8 0.1 0.1 0.2 0.3 1.2 5.4 0.1 0.1 4.8 1.2 1.5 0.5 0.3 0.1 8.2 1.9 0.8 5.8 2.0 19.8 4.6 3.5 8.6 0.1 8.9 2.4 3.5 0.1 3.2 1.7 15.4 7.1 6.1 16.7 0.0 0.0 0.0 0.0 0.2 17.9 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 3.0 0.0 0.0 1.8 0.5 0.0 0.2 0.0 0.0 17.9 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 MEPCE "BCDIN3, FLJ20257, MePCE" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434126 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: " "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavourable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favourable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 17.5 24.1 17.7 13.9 22.8 18.5 15.0 24.1 24.1 15.7 14.0 16.7 26.9 14.1 18.8 22.5 16.1 18.6 22.9 12.4 20.1 13.7 18.7 20.8 13.5 19.7 19.7 16.4 29.2 18.3 32.5 15.0 19.0 19.3 15.8 10.2 17.2 18.5 24.2 21.4 26.1 15.8 15.7 17.7 34.9 14.4 63.1 20.4 21.7 25.7 17.1 17.9 16.3 20.4 8.4 8.7 9.3 3.6 7.3 9.1 10.6 13.5 17.5 13.0 13.9 12.6 12.7 9.6 15.1 22.2 16.4 12.7 14.3 19.9 27.9 25.3 9.5 12.5 14.2 11.5 10.9 12.5 16.1 14.4 13.5 10.7 10.7 18.3 17.8 13.1 13.8 18.7 23.8 13.6 28.3 20.7 15.7 50.3 20.9 41.8 24.0 19.6 16.9 10.5 25.3 11.0 8.4 19.6 16.9 23.7 46.5 15.8 11.8 16.8 11.7 27.7 21.5 18.6 19.9 13.8 13.0 31.1 15.5 23.0 24.2 2.5 3.6 4.8 5.6 3.2 6.5 8.0 6.4 6.0 4.4 8.4 9.1 8.0 9.3 7.3 2.6 8.7 5.7 10.6 17.7 22.8 24.1 24.1 20.1 13.7 19.7 16.4 19.3 20.4 METAP1 "KIAA0094, MAP1A, MetAP1A" ENSG00000164024 "Methionyl aminopeptidase 1" P53582 4 98995620-99062813 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025485, HPA037997, HPA037998" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 11000 Cytosol "Nucleoplasm, Plasma membrane" "CAB025485: , HPA037997: , HPA037998: " "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "prognostic favourable (7.22e-4)" "unprognostic (1.58e-2)" "unprognostic (6.53e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (3.08e-5)" "unprognostic (1.09e-1)" "unprognostic (1.51e-3)" "unprognostic (2.05e-1)" "prognostic unfavourable (2.28e-5)" "unprognostic (2.00e-1)" "prognostic favourable (1.72e-4)" "unprognostic (5.50e-2)" "unprognostic (8.51e-2)" "unprognostic (1.15e-3)" "prognostic favourable (9.31e-4)" 12.1 8.3 10.0 16.0 10.1 11.8 18.6 9.2 13.8 16.0 17.9 7.0 22.9 13.4 24.1 25.9 37.2 14.0 12.3 27.9 9.5 7.1 14.3 13.7 10.7 12.6 7.9 9.8 11.3 13.0 7.8 14.4 9.2 9.9 19.1 19.3 7.5 19.0 21.5 27.2 16.4 15.2 27.8 10.1 13.9 11.6 46.8 8.1 27.0 10.8 21.8 19.1 36.6 22.6 12.7 11.7 10.4 11.1 12.5 19.2 10.8 21.7 21.5 18.9 20.2 15.0 24.1 21.0 31.2 20.1 26.7 25.5 24.1 32.5 32.2 12.5 25.2 21.9 33.1 31.2 37.1 22.5 15.8 28.8 15.7 25.8 16.3 38.9 24.1 17.3 22.7 22.6 24.1 21.9 22.5 19.5 28.5 16.5 34.0 18.6 23.2 17.5 22.4 29.5 17.2 42.8 28.2 25.9 15.3 10.4 32.3 12.3 12.4 14.9 17.8 21.6 27.5 19.7 27.1 14.1 19.9 25.5 18.6 19.9 21.4 10.4 9.4 4.2 14.9 11.1 19.2 12.7 15.4 14.5 11.7 10.1 15.1 13.5 2.3 12.5 10.7 5.8 13.4 10.8 10.0 10.1 9.2 13.8 9.5 7.1 7.9 9.8 9.9 8.1 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell line enhanced" "Detected in many" "MCF7: 52.2;PC-3: 40.4" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in many" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: " "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.1 4.3 22.0 7.7 4.3 7.0 5.2 2.6 2.1 1.3 3.2 6.5 0.4 12.3 3.7 9.7 0.6 5.1 0.3 1.4 9.7 0.8 4.0 16.6 4.7 1.8 2.8 10.4 5.6 0.6 1.3 0.7 1.5 0.5 1.5 52.2 0.7 6.4 1.6 40.4 7.1 5.0 7.1 5.4 0.7 6.9 8.7 2.1 5.8 26.8 8.7 3.7 2.4 6.0 11.4 6.9 4.5 3.3 0.9 0.4 9.4 1.4 14.1 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 METTL18 "AsTP2, C1orf156, HPM1, MGC9084" ENSG00000171806 "Methyltransferase like 18" O95568 1 169792529-169794966 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035314 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035314: AB_10601146" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" "unprognostic (3.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (1.01e-4)" "unprognostic (1.41e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (5.67e-2)" "unprognostic (2.14e-2)" "prognostic unfavourable (4.06e-4)" "unprognostic (3.65e-1)" "unprognostic (3.06e-2)" "unprognostic (3.03e-2)" "prognostic favourable (3.28e-4)" 8.7 7.3 12.1 9.9 9.0 3.8 11.5 13.5 11.8 6.5 6.8 3.5 8.4 5.6 7.7 9.8 7.8 8.2 5.2 10.2 8.5 6.8 8.6 8.5 5.9 16.5 11.1 10.1 10.4 9.4 31.9 9.4 6.3 9.2 11.2 6.8 3.4 8.4 7.5 5.0 6.5 9.2 6.3 12.7 14.3 8.2 6.7 11.2 9.8 10.0 8.0 11.8 7.8 8.9 13.4 5.4 12.2 5.8 12.4 19.3 9.8 9.1 5.3 8.7 6.0 5.1 9.5 6.0 4.3 5.0 5.5 4.8 6.8 15.0 15.7 12.0 5.7 10.6 8.7 9.8 7.5 9.4 7.0 11.2 4.8 5.5 10.5 11.8 5.2 4.3 10.4 5.6 6.2 10.5 11.8 7.5 7.4 4.5 12.5 8.1 10.9 13.4 9.3 8.6 11.8 8.9 9.2 6.5 9.9 9.2 10.4 12.7 13.8 13.0 4.7 7.0 6.7 6.9 10.0 14.6 19.0 21.3 5.1 9.5 7.0 9.3 5.2 12.2 14.6 5.8 18.5 12.1 16.3 17.0 5.4 13.4 19.3 18.3 3.0 12.4 3.4 4.2 18.4 9.8 12.1 9.0 13.5 11.8 8.5 6.8 11.1 10.1 9.2 11.2 METTL21A "FAM119A, HCA557b, HSPA-KMT, LOC151194" ENSG00000144401 "Methyltransferase like 21A" Q8WXB1 2 207580631-207625928 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034712 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034712: AB_10670160" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (4.56e-2)" "unprognostic (2.09e-3)" "unprognostic (2.00e-1)" "unprognostic (1.64e-2)" "prognostic unfavourable (1.87e-5)" "unprognostic (4.80e-2)" "unprognostic (2.30e-2)" "unprognostic (2.47e-3)" "unprognostic (6.65e-2)" "unprognostic (2.33e-2)" "prognostic unfavourable (5.43e-4)" "unprognostic (5.01e-2)" "unprognostic (3.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.05e-1)" 10.4 9.1 16.5 13.8 18.2 20.2 14.6 14.0 16.9 9.0 9.3 8.7 3.8 8.1 10.0 8.4 6.7 8.3 7.1 13.2 16.3 15.4 11.1 20.9 8.9 15.4 25.8 10.6 12.0 10.6 11.6 10.1 12.7 20.2 8.8 9.2 8.8 8.4 7.1 19.5 9.0 8.3 8.3 19.2 15.4 12.3 7.1 18.8 18.5 15.2 6.2 14.8 10.1 24.3 25.2 14.8 25.9 20.6 7.5 14.4 8.3 7.9 7.5 12.5 9.4 5.5 5.8 24.2 4.5 5.5 7.3 7.4 14.3 12.8 11.5 9.9 3.4 4.6 17.8 5.9 6.0 6.7 12.2 13.5 12.0 23.4 9.8 17.6 13.7 5.2 7.9 3.6 6.1 8.1 19.3 6.8 4.8 12.9 17.7 30.2 20.6 5.3 13.1 5.2 16.8 10.4 6.8 14.8 12.1 9.6 3.4 9.3 4.6 26.2 4.2 6.3 13.9 5.8 7.8 10.1 12.7 23.8 10.4 13.9 9.4 13.8 14.4 25.9 5.0 13.9 8.3 25.2 7.6 7.1 11.8 21.6 14.4 9.2 5.0 7.5 20.6 14.8 5.9 8.3 16.5 18.2 14.0 16.9 16.3 15.4 25.8 10.6 20.2 18.8 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: , HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.4 10.3 26.0 22.5 26.9 48.8 9.3 21.6 31.0 17.1 20.7 7.4 24.6 23.7 18.5 37.8 8.4 17.2 19.3 23.4 18.0 14.1 10.2 10.4 27.5 19.3 8.0 21.3 28.7 20.6 17.6 23.1 32.6 15.1 19.5 33.8 14.9 20.8 13.4 23.3 10.7 30.4 20.3 21.5 28.2 13.2 15.1 27.3 18.3 12.7 46.0 12.9 4.2 18.4 28.5 12.4 17.3 13.3 16.6 26.6 19.0 27.9 19.9 20.0 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046141 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 15.6;testis: 33.3" "Cell line enhanced" "Detected in many" "AN3-CA: 32.7;HEL: 24.0;SH-SY5Y: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.0 0.6 1.5 1.8 1.6 2.0 1.6 3.8 4.5 15.6 2.8 1.6 2.5 0.8 7.9 0.6 1.1 1.2 2.8 2.0 2.0 1.4 1.0 1.0 1.4 2.8 2.2 3.3 6.8 0.7 0.2 0.9 3.3 1.0 3.7 0.9 1.2 3.0 3.8 1.6 1.1 1.1 4.0 1.0 1.2 1.0 33.3 0.7 8.4 1.0 1.8 1.2 3.1 4.2 0.0 1.3 0.0 0.1 0.4 0.1 0.0 0.1 1.2 8.6 32.7 0.7 1.0 2.5 1.0 0.5 1.8 1.6 0.2 0.1 1.5 0.6 1.9 0.2 4.1 0.1 1.3 0.3 2.7 24.0 1.4 1.0 1.4 0.2 7.6 0.5 0.6 1.0 2.0 3.7 1.1 0.0 3.1 0.8 3.9 2.0 11.2 0.3 5.5 5.2 0.8 0.0 0.0 6.9 13.4 1.7 0.3 1.1 0.1 0.4 3.4 4.5 5.3 2.5 1.5 3.1 1.6 1.8 1.4 2.4 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 1.6 3.8 4.5 2.0 1.4 2.2 3.3 1.0 0.7 MFAP3 ENSG00000037749 "Microfibril associated protein 3" P55082 5 154038906-154220478 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015883, HPA049198" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" Nucleoplasm "HPA015883: AB_1853840, HPA049198: " "unprognostic (6.02e-2)" "prognostic unfavourable (4.28e-4)" "unprognostic (1.58e-3)" "unprognostic (2.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.07e-2)" "unprognostic (1.53e-2)" "unprognostic (7.00e-2)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (9.35e-3)" 21.3 7.6 5.8 8.0 12.2 7.9 11.3 12.6 11.4 11.1 8.3 6.3 7.8 7.2 14.1 7.3 11.6 7.5 8.9 9.2 7.2 6.8 9.5 9.4 10.9 6.8 6.4 7.1 9.4 6.3 27.2 9.6 15.0 8.8 7.8 8.4 9.5 8.8 6.4 13.2 6.4 9.5 11.7 8.9 7.9 7.4 8.3 7.0 9.1 11.3 6.3 9.2 12.2 10.1 3.0 10.6 14.6 10.3 7.7 9.6 5.4 9.5 12.5 21.3 22.3 19.2 18.0 20.9 17.4 18.6 18.1 23.5 18.8 21.8 13.8 20.1 16.3 21.6 20.0 21.7 29.0 6.2 13.1 9.0 19.2 6.8 18.3 16.1 10.6 19.4 21.5 21.7 18.5 25.3 10.3 15.0 15.7 6.3 8.9 3.7 11.0 7.4 8.6 25.2 12.6 11.7 13.6 22.0 24.5 19.0 21.5 17.1 22.6 8.0 23.0 23.6 16.5 13.0 17.6 15.0 19.3 13.0 12.0 11.2 18.5 8.1 10.3 14.6 6.5 9.8 9.6 3.0 5.6 4.9 10.6 3.0 7.4 5.4 8.4 7.7 7.0 3.8 4.9 5.4 5.8 12.2 12.6 11.4 7.2 6.8 6.4 7.1 8.8 7.0 MFHAS1 "LRRC65, MASL1, ROCO4" ENSG00000147324 "Malignant fibrous histiocytoma amplified sequence 1" Q9Y4C4 8 8783354-8893645 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.5;MAIT T-cell: 2.1;memory B-cell: 1.1;memory CD4 T-cell: 3.9;memory CD8 T-cell: 2.2;naive B-cell: 1.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.7;T-reg: 3.1" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051213, HPA054471" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051213: , HPA054471: " "unprognostic (1.33e-1)" "unprognostic (4.46e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-1)" "unprognostic (1.95e-1)" "unprognostic (8.91e-3)" "unprognostic (2.70e-2)" "unprognostic (2.68e-3)" "unprognostic (9.23e-3)" "unprognostic (7.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.81e-1)" "unprognostic (2.01e-3)" "unprognostic (5.93e-2)" "unprognostic (4.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.81e-1)" 8.0 2.7 10.1 14.9 10.2 12.5 5.8 10.3 10.0 8.7 16.6 5.0 5.0 7.6 7.7 4.8 7.6 9.9 10.7 7.6 10.0 6.5 15.8 10.5 12.5 12.1 6.2 4.7 6.8 6.3 6.2 3.3 11.1 7.4 8.9 14.9 5.4 7.6 6.1 4.4 8.5 9.5 10.4 3.6 13.5 9.0 7.6 5.2 24.9 10.8 3.6 10.6 9.3 15.0 1.1 0.5 0.0 0.3 0.4 3.9 0.9 7.7 5.9 3.6 2.7 3.4 4.4 11.9 3.2 7.0 2.3 3.2 9.4 1.5 11.5 4.0 3.1 2.6 3.7 2.9 2.1 14.8 3.3 0.8 2.2 6.1 4.0 3.2 1.2 2.3 6.3 3.2 3.2 5.2 5.3 0.0 1.9 2.8 50.5 2.9 7.0 2.5 6.9 5.5 1.8 16.5 8.1 5.7 4.6 1.9 3.0 5.1 2.0 4.5 2.2 2.8 4.3 11.4 6.2 0.6 2.7 9.0 5.3 4.4 1.7 0.0 0.3 0.0 2.5 0.1 2.1 1.1 3.9 2.2 0.5 1.0 1.9 1.7 0.0 0.4 0.0 0.1 3.1 0.9 10.1 10.2 10.3 10.0 10.0 6.5 6.2 4.7 7.4 5.2 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057924, HPA065858" Approved Approved Nucleoplasm,Nucleoli 14000 Nucleoplasm Nucleoli "HPA057924: , HPA065858: " "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.7 6.3 1.6 4.9 8.6 8.1 10.2 23.1 10.4 8.2 8.1 2.6 14.6 4.1 17.0 14.8 7.7 4.0 5.1 7.7 16.4 10.7 11.1 4.8 1.1 9.3 40.9 27.8 12.1 6.7 7.4 2.0 6.4 8.6 8.5 14.6 3.4 2.5 12.0 1.6 16.2 5.5 2.4 36.3 3.0 3.9 4.8 7.2 17.1 13.2 4.1 10.4 16.0 21.1 11.8 4.5 17.4 11.3 27.1 19.0 2.3 14.8 29.6 8.2 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 MFSD10 "IT10C3, TETRAN" ENSG00000109736 "Major facilitator superfamily domain containing 10" Q14728 4 2930561-2934859 "Predicted membrane proteins" "Apoptosis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043209 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA043209: " "unprognostic (1.44e-1)" "unprognostic (2.26e-2)" "unprognostic (7.06e-2)" "unprognostic (2.11e-3)" "unprognostic (7.76e-2)" "unprognostic (9.43e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (6.82e-3)" "unprognostic (4.70e-3)" "unprognostic (3.21e-1)" "unprognostic (1.91e-2)" "unprognostic (5.42e-3)" "prognostic unfavourable (5.68e-5)" "unprognostic (8.32e-2)" "unprognostic (2.30e-1)" "unprognostic (8.03e-2)" "unprognostic (1.00e-2)" 21.6 9.1 10.3 15.2 10.7 62.9 34.4 20.2 13.0 17.1 18.1 8.9 17.5 13.8 16.0 17.1 18.0 16.3 23.5 13.5 9.6 10.1 15.7 6.0 16.8 17.6 9.1 10.1 20.6 20.9 4.2 13.3 13.5 8.4 22.0 5.2 7.1 27.1 14.5 10.3 10.0 19.0 10.9 7.7 16.3 18.7 11.1 7.4 8.3 29.9 15.0 14.9 15.2 16.7 18.4 22.2 42.5 33.1 16.1 33.2 15.0 12.7 12.0 3.4 8.8 5.9 4.2 9.6 11.7 5.8 5.7 6.6 6.3 30.7 2.2 6.2 7.3 11.9 3.1 17.0 1.6 14.3 10.8 4.8 10.3 6.6 9.9 15.2 7.0 6.4 10.0 6.5 4.1 6.5 6.6 4.7 4.3 13.7 4.3 70.3 11.4 14.5 5.3 1.7 10.5 8.6 7.8 9.1 10.9 2.8 8.2 12.3 21.6 28.9 9.6 4.6 8.1 5.8 9.3 3.1 1.4 3.4 13.4 38.9 7.3 21.0 21.4 42.5 29.9 26.4 25.3 18.4 19.3 33.2 22.2 14.8 9.9 17.3 16.8 16.1 33.1 17.4 12.6 15.0 10.3 10.7 20.2 13.0 9.6 10.1 9.1 10.1 8.4 7.4 MFSD12 "C19orf28, MGC20700, PP3501" ENSG00000161091 "Major facilitator superfamily domain containing 12" Q6NUT3 19 3538261-3574290 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.3;WM-115: 111.4" "Cancer enriched" "Detected in all" 7 "melanoma: 124.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042149, HPA043088" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA042149: , HPA043088: " "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "prognostic favourable (5.66e-6)" "unprognostic (1.56e-2)" "unprognostic (6.51e-2)" "prognostic unfavourable (6.61e-4)" "prognostic unfavourable (2.34e-4)" "unprognostic (3.19e-2)" "unprognostic (9.12e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "prognostic favourable (7.70e-4)" "unprognostic (1.95e-1)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" 25.9 13.0 15.4 19.0 14.4 23.5 9.3 10.4 22.9 8.1 8.9 24.3 11.2 12.5 10.2 12.7 11.1 14.3 10.0 7.6 23.9 12.8 38.0 21.5 13.8 15.2 20.7 10.0 9.7 19.8 15.7 11.9 46.6 15.6 10.2 5.7 13.5 23.7 10.5 8.1 43.6 13.8 9.9 18.6 19.7 14.1 7.5 16.1 37.0 9.1 6.1 11.8 7.9 7.8 2.4 12.9 2.6 7.9 0.5 3.1 1.6 16.6 13.5 3.3 8.8 6.9 5.4 12.0 10.2 5.5 12.0 13.2 5.7 5.7 4.7 7.8 5.4 10.5 4.3 5.3 4.3 10.3 12.2 2.7 43.2 5.9 8.7 5.9 9.3 4.8 8.0 12.3 2.9 3.2 13.1 6.8 3.0 10.0 5.8 10.6 6.2 11.0 4.2 4.8 19.9 5.0 7.2 12.7 6.4 20.3 9.5 58.3 3.2 12.4 13.3 5.4 8.1 22.2 11.6 7.9 4.4 4.3 24.1 15.2 111.4 0.1 4.0 2.6 2.1 7.9 2.1 2.4 3.1 1.6 2.8 1.7 2.7 2.1 1.3 0.5 7.6 12.9 0.5 1.6 15.4 14.4 10.4 22.9 23.9 12.8 20.7 10.0 15.6 16.1 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.8 13.1 10.3 28.9 20.7 20.9 25.3 22.0 22.6 22.2 8.4 31.2 31.3 15.1 21.8 57.6 15.6 16.2 22.0 22.3 8.4 10.8 16.1 12.6 20.5 33.9 20.0 19.0 24.4 23.9 18.4 19.3 20.3 18.7 30.0 19.7 24.8 19.5 19.2 13.5 12.5 30.2 10.1 24.0 20.1 12.6 16.7 21.6 25.5 26.8 11.6 20.1 20.6 23.7 16.7 36.3 23.4 20.7 25.6 8.6 21.1 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 MFSD6 FLJ20160 ENSG00000151690 "Major facilitator superfamily domain containing 6" Q6ZSS7 2 190408355-190509205 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022274 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" Cytosol "Nucleoplasm, Actin filaments" "HPA022274: AB_2142776" "unprognostic (9.47e-2)" "unprognostic (7.01e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-2)" "unprognostic (2.49e-1)" "unprognostic (4.13e-3)" "unprognostic (1.78e-2)" "unprognostic (3.08e-2)" "unprognostic (3.92e-1)" "unprognostic (3.77e-1)" "unprognostic (9.54e-2)" "unprognostic (2.08e-1)" "prognostic favourable (1.05e-4)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" "unprognostic (9.14e-2)" "unprognostic (9.18e-2)" 12.3 26.9 20.8 9.3 23.3 4.2 13.8 19.4 33.1 15.3 20.0 29.0 29.0 12.6 7.1 22.3 26.6 13.0 10.3 11.1 25.4 26.5 7.4 2.0 16.9 8.7 36.2 22.9 3.5 10.9 28.2 35.7 5.6 43.1 15.7 19.0 12.2 19.2 29.6 3.8 18.9 15.4 9.5 36.7 12.7 20.2 4.9 18.3 13.0 25.5 10.8 12.7 13.3 13.6 2.4 2.6 8.1 2.0 3.3 5.6 1.2 10.5 6.5 0.2 2.3 4.8 6.2 9.0 5.4 11.0 3.7 4.7 2.4 13.4 16.5 2.6 11.3 17.9 3.2 9.5 4.2 33.4 4.9 8.8 6.4 1.2 1.9 3.4 2.8 0.9 17.3 5.4 3.6 1.3 2.2 18.4 0.9 4.0 16.0 0.7 1.5 7.0 3.6 0.5 14.1 7.0 19.3 21.0 5.4 7.7 18.2 10.5 5.9 4.0 5.4 0.6 1.3 7.2 8.3 8.4 3.5 5.9 6.0 7.2 2.9 8.1 2.0 0.6 2.6 0.6 2.7 2.4 3.5 3.6 2.6 1.3 1.6 3.6 0.1 3.3 0.9 1.3 5.6 1.2 20.8 23.3 19.4 33.1 25.4 26.5 36.2 22.9 43.1 18.3 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell line enhanced" "Detected in many" "A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: " "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.6 4.4 2.2 0.0 0.0 2.3 0.3 0.9 7.9 4.7 0.0 0.5 0.0 1.7 1.0 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.2 1.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 2.2 3.0 3.8 4.5 6.2 0.0 11.1 4.2 3.8 1.7 3.4 0.1 0.1 4.0 13.1 14.2 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 MGST3 GST-III ENSG00000143198 "Microsomal glutathione S-transferase 3" O14880 1 165630861-165661796 "Enzymes, Predicted membrane proteins" "Lyase, Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 92.7;HDLM-2: 98.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053311 Approved Nucleoplasm 40000 Nucleoplasm "HPA053311: " "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.65e-2)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (7.78e-2)" "unprognostic (3.09e-1)" "unprognostic (2.06e-2)" "unprognostic (2.16e-1)" "unprognostic (1.90e-1)" "unprognostic (3.96e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.60e-2)" "unprognostic (8.88e-2)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" 42.8 30.8 52.5 9.7 30.5 19.0 51.2 17.9 56.0 18.4 39.7 18.4 19.1 65.2 19.5 101.8 19.7 20.6 26.5 133.6 38.1 33.9 45.2 29.5 20.8 11.0 44.2 37.6 22.7 17.7 11.1 18.3 30.9 39.6 21.2 40.4 20.3 29.8 20.6 87.2 15.6 53.4 24.7 38.7 12.4 29.8 19.4 23.3 2.7 25.7 41.8 8.2 19.9 17.3 21.3 35.1 20.7 47.0 15.7 38.0 40.7 23.1 17.0 18.4 14.5 64.7 38.9 92.7 19.4 31.3 15.1 26.4 17.7 30.3 1.4 15.4 23.7 28.4 4.5 19.0 15.3 98.4 11.5 3.5 13.4 8.0 18.2 5.6 7.8 33.2 15.3 20.9 8.0 24.6 8.7 8.9 28.3 5.1 6.1 12.8 40.3 21.9 5.8 7.9 2.9 79.8 21.7 14.3 17.5 19.5 25.4 38.6 19.2 27.3 22.3 18.8 11.2 12.9 14.0 6.6 4.5 0.8 34.8 14.7 12.0 10.4 45.7 20.7 30.1 37.0 30.3 21.3 38.0 33.5 35.1 19.9 24.4 26.7 9.8 15.7 47.0 15.1 32.3 40.7 52.5 30.5 17.9 56.0 38.1 33.9 44.2 37.6 39.6 23.3 MICU2 EFHA1 ENSG00000165487 "Mitochondrial calcium uptake 2" Q8IYU8 13 21492691-21604214 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045511, HPA058790" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA045511: AB_10959894, HPA058790: " "unprognostic (4.32e-3)" "unprognostic (1.50e-2)" "unprognostic (2.00e-1)" "unprognostic (7.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.11e-2)" "unprognostic (1.47e-2)" "unprognostic (8.01e-2)" "unprognostic (4.79e-3)" "unprognostic (1.63e-3)" "unprognostic (1.58e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.40e-7)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (5.15e-2)" "unprognostic (3.50e-1)" 14.8 32.4 23.9 23.5 23.2 20.9 22.9 28.6 25.4 19.5 25.4 17.3 16.1 18.0 16.7 21.1 19.9 17.8 16.3 41.7 22.9 24.1 52.8 24.5 15.6 16.8 23.4 25.6 17.0 16.9 19.5 30.3 31.2 20.6 20.3 23.9 14.5 16.9 23.6 39.6 15.5 21.0 14.7 28.1 19.4 20.1 17.5 22.6 25.2 26.3 25.6 19.4 15.6 15.4 33.2 21.8 26.5 23.5 22.8 30.7 17.2 12.0 6.9 16.6 10.5 14.8 19.9 14.3 20.6 16.8 22.0 15.3 10.1 19.6 18.9 13.3 19.6 16.2 16.3 17.2 30.3 19.1 16.9 32.6 7.6 11.6 17.9 24.4 19.0 17.2 17.1 12.3 8.7 14.6 11.5 8.5 35.8 10.5 16.2 23.3 11.3 11.0 17.9 42.3 12.6 43.2 9.9 13.4 10.3 14.0 16.5 13.3 16.1 23.1 18.0 9.6 8.6 19.5 16.9 6.4 8.3 13.8 9.4 20.5 23.7 22.1 20.1 26.5 26.1 23.5 24.1 33.2 23.0 26.0 21.8 20.8 20.9 26.0 18.7 22.8 19.3 20.1 30.7 17.2 23.9 23.2 28.6 25.4 22.9 24.1 23.4 25.6 20.6 22.6 MIDN ENSG00000167470 Midnolin Q504T8 19 1248553-1259140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 13.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042018, HPA049432" Uncertain Approved Nucleoplasm Nucleoplasm "HPA042018: , HPA049432: " "unprognostic (1.82e-2)" "unprognostic (6.21e-2)" "unprognostic (2.27e-2)" "unprognostic (2.18e-2)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (1.06e-2)" "unprognostic (2.04e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.49e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "unprognostic (3.56e-1)" "unprognostic (1.19e-2)" 28.0 32.6 9.7 22.7 16.1 59.4 16.6 8.9 19.5 19.5 24.7 17.6 12.6 19.0 14.1 14.2 38.7 28.3 40.8 27.8 10.4 9.8 17.9 19.3 28.7 19.9 10.2 6.5 36.7 20.0 8.2 32.7 19.7 22.3 20.1 11.1 19.5 18.8 22.2 48.2 26.6 31.6 14.6 14.6 30.7 21.9 10.5 9.2 28.6 14.0 31.3 34.5 19.4 20.1 0.4 0.5 13.5 1.2 1.4 1.2 0.6 5.1 11.4 19.6 9.1 4.2 7.1 14.4 8.9 5.4 4.6 3.2 14.8 5.8 8.2 9.8 6.7 10.6 5.9 9.5 1.8 11.5 10.8 11.5 7.4 11.6 8.5 11.5 17.2 11.0 9.0 5.5 5.3 7.5 14.7 8.7 4.8 20.6 15.4 4.7 42.9 7.6 24.1 5.5 3.7 8.6 6.1 15.7 20.5 18.9 18.2 11.8 7.3 13.3 9.3 8.4 9.4 38.8 9.6 8.2 4.4 11.2 16.2 5.2 28.7 1.1 1.2 1.2 1.2 1.2 0.8 0.3 0.4 0.8 0.5 0.4 0.2 0.6 13.5 1.4 1.2 0.5 0.1 0.6 9.7 16.1 8.9 15.5 10.4 9.8 10.2 6.5 22.3 9.2 MIER2 KIAA1193 ENSG00000105556 "MIER family member 2" Q8N344 19 301444-344815 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041439 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041439: AB_2677481" "unprognostic (1.48e-1)" "unprognostic (1.45e-3)" "prognostic unfavourable (2.89e-4)" "prognostic favourable (1.72e-5)" "unprognostic (6.71e-2)" "unprognostic (2.96e-1)" "unprognostic (6.95e-3)" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (4.24e-1)" "unprognostic (1.18e-2)" "unprognostic (7.24e-2)" "prognostic unfavourable (7.22e-6)" "unprognostic (8.05e-2)" "unprognostic (4.28e-2)" "unprognostic (4.94e-3)" "unprognostic (1.68e-2)" 15.5 6.8 9.1 9.3 11.8 4.3 9.7 14.4 12.5 8.6 7.5 10.0 6.6 9.8 12.0 7.8 9.4 7.9 8.5 9.1 9.8 6.7 6.4 3.4 12.5 8.5 9.1 7.8 8.5 11.6 3.7 9.8 13.5 9.1 10.9 3.3 8.3 12.9 10.9 17.0 18.4 9.3 6.4 6.4 17.2 10.3 31.5 12.1 4.6 8.3 7.1 6.6 9.1 16.5 2.2 6.6 6.4 5.8 1.6 3.3 3.0 8.8 5.6 5.0 5.8 1.8 2.8 10.9 7.3 3.5 5.5 5.8 8.6 2.8 4.6 3.9 3.8 7.5 3.2 4.3 1.7 11.0 15.6 2.7 4.5 6.5 5.5 0.0 21.9 3.6 3.3 4.5 1.6 6.2 7.7 0.0 3.0 9.3 7.2 9.9 13.0 0.0 6.3 1.6 1.2 2.6 5.0 8.1 7.3 4.2 3.2 7.2 3.6 4.9 6.5 7.5 5.3 11.4 8.0 13.4 6.6 3.7 7.1 3.9 7.4 6.4 5.8 4.2 2.0 5.2 1.8 0.9 2.7 3.0 6.6 2.2 3.3 2.2 0.5 1.6 5.8 3.7 1.1 3.0 9.1 11.8 14.4 12.5 9.8 6.7 9.1 7.8 9.1 12.1 MIF "GIF, GLIF" ENSG00000240972 "Macrophage migration inhibitory factor" P14174 22 23894004-23895227 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Isomerase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 127.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003868, CAB005284" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" 13800000 14000000 Cytosol Nucleoplasm "CAB005284: AB_648587, HPA003868: AB_1079290" "unprognostic (1.68e-1)" "unprognostic (7.79e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.36e-2)" "unprognostic (9.48e-2)" "unprognostic (1.22e-3)" "unprognostic (2.17e-2)" "unprognostic (1.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-2)" "unprognostic (2.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" 30.6 49.8 43.9 42.0 39.9 46.0 71.6 19.0 66.1 23.0 42.7 10.4 55.6 39.9 22.5 113.3 51.9 23.3 42.5 60.7 42.8 40.3 71.8 58.8 46.2 113.9 33.5 43.7 24.5 80.2 16.2 41.1 30.5 45.2 54.8 11.6 15.0 57.3 101.2 36.0 63.3 50.6 26.7 78.3 42.5 56.2 24.9 19.2 19.0 28.9 43.7 16.7 21.4 44.6 56.8 42.5 17.6 23.8 38.3 52.7 66.0 48.9 10.9 2.4 11.0 0.9 2.2 18.4 18.5 3.1 5.9 7.7 8.1 8.1 23.3 14.7 1.3 21.8 2.5 11.2 0.7 19.6 127.1 8.8 9.9 16.9 4.8 34.0 20.7 4.7 6.7 3.5 1.7 4.7 13.6 11.8 2.0 24.6 23.1 63.0 14.0 59.3 29.7 4.1 65.3 4.6 3.4 31.9 37.2 11.8 12.5 30.5 16.1 10.2 13.5 5.2 35.0 3.1 0.4 51.4 18.1 24.0 21.1 12.7 10.6 16.3 23.8 17.6 37.4 22.3 52.7 56.8 51.8 40.4 31.6 49.1 46.1 38.0 7.1 38.3 14.6 42.5 48.3 66.0 43.9 39.9 19.0 66.1 42.8 40.3 33.5 43.7 45.2 19.2 MIIP "FLJ12438, IIp45" ENSG00000116691 "Migration and invasion inhibitory protein" Q5JXC2 1 12019466-12032045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "HDLM-2: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044948 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044948: AB_10795887" "unprognostic (1.36e-2)" "unprognostic (1.95e-2)" "unprognostic (5.02e-3)" "unprognostic (3.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.65e-3)" "unprognostic (7.16e-2)" "unprognostic (2.97e-1)" "unprognostic (4.03e-2)" "unprognostic (3.73e-3)" "unprognostic (6.56e-2)" "prognostic unfavourable (8.26e-7)" "unprognostic (8.02e-3)" "unprognostic (5.09e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 13.2 9.4 12.2 17.0 17.3 53.4 10.8 13.7 15.3 11.1 11.4 11.9 11.6 11.0 16.5 8.8 11.1 13.0 8.9 13.3 12.9 10.1 9.2 11.7 13.3 18.3 15.9 10.6 20.4 13.5 5.8 7.1 14.6 17.0 11.3 4.5 8.5 18.1 14.2 26.3 14.8 12.7 12.3 11.0 20.4 10.0 18.2 15.2 10.5 22.5 9.7 12.5 12.3 11.9 14.8 45.0 18.3 27.1 10.6 19.0 12.5 4.9 3.3 2.6 5.1 1.4 1.6 9.2 2.7 1.4 5.3 4.0 6.5 7.9 6.3 6.4 1.4 5.1 1.9 3.0 0.6 88.7 7.4 3.9 5.3 6.8 3.0 5.9 12.1 2.1 3.9 4.6 2.0 2.9 11.7 5.8 1.6 5.0 5.9 8.9 4.7 5.0 8.4 3.3 9.6 2.2 1.5 4.9 5.2 3.9 5.0 9.6 3.3 10.4 3.1 4.8 5.2 9.7 4.1 4.9 6.2 8.4 3.1 10.4 4.9 4.9 23.2 7.1 9.0 25.9 8.4 14.8 9.3 7.8 14.2 13.0 5.8 4.5 18.3 10.6 27.1 45.0 19.0 12.5 12.2 17.3 13.7 15.3 12.9 10.1 15.9 10.6 17.0 15.2 MIS18A "B28, C21orf45, C21orf46, FASP1, hMis18alpha" ENSG00000159055 "MIS18 kinetochore protein A" Q9NYP9 21 32268219-32279069 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA018286, HPA020585" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA018286: AB_1845693, HPA020585: AB_1845694" "unprognostic (1.19e-1)" "unprognostic (1.55e-2)" "unprognostic (4.44e-2)" "unprognostic (1.98e-3)" "unprognostic (3.45e-2)" "unprognostic (2.29e-2)" "unprognostic (1.64e-2)" "unprognostic (2.35e-2)" "unprognostic (1.19e-2)" "unprognostic (4.39e-3)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" "unprognostic (3.34e-2)" "unprognostic (1.85e-2)" "unprognostic (1.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.28e-1)" 5.5 7.5 7.8 6.6 10.7 13.8 7.4 16.4 8.3 6.1 8.9 5.4 1.9 7.9 6.6 6.3 11.4 5.6 5.3 3.9 6.8 4.7 6.7 5.7 3.7 9.7 6.8 9.3 9.8 5.8 3.3 4.3 7.1 6.6 5.5 10.6 4.4 6.0 4.1 4.0 7.8 8.5 7.7 6.2 7.3 6.1 26.6 5.4 19.3 3.9 6.8 11.3 5.3 6.5 18.5 13.2 8.2 11.7 10.4 15.5 6.4 20.9 5.2 15.1 14.5 2.3 4.0 23.2 11.1 5.7 10.9 9.5 10.4 11.7 23.0 8.2 4.2 7.1 14.8 8.4 13.1 13.1 16.5 26.3 5.5 13.3 1.5 22.5 8.9 1.7 3.7 9.1 6.6 7.6 30.6 19.4 10.6 14.3 25.7 20.5 31.2 15.4 22.5 22.6 21.4 7.5 7.2 18.2 8.9 16.9 14.4 10.3 17.4 13.8 4.4 13.7 25.4 10.6 11.3 10.5 16.6 28.9 8.7 36.2 12.4 2.4 5.3 8.2 10.2 6.8 10.2 18.2 11.2 11.7 4.9 18.5 15.5 11.5 1.7 10.4 11.7 13.2 14.6 6.4 7.8 10.7 16.4 8.3 6.8 4.7 6.8 9.3 6.6 5.4 MIXL1 "MILD1, MIXL" ENSG00000185155 "Mix paired-like homeobox" Q9H2W2 1 226223618-226227054 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 23.9;lymphoid tissue: 8.9" "Cell line enhanced" "Detected in some" "HAP1: 2.7;Hep G2: 13.2;U-698: 3.5" "Cancer enriched" "Detected in some" 9 "testis cancer: 6.3" "Group enriched" "Detected in some" 5 "cerebellum: 5.1;cerebral cortex: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA005662 Approved Nucleoplasm Nucleoplasm "HPA005662: " "unprognostic (4.09e-2)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.03e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (5.05e-2)" "unprognostic (7.40e-3)" "unprognostic (2.78e-2)" "unprognostic (2.70e-1)" "unprognostic (2.71e-13)" "unprognostic (1.54e-1)" "unprognostic (1.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.47e-2)" 0.6 0.2 0.6 8.9 0.4 0.3 0.3 5.1 1.8 0.7 1.4 0.4 0.0 2.7 0.4 0.1 0.6 0.3 0.2 0.4 0.6 0.6 0.3 0.6 0.5 8.2 0.6 0.0 1.2 0.2 2.3 0.3 0.3 0.6 1.0 1.1 0.2 4.9 0.4 0.2 0.3 1.3 0.0 0.5 7.8 1.4 2.2 0.0 1.0 0.4 0.7 7.0 2.6 0.3 7.5 7.7 23.9 12.2 14.6 9.5 4.0 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.1 2.7 0.0 0.2 0.0 0.1 0.2 0.2 13.2 0.6 0.0 0.1 0.2 0.1 0.7 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 23.9 4.7 8.4 4.8 7.1 9.5 7.5 5.6 5.4 4.8 7.2 7.4 7.3 12.9 14.6 12.2 7.7 7.1 4.0 0.6 0.4 5.1 1.8 0.6 0.6 0.6 0.0 0.6 0.0 MKRN1 RNF61 ENSG00000133606 "Makorin ring finger protein 1" Q9UHC7 7 140453040-140479569 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000567 Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA000567: AB_1079299" "unprognostic (9.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (7.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.41e-1)" "unprognostic (4.87e-3)" "unprognostic (1.24e-2)" "unprognostic (8.02e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.35e-1)" "unprognostic (2.89e-3)" "unprognostic (5.76e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (1.22e-2)" 16.8 17.6 26.8 20.8 28.8 69.9 20.1 37.2 32.6 20.4 39.6 16.1 19.7 28.4 20.1 18.6 23.3 22.2 22.4 38.5 24.9 29.8 20.6 17.5 23.6 18.3 25.7 23.3 24.9 27.3 28.2 21.5 31.7 29.4 21.0 33.7 19.4 24.8 23.1 38.5 24.4 26.6 26.3 20.5 22.5 21.7 95.4 20.2 21.0 23.6 18.8 22.3 25.3 36.4 13.1 7.5 39.3 10.5 12.8 17.8 6.4 27.9 21.6 16.9 25.0 26.8 23.5 23.9 19.3 25.1 15.2 17.6 8.8 29.5 20.3 30.3 18.8 13.6 19.0 21.2 19.3 40.2 16.5 21.1 13.0 16.3 21.6 18.0 32.7 23.4 32.0 17.1 16.2 15.1 16.6 25.7 14.6 24.1 21.1 32.4 43.4 16.0 15.3 14.5 31.1 24.4 32.4 23.4 24.2 24.2 32.8 34.5 16.1 15.7 21.4 10.7 8.5 26.1 17.6 61.3 44.9 17.8 30.6 28.4 22.0 19.4 9.2 39.3 6.7 8.7 8.0 13.1 13.0 10.1 7.5 10.9 17.8 11.3 18.1 12.8 10.5 2.5 14.0 6.4 26.8 28.8 37.2 32.6 24.9 29.8 25.7 23.3 29.4 20.2 MKRN2 "HSPC070, RNF62" ENSG00000075975 "Makorin ring finger protein 2" Q9H000 3 12557014-12583713 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037559, HPA037560" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037559: AB_10672460, HPA037560: AB_10696936" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-2)" "unprognostic (5.99e-2)" "unprognostic (3.89e-2)" "unprognostic (1.47e-2)" "prognostic unfavourable (1.58e-4)" "unprognostic (4.38e-1)" "unprognostic (8.49e-2)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (2.56e-3)" "prognostic favourable (6.04e-4)" "unprognostic (3.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-2)" "unprognostic (3.32e-2)" 13.7 10.4 15.1 11.1 18.3 16.4 11.6 29.3 19.5 13.7 12.7 12.4 16.1 12.5 15.2 12.3 16.2 13.1 10.9 26.3 14.0 15.1 13.7 12.5 12.1 12.6 15.2 14.8 20.8 26.6 17.3 11.9 14.4 16.0 11.3 11.5 13.2 12.8 13.1 24.5 12.8 10.9 15.9 16.2 10.1 11.7 46.1 14.7 15.4 18.2 17.0 13.7 13.0 12.6 21.3 19.0 30.0 20.3 25.3 26.2 18.7 10.7 12.4 14.8 11.1 23.2 22.6 28.7 16.6 17.8 21.2 17.8 12.0 10.7 15.2 9.5 18.3 6.6 19.3 16.3 18.9 17.2 16.2 21.7 14.2 16.0 26.7 21.3 9.9 25.1 15.2 24.6 15.6 17.4 20.2 21.6 18.2 15.1 26.1 11.1 9.9 21.8 25.2 14.3 17.1 14.9 14.2 8.7 14.7 14.4 7.4 14.8 16.7 18.9 17.5 14.5 14.3 17.2 22.5 16.4 33.6 32.7 15.7 25.5 21.8 18.9 17.2 30.0 21.5 15.6 26.2 21.3 22.1 22.0 19.0 16.4 23.9 22.3 15.0 25.3 20.3 15.1 23.4 18.7 15.1 18.3 29.3 19.2 14.0 15.1 15.2 14.8 16.0 14.7 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.7 3.4 3.0 3.1 0.0 0.0 7.1 0.3 0.0 2.9 2.0 8.5 0.0 0.2 0.1 0.0 8.2 1.3 0.0 0.7 0.0 0.3 6.8 9.1 0.3 0.2 8.0 6.1 0.1 0.0 6.0 0.0 0.0 17.5 7.5 0.8 0.0 8.4 3.5 0.0 10.4 6.0 1.1 4.2 0.0 0.1 0.7 2.4 0.0 3.4 0.0 2.7 2.4 0.1 8.0 6.7 0.4 5.6 9.4 11.5 5.6 4.7 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell line enhanced" "Detected in some" "BJ: 18.8;BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 12.4;BJ hTERT+ SV40 Large T+ RasG12V: 8.5;fHDF/TERT166: 53.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.8 10.8 12.4 8.5 0.0 0.0 0.0 0.0 53.9 0.0 0.1 0.0 3.3 0.0 1.2 0.0 3.4 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.2 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1" "Cell line enhanced" "Detected in many" "A-431: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in single" 12 "T-cells: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069479 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA069479: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavourable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavourable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 3.5 2.6 6.0 1.8 11.9 0.9 5.3 3.4 7.1 3.1 2.7 6.5 0.5 0.8 4.9 5.6 3.5 18.3 4.9 41.4 6.3 6.3 5.7 1.2 5.2 1.0 4.9 6.3 6.2 3.1 5.2 10.4 1.0 20.1 2.0 1.7 2.8 2.2 1.6 53.6 1.8 1.3 4.5 4.7 1.2 1.9 101.1 5.7 0.0 5.3 18.9 1.4 4.2 1.5 0.6 0.3 0.4 0.3 0.8 10.4 2.3 34.1 4.5 11.5 0.0 6.1 7.2 3.4 3.5 3.4 13.0 11.8 0.0 19.5 0.0 13.5 6.1 6.6 0.1 6.0 17.3 0.0 7.5 2.0 3.3 0.3 4.2 0.0 2.6 4.4 8.8 6.2 3.4 3.0 2.5 0.0 8.5 5.0 0.0 0.1 2.7 10.0 0.0 6.4 0.4 9.9 2.4 14.9 8.8 16.1 5.7 16.9 16.4 3.4 1.1 12.1 12.4 14.3 13.7 6.1 3.8 0.0 8.7 0.0 8.7 0.0 0.0 0.0 3.6 0.0 1.6 0.6 8.3 8.7 0.3 0.3 2.1 4.4 0.4 0.8 0.3 0.2 10.4 2.3 6.0 11.9 3.4 7.1 6.3 6.3 4.9 6.3 20.1 5.7 MLF2 NTN4 ENSG00000089693 "Myeloid leukemia factor 2" Q15773 12 6747996-6767475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010811, HPA010859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA010811: AB_1079389, HPA010859: AB_1079388" "unprognostic (1.65e-1)" "unprognostic (6.55e-2)" "unprognostic (4.42e-1)" "unprognostic (9.88e-3)" "unprognostic (1.76e-1)" "unprognostic (4.19e-2)" "unprognostic (1.52e-1)" "unprognostic (4.15e-2)" "unprognostic (1.31e-1)" "unprognostic (9.11e-2)" "unprognostic (3.37e-1)" "unprognostic (6.23e-2)" "unprognostic (1.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.72e-1)" "unprognostic (8.44e-2)" "unprognostic (3.63e-1)" 31.4 45.6 55.8 23.3 65.4 36.9 24.9 50.5 100.5 28.6 30.9 44.0 23.9 36.5 32.1 30.5 39.3 31.7 28.6 44.1 54.4 47.2 37.9 77.4 24.8 21.5 40.2 42.5 28.3 33.4 43.3 31.1 32.5 44.8 38.4 27.6 28.2 43.1 36.7 45.3 33.6 35.1 35.9 33.7 21.8 27.7 21.0 30.7 26.0 36.3 28.9 29.4 29.3 23.6 17.0 38.9 86.7 20.1 11.8 14.8 16.9 39.0 64.6 33.2 58.5 31.1 31.7 51.1 38.4 46.2 66.2 58.1 62.4 38.8 28.2 10.2 50.0 32.8 40.9 55.6 41.2 44.4 37.9 19.9 34.2 35.7 34.4 21.1 27.5 29.7 45.4 51.1 39.2 26.9 25.0 11.8 46.0 55.4 29.0 32.7 107.4 22.3 18.6 30.6 25.0 55.2 49.3 21.2 42.0 34.7 61.4 37.1 17.8 35.0 26.5 39.5 52.6 41.6 56.1 14.3 16.2 37.4 52.7 18.4 46.4 35.4 20.1 73.9 14.8 18.0 14.3 15.3 11.5 13.9 22.6 17.0 12.2 13.5 86.7 11.8 19.5 38.9 11.2 16.9 55.8 65.4 50.5 100.5 54.4 47.2 40.2 42.5 44.8 30.7 MLH3 ENSG00000119684 "MutL homolog 3" Q9UHC1 14 75013764-75051532 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060570 Approved Nucleoplasm Nucleoplasm "HPA060570: " "unprognostic (2.94e-1)" "unprognostic (6.70e-3)" "unprognostic (7.14e-3)" "unprognostic (7.35e-2)" "unprognostic (7.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.49e-2)" "unprognostic (1.62e-2)" "unprognostic (3.77e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-2)" "unprognostic (8.42e-2)" "unprognostic (3.53e-1)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" 13.6 15.6 10.3 9.0 14.4 3.3 13.4 15.2 18.6 13.7 11.8 17.3 17.0 8.4 13.1 12.9 9.4 10.9 10.7 11.0 11.2 10.6 12.8 11.7 8.6 10.3 18.5 15.4 13.3 9.4 24.6 33.6 10.3 16.6 13.4 11.0 8.4 9.2 19.4 13.6 8.0 13.3 12.0 15.6 9.9 7.9 10.7 18.5 7.7 19.2 5.7 12.6 12.0 9.6 8.1 4.1 4.6 3.8 9.8 7.0 8.3 10.3 10.3 7.3 1.3 8.2 13.8 7.8 3.3 3.2 6.1 5.5 8.0 12.3 11.9 3.1 3.9 7.6 0.1 3.8 8.7 11.4 0.1 7.3 6.7 5.0 6.7 3.3 5.0 5.5 7.7 6.1 0.4 9.9 7.4 9.3 13.3 7.8 4.7 3.2 6.7 5.8 9.2 4.9 2.3 13.3 10.8 11.9 9.1 11.1 8.0 0.6 10.8 6.7 5.3 2.5 4.8 3.5 3.6 11.0 10.8 11.6 9.1 0.3 11.3 4.6 3.8 2.4 7.0 2.9 5.8 4.8 4.1 6.4 4.1 8.1 6.4 5.1 1.9 9.8 2.0 3.5 4.5 8.3 10.3 14.4 15.2 18.6 11.2 10.6 18.5 15.4 16.6 18.5 MLIP "C6orf142, CIP, MGC18257" ENSG00000146147 "Muscular LMNA interacting protein" Q5VWP3 6 53929982-54266280 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 17.7;SK-MEL-30: 17.0" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA029252, HPA046654" Approved Approved Nucleoplasm Nucleoplasm "HPA029252: , HPA046654: " "unprognostic (7.95e-3)" "unprognostic (4.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-4)" "unprognostic (2.38e-2)" "unprognostic (1.26e-2)" "unprognostic (5.60e-2)" "unprognostic (2.74e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.91e-5)" "unprognostic (7.49e-2)" "unprognostic (2.65e-2)" "unprognostic (5.27e-2)" "unprognostic (3.29e-3)" 5.7 1.9 4.2 0.2 5.2 0.1 1.6 0.8 11.5 0.8 0.5 0.0 0.0 0.3 0.4 3.5 4.9 0.5 0.8 61.7 1.8 0.8 0.5 47.4 0.4 0.2 7.2 8.3 0.4 0.6 0.3 0.5 0.2 1.8 0.8 0.4 1.3 2.6 0.3 101.9 6.5 1.1 0.3 2.9 0.3 0.4 0.5 0.0 0.0 2.7 31.6 2.2 0.6 1.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 2.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 17.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.1 0.6 1.3 0.0 0.0 0.5 17.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 5.2 0.8 11.5 1.8 0.8 7.2 8.3 1.8 0.0 MLLT6 "AF17, FLJ23480" ENSG00000275023 "MLLT6, PHD finger containing" 17 38705542-38729803 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004021 Approved Approved Nucleoplasm Nucleoplasm "HPA004021: AB_1853995" "prognostic favourable (4.18e-4)" "unprognostic (1.50e-1)" "unprognostic (2.53e-1)" "unprognostic (1.44e-2)" "unprognostic (1.29e-1)" "prognostic favourable (3.98e-4)" "unprognostic (4.98e-2)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (7.12e-3)" "prognostic favourable (7.41e-4)" "unprognostic (1.78e-1)" "unprognostic (1.84e-2)" "unprognostic (9.12e-2)" "unprognostic (1.12e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-3)" 6.5 7.6 10.0 10.3 10.6 7.3 6.3 14.1 16.9 6.2 6.8 7.2 11.1 7.2 9.2 8.6 5.5 10.3 9.2 7.5 9.7 5.8 1.2 8.5 11.8 8.5 9.6 13.0 9.0 12.8 10.1 4.8 7.2 7.3 5.7 10.0 10.3 12.5 22.3 8.5 8.9 8.2 8.1 11.7 6.7 4.1 9.2 6.3 7.2 4.8 10.1 5.5 11.5 1.4 0.9 2.0 0.8 2.8 6.0 1.7 5.7 6.4 6.5 14.2 7.2 6.5 3.4 3.6 6.6 4.4 5.3 2.3 11.3 16.4 5.2 4.2 15.0 4.2 7.4 3.9 17.5 11.4 6.0 10.7 10.5 3.5 9.2 8.2 6.6 7.6 3.9 8.8 7.2 10.0 13.9 3.8 4.8 18.0 8.9 0.8 3.3 10.6 8.9 15.1 5.1 13.3 14.6 16.1 3.8 12.4 10.6 12.3 6.8 9.5 5.2 7.7 7.2 6.5 23.6 7.7 11.0 7.6 8.5 5.5 1.7 0.8 0.4 6.0 0.5 4.6 1.4 3.2 4.2 0.4 1.4 3.1 4.1 2.0 2.8 0.3 0.9 1.7 1.7 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: " "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favourable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 12.4 18.6 24.0 11.9 22.8 15.7 10.4 23.1 39.1 11.6 14.4 15.7 12.5 16.6 9.9 14.0 15.9 17.4 12.6 18.4 23.9 18.5 15.5 17.9 9.1 13.3 20.7 20.0 16.0 32.3 11.1 12.6 15.5 16.1 14.4 6.8 17.3 25.5 13.0 36.6 13.5 13.9 8.7 14.1 10.5 15.6 25.5 13.3 13.4 20.8 13.9 11.8 13.2 9.0 8.5 14.8 2.5 18.6 7.4 9.6 11.5 7.2 20.9 8.7 22.1 11.4 8.0 14.3 6.0 8.2 10.5 9.7 28.3 10.2 18.7 15.1 7.1 8.9 8.8 18.1 1.2 14.2 40.0 12.7 20.7 18.1 16.6 19.5 18.0 11.5 13.1 12.2 15.8 11.2 18.3 13.0 5.5 30.6 18.4 26.1 16.7 19.5 19.4 8.7 32.9 7.9 4.3 27.4 14.0 9.9 22.4 15.9 13.2 19.1 7.9 12.3 13.9 9.8 8.1 14.9 9.0 20.5 6.1 17.2 10.3 0.0 15.2 2.5 8.5 18.6 6.6 8.5 7.5 9.6 14.8 7.2 9.0 9.0 1.7 7.4 16.9 8.2 7.2 11.5 24.0 22.8 23.1 39.1 23.9 18.5 20.7 20.0 16.1 13.3 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell line enhanced" "Detected in many" "BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: " "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favourable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favourable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.3 2.3 11.8 2.4 0.1 36.8 0.5 0.3 2.1 0.4 3.4 14.8 0.0 7.0 0.6 8.1 1.9 1.7 0.6 0.0 3.9 0.0 1.9 19.1 3.1 0.1 7.7 1.2 3.0 0.3 0.9 1.4 4.7 0.0 0.7 2.8 0.2 0.9 6.7 1.2 2.8 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.5 3.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "HaCaT: 28.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9" "Lineage enriched" "Detected in many" 5 "T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 8.0 1.6 1.8 2.7 3.7 0.5 4.3 0.0 5.1 1.7 7.3 1.6 1.4 3.0 3.2 4.8 4.3 1.5 12.3 0.5 2.8 0.8 0.2 10.3 0.4 0.0 2.9 0.1 1.3 0.5 0.0 0.7 1.3 2.9 4.1 2.7 0.1 2.1 0.6 4.5 9.3 4.3 0.2 0.6 7.2 13.4 0.2 0.0 4.2 4.4 2.5 5.5 2.2 1.1 1.5 0.1 0.2 1.3 7.2 0.9 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.7 0.0 28.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.5 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.0 1.1 0.4 1.7 0.1 0.9 7.2 5.9 0.1 1.3 0.2 1.5 0.0 0.9 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530753 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3" "Cell line enhanced" "Detected in some" "A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: " "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavourable (2.53e-4)" "prognostic unfavourable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 6.8 0.2 0.2 1.2 0.2 0.0 28.8 0.2 0.2 5.2 0.2 0.2 2.1 0.0 17.2 12.3 3.3 16.4 93.0 0.2 0.2 0.2 129.5 1.4 5.0 0.9 0.2 0.2 3.9 23.5 0.0 0.7 2.7 1.3 42.0 0.0 0.2 79.3 6.7 0.2 7.8 0.3 0.5 0.2 0.2 0.9 9.4 0.2 1.2 0.3 1.4 4.5 19.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 126.5 0.0 30.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 MN1 "MGCR, MGCR1, MGCR1-PEN" ENSG00000169184 "MN1 proto-oncogene, transcriptional regulator" Q10571 22 27748277-27801498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 62.7" "Cell line enhanced" "Detected in some" "AF22: 22.0;HeLa: 8.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.0;U-2197: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 8 "monocytes: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003072 Approved Approved Nucleoplasm Nucleoplasm "HPA003072: AB_1079399" "unprognostic (5.64e-2)" "unprognostic (2.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (2.88e-2)" "unprognostic (2.52e-2)" "unprognostic (7.01e-2)" "unprognostic (3.03e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (4.00e-2)" "unprognostic (7.33e-2)" "unprognostic (5.13e-7)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (5.28e-3)" "unprognostic (2.21e-4)" 3.7 2.0 3.4 4.2 17.3 2.4 1.9 1.3 5.6 5.9 4.2 2.6 2.5 2.1 3.0 9.0 7.0 3.4 11.1 5.1 2.5 2.7 1.6 1.4 4.3 1.3 3.3 3.5 12.4 1.5 1.3 2.3 2.6 4.5 3.1 2.2 10.8 2.1 2.7 62.7 2.9 2.1 5.8 1.0 1.5 3.5 2.0 5.4 0.0 1.8 14.8 2.1 5.0 4.7 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 1.0 22.0 0.6 0.4 0.9 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 2.2 3.9 1.8 1.1 1.3 0.0 0.0 0.6 0.0 8.9 0.0 0.5 0.0 0.2 0.0 2.5 0.5 2.2 0.2 0.0 0.1 0.7 0.0 0.0 0.2 2.9 2.0 3.6 8.9 0.0 0.3 0.0 0.0 0.3 1.9 0.0 0.0 0.2 0.0 14.0 0.7 12.0 12.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 3.4 17.3 1.3 4.2 2.5 2.7 3.3 3.5 4.5 5.4 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.0 4.5 2.4 7.0 2.0 4.3 0.4 4.6 2.7 5.5 11.8 6.3 9.2 10.7 5.9 1.9 7.5 2.9 2.6 11.3 0.0 1.2 13.7 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.1 1.6 1.0 3.0 0.0 4.6 2.5 0.1 5.8 0.7 2.6 8.9 14.0 0.1 5.4 3.7 18.4 5.6 7.7 2.3 8.1 5.6 7.2 0.4 7.5 8.6 7.2 11.3 2.2 7.0 0.2 8.4 11.0 8.6 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA071717: " "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 3.8 0.0 11.5 0.0 0.0 8.6 0.0 0.0 0.1 0.0 5.0 1.6 0.9 11.1 0.0 0.2 2.0 1.5 0.9 1.4 8.8 0.0 0.7 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 3.6 1.9 0.0 6.4 0.6 0.1 0.0 0.7 0.0 1.7 24.2 4.3 0.4 13.0 0.0 1.6 1.4 0.2 3.6 2.9 0.0 0.0 0.0 0.0 0.0 3.6 1.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182196-93184928 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000939 Enhanced Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA000939: AB_1079402" "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favourable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favourable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 6.9 14.5 21.9 5.7 30.0 15.9 8.6 30.5 69.5 12.8 10.1 7.1 7.7 7.1 9.3 12.0 8.0 11.1 8.2 23.9 24.2 35.9 14.2 9.0 9.7 7.9 22.9 27.8 8.6 9.0 25.0 12.0 7.1 27.8 15.0 7.4 10.1 8.2 14.9 13.9 5.2 7.0 10.1 11.2 7.8 8.3 4.4 7.8 5.9 10.6 3.6 7.5 8.4 3.8 6.3 4.2 16.4 4.4 8.8 14.3 7.5 3.8 3.0 7.3 9.8 6.3 2.4 4.9 4.5 5.2 4.7 5.3 3.2 3.8 11.6 8.3 5.2 6.0 5.2 4.5 5.2 5.3 6.6 6.5 6.1 4.3 8.2 5.8 11.8 4.3 6.8 2.8 5.7 5.7 2.3 7.1 5.3 15.9 9.1 5.5 3.3 3.9 5.6 9.9 7.0 11.9 10.9 16.8 14.6 4.6 6.5 18.4 10.0 4.3 6.2 1.8 2.9 4.2 2.2 13.4 13.7 7.0 4.8 3.7 3.2 16.4 4.0 10.3 11.3 4.4 12.6 6.0 10.5 11.5 4.2 6.3 14.3 12.2 3.7 8.8 4.4 4.0 9.8 7.5 21.9 30.0 30.5 69.5 24.2 35.9 22.9 27.8 27.8 7.8 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA047088: , HPA071690: " "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavourable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 20.7 11.9 15.0 16.1 24.7 27.0 17.7 16.7 22.5 21.8 21.6 16.2 15.1 42.6 14.3 20.9 17.4 19.1 19.1 33.2 29.9 11.4 38.4 8.2 17.1 19.7 33.2 62.1 22.8 18.7 17.4 14.8 22.8 16.4 15.8 21.1 11.2 41.6 28.3 13.9 9.8 28.7 51.5 22.6 18.7 26.0 7.6 9.9 23.7 17.6 15.2 14.0 15.8 21.6 28.4 15.0 19.8 26.4 11.8 10.4 32.7 19.1 28.4 15.1 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA047088: , HPA071690: " "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavourable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.8 3.1 11.9 9.7 6.5 8.3 9.8 11.7 6.4 6.6 5.8 4.1 7.4 21.6 5.6 10.4 2.7 7.4 9.8 16.0 11.4 2.6 33.8 3.6 3.2 6.5 7.3 6.8 6.8 5.4 7.3 6.0 7.7 20.7 7.1 10.4 4.1 22.8 4.6 3.9 4.2 7.3 11.6 2.9 10.9 6.8 4.2 8.0 5.0 2.2 15.7 5.3 4.8 9.2 18.3 9.4 8.2 4.7 4.6 1.5 9.2 6.4 5.4 8.4 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 MON2 KIAA1040 ENSG00000061987 "MON2 homolog, regulator of endosome-to-Golgi trafficking" Q7Z3U7 12 62466817-62600479 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038697, HPA057607" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA038697: AB_10697396, HPA057607: " "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (9.91e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "prognostic favourable (2.03e-4)" "unprognostic (7.69e-2)" "unprognostic (5.99e-2)" "unprognostic (2.24e-2)" "unprognostic (6.20e-2)" "unprognostic (5.57e-2)" "unprognostic (1.58e-2)" "unprognostic (1.93e-1)" "unprognostic (1.77e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-3)" "unprognostic (4.36e-2)" 16.4 14.8 12.1 16.9 20.7 13.3 16.8 28.6 20.6 20.8 14.4 25.8 21.3 13.3 22.3 16.8 16.2 16.8 15.6 14.5 14.2 13.0 17.5 22.6 14.3 14.3 20.4 18.7 22.8 24.0 36.7 31.9 17.8 22.6 16.9 17.3 16.7 22.4 24.3 15.7 16.4 15.0 15.2 17.4 15.7 17.0 11.2 18.1 21.8 21.3 10.9 17.6 15.8 17.2 6.2 5.5 8.9 6.2 3.7 7.2 3.6 10.3 16.1 12.1 6.4 15.8 14.7 11.1 11.3 9.6 10.5 10.4 7.2 4.2 7.3 8.8 10.9 10.0 11.9 8.3 14.4 9.4 9.4 11.6 11.9 7.2 6.8 10.1 8.3 10.0 6.3 11.3 14.0 10.1 10.9 17.9 9.1 12.0 8.8 4.8 7.2 8.9 8.2 10.9 10.1 5.8 14.1 5.2 5.7 19.0 10.4 7.8 22.5 7.4 14.0 10.1 7.4 12.7 7.2 9.9 9.1 8.4 10.8 6.3 11.3 2.0 6.1 6.3 5.5 6.2 7.0 5.0 4.4 7.2 5.5 6.2 6.2 6.9 8.9 3.7 4.6 3.2 5.0 3.6 12.1 20.7 28.6 20.6 14.2 13.0 20.4 18.7 22.6 18.1 MORN1 FLJ13941 ENSG00000116151 "MORN repeat containing 1" Q5T089 1 2321253-2391707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA005858, HPA070703" Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA005858: AB_1848709, HPA070703: " "unprognostic (1.39e-3)" "unprognostic (6.49e-2)" "unprognostic (1.58e-1)" "unprognostic (8.21e-3)" "unprognostic (9.12e-2)" "unprognostic (5.87e-3)" "unprognostic (1.87e-1)" "unprognostic (2.65e-1)" "unprognostic (3.61e-2)" "unprognostic (5.97e-2)" "unprognostic (1.11e-2)" "unprognostic (2.60e-1)" "unprognostic (8.88e-3)" "unprognostic (2.53e-1)" "unprognostic (6.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" 4.2 4.0 6.9 5.6 15.1 2.5 4.9 25.8 6.6 7.3 4.4 6.1 14.4 4.5 9.3 13.9 3.7 23.5 7.4 3.0 5.5 5.7 7.8 4.1 5.8 3.5 3.9 8.0 15.2 8.6 4.9 11.6 2.5 11.7 6.7 3.1 8.8 9.1 11.7 4.7 6.4 4.3 6.0 4.9 4.6 5.4 17.3 4.8 5.8 15.0 3.3 3.8 3.5 4.6 2.1 3.7 4.2 4.3 0.8 2.6 1.0 6.3 7.6 5.3 4.8 1.8 0.9 5.5 1.9 1.3 3.1 2.7 3.6 7.1 1.7 4.1 1.2 7.8 1.1 3.1 3.1 3.8 8.2 1.7 14.0 4.1 1.6 2.1 0.9 1.1 0.7 3.0 2.6 2.2 2.6 2.0 1.1 8.7 2.1 0.7 3.1 6.7 2.2 4.8 2.7 2.5 2.8 8.7 4.3 5.0 9.3 4.0 4.9 0.6 0.7 3.6 5.2 2.5 2.3 4.7 1.7 1.1 7.2 1.2 2.4 0.0 0.8 0.2 1.4 0.3 0.8 1.0 1.5 1.1 1.0 2.1 2.6 1.2 4.2 0.8 4.3 3.7 0.1 1.0 6.9 15.1 25.8 6.6 5.5 5.7 3.9 8.0 11.7 4.8 MORN2 MOPT ENSG00000188010 "MORN repeat containing 2" Q502X0 2 38875962-38929072 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 88.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057815 Approved Nucleoplasm Nucleoplasm "HPA057815: " "unprognostic (7.28e-3)" "unprognostic (3.84e-2)" "unprognostic (8.65e-2)" "unprognostic (1.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (6.01e-2)" "unprognostic (2.60e-2)" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-2)" "unprognostic (3.55e-1)" "unprognostic (8.80e-2)" 5.9 14.4 20.5 3.1 22.7 4.1 10.2 6.8 14.8 14.9 6.5 10.3 13.8 3.4 8.3 34.6 5.0 43.7 9.1 10.7 16.4 18.6 31.4 8.6 8.6 2.9 16.5 12.7 9.6 9.5 22.7 27.1 4.0 30.1 8.4 6.8 8.3 11.4 9.7 7.1 3.6 3.3 5.7 11.1 3.1 6.9 88.7 9.5 2.0 21.9 7.2 2.9 6.1 4.4 3.6 7.5 2.0 11.0 3.1 4.8 4.8 23.2 12.3 15.1 18.4 16.5 24.9 8.4 10.8 17.1 17.3 16.7 7.1 13.3 1.5 9.1 16.1 6.4 6.7 14.0 25.8 9.9 13.0 5.1 13.9 18.9 14.5 8.2 3.7 14.9 17.2 21.2 7.7 15.9 8.6 3.5 14.1 23.3 3.7 15.7 11.5 12.9 2.0 15.8 5.2 32.3 13.9 15.1 19.9 16.1 10.7 22.9 14.7 11.3 10.6 12.1 12.1 19.2 17.1 6.8 9.8 0.8 28.0 2.4 21.7 2.0 11.0 1.5 2.2 8.4 4.1 3.4 2.6 3.3 7.5 3.6 4.4 4.6 0.9 3.1 6.9 3.8 4.8 4.8 20.5 22.7 6.8 14.8 16.4 18.6 16.5 12.7 30.1 9.5 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 30.1;testis: 51.5" "Group enriched" "Detected in some" 9 "BEWO: 12.3;CACO-2: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favourable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.3 0.2 1.2 0.5 1.4 0.9 0.3 0.3 1.6 0.4 0.3 0.3 0.3 0.2 0.3 1.4 0.3 5.6 0.4 0.3 1.4 1.2 0.4 0.3 1.0 1.4 0.3 0.3 0.3 0.4 3.4 0.7 30.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 2.5 0.3 0.3 0.3 0.8 0.8 51.5 0.3 0.3 0.5 0.3 0.6 0.3 0.3 1.2 1.2 3.1 0.6 2.2 2.3 0.6 0.1 0.2 0.4 0.2 0.0 0.3 12.3 0.2 0.0 0.1 0.1 6.6 0.3 0.2 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.4 0.3 0.4 0.9 0.1 0.3 0.3 0.0 0.2 0.2 0.3 0.1 0.2 0.8 0.5 0.2 0.1 0.3 0.0 0.1 0.4 0.1 1.0 1.0 0.1 0.2 0.0 0.9 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.1 0.3 0.9 0.3 0.1 2.3 0.6 0.4 2.1 0.3 2.0 0.8 2.3 1.3 0.2 1.2 2.1 1.4 3.1 2.2 0.5 1.2 2.0 0.6 1.2 1.4 0.3 1.2 1.4 1.2 0.3 0.3 0.3 0.3 MOSPD1 dJ473B4 ENSG00000101928 "Motile sperm domain containing 1" Q9UJG1 X 134887626-134915267 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031158 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA031158: AB_10603874" "unprognostic (2.23e-3)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.77e-1)" "unprognostic (3.36e-1)" "unprognostic (6.78e-3)" "unprognostic (5.15e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (6.20e-3)" "unprognostic (4.27e-2)" "unprognostic (6.45e-3)" "unprognostic (2.92e-2)" "unprognostic (2.01e-1)" "unprognostic (5.71e-2)" "unprognostic (1.15e-1)" 11.0 19.7 6.2 6.5 8.0 12.3 7.9 7.8 10.4 11.1 6.9 8.8 5.5 5.4 19.3 12.5 20.5 25.1 6.6 17.4 7.3 6.2 11.8 10.3 8.0 5.5 9.9 7.4 12.9 8.9 10.3 8.1 23.2 21.2 8.1 7.0 10.3 14.6 7.6 17.6 14.5 6.9 10.7 9.0 8.3 7.5 16.4 7.5 10.2 9.1 13.5 10.1 9.5 12.0 6.2 8.3 12.3 6.8 6.0 14.3 5.1 7.9 6.3 5.3 3.6 8.4 4.9 11.6 13.4 24.4 12.9 12.6 15.3 3.2 2.7 18.7 8.5 2.9 8.2 6.9 17.1 8.9 4.8 2.2 16.6 6.2 35.8 6.3 3.9 8.9 8.5 14.5 6.3 9.4 2.8 10.9 15.6 11.1 4.4 2.8 5.4 14.3 3.3 9.4 5.0 5.5 22.8 3.1 3.9 6.8 6.8 23.1 2.7 3.9 4.7 6.4 3.9 23.7 11.9 8.5 11.4 4.3 8.7 10.8 8.3 6.0 6.8 12.3 7.6 5.0 10.0 6.2 9.0 8.3 7.5 5.1 10.2 9.8 4.0 6.0 5.5 8.3 14.3 5.1 6.2 8.0 7.8 10.4 7.3 6.2 9.9 7.4 21.2 7.5 MOSPD3 "CDS3, NET30" ENSG00000106330 "Motile sperm domain containing 3" O75425 7 100612102-100615384 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041137, HPA048240" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041137: AB_10803996, HPA048240: " "unprognostic (1.24e-1)" "unprognostic (8.98e-2)" "unprognostic (1.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.25e-2)" "unprognostic (1.80e-2)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (9.88e-2)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (8.65e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" 13.8 22.3 13.0 7.7 12.8 17.4 9.8 9.0 16.9 14.7 9.1 14.5 13.9 9.9 12.0 12.9 22.5 12.0 14.9 10.2 11.2 10.8 19.3 29.8 11.1 18.5 10.6 11.6 13.1 17.1 6.7 9.8 7.8 12.0 12.9 4.8 14.9 19.1 11.3 11.3 24.4 10.6 10.3 9.5 11.8 14.7 37.0 9.9 16.6 12.2 13.6 16.8 12.4 13.4 11.6 17.9 22.2 16.7 20.9 29.7 8.0 5.9 8.1 6.5 11.2 3.4 2.5 4.6 4.5 5.4 4.7 4.8 7.4 8.0 3.7 10.0 4.1 4.6 3.8 6.5 0.8 9.7 5.0 3.8 6.0 11.1 4.4 2.9 14.9 7.2 5.6 4.0 2.4 8.0 9.0 7.7 4.8 17.6 8.3 22.6 5.9 12.2 7.7 6.7 8.9 7.4 8.9 3.6 21.3 8.5 13.1 4.5 8.0 8.8 9.1 9.2 14.4 18.9 4.3 6.0 5.7 2.5 9.1 33.1 11.2 18.5 16.7 22.2 18.8 12.4 22.2 11.6 21.8 21.8 17.9 11.3 13.0 13.5 12.3 20.9 8.5 12.0 29.7 8.0 13.0 12.8 9.0 16.9 11.2 10.8 10.6 11.6 12.0 9.9 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170226 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavourable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favourable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 13.7 15.5 32.0 17.5 25.1 12.3 54.1 37.1 32.6 18.5 16.0 9.3 7.0 9.9 18.9 17.1 26.5 11.9 12.3 9.4 25.4 22.2 12.0 11.5 13.6 16.1 17.5 21.9 10.4 7.2 13.6 43.5 17.4 24.0 11.3 18.7 10.8 18.1 10.3 15.4 28.4 11.0 16.8 31.7 12.7 11.2 9.9 17.9 10.8 8.7 12.9 18.2 19.6 18.5 18.6 24.6 19.4 25.2 17.1 28.3 15.6 19.3 10.6 23.7 11.6 11.6 16.3 13.1 20.9 25.1 18.3 8.9 17.0 11.4 16.0 12.7 11.4 20.4 22.6 21.7 24.6 11.8 14.8 12.8 8.8 30.6 11.5 31.9 19.9 10.3 19.5 10.8 31.3 20.9 30.1 4.5 27.8 15.7 24.5 37.7 21.7 14.7 30.4 11.0 10.5 16.5 20.4 16.3 7.0 35.2 15.7 15.0 27.5 19.9 16.4 17.2 17.1 15.1 14.8 6.7 16.2 63.5 15.5 26.2 21.7 13.0 22.0 19.4 22.3 25.2 28.3 18.6 23.1 23.2 24.6 14.6 24.8 23.6 2.7 17.1 17.4 14.7 23.0 15.6 32.0 25.1 37.1 32.6 25.4 22.2 17.5 21.9 24.0 17.9 MPND FLJ14981 ENSG00000008382 "MPN domain containing" Q8N594 19 4343527-4360086 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043274, HPA045475" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043274: AB_2678403, HPA045475: " "unprognostic (3.16e-2)" "prognostic favourable (2.99e-4)" "unprognostic (4.85e-2)" "prognostic favourable (6.12e-4)" "unprognostic (8.60e-2)" "unprognostic (5.37e-3)" "unprognostic (3.16e-2)" "prognostic favourable (1.55e-4)" "unprognostic (1.23e-1)" "unprognostic (2.87e-2)" "unprognostic (3.94e-3)" "unprognostic (5.18e-2)" "prognostic favourable (7.04e-4)" "unprognostic (2.22e-3)" "unprognostic (3.22e-1)" "unprognostic (5.44e-2)" "unprognostic (9.04e-2)" 7.7 13.7 18.9 14.1 12.3 11.5 8.0 12.1 21.6 6.5 19.9 6.6 15.7 25.9 8.5 7.8 13.8 8.2 11.8 12.1 14.2 11.3 12.8 25.1 14.3 8.5 12.7 20.0 8.7 20.7 14.5 7.2 7.0 11.9 12.1 13.9 11.5 14.3 9.0 17.4 12.5 20.7 9.3 8.9 10.1 12.5 4.2 6.7 13.5 8.6 8.3 10.1 9.3 11.0 3.1 4.5 10.3 6.0 2.4 5.6 1.9 7.9 6.7 11.1 12.6 6.9 3.3 11.3 3.8 3.7 3.2 4.0 12.9 4.1 7.2 12.2 5.0 8.2 5.0 6.7 1.8 8.1 11.3 5.5 9.4 20.8 5.5 7.3 9.9 5.0 4.8 3.5 3.7 9.8 2.9 18.8 4.0 22.9 17.3 6.3 5.0 9.7 14.3 3.4 10.4 8.2 14.0 12.4 12.7 7.0 10.0 5.3 6.7 9.0 3.7 5.1 5.5 31.3 7.7 15.6 9.6 4.7 5.7 4.1 5.9 10.3 5.1 2.4 2.2 6.0 3.4 1.8 2.6 3.1 4.5 3.1 1.7 1.9 1.2 2.4 2.7 4.5 5.6 1.9 18.9 12.3 12.1 21.6 14.2 11.3 12.7 20.0 11.9 6.7 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269856-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 315.2" "Group enriched" "Detected in some" 93 "HL-60: 212.9;NB-4: 279.1" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0" "Group enriched" "Detected in many" 30 "dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 15000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.2 0.1 0.5 0.1 0.8 315.2 0.1 0.4 1.0 0.1 0.1 1.4 0.0 0.1 0.2 0.2 0.1 0.1 0.1 21.5 0.6 0.8 0.1 1.4 6.9 0.8 0.6 0.0 0.6 0.1 0.1 1.0 2.9 0.4 0.2 0.1 0.2 6.3 0.1 0.7 0.5 0.1 0.1 0.4 17.8 0.1 0.4 0.2 19.7 0.6 0.0 0.5 0.1 0.0 0.0 3.2 2.0 7.6 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 279.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.1 7.2 0.5 0.8 0.4 1.0 0.6 0.8 0.6 0.0 0.4 0.2 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.4;SCLC-21H: 13.0;T-47d: 6.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 46.7;pons and medulla: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 5.1 2.0 4.8 2.1 2.9 0.6 5.1 46.7 5.2 3.3 1.7 2.2 4.5 1.4 3.5 4.0 3.0 2.7 5.4 12.3 2.7 5.0 2.1 1.2 7.4 1.3 3.0 1.5 1.7 5.9 3.0 2.6 2.1 13.0 3.0 1.1 1.7 1.6 4.3 1.5 2.4 1.3 3.5 2.5 2.2 4.3 3.7 1.1 0.0 1.7 0.9 1.4 1.6 4.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.8 0.7 1.8 1.4 0.0 1.5 0.6 1.2 0.7 1.2 1.9 0.0 0.6 1.3 1.5 1.2 2.3 1.7 0.0 1.5 1.5 3.7 0.7 0.1 0.0 0.1 0.9 3.1 2.1 6.4 1.5 0.9 0.0 0.6 0.9 0.0 0.0 0.8 1.2 0.0 1.0 0.4 4.3 0.6 13.0 3.4 0.7 2.8 0.5 6.9 1.5 1.4 3.4 3.2 0.9 3.0 0.9 0.4 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 2.9 46.7 3.3 2.7 5.0 3.0 1.5 13.0 1.1 MROH1 "HEATR7A, KIAA1833" ENSG00000179832 "Maestro heat like repeat family member 1" Q8NDA8 8 144148016-144261940 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024287, HPA044465" Approved Supported Approved Nucleoplasm Nucleoplasm "HPA024287: , HPA044465: AB_10960985" "unprognostic (1.25e-1)" "unprognostic (4.85e-2)" "unprognostic (1.38e-1)" "prognostic favourable (6.74e-4)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.48e-2)" "unprognostic (6.64e-2)" "unprognostic (1.92e-1)" "prognostic favourable (3.65e-6)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-2)" 5.7 7.5 11.9 7.6 10.0 19.7 6.1 17.8 16.0 6.0 8.5 4.5 13.0 16.7 5.4 7.3 9.2 6.8 7.0 5.4 7.0 6.0 8.3 5.8 9.4 8.1 5.2 11.7 5.1 17.3 5.4 11.1 8.3 10.3 9.0 4.5 6.9 14.3 9.8 5.2 13.4 14.3 6.5 3.9 11.5 14.0 7.5 5.0 5.2 33.3 3.9 7.5 8.5 6.6 1.9 5.5 4.4 9.5 1.1 5.6 2.8 9.7 4.0 0.5 3.9 1.9 2.0 17.7 4.3 3.0 2.4 3.3 6.8 17.6 5.2 6.3 2.4 9.4 0.6 6.6 1.1 2.9 5.6 6.2 11.7 6.1 4.8 2.7 6.6 3.8 6.9 3.8 5.6 3.4 2.5 2.3 2.7 20.8 4.7 5.8 1.5 19.1 6.2 1.3 5.3 3.5 19.3 4.5 3.9 10.8 10.4 3.2 7.7 3.8 8.5 4.9 9.3 9.9 3.5 4.1 2.0 5.5 9.7 8.4 2.9 4.4 7.4 1.9 2.4 9.5 1.9 1.1 2.1 2.5 5.5 1.9 2.0 1.4 1.5 1.1 7.9 1.7 5.6 2.8 11.9 10.0 17.8 16.0 7.0 6.0 5.2 11.7 10.3 5.0 MROH6 C8orf73 ENSG00000204839 "Maestro heat like repeat family member 6" A6NGR9 8 143566187-143572971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 11.8;HaCaT: 10.0;SK-BR-3: 21.3;U-937: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA068049 Uncertain Approved Nucleoplasm Nucleoplasm "HPA068049: " "unprognostic (2.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-3)" "unprognostic (2.26e-3)" "unprognostic (8.04e-2)" "unprognostic (8.96e-2)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" "unprognostic (5.97e-2)" "unprognostic (2.81e-2)" "unprognostic (1.09e-2)" "unprognostic (9.04e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (1.44e-1)" "unprognostic (9.16e-3)" "unprognostic (1.18e-1)" 1.8 2.3 3.4 2.3 2.8 15.8 1.5 7.6 3.9 5.8 2.7 2.0 3.6 5.7 1.9 2.6 17.4 1.6 11.0 1.3 2.4 0.9 3.1 5.3 2.8 5.4 1.1 1.2 2.6 1.2 2.1 1.4 8.7 2.4 3.7 1.2 4.8 3.1 3.3 1.2 10.1 4.7 4.1 2.6 3.6 6.7 4.1 1.5 0.7 1.2 7.8 15.0 3.2 6.3 0.1 0.8 1.6 1.0 0.0 0.4 0.1 11.8 2.7 0.2 0.5 0.6 0.5 1.3 0.3 0.3 0.2 0.1 0.8 6.5 1.2 0.6 0.1 10.0 0.3 3.4 0.0 1.6 1.9 1.2 3.6 0.4 0.4 0.4 1.6 0.6 0.9 0.3 0.2 0.1 0.9 1.0 0.0 6.7 0.5 1.1 0.3 2.0 1.1 0.2 2.0 0.5 1.2 0.5 0.2 0.4 21.3 1.0 2.3 0.8 0.0 0.2 7.5 0.8 1.8 1.0 0.7 0.2 0.4 12.2 0.3 0.0 1.0 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.8 0.1 0.3 0.4 1.6 0.0 0.6 0.4 0.0 0.1 3.4 2.8 7.6 3.9 2.4 0.9 1.1 1.2 2.4 1.5 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" Q9H579 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" HPA060298 Uncertain Approved Nucleoplasm Nucleoplasm "HPA060298: " "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 3.6 3.1 4.0 1.8 5.9 2.7 2.9 6.6 7.7 3.4 3.4 4.6 2.4 2.1 4.3 9.5 2.0 4.0 2.2 4.9 3.6 5.0 3.6 4.0 1.7 5.5 3.8 5.0 3.7 4.5 4.8 7.3 1.9 4.1 3.4 2.1 6.2 4.7 5.9 12.0 3.4 1.9 4.1 3.4 2.6 2.5 33.7 2.7 3.1 4.8 2.4 3.7 2.8 2.0 2.6 7.2 8.0 2.2 1.0 2.0 1.1 1.3 3.6 8.8 2.2 3.5 3.5 1.4 1.3 4.9 3.0 3.8 2.3 1.7 7.6 0.4 1.3 2.2 2.3 1.0 2.4 1.3 0.2 2.3 1.9 1.9 3.1 2.4 3.8 2.1 2.2 1.1 0.1 2.4 3.2 1.6 1.9 0.7 6.8 6.9 1.0 2.2 5.9 1.9 1.5 1.7 1.4 3.1 4.2 2.3 0.9 1.5 2.2 2.7 2.8 9.4 1.4 0.5 0.6 2.9 2.2 4.7 3.2 1.6 3.1 1.9 2.1 0.7 1.8 2.2 2.0 2.6 1.2 2.0 1.0 2.5 0.6 1.4 8.0 1.0 1.0 7.2 0.7 1.1 4.0 5.9 6.6 7.7 3.6 5.0 3.8 5.0 4.1 2.7 MRPL2 "CGI-22, MRP-L14, RPML14" ENSG00000112651 "Mitochondrial ribosomal protein L2" Q5T653 6 43054029-43059806 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007455, HPA064814" Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA007455: AB_1079410, HPA064814: " "unprognostic (2.31e-1)" "unprognostic (1.49e-2)" "unprognostic (3.06e-1)" "unprognostic (1.48e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-1)" "unprognostic (3.17e-1)" "prognostic favourable (6.01e-4)" "unprognostic (3.07e-1)" "unprognostic (1.79e-1)" "unprognostic (3.24e-2)" "unprognostic (6.42e-2)" "unprognostic (2.33e-2)" "unprognostic (3.13e-1)" "unprognostic (2.78e-1)" 16.9 19.9 17.4 13.1 22.5 16.0 14.2 13.6 21.8 13.0 15.6 13.3 16.4 20.3 14.1 16.9 13.6 16.2 15.5 31.7 16.0 16.8 20.9 55.0 12.9 16.2 18.8 20.3 15.7 17.4 25.8 17.8 11.7 15.3 12.9 15.0 12.6 21.1 19.6 53.2 13.8 15.2 13.4 12.4 11.5 13.4 21.0 13.2 17.5 15.7 25.5 12.3 12.4 11.9 21.0 26.9 14.3 18.5 17.5 16.9 13.6 11.4 13.3 6.7 11.6 8.2 6.5 10.4 5.2 7.3 13.5 12.1 25.4 4.0 16.3 12.9 7.2 12.2 14.3 13.8 8.5 9.5 29.7 13.2 10.7 30.7 16.0 10.9 6.4 8.5 14.7 15.6 21.2 9.4 22.0 11.0 7.2 22.4 14.1 39.0 6.0 15.7 16.5 6.6 20.9 10.1 7.3 16.0 8.3 5.1 9.0 15.9 10.1 19.7 8.6 7.9 10.6 10.4 14.4 12.8 11.6 33.7 5.8 17.7 7.7 6.8 18.5 14.3 13.5 17.2 16.9 20.4 15.6 16.0 25.2 21.0 15.9 16.1 5.5 17.5 13.4 26.9 16.6 13.6 17.4 22.5 13.6 21.8 16.0 16.8 18.8 20.3 15.3 13.2 MRPL21 ENSG00000197345 "Mitochondrial ribosomal protein L21" Q7Z2W9 11 68891276-68903835 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051657 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" "Nucleoplasm, Mitochondria" "HPA051657: " "unprognostic (1.80e-1)" "unprognostic (6.09e-2)" "unprognostic (4.80e-2)" "unprognostic (8.96e-3)" "unprognostic (9.25e-3)" "prognostic unfavourable (5.97e-4)" "unprognostic (3.23e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.06e-1)" "unprognostic (4.84e-2)" "unprognostic (7.36e-2)" "unprognostic (1.26e-2)" "unprognostic (3.73e-2)" "unprognostic (1.72e-1)" "unprognostic (4.36e-2)" "unprognostic (3.12e-1)" 16.5 18.0 30.5 21.4 29.7 25.5 26.5 27.7 28.0 19.6 24.0 13.3 26.8 18.9 20.4 25.2 24.2 23.0 28.3 47.3 24.6 26.1 33.1 33.7 12.4 30.0 27.6 21.0 21.4 23.8 13.2 17.7 16.1 25.6 18.0 21.8 14.4 56.9 39.4 56.6 17.9 25.0 17.6 16.4 14.9 19.3 18.7 21.9 21.3 22.2 40.3 20.4 17.2 16.5 49.1 42.2 20.3 39.3 29.1 36.4 34.6 23.7 33.0 20.1 19.2 14.2 15.5 23.9 16.6 17.9 31.4 21.7 67.6 30.6 36.8 37.1 18.0 29.6 33.5 31.6 24.7 24.1 25.3 26.0 25.4 40.5 28.3 44.6 19.7 22.8 16.3 31.3 37.2 21.5 50.3 28.0 18.7 43.8 21.1 47.2 18.3 48.7 29.9 24.3 57.2 30.9 27.5 32.7 26.1 21.1 42.5 65.8 43.9 25.9 18.0 21.5 21.5 47.1 30.2 20.9 32.2 51.8 28.7 27.5 29.1 20.3 39.3 19.4 25.9 39.3 27.2 49.1 34.1 28.7 42.2 33.4 32.7 27.0 10.8 29.1 36.1 31.0 36.4 34.6 30.5 29.7 27.7 28.0 24.6 26.1 27.6 21.0 25.6 21.9 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957404-223967714 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" Mitochondria "Nucleoplasm, Plasma membrane" "HPA038147: AB_10671521, HPA038148: " "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favourable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.4 29.2 15.3 16.8 16.4 32.7 26.7 15.1 24.2 11.7 17.9 12.8 9.2 16.0 13.9 12.6 18.3 14.1 14.8 29.0 14.6 16.9 31.0 38.9 13.0 24.1 15.2 17.0 13.5 26.1 11.0 12.7 17.3 13.8 13.3 19.6 11.8 14.1 13.9 35.3 14.7 15.5 12.3 15.6 18.8 14.9 18.4 12.8 23.6 16.2 22.9 21.0 14.1 11.3 31.5 28.2 39.8 30.1 21.2 26.9 23.3 11.9 10.1 15.1 17.4 14.3 17.0 24.0 13.5 15.1 22.0 23.3 35.9 15.0 18.1 14.7 11.5 16.0 24.5 18.6 20.4 17.0 17.4 19.7 11.7 28.1 21.1 21.8 15.2 19.9 23.3 13.3 17.9 21.5 18.8 14.4 17.6 13.8 16.2 27.6 22.6 10.6 19.2 18.6 11.1 29.3 10.1 20.6 11.9 9.9 22.3 32.5 18.8 31.5 14.1 14.7 11.4 12.5 10.8 15.9 11.0 25.9 14.9 20.8 16.1 31.5 30.1 22.6 20.5 29.1 25.9 31.5 22.1 24.4 28.2 27.0 26.9 23.5 39.8 21.2 25.6 22.6 22.2 23.3 15.3 16.4 15.1 24.2 14.6 16.9 15.2 17.0 13.8 12.8 MRPL52 ENSG00000172590 "Mitochondrial ribosomal protein L52" Q86TS9 14 22829879-22835037 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012319 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA012319: AB_1854118" "unprognostic (8.98e-2)" "unprognostic (9.07e-2)" "unprognostic (1.36e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.74e-2)" "unprognostic (4.01e-3)" "unprognostic (1.29e-1)" "unprognostic (6.52e-2)" "unprognostic (8.05e-3)" "unprognostic (8.07e-2)" "unprognostic (2.87e-1)" "unprognostic (7.46e-2)" "unprognostic (2.19e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-1)" "unprognostic (1.41e-1)" 24.3 29.4 31.8 31.8 36.8 27.8 54.5 18.8 34.7 22.7 35.5 13.5 31.4 43.7 21.3 23.5 37.5 20.8 39.2 73.7 28.3 31.0 34.1 41.9 36.9 55.9 35.5 27.8 17.2 58.5 21.6 20.7 20.9 40.1 22.4 22.4 12.7 41.6 43.0 79.5 24.3 35.1 22.9 37.0 27.6 39.9 30.6 24.0 27.8 27.4 38.4 25.2 15.6 31.6 43.9 50.6 25.4 39.0 21.9 30.7 29.7 43.7 34.4 18.8 23.3 11.7 13.8 45.9 30.6 22.1 27.4 26.1 42.2 61.4 33.4 33.7 21.0 40.0 15.4 42.3 20.7 35.3 25.3 24.8 13.7 95.7 35.8 39.0 35.7 20.7 29.3 35.4 30.2 43.4 25.4 33.3 20.0 61.5 31.5 59.3 34.7 76.2 39.0 23.5 39.3 28.5 26.2 18.8 24.3 23.7 23.2 32.5 22.3 37.3 33.4 28.7 33.6 35.8 46.3 32.9 38.9 40.6 26.1 26.8 45.7 25.4 36.0 18.0 25.4 39.0 23.2 43.9 27.9 22.9 50.6 37.7 26.4 25.3 6.1 21.9 28.7 41.9 30.7 29.7 31.8 36.8 18.8 34.7 28.3 31.0 35.5 27.8 40.1 24.0 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavourable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.1 17.2 14.2 18.6 6.9 11.1 12.6 18.9 10.7 32.5 21.4 24.8 25.1 35.7 15.9 15.6 19.2 39.4 28.5 32.8 12.7 30.1 26.4 15.4 21.2 8.8 34.8 11.1 9.7 18.9 36.6 19.0 18.2 39.9 11.6 19.2 17.7 28.3 25.2 18.2 26.2 26.6 17.4 27.6 17.6 8.3 23.0 16.8 14.5 20.0 20.0 14.2 20.5 11.9 17.8 22.0 27.2 32.2 9.4 16.4 47.1 17.3 44.8 28.3 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Cell line enriched" "Detected in single" 24 "THP-1: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" HPA058973 Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 MSANTD3 "C9orf30, MGC17337" ENSG00000066697 "Myb/SANT DNA binding domain containing 3" Q96H12 9 100427156-100451711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062662 Approved Nucleoplasm Nucleoplasm "HPA062662: " "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (5.51e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (6.66e-5)" "prognostic unfavourable (3.23e-6)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.51e-1)" "unprognostic (2.61e-3)" "unprognostic (5.52e-2)" "unprognostic (3.38e-1)" "prognostic unfavourable (3.22e-7)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (2.28e-1)" "unprognostic (2.16e-2)" 11.4 12.5 17.0 16.8 17.5 14.7 21.2 22.7 22.6 15.1 13.2 15.8 5.5 8.8 16.4 12.2 12.6 8.6 19.3 21.5 16.9 14.9 13.0 15.1 15.5 9.3 19.6 18.2 11.1 15.0 10.4 11.3 16.7 20.1 11.6 10.1 9.7 10.9 14.9 21.5 10.9 7.9 20.4 17.6 7.2 11.6 7.8 14.5 5.4 18.2 11.6 11.0 17.3 13.0 3.7 1.5 9.0 0.6 5.7 6.2 2.7 15.3 13.9 10.1 10.0 15.9 18.7 11.4 22.3 25.1 21.8 16.4 8.8 14.5 9.3 11.4 21.8 17.6 6.9 23.4 25.8 13.6 4.7 4.3 11.2 7.3 16.6 6.2 5.5 8.2 10.1 19.6 38.8 24.9 7.7 3.5 32.3 11.0 8.2 4.5 15.0 24.2 9.7 26.7 2.8 22.5 4.3 12.0 15.0 8.0 7.1 18.9 3.0 7.0 27.1 28.2 35.7 21.9 33.1 5.0 9.4 4.2 39.4 4.2 21.2 9.0 0.6 3.3 4.2 0.3 6.2 3.6 3.6 5.0 1.5 3.7 4.4 4.0 0.5 5.7 0.2 0.8 2.9 2.7 17.0 17.5 22.7 22.6 16.9 14.9 19.6 18.2 20.1 14.5 MSANTD4 KIAA1826 ENSG00000170903 "Myb/SANT DNA binding domain containing 4 with coiled-coils" Q8NCY6 11 105995623-106022403 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014411 Approved Approved Nucleoplasm Nucleoplasm "HPA014411: " "prognostic unfavourable (4.95e-4)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (1.30e-1)" "unprognostic (7.04e-3)" "unprognostic (8.21e-3)" "unprognostic (1.41e-2)" "unprognostic (2.13e-2)" "unprognostic (8.84e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.83e-1)" "prognostic favourable (1.26e-5)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.78e-2)" "unprognostic (2.90e-1)" 8.5 11.3 15.4 8.5 16.5 2.9 9.0 21.6 20.7 13.8 8.6 12.6 6.0 5.4 12.8 7.7 9.6 8.3 7.7 17.0 19.2 14.2 10.6 7.4 9.0 9.6 17.1 18.2 12.4 10.2 12.1 20.6 7.7 15.9 10.9 6.9 7.8 7.3 13.9 14.6 4.8 6.9 11.6 13.1 8.5 7.5 10.6 17.9 7.2 14.7 6.0 10.4 10.9 9.0 8.9 8.5 3.6 10.0 9.2 11.8 6.1 4.2 6.3 14.3 0.1 15.6 17.3 0.1 12.3 16.8 9.6 12.3 11.1 8.4 9.4 20.8 10.3 11.1 16.0 7.8 12.0 17.2 7.7 18.4 7.5 6.8 23.6 14.3 14.6 11.7 9.7 12.9 25.7 8.6 8.5 6.1 14.0 1.7 13.6 7.2 5.5 13.0 9.1 18.6 13.4 13.2 5.3 9.5 18.2 3.2 11.1 8.9 8.8 7.4 12.1 14.2 11.2 7.4 12.2 6.1 6.9 4.8 6.6 5.7 10.3 2.8 6.9 3.6 10.7 10.0 10.5 8.3 10.0 7.7 8.5 8.9 11.8 10.1 1.7 9.2 5.9 7.3 7.1 6.1 15.4 16.5 21.6 20.7 19.2 14.2 17.1 18.2 15.9 17.9 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell line enhanced" "Detected in some" "AF22: 42.9;HAP1: 19.6;NTERA-2: 22.3;SCLC-21H: 31.8;SH-SY5Y: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favourable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 42.9 10.8 0.0 0.0 5.4 0.0 0.0 0.2 0.5 7.5 0.2 0.0 0.6 0.0 0.1 19.6 0.0 0.1 0.2 4.4 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.1 22.3 0.2 0.1 0.0 0.1 0.0 0.0 31.8 15.5 0.0 0.3 0.3 6.6 0.0 0.0 0.1 5.9 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 MSL2 "FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184" ENSG00000174579 "MSL complex subunit 2" Q9HCI7 3 136148922-136197241 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003339, HPA003413" Uncertain Approved Nucleoplasm,Midbody Nucleoplasm Midbody "HPA003339: , HPA003413: AB_1848659" "unprognostic (9.86e-2)" "prognostic favourable (4.80e-4)" "unprognostic (1.30e-1)" "unprognostic (2.32e-1)" "unprognostic (4.41e-2)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (4.62e-2)" "unprognostic (7.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.71e-1)" "unprognostic (2.54e-2)" "unprognostic (2.23e-1)" "unprognostic (5.79e-3)" "unprognostic (4.54e-2)" "unprognostic (3.52e-2)" "unprognostic (1.76e-3)" 13.1 10.1 13.3 16.2 15.6 40.2 13.5 31.0 15.8 13.7 11.3 14.8 9.9 11.1 15.5 8.2 12.2 14.1 10.0 9.8 12.4 9.0 10.0 14.1 13.4 23.7 12.6 11.2 18.3 12.7 19.9 19.8 15.9 12.0 13.0 10.1 10.6 13.2 9.8 14.9 14.1 18.2 9.6 14.2 24.2 12.3 13.6 15.6 59.3 13.8 7.4 23.9 13.4 12.9 7.6 3.8 8.7 3.9 6.6 13.3 5.4 12.5 4.2 8.6 9.8 6.0 6.7 15.7 7.6 6.4 6.1 6.1 8.3 6.6 23.5 10.5 5.6 9.0 9.9 6.6 9.6 12.4 7.6 25.6 8.3 4.7 6.2 21.0 13.4 5.2 7.2 5.0 14.1 6.1 9.1 20.4 5.1 7.7 37.9 12.3 11.5 7.3 17.7 14.7 14.9 3.0 8.9 11.2 8.0 17.3 7.1 11.5 6.3 13.8 9.5 8.3 7.2 7.6 7.0 24.2 12.6 35.1 7.0 9.0 5.5 5.2 3.7 5.0 7.0 3.9 8.8 4.5 6.6 8.2 3.8 7.6 13.3 8.9 8.7 6.6 2.8 2.5 5.0 5.4 13.3 15.6 31.0 15.8 12.4 9.0 12.6 11.2 12.0 15.6 MSL3 MSL3L1 ENSG00000005302 "MSL complex subunit 3" Q8N5Y2 X 11758159-11775753 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034535, HPA034536" Uncertain Approved Nucleoplasm Nucleoplasm "HPA034535: AB_10603878, HPA034536: AB_10670973" "unprognostic (2.58e-1)" "unprognostic (1.76e-3)" "unprognostic (1.04e-1)" "unprognostic (9.56e-2)" "unprognostic (5.36e-2)" "prognostic favourable (3.28e-4)" "prognostic unfavourable (4.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.48e-2)" "unprognostic (4.88e-3)" "unprognostic (2.13e-1)" "unprognostic (5.04e-2)" "prognostic unfavourable (3.14e-9)" "unprognostic (1.20e-1)" "unprognostic (2.06e-1)" "unprognostic (4.35e-1)" "prognostic favourable (2.17e-4)" 11.4 8.1 11.7 23.4 13.3 19.0 10.7 11.9 18.8 7.8 9.3 10.0 6.4 8.6 9.6 7.5 11.9 9.4 10.9 7.7 11.1 11.2 9.9 9.2 14.4 32.5 11.8 10.5 8.6 7.5 7.0 7.9 12.3 15.7 9.7 10.5 4.6 9.9 8.9 24.0 13.7 16.2 10.1 11.3 34.1 9.5 10.5 10.0 49.1 10.1 9.4 30.2 13.9 15.5 25.7 27.1 39.0 33.4 24.5 37.1 30.9 11.3 12.4 16.4 14.4 13.6 18.9 7.0 14.6 13.2 16.0 19.3 7.6 11.6 16.4 15.1 13.9 9.5 19.5 11.9 19.5 10.5 13.7 8.7 14.1 3.9 12.4 13.2 16.9 11.6 15.4 19.3 8.4 27.3 15.8 10.3 16.0 11.6 10.6 15.0 13.4 20.4 7.7 16.7 19.8 11.2 14.2 10.8 13.0 15.8 6.8 9.5 11.5 8.7 26.1 15.5 10.9 25.2 13.4 8.2 9.8 18.9 11.3 7.5 12.8 26.7 31.1 22.4 24.2 27.5 23.0 25.7 28.6 27.8 24.0 25.3 37.1 34.5 39.0 24.5 33.4 27.1 33.6 30.9 11.7 13.3 11.9 18.8 11.1 11.2 11.8 10.5 15.7 10.0 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favourable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.4 102.3 0.0 15.8 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.2 1.1 0.9 0.0 0.0 0.0 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA053069" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" 25000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA023804: AB_1853826, HPA053069: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 0.9 0.5 0.3 5.9 0.2 0.0 0.3 0.8 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 MT1E "MT1, MTD" ENSG00000169715 "Metallothionein 1E" P04732 16 56625475-56627112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 248.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 122.6;LHCN-M2: 93.4;RPTEC TERT1: 105.8;U-2 OS: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.9;T-cells: 14.2" HPA041152 Approved Approved Nucleoplasm Nucleoplasm "HPA041152: AB_10794546" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.77e-2)" "unprognostic (1.19e-2)" "unprognostic (3.63e-1)" "unprognostic (9.80e-2)" "unprognostic (7.85e-2)" "unprognostic (3.45e-2)" "unprognostic (2.78e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (5.06e-5)" "unprognostic (1.86e-1)" "unprognostic (9.53e-2)" "unprognostic (1.97e-1)" "unprognostic (3.78e-2)" 68.4 71.5 38.0 18.4 104.6 2.5 47.7 13.8 42.3 10.1 75.3 20.0 10.7 36.2 7.3 18.4 27.1 33.1 44.2 19.6 40.0 27.0 66.1 248.5 21.1 13.7 66.0 27.4 13.4 145.0 4.5 5.1 7.8 94.3 22.6 64.3 13.9 9.1 9.1 28.0 16.4 114.5 29.8 58.6 5.4 47.0 4.1 24.5 0.0 110.7 21.3 4.9 9.4 11.8 0.3 3.9 0.0 2.0 0.1 14.2 1.9 11.1 0.0 0.0 0.0 18.0 20.8 0.1 29.5 31.6 8.1 9.5 0.1 14.9 0.0 2.3 10.1 24.2 27.2 122.6 11.2 11.2 0.0 0.4 16.2 1.9 8.1 0.0 0.0 14.3 41.6 21.2 24.4 4.9 0.0 0.0 93.4 0.0 0.0 7.3 10.7 0.1 0.0 0.0 0.3 105.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 13.6 12.1 0.0 59.7 9.4 5.6 0.0 0.2 0.2 34.3 18.6 0.1 0.0 2.0 0.0 10.5 1.4 3.7 0.3 5.9 14.2 3.9 0.0 2.7 10.7 0.0 0.1 1.2 0.2 13.7 1.9 38.0 104.6 13.8 42.3 40.0 27.0 66.0 27.4 94.3 24.5 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: " "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 3.7 2.4 4.9 8.3 6.9 7.1 5.4 16.8 7.3 3.8 3.4 4.1 3.2 3.0 5.8 5.2 4.2 3.6 2.5 2.2 3.6 3.2 2.3 1.8 2.6 8.2 4.8 3.3 5.3 2.7 2.6 3.9 4.2 5.1 3.2 5.5 3.2 3.6 2.3 2.0 6.0 3.2 4.2 4.6 4.6 2.7 11.0 4.8 12.6 2.3 3.4 8.0 2.9 3.5 2.7 0.6 0.6 2.0 1.7 3.2 1.1 9.7 2.9 9.7 3.9 1.4 2.4 4.8 7.4 4.3 10.9 14.2 3.1 5.4 8.9 7.5 2.4 8.4 9.1 4.5 13.5 7.3 6.9 7.4 4.2 3.6 0.7 7.8 5.7 0.9 1.9 8.3 5.4 4.8 4.7 6.7 6.3 4.3 12.4 4.8 4.3 5.8 7.2 10.0 6.3 2.6 3.4 5.0 5.8 5.0 29.7 4.5 5.6 5.7 2.9 4.7 8.6 6.0 11.9 2.6 5.5 5.1 4.5 9.7 5.3 0.0 0.4 0.6 1.3 2.0 2.0 2.7 1.9 2.3 0.6 1.9 3.2 2.7 0.2 1.7 1.0 0.0 2.2 1.1 4.9 6.9 16.8 7.3 3.6 3.2 4.8 3.3 5.1 4.8 MTCP1 "P13MTCP1, p8MTCP1" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155061622-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA032040: " "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavourable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 6.4 7.1 4.1 5.3 5.3 7.2 15.8 4.4 4.8 6.0 6.2 3.4 7.7 5.7 6.0 8.2 7.0 6.1 4.4 30.1 4.7 2.9 6.7 12.8 8.5 15.5 4.5 2.7 9.1 20.7 3.9 6.5 3.5 6.4 5.8 6.1 3.9 7.3 7.0 11.4 12.0 6.7 8.7 7.2 6.7 6.2 16.1 3.8 2.5 8.2 5.4 7.2 6.9 4.0 0.2 0.0 0.8 0.7 0.5 2.0 0.1 1.4 4.9 2.4 3.8 1.6 1.3 2.6 3.0 1.5 1.9 4.7 4.2 7.4 2.6 3.0 0.6 4.7 3.1 3.5 2.3 1.8 3.1 1.2 14.0 2.3 1.3 2.8 3.2 2.4 1.6 3.1 3.0 1.7 1.1 4.8 1.3 2.0 3.7 6.0 1.1 0.8 3.9 2.5 6.0 2.4 2.0 1.2 1.8 2.1 1.2 2.1 2.1 1.3 1.8 2.2 3.8 2.1 2.2 10.5 4.5 5.1 4.2 3.4 3.1 0.0 0.6 0.8 1.1 0.0 2.0 0.2 1.2 0.4 0.0 0.1 0.2 1.4 0.0 0.5 0.7 0.0 0.0 0.1 4.1 5.3 4.4 4.8 4.7 2.9 4.5 2.7 6.4 3.8 MTERF3 "CGI-12, FLJ10939, MTERFD1" ENSG00000156469 "Mitochondrial transcription termination factor 3" Q96E29 8 96239398-96261610 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002966 Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA002966: AB_2147359" "unprognostic (4.08e-2)" "unprognostic (1.46e-1)" "unprognostic (4.68e-2)" "unprognostic (2.31e-2)" "unprognostic (3.86e-2)" "unprognostic (6.66e-2)" "unprognostic (2.75e-3)" "unprognostic (3.11e-3)" "unprognostic (6.43e-2)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (8.56e-2)" "prognostic unfavourable (5.88e-5)" "unprognostic (8.67e-3)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (1.74e-3)" 13.8 16.4 14.2 15.9 20.1 9.9 22.9 17.8 18.0 14.8 13.8 12.3 17.4 11.9 15.4 23.8 12.6 13.2 12.9 21.9 17.3 15.3 15.9 22.2 18.5 18.3 18.1 16.0 13.7 14.8 18.9 14.1 16.1 23.7 15.5 14.5 9.8 12.1 17.9 28.8 16.1 11.6 21.9 13.2 16.9 12.8 10.9 13.5 16.0 15.0 14.1 18.1 13.9 12.3 15.3 18.0 18.6 11.6 16.7 17.8 7.8 19.3 12.5 18.7 14.8 13.4 13.9 8.5 14.9 12.3 21.9 22.1 8.9 14.4 17.4 31.5 8.7 10.9 19.3 11.6 26.7 16.7 14.2 24.9 9.6 10.7 18.8 8.4 10.2 13.9 17.4 17.7 16.7 17.8 20.9 9.2 21.9 12.5 35.6 24.8 9.8 19.4 21.6 15.3 13.6 16.0 10.3 12.8 10.1 11.1 3.2 15.8 16.8 11.9 7.9 15.4 10.4 17.7 13.1 10.5 13.1 20.2 16.7 22.5 20.1 18.6 10.3 4.3 12.4 11.6 17.8 15.3 14.1 14.0 14.8 13.2 16.1 16.1 1.8 16.7 11.0 18.0 13.3 7.8 14.2 20.1 17.8 18.0 17.3 15.3 18.1 16.0 23.7 13.5 MTFMT FMT1 ENSG00000103707 "Mitochondrial methionyl-tRNA formyltransferase" Q96DP5 15 65001512-65029639 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040710 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040710: AB_10794879" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (9.28e-3)" "unprognostic (4.35e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (6.63e-2)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (2.41e-2)" "unprognostic (1.78e-1)" "prognostic favourable (3.31e-8)" "unprognostic (2.75e-2)" "unprognostic (4.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.85e-2)" 8.7 10.2 7.9 10.0 11.5 11.6 7.5 13.5 12.7 9.5 12.7 6.8 8.0 9.7 11.8 10.6 9.5 10.9 9.7 13.8 8.0 7.8 12.8 13.4 8.4 8.6 6.8 9.4 14.0 5.9 7.3 9.3 7.5 10.3 10.8 10.8 12.2 8.7 9.8 13.3 11.6 13.9 12.0 5.7 9.2 8.7 7.2 5.2 9.2 11.7 4.6 8.8 12.0 9.1 5.0 9.6 16.9 3.6 4.6 5.9 1.9 2.6 3.6 3.5 6.1 5.0 3.5 3.1 2.4 4.3 3.2 3.0 2.2 3.0 9.1 3.3 4.4 7.7 6.5 4.3 3.1 3.5 4.8 3.9 3.4 2.5 5.9 5.3 1.2 5.1 5.4 1.7 3.8 2.9 4.1 4.4 4.8 3.6 4.2 5.6 4.8 6.2 3.9 5.1 4.2 5.2 3.1 3.6 3.6 5.8 5.4 4.4 3.3 3.8 5.3 3.8 3.9 4.4 4.8 3.7 5.4 3.6 3.3 8.6 3.9 3.1 3.6 2.4 4.9 2.9 4.9 4.7 4.9 5.2 5.6 5.0 5.5 5.9 16.9 4.6 2.0 9.6 4.9 1.9 7.9 11.5 13.5 12.7 8.0 7.8 6.8 9.4 10.3 5.2 MTHFSD FLJ12998 ENSG00000103248 "Methenyltetrahydrofolate synthetase domain containing" Q2M296 16 86530176-86555235 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041333 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA041333: AB_10795006" "unprognostic (4.09e-2)" "unprognostic (2.52e-2)" "prognostic unfavourable (9.88e-5)" "unprognostic (2.66e-2)" "unprognostic (7.71e-2)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (6.24e-2)" "unprognostic (3.29e-1)" "unprognostic (4.05e-2)" "unprognostic (2.96e-2)" "unprognostic (3.90e-3)" "unprognostic (1.94e-3)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (4.77e-1)" "unprognostic (5.85e-3)" 12.6 12.6 10.9 10.0 11.4 7.1 13.1 17.1 16.5 12.1 10.8 19.3 18.2 9.1 17.5 15.6 14.4 16.8 11.9 10.0 11.1 7.9 12.2 11.9 10.4 13.3 13.4 13.6 14.8 14.2 24.0 15.8 10.1 14.4 15.9 13.4 16.2 17.2 15.7 14.7 15.6 12.5 14.1 9.5 15.9 12.1 21.5 12.8 14.7 14.7 13.3 14.9 13.3 18.7 8.3 9.9 10.1 7.6 9.3 9.3 7.2 9.3 9.0 8.8 7.7 7.6 11.6 10.8 9.4 7.0 11.9 6.0 7.8 15.9 8.4 10.2 8.2 13.0 9.7 9.2 11.2 5.6 7.9 7.4 11.8 7.3 10.2 5.9 4.3 7.3 14.9 15.3 13.2 7.1 15.9 0.0 8.6 12.0 7.5 9.0 5.8 11.3 22.8 5.2 6.6 6.9 5.8 8.6 5.9 21.4 4.2 7.9 21.4 6.3 7.3 11.6 10.0 7.7 9.0 7.0 8.5 24.8 10.6 9.7 11.3 10.1 7.6 3.8 8.5 5.8 8.8 8.3 9.3 8.5 9.9 6.8 7.8 8.8 3.1 9.3 7.1 4.5 7.6 7.2 10.9 11.4 17.1 16.5 11.1 7.9 13.4 13.6 14.4 12.8 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: " "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favourable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.3 6.1 5.6 3.1 12.6 6.9 4.1 7.8 16.5 6.6 6.5 3.9 1.9 2.2 10.7 10.4 8.0 4.4 4.7 6.3 8.1 1.2 2.8 4.0 5.8 7.4 5.4 5.7 9.2 3.8 4.2 4.7 16.3 3.1 6.4 6.0 1.6 5.7 1.5 2.8 2.5 4.3 4.9 12.8 24.7 8.6 2.1 5.3 3.8 4.5 1.6 2.9 10.2 7.8 7.7 4.8 4.0 4.8 5.8 4.9 5.9 4.5 2.0 8.6 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 MTO1 ENSG00000135297 "Mitochondrial tRNA translation optimization 1" Q9Y2Z2 6 73461578-73509236 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030230, HPA030232" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030230: AB_10598910, HPA030232: AB_10600891" "unprognostic (2.17e-2)" "unprognostic (5.29e-2)" "unprognostic (1.05e-2)" "unprognostic (3.22e-2)" "unprognostic (6.47e-2)" "unprognostic (8.58e-2)" "unprognostic (6.28e-2)" "unprognostic (5.48e-2)" "unprognostic (2.97e-1)" "unprognostic (2.12e-3)" "unprognostic (9.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" "unprognostic (1.64e-1)" 10.4 11.0 11.1 13.5 13.7 14.7 11.5 21.8 13.6 14.0 14.0 11.3 12.4 12.7 12.6 11.2 12.1 10.0 8.1 13.3 10.0 10.9 19.7 28.4 9.8 15.8 19.3 10.0 14.5 12.1 24.6 15.6 8.7 13.9 12.2 12.7 10.1 10.7 12.3 15.8 9.8 13.6 11.9 12.1 18.6 11.9 20.5 15.0 13.0 14.0 11.0 16.6 12.1 15.0 10.4 7.4 5.3 7.8 10.5 14.0 8.7 5.0 4.6 6.4 5.2 9.3 10.8 5.8 10.5 9.6 10.3 12.6 9.5 3.9 13.2 8.2 9.8 8.7 11.7 8.4 15.8 7.7 7.7 10.1 11.2 10.3 12.2 18.2 6.9 9.3 13.3 11.1 12.5 7.7 17.3 12.8 10.7 8.8 5.0 15.7 4.7 4.7 8.4 18.3 21.9 8.2 7.9 5.4 3.3 5.4 9.1 9.4 6.0 19.2 4.9 6.1 6.0 3.5 10.0 8.3 12.8 5.3 3.1 13.6 8.0 1.7 6.4 5.3 9.7 7.2 11.9 10.4 11.7 9.8 7.4 7.9 12.9 10.5 1.8 10.5 7.8 5.5 14.0 8.7 11.1 13.7 21.8 13.6 10.0 10.9 19.3 10.0 13.9 15.0 MTRR cblE ENSG00000124275 "5-methyltetrahydrofolate-homocysteine methyltransferase reductase" Q9UBK8 5 7851186-7906025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038113 Supported Approved "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA038113: AB_10671520" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (5.32e-2)" "unprognostic (1.17e-2)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (6.60e-4)" "unprognostic (2.56e-2)" "unprognostic (5.82e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (9.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" 12.2 12.3 11.2 10.5 13.8 5.4 9.7 15.6 14.3 10.8 10.4 24.1 11.5 10.3 17.3 15.9 10.5 11.3 13.3 15.8 14.2 12.9 22.0 23.9 14.9 11.4 18.1 9.6 13.6 13.6 9.4 13.1 11.6 16.6 10.8 11.9 13.6 11.3 7.4 34.6 10.5 11.5 14.2 22.1 9.3 9.2 8.4 12.5 8.1 14.7 9.9 13.5 13.6 8.8 4.6 4.8 4.6 6.8 3.4 11.4 4.2 9.3 8.8 4.7 10.4 17.9 5.8 13.3 14.5 8.6 7.2 8.2 13.2 7.5 15.7 13.9 11.6 6.0 7.2 7.1 13.6 9.9 8.1 7.5 30.5 7.0 10.9 11.4 3.2 9.4 6.5 12.2 9.0 4.7 9.7 11.9 4.2 1.8 7.3 5.8 3.5 9.8 6.0 5.0 6.6 7.8 7.3 7.3 0.9 25.4 18.5 15.9 5.7 8.9 7.2 16.8 10.6 12.9 11.3 17.7 5.8 12.9 12.2 25.2 8.9 4.6 5.1 4.1 5.5 6.8 9.5 4.6 9.2 7.9 4.8 4.1 5.4 5.1 0.1 3.4 5.4 2.7 11.4 4.2 11.2 13.8 15.6 14.3 14.2 12.9 18.1 9.6 16.6 12.5 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 24.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favourable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.5 0.0 1.3 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 24.8 0.1 0.1 0.0 0.0 0.2 0.7 0.8 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favourable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 16.9 16.4 9.5 19.6 20.6 11.6 10.3 16.9 20.2 21.0 20.3 10.1 28.2 12.8 18.9 23.8 25.9 17.0 24.4 15.3 12.7 13.5 9.8 11.1 14.6 24.3 13.4 16.8 18.9 32.2 21.5 22.4 13.7 12.7 15.6 22.8 8.6 8.0 9.0 9.7 15.7 7.9 11.9 16.5 24.7 9.5 9.7 14.3 15.1 16.2 20.7 11.4 12.9 15.4 20.5 11.8 17.8 15.1 18.3 15.9 13.8 16.1 18.2 19.0 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA059530: " "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 15.6 14.3 17.2 21.4 19.5 13.6 24.7 21.6 19.5 19.3 22.2 19.1 18.3 22.1 28.2 12.4 14.4 20.4 19.5 18.4 16.6 12.3 17.7 13.8 17.9 22.2 24.0 14.1 23.5 17.0 19.5 17.2 16.6 17.2 19.4 9.8 13.4 14.9 23.2 28.1 18.2 26.5 19.4 17.5 21.6 17.7 11.3 22.4 32.2 17.8 15.6 17.7 18.2 21.7 12.5 13.2 23.2 15.2 10.8 20.0 11.2 10.7 6.8 11.7 11.5 5.2 6.4 14.9 11.7 9.5 15.1 10.2 9.1 17.8 10.4 15.9 9.3 10.6 10.5 10.4 3.4 22.5 7.7 18.9 18.5 5.4 15.9 13.3 20.2 10.1 19.4 19.1 15.2 12.7 11.3 29.4 9.9 7.2 19.0 20.7 8.4 15.4 18.8 5.6 19.9 11.5 6.9 11.7 13.4 8.0 14.5 25.2 16.9 14.0 11.1 11.4 9.6 14.4 12.6 19.8 13.1 15.0 12.8 9.0 18.8 16.2 12.4 23.2 20.0 14.3 19.6 12.5 15.1 17.2 13.0 10.6 12.0 14.7 8.5 10.8 15.2 13.2 12.8 11.2 17.2 19.5 21.6 19.5 16.6 12.3 24.0 14.1 17.2 22.4 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.1;lymphoid tissue: 59.4" "Cell line enhanced" "Detected in many" "HDLM-2: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Group enriched" "Detected in many" 6 "granulocytes: 14.1;monocytes: 8.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA070111: " "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavourable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 2.5 1.8 1.3 28.2 1.9 32.1 5.4 1.2 3.4 2.4 6.8 1.2 2.8 6.9 2.7 6.2 6.6 3.6 2.8 2.4 1.6 0.8 2.7 6.6 5.4 7.3 2.2 1.2 2.6 5.8 0.7 4.3 4.5 2.1 5.0 0.9 1.1 4.7 2.1 3.6 10.3 5.6 1.4 1.3 10.3 3.8 3.1 2.9 59.4 3.5 3.7 13.5 2.7 3.6 2.0 1.6 14.1 8.7 0.7 0.8 1.1 8.0 5.6 3.4 9.4 0.2 0.4 5.7 10.6 3.5 4.8 4.6 3.6 8.4 4.3 4.4 1.4 4.0 0.4 1.2 0.2 58.7 7.1 2.4 8.0 5.3 0.5 2.3 7.4 0.3 0.6 0.3 0.2 4.4 1.4 13.5 0.9 10.3 21.4 6.4 1.2 9.7 10.5 10.7 6.1 1.0 1.1 8.5 7.0 6.8 6.9 3.6 10.8 6.1 3.2 5.8 14.9 4.5 5.6 17.9 5.9 4.7 4.5 8.1 3.3 3.5 2.6 7.7 0.7 7.2 0.0 1.6 0.1 0.1 1.6 2.0 0.0 0.3 14.1 0.7 8.7 1.0 0.8 1.1 1.3 1.9 1.2 3.4 1.6 0.8 2.2 1.2 2.1 2.9 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Group enriched" "Detected in some" 5 "CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: " "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 MYCBP AMY-1 ENSG00000214114 "MYC binding protein" Q99417 1 38862964-38874105 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041188, HPA078331" Supported Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: " "unprognostic (2.42e-2)" "unprognostic (6.60e-2)" "unprognostic (3.85e-3)" "unprognostic (9.46e-3)" "unprognostic (8.77e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (6.03e-6)" "unprognostic (7.59e-2)" "unprognostic (3.00e-3)" "unprognostic (5.03e-3)" "unprognostic (4.41e-3)" "unprognostic (2.34e-3)" "unprognostic (5.81e-3)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (2.41e-2)" 8.6 10.5 4.8 13.6 7.4 9.0 14.5 4.6 4.9 11.6 14.9 3.6 21.3 10.5 9.6 18.2 23.4 17.7 15.6 16.8 5.2 4.9 26.5 21.1 16.1 20.7 4.6 3.1 9.3 20.0 13.9 12.5 24.8 11.2 13.6 15.6 6.6 22.9 17.3 11.8 12.0 24.4 14.6 4.9 16.8 13.1 28.9 5.2 16.8 24.3 18.1 19.6 13.0 11.9 9.0 21.7 32.1 15.1 11.0 12.9 8.1 18.8 8.2 7.3 5.3 4.2 7.5 29.1 15.1 4.9 15.3 12.0 9.6 22.6 15.5 16.8 6.9 14.0 11.3 19.7 18.5 19.4 18.9 16.5 11.8 10.2 1.1 41.0 15.0 6.7 15.7 12.7 8.0 11.1 24.0 14.4 16.0 11.1 13.1 19.7 18.5 20.7 12.6 21.5 21.7 20.0 16.0 13.8 9.4 14.5 19.3 9.7 13.2 19.8 8.8 8.0 13.5 12.3 17.3 9.6 17.3 17.1 8.0 24.2 10.4 14.8 12.6 32.1 7.8 15.1 8.9 9.0 9.7 9.3 16.0 6.4 8.4 9.3 25.1 11.0 13.5 21.7 12.9 8.1 4.8 7.4 4.6 4.9 5.2 4.9 4.6 3.1 11.2 5.2 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940564-15947007 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.8" "Cell line enhanced" "Detected in some" "AF22: 12.7;BEWO: 68.9;HMC-1: 16.6;NTERA-2: 26.1;RH-30: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA057420: " "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.9 1.9 5.1 1.8 5.5 1.6 1.2 1.4 8.4 3.1 1.2 12.1 0.0 3.0 1.9 0.8 1.3 1.4 2.6 2.3 7.0 4.7 6.0 1.5 1.6 2.9 6.0 2.2 10.3 0.7 0.4 0.7 16.8 6.8 0.6 1.3 1.1 6.6 0.7 1.0 2.4 1.7 0.9 8.9 0.9 8.5 6.5 4.0 5.7 5.1 2.3 3.5 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 68.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 26.1 0.0 0.0 18.2 3.5 0.0 0.8 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 1.4 7.0 7.0 4.7 6.0 2.2 6.8 4.0 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell line enhanced" "Detected in some" "A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" HPA012949 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavourable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavourable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 57.8 27.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.5 0.2 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 1.2 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 1.0 0.1 0.8 0.0 12.8 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 MYH14 "DFNA4, FLJ13881, KIAA2034, MHC16, MYH17" ENSG00000105357 "Myosin heavy chain 14" Q7Z406 19 50188186-50310544 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;skeletal muscle: 53.1" "Cell line enhanced" "Detected in some" "A-431: 15.0;CAPAN-2: 19.0;HaCaT: 37.8;MCF7: 18.4;RT4: 46.9;SK-BR-3: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062391, HPA067889, HPA070260" Enhanced Approved Nucleoplasm 59000000 Nucleoplasm "HPA062391: , HPA067889: , HPA070260: " "unprognostic (2.52e-1)" "unprognostic (5.81e-2)" "unprognostic (9.63e-2)" "unprognostic (3.73e-3)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.71e-1)" "unprognostic (3.48e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "prognostic favourable (3.97e-8)" "prognostic favourable (7.83e-4)" "unprognostic (8.50e-2)" "unprognostic (3.12e-1)" "unprognostic (2.77e-1)" 5.5 0.5 6.1 8.4 6.1 0.1 2.7 4.6 9.4 3.4 63.9 10.5 3.5 38.7 1.1 4.6 14.7 7.5 9.2 16.2 6.4 5.4 4.3 8.7 11.5 0.2 8.5 3.9 1.1 7.5 7.3 4.5 0.7 7.8 3.2 9.4 4.6 12.0 3.1 53.1 20.3 78.6 0.8 11.1 0.2 21.0 0.7 4.2 0.4 16.7 11.4 9.5 4.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 1.5 0.0 8.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.4 19.0 0.0 9.9 0.0 37.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 18.4 0.0 0.1 0.2 0.2 0.0 9.6 0.2 0.0 46.9 0.0 0.0 0.9 16.8 0.0 3.1 0.5 0.0 0.0 3.9 0.0 0.0 0.3 3.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 6.1 4.6 9.4 6.4 5.4 8.5 3.9 7.8 4.2 MYL12A "MLCB, MRCL3, MRLC3, MYL2B" ENSG00000101608 "Myosin light chain 12A" P19105 18 3247481-3256236 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004503, HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" 70000000 "Nucleoplasm, Nucleoli fibrillar center" "CAB004503: AB_2282358, HPA039262: , HPA045244: , HPA059197: " "unprognostic (2.14e-3)" "unprognostic (5.30e-2)" "unprognostic (1.80e-1)" "unprognostic (5.31e-2)" "unprognostic (3.03e-2)" "unprognostic (7.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.57e-3)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-3)" "unprognostic (2.30e-1)" "unprognostic (9.86e-2)" "unprognostic (1.30e-1)" "unprognostic (4.98e-2)" "unprognostic (4.58e-3)" "unprognostic (7.13e-2)" 60.9 19.9 7.1 31.1 13.1 21.7 63.9 5.1 7.6 25.1 31.2 7.4 22.5 15.6 24.1 29.0 43.6 22.8 32.4 248.0 8.2 6.8 52.7 43.1 58.3 58.4 14.6 5.7 28.6 24.8 24.9 11.1 49.5 18.9 24.3 27.2 14.7 26.5 18.6 423.8 24.2 41.5 27.9 22.1 68.6 22.5 20.4 10.3 40.3 38.6 80.1 42.0 30.6 31.2 103.4 166.8 173.4 91.9 104.2 168.7 245.4 30.7 19.6 44.7 18.7 52.8 55.6 27.4 70.1 92.6 66.7 72.8 29.6 39.0 14.9 18.5 101.7 13.4 25.8 44.0 59.9 21.0 9.2 15.2 23.3 26.0 88.5 43.2 29.7 87.0 62.4 51.8 31.3 104.6 19.0 52.1 136.8 52.6 20.1 43.5 18.3 14.5 11.6 23.4 26.2 146.3 49.8 6.3 15.3 55.4 23.9 48.5 16.8 63.9 111.9 16.5 37.7 45.2 55.4 11.9 17.2 24.1 49.7 17.4 59.1 173.4 74.5 154.6 166.4 77.4 166.7 103.4 156.8 168.7 109.0 80.4 142.5 167.0 122.8 104.2 91.9 166.8 133.2 245.4 7.1 13.1 5.1 7.6 8.2 6.8 14.6 5.7 18.9 10.3 MYL12B MRLC2 ENSG00000118680 "Myosin light chain 12B" O14950 18 3261909-3278284 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: , HPA045244: , HPA059197: " "unprognostic (2.55e-2)" "unprognostic (7.31e-2)" "unprognostic (5.69e-2)" "unprognostic (4.05e-2)" "unprognostic (3.66e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-2)" "unprognostic (7.65e-2)" "unprognostic (2.89e-2)" "unprognostic (1.27e-2)" "prognostic unfavourable (9.69e-4)" "unprognostic (1.18e-1)" "prognostic favourable (8.17e-5)" "unprognostic (3.38e-1)" "unprognostic (3.77e-1)" "prognostic favourable (6.62e-6)" "unprognostic (1.27e-2)" 64.1 82.2 38.7 46.1 38.2 41.9 66.1 27.0 48.9 63.9 84.8 21.4 58.7 67.6 52.9 86.8 106.9 49.6 65.2 53.0 37.8 34.0 150.0 105.3 85.9 68.7 36.0 31.9 53.4 48.9 48.4 37.5 139.8 46.8 56.8 75.0 37.1 69.8 52.8 71.8 59.6 129.4 54.7 30.9 62.2 52.8 42.8 26.0 65.1 107.2 89.8 61.1 58.6 61.5 46.7 83.6 151.5 78.1 47.6 77.7 109.0 48.0 25.5 22.6 21.8 65.9 56.3 39.0 73.4 64.6 68.6 70.8 53.4 38.6 24.1 32.4 99.7 24.4 37.4 84.4 70.5 14.1 15.8 24.3 28.9 42.8 68.0 54.4 38.3 48.4 81.0 45.6 29.2 102.7 20.8 23.7 89.0 97.5 31.1 39.3 15.1 21.9 15.5 28.5 19.3 144.6 89.2 18.6 19.4 72.9 44.4 44.2 38.0 32.6 123.6 66.8 99.7 58.2 88.8 13.2 12.6 29.4 40.5 22.1 51.9 123.3 51.4 151.5 72.2 68.0 61.4 46.7 70.7 77.7 60.9 37.8 58.0 66.8 120.5 47.6 78.1 83.6 75.2 109.0 38.7 38.2 27.0 48.9 37.8 34.0 36.0 31.9 46.8 26.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell line enhanced" "Detected in many" "ASC diff: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: " "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.6 13.3 7.0 33.2 22.9 6.4 5.3 7.2 5.5 5.0 4.4 9.3 2.5 2.6 8.7 3.2 2.1 3.7 1.6 4.7 2.6 3.8 5.0 4.1 11.6 5.8 3.5 17.2 3.5 4.3 4.6 3.3 3.9 3.5 6.7 4.1 3.1 4.0 2.8 5.5 2.8 2.8 1.5 9.0 10.4 6.1 3.4 1.8 4.5 3.6 7.3 5.3 5.4 4.7 0.9 4.0 3.1 13.3 2.6 1.5 5.2 5.2 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 MYL9 "LC20, MLC2, MRLC1, MYRL2" ENSG00000101335 "Myosin light chain 9" P24844 20 36541484-36551447 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 717.2;urinary bladder: 496.7" "Cell line enhanced" "Detected in many" "ASC diff: 85.0;BJ: 110.2;fHDF/TERT166: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.6;neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" 92000000 "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: , HPA045244: , HPA059197: " "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" "unprognostic (2.67e-3)" "unprognostic (5.38e-2)" "unprognostic (7.17e-2)" "unprognostic (5.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (9.06e-2)" "unprognostic (8.90e-2)" "prognostic unfavourable (7.92e-7)" "unprognostic (1.90e-2)" "unprognostic (8.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.92e-2)" 61.9 46.0 2.0 58.1 5.8 0.2 64.8 1.4 6.4 123.3 361.6 6.0 162.9 22.7 278.8 102.0 242.7 80.3 199.0 169.8 1.9 2.1 27.7 6.8 36.0 14.9 4.7 8.7 107.8 5.4 2.8 4.8 31.7 10.5 218.9 30.4 71.8 22.6 203.9 22.2 14.7 70.3 717.2 5.2 22.8 120.7 55.1 1.4 1.4 48.8 21.9 8.7 496.7 107.7 1.2 0.5 2.7 0.2 0.3 0.1 10.8 8.0 0.1 6.4 0.1 85.0 32.7 28.3 110.2 47.7 57.7 37.5 63.5 0.9 0.0 57.8 87.5 3.0 0.0 0.2 13.6 0.0 0.0 1.6 12.4 5.9 54.9 0.0 1.9 45.7 5.8 38.1 0.1 2.0 0.2 2.9 48.4 0.0 0.0 0.8 2.5 0.5 0.0 0.0 0.5 0.4 0.6 0.0 0.4 1.1 2.8 0.0 24.6 1.6 14.1 55.2 23.3 8.0 0.1 0.0 0.4 0.2 20.9 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.1 1.2 0.0 0.1 0.3 0.2 0.0 0.0 2.7 0.3 0.0 0.5 0.0 10.8 2.0 5.8 1.4 6.4 1.9 2.1 4.7 8.7 10.5 1.4 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HEL: 28.5;K-562: 4.4;SK-BR-3: 6.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in some" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA073447: " "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 1.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "intestine: 148.0" "Cell line enhanced" "Detected in some" "BEWO: 3.0;CACO-2: 11.9;Hep G2: 7.9;NB-4: 2.3" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;monocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm Nucleoplasm "HPA053490: " "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.1 0.1 0.1 5.2 0.2 0.0 0.1 0.1 0.2 0.1 57.2 0.3 0.1 70.0 0.1 0.1 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 14.1 0.1 0.2 0.1 0.1 0.1 148.0 0.4 4.7 0.1 3.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 2.9 0.0 1.2 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 11.9 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 7.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 2.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.1 1.3 0.1 MYOCD MYCD ENSG00000141052 Myocardin Q8IZQ8 17 12665890-12768949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 63.4" "Cell line enhanced" "Detected in some" "BJ: 6.8;BJ hTERT+: 6.8;HBF TERT88: 11.3;hTEC/SVTERT24-B: 12.5;REH: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "cerebellum: 6.4" "CAB046485, HPA071528, HPA072582" Approved Approved Nucleoplasm Nucleoplasm "CAB046485: AB_10600720, HPA071528: , HPA072582: " "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (1.90e-1)" "unprognostic (3.79e-2)" "unprognostic (5.33e-2)" "unprognostic (2.15e-4)" "unprognostic (2.71e-2)" "unprognostic (1.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (4.83e-2)" "unprognostic (1.01e-4)" "unprognostic (2.88e-2)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.91e-2)" 3.1 0.8 0.6 5.1 1.0 0.0 1.9 0.3 0.5 19.6 19.9 0.2 17.6 2.1 16.6 10.9 14.4 7.4 12.2 18.6 0.4 0.4 0.9 0.4 2.5 0.0 0.5 0.8 10.6 0.4 0.0 0.5 2.6 0.6 17.2 4.2 5.1 0.4 18.7 1.2 1.5 6.6 63.4 0.6 0.5 6.7 3.7 0.1 0.0 1.0 1.2 0.0 33.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.8 6.8 2.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 12.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 8.6 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.3 0.5 0.4 0.4 0.5 0.8 0.6 0.1 MYOZ2 "C4orf5, CS-1" ENSG00000172399 "Myozenin 2" Q9NPC6 4 119135784-119187789 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 219.1;skeletal muscle: 188.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.2;HSkMC: 3.7;SK-MEL-30: 9.3;U-87 MG: 9.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035763, HPA035764" Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035763: AB_2674770, HPA035764: AB_10696509" "unprognostic (2.53e-1)" "unprognostic (9.20e-2)" "unprognostic (6.94e-2)" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.34e-2)" "unprognostic (5.71e-1)" "unprognostic (2.18e-1)" "unprognostic (4.77e-2)" "unprognostic (4.04e-1)" "unprognostic (8.25e-2)" "unprognostic (5.07e-2)" "unprognostic (6.19e-7)" "unprognostic (6.66e-4)" "unprognostic (2.43e-1)" "unprognostic (3.06e-1)" "unprognostic (2.83e-2)" 3.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 2.4 2.6 0.2 0.1 219.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.9 0.1 188.6 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.0 13.9 3.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.7 0.0 0.6 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.3 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell line enhanced" "Detected in some" "BJ: 16.3;fHDF/TERT166: 45.8;HBF TERT88: 10.8;LHCN-M2: 19.7" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: " "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.1 0.5 0.0 0.0 0.3 1.7 0.0 16.3 8.2 6.1 2.3 0.0 0.0 0.0 0.0 45.8 0.3 0.0 0.1 10.8 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.3 0.1 0.0 0.1 19.7 3.4 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 1.9 0.0 1.7 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 MYPOP P42pop ENSG00000176182 "Myb related transcription factor, partner of profilin" Q86VE0 19 45890020-45902604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Cell line enhanced" "Detected in all" "HDLM-2: 18.8;NB-4: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065307 Approved Nucleoplasm Nucleoplasm "HPA065307: " "unprognostic (5.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.87e-3)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.94e-1)" "unprognostic (2.10e-1)" "prognostic unfavourable (8.67e-5)" "unprognostic (1.28e-3)" "unprognostic (1.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.19e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-3)" 7.6 9.4 15.7 7.9 14.3 4.2 8.0 15.1 25.9 6.5 7.5 6.8 5.9 11.4 7.2 7.0 6.4 6.1 7.1 8.0 15.9 9.2 9.5 6.1 5.9 8.3 8.5 7.7 6.5 8.5 7.0 12.9 6.1 11.3 7.7 6.0 6.3 9.5 8.2 36.4 10.1 10.1 6.5 9.0 12.3 8.5 6.8 8.7 5.3 5.0 4.3 7.0 6.8 10.7 1.0 1.5 2.7 1.4 0.6 1.1 0.4 4.1 6.7 2.6 5.2 3.3 2.1 5.1 3.1 3.2 3.4 4.5 2.7 2.7 4.0 3.0 1.5 3.5 1.9 1.4 2.4 18.8 10.9 1.9 3.8 4.3 3.6 1.9 6.0 2.0 4.0 1.9 1.8 2.8 2.5 3.6 2.2 1.8 9.9 25.7 2.8 6.8 7.9 1.1 2.3 2.0 2.3 5.3 4.0 3.0 3.3 3.2 2.3 7.0 3.6 3.2 5.3 3.0 4.9 10.7 7.7 2.6 4.7 5.1 3.8 0.0 1.4 2.7 1.1 0.6 0.3 1.0 0.8 0.6 1.5 0.3 0.6 0.7 1.6 0.6 0.7 1.0 0.7 0.4 15.7 14.3 15.1 25.9 15.9 9.2 8.5 7.7 11.3 8.7 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell line enhanced" "Detected in some" "A549: 18.3;CACO-2: 30.5;CAPAN-2: 17.6;EFO-21: 23.9;Hep G2: 12.9;HHSteC: 13.7;U-2 OS: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavourable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 18.3 3.3 1.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 30.5 17.6 0.6 23.9 0.0 0.8 1.0 0.1 1.3 0.1 0.3 0.1 0.4 12.9 13.7 0.0 0.3 0.3 0.2 0.4 0.0 0.1 5.6 0.2 0.1 0.3 0.0 0.6 0.9 2.4 0.0 0.1 1.2 8.1 0.1 0.1 0.6 0.1 1.3 0.3 0.4 0.1 0.6 0.2 10.6 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 MYRIP "DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 36.3" "Cell line enhanced" "Detected in some" "HAP1: 4.4;HUVEC TERT2: 16.6;REH: 3.9;SCLC-21H: 3.5;SH-SY5Y: 10.3;T-47d: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favourable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.8 2.0 31.0 2.2 7.8 0.5 3.4 23.7 19.4 9.0 4.2 3.9 1.3 2.9 6.0 3.8 2.4 3.3 4.3 2.8 13.9 9.6 2.7 16.7 1.7 2.6 8.5 11.0 5.3 13.1 2.1 8.4 0.6 10.8 3.4 4.4 36.3 16.0 1.8 2.7 1.8 2.8 3.9 5.5 10.2 7.7 1.7 4.2 0.0 2.1 1.6 2.9 2.8 2.7 0.8 0.1 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 16.6 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.1 3.9 0.0 0.0 0.4 2.1 3.5 10.3 0.0 0.0 0.0 4.1 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 31.0 7.8 23.7 18.4 13.9 9.6 8.5 11.0 10.8 4.2 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell line enhanced" "Detected in many" "MOLT-4: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: , HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.3 1.5 0.6 3.1 7.6 1.7 1.9 1.0 2.2 2.9 3.1 8.2 3.4 1.6 1.1 5.9 1.9 2.4 2.6 1.9 3.7 1.4 1.4 1.6 9.9 8.8 3.4 2.7 1.7 3.7 2.7 8.1 3.6 2.0 1.5 20.0 4.3 4.6 1.3 11.7 11.0 1.9 0.8 3.6 3.8 6.6 1.6 1.3 1.5 1.1 2.7 3.6 1.1 5.9 0.7 1.3 5.9 5.9 5.6 1.1 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 N4BP2L2 "CG005, PFAAP5" ENSG00000244754 "NEDD4 binding protein 2 like 2" Q92802 13 32432417-32538885 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039338, HPA039434, HPA059327" Approved Approved Nucleoplasm Nucleoplasm "HPA039338: , HPA039434: AB_10673143, HPA059327: " "unprognostic (1.13e-1)" "unprognostic (1.72e-1)" "unprognostic (3.15e-1)" "unprognostic (5.81e-2)" "unprognostic (6.83e-2)" "unprognostic (6.51e-2)" "unprognostic (8.95e-2)" "unprognostic (6.29e-3)" "unprognostic (6.04e-2)" "unprognostic (1.87e-1)" "unprognostic (2.71e-3)" "unprognostic (2.67e-2)" "unprognostic (4.73e-3)" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (4.03e-3)" 24.4 22.6 22.8 27.3 28.0 17.4 29.7 43.4 34.0 34.1 25.2 18.0 31.6 13.9 38.3 25.8 19.5 26.3 22.1 30.3 23.7 18.8 23.7 25.4 26.2 20.1 30.2 23.3 38.5 19.5 19.1 75.7 20.6 24.6 28.1 23.3 15.5 22.4 27.3 49.3 23.0 21.4 28.7 39.8 24.3 23.1 14.7 29.6 31.4 27.8 21.1 20.4 29.4 27.1 12.7 10.2 23.0 12.5 14.2 17.7 7.7 8.2 5.8 18.8 13.2 15.8 19.8 15.4 16.0 15.7 13.4 12.5 10.7 21.8 10.4 9.1 16.1 14.3 18.3 14.9 17.0 22.2 8.1 20.9 12.9 11.6 24.1 22.5 10.1 20.7 19.9 11.6 14.9 20.0 15.1 10.5 19.4 9.8 18.9 19.6 18.4 7.7 14.3 17.5 10.3 16.5 10.4 7.3 15.8 11.6 12.8 22.8 13.5 26.4 15.9 8.5 8.7 7.7 8.0 8.0 8.4 8.5 9.7 15.8 12.6 23.0 8.6 19.7 12.4 9.6 17.0 12.7 14.4 12.4 7.7 11.4 17.7 15.2 15.4 14.2 12.5 10.2 13.3 7.7 22.8 28.0 43.4 34.0 23.7 18.8 30.2 23.3 24.6 29.6 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113443-178126087 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.5" "Cell line enhanced" "Detected in many" "BEWO: 7.9;MCF7: 10.6;RH-30: 10.7;SK-BR-3: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4" "Group enriched" "Detected in many" 18 "B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favourable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 6.6 1.3 1.9 2.6 2.1 3.5 13.9 6.5 4.3 2.5 1.8 0.7 0.5 0.8 1.1 0.6 16.2 1.5 1.3 3.2 1.8 2.6 2.5 0.2 8.4 4.0 2.1 1.2 1.4 1.1 10.1 2.5 31.5 3.1 2.0 0.6 1.5 9.5 1.3 5.7 7.8 1.9 1.3 1.2 5.9 3.1 1.4 1.3 0.4 2.0 4.7 11.2 4.9 3.8 4.0 4.4 0.0 0.0 0.2 2.6 0.5 0.0 0.0 1.2 0.9 0.1 0.0 7.9 0.0 0.0 0.0 0.0 1.6 0.5 0.7 1.0 0.0 2.4 0.2 0.0 0.0 1.2 0.4 2.0 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 6.3 1.3 0.5 0.0 10.6 0.1 0.1 5.9 0.0 5.9 10.7 2.7 0.6 1.2 0.9 0.4 0.3 37.9 2.5 1.4 0.0 1.2 0.0 0.9 0.0 0.0 1.7 1.1 6.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 4.0 0.2 0.2 0.0 4.0 0.9 2.6 0.0 0.2 0.0 4.4 0.0 0.5 1.9 2.1 6.5 4.3 1.8 2.6 2.1 1.2 3.1 1.3 N6AMT1 "C21orf127, HEMK2, MTQ2, N6AMT, PRED28" ENSG00000156239 "N-6 adenine-specific DNA methyltransferase 1" Q9Y5N5 21 28872191-28885371 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034133, CAB034135, HPA059242" Approved Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "CAB034133: AB_2147189, CAB034135: AB_2250945, HPA059242: " "unprognostic (2.20e-2)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (7.46e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (3.67e-1)" "unprognostic (2.64e-1)" "unprognostic (1.04e-1)" "unprognostic (1.94e-2)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (5.24e-2)" "unprognostic (6.99e-2)" "unprognostic (5.43e-2)" "unprognostic (5.51e-3)" 5.4 10.9 10.1 6.0 18.6 2.0 10.5 7.4 14.8 9.9 7.0 17.0 6.0 6.7 13.8 13.7 5.6 9.3 6.2 10.8 10.8 9.2 9.0 6.3 5.5 6.7 21.3 8.4 18.3 6.6 14.6 15.6 13.1 14.1 10.1 7.4 8.4 6.5 9.0 11.3 8.0 6.2 7.8 14.5 7.9 6.7 7.6 19.3 3.9 12.1 4.0 6.9 8.7 9.2 2.2 2.0 1.6 2.1 4.1 4.8 1.8 3.4 3.0 7.7 10.7 6.4 7.1 5.9 7.4 3.0 4.3 2.6 3.8 6.1 3.8 3.7 4.0 4.0 6.6 3.7 5.4 4.8 5.0 8.0 4.7 4.7 5.8 4.8 3.1 3.6 8.0 4.4 3.0 3.2 9.8 6.7 8.9 3.4 2.2 3.8 9.7 4.3 3.4 7.3 2.8 8.0 5.0 5.9 8.3 6.7 2.4 2.7 3.3 4.2 7.4 3.7 6.5 6.6 4.4 4.1 4.6 2.1 5.7 12.5 6.8 1.1 1.5 1.6 1.8 2.1 2.0 2.2 3.4 2.3 2.0 2.2 4.8 3.4 0.5 4.1 1.6 1.7 1.4 1.8 10.1 18.6 7.4 14.8 10.8 9.2 21.3 8.4 14.1 19.3 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 44.1" "Group enriched" "Detected in some" 5 "CACO-2: 19.7;SH-SY5Y: 6.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 12 "monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm Nucleoplasm "HPA060820: , HPA065419: " "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 7.7 13.0 5.3 1.8 9.9 1.1 3.1 2.1 9.8 7.8 2.1 3.7 2.8 1.3 10.3 5.4 1.8 4.7 3.7 2.5 5.5 7.4 2.7 1.7 2.8 1.6 6.5 5.0 12.9 2.5 0.9 44.1 8.8 11.9 5.2 2.2 5.8 1.9 3.7 2.1 1.5 2.1 3.5 6.2 4.4 1.8 16.6 7.4 0.0 1.7 1.7 1.2 1.8 3.8 0.0 0.1 0.0 2.4 0.0 0.1 0.1 0.1 0.2 1.9 0.1 0.6 0.1 2.4 0.1 0.1 0.1 0.0 19.7 0.7 0.3 0.2 0.0 0.3 1.4 0.0 0.0 0.0 0.4 1.8 0.4 1.7 0.2 0.1 0.1 2.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.6 0.0 0.2 0.0 0.2 0.4 2.5 0.1 1.6 0.4 0.3 1.1 0.3 0.3 0.7 0.3 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 5.3 9.9 2.1 9.8 5.5 7.4 6.5 5.0 11.9 7.4 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 19.1 10.3 12.1 12.5 13.7 7.6 28.3 28.2 15.7 18.5 19.9 10.4 7.2 7.4 16.2 26.4 32.3 14.1 13.9 21.2 12.1 9.7 10.6 18.6 12.5 13.8 14.5 12.0 15.7 9.3 16.4 20.2 12.8 12.4 16.3 12.9 19.8 15.9 17.5 6.9 33.2 10.9 13.3 14.3 9.3 18.4 12.3 12.4 13.6 19.0 15.7 13.0 13.0 25.8 1.4 1.7 5.4 6.1 4.6 6.0 1.4 12.1 9.1 23.1 8.0 9.0 15.8 40.0 12.4 19.7 9.4 10.7 22.0 13.6 13.6 14.7 9.8 31.3 13.2 16.0 18.7 43.6 11.2 16.0 32.4 10.5 5.8 6.7 8.1 9.1 25.7 20.0 6.1 14.6 15.7 11.8 14.5 6.0 9.7 7.0 8.1 12.5 12.0 16.7 5.4 7.1 11.9 20.9 17.0 14.7 5.0 13.1 4.0 10.6 10.1 19.8 15.8 11.2 7.4 9.4 10.0 10.2 20.9 6.2 15.4 0.0 2.6 1.1 2.7 2.0 4.0 1.4 2.8 3.5 1.7 0.9 2.9 3.1 5.4 4.6 6.1 1.6 6.0 1.4 12.1 13.7 28.2 15.7 12.1 9.7 14.5 12.0 12.4 12.4 NAB2 MADER ENSG00000166886 "NGFI-A binding protein 2" Q15742 12 57088894-57095476 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004510, HPA027464" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB004510: AB_627982, HPA027464: AB_10601138" "prognostic favourable (7.41e-4)" "unprognostic (4.04e-2)" "unprognostic (2.20e-3)" "unprognostic (2.43e-2)" "unprognostic (4.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.88e-3)" "unprognostic (1.80e-1)" "unprognostic (5.85e-2)" "unprognostic (1.19e-1)" "unprognostic (2.13e-1)" "unprognostic (6.98e-2)" "prognostic unfavourable (9.38e-6)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (5.67e-3)" "unprognostic (6.19e-3)" 9.5 12.6 11.7 9.9 14.2 4.8 7.9 33.3 20.4 18.7 13.7 5.3 9.6 8.2 22.8 18.9 10.5 15.6 14.5 9.6 8.6 6.8 8.4 18.7 12.8 9.1 4.4 14.6 29.2 8.5 14.5 17.0 13.4 6.8 15.0 4.4 8.5 5.6 14.5 7.1 18.6 7.1 14.5 4.1 8.0 8.2 11.8 7.0 12.4 9.8 7.7 8.6 14.5 26.5 4.2 1.2 0.9 5.4 0.9 2.5 1.2 5.5 3.5 18.7 17.1 16.8 22.0 2.0 16.6 15.0 10.5 8.8 5.7 3.2 3.5 6.8 16.3 10.0 6.4 12.2 5.6 1.4 1.7 4.1 2.7 5.8 12.8 3.3 10.0 24.5 13.5 12.5 4.3 2.8 9.4 3.6 12.2 25.7 5.0 16.1 3.8 6.2 3.7 24.6 1.8 4.5 2.1 2.1 4.9 8.0 4.7 34.9 10.5 7.3 3.1 15.5 13.0 11.0 4.8 8.6 2.1 1.8 15.1 2.2 9.3 0.0 2.3 0.3 1.2 5.3 1.4 2.1 2.0 1.5 1.2 4.2 2.5 2.5 0.9 0.9 5.4 0.0 1.9 1.2 11.7 14.2 33.3 20.4 8.6 6.8 4.4 14.6 6.8 7.0 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080438-45088914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 6.5;SCLC-21H: 21.5;SH-SY5Y: 14.9" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 12 "monocytes: 1.8;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020981 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020981: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavourable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 4.7 8.9 11.5 2.7 19.4 1.1 2.1 16.7 45.0 4.8 3.5 43.1 0.1 2.1 6.9 2.3 3.9 4.8 3.7 5.1 16.7 15.9 2.2 1.2 3.0 1.9 30.2 12.9 10.4 2.4 3.2 11.7 3.8 26.7 4.7 2.3 1.1 3.2 5.7 2.0 2.1 2.7 7.4 30.8 2.7 2.5 4.5 21.5 0.0 1.4 0.0 1.5 3.2 2.3 0.1 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 2.1 0.0 1.3 0.6 0.0 2.3 2.9 6.5 4.1 0.2 0.1 0.0 1.9 4.2 0.2 1.8 1.6 2.3 0.0 0.6 0.0 1.4 0.0 1.6 0.0 0.0 1.4 0.0 2.8 0.3 2.0 0.0 2.9 1.6 0.0 0.0 0.0 1.9 1.8 0.0 0.8 0.0 0.2 0.0 21.5 14.9 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.4 1.5 0.8 0.0 1.2 0.0 4.4 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.1 11.5 19.4 16.7 24.1 16.7 15.9 30.2 12.9 26.7 21.5 NADK FLJ13052 ENSG00000008130 "NAD kinase" O95544 1 1751232-1780457 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.4" "Group enriched" "Detected in many" 7 "granulocytes: 80.4;monocytes: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048909, HPA053368" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA048909: , HPA053368: " "unprognostic (1.29e-1)" "unprognostic (4.29e-1)" "unprognostic (7.07e-2)" "unprognostic (6.82e-2)" "unprognostic (1.98e-1)" "unprognostic (1.58e-2)" "unprognostic (3.32e-1)" "unprognostic (9.03e-2)" "unprognostic (7.81e-2)" "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (4.54e-3)" "unprognostic (1.40e-1)" "unprognostic (5.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" 24.7 34.3 11.1 19.0 11.9 49.0 25.5 9.9 12.6 12.4 18.2 10.8 14.1 20.3 13.9 14.5 12.5 14.3 17.1 11.9 9.9 7.9 12.7 52.3 17.5 27.0 15.8 8.6 16.9 32.2 8.3 11.9 22.5 10.3 13.7 14.1 13.9 21.4 14.5 10.6 11.7 19.4 14.4 8.3 39.4 22.1 17.3 9.6 10.8 14.0 12.0 19.2 13.7 28.3 1.8 7.2 80.4 24.7 0.5 1.4 10.4 15.1 14.6 13.1 19.2 18.7 13.6 16.9 15.3 13.4 17.5 15.6 15.6 27.9 20.1 11.7 11.3 12.9 14.0 12.1 7.8 19.5 22.3 16.4 22.9 26.9 18.1 23.0 27.7 15.9 11.0 10.8 15.5 16.9 20.1 28.8 13.0 17.4 17.3 20.0 8.9 16.6 22.1 11.2 41.1 15.1 12.6 17.7 13.5 17.1 37.7 15.7 13.0 16.1 16.3 12.8 9.2 13.1 13.7 25.7 11.6 45.0 12.6 25.6 6.6 11.8 21.1 49.5 1.2 24.7 1.4 1.8 0.7 0.9 7.2 1.7 0.5 0.7 80.4 0.5 23.8 5.9 1.0 10.4 11.1 11.9 9.9 12.6 9.9 7.9 15.8 8.6 10.3 9.6 NAE1 "APP-BP1, APPBP1, ula-1" ENSG00000159593 "NEDD8 activating enzyme E1 subunit 1" Q13564 16 66802875-66873256 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041178, HPA042041" Enhanced Approved Nucleoplasm,Microtubules,Centrosome 53000 Nucleoplasm "Microtubules, Centrosome" "HPA041178: AB_10964773, HPA042041: AB_10964772" "unprognostic (3.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-2)" "unprognostic (1.13e-1)" "unprognostic (2.00e-2)" "unprognostic (1.06e-2)" "prognostic unfavourable (3.92e-8)" "unprognostic (2.31e-1)" "unprognostic (5.58e-2)" "unprognostic (3.12e-3)" "unprognostic (5.34e-2)" "unprognostic (3.85e-2)" "unprognostic (7.09e-3)" "unprognostic (2.50e-1)" "unprognostic (1.84e-1)" "prognostic favourable (9.44e-5)" "unprognostic (1.97e-1)" 23.6 27.4 25.3 20.2 31.8 27.2 27.3 36.7 41.7 26.0 25.8 24.4 23.7 26.2 27.9 31.0 27.5 23.9 20.2 23.6 25.4 29.0 24.3 25.9 18.3 27.0 27.7 31.9 31.0 26.6 38.8 42.2 26.4 34.9 24.9 30.0 22.1 24.3 23.5 33.2 26.9 27.6 25.4 25.3 18.4 22.2 36.9 25.9 28.9 27.9 28.0 24.9 24.7 22.4 9.4 6.4 6.7 3.2 8.6 19.4 9.4 22.6 17.5 31.2 30.7 12.5 17.8 25.9 17.3 17.6 25.7 31.2 21.2 17.6 25.1 19.9 13.0 23.0 23.4 20.8 36.5 9.2 26.7 17.8 12.1 32.9 14.4 33.1 22.4 14.4 15.5 20.4 18.0 17.9 42.1 8.9 19.7 7.9 34.6 37.9 43.2 31.6 37.2 37.2 33.5 19.8 20.0 33.6 24.7 51.8 11.1 19.9 11.9 22.4 13.9 18.0 18.0 18.7 20.0 16.8 25.9 90.5 16.2 22.0 21.7 1.3 3.1 6.7 15.4 3.0 19.4 9.4 16.4 16.6 4.2 7.9 17.8 17.7 1.4 8.6 3.2 6.4 14.0 9.4 25.3 31.8 36.7 41.7 25.4 29.0 27.7 31.9 34.9 25.9 NAGK GNK ENSG00000124357 "N-acetylglucosamine kinase" Q9UJ70 2 71064344-71079805 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035206, HPA035207" Enhanced Approved Nucleoplasm,Cytosol 690000 Cytosol Nucleoplasm "HPA035206: AB_2674517, HPA035207: AB_10602031" "unprognostic (6.15e-2)" "unprognostic (4.23e-3)" "unprognostic (2.97e-2)" "prognostic unfavourable (6.88e-4)" "unprognostic (2.44e-1)" "prognostic favourable (5.87e-4)" "unprognostic (4.65e-3)" "unprognostic (2.18e-2)" "unprognostic (2.31e-1)" "unprognostic (9.99e-2)" "unprognostic (4.32e-2)" "unprognostic (1.59e-1)" "prognostic unfavourable (4.35e-4)" "unprognostic (8.60e-2)" "unprognostic (1.45e-2)" "unprognostic (5.50e-3)" "unprognostic (2.13e-2)" 20.0 17.6 21.8 30.9 24.5 9.8 15.7 13.9 18.8 23.6 15.5 23.7 17.4 11.4 16.4 19.7 67.0 13.7 20.0 14.0 17.6 20.4 16.9 20.2 18.3 30.6 31.1 20.3 15.0 25.8 27.5 21.8 43.9 26.2 15.8 15.8 14.7 49.0 17.8 11.3 29.5 14.6 22.8 21.6 43.4 15.5 24.8 26.7 20.2 13.0 27.2 39.9 24.5 26.1 14.3 53.0 37.4 79.3 8.5 7.1 52.2 18.8 15.3 8.6 8.8 34.5 21.1 33.9 42.1 18.2 28.2 25.7 17.9 9.9 10.5 10.1 29.2 9.1 6.6 12.5 17.5 15.0 5.2 5.9 5.0 11.1 25.9 3.7 15.1 18.9 13.1 30.3 4.7 29.6 2.7 11.9 39.1 17.3 9.3 13.2 9.2 11.9 7.3 24.1 5.4 17.1 33.8 9.0 4.9 12.7 20.1 13.2 10.4 4.7 26.0 33.7 13.1 13.0 14.7 8.3 7.2 6.2 23.0 10.1 18.4 10.3 79.3 31.5 5.4 69.8 5.5 14.3 6.4 5.2 53.0 13.3 5.5 4.5 37.4 8.5 46.6 42.4 7.1 52.2 21.8 24.5 13.9 18.8 17.6 20.4 31.1 20.3 26.2 26.7 NAIF1 "bA379C10.2, C9orf90, DKFZp762G199" ENSG00000171169 "Nuclear apoptosis inducing factor 1" Q69YI7 9 128061233-128068206 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054898, HPA064931" Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA054898: , HPA064931: " "unprognostic (7.09e-2)" "unprognostic (5.92e-2)" "unprognostic (1.20e-2)" "unprognostic (5.56e-3)" "unprognostic (1.58e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (6.15e-2)" "unprognostic (9.41e-2)" "prognostic favourable (1.02e-5)" "unprognostic (3.08e-1)" "prognostic favourable (8.30e-5)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (3.92e-2)" 7.1 7.2 4.5 5.1 4.5 11.3 10.3 5.6 5.5 6.0 4.5 2.4 10.9 6.0 6.3 5.1 7.1 5.4 6.6 7.4 5.5 3.4 5.2 8.3 9.3 8.3 3.8 4.2 5.4 7.3 3.4 4.5 7.3 5.3 6.0 3.7 5.5 6.5 9.5 7.1 5.5 6.2 5.2 4.8 9.0 5.5 15.6 2.9 12.5 6.2 6.1 7.8 5.5 16.3 3.4 2.2 4.5 3.0 1.6 3.4 1.5 4.8 4.1 2.6 6.8 2.5 2.2 6.0 3.7 2.2 3.1 2.5 3.3 3.8 5.8 3.2 2.3 3.6 2.7 2.8 2.6 17.8 3.7 4.3 5.0 1.9 4.1 5.9 12.2 2.0 3.3 2.4 3.9 2.8 10.1 3.7 2.9 5.5 5.7 7.2 2.9 7.1 5.5 4.2 5.3 2.4 3.0 3.8 4.4 3.5 5.0 3.8 3.9 5.9 1.9 3.7 11.7 3.1 4.2 6.1 12.7 3.9 3.5 3.9 4.9 0.0 2.2 3.3 1.7 2.0 1.4 1.1 3.4 2.5 2.2 3.4 2.6 2.2 4.5 1.6 3.0 1.7 0.9 1.5 4.5 4.5 5.6 5.5 5.5 3.4 3.8 4.2 5.3 2.9 NANS SAS ENSG00000095380 "N-acetylneuraminate synthase" Q9NR45 9 98056739-98083075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019223 Approved Approved Nucleoplasm 200000 Nucleoplasm "HPA019223: AB_1854298" "unprognostic (2.95e-1)" "unprognostic (5.10e-3)" "unprognostic (2.24e-2)" "prognostic favourable (1.71e-4)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "prognostic unfavourable (6.42e-4)" "unprognostic (2.08e-1)" "unprognostic (7.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-2)" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (7.36e-2)" "unprognostic (3.62e-3)" "unprognostic (1.79e-1)" 17.2 10.1 8.8 20.2 11.4 22.2 16.4 7.0 11.7 20.2 47.6 6.4 17.0 19.4 11.0 15.1 18.6 10.4 25.0 20.9 14.4 12.4 15.0 49.6 17.1 20.1 11.5 10.6 14.1 59.2 6.1 16.3 15.8 12.1 37.2 49.6 9.4 80.0 18.3 11.9 10.3 18.9 11.0 9.0 22.2 28.3 11.5 9.8 10.6 19.7 15.2 25.0 15.7 14.8 12.3 41.9 16.4 49.8 7.4 12.1 18.3 74.0 21.9 6.5 18.8 13.1 14.2 14.1 23.7 18.6 19.4 15.9 26.2 10.6 22.8 11.5 26.0 26.4 12.1 20.4 16.3 18.3 18.0 13.5 24.5 52.1 36.3 15.3 11.1 12.0 13.9 20.6 23.6 20.7 24.5 23.9 14.1 50.9 10.2 22.0 11.2 28.5 19.8 17.8 23.2 15.5 22.8 13.2 6.9 15.2 82.6 20.1 27.4 16.5 53.7 15.2 14.7 38.7 24.3 22.2 18.5 8.7 17.9 18.5 11.8 5.3 42.1 6.0 8.0 49.8 12.1 12.3 10.5 8.3 41.9 10.1 11.5 7.8 16.4 7.4 43.0 38.4 11.9 18.3 8.8 11.4 7.0 11.7 14.4 12.4 11.5 10.6 12.1 9.8 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695915-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.4" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058227: " "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 7.3 21.8 24.5 3.6 23.3 4.9 4.9 25.8 53.4 6.2 3.1 4.2 2.1 1.9 6.4 10.5 4.1 4.9 5.4 5.6 23.9 52.8 6.1 5.0 3.1 3.0 28.4 33.6 8.2 2.8 7.9 12.9 4.7 35.6 6.7 3.1 3.6 2.5 8.7 1.8 1.7 2.4 6.4 11.5 3.5 2.8 4.9 5.4 0.5 9.3 1.3 2.4 5.2 2.0 0.7 0.9 0.6 0.8 1.5 3.9 1.0 0.0 1.0 7.1 4.3 10.5 6.7 0.0 7.7 4.7 3.9 6.2 0.0 0.9 0.0 3.1 4.4 1.4 12.7 3.0 7.1 2.4 0.0 13.3 4.6 1.1 9.1 6.8 8.8 10.6 1.0 4.6 0.7 6.9 3.7 0.0 11.5 0.1 8.3 0.5 2.9 0.0 4.5 2.0 0.8 2.6 3.2 9.6 29.0 0.0 1.3 5.6 0.0 1.9 5.0 4.5 1.1 2.8 3.8 2.0 0.0 0.0 9.6 0.0 3.5 0.0 0.2 0.4 3.9 0.4 2.6 0.0 1.9 3.0 0.9 0.7 3.5 3.3 0.6 1.5 0.8 0.7 1.7 1.0 24.5 23.3 25.8 41.9 23.9 52.8 28.4 33.6 35.6 5.4 NAPRT "NAPRT1, PP3856" ENSG00000147813 "Nicotinate phosphoribosyltransferase" Q6XQN6 8 143574785-143578649 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Ligase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.9;SK-BR-3: 23.5;U-937: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023739, HPA024017, CAB068206, CAB068207" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" 2000000 "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB068206: , CAB068207: , HPA023739: AB_1854308, HPA024017: AB_1854309" "unprognostic (7.08e-2)" "unprognostic (1.55e-1)" "unprognostic (5.76e-3)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.30e-1)" "unprognostic (7.65e-2)" "unprognostic (2.19e-1)" "unprognostic (2.84e-1)" "unprognostic (1.08e-2)" "unprognostic (1.75e-1)" "unprognostic (4.13e-2)" "prognostic favourable (6.28e-4)" "unprognostic (6.02e-2)" "unprognostic (3.97e-1)" "unprognostic (2.28e-2)" "unprognostic (1.61e-2)" 9.7 6.4 4.9 9.7 6.2 21.1 13.2 10.7 5.4 6.7 25.2 2.3 9.9 33.0 4.7 4.7 16.4 4.8 15.5 4.9 3.9 2.1 10.7 28.3 8.3 12.1 3.7 0.1 5.9 6.5 2.4 2.8 8.6 4.1 6.9 3.8 5.2 12.8 3.8 7.1 12.4 34.4 5.2 2.2 9.8 11.8 5.5 4.0 3.0 6.8 8.9 9.5 7.6 8.1 0.8 4.7 4.6 8.4 0.5 1.6 2.4 3.4 3.9 0.4 0.8 0.3 1.2 2.5 0.8 0.4 1.3 0.8 3.2 21.9 0.9 6.1 0.2 7.5 0.2 6.2 0.0 4.0 6.3 5.2 10.3 0.9 2.8 1.2 2.8 0.1 2.2 0.1 0.0 1.4 4.8 4.1 0.1 4.2 2.5 2.7 1.0 2.5 4.5 0.1 10.8 0.9 1.3 1.7 0.4 9.9 23.5 2.9 0.9 3.0 4.1 0.7 6.2 4.6 1.7 0.5 0.2 1.1 1.1 18.2 3.2 0.0 4.4 4.6 1.6 8.4 0.5 0.8 0.7 1.5 4.7 0.2 0.8 0.7 2.7 0.5 8.4 1.5 0.2 2.4 4.9 6.2 10.7 5.4 3.9 2.1 3.7 0.1 4.1 4.0 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favourable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.4 10.5 11.0 7.2 7.7 6.5 9.2 6.2 6.1 9.7 8.0 17.9 8.1 18.5 16.2 3.9 9.9 18.5 12.1 13.5 12.1 9.9 13.0 8.1 15.2 6.4 13.9 4.8 4.5 7.8 8.5 15.2 8.3 19.6 5.1 10.8 8.7 14.4 22.6 12.0 12.7 15.1 18.0 25.0 12.9 10.6 13.1 8.3 9.2 11.9 15.9 11.2 5.5 5.0 13.2 15.6 15.0 10.4 8.5 14.3 40.8 2.5 12.6 8.9 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170493-101180276 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.5;SH-SY5Y: 6.8;SK-MEL-30: 5.0;U-2 OS: 5.9;U-87 MG: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Group enriched" "Detected in many" 4 "amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA021918 Uncertain Approved Nucleoplasm Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.2 0.4 3.1 0.2 9.1 0.7 0.1 0.4 8.2 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.1 0.9 4.8 0.1 0.5 0.1 0.2 0.7 0.6 0.1 6.0 0.2 5.8 0.1 0.8 0.2 0.3 0.5 0.3 0.1 0.3 0.4 0.2 0.2 0.4 0.3 1.2 0.4 1.2 0.0 4.6 0.0 0.0 0.1 0.0 1.2 0.7 2.2 0.6 1.3 0.8 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.5 0.1 0.1 0.8 0.6 0.2 0.1 4.5 0.0 0.4 0.1 6.8 0.0 0.3 5.0 0.3 0.0 0.0 0.4 5.9 0.5 0.1 0.1 0.0 0.1 3.4 0.0 1.6 0.4 0.6 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.2 1.2 0.8 0.4 2.2 1.3 0.3 0.7 0.3 0.0 3.1 9.1 0.4 2.9 0.9 4.8 0.7 0.6 0.8 1.2 NAT9 DKFZP564C103 ENSG00000109065 "N-acetyltransferase 9 (putative)" Q9BTE0 17 74770547-74776367 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021820, HPA057149" Approved Approved Nucleoplasm Nucleoplasm "HPA021820: AB_1847958, HPA057149: " "unprognostic (7.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.40e-1)" "unprognostic (2.18e-1)" "unprognostic (1.81e-1)" "prognostic unfavourable (3.25e-5)" "unprognostic (1.27e-1)" "unprognostic (5.77e-2)" "unprognostic (1.41e-1)" "prognostic favourable (3.21e-5)" "unprognostic (6.50e-3)" "prognostic unfavourable (6.26e-6)" "prognostic favourable (7.80e-4)" "unprognostic (8.50e-2)" "unprognostic (8.64e-2)" "unprognostic (1.03e-3)" 9.4 31.6 20.1 11.3 17.8 11.8 13.5 20.0 20.6 13.6 11.2 9.9 21.7 8.0 11.6 24.5 9.1 16.8 12.9 11.3 18.4 12.1 12.9 16.6 10.5 12.0 18.1 17.8 21.5 14.5 18.5 25.1 13.8 23.1 15.8 9.9 11.6 18.1 13.2 9.5 10.9 8.5 11.2 17.0 12.1 11.2 12.2 20.7 7.9 14.9 7.0 10.8 11.3 10.3 19.6 13.7 9.7 16.7 10.9 21.5 8.4 9.3 13.6 8.7 7.9 14.3 17.9 10.4 17.7 15.8 19.0 16.5 23.5 10.4 25.5 6.8 14.2 10.2 11.7 19.7 12.2 5.3 17.6 16.4 10.1 20.9 16.7 8.4 10.5 16.3 14.7 18.9 28.9 20.7 20.4 8.1 13.8 8.9 16.8 6.9 6.7 19.9 11.3 25.6 14.8 13.7 15.3 12.6 16.7 7.5 22.1 34.3 20.5 11.3 11.9 22.0 17.8 9.5 16.8 11.2 4.0 14.3 9.1 5.8 14.0 9.7 11.5 4.6 6.9 16.7 13.7 14.0 12.3 10.1 13.7 19.6 21.5 15.5 2.9 10.9 9.4 10.3 6.5 8.4 20.1 17.8 20.0 20.6 18.4 12.1 18.1 17.8 23.1 20.7 NBEA "BCL8B, FLJ10197, KIAA1544, LYST2" ENSG00000172915 Neurobeachin Q8NFP9 13 34942287-35673022 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 41.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039730, HPA040385" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA039730: AB_10794202, HPA040385: AB_10795523" "unprognostic (1.80e-2)" "unprognostic (2.90e-1)" "unprognostic (4.99e-2)" "unprognostic (3.89e-4)" "unprognostic (3.59e-1)" "unprognostic (2.04e-1)" "unprognostic (8.75e-2)" "unprognostic (6.95e-3)" "unprognostic (5.01e-1)" "unprognostic (7.43e-2)" "unprognostic (1.03e-3)" "unprognostic (2.45e-1)" "prognostic favourable (7.86e-8)" "unprognostic (2.28e-2)" "unprognostic (9.35e-2)" "unprognostic (1.17e-1)" "unprognostic (6.46e-2)" 3.9 11.9 12.2 2.7 20.6 1.0 8.2 32.6 28.5 7.4 9.8 3.9 10.9 2.7 10.3 6.2 6.2 9.4 5.4 11.7 13.5 10.6 6.6 1.7 3.6 2.6 6.9 22.2 10.4 5.7 9.3 25.0 1.5 14.2 11.9 4.8 13.3 7.0 14.2 8.5 2.0 3.8 11.4 4.7 5.1 4.8 7.7 6.0 6.1 9.6 0.7 2.4 7.1 6.4 1.1 1.3 0.0 0.5 0.4 1.4 0.1 0.0 2.3 5.4 3.0 0.4 0.0 0.1 3.4 5.3 4.0 3.3 0.0 0.5 1.4 0.0 5.8 0.1 1.8 0.7 8.5 0.7 1.8 0.0 1.6 0.5 0.3 0.9 2.2 0.9 0.6 0.0 0.4 0.7 0.0 9.7 0.5 1.0 0.5 0.0 2.3 0.9 0.6 2.3 0.4 4.6 1.0 3.1 41.2 2.5 0.0 1.7 0.9 0.2 0.0 1.0 0.6 0.0 0.7 0.9 0.2 0.7 2.6 0.3 2.1 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.1 0.2 0.0 1.1 1.4 1.3 0.0 0.4 0.0 1.3 0.0 0.1 12.2 20.6 32.6 18.4 13.5 10.6 6.9 22.2 14.2 6.0 NBEAL1 "ALS2CR16, ALS2CR17, MGC164581" ENSG00000144426 "Neurobeachin like 1" Q6ZS30 2 203014879-203226378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049189, HPA049447" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049189: , HPA049447: " "unprognostic (3.66e-2)" "unprognostic (5.26e-2)" "unprognostic (2.86e-2)" "unprognostic (1.11e-1)" "unprognostic (4.52e-4)" "unprognostic (1.16e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-3)" "unprognostic (2.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (2.22e-1)" "unprognostic (7.98e-3)" "unprognostic (7.59e-2)" 11.2 7.8 5.2 7.3 7.9 2.7 13.4 7.5 6.0 9.2 14.5 6.5 8.4 9.9 19.1 7.0 8.7 7.9 8.9 8.2 4.8 2.9 14.4 12.3 14.7 3.3 5.1 2.7 8.8 8.5 9.2 13.6 10.2 7.0 6.7 14.4 9.7 8.1 10.6 6.9 6.6 11.7 11.9 7.3 5.0 14.7 9.9 6.2 2.8 10.1 6.4 5.3 9.8 9.5 0.9 0.7 0.9 0.6 0.6 3.0 0.2 4.9 4.6 1.9 1.7 12.0 9.4 2.7 4.7 3.5 2.5 3.9 5.2 2.6 1.1 3.9 7.9 4.0 3.8 5.5 5.9 2.2 1.6 1.9 6.9 2.9 2.9 1.7 2.3 3.6 3.7 4.2 5.2 4.0 3.3 1.7 5.7 3.4 0.7 0.9 0.9 4.3 0.8 3.2 1.1 7.1 9.2 1.2 0.9 4.1 3.0 3.1 3.5 1.7 6.7 6.7 5.7 3.2 2.1 2.9 2.2 1.5 4.0 0.8 2.3 0.0 0.5 0.9 0.8 0.4 1.0 0.4 0.9 0.5 0.4 0.9 0.7 0.5 0.3 0.6 0.6 0.7 3.0 0.2 5.2 7.9 7.5 6.0 4.8 2.9 5.1 2.7 7.0 6.2 NBN "AT-V1, AT-V2, ATV, NBS, NBS1" ENSG00000104320 Nibrin O60934 8 89933336-90003228 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 76.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001429, CAB003836" Supported Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "CAB003836: AB_562172, HPA001429: AB_1854460" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-3)" "unprognostic (7.46e-2)" "unprognostic (2.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "prognostic unfavourable (5.46e-5)" "unprognostic (5.05e-2)" "unprognostic (4.61e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (1.15e-1)" "unprognostic (6.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.28e-1)" "unprognostic (2.84e-2)" "unprognostic (1.03e-1)" 19.2 16.1 17.9 23.6 29.5 41.3 23.0 17.4 21.0 19.3 22.6 12.2 16.9 13.3 33.2 16.6 19.7 17.5 20.2 14.2 19.4 16.7 25.9 19.3 17.9 26.7 16.9 18.1 19.3 17.1 21.0 29.4 13.2 18.4 17.6 20.9 7.1 18.4 17.6 15.7 11.2 18.0 22.2 18.1 26.5 14.7 13.9 18.9 23.4 20.8 14.7 22.8 17.5 16.0 10.1 12.0 21.8 18.5 9.7 8.6 7.6 15.1 8.5 8.6 4.5 4.7 11.8 5.5 10.8 14.4 13.8 15.0 4.9 11.5 22.9 12.6 9.8 5.1 10.4 10.1 17.7 10.7 6.0 19.4 5.3 6.9 9.2 11.6 10.3 8.8 5.4 7.7 17.1 11.1 14.2 13.4 15.6 13.5 17.7 7.3 2.5 9.3 11.9 7.5 13.6 17.8 20.9 2.5 7.9 6.8 76.8 6.4 14.4 8.6 8.3 12.0 8.5 7.2 10.6 6.2 7.1 12.8 12.1 10.9 11.0 14.1 11.1 20.3 8.1 12.5 8.6 10.1 5.9 5.9 12.0 6.1 5.7 6.2 21.8 9.7 18.5 6.6 3.7 7.6 17.9 29.5 17.4 21.0 19.4 16.7 16.9 18.1 18.4 18.9 NBPF1 "FLJ20719, KIAA1693" ENSG00000219481 "NBPF member 1" 1 16562319-16613562 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (8.16e-3)" "unprognostic (6.96e-2)" "unprognostic (1.33e-2)" "unprognostic (6.09e-2)" "unprognostic (3.49e-1)" "unprognostic (4.76e-2)" "unprognostic (1.15e-5)" "unprognostic (2.16e-2)" "unprognostic (5.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.90e-2)" "unprognostic (2.14e-2)" "prognostic favourable (1.06e-4)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.68e-1)" 6.8 23.3 14.2 6.4 18.3 4.5 7.4 32.7 13.1 11.7 11.6 21.5 6.0 7.5 9.5 6.2 6.6 13.9 7.9 5.2 13.4 9.3 8.1 7.7 7.3 3.2 32.8 4.2 18.6 5.5 22.3 12.3 9.7 18.4 9.0 11.3 9.3 6.5 9.6 4.5 5.9 16.6 12.2 21.3 6.7 7.3 22.3 21.5 3.7 9.5 3.3 4.3 10.4 8.5 2.0 0.9 4.3 1.0 0.4 1.7 0.5 5.4 7.8 7.9 4.8 2.2 2.6 1.5 3.8 4.9 7.2 6.5 2.8 2.3 4.3 1.1 10.6 5.1 3.8 2.3 8.5 2.7 4.2 1.4 2.6 2.7 3.5 2.1 3.4 2.8 2.9 10.4 3.0 3.2 4.6 2.4 2.8 4.3 9.2 1.6 1.5 15.4 7.9 4.3 0.4 2.0 1.1 9.8 9.6 9.7 4.0 5.4 6.1 1.5 3.8 6.4 3.5 8.6 3.3 1.3 5.9 2.4 1.5 3.2 2.6 0.4 0.7 4.3 1.2 0.8 1.4 1.1 1.1 1.5 0.5 2.0 1.3 1.7 0.2 0.4 1.0 0.9 0.0 0.5 14.2 18.3 32.7 13.1 13.4 9.3 32.8 4.2 18.4 21.5 NBPF10 AG1 ENSG00000271425 "NBPF member 10" 1 146064699-146144804 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (2.05e-1)" "unprognostic (8.84e-2)" "unprognostic (5.84e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-1)" "unprognostic (5.16e-3)" "unprognostic (3.26e-1)" "unprognostic (2.17e-1)" "unprognostic (9.49e-2)" "unprognostic (6.64e-5)" "unprognostic (1.60e-1)" "unprognostic (6.01e-2)" "unprognostic (1.11e-3)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (9.61e-2)" "unprognostic (6.68e-2)" 1.5 0.0 0.9 3.3 2.3 0.0 3.0 0.9 0.0 1.6 1.9 1.0 1.3 0.5 0.0 0.4 1.2 1.3 0.6 3.2 1.1 1.5 0.7 1.1 1.1 0.3 1.3 0.0 4.2 0.0 1.5 2.0 0.1 1.2 0.7 0.6 0.2 1.3 2.4 3.7 1.5 0.4 0.4 0.2 5.4 1.4 3.2 2.3 11.3 13.5 2.8 3.1 4.2 3.1 3.2 1.4 2.5 2.5 0.6 6.1 2.7 3.8 4.2 6.4 2.8 2.4 5.4 3.8 0.7 4.5 2.5 1.7 12.3 4.0 8.3 8.5 3.8 1.7 7.7 6.7 6.7 1.0 2.2 1.5 4.4 1.3 2.0 3.3 2.4 3.7 0.3 0.4 4.7 4.7 1.6 3.8 3.1 11.4 3.1 2.7 2.9 3.8 4.7 1.9 3.0 2.8 2.7 2.4 0.8 1.5 1.8 0.4 1.1 0.2 1.1 0.2 0.3 0.7 1.3 0.4 0.3 3.7 0.4 1.2 2.4 0.3 0.2 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favourable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favourable (3.20e-5)" 1.5 2.1 3.4 2.1 3.9 3.0 3.8 5.7 5.3 4.6 1.5 3.1 9.6 1.4 5.7 9.6 1.2 3.0 1.5 0.7 3.0 1.4 3.7 3.3 3.0 6.0 1.1 5.3 3.2 5.4 1.6 3.3 4.4 2.9 2.4 3.4 3.2 5.6 0.6 5.7 2.0 3.0 5.7 3.1 2.1 1.5 3.1 1.5 3.0 0.0 3.5 1.3 0.0 5.2 3.9 6.1 3.5 1.0 4.1 1.0 5.6 4.5 8.9 8.6 6.2 5.2 6.0 5.1 4.7 4.3 4.6 3.5 5.7 9.4 4.0 6.0 7.3 5.6 1.9 5.3 5.1 6.1 4.1 14.0 3.7 4.4 5.9 15.2 4.5 5.2 5.5 10.4 3.1 6.7 0.6 4.3 11.0 6.7 10.7 7.8 5.8 9.1 5.2 3.6 4.2 10.9 3.6 9.4 8.0 5.5 7.6 8.0 10.1 7.7 5.7 4.7 8.8 6.4 5.6 4.6 6.5 5.4 3.8 3.2 6.1 1.9 5.7 4.1 1.3 2.9 3.3 3.4 2.4 1.9 5.2 3.8 2.9 0.3 1.0 3.5 3.9 1.3 1.0 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 29.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favourable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favourable (2.47e-5)" 2.7 1.7 2.2 4.0 3.9 5.1 3.2 4.4 4.7 2.6 1.9 5.8 2.2 2.4 6.0 3.6 1.5 2.4 3.1 0.9 2.3 1.7 6.1 2.8 3.4 4.2 4.2 4.3 29.8 4.2 5.0 1.8 3.8 2.5 1.8 4.2 3.5 4.0 0.9 2.5 1.9 3.0 3.2 3.1 5.3 7.0 1.1 3.3 2.9 0.9 2.9 1.2 3.9 3.8 2.6 6.1 2.3 0.9 3.5 0.8 6.9 5.6 11.8 10.1 5.5 5.2 7.6 7.2 5.4 5.1 5.2 5.1 6.6 15.5 4.5 6.2 5.2 8.4 4.1 5.0 5.8 5.9 6.8 12.1 4.3 4.6 5.1 10.1 5.4 7.5 5.1 11.8 4.6 10.8 2.7 4.1 10.6 10.9 6.4 6.8 7.3 10.6 4.3 3.7 3.9 15.4 5.9 12.4 9.5 8.4 4.7 7.1 15.4 5.5 4.6 7.5 10.3 10.0 9.5 7.0 6.5 4.9 3.6 5.1 6.1 2.3 1.8 3.5 1.1 2.0 3.4 2.3 1.9 1.0 3.8 2.6 2.0 0.7 0.9 1.4 2.6 2.2 0.8 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679751 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 4.4 0.7 2.5 3.2 4.6 6.7 4.3 2.1 4.3 5.4 2.4 2.1 0.9 0.4 4.3 11.2 3.9 3.4 2.9 6.7 4.2 3.4 3.4 3.4 4.0 2.6 2.8 7.7 6.3 3.1 0.9 1.8 4.6 3.6 2.7 6.9 3.2 1.9 1.2 8.5 1.9 4.1 3.8 4.5 0.8 5.2 5.1 2.8 2.6 9.1 4.7 1.8 4.7 21.8 16.5 25.2 17.2 3.4 3.1 3.5 26.7 5.1 10.1 7.4 21.1 29.5 5.0 10.0 10.2 7.0 8.0 4.1 8.9 5.0 2.6 10.3 8.1 6.7 10.5 10.1 9.8 7.6 13.3 16.4 1.0 8.3 10.4 5.4 29.6 8.7 18.5 24.7 10.7 4.5 27.2 16.4 16.0 2.7 7.5 4.3 12.4 4.3 9.1 15.8 8.6 11.1 0.1 0.1 20.4 11.3 4.8 14.1 9.0 42.8 7.9 8.8 9.5 16.6 47.9 15.3 12.3 14.3 9.1 11.9 9.8 17.2 25.2 2.3 11.5 1.7 21.8 2.4 2.1 14.9 15.1 3.1 2.6 22.9 3.4 13.1 16.5 3.1 3.5 NBPF15 "MGC8902, NBPF16" ENSG00000266338 "NBPF member 15" Q8N660 1 144421386-144461674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.1;NK-cells: 2.7;T-cells: 5.5" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "unprognostic (7.10e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" "unprognostic (1.84e-3)" "unprognostic (3.50e-3)" "unprognostic (8.16e-3)" "unprognostic (1.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.69e-2)" "prognostic unfavourable (4.11e-5)" "unprognostic (1.36e-1)" "unprognostic (1.91e-1)" "unprognostic (6.67e-2)" "unprognostic (6.26e-2)" 2.2 1.1 1.3 2.7 3.3 0.0 4.9 6.1 3.6 3.2 1.1 1.8 2.9 0.4 4.0 7.7 1.7 2.4 1.9 0.5 7.1 1.5 4.9 2.8 5.0 1.4 1.5 3.4 1.7 3.6 3.2 2.7 4.2 2.8 2.1 3.0 5.2 3.1 0.7 2.2 0.7 3.8 6.3 3.6 0.9 0.9 4.8 1.0 3.0 1.9 3.7 1.4 0.5 3.1 0.2 0.6 0.4 2.7 5.5 1.8 7.4 4.8 8.9 16.6 10.5 16.6 10.9 13.5 13.2 8.3 8.5 4.2 8.1 3.7 3.7 9.8 5.8 9.7 4.3 13.2 12.4 5.2 0.3 11.0 5.2 8.0 0.3 3.7 13.5 7.6 9.8 20.6 11.5 1.6 11.4 19.9 15.9 0.2 3.3 3.6 11.0 3.3 5.2 5.9 9.1 6.8 0.8 20.0 5.7 8.8 9.3 8.8 3.3 12.3 13.4 8.8 11.8 12.5 10.1 10.9 6.4 0.2 0.4 6.2 0.2 0.3 0.1 1.3 0.0 1.9 3.1 3.5 2.4 0.2 1.8 4.2 1.6 0.6 2.7 0.4 0.2 5.5 1.8 NBPF19 ENSG00000271383 "NBPF member 19" A0A087WUL8 1 149390623-149556361 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (7.92e-3)" "unprognostic (9.12e-2)" "unprognostic (2.95e-2)" "unprognostic (8.53e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-3)" "unprognostic (5.59e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-4)" "unprognostic (3.54e-3)" "unprognostic (2.12e-1)" "unprognostic (1.76e-2)" "unprognostic (1.92e-5)" "unprognostic (1.10e-1)" "unprognostic (3.32e-1)" "unprognostic (8.93e-2)" "unprognostic (4.61e-2)" 6.8 0.9 3.2 10.4 2.7 9.5 8.4 1.7 4.5 6.6 3.7 4.0 10.1 1.1 8.8 8.0 5.3 6.0 7.3 4.8 3.4 2.3 3.1 12.1 6.0 3.2 4.7 10.6 6.2 4.0 0.9 7.0 5.5 5.0 3.9 7.5 7.7 8.6 6.2 13.0 1.7 6.0 2.6 6.7 1.7 9.5 2.9 2.5 6.3 5.2 5.2 3.9 7.4 6.2 11.7 18.0 16.7 6.9 7.0 1.5 23.4 6.3 13.6 6.9 26.7 23.1 6.4 11.6 8.9 8.2 8.0 5.5 8.5 6.9 2.9 17.9 10.8 18.7 10.8 12.7 12.4 10.4 19.6 17.5 1.9 5.5 19.6 7.1 16.1 4.8 23.4 30.6 5.2 4.7 11.2 17.1 17.2 10.7 11.7 11.8 9.7 9.7 14.9 11.3 5.1 11.9 1.2 2.8 27.5 9.6 5.2 17.8 26.9 31.1 16.4 12.1 10.1 17.9 9.4 5.4 21.7 18.7 13.7 4.8 9.8 16.7 5.3 7.0 6.4 4.7 2.3 3.8 2.5 3.2 6.2 5.2 6.5 18.0 6.9 5.2 11.7 1.4 1.5 NBPF20 ENSG00000162825 "NBPF member 20" 1 145289900-145405778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in all" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (6.25e-3)" "unprognostic (4.74e-2)" "unprognostic (1.23e-1)" "unprognostic (8.05e-2)" "unprognostic (1.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.25e-2)" "unprognostic (5.37e-2)" "unprognostic (3.22e-3)" "unprognostic (3.54e-1)" "unprognostic (4.26e-4)" "unprognostic (1.69e-1)" "unprognostic (1.45e-4)" "unprognostic (9.74e-2)" "unprognostic (5.21e-2)" "unprognostic (1.00e-1)" "unprognostic (1.70e-1)" 1.1 1.2 1.1 1.2 1.2 1.0 1.5 2.5 1.2 1.4 1.1 0.0 1.3 1.8 1.1 1.2 0.7 1.1 1.1 1.1 1.1 2.6 1.1 1.2 1.0 2.2 1.3 5.9 1.1 0.0 1.5 1.1 1.6 2.1 1.1 2.4 1.1 1.7 1.0 1.1 1.1 3.6 1.1 1.5 1.4 1.1 4.0 13.3 1.0 1.8 2.9 1.0 0.3 14.4 7.4 2.1 5.9 13.0 22.9 5.3 7.1 1.7 2.5 2.6 8.0 1.8 3.4 2.8 7.3 4.5 7.2 8.4 7.2 6.9 8.8 2.2 9.3 5.8 2.7 4.0 3.9 6.8 6.5 14.0 11.9 6.7 9.1 5.2 10.3 9.5 0.6 1.8 2.0 11.8 3.4 6.0 2.2 3.7 2.7 3.7 6.5 14.5 7.5 4.0 5.7 5.6 12.2 12.5 15.6 6.6 16.4 3.0 2.5 7.9 6.8 1.7 1.8 0.5 1.5 0.5 1.0 0.9 0.8 1.5 0.7 1.0 0.4 4.0 1.0 0.9 1.0 2.9 1.8 13.3 0.9 0.3 NBPF26 ENSG00000273136 "NBPF member 26" 1 120723923-120841481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in all" "neutrophil: 17.7" "Group enriched" "Detected in all" 4 "granulocytes: 17.7;monocytes: 10.0" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA038752: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (2.24e-1)" "unprognostic (7.64e-3)" "unprognostic (4.21e-1)" "unprognostic (1.34e-3)" "unprognostic (1.69e-1)" "unprognostic (1.26e-2)" "unprognostic (6.31e-5)" "unprognostic (9.78e-3)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.82e-5)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (8.11e-2)" "unprognostic (1.65e-1)" 2.7 0.8 2.3 4.3 2.2 2.1 1.8 1.1 2.5 3.2 1.9 1.1 1.1 0.0 3.0 5.6 4.8 2.4 3.1 1.1 1.1 3.5 1.7 2.3 2.0 1.1 1.1 3.6 1.1 1.1 1.1 1.1 2.0 2.5 1.4 1.7 1.6 1.3 1.1 9.9 1.1 6.0 2.4 10.6 0.5 3.4 1.1 1.1 1.8 3.3 1.8 2.0 1.1 3.4 2.8 17.7 10.0 2.4 2.1 1.0 26.9 0.1 8.1 8.9 11.4 9.4 0.6 9.6 4.9 6.0 6.5 5.8 1.0 1.9 9.1 11.1 8.0 13.1 13.7 8.4 12.8 0.5 18.5 2.9 2.3 5.2 7.6 5.6 5.7 5.9 15.7 17.3 0.3 1.5 16.7 15.7 15.1 2.1 12.3 2.9 10.9 3.0 9.1 4.9 4.7 11.0 0.7 0.5 11.2 16.3 8.4 0.6 3.3 8.2 7.2 19.2 23.7 7.6 7.4 2.0 7.9 6.7 11.4 1.0 7.7 6.4 7.2 1.9 5.2 1.7 1.2 2.0 1.9 2.8 3.4 1.7 2.1 17.7 2.4 10.0 2.1 1.1 1.0 NBPF3 AE2 ENSG00000142794 "NBPF member 3" Q9H094 1 21440128-21485005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 29.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.1;HHSteC: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042595, HPA043692, HPA044023, HPA046971, HPA058050" Supported Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (5.49e-2)" "unprognostic (1.19e-2)" "unprognostic (5.09e-3)" "unprognostic (2.57e-2)" "unprognostic (3.11e-1)" "unprognostic (2.01e-1)" "unprognostic (2.82e-2)" "unprognostic (2.10e-1)" "unprognostic (2.22e-3)" "unprognostic (1.09e-1)" "unprognostic (3.11e-3)" "unprognostic (1.63e-1)" "unprognostic (5.31e-5)" "unprognostic (8.35e-2)" "unprognostic (1.23e-2)" "unprognostic (2.69e-2)" "unprognostic (1.66e-2)" 3.2 5.1 4.5 2.6 4.6 2.3 6.5 12.7 5.3 4.1 3.5 3.7 4.2 1.5 3.7 4.6 3.7 3.6 2.9 2.8 4.7 3.5 4.0 4.6 3.0 3.0 5.0 3.8 4.7 4.3 2.6 9.4 11.7 4.5 4.5 3.6 3.3 4.9 4.0 2.2 6.2 4.0 5.3 4.6 3.2 4.7 29.5 4.9 2.4 4.8 1.3 4.5 5.1 5.6 1.1 0.3 2.3 0.7 1.1 5.3 1.6 1.7 2.4 0.2 5.6 3.7 1.3 4.7 3.2 15.1 4.4 3.7 3.3 5.7 2.8 1.3 8.3 0.2 2.6 3.8 0.5 1.5 2.9 1.9 0.1 1.2 14.6 1.1 1.9 1.0 1.1 4.0 0.7 0.4 0.8 1.0 1.0 6.3 0.0 2.8 0.8 3.5 0.0 0.0 2.6 0.7 2.4 3.9 4.0 4.9 1.3 3.9 1.8 2.4 3.6 1.8 2.2 5.5 1.3 0.0 1.6 4.5 0.4 2.4 2.5 0.0 0.5 2.3 3.8 0.7 5.3 1.1 1.6 3.0 0.3 0.5 2.8 3.5 0.2 1.1 0.0 0.0 1.5 1.6 4.5 4.6 12.7 5.3 4.7 3.5 5.0 3.8 4.5 4.9 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.1;testis: 8.8" "Group enriched" "Detected in some" 4 "BEWO: 8.0;K-562: 11.5;Karpas-707: 3.4;MCF7: 13.6;THP-1: 4.1" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045044: , HPA046411: , HPA047447: , HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 3.4 0.0 13.6 0.0 0.0 0.6 0.0 0.0 2.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.6 0.2 4.1 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;testis: 7.1" "Cell line enhanced" "Detected in some" "BEWO: 8.7;K-562: 13.6;SK-BR-3: 3.3;SK-MEL-30: 2.4" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045044: , HPA046411: , HPA047447: , HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 1.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.4 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF9 AE01 ENSG00000269713 "NBPF member 9" 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.9" "Low lineage specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA038748: , HPA042595: , HPA043105: , HPA043692: , HPA044023: , HPA046971: , HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 3.3 2.0 5.6 6.5 5.3 2.4 2.6 12.3 5.0 4.2 3.3 2.1 4.5 1.7 4.9 7.2 2.8 2.9 4.7 3.8 5.3 3.6 5.4 8.3 4.6 2.8 1.8 4.9 6.3 4.4 1.9 2.2 4.3 3.0 3.1 6.8 2.2 2.4 1.7 4.5 3.2 4.4 2.0 2.7 1.8 2.9 2.0 1.8 5.2 2.5 4.0 2.3 0.0 4.2 5.2 21.9 7.6 5.6 1.8 0.8 22.2 9.8 12.2 16.4 11.1 13.5 9.7 20.5 15.0 10.8 11.8 7.3 9.7 5.3 5.7 10.5 6.6 8.4 9.6 18.7 13.4 8.8 1.7 16.5 4.4 12.9 2.2 6.5 13.3 7.2 11.8 20.8 9.4 6.1 13.9 13.2 17.5 0.7 3.6 4.6 13.3 6.0 7.5 8.0 8.9 10.3 7.9 16.4 6.7 16.6 9.1 12.3 4.2 22.1 24.5 7.2 17.9 31.5 17.2 9.1 10.5 8.9 1.6 8.6 21.9 7.6 0.3 0.4 3.6 0.7 1.9 1.3 0.4 1.3 4.2 1.8 1.0 5.8 5.6 1.2 5.2 1.6 0.8 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1, autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: , HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favourable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 26.3 29.5 27.1 17.2 27.3 7.7 28.0 27.3 29.4 25.6 32.9 33.3 29.0 31.0 28.4 25.5 23.1 25.6 20.7 29.8 26.0 22.0 38.3 39.6 21.1 25.4 27.2 21.8 34.1 26.5 55.8 25.0 31.2 22.8 30.1 32.1 20.7 25.5 29.5 62.9 23.9 37.7 24.2 34.2 23.3 23.2 57.0 31.7 29.8 32.1 24.5 19.8 32.5 23.7 9.6 12.6 25.2 21.5 15.5 17.1 14.4 12.5 15.4 13.2 13.9 30.0 31.2 12.7 23.8 47.2 19.8 16.4 8.0 20.0 6.7 24.7 33.0 13.9 15.0 30.7 28.8 20.9 15.9 8.0 19.5 17.1 28.7 6.7 12.4 35.5 34.8 21.6 42.7 30.7 17.1 18.1 26.1 7.1 14.3 4.9 4.2 10.0 4.8 20.7 21.9 25.0 14.3 7.9 14.2 16.4 8.1 23.8 22.1 11.1 25.5 29.1 10.8 13.3 9.4 21.7 17.6 8.8 19.7 9.3 19.9 23.5 16.1 25.2 14.2 15.3 14.6 9.6 12.9 13.7 12.6 6.7 12.4 11.9 23.1 15.5 21.5 8.0 17.1 14.4 27.1 27.3 27.3 29.4 26.0 22.0 27.2 21.8 22.8 31.7 NCLN "NET59, NICALIN" ENSG00000125912 Nicalin Q969V3 19 3185563-3209575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006625 Approved Approved "Nucleoplasm,Lipid droplets" 12000 "Lipid droplets" Nucleoplasm "HPA006625: AB_1079453" "unprognostic (4.32e-2)" "unprognostic (1.88e-1)" "unprognostic (1.89e-1)" "prognostic favourable (1.19e-4)" "unprognostic (8.55e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (2.15e-4)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (9.38e-2)" "unprognostic (2.02e-2)" "unprognostic (1.26e-3)" "prognostic unfavourable (8.37e-5)" "prognostic favourable (8.82e-5)" "unprognostic (1.75e-1)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" 15.8 27.4 10.2 18.2 15.3 31.1 10.2 21.2 23.6 9.3 20.4 14.7 14.9 32.9 12.7 7.2 14.1 11.0 15.5 10.5 12.2 8.5 13.3 48.3 15.5 19.8 9.7 9.0 12.1 41.3 9.5 11.5 11.3 10.8 13.3 9.7 13.0 18.7 9.9 16.3 14.9 27.8 9.5 8.0 20.6 18.9 17.2 12.1 11.8 11.8 11.8 13.2 9.4 11.8 5.3 17.8 8.8 12.2 4.3 7.7 7.1 27.1 31.8 7.9 24.6 7.8 6.5 20.6 30.0 12.6 22.6 18.4 43.1 15.8 16.5 26.1 19.7 32.3 9.4 22.8 5.0 21.5 21.5 11.5 19.6 29.3 15.6 20.5 21.5 11.3 14.5 18.2 9.9 12.5 29.4 18.5 10.3 24.1 17.8 21.9 22.4 22.5 28.7 8.4 26.2 13.3 18.7 17.1 16.9 12.1 22.6 19.0 16.4 23.6 16.9 19.7 17.1 32.0 36.2 23.2 21.0 12.7 20.7 26.3 30.1 1.1 11.9 8.8 6.9 12.2 6.1 5.3 4.2 7.7 8.7 4.4 4.6 6.1 7.3 4.3 4.9 17.8 3.8 7.1 10.2 15.3 21.2 23.6 12.2 8.5 9.7 9.0 10.8 12.1 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687330 "Plasma proteins, Predicted membrane proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 20.7;ASC diff: 20.4;HSkMC: 27.5;NTERA-2: 16.5;U-2 OS: 30.8;U-266/70: 19.5;U-266/84: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.5;plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA074457: " "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavourable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 29.9 35.5 19.2 7.7 39.1 1.3 25.0 2.6 28.2 32.7 12.9 12.9 8.1 8.0 29.9 17.7 12.3 21.4 19.1 20.3 18.1 40.3 6.9 3.0 10.3 8.9 14.8 17.6 50.7 7.1 2.1 23.2 22.4 19.0 18.8 8.1 16.5 9.2 29.3 9.2 4.7 8.4 23.5 11.8 11.8 8.6 16.4 7.3 7.1 8.4 8.7 4.9 13.1 17.3 0.0 4.3 0.0 0.8 0.4 0.0 0.0 0.0 0.0 20.7 0.0 20.4 7.8 0.0 13.1 0.0 0.3 3.6 0.0 0.0 0.0 0.0 3.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 12.0 27.5 0.0 3.8 0.0 0.0 0.4 0.0 6.7 0.0 9.8 0.0 16.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 3.5 0.0 0.0 1.0 30.8 0.0 0.0 19.5 18.1 0.0 2.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.6 4.3 0.0 0.0 19.2 39.1 2.6 28.2 18.1 40.3 14.8 17.6 19.0 7.3 NDOR1 "bA350O14.9, NR1" ENSG00000188566 "NADPH dependent diflavin oxidoreductase 1" Q9UHB4 9 137205685-137217009 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024504 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA024504: AB_1854338" "unprognostic (1.67e-1)" "unprognostic (1.44e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (5.89e-3)" "unprognostic (5.99e-2)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (2.61e-3)" "unprognostic (1.14e-1)" "unprognostic (1.07e-1)" "unprognostic (4.69e-3)" "unprognostic (2.05e-1)" "unprognostic (4.30e-2)" "unprognostic (6.74e-3)" 9.6 11.4 10.6 18.4 17.4 29.2 10.0 15.0 16.2 9.4 10.4 18.7 7.4 19.1 11.4 10.5 11.2 11.0 10.4 7.4 11.6 7.7 12.1 9.4 11.6 20.5 18.6 8.6 10.2 14.7 9.7 12.2 9.2 13.5 13.0 6.8 12.5 17.3 16.1 6.5 18.5 16.5 8.7 14.2 19.9 13.9 22.2 14.2 20.6 14.4 4.9 15.8 9.7 9.4 2.7 3.7 6.6 4.8 1.6 4.0 3.0 7.1 10.8 7.4 11.3 3.1 3.2 22.4 10.5 4.9 10.3 7.1 10.8 8.5 10.0 8.3 4.1 26.8 5.3 7.4 2.1 12.9 8.3 8.9 26.0 5.8 5.3 10.0 19.1 4.3 5.3 11.5 4.3 4.7 14.4 10.7 3.7 12.9 10.3 17.7 11.8 13.5 19.1 8.7 14.3 3.2 6.3 9.3 9.2 8.7 8.9 5.4 14.2 11.6 6.2 19.0 12.4 21.8 11.7 6.6 13.1 10.5 8.2 9.1 10.7 1.7 4.4 6.3 3.2 4.8 2.7 1.3 2.8 2.7 3.7 2.7 1.6 1.4 6.6 1.6 3.8 2.4 4.0 3.0 10.6 17.4 15.0 16.2 11.6 7.7 18.6 8.6 13.5 14.2 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell line enriched" "Detected in some" 17 "U-87 MG: 40.3" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.9 0.0 0.1 1.0 0.7 0.0 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 40.3 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA042268: AB_2677922, HPA073212: " "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favourable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favourable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.7 19.5 9.6 12.7 7.1 7.1 27.9 8.3 8.4 16.0 12.2 42.2 21.7 12.2 4.4 8.9 18.2 13.9 12.2 10.5 23.6 24.4 11.9 20.7 31.9 15.6 17.4 12.9 9.0 11.9 10.9 14.9 12.0 8.3 23.1 11.8 20.9 17.3 20.0 24.8 16.2 24.5 14.2 12.7 22.0 24.7 7.0 7.8 10.4 28.1 14.5 5.8 16.6 8.4 12.2 24.8 11.1 19.1 4.5 5.3 20.1 12.7 10.8 13.3 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054364 Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA054364: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favourable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 27.7 20.5 25.7 22.9 18.3 19.9 35.8 21.4 15.9 21.6 17.8 17.8 22.6 46.0 35.2 15.4 23.0 44.7 25.4 17.1 26.0 51.6 24.7 36.8 87.3 19.2 45.7 20.5 18.4 35.4 15.9 17.2 27.4 51.6 23.4 23.3 42.0 35.4 69.6 66.8 47.7 48.7 28.9 62.5 19.8 25.0 35.4 27.6 23.9 43.9 40.0 35.4 38.3 21.5 19.8 20.9 19.2 29.3 29.9 43.4 51.5 22.2 37.1 22.4 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051377: " "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favourable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.1 24.0 52.4 38.7 39.3 34.9 30.0 26.2 31.1 29.6 51.8 41.2 31.4 44.9 36.2 20.4 21.4 42.1 24.7 52.3 73.7 23.0 57.3 58.2 30.6 35.3 30.9 43.6 36.5 29.5 18.1 46.1 38.7 37.9 42.9 122.1 55.4 91.2 55.7 76.7 31.9 23.4 72.2 62.2 81.9 48.9 48.3 41.0 67.2 35.9 29.2 40.5 38.5 41.0 24.2 48.4 51.5 36.2 67.3 54.9 62.5 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favourable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 32.2 39.6 41.3 16.0 44.6 12.1 27.2 20.0 45.7 23.7 32.3 22.0 21.2 43.7 16.2 15.4 26.4 20.0 20.5 86.9 34.1 31.7 48.1 42.3 17.8 21.7 39.4 33.6 22.1 23.2 31.1 18.7 21.3 37.6 19.6 29.9 24.8 35.8 21.3 96.3 17.5 38.5 21.3 30.9 20.4 24.9 21.8 18.4 22.7 27.7 47.3 18.5 26.5 17.3 27.7 41.4 19.5 44.9 14.6 25.0 26.7 23.2 6.5 16.3 19.7 21.5 29.0 22.1 14.8 18.7 21.2 21.4 19.6 17.0 20.4 44.9 12.5 25.8 17.6 19.6 21.4 42.1 14.7 21.9 11.9 16.3 19.8 26.1 17.4 26.7 25.4 11.9 19.9 24.3 18.4 29.7 22.7 16.6 15.0 20.3 23.5 26.5 16.7 18.9 63.1 38.3 18.0 11.6 19.5 9.0 50.6 34.9 77.1 42.6 15.6 14.0 13.3 19.1 35.2 39.5 40.9 30.1 22.6 28.0 19.9 19.5 29.9 14.4 13.9 37.6 22.1 27.7 20.0 17.0 41.4 19.5 20.8 21.0 6.7 14.6 44.9 24.0 25.0 26.7 41.3 44.6 20.0 45.7 34.1 31.7 39.4 33.6 37.6 18.4 NEDD1 "GCP-WD, TUBGCP7" ENSG00000139350 "Neural precursor cell expressed, developmentally down-regulated 1" Q8NHV4 12 96907223-96953777 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038591 Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" "Nucleoplasm, Centrosome" "Plasma membrane" "HPA038591: AB_10674688" "unprognostic (7.93e-2)" "unprognostic (3.18e-1)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (2.21e-1)" "unprognostic (5.92e-2)" "prognostic unfavourable (1.94e-4)" "prognostic unfavourable (3.70e-4)" "unprognostic (1.81e-2)" "unprognostic (9.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.56e-1)" "unprognostic (2.46e-3)" "unprognostic (7.29e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-1)" "unprognostic (5.59e-2)" 10.7 6.2 5.7 10.0 6.6 9.8 9.8 2.5 7.1 10.8 9.3 7.1 1.7 4.9 13.5 8.3 11.6 10.0 5.5 8.3 6.0 4.4 12.6 5.4 9.4 10.3 7.0 3.7 13.3 7.7 14.9 13.5 7.9 6.5 11.9 7.2 6.3 8.5 6.3 25.5 7.8 10.3 15.4 8.4 14.5 7.2 17.8 8.3 30.6 11.9 24.3 10.7 15.1 9.6 9.4 5.9 19.9 11.1 15.6 14.0 7.3 13.4 8.9 15.4 9.4 7.7 6.9 10.9 46.8 16.6 21.6 18.7 5.8 5.0 8.3 4.5 37.4 12.1 10.4 10.8 29.2 15.9 8.9 10.4 5.9 5.1 6.4 14.1 9.4 5.1 8.9 13.1 10.2 10.5 6.0 6.1 15.4 5.5 25.7 6.4 8.5 28.5 13.6 15.7 8.2 8.8 8.8 4.8 8.5 13.1 7.4 8.1 10.0 5.0 7.5 13.6 10.5 9.7 11.0 6.0 7.3 11.1 4.2 7.2 16.4 10.0 6.9 19.9 12.1 11.1 13.7 9.4 13.4 12.9 5.9 8.1 14.0 10.9 5.4 15.6 7.8 4.6 14.0 7.3 5.7 6.6 2.5 7.1 6.0 4.4 7.0 3.7 6.5 8.3 NEDD8-MDP1 ENSG00000255526 "NEDD8-MDP1 readthrough" 14 24213955-24232352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 7.6;U-266/70: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA060254" Uncertain Approved Nucleoplasm Nucleoplasm "HPA003064: AB_10602350, HPA060254: " "unprognostic (2.72e-3)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (6.44e-2)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (6.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.32e-3)" "unprognostic (2.33e-1)" "unprognostic (1.99e-2)" "unprognostic (1.64e-1)" "unprognostic (4.43e-2)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-2)" 4.8 6.0 6.6 5.6 9.0 5.0 4.5 5.7 8.5 4.0 8.8 3.2 4.3 3.0 4.1 5.0 5.2 4.7 4.1 7.6 5.3 5.2 6.2 6.1 4.6 4.7 4.9 8.3 4.1 4.5 11.2 5.9 5.6 6.6 4.8 5.2 3.3 5.1 4.5 20.1 6.7 8.6 4.4 4.2 4.2 5.5 16.4 4.6 3.3 5.2 6.5 3.8 4.0 4.1 0.7 1.9 1.0 0.9 0.4 2.3 1.0 3.2 0.0 0.8 0.5 0.8 0.0 0.0 4.0 0.1 0.2 0.2 0.4 1.0 0.2 1.7 1.2 1.3 0.6 0.9 0.5 2.2 0.4 1.1 0.0 0.0 0.0 1.5 0.0 0.6 1.4 0.0 0.4 0.0 0.3 0.0 0.2 2.9 7.6 0.6 0.4 0.0 0.5 0.0 2.0 0.2 0.0 1.0 0.5 0.0 1.2 1.4 0.6 1.1 0.0 0.0 3.6 0.0 1.2 4.9 3.6 3.3 0.5 0.0 0.6 0.8 0.3 1.0 0.6 0.8 0.2 0.7 2.3 0.0 0.2 0.5 1.8 0.5 0.4 0.4 0.9 1.9 1.4 1.0 6.6 9.0 5.7 8.5 5.3 5.2 4.9 8.3 6.6 4.6 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.4" "Cell line enhanced" "Detected in many" "BJ: 7.6;LHCN-M2: 10.5;U-2 OS: 8.9" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favourable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.4 0.5 4.5 0.5 14.6 0.4 14.2 0.6 6.8 1.6 2.0 1.1 2.0 2.5 0.9 8.3 2.0 10.5 2.1 3.1 8.4 3.8 1.4 2.5 4.5 0.6 0.8 6.7 2.7 0.8 0.5 9.0 0.3 3.4 1.9 0.7 1.3 0.5 1.4 10.5 0.4 1.0 1.2 0.8 0.6 1.1 31.4 1.3 0.3 0.8 0.3 0.7 1.4 0.4 0.4 0.2 1.9 0.1 0.1 0.6 0.1 1.0 2.0 1.0 1.2 0.9 2.0 0.4 7.6 1.2 2.1 1.9 0.0 0.5 0.7 1.9 3.2 0.1 0.5 0.5 2.3 1.4 0.8 0.2 4.1 3.7 0.2 0.4 1.0 2.4 0.5 3.2 0.1 1.4 0.1 0.7 10.5 0.1 0.8 0.5 0.7 0.3 1.0 0.4 0.3 4.0 0.6 0.2 0.2 1.2 0.4 0.6 6.1 0.4 0.9 5.6 8.9 0.3 0.7 0.3 0.2 0.5 4.8 0.8 2.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.5 0.4 0.0 0.4 0.1 0.5 1.9 0.1 0.0 0.2 0.0 0.1 4.5 14.6 0.6 6.8 8.4 3.8 0.8 6.7 3.4 1.3 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49853203 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favourable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 13.6 12.2 15.0 14.8 20.9 30.9 12.5 28.0 22.1 15.0 14.4 14.6 14.4 8.1 14.3 12.2 18.2 11.6 11.2 15.0 16.9 15.0 14.6 11.2 11.6 13.4 21.1 17.2 15.2 13.1 26.4 30.9 15.5 27.9 13.9 12.4 10.7 14.8 14.8 17.4 11.5 15.1 13.9 24.8 14.7 13.7 8.4 23.2 17.0 15.7 9.8 14.5 13.5 13.4 36.1 33.0 28.4 21.9 20.3 26.8 7.8 18.7 21.0 20.1 13.3 22.7 18.4 18.0 23.7 15.7 15.6 15.4 10.7 20.1 5.2 18.2 19.5 26.9 18.9 14.8 25.3 20.9 10.8 20.8 20.0 16.2 13.3 27.1 19.1 16.3 10.9 16.5 15.5 22.2 25.7 19.7 21.3 17.2 16.1 8.9 12.0 21.2 16.7 19.9 11.9 18.4 24.8 13.3 12.4 21.9 23.7 21.9 20.4 17.7 26.2 23.0 20.2 14.9 16.2 14.0 24.9 22.3 8.5 12.9 20.5 27.6 18.2 20.1 20.5 16.3 19.5 32.8 21.0 19.2 15.2 36.1 24.8 26.8 28.4 20.3 21.9 33.0 17.9 7.8 15.0 20.9 28.0 22.1 16.9 15.0 21.1 17.2 27.9 23.2 NEMP1 "KIAA0286, TMEM194, TMEM194A" ENSG00000166881 "Nuclear envelope integral membrane protein 1" O14524 12 57055643-57088063 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014394 Uncertain Approved Nucleoplasm Nucleoplasm "HPA014394: AB_2204899" "unprognostic (9.24e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "unprognostic (4.97e-2)" "unprognostic (1.43e-1)" "unprognostic (4.57e-3)" "prognostic unfavourable (1.93e-4)" "unprognostic (8.36e-2)" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (1.64e-1)" "unprognostic (6.61e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (2.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.63e-2)" "unprognostic (7.05e-2)" 9.5 7.3 7.6 16.7 7.8 7.8 8.6 10.6 8.5 8.1 12.2 8.1 3.6 4.9 14.8 7.6 8.8 9.4 5.8 4.8 6.6 3.8 6.0 8.1 9.7 15.1 7.7 5.8 12.3 6.4 5.9 12.7 20.6 6.2 9.6 9.4 8.2 7.2 7.5 3.6 14.3 11.0 12.8 8.3 11.4 8.5 15.4 6.9 26.6 8.7 4.1 15.1 9.3 8.9 4.6 2.2 5.5 3.5 5.4 4.7 2.0 7.9 6.8 15.6 16.8 5.2 5.2 9.0 12.3 7.1 17.2 14.1 8.0 15.3 19.0 16.0 4.2 11.8 20.8 5.3 19.9 10.0 9.5 11.2 7.8 4.2 2.2 13.9 12.9 1.7 5.1 14.1 8.9 4.7 22.7 37.9 14.5 4.3 15.1 11.8 8.7 7.6 15.4 22.2 8.6 3.8 5.0 9.3 6.3 10.5 8.8 9.9 15.9 14.0 3.3 16.5 9.6 15.2 11.5 17.1 32.5 16.7 9.7 13.3 16.9 5.5 1.1 1.9 2.8 3.5 3.7 4.6 3.1 3.6 1.2 3.6 4.7 3.9 0.5 5.4 2.0 2.2 2.8 2.0 7.6 7.8 10.6 8.5 6.6 3.8 7.7 5.8 6.2 6.9 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504342-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057719 Approved Nucleoplasm Nucleoplasm "HPA057719: " "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavourable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 7.8 4.9 2.9 14.5 2.9 4.5 4.3 7.5 3.6 6.0 3.6 4.3 2.2 2.5 8.5 6.8 4.4 3.3 3.0 4.3 3.5 2.9 5.7 5.7 9.3 11.3 3.8 3.2 5.6 3.2 2.6 4.0 3.7 3.4 3.9 2.6 6.6 9.3 4.8 1.7 5.1 4.5 3.4 3.4 12.3 5.1 8.1 2.4 27.3 5.4 3.5 15.8 4.4 4.3 3.6 3.4 0.2 0.8 2.4 5.6 2.2 5.1 2.8 1.9 2.4 1.1 3.0 5.1 3.7 3.2 3.7 4.7 4.2 7.2 7.5 2.4 1.9 9.2 3.0 8.0 7.5 5.6 2.6 5.4 2.8 2.8 2.8 5.8 1.9 3.0 3.4 17.1 4.5 1.7 4.7 8.9 7.2 2.4 6.4 2.8 2.0 3.1 2.7 4.2 3.5 3.4 3.9 3.5 2.9 5.9 0.6 5.6 1.5 6.3 3.0 8.4 6.5 1.6 4.1 4.9 5.3 4.0 6.5 6.1 6.0 0.1 0.8 0.1 3.0 0.7 3.9 2.7 3.3 2.7 0.9 3.6 5.4 4.6 0.2 2.4 0.6 3.4 5.6 2.2 2.9 2.9 7.5 3.6 3.5 2.9 3.8 3.2 3.4 2.4 NET1 "ARHGEF8, NET1A" ENSG00000173848 "Neuroepithelial cell transforming 1" Q7Z628 10 5412551-5458463 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020068 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA020068: " "unprognostic (1.77e-2)" "unprognostic (1.87e-1)" "unprognostic (3.40e-1)" "unprognostic (4.05e-2)" "unprognostic (3.37e-3)" "unprognostic (2.15e-1)" "prognostic unfavourable (3.87e-5)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (8.27e-4)" "unprognostic (2.26e-1)" "unprognostic (5.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (2.46e-1)" 19.4 4.8 14.2 25.8 16.7 15.0 39.8 11.8 15.2 30.2 39.3 21.0 32.1 24.1 19.4 25.7 38.2 20.7 25.9 8.4 16.5 12.7 21.3 19.0 9.5 10.5 19.0 9.4 15.2 19.4 2.9 6.6 51.8 20.8 23.0 38.9 20.3 43.0 23.2 16.7 21.8 54.7 33.4 19.9 3.9 33.5 11.8 10.9 14.8 18.1 26.8 20.2 28.0 31.8 1.8 5.9 2.7 1.2 1.0 11.5 2.4 27.9 16.6 11.6 12.9 6.8 3.1 63.7 16.9 9.3 13.7 13.1 9.1 53.3 10.3 7.1 10.3 45.8 14.0 25.6 16.5 9.6 10.1 18.6 5.6 20.3 1.8 5.3 8.1 4.6 15.3 13.5 3.2 7.9 32.8 16.3 7.5 13.3 17.9 7.4 15.6 12.7 11.3 21.4 8.0 8.4 14.0 9.9 5.5 14.9 27.7 5.0 9.2 15.9 7.2 5.2 8.2 8.0 13.7 10.0 5.4 13.5 4.7 8.1 10.8 2.7 0.8 1.8 0.9 1.2 0.0 1.8 1.6 0.5 5.9 0.9 11.5 2.1 0.1 1.0 0.6 2.5 5.1 2.4 14.2 16.7 11.8 15.2 16.5 12.7 19.0 9.4 20.8 10.9 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Cell line enriched" "Detected in some" 5 "THP-1: 15.0" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 NFATC2IP "ESC2, FLJ14639, NIP45, RAD60" ENSG00000176953 "Nuclear factor of activated T cells 2 interacting protein" Q8NCF5 16 28950807-28967097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053587 Approved Nucleoplasm Nucleoplasm "HPA053587: " "unprognostic (6.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.48e-2)" "unprognostic (1.33e-1)" "unprognostic (4.90e-1)" "unprognostic (7.09e-2)" "unprognostic (8.82e-3)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (5.80e-2)" "unprognostic (5.32e-2)" "prognostic unfavourable (5.23e-4)" "prognostic unfavourable (1.03e-5)" "unprognostic (8.00e-2)" "unprognostic (3.85e-2)" "unprognostic (3.25e-1)" "unprognostic (5.94e-2)" 14.0 11.9 16.6 26.5 15.0 32.5 16.1 29.9 16.8 14.6 23.6 12.7 19.0 16.1 17.8 11.8 20.4 17.5 15.8 15.6 13.0 7.8 15.9 18.9 18.1 26.0 16.5 18.0 18.6 16.2 21.9 11.2 14.0 12.0 17.1 25.7 15.7 17.1 12.9 20.7 24.8 25.1 19.4 12.2 32.7 17.8 27.1 15.3 37.7 16.3 6.9 28.6 19.8 16.0 3.5 6.3 8.7 3.7 5.8 4.9 1.3 17.7 12.9 17.6 17.6 10.8 11.4 22.3 17.4 13.1 20.4 26.3 14.9 22.3 19.1 13.2 12.4 21.3 21.1 19.1 27.9 16.2 15.5 17.4 33.6 18.4 6.9 15.7 26.7 8.0 15.6 22.2 13.5 16.3 15.7 23.8 18.0 22.1 20.4 27.9 17.3 15.4 35.6 15.7 17.4 14.6 16.1 13.6 9.7 11.7 18.2 6.8 18.7 11.7 18.0 22.7 12.8 17.7 13.1 17.7 23.1 23.4 12.5 26.0 13.3 8.7 3.2 3.2 4.1 3.7 3.8 3.2 3.1 4.7 1.8 3.5 4.9 4.4 2.4 5.8 2.3 6.3 4.5 1.3 16.6 15.0 29.9 16.8 13.0 7.8 16.5 18.0 12.0 15.3 NFE2 NF-E2 ENSG00000123405 "Nuclear factor, erythroid 2" Q16621 12 54292111-54301121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2" "Group enriched" "Detected in some" 4 "HEL: 83.6;K-562: 36.2;NB-4: 25.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 119.7;neutrophil: 80.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 119.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA001914 Enhanced Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA001914: AB_1079475" "unprognostic (2.68e-4)" "unprognostic (2.93e-2)" "unprognostic (2.20e-2)" "unprognostic (2.31e-2)" "unprognostic (2.33e-2)" "unprognostic (1.85e-1)" "unprognostic (1.20e-2)" "unprognostic (4.55e-2)" "unprognostic (4.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-3)" "unprognostic (9.90e-6)" "unprognostic (1.81e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-2)" "unprognostic (3.46e-2)" 2.3 0.3 0.9 3.5 1.5 54.3 0.5 0.4 1.7 0.9 0.4 0.2 0.0 0.5 0.4 0.4 0.7 2.0 0.9 7.8 1.5 0.4 0.9 2.6 9.6 20.9 5.2 0.2 1.2 0.6 1.2 0.8 15.9 1.2 1.0 0.3 1.2 0.5 0.2 1.0 2.9 0.5 1.1 1.0 32.2 0.7 0.9 0.7 1.8 1.7 0.2 0.5 1.2 8.1 0.0 15.2 119.7 23.1 0.0 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.5 0.1 0.2 1.1 2.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.2 1.9 0.0 1.2 11.0 0.1 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 3.3 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 4.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 119.7 23.1 21.7 0.0 6.4 0.1 0.0 0.0 0.0 15.2 0.0 0.1 0.0 80.0 0.0 3.8 0.2 0.0 12.9 0.9 1.5 0.4 1.7 1.5 0.4 5.2 0.2 1.2 0.7 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061487 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 194.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA063384: , HPA065424: " "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favourable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavourable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favourable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 24.2 25.7 15.5 13.1 15.5 4.6 50.3 9.1 19.8 18.8 17.5 17.4 32.3 17.4 31.4 30.5 21.4 22.7 16.3 85.5 18.2 19.2 27.9 18.4 13.9 12.6 21.7 21.2 26.2 11.1 16.6 16.3 16.6 25.0 16.5 13.6 22.6 17.7 26.1 194.7 19.9 18.3 24.3 27.5 17.7 13.9 18.8 16.5 5.8 22.4 58.9 10.7 17.3 24.2 4.1 9.4 19.7 9.4 2.1 2.6 0.9 18.9 42.3 27.7 23.4 58.2 28.4 20.8 31.0 43.1 22.0 24.6 51.5 21.9 21.8 62.9 39.0 39.4 19.6 24.7 23.7 37.4 16.3 12.3 28.6 17.2 69.1 27.3 19.9 38.7 61.7 40.1 45.0 34.4 21.7 60.6 27.0 16.2 17.3 8.5 17.9 16.1 12.3 39.2 20.8 24.3 28.4 17.1 25.9 21.2 14.2 43.6 28.1 18.8 45.9 54.0 23.4 18.2 31.0 101.3 67.8 20.4 51.3 11.6 30.6 7.9 9.4 2.7 2.6 4.8 1.5 3.8 2.5 2.6 1.9 4.1 1.9 2.1 19.7 2.1 5.6 9.4 0.9 0.9 15.5 15.5 9.1 19.8 18.2 19.2 21.7 21.2 25.0 16.5 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Cell line enhanced" "Detected in many" "BEWO: 43.4;NTERA-2: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" "Nucleoplasm, Vesicles" "HPA055889: " "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavourable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavourable (7.58e-12)" "prognostic favourable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.5 1.1 0.5 1.3 0.0 0.0 43.4 2.5 4.9 4.9 9.0 8.3 22.0 0.9 16.6 0.2 2.6 1.9 4.2 11.2 8.6 2.7 1.7 1.8 6.1 3.4 1.5 16.8 0.4 0.5 2.0 0.7 11.3 2.6 22.3 0.9 1.7 1.0 2.7 36.4 4.4 1.5 0.1 6.2 6.6 12.4 3.9 4.7 0.0 1.0 0.3 0.6 0.9 23.5 0.4 0.7 0.2 10.1 13.6 21.6 1.0 0.0 5.4 16.8 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 NFKB2 "LYT-10, NF-kB2, p105, p49/p100, p52" ENSG00000077150 "Nuclear factor kappa B subunit 2" Q00653 10 102394110-102402529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 49.5;Karpas-707: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008422, CAB022098, HPA023900" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435" "unprognostic (1.10e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (3.86e-4)" "unprognostic (1.53e-2)" "unprognostic (8.08e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-3)" "unprognostic (3.98e-2)" "prognostic favourable (8.45e-5)" "unprognostic (4.04e-1)" "unprognostic (8.34e-2)" "unprognostic (4.14e-2)" "prognostic unfavourable (6.69e-12)" "unprognostic (2.37e-3)" "unprognostic (1.63e-1)" "unprognostic (4.90e-2)" "unprognostic (1.56e-1)" 14.9 10.8 5.6 43.6 7.1 40.6 18.7 2.0 4.9 12.5 20.1 4.2 9.4 11.3 18.8 11.0 12.9 10.8 20.4 10.9 4.6 2.5 15.5 14.5 20.6 34.2 6.6 2.5 15.1 17.4 5.2 6.3 12.8 7.9 19.6 5.2 7.3 16.7 15.1 13.6 10.4 14.1 24.0 7.7 28.0 13.1 6.6 5.8 19.5 11.5 14.8 39.2 21.9 24.4 5.2 1.4 7.5 3.4 1.3 2.0 0.9 21.0 13.1 2.6 10.5 3.3 5.0 6.2 6.0 19.2 6.1 8.9 7.8 17.3 9.7 15.0 3.6 12.8 6.0 8.2 2.4 49.5 3.5 2.4 3.2 4.5 9.2 1.6 14.1 6.9 4.0 10.2 10.1 2.1 2.3 54.1 2.3 7.2 2.4 6.6 3.3 4.7 5.3 7.3 7.7 10.3 6.2 0.5 2.9 4.9 11.9 8.4 9.2 4.7 6.3 6.3 9.3 8.9 15.9 35.8 33.1 10.2 10.3 4.2 3.3 0.3 2.4 0.1 1.4 1.5 1.4 5.2 1.7 1.5 1.4 4.5 1.8 1.5 7.5 1.3 3.4 0.9 2.0 0.9 5.6 7.1 2.0 4.9 4.6 2.5 6.6 2.5 7.9 5.8 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA063734: " "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.0 10.0 1.4 3.6 1.5 0.9 4.8 5.4 2.2 2.9 3.3 7.1 4.4 8.9 6.1 1.2 4.4 3.8 2.6 0.9 27.2 4.8 5.9 1.9 4.0 5.2 6.8 12.6 1.2 3.0 3.2 4.1 1.6 6.9 8.2 1.1 5.2 8.4 6.7 5.1 4.1 11.8 6.2 8.1 1.4 3.2 8.7 5.2 3.4 5.0 3.8 3.0 5.8 3.8 5.0 6.4 8.6 8.3 17.0 15.1 19.0 3.2 7.1 6.1 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 NFXL1 HOZFP ENSG00000170448 "Nuclear transcription factor, X-box binding like 1" Q6ZNB6 4 47847233-47914667 "Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059132 Approved Approved Nucleoplasm Nucleoplasm "HPA059132: " "unprognostic (5.37e-2)" "unprognostic (2.89e-1)" "unprognostic (5.14e-3)" "unprognostic (6.13e-2)" "unprognostic (1.81e-2)" "unprognostic (4.33e-2)" "prognostic unfavourable (9.28e-4)" "unprognostic (1.13e-2)" "unprognostic (6.26e-3)" "unprognostic (8.48e-3)" "unprognostic (8.34e-2)" "unprognostic (4.47e-2)" "unprognostic (4.72e-3)" "unprognostic (8.89e-2)" "unprognostic (3.15e-1)" "unprognostic (6.67e-2)" "unprognostic (8.01e-2)" 8.3 5.8 7.8 7.2 8.7 6.5 10.8 19.1 9.4 10.1 7.4 6.2 12.2 7.8 13.3 19.2 9.7 9.6 6.9 5.5 6.7 5.5 7.4 9.5 7.4 6.5 7.0 9.6 10.9 12.8 11.9 19.6 8.7 7.6 9.0 8.6 5.3 12.4 10.2 7.1 9.3 7.4 8.8 8.8 7.5 8.2 21.3 7.0 5.9 17.2 4.4 7.7 9.2 10.9 2.5 1.9 5.6 2.3 1.5 3.5 1.7 5.4 3.5 3.9 8.0 7.3 12.2 13.2 3.7 5.3 6.1 7.6 5.8 12.5 4.3 7.2 2.5 5.6 9.9 7.5 7.3 3.3 3.9 4.7 6.4 10.6 9.6 11.3 9.4 7.9 10.0 4.2 25.2 5.3 8.3 5.4 6.3 5.2 8.9 5.4 9.3 5.4 8.0 7.5 7.2 7.8 10.4 12.3 5.9 2.8 7.9 5.4 5.5 3.3 4.3 8.0 5.1 3.7 8.3 8.8 5.3 8.8 4.7 6.4 7.0 0.0 1.7 1.7 2.3 2.3 2.8 2.2 3.2 2.5 1.6 2.5 3.5 3.4 5.6 1.5 1.1 1.9 2.0 1.7 7.8 8.7 19.1 9.4 6.7 5.5 7.0 9.6 7.6 7.0 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 10.7 21.5 16.4 15.4 16.0 11.6 21.7 14.4 15.0 30.7 24.9 21.1 19.9 26.9 10.6 13.1 18.8 32.5 17.8 36.2 17.8 17.2 24.1 13.1 65.4 21.8 31.8 17.2 14.5 22.6 24.2 28.8 15.5 26.6 19.2 15.0 25.7 23.6 24.0 20.8 29.0 19.4 19.7 13.7 19.6 20.6 16.8 19.1 17.0 20.4 23.5 12.6 20.4 11.7 14.5 17.2 13.6 20.8 24.1 41.7 39.0 6.2 16.3 15.5 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "RH-30: 54.7;WM-115: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" 100000 Nucleoplasm "Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavourable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 5.8 0.0 0.1 0.4 0.0 0.0 0.0 7.9 0.1 0.0 0.0 1.0 0.0 1.0 54.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.9 0.1 2.7 0.0 0.0 0.0 0.0 0.5 60.7 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA055238: " "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 NHLRC2 "DKFZp779F115, FLJ20147, FLJ25621, FLJ33312, MGC45492" ENSG00000196865 "NHL repeat containing 2" Q8NBF2 10 113854661-113917194 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038493, HPA057564" Approved Approved Nucleoplasm 73000 Nucleoplasm "HPA038493: AB_10672519, HPA057564: " "unprognostic (7.09e-2)" "unprognostic (7.33e-2)" "unprognostic (3.00e-1)" "unprognostic (4.74e-2)" "unprognostic (5.15e-2)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.49e-1)" "unprognostic (1.36e-1)" "unprognostic (4.88e-2)" "unprognostic (8.98e-2)" "unprognostic (1.05e-1)" "unprognostic (8.99e-2)" "unprognostic (2.52e-1)" "unprognostic (8.60e-2)" "unprognostic (1.68e-2)" 11.2 10.3 7.7 8.1 8.4 5.2 10.3 10.5 8.7 10.2 11.7 7.0 14.7 7.5 10.5 10.2 8.9 8.9 10.5 24.8 8.0 4.1 8.1 12.0 10.9 7.6 8.1 6.6 12.3 13.1 17.0 17.9 12.3 7.3 13.1 8.5 11.4 12.5 10.3 18.7 9.8 13.1 9.8 8.4 9.7 9.4 5.3 9.3 8.7 10.9 6.1 7.6 10.8 10.7 3.6 3.9 3.9 3.9 3.2 3.7 1.4 10.1 6.5 12.9 10.5 4.7 8.5 8.2 7.1 8.5 6.2 6.9 4.4 10.0 5.5 5.2 7.2 9.2 10.5 5.9 10.6 6.6 5.3 5.8 5.3 6.3 7.2 8.3 6.7 5.9 7.3 6.9 14.4 7.5 6.9 6.4 8.4 4.7 4.7 6.6 3.8 3.3 4.4 18.5 3.2 7.6 5.6 3.4 6.8 5.5 7.1 8.7 5.2 6.2 9.5 7.5 7.6 4.7 10.7 4.3 2.1 5.5 6.2 13.3 5.0 3.9 2.7 3.1 3.3 2.2 3.1 3.4 2.6 3.7 3.2 3.6 2.3 3.0 2.1 3.2 3.9 3.9 2.3 1.4 7.7 8.4 10.5 8.7 8.0 4.1 8.1 6.6 7.3 9.3 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 93.0" "Cell line enhanced" "Detected in many" "Hep G2: 22.1;TIME: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 14 "dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: " "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 7.4 1.1 6.0 5.4 5.7 0.2 2.4 3.7 8.6 2.2 46.3 4.3 3.4 13.4 3.0 11.2 10.0 0.9 7.2 18.4 4.8 3.4 17.4 19.5 15.0 2.0 4.2 1.3 1.2 4.6 2.8 1.7 3.5 6.3 1.7 10.0 7.9 3.4 0.4 2.3 10.5 93.0 3.0 2.8 2.0 6.8 1.6 1.6 0.2 1.2 3.6 1.7 2.4 3.9 0.1 1.2 1.0 3.8 0.1 0.1 0.7 2.6 2.3 16.4 6.9 4.8 5.9 6.1 2.3 1.1 0.8 0.8 3.0 1.5 0.0 3.0 2.0 6.0 9.9 6.1 0.4 0.2 6.6 1.6 1.1 22.1 7.1 5.8 1.1 8.5 3.5 0.4 7.1 11.5 0.0 0.9 3.6 5.1 0.6 0.4 6.5 4.3 6.7 1.7 0.5 5.6 6.7 6.2 0.0 2.5 5.1 16.5 1.6 1.8 31.5 2.3 2.3 2.3 6.5 0.6 1.2 0.0 0.2 2.4 12.6 1.0 3.4 0.5 0.1 3.8 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 3.8 0.7 0.0 0.7 6.0 5.7 3.7 3.5 4.8 3.4 4.2 1.3 6.3 1.6 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell line enhanced" "Detected in many" "BJ: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favourable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favourable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.6 5.1 0.5 1.6 7.7 8.7 1.8 41.0 29.4 15.0 11.1 1.7 14.5 5.9 13.2 22.7 12.4 5.0 15.2 14.8 12.0 15.7 6.5 8.5 2.0 7.2 5.7 5.9 8.6 14.2 10.0 30.3 5.1 3.8 3.7 9.0 2.8 4.6 2.4 3.1 14.4 2.2 0.0 6.7 15.9 4.1 19.1 1.8 5.5 7.8 11.0 10.7 4.4 7.3 13.5 2.9 4.5 9.0 11.7 9.5 2.1 9.0 10.4 12.0 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA062861: " "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavourable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 15.3 10.9 6.7 11.5 8.4 12.5 12.9 9.2 10.3 12.0 14.6 11.0 10.3 8.7 15.4 12.5 22.0 10.5 14.1 27.5 6.1 5.6 14.0 16.1 11.7 10.4 8.5 3.6 14.9 10.7 8.4 9.0 30.8 7.2 12.5 9.9 14.6 12.3 11.1 31.5 16.1 15.6 15.7 8.3 12.4 11.3 17.1 6.0 17.7 9.5 15.4 19.1 14.5 12.7 8.2 23.0 21.0 25.5 12.0 7.4 10.4 9.0 15.6 24.1 12.5 17.0 11.4 14.3 15.5 11.7 24.3 18.2 17.1 12.8 15.1 24.4 15.6 19.2 19.5 11.6 12.4 12.5 21.3 13.5 14.6 12.5 26.6 17.9 11.1 16.9 20.6 16.1 12.4 29.4 19.0 15.2 13.7 8.9 34.5 11.1 14.2 12.0 27.3 27.7 14.1 15.7 9.3 28.9 37.8 11.3 34.2 15.3 21.7 21.7 21.2 15.3 16.5 16.4 17.2 20.1 32.4 12.4 10.3 10.7 21.5 21.0 25.5 20.5 7.0 20.5 6.9 7.8 7.1 7.0 20.5 8.2 7.4 7.1 14.4 12.0 21.5 23.0 6.0 10.4 6.7 8.4 9.2 10.3 6.1 5.6 8.5 3.6 7.2 6.0 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119605895 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavourable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 3.8 7.9 14.5 6.2 24.3 7.6 6.5 11.4 34.9 4.9 4.0 4.4 1.1 4.7 4.8 5.6 5.6 5.2 4.1 3.8 15.4 14.0 6.9 6.9 4.1 9.7 8.1 24.6 7.4 3.9 8.3 6.5 7.5 25.7 4.9 4.5 2.9 4.6 4.3 4.8 6.4 4.4 4.7 6.0 6.4 4.0 1.9 3.5 7.4 5.4 1.4 9.7 5.2 4.8 3.8 2.7 2.8 2.2 1.3 5.5 1.7 10.8 11.1 6.6 7.6 5.7 5.8 10.0 6.6 5.4 9.0 9.7 11.8 9.4 19.4 11.7 5.7 12.8 27.4 10.2 11.0 9.7 18.7 10.2 13.2 7.8 5.4 19.7 7.9 6.1 8.4 10.4 12.2 9.1 11.0 8.2 8.0 16.8 12.6 15.8 14.6 12.5 9.9 9.4 19.9 11.9 8.1 10.8 9.0 9.3 14.5 9.8 6.1 12.0 7.4 5.8 6.2 12.2 16.6 6.7 8.1 20.5 5.9 22.2 6.4 2.8 1.3 1.5 3.3 2.2 3.1 3.7 3.6 3.7 1.3 3.8 5.5 4.8 0.2 1.3 1.1 2.7 4.3 1.7 14.5 24.3 11.4 34.9 15.4 14.0 8.1 24.6 25.7 3.5 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235357 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 95.6" "Cell line enhanced" "Detected in some" "HEK 293: 20.5;NTERA-2: 7.4;SK-MEL-30: 9.1;U-2 OS: 16.9;U-251 MG: 12.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA065034: " "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.2 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.0 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 20.5 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.3 4.2 0.0 9.1 0.0 0.0 0.0 3.9 16.9 5.2 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in some" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA062879: " "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 9.7 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13545050 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 18.3;lymphoid tissue: 6.5" "Cell line enhanced" "Detected in some" "HAP1: 4.5;NB-4: 12.4;NTERA-2: 7.1;THP-1: 7.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 1.7 0.0 0.1 6.5 0.1 0.0 0.1 0.1 0.1 1.1 18.3 0.1 0.1 1.6 0.9 0.1 2.3 0.2 0.4 1.8 0.1 0.0 0.4 0.1 0.1 2.0 0.1 0.1 2.9 0.2 0.0 0.9 0.1 0.1 0.6 2.4 0.1 1.5 0.6 0.1 0.1 2.0 3.2 0.1 5.3 2.8 0.9 0.1 0.1 0.3 0.9 0.1 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 1.9 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.5 0.6 1.6 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.3 12.4 7.1 0.5 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 1.0 7.4 0.0 0.5 2.9 0.1 0.5 2.2 0.0 0.0 0.4 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128753-35142315 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 40.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavourable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavourable (6.39e-4)" 6.3 6.9 7.0 8.2 7.6 6.4 11.4 7.6 9.1 5.6 5.8 5.4 3.3 5.1 10.0 5.5 7.9 10.0 8.3 4.8 6.0 6.4 4.8 6.9 4.5 9.1 5.6 7.7 16.3 40.3 5.1 4.2 6.1 5.4 9.2 5.3 6.2 9.1 7.5 8.8 7.6 5.1 10.2 5.1 8.3 6.8 7.2 6.4 10.0 10.0 6.6 8.3 6.3 5.4 6.4 4.5 0.4 3.2 2.4 9.1 3.0 8.1 19.9 6.7 11.9 4.2 6.2 10.7 7.3 6.9 13.1 10.9 13.7 7.9 18.1 10.2 6.1 10.9 15.1 18.8 9.1 2.9 23.6 8.1 9.5 17.1 5.6 15.6 6.5 7.0 10.1 13.6 20.8 8.5 21.8 6.6 7.7 11.2 23.9 12.7 12.6 8.8 19.3 11.7 19.9 7.7 7.9 13.8 8.4 7.0 7.1 8.7 17.4 11.3 7.5 7.1 10.0 6.8 24.5 5.2 4.0 15.1 5.0 12.9 13.6 0.1 3.0 0.0 5.7 3.2 9.1 4.8 5.4 6.0 4.5 6.4 7.4 5.1 0.4 2.4 1.6 1.0 3.0 3.0 7.0 7.6 7.6 9.1 6.0 6.4 5.6 7.7 5.4 6.4 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7959424-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 13.2;skin 1: 10.5" "Cell line enhanced" "Detected in some" "A-431: 17.6;BJ: 5.3;HBF TERT88: 7.6;LHCN-M2: 3.4" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 2.6" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 17.6 0.0 0.0 0.0 0.0 0.2 0.0 5.3 2.6 1.2 2.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell line enhanced" "Detected in many" "A-431: 27.5" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favourable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavourable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 27.5 10.5 1.9 0.4 5.5 2.4 0.2 1.7 3.3 3.7 5.1 3.7 7.6 1.2 4.4 4.4 4.9 10.6 2.1 2.1 10.3 13.3 4.2 4.1 17.1 1.4 2.8 4.6 2.5 0.8 5.8 2.2 5.4 0.0 0.4 2.0 16.1 2.6 9.3 7.8 3.0 8.3 0.0 12.2 3.5 2.2 1.0 12.0 2.7 1.6 12.5 1.8 11.0 1.3 0.7 3.7 3.5 2.6 0.2 3.0 2.6 8.5 15.9 4.4 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 NME3 "DR-nm23, NDPKC, NM23-H3" ENSG00000103024 "NME/NM23 nucleoside diphosphate kinase 3" Q13232 16 1770286-1771730 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041113, HPA052733" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" 7900000 Nucleoplasm Cytosol "HPA041113: , HPA052733: " "prognostic favourable (6.81e-5)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.54e-2)" "unprognostic (1.13e-1)" "unprognostic (6.22e-3)" "unprognostic (4.40e-2)" "unprognostic (4.43e-2)" "unprognostic (7.09e-3)" "unprognostic (1.79e-1)" "unprognostic (3.84e-1)" "unprognostic (3.64e-1)" "unprognostic (6.11e-3)" 20.6 45.6 18.0 12.9 19.8 6.6 20.0 21.9 18.2 16.6 18.0 11.0 31.6 25.7 14.4 19.1 12.9 14.3 21.5 11.8 17.5 16.1 17.7 11.2 17.3 11.3 18.4 15.9 22.1 26.8 15.1 24.1 9.7 14.4 26.9 6.4 13.8 34.3 41.4 15.2 9.2 24.6 14.6 14.1 20.4 17.5 7.2 14.6 5.1 24.1 11.7 8.8 11.5 17.9 19.3 34.1 15.5 25.6 20.1 24.4 20.0 0.7 11.6 0.2 9.5 2.7 1.4 1.1 6.8 2.0 1.2 0.9 0.0 13.8 0.1 18.9 0.9 9.8 0.6 3.8 0.1 13.5 30.8 0.0 5.4 5.5 5.1 2.3 4.3 6.3 3.4 1.2 0.6 2.4 4.6 1.9 1.1 16.8 0.2 4.5 12.3 9.4 6.4 0.1 18.0 2.0 0.5 13.5 10.4 20.4 15.4 1.6 14.7 5.6 8.5 2.5 9.6 8.1 4.6 4.9 1.5 1.0 3.5 0.4 5.8 4.9 25.6 15.5 17.5 22.9 17.1 19.3 24.4 16.4 22.0 16.3 21.4 16.8 5.3 20.1 24.5 34.1 21.8 20.0 18.0 19.8 21.9 18.2 17.5 16.1 18.4 15.9 14.4 14.6 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115172-138139443 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.1;testis: 36.2" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 25.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555" Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA035648: , HPA044555: AB_10960286" "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favourable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favourable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.3 5.2 12.3 0.6 18.4 0.3 3.7 3.5 13.9 7.1 1.2 3.9 4.7 0.5 4.1 18.2 1.0 28.1 6.8 2.9 12.0 10.7 15.4 0.6 3.6 0.6 9.4 9.9 4.5 3.5 12.1 8.9 0.4 13.1 4.2 1.1 4.8 3.1 3.9 0.4 0.4 0.5 2.6 4.2 0.4 2.2 36.2 4.8 0.0 9.6 0.3 0.4 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.6 0.0 0.0 0.0 0.6 0.4 0.6 0.2 0.1 1.5 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 1.8 0.0 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 25.1 0.0 5.7 2.1 0.0 0.7 3.7 0.4 1.3 0.0 0.6 0.0 0.0 0.8 0.4 0.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 18.4 3.5 13.9 12.0 10.7 9.4 9.9 13.1 4.8 NMI ENSG00000123609 "N-myc and STAT interactor" Q13287 2 151270465-151290057 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell line enhanced" "Detected in many" "NB-4: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 75.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008588 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008588: AB_1079493" "unprognostic (5.28e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.63e-2)" "prognostic unfavourable (1.15e-4)" "unprognostic (1.42e-2)" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "prognostic unfavourable (3.54e-4)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.57e-7)" "unprognostic (1.91e-1)" "unprognostic (4.69e-2)" "unprognostic (1.52e-2)" "unprognostic (4.57e-2)" 12.0 14.2 5.0 18.6 7.1 26.4 14.0 1.3 5.8 8.9 15.0 3.4 11.1 13.2 8.6 10.4 16.1 9.8 14.7 8.7 5.9 3.8 13.0 20.4 18.5 26.9 5.1 2.7 14.8 8.4 2.9 6.5 24.6 6.9 13.6 10.5 5.0 9.8 7.9 5.1 7.3 26.0 13.1 7.7 30.2 10.2 5.3 6.4 36.7 14.9 10.2 14.2 10.4 10.3 10.8 17.0 75.1 26.9 14.3 12.5 14.9 10.7 5.3 0.2 0.0 3.0 8.4 10.5 3.1 7.4 15.1 23.0 1.1 24.6 10.5 11.7 4.7 6.1 1.1 2.8 3.9 22.3 0.6 29.5 5.5 0.6 12.9 28.0 8.5 5.4 3.8 9.0 2.0 18.7 14.7 2.6 2.8 8.3 23.4 41.8 6.2 7.9 25.3 0.6 9.0 12.5 9.3 1.5 0.0 6.6 7.2 4.0 1.1 32.0 10.1 2.2 5.0 7.1 4.5 0.4 0.3 0.6 5.2 33.7 2.3 31.6 19.7 21.6 10.8 26.9 12.5 10.8 11.3 10.7 17.0 9.1 9.2 9.4 75.1 14.3 24.4 6.9 9.7 14.9 5.0 7.1 1.3 5.8 5.9 3.8 5.1 2.7 6.9 6.4 NMRK1 "bA235O14.2, C9orf95, FLJ20559, NRK1" ENSG00000106733 "Nicotinamide riboside kinase 1" Q9NWW6 9 75060573-75088217 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 29.6;Karpas-707: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049795 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049795: " "unprognostic (1.12e-1)" "unprognostic (4.13e-2)" "unprognostic (3.58e-2)" "prognostic favourable (3.70e-6)" "unprognostic (3.56e-2)" "unprognostic (2.35e-1)" "unprognostic (5.20e-3)" "unprognostic (2.21e-2)" "unprognostic (3.27e-2)" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (1.78e-1)" "prognostic favourable (5.60e-4)" "unprognostic (9.25e-2)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "unprognostic (5.64e-2)" 15.5 7.7 11.1 15.9 10.7 6.9 14.3 21.5 14.6 13.2 15.2 5.8 20.1 12.2 8.1 15.6 24.6 9.4 10.9 9.4 10.2 9.7 22.1 40.3 15.4 19.9 10.8 9.7 15.2 30.6 45.8 18.1 19.7 10.2 15.9 10.3 10.9 29.5 17.7 15.0 15.6 26.6 8.3 8.7 18.8 13.6 6.7 8.9 14.4 31.6 11.2 22.0 12.6 14.8 6.7 8.8 7.3 6.7 8.2 24.2 10.1 5.0 1.1 1.5 3.5 12.1 16.3 8.3 7.4 11.7 1.9 3.0 0.0 13.5 3.0 4.5 7.1 8.9 1.6 5.0 6.0 29.6 1.8 2.1 2.4 2.6 10.8 2.0 0.4 11.3 12.7 3.1 6.4 12.9 0.2 36.5 13.1 3.8 1.9 1.8 1.9 4.7 0.6 13.4 19.2 15.2 9.1 1.0 0.2 3.2 3.3 4.1 8.4 2.1 8.9 6.4 1.2 5.9 2.0 16.2 12.9 1.8 10.5 2.2 6.5 7.3 2.7 4.5 13.9 2.5 16.7 6.7 24.2 16.0 3.1 3.9 22.1 16.7 5.2 8.2 6.7 8.8 15.4 10.1 11.1 10.7 21.5 14.6 10.2 9.7 10.8 9.7 10.2 8.9 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313285 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 97.7" "Cell line enhanced" "Detected in many" "HSkMC: 67.4;LHCN-M2: 40.0;RPTEC TERT1: 103.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" 15000 "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA059180: " "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (1.02e-6)" "prognostic unfavourable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 23.7 1.4 0.6 8.8 0.9 0.1 14.6 0.6 1.7 13.1 8.5 0.7 4.9 0.5 15.8 8.7 12.0 8.3 15.3 8.2 1.6 0.0 4.7 97.7 10.0 3.4 1.1 0.6 11.2 2.0 0.6 2.6 8.6 3.3 9.6 3.3 1.6 3.6 6.7 18.3 8.2 4.3 12.4 1.5 5.8 5.1 7.3 0.6 1.3 5.3 2.2 3.1 10.9 35.3 0.6 0.1 0.7 0.2 0.0 0.9 0.0 0.0 4.7 0.0 4.2 24.3 31.6 0.0 6.0 15.9 9.6 19.1 0.0 6.5 0.0 21.4 12.2 0.0 0.0 2.1 9.7 0.0 0.0 0.0 7.4 0.0 33.1 0.0 0.0 67.4 23.3 6.8 10.1 13.2 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.1 0.0 26.8 0.0 103.7 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 9.3 5.5 22.1 8.5 1.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.9 0.2 0.0 0.2 0.1 0.6 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.6 1.7 1.6 0.0 1.1 0.6 3.3 0.6 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144448-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA053424: " "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 11.9 10.3 9.0 14.2 11.6 18.8 11.1 11.5 17.2 9.9 9.2 14.1 7.8 14.8 11.5 6.4 12.0 10.7 10.4 8.6 8.0 7.5 11.2 15.6 9.2 13.7 14.7 8.5 13.6 16.8 7.1 10.4 9.7 12.1 9.8 6.9 10.3 16.2 8.8 22.5 15.7 11.9 8.2 9.2 15.5 12.5 28.4 10.6 15.7 10.5 13.2 12.3 9.5 9.5 13.9 18.8 5.9 16.1 7.4 11.4 8.1 12.3 22.9 5.1 7.9 2.5 2.7 26.0 8.5 4.3 10.5 5.8 18.6 5.9 18.9 9.4 4.3 11.1 9.0 9.3 2.3 7.4 24.7 12.7 7.6 12.2 6.8 14.8 14.9 4.0 6.5 8.2 6.6 7.4 21.5 4.4 4.3 14.5 14.0 34.8 14.9 18.2 18.3 5.7 16.5 5.4 9.2 12.5 9.9 7.3 9.9 6.3 13.9 9.2 9.8 6.3 15.9 10.0 14.2 11.1 6.8 16.6 9.6 12.8 13.2 2.5 11.8 5.9 11.4 16.1 11.0 13.8 10.6 11.3 15.8 13.9 9.3 8.9 1.7 7.4 12.1 18.8 8.7 8.1 9.0 11.6 11.5 17.2 8.0 7.5 14.7 8.5 12.1 10.6 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: , HPA053714: " "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavourable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavourable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavourable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.8 5.6 2.2 4.2 5.0 2.1 13.7 7.2 5.2 10.3 7.4 7.5 2.0 16.0 5.8 5.3 3.5 11.5 6.3 9.7 7.2 4.7 7.4 3.4 6.5 4.6 10.8 4.4 2.4 3.1 11.4 7.8 4.5 13.3 5.3 4.5 5.5 7.4 5.7 7.1 6.0 6.1 6.5 5.6 6.9 3.1 8.3 5.5 4.5 5.2 4.1 3.8 8.4 6.7 5.5 7.2 5.2 8.6 4.3 4.0 10.1 5.1 21.5 7.0 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003547 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favourable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favourable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavourable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favourable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 17.0 15.7 11.8 13.4 3.8 4.1 14.8 8.5 3.9 3.9 4.1 8.9 7.1 14.5 5.1 3.8 18.6 6.7 22.5 1.4 15.2 24.5 12.3 12.7 20.2 10.3 29.1 18.1 5.9 7.3 15.3 5.9 7.3 9.1 13.2 3.3 14.8 15.9 21.8 13.5 21.2 21.8 7.6 10.9 8.5 6.0 9.6 18.7 9.9 9.1 13.5 13.0 13.8 10.2 16.2 16.4 11.8 15.7 11.0 13.4 18.7 15.4 21.7 19.0 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favourable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.1 10.2 8.3 10.4 7.2 6.2 8.3 9.1 6.8 10.8 8.5 7.6 9.0 13.1 5.2 8.3 13.3 16.4 11.3 11.3 8.3 6.2 9.6 14.1 17.5 5.8 22.0 11.0 6.2 8.9 7.9 7.4 10.0 8.1 6.5 7.5 8.8 10.1 8.3 3.7 13.1 12.8 5.0 8.4 6.6 11.7 8.4 6.4 12.8 15.0 2.8 6.3 5.8 10.2 7.3 6.0 6.0 8.6 9.2 8.1 9.9 4.0 10.1 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 13.4;skeletal muscle: 36.3" "Cell line enhanced" "Detected in some" "HaCaT: 6.2;RH-30: 12.8;RPTEC TERT1: 8.0;U-2 OS: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: , HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.5 0.6 3.8 3.5 13.4 0.7 0.6 4.4 4.8 0.7 2.0 1.1 0.0 0.5 0.6 0.7 1.3 0.8 0.5 0.5 2.8 4.4 1.9 0.5 1.4 0.6 2.4 1.6 0.5 1.9 0.4 0.8 0.4 5.9 1.6 0.9 0.6 3.8 0.6 36.3 2.2 0.6 0.8 1.2 0.5 0.5 0.9 3.0 0.0 0.6 0.0 0.5 0.9 0.6 0.9 0.6 2.1 0.5 0.8 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 6.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 1.4 0.0 12.8 0.1 8.0 0.0 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 2.1 0.5 0.5 0.5 0.4 0.4 0.7 0.4 0.3 0.2 0.9 0.5 0.5 1.9 0.8 0.5 0.6 0.3 0.0 3.8 13.4 4.4 4.8 2.8 4.4 2.4 1.6 5.9 3.0 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069774-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1" "Cell line enhanced" "Detected in many" "A-431: 6.7;HEL: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: , HPA055561: " "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 2.1 7.9 10.2 1.6 7.0 4.8 6.2 23.1 34.1 2.4 3.7 3.1 7.1 2.7 2.4 1.7 2.2 2.6 7.4 2.3 19.0 10.1 2.9 7.6 2.3 1.4 6.5 13.0 1.6 3.5 2.0 2.7 2.2 5.5 2.5 3.9 2.7 4.6 9.7 1.7 2.4 3.1 2.1 4.4 1.3 3.8 4.0 3.1 0.0 1.6 0.2 1.8 1.8 2.2 0.0 0.1 1.1 0.5 0.0 0.3 0.1 6.7 0.0 3.2 1.8 0.1 0.0 0.5 0.6 0.7 0.9 0.8 1.5 1.7 0.0 4.3 0.2 5.1 1.0 0.2 0.3 0.1 3.1 8.1 1.1 1.7 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.7 0.6 0.1 0.1 3.5 0.6 0.0 2.3 3.0 0.1 1.2 0.2 1.5 2.3 2.6 1.8 1.5 0.3 1.2 1.9 0.4 0.7 0.1 0.8 0.0 1.2 4.6 0.0 0.0 1.0 0.1 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 10.2 7.0 23.1 21.1 19.0 10.1 6.5 13.0 5.5 3.1 NOTCH1 TAN1 ENSG00000148400 "Notch 1" P46531 9 136494433-136545786 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 24.5;HMC-1: 21.3;hTCEpi: 23.6;MOLT-4: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.8" "Group enriched" "Detected in many" 4 "granulocytes: 8.8;NK-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008112, CAB022466, HPA067168" Supported Approved Nucleoplasm 8100000 Nucleoplasm "CAB008112: AB_2153490, CAB022466: , HPA067168: " "unprognostic (1.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.16e-1)" "unprognostic (8.38e-3)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-3)" "unprognostic (5.50e-3)" "unprognostic (8.78e-2)" "unprognostic (8.50e-2)" "prognostic unfavourable (5.45e-4)" "unprognostic (2.14e-2)" "unprognostic (1.92e-1)" "unprognostic (5.65e-2)" "unprognostic (8.84e-2)" 20.0 4.0 10.0 14.5 10.4 14.6 12.8 3.8 18.8 12.8 14.2 19.9 8.2 9.8 11.2 5.1 13.3 9.6 13.1 9.6 10.7 5.8 9.4 7.2 17.4 13.7 11.6 7.5 9.2 17.8 3.7 5.6 8.5 9.3 12.1 5.7 10.4 14.2 11.8 8.2 32.3 10.8 7.7 6.6 20.7 8.6 4.1 9.9 34.8 9.4 10.2 10.9 12.3 22.2 0.6 1.1 8.8 1.0 2.7 1.3 0.9 4.4 7.3 6.1 3.0 0.2 0.5 7.6 2.2 0.6 1.3 0.4 1.0 0.5 5.9 4.6 1.7 24.5 2.0 10.0 0.2 13.5 1.1 3.3 3.0 0.4 3.4 3.5 21.3 0.3 23.6 1.7 3.7 7.8 1.4 1.1 0.8 7.9 37.4 5.7 5.1 3.4 7.7 4.9 11.0 0.9 3.7 0.0 0.4 3.2 3.4 1.4 2.1 5.6 11.5 3.2 4.7 3.1 2.4 1.2 1.0 2.4 2.2 2.5 16.5 0.7 1.0 2.8 1.3 0.4 0.8 0.4 0.6 1.0 0.6 0.6 0.4 1.1 8.8 2.7 0.4 1.1 0.4 0.9 10.0 10.4 3.8 11.7 10.7 5.8 11.6 7.5 9.3 9.9 NOVA2 "ANOVA, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45973546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Cell line enhanced" "Detected in some" "AF22: 8.1;HDLM-2: 8.6;HUVEC TERT2: 13.9;TIME: 20.7;U-2 OS: 5.1" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavourable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 11.8 4.5 23.9 2.7 22.7 1.3 5.7 13.0 33.5 3.9 2.5 7.2 0.0 2.5 5.6 2.7 2.4 3.6 4.2 5.8 17.1 10.9 3.2 2.7 9.4 2.2 7.1 17.3 2.0 2.5 3.3 5.7 9.7 11.1 2.6 2.4 2.5 2.4 3.1 5.5 2.7 2.0 5.7 5.5 2.4 2.5 4.3 8.7 0.0 4.5 0.4 1.8 3.9 3.5 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.0 0.1 8.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.7 4.6 0.0 0.0 0.0 0.0 0.0 20.7 0.0 5.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 23.9 22.7 13.0 29.3 17.1 10.9 7.1 17.3 11.1 8.7 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 15.4;TIME: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favourable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 15.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 0.3 0.0 34.4 0.1 2.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019820-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.2;skin 1: 10.5;stomach 1: 8.0" "Cell line enhanced" "Detected in many" "BJ: 8.7;Daudi: 8.9;HEK 293: 9.8;HMC-1: 8.1;NB-4: 15.6;U-266/84: 9.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Lineage enhanced" "Detected in single" "B-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm Nucleoplasm "HPA043364: , HPA072259: " "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.6 0.6 9.5 1.3 4.1 0.9 1.3 0.4 14.2 0.4 0.9 0.4 0.0 0.5 0.6 0.4 0.8 1.2 0.5 0.9 9.0 5.2 1.2 0.8 0.9 1.7 3.0 4.1 0.4 1.5 0.7 1.1 0.8 5.1 0.6 0.5 3.4 0.7 0.5 0.5 10.5 0.4 0.7 0.8 3.9 8.0 0.8 0.2 0.0 0.6 0.0 1.3 0.5 0.4 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.1 0.2 0.4 0.2 0.1 0.0 8.7 0.2 0.1 0.4 0.6 0.5 8.9 2.0 7.0 0.2 1.8 0.2 0.1 0.6 9.8 0.7 0.8 2.1 0.0 4.7 8.1 0.8 0.3 0.0 0.1 0.2 3.0 0.7 1.1 0.7 0.3 15.6 2.1 1.5 0.8 0.3 0.7 0.5 0.5 0.7 0.6 0.7 0.3 2.0 1.9 1.5 0.1 0.1 0.9 0.1 0.2 4.9 9.5 1.9 1.1 0.9 6.4 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.1 0.4 14.2 9.0 5.2 3.0 4.1 5.1 0.2 NPAS2 "bHLHe9, MOP4, PASD4" ENSG00000170485 "Neuronal PAS domain protein 2" Q99743 2 100820152-100996829 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 24.1;PC-3: 36.4;RT4: 29.3;U-87 MG: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019674 Uncertain Supported Approved Nucleoplasm Nucleoplasm "HPA019674: AB_10601275" "unprognostic (2.74e-1)" "unprognostic (8.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.06e-3)" "unprognostic (4.39e-2)" "unprognostic (3.05e-1)" "prognostic unfavourable (2.07e-4)" "unprognostic (5.47e-3)" "unprognostic (4.48e-1)" "unprognostic (1.56e-1)" "unprognostic (1.59e-3)" "unprognostic (2.13e-1)" "prognostic unfavourable (3.55e-7)" "unprognostic (7.03e-2)" "unprognostic (6.58e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-3)" 6.6 11.5 16.8 8.2 24.8 1.2 10.1 7.6 23.0 11.9 14.4 4.3 1.3 26.7 8.8 4.9 32.4 8.2 13.6 27.3 15.3 6.8 15.9 14.1 5.3 3.6 6.2 14.1 3.3 32.5 1.7 12.7 14.2 10.3 12.2 15.1 6.5 23.7 7.0 12.7 18.5 20.2 17.9 11.0 5.7 19.1 9.9 8.5 0.5 6.3 6.0 13.4 22.4 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 4.2 24.1 0.0 0.2 23.8 10.4 3.5 7.9 23.9 3.3 7.1 0.4 1.9 0.0 9.6 1.3 0.2 3.5 5.9 3.4 0.3 1.4 0.0 4.3 11.0 11.3 0.0 1.0 8.7 9.6 8.0 12.9 13.5 0.1 0.0 2.6 8.6 1.6 0.2 0.4 36.4 0.1 0.5 0.2 17.0 29.3 0.0 0.4 0.0 1.4 17.9 0.2 0.2 5.1 2.4 3.3 4.8 3.4 0.0 0.0 0.0 26.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.0 1.3 0.0 16.8 24.8 7.6 23.0 15.3 6.8 6.2 14.1 10.3 8.5 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.3;U-87 MG: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.6 4.5 7.4 14.9 11.6 10.5 9.3 20.2 9.9 21.4 7.1 7.8 4.5 7.2 13.4 15.0 5.8 15.9 8.8 3.5 4.6 1.6 9.6 16.0 21.4 6.1 7.3 11.1 15.8 20.8 70.3 9.7 4.8 12.0 11.0 8.1 2.5 3.6 3.2 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.1 13.7 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.2 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 NPDC1 "CAB-, CAB1, DKFZp586J0523" ENSG00000107281 "Neural proliferation, differentiation and control 1" Q9NQX5 9 137039470-137046203 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.4;MAIT T-cell: 10.7;memory CD4 T-cell: 13.2;memory CD8 T-cell: 13.6;T-reg: 10.4" "Lineage enriched" "Detected in many" 7 "T-cells: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008189 Approved Approved Nucleoplasm,Cytosol 180000 Nucleoplasm Cytosol "HPA008189: AB_1854584" "unprognostic (6.94e-2)" "unprognostic (1.07e-1)" "prognostic unfavourable (2.01e-5)" "prognostic favourable (6.19e-5)" "unprognostic (2.06e-1)" "unprognostic (4.83e-3)" "unprognostic (1.24e-1)" "unprognostic (4.35e-2)" "unprognostic (8.65e-2)" "unprognostic (1.53e-1)" "prognostic favourable (3.18e-4)" "unprognostic (2.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.23e-2)" "unprognostic (2.35e-1)" "unprognostic (4.20e-2)" "unprognostic (8.84e-2)" 35.4 21.7 33.1 11.9 35.5 4.1 21.6 59.7 65.6 27.8 27.1 18.4 23.8 22.2 26.7 10.8 11.6 25.4 32.3 20.4 34.5 35.3 12.7 5.9 18.9 11.5 25.1 49.0 12.0 28.6 17.2 47.7 20.1 29.5 73.1 13.3 10.6 58.0 35.5 19.0 17.7 23.0 16.4 30.3 32.4 59.6 10.4 14.5 0.8 11.5 8.6 7.2 12.8 20.2 0.1 2.0 0.5 0.4 0.1 13.6 2.6 9.4 11.4 2.8 18.4 6.6 6.7 0.7 20.4 6.4 4.6 1.8 4.6 5.2 9.4 15.5 7.8 35.6 2.4 5.5 0.5 7.6 11.6 3.8 29.2 3.3 9.5 3.3 0.0 4.7 8.6 2.5 5.0 11.8 0.2 0.2 0.9 35.9 0.2 0.3 6.1 19.0 5.6 0.0 36.0 7.7 6.1 22.7 15.7 5.4 18.2 12.2 39.3 4.7 20.2 3.4 6.2 24.2 6.2 0.0 0.1 0.3 5.0 0.3 2.9 0.0 0.4 0.5 8.4 0.0 10.7 0.1 13.2 13.6 0.7 0.0 0.3 2.3 0.0 0.1 0.0 2.0 10.4 2.6 33.1 35.5 59.7 65.6 34.5 35.3 25.1 49.0 29.5 14.5 NPEPL1 "bA261P9.2, FLJ11583" ENSG00000215440 "Aminopeptidase like 1" Q8NDH3 20 58689131-58719238 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 12.2;classical monocyte: 13.4;eosinophil: 4.9;intermediate monocyte: 8.9;myeloid DC: 8.2;neutrophil: 9.6;non-classical monocyte: 11.9" "Group enriched" "Detected in all" 5 "dendritic cells: 8.2;granulocytes: 12.2;monocytes: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004986, CAB017025, HPA036356" Approved Approved Nucleoplasm 16000 Nucleoplasm "CAB004986: AB_426073, CAB017025: , HPA036356: " "unprognostic (1.68e-1)" "unprognostic (5.87e-3)" "unprognostic (8.28e-2)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (2.86e-3)" "unprognostic (3.11e-2)" "unprognostic (4.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.62e-3)" "unprognostic (3.78e-2)" "prognostic unfavourable (1.87e-9)" "unprognostic (7.97e-2)" "unprognostic (1.64e-1)" "unprognostic (2.21e-1)" "prognostic favourable (5.73e-4)" 17.2 10.3 9.9 9.7 15.3 15.8 25.0 24.2 10.1 9.6 14.9 10.2 17.2 14.4 11.9 23.5 17.9 12.5 24.5 19.4 10.1 8.6 16.7 11.9 14.5 12.6 12.9 7.2 12.5 15.6 13.6 11.4 11.2 13.1 15.0 4.5 15.7 19.1 17.2 51.8 15.2 13.7 25.8 10.0 16.5 12.8 13.0 9.0 5.6 16.5 20.4 11.8 15.3 20.4 1.0 8.2 12.2 13.4 2.0 2.3 4.1 9.1 12.9 2.3 1.9 5.2 9.6 0.7 3.4 0.3 11.6 6.5 7.4 7.0 0.4 19.2 6.6 9.9 3.2 4.4 1.1 8.1 2.8 3.0 9.9 3.2 13.2 3.3 5.5 9.4 13.7 4.0 0.0 9.7 0.4 1.4 4.5 43.0 1.3 8.7 3.4 13.4 2.6 1.1 5.0 4.7 5.9 4.3 1.3 9.4 2.6 17.3 10.0 6.3 10.2 2.9 2.3 5.8 1.8 4.5 1.6 0.3 4.2 6.3 1.1 12.2 13.4 4.9 1.9 8.9 2.3 1.0 1.1 1.3 8.2 0.7 0.7 1.3 9.6 2.0 11.9 0.4 2.3 4.1 9.9 15.3 24.2 10.1 10.1 8.6 12.9 7.2 13.1 9.0 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease mutation, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: " "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 5.6 4.7 7.3 4.7 11.2 7.2 4.9 6.3 12.0 5.4 3.5 4.9 8.9 4.4 5.2 11.9 3.7 17.4 5.7 3.7 6.6 3.9 4.5 2.5 6.7 4.6 2.8 6.4 7.0 4.9 7.1 17.8 3.7 5.4 4.5 2.9 8.3 4.1 5.7 3.7 9.6 4.5 5.3 3.5 4.6 4.3 11.4 3.7 5.8 14.9 3.7 2.6 4.3 4.5 0.5 0.4 2.6 1.0 0.5 0.8 0.4 7.5 4.2 5.6 4.4 5.1 7.4 4.4 4.0 4.1 5.6 4.4 4.0 6.7 4.0 10.0 4.5 7.1 2.8 6.8 2.8 4.9 6.4 3.3 7.7 3.6 3.5 6.6 5.2 5.9 3.4 6.6 4.2 3.9 6.1 4.3 2.5 5.6 8.0 6.6 0.9 4.5 6.9 3.6 6.5 2.5 1.0 17.9 5.5 6.2 4.6 6.6 6.1 7.2 3.5 8.1 3.4 13.3 4.8 5.2 6.8 4.0 3.4 8.3 2.1 2.6 1.0 0.0 0.5 0.2 0.8 0.3 0.5 0.0 0.4 0.5 0.4 0.0 1.4 0.5 0.8 0.3 0.2 0.4 7.3 11.2 6.3 12.0 6.6 3.9 2.8 6.4 5.4 3.7 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell line enhanced" "Detected in many" "HHSteC: 33.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" HPA053611 Supported Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.2 24.1 9.3 0.0 0.4 4.2 9.2 6.4 8.5 7.6 3.6 5.7 1.5 13.2 12.7 4.2 11.1 1.2 8.7 4.7 4.2 0.0 8.1 19.2 33.5 11.5 2.7 18.6 18.2 7.0 12.8 4.1 1.2 6.4 9.6 11.1 0.0 6.1 0.2 0.2 4.5 0.1 2.1 13.6 11.1 1.0 9.2 4.9 0.6 10.4 1.9 10.1 0.8 11.3 0.5 0.2 2.9 3.8 2.7 3.0 0.4 0.7 5.7 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell line enhanced" "Detected in some" "BEWO: 12.0;NB-4: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " 1.6 1.2 1.3 1.1 1.5 0.9 1.8 11.8 3.8 0.6 3.2 0.6 1.7 2.7 1.1 2.4 0.8 1.3 1.8 1.5 0.6 0.5 1.6 0.9 1.0 2.6 1.2 2.3 4.1 1.1 2.2 2.6 3.1 1.0 4.2 4.1 1.0 0.8 1.3 0.9 1.6 5.9 1.2 0.8 3.3 1.5 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.4 0.4 0.3 0.0 0.4 0.3 12.0 1.0 0.5 0.1 0.3 0.4 1.7 0.0 1.1 0.9 1.4 0.3 0.0 0.1 0.9 0.7 0.8 0.9 0.2 0.4 0.2 2.8 0.1 1.6 1.6 1.2 0.3 0.8 0.8 0.2 2.3 1.3 4.1 0.8 0.5 1.3 0.8 0.2 0.7 0.6 1.1 0.6 0.4 0.7 1.7 0.0 1.0 0.9 0.4 0.3 0.0 0.5 0.4 0.3 0.3 1.4 0.6 1.0 0.1 0.1 0.0 0.5 0.0 0.3 0.7 0.5 0.1 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell line enhanced" "Detected in some" "HSkMC: 5.0;NB-4: 11.2;SK-MEL-30: 16.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 1.3 1.4 1.8 2.3 1.3 1.9 1.2 13.2 5.0 0.8 2.9 0.5 2.4 2.2 1.1 2.8 6.4 1.0 2.2 1.8 1.1 0.8 1.2 1.0 1.1 2.8 1.5 7.2 4.1 1.3 2.3 2.6 1.9 2.9 5.3 3.2 3.4 1.2 1.0 1.0 1.3 1.8 1.4 1.0 1.9 1.6 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.3 0.0 0.1 1.5 0.5 0.0 0.4 0.4 0.0 2.1 3.5 0.2 1.3 0.1 0.1 2.3 0.3 0.1 0.0 0.4 0.7 0.4 0.2 0.1 0.5 5.0 0.7 1.3 0.2 0.1 0.1 0.3 0.3 1.2 0.0 11.2 0.9 0.0 0.1 0.0 0.0 3.1 1.0 0.5 0.5 0.0 0.2 16.1 0.2 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.9 0.1 2.0 1.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell line enhanced" "Detected in many" "THP-1: 15.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.2 9.7 0.7 1.9 4.6 6.4 6.5 2.0 0.8 2.0 0.5 4.9 2.0 1.7 4.9 3.3 3.9 1.9 2.6 5.8 9.7 1.3 0.6 3.6 1.9 8.4 2.5 3.4 3.3 2.7 1.5 6.1 1.0 2.0 3.2 6.8 0.9 0.7 0.7 0.6 5.4 1.9 0.0 0.7 5.4 2.4 6.0 2.4 15.5 7.7 0.0 2.5 7.5 0.4 4.3 6.0 7.2 0.9 3.7 1.3 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 NPIPA7 ENSG00000214967 "Nuclear pore complex interacting protein family member A7" E9PJI5 16 16379055-16393954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 38.6;THP-1: 33.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "B-cells: 1.7;T-cells: 1.9" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.17e-2)" 3.6 5.7 3.0 2.8 3.0 3.7 2.9 19.7 4.0 3.2 5.1 3.1 3.7 10.1 5.3 5.5 6.2 1.9 3.8 3.4 4.4 5.9 3.8 5.2 1.7 5.1 8.8 12.4 18.0 3.2 6.1 9.0 6.6 3.2 2.6 13.8 4.2 3.9 1.6 6.3 4.2 6.1 6.8 4.3 4.1 3.3 1.7 0.1 0.2 0.1 0.4 1.9 0.2 3.0 6.8 8.2 3.1 4.9 4.0 5.4 6.4 2.5 7.4 3.9 7.1 4.9 7.8 5.2 6.7 9.5 5.7 6.6 5.5 2.2 1.7 7.7 20.9 10.3 4.6 2.7 38.6 7.0 25.5 4.0 8.7 3.7 4.5 10.0 8.0 13.1 6.2 15.9 5.6 2.3 9.2 5.5 4.4 12.1 13.2 10.6 5.7 5.1 11.8 5.4 8.5 33.1 3.2 7.1 3.4 3.2 5.4 2.1 7.5 6.3 4.1 8.6 3.1 0.2 0.1 0.0 1.9 0.0 0.4 1.5 1.2 1.9 0.0 1.7 0.2 0.3 0.0 0.4 0.1 0.1 0.4 0.2 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell line enhanced" "Detected in some" "Daudi: 17.8;EFO-21: 17.8;HMC-1: 66.0;SCLC-21H: 16.1;THP-1: 17.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 2.6 7.9 2.0 1.3 2.8 3.9 2.3 14.1 10.8 1.4 5.5 0.0 0.6 0.0 0.9 5.1 0.0 2.6 3.4 1.9 1.1 1.0 2.4 1.5 0.5 6.0 1.1 7.6 6.6 4.8 2.3 1.3 1.5 6.5 1.5 4.6 1.7 0.0 0.2 4.4 1.4 2.1 1.6 0.0 3.8 0.5 1.8 0.5 1.7 0.6 0.1 1.1 0.3 0.0 0.6 0.0 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 3.1 17.8 17.8 0.1 0.0 7.0 2.1 0.0 0.0 0.0 0.0 0.5 0.5 3.0 0.0 66.0 0.1 0.0 0.0 0.0 1.3 6.9 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.7 10.9 0.5 0.0 0.0 16.1 5.1 0.0 0.1 0.1 0.0 17.8 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 5.7 4.9 0.4 0.0 0.6 0.0 0.6 0.0 1.1 1.8 0.5 0.2 0.3 0.2 0.7 0.4 1.7 0.1 0.0 0.5 0.0 0.3 NPIPB11 ENSG00000254206 "Nuclear pore complex interacting protein family member B11" E5RHQ5 16 29381354-29404029 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 12.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (6.82e-2)" "unprognostic (2.99e-1)" "unprognostic (1.93e-3)" "unprognostic (1.42e-1)" "unprognostic (1.14e-1)" "unprognostic (6.92e-3)" "unprognostic (3.06e-1)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (1.36e-1)" "unprognostic (5.57e-4)" "unprognostic (7.41e-2)" "unprognostic (2.94e-6)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "unprognostic (5.96e-3)" "unprognostic (4.79e-5)" 2.0 1.0 1.9 3.2 2.5 5.3 1.9 5.9 2.4 1.6 1.8 2.3 2.1 4.2 1.7 2.9 2.1 1.8 2.4 1.9 2.7 3.5 1.9 7.4 1.5 4.4 1.6 0.7 2.3 1.2 2.3 2.0 2.8 0.5 5.1 8.8 3.1 0.9 1.7 5.5 3.2 4.5 2.9 1.0 1.0 1.9 3.1 0.7 1.4 0.5 0.4 1.1 0.2 1.9 1.6 2.9 4.2 2.2 1.7 4.0 1.8 0.8 1.6 0.7 2.1 3.7 12.3 2.8 0.9 3.4 2.3 2.7 1.7 2.8 3.2 2.6 4.9 3.5 1.1 3.3 6.5 1.0 2.2 1.7 2.4 0.8 3.4 3.6 1.5 4.3 2.7 10.5 5.1 3.5 4.3 1.2 3.7 1.8 1.4 3.8 1.9 0.5 2.6 1.4 1.4 4.2 3.8 4.0 1.7 2.9 2.5 3.3 2.1 10.0 2.2 4.2 2.9 0.2 0.5 0.1 1.0 0.0 0.2 0.5 0.5 0.8 0.7 3.1 1.1 1.1 1.4 0.4 0.4 0.2 0.0 0.2 NPIPB12 ENSG00000169203 "Nuclear pore complex interacting protein family, member B12" 16 29483642-29505999 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 58.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (3.83e-2)" "unprognostic (1.08e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "unprognostic (7.92e-2)" "unprognostic (1.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.20e-2)" "unprognostic (2.42e-1)" "unprognostic (6.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.28e-7)" "unprognostic (3.32e-2)" "unprognostic (4.11e-2)" "unprognostic (2.33e-1)" "unprognostic (2.14e-4)" 4.4 2.8 3.2 7.5 4.2 11.3 3.7 10.1 6.3 4.1 5.0 4.4 4.3 7.9 2.9 3.3 4.7 4.3 3.9 3.4 4.7 8.2 5.3 10.8 2.9 5.6 3.8 4.7 5.8 3.5 4.6 4.9 7.8 3.7 8.1 23.7 6.2 3.5 4.0 9.0 4.2 5.3 6.7 5.3 3.1 4.0 9.0 2.2 14.5 3.0 12.6 3.7 0.9 9.2 9.3 7.5 19.4 9.2 5.4 14.1 5.6 1.6 2.9 2.5 8.0 19.2 15.4 10.2 4.5 12.1 12.8 8.9 3.8 10.0 9.5 11.5 10.7 15.7 8.4 12.4 22.6 8.6 7.1 6.2 6.6 3.2 11.5 13.3 4.5 15.2 8.8 58.4 11.6 6.8 21.6 3.2 14.9 6.8 6.7 8.2 5.7 3.1 13.9 8.1 6.8 15.6 8.1 18.7 7.0 12.9 10.6 7.4 7.1 15.2 7.6 22.5 8.6 14.5 3.0 1.1 3.7 1.0 0.9 3.4 2.1 2.4 2.0 9.0 2.9 1.9 8.1 12.6 2.3 2.2 1.5 0.9 NPIPB13 ENSG00000198064 "Nuclear pore complex interacting protein family, member B13" A6NJU9 16 30222937-30254510 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (7.11e-3)" "unprognostic (4.08e-2)" "unprognostic (1.83e-1)" "unprognostic (1.89e-3)" "unprognostic (4.87e-2)" "unprognostic (2.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.69e-2)" "unprognostic (3.67e-1)" "unprognostic (1.41e-1)" "unprognostic (3.09e-7)" "unprognostic (1.86e-2)" "unprognostic (2.98e-1)" "unprognostic (3.17e-1)" "unprognostic (2.58e-2)" 1.8 1.1 1.9 2.3 2.0 6.5 2.3 7.6 3.3 2.3 2.3 1.7 2.4 6.2 2.0 1.9 1.7 1.5 2.4 1.6 1.6 2.3 2.7 4.2 1.5 2.7 1.4 4.8 2.9 1.7 2.8 2.5 2.8 1.7 3.5 9.0 3.3 0.4 1.4 3.9 3.5 1.8 2.8 2.1 1.4 2.2 1.3 0.6 0.8 1.6 1.9 3.2 0.5 3.3 7.8 2.0 6.8 2.0 2.4 3.8 0.6 0.0 0.7 0.3 0.9 4.5 4.6 3.4 1.4 3.9 4.2 1.8 1.1 2.8 1.7 5.0 8.7 4.1 0.9 6.8 4.3 3.0 2.7 3.0 1.9 1.3 2.1 7.2 1.6 7.0 2.9 6.4 2.7 2.0 6.0 1.0 2.7 2.1 5.5 2.4 2.4 0.9 2.6 1.2 2.2 1.8 3.4 4.0 3.9 3.6 1.9 2.8 3.2 6.1 3.8 3.0 1.9 0.1 1.6 0.2 3.2 0.4 1.6 0.4 1.3 1.3 0.5 1.3 1.4 0.4 0.8 1.9 1.6 0.6 0.4 0.5 NPIPB15 "LOC440348, NPIPL2" ENSG00000196436 "Nuclear pore complex interacting protein family member B15" A6NHN6 16 74377878-74392080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Cell line enhanced" "Detected in many" "T-47d: 13.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "memory B-cell: 4.0" "Lineage enriched" "Detected in single" 5 "B-cells: 4.0" "HPA011188, HPA053611" Supported Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (2.23e-2)" "unprognostic (3.48e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-1)" "unprognostic (9.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" "unprognostic (5.53e-2)" "unprognostic (2.41e-2)" "unprognostic (7.73e-2)" "unprognostic (4.58e-3)" "unprognostic (1.53e-1)" "unprognostic (2.81e-2)" "unprognostic (1.97e-1)" "unprognostic (7.34e-3)" "unprognostic (2.53e-1)" "unprognostic (1.14e-3)" 1.8 1.2 0.8 0.5 1.3 2.9 3.8 4.5 1.5 2.1 6.2 4.1 1.1 0.0 3.0 2.1 2.1 1.1 1.1 0.8 3.1 8.4 2.4 2.6 0.8 1.8 6.1 4.4 5.2 2.7 7.1 11.2 6.1 1.1 3.0 4.1 5.3 1.5 0.9 3.1 4.3 18.6 4.4 2.2 1.4 1.8 4.0 0.2 0.8 0.3 0.6 0.6 0.5 2.7 0.1 2.7 1.6 3.2 2.3 0.6 1.8 2.6 2.1 5.9 1.6 0.1 4.6 0.0 3.6 5.2 0.0 2.2 1.6 0.0 2.9 0.1 6.2 2.7 1.5 1.9 9.4 3.1 4.7 4.2 3.2 0.0 0.3 1.9 1.7 4.2 1.0 0.0 0.6 0.0 1.0 2.6 3.1 0.0 1.8 3.8 0.0 6.9 0.0 4.5 13.4 2.2 0.2 2.0 5.5 0.0 1.0 6.4 1.8 1.1 2.7 1.3 1.4 0.0 0.3 0.2 0.6 0.0 0.0 4.0 0.2 0.6 0.2 0.7 0.2 0.0 0.8 0.6 0.1 0.1 0.0 0.5 NPIPB2 ENSG00000234719 "Nuclear pore complex interacting protein family, member B2" A6NJ64 16 11927373-11976643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.2;U-266/70: 21.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA053611 Supported Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (8.80e-2)" "unprognostic (4.83e-1)" "unprognostic (5.20e-2)" "unprognostic (8.24e-2)" "unprognostic (2.45e-1)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.73e-1)" "unprognostic (5.92e-2)" "unprognostic (3.01e-3)" "unprognostic (2.80e-2)" "unprognostic (2.21e-1)" "unprognostic (4.89e-3)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (2.25e-1)" "unprognostic (2.58e-2)" 3.4 3.8 3.8 3.6 5.0 1.8 3.0 4.6 8.2 3.6 2.7 4.9 13.8 3.4 4.9 10.3 1.6 3.3 4.2 2.7 8.2 2.9 4.9 2.3 4.0 4.9 3.0 1.7 4.5 6.6 11.0 3.5 2.4 3.6 3.3 2.9 3.8 6.1 13.2 3.1 6.8 3.9 4.8 3.5 2.7 2.2 17.4 2.4 10.2 6.1 1.8 1.9 2.1 2.8 2.7 2.2 0.7 3.1 3.5 2.7 1.0 0.1 1.4 1.6 0.9 3.6 6.3 2.4 1.8 3.0 0.8 0.4 1.0 1.4 0.9 0.6 1.8 0.3 1.1 1.4 1.7 0.8 1.5 0.4 1.4 1.5 6.3 0.9 0.4 0.3 3.2 1.8 4.0 0.2 0.1 4.1 0.5 2.0 0.2 0.5 0.4 1.3 1.8 0.1 12.2 0.6 0.8 2.2 0.0 4.2 0.2 0.0 0.3 2.6 0.4 0.3 0.2 0.3 0.2 21.5 6.9 1.0 2.5 0.3 1.0 0.0 3.1 0.6 1.0 0.2 0.2 2.7 1.7 1.3 2.2 1.6 2.7 0.6 0.7 3.5 0.5 2.2 0.0 1.0 3.8 5.0 4.6 8.2 8.2 2.9 3.0 1.7 3.6 2.4 NPIPB3 "KIAA0220, NPIPL3" ENSG00000169246 "Nuclear pore complex interacting protein family member B3" Q92617 16 21402237-21448567 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 53.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (2.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "unprognostic (8.01e-2)" "unprognostic (9.97e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-2)" "unprognostic (3.14e-1)" "unprognostic (3.91e-1)" "unprognostic (1.65e-1)" "unprognostic (4.66e-5)" "unprognostic (1.50e-7)" "unprognostic (1.30e-1)" "unprognostic (3.02e-2)" "unprognostic (5.94e-2)" "unprognostic (9.00e-4)" 7.3 5.0 8.2 8.6 9.8 32.4 8.8 15.5 8.8 6.4 7.6 6.9 5.2 12.4 6.2 6.4 6.8 5.5 9.6 7.2 8.2 9.6 7.9 18.1 6.7 6.7 5.9 4.0 9.5 5.0 9.8 8.2 11.7 5.6 19.7 36.9 9.6 6.1 7.6 14.6 7.1 7.3 9.7 7.9 5.2 6.6 5.3 9.0 6.5 3.6 3.4 5.7 0.4 13.5 12.3 8.4 14.7 11.4 6.5 25.1 9.4 3.3 5.0 5.6 19.0 16.7 19.7 9.4 12.8 15.5 5.5 13.9 4.6 11.0 7.8 8.6 17.0 53.2 10.2 15.7 16.7 3.5 6.0 12.0 15.4 6.6 15.7 26.2 6.8 24.3 16.6 38.6 15.5 14.4 26.5 8.8 11.6 10.0 7.9 10.7 8.2 5.4 12.9 9.8 12.7 7.6 10.8 23.8 13.1 2.2 13.6 13.9 9.7 17.8 9.4 13.9 12.5 6.5 3.6 2.6 5.7 2.7 2.3 4.4 3.0 2.9 2.2 5.3 3.9 2.6 3.9 3.4 2.0 9.0 2.0 0.4 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skin 1: 31.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 5.5 3.7 4.4 7.0 4.6 23.5 6.1 10.4 5.4 5.1 6.5 4.5 5.4 22.4 4.5 5.7 4.9 4.2 5.0 4.0 5.4 6.6 6.0 10.7 3.8 5.9 5.3 3.3 5.4 3.8 6.6 8.2 5.5 3.2 7.1 31.2 8.6 3.5 4.4 10.1 7.3 4.3 7.9 7.5 4.1 5.4 6.3 3.7 4.7 2.5 5.2 2.3 0.3 7.1 9.6 9.2 7.2 6.6 9.6 15.6 8.7 2.7 3.0 4.9 20.4 10.1 13.7 6.7 7.6 8.1 5.1 7.4 5.9 5.5 4.6 5.4 24.5 27.0 4.4 22.4 14.5 7.2 9.1 7.9 13.2 6.4 11.7 12.0 4.4 20.7 8.5 14.1 11.2 5.4 12.9 5.6 7.9 3.3 7.0 9.3 5.6 5.8 6.8 4.7 8.9 6.7 14.1 15.8 7.9 7.6 7.5 6.3 5.8 14.5 5.0 10.7 7.3 4.7 2.5 0.7 1.8 1.0 1.3 2.2 2.3 1.1 0.4 6.3 1.8 1.9 3.0 5.2 1.2 3.7 0.6 0.3 NPIPB5 ENSG00000243716 "Nuclear pore complex interacting protein family member B5" A8MRT5 16 22479121-22536521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm Nucleoplasm "HPA053611: " "unprognostic (7.52e-4)" "unprognostic (2.08e-1)" "unprognostic (2.32e-2)" "unprognostic (9.43e-3)" "unprognostic (3.96e-1)" "unprognostic (2.64e-3)" "unprognostic (2.40e-3)" "unprognostic (4.20e-2)" "unprognostic (1.65e-1)" "unprognostic (4.19e-2)" "unprognostic (1.09e-1)" "unprognostic (3.87e-2)" "unprognostic (1.90e-10)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (3.86e-2)" "unprognostic (3.76e-5)" 10.8 7.0 13.4 34.7 12.0 30.6 10.4 18.3 13.4 9.6 10.8 9.6 12.5 7.7 8.6 33.3 7.2 8.4 6.6 8.4 24.1 6.1 8.7 6.1 13.6 19.3 17.5 16.7 9.9 10.1 6.4 8.7 7.2 13.7 10.5 12.1 14.6 12.2 22.9 17.8 54.2 17.1 6.8 9.7 16.3 8.9 10.6 11.8 7.0 14.4 6.8 14.2 8.0 10.0 11.7 7.0 8.3 3.5 4.4 5.9 1.3 10.8 9.5 6.0 7.7 10.4 9.7 14.4 6.7 2.3 4.2 5.3 13.4 18.3 15.0 12.4 8.8 9.7 14.1 9.5 7.5 18.5 5.1 5.8 25.0 25.8 10.0 31.3 9.7 11.8 7.3 10.2 18.8 7.4 15.9 24.3 5.1 18.5 13.8 42.0 16.9 4.1 15.2 4.4 17.9 7.6 6.3 6.7 5.7 8.2 11.6 5.6 6.8 10.8 25.0 13.4 6.1 11.1 11.2 13.5 6.3 19.5 5.6 22.8 6.0 6.7 3.5 2.7 5.5 1.7 2.3 8.6 5.2 3.7 2.0 11.7 5.9 4.9 8.3 4.4 3.2 7.0 2.4 1.3 13.4 12.0 18.3 13.4 24.1 6.1 17.5 16.7 13.7 11.8 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 26.8" "Cell line enhanced" "Detected in many" "A549: 5.9;BEWO: 5.5;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 5.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.1;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "HPA011188, HPA053611" Approved Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 0.2 0.0 0.9 0.3 1.4 0.5 0.6 1.8 0.9 0.4 0.5 0.3 0.7 1.0 0.1 0.9 0.1 0.1 1.1 0.7 0.1 0.1 0.2 0.4 0.7 1.2 0.2 0.4 0.9 0.2 0.7 0.6 0.2 0.5 0.6 1.8 0.3 0.4 0.9 0.6 0.6 26.8 0.6 0.2 0.2 0.3 3.1 0.1 0.1 0.0 0.1 0.6 0.5 0.2 5.9 2.8 0.6 1.4 0.3 5.5 0.3 0.5 0.1 0.5 0.2 2.4 1.9 0.5 0.2 0.7 0.3 0.5 0.3 1.3 0.5 1.4 1.1 0.0 0.0 1.7 0.4 0.9 5.8 0.4 1.3 0.1 0.2 4.7 0.0 1.4 0.5 5.8 1.6 0.2 3.1 2.5 5.9 0.1 0.1 0.7 1.2 0.2 0.3 0.6 1.2 0.4 0.5 0.7 2.3 0.5 0.4 2.2 2.2 0.7 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.5 0.0 1.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 14.9" "Cell line enhanced" "Detected in some" "BEWO: 6.1;hTCEpi: 2.4;U-266/70: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 0.0 0.0 0.5 0.2 0.9 0.1 0.1 2.3 0.5 0.1 0.3 0.3 0.3 0.3 0.0 0.2 0.1 0.1 0.5 0.8 0.0 0.0 0.2 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.8 0.2 0.1 0.2 0.1 0.1 14.9 0.4 0.1 0.1 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 6.1 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.4 0.4 0.2 0.0 0.0 0.1 0.0 0.9 0.1 1.0 0.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.1 0.0 1.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 14.4" "Cell line enriched" "Detected in single" 29 "hTCEpi: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.4 0.7 0.0 0.6 0.3 0.5 0.5 1.6 0.4 0.3 0.9 2.2 0.6 0.7 0.5 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.6 0.3 0.1 1.1 1.1 0.1 1.3 0.2 1.1 0.4 1.3 0.4 0.9 0.7 2.2 0.2 0.1 0.6 0.7 14.4 1.0 0.4 0.5 0.6 0.6 0.3 0.1 0.1 0.5 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.6 0.2 21.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 13.6" "Cell line enhanced" "Detected in many" "hTCEpi: 7.9;U-266/70: 6.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "HPA011188, HPA053611" Approved Approved Nucleoplasm Nucleoplasm "HPA011188: , HPA053611: " "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 0.6 0.3 1.7 0.9 1.8 1.6 0.4 2.7 1.4 0.4 1.0 0.0 1.1 2.4 0.4 1.5 0.6 0.2 2.2 1.3 0.4 0.4 0.4 1.5 1.7 1.4 0.2 0.5 1.4 0.4 1.2 0.8 0.9 0.9 1.1 2.8 0.8 0.8 2.2 1.1 0.5 13.6 1.7 1.0 0.3 0.7 3.1 0.1 0.5 0.2 1.8 0.7 0.3 0.4 3.9 1.1 0.6 0.5 1.3 3.2 0.0 0.1 0.0 0.0 0.4 2.1 1.5 1.1 0.0 0.4 0.7 0.2 0.1 0.4 1.9 0.7 0.0 0.8 0.1 2.5 2.7 0.1 7.9 0.6 1.5 0.0 0.4 2.4 0.2 2.9 0.8 3.3 1.6 0.9 3.3 0.0 1.5 0.0 0.3 0.1 0.0 0.2 0.4 0.2 2.2 1.1 0.0 0.0 2.8 1.9 0.6 6.6 2.8 2.0 0.1 0.9 0.5 0.0 0.2 0.0 0.7 0.0 0.2 3.1 0.4 0.1 0.1 1.2 0.3 0.1 0.5 1.8 0.2 0.0 0.3 0.3 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2" "Cell line enhanced" "Detected in some" "HaCaT: 13.1;HEL: 10.6;Hep G2: 23.4;THP-1: 8.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 4.1;T-cells: 2.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA041070: " "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favourable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favourable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.8 15.6 14.4 0.5 11.4 1.3 2.3 20.4 27.6 1.9 1.4 0.8 0.3 2.4 4.9 1.3 1.4 2.8 2.2 1.5 13.0 13.8 2.9 1.3 2.0 1.0 14.9 15.7 0.8 7.4 40.2 7.8 0.9 7.2 4.7 1.4 3.7 3.1 1.8 0.8 2.0 1.4 4.0 3.0 7.5 2.0 3.1 2.4 0.1 23.2 0.0 0.8 1.4 0.8 0.4 0.0 4.1 0.0 0.0 2.2 0.1 2.8 0.4 0.1 0.2 0.7 0.0 1.2 0.3 0.4 1.8 3.7 1.2 2.7 0.0 0.9 0.0 13.1 0.3 0.0 1.1 0.1 0.3 10.6 0.7 23.4 2.4 1.4 1.0 0.4 1.8 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 2.8 0.5 0.3 0.2 1.0 0.6 4.4 0.0 2.8 0.2 0.0 0.0 3.5 0.5 8.3 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.9 0.0 2.2 0.0 0.9 2.1 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.1 14.4 11.4 20.4 27.6 13.0 13.8 14.9 15.7 7.2 2.4 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell line enhanced" "Detected in some" "BEWO: 14.9;HeLa: 16.8;Hep G2: 13.5;MCF7: 12.0;RPTEC TERT1: 19.6;T-47d: 26.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: " "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favourable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 14.9 0.1 0.0 0.0 0.0 7.4 9.7 0.1 0.4 0.1 0.9 3.7 0.0 0.0 0.0 3.8 0.3 16.8 13.5 0.0 0.0 0.1 1.6 1.3 0.0 0.0 0.0 0.0 0.2 0.0 12.0 0.2 0.7 0.1 6.0 0.0 0.0 0.1 19.6 0.8 0.8 0.3 0.9 7.2 0.0 26.3 0.6 0.0 0.3 0.2 0.2 0.5 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell line enriched" "Detected in some" 6 "ASC diff: 59.1" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in many" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 59.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.8 0.0 7.1 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favourable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 5.9 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.4 0.5 0.4 0.8 0.1 1.2 0.2 1.0 0.0 0.1 4.4 0.6 0.0 0.1 1.9 0.1 3.4 0.0 0.1 3.5 0.1 0.1 4.4 0.0 0.2 3.5 1.0 0.7 0.0 6.9 0.9 7.9 14.8 0.9 11.0 0.0 0.3 4.7 1.1 0.2 6.8 4.2 0.0 0.3 1.0 0.0 0.0 42.5 8.6 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 NPY1R NPYR ENSG00000164128 "Neuropeptide Y receptor Y1" P25929 4 163323961-163344832 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.2" "Cell line enriched" "Detected in some" 18 "HEL: 50.2" "Cancer enriched" "Detected in many" 13 "breast cancer: 65.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029903 Approved Nucleoplasm,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoplasm "HPA029903: AB_10601276" "prognostic favourable (7.68e-5)" "unprognostic (9.14e-3)" "unprognostic (1.55e-1)" "unprognostic (5.09e-2)" "unprognostic (2.60e-1)" "unprognostic (9.29e-2)" "unprognostic (5.28e-3)" "unprognostic (2.26e-1)" "unprognostic (4.14e-2)" "unprognostic (2.50e-1)" "unprognostic (1.89e-2)" "unprognostic (5.92e-2)" "unprognostic (7.39e-2)" "unprognostic (1.92e-3)" "unprognostic (5.48e-2)" "unprognostic (1.74e-1)" "unprognostic (2.21e-1)" 18.0 15.9 5.2 1.5 17.1 0.2 17.5 0.9 11.4 6.2 3.1 0.7 3.9 0.7 5.0 5.4 2.3 4.3 2.4 2.6 7.1 4.2 16.6 8.3 1.2 7.2 1.5 5.8 1.8 14.5 1.1 3.9 2.7 3.5 1.9 2.4 2.0 11.0 4.5 1.5 5.0 0.9 3.1 3.7 55.2 1.2 2.7 6.0 0.0 4.4 1.4 0.6 3.4 3.3 0.5 0.3 1.2 0.4 0.3 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.9 0.7 0.4 1.2 0.5 0.1 0.6 0.4 0.7 0.9 0.0 0.5 0.7 1.2 1.1 0.3 0.2 0.3 0.3 0.0 5.2 17.1 0.9 11.4 7.1 4.2 1.5 5.8 3.5 6.0 NQO2 "DHQV, DIA6, NMOR2, QR2" ENSG00000124588 "N-ribosyldihydronicotinamide:quinone reductase 2" P16083 6 2987987-3028869 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.1" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021283, HPA021332" Enhanced Supported Nucleoplasm,Cytosol 6500000 Cytosol Nucleoplasm "HPA021283: AB_1854600, HPA021332: AB_1854601" "unprognostic (7.11e-3)" "unprognostic (1.43e-3)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.00e-2)" "unprognostic (3.58e-1)" "prognostic unfavourable (8.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (4.90e-2)" "unprognostic (6.59e-2)" "unprognostic (3.60e-2)" "unprognostic (8.28e-2)" "unprognostic (2.03e-1)" "unprognostic (3.32e-2)" "unprognostic (3.96e-1)" "unprognostic (2.02e-1)" 24.7 45.6 18.2 11.0 17.6 27.2 21.9 44.3 28.1 12.9 11.5 8.9 8.8 15.6 10.4 15.4 12.1 11.2 12.8 38.2 16.0 13.3 82.9 47.0 11.7 17.5 17.0 23.5 13.5 18.4 12.1 9.3 12.1 24.5 12.7 9.0 18.0 24.5 13.5 41.3 20.2 15.5 10.7 11.8 15.3 12.8 7.7 12.5 7.0 11.9 13.9 7.9 10.4 11.0 3.2 16.6 62.1 25.2 7.3 9.3 13.1 12.6 21.4 13.0 28.7 23.1 13.7 14.0 12.3 15.8 11.3 12.8 22.5 4.8 11.1 44.9 21.1 9.7 13.4 8.5 8.9 25.8 11.4 6.8 26.3 22.5 18.8 6.8 21.8 8.4 10.2 13.8 12.8 11.0 38.9 6.6 9.4 28.1 7.8 12.7 17.7 17.8 14.6 15.6 32.4 17.1 6.8 2.8 5.1 18.6 8.0 39.0 10.9 4.7 19.0 10.7 4.2 14.3 5.3 14.5 32.8 3.4 12.6 20.8 21.1 5.6 25.2 13.5 9.2 15.7 6.6 3.2 8.3 8.3 16.6 2.1 5.0 5.7 62.1 7.3 13.9 1.7 9.3 13.1 18.2 17.6 44.3 28.1 16.0 13.3 17.0 23.5 24.5 12.5 NR1D2 "BD73, EAR-1r, Hs.37288, HZF2, RVR" ENSG00000174738 "Nuclear receptor subfamily 1 group D member 2" Q14995 3 23945260-23980618 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053868, HPA054798" Approved Approved Nucleoplasm Nucleoplasm "HPA053868: , HPA054798: AB_2616453" "unprognostic (8.64e-2)" "unprognostic (9.96e-3)" "unprognostic (2.27e-1)" "unprognostic (2.46e-1)" "unprognostic (8.67e-2)" "unprognostic (2.09e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (2.60e-1)" "unprognostic (6.79e-3)" "unprognostic (2.21e-1)" "unprognostic (5.73e-2)" "prognostic favourable (4.47e-7)" "unprognostic (2.36e-3)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 15.2 12.5 15.2 7.9 17.1 9.5 15.9 40.9 31.9 21.1 13.3 14.0 20.9 10.0 19.0 11.0 12.2 13.3 11.0 22.5 15.0 13.4 16.8 22.1 10.6 9.6 14.4 16.1 24.3 12.7 41.6 15.8 10.0 16.1 15.1 9.0 16.3 22.2 23.1 35.4 14.2 10.4 15.6 14.6 13.1 10.9 5.6 15.1 5.5 40.7 23.2 10.5 13.0 14.3 2.4 0.9 0.2 2.5 1.1 6.1 1.0 9.7 2.2 5.2 4.9 5.5 5.9 3.2 14.6 19.2 8.1 9.1 1.6 9.7 7.0 4.9 20.4 6.6 6.5 9.5 17.0 2.5 7.6 1.1 5.2 1.9 11.5 3.7 1.0 7.8 10.1 9.9 25.5 5.5 2.5 25.5 6.4 5.6 2.0 1.2 5.6 11.2 1.8 8.4 4.7 4.5 13.5 5.4 12.0 10.6 6.1 12.6 5.4 3.2 10.9 21.3 21.7 13.7 16.6 12.5 16.8 3.3 12.1 5.6 12.3 0.0 0.8 0.1 3.3 2.5 6.1 2.4 3.7 3.1 0.9 1.9 2.6 2.6 0.2 1.1 1.4 0.9 2.2 1.0 15.2 17.1 40.9 31.9 15.0 13.4 14.4 16.1 16.1 15.1 NR1H4 "FXR, HRR-1, HRR1, RIP14" ENSG00000012504 "Nuclear receptor subfamily 1 group H member 4" Q96RI1 12 100473708-100564413 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 109.4" "Group enriched" "Detected in some" 32 "Hep G2: 17.9;HHSteC: 10.8;RPTEC TERT1: 29.0" "Group enriched" "Detected in some" 11 "liver cancer: 18.7;renal cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047699 Approved Nucleoplasm Nucleoplasm "HPA047699: AB_10965320" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (6.68e-2)" "unprognostic (2.49e-1)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (2.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (3.77e-3)" 0.1 11.3 0.1 1.4 0.4 0.0 0.2 0.1 0.2 0.2 5.8 0.4 0.1 11.3 0.1 0.4 0.1 0.1 7.0 0.1 0.1 0.0 25.0 109.4 0.6 2.4 0.1 0.1 7.7 2.7 0.0 2.9 0.2 0.3 0.5 0.4 0.6 0.1 0.1 0.1 0.0 19.5 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 NR1I3 "CAR, CAR1, MB67" ENSG00000143257 "Nuclear receptor subfamily 1 group I member 3" Q14994 1 161229666-161238302 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 63.1" "Cell line enhanced" "Detected in many" "CACO-2: 9.2" "Cancer enriched" "Detected in single" 67 "liver cancer: 17.6" "Region enriched" "Detected in single" 6 "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051365 Approved Nucleoplasm Nucleoplasm "HPA051365: AB_2616454" "unprognostic (2.59e-3)" "unprognostic (1.06e-2)" "unprognostic (9.33e-2)" "unprognostic (6.92e-4)" "unprognostic (2.55e-1)" "unprognostic (1.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.85e-1)" "unprognostic (6.23e-2)" "unprognostic (5.63e-3)" "unprognostic (2.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.44e-2)" "unprognostic (5.48e-3)" "unprognostic (2.62e-2)" 0.1 0.0 0.2 0.1 1.9 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 3.5 63.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.3 2.3 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.7 0.3 0.0 0.6 0.3 0.3 0.9 1.1 0.6 0.0 0.0 0.9 0.3 0.0 0.0 0.0 9.2 0.3 1.0 0.6 0.0 0.6 0.0 0.0 0.0 1.0 0.9 0.0 0.1 2.2 0.0 1.7 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.8 0.3 0.6 1.7 1.2 0.9 0.8 0.5 0.0 1.8 2.2 1.4 0.3 2.9 0.4 2.0 1.1 2.2 0.6 0.7 1.4 0.2 1.4 2.1 1.2 0.5 2.8 0.5 0.7 0.2 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.9 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 NR2F1 "COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1" ENSG00000175745 "Nuclear receptor subfamily 2 group F member 1" P10589 5 93583224-93594615 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 57.8;AN3-CA: 22.9;HHSteC: 44.5;PC-3: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019281, HPA058974" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB019281: , HPA058974: " "unprognostic (8.07e-2)" "unprognostic (1.06e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-1)" "unprognostic (4.75e-1)" "unprognostic (7.68e-3)" "unprognostic (3.18e-3)" "unprognostic (3.07e-2)" "unprognostic (2.21e-1)" "unprognostic (2.71e-3)" "unprognostic (5.24e-3)" "unprognostic (2.37e-1)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.28e-2)" "prognostic unfavourable (1.47e-4)" 15.8 22.9 22.5 5.0 13.7 1.2 9.1 27.4 25.1 31.7 4.6 12.9 10.8 3.3 20.6 24.1 9.4 32.3 30.7 7.2 20.9 13.7 16.4 10.6 18.0 12.7 13.4 23.0 40.4 4.4 1.8 10.3 46.0 14.6 20.5 3.8 44.4 7.2 38.9 1.2 1.6 4.4 14.2 26.7 6.7 12.9 5.9 11.4 0.0 7.5 4.8 4.2 20.9 18.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 4.7 2.3 57.8 22.9 12.3 3.8 2.7 2.8 1.1 1.7 1.8 0.3 0.8 0.0 0.1 1.1 1.2 1.4 0.0 0.7 5.8 11.1 2.2 14.0 3.5 44.5 0.4 0.2 17.7 0.0 0.8 0.3 6.4 0.0 0.0 5.2 0.0 0.0 0.6 0.0 47.8 0.6 0.4 0.0 0.3 0.2 5.9 12.1 1.2 0.0 0.1 0.4 0.9 6.4 9.8 0.4 5.1 7.0 0.0 0.0 0.0 16.1 0.2 4.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 22.5 13.7 27.4 19.8 20.9 13.7 13.4 23.0 14.6 11.4 NR2F2 "ARP1, COUP-TFII, COUPTFB, NF-E3, SVP40, TFCOUP2" ENSG00000185551 "Nuclear receptor subfamily 2 group F member 2" P24468 15 96325938-96340263 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058974 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058974: " "unprognostic (9.28e-2)" "unprognostic (2.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.42e-2)" "unprognostic (8.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.89e-1)" "unprognostic (9.19e-2)" "unprognostic (5.14e-2)" "unprognostic (5.96e-2)" "unprognostic (1.72e-2)" "unprognostic (7.47e-2)" "unprognostic (1.28e-2)" 30.8 15.0 19.6 13.8 5.3 0.2 81.2 3.7 6.2 85.7 21.9 2.9 22.3 7.0 70.0 32.6 27.7 32.4 50.8 30.1 12.5 8.4 39.8 15.0 25.0 35.4 7.8 3.4 105.1 7.3 12.3 9.6 24.0 7.1 28.6 9.0 30.5 7.7 43.5 18.4 8.3 10.8 27.2 9.8 63.4 26.9 32.5 4.8 1.1 18.5 16.2 7.0 32.6 34.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 31.1 8.0 26.5 16.4 53.8 18.6 8.8 22.6 17.4 23.5 20.2 27.7 31.9 0.0 18.5 11.3 18.7 4.6 16.2 29.7 0.1 18.1 10.1 10.4 5.0 15.0 7.7 3.8 13.2 5.6 19.5 4.2 43.2 26.8 0.0 14.8 21.5 0.0 5.5 0.2 11.0 0.0 6.5 0.0 51.4 34.1 3.3 0.0 2.5 0.7 3.4 12.8 0.5 44.4 25.6 8.4 5.9 7.9 0.0 0.0 0.0 14.3 3.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 5.3 3.7 6.2 12.5 8.4 7.8 3.4 7.1 4.8 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137300482-137302251 "Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 41.7" "Cell line enhanced" "Detected in many" "HaCaT: 23.3;HEK 293: 11.7;NTERA-2: 17.1;T-47d: 11.9;TIME: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.9 1.6 6.5 8.4 7.8 1.7 13.8 3.9 11.7 5.6 41.7 6.1 1.1 17.1 5.2 1.9 17.4 3.2 26.0 7.1 5.0 6.5 3.2 2.9 7.0 1.8 6.0 3.0 5.6 14.2 3.1 7.1 8.9 7.4 11.8 22.8 5.6 1.9 2.8 4.4 19.7 15.7 4.5 3.2 7.7 8.7 6.0 3.4 2.3 4.2 14.0 14.4 7.6 10.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.5 3.5 4.2 0.0 0.0 1.6 0.1 0.1 0.0 0.0 2.7 1.4 0.0 6.4 0.0 23.3 6.4 0.2 0.1 0.2 11.7 0.7 1.0 2.6 0.4 0.9 2.3 0.0 1.1 0.0 0.2 5.3 6.9 0.1 0.0 7.7 0.1 2.7 17.1 3.5 4.6 0.7 8.4 0.6 0.2 2.4 4.4 0.7 1.2 0.0 11.9 1.9 17.0 0.0 0.0 0.1 0.9 0.1 0.1 1.4 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 6.5 7.8 3.9 6.8 5.0 6.5 6.0 3.0 7.4 3.4 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 100.9" "Lineage enriched" "Detected in all" 8 "granulocytes: 100.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA021670: , HPA059477: " "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavourable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 15.1 10.0 10.7 16.1 10.2 22.1 21.6 10.9 13.9 12.3 12.3 7.0 9.0 12.4 13.9 9.9 13.9 10.0 13.2 13.6 10.9 9.5 10.6 50.2 19.1 29.4 13.1 8.9 9.2 10.3 6.9 11.5 21.3 11.7 8.7 12.8 6.0 14.8 11.0 46.2 14.6 15.0 10.8 11.7 22.9 10.5 10.0 8.9 16.4 14.2 13.9 14.6 14.6 13.5 7.0 10.0 100.9 13.3 4.3 5.7 7.2 8.7 8.0 8.0 7.3 19.2 29.6 8.0 12.6 21.6 10.1 14.4 16.9 9.4 11.4 6.2 14.1 6.9 7.7 10.6 13.8 10.2 7.8 8.4 4.2 13.5 24.6 11.1 9.9 27.4 22.9 16.4 40.4 10.3 8.5 13.3 12.8 6.5 9.4 19.8 9.3 33.3 9.2 7.2 6.6 11.6 5.0 4.6 7.9 7.5 14.6 21.9 9.1 11.1 10.5 7.0 10.4 10.9 13.3 16.8 12.8 13.8 19.6 17.9 5.6 13.8 11.8 22.8 4.5 13.3 4.7 7.0 4.6 4.9 10.0 5.9 5.7 5.3 100.9 4.3 12.5 4.9 5.1 7.2 10.7 10.2 10.9 13.9 10.9 9.5 13.1 8.9 11.7 8.9 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell line enhanced" "Detected in some" "A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.0 25.2 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.5 0.0 0.0 47.1 0.2 0.1 0.5 0.4 0.2 0.0 3.3 0.0 0.2 0.2 0.0 0.2 50.3 4.2 0.0 0.0 0.1 16.2 0.0 0.2 0.4 9.7 0.1 0.0 3.4 0.0 0.0 7.4 8.5 5.8 0.0 4.9 31.0 0.3 0.0 0.5 0.0 0.0 17.2 1.1 0.2 0.0 4.2 0.0 0.1 0.2 0.1 0.0 14.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 NRDC "hNRD1, hNRD2, NRD1" ENSG00000078618 "Nardilysin convertase" O43847 1 51789191-51878937 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053661 Approved Nucleoplasm Nucleoplasm "HPA053661: " "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (2.14e-2)" "unprognostic (5.62e-2)" "unprognostic (2.61e-1)" "unprognostic (3.25e-2)" "prognostic unfavourable (5.49e-6)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (1.67e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (2.12e-9)" "unprognostic (2.75e-1)" "unprognostic (2.35e-2)" "unprognostic (9.54e-2)" "unprognostic (5.53e-3)" 16.4 15.9 13.4 15.8 17.5 14.5 11.7 14.7 16.9 12.2 13.7 11.0 9.9 11.2 11.8 12.1 14.4 10.9 10.9 25.7 13.1 13.3 12.4 28.5 12.0 13.6 16.2 10.6 11.7 15.9 19.3 21.4 14.2 15.7 13.8 12.1 9.8 11.9 11.3 96.4 19.1 10.3 13.3 14.0 13.6 11.9 32.3 14.5 19.4 11.7 21.5 15.1 13.0 16.0 13.8 18.5 36.3 19.1 15.8 15.1 16.2 47.6 26.8 26.9 38.7 28.3 43.9 31.4 48.1 41.6 35.0 37.2 18.8 18.8 31.4 25.8 36.2 27.8 39.6 37.3 44.4 37.2 19.5 37.5 36.5 16.3 29.1 32.7 28.6 34.9 28.6 51.1 47.5 36.4 49.4 21.1 43.8 17.4 29.6 11.3 47.8 28.9 29.0 32.2 34.6 25.9 27.7 25.9 19.5 43.9 35.3 26.0 23.6 39.9 30.2 30.8 28.6 33.5 40.9 31.5 47.6 29.4 36.4 41.3 35.3 19.3 18.1 26.0 13.7 19.1 13.7 13.8 12.7 15.1 18.5 9.3 12.5 13.4 36.3 15.8 14.5 15.0 14.4 16.2 13.4 17.5 14.7 16.9 13.1 13.3 16.2 10.6 15.7 14.5 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell line enhanced" "Detected in many" "A549: 38.9;BJ: 26.6;fHDF/TERT166: 29.8;HBF TERT88: 26.2;hTEC/SVTERT24-B: 27.9;hTERT-HME1: 29.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.9 0.7 0.0 0.3 0.8 0.0 26.6 18.9 22.1 16.9 0.0 0.8 0.0 4.9 29.8 21.0 0.2 10.6 26.2 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.9 29.3 12.7 0.0 0.1 7.9 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 16.3 1.1 1.1 1.3 2.0 0.0 0.0 0.0 0.0 9.2 15.4 4.7 24.5 14.8 0.0 0.0 0.2 7.9 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavourable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favourable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.7 2.1 0.0 0.0 0.0 4.4 2.2 2.3 0.6 0.0 1.7 0.0 0.0 0.0 1.6 2.6 3.7 4.6 0.5 0.0 4.5 2.8 0.1 0.0 0.0 0.0 0.0 2.1 5.4 0.0 1.8 2.8 2.4 3.0 0.8 1.7 3.1 1.4 0.0 3.0 2.3 3.4 1.6 2.4 0.5 1.7 0.8 2.3 1.2 1.5 1.8 3.1 0.9 0.2 3.5 3.0 2.2 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 7.3 0.0 19.9 0.4 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favourable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.7 22.9 13.8 13.0 18.3 20.5 5.4 12.5 24.2 22.7 22.9 12.6 0.4 0.0 4.4 23.1 8.3 11.1 1.9 14.5 0.1 11.2 6.8 10.9 23.8 18.5 0.2 1.1 23.2 1.5 16.2 2.7 15.6 13.4 12.2 19.9 3.3 0.3 5.8 10.6 11.8 10.7 7.7 0.9 22.7 0.1 28.2 20.3 14.9 4.4 21.4 18.3 7.0 10.4 24.4 12.9 0.9 15.2 2.2 0.4 5.1 3.2 0.2 12.8 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 NSUN2 "FLJ20303, Misu, MRT5, TRM4" ENSG00000037474 "NOP2/Sun RNA methyltransferase family member 2" Q08J23 5 6599239-6633291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037896 Supported Approved Nucleoplasm Nucleoplasm "HPA037896: AB_10670532" "unprognostic (3.99e-2)" "unprognostic (5.73e-2)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (8.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.44e-3)" "unprognostic (5.12e-2)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (2.48e-2)" "prognostic unfavourable (5.69e-5)" "unprognostic (1.98e-1)" "unprognostic (1.47e-1)" "unprognostic (4.30e-3)" "unprognostic (1.70e-2)" 19.0 19.1 11.3 20.4 17.4 16.7 28.1 13.4 16.0 17.4 17.9 20.2 18.2 15.4 21.5 20.6 27.0 19.3 17.1 20.1 12.7 9.7 15.0 34.9 15.0 22.5 13.6 16.5 17.2 18.7 19.5 22.3 18.2 16.1 15.5 21.2 14.3 20.0 15.8 42.3 22.9 20.9 19.1 15.9 23.7 19.9 15.8 13.2 26.7 14.3 17.1 29.5 19.2 17.1 18.1 16.7 15.6 17.3 17.6 22.7 12.7 26.9 23.4 13.8 12.1 8.8 9.8 32.5 21.1 12.8 22.5 19.6 30.4 20.2 46.5 21.6 16.9 20.7 28.5 24.6 30.6 31.7 23.0 27.7 55.5 17.6 12.6 47.7 22.4 11.2 18.2 25.5 22.3 15.9 35.7 17.1 20.8 18.8 26.0 20.7 22.8 30.6 34.0 14.5 14.3 15.8 30.0 13.2 18.6 52.2 26.5 20.3 23.1 21.3 18.5 18.0 23.7 18.6 31.4 14.1 26.5 44.6 14.4 38.0 20.6 9.7 14.6 15.6 17.5 17.3 22.7 18.1 18.4 20.7 16.7 16.5 20.4 20.6 2.9 17.6 15.2 16.5 13.0 12.7 11.3 17.4 13.4 16.0 12.7 9.7 13.6 16.5 16.1 13.2 NSUN3 FLJ22609 ENSG00000178694 "NOP2/Sun RNA methyltransferase family member 3" Q9H649 3 94062916-94128545 "Disease related genes, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036181, HPA057979" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA036181: AB_10602715, HPA057979: " "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.13e-1)" "unprognostic (7.35e-4)" "unprognostic (1.44e-1)" "unprognostic (9.50e-2)" "unprognostic (1.22e-1)" "unprognostic (8.63e-3)" "unprognostic (6.94e-3)" "unprognostic (6.47e-2)" "unprognostic (2.67e-1)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.33e-2)" 9.1 11.3 8.7 17.4 14.1 10.9 10.3 9.3 11.6 11.5 13.3 10.4 8.7 10.7 10.9 13.7 9.1 10.4 9.0 9.2 9.0 9.4 10.3 15.0 11.7 15.4 8.8 10.6 12.5 11.7 11.8 19.8 8.7 13.0 11.6 14.9 8.6 10.3 8.2 4.8 9.4 18.2 10.2 9.7 14.1 11.4 11.2 10.6 19.5 11.8 7.6 10.7 10.3 9.3 5.5 4.4 10.4 7.9 8.3 6.5 3.5 4.3 6.0 6.4 4.9 3.8 6.0 2.9 6.9 5.5 8.4 8.8 3.6 4.9 6.7 8.7 4.6 6.2 7.4 5.1 11.7 11.6 5.4 10.9 7.5 4.8 5.1 10.7 9.2 5.7 6.1 6.1 7.0 7.1 4.6 10.3 7.4 4.4 9.9 5.1 5.3 6.7 7.8 11.1 7.2 6.3 4.3 11.7 8.3 7.1 4.6 7.0 8.1 6.8 6.3 5.9 6.6 3.1 7.6 8.2 9.5 12.9 7.4 9.1 8.7 10.4 4.9 5.8 4.1 4.7 6.5 5.5 4.6 5.2 4.4 4.3 5.2 6.0 8.5 8.3 7.9 3.9 5.3 3.5 8.7 14.1 9.3 11.6 9.0 9.4 8.8 10.6 13.0 10.6 NT5E "CALJA, CD73, eN, eNT, NT5" ENSG00000135318 "5'-nucleotidase ecto" P21589 6 85449584-85495791 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 108.8;TIME: 63.0;U-87 MG: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3" "Group enriched" "Detected in many" 47 "B-cells: 19.9;T-cells: 17.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017357 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 1600000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017357: AB_1846330" "unprognostic (1.92e-2)" "unprognostic (4.44e-3)" "unprognostic (1.54e-1)" "unprognostic (1.57e-3)" "unprognostic (9.33e-2)" "unprognostic (1.82e-3)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.32e-5)" "unprognostic (1.39e-1)" "unprognostic (3.11e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (3.49e-2)" "unprognostic (2.26e-1)" "unprognostic (2.78e-1)" 12.2 3.2 9.3 7.7 11.6 0.5 16.6 1.1 6.9 58.8 13.9 3.6 8.1 18.6 33.3 14.8 7.6 12.2 15.4 6.1 5.7 5.5 8.8 26.0 3.4 6.8 6.3 6.6 25.4 1.4 1.6 9.3 42.2 5.3 16.4 15.6 15.3 4.6 17.8 5.7 4.5 14.9 35.3 6.3 7.0 6.0 12.4 4.2 1.6 26.5 7.3 7.1 16.6 20.2 19.9 0.0 0.2 0.0 0.4 17.3 3.9 5.4 2.9 5.0 0.1 11.5 36.7 0.0 35.5 38.9 17.5 32.9 0.0 54.5 0.0 12.8 31.0 2.8 0.0 35.7 41.7 0.0 0.0 0.0 0.8 0.6 5.7 0.0 0.0 9.4 0.4 35.7 22.8 14.5 0.0 0.1 108.8 0.9 0.0 0.0 0.1 3.9 0.1 1.1 0.1 37.9 2.4 0.0 0.6 0.4 2.2 12.0 0.0 0.9 63.0 14.3 0.1 18.0 57.7 2.7 1.7 0.0 98.1 0.0 44.8 0.0 0.0 0.2 2.0 0.0 3.5 13.4 2.3 6.6 0.0 19.9 2.4 17.3 0.2 0.4 0.0 0.0 0.8 3.9 9.3 11.6 1.1 6.9 5.7 5.5 6.3 6.6 5.3 4.2 NTAN1 ENSG00000157045 "N-terminal asparagine amidase" Q96AB6 16 15037853-15056079 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051418 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA051418: " "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (6.69e-4)" "unprognostic (1.87e-2)" "unprognostic (9.16e-2)" "unprognostic (8.11e-3)" "unprognostic (2.79e-1)" "unprognostic (1.75e-1)" "unprognostic (5.05e-2)" "unprognostic (1.65e-1)" "unprognostic (9.30e-3)" "prognostic unfavourable (9.07e-4)" "unprognostic (4.35e-1)" "unprognostic (2.12e-2)" "unprognostic (1.10e-1)" 24.2 8.3 11.7 8.1 11.7 11.9 48.2 5.2 12.1 16.1 18.0 5.4 8.6 6.8 14.4 24.5 14.6 10.2 12.2 23.2 8.0 6.0 10.6 16.9 13.5 12.4 7.4 8.0 13.0 13.3 7.6 5.0 7.8 9.8 15.9 15.7 17.9 11.1 7.7 14.4 13.6 9.7 19.8 7.4 13.7 12.9 14.0 6.4 8.1 10.5 12.7 11.7 18.8 19.9 9.4 12.0 31.2 5.7 5.3 12.3 5.2 9.8 7.2 8.7 7.5 11.1 21.4 3.3 12.0 16.4 12.3 21.2 3.3 7.4 6.8 9.5 22.9 4.2 6.9 14.1 17.3 6.5 9.5 3.9 6.5 18.5 11.4 2.9 2.2 11.1 8.4 11.9 4.5 27.9 4.6 7.8 22.9 8.3 5.8 12.1 6.3 8.0 11.6 11.8 9.1 8.9 13.7 2.6 9.8 5.0 1.8 8.5 3.3 4.4 15.6 17.8 7.1 7.5 10.5 7.6 15.0 8.9 10.7 6.4 8.0 2.5 4.1 31.2 5.5 5.7 6.5 9.4 7.2 7.3 3.8 6.1 5.9 3.7 1.9 5.3 5.5 12.0 12.3 5.2 11.7 11.7 5.2 12.1 8.0 6.0 7.4 8.0 9.8 6.4 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302059-205321791 "Enzymes, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.4" "Cell line enhanced" "Detected in many" "BEWO: 24.3;CACO-2: 12.9;RPMI-8226: 18.7;RPTEC TERT1: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 42.4" "Group enriched" "Detected in all" 4 "B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008958 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favourable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.4 2.8 0.8 12.5 2.4 8.3 0.9 9.2 1.5 18.9 10.4 3.9 2.4 13.6 2.7 3.8 31.3 3.4 1.3 1.1 1.7 1.0 14.5 3.6 16.2 20.3 5.5 1.5 3.3 13.2 0.1 2.3 7.2 2.0 1.5 7.5 9.8 9.7 2.0 0.7 12.9 15.4 0.9 2.7 10.4 2.0 5.6 2.4 5.5 14.5 20.1 31.7 2.8 24.6 15.3 3.6 42.4 5.6 5.7 10.7 5.4 2.2 12.3 7.5 0.3 0.2 0.3 24.3 2.9 3.0 8.1 3.3 12.9 0.4 3.7 1.8 0.8 4.5 1.7 4.4 3.5 0.0 0.2 0.0 0.7 2.2 5.2 0.0 0.0 1.4 3.3 4.7 2.8 0.3 0.5 0.9 1.5 0.5 0.0 0.0 4.8 0.4 0.0 0.5 18.7 22.2 0.0 1.1 0.1 0.8 3.5 0.3 3.6 0.0 0.9 2.9 1.4 0.3 4.6 6.6 1.0 2.3 0.4 0.0 1.1 3.4 5.6 13.2 3.9 4.2 2.8 14.2 4.8 4.6 3.6 15.3 10.7 8.1 42.4 5.7 4.1 1.4 2.8 5.4 0.8 2.4 9.2 1.5 1.7 1.0 5.5 1.5 2.0 2.4 NUBP2 CFD1 ENSG00000095906 "Nucleotide binding protein 2" Q9Y5Y2 16 1782901-1789191 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041704 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041704: AB_10804006" "unprognostic (1.94e-1)" "unprognostic (5.73e-3)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.02e-2)" "unprognostic (8.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.42e-1)" "unprognostic (1.53e-1)" "unprognostic (8.64e-2)" "unprognostic (1.20e-1)" "prognostic favourable (9.63e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.83e-2)" 16.9 22.8 12.9 15.4 12.4 19.5 14.7 16.3 19.8 13.9 15.1 14.9 16.1 21.6 14.1 14.2 20.3 15.6 15.2 13.8 12.0 10.4 16.5 32.3 12.1 18.0 14.4 17.4 14.6 37.6 8.3 13.8 14.7 12.9 17.7 6.4 14.8 26.9 16.3 30.2 17.2 19.1 16.4 12.0 17.9 18.8 14.5 13.2 22.7 19.4 20.7 16.6 15.3 13.6 25.8 44.1 28.8 29.7 25.8 41.3 31.1 9.2 30.2 5.2 15.9 4.3 3.1 17.0 11.2 4.8 6.9 7.8 17.0 14.1 14.9 12.3 2.4 10.8 3.6 10.2 1.3 12.4 29.0 6.3 22.4 26.7 8.3 9.4 13.0 4.5 8.9 5.3 4.0 8.6 15.5 9.5 2.8 34.1 18.9 15.4 14.3 17.6 24.9 11.4 33.2 5.5 7.1 20.0 23.4 11.2 16.4 11.3 25.1 11.2 9.6 10.9 14.4 10.9 10.9 21.9 13.9 17.3 6.6 11.8 14.3 25.6 29.1 28.8 34.7 29.7 31.7 24.3 30.9 30.5 30.2 25.8 25.8 24.2 14.4 25.8 28.2 44.1 41.3 31.1 12.9 12.4 16.3 19.8 12.0 10.4 14.4 17.4 12.9 13.2 NUDCD3 "KIAA1068, NudCL" ENSG00000015676 "NudC domain containing 3" Q8IVD9 7 44379121-44490880 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019136, HPA019528, HPA019529" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA019136: AB_1852370, HPA019528: AB_1852372, HPA019529: AB_1852374" "unprognostic (3.72e-2)" "unprognostic (9.28e-3)" "unprognostic (2.33e-2)" "unprognostic (2.05e-3)" "unprognostic (2.18e-3)" "unprognostic (2.05e-2)" "unprognostic (4.73e-2)" "unprognostic (2.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "unprognostic (5.62e-2)" "prognostic favourable (9.16e-4)" "unprognostic (3.51e-2)" "unprognostic (1.58e-2)" "unprognostic (1.45e-1)" "unprognostic (6.50e-2)" 8.3 6.3 15.3 5.4 20.8 7.3 7.2 10.9 26.0 7.8 5.8 7.7 6.4 4.0 6.9 7.3 8.0 10.3 6.7 19.5 15.2 13.0 6.0 5.8 7.2 6.2 12.5 16.8 9.3 6.8 12.8 4.7 5.3 10.1 8.4 5.7 6.1 7.1 9.9 18.3 7.0 5.0 8.8 10.1 5.8 5.9 9.9 7.1 4.1 8.1 4.8 6.6 6.3 5.3 4.7 2.8 3.2 3.1 2.5 4.7 3.5 3.1 5.9 4.3 7.8 5.4 4.5 1.7 5.1 5.0 5.9 6.3 4.0 2.2 10.0 3.8 6.7 3.7 5.9 6.8 3.5 5.7 6.3 2.8 3.6 2.9 5.0 4.8 1.8 3.9 4.6 4.4 5.2 7.3 7.1 3.2 4.4 2.8 2.1 4.5 5.4 7.8 3.2 4.7 3.7 3.4 4.8 4.7 13.4 3.0 5.6 2.3 4.2 6.9 7.0 4.2 4.4 2.7 4.1 9.2 9.5 5.1 4.5 5.7 7.3 2.0 2.8 3.2 4.6 2.7 4.7 3.5 4.4 3.8 2.6 4.7 4.6 4.0 1.8 2.5 3.1 2.8 4.4 3.5 15.3 20.8 10.9 26.0 15.2 13.0 12.5 16.8 10.1 7.1 NUDT13 DKFZp586P2219 ENSG00000166321 "Nudix hydrolase 13" Q86X67 10 73110375-73131828 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040636 Approved Approved Nucleoplasm Nucleoplasm "HPA040636: AB_10960360" "unprognostic (3.75e-1)" "unprognostic (3.85e-1)" "unprognostic (1.07e-1)" "unprognostic (2.48e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.33e-1)" "unprognostic (2.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-1)" "unprognostic (9.40e-2)" "unprognostic (5.07e-4)" "unprognostic (1.91e-1)" "unprognostic (3.82e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (5.96e-2)" 4.3 7.4 3.7 9.9 8.9 5.0 6.3 3.5 5.1 3.4 8.1 7.2 9.5 7.0 6.5 13.8 3.8 4.5 7.0 7.0 5.9 3.0 7.1 12.8 5.1 5.3 7.3 4.5 4.4 7.8 7.4 4.1 3.6 5.8 5.2 4.7 3.7 5.0 8.8 8.6 7.2 5.8 5.2 11.8 5.8 6.0 5.6 7.2 2.4 4.6 2.8 4.8 6.8 3.7 6.2 1.9 2.5 3.4 4.9 3.7 1.1 5.0 3.6 5.9 7.4 3.7 3.2 1.3 4.5 4.0 2.3 2.6 9.5 10.6 2.5 2.2 2.7 5.9 0.6 4.2 2.4 1.9 10.3 6.9 5.9 5.2 0.3 3.8 2.8 2.3 4.6 3.0 1.7 1.8 5.8 3.9 2.3 2.3 2.2 5.4 2.2 11.6 5.0 1.0 0.2 3.3 2.3 2.6 3.8 2.4 6.1 2.0 3.4 2.5 3.4 2.1 8.1 0.8 1.7 2.9 3.3 3.3 5.7 7.0 1.9 0.1 2.6 2.5 1.8 2.5 2.1 3.0 1.5 1.6 1.9 6.2 2.3 2.4 1.0 4.9 3.4 0.6 3.7 1.1 3.7 8.9 3.5 5.1 5.9 3.0 7.3 4.5 5.8 7.2 NUDT5 "hYSAH1, YSA1H" ENSG00000165609 "Nudix hydrolase 5" Q9UKK9 10 12165325-12196144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019827 Approved Approved Nucleoplasm,Vesicles,Centrosome 660000 Vesicles "Nucleoplasm, Centrosome" "HPA019827: AB_1854704" "unprognostic (2.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (3.77e-3)" "unprognostic (4.91e-2)" "unprognostic (2.54e-2)" "unprognostic (4.60e-2)" "unprognostic (1.32e-1)" "unprognostic (6.39e-3)" "unprognostic (2.06e-1)" "unprognostic (9.97e-2)" "prognostic unfavourable (7.14e-12)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (3.68e-2)" 19.6 22.0 17.4 18.6 21.2 13.5 20.2 15.4 21.4 16.7 20.4 16.1 15.2 17.3 10.0 16.5 25.8 16.3 12.1 10.0 16.2 14.3 26.0 57.1 16.8 22.7 21.7 12.8 12.5 16.9 19.1 35.7 19.9 18.5 13.4 24.2 13.2 16.7 19.7 5.1 20.6 15.9 11.6 17.9 22.4 14.1 8.0 21.5 28.2 19.1 16.5 29.5 16.2 18.6 22.4 45.9 50.1 19.5 16.2 37.0 20.4 37.3 27.6 33.0 30.7 32.0 31.6 29.3 27.7 17.7 32.7 35.1 39.6 35.7 37.4 24.1 22.4 37.6 46.0 42.9 30.0 30.6 45.0 31.1 33.9 58.1 33.4 20.6 21.9 33.2 25.6 35.6 18.2 41.6 41.6 25.6 29.7 34.3 38.6 24.2 28.7 17.2 35.3 12.0 43.4 30.5 12.9 15.9 23.9 33.6 25.9 38.5 44.4 21.3 26.0 13.9 26.7 38.8 33.8 21.6 37.9 50.3 29.3 26.9 10.3 8.1 19.1 33.5 22.8 19.5 26.2 22.4 24.6 26.8 27.0 18.3 17.0 23.0 50.1 16.2 14.8 45.9 37.0 20.4 17.4 21.2 15.4 21.4 16.2 14.3 21.7 12.8 18.5 21.5 NUDT7 ENSG00000140876 "Nudix hydrolase 7" P0C024 16 77722492-77742260 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.1" "Cell line enhanced" "Detected in many" "ASC diff: 16.7;THP-1: 27.5;U-698: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042042 Supported Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA042042: AB_10806232" "unprognostic (1.92e-1)" "unprognostic (1.17e-2)" "unprognostic (6.64e-2)" "unprognostic (5.95e-2)" "unprognostic (1.45e-1)" "prognostic unfavourable (1.84e-4)" "unprognostic (2.48e-1)" "unprognostic (4.05e-2)" "unprognostic (2.11e-1)" "unprognostic (2.46e-2)" "unprognostic (4.74e-2)" "unprognostic (4.52e-1)" "prognostic favourable (5.36e-11)" "unprognostic (1.19e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (3.42e-2)" 8.7 19.0 5.4 4.8 8.3 1.4 6.2 4.2 8.6 4.6 8.4 5.7 5.9 7.1 6.2 12.4 8.6 7.1 5.7 24.8 4.8 7.3 14.8 45.1 5.0 6.8 6.3 6.2 5.2 8.5 9.1 4.7 4.2 7.8 6.4 8.3 11.6 5.9 5.3 5.0 6.0 9.4 7.1 7.2 5.5 5.4 6.7 3.5 6.1 19.7 6.5 5.9 6.3 6.0 13.6 7.9 2.5 11.0 2.3 20.6 6.0 1.1 3.9 3.5 2.0 16.7 4.2 3.3 1.0 5.2 1.6 2.0 1.1 4.9 5.7 3.8 3.8 3.9 2.7 4.2 0.9 1.8 3.6 0.0 0.2 5.2 1.8 3.9 0.8 7.2 5.4 0.8 3.1 2.7 4.1 2.5 0.6 10.5 2.0 9.1 3.7 0.9 4.3 0.4 1.7 7.9 0.0 2.9 2.9 3.6 1.5 3.0 10.6 27.5 2.1 1.8 0.2 0.8 0.2 0.0 0.0 22.1 7.0 4.9 0.0 2.5 8.5 1.0 9.1 11.0 10.1 8.8 10.8 10.8 6.8 13.6 14.3 9.9 1.4 2.3 10.6 7.9 20.6 6.0 5.4 8.3 4.2 8.6 4.8 7.3 6.3 6.2 7.8 3.5 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell line enhanced" "Detected in all" "K-562: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: " "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favourable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.7 9.6 8.2 4.9 6.6 6.4 8.6 6.0 6.2 7.8 6.3 7.8 4.9 10.9 4.8 8.2 15.4 11.0 7.8 7.6 7.9 5.4 6.8 13.7 15.2 5.8 10.6 7.3 7.0 7.2 10.0 8.1 8.0 71.4 6.3 8.0 12.5 13.9 16.0 8.9 8.5 4.8 10.3 10.9 9.0 6.2 7.0 7.2 10.0 9.2 5.2 12.1 26.4 6.8 13.8 7.8 9.0 9.6 5.5 10.7 10.5 6.7 6.4 8.3 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 NUP37 "FLJ22618, MGC5585" ENSG00000075188 "Nucleoporin 37" Q8NFH4 12 102073103-102120124 "Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056300, HPA073708" Supported Approved Nucleoplasm Nucleoplasm "HPA056300: AB_2683092, HPA073708: AB_2686629" "unprognostic (1.42e-3)" "unprognostic (5.39e-2)" "unprognostic (3.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (6.72e-4)" "prognostic unfavourable (7.70e-6)" "unprognostic (2.48e-3)" "unprognostic (2.37e-3)" "unprognostic (7.77e-2)" "unprognostic (2.90e-3)" "unprognostic (1.67e-2)" "unprognostic (7.47e-2)" "unprognostic (5.55e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-1)" 11.1 18.4 6.0 17.5 7.7 12.6 12.8 8.1 7.4 12.4 12.8 8.7 14.9 8.1 13.0 14.7 22.0 12.6 7.8 12.3 5.7 5.4 11.4 8.6 9.0 16.4 6.0 5.1 12.6 11.7 12.6 15.2 17.6 10.6 13.7 16.0 11.2 11.7 9.6 18.0 11.3 14.5 11.4 9.3 16.5 11.5 17.8 6.2 28.4 16.4 18.5 20.8 13.6 11.0 19.4 18.1 30.6 17.2 13.2 26.7 13.0 31.4 23.3 20.5 9.3 16.9 22.5 45.4 20.3 19.2 32.1 21.9 29.6 17.2 21.4 14.5 15.7 23.4 35.8 31.4 40.3 30.1 20.4 23.0 12.5 26.5 21.7 32.4 7.3 17.4 13.9 24.9 18.5 26.1 40.6 8.2 29.6 21.9 24.0 26.8 20.2 37.1 15.9 29.0 16.2 25.3 23.7 10.7 7.6 15.3 16.5 14.5 28.8 18.8 8.5 11.5 12.7 16.2 27.8 12.3 23.4 36.7 13.3 26.4 19.3 30.6 14.7 16.4 13.8 17.2 15.0 19.4 16.9 14.0 18.1 17.7 15.3 17.3 4.3 13.2 14.2 15.3 26.7 13.0 6.0 7.7 8.1 7.4 5.7 5.4 6.0 5.1 10.6 6.2 NUP54 ENSG00000138750 "Nucleoporin 54" Q7Z3B4 4 76114659-76148515 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035929, HPA058122" Approved Approved Nucleoplasm Nucleoplasm "HPA035929: AB_10671236, HPA058122: " "unprognostic (6.70e-2)" "unprognostic (3.51e-2)" "prognostic favourable (8.80e-4)" "unprognostic (3.02e-1)" "unprognostic (3.58e-2)" "unprognostic (4.24e-2)" "prognostic unfavourable (4.64e-4)" "unprognostic (1.51e-3)" "unprognostic (3.05e-2)" "unprognostic (1.62e-1)" "unprognostic (2.49e-3)" "unprognostic (3.36e-2)" "unprognostic (2.10e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (3.65e-3)" 23.7 14.5 13.5 18.2 15.2 28.4 25.7 26.0 17.2 23.1 20.0 14.6 17.9 15.3 22.9 18.2 21.4 22.5 15.1 17.0 12.2 10.8 16.4 20.3 17.8 22.8 20.5 13.1 25.3 19.3 13.3 16.8 22.8 14.9 19.8 19.7 12.2 20.0 24.1 17.8 21.2 18.4 24.7 14.7 23.6 19.2 19.6 20.0 36.1 19.8 18.1 22.1 24.1 21.8 10.0 11.4 7.7 10.0 21.6 16.5 7.5 16.8 6.6 21.4 15.4 18.3 17.5 18.9 17.1 24.7 25.4 26.1 15.7 24.2 25.6 14.4 17.0 11.4 23.0 19.1 31.8 16.8 13.4 15.5 8.4 14.9 17.3 29.9 18.7 16.0 13.8 20.1 21.3 21.7 26.4 16.1 18.3 14.7 31.4 14.0 34.3 6.0 24.7 33.8 9.8 15.0 16.2 13.0 10.8 15.8 18.8 13.7 8.0 18.4 14.5 20.4 18.2 24.3 20.8 10.5 3.8 24.4 14.6 17.6 17.9 6.5 7.5 7.7 12.2 9.0 16.5 9.0 12.9 11.7 11.4 10.0 13.8 13.0 3.5 21.6 10.0 8.4 12.5 7.5 13.5 15.2 26.0 17.2 12.2 10.8 20.5 13.1 14.9 20.0 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavourable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavourable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.1 25.7 15.8 29.1 18.5 19.8 16.1 28.3 21.7 18.2 17.1 21.0 13.4 20.0 24.1 13.7 21.5 22.1 20.9 16.9 14.3 15.1 16.8 27.5 16.2 29.0 15.2 14.2 26.6 18.6 14.0 21.3 24.1 17.4 19.8 17.7 16.2 18.8 20.2 27.1 18.8 20.2 23.3 14.2 26.0 16.4 70.9 17.6 45.5 16.8 17.3 29.6 18.9 19.4 10.7 21.1 6.2 22.3 13.7 16.9 12.5 31.5 30.1 22.3 18.9 7.0 8.0 20.8 23.9 16.4 25.2 25.2 20.2 18.6 35.5 13.1 15.2 18.8 27.1 16.6 24.5 51.4 28.9 28.5 15.1 18.7 8.4 26.1 28.5 8.2 11.5 16.7 13.9 18.5 34.8 34.8 17.2 15.2 47.3 20.0 21.1 26.7 42.7 26.0 30.2 12.1 24.5 24.9 17.7 22.8 26.1 11.9 21.2 13.4 14.3 39.7 23.3 12.8 38.8 25.2 68.7 32.7 16.4 22.9 29.5 6.2 20.7 4.2 12.0 22.3 16.9 10.6 12.0 13.2 21.1 10.7 8.2 10.5 3.3 13.7 11.8 18.3 10.7 12.5 15.8 18.5 28.3 21.7 14.3 15.1 15.2 14.2 17.4 17.6 NUP88 MGC8530 ENSG00000108559 "Nucleoporin 88" Q99567 17 5360963-5420160 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002209, HPA021816" Approved Approved Nucleoplasm Nucleoplasm "CAB002209: AB_564128, HPA021816: AB_1854725" "unprognostic (3.46e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.83e-2)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" "unprognostic (3.94e-1)" "unprognostic (4.72e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-2)" "unprognostic (5.75e-3)" "unprognostic (1.49e-1)" "unprognostic (1.10e-1)" "unprognostic (9.03e-2)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" 10.8 12.4 8.1 17.2 8.8 13.2 14.1 15.0 9.2 9.0 12.5 6.6 8.1 7.4 10.1 12.2 13.1 10.5 7.7 15.3 8.0 5.6 11.3 25.7 9.1 17.8 6.9 6.9 9.9 11.1 11.9 12.4 10.0 7.5 9.6 14.3 6.9 11.7 12.5 33.4 11.8 12.4 10.2 7.7 20.0 11.4 34.4 8.4 28.9 15.8 10.3 23.1 10.9 10.5 24.2 7.4 3.5 8.6 12.2 10.5 7.4 20.2 22.4 18.0 15.2 8.6 8.8 19.5 15.5 13.9 28.6 26.2 19.2 8.6 36.9 6.3 15.1 20.5 31.0 18.3 31.8 10.2 21.3 16.1 20.0 13.9 12.2 13.2 17.0 6.6 13.3 21.2 32.6 19.5 18.3 9.7 19.9 9.8 20.1 9.0 19.0 11.2 19.8 20.4 17.6 13.2 9.4 7.8 15.2 19.0 9.2 11.6 10.3 15.3 11.9 12.1 13.8 12.7 28.2 6.3 8.2 18.3 14.4 14.8 18.8 3.5 4.9 2.2 8.2 7.3 8.1 24.2 9.1 9.8 6.9 23.2 9.5 10.1 0.5 12.2 8.6 7.4 10.5 7.4 8.1 8.8 15.0 9.2 8.0 5.6 6.9 6.9 7.5 8.4 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell line enhanced" "Detected in many" "Karpas-707: 37.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavourable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.7 11.8 10.2 3.7 11.0 11.6 2.2 8.6 10.9 10.3 15.1 2.7 0.8 11.4 25.5 9.7 1.7 11.3 9.2 12.9 14.1 3.6 8.7 7.5 7.3 14.6 7.4 8.2 6.6 1.6 8.6 3.1 11.1 1.8 37.3 17.1 4.0 9.8 1.8 5.8 7.3 4.5 12.4 4.8 7.6 1.9 8.1 9.6 3.7 0.9 6.4 1.7 10.6 9.6 11.5 13.7 1.3 8.9 17.7 17.6 13.4 9.8 32.8 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.1;U-2 OS: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045531 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045531: AB_10960749" "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 2.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.0;HEL: 9.0;HUVEC TERT2: 22.3;RT4: 18.4;TIME: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 2.9 0.0 4.1 8.5 0.2 1.3 1.4 0.9 1.0 2.0 9.0 0.2 0.4 5.3 0.0 4.7 0.1 1.0 0.0 0.5 9.0 1.2 0.2 3.0 0.0 0.0 8.6 0.3 0.6 0.0 22.3 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.0 1.1 0.0 0.0 0.0 18.4 0.4 6.4 0.0 0.8 0.1 1.6 1.3 10.8 0.1 5.4 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120210767-120230332 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell line enhanced" "Detected in many" "EFO-21: 34.3;Hep G2: 53.7;NB-4: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6" "Group enriched" "Detected in many" 12 "dendritic cells: 4.6;monocytes: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" 65000000 Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavourable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 16.2 22.5 8.6 6.9 15.4 3.5 24.9 1.2 10.3 18.7 16.8 4.0 8.0 19.4 14.3 17.2 10.7 13.4 20.6 13.7 8.7 1.4 21.5 93.4 5.6 8.1 5.4 6.4 26.2 43.7 2.4 7.4 4.6 3.2 10.3 13.5 18.2 26.5 5.8 3.7 3.0 22.1 11.7 3.3 15.3 9.9 5.5 5.5 1.2 6.8 8.6 3.6 11.2 10.9 0.1 4.6 0.3 6.2 0.0 0.4 1.3 6.9 2.1 8.2 4.1 12.9 14.5 0.4 13.5 14.0 5.5 8.0 2.1 10.8 0.0 34.3 9.1 7.3 2.3 3.4 2.1 5.0 5.6 5.7 1.3 53.7 11.5 12.6 2.3 18.0 2.1 5.2 14.6 15.7 3.7 6.5 1.3 2.5 0.0 36.0 3.3 11.0 3.2 0.2 6.7 8.2 3.8 0.4 2.9 3.9 4.4 11.2 1.4 20.9 9.5 11.8 4.4 12.0 1.3 0.2 0.1 0.1 9.1 21.0 4.0 0.0 6.2 0.0 0.2 2.9 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.4 0.3 0.0 0.6 0.9 0.3 1.3 8.6 15.4 1.2 10.3 8.7 1.4 5.4 6.4 3.2 5.5 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favourable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 14.6 19.1 19.1 15.8 19.3 15.3 19.3 13.2 20.2 13.6 17.4 18.8 30.3 19.1 12.6 26.6 15.8 20.1 15.9 13.5 19.1 18.6 27.8 35.4 16.2 24.8 21.4 19.6 22.5 25.3 21.6 22.4 13.8 20.9 16.8 20.4 17.6 15.9 24.2 16.7 14.9 17.9 15.8 21.4 16.2 22.7 44.7 20.9 21.4 24.6 14.2 20.7 16.0 14.1 27.6 16.5 23.4 16.2 27.4 24.4 13.2 14.3 9.3 20.1 13.5 11.6 13.3 11.9 8.8 12.6 10.5 11.7 13.9 10.6 19.9 9.8 5.4 10.6 12.4 11.9 15.7 17.5 6.7 24.1 9.8 26.0 10.9 16.5 15.8 10.4 17.5 10.2 34.9 7.3 30.5 17.1 11.3 21.4 26.9 19.4 18.9 6.1 12.5 17.5 19.3 20.8 7.9 21.1 14.1 8.3 8.4 28.9 14.8 15.3 7.5 11.0 13.0 7.0 15.2 22.5 22.4 44.2 9.1 16.8 9.3 20.4 13.8 23.4 17.2 14.2 21.6 27.6 19.7 17.0 16.5 25.8 24.4 23.2 13.4 27.4 16.2 16.0 21.8 13.2 19.1 19.3 13.2 20.2 19.1 18.6 21.4 19.6 20.9 20.9 OASL "OASL1, p59OASL, TRIP14" ENSG00000135114 "2'-5'-oligoadenylate synthetase like" Q15646 12 121019111-121039242 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;bone marrow: 33.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 51.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;hTEC/SVTERT24-B: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA001474 Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001474: AB_1079518" "unprognostic (2.39e-2)" "unprognostic (7.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (1.62e-2)" "unprognostic (6.22e-2)" "unprognostic (5.93e-3)" "prognostic unfavourable (9.20e-4)" "unprognostic (4.61e-1)" "prognostic unfavourable (3.70e-9)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (3.17e-2)" 20.5 0.5 1.0 8.3 1.4 33.1 2.7 0.4 1.9 3.6 5.9 1.7 0.1 1.6 1.7 1.3 4.7 0.6 3.1 2.2 0.7 0.9 4.0 22.6 16.5 1.9 1.3 1.2 1.4 0.4 0.2 0.8 3.6 2.3 2.5 3.0 2.3 3.4 0.3 1.1 0.8 2.0 1.1 1.9 5.2 15.7 2.1 0.6 6.0 3.2 3.7 7.6 2.9 1.5 0.8 3.2 44.5 10.8 6.9 23.6 10.8 1.0 0.2 0.0 0.3 0.3 0.9 0.0 0.1 0.5 51.5 26.5 0.0 4.9 0.3 1.5 0.0 2.7 0.0 0.3 3.8 9.1 0.0 0.0 5.2 0.0 0.3 0.0 0.7 0.3 0.2 20.6 0.0 0.1 0.0 1.8 0.2 0.4 0.0 2.6 0.0 1.1 0.0 0.1 0.6 0.2 4.8 0.0 0.0 0.4 0.2 8.1 0.1 0.8 0.0 0.2 0.4 0.6 0.1 1.9 3.7 0.0 7.7 0.4 0.1 4.2 10.3 22.4 20.4 10.8 5.3 0.8 14.1 23.6 3.2 0.3 4.0 15.7 44.5 6.9 7.4 0.1 9.9 10.8 1.0 1.4 0.4 1.9 0.7 0.9 1.3 1.2 2.3 0.6 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: " "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 41.4 7.5 4.9 17.6 50.3 48.5 16.8 25.1 51.3 22.5 24.7 19.2 5.4 0.0 18.3 42.4 44.2 22.5 47.0 24.5 7.3 31.2 46.4 5.3 14.3 25.9 0.0 30.6 31.7 24.3 20.2 23.6 26.1 79.8 8.9 31.3 10.7 12.2 2.6 9.8 10.6 11.4 18.8 11.2 21.5 0.6 10.3 11.0 15.8 42.1 35.3 14.0 11.4 20.1 12.8 12.0 21.2 15.6 7.6 8.0 11.2 17.7 12.5 6.1 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: " "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favourable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 8.0 9.1 10.2 8.0 12.4 11.9 19.3 13.2 8.4 8.6 8.6 17.9 18.7 5.8 15.9 6.5 20.9 7.4 7.1 8.4 5.1 7.6 5.4 11.6 10.1 11.5 8.9 6.7 9.0 14.4 10.0 16.2 9.2 20.2 11.7 10.4 8.5 6.3 8.8 14.0 3.1 7.2 6.9 15.8 17.1 8.3 7.3 11.4 10.0 21.7 15.4 18.9 7.7 8.4 12.1 7.6 8.3 12.3 14.3 8.6 9.0 6.7 4.8 10.9 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 OGFOD3 "C17orf101, FLJ22222" ENSG00000181396 "2-oxoglutarate and iron dependent oxygenase domain containing 3" Q6PK18 17 82389223-82418637 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052099 Uncertain Approved Nucleoplasm Nucleoplasm "HPA052099: AB_2681725" "unprognostic (1.12e-2)" "unprognostic (5.85e-2)" "unprognostic (9.66e-2)" "unprognostic (9.69e-2)" "unprognostic (4.11e-3)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.99e-1)" "unprognostic (5.41e-2)" "unprognostic (7.15e-2)" "unprognostic (8.05e-3)" "unprognostic (2.95e-1)" "prognostic favourable (5.72e-4)" "unprognostic (7.43e-2)" "unprognostic (1.40e-1)" "unprognostic (7.08e-2)" "unprognostic (1.02e-1)" 12.9 18.0 7.6 11.3 10.4 10.2 12.1 15.4 13.7 12.0 11.1 14.3 21.8 11.5 14.7 24.9 10.7 15.0 19.0 20.9 7.2 8.5 13.7 16.8 14.4 12.3 9.1 11.9 15.1 30.0 15.3 20.4 12.8 9.0 13.8 6.6 13.9 21.8 22.9 24.4 11.3 11.6 13.4 10.7 10.5 13.0 9.8 8.6 6.9 18.8 17.0 12.8 11.6 12.0 10.1 18.5 3.1 10.3 5.2 10.9 5.2 12.4 15.7 5.3 17.6 10.2 13.0 9.2 12.8 11.9 13.3 13.7 16.8 17.1 8.5 10.3 9.8 9.3 4.5 10.7 5.5 6.7 14.1 13.1 12.0 21.2 9.2 15.0 15.4 10.4 8.0 6.1 5.3 13.8 16.4 6.7 3.8 11.7 10.1 15.6 5.0 19.1 6.9 10.3 13.0 7.5 11.7 11.5 22.8 22.0 20.1 10.3 11.9 19.7 10.6 25.1 15.8 9.8 16.2 12.0 1.0 8.1 15.6 8.8 12.9 0.1 10.3 3.1 5.4 9.4 6.1 10.1 7.8 10.9 18.5 8.8 9.4 7.8 1.3 5.2 6.3 9.6 2.9 5.2 7.6 10.4 15.4 13.7 7.2 8.5 9.1 11.9 9.0 8.6 OGFR 7-60 ENSG00000060491 "Opioid growth factor receptor" Q9NZT2 20 62804835-62814000 "Predicted intracellular proteins" "Growth regulation" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 13.0;neutrophil: 3.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.0" "Low region specificity" "Detected in all" HPA017899 Supported Approved Nucleoplasm 11000 Nucleoplasm "HPA017899: AB_1854774" "unprognostic (1.33e-2)" "unprognostic (3.28e-2)" "unprognostic (2.32e-2)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-1)" "unprognostic (1.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.39e-3)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (4.21e-2)" "unprognostic (2.46e-3)" "unprognostic (1.60e-2)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "prognostic favourable (5.19e-4)" 21.8 15.9 25.9 30.4 18.4 33.0 16.8 18.7 34.6 18.2 24.4 13.9 22.1 30.5 17.8 16.3 14.1 17.8 22.4 21.0 23.6 19.3 19.7 38.8 27.4 27.9 14.5 18.1 23.4 23.0 15.1 20.8 22.3 17.5 22.0 11.3 15.1 31.3 18.3 25.6 23.2 29.2 19.5 13.1 38.7 23.4 10.3 16.3 21.0 22.2 12.6 20.2 18.3 29.3 1.6 1.1 13.0 1.8 0.7 1.1 0.4 18.4 12.4 7.6 9.8 7.6 8.4 21.1 11.8 12.3 44.3 19.5 28.1 13.7 22.7 21.6 9.5 21.5 8.8 14.1 10.9 6.9 13.9 11.0 15.6 25.4 12.5 13.7 26.3 10.6 10.3 10.8 4.5 9.4 10.3 11.6 7.0 27.4 28.4 25.0 5.0 24.2 22.5 13.5 9.9 6.1 10.0 7.6 11.4 16.1 22.3 17.6 11.3 20.6 12.7 23.5 20.7 18.1 16.6 14.6 4.2 12.1 18.7 14.5 9.0 1.8 1.8 13.0 0.8 1.6 0.5 1.1 1.1 1.0 1.1 1.6 1.1 0.7 3.8 0.7 1.5 0.9 0.6 0.4 25.9 18.4 18.7 34.6 23.6 19.3 14.5 18.1 17.5 16.3 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288803-71308950 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavourable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 16.9 8.7 20.2 11.3 26.8 16.9 36.0 22.3 33.3 6.7 7.2 29.1 2.8 2.9 8.3 10.7 24.5 5.2 8.3 5.8 30.2 17.6 5.7 4.8 8.5 9.6 27.7 18.3 5.4 6.0 5.8 10.0 9.9 37.8 6.7 4.3 3.3 31.8 10.3 4.1 14.6 5.7 24.1 52.2 11.7 5.4 2.4 29.1 3.2 4.8 4.3 17.8 5.4 9.4 0.7 2.4 12.8 3.0 0.5 0.5 0.6 3.8 1.1 4.0 0.0 11.0 10.1 1.5 17.1 10.6 6.9 7.0 1.4 0.7 23.3 23.5 7.3 1.9 3.1 11.7 24.6 4.9 2.5 5.1 4.1 0.6 9.0 2.4 1.8 10.2 10.2 5.1 16.1 5.5 0.3 1.8 23.7 3.2 0.0 3.8 1.6 0.9 1.6 12.4 5.3 16.0 0.3 13.9 6.3 5.0 3.1 1.1 5.4 18.9 8.4 17.0 8.6 1.8 5.6 2.5 0.1 3.0 5.7 16.2 2.9 3.1 3.0 0.1 0.5 2.0 0.5 0.4 0.4 0.5 2.4 0.7 0.1 0.3 12.8 0.5 1.4 0.9 0.2 0.6 20.2 26.8 22.3 27.4 30.2 17.6 27.7 18.3 37.8 29.1 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell line enhanced" "Detected in some" "HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: " "unprognostic (6.77e-2)" "prognostic favourable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.5 3.1 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 21.2 0.1 0.0 28.3 0.0 0.0 0.0 11.9 0.0 0.0 40.8 5.4 33.8 0.1 2.1 52.4 0.0 0.0 2.0 4.5 22.8 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.4;skin 1: 60.2" "Cell line enhanced" "Detected in many" "AN3-CA: 15.4;ASC diff: 14.6;BJ hTERT+: 11.1;SH-SY5Y: 14.8;U-2 OS: 17.8;WM-115: 15.4" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in many" 27 "granulocytes: 24.9;T-cells: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" 2300000 Nucleoplasm "HPA049961: , HPA057771: " "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 20.9 12.2 37.2 2.7 39.7 0.8 5.8 9.1 51.4 4.5 1.9 11.6 0.3 2.1 7.9 3.8 3.9 6.6 4.9 3.9 26.2 21.6 1.8 23.5 3.2 5.0 19.6 17.9 3.5 7.9 1.1 4.4 5.2 15.4 5.2 1.4 3.2 7.1 10.3 1.7 60.2 2.0 5.1 9.0 2.2 1.4 5.2 4.6 16.0 8.4 1.1 3.7 2.6 3.2 0.0 0.0 24.9 0.0 0.6 8.9 1.7 0.0 2.2 1.8 15.4 14.6 9.0 1.0 3.3 11.1 0.7 0.9 0.1 1.4 0.0 1.4 2.5 0.9 5.9 1.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 2.6 4.7 0.9 0.1 0.1 0.0 0.1 0.2 0.0 4.8 0.1 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 14.8 0.5 0.0 3.0 0.5 0.0 0.1 6.5 17.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 15.4 9.6 0.0 24.9 3.5 0.0 3.8 0.0 4.1 3.1 0.0 0.0 8.0 5.1 0.3 0.6 0.0 0.0 8.9 1.7 37.2 39.7 9.1 38.0 26.2 21.6 19.6 17.9 15.4 4.6 OLFML2A FLJ00237 ENSG00000185585 "Olfactomedin like 2A" Q68BL7 9 124777158-124814885 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.9;HeLa: 14.6;WM-115: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021180, HPA022254" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" "Nucleoplasm, Cytosol" "HPA021180: AB_1854790, HPA022254: AB_1854791" "unprognostic (1.12e-1)" "unprognostic (3.07e-2)" "unprognostic (3.16e-1)" "unprognostic (2.45e-1)" "unprognostic (4.01e-2)" "unprognostic (1.27e-1)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (1.26e-3)" "unprognostic (7.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (3.73e-5)" "unprognostic (5.72e-3)" "unprognostic (3.30e-2)" "unprognostic (7.91e-2)" "unprognostic (1.05e-2)" 17.3 2.1 1.0 7.4 1.7 0.1 10.9 1.9 3.4 34.2 18.9 3.1 6.3 2.3 29.2 8.3 11.8 4.2 7.6 12.5 1.2 1.0 3.0 0.6 10.3 1.5 2.1 1.5 13.2 3.4 3.6 2.1 5.0 4.0 16.1 4.6 18.9 4.7 9.5 9.8 11.6 5.0 33.7 1.6 23.8 4.0 3.1 0.6 3.7 20.0 11.9 5.0 22.0 10.4 1.4 0.7 2.6 0.9 0.6 0.6 0.4 0.3 5.2 0.4 0.1 6.0 57.9 0.0 0.8 2.8 1.2 1.2 0.0 0.7 0.0 1.5 0.0 9.7 0.1 0.3 1.4 0.0 0.0 0.0 14.6 0.0 0.3 0.0 0.0 4.1 0.9 3.6 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 1.3 0.5 0.0 3.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 1.4 1.3 0.1 0.0 1.8 1.9 2.0 0.2 0.7 0.0 0.0 5.5 0.3 22.6 1.9 0.9 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.7 1.4 0.4 0.6 2.6 0.6 0.3 0.6 0.3 0.4 1.0 1.7 1.9 3.4 1.2 1.0 2.1 1.5 4.0 0.6 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA055120: " "prognostic favourable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favourable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favourable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 10.2 22.4 13.8 21.5 18.1 9.2 15.8 10.6 14.6 14.5 16.4 14.1 20.1 12.1 15.4 15.1 17.1 15.9 12.1 15.8 12.6 10.0 23.0 23.8 19.1 17.9 16.7 9.6 15.0 18.2 15.7 20.9 8.9 13.0 17.8 16.1 11.3 20.6 22.7 20.9 10.2 16.1 24.2 18.2 17.2 13.9 6.9 19.4 18.4 18.3 14.5 16.4 17.0 20.6 22.5 9.5 18.6 19.5 18.6 22.8 10.2 13.5 5.7 3.8 3.5 19.2 18.0 10.9 5.6 6.1 4.9 6.2 1.6 8.2 30.7 11.9 5.8 13.9 13.4 13.7 5.9 23.5 7.5 9.6 4.4 6.6 9.6 23.3 6.7 17.0 15.3 4.8 10.0 4.3 18.0 9.2 13.4 8.3 7.9 8.3 5.6 12.4 9.9 12.5 12.8 10.7 9.1 4.0 1.9 11.4 18.9 15.8 8.5 9.0 2.5 2.5 5.1 12.6 5.8 7.5 9.8 20.2 7.8 18.3 6.2 10.8 9.2 18.6 12.8 14.5 16.5 22.5 15.7 15.0 9.5 21.4 22.8 20.8 10.6 18.6 19.5 5.0 13.9 10.2 13.8 18.1 10.6 14.6 12.6 10.0 16.7 9.6 13.0 19.4 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1, mitochondrial dynamin like GTPase" O60313 3 193593144-193697823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria 13000 "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: " "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavourable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavourable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favourable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 17.0 19.7 18.2 13.5 31.7 25.9 15.9 20.2 30.9 13.9 21.8 11.1 12.6 20.0 15.2 11.8 18.8 11.8 12.8 43.9 23.0 19.4 21.8 24.1 10.7 15.3 19.0 22.4 13.2 13.4 20.9 15.6 13.8 28.0 15.5 20.5 9.1 15.7 20.8 38.4 14.6 17.3 16.5 17.0 13.1 16.7 7.6 10.8 18.0 16.8 18.4 14.2 16.5 13.6 8.3 8.8 8.2 17.6 5.0 7.5 5.9 25.9 8.3 8.5 9.3 7.5 11.9 9.0 12.6 11.6 13.9 13.6 20.3 8.8 17.3 27.3 11.8 16.9 14.8 14.3 24.6 20.8 12.0 29.9 7.4 10.1 11.7 24.5 13.8 13.2 12.8 13.4 19.0 11.7 12.6 17.0 13.8 20.5 9.5 13.6 11.9 27.9 12.5 18.6 18.5 10.4 16.2 18.5 11.2 18.9 21.1 13.4 27.7 19.4 11.7 12.9 9.8 13.8 26.5 15.3 17.8 33.8 14.2 19.7 12.9 8.2 8.1 7.7 7.2 9.3 6.6 8.3 6.8 6.8 8.8 6.3 6.9 7.3 3.2 5.0 17.6 4.6 7.5 5.9 18.2 31.7 20.2 30.9 23.0 19.4 19.0 22.4 28.0 10.8 OPA3 "FLJ22187, MGA3" ENSG00000125741 "OPA3, outer mitochondrial membrane lipid metabolism regulator" Q9H6K4 19 45527427-45602212 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044881 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA044881: AB_10964052" "unprognostic (3.37e-1)" "unprognostic (3.89e-2)" "unprognostic (2.66e-1)" "unprognostic (5.71e-3)" "unprognostic (1.24e-2)" "unprognostic (2.87e-2)" "prognostic unfavourable (5.60e-4)" "unprognostic (3.14e-3)" "unprognostic (4.53e-2)" "unprognostic (8.06e-3)" "unprognostic (1.72e-3)" "unprognostic (8.73e-2)" "prognostic favourable (9.30e-12)" "unprognostic (5.85e-2)" "unprognostic (1.94e-1)" "unprognostic (3.82e-2)" "unprognostic (1.81e-1)" 21.6 14.8 8.5 9.4 15.9 7.9 21.8 8.5 13.1 6.2 8.9 7.2 5.7 8.4 10.5 7.7 11.3 7.6 9.8 21.8 9.8 9.6 15.9 16.4 19.3 9.7 11.0 4.5 8.9 9.3 23.9 12.3 11.4 18.4 7.9 8.7 12.1 8.2 9.4 19.7 12.5 9.7 10.2 12.4 12.0 9.2 15.7 11.1 5.3 11.8 9.7 9.6 9.5 30.3 6.7 7.8 7.4 13.0 10.9 6.2 4.5 11.3 14.5 5.8 5.8 3.9 4.8 8.9 7.4 6.9 8.0 8.5 6.7 8.2 9.8 5.4 7.4 9.1 9.7 10.2 7.0 17.9 9.8 15.2 8.1 6.9 7.0 10.7 19.8 7.2 7.9 8.8 9.7 5.6 12.9 11.1 5.4 7.0 8.3 4.4 5.1 10.0 8.3 5.2 5.3 6.2 20.6 4.4 5.2 9.5 8.8 4.0 4.9 6.1 12.1 6.8 7.8 5.6 12.6 7.5 13.8 8.2 6.6 7.7 10.2 6.0 7.4 3.8 5.3 10.5 5.6 6.7 4.8 4.5 7.8 5.6 6.0 5.9 7.4 10.9 13.0 7.3 6.2 4.5 8.5 15.9 8.5 13.1 9.8 9.6 11.0 4.5 18.4 11.1 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 68042344-68433913 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 5.8 8.2 21.9 2.4 22.6 3.6 7.1 12.3 21.6 9.9 4.9 10.7 3.2 3.5 9.7 4.8 6.1 5.3 4.5 4.1 19.5 9.7 7.0 1.7 6.6 2.0 9.6 12.2 7.1 4.0 6.6 4.8 20.7 9.1 16.2 5.1 7.9 7.2 8.0 7.8 8.6 4.1 6.3 6.2 2.9 5.9 2.9 12.4 0.1 7.2 2.0 2.3 3.9 6.2 2.7 3.3 4.1 1.7 1.7 1.2 0.3 15.1 3.8 2.4 5.9 5.5 5.7 3.9 2.8 3.9 5.3 6.4 2.4 3.1 0.7 10.8 3.4 4.1 2.1 1.2 8.2 0.4 1.5 3.2 4.3 2.4 1.8 0.8 3.8 3.2 3.9 4.9 4.8 4.3 2.1 1.4 3.1 7.8 0.5 0.8 4.6 3.2 0.4 4.8 0.7 6.9 5.8 0.9 2.3 5.5 7.0 12.4 4.7 1.3 4.7 3.6 5.8 12.7 3.6 2.1 2.5 0.5 2.7 1.9 2.6 1.1 1.7 0.6 1.2 0.9 1.0 1.3 1.0 0.8 0.7 2.7 1.1 1.2 4.1 1.7 1.2 3.3 0.7 0.3 21.9 22.6 12.3 18.6 19.5 9.7 9.6 12.2 9.1 12.4 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell line enhanced" "Detected in many" "U-87 MG: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavourable (2.26e-8)" "prognostic unfavourable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavourable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.6 2.2 5.1 1.7 0.0 0.0 1.5 9.6 0.0 0.0 0.0 5.0 2.0 2.5 1.4 0.0 1.4 0.0 0.0 0.0 0.3 3.6 1.5 3.0 2.5 0.0 1.9 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.6 1.0 0.7 2.0 3.5 4.6 2.9 1.0 5.3 2.9 0.0 0.6 0.7 6.8 2.3 5.2 4.3 0.5 1.9 4.0 9.8 1.0 7.6 8.6 2.0 2.1 1.5 36.9 4.5 9.1 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 OPN3 "ECPN, encephalopsin, ERO, NMO-1, PPP1R116" ENSG00000054277 "Opsin 3" Q9H1Y3 1 241590102-241677376 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.1" "Low region specificity" "Detected in all" "CAB013682, HPA064443" Uncertain Approved Nucleoplasm Nucleoplasm "CAB013682: , HPA064443: " "unprognostic (2.41e-2)" "prognostic unfavourable (3.17e-5)" "unprognostic (1.75e-2)" "unprognostic (1.93e-1)" "prognostic unfavourable (1.70e-4)" "unprognostic (7.12e-2)" "unprognostic (5.10e-3)" "unprognostic (1.24e-2)" "unprognostic (2.39e-1)" "unprognostic (4.96e-1)" "unprognostic (2.66e-2)" "unprognostic (3.44e-1)" "unprognostic (9.13e-2)" "unprognostic (9.15e-3)" "unprognostic (2.61e-2)" "unprognostic (7.12e-2)" "unprognostic (9.44e-3)" 5.3 4.2 5.1 4.5 8.8 1.7 6.4 1.9 22.1 4.4 9.0 2.4 1.0 2.6 6.2 6.7 7.9 6.7 4.6 3.5 5.2 4.9 6.2 18.1 11.8 8.4 5.0 11.1 6.8 4.2 1.8 6.9 26.4 3.4 2.3 8.0 1.4 4.1 2.3 2.6 4.1 4.4 2.9 3.2 7.8 5.6 4.7 1.7 12.5 9.3 1.7 7.1 6.2 5.1 2.5 12.1 0.9 1.4 0.5 0.5 0.6 2.1 7.0 5.1 0.4 18.8 35.9 3.9 3.7 2.8 2.7 2.7 0.5 5.9 0.3 0.2 4.5 12.3 1.6 2.6 2.7 7.7 0.4 0.0 1.6 4.3 9.6 1.7 4.0 18.1 7.4 1.6 4.1 5.4 3.5 1.0 4.3 1.1 0.6 2.2 13.9 3.8 2.9 0.3 6.7 18.4 3.1 1.4 5.2 2.4 7.5 2.0 0.4 6.8 6.5 0.6 0.5 1.0 3.9 2.5 3.9 0.3 2.0 5.7 7.9 0.0 1.1 0.9 0.1 1.4 0.1 2.2 0.2 0.2 2.7 2.5 0.3 0.5 0.3 0.5 1.2 12.1 0.2 0.6 5.1 8.8 1.9 22.1 5.2 4.9 5.0 11.1 3.4 1.7 ORAI2 "C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B" ENSG00000160991 "ORAI calcium release-activated calcium modulator 2" Q96SN7 7 102433106-102456821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.7;RPMI-8226: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 30.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055137, HPA065937" Uncertain Approved Nucleoplasm Nucleoplasm "HPA055137: , HPA065937: " "unprognostic (5.09e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (5.07e-3)" "unprognostic (8.56e-2)" "unprognostic (3.82e-2)" "unprognostic (7.07e-2)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "prognostic favourable (8.49e-5)" "unprognostic (7.16e-2)" "unprognostic (1.57e-3)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "prognostic favourable (6.65e-4)" "unprognostic (2.46e-1)" 6.3 7.2 13.8 28.1 15.8 24.3 8.0 18.6 15.9 4.7 5.7 5.0 5.6 5.6 7.7 6.2 2.7 7.7 6.6 4.1 11.9 17.1 6.9 1.5 6.2 25.9 9.3 4.8 5.0 4.8 13.9 24.8 4.1 10.3 4.3 2.8 4.3 5.1 7.6 1.8 1.6 10.3 4.6 7.0 21.9 7.7 1.8 5.1 9.9 10.9 1.3 20.3 10.0 4.4 14.4 2.5 30.9 2.7 7.4 2.3 2.5 6.3 14.4 5.6 10.7 5.1 5.8 0.3 6.2 6.9 6.9 6.0 8.3 6.7 45.7 17.3 10.5 2.5 2.1 1.6 2.4 4.9 4.0 6.5 6.7 2.5 7.8 15.5 8.8 5.4 1.1 11.2 1.8 12.2 8.1 36.6 5.3 13.3 22.9 7.2 7.0 6.7 9.5 5.0 44.9 4.0 4.8 9.6 23.7 6.1 2.6 3.3 3.7 6.1 11.7 16.2 18.0 11.1 8.2 35.8 25.1 33.4 12.1 9.4 8.3 4.9 2.7 30.9 2.0 2.4 2.3 13.3 1.8 1.6 1.6 14.4 1.2 1.4 25.6 7.4 1.4 2.5 0.8 2.5 13.8 15.8 18.6 11.2 11.9 17.1 9.3 4.8 10.3 5.1 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949066-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 13.4 22.9 5.5 13.0 5.6 12.4 14.8 6.0 8.1 17.0 12.8 9.1 13.3 7.5 12.4 16.9 19.9 13.6 16.5 10.8 4.9 5.1 16.5 39.6 15.4 20.7 5.9 3.6 16.9 14.5 13.5 12.1 14.8 5.8 26.2 7.3 13.3 10.3 15.3 9.4 10.2 9.9 16.4 5.1 20.0 10.4 19.7 5.2 14.2 25.6 6.3 13.7 29.1 15.2 5.1 6.8 17.9 8.5 8.1 2.8 2.2 1.0 5.8 3.0 4.0 26.1 23.5 0.2 3.4 23.0 2.5 6.5 0.5 9.6 1.4 7.8 6.5 4.7 0.5 6.4 1.7 4.4 1.9 3.7 1.8 5.7 36.5 4.0 11.5 25.2 17.3 4.9 9.7 4.3 4.1 7.7 8.2 3.8 0.2 15.0 2.4 1.6 3.1 2.3 10.9 9.7 2.5 0.7 5.0 3.1 0.9 5.2 7.3 16.5 3.1 1.9 1.3 4.2 0.8 19.0 1.3 1.1 9.6 9.5 2.9 14.1 6.5 17.9 2.5 6.3 2.8 5.1 1.4 2.0 6.1 4.8 1.7 2.3 10.9 8.1 8.5 6.8 1.9 2.2 5.5 5.6 6.0 8.1 4.9 5.1 5.9 3.6 5.8 5.2 ORAOV1 TAOS1 ENSG00000149716 "Oral cancer overexpressed 1" Q8WV07 11 69653076-69675416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062696 Approved Nucleoplasm Nucleoplasm "HPA062696: " "unprognostic (2.15e-1)" "unprognostic (1.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.20e-1)" "unprognostic (2.09e-2)" "unprognostic (6.76e-3)" "unprognostic (4.65e-2)" "unprognostic (9.87e-3)" "unprognostic (1.82e-1)" "unprognostic (6.51e-3)" "unprognostic (1.18e-2)" "prognostic unfavourable (1.51e-5)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (2.77e-1)" "unprognostic (5.19e-3)" 11.3 14.8 19.0 14.0 20.2 13.5 12.2 24.0 24.0 11.1 11.3 19.6 14.1 16.0 13.8 33.8 15.6 12.1 9.8 9.4 17.7 13.5 12.6 11.7 11.1 16.3 22.5 16.8 14.5 18.6 12.8 15.7 10.1 16.7 14.1 12.6 11.6 14.4 20.0 15.5 25.4 13.1 15.1 16.2 17.8 13.6 14.7 21.0 9.3 14.1 10.3 15.6 12.4 12.5 8.0 8.0 5.3 9.9 4.1 9.9 4.2 37.7 8.2 5.8 6.7 5.9 5.1 7.0 12.7 7.0 9.7 5.6 13.5 12.4 8.7 6.8 7.6 15.7 8.1 6.7 12.0 5.0 10.5 9.1 15.3 8.6 9.1 6.7 5.7 5.9 8.7 10.7 10.8 7.0 9.2 6.0 9.4 12.5 6.2 12.8 6.1 15.9 5.8 9.9 7.4 6.3 6.0 7.0 6.3 8.7 6.8 29.3 10.1 7.2 7.6 10.4 8.6 16.5 10.2 8.1 5.3 6.8 16.4 7.5 9.8 2.3 5.2 3.9 8.8 4.2 6.6 8.0 8.0 5.9 5.5 7.6 9.9 8.7 5.3 4.1 9.9 8.0 8.7 4.2 19.0 20.2 24.0 24.0 17.7 13.5 22.5 16.8 16.7 21.0 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: " "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavourable (3.53e-4)" "prognostic favourable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.8 1.4 4.1 8.9 7.0 14.2 1.1 3.8 6.1 1.3 2.8 1.2 1.4 2.7 1.5 1.9 6.7 0.9 1.2 2.3 4.4 3.5 0.8 1.6 1.5 10.6 3.1 4.5 0.9 0.6 0.3 1.2 5.2 2.4 0.8 3.1 0.5 1.4 0.6 0.4 1.9 2.7 1.7 2.9 4.1 1.5 23.1 1.4 12.8 0.9 4.2 10.7 2.6 2.0 4.1 3.4 1.0 2.6 2.8 4.1 2.5 10.7 10.0 15.9 12.4 2.0 2.5 11.8 19.3 7.2 21.3 11.2 14.0 6.6 12.5 10.1 3.6 11.0 20.4 5.3 18.1 6.4 16.5 10.4 5.3 14.1 2.4 16.9 10.9 0.7 0.9 11.6 6.1 7.0 12.5 6.4 12.9 9.5 22.7 21.2 17.6 27.4 27.4 29.2 12.7 5.2 3.7 19.1 11.3 9.8 10.9 6.7 5.8 13.4 4.2 19.7 13.3 12.4 18.1 4.9 6.6 43.6 8.3 11.1 15.2 0.0 1.1 1.0 3.5 2.6 1.4 2.7 2.0 2.0 2.2 4.1 2.9 1.4 0.5 2.8 2.5 3.4 4.1 2.5 4.1 7.0 3.8 6.1 4.4 3.5 3.1 4.5 2.4 1.4 OSBP OSBP1 ENSG00000110048 "Oxysterol binding protein" P22059 11 59574398-59616144 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039227, HPA043625" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039227: , HPA043625: " "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "prognostic favourable (2.08e-5)" "unprognostic (7.80e-3)" "unprognostic (7.32e-2)" "unprognostic (2.79e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (7.42e-2)" "unprognostic (1.42e-3)" "unprognostic (1.22e-1)" "prognostic favourable (3.08e-7)" "unprognostic (1.25e-1)" "unprognostic (9.00e-2)" "unprognostic (1.93e-1)" "unprognostic (2.67e-1)" 15.6 36.6 12.3 10.6 16.3 13.8 16.5 14.7 18.0 16.1 18.8 13.7 35.4 17.3 15.9 19.9 15.9 13.8 19.5 14.7 10.3 11.6 26.3 54.8 12.9 9.7 12.4 12.7 16.6 30.2 31.4 14.7 29.4 17.9 16.1 17.3 12.6 27.7 26.2 32.5 20.9 22.3 15.1 9.5 12.5 19.1 11.3 12.1 18.8 19.6 12.5 13.8 16.7 13.7 4.6 7.9 3.5 3.1 4.0 6.1 2.1 17.5 14.7 10.9 14.7 25.9 24.3 12.1 14.3 18.7 17.3 15.6 16.6 17.8 17.7 19.3 16.5 18.4 20.1 19.1 19.5 17.1 9.3 11.9 11.5 11.1 27.7 15.2 23.7 18.5 23.8 16.2 42.8 18.4 20.5 16.6 15.3 8.1 14.3 11.2 12.4 14.5 13.9 17.6 12.3 20.5 20.4 13.0 9.2 17.0 21.3 19.6 29.8 9.8 19.9 14.8 10.4 22.1 9.6 23.2 18.8 18.1 16.7 11.0 11.9 3.5 3.1 2.8 5.9 2.9 5.5 4.6 6.1 4.6 3.2 3.4 5.6 4.7 3.0 4.0 2.5 7.9 2.6 2.1 12.3 16.3 14.7 18.0 10.3 11.6 12.4 12.7 17.9 12.1 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595090 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 8.1 5.1 12.6 8.1 16.9 4.7 13.2 5.7 9.7 5.4 7.2 14.1 4.9 5.1 6.1 6.1 6.8 5.0 5.2 5.3 11.0 7.7 6.8 22.4 10.9 11.1 11.2 8.3 4.5 3.8 8.5 5.1 9.0 8.7 4.6 6.6 4.6 5.1 9.7 48.9 6.3 6.0 7.0 10.3 11.4 5.2 7.8 10.9 8.3 5.9 6.0 9.4 6.3 5.3 3.5 11.8 12.8 9.5 1.9 2.2 3.2 12.8 7.0 13.4 7.5 15.2 8.1 17.4 9.7 7.8 12.4 14.2 13.5 4.6 21.3 12.2 8.0 9.7 14.8 8.6 16.6 5.7 6.4 9.8 8.5 8.9 8.5 7.3 13.3 6.6 10.5 10.3 9.1 8.9 10.0 9.7 11.2 7.6 14.4 3.5 18.4 6.3 12.7 7.7 24.8 10.3 8.0 3.0 7.9 12.0 6.9 10.3 7.1 3.8 9.2 9.9 9.0 14.4 7.5 6.1 6.5 26.1 6.9 2.6 9.5 10.8 9.3 2.4 1.8 9.5 1.5 3.5 1.0 1.8 11.8 2.7 1.2 1.4 12.8 1.9 7.8 4.5 2.2 3.2 12.6 16.9 5.7 8.4 11.0 7.7 11.2 8.3 8.7 10.9 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell line enhanced" "Detected in many" "HaCaT: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA036076: AB_10601042, HPA053083: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavourable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favourable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.9 4.7 2.0 2.3 2.3 3.3 1.7 1.5 2.2 2.5 2.9 4.6 12.0 4.0 5.9 2.1 29.2 1.1 3.2 0.8 13.2 1.6 2.9 8.7 3.1 2.1 6.1 0.1 5.1 0.6 1.7 1.1 5.1 2.8 5.4 3.9 5.0 6.1 6.5 1.2 5.9 5.6 3.1 5.4 3.4 3.0 2.1 4.8 2.4 0.8 2.3 4.3 3.9 6.0 3.9 3.4 0.0 1.2 10.0 3.6 3.9 4.2 5.2 1.5 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Cell line enhanced" "Detected in some" "EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavourable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.1 0.7 0.0 0.0 0.2 0.6 4.7 0.0 0.0 0.4 0.1 0.1 0.0 5.3 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.8 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.5 16.5 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favourable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favourable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.1 4.9 6.1 7.1 7.3 7.2 1.1 3.1 7.7 7.8 5.4 0.1 4.6 1.1 5.9 5.7 4.1 0.2 5.9 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.7 11.0 4.8 5.3 0.1 1.3 6.1 3.7 2.7 1.9 6.2 2.1 2.9 2.5 0.9 12.8 1.8 16.5 7.3 5.9 2.8 4.1 6.0 0.8 4.6 5.7 2.1 10.2 5.3 2.3 2.3 0.5 10.9 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 OSGIN1 "BDGI, OKL38" ENSG00000140961 "Oxidative stress induced growth inhibitor 1" Q9UJX0 16 83948282-83966332 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 63.5" "Cell line enhanced" "Detected in many" "A549: 25.2;Hep G2: 37.9;T-47d: 28.2;WM-115: 23.6" "Cancer enriched" "Detected in all" 5 "liver cancer: 65.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 4.5;monocytes: 12.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019239 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA019239: AB_1854779" "unprognostic (8.36e-2)" "unprognostic (9.44e-2)" "unprognostic (4.28e-2)" "prognostic favourable (4.89e-5)" "unprognostic (3.31e-3)" "unprognostic (9.14e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" "unprognostic (2.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.20e-2)" "unprognostic (2.80e-2)" "unprognostic (2.45e-2)" "unprognostic (2.48e-2)" "unprognostic (8.28e-3)" "unprognostic (1.89e-1)" 4.0 9.8 1.7 3.0 6.5 0.8 28.2 0.6 3.7 1.7 17.4 2.1 0.7 18.1 1.3 1.7 5.6 1.8 5.1 6.9 1.3 1.4 13.8 63.5 8.2 1.6 13.4 0.0 3.2 5.2 2.5 1.4 1.2 6.6 2.1 1.8 5.1 2.0 1.7 7.8 1.6 21.3 5.5 13.7 5.4 5.0 5.6 1.9 0.0 5.2 13.5 2.9 6.0 10.6 0.0 1.0 4.5 12.3 0.0 0.0 0.8 1.7 25.2 0.2 1.1 1.6 2.3 1.9 2.9 2.7 2.6 0.9 6.2 9.2 0.0 6.8 2.4 4.6 1.0 1.8 1.0 0.3 0.3 0.4 5.6 37.9 5.5 0.8 9.9 1.4 1.5 6.9 1.6 2.5 2.2 2.5 3.4 11.7 0.3 0.3 0.2 5.8 0.8 2.6 1.2 1.8 2.1 0.1 0.6 6.1 1.9 12.3 28.2 1.0 8.7 4.1 6.2 6.0 1.9 1.1 0.4 0.0 13.7 1.3 23.6 0.1 2.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.5 0.0 12.3 0.0 0.0 0.8 1.7 6.5 0.6 3.7 1.3 1.4 13.4 0.0 6.6 1.9 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Cell line enriched" "Detected in some" 17 "ASC diff: 111.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA052425: , HPA063486: " "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favourable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.1 0.8 0.0 0.8 111.2 3.5 0.8 3.4 6.6 2.7 2.7 0.6 0.7 0.0 0.5 5.2 2.4 0.5 0.9 1.3 0.2 2.5 0.1 0.6 0.3 1.8 0.1 0.1 3.5 1.9 0.4 0.3 0.0 0.7 0.0 0.1 2.8 0.5 1.0 0.0 0.5 2.6 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.4 0.0 0.8 1.4 0.0 0.4 0.0 2.7 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 OSTM1 "GL, HSPC019" ENSG00000081087 "Osteopetrosis associated transmembrane protein 1" Q86WC4 6 108041409-108165854 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Osteopetrosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010851 Uncertain Approved Nucleoplasm,Vesicles,Cytosol 130000 Cytosol "Nucleoplasm, Vesicles" "HPA010851: AB_1079533" "prognostic unfavourable (4.36e-4)" "unprognostic (4.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (1.72e-3)" "prognostic unfavourable (4.26e-4)" "unprognostic (9.40e-2)" "unprognostic (2.56e-1)" "unprognostic (2.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.34e-6)" "prognostic unfavourable (1.20e-4)" "unprognostic (2.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" 26.3 21.9 9.0 18.1 13.5 5.5 16.7 13.7 17.2 14.4 17.8 12.8 9.9 8.4 21.8 10.3 14.1 15.0 13.5 23.2 10.4 16.5 22.0 15.9 17.0 17.2 11.0 10.5 15.6 9.7 11.8 26.0 24.7 20.0 15.4 12.4 29.7 10.8 19.0 18.0 10.4 12.9 24.7 13.1 21.7 14.3 11.1 10.7 13.6 12.4 8.1 13.9 21.0 19.4 10.8 12.4 20.9 28.1 14.5 16.4 16.9 2.2 6.5 7.8 11.3 23.3 7.6 11.0 16.2 16.3 11.9 19.8 3.9 3.7 5.1 13.4 11.3 4.2 7.6 5.5 18.4 11.7 6.0 10.7 4.2 4.8 18.1 11.8 25.1 11.1 13.8 14.6 11.7 6.0 8.5 18.7 19.2 3.1 2.5 2.7 3.1 5.0 4.2 11.2 2.7 8.5 5.9 0.8 4.6 13.1 3.3 29.0 3.8 17.1 7.3 10.4 3.8 23.0 22.9 7.2 12.3 4.4 30.8 8.0 23.0 16.8 13.9 15.2 15.0 19.9 16.0 10.8 12.8 16.4 12.4 6.2 12.0 15.0 20.9 14.5 28.1 8.9 15.4 16.9 9.0 13.5 13.7 17.2 10.4 16.5 11.0 10.5 20.0 10.7 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol 630000 "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 19.8 24.7 41.9 24.1 61.6 32.6 20.8 41.8 101.9 24.3 25.0 31.9 22.3 24.7 21.9 23.6 37.8 34.5 21.6 31.6 46.9 37.8 27.2 27.6 23.0 31.9 33.1 45.4 23.4 23.0 26.0 21.6 30.7 60.4 23.8 24.1 24.2 30.4 27.7 26.7 36.9 26.0 23.1 26.7 25.7 23.9 22.1 21.2 27.8 29.9 24.5 32.8 27.1 22.9 46.0 60.8 56.1 71.3 44.8 64.5 78.2 30.5 55.2 30.5 26.9 20.6 22.8 23.4 18.4 27.4 41.0 30.3 37.0 29.3 16.3 35.0 29.5 38.2 39.3 45.8 25.5 18.8 30.5 27.1 33.1 46.8 28.9 26.9 29.8 24.2 29.8 31.3 20.0 38.6 18.9 18.5 27.5 62.8 29.3 35.6 35.7 26.3 24.1 11.9 27.8 42.6 44.7 23.1 33.3 20.8 32.0 33.6 49.6 23.8 27.9 21.9 21.3 29.3 24.1 21.8 13.7 23.3 28.3 17.5 20.9 55.1 56.3 54.3 53.1 71.3 41.4 46.0 49.1 48.6 60.8 41.9 38.4 42.6 56.1 44.8 60.9 42.1 64.5 78.2 41.9 61.6 41.8 101.9 46.9 37.8 33.1 45.4 60.4 21.2 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439458-23442390 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.8;tongue: 61.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 24.7;HaCaT: 23.3;SiHa: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: , HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favourable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 11.6 9.2 5.9 8.5 6.9 39.3 14.7 9.7 9.5 13.8 8.8 9.3 6.9 4.9 9.8 10.0 8.2 9.0 9.9 25.9 6.0 5.9 14.7 7.3 26.6 11.0 6.2 6.7 10.9 6.5 12.8 7.8 11.5 5.4 8.0 5.8 9.8 6.4 6.2 60.8 17.5 7.9 7.3 6.5 13.1 16.9 9.9 5.8 8.1 14.9 61.1 12.3 12.7 10.5 3.5 1.0 5.1 4.0 0.2 3.5 0.5 2.9 1.4 1.6 0.7 6.3 3.2 2.0 1.2 2.7 2.9 2.6 0.6 24.7 1.4 2.6 1.5 23.3 1.7 2.9 1.9 10.5 4.5 0.0 3.6 0.9 5.4 0.2 2.0 3.2 12.9 0.8 4.1 0.9 0.3 9.9 1.6 1.4 0.9 0.9 1.2 0.8 1.5 7.1 1.3 3.8 2.6 0.7 1.7 15.1 2.7 6.8 1.1 2.1 1.7 1.6 2.4 4.5 0.5 4.8 9.0 0.7 2.5 0.9 0.6 5.1 1.6 2.6 0.8 1.7 1.0 1.9 1.5 0.8 1.0 3.5 1.2 1.7 3.6 0.2 4.0 0.6 3.5 0.5 5.9 6.9 9.7 9.5 6.0 5.9 6.2 6.7 5.4 5.8 OTUD3 "DUBA4, KIAA0459" ENSG00000169914 "OTU deubiquitinase 3" Q5T2D3 1 19882513-19912945 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028543, HPA028544" Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" Cytosol "Nucleoplasm, Intermediate filaments" "HPA028543: AB_10599302, HPA028544: AB_10602277" "unprognostic (6.45e-3)" "unprognostic (9.26e-2)" "unprognostic (3.77e-1)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" "unprognostic (3.16e-3)" "unprognostic (1.70e-3)" "unprognostic (3.15e-3)" "unprognostic (4.99e-2)" "unprognostic (1.09e-1)" "unprognostic (8.81e-2)" "unprognostic (4.68e-2)" "unprognostic (1.08e-1)" "unprognostic (9.83e-2)" "unprognostic (1.94e-1)" "unprognostic (7.28e-2)" "unprognostic (2.21e-2)" 6.5 11.0 15.0 6.9 19.2 11.4 10.0 19.3 23.2 10.6 8.9 6.6 6.4 10.2 14.2 13.0 6.1 8.2 7.2 5.2 12.6 7.3 7.1 4.8 8.5 7.0 9.9 12.5 11.2 7.2 9.3 20.2 5.4 9.0 9.8 8.3 6.9 6.2 9.2 9.2 13.0 9.6 11.9 8.1 7.7 7.3 28.4 9.7 6.0 6.9 2.9 6.3 7.0 7.6 1.7 0.6 0.8 0.4 0.6 2.2 0.3 5.0 1.9 8.6 10.3 3.7 3.3 8.5 5.4 3.1 2.8 2.7 9.0 4.8 8.0 4.4 11.9 5.0 8.0 3.1 5.5 5.2 10.7 7.7 10.2 6.2 2.0 5.6 7.1 2.7 3.1 4.4 5.7 3.7 5.4 3.4 4.8 2.7 4.3 5.6 4.1 5.1 10.0 22.0 3.0 4.7 5.5 7.6 5.4 3.9 3.1 4.2 4.7 4.2 4.4 6.7 8.6 7.4 4.6 4.0 3.4 5.0 4.7 7.6 3.1 0.8 0.4 0.1 1.5 0.3 1.4 1.7 1.7 1.4 0.3 1.3 2.2 1.8 0.7 0.6 0.1 0.6 0.9 0.3 15.0 19.2 19.3 23.2 12.6 7.3 9.9 12.5 9.0 9.7 OTUD5 "DKFZp761A052, DUBA" ENSG00000068308 "OTU deubiquitinase 5" Q96G74 X 48922028-48958386 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "U-266/70: 182.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017375 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Cytosol "Nucleoplasm, Nucleoli fibrillar center" "HPA017375: AB_1854844" "unprognostic (9.73e-2)" "prognostic favourable (9.57e-4)" "unprognostic (2.67e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (6.65e-2)" "unprognostic (2.33e-3)" "prognostic favourable (1.48e-4)" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "prognostic favourable (8.20e-4)" "unprognostic (1.32e-1)" "unprognostic (3.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-2)" "unprognostic (5.05e-3)" 23.5 27.5 32.4 26.8 40.9 38.4 21.9 35.0 52.4 21.3 22.9 28.2 23.4 30.5 25.5 26.8 20.5 25.1 20.9 16.6 29.8 31.3 22.6 24.5 25.2 30.8 25.4 29.8 30.0 25.4 29.6 26.8 23.1 29.4 24.0 17.8 20.4 26.9 27.4 24.4 24.5 29.1 27.1 21.4 34.5 22.3 12.7 24.0 34.8 24.5 14.4 27.2 22.1 22.7 7.8 6.3 8.6 5.1 18.6 7.5 3.5 6.1 9.3 4.3 10.7 7.4 6.6 5.0 5.4 6.3 6.8 7.4 4.6 6.8 6.9 3.5 6.8 7.5 6.5 5.4 6.4 8.0 7.9 5.2 9.4 5.3 6.2 4.9 5.8 7.3 5.1 7.1 4.8 5.4 6.5 10.9 4.8 6.1 7.7 10.7 7.8 7.3 6.1 6.4 8.9 4.8 5.5 4.2 7.4 7.1 4.6 7.1 6.1 4.5 7.6 4.4 5.6 11.7 4.4 182.8 45.6 6.6 6.9 6.9 3.0 5.2 3.4 7.0 7.0 5.1 5.8 7.8 5.5 6.0 4.8 6.0 5.2 7.5 8.6 18.6 4.7 6.3 7.0 3.5 32.4 40.9 35.0 52.4 29.8 31.3 25.4 29.8 29.4 24.0 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU domain containing 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavourable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 11.4 11.3 14.6 14.1 18.2 8.9 13.2 13.8 19.6 12.3 11.3 9.9 10.3 9.2 12.1 9.0 13.2 9.1 8.6 14.0 14.9 13.7 11.0 10.5 10.0 13.8 18.5 15.5 12.5 9.9 11.2 14.4 14.9 16.2 11.6 11.3 6.0 9.5 14.8 35.3 11.2 9.1 12.4 19.9 11.3 8.8 11.9 17.4 13.9 11.8 11.0 11.9 11.9 14.0 7.2 12.9 8.8 7.8 7.8 6.8 2.9 16.0 9.3 8.3 6.2 3.7 2.8 8.7 12.7 4.8 11.9 7.7 7.9 10.1 17.1 6.2 6.7 5.5 17.2 10.4 18.5 13.7 10.5 23.2 9.6 6.0 8.0 11.8 12.3 4.7 5.0 9.6 22.7 9.6 23.2 10.7 10.1 8.7 19.8 7.7 4.5 18.4 8.9 8.0 15.2 9.3 11.6 2.0 7.5 1.2 28.3 12.3 14.5 5.7 9.8 7.1 10.7 10.8 12.1 10.7 20.4 25.0 10.4 14.8 13.6 8.8 6.5 4.3 5.9 7.8 6.8 7.2 4.8 5.7 8.1 6.8 6.7 5.9 0.9 7.8 5.8 12.9 3.6 2.9 14.6 18.2 13.8 19.6 14.9 13.7 18.5 15.5 16.2 17.4 OTUD7B "CEZANNE, ZA20D1" ENSG00000264522 "OTU deubiquitinase 7B" Q6GQQ9 1 149937812-150010676 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.7" "Group enriched" "Detected in many" 4 "granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027045 Supported Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA027045: AB_1854847" "unprognostic (2.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.90e-1)" "prognostic favourable (7.47e-4)" "unprognostic (1.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.23e-3)" "unprognostic (1.46e-2)" "prognostic favourable (5.09e-5)" "unprognostic (4.90e-2)" "unprognostic (7.72e-2)" "unprognostic (8.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.67e-2)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (1.58e-2)" 8.8 6.2 5.8 2.6 12.3 0.3 6.2 8.5 8.9 8.6 6.3 20.6 4.0 4.6 8.5 4.1 6.1 7.6 4.3 5.3 6.0 4.5 8.6 5.6 0.9 12.7 5.1 9.2 4.5 12.5 4.3 5.3 11.6 5.3 5.6 7.4 5.4 6.3 13.2 4.3 5.1 8.9 8.5 2.3 5.2 9.6 12.5 0.0 8.3 2.3 2.1 6.3 7.1 0.6 0.6 4.7 0.3 1.4 2.3 0.2 11.4 9.2 6.5 10.8 8.6 8.0 6.1 8.1 11.9 9.7 6.7 6.8 9.3 0.1 5.3 14.6 9.2 9.1 8.9 10.3 11.0 4.7 4.4 12.8 4.5 9.2 5.0 4.8 8.8 6.9 16.5 14.5 7.9 12.0 12.5 7.0 11.7 0.8 1.4 8.2 9.0 1.2 8.9 2.9 3.8 15.7 4.2 7.9 14.2 10.5 12.8 8.7 2.6 9.5 10.1 9.4 6.8 9.4 13.4 12.9 1.3 9.0 1.5 16.5 4.7 0.3 1.3 2.3 0.2 1.7 0.6 1.0 1.4 0.1 0.6 0.9 1.0 1.2 1.4 0.3 0.6 0.6 0.2 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell line enhanced" "Detected in some" "A-431: 9.9;BEWO: 28.5;CACO-2: 7.2;HaCaT: 16.8;RT4: 16.6;SK-BR-3: 13.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003984 Uncertain Approved Nucleoplasm Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavourable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favourable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 7.2 2.7 0.0 0.1 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 16.6 0.1 0.0 0.0 13.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 OVOL2 "bA504H3.3, CHED, CHED1, HOVO2, ZNF339" ENSG00000125850 "Ovo like zinc finger 2" Q9BRP0 20 17956979-18059188 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 6.7;CACO-2: 5.2;CAPAN-2: 8.9;HaCaT: 6.6;SCLC-21H: 10.3;SK-BR-3: 6.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 10.5;hippocampal formation: 6.8" "Group enriched" "Detected in some" 5 "cerebral cortex: 7.6;hippocampal formation: 5.8" HPA038531 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038531: AB_10673012" "unprognostic (2.85e-2)" "unprognostic (5.13e-2)" "unprognostic (2.41e-2)" "unprognostic (7.35e-2)" "unprognostic (2.14e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.40e-1)" "unprognostic (2.61e-1)" "unprognostic (2.63e-2)" "unprognostic (1.62e-1)" "unprognostic (1.84e-4)" "unprognostic (4.77e-3)" "unprognostic (2.92e-1)" "unprognostic (2.57e-2)" "unprognostic (3.76e-2)" 0.0 0.0 0.0 3.4 0.0 0.0 3.7 0.0 0.6 3.0 9.8 0.0 18.2 5.0 1.0 3.3 7.6 1.6 8.9 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.6 8.7 1.0 1.8 2.5 0.0 7.0 2.6 0.0 10.5 14.2 0.1 7.6 8.7 0.5 0.0 0.0 14.7 1.5 0.0 0.3 18.1 5.0 4.4 2.6 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 5.2 8.9 0.0 1.2 0.0 6.6 1.6 1.7 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.1 3.2 10.3 0.0 0.0 6.9 0.1 3.5 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 OXNAD1 MGC15763 ENSG00000154814 "Oxidoreductase NAD binding domain containing 1" Q96HP4 3 16265160-16350299 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 33.0" "Lineage enriched" "Detected in all" 5 "T-cells: 33.0" "Low region specificity" "Detected in all" "HPA036830, HPA059160" Approved Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA036830: , HPA059160: " "unprognostic (4.49e-2)" "unprognostic (7.41e-3)" "unprognostic (2.71e-3)" "unprognostic (2.38e-3)" "unprognostic (4.65e-2)" "unprognostic (3.23e-2)" "unprognostic (1.46e-1)" "unprognostic (2.31e-2)" "unprognostic (1.23e-2)" "unprognostic (8.05e-2)" "unprognostic (1.46e-1)" "unprognostic (8.08e-2)" "prognostic favourable (1.00e-7)" "unprognostic (2.22e-2)" "unprognostic (1.03e-1)" "unprognostic (6.95e-3)" "prognostic favourable (7.63e-4)" 8.1 8.8 7.5 14.1 11.1 10.9 8.1 9.1 13.6 5.4 11.4 9.1 7.3 16.3 7.7 4.3 10.8 6.2 7.1 12.0 7.1 5.9 15.5 22.4 6.6 20.7 10.9 7.9 6.9 7.4 6.5 12.4 5.2 9.5 5.4 10.2 6.8 9.4 9.3 18.1 8.2 18.4 4.2 8.9 9.2 9.4 9.3 12.1 8.2 8.0 7.0 16.0 7.8 6.6 1.9 2.2 1.3 2.0 6.4 33.0 7.5 5.5 8.1 5.3 8.4 6.3 5.6 20.9 6.0 4.5 8.3 6.7 11.7 5.7 8.0 3.8 3.7 4.0 11.0 9.8 8.0 14.4 7.3 11.7 7.0 6.2 6.5 18.8 7.1 4.2 7.4 13.5 6.5 6.4 15.9 19.1 3.6 9.9 10.9 9.9 11.3 9.6 9.8 6.5 13.9 5.6 6.7 3.8 5.3 6.7 11.3 9.3 7.2 10.9 2.9 5.4 6.9 5.9 9.7 6.9 12.5 12.9 6.5 16.5 7.2 0.0 1.4 1.1 9.0 2.0 11.9 1.9 13.8 9.7 2.2 1.5 33.0 24.4 1.3 6.4 1.8 1.7 7.3 7.5 7.5 11.1 9.1 13.6 7.1 5.9 10.9 7.9 9.5 12.1 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.5" "Cell line enhanced" "Detected in many" "HaCaT: 36.0;RPTEC TERT1: 36.7;RT4: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 20.3" "Lineage enriched" "Detected in single" 104 "dendritic cells: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" "Golgi apparatus" Nucleoplasm "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 2.4 22.6 2.9 4.0 3.9 0.2 3.1 0.7 2.2 14.3 11.8 6.2 11.5 1.2 15.0 13.5 8.9 4.6 8.4 3.8 2.8 2.1 74.5 3.5 22.5 3.6 8.1 1.0 11.2 3.9 1.4 6.1 11.0 5.6 19.9 5.3 10.3 2.7 14.3 0.6 8.6 3.6 16.3 7.6 33.7 12.0 2.8 5.3 2.0 1.7 6.3 2.7 5.7 9.8 0.0 20.3 0.1 0.1 0.0 0.0 0.1 14.9 5.9 11.7 0.0 0.2 0.4 14.0 15.9 6.3 2.6 4.2 4.8 5.9 0.0 9.1 2.8 36.0 0.0 21.3 5.5 0.1 2.0 0.0 4.0 0.0 12.1 0.0 0.1 5.7 7.2 5.0 1.8 0.4 0.0 0.1 4.0 0.3 0.0 0.1 3.6 1.2 0.0 2.3 0.8 36.7 25.1 0.8 0.1 21.6 1.2 9.5 0.0 0.2 7.9 15.5 5.8 0.1 2.8 1.1 0.0 0.1 3.6 0.0 19.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.1 2.9 3.9 0.7 2.2 2.8 2.1 8.1 1.0 5.6 5.3 PAAF1 "FLJ11848, Rpn14, WDR71" ENSG00000175575 "Proteasomal ATPase associated factor 1" Q9BRP4 11 73876699-73931124 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039952, HPA040020" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039952: AB_10793925, HPA040020: " "unprognostic (3.13e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.13e-2)" "unprognostic (4.51e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (1.74e-1)" "unprognostic (4.48e-1)" "unprognostic (2.30e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (2.73e-1)" "unprognostic (4.42e-1)" 9.5 12.8 32.4 6.9 30.6 5.2 12.3 18.0 23.2 11.7 8.7 34.4 7.6 7.8 11.5 17.2 10.0 13.9 8.0 9.9 30.5 27.4 16.0 13.8 7.9 7.6 37.4 19.6 17.8 19.8 16.8 10.1 7.7 25.4 14.5 11.5 12.9 9.9 14.5 11.9 12.8 7.8 12.1 38.9 7.1 6.8 18.8 27.0 8.2 13.0 2.1 11.1 7.9 6.3 22.6 19.3 22.1 15.1 16.5 22.6 15.1 5.6 13.1 11.9 9.3 13.0 13.4 6.8 9.7 11.3 15.6 11.1 25.6 4.5 17.1 15.2 9.9 13.0 14.5 11.7 23.2 12.7 9.0 17.4 12.9 21.0 15.6 16.2 6.7 13.7 18.4 17.0 20.9 11.7 21.0 14.7 14.4 11.0 14.3 16.9 5.5 10.3 13.3 31.8 27.9 11.5 9.8 12.7 14.9 11.5 7.7 30.0 23.1 9.2 8.4 11.0 7.0 15.5 9.4 18.2 20.4 34.8 7.7 10.6 11.4 22.1 15.1 17.4 16.0 9.5 17.5 22.6 17.5 16.2 19.3 18.8 22.6 19.4 1.3 16.5 3.4 14.0 19.6 15.1 32.4 30.6 18.0 22.3 30.5 27.4 37.4 19.6 25.4 27.0 PABPN1 "OPMD, PAB2, PABP2" ENSG00000100836 "Poly(A) binding protein nuclear 1" Q86U42 14 23321289-23326185 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000637 Supported Approved "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA000637: AB_1079553" "unprognostic (5.11e-3)" "unprognostic (2.65e-2)" "unprognostic (7.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.95e-3)" "prognostic favourable (9.66e-4)" "unprognostic (5.88e-2)" "prognostic unfavourable (2.41e-7)" "unprognostic (1.52e-2)" "unprognostic (1.31e-2)" "unprognostic (1.07e-1)" "unprognostic (8.25e-3)" 41.1 46.0 67.4 39.8 73.7 57.1 34.0 79.5 80.2 36.1 42.2 39.4 51.2 55.1 55.3 67.7 38.3 43.2 43.4 35.3 64.4 44.7 46.6 47.1 33.2 46.4 62.4 45.8 48.6 35.2 44.8 54.0 40.6 60.3 46.2 52.8 39.4 42.3 45.2 46.6 53.7 55.9 50.2 47.4 46.0 41.4 54.1 69.3 53.5 51.0 29.6 54.6 33.3 46.5 11.4 15.6 13.1 9.8 12.0 9.0 2.8 25.3 28.5 63.0 49.7 29.6 33.3 41.0 26.4 26.0 36.1 34.6 34.0 47.7 45.5 14.2 33.3 40.3 70.2 36.4 50.2 38.8 26.8 35.1 40.7 87.9 33.1 54.4 48.3 38.7 36.5 26.8 31.6 39.5 32.8 35.7 34.5 48.3 57.2 66.6 68.9 32.5 57.2 24.4 27.4 40.8 52.7 43.5 34.0 33.8 31.5 26.8 23.8 39.5 33.3 25.2 32.2 24.6 33.4 42.7 29.5 53.9 15.0 44.7 29.3 13.1 9.8 8.9 7.3 7.0 5.9 8.7 7.3 6.3 7.6 11.4 9.0 8.5 11.9 12.0 7.7 15.6 7.9 2.8 67.4 73.7 79.5 80.2 64.4 44.7 62.4 45.8 60.3 69.3 PACRGL "C4orf28, MGC29898" ENSG00000163138 "Parkin coregulated like" Q8N7B6 4 20696282-20752907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054666 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA054666: " "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.90e-3)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-2)" "unprognostic (1.09e-2)" "unprognostic (2.97e-1)" "unprognostic (4.55e-2)" "unprognostic (2.20e-2)" "unprognostic (5.08e-2)" "unprognostic (3.35e-2)" "unprognostic (1.25e-2)" "unprognostic (6.74e-3)" "unprognostic (3.63e-2)" "unprognostic (1.07e-2)" "prognostic favourable (4.85e-4)" 7.9 8.7 12.2 10.7 15.6 3.2 16.5 7.8 19.0 9.1 8.9 9.3 14.6 6.6 13.9 15.1 9.6 14.2 10.0 9.5 14.1 12.4 8.7 4.7 7.7 7.3 12.1 12.9 14.0 6.7 9.7 13.7 7.4 10.5 11.2 9.4 8.4 7.7 11.4 10.1 14.3 7.7 13.1 15.1 6.8 7.7 37.3 10.7 4.5 15.8 10.0 6.3 11.1 8.9 4.3 7.0 1.4 4.7 4.1 6.1 2.9 8.9 7.0 12.3 9.3 16.7 15.5 6.0 11.5 9.1 10.6 12.9 6.3 19.1 9.5 7.7 6.5 4.3 6.9 8.6 18.2 2.9 6.1 6.0 10.5 10.0 8.8 12.3 6.4 10.7 12.9 13.3 12.4 10.7 10.3 5.5 9.0 6.5 12.3 11.4 15.6 9.9 6.6 13.4 5.8 10.6 5.9 20.4 13.4 8.5 4.3 8.6 7.9 7.0 8.3 10.4 9.6 14.3 15.9 5.7 1.6 8.8 15.2 8.3 17.9 0.0 3.1 1.4 2.7 4.7 6.1 4.3 3.0 2.7 5.3 4.0 4.7 3.0 1.2 4.1 3.7 7.0 3.5 2.9 12.2 15.6 7.8 19.0 14.1 12.4 12.1 12.9 10.5 10.7 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Cell line enhanced" "Detected in some" "MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: " "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.7 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 9.7 0.5 0.0 2.4 0.0 0.1 0.0 11.3 0.0 0.3 3.6 0.2 0.0 1.8 0.0 18.0 1.9 0.0 0.0 0.3 0.0 0.0 3.0 13.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 PADI1 "HPAD10, PAD1, PDI, PDI1" ENSG00000142623 "Peptidyl arginine deiminase 1" Q9ULC6 1 17205126-17246005 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 48.7;lymphoid tissue: 60.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.3;EFO-21: 4.5;HaCaT: 2.8;LHCN-M2: 3.6;RPTEC TERT1: 4.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Low region specificity" "Detected in some" HPA062294 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA062294: " "unprognostic (9.30e-2)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.40e-1)" "unprognostic (5.22e-2)" "unprognostic (7.27e-2)" "unprognostic (3.84e-1)" "unprognostic (3.37e-2)" "unprognostic (1.41e-1)" "unprognostic (7.75e-2)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "prognostic unfavourable (8.34e-11)" "unprognostic (2.00e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.3 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.1 0.0 4.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 60.2 1.3 6.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.1 9.3 0.0 4.5 0.4 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;RT4: 15.8;T-47d: 11.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 3.2 10.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 6.4 0.0 2.3 0.0 9.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 28.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.2 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 15.8 0.0 0.0 0.0 2.3 0.1 11.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Group enriched" "Detected in some" 7 "A-431: 47.9;Karpas-707: 37.0;U-266/84: 57.0" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 37.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles 590000 "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.36e-4)" "prognostic unfavourable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 28.7 18.9 22.4 27.6 23.5 21.4 56.5 17.4 20.7 19.5 23.0 27.8 17.4 19.0 22.6 19.2 23.4 17.9 20.7 29.0 22.6 22.0 19.5 34.3 35.7 50.2 26.8 13.5 19.9 16.6 30.5 13.0 27.6 22.8 17.7 23.0 12.9 19.6 21.2 34.2 16.3 25.2 23.0 32.1 34.6 18.4 15.9 24.8 44.9 16.9 19.1 31.9 24.1 32.7 6.6 13.7 25.9 12.6 6.6 10.8 7.0 35.2 12.6 17.8 13.0 12.6 16.7 26.4 17.9 14.8 19.5 17.8 29.9 18.1 22.6 51.2 18.1 18.1 18.8 17.0 30.2 10.1 9.1 33.5 14.5 23.5 25.6 32.5 32.2 13.3 14.0 17.4 37.1 19.2 16.1 28.2 18.9 37.2 30.9 16.8 10.6 19.0 28.3 10.1 20.5 17.0 24.8 10.4 11.8 23.9 16.9 13.5 59.3 23.6 19.8 16.2 9.0 16.9 26.3 19.2 33.9 55.7 13.4 32.6 15.3 16.5 10.3 24.5 6.3 12.6 8.5 6.4 7.3 7.1 13.7 6.6 5.4 6.3 25.9 6.6 10.8 5.1 10.8 7.0 22.4 23.5 17.4 20.7 22.6 22.0 26.8 13.5 22.8 24.8 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537389-9839041 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.3" "Group enriched" "Detected in some" 9 "SCLC-21H: 10.0;SH-SY5Y: 3.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.5 5.2 5.7 0.6 11.7 0.5 1.6 30.3 19.6 0.8 0.6 0.8 0.0 0.7 1.0 2.2 1.0 0.7 3.4 0.6 4.0 3.3 1.0 2.3 0.7 0.6 1.6 8.8 0.6 3.5 0.5 2.0 0.6 5.3 1.6 0.6 0.6 1.2 1.6 0.6 1.6 0.6 0.6 1.2 0.6 1.2 1.0 1.7 0.0 0.6 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 5.7 11.7 30.3 13.6 4.0 3.3 1.6 8.8 5.3 1.7 PALM2-AKAP2 ENSG00000157654 "PALM2-AKAP2 readthrough" 9 109780309-110172512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.0;heart muscle: 26.8" "Cell line enhanced" "Detected in many" "ASC diff: 15.4;hTEC/SVTERT24-B: 14.8;RH-30: 29.1;U-251 MG: 13.0;WM-115: 17.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: , HPA074153: , HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 41.0 2.8 1.6 3.3 1.6 0.1 19.6 0.7 4.7 4.8 2.3 1.5 2.1 1.1 15.2 4.7 2.1 2.5 5.0 26.8 1.8 2.4 2.4 24.8 9.7 1.2 1.9 0.5 5.9 1.1 1.6 1.1 9.2 3.0 3.2 0.6 1.1 2.0 3.6 4.5 1.8 1.0 7.8 1.4 0.5 1.1 1.4 0.9 0.0 3.8 2.5 0.3 5.2 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.3 0.0 15.4 5.5 1.3 5.4 5.3 1.6 3.6 0.0 0.1 0.0 0.5 5.6 2.0 0.0 1.2 4.5 0.2 1.6 0.0 5.0 0.1 0.1 0.0 0.0 7.0 0.1 14.8 2.4 0.1 0.0 0.0 5.7 0.0 0.0 0.0 4.3 1.4 0.0 29.1 0.0 4.0 0.0 1.7 0.0 2.1 0.2 7.4 0.6 0.0 0.1 3.4 8.5 0.3 13.0 0.0 0.2 0.0 4.2 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.6 1.6 0.7 3.0 1.8 2.4 1.9 0.5 3.0 0.9 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053365-14059159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.5;testis: 19.7" "Group enriched" "Detected in some" 4 "AN3-CA: 21.7;CACO-2: 23.2;HAP1: 19.4;NTERA-2: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: , HPA056119: " "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavourable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.2 0.2 4.3 0.9 1.9 0.0 2.1 3.7 3.6 2.9 0.5 3.2 0.2 2.7 0.4 11.1 0.2 1.5 1.6 0.2 4.2 2.8 12.9 26.5 2.4 0.2 1.7 4.3 0.4 11.7 1.8 0.2 0.7 10.1 1.8 0.2 1.1 6.9 8.0 0.2 0.2 0.8 0.9 2.7 0.2 13.0 19.7 4.9 0.2 6.8 0.2 1.0 3.9 1.9 0.9 0.2 0.0 0.3 0.0 1.8 0.0 1.6 1.5 3.6 21.7 0.3 0.1 4.4 0.4 0.1 1.2 0.6 23.2 0.5 0.0 0.2 0.4 0.1 19.4 0.0 0.3 0.0 1.3 0.1 0.5 2.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.1 4.5 0.0 0.0 3.6 0.2 0.1 14.0 1.3 0.0 0.0 0.0 0.0 1.8 2.7 3.6 0.1 0.0 0.0 1.3 0.0 0.2 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.9 0.8 0.3 0.0 0.1 0.9 1.8 1.8 0.0 0.0 0.1 0.2 0.5 0.0 4.3 1.9 3.7 3.6 4.2 2.8 1.7 4.3 10.1 4.9 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579600 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062358 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA062358: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favourable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 9.1 16.6 11.6 17.5 10.4 10.5 17.6 22.8 11.9 8.9 23.9 9.0 8.5 28.0 10.2 8.8 12.8 7.8 6.9 7.4 11.7 9.1 13.2 39.2 12.5 8.2 8.4 7.5 10.7 8.8 14.6 11.2 9.4 10.8 9.1 17.9 6.7 11.0 9.6 8.2 11.9 63.0 8.0 10.3 9.6 10.9 10.2 11.0 10.2 10.5 13.4 8.2 9.9 11.6 4.1 2.7 3.5 4.7 0.9 2.5 1.1 13.8 7.8 32.3 17.2 12.1 14.1 13.7 8.3 8.9 11.2 16.5 12.9 12.9 21.3 13.7 11.7 10.0 21.6 16.7 20.1 19.8 10.5 10.9 7.4 9.5 14.1 14.7 14.8 11.2 22.6 14.0 15.8 13.1 10.0 21.6 15.2 7.7 14.6 6.7 13.8 5.7 10.7 22.1 8.7 14.0 20.5 15.1 32.3 9.6 15.8 23.6 20.6 18.6 13.4 15.1 21.2 8.9 17.7 15.1 20.7 15.9 8.9 15.0 11.7 3.5 3.2 1.6 1.9 3.8 2.5 4.1 1.9 1.9 2.0 1.6 1.3 2.3 1.3 0.9 4.7 2.7 2.4 1.1 11.6 10.4 22.8 11.8 11.7 9.1 8.4 7.5 10.8 11.0 PAPLN MGC50452 ENSG00000100767 "Papilin, proteoglycan like sulfated glycoprotein" O95428 14 73237497-73274640 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 12.9;HSkMC: 24.3;hTCEpi: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "neutrophil: 4.4;plasmacytoid DC: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 8.8;granulocytes: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA048682, HPA053453" Uncertain Approved Nucleoplasm "Secreted - unknown location" 46000000 Nucleoplasm "HPA048682: , HPA053453: " "unprognostic (1.97e-3)" "unprognostic (3.27e-2)" "unprognostic (1.88e-1)" "unprognostic (3.56e-3)" "unprognostic (7.42e-2)" "unprognostic (7.91e-3)" "unprognostic (2.01e-2)" "unprognostic (2.46e-3)" "unprognostic (9.13e-3)" "unprognostic (3.69e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.89e-2)" "unprognostic (2.14e-2)" "unprognostic (3.05e-3)" "unprognostic (2.69e-2)" "unprognostic (5.58e-2)" 9.3 6.1 13.6 11.8 14.8 2.9 11.0 4.1 11.1 10.8 7.0 6.0 3.8 4.1 14.2 19.5 4.6 12.1 8.0 4.8 15.7 3.0 24.9 1.9 7.8 23.3 4.1 9.7 10.9 2.7 1.0 11.1 5.2 5.7 8.1 6.2 14.9 4.7 10.2 1.8 16.2 10.3 8.6 6.0 17.6 7.4 6.5 8.9 5.1 15.3 2.2 16.5 6.8 5.6 1.1 8.8 4.4 0.8 0.5 0.5 0.2 2.0 1.9 0.8 0.3 1.5 1.8 4.6 0.4 0.0 0.1 0.1 2.5 0.6 0.4 2.1 0.0 3.3 2.0 1.5 0.2 2.3 3.1 0.9 3.2 0.3 12.9 0.3 1.7 24.3 9.0 0.4 1.3 0.4 0.6 0.3 0.0 1.0 0.2 2.2 0.5 0.6 0.3 0.3 2.1 1.8 0.4 0.2 0.4 4.8 5.4 0.9 0.1 3.6 0.4 0.6 1.8 0.2 0.2 1.0 0.1 0.2 1.1 1.0 0.5 1.1 0.8 0.6 0.4 0.5 0.2 0.7 0.3 0.5 0.2 1.1 0.5 0.5 4.4 0.5 0.4 8.8 0.5 0.2 13.6 14.8 4.1 11.1 15.7 3.0 4.1 9.7 5.7 8.9 PAPSS1 "ATPSK1, PAPSS" ENSG00000138801 "3'-phosphoadenosine 5'-phosphosulfate synthase 1" O43252 4 107590276-107720452 "Enzymes, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.3;eosinophil: 62.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049781 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA049781: " "unprognostic (1.36e-2)" "unprognostic (5.03e-2)" "prognostic favourable (9.14e-4)" "prognostic favourable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic unfavourable (2.70e-5)" "unprognostic (1.58e-2)" "unprognostic (1.05e-1)" "unprognostic (8.92e-2)" "unprognostic (1.42e-1)" "unprognostic (5.76e-2)" "unprognostic (6.23e-3)" "unprognostic (1.29e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-2)" "unprognostic (1.38e-1)" 13.5 7.4 24.3 14.4 28.5 11.1 25.2 16.4 32.2 26.6 10.0 45.0 9.4 7.9 25.1 22.8 18.3 24.9 13.3 7.7 31.3 23.9 16.7 5.1 22.0 14.7 29.7 21.9 15.6 24.6 15.6 15.5 8.5 38.2 21.7 12.7 9.5 32.2 14.0 3.3 24.5 8.5 17.0 59.9 9.6 30.4 8.1 25.5 14.7 10.3 11.0 24.6 16.5 13.7 8.5 9.2 62.2 10.2 4.6 6.8 5.8 10.5 9.6 16.3 20.4 20.2 25.5 13.1 13.4 25.4 13.2 17.7 14.7 15.3 16.5 8.6 24.7 13.3 15.4 26.6 17.0 38.7 11.7 19.2 20.9 32.9 11.1 29.1 33.3 21.1 13.8 15.2 12.5 29.2 4.2 32.1 36.9 16.1 23.4 9.0 17.5 10.7 19.7 25.9 4.7 19.8 14.7 18.6 26.9 13.9 21.1 16.4 12.5 4.5 17.2 16.5 17.0 11.0 11.3 25.8 17.1 15.4 20.1 22.3 25.9 50.3 8.9 62.2 3.0 9.6 3.5 8.5 4.0 3.4 9.2 4.1 2.5 2.9 9.4 4.6 10.2 1.8 6.8 5.8 24.3 28.5 16.4 32.2 31.3 23.9 29.7 21.9 38.2 25.5 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell line enhanced" "Detected in many" "U-266/70: 20.7" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" HPA073505 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA073505: " "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavourable (1.99e-4)" "prognostic unfavourable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favourable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.7 2.0 3.3 3.4 0.6 0.5 8.1 0.2 0.5 0.0 0.2 0.9 6.3 3.2 1.5 0.5 5.7 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 0.2 1.5 9.4 0.5 6.7 0.2 1.0 3.7 0.9 1.4 0.7 1.5 2.3 10.6 2.8 5.7 0.7 0.7 3.8 10.7 1.1 0.5 1.0 5.3 1.7 0.5 20.7 4.5 2.0 0.2 7.4 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 PARP12 "FLJ22693, PARP-12, ZC3H1, ZC3HDC1" ENSG00000059378 "Poly(ADP-ribose) polymerase family member 12" Q9H0J9 7 140023744-140063721 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 11.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003584, HPA063872" Approved Approved Nucleoplasm Nucleoplasm "HPA003584: AB_1079568, HPA063872: " "unprognostic (1.46e-3)" "unprognostic (2.93e-2)" "unprognostic (1.73e-1)" "unprognostic (2.71e-2)" "unprognostic (6.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavourable (1.63e-4)" "unprognostic (2.30e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (7.51e-3)" "unprognostic (2.68e-1)" "prognostic unfavourable (4.12e-7)" "unprognostic (3.31e-2)" "unprognostic (2.76e-1)" "unprognostic (1.75e-2)" "unprognostic (6.01e-2)" 3.1 1.8 1.0 3.7 0.9 6.1 2.5 0.1 0.7 2.1 2.2 4.2 2.8 4.2 2.1 2.5 3.1 1.7 1.0 1.0 3.1 3.0 5.2 3.8 1.0 3.2 2.7 2.5 3.3 3.4 2.8 3.9 4.3 1.4 0.9 8.6 4.4 1.5 1.3 6.0 2.3 5.7 3.2 2.7 1.9 3.1 1.0 1.3 3.4 2.0 2.3 3.3 2.4 3.7 2.3 0.0 0.4 1.1 0.4 3.8 0.6 0.5 4.6 7.8 2.7 3.5 1.7 2.8 1.1 3.7 1.5 4.3 1.3 4.6 4.6 1.4 1.3 1.7 2.0 0.4 1.4 1.5 2.5 2.0 4.2 4.9 4.1 2.3 0.0 2.9 4.4 11.9 0.2 6.8 2.0 0.0 0.0 2.0 2.3 1.4 0.0 2.4 1.1 3.4 0.6 0.9 9.4 1.5 2.1 0.5 3.4 0.1 0.1 0.4 0.9 5.8 0.8 0.7 2.0 2.2 2.9 1.7 1.1 0.3 1.9 2.9 1.3 1.0 0.6 1.9 3.4 2.3 1.9 0.7 3.3 2.4 PARP8 "FLJ21308, pART16" ENSG00000151883 "Poly(ADP-ribose) polymerase family member 8" Q8N3A8 5 50665899-50846522 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049183 Approved Approved "Nucleoplasm,Midbody ring,Cytosol" Nucleoplasm "Midbody ring, Cytosol" "HPA049183: " "unprognostic (1.22e-2)" "unprognostic (2.53e-1)" "unprognostic (1.77e-1)" "unprognostic (1.05e-1)" "unprognostic (2.12e-1)" "unprognostic (6.33e-2)" "unprognostic (8.86e-3)" "unprognostic (7.27e-2)" "unprognostic (1.86e-2)" "unprognostic (8.96e-2)" "unprognostic (2.85e-1)" "unprognostic (6.81e-2)" "unprognostic (9.63e-2)" "unprognostic (2.84e-2)" "unprognostic (4.42e-2)" "unprognostic (4.23e-2)" "prognostic favourable (1.12e-4)" 6.2 7.8 8.8 17.1 9.5 33.5 5.3 2.4 18.7 5.6 5.5 3.3 0.6 6.8 5.2 5.4 5.2 7.4 12.3 3.6 12.8 8.0 5.8 4.2 10.9 18.2 4.9 11.0 5.9 7.1 9.8 14.4 5.6 5.4 6.1 4.3 4.1 7.6 4.2 1.7 4.2 14.2 5.4 7.0 20.1 10.2 6.4 2.8 9.9 21.9 1.1 12.3 8.8 7.0 7.1 3.9 13.1 5.9 15.5 32.0 9.5 11.7 0.0 5.4 8.6 1.5 2.7 8.6 1.9 7.0 1.9 5.6 0.3 15.4 6.9 8.2 0.2 5.8 0.9 5.9 4.5 9.7 7.5 5.1 4.7 0.5 2.9 11.9 0.1 3.3 4.9 3.8 2.7 0.1 0.7 4.2 2.6 3.8 14.3 15.1 5.8 2.9 7.2 11.5 8.0 3.5 5.8 6.0 9.3 6.3 10.3 1.6 0.4 42.2 0.0 0.4 7.3 0.5 5.7 3.1 0.1 13.5 6.5 3.4 8.0 10.3 5.9 13.1 20.6 1.6 32.0 6.0 16.1 23.0 3.9 7.1 10.0 16.7 12.3 15.5 1.1 1.8 9.5 9.5 8.8 9.5 2.4 18.7 12.8 8.0 4.9 11.0 5.4 2.8 PAXBP1 "C21orf66, fSAP105, GCFC, GCFC1" ENSG00000159086 "PAX3 and PAX7 binding protein 1" Q9Y5B6 21 32733899-32771858 "Plasma proteins, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003757 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003757: AB_10600796" "unprognostic (8.21e-2)" "unprognostic (7.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (6.53e-2)" "unprognostic (2.03e-3)" "unprognostic (2.38e-3)" "unprognostic (2.54e-2)" "unprognostic (6.89e-2)" "unprognostic (2.65e-1)" "unprognostic (2.01e-2)" "prognostic unfavourable (9.43e-4)" "prognostic unfavourable (1.50e-5)" "unprognostic (3.16e-1)" "unprognostic (3.78e-2)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" 8.9 10.6 11.9 16.6 19.6 42.0 11.6 25.7 20.0 13.5 14.1 11.3 10.1 15.8 16.3 12.4 10.3 11.6 10.1 8.3 11.2 9.7 11.3 10.3 10.1 13.7 22.7 10.0 19.8 12.3 11.6 19.3 13.2 14.7 11.2 12.6 6.9 10.2 10.5 15.2 12.6 12.8 10.8 19.0 11.2 9.5 12.9 19.7 18.5 11.3 5.0 12.3 11.2 18.9 2.2 1.6 0.3 1.3 0.7 3.1 0.4 7.3 6.1 12.3 9.6 4.8 3.9 17.5 5.5 3.5 7.2 5.3 12.8 6.7 8.8 4.3 3.1 7.6 12.3 5.1 7.6 7.1 10.1 15.1 10.0 9.3 2.3 17.0 9.0 2.1 7.7 8.4 3.7 4.7 17.6 8.1 5.3 6.5 11.6 9.9 34.7 6.2 10.8 11.7 12.8 5.6 6.8 10.1 5.7 7.9 9.1 6.2 5.8 9.5 4.2 5.4 7.4 6.2 8.5 8.0 10.0 16.3 3.9 15.5 5.4 0.0 1.3 0.3 2.2 0.6 3.1 1.6 2.5 1.9 1.6 2.2 2.7 2.6 0.0 0.7 0.8 1.1 1.4 0.4 11.9 19.6 25.7 20.0 11.2 9.7 22.7 10.0 14.7 19.7 PAXIP1 "CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2" ENSG00000157212 "PAX interacting protein 1" Q6ZW49 7 154943687-155003084 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 32.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006694, HPA016950" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA006694: AB_1855011, HPA016950: AB_2669489" "unprognostic (2.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.14e-2)" "unprognostic (2.66e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (7.39e-3)" "unprognostic (2.65e-2)" "unprognostic (1.34e-3)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.36e-1)" "unprognostic (3.28e-2)" "unprognostic (4.99e-3)" "unprognostic (3.98e-1)" "unprognostic (2.44e-3)" "unprognostic (2.30e-1)" 6.0 5.4 5.7 6.2 5.0 9.7 6.3 32.3 5.7 7.8 5.5 5.8 4.5 5.2 6.5 6.7 7.1 5.7 5.0 4.7 6.0 3.4 5.7 6.9 4.7 9.4 5.7 1.4 7.1 8.4 7.2 8.7 7.9 5.6 7.7 5.7 6.9 6.6 5.4 7.1 7.4 6.9 9.3 4.2 6.4 5.9 10.4 6.2 31.2 6.4 4.7 6.9 6.1 5.9 2.2 3.3 1.4 3.1 2.9 6.5 2.5 9.8 8.1 10.7 18.2 4.7 3.9 9.6 4.4 4.6 6.0 7.1 8.9 7.8 12.9 5.5 5.2 7.8 13.7 6.9 7.5 12.9 10.7 9.8 5.8 7.6 3.3 13.3 13.1 3.8 5.2 6.0 2.4 5.7 13.4 8.7 6.0 13.7 28.3 11.1 17.4 5.5 16.2 11.0 14.0 6.2 8.3 8.6 5.5 11.6 8.7 5.4 6.6 11.5 2.9 5.1 0.9 7.2 10.4 8.9 5.2 17.8 12.5 15.7 13.6 0.7 2.3 1.4 2.5 2.6 3.8 1.3 4.0 2.9 2.6 2.2 6.5 1.7 1.0 2.9 3.1 3.3 3.2 2.5 5.7 5.0 32.3 5.7 6.0 3.4 5.7 1.4 5.6 6.2 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favourable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.8 15.2 10.4 19.5 19.5 13.1 21.6 18.6 20.0 17.2 17.0 16.9 16.7 14.6 21.8 17.6 25.4 24.2 26.1 12.3 16.1 12.3 10.0 25.4 30.7 36.2 18.1 15.5 20.0 27.3 23.3 25.3 17.4 8.3 24.3 14.3 17.0 26.5 42.3 27.9 14.6 16.0 2.1 29.1 22.6 8.9 11.5 9.6 15.9 0.1 9.7 13.7 21.8 14.9 15.0 17.7 19.8 14.7 25.8 9.9 16.6 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 PBX2 "G17, HOX12, PBX2MHC" ENSG00000204304 "PBX homeobox 2" P40425 6 32184741-32190186 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061478 Supported Approved Nucleoplasm Nucleoplasm "HPA061478: " "unprognostic (9.73e-3)" "unprognostic (2.16e-2)" "unprognostic (1.40e-2)" "prognostic unfavourable (8.90e-5)" "unprognostic (4.98e-1)" "unprognostic (2.68e-2)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (1.81e-2)" "prognostic favourable (6.84e-4)" "unprognostic (3.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.06e-1)" "unprognostic (2.52e-2)" "unprognostic (2.27e-1)" 15.3 17.7 14.1 14.9 14.8 8.1 12.3 19.3 16.4 17.0 20.8 16.4 36.2 13.7 23.0 39.1 19.7 21.9 19.1 13.6 15.9 10.7 14.8 14.6 26.4 24.0 13.7 10.0 25.0 12.3 10.8 24.3 30.7 12.9 18.4 15.3 15.0 14.6 29.1 17.2 22.0 17.2 22.3 12.2 29.6 22.4 9.9 17.7 17.1 25.6 14.4 20.6 17.4 18.4 0.2 1.8 0.7 0.2 0.0 0.2 0.1 2.3 2.4 12.3 9.5 13.2 16.7 6.9 2.0 4.7 5.4 5.5 3.3 3.7 10.8 12.4 7.2 6.8 3.8 14.0 5.4 8.0 15.6 8.8 4.3 2.6 11.5 6.1 9.5 22.0 7.7 4.0 11.7 9.6 13.3 5.2 2.1 10.7 6.7 13.1 0.1 1.5 9.0 2.6 12.5 11.8 4.0 4.6 6.4 1.6 3.4 13.4 8.7 12.6 2.5 4.1 10.6 1.7 2.1 27.7 18.1 13.9 8.7 5.0 6.9 0.0 0.2 0.7 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.0 0.1 1.8 0.0 0.1 14.1 14.8 19.3 16.4 15.9 10.7 13.7 10.0 12.9 17.7 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell line enhanced" "Detected in many" "THP-1: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in many" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.6 4.5 20.5 19.0 5.7 9.3 3.7 12.3 7.0 8.6 6.2 5.8 9.3 4.6 1.5 9.8 3.6 11.5 5.0 17.0 4.9 8.2 3.9 3.5 2.3 7.3 4.4 7.2 4.8 5.6 6.7 4.3 9.6 0.2 4.4 17.7 2.5 4.0 2.0 15.1 3.1 7.6 30.6 0.5 6.5 2.8 11.0 19.2 8.5 1.6 3.7 7.0 36.0 11.5 17.4 4.8 10.2 22.9 3.2 4.9 4.9 8.3 6.2 8.9 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.5;HDLM-2: 26.6;HSkMC: 20.4;SH-SY5Y: 23.1;U-87 MG: 12.3;U-937: 14.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" HPA030247 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244" "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.7 14.5 0.0 0.8 0.2 1.5 0.6 0.0 0.0 0.0 0.3 3.9 0.0 0.8 0.0 0.2 26.6 0.0 0.0 0.0 0.0 6.9 0.0 0.0 20.4 0.1 0.2 0.4 0.0 0.0 0.1 0.9 0.3 7.6 1.5 0.4 1.3 0.0 0.0 1.1 0.0 0.0 2.5 23.1 0.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 6.0 0.0 0.3 1.4 0.0 12.3 14.8 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.8;MOLT-4: 13.2;TIME: 31.4;U-138 MG: 8.5;U-251 MG: 7.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: " "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.1 0.0 0.0 4.9 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.2 0.0 2.4 0.0 13.2 0.0 0.0 0.1 0.3 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 31.4 8.5 0.0 0.0 7.2 0.0 0.0 0.0 0.5 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell line enhanced" "Detected in many" "AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.3 12.4 0.0 3.3 2.6 0.0 1.8 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.0 1.0 0.3 0.6 0.0 4.9 0.1 0.1 0.0 3.2 0.3 0.1 6.1 0.3 1.5 2.5 1.0 0.3 0.1 20.3 0.7 5.6 0.0 0.1 1.2 8.5 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.0 0.0 23.6 0.7 0.6 2.9 0.9 3.6 0.0 31.0 5.3 0.0 2.4 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell line enhanced" "Detected in some" "A549: 8.9;AF22: 8.7;EFO-21: 7.6;T-47d: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: " "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 8.9 8.7 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.6 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.3 0.6 0.3 0.1 0.3 0.5 0.4 2.3 0.2 0.4 0.5 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.2 0.2 0.2 0.3 0.3 0.4 0.4 3.7 0.1 1.9 0.8 7.6 0.3 0.9 1.9 1.2 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell line enhanced" "Detected in some" "A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA052775: " "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.5 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.5 0.4 4.9 2.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA076190 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA076190: " "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.7 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.7 3.9 0.0 0.0 0.1 0.0 8.2 0.0 0.5 0.0 0.0 0.1 5.3 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.4 0.0 0.0 0.0 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 PCDHB2 PCDH-BETA2 ENSG00000112852 "Protocadherin beta 2" Q9Y5E7 5 141094578-141098703 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.4;AN3-CA: 28.8;EFO-21: 16.4;U-138 MG: 12.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007548 Enhanced Approved Nucleoplasm Nucleoplasm "HPA007548: " "unprognostic (2.94e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-4)" "unprognostic (1.31e-1)" "unprognostic (3.03e-3)" "unprognostic (7.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.24e-1)" "unprognostic (3.99e-1)" "unprognostic (2.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (6.99e-4)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (4.84e-4)" 7.3 3.0 3.4 1.6 8.6 0.8 5.5 5.7 13.3 3.9 4.4 7.0 0.0 2.1 6.7 2.1 4.0 2.8 4.4 4.3 4.1 1.9 2.9 0.8 6.2 1.0 3.2 5.1 4.3 2.7 0.9 5.3 2.4 4.8 5.9 2.8 4.0 3.8 1.7 1.9 4.3 2.6 4.3 8.4 1.6 1.9 12.1 5.0 0.0 2.8 1.2 0.9 4.4 2.6 0.2 0.2 0.8 0.1 0.5 0.4 0.3 0.2 1.9 13.4 28.8 3.7 1.8 6.2 0.5 2.1 0.0 0.0 0.3 0.1 0.5 16.4 0.9 0.0 0.6 0.1 0.0 0.1 0.4 0.0 0.0 3.8 0.0 0.0 1.3 0.9 0.0 0.0 0.2 0.3 0.4 0.4 4.0 0.1 3.7 0.0 5.9 3.8 0.0 9.9 0.1 1.5 0.0 7.4 2.0 0.0 1.8 4.2 8.2 2.4 1.5 12.7 3.9 5.9 1.9 0.2 0.0 0.1 2.8 0.1 7.5 0.5 0.1 0.0 0.4 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.1 0.2 0.8 0.5 0.1 0.2 0.0 0.3 3.4 8.6 5.7 11.0 4.1 1.9 3.2 5.1 4.8 5.0 PCED1A "bA12M19.1, C20orf81, FAM113A, FLJ22376" ENSG00000132635 "PC-esterase domain containing 1A" Q9H1Q7 20 2835314-2841190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050816 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA050816: " "unprognostic (3.20e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-3)" "unprognostic (1.90e-2)" "unprognostic (3.42e-1)" "unprognostic (6.91e-3)" "prognostic unfavourable (7.31e-4)" "unprognostic (1.00e-1)" "unprognostic (8.02e-2)" "unprognostic (2.99e-1)" "prognostic favourable (5.96e-5)" "unprognostic (1.03e-1)" "unprognostic (1.29e-2)" "unprognostic (4.10e-1)" "unprognostic (2.48e-1)" "unprognostic (7.30e-2)" "unprognostic (2.97e-3)" 18.0 17.3 25.5 21.9 29.1 13.1 14.4 18.7 29.0 17.6 13.4 27.6 18.8 17.1 23.8 20.3 12.6 22.4 23.0 9.7 24.2 17.1 23.1 21.0 16.4 23.5 30.0 20.8 28.4 16.1 38.2 27.0 16.4 25.1 25.4 9.1 21.6 23.7 18.3 6.9 12.7 18.2 15.2 14.5 33.1 20.0 9.4 28.7 14.2 36.0 4.8 16.7 15.8 17.6 9.4 8.2 3.1 7.4 14.2 12.0 6.8 12.4 16.4 16.7 9.2 17.5 24.2 12.1 12.0 13.7 12.9 14.0 11.4 22.9 3.7 8.3 8.1 20.5 4.0 11.2 6.0 18.0 12.2 14.3 18.2 15.8 14.2 2.7 4.8 32.1 23.9 15.8 21.0 9.2 11.2 17.2 9.4 8.6 1.9 18.1 18.4 9.8 9.9 5.5 7.5 14.5 10.4 15.5 24.0 11.9 15.7 20.6 20.1 9.7 8.8 12.6 8.7 13.0 5.7 28.3 14.1 1.0 3.1 10.2 14.8 2.9 7.4 3.1 11.0 6.6 10.6 8.6 6.4 9.3 8.2 9.4 12.0 10.6 0.6 14.2 6.1 7.1 4.5 6.8 25.5 29.1 18.7 29.0 24.2 17.1 30.0 20.8 25.1 28.7 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177539-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA069107: , HPA073074: " "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavourable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 17.6 22.6 13.7 14.6 16.0 11.3 21.0 33.5 15.9 20.9 18.2 14.6 20.4 10.3 24.0 20.7 15.6 22.5 14.7 31.3 12.8 10.8 15.4 18.1 14.8 19.6 16.9 13.0 30.6 28.6 12.1 37.6 13.4 14.9 20.0 16.3 14.4 21.4 19.3 21.6 15.0 15.2 19.7 13.4 20.1 19.2 43.4 16.5 19.4 25.4 11.6 20.6 18.0 21.2 15.1 9.7 8.1 12.5 7.6 32.4 19.0 22.3 9.5 14.6 12.8 26.9 20.2 10.2 17.3 26.0 24.1 22.3 18.7 21.2 18.0 11.5 23.4 14.3 23.1 15.6 26.9 15.6 22.8 23.1 24.8 16.4 26.8 39.2 9.5 16.6 17.5 15.1 26.9 18.9 17.7 7.4 27.2 10.8 20.9 27.7 14.4 12.2 19.0 16.2 17.2 21.9 11.4 19.5 12.0 10.7 26.8 19.7 14.8 48.0 12.2 7.2 25.8 10.3 12.9 11.3 10.6 25.1 24.7 26.7 16.3 8.1 9.6 7.1 27.6 12.5 32.4 15.1 23.6 28.7 9.7 14.2 21.5 22.3 1.5 7.6 11.5 9.2 23.5 19.0 13.7 16.0 33.5 15.9 12.8 10.8 16.9 13.0 14.9 16.5 PCMTD1 FLJ10883 ENSG00000168300 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1" Q96MG8 8 51817575-51899186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025696, HPA061444" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA025696: AB_1855077, HPA061444: " "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.73e-3)" "unprognostic (2.58e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (2.18e-2)" "unprognostic (8.38e-2)" "unprognostic (3.73e-1)" "unprognostic (2.48e-2)" "unprognostic (1.13e-1)" "unprognostic (3.11e-3)" "unprognostic (3.11e-3)" 22.0 24.1 13.1 18.2 17.1 9.0 41.1 24.3 21.7 22.8 24.4 11.7 33.2 14.8 29.0 24.5 21.6 21.5 22.1 26.1 13.5 12.6 21.5 16.7 29.2 21.0 18.4 11.4 33.3 53.8 57.9 34.2 19.2 15.6 22.8 14.8 15.0 39.8 38.8 45.7 18.0 18.7 38.5 18.9 24.3 19.6 10.4 16.9 27.8 33.6 23.6 15.5 28.4 28.6 16.5 15.4 32.4 12.1 22.3 15.2 10.6 6.5 4.2 14.5 2.5 21.4 20.0 8.2 8.6 15.4 3.7 5.9 1.9 15.1 6.3 12.2 11.6 16.2 2.5 10.1 6.5 8.0 4.9 7.2 7.5 4.4 28.3 2.6 7.4 19.9 19.5 4.6 12.7 17.4 5.5 20.6 5.8 2.7 15.1 6.6 5.6 1.9 4.7 2.8 8.0 15.0 13.0 9.5 8.1 6.1 8.0 8.7 7.9 4.0 14.3 3.3 4.4 5.0 3.1 12.6 9.4 2.2 9.9 6.2 4.0 19.6 9.6 22.9 10.2 12.1 12.4 16.2 13.0 12.1 9.7 16.5 15.2 13.4 32.4 22.3 12.1 15.4 13.8 10.6 13.1 17.1 24.3 21.7 13.5 12.6 18.4 11.4 15.6 16.9 PCMTD2 "C20orf36, FLJ10883" ENSG00000203880 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2" Q9NV79 20 64255695-64287821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057849 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA057849: " "unprognostic (2.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (2.88e-2)" "unprognostic (2.23e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-1)" "prognostic favourable (2.13e-4)" "unprognostic (1.07e-1)" "unprognostic (4.07e-2)" "unprognostic (1.90e-2)" "unprognostic (1.40e-2)" "prognostic favourable (3.82e-4)" "unprognostic (1.10e-1)" "unprognostic (3.46e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-3)" 18.5 22.6 24.2 28.9 24.9 9.7 32.4 49.7 27.3 20.1 14.9 21.1 19.2 14.9 26.0 33.5 15.2 17.2 21.2 26.2 19.8 20.2 22.9 20.2 20.0 25.6 18.5 22.8 38.9 18.1 20.4 21.8 26.3 18.0 19.9 13.6 57.8 20.5 16.9 25.7 42.1 15.7 17.3 19.6 22.1 13.7 17.0 18.2 31.2 19.5 10.5 18.5 17.7 18.1 9.5 7.5 8.3 6.6 14.1 18.1 7.9 10.9 4.0 16.0 12.4 15.4 19.2 15.3 6.8 7.5 9.9 6.1 9.5 17.7 16.5 12.1 8.1 13.6 8.7 11.0 13.4 3.5 11.9 7.9 18.0 15.8 13.0 8.2 12.2 27.1 15.3 5.2 9.1 14.4 14.6 14.9 8.1 7.1 18.8 27.2 11.7 17.0 15.8 6.3 19.6 15.1 12.7 25.4 30.0 13.0 15.0 17.6 16.0 16.5 10.4 14.9 5.3 9.5 5.4 18.1 14.6 15.9 9.9 8.7 8.7 7.6 6.6 7.6 8.4 4.5 10.0 8.9 12.5 9.5 7.5 9.5 17.7 12.7 8.3 14.1 4.1 4.7 18.1 7.9 24.2 24.9 49.7 27.3 19.8 20.2 18.5 22.8 18.0 18.2 PCNX1 "KIAA0805, KIAA0995, PCNX, PCNXL1, pecanex" ENSG00000100731 "Pecanex homolog 1" Q96RV3 14 70907405-71115382 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053532 Approved Nucleoplasm Nucleoplasm "HPA053532: " "unprognostic (1.96e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-1)" "unprognostic (2.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-2)" "unprognostic (4.16e-2)" "unprognostic (5.56e-2)" "prognostic favourable (4.05e-5)" "unprognostic (9.01e-3)" "unprognostic (2.90e-1)" "unprognostic (8.11e-2)" "unprognostic (7.37e-2)" 18.2 32.2 14.0 18.8 19.8 20.0 17.4 16.3 21.2 15.7 18.5 14.5 8.8 10.2 18.7 10.3 12.2 14.5 13.2 16.2 11.4 8.1 16.1 14.7 20.2 21.4 14.1 13.1 27.1 12.3 26.3 22.3 11.5 12.0 12.8 10.3 16.8 11.7 12.3 22.8 12.0 18.7 17.1 12.4 22.2 14.1 26.4 13.3 16.4 16.1 10.2 16.7 16.6 17.3 2.3 4.1 11.2 2.0 1.9 10.5 1.6 12.4 8.8 10.1 6.3 17.1 11.6 5.6 13.3 13.3 10.4 14.7 8.6 5.6 8.9 4.6 13.6 12.5 10.8 10.7 15.8 27.2 4.2 1.7 5.6 9.1 10.4 13.5 4.6 11.9 9.6 10.4 18.7 10.3 0.7 13.0 12.0 10.0 6.3 12.2 5.1 4.8 5.8 11.6 2.6 7.2 9.3 4.2 6.6 10.1 6.1 7.4 5.4 12.8 12.2 19.3 21.5 6.2 9.5 7.9 4.0 7.5 11.9 11.1 6.7 2.8 2.0 1.8 4.0 1.1 5.5 1.6 6.9 4.1 0.5 2.3 3.0 4.6 11.2 1.9 0.7 4.1 10.5 1.6 14.0 19.8 16.3 21.2 11.4 8.1 14.1 13.1 12.0 13.3 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889203 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 55.6" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;RPMI-8226: 13.2;U-2197: 28.4;U-266/70: 28.2;U-266/84: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavourable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavourable (1.08e-4)" 35.2 1.2 1.0 2.0 0.5 5.5 29.0 0.3 0.7 12.4 3.6 0.5 9.1 0.0 3.9 6.0 16.8 2.1 3.8 55.6 1.4 1.2 7.3 7.9 6.9 1.6 0.6 0.7 2.5 0.6 0.1 13.8 20.1 0.4 14.2 2.1 2.5 2.7 3.9 6.3 2.7 1.5 41.6 0.8 1.2 2.0 1.9 0.3 0.0 3.5 6.2 0.9 28.2 30.6 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.5 4.2 1.4 0.0 25.4 7.0 0.0 0.3 0.1 1.1 1.5 0.2 0.5 0.0 1.2 1.9 0.0 5.0 0.0 1.4 0.0 8.4 0.8 2.8 0.0 0.0 0.5 0.0 2.8 0.0 2.6 0.6 0.0 0.2 0.0 0.5 0.7 1.5 0.4 2.1 8.8 0.0 3.2 13.2 1.2 0.0 2.7 1.7 6.6 0.0 2.4 0.0 1.7 0.0 2.2 5.1 28.4 2.1 28.2 13.0 0.0 6.3 0.7 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 1.0 0.5 0.3 0.7 1.4 1.2 0.6 0.7 0.4 0.3 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867317-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 177.9;seminal vesicle: 234.5" "Cell line enhanced" "Detected in some" "RPMI-8226: 56.4;SK-BR-3: 9.5;T-47d: 17.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 177.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favourable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favourable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 2.1 11.0 5.6 1.4 177.9 1.0 2.6 15.8 15.8 39.3 10.6 11.4 50.8 1.9 11.4 65.7 38.4 2.9 1.7 1.7 8.3 14.0 9.7 1.0 1.1 1.0 11.6 3.7 1.2 2.1 3.4 1.0 1.3 20.0 60.9 6.9 49.0 1.7 234.5 1.0 1.4 1.5 93.5 3.7 1.5 1.1 1.2 37.5 0.0 39.2 0.0 1.2 65.6 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.5 0.0 0.0 0.0 56.4 0.0 0.0 0.1 0.1 0.0 9.5 0.0 17.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 177.9 15.8 15.8 8.3 14.0 11.6 3.7 20.0 37.5 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258727-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;urinary bladder: 33.2" "Group enriched" "Detected in some" 6 "RT4: 15.7;T-47d: 10.3" "Group enriched" "Detected in many" 6 "cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8" "Group enriched" "Detected in all" 5 "basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8" "Cell type enhanced" "Detected in single" "T-reg: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Low region specificity" "Detected in all" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA052833: " "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favourable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 3.2 1.0 5.7 1.3 67.7 0.6 2.2 4.4 28.9 4.3 4.3 1.4 1.5 2.2 2.2 3.3 16.5 2.1 3.9 1.3 3.9 6.3 1.0 4.3 5.0 0.7 7.8 4.6 2.6 0.5 0.6 21.9 0.9 30.8 5.5 3.2 5.9 1.2 17.8 1.0 2.8 3.3 6.8 7.5 0.8 1.2 2.3 5.3 0.0 1.0 0.0 3.0 33.2 4.1 0.0 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 15.7 2.2 0.0 0.0 0.3 0.0 10.3 0.4 0.2 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.7 67.7 4.4 17.9 3.9 6.3 7.8 4.6 30.8 5.3 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55750979-55842830 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.4;liver: 53.2" "Cell line enhanced" "Detected in all" "HDLM-2: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 56.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022979 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA022979: " "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavourable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 8.2 5.6 4.9 8.2 8.2 5.1 8.4 3.1 5.3 6.2 11.9 3.0 29.8 9.3 5.2 15.8 6.6 4.9 10.1 12.1 5.1 4.7 17.0 53.2 11.6 7.8 6.2 4.9 5.2 7.5 4.2 5.3 19.4 5.5 7.5 12.7 5.3 7.1 32.1 10.8 4.1 9.8 8.3 5.0 10.0 12.5 8.0 3.9 3.0 5.7 5.8 5.2 8.1 9.9 2.0 12.1 56.4 15.3 6.2 2.7 6.5 8.6 7.9 6.0 2.2 8.1 7.9 15.5 3.4 4.5 5.4 5.3 8.9 11.2 2.4 26.5 5.3 4.8 3.5 5.7 4.9 38.3 8.0 21.4 2.4 16.7 7.2 8.1 17.0 6.5 7.6 3.2 5.9 10.5 15.3 8.6 5.9 7.5 6.4 6.6 6.5 7.1 3.3 8.7 1.9 5.7 6.4 3.0 6.8 1.7 3.7 14.3 10.0 14.1 7.6 6.2 4.4 6.9 4.4 24.6 7.7 1.5 5.7 13.5 10.7 15.1 15.3 56.4 2.5 12.6 1.5 2.0 1.6 2.5 12.1 1.4 0.9 2.2 15.9 6.2 13.2 0.9 2.7 6.5 4.9 8.2 3.1 5.3 5.1 4.7 6.2 4.9 5.5 3.9 PCYOX1L MGC3265 ENSG00000145882 "Prenylcysteine oxidase 1 like" Q8NBM8 5 149358007-149369653 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037463, HPA038402" Approved Approved Nucleoplasm,Mitochondria "Secreted - unknown location" 930000 "Nucleoplasm, Mitochondria" "HPA037463: AB_10673632, HPA038402: " "unprognostic (1.34e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (7.83e-2)" "unprognostic (5.73e-2)" "unprognostic (4.18e-3)" "unprognostic (7.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.25e-1)" "unprognostic (3.05e-3)" "unprognostic (8.77e-2)" "unprognostic (4.90e-2)" "unprognostic (2.86e-1)" "unprognostic (2.49e-1)" "unprognostic (2.26e-3)" "unprognostic (3.28e-1)" 4.8 6.6 4.5 7.2 13.5 6.9 4.0 15.9 19.0 6.5 4.4 8.2 2.7 2.3 6.2 2.7 4.6 7.9 5.8 5.2 4.6 8.9 3.7 1.2 4.2 9.6 5.5 9.9 7.9 6.7 27.0 6.4 6.2 13.7 6.4 2.1 9.4 3.4 6.6 1.6 6.6 5.6 6.0 4.6 6.3 5.8 11.5 2.4 5.8 3.3 3.1 7.4 5.0 4.7 1.8 13.5 3.9 9.6 4.5 7.2 4.5 2.1 1.4 2.9 6.2 2.4 1.5 2.1 5.0 1.0 2.5 5.3 0.4 3.5 9.7 15.4 1.6 4.3 3.2 7.1 0.3 4.7 4.7 4.4 0.0 0.3 6.9 2.9 4.1 6.3 1.2 5.0 4.3 7.9 2.6 19.1 0.2 3.4 2.6 4.2 2.7 9.2 5.2 2.3 25.6 1.0 0.6 5.9 7.7 10.0 3.6 7.8 9.4 5.5 4.6 2.8 3.0 7.2 2.0 11.2 15.2 5.5 6.1 17.7 7.3 3.0 7.1 3.9 3.0 9.6 4.0 1.8 5.7 2.3 13.5 1.2 6.8 4.7 1.2 4.5 9.1 1.3 7.2 4.5 4.5 13.5 15.9 19.0 4.6 8.9 5.5 9.9 13.7 2.4 PCYT1A "CT, CTPCT, PCYT1" ENSG00000161217 "Phosphate cytidylyltransferase 1, choline, alpha" P49585 3 196214222-196287957 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Cone-rod dystrophy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035428 Approved Approved Nucleoplasm Nucleoplasm "HPA035428: AB_10602045" "unprognostic (8.58e-3)" "unprognostic (2.63e-1)" "unprognostic (8.45e-2)" "unprognostic (8.61e-3)" "unprognostic (2.87e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (8.65e-5)" "unprognostic (8.52e-2)" "unprognostic (5.99e-2)" "unprognostic (1.65e-2)" "unprognostic (6.72e-3)" "unprognostic (1.74e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.47e-2)" "unprognostic (7.16e-3)" "unprognostic (2.41e-2)" 24.8 22.2 15.3 19.9 18.7 25.8 18.0 14.2 17.8 13.6 25.3 23.0 21.1 41.1 18.2 18.7 25.2 15.0 19.8 36.0 14.8 13.8 20.2 17.8 18.7 15.6 16.6 14.1 15.6 13.9 16.0 12.1 14.2 20.5 13.3 16.5 14.4 17.1 19.2 45.8 32.8 37.2 19.5 18.3 23.4 18.1 19.4 18.6 13.2 14.8 28.0 19.0 17.6 16.7 7.8 8.7 20.5 9.8 7.9 13.5 4.6 28.2 11.4 8.0 11.7 16.4 18.3 12.1 21.6 15.4 18.6 16.4 27.8 10.3 7.2 72.5 24.7 22.1 12.7 16.6 15.9 13.2 8.9 20.8 12.0 11.8 14.7 10.0 17.9 15.4 12.7 18.0 12.9 19.9 11.6 16.2 18.5 23.8 6.2 5.3 6.9 17.0 10.4 10.2 11.6 11.4 15.9 7.8 5.8 14.6 25.3 14.0 37.1 12.5 29.6 14.8 8.2 20.1 29.2 15.0 28.6 13.4 22.7 14.0 18.6 7.5 8.7 9.2 9.6 9.2 8.0 7.8 7.2 10.2 8.7 5.7 4.6 6.8 20.5 7.9 9.8 5.6 13.5 4.6 15.3 18.7 14.2 17.8 14.8 13.8 16.6 14.1 20.5 18.6 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: " "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavourable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 22.8 24.2 18.1 25.4 16.7 20.0 73.3 14.2 20.2 19.6 25.6 12.0 26.6 21.6 23.1 28.5 29.8 23.3 28.3 32.0 17.0 15.6 28.5 33.4 27.5 52.9 16.5 12.8 24.3 53.4 19.9 16.4 21.2 15.4 21.6 26.8 18.0 27.0 32.0 30.8 19.1 26.1 20.7 20.8 30.3 26.3 17.2 10.5 44.3 31.9 28.5 32.9 25.2 22.3 13.8 15.3 9.6 12.3 16.4 17.5 10.6 13.4 9.8 15.0 35.1 21.7 23.8 16.6 16.0 18.4 19.0 21.3 17.6 11.8 24.4 13.1 17.6 19.3 32.1 26.6 28.0 19.9 35.1 34.5 12.7 31.9 26.4 42.9 23.4 21.6 26.2 24.1 39.2 26.4 68.6 16.0 23.2 29.3 29.7 31.0 21.5 15.2 21.2 11.6 31.6 28.7 8.0 27.6 28.8 18.3 29.9 18.7 15.2 44.0 19.9 9.4 20.2 22.3 28.3 21.5 25.0 26.5 17.5 42.0 24.0 3.7 11.0 9.6 13.4 10.6 15.7 13.3 15.3 14.1 15.3 13.8 15.2 14.1 4.7 16.4 12.3 14.2 17.5 10.6 18.1 16.7 14.2 20.2 17.0 15.6 16.5 12.8 15.4 10.5 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 153.1" "Cell line enhanced" "Detected in all" "U-266/70: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 14.9 9.1 9.4 20.6 9.8 11.8 28.1 15.6 8.1 20.0 46.7 9.1 64.0 18.0 19.1 18.1 40.6 12.3 11.9 8.1 8.4 8.1 6.5 30.6 9.9 13.8 7.8 6.4 27.8 153.1 61.2 30.3 51.4 8.5 18.7 26.1 16.2 81.7 61.7 5.8 37.3 47.1 13.2 8.6 24.0 27.6 10.1 9.5 22.6 55.4 18.8 27.8 15.1 22.7 18.5 12.6 50.9 9.0 26.9 33.1 11.2 5.1 5.0 8.1 8.5 12.2 22.6 4.9 6.0 17.7 3.0 5.1 3.1 12.8 49.3 16.9 8.2 23.7 4.9 15.3 6.4 42.6 9.9 24.9 29.3 5.2 5.5 12.3 27.1 17.9 48.9 3.0 16.6 5.5 6.6 23.4 7.3 13.1 4.5 14.3 2.1 8.9 2.0 14.6 26.1 4.8 7.2 3.5 15.0 11.5 6.2 20.9 58.4 23.5 14.0 4.6 3.5 3.4 2.2 64.1 31.0 28.4 4.3 17.3 4.8 50.9 6.1 15.9 18.5 8.3 33.1 18.5 17.1 20.2 7.3 14.3 14.9 18.1 12.0 26.9 9.0 12.6 9.2 11.2 9.4 9.8 15.6 8.1 8.4 8.1 7.8 6.4 8.5 9.5 PDCD5 "MGC9294, TFAR19" ENSG00000105185 "Programmed cell death 5" O14737 19 32581068-32587452 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018471 Enhanced Approved Nucleoplasm,Cytosol 31000 Cytosol Nucleoplasm "HPA018471: AB_1855108" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.60e-4)" "unprognostic (2.02e-1)" "unprognostic (8.64e-2)" "unprognostic (3.64e-3)" "unprognostic (2.43e-2)" "unprognostic (6.22e-2)" "unprognostic (8.49e-2)" "unprognostic (3.87e-2)" "unprognostic (1.93e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (6.00e-2)" "unprognostic (3.35e-2)" "unprognostic (1.10e-1)" "unprognostic (9.54e-2)" 34.1 40.6 42.1 32.3 35.9 18.9 28.9 28.7 33.0 21.2 31.7 16.4 27.0 31.4 22.9 24.8 33.8 21.4 23.1 63.7 33.0 34.2 37.0 52.0 20.6 25.9 32.9 31.9 25.8 47.6 14.7 38.8 29.5 31.0 23.2 27.6 14.7 27.3 24.5 107.4 23.9 27.1 32.1 26.4 26.8 28.0 52.4 23.5 15.2 25.4 42.7 26.6 30.6 31.8 34.6 29.1 11.2 44.8 24.2 49.8 26.9 69.1 86.1 20.8 22.3 35.1 54.2 26.8 51.0 32.9 41.5 35.8 69.7 26.6 37.7 74.6 24.9 18.5 28.7 38.9 31.8 67.9 46.1 56.9 37.8 41.6 41.8 72.5 22.9 34.4 37.1 28.1 46.2 27.6 51.7 41.4 34.9 44.3 32.4 37.7 22.7 29.2 31.9 31.9 45.6 31.8 18.0 43.8 24.9 48.5 47.2 35.2 20.6 42.5 42.6 37.3 41.7 40.2 82.3 40.2 56.9 65.5 44.3 66.5 32.9 6.9 23.1 11.2 26.7 34.9 33.9 34.6 42.9 33.0 28.5 25.5 30.4 29.3 3.2 24.2 44.8 29.1 49.8 26.9 42.1 35.9 28.7 33.0 33.0 34.2 32.9 31.9 31.0 23.5 PDCL "DKFZp564M1863, PhLP" ENSG00000136940 "Phosducin like" Q13371 9 122798389-122828631 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021571, HPA021647, CAB026473" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB026473: , HPA021571: AB_1855114, HPA021647: AB_1855115" "unprognostic (3.51e-2)" "unprognostic (4.11e-2)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (1.39e-1)" "unprognostic (8.74e-3)" "unprognostic (1.77e-1)" "unprognostic (3.13e-2)" "unprognostic (1.49e-2)" "unprognostic (1.52e-1)" "unprognostic (1.50e-1)" "prognostic favourable (7.00e-4)" "unprognostic (9.84e-2)" "unprognostic (1.35e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-1)" 20.7 14.8 17.5 14.1 21.0 23.8 23.0 20.5 21.9 19.6 15.1 23.7 11.4 13.2 21.5 12.8 18.4 15.9 14.9 14.6 18.4 17.3 13.7 10.1 19.7 17.5 20.2 17.1 15.5 13.0 17.5 13.7 20.6 22.2 17.1 15.9 13.9 21.7 14.7 8.1 15.4 14.7 17.2 22.8 18.4 15.5 12.1 18.8 19.1 17.3 13.3 17.6 15.8 16.4 12.6 14.7 20.6 16.3 16.2 25.3 10.8 9.4 13.1 22.6 8.4 20.6 13.9 12.5 13.3 14.1 12.3 12.6 8.7 12.6 15.8 10.9 15.9 18.5 13.9 13.0 13.7 15.4 7.1 16.2 17.5 14.4 10.6 13.7 32.3 11.9 9.5 12.0 6.1 25.2 16.3 9.3 13.8 14.6 14.6 12.4 16.6 10.3 15.4 21.5 11.6 14.9 0.0 18.2 16.2 17.9 10.2 7.9 15.4 9.5 27.4 11.5 13.6 16.7 12.8 7.2 14.3 16.8 9.8 11.0 10.9 20.6 11.9 19.6 13.9 10.4 15.0 11.4 16.7 12.8 12.3 12.6 17.5 15.2 9.8 16.2 16.3 14.7 25.3 10.8 17.5 21.0 20.5 21.9 18.4 17.3 20.2 17.1 22.2 18.8 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in some" 5 "ASC diff: 22.3;HHSteC: 13.2;HSkMC: 28.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in many" HPA022151 Approved Approved Nucleoplasm Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.2 0.0 22.3 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 3.1 0.0 13.2 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 4.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32299329 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.6;heart muscle: 56.2" "Cell line enhanced" "Detected in some" "BJ: 15.0;fHDF/TERT166: 48.3;U-251 MG: 26.1;WM-115: 34.5" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm Nucleoplasm "HPA052375: " "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.9 2.7 10.6 3.2 27.7 0.9 5.1 2.4 17.1 1.2 2.7 30.1 0.0 2.3 3.1 6.8 7.4 8.4 2.4 56.2 14.8 7.5 4.0 1.0 5.0 1.4 31.1 12.0 4.9 2.7 1.3 1.3 4.0 16.3 2.9 2.7 7.9 2.6 4.2 1.4 0.9 2.8 10.4 17.1 1.4 3.8 4.2 33.6 0.0 3.9 0.2 1.0 7.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.2 0.1 0.0 15.0 6.1 7.1 5.8 0.0 0.0 0.0 0.0 48.3 0.4 0.0 0.0 9.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 10.8 0.6 0.0 1.4 0.0 2.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 7.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 2.9 0.1 26.1 0.0 0.0 0.0 0.7 0.1 34.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 27.7 2.4 17.1 14.8 7.5 31.1 12.0 16.3 33.6 PDE7B ENSG00000171408 "Phosphodiesterase 7B" Q9NP56 6 135851696-136195574 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 7.1;ASC TERT1: 8.5;EFO-21: 13.1;HeLa: 7.6;HSkMC: 18.3;HUVEC TERT2: 8.5;U-2197: 9.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 112.3" "Low region specificity" "Detected in all" HPA023967 Uncertain Approved Nucleoplasm Nucleoplasm "HPA023967: AB_1855128" "unprognostic (3.18e-1)" "unprognostic (3.47e-1)" "unprognostic (2.34e-1)" "unprognostic (1.79e-3)" "unprognostic (3.34e-1)" "unprognostic (3.22e-4)" "unprognostic (1.37e-2)" "unprognostic (3.00e-1)" "unprognostic (2.80e-1)" "unprognostic (6.73e-3)" "unprognostic (1.11e-2)" "unprognostic (7.85e-2)" "prognostic favourable (1.59e-4)" "unprognostic (3.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-2)" 5.8 4.3 7.3 4.0 21.9 0.8 3.6 1.6 12.8 6.2 4.0 2.3 25.2 3.6 14.2 4.9 2.8 4.2 6.1 7.9 5.1 7.4 9.6 6.4 3.3 2.8 6.4 4.2 22.7 1.6 3.7 8.7 2.2 5.9 6.8 5.0 5.4 5.0 28.5 7.2 1.5 3.7 13.5 5.3 2.3 5.2 2.9 7.1 7.7 8.3 6.1 1.9 10.6 5.1 4.3 2.6 0.6 0.9 0.7 1.8 0.3 0.0 4.4 0.1 0.0 7.1 8.5 0.0 0.4 2.3 1.7 0.9 0.0 0.0 0.0 13.1 2.8 0.0 0.0 0.0 0.6 0.0 0.1 0.0 7.6 0.0 3.1 0.1 0.0 18.3 0.0 3.4 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.5 3.1 2.9 0.1 0.1 0.0 1.5 0.0 1.8 0.0 9.1 0.0 0.1 0.0 0.0 0.5 0.0 0.7 0.2 0.9 0.6 0.2 0.2 0.1 1.5 0.4 0.2 2.6 4.3 1.8 1.0 0.3 0.7 0.1 0.2 0.2 0.3 7.3 21.9 1.6 12.8 5.1 7.4 6.4 4.2 5.9 7.1 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77429807 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 67.7" "Group enriched" "Detected in some" 4 "BJ hTERT+: 12.1;HeLa: 27.8;SK-BR-3: 7.4" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036911: , HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 6.8 2.5 9.9 0.7 14.2 0.4 3.8 1.1 16.3 6.3 1.2 2.3 0.3 1.2 11.3 3.2 1.1 10.1 2.1 7.9 8.2 9.2 3.1 1.2 2.2 0.7 5.4 8.3 1.9 4.2 0.3 3.8 13.1 8.6 10.5 0.8 2.0 5.3 7.1 0.4 0.7 1.3 10.3 2.3 0.4 1.5 1.5 5.7 0.3 67.7 0.3 0.7 0.8 1.4 0.2 0.8 1.4 2.3 0.4 0.4 0.1 0.3 3.3 1.3 0.3 1.2 0.0 0.5 1.1 12.1 0.2 0.1 1.3 0.2 0.5 0.2 0.1 0.9 0.1 0.0 0.2 0.2 1.0 0.7 27.8 0.3 0.0 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.6 0.7 0.8 0.1 0.8 1.4 0.7 0.0 0.3 3.7 1.0 1.6 7.4 0.8 1.6 1.1 0.6 0.4 0.2 0.2 0.6 0.9 0.5 0.6 1.6 0.7 0.4 0.0 0.3 1.4 0.3 2.2 0.1 0.2 0.2 0.3 0.8 0.2 0.4 0.0 0.3 0.4 2.3 0.5 0.1 0.1 9.9 14.2 1.1 16.3 8.2 9.2 5.4 8.3 8.6 5.7 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653636-42775509 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.1;EFO-21: 16.2;MCF7: 12.0;NB-4: 17.9;NTERA-2: 22.1;SCLC-21H: 12.3" "Cancer enhanced" "Detected in all" "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.8" "Group enriched" "Detected in many" 4 "NK-cells: 1.7;T-cells: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011380 Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA011380: AB_1855132" "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 6.1 6.6 9.9 6.8 15.2 0.8 9.4 13.7 9.0 3.7 37.1 11.9 14.0 3.0 5.7 18.8 6.1 10.3 7.7 3.5 6.2 7.7 13.2 2.5 4.7 4.6 10.0 4.9 4.1 4.0 4.7 6.0 9.6 6.9 33.2 15.8 9.7 8.8 15.9 2.3 3.8 26.1 22.3 8.0 15.9 8.4 1.5 8.9 4.9 5.2 2.1 4.1 12.6 4.0 0.5 0.9 1.0 0.1 1.7 6.8 0.5 0.0 1.5 16.1 1.9 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.7 9.7 0.0 16.2 0.0 0.0 1.4 5.2 0.0 0.0 5.5 0.0 0.0 3.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.0 0.8 17.9 22.1 0.0 0.0 0.0 0.6 11.0 4.4 12.3 7.3 2.7 0.0 0.2 0.1 9.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.1 0.6 0.2 0.5 6.8 1.7 1.0 1.7 0.1 0.9 2.2 0.5 9.9 15.2 13.7 6.7 6.2 7.7 10.0 4.9 6.9 8.9 PDF ENSG00000258429 "Peptide deformylase, mitochondrial" Q9HBH1 16 69328621-69330595 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063409 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA063409: " "unprognostic (4.28e-2)" "prognostic unfavourable (4.63e-4)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-1)" "prognostic unfavourable (2.73e-4)" "unprognostic (2.98e-3)" "prognostic unfavourable (7.35e-4)" "unprognostic (5.84e-2)" "unprognostic (4.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-1)" "prognostic favourable (6.11e-4)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (5.98e-2)" "unprognostic (1.22e-2)" 6.6 7.9 4.8 7.8 4.5 5.3 4.8 3.1 6.9 3.6 7.6 3.8 3.3 7.1 5.3 5.6 8.4 4.4 6.5 3.8 4.6 3.3 14.9 30.2 3.7 7.0 3.0 5.2 5.0 14.2 8.2 3.9 4.9 4.4 5.3 4.1 4.3 12.8 4.6 10.4 6.0 5.2 3.4 2.3 5.0 8.3 3.7 2.0 10.2 7.3 9.2 6.2 3.7 4.0 10.3 3.2 2.5 2.8 1.7 6.9 1.5 8.9 6.0 1.2 2.9 1.8 1.3 10.6 7.5 2.0 5.4 4.7 14.9 6.4 16.6 10.0 2.6 12.9 3.7 4.0 2.2 4.0 30.8 8.4 5.7 21.3 3.7 11.7 6.7 2.8 7.1 4.8 2.3 3.1 20.2 1.9 2.9 11.5 9.1 12.3 7.7 11.1 21.6 1.9 15.4 4.3 5.6 10.3 8.2 13.0 2.2 6.3 12.8 3.8 4.6 4.6 8.8 5.4 8.7 15.7 10.4 19.6 3.1 8.7 6.0 0.0 2.8 2.5 1.2 1.6 3.1 4.3 3.9 3.9 3.0 10.3 6.9 2.5 0.0 1.7 1.5 3.2 3.0 1.5 4.8 4.5 3.1 6.9 4.6 3.3 3.0 5.2 4.4 2.0 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Group enriched" "Detected in some" 5 "AN3-CA: 48.4;BJ hTERT+: 39.2;HSkMC: 21.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" "Nucleoli, Golgi apparatus" Nucleoplasm "HPA052801: " "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.4 0.2 48.4 1.5 0.6 3.1 0.9 39.2 1.8 7.8 0.2 0.0 0.0 0.2 0.6 0.0 2.6 0.2 0.9 0.0 2.9 0.0 1.4 1.0 3.7 0.0 0.0 21.4 0.0 2.2 0.0 3.2 0.0 0.6 0.2 3.1 0.0 0.1 2.4 0.6 0.0 0.0 0.1 0.2 2.8 0.1 0.3 0.3 0.3 0.8 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favourable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 23.9 13.8 5.5 10.2 12.0 13.5 17.0 13.9 19.3 18.7 30.8 8.4 12.5 11.2 14.4 17.7 26.7 14.3 19.2 11.2 22.4 11.8 25.2 35.4 22.0 22.2 13.9 12.3 17.8 10.5 14.4 13.9 25.2 11.6 15.1 15.5 13.7 13.7 11.3 14.3 12.1 24.7 10.9 28.8 24.0 14.6 10.6 15.0 22.7 23.3 25.5 13.7 9.6 14.4 16.2 14.7 18.8 11.1 21.9 15.5 11.2 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Supported Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favourable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favourable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.4 11.3 10.1 11.9 9.0 1.2 7.1 10.5 10.6 10.3 0.9 7.1 8.2 11.9 19.8 3.1 7.5 2.8 10.5 16.5 10.4 7.3 9.2 6.9 6.4 0.0 8.0 18.9 11.0 6.9 0.5 9.2 2.9 8.2 6.0 8.3 6.1 0.0 2.4 9.1 9.2 25.2 11.1 5.8 5.5 7.5 11.4 10.0 3.2 4.7 18.5 7.3 4.7 12.5 10.3 8.5 5.1 16.2 15.3 4.4 18.3 2.6 8.0 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 42.1;T-47d: 109.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favourable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.2 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.5 0.1 0.1 0.2 1.1 0.5 0.0 0.0 0.1 1.7 0.3 0.1 0.4 7.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.1 0.2 0.2 0.5 0.0 1.2 0.2 42.1 0.0 0.1 1.2 0.2 0.3 0.0 109.4 0.1 0.1 0.2 0.2 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Approved Nucleoplasm,Cytosol 240000 "Nucleoplasm, Cytosol" "HPA028356: AB_10602814, HPA070820: " "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavourable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.7 5.8 24.3 10.5 45.1 25.3 8.1 72.8 63.6 60.6 42.6 12.8 9.1 7.8 26.4 90.8 18.3 9.0 22.8 47.4 4.2 5.0 6.4 4.1 3.2 55.7 2.1 7.9 21.2 12.9 33.3 42.5 45.5 6.6 14.3 81.0 8.3 2.5 5.0 16.1 16.8 4.2 25.6 5.3 22.0 8.8 4.8 12.9 38.6 26.4 22.2 16.2 15.1 60.6 40.3 31.6 30.0 31.2 11.3 6.9 14.8 37.1 4.1 57.0 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 PEAR1 "FLJ00193, JEDI, MEGF12" ENSG00000187800 "Platelet endothelial aggregation receptor 1" Q5VY43 1 156893698-156916434 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.9;HBEC3-KT: 13.5;HHSteC: 10.2;HUVEC TERT2: 23.8;TIME: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035217 Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" 35000000 "Nucleoplasm, Cell Junctions" Centrosome "HPA035217: AB_10669902" "unprognostic (1.02e-1)" "unprognostic (1.84e-5)" "unprognostic (4.77e-2)" "unprognostic (1.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (5.93e-2)" "unprognostic (1.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.17e-1)" "unprognostic (5.04e-1)" "prognostic unfavourable (4.31e-4)" "unprognostic (1.20e-2)" "unprognostic (3.37e-3)" "unprognostic (8.51e-2)" "unprognostic (2.64e-2)" 18.5 7.1 1.8 3.0 5.1 2.8 29.2 1.2 2.9 16.5 5.8 2.7 6.3 2.3 15.9 10.5 6.6 8.9 10.3 11.1 2.7 1.8 6.8 3.8 12.0 10.1 3.2 2.1 10.6 3.2 1.7 3.9 15.5 3.7 9.6 1.4 15.5 4.1 5.5 11.4 4.4 4.1 9.6 3.1 12.2 4.1 8.1 1.5 0.6 10.5 5.8 2.1 6.7 11.5 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.2 1.3 0.3 0.0 0.0 1.7 0.0 5.2 8.9 2.2 1.3 0.1 0.2 0.0 0.2 3.9 0.1 0.0 13.5 0.6 0.0 0.0 6.5 0.2 0.3 10.2 0.0 0.0 5.3 0.0 3.0 0.7 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 1.8 5.1 1.2 2.9 2.7 1.8 3.2 2.1 3.7 1.5 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Cell line enhanced" "Detected in many" "AF22: 93.1;HAP1: 120.8;Hep G2: 93.1;SCLC-21H: 59.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: , HPA051038: " "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.1 93.1 39.3 1.9 3.5 5.4 7.1 4.2 5.1 7.0 21.8 4.3 0.2 0.2 8.2 0.8 120.8 5.0 7.2 0.3 12.7 0.0 15.0 93.1 1.4 14.8 0.0 7.8 1.6 12.7 8.9 3.0 0.0 29.1 10.0 0.6 0.0 0.0 42.6 8.4 5.6 29.8 7.8 23.4 9.7 59.1 3.4 0.0 2.0 7.0 12.6 0.0 0.0 4.1 0.2 0.5 5.4 7.8 5.2 11.6 9.3 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;U-698: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavourable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.2 1.0 13.7 9.1 1.6 1.2 3.1 1.7 2.0 1.6 2.6 21.3 1.5 17.5 4.3 0.6 2.1 4.1 3.8 3.2 4.3 3.3 1.6 0.6 3.4 4.8 1.7 3.1 1.6 3.0 2.4 8.2 9.0 0.9 4.4 1.3 0.1 3.7 2.5 8.9 0.6 4.7 4.7 9.9 6.6 3.9 6.3 8.8 1.3 2.0 4.7 1.1 1.2 6.4 1.5 2.2 1.5 2.5 10.1 0.9 53.0 0.8 1.5 4.0 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favourable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.9 5.5 0.0 3.1 4.6 0.1 0.7 2.5 0.5 0.0 0.1 0.4 0.1 2.6 1.5 0.5 4.2 0.0 0.2 1.3 1.5 4.7 8.5 0.0 2.6 0.7 20.7 2.9 0.2 0.0 0.0 1.0 3.5 0.1 0.6 0.0 23.2 0.2 9.0 0.7 11.4 0.3 1.0 2.2 9.3 10.9 0.0 0.5 0.0 6.1 0.0 3.8 0.3 1.6 2.8 0.5 2.6 0.4 0.0 0.6 2.9 3.2 1.6 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: , HPA062281: " "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favourable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.3 6.5 5.3 4.1 8.5 3.3 4.2 4.9 6.4 4.7 4.0 9.5 3.5 3.8 4.9 5.4 8.2 3.5 6.2 1.9 7.5 3.0 1.0 5.4 2.8 5.4 0.8 7.5 3.1 7.0 4.8 1.7 0.9 1.8 6.1 2.0 9.4 3.1 2.4 3.3 6.7 10.7 3.9 4.0 2.6 4.9 6.4 3.5 2.5 7.1 16.7 8.3 4.2 2.7 4.2 6.4 18.1 4.1 5.6 3.2 2.0 8.7 2.5 3.4 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521794 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 92.9;kidney: 106.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm 1000000000 Nucleoplasm "HPA015599: AB_1855192, HPA072045: " "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favourable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 23.5 17.2 9.8 8.9 10.4 4.1 21.8 7.6 14.9 9.8 60.1 18.7 6.9 58.1 14.3 11.5 14.9 9.6 13.6 8.0 10.8 9.1 106.0 48.6 11.1 10.6 16.0 7.7 12.6 9.0 9.6 12.5 10.4 13.0 9.2 6.6 13.3 9.6 9.0 9.7 11.4 92.9 10.4 17.4 13.4 9.3 8.4 11.5 8.4 15.0 9.7 10.6 11.9 11.9 17.1 32.3 27.5 39.1 16.8 25.8 32.6 13.2 35.9 10.6 17.0 45.2 17.4 24.5 11.7 24.1 15.0 17.1 31.2 11.6 5.4 17.6 29.5 3.4 15.2 9.6 12.4 15.2 15.0 34.3 7.3 31.7 30.9 9.9 41.6 21.4 9.1 13.7 8.5 20.0 6.5 15.6 16.3 16.1 7.6 3.3 14.6 14.6 15.0 14.4 14.9 13.0 34.9 13.0 33.4 21.9 10.8 17.7 7.5 10.8 16.7 14.5 15.7 18.8 13.6 14.3 21.2 4.7 15.5 14.4 20.6 27.5 36.1 2.5 25.8 39.1 22.6 17.1 25.7 23.8 32.3 16.3 16.9 19.6 1.9 16.8 27.2 9.9 23.6 32.6 9.8 10.4 7.6 14.9 10.8 9.1 16.0 7.7 13.0 11.5 PET100 C19orf79 ENSG00000229833 "PET100 homolog" P0DJ07 19 7629737-7631956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 106.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067288 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA067288: " "unprognostic (7.02e-2)" "prognostic favourable (6.81e-4)" "unprognostic (1.57e-1)" "unprognostic (9.87e-3)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (1.70e-1)" "prognostic favourable (7.97e-4)" "unprognostic (4.89e-1)" "unprognostic (2.88e-3)" "unprognostic (2.49e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (2.66e-2)" "prognostic favourable (2.44e-4)" 18.7 27.8 24.9 21.3 23.3 42.3 22.9 16.1 27.8 13.2 21.9 9.7 29.3 22.2 13.4 27.4 18.0 11.0 24.0 47.3 31.6 18.3 24.7 36.8 14.9 20.5 19.8 25.3 11.9 24.7 11.0 20.7 18.0 21.0 16.4 16.4 14.7 29.9 30.1 41.1 14.8 18.8 12.9 21.3 18.2 25.6 14.4 12.4 16.4 17.5 29.9 17.5 10.2 13.6 52.6 86.9 106.6 82.2 33.8 60.1 72.1 18.1 16.3 30.0 17.9 14.6 10.5 11.0 15.5 8.9 10.7 10.5 14.6 12.3 12.1 27.4 11.7 16.2 13.5 14.1 8.9 27.6 27.3 17.3 34.5 23.2 7.3 29.4 16.6 11.9 9.2 7.2 7.6 15.1 12.4 46.9 11.2 19.7 31.6 46.3 19.4 35.7 20.0 17.0 28.1 21.5 22.1 16.7 20.0 20.6 18.6 16.7 13.5 39.1 16.4 8.5 10.4 16.9 23.1 42.2 32.9 22.0 15.5 22.8 10.0 106.6 82.2 89.2 41.9 63.7 39.0 52.6 48.6 43.8 49.8 51.0 45.4 47.7 77.2 33.8 56.1 86.9 60.1 72.1 24.9 23.3 16.1 27.8 31.6 18.3 19.8 25.3 21.0 12.4 PEX10 RNF69 ENSG00000157911 "Peroxisomal biogenesis factor 10" O60683 1 2403964-2413797 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049458, HPA049755" Approved Approved Nucleoplasm Nucleoplasm "HPA049458: , HPA049755: " "prognostic favourable (4.50e-6)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (1.81e-2)" "unprognostic (2.91e-1)" "unprognostic (9.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "prognostic favourable (4.16e-6)" "unprognostic (4.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.42e-1)" 14.6 18.7 20.5 6.2 19.9 5.6 16.3 7.6 24.6 9.8 9.2 23.1 6.6 10.1 7.6 13.6 10.6 11.4 8.3 12.9 17.8 15.5 12.0 12.1 8.3 7.6 19.2 13.5 13.0 19.4 12.5 12.2 10.2 16.0 15.4 7.0 11.4 17.4 12.3 22.1 10.8 9.0 6.6 21.3 8.9 10.1 17.3 12.6 6.0 10.5 11.8 9.0 8.1 6.8 7.4 11.5 2.2 10.7 4.5 6.4 4.8 12.0 10.1 7.8 8.7 5.7 6.6 7.3 6.4 7.4 10.6 7.7 16.0 18.2 6.3 16.9 8.4 9.4 7.1 11.8 5.0 10.2 13.8 4.8 10.3 31.9 11.0 8.5 2.6 6.5 6.2 7.8 10.7 9.0 5.8 7.9 9.3 15.7 7.9 4.0 6.7 20.2 6.5 8.1 13.1 11.4 4.2 12.3 9.4 7.5 11.4 20.7 9.9 3.4 8.7 9.7 4.3 14.9 8.5 11.5 4.7 5.7 11.2 6.6 7.7 1.9 6.9 2.2 5.2 10.7 6.0 7.4 4.5 6.4 11.5 6.9 5.2 3.9 1.6 4.5 8.7 9.8 2.5 4.8 20.5 19.9 7.6 24.6 17.8 15.5 19.2 13.5 16.0 12.6 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450807-143490010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Supported Nucleoplasm,Peroxisomes "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favourable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 10.1 47.5 13.7 14.0 15.5 3.3 14.5 17.3 17.7 13.6 8.5 12.1 14.0 7.0 12.5 16.4 21.1 12.5 9.0 15.8 14.3 11.4 22.7 29.2 9.6 10.3 13.7 15.9 14.4 8.6 16.2 14.8 22.2 17.4 15.0 8.1 10.4 12.8 15.7 12.6 14.6 8.8 12.7 14.6 8.7 11.3 14.4 12.7 10.1 19.3 13.5 11.6 11.9 15.1 18.2 8.7 7.8 9.6 12.0 18.7 8.1 14.4 3.6 7.6 16.0 12.7 12.5 9.6 13.0 10.6 18.0 22.0 23.4 9.4 25.4 15.5 13.9 12.3 10.5 18.4 22.3 14.7 12.9 17.9 7.3 15.0 11.7 28.9 7.3 15.2 12.6 17.3 13.0 9.9 15.2 11.7 17.2 10.2 14.6 11.7 4.9 13.0 11.2 17.2 10.9 22.1 6.3 11.8 4.2 17.3 15.0 11.5 7.5 9.6 9.0 12.9 11.1 22.0 15.4 8.4 10.6 25.4 16.9 20.0 10.1 7.8 5.1 4.9 13.2 8.0 15.1 18.2 14.1 13.1 7.9 15.4 18.7 17.9 0.8 12.0 9.6 8.7 16.5 8.1 13.7 15.5 17.3 17.7 14.3 11.4 13.7 15.9 17.4 12.7 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963870-42979220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 73.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 13.0 14.9 12.1 11.5 18.9 9.0 11.5 21.7 19.0 14.7 16.9 14.6 15.3 9.8 11.9 8.8 18.2 23.4 13.0 10.4 12.9 12.1 11.3 18.8 7.4 17.6 17.3 9.1 20.0 73.2 21.3 18.2 10.6 16.0 17.8 8.5 10.8 15.0 12.8 15.2 14.2 24.6 10.5 9.9 12.8 10.6 10.6 17.2 22.3 21.5 6.9 10.9 11.2 12.4 4.3 4.3 4.8 3.2 4.0 6.1 2.5 17.7 8.5 4.3 16.1 16.1 15.5 4.5 3.1 4.9 2.6 5.4 5.4 5.2 7.2 4.4 7.4 16.8 15.0 16.2 2.7 14.0 7.9 2.4 12.0 3.1 10.9 2.4 5.0 19.3 18.8 10.6 2.9 12.9 12.6 7.4 5.6 2.0 6.3 8.0 5.3 7.5 13.6 7.6 2.9 6.5 5.2 13.6 5.9 2.9 11.6 16.3 22.7 10.9 7.2 8.2 1.6 4.0 7.1 11.1 9.8 9.9 2.8 12.6 6.5 2.1 3.2 4.8 3.0 2.4 5.4 2.6 4.4 6.1 4.3 4.3 5.5 5.1 2.0 4.0 1.5 2.5 2.1 2.5 12.1 18.9 21.7 19.0 12.9 12.1 17.3 9.1 16.0 17.2 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913937 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049202: " "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favourable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favourable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 5.5 17.8 8.1 7.0 8.9 4.0 13.5 7.0 10.7 8.7 8.5 7.9 14.0 6.1 5.5 18.9 9.1 8.9 17.0 14.5 7.2 6.7 16.3 10.0 9.2 4.7 8.9 9.5 6.1 43.6 15.5 10.2 6.7 6.9 11.7 9.2 13.6 15.4 18.9 11.7 12.0 6.6 7.5 9.6 4.7 14.5 19.4 5.4 5.9 11.5 7.5 6.8 6.9 7.0 4.6 5.4 4.3 5.3 2.9 6.9 1.8 4.7 4.6 4.6 6.5 6.0 8.9 2.5 6.6 8.3 7.1 7.5 5.7 5.6 1.7 12.6 7.1 6.1 3.3 12.3 8.8 4.9 8.0 6.4 4.6 0.8 14.4 8.0 3.7 8.5 13.0 5.1 10.2 5.3 11.9 5.1 9.7 11.3 3.5 9.9 4.7 7.9 4.7 4.7 4.9 15.4 6.4 8.7 12.6 6.1 8.7 8.5 5.7 10.1 4.0 4.6 2.2 7.2 5.1 7.2 4.7 0.0 3.7 7.3 5.6 0.2 3.0 4.3 2.6 2.5 2.0 4.6 3.4 4.2 5.3 2.9 6.9 4.1 0.5 2.9 5.3 5.4 6.4 1.8 8.1 8.9 7.0 10.7 7.2 6.7 8.9 9.5 6.9 5.4 PFDN6 "H2-KE2, HKE2, KE-2, PFD6" ENSG00000204220 "Prefoldin subunit 6" O15212 6 33289302-33298401 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043032, HPA048123" Enhanced Approved "Nucleoplasm,Golgi apparatus" 110000 "Nucleoplasm, Golgi apparatus" "HPA043032: AB_2678278, HPA048123: AB_2680273" "unprognostic (1.04e-1)" "unprognostic (1.96e-2)" "unprognostic (7.66e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.35e-2)" "unprognostic (8.29e-2)" "unprognostic (3.36e-1)" "unprognostic (1.55e-1)" "prognostic favourable (1.01e-4)" "unprognostic (6.93e-2)" "unprognostic (6.67e-2)" "prognostic unfavourable (8.97e-4)" "unprognostic (1.79e-1)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.68e-3)" 12.5 19.1 29.2 15.4 27.8 15.0 15.6 13.2 33.9 12.0 17.7 12.9 13.1 13.8 14.4 22.4 15.1 12.5 11.4 16.2 31.6 24.8 19.1 23.2 10.8 15.7 27.0 31.9 14.5 21.3 15.3 14.6 14.0 20.7 12.5 16.2 8.2 15.8 16.0 43.6 10.8 13.7 13.4 20.7 11.3 12.2 33.1 17.5 10.7 12.2 22.5 18.9 11.8 9.8 6.8 5.0 3.4 7.1 3.9 7.5 4.3 14.8 9.9 6.9 14.2 7.7 6.6 11.3 11.4 5.8 10.0 9.5 9.3 7.3 21.9 13.9 6.4 10.9 11.3 13.1 15.1 14.7 12.0 19.6 11.0 15.5 8.7 15.0 12.8 5.9 15.1 14.1 10.1 9.8 23.8 9.4 10.7 10.1 17.9 15.8 11.6 8.7 15.5 10.1 22.1 16.2 7.1 16.0 19.4 9.9 26.0 16.5 14.9 21.6 8.2 7.1 10.6 8.8 18.8 19.0 51.8 24.4 6.9 19.9 10.1 3.2 5.1 3.4 4.1 6.5 4.2 5.9 5.6 7.5 4.9 6.8 3.3 4.6 2.7 3.9 7.1 5.0 5.3 4.3 29.2 27.8 13.2 33.9 31.6 24.8 27.0 31.9 20.7 17.5 PGAM1 "PGAM-B, PGAMA" ENSG00000171314 "Phosphoglycerate mutase 1" P18669 10 97426160-97433441 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042528, HPA060483" Approved Approved Nucleoplasm 200000000 Nucleoplasm "HPA042528: , HPA060483: " "prognostic unfavourable (2.04e-4)" "prognostic unfavourable (3.86e-4)" "unprognostic (3.64e-1)" "unprognostic (5.64e-2)" "unprognostic (1.16e-1)" "unprognostic (9.47e-3)" "unprognostic (7.60e-3)" "unprognostic (1.74e-3)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "unprognostic (2.48e-2)" "unprognostic (1.48e-1)" "unprognostic (5.74e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-1)" "unprognostic (2.61e-3)" 26.5 46.1 42.8 28.9 50.3 30.2 19.0 32.6 90.0 26.5 27.6 24.9 14.2 29.8 24.3 20.6 63.5 17.7 21.2 54.1 47.4 44.9 32.7 35.7 18.5 29.5 45.7 61.1 22.9 14.3 27.8 23.2 30.8 72.4 21.9 29.2 30.4 24.5 33.7 8.4 30.0 27.4 35.6 25.7 21.7 20.3 26.1 21.0 26.6 17.4 27.0 43.7 31.0 31.9 22.5 49.7 88.0 65.3 22.8 41.2 72.8 120.6 57.4 39.7 75.6 37.6 34.7 54.1 77.4 101.2 91.0 127.0 62.3 36.1 64.0 53.1 65.7 75.8 69.0 112.5 110.4 59.2 65.9 41.3 45.1 69.6 27.8 59.1 55.3 33.9 46.1 60.4 45.1 65.8 27.0 36.3 95.5 49.9 52.8 73.0 60.8 68.9 40.2 36.4 50.7 70.3 45.8 8.6 40.6 41.6 24.9 39.7 67.7 49.9 49.4 48.8 42.9 43.0 88.8 54.7 60.3 58.4 113.4 99.0 22.5 30.4 65.3 88.0 37.0 57.2 32.7 22.5 31.8 36.6 49.7 18.8 20.7 28.9 50.3 22.8 62.8 17.6 41.2 72.8 42.8 50.3 32.6 90.0 47.4 44.9 45.7 61.1 72.4 21.0 PGAM4 "dJ1000K24.1, PGAM-B, PGAM1, PGAM3" ENSG00000226784 "Phosphoglycerate mutase family member 4" Q8N0Y7 X 77968874-77969638 "Enzymes, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 5.3" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042528, HPA060483" Uncertain Approved Nucleoplasm Nucleoplasm "HPA042528: , HPA060483: " "unprognostic (3.10e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (4.37e-2)" "unprognostic (4.21e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (7.52e-3)" "unprognostic (3.19e-2)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (1.20e-1)" "unprognostic (4.15e-2)" "unprognostic (1.10e-1)" "unprognostic (2.76e-3)" 0.9 2.1 0.9 2.6 1.5 3.0 0.4 0.8 2.1 1.9 0.6 2.4 1.4 0.7 2.9 1.3 0.0 1.3 1.0 1.5 0.9 1.2 0.4 1.2 1.5 1.0 0.1 0.7 0.7 0.7 0.5 0.7 0.6 0.2 1.1 0.8 2.0 1.3 0.4 1.0 1.3 0.5 0.3 0.7 1.6 1.2 0.7 1.9 3.7 2.4 0.8 1.6 3.5 5.3 3.1 0.3 0.9 0.4 0.0 2.7 0.5 0.1 0.6 0.8 0.0 0.5 0.8 1.4 0.3 2.3 0.2 0.0 0.7 0.6 0.3 0.0 1.1 0.7 0.0 1.6 0.9 0.4 0.2 0.2 0.0 0.5 0.0 0.6 0.8 0.9 2.6 3.9 1.1 0.7 0.8 0.9 2.0 0.0 0.7 0.1 2.6 0.3 0.0 1.3 1.0 0.6 0.0 1.0 1.8 1.6 3.0 2.7 1.4 0.7 3.7 1.5 0.5 0.6 2.4 3.7 1.4 2.2 1.1 0.7 1.1 1.3 1.9 0.7 0.6 0.9 1.5 0.8 2.1 0.5 1.6 3.5 PGBD1 "dJ874C20.4, HUCEP-4, SCAND4" ENSG00000137338 "PiggyBac transposable element derived 1" Q96JS3 6 28281572-28302549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5;plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007267 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007267: AB_1079601" "unprognostic (2.26e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-1)" "unprognostic (1.96e-3)" "unprognostic (1.28e-2)" "unprognostic (8.81e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (1.27e-1)" "prognostic unfavourable (1.71e-4)" "unprognostic (5.38e-3)" "prognostic favourable (6.79e-4)" "unprognostic (7.32e-3)" "prognostic unfavourable (4.97e-4)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (5.23e-2)" "unprognostic (2.68e-1)" 6.1 4.5 7.4 3.8 7.2 2.8 8.5 9.6 12.8 6.1 7.4 4.0 1.3 3.0 9.2 6.0 4.5 4.3 4.0 7.0 7.1 6.3 5.9 5.1 5.4 3.1 7.0 7.7 6.0 4.0 6.6 8.6 4.3 5.1 6.0 4.6 4.4 3.8 7.4 4.1 3.0 4.0 11.7 7.0 4.9 4.8 5.2 3.6 8.9 4.0 3.1 3.4 5.2 3.8 1.0 4.4 3.5 0.2 1.2 1.2 0.3 5.1 2.8 9.1 12.9 7.3 5.3 3.0 6.8 4.6 8.6 9.8 3.2 2.2 3.4 4.3 4.6 2.3 9.9 5.5 11.2 3.7 5.7 6.2 5.7 4.0 3.5 7.7 0.8 4.3 2.6 8.4 2.9 10.5 8.0 0.4 9.5 1.5 6.5 9.7 3.4 5.7 11.2 11.6 0.0 4.2 2.8 6.3 12.0 4.6 0.8 5.1 2.5 4.8 7.4 12.9 8.6 0.9 10.6 3.3 3.3 4.4 2.9 4.5 6.0 3.5 0.1 0.0 0.6 0.2 0.3 0.5 0.2 1.2 0.7 1.0 0.1 0.5 0.0 1.2 0.1 4.4 0.5 0.3 7.4 7.2 9.6 12.8 7.1 6.3 7.0 7.7 5.1 3.6 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102073-34108684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: " "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 2.5 3.6 3.9 4.1 8.5 6.7 3.4 5.3 11.1 2.6 2.8 4.8 4.7 3.2 2.6 3.9 3.8 4.6 2.4 4.0 5.4 3.6 3.4 5.3 2.4 5.2 6.0 6.1 3.0 4.6 4.9 6.7 2.5 12.7 3.0 3.4 3.2 3.3 2.6 18.6 4.4 5.1 2.2 4.0 6.0 4.5 7.9 5.8 4.5 3.3 2.0 4.2 3.2 2.7 2.8 1.7 6.4 1.4 1.6 2.6 0.6 2.0 3.6 2.5 4.1 7.4 4.9 1.6 3.1 3.0 2.0 2.5 2.5 2.7 4.2 2.6 2.4 5.6 1.5 3.6 2.5 4.3 3.8 6.7 6.9 1.8 3.1 2.3 6.1 3.8 4.1 2.6 4.7 2.2 4.6 5.0 4.1 1.4 3.8 5.5 1.0 2.7 5.6 3.5 2.1 2.6 4.3 3.7 3.4 1.6 3.6 1.1 3.5 3.6 2.6 6.1 3.5 3.2 2.1 5.9 3.8 2.3 5.4 5.3 3.6 6.4 1.4 1.5 1.3 1.2 1.1 1.5 1.7 1.3 0.8 2.8 2.6 2.4 3.2 1.6 0.9 1.7 1.3 0.6 3.9 8.5 5.3 11.1 5.4 3.6 6.0 6.1 12.7 5.8 PGBD5 "DKFZp761A0620, FLJ11413" ENSG00000177614 "PiggyBac transposable element derived 5" Q8N414 1 230314482-230426371 "Disease related genes, Predicted intracellular proteins" Transposition "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6" "Cell line enhanced" "Detected in some" "Daudi: 17.7;NTERA-2: 18.1;RH-30: 9.8;SCLC-21H: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065010 Approved Nucleoplasm Nucleoplasm "HPA065010: " "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.61e-2)" "prognostic unfavourable (8.78e-5)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (4.91e-2)" "unprognostic (3.97e-1)" "unprognostic (1.15e-1)" "unprognostic (7.48e-3)" "unprognostic (2.57e-1)" "unprognostic (3.29e-2)" "unprognostic (6.69e-2)" "unprognostic (2.12e-1)" "unprognostic (3.13e-3)" "unprognostic (2.51e-1)" 0.8 10.8 16.0 0.8 14.1 0.6 0.7 17.9 27.0 21.9 1.5 6.0 0.1 1.0 5.8 0.5 1.8 5.6 2.2 13.3 20.0 8.0 1.5 2.8 1.8 0.9 7.1 8.9 0.9 21.6 0.9 4.0 2.6 8.0 1.4 1.3 1.0 3.2 1.2 2.8 0.9 1.0 3.0 5.0 2.6 1.6 5.8 4.6 0.5 6.0 0.6 5.1 1.6 1.5 0.8 0.6 1.5 0.6 0.6 0.6 0.2 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 4.0 0.0 17.7 1.7 0.0 3.3 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.1 3.6 18.1 0.1 0.0 9.8 2.8 2.1 0.0 25.0 4.7 0.6 0.0 0.2 0.2 6.1 0.0 0.0 1.5 0.0 1.4 7.6 5.7 0.0 0.0 1.5 0.2 1.5 0.6 1.2 0.6 0.6 0.5 0.4 0.5 0.4 0.4 0.8 0.6 0.6 1.2 0.6 0.6 0.6 0.4 0.2 16.0 14.1 17.9 23.8 20.0 8.0 7.1 8.9 8.0 4.6 PGC ENSG00000096088 Progastricsin P20142 6 41736711-41754109 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Digestion "Aspartyl protease, Hydrolase, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7" "Cell line enriched" "Detected in some" 13 "Hep G2: 73.2" "Cancer enhanced" "Detected in many" "stomach cancer: 1050.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 7 "monocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031717, HPA031718" Enhanced Approved Nucleoplasm "Secreted to digestive system" Nucleoplasm "HPA031717: AB_10670130, HPA031718: AB_10610148" "unprognostic (9.18e-2)" "unprognostic (1.87e-1)" "unprognostic (9.83e-2)" "unprognostic (2.27e-1)" "unprognostic (7.18e-2)" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (8.50e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "unprognostic (8.74e-2)" 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 3.0 249.6 41.7 0.1 0.0 3.3 0.3 16.8 0.1 0.1 0.1 0.1 0.3 139.4 0.0 0.1 0.0 0.1 798.6 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.1 35.9 0.1 0.1 0.1 0.0 0.1 0.1 963.7 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.7 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in some" 6 "BEWO: 91.3;HUVEC TERT2: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" 12380 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavourable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavourable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.2 0.4 0.0 91.3 0.8 0.8 0.4 0.5 2.1 0.1 0.0 2.0 0.6 0.1 0.4 4.1 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.0 1.0 1.6 0.4 43.0 0.0 0.0 12.1 0.1 0.0 0.1 0.4 0.7 0.0 11.3 0.0 0.1 0.2 6.9 3.7 0.0 0.1 1.6 0.0 0.1 8.7 0.0 2.3 0.0 3.6 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 PGGT1B "BGGI, GGTI" ENSG00000164219 "Protein geranylgeranyltransferase type I subunit beta" P53609 5 115204012-115262872 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030646 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" "Nucleoplasm, Endoplasmic reticulum" Cytosol "HPA030646: AB_10602019" "unprognostic (2.73e-2)" "unprognostic (1.67e-1)" "unprognostic (3.92e-2)" "unprognostic (7.34e-2)" "unprognostic (5.57e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (3.25e-2)" "unprognostic (1.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (4.38e-2)" "unprognostic (1.58e-1)" "unprognostic (3.75e-1)" "unprognostic (5.93e-3)" "unprognostic (1.15e-2)" 10.5 12.4 7.3 13.3 10.1 10.9 13.9 8.8 22.1 10.8 13.8 7.7 7.9 12.3 9.2 4.6 14.9 7.3 7.0 13.5 9.5 5.9 8.2 13.7 22.2 22.2 10.2 10.0 9.6 10.1 12.0 13.4 7.8 8.2 8.4 15.1 5.7 10.6 8.4 10.2 9.9 10.4 9.5 6.9 10.4 11.0 5.1 10.5 10.2 8.8 9.9 10.1 9.6 10.5 8.0 11.5 21.8 16.7 6.7 6.3 6.4 10.1 11.1 12.6 16.3 7.4 6.2 6.2 12.6 7.4 10.5 10.8 12.0 10.9 20.7 17.1 8.8 8.0 16.6 16.5 15.8 22.8 9.2 11.9 14.4 9.6 9.9 16.3 17.6 9.3 10.2 10.3 10.8 10.5 9.6 8.9 12.0 15.8 14.3 5.4 9.4 8.6 15.7 16.9 20.9 11.0 19.2 12.4 9.4 14.9 11.4 12.0 15.3 12.2 12.0 10.8 10.2 7.4 14.6 14.8 16.5 10.9 7.8 17.0 14.9 8.3 12.8 21.8 5.0 16.6 5.6 6.8 5.7 6.3 11.5 8.0 5.4 5.0 13.1 6.7 16.7 10.3 4.9 6.4 7.3 10.1 8.8 22.1 9.5 5.9 10.2 10.0 8.2 10.5 PGM3 "AGM1, DKFZP434B187, PAGM" ENSG00000013375 "Phosphoglucomutase 3" O95394 6 83161150-83193936 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004998, HPA029759, HPA029760" Enhanced Approved Nucleoplasm,Cytosol 73000 "Nucleoplasm, Cytosol" "CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109" "prognostic unfavourable (8.78e-4)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.45e-2)" "unprognostic (3.03e-2)" "unprognostic (1.51e-2)" "unprognostic (4.04e-2)" "unprognostic (1.09e-3)" "unprognostic (6.72e-3)" "unprognostic (3.11e-1)" "prognostic favourable (9.96e-4)" "unprognostic (4.00e-1)" "unprognostic (1.30e-1)" "prognostic unfavourable (2.39e-7)" "unprognostic (2.21e-1)" "unprognostic (7.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.22e-3)" 15.5 16.7 11.2 10.4 13.7 4.8 12.3 19.1 13.3 15.4 10.1 9.0 30.7 8.9 10.6 26.2 10.3 8.8 14.2 12.2 11.0 8.6 12.2 44.9 13.4 6.3 13.5 9.9 15.5 36.3 9.3 36.2 27.6 18.1 30.9 13.7 7.4 29.2 23.4 5.5 7.5 11.6 11.1 9.7 8.1 14.4 16.8 11.3 4.0 14.9 7.6 8.7 11.1 10.0 8.2 7.4 11.1 6.5 5.3 8.7 3.9 10.0 6.6 12.9 15.4 21.0 22.4 14.9 34.3 24.9 16.6 26.2 17.2 4.7 5.3 7.3 34.2 6.4 11.7 14.4 31.9 3.9 11.4 6.8 13.1 28.8 23.8 6.6 3.4 14.2 11.9 29.3 37.1 19.5 22.1 5.8 17.9 10.4 1.1 4.4 5.7 9.1 4.7 28.8 3.1 12.9 9.9 5.1 8.0 9.9 8.8 6.8 7.7 7.4 28.5 11.5 6.3 23.0 18.4 11.3 4.4 3.8 9.0 5.3 17.9 11.1 6.4 3.8 5.0 6.0 6.7 8.2 5.2 6.2 5.5 5.0 8.7 8.2 2.7 5.3 6.5 7.4 3.6 3.9 11.2 13.7 19.1 13.3 11.0 8.6 13.5 9.9 18.1 11.3 PHF1 "MTF2L2, PCL1, TDRD19C" ENSG00000112511 "PHD finger protein 1" O43189 6 33410399-33416453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031038 Approved Approved Nucleoplasm Nucleoplasm "HPA031038: AB_10671365" "unprognostic (1.96e-3)" "unprognostic (4.77e-2)" "prognostic unfavourable (9.64e-5)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (2.43e-3)" "unprognostic (2.31e-2)" "unprognostic (8.87e-3)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (2.42e-3)" "unprognostic (4.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.48e-2)" "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "prognostic favourable (1.72e-4)" 10.7 10.2 12.0 15.5 15.2 23.5 29.0 14.2 12.5 29.7 14.6 9.4 26.4 11.0 18.2 30.7 10.0 16.3 18.3 15.4 13.2 13.3 13.0 10.5 19.7 16.7 16.9 12.0 31.5 24.9 21.1 26.6 7.7 14.6 16.9 6.2 14.6 17.6 28.5 12.9 7.7 12.1 18.9 12.3 18.8 12.7 26.7 12.8 5.0 22.4 9.3 21.3 20.7 29.2 1.5 0.5 3.2 0.4 1.1 4.6 0.9 1.7 2.4 5.4 3.5 2.4 1.4 10.9 3.7 5.9 2.8 3.2 3.3 1.6 0.6 2.3 8.9 0.5 1.1 1.9 0.7 2.2 1.2 5.1 4.0 1.4 0.4 2.9 12.7 2.8 2.6 5.6 5.0 1.8 2.0 4.4 2.2 1.3 0.9 1.8 1.9 1.7 2.2 0.7 1.8 0.3 2.3 3.6 3.8 1.9 2.0 3.0 1.5 3.6 3.5 5.6 1.6 3.3 4.0 3.0 4.8 5.9 4.1 3.2 3.3 0.2 0.3 0.7 1.4 0.4 4.6 1.2 2.8 3.5 0.5 1.5 3.3 1.7 3.2 1.1 0.4 0.3 0.9 0.9 12.0 15.2 14.2 12.5 13.2 13.3 16.9 12.0 14.6 12.8 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169630 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: " "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 12.5 10.9 25.0 12.4 20.4 6.4 18.4 21.4 23.8 14.0 12.7 10.7 7.2 10.3 17.9 11.0 10.6 12.4 12.6 7.7 24.7 22.1 12.2 14.8 11.3 12.0 18.5 15.5 20.2 9.8 18.4 21.4 11.0 20.0 13.9 14.3 7.1 10.0 11.5 9.3 11.3 10.1 14.9 16.2 12.9 13.3 12.0 14.9 31.5 12.7 7.6 12.9 11.9 10.6 3.9 5.8 1.6 2.0 3.4 4.6 0.8 6.7 14.1 20.7 21.4 7.3 7.1 9.9 5.3 4.5 6.5 7.1 12.5 12.2 26.5 9.9 5.0 9.5 18.4 6.3 7.1 9.6 7.0 13.1 12.5 16.3 6.7 28.9 12.4 6.4 6.8 7.5 13.8 9.3 17.3 9.5 7.7 8.7 11.4 12.8 17.3 10.1 19.4 13.3 8.3 6.7 13.2 18.6 26.0 8.2 28.1 8.9 14.9 21.3 8.6 9.1 12.1 5.7 10.4 12.1 20.9 18.5 6.3 24.6 21.1 1.6 2.0 1.2 2.9 1.8 2.3 3.9 3.2 3.7 1.2 3.4 4.6 3.8 0.1 3.4 1.6 5.8 4.1 0.8 25.0 20.4 21.4 23.8 24.7 22.1 18.5 15.5 20.0 14.9 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 14.5 19.9 15.3 15.7 26.6 27.1 17.6 22.2 22.0 15.7 14.2 12.6 11.7 11.6 17.6 13.0 16.0 12.4 13.6 22.5 15.9 10.5 13.6 16.4 12.9 13.5 11.8 14.8 16.9 12.7 22.4 18.6 15.1 12.9 13.1 12.9 10.0 14.9 14.6 27.0 9.5 12.9 14.5 12.9 15.4 12.8 15.9 13.7 38.9 28.5 9.2 14.7 14.7 16.9 2.4 4.0 14.7 4.3 3.0 3.4 1.6 9.9 10.0 16.5 9.5 13.0 15.5 5.9 14.7 11.6 10.1 10.0 5.6 6.9 11.4 12.9 14.7 5.9 11.1 7.8 12.7 19.2 7.9 12.3 11.9 3.9 13.6 9.8 8.8 11.5 9.8 10.5 15.8 11.2 15.1 18.1 15.0 10.0 31.8 4.4 7.3 13.4 15.6 11.0 9.8 8.3 8.6 40.9 12.0 9.3 6.7 11.9 13.1 11.1 14.4 16.5 13.2 10.7 14.0 10.8 14.0 14.7 14.6 17.4 14.6 3.7 4.3 7.5 2.5 2.5 2.5 2.2 2.3 2.9 4.0 2.4 3.4 2.7 14.7 3.0 3.8 3.3 2.6 1.6 15.3 26.6 22.2 22.0 15.9 10.5 11.8 14.8 12.9 13.7 PHF21A "BHC80, BM-006, KIAA1696" ENSG00000135365 "PHD finger protein 21A" Q96BD5 11 45929323-46121178 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 20.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023253, HPA023580" Uncertain Approved Nucleoplasm Nucleoplasm "HPA023253: , HPA023580: AB_10962727" "unprognostic (5.30e-3)" "unprognostic (8.93e-2)" "prognostic unfavourable (6.15e-4)" "unprognostic (1.93e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-2)" "prognostic unfavourable (1.66e-6)" "unprognostic (2.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (1.25e-3)" "unprognostic (3.84e-1)" "prognostic unfavourable (2.59e-8)" "unprognostic (1.89e-1)" "unprognostic (1.97e-1)" "unprognostic (9.53e-2)" "unprognostic (1.21e-1)" 14.6 17.9 18.4 19.1 22.2 25.6 12.8 24.9 20.3 16.6 18.9 15.1 9.0 6.9 17.3 11.2 11.7 12.5 13.2 21.4 16.3 10.5 8.1 9.5 20.5 14.4 17.7 10.7 25.2 8.5 27.5 28.7 13.0 13.6 15.6 10.0 14.4 10.0 14.2 15.7 12.8 10.1 17.2 19.4 17.8 10.1 23.5 18.9 18.3 13.1 5.0 14.6 16.7 13.9 3.2 2.8 20.9 5.0 3.6 4.2 2.1 3.7 10.1 19.0 18.3 7.9 12.3 2.6 7.6 13.2 6.6 11.2 2.0 5.8 15.4 5.3 7.3 4.3 11.5 4.9 6.8 17.2 7.9 8.8 10.0 4.0 9.5 6.2 13.6 10.9 11.2 3.8 11.0 9.6 10.5 25.9 7.8 3.6 6.7 10.1 16.4 6.0 11.4 9.8 5.1 6.6 6.2 12.4 15.4 11.2 5.6 7.9 10.2 11.6 9.5 11.0 8.9 8.8 6.1 27.6 22.5 10.2 8.6 6.8 8.5 16.5 5.0 2.5 4.2 2.6 3.6 3.2 3.2 3.6 2.8 3.0 2.0 3.4 20.9 3.6 4.2 1.9 3.8 2.1 18.4 22.2 24.9 20.3 16.3 10.5 17.7 10.7 13.6 18.9 PHF3 ENSG00000118482 "PHD finger protein 3" Q92576 6 63635820-63779336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024676, HPA025763" Approved Approved Nucleoplasm Nucleoplasm "HPA024676: AB_10599736, HPA025763: AB_10600987" "unprognostic (4.33e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.23e-2)" "unprognostic (2.89e-1)" "unprognostic (6.17e-2)" "unprognostic (1.44e-1)" "unprognostic (3.19e-2)" "unprognostic (1.76e-2)" "unprognostic (1.84e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.30e-1)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (3.37e-1)" 23.7 19.6 17.1 22.9 20.0 33.0 23.5 44.4 19.4 32.6 23.5 9.4 21.9 14.9 22.7 23.4 18.8 16.9 15.9 16.2 19.1 13.3 19.5 26.7 21.0 21.5 20.0 18.5 34.1 17.4 30.3 43.5 23.0 18.7 25.6 17.5 8.5 19.1 21.5 24.5 19.4 19.2 18.1 26.8 21.9 17.1 16.8 24.9 36.3 26.0 12.9 16.9 30.5 26.6 10.3 7.5 16.2 11.5 5.5 12.2 4.5 19.0 9.2 16.0 9.3 16.2 17.2 15.7 12.5 18.1 9.4 12.7 12.8 8.9 23.3 10.9 11.2 8.4 15.3 13.2 15.9 18.6 12.4 28.0 11.8 20.2 14.4 23.8 11.4 12.4 11.9 13.4 19.4 11.0 30.4 22.1 9.6 11.3 10.1 12.7 9.0 5.7 17.9 14.4 11.1 11.4 11.4 17.2 12.7 15.1 6.8 11.2 11.6 22.1 15.3 14.6 17.3 11.1 14.9 18.7 19.4 22.3 6.7 19.1 11.2 14.4 6.8 7.3 9.0 8.9 8.9 8.4 8.5 7.0 6.0 10.3 12.2 8.9 16.2 5.5 11.5 7.5 5.9 4.5 17.1 20.0 44.4 19.4 19.1 13.3 20.0 18.5 18.7 24.9 PHGDH "PDG, PGDH, SERA" ENSG00000092621 "Phosphoglycerate dehydrogenase" O43175 1 119648411-119744226 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 16.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003681, HPA021241, HPA024031, CAB068216" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" 9000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300" "unprognostic (2.30e-1)" "unprognostic (2.16e-1)" "unprognostic (1.80e-2)" "prognostic unfavourable (1.48e-4)" "prognostic favourable (1.62e-4)" "unprognostic (9.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.24e-2)" "unprognostic (4.45e-3)" "unprognostic (8.80e-3)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (1.78e-3)" 18.8 1.9 33.3 4.4 32.1 4.4 13.8 7.8 27.2 11.9 5.8 49.7 9.4 4.2 6.1 41.0 16.7 24.5 3.9 5.3 26.7 20.5 14.0 53.2 4.3 5.7 42.0 20.7 17.3 58.2 67.5 5.7 6.4 23.3 24.5 4.7 8.7 62.9 16.4 1.7 35.9 3.0 8.1 28.3 1.9 9.0 8.6 38.1 9.9 15.8 7.3 7.3 7.9 14.1 6.7 3.2 2.9 0.7 1.2 16.5 3.2 13.5 5.5 14.5 34.9 8.3 11.0 27.1 12.3 22.2 17.6 29.2 28.7 2.4 0.0 5.3 32.9 18.3 26.9 25.6 12.4 0.1 24.5 4.3 19.5 19.8 17.3 27.4 0.1 15.8 42.8 16.8 20.0 12.6 7.8 32.5 7.7 53.3 18.3 8.4 36.3 42.3 16.1 25.2 2.3 1.1 16.2 15.7 14.3 9.0 6.0 98.9 12.2 46.8 0.1 2.9 15.3 17.9 13.7 26.8 6.7 27.4 35.6 38.3 22.6 2.9 0.7 0.2 2.9 0.2 0.2 6.7 1.8 4.9 3.2 2.7 9.1 16.5 2.0 1.2 0.2 1.8 2.4 3.2 33.3 32.1 7.8 27.2 26.7 20.5 42.0 20.7 23.3 38.1 PHKA2 "PHK, PYK" ENSG00000044446 "Phosphorylase kinase regulatory subunit alpha 2" P46019 X 18892300-18984598 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" Calmodulin-binding "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002912 Approved Approved Nucleoplasm Nucleoplasm "HPA002912: AB_10961321" "unprognostic (3.90e-2)" "unprognostic (2.06e-2)" "unprognostic (5.10e-2)" "unprognostic (1.43e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-2)" "prognostic unfavourable (1.25e-5)" "unprognostic (2.07e-2)" "unprognostic (3.42e-1)" "unprognostic (1.82e-1)" "prognostic favourable (7.68e-4)" "unprognostic (7.51e-2)" "prognostic unfavourable (1.55e-5)" "unprognostic (2.05e-1)" "unprognostic (1.58e-2)" "unprognostic (7.16e-2)" "prognostic favourable (2.96e-5)" 9.5 8.6 4.0 9.8 8.3 10.8 7.9 10.9 5.9 8.7 7.7 7.8 4.5 10.1 8.5 5.4 5.8 8.3 10.9 8.6 4.2 3.7 6.2 29.4 5.4 14.1 7.1 3.6 14.5 13.1 8.8 16.9 11.6 6.9 8.3 5.2 9.5 7.4 12.4 6.0 6.9 10.1 4.9 6.6 8.5 6.9 12.4 5.4 29.6 9.2 3.4 9.1 7.2 10.4 3.0 3.2 9.9 5.6 4.2 3.4 2.6 8.5 8.0 4.7 7.7 6.4 6.0 13.1 3.7 3.1 5.5 6.0 8.4 5.5 9.9 2.8 4.8 7.9 8.4 9.6 5.9 5.0 8.8 11.9 12.4 10.1 4.5 11.1 15.4 9.9 6.4 6.6 9.7 5.6 3.9 6.2 3.8 8.7 11.7 18.6 5.7 8.8 9.3 9.7 11.0 3.6 3.8 4.1 6.3 11.4 11.7 5.1 14.5 6.4 10.0 7.5 4.4 8.0 5.7 6.0 5.0 7.6 4.3 6.1 4.0 5.1 4.6 9.9 3.2 5.6 3.4 2.5 2.6 2.3 3.2 3.0 3.2 3.0 8.2 4.2 3.6 1.7 3.2 2.6 4.0 8.3 10.9 5.9 4.2 3.7 7.1 3.6 6.9 5.4 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;ASC TERT1: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448, HPA061506" Approved Approved "Nucleoplasm,Mitotic spindle" Nucleoplasm "Mitotic spindle" "HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: " "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavourable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 40.5 7.4 19.6 9.5 52.2 0.9 19.0 4.6 30.8 25.0 10.7 87.0 3.6 8.1 22.0 9.6 8.2 18.7 18.5 20.8 22.4 11.8 9.6 2.8 13.7 4.0 47.0 19.9 21.4 18.9 4.9 4.5 20.8 26.9 9.4 5.9 8.0 7.1 14.6 10.0 9.2 8.8 16.0 27.6 10.2 7.9 7.0 51.0 0.0 10.7 5.4 2.3 10.8 11.6 0.5 0.4 2.1 0.3 1.9 0.7 0.1 1.6 2.6 10.3 5.0 38.5 39.1 3.6 7.6 9.4 4.5 2.6 3.9 11.2 0.0 14.5 15.4 6.5 2.3 15.7 0.7 0.2 1.5 2.9 1.9 1.8 10.0 0.0 5.6 20.4 3.4 6.3 4.4 12.9 2.5 0.1 5.8 1.1 0.0 0.1 3.6 1.3 0.4 2.6 0.2 4.5 2.4 2.3 5.1 19.5 1.7 5.4 7.1 0.9 15.7 9.3 8.5 4.7 6.0 0.0 0.0 0.0 2.7 0.5 10.5 0.5 0.3 0.4 0.2 0.0 0.3 0.2 0.3 0.7 0.0 0.5 0.7 0.5 2.1 1.9 0.2 0.4 0.2 0.1 19.6 52.2 4.6 30.8 22.4 11.8 47.0 19.9 26.9 51.0 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA012312: " "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.0 6.9 9.5 19.3 8.3 9.2 7.9 26.7 24.5 16.0 18.2 11.8 12.3 13.6 2.2 20.6 12.5 13.5 6.9 22.8 9.1 10.8 5.5 7.6 3.4 9.0 7.3 15.3 5.4 6.6 9.3 14.1 5.7 9.0 24.1 17.0 9.5 6.0 4.8 8.6 8.2 6.0 19.3 11.0 4.4 20.4 9.2 12.8 14.9 17.0 9.7 18.0 5.7 5.6 27.6 14.9 15.4 15.6 11.4 13.3 16.9 8.7 11.8 23.7 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.7;SH-SY5Y: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" HPA069318 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA069318: " "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.4 0.0 0.3 0.8 1.1 0.3 1.2 0.4 0.4 0.1 1.9 0.0 2.1 0.6 3.7 0.0 0.6 0.1 0.0 0.2 0.0 3.9 1.4 1.6 0.0 0.0 0.9 0.0 0.8 0.0 2.5 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 12.7 0.0 0.0 4.3 4.9 2.9 0.0 3.3 0.0 0.3 1.1 0.0 2.1 1.5 0.7 1.0 0.2 0.0 2.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Cell line enhanced" "Detected in all" "K-562: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: " "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favourable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favourable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.7 8.2 7.3 10.9 20.8 12.6 10.4 8.9 13.5 13.1 12.8 6.4 4.2 18.4 5.3 17.8 8.6 13.8 8.5 8.0 15.6 21.2 18.9 11.2 7.3 10.4 18.7 15.2 11.2 5.4 11.1 6.2 10.6 51.5 15.6 10.1 13.5 16.3 6.4 5.7 8.5 16.4 15.9 3.4 7.3 15.6 17.9 13.1 11.6 13.5 9.2 11.4 8.6 10.7 23.9 12.4 8.8 7.4 12.0 12.2 14.6 15.8 13.5 9.9 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.0;HAP1: 8.0;NTERA-2: 16.9;SH-SY5Y: 15.9;U-2 OS: 8.9" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 6.0 1.2 0.2 0.3 0.2 1.6 8.0 4.2 3.8 0.1 0.2 0.1 0.0 2.8 0.2 8.0 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.3 1.0 0.0 1.7 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 16.9 0.0 1.1 0.0 0.1 0.1 0.1 2.2 15.9 0.0 0.1 0.0 0.0 0.0 0.0 4.3 8.9 4.5 1.1 0.2 0.0 0.3 5.9 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 PIAS4 "FLJ12419, Piasg, PIASY, ZMIZ6" ENSG00000105229 "Protein inhibitor of activated STAT 4" Q8N2W9 19 4007646-4039386 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010598 Enhanced Approved Nucleoplasm Nucleoplasm "HPA010598: AB_1079616" "unprognostic (1.23e-1)" "unprognostic (8.94e-3)" "unprognostic (3.50e-2)" "prognostic favourable (1.18e-5)" "unprognostic (2.45e-1)" "unprognostic (4.77e-3)" "unprognostic (4.01e-3)" "unprognostic (9.79e-2)" "unprognostic (6.89e-2)" "unprognostic (6.22e-2)" "prognostic favourable (7.04e-4)" "unprognostic (1.33e-2)" "unprognostic (5.98e-2)" "unprognostic (4.52e-3)" "unprognostic (5.76e-2)" "unprognostic (1.25e-1)" "unprognostic (4.67e-3)" 11.0 9.2 12.4 11.1 16.8 8.6 7.6 22.5 15.7 8.8 11.9 16.7 8.1 13.0 9.5 9.2 9.1 8.4 9.7 6.9 9.7 7.1 7.3 12.4 7.8 10.2 18.2 9.3 11.2 16.0 7.1 9.3 12.9 12.6 9.9 5.4 6.5 14.7 8.7 15.2 12.2 11.2 8.0 12.3 12.0 13.9 38.1 15.9 11.0 6.6 6.3 8.3 8.8 9.8 17.9 11.8 20.2 19.1 16.3 17.3 11.3 10.5 7.6 7.1 6.8 3.5 3.2 11.3 6.4 3.6 6.8 6.2 11.8 4.9 8.0 5.9 3.4 11.1 7.3 5.1 2.9 12.9 11.4 5.7 5.4 9.1 7.2 8.3 10.1 3.7 5.7 6.1 3.8 8.0 10.7 11.1 3.3 10.8 15.1 9.8 15.7 7.0 13.5 7.3 10.4 4.4 5.9 13.0 14.5 9.2 9.0 7.0 8.3 7.7 5.9 6.8 9.8 14.1 10.0 20.8 15.5 10.2 5.7 10.3 8.3 10.5 14.9 20.2 17.3 16.0 12.2 17.9 12.6 15.9 11.8 15.9 11.1 12.5 16.6 16.3 19.1 11.8 13.4 11.3 12.4 16.8 22.5 15.7 9.7 7.1 18.2 9.3 12.6 15.9 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+ SV40 Large T+: 10.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HeLa: 23.4;U-266/70: 14.9;U-698: 9.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA031975, HPA040616" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA031975: , HPA040616: " "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavourable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.0 0.0 0.5 2.7 10.5 14.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.7 0.0 0.3 0.0 23.4 5.5 3.3 0.0 0.0 0.0 0.1 2.7 0.7 3.2 0.0 0.2 1.6 0.0 0.1 0.0 2.9 0.0 0.0 0.0 4.1 0.0 3.2 8.1 0.0 0.1 0.0 0.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 14.9 0.1 9.7 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGL ENSG00000108474 "Phosphatidylinositol glycan anchor biosynthesis class L" Q9Y2B2 17 16217191-16351797 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "GPI-anchor biosynthesis" Hydrolase "Deafness, Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012739 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA012739: AB_1855367" "unprognostic (3.07e-2)" "unprognostic (2.65e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (7.70e-2)" "unprognostic (6.14e-2)" "unprognostic (9.39e-5)" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.63e-2)" "unprognostic (6.37e-3)" "prognostic unfavourable (2.57e-4)" "prognostic unfavourable (1.47e-4)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (3.38e-1)" "unprognostic (2.75e-3)" 17.3 12.6 11.1 14.3 18.8 8.6 18.0 14.6 15.6 12.9 13.0 17.6 12.8 17.1 19.8 20.2 12.6 13.1 12.7 8.8 8.5 7.5 11.2 18.5 12.5 12.0 14.5 10.7 16.5 16.5 11.9 18.1 10.3 13.6 14.0 14.4 15.5 14.8 16.3 13.4 20.0 15.8 10.1 9.7 12.3 14.8 11.1 13.6 13.7 15.7 11.1 20.4 10.9 12.3 5.2 7.4 5.5 3.7 5.4 9.3 3.3 8.2 11.8 8.0 6.6 11.5 10.8 3.3 4.6 5.5 7.7 13.8 12.0 10.6 4.0 9.4 4.4 12.1 9.8 5.8 11.1 8.6 25.7 8.0 8.2 14.3 12.3 3.4 5.2 9.1 15.2 13.5 15.4 8.8 9.5 5.1 6.1 8.2 6.2 8.0 3.1 6.1 6.1 6.7 11.6 8.7 4.5 4.2 6.0 4.8 3.4 9.4 3.7 3.1 5.7 7.0 4.3 4.6 13.0 3.6 0.1 6.5 8.8 8.5 4.4 0.0 3.7 5.5 6.5 3.2 5.6 5.2 8.5 5.0 2.7 4.4 9.3 7.5 0.0 5.4 2.4 7.4 6.7 3.3 11.1 18.8 14.6 15.6 8.5 7.5 14.5 10.7 13.6 13.6 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favourable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 9.4 16.6 7.2 8.7 11.7 5.4 11.6 12.6 15.6 10.8 11.5 17.8 15.6 14.1 14.0 13.6 12.6 15.8 13.4 9.5 7.4 6.4 16.1 15.2 10.6 13.8 9.0 10.1 15.9 17.5 47.3 13.4 27.6 11.5 13.1 13.2 18.0 17.5 17.4 7.6 10.0 12.9 10.7 11.0 14.2 13.9 16.5 9.7 11.3 20.0 8.3 13.4 13.6 9.9 7.4 13.7 8.0 8.8 7.1 10.0 4.1 15.9 27.3 7.8 11.2 7.0 7.8 14.0 6.8 11.8 16.4 13.5 10.0 16.2 9.0 12.4 8.1 11.6 13.0 21.3 9.9 9.9 8.4 5.4 17.8 7.6 13.7 7.2 9.4 9.6 23.5 14.6 24.0 8.5 5.9 12.9 13.4 8.8 8.5 8.3 5.0 11.2 8.9 6.3 9.8 18.1 11.1 6.6 8.8 9.4 23.3 5.3 17.5 4.8 5.1 12.1 10.7 6.4 12.4 7.9 11.6 3.8 13.0 5.4 14.9 7.0 6.7 8.0 9.2 8.8 9.3 5.0 5.1 10.0 13.7 7.4 6.5 7.6 2.4 7.1 5.9 9.5 7.6 4.1 7.2 11.7 12.6 15.6 7.4 6.4 9.0 10.1 11.5 9.7 PIGQ "GPI1, hGPI1" ENSG00000007541 "Phosphatidylinositol glycan anchor biosynthesis class Q" Q9BRB3 16 566995-584136 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039105, HPA039828, HPA061414" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA039105: AB_10796221, HPA039828: AB_10795158, HPA061414: " "unprognostic (1.23e-2)" "unprognostic (6.12e-3)" "unprognostic (2.81e-1)" "unprognostic (2.65e-2)" "unprognostic (1.09e-2)" "unprognostic (2.42e-1)" "unprognostic (9.58e-2)" "unprognostic (8.05e-2)" "unprognostic (2.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (8.98e-2)" "prognostic favourable (2.53e-6)" "unprognostic (2.73e-1)" "unprognostic (2.60e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" 13.9 15.7 12.8 8.7 13.9 48.4 8.4 12.8 20.6 8.4 9.7 11.4 16.7 15.4 10.9 23.3 7.2 10.0 13.6 7.4 10.5 11.1 18.9 12.5 13.0 6.2 9.1 13.2 10.4 29.3 18.1 15.3 8.4 9.4 11.2 4.1 15.4 15.5 17.6 12.4 12.8 8.1 5.5 7.2 10.3 13.6 15.3 8.2 11.8 18.4 4.2 7.9 9.8 6.7 5.6 10.5 5.9 6.0 5.5 5.3 3.9 8.5 12.9 4.6 6.4 3.0 1.8 8.7 9.0 3.5 3.9 4.2 9.0 8.0 4.5 11.8 2.0 13.7 2.1 4.0 0.8 13.0 18.9 6.9 14.0 6.4 5.8 6.0 6.5 3.2 6.0 6.5 1.3 3.6 15.4 2.6 1.3 11.1 11.1 6.9 6.2 13.3 21.5 3.8 10.4 3.5 3.4 8.3 13.2 10.2 4.7 6.5 10.7 4.1 8.7 6.6 8.4 7.4 6.2 9.9 2.9 3.6 2.2 3.2 6.4 1.2 4.8 3.0 5.3 5.6 4.6 4.4 4.6 5.1 4.9 5.6 5.1 3.1 5.9 5.5 6.0 10.5 4.2 3.9 12.8 13.9 12.8 20.6 10.5 11.1 9.1 13.2 9.4 8.2 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041706: , HPA046766: " "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 16.8 17.6 18.9 12.9 23.6 10.0 15.2 15.7 26.5 14.7 21.5 43.0 10.8 13.3 21.8 22.8 20.0 28.2 12.7 17.4 21.4 20.2 18.4 16.3 11.3 11.6 21.5 11.9 23.9 16.2 34.4 21.7 17.3 26.9 14.1 24.9 20.1 17.9 15.9 16.4 14.0 14.2 19.6 30.5 11.1 11.5 22.1 18.1 16.5 14.7 15.9 19.5 14.2 15.0 10.0 10.8 9.4 6.3 12.1 15.0 6.7 11.7 15.0 19.1 13.9 12.6 15.1 19.2 12.1 14.4 20.6 18.1 27.7 25.0 15.2 19.7 11.9 21.9 17.4 22.9 21.0 6.2 9.4 34.2 9.9 31.1 11.6 20.7 8.2 13.4 14.7 11.8 13.5 14.8 17.1 13.5 17.4 13.2 17.6 21.2 9.6 22.7 12.8 24.0 24.2 18.2 11.0 12.3 11.6 22.6 41.2 14.7 22.7 14.6 8.7 33.9 12.0 18.2 12.1 9.1 12.7 10.1 20.7 21.7 14.6 9.4 4.4 1.9 13.4 6.3 12.2 9.2 12.4 15.0 10.8 10.0 12.7 12.5 0.9 12.1 5.3 10.6 11.2 6.7 18.9 23.6 15.7 26.5 21.4 20.2 21.5 11.9 26.9 18.1 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.5;eosinophil: 34.5;neutrophil: 8.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029409 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029409: AB_10610280" "unprognostic (8.83e-2)" "prognostic favourable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavourable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 19.1 13.7 25.1 12.7 25.5 9.3 19.2 16.9 25.8 13.1 15.5 13.1 7.8 12.3 15.2 18.5 16.6 12.6 12.7 13.9 23.2 25.4 18.1 12.5 15.6 27.0 24.8 13.4 10.9 16.0 28.1 18.2 17.7 14.5 18.6 17.1 16.3 12.9 18.5 18.6 12.3 11.8 17.1 21.7 18.4 10.6 9.0 14.2 24.6 15.5 10.6 14.7 13.6 10.7 1.7 3.2 34.5 4.4 3.6 2.1 1.5 21.9 10.0 13.1 9.2 13.9 10.6 7.5 9.9 12.0 12.2 12.7 9.7 14.3 10.8 33.3 9.9 12.1 11.2 9.4 15.1 9.8 10.4 8.9 6.9 6.5 12.9 10.0 16.7 7.9 14.8 9.8 9.3 6.6 6.1 21.7 11.1 19.9 25.8 13.0 5.9 11.3 14.0 15.5 15.6 12.6 7.4 12.7 14.1 16.7 11.5 13.6 39.8 9.4 3.4 11.7 5.1 12.8 15.2 27.4 31.5 20.4 10.6 12.3 12.0 15.5 3.0 34.5 1.5 4.4 1.3 1.7 1.4 2.1 3.2 1.7 1.6 1.4 8.6 3.6 4.4 1.4 1.7 1.5 25.1 25.5 16.9 25.8 23.2 25.4 24.8 13.4 14.5 14.2 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell line enhanced" "Detected in some" "Daudi: 24.1;NB-4: 17.4;REH: 51.7;THP-1: 26.4;U-698: 32.9;U-937: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" Nucleoplasm "CAB026136: , HPA038452: " "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.1 2.5 0.0 0.0 5.1 0.0 0.2 13.4 0.8 3.7 0.0 0.4 0.0 10.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 17.4 0.2 0.3 51.7 1.2 5.6 0.0 0.0 1.0 0.6 0.0 0.0 0.3 0.0 26.4 0.0 0.0 0.8 0.0 0.2 0.2 0.0 32.9 0.0 27.1 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 PIK3C2B "C2-PI3K, PI3K-C2beta" ENSG00000133056 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta" O00750 1 204422628-204494724 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 31.9;RT4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030515, HPA050360" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030515: AB_10670043, HPA050360: " "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.45e-1)" "unprognostic (2.19e-3)" "prognostic unfavourable (5.42e-4)" "unprognostic (3.35e-3)" "unprognostic (3.57e-3)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (5.36e-2)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "prognostic favourable (1.16e-4)" 12.9 4.5 11.0 16.0 19.3 5.3 11.0 9.1 17.5 7.4 17.0 36.0 9.6 15.5 10.5 5.8 14.6 7.7 14.7 10.7 14.4 9.1 7.6 5.8 18.0 23.9 24.2 11.2 3.9 6.1 4.7 4.3 20.4 14.5 7.3 14.5 6.3 8.0 14.1 20.0 22.6 15.7 11.2 16.2 14.2 20.7 2.4 23.0 31.8 9.8 8.1 23.1 13.1 11.8 7.4 0.3 0.5 0.2 1.6 2.0 0.4 3.2 6.5 5.8 5.3 3.4 0.3 31.9 0.4 1.3 1.3 0.9 3.8 8.5 5.5 1.2 0.7 8.1 3.4 2.3 0.5 3.3 0.9 0.1 12.9 1.4 0.2 1.9 4.2 0.4 2.4 0.3 0.2 8.5 2.0 3.7 0.1 7.2 6.6 5.5 5.3 4.1 7.2 1.4 1.0 1.6 33.3 6.4 3.5 11.5 16.2 3.7 7.2 1.0 0.3 0.2 2.1 0.6 0.1 4.0 1.1 7.2 0.2 2.9 0.8 0.1 0.2 0.0 1.2 0.0 1.0 2.9 1.3 0.8 0.3 7.4 0.7 0.6 0.5 1.6 0.0 0.1 2.0 0.4 11.0 19.3 9.1 17.5 14.4 9.1 24.2 11.2 14.5 23.0 PIK3R3 p55 ENSG00000117461 "Phosphoinositide-3-kinase regulatory subunit 3" Q92569 1 46040140-46133036 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Group enriched" "Detected in many" 8 "granulocytes: 8.6;monocytes: 3.1;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005751, HPA071988" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA005751: AB_1855350, HPA071988: " "unprognostic (1.98e-1)" "unprognostic (3.75e-3)" "unprognostic (8.04e-2)" "prognostic favourable (1.93e-4)" "unprognostic (6.32e-2)" "prognostic favourable (3.62e-4)" "unprognostic (4.88e-2)" "unprognostic (3.33e-3)" "unprognostic (4.16e-2)" "unprognostic (4.63e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (9.99e-3)" "unprognostic (2.87e-2)" "unprognostic (9.74e-2)" "unprognostic (6.71e-2)" "unprognostic (8.22e-3)" 33.7 10.9 7.4 7.0 8.2 0.8 24.7 36.4 11.0 16.9 6.3 3.5 9.1 3.3 15.8 11.0 8.4 7.6 10.9 28.7 6.8 8.5 10.4 4.1 20.0 6.0 8.7 3.1 4.6 4.0 18.7 10.2 13.4 10.4 9.0 5.3 13.6 9.4 8.0 14.8 4.6 6.0 12.3 7.1 10.9 7.4 24.0 4.5 5.9 12.7 6.2 5.3 12.3 8.7 0.5 0.6 8.6 3.1 0.1 3.5 0.9 4.6 1.6 21.4 10.8 2.1 0.9 6.8 2.8 2.0 3.7 4.6 0.9 1.4 6.1 8.5 1.0 2.8 7.4 2.5 2.4 4.8 6.7 3.8 19.2 0.7 0.7 3.5 5.3 2.6 1.5 3.9 1.4 7.6 1.4 4.4 5.2 7.1 14.0 2.1 7.5 4.3 18.0 5.7 7.3 9.2 33.3 15.5 11.2 9.0 23.9 2.5 6.6 3.1 14.2 3.9 3.7 0.6 2.7 6.3 6.5 3.7 3.1 4.7 2.0 0.0 0.3 8.6 3.3 0.5 3.0 0.5 0.8 2.9 0.0 0.0 0.3 1.9 0.1 0.1 3.1 0.6 3.5 0.9 7.4 8.2 36.4 8.9 6.8 8.5 8.7 3.1 10.4 4.5 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802723-8867677 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 12.2" "Cell line enriched" "Detected in some" 8 "HMC-1: 57.5" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "eosinophil: 32.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 32.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavourable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 2.2 0.0 2.1 12.2 5.4 5.3 1.0 0.0 3.7 1.5 1.9 2.5 1.4 3.5 2.6 2.3 1.2 0.4 6.6 2.6 3.1 0.0 0.6 3.4 4.4 2.5 0.0 0.3 0.8 0.3 0.0 1.4 3.2 2.4 1.5 1.4 0.9 0.7 1.0 1.8 5.2 2.2 3.1 6.3 2.3 1.1 2.7 6.9 0.0 0.8 6.4 3.0 3.3 1.3 4.9 32.1 4.3 0.5 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 7.3 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.7 3.4 32.1 0.2 4.3 0.2 1.3 0.0 0.1 4.9 0.1 0.0 0.1 0.5 0.5 3.3 0.0 0.0 1.4 PIP5K1B "MSS4, STM7" ENSG00000107242 "Phosphatidylinositol-4-phosphate 5-kinase type 1 beta" O14986 9 68705414-69009176 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 30.3;HEL: 11.3;Hep G2: 9.2;Karpas-707: 6.4;U-266/70: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 22.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009687 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA009687: AB_1855391" "unprognostic (2.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.77e-2)" "unprognostic (2.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-3)" "unprognostic (1.80e-2)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-2)" "unprognostic (2.92e-2)" "prognostic favourable (1.03e-9)" "unprognostic (2.10e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" 4.0 9.5 9.4 8.4 6.5 10.2 4.2 33.4 14.6 5.6 26.9 4.1 10.8 26.1 6.1 2.0 1.2 5.0 7.6 24.6 8.1 11.7 6.1 0.8 12.6 2.1 10.4 6.4 1.4 6.7 21.3 8.5 16.8 32.8 3.3 23.1 28.7 11.6 13.6 3.0 2.4 39.7 2.6 3.7 3.1 19.9 17.6 1.5 0.0 1.6 1.9 3.3 3.5 2.9 3.9 0.9 22.1 0.3 0.0 1.0 0.2 0.0 0.0 30.3 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 3.2 0.0 2.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 11.3 0.2 9.2 0.0 0.6 2.8 0.0 1.3 0.0 0.0 0.1 0.5 6.4 0.2 0.7 0.0 0.1 1.5 0.9 0.9 0.1 0.1 0.2 2.3 0.6 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.0 11.7 2.2 1.4 0.0 2.1 0.0 3.1 0.3 22.1 0.0 0.0 0.0 3.3 0.2 0.0 0.1 3.9 0.5 0.0 1.2 0.0 0.1 0.9 1.0 0.2 9.4 6.5 33.4 14.6 8.1 11.7 10.4 6.4 32.8 1.5 PIP5K1C "KIAA0589, LCCS3, PIP5Kgamma" ENSG00000186111 "Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma" O60331 19 3630183-3700479 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017168 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA017168: AB_1855395" "unprognostic (1.20e-1)" "prognostic favourable (1.79e-4)" "unprognostic (1.36e-3)" "prognostic favourable (7.28e-5)" "unprognostic (7.03e-2)" "unprognostic (4.02e-3)" "unprognostic (5.80e-3)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (2.57e-3)" "prognostic favourable (2.32e-4)" "unprognostic (1.51e-1)" "prognostic favourable (3.00e-4)" "unprognostic (2.25e-1)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" 16.1 10.2 20.5 12.8 25.8 4.5 8.0 58.6 46.3 10.7 23.5 8.5 14.8 10.9 19.8 10.0 12.3 12.8 12.7 13.8 22.8 10.7 7.5 3.8 11.5 7.5 11.3 17.1 11.5 17.2 10.0 9.2 13.7 19.0 16.7 6.4 16.9 20.0 33.4 13.5 10.2 11.5 19.2 6.3 15.8 13.6 23.9 8.7 5.3 9.3 3.9 6.0 17.3 19.0 2.5 3.2 3.6 3.0 1.7 2.8 2.0 9.0 8.6 6.8 8.8 13.3 10.8 10.2 17.5 11.1 7.5 6.1 7.6 2.6 3.8 6.7 18.8 8.1 3.2 5.6 3.1 13.5 5.7 4.4 7.1 6.2 11.0 4.4 13.5 12.0 5.4 6.1 2.3 12.8 6.6 7.1 7.1 7.5 5.3 3.3 7.0 12.0 10.0 5.2 5.2 5.6 7.8 6.8 5.9 9.1 4.9 5.3 3.9 6.6 28.0 10.6 6.0 37.3 8.1 8.2 6.5 1.7 14.3 9.3 7.6 3.6 2.8 0.0 2.8 2.6 1.2 2.5 2.1 2.0 3.2 1.3 1.0 1.6 2.2 1.7 3.0 2.2 1.4 2.0 20.5 25.8 58.6 46.3 22.8 10.7 11.3 17.1 19.0 8.7 PITPNC1 "RDGB-BETA, RDGBB, RDGBB1" ENSG00000154217 "Phosphatidylinositol transfer protein, cytoplasmic 1" Q9UKF7 17 67377281-67697261 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026563, HPA031250" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA026563: AB_1855409, HPA031250: " "unprognostic (1.33e-1)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (1.14e-3)" "unprognostic (4.17e-2)" "prognostic favourable (4.85e-5)" "unprognostic (6.57e-2)" "unprognostic (6.32e-3)" "unprognostic (1.23e-3)" "unprognostic (1.19e-1)" "unprognostic (5.70e-2)" "unprognostic (2.31e-2)" "unprognostic (1.34e-2)" "unprognostic (9.83e-2)" "unprognostic (7.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.16e-2)" 20.8 10.0 22.9 18.0 31.0 11.3 16.6 18.9 33.5 12.0 7.5 18.7 7.0 4.6 10.7 11.7 11.0 22.4 12.5 11.7 23.4 19.1 17.3 14.3 13.5 24.3 21.4 17.0 16.7 23.3 5.4 12.3 19.0 22.7 11.2 9.1 31.2 18.3 13.1 5.1 5.2 8.1 11.7 14.8 13.9 11.8 5.1 17.8 14.5 10.4 6.0 27.0 12.0 16.8 1.6 1.6 16.1 5.5 7.2 16.4 5.0 5.8 2.2 5.9 11.4 5.1 7.0 6.8 6.6 5.3 1.3 1.0 0.0 8.7 7.2 2.2 6.1 2.4 10.3 9.9 1.4 13.2 6.0 0.8 9.7 4.7 1.3 1.4 13.6 5.5 4.4 0.8 5.3 5.1 0.6 26.2 5.0 12.7 16.8 6.1 9.9 12.0 21.3 1.3 6.4 12.5 7.1 7.2 19.0 2.6 5.0 5.9 3.7 7.2 5.1 3.1 1.2 4.0 3.1 17.1 8.5 5.6 19.9 5.9 2.5 1.1 2.5 16.1 16.4 4.0 9.6 1.0 10.7 15.5 1.6 1.6 12.3 13.0 3.1 7.2 5.5 0.4 4.0 5.0 22.9 31.0 18.9 25.3 23.4 19.1 21.4 17.0 22.7 17.8 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;testis: 30.9" "Cell line enriched" "Detected in some" 5 "NB-4: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036587, HPA036588, HPA057508" Enhanced Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA036587: , HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 1.9 0.6 1.9 1.9 3.1 17.8 2.7 4.1 1.7 2.2 3.8 1.7 1.7 4.5 2.5 1.7 1.7 2.0 3.6 1.7 1.9 1.7 1.7 1.7 1.7 2.5 1.7 1.7 2.2 8.2 0.2 1.7 2.3 1.7 1.7 5.0 1.7 7.6 2.0 1.7 0.8 4.3 1.7 2.5 2.3 3.6 30.9 1.7 1.7 1.7 1.7 1.8 1.7 1.7 0.0 0.8 0.5 2.4 0.3 1.3 1.0 0.1 0.0 0.2 0.0 3.2 2.2 0.2 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 1.3 0.0 0.4 0.0 0.1 1.2 0.1 0.1 0.3 0.0 1.3 3.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.2 0.1 43.9 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.1 0.1 0.1 0.4 0.2 0.0 9.6 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 2.4 0.5 1.0 1.0 0.0 0.0 0.1 0.6 0.8 0.0 1.3 0.4 0.0 0.3 1.0 0.0 0.4 1.0 1.9 3.1 4.1 1.7 1.9 1.7 1.7 1.7 1.7 1.7 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 98.7" "Cell line enhanced" "Detected in many" "HAP1: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favourable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 12.6 9.9 21.6 5.5 35.7 2.6 7.9 13.4 23.7 12.2 5.8 8.9 19.3 4.7 9.2 98.7 5.7 10.2 7.1 7.5 18.4 23.4 7.5 4.4 7.4 5.9 14.9 16.7 16.2 6.0 27.1 12.5 10.7 11.7 9.9 5.3 7.2 6.4 20.3 4.7 7.1 4.4 9.8 12.0 5.9 6.5 13.7 9.5 3.0 13.8 2.9 7.4 7.8 7.9 11.2 4.3 2.7 4.5 14.8 17.8 9.0 10.4 8.0 25.1 17.5 8.8 9.3 7.5 7.0 8.4 6.6 8.9 6.5 9.9 1.6 10.9 11.0 9.1 38.5 13.6 8.3 7.8 13.7 3.1 6.6 4.3 11.0 1.8 6.0 9.7 9.1 11.2 6.7 7.4 2.9 1.1 6.7 5.6 0.8 3.5 17.1 13.1 7.5 11.2 2.5 10.6 8.8 18.6 12.1 11.2 1.9 8.5 3.1 2.6 6.7 5.7 9.2 16.9 3.2 0.0 0.1 3.8 6.2 5.1 7.6 2.7 3.3 1.0 15.5 4.5 17.8 8.7 13.7 14.2 3.6 11.2 14.4 16.6 1.1 14.8 2.9 4.3 8.3 9.0 21.6 35.7 13.4 23.7 18.4 23.4 14.9 16.7 11.7 9.5 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in some" 5 "HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 44.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.0 1.0 25.5 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: " "unprognostic (1.35e-1)" "prognostic favourable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.7 0.2 0.5 0.1 0.0 0.2 0.0 0.0 23.4 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 PLA2G15 "GXVPLA2, LLPL, LYPLA3" ENSG00000103066 "Phospholipase A2 group XV" Q8NCC3 16 68245304-68261062 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041702, HPA041727" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" 20000000 "Nucleoplasm, Vesicles" "HPA041702: AB_10794486, HPA041727: AB_10793931" "unprognostic (3.47e-2)" "unprognostic (9.99e-2)" "unprognostic (1.54e-3)" "unprognostic (6.84e-3)" "unprognostic (1.38e-2)" "unprognostic (1.65e-2)" "unprognostic (4.12e-3)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.84e-2)" "unprognostic (2.56e-1)" "unprognostic (9.29e-2)" "unprognostic (2.45e-3)" "unprognostic (2.98e-2)" "unprognostic (5.40e-3)" "unprognostic (6.28e-2)" "unprognostic (3.47e-2)" 23.8 9.1 9.6 6.6 9.4 5.6 19.7 16.4 16.1 5.4 6.2 10.0 4.7 5.0 7.7 11.2 5.7 7.2 8.5 31.3 7.9 8.6 24.1 11.8 15.9 23.1 7.5 9.2 7.4 6.4 11.3 9.2 24.4 7.7 6.2 5.7 8.5 7.6 5.8 39.9 10.0 5.3 8.2 6.8 16.2 6.2 9.3 6.2 11.3 10.4 6.8 4.9 9.1 5.0 3.7 8.8 9.4 18.2 1.3 4.5 7.7 4.7 5.0 4.0 12.7 19.2 14.1 9.3 11.8 15.7 17.8 15.0 11.7 8.8 8.6 14.8 16.7 7.3 4.3 5.0 8.2 2.4 6.5 2.5 4.9 9.3 10.3 2.3 12.7 9.6 5.7 17.8 2.8 10.8 3.6 4.6 11.4 10.2 3.2 7.0 2.5 5.8 4.7 5.8 26.6 8.9 4.4 1.3 2.6 15.7 4.7 9.7 12.3 11.5 8.8 15.5 7.6 20.1 7.3 17.2 14.6 10.4 14.2 6.6 5.9 9.4 14.4 9.3 3.1 16.8 3.2 3.3 3.4 4.5 8.8 3.7 4.5 3.7 0.6 1.3 18.2 7.8 3.2 7.7 9.6 9.4 16.4 16.1 7.9 8.6 7.5 9.2 7.7 6.2 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell line enriched" "Detected in some" 4 "RT4: 13.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: " "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavourable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 3.2 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 13.2 0.7 0.1 0.0 1.4 0.0 1.4 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084386-146104369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 20.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074266 Approved Nucleoplasm Nucleoplasm "HPA074266: " "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.4 0.1 0.9 0.4 1.0 0.1 1.0 1.6 0.8 0.4 0.4 0.4 0.4 0.0 0.5 0.5 0.4 0.6 0.4 0.4 1.0 1.0 0.4 0.5 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.9 3.1 0.6 0.5 1.9 0.4 0.1 20.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.9 2.7 2.6 9.6 0.7 1.1 0.6 1.0 0.4 4.2 2.7 0.4 1.2 1.5 2.1 1.1 0.7 3.9 0.0 3.4 3.2 5.5 2.2 0.9 1.0 0.5 0.9 1.8 0.0 6.2 3.1 2.5 1.4 0.2 2.0 1.1 0.0 0.9 2.9 0.4 3.8 0.9 0.4 0.0 0.3 0.0 2.3 1.2 1.1 0.4 2.3 0.2 0.8 1.1 0.0 3.6 1.1 1.9 1.2 3.1 1.2 0.7 1.6 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 1.0 1.6 0.8 1.0 1.0 1.1 0.4 0.4 0.4 PLAGL2 ZNF900 ENSG00000126003 "PLAG1 like zinc finger 2" Q9UPG8 20 32192503-32207791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "intermediate monocyte: 11.7;non-classical monocyte: 20.7" "Lineage enriched" "Detected in many" 14 "monocytes: 20.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005900 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005900: AB_1079629" "unprognostic (9.40e-2)" "unprognostic (1.67e-1)" "unprognostic (6.95e-3)" "unprognostic (1.09e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.11e-3)" "unprognostic (8.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.99e-1)" "unprognostic (1.29e-2)" "unprognostic (2.26e-1)" "unprognostic (3.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (7.90e-2)" "unprognostic (1.09e-1)" 5.9 5.1 6.1 9.0 7.8 30.2 5.8 10.5 7.7 6.9 10.6 6.8 5.6 11.5 9.6 6.6 17.9 10.9 5.8 5.6 6.2 4.0 7.0 6.1 9.3 9.0 5.8 4.9 11.7 11.6 8.5 12.9 5.4 7.2 7.6 9.2 9.8 10.2 6.7 10.1 10.4 24.8 8.3 4.2 10.4 10.1 33.2 7.4 16.4 7.9 13.7 12.9 6.8 11.4 0.9 1.4 1.4 20.7 0.3 1.0 1.2 7.8 4.5 12.0 4.3 4.5 3.4 7.5 3.1 4.9 6.7 6.2 33.5 3.9 8.0 4.3 3.2 7.7 14.9 7.1 9.0 4.7 6.7 32.5 3.6 16.0 5.4 14.2 7.2 4.2 6.4 5.4 3.8 4.8 11.4 7.3 3.5 4.4 15.5 9.8 5.6 5.1 10.1 15.5 5.1 2.9 6.0 5.4 6.0 7.6 4.1 6.7 6.2 17.4 3.6 8.2 8.8 5.9 6.3 20.1 11.1 10.4 4.8 30.1 5.0 1.4 2.1 0.5 0.5 11.7 1.0 0.9 0.6 1.0 1.4 0.6 0.8 0.4 0.6 0.3 20.7 0.3 0.5 1.2 6.1 7.8 10.5 7.7 6.2 4.0 5.8 4.9 7.2 7.4 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;retina: 40.2;salivary gland: 39.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.0;hTERT-HME1: 18.6;LHCN-M2: 30.6;RPTEC TERT1: 39.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Group enriched" "Detected in all" 4 "cerebellum: 44.9;pons and medulla: 11.9" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA007951: " "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favourable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 5.5 5.0 2.1 4.5 4.6 0.2 5.6 44.9 5.2 6.0 13.1 2.7 2.4 1.6 12.3 16.2 6.9 10.9 6.2 12.4 2.3 6.6 2.3 0.9 4.4 1.0 4.0 3.3 2.9 1.3 0.5 15.1 4.4 11.9 6.9 12.6 40.2 39.8 7.1 2.5 4.3 3.1 12.3 3.1 1.1 9.7 2.1 2.4 4.3 21.9 4.4 2.0 7.1 8.8 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 6.1 3.0 0.0 0.0 0.1 0.0 13.3 3.8 4.0 2.5 1.1 0.9 0.0 0.2 38.0 0.0 0.9 2.9 6.0 0.0 1.8 1.6 2.2 0.0 0.5 0.0 0.0 0.9 1.2 5.1 18.6 0.0 1.5 0.1 30.6 1.9 0.0 0.0 3.2 3.8 0.0 0.0 0.2 39.1 2.8 10.2 7.0 0.0 9.2 5.6 7.8 0.0 0.1 4.3 0.3 0.4 5.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.0 2.1 4.6 44.9 5.2 2.3 6.6 4.0 3.3 11.9 2.4 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.0" "Cell line enhanced" "Detected in many" "HBF TERT88: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.2" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm Nucleoplasm "HPA055947: " "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favourable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favourable (2.99e-4)" 1.5 1.0 1.9 3.4 5.8 9.6 1.2 5.8 10.9 1.6 2.8 0.4 0.0 6.1 1.0 0.6 1.8 1.2 1.9 1.5 3.6 2.5 2.5 4.1 2.0 5.9 2.9 6.8 1.1 2.3 0.4 4.1 16.0 10.3 1.5 3.6 4.1 2.0 0.7 1.2 1.5 5.9 0.9 2.9 3.5 2.1 4.2 1.1 3.1 3.2 0.5 4.8 1.9 1.6 0.9 7.2 0.6 0.0 2.1 3.6 0.6 3.0 2.7 2.6 1.2 0.1 0.1 0.8 5.2 2.5 4.9 4.3 1.9 1.5 2.1 2.7 0.2 7.3 1.1 5.0 9.6 0.6 1.3 0.5 4.9 1.7 0.4 0.7 2.6 0.0 1.0 1.6 2.9 2.7 0.1 5.3 0.5 0.3 1.5 0.5 0.9 6.7 1.4 3.7 2.0 2.3 3.1 0.6 4.6 1.1 0.7 1.0 0.4 0.2 2.6 1.1 6.6 0.5 1.0 6.3 0.9 0.4 0.5 0.4 0.3 0.6 0.0 0.0 3.6 0.0 3.5 0.5 1.9 3.5 0.3 0.9 0.9 2.0 0.2 2.1 0.0 7.2 1.7 0.6 1.9 5.8 5.8 10.9 3.6 2.5 2.9 6.8 10.3 1.1 PLEKHA8 "FAPP2, MGC3358" ENSG00000106086 "Pleckstrin homology domain containing A8" Q96JA3 7 30027404-30130483 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072314 Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA072314: " "unprognostic (5.49e-3)" "unprognostic (8.62e-3)" "unprognostic (2.39e-1)" "unprognostic (5.14e-2)" "unprognostic (1.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.70e-4)" "unprognostic (5.96e-2)" "unprognostic (2.86e-1)" "unprognostic (3.21e-2)" "unprognostic (1.41e-1)" "unprognostic (2.31e-2)" "unprognostic (2.96e-2)" "unprognostic (1.48e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (3.07e-2)" 7.3 5.6 9.7 7.2 11.6 3.2 7.5 16.3 13.0 8.5 7.8 8.3 4.8 8.3 8.6 10.0 9.2 5.4 7.7 6.0 8.2 7.5 14.0 6.1 7.1 8.7 9.9 5.8 9.3 9.0 10.5 8.8 21.0 9.9 7.6 8.4 9.1 8.5 9.0 4.8 7.9 9.0 8.7 7.8 5.2 6.9 8.1 9.6 6.9 6.6 1.7 10.2 8.7 8.6 1.2 0.5 2.8 0.9 1.0 1.7 0.3 6.5 4.5 20.7 21.9 5.9 4.7 14.4 4.8 3.8 3.8 5.0 8.5 2.9 15.4 6.6 4.8 4.8 10.8 5.7 5.5 2.9 7.2 8.9 7.6 7.9 5.1 3.9 3.1 2.3 4.4 5.2 7.4 8.2 8.1 5.6 5.5 4.4 7.7 2.8 13.8 5.1 0.0 5.9 10.3 4.3 5.3 2.7 15.8 5.3 17.3 6.9 6.0 4.0 7.0 3.4 14.5 3.5 5.5 11.6 20.2 9.0 6.7 2.5 8.1 2.8 0.6 2.5 1.7 0.6 0.9 1.2 1.0 1.1 0.5 0.8 1.2 1.6 0.1 1.0 0.9 0.1 1.0 0.3 9.7 11.6 16.3 13.0 8.2 7.5 9.9 5.8 9.9 9.6 PLEKHG2 "ARHGEF42, CLG, FLJ00018" ENSG00000090924 "Pleckstrin homology and RhoGEF domain containing G2" Q9H7P9 19 39412585-39428415 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Leukodystrophy, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 31.9;REH: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017973, HPA048054" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017973: , HPA048054: " "unprognostic (3.55e-1)" "unprognostic (6.73e-2)" "prognostic unfavourable (3.53e-4)" "unprognostic (3.97e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-3)" "unprognostic (1.24e-2)" "unprognostic (4.48e-2)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (2.10e-1)" "unprognostic (4.99e-1)" "prognostic unfavourable (3.79e-8)" "unprognostic (8.01e-2)" "unprognostic (3.90e-2)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" 15.7 6.1 2.9 30.8 4.4 14.8 14.2 2.8 4.0 18.7 12.4 3.9 5.6 5.9 20.3 10.1 9.7 12.6 17.6 13.5 3.5 2.6 10.7 5.1 21.4 20.2 4.5 2.2 17.5 4.4 5.8 7.6 17.4 7.4 12.3 3.9 13.6 6.8 15.0 7.1 4.4 9.6 14.1 6.9 24.8 8.8 8.7 3.6 49.3 11.1 9.5 24.6 13.0 10.1 3.9 4.2 2.8 1.8 1.4 4.4 2.7 3.5 17.5 31.9 17.3 3.0 4.0 4.6 9.4 7.4 6.5 5.6 11.2 6.4 6.2 6.9 12.2 1.2 4.8 8.3 3.5 20.5 4.4 8.1 9.1 5.1 5.3 0.9 10.1 9.2 1.4 7.8 3.8 8.3 5.4 7.3 10.4 7.1 10.0 3.1 7.5 1.7 36.1 3.9 1.8 5.6 6.6 0.8 10.3 2.1 0.7 3.1 9.4 9.2 10.6 17.2 13.5 6.3 6.0 5.4 1.6 9.1 9.5 3.6 9.5 2.8 1.4 0.4 4.4 0.8 2.6 3.9 2.1 2.5 1.0 3.6 2.8 3.5 2.6 1.4 1.8 4.2 3.9 2.7 2.9 4.4 2.8 4.0 3.5 2.6 4.5 2.2 7.4 3.6 PLEKHG4B KIAA1909 ENSG00000153404 "Pleckstrin homology and RhoGEF domain containing G4B" Q96PX9 5 92151-189972 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 10.3;HAP1: 9.2;NTERA-2: 9.5;REH: 21.5;SCLC-21H: 9.6;SH-SY5Y: 8.6;SK-BR-3: 9.1;T-47d: 12.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 8.5" "Cell type enriched" "Detected in single" 21 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 21 "dendritic cells: 5.4" "HPA036274, HPA058157" Uncertain Approved Nucleoplasm Nucleoplasm "HPA036274: AB_10669668, HPA058157: " "unprognostic (3.60e-2)" "unprognostic (8.52e-2)" "unprognostic (5.44e-3)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.91e-1)" "unprognostic (3.59e-1)" "prognostic favourable (3.47e-4)" "unprognostic (5.96e-2)" "unprognostic (7.08e-2)" "unprognostic (2.56e-2)" "unprognostic (1.58e-1)" "unprognostic (9.98e-7)" "unprognostic (1.43e-2)" "unprognostic (7.00e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-3)" 0.1 0.2 1.7 0.3 0.5 1.4 3.9 1.5 0.6 4.4 1.0 3.1 0.0 0.6 3.6 1.0 0.6 3.1 0.0 0.1 1.3 0.9 1.4 0.1 1.3 1.5 0.8 0.0 3.3 2.5 0.2 8.2 7.9 8.5 5.4 0.1 5.1 4.5 1.2 0.4 0.9 0.9 0.7 0.4 0.2 2.1 4.8 1.1 5.2 8.2 0.6 1.6 0.3 0.8 0.0 5.4 0.2 0.0 0.1 0.2 0.0 0.0 0.9 6.9 10.3 0.0 0.0 0.1 0.7 0.2 0.6 1.5 1.1 0.1 0.1 2.3 0.9 0.4 9.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 9.5 0.1 21.5 4.8 5.6 0.8 0.0 9.6 8.6 5.2 9.1 0.0 12.9 0.0 0.0 0.2 2.6 0.0 0.2 0.1 0.0 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 5.4 0.0 0.0 1.7 0.5 1.5 0.6 1.3 0.9 0.8 0.0 8.5 1.1 PLEKHG5 "GEF720, KIAA0720, Syx, Tech" ENSG00000171680 "Pleckstrin homology and RhoGEF domain containing G5" O94827 1 6466092-6520061 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.8;skin 1: 60.0" "Cell line enhanced" "Detected in many" "TIME: 17.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2" "Low region specificity" "Detected in all" HPA049570 Uncertain Approved Nucleoplasm Nucleoplasm "HPA049570: " "unprognostic (5.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.47e-1)" "unprognostic (2.81e-1)" "unprognostic (1.50e-3)" "unprognostic (5.10e-2)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.02e-2)" "unprognostic (4.85e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-3)" "unprognostic (4.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (4.85e-2)" 10.6 9.7 8.7 2.9 6.3 0.7 4.1 59.8 11.6 3.9 3.0 1.2 2.5 3.3 3.8 4.5 7.1 3.9 6.5 5.4 7.7 2.9 2.3 0.8 3.6 2.7 1.8 6.7 2.6 3.1 4.0 15.2 7.6 4.4 3.4 2.8 4.9 4.2 5.3 3.4 60.0 4.3 2.7 1.8 16.9 2.6 2.6 1.4 0.0 2.4 6.5 4.8 2.3 4.4 0.5 0.6 2.1 0.5 0.3 1.0 0.4 3.9 1.1 8.0 4.7 0.8 2.7 1.4 5.4 3.0 1.7 1.0 2.3 7.9 0.1 12.4 1.7 13.6 0.9 11.9 0.8 7.8 1.5 0.0 5.5 1.4 1.2 0.0 0.7 2.9 6.4 5.8 6.8 12.1 0.0 1.0 0.4 3.4 0.1 15.4 2.5 12.0 0.0 1.0 1.0 4.3 1.3 5.2 14.7 0.6 4.1 0.3 5.3 0.1 17.3 4.1 3.0 0.0 3.3 0.1 0.0 0.9 4.5 0.0 0.3 1.8 0.5 0.3 0.4 0.4 1.0 0.2 0.8 0.7 0.1 0.5 0.5 0.6 2.1 0.3 0.2 0.6 0.2 0.4 8.7 6.3 59.8 11.6 7.7 2.9 1.8 6.7 4.4 1.4 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637273-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.1;RPTEC TERT1: 8.3" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: " "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 10.1 2.7 3.7 9.2 6.5 0.3 7.5 5.4 5.6 27.2 8.5 2.9 3.6 4.1 30.0 9.5 5.2 9.8 8.1 3.7 4.2 2.7 8.7 1.8 21.7 3.0 3.4 3.3 19.4 2.5 9.6 1.8 4.2 8.3 7.9 5.0 7.4 3.8 7.8 5.4 6.9 5.7 13.1 9.7 4.7 4.1 4.2 4.0 0.0 4.7 4.7 4.3 11.1 8.6 0.8 0.6 1.4 0.4 0.7 1.0 0.0 0.6 5.1 2.1 0.1 4.2 10.1 0.4 0.7 2.6 1.0 2.7 0.0 1.8 1.3 0.3 0.8 3.4 0.6 0.8 2.0 0.1 1.5 0.1 0.7 0.2 0.6 0.0 0.7 2.9 0.8 2.6 0.1 2.3 4.8 0.2 0.9 1.4 0.9 0.2 1.1 5.1 0.0 6.1 0.1 8.3 0.3 1.6 0.8 0.5 0.0 5.1 0.7 0.2 0.2 6.0 1.7 0.3 1.8 1.2 0.3 0.0 2.4 0.0 0.6 0.8 0.4 0.4 0.4 0.2 0.4 0.3 0.7 0.5 0.2 0.8 1.0 0.6 1.4 0.7 0.3 0.6 0.5 0.0 3.7 6.5 5.4 5.6 4.2 2.7 3.4 3.3 8.3 4.0 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell line enhanced" "Detected in many" "ASC diff: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" HPA040055 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.4 3.4 30.8 17.7 8.1 8.0 12.0 8.5 8.8 2.1 1.7 7.3 4.2 16.2 0.9 3.9 3.2 5.0 11.2 1.2 7.3 0.8 2.5 23.7 8.1 10.9 12.8 2.9 10.6 3.4 11.8 2.1 26.1 11.3 0.8 1.7 8.8 6.6 1.6 6.3 8.3 5.2 1.3 1.9 0.2 3.0 3.3 1.1 10.9 1.2 11.1 15.2 6.6 6.1 6.2 3.3 9.7 15.2 2.5 7.1 10.6 3.8 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 42.9;T-47d: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavourable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavourable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 22.9 20.7 7.2 0.5 3.8 6.2 2.8 4.9 8.2 16.3 9.5 1.5 20.3 0.0 32.3 17.6 28.8 0.3 11.3 14.9 0.0 0.6 0.0 9.3 1.7 20.7 0.1 0.6 3.6 15.7 6.3 17.6 32.8 0.0 0.8 32.2 8.3 0.0 0.0 1.3 3.4 1.1 20.0 0.0 42.9 4.6 0.4 0.9 15.1 3.0 13.2 72.3 0.3 41.8 4.5 12.2 2.0 39.1 0.0 0.0 0.0 3.5 0.0 20.0 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell line enhanced" "Detected in some" "BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA045188: " "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 1.1 2.3 1.4 0.1 1.3 0.0 0.0 10.7 0.1 0.9 0.2 1.2 1.4 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.0 8.7 0.9 2.1 0.9 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 4.4 0.0 0.8 0.2 0.7 0.0 0.7 1.9 0.0 12.0 9.6 5.3 0.5 46.4 0.0 0.0 0.0 8.9 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662315-4665258 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HDLM-2: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favourable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 4.0 8.3 4.4 7.2 6.8 1.1 7.3 11.9 9.7 5.7 9.4 6.2 4.2 10.2 4.9 13.2 9.2 4.1 9.7 3.0 4.9 4.8 6.3 20.0 4.7 8.3 8.6 6.3 4.2 19.2 8.7 5.5 13.1 9.4 16.9 10.0 4.7 10.4 8.5 2.2 8.6 15.4 3.3 4.9 7.1 10.7 8.4 3.4 16.2 7.2 6.9 9.6 7.4 5.5 4.3 5.1 8.5 5.1 4.7 13.0 5.1 3.8 4.0 4.3 5.3 3.5 3.9 4.3 2.6 3.4 2.1 2.5 1.0 2.6 3.7 1.1 2.6 4.8 3.0 3.7 2.3 46.6 2.8 7.4 3.8 5.3 3.1 2.7 5.6 4.3 3.0 1.6 3.7 3.2 1.2 3.9 2.7 4.1 2.5 7.0 4.0 1.4 2.5 0.0 2.8 3.7 4.4 10.9 5.5 3.1 2.8 1.6 4.0 6.0 3.7 1.9 1.6 2.6 1.7 0.8 2.9 0.9 3.0 1.9 1.7 8.5 5.1 4.1 4.2 4.4 4.6 3.5 7.4 6.3 5.1 4.3 13.0 9.2 2.1 4.7 4.9 3.9 10.0 5.1 4.4 6.8 11.9 9.7 4.9 4.8 8.6 6.3 9.4 3.4 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Approved Nucleoplasm Nucleoplasm "HPA048973: " "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavourable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.7 5.4 3.0 12.5 12.7 12.2 0.8 15.6 14.6 9.7 9.9 1.0 1.6 1.7 9.3 19.9 1.6 1.7 4.7 5.2 4.6 3.2 0.5 3.8 1.0 6.6 0.5 17.8 10.9 8.5 8.3 1.6 6.5 8.4 14.0 8.1 12.9 0.2 2.4 3.3 30.4 0.2 0.4 4.8 4.5 4.1 3.2 10.8 6.5 5.6 3.3 8.1 11.2 7.5 22.0 4.7 37.1 8.2 8.7 5.3 0.6 21.3 8.0 8.6 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Group enriched" "Detected in some" 6 "NB-4: 23.5;THP-1: 49.8" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: , HPA057034: " "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 4.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.1 0.9 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.2 1.6 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.4 0.0 23.5 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.1 0.0 0.0 2.1 49.8 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192339-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 24.8;ASC TERT1: 19.5;HUVEC TERT2: 20.0;TIME: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavourable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavourable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 40.5 29.6 19.4 5.9 20.4 1.7 53.3 19.1 23.4 25.1 17.7 14.8 10.8 4.6 21.9 13.9 15.8 28.0 29.4 20.3 23.1 13.8 16.9 43.4 24.2 16.7 13.7 14.6 25.2 13.0 3.8 11.7 35.9 21.8 17.9 16.9 15.9 14.8 18.2 8.7 11.1 9.3 25.0 28.7 18.4 11.0 16.8 16.6 0.9 25.1 8.9 4.5 23.3 28.7 0.0 0.2 0.0 0.2 1.3 0.0 0.5 0.0 3.6 0.6 0.0 24.8 19.5 0.1 4.4 6.0 2.0 4.3 0.4 4.8 0.0 4.8 8.2 0.5 0.9 0.4 1.1 0.0 0.0 1.9 3.0 0.5 11.3 0.0 0.5 11.8 0.6 4.1 1.2 20.0 0.1 0.3 2.9 0.1 0.0 0.0 0.8 1.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.5 0.0 1.4 0.3 0.2 41.2 4.2 1.0 9.2 0.8 0.1 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.5 19.4 20.4 19.1 23.4 23.1 13.8 13.7 14.6 21.8 16.6 PLXNA3 "6.3, Plxn3, PLXN4, SEX, XAP-6" ENSG00000130827 "Plexin A3" P51805 X 154458281-154477779 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058989 Approved "Nucleoplasm,Vesicles,Plasma membrane" 58000 "Vesicles, Plasma membrane" Nucleoplasm "HPA058989: " "unprognostic (2.79e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-3)" "unprognostic (8.04e-3)" "unprognostic (1.63e-1)" "unprognostic (9.05e-3)" "unprognostic (1.06e-2)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (6.26e-2)" "unprognostic (1.05e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (2.30e-1)" "unprognostic (3.00e-1)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" 6.9 7.6 9.8 6.6 9.3 3.5 13.3 25.9 7.4 8.1 6.2 13.8 7.3 7.2 8.6 9.2 5.3 8.3 7.9 6.6 10.5 8.0 5.1 2.5 7.2 7.1 8.7 3.6 16.4 9.9 5.1 35.2 7.4 8.2 9.2 4.8 6.1 13.8 7.5 2.9 19.5 7.2 8.2 8.4 7.0 10.0 5.8 9.8 4.6 9.3 1.8 7.2 6.3 16.4 1.8 0.5 2.7 0.5 2.1 1.0 0.3 8.1 1.6 4.8 12.2 5.1 6.5 6.5 11.7 2.5 2.7 3.8 6.1 3.5 1.5 6.3 12.5 7.2 4.9 5.7 1.0 0.7 3.6 1.5 19.1 3.3 4.0 0.7 6.8 8.8 4.2 4.1 0.3 3.1 3.8 1.3 4.3 10.1 1.4 6.2 1.5 3.7 5.3 0.4 0.5 3.7 5.4 10.2 5.3 4.3 7.8 1.9 4.7 1.7 7.7 6.0 5.5 0.6 4.9 0.9 0.1 2.1 11.2 1.1 1.6 2.7 0.5 0.8 0.8 0.4 0.6 1.8 1.0 0.8 0.1 1.2 0.6 0.8 1.4 2.1 0.3 0.5 0.7 0.3 9.8 9.3 25.9 7.4 10.5 8.0 8.7 3.6 8.2 9.8 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA034583: , HPA071854: " "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 20.6 21.7 18.2 19.8 20.4 40.8 23.3 24.3 23.7 27.4 20.3 26.1 25.2 20.1 25.2 27.5 26.4 20.4 24.4 37.9 16.4 15.5 38.0 32.4 21.3 30.5 23.9 17.4 25.1 28.0 23.6 22.8 35.5 17.1 25.5 18.0 27.6 26.8 20.5 65.7 28.9 20.1 20.9 21.3 29.9 22.8 13.4 22.4 23.6 30.5 48.3 29.5 21.6 22.7 22.8 41.1 26.2 36.5 19.9 31.1 29.0 21.1 26.2 28.2 21.3 5.3 11.1 22.0 11.0 15.7 29.9 24.8 32.1 30.6 19.5 24.0 14.1 14.2 28.3 18.4 15.4 13.9 33.7 14.5 20.0 28.6 11.1 20.3 20.1 10.0 18.6 13.4 14.2 22.5 21.5 22.7 14.4 43.2 21.2 26.3 49.1 23.3 23.4 15.1 38.6 31.2 16.0 25.8 32.6 18.3 21.1 14.3 34.3 25.0 12.9 13.0 16.6 14.4 21.6 17.0 17.5 38.3 10.4 19.7 17.9 7.9 36.5 16.4 20.2 25.2 18.1 22.8 19.9 18.8 30.0 21.6 19.4 19.5 26.2 19.9 22.1 41.1 31.1 29.0 18.2 20.4 24.3 23.7 16.4 15.5 23.9 17.4 17.1 22.4 PMF1-BGLAP ENSG00000260238 "PMF1-BGLAP readthrough" 1 156212982-156243332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA034583: , HPA071854: " "unprognostic (8.15e-2)" "unprognostic (1.80e-1)" "unprognostic (8.56e-4)" "unprognostic (1.65e-2)" "unprognostic (4.01e-2)" "unprognostic (1.99e-1)" "prognostic unfavourable (1.50e-4)" "unprognostic (4.66e-2)" "unprognostic (1.28e-1)" "unprognostic (8.52e-3)" "unprognostic (1.85e-4)" "unprognostic (2.39e-1)" "prognostic unfavourable (3.22e-4)" "unprognostic (1.12e-1)" "unprognostic (2.37e-1)" "unprognostic (5.31e-3)" "unprognostic (2.36e-1)" 9.8 15.7 16.2 10.3 16.2 12.1 7.8 18.1 14.6 14.6 13.0 13.9 13.4 8.6 13.1 16.3 11.7 15.0 12.9 24.6 14.1 14.2 20.6 17.4 11.0 16.4 12.6 9.0 15.6 15.0 10.4 16.2 19.2 8.8 15.7 7.0 14.8 21.5 13.2 31.8 10.7 10.5 10.9 11.2 14.0 9.5 7.4 11.8 12.5 16.4 26.4 15.8 9.8 11.1 9.8 7.1 10.2 8.9 5.1 10.7 8.1 6.9 7.2 9.5 6.5 2.6 6.7 4.2 6.3 4.1 6.2 5.1 5.4 6.5 6.1 10.6 5.6 4.8 8.9 8.1 3.2 10.5 15.0 4.2 7.0 9.9 12.2 4.1 7.6 8.2 7.6 5.7 5.0 5.9 4.1 9.9 4.4 8.5 3.7 8.9 19.6 13.2 7.0 3.8 9.0 4.8 3.4 6.6 8.4 4.1 1.7 10.9 9.7 16.7 6.4 3.1 3.1 3.9 5.7 6.0 7.2 9.3 4.4 5.5 6.1 3.6 8.9 4.4 4.9 5.8 4.8 4.8 7.7 7.1 6.6 9.8 10.7 6.0 10.2 5.1 6.1 7.1 8.4 8.1 16.2 16.2 18.1 12.8 14.1 14.2 12.6 9.0 8.8 11.8 PMM2 "CDG1, CDG1a, CDGS, PMI, PMI1" ENSG00000140650 "Phosphomannomutase 2" O15305 16 8788823-8849331 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "basophil: 52.2" "Lineage enriched" "Detected in all" 10 "granulocytes: 52.2" "Low region specificity" "Detected in all" "HPA040852, HPA063649" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040852: AB_10794069, HPA063649: AB_2685074" "unprognostic (8.62e-3)" "unprognostic (8.00e-3)" "prognostic favourable (1.04e-4)" "unprognostic (3.58e-2)" "unprognostic (1.79e-1)" "unprognostic (1.98e-2)" "unprognostic (6.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (5.14e-3)" "unprognostic (2.62e-1)" "prognostic unfavourable (8.97e-6)" "unprognostic (1.22e-1)" "unprognostic (2.50e-2)" "unprognostic (6.89e-2)" "unprognostic (5.02e-2)" 14.8 13.1 6.8 15.4 9.0 4.3 13.6 8.2 8.2 11.4 19.4 7.0 11.6 18.9 9.7 13.1 22.7 10.0 13.9 10.7 4.7 2.9 14.6 43.3 11.8 11.2 6.6 4.3 7.8 40.4 7.8 28.3 19.9 6.6 12.0 20.4 8.8 21.2 13.5 12.5 13.2 19.6 9.5 5.7 12.0 15.2 9.7 7.8 7.6 10.0 12.0 22.0 10.5 12.2 2.9 3.5 52.2 4.9 1.6 3.6 3.0 10.9 24.5 5.4 14.2 9.7 15.3 12.1 17.1 20.7 17.2 18.6 18.3 13.6 17.5 7.2 29.8 15.2 11.1 20.9 17.6 13.0 13.0 5.8 14.8 31.2 18.4 15.3 13.9 22.8 14.9 18.3 16.9 17.5 7.8 17.1 11.4 28.7 15.6 14.1 23.0 15.9 19.9 12.1 34.8 19.1 19.4 10.3 19.5 14.1 31.1 10.2 20.2 13.4 20.3 12.4 14.0 33.4 16.7 21.2 17.7 22.0 10.3 19.3 16.4 52.2 4.9 0.9 2.5 3.7 3.6 2.9 2.2 3.2 3.5 2.4 2.5 2.4 7.8 1.6 2.3 3.2 1.6 3.0 6.8 9.0 8.2 8.2 4.7 2.9 6.6 4.3 6.6 7.8 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Cell line enhanced" "Detected in many" "HAP1: 17.7;K-562: 18.7;LHCN-M2: 19.4;SH-SY5Y: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012956 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.7 10.6 3.1 7.1 1.9 0.7 0.1 1.3 0.6 0.1 0.8 0.0 10.0 0.5 0.1 17.7 2.8 0.9 0.0 6.6 0.0 0.2 0.2 5.2 0.1 0.1 1.8 3.5 4.5 0.0 1.0 18.7 0.1 19.4 0.0 0.1 0.1 9.0 0.0 0.0 11.7 0.0 4.5 0.0 8.7 17.1 0.0 0.2 0.0 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.1 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157844-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavourable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 18.5 19.2 13.0 17.2 19.0 21.8 15.4 10.0 12.8 10.8 13.1 9.1 10.2 9.9 15.3 15.4 14.9 13.8 13.2 24.5 19.1 9.6 16.6 27.4 12.9 15.0 15.0 11.9 20.0 27.0 13.2 15.7 16.3 13.1 14.4 12.2 8.9 12.7 15.0 48.8 12.4 9.5 15.1 11.7 13.6 13.2 11.4 13.9 9.7 16.6 15.1 15.2 15.8 21.4 14.7 12.6 2.0 13.2 10.6 15.5 14.4 15.1 16.6 7.7 12.6 9.5 7.9 19.4 14.5 9.4 16.3 11.6 31.8 9.0 20.8 12.2 9.6 13.0 24.8 17.1 25.7 14.4 17.4 20.2 7.9 23.3 14.8 16.1 9.3 10.2 12.6 16.5 18.9 11.9 27.8 11.3 14.6 11.2 15.7 15.2 21.7 18.1 13.3 19.0 22.1 12.4 12.9 13.8 10.3 10.8 13.4 23.2 9.5 9.0 8.9 18.8 20.3 16.7 40.1 9.1 13.1 32.1 15.4 24.1 25.5 0.4 9.4 1.9 10.1 13.2 15.5 14.7 11.4 11.5 12.6 11.1 13.3 12.2 2.0 10.6 9.4 9.0 11.7 14.4 13.0 19.0 10.0 12.8 19.1 9.6 15.0 11.9 13.1 13.9 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818902-825573 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 158.1;breast: 155.2" "Cell line enhanced" "Detected in all" "ASC diff: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" "Lipid droplets" Nucleoplasm "HPA055173: , HPA062602: , HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 158.1 7.2 1.6 9.4 1.8 11.2 155.2 2.7 2.3 4.1 35.9 1.5 3.8 5.6 4.5 7.8 8.6 4.3 7.2 12.6 1.7 1.1 15.6 7.4 11.3 4.5 1.6 1.6 4.9 11.8 2.5 4.2 11.6 1.8 5.2 1.5 1.9 8.1 8.1 25.0 6.1 23.1 3.0 2.1 4.9 8.2 4.0 1.5 1.5 11.3 4.8 5.1 13.0 18.6 4.2 6.5 18.7 8.5 3.6 5.3 3.6 10.4 8.2 1.7 4.4 64.1 5.7 11.0 11.1 9.0 7.0 6.2 6.9 10.5 6.2 6.6 8.3 9.4 2.5 4.6 2.1 7.9 22.7 8.5 3.6 11.1 21.0 5.8 10.8 11.2 6.0 4.7 5.4 5.7 7.2 6.3 6.2 6.1 7.8 12.9 4.9 17.6 7.6 3.7 13.8 6.8 2.4 6.3 8.4 20.6 17.6 6.4 7.5 6.8 10.2 6.3 4.9 4.1 5.0 24.3 15.0 5.2 15.8 8.4 4.4 9.3 8.5 18.7 3.6 5.5 3.5 4.2 4.6 5.2 5.7 3.6 5.3 4.3 7.7 3.6 6.0 6.5 3.9 3.6 1.6 1.8 2.7 1.9 1.7 1.1 1.6 1.6 1.8 1.5 PNPLA8 "IPLA2-2, IPLA2G, iPLA2gamma" ENSG00000135241 "Patatin like phospholipase domain containing 8" Q9NP80 7 108470422-108569666 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020083 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA020083: AB_1851849" "unprognostic (4.48e-2)" "unprognostic (3.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (4.61e-1)" "unprognostic (2.73e-2)" "unprognostic (3.48e-2)" "unprognostic (3.32e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (2.49e-1)" "prognostic favourable (1.86e-6)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (4.28e-3)" "unprognostic (1.24e-1)" 21.5 35.7 29.3 12.4 28.9 51.5 15.0 15.6 27.2 15.4 13.4 9.5 9.3 8.6 13.4 13.7 18.3 9.7 15.9 17.9 23.0 22.1 23.1 24.6 16.7 12.0 20.7 17.5 15.6 10.1 20.7 33.4 25.2 23.2 14.4 11.4 6.0 11.4 13.9 29.8 11.4 10.8 15.3 20.3 19.5 11.1 10.8 21.1 16.1 22.6 13.0 15.3 22.5 12.8 20.0 19.3 16.7 26.8 14.6 12.5 13.7 14.0 6.3 11.2 10.0 25.0 17.2 16.6 13.4 23.7 11.0 18.4 6.1 8.1 7.8 16.9 13.1 5.3 19.0 8.5 16.8 11.7 5.2 5.3 10.4 4.5 18.3 3.7 11.1 15.6 16.2 14.8 13.7 14.8 6.3 22.5 13.7 9.2 8.6 8.8 4.9 9.0 3.2 11.8 16.6 13.2 17.8 9.3 13.1 12.8 13.9 16.0 5.8 6.3 12.0 18.2 8.1 27.0 7.3 19.1 19.3 11.6 17.3 5.7 11.7 14.1 19.7 16.7 10.5 21.8 12.5 20.0 10.3 10.3 19.3 18.7 11.2 10.7 16.5 14.6 26.8 7.6 12.5 13.7 29.3 28.9 15.6 27.2 23.0 22.1 20.7 17.5 23.2 21.1 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 53.8;hTCEpi: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: " "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavourable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 70.5 58.1 21.3 46.1 28.3 105.4 48.1 30.8 31.8 55.9 51.5 30.3 27.0 23.6 60.3 30.9 45.4 73.6 45.0 48.5 20.8 17.9 32.9 97.9 59.5 87.1 23.1 22.3 83.4 41.3 31.3 29.5 38.8 20.4 56.6 26.0 46.5 35.5 40.8 154.1 49.0 32.4 63.6 31.1 46.9 38.2 35.5 20.8 91.2 38.4 30.8 45.4 113.2 41.0 9.6 7.3 37.5 7.1 6.9 10.4 3.8 2.9 2.8 6.0 10.2 24.6 41.6 4.2 3.8 26.6 7.1 16.8 2.4 8.2 6.3 18.6 4.6 10.0 3.2 5.7 11.0 7.9 9.9 1.1 16.4 7.6 53.8 5.9 14.8 29.8 57.2 4.8 22.1 11.7 0.9 19.6 7.9 2.8 1.5 31.1 1.7 6.1 7.0 7.4 5.0 16.8 5.2 3.8 10.9 9.8 13.5 9.9 6.7 29.7 11.1 5.7 3.4 3.9 1.4 30.8 15.1 2.1 11.4 5.1 3.5 10.3 6.6 36.7 7.5 7.1 7.8 8.3 8.9 7.8 4.2 9.6 10.4 10.4 37.5 6.9 6.3 7.3 7.1 3.8 21.3 28.3 30.8 31.8 20.8 17.9 23.1 22.3 20.4 20.8 POF1B "FLJ22792, POF" ENSG00000124429 "POF1B, actin binding protein" Q8WVV4 X 85277396-85379743 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.8;skin 1: 55.6" "Cell line enhanced" "Detected in some" "A549: 11.0;CAPAN-2: 11.3;HaCaT: 11.5;RT4: 38.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.0;naive B-cell: 3.2" "Lineage enriched" "Detected in single" 7 "B-cells: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002033, HPA050027" Approved Supported "Nucleoplasm,Golgi apparatus" 430000 "Golgi apparatus" Nucleoplasm "HPA002033: AB_1079650, HPA050027: " "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.54e-3)" "prognostic unfavourable (3.08e-4)" "unprognostic (1.97e-1)" "unprognostic (3.39e-2)" "prognostic unfavourable (2.03e-4)" "unprognostic (1.86e-1)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (1.17e-2)" "unprognostic (2.50e-1)" "unprognostic (4.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.81e-1)" "unprognostic (5.57e-4)" "unprognostic (1.01e-2)" 0.5 0.4 0.3 9.9 0.3 0.0 3.7 0.4 0.4 7.0 41.8 0.0 0.5 10.9 0.8 1.6 21.4 1.6 10.0 6.3 0.3 0.3 2.5 0.5 1.4 0.4 0.3 0.2 1.0 2.9 0.0 2.5 3.4 0.1 3.9 16.9 0.1 5.6 0.9 0.4 55.6 55.8 0.7 0.4 5.5 7.6 0.4 0.0 0.3 0.7 20.3 9.2 4.9 6.9 6.0 0.0 0.0 0.0 0.0 0.8 0.1 1.7 11.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 11.3 5.8 1.6 0.0 11.5 2.5 0.1 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 1.9 0.0 4.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 38.6 0.0 0.0 0.0 2.9 0.0 1.2 0.5 0.1 0.0 0.0 0.1 0.1 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.2 0.1 0.0 POLE3 "CHARAC17, CHRAC17, p17, Ybl1" ENSG00000148229 "DNA polymerase epsilon 3, accessory subunit" Q9NRF9 9 113407235-113410672 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047945 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047945: " "unprognostic (9.55e-2)" "unprognostic (3.39e-3)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (8.35e-4)" "unprognostic (1.04e-2)" "unprognostic (1.60e-2)" "unprognostic (1.10e-1)" "unprognostic (4.59e-3)" "unprognostic (2.31e-3)" "unprognostic (1.75e-2)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" 16.9 23.9 18.2 22.0 18.5 56.3 19.3 36.0 25.0 17.0 17.6 15.8 12.5 15.1 18.2 16.5 27.8 17.6 17.0 17.9 16.1 14.8 14.3 29.5 15.8 29.0 15.1 18.5 15.4 20.8 13.1 8.4 21.2 20.0 15.9 20.3 12.4 17.9 16.3 48.3 24.7 17.3 16.9 16.9 26.8 17.2 29.9 15.9 35.0 16.3 27.3 32.4 18.8 16.7 34.9 33.5 34.3 34.4 28.0 44.0 47.7 15.7 19.7 13.9 20.8 7.9 7.1 12.2 21.1 10.8 23.9 18.9 18.2 14.4 57.4 13.1 12.3 27.1 27.0 23.2 22.1 10.9 16.3 29.8 20.4 18.6 8.5 61.7 18.0 8.1 16.0 20.7 26.8 16.5 41.5 32.1 16.6 40.1 42.3 33.2 17.9 35.7 43.4 57.9 32.2 10.4 15.1 30.1 17.4 30.6 19.4 16.5 29.0 27.8 13.6 17.8 24.1 22.4 36.0 16.8 54.9 77.4 16.2 36.5 21.2 25.4 34.0 34.3 35.5 34.4 44.0 34.9 34.0 33.7 33.2 33.5 36.9 34.3 7.2 28.0 26.6 33.5 39.0 47.7 18.2 18.5 36.0 25.0 16.1 14.8 15.1 18.5 20.0 15.9 POLE4 p12 ENSG00000115350 "DNA polymerase epsilon 4, accessory subunit" Q9NR33 2 74958492-74970128 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054979, HPA071815" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054979: , HPA071815: " "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.19e-2)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (3.09e-1)" "unprognostic (1.99e-1)" "unprognostic (2.95e-1)" "unprognostic (1.39e-2)" "unprognostic (4.44e-2)" "unprognostic (8.64e-3)" "unprognostic (6.61e-2)" "unprognostic (3.73e-1)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" 19.2 14.5 23.6 15.2 17.3 27.1 21.4 4.4 15.5 18.4 13.4 8.6 7.0 9.0 10.4 9.0 10.0 9.7 13.1 18.1 15.9 10.6 11.6 18.8 10.7 17.0 13.9 12.6 12.8 12.5 2.8 3.9 9.6 12.2 12.0 8.8 13.9 16.2 11.2 28.1 8.1 12.4 14.1 11.7 12.2 12.5 11.0 10.0 5.5 13.1 15.1 10.4 13.9 31.9 14.7 14.7 8.0 22.2 4.4 9.9 12.3 11.7 11.2 1.0 1.0 3.8 8.6 0.0 8.0 9.9 12.8 10.9 14.9 5.2 11.5 6.7 9.0 5.3 5.3 6.6 15.0 5.2 14.4 8.9 6.5 14.7 13.9 12.6 14.1 8.7 13.0 5.3 11.8 5.5 10.9 6.8 9.7 11.4 3.7 35.6 7.8 21.1 4.5 9.6 9.3 10.6 0.3 3.5 5.3 11.0 4.6 6.3 3.4 4.1 6.2 2.9 3.3 2.0 7.6 2.4 1.6 4.2 10.5 18.9 14.1 2.3 22.2 8.0 6.3 13.2 7.0 14.7 8.9 7.8 12.9 13.7 9.9 6.9 1.6 4.4 12.4 14.7 8.5 12.3 23.6 17.3 4.4 15.5 15.9 10.6 13.9 12.6 12.2 10.0 POLR1A "DKFZP586M0122, FLJ21915, RPA1, RPO1-4" ENSG00000068654 "RNA polymerase I subunit A" O95602 2 86020216-86106155 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Nucleotidyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010145, HPA031513, HPA049700" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" "Nucleoli fibrillar center" "Nucleoplasm, Intermediate filaments" "CAB010145: AB_675814, HPA031513: , HPA049700: " "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "unprognostic (1.32e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (3.70e-9)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.31e-2)" "unprognostic (4.56e-2)" "unprognostic (3.27e-1)" "unprognostic (2.20e-3)" "unprognostic (1.94e-1)" "prognostic unfavourable (8.41e-4)" "unprognostic (7.20e-2)" 14.3 12.9 10.1 12.4 16.5 9.7 10.3 12.2 20.3 11.1 11.0 17.4 8.3 9.4 19.5 7.4 13.5 12.3 11.7 12.7 9.0 9.2 11.5 15.1 9.4 9.6 9.0 9.4 12.6 14.3 18.2 15.9 11.4 13.8 10.7 11.8 13.9 11.2 12.5 22.5 12.3 8.6 16.0 8.0 11.2 10.4 14.9 10.9 14.0 10.3 11.4 14.2 10.9 9.6 2.6 2.6 1.8 2.5 2.0 3.8 1.2 9.3 21.3 9.5 18.3 9.3 7.5 13.8 8.6 5.7 12.4 7.7 26.7 7.4 21.5 9.2 8.8 10.9 24.5 12.7 11.1 8.9 12.6 18.5 9.1 17.9 6.6 17.5 10.0 5.7 8.0 18.4 14.4 9.6 24.5 5.4 8.5 8.3 12.9 7.5 17.3 14.1 15.6 20.9 10.0 5.5 15.4 14.8 7.7 9.5 12.6 6.8 7.4 6.1 15.2 15.1 11.9 12.8 17.3 7.7 7.4 18.8 7.8 15.1 13.3 1.8 1.5 0.2 3.0 2.5 3.8 2.0 1.5 2.5 1.8 2.6 1.4 1.8 0.7 2.0 1.9 2.6 0.7 1.2 10.1 16.5 12.2 20.3 9.0 9.2 9.0 9.4 13.8 10.9 POLR1D "MGC9850, RPA16, RPA9, RPAC2, RPO1-3" ENSG00000186184 "RNA polymerase I subunit D" "P0DPB5, P0DPB6" 13 27620742-27744237 "Disease related genes, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039337 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA039337: AB_10672961" "unprognostic (1.33e-3)" "unprognostic (5.96e-2)" "unprognostic (4.35e-2)" "unprognostic (8.50e-3)" "unprognostic (1.98e-2)" "unprognostic (3.71e-3)" "unprognostic (5.33e-3)" "unprognostic (2.04e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-2)" "unprognostic (2.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (2.56e-2)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" 30.5 43.8 17.0 35.4 22.1 46.5 36.5 41.2 23.7 34.6 40.8 15.9 34.4 30.9 26.0 29.9 58.9 21.4 32.3 28.5 16.7 14.4 27.3 29.9 32.6 36.5 14.8 20.6 43.6 115.9 16.7 24.3 24.7 15.6 37.4 32.7 20.9 46.2 39.5 38.1 44.8 36.4 41.2 17.4 31.9 41.7 23.7 13.0 50.9 32.3 40.7 40.7 56.8 54.0 29.2 42.7 21.4 39.3 27.9 56.6 26.2 20.0 18.9 21.8 22.3 25.1 45.1 29.3 19.9 34.4 26.3 26.2 30.5 40.9 65.0 15.1 22.4 31.0 40.0 63.5 31.4 20.1 23.8 46.2 20.6 51.0 37.9 41.9 36.3 40.5 67.2 21.4 40.0 36.4 25.2 11.6 25.5 20.8 41.2 51.1 52.5 20.1 28.3 37.5 29.2 41.5 31.2 37.2 29.1 13.3 26.8 71.7 16.4 39.2 25.2 11.7 18.3 20.0 21.7 19.0 21.5 36.7 10.2 30.4 22.7 21.4 38.4 17.3 24.9 39.3 32.8 28.4 40.2 31.4 42.7 29.2 43.6 34.2 13.7 27.9 34.2 31.2 56.6 26.2 17.0 22.1 41.2 23.7 16.7 14.4 14.8 20.6 15.6 13.0 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" P24928 17 7484366-7514616 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription" "DNA-binding, Nucleotidyltransferase, RNA-directed RNA polymerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEK 293: 3.0;HL-60: 2.6;HMC-1: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.9" "CAB012226, CAB016388, CAB022311" Enhanced Approved Nucleoplasm Nucleoplasm "CAB012226: AB_304749, CAB016388: AB_677353, CAB022311: " "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 5.0 5.9 4.5 5.7 7.4 26.4 8.5 5.8 7.8 7.2 4.3 4.8 4.5 4.3 5.5 5.4 7.0 4.6 4.2 4.5 6.0 3.5 4.6 4.4 6.4 11.5 4.7 4.2 5.2 5.8 5.4 4.8 4.2 5.4 4.3 4.9 6.3 5.5 8.1 6.6 6.6 6.0 4.5 6.1 6.2 5.3 13.2 2.9 15.0 5.6 4.1 5.0 5.3 4.6 0.7 0.7 4.9 1.0 0.0 1.2 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.4 0.1 0.5 0.0 0.2 0.0 0.2 0.4 3.0 0.7 1.2 0.2 0.0 2.6 3.9 0.4 0.0 0.3 0.0 0.2 0.3 0.0 0.5 0.0 0.1 0.8 0.4 0.9 1.1 0.0 0.0 0.0 1.4 0.3 0.9 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.8 0.4 0.2 0.4 0.0 0.6 0.3 3.0 0.5 0.6 1.2 0.4 0.3 0.3 0.5 0.4 0.1 0.7 0.6 0.5 4.9 0.0 1.0 0.7 0.5 0.0 4.5 7.4 5.8 7.8 6.0 3.5 4.7 4.2 5.4 2.9 POLR2J "hRPB14, POLR2J1, RPB11, RPB11A, RPB11m" ENSG00000005075 "RNA polymerase II subunit J" P52435 7 102473118-102478907 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046970 Approved Nucleoplasm Nucleoplasm "HPA046970: " "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (1.62e-1)" "unprognostic (1.90e-2)" "unprognostic (4.80e-2)" "unprognostic (6.47e-2)" "unprognostic (4.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.53e-3)" "unprognostic (4.46e-2)" "unprognostic (7.32e-2)" "unprognostic (7.13e-2)" "unprognostic (2.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" 19.0 28.1 30.9 16.5 28.9 37.0 52.2 17.9 27.6 20.0 20.6 15.1 22.7 22.2 16.3 27.9 20.0 19.6 27.9 65.7 26.1 25.1 21.0 40.9 21.2 31.9 28.5 17.8 21.7 50.2 16.0 23.4 15.6 22.3 18.4 16.7 19.4 28.2 23.9 75.9 19.1 24.3 28.1 35.9 18.6 20.7 18.1 23.1 20.8 24.9 38.8 18.6 19.9 18.3 42.8 42.3 63.4 40.1 25.5 44.8 38.1 30.9 31.7 21.8 28.6 20.7 16.0 16.0 17.2 18.5 25.3 21.6 28.8 24.2 14.4 33.3 24.0 16.7 20.1 21.2 15.6 26.7 35.9 14.3 22.8 27.8 25.3 27.7 21.6 20.8 26.6 22.7 12.8 22.6 33.5 42.9 20.7 95.6 45.4 49.5 20.2 40.9 21.7 21.4 42.2 20.2 20.7 18.5 30.9 20.8 39.7 24.5 17.8 34.0 18.2 28.7 36.6 44.9 33.6 26.5 38.5 37.1 25.5 34.5 33.3 48.3 40.1 63.4 32.1 39.1 30.4 42.8 34.5 35.6 31.3 37.6 29.8 30.0 58.5 25.5 35.5 42.3 44.8 38.1 30.9 28.9 17.9 27.6 26.1 25.1 28.5 17.8 22.3 23.1 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.6" "Cell line enhanced" "Detected in many" "MOLT-4: 17.7;RT4: 12.8;U-2 OS: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046970 Approved Nucleoplasm Nucleoplasm "HPA046970: " 3.8 3.9 12.0 9.5 10.0 5.4 6.6 10.6 32.6 7.2 4.6 6.5 3.4 7.9 6.9 6.5 4.8 4.6 7.4 4.3 12.5 5.5 5.8 6.1 6.1 7.8 10.1 7.7 9.0 3.7 3.2 6.1 5.7 7.8 4.6 5.2 4.5 11.2 3.4 11.9 9.9 10.3 9.8 9.3 7.5 6.6 3.5 6.2 4.2 5.8 1.3 11.0 4.7 5.1 7.9 6.0 11.3 4.0 2.9 6.5 1.3 2.4 2.1 1.5 1.8 3.3 4.7 3.0 2.8 0.6 1.7 1.7 1.6 5.0 2.6 0.5 1.8 2.4 1.1 0.7 4.2 1.8 2.9 1.4 3.0 1.0 1.5 6.0 2.7 0.9 0.5 1.2 2.4 0.6 2.6 6.5 1.2 0.9 17.7 1.8 1.1 0.6 2.3 0.4 2.3 1.0 12.8 1.4 1.7 2.3 1.3 1.0 0.8 1.0 1.0 3.8 12.5 0.6 2.1 2.9 2.0 2.3 1.6 2.6 1.3 11.3 4.0 2.9 5.9 2.3 3.9 5.5 6.0 4.2 1.9 7.9 6.5 5.0 3.2 2.9 3.6 6.0 3.5 1.3 12.0 10.0 10.6 32.6 12.5 5.5 10.1 7.7 7.8 6.2 POLR2J3 ENSG00000168255 "RNA polymerase II subunit J3" 7 102537918-102572653 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 12.3" "Cell line enhanced" "Detected in many" "HDLM-2: 21.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011403, HPA046970" Uncertain Approved Nucleoplasm Nucleoplasm "HPA011403: , HPA046970: " "unprognostic (3.55e-2)" "unprognostic (2.04e-4)" "unprognostic (4.55e-3)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (9.26e-2)" "unprognostic (2.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.12e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (1.00e-1)" "unprognostic (5.90e-4)" "unprognostic (3.04e-1)" "unprognostic (7.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" 2.8 3.0 0.9 1.7 1.4 2.3 1.9 4.0 4.7 3.1 2.4 3.6 4.5 0.1 2.3 4.9 0.3 1.3 1.1 1.1 2.2 2.8 2.2 1.0 1.5 4.5 1.7 2.9 2.3 1.7 2.5 2.1 4.1 0.2 1.0 5.0 3.5 1.8 1.6 3.9 2.2 0.8 4.0 3.5 4.1 2.2 4.9 5.9 12.3 5.6 4.4 4.4 3.4 8.4 4.1 1.7 0.1 0.2 0.7 0.7 5.0 1.4 3.3 3.8 3.2 2.4 1.1 0.3 0.0 4.0 2.7 2.0 3.5 21.1 4.6 2.4 3.2 1.0 0.9 3.0 2.2 0.3 1.7 1.6 1.7 5.1 2.6 1.5 0.5 6.7 7.4 0.4 0.0 5.1 0.3 2.8 2.0 0.7 1.1 1.7 0.3 9.2 0.8 4.9 0.0 1.4 4.1 3.1 8.1 0.0 1.3 0.2 0.6 3.5 5.1 2.4 3.3 9.0 5.6 7.8 3.3 2.0 1.7 4.7 3.1 4.4 5.9 4.9 3.8 3.6 12.3 4.4 3.5 4.3 4.2 3.4 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.2;skeletal muscle: 14.6" "Low cell line specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046970 Approved Nucleoplasm Nucleoplasm "HPA046970: " 0.5 2.3 1.9 5.5 1.3 5.7 0.0 3.9 2.0 2.7 3.7 1.7 0.0 0.5 0.0 2.9 2.7 0.5 1.9 1.3 0.3 0.0 0.5 0.5 2.0 0.0 0.6 14.6 2.0 1.6 0.0 2.1 1.6 1.2 0.5 1.1 0.5 22.4 26.8 29.2 25.2 16.5 23.5 14.4 14.2 1.8 20.3 18.1 1.0 4.2 7.7 20.0 0.7 4.4 1.2 6.7 11.3 6.6 10.0 3.4 8.7 2.7 4.7 13.1 0.8 3.1 15.1 25.6 19.9 2.8 25.3 14.9 4.6 5.9 2.3 1.7 5.8 13.1 38.5 1.8 7.2 35.9 11.2 6.1 0.5 16.9 18.3 19.0 5.7 18.1 9.8 14.5 15.8 15.9 14.0 6.1 14.6 6.3 27.2 12.3 23.8 16.1 17.3 25.5 39.9 15.2 17.8 16.3 26.8 19.9 29.2 17.7 18.0 16.1 22.4 23.5 20.0 17.9 20.2 20.4 19.5 21.1 16.5 25.2 26.8 21.8 14.4 POLR2K RPB10alpha ENSG00000147669 "RNA polymerase II subunit K" P53803 8 100150584-100154002 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047477 Approved "Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments" "Nucleoplasm, Nucleoli fibrillar center" "Intermediate filaments" "HPA047477: " "unprognostic (3.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-3)" "unprognostic (2.75e-2)" "unprognostic (4.68e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" "unprognostic (9.75e-3)" "unprognostic (5.73e-2)" "unprognostic (5.65e-2)" "unprognostic (3.46e-2)" "unprognostic (3.07e-2)" "unprognostic (9.16e-2)" "unprognostic (3.43e-2)" 31.4 43.7 51.1 22.0 38.7 32.9 41.5 34.7 53.0 33.8 28.5 24.7 20.8 21.2 29.3 42.7 33.1 23.8 23.9 35.3 46.2 51.0 47.5 46.6 27.3 29.7 49.0 35.0 26.2 20.2 28.2 36.8 27.1 46.0 37.8 31.8 21.5 32.7 33.3 23.3 21.8 28.4 34.8 40.4 31.9 26.6 22.6 23.7 24.9 36.6 22.3 31.5 39.3 23.1 29.0 30.0 24.2 19.2 25.0 30.9 24.2 39.3 19.9 25.7 18.1 27.7 25.3 17.4 29.2 24.1 29.8 36.3 12.3 27.1 26.4 58.0 23.1 18.1 27.6 24.1 39.5 42.0 30.6 35.8 25.1 25.9 22.0 23.1 26.1 20.5 32.2 23.7 24.3 27.0 28.0 25.9 29.1 25.0 58.4 34.3 26.8 39.6 23.0 14.9 38.1 37.1 22.2 54.3 35.7 19.8 17.8 42.3 36.3 35.3 20.4 17.6 25.3 27.2 31.0 26.7 42.2 41.5 33.4 40.7 27.4 24.2 15.2 22.1 23.7 19.2 28.2 29.0 30.9 29.4 19.0 19.7 27.1 29.3 5.8 25.0 18.2 30.0 30.9 24.2 51.1 38.7 34.7 53.0 46.2 51.0 49.0 35.0 46.0 23.7 POLR2M "GCOM1, Gdown, Gdown1, GRINL1A" ENSG00000255529 "RNA polymerase II subunit M" "P0CAP2, Q6EEV4" 15 57706629-57782762 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068141 Approved Nucleoplasm Nucleoplasm "HPA068141: " "unprognostic (3.07e-1)" "unprognostic (1.08e-1)" "unprognostic (2.63e-1)" "unprognostic (3.73e-1)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (9.80e-2)" "unprognostic (7.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.25e-2)" "unprognostic (2.81e-1)" "unprognostic (3.56e-2)" "unprognostic (6.61e-2)" "unprognostic (1.39e-1)" "unprognostic (3.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.07e-1)" 17.0 16.3 22.9 8.5 26.5 25.2 33.5 15.3 25.1 18.1 11.5 21.0 14.0 9.6 28.0 15.5 12.1 16.1 13.1 22.2 22.7 21.9 15.8 12.0 14.7 19.5 29.9 15.8 27.0 14.8 23.6 12.3 14.4 19.7 21.1 11.5 19.2 12.6 20.5 25.3 11.8 9.6 21.5 25.0 13.2 10.2 10.8 24.0 11.7 19.0 7.1 12.5 18.9 15.1 15.2 14.3 16.2 13.9 22.4 19.5 13.5 9.2 15.6 10.9 27.5 19.2 20.1 10.4 15.3 24.3 16.1 15.3 11.4 7.0 14.8 15.5 10.4 15.4 12.3 11.5 21.7 15.5 8.3 18.0 12.2 7.2 21.1 16.7 17.2 17.9 18.8 9.1 26.5 12.4 18.2 13.0 13.6 5.8 15.1 10.5 17.8 8.0 15.0 24.2 11.2 12.1 9.3 8.2 14.2 11.8 12.0 18.0 13.7 23.7 11.3 24.4 20.4 36.5 18.0 15.0 15.4 19.7 14.7 25.0 17.0 16.2 13.9 15.4 15.8 13.5 19.4 15.2 17.2 16.1 14.3 14.7 19.5 17.2 1.6 22.4 11.1 9.9 18.9 13.5 22.9 26.5 15.3 25.1 22.7 21.9 29.9 15.8 19.7 24.0 POLR3F "RPC39, RPC6" ENSG00000132664 "RNA polymerase III subunit F" Q9H1D9 20 18467127-18484643 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049441, HPA050173, HPA072298" Uncertain Approved Nucleoplasm Nucleoplasm "HPA049441: AB_2680768, HPA050173: , HPA072298: " "unprognostic (4.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.55e-1)" "unprognostic (7.39e-2)" "prognostic unfavourable (8.87e-9)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "prognostic favourable (6.48e-4)" "unprognostic (3.04e-1)" "unprognostic (4.01e-1)" "unprognostic (3.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.88e-3)" "unprognostic (4.98e-3)" 8.6 7.8 8.1 6.0 11.9 4.4 8.0 24.6 15.3 9.9 7.5 8.7 8.5 5.6 11.6 6.5 11.0 9.6 6.7 14.2 8.7 10.1 11.2 7.3 5.9 8.8 7.8 12.9 12.5 7.3 4.5 9.8 8.0 13.9 9.2 6.4 6.7 7.5 7.4 12.0 6.2 5.0 9.0 8.5 6.3 6.7 10.0 7.7 6.3 16.3 7.2 9.1 10.7 6.5 3.1 3.2 1.9 4.5 3.3 6.4 4.1 6.4 6.6 6.9 8.6 5.6 6.8 12.4 9.6 6.7 12.3 9.4 8.2 6.6 5.0 4.0 9.2 8.9 9.1 7.9 8.1 5.0 7.6 3.6 2.5 3.6 8.0 10.8 6.2 4.3 5.1 18.4 8.4 5.5 9.3 4.4 8.4 7.0 9.0 4.6 9.7 15.0 6.4 15.0 5.5 5.5 2.8 14.4 9.5 7.3 12.4 15.4 5.7 7.3 5.3 12.7 6.2 9.4 13.3 2.3 15.1 4.0 5.3 5.0 9.1 0.1 2.1 1.9 4.3 4.5 6.4 2.8 3.9 1.2 2.2 3.1 4.1 2.1 0.8 3.3 1.9 3.2 3.4 4.1 8.1 11.9 24.6 15.3 8.7 10.1 7.8 12.9 13.9 7.7 POM121C ENSG00000272391 "POM121 transmembrane nucleoporin C" 7 75416787-75486271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA043809, HPA049817" Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA043809: , HPA049817: " "unprognostic (9.11e-2)" "unprognostic (1.27e-1)" "unprognostic (2.85e-1)" "unprognostic (1.44e-1)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-2)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-3)" "unprognostic (2.03e-1)" "unprognostic (5.06e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-1)" "unprognostic (1.44e-2)" "unprognostic (4.00e-2)" 5.5 5.5 6.5 9.9 8.4 11.0 4.5 11.2 7.4 5.9 5.1 5.8 6.5 4.5 7.0 7.5 6.6 5.9 6.0 5.3 6.8 6.9 6.3 5.0 10.3 4.3 4.4 8.4 7.5 7.7 10.1 6.6 5.4 5.4 5.2 9.3 6.5 5.3 5.7 5.5 6.2 6.2 4.6 6.7 5.3 4.6 6.3 13.1 7.0 7.3 12.0 6.6 5.0 3.5 3.4 3.9 1.6 2.7 3.8 1.7 15.5 13.0 18.0 34.5 6.8 7.6 11.9 11.3 10.5 9.3 9.0 15.6 10.1 27.5 4.7 12.3 14.1 15.3 14.0 15.4 18.6 21.1 13.6 15.0 10.4 9.0 36.0 19.4 6.5 8.9 14.1 10.6 9.4 38.1 15.5 15.0 15.7 21.9 18.3 14.3 14.7 19.8 12.0 14.1 5.1 21.2 20.2 26.5 13.1 21.0 9.2 18.3 12.9 10.4 22.6 12.2 16.4 23.4 16.6 19.3 34.0 14.7 18.5 20.8 0.6 1.2 1.3 3.8 1.6 3.3 2.6 2.9 1.1 0.9 3.5 1.5 1.9 3.9 2.7 1.0 3.4 0.5 1.7 POMK "FLJ23356, SgK196" ENSG00000185900 "Protein-O-mannose kinase" Q9H5K3 8 43093506-43123434 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013321 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA013321: AB_2668809" "unprognostic (1.66e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-1)" "unprognostic (4.37e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.56e-2)" "unprognostic (2.42e-1)" "unprognostic (2.50e-1)" "unprognostic (8.10e-2)" "unprognostic (1.23e-3)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (7.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.10e-2)" 4.7 5.5 9.8 5.6 14.3 12.5 5.1 12.3 18.6 6.9 4.8 8.3 2.2 4.5 6.9 4.4 7.1 6.2 4.8 3.8 7.7 7.0 3.4 4.5 5.5 6.0 4.8 11.1 5.8 9.3 6.3 7.4 6.1 10.5 5.6 5.9 6.1 6.8 4.0 6.2 7.1 5.6 6.4 6.7 7.6 6.8 7.1 7.2 7.5 7.4 3.2 7.4 4.6 5.0 2.6 2.6 6.7 2.9 1.0 3.3 1.3 3.5 7.5 5.8 15.1 2.8 3.4 5.5 2.1 3.1 5.5 4.0 5.5 9.1 4.9 4.6 3.8 5.8 8.2 6.3 5.3 1.9 1.4 13.9 5.5 2.4 2.0 4.7 7.8 3.8 2.7 7.3 5.3 5.4 3.2 14.8 3.7 1.6 9.9 2.0 11.8 1.0 6.8 6.8 2.8 1.5 9.8 5.6 4.1 9.1 3.1 3.0 9.7 3.2 7.4 8.4 8.4 8.6 4.2 4.8 8.5 9.3 3.5 3.2 9.9 0.8 2.9 1.9 2.3 2.4 3.3 1.8 1.3 1.3 2.6 2.6 1.8 2.3 6.7 1.0 1.5 2.5 1.1 1.3 9.8 14.3 12.3 18.6 7.7 7.0 4.8 11.1 10.5 7.2 POMZP3 "POM-ZP3, POM121" ENSG00000146707 "POM121 and ZP3 fusion" Q6PJE2 7 76609986-76627261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA049817 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA049817: " "unprognostic (2.23e-1)" "prognostic favourable (4.34e-4)" "unprognostic (1.06e-1)" "unprognostic (2.17e-1)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (4.31e-1)" "unprognostic (7.49e-2)" "prognostic favourable (9.31e-4)" "unprognostic (4.94e-1)" "unprognostic (3.40e-1)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.99e-2)" 4.0 3.0 4.7 3.4 5.6 6.6 4.5 6.0 5.3 4.7 4.6 2.4 5.8 5.2 3.8 2.8 2.1 3.8 4.7 3.5 4.4 2.2 3.6 3.1 3.5 5.8 4.7 2.0 3.1 1.7 4.5 3.7 4.3 5.1 14.2 5.3 3.0 7.0 4.0 2.5 3.9 9.5 3.9 3.6 4.0 3.9 4.2 3.5 5.7 3.3 3.0 4.8 1.1 1.9 8.1 13.1 16.8 8.6 3.4 2.0 2.9 4.5 2.1 2.7 4.7 3.7 1.2 0.8 2.6 1.2 3.0 1.3 2.0 5.0 4.7 5.4 4.4 2.8 2.0 2.4 3.6 2.9 5.4 7.2 2.5 1.3 2.9 9.4 9.3 2.5 4.3 10.0 5.8 4.1 1.8 9.5 2.0 1.6 3.0 6.8 12.4 2.5 11.9 4.3 4.5 3.2 5.0 6.7 0.9 16.5 6.8 2.4 2.1 8.8 1.3 9.8 9.2 1.4 3.3 5.7 2.4 1.5 3.5 2.5 3.9 4.0 3.3 4.2 4.8 2.7 3.8 3.0 1.6 3.5 3.4 1.1 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581398 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA047598: , HPA069204: " "unprognostic (1.50e-2)" "prognostic favourable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavourable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 16.3 33.8 16.2 25.6 14.4 14.1 23.9 8.7 16.7 18.6 17.5 13.6 24.2 11.8 14.5 27.1 15.9 14.6 19.5 25.8 18.1 13.9 24.1 24.1 18.3 19.7 16.9 15.9 11.7 18.9 25.0 17.5 8.2 14.2 15.6 18.0 15.1 20.9 22.6 13.3 12.7 15.1 19.5 14.4 20.3 15.2 9.0 12.1 24.2 19.8 18.9 19.6 13.7 19.2 32.0 33.5 3.6 19.7 18.2 28.2 22.8 20.1 34.5 12.3 15.0 23.3 12.6 19.5 17.0 11.0 20.7 15.9 29.7 9.3 11.8 25.8 13.6 21.4 20.5 32.3 18.6 28.0 31.1 14.4 22.5 33.6 16.4 20.4 15.2 15.8 18.6 23.9 11.0 17.3 17.6 7.6 20.6 44.3 16.5 18.4 14.6 29.8 19.5 15.0 32.4 29.0 20.7 9.6 10.5 28.7 8.4 21.8 39.3 19.6 12.4 10.8 16.3 17.3 18.5 19.9 33.4 20.9 21.1 24.9 17.3 3.6 16.2 3.5 24.7 19.7 22.6 32.0 22.6 23.0 19.0 22.4 28.2 26.8 1.1 18.2 16.7 33.5 21.4 22.8 16.2 14.4 8.7 16.7 18.1 13.9 16.9 15.9 14.2 12.1 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 73.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavourable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.7 27.9 12.8 23.7 48.5 18.4 21.4 5.3 17.5 10.1 14.1 20.9 56.7 12.2 4.9 11.6 6.2 16.8 8.4 4.3 10.4 12.4 5.6 8.2 38.7 33.7 5.6 10.1 37.8 10.6 13.3 9.7 9.4 16.9 5.3 9.1 18.7 6.1 10.1 15.9 15.8 8.7 8.4 13.1 11.4 15.4 13.4 12.8 14.4 73.3 19.3 21.0 9.6 8.4 9.5 10.5 14.3 10.5 5.2 8.0 8.3 13.4 8.6 12.2 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 POSTN "OSF-2, periostin, PN" ENSG00000133110 Periostin Q15063 13 37562583-37598844 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hTEC/SVTERT24-B: 77.4;U-138 MG: 98.9;U-2197: 67.3" "Cancer enhanced" "Detected in all" "breast cancer: 231.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012306 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to extracellular matrix" 740000000 "Golgi apparatus" Nucleoplasm "HPA012306: AB_1854827" "unprognostic (7.73e-2)" "unprognostic (1.44e-3)" "unprognostic (2.19e-2)" "unprognostic (2.57e-2)" "unprognostic (4.73e-2)" "unprognostic (2.22e-2)" "unprognostic (4.19e-3)" "prognostic unfavourable (2.93e-4)" "unprognostic (3.05e-3)" "unprognostic (7.10e-2)" "unprognostic (1.32e-2)" "unprognostic (5.93e-2)" "prognostic unfavourable (1.83e-7)" "prognostic unfavourable (4.86e-4)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (8.32e-3)" 60.9 2.0 5.3 12.7 4.0 0.0 26.9 0.5 2.7 17.6 14.1 0.6 11.7 0.6 29.0 20.0 16.5 20.3 14.5 34.1 6.2 0.5 47.5 3.0 28.4 19.5 0.5 1.1 21.0 3.1 8.2 1.7 17.3 2.5 12.4 19.7 0.8 10.8 10.2 14.2 46.1 9.6 14.5 1.7 0.7 37.3 21.5 0.1 3.1 8.0 5.5 1.7 23.5 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.2 13.7 8.3 0.0 3.5 0.0 0.8 0.1 0.0 0.2 0.0 0.0 2.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 14.6 0.0 77.4 0.3 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 98.9 0.0 67.3 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.0 0.5 2.7 6.2 0.5 0.5 1.1 2.5 0.1 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741637 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell line enriched" "Detected in some" 7 "U-2 OS: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077615 Enhanced Approved Nucleoplasm Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.2 0.2 0.2 0.2 0.2 1.2 0.8 0.2 0.9 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.2 1.4 0.6 0.2 0.2 0.3 0.5 26.8 0.2 0.2 0.5 0.2 0.2 0.2 0.2 2.0 0.5 2.7 0.6 1.1 1.3 0.3 0.4 0.6 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.3 0.1 0.3 0.4 0.9 0.4 0.2 0.6 0.8 0.3 0.5 0.5 0.7 0.8 0.7 0.6 0.2 0.8 0.8 0.5 0.7 0.5 0.4 0.1 0.6 1.1 0.3 0.4 0.7 1.0 0.7 0.2 0.5 1.1 0.9 0.2 0.3 1.0 0.9 0.6 0.7 0.2 0.5 0.7 0.6 0.5 8.3 0.7 0.7 0.8 0.5 0.8 0.4 0.9 0.4 1.4 0.6 0.3 1.0 0.4 1.0 0.8 0.7 0.6 0.1 2.0 0.7 1.1 2.7 1.1 0.4 0.5 1.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 PPA2 FLJ20459 ENSG00000138777 "Pyrophosphatase (inorganic) 2" Q9H2U2 4 105369077-105474081 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030888, HPA031671, HPA031672" Supported Approved Nucleoplasm,Mitochondria 8300 Mitochondria Nucleoplasm "HPA030888: , HPA031671: AB_10603986, HPA031672: AB_2673988" "prognostic unfavourable (2.98e-4)" "unprognostic (5.64e-2)" "prognostic favourable (6.60e-4)" "unprognostic (9.26e-3)" "unprognostic (2.93e-2)" "unprognostic (5.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.44e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "unprognostic (9.54e-2)" "prognostic favourable (1.27e-11)" "unprognostic (3.69e-1)" "unprognostic (1.94e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" 9.2 18.0 18.4 17.2 15.4 24.0 20.6 12.3 17.6 10.2 19.8 9.3 20.3 18.1 13.3 20.7 14.8 10.7 18.7 42.5 15.6 15.3 23.7 21.2 23.1 34.8 17.2 12.1 9.5 25.0 10.4 15.0 9.3 15.4 16.1 16.7 12.6 21.4 26.8 29.6 15.0 16.8 22.8 12.4 12.1 15.0 9.7 10.7 9.4 14.3 28.2 10.6 12.2 9.5 20.0 35.3 14.7 20.8 22.0 17.0 14.6 11.5 5.5 10.7 18.1 6.8 5.5 7.8 6.5 8.6 8.0 5.7 12.1 17.0 9.5 8.7 5.3 5.8 21.4 10.3 9.5 13.4 7.6 8.5 8.9 11.0 5.4 20.1 8.2 5.3 10.7 5.5 4.3 7.7 14.1 13.1 7.3 14.6 17.1 14.5 7.8 18.7 15.2 6.6 9.3 26.5 8.9 11.0 6.6 4.5 26.7 9.4 14.0 16.4 4.1 5.8 11.3 6.2 11.3 11.6 14.6 9.9 10.1 10.9 7.8 14.7 15.0 9.7 15.3 20.8 13.3 20.0 16.0 16.2 35.3 16.6 15.5 17.0 6.4 22.0 16.2 17.7 15.9 14.6 18.4 15.4 12.3 17.6 15.6 15.3 17.2 12.1 15.4 10.7 PPCS FLJ11838 ENSG00000127125 "Phosphopantothenoylcysteine synthetase" Q9HAB8 1 42456117-42473385 "Enzymes, Predicted intracellular proteins" Ligase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031361, HPA031363" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" 16000 "Nucleoli fibrillar center, Mitochondria" Nucleoplasm "HPA031361: AB_10602150, HPA031363: AB_2673844" "unprognostic (1.49e-1)" "unprognostic (6.71e-2)" "unprognostic (8.15e-2)" "unprognostic (1.55e-1)" "unprognostic (3.84e-3)" "unprognostic (1.68e-2)" "prognostic unfavourable (5.96e-5)" "unprognostic (2.71e-1)" "unprognostic (7.79e-3)" "unprognostic (9.13e-3)" "unprognostic (3.24e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-2)" "unprognostic (6.45e-2)" "unprognostic (2.32e-1)" "unprognostic (2.80e-1)" "unprognostic (4.30e-2)" 23.4 36.3 18.9 20.5 21.9 10.7 30.7 12.0 26.0 23.2 32.0 12.4 27.3 25.5 18.2 34.4 31.6 14.5 30.9 22.1 17.8 16.4 41.4 43.9 26.5 28.1 19.3 14.9 19.6 47.0 22.8 16.1 37.6 17.2 27.2 27.3 19.6 36.6 35.0 19.6 21.9 41.0 27.6 18.9 24.4 27.2 13.5 13.4 22.6 31.3 26.0 20.5 24.0 19.4 41.9 44.4 76.1 55.7 42.0 41.0 52.0 22.5 9.4 5.5 8.5 17.1 17.8 20.5 11.4 13.1 15.4 13.7 7.9 27.6 6.8 22.5 14.4 13.3 3.6 17.3 13.0 17.9 10.9 11.4 10.4 9.4 23.5 11.7 20.2 15.7 31.4 10.8 20.0 14.3 4.6 4.9 15.7 13.5 5.7 11.5 6.3 14.6 6.5 5.6 12.1 33.7 21.3 6.5 7.1 14.0 34.2 35.4 16.1 51.8 8.9 8.5 11.3 12.9 13.0 16.2 10.1 4.9 3.5 13.5 17.3 58.1 55.7 76.1 30.7 55.1 35.7 41.9 37.0 33.0 44.4 39.9 41.0 34.9 41.2 42.0 51.8 33.2 36.4 52.0 18.9 21.9 12.0 26.0 17.8 16.4 19.3 14.9 17.2 13.4 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favourable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.0 13.7 9.4 19.0 10.7 18.0 30.3 27.2 8.8 35.5 14.0 25.1 26.6 9.5 36.6 18.1 46.7 4.7 31.0 5.7 16.9 9.3 3.9 12.8 4.7 29.3 0.0 20.4 17.7 62.6 9.0 12.5 13.9 15.9 22.4 12.9 60.0 45.1 0.4 10.1 79.8 20.6 21.2 19.2 25.4 18.2 32.2 24.5 27.0 43.5 18.6 62.2 25.8 22.9 30.1 34.1 39.7 22.4 17.8 14.0 6.4 21.2 11.2 19.5 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 PPIB "CYPB, OI9" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155812-64163205 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Isomerase, Rotamase" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" 120000000 "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favourable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavourable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 56.9 64.3 23.9 49.3 26.9 54.9 48.1 15.1 32.1 75.3 44.1 35.4 102.8 42.0 64.2 106.9 48.0 54.8 58.1 44.5 23.8 27.3 89.5 285.9 57.2 63.8 29.7 19.6 67.5 193.7 26.7 71.8 120.2 27.5 51.0 47.7 36.2 123.3 95.4 19.5 33.1 57.5 54.3 30.7 78.0 47.7 27.2 29.5 53.7 154.3 45.7 69.1 49.2 51.7 63.5 191.6 41.0 51.1 44.9 71.6 87.1 39.3 49.5 44.7 101.6 156.7 91.0 39.3 94.0 123.5 74.4 88.5 71.2 73.1 37.6 76.4 145.5 64.2 81.7 63.1 38.4 23.8 30.8 53.0 54.7 93.1 164.3 52.9 48.0 83.8 68.1 43.4 105.8 89.8 37.0 131.0 56.4 62.8 16.1 81.1 39.0 31.8 30.9 47.5 191.8 77.2 61.4 25.3 39.9 43.0 74.0 68.4 44.2 161.8 55.2 74.4 61.7 41.6 63.4 71.2 68.9 39.5 69.5 85.2 74.2 41.0 51.1 33.9 71.6 39.2 71.5 63.5 50.5 58.1 67.4 38.0 33.0 44.2 25.5 44.9 25.2 191.6 40.1 87.1 23.9 26.9 15.1 32.1 23.8 27.3 29.7 19.6 27.5 29.5 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;ASC diff: 10.6;ASC TERT1: 13.2;hTCEpi: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.1 1.2 6.6 10.6 13.2 1.2 0.0 2.4 0.6 0.2 0.1 1.8 0.0 0.5 0.6 1.2 1.0 0.0 0.4 0.5 0.9 0.5 0.1 0.0 5.3 0.6 0.3 2.7 6.3 0.2 4.0 0.8 0.9 0.4 0.4 0.6 0.1 0.6 0.2 1.3 0.8 0.0 0.6 5.1 0.1 1.5 2.5 0.2 0.3 4.4 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.2 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: , HPA059859: " "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.8 2.5 0.0 0.0 18.3 26.6 8.8 0.0 0.4 0.0 0.1 11.3 17.4 0.1 4.0 0.3 55.8 0.3 6.7 0.0 0.0 0.3 0.0 13.5 2.0 1.1 0.0 0.0 1.3 6.2 0.0 2.1 0.0 0.0 0.0 0.0 20.4 0.0 0.0 1.7 5.3 0.0 0.0 8.6 13.3 10.9 9.2 0.1 29.9 10.0 0.1 5.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell line enhanced" "Detected in some" "AF22: 10.0;HAP1: 16.2;MOLT-4: 7.6;SCLC-21H: 7.5;SH-SY5Y: 15.5;THP-1: 6.9" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.5 0.0 0.0 0.7 0.0 0.0 0.8 1.1 0.0 0.0 6.3 0.1 0.1 0.0 16.2 0.0 0.4 0.1 4.8 0.0 0.1 0.0 1.1 0.5 2.1 0.3 1.3 0.0 0.0 0.0 1.6 0.0 0.0 2.8 7.6 0.0 2.8 0.8 0.0 1.3 0.0 0.0 0.0 7.5 15.5 0.2 0.0 1.0 0.0 6.9 0.0 0.0 1.9 0.0 2.3 0.0 0.1 4.3 0.2 0.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 PPM1F "CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2" ENSG00000100034 "Protein phosphatase, Mg2+/Mn2+ dependent 1F" P49593 22 21919420-21952837 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030989, HPA030990" Approved Approved "Nucleoplasm,Plasma membrane" 780000 Nucleoplasm "Plasma membrane" "HPA030989: AB_10669549, HPA030990: AB_10601249" "unprognostic (6.26e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.77e-3)" "unprognostic (4.88e-3)" "unprognostic (1.94e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-2)" "unprognostic (1.45e-2)" "unprognostic (4.81e-2)" "prognostic unfavourable (6.03e-5)" "unprognostic (6.44e-2)" "unprognostic (3.02e-2)" "unprognostic (3.30e-1)" "unprognostic (4.11e-2)" 25.0 15.6 14.0 21.8 14.3 24.3 18.4 16.9 16.3 18.1 13.2 7.6 12.5 9.6 17.6 9.7 23.6 12.3 13.1 17.0 13.9 14.9 13.2 8.5 21.6 15.1 11.6 10.1 14.4 10.7 8.3 7.7 28.1 14.5 15.6 4.9 11.2 11.2 16.5 15.8 15.5 11.1 15.4 15.5 31.4 10.5 6.7 10.9 6.2 10.9 15.1 10.2 15.8 37.6 0.7 5.5 17.7 13.9 1.7 1.4 2.8 9.1 9.8 6.3 6.1 3.5 6.2 7.9 10.4 6.2 9.2 6.3 4.4 3.7 5.5 13.0 7.3 11.0 2.7 6.4 3.3 7.8 8.8 21.3 4.5 4.2 5.8 7.8 5.8 5.8 1.9 9.0 4.2 35.8 54.2 2.3 11.8 8.4 4.6 6.1 2.6 10.7 7.0 16.2 1.6 3.1 3.9 2.5 9.8 9.9 3.3 8.5 4.1 5.5 30.1 11.1 11.3 10.1 9.9 4.6 3.7 6.1 11.2 15.0 21.2 0.0 7.7 3.3 1.0 12.9 0.7 0.7 0.7 0.6 5.5 0.6 0.7 0.8 17.7 1.7 13.9 1.4 1.4 2.8 14.0 14.3 16.9 16.3 13.9 14.9 11.6 10.1 14.5 10.9 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078907 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HDLM-2: 34.9;U-266/70: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavourable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 7.7 8.5 7.4 3.5 11.5 3.3 6.3 15.8 23.2 11.3 7.0 5.5 1.1 3.0 6.2 3.7 8.7 6.1 12.6 9.9 6.3 7.8 8.4 6.0 4.6 1.9 8.0 10.1 3.7 5.4 33.6 26.3 11.5 13.8 9.6 5.9 5.6 18.9 3.7 25.7 7.6 3.6 16.4 4.6 3.4 8.4 2.8 3.7 5.6 14.4 9.6 3.5 16.6 10.8 0.7 1.3 4.9 7.6 1.1 2.6 2.0 1.1 0.7 4.0 2.1 2.3 0.0 2.5 0.2 0.1 0.4 0.1 0.2 0.2 0.2 0.4 0.1 3.6 3.3 0.2 0.1 34.9 3.5 3.4 3.3 0.4 0.1 2.1 4.0 0.4 1.6 0.1 0.2 0.2 0.1 5.5 0.0 1.8 0.8 0.2 2.3 0.8 4.1 0.7 0.8 0.1 3.7 4.8 4.1 2.0 2.3 0.1 2.7 2.1 0.2 0.4 0.4 0.3 1.3 34.9 0.1 1.9 0.6 1.7 0.8 0.7 2.3 4.9 2.6 5.5 0.2 0.2 0.6 1.7 1.3 0.7 1.0 1.8 0.2 1.1 7.6 0.8 0.0 2.0 7.4 11.5 15.8 17.9 6.3 7.8 8.0 10.1 13.8 3.7 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.5" "Cell line enhanced" "Detected in many" "HMC-1: 34.6;U-937: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "eosinophil: 54.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavourable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 17.2 7.1 5.6 24.7 7.9 34.0 16.1 1.7 4.7 12.6 15.9 6.2 4.6 5.3 17.5 7.3 11.5 10.9 13.9 10.1 6.5 3.4 6.1 8.3 20.2 44.9 7.2 1.8 14.9 4.0 2.3 2.9 13.3 6.0 11.2 3.7 7.3 7.9 6.1 6.6 9.5 11.3 13.9 9.8 37.4 9.1 4.9 6.2 48.2 7.8 7.8 23.6 18.2 18.0 4.2 3.4 54.5 4.1 10.2 11.9 5.2 9.9 1.6 5.9 7.2 4.3 11.5 0.2 5.9 6.9 5.3 3.6 1.2 2.0 9.7 5.4 10.4 6.6 2.9 6.5 2.7 8.1 0.6 23.3 2.9 1.2 3.4 6.1 34.6 7.0 7.6 13.0 11.7 4.2 4.3 4.9 6.2 1.0 8.6 12.0 0.0 0.4 27.5 5.2 7.9 3.1 0.6 0.4 2.0 5.5 2.1 11.0 1.6 8.3 14.1 20.8 5.3 0.0 14.7 1.8 9.5 12.0 6.0 36.0 24.2 8.1 2.8 54.5 11.7 4.1 8.5 3.1 5.7 11.9 1.8 4.2 4.7 9.0 13.2 10.2 3.0 3.4 9.4 5.2 5.6 7.9 1.7 4.7 6.5 3.4 7.2 1.8 6.0 6.2 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;MOLT-4: 2.1;SiHa: 1.3;U-266/70: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: " "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514425-195543386 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043729: , HPA059420: " "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 16.4 12.7 19.9 17.7 26.0 45.2 18.3 16.2 22.9 16.1 21.2 11.4 17.4 19.5 18.9 20.7 25.6 15.3 15.8 23.3 18.6 21.7 16.7 13.0 21.7 30.4 16.5 15.4 17.1 12.0 9.5 17.6 16.1 21.2 17.0 16.0 13.7 15.0 19.0 57.1 14.1 22.6 17.7 15.4 24.2 13.9 21.8 7.0 38.1 19.1 25.2 23.5 26.5 15.5 26.0 26.6 63.2 16.9 22.8 50.2 30.1 11.4 2.5 4.2 4.8 7.1 7.7 7.7 7.1 10.4 7.6 6.6 38.6 5.1 4.5 28.6 8.7 5.1 4.4 7.2 9.4 8.9 8.3 5.1 4.2 12.9 11.0 5.4 5.4 9.3 5.6 5.7 11.6 6.5 3.9 9.7 6.7 8.0 9.6 6.0 4.4 11.6 4.5 7.4 13.4 9.1 8.7 10.0 5.5 8.6 9.5 12.8 15.0 5.5 7.2 4.9 5.7 8.0 9.7 66.1 28.7 21.7 6.9 9.9 9.5 26.3 16.7 63.2 19.6 16.9 26.9 26.0 41.2 27.0 17.6 23.6 50.2 34.0 39.4 22.8 16.4 26.6 41.7 30.1 19.9 26.0 16.2 22.9 18.6 21.7 16.5 15.4 21.2 7.0 PPP1R21 "CCDC128, FLJ16566, KLRAQ1" ENSG00000162869 "Protein phosphatase 1 regulatory subunit 21" Q6ZMI0 2 48440598-48515391 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036791, HPA036792" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA036791: AB_10671713, HPA036792: " "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (2.51e-1)" "prognostic unfavourable (6.83e-4)" "unprognostic (1.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.78e-3)" "unprognostic (1.44e-2)" "unprognostic (7.46e-2)" "unprognostic (3.00e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.13e-1)" "prognostic favourable (4.59e-6)" "unprognostic (9.23e-2)" "unprognostic (1.93e-1)" "prognostic favourable (9.87e-4)" "unprognostic (6.60e-2)" 9.0 10.4 16.4 8.9 18.7 8.1 7.9 16.2 21.6 8.3 8.8 15.0 7.9 7.0 15.8 18.8 11.2 13.5 9.8 8.9 13.2 12.2 25.6 10.4 10.0 10.9 17.7 13.6 12.7 7.3 35.5 11.9 11.3 14.4 10.8 9.8 8.4 6.8 10.2 6.4 9.5 9.0 11.9 12.0 11.0 9.4 8.4 15.9 10.4 19.5 2.4 10.8 12.7 8.8 7.7 5.6 14.1 6.0 3.8 7.9 2.3 13.8 6.7 5.8 7.1 14.6 10.8 15.2 8.3 9.3 5.0 6.1 3.7 8.7 9.4 13.7 11.5 7.7 4.8 7.4 10.6 12.0 4.1 10.1 5.7 8.9 10.1 4.5 8.1 13.5 6.8 9.1 11.2 12.7 4.1 15.8 13.8 7.6 8.6 7.3 14.6 7.1 7.2 15.5 10.2 10.6 9.2 7.7 4.8 15.3 4.0 14.7 7.2 7.3 11.3 5.4 6.7 4.8 6.5 11.8 3.3 8.6 8.6 10.2 7.1 14.1 5.4 8.5 4.4 6.0 3.5 5.9 5.2 5.1 5.6 7.7 7.9 6.4 13.0 3.8 5.1 3.5 5.0 2.3 16.4 18.7 16.2 21.6 13.2 12.2 17.7 13.6 14.4 15.9 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" 5 156850538-156852528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 36.0" "Cell line enriched" "Detected in single" 13 "U-266/84: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043729: , HPA059420: " "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 36.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.5 0.4 0.9 0.5 0.5 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 0.5 0.1 0.9 0.2 0.5 0.5 0.5 0.6 0.5 0.4 0.2 1.1 0.5 0.6 0.5 0.2 0.1 0.7 0.2 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436565 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm Nucleoplasm "HPA021604: , HPA051607: " "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favourable (4.97e-4)" 5.3 12.0 4.4 12.5 5.6 8.8 5.9 9.7 8.7 9.9 9.6 3.6 7.2 12.8 7.1 6.1 7.4 6.3 7.2 5.4 4.2 4.1 7.4 11.1 5.6 14.4 3.9 7.1 10.6 12.4 7.4 7.9 7.9 4.8 7.7 2.8 7.4 10.6 6.8 7.0 7.7 11.2 6.8 3.6 20.8 8.8 32.2 2.6 20.3 8.6 4.5 10.7 7.6 6.1 4.6 6.8 12.1 2.0 2.7 6.8 2.5 16.2 7.0 5.0 8.8 1.6 1.7 6.4 4.5 4.9 3.8 4.3 2.6 16.7 5.3 8.0 2.7 5.2 2.6 4.4 0.7 11.6 6.5 5.2 4.9 6.3 7.0 4.5 7.0 3.2 7.8 3.4 5.1 7.8 7.5 10.9 4.7 15.5 13.6 22.3 9.7 9.4 3.6 1.8 16.0 4.9 4.4 4.7 11.7 4.0 28.4 12.9 8.5 13.1 6.0 5.6 6.6 6.4 11.4 12.6 7.0 7.0 6.2 8.0 11.1 12.1 2.0 4.5 5.2 0.8 5.6 3.5 5.3 6.0 1.7 4.6 3.1 3.0 9.3 2.7 0.5 6.8 6.8 2.5 4.4 5.6 9.7 8.7 4.2 4.1 3.9 7.1 4.8 2.6 PPP1R3F Hb2E ENSG00000049769 "Protein phosphatase 1 regulatory subunit 3F" Q6ZSY5 X 49269843-49301461 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "T-reg: 15.3" "Lineage enriched" "Detected in single" 16 "T-cells: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000244, HPA000918" Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA000244: , HPA000918: AB_2268692" "unprognostic (6.69e-2)" "unprognostic (2.87e-2)" "unprognostic (4.98e-4)" "unprognostic (1.83e-2)" "unprognostic (6.48e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-1)" "unprognostic (5.17e-2)" "unprognostic (1.91e-2)" "unprognostic (2.89e-1)" "prognostic favourable (1.85e-6)" "unprognostic (5.99e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (7.96e-2)" "unprognostic (1.55e-1)" 3.0 7.6 15.9 3.7 13.8 2.7 2.3 17.2 21.2 4.3 3.5 7.6 4.5 2.4 4.7 15.9 5.4 6.7 3.6 16.1 16.0 13.1 3.3 2.8 3.4 4.6 12.3 5.4 7.5 2.6 4.4 8.6 2.4 9.1 4.6 1.7 5.3 5.3 6.1 24.0 3.1 3.1 4.1 11.3 5.1 2.9 4.5 7.3 3.5 5.5 1.9 3.0 3.5 4.8 0.4 0.3 0.0 0.9 0.4 15.3 0.5 2.6 5.4 4.8 5.3 6.6 4.7 2.3 3.1 4.8 2.1 3.3 3.8 3.1 3.1 0.6 2.3 4.2 1.8 1.3 1.1 17.0 5.9 0.3 3.1 0.3 4.3 0.4 1.9 3.3 3.9 2.2 1.7 0.5 0.8 1.3 2.5 9.3 1.2 4.2 14.7 10.2 6.9 4.1 1.0 2.1 1.2 5.6 4.8 1.6 0.6 8.0 4.8 2.7 2.5 5.9 1.2 5.2 2.3 3.9 4.8 2.1 2.0 6.6 7.5 0.0 0.2 0.0 0.2 0.4 1.0 0.4 3.0 1.0 0.2 0.1 2.4 1.1 0.0 0.4 0.9 0.3 15.3 0.5 15.9 13.8 17.2 19.3 16.0 13.1 12.3 5.4 9.1 7.3 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.9" "Cell line enhanced" "Detected in all" "U-698: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" Cytosol "Nucleoplasm, Plasma membrane, Centrosome" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favourable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 31.6 7.2 7.1 7.6 9.8 7.7 13.5 14.8 7.1 7.9 8.2 13.6 5.7 7.7 6.3 5.6 7.9 5.0 7.8 4.6 7.4 5.0 10.3 94.9 5.4 6.2 12.6 3.4 8.7 18.5 5.4 19.4 6.7 9.8 4.6 8.5 6.6 8.8 4.0 6.2 6.7 9.4 5.9 8.7 4.2 11.9 28.6 13.9 10.1 6.1 7.2 9.4 6.0 5.1 11.5 14.7 9.9 11.9 14.1 14.3 12.0 12.8 8.6 12.4 8.4 12.5 6.8 12.5 12.7 8.9 9.5 8.7 29.2 13.5 16.3 9.6 8.2 12.2 18.4 10.4 12.2 11.2 5.7 15.9 5.1 12.7 6.2 18.5 12.7 7.7 6.3 10.7 7.9 11.7 19.2 21.7 10.4 4.2 20.0 7.5 15.3 9.4 15.4 8.3 19.9 14.1 14.2 4.1 11.0 11.4 10.5 2.1 12.1 6.9 12.6 11.1 13.4 5.5 8.1 2.3 5.7 59.6 3.9 21.7 14.0 5.4 10.0 9.9 13.7 11.9 13.4 10.4 13.9 12.7 14.7 11.5 12.3 13.1 2.5 14.1 10.7 6.3 14.3 12.0 7.1 9.8 14.8 7.1 7.4 5.0 12.6 3.4 9.8 13.9 PPP2R5C "B56G, B56gamma, PR61G" ENSG00000078304 "Protein phosphatase 2 regulatory subunit B'gamma" Q13362 14 101761798-101927989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027553 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA027553: AB_10602081" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (1.23e-1)" "unprognostic (1.99e-1)" "unprognostic (1.31e-3)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.72e-1)" 25.5 29.4 52.6 37.7 45.3 48.1 27.4 25.7 38.9 27.8 31.1 25.6 30.1 22.4 24.0 29.2 32.7 22.3 25.4 48.4 49.3 35.6 25.5 38.1 34.5 53.8 44.7 32.4 28.4 25.6 27.6 35.3 19.5 27.5 23.1 33.3 26.6 28.9 27.8 30.5 28.9 31.7 27.7 45.5 36.8 25.4 27.6 29.5 51.4 29.6 28.3 52.1 33.2 21.9 20.1 24.9 35.3 25.3 16.8 60.5 20.9 20.7 14.3 24.3 23.4 22.0 31.0 23.5 19.7 26.0 24.7 23.7 14.3 36.3 56.9 19.0 25.5 21.9 22.1 20.8 32.2 25.6 10.4 16.5 16.9 13.9 16.3 25.2 35.4 20.4 27.0 16.9 15.8 22.1 34.2 24.1 23.5 31.7 25.3 27.9 14.1 23.9 21.5 27.3 14.0 23.6 23.6 19.0 35.6 26.7 17.7 33.2 32.4 19.4 21.8 15.6 14.9 59.9 19.4 33.7 50.3 94.8 23.4 18.7 17.3 20.1 19.8 18.2 60.5 24.3 38.9 20.1 39.7 47.5 16.9 17.8 28.6 44.1 35.3 16.8 25.3 24.9 39.7 20.9 52.6 45.3 25.7 38.9 49.3 35.6 44.7 32.4 27.5 29.5 PPP2R5D "B56D, B56delta" ENSG00000112640 "Protein phosphatase 2 regulatory subunit B'delta" Q14738 6 42984499-43012342 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029045, HPA029046" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029045: AB_10598912, HPA029046: AB_10600988" "unprognostic (2.25e-1)" "unprognostic (7.14e-2)" "unprognostic (4.73e-2)" "unprognostic (6.89e-2)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (3.89e-4)" "unprognostic (4.08e-2)" "unprognostic (1.24e-1)" "unprognostic (9.44e-2)" "unprognostic (2.59e-1)" "unprognostic (2.71e-1)" "unprognostic (1.21e-1)" "unprognostic (9.96e-2)" "unprognostic (2.70e-1)" "unprognostic (7.95e-2)" "unprognostic (6.05e-2)" 17.9 14.4 19.7 17.0 31.5 15.1 14.2 28.3 41.0 20.2 24.5 13.7 15.9 31.1 20.7 11.4 18.1 19.0 14.3 22.0 17.7 18.4 15.7 15.8 15.0 16.2 16.6 25.1 20.7 16.5 17.4 11.2 16.6 26.3 18.4 18.6 16.5 13.7 19.2 41.0 17.9 36.4 20.8 11.2 14.4 14.9 27.1 13.1 35.5 13.4 11.1 14.7 19.1 18.5 9.2 12.5 17.9 11.3 11.8 19.7 15.3 26.6 14.0 21.5 28.0 13.3 18.4 12.1 14.8 10.5 29.6 26.2 22.8 7.3 20.0 14.4 17.9 15.1 28.9 17.0 26.5 17.0 25.2 23.8 17.4 21.4 9.3 16.4 17.6 10.1 11.2 23.6 10.7 22.5 24.9 15.5 17.0 11.4 42.2 15.0 9.6 13.4 29.6 26.7 13.0 9.0 12.6 27.3 17.9 20.1 13.4 15.9 18.7 15.4 21.3 21.4 19.8 22.3 23.5 16.0 20.1 40.9 8.4 15.3 18.4 14.8 11.3 17.9 16.8 9.8 17.6 9.2 15.3 19.0 11.6 9.0 11.8 14.1 6.9 11.8 7.4 12.5 19.7 15.3 19.7 31.5 28.3 41.0 17.7 18.4 16.6 25.1 26.3 13.1 PPP4R1 PP4R1 ENSG00000154845 "Protein phosphatase 4 regulatory subunit 1" Q8TF05 18 9546791-9615240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 23.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.9" "Low region specificity" "Detected in all" "HPA040905, HPA041089" Uncertain Approved Nucleoplasm Nucleoplasm "HPA040905: AB_10794869, HPA041089: AB_10805836" "unprognostic (1.76e-1)" "unprognostic (5.33e-2)" "unprognostic (1.40e-2)" "unprognostic (5.14e-2)" "unprognostic (3.74e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-3)" "unprognostic (9.36e-2)" "unprognostic (1.16e-2)" "unprognostic (4.00e-3)" "unprognostic (3.13e-3)" "unprognostic (4.15e-1)" "unprognostic (7.06e-3)" "unprognostic (1.45e-1)" "unprognostic (2.76e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" 18.0 11.1 9.6 10.7 11.4 16.5 25.1 11.6 12.4 17.7 22.0 13.0 15.5 13.7 16.1 14.5 46.2 13.1 14.3 12.2 9.9 8.9 13.5 12.9 26.7 14.8 9.9 7.8 12.1 20.5 15.9 9.3 28.1 10.3 13.1 12.2 10.1 15.8 13.8 12.8 16.3 25.5 18.1 11.1 15.3 14.4 24.2 11.9 9.4 12.1 28.2 25.3 16.8 21.6 2.5 4.6 23.9 3.9 2.5 3.5 2.0 23.5 16.7 40.3 11.0 8.0 12.2 20.5 23.0 15.5 22.9 22.1 15.1 13.7 11.5 16.9 22.6 10.1 18.7 34.1 30.9 13.3 7.5 10.9 12.3 10.8 12.5 27.6 16.4 10.8 22.1 19.7 18.8 26.1 15.7 10.4 24.6 11.9 19.2 10.6 16.1 10.5 24.0 24.3 7.2 19.2 33.2 11.8 14.0 27.3 12.3 8.9 6.7 10.7 27.8 40.3 25.0 20.8 28.2 9.3 12.9 20.8 15.1 11.5 18.2 7.2 3.9 6.7 2.7 3.1 3.5 2.5 2.9 2.7 4.6 1.4 1.0 2.3 23.9 2.5 3.0 1.9 3.0 2.0 9.6 11.4 11.6 12.4 9.9 8.9 9.9 7.8 10.3 11.9 PQLC1 FLJ22378 ENSG00000122490 "PQ loop repeat containing 1" Q8N2U9 18 79902420-79951664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051666 Uncertain Approved Nucleoplasm Nucleoplasm "HPA051666: " "unprognostic (6.03e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (6.45e-2)" "unprognostic (3.94e-2)" "unprognostic (2.07e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" "unprognostic (4.34e-1)" "unprognostic (1.40e-3)" "unprognostic (2.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.70e-2)" 31.3 12.5 17.4 12.4 16.6 28.3 23.0 12.5 27.0 9.4 16.9 12.3 9.6 8.9 13.4 12.0 20.0 10.8 13.2 13.8 21.3 12.6 16.5 56.7 14.3 14.2 13.0 13.8 9.9 23.8 8.0 8.5 9.5 14.2 10.8 7.1 19.9 21.4 10.1 29.6 19.2 10.0 12.4 7.5 14.0 10.1 22.9 9.7 8.7 25.8 14.4 13.6 11.7 15.8 1.7 7.2 3.8 3.8 2.0 2.5 1.9 16.5 5.7 5.9 11.3 13.1 8.5 8.0 10.9 7.5 8.8 8.4 7.5 9.1 6.9 4.3 9.8 17.1 8.0 11.6 2.3 21.5 11.7 8.8 8.0 20.2 15.8 20.9 22.4 9.5 11.6 8.1 3.1 7.5 3.3 5.7 4.5 12.7 10.3 22.5 1.9 15.5 18.5 6.2 11.7 5.9 11.9 17.4 7.8 8.2 10.5 12.0 6.2 23.1 9.4 13.4 13.8 7.1 8.2 3.0 4.6 9.0 10.3 25.5 5.9 0.7 3.8 3.8 1.7 3.8 1.0 1.7 1.7 0.8 4.0 1.5 2.1 2.5 2.5 2.0 3.1 7.2 1.5 1.9 17.4 16.6 12.5 27.0 21.3 12.6 13.0 13.8 14.2 9.7 PQLC2L C3orf55 ENSG00000174899 "PQ loop repeat containing 2 like" A1A4F0 3 157543246-157677749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.8;breast: 36.0" "Cell line enhanced" "Detected in some" "ASC diff: 33.6;ASC TERT1: 18.6;EFO-21: 12.7;HSkMC: 12.1;LHCN-M2: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA054395 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA054395: " "unprognostic (1.25e-1)" "unprognostic (1.19e-1)" "unprognostic (6.80e-2)" "unprognostic (1.41e-2)" "unprognostic (3.80e-3)" "unprognostic (1.65e-3)" "unprognostic (1.83e-5)" "unprognostic (2.29e-2)" "unprognostic (2.67e-1)" "unprognostic (3.56e-2)" "unprognostic (3.34e-2)" "unprognostic (4.59e-3)" "unprognostic (7.47e-7)" "unprognostic (1.17e-3)" "unprognostic (2.75e-1)" "unprognostic (4.81e-2)" "unprognostic (7.56e-3)" 29.8 1.6 0.2 1.8 1.3 0.1 36.0 0.0 0.8 5.3 4.1 0.0 0.0 0.1 1.3 2.0 3.1 1.8 4.3 5.6 0.3 1.2 4.5 0.1 8.4 1.6 0.5 0.1 0.4 1.4 0.1 5.9 2.6 1.3 3.9 1.4 4.6 4.5 1.0 4.8 2.2 1.6 3.4 0.3 0.1 3.8 2.7 0.0 0.0 11.8 3.0 0.5 4.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 0.0 33.6 18.6 0.0 1.7 3.5 0.7 1.0 0.0 2.4 0.0 12.7 5.3 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 12.1 0.6 5.2 0.3 5.3 0.3 0.0 16.9 0.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.1 0.0 4.8 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.8 0.3 1.2 0.5 0.1 1.3 0.0 PRAME "CT130, MAPE" ENSG00000185686 "Preferentially expressed antigen in melanoma" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 54.3" "Cell line enriched" "Detected in some" 5 "K-562: 139.9" "Group enriched" "Detected in many" 5 "endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavourable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavourable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 1.7 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.5 0.0 2.8 10.9 0.1 0.2 0.1 0.3 0.2 0.0 0.7 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.0 54.3 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 9.1 0.0 19.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 13.9 0.0 0.0 0.6 0.0 0.0 8.4 2.0 4.9 3.6 0.1 0.0 0.4 26.7 0.0 0.0 0.0 0.0 0.0 139.9 2.2 0.0 1.2 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.1 28.7 0.0 0.0 0.0 4.2 3.4 0.7 0.0 25.2 0.0 0.0 0.4 1.9 0.1 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.1 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 106086320-106109939 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Cell line enhanced" "Detected in some" "Karpas-707: 66.9;RPMI-8226: 12.5;U-266/70: 25.1;U-266/84: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4" "Group enriched" "Detected in many" 5 "granulocytes: 6.8;T-cells: 19.3" "Region enriched" "Detected in single" 6 "olfactory region: 4.4" "Low region specificity" "Detected in all" HPA030033 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA030033: AB_10601050" "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavourable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 11.6 1.5 1.6 26.3 3.2 10.4 7.0 5.3 1.6 14.0 16.5 1.9 1.4 5.4 11.6 2.2 33.4 3.8 8.1 2.3 1.9 2.0 3.1 2.4 18.8 33.3 2.1 0.5 4.2 1.8 1.2 2.1 9.0 4.9 3.6 11.0 4.3 10.6 3.0 2.0 8.9 18.2 3.4 7.4 24.2 8.6 3.0 1.5 3.1 7.7 35.7 49.9 12.8 18.0 1.5 0.2 6.8 0.6 2.5 19.3 1.3 0.4 0.1 0.3 0.0 0.5 0.6 0.0 2.3 7.0 0.7 1.3 0.4 2.7 0.5 0.1 4.5 0.1 0.0 1.0 0.8 6.3 0.0 0.1 1.4 0.0 1.1 0.2 0.5 0.7 3.5 1.0 3.0 0.8 0.4 66.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 12.5 0.6 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.7 0.4 1.1 0.6 0.6 2.1 25.1 16.2 1.4 1.5 0.4 0.6 1.2 0.4 5.6 12.6 0.6 19.3 1.5 12.0 11.6 0.2 0.5 1.1 6.8 6.8 2.5 0.1 0.2 15.4 1.3 1.6 3.2 5.3 1.6 1.9 2.0 2.1 0.5 4.9 1.5 PRDM10 "KIAA1231, MGC131802, PFM7" ENSG00000170325 "PR/SET domain 10" Q9NQV6 11 129899706-130002835 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026997 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" "Nucleoplasm, Nucleoli fibrillar center, Vesicles" "HPA026997: AB_1855681" "unprognostic (4.40e-2)" "unprognostic (2.17e-1)" "unprognostic (5.32e-3)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (1.52e-3)" "unprognostic (2.19e-2)" "unprognostic (2.48e-1)" "unprognostic (1.87e-3)" "unprognostic (3.33e-2)" "unprognostic (4.45e-2)" "unprognostic (3.57e-2)" "unprognostic (1.87e-1)" "unprognostic (5.69e-2)" "unprognostic (4.88e-1)" "unprognostic (6.23e-2)" "unprognostic (1.51e-1)" 5.8 5.4 7.6 7.2 8.9 14.2 8.5 20.3 10.4 7.4 7.8 6.4 5.8 6.6 8.2 6.8 8.4 5.4 5.5 4.6 7.7 6.2 5.0 7.3 6.3 6.9 6.6 6.5 7.3 6.2 9.7 11.2 8.3 6.4 7.1 8.0 5.5 6.7 5.4 12.9 12.1 7.0 6.1 6.3 6.7 7.8 5.6 6.3 14.4 6.5 4.7 9.9 6.2 7.0 8.8 3.3 9.4 3.8 7.1 5.0 1.8 2.9 4.0 5.0 3.3 2.3 2.8 3.3 2.5 3.2 2.1 2.7 4.1 3.2 11.9 3.1 2.9 4.0 4.2 2.1 3.4 4.6 4.1 7.8 4.9 3.1 1.5 7.1 32.6 1.9 4.7 3.1 2.0 3.7 4.3 4.5 3.0 3.5 4.7 3.5 3.8 2.9 4.4 3.2 1.8 3.0 5.4 5.5 2.9 3.6 4.2 1.1 2.9 3.0 3.6 4.9 2.2 2.5 3.2 1.1 1.9 16.5 2.2 3.8 4.4 3.9 3.4 8.5 4.5 3.4 4.1 8.8 3.5 3.5 3.3 6.0 5.0 2.4 9.4 7.1 3.8 3.2 4.1 1.8 7.6 8.9 20.3 10.4 7.7 6.2 6.6 6.5 6.4 6.3 PRDM12 ENSG00000130711 "PR/SET domain 12" Q9H4Q4 9 130664594-130682981 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.7" "Cell line enriched" "Detected in single" 20 "RH-30: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 11.2" "Group enriched" "Detected in some" 33 "basal ganglia: 6.1;hypothalamus: 2.0" HPA043143 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA043143: AB_10806379" "unprognostic (3.25e-2)" "unprognostic (2.32e-1)" "unprognostic (3.40e-1)" "unprognostic (1.81e-4)" "unprognostic (7.90e-2)" "unprognostic (4.75e-3)" "unprognostic (2.48e-3)" "unprognostic (4.18e-2)" "unprognostic (4.61e-1)" "unprognostic (2.70e-1)" "unprognostic (6.43e-2)" "unprognostic (7.58e-2)" "unprognostic (4.03e-3)" "unprognostic (3.01e-2)" "unprognostic (4.79e-2)" "unprognostic (6.30e-4)" "unprognostic (1.40e-1)" 0.1 0.7 1.0 0.3 1.5 0.0 0.1 1.1 2.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 1.0 3.7 0.0 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.8 0.0 0.1 0.0 19.0 0.5 0.0 0.0 0.9 0.3 0.4 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 PRDM6 "KMT8C, PRISM" ENSG00000061455 "PR/SET domain 6" Q9NQX0 5 123089121-123194266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7" "Cell line enhanced" "Detected in some" "BEWO: 6.8;HEK 293: 9.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "pons and medulla: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA030324 Uncertain Approved Nucleoplasm Nucleoplasm "HPA030324: AB_10670032" "unprognostic (2.33e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (3.12e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" "unprognostic (1.54e-2)" "unprognostic (4.66e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-7)" "unprognostic (9.30e-4)" "unprognostic (1.10e-1)" "unprognostic (3.43e-4)" "unprognostic (1.27e-1)" 1.3 0.3 0.3 0.6 0.3 0.0 1.4 0.4 0.5 1.6 6.7 0.4 0.3 0.4 1.8 0.6 1.2 0.6 19.7 0.9 0.4 0.3 0.6 0.3 10.6 0.0 0.5 0.4 3.8 0.5 0.3 0.5 8.1 3.6 14.1 1.9 0.0 0.3 0.8 0.2 0.4 1.0 29.7 0.8 0.1 1.1 0.5 0.0 0.0 1.4 0.2 0.6 18.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.6 0.9 6.8 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.5 0.0 1.4 0.0 0.0 0.3 9.6 2.0 0.9 0.0 2.0 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.4 0.1 1.5 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.4 0.3 0.5 0.4 3.6 0.0 PRELID2 "FLJ38376, MGC21644" ENSG00000186314 "PRELI domain containing 2" Q8N945 5 145471799-145835369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 15.8;myeloid DC: 5.2" "Group enriched" "Detected in all" 5 "dendritic cells: 5.2;granulocytes: 15.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042486 Uncertain Approved Nucleoplasm Nucleoplasm "HPA042486: AB_10797498" "unprognostic (9.45e-3)" "unprognostic (1.95e-1)" "unprognostic (7.58e-3)" "unprognostic (2.71e-5)" "unprognostic (1.96e-3)" "unprognostic (6.53e-4)" "unprognostic (6.62e-5)" "unprognostic (2.27e-1)" "unprognostic (4.21e-1)" "unprognostic (1.04e-1)" "prognostic unfavourable (3.78e-4)" "unprognostic (3.83e-1)" "prognostic unfavourable (9.65e-6)" "unprognostic (2.65e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-4)" "unprognostic (6.42e-3)" 6.6 2.4 1.6 5.3 2.0 3.9 4.4 0.7 2.9 4.9 16.4 2.3 2.8 10.6 5.2 2.9 2.4 3.0 14.5 6.4 1.4 1.4 2.6 2.7 2.4 2.7 2.3 1.1 5.2 15.9 1.3 2.8 0.9 2.0 4.2 16.2 9.2 4.3 2.7 1.3 3.0 31.2 6.2 2.5 2.1 7.8 2.5 1.5 0.8 4.1 2.4 1.9 4.3 11.6 1.8 5.2 15.8 1.9 1.8 2.0 0.9 11.2 3.7 3.5 5.6 0.8 2.0 0.0 3.7 6.5 7.0 9.9 12.0 18.5 0.0 6.4 4.4 3.4 2.7 8.4 10.4 3.2 4.4 12.9 4.1 6.2 2.1 1.7 13.8 1.1 3.6 8.0 7.1 7.9 7.0 5.2 3.4 1.9 0.0 1.9 1.8 2.5 0.1 0.0 1.8 3.3 1.7 1.5 3.1 4.7 0.6 7.4 5.6 2.5 7.2 6.1 3.3 10.7 8.4 0.2 0.0 0.0 11.0 0.0 2.4 15.8 1.3 0.4 0.8 1.9 0.4 1.7 1.6 1.2 5.2 1.8 0.2 1.2 0.5 1.8 1.3 0.6 2.0 0.9 1.6 2.0 0.7 2.9 1.4 1.4 2.3 1.1 2.0 1.5 PRELID3B "C20orf45, dJ543J19.5, SLMO2" ENSG00000101166 "PRELI domain containing 3B" Q9Y3B1 20 59033145-59042909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 91.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047721 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047721: " "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.82e-2)" "prognostic unfavourable (5.04e-4)" "unprognostic (1.37e-1)" "unprognostic (3.54e-3)" "prognostic unfavourable (6.96e-5)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (1.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.20e-3)" "unprognostic (5.84e-2)" "unprognostic (2.64e-1)" "unprognostic (2.61e-2)" "unprognostic (8.96e-2)" 18.6 17.0 14.1 17.0 13.9 13.7 20.4 10.3 14.1 10.0 45.2 8.7 11.2 41.3 9.6 9.6 26.7 8.8 10.3 13.3 12.9 13.4 20.5 30.1 13.5 19.1 15.4 10.0 11.1 24.2 12.7 34.3 28.8 12.3 10.5 30.0 6.1 15.3 12.6 17.2 14.0 91.2 11.6 16.7 19.9 19.3 11.5 12.1 21.4 18.9 25.5 21.2 13.9 14.4 25.8 17.5 26.6 21.0 27.1 27.6 20.2 25.9 12.9 12.6 16.4 9.3 13.3 17.7 19.3 17.2 36.3 19.4 35.8 22.0 41.4 34.1 14.8 28.5 25.4 30.6 38.1 24.5 15.9 28.7 21.8 7.6 19.8 37.4 26.7 11.7 40.6 20.8 48.4 11.7 11.2 18.2 15.4 33.4 42.2 16.7 6.2 35.7 22.0 28.5 23.4 18.0 22.3 22.7 21.7 30.9 52.6 44.4 26.5 29.2 13.8 13.1 12.7 24.0 10.1 12.3 17.5 33.5 14.3 18.4 14.7 26.6 13.6 13.5 21.4 17.9 25.9 25.8 26.1 24.0 17.5 18.6 23.6 24.8 11.7 27.1 21.0 14.7 27.6 20.2 14.1 13.9 10.3 14.1 12.9 13.4 15.4 10.0 12.3 12.1 PRICKLE1 "EPM1B, FLJ31937, RILP" ENSG00000139174 "Prickle planar cell polarity protein 1" Q96MT3 12 42456757-42590355 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 18 "HBEC3-KT: 148.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 8.1;naive B-cell: 13.3" "Lineage enriched" "Detected in many" 5 "B-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001379, HPA050037" Approved Approved Nucleoplasm Nucleoplasm "HPA001379: AB_1855703, HPA050037: " "unprognostic (2.44e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-2)" "unprognostic (2.48e-1)" "prognostic unfavourable (3.93e-4)" "unprognostic (1.22e-1)" "unprognostic (2.34e-4)" "unprognostic (3.53e-1)" "unprognostic (1.69e-2)" "unprognostic (5.89e-2)" "unprognostic (5.29e-2)" "unprognostic (7.77e-2)" "unprognostic (1.21e-3)" "unprognostic (2.29e-4)" "unprognostic (1.12e-1)" "unprognostic (8.95e-3)" "unprognostic (5.33e-4)" 9.1 4.1 8.8 6.1 12.6 2.1 17.2 6.6 27.0 16.6 6.1 2.0 5.2 3.4 15.7 8.4 3.2 10.1 17.5 16.4 7.5 5.8 6.4 2.3 11.7 5.4 4.5 10.5 16.3 2.9 2.3 3.9 6.5 5.5 7.1 3.1 11.2 12.6 7.4 4.5 7.2 3.9 16.0 4.4 16.7 3.8 7.2 1.5 0.1 9.9 3.7 4.4 8.6 12.4 13.3 1.7 2.6 1.8 0.6 0.8 0.8 1.1 0.6 2.5 0.0 1.9 2.0 0.1 1.6 0.7 0.4 0.7 0.0 2.3 0.0 4.7 0.2 0.4 1.8 148.9 0.5 0.0 0.9 2.5 0.1 0.0 0.2 0.0 0.0 2.9 1.1 1.9 0.2 5.8 0.2 0.4 0.4 0.0 0.0 0.0 8.3 2.6 0.0 0.1 0.0 3.1 0.1 0.6 0.4 0.0 0.1 0.1 0.0 5.0 0.4 0.1 2.0 2.1 2.0 0.1 0.0 0.9 0.0 1.5 0.1 1.8 1.8 0.4 0.3 1.0 0.8 8.1 0.3 0.3 1.0 13.3 0.5 0.3 2.6 0.6 0.6 1.7 0.2 0.8 8.8 12.6 6.6 27.0 7.5 5.8 4.5 10.5 5.5 1.5 PRKAB1 ENSG00000111725 "Protein kinase AMP-activated non-catalytic subunit beta 1" Q9Y478 12 119667753-119681630 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004247, CAB005058" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB005058: AB_562038, HPA004247: AB_1078149" "unprognostic (1.20e-1)" "unprognostic (3.08e-2)" "unprognostic (7.42e-2)" "prognostic favourable (8.66e-4)" "unprognostic (2.33e-1)" "unprognostic (2.89e-2)" "unprognostic (8.97e-3)" "unprognostic (1.46e-2)" "unprognostic (6.26e-2)" "unprognostic (3.63e-2)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "prognostic favourable (5.40e-9)" "unprognostic (5.60e-2)" "unprognostic (2.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.32e-2)" 16.3 17.2 8.1 16.6 11.9 23.4 13.8 12.5 20.7 16.8 22.8 14.6 6.7 20.4 13.6 13.2 17.9 11.6 19.3 9.2 8.3 7.2 40.1 12.3 21.4 20.6 8.9 9.8 14.2 21.7 11.7 10.8 19.1 11.1 9.7 22.7 20.6 15.3 10.7 12.0 10.6 23.9 12.5 10.5 20.7 25.0 33.4 8.3 20.0 17.5 9.4 16.6 16.3 10.6 26.4 17.4 38.8 19.9 22.1 20.9 18.3 4.7 12.8 10.1 9.6 8.7 7.5 13.4 7.7 10.0 12.5 9.6 13.4 10.8 15.9 10.2 10.5 6.7 10.2 15.9 11.6 10.1 9.4 24.9 5.6 19.4 15.7 11.5 31.6 11.3 13.5 11.4 15.3 9.3 37.9 6.2 9.7 13.1 26.0 12.9 14.3 14.3 15.1 8.7 9.2 14.3 15.1 8.1 13.8 10.2 3.9 10.5 12.5 15.1 11.0 7.7 8.2 5.9 7.7 20.0 17.5 11.8 7.6 7.8 11.0 24.8 16.4 38.8 17.2 18.4 20.9 26.4 18.3 18.3 17.4 21.7 19.9 18.6 19.1 22.1 19.9 15.4 19.7 18.3 8.1 11.9 12.5 20.7 8.3 7.2 8.9 9.8 11.1 8.3 PRKAB2 ENSG00000131791 "Protein kinase AMP-activated non-catalytic subunit beta 2" O43741 1 147155106-147172550 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044342 Approved Approved Nucleoplasm Nucleoplasm "HPA044342: AB_10966508" "prognostic unfavourable (4.55e-4)" "unprognostic (2.03e-2)" "unprognostic (1.84e-1)" "unprognostic (4.03e-2)" "unprognostic (9.59e-3)" "prognostic unfavourable (7.32e-4)" "unprognostic (6.30e-2)" "unprognostic (1.23e-1)" "unprognostic (3.06e-2)" "unprognostic (6.78e-2)" "unprognostic (4.65e-2)" "unprognostic (1.98e-1)" "unprognostic (5.34e-2)" "unprognostic (1.31e-1)" "unprognostic (3.57e-1)" "prognostic unfavourable (6.78e-7)" "unprognostic (4.78e-2)" 7.7 7.6 5.6 4.6 7.1 4.7 7.6 13.3 10.9 9.3 24.6 8.9 8.9 19.1 13.0 8.1 10.0 7.4 6.5 15.2 5.6 5.2 6.2 32.6 6.3 3.8 5.9 9.3 8.1 21.0 18.4 6.2 7.5 7.8 10.9 6.9 6.3 5.7 12.6 52.1 9.4 19.1 20.5 8.4 5.7 11.1 6.9 5.5 2.6 5.8 19.9 4.7 19.0 10.3 1.2 1.7 2.9 1.6 5.1 2.5 0.8 4.0 2.2 5.9 4.6 14.1 12.2 21.6 7.6 4.2 5.1 5.6 8.9 8.0 7.2 3.9 6.0 10.7 6.9 8.4 5.0 2.8 4.8 3.2 7.1 14.3 9.7 3.7 1.4 9.6 17.1 5.3 25.0 5.0 4.5 3.0 4.3 4.0 2.8 2.1 12.5 9.9 4.4 8.0 3.5 3.7 3.2 3.8 7.2 5.7 6.5 27.0 6.1 4.7 5.6 5.8 12.8 5.3 12.2 4.8 5.1 3.7 6.0 3.3 7.5 2.9 1.2 1.9 1.5 1.2 2.5 1.2 1.6 0.9 1.7 1.1 1.7 1.1 0.3 5.1 1.6 0.8 0.7 0.8 5.6 7.1 13.3 10.9 5.6 5.2 5.9 9.3 7.8 5.5 PRKAG1 ENSG00000181929 "Protein kinase AMP-activated non-catalytic subunit gamma 1" P54619 12 49002274-49019197 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077805 Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA077805: " "unprognostic (3.24e-2)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (2.03e-2)" "prognostic unfavourable (2.84e-7)" "unprognostic (1.45e-1)" "unprognostic (4.68e-2)" "unprognostic (1.93e-2)" "unprognostic (5.35e-2)" "unprognostic (8.49e-2)" "prognostic favourable (1.83e-4)" "unprognostic (3.40e-1)" "unprognostic (2.57e-1)" "unprognostic (1.97e-2)" "unprognostic (5.57e-2)" 23.8 30.3 18.5 13.6 18.6 22.6 25.5 14.2 27.0 19.2 18.8 19.6 18.0 13.3 16.0 23.9 26.8 14.1 14.2 39.4 15.2 18.2 27.1 30.8 13.9 14.9 19.7 18.4 18.9 19.6 19.2 22.2 18.9 22.1 19.1 17.0 20.3 18.4 21.0 58.4 21.7 19.8 20.4 15.9 18.7 17.4 19.2 10.7 22.5 22.5 24.9 23.0 23.2 15.7 29.2 41.0 44.0 35.9 40.1 36.9 37.9 21.5 13.4 15.3 24.1 39.2 40.2 8.7 23.7 31.2 24.3 15.6 13.2 19.3 13.9 21.4 27.3 18.9 11.1 30.6 23.5 15.9 18.3 18.9 20.8 10.5 32.5 25.0 14.9 31.6 24.1 17.6 37.1 23.3 14.3 20.0 32.5 13.9 10.3 9.5 9.4 28.2 5.8 13.5 17.6 32.5 18.2 12.8 16.3 16.8 31.0 36.0 37.8 14.0 21.6 11.4 15.4 26.0 17.9 32.9 32.1 9.3 27.7 18.0 10.3 41.1 35.9 33.6 31.5 34.2 30.3 29.2 28.4 29.4 41.0 26.4 25.9 26.8 44.0 40.1 33.0 27.6 36.9 37.9 18.5 18.6 14.2 27.0 15.2 18.2 19.7 18.4 22.1 10.7 PRKAG2 "AAKG, AAKG2, CMH6, H91620p, WPWS" ENSG00000106617 "Protein kinase AMP-activated non-catalytic subunit gamma 2" Q9UGJ0 7 151556111-151877125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Cardiomyopathy, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 77.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004246, CAB018641" Uncertain Approved Nucleoplasm Nucleoplasm "CAB018641: AB_2170355, HPA004246: AB_1078151" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.46e-2)" "unprognostic (9.29e-2)" "unprognostic (1.76e-1)" "unprognostic (4.33e-3)" "unprognostic (7.13e-2)" "unprognostic (8.09e-2)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (2.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.80e-1)" "unprognostic (3.61e-2)" "unprognostic (4.52e-1)" 12.8 5.5 15.3 8.7 28.8 6.3 9.7 31.1 19.2 8.8 11.5 7.5 9.4 16.7 10.4 10.9 10.8 8.6 12.0 77.2 15.1 13.5 15.4 18.5 8.6 7.7 12.3 14.3 6.8 6.2 6.7 5.1 20.0 18.3 17.5 13.5 7.8 11.9 14.8 21.5 6.9 17.8 32.8 8.5 12.8 13.8 9.7 9.5 2.3 12.6 5.2 7.1 22.4 12.4 7.9 7.8 18.4 6.0 3.1 6.1 3.5 18.2 5.3 3.6 4.2 16.4 14.0 6.4 8.4 7.6 9.1 8.9 3.4 23.4 0.0 13.9 11.2 5.9 2.2 9.8 14.8 4.4 2.5 4.9 0.6 0.4 24.4 3.6 4.7 6.8 21.0 9.1 9.7 15.6 1.6 2.3 27.5 6.9 1.9 2.6 3.7 15.5 1.8 2.6 3.8 17.3 4.4 16.1 2.5 4.9 9.2 3.7 2.9 4.9 20.8 2.1 1.8 1.0 5.3 1.6 1.9 0.0 25.9 11.3 20.4 18.4 6.0 10.5 5.1 5.4 3.7 7.9 4.5 4.5 4.3 3.8 4.2 6.1 13.6 3.1 5.4 7.8 2.4 3.5 15.3 28.8 31.1 19.2 15.1 13.5 12.3 14.3 18.3 9.5 PRKD3 "EPK2, PRKCN" ENSG00000115825 "Protein kinase D3" O94806 2 37250502-37324808 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029529 Uncertain Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029529: AB_10602082" "unprognostic (1.39e-1)" "unprognostic (7.34e-2)" "prognostic favourable (4.84e-4)" "unprognostic (1.23e-2)" "unprognostic (5.61e-2)" "unprognostic (2.08e-1)" "prognostic unfavourable (3.47e-4)" "unprognostic (1.10e-1)" "unprognostic (1.16e-1)" "unprognostic (2.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.81e-1)" "unprognostic (7.62e-3)" "unprognostic (2.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.35e-1)" 16.1 22.1 9.5 20.7 10.7 5.3 35.1 4.8 9.2 17.2 18.0 7.2 7.2 6.0 19.2 16.0 9.8 11.3 10.0 11.6 12.7 6.1 9.9 8.4 20.4 22.3 11.4 3.7 15.0 7.6 12.9 20.7 11.1 10.3 14.4 8.3 27.8 11.1 13.3 19.1 11.5 12.1 16.5 15.4 22.0 10.5 16.8 10.8 16.2 11.8 9.3 21.2 12.4 17.7 16.4 8.2 5.7 8.3 6.3 11.5 3.4 12.6 5.4 14.3 11.8 10.9 18.4 10.5 8.2 15.3 9.3 9.5 8.6 4.5 18.6 6.9 12.3 5.0 9.7 10.1 12.6 24.0 14.2 12.2 8.3 5.8 4.5 8.7 7.5 8.6 5.2 14.7 9.7 16.5 10.2 22.9 10.8 2.1 3.8 6.8 15.1 5.2 12.8 22.6 15.9 6.2 14.3 10.8 28.0 7.9 4.5 48.2 4.9 8.0 15.9 26.7 13.9 10.6 9.2 26.2 48.5 21.7 9.3 3.7 16.0 5.7 8.3 5.5 10.5 6.6 9.1 12.4 8.8 8.4 7.8 16.4 10.4 11.5 1.5 6.3 3.3 8.2 4.1 3.4 9.5 10.7 4.8 9.2 12.7 6.1 11.4 3.7 10.3 10.8 PRMT9 "FLJ46629, PRMT10" ENSG00000164169 "Protein arginine methyltransferase 9" Q6P2P2 4 147637785-147684230 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036844, HPA042537" Uncertain Approved Nucleoplasm,Microtubules,Cytosol Microtubules "Nucleoplasm, Cytosol" "HPA036844: AB_10672341, HPA042537: " "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" "unprognostic (4.65e-3)" "unprognostic (2.35e-1)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (4.14e-2)" "unprognostic (7.29e-2)" "unprognostic (2.11e-2)" "unprognostic (2.33e-1)" "prognostic favourable (3.58e-7)" "unprognostic (1.72e-1)" "unprognostic (4.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.30e-2)" 6.0 17.2 6.0 5.2 8.6 12.4 6.9 8.0 8.9 5.6 4.5 4.2 7.9 2.5 8.6 7.6 5.0 7.5 8.4 6.5 5.6 5.0 7.5 5.8 7.6 5.3 5.8 5.3 22.6 7.2 16.3 10.0 5.0 7.1 6.0 4.5 9.8 5.8 11.3 6.7 5.6 4.3 6.1 4.6 4.5 5.9 11.2 3.9 11.6 15.8 2.8 5.4 5.5 5.2 9.6 6.0 10.8 6.1 5.1 10.4 2.7 3.5 2.3 5.6 4.3 4.4 7.4 4.9 3.9 6.2 5.9 6.3 1.8 3.9 12.1 1.8 3.3 2.4 6.5 3.3 8.2 4.4 3.8 6.7 4.4 3.0 3.3 9.7 3.7 5.1 3.5 3.6 3.2 4.9 6.5 7.0 5.0 2.0 8.2 3.8 2.9 4.2 5.6 4.8 4.4 4.8 2.8 3.5 5.3 6.2 4.9 3.2 2.1 2.1 4.2 3.8 3.1 4.2 4.2 8.0 6.4 7.9 4.3 6.0 2.8 7.4 6.0 10.8 6.7 6.1 6.5 9.5 8.1 8.2 4.0 9.6 10.4 9.0 4.2 5.1 4.4 6.0 6.8 2.7 6.0 8.6 8.0 8.9 5.6 5.0 5.8 5.3 7.1 3.9 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell line enriched" "Detected in some" 6 "HDLM-2: 47.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060103 Enhanced Approved Nucleoplasm Nucleoplasm "HPA060103: " "unprognostic (4.14e-2)" "prognostic favourable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 1.9 1.2 2.9 0.5 1.5 0.3 0.2 0.0 0.1 47.0 0.6 0.7 1.1 0.2 1.3 0.0 1.6 0.4 0.4 1.1 0.3 0.0 0.2 3.0 1.6 0.5 2.4 1.2 0.6 1.2 7.5 0.2 5.6 0.1 0.0 0.6 0.3 2.8 2.9 0.1 1.1 1.6 0.2 0.0 0.1 0.1 0.2 0.4 0.8 4.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "kidney: 51.2;liver: 49.3" "Cell line enriched" "Detected in some" 18 "Hep G2: 25.9" "Group enriched" "Detected in some" 50 "liver cancer: 28.1;renal cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA051287 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051287: " "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.7 0.1 0.0 0.3 0.1 0.1 0.0 51.2 49.3 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 PROM2 ENSG00000155066 "Prominin 2" Q8N271 2 95274453-95291308 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 23.2;CAPAN-2: 41.1;HaCaT: 22.2;hTCEpi: 24.1;MCF7: 18.2;RT4: 25.0;SK-BR-3: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB046005, HPA063728" Enhanced Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB046005: AB_2284371, HPA063728: " "prognostic unfavourable (2.16e-4)" "unprognostic (1.60e-1)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.26e-1)" "prognostic unfavourable (1.55e-6)" "unprognostic (1.46e-2)" "unprognostic (4.59e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-2)" 0.3 0.2 0.5 2.9 0.6 0.0 9.3 1.1 0.5 11.4 5.2 0.3 22.2 4.4 1.4 22.5 42.6 2.2 37.2 0.5 0.6 0.5 18.8 0.4 1.3 0.3 0.6 0.3 1.5 8.6 8.1 1.5 12.5 0.3 11.6 4.2 0.3 35.6 20.0 1.3 26.7 2.6 2.7 0.7 0.4 11.5 1.8 0.3 1.7 5.7 21.6 22.2 20.0 14.8 0.0 0.2 0.6 0.0 0.0 0.3 0.0 23.2 0.0 0.0 0.2 0.1 0.0 11.8 0.0 0.0 0.1 0.1 0.2 41.1 0.0 0.0 0.0 22.2 0.0 12.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 25.0 0.2 0.0 0.0 35.9 0.0 11.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 0.5 0.6 1.1 0.5 0.6 0.5 0.6 0.3 0.3 0.3 PROSER1 "bA50D16.2, C13orf23, FLJ12661" ENSG00000120685 "Proline and serine rich 1" Q86XN7 13 39009866-39038076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034225, HPA055687" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB034225: AB_1564157, HPA055687: " "unprognostic (6.75e-3)" "unprognostic (9.56e-3)" "unprognostic (1.33e-1)" "unprognostic (3.81e-2)" "unprognostic (7.06e-2)" "unprognostic (2.92e-2)" "unprognostic (3.73e-3)" "unprognostic (5.98e-2)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (3.60e-1)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (9.31e-3)" "unprognostic (2.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.95e-1)" 10.8 9.9 10.6 12.8 13.3 26.8 11.3 22.6 14.3 8.5 13.7 17.4 9.6 12.9 11.9 11.8 14.5 9.2 8.0 8.8 10.7 6.9 12.6 11.3 15.0 15.2 14.8 9.0 10.0 19.0 7.0 19.5 35.4 12.2 13.4 17.3 11.0 17.9 8.3 11.8 18.5 15.0 9.9 16.3 16.6 12.8 19.0 15.0 26.1 14.3 8.2 17.3 10.8 11.2 4.1 4.8 6.0 4.4 7.5 6.4 4.2 7.1 5.6 17.6 12.1 6.0 4.8 27.9 6.8 6.0 6.9 7.4 17.7 11.3 16.8 5.5 6.6 12.5 18.8 12.2 11.3 25.4 15.4 24.8 6.1 12.2 13.8 25.8 15.3 6.4 14.8 10.9 24.9 11.2 12.2 10.2 7.3 12.5 15.6 13.8 26.2 6.1 16.5 18.6 10.6 6.9 11.3 9.9 11.4 4.8 12.5 10.1 13.5 14.9 10.2 4.0 6.5 7.8 8.6 9.6 9.8 18.3 6.5 14.4 7.8 6.0 3.4 0.6 5.7 3.2 6.4 4.1 5.5 6.1 4.1 3.1 4.9 5.3 0.9 7.5 4.4 4.8 3.0 4.2 10.6 13.3 22.6 14.3 10.7 6.9 14.8 9.0 12.2 15.0 PRPF39 "FLJ11128, FLJ20666" ENSG00000185246 "Pre-mRNA processing factor 39" Q86UA1 14 45084099-45116282 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001176 Approved Approved Nucleoplasm Nucleoplasm "HPA001176: AB_2171026" "unprognostic (1.79e-1)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (2.19e-1)" "unprognostic (1.91e-2)" "unprognostic (6.75e-3)" "prognostic unfavourable (3.84e-5)" "unprognostic (9.51e-3)" "prognostic unfavourable (6.51e-4)" "prognostic favourable (8.48e-4)" "unprognostic (4.34e-3)" "prognostic unfavourable (4.04e-4)" "unprognostic (5.02e-3)" "unprognostic (1.83e-1)" "unprognostic (9.04e-2)" "unprognostic (8.93e-2)" "prognostic favourable (2.99e-4)" 11.9 8.6 15.3 13.3 19.1 12.8 12.4 34.0 21.4 10.5 11.9 11.2 12.6 9.1 14.3 11.6 8.3 13.4 6.4 8.7 12.5 11.5 13.1 10.6 9.1 11.2 14.5 14.4 15.2 9.4 12.9 22.3 9.7 11.4 13.9 8.1 7.0 9.5 13.5 14.2 9.5 11.0 12.2 14.2 10.6 10.1 10.2 15.6 9.5 10.8 6.7 10.4 9.8 13.8 8.7 7.6 7.7 7.4 6.5 11.0 4.9 11.6 8.8 14.6 7.6 9.7 6.6 9.6 11.6 6.5 10.5 10.7 6.1 9.8 9.1 8.3 6.9 8.6 15.4 9.9 15.9 12.3 8.8 12.4 10.3 9.1 7.9 16.6 6.0 4.4 7.0 6.4 8.1 8.1 13.4 11.4 13.2 12.4 15.7 12.0 9.9 9.3 15.7 14.3 10.3 8.5 11.9 12.2 3.7 8.8 11.2 12.7 6.9 11.1 10.3 6.9 10.2 7.6 12.5 9.3 16.2 18.9 4.9 11.5 7.3 7.7 4.3 6.6 8.3 7.0 10.8 8.7 7.6 8.2 7.6 8.2 10.0 11.0 3.0 6.5 7.4 3.2 8.7 4.9 15.3 19.1 34.0 21.4 12.5 11.5 14.5 14.4 11.4 15.6 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 6.2 12.3 16.6 5.8 12.6 1.5 9.7 15.6 20.3 12.8 8.8 11.7 13.2 5.5 14.7 13.8 8.5 15.2 8.3 16.3 12.6 10.6 12.9 5.5 6.6 4.1 13.3 14.5 22.0 10.3 30.3 17.5 11.8 12.0 11.0 4.9 10.4 14.2 17.9 22.3 13.1 4.7 10.4 9.6 7.3 8.9 25.1 12.9 2.3 19.4 5.5 5.2 9.9 9.1 1.8 1.5 0.0 0.4 3.1 3.5 0.8 5.1 7.5 7.6 7.4 6.3 4.1 7.0 4.2 5.9 4.5 2.3 8.7 11.5 4.1 9.0 5.5 3.0 4.6 14.6 2.3 3.0 1.8 4.3 2.8 3.1 8.0 1.4 5.8 5.8 12.4 4.5 16.4 3.5 2.1 2.2 5.4 4.8 1.0 2.9 3.2 2.8 3.6 1.2 3.3 9.5 4.7 8.1 9.8 3.4 9.5 5.1 18.0 4.0 1.5 2.8 11.3 3.6 1.8 5.3 3.0 1.6 8.4 1.1 2.5 0.0 0.4 0.0 2.4 0.3 3.5 1.1 2.3 1.1 0.6 1.8 2.7 2.9 0.0 3.1 0.2 1.5 1.0 0.8 16.6 12.6 15.6 20.3 12.6 10.6 13.3 14.5 12.0 12.9 PRPSAP2 PAP41 ENSG00000141127 "Phosphoribosyl pyrophosphate synthetase associated protein 2" O60256 17 18840085-18931287 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021881 Approved Approved Nucleoplasm,Cytosol 28000 "Nucleoplasm, Cytosol" "HPA021881: AB_1855782" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.78e-2)" "unprognostic (1.18e-1)" "unprognostic (2.01e-2)" "unprognostic (1.90e-1)" "unprognostic (3.25e-2)" "unprognostic (9.82e-2)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.71e-4)" "unprognostic (4.57e-2)" "unprognostic (8.98e-3)" "unprognostic (1.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-1)" "unprognostic (9.08e-2)" 9.5 15.5 18.9 22.7 20.0 16.0 12.7 42.9 23.0 13.6 16.1 27.2 13.7 19.0 16.3 14.6 15.9 16.6 16.6 13.9 20.5 22.0 22.9 16.2 13.7 35.9 23.6 19.4 20.9 16.2 18.5 24.9 10.4 20.2 13.1 19.1 16.2 13.4 13.6 9.8 15.3 16.4 13.5 35.0 14.8 17.0 22.7 22.6 28.1 20.5 10.3 41.1 12.7 13.5 26.0 18.9 17.0 14.7 21.4 29.9 16.7 15.9 17.5 25.5 18.3 11.2 7.1 26.2 12.0 9.4 15.7 14.8 22.0 7.6 40.7 12.4 10.3 19.5 29.9 15.1 17.3 18.3 24.0 12.7 14.7 18.3 15.5 8.1 11.5 8.1 10.2 19.9 15.3 14.7 18.8 6.8 14.0 17.6 17.1 9.5 18.2 11.7 24.1 42.1 18.0 9.7 10.1 15.0 19.5 18.3 7.2 18.5 20.2 11.8 9.7 6.6 12.9 22.0 14.8 11.1 13.0 16.9 13.4 11.9 13.3 12.7 13.8 17.0 16.7 14.1 18.5 26.0 21.2 17.1 18.9 24.3 29.9 22.3 5.8 21.4 14.7 13.1 21.1 16.7 18.9 20.0 42.9 20.1 20.5 22.0 23.6 19.4 20.2 22.6 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656440 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265" Uncertain Approved Nucleoplasm Nucleoplasm "HPA052022: , HPA060265: " "unprognostic (1.57e-1)" "prognostic favourable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 17.7 13.8 15.1 18.2 14.1 24.4 16.1 27.4 17.2 19.5 18.8 19.2 16.4 19.3 21.7 11.1 18.1 17.2 16.7 10.1 14.5 9.1 16.5 15.1 15.8 18.9 16.4 7.8 18.2 19.6 18.6 15.3 13.9 10.6 17.8 9.8 14.8 22.1 22.6 13.6 24.5 18.4 15.6 13.6 23.4 23.2 9.3 13.7 31.2 17.7 10.0 19.3 16.4 19.6 8.8 5.8 18.1 8.2 6.1 8.4 4.5 8.6 10.9 9.1 7.1 8.0 5.6 6.2 9.3 5.3 9.2 8.3 5.0 7.3 15.1 8.0 5.6 8.9 7.1 10.2 2.7 21.3 20.7 8.7 11.2 9.9 11.5 7.2 20.8 5.3 10.9 5.9 5.5 11.3 11.3 9.9 4.8 21.8 16.2 12.5 2.9 5.8 12.3 4.2 20.7 5.3 3.7 7.0 16.4 3.6 12.6 8.2 15.4 4.1 8.2 7.9 8.8 7.3 9.2 23.1 14.6 8.9 5.3 15.7 6.9 8.6 4.9 17.8 8.4 4.8 6.4 6.3 6.9 8.4 4.6 8.8 6.4 6.5 18.1 6.1 8.2 5.8 8.2 4.5 15.1 14.1 27.4 17.2 14.5 9.1 16.4 7.8 10.6 13.7 PRR14L "C22orf30, MGC50372" ENSG00000183530 "Proline rich 14 like" Q5THK1 22 31676256-31750140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062645 Uncertain Approved Nucleoplasm Nucleoplasm "HPA062645: " "unprognostic (2.87e-1)" "unprognostic (1.34e-1)" "unprognostic (3.36e-2)" "unprognostic (2.79e-1)" "unprognostic (2.42e-2)" "unprognostic (2.13e-1)" "unprognostic (1.37e-2)" "unprognostic (4.10e-2)" "unprognostic (8.86e-3)" "unprognostic (1.80e-1)" "unprognostic (2.10e-1)" "unprognostic (4.90e-2)" "prognostic favourable (3.00e-4)" "unprognostic (1.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.48e-2)" "unprognostic (4.14e-3)" 10.9 10.6 9.8 13.9 12.0 15.1 10.8 18.2 14.0 9.7 11.9 9.9 8.9 8.1 10.0 8.4 14.4 10.4 8.3 9.0 10.1 7.2 8.6 9.8 10.3 12.0 9.4 9.3 13.9 9.7 18.7 21.5 13.5 11.2 8.7 13.6 7.6 11.6 11.9 8.0 13.0 16.4 9.8 10.6 12.8 11.1 11.0 11.8 20.3 10.3 5.8 13.3 11.1 12.1 4.2 4.4 10.0 12.2 3.2 3.8 1.9 9.5 9.2 10.1 9.9 9.3 8.7 10.5 5.2 6.2 8.2 7.7 8.4 3.5 10.8 5.1 10.2 9.5 19.7 7.8 8.6 14.4 8.4 6.5 7.8 6.7 7.9 20.1 14.2 7.8 7.9 11.4 9.9 11.5 9.9 7.2 8.6 9.1 7.0 6.5 11.6 3.6 10.8 16.2 6.2 6.8 10.9 14.0 8.2 12.2 7.4 6.9 6.5 8.1 10.8 5.0 10.2 6.7 7.1 11.3 13.3 8.3 7.8 10.0 7.7 9.2 5.3 6.1 3.8 6.4 3.3 3.9 2.3 3.1 3.9 4.2 3.5 3.5 10.0 3.2 12.2 4.4 3.0 1.9 9.8 12.0 18.2 14.0 10.1 7.2 9.4 9.3 11.2 11.8 PRR16 DSC54 ENSG00000184838 "Proline rich 16" Q569H4 5 120464278-120687332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 24.9;BJ hTERT+: 25.9;fHDF/TERT166: 31.2;HSkMC: 20.0;LHCN-M2: 30.2;U-138 MG: 37.2" "Cancer enriched" "Detected in many" 5 "prostate cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049254 Approved Approved Nucleoplasm,Midbody,Cytosol Nucleoplasm "Midbody, Cytosol" "HPA049254: " "unprognostic (1.71e-1)" "unprognostic (3.87e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-1)" "unprognostic (6.61e-2)" "unprognostic (7.07e-2)" "unprognostic (1.53e-1)" "unprognostic (2.42e-2)" "unprognostic (8.33e-2)" "unprognostic (4.40e-2)" "unprognostic (2.76e-2)" "unprognostic (2.06e-1)" "unprognostic (2.54e-8)" "unprognostic (3.05e-2)" "unprognostic (9.13e-2)" "unprognostic (2.65e-1)" "unprognostic (2.38e-3)" 11.6 4.4 4.7 7.0 4.9 0.9 11.3 21.1 7.6 20.3 5.2 2.2 1.8 2.9 15.7 4.6 4.1 5.8 8.2 16.9 4.7 3.8 3.6 1.5 10.0 3.1 2.3 4.9 6.9 2.4 1.8 2.5 12.8 9.6 10.9 6.7 1.4 3.2 3.9 30.4 4.4 4.9 11.6 3.0 4.3 4.3 3.2 1.6 0.0 4.9 14.2 1.8 8.7 23.2 0.5 1.4 0.7 3.2 0.2 0.2 1.0 1.1 0.0 2.5 0.0 7.1 24.9 0.0 11.2 25.9 16.2 12.4 0.0 0.0 0.0 0.0 31.2 0.0 2.5 0.2 17.0 0.0 0.6 0.0 0.3 0.0 6.8 0.0 0.0 20.0 2.8 4.8 15.2 0.5 0.0 0.0 30.2 0.0 0.0 0.0 0.2 0.4 0.0 1.9 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.3 0.0 0.0 0.1 37.2 4.3 1.2 5.8 0.1 0.0 0.0 2.1 0.0 1.2 0.5 3.2 0.2 0.1 1.8 0.1 0.2 0.1 0.0 1.4 0.5 0.1 0.2 0.7 0.2 1.1 0.5 0.1 1.0 4.7 4.9 21.1 7.6 4.7 3.8 2.3 4.9 9.6 1.6 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Mitochondria" Nucleoli "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: " "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.0 3.3 4.4 0.2 0.3 3.5 2.3 1.8 5.3 5.1 2.5 3.7 0.7 6.9 1.9 1.3 1.5 1.7 1.2 2.6 1.5 4.1 3.5 1.4 1.2 1.1 2.5 1.8 2.3 3.5 0.7 0.9 2.2 2.0 2.4 9.2 3.9 2.0 3.5 0.0 1.5 0.6 0.4 1.8 3.4 7.5 3.0 3.2 2.3 0.9 3.0 1.4 1.2 3.5 5.2 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Cell line enhanced" "Detected in many" "HMC-1: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.1 1.3 6.6 0.0 0.2 6.5 1.3 0.5 1.0 1.6 3.1 1.8 2.9 3.7 0.2 2.3 1.0 1.3 0.2 4.5 10.2 1.3 1.3 1.1 0.5 3.1 15.9 0.8 1.1 1.4 0.4 0.2 7.1 0.0 0.8 6.8 3.5 3.8 8.1 3.2 3.4 1.2 4.5 0.2 2.1 1.7 3.2 0.3 2.4 3.6 2.7 2.5 1.0 2.4 6.7 8.6 1.6 9.3 7.2 5.5 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 PRR3 "CAT56, Em:AB014077.1, Em:AB023052.2" ENSG00000204576 "Proline rich 3" P79522 6 30556886-30563723 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;HAP1: 12.6;U-266/84: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064061 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064061: " "unprognostic (3.76e-2)" "unprognostic (6.72e-3)" "unprognostic (8.90e-2)" "unprognostic (2.10e-3)" "unprognostic (1.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.65e-3)" "unprognostic (1.25e-2)" "unprognostic (3.73e-2)" "prognostic favourable (6.49e-6)" "prognostic favourable (5.61e-5)" "unprognostic (4.71e-2)" "prognostic unfavourable (7.84e-7)" "unprognostic (2.80e-1)" "unprognostic (2.82e-1)" "unprognostic (3.66e-1)" "unprognostic (1.21e-3)" 7.6 5.6 9.7 5.5 7.4 4.0 3.5 15.0 13.8 5.4 4.5 5.6 3.1 2.5 7.3 15.3 3.6 6.2 4.0 3.2 10.1 12.1 4.3 3.8 4.9 6.1 5.9 7.6 13.5 5.4 10.6 8.8 3.4 8.0 4.4 5.3 6.9 2.6 6.9 3.1 6.5 3.4 3.8 4.6 5.0 5.9 8.6 5.7 11.1 4.9 1.7 5.6 6.4 4.0 2.0 2.3 1.5 1.2 1.3 1.9 0.4 0.6 1.6 5.3 10.0 2.6 0.9 0.0 0.0 0.0 0.0 0.0 4.6 0.5 4.6 3.9 0.9 0.6 12.6 1.0 0.0 2.7 4.6 6.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.1 0.0 0.0 7.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 6.8 2.3 0.6 0.0 0.0 3.1 0.7 4.0 0.0 0.0 0.0 7.6 8.5 4.5 0.0 2.6 2.9 1.5 1.2 0.3 0.5 0.3 1.0 1.0 1.6 1.2 1.0 2.0 0.9 1.9 1.0 1.3 0.6 2.3 0.0 0.4 9.7 7.4 15.0 13.8 10.1 12.1 5.9 7.6 8.0 5.7 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell line enhanced" "Detected in some" "REH: 21.8;SCLC-21H: 6.3;SH-SY5Y: 14.2;T-47d: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062741: " "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favourable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.7 5.2 4.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 2.3 0.0 1.5 0.0 0.1 4.0 0.0 0.0 0.0 5.0 0.0 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.4 21.8 0.0 0.2 2.9 4.2 6.3 14.2 0.0 0.2 0.0 7.1 0.0 0.0 0.0 2.6 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell line enhanced" "Detected in many" "PC-3: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046636 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: " "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavourable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavourable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.1 2.8 0.8 5.6 0.0 0.4 2.4 3.4 0.6 1.0 1.3 0.6 3.8 6.9 8.9 0.5 6.0 0.4 3.0 0.4 6.0 8.9 2.1 2.6 2.1 0.6 4.1 5.0 0.6 1.3 0.4 0.2 0.4 1.0 4.9 0.9 9.6 3.4 10.6 1.3 17.1 9.8 2.6 6.9 1.2 0.5 13.9 9.9 1.3 3.3 15.9 3.0 0.6 2.6 5.7 9.5 5.0 8.1 2.7 1.5 3.3 5.5 6.7 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: " "unprognostic (8.82e-2)" "prognostic unfavourable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favourable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 14.7 3.4 2.7 2.7 9.2 7.5 1.2 6.2 8.4 2.3 4.0 8.1 9.5 0.0 10.9 4.9 4.8 7.4 4.7 3.9 0.0 2.4 2.6 3.5 2.7 11.3 0.0 3.4 11.6 4.0 4.4 3.7 11.7 1.2 0.0 7.8 1.1 0.0 0.0 3.3 7.0 0.0 6.1 0.0 38.6 0.7 0.0 0.0 4.6 7.3 2.8 0.0 1.6 8.3 3.5 2.1 6.8 1.9 0.0 0.0 0.0 3.5 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.6;CAPAN-2: 12.0;RT4: 9.2;SK-BR-3: 10.8;T-47d: 11.6;U-266/84: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favourable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.6 0.3 0.2 0.7 1.1 0.0 3.7 0.2 0.0 0.3 0.3 1.7 12.0 0.5 1.3 0.1 7.0 0.2 6.8 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 6.0 0.2 0.2 2.7 0.2 0.6 0.0 1.9 0.1 0.7 0.5 1.1 0.2 0.3 6.7 5.3 9.2 1.9 0.2 1.0 10.8 0.1 11.6 0.1 0.4 0.7 0.5 0.3 0.1 4.2 14.0 0.4 0.1 0.3 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.5;MCF7: 15.8;SK-BR-3: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" 18000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA035127: AB_10602822, HPA035128: , HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.5 3.3 12.5 1.7 0.8 1.2 2.4 1.4 3.3 0.2 2.4 1.3 0.3 2.9 0.2 0.9 3.1 0.6 6.7 1.4 0.5 1.3 0.0 1.2 0.3 1.2 3.2 0.2 1.2 0.5 0.6 0.7 3.3 1.8 15.8 3.0 0.2 6.1 1.5 1.8 0.3 1.3 0.7 0.2 4.8 3.2 1.2 23.8 0.4 6.4 0.2 0.6 0.3 3.4 0.6 0.9 4.3 4.4 0.4 7.9 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 70.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: , HPA052681: " "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 13.8 0.3 0.0 3.8 0.2 0.3 0.0 0.0 0.1 70.3 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 PRRX2 "PMX2, PRX2" ENSG00000167157 "Paired related homeobox 2" Q99811 9 129665641-129722674 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.9;BJ: 16.7;BJ hTERT+: 12.0;fHDF/TERT166: 24.0;U-2197: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006607, HPA026808" Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA006607: , HPA026808: AB_10603228" "unprognostic (4.02e-2)" "unprognostic (5.17e-2)" "unprognostic (7.65e-3)" "unprognostic (4.47e-3)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (2.16e-2)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.94e-10)" "unprognostic (6.66e-2)" "unprognostic (4.48e-1)" "unprognostic (2.65e-2)" "unprognostic (9.47e-3)" 8.4 2.1 0.4 2.5 0.4 0.2 7.3 0.2 0.6 15.6 2.4 0.5 3.5 0.7 4.6 5.4 5.3 2.1 2.3 8.6 0.4 0.2 0.6 0.4 2.8 1.8 0.3 0.1 3.2 2.2 0.3 2.8 2.6 1.7 15.1 0.7 12.8 4.6 5.2 6.6 15.8 1.1 10.2 1.2 0.4 1.6 6.7 0.0 0.6 7.9 9.3 6.5 10.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 2.0 7.9 0.0 16.7 12.0 2.1 2.4 0.0 0.0 0.0 6.1 24.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 2.6 3.7 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.8 0.0 0.0 1.6 0.3 0.0 0.0 5.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.4 0.2 0.3 0.1 1.7 0.0 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.5;testis: 31.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.4;SH-SY5Y: 64.8;THP-1: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favourable (2.66e-4)" "prognostic favourable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.9 0.5 2.1 4.1 1.4 0.0 1.9 0.5 2.8 16.5 6.0 2.0 1.3 2.2 3.0 2.7 3.6 9.8 27.5 0.3 2.2 0.9 1.1 0.8 8.0 0.0 0.7 2.4 1.9 9.8 0.0 0.9 20.4 4.1 2.0 5.8 20.0 3.1 3.2 0.3 5.9 8.6 1.0 0.5 0.3 8.1 31.3 0.2 0.3 0.6 7.7 7.7 3.1 16.2 0.3 0.4 0.0 0.1 0.0 0.7 0.0 1.4 0.0 0.5 0.0 0.0 4.1 0.0 13.5 12.2 2.9 4.8 0.0 5.5 0.0 0.0 20.4 0.2 9.1 2.7 3.8 0.0 2.1 0.0 1.1 0.0 0.4 0.0 0.0 1.2 5.2 1.0 3.0 0.0 0.0 0.0 2.3 0.0 0.1 2.7 0.6 0.8 0.0 11.5 0.0 0.0 2.0 1.5 64.8 0.0 0.0 0.8 0.0 29.0 0.0 5.8 0.8 3.6 2.6 0.3 0.0 0.0 0.3 0.9 3.3 0.0 0.1 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.1 1.4 0.5 2.8 2.2 0.9 0.7 2.4 4.1 0.2 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852727-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;MCF7: 12.4;RT4: 5.8;SK-BR-3: 13.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "cerebellum: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" Nucleoplasm "HPA049161: " "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.4 0.7 0.0 0.4 0.0 0.6 1.3 1.5 0.4 9.9 1.0 0.0 8.6 1.5 3.0 0.6 40.4 3.0 6.8 0.4 0.0 0.0 2.4 0.7 3.0 0.4 0.0 0.0 0.4 7.5 0.4 1.1 4.3 0.0 5.1 0.6 0.0 13.4 10.6 2.3 1.3 0.4 0.7 0.0 0.4 3.5 0.4 0.0 0.0 1.5 36.5 40.1 5.2 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 13.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell line enhanced" "Detected in many" "CACO-2: 29.6;CAPAN-2: 37.3;HEL: 21.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavourable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.4 16.2 12.1 4.9 2.0 10.1 0.0 7.9 6.0 5.7 7.8 29.6 37.3 0.0 1.2 9.3 4.2 13.7 0.0 8.9 0.0 0.5 21.7 3.0 0.0 6.0 0.0 0.0 2.9 0.1 3.1 0.0 8.9 7.0 4.2 2.7 0.2 3.3 0.0 8.3 0.3 3.7 0.0 0.0 5.1 0.2 8.7 0.4 7.6 0.0 0.0 0.4 1.7 4.8 2.5 6.4 9.2 4.7 0.4 0.0 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Cell line enhanced" "Detected in some" "HSkMC: 10.1;MOLT-4: 5.4;SCLC-21H: 9.4;SH-SY5Y: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: " "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.8 3.4 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.6 0.4 0.3 2.4 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.1 0.0 0.1 10.1 0.3 0.6 0.1 0.0 0.5 0.9 0.0 2.0 5.4 0.3 0.5 0.0 1.4 0.0 0.1 0.0 0.2 9.4 8.3 0.1 0.1 0.2 0.6 0.5 0.0 2.8 4.6 0.2 0.0 2.4 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;LHCN-M2: 22.4;U-87 MG: 24.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA002455: " "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favourable (7.55e-4)" "prognostic unfavourable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 5.0 2.6 11.9 0.0 4.3 26.6 0.6 2.7 4.2 2.4 5.1 1.5 2.0 3.0 1.7 10.9 0.4 3.4 4.7 4.7 0.0 3.1 0.2 2.1 0.2 7.8 0.0 0.1 7.0 3.0 13.5 2.4 3.2 0.3 2.4 22.4 1.7 0.0 0.5 2.3 7.0 2.3 10.4 1.3 6.2 6.5 5.1 5.7 1.1 0.5 1.8 0.0 1.2 13.1 7.6 5.3 17.9 2.3 0.2 0.3 6.9 24.0 1.2 2.6 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: " "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavourable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favourable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 16.3 15.3 21.0 13.4 34.9 19.2 15.7 15.5 24.7 16.5 26.2 66.1 9.5 26.6 14.2 15.4 19.0 12.6 17.1 9.9 28.6 18.2 19.7 16.9 16.9 10.8 42.1 20.7 13.5 15.0 21.8 9.2 22.7 31.8 13.6 25.6 15.0 16.8 13.4 13.0 24.7 27.9 14.6 61.9 14.6 16.3 16.8 39.7 15.4 19.7 8.7 15.9 17.2 13.5 9.0 24.4 38.1 34.0 11.7 10.5 17.1 14.2 21.9 20.5 8.1 28.7 20.5 18.7 21.0 24.1 21.5 27.2 27.2 35.7 9.3 13.9 19.9 38.0 17.2 15.9 23.6 21.2 10.7 10.6 14.9 13.2 26.5 10.7 20.8 21.0 28.9 17.8 22.0 17.2 11.8 19.0 20.1 28.3 8.1 13.9 8.9 16.3 10.3 17.4 11.8 30.0 30.3 11.4 15.2 22.9 21.5 18.7 26.6 23.9 18.2 21.9 18.1 17.9 9.9 12.4 18.2 9.4 18.4 13.0 13.3 29.2 27.1 27.1 7.2 30.8 7.0 7.2 7.0 5.9 24.4 9.0 6.6 6.4 38.1 11.7 34.0 12.8 10.5 17.1 21.0 34.9 15.5 24.7 28.6 18.2 42.1 20.7 31.8 39.7 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893272-67929678 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053927 Approved Approved Nucleoplasm Nucleoplasm "HPA053927: AB_2682312" "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favourable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.3 18.3 13.6 14.0 16.6 4.8 15.1 13.3 13.3 11.0 14.7 17.7 24.0 14.0 19.2 14.6 17.7 20.2 19.3 17.8 12.2 8.4 18.8 15.1 13.1 10.4 16.2 12.7 21.2 35.3 33.2 13.0 9.8 16.1 14.3 11.4 16.2 19.0 14.8 19.9 14.0 15.2 16.3 11.3 12.8 19.1 31.7 15.0 12.5 14.9 12.9 8.6 14.8 18.7 4.0 5.2 4.5 5.8 5.2 5.6 3.5 7.3 13.1 14.9 16.5 23.3 11.8 9.7 8.8 13.5 9.4 8.4 9.9 10.6 6.9 13.5 14.9 11.2 8.6 9.1 3.2 2.7 9.6 7.9 9.7 12.5 16.0 7.5 4.8 21.7 15.8 11.1 11.8 13.7 12.0 3.0 9.7 16.4 10.2 4.8 14.3 8.2 15.7 5.7 14.3 11.1 9.2 13.0 15.5 27.4 7.5 9.0 13.8 13.7 12.0 10.6 3.8 8.8 4.4 9.1 4.8 14.9 12.8 5.1 11.6 0.0 4.3 4.5 5.6 5.8 3.8 4.0 3.9 5.3 5.2 3.5 3.4 4.3 2.7 5.2 3.6 3.8 2.3 3.5 13.6 16.6 13.3 13.3 12.2 8.4 16.2 12.7 16.1 15.0 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell line enriched" "Detected in single" 18 "HEL: 13.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015095, HPA056839" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PSMC6 p42 ENSG00000100519 "Proteasome 26S subunit, ATPase 6" P62333 14 52707172-52728587 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042823 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 190000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042823: " "unprognostic (2.38e-2)" "unprognostic (2.72e-2)" "unprognostic (9.18e-2)" "unprognostic (1.29e-1)" "unprognostic (1.19e-2)" "unprognostic (4.26e-3)" "unprognostic (3.14e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (2.79e-2)" "unprognostic (3.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.52e-2)" "unprognostic (5.00e-2)" "unprognostic (2.68e-1)" "unprognostic (4.13e-2)" "unprognostic (4.67e-1)" 30.4 31.1 29.1 23.0 36.8 19.9 30.7 30.1 40.9 26.4 26.4 19.7 29.8 25.6 27.8 27.0 38.0 26.1 19.3 39.7 30.6 28.3 36.1 45.7 21.6 25.7 29.9 35.0 27.8 25.2 26.5 34.7 37.1 44.0 25.5 28.8 14.7 23.4 25.3 73.3 23.0 26.4 29.5 30.1 28.2 24.9 15.5 31.1 30.0 28.6 44.9 32.9 31.6 24.5 37.6 43.1 37.0 40.9 29.8 48.5 40.6 46.5 30.2 36.4 26.9 25.4 26.6 39.3 36.7 35.3 59.7 45.0 37.8 38.3 40.6 46.0 31.8 35.6 46.2 32.1 62.8 38.9 20.1 29.7 24.8 40.3 30.8 42.1 28.9 19.7 32.2 30.1 30.5 37.4 44.1 17.6 43.4 42.7 32.8 29.2 29.3 41.6 28.0 63.8 18.1 39.3 47.5 26.2 19.4 32.6 20.5 31.3 42.1 30.8 28.6 33.3 46.7 25.7 37.6 12.5 31.6 45.4 21.5 28.9 30.1 35.8 36.5 37.0 32.1 40.9 37.1 37.6 39.6 34.9 43.1 34.2 38.2 37.3 30.6 29.8 39.9 22.4 48.5 40.6 29.1 36.8 30.1 40.9 30.6 28.3 29.9 35.0 44.0 31.1 PSMD1 "P112, Rpn2, S1" ENSG00000173692 "Proteasome 26S subunit, non-ATPase 1" Q99460 2 231056864-231172827 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021092, HPA036736, HPA036737" Enhanced Approved "Nucleoplasm,Actin filaments" 49000 Nucleoplasm "Actin filaments" "CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279" "unprognostic (9.32e-3)" "unprognostic (2.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (2.71e-1)" "unprognostic (1.78e-2)" "prognostic unfavourable (8.63e-12)" "prognostic unfavourable (2.34e-4)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (3.09e-3)" "unprognostic (2.49e-1)" "unprognostic (8.91e-3)" "unprognostic (1.10e-2)" "unprognostic (6.26e-2)" "unprognostic (4.16e-2)" "unprognostic (1.70e-3)" 21.9 25.5 21.5 19.0 27.8 14.4 18.4 22.3 29.0 17.3 20.6 16.2 15.3 21.7 24.3 17.6 25.3 16.1 13.0 34.9 31.8 22.1 20.9 27.8 16.8 16.3 20.3 27.2 16.4 10.9 73.9 24.6 28.5 34.0 18.7 23.7 15.0 16.7 21.1 75.5 20.2 17.9 27.2 17.5 18.7 17.4 16.8 17.8 20.6 17.3 23.7 22.3 17.8 16.4 14.3 21.2 23.5 26.7 25.6 21.6 15.4 28.8 31.5 35.5 27.7 37.0 26.7 34.4 38.5 40.1 39.0 39.7 38.2 28.9 22.7 36.3 42.9 27.8 49.3 35.9 53.3 34.3 26.4 41.9 25.9 43.8 19.1 36.9 36.4 23.0 17.8 41.9 22.3 45.9 57.9 17.2 46.2 28.1 28.8 21.2 45.7 25.2 24.5 54.5 21.7 28.7 30.0 23.7 21.3 30.8 27.9 18.8 22.1 21.8 42.8 31.1 32.8 37.5 36.5 14.9 21.9 40.4 48.0 28.5 35.5 23.5 19.2 14.6 19.2 25.9 19.0 14.3 18.3 16.9 21.2 12.0 14.9 16.8 10.8 25.6 26.7 12.1 21.6 15.4 21.5 27.8 22.3 27.6 31.8 22.1 20.3 27.2 34.0 17.8 PSMD11 "MGC3844, p44.5, Rpn6, S9" ENSG00000108671 "Proteasome 26S subunit, non-ATPase 11" O00231 17 32444261-32483318 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042275, HPA067433" Approved Approved "Nucleoplasm,Golgi apparatus" 78000 "Nucleoplasm, Golgi apparatus" "HPA042275: AB_10794793, HPA067433: " "unprognostic (1.16e-1)" "unprognostic (2.71e-1)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.20e-2)" "prognostic unfavourable (6.33e-6)" "unprognostic (2.64e-2)" "unprognostic (3.97e-1)" "unprognostic (8.10e-2)" "unprognostic (5.88e-2)" "unprognostic (9.17e-3)" "prognostic unfavourable (5.73e-6)" "unprognostic (9.39e-3)" "unprognostic (6.65e-2)" "unprognostic (2.90e-1)" "unprognostic (2.17e-2)" 26.0 22.4 20.7 19.9 22.3 19.9 17.4 22.2 27.1 16.3 19.2 23.8 14.9 19.2 24.2 17.2 28.5 17.6 16.5 24.7 18.3 18.7 21.7 38.2 19.1 19.5 24.4 16.9 19.1 25.8 30.1 19.1 27.5 28.1 18.6 23.7 17.3 19.2 16.7 69.0 25.3 18.8 25.4 19.1 20.0 18.3 22.8 19.8 27.7 19.5 26.9 26.8 18.9 18.9 24.4 30.8 22.8 28.0 30.1 33.1 26.8 35.7 39.7 29.0 31.2 19.7 14.7 31.0 20.4 26.5 45.4 36.9 40.0 32.8 28.1 32.6 22.1 41.6 33.0 28.4 44.7 14.1 22.5 22.7 20.1 30.9 19.2 26.9 24.4 13.1 15.0 39.4 27.4 31.8 43.0 33.0 26.6 22.2 40.2 15.9 39.8 20.0 25.0 37.6 38.0 22.3 26.8 25.7 17.4 25.9 18.8 20.6 45.5 12.9 21.8 25.4 29.6 31.3 47.1 18.4 28.7 37.2 36.8 21.1 42.6 22.8 27.4 16.7 28.3 27.1 31.0 24.4 27.7 28.4 30.8 23.7 24.9 26.0 12.6 30.1 28.0 25.1 33.1 26.8 20.7 22.3 22.2 27.1 18.3 18.7 24.4 16.9 28.1 19.8 PSMD12 "p55, Rpn5" ENSG00000197170 "Proteasome 26S subunit, non-ATPase 12" O00232 17 67337916-67366627 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023119 Approved Approved Nucleoplasm,Microtubules,Cytosol 44000 Microtubules "Nucleoplasm, Cytosol" "HPA023119: AB_1855845" "unprognostic (6.06e-2)" "unprognostic (3.16e-2)" "prognostic favourable (4.39e-4)" "unprognostic (1.35e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-3)" "prognostic unfavourable (1.21e-4)" "unprognostic (1.28e-2)" "unprognostic (3.72e-2)" "prognostic favourable (6.32e-4)" "unprognostic (2.63e-1)" "unprognostic (7.32e-3)" "prognostic unfavourable (4.73e-6)" "unprognostic (1.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" 16.4 18.0 16.0 12.3 16.0 11.8 14.1 19.5 26.7 11.7 11.8 8.8 11.5 9.4 12.5 13.3 16.4 9.9 11.4 14.9 17.0 19.7 17.1 31.4 10.8 11.3 23.6 15.3 12.6 17.6 15.7 12.9 13.7 32.5 12.8 13.8 8.1 12.5 11.0 42.3 11.6 10.8 15.7 13.4 12.0 12.4 15.5 11.3 12.7 12.2 18.9 16.7 17.2 19.6 8.8 10.8 12.1 18.1 11.4 14.0 8.9 28.1 17.2 13.6 14.9 10.5 12.7 18.7 20.1 12.9 22.4 19.9 17.8 12.5 16.2 13.0 16.3 16.7 23.6 20.6 33.6 7.8 17.6 18.9 14.3 18.3 13.6 19.6 11.7 14.1 13.7 21.2 16.7 22.0 25.1 9.7 20.9 19.3 17.9 18.9 16.4 22.8 9.2 35.1 14.6 16.7 23.5 13.1 18.9 14.8 29.1 19.4 20.8 16.7 22.5 23.8 16.0 17.8 36.2 9.9 15.2 13.7 28.1 20.8 13.7 12.1 10.6 8.8 9.9 17.4 14.0 8.6 13.0 11.1 10.8 8.8 11.7 12.3 7.6 11.4 18.1 7.0 12.1 8.9 16.0 16.0 19.5 26.7 17.0 19.7 23.6 15.3 32.5 11.3 PSMD5 "KIAA0072, S5B" ENSG00000095261 "Proteasome 26S subunit, non-ATPase 5" Q16401 9 120815496-120842984 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003216 Uncertain Approved Nucleoplasm,Cytosol 12000000 Cytosol Nucleoplasm "HPA003216: AB_1079709" "unprognostic (7.72e-2)" "unprognostic (5.20e-2)" "unprognostic (2.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.44e-3)" "unprognostic (8.02e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-1)" "unprognostic (3.45e-2)" "unprognostic (2.04e-3)" "unprognostic (4.39e-1)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.87e-1)" 14.1 20.1 10.2 12.2 16.2 14.7 32.5 20.7 21.8 14.6 12.9 10.2 12.3 10.3 14.8 14.1 17.3 13.8 10.6 12.7 11.7 12.3 11.5 21.0 34.8 23.6 9.8 14.1 16.7 32.2 13.3 11.7 10.5 14.5 16.1 12.5 8.8 15.1 15.7 10.0 16.7 11.2 24.5 9.9 12.3 14.4 11.3 8.1 13.0 12.6 9.2 15.5 14.9 13.5 17.5 14.4 15.2 17.9 14.2 25.2 14.2 13.2 17.3 8.4 15.6 18.8 18.7 9.9 19.7 15.5 18.7 17.1 15.3 8.8 13.6 9.0 20.0 19.9 0.0 19.4 21.8 12.4 1.9 11.3 24.0 8.5 14.2 3.9 4.3 15.6 12.6 18.1 19.4 10.8 41.4 9.1 17.4 16.5 12.1 8.2 12.4 12.4 11.1 18.3 10.7 17.2 11.7 11.5 7.4 23.8 20.3 9.4 24.3 9.7 16.7 0.0 10.1 7.8 17.4 5.5 5.5 14.9 11.6 13.1 16.4 15.2 14.9 12.3 17.1 16.5 18.6 17.5 19.9 20.5 14.4 13.2 19.4 15.1 8.1 14.2 17.9 10.5 25.2 14.2 10.2 16.2 20.7 21.8 11.7 12.3 9.8 14.1 14.5 8.1 PSME2 PA28beta ENSG00000100911 "Proteasome activator subunit 2" Q9UL46 14 24143362-24147570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA062661 Approved Nucleoplasm 8000000 Nucleoplasm "HPA062661: " "prognostic favourable (1.27e-4)" "unprognostic (7.55e-3)" "unprognostic (2.84e-1)" "unprognostic (8.72e-2)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (2.30e-2)" "unprognostic (2.90e-3)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavourable (3.47e-5)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (6.43e-3)" "unprognostic (3.07e-3)" 15.4 43.4 14.9 33.9 17.1 16.4 17.1 14.2 14.3 17.5 42.7 9.9 33.5 63.3 17.6 30.2 24.4 17.6 31.3 15.8 13.1 14.7 36.3 64.6 27.5 38.7 13.9 11.0 20.7 26.4 14.6 30.1 25.9 15.3 22.2 35.5 14.3 28.2 36.8 13.6 15.1 102.2 18.6 12.3 61.5 21.4 12.5 13.8 32.7 27.5 27.9 35.9 20.0 18.5 38.8 48.9 20.0 112.2 49.9 45.1 120.2 18.5 19.4 12.5 28.3 9.4 13.6 18.5 11.1 25.7 35.0 43.9 15.0 43.4 25.3 6.5 12.3 16.8 7.5 19.4 21.1 40.2 6.4 14.8 10.8 59.8 30.2 20.8 22.4 13.5 6.0 24.2 9.9 17.2 7.3 32.0 13.4 41.3 40.6 30.8 4.3 26.3 38.4 19.1 27.7 23.7 43.6 7.6 10.1 20.1 34.3 14.3 17.6 24.9 13.1 17.4 16.0 8.0 20.1 29.8 38.9 28.2 12.8 22.8 21.7 8.3 60.5 20.0 43.6 112.2 45.1 38.8 43.6 42.8 48.9 29.4 32.8 39.9 19.4 49.9 71.7 35.8 41.7 120.2 14.9 17.1 14.2 14.3 13.1 14.7 13.9 11.0 15.3 13.8 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA057193: , HPA070225: " "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavourable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 26.8 8.8 6.4 8.8 3.2 3.6 17.1 14.9 6.5 11.6 7.5 16.1 7.1 29.1 7.9 4.2 7.7 10.1 7.9 7.6 12.4 15.9 54.9 13.7 20.9 5.8 26.1 11.0 5.0 5.9 12.3 12.5 6.1 40.4 16.7 6.9 14.2 16.1 14.1 22.2 13.7 26.2 8.0 29.6 4.8 8.0 20.5 6.0 18.7 10.5 14.7 10.0 13.1 6.9 13.4 4.6 18.0 20.9 12.8 20.3 25.2 11.4 44.2 10.3 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 PSMG2 "CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1" ENSG00000128789 "Proteasome assembly chaperone 2" Q969U7 18 12658043-12725740 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041517, HPA046741" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA041517: AB_2677530, HPA046741: " "unprognostic (2.28e-2)" "unprognostic (9.44e-3)" "unprognostic (9.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.40e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "prognostic favourable (3.09e-4)" "unprognostic (5.91e-2)" "unprognostic (2.27e-1)" "unprognostic (1.73e-1)" "unprognostic (9.04e-2)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (6.75e-3)" 37.3 31.0 24.1 25.2 25.2 42.0 37.4 26.2 27.4 30.5 30.3 24.7 20.6 25.6 34.8 39.6 43.4 27.8 39.2 28.5 23.5 23.4 38.7 46.8 30.9 41.8 24.0 18.9 35.7 44.8 9.9 26.4 35.4 23.0 32.5 35.2 24.8 31.9 28.5 29.0 32.2 34.6 38.1 27.0 35.1 31.0 71.6 20.6 49.0 40.3 37.1 41.3 38.1 29.9 28.8 31.2 33.0 40.9 27.6 41.5 33.2 21.0 13.6 15.8 20.5 29.6 43.3 21.1 20.2 33.2 38.1 43.1 23.0 23.7 24.4 16.6 24.5 13.5 25.6 27.8 33.3 12.6 12.2 13.4 12.2 27.9 28.3 45.2 20.8 34.6 22.0 22.4 30.8 26.6 19.9 31.3 29.5 21.0 28.6 62.6 12.4 16.0 19.5 23.8 35.0 34.3 29.7 19.3 14.8 19.9 23.5 19.1 20.5 37.9 17.0 42.4 54.4 35.6 23.6 26.1 36.2 28.7 24.9 23.5 17.0 29.0 35.8 33.0 27.5 36.3 32.7 28.8 36.1 31.6 31.2 26.1 33.1 31.0 12.0 27.6 40.9 25.8 41.5 33.2 24.1 25.2 26.2 27.4 23.5 23.4 24.0 18.9 23.0 20.6 PSMG4 "C6orf86, PAC4" ENSG00000180822 "Proteasome assembly chaperone 4" Q5JS54 6 3231403-3303373 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067652 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA067652: " "unprognostic (3.13e-3)" "unprognostic (6.00e-2)" "unprognostic (3.60e-1)" "unprognostic (4.11e-2)" "unprognostic (4.11e-1)" "unprognostic (2.20e-1)" "unprognostic (6.52e-3)" "unprognostic (1.57e-2)" "unprognostic (6.96e-2)" "unprognostic (6.74e-3)" "unprognostic (7.40e-3)" "unprognostic (3.02e-2)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.59e-1)" "unprognostic (8.18e-2)" "unprognostic (2.54e-1)" "unprognostic (3.48e-2)" 13.9 12.7 12.6 13.0 26.1 14.3 16.0 18.5 14.4 15.8 15.1 11.8 11.3 17.3 16.7 23.1 16.9 13.4 18.7 12.9 11.4 14.0 13.1 18.1 11.0 15.2 10.7 12.2 13.8 30.9 8.9 16.2 9.6 10.7 15.5 8.9 13.6 21.0 18.8 36.6 17.9 16.8 18.1 10.6 11.9 17.4 13.3 9.8 13.5 17.2 16.5 14.6 13.1 11.3 25.6 18.5 12.2 20.1 16.2 24.4 13.2 21.1 10.4 6.3 15.5 5.7 8.4 10.8 9.6 7.2 9.2 15.1 8.8 7.3 7.1 26.3 5.7 10.0 5.2 6.4 6.0 12.0 22.4 5.7 10.7 22.6 6.8 16.5 6.1 7.1 7.2 6.7 10.0 11.5 22.1 5.5 4.9 20.2 9.4 30.5 7.6 20.5 12.5 3.4 39.4 7.3 8.4 27.0 7.8 4.3 6.1 20.5 7.8 7.4 10.9 7.9 7.4 8.7 9.2 17.9 25.3 13.1 5.5 11.9 10.6 6.2 20.1 12.2 14.8 18.4 17.0 25.3 24.4 17.8 15.5 25.6 24.4 20.9 4.8 16.2 18.1 18.5 20.5 13.2 12.6 26.1 18.5 14.4 11.4 14.0 10.7 12.2 10.7 9.8 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" "HPA049315, HPA056561" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA049315: , HPA056561: " "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavourable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.4 9.5 39.1 18.9 1.5 3.1 10.7 14.7 11.9 20.1 19.3 14.7 7.7 9.4 5.4 7.2 13.3 21.1 12.0 16.9 3.6 10.1 5.9 12.8 12.0 1.8 6.2 6.7 3.5 1.1 7.9 5.6 9.8 13.3 4.3 16.0 16.8 9.5 4.2 16.2 10.9 14.7 37.7 3.1 6.7 4.8 16.5 9.5 8.3 12.7 15.0 7.6 6.0 5.0 12.4 20.6 8.7 24.1 3.4 2.2 3.2 10.0 15.0 34.5 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell line enhanced" "Detected in many" "HEL: 37.1;HMC-1: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.8 5.5 2.7 2.0 1.7 4.2 1.5 0.0 0.3 1.8 13.5 7.6 10.4 2.5 0.0 1.2 37.1 1.8 0.0 2.2 2.1 41.2 1.9 13.0 1.9 6.2 3.9 8.8 0.0 8.6 1.3 0.3 0.0 0.8 0.0 0.0 2.8 1.8 4.2 13.6 0.1 0.8 0.9 3.8 0.1 12.2 4.3 2.8 0.2 3.1 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 PTBP2 "brPTB, nPTB, PTB, PTBLP" ENSG00000117569 "Polypyrimidine tract binding protein 2" Q9UKA9 1 96721665-96823738 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047420 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047420: AB_10962353" "unprognostic (2.14e-2)" "unprognostic (3.01e-2)" "unprognostic (1.27e-1)" "prognostic unfavourable (7.80e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-2)" "unprognostic (2.41e-5)" "unprognostic (2.26e-3)" "unprognostic (1.50e-2)" "unprognostic (6.83e-3)" "unprognostic (1.70e-2)" "unprognostic (3.31e-2)" "unprognostic (5.48e-3)" "unprognostic (3.01e-2)" "unprognostic (1.75e-1)" "unprognostic (5.24e-2)" "unprognostic (1.27e-2)" 12.5 10.5 17.1 9.9 21.2 34.4 15.3 22.0 25.8 16.7 26.6 20.0 11.3 7.6 23.6 11.2 12.8 11.9 10.7 7.8 18.8 18.4 12.0 8.1 7.3 9.8 17.9 18.9 14.6 7.3 6.1 22.0 8.1 21.7 16.3 13.0 9.0 7.4 17.3 15.4 8.3 11.0 28.1 18.6 10.3 11.6 35.4 19.9 16.6 14.7 6.8 8.4 21.1 12.8 3.6 1.6 1.4 1.8 4.1 4.2 0.7 3.5 1.9 16.4 8.7 3.9 4.8 9.2 3.1 3.4 5.4 5.0 2.4 3.4 12.0 3.6 2.1 2.3 9.8 2.5 7.9 2.0 3.0 6.6 5.5 3.1 2.2 3.4 3.4 2.7 1.6 6.8 2.9 2.7 4.8 3.3 7.1 1.2 10.8 10.9 10.0 4.3 6.4 39.0 1.7 5.5 2.0 9.5 9.8 4.0 2.6 4.7 2.6 6.9 2.5 3.8 7.4 3.1 4.0 2.6 1.9 14.0 1.8 5.5 1.6 0.9 1.4 0.9 2.7 1.7 2.0 3.5 3.5 2.5 0.8 3.6 4.2 2.9 1.4 4.1 1.8 1.6 3.2 0.7 17.1 21.2 22.0 24.7 18.8 18.4 17.9 18.9 21.7 19.9 PTBP3 "DKFZp781I1117, ROD1" ENSG00000119314 "Polypyrimidine tract binding protein 3" O95758 9 112217716-112333667 "Predicted intracellular proteins" "Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048374 Approved Nucleoplasm Nucleoplasm "HPA048374: " "unprognostic (6.12e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.44e-1)" "unprognostic (2.12e-1)" "unprognostic (4.38e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.39e-2)" "unprognostic (6.23e-2)" "prognostic unfavourable (1.22e-4)" "unprognostic (1.17e-1)" "prognostic favourable (2.51e-4)" "unprognostic (1.72e-2)" "unprognostic (4.99e-2)" "unprognostic (3.04e-2)" "unprognostic (5.10e-2)" 22.4 9.4 7.2 24.5 9.2 22.9 26.3 9.5 6.8 17.2 21.7 5.6 18.9 17.7 14.3 18.9 38.4 10.0 17.2 11.6 6.1 8.7 26.8 12.7 25.1 37.2 6.2 4.5 13.0 17.9 9.0 17.8 25.8 6.6 13.8 22.1 9.0 20.2 22.6 8.0 25.0 32.4 12.8 11.4 23.9 20.9 22.6 6.6 41.7 12.6 30.7 38.4 22.1 21.5 7.0 11.8 23.9 9.5 4.3 8.7 4.5 19.9 21.2 8.1 7.0 7.2 7.9 41.4 8.2 6.6 10.1 10.5 24.1 30.1 23.0 9.2 10.5 28.5 11.2 23.3 13.5 25.6 3.9 23.2 8.7 16.9 9.1 30.5 28.3 8.8 15.8 13.5 18.7 17.1 31.1 21.5 11.5 18.6 30.1 8.3 12.8 7.2 19.5 27.7 11.6 14.9 26.5 10.1 6.5 16.3 21.4 7.9 25.2 13.8 13.2 8.9 12.2 12.8 10.1 11.1 27.3 20.8 7.7 15.5 8.7 14.2 6.3 11.8 8.4 7.7 8.7 5.5 6.3 6.8 7.2 7.0 5.0 6.0 23.9 4.3 9.5 11.8 6.5 4.5 7.2 9.2 9.5 6.8 6.1 8.7 6.2 4.5 6.6 6.6 PTDSS1 "KIAA0024, PSS1, PSSA" ENSG00000156471 "Phosphatidylserine synthase 1" P48651 8 96261715-96336995 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016852 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA016852: AB_1855878" "unprognostic (1.44e-1)" "unprognostic (1.71e-1)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (7.48e-2)" "unprognostic (5.68e-3)" "prognostic unfavourable (1.08e-5)" "prognostic unfavourable (9.83e-4)" "unprognostic (2.79e-1)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.19e-1)" "unprognostic (2.29e-3)" "unprognostic (4.78e-2)" "unprognostic (1.79e-1)" "unprognostic (4.08e-2)" "unprognostic (3.55e-2)" 8.2 7.9 8.0 8.1 14.7 10.2 10.4 10.2 15.0 9.7 8.3 5.1 22.5 10.6 8.4 7.8 9.6 7.0 7.9 20.1 8.6 9.9 9.5 12.8 7.8 21.8 7.1 8.0 9.6 12.1 23.2 4.9 10.8 9.6 5.7 7.4 5.2 8.8 29.8 10.1 10.4 8.3 9.0 6.0 11.8 8.1 5.1 3.6 20.7 11.0 7.7 11.8 9.3 6.8 3.6 6.1 9.4 3.7 5.0 4.6 7.8 10.4 8.1 1.4 3.9 2.9 6.1 2.4 7.6 10.5 7.3 5.1 3.0 3.0 17.2 7.0 7.1 4.3 9.9 7.6 11.4 8.8 7.1 16.9 15.6 1.6 3.0 12.4 5.9 5.1 7.3 10.2 7.2 4.7 8.4 8.9 6.6 3.0 9.6 1.9 2.2 7.6 7.7 7.3 13.0 4.1 8.9 6.1 2.5 2.8 2.5 1.1 5.9 4.2 8.3 6.6 4.1 4.5 8.7 1.8 9.2 8.4 4.1 13.1 5.3 9.4 3.7 2.1 2.8 2.5 4.0 2.6 4.6 3.4 6.1 3.6 4.0 2.9 1.3 5.0 2.4 1.8 2.6 7.8 8.0 14.7 10.2 15.0 8.6 9.9 7.1 8.0 9.6 3.6 PTER ENSG00000165983 "Phosphotriesterase related" Q96BW5 10 16436943-16513745 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038044, HPA038045" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038044: , HPA038045: AB_10672616" "unprognostic (5.57e-2)" "unprognostic (1.04e-1)" "unprognostic (2.76e-2)" "unprognostic (3.14e-2)" "unprognostic (9.72e-3)" "unprognostic (2.45e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.17e-1)" "unprognostic (4.51e-2)" "unprognostic (2.86e-1)" "unprognostic (2.05e-3)" "unprognostic (1.86e-1)" "prognostic favourable (6.52e-6)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (1.54e-2)" "unprognostic (5.36e-3)" 11.1 5.4 21.6 10.6 2.9 1.3 8.7 8.9 30.8 6.2 12.1 1.6 14.5 9.2 5.8 8.1 6.9 3.4 3.8 7.8 22.7 8.9 31.3 21.9 9.2 12.6 4.2 1.3 5.3 17.9 11.1 3.4 11.2 3.1 11.3 5.4 6.8 10.6 12.9 6.2 4.0 21.9 5.7 2.6 11.8 9.2 2.9 1.5 17.2 12.0 3.9 9.6 7.7 10.9 15.3 11.7 6.9 16.7 7.6 19.5 9.4 16.1 9.7 0.1 2.9 4.1 8.1 9.7 4.8 0.5 1.8 2.7 8.9 15.3 17.0 4.0 3.2 7.4 5.5 3.2 2.7 16.6 7.2 15.8 4.6 3.6 4.9 5.1 4.8 5.9 10.4 5.5 0.9 0.8 10.8 6.0 2.8 5.4 11.9 5.1 3.9 2.4 8.9 1.3 8.9 25.5 5.1 12.3 0.8 8.5 2.4 14.0 5.7 16.2 2.1 0.1 4.3 3.9 0.1 4.5 5.6 18.0 2.0 9.4 6.0 3.5 11.7 6.9 12.7 16.7 13.5 15.3 14.6 12.6 11.7 8.8 11.0 10.9 2.2 7.6 14.5 9.9 19.5 9.4 21.6 2.9 8.9 30.8 22.7 8.9 4.2 1.3 3.1 1.5 PTF1A "bHLHa29, PTF1-p48" ENSG00000168267 "Pancreas specific transcription factor, 1a" Q7RTS3 10 23192327-23194252 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "pancreas: 129.8" "Cell line enriched" "Detected in single" 11 "U-2 OS: 7.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB022612 Approved Nucleoplasm Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PTGES3 "cPGES, p23, TEBP" ENSG00000110958 "Prostaglandin E synthase 3" Q15185 12 56663341-56688408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 358.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034319, HPA038672, HPA038673" Enhanced Approved Nucleoplasm,Cytosol 580000 Cytosol Nucleoplasm "CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786" "prognostic unfavourable (2.15e-5)" "unprognostic (2.60e-1)" "unprognostic (8.67e-3)" "unprognostic (7.07e-2)" "unprognostic (2.24e-1)" "unprognostic (2.96e-3)" "prognostic unfavourable (4.44e-6)" "unprognostic (4.33e-3)" "unprognostic (3.64e-2)" "prognostic favourable (4.36e-4)" "unprognostic (2.73e-2)" "unprognostic (2.31e-2)" "unprognostic (3.05e-3)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (2.07e-1)" 44.7 41.4 56.0 41.2 55.7 39.6 175.0 44.2 51.7 49.0 51.9 38.1 49.5 46.4 57.7 52.0 52.6 69.8 36.0 46.0 54.6 57.2 52.1 67.1 46.4 62.0 67.0 41.4 82.3 55.1 43.2 49.2 50.3 57.0 60.7 55.3 24.0 36.6 49.4 64.2 37.0 46.7 64.7 72.5 42.7 36.6 39.7 65.1 53.5 72.5 36.7 55.1 72.7 358.9 40.6 36.9 27.3 74.8 29.2 42.5 60.5 79.9 69.8 56.6 33.7 41.7 37.9 86.3 52.4 40.1 67.5 50.5 59.1 84.4 88.7 79.7 44.7 51.6 106.1 68.5 85.6 65.1 70.6 69.2 44.1 68.2 30.6 82.2 50.3 27.4 50.1 51.0 61.9 69.4 111.0 85.0 65.9 49.9 81.6 78.1 96.7 81.5 71.4 53.4 119.0 59.4 62.6 73.4 42.9 53.5 77.2 45.4 88.9 69.1 41.6 40.6 47.2 48.7 72.4 35.8 98.6 71.3 44.2 67.9 73.0 27.3 37.5 23.2 32.0 59.0 42.0 40.6 42.5 38.1 36.9 28.5 42.3 36.4 14.8 29.2 74.8 31.3 42.5 60.5 56.0 55.7 44.2 51.7 54.6 57.2 67.0 41.4 57.0 65.1 PTMS ParaT ENSG00000159335 Parathymosin P20962 12 6765516-6770952 "Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 4.2;granulocytes: 12.9" HPA038186 Approved Approved Nucleoplasm,Nucleoli 31000 Nucleoli Nucleoplasm "HPA038186: AB_10673042" "unprognostic (3.11e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (1.09e-1)" "unprognostic (2.83e-1)" "unprognostic (1.13e-1)" "unprognostic (2.47e-1)" "unprognostic (4.16e-1)" "unprognostic (1.01e-1)" "unprognostic (8.69e-3)" "unprognostic (2.52e-1)" "prognostic unfavourable (6.18e-5)" "unprognostic (1.02e-1)" "unprognostic (3.21e-1)" "unprognostic (2.35e-3)" "unprognostic (1.55e-2)" 47.0 24.7 45.4 23.5 54.9 7.5 79.3 54.0 40.3 46.0 58.1 7.9 32.4 17.8 71.3 24.9 43.7 36.5 30.8 21.8 31.7 20.0 43.4 155.3 50.7 19.4 11.1 28.6 72.9 18.3 45.8 21.0 26.3 17.9 58.7 19.1 26.6 22.7 58.1 22.6 29.9 24.4 62.5 17.7 20.8 28.3 16.1 15.3 9.5 28.3 29.8 13.0 44.4 81.6 0.1 4.2 12.9 0.3 0.2 1.3 0.3 6.0 26.9 46.2 43.3 25.0 21.0 16.7 26.5 29.7 24.2 20.8 17.0 24.9 2.3 19.9 48.1 12.7 26.8 24.6 9.6 83.3 36.4 2.9 15.8 5.8 28.3 0.7 7.1 19.9 10.0 17.4 35.8 27.0 21.1 6.1 22.0 15.3 1.1 4.9 44.0 29.1 0.5 12.1 5.0 19.0 1.2 14.2 46.0 29.0 10.9 22.7 9.9 3.0 36.6 33.3 46.3 4.6 24.1 5.3 2.5 3.1 25.9 2.0 24.2 12.9 0.3 3.3 1.3 0.1 0.6 0.1 0.1 1.2 0.3 0.0 0.0 0.2 1.0 0.2 0.0 4.2 0.5 0.3 45.4 54.9 54.0 40.3 31.7 20.0 11.1 28.6 17.9 15.3 PTPN21 "PTPD1, PTPRL10" ENSG00000070778 "Protein tyrosine phosphatase, non-receptor type 21" Q16825 14 88465778-88554733 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB011468, HPA073999" Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus, Centriolar satellite" "CAB011468: AB_442979, HPA073999: " "unprognostic (2.18e-1)" "unprognostic (4.21e-2)" "unprognostic (7.60e-2)" "unprognostic (3.09e-2)" "unprognostic (4.60e-2)" "unprognostic (5.71e-2)" "unprognostic (6.55e-2)" "unprognostic (5.19e-3)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-3)" "unprognostic (3.04e-3)" "prognostic favourable (3.16e-9)" "unprognostic (6.52e-2)" "unprognostic (2.69e-1)" "unprognostic (2.56e-1)" "unprognostic (7.67e-2)" 10.5 4.7 5.3 8.6 7.3 0.0 13.2 4.4 5.8 10.7 8.7 10.7 7.4 4.9 10.6 10.7 8.9 8.3 12.7 17.4 7.4 4.2 8.1 6.0 15.3 1.6 6.6 4.2 15.8 7.8 10.6 3.9 15.6 6.4 11.9 6.5 12.6 6.5 10.5 8.8 24.2 10.5 15.7 7.3 3.7 7.4 15.2 6.5 0.8 16.0 8.4 3.1 12.0 26.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 3.5 2.9 7.6 2.9 8.1 7.0 7.8 9.6 7.4 5.7 7.9 5.1 6.5 0.0 2.3 12.2 3.4 1.1 3.4 8.4 0.2 1.7 0.0 3.1 2.1 9.0 0.0 0.1 4.7 6.7 4.8 5.7 4.6 1.1 0.1 14.6 2.9 0.0 0.1 2.2 5.6 0.0 22.7 0.0 4.9 2.6 0.5 8.8 5.5 13.8 3.2 6.8 1.4 9.0 10.6 8.4 4.3 6.5 0.3 1.1 0.0 3.9 0.1 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.3 4.4 5.8 7.4 4.2 6.6 4.2 6.4 6.5 PTPN4 PTPMEG ENSG00000088179 "Protein tyrosine phosphatase, non-receptor type 4" P29074 2 119759631-119983818 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "NK-cells: 12.2;T-cells: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019351 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA019351: AB_1855928" "unprognostic (1.45e-1)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-2)" "unprognostic (9.00e-2)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "prognostic favourable (5.16e-4)" "unprognostic (3.31e-2)" "unprognostic (3.34e-3)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (3.34e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.81e-1)" 6.8 6.9 10.0 5.9 12.2 7.3 7.2 37.4 16.9 9.6 5.5 7.2 5.2 8.1 7.2 6.6 6.9 8.9 6.3 8.9 10.2 8.4 12.0 6.6 8.0 7.9 7.3 13.1 8.9 6.3 11.6 16.3 4.1 8.3 6.2 4.0 7.1 7.9 6.6 11.2 5.8 5.5 4.7 7.3 9.2 8.9 7.7 6.5 18.9 22.5 6.8 6.5 5.3 5.8 0.5 0.3 0.9 0.4 12.2 19.3 4.7 7.3 4.3 5.7 7.6 5.1 5.3 9.7 3.3 9.4 1.9 5.2 6.4 11.4 5.3 8.0 3.7 6.5 4.4 5.2 5.1 12.3 3.7 3.6 4.1 6.1 3.4 3.7 2.7 4.8 9.8 8.8 4.0 8.3 6.2 5.4 5.0 5.6 5.1 4.3 7.5 7.1 3.5 9.8 7.4 6.9 10.0 7.4 9.2 4.6 5.9 3.8 2.8 2.4 10.4 0.2 6.5 2.2 4.0 9.3 13.0 6.7 4.9 0.2 3.1 0.2 0.2 0.9 19.3 0.3 15.6 0.5 9.6 15.1 0.3 0.5 3.2 11.0 0.7 12.2 0.4 0.3 5.6 4.7 10.0 12.2 37.4 16.9 10.2 8.4 7.3 13.1 8.3 6.5 PTPRA "HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA" ENSG00000132670 "Protein tyrosine phosphatase, receptor type A" P18433 20 2864184-3039076 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029412, CAB034366, HPA069480" Approved Approved Nucleoplasm,Vesicles 21000 Vesicles Nucleoplasm "CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: " "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" "unprognostic (4.58e-2)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.62e-1)" "unprognostic (5.43e-3)" "unprognostic (5.34e-2)" "unprognostic (1.55e-1)" "unprognostic (3.24e-1)" "unprognostic (7.33e-2)" "unprognostic (1.16e-1)" "prognostic favourable (3.29e-6)" "unprognostic (1.25e-1)" "unprognostic (4.02e-1)" "unprognostic (1.60e-2)" "unprognostic (4.19e-1)" 21.9 18.5 55.6 14.3 48.6 16.4 23.3 44.5 56.0 29.7 19.7 37.5 9.4 14.7 26.3 18.7 22.7 26.5 21.3 14.0 45.9 41.1 22.1 13.5 21.6 16.9 38.0 46.7 28.6 14.9 41.5 23.4 29.0 52.5 23.5 20.0 18.5 16.7 21.8 8.2 21.0 15.3 25.7 52.6 17.9 16.3 27.4 30.4 20.6 32.4 8.5 20.4 22.9 19.2 7.7 5.7 7.9 6.7 6.2 11.0 3.7 20.5 12.6 36.3 11.1 40.2 73.4 7.7 15.5 30.3 19.2 23.5 15.0 28.6 13.5 12.2 20.7 22.1 14.6 22.1 21.7 20.8 9.4 19.2 5.3 19.0 14.4 19.2 9.1 32.8 22.9 15.8 16.7 26.5 19.2 17.3 19.0 8.4 22.2 21.8 14.0 10.1 17.0 17.6 16.8 16.4 16.0 20.1 19.3 15.0 25.5 23.0 15.9 16.5 18.9 17.1 8.5 19.1 13.6 12.7 17.6 17.8 7.9 18.2 16.0 7.9 4.8 7.5 11.0 4.8 9.0 7.7 7.4 7.9 3.7 5.1 7.4 9.0 6.0 6.2 6.7 5.7 8.1 3.7 55.6 48.6 44.5 56.0 45.9 41.1 38.0 46.7 52.5 30.4 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell line enhanced" "Detected in some" "AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" 2500000 Vesicles Nucleoplasm "HPA054829: " "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favourable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.0 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 2.6 4.7 0.6 0.0 0.0 0.0 0.2 7.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 2.7 0.0 5.6 1.4 2.8 8.5 0.0 2.1 0.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 PTRHD1 "C2orf79, LOC391356" ENSG00000184924 "Peptidyl-tRNA hydrolase domain containing 1" Q6GMV3 2 24789734-24793382 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019951 Approved Approved Nucleoplasm 55000 Nucleoplasm "HPA019951: AB_1853109" "unprognostic (1.28e-2)" "unprognostic (5.79e-2)" "unprognostic (6.34e-2)" "unprognostic (1.34e-2)" "unprognostic (2.61e-2)" "unprognostic (3.99e-1)" "unprognostic (8.84e-3)" "unprognostic (1.26e-1)" "unprognostic (3.69e-1)" "unprognostic (8.31e-3)" "unprognostic (1.58e-1)" "unprognostic (2.12e-1)" "prognostic unfavourable (2.31e-4)" "unprognostic (2.93e-1)" "unprognostic (1.55e-1)" "unprognostic (1.51e-1)" "unprognostic (5.76e-2)" 8.2 20.0 19.4 10.8 16.2 20.4 13.3 4.6 13.0 6.7 13.6 8.5 7.8 16.1 5.6 11.9 12.7 8.2 10.2 15.8 15.6 14.4 11.3 16.0 9.2 17.6 16.9 8.8 8.5 28.1 2.7 8.4 12.2 10.4 11.0 9.4 7.6 25.9 7.5 30.1 10.3 15.0 5.6 15.5 10.4 11.7 25.2 6.9 17.5 15.6 19.9 12.9 8.3 8.4 29.1 44.1 8.2 27.9 14.5 23.7 26.1 8.0 19.4 6.3 2.7 3.6 8.0 10.9 5.9 5.7 7.8 5.0 19.1 7.7 6.8 2.5 6.3 5.4 5.2 5.5 2.6 9.2 35.0 12.3 9.4 20.8 7.4 10.0 11.5 7.6 4.5 3.6 4.0 7.2 12.2 5.4 5.7 17.7 8.2 18.7 13.2 11.7 6.7 19.2 11.2 9.0 15.2 9.8 15.2 6.5 8.8 7.6 8.5 7.6 11.8 6.6 10.3 3.1 5.0 4.3 13.1 7.3 6.2 6.3 4.5 8.2 27.9 5.9 16.6 19.0 8.5 29.1 16.4 14.5 42.9 22.1 15.3 17.8 3.2 14.5 13.7 44.1 23.7 26.1 19.4 16.2 4.6 13.0 15.6 14.4 16.9 8.8 10.4 6.9 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Cell line enhanced" "Detected in some" "AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: " "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 1.1 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 4.3 0.4 0.5 0.2 0.0 0.9 0.0 6.9 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.3 0.0 0.0 0.0 0.0 0.0 2.7 3.0 3.7 0.0 0.4 0.3 0.0 0.2 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridylate synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: " "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 7.0 8.7 7.4 5.0 7.3 3.9 7.3 6.8 7.9 4.8 10.0 5.1 3.0 9.2 7.7 9.1 5.0 5.4 6.4 4.6 6.5 6.9 8.5 17.6 6.3 6.5 8.5 4.6 6.8 7.2 6.3 10.3 4.2 5.9 6.6 6.0 6.7 6.2 3.9 6.7 4.3 19.8 3.6 7.1 5.9 4.2 7.8 8.0 9.1 10.4 4.1 8.3 4.4 4.4 5.2 4.9 9.8 6.9 4.8 4.3 1.8 2.7 1.6 4.4 7.6 3.9 4.3 5.2 5.6 5.2 5.5 5.2 4.2 3.9 8.7 5.8 3.1 3.0 5.1 4.5 6.7 8.8 2.5 7.9 2.1 13.3 7.1 8.7 5.0 5.2 5.4 3.9 9.4 6.9 8.0 6.1 3.8 2.5 6.9 7.0 4.0 3.0 6.7 5.9 4.4 3.2 5.2 2.6 3.6 4.5 8.0 9.0 3.1 5.5 5.3 5.4 4.2 3.5 4.0 7.3 3.2 18.4 4.6 5.1 6.0 9.8 1.9 2.0 3.9 2.2 4.3 5.2 2.5 2.6 1.6 3.2 3.0 3.4 4.1 4.8 6.9 4.9 1.5 1.8 7.4 7.3 6.8 7.9 6.5 6.9 8.5 4.6 5.9 8.0 PUS3 FKSG32 ENSG00000110060 "Pseudouridylate synthase 3" Q9BZE2 11 125893485-125903221 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Isomerase "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038040, HPA063802" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038040: AB_10697092, HPA063802: " "unprognostic (5.89e-2)" "unprognostic (7.24e-2)" "unprognostic (1.29e-1)" "unprognostic (4.37e-3)" "unprognostic (4.59e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (7.67e-2)" "unprognostic (1.77e-1)" "unprognostic (8.92e-3)" "unprognostic (4.47e-3)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-3)" "unprognostic (9.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.13e-1)" "unprognostic (2.44e-1)" 8.6 8.8 5.9 7.4 7.7 2.3 8.7 9.0 8.4 7.4 9.2 3.6 4.6 9.9 8.4 8.6 8.1 6.4 5.9 7.6 8.0 6.4 9.6 36.6 6.1 11.0 8.7 7.2 7.7 17.9 8.2 21.1 7.6 7.7 10.4 7.4 5.4 10.6 5.1 15.2 8.2 11.5 13.9 9.7 8.9 9.3 5.3 7.3 9.6 12.4 10.6 9.2 11.1 7.3 13.0 8.8 9.9 12.3 13.0 16.5 7.1 3.5 4.3 13.3 14.9 13.7 17.5 6.4 11.9 10.0 6.8 7.6 14.1 13.4 18.1 19.6 5.2 12.4 21.6 11.0 6.9 15.4 10.4 18.6 5.5 10.1 14.5 11.7 5.5 13.8 13.3 8.1 17.4 12.5 18.9 9.5 7.3 2.1 13.0 12.5 11.5 8.5 2.6 12.2 10.2 11.2 5.6 15.5 13.8 8.1 11.4 6.5 24.3 7.6 8.4 14.4 5.9 6.8 9.8 7.1 10.6 19.1 3.9 18.8 9.8 9.9 9.7 7.8 13.0 9.4 15.2 13.0 12.8 12.5 8.8 12.2 16.5 15.6 3.7 13.0 12.3 7.8 12.9 7.1 5.9 7.7 9.0 8.4 8.0 6.4 8.7 7.2 7.7 7.3 PUS7 FLJ20485 ENSG00000091127 "Pseudouridylate synthase 7 (putative)" Q96PZ0 7 105439661-105522267 "Predicted intracellular proteins" "tRNA processing" Isomerase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024116 Approved Approved Nucleoplasm Nucleoplasm "HPA024116: AB_1848754" "unprognostic (3.07e-1)" "unprognostic (1.52e-3)" "unprognostic (9.03e-2)" "unprognostic (4.94e-2)" "unprognostic (8.91e-2)" "unprognostic (7.95e-2)" "prognostic unfavourable (4.89e-6)" "unprognostic (2.86e-2)" "prognostic unfavourable (7.58e-5)" "unprognostic (1.87e-1)" "unprognostic (5.64e-3)" "unprognostic (4.14e-2)" "prognostic unfavourable (1.03e-8)" "unprognostic (2.76e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (6.28e-4)" "unprognostic (4.90e-2)" 12.7 6.9 7.7 13.0 12.5 5.8 14.1 12.2 12.9 10.2 9.6 8.5 4.6 7.0 11.4 5.6 14.7 9.8 6.0 9.4 8.3 7.0 7.5 11.8 8.8 8.3 12.3 8.0 10.0 11.9 17.0 8.1 9.8 11.4 8.6 11.6 5.3 9.3 11.0 19.5 13.3 6.3 13.2 9.0 5.4 8.0 8.5 13.8 4.3 14.6 13.5 10.0 8.0 11.0 5.9 3.3 0.4 5.0 2.7 5.4 2.0 15.2 10.3 9.1 14.0 6.5 7.7 9.9 7.6 6.6 13.6 11.7 13.6 5.8 8.9 12.8 7.8 11.9 17.2 9.1 21.1 6.3 13.1 13.6 8.7 12.2 8.1 20.8 4.9 7.6 9.9 11.5 14.6 13.6 30.3 7.2 8.6 20.3 22.9 16.3 22.1 12.1 14.3 14.7 38.0 14.0 11.5 14.8 14.6 15.1 24.6 9.4 8.9 4.3 8.3 19.1 13.1 23.9 15.9 5.6 10.7 25.4 6.4 17.5 15.8 0.0 2.1 0.4 2.6 5.0 5.4 5.9 3.5 2.8 3.3 3.6 2.9 3.8 0.2 2.7 4.2 0.1 2.2 2.0 7.7 12.5 12.2 12.9 8.3 7.0 12.3 8.0 11.4 13.8 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 130.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in many" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: " "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 130.9 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell line enhanced" "Detected in many" "TIME: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" HPA012568 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248" "unprognostic (2.90e-3)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavourable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavourable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.5 15.1 1.5 6.1 1.8 2.2 2.6 36.4 10.2 12.0 13.7 8.8 9.2 0.0 21.0 10.5 14.2 5.1 13.8 8.0 2.6 9.9 3.8 9.5 5.9 12.7 1.4 8.3 2.9 6.8 10.5 20.7 13.0 1.8 0.0 5.5 1.9 1.3 1.3 3.4 11.2 0.0 6.9 2.0 25.7 6.6 6.5 7.6 23.1 14.5 5.1 8.2 3.7 52.7 14.5 17.9 10.7 28.4 0.0 2.1 0.0 11.6 7.4 8.2 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603913-143609773 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063416, HPA069706" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA063416: , HPA069706: " "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 6.1 8.1 11.5 6.7 9.7 4.8 5.6 5.3 13.4 6.9 5.4 6.1 10.8 4.4 4.7 5.2 6.1 10.1 6.3 4.4 12.2 8.5 7.7 20.5 5.9 6.7 7.6 12.1 6.7 10.6 4.3 9.1 3.5 9.7 7.5 4.0 4.5 13.7 9.1 4.8 4.7 4.9 4.0 4.4 5.9 7.0 8.6 4.5 3.8 9.5 6.3 6.1 3.6 3.1 11.1 5.4 0.4 1.4 3.2 3.2 2.1 5.8 11.0 2.0 4.2 1.9 1.2 4.1 5.2 2.2 4.2 2.4 4.8 5.8 7.7 7.0 3.7 4.9 1.9 6.1 0.8 5.2 6.7 3.8 4.2 3.2 1.9 1.7 1.1 2.1 1.6 4.8 2.7 2.4 5.9 2.4 2.0 18.0 7.3 1.3 1.8 17.7 5.1 1.9 11.5 3.9 3.8 7.1 2.4 8.4 10.8 1.9 13.3 2.2 2.1 3.8 7.9 5.9 4.9 4.2 1.0 4.8 4.4 2.4 3.5 0.3 1.4 0.2 3.2 1.1 3.1 5.8 2.1 2.6 2.1 11.1 3.0 3.0 0.4 3.2 1.0 5.4 1.8 2.1 11.5 9.7 5.3 13.4 12.2 8.5 7.6 12.1 9.7 4.5 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538890-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 26.6" "Cell line enhanced" "Detected in many" "U-698: 25.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 3.0 3.8 3.8 1.6 8.2 0.6 3.1 10.1 5.1 10.8 5.1 2.8 8.2 0.9 9.8 5.8 3.3 4.2 3.9 2.6 5.2 4.3 1.8 0.6 3.2 1.0 4.2 2.8 14.2 2.3 26.6 6.9 3.2 5.0 7.9 1.9 5.5 1.9 9.4 18.7 1.5 1.8 7.9 5.2 0.8 2.8 6.0 3.2 0.0 10.1 5.7 1.0 7.6 9.2 0.6 0.2 0.9 0.2 0.3 0.4 0.0 2.7 5.0 8.8 4.6 3.3 7.6 3.7 6.0 6.6 4.8 5.5 3.3 0.0 0.0 1.8 3.8 0.0 9.0 0.0 6.1 0.0 3.0 1.3 1.4 0.2 4.8 4.9 0.0 4.0 4.7 4.3 0.6 2.4 0.0 0.0 7.4 0.1 0.2 0.0 2.4 2.6 0.0 11.2 0.0 1.5 1.9 4.8 5.7 5.4 0.0 4.2 1.7 1.4 0.0 11.9 5.4 0.2 7.0 0.1 0.1 25.5 3.7 0.0 2.7 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.3 0.0 0.0 0.6 0.3 0.4 0.9 0.3 0.1 0.2 0.1 0.0 3.8 8.2 10.1 2.8 5.2 4.3 4.2 2.8 5.0 3.2 PYGO2 ENSG00000163348 "Pygopus family PHD finger 2" Q9BRQ0 1 154957026-154963853 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023689 Supported Approved Nucleoplasm Nucleoplasm "HPA023689: AB_1855974" "unprognostic (1.49e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-3)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "unprognostic (4.32e-3)" "prognostic unfavourable (3.88e-6)" "unprognostic (2.45e-1)" "unprognostic (2.07e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-1)" "unprognostic (7.40e-3)" "unprognostic (1.63e-2)" "unprognostic (2.81e-2)" "unprognostic (2.17e-1)" "prognostic favourable (1.76e-4)" 14.0 28.4 22.2 22.8 23.7 6.6 26.1 28.5 26.8 20.8 20.5 23.4 22.1 21.3 18.7 27.9 21.4 24.1 21.6 15.0 18.7 22.9 19.1 17.4 17.2 26.7 22.2 19.4 32.5 17.5 37.7 31.0 18.4 21.3 24.5 17.9 21.3 25.3 32.6 16.4 25.0 22.5 18.3 22.1 26.4 19.1 15.7 22.1 30.9 35.5 12.9 30.1 20.3 21.8 8.9 4.3 10.5 8.2 6.3 12.8 5.7 13.0 9.2 19.6 17.3 19.8 9.7 18.0 8.1 11.0 12.9 11.2 12.3 16.4 16.4 12.9 9.4 17.7 17.1 11.3 8.5 16.1 12.1 13.0 15.0 10.9 9.2 11.9 11.6 8.1 16.4 11.6 9.8 7.9 17.0 27.8 12.1 19.8 16.4 13.9 20.9 16.6 18.6 12.5 25.7 13.2 12.3 23.6 35.1 12.8 23.4 16.1 28.8 21.5 6.7 11.5 17.4 12.4 11.7 27.7 24.5 17.4 9.6 15.2 15.2 2.4 3.9 10.5 9.0 6.8 11.6 7.5 11.5 11.9 4.3 8.9 12.8 9.6 4.0 6.3 8.2 4.2 6.0 5.7 22.2 23.7 28.5 26.8 18.7 22.9 22.2 19.4 21.3 22.1 PYURF PreY ENSG00000145337 "PIGY upstream reading frame" Q96I23 4 88520985-88523813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036455 Uncertain Approved Nucleoplasm Nucleoplasm "HPA036455: AB_10673388" "unprognostic (8.25e-2)" "unprognostic (9.14e-2)" "unprognostic (6.61e-2)" "unprognostic (2.03e-1)" "unprognostic (5.03e-2)" "unprognostic (7.23e-2)" "unprognostic (1.10e-2)" "unprognostic (8.84e-3)" "unprognostic (3.64e-1)" "unprognostic (1.48e-2)" "unprognostic (1.20e-2)" "unprognostic (2.35e-2)" "unprognostic (9.04e-3)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" 40.4 48.3 47.3 29.2 43.9 44.2 63.2 28.2 43.4 40.6 38.4 31.2 35.2 35.8 47.4 56.4 40.9 41.0 36.4 62.5 45.4 45.1 48.7 59.1 33.5 43.1 47.6 35.3 44.9 61.8 40.7 42.6 39.0 43.2 42.7 37.7 31.6 48.6 42.9 54.0 37.1 37.5 44.7 51.4 36.9 33.8 28.5 38.4 28.3 47.7 40.5 33.0 41.7 51.4 45.3 50.8 35.0 43.3 47.3 54.1 74.3 29.1 9.8 19.7 23.4 39.9 41.1 13.3 21.6 30.4 27.1 22.9 7.6 23.2 0.1 24.3 30.5 12.6 17.8 27.1 34.3 35.7 31.0 32.4 13.1 29.1 30.3 53.5 20.9 28.3 41.1 17.4 35.7 44.3 36.4 32.9 39.1 22.1 32.4 32.8 16.6 18.9 33.2 18.5 34.0 22.3 16.5 23.9 23.4 27.4 25.0 56.8 11.6 27.0 30.1 28.9 26.7 28.1 19.8 23.3 19.0 3.6 25.4 27.3 31.7 30.9 43.3 35.0 45.0 42.0 50.2 45.3 52.0 48.5 50.8 35.5 54.1 51.6 8.6 47.3 41.0 31.9 51.8 74.3 47.3 43.9 28.2 43.4 45.4 45.1 47.6 35.3 43.2 38.4 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: " "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.1 2.5 4.7 5.3 2.6 2.3 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.3 0.5 6.2 1.1 2.0 1.8 3.8 0.5 1.7 5.7 1.3 0.8 2.9 2.1 1.0 1.9 0.1 2.0 3.4 1.2 0.5 3.7 3.4 0.7 1.9 5.1 7.5 3.9 0.2 0.8 2.3 4.3 4.3 1.1 0.6 2.6 1.9 2.7 2.1 1.4 5.0 6.7 2.6 1.7 1.6 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 QSER1 FLJ21924 ENSG00000060749 "Glutamine and serine rich 1" Q2KHR3 11 32893178-32993316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005682 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA005682: AB_1855985" "unprognostic (2.94e-1)" "unprognostic (6.55e-2)" "unprognostic (1.36e-1)" "unprognostic (2.76e-1)" "unprognostic (6.78e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (7.94e-5)" "unprognostic (1.14e-1)" "unprognostic (4.75e-2)" "unprognostic (6.71e-2)" "prognostic unfavourable (5.27e-5)" "unprognostic (6.77e-2)" "prognostic unfavourable (6.87e-4)" "unprognostic (1.80e-2)" "unprognostic (7.20e-2)" "unprognostic (8.12e-2)" "unprognostic (7.96e-2)" 10.8 8.3 13.6 9.1 11.3 8.3 22.0 21.3 14.9 13.1 8.7 9.8 9.5 5.4 13.8 13.1 15.9 11.2 8.9 10.0 12.5 7.1 9.3 9.5 9.1 8.2 13.1 10.9 21.4 15.6 16.5 11.4 9.0 11.5 11.5 9.2 10.9 16.7 9.7 9.8 20.1 7.9 10.4 11.5 10.1 9.3 14.2 12.8 14.2 14.2 14.0 10.1 11.8 24.8 2.0 2.2 0.3 2.4 1.7 1.1 0.4 11.2 13.9 16.3 15.0 6.3 12.4 7.8 9.8 8.8 7.2 8.8 12.1 5.3 11.8 6.3 11.9 14.7 14.9 8.8 15.3 5.0 9.6 11.0 13.4 10.0 4.8 13.2 6.0 5.9 9.4 9.1 14.9 9.8 16.8 5.3 11.1 10.0 6.3 5.3 17.2 8.5 10.6 32.2 4.9 7.4 12.4 8.5 12.2 18.5 9.9 6.2 10.2 7.0 9.7 17.4 17.5 31.3 21.0 3.6 4.9 12.3 11.2 6.3 11.2 0.0 1.2 0.3 1.1 2.4 0.5 2.0 0.7 1.0 1.1 0.9 0.6 0.7 0.0 1.7 0.6 2.2 0.2 0.4 13.6 11.3 21.3 14.9 12.5 7.1 13.1 10.9 11.5 12.8 QSOX2 "DKFZp762A2013, QSCN6L1, SOXN" ENSG00000165661 "Quiescin sulfhydryl oxidase 2" Q6ZRP7 9 136206333-136245841 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012716, HPA017280" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" 5700000 "Golgi apparatus" Nucleoplasm "HPA012716: AB_2173315, HPA017280: " "unprognostic (7.29e-2)" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (5.28e-2)" "unprognostic (1.49e-1)" "unprognostic (4.46e-3)" "unprognostic (1.10e-3)" "unprognostic (4.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.06e-3)" "unprognostic (5.96e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (9.64e-6)" "unprognostic (1.23e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.10e-2)" 7.2 8.0 8.4 15.9 14.1 16.0 7.3 30.3 10.6 5.8 5.8 9.4 8.9 6.0 8.1 13.2 5.6 8.1 5.5 7.0 7.6 7.1 7.0 9.2 6.5 19.1 11.0 6.7 9.4 21.7 12.1 29.2 5.8 9.6 6.1 6.7 7.9 6.5 4.9 5.1 12.4 10.3 8.1 7.1 14.6 7.6 11.7 10.1 8.3 12.1 6.0 16.7 5.4 6.4 3.4 0.8 1.6 0.3 0.4 0.8 0.2 7.2 17.7 14.7 19.5 8.3 10.1 18.6 9.3 10.4 18.1 16.7 13.2 15.8 11.2 15.3 12.4 23.6 17.4 13.4 14.7 16.5 8.7 6.0 29.3 14.5 11.8 17.8 9.2 8.0 13.6 17.9 21.8 13.2 14.4 30.3 9.6 12.3 6.6 11.9 17.4 11.3 12.2 19.1 18.3 6.2 6.6 15.8 11.9 14.6 11.6 7.8 8.3 10.4 7.5 22.0 16.0 18.0 21.1 10.7 14.3 24.7 14.7 9.4 20.5 1.6 0.3 0.7 0.5 0.0 0.8 1.9 0.6 0.2 0.1 3.4 0.2 0.4 0.1 0.4 0.0 0.8 0.3 0.2 8.4 14.1 30.3 10.6 7.6 7.1 11.0 6.7 9.6 10.1 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA036827: , HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavourable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 17.1 13.9 8.7 12.4 10.4 13.3 14.1 6.4 10.3 11.0 11.2 14.9 7.9 10.4 16.1 9.2 13.7 13.1 13.6 7.5 6.7 6.7 15.8 15.7 12.2 14.9 11.0 7.6 12.6 15.3 10.7 16.9 11.6 9.4 11.2 12.5 17.7 11.8 9.8 7.5 12.4 12.9 10.8 11.3 19.9 10.7 14.1 10.0 17.3 13.2 10.9 21.6 11.6 10.9 13.9 15.8 5.3 12.9 6.4 6.6 5.0 13.3 13.9 11.6 12.8 5.1 6.3 11.0 7.0 4.4 12.0 11.1 13.2 9.7 24.9 10.3 6.4 13.4 22.5 10.6 15.8 4.7 10.2 11.2 8.3 9.4 7.3 20.3 10.5 4.9 9.6 10.9 15.6 12.4 11.7 8.9 6.8 10.6 16.9 7.9 22.2 15.2 15.4 8.2 13.3 9.4 9.3 15.8 7.5 10.2 10.1 12.9 11.2 10.3 8.1 10.5 11.5 4.1 13.6 6.3 9.1 34.8 9.2 15.0 21.1 0.3 12.4 2.9 5.6 12.9 5.3 13.9 4.8 5.5 15.8 9.5 6.6 5.3 5.3 6.4 9.1 6.6 5.9 5.0 8.7 10.4 6.4 10.3 6.7 6.7 11.0 7.6 9.4 10.0 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favourable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favourable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favourable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 14.8 14.2 21.4 14.8 20.9 18.4 24.6 16.5 36.3 13.9 18.4 26.0 14.8 14.5 16.4 18.2 12.5 17.9 16.4 23.8 21.5 16.9 13.2 16.6 18.8 15.9 30.1 16.3 22.1 50.3 16.0 14.7 10.4 20.7 14.8 12.0 15.3 24.8 20.7 36.6 16.3 14.4 18.3 33.7 13.0 16.9 17.4 21.4 15.8 13.6 14.7 13.9 12.9 12.6 28.5 29.7 41.6 27.1 29.7 36.5 25.7 20.9 26.3 21.2 20.5 9.1 12.4 14.4 13.9 13.4 23.8 17.4 18.3 9.9 21.2 14.8 17.0 15.8 22.3 25.9 16.1 13.6 21.9 19.7 18.1 15.3 21.5 13.4 14.8 14.6 20.5 20.3 9.6 18.1 22.8 17.9 13.9 17.2 30.3 22.5 16.9 19.2 20.7 25.8 12.6 11.4 23.0 27.2 23.3 15.8 18.8 22.6 17.1 16.1 15.4 21.9 18.2 18.2 28.2 13.3 11.8 21.8 16.9 18.8 27.1 17.8 27.1 41.6 36.5 22.6 31.5 28.5 29.6 30.4 29.7 21.0 23.2 26.6 16.6 29.7 24.2 27.7 30.5 25.7 21.4 20.9 16.5 36.3 21.5 16.9 30.1 16.3 20.7 21.4 R3HCC1L "C10orf28, GIDRP86, PSORT" ENSG00000166024 "R3H domain and coiled-coil containing 1 like" Q7Z5L2 10 98134624-98244897 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037367 Enhanced Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA037367: AB_10696930" "unprognostic (3.00e-1)" "unprognostic (2.55e-2)" "unprognostic (1.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.67e-2)" "unprognostic (7.04e-2)" "unprognostic (1.15e-3)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (6.00e-2)" "unprognostic (1.55e-1)" "unprognostic (1.74e-3)" "unprognostic (7.39e-2)" "unprognostic (3.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-2)" 14.5 8.2 9.5 14.9 12.9 19.1 13.0 16.4 11.4 11.1 12.9 8.9 10.3 8.0 11.4 13.0 12.0 8.0 7.7 8.1 10.2 6.2 9.6 10.8 10.9 13.8 11.9 5.4 9.3 10.1 15.6 20.7 14.4 11.8 13.7 13.1 12.9 12.0 9.5 10.0 14.1 15.0 10.1 16.7 13.2 9.4 25.2 12.5 17.1 11.0 6.9 15.7 11.5 16.0 10.2 6.0 18.6 12.9 10.2 13.9 5.5 10.5 6.9 10.6 9.3 9.1 9.7 8.8 12.0 16.8 11.8 13.1 9.4 7.6 14.9 6.5 7.1 12.1 10.6 7.2 13.3 11.2 7.2 8.8 5.4 10.5 11.2 12.0 10.8 8.9 8.3 10.3 15.4 7.5 7.6 9.3 9.1 10.1 9.5 12.5 7.6 9.1 9.7 12.1 6.0 8.5 6.3 3.6 7.8 6.2 4.5 23.4 8.2 7.6 8.3 7.9 8.5 8.8 9.0 9.5 10.0 25.6 11.3 12.6 5.8 10.7 6.9 18.6 9.9 9.4 8.8 10.2 10.2 10.0 5.3 9.5 9.0 8.8 8.5 10.2 12.9 6.0 13.9 5.5 9.5 12.9 16.4 11.4 10.2 6.2 11.9 5.4 11.8 12.5 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavourable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavourable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 6.5 6.4 23.2 8.3 27.8 13.4 5.3 22.2 57.6 6.7 7.5 4.5 2.4 4.5 6.9 6.6 6.2 5.5 6.3 5.3 17.9 15.5 6.0 6.2 5.0 11.0 11.5 32.7 5.3 8.4 20.1 13.2 4.2 7.7 5.4 10.3 4.3 4.3 6.1 13.5 5.3 5.6 8.6 7.9 6.6 5.4 14.3 7.6 14.2 8.7 3.6 13.2 8.4 4.3 6.5 12.7 3.5 8.4 9.6 9.6 5.0 20.5 12.6 17.9 20.7 9.6 13.2 10.6 12.9 13.5 13.0 14.3 22.6 14.3 32.7 10.3 18.3 9.3 23.4 24.0 22.9 20.5 11.7 26.3 16.1 22.5 11.6 22.4 17.1 12.4 10.7 22.9 29.5 20.9 27.2 28.1 14.9 21.2 38.8 15.4 13.8 14.9 23.2 12.4 19.5 12.9 18.2 18.3 14.2 20.8 8.5 9.3 11.4 12.0 15.2 12.1 12.1 15.2 16.2 22.5 30.8 30.7 13.6 18.4 15.4 3.5 7.8 3.0 6.1 8.4 5.8 6.5 6.6 9.1 11.2 4.4 6.4 7.2 1.0 9.6 7.1 12.7 9.6 5.0 23.2 27.8 22.2 57.6 17.9 15.5 11.5 32.7 7.7 7.6 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 93.1" "Lineage enriched" "Detected in all" 12 "granulocytes: 93.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043025: , HPA048638: " "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favourable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 15.4 11.7 23.3 33.2 19.5 57.7 15.4 12.7 26.6 15.9 16.5 16.3 10.0 17.1 15.3 13.2 33.0 15.7 20.1 12.5 20.2 11.9 18.8 24.1 22.7 43.3 14.8 11.9 19.2 34.9 10.0 16.2 18.5 12.8 17.7 12.6 15.5 24.2 14.5 21.6 22.4 18.0 13.4 10.3 41.1 24.1 8.1 12.5 31.9 14.6 19.6 43.0 20.6 19.0 6.4 2.2 93.1 2.0 1.2 7.7 3.8 17.9 10.5 11.3 15.2 7.2 12.7 18.5 12.2 9.7 12.3 10.9 11.1 15.4 13.0 10.2 13.8 16.4 6.5 14.5 5.6 19.9 13.8 17.9 9.2 19.5 21.6 9.7 31.7 16.9 28.0 8.0 16.8 14.1 33.0 26.6 11.4 32.1 13.9 18.8 14.5 17.3 13.8 5.4 24.7 20.3 18.9 19.9 19.3 10.7 23.8 19.9 20.9 23.6 14.2 22.5 12.5 26.2 12.1 29.6 15.4 19.0 14.4 14.1 19.6 14.6 2.0 16.2 2.5 1.5 3.9 6.4 5.0 3.4 2.2 3.8 4.8 3.3 93.1 1.2 2.0 0.9 7.7 3.8 23.3 19.5 12.7 26.6 20.2 11.9 14.8 11.9 12.8 12.5 RAB11FIP2 "KIAA0941, nRip11, Rab11-FIP2" ENSG00000107560 "RAB11 family interacting protein 2" Q7L804 10 118004916-118046603 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037726 Approved Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA037726: AB_10672390" "unprognostic (1.97e-1)" "unprognostic (1.68e-2)" "unprognostic (3.61e-1)" "unprognostic (4.45e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-2)" "unprognostic (2.17e-2)" "unprognostic (3.34e-2)" "unprognostic (1.83e-2)" "unprognostic (2.15e-1)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favourable (9.69e-5)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (2.17e-1)" 8.8 7.1 11.8 6.4 21.6 12.0 7.2 13.3 19.9 11.4 9.7 7.9 19.0 3.8 23.0 29.8 6.8 12.9 8.6 7.2 10.5 7.1 12.8 5.6 7.7 8.5 8.0 12.9 10.7 7.0 8.6 6.6 8.3 11.5 12.7 5.3 6.9 6.2 27.2 6.5 6.3 6.7 20.0 7.5 7.7 15.5 8.6 8.8 10.0 11.8 3.8 5.6 10.5 13.7 2.3 2.6 1.9 1.2 0.9 2.3 0.4 5.2 6.7 5.6 7.1 9.4 12.0 6.1 10.4 12.1 6.4 6.7 5.4 5.6 10.8 8.4 10.6 3.7 7.8 4.6 10.0 2.7 8.2 3.9 6.9 3.7 13.6 7.1 4.2 11.7 8.7 9.1 20.0 3.9 2.8 9.2 8.3 1.9 5.4 5.3 4.8 4.7 4.7 19.9 3.6 9.6 4.2 1.3 10.4 7.3 3.0 12.8 2.3 6.7 5.7 8.6 7.0 10.1 10.3 6.7 5.6 7.0 8.9 12.3 5.3 1.5 1.2 1.4 1.5 0.8 1.4 2.2 1.2 1.5 0.6 2.3 2.3 1.3 1.9 0.9 0.7 2.6 0.6 0.4 11.8 21.6 13.3 19.9 10.5 7.1 8.0 12.9 11.5 8.8 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell line enhanced" "Detected in many" "PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavourable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favourable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.3 3.2 3.8 1.0 1.4 2.0 1.2 1.4 1.9 0.9 0.5 3.3 2.2 1.6 2.7 10.7 1.3 0.7 0.7 3.4 1.3 3.9 3.7 0.9 2.2 4.1 3.1 1.3 0.8 0.4 0.4 0.7 1.1 1.3 3.2 5.0 0.6 1.9 13.5 3.5 0.2 2.8 1.5 0.5 24.7 11.8 1.0 4.3 2.3 0.9 0.4 0.4 1.2 0.9 17.1 1.1 2.1 4.5 0.8 3.2 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 RAB3GAP1 "KIAA0066, RAB3GAP, RAB3GAP130, WARBM1" ENSG00000115839 "RAB3 GTPase activating protein catalytic subunit 1" Q15042 2 135052265-135176394 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034494, HPA034495" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA034494: , HPA034495: AB_10670158" "unprognostic (1.02e-2)" "unprognostic (2.43e-2)" "unprognostic (5.73e-2)" "prognostic unfavourable (2.96e-4)" "unprognostic (2.18e-1)" "unprognostic (9.57e-2)" "unprognostic (2.96e-2)" "unprognostic (7.00e-2)" "unprognostic (3.18e-1)" "unprognostic (1.13e-2)" "unprognostic (3.15e-2)" "unprognostic (2.05e-1)" "unprognostic (8.40e-3)" "unprognostic (2.41e-2)" "unprognostic (3.75e-1)" "unprognostic (4.11e-1)" "unprognostic (2.15e-1)" 24.1 18.4 22.1 20.8 32.9 27.3 21.8 27.1 37.2 25.1 24.0 21.2 20.0 15.7 42.2 27.0 26.1 20.1 18.3 28.4 21.4 29.1 20.1 16.9 18.6 19.7 24.5 28.1 31.3 29.4 31.7 50.0 33.0 34.5 26.0 24.0 23.2 37.3 25.4 37.4 25.1 19.4 26.4 26.0 17.5 22.7 19.6 21.3 28.8 26.2 20.9 24.6 25.2 24.8 9.1 5.4 9.3 7.1 3.6 10.7 2.4 19.4 7.9 14.0 11.5 27.5 23.5 12.9 29.9 24.7 23.8 23.6 17.5 16.0 29.0 18.6 30.5 16.5 14.7 27.6 29.2 13.8 14.9 14.4 10.0 15.2 19.2 17.7 15.7 20.5 36.5 21.9 39.7 17.1 18.6 16.9 21.6 11.5 9.0 6.9 10.7 13.3 15.6 17.9 12.1 14.0 17.4 11.3 8.9 20.3 12.2 14.1 10.7 12.9 20.6 24.2 18.4 10.3 12.5 12.0 6.8 21.8 15.8 10.7 13.4 9.3 5.0 7.6 2.0 6.7 1.8 7.0 5.0 2.8 5.4 9.1 10.7 5.3 2.0 3.6 7.1 2.9 6.5 2.4 22.1 32.9 27.1 37.2 21.4 29.1 24.5 28.1 34.5 21.3 RABL3 MGC23920 ENSG00000144840 "RAB, member of RAS oncogene family like 3" Q5HYI8 3 120686681-120742993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035150, HPA035151" Uncertain Approved Nucleoplasm Nucleoplasm "HPA035150: , HPA035151: AB_10601154" "unprognostic (1.69e-2)" "unprognostic (5.10e-2)" "unprognostic (8.32e-2)" "unprognostic (3.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.22e-2)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (2.94e-1)" "unprognostic (2.11e-3)" "unprognostic (2.78e-1)" "prognostic favourable (2.79e-5)" "unprognostic (2.33e-1)" "unprognostic (6.15e-2)" "unprognostic (8.44e-3)" "unprognostic (3.65e-1)" 21.5 26.7 16.5 9.3 19.5 8.8 14.8 15.7 19.9 12.2 14.1 16.6 13.6 10.6 11.8 12.2 16.6 11.0 9.9 11.9 14.6 16.6 19.7 20.5 10.3 10.3 19.2 16.2 18.7 13.9 23.3 14.7 13.4 20.9 14.4 15.1 12.8 11.2 14.9 19.6 10.3 13.0 11.6 22.5 11.3 11.4 8.2 14.0 11.2 22.9 12.6 11.8 13.8 11.9 7.8 11.4 5.7 11.8 13.1 10.9 5.6 16.6 12.8 11.6 3.6 12.5 17.1 9.7 15.0 11.2 8.7 8.1 8.8 6.9 13.5 7.8 13.2 6.8 11.7 8.2 16.5 11.3 5.5 13.7 9.2 11.3 8.1 24.0 8.7 8.8 15.8 7.4 8.9 13.0 11.1 9.1 11.4 14.3 18.3 6.3 7.1 7.7 8.6 14.2 7.5 11.4 7.5 5.5 7.3 7.1 6.4 8.3 11.8 15.7 17.6 6.7 6.0 4.9 15.7 6.7 6.3 11.4 19.0 23.7 8.1 5.6 5.8 4.2 10.9 11.8 9.0 7.8 9.7 10.3 10.7 6.8 9.3 10.8 5.7 13.1 6.6 11.4 10.3 5.6 16.5 19.5 15.7 19.9 14.6 16.6 19.2 16.2 20.9 14.0 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: " "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavourable (1.74e-5)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 73.9 33.6 34.7 37.7 41.2 52.7 20.7 41.7 51.3 55.7 56.8 32.9 70.0 20.9 27.1 58.2 52.8 37.0 50.6 71.4 9.7 30.7 21.0 27.2 23.8 49.6 18.9 17.2 35.1 45.3 40.1 45.0 49.0 37.4 16.5 60.0 53.9 10.4 44.4 62.2 40.3 18.4 35.3 30.6 71.6 46.9 26.3 44.3 29.4 107.9 33.5 60.8 56.9 51.4 36.6 55.1 44.8 48.1 12.6 13.8 19.6 33.7 36.1 69.3 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560048 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Nucleoplasm "HPA051499: " "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavourable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavourable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavourable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavourable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 3.0 2.0 1.7 9.2 3.6 15.4 2.7 4.5 2.6 1.8 5.4 1.4 3.8 5.4 1.5 3.2 7.6 1.1 2.2 1.9 1.5 1.2 1.7 1.7 2.6 8.8 2.1 1.7 1.5 1.2 0.5 1.2 4.2 1.8 1.7 7.1 1.5 2.8 1.0 1.2 3.2 6.2 1.9 2.9 5.8 2.9 9.2 2.5 29.8 1.4 4.7 8.2 2.1 3.1 4.5 9.7 0.9 3.1 1.9 1.5 0.9 12.8 4.5 16.2 8.0 0.9 2.1 19.0 16.9 7.5 18.9 25.0 12.3 12.5 16.8 2.5 3.6 8.1 11.2 5.0 29.0 13.2 9.5 21.1 7.8 8.5 0.2 19.2 10.7 0.4 0.5 11.3 11.0 7.5 13.2 19.4 11.9 4.6 15.6 7.0 39.4 5.1 15.8 19.4 6.6 5.7 6.4 5.4 6.0 12.6 9.8 4.0 4.0 11.3 3.3 12.8 13.2 13.9 18.0 2.9 3.3 32.2 4.8 13.8 10.4 0.0 0.8 0.9 0.2 3.1 0.8 4.2 0.6 1.5 0.6 4.5 0.2 0.4 0.0 1.9 2.7 9.7 1.4 0.9 1.7 3.6 4.5 2.6 1.5 1.2 2.1 1.7 1.8 2.5 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: " "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 5.1 4.9 4.2 4.6 10.1 9.2 8.2 2.0 5.6 8.2 4.3 11.6 11.2 1.7 10.8 13.8 7.0 6.0 6.4 3.4 5.6 3.2 4.3 3.2 5.0 6.6 9.2 4.0 10.0 5.7 8.0 10.0 8.0 7.5 7.0 4.0 9.4 18.7 3.8 2.4 7.1 5.8 6.7 7.3 6.9 3.7 3.4 7.3 12.6 4.9 4.6 12.1 7.7 8.3 13.6 6.6 14.0 5.9 7.8 10.1 4.8 12.2 4.8 5.4 3.3 5.1 8.7 3.4 6.2 4.8 6.9 8.9 3.4 16.7 15.1 4.1 3.8 11.1 3.4 9.9 9.5 6.7 3.5 7.2 4.4 2.7 2.7 6.0 7.3 4.4 7.7 7.9 8.4 6.2 5.8 7.0 5.6 9.5 11.8 2.1 3.2 4.9 13.3 6.5 5.5 5.4 3.5 3.7 2.4 5.0 1.8 10.7 8.4 5.5 1.6 8.5 8.2 6.6 5.1 3.4 3.4 12.0 4.6 10.7 4.7 14.0 5.9 5.4 8.6 4.7 7.1 13.6 8.2 9.2 6.5 11.5 10.1 9.7 0.7 7.8 4.5 6.6 9.1 4.8 4.2 10.1 2.0 5.6 5.6 3.2 9.2 4.0 7.5 7.3 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: , HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favourable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.4 4.1 3.3 3.5 4.3 5.2 4.1 7.8 4.3 3.6 4.4 2.2 5.3 4.6 3.6 3.9 2.5 3.1 3.4 3.5 3.4 8.8 4.2 3.8 3.4 5.6 5.0 5.3 3.9 4.9 3.8 3.5 3.7 4.2 7.3 4.6 4.1 4.3 4.1 4.7 4.4 4.7 4.2 5.2 3.8 3.5 6.9 5.2 6.5 7.1 6.3 8.3 4.0 5.6 4.4 11.4 11.2 6.4 4.6 6.0 4.8 6.8 6.6 6.3 7.8 3.3 14.8 1.4 8.4 4.4 17.9 6.0 8.2 7.8 4.0 12.7 9.5 5.1 5.8 14.1 7.6 5.2 4.8 10.1 9.8 7.3 8.3 8.1 5.2 4.3 12.6 6.4 9.0 4.8 5.8 8.8 2.0 3.3 7.3 4.7 8.9 7.6 7.3 4.9 4.8 8.5 9.5 7.0 8.0 7.1 9.3 8.7 8.8 15.0 7.5 8.0 8.8 6.5 4.8 4.7 8.1 6.0 8.3 4.3 7.1 6.6 5.2 6.9 4.7 5.4 2.2 6.3 7.1 5.2 6.3 4.0 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883719 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;testis: 18.5" "Cell line enhanced" "Detected in some" "AN3-CA: 7.6;HEK 293: 5.9;NTERA-2: 6.6;SCLC-21H: 9.3;SH-SY5Y: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA051776: " "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 7.5 2.4 4.3 0.8 4.6 0.5 3.7 29.9 9.9 5.9 3.3 3.3 0.7 0.8 6.1 1.4 1.7 6.4 2.1 7.8 4.1 4.0 1.1 0.7 7.5 0.6 3.4 4.4 1.6 2.5 1.5 3.3 7.2 7.5 2.1 1.1 2.7 1.1 4.3 4.5 1.2 1.8 3.1 4.3 1.0 1.4 18.5 4.0 0.0 2.8 0.6 0.7 2.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.7 7.6 0.2 1.8 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.4 2.1 0.0 0.0 6.6 1.3 4.9 0.2 0.0 0.0 0.0 9.3 20.1 0.1 0.0 0.0 3.0 0.6 0.0 0.0 0.0 5.4 1.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.6 29.9 9.9 4.1 4.0 3.4 4.4 7.5 4.0 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease mutation, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 165.8" "Group enriched" "Detected in some" 90 "MOLT-4: 15.4;REH: 61.7" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA065704 Approved Nucleoplasm Nucleoplasm "HPA065704: " "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 165.8 24.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 61.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell line enriched" "Detected in some" 5 "AF22: 9.5" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Approved Nucleoplasm Nucleoplasm "HPA055868: , HPA059112: " "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.9 1.1 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.6 0.1 0.2 0.1 0.5 0.4 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.4 0.4 0.0 1.0 0.0 0.0 0.0 1.8 0.3 0.2 0.5 0.2 0.2 0.0 0.9 0.4 0.2 0.4 0.2 0.5 0.5 0.2 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.8;HDLM-2: 37.1;PC-3: 43.2;SH-SY5Y: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057814: " "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favourable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavourable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.7 0.0 0.1 0.0 3.4 5.2 0.3 0.5 0.9 0.5 0.4 0.0 12.8 0.0 0.1 0.2 0.0 2.0 0.0 0.0 37.1 1.0 0.0 0.0 0.2 10.4 0.0 0.0 4.0 6.1 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 43.2 0.0 0.4 0.2 0.0 0.0 0.4 54.4 0.8 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 RAPGEF2 "DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF" ENSG00000109756 "Rap guanine nucleotide exchange factor 2" Q9Y4G8 4 159103013-159360174 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, GTPase activation, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.4;NK-cells: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057169 Supported Nucleoplasm,Vesicles,Centrosome "Nucleoplasm, Vesicles, Centrosome" "HPA057169: " "unprognostic (4.88e-2)" "unprognostic (7.42e-2)" "unprognostic (1.67e-2)" "unprognostic (7.79e-3)" "unprognostic (8.16e-2)" "unprognostic (4.71e-3)" "unprognostic (4.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (9.71e-2)" "unprognostic (1.07e-1)" "prognostic favourable (1.76e-7)" "unprognostic (2.29e-1)" "unprognostic (2.07e-1)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" 16.7 8.0 28.4 8.8 23.8 51.0 16.3 21.5 34.1 12.6 14.5 11.3 10.4 10.9 12.7 7.3 9.9 10.2 14.1 14.9 23.4 15.3 16.4 20.9 18.1 8.5 14.1 29.6 10.2 13.4 20.7 13.8 26.1 16.9 9.3 14.8 10.0 18.7 9.4 15.7 12.7 11.9 14.0 13.9 19.2 13.7 6.7 14.3 9.3 27.5 8.9 7.8 11.9 13.8 0.4 1.4 9.4 1.4 5.2 1.5 0.3 3.2 4.4 21.1 6.5 8.3 9.4 32.4 6.3 8.0 5.8 4.2 13.6 7.3 18.6 2.3 6.3 3.0 7.1 8.1 6.9 3.1 5.0 28.9 9.3 7.8 6.0 3.5 40.0 5.4 4.6 13.9 4.9 16.5 6.3 17.4 7.1 5.7 8.7 0.5 9.0 4.4 7.1 5.3 0.7 5.2 7.5 6.0 8.0 9.3 4.5 7.7 2.2 2.3 17.5 9.2 9.7 11.7 5.2 19.4 11.5 0.3 10.9 1.5 5.5 2.7 1.4 1.0 0.8 0.8 1.0 0.4 0.7 0.5 0.8 0.3 0.9 0.4 9.4 5.2 0.9 1.4 1.5 0.3 28.4 23.8 21.5 34.1 23.4 15.3 14.1 29.6 16.9 14.3 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell line enhanced" "Detected in many" "HaCaT: 38.2;hTCEpi: 19.2;T-47d: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favourable (8.43e-4)" "prognostic favourable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavourable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.0 5.7 4.2 0.6 1.4 2.7 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 38.2 1.1 1.3 1.6 3.1 2.8 1.0 1.2 2.3 0.7 2.0 3.5 1.6 19.2 1.1 0.5 1.7 0.7 1.1 0.8 5.8 1.9 2.5 1.7 1.0 3.5 0.6 1.0 0.7 11.2 11.0 2.2 1.3 13.0 0.5 33.4 1.5 3.2 1.4 2.9 1.4 1.2 1.9 1.8 1.4 3.3 1.2 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 RARS DALRD1 ENSG00000113643 "Arginyl-tRNA synthetase" P54136 5 168486445-168519299 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003979, HPA004130" Approved Enhanced Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA003979: AB_1856083, HPA004130: AB_1856084" "unprognostic (1.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-3)" "unprognostic (2.82e-2)" "unprognostic (2.50e-1)" "prognostic unfavourable (7.59e-5)" "prognostic unfavourable (1.10e-8)" "unprognostic (3.26e-3)" "unprognostic (5.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.92e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.43e-2)" "unprognostic (2.35e-1)" "unprognostic (2.39e-1)" "unprognostic (1.33e-2)" 21.8 26.3 16.0 18.3 15.3 6.2 22.6 17.1 18.4 21.2 29.4 9.1 20.4 33.3 22.9 21.4 34.7 19.5 14.4 21.7 19.8 12.3 29.8 33.5 18.7 18.6 13.9 15.2 21.3 33.0 19.9 34.5 30.3 15.8 18.9 27.4 15.5 34.0 15.4 27.8 27.9 48.7 21.5 14.5 22.1 24.4 17.2 11.8 20.5 21.5 32.3 23.7 22.4 22.6 11.1 21.8 5.2 17.7 16.8 16.3 11.7 27.1 32.2 23.9 26.4 33.1 37.9 41.1 40.0 34.4 41.7 48.8 54.7 29.6 28.9 32.8 38.0 26.4 31.2 53.8 54.4 30.0 21.5 19.4 29.4 34.3 28.7 45.7 20.7 29.1 28.8 45.4 21.8 33.3 28.9 14.7 44.6 25.1 19.0 18.3 39.2 22.0 8.4 34.8 27.4 37.1 31.0 22.8 28.0 30.6 35.4 41.2 32.1 19.2 33.0 30.2 27.8 23.3 46.6 14.6 26.8 29.6 32.9 32.7 28.7 3.4 14.4 5.2 12.5 17.7 14.3 11.1 12.6 13.3 21.8 6.6 15.6 16.3 4.0 16.8 16.4 10.3 12.8 11.7 16.0 15.3 17.1 18.4 19.8 12.3 13.9 15.2 15.8 11.8 RASAL3 FLJ21438 ENSG00000105122 "RAS protein activator like 3" Q86YV0 19 15451624-15464571 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.9" "Cell line enhanced" "Detected in some" "HDLM-2: 14.1;HEL: 11.7;HMC-1: 22.6;Karpas-707: 25.2;NB-4: 12.8;RPMI-8226: 10.6;TIME: 16.7;U-937: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043417 Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA043417: " "unprognostic (2.72e-2)" "prognostic favourable (8.75e-4)" "unprognostic (3.27e-2)" "prognostic favourable (3.58e-5)" "unprognostic (2.31e-1)" "prognostic favourable (3.07e-4)" "unprognostic (1.82e-2)" "unprognostic (6.21e-3)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (3.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavourable (1.16e-6)" "unprognostic (2.98e-1)" "unprognostic (1.90e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" 2.8 2.1 3.1 19.2 3.8 16.7 1.7 0.5 1.9 1.4 3.4 4.6 0.7 3.6 1.7 1.1 3.0 1.9 4.5 1.1 4.1 1.8 3.3 2.8 8.0 23.5 4.5 1.3 0.9 1.3 0.3 1.4 0.8 3.7 2.3 1.9 1.5 7.5 1.1 0.7 1.2 14.5 0.9 5.1 29.9 4.0 0.6 4.6 27.3 3.1 1.6 28.9 4.5 2.0 2.9 3.2 8.8 9.3 8.9 16.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 11.7 0.0 0.0 0.2 9.3 22.6 0.0 0.0 0.0 0.0 0.1 0.0 25.2 0.0 0.1 4.9 12.8 0.0 0.0 1.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 16.7 0.0 0.0 0.0 0.0 0.2 4.5 6.9 0.0 15.8 0.0 4.3 1.7 8.8 14.9 3.4 8.9 2.2 9.5 16.4 2.6 2.9 8.0 9.6 2.5 8.9 9.3 3.2 6.4 3.5 3.1 3.8 0.5 1.9 4.1 1.8 4.5 1.3 3.7 4.6 RASD1 "AGS1, DEXRAS1" ENSG00000108551 "Ras related dexamethasone induced 1" Q9Y272 17 17494437-17496395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 33.7;HSkMC: 8.2;REH: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 47 "plasmacytoid DC: 48.0" "Lineage enriched" "Detected in many" 47 "dendritic cells: 48.0" "Group enriched" "Detected in many" 5 "basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1" "Low region specificity" "Detected in all" HPA047896 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA047896: AB_10960535" "unprognostic (1.59e-1)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "unprognostic (3.31e-2)" "unprognostic (6.40e-2)" "unprognostic (8.13e-2)" "unprognostic (8.65e-2)" "unprognostic (7.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" "unprognostic (3.17e-3)" "unprognostic (2.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" 79.6 24.3 14.0 6.2 23.2 8.3 30.4 11.6 32.0 49.1 7.1 8.5 18.6 5.9 19.9 17.1 10.9 11.6 11.8 20.1 14.7 15.5 30.2 85.9 5.6 3.7 10.0 22.5 33.5 17.5 7.2 81.3 2.6 22.2 17.8 6.9 6.6 49.4 51.8 37.2 9.1 6.1 4.3 19.6 12.2 6.1 13.8 8.9 9.1 37.7 9.2 2.5 6.2 5.5 0.0 48.0 0.0 1.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 33.7 1.8 0.1 0.4 0.6 0.0 0.1 1.3 0.0 0.0 3.8 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 3.7 0.2 0.0 0.1 8.2 0.0 0.3 0.0 0.1 0.0 0.0 0.1 3.4 6.1 0.5 0.6 2.0 32.2 0.0 0.0 0.7 0.0 6.1 0.2 0.5 0.4 7.0 0.0 0.0 1.8 0.0 0.3 0.2 0.1 6.9 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.0 0.0 0.3 14.0 23.2 11.6 32.0 14.7 15.5 10.0 22.5 22.2 8.9 RASGEF1B "FLJ31695, GPIG4" ENSG00000138670 "RasGEF domain family member 1B" Q0VAM2 4 81426393-82044244 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 12.2;Daudi: 15.6;Karpas-707: 10.5;NTERA-2: 7.2;SCLC-21H: 7.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "intermediate monocyte: 7.7;memory B-cell: 6.4;naive B-cell: 8.8;non-classical monocyte: 12.4;plasmacytoid DC: 18.0" "Group enriched" "Detected in many" 5 "B-cells: 8.8;dendritic cells: 18.0;monocytes: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044574 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044574: AB_10794292" "unprognostic (3.24e-1)" "prognostic favourable (6.40e-4)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "prognostic favourable (1.49e-5)" "unprognostic (4.42e-2)" "unprognostic (6.31e-2)" "unprognostic (4.43e-1)" "unprognostic (4.85e-2)" "unprognostic (1.13e-2)" "unprognostic (3.88e-2)" "prognostic favourable (4.21e-6)" "unprognostic (4.19e-3)" "unprognostic (1.44e-2)" "unprognostic (3.19e-2)" "unprognostic (6.04e-2)" 11.7 5.3 12.2 8.4 18.9 22.2 14.3 3.5 8.4 7.6 8.0 10.0 2.6 10.8 3.0 9.9 10.9 6.6 10.1 4.9 6.2 8.2 9.4 32.8 19.1 9.2 13.0 3.5 3.3 2.5 1.7 12.6 10.3 38.3 3.8 6.0 6.1 9.7 4.2 3.5 20.3 10.7 5.0 8.7 13.2 12.2 1.9 19.3 8.0 3.9 4.7 8.5 4.8 5.6 8.8 18.0 0.8 12.4 2.5 2.0 0.7 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 12.2 0.3 15.6 0.0 0.0 0.3 1.0 0.1 0.0 0.1 2.3 1.3 1.0 0.5 0.5 0.3 0.7 0.2 0.5 0.0 0.5 0.0 0.2 10.5 0.0 0.5 5.0 0.5 7.2 3.2 1.5 0.1 5.9 0.5 0.2 7.0 0.1 0.0 2.2 0.0 1.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.0 4.7 1.1 0.2 0.2 0.4 2.1 0.2 1.4 7.7 1.5 6.4 1.1 1.1 1.7 8.8 2.0 1.9 0.8 2.5 12.4 18.0 0.3 0.7 12.2 18.9 3.5 8.4 6.2 8.2 13.0 3.5 38.3 19.3 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.4;skeletal muscle: 28.7" "Group enriched" "Detected in some" 6 "Daudi: 29.3;HEL: 30.9;U-266/70: 48.4;U-266/84: 18.4;U-698: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4" "Group enriched" "Detected in many" 16 "B-cells: 13.4;granulocytes: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA058937: " "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.6 9.4 13.6 13.3 3.2 4.9 2.0 9.6 3.1 3.5 35.0 0.0 5.7 2.6 1.3 2.0 2.1 5.0 24.3 13.4 8.8 5.1 4.1 5.8 19.8 25.2 5.5 1.6 3.7 9.3 3.1 8.2 19.9 2.1 5.3 6.7 5.4 1.7 28.7 2.3 4.5 3.7 42.4 10.1 5.4 1.3 26.3 1.9 6.7 5.0 25.0 5.4 2.1 13.4 0.2 11.4 0.1 0.2 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 1.5 4.4 0.8 0.2 29.3 0.1 0.2 0.0 0.0 0.0 0.4 3.0 0.3 30.9 0.2 0.0 0.4 0.1 4.2 0.0 0.0 0.0 0.0 1.7 0.1 1.6 0.6 0.0 0.2 2.3 0.1 0.0 0.0 1.4 0.0 0.3 1.8 0.2 0.0 0.0 0.1 1.4 0.0 0.1 0.5 0.1 0.1 0.1 0.2 48.4 18.4 12.9 0.0 0.1 0.1 11.4 0.0 0.0 0.3 0.0 0.4 10.4 0.5 0.5 0.2 13.4 0.7 0.2 0.0 0.2 0.1 0.0 0.7 0.9 9.4 13.3 2.0 9.6 13.4 8.8 25.2 5.5 19.9 26.3 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1" "Group enriched" "Detected in some" 5 "HEL: 18.9;HMC-1: 18.9;U-937: 4.9" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 4.5 1.8 2.4 8.0 3.3 23.3 5.4 0.7 1.8 1.8 1.7 2.8 0.1 1.4 1.6 2.9 1.6 2.6 3.4 6.2 2.0 1.3 1.5 1.8 11.8 23.1 3.4 0.2 1.1 1.6 0.5 0.9 3.0 1.8 1.7 1.2 1.7 1.6 0.8 1.5 1.4 2.4 2.7 4.2 19.2 1.9 0.8 2.4 0.5 1.0 0.2 1.0 2.6 3.1 0.1 5.2 22.4 9.5 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 18.9 0.0 0.0 0.0 0.1 18.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 6.0 7.1 10.6 0.0 8.5 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 22.4 0.0 9.5 0.4 0.7 2.1 2.4 3.3 0.7 1.8 2.0 1.3 3.4 0.2 1.8 2.4 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.0;RH-30: 53.4;RPMI-8226: 17.4;U-937: 27.3;WM-115: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038834 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA038834: AB_10795576" "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 1.9 3.8 6.0 0.3 1.3 0.2 0.3 0.6 1.1 1.5 0.1 0.0 0.7 0.2 0.0 0.8 0.9 0.9 11.9 0.0 0.0 0.0 12.4 6.3 0.8 0.0 4.4 0.0 0.6 0.0 0.9 0.0 21.0 0.9 0.0 0.9 13.6 0.3 0.4 2.5 53.4 17.4 0.1 0.3 0.3 0.2 0.0 0.1 0.6 0.3 10.4 0.2 0.1 1.2 1.0 2.0 0.2 0.2 0.0 6.3 27.3 17.7 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 RASSF6 ENSG00000169435 "Ras association domain family member 6" Q6ZTQ3 4 73571550-73620631 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.9" "Cell line enhanced" "Detected in some" "Daudi: 31.6;hTERT-HME1: 9.5;RPTEC TERT1: 10.1;RT4: 29.4;U-266/70: 8.7;U-698: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "memory B-cell: 6.4" "Lineage enriched" "Detected in single" 13 "B-cells: 6.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037712 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA037712: " "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (3.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.05e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (6.76e-2)" "unprognostic (3.89e-2)" "unprognostic (5.86e-2)" "unprognostic (2.95e-1)" "unprognostic (8.97e-3)" "unprognostic (5.03e-2)" 0.5 0.3 0.3 12.9 0.3 0.0 4.8 0.3 0.3 1.8 12.1 0.4 3.7 5.8 0.4 3.7 3.7 1.3 7.7 0.3 0.3 0.5 13.4 1.2 4.2 3.0 0.3 0.1 1.8 11.3 0.0 2.2 11.2 1.1 6.4 7.8 0.4 5.1 6.3 0.4 3.1 23.2 2.1 0.5 0.6 21.5 0.9 0.1 77.9 3.3 2.0 8.2 11.0 2.5 6.4 0.0 0.4 0.0 0.0 0.4 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 5.1 31.6 0.5 0.0 1.6 0.0 2.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.5 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 10.1 29.4 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.7 0.0 25.8 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 6.4 0.4 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.1 1.1 0.1 RAVER2 "FLJ10770, KIAA1579" ENSG00000162437 "Ribonucleoprotein, PTB binding 2" Q9HCJ3 1 64745095-64833232 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "basophil: 7.8" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.8" "Low region specificity" "Detected in all" HPA045785 Approved Approved Nucleoplasm Nucleoplasm "HPA045785: AB_10964058" "unprognostic (8.02e-2)" "unprognostic (5.23e-2)" "unprognostic (4.23e-3)" "unprognostic (2.73e-1)" "unprognostic (2.32e-1)" "unprognostic (2.89e-2)" "unprognostic (2.22e-3)" "unprognostic (1.23e-2)" "unprognostic (3.14e-1)" "unprognostic (1.47e-1)" "unprognostic (6.56e-2)" "unprognostic (1.09e-1)" "prognostic favourable (5.14e-6)" "unprognostic (1.74e-1)" "unprognostic (3.50e-2)" "unprognostic (1.41e-1)" "unprognostic (5.09e-2)" 5.2 9.6 13.2 9.2 14.0 7.8 9.0 17.4 9.3 11.5 21.8 7.2 13.9 22.3 9.1 5.9 10.8 7.5 15.2 17.1 13.4 8.1 7.5 1.7 7.9 1.9 8.6 6.1 8.2 7.3 15.2 27.7 6.9 9.1 12.0 25.7 12.6 15.3 15.1 18.5 6.5 41.4 9.1 9.5 4.6 11.8 2.6 7.4 7.0 7.2 10.7 6.8 8.4 8.4 0.2 0.9 7.8 0.1 0.2 0.4 0.0 10.2 3.2 9.8 10.6 1.7 1.5 2.6 2.3 4.1 4.7 5.3 8.4 4.6 0.0 5.3 2.4 7.8 9.9 6.9 5.8 0.0 11.0 12.4 8.5 7.5 3.3 16.7 0.1 4.4 6.3 0.3 4.9 7.7 2.7 10.4 0.4 3.8 5.6 3.4 12.0 8.5 19.1 15.3 4.1 5.1 7.7 7.4 16.5 10.3 0.0 10.0 8.0 2.7 2.9 4.4 7.2 4.3 8.1 7.9 8.9 4.3 2.6 0.0 4.0 7.8 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.0 0.4 0.1 0.0 13.2 14.0 17.4 9.3 13.4 8.1 8.6 6.1 9.1 7.4 RBM12B ENSG00000183808 "RNA binding motif protein 12B" Q8IXT5 8 93729356-93741017 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024398, HPA053050" Uncertain Approved Nucleoplasm Nucleoplasm "HPA024398: AB_1856109, HPA053050: " "unprognostic (4.57e-2)" "unprognostic (7.72e-2)" "unprognostic (3.39e-1)" "unprognostic (3.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.66e-2)" "unprognostic (2.40e-3)" "unprognostic (3.05e-1)" "unprognostic (3.92e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.54e-2)" "unprognostic (1.84e-3)" "unprognostic (9.15e-2)" "unprognostic (4.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.62e-2)" 10.0 10.6 14.1 15.5 14.5 9.3 13.2 22.9 15.1 18.1 10.8 16.2 11.0 10.1 24.3 11.4 11.4 13.6 9.5 14.8 12.3 7.3 10.7 10.0 12.3 20.6 13.3 12.3 28.0 11.4 15.3 21.1 14.8 11.7 15.2 10.8 13.4 15.3 10.2 12.6 9.4 13.1 16.6 14.5 14.3 11.8 18.9 14.2 22.0 18.1 7.4 18.2 13.2 16.6 3.4 3.9 13.4 3.2 3.7 6.1 2.7 12.3 9.4 24.0 17.0 5.9 11.4 11.6 10.4 7.7 11.9 12.5 7.0 16.9 21.8 16.6 5.8 12.6 20.7 5.5 13.4 15.3 10.7 28.2 21.8 6.0 7.0 10.4 14.3 7.4 7.2 7.8 7.8 8.0 23.1 18.3 10.5 7.1 19.3 8.2 0.1 10.0 14.4 17.0 7.2 6.1 10.6 15.8 12.5 11.2 3.5 8.8 13.6 8.1 15.5 11.2 16.9 8.1 10.7 21.5 15.7 18.4 7.9 14.9 18.7 13.4 3.0 5.8 3.5 2.9 5.0 2.2 4.4 3.4 3.1 3.4 6.1 5.0 4.5 3.7 3.2 3.9 4.9 2.7 14.1 14.5 22.9 15.1 12.3 7.3 13.3 12.3 11.7 14.2 RBM14-RBM4 ENSG00000248643 "RBM14-RBM4 readthrough" 11 66616626-66646469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047849 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047849: " "unprognostic (2.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" "unprognostic (2.52e-2)" "unprognostic (2.01e-2)" "unprognostic (1.37e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-4)" "unprognostic (3.92e-2)" "unprognostic (2.52e-1)" "unprognostic (3.77e-4)" "unprognostic (5.74e-7)" "unprognostic (1.43e-1)" "unprognostic (2.53e-2)" "unprognostic (1.30e-1)" "unprognostic (3.10e-2)" 7.3 5.9 5.7 7.4 7.7 13.9 5.0 12.3 8.2 5.4 7.5 6.9 7.5 2.8 8.1 11.4 6.4 4.9 7.1 12.2 5.9 5.4 6.2 14.7 6.3 6.4 8.5 4.9 6.0 7.9 2.8 9.1 5.9 5.5 7.6 4.8 7.5 5.8 5.8 9.3 4.0 6.3 7.3 5.3 7.5 7.7 11.9 6.5 13.2 7.2 4.9 9.2 6.7 5.7 8.6 10.8 7.5 6.4 4.3 5.4 4.4 2.1 1.4 0.8 1.8 1.5 0.2 1.1 1.1 0.5 2.0 0.4 3.4 0.6 0.7 1.2 0.2 3.6 1.4 0.4 0.5 0.0 0.6 3.2 1.3 2.3 0.6 1.8 1.7 0.0 0.3 0.9 0.2 0.0 4.6 1.5 1.1 3.7 2.5 12.1 1.2 4.6 1.8 5.1 0.6 0.4 2.3 2.6 0.9 0.6 1.7 6.8 0.8 1.3 0.0 2.6 2.5 1.7 1.4 0.2 0.6 1.5 0.9 1.1 0.8 6.4 6.4 7.5 5.4 5.6 3.8 8.6 3.6 4.1 6.7 8.0 1.3 3.1 3.5 4.3 5.3 10.8 2.3 4.4 5.7 7.7 12.3 8.2 5.9 5.4 8.5 4.9 5.5 6.5 RBM18 MGC2734 ENSG00000119446 "RNA binding motif protein 18" Q96H35 9 122237624-122264839 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057281, HPA077955" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Midbody,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Midbody, Cytosol" "HPA057281: , HPA077955: " "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (9.39e-3)" "unprognostic (7.27e-3)" "unprognostic (2.79e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "prognostic favourable (8.00e-7)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 12.8 14.8 16.5 9.1 16.5 15.1 24.6 18.1 20.3 14.4 13.4 10.5 13.7 10.4 13.6 16.2 11.8 11.6 11.7 27.2 16.7 18.6 17.3 12.2 10.7 10.9 17.8 13.2 15.1 13.7 16.0 18.2 16.2 16.3 17.2 12.6 8.2 12.6 13.9 29.4 10.1 10.8 13.2 16.0 12.4 12.3 7.6 15.0 11.9 15.3 13.5 11.1 13.0 14.4 8.7 9.5 16.0 13.0 7.7 10.0 8.2 5.8 6.1 8.4 9.3 12.5 15.4 7.4 13.3 11.0 9.2 8.5 7.0 5.8 10.2 5.8 8.6 13.8 13.1 13.9 11.6 10.5 6.0 7.6 10.2 5.9 14.0 15.2 10.6 13.1 15.8 9.6 19.7 13.1 10.4 8.1 13.7 6.4 7.9 9.4 6.5 10.2 7.0 17.5 13.9 12.8 6.6 17.7 9.3 10.0 14.2 15.1 8.2 8.6 7.2 8.6 4.9 13.7 13.0 11.8 21.7 8.6 14.2 9.4 10.3 6.8 9.2 16.0 10.0 10.5 9.6 8.7 8.9 9.7 9.5 6.0 9.3 9.7 9.7 7.7 13.0 6.9 9.1 8.2 16.5 16.5 18.1 20.3 16.7 18.6 17.8 13.2 16.3 15.0 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.5;RH-30: 15.5;SH-SY5Y: 14.3;T-47d: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Low region specificity" "Detected in many" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytokinetic bridge" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.0 0.0 0.0 0.4 1.3 0.0 15.5 0.0 0.0 0.0 0.1 14.3 0.1 0.0 0.6 8.7 0.0 0.0 0.2 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 RBM23 "CAPERbeta, FLJ10482, RNPC4" ENSG00000100461 "RNA binding motif protein 23" Q86U06 14 22893206-22919184 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004144 Uncertain Approved "Nucleoplasm,Intermediate filaments" "Intermediate filaments" Nucleoplasm "HPA004144: AB_1079747" "unprognostic (5.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (2.14e-2)" "unprognostic (1.06e-1)" "unprognostic (4.27e-2)" "unprognostic (4.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.29e-1)" "prognostic favourable (8.06e-9)" "unprognostic (4.41e-2)" "unprognostic (3.06e-1)" "unprognostic (5.05e-2)" "unprognostic (1.81e-1)" 18.7 26.9 22.0 22.1 29.3 28.1 24.8 33.7 35.7 28.6 22.5 26.9 25.9 18.3 35.0 24.7 25.9 36.9 24.2 20.3 19.9 24.2 27.8 27.0 25.2 25.0 19.7 23.7 40.8 23.2 56.6 37.5 43.9 23.9 27.2 25.7 35.4 25.3 25.8 18.0 22.3 24.8 28.2 22.6 32.7 25.3 23.5 26.7 44.0 42.4 19.7 31.2 24.8 34.9 14.0 17.8 49.9 17.2 20.5 14.3 9.8 19.7 31.4 32.0 16.7 17.6 15.1 13.4 21.7 29.8 42.4 33.3 14.1 24.4 33.2 17.2 20.1 28.2 35.9 18.2 34.6 26.0 29.6 15.6 24.5 1.0 27.7 30.0 25.7 19.3 25.3 24.4 16.2 23.6 19.7 21.6 20.8 25.3 32.8 13.5 14.2 29.5 28.3 26.6 20.2 16.5 28.1 22.1 24.7 32.6 25.3 13.7 18.7 17.8 21.8 7.4 12.6 17.6 20.1 20.5 26.2 31.4 12.3 17.3 26.3 11.3 17.2 17.6 14.3 13.3 9.8 10.8 10.2 12.3 17.8 14.0 12.5 10.9 49.9 20.5 16.4 9.3 10.4 9.8 22.0 29.3 33.7 35.7 19.9 24.2 19.7 23.7 23.9 26.7 RBM33 "DKFZp434D1319, DKFZp686F102, MGC20460, PRR8" ENSG00000184863 "RNA binding motif protein 33" Q96EV2 7 155644451-155781485 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019232, HPA021497, HPA021768" Approved Approved Nucleoplasm Nucleoplasm "HPA019232: AB_1856121, HPA021497: AB_2176261, HPA021768: AB_1856123" "unprognostic (1.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (3.04e-2)" "unprognostic (2.06e-1)" "prognostic favourable (9.63e-5)" "unprognostic (3.48e-2)" "unprognostic (2.07e-2)" "unprognostic (6.85e-2)" "unprognostic (3.89e-2)" "unprognostic (8.90e-2)" "unprognostic (7.13e-2)" "prognostic unfavourable (1.05e-4)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.46e-2)" "prognostic favourable (4.29e-4)" 16.8 14.1 18.6 24.5 20.9 65.0 16.2 46.1 27.6 14.8 15.1 24.1 13.4 17.2 16.3 21.9 16.4 11.9 14.1 13.2 16.3 12.5 15.6 21.0 19.8 21.1 22.8 14.9 19.3 20.5 14.3 29.1 13.2 16.4 15.7 16.2 13.8 15.9 13.6 33.0 26.9 20.8 14.0 25.5 21.4 17.1 16.0 20.8 28.5 17.3 10.2 19.7 13.8 18.7 5.7 5.7 23.9 6.8 5.0 5.6 2.5 16.6 19.6 12.3 11.4 6.6 8.7 12.5 10.5 7.5 6.5 9.5 17.8 16.0 18.4 14.3 7.7 12.0 11.2 8.8 8.7 17.4 16.2 17.6 20.5 11.6 7.4 24.6 17.7 8.4 10.5 10.4 14.9 11.4 22.3 15.3 9.2 16.1 25.4 21.4 13.3 12.9 20.5 13.8 15.2 9.4 18.0 12.7 13.0 17.6 11.9 9.9 9.0 13.1 13.4 11.1 6.6 19.9 14.0 27.0 20.4 27.4 18.2 16.4 14.1 16.3 6.8 13.7 4.5 6.3 3.6 5.7 4.5 5.4 5.6 5.3 4.1 5.2 23.9 5.0 4.9 5.7 5.6 2.5 18.6 20.9 46.1 27.6 16.3 12.5 22.8 14.9 16.4 20.8 RBM34 KIAA0117 ENSG00000188739 "RNA binding motif protein 34" P42696 1 235131183-235161457 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028606 Approved Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028606: AB_10601494" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (7.30e-2)" "unprognostic (3.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (6.57e-4)" "unprognostic (2.98e-2)" "unprognostic (5.65e-3)" "unprognostic (2.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-8)" "unprognostic (8.50e-2)" "unprognostic (1.85e-1)" "unprognostic (8.73e-2)" "unprognostic (7.09e-4)" 15.8 10.5 17.2 16.4 18.1 30.6 14.8 15.5 22.3 11.0 13.5 10.6 7.0 16.7 10.9 15.2 15.4 9.9 11.3 15.2 13.4 11.6 19.4 14.2 11.5 20.0 16.9 9.9 13.9 13.5 6.6 24.9 14.7 20.9 13.5 12.6 7.6 18.3 11.2 22.2 17.9 17.6 10.9 17.9 14.6 13.1 28.8 17.3 17.5 14.7 10.9 17.1 14.1 16.0 34.2 27.2 38.0 19.2 25.3 35.5 22.7 12.0 9.1 9.5 12.0 7.1 12.9 23.5 12.7 8.9 11.4 11.0 12.3 13.7 20.6 13.8 7.6 18.0 11.2 11.6 11.0 18.7 18.2 15.4 6.4 8.5 14.3 24.4 15.2 11.3 13.4 10.6 7.3 9.1 21.9 10.6 14.3 6.9 21.2 21.0 27.4 6.4 19.9 10.4 23.9 11.8 9.2 11.7 21.3 17.5 11.3 28.6 24.4 26.6 9.5 11.6 10.1 16.0 25.4 12.9 20.8 21.8 13.6 16.4 18.1 38.0 16.9 20.4 23.7 19.2 28.2 34.2 27.3 30.4 17.2 26.3 26.0 29.9 8.2 25.3 19.1 27.2 35.5 22.7 17.2 18.1 15.5 22.3 13.4 11.6 16.9 9.9 20.9 17.3 RBM39 "CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2" ENSG00000131051 "RNA binding motif protein 39" Q14498 20 35701347-35742312 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001591 Supported Supported "Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite" "Nucleoplasm, Nuclear speckles" "Microtubules, Centriolar satellite" "HPA001591: AB_1079749" "unprognostic (1.37e-2)" "unprognostic (4.97e-1)" "unprognostic (2.72e-2)" "unprognostic (9.09e-2)" "unprognostic (3.47e-1)" "unprognostic (4.99e-2)" "unprognostic (3.55e-3)" "unprognostic (4.56e-2)" "unprognostic (7.83e-2)" "unprognostic (2.65e-1)" "unprognostic (2.04e-2)" "unprognostic (7.65e-3)" "prognostic unfavourable (2.78e-5)" "unprognostic (1.88e-1)" "unprognostic (2.86e-1)" "unprognostic (2.64e-1)" "unprognostic (2.28e-3)" 41.4 44.1 37.5 41.5 41.4 120.8 38.5 57.5 41.8 43.4 35.0 30.7 46.3 29.5 51.9 34.3 42.8 35.3 40.7 40.2 35.8 29.9 39.2 32.4 40.4 41.8 41.1 31.4 52.3 35.6 40.9 71.5 45.2 37.4 39.2 27.0 28.9 37.1 46.0 44.1 32.1 30.6 40.2 43.0 38.4 33.5 22.9 46.4 52.4 40.7 28.2 40.5 39.9 46.1 27.6 32.5 88.9 25.1 24.2 22.5 16.8 28.7 26.7 27.8 24.6 21.9 24.9 30.3 38.6 19.3 25.2 23.8 38.6 26.7 39.7 30.1 14.9 27.2 41.2 24.4 29.1 26.6 29.5 52.8 27.0 44.6 24.8 48.6 33.0 10.1 42.4 21.1 24.0 23.5 54.4 35.4 21.6 24.9 56.5 35.0 33.5 32.0 34.5 44.1 29.9 22.9 20.8 27.1 23.5 30.2 38.5 33.7 25.9 34.3 27.0 32.8 28.1 30.4 34.6 22.8 46.3 58.3 22.5 39.1 24.0 41.2 25.1 38.2 22.5 22.1 22.1 25.3 19.8 20.7 22.4 27.6 18.9 18.0 88.9 24.2 19.4 32.5 22.1 16.8 37.5 41.4 57.5 41.8 35.8 29.9 41.1 31.4 37.4 46.4 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638617-66666682 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042174: , HPA047849: " "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 41.6 50.3 37.1 34.4 37.2 57.5 38.3 55.5 43.9 40.6 39.1 35.5 43.4 33.9 42.2 48.3 44.5 37.4 33.6 33.0 32.1 31.0 40.9 37.2 34.3 44.7 30.1 32.7 51.1 63.9 44.9 41.5 42.5 31.1 42.7 33.2 41.3 54.6 33.2 40.8 37.4 36.2 36.7 26.9 48.5 42.1 47.3 32.2 68.2 59.5 37.9 48.7 36.5 37.2 51.4 45.0 61.7 51.9 57.5 72.7 54.3 26.5 35.2 53.5 30.1 19.7 21.4 32.5 28.1 22.8 29.6 21.3 58.7 34.7 34.4 38.8 28.1 29.7 57.1 33.4 31.8 34.1 29.7 46.8 36.0 34.9 39.0 32.0 20.4 31.3 29.1 34.1 48.4 39.2 36.8 25.5 30.9 54.9 52.6 32.9 67.2 38.8 49.2 50.2 38.0 39.3 43.1 45.1 32.5 49.5 36.3 78.7 69.0 32.2 39.8 31.0 27.3 19.1 22.7 32.0 33.4 55.6 24.8 25.3 44.2 61.7 45.7 48.6 56.8 46.8 51.0 48.0 59.0 61.8 45.0 51.4 63.8 63.5 53.6 57.5 51.9 40.6 72.7 54.3 37.1 37.2 55.5 43.9 32.1 31.0 30.1 32.7 31.1 32.2 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 26.0 22.0 16.6 20.3 16.0 29.2 23.6 12.1 23.4 20.4 27.3 22.6 18.8 24.2 25.5 21.8 25.5 18.3 23.6 24.9 13.7 12.0 22.2 33.3 19.3 19.2 15.7 17.6 27.6 17.7 20.7 15.0 41.3 16.0 19.5 9.9 15.9 25.1 24.6 44.6 31.5 24.7 18.6 18.1 25.4 22.0 23.7 16.0 41.1 25.8 21.9 21.3 21.2 22.4 43.6 49.1 61.3 48.9 38.9 45.6 33.9 32.4 51.1 11.4 15.5 10.4 8.3 31.2 22.3 12.4 26.4 20.8 30.1 21.2 18.1 40.9 14.2 13.4 13.1 15.7 7.7 46.8 23.4 24.9 17.0 24.6 27.1 22.0 24.1 11.7 12.6 19.4 10.7 14.4 25.9 14.9 11.9 36.9 27.8 29.1 13.0 21.1 30.4 15.6 18.0 12.5 15.1 15.0 21.7 25.4 20.9 17.0 16.7 34.7 21.9 18.8 25.8 24.9 38.8 36.5 38.4 27.8 18.2 21.0 26.3 46.1 42.1 61.3 45.6 48.9 39.3 41.0 37.9 45.5 49.1 43.6 34.2 37.7 38.6 38.9 45.4 45.4 41.9 33.9 16.6 16.0 12.1 23.4 13.7 12.0 15.7 17.6 16.0 16.0 RBM43 "C2orf38, FLJ45645" ENSG00000184898 "RNA binding motif protein 43" Q6ZSC3 2 151247940-151261879 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0;HSkMC: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038204 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA038204: AB_10669520" "unprognostic (3.50e-2)" "unprognostic (5.45e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (1.12e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (9.72e-3)" "unprognostic (2.57e-2)" "unprognostic (3.43e-3)" "unprognostic (1.22e-2)" "unprognostic (3.07e-2)" "unprognostic (1.12e-2)" "unprognostic (9.94e-2)" 10.7 14.8 5.2 7.6 6.4 6.0 7.9 1.6 4.9 14.4 8.1 5.4 7.4 3.1 14.6 14.6 8.4 13.6 7.2 4.4 6.0 4.8 7.8 7.0 14.3 13.6 4.5 5.3 17.6 6.8 8.7 7.8 6.0 4.3 14.4 4.7 14.3 6.2 8.9 4.5 6.2 6.3 11.5 5.6 8.4 5.9 6.5 4.1 11.0 13.4 3.6 6.9 20.5 6.6 3.2 1.1 5.9 4.6 5.3 4.9 1.2 2.9 1.8 3.0 4.0 8.2 18.0 2.0 3.4 7.8 4.3 6.2 0.1 4.8 2.3 1.3 6.0 1.5 0.9 3.9 2.2 3.4 2.1 5.4 0.7 0.2 8.0 6.6 1.9 16.2 4.3 3.4 2.5 9.0 2.2 2.5 5.8 2.9 3.8 3.2 1.1 3.5 2.6 3.5 1.3 7.2 2.5 1.1 3.6 3.2 2.4 6.3 3.5 4.3 5.1 3.2 2.9 2.7 1.4 0.9 0.6 0.0 8.4 2.7 1.9 1.9 1.7 5.9 2.8 2.1 4.6 2.8 3.9 3.5 1.1 3.2 4.9 3.4 2.0 5.3 4.6 0.5 1.9 1.2 5.2 6.4 1.6 4.9 6.0 4.8 4.5 5.3 4.3 4.1 RBM4B "MGC10871, RBM30, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B" ENSG00000173914 "RNA binding motif protein 4B" Q9BQ04 11 66664998-66677921 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA042174: , HPA047849: " "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (3.32e-2)" "unprognostic (1.98e-3)" "unprognostic (3.57e-1)" "unprognostic (1.87e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.28e-1)" "unprognostic (1.09e-2)" "unprognostic (6.22e-2)" "prognostic favourable (2.10e-4)" "unprognostic (1.05e-2)" "prognostic unfavourable (1.02e-4)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.29e-2)" "unprognostic (1.71e-2)" 7.1 12.3 17.6 9.6 17.3 4.0 10.2 35.9 19.3 13.4 10.0 22.8 13.5 9.3 19.0 20.2 10.1 18.3 9.8 9.2 17.5 17.4 9.9 9.8 8.8 13.8 15.4 16.2 29.8 11.8 15.7 25.6 12.2 17.3 14.6 11.5 14.5 14.1 15.0 13.9 17.4 10.3 14.0 16.4 11.8 9.8 17.0 18.7 8.5 12.3 7.6 15.5 11.3 11.5 21.8 11.4 26.8 15.1 13.2 12.5 8.4 13.5 13.6 29.8 24.9 14.7 15.1 10.1 13.0 13.1 14.6 15.0 19.0 14.2 15.1 18.7 16.4 17.6 19.6 17.9 15.5 14.6 13.3 16.5 17.1 20.2 10.8 16.6 16.3 15.7 12.3 14.9 12.7 14.0 12.5 15.2 19.6 21.7 10.3 12.8 17.8 18.3 21.1 23.8 15.5 13.3 13.7 18.4 16.8 15.6 8.0 29.1 21.3 15.8 12.9 16.2 16.6 15.7 11.6 7.5 12.6 15.5 14.9 11.8 14.2 12.7 9.6 26.8 10.8 14.1 10.4 21.8 10.1 10.4 11.4 18.6 12.5 9.2 6.1 13.2 15.1 9.4 7.4 8.4 17.6 17.3 35.9 19.3 17.5 17.4 15.4 16.2 17.3 18.7 RBMS2 SCR3 ENSG00000076067 "RNA binding motif single stranded interacting protein 2" Q15434 12 56521929-56596196 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039225, HPA058784" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA039225: AB_10963056, HPA058784: " "unprognostic (1.35e-1)" "unprognostic (5.31e-2)" "unprognostic (2.61e-1)" "unprognostic (5.29e-2)" "unprognostic (9.09e-2)" "unprognostic (3.19e-3)" "unprognostic (4.78e-2)" "unprognostic (1.89e-2)" "unprognostic (7.01e-2)" "unprognostic (2.80e-1)" "unprognostic (2.86e-2)" "unprognostic (2.15e-1)" "prognostic favourable (3.22e-4)" "unprognostic (2.67e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (2.63e-2)" 24.5 7.2 5.7 5.8 10.0 3.6 31.3 8.5 8.7 12.2 9.9 6.0 6.1 4.7 17.5 11.9 9.3 10.4 10.4 19.3 8.6 5.1 12.4 4.4 53.1 8.0 7.5 5.2 12.6 7.5 11.5 12.1 24.8 11.4 9.6 9.6 14.3 10.3 9.8 9.3 7.5 7.5 12.9 19.2 13.2 8.0 4.8 7.4 2.7 16.5 8.1 5.3 11.7 19.2 1.1 4.9 3.0 8.3 2.1 2.3 1.5 11.5 9.7 4.2 6.1 10.2 9.9 4.2 14.7 15.2 11.3 10.0 7.6 20.6 0.2 17.6 14.9 8.4 3.8 23.4 12.7 3.8 3.1 1.4 7.5 2.3 6.6 1.6 2.7 8.8 5.9 11.8 13.9 20.8 0.7 2.8 19.2 1.5 1.6 1.9 2.5 3.6 0.9 4.6 0.2 14.0 2.8 0.4 3.2 17.1 6.2 2.1 6.6 3.1 31.8 7.1 15.1 3.9 3.4 2.5 1.1 0.8 2.5 0.4 9.8 1.0 8.3 2.6 1.6 2.6 1.7 0.6 0.7 2.3 4.9 1.1 1.8 1.2 3.0 2.1 0.6 1.3 0.9 1.5 5.7 10.0 8.5 8.7 8.6 5.1 7.5 5.2 11.4 7.4 RBMX "hnRNP-G, HNRNPG, RNMX" ENSG00000147274 "RNA binding motif protein, X-linked" P38159 X 136848004-136880764 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Cancer-related genes, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm Nucleoplasm "HPA057707: " "unprognostic (1.53e-1)" "unprognostic (1.52e-3)" "unprognostic (2.12e-3)" "unprognostic (1.14e-2)" "unprognostic (2.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavourable (5.16e-6)" "unprognostic (5.59e-2)" "unprognostic (1.05e-2)" "unprognostic (1.68e-2)" "unprognostic (4.87e-2)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (1.57e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.64e-3)" 31.0 25.0 30.6 57.1 41.1 48.0 40.6 28.7 33.0 44.2 28.3 32.5 32.7 24.6 45.9 31.7 26.7 38.9 22.1 31.4 26.5 18.0 25.6 20.9 34.4 64.6 34.0 29.3 81.9 39.1 30.1 30.1 25.3 30.5 28.4 33.4 27.5 29.9 29.4 50.0 27.6 27.3 43.0 44.2 27.4 30.1 23.6 29.2 70.1 31.5 34.4 44.8 36.1 33.4 47.1 41.9 25.0 44.9 39.4 60.7 62.9 39.9 43.7 80.1 35.6 20.0 34.0 46.8 39.9 43.5 55.3 58.7 46.6 40.2 72.8 41.3 28.5 26.8 85.0 41.7 64.1 31.4 40.0 55.7 43.0 49.6 17.6 60.7 51.3 27.8 20.2 43.0 60.3 44.5 49.9 37.4 44.9 50.9 88.6 41.0 50.8 36.6 73.7 53.6 44.9 41.0 47.9 46.8 50.6 31.8 28.8 36.9 33.1 41.0 28.2 31.4 34.1 21.7 50.7 26.8 35.7 77.1 22.4 44.4 42.7 25.0 37.5 20.8 36.4 44.9 50.3 47.1 47.4 43.1 41.9 45.0 60.7 49.6 6.0 39.4 39.2 25.4 46.8 62.9 30.6 41.1 28.7 33.0 26.5 18.0 34.0 29.3 30.5 29.2 RBMXL1 KAT3 ENSG00000213516 "RNA binding motif protein, X-linked like 1" Q96E39 1 88979456-88992960 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA057707 Supported Approved Nucleoplasm Nucleoplasm "HPA057707: " "prognostic favourable (7.60e-4)" "unprognostic (2.22e-1)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-1)" "unprognostic (5.84e-2)" "unprognostic (1.17e-3)" "unprognostic (2.89e-1)" "unprognostic (2.09e-1)" "unprognostic (1.03e-2)" "prognostic unfavourable (7.26e-4)" "unprognostic (2.55e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" "unprognostic (2.35e-1)" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" 13.3 9.8 18.5 11.7 15.3 23.8 13.4 12.0 18.0 18.2 12.2 15.3 9.7 9.8 18.5 16.2 20.9 16.7 11.5 14.0 17.1 15.2 17.4 18.3 13.0 13.5 17.1 17.0 22.8 14.5 25.0 14.1 16.7 17.9 16.3 9.5 14.8 11.8 14.3 8.9 12.1 12.2 16.9 17.4 14.4 13.9 14.2 13.0 11.7 16.2 10.1 14.0 19.3 12.4 8.8 8.6 12.3 10.1 6.3 10.8 8.4 11.1 3.3 9.5 12.4 11.3 11.5 18.2 4.7 11.0 9.8 11.4 5.4 7.6 9.4 9.5 5.7 6.5 18.0 11.8 10.8 8.5 8.0 11.1 11.6 7.2 6.5 8.8 6.2 6.6 7.0 8.7 7.8 6.3 15.6 6.2 5.8 4.2 9.3 4.6 17.4 7.6 8.6 23.4 4.7 6.4 12.9 6.9 10.6 5.2 11.7 12.0 8.5 9.2 4.5 6.3 13.0 7.4 8.1 9.8 9.2 9.7 4.4 5.4 5.7 2.5 6.6 5.9 6.9 8.9 9.3 6.7 9.7 7.3 8.6 8.8 10.8 6.6 12.3 6.3 10.1 4.4 7.6 8.4 18.5 15.3 12.0 18.0 17.1 15.2 17.1 17.0 17.9 13.0 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 161.0;pancreas: 107.4;retina: 85.3" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 134.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 56.8" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 1.9 43.1 6.5 3.3 11.3 0.1 7.5 5.1 7.8 7.8 3.2 11.5 8.4 4.5 26.8 11.3 3.3 58.4 42.7 7.5 7.7 8.1 3.7 20.1 4.9 6.5 10.4 4.9 161.0 107.4 4.3 26.2 20.6 31.5 9.8 2.1 85.3 4.7 6.4 1.8 2.9 4.8 17.5 8.7 4.7 2.8 12.9 4.3 0.9 3.3 2.6 2.0 7.7 7.2 0.5 0.5 2.1 0.9 0.7 0.4 0.2 1.2 0.3 1.1 26.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 8.6 0.0 0.0 6.0 0.1 0.0 0.0 0.7 0.0 0.4 11.0 25.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 5.1 0.0 0.0 0.0 3.1 134.2 5.5 0.0 0.0 0.5 0.1 0.0 0.0 19.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.9 0.8 0.4 0.8 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 2.1 0.7 0.5 0.5 0.1 0.2 6.5 11.3 5.1 7.8 7.7 8.1 10.4 4.9 31.5 4.3 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 24.7;HDLM-2: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA053880: " "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favourable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favourable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 5.9 0.4 0.0 0.0 0.0 0.0 0.3 24.7 0.0 0.0 0.0 0.1 49.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.1 5.5 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 RCBTB1 "CLLD7, CLLL7, FLJ10716" ENSG00000136144 "RCC1 and BTB domain containing protein 1" Q8NDN9 13 49531946-49585583 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056783 Approved Nucleoplasm Nucleoplasm "HPA056783: " "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (1.49e-1)" "unprognostic (5.70e-2)" "unprognostic (2.34e-2)" "unprognostic (2.40e-1)" "unprognostic (7.52e-2)" "prognostic favourable (5.51e-5)" "unprognostic (1.61e-1)" "prognostic unfavourable (1.21e-5)" "unprognostic (1.17e-3)" "unprognostic (1.52e-1)" "prognostic favourable (1.75e-4)" "unprognostic (1.29e-1)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (5.49e-2)" 7.4 17.6 16.9 6.5 19.7 8.8 10.3 9.4 16.9 7.0 5.0 27.5 21.3 4.5 12.2 15.1 4.1 9.6 7.0 11.1 18.3 16.5 13.7 6.2 9.3 9.4 26.5 11.2 5.8 8.2 30.9 15.3 9.2 15.8 8.4 6.3 15.1 6.0 14.6 5.0 5.8 5.6 10.8 22.7 9.9 7.4 6.4 22.3 10.9 32.0 4.1 7.7 8.5 6.5 4.6 7.4 15.3 8.1 2.5 8.7 3.2 3.0 7.1 15.7 14.2 21.0 18.3 9.2 11.7 11.7 8.9 9.2 6.0 7.8 10.5 2.6 9.6 4.4 11.6 18.1 15.4 15.2 8.9 12.5 5.7 15.2 25.2 10.0 10.0 16.3 11.1 7.4 11.9 15.4 5.5 4.6 17.8 2.8 14.3 5.8 16.3 4.3 18.8 11.8 6.6 11.1 8.4 8.3 11.0 5.9 4.6 11.6 6.1 7.2 10.8 6.7 5.4 13.9 5.7 4.7 5.7 17.1 6.0 10.0 9.4 15.3 5.8 6.1 2.9 7.2 3.4 4.6 4.8 2.3 7.4 3.2 3.0 2.8 2.9 2.5 8.1 1.0 8.7 3.2 16.9 19.7 9.4 14.3 18.3 16.5 26.5 11.2 15.8 22.3 RCBTB2 CHC1L ENSG00000136161 "RCC1 and BTB domain containing protein 2" O95199 13 48488959-48533256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 12 "MOLT-4: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040242 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA040242: AB_10795362" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (8.47e-2)" "unprognostic (9.47e-3)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-1)" "unprognostic (5.40e-3)" "unprognostic (8.28e-3)" "unprognostic (1.20e-1)" "unprognostic (4.85e-2)" "unprognostic (3.60e-1)" "prognostic favourable (2.45e-4)" "unprognostic (1.06e-2)" "unprognostic (8.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.98e-1)" 15.8 10.6 9.1 10.3 8.9 3.8 9.7 7.3 12.1 14.2 7.3 19.0 15.2 4.3 22.3 11.1 11.9 11.7 10.5 11.6 9.0 8.6 14.8 8.0 8.8 8.5 15.8 6.2 18.0 6.1 4.7 25.8 14.9 11.4 14.6 7.0 20.0 27.4 18.5 6.1 4.6 6.1 11.9 16.3 14.9 8.0 5.8 12.8 4.4 23.9 6.9 10.6 10.3 11.3 0.5 13.1 25.9 19.0 6.7 7.3 9.1 0.4 0.3 6.3 0.4 5.0 4.4 0.0 1.9 2.3 1.1 0.8 0.2 0.4 1.3 1.4 3.0 0.8 0.9 0.7 1.2 1.5 1.2 3.3 0.8 0.3 1.9 1.5 2.1 4.5 1.8 1.4 0.7 3.4 0.2 2.0 4.0 0.1 76.5 4.3 3.5 1.0 6.5 0.6 5.4 2.1 1.0 1.4 1.2 1.5 0.3 2.3 0.1 3.8 2.9 1.3 0.5 0.3 0.7 0.1 0.1 1.5 0.7 3.4 2.5 2.2 19.0 2.1 7.1 13.7 4.3 0.5 6.0 7.3 13.1 0.5 3.6 5.4 25.9 6.7 12.0 0.2 7.1 9.1 9.1 8.9 7.3 9.7 9.0 8.6 15.8 6.2 11.4 12.8 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA052184: , HPA060643: " "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavourable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 7.4 8.5 4.4 7.0 5.1 4.2 3.3 4.3 5.6 5.8 6.4 7.0 7.2 6.4 5.0 4.8 7.4 4.8 7.7 11.5 3.7 7.9 12.0 3.9 5.5 5.6 4.0 7.1 9.1 4.9 3.3 6.5 3.8 7.2 3.2 7.3 7.8 6.4 33.4 4.3 6.0 9.5 2.3 6.8 4.8 5.4 5.7 3.6 8.7 8.4 6.8 5.8 7.7 6.8 5.5 4.8 4.9 6.7 9.2 2.6 15.1 23.4 12.4 20.9 8.8 7.2 17.0 14.9 10.7 12.8 10.6 23.5 18.8 16.1 6.8 12.0 18.0 10.4 10.0 5.3 17.8 16.6 12.0 15.6 21.9 12.6 19.0 19.4 9.0 8.2 11.1 9.1 11.3 38.1 10.5 9.9 32.4 0.8 28.9 28.8 18.3 9.2 10.0 33.8 11.1 13.8 13.4 20.1 19.9 42.3 18.2 29.8 19.9 12.7 16.9 14.2 15.1 19.3 11.8 9.4 25.5 13.0 20.2 22.3 4.8 3.8 2.2 7.3 4.9 5.7 5.7 7.8 6.4 5.3 6.8 7.5 9.2 1.4 6.7 3.5 5.5 5.9 2.6 RCL1 "RNAC, RPCL1" ENSG00000120158 "RNA terminal phosphate cyclase like 1" Q9Y2P8 9 4792869-4885917 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "liver: 108.1;pancreas: 37.5" "Group enriched" "Detected in all" 4 "HDLM-2: 34.3;HEL: 88.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071308 Approved Nucleoplasm Nucleoplasm "HPA071308: " "prognostic favourable (5.48e-4)" "unprognostic (7.60e-3)" "unprognostic (7.55e-2)" "unprognostic (4.19e-2)" "unprognostic (1.07e-2)" "unprognostic (3.29e-1)" "prognostic favourable (8.02e-4)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.59e-2)" "prognostic favourable (2.40e-7)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-1)" "unprognostic (3.66e-2)" 15.9 6.8 4.2 6.7 5.9 17.2 12.9 5.5 6.3 5.6 3.8 6.2 6.3 2.4 5.5 5.4 5.5 5.6 3.8 3.7 4.1 3.6 5.7 108.1 6.9 9.1 5.8 4.2 9.0 37.5 3.8 5.1 6.8 5.6 3.6 4.2 4.5 4.8 9.1 10.9 10.5 4.1 5.2 7.1 5.0 5.2 6.8 5.6 5.7 4.5 8.1 7.2 5.3 6.8 10.4 6.8 12.9 2.3 10.8 9.1 3.5 5.5 6.6 2.5 4.0 3.8 2.5 6.7 2.6 2.8 4.9 4.1 3.3 3.3 10.6 1.8 2.3 3.5 11.6 7.8 5.7 34.3 5.9 88.1 7.9 6.6 5.4 7.9 7.2 5.7 4.5 4.7 7.2 4.8 8.9 6.9 2.9 7.1 6.4 13.7 8.7 2.7 8.0 3.3 5.6 6.0 6.2 7.3 6.0 3.3 4.8 3.8 4.6 9.3 3.3 2.9 3.2 4.0 8.0 2.8 8.0 11.5 5.3 4.9 1.9 12.9 1.5 3.8 5.6 2.3 6.8 8.0 6.6 7.6 4.0 10.4 8.9 9.1 0.6 10.8 1.2 6.8 5.5 3.5 4.2 5.9 5.5 6.3 4.1 3.6 5.8 4.2 5.6 5.6 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell line enhanced" "Detected in some" "AF22: 17.7;NTERA-2: 22.8;SCLC-21H: 35.8;SH-SY5Y: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 17.7 1.2 0.2 1.5 5.3 0.1 0.3 0.2 0.6 0.6 0.1 0.1 0.2 0.4 0.2 7.7 0.0 0.2 0.2 0.9 0.2 0.1 5.6 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.1 0.9 0.0 0.0 1.5 1.6 6.2 22.8 0.0 5.7 1.0 0.5 0.0 0.0 35.8 23.9 0.1 1.6 0.8 1.3 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 RCOR3 FLJ10876 ENSG00000117625 "REST corepressor 3" Q9P2K3 1 211258377-211316385 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007413, HPA007621, HPA071997" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193" "unprognostic (2.39e-2)" "unprognostic (1.23e-1)" "unprognostic (9.35e-2)" "unprognostic (3.07e-2)" "prognostic favourable (1.35e-5)" "unprognostic (4.02e-3)" "unprognostic (2.28e-2)" "prognostic favourable (5.75e-5)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (9.86e-2)" "unprognostic (1.03e-2)" "unprognostic (3.62e-2)" "unprognostic (1.82e-1)" "unprognostic (3.95e-1)" "unprognostic (3.56e-3)" 15.1 15.0 17.2 14.9 19.6 25.8 18.9 33.7 21.7 17.3 16.2 17.3 26.8 11.8 19.1 21.9 13.5 16.0 17.1 20.8 16.3 14.4 15.7 13.5 15.8 15.3 18.8 20.8 27.5 18.2 21.4 23.8 14.1 18.6 23.7 13.4 17.3 18.0 35.5 55.3 17.7 16.5 23.6 18.1 17.5 14.4 31.4 21.3 20.6 30.0 16.4 13.4 17.9 16.3 10.0 9.5 27.3 8.5 11.8 10.7 5.4 9.8 7.7 15.8 8.8 13.7 12.8 17.5 11.2 11.2 12.7 13.2 7.6 12.9 14.5 7.9 14.4 14.8 12.6 11.0 9.8 14.8 7.4 13.1 13.9 10.0 15.3 19.9 12.7 14.2 10.5 13.7 17.0 7.8 13.6 18.1 18.3 6.5 10.2 11.5 17.3 9.5 11.2 30.5 16.5 10.5 17.0 10.1 22.0 28.7 15.0 20.9 18.7 14.3 10.7 11.3 12.8 14.5 12.5 16.0 10.5 18.1 9.4 11.9 9.9 15.3 8.1 27.3 6.0 7.5 7.9 10.0 6.5 6.2 8.5 8.0 10.7 7.6 13.7 11.8 8.5 9.5 7.6 5.4 17.2 19.6 33.7 21.7 16.3 14.4 18.8 20.8 18.6 21.3 RDH14 "PAN2, SDR7C4" ENSG00000240857 "Retinol dehydrogenase 14" Q9HBH5 2 18554723-18560680 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056686 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA056686: " "unprognostic (5.79e-2)" "unprognostic (3.96e-2)" "unprognostic (1.64e-1)" "unprognostic (7.03e-2)" "unprognostic (1.99e-2)" "unprognostic (8.71e-3)" "unprognostic (1.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-1)" "unprognostic (8.98e-2)" "unprognostic (1.58e-2)" "unprognostic (4.32e-2)" "unprognostic (3.69e-2)" 13.8 16.2 10.7 8.7 14.3 5.1 14.0 14.2 15.4 11.3 14.1 11.0 9.6 12.7 16.2 14.3 16.0 12.7 11.0 29.0 12.2 10.4 23.0 22.1 12.5 14.6 11.7 9.0 11.7 21.0 23.5 13.5 14.2 13.2 20.7 12.0 10.6 13.8 13.1 27.8 9.9 16.3 22.9 10.3 15.4 15.9 11.1 8.8 17.4 18.1 13.6 10.7 18.1 17.9 9.9 7.6 7.2 2.0 3.7 7.6 1.6 18.3 5.8 4.9 4.0 14.8 15.8 16.6 11.2 11.6 10.2 10.2 4.5 9.6 18.1 6.7 6.7 10.0 7.1 13.1 11.9 10.0 19.5 7.1 6.4 13.6 12.7 8.6 9.6 12.0 13.4 9.8 15.5 9.3 12.6 6.2 16.6 5.9 7.4 15.1 13.3 16.6 10.8 13.4 7.8 19.9 12.0 7.6 13.2 6.1 13.5 15.9 6.7 4.9 9.4 14.5 8.9 11.4 13.3 17.6 14.5 13.4 10.3 5.9 11.3 1.7 1.8 7.2 4.4 2.0 7.6 7.4 5.1 6.3 2.3 9.9 7.3 6.0 0.8 3.7 1.9 7.6 5.8 1.6 10.7 14.3 14.2 15.4 12.2 10.4 11.7 9.0 13.2 8.8 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 30.4" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favourable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favourable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavourable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 2.8 4.6 3.1 2.9 4.6 8.2 1.5 20.3 6.1 3.0 2.7 5.2 9.9 2.0 3.3 3.0 1.5 17.4 30.4 1.6 3.8 3.8 6.3 1.7 3.6 4.0 3.8 5.4 2.2 1.7 0.9 21.4 1.0 10.8 3.2 0.9 8.0 2.1 10.3 1.3 1.4 2.2 3.7 5.1 4.2 8.5 13.3 3.4 22.3 2.0 0.0 4.4 1.7 1.7 2.1 6.2 10.7 6.3 3.3 6.9 1.3 0.0 0.1 7.0 0.0 0.2 0.3 0.4 0.3 0.3 0.6 0.5 0.1 0.7 0.1 0.0 0.0 0.3 0.2 0.0 0.4 0.6 0.1 0.2 0.3 0.0 5.9 0.1 0.9 3.2 0.3 0.2 0.0 1.2 0.0 1.0 0.0 0.1 7.1 1.1 2.2 0.1 0.1 0.0 0.0 0.2 0.2 0.1 31.4 0.0 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 1.1 0.3 0.1 0.0 0.1 0.1 2.6 0.1 10.7 6.1 1.2 6.9 2.1 2.2 3.3 3.8 1.6 1.0 3.1 0.1 3.3 6.3 6.2 3.5 1.3 3.1 4.6 20.3 6.1 3.8 3.8 3.8 5.4 10.8 3.4 RERGL FLJ22655 ENSG00000111404 "RERG like" Q9H628 12 18080869-18320107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in single" 708 "REH: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041740 Uncertain Approved Nucleoplasm Nucleoplasm "HPA041740: AB_10795694" "unprognostic (3.53e-2)" "unprognostic (7.03e-4)" "unprognostic (6.29e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-2)" "unprognostic (4.39e-2)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (5.51e-2)" "unprognostic (7.26e-2)" "unprognostic (8.47e-2)" "unprognostic (1.25e-1)" "unprognostic (6.76e-3)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "unprognostic (1.66e-2)" 22.4 4.0 5.4 3.2 8.3 0.0 13.0 1.8 8.9 33.4 10.3 4.3 3.5 2.1 16.5 29.2 8.7 19.6 17.3 4.7 7.5 6.1 12.8 0.9 3.1 0.9 9.4 6.0 11.3 1.0 0.8 0.7 0.3 9.0 12.6 12.3 1.6 2.1 14.1 7.7 5.6 6.3 11.8 6.2 1.1 3.9 11.7 4.2 0.4 7.0 8.0 1.1 8.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 8.3 1.8 8.9 7.5 6.1 9.4 6.0 9.0 4.2 RETREG3 "DKFZp686B1036, FAM134C, FLJ33806" ENSG00000141699 "Reticulophagy regulator family member 3" Q86VR2 17 42579513-42610623 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016492 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA016492: AB_1853027" "unprognostic (6.79e-2)" "unprognostic (1.29e-2)" "unprognostic (2.78e-1)" "prognostic favourable (1.61e-4)" "unprognostic (5.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.53e-2)" "unprognostic (2.21e-1)" "unprognostic (2.61e-1)" "unprognostic (2.58e-2)" "unprognostic (1.00e-2)" "unprognostic (2.51e-1)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.24e-1)" "unprognostic (5.68e-1)" "unprognostic (9.64e-3)" "unprognostic (5.43e-2)" 23.2 17.4 11.9 15.8 15.6 5.8 16.3 23.1 21.9 17.0 18.8 13.2 15.5 13.1 25.4 20.9 21.6 15.0 20.8 10.0 11.2 12.3 16.0 28.7 16.2 19.0 11.3 9.8 17.4 43.2 19.6 16.5 29.4 13.7 19.4 16.1 32.5 24.6 14.1 18.5 31.1 17.5 15.7 7.8 24.0 17.1 27.2 8.5 29.9 17.8 16.7 26.3 14.8 17.1 14.1 7.8 22.6 11.4 13.7 27.8 16.6 6.4 20.2 8.9 14.4 22.9 12.7 12.7 9.3 12.7 11.1 13.1 9.5 14.1 14.3 13.1 15.1 25.5 11.4 14.0 10.8 15.3 10.9 5.8 12.3 16.9 15.7 9.9 15.0 19.4 19.2 12.1 12.4 11.9 11.8 14.3 8.7 11.2 14.5 14.5 5.6 5.0 7.9 13.8 14.6 12.7 21.0 16.0 11.0 10.0 8.2 14.1 23.2 7.8 14.9 12.1 7.4 11.9 8.8 24.6 29.2 12.7 11.0 6.4 9.1 22.6 8.0 17.7 24.2 10.0 21.2 13.0 20.0 23.0 7.8 14.1 19.8 22.2 7.2 13.7 11.4 7.7 27.8 16.6 11.9 15.6 23.1 21.9 11.2 12.3 11.3 9.8 13.7 8.5 REV3L "POLZ, REV3" ENSG00000009413 "REV3 like, DNA directed polymerase zeta catalytic subunit" O60673 6 111299028-111483715 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 39.4;ASC TERT1: 30.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064853, HPA069382" Uncertain Approved Nucleoplasm Nucleoplasm "HPA064853: , HPA069382: " "unprognostic (5.54e-2)" "unprognostic (2.06e-1)" "unprognostic (5.09e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" "unprognostic (8.59e-3)" "unprognostic (4.42e-2)" "unprognostic (1.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.17e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.34e-2)" "unprognostic (2.80e-1)" "unprognostic (1.67e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-3)" 21.0 7.1 7.8 8.8 7.3 7.3 15.1 26.0 7.6 31.7 11.0 5.8 14.1 5.4 34.5 18.5 7.6 12.2 7.4 7.1 6.5 6.1 6.5 6.4 10.8 6.3 5.4 5.8 11.3 8.1 7.8 15.1 10.2 6.8 11.4 7.4 8.3 6.9 16.3 17.1 8.2 7.0 18.0 6.9 7.1 8.6 10.3 6.7 10.2 9.2 7.2 5.5 18.3 16.2 5.1 2.8 6.0 2.9 1.7 4.6 1.0 4.6 2.9 5.7 8.6 39.4 30.0 6.2 6.6 10.8 3.6 5.9 5.2 2.8 10.2 4.8 9.5 4.8 8.4 3.7 6.2 5.9 4.6 6.8 7.5 7.0 5.5 7.0 4.1 19.1 3.3 6.7 10.5 6.6 8.6 6.5 7.0 4.3 8.3 1.5 2.0 4.9 5.4 6.3 3.3 2.7 5.8 7.5 6.0 8.2 3.0 7.0 3.8 7.6 7.6 5.4 5.1 25.5 7.5 6.8 8.0 9.1 5.3 5.5 7.1 1.9 1.7 3.3 3.3 1.3 4.6 2.8 2.5 3.0 1.7 5.1 1.6 2.8 6.0 1.7 2.9 2.8 1.9 1.0 7.8 7.3 26.0 7.2 6.5 6.1 5.4 5.8 6.8 6.7 RFC5 RFC36 ENSG00000111445 "Replication factor C subunit 5" P40937 12 118013588-118033130 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041037 Supported Approved Nucleoplasm Nucleoplasm "HPA041037: AB_10805834" "unprognostic (9.63e-2)" "prognostic favourable (8.05e-5)" "unprognostic (5.12e-3)" "unprognostic (2.25e-2)" "unprognostic (1.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (2.81e-2)" "prognostic unfavourable (2.30e-4)" "unprognostic (1.44e-1)" "unprognostic (2.15e-1)" "unprognostic (2.70e-1)" "unprognostic (5.06e-1)" 9.4 9.3 9.8 15.1 10.7 30.3 11.7 14.4 12.5 11.4 11.0 10.2 12.6 10.2 12.9 10.8 14.3 12.2 8.4 6.7 15.2 6.5 9.3 13.9 8.4 16.0 7.0 10.1 18.7 12.3 7.3 11.4 9.1 11.0 8.7 14.5 8.5 9.9 12.6 7.3 11.2 11.5 9.0 9.3 11.1 9.8 16.4 9.3 33.4 12.0 11.2 17.0 12.6 10.8 12.9 8.8 14.2 10.4 9.1 14.1 7.9 19.3 21.2 20.8 11.6 5.1 6.1 22.7 14.6 10.0 28.4 21.3 21.7 8.4 22.9 10.3 7.6 18.6 28.6 14.4 26.8 16.0 23.8 17.9 16.6 14.3 3.1 28.0 13.7 3.2 4.8 21.4 6.9 11.8 23.8 8.3 13.3 21.1 35.2 21.2 15.7 19.5 26.4 25.5 21.7 12.3 17.6 27.9 12.2 25.3 7.0 9.0 26.0 10.8 5.5 15.3 17.1 20.7 27.5 14.2 18.3 28.0 14.7 20.2 25.9 14.2 6.2 3.9 11.2 10.4 10.0 12.9 13.7 9.8 8.8 11.1 10.7 9.3 6.1 9.1 5.8 7.6 14.1 7.9 9.8 10.7 14.4 12.5 15.2 6.5 7.0 10.1 11.0 9.3 RFESD ENSG00000175449 "Rieske Fe-S domain containing" Q8TAC1 5 95646754-95684773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.3" "Cell line enhanced" "Detected in many" "HEL: 20.8;K-562: 38.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016546 Uncertain Approved Nucleoplasm Nucleoplasm "CAB016546: AB_630417" "unprognostic (1.15e-1)" "unprognostic (5.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.37e-2)" "unprognostic (6.07e-3)" "unprognostic (2.72e-1)" "unprognostic (1.33e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (9.91e-2)" "unprognostic (8.24e-3)" "unprognostic (4.89e-2)" "unprognostic (5.83e-3)" "unprognostic (6.78e-2)" "unprognostic (9.03e-2)" "unprognostic (9.35e-2)" "unprognostic (1.09e-1)" 2.4 3.8 2.8 2.8 5.5 28.3 8.6 4.9 5.1 3.5 2.6 3.1 3.3 1.8 3.1 6.2 3.4 2.8 1.9 5.4 3.8 3.1 3.4 4.4 3.7 3.8 4.5 4.1 4.2 10.7 6.9 9.7 2.9 5.5 4.5 2.2 2.8 8.1 4.9 6.8 9.7 2.3 2.1 8.6 3.7 3.4 16.0 3.9 8.6 4.5 1.4 4.1 3.3 2.9 3.7 1.6 0.3 0.9 5.0 12.7 2.8 1.8 2.8 0.5 1.8 1.8 3.3 0.0 0.9 1.5 1.6 1.6 2.2 1.9 2.9 2.0 0.8 2.6 1.9 1.5 1.7 4.4 1.7 20.8 2.8 0.8 2.3 1.9 2.2 1.5 2.9 2.1 1.9 1.6 38.7 2.3 2.5 1.2 6.1 8.2 2.3 2.7 3.0 0.3 1.2 0.6 1.0 2.8 2.0 2.8 1.2 0.0 1.4 1.0 0.8 2.0 1.6 1.5 1.7 2.1 4.9 2.3 1.8 2.3 1.0 0.0 0.7 0.3 3.5 0.9 9.4 3.7 8.5 6.0 1.5 2.9 12.7 7.2 0.0 5.0 0.8 1.6 4.9 2.8 2.8 5.5 4.9 5.1 3.8 3.1 4.5 4.1 5.5 3.9 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "stomach 1: 118.3" "Group enriched" "Detected in some" 4 "hTEC/SVTERT24-B: 10.0;HUVEC TERT2: 14.2;LHCN-M2: 24.8;RH-30: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA058911: , HPA078021: " "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavourable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 5.5 3.0 6.4 5.2 8.6 2.6 8.2 10.8 6.6 11.7 20.9 9.7 7.0 19.5 4.8 4.8 3.0 5.5 3.7 5.1 6.3 6.3 5.4 5.3 3.2 2.8 9.8 5.2 5.2 7.6 2.7 9.4 3.4 9.0 6.3 15.4 6.3 8.7 5.4 8.5 4.2 20.7 3.4 8.3 2.8 118.3 2.7 8.3 1.9 9.6 2.3 2.8 3.3 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.3 1.2 0.9 0.0 0.1 3.5 0.0 1.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.5 0.0 10.0 0.0 14.2 0.0 0.0 24.8 0.0 0.0 0.0 2.1 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.6 10.8 6.6 6.3 6.3 9.8 5.2 9.0 8.3 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.5" "Cell line enhanced" "Detected in many" "HMC-1: 16.0;SCLC-21H: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 18.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favourable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favourable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favourable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 6.7 2.0 8.4 5.3 9.4 8.6 6.4 8.3 7.0 6.9 11.3 7.2 0.7 4.1 15.7 7.0 9.0 22.0 6.4 5.4 9.5 3.6 1.9 2.5 10.0 2.1 4.4 4.0 7.2 5.3 2.9 12.9 2.2 9.9 4.1 2.6 3.1 2.4 3.3 2.5 6.6 5.7 14.8 9.0 2.1 5.9 51.5 7.5 4.1 3.0 12.1 3.1 8.7 5.3 0.3 1.6 18.3 2.0 0.5 0.5 0.6 3.9 3.2 5.2 10.2 2.7 1.6 3.1 2.5 3.6 2.2 3.5 1.4 5.0 4.5 2.8 3.3 6.2 1.3 5.1 3.0 1.1 0.7 7.1 3.2 1.4 3.1 3.1 16.0 1.8 4.5 4.8 2.5 3.3 4.5 0.2 2.1 2.0 6.1 4.2 1.4 2.0 1.6 3.1 0.5 2.8 7.8 19.8 2.5 2.5 1.9 1.3 3.3 3.4 4.7 0.9 4.6 3.6 2.5 6.6 2.1 2.5 2.7 11.5 1.9 0.0 2.0 0.8 0.1 0.4 0.0 0.3 0.4 0.3 1.6 0.1 0.4 0.5 18.3 0.5 1.1 0.0 0.0 0.6 8.4 9.4 8.3 7.0 9.5 3.6 4.4 4.0 9.9 7.5 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.5" "Cell line enhanced" "Detected in many" "AF22: 21.9;HDLM-2: 12.9;SCLC-21H: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favourable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 5.2 4.6 17.9 7.6 14.9 11.4 6.7 35.1 19.5 6.9 4.7 6.9 5.0 5.0 6.8 6.3 3.8 22.0 5.2 4.0 12.8 7.5 5.0 4.1 7.2 6.7 6.0 11.9 7.0 5.4 9.0 21.7 5.8 9.9 6.1 5.6 4.2 4.7 4.6 5.7 4.4 5.0 4.0 12.5 5.7 6.6 36.5 11.0 12.7 5.7 2.9 7.5 4.5 7.8 8.3 4.6 8.9 4.8 5.3 9.3 3.2 1.9 2.7 21.9 5.3 0.9 1.0 2.2 0.8 2.3 1.9 1.4 0.8 2.5 3.1 0.9 1.1 1.1 5.3 2.2 3.3 12.9 1.4 5.9 2.9 1.8 1.1 1.2 0.8 1.3 1.0 2.3 3.7 3.2 1.1 3.2 2.0 1.5 3.7 4.3 5.8 1.1 3.9 1.5 0.8 3.0 1.6 11.8 5.2 1.3 0.6 2.0 1.1 3.1 2.0 1.4 3.2 0.7 1.3 1.1 0.5 6.3 1.5 1.4 1.4 3.5 3.2 6.2 8.8 4.8 5.4 6.3 8.1 7.2 3.1 8.3 5.7 7.0 8.9 5.3 1.4 4.6 9.3 3.2 17.9 14.9 35.1 19.5 12.8 7.5 6.0 11.9 9.9 11.0 RFX4 ENSG00000111783 "Regulatory factor X4" Q33E94 12 106582907-106762803 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 43.9;testis: 70.5" "Cell line enriched" "Detected in some" 14 "AF22: 32.5" "Cancer enriched" "Detected in single" 54 "glioma: 15.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050527 Enhanced Approved Nucleoplasm Nucleoplasm "HPA050527: " "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-2)" "unprognostic (1.09e-1)" "unprognostic (6.97e-2)" "unprognostic (7.97e-2)" "unprognostic (3.04e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-3)" "unprognostic (1.66e-3)" "unprognostic (1.15e-2)" "unprognostic (1.30e-2)" "unprognostic (5.46e-2)" 1.3 1.2 13.8 1.2 14.5 1.2 1.2 7.6 20.6 1.2 1.2 21.0 0.0 1.2 1.2 1.3 1.2 1.3 1.3 1.3 15.7 9.9 1.3 1.2 1.3 1.3 12.0 8.6 1.2 1.4 1.2 8.0 1.2 20.6 1.4 1.2 0.0 1.2 1.3 1.2 1.2 1.3 1.2 43.9 1.2 1.3 70.5 13.7 0.0 1.4 0.0 1.2 1.2 0.1 0.5 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.2 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 13.8 14.5 7.6 13.6 15.7 9.9 12.0 8.6 20.6 13.7 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56243266 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035462 Supported Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152" "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 6.6 6.6 4.2 4.1 7.1 6.7 5.0 28.2 11.7 4.4 3.5 8.6 3.0 4.3 4.4 4.9 5.1 4.1 3.1 4.2 4.7 3.6 4.4 4.2 4.1 7.1 4.5 8.3 4.7 6.3 7.1 10.6 4.1 8.1 3.9 3.9 2.7 5.3 7.1 13.7 9.8 4.6 4.1 6.4 6.0 4.1 6.0 6.8 15.4 4.2 3.7 7.2 4.9 4.8 1.3 1.5 4.6 0.8 1.4 2.6 0.5 3.9 6.1 14.6 11.1 6.3 7.2 3.8 2.9 4.1 3.9 6.2 4.3 2.9 11.2 4.8 4.3 10.2 8.8 5.6 5.3 5.9 3.5 13.1 8.3 9.3 6.5 10.6 2.3 5.9 13.3 3.5 8.8 7.1 6.1 5.8 6.6 4.6 8.9 4.3 6.9 2.3 9.9 9.4 10.1 5.7 10.2 8.1 10.2 3.7 4.3 5.2 3.3 8.6 5.8 10.7 5.4 2.7 6.3 5.5 5.2 12.6 3.8 11.4 4.7 4.6 0.5 0.9 1.2 0.8 1.6 1.2 1.8 1.9 0.9 1.3 1.0 1.3 0.0 1.4 0.4 1.5 2.6 0.5 4.2 7.1 28.2 11.7 4.7 3.6 4.5 8.3 8.1 6.8 RFX8 FLJ42986 ENSG00000196460 "RFX family member 8, lacking RFX DNA binding domain" Q6ZV50 2 101397361-101474703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.9;hTEC/SVTERT24-B: 15.4;LHCN-M2: 7.3;U-87 MG: 10.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 12 "basophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA059745: " "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 2.1 0.6 0.4 0.8 0.7 10.0 7.5 0.2 2.3 0.9 0.5 0.8 1.3 0.4 0.7 1.7 0.7 0.2 1.0 0.8 0.4 0.9 0.6 0.7 0.7 0.9 0.7 1.6 0.7 0.6 1.0 2.2 0.9 1.6 0.5 0.1 0.8 0.9 0.1 0.5 1.4 0.3 0.8 0.8 0.4 0.4 2.6 0.0 7.8 1.5 0.0 0.3 0.6 2.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 2.0 1.4 1.3 1.4 0.0 3.1 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.0 0.0 15.4 0.1 0.0 0.0 0.0 7.3 0.0 0.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 1.9 2.8 0.0 0.0 0.0 10.1 4.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 2.3 0.4 0.9 0.7 1.6 1.6 0.0 RGL1 RGL ENSG00000143344 "Ral guanine nucleotide dissociation stimulator like 1" Q9NZL6 1 183636085-183928531 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 18.4;HSkMC: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 5.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019788 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA019788: AB_1856215" "unprognostic (3.08e-1)" "unprognostic (5.25e-3)" "unprognostic (8.73e-2)" "unprognostic (1.24e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "prognostic unfavourable (1.49e-5)" "prognostic favourable (4.32e-4)" "unprognostic (1.12e-1)" "unprognostic (6.34e-2)" "unprognostic (5.77e-3)" "unprognostic (4.59e-2)" "unprognostic (2.63e-3)" "unprognostic (4.87e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (2.88e-2)" 22.1 15.7 22.1 16.9 24.8 1.5 19.7 14.2 23.2 18.1 9.9 25.5 8.8 7.9 17.4 11.5 9.9 14.4 20.3 15.0 21.5 15.0 25.7 14.3 18.4 17.4 18.2 16.3 18.7 6.3 10.5 9.7 14.2 19.1 12.5 11.9 21.0 7.8 11.1 3.0 8.4 9.4 19.8 19.6 37.5 7.6 13.0 20.4 1.7 9.1 2.9 8.9 18.1 12.6 0.0 2.4 0.2 5.2 0.0 1.1 1.2 0.1 0.7 13.5 2.0 18.4 8.5 13.8 6.2 10.5 2.8 3.5 6.0 0.4 0.1 5.8 4.4 0.3 0.9 1.5 2.8 0.2 1.0 0.1 1.4 6.1 4.9 0.2 0.7 28.9 0.3 7.2 1.7 10.5 0.0 10.0 6.0 0.0 1.4 0.1 4.9 0.4 11.7 0.8 11.9 0.7 3.8 1.7 4.0 1.9 2.1 1.0 0.1 0.1 7.7 4.1 1.6 12.7 3.3 1.0 0.2 0.0 4.3 0.1 11.2 0.0 2.1 0.0 0.2 5.2 0.4 0.0 0.8 0.0 2.4 0.0 1.1 0.6 0.2 0.0 1.8 0.0 0.6 1.2 22.1 24.8 14.2 21.9 21.5 15.0 18.2 16.3 19.1 20.4 RGL2 "HKE1.5, KE1.5, RAB2L" ENSG00000237441 "Ral guanine nucleotide dissociation stimulator like 2" O15211 6 33291654-33299324 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047039, HPA053444" Approved Approved Nucleoplasm Nucleoplasm "HPA047039: , HPA053444: " "unprognostic (4.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-2)" "unprognostic (2.74e-3)" "unprognostic (2.64e-1)" "unprognostic (1.04e-2)" "unprognostic (3.30e-2)" "unprognostic (2.35e-1)" "prognostic favourable (6.16e-4)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (1.62e-2)" 12.1 9.2 6.7 10.0 8.4 4.5 6.8 9.4 8.4 8.6 7.0 7.1 15.3 6.7 8.9 9.5 6.5 8.3 9.9 9.1 7.2 3.2 7.5 4.2 9.9 7.2 7.5 4.8 10.7 6.6 4.9 17.1 7.7 8.6 7.5 4.2 7.5 6.8 13.3 19.9 4.6 6.6 6.3 4.9 19.0 7.1 6.4 6.6 4.6 12.8 4.5 6.8 7.5 10.7 0.5 0.7 4.2 0.9 0.7 0.4 0.8 3.6 1.0 4.1 2.1 0.6 0.4 1.9 1.7 1.0 0.5 0.6 0.5 0.9 1.2 6.0 0.3 0.8 0.8 0.5 0.2 3.0 2.1 2.4 1.0 0.8 0.4 1.7 3.9 0.7 0.5 1.6 0.3 1.0 3.0 0.8 0.3 0.7 1.2 2.5 0.1 1.7 1.2 2.3 1.3 0.8 0.7 3.5 3.4 1.2 2.2 5.1 1.8 2.1 3.1 1.9 2.8 1.3 4.5 5.0 2.8 3.1 0.6 1.3 3.5 1.6 0.8 2.0 0.4 0.9 0.4 0.5 0.3 0.4 0.7 0.5 0.2 0.3 4.2 0.7 0.2 0.0 0.3 0.8 6.7 8.4 9.4 8.4 7.2 3.2 7.5 4.8 8.6 6.6 RGMA "RGM, RGMa" ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;skeletal muscle: 85.5" "Cell line enhanced" "Detected in some" "AF22: 30.4;BEWO: 8.9;MOLT-4: 9.0;NTERA-2: 13.6" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" 1400000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: , HPA044222: " "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favourable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 12.2 3.3 17.4 17.6 24.7 1.8 9.3 11.0 59.0 21.0 22.2 22.2 0.9 9.1 21.8 9.4 23.1 12.1 9.5 7.7 19.3 16.2 2.3 1.6 2.8 3.1 23.0 12.8 16.6 9.1 1.9 2.1 2.5 30.9 5.5 6.5 2.3 16.2 7.0 85.5 4.9 12.3 46.9 36.8 2.2 26.6 15.8 23.1 0.2 2.9 12.2 5.6 4.1 8.8 1.3 0.7 1.7 1.0 0.7 0.5 0.2 1.2 0.2 30.4 0.5 6.4 3.6 8.9 0.2 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.2 2.0 5.0 0.1 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.1 3.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 9.0 0.1 13.6 0.0 7.9 7.0 0.0 0.0 0.3 3.2 1.8 0.3 0.1 0.0 2.4 1.6 0.0 0.0 6.6 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.8 1.4 0.7 0.6 0.4 1.0 0.3 0.6 0.5 0.5 0.1 1.3 0.4 0.5 1.7 0.7 0.4 0.7 0.3 0.2 17.4 24.7 11.0 21.3 19.3 16.2 23.0 12.8 30.9 23.1 RGMB "DRAGON, FLJ90406" ENSG00000174136 "Repulsive guidance molecule BMP co-receptor b" Q6NW40 5 98768650-98798643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 67.0;fHDF/TERT166: 36.7;HBF TERT88: 47.5;LHCN-M2: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.3" "Group enriched" "Detected in many" 12 "B-cells: 4.1;T-cells: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016993 Approved Nucleoplasm 150000 Nucleoplasm "HPA016993: AB_1856216" "unprognostic (1.50e-2)" "unprognostic (3.77e-2)" "unprognostic (9.03e-2)" "unprognostic (8.92e-2)" "unprognostic (2.88e-1)" "unprognostic (5.27e-2)" "unprognostic (7.44e-2)" "unprognostic (1.60e-2)" "unprognostic (8.24e-2)" "unprognostic (2.19e-1)" "unprognostic (3.60e-3)" "unprognostic (9.00e-2)" "unprognostic (3.88e-2)" "unprognostic (3.90e-2)" "unprognostic (6.40e-2)" "unprognostic (4.20e-2)" "unprognostic (3.78e-3)" 8.3 7.2 14.0 9.9 11.7 0.8 14.4 18.0 23.9 8.8 19.7 5.6 9.9 19.0 8.4 5.7 17.7 10.1 8.9 8.8 9.8 14.4 3.9 6.6 10.8 4.1 7.2 13.3 20.1 15.4 9.0 12.3 5.1 11.5 19.2 28.5 6.8 18.4 15.6 23.1 28.1 22.9 10.6 11.6 6.2 34.5 13.3 5.6 1.0 13.5 7.2 7.7 9.7 15.7 4.1 0.1 0.5 0.2 0.3 8.3 1.6 1.8 1.3 18.7 1.7 5.6 9.7 2.6 67.0 29.8 29.9 21.1 0.9 0.8 1.0 2.8 36.7 1.8 2.1 5.8 47.5 3.3 2.8 0.0 1.5 1.0 2.8 0.1 0.0 8.0 2.0 19.5 6.0 5.4 0.0 0.7 34.8 1.7 0.0 0.0 1.4 4.3 2.7 11.4 1.8 1.1 1.7 8.1 4.1 0.9 2.0 3.1 1.7 0.0 13.2 19.0 3.9 12.2 30.4 1.8 2.2 1.4 7.2 0.0 4.1 0.0 0.0 0.2 0.3 0.2 1.4 3.1 3.9 1.3 0.1 4.1 8.3 3.9 0.5 0.3 0.0 0.0 5.3 1.6 14.0 11.7 18.0 21.5 9.8 14.4 7.2 13.3 11.5 5.6 RGN "RC, SMP30" ENSG00000130988 Regucalcin Q15493 X 47078355-47093314 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 51.0;liver: 118.8" "Cell line enhanced" "Detected in some" "CACO-2: 16.1;fHDF/TERT166: 5.1;Hep G2: 24.1" "Cancer enriched" "Detected in many" 6 "liver cancer: 47.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029102, HPA029103" Enhanced Approved Nucleoplasm 47000 Nucleoplasm "HPA029102: AB_10599846, HPA029103: AB_10602097" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (5.56e-3)" "unprognostic (8.22e-3)" "unprognostic (1.32e-2)" "prognostic favourable (7.55e-4)" "unprognostic (2.60e-3)" "unprognostic (2.23e-2)" "unprognostic (8.38e-2)" "unprognostic (3.37e-2)" "unprognostic (1.14e-2)" "prognostic favourable (5.10e-10)" "unprognostic (1.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.82e-2)" "unprognostic (5.22e-2)" 2.6 51.0 6.7 0.6 6.5 0.4 1.5 8.4 6.2 2.8 1.9 6.2 2.5 4.5 2.3 6.1 1.5 1.7 2.0 4.5 6.1 4.2 17.6 118.8 4.9 0.7 5.9 4.5 7.5 12.7 6.2 2.5 4.2 5.0 4.8 1.1 8.4 7.5 6.3 3.8 0.6 4.6 4.9 4.4 1.1 2.9 1.5 5.2 0.0 6.5 1.6 0.6 2.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.3 0.6 0.0 0.0 16.1 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.1 0.8 0.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.7 6.5 8.4 6.2 6.1 4.2 5.9 4.5 5.0 5.2 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell line enhanced" "Detected in many" "HDLM-2: 39.8;HMC-1: 35.6;NB-4: 15.7;RPMI-8226: 20.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Group enriched" "Detected in all" 5 "amygdala: 38.0;basal ganglia: 118.5;cerebral cortex: 32.0;hippocampal formation: 90.8" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: , HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavourable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.8 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.1 3.7 4.7 2.6 0.0 3.8 0.0 1.2 0.0 39.8 0.1 7.4 0.1 1.5 0.2 5.7 35.6 0.6 0.3 0.2 0.2 0.2 1.2 9.6 0.0 0.1 7.6 15.7 0.6 1.0 3.5 0.0 20.5 0.4 0.1 0.1 0.7 0.0 0.1 3.0 1.3 9.0 0.3 0.0 0.7 0.0 3.4 5.1 2.4 2.0 0.6 10.8 0.8 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in some" 8 "HDLM-2: 22.9;HEL: 9.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in many" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: " "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favourable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.0 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.1 0.0 0.1 0.2 22.9 0.5 9.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell line enhanced" "Detected in many" "HeLa: 9.1;MCF7: 9.6;U-266/70: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm Nucleoplasm "HPA030359: , HPA030360: , HPA046593: " "prognostic favourable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.7 2.3 1.3 2.0 1.0 2.6 6.7 0.8 1.2 0.4 0.1 4.7 1.3 0.7 1.6 0.5 1.2 0.1 0.4 0.0 1.7 8.5 1.0 9.1 1.9 0.9 1.7 1.3 1.8 3.2 0.3 0.0 0.1 1.3 1.3 0.1 9.6 0.4 4.6 1.2 0.7 8.1 1.2 1.7 0.1 1.6 1.6 2.2 1.0 0.5 2.2 3.5 4.8 0.5 2.8 2.6 0.9 0.6 11.7 1.6 2.3 1.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Group enriched" "Detected in some" 65 "CACO-2: 4.7;Hep G2: 5.6;RT4: 9.7" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm Nucleoplasm "HPA042726: , HPA048489: " "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favourable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Cell line enhanced" "Detected in many" "Hep G2: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040205: , HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.1 9.3 0.0 4.4 3.9 0.0 2.7 2.5 2.2 3.4 0.3 0.1 0.0 11.5 14.3 0.1 2.7 0.8 2.7 0.0 2.5 0.5 4.5 33.9 4.9 0.6 0.2 5.7 1.5 1.4 1.4 10.7 5.0 0.0 9.9 0.2 2.5 0.0 4.0 4.0 2.2 13.1 3.2 7.4 0.3 2.6 10.0 3.2 3.6 3.5 0.7 1.2 9.5 4.4 11.5 0.1 2.9 0.0 0.0 0.0 2.1 2.0 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 RHOF "ARHF, FLJ20247, RIF" ENSG00000139725 "Ras homolog family member F, filopodia associated" Q9HBH0 12 121777754-121803403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 36.7;HDLM-2: 51.6;PC-3: 36.2;RPTEC TERT1: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045912, HPA076019" Enhanced Approved "Nucleoplasm,Golgi apparatus" 58000 "Nucleoplasm, Golgi apparatus" "HPA045912: , HPA076019: " "unprognostic (1.26e-1)" "unprognostic (8.73e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "unprognostic (4.26e-5)" "unprognostic (1.38e-3)" "unprognostic (2.37e-4)" "unprognostic (1.34e-1)" "unprognostic (5.51e-2)" "unprognostic (1.10e-4)" "unprognostic (1.10e-1)" "unprognostic (5.01e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-2)" "unprognostic (7.51e-4)" "unprognostic (1.14e-1)" 5.0 13.8 13.3 19.2 15.6 29.3 5.8 53.2 19.3 16.5 17.8 8.9 15.9 24.7 12.7 17.5 13.7 10.9 10.3 13.5 13.8 9.8 16.4 6.9 18.7 28.6 20.2 8.7 8.8 7.5 9.1 14.7 4.7 14.2 8.3 14.1 12.4 9.6 12.1 8.5 7.3 26.5 9.9 11.2 28.4 20.9 9.0 18.9 27.2 18.3 6.2 24.4 14.2 10.2 17.4 24.2 13.4 21.0 18.5 32.9 13.6 16.1 18.7 3.5 4.1 1.2 1.9 1.6 1.6 1.5 0.7 1.3 7.5 36.7 1.6 12.5 1.6 2.3 6.2 9.6 0.5 51.6 2.0 8.6 12.7 7.1 2.8 9.6 7.2 2.5 2.0 1.5 0.8 4.9 1.4 2.6 0.3 10.3 13.4 14.5 2.9 36.2 7.1 0.2 2.9 29.3 1.4 2.9 2.4 9.7 1.2 0.7 5.5 4.2 6.0 1.2 11.2 3.5 0.4 3.7 1.9 4.9 1.4 11.0 0.7 6.2 3.5 13.4 32.9 11.1 31.0 17.4 26.0 28.1 10.9 14.8 20.1 24.5 7.7 18.5 21.0 24.2 27.3 13.6 13.3 15.6 53.2 19.3 13.8 9.8 20.2 8.7 14.2 18.9 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;HUVEC TERT2: 88.4;TIME: 23.5;WM-115: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavourable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 2.5 10.2 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 88.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 23.5 0.0 0.2 0.1 1.4 0.0 0.0 0.0 0.0 0.0 25.4 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Cell line enhanced" "Detected in some" "K-562: 60.7;NB-4: 45.0;THP-1: 16.9;U-266/84: 27.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120070672-120077705 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.6;testis: 9.4" "Group enriched" "Detected in some" 348 "HL-60: 46.0;K-562: 46.1;NB-4: 74.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.0 0.0 0.0 1.0 1.6 2.6 1.3 1.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.7 0.8 0.5 0.9 1.0 0.7 0.5 0.7 0.7 1.0 0.7 0.7 1.4 1.7 1.3 1.6 0.5 0.2 RHPN1 "KIAA1929, ODF5, RHPN" ENSG00000158106 "Rhophilin Rho GTPase binding protein 1" Q8TCX5 8 143368887-143384220 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 16.7;MOLT-4: 15.1;RPMI-8226: 11.1;T-47d: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024288, HPA024671" Approved Approved Nucleoplasm Nucleoplasm "HPA024288: AB_1856274, HPA024671: AB_1856275" "unprognostic (2.04e-1)" "unprognostic (3.71e-1)" "unprognostic (1.54e-2)" "unprognostic (2.20e-1)" "unprognostic (5.82e-2)" "unprognostic (6.38e-2)" "unprognostic (2.07e-3)" "unprognostic (3.12e-1)" "unprognostic (3.57e-1)" "unprognostic (1.02e-1)" "unprognostic (8.27e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-2)" "unprognostic (1.24e-3)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-2)" 3.3 3.2 17.9 3.6 11.9 5.9 4.0 2.5 14.3 5.7 2.6 10.8 6.2 1.2 1.1 6.2 1.9 8.0 3.7 1.3 19.4 9.7 9.7 0.9 4.0 4.0 9.0 9.4 0.8 7.8 10.3 14.8 1.4 10.9 3.2 1.3 2.0 6.6 7.2 0.8 5.3 1.9 1.7 8.3 5.6 5.2 2.7 14.1 15.4 14.9 0.5 2.5 2.4 1.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 1.7 3.0 0.7 2.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 1.2 0.1 6.0 0.0 0.7 0.0 0.0 0.0 0.3 2.7 0.0 1.8 0.1 0.2 0.1 1.9 0.0 0.5 0.0 0.0 0.6 0.6 3.6 0.0 16.7 15.1 1.5 1.1 8.1 4.1 0.0 11.1 2.7 2.8 4.5 1.7 0.9 5.0 1.0 27.2 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.3 0.3 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 11.9 2.5 12.7 19.4 9.7 9.0 9.4 10.9 14.1 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 43.4;pituitary gland: 29.2" "Group enriched" "Detected in some" 9 "CACO-2: 6.4;SCLC-21H: 3.5;SH-SY5Y: 6.9;SK-BR-3: 11.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favourable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.5 2.7 4.0 0.5 9.3 0.5 1.1 0.5 5.6 1.6 1.1 0.8 1.2 0.6 2.1 6.1 0.7 43.4 0.9 0.5 4.6 5.1 0.6 0.5 3.1 0.5 2.5 5.2 2.6 1.2 1.1 29.2 0.5 3.6 1.0 1.3 1.2 0.5 1.9 0.5 0.6 0.8 1.1 0.5 0.5 2.0 14.7 2.1 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 3.5 6.9 0.0 11.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.3 0.5 5.6 4.6 5.1 2.5 5.2 3.6 2.1 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 6.0 8.5 7.7 6.0 8.7 8.2 8.1 10.9 6.1 6.0 5.3 5.3 1.4 0.3 5.5 10.6 6.6 5.7 5.2 2.4 6.1 10.4 0.8 5.5 7.7 15.2 0.3 2.3 9.3 10.4 6.7 9.7 6.0 4.8 0.4 6.0 10.0 0.7 1.9 5.6 9.0 1.0 4.2 0.3 4.2 6.3 1.2 7.2 5.8 5.1 13.0 6.8 0.2 12.0 7.8 3.9 11.3 6.9 1.3 0.6 0.2 8.0 0.1 4.9 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.2;SH-SY5Y: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: " "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favourable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.2 4.1 0.0 0.0 17.2 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 RIMKLB "FAM80B, KIAA1238, NAAGS, NAAGS-I" ENSG00000166532 "Ribosomal modification protein rimK like family member B" Q9ULI2 12 8681600-8783095 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 53.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059552 Approved "Nucleoplasm,Centriolar satellite" "Nucleoplasm, Centriolar satellite" "HPA059552: " "unprognostic (5.29e-3)" "unprognostic (2.26e-2)" "unprognostic (1.89e-5)" "unprognostic (2.40e-2)" "unprognostic (2.30e-1)" "unprognostic (3.35e-2)" "unprognostic (6.56e-2)" "unprognostic (8.52e-2)" "unprognostic (8.67e-3)" "unprognostic (1.76e-1)" "unprognostic (3.25e-1)" "unprognostic (2.15e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-2)" "unprognostic (3.02e-1)" "unprognostic (3.74e-1)" "unprognostic (3.99e-1)" 22.5 10.7 15.9 10.7 19.2 15.8 20.1 23.3 21.2 18.1 17.6 16.4 11.2 5.1 35.9 18.2 10.4 25.4 12.5 10.7 17.6 12.8 9.2 3.2 13.9 7.6 10.2 19.0 22.7 7.3 36.2 10.1 21.2 19.9 11.7 6.5 18.0 9.0 13.5 9.5 8.8 8.7 25.5 14.0 11.5 7.7 27.8 12.1 13.6 15.6 4.8 6.4 11.8 18.4 4.0 1.3 5.3 2.9 2.8 3.9 2.5 1.2 7.2 16.6 17.7 2.3 2.0 23.8 6.9 3.4 5.9 4.0 0.6 7.6 10.5 6.6 4.5 2.7 8.4 9.3 6.5 0.1 5.1 4.8 20.3 0.0 2.6 1.4 4.9 4.4 4.2 5.5 9.7 7.6 6.6 0.0 3.6 4.3 9.6 0.6 19.6 0.4 15.1 22.7 0.0 9.0 3.7 0.5 10.9 7.6 9.9 6.8 2.1 4.8 14.3 6.2 20.7 3.2 2.2 0.1 0.0 53.0 5.4 0.9 4.3 5.3 2.9 1.2 2.4 1.1 3.0 2.2 2.4 3.5 1.2 4.0 3.9 1.5 0.7 2.8 1.4 1.3 0.1 2.5 15.9 19.2 23.3 19.5 17.6 12.8 10.2 19.0 19.9 12.1 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810338 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 14.6" "Cell line enhanced" "Detected in some" "HAP1: 12.8;MCF7: 8.6;SCLC-21H: 26.5;SH-SY5Y: 13.6;SiHa: 9.2;U-2 OS: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm Nucleoplasm "HPA060928: " "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 1.0 2.1 13.8 0.8 23.3 0.4 1.2 9.6 23.8 11.8 1.2 0.2 0.0 0.6 3.2 2.2 1.3 11.9 1.4 0.6 14.1 7.5 0.6 0.5 1.7 0.6 4.9 8.8 9.5 0.6 0.5 6.0 0.6 4.1 3.2 1.2 1.0 2.0 1.8 1.8 0.5 0.7 4.3 1.3 0.5 2.3 14.6 2.6 0.0 7.5 0.9 1.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.0 12.8 0.1 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 26.5 13.6 9.2 0.0 0.1 4.0 0.4 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 23.3 9.6 19.0 14.1 7.5 4.9 8.8 4.1 2.6 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330242-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 31.5" "Cell line enhanced" "Detected in many" "hTCEpi: 26.2;U-2197: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.7;non-classical monocyte: 19.1" "Lineage enriched" "Detected in many" 6 "monocytes: 19.1" "Group enriched" "Detected in many" 6 "amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6" "Group enriched" "Detected in many" 6 "amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favourable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavourable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.9 5.1 11.1 7.1 22.7 3.9 3.4 13.0 13.5 5.9 5.2 1.5 2.4 8.0 4.2 2.3 15.8 5.8 8.7 3.3 9.7 2.3 2.3 2.7 3.8 5.4 1.4 5.8 4.8 6.6 1.5 5.0 4.5 2.2 4.7 3.6 2.5 4.8 3.5 10.3 31.5 5.8 2.8 0.8 4.6 11.1 2.8 2.5 0.0 1.5 8.7 8.6 3.4 7.0 0.1 3.3 0.0 19.1 0.0 1.5 2.0 1.6 4.4 1.3 2.7 1.5 8.6 1.0 9.9 9.1 7.6 3.7 2.7 5.0 0.3 5.0 7.2 10.5 0.0 13.4 1.0 0.5 0.0 0.4 4.3 2.3 3.0 0.1 4.6 8.3 26.2 7.8 4.7 1.6 0.2 0.1 3.3 0.3 0.1 11.3 0.6 19.8 0.1 3.8 0.0 2.2 1.7 9.9 2.6 2.6 1.3 13.6 0.9 0.8 4.3 12.3 7.3 28.8 2.5 0.2 0.5 0.0 17.1 2.6 4.9 0.0 4.3 0.0 0.2 9.7 1.5 0.1 1.0 0.3 3.3 0.0 1.1 0.5 0.0 0.0 19.1 0.0 0.1 2.0 11.1 22.7 13.0 13.5 9.7 2.3 1.4 5.8 2.2 2.5 RING1 RNF1 ENSG00000204227 "Ring finger protein 1" Q06587 6 33208495-33212722 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008701 Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA008701: AB_1079814" "unprognostic (2.12e-3)" "unprognostic (7.98e-2)" "unprognostic (3.77e-2)" "unprognostic (1.37e-1)" "unprognostic (3.91e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (4.75e-2)" "unprognostic (7.76e-2)" "unprognostic (1.26e-2)" "unprognostic (3.70e-2)" "unprognostic (1.62e-2)" "unprognostic (2.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.55e-1)" "unprognostic (2.13e-1)" "unprognostic (9.88e-2)" 26.7 22.6 17.8 15.9 21.3 12.0 14.6 27.6 24.2 22.2 17.6 22.0 21.0 18.2 31.9 17.3 14.5 18.8 21.4 14.4 17.3 18.2 19.3 21.6 16.8 14.5 24.0 15.4 25.0 18.3 24.0 34.0 14.9 17.0 21.8 7.6 20.0 19.0 20.5 18.0 21.7 19.5 22.9 18.5 23.2 24.1 16.9 20.8 25.5 29.3 13.1 14.3 13.9 17.1 1.2 2.2 0.8 1.5 0.2 2.2 0.2 4.2 3.5 4.2 4.0 4.2 1.4 9.7 11.1 6.8 4.5 4.6 3.8 3.1 6.9 4.6 4.4 7.6 3.6 3.3 3.2 8.5 2.9 8.3 5.8 7.1 9.6 4.7 6.8 0.0 3.4 4.0 7.5 1.6 11.9 5.3 4.7 0.0 0.3 3.7 1.9 4.6 4.5 6.9 7.6 5.0 3.7 8.3 5.2 4.0 4.3 11.5 4.9 8.3 2.3 5.0 3.8 0.0 9.1 6.0 6.2 6.6 3.7 4.3 3.1 0.0 1.5 0.8 2.2 0.4 0.4 1.1 0.7 1.0 0.7 1.2 1.7 0.9 0.3 0.2 0.5 2.2 0.4 0.2 17.8 21.3 27.6 24.2 17.3 18.2 24.0 15.4 17.0 20.8 RINL FLJ45909 ENSG00000187994 "Ras and Rab interactor like" Q6ZS11 19 38867834-38878279 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 17.0;Karpas-707: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042083, HPA042103" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA042083: AB_10793977, HPA042103: AB_10797380" "unprognostic (1.30e-1)" "prognostic favourable (6.49e-5)" "unprognostic (7.38e-2)" "unprognostic (1.75e-2)" "unprognostic (6.05e-2)" "prognostic favourable (1.64e-4)" "unprognostic (2.61e-2)" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (5.95e-2)" "unprognostic (1.85e-1)" "unprognostic (7.90e-2)" "unprognostic (3.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (3.17e-2)" "unprognostic (6.40e-3)" 5.5 3.7 6.3 10.2 10.3 5.4 10.4 6.5 5.8 2.6 3.9 4.2 6.2 3.4 1.8 2.4 5.3 4.6 6.1 3.9 5.1 6.4 5.0 6.0 7.0 20.4 5.5 3.8 1.7 17.4 4.9 5.7 3.3 5.5 2.6 3.5 5.9 7.9 4.5 3.0 3.2 6.3 2.6 4.5 13.0 6.1 1.4 3.5 7.6 6.4 3.1 15.7 4.3 2.9 16.6 12.3 3.1 2.1 4.1 8.7 2.9 0.0 1.3 0.4 0.2 0.6 0.3 2.6 0.3 0.2 0.3 0.4 2.3 6.9 7.7 3.6 0.4 0.2 1.3 2.9 0.4 1.7 0.8 9.6 2.0 4.9 1.6 5.4 17.0 1.6 0.5 0.9 0.6 3.4 1.9 20.0 0.0 1.2 1.7 3.8 0.6 0.3 1.1 0.1 5.8 1.9 0.2 2.6 1.1 3.1 5.1 2.7 0.6 6.6 2.2 0.1 1.5 0.4 0.0 8.6 7.1 6.1 0.6 3.0 0.4 3.1 0.9 1.5 8.7 2.1 5.5 12.4 5.8 6.3 1.6 16.6 4.6 5.4 2.8 4.1 2.0 12.3 6.1 2.9 6.3 10.3 6.5 5.8 5.1 6.4 5.5 3.8 5.5 3.5 RIPOR3 "C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C" ENSG00000042062 "RIPOR family member 3" Q96MK2 20 50586108-50691528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 19.5;ASC TERT1: 9.1;HEL: 28.5;HSkMC: 17.9;K-562: 16.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA051823, HPA054759" Uncertain Approved Nucleoplasm Nucleoplasm "HPA051823: , HPA054759: " "unprognostic (7.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic favourable (1.66e-5)" "unprognostic (4.96e-4)" "unprognostic (1.32e-1)" "unprognostic (2.66e-2)" "unprognostic (2.18e-1)" "unprognostic (2.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.98e-1)" "unprognostic (9.21e-3)" "unprognostic (1.67e-2)" "unprognostic (4.58e-2)" 18.9 11.8 4.6 4.2 8.1 22.8 8.1 3.0 5.3 18.6 6.4 2.9 2.4 3.3 14.1 5.7 5.8 13.5 4.3 5.7 4.3 1.1 15.1 7.7 2.9 9.1 5.1 0.9 5.1 2.1 1.5 5.5 2.7 5.2 5.4 2.2 6.3 4.3 1.1 11.7 3.0 5.8 5.8 3.8 4.2 3.2 6.4 6.3 2.7 4.2 2.5 2.6 6.6 24.6 1.1 0.7 1.9 0.3 0.1 1.1 1.0 0.0 0.0 0.5 0.0 19.5 9.1 0.0 0.0 6.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.1 2.3 0.0 0.0 17.9 0.0 0.5 0.0 0.0 16.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 1.7 0.0 2.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 1.4 0.1 1.9 1.1 0.3 0.0 1.1 0.8 0.4 0.1 0.8 0.8 0.4 1.1 0.1 0.2 0.7 0.3 1.0 4.6 8.1 3.0 5.3 4.3 1.1 5.1 0.9 5.2 6.3 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.4" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA042051: , HPA044083: " "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 RLF "Zn-15L, ZNF292L" ENSG00000117000 "Rearranged L-myc fusion" Q13129 1 40161373-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA054653: , HPA057300: " "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavourable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavourable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 14.8 8.1 12.6 11.3 12.6 44.5 13.9 20.8 17.1 12.4 11.1 11.6 7.1 8.6 14.1 8.6 12.4 9.9 11.2 12.3 11.0 8.3 8.7 12.7 12.8 11.8 12.8 11.8 14.6 9.4 12.5 15.1 11.9 15.4 13.2 9.2 10.2 9.4 9.9 13.4 17.7 9.9 14.3 14.1 10.1 9.3 15.9 11.8 14.9 10.0 8.4 13.5 18.1 14.8 4.1 3.5 10.1 4.1 4.1 4.9 2.4 12.3 4.7 9.4 9.8 8.4 6.9 11.2 4.6 7.0 8.0 10.7 9.7 6.6 12.4 6.1 5.9 11.7 11.9 8.2 14.7 5.8 8.0 10.2 5.8 5.9 6.7 8.4 6.2 6.8 8.7 8.6 9.7 5.5 15.4 7.6 7.3 3.9 7.1 5.1 12.6 5.5 5.5 15.5 7.2 5.1 12.6 6.7 9.4 8.7 11.7 8.3 5.5 30.6 4.6 9.5 10.2 7.8 8.6 7.0 6.5 11.6 8.2 7.9 5.9 10.1 2.8 5.5 3.7 3.9 4.9 4.1 3.7 3.8 3.5 4.1 4.8 4.0 6.3 4.1 4.1 1.6 3.3 2.4 12.6 12.6 20.8 17.1 11.0 8.3 12.8 11.8 15.4 11.8 RMND5A "FLJ13910, GID2, GID2A, p44CTLH, RMD5" ENSG00000153561 "Required for meiotic nuclear division 5 homolog A" Q9H871 2 86720173-86778041 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046795, HPA060843" Uncertain Approved Nucleoplasm Nucleoplasm "HPA046795: AB_10963573, HPA060843: " "unprognostic (4.54e-2)" "unprognostic (9.23e-2)" "unprognostic (3.45e-2)" "prognostic unfavourable (3.03e-4)" "unprognostic (2.32e-2)" "unprognostic (4.40e-2)" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (1.49e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-2)" "unprognostic (8.34e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.56e-1)" 9.8 7.0 11.1 6.5 11.7 15.6 10.1 47.3 19.2 9.0 11.8 8.4 6.8 9.7 11.3 8.4 19.7 8.1 8.9 23.1 12.5 8.5 11.2 25.6 6.9 12.6 9.3 10.0 9.0 9.9 15.8 7.6 9.6 7.0 8.4 13.1 10.3 12.0 7.1 34.2 13.4 9.0 12.0 11.2 8.0 7.2 5.5 5.5 24.1 7.9 10.6 8.1 9.2 12.0 4.6 6.4 20.7 8.7 6.0 8.8 5.1 8.1 4.4 7.7 4.6 10.3 4.6 16.0 3.2 2.6 4.3 4.9 16.0 8.8 28.3 9.9 2.9 9.8 19.6 6.8 6.7 8.1 15.0 24.9 9.6 14.4 10.4 18.0 8.2 6.9 13.5 4.5 15.7 7.4 15.7 16.3 3.4 5.3 16.6 15.5 13.1 5.6 20.0 23.9 17.8 8.8 9.8 14.4 11.1 7.3 14.7 11.8 7.3 15.7 7.0 3.0 5.8 5.3 5.0 7.4 7.7 19.5 2.5 21.9 3.4 20.7 8.7 5.4 6.0 6.8 7.1 3.2 4.6 6.7 6.4 4.6 6.4 8.8 19.0 6.0 7.9 5.1 3.1 5.1 11.1 11.7 47.3 19.2 12.5 8.5 9.3 10.0 7.0 5.5 RMND5B "FLJ22318, GID2, GID2B" ENSG00000145916 "Required for meiotic nuclear division 5 homolog B" Q96G75 5 178130996-178150565 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047778 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047778: " "unprognostic (2.08e-1)" "unprognostic (6.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.35e-2)" "unprognostic (4.38e-2)" "unprognostic (9.81e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "prognostic favourable (7.66e-4)" "unprognostic (1.60e-1)" "prognostic favourable (7.22e-8)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (6.43e-2)" "unprognostic (5.78e-2)" 12.2 12.6 11.6 7.3 13.7 7.7 9.7 10.4 18.8 11.4 11.8 16.2 9.1 9.0 16.2 11.8 36.7 12.8 12.5 17.2 11.4 9.0 11.3 13.1 11.5 11.1 14.5 16.7 11.8 16.9 12.8 15.7 11.3 13.0 12.2 8.2 16.1 15.8 11.9 23.4 18.0 11.7 18.7 9.1 10.5 12.0 42.0 9.2 11.2 14.3 13.0 18.2 11.5 14.0 13.2 8.5 22.4 13.8 2.2 12.8 7.2 6.3 10.7 7.4 17.7 9.5 1.0 22.0 5.3 6.0 7.7 9.3 12.5 9.4 13.8 10.6 3.9 8.8 7.2 11.1 3.0 38.7 9.7 14.1 12.8 6.6 10.1 6.7 5.3 2.0 8.9 5.4 9.2 8.0 11.8 9.8 2.5 55.7 4.9 4.1 9.4 6.6 6.1 5.3 9.5 7.2 10.3 7.6 10.6 7.1 24.3 12.4 17.0 9.8 5.5 4.7 6.9 4.4 6.6 14.2 13.2 11.4 5.9 6.8 6.4 9.2 9.7 22.4 4.2 11.2 1.8 11.1 8.5 4.8 5.7 13.2 12.8 7.6 6.8 2.2 13.8 8.5 12.5 7.2 11.6 13.7 10.4 18.8 11.4 9.0 14.5 16.7 13.0 9.2 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 73.2;RT4: 28.7;TIME: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 73.2 7.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 28.7 0.3 0.3 0.0 0.2 0.0 0.0 0.0 38.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 RNASEH2C "AGS3, AYP1" ENSG00000172922 "Ribonuclease H2 subunit C" Q8TDP1 11 65714005-65720947 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065375 Supported Approved Nucleoplasm Nucleoplasm "HPA065375: " "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "unprognostic (2.06e-1)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (7.88e-3)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "prognostic favourable (3.68e-5)" "unprognostic (1.48e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (3.72e-2)" "unprognostic (1.84e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" 10.3 18.0 16.6 16.6 17.9 29.9 16.2 33.3 21.2 13.4 18.9 13.5 19.8 15.6 19.1 12.6 8.8 15.7 16.0 25.8 14.8 11.4 14.5 10.0 10.6 22.6 20.1 9.6 24.7 17.0 19.7 22.2 10.0 14.5 20.2 7.9 14.6 13.0 22.4 10.9 20.4 14.3 11.5 11.0 25.0 13.6 7.3 19.1 20.0 14.2 12.0 14.4 14.6 17.1 12.6 20.1 3.6 13.5 9.4 10.3 9.4 5.0 6.2 8.5 6.0 7.3 3.4 3.6 3.4 2.3 9.9 7.8 6.5 8.2 10.5 4.0 3.6 8.3 6.4 5.0 6.5 8.9 18.0 9.4 18.5 3.3 0.7 1.5 10.3 3.6 1.7 8.4 2.6 4.0 4.7 13.0 3.7 8.6 17.6 11.8 5.3 9.0 16.1 4.8 16.5 2.5 3.4 10.8 8.6 1.8 6.8 3.2 9.9 5.1 3.6 10.0 8.0 7.2 4.7 13.0 3.9 2.3 13.8 8.2 8.4 2.7 13.5 3.6 10.3 9.2 10.2 11.7 6.8 7.6 8.5 12.6 8.6 6.8 2.8 9.4 6.9 20.1 6.7 9.4 16.6 17.9 33.3 16.3 14.8 11.4 20.1 9.6 14.5 19.1 RNF10 "KIAA0262, RIE2" ENSG00000022840 "Ring finger protein 10" Q8N5U6 12 120533480-120577594 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052643 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA052643: " "unprognostic (1.54e-1)" "unprognostic (3.04e-1)" "unprognostic (5.40e-2)" "unprognostic (2.83e-3)" "unprognostic (1.09e-2)" "unprognostic (3.58e-2)" "prognostic unfavourable (5.30e-5)" "unprognostic (5.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.40e-1)" 26.2 37.7 32.6 23.0 34.5 64.3 64.2 33.4 44.0 27.7 30.5 25.3 30.1 23.8 24.1 41.4 40.2 22.5 32.2 79.6 32.4 27.0 36.0 37.9 43.8 44.8 27.2 27.0 25.2 34.0 36.0 27.0 26.5 21.9 25.2 27.7 23.8 26.6 33.8 118.9 26.6 29.5 32.1 26.9 29.0 28.1 46.0 23.5 23.9 25.7 45.0 27.0 28.4 51.7 11.3 17.7 49.7 15.2 13.1 17.2 14.0 29.5 39.2 19.3 30.6 37.8 30.0 22.8 27.9 31.8 23.2 24.7 32.2 13.7 35.1 25.5 46.0 20.5 35.3 37.8 33.2 34.4 19.8 35.9 21.9 33.2 50.8 32.1 25.4 30.5 43.8 32.5 44.8 46.9 35.7 24.3 34.7 34.0 21.1 35.3 29.2 39.1 19.0 24.7 50.1 45.8 60.9 19.0 20.7 38.8 25.1 21.3 40.4 18.7 37.2 16.9 18.9 26.9 18.0 21.1 37.7 24.9 28.0 22.0 18.1 41.0 15.2 49.7 14.3 13.2 15.5 11.3 14.1 16.3 17.7 10.0 12.8 12.8 35.1 13.1 14.8 9.1 17.2 14.0 32.6 34.5 33.4 44.0 32.4 27.0 27.2 27.0 21.9 23.5 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favourable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 5.0 10.9 11.3 8.3 11.0 8.6 7.9 9.3 10.1 14.8 15.6 21.3 11.2 4.7 8.2 10.5 11.9 12.4 11.2 16.0 6.7 7.2 7.9 10.7 10.5 8.2 6.8 6.7 8.1 10.1 16.0 9.7 26.4 11.8 5.0 13.0 11.4 4.6 7.8 7.8 11.1 5.9 23.9 4.3 16.8 9.9 8.0 8.6 12.1 10.4 17.0 12.0 5.0 16.4 10.5 10.0 7.0 7.8 6.1 5.5 5.3 9.2 4.4 9.3 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 RNF126 FLJ20552 ENSG00000070423 "Ring finger protein 126" Q9BV68 19 647526-663277 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043050 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA043050: AB_10794768" "unprognostic (2.24e-1)" "unprognostic (1.64e-1)" "unprognostic (1.97e-1)" "unprognostic (2.48e-3)" "unprognostic (1.90e-1)" "unprognostic (2.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (9.96e-3)" "unprognostic (7.04e-3)" "unprognostic (3.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 14.2 14.2 13.4 17.0 13.7 18.7 14.5 12.2 24.7 9.8 16.0 14.8 7.4 24.3 10.4 9.2 19.8 9.5 13.1 14.2 13.1 10.2 11.6 27.9 10.4 19.9 11.4 11.6 12.1 22.4 5.9 10.0 14.1 12.3 10.0 6.3 10.1 13.2 9.3 50.3 21.9 20.3 9.9 10.0 18.6 21.0 33.6 9.3 16.1 8.6 19.5 18.6 13.1 11.2 15.9 13.6 7.5 13.8 17.1 17.3 9.2 25.9 8.6 7.3 10.4 1.7 2.4 12.5 13.7 5.2 7.9 7.5 17.4 9.1 21.5 8.9 5.7 17.5 4.4 10.2 2.2 14.2 31.8 10.9 9.0 14.4 6.6 21.7 16.1 4.1 8.1 6.5 5.1 7.2 21.9 21.7 4.1 20.9 22.1 10.2 19.5 17.0 16.1 6.3 33.9 6.0 14.5 17.5 13.6 10.3 13.6 14.0 8.7 17.1 9.4 14.4 10.4 21.1 23.3 38.4 19.0 25.2 18.3 12.7 14.8 0.6 9.8 7.5 17.3 11.5 14.2 15.9 15.7 16.7 12.4 15.6 12.2 11.4 2.2 17.1 13.8 13.6 16.8 9.2 13.4 13.7 12.2 24.7 13.1 10.2 11.4 11.6 12.3 9.3 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812708-149962139 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 72.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA064784: " "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favourable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 24.0 21.3 30.6 19.0 39.4 9.8 28.5 19.9 30.4 19.0 17.7 39.9 16.2 14.3 16.8 33.7 16.8 15.9 20.4 16.4 40.5 29.7 35.8 39.2 31.7 19.6 60.9 26.8 18.1 19.6 23.5 14.9 32.4 40.7 25.5 20.3 19.5 36.1 20.9 18.0 18.4 16.3 20.4 102.2 25.5 17.0 12.5 51.2 13.3 32.1 18.8 15.9 21.4 16.5 8.8 15.7 72.4 31.5 7.8 8.5 14.6 19.4 12.1 8.2 9.3 32.3 19.8 13.7 10.8 27.8 10.4 15.5 10.6 28.0 8.1 15.8 13.2 18.5 11.0 13.8 14.7 9.9 8.0 9.7 5.6 10.3 21.5 10.4 13.9 20.9 26.3 8.8 23.9 11.5 3.0 16.5 9.3 10.9 7.5 6.9 5.5 9.5 5.4 8.8 34.3 20.2 9.1 4.3 12.5 8.9 13.4 34.7 25.5 11.1 12.0 14.2 5.7 15.0 6.9 28.0 18.4 16.7 11.9 9.8 7.6 12.9 20.3 16.6 6.8 25.2 8.5 8.8 7.6 7.6 15.7 8.3 7.3 7.5 72.4 7.8 31.5 11.2 8.3 14.6 30.6 39.4 19.9 29.2 40.5 29.7 60.9 26.8 40.7 51.2 RNF141 "ZFP26, ZNF230" ENSG00000110315 "Ring finger protein 141" Q8WVD5 11 10511678-10541230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018133 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA018133: AB_1859142" "unprognostic (7.41e-2)" "unprognostic (1.16e-1)" "unprognostic (7.88e-3)" "unprognostic (8.42e-2)" "unprognostic (2.12e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (1.44e-1)" "unprognostic (5.50e-2)" "prognostic unfavourable (1.14e-4)" "unprognostic (4.57e-2)" "prognostic favourable (2.60e-4)" "unprognostic (6.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.71e-2)" "unprognostic (1.61e-2)" 14.0 17.6 27.9 14.8 39.0 10.0 15.8 10.2 28.8 10.9 10.0 44.4 6.0 12.5 8.2 11.8 33.7 9.7 8.4 12.8 30.1 23.6 14.2 12.4 12.3 9.4 44.7 18.7 6.5 8.2 19.4 9.5 8.5 33.7 13.6 9.9 7.3 20.6 8.8 23.9 24.2 17.5 7.8 56.2 15.1 12.3 42.2 39.3 7.7 13.3 12.8 15.4 10.6 12.9 19.1 8.2 43.5 29.2 2.4 4.2 8.6 17.3 9.1 12.6 7.6 19.3 18.8 9.3 11.9 9.3 4.5 5.5 13.6 62.3 7.2 10.9 9.1 12.6 5.4 13.6 6.9 7.8 7.3 4.9 5.8 7.0 7.5 7.7 5.9 12.4 15.9 2.4 15.0 12.2 13.2 6.8 11.2 7.3 7.7 2.9 6.3 5.1 9.8 5.7 7.8 7.3 18.8 3.9 8.3 11.5 13.4 7.3 8.6 4.1 12.9 11.3 7.0 9.3 3.6 3.0 5.8 8.0 13.9 11.0 13.6 8.5 15.0 25.2 2.5 29.2 4.2 19.1 2.9 2.4 8.2 18.4 3.3 2.2 43.5 2.4 27.0 7.6 3.4 8.6 27.9 39.0 10.2 28.4 30.1 23.6 44.7 18.7 33.7 39.3 RNF145 FLJ31951 ENSG00000145860 "Ring finger protein 145" Q96MT1 5 159157409-159210053 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036562 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA036562: AB_10696657" "unprognostic (1.57e-1)" "unprognostic (9.02e-3)" "unprognostic (4.11e-2)" "unprognostic (3.88e-2)" "unprognostic (3.24e-2)" "unprognostic (2.93e-2)" "prognostic unfavourable (1.64e-6)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.54e-1)" "unprognostic (3.53e-1)" "unprognostic (1.67e-1)" "unprognostic (8.92e-3)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" 13.3 20.1 23.9 15.6 23.0 7.1 24.1 30.2 27.3 11.3 11.7 5.7 5.3 4.7 12.6 13.6 26.7 11.4 20.8 16.8 22.0 8.4 8.2 6.1 30.7 36.3 17.5 9.7 14.1 6.0 26.9 29.0 21.9 18.5 11.8 12.6 10.2 17.8 14.8 5.5 14.9 11.0 13.8 12.4 12.7 11.2 7.9 18.0 12.4 14.3 8.0 19.6 19.3 15.7 8.9 2.7 14.4 2.6 2.1 6.2 1.3 20.1 20.0 30.7 36.8 32.5 14.5 6.0 16.2 28.3 15.0 24.4 6.9 16.8 6.9 29.1 14.2 26.5 24.2 21.3 26.5 28.5 8.6 14.6 22.7 5.7 13.9 9.6 14.0 8.9 38.5 13.9 20.5 14.7 14.5 26.8 14.0 0.5 10.9 3.0 13.2 10.2 14.6 13.4 13.8 20.0 7.0 11.2 20.7 16.3 17.5 26.6 12.3 8.8 15.6 16.8 15.5 13.4 28.6 5.9 8.3 6.5 19.6 12.0 36.0 2.8 2.6 14.4 3.2 2.5 3.7 8.9 4.7 3.8 1.9 4.4 6.2 4.3 9.7 2.1 2.2 2.7 5.7 1.3 23.9 23.0 30.2 27.3 22.0 8.4 17.5 9.7 18.5 18.0 RNF146 "dactylidin, dJ351K20.1, DKFZp434O1427" ENSG00000118518 "Ring finger protein 146" Q9NTX7 6 127266610-127288567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027158, HPA027209" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA027158: AB_10600772, HPA027209: AB_10602312" "unprognostic (8.22e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.37e-1)" "unprognostic (5.47e-3)" "unprognostic (1.87e-1)" "unprognostic (6.74e-2)" "prognostic favourable (5.26e-5)" "unprognostic (2.65e-2)" "prognostic favourable (7.32e-4)" "unprognostic (4.04e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "unprognostic (2.15e-2)" 27.3 20.9 28.5 16.6 29.1 5.1 23.9 63.7 34.5 22.7 18.6 29.2 10.5 11.8 32.0 35.2 14.2 17.9 21.3 25.2 26.3 21.7 20.9 16.8 21.0 17.3 30.0 27.7 28.5 12.6 26.5 27.4 27.8 31.3 18.6 17.6 17.5 16.7 20.3 55.9 16.0 15.2 26.1 28.7 24.6 15.5 16.3 27.7 9.2 26.7 15.5 17.6 19.2 18.7 11.7 14.2 22.8 22.8 11.5 10.3 9.1 5.5 7.0 26.7 23.5 24.7 24.8 9.7 18.9 30.2 10.1 14.5 9.1 8.4 10.0 13.4 15.4 7.1 7.9 8.8 14.8 11.5 6.9 12.7 8.4 12.7 24.5 7.5 9.0 21.6 18.7 11.4 22.8 17.7 13.6 9.8 22.2 10.6 7.3 13.6 9.7 7.3 9.4 6.9 5.0 14.4 6.1 16.0 16.1 7.3 10.4 11.6 7.1 26.0 20.8 17.8 5.9 18.4 13.3 14.2 8.8 6.6 13.6 13.2 16.8 16.8 18.9 16.1 9.3 20.0 9.7 11.1 8.0 10.3 14.2 11.7 7.3 10.2 22.8 11.5 22.8 7.1 8.6 9.1 28.5 29.1 63.7 34.5 26.3 21.7 30.0 27.7 31.3 27.7 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Cell line enhanced" "Detected in some" "AF22: 12.5;HaCaT: 6.8;HeLa: 6.7;RPMI-8226: 6.5;SCLC-21H: 12.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA041615: , HPA047798: " "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.5 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 6.8 0.5 1.0 0.0 0.0 1.0 0.1 6.7 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 1.0 1.7 1.2 2.4 0.5 6.5 0.8 2.1 12.9 14.7 2.3 0.0 0.0 0.3 0.5 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell line enhanced" "Detected in all" "NB-4: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favourable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavourable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.1 6.7 5.2 8.2 2.5 2.2 9.9 4.2 2.7 5.0 2.3 4.5 2.7 5.0 5.5 2.4 4.6 3.0 2.8 2.0 2.6 9.0 6.8 4.9 7.6 6.8 6.7 8.7 2.6 2.7 4.0 3.2 5.2 11.3 3.7 2.0 8.2 15.6 43.8 8.5 9.0 14.7 3.3 13.0 2.2 1.9 4.8 5.4 9.6 2.0 5.2 5.7 22.9 7.2 3.8 5.6 5.6 5.1 8.4 4.9 12.2 3.3 25.5 5.2 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597613 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046112: , HPA062121: " "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavourable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favourable (4.59e-5)" "unprognostic (1.49e-2)" 32.9 41.5 42.2 26.4 36.2 32.8 40.4 19.0 38.7 34.4 40.5 33.0 36.0 34.5 28.1 44.5 40.2 33.3 34.8 52.4 34.5 32.9 57.8 85.1 36.0 33.1 41.2 29.3 31.6 85.1 21.8 20.2 50.7 36.0 34.2 35.4 32.1 42.1 45.7 47.0 30.4 46.5 33.2 42.2 37.2 35.7 36.3 31.3 31.0 43.7 39.2 42.6 43.8 29.4 53.2 80.2 78.6 94.7 39.3 54.4 83.3 32.2 32.7 25.5 27.6 26.1 32.3 41.2 27.3 53.8 58.3 55.4 49.9 34.3 30.8 53.7 40.5 30.3 22.0 43.7 62.7 35.0 27.1 23.4 16.9 59.9 45.8 25.9 32.1 33.7 58.1 38.8 65.0 48.4 27.4 32.1 78.6 51.7 24.4 60.3 17.8 49.4 26.1 53.6 43.7 54.4 30.1 15.2 20.1 23.1 33.6 44.8 33.3 34.3 41.8 28.6 20.4 57.2 38.9 44.8 37.3 38.6 44.7 39.1 25.1 40.4 94.7 71.6 40.7 69.3 37.7 53.2 42.6 39.1 71.0 44.3 36.7 36.8 78.6 39.3 51.8 80.2 54.4 83.3 42.2 36.2 19.0 38.7 34.5 32.9 41.2 29.3 36.0 31.3 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Cell line enhanced" "Detected in many" "HeLa: 36.3;RPTEC TERT1: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavourable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 5.2 0.0 1.8 2.2 0.3 2.6 3.6 7.4 7.1 0.1 0.0 0.0 0.0 2.8 0.0 6.1 0.0 13.5 0.0 2.0 0.1 36.3 0.0 0.0 0.0 0.0 1.2 0.0 11.3 0.1 0.1 0.2 0.0 5.1 0.0 0.0 0.9 2.9 10.1 1.5 1.2 0.4 29.1 0.0 6.3 6.0 0.2 0.0 10.2 0.0 1.0 2.7 9.0 1.9 0.1 6.0 0.0 0.0 0.0 6.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 RNF216 "TRIAD3, UBCE7IP1, ZIN" ENSG00000011275 "Ring finger protein 216" Q9NWF9 7 5620047-5781739 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018955, HPA021123" Supported Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA018955: AB_1858500, HPA021123: AB_1858501" "unprognostic (3.31e-2)" "unprognostic (4.24e-2)" "unprognostic (1.28e-2)" "unprognostic (1.58e-2)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (2.26e-4)" "unprognostic (2.35e-1)" "unprognostic (2.40e-1)" "unprognostic (1.40e-2)" "prognostic favourable (6.24e-5)" "unprognostic (2.88e-2)" "unprognostic (9.01e-2)" "unprognostic (3.49e-1)" "unprognostic (1.73e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-3)" 16.9 14.9 22.0 18.8 24.8 22.2 18.4 33.5 27.8 17.8 26.9 22.0 13.4 11.5 26.9 13.3 18.7 19.6 14.2 29.1 20.5 17.4 12.7 11.8 14.9 23.8 23.8 14.8 25.6 21.3 23.2 24.9 14.6 20.4 17.7 11.8 18.9 16.2 21.5 22.5 15.1 20.1 25.0 18.7 23.3 18.3 34.3 26.3 18.5 19.8 9.6 24.1 17.7 30.7 8.8 6.7 24.5 8.4 10.0 9.7 6.5 14.4 15.6 12.8 21.8 15.3 13.3 8.8 15.5 16.3 16.1 14.9 11.3 8.3 12.7 8.0 17.3 10.4 13.3 10.9 13.2 7.9 11.6 9.8 9.5 11.4 18.4 16.0 16.8 13.7 14.0 12.3 15.1 12.7 19.6 8.9 17.8 22.2 6.0 25.5 17.6 13.0 15.3 18.1 7.1 9.6 12.2 9.8 15.6 9.8 24.6 8.8 9.7 16.4 13.8 16.3 29.4 16.6 13.9 7.2 5.4 10.3 12.2 14.9 25.9 1.3 7.7 24.5 9.0 8.4 9.0 7.3 7.9 6.7 6.7 8.8 9.7 9.1 13.1 10.0 7.7 5.4 7.0 6.5 22.0 24.8 33.5 27.8 20.5 17.4 23.8 14.8 20.4 26.3 RNF219 "C13orf7, FLJ13449" ENSG00000152193 "Ring finger protein 219" Q5W0B1 13 78614291-78659179 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavourable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 17.6 7.7 10.7 8.9 15.5 3.4 10.6 24.2 16.3 11.9 8.0 4.7 7.3 7.4 11.3 7.8 8.7 9.1 7.1 10.6 10.7 10.3 7.6 6.7 8.0 13.9 11.9 12.1 12.3 6.6 5.0 11.5 12.2 12.7 10.2 8.5 4.0 7.1 10.1 8.7 8.5 8.7 12.7 13.4 13.6 6.8 21.7 13.4 21.8 9.5 8.5 16.7 12.8 9.2 10.5 7.0 8.2 10.6 12.3 13.3 7.8 11.0 4.3 19.0 11.1 6.7 6.5 8.7 9.2 6.9 9.1 11.5 8.6 8.3 18.6 4.5 5.8 11.0 14.9 7.2 16.0 11.6 10.9 28.5 5.5 7.5 5.6 27.5 8.9 6.1 8.1 7.6 8.2 7.5 7.3 2.5 11.8 3.0 16.6 9.4 0.0 4.8 19.5 15.6 7.2 6.1 5.9 13.9 7.8 6.4 8.1 6.9 4.1 22.2 6.1 7.9 7.2 5.2 7.6 2.7 3.0 17.9 12.7 16.8 8.5 4.8 6.0 8.2 9.5 9.7 11.3 10.5 10.7 11.6 7.0 10.1 13.3 11.9 2.0 12.3 10.6 5.9 10.4 7.8 10.7 15.5 24.2 16.3 10.7 10.3 11.9 12.1 12.7 13.4 RNF220 "C1orf164, FLJ10597" ENSG00000187147 "Ring finger protein 220" Q5VTB9 1 44405194-44651724 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.4" "Cell line enhanced" "Detected in all" "U-937: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027577, HPA027578" Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA027577: , HPA027578: AB_10601482" "unprognostic (3.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-2)" "unprognostic (2.56e-1)" "unprognostic (2.94e-2)" "unprognostic (6.96e-3)" "prognostic unfavourable (2.35e-6)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.13e-1)" "unprognostic (2.14e-3)" "unprognostic (2.96e-2)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.51e-2)" "unprognostic (1.98e-1)" "unprognostic (1.37e-3)" "unprognostic (6.46e-2)" 9.8 7.4 20.9 9.6 38.5 12.7 6.7 12.6 40.1 5.4 9.2 40.7 2.7 10.7 8.0 8.8 6.0 9.3 4.5 9.2 33.4 20.9 7.4 5.1 7.4 7.6 49.8 19.8 9.5 8.1 7.0 5.7 8.7 25.8 7.7 5.9 4.2 9.3 7.1 28.4 8.7 8.8 8.0 57.4 7.9 7.6 7.0 49.6 5.0 7.3 4.6 8.0 7.9 5.6 3.6 6.6 2.8 2.3 1.9 4.3 1.4 5.9 2.8 12.3 4.2 4.8 4.4 9.3 7.1 6.5 5.5 8.1 4.9 5.9 11.6 6.3 5.6 3.9 13.8 5.8 7.5 14.4 12.2 16.0 8.9 8.3 7.8 11.3 8.2 4.8 13.3 6.1 9.8 3.1 11.7 5.8 3.4 4.1 11.1 8.6 13.4 6.5 9.4 7.3 8.3 3.5 3.7 5.6 6.9 6.0 4.2 8.6 3.1 20.0 4.8 5.8 6.2 5.4 13.1 13.2 12.7 8.4 4.8 36.5 3.5 2.4 2.3 2.8 3.2 1.8 2.4 2.4 1.0 4.3 3.4 3.6 1.9 1.7 1.5 1.9 1.3 6.6 3.2 1.4 20.9 38.5 12.6 30.8 33.4 20.9 49.8 19.8 25.8 49.6 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663864-218672411 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA036420: , HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 13.4 12.7 13.9 11.1 16.1 6.2 13.7 13.4 27.6 17.3 13.3 17.1 9.8 4.3 16.6 16.2 12.2 16.8 11.8 17.2 13.1 16.5 13.7 15.6 11.9 12.1 12.1 11.6 17.8 13.0 19.3 14.8 17.7 15.4 14.7 9.0 15.3 13.6 17.9 16.9 15.7 10.3 16.0 10.0 12.9 11.8 18.4 9.1 15.3 16.8 12.7 16.8 14.0 11.8 13.3 8.2 23.3 11.2 14.8 15.0 13.9 5.9 7.6 6.9 8.0 10.5 6.4 7.4 6.7 17.0 23.2 21.7 12.6 4.0 3.9 5.4 14.2 5.4 7.9 13.2 10.1 4.3 10.9 5.4 5.6 11.9 12.9 4.7 5.9 14.2 12.4 21.1 14.2 12.7 9.0 6.2 14.9 16.9 5.3 5.8 10.9 8.7 7.5 4.3 5.8 14.2 6.3 7.0 7.9 5.2 5.8 10.0 6.9 8.8 7.3 13.2 6.3 5.1 9.6 5.3 4.2 6.6 11.1 5.9 8.0 23.3 10.6 14.9 13.9 10.3 12.6 11.9 13.7 13.6 8.2 13.3 15.0 11.7 8.9 14.8 11.2 7.4 11.5 13.9 13.9 16.1 13.4 27.6 13.1 16.5 12.1 11.6 15.4 9.1 RNF26 MGC2642 ENSG00000173456 "Ring finger protein 26" Q9BY78 11 119334527-119337313 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027620 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA027620: AB_1856356" "unprognostic (9.23e-3)" "unprognostic (3.54e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (3.40e-1)" "unprognostic (1.07e-2)" "prognostic unfavourable (3.19e-4)" "unprognostic (2.14e-2)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (7.24e-3)" "unprognostic (6.22e-2)" "prognostic favourable (3.45e-6)" "unprognostic (9.61e-2)" "unprognostic (3.50e-2)" "unprognostic (4.41e-2)" "prognostic unfavourable (7.73e-4)" 19.0 21.5 13.6 15.4 21.6 25.6 16.9 18.4 38.9 19.8 22.0 17.6 14.5 20.3 31.2 15.6 26.0 24.4 19.8 15.1 17.1 13.8 22.3 28.7 17.3 17.5 15.0 16.6 25.6 18.5 31.4 14.3 27.5 27.2 19.2 18.2 20.2 20.0 28.5 17.6 19.8 21.4 27.0 14.3 19.8 24.3 27.6 13.0 26.7 20.6 14.0 21.1 25.8 18.1 13.8 14.2 7.1 15.5 9.8 16.7 16.2 15.6 17.3 16.2 19.1 16.0 12.7 17.3 17.0 18.4 19.9 15.8 29.2 32.8 13.8 23.6 20.2 28.5 23.0 25.6 12.5 16.5 12.6 36.4 8.1 24.1 12.3 15.2 15.2 13.1 13.2 24.8 22.4 15.1 17.6 21.7 13.6 34.1 13.9 15.8 16.2 22.2 14.5 16.7 11.0 12.2 11.3 11.6 11.2 13.7 17.5 4.5 39.5 12.8 9.9 24.1 16.1 12.6 15.5 5.2 8.5 0.1 8.0 25.8 18.7 7.1 15.5 3.9 16.7 14.5 11.0 9.0 12.7 14.5 14.2 13.8 14.5 12.4 1.1 9.8 14.1 8.1 6.6 16.2 13.6 21.6 18.4 38.9 17.1 13.8 15.0 16.6 27.2 13.0 RNF41 "NRDP1, SBBI03" ENSG00000181852 "Ring finger protein 41" Q9H4P4 12 56202175-56221933 "Enzymes, Predicted intracellular proteins" "Apoptosis, Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016812 Approved Approved "Nucleoplasm,Nuclear bodies,Midbody ring" "Nucleoplasm, Nuclear bodies" "Midbody ring" "HPA016812: AB_1856370" "unprognostic (1.14e-2)" "unprognostic (6.30e-2)" "unprognostic (4.04e-2)" "unprognostic (6.86e-2)" "unprognostic (9.59e-2)" "unprognostic (8.22e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (6.93e-2)" "unprognostic (4.18e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.90e-2)" "prognostic favourable (2.52e-5)" "unprognostic (1.64e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" 22.2 17.6 18.6 11.8 30.2 12.0 14.3 30.9 47.1 16.2 15.0 16.9 12.3 8.5 16.4 9.7 16.5 17.7 18.0 22.6 17.3 22.4 14.1 10.5 16.5 14.8 15.3 18.2 17.0 16.0 17.9 16.7 14.6 25.3 25.2 13.6 14.6 10.5 15.6 21.2 10.1 10.8 20.3 11.8 13.5 12.2 10.1 12.1 11.3 20.5 10.1 17.0 16.2 11.5 24.6 13.1 41.1 11.5 13.4 12.5 12.3 7.5 11.6 12.6 20.0 26.5 19.3 9.4 25.3 25.1 22.8 18.5 14.2 9.9 14.6 13.5 21.4 8.7 17.0 12.2 16.6 15.2 9.3 19.6 8.3 8.1 55.6 21.4 21.4 24.6 28.7 19.0 33.6 22.1 13.8 15.0 12.6 12.2 12.2 9.6 15.2 13.6 13.3 9.1 8.8 12.1 11.1 23.1 14.0 22.1 12.7 20.0 17.8 25.2 13.3 11.5 12.3 14.8 9.7 10.8 12.4 13.3 13.7 12.9 13.7 21.0 11.5 41.1 12.5 11.4 11.2 22.7 10.6 10.9 13.1 24.6 11.0 11.2 15.8 13.4 11.2 10.2 12.1 12.3 18.6 30.2 30.9 47.1 17.3 22.4 15.3 18.2 25.3 12.1 RNF44 KIAA1100 ENSG00000146083 "Ring finger protein 44" Q7L0R7 5 176526697-176538025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038981 Uncertain Approved Nucleoplasm Nucleoplasm "HPA038981: AB_10674846" "unprognostic (1.85e-1)" "unprognostic (3.07e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (2.57e-7)" "unprognostic (1.50e-1)" "unprognostic (2.56e-2)" "prognostic unfavourable (8.45e-4)" "unprognostic (1.61e-1)" "unprognostic (4.54e-2)" "unprognostic (5.36e-2)" "unprognostic (5.78e-2)" "unprognostic (1.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-3)" "unprognostic (1.62e-1)" "unprognostic (5.12e-3)" "unprognostic (1.15e-2)" 10.8 12.7 16.5 27.1 17.7 38.5 12.4 27.1 21.6 10.3 14.8 14.3 7.3 20.5 12.6 10.0 17.0 12.1 12.4 10.0 15.7 10.9 15.2 9.3 14.1 34.9 14.6 13.7 17.8 16.0 10.3 11.0 20.6 13.4 12.8 13.5 11.1 15.9 10.8 10.2 20.5 22.2 8.6 14.5 38.1 16.4 14.5 16.1 43.3 17.3 7.5 24.1 14.1 13.3 4.1 1.9 9.4 3.1 3.3 5.5 2.6 3.6 8.4 13.5 12.6 2.7 2.2 36.3 2.1 1.9 1.4 1.8 12.8 8.2 7.0 13.3 1.2 10.0 6.0 12.9 1.6 27.2 10.6 7.5 7.2 11.7 3.4 8.7 10.4 4.3 10.4 1.6 4.9 4.0 8.3 10.6 1.9 12.7 20.1 19.5 17.9 10.4 8.3 3.6 10.1 4.9 8.6 16.6 20.3 3.2 8.9 12.3 9.8 17.5 6.4 3.6 5.5 2.9 4.0 13.5 10.1 9.6 1.8 17.9 4.7 0.0 2.7 4.7 5.5 3.1 4.1 3.5 4.2 4.6 1.8 4.1 4.2 5.0 9.4 3.3 2.5 1.9 5.0 2.6 16.5 17.7 27.1 21.6 15.7 10.9 14.6 13.7 13.4 16.1 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell line enhanced" "Detected in many" "AN3-CA: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA064161: " "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.0 4.7 15.3 0.2 0.0 7.9 0.6 0.7 1.9 1.7 3.6 1.7 7.9 2.2 0.1 1.9 10.0 0.7 1.8 7.5 5.0 1.5 7.3 4.8 2.0 0.6 4.6 0.2 0.2 3.1 1.0 0.3 6.0 2.9 0.2 7.6 7.7 1.9 4.7 1.8 5.0 2.7 4.1 3.7 1.8 7.3 6.6 2.2 1.2 2.2 7.2 1.7 0.5 1.3 5.2 3.1 3.1 3.6 12.0 8.3 5.7 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 RNGTT "hCAP, HCE, HCE1" ENSG00000111880 "RNA guanylyltransferase and 5'-phosphatase" O60942 6 88610272-88963721 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA capping, mRNA processing" "Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003750 Approved Approved Nucleoplasm Nucleoplasm "HPA003750: AB_1856383" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (2.82e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-2)" "unprognostic (1.10e-1)" "prognostic unfavourable (1.37e-4)" "unprognostic (4.48e-3)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (3.76e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-3)" "unprognostic (9.83e-2)" "unprognostic (6.55e-2)" "unprognostic (1.67e-1)" "unprognostic (8.08e-3)" 9.1 12.1 10.2 19.6 12.2 14.2 9.9 18.5 13.1 10.0 8.1 8.7 7.0 7.4 11.1 7.2 12.5 8.7 7.2 9.6 10.5 16.0 9.4 11.8 9.4 26.3 9.8 6.4 10.4 6.6 12.1 23.1 11.6 11.1 9.8 9.8 9.4 8.4 11.6 10.5 9.0 10.7 10.7 10.7 14.3 7.5 15.0 10.4 28.0 10.0 7.8 28.2 10.9 13.8 18.6 4.4 5.7 4.6 8.0 8.4 4.3 5.6 8.6 13.5 17.1 7.9 8.4 8.1 12.9 8.5 10.5 13.3 9.8 4.3 14.6 10.6 9.2 7.1 15.7 10.4 19.4 19.8 12.3 19.0 7.8 7.8 6.5 20.3 10.8 5.3 9.2 10.9 10.6 9.3 18.7 11.8 15.6 7.5 8.9 14.5 8.1 7.6 17.7 20.9 8.3 9.4 8.8 7.9 11.4 10.7 6.5 7.0 7.0 20.4 7.3 8.5 7.9 9.6 17.4 10.7 18.7 8.2 12.5 15.2 15.5 3.5 3.0 5.7 6.4 4.6 6.4 18.6 7.2 7.9 4.4 16.8 8.2 8.4 2.5 8.0 3.9 3.1 6.7 4.3 10.2 12.2 18.5 13.1 10.5 16.0 9.8 6.4 11.1 10.4 RNPEPL1 ENSG00000142327 "Arginyl aminopeptidase like 1" Q9HAU8 2 240565804-240581372 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036772 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA036772: AB_10670848" "unprognostic (3.92e-2)" "unprognostic (7.28e-2)" "unprognostic (1.20e-2)" "unprognostic (2.39e-1)" "unprognostic (5.24e-3)" "prognostic favourable (7.43e-4)" "prognostic unfavourable (5.06e-4)" "unprognostic (3.72e-3)" "unprognostic (9.10e-2)" "unprognostic (1.66e-3)" "unprognostic (3.10e-1)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (5.31e-2)" "unprognostic (9.86e-2)" 17.2 13.7 10.1 13.7 8.8 17.2 48.4 7.2 10.5 11.0 21.0 9.5 11.8 18.6 8.0 8.9 22.1 8.0 22.3 28.3 9.2 6.0 18.2 26.7 32.2 54.1 12.9 8.2 7.1 40.0 7.7 4.3 10.1 8.1 14.9 9.1 7.0 21.5 13.5 26.5 22.5 31.0 11.4 9.7 25.7 20.0 5.9 7.6 23.1 8.8 16.7 12.1 14.4 18.8 7.0 7.6 22.4 9.1 7.6 12.4 5.4 6.8 11.5 2.5 6.8 9.4 9.8 8.7 4.4 11.0 5.0 6.2 3.1 20.2 2.0 2.3 11.1 7.5 2.9 8.2 0.5 12.0 4.0 4.5 3.7 18.6 23.7 2.9 8.2 11.6 13.4 2.6 5.1 17.0 3.3 13.4 3.3 9.7 3.7 11.1 3.4 4.6 7.8 3.8 16.6 20.2 9.5 2.4 5.1 3.0 10.3 20.0 7.2 13.6 11.6 5.4 5.6 7.5 5.0 12.7 1.9 2.3 11.1 8.3 8.1 5.8 9.1 22.4 12.4 7.8 10.6 7.0 9.6 11.1 6.4 6.8 5.4 8.1 16.0 7.6 7.6 7.6 11.1 5.4 10.1 8.8 7.2 10.5 9.2 6.0 12.9 8.2 8.1 7.6 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in some" 5 "BJ hTERT+: 14.9;HEL: 40.7" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.9 4.2 0.0 0.1 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.8 40.7 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.6 0.0 0.0 0.5 6.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 RORB "NR1F2, ROR-BETA, RZRB" ENSG00000198963 "RAR related orphan receptor B" Q92753 9 74497365-74693177 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.5;cervix, uterine: 20.8" "Cell line enhanced" "Detected in some" "HHSteC: 19.9;HSkMC: 10.9;MOLT-4: 5.6;SH-SY5Y: 11.7" "Group enriched" "Detected in some" 5 "glioma: 2.1;prostate cancer: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008393 Uncertain Approved Nucleoplasm Nucleoplasm "HPA008393: AB_1079830" "unprognostic (6.89e-3)" "unprognostic (4.06e-3)" "unprognostic (1.38e-1)" "unprognostic (3.97e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.28e-1)" "unprognostic (1.18e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (5.46e-2)" "unprognostic (8.81e-8)" "unprognostic (5.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.26e-2)" "unprognostic (4.00e-2)" 3.1 7.9 8.3 1.2 11.1 1.0 1.4 1.8 35.5 20.8 1.3 2.1 2.2 1.1 8.9 0.9 1.7 1.5 4.5 3.9 5.6 7.0 2.0 1.0 2.0 0.9 4.1 18.7 1.4 1.1 1.1 4.0 10.6 6.1 10.5 1.6 18.7 1.2 11.7 0.9 1.3 1.1 1.7 6.7 1.0 1.6 2.0 3.7 2.2 1.5 0.0 1.5 2.3 2.2 0.2 0.2 1.8 0.2 0.6 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.9 0.0 0.6 10.9 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 5.6 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.2 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.4 2.7 0.0 1.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.6 1.8 0.6 0.1 0.2 0.0 0.0 8.3 11.1 1.8 35.5 5.6 7.0 4.1 18.7 6.1 3.7 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041739: " "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavourable (9.32e-4)" "unprognostic (4.30e-3)" 10.1 10.2 12.8 8.5 12.4 4.7 8.1 7.8 15.6 7.8 10.2 12.6 7.9 8.5 10.7 6.0 12.3 10.4 6.9 9.5 10.9 6.1 6.7 10.8 7.3 9.8 12.3 10.1 12.4 9.4 12.9 9.4 8.7 11.9 9.4 7.1 9.5 9.8 9.2 27.0 10.3 8.0 10.1 8.0 9.1 9.4 12.6 11.8 11.2 8.3 7.9 10.7 11.2 8.4 5.9 4.5 0.0 5.9 4.9 7.2 3.3 7.1 8.5 11.7 12.3 9.8 7.1 9.9 7.0 6.1 9.1 9.0 23.1 6.5 5.6 11.6 7.8 16.9 21.1 10.3 7.8 9.8 10.2 10.6 11.9 10.1 6.2 8.6 6.7 7.2 13.1 10.9 7.6 10.2 24.6 6.4 8.4 4.5 9.3 5.3 20.6 7.9 16.9 10.1 6.0 4.0 16.8 10.7 14.4 9.0 9.5 4.8 15.6 10.8 9.3 14.4 9.4 14.3 11.2 10.8 29.6 6.3 10.3 9.4 13.5 0.0 2.6 0.0 7.2 3.5 6.6 4.8 4.3 4.5 4.5 5.9 6.1 5.3 0.0 4.9 5.9 2.9 4.4 3.3 12.8 12.4 7.8 15.6 10.9 6.1 12.3 10.1 11.9 11.8 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022259 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: , HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavourable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavourable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 19.4 26.9 20.6 16.7 28.0 14.6 22.6 26.4 27.7 18.7 19.7 23.3 20.7 17.4 27.8 21.5 24.0 17.6 17.3 17.2 21.1 21.0 26.7 23.3 19.4 21.6 21.7 21.7 22.9 14.1 14.8 41.9 24.4 18.6 20.5 26.6 18.9 18.3 27.9 12.3 17.2 16.0 27.1 25.8 15.6 19.8 11.9 19.7 23.5 25.2 14.5 23.2 24.1 20.2 8.6 28.9 8.0 20.5 30.5 10.7 11.3 21.0 27.2 17.7 17.8 28.8 27.9 30.4 27.7 22.2 26.3 35.4 39.2 32.2 14.2 18.2 21.4 20.7 26.0 29.5 40.3 17.0 18.4 26.2 40.0 36.5 39.3 27.8 20.2 19.5 29.4 30.2 39.4 34.2 26.4 19.8 21.6 33.5 15.1 24.2 26.0 20.0 19.0 21.1 20.3 30.4 31.4 21.3 12.2 23.4 22.9 18.5 19.7 32.0 28.0 35.4 23.5 17.2 25.5 11.8 15.0 30.4 25.6 27.5 22.8 6.9 17.3 8.0 10.2 20.5 8.9 8.6 8.0 9.6 28.9 8.4 10.7 9.6 1.7 30.5 13.7 10.6 10.7 11.3 20.6 28.0 26.4 27.7 21.1 21.0 21.7 21.7 18.6 19.7 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: , HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 1.0 0.7 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 RPF2 "bA397G5.4, BXDC1, FLJ21087" ENSG00000197498 "Ribosome production factor 2 homolog" Q9H7B2 6 110982015-111028263 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035475 Supported Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA035475: AB_10669861" "unprognostic (2.85e-3)" "unprognostic (2.19e-2)" "unprognostic (6.00e-2)" "unprognostic (2.90e-3)" "unprognostic (4.45e-1)" "prognostic unfavourable (2.04e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.99e-1)" "unprognostic (8.43e-2)" "unprognostic (9.16e-2)" "prognostic unfavourable (2.07e-6)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-1)" 21.1 17.1 13.9 14.1 19.2 15.4 20.7 16.7 17.3 14.5 13.8 9.0 10.3 10.3 15.4 12.1 19.2 15.8 14.4 19.6 16.5 11.0 18.8 30.7 12.2 15.3 16.8 11.3 20.9 25.9 13.7 21.6 15.5 19.3 15.5 14.1 9.5 14.0 11.5 46.3 16.7 10.6 19.8 17.4 16.3 14.2 18.1 18.7 10.0 20.4 29.3 15.8 22.1 15.1 10.3 9.3 0.8 7.7 11.1 12.4 6.1 7.9 3.8 4.3 17.0 7.6 11.9 11.3 11.4 6.8 10.1 10.1 15.4 5.7 18.6 10.9 5.7 9.1 14.3 10.8 22.9 7.9 13.1 12.2 4.8 8.9 9.1 18.4 5.9 7.2 8.7 14.0 28.7 8.0 32.3 10.3 12.6 7.7 13.6 19.4 12.5 6.9 13.1 8.2 13.3 9.7 7.9 7.3 9.5 5.0 6.7 18.7 6.1 15.7 5.2 8.3 7.4 81.5 30.4 4.4 6.8 23.2 11.1 23.3 16.7 0.3 6.9 0.8 5.9 7.7 12.4 10.3 8.4 7.7 8.1 7.8 11.1 10.5 0.2 11.1 4.9 9.3 7.3 6.1 13.9 19.2 16.7 17.3 16.5 11.0 16.8 11.3 19.3 18.7 RPIA ENSG00000153574 "Ribose 5-phosphate isomerase A" P49247 2 88691644-88750935 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042620, HPA057954" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" 4100000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA042620: AB_10793980, HPA057954: " "unprognostic (3.35e-2)" "unprognostic (1.35e-2)" "unprognostic (6.96e-2)" "unprognostic (9.24e-2)" "unprognostic (4.31e-1)" "unprognostic (8.24e-2)" "prognostic unfavourable (1.46e-5)" "unprognostic (2.73e-3)" "unprognostic (1.82e-3)" "unprognostic (8.70e-2)" "unprognostic (8.82e-2)" "unprognostic (2.79e-1)" "prognostic unfavourable (8.53e-6)" "unprognostic (3.47e-2)" "unprognostic (2.53e-1)" "unprognostic (1.01e-2)" "unprognostic (8.79e-3)" 12.9 8.8 6.6 15.6 7.0 43.0 12.1 11.1 6.4 8.1 12.7 6.1 11.0 12.4 11.1 7.3 18.3 8.5 14.0 10.9 5.0 4.9 6.8 6.2 9.0 16.2 7.2 3.8 11.7 26.5 3.6 11.4 26.1 6.5 8.8 13.4 6.0 12.6 8.5 17.6 9.2 12.7 7.7 5.1 15.4 10.4 8.9 7.6 30.7 9.6 10.5 19.3 8.1 11.8 18.5 14.1 21.4 12.5 13.3 22.4 11.6 8.5 5.0 10.2 8.0 7.2 7.4 22.3 4.8 4.5 7.9 5.4 17.8 11.4 43.7 10.4 5.5 5.2 12.6 4.0 12.5 20.7 16.5 17.5 3.2 17.5 7.3 32.0 12.9 6.8 3.4 7.0 11.0 11.1 18.7 7.6 7.4 13.4 35.1 28.0 9.2 8.2 18.4 12.1 10.6 6.5 13.8 7.3 8.3 5.7 7.4 11.0 4.0 13.2 6.3 4.7 12.4 15.4 13.6 5.9 4.8 43.7 4.8 29.1 6.7 5.5 9.7 21.4 11.1 9.8 14.2 18.5 15.5 16.4 14.1 15.4 22.4 18.4 2.3 13.3 12.5 6.8 12.6 11.6 6.6 7.0 11.1 6.4 5.0 4.9 7.2 3.8 6.5 7.6 RPL22 "EAP, L22" ENSG00000116251 "Ribosomal protein L22" P35268 1 6181269-6209389 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068294 Approved Nucleoplasm,Nucleoli 320000 Nucleoli Nucleoplasm "HPA068294: " "unprognostic (3.16e-3)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.62e-2)" "unprognostic (2.27e-2)" "unprognostic (1.09e-1)" "unprognostic (1.29e-3)" "unprognostic (4.40e-2)" "unprognostic (7.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.48e-1)" "unprognostic (4.24e-2)" "unprognostic (1.46e-3)" "unprognostic (3.83e-1)" "unprognostic (3.88e-2)" "unprognostic (2.46e-1)" "unprognostic (1.98e-1)" 75.5 71.5 54.3 79.7 42.8 124.7 75.0 46.7 39.5 95.8 73.9 39.2 53.9 66.5 133.6 63.9 103.9 59.1 61.8 50.8 47.4 38.6 58.8 90.2 55.3 142.6 50.6 39.7 163.1 154.8 30.4 57.0 49.8 37.4 90.8 46.4 57.0 140.3 66.8 114.0 79.7 62.6 106.6 58.3 79.1 62.0 38.2 35.0 95.3 91.0 112.8 81.1 101.5 91.9 75.6 62.3 11.0 38.9 42.2 98.8 73.9 88.0 25.1 53.5 54.6 37.7 59.3 42.3 76.9 30.9 28.3 24.2 49.8 76.6 136.7 63.3 28.5 50.9 40.2 40.0 37.3 66.9 65.4 132.8 57.2 61.7 37.4 175.7 53.3 52.3 33.1 25.2 52.2 35.3 109.4 82.8 32.5 38.8 76.8 143.4 33.3 55.7 74.1 111.0 105.8 41.4 30.6 74.0 67.9 62.6 181.4 140.8 58.4 139.3 86.3 40.4 44.5 53.3 72.2 66.7 91.4 206.8 26.7 181.7 25.0 11.0 38.9 8.8 38.0 34.3 66.9 75.6 71.1 52.3 59.8 72.4 98.8 78.1 2.9 42.2 27.8 62.3 54.0 73.9 54.3 42.8 46.7 39.5 47.4 38.6 50.6 39.7 37.4 35.0 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870483 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA048060: , HPA056207: , HPA068294: " "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favourable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavourable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 17.2 14.6 8.9 28.1 9.5 36.0 21.5 6.0 9.3 14.3 15.7 5.3 6.6 8.4 12.2 12.3 33.6 15.3 11.8 11.3 7.4 8.5 11.4 64.3 18.8 31.4 10.1 5.7 18.6 71.6 1.9 12.1 10.5 10.7 14.7 15.7 6.4 15.7 14.0 17.7 19.4 13.7 12.2 11.5 37.5 17.4 9.7 8.9 17.9 15.2 32.5 27.8 18.9 15.9 24.1 24.2 1.9 7.6 13.1 13.8 3.5 15.5 17.5 5.7 66.3 17.0 100.0 17.5 15.8 36.5 12.9 8.4 7.5 3.6 48.1 3.6 14.7 4.0 14.1 40.4 7.2 2.9 2.5 4.3 2.1 16.8 68.7 8.9 6.4 72.6 82.5 4.1 43.8 43.7 3.0 3.1 70.5 19.7 64.5 5.0 89.3 3.2 86.6 2.0 7.4 31.9 34.7 0.9 4.8 1.6 7.9 6.8 11.1 7.8 20.2 2.4 19.0 4.9 22.0 5.0 3.4 7.6 45.0 5.4 51.1 1.0 4.8 1.9 6.8 5.7 13.8 24.1 10.0 9.0 5.1 17.9 6.7 7.4 1.0 13.1 7.6 24.2 6.3 3.5 8.9 9.5 6.0 8.1 7.4 8.5 10.1 5.7 10.7 8.9 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306247-58324695 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favourable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavourable (2.96e-4)" "unprognostic (5.78e-2)" 7.1 8.5 8.3 5.7 12.9 5.3 7.1 15.8 10.7 6.6 8.6 5.9 6.6 10.2 8.2 7.8 8.5 7.4 6.2 11.8 7.2 6.8 11.2 15.0 5.6 7.6 6.5 9.9 8.4 11.9 10.8 9.4 6.0 7.2 7.4 8.2 9.0 8.5 7.0 53.5 7.4 9.1 11.7 5.5 7.7 7.7 9.1 5.9 6.3 8.1 18.5 8.5 7.2 7.0 4.6 6.6 4.7 9.8 9.8 6.4 3.5 10.1 8.0 9.4 7.4 7.8 8.4 10.3 8.6 9.2 12.3 13.9 12.2 6.7 12.1 2.0 11.5 6.2 14.0 12.7 12.0 8.4 7.4 11.5 9.6 6.6 7.7 19.8 9.6 9.2 12.3 14.6 14.0 9.7 9.9 8.7 11.9 5.5 13.4 7.0 12.3 15.3 5.5 7.4 11.7 9.0 14.5 5.9 10.4 8.0 9.6 11.5 9.2 9.6 8.8 9.3 10.4 9.8 16.2 13.0 22.2 17.5 10.7 13.9 6.6 3.0 5.7 4.7 4.2 4.9 5.6 4.1 5.5 5.8 6.6 4.6 6.4 6.2 2.6 9.8 9.8 6.2 3.0 3.5 8.3 12.9 15.8 10.7 7.2 6.8 6.5 9.9 7.2 5.9 RPP30 TSG15 ENSG00000148688 "Ribonuclease P/MRP subunit p30" P78346 10 90871716-90908553 "Enzymes, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037578 Approved Approved "Nucleoplasm,Nucleoli,Microtubule ends,Cytosol" "Nucleoplasm, Nucleoli" "Microtubule ends, Cytosol" "HPA037578: AB_10696939" "unprognostic (1.55e-1)" "unprognostic (1.77e-3)" "unprognostic (2.35e-1)" "unprognostic (4.08e-1)" "unprognostic (5.64e-2)" "unprognostic (3.05e-2)" "unprognostic (3.80e-3)" "unprognostic (1.27e-1)" "unprognostic (2.73e-1)" "unprognostic (1.03e-1)" "unprognostic (2.27e-2)" "unprognostic (2.65e-1)" "prognostic unfavourable (1.01e-6)" "unprognostic (1.98e-1)" "unprognostic (9.84e-3)" "unprognostic (3.43e-2)" "unprognostic (2.10e-2)" 24.2 19.0 20.9 16.8 20.3 27.2 22.3 26.0 24.0 18.9 19.0 16.2 16.3 11.5 25.2 18.6 23.8 19.2 16.0 26.6 19.8 16.8 20.6 18.4 17.1 23.2 18.5 20.4 23.9 17.7 37.7 23.6 23.6 19.3 18.8 19.3 18.7 19.2 16.5 35.9 23.5 16.4 20.6 19.2 21.3 19.2 32.0 21.6 31.2 18.1 24.0 26.3 21.7 18.9 19.4 22.2 16.2 19.5 14.2 20.3 16.2 28.0 18.7 19.6 23.6 12.8 13.8 6.9 20.1 18.1 33.7 35.4 31.6 22.6 16.6 15.4 12.8 19.7 26.1 17.8 34.7 26.6 18.0 11.1 12.0 24.9 12.1 22.5 14.1 11.3 11.6 25.3 28.8 19.1 22.1 15.2 22.2 17.3 26.1 30.7 12.1 21.3 14.6 16.7 17.4 12.7 13.3 10.6 10.7 11.7 8.5 23.6 23.0 14.3 10.8 16.8 16.8 9.5 41.4 10.3 26.3 35.6 21.1 12.2 12.9 4.3 19.5 16.2 17.1 18.7 18.6 19.4 19.6 18.7 22.2 16.7 17.0 18.5 2.2 14.2 15.3 20.7 20.3 16.2 20.9 20.3 26.0 24.0 19.8 16.8 18.5 20.4 19.3 21.6 RPP40 "bA428J1.3, RNASEP1" ENSG00000124787 "Ribonuclease P/MRP subunit p40" O75818 6 4994732-5004063 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035685, HPA035686" Uncertain Approved Nucleoplasm Nucleoplasm "HPA035685: , HPA035686: AB_10670153" "unprognostic (2.93e-2)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "prognostic unfavourable (6.10e-6)" "unprognostic (8.00e-2)" "unprognostic (4.78e-2)" "prognostic unfavourable (5.41e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.17e-2)" "unprognostic (9.57e-2)" "prognostic unfavourable (7.54e-8)" "unprognostic (1.54e-1)" "unprognostic (5.10e-1)" "unprognostic (4.08e-2)" "unprognostic (2.19e-1)" 6.9 16.8 10.8 7.2 10.7 6.7 11.1 3.5 11.9 6.0 5.5 4.2 6.3 4.6 6.1 6.6 11.9 5.5 4.7 5.5 10.0 8.8 5.6 10.8 3.9 10.1 9.9 5.8 6.2 7.8 5.2 8.6 5.6 9.1 5.3 5.3 1.5 4.0 6.7 7.7 9.8 3.6 7.5 5.3 6.8 4.3 10.5 8.0 6.1 5.6 13.0 8.3 9.1 6.9 7.8 12.3 0.0 11.1 7.9 8.4 5.0 6.4 10.7 3.4 9.6 6.3 8.1 10.8 6.3 3.2 12.1 9.7 14.5 4.9 13.9 28.1 6.6 6.8 7.0 9.8 11.1 5.2 14.0 8.7 7.0 19.7 7.4 11.2 5.0 6.3 8.4 12.1 12.1 11.9 13.7 2.8 8.8 18.2 5.6 19.3 5.6 17.5 12.1 6.4 25.4 6.2 7.0 12.2 3.5 5.9 5.7 6.3 10.4 9.3 5.6 16.1 10.8 10.8 14.4 5.0 20.9 10.9 3.0 18.8 8.2 0.0 6.9 0.0 3.4 11.1 5.0 7.8 5.9 4.1 12.3 6.5 8.1 7.2 0.0 7.9 3.5 5.9 8.4 5.0 10.8 10.7 3.5 11.9 10.0 8.8 9.9 5.8 9.1 8.0 RPRD2 "FLJ32145, HSPC099, KIAA0460" ENSG00000163125 "Regulation of nuclear pre-mRNA domain containing 2" Q5VT52 1 150363091-150476566 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061693 Approved Approved Nucleoplasm,Vesicles 91000 "Nucleoplasm, Vesicles" "HPA061693: " "unprognostic (1.68e-1)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (7.25e-2)" "unprognostic (5.67e-3)" "unprognostic (3.79e-2)" "unprognostic (1.75e-2)" "unprognostic (9.03e-2)" "unprognostic (1.50e-1)" "unprognostic (3.93e-2)" "unprognostic (2.52e-1)" "unprognostic (1.27e-1)" "unprognostic (1.10e-3)" "unprognostic (1.11e-1)" "unprognostic (1.71e-1)" "unprognostic (7.92e-2)" "unprognostic (1.38e-1)" 14.0 16.9 16.8 12.0 21.6 13.2 14.0 40.1 22.1 20.2 17.9 21.4 16.6 11.5 21.0 16.4 17.0 24.2 12.2 14.1 16.3 14.1 18.3 12.5 14.0 13.8 16.3 14.1 34.2 17.9 27.5 29.4 10.7 15.2 18.3 16.3 19.8 14.5 19.2 28.5 15.6 13.9 20.1 13.8 16.7 14.2 16.2 17.4 25.6 25.4 10.4 17.3 21.6 17.1 8.0 4.2 6.0 8.6 5.1 9.1 2.5 15.7 12.1 16.0 16.2 16.7 14.2 15.2 11.4 13.7 12.6 12.5 10.4 19.4 25.0 13.2 14.0 17.6 22.5 17.0 13.9 11.5 9.4 14.4 14.3 12.5 12.0 21.5 17.8 15.0 13.0 17.6 23.3 15.6 14.0 27.3 12.8 22.7 18.8 7.0 20.0 13.7 17.4 11.9 25.2 18.6 14.6 17.1 17.3 23.4 20.0 15.2 15.7 19.1 14.2 11.7 12.2 9.8 16.2 16.7 18.4 18.9 11.7 16.2 11.5 6.0 3.6 4.4 8.1 2.4 7.4 7.6 7.6 6.4 3.5 8.0 8.9 8.8 2.0 5.1 8.6 4.2 9.1 2.5 16.8 21.6 40.1 22.1 16.3 14.1 16.3 14.1 15.2 17.4 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.6 22.2 8.4 4.3 8.2 14.5 2.5 11.0 16.8 8.2 11.3 25.1 16.4 8.3 3.8 11.5 9.0 9.6 9.3 15.3 7.0 7.6 9.8 14.0 67.5 8.4 19.0 10.2 9.2 7.5 12.9 16.3 29.8 6.4 23.9 8.6 6.0 12.3 5.8 6.0 13.4 6.6 17.8 9.6 7.1 10.6 3.9 3.8 14.8 4.5 16.0 0.0 5.7 16.6 9.0 6.3 28.5 6.2 19.1 11.6 9.3 17.0 9.5 21.2 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 RPS6KL1 MGC11287 ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903954-74923396 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell line enhanced" "Detected in many" "HMC-1: 12.8;SCLC-21H: 24.5;SK-BR-3: 14.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 26 "B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 4.2 7.5 14.7 2.3 13.6 4.2 5.7 18.2 29.1 2.1 4.8 9.0 2.2 3.8 5.1 8.8 5.3 2.5 3.7 10.2 14.3 13.7 2.3 2.1 2.5 2.5 11.1 15.3 1.5 6.7 4.0 10.6 1.4 8.4 2.8 5.6 5.9 3.2 5.4 12.7 1.2 2.8 6.9 8.8 1.7 2.0 11.4 6.8 0.0 3.8 1.2 2.5 1.9 0.8 2.0 5.4 0.1 0.0 0.0 2.0 0.1 2.3 0.3 0.9 3.7 0.1 0.0 4.4 0.4 0.2 1.8 0.5 5.5 1.6 0.0 3.4 0.7 0.3 1.8 0.3 2.3 0.0 0.8 1.9 0.7 4.1 4.6 2.2 12.8 0.3 3.2 2.0 0.0 5.8 2.6 0.7 0.1 7.5 0.0 0.7 0.8 3.6 1.8 0.0 7.1 1.8 0.0 24.5 3.0 0.2 14.1 2.3 1.3 1.5 3.9 0.1 0.2 3.0 0.0 9.9 5.2 5.2 1.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 2.0 0.4 0.1 0.0 0.4 1.9 2.0 0.1 0.0 0.0 5.4 0.0 0.1 14.7 13.6 18.2 18.2 14.3 13.7 11.1 15.3 8.4 6.8 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridylate synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 9.5 9.7 12.0 16.5 14.8 20.9 10.4 15.3 23.8 7.4 11.2 9.4 6.2 17.6 10.5 14.0 13.9 8.6 11.2 8.1 12.7 10.4 10.7 13.4 8.2 18.2 9.5 11.3 10.0 15.3 9.9 8.9 8.2 11.2 11.3 5.1 10.9 19.8 10.5 11.1 16.8 12.8 8.3 7.0 17.4 15.1 6.2 9.2 15.5 8.5 15.1 15.6 10.8 10.7 17.3 23.1 17.7 19.9 18.0 20.4 15.8 10.5 12.5 3.1 13.9 2.7 3.2 14.3 8.8 5.1 11.6 8.5 29.1 10.0 14.8 9.7 4.2 18.2 7.1 8.9 2.1 13.4 28.8 7.3 19.2 10.5 4.4 13.4 12.3 4.7 8.6 10.0 2.6 8.0 17.0 6.7 3.9 33.6 16.7 14.1 15.7 21.6 29.8 8.3 30.4 4.2 6.5 16.1 11.6 10.2 16.7 9.7 8.6 16.8 9.0 11.6 15.1 12.1 12.7 10.7 10.7 17.0 5.6 10.5 9.5 17.5 19.9 17.7 18.3 18.0 18.1 14.9 15.5 20.4 23.1 17.3 16.2 16.3 12.7 18.0 17.4 21.2 18.7 15.8 12.0 14.8 15.3 23.8 12.7 10.4 9.5 11.3 11.2 9.2 RPUSD2 "C15orf19, C18B11, FLJ31409" ENSG00000166133 "RNA pseudouridylate synthase domain containing 2" Q8IZ73 15 40569300-40574943 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042079, HPA042194" Approved Approved Nucleoplasm,Microtubules "Nucleoplasm, Microtubules" "HPA042079: AB_10794643, HPA042194: AB_10794416" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (1.32e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (1.31e-1)" "unprognostic (6.60e-2)" "unprognostic (8.32e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-2)" "unprognostic (1.16e-1)" "prognostic favourable (7.63e-7)" "unprognostic (7.27e-2)" "unprognostic (8.28e-2)" "unprognostic (3.12e-2)" "unprognostic (2.75e-2)" 6.6 9.8 7.8 7.7 15.3 14.2 9.3 7.7 14.6 7.7 9.3 7.7 8.1 8.3 10.9 9.9 9.9 8.5 6.4 11.4 7.6 7.4 7.0 12.2 6.5 10.6 6.8 8.8 11.0 9.8 6.9 7.5 7.5 8.4 8.5 7.3 7.7 13.3 8.9 19.8 10.6 8.8 6.5 5.0 11.0 7.9 7.9 6.6 13.7 10.4 10.5 10.5 8.2 6.3 20.1 8.9 2.9 8.9 17.8 16.0 8.1 7.6 8.7 7.4 12.2 6.4 4.9 14.0 6.9 8.2 11.9 9.5 10.7 4.8 7.4 10.0 7.9 20.8 17.1 12.0 6.8 8.5 11.7 13.0 12.0 12.5 9.6 10.7 9.4 6.8 11.4 7.8 10.8 7.4 16.0 8.8 5.9 9.3 12.8 13.7 9.5 9.5 16.5 8.2 11.3 7.6 6.7 8.5 9.7 9.2 10.6 5.6 10.1 14.8 4.6 8.2 9.6 10.5 7.8 9.1 18.0 19.8 7.1 17.0 6.4 0.0 3.5 2.9 13.5 4.1 12.4 15.6 13.3 14.3 6.8 20.1 16.0 13.3 0.4 17.8 8.9 8.9 13.6 8.1 7.8 15.3 7.7 14.6 7.6 7.4 6.8 8.8 8.4 6.6 RPUSD3 MGC29784 ENSG00000156990 "RNA pseudouridylate synthase domain containing 3" Q6P087 3 9837849-9844602 "Predicted intracellular proteins" "mRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037551, HPA037552" Uncertain Approved Nucleoplasm Nucleoplasm "HPA037551: , HPA037552: AB_10672600" "unprognostic (1.57e-1)" "unprognostic (8.88e-2)" "unprognostic (5.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "prognostic unfavourable (1.73e-5)" "unprognostic (1.31e-1)" "unprognostic (2.36e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (5.17e-3)" "unprognostic (2.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.94e-2)" "unprognostic (8.83e-2)" 10.8 18.9 19.5 11.8 25.9 17.0 13.2 21.1 26.5 11.1 14.9 12.9 9.8 16.0 14.0 14.4 19.3 13.9 14.0 20.7 17.2 17.0 16.9 19.5 11.8 14.3 14.4 16.5 14.7 17.5 24.1 17.0 15.2 17.4 13.3 15.6 14.6 12.5 17.5 43.3 18.6 11.9 15.6 10.6 13.2 13.6 36.3 16.4 16.5 15.3 13.9 18.7 15.0 12.2 23.7 22.2 12.4 24.7 37.0 29.7 19.0 8.8 13.3 10.1 6.5 17.0 12.6 75.6 7.7 11.0 12.7 13.6 11.6 9.1 15.3 9.6 8.4 7.6 22.5 13.7 10.2 11.8 23.5 20.4 11.9 12.3 13.4 12.4 12.9 15.5 19.1 14.8 17.2 16.7 15.0 10.6 12.5 20.8 17.0 22.8 10.9 19.9 12.1 8.3 25.6 14.0 6.7 7.9 6.5 9.6 12.3 21.1 21.1 13.5 9.9 5.1 9.2 8.9 11.2 15.9 18.9 20.1 10.8 23.7 11.8 12.4 24.7 11.9 22.6 17.6 22.9 23.7 21.2 21.1 22.2 20.0 24.2 21.5 6.0 37.0 12.0 21.3 29.7 19.0 19.5 25.9 21.1 26.5 17.2 17.0 14.4 16.5 17.4 16.4 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favourable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavourable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.6 7.9 9.5 12.5 16.3 5.7 7.5 10.4 8.1 7.2 20.4 13.1 15.5 7.3 6.6 11.6 18.2 11.4 8.6 13.0 10.1 36.3 7.1 19.0 8.2 19.0 8.3 15.0 17.3 8.8 11.1 16.2 22.6 11.5 9.6 6.4 11.9 22.0 8.7 11.7 13.9 12.1 14.4 12.4 9.6 13.8 9.4 9.5 14.2 7.0 21.2 10.1 9.8 9.2 6.3 6.8 8.7 4.9 5.1 13.4 4.1 21.7 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Group enriched" "Detected in some" 8 "HDLM-2: 60.8;U-87 MG: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: " "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.6 1.9 0.0 1.6 0.1 0.1 0.0 0.1 0.2 60.8 0.1 0.0 0.0 0.7 2.7 0.0 0.2 0.8 0.3 4.9 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364636-89412270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell line enhanced" "Detected in many" "Karpas-707: 27.8;SCLC-21H: 14.5;U-266/70: 35.2;U-266/84: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.3" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;monocytes: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA068664: " "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavourable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favourable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 8.1 8.4 9.2 2.6 12.8 8.9 8.8 22.4 16.3 8.7 3.3 7.9 3.1 2.2 2.1 6.6 12.8 11.9 3.7 29.9 8.6 7.4 21.8 5.0 6.4 2.8 8.5 7.9 2.2 6.4 16.0 11.5 3.4 10.7 5.9 2.4 12.8 38.7 4.2 60.0 5.5 2.1 7.5 12.6 4.4 2.3 6.1 9.2 4.1 23.3 13.9 5.2 9.2 9.3 0.1 0.7 6.3 3.9 0.1 0.6 0.3 0.0 0.7 1.9 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 0.0 10.5 0.0 0.0 0.0 5.2 2.4 0.0 0.0 0.8 7.0 8.3 0.1 0.6 0.0 0.0 0.0 0.2 27.8 0.0 0.7 3.3 3.5 1.5 0.7 7.0 10.1 0.1 2.5 0.2 14.5 0.8 0.2 0.9 11.8 0.3 5.6 0.0 0.8 1.2 5.0 1.3 35.2 16.3 0.0 2.7 5.3 0.8 3.9 1.2 2.6 0.0 1.1 0.1 0.1 0.4 0.0 0.7 0.0 0.3 0.6 6.3 0.1 3.9 0.6 0.0 0.3 9.2 12.8 22.4 9.1 8.6 7.4 8.5 7.9 10.7 9.2 RRAS2 TC21 ENSG00000133818 "RAS related 2" P62070 11 14277926-14364506 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 12.3" "Group enriched" "Detected in many" 5 "B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2" "Low region specificity" "Detected in all" "CAB010420, HPA050942" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB010420: AB_2253855, HPA050942: " "unprognostic (6.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (7.80e-4)" "prognostic unfavourable (3.31e-4)" "unprognostic (4.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.97e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (4.50e-2)" "unprognostic (4.15e-1)" "unprognostic (9.02e-2)" "unprognostic (1.05e-1)" "unprognostic (6.80e-2)" "unprognostic (1.63e-1)" 22.3 11.8 8.3 27.5 7.8 2.3 22.6 9.5 7.0 14.1 16.9 6.4 7.8 11.9 16.2 9.8 13.5 11.1 12.9 29.8 8.7 8.1 25.6 33.0 18.1 15.2 6.5 7.6 16.6 18.5 13.5 7.4 50.8 8.4 16.7 11.0 14.5 15.1 12.9 31.4 9.2 37.7 31.4 7.6 17.6 13.7 21.0 5.2 11.3 26.2 14.4 20.8 27.3 15.0 12.3 0.4 1.5 0.0 3.5 6.2 0.9 15.1 6.5 6.2 5.5 22.4 22.0 9.4 53.3 27.9 46.0 58.5 13.3 18.8 17.4 9.0 35.8 17.4 10.6 19.1 46.4 15.4 10.3 1.1 3.9 10.5 24.1 0.0 0.1 23.3 36.2 18.3 59.0 22.8 7.6 0.0 39.9 7.3 3.7 0.9 17.9 6.2 3.6 20.8 0.3 23.6 8.3 1.7 3.2 12.8 8.2 7.2 5.3 1.1 52.1 24.9 13.8 47.8 14.4 0.0 0.0 8.2 10.0 0.0 5.0 1.5 0.0 0.0 6.2 0.0 2.6 12.3 1.1 3.2 0.0 6.9 0.6 2.5 0.4 3.5 0.0 0.4 0.0 0.9 8.3 7.8 9.5 7.0 8.7 8.1 6.5 7.6 8.4 5.2 RRP15 "CGI-115, KIAA0507" ENSG00000067533 "Ribosomal RNA processing 15 homolog" Q9Y3B9 1 218285287-218337983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024639 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoli "Nucleoplasm, Mitochondria" "HPA024639: AB_1844368" "unprognostic (2.68e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (5.19e-2)" "unprognostic (1.33e-2)" "prognostic unfavourable (4.26e-5)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (3.65e-3)" "unprognostic (2.54e-1)" "unprognostic (2.76e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-1)" "unprognostic (1.11e-2)" "unprognostic (3.23e-2)" 10.3 7.2 8.9 8.0 9.9 8.5 11.6 11.6 10.4 8.4 8.0 5.5 5.4 5.3 10.1 7.1 8.7 8.9 5.0 11.4 8.6 6.3 9.3 10.7 7.5 8.3 8.0 5.0 9.8 8.4 12.1 10.0 8.7 8.6 7.8 7.2 5.8 7.9 6.4 33.5 8.5 6.8 11.8 9.4 10.3 7.6 6.3 9.0 6.5 8.9 10.5 8.3 8.5 9.4 5.1 3.3 0.6 2.4 3.1 5.7 1.6 8.0 6.1 6.8 4.9 5.0 6.9 5.9 8.3 6.3 8.7 6.3 11.8 7.5 11.7 11.4 6.4 7.4 11.6 11.0 14.6 4.7 8.7 9.1 5.7 6.5 10.3 14.0 4.9 4.7 6.8 11.3 15.2 5.6 18.5 3.8 9.7 7.4 9.2 6.8 13.5 12.7 6.5 4.2 11.5 7.0 7.5 7.9 11.5 7.1 13.2 12.2 9.5 10.1 7.8 7.1 6.5 12.4 15.3 4.7 7.2 12.2 8.0 6.9 11.1 0.6 1.6 0.2 3.5 2.4 4.8 4.7 4.2 2.9 2.4 5.1 5.7 5.5 0.5 3.1 2.1 3.3 2.5 1.6 8.9 9.9 11.6 10.4 8.6 6.3 8.0 5.0 8.6 9.0 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021645-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: " "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavourable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavourable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 25.0 29.7 21.0 24.9 27.2 23.3 57.7 18.0 42.1 21.3 22.4 16.0 24.9 19.4 23.8 24.7 31.9 20.6 20.1 31.3 22.7 21.4 25.2 32.7 24.1 46.5 21.1 28.0 17.3 37.4 37.0 28.8 23.4 27.3 24.6 23.8 19.5 23.5 36.4 61.9 28.4 21.4 28.3 28.5 29.4 25.7 23.9 15.8 25.0 22.6 30.9 31.8 23.7 28.2 6.5 9.7 4.0 4.6 3.1 7.7 1.2 42.6 24.1 24.0 35.0 25.9 24.3 20.2 33.8 30.7 43.4 42.7 43.7 18.6 19.8 27.6 35.1 22.9 40.0 41.0 48.1 25.0 40.7 31.7 26.7 46.6 30.1 26.3 24.7 24.5 25.1 51.8 22.2 35.2 38.3 21.6 40.1 45.0 31.6 28.8 26.6 25.0 29.9 23.7 22.8 26.5 40.3 30.7 26.9 24.9 22.9 38.6 31.5 32.5 28.2 40.1 30.6 26.4 53.0 20.3 30.5 52.8 17.5 33.3 37.2 3.9 3.6 3.1 5.9 4.6 4.7 6.5 4.2 7.0 3.7 2.6 3.9 7.7 4.0 3.1 3.6 9.7 2.1 1.2 21.0 27.2 18.0 42.1 22.7 21.4 21.1 28.0 27.3 15.8 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: " "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavourable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 12.8 18.1 10.0 11.7 6.4 4.3 20.2 11.0 6.6 14.2 12.1 23.1 7.4 21.4 5.6 7.8 14.3 11.4 15.2 6.1 5.4 23.4 11.7 12.7 12.4 6.1 27.9 10.1 5.4 7.7 19.2 9.8 8.6 16.4 6.2 8.4 26.1 26.8 11.4 8.3 13.2 46.7 10.2 9.5 7.4 15.8 5.4 3.9 8.0 23.2 10.6 9.5 12.6 6.4 10.9 14.0 8.3 11.1 9.5 7.1 25.3 9.0 10.7 15.5 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 RSAD1 FLJ11164 ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478800-50485975 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA022436: AB_2180789, HPA022967: AB_1856484" "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favourable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 13.5 22.2 16.1 16.8 23.9 8.9 14.1 32.2 20.3 16.8 13.1 12.7 13.5 13.9 13.8 15.1 8.8 12.9 13.6 25.7 13.7 11.6 18.5 28.2 14.0 16.6 19.0 13.7 20.9 46.0 20.3 12.9 10.1 16.3 12.8 14.9 12.6 21.4 14.0 37.0 13.5 12.0 13.7 23.6 16.7 16.0 8.8 19.1 11.6 15.8 20.9 14.0 11.7 12.4 7.4 5.8 3.8 4.6 6.7 10.9 5.1 6.2 21.4 10.3 16.9 17.6 14.5 3.7 11.0 10.8 14.2 12.1 21.1 8.0 17.1 24.5 7.7 6.0 11.6 15.4 12.3 18.8 21.1 22.9 9.6 20.5 12.3 13.8 16.1 10.5 17.0 9.4 18.3 13.8 17.6 16.3 11.9 14.7 23.0 10.1 4.1 23.1 9.5 11.8 15.3 17.2 9.6 5.6 19.3 2.8 13.3 14.2 19.9 14.1 9.7 14.9 15.9 11.3 12.9 25.4 17.8 6.6 11.1 19.8 10.3 1.1 4.1 3.8 9.5 4.6 9.9 5.1 8.2 9.4 5.1 7.4 10.9 10.5 0.0 6.7 4.3 5.8 6.2 5.1 16.1 23.9 32.2 20.3 13.7 11.6 19.0 13.7 16.3 19.1 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head 4 homolog A" Q5TD94 6 116616479-116632985 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 7.4;U-266/84: 5.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.4;pons and medulla: 19.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.5 0.7 1.8 0.5 9.4 0.9 0.7 1.2 0.9 2.2 0.4 10.2 0.4 0.5 1.9 13.3 0.4 35.9 0.8 0.5 3.0 3.3 0.7 0.4 11.1 0.5 0.5 1.1 13.7 0.6 2.8 16.7 0.3 19.8 0.6 0.4 0.2 0.4 0.5 1.0 0.6 0.4 0.6 0.7 1.0 0.8 6.6 1.8 0.0 1.0 0.0 0.5 0.4 0.1 0.8 0.1 1.3 0.2 0.2 1.0 0.0 0.1 0.2 1.4 3.2 0.1 0.1 0.3 0.4 0.8 0.6 0.8 0.7 1.1 1.0 0.3 0.1 0.2 0.3 0.6 0.6 0.8 1.1 0.4 0.5 1.2 0.0 0.8 1.1 0.4 0.2 1.0 0.2 0.0 0.2 0.1 0.6 0.2 0.6 0.1 0.5 0.1 0.8 1.6 7.4 3.1 0.4 2.8 1.2 0.2 0.2 0.4 0.5 0.6 0.5 0.4 0.7 0.5 0.5 0.5 5.4 0.4 0.1 0.4 0.5 1.3 0.2 0.8 1.0 0.1 0.1 0.4 0.3 0.0 0.0 0.8 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.0 1.8 9.4 1.2 0.7 3.0 3.3 0.5 1.1 19.8 1.8 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242237-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm Nucleoplasm "HPA058992: , HPA067651: " "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favourable (2.91e-5)" 11.3 55.9 13.2 23.7 20.6 21.3 9.4 18.3 16.7 48.3 13.4 17.8 44.2 10.4 19.2 26.0 15.6 14.7 30.3 16.5 16.8 13.6 19.4 17.5 16.3 11.0 31.0 15.6 20.2 22.8 6.7 25.0 17.0 18.6 21.4 6.4 12.7 36.7 36.6 9.9 16.9 12.6 12.0 25.9 15.0 17.3 14.0 21.5 23.1 17.5 10.5 20.9 12.2 21.1 7.7 18.6 39.2 18.0 10.0 10.5 7.7 3.3 9.5 1.4 1.3 8.3 2.2 3.2 3.3 1.3 4.7 5.0 7.4 3.9 2.7 12.1 0.8 5.5 7.4 0.8 1.2 6.8 5.0 11.0 10.6 8.8 2.4 4.8 5.6 0.8 4.5 1.9 0.2 2.8 8.5 27.1 1.3 4.0 1.3 9.3 5.3 5.5 4.0 3.7 4.0 3.3 0.2 4.6 1.3 2.5 1.7 2.0 2.0 4.9 3.9 3.0 2.4 2.8 2.1 14.9 13.2 3.0 2.2 12.2 2.1 36.5 18.0 25.5 7.9 11.4 8.2 7.4 8.2 6.4 18.6 7.7 7.9 5.2 39.2 10.0 14.9 11.8 10.5 7.7 13.2 20.6 18.3 16.7 16.8 13.6 31.0 15.6 18.6 21.5 RTF1 KIAA0252 ENSG00000137815 "RTF1 homolog, Paf1/RNA polymerase II complex component" Q92541 15 41408408-41483563 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006714 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" Nucleoplasm Cytosol "HPA006714: AB_1079855" "unprognostic (1.10e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.88e-1)" "unprognostic (8.87e-2)" "unprognostic (5.36e-2)" "unprognostic (4.21e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (3.05e-4)" "unprognostic (1.19e-1)" "unprognostic (1.69e-2)" "unprognostic (8.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (9.50e-2)" 20.4 27.8 27.6 21.6 33.8 34.3 20.4 40.5 34.5 23.7 22.5 14.3 17.6 16.9 25.7 18.4 22.4 18.5 18.4 24.8 26.5 21.4 17.6 19.6 17.2 23.0 17.0 35.1 27.7 15.2 37.0 20.3 36.9 27.2 22.0 20.6 15.4 19.5 23.2 55.2 24.8 20.7 24.7 14.9 23.5 19.0 25.4 13.5 25.3 26.7 15.6 21.6 27.8 20.2 8.0 7.4 11.6 4.3 8.6 5.7 1.4 15.2 10.0 33.0 26.8 18.8 22.3 15.6 20.4 23.0 28.0 23.4 19.4 9.7 14.5 16.6 21.3 27.1 19.1 16.9 24.0 22.0 17.8 30.4 22.6 14.5 13.2 27.0 17.8 16.0 17.2 14.9 15.2 22.5 23.0 16.8 22.9 11.5 25.8 16.7 17.8 13.8 28.1 25.8 13.8 18.2 32.7 17.0 22.5 18.3 23.4 9.2 19.2 26.2 18.4 27.5 17.5 27.3 22.3 19.4 29.9 24.1 19.8 25.8 16.7 5.9 4.3 8.4 4.8 2.8 4.4 8.0 4.7 4.1 3.0 6.5 5.7 4.7 11.6 8.6 3.3 7.4 5.4 1.4 27.6 33.8 40.5 34.5 26.5 21.4 17.0 35.1 27.2 13.5 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA053986: " "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavourable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 33.4 34.2 43.5 29.1 43.9 52.6 28.9 27.4 48.7 28.8 29.4 53.0 20.1 28.0 31.4 24.1 30.5 31.6 23.2 38.7 40.6 35.6 31.8 30.3 24.2 29.7 49.6 35.7 35.2 27.5 26.0 29.3 30.5 46.6 28.5 26.0 26.0 25.8 31.7 74.6 27.9 29.8 34.1 59.7 30.2 25.3 29.1 45.2 31.4 29.1 28.9 34.4 29.0 23.9 20.0 35.1 91.6 31.8 29.4 23.0 33.2 28.5 20.5 20.8 20.3 26.0 23.3 19.4 44.6 33.7 64.4 37.0 41.9 27.8 24.5 52.9 36.1 32.1 20.8 34.3 44.6 11.4 16.1 30.6 22.4 32.3 29.9 43.5 42.3 20.6 35.7 28.7 25.0 27.6 23.6 25.6 31.5 54.5 36.4 37.1 15.4 39.1 25.0 56.7 32.2 26.8 18.8 21.5 23.3 46.8 79.4 41.9 36.8 41.6 29.5 55.1 35.7 29.9 36.0 21.4 24.6 34.8 43.4 29.6 30.0 39.2 31.8 84.1 20.9 29.6 17.6 18.6 18.0 20.3 35.1 20.0 20.5 18.8 91.6 29.4 28.8 29.9 23.0 33.2 43.5 43.9 27.4 48.7 40.6 35.6 49.6 35.7 46.6 45.2 RTKN B5 ENSG00000114993 Rhotekin Q9BST9 2 74425836-74442422 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030259 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA030259: AB_10601484" "unprognostic (4.09e-1)" "unprognostic (1.28e-1)" "unprognostic (1.20e-2)" "unprognostic (2.47e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-3)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (2.57e-2)" "unprognostic (9.43e-3)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (2.96e-2)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.23e-3)" 3.2 4.9 17.1 3.9 24.2 0.4 7.1 3.9 23.6 5.6 8.7 29.7 7.3 21.2 5.1 4.0 8.0 9.0 9.7 7.2 22.2 13.7 27.0 39.0 6.3 1.9 34.8 7.7 3.6 16.3 12.8 5.3 7.9 17.2 6.5 8.8 6.0 17.3 7.0 7.5 21.1 16.4 4.4 36.3 2.2 6.0 1.4 29.4 1.9 7.4 5.3 4.3 3.1 5.6 1.7 9.7 0.0 0.0 3.1 0.4 0.6 16.8 5.2 6.7 19.8 4.1 4.8 28.9 2.6 3.3 3.8 2.8 26.1 9.4 0.1 7.5 2.5 23.1 2.5 16.8 1.8 3.3 10.9 4.0 0.9 32.8 2.5 0.0 0.0 2.9 13.4 3.2 10.7 1.9 2.0 0.1 5.6 12.0 0.6 3.3 7.3 10.5 3.7 20.9 2.5 18.5 0.1 6.8 6.5 7.2 28.0 14.9 15.6 1.5 0.2 7.2 4.9 3.2 3.5 1.7 1.1 0.6 6.9 0.0 6.6 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.2 0.3 0.9 1.7 0.0 0.1 0.0 3.1 0.0 9.7 0.0 0.6 17.1 24.2 3.9 14.9 22.2 13.7 34.8 7.7 17.2 29.4 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell line enhanced" "Detected in many" "A-431: 24.9;HaCaT: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 24.9 1.4 13.4 6.2 0.0 0.1 3.3 3.6 4.2 4.1 6.5 10.4 5.0 0.0 1.6 1.4 20.0 7.5 0.6 4.3 3.5 5.1 4.1 3.0 4.3 0.0 5.5 3.2 0.2 0.3 5.1 0.5 0.6 0.2 0.2 5.5 3.1 10.8 7.2 5.6 5.1 9.3 14.3 0.0 2.6 10.9 7.3 8.4 2.4 8.4 3.4 7.6 3.1 0.0 1.9 12.2 0.1 9.1 0.1 0.0 9.5 2.4 0.0 2.9 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: , HPA053174: , HPA075136: " "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Cell line enhanced" "Detected in single" "NTERA-2: 2.0" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL5 "KIAA2001, Mar5, Mart5, RGAG4, SIRH8" ENSG00000242732 "Retrotransposon Gag like 5" Q5HYW3 X 72127110-72131901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.5;AN3-CA: 6.1;SCLC-21H: 7.5;SH-SY5Y: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003652 Approved Approved Nucleoplasm Nucleoplasm "HPA003652: AB_1079805" "unprognostic (7.97e-2)" "unprognostic (1.31e-2)" "unprognostic (5.29e-3)" "unprognostic (2.98e-2)" "unprognostic (3.93e-2)" "unprognostic (3.64e-1)" "unprognostic (4.20e-1)" "prognostic favourable (7.30e-4)" "unprognostic (1.62e-1)" "unprognostic (2.82e-1)" "prognostic favourable (3.41e-4)" "unprognostic (4.23e-1)" "unprognostic (4.18e-3)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" 5.4 7.2 7.0 2.7 12.5 1.9 7.7 22.7 14.2 4.9 4.5 3.5 6.2 2.8 9.6 10.1 2.6 4.9 6.0 4.0 10.3 8.9 4.4 4.2 5.5 2.4 5.2 11.2 10.5 1.1 7.4 16.3 5.2 6.3 5.7 3.0 3.0 3.7 6.9 2.3 2.1 3.2 6.7 9.5 2.7 5.4 12.4 4.8 0.0 11.7 0.8 2.0 5.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 5.5 6.1 1.4 1.7 0.3 2.0 0.7 0.3 0.8 0.3 0.0 0.0 0.9 0.4 0.0 1.1 0.1 1.1 0.0 0.8 0.2 0.1 0.0 0.1 0.0 0.7 3.3 0.1 0.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.1 0.0 7.5 10.4 0.4 0.0 0.0 0.2 0.0 0.6 0.7 0.7 1.4 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 12.5 22.7 14.2 10.3 8.9 5.2 11.2 6.3 4.8 RUFY2 "FLJ10063, KIAA1537, RABIP4R, ZFYVE13" ENSG00000204130 "RUN and FYVE domain containing 2" Q8WXA3 10 68341107-68407294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039792 Approved Approved Nucleoplasm Nucleoplasm "HPA039792: AB_10673363" "unprognostic (1.23e-1)" "unprognostic (3.37e-1)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (2.48e-3)" "unprognostic (2.22e-2)" "unprognostic (4.36e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.92e-1)" "unprognostic (1.28e-2)" "unprognostic (2.00e-3)" "unprognostic (3.23e-1)" "unprognostic (3.82e-1)" "unprognostic (7.74e-2)" "unprognostic (3.40e-2)" 8.1 7.0 15.5 5.4 16.3 2.6 10.1 34.3 28.7 9.6 6.6 14.8 6.4 4.9 12.1 7.7 8.1 8.9 7.6 6.5 16.9 16.2 8.3 3.2 7.8 5.2 19.1 11.6 15.0 6.9 11.3 11.9 8.3 16.5 10.0 7.9 5.2 6.2 8.3 6.3 6.9 5.7 10.4 32.8 6.4 7.3 5.8 16.3 5.7 9.7 4.8 5.9 8.6 6.4 2.1 1.0 2.3 1.7 6.5 3.0 0.7 9.9 3.6 5.9 7.4 8.0 12.8 3.6 8.6 10.8 9.5 9.7 5.3 9.0 2.9 6.3 13.6 7.0 2.6 9.2 9.6 1.4 5.9 1.8 2.8 2.6 8.6 2.3 1.2 10.3 9.9 10.9 11.1 9.8 3.8 4.8 9.5 4.0 2.3 3.1 2.6 10.1 3.1 5.2 1.7 8.7 5.7 7.1 6.9 6.0 7.7 4.9 11.5 3.0 11.4 11.4 8.4 6.5 11.6 5.1 2.6 1.6 10.3 2.6 4.4 1.5 1.0 2.3 1.7 1.4 1.7 1.7 2.2 2.3 0.6 2.1 2.5 3.0 1.2 6.5 1.7 1.0 0.6 0.7 15.5 16.3 34.3 17.7 16.9 16.2 19.1 11.6 16.5 16.3 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400917-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 28.3" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 89.8" "Low region specificity" "Detected in all" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: " "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favourable (9.40e-5)" "unprognostic (5.03e-2)" 1.9 3.9 5.4 1.0 14.9 0.6 1.0 0.3 5.9 4.0 2.5 5.3 0.6 1.3 1.8 1.3 1.7 3.6 1.2 5.8 7.5 8.9 0.7 0.8 3.4 0.8 4.1 4.3 1.7 2.7 0.8 29.8 1.3 14.1 1.1 2.7 13.5 1.9 2.1 44.8 2.9 2.0 1.8 8.9 1.0 1.1 1.5 5.4 0.0 1.1 2.5 0.6 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 14.9 0.3 5.9 7.5 8.9 4.1 4.3 14.1 5.4 RXYLT1 "HP10481, TMEM5" ENSG00000118600 "Ribitol xylosyltransferase 1" Q9Y2B1 12 63779803-63809558 "Disease related genes, Predicted intracellular proteins" Transferase "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064014 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA064014: " "unprognostic (1.19e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (3.58e-1)" "unprognostic (1.33e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (5.24e-5)" "unprognostic (1.47e-2)" "unprognostic (2.09e-3)" "unprognostic (3.17e-1)" "unprognostic (7.03e-2)" "unprognostic (1.39e-1)" "unprognostic (9.33e-2)" "unprognostic (5.27e-2)" "unprognostic (2.29e-2)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" 9.7 19.6 10.3 9.8 11.3 5.7 14.7 8.2 13.6 10.3 9.3 10.6 11.3 7.8 9.2 20.8 9.6 10.9 9.6 21.1 9.8 11.4 15.2 20.1 11.9 14.8 10.7 8.0 17.4 33.4 20.2 19.0 10.5 9.5 12.1 10.1 12.4 17.0 14.5 14.7 11.1 8.2 12.2 13.1 10.6 8.1 16.1 9.0 9.1 17.2 10.7 9.7 11.8 8.1 6.6 7.2 1.8 3.6 4.7 7.0 2.2 7.5 14.1 9.9 8.4 8.7 11.7 11.5 8.5 12.4 12.8 8.5 5.1 7.3 16.4 14.9 8.9 7.0 12.0 10.9 15.3 17.0 12.2 8.9 4.0 8.1 13.2 13.5 7.8 10.4 10.9 12.4 16.2 7.1 9.9 14.0 19.3 12.2 7.3 5.6 6.0 18.0 7.4 11.6 8.8 12.2 10.1 24.6 4.3 8.9 6.8 16.9 14.4 6.8 8.1 11.5 11.8 7.1 11.7 9.3 13.3 11.5 7.8 8.2 15.1 1.2 3.1 1.8 4.0 2.9 6.9 6.6 4.4 4.8 3.0 4.2 5.9 4.8 0.6 4.7 3.6 7.2 7.0 2.2 10.3 11.3 8.2 13.6 9.8 11.4 10.7 8.0 9.5 9.0 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.3 0.5 0.0 0.0 7.7 10.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 2.7 3.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 S100A13 ENSG00000189171 "S100 calcium binding protein A13" Q99584 1 153618787-153631360 "Predicted intracellular proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 99.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 19.4" "Group enriched" "Detected in many" 5 "dendritic cells: 8.4;NK-cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019592, CAB025494" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Secreted in other tissues" "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "CAB025494: , HPA019592: AB_10601499" "unprognostic (1.50e-2)" "unprognostic (9.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.45e-1)" "unprognostic (7.77e-2)" "unprognostic (9.72e-3)" "unprognostic (1.75e-3)" "unprognostic (9.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.83e-3)" "prognostic unfavourable (1.97e-4)" "unprognostic (3.43e-2)" "unprognostic (8.10e-2)" "unprognostic (1.82e-3)" "unprognostic (1.72e-2)" 38.2 20.9 49.6 13.8 48.3 1.2 61.8 11.5 28.2 39.1 32.3 25.0 13.9 9.4 23.5 25.0 19.9 34.5 32.0 56.3 30.3 32.0 28.0 20.2 23.3 12.7 54.2 32.7 29.9 13.9 45.9 9.7 21.6 37.7 23.0 19.3 21.1 19.8 21.7 73.8 14.1 13.7 27.2 38.9 13.7 11.9 10.3 28.5 2.4 79.0 28.2 14.6 21.1 16.0 2.6 8.4 3.0 1.5 19.4 0.9 0.8 22.1 18.6 21.5 13.6 19.0 55.8 7.7 30.8 48.9 18.7 21.5 18.0 24.8 0.5 58.6 52.3 21.2 8.9 19.2 16.5 0.0 8.3 1.4 23.3 15.3 12.6 0.6 4.8 44.8 7.3 16.7 18.1 42.2 7.1 0.0 58.0 78.7 0.0 0.4 17.3 56.1 3.5 22.3 0.1 99.4 17.0 6.6 0.2 66.0 34.0 66.6 27.7 0.8 59.7 12.9 7.2 17.2 37.1 0.2 0.5 1.0 23.1 0.3 7.5 3.0 1.5 0.1 0.3 0.7 0.6 2.6 0.3 0.2 5.0 1.6 0.5 0.3 0.2 19.4 0.9 8.4 0.9 0.8 49.6 48.3 11.5 28.2 30.3 32.0 54.2 32.7 37.7 28.5 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Group enriched" "Detected in some" 5 "HBEC3-KT: 656.0;RT4: 256.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: " "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavourable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 24.8 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.2 0.5 61.7 0.0 656.0 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 87.4 0.7 99.7 0.4 0.0 0.0 1.4 0.1 0.0 0.0 0.0 4.8 0.0 15.6 0.0 15.5 256.5 0.5 0.0 1.0 0.1 0.2 0.1 0.1 0.1 0.3 21.7 2.9 8.4 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.6;thyroid gland: 9.1" "Cell line enhanced" "Detected in many" "PC-3: 8.3;RPTEC TERT1: 10.1;RT4: 16.7;SCLC-21H: 15.0;SK-BR-3: 7.7" "Group enriched" "Detected in many" 5 "ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 85 "olfactory region: 1210.8" "Region enriched" "Detected in single" 29 "olfactory region: 16.8" HPA064184 Approved Nucleoplasm Nucleoplasm "HPA064184: " "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.5 0.1 0.8 2.4 0.2 0.9 0.4 0.2 0.9 0.6 0.3 0.2 0.2 2.3 1.0 0.2 1.3 0.7 1.6 0.2 0.4 0.1 2.3 0.2 3.0 4.6 0.2 0.2 0.2 0.2 0.0 0.4 1.1 0.2 1.5 0.0 0.2 3.8 0.2 0.2 6.0 0.5 0.2 0.2 1.1 1.9 0.2 0.2 1.6 9.1 0.2 2.6 1.8 0.6 0.9 4.6 2.3 1.2 0.0 7.6 1.2 1.8 4.8 0.0 0.0 0.5 0.4 0.3 0.8 1.1 0.6 1.2 0.5 3.5 0.0 3.2 1.7 1.5 0.1 0.8 0.8 0.4 0.0 2.2 1.8 0.2 0.4 0.0 3.0 0.0 0.9 2.3 0.7 0.5 0.6 0.2 2.5 0.2 0.4 1.1 0.1 8.3 0.0 1.5 0.9 10.1 16.7 15.0 0.0 0.2 7.7 0.7 0.0 0.4 0.4 0.1 1.1 2.2 1.4 0.0 0.7 0.0 0.5 0.6 0.3 0.0 1.2 2.3 2.0 0.2 7.6 0.9 4.2 2.2 2.8 0.5 2.4 1.1 1.9 0.0 0.6 4.6 6.1 1.2 0.8 0.2 0.2 0.9 0.4 0.1 0.2 0.2 0.2 0.2 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745424 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" 8400000 "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: " "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favourable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 18.4 24.9 22.0 18.9 23.3 14.9 18.2 23.3 26.3 19.0 19.4 16.4 21.2 18.9 22.6 19.3 17.0 18.1 16.6 15.6 21.8 22.8 31.9 22.7 23.2 19.9 20.5 24.9 15.7 18.3 25.1 31.9 21.2 28.7 21.1 20.1 17.7 20.0 18.2 12.7 14.7 20.4 17.0 22.2 20.9 20.5 11.0 19.6 26.8 35.8 8.5 19.7 20.9 20.9 5.8 13.7 13.4 8.7 30.1 14.9 13.4 10.8 8.1 15.2 8.5 25.9 17.8 11.7 16.6 17.7 15.7 13.5 10.8 8.8 17.7 9.6 16.0 8.5 18.7 11.3 20.2 11.1 11.3 18.2 13.4 10.4 14.0 27.3 22.4 11.7 17.8 15.9 12.2 10.7 20.0 18.3 25.6 5.3 23.2 15.0 16.2 16.6 6.1 7.9 16.7 17.2 15.9 6.0 14.4 11.5 15.2 17.6 11.4 26.4 12.1 14.3 7.9 14.4 17.1 10.5 25.5 12.7 16.7 42.3 14.3 4.3 8.7 13.4 13.6 7.0 14.9 5.8 9.8 13.6 13.7 5.3 10.1 13.1 7.1 30.1 6.0 5.7 8.2 13.4 22.0 23.3 23.3 26.3 21.8 22.8 20.5 24.9 28.7 19.6 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Cell line enhanced" "Detected in some" "AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: , HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favourable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favourable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 14.8 0.1 0.4 0.3 0.0 4.9 12.7 0.3 0.7 0.0 0.0 0.0 5.7 6.9 0.0 9.2 0.0 0.4 0.0 5.6 0.0 0.0 8.9 0.3 0.0 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 1.8 0.9 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 23.5 0.0 4.9 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521081-21537216 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9;parathyroid gland: 36.0" "Cell line enhanced" "Detected in many" "AF22: 46.1;NTERA-2: 34.8;SCLC-21H: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004162: " "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favourable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 2.6 4.7 11.5 1.6 12.7 0.5 5.3 30.9 21.9 7.5 4.5 10.4 2.9 2.3 10.5 6.0 3.5 11.6 4.0 3.7 11.7 8.9 4.2 1.7 4.8 1.9 7.4 9.3 19.5 3.7 36.0 10.9 1.5 13.5 5.8 2.4 4.3 3.3 10.0 2.1 2.2 3.1 10.5 9.5 2.1 3.2 1.9 11.4 3.7 12.0 0.1 1.9 4.6 4.8 0.3 1.7 0.0 0.0 0.5 3.8 0.6 0.0 0.8 46.1 11.5 0.8 0.7 0.0 1.0 1.4 3.6 3.0 0.8 0.6 0.0 1.0 1.3 0.1 11.2 1.2 4.3 0.7 6.4 0.0 0.4 1.0 1.4 0.0 0.0 3.1 0.3 1.5 0.0 0.9 7.5 0.0 2.9 0.8 7.1 0.0 34.8 0.2 6.7 1.1 0.0 3.3 4.8 15.7 8.8 0.0 0.2 0.1 4.6 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 1.0 0.1 1.5 1.2 0.2 0.3 1.8 3.8 0.0 0.5 0.0 1.7 1.6 0.6 11.5 12.7 30.9 14.3 11.7 8.9 7.4 9.3 13.5 11.4 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974113-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;T-cells: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040973 Approved Approved Nucleoplasm Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavourable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 2.4 2.8 6.4 6.1 14.5 3.4 5.4 25.7 10.4 2.3 4.4 1.6 9.2 7.3 1.4 3.0 10.3 4.7 8.8 3.2 5.5 5.0 6.5 4.4 3.6 10.1 3.5 3.5 0.5 5.6 5.3 3.3 3.3 3.2 4.8 3.7 2.7 9.7 6.5 1.7 9.3 6.8 1.5 1.9 5.7 10.2 3.2 2.4 5.7 3.1 2.7 12.3 5.4 4.2 2.9 1.0 0.6 0.4 1.0 6.2 1.6 5.9 0.0 2.0 0.2 0.5 0.6 0.1 1.9 1.5 3.9 1.8 5.7 11.4 0.4 4.0 0.9 8.0 1.9 2.4 2.0 11.9 4.0 1.9 5.9 8.5 0.8 9.8 16.0 0.5 4.3 2.1 0.3 1.8 4.7 4.9 0.7 4.5 4.4 9.2 3.2 9.1 6.3 0.1 10.4 6.4 10.3 2.2 4.6 1.3 11.1 2.4 7.5 4.9 1.7 1.2 2.8 0.0 0.3 1.0 0.7 3.3 3.8 8.0 1.1 0.0 0.2 0.6 4.9 0.2 2.7 2.9 3.3 2.9 0.6 1.3 5.6 6.2 0.0 1.0 0.4 1.0 2.5 1.6 6.4 14.5 25.7 10.4 5.5 5.0 3.5 3.5 3.2 2.4 SAMD11 MGC45873 ENSG00000187634 "Sterile alpha motif domain containing 11" Q96NU1 1 923928-944581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEK 293: 37.9;HeLa: 41.9;SCLC-21H: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "NK-cell: 4.7" "Lineage enriched" "Detected in single" 10 "NK-cells: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA030110 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA030110: " "unprognostic (9.96e-2)" "unprognostic (1.75e-1)" "unprognostic (4.11e-2)" "unprognostic (1.11e-2)" "unprognostic (1.20e-2)" "unprognostic (2.42e-1)" "unprognostic (9.28e-2)" "unprognostic (6.90e-2)" "unprognostic (3.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.62e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.35e-5)" "unprognostic (3.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.26e-2)" "unprognostic (1.18e-1)" 2.1 10.0 2.4 5.0 3.0 1.0 1.6 1.6 4.7 4.4 3.0 7.2 2.5 5.1 9.5 7.4 4.2 13.6 4.5 8.5 5.7 4.0 10.0 2.9 2.4 2.1 6.9 2.0 5.9 1.8 0.6 21.9 0.6 5.9 12.4 1.4 16.9 2.4 22.1 1.4 0.3 5.6 6.0 8.8 11.7 5.5 2.7 5.1 0.3 4.6 0.6 0.5 7.2 22.8 0.3 0.0 0.0 0.2 4.7 0.4 0.0 0.1 2.6 0.0 2.4 0.1 0.0 0.8 4.1 0.2 0.2 0.1 0.1 0.8 0.0 8.0 8.5 5.3 2.7 0.0 0.0 0.3 37.9 0.0 41.9 0.1 0.7 0.0 0.3 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.8 0.0 0.0 1.6 0.3 0.2 0.5 2.2 0.4 0.0 27.3 8.4 8.6 4.1 0.0 4.8 0.2 0.5 1.4 6.3 0.0 0.9 0.5 0.0 0.1 1.8 0.6 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.3 0.2 0.2 0.0 0.1 0.1 0.4 0.0 4.7 0.1 0.0 0.0 0.0 2.4 3.0 1.6 4.7 5.7 4.0 6.9 2.0 5.9 5.1 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Cell line enhanced" "Detected in some" "HDLM-2: 10.6;HEL: 6.7;HMC-1: 22.7;SH-SY5Y: 10.7" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: " "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 3.9 0.0 1.0 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.6 1.0 0.1 0.2 0.0 0.1 10.6 0.1 6.7 0.2 0.0 0.6 0.0 22.7 0.3 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 3.6 10.7 0.0 0.0 0.0 0.2 0.1 0.1 0.4 1.4 0.2 0.0 0.2 0.0 0.0 1.9 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Cell line enhanced" "Detected in many" "MCF7: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.5 4.8 1.9 4.0 0.5 2.1 1.8 1.4 1.3 3.9 3.5 3.5 3.2 3.9 1.6 1.4 3.4 1.4 2.0 5.4 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.2 1.9 1.3 3.3 0.4 2.6 0.4 1.2 1.6 10.6 0.9 0.4 0.8 1.5 1.7 1.8 0.2 6.8 1.9 4.2 2.6 5.0 0.8 0.7 6.3 1.2 1.0 3.7 2.2 3.8 1.9 0.6 3.2 2.6 4.6 0.2 1.8 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 SASH1 "dJ323M4.1, KIAA0790, SH3D6A" ENSG00000111961 "SAM and SH3 domain containing 1" O94885 6 148272304-148552050 "Predicted intracellular proteins" "Disease mutation, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 58.9;ASC TERT1: 22.3;WM-115: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.9;intermediate monocyte: 5.5;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 32 "monocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029947, HPA029949" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA029947: AB_10598915, HPA029949: AB_10602280" "unprognostic (9.71e-2)" "unprognostic (4.74e-2)" "unprognostic (5.32e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (3.55e-2)" "unprognostic (4.79e-3)" "unprognostic (6.69e-2)" "unprognostic (4.76e-2)" "unprognostic (2.06e-1)" "unprognostic (8.65e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-1)" "unprognostic (2.13e-3)" "unprognostic (5.45e-2)" "unprognostic (3.53e-1)" "unprognostic (8.04e-3)" "unprognostic (1.54e-1)" 41.4 5.4 19.6 5.3 21.7 0.7 25.7 9.9 28.1 16.8 9.2 22.2 4.4 5.6 11.2 9.3 35.6 10.0 15.6 13.2 21.9 14.2 13.5 7.7 16.7 4.7 26.3 11.4 5.3 7.7 15.0 3.5 23.5 22.8 9.8 8.3 9.2 12.2 8.1 10.6 17.5 6.7 13.2 28.6 10.3 6.0 4.8 22.3 0.2 30.9 10.4 8.2 13.2 17.9 0.0 0.0 0.1 5.5 0.0 0.1 0.6 1.3 0.8 6.8 2.2 58.9 22.3 1.1 7.7 18.7 5.9 9.0 1.7 1.6 0.0 4.1 20.6 1.6 2.0 1.8 4.9 0.0 1.5 0.0 3.9 1.5 1.8 0.0 0.3 10.3 1.9 8.8 2.4 21.3 0.1 0.0 5.5 1.5 0.0 0.0 2.0 1.0 0.0 4.9 0.0 4.3 4.2 0.2 0.0 2.3 8.8 6.1 0.6 3.9 18.5 5.7 1.1 18.2 1.6 0.0 0.0 0.0 9.2 0.0 27.2 0.1 2.9 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.6 19.6 21.7 9.9 17.9 21.9 14.2 26.3 11.4 22.8 22.3 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779979-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3" "Cell line enhanced" "Detected in some" "Daudi: 43.9;HL-60: 15.4;MOLT-4: 31.3;NB-4: 23.8;REH: 23.5;U-698: 40.0;U-937: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favourable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavourable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 7.8 3.4 2.8 34.6 5.2 33.2 2.7 0.7 2.2 2.0 3.3 4.0 0.2 3.9 1.9 2.1 2.9 3.4 3.6 2.0 3.3 2.4 3.3 3.0 10.6 38.2 5.2 1.1 1.3 1.8 0.2 1.8 2.5 4.2 2.7 3.5 1.6 7.8 0.8 0.9 1.1 18.8 2.4 6.2 55.7 4.2 0.8 4.0 85.3 2.5 2.0 38.6 7.0 2.0 22.0 27.6 53.7 44.2 33.4 46.9 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 31.3 23.8 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 8.9 40.0 0.0 31.1 0.0 7.9 29.4 53.7 46.9 44.1 38.7 19.1 26.7 43.1 27.6 22.0 19.3 30.0 29.1 33.4 44.2 12.7 32.3 61.8 2.8 5.2 0.7 2.2 3.3 2.4 5.2 1.1 4.2 4.0 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.8" "Cell line enhanced" "Detected in many" "HaCaT: 12.0;K-562: 11.0;SCLC-21H: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.3 4.1 1.3 5.4 0.7 2.8 4.4 5.3 2.7 1.2 3.5 5.0 0.9 2.1 14.8 0.7 46.8 1.9 1.4 5.5 2.8 2.3 1.1 9.1 1.1 3.1 2.8 9.2 2.6 4.7 11.5 0.7 5.6 2.4 1.8 1.6 2.3 3.0 1.2 1.9 1.6 0.9 2.3 1.3 2.3 18.0 3.7 1.0 3.1 0.1 1.6 1.0 1.2 6.7 1.3 5.3 0.2 3.2 2.7 0.5 1.6 2.1 1.3 4.8 1.1 2.2 0.6 0.5 0.4 0.9 1.8 0.2 2.6 1.6 1.2 0.0 12.0 2.1 1.8 2.1 1.1 7.8 0.5 3.7 0.0 0.1 0.4 0.5 1.5 2.6 1.7 1.4 1.9 11.0 0.9 1.2 1.1 0.6 0.0 3.2 0.9 1.5 0.6 1.0 0.9 1.1 9.2 1.4 1.3 0.0 1.7 4.6 0.4 0.2 2.3 1.4 4.9 0.9 2.5 2.7 1.0 2.2 0.6 1.5 0.0 0.1 5.3 1.1 0.0 1.4 2.5 0.4 2.7 0.1 6.7 1.8 0.8 0.1 3.2 0.2 1.3 0.1 0.5 4.1 5.4 4.4 5.3 5.5 2.8 3.1 2.8 5.6 3.7 SBF2 "CMT4B2, DENND7B, KIAA1766, MTMR13" ENSG00000133812 "SET binding factor 2" Q86WG5 11 9778667-10294207 "Disease related genes, Predicted intracellular proteins" Autophagy "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050933 Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" Nucleoplasm "Intermediate filaments, Cytosol" "HPA050933: " "unprognostic (2.26e-1)" "unprognostic (1.45e-2)" "unprognostic (1.91e-2)" "unprognostic (1.00e-1)" "unprognostic (2.28e-1)" "unprognostic (5.36e-2)" "unprognostic (5.55e-2)" "unprognostic (6.44e-3)" "unprognostic (2.84e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-3)" "unprognostic (2.43e-1)" "prognostic favourable (3.66e-5)" "unprognostic (3.72e-2)" "unprognostic (8.77e-2)" "unprognostic (3.43e-1)" "unprognostic (4.11e-2)" 26.2 12.7 19.8 8.9 22.5 6.1 17.9 26.7 17.4 23.6 15.6 18.4 13.2 9.8 19.1 14.2 16.9 15.3 14.9 13.7 16.3 12.3 20.8 13.8 13.8 8.7 14.6 12.0 26.8 8.0 33.9 23.2 20.5 13.7 16.8 15.3 15.6 14.7 17.7 8.8 13.2 11.1 22.0 16.1 12.4 13.3 15.3 19.1 7.8 24.0 9.1 9.2 20.2 25.5 0.6 1.0 3.9 3.9 0.9 0.6 0.5 6.6 5.9 9.4 6.6 12.6 16.8 48.2 5.1 9.4 6.2 8.7 3.9 8.1 2.5 2.8 9.1 4.4 5.6 4.2 10.8 2.6 4.0 1.0 4.3 5.3 5.1 2.3 3.5 8.6 5.6 3.2 12.0 10.0 2.1 2.4 7.2 1.9 3.4 0.7 4.0 6.0 3.2 6.6 3.3 5.5 6.0 3.1 6.9 7.1 10.0 4.4 3.0 1.7 10.9 11.1 5.5 10.9 4.2 0.8 1.9 3.6 8.2 1.1 7.7 0.0 1.9 0.1 0.2 1.8 0.6 0.3 0.2 0.4 1.0 0.6 0.3 0.1 3.9 0.9 3.9 0.4 0.2 0.5 19.8 22.5 26.7 17.4 16.3 12.3 14.6 12.0 13.7 19.1 SBNO1 "FLJ10701, FLJ10833, MOP3, Sno" ENSG00000139697 "Strawberry notch homolog 1" A3KN83 12 123289109-123364843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042388 Approved Approved Nucleoplasm Nucleoplasm "HPA042388: AB_10795704" "unprognostic (1.61e-2)" "unprognostic (9.61e-2)" "unprognostic (5.12e-2)" "unprognostic (2.54e-3)" "unprognostic (3.50e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (1.48e-1)" "unprognostic (5.33e-2)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (6.61e-3)" "unprognostic (2.06e-1)" "unprognostic (3.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-2)" 7.6 7.6 12.9 9.8 12.2 21.4 9.0 24.3 15.9 9.4 8.6 6.4 6.9 7.4 10.9 6.4 10.7 9.3 6.4 7.5 11.3 9.2 9.5 11.0 7.4 12.7 12.1 10.9 10.4 9.5 13.7 15.6 11.8 12.2 10.2 9.5 5.3 7.2 9.1 11.2 8.6 10.1 10.0 9.7 9.4 8.7 57.1 12.3 19.5 14.6 4.8 12.0 8.6 10.4 11.6 8.1 13.8 13.5 7.9 14.7 6.7 11.1 21.7 8.7 16.2 12.4 9.7 18.1 10.2 10.2 9.2 7.6 15.3 7.2 24.1 12.3 11.7 13.3 18.5 11.4 15.2 17.7 7.0 23.4 13.5 12.3 6.4 28.5 20.3 7.7 9.0 12.8 12.6 8.9 28.7 7.8 15.7 11.3 15.7 11.5 13.3 11.3 16.9 12.8 12.4 7.1 29.1 14.8 6.3 17.8 12.6 9.4 21.8 9.9 11.8 12.4 15.7 14.6 9.1 7.9 16.9 30.7 7.1 17.0 13.9 8.3 8.2 10.9 12.6 9.6 14.7 11.6 12.2 12.5 8.1 9.7 12.0 12.9 13.8 7.9 13.5 7.6 9.4 6.7 12.9 12.2 24.3 15.9 11.3 9.2 12.1 10.9 12.2 12.3 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell line enhanced" "Detected in all" "AF22: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: , HPA070248: " "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavourable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavourable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 7.1 3.6 53.9 11.5 21.0 18.2 7.6 8.0 15.1 5.4 9.6 22.5 26.6 6.7 25.4 8.7 26.7 16.8 20.3 5.3 3.3 22.9 10.0 23.5 17.9 17.1 6.3 3.4 14.9 16.7 17.1 17.6 8.2 6.5 9.8 24.9 7.4 2.5 8.2 16.8 11.4 3.5 13.6 5.7 38.0 32.0 14.2 8.0 18.4 4.2 10.5 16.8 10.9 15.5 5.2 8.4 9.2 3.7 1.8 3.1 9.0 2.0 13.9 9.0 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 SCAF1 "FLJ00034, SR-A1" ENSG00000126461 "SR-related CTD associated factor 1" Q9H7N4 19 49642125-49658642 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046828, HPA054593" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046828: AB_10961907, HPA054593: " "unprognostic (1.16e-1)" "unprognostic (3.08e-1)" "prognostic unfavourable (9.59e-4)" "unprognostic (3.38e-2)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (4.43e-3)" "unprognostic (4.11e-3)" "unprognostic (1.01e-1)" "unprognostic (8.30e-3)" "unprognostic (1.29e-2)" "unprognostic (3.52e-3)" "unprognostic (4.78e-2)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.18e-2)" 21.6 15.6 22.2 17.0 30.5 14.4 12.9 24.9 48.3 14.1 15.0 27.0 7.4 18.2 18.9 7.4 27.2 24.0 17.2 21.3 21.4 18.9 12.4 13.9 13.9 17.7 17.5 21.6 24.1 21.1 13.7 17.5 18.4 26.1 15.0 8.6 14.1 20.8 11.8 28.4 18.5 17.0 14.6 14.8 20.2 17.0 15.9 15.7 19.7 18.4 8.4 13.1 16.9 13.6 5.1 5.1 7.8 2.9 1.9 4.2 3.2 26.2 46.2 12.7 20.9 6.0 5.8 15.5 19.9 6.5 9.3 7.9 25.0 16.4 15.4 13.6 7.3 20.3 9.1 12.2 2.7 23.7 26.0 17.2 22.9 12.5 10.4 16.3 17.1 9.6 7.7 11.2 8.0 7.5 22.1 15.8 7.3 16.9 16.3 8.7 16.2 27.7 20.3 17.6 15.8 6.1 38.1 18.9 20.6 20.5 21.6 7.3 15.1 9.2 20.5 34.0 19.7 12.1 29.1 22.4 33.3 14.6 20.5 10.4 19.2 4.0 2.9 2.7 4.2 2.5 2.7 5.1 2.4 2.8 2.3 4.7 2.2 2.4 7.8 1.9 2.2 5.1 0.5 3.2 22.2 30.5 24.9 48.3 21.4 18.9 17.5 21.6 26.1 15.7 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360583-78479071 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Approved "Nucleoplasm,Vesicles,Cell Junctions" "Nucleoplasm, Vesicles, Cell Junctions" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 7.5 8.3 9.2 4.0 19.3 2.4 10.0 12.8 19.5 8.4 6.4 5.4 9.9 5.3 8.7 9.3 8.6 10.7 6.4 8.0 15.8 10.4 6.2 5.9 3.9 6.5 15.8 8.8 8.8 17.5 14.6 7.6 14.6 12.2 7.3 7.6 10.6 11.0 4.7 5.8 5.3 9.1 9.0 3.9 9.6 4.5 7.1 4.1 14.2 3.8 3.7 8.8 6.3 7.9 14.9 15.3 15.8 10.0 9.9 7.4 12.7 10.1 10.1 31.3 14.0 18.1 15.9 11.8 17.3 9.8 22.3 3.8 24.0 18.9 13.4 17.3 10.4 14.3 22.2 17.5 6.7 13.6 8.7 8.0 7.7 9.0 5.5 6.7 11.9 20.6 11.1 17.7 15.0 3.3 13.6 18.6 15.0 9.5 11.8 8.2 10.4 11.7 16.7 21.6 17.8 15.3 28.8 17.5 10.9 15.5 11.2 21.6 10.1 15.2 10.9 8.0 11.9 9.9 9.5 11.4 11.8 21.2 20.7 9.0 15.3 11.4 12.8 8.2 12.6 9.9 7.9 9.4 9.8 14.9 6.6 7.8 6.8 7.0 10.0 15.8 4.6 9.1 7.4 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424815-20437826 "Disease related genes, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 13.9;SH-SY5Y: 15.5;SK-MEL-30: 15.4;U-138 MG: 21.4;U-2 OS: 22.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" 360000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavourable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavourable (4.28e-4)" 6.5 2.4 0.0 4.1 0.3 0.1 9.2 0.0 1.2 10.6 3.2 0.4 2.9 1.4 8.1 6.6 1.8 2.6 11.3 3.4 0.6 3.2 1.1 5.9 5.1 0.8 0.4 12.6 1.6 0.0 0.6 5.6 0.9 5.5 0.0 9.2 1.1 6.8 1.8 2.2 1.9 9.9 0.5 5.3 1.4 2.5 0.0 0.0 5.4 3.3 1.4 7.1 10.9 0.1 0.1 0.9 0.0 0.0 1.8 0.0 0.4 0.2 3.1 5.4 1.9 2.6 1.2 13.9 5.7 3.3 1.7 0.0 0.0 0.2 8.1 6.7 0.1 1.8 0.0 0.4 0.4 11.7 1.1 0.2 2.5 11.6 0.0 0.6 4.6 0.0 1.6 0.8 1.7 0.1 0.1 1.2 0.5 0.0 0.2 4.2 1.8 0.3 8.9 0.0 0.0 0.0 1.3 15.5 0.0 0.0 15.4 0.5 0.0 2.0 21.4 22.4 0.5 3.1 0.6 0.2 0.2 0.1 0.3 10.6 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 1.8 0.0 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622112-30735812 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved Approved Nucleoplasm,Cytosol 59000 Nucleoplasm Cytosol "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 22.4 22.7 20.6 17.6 29.7 15.5 21.7 21.9 28.1 27.7 20.0 12.6 19.3 17.1 20.5 23.3 25.9 19.0 13.4 20.9 19.2 17.8 24.5 33.9 18.8 16.6 16.5 19.4 21.8 33.8 28.5 68.5 29.4 26.0 20.3 21.9 14.5 34.5 22.3 24.7 15.7 22.0 19.6 15.6 20.4 18.8 18.8 17.1 24.4 31.0 18.0 19.0 17.2 22.3 14.3 16.3 18.8 17.2 19.4 15.9 9.2 24.1 10.5 13.4 8.9 22.2 25.0 19.6 18.1 25.2 26.7 31.7 17.0 18.2 13.4 8.7 28.5 14.0 16.5 19.1 31.2 18.7 9.1 9.2 14.7 57.3 27.8 17.2 11.9 18.5 14.7 16.4 27.9 18.1 15.1 25.5 26.2 28.5 10.6 10.0 12.8 18.5 9.3 14.7 16.1 21.5 20.9 14.0 11.7 17.5 17.4 17.9 25.6 12.8 14.5 18.5 14.2 15.4 15.1 17.6 16.4 18.2 8.7 13.3 19.1 18.8 13.4 15.6 9.6 14.4 12.4 14.3 11.1 12.0 16.3 12.3 10.5 10.7 4.3 19.4 17.2 13.3 15.9 9.2 20.6 29.7 21.9 28.1 19.2 17.8 16.5 19.4 26.0 17.1 SCFD2 "FLJ39514, STXBP1L1" ENSG00000184178 "Sec1 family domain containing 2" Q8WU76 4 52872982-53366075 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036526, HPA036527" Enhanced Approved Nucleoplasm Nucleoplasm "HPA036526: AB_10673499, HPA036527: AB_2675175" "unprognostic (1.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.99e-2)" "unprognostic (3.31e-1)" "unprognostic (4.22e-2)" "unprognostic (6.16e-2)" "unprognostic (1.27e-2)" "unprognostic (7.08e-2)" "unprognostic (4.02e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "prognostic favourable (3.81e-6)" "unprognostic (9.39e-3)" "unprognostic (1.10e-1)" "unprognostic (4.86e-3)" "unprognostic (2.51e-2)" 13.7 19.4 11.0 15.8 15.1 12.5 13.7 7.8 17.6 12.9 11.7 16.2 6.5 10.5 14.2 9.0 16.7 9.9 10.0 11.9 11.5 13.2 13.6 17.2 10.4 12.7 15.7 9.3 13.2 18.3 11.4 15.3 11.2 16.4 8.7 11.8 10.5 13.0 10.4 13.8 13.5 10.7 14.2 13.2 12.7 10.6 5.1 12.4 16.2 10.1 10.2 19.3 10.4 12.1 6.5 15.9 1.4 9.7 13.9 9.5 9.1 6.6 6.2 3.6 8.3 11.9 12.1 4.4 15.5 11.7 5.4 4.6 4.4 8.6 12.7 12.0 29.5 4.2 11.5 13.5 10.4 3.9 6.7 7.1 6.6 5.3 5.6 8.4 13.1 8.3 8.2 10.4 4.1 9.1 12.0 7.4 9.2 7.7 12.4 5.4 2.1 7.8 7.7 3.3 13.4 6.0 4.5 10.3 5.8 3.5 13.1 6.9 5.1 4.1 8.4 11.8 7.5 13.3 11.3 8.7 4.7 15.0 8.0 10.5 33.5 0.0 5.6 1.4 7.8 9.7 7.8 6.5 6.4 8.8 15.9 5.7 9.5 8.6 1.2 13.9 9.3 10.3 5.5 9.1 11.0 15.1 7.8 16.9 11.5 13.2 15.7 9.3 16.4 12.4 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell line enhanced" "Detected in some" "AF22: 9.3;AN3-CA: 16.9;HUVEC TERT2: 20.0;NTERA-2: 10.3;SH-SY5Y: 58.2" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: " "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favourable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.3 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.3 0.1 3.9 20.0 0.0 0.0 1.2 0.0 0.0 0.0 10.3 0.0 0.0 1.9 0.0 0.4 0.0 0.0 58.2 0.0 0.0 0.0 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 SCML1 ENSG00000047634 "Scm polycomb group protein like 1" Q9UN30 X 17737449-17754988 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.1" "Low lineage specificity" "Detected in many" "HPA035270, HPA035271, HPA061397" Enhanced Approved Nucleoplasm Nucleoplasm "HPA035270: AB_10672860, HPA035271: AB_10602795, HPA061397: " "unprognostic (6.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.83e-1)" "unprognostic (3.18e-1)" "unprognostic (1.73e-1)" "unprognostic (5.18e-1)" "unprognostic (2.12e-3)" "unprognostic (9.49e-2)" "unprognostic (8.40e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.44e-3)" "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-3)" 12.6 12.1 5.9 6.7 6.2 3.1 9.6 5.5 7.7 9.6 10.7 6.7 13.5 8.8 10.4 8.3 6.8 7.2 6.2 7.2 6.4 4.6 7.8 30.4 11.9 8.2 5.1 4.1 19.6 7.4 4.1 8.8 10.9 9.5 8.5 8.3 12.7 7.1 15.0 19.5 6.2 8.5 11.1 8.0 7.9 6.0 35.4 4.3 6.3 5.2 7.3 6.1 11.5 7.6 3.5 2.2 0.8 3.2 8.0 17.1 2.1 10.0 2.7 8.6 3.0 8.2 10.9 1.0 9.7 9.5 10.8 13.9 5.7 4.6 0.0 4.3 6.8 5.8 11.2 7.0 16.1 0.0 22.2 0.7 7.8 11.0 11.0 0.0 5.4 7.2 6.4 14.3 10.6 0.1 1.6 0.0 9.9 3.2 0.0 0.0 1.4 10.8 0.0 4.5 4.5 4.3 2.4 1.8 2.2 4.5 0.0 3.7 1.5 0.2 5.1 10.5 4.3 39.0 6.4 6.0 5.5 0.0 8.5 0.9 2.9 0.0 1.1 0.7 0.2 2.9 0.2 1.3 2.9 0.3 2.2 3.5 17.1 8.0 0.8 8.0 3.2 0.5 0.4 2.1 5.9 6.2 5.5 7.7 6.4 4.6 5.1 4.1 9.5 4.3 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.3;Hep G2: 6.0" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: " "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 53.7" "Group enriched" "Detected in some" 11 "REH: 9.8;RH-30: 30.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053992 Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA053992: " "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 5.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.5 0.0 53.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 9.8 30.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Group enriched" "Detected in some" 4 "LHCN-M2: 21.5;RH-30: 17.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.3 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.8 2.7 0.0 0.3 0.0 1.1 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 3.5 0.0 0.0 21.5 1.0 0.0 0.0 2.0 0.0 0.0 17.9 0.0 0.0 2.4 0.3 2.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 SCNM1 MGC3180 ENSG00000163156 "Sodium channel modifier 1" Q9BWG6 1 151156664-151170297 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052439, HPA054324" Uncertain Approved Nucleoplasm Nucleoplasm "HPA052439: , HPA054324: " "unprognostic (1.20e-1)" "unprognostic (4.42e-2)" "unprognostic (6.13e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-3)" "unprognostic (1.77e-1)" "unprognostic (4.25e-3)" "unprognostic (1.25e-2)" "unprognostic (1.77e-1)" "prognostic favourable (1.23e-4)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "prognostic unfavourable (2.17e-13)" "unprognostic (8.74e-2)" "unprognostic (1.13e-1)" "unprognostic (8.48e-2)" "unprognostic (9.71e-2)" 20.5 15.5 22.2 21.1 21.1 32.9 16.2 17.0 20.0 15.3 16.8 21.0 8.0 16.3 18.4 15.0 19.4 16.5 15.5 16.5 19.8 17.1 19.5 19.8 16.1 34.0 22.9 14.9 16.8 13.5 10.3 12.1 23.6 20.2 17.3 14.7 20.3 16.2 15.2 47.9 21.7 20.5 18.0 22.3 41.8 14.6 14.4 19.4 40.9 16.1 20.1 27.2 21.6 15.6 28.2 61.4 50.9 45.3 28.8 30.1 37.8 12.9 9.1 10.2 11.9 14.2 10.7 17.1 10.3 11.9 25.0 19.5 19.8 12.6 20.7 16.8 11.0 17.5 11.8 9.4 12.2 12.9 13.1 17.8 13.0 12.6 20.7 23.6 17.5 11.2 18.3 17.6 15.7 15.0 14.2 15.8 12.2 31.9 16.7 36.7 25.7 14.1 22.9 12.1 25.6 13.4 8.6 12.6 20.2 11.6 18.9 22.9 17.5 75.8 11.0 12.0 11.2 12.4 21.8 20.6 27.9 32.3 12.5 25.1 15.3 50.9 45.3 45.6 20.4 33.7 19.3 28.2 24.8 23.0 60.2 24.7 22.9 19.9 45.7 28.8 21.0 61.4 30.1 37.8 22.2 21.1 17.0 20.0 19.8 17.1 22.9 14.9 20.2 19.4 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Group enriched" "Detected in some" 7 "hTCEpi: 30.7;RT4: 13.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA071194: " "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 13.8 1.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 SCOC "HRIHFB2072, SCOCO, UNC-69" ENSG00000153130 "Short coiled-coil protein" Q9UIL1 4 140257286-140385726 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061198, HPA070321" Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA061198: , HPA070321: " "unprognostic (2.27e-2)" "unprognostic (2.26e-2)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (7.34e-3)" "unprognostic (1.37e-3)" "unprognostic (8.99e-3)" "unprognostic (1.13e-1)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-1)" "unprognostic (4.03e-1)" "prognostic favourable (4.82e-12)" "unprognostic (2.98e-2)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-2)" 16.2 26.6 49.3 9.7 45.0 4.5 27.7 36.3 57.1 17.7 16.1 25.0 15.0 16.5 18.8 32.2 20.4 17.3 15.3 38.3 47.1 66.9 38.6 27.9 13.7 9.7 59.7 32.5 16.6 19.0 29.6 30.5 18.5 74.5 24.2 19.2 15.0 17.9 20.1 13.5 11.0 16.0 19.9 61.8 9.9 19.6 11.1 25.0 6.0 26.0 13.0 11.8 14.8 11.8 18.8 14.3 18.5 12.4 19.2 27.9 19.2 14.7 10.0 27.6 14.4 24.7 34.4 19.8 24.1 23.6 19.5 22.0 6.7 22.0 6.1 21.6 24.8 6.4 16.8 34.4 29.8 20.8 12.0 9.5 5.2 15.8 21.9 19.1 12.1 22.9 46.6 17.4 19.6 26.0 14.7 18.0 34.1 9.7 23.7 11.6 8.6 17.3 14.5 11.5 8.9 57.4 13.5 19.5 20.3 16.4 24.6 26.5 18.0 11.8 19.9 30.0 17.4 24.5 23.4 27.7 47.2 16.1 34.8 8.7 29.2 18.5 9.0 11.7 15.7 12.4 20.1 18.8 19.0 15.5 11.2 15.2 27.9 21.4 5.2 19.2 12.0 14.3 16.6 19.2 49.3 45.0 36.3 57.1 47.1 66.9 59.7 32.5 74.5 25.0 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-676179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.9;retina: 6.1" "Group enriched" "Detected in some" 5 "Karpas-707: 3.9;NTERA-2: 3.6;RPMI-8226: 7.9;SCLC-21H: 3.8;SH-SY5Y: 4.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Group enriched" "Detected in many" 4 "cerebellum: 8.8;cerebral cortex: 17.9" "Cell type enriched" "Detected in single" 25 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067697 Approved Nucleoplasm Nucleoplasm "HPA067697: " "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.3 0.3 0.7 0.3 0.7 0.3 0.3 8.8 17.9 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.6 0.3 0.3 0.3 0.3 1.9 0.0 0.3 1.3 0.3 0.0 0.4 3.2 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.6 0.3 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.9 0.0 0.0 3.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 8.8 17.9 0.7 0.6 1.9 0.0 3.2 0.0 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavourable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favourable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 17.0 17.9 19.6 16.5 30.2 7.3 21.5 17.6 26.7 19.9 17.9 9.6 14.0 14.0 26.2 23.2 19.5 18.9 10.6 16.4 18.2 15.4 21.9 23.9 14.6 22.8 16.4 19.1 22.7 26.9 20.4 30.6 17.5 22.6 18.5 18.6 9.4 18.3 20.8 32.3 19.6 16.1 24.9 16.2 23.5 18.1 24.1 19.9 21.5 25.8 17.1 22.9 21.3 17.5 13.2 10.3 5.6 16.8 15.4 17.8 10.5 14.4 5.9 14.5 19.3 17.2 15.6 15.2 20.6 17.9 17.3 15.0 18.0 20.8 22.8 15.5 18.9 15.0 22.0 19.9 21.7 20.0 11.6 19.5 12.9 14.9 16.3 32.9 22.2 13.5 22.6 18.2 20.1 15.0 34.7 18.8 17.6 16.0 33.4 11.6 23.5 9.0 20.3 27.2 19.1 16.5 16.2 21.9 18.2 14.1 28.8 23.3 13.2 19.4 14.2 18.6 18.8 22.2 17.1 17.3 18.0 31.1 20.9 14.9 22.9 5.6 9.9 2.7 14.2 12.7 17.7 12.1 17.4 16.1 10.3 13.2 17.8 14.9 1.6 15.4 16.8 9.0 14.7 10.5 19.6 30.2 17.6 26.7 18.2 15.4 16.4 19.1 22.6 19.9 SDC3 "N-syndecan, SYND3" ENSG00000162512 "Syndecan 3" O75056 1 30869467-30908761 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 51.6;WM-115: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017087, CAB025786, HPA048085" Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "CAB025786: , HPA017087: AB_1857706, HPA048085: " "unprognostic (1.42e-3)" "unprognostic (5.52e-2)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.87e-1)" "unprognostic (1.79e-3)" "unprognostic (2.83e-1)" "prognostic favourable (2.36e-4)" "unprognostic (9.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (6.45e-2)" "unprognostic (2.74e-1)" "unprognostic (9.80e-3)" "unprognostic (1.46e-1)" 17.9 48.8 35.4 11.6 44.7 1.9 9.2 10.4 53.1 20.4 20.8 21.7 10.9 6.9 25.6 7.1 9.8 13.7 15.9 11.1 26.8 32.2 4.7 11.5 12.0 15.4 36.1 16.4 6.2 4.4 6.1 5.4 9.7 34.1 14.8 8.1 8.2 8.6 29.2 17.7 5.7 9.1 33.1 28.3 45.3 9.3 2.4 15.5 2.6 5.5 1.7 4.2 14.4 6.0 1.2 1.0 3.2 2.5 2.1 1.2 0.9 2.7 2.0 16.1 7.5 12.4 3.0 3.1 6.7 9.5 3.2 1.9 0.3 2.5 0.2 17.0 18.7 3.6 1.7 1.5 2.0 1.4 1.3 0.0 0.8 0.4 11.9 0.0 1.8 7.1 7.3 0.2 3.1 3.9 1.3 0.2 6.1 2.9 0.1 0.1 8.1 2.3 0.1 15.3 0.6 3.9 2.9 6.3 4.0 8.4 1.1 51.6 1.2 1.1 4.4 4.0 6.8 0.5 1.5 0.0 0.1 0.2 0.4 0.0 71.8 3.2 1.3 1.0 0.8 2.5 1.2 0.8 0.8 0.9 0.9 1.2 1.0 1.0 2.5 2.1 1.8 1.0 0.9 0.9 35.4 44.7 10.4 29.5 26.8 32.2 36.1 16.4 34.1 15.5 SDHAF4 "C6orf57, Sdh8" ENSG00000154079 "Succinate dehydrogenase complex assembly factor 4" Q5VUM1 6 70566917-70589569 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031824 Supported Approved Nucleoplasm,Mitochondria "Intracellular and membrane" Mitochondria Nucleoplasm "HPA031824: AB_10602113" "unprognostic (8.72e-2)" "unprognostic (1.64e-1)" "unprognostic (4.95e-2)" "unprognostic (9.96e-2)" "unprognostic (4.58e-1)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (3.18e-2)" "unprognostic (3.17e-1)" "prognostic favourable (1.95e-5)" "unprognostic (2.45e-2)" "unprognostic (9.37e-2)" "unprognostic (3.05e-1)" "unprognostic (9.94e-2)" 13.4 14.5 18.1 6.5 20.1 6.1 14.3 15.7 25.7 8.3 9.5 7.9 10.3 7.9 9.0 14.6 9.8 16.0 8.5 17.6 18.0 21.2 14.9 10.7 8.4 10.6 14.7 17.4 9.7 14.2 10.5 18.3 10.2 15.5 10.6 10.6 11.1 9.7 8.9 30.5 9.7 7.9 8.8 13.0 6.9 8.8 7.3 9.7 7.4 11.5 10.2 7.8 8.1 6.9 10.5 13.4 9.1 10.5 9.6 9.3 6.2 9.9 3.2 14.1 8.7 7.2 10.7 2.8 5.3 4.1 2.6 3.9 2.9 8.4 6.8 10.2 2.8 1.8 4.8 4.7 3.9 14.2 3.2 4.7 1.3 2.9 12.2 4.6 3.8 7.7 15.2 1.9 11.6 6.4 3.1 10.6 8.4 6.8 4.1 11.6 6.7 3.3 4.7 9.6 7.9 11.2 3.3 13.0 9.4 3.2 1.5 6.7 7.2 12.0 4.7 2.7 2.0 2.2 5.8 4.9 3.3 2.2 2.9 11.1 6.4 6.0 10.5 9.1 7.7 9.2 8.0 8.7 8.5 9.0 11.3 10.5 9.3 8.5 7.1 9.6 9.5 13.4 9.1 6.2 18.1 20.1 15.7 25.7 18.0 21.2 14.7 17.4 15.5 9.7 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644089 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.6" "Cell line enhanced" "Detected in some" "AF22: 14.8;BEWO: 12.1;RPMI-8226: 4.9;U-2 OS: 5.1;U-266/70: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 2.7;dendritic cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014725 Approved Nucleoplasm 2000000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.4 0.6 2.1 5.3 1.2 0.7 2.6 0.5 2.7 8.9 0.5 0.6 0.0 0.0 3.1 5.1 0.9 3.5 1.4 3.5 1.7 4.1 1.1 0.5 4.2 4.8 1.6 0.0 0.8 0.4 0.0 1.9 3.7 1.9 2.6 0.3 2.2 2.0 1.4 0.4 0.5 0.5 0.3 3.0 3.6 0.6 13.6 0.0 0.1 1.8 1.1 2.9 0.7 7.2 2.7 2.3 0.0 0.0 0.2 0.5 0.0 0.0 2.1 14.8 4.2 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.9 0.0 0.5 0.0 4.9 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 4.4 1.8 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 2.7 0.5 0.4 0.0 0.2 0.0 2.3 0.0 0.0 2.1 1.2 0.5 2.5 1.7 4.1 1.6 0.0 1.9 0.0 SDR39U1 "C14orf124, HCDI" ENSG00000100445 "Short chain dehydrogenase/reductase family 39U member 1" Q9NRG7 14 24439766-24442905 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044294 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044294: AB_10961400" "unprognostic (2.99e-2)" "unprognostic (1.21e-1)" "unprognostic (4.13e-2)" "unprognostic (2.42e-2)" "unprognostic (2.36e-1)" "unprognostic (6.28e-2)" "unprognostic (2.06e-2)" "unprognostic (1.67e-3)" "unprognostic (4.24e-1)" "unprognostic (2.87e-3)" "prognostic favourable (2.34e-4)" "unprognostic (9.13e-2)" "unprognostic (1.13e-3)" "unprognostic (7.47e-2)" "unprognostic (2.48e-1)" "unprognostic (1.63e-1)" "unprognostic (5.32e-2)" 19.5 29.3 21.6 12.4 24.1 21.4 15.6 47.7 26.9 13.9 13.5 23.0 17.1 14.8 16.3 16.5 12.0 19.6 10.4 37.1 21.7 18.5 22.2 18.6 11.8 17.0 32.5 19.6 19.2 22.3 17.2 27.9 12.9 22.0 17.2 8.7 19.5 31.1 21.9 64.2 16.2 14.9 13.9 18.8 22.4 16.5 15.2 29.8 13.3 18.0 17.0 12.2 13.9 14.7 25.8 30.6 17.2 19.5 27.5 24.5 15.6 10.9 18.2 12.9 15.1 18.0 13.9 13.2 6.5 8.2 13.5 15.6 14.1 13.7 14.8 16.0 6.6 19.1 11.5 14.5 5.9 20.1 20.2 12.9 13.5 35.8 8.8 11.8 13.1 15.4 17.5 9.6 13.9 14.3 11.6 12.7 13.1 19.1 19.4 19.1 12.4 16.9 25.0 6.7 10.3 23.6 13.7 22.6 19.6 15.9 28.4 13.9 19.6 17.5 7.6 4.2 14.1 12.2 8.0 21.8 13.7 17.7 11.0 15.0 11.2 17.2 19.5 11.5 21.9 11.6 21.0 25.8 16.6 17.1 21.9 25.2 23.7 24.5 6.0 27.5 9.5 30.6 19.3 15.6 21.6 24.1 47.7 26.9 21.7 18.5 32.5 19.6 22.0 29.8 SEC14L1 "PRELID4A, SEC14L" ENSG00000129657 "SEC14 like lipid binding 1" Q92503 17 77086716-77217101 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 90.8;TIME: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 71.8" "Lineage enriched" "Detected in all" 11 "granulocytes: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021463, HPA028703" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021463: , HPA028703: AB_10602300" "unprognostic (1.19e-1)" "unprognostic (8.61e-2)" "unprognostic (1.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (7.37e-2)" "unprognostic (1.21e-1)" "unprognostic (7.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.32e-1)" "unprognostic (1.37e-1)" "unprognostic (1.33e-3)" "unprognostic (3.09e-1)" "unprognostic (4.30e-2)" 40.8 34.0 25.4 25.3 39.1 33.4 40.6 42.3 33.2 27.7 11.1 21.9 12.2 13.3 15.8 18.9 18.8 15.9 21.2 18.2 27.0 19.5 25.1 15.8 38.4 25.8 31.6 20.6 12.6 18.3 17.3 18.6 49.3 22.5 10.8 10.5 24.2 21.4 12.9 51.0 11.9 12.2 16.2 25.8 33.9 18.4 35.4 24.4 10.0 24.0 14.4 26.0 15.7 14.7 2.4 2.3 71.8 6.2 1.5 2.0 1.9 11.7 8.6 15.2 23.3 6.4 7.9 5.4 10.7 9.2 12.6 10.9 11.4 7.7 31.4 21.5 14.7 4.5 6.7 10.4 16.4 5.8 6.1 16.4 6.6 14.8 10.8 3.3 7.7 11.1 4.2 10.5 11.0 90.8 10.0 26.5 17.7 5.9 5.7 4.4 5.5 7.8 4.4 24.4 23.3 21.4 4.7 11.7 9.1 11.8 6.2 6.6 5.2 3.6 56.7 14.3 13.5 7.8 7.6 15.2 11.9 16.5 6.2 3.4 4.2 4.2 3.2 9.2 0.7 5.5 0.6 2.4 0.7 0.5 2.3 1.2 0.8 0.5 71.8 1.5 6.2 0.8 2.0 1.9 25.4 39.1 42.3 33.2 27.0 19.5 31.6 20.6 22.5 24.4 SEC14L6 ENSG00000214491 "SEC14 like lipid binding 6" B5MCN3 22 30522799-30546682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 15.4;parathyroid gland: 20.9" "Group enriched" "Detected in some" 4 "K-562: 11.0;RPTEC TERT1: 20.6;SiHa: 6.1" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA067695 Approved Nucleoplasm Nucleoplasm "HPA067695: " "unprognostic (3.49e-2)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (4.09e-2)" "unprognostic (3.04e-2)" "unprognostic (1.12e-1)" "unprognostic (7.28e-3)" "unprognostic (3.88e-2)" "unprognostic (3.13e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.25e-2)" "unprognostic (8.69e-2)" "unprognostic (8.20e-2)" "unprognostic (2.12e-1)" "unprognostic (2.48e-2)" "unprognostic (6.02e-2)" 0.7 0.7 3.3 0.0 3.6 1.1 2.4 1.1 2.1 2.3 0.0 0.1 2.0 15.4 0.0 0.9 2.8 0.0 2.4 3.4 7.2 0.0 7.9 0.0 4.0 1.7 3.5 20.9 1.8 0.0 1.0 0.0 0.0 1.6 0.0 7.3 0.0 1.3 3.9 0.0 0.6 3.8 0.0 0.1 0.1 0.0 1.2 0.9 2.7 0.8 1.9 2.2 0.3 0.2 0.1 0.9 0.3 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.5 0.3 1.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 2.8 0.3 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 11.0 0.2 0.0 0.4 0.1 0.4 0.5 0.1 0.2 0.0 0.1 20.6 0.2 0.2 0.1 6.1 0.1 0.0 1.6 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.3 0.1 1.9 0.8 0.7 0.6 0.6 1.6 0.7 0.5 0.5 0.2 1.2 0.6 0.9 2.7 1.9 0.7 0.9 2.2 0.3 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavourable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favourable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 25.3 20.9 27.6 13.4 30.5 28.0 28.8 19.0 30.5 24.1 21.1 32.8 17.4 28.4 26.2 25.8 16.4 22.2 17.4 22.6 27.5 25.4 22.5 14.1 24.6 18.9 34.7 24.6 29.0 26.6 23.8 23.7 17.7 27.6 36.4 14.5 25.7 23.3 25.1 15.4 14.5 31.6 24.9 49.2 15.8 20.7 32.0 25.6 14.5 23.5 11.8 15.2 18.4 17.6 11.5 10.3 18.8 10.7 9.9 19.4 9.2 12.1 11.5 16.0 14.4 32.1 30.3 4.4 22.2 20.4 21.3 22.5 8.1 18.2 11.9 9.1 23.0 6.5 12.4 18.7 19.2 16.5 14.0 18.5 19.4 9.2 25.5 10.2 19.0 18.0 22.9 26.6 28.4 24.2 18.3 20.9 20.9 7.9 12.2 9.4 10.1 17.1 6.3 11.4 10.4 17.5 10.0 9.4 13.5 16.9 12.5 15.6 24.2 9.5 22.1 19.4 15.5 29.4 21.4 17.6 26.6 11.2 21.1 13.0 18.0 8.7 10.7 18.8 13.7 7.7 19.4 11.5 17.7 16.1 9.9 9.8 15.2 13.4 6.0 9.9 8.0 10.3 14.2 9.2 27.6 30.5 19.0 30.5 27.5 25.4 34.7 24.6 27.6 25.6 SEC23A ENSG00000100934 "Sec23 homolog A, coat complex II component" Q15436 14 39031919-39109646 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043806, HPA069974" Uncertain Approved Nucleoplasm,Vesicles 54000 "Nucleoplasm, Vesicles" "HPA043806: , HPA069974: " "unprognostic (2.40e-1)" "prognostic unfavourable (5.75e-4)" "prognostic favourable (3.56e-4)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.39e-2)" "unprognostic (1.15e-2)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.69e-4)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.16e-1)" "unprognostic (2.73e-1)" "unprognostic (1.41e-3)" 23.9 23.5 10.2 16.8 19.1 7.1 22.1 18.6 20.6 21.4 29.6 8.4 14.0 30.2 30.0 16.8 20.3 19.0 17.2 26.5 11.0 14.8 14.4 55.7 13.5 15.5 12.5 12.8 24.3 8.5 4.7 17.2 15.5 19.8 18.6 18.6 16.2 9.8 31.0 31.7 9.6 38.3 52.8 8.3 11.8 16.9 12.3 6.9 12.9 11.8 11.3 11.3 31.9 18.9 15.6 19.8 38.1 21.6 26.0 26.1 17.9 10.6 20.1 17.5 15.5 32.1 36.8 5.3 43.0 37.1 30.6 38.3 20.1 9.0 2.5 10.5 59.9 8.6 22.0 17.3 44.8 8.1 7.6 4.4 16.0 65.2 24.5 7.4 6.8 28.1 9.3 21.1 15.6 25.6 3.2 6.2 23.8 9.9 6.6 3.0 3.9 19.2 9.6 24.2 3.8 16.1 16.2 1.8 4.2 29.8 8.8 9.5 10.9 2.3 28.5 16.2 12.4 23.6 10.8 6.0 7.3 12.0 11.0 6.3 15.5 38.1 21.6 24.2 18.2 18.6 26.1 15.6 23.0 23.4 19.8 14.5 24.2 19.6 19.6 26.0 16.3 17.4 24.0 17.9 10.2 19.1 18.6 20.6 11.0 14.8 12.5 12.8 19.8 6.9 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favourable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 25.5 20.2 15.8 18.3 16.5 26.6 34.5 26.9 18.9 21.4 20.0 16.8 19.9 15.5 26.2 19.2 22.6 18.9 18.7 20.5 14.2 12.1 18.9 49.5 20.4 17.8 15.7 11.8 24.9 20.4 30.7 27.7 22.3 15.1 19.1 18.3 22.5 20.2 28.3 37.0 25.8 17.4 25.5 14.8 17.4 18.0 12.1 16.7 31.7 20.8 18.3 21.9 24.9 31.1 13.9 15.7 14.6 13.7 15.7 16.1 10.6 11.9 11.0 17.4 13.0 21.2 21.3 10.0 15.7 19.2 13.4 11.9 10.0 13.9 11.1 8.3 23.8 10.2 19.5 15.7 19.9 13.6 9.7 11.6 10.0 10.9 14.3 15.2 13.7 21.0 20.2 15.3 18.5 19.7 17.6 10.2 19.8 9.7 22.0 7.1 6.6 8.8 14.3 15.4 6.4 16.3 15.0 12.3 9.9 12.1 25.9 9.3 7.6 5.9 18.2 15.8 10.6 13.7 11.2 9.9 12.4 10.6 14.0 6.1 12.6 8.2 12.3 14.6 12.3 13.7 13.7 13.9 13.7 12.8 15.7 11.6 16.1 13.2 12.3 15.7 13.2 6.2 11.9 10.6 15.8 16.5 26.9 18.9 14.2 12.1 15.7 11.8 15.1 16.7 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favourable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 13.2 12.6 30.1 8.5 32.2 14.4 14.3 18.1 38.0 15.2 10.8 40.7 12.1 7.2 14.1 17.4 13.2 14.4 11.1 11.1 38.4 23.8 19.3 13.9 27.3 9.5 38.8 24.8 15.5 10.9 42.0 12.7 29.4 36.7 16.3 9.2 8.1 30.8 14.8 10.1 8.3 8.5 11.5 66.1 10.6 13.6 9.9 35.6 6.7 18.2 6.7 9.8 10.8 10.3 14.7 8.1 14.6 6.0 7.8 11.1 4.0 4.8 5.1 11.6 9.7 16.6 12.9 6.8 17.0 14.3 14.4 17.9 5.8 4.3 3.3 8.1 12.9 4.0 14.6 4.2 17.1 19.4 3.5 9.6 7.4 4.6 8.7 5.3 10.9 10.1 5.5 12.3 6.9 13.6 5.8 8.6 16.6 2.0 5.4 5.1 4.1 4.6 5.6 12.7 13.2 18.6 10.3 2.0 7.9 11.0 20.2 16.1 5.9 6.2 16.3 12.7 6.0 12.0 7.8 7.1 12.5 6.1 10.0 7.7 16.7 9.3 5.1 14.6 9.0 4.9 8.5 12.2 8.1 6.1 3.6 14.7 11.1 8.7 9.2 7.8 6.0 8.1 5.8 4.0 30.1 32.2 18.1 31.5 38.4 23.8 38.8 24.8 36.7 35.6 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA048362: " "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavourable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favourable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 27.5 49.3 34.8 35.6 49.9 36.2 30.4 17.0 52.5 23.6 30.6 14.8 23.3 38.5 22.1 38.1 36.3 26.9 28.7 32.7 29.7 31.9 33.8 49.5 26.4 40.1 29.3 40.0 28.4 41.5 9.7 30.7 28.9 22.2 32.8 16.2 22.8 48.2 26.0 52.7 21.1 37.8 15.5 19.5 49.3 36.8 30.8 18.7 44.4 43.2 25.4 35.5 21.6 23.3 61.7 83.7 39.6 71.7 29.9 53.1 71.6 31.8 23.3 25.2 14.5 3.8 12.3 4.6 12.9 10.9 11.0 6.5 6.3 16.2 15.4 36.0 7.1 14.2 11.7 15.6 7.4 22.3 25.3 20.3 14.8 15.3 22.6 30.0 39.9 12.9 13.3 13.0 12.2 19.1 19.4 14.5 13.1 30.6 25.9 46.1 44.6 30.6 33.0 24.3 29.2 10.5 14.8 13.5 27.7 11.3 10.6 33.0 29.2 22.5 19.1 12.5 27.5 24.6 18.5 73.1 52.4 10.1 26.9 23.9 29.6 39.6 71.7 34.5 29.9 71.0 28.2 59.7 39.7 31.3 71.2 61.7 53.1 37.6 5.4 29.9 65.4 83.7 29.4 71.6 34.8 49.9 17.0 52.5 29.7 31.9 29.3 40.0 22.2 18.7 SELENOM "SELM, SEPM" ENSG00000198832 "Selenoprotein M" Q8WWX9 22 31104772-31120069 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 39.6;BJ hTERT+: 38.0;HHSteC: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7" "Group enriched" "Detected in all" 6 "B-cells: 32.4;T-cells: 51.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008667, HPA019601" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" 110000 "Nucleoplasm, Cytosol" "CAB008667: AB_1622762, HPA019601: AB_1856666" "unprognostic (5.29e-3)" "unprognostic (1.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.59e-3)" "unprognostic (1.45e-1)" "unprognostic (1.60e-2)" "unprognostic (1.60e-1)" "unprognostic (3.51e-3)" "unprognostic (8.31e-2)" "prognostic unfavourable (2.55e-6)" "unprognostic (1.32e-2)" "unprognostic (3.80e-1)" "unprognostic (5.20e-2)" "unprognostic (3.19e-2)" 35.9 19.5 19.8 31.3 20.6 2.4 33.4 13.5 20.8 83.5 66.2 9.1 38.3 22.0 67.5 34.2 53.4 46.1 67.2 25.5 19.1 20.6 19.2 6.6 18.2 35.1 20.7 11.7 49.9 38.1 18.1 27.2 22.1 15.9 59.5 10.7 41.4 57.3 89.1 29.4 11.6 24.0 76.2 14.1 18.2 35.2 21.9 8.8 1.4 45.7 12.2 12.8 92.5 36.1 32.4 1.3 2.4 7.5 7.5 51.6 21.9 3.2 6.7 1.9 11.2 18.7 22.0 21.9 39.6 38.0 18.5 13.4 0.2 0.5 0.4 8.2 23.2 0.3 1.8 2.4 1.2 1.7 6.7 0.7 2.1 3.3 50.1 0.0 3.5 21.3 7.2 8.8 3.3 2.3 0.6 3.8 4.6 1.7 0.1 0.4 2.5 7.1 0.0 0.0 4.5 2.9 0.0 4.3 9.5 12.3 11.0 0.1 15.2 0.2 8.0 5.6 15.8 20.6 0.0 3.5 1.6 0.2 22.3 0.0 3.6 2.4 2.2 0.9 23.0 3.8 29.7 32.4 38.3 27.4 1.3 24.2 51.6 30.4 1.6 7.5 7.5 0.4 34.7 21.9 19.8 20.6 13.5 20.8 19.1 20.6 20.7 11.7 15.9 8.8 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Group enriched" "Detected in many" 4 "Hep G2: 90.8;HSkMC: 79.4" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" 2223100000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favourable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.3 0.1 7.5 2.1 1.3 0.6 1.9 0.0 0.0 2.0 10.7 0.3 6.7 0.2 0.3 0.0 0.0 0.0 0.4 8.7 0.5 0.0 90.8 4.6 0.5 0.0 79.4 0.1 0.0 0.0 0.0 1.0 2.2 3.9 0.2 0.1 1.1 5.2 0.1 0.2 0.3 15.6 2.1 1.2 0.3 0.5 0.4 2.7 0.2 21.2 0.1 0.1 0.5 0.3 0.9 0.1 1.4 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 24.5" "Cell line enhanced" "Detected in many" "AF22: 42.0;BJ: 32.6;fHDF/TERT166: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 15 "monocytes: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" 1200000 Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: " "unprognostic (1.20e-1)" "prognostic unfavourable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 9.6 1.1 2.9 5.2 14.6 0.3 3.7 1.0 6.0 7.4 17.8 1.4 0.7 2.3 1.5 3.3 8.6 3.5 8.6 3.7 2.0 2.1 1.3 1.1 4.9 12.9 1.6 6.5 1.4 1.0 1.3 12.0 14.7 11.1 5.0 8.7 8.2 1.5 0.8 1.0 2.7 5.3 24.5 3.3 17.9 5.4 1.8 1.8 0.0 4.2 1.4 2.4 11.9 2.1 0.0 0.2 0.0 4.7 0.3 0.3 0.0 3.6 10.0 42.0 0.0 1.3 1.0 2.7 32.6 19.2 2.7 1.7 3.5 9.8 0.0 1.5 35.5 18.1 0.1 7.8 3.9 0.0 1.3 0.0 1.8 0.0 1.1 0.8 0.0 1.3 0.0 5.9 1.4 10.2 0.0 0.0 1.1 0.1 0.0 0.0 15.7 3.7 0.7 17.9 1.0 6.1 0.2 3.2 1.7 0.2 0.0 0.3 0.1 0.3 5.7 3.7 3.9 10.5 4.7 2.4 1.6 0.0 3.8 1.4 7.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 4.7 0.0 0.0 0.0 2.9 14.6 1.0 6.0 2.0 2.1 1.6 6.5 11.1 1.8 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649113 "Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 4.0;SK-BR-3: 20.2;U-2 OS: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: " "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 4.0 1.1 2.4 1.0 12.2 0.6 7.8 2.0 12.2 5.5 6.4 1.9 0.5 2.2 5.4 1.4 4.7 2.3 6.5 0.9 4.0 4.7 1.0 1.0 6.1 0.6 5.9 6.4 0.9 9.6 0.7 1.4 1.1 5.1 15.0 4.9 2.4 6.2 9.1 1.0 2.2 3.6 10.3 6.6 0.7 3.8 0.9 3.1 0.9 2.2 0.5 0.8 9.8 3.3 0.5 0.3 1.4 0.6 0.7 0.5 0.2 0.2 1.1 0.2 0.0 0.5 3.2 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.0 1.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 20.2 0.0 1.6 0.0 0.0 0.8 6.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 1.4 0.3 0.5 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.5 0.5 0.8 0.7 0.6 0.3 0.3 0.2 2.4 12.2 2.0 8.7 4.0 4.7 5.9 6.4 5.1 3.1 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.8;RPTEC TERT1: 32.1;RT4: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 14.7;granulocytes: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavourable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 7.0 19.8 13.1 13.7 16.7 7.1 13.6 9.1 13.1 16.2 21.7 9.4 18.2 24.0 9.0 12.3 56.7 16.3 20.3 13.8 13.3 7.6 18.6 32.1 11.6 10.0 13.4 11.1 17.0 19.8 9.4 10.8 14.6 15.4 18.1 10.0 15.4 21.3 15.7 4.0 29.0 22.2 13.5 18.8 16.3 22.4 8.3 14.8 12.8 32.7 15.5 27.2 31.6 24.6 14.7 0.9 4.0 2.0 0.3 0.7 1.0 5.8 15.9 1.2 3.8 1.1 0.8 8.8 1.8 3.9 2.2 2.4 1.9 51.8 4.1 20.1 1.3 27.8 1.0 25.8 1.8 23.6 3.3 5.4 3.9 2.6 4.4 0.6 2.5 3.1 11.3 2.4 5.1 2.5 2.6 6.6 1.2 4.3 1.4 2.3 5.4 14.6 1.7 0.9 9.0 32.1 34.9 3.8 3.9 6.3 10.2 2.4 7.1 1.6 5.6 1.8 3.4 3.7 4.0 9.6 11.5 2.0 17.1 4.5 1.8 0.0 2.0 0.3 0.7 1.2 0.5 14.7 0.5 0.4 0.9 11.8 0.4 0.5 4.0 0.3 2.0 0.1 0.1 1.0 13.1 16.7 9.1 13.1 13.3 7.6 13.4 11.1 15.4 14.8 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: , HPA065969: " "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavourable (5.94e-5)" "prognostic unfavourable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favourable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 7.1 4.9 5.3 7.5 8.7 4.8 3.3 5.0 10.4 9.1 8.4 2.0 4.1 2.4 5.4 7.9 2.1 7.7 8.5 10.1 6.3 6.6 4.2 2.0 4.0 3.1 0.9 6.7 4.4 7.4 6.1 3.2 3.9 0.3 0.1 5.3 2.1 3.8 0.7 2.9 4.7 0.0 6.9 0.0 7.1 3.4 3.3 8.0 7.2 3.0 9.0 3.5 0.5 4.2 15.5 7.5 3.7 9.1 5.8 5.8 0.3 18.9 0.3 8.3 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell line enhanced" "Detected in some" "AF22: 14.5;AN3-CA: 17.3;BEWO: 15.1;HAP1: 20.3;NTERA-2: 45.2;RT4: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavourable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 14.5 17.3 0.1 0.0 15.1 0.2 0.1 0.0 0.1 0.8 0.6 0.6 0.6 0.2 0.1 20.3 0.0 0.0 0.6 3.0 0.2 0.2 4.9 0.2 0.2 1.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.2 1.4 45.2 0.1 2.6 9.5 0.6 7.5 12.9 4.1 1.5 0.1 0.2 7.7 5.6 1.0 0.3 1.4 1.2 0.1 0.5 0.2 0.2 0.3 0.2 0.7 5.3 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell line enhanced" "Detected in many" "AF22: 11.7;HUVEC TERT2: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavourable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favourable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.7 0.8 11.7 4.5 4.9 1.6 1.0 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.1 1.1 0.4 0.7 1.0 3.4 6.1 0.5 0.9 0.6 0.1 2.3 2.8 1.4 1.0 0.5 20.4 0.5 0.6 1.9 0.4 1.0 0.8 5.2 1.3 7.2 2.6 0.2 0.4 0.3 5.9 7.7 1.1 0.5 0.9 1.3 1.0 9.5 2.0 2.8 2.9 0.4 4.9 0.9 5.0 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 SENP7 ENSG00000138468 "SUMO1/sentrin specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027259 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA027259: AB_1856679" "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favourable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 17.0 9.0 11.0 19.1 14.5 19.5 16.5 35.5 19.5 21.7 13.1 11.8 8.2 6.4 24.3 15.2 11.9 18.6 12.8 10.0 13.2 9.1 10.5 7.7 11.5 19.0 12.9 10.8 27.9 15.9 22.4 24.4 17.0 18.7 15.1 10.0 9.2 10.2 11.1 11.1 18.6 13.8 16.0 17.3 14.1 13.6 7.9 16.8 32.1 16.0 9.4 15.4 17.2 14.0 6.8 3.2 24.5 4.1 6.2 7.6 3.8 6.9 4.7 23.4 12.9 4.5 6.9 4.3 4.1 3.0 6.8 8.4 3.1 6.5 5.4 6.3 3.9 7.1 7.3 3.7 13.7 10.0 2.1 9.8 3.7 4.2 3.7 5.6 9.6 5.2 6.8 3.4 7.8 9.7 8.0 13.9 6.4 4.6 10.3 6.6 4.8 5.1 11.6 6.2 4.9 8.1 4.1 9.1 7.0 3.8 3.8 5.1 6.3 7.6 7.9 9.5 5.8 3.1 4.0 9.9 5.9 12.7 3.3 7.5 7.7 24.5 4.1 3.8 4.2 3.6 5.2 4.2 5.6 4.2 3.2 6.8 7.6 5.1 12.6 6.2 3.8 2.8 4.5 3.8 11.0 14.5 35.5 19.5 13.2 9.1 12.9 10.8 18.7 16.8 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO/sentrin peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143688 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 2.5 4.8 6.4 3.4 8.1 5.0 4.4 5.7 8.0 4.0 4.0 3.9 6.4 3.8 3.9 6.7 4.8 5.1 4.2 7.7 7.3 6.9 9.3 5.0 3.3 3.1 6.2 7.7 5.3 6.2 3.9 12.7 3.7 8.0 5.9 4.3 4.2 5.6 6.6 11.0 3.5 3.3 4.2 5.0 3.1 4.3 26.5 4.3 2.2 12.0 4.5 2.7 4.9 3.0 3.0 5.7 2.1 5.6 7.1 3.7 2.1 1.9 3.2 6.3 5.0 7.6 9.2 3.5 5.0 3.1 3.0 2.8 2.7 4.5 1.9 7.4 3.2 4.5 9.6 7.7 4.4 2.1 5.3 3.0 4.5 2.2 5.3 3.6 1.7 4.5 7.8 1.9 8.4 2.8 4.6 3.6 7.1 4.9 3.6 4.7 5.0 3.3 2.4 5.4 4.0 7.9 3.4 7.7 2.5 5.3 4.4 5.2 6.7 2.7 2.9 6.1 2.2 10.1 2.5 3.0 3.6 2.3 2.9 5.0 4.3 2.1 1.9 1.4 1.6 3.9 2.3 3.0 2.8 2.5 5.7 1.4 3.1 3.7 0.7 7.1 5.6 1.7 2.1 2.1 6.4 8.1 5.7 8.0 7.3 6.9 6.2 7.7 8.0 4.3 SEPHS2 "SPS2, SPS2b" ENSG00000179918 "Selenophosphate synthetase 2" Q99611 16 30443631-30446181 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.8;liver: 111.2" "Cell line enhanced" "Detected in all" "HMC-1: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047931 Approved Approved Nucleoplasm Nucleoplasm "HPA047931: " "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (1.92e-2)" "unprognostic (9.85e-2)" "unprognostic (2.67e-2)" "unprognostic (6.29e-2)" "unprognostic (5.67e-2)" "unprognostic (7.69e-3)" "unprognostic (2.38e-1)" "unprognostic (9.86e-2)" "unprognostic (9.66e-3)" "unprognostic (1.49e-1)" "prognostic favourable (4.35e-8)" "unprognostic (2.24e-2)" "unprognostic (1.35e-1)" "unprognostic (3.25e-2)" "unprognostic (3.62e-2)" 9.0 9.0 4.9 6.9 6.4 4.0 6.7 6.3 8.4 5.3 25.6 5.2 5.5 26.6 7.6 6.1 6.0 6.1 12.6 5.3 5.2 5.1 32.8 111.2 5.8 7.6 5.5 3.8 5.2 10.0 7.3 6.4 7.5 7.7 6.6 13.1 6.2 10.6 4.7 11.1 5.5 52.8 4.9 4.4 10.5 12.1 3.0 4.6 14.1 11.9 6.4 9.5 8.1 4.4 14.6 15.3 20.5 13.7 23.2 18.9 8.9 14.5 13.2 4.7 16.2 14.4 9.2 12.3 10.1 12.5 9.9 12.3 8.1 11.1 20.9 15.6 10.6 8.1 8.6 9.2 10.1 13.3 26.6 20.9 7.1 38.2 18.2 11.6 94.5 11.7 19.7 9.3 17.4 9.1 16.8 13.6 8.8 21.5 17.4 23.9 11.6 9.9 17.0 8.2 16.0 12.2 13.1 9.9 8.5 8.6 25.3 32.7 22.2 38.7 7.6 10.4 7.4 10.0 6.0 11.8 18.8 10.9 9.0 21.6 11.5 6.1 12.9 20.5 11.2 11.2 17.1 12.4 15.9 16.1 15.3 14.6 18.9 12.9 12.9 23.2 13.7 10.9 15.1 8.9 4.9 6.4 6.3 8.4 5.2 5.1 5.5 3.8 7.7 4.6 SEPT2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" 8800000 "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favourable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavourable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 64.2 46.4 76.5 42.9 69.9 29.1 58.7 34.9 61.8 69.3 48.4 85.2 57.4 37.8 59.5 59.8 46.8 48.2 54.0 56.2 65.8 55.4 64.6 31.4 51.2 51.3 76.5 52.7 63.4 73.0 56.6 56.3 58.9 60.7 53.7 53.3 48.8 43.6 64.7 39.5 32.0 42.2 81.8 100.8 51.5 45.6 67.7 57.2 36.2 64.2 39.0 47.5 56.5 42.6 25.5 51.2 38.5 50.5 51.3 36.9 59.4 31.9 28.8 78.5 51.3 73.1 79.8 40.6 70.8 69.8 45.5 58.0 16.1 34.8 13.0 16.9 80.9 28.5 51.2 47.9 74.9 32.8 36.4 52.2 28.8 59.4 44.8 49.7 31.9 71.0 31.4 37.9 36.6 79.2 46.5 19.1 66.9 23.0 29.4 30.4 57.1 21.1 29.1 98.7 27.5 67.5 48.9 56.3 37.9 49.0 33.9 46.7 20.3 44.9 74.8 55.8 23.7 53.8 41.8 37.7 32.8 45.8 48.0 30.4 77.0 38.5 46.0 26.3 30.3 50.5 36.9 25.5 29.6 31.2 51.2 21.6 26.2 27.4 16.3 51.3 37.2 38.6 29.5 59.4 76.5 69.9 34.9 52.3 65.8 55.4 76.5 52.7 60.7 57.2 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell line enhanced" "Detected in many" "AF22: 13.5;SCLC-21H: 36.5" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavourable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.5 10.1 0.1 0.0 6.7 0.1 0.1 0.9 0.4 0.2 1.5 10.9 0.4 0.1 0.0 7.0 0.0 0.3 4.5 2.3 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.7 0.0 1.1 1.8 0.1 9.2 0.3 8.7 0.0 0.6 0.0 1.3 36.5 7.6 5.4 0.0 8.9 1.3 3.3 0.0 0.0 4.8 0.4 0.5 7.2 6.2 0.1 0.1 4.4 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell line enhanced" "Detected in many" "K-562: 65.7;THP-1: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: , HPA063885: " "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavourable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.0 12.0 18.5 1.1 3.9 0.1 4.6 5.8 5.2 3.0 0.2 1.6 0.4 1.8 10.2 1.7 8.7 1.7 2.6 3.1 1.0 0.2 0.6 0.0 4.8 0.2 12.7 5.2 2.1 1.7 0.7 2.1 65.7 0.1 8.1 1.2 1.3 7.3 1.6 3.2 13.3 0.3 2.0 0.3 0.4 19.2 15.6 0.6 0.9 0.8 4.8 21.1 0.8 13.7 18.4 0.5 0.9 1.3 0.0 0.1 1.7 0.6 4.4 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.5;HaCaT: 53.0;HBEC3-KT: 83.7;hTCEpi: 47.6;RT4: 57.3;SK-BR-3: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favourable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavourable (2.11e-4)" "prognostic unfavourable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 12.8 3.0 2.7 8.7 5.9 8.0 7.4 24.7 18.4 1.6 2.0 4.6 46.5 8.5 32.6 23.2 53.0 0.3 83.7 0.3 0.8 2.0 0.0 2.7 2.4 6.6 0.0 9.9 7.3 47.6 10.2 22.5 1.0 0.3 0.0 2.7 2.1 0.3 0.3 2.8 6.5 0.0 5.3 2.8 8.8 57.3 1.1 6.6 6.3 47.9 1.0 28.0 1.4 6.1 0.4 2.0 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.0 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell line enriched" "Detected in many" 8 "Hep G2: 20.7" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" 3955000000 5900000000 Nucleoplasm Cytosol "HPA048739: " "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favourable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.0 0.7 0.8 0.7 0.5 0.5 0.6 0.9 0.9 2.5 0.6 2.2 0.3 0.4 0.3 2.4 0.5 1.4 0.9 1.4 2.1 0.7 20.7 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.1 0.5 1.4 1.1 0.3 1.4 1.1 0.9 0.6 0.9 1.1 0.9 0.5 0.7 1.0 0.9 0.5 0.5 0.2 1.5 0.9 0.5 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SERPINB8 "CAP2, PI8" ENSG00000166401 "Serpin family B member 8" P50452 18 63969925-64019779 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.6" "Cell line enhanced" "Detected in many" "HL-60: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB034300 Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB034300: AB_2186486" "unprognostic (8.49e-2)" "unprognostic (4.87e-2)" "unprognostic (4.10e-3)" "unprognostic (2.86e-2)" "unprognostic (1.52e-2)" "unprognostic (7.71e-2)" "unprognostic (4.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.58e-3)" "unprognostic (1.50e-1)" "prognostic unfavourable (3.31e-5)" "unprognostic (8.73e-2)" "unprognostic (3.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.90e-1)" 12.4 7.4 2.9 9.3 4.2 16.0 6.1 1.3 5.5 7.7 7.4 7.1 0.0 3.7 4.1 4.3 20.6 3.7 13.7 4.5 3.1 3.3 7.1 23.7 8.2 10.1 4.7 4.0 8.1 4.2 1.1 5.0 9.5 7.4 4.2 6.1 3.4 8.1 2.1 4.5 36.6 8.7 4.4 6.0 9.8 4.2 2.9 3.5 4.2 5.0 17.5 11.3 9.6 11.0 5.1 25.3 5.9 20.5 2.1 4.2 5.0 7.4 1.5 1.3 9.2 4.6 6.5 0.6 24.3 23.6 15.4 15.4 0.3 3.4 0.1 8.9 14.5 12.2 0.2 15.4 22.1 10.3 0.3 0.0 2.8 0.8 10.5 37.3 3.2 6.2 13.4 20.8 6.8 16.4 0.2 4.3 10.6 0.6 0.6 4.1 0.5 7.5 0.5 3.4 0.6 6.9 8.5 0.7 0.7 4.8 0.7 8.9 0.3 14.0 25.4 23.6 5.0 2.8 9.7 1.9 0.3 0.0 24.2 21.7 20.3 1.1 20.5 0.8 3.8 16.1 3.4 3.6 3.1 2.3 25.3 5.1 1.7 2.6 5.9 2.1 8.0 13.7 4.2 5.0 2.9 4.2 1.3 5.5 3.1 3.3 4.7 4.0 7.4 3.5 SERPINB9 "CAP3, PI9" ENSG00000170542 "Serpin family B member 9" P50453 6 2887266-2903280 "Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.0;lymphoid tissue: 39.6" "Cell line enhanced" "Detected in many" "BEWO: 66.8;HUVEC TERT2: 14.6;TIME: 15.2;U-266/84: 13.7;U-698: 28.7" "Cancer enhanced" "Detected in all" "testis cancer: 46.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030067 Uncertain Approved Nucleoplasm,Cytosol 4900000 Nucleoplasm Cytosol "HPA030067: " "unprognostic (6.82e-3)" "unprognostic (8.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-1)" "unprognostic (4.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" "unprognostic (9.48e-2)" "unprognostic (2.12e-2)" "unprognostic (3.83e-3)" "unprognostic (1.06e-1)" "unprognostic (9.85e-2)" "prognostic unfavourable (1.66e-6)" "unprognostic (9.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-2)" 5.6 5.1 3.3 15.9 4.1 7.2 2.6 3.6 6.7 3.9 2.1 4.4 1.3 1.7 1.9 1.9 4.6 4.1 5.3 4.9 3.4 3.6 2.5 7.6 13.7 39.6 4.8 3.9 3.8 1.3 4.7 4.9 24.5 4.7 2.6 2.9 3.5 7.5 1.3 2.0 1.0 5.5 2.4 7.1 14.4 2.0 4.4 2.0 6.4 4.2 2.1 18.9 3.4 3.8 10.3 6.4 2.9 38.0 18.8 17.9 12.3 0.0 2.8 0.1 0.0 0.2 0.1 66.8 0.5 0.1 0.6 1.0 0.8 5.4 10.9 6.8 0.6 0.0 8.0 0.0 0.6 3.5 0.8 1.0 1.0 1.5 3.9 0.0 0.0 3.0 0.0 1.2 0.0 14.6 4.9 0.1 0.5 0.2 0.0 0.0 9.3 0.0 1.0 0.0 0.1 0.4 0.0 0.4 0.1 6.5 0.0 0.0 0.0 0.1 15.2 0.0 0.1 0.0 0.0 0.0 13.7 28.7 0.0 0.0 0.0 1.7 18.3 0.1 17.9 38.0 14.7 8.3 13.0 16.8 6.1 10.3 12.1 17.5 2.9 18.8 22.0 6.4 13.0 12.3 3.3 4.1 3.6 6.7 3.4 3.6 4.8 3.9 4.7 2.0 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421592-40426025 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA063323: " "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 17.3 10.6 5.7 11.3 6.2 30.4 9.6 4.4 9.0 11.4 10.8 5.3 5.3 7.9 10.7 4.4 18.2 13.1 16.1 13.8 8.0 5.4 10.3 14.3 20.8 7.9 8.1 2.8 10.3 17.3 2.8 7.3 19.5 10.3 15.3 3.9 5.8 10.0 6.8 11.4 10.9 13.7 8.4 6.3 8.9 14.2 5.5 8.6 6.6 19.1 23.7 10.0 10.5 18.9 10.6 20.2 14.4 17.2 12.1 10.5 9.7 11.4 13.5 1.9 4.7 5.5 3.9 5.3 18.4 5.6 10.0 9.9 6.0 9.3 2.3 8.8 6.1 4.7 1.5 16.6 3.1 6.3 3.3 2.0 3.3 5.1 6.2 0.7 7.2 6.3 10.2 10.9 2.0 5.6 4.1 3.6 9.0 17.1 1.0 3.7 1.5 9.1 1.4 3.1 5.7 5.2 8.0 0.6 0.9 9.7 9.1 8.9 9.0 1.9 10.2 10.0 11.2 8.0 12.2 5.3 2.2 3.0 13.9 3.0 4.6 14.4 17.2 11.0 8.1 14.9 4.8 10.4 8.0 7.6 20.2 10.6 9.4 6.5 13.9 12.1 14.0 18.4 10.5 9.7 5.7 6.2 4.4 9.0 8.0 5.4 8.1 2.8 10.3 8.6 SESN3 "MGC29667, SEST3" ENSG00000149212 "Sestrin 3" P58005 11 95165513-95232541 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 14.6;ASC diff: 24.8;ASC TERT1: 27.1;HSkMC: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037935 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA037935: AB_10670534" "unprognostic (2.72e-2)" "unprognostic (3.06e-1)" "unprognostic (2.67e-1)" "unprognostic (8.09e-3)" "unprognostic (5.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (8.19e-3)" "unprognostic (1.38e-1)" "unprognostic (3.78e-1)" "unprognostic (2.34e-3)" "unprognostic (4.43e-2)" "unprognostic (1.67e-3)" "unprognostic (1.69e-1)" "unprognostic (1.96e-1)" "unprognostic (1.76e-2)" "unprognostic (9.42e-2)" 7.3 14.2 22.3 10.4 38.6 11.9 11.6 10.2 20.8 10.3 6.8 11.1 3.3 5.2 9.3 11.7 7.6 7.0 9.9 5.1 15.9 12.9 8.7 6.0 7.2 17.3 12.6 12.0 18.4 3.3 27.7 10.7 6.6 13.9 8.5 5.4 19.7 9.1 4.8 5.4 8.4 10.6 7.6 11.6 12.7 3.9 41.6 14.1 11.3 17.3 4.0 18.3 10.0 7.7 4.2 1.1 1.0 3.5 0.8 4.5 0.8 0.0 0.5 14.6 0.0 24.8 27.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 3.8 1.7 0.0 2.9 8.8 6.3 0.0 3.1 4.6 1.9 7.7 0.5 0.5 1.6 0.3 14.9 11.1 0.0 3.3 0.5 0.2 0.7 1.2 0.1 1.2 4.5 5.9 0.6 2.8 0.9 0.3 3.3 9.6 1.9 4.1 0.1 0.1 0.8 0.0 5.5 0.1 1.7 3.8 0.3 0.5 0.1 0.0 0.5 0.7 2.0 3.5 1.0 0.8 0.6 0.7 1.7 0.8 4.2 2.3 1.3 0.7 2.7 4.5 1.7 0.8 0.8 3.5 1.1 4.0 0.8 22.3 38.6 10.2 20.8 15.9 12.9 12.6 12.0 13.9 14.1 SETD9 "C5orf35, MGC33648" ENSG00000155542 "SET domain containing 9" Q8NE22 5 56909260-56925532 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049936 Approved Nucleoplasm Nucleoplasm "HPA049936: " "unprognostic (1.13e-1)" "unprognostic (3.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-1)" "unprognostic (2.29e-1)" "unprognostic (7.37e-2)" "unprognostic (8.75e-3)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-2)" "unprognostic (1.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" 7.2 2.6 2.3 1.2 4.4 2.4 11.1 1.4 5.2 2.6 4.4 4.7 4.6 4.4 2.7 2.5 2.4 1.9 2.1 7.0 2.1 2.4 5.4 8.8 2.4 5.3 5.3 3.8 2.6 7.3 2.4 2.0 2.6 3.7 4.3 3.3 2.8 5.3 1.2 4.1 1.9 5.2 4.4 3.6 1.8 2.7 23.8 3.2 1.1 4.4 3.4 2.0 2.9 8.1 1.1 2.0 4.3 3.0 1.6 2.9 0.8 4.8 1.8 3.0 3.8 4.6 2.5 5.2 1.4 2.2 2.4 6.1 4.5 5.6 4.5 7.0 2.1 4.5 3.2 1.8 6.2 3.1 6.7 1.2 1.5 3.7 1.8 1.4 4.2 1.2 2.5 2.2 3.2 3.9 3.7 3.2 5.5 7.1 0.7 3.4 4.6 7.2 4.6 1.9 5.9 2.6 1.7 3.4 5.4 1.2 3.5 5.9 5.5 3.4 4.2 1.6 7.3 4.5 3.0 3.3 9.5 7.4 2.1 1.3 0.7 1.4 2.3 4.3 1.4 2.0 1.3 0.5 1.6 0.4 2.0 1.1 0.5 0.6 2.7 1.6 3.0 0.8 2.9 0.8 2.3 4.4 1.4 5.2 2.1 2.4 5.3 3.8 3.7 3.2 SETDB2 "C13orf4, CLLD8, CLLL8, KMT1F" ENSG00000136169 "SET domain bifurcated 2" Q96T68 13 49444374-49495003 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012190, HPA071677" Approved Approved Nucleoplasm Nucleoplasm "CAB012190: AB_2186195, HPA071677: " "unprognostic (1.77e-1)" "unprognostic (1.11e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-2)" "unprognostic (4.20e-1)" "unprognostic (3.70e-3)" "unprognostic (3.74e-2)" "unprognostic (3.44e-3)" "unprognostic (7.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.09e-3)" "unprognostic (7.95e-2)" "prognostic favourable (1.92e-7)" "unprognostic (2.83e-2)" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.85e-1)" 10.2 14.5 9.8 20.5 10.8 9.5 14.1 14.4 12.3 13.0 12.4 8.3 13.6 7.8 13.1 11.6 9.8 9.9 9.7 12.7 8.2 6.9 12.4 11.0 16.3 19.0 7.2 11.1 21.0 15.0 10.8 15.8 7.8 9.5 13.6 11.9 13.5 11.7 10.9 5.5 9.6 11.4 11.3 8.4 19.0 10.7 18.1 8.7 17.3 14.6 3.7 16.6 11.9 10.3 8.4 7.4 4.7 5.4 7.8 10.2 4.5 2.0 1.3 4.2 4.3 6.0 6.7 2.1 5.8 7.3 5.2 4.9 8.5 4.9 25.1 1.1 3.7 4.2 4.4 3.9 5.1 5.7 3.9 8.7 3.8 5.1 8.4 13.3 5.0 5.2 7.2 4.0 13.1 4.4 3.8 3.5 4.7 1.7 5.0 9.9 2.2 3.4 9.8 5.3 5.3 4.8 1.9 2.1 2.5 2.5 3.6 12.4 3.0 11.5 2.6 5.0 1.8 6.6 2.3 4.3 5.8 13.3 1.5 10.8 2.3 4.1 4.1 4.7 6.9 5.4 5.8 8.4 7.1 7.1 7.4 8.1 10.2 7.6 1.4 7.8 4.3 5.2 9.4 4.5 9.8 10.8 14.4 12.3 8.2 6.9 7.2 11.1 9.5 8.7 SF3A2 "Prp11, PRPF11, SAP62, SF3a66" ENSG00000104897 "Splicing factor 3a subunit 2" Q15428 19 2236504-2248679 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042843, HPA049439" Enhanced Approved Nucleoplasm Nucleoplasm "HPA042843: AB_2678199, HPA049439: AB_2680766" "unprognostic (5.29e-2)" "prognostic favourable (7.16e-4)" "prognostic unfavourable (8.64e-4)" "unprognostic (3.09e-3)" "unprognostic (9.19e-2)" "unprognostic (7.98e-2)" "prognostic unfavourable (3.23e-5)" "unprognostic (1.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.71e-1)" "unprognostic (5.72e-3)" "unprognostic (7.94e-2)" "prognostic unfavourable (2.07e-4)" "unprognostic (4.09e-3)" "unprognostic (5.38e-2)" "unprognostic (2.85e-1)" "unprognostic (8.73e-2)" 21.1 12.0 12.1 27.1 16.6 35.7 21.3 25.7 22.3 29.2 19.7 20.5 13.2 29.7 32.5 18.2 22.4 23.7 19.5 13.8 10.9 9.0 15.7 13.5 17.4 28.7 13.5 13.1 39.3 25.1 7.5 17.7 24.9 12.1 22.9 7.0 18.4 29.9 21.6 24.8 36.0 26.0 22.8 12.8 27.9 21.0 45.3 14.6 54.2 19.6 20.3 27.0 30.3 24.2 3.4 4.2 9.3 4.3 2.1 5.5 2.8 25.8 11.4 15.7 15.7 4.6 6.9 27.3 9.0 8.3 14.5 13.9 16.6 9.1 28.2 10.6 7.3 20.8 15.3 11.6 3.1 21.6 23.3 18.0 11.3 13.6 12.3 22.5 23.4 9.6 10.4 12.5 9.8 14.2 21.3 26.7 5.3 14.1 29.2 21.8 31.0 9.6 49.4 8.9 24.5 6.2 7.6 19.3 32.0 13.7 10.6 11.5 14.8 25.8 14.0 15.1 16.6 31.3 28.5 29.8 29.4 28.2 11.0 17.5 14.9 1.2 2.9 9.3 5.1 4.3 3.5 2.8 3.9 5.5 2.9 3.4 3.5 3.1 2.9 2.1 2.8 4.2 4.6 2.8 12.1 16.6 25.7 19.6 10.9 9.0 13.5 13.1 12.1 14.6 SF3A3 "PRP9, PRPF9, SAP61, SF3a60" ENSG00000183431 "Splicing factor 3a subunit 3" Q12874 1 37956975-37990921 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032054, HPA032055" Supported Supported "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA032054: AB_10602184, HPA032055: " "unprognostic (1.56e-1)" "unprognostic (1.21e-1)" "unprognostic (7.08e-3)" "unprognostic (6.19e-3)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "prognostic unfavourable (2.11e-8)" "unprognostic (1.34e-1)" "unprognostic (2.74e-2)" "unprognostic (5.74e-3)" "unprognostic (9.18e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (2.52e-3)" "unprognostic (8.39e-2)" "unprognostic (2.24e-1)" "unprognostic (3.68e-2)" 7.0 6.4 5.3 6.3 5.9 13.6 7.6 7.4 5.5 6.3 6.5 4.3 9.4 8.7 6.8 7.7 4.1 4.3 4.8 4.9 5.9 6.2 6.1 8.4 5.3 8.7 6.7 6.4 5.7 5.6 6.1 7.2 5.9 7.2 15.3 7.7 5.9 7.7 4.3 7.9 6.2 5.8 6.3 10.3 6.2 6.1 23.6 19.0 10.6 20.6 18.7 27.8 20.6 15.7 12.0 21.7 18.5 13.6 12.6 26.3 15.4 14.1 27.0 21.9 19.7 16.7 29.9 13.5 14.9 13.6 27.6 22.4 33.2 13.6 26.9 38.0 19.2 17.0 12.5 46.2 18.4 11.9 15.7 28.0 18.5 18.7 33.4 11.8 19.5 10.5 24.3 26.7 53.6 18.7 29.1 37.3 21.5 12.4 16.4 19.0 14.1 19.7 9.2 16.2 10.9 18.3 16.8 14.2 15.6 13.0 30.5 11.4 16.1 30.5 13.6 42.6 17.6 10.6 15.3 9.8 21.8 18.9 21.2 20.4 25.8 22.0 19.0 23.6 27.8 23.6 2.0 18.7 20.6 11.8 26.3 20.6 SFSWAP "SFRS8, SWAP" ENSG00000061936 "Splicing factor SWAP" Q12872 12 131711081-131799737 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039362, HPA040063" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039362: AB_10794089, HPA040063: AB_10795413" "unprognostic (1.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.39e-3)" "unprognostic (2.04e-1)" "unprognostic (4.45e-2)" "unprognostic (2.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.31e-1)" "prognostic unfavourable (1.10e-4)" "unprognostic (3.44e-1)" "unprognostic (1.50e-2)" "unprognostic (3.30e-2)" "prognostic unfavourable (3.33e-8)" "unprognostic (7.50e-2)" "unprognostic (2.93e-2)" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" 20.2 15.0 17.7 23.2 24.0 47.1 17.9 31.1 23.8 16.6 15.7 31.1 11.6 20.4 25.7 15.1 15.7 15.7 16.5 11.9 20.5 15.9 15.7 12.3 16.4 20.7 27.0 17.2 21.4 19.8 19.5 18.0 16.6 16.6 14.7 9.9 16.9 22.1 15.5 27.4 30.0 19.0 17.3 21.1 23.7 18.4 17.5 26.4 21.9 17.1 15.9 16.8 16.7 20.5 6.6 11.0 8.5 6.4 8.4 5.5 2.6 13.7 12.4 8.8 9.3 7.1 5.9 19.8 10.7 7.4 12.7 8.7 12.1 6.7 16.9 10.0 7.9 12.9 12.4 9.8 7.4 5.2 19.5 15.3 6.7 14.1 7.6 19.7 15.2 6.6 11.3 11.4 13.8 7.8 21.2 6.7 5.6 17.2 16.6 30.0 23.0 20.7 19.4 8.9 13.3 7.3 10.1 13.8 15.6 10.1 8.5 12.7 12.3 15.5 10.0 10.5 13.8 8.1 11.8 19.3 21.0 17.1 10.4 13.6 14.0 3.0 6.4 2.6 5.2 4.4 5.0 3.5 4.6 4.2 4.5 6.6 4.9 5.5 8.5 8.4 5.0 11.0 3.8 2.6 17.7 24.0 31.1 23.8 20.5 15.9 27.0 17.2 16.6 26.4 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342591 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavourable (7.47e-4)" "prognostic unfavourable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavourable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favourable (5.90e-4)" "unprognostic (2.75e-2)" 21.1 24.6 33.6 21.7 31.8 16.4 24.5 15.6 25.0 20.2 27.9 43.4 23.4 23.5 14.7 37.0 19.6 18.8 18.6 15.6 34.9 26.2 27.6 12.5 27.2 23.9 43.9 18.6 18.3 32.6 13.4 11.8 25.9 27.8 27.3 26.8 15.0 38.0 19.4 11.2 12.5 24.9 16.0 61.2 24.6 27.6 18.3 32.8 20.6 24.9 15.3 23.7 17.1 16.1 25.5 57.6 50.1 30.1 14.9 21.7 24.2 13.2 13.0 10.6 22.2 19.5 17.4 16.7 20.6 17.8 14.6 22.1 27.0 27.3 11.7 15.8 16.9 16.2 15.5 17.0 22.3 16.2 28.3 13.8 10.9 37.9 17.6 34.9 28.2 16.3 20.2 16.8 14.7 7.8 25.6 11.8 22.5 21.4 10.2 59.7 10.4 12.7 7.2 12.3 27.4 35.7 13.9 2.0 9.3 14.1 23.1 18.4 12.5 63.3 7.2 9.1 17.6 24.2 21.4 11.3 8.2 12.8 19.4 22.0 22.3 29.5 28.5 34.7 18.1 28.1 11.3 25.5 14.7 15.1 30.4 21.2 15.9 15.9 50.1 14.9 30.1 57.6 21.7 24.2 33.6 31.8 15.6 25.0 34.9 26.2 43.9 18.6 27.8 32.8 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: " "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favourable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.3 11.6 8.9 2.8 1.8 4.2 6.9 3.9 11.0 5.8 11.2 8.7 2.0 7.2 7.2 3.0 9.0 9.9 5.2 8.3 5.8 8.4 7.2 14.7 3.5 4.3 9.2 4.8 2.7 7.7 0.9 6.4 7.3 1.7 2.9 6.6 1.2 6.5 14.3 4.7 8.0 9.6 2.5 6.4 8.0 7.5 2.1 6.4 3.3 2.6 1.7 2.2 4.6 3.3 11.0 4.7 7.9 3.0 2.9 2.4 11.5 7.9 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 SGCE DYT11 ENSG00000127990 "Sarcoglycan epsilon" O43556 7 94524204-94656572 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 2.9;memory B-cell: 6.4;naive B-cell: 9.2" "Group enriched" "Detected in many" 4 "B-cells: 9.2;T-cells: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074790 Approved "Nucleoplasm,Golgi apparatus,Vesicles,Plasma membrane" 50000 "Vesicles, Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA074790: " "unprognostic (3.16e-3)" "unprognostic (9.06e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-3)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.61e-5)" "unprognostic (1.19e-2)" "unprognostic (2.82e-2)" "unprognostic (6.93e-2)" "unprognostic (3.37e-1)" "unprognostic (6.80e-3)" "unprognostic (9.69e-2)" "unprognostic (5.71e-2)" "prognostic unfavourable (1.35e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" 22.4 35.7 16.9 7.5 19.0 0.6 23.2 23.6 18.5 22.5 20.5 16.8 14.0 5.3 23.6 16.8 11.1 17.1 19.0 19.3 17.7 14.3 12.9 8.9 17.3 9.0 21.5 12.9 59.3 12.9 8.7 23.1 31.9 15.0 15.6 9.7 11.2 11.9 22.7 6.1 3.5 8.0 28.1 20.9 15.8 11.2 13.2 17.5 2.9 15.4 6.9 4.4 22.7 16.1 9.2 0.3 0.6 0.1 1.4 2.9 0.5 3.8 12.0 12.2 19.7 19.4 36.5 2.2 14.5 29.3 12.4 18.8 7.5 22.8 3.6 20.7 25.6 2.5 18.3 6.4 16.9 0.6 9.9 0.3 11.8 8.1 15.2 1.1 0.0 29.4 9.0 18.2 23.8 8.7 0.0 28.8 14.4 12.0 0.0 0.0 9.3 9.5 5.4 15.1 7.6 24.0 3.8 7.7 6.2 0.0 16.1 18.4 5.6 0.1 0.0 39.2 13.1 3.6 22.4 14.9 18.5 4.4 14.6 0.0 22.0 0.6 0.1 0.1 2.9 0.1 1.2 6.4 0.9 1.4 0.1 9.2 0.3 1.0 0.5 1.4 0.1 0.3 0.2 0.5 16.9 19.0 23.6 18.5 17.7 14.3 21.5 12.9 15.0 17.5 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA052590: , HPA053608: " "unprognostic (1.38e-2)" "prognostic favourable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favourable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favourable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 11.1 11.4 7.9 11.8 12.5 9.9 15.5 20.9 11.0 19.5 17.1 10.6 16.9 11.6 21.4 10.2 9.0 17.6 11.1 10.7 7.9 6.8 9.8 12.9 11.1 17.2 16.5 7.1 31.5 17.7 8.6 9.4 8.4 10.8 13.1 6.9 12.1 14.8 20.0 36.1 12.2 13.4 21.4 13.4 11.6 13.5 35.6 14.4 17.6 19.5 9.0 10.4 17.1 25.1 25.4 27.6 18.8 18.2 19.5 36.1 20.4 6.9 11.9 9.1 5.9 6.3 6.2 16.6 4.7 5.4 12.5 11.8 13.6 6.3 21.2 11.9 3.7 8.3 7.0 8.3 3.5 6.8 13.2 13.1 7.3 18.1 15.5 11.7 14.8 6.6 11.4 7.4 7.6 4.6 11.0 10.8 4.4 23.4 13.3 23.1 12.6 11.6 20.8 5.9 18.3 6.2 10.6 14.8 6.8 7.4 14.1 7.9 11.6 9.7 3.2 8.7 7.4 5.0 8.3 12.6 18.3 12.3 6.2 19.9 6.9 5.0 18.2 18.8 22.3 15.6 26.9 22.2 31.2 27.2 18.3 25.4 36.1 27.8 5.6 19.5 12.5 27.6 29.6 20.4 7.9 12.5 20.9 11.0 7.9 6.8 16.5 7.1 10.8 14.4 SGK3 "SGK2, SGKL" ENSG00000104205 "Serum/glucocorticoid regulated kinase family member 3" Q96BR1 8 66667596-66862022 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006699, HPA027146" Supported Supported Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA006699: , HPA027146: AB_1856745" "prognostic favourable (5.52e-6)" "prognostic favourable (8.28e-4)" "unprognostic (8.52e-3)" "unprognostic (1.10e-2)" "unprognostic (3.75e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-1)" "unprognostic (1.69e-3)" "unprognostic (9.51e-2)" "unprognostic (8.86e-3)" "prognostic favourable (9.65e-4)" "unprognostic (1.94e-2)" "unprognostic (8.95e-2)" "unprognostic (4.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (5.29e-3)" 6.5 5.9 13.9 8.7 20.9 7.7 23.9 9.8 14.8 12.0 10.0 24.0 8.7 8.6 8.0 10.3 7.6 7.8 7.8 5.4 16.1 10.2 14.9 13.6 9.9 8.5 28.8 9.3 9.8 15.6 29.2 14.8 5.9 14.6 7.8 10.7 17.2 7.0 7.7 6.1 12.4 10.8 6.0 32.8 8.2 7.2 8.9 21.9 8.3 17.3 4.3 6.8 6.1 8.0 5.8 13.8 21.4 15.7 6.9 13.3 8.0 11.4 2.9 0.5 1.8 3.5 6.8 6.5 7.3 6.9 4.0 4.2 5.2 7.7 8.6 1.8 8.0 3.7 6.0 4.3 5.0 4.8 10.2 7.8 2.1 5.1 3.5 7.0 9.3 3.3 3.8 1.9 6.7 6.4 1.5 4.2 7.6 1.8 5.5 4.3 1.6 4.0 9.7 4.3 5.8 5.4 2.6 2.5 1.9 3.3 4.9 11.0 23.1 14.0 7.6 3.8 3.4 3.3 2.7 5.2 9.9 9.9 4.4 11.8 3.9 21.4 15.7 6.2 8.1 9.3 13.3 3.7 8.4 8.5 13.8 5.8 9.0 6.9 2.5 6.9 4.4 7.7 5.3 8.0 13.9 20.9 9.8 14.8 16.1 10.2 28.8 9.3 14.6 21.9 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: " "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.2 6.2 5.7 2.0 2.5 4.5 0.8 0.4 2.1 1.9 6.2 0.7 7.1 0.9 2.9 3.1 4.6 2.5 2.7 4.0 6.8 7.4 4.0 3.6 0.2 9.9 5.2 1.2 7.4 7.5 4.2 2.3 7.1 0.6 1.3 7.2 2.5 6.6 6.2 1.0 7.2 8.8 4.7 1.2 6.8 3.8 3.5 4.4 2.4 3.7 3.7 5.5 3.1 4.2 3.6 4.2 5.0 3.9 3.6 8.6 3.1 7.3 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favourable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 15.8 7.5 2.2 4.9 8.0 10.6 10.4 10.6 10.7 7.5 7.0 6.2 16.5 11.7 6.2 13.9 10.1 5.2 11.1 7.8 10.2 5.5 16.9 10.1 4.8 9.3 3.8 4.2 6.8 13.1 9.9 12.1 10.5 32.5 17.7 8.0 6.7 1.7 2.2 5.0 7.2 2.8 10.2 4.5 10.9 16.8 3.4 2.7 7.7 7.8 4.0 11.7 1.4 14.6 8.1 9.9 7.7 7.7 6.0 4.7 3.3 10.1 6.4 6.6 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 SGSM2 "KIAA0397, RUTBC1" ENSG00000141258 "Small G protein signaling modulator 2" O43147 17 2337498-2381058 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 8.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021641, HPA024553" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021641: AB_2188702, HPA024553: AB_1856512" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-2)" "unprognostic (4.88e-2)" "prognostic favourable (3.11e-4)" "unprognostic (1.49e-1)" "unprognostic (7.84e-2)" "unprognostic (7.63e-2)" "unprognostic (1.90e-1)" "prognostic favourable (9.00e-6)" "unprognostic (2.78e-2)" "unprognostic (8.27e-2)" "unprognostic (1.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-2)" 11.1 15.3 51.8 13.3 45.8 17.3 15.9 14.4 43.7 11.6 12.1 12.6 14.9 10.8 13.3 38.6 16.5 12.7 15.1 12.3 43.2 24.9 12.6 6.6 14.7 15.4 13.9 34.8 11.3 14.8 25.4 30.7 11.1 18.9 20.6 7.4 13.6 23.0 18.1 13.4 23.0 13.0 14.2 13.7 16.6 14.2 10.0 17.6 9.4 15.7 6.0 10.8 16.1 10.9 0.6 0.9 8.6 0.4 1.3 2.1 0.7 10.1 15.7 14.4 20.0 8.2 9.9 21.4 8.8 10.4 12.3 12.5 15.8 19.6 4.9 9.6 12.8 14.4 8.8 10.4 4.3 7.2 18.0 8.6 23.8 16.7 7.0 5.1 13.0 10.6 6.9 12.4 7.2 12.7 5.1 7.4 7.3 21.6 10.9 6.9 7.0 6.9 24.0 7.3 3.9 15.8 21.4 7.0 16.6 11.0 8.3 6.6 21.5 6.2 14.8 9.9 11.3 14.5 11.6 6.1 0.9 4.5 8.6 6.8 8.7 8.6 0.4 2.1 1.7 0.3 1.5 0.1 0.7 1.0 0.7 0.6 2.1 1.1 0.2 1.3 0.0 0.9 1.0 0.7 51.8 45.8 14.4 43.7 43.2 24.9 13.9 34.8 18.9 17.6 SGTA SGT ENSG00000104969 "Small glutamine rich tetratricopeptide repeat containing alpha" O43765 19 2754714-2783371 "Predicted intracellular proteins" "Host-virus interaction" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056309 Approved Approved Nucleoplasm 20000 Nucleoplasm "HPA056309: " "unprognostic (2.31e-2)" "prognostic favourable (9.70e-4)" "unprognostic (1.13e-1)" "prognostic favourable (1.04e-4)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" "unprognostic (2.52e-3)" "unprognostic (1.47e-1)" "unprognostic (7.23e-2)" "unprognostic (1.97e-1)" "unprognostic (7.58e-3)" "unprognostic (2.89e-2)" "prognostic favourable (2.35e-4)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.04e-1)" "unprognostic (3.04e-1)" 19.1 18.6 28.6 16.7 28.8 27.3 15.7 25.8 44.4 17.3 19.3 46.8 21.1 26.8 18.7 18.9 23.9 23.9 16.0 44.6 30.6 24.7 21.6 29.5 15.6 18.9 28.8 27.0 30.2 41.8 14.9 23.9 30.4 27.0 20.4 11.4 22.2 31.9 22.4 62.9 16.2 24.0 18.4 35.7 20.9 19.6 28.9 21.0 33.2 25.0 18.6 15.9 16.6 19.7 16.4 22.5 22.9 29.7 19.6 23.1 19.0 28.2 23.3 21.4 20.4 8.8 9.3 17.7 19.1 13.8 29.5 25.3 37.0 12.8 26.5 15.5 14.9 20.3 27.0 30.0 11.6 0.1 24.0 15.0 12.2 27.1 21.2 20.5 17.3 15.3 16.1 22.1 19.8 19.8 38.8 22.3 14.7 17.1 31.3 22.3 37.0 22.5 39.4 19.3 30.0 15.7 17.5 40.0 30.9 14.7 21.0 27.3 24.9 24.6 16.4 19.0 19.6 36.3 34.4 38.7 38.4 31.7 24.5 42.7 29.4 13.4 21.1 20.6 18.5 26.0 21.0 16.4 19.4 20.1 22.5 15.0 15.7 15.4 22.9 19.6 29.7 19.4 23.1 19.0 28.6 28.8 25.8 44.4 30.6 24.7 28.8 27.0 27.0 21.0 SH2B3 "IDDM20, LNK" ENSG00000111252 "SH2B adaptor protein 3" Q9UQQ2 12 111405948-111451623 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.8;hTEC/SVTERT24-B: 36.4;U-87 MG: 55.3;WM-115: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005483 Approved Approved Nucleoplasm Nucleoplasm "HPA005483: AB_1079260" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.09e-2)" "unprognostic (1.23e-1)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (4.65e-2)" "unprognostic (8.17e-3)" "unprognostic (9.08e-2)" "prognostic unfavourable (6.20e-4)" "unprognostic (2.86e-1)" "unprognostic (3.89e-3)" "unprognostic (1.11e-1)" "unprognostic (2.24e-2)" 17.6 9.0 7.9 13.7 7.9 34.4 19.8 3.8 9.3 8.9 7.5 7.2 3.1 5.3 8.0 7.1 5.6 7.5 12.7 15.3 5.8 5.5 9.2 12.5 17.6 27.8 6.6 4.0 8.2 11.0 4.7 7.6 16.1 5.2 8.4 9.3 8.7 5.0 4.2 10.2 3.6 10.3 9.1 7.8 31.7 5.5 13.3 6.8 9.5 10.2 3.2 11.8 10.0 5.8 1.8 6.1 3.8 10.3 2.3 1.7 1.9 2.2 1.3 1.8 1.8 6.3 9.5 1.2 7.4 20.3 5.7 6.1 2.1 1.3 3.9 5.3 11.2 0.4 1.4 4.2 9.2 3.2 0.6 13.2 0.6 1.5 6.2 5.8 31.8 5.6 0.9 36.4 3.3 30.4 9.5 1.5 20.6 0.8 2.3 11.6 2.8 5.4 2.3 4.1 2.5 2.7 0.9 1.2 1.2 1.3 0.1 10.6 0.9 8.3 23.5 5.2 2.9 4.5 12.0 3.6 3.7 4.4 55.3 4.2 42.2 1.1 4.3 1.5 1.6 10.3 1.4 1.8 1.4 1.7 5.9 0.7 1.0 1.3 3.8 2.3 7.6 6.1 0.5 1.9 7.9 7.9 3.8 9.3 5.8 5.5 6.6 4.0 5.2 6.8 SH2D3A NSP1 ENSG00000125731 "SH2 domain containing 3A" Q9BRG2 19 6752160-6767588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.5;HaCaT: 15.9;HBEC3-KT: 30.6;SK-BR-3: 15.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA035722, HPA064382" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA035722: AB_10670024, HPA064382: " "unprognostic (3.32e-2)" "unprognostic (5.48e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.96e-1)" "unprognostic (2.60e-3)" "unprognostic (3.63e-1)" "unprognostic (8.41e-2)" "unprognostic (6.48e-3)" "prognostic unfavourable (6.21e-4)" "prognostic favourable (1.42e-4)" "unprognostic (7.31e-2)" "unprognostic (1.74e-1)" "unprognostic (1.32e-3)" "unprognostic (1.81e-3)" 0.5 0.2 0.4 9.2 0.9 1.9 5.3 0.6 0.5 4.7 19.7 0.5 8.7 10.9 3.8 6.7 20.0 3.0 15.8 0.4 0.4 0.0 9.6 1.7 13.4 5.4 0.6 0.4 1.1 18.8 4.9 3.4 14.3 0.9 11.0 4.3 1.6 24.0 13.3 0.8 15.3 18.0 2.2 1.0 3.8 11.0 2.5 0.4 5.0 10.9 11.0 17.2 9.0 9.4 5.6 0.4 0.0 0.1 1.9 9.2 1.0 18.5 2.7 0.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 6.7 14.4 2.9 8.5 0.0 15.9 1.1 30.6 0.0 1.3 2.7 0.1 2.3 1.0 0.0 0.2 4.0 0.0 12.8 0.0 3.1 0.0 3.1 7.0 0.0 6.5 1.3 0.0 0.6 5.3 0.5 0.0 11.3 5.5 11.8 0.0 0.0 1.0 15.4 0.0 10.3 0.1 0.3 0.3 1.0 0.2 0.1 6.1 6.6 3.5 0.1 2.0 0.1 0.0 0.0 0.0 3.0 0.1 5.2 3.9 6.8 6.2 0.1 5.6 9.2 4.7 0.0 1.9 0.1 0.4 3.3 1.0 0.4 0.9 0.6 0.5 0.4 0.0 0.6 0.4 0.9 0.4 SH3BP2 "CRBM, RES4-23" ENSG00000087266 "SH3 domain binding protein 2" P78314 4 2793023-2841098 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036790 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA036790: AB_10671712" "unprognostic (7.86e-2)" "unprognostic (3.45e-1)" "unprognostic (9.83e-2)" "prognostic unfavourable (5.42e-6)" "prognostic unfavourable (9.52e-4)" "prognostic favourable (1.57e-5)" "unprognostic (6.58e-2)" "unprognostic (3.16e-2)" "unprognostic (3.17e-2)" "unprognostic (6.41e-3)" "unprognostic (3.35e-2)" "unprognostic (3.30e-2)" "unprognostic (3.24e-3)" "unprognostic (1.78e-2)" "unprognostic (5.32e-1)" "unprognostic (1.78e-1)" "prognostic favourable (2.67e-4)" 17.5 7.0 9.7 20.4 14.5 30.2 13.1 6.1 10.1 9.0 11.6 9.8 7.5 8.9 7.9 18.7 10.8 8.7 9.5 9.9 9.3 8.8 26.3 18.3 20.2 18.5 12.0 3.5 8.8 10.1 3.6 7.6 20.8 15.4 8.4 7.4 11.6 9.3 7.8 11.0 31.2 14.2 8.9 14.5 46.8 10.8 5.0 12.2 5.2 8.0 6.9 17.4 11.6 10.9 4.4 8.6 16.7 21.9 3.8 7.0 5.4 5.2 3.2 3.7 5.1 3.1 7.7 3.5 8.3 6.9 6.5 5.8 2.3 16.3 8.2 9.6 6.9 2.5 0.2 5.5 3.9 4.2 3.3 19.3 6.5 2.7 10.1 7.9 13.7 14.6 5.2 3.7 3.3 14.2 1.1 19.2 7.7 4.2 1.2 9.5 5.9 6.2 0.3 3.3 3.6 11.0 8.2 11.1 8.2 6.1 5.8 4.1 8.8 13.3 17.9 6.3 4.8 2.2 6.2 8.1 3.8 1.7 7.3 21.5 6.7 1.8 10.5 6.7 7.0 18.6 4.4 1.4 1.9 4.6 8.6 4.4 1.0 2.7 16.7 3.8 21.9 3.5 3.5 5.4 9.7 14.5 6.1 10.1 9.3 8.8 12.0 3.5 15.4 12.2 SH3BP5L KIAA1720 ENSG00000175137 "SH3 binding domain protein 5 like" Q7L8J4 1 248810446-248826633 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038067, HPA038068" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA038067: AB_2675814, HPA038068: AB_10670651" "unprognostic (2.48e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (4.41e-1)" "unprognostic (2.78e-1)" "unprognostic (2.27e-3)" "unprognostic (1.99e-3)" "unprognostic (5.84e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-3)" "unprognostic (1.50e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-2)" "unprognostic (4.66e-2)" 4.1 5.0 5.3 4.0 4.8 3.0 3.3 10.3 8.7 4.1 4.9 6.2 4.9 2.5 7.2 4.7 3.3 6.5 5.5 4.0 4.1 4.5 3.9 4.2 4.2 3.9 4.2 5.9 2.4 5.0 3.9 2.9 5.1 5.7 13.6 8.0 5.6 4.3 5.0 5.4 4.3 3.6 3.6 4.0 4.1 3.7 1.1 1.2 6.2 1.8 0.4 1.5 1.0 9.8 6.2 8.2 9.4 11.8 8.0 10.9 22.3 7.7 13.1 9.9 6.0 8.8 5.0 13.6 18.7 10.6 7.8 9.6 6.3 11.3 2.8 8.1 6.7 4.8 7.2 8.8 9.8 6.5 10.3 14.5 5.6 8.6 13.8 5.2 8.7 3.2 8.3 6.0 14.5 16.0 9.4 5.8 10.0 8.9 4.4 9.6 13.2 6.9 8.6 7.4 9.2 18.1 11.9 16.1 6.9 6.5 34.0 13.0 14.5 4.5 12.0 10.1 6.8 5.5 1.8 5.4 1.1 1.0 1.1 0.5 1.5 0.9 1.2 1.1 0.5 0.4 6.2 0.4 0.4 0.8 0.2 1.0 SH3GLB2 KIAA1848 ENSG00000148341 "SH3 domain containing GRB2 like, endophilin B2" Q9NR46 9 129007036-129028303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021438, HPA024734" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA021438: AB_1856820, HPA024734: AB_1856821" "unprognostic (2.59e-1)" "prognostic favourable (1.56e-6)" "unprognostic (1.88e-1)" "unprognostic (7.51e-2)" "unprognostic (2.94e-1)" "unprognostic (1.09e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (5.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.81e-2)" "unprognostic (6.25e-2)" "prognostic favourable (2.32e-4)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-3)" "prognostic favourable (4.28e-4)" 9.3 18.8 36.9 11.7 27.0 30.4 16.6 31.3 47.2 15.8 16.4 33.0 43.7 25.7 14.4 14.2 29.5 21.0 13.6 14.8 34.2 24.4 15.8 6.6 14.9 13.6 28.8 37.9 20.0 35.9 29.1 26.8 45.2 26.3 21.3 10.1 13.4 30.0 33.8 19.4 46.6 20.4 16.6 30.9 14.9 25.8 7.8 24.1 16.9 16.4 15.0 15.8 27.8 18.1 7.7 7.6 6.6 4.6 5.0 4.9 2.8 13.2 11.2 5.5 7.5 3.3 4.2 16.5 4.6 10.5 9.2 8.5 7.0 22.9 14.0 3.7 8.2 32.7 1.7 10.0 2.6 8.9 7.5 3.5 18.0 6.1 7.0 3.1 8.6 3.0 11.5 4.7 4.2 7.7 4.7 18.7 4.6 32.6 18.0 8.4 4.9 7.9 36.6 10.4 62.6 10.3 16.1 17.4 14.1 6.7 17.5 7.2 25.1 4.7 7.0 4.3 7.4 10.9 10.1 18.2 8.9 8.9 10.0 3.9 2.3 4.4 3.3 6.6 4.1 1.6 4.9 7.7 4.7 3.8 2.7 3.8 3.4 3.0 2.7 5.0 4.6 7.6 3.9 2.8 36.9 27.0 31.3 47.2 34.2 24.4 28.8 37.9 26.3 24.1 SH3PXD2B "FLJ20831, KIAA1295" ENSG00000174705 "SH3 and PX domains 2B" A1X283 5 172325000-172454523 "Disease related genes, Predicted intracellular proteins" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 36.8;ASC TERT1: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "classical monocyte: 1.3;myeloid DC: 1.7" "Group enriched" "Detected in many" 15 "dendritic cells: 1.7;monocytes: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036471 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA036471: AB_10670799" "unprognostic (3.32e-1)" "unprognostic (1.95e-2)" "unprognostic (4.84e-1)" "unprognostic (2.96e-1)" "unprognostic (1.84e-1)" "unprognostic (2.38e-1)" "prognostic unfavourable (7.51e-5)" "unprognostic (5.38e-3)" "unprognostic (3.11e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-2)" "unprognostic (1.76e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.87e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-2)" "prognostic unfavourable (8.45e-4)" 26.9 17.8 6.9 12.4 10.1 0.7 28.0 13.3 8.7 28.0 10.0 16.6 13.4 3.1 26.4 19.6 12.3 14.6 21.4 5.8 7.6 4.1 2.8 2.6 13.2 11.4 16.0 4.5 18.1 7.9 16.7 4.3 10.2 10.9 10.6 6.9 15.9 14.8 16.8 5.1 15.0 8.2 25.8 10.0 7.7 11.1 10.9 9.6 1.8 6.5 4.3 4.2 17.0 14.9 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.3 5.2 19.7 12.9 36.8 31.1 16.7 3.1 11.0 2.0 4.1 1.4 0.4 0.0 4.3 12.2 3.0 6.9 3.6 2.0 0.3 1.3 0.0 5.0 1.0 11.8 0.0 13.8 19.9 5.7 8.4 2.4 14.1 0.0 0.1 8.9 1.1 0.0 1.6 7.5 1.2 6.2 3.2 1.8 2.1 0.5 1.7 11.0 2.2 1.4 4.0 0.5 0.7 15.1 12.7 5.1 7.8 1.3 0.0 0.0 0.0 8.6 0.8 10.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 10.1 13.3 8.4 7.6 4.1 16.0 4.5 10.9 9.6 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.0;MOLT-4: 26.0;SK-MEL-30: 14.9;U-2197: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: " "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.1 3.4 0.1 0.0 0.0 0.3 2.5 0.2 0.2 0.3 0.4 1.7 1.3 3.0 3.0 0.0 1.3 0.0 6.4 0.0 7.9 0.1 0.0 2.7 2.8 2.6 0.0 0.4 0.1 8.0 0.1 6.5 15.0 0.4 4.2 0.3 2.4 26.0 2.1 0.1 2.8 1.7 0.8 0.8 0.3 0.4 0.2 1.4 0.9 0.3 14.9 0.0 0.5 6.1 0.0 1.7 11.3 0.2 0.1 0.6 2.6 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell line enhanced" "Detected in some" "CACO-2: 6.1;RT4: 9.7;SK-MEL-30: 8.7;WM-115: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA037683: , HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.2 0.5 0.2 6.1 5.0 0.0 5.5 0.3 4.2 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 5.5 0.0 3.8 0.0 2.0 9.7 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.2 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 SH3YL1 "DKFZP586F1318, Ray" ENSG00000035115 "SH3 and SYLF domain containing 1" Q96HL8 2 217730-266398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.0;hTCEpi: 27.0;RT4: 27.0;SK-BR-3: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030926, HPA030927" Approved Approved Nucleoplasm Nucleoplasm "HPA030926: AB_10670148, HPA030927: AB_10669874" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (5.10e-2)" "unprognostic (2.28e-3)" "unprognostic (5.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.46e-1)" "unprognostic (6.57e-3)" "unprognostic (9.25e-2)" "unprognostic (6.40e-2)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "prognostic favourable (7.70e-4)" "unprognostic (1.95e-3)" "unprognostic (1.10e-1)" "unprognostic (1.47e-1)" "unprognostic (3.22e-3)" 3.6 11.7 10.3 8.7 10.1 2.6 16.0 8.7 9.7 9.6 12.9 8.6 16.1 9.8 7.9 12.4 17.4 12.8 22.9 4.1 10.5 8.0 42.5 3.8 14.9 10.4 10.9 11.8 9.9 94.7 13.9 20.7 11.4 7.9 17.7 15.8 7.3 35.3 26.9 3.2 21.5 32.1 7.6 13.1 5.5 23.6 6.0 8.2 5.7 22.5 15.3 14.4 18.0 9.5 7.2 3.3 14.0 2.3 12.4 20.6 5.2 4.7 0.9 5.3 2.3 7.2 6.8 3.5 6.1 6.8 2.3 2.4 12.8 17.8 0.2 2.9 5.3 19.9 1.3 26.0 2.1 4.0 0.9 1.2 1.4 4.0 5.8 0.6 1.5 7.5 27.0 1.3 4.4 3.3 0.3 0.7 4.7 13.8 5.0 2.6 1.7 1.0 2.3 1.6 0.3 16.2 27.0 2.1 3.6 1.0 25.2 4.3 17.2 4.0 2.5 1.1 0.3 6.7 2.6 0.7 0.0 0.5 11.5 7.9 3.8 14.0 1.3 1.0 2.6 1.6 8.4 7.2 13.3 6.7 3.3 5.5 20.6 11.9 0.8 12.4 2.3 2.9 16.2 5.2 10.3 10.1 8.7 9.7 10.5 8.0 10.9 11.8 7.9 8.2 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" "Nuclear speckles" "Nucleoplasm, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favourable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.7 4.2 0.0 0.4 0.7 3.1 0.6 0.3 0.0 0.0 8.1 2.9 5.1 1.5 0.0 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 1.7 0.2 1.5 0.0 0.0 0.0 0.0 16.6 1.6 9.5 0.0 0.0 3.3 0.3 0.0 7.6 7.5 3.9 15.4 2.5 1.0 0.0 6.2 0.0 11.8 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell line enhanced" "Detected in some" "HEL: 6.3;TIME: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.6 0.0 1.2 0.2 0.6 0.9 0.4 0.0 0.0 0.0 6.3 0.4 1.7 1.5 0.8 0.3 1.5 1.0 0.1 0.3 2.0 0.1 0.1 0.1 0.9 0.5 0.2 1.3 1.8 1.7 0.0 0.7 0.3 0.5 1.2 1.9 1.7 0.0 0.8 0.3 0.3 10.0 0.2 1.7 0.6 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 SHB ENSG00000107338 "SH2 domain containing adaptor protein B" Q15464 9 37919134-38069211 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 71 "basophil: 8.1" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.1" "CAB010161, HPA049911, HPA052108" Uncertain Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" Cytosol "Nucleoplasm, Cytoplasmic bodies" "CAB010161: AB_2187742, HPA049911: , HPA052108: " "unprognostic (4.57e-2)" "unprognostic (1.13e-1)" "unprognostic (5.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (5.96e-3)" "unprognostic (2.48e-2)" "unprognostic (3.31e-3)" "unprognostic (7.68e-3)" "unprognostic (1.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.10e-1)" 8.6 5.6 7.5 5.3 15.9 7.2 8.0 1.4 12.5 8.2 8.4 16.1 3.2 10.1 6.1 5.6 19.6 5.9 29.4 20.2 8.9 5.0 13.6 34.2 11.6 3.1 17.9 5.3 5.6 17.8 13.7 13.1 7.7 12.6 12.9 7.0 7.6 18.9 11.3 6.4 13.0 9.5 11.9 7.6 6.7 14.1 3.5 16.3 2.7 7.7 10.3 11.1 10.7 11.9 0.0 0.0 8.1 0.0 0.0 0.1 0.0 9.2 14.7 1.5 0.2 1.7 4.1 2.6 10.2 12.5 7.1 5.5 3.5 6.4 0.0 12.4 8.8 8.9 5.8 15.0 5.1 7.8 11.7 0.0 5.1 10.8 11.3 0.4 0.5 3.6 4.8 11.2 8.6 7.3 3.7 3.1 8.3 6.2 1.1 0.4 3.8 14.0 0.5 4.3 0.5 14.8 3.3 15.7 12.6 1.3 11.2 2.5 7.0 0.5 9.0 3.3 12.0 1.7 16.2 0.9 0.3 0.1 19.7 0.9 3.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 15.9 1.4 12.5 8.9 5.0 17.9 5.3 12.6 16.3 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 84.3" "Cell line enhanced" "Detected in many" "SCLC-21H: 49.5;SH-SY5Y: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 84.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 269.9" HPA057381 Approved Nucleoplasm Nucleoplasm "HPA057381: " "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 2.9 19.3 6.9 3.3 10.4 0.6 3.3 84.3 14.5 7.3 6.3 3.9 2.2 10.5 8.5 4.0 4.1 6.2 5.3 4.5 5.9 7.2 1.8 18.9 2.9 1.8 4.5 6.7 20.5 2.5 2.5 3.5 1.5 7.1 5.3 4.4 6.3 5.3 5.2 2.6 6.5 7.9 6.3 5.2 2.3 2.9 4.1 3.2 1.6 4.9 2.4 1.8 5.8 5.5 3.3 2.6 2.5 1.9 5.1 4.2 1.5 0.0 0.5 9.7 0.3 0.7 0.4 4.6 1.2 0.8 2.7 3.9 1.4 4.6 0.5 3.9 1.6 0.8 3.7 0.3 1.3 0.8 1.7 0.3 0.8 9.6 0.4 0.0 3.2 0.9 0.2 0.3 0.0 2.1 1.9 0.2 3.8 1.6 2.1 0.3 3.8 0.2 5.8 7.7 0.2 0.9 0.2 49.5 22.1 0.3 0.3 0.1 0.4 0.9 0.1 0.3 4.2 0.3 0.1 0.4 0.3 0.4 0.1 0.2 1.5 0.3 1.9 1.2 3.8 1.7 4.2 2.4 1.6 2.4 1.8 3.3 2.2 1.7 2.5 5.1 1.7 2.6 0.3 1.5 6.9 10.4 84.3 12.1 5.9 7.2 4.5 6.7 7.1 3.2 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell line enhanced" "Detected in some" "LHCN-M2: 13.8;NTERA-2: 10.0;RH-30: 32.0;U-2197: 20.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: " "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favourable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favourable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.6 1.0 0.0 0.0 1.2 0.7 0.0 0.0 13.8 0.7 1.4 0.3 10.0 5.0 0.0 32.0 0.2 1.2 4.5 0.3 0.0 0.2 0.0 3.5 0.4 0.1 1.1 0.0 0.5 20.0 4.3 0.0 0.0 0.0 0.0 0.0 2.7 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 SHOC2 "KIAA0862, SOC-2, SOC2, SUR-8, SUR8" ENSG00000108061 "SHOC2, leucine rich repeat scaffold protein" Q9UQ13 10 110919547-111013667 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009164, HPA048134" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA009164: AB_1079960, HPA048134: " "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" "unprognostic (4.23e-3)" "unprognostic (3.27e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (6.09e-2)" "unprognostic (5.56e-2)" "unprognostic (1.59e-1)" "unprognostic (1.07e-1)" "unprognostic (4.33e-2)" "unprognostic (1.01e-1)" "unprognostic (3.70e-3)" "unprognostic (6.97e-3)" "unprognostic (8.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.67e-1)" 22.9 13.2 22.3 17.2 32.4 31.2 18.0 24.9 25.2 19.3 16.7 8.9 12.1 12.5 17.3 17.4 19.1 14.1 15.8 14.6 19.0 24.8 20.9 18.2 16.8 20.9 22.3 20.1 21.9 15.7 26.5 33.4 17.9 17.7 18.1 17.0 9.8 13.9 14.4 21.7 15.8 24.2 25.0 23.3 23.2 13.9 26.7 17.7 29.4 21.5 9.4 23.3 23.7 17.1 16.4 11.3 34.6 13.7 9.8 9.6 11.2 11.2 7.1 9.1 15.2 20.9 21.4 5.9 13.8 20.7 12.9 15.7 6.4 10.2 24.6 6.9 24.7 9.6 11.0 9.9 18.9 13.4 6.5 11.2 11.0 6.2 15.2 19.0 20.1 23.6 15.7 14.9 28.1 13.0 6.9 17.6 18.3 6.0 9.3 15.3 5.6 7.4 13.4 18.2 6.9 13.6 7.7 4.8 9.5 12.0 6.0 13.5 30.8 16.2 13.1 10.4 9.3 13.1 9.4 16.3 16.6 39.4 12.4 19.7 7.4 20.9 12.0 16.7 7.0 13.7 8.4 16.4 8.3 8.1 11.3 13.0 8.8 8.5 34.6 9.8 13.5 8.1 9.6 11.2 22.3 32.4 24.9 25.2 19.0 24.8 22.3 20.1 17.7 17.7 SHPK "CARKL, SHK" ENSG00000197417 Sedoheptulokinase Q9UHJ6 17 3608262-3636322 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA024361, HPA064939" Enhanced Approved "Nucleoplasm,Nuclear speckles" 150000 "Nucleoplasm, Nuclear speckles" "HPA024361: AB_1846030, HPA064939: " "unprognostic (1.75e-2)" "unprognostic (1.51e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (3.57e-3)" "unprognostic (1.54e-2)" "unprognostic (1.95e-2)" "unprognostic (3.01e-2)" "unprognostic (1.56e-1)" "unprognostic (3.64e-2)" "unprognostic (1.08e-2)" "unprognostic (1.42e-1)" "unprognostic (3.82e-2)" "unprognostic (6.75e-2)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" 8.9 12.9 7.6 6.2 10.6 5.9 8.9 17.3 12.3 8.8 14.1 14.9 8.8 18.5 10.7 6.1 11.6 7.6 5.3 5.9 7.0 5.5 14.3 26.7 6.3 5.3 12.0 4.5 10.2 13.7 11.8 6.2 8.6 9.8 7.4 8.6 12.3 8.9 9.4 7.5 12.1 22.8 5.1 6.7 6.1 9.7 5.2 13.0 7.7 7.7 4.0 7.6 7.5 9.6 5.2 7.1 5.1 4.8 6.4 7.5 5.4 5.2 10.7 11.5 7.3 4.8 4.8 6.4 3.5 3.2 6.9 4.2 18.5 4.9 6.2 7.9 6.8 10.3 15.2 11.5 5.1 10.0 14.8 6.8 9.2 13.2 5.7 5.9 9.7 8.1 5.5 7.6 5.2 13.0 9.0 8.0 6.7 9.4 7.5 4.6 5.8 7.2 10.4 6.0 9.9 9.8 6.8 3.3 8.8 12.9 12.0 3.6 10.7 3.5 9.3 10.6 5.1 10.2 8.5 2.7 3.4 4.1 11.5 5.3 5.4 3.3 4.7 5.1 4.6 4.8 4.7 5.2 4.2 3.7 6.5 4.0 7.5 4.7 0.9 6.4 4.1 7.1 3.6 5.4 7.6 10.6 17.3 12.3 7.0 5.5 12.0 4.5 9.8 13.0 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavourable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavourable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.6 8.8 0.9 1.9 0.0 0.0 8.8 1.3 3.5 2.7 5.2 9.9 10.4 0.0 2.7 4.9 8.1 7.0 5.9 2.8 0.0 7.3 0.0 9.3 6.1 1.2 2.8 2.5 0.4 5.2 2.7 5.1 6.5 4.3 0.0 1.9 6.3 0.0 0.1 3.4 6.0 0.0 11.9 3.5 7.3 2.1 9.8 3.9 10.6 15.4 9.6 12.4 2.5 11.2 0.9 6.6 0.0 7.7 1.7 0.0 0.0 4.9 0.0 4.8 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741127-150763477 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: " "prognostic favourable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavourable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 9.6 48.0 7.6 11.8 10.3 22.7 23.5 10.9 17.2 30.0 10.5 8.4 20.3 7.9 23.5 13.9 28.8 14.9 11.0 10.7 7.2 7.3 8.4 35.5 11.8 19.1 9.9 7.5 19.0 14.6 6.4 8.1 31.4 7.9 18.8 9.2 8.3 11.2 21.7 8.3 19.3 9.5 17.4 9.4 16.9 12.0 8.7 8.6 23.6 11.4 10.6 25.1 22.7 25.6 3.0 3.1 10.0 2.7 1.6 3.6 1.1 16.6 4.1 3.2 6.4 11.1 8.4 13.1 6.9 8.0 8.4 10.3 8.4 7.5 9.3 10.2 7.2 10.3 8.7 6.2 7.9 7.8 6.2 18.2 5.0 27.9 15.9 10.0 5.4 7.6 14.5 5.0 11.5 6.5 4.5 36.7 5.3 20.0 18.3 5.1 10.5 8.2 13.5 7.0 33.3 5.3 5.8 12.5 5.9 5.2 4.9 12.3 32.9 15.1 4.5 5.8 5.2 12.6 9.3 43.7 16.6 13.0 5.5 14.5 2.9 9.5 2.7 10.0 2.1 1.5 3.2 2.5 3.6 3.2 2.4 3.0 1.9 1.9 5.9 1.6 1.5 3.1 2.0 1.1 7.6 10.3 10.9 17.2 7.2 7.3 9.9 7.5 7.9 8.6 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825512-45844080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Group enriched" "Detected in some" 7 "PC-3: 8.5;U-87 MG: 25.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 5.9;myeloid DC: 2.1" "Group enriched" "Detected in many" 40 "dendritic cells: 2.1;monocytes: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053509 Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favourable (9.14e-5)" 1.1 0.3 0.1 4.3 0.1 0.0 3.0 0.2 0.1 2.1 0.2 0.0 0.0 1.6 0.3 0.0 0.3 0.3 3.4 1.9 0.1 0.1 0.5 1.4 2.0 0.9 0.1 0.0 0.5 0.2 0.0 0.1 1.1 0.0 1.1 0.1 0.1 0.2 0.2 0.7 0.3 2.5 3.2 0.1 3.7 0.9 0.3 0.0 1.2 0.2 0.0 2.6 4.2 0.2 0.0 2.1 0.0 5.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.8 0.1 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.0 0.0 0.0 25.7 0.6 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427189 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 34.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "B-cells: 2.0;dendritic cells: 1.6" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB023801: , HPA038211: , HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 8.8 2.3 3.0 3.6 3.0 5.9 7.5 3.0 3.0 13.5 3.0 3.0 3.0 0.0 3.0 3.0 12.9 5.5 10.7 7.1 3.0 0.8 3.0 12.3 5.4 3.0 3.0 3.0 13.7 7.3 3.5 5.7 8.2 3.0 3.9 0.1 3.0 4.6 9.8 5.0 34.5 3.0 3.3 3.0 4.0 5.3 3.0 3.0 3.0 3.9 3.0 3.0 10.5 6.1 2.0 1.6 0.0 0.1 0.0 0.1 0.1 0.5 1.7 2.0 0.0 0.1 0.8 0.7 0.9 0.3 1.6 1.3 2.4 0.0 2.4 0.7 0.2 11.1 1.6 16.7 1.0 0.1 0.5 0.7 27.8 0.9 2.3 0.7 0.1 1.0 21.5 0.4 5.1 0.3 0.1 0.5 21.6 0.1 0.4 1.7 0.8 1.5 0.0 0.3 2.5 1.9 6.3 0.0 0.0 10.9 1.8 0.4 1.1 0.3 3.7 0.4 2.0 0.1 0.0 4.3 15.7 0.4 4.6 2.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 3.0 3.0 3.0 3.0 3.0 0.8 3.0 3.0 3.0 3.0 SIK1B ENSG00000275993 "Salt inducible kinase 1B (putative)" 21 6111134-6123739 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 29.9;Karpas-707: 40.7;LHCN-M2: 28.0;SiHa: 29.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 6 "B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7" "HPA038211, HPA078064" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA038211: , HPA078064: " "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (3.32e-2)" "unprognostic (2.44e-1)" "unprognostic (6.58e-3)" "unprognostic (2.62e-2)" "unprognostic (6.56e-2)" "unprognostic (3.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.01e-2)" "unprognostic (9.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.41e-1)" "unprognostic (2.69e-3)" "unprognostic (7.41e-2)" 9.7 13.7 0.4 3.0 1.7 8.4 5.2 0.4 3.1 2.9 3.0 1.3 4.6 0.9 3.1 1.9 6.8 1.0 15.5 6.2 1.5 1.7 12.3 8.5 1.2 1.8 0.6 10.2 11.2 1.6 2.2 3.2 2.6 5.1 2.3 7.6 3.9 14.3 9.1 2.9 6.1 1.7 2.1 2.0 5.0 1.7 1.0 1.0 0.9 5.6 3.2 7.1 2.7 1.6 5.0 0.0 1.7 0.3 0.5 0.1 3.1 15.7 1.2 1.0 0.2 0.1 2.8 0.4 0.2 0.6 0.3 17.6 2.3 1.1 0.5 0.0 0.3 1.8 0.0 0.2 2.8 0.6 2.4 29.9 3.3 1.1 0.4 0.2 0.4 13.9 1.6 9.1 0.6 0.9 40.7 28.0 1.5 0.3 0.7 1.7 1.8 0.6 7.2 4.7 1.6 5.4 1.5 0.7 29.4 1.9 1.6 0.3 1.3 0.8 0.4 1.6 0.6 6.5 5.6 12.2 0.5 4.5 1.0 1.9 0.0 0.1 0.0 0.1 0.8 0.5 1.6 0.0 0.1 0.7 1.6 0.1 0.1 0.0 0.3 1.7 5.0 0.0 0.1 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829400-16880353 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA050329: " "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favourable (4.37e-4)" "prognostic unfavourable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 19.1 17.9 22.2 17.2 28.1 9.8 21.5 25.1 38.6 24.4 16.0 20.8 50.0 12.8 37.5 21.5 14.5 23.3 17.3 15.7 24.2 20.8 15.9 9.8 21.7 20.8 16.5 30.4 32.5 16.2 60.8 17.7 53.2 24.8 22.7 11.0 15.5 20.2 54.7 17.1 22.7 17.7 26.5 14.8 25.1 13.7 30.2 13.4 9.3 22.5 9.6 15.8 17.2 22.2 4.8 2.6 6.1 6.7 1.9 2.0 2.3 14.5 7.8 13.2 16.9 10.9 10.1 41.8 12.4 10.3 17.2 15.3 19.2 13.7 13.1 14.0 14.3 12.6 10.9 11.1 16.0 13.6 19.7 14.0 17.1 8.7 14.4 8.2 11.4 16.6 14.7 11.6 10.0 15.6 11.4 8.1 12.0 17.4 11.1 13.2 16.4 25.0 14.7 12.2 8.6 9.8 12.4 9.8 12.3 15.7 12.1 9.7 8.5 7.7 20.4 16.8 10.2 24.2 13.8 11.6 8.5 13.1 11.6 10.8 12.4 0.1 6.7 6.1 1.8 6.0 1.2 4.8 1.7 2.0 2.1 3.8 2.0 1.4 3.3 1.9 5.3 2.6 0.5 2.3 22.2 28.1 25.1 38.6 24.2 20.8 16.5 30.4 24.8 13.4 SINHCAF "C12orf14, FAM60A, TERA" ENSG00000139146 "SIN3-HDAC complex associated factor" Q9NP50 12 31280584-31327058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 83.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038167, HPA057585" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA038167: AB_10675629, HPA057585: " "unprognostic (2.89e-1)" "unprognostic (1.33e-2)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (2.80e-3)" "unprognostic (1.84e-2)" "prognostic unfavourable (5.78e-4)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (1.15e-1)" "prognostic favourable (7.89e-4)" "unprognostic (3.22e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" "unprognostic (9.75e-2)" 13.1 6.5 1.6 21.4 5.1 7.9 11.1 4.5 1.9 25.4 15.8 3.4 15.8 6.7 28.3 16.8 19.8 14.6 8.4 5.6 2.9 1.8 16.6 3.3 17.0 22.5 3.4 0.9 18.5 19.6 7.6 19.6 18.9 5.2 18.6 8.3 6.0 16.3 20.1 3.2 12.7 17.0 11.7 3.8 18.5 7.0 13.6 3.7 39.0 14.9 12.3 27.3 19.3 13.6 22.8 28.3 7.9 8.0 19.0 15.1 10.4 3.4 5.1 17.3 3.4 1.0 2.1 32.0 1.8 1.3 3.5 4.7 13.8 9.0 11.9 14.7 0.5 6.2 14.4 6.9 6.9 12.7 6.4 8.2 3.5 8.6 4.3 13.4 8.1 1.9 10.9 3.0 14.7 8.2 11.3 4.7 1.5 2.6 23.9 9.8 83.4 2.8 20.3 8.3 10.2 7.9 10.3 24.1 16.2 4.2 7.6 9.9 3.2 7.9 8.9 0.8 5.2 0.4 6.0 5.3 7.6 24.0 2.4 5.1 4.6 7.9 4.8 7.5 8.8 5.8 10.3 22.8 12.3 10.4 10.4 17.9 15.1 11.8 1.5 19.0 8.0 28.3 5.8 10.4 1.6 5.1 4.5 1.9 2.9 1.8 3.4 0.9 5.2 3.7 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638097-65650930 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: " "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 10.5 9.1 7.5 27.1 12.0 29.8 10.0 2.6 8.7 8.9 10.8 9.4 2.9 7.7 10.9 3.0 7.6 9.0 9.9 8.0 8.4 4.6 9.5 7.8 17.6 33.2 11.5 4.7 7.7 4.6 2.7 4.2 11.9 10.3 8.6 3.9 8.2 8.7 6.8 5.4 4.2 17.2 9.0 14.3 47.1 8.1 3.0 10.5 25.3 7.7 4.6 32.7 8.5 7.8 6.6 2.8 14.1 5.2 5.8 7.4 3.0 0.7 6.2 4.4 9.5 2.6 5.4 10.5 7.1 6.0 5.5 5.4 1.9 6.8 9.8 16.0 3.5 3.6 1.6 2.3 1.8 10.6 3.9 23.9 9.1 3.3 4.6 9.6 10.3 5.5 1.1 7.7 1.0 16.2 13.5 4.5 2.7 2.7 3.8 16.5 3.0 5.7 17.5 2.4 8.7 2.1 0.5 1.7 10.1 3.5 6.1 14.5 4.6 14.9 22.7 6.9 13.9 7.5 1.4 6.8 5.3 22.0 9.4 15.4 19.8 4.0 4.1 10.2 7.4 4.8 5.5 5.3 3.7 4.8 2.8 6.6 2.9 4.4 14.1 5.8 5.2 2.7 3.5 3.0 7.5 12.0 2.6 8.7 8.4 4.6 11.5 4.7 10.3 10.5 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.1 5.1 4.4 11.0 25.3 17.4 3.0 6.0 10.7 9.4 12.2 9.2 5.2 2.8 13.1 11.2 4.4 8.0 12.9 5.7 13.0 8.3 5.5 5.8 5.5 17.8 3.8 12.2 18.1 15.6 7.7 9.2 16.4 5.2 22.6 14.3 4.6 7.7 3.0 0.7 7.2 10.2 12.4 7.8 7.5 7.3 11.1 5.0 7.0 9.4 6.6 4.2 9.9 15.6 12.7 2.8 19.6 8.9 9.3 4.5 6.5 10.2 9.6 11.7 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941898-44946077 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5" "Cell line enhanced" "Detected in some" "HAP1: 6.8;SCLC-21H: 36.7;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "basal ganglia: 40.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 38.7" HPA067988 Approved Nucleoplasm Nucleoplasm "HPA067988: " "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.4 0.4 3.7 0.5 40.2 0.5 0.5 0.7 0.7 1.5 0.4 1.5 0.0 0.5 0.4 0.4 0.5 0.4 0.5 0.4 1.6 7.2 0.4 0.4 0.5 0.5 1.1 2.7 0.4 1.0 32.1 30.9 0.4 0.1 0.4 0.4 66.5 0.4 0.4 1.1 0.5 0.4 0.4 0.0 0.4 0.5 0.8 6.5 0.0 0.4 0.0 0.4 0.4 0.0 1.1 1.1 4.5 2.2 1.9 1.7 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 6.8 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 36.7 14.7 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 1.2 1.0 1.1 1.7 1.1 1.1 0.8 0.8 1.1 1.3 1.4 1.7 1.9 2.2 1.1 1.3 0.7 3.7 40.2 0.7 0.7 1.6 7.2 1.1 2.7 0.1 6.5 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709528-60724348 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3" "Cell line enhanced" "Detected in many" "A-431: 21.0;RH-30: 21.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA031794 Uncertain Approved Nucleoplasm Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 2.0 1.5 0.9 0.6 0.9 0.3 4.8 4.3 4.5 3.3 0.7 0.1 3.3 0.4 1.6 1.3 0.5 3.5 1.1 1.5 1.0 1.0 1.4 0.5 2.1 0.2 1.0 2.2 2.9 3.3 20.4 6.3 2.1 3.6 4.0 0.3 0.8 16.4 2.7 19.3 0.5 0.5 0.9 1.8 0.3 2.0 0.7 1.1 0.8 3.9 2.4 1.4 1.7 14.3 0.2 0.1 1.0 0.1 0.3 0.2 0.0 21.0 1.6 1.3 5.6 5.0 6.3 9.9 4.8 7.2 1.4 2.1 1.0 6.7 0.0 3.2 2.4 8.0 5.7 3.9 3.3 1.7 4.6 0.6 2.1 1.4 1.6 2.1 0.2 2.9 1.8 1.3 6.7 1.2 4.1 0.0 7.3 5.2 0.0 0.2 3.6 9.1 1.3 21.3 0.0 2.5 12.1 3.4 0.3 3.0 4.8 1.3 6.5 0.1 4.1 4.4 9.8 3.0 4.3 1.4 0.0 0.0 1.5 0.0 0.8 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.9 0.9 4.3 4.5 1.0 1.0 1.0 2.2 3.6 1.1 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell line enriched" "Detected in some" 16 "MOLT-4: 29.4" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA001403 Approved Approved Nucleoplasm Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.6;HDLM-2: 10.1;HMC-1: 8.6;Karpas-707: 10.7;RPMI-8226: 12.6;RPTEC TERT1: 15.6;U-266/70: 9.7;U-266/84: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favourable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favourable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 10.1 0.2 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.6 15.6 0.0 0.0 0.0 1.0 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 9.7 6.9 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell line enhanced" "Detected in some" "AF22: 22.6;AN3-CA: 5.8;BEWO: 10.5;SH-SY5Y: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" Cytosol "Nucleoplasm, Nuclear bodies" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 0.9 22.6 5.8 0.5 0.2 10.5 0.4 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 1.4 2.0 0.4 0.0 0.0 2.5 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.9 0.7 0.1 1.3 0.0 0.3 0.7 0.0 0.4 0.5 2.5 5.2 0.8 3.9 0.1 0.4 4.5 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.2 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008472 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA008472: AB_1856933" "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavourable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 16.2 15.0 10.5 21.1 14.7 22.8 12.4 5.0 18.2 14.0 11.8 12.2 13.4 15.9 17.1 12.7 14.4 12.0 26.8 21.7 11.2 11.4 15.0 18.0 23.8 15.2 11.6 10.6 17.8 11.4 9.6 21.1 26.6 16.0 15.8 11.7 14.8 14.2 17.0 19.5 10.3 28.0 13.5 17.3 12.6 17.9 14.4 8.3 14.0 18.9 13.5 21.1 15.3 16.3 5.7 2.9 5.4 11.3 3.2 2.6 2.3 8.2 10.2 6.8 4.4 8.8 3.9 12.6 8.3 5.7 5.8 4.6 2.1 18.0 10.3 26.8 7.6 19.0 4.2 3.8 9.2 17.8 4.1 13.7 9.9 4.5 7.6 5.7 7.6 6.6 3.8 8.5 6.6 14.6 6.0 11.7 12.1 8.8 2.3 1.8 26.7 3.6 5.6 23.1 2.1 8.8 13.1 5.1 6.2 20.7 21.1 4.4 14.1 6.3 27.9 16.8 15.6 14.2 15.4 15.6 7.2 19.8 6.4 3.0 7.8 3.4 4.3 2.0 1.6 9.8 2.3 4.6 1.4 2.1 2.9 5.7 2.5 2.6 5.4 3.2 11.3 2.0 0.5 2.3 10.5 14.7 5.0 18.2 11.2 11.4 11.6 10.6 16.0 8.3 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959080-31969755 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051959, HPA054419" Uncertain Approved Nucleoplasm Nucleoplasm "HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavourable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 14.5 32.8 12.4 19.4 15.2 19.0 11.3 15.4 20.2 11.6 12.6 16.0 10.6 36.7 12.5 37.4 14.8 11.7 10.3 12.3 10.7 8.2 12.6 27.8 17.9 13.9 12.3 10.1 13.6 13.1 3.8 21.6 11.3 12.7 17.2 11.1 14.6 11.5 14.3 17.1 14.3 15.7 17.8 10.6 21.7 22.7 10.7 13.7 17.4 14.9 7.5 15.0 13.6 10.7 2.2 2.3 1.1 4.3 0.4 3.2 1.2 0.3 8.0 7.1 0.6 2.1 4.0 8.2 5.7 3.4 4.3 7.5 0.4 0.1 0.3 12.4 8.5 5.7 0.0 9.9 3.5 8.2 15.7 0.0 0.5 0.7 0.0 0.3 0.4 10.1 8.7 0.1 0.1 0.0 0.1 7.1 0.0 0.5 0.5 0.7 10.0 0.1 1.1 0.1 0.5 2.2 0.1 0.3 0.4 9.2 0.1 4.9 0.4 7.7 6.6 8.5 2.9 10.2 0.2 15.8 19.0 3.4 12.2 0.4 0.3 1.0 1.3 0.3 2.4 4.3 1.6 1.5 2.2 1.6 2.3 2.2 3.2 2.6 1.1 0.4 2.9 0.6 0.2 1.2 12.4 15.2 15.4 20.2 10.7 8.2 12.3 10.1 12.7 13.7 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell line enriched" "Detected in some" 8 "HEL: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: , HPA058217: " "unprognostic (4.16e-3)" "prognostic favourable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavourable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.2 1.7 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.1 3.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.6 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Group enriched" "Detected in some" 6 "CAPAN-2: 29.5;SK-BR-3: 29.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 29.5 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.6 1.7 0.6 0.1 0.3 0.0 29.4 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favourable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.5 16.0 0.1 9.7 6.3 3.4 3.0 0.2 5.8 5.0 2.3 16.4 0.5 0.6 1.2 5.1 1.3 0.3 9.0 10.2 0.3 5.5 14.7 0.1 8.3 3.1 0.9 9.6 1.2 0.1 11.0 5.4 2.0 4.2 2.2 0.6 3.0 0.3 0.0 2.4 7.4 14.1 2.5 0.6 0.0 0.2 4.6 0.3 1.8 0.0 8.0 2.7 14.5 0.3 10.6 0.1 8.4 9.1 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell line enhanced" "Detected in some" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.8;U-251 MG: 8.3;U-937: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA049286: " "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favourable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.5 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.3 6.1 0.1 0.4 3.3 2.3 0.0 16.4 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.8 0.1 0.3 0.0 2.7 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952647-62969585 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell line enhanced" "Detected in many" "BJ: 15.7;CACO-2: 14.5;Hep G2: 30.1;NB-4: 16.2;RPMI-8226: 15.6;U-937: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 7.3" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA047470 Approved Nucleoplasm Nucleoplasm "HPA047470: " "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavourable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 4.2 1.3 1.6 11.4 3.4 11.9 2.2 0.4 1.4 1.9 4.8 0.6 0.1 6.4 1.7 1.2 1.5 2.1 7.3 1.5 1.5 0.7 1.5 42.7 5.7 6.6 4.8 0.0 1.9 3.4 0.0 2.5 1.9 3.4 1.6 3.8 1.1 3.6 1.2 3.4 0.9 3.9 1.4 3.9 10.5 10.7 0.8 2.9 0.5 1.4 0.5 11.8 5.6 2.4 4.0 4.2 0.0 2.7 7.3 1.3 1.2 0.0 0.0 0.0 0.1 0.1 1.3 0.0 15.7 4.5 5.2 8.3 14.5 0.0 11.3 0.0 12.5 0.0 2.3 0.0 1.1 0.0 0.0 4.9 0.3 30.1 3.6 8.8 0.0 1.1 0.0 6.2 0.0 3.4 0.0 6.6 0.0 0.0 0.3 16.2 0.0 0.0 11.6 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 1.1 0.0 0.0 0.5 0.0 2.2 0.1 6.1 0.0 19.0 0.0 0.0 1.6 0.0 1.3 2.7 0.9 4.0 0.0 0.6 4.2 3.2 0.0 0.6 0.0 7.3 0.6 0.0 0.1 1.2 1.6 3.4 0.4 1.4 1.5 0.7 4.8 0.0 3.4 2.9 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.1 0.4 7.2 0.1 0.2 0.3 0.6 18.4 0.5 0.4 0.2 0.1 0.5 0.5 0.5 0.8 0.1 1.2 0.1 0.9 0.7 1.7 0.2 0.2 3.2 0.4 0.1 0.9 0.0 0.2 0.8 0.0 1.8 0.1 0.6 3.2 0.3 0.3 0.2 0.2 0.2 0.3 1.0 0.1 0.5 2.0 0.5 0.3 0.2 0.5 0.5 0.5 4.1 0.3 0.2 0.1 0.6 1.4 0.3 0.4 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favourable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.7 12.6 14.0 4.5 5.0 16.1 0.4 0.1 0.7 0.3 12.6 0.4 0.6 1.5 2.7 3.6 2.5 6.7 0.2 2.0 7.8 5.9 2.2 11.1 0.6 0.3 0.4 1.2 13.2 12.2 0.6 0.4 5.3 3.4 0.4 2.9 0.5 1.4 4.3 2.3 1.3 0.8 10.0 0.0 15.4 1.4 0.2 3.3 4.8 4.1 18.7 0.1 3.1 7.4 2.3 9.5 1.5 7.6 0.1 0.2 12.9 0.4 4.5 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348268-160452581 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 98.6" "Cell line enhanced" "Detected in some" "A549: 17.4;HeLa: 23.4;Hep G2: 14.5;RPTEC TERT1: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029750 Approved Approved Nucleoplasm,Vesicles,Cytosol "Vesicles, Cytosol" Nucleoplasm "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavourable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavourable (7.26e-4)" 4.1 6.9 1.0 2.1 1.3 0.0 5.2 1.8 0.9 7.6 4.1 0.9 4.1 0.2 14.2 11.8 4.1 9.0 9.0 1.1 1.2 1.3 2.4 15.2 12.7 9.7 2.2 0.9 10.3 1.3 0.0 0.9 17.8 1.9 18.9 0.6 0.9 34.5 23.0 98.6 5.1 2.7 10.8 4.4 0.3 2.9 3.4 0.6 0.4 3.4 5.7 2.1 3.2 7.3 0.0 0.0 0.8 0.0 0.1 1.5 0.0 0.0 17.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.0 23.4 14.5 0.8 0.0 0.0 0.5 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.9 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.0 1.3 1.8 0.9 1.2 1.3 2.2 0.9 1.9 0.6 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell line enhanced" "Detected in many" "hTCEpi: 8.9;U-266/70: 6.5" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Low region specificity" "Detected in single" HPA019059 Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 3.9 2.2 0.8 2.2 0.6 0.4 1.3 2.3 1.6 0.5 0.8 1.5 3.2 0.7 0.3 0.6 1.8 1.8 2.0 1.9 0.1 0.7 0.2 0.9 0.7 8.9 0.9 2.9 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.2 0.5 0.5 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.3 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.5 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell line enhanced" "Detected in many" "Hep G2: 49.6;SK-BR-3: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" HPA023048 Supported Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favourable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favourable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favourable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.0 26.0 2.5 12.4 0.9 0.7 5.0 6.0 1.9 7.7 5.8 15.7 6.0 6.3 4.7 1.4 9.0 3.5 6.2 1.4 4.6 20.1 5.1 15.8 49.6 1.1 11.5 6.3 0.5 3.2 5.4 1.0 4.4 8.6 7.9 2.6 26.4 16.8 12.2 2.5 19.6 12.8 5.3 19.9 6.8 12.7 16.4 11.1 5.6 38.2 1.3 16.3 6.4 1.9 5.9 19.5 8.6 10.8 4.9 2.5 3.6 2.6 12.2 5.1 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.2 15.1 8.9 7.9 3.7 6.8 8.4 11.1 9.4 12.4 7.9 14.9 16.0 7.0 8.4 9.3 20.6 9.8 13.4 2.8 13.1 17.9 6.4 7.4 9.1 16.1 10.3 10.8 6.8 8.1 9.4 10.1 5.7 13.0 11.0 5.5 14.1 10.7 9.7 19.2 23.2 12.7 4.8 16.5 7.4 3.9 43.9 19.7 6.4 15.4 7.9 7.4 5.2 5.5 13.9 9.3 6.4 10.4 9.7 5.6 8.9 16.7 9.2 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 SLC25A30 ENSG00000174032 "Solute carrier family 25 member 30" Q5SVS4 13 45393316-45418455 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 38.0;skeletal muscle: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045260 Approved Nucleoplasm Nucleoplasm "HPA045260: AB_10962505" "unprognostic (9.23e-2)" "unprognostic (9.92e-2)" "unprognostic (1.05e-1)" "unprognostic (4.28e-2)" "unprognostic (1.96e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-2)" "unprognostic (3.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavourable (3.32e-4)" "unprognostic (5.69e-2)" "unprognostic (1.58e-1)" "prognostic favourable (9.91e-8)" "unprognostic (2.24e-1)" "unprognostic (5.19e-2)" "unprognostic (4.12e-1)" "unprognostic (6.19e-3)" 7.7 6.3 6.2 4.7 5.7 5.3 7.1 3.6 6.3 6.5 4.2 2.1 9.7 2.5 7.7 7.2 5.3 3.9 4.5 38.0 5.8 3.8 24.6 19.5 5.9 9.3 5.4 4.3 10.8 7.5 2.4 5.7 3.4 8.1 8.0 3.5 9.5 6.8 9.1 43.1 4.4 3.5 9.4 7.6 6.1 4.0 5.0 4.9 1.2 6.5 6.7 4.4 6.6 9.0 1.6 5.3 4.3 3.4 1.7 2.7 1.1 2.2 5.0 3.0 12.9 15.1 9.7 1.0 10.8 6.3 9.3 5.6 5.2 6.2 0.0 9.5 11.0 4.4 6.9 10.8 11.1 7.4 5.6 8.5 3.2 13.9 8.9 12.1 11.5 6.3 7.4 13.7 10.2 16.1 5.1 0.0 18.8 2.7 4.4 8.4 4.4 6.4 11.1 5.0 4.5 20.2 1.9 0.6 3.0 6.0 9.2 8.6 7.2 16.4 5.9 8.7 5.0 9.7 7.4 2.2 4.5 0.1 9.5 11.5 13.3 0.0 2.8 4.3 2.2 3.4 1.5 1.6 2.2 2.2 4.0 1.5 2.7 1.2 0.0 1.7 1.5 5.3 0.8 1.1 6.2 5.7 3.6 6.3 5.8 3.8 5.4 4.3 8.1 4.9 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favourable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.5 5.3 17.4 14.2 15.9 20.4 21.8 8.9 11.4 10.0 14.2 14.8 11.2 19.6 22.2 7.5 15.8 20.9 8.7 20.4 15.0 17.0 16.3 12.9 9.3 24.0 23.1 10.1 23.0 29.3 7.3 22.5 10.5 8.6 12.7 14.5 10.2 13.8 15.9 17.2 10.0 15.0 15.4 27.9 11.7 8.1 11.2 18.3 12.0 21.9 38.7 15.2 13.2 10.6 13.9 7.8 24.6 8.5 25.9 16.9 23.0 18.0 9.7 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399060-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035188 Uncertain Approved Nucleoplasm Nucleoplasm "HPA035188: AB_10602400" "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavourable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavourable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 12.7 3.0 4.4 11.1 3.7 1.3 11.8 5.9 3.8 8.9 12.3 4.3 5.6 12.8 8.0 7.3 23.5 5.8 6.3 6.0 5.1 3.4 11.4 11.3 10.4 9.5 3.8 2.7 7.8 15.6 4.0 3.0 7.3 5.8 8.5 14.2 7.4 12.8 4.4 6.3 14.0 13.3 7.7 8.2 9.0 7.9 4.3 4.3 1.9 5.7 9.6 16.2 8.9 12.9 4.3 6.3 0.2 10.7 6.6 3.2 1.4 13.6 10.1 0.7 4.0 14.0 21.1 5.4 7.4 9.6 6.1 5.9 5.2 6.9 1.5 4.6 21.0 10.1 7.9 7.1 5.4 11.7 2.4 4.9 3.3 7.0 8.6 4.6 5.2 8.7 12.6 10.1 8.5 7.5 0.9 7.3 7.0 24.3 0.0 6.4 4.6 15.8 1.2 0.0 2.0 10.1 4.7 0.6 0.0 10.1 21.5 11.9 3.8 4.6 10.4 10.0 2.9 10.8 11.5 0.1 5.7 3.3 9.9 7.6 8.7 0.0 3.4 0.2 1.0 5.1 1.8 4.3 2.0 3.2 6.3 3.6 1.1 1.9 0.0 6.6 10.7 1.6 1.6 1.4 4.4 3.7 5.9 3.8 5.1 3.4 3.8 2.7 5.8 4.3 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 33.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA065411: " "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favourable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 14.3 9.0 15.9 9.3 23.1 10.2 8.9 18.6 31.9 9.1 10.4 19.7 6.6 16.8 8.1 11.1 9.0 7.8 10.7 10.6 16.1 16.7 25.9 31.2 10.6 8.7 14.4 18.1 7.1 8.3 17.7 10.9 7.8 22.5 8.7 11.1 9.3 7.0 9.5 12.8 9.1 13.9 10.8 13.5 13.3 8.4 8.9 12.1 10.6 9.7 6.0 11.2 9.7 7.9 3.7 6.3 33.8 9.1 4.2 4.9 5.6 10.2 17.5 8.6 11.3 18.8 10.1 6.8 11.0 16.2 20.0 16.4 17.1 9.3 8.1 9.7 16.4 15.3 31.4 12.9 17.8 9.3 10.5 7.4 11.2 10.3 14.4 9.6 13.7 14.3 11.4 20.2 12.3 16.2 7.7 13.5 13.7 18.4 10.0 6.8 20.3 18.2 6.4 8.7 13.9 26.2 12.2 13.4 18.2 12.8 23.4 14.6 17.6 15.8 13.1 11.6 9.8 13.0 13.1 13.8 10.5 12.3 12.8 10.1 11.4 6.5 8.4 8.7 4.7 9.1 4.9 3.7 3.8 4.4 6.3 2.4 3.1 3.7 33.8 4.2 7.1 2.8 3.3 5.6 15.9 23.1 18.6 31.9 16.1 16.7 14.4 18.1 22.5 12.1 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;Karpas-707: 18.6;RPMI-8226: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA050821: " "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favourable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.6 0.2 6.8 1.3 0.6 3.4 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 0.5 0.5 0.3 0.0 13.7 1.0 4.4 2.5 0.3 0.8 1.4 4.7 1.6 0.1 0.5 0.4 0.7 0.6 18.6 0.7 1.5 3.2 0.1 0.3 2.1 6.0 0.9 13.4 0.7 0.0 2.3 3.0 1.4 3.6 0.7 1.8 0.7 1.3 0.5 1.7 4.4 0.3 7.7 4.8 1.1 1.4 1.0 2.6 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 SLC26A11 ENSG00000181045 "Solute carrier family 26 member 11" Q86WA9 17 80219699-80253500 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029893 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA029893: AB_10600809" "unprognostic (5.86e-2)" "unprognostic (6.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavourable (1.55e-5)" "unprognostic (3.80e-2)" "unprognostic (2.63e-3)" "prognostic unfavourable (1.82e-6)" "unprognostic (2.05e-2)" "unprognostic (3.54e-2)" "unprognostic (1.03e-1)" "prognostic favourable (1.43e-5)" "unprognostic (2.86e-1)" "unprognostic (3.50e-1)" "unprognostic (9.54e-3)" "unprognostic (8.40e-2)" "unprognostic (8.69e-2)" "unprognostic (7.32e-2)" 9.9 30.9 10.2 10.2 19.3 16.3 8.4 9.1 18.0 11.6 8.2 12.6 14.1 8.7 11.6 14.6 6.9 9.2 10.0 5.1 9.4 30.5 12.4 6.9 12.8 14.3 10.5 17.4 18.3 7.9 14.9 25.6 21.1 17.2 11.8 5.1 15.6 12.2 14.8 6.5 13.1 11.9 11.6 9.3 17.3 7.3 4.8 7.3 1.8 18.1 4.9 6.7 9.8 14.1 0.4 1.3 0.1 2.3 0.1 4.9 1.9 0.5 8.3 9.8 7.6 4.9 3.7 11.4 4.7 5.9 10.7 6.7 9.5 1.7 0.1 9.7 4.9 3.2 5.4 3.5 4.2 11.3 9.8 0.0 10.5 8.8 13.1 0.0 1.5 6.7 5.8 5.1 2.4 9.0 4.1 12.1 6.3 7.8 0.4 0.2 4.4 8.1 0.4 1.1 4.4 9.7 9.1 3.9 12.0 4.8 11.9 12.3 14.3 0.2 6.7 8.6 5.1 7.3 0.5 13.6 5.1 1.3 4.5 0.0 6.9 0.0 2.3 0.0 1.8 0.9 2.6 0.4 3.2 2.6 1.3 0.2 4.9 2.0 0.1 0.1 0.3 0.0 4.0 1.9 10.2 19.3 9.1 18.0 9.4 30.5 10.5 17.4 17.2 7.3 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: , HPA067637: " "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.7 1.4 0.0 0.1 3.8 0.0 0.3 1.4 0.0 18.9 9.8 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.7 0.0 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093646-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 19.4 22.1 14.4 19.4 15.7 13.3 29.7 14.9 18.5 25.0 20.9 13.2 33.7 19.7 24.3 32.4 20.5 20.3 23.5 25.4 14.5 15.4 28.6 39.2 24.3 23.7 15.5 13.1 25.4 50.5 29.6 38.1 34.3 13.9 24.5 19.8 17.6 36.8 35.3 17.1 21.2 25.0 18.1 13.2 20.1 20.3 18.1 12.7 22.1 33.5 18.8 19.6 18.2 28.9 8.3 13.2 12.4 6.9 5.6 9.1 3.3 15.6 12.2 11.3 19.9 29.9 23.1 36.0 24.9 22.6 15.7 24.1 11.2 19.8 20.8 31.7 16.9 17.0 15.7 18.9 26.7 24.8 18.1 23.2 15.4 18.2 24.1 14.5 25.8 15.6 25.0 16.2 19.3 15.2 13.9 24.9 20.0 19.8 19.1 30.3 12.9 13.9 15.4 14.4 37.5 23.5 14.7 20.3 16.1 19.7 19.8 33.7 19.1 32.4 13.8 10.3 13.3 25.6 24.6 22.6 27.7 16.2 20.2 26.5 25.2 12.4 6.7 10.7 6.1 6.8 6.5 8.3 9.1 8.9 8.4 6.3 8.4 7.1 5.9 5.6 6.9 13.2 6.1 3.3 14.4 15.7 14.9 18.5 14.5 15.4 15.5 13.1 13.9 12.7 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042430, HPA060345" Uncertain Approved Nucleoplasm Nucleoplasm "HPA042430: AB_10806238, HPA060345: " "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 11.3 17.3 6.5 9.9 8.6 3.1 12.1 9.4 9.4 18.8 13.1 10.5 29.9 11.3 14.0 22.9 11.8 12.3 11.5 12.9 7.8 6.7 19.4 38.3 12.8 13.6 9.4 5.6 13.6 42.4 18.8 24.6 13.9 8.9 15.0 10.5 9.2 26.6 33.9 7.0 9.4 15.2 10.4 8.2 11.9 12.4 8.9 8.8 14.9 26.1 5.8 10.7 10.2 11.6 6.0 16.7 12.1 8.3 6.9 10.8 6.0 14.6 10.2 5.3 6.5 19.7 17.0 10.0 11.0 14.8 13.4 13.1 5.8 15.7 7.6 17.8 9.0 12.5 9.1 10.8 15.1 10.7 9.4 7.8 4.9 11.4 28.4 8.6 6.9 13.5 21.7 7.1 27.6 14.6 6.2 18.2 11.9 9.3 3.5 5.1 5.1 9.9 3.9 5.9 22.7 13.7 9.3 6.2 5.1 9.2 21.5 19.5 6.8 11.0 15.2 7.9 3.9 14.4 11.5 21.5 7.5 8.0 11.3 7.0 11.2 12.1 8.3 6.0 9.4 6.5 10.8 6.0 6.8 7.4 10.7 4.1 6.5 6.3 1.8 6.9 6.3 16.7 6.1 6.0 6.5 8.6 9.4 9.4 7.8 6.7 9.4 5.6 8.9 8.8 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in some" 81 "BEWO: 12.3;EFO-21: 46.6;RPTEC TERT1: 33.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037989 Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "Nucleoplasm, Golgi apparatus" "HPA037989: AB_10670536" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "Q96G79, L0R6Q1" 5 140564456-140569103 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm Nucleoplasm "HPA062210: " "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favourable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 22.0 30.4 12.3 18.6 17.1 8.4 19.6 14.0 21.8 18.2 25.5 24.9 22.6 19.2 18.2 19.8 30.3 20.6 26.0 25.7 13.1 10.3 35.1 39.2 23.1 22.5 16.0 11.1 19.0 28.3 28.2 14.9 24.6 19.4 20.4 26.5 20.5 32.6 15.9 54.3 28.3 30.6 19.8 13.0 28.5 21.7 30.5 15.3 26.0 29.2 28.0 27.5 18.3 18.0 15.4 32.8 15.8 36.9 26.9 27.6 32.4 15.3 46.1 18.4 34.7 25.3 15.9 27.5 22.3 15.1 27.3 28.8 55.7 17.7 45.4 27.7 21.0 17.0 0.0 32.7 23.5 55.2 25.2 33.9 45.0 0.2 18.0 33.2 25.6 21.0 25.6 27.2 24.3 23.3 26.2 45.8 27.0 28.4 34.5 14.4 12.5 23.5 25.7 37.3 39.3 20.4 30.4 20.6 27.5 28.3 47.1 22.0 39.1 14.2 27.3 24.6 17.1 24.4 25.0 19.1 44.7 19.1 18.1 37.5 28.5 7.5 26.9 15.8 27.6 36.9 26.3 14.3 22.1 24.7 32.8 15.4 25.9 23.0 9.9 26.9 33.3 12.0 14.7 32.4 12.3 17.1 14.0 21.8 13.1 10.3 16.0 11.1 19.4 15.3 SLC35B1 UGTREL1 ENSG00000121073 "Solute carrier family 35 member B1" P78383 17 49700943-49709014 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048655, HPA057418" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA048655: , HPA057418: " "unprognostic (1.35e-1)" "unprognostic (2.15e-2)" "unprognostic (1.09e-3)" "unprognostic (6.36e-2)" "unprognostic (8.31e-2)" "unprognostic (2.86e-3)" "unprognostic (6.17e-3)" "unprognostic (4.39e-2)" "unprognostic (2.47e-2)" "unprognostic (4.00e-3)" "unprognostic (3.37e-2)" "unprognostic (4.42e-2)" "prognostic unfavourable (5.69e-7)" "unprognostic (6.28e-2)" "unprognostic (7.88e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-2)" 8.5 8.3 8.4 7.4 11.8 8.0 10.7 8.2 14.0 9.3 13.0 9.3 9.2 13.7 7.6 26.5 9.4 9.9 7.3 15.8 8.6 9.2 16.0 46.7 10.1 16.0 9.8 7.9 7.5 22.3 13.5 13.2 12.4 9.9 7.4 13.1 8.4 22.4 12.7 33.7 9.2 27.3 8.0 8.1 10.2 9.3 9.1 7.1 6.5 19.7 13.8 10.8 9.9 6.7 6.6 25.0 8.1 15.1 7.0 9.5 7.9 13.5 22.7 17.0 26.7 15.6 9.8 19.2 14.3 23.3 30.5 24.5 46.7 15.8 9.4 33.6 19.8 10.1 26.8 17.1 33.4 11.5 19.5 11.9 14.9 27.3 27.2 22.2 11.2 10.0 18.8 22.0 27.5 18.8 11.6 27.0 20.9 27.5 16.3 14.4 7.6 25.5 11.0 18.3 25.3 15.0 14.3 14.7 18.9 8.4 6.8 9.8 21.5 15.2 8.0 23.3 10.3 24.9 18.8 14.3 23.5 14.0 15.2 16.9 20.4 8.1 15.1 5.0 9.5 13.5 6.9 6.6 6.5 8.9 16.7 3.6 6.6 6.0 6.7 7.0 9.1 25.0 7.4 7.9 8.4 11.8 8.2 14.0 8.6 9.2 9.8 7.9 9.9 7.1 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA027011: " "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavourable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavourable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 16.8 25.9 19.4 26.7 24.0 25.6 17.5 30.3 25.0 19.1 19.3 22.8 21.3 22.0 19.2 20.9 23.4 24.3 20.2 13.5 19.0 12.9 20.7 26.7 17.4 22.9 19.9 13.6 21.0 30.5 18.0 23.7 29.8 17.7 23.6 12.2 28.9 30.9 17.3 13.4 25.6 20.7 15.8 19.3 26.1 21.6 19.6 23.3 19.7 23.0 13.5 23.4 19.1 19.3 17.4 42.9 26.8 21.9 18.3 28.3 23.5 14.1 17.1 8.0 6.4 11.2 10.7 14.8 7.7 14.7 8.7 10.3 24.0 22.6 9.5 26.5 9.1 20.1 4.5 17.5 3.2 7.6 13.5 8.3 10.5 19.1 21.2 10.9 9.9 15.4 22.3 12.3 14.4 7.2 13.1 17.5 6.4 34.3 7.6 16.3 10.3 16.7 7.2 8.6 18.3 11.0 14.0 11.8 16.4 7.2 37.6 24.1 22.2 19.1 6.9 22.4 14.3 11.3 12.3 23.4 19.2 9.8 25.3 12.4 9.9 19.0 21.9 26.8 23.8 21.5 22.2 17.4 24.4 24.0 23.9 16.9 28.3 25.5 19.5 18.3 16.7 42.9 22.1 23.5 19.4 24.0 30.3 25.0 19.0 12.9 19.9 13.6 17.7 23.3 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Group enriched" "Detected in some" 9 "AF22: 23.3;WM-115: 39.2" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.3 0.0 0.0 0.1 0.0 39.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 SLC35F6 "ANT2BP, C2orf18, FLJ20555, TANGO9" ENSG00000213699 "Solute carrier family 35 member F6" Q8N357 2 26764284-26781231 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 47.8;Karpas-707: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034655 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA034655: AB_10696359" "unprognostic (2.26e-1)" "unprognostic (7.45e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-1)" "unprognostic (7.71e-2)" "unprognostic (1.03e-1)" "prognostic unfavourable (1.11e-4)" "prognostic unfavourable (3.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.35e-1)" "unprognostic (3.24e-1)" "unprognostic (2.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.07e-2)" "unprognostic (9.95e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-2)" 37.3 24.1 9.7 10.5 11.7 6.5 42.2 8.3 15.6 17.9 14.5 16.0 12.4 10.4 14.1 14.0 25.2 12.5 14.4 15.0 10.4 11.6 37.4 25.4 15.3 22.0 12.3 9.3 20.4 12.6 13.1 12.2 26.6 11.9 15.3 9.0 13.8 16.7 14.2 16.7 30.9 14.7 15.4 11.4 14.8 16.3 11.7 9.1 10.5 24.1 20.4 15.5 13.8 18.2 3.1 7.1 7.8 19.0 8.6 8.8 5.9 8.1 14.5 4.4 11.2 15.2 6.9 6.8 4.7 7.2 6.0 5.5 9.1 15.8 2.2 7.9 6.5 10.3 6.3 9.3 4.3 3.8 3.1 2.4 5.6 7.6 47.8 2.7 12.6 10.9 9.6 6.8 22.8 6.9 4.6 42.1 6.0 13.3 3.3 2.4 2.4 3.8 3.0 12.7 3.4 15.9 6.6 3.3 4.4 7.8 12.9 8.4 4.8 2.8 6.3 7.8 8.4 10.7 5.1 8.1 10.2 4.3 8.4 4.6 7.1 7.0 12.0 5.3 8.8 16.5 5.0 3.1 6.1 8.0 7.1 2.5 4.2 6.0 7.8 8.6 19.0 5.5 3.8 5.9 9.7 11.7 8.3 15.6 10.4 11.6 12.3 9.3 11.9 9.1 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58685104 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041777 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782" "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favourable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favourable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 7.0 11.1 10.6 6.7 10.0 2.7 7.2 7.7 13.7 6.2 5.3 10.6 6.8 4.8 6.0 7.4 6.0 4.2 6.5 13.8 7.2 7.2 7.4 12.1 5.2 4.3 6.1 11.0 4.7 5.0 16.9 10.2 8.4 8.3 5.2 6.9 8.9 6.1 5.6 9.6 5.3 4.9 8.5 5.8 10.3 5.4 27.1 6.6 4.2 8.0 8.1 5.1 6.5 6.3 2.8 6.1 2.5 8.6 2.3 5.2 6.6 4.3 6.8 6.8 10.4 14.2 8.5 12.8 10.3 12.0 14.5 10.2 6.4 6.8 2.7 5.9 14.3 10.6 6.5 7.2 8.6 1.7 5.9 3.1 5.7 10.3 21.5 6.5 9.0 17.1 15.2 10.1 6.7 14.9 9.2 4.2 10.5 5.2 2.5 3.8 7.4 10.2 9.4 7.3 7.5 6.4 10.1 5.0 7.6 15.5 10.7 4.5 5.0 2.7 11.6 8.0 6.1 13.8 3.1 6.2 4.0 3.2 10.8 3.9 5.9 0.2 8.6 2.5 5.2 8.4 3.1 1.9 3.3 3.8 6.1 2.8 2.7 2.9 0.8 2.3 7.5 2.1 2.2 6.6 10.6 10.0 7.7 13.7 7.2 7.2 6.1 11.0 8.3 6.6 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: , HPA036513: AB_10670801, HPA066087: " "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favourable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 3.1 10.5 20.2 5.5 3.9 9.4 10.4 14.6 7.1 7.1 3.5 15.7 11.3 4.3 22.3 8.3 4.5 12.3 13.5 8.9 2.3 9.1 4.9 16.4 12.9 4.4 17.9 2.1 5.5 2.0 7.8 9.0 15.8 14.1 6.1 11.3 3.0 5.1 5.6 23.5 8.3 12.0 7.1 10.8 30.7 5.2 7.8 10.7 14.6 29.9 7.6 4.8 11.1 15.4 12.9 14.9 8.4 7.6 2.1 1.3 2.6 10.4 8.4 13.0 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 SLC39A11 C17orf26 ENSG00000133195 "Solute carrier family 39 member 11" Q8N1S5 17 72645949-73092712 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 47.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021455 Approved Nucleoplasm Nucleoplasm "HPA021455: " "unprognostic (2.29e-2)" "unprognostic (2.75e-1)" "unprognostic (1.25e-1)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (2.30e-1)" "unprognostic (1.57e-3)" "unprognostic (5.26e-2)" "unprognostic (1.17e-1)" "unprognostic (4.96e-3)" "unprognostic (3.85e-2)" 10.4 7.4 12.4 7.8 17.9 10.7 10.8 5.3 14.4 9.3 13.3 19.8 6.6 11.5 4.8 9.6 13.0 5.6 8.6 4.2 13.3 6.3 7.9 21.9 8.2 4.8 27.8 6.6 2.8 23.8 3.1 3.8 7.0 15.3 5.3 13.8 6.7 16.6 5.2 3.7 11.2 12.7 5.7 15.7 6.5 27.6 4.1 22.5 6.0 20.6 3.6 8.6 8.3 7.6 6.0 14.9 9.8 16.2 8.7 6.9 6.3 4.2 7.8 0.9 3.8 6.8 5.5 5.3 4.6 4.1 2.1 2.8 2.9 19.4 5.3 4.7 4.6 3.7 1.3 2.3 3.2 5.7 2.7 4.9 2.0 3.3 4.1 5.2 47.6 4.7 4.4 4.3 2.5 2.1 2.5 6.7 2.6 6.0 3.3 11.4 0.7 3.3 2.2 3.5 4.4 3.5 4.4 2.2 3.0 2.4 18.4 2.7 12.6 7.3 1.8 4.2 3.9 3.5 2.8 5.4 2.4 3.7 6.8 10.7 2.4 5.5 16.2 9.8 6.9 15.4 4.6 6.0 5.3 5.2 14.9 3.9 3.8 5.2 2.5 8.7 11.9 10.5 6.5 6.3 12.4 17.9 5.3 14.4 13.3 6.3 27.8 6.6 15.3 22.5 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in some" 60 "CACO-2: 22.2;Hep G2: 32.1" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Low region specificity" "Detected in many" HPA018423 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favourable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Cell line enhanced" "Detected in some" "ASC diff: 91.2;CACO-2: 20.8;HEL: 73.9;HMC-1: 19.5;T-47d: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA065634: " "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favourable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.2 0.1 0.0 91.2 0.6 4.4 0.0 1.1 0.3 0.5 20.8 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.3 73.9 0.3 7.6 0.3 0.2 19.5 6.4 0.0 0.2 0.0 2.2 7.5 0.2 1.1 0.0 3.0 4.8 0.2 0.3 0.0 0.8 0.4 0.9 3.0 0.1 0.9 0.1 6.1 0.0 36.0 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell line enhanced" "Detected in many" "ASC diff: 71.8;ASC TERT1: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064714 Supported Nucleoplasm,Mitochondria 270000 Mitochondria Nucleoplasm "HPA064714: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavourable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favourable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.7 5.7 1.5 1.9 71.8 56.8 4.9 5.7 14.9 3.7 5.0 6.0 18.0 9.0 2.9 21.5 13.5 4.6 8.2 6.4 7.8 3.8 11.2 4.0 7.5 4.8 2.2 5.8 31.5 6.8 7.1 6.5 11.7 0.3 18.8 4.2 9.6 8.9 2.5 8.7 5.5 1.8 6.0 6.8 5.1 15.9 7.5 2.9 8.0 8.9 8.0 8.8 6.8 10.0 3.7 3.4 4.0 4.1 14.5 9.5 6.8 7.2 4.9 4.9 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Cell line enriched" "Detected in some" 30 "HMC-1: 138.2" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavourable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favourable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.4 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.2 0.5 0.0 0.6 0.4 4.6 0.1 0.3 0.3 0.7 138.2 0.0 0.1 0.3 0.0 1.5 0.7 0.2 0.2 0.3 0.1 1.3 2.0 1.7 0.1 0.6 0.2 0.6 2.1 0.2 0.4 0.2 3.4 0.6 0.7 0.2 1.5 0.2 1.5 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627327-219641980 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.6;ovary: 30.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "myeloid DC: 2.3;plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 58 "dendritic cells: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm Nucleoplasm "HPA063498: " "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (4.12e-4)" 1.8 5.4 11.8 1.6 22.5 1.2 2.0 8.8 22.0 2.8 1.3 3.0 0.4 1.4 3.4 2.6 2.9 2.7 2.3 103.6 10.4 8.2 1.6 1.0 1.3 1.4 6.5 9.0 30.2 2.7 4.5 9.9 2.5 24.1 4.2 1.1 4.9 3.1 4.3 1.2 1.6 1.3 3.1 1.6 2.6 1.4 4.2 3.5 0.0 1.5 0.0 1.3 1.6 0.9 0.0 8.9 0.0 0.1 0.0 0.0 0.0 6.8 0.3 2.5 7.1 0.4 0.5 4.9 4.3 4.5 5.8 4.1 5.0 4.0 0.0 1.7 1.6 4.0 1.2 7.7 1.7 0.0 1.1 0.0 0.0 0.1 1.2 0.1 0.4 3.4 7.4 0.0 2.3 0.0 0.2 0.0 1.7 2.3 0.0 0.0 4.0 5.8 0.0 0.0 0.0 4.0 1.6 1.5 7.0 2.7 7.5 3.7 0.7 1.8 0.0 3.6 6.3 0.0 3.4 0.0 0.0 0.0 3.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 11.8 22.5 8.8 22.0 10.4 8.2 6.5 9.0 24.1 3.5 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Low region specificity" "Detected in all" "CAB015467, HPA051805, HPA055106" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB015467: , HPA051805: , HPA055106: " "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favourable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favourable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.3 1.3 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.0 4.8 0.0 0.1 1.8 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 6 "Hep G2: 18.4;Karpas-707: 5.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 5.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 27.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007663, HPA008044" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA007663: AB_1857194, HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.4 1.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.6 4.7 1.4 27.6 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.6 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2;skin 1: 38.2" "Cell line enhanced" "Detected in many" "HaCaT: 23.5;hTCEpi: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavourable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 2.9 22.8 8.8 4.6 18.3 8.6 5.4 5.5 14.3 6.0 7.9 38.1 2.6 2.5 6.2 1.5 16.5 9.6 4.9 1.3 9.9 10.0 2.0 4.9 5.6 1.4 29.5 4.5 4.0 7.8 2.1 1.0 1.7 26.8 2.6 6.2 24.0 7.9 6.1 1.3 38.2 5.6 8.9 42.2 1.1 3.5 1.2 26.3 0.0 4.9 7.2 4.3 6.6 10.9 0.2 0.0 0.2 0.1 0.0 1.4 0.2 7.2 5.4 2.7 6.9 4.3 1.4 6.1 5.8 15.6 9.4 11.7 1.8 2.8 0.1 0.6 15.9 23.5 4.1 4.6 1.9 0.0 0.7 6.4 12.8 2.1 19.8 1.4 0.3 4.4 41.1 4.6 11.0 0.2 4.9 18.5 0.4 4.0 1.0 0.0 2.0 7.2 0.8 0.0 8.2 0.9 0.8 1.7 1.6 2.9 13.4 2.6 3.5 3.8 0.1 1.0 4.4 0.9 3.0 20.4 14.0 1.6 3.5 0.0 1.4 0.0 0.0 0.2 0.4 0.1 0.2 0.2 0.4 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 8.8 18.3 5.5 9.4 9.9 10.0 29.5 4.5 26.8 26.3 SLC7A6OS FLJ13291 ENSG00000103061 "Solute carrier family 7 member 6 opposite strand" Q96CW6 16 68284503-68310946 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041533 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041533: AB_10794298" "unprognostic (1.43e-1)" "unprognostic (2.02e-2)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "unprognostic (5.51e-2)" "unprognostic (4.62e-4)" "unprognostic (2.44e-4)" "unprognostic (2.05e-1)" "unprognostic (3.41e-1)" "unprognostic (2.38e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-2)" "prognostic favourable (2.35e-4)" "unprognostic (1.84e-1)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" 19.8 14.1 15.7 16.1 20.0 20.1 17.4 29.1 18.2 13.2 13.1 20.2 10.9 13.9 15.5 18.0 12.4 13.4 10.7 16.5 14.6 11.7 13.4 9.3 13.8 24.7 19.8 14.2 17.0 14.7 18.8 13.1 15.9 18.1 13.4 13.4 14.2 14.1 15.0 24.5 15.5 16.3 12.3 17.4 20.3 13.7 12.2 24.5 17.0 15.7 8.7 19.8 14.0 21.6 13.3 11.2 21.8 13.3 12.7 14.9 10.6 7.9 8.2 12.0 9.0 7.1 9.7 13.8 10.1 5.8 12.1 10.7 20.8 11.6 14.0 9.3 6.7 14.5 11.3 8.6 11.0 5.2 6.9 9.3 13.1 17.1 9.1 13.1 10.2 7.4 9.6 9.9 16.1 9.0 14.4 6.3 11.0 12.0 16.9 13.3 8.6 7.0 20.1 7.4 17.1 7.6 10.5 12.8 9.3 19.5 4.5 11.4 12.2 12.2 13.2 9.7 8.3 9.4 8.0 15.6 12.6 20.9 10.0 15.9 9.9 21.5 11.4 21.8 13.4 13.3 14.9 13.1 13.4 12.0 8.7 13.3 14.5 11.4 10.3 12.7 10.8 11.2 13.3 10.6 15.7 20.0 29.1 18.2 14.6 11.7 19.8 14.2 18.1 24.5 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 67.7" "Cell line enhanced" "Detected in many" "BJ: 15.1;fHDF/TERT166: 36.6;hTERT-HME1: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: " "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 3.9 2.9 7.7 4.4 14.3 1.4 2.0 3.5 15.3 5.5 7.3 1.8 7.1 3.3 12.2 3.9 4.0 3.9 5.3 67.7 7.7 6.6 11.0 2.2 3.7 2.5 5.2 8.2 2.1 1.5 1.1 1.9 6.8 7.6 12.2 3.4 1.0 1.5 17.2 1.5 2.1 3.6 20.5 2.8 4.4 2.5 1.4 2.5 0.1 1.6 0.0 1.3 9.8 2.8 0.0 2.4 25.2 6.0 0.0 0.0 0.5 1.5 1.1 1.1 0.1 1.7 3.5 0.0 15.1 5.8 5.0 3.3 0.0 2.5 0.0 1.2 36.6 0.6 0.2 2.5 5.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 5.7 10.7 0.4 0.0 0.2 6.4 0.0 0.4 0.0 0.7 2.1 4.0 7.9 0.0 1.7 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.3 5.1 4.8 0.1 0.0 1.6 0.8 0.0 0.0 0.8 0.9 0.7 0.0 4.9 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 25.2 0.0 6.0 0.1 0.0 0.5 7.7 14.3 3.5 15.3 7.7 6.6 5.2 8.2 7.6 2.5 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;HDLM-2: 5.0;RT4: 8.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Region enriched" "Detected in single" 5 "olfactory region: 1.7" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA036096: " "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.3 0.3 0.8 0.0 0.1 0.1 0.3 0.0 0.0 0.0 1.4 0.5 0.2 3.0 0.0 0.4 0.0 0.0 0.0 5.0 0.2 0.3 0.5 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.5 0.1 0.2 1.4 0.6 0.2 0.6 0.4 0.0 8.9 0.2 0.3 0.2 0.5 0.1 0.2 0.2 0.6 0.6 1.4 0.9 0.3 0.3 0.2 0.1 0.7 0.2 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 0.7 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA047008: " "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.4 15.5 13.0 0.0 11.9 4.7 2.0 1.8 1.3 1.7 16.8 2.1 13.8 0.8 7.0 5.0 2.8 14.7 4.9 16.8 4.2 12.1 8.3 11.7 5.3 11.4 6.7 4.2 14.5 8.5 5.6 12.3 6.2 1.0 9.4 7.2 2.3 3.8 0.0 3.4 7.3 5.7 1.0 10.7 9.7 5.4 1.4 3.5 1.4 7.8 10.5 4.4 2.7 6.9 4.1 10.5 7.6 12.2 5.3 10.3 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Cell line enhanced" "Detected in some" "Karpas-707: 7.9;RPTEC TERT1: 44.8;U-937: 11.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favourable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.5 44.8 0.0 0.3 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.3 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 SLF1 "ANKRD32, BRCTD1, BRCTx, DKFZp564C0469, DKFZp761C121" ENSG00000133302 "SMC5-SMC6 complex localization factor 1" Q9BQI6 5 94618347-94739436 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HeLa: 34.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040793, HPA054213" Uncertain Approved Nucleoplasm Nucleoplasm "HPA040793: AB_10796560, HPA054213: " "unprognostic (7.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.44e-3)" "unprognostic (1.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-5)" "unprognostic (1.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (6.57e-6)" "unprognostic (3.27e-2)" "unprognostic (2.83e-1)" "unprognostic (1.77e-1)" "unprognostic (8.32e-2)" 3.4 3.6 9.8 4.5 14.1 6.3 4.0 17.6 14.7 3.4 4.0 2.1 2.7 4.3 3.7 3.3 3.7 4.8 4.6 4.7 6.1 6.2 3.8 3.1 3.4 6.5 3.1 9.8 6.3 4.7 3.3 7.9 3.4 5.3 3.0 5.2 1.7 3.4 3.1 3.4 7.8 6.7 3.3 5.1 5.9 3.2 14.8 4.8 9.2 4.0 3.4 5.2 3.5 3.4 5.3 1.9 10.8 1.9 1.5 4.6 1.0 3.0 4.0 5.7 5.3 1.8 2.2 3.6 4.7 2.5 5.5 7.7 2.1 4.2 4.8 3.2 1.4 4.2 4.6 3.8 7.4 1.6 3.8 3.2 34.1 1.8 0.5 1.6 3.6 1.1 1.1 4.8 2.1 2.2 3.5 3.0 4.7 2.8 4.5 2.2 5.9 2.2 2.8 6.4 5.2 1.7 2.4 5.8 5.7 5.7 2.5 2.0 3.3 4.8 1.6 2.6 3.6 3.7 6.2 2.3 4.6 3.9 4.1 4.7 5.2 1.0 1.9 1.1 2.6 1.5 1.4 3.1 3.9 4.6 1.2 5.3 1.8 2.4 10.8 1.5 1.2 1.9 2.2 1.0 9.8 14.1 17.6 14.7 6.1 6.2 3.1 9.8 5.3 4.8 SLFN5 MGC19764 ENSG00000166750 "Schlafen family member 5" Q08AF3 17 35243036-35273655 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 33.1;hTERT-HME1: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 11.1;MAIT T-cell: 13.7;memory CD4 T-cell: 13.6;memory CD8 T-cell: 12.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 13.7;NK-cell: 16.8;T-reg: 27.8" "Group enriched" "Detected in many" 7 "NK-cells: 16.8;T-cells: 27.8" "Low region specificity" "Detected in all" HPA017760 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA017760: AB_2189993" "unprognostic (3.43e-1)" "unprognostic (3.26e-1)" "unprognostic (4.66e-2)" "unprognostic (1.60e-1)" "unprognostic (8.35e-2)" "unprognostic (1.15e-3)" "unprognostic (1.70e-2)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (7.01e-2)" "unprognostic (2.41e-3)" "unprognostic (2.39e-1)" "unprognostic (6.05e-3)" "unprognostic (3.27e-1)" "unprognostic (7.77e-2)" "unprognostic (3.92e-1)" "unprognostic (1.48e-1)" 32.9 12.8 2.8 21.2 2.6 2.8 11.5 1.7 3.0 18.9 7.7 6.6 25.3 4.0 13.6 7.7 10.0 9.3 8.3 6.4 3.6 2.8 5.9 4.0 18.6 20.9 4.8 1.2 10.7 5.0 4.5 3.2 9.9 6.0 15.9 5.0 7.9 15.4 43.1 27.5 5.0 8.5 10.9 6.1 25.3 7.6 3.8 2.2 51.4 7.6 7.2 22.3 17.0 8.5 0.7 1.4 1.9 3.0 16.8 27.8 7.1 6.0 3.1 0.4 0.5 9.0 15.9 1.2 15.8 25.0 13.2 14.8 0.0 3.9 0.7 10.2 15.5 25.5 0.3 7.1 9.3 0.1 0.5 0.1 3.3 0.3 33.1 0.4 0.1 18.1 18.0 10.1 44.2 6.0 0.0 9.1 9.2 0.5 7.4 0.3 0.5 2.3 0.0 5.3 0.0 3.4 15.0 1.0 0.0 1.7 1.6 28.1 10.5 0.2 23.6 5.3 2.0 3.8 3.6 1.6 0.1 0.1 15.5 0.0 7.5 1.9 1.7 1.1 11.1 2.7 13.7 0.4 13.6 12.6 1.4 0.7 17.0 13.7 0.7 16.8 3.0 0.5 27.8 7.1 2.8 2.6 1.7 3.0 3.6 2.8 4.8 1.2 6.0 2.2 SLU7 9G8 ENSG00000164609 "SLU7 homolog, splicing factor" O95391 5 160401641-160421711 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035907, HPA058120" Uncertain Approved "Nucleoplasm,Nuclear speckles" Nucleoplasm "Nuclear speckles" "HPA035907: AB_10671717, HPA058120: " "unprognostic (3.70e-2)" "unprognostic (7.18e-2)" "unprognostic (1.86e-2)" "unprognostic (9.96e-3)" "unprognostic (8.01e-2)" "unprognostic (3.52e-1)" "unprognostic (3.38e-3)" "unprognostic (3.76e-2)" "unprognostic (2.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (7.69e-2)" "prognostic favourable (1.98e-4)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" 19.4 18.9 25.7 14.1 30.7 32.9 22.0 30.4 32.9 18.0 16.2 14.2 14.2 12.9 18.1 21.4 17.8 14.6 14.8 19.3 23.7 23.6 19.4 19.0 18.1 19.4 25.7 28.1 17.5 15.4 18.4 21.6 18.5 28.4 17.5 16.8 10.3 18.6 16.6 33.8 17.7 17.0 18.6 26.2 20.6 17.8 20.3 25.8 21.4 26.0 20.2 23.5 20.6 17.7 18.4 13.2 33.5 20.1 20.6 17.9 12.2 12.3 15.6 13.4 19.0 17.7 18.8 17.4 17.4 25.4 19.3 23.3 20.7 15.0 20.1 17.8 18.6 13.7 11.7 19.3 24.3 32.3 17.3 14.9 21.3 13.2 17.8 25.1 18.4 20.2 18.1 17.6 20.1 13.2 13.5 18.8 17.2 10.8 12.2 16.1 9.8 14.0 10.5 27.9 19.8 17.0 20.0 16.3 22.5 20.4 18.7 30.7 25.1 23.8 16.7 18.8 9.7 13.6 18.4 21.0 24.0 17.9 27.1 16.7 17.7 24.7 13.2 22.5 17.4 14.8 16.3 18.4 16.3 17.1 12.1 16.6 17.9 17.1 33.5 20.6 20.1 13.2 17.4 12.2 25.7 30.7 30.4 32.9 23.7 23.6 25.7 28.1 28.4 25.8 SLX1A GIYD1 ENSG00000132207 "SLX1 homolog A, structure-specific endonuclease subunit" Q9BQ83 16 30193887-30197561 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.2;intestine: 26.0" "Cell line enhanced" "Detected in many" "U-266/70: 43.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047038 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047038: " "unprognostic (3.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.84e-1)" "unprognostic (5.60e-2)" "unprognostic (6.04e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-1)" "unprognostic (1.26e-6)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (3.86e-1)" 3.4 5.2 2.9 7.7 1.7 7.7 3.7 0.7 1.9 2.0 8.2 26.0 1.6 0.0 5.4 1.0 2.7 4.2 2.7 2.5 7.1 13.1 3.5 5.4 3.0 0.5 6.7 0.9 2.3 2.9 1.8 2.6 2.9 1.5 4.9 3.1 19.6 1.5 2.8 9.5 12.6 0.3 2.1 3.7 3.7 1.9 19.4 35.8 41.6 44.2 17.7 30.6 26.4 15.3 9.6 3.5 3.9 1.0 0.8 21.7 3.4 3.2 1.4 1.3 2.0 11.0 6.3 14.0 2.1 12.2 1.0 1.8 1.6 11.3 11.1 6.5 3.2 19.0 2.2 7.7 17.8 0.9 3.0 1.2 1.7 1.3 5.7 12.2 1.3 15.5 10.0 26.8 11.1 6.4 29.6 0.6 33.7 3.4 4.9 7.0 18.8 0.0 30.0 7.1 5.3 6.7 0.0 9.2 10.6 9.2 5.1 43.7 16.8 5.8 10.2 8.0 6.3 5.8 44.2 41.6 23.5 40.9 16.7 19.4 17.6 19.1 35.8 18.1 8.8 14.9 16.1 17.7 32.5 18.3 30.6 26.4 SLX1B "GIYD2, MGC5178" ENSG00000181625 "SLX1 homolog B, structure-specific endonuclease subunit" Q9BQ83 16 29454501-29458219 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.5" "Cell line enhanced" "Detected in many" "SK-BR-3: 30.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA047038 Uncertain Approved Nucleoplasm Nucleoplasm "HPA047038: " "unprognostic (2.93e-1)" "unprognostic (1.11e-1)" "unprognostic (2.16e-2)" "unprognostic (5.12e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (7.20e-2)" "unprognostic (2.72e-2)" "unprognostic (2.35e-3)" "unprognostic (3.63e-1)" "unprognostic (1.22e-1)" "unprognostic (3.64e-2)" "unprognostic (2.51e-7)" "unprognostic (4.84e-2)" "unprognostic (1.96e-1)" "unprognostic (4.44e-1)" "unprognostic (5.25e-3)" 4.6 2.9 0.2 3.9 0.5 8.8 4.9 2.0 2.7 5.6 6.6 14.1 5.4 2.7 3.0 4.4 1.1 2.2 0.4 0.5 3.3 11.1 5.7 3.0 0.6 4.2 3.1 3.4 2.2 5.4 4.0 4.6 8.0 5.4 11.2 5.7 13.4 2.9 1.8 6.3 4.7 0.0 6.1 6.6 5.7 3.9 3.2 20.8 26.5 24.7 3.7 6.5 6.7 6.8 5.9 15.5 0.7 3.2 4.6 21.4 6.5 15.1 14.8 12.5 1.6 10.6 17.4 5.7 4.5 2.7 5.8 9.3 3.6 1.0 4.3 7.2 3.1 9.3 10.0 7.2 2.9 6.2 6.6 9.7 6.6 16.3 3.7 7.1 6.8 9.8 1.3 7.2 1.3 8.7 7.1 12.3 15.6 12.4 4.3 2.5 14.9 2.7 30.4 1.4 1.4 4.1 10.9 4.9 1.5 2.9 1.1 3.3 20.2 11.1 5.4 5.5 2.1 3.3 24.7 26.5 2.8 20.7 0.8 3.2 2.5 2.8 20.8 2.5 1.2 1.6 14.8 3.7 11.9 1.2 6.5 6.7 SMCHD1 "FSHD2, KIAA0650" ENSG00000101596 "Structural maintenance of chromosomes flexible hinge domain containing 1" A6NHR9 18 2655738-2805017 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Hydrolase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 30.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039441 Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA039441: AB_10671042" "unprognostic (2.99e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-2)" "unprognostic (9.03e-2)" "unprognostic (8.66e-2)" "unprognostic (1.36e-2)" "prognostic unfavourable (5.39e-4)" "unprognostic (1.32e-1)" "unprognostic (4.14e-2)" "unprognostic (3.11e-3)" "unprognostic (3.32e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (8.92e-2)" "unprognostic (2.63e-2)" 19.8 8.1 9.1 29.9 11.1 35.6 17.2 18.0 11.3 21.9 17.3 8.2 16.0 13.7 19.2 12.3 12.4 15.6 13.3 12.6 8.3 8.0 9.3 10.2 21.5 31.3 12.7 8.6 20.0 21.2 15.9 14.8 16.2 9.4 15.6 15.3 11.6 14.0 14.0 12.9 10.8 23.7 23.1 9.8 32.0 14.0 13.7 11.5 34.4 12.1 9.6 22.1 25.7 23.5 4.1 1.2 30.3 1.2 1.1 3.2 0.5 10.7 4.9 16.7 10.4 7.1 10.5 12.0 10.8 7.7 10.3 13.1 9.2 3.5 23.2 4.8 9.6 5.9 13.4 6.2 16.3 4.7 7.0 14.5 9.6 8.7 8.0 41.6 11.4 6.9 5.7 13.0 10.8 8.4 16.8 14.5 9.8 3.8 17.4 10.6 6.7 5.7 14.2 13.5 10.2 6.3 16.6 13.7 8.6 14.6 4.9 8.5 3.6 17.7 8.0 12.8 17.7 17.3 19.8 8.8 13.3 21.3 8.2 7.7 11.0 1.9 1.2 3.1 1.9 0.8 1.4 2.9 2.5 2.2 0.4 4.1 3.2 2.0 30.3 1.1 1.1 1.2 2.5 0.5 9.1 11.1 18.0 11.3 8.3 8.0 12.7 8.6 9.4 11.5 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: " "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favourable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favourable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favourable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 8.7 12.3 20.3 14.6 18.0 15.3 19.9 19.5 17.9 15.2 12.9 10.2 14.7 11.0 13.0 20.2 16.4 15.7 10.7 21.3 15.8 16.2 14.1 18.4 10.1 14.4 16.3 12.4 23.2 21.6 11.3 12.9 9.8 9.9 16.4 12.1 15.5 37.0 15.9 26.4 10.4 18.0 9.8 13.3 10.6 12.9 10.9 7.9 15.2 23.4 18.7 16.1 14.9 16.9 5.4 5.0 2.3 3.5 2.9 5.9 3.0 2.2 1.5 3.0 3.7 5.7 4.1 2.4 0.8 4.1 5.1 4.4 2.9 2.2 5.8 1.0 4.3 2.5 4.0 4.3 3.3 1.5 6.6 1.9 3.2 4.1 7.1 3.5 2.5 3.2 7.3 2.0 4.2 5.0 3.1 5.1 3.5 5.8 4.9 5.3 1.1 3.3 4.3 2.7 8.4 6.4 2.6 3.8 2.5 2.0 4.6 5.0 3.9 3.8 2.0 2.2 2.4 1.9 1.5 3.5 3.8 6.9 3.3 3.4 1.6 2.3 3.5 1.6 2.7 1.7 3.7 3.7 5.4 2.8 5.0 5.4 5.9 3.9 0.3 2.9 2.5 3.8 3.0 3.0 20.3 18.0 19.5 17.9 15.8 16.2 16.3 12.4 9.9 7.9 SMG8 "C17orf71, FLJ10587, FLJ23205" ENSG00000167447 "SMG8, nonsense mediated mRNA decay factor" Q8ND04 17 59209400-59215247 "Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024841 Approved Approved Nucleoplasm Nucleoplasm "HPA024841: AB_10600790" "unprognostic (2.68e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-3)" "unprognostic (9.91e-2)" "unprognostic (8.59e-2)" "unprognostic (1.35e-2)" "prognostic unfavourable (3.72e-5)" "unprognostic (1.91e-1)" "unprognostic (1.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-3)" "unprognostic (4.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-1)" 14.7 17.9 11.9 9.4 15.1 15.0 13.8 14.5 19.8 12.9 9.6 15.4 14.8 9.2 15.9 11.7 13.9 14.1 8.1 11.5 11.3 13.2 11.6 12.5 9.9 13.6 12.3 13.3 19.0 11.4 13.8 12.8 18.5 16.1 11.7 9.7 13.2 12.7 11.9 13.7 13.3 11.3 11.8 9.8 15.9 11.9 18.3 11.6 24.2 13.3 9.0 15.5 12.0 9.2 7.8 10.8 15.3 17.8 7.0 7.9 6.2 10.3 14.7 11.7 11.6 14.6 12.3 15.7 15.0 15.5 21.2 18.5 9.9 9.2 15.2 23.7 14.4 12.6 18.6 14.1 20.5 20.1 17.7 17.4 8.5 14.3 16.8 16.9 15.1 16.1 17.4 15.5 11.6 13.9 21.0 8.1 14.6 23.0 16.4 7.9 11.4 14.4 11.0 17.3 14.4 10.0 7.5 10.3 16.7 10.5 5.8 12.5 17.8 11.9 13.3 8.0 18.4 8.6 13.5 16.2 22.5 17.8 10.2 9.0 13.0 15.3 14.2 6.6 6.7 17.8 7.9 7.8 6.2 6.3 10.8 4.8 6.3 5.6 3.4 7.0 17.6 3.6 5.8 6.2 11.9 15.1 14.5 19.8 11.3 13.2 12.3 13.3 16.1 11.6 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: " "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.6 4.9 7.6 6.4 7.9 9.1 8.0 15.9 6.8 8.2 9.2 6.5 1.8 7.1 21.7 5.1 5.0 15.8 5.6 14.9 3.9 11.5 7.4 5.5 5.1 10.6 13.7 1.7 10.8 15.6 8.4 11.1 8.7 10.4 3.0 15.6 3.1 5.8 8.0 3.6 4.3 7.7 14.1 9.9 5.0 4.5 17.8 9.8 3.3 11.0 18.6 2.7 5.7 12.3 12.5 9.0 5.1 10.6 5.5 18.4 10.2 2.9 5.8 19.1 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favourable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.7 10.7 14.4 13.9 16.0 34.8 19.2 12.4 15.2 10.7 13.7 9.5 22.7 21.0 21.7 13.8 3.7 16.7 15.9 15.1 11.9 13.3 12.1 7.8 18.0 27.1 14.4 8.1 24.6 32.0 13.7 20.8 8.2 19.3 6.9 13.2 8.2 15.6 24.5 27.2 16.0 12.9 18.8 13.5 23.9 9.4 18.6 17.3 8.0 5.6 27.4 11.6 20.5 13.7 11.7 13.8 13.1 15.8 13.6 11.2 22.0 17.7 15.3 14.7 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Group enriched" "Detected in some" 7 "CAPAN-2: 72.8;RT4: 26.8;SCLC-21H: 19.0;SK-BR-3: 54.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA077331: " "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 72.8 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.2 0.0 0.2 0.1 6.2 0.3 26.8 19.0 0.3 0.1 54.7 0.0 4.3 0.0 0.0 0.2 0.2 0.3 0.0 0.1 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell line enhanced" "Detected in some" "CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favourable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 45.8 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.2 34.2 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.6 4.6 0.0 0.0 17.9 0.0 1.2 0.4 0.0 0.4 0.7 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 25.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA068733: " "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favourable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.4 30.5 22.9 24.0 21.1 29.1 27.1 17.5 20.7 20.3 23.3 18.8 27.1 23.2 20.1 18.8 25.8 21.6 28.6 23.1 10.0 27.3 30.9 14.2 62.0 40.5 20.2 23.7 24.7 38.2 23.1 37.2 30.5 22.6 21.9 25.1 28.8 23.8 55.8 13.2 36.9 15.6 27.1 31.7 45.5 23.5 23.0 24.6 18.4 35.5 67.6 26.0 29.9 15.9 14.3 15.2 17.8 18.3 21.3 51.3 25.8 13.0 13.1 10.8 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA047771: " "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favourable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favourable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favourable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 22.7 8.0 9.3 23.6 11.0 5.7 19.1 10.3 4.8 11.9 10.4 9.7 6.1 9.8 4.7 4.3 12.0 3.0 8.3 4.8 6.5 24.2 9.2 22.8 19.6 16.7 11.0 12.9 12.3 5.1 10.0 7.3 10.8 12.2 14.7 8.0 9.9 10.1 15.3 15.9 17.0 7.0 9.0 19.4 6.6 10.0 10.1 12.8 20.2 6.7 19.5 6.9 9.2 9.5 6.6 21.7 31.1 20.9 17.2 18.7 21.5 36.2 20.5 9.0 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Cell line enhanced" "Detected in some" "A549: 13.3;CACO-2: 4.3;CAPAN-2: 4.1;EFO-21: 10.3;HEL: 7.5;Hep G2: 4.0;RPTEC TERT1: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" HPA065721 Uncertain Approved Nucleoplasm Nucleoplasm "HPA065721: " "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favourable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favourable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favourable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.8 13.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 4.1 0.0 10.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.5 0.3 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 2.2 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 23.8;hTCEpi: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favourable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.3 3.2 1.5 23.8 10.8 10.3 5.4 14.5 1.6 3.5 1.7 1.4 0.0 0.8 3.4 2.5 0.9 2.7 1.3 0.0 2.8 1.2 5.4 4.5 15.3 0.0 0.1 13.1 19.5 1.5 2.8 2.8 1.9 0.0 6.6 4.7 0.0 0.1 0.5 4.2 0.0 5.7 0.2 7.9 2.1 2.4 0.0 0.7 9.7 13.6 1.6 0.7 5.6 3.2 1.9 0.3 3.5 0.0 0.0 0.0 4.6 2.5 7.1 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 SMYD3 "KMT3E, ZMYND1, ZNFN3A1" ENSG00000185420 "SET and MYND domain containing 3" Q9H7B4 1 245749342-246507312 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 92.9;K-562: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012229, HPA045821, HPA054352" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB012229: , HPA045821: , HPA054352: " "unprognostic (7.00e-3)" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (6.18e-3)" "unprognostic (3.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.25e-3)" "unprognostic (1.72e-3)" "unprognostic (4.53e-2)" "unprognostic (1.57e-1)" "unprognostic (1.71e-1)" "unprognostic (2.10e-1)" "unprognostic (3.78e-5)" "unprognostic (9.03e-3)" "unprognostic (2.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.58e-1)" 6.0 12.0 9.9 9.7 16.2 7.6 10.6 25.9 14.7 8.9 6.5 6.4 3.7 4.5 8.7 21.8 6.1 10.0 7.7 5.8 10.3 12.0 8.9 5.5 9.2 6.3 12.0 10.2 8.0 7.2 6.7 11.9 4.6 15.3 6.8 8.3 9.5 5.3 5.9 9.5 6.7 5.2 7.6 6.8 5.3 6.1 10.5 8.1 7.5 18.8 3.6 9.3 8.3 6.6 11.3 5.9 8.3 3.4 19.4 12.9 8.7 4.6 2.8 4.1 3.5 4.7 6.4 4.1 6.5 4.9 7.7 17.3 3.7 5.4 7.6 5.3 6.0 3.0 3.7 7.3 25.9 4.0 3.8 4.4 4.2 4.4 8.8 4.4 92.9 17.3 1.7 10.2 6.6 5.2 35.1 2.6 7.5 1.6 8.5 8.6 3.7 4.5 7.9 5.0 10.9 5.6 6.8 9.8 4.7 3.1 0.4 5.9 3.8 7.6 4.0 3.7 2.6 2.6 7.7 13.3 3.6 3.9 7.1 6.1 4.3 8.1 3.4 8.3 10.5 3.0 10.8 11.3 11.1 12.8 5.9 11.1 12.3 12.9 2.4 19.4 3.3 3.8 11.8 8.7 9.9 16.2 25.9 14.7 10.3 12.0 12.0 10.2 15.3 8.1 SMYD4 "KIAA1936, ZMYND21" ENSG00000186532 "SET and MYND domain containing 4" Q8IYR2 17 1779485-1830634 "Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030059 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA030059: AB_2191728" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (2.47e-1)" "unprognostic (4.23e-2)" "unprognostic (1.13e-2)" "unprognostic (3.66e-2)" "unprognostic (4.03e-2)" "unprognostic (1.04e-1)" "unprognostic (1.79e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-3)" "unprognostic (9.26e-3)" "unprognostic (3.63e-2)" "unprognostic (1.33e-2)" "unprognostic (7.35e-2)" "unprognostic (1.52e-1)" "unprognostic (1.18e-1)" 10.6 10.0 8.6 13.8 9.6 4.8 11.0 16.3 11.8 9.9 10.8 9.6 9.6 11.5 15.3 8.7 6.3 10.1 7.1 11.0 6.3 6.1 6.1 7.4 8.5 10.4 7.4 6.7 15.5 21.7 5.4 11.3 7.7 9.2 10.1 8.3 10.7 14.1 15.5 19.3 10.6 12.9 10.0 9.2 10.0 7.6 9.2 8.2 12.8 9.1 5.6 12.2 10.8 12.8 6.1 6.3 11.5 4.3 4.1 7.9 3.0 6.0 11.3 11.4 8.1 7.8 5.4 13.3 9.8 5.7 10.5 10.8 18.0 5.2 16.1 6.7 4.0 11.7 10.8 6.4 13.1 4.6 10.9 5.9 12.0 4.8 3.9 5.9 5.8 3.8 5.8 10.7 9.5 5.1 6.1 6.3 8.1 3.7 10.9 4.2 5.2 5.6 13.5 5.8 4.1 4.2 7.3 4.7 6.5 9.1 3.8 9.4 5.5 3.7 5.0 10.3 5.3 8.6 8.5 4.4 5.9 5.8 5.8 5.3 10.0 11.5 3.6 3.2 7.9 4.3 6.5 6.1 4.6 5.0 2.1 3.8 5.3 7.6 2.1 4.1 3.3 6.3 4.8 3.0 8.6 9.6 16.3 11.8 6.3 6.1 7.4 6.7 9.2 8.2 SNAI2 "SLUG, SLUGH, SLUGH1, SNAIL2" ENSG00000019549 "Snail family transcriptional repressor 2" O43623 8 48917604-48921740 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Deafness, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 54.7;ASC TERT1: 56.4;HSkMC: 41.6;hTERT-HME1: 38.8;LHCN-M2: 51.5;U-138 MG: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "basophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" CAB011671 Supported Approved Nucleoplasm Nucleoplasm "CAB011671: AB_777968" "unprognostic (3.52e-2)" "unprognostic (3.95e-1)" "unprognostic (1.55e-1)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (1.74e-2)" "unprognostic (1.79e-1)" "unprognostic (1.04e-2)" "unprognostic (4.24e-2)" "unprognostic (1.92e-2)" "prognostic unfavourable (7.83e-4)" "unprognostic (2.38e-1)" "prognostic unfavourable (4.69e-8)" "unprognostic (1.65e-3)" "unprognostic (3.76e-2)" "unprognostic (1.87e-1)" "prognostic unfavourable (7.16e-4)" 13.9 6.1 1.0 13.7 1.4 0.0 60.3 4.8 1.8 52.9 7.8 2.0 14.4 2.2 31.3 17.3 15.6 20.7 12.8 12.5 1.0 0.8 17.8 4.8 6.7 14.2 1.9 1.6 27.6 5.8 1.2 2.5 11.5 3.4 34.4 4.6 20.5 11.0 18.8 6.1 21.7 6.3 21.7 3.9 10.6 5.5 9.0 0.9 4.7 6.0 11.6 8.2 22.4 37.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.7 0.1 9.2 0.0 54.7 56.4 0.0 8.6 14.6 8.5 11.7 0.0 3.8 0.0 0.0 10.7 6.3 0.0 25.1 9.4 0.0 0.1 0.0 1.9 0.0 19.3 0.0 0.0 41.6 26.4 7.1 38.8 0.2 0.0 3.9 51.5 0.0 0.0 0.0 0.4 7.2 0.0 26.1 0.0 0.0 1.5 1.1 0.8 0.7 0.0 13.4 0.0 0.0 2.3 47.1 1.6 7.9 4.3 0.0 0.0 0.8 16.5 0.0 16.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 4.8 1.8 1.0 0.8 1.9 1.6 3.4 0.9 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677682-88686493 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;skeletal muscle: 33.9" "Group enriched" "Detected in some" 5 "NB-4: 14.4;RPMI-8226: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Low region specificity" "Detected in many" HPA071127 Approved Nucleoplasm Nucleoplasm "HPA071127: " "unprognostic (1.03e-2)" "prognostic favourable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favourable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.9 0.8 2.4 6.3 2.3 2.3 0.8 1.9 2.9 1.3 3.4 2.1 0.2 2.2 0.8 1.3 1.3 1.4 2.6 2.4 2.5 1.7 1.3 1.0 5.3 4.5 3.1 0.8 1.5 6.1 2.1 1.0 0.9 2.2 1.6 0.8 1.4 3.6 0.7 33.9 1.1 4.6 1.1 2.4 9.2 3.5 2.1 2.2 2.1 3.0 9.5 13.0 2.7 2.4 4.6 9.2 25.5 7.7 0.5 11.6 5.4 0.2 0.7 0.2 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 2.8 0.2 1.9 0.4 0.0 0.6 0.2 0.2 0.0 0.3 1.1 0.8 0.1 0.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.6 3.5 0.0 2.6 0.1 14.4 0.3 0.3 3.1 0.2 22.7 0.0 0.3 1.4 0.1 0.6 0.0 0.2 1.0 1.7 0.3 0.1 0.9 0.2 0.0 0.6 3.2 3.2 0.2 3.9 0.4 2.8 7.7 25.5 6.1 2.9 10.9 4.6 9.9 5.7 9.2 3.8 6.1 3.8 17.1 0.5 0.7 6.5 11.6 5.4 2.4 2.3 1.9 2.4 2.5 1.7 3.1 0.8 2.2 2.2 SNAPC4 "FLJ13451, PTFalpha, SNAP190" ENSG00000165684 "Small nuclear RNA activating complex polypeptide 4" Q5SXM2 9 136375577-136400168 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046627, HPA073243" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA046627: AB_10961152, HPA073243: " "unprognostic (3.34e-2)" "unprognostic (2.12e-1)" "unprognostic (5.26e-2)" "unprognostic (1.75e-2)" "unprognostic (3.17e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (2.40e-1)" "prognostic favourable (4.52e-5)" "unprognostic (3.15e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (6.41e-2)" 6.8 5.8 7.6 9.5 15.4 12.7 7.6 20.1 19.4 8.0 6.6 10.9 8.7 9.5 9.9 10.1 6.6 14.5 9.2 6.3 10.1 8.0 8.6 11.5 8.0 10.8 7.7 10.1 11.2 17.8 13.4 13.3 6.7 10.4 9.1 7.2 11.8 10.8 8.5 7.2 13.5 7.8 8.0 8.2 11.7 8.1 20.0 10.2 11.2 10.0 5.7 10.2 9.4 7.1 3.4 1.7 3.7 1.6 2.3 2.6 0.6 6.0 7.1 7.3 10.1 4.7 9.2 13.4 7.9 5.3 8.3 6.7 16.2 5.6 9.3 5.7 6.2 19.7 8.8 10.2 5.0 13.1 13.8 6.3 18.0 7.7 4.2 13.2 7.5 7.3 8.6 7.2 6.9 7.3 12.9 6.9 5.8 13.6 7.6 15.0 15.1 9.3 12.6 7.4 13.2 4.8 11.0 21.1 14.7 7.9 13.2 4.2 13.5 7.7 10.4 8.6 7.9 15.4 11.2 4.3 5.1 7.6 6.0 6.2 5.0 0.0 1.6 1.3 2.6 1.3 1.2 2.0 1.1 1.1 0.6 3.4 0.9 0.7 3.7 2.3 0.5 1.7 0.9 0.6 7.6 15.4 20.1 19.4 10.1 8.0 7.7 10.1 10.4 10.2 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Cell line enriched" "Detected in some" 14 "Hep G2: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA052824 Uncertain Approved Nucleoplasm,Nucleoli "Intracellular and membrane" "Nucleoplasm, Nucleoli" "HPA052824: " "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavourable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.8 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 35.5 0.5 0.0 1.0 0.0 0.8 0.2 0.5 0.9 0.1 0.1 0.1 0.1 0.1 0.3 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.3 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 50.8;TIME: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favourable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favourable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 31.5 8.8 9.8 13.1 14.4 41.0 22.6 34.5 21.1 17.6 14.4 7.9 5.9 12.8 20.9 10.5 16.2 11.5 16.4 13.9 11.0 11.0 16.8 20.3 24.7 19.8 11.4 10.6 15.1 18.0 18.4 16.2 26.2 22.5 12.1 9.9 14.7 10.7 9.4 12.5 24.5 17.0 18.7 9.8 25.4 11.2 13.9 7.2 48.4 24.8 13.5 14.4 15.8 19.3 3.2 3.0 20.9 5.5 8.1 10.7 6.5 3.2 2.0 3.7 3.5 11.1 4.0 3.5 3.5 5.9 3.8 3.8 2.7 4.7 5.1 2.8 4.4 2.1 4.3 7.5 4.0 5.9 3.5 5.9 3.7 3.1 5.8 6.6 6.6 4.4 5.2 4.3 7.4 50.8 2.6 6.0 3.5 1.7 6.6 5.8 4.1 9.1 4.6 2.7 5.4 9.9 5.6 2.6 5.5 3.0 3.3 4.2 2.2 8.4 29.5 3.4 3.4 3.9 4.1 9.7 6.9 4.4 2.4 7.9 4.8 4.8 2.8 5.4 7.6 5.5 10.7 2.8 6.7 7.6 3.0 3.2 10.1 10.1 20.9 8.1 5.0 0.9 7.1 6.5 9.8 14.4 34.5 21.1 11.0 11.0 11.4 10.6 22.5 7.2 SNRNP27 "RY1, U4/U6.U5-27K" ENSG00000124380 "Small nuclear ribonucleoprotein U4/U6.U5 subunit 27" Q8WVK2 2 69893560-69905575 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034541 Approved Approved Nucleoplasm Nucleoplasm "HPA034541: AB_10602408" "unprognostic (2.24e-1)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (2.33e-4)" "unprognostic (4.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.61e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.18e-1)" "unprognostic (4.35e-3)" "unprognostic (9.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" 20.4 24.3 35.1 15.8 28.0 25.9 19.3 25.4 27.3 14.4 12.9 18.3 12.7 12.6 17.2 19.2 13.7 13.7 15.3 27.2 27.5 28.4 17.5 16.9 13.8 20.8 28.7 23.2 16.5 12.7 18.7 26.5 20.6 22.7 17.6 15.0 12.1 14.4 14.4 73.7 14.1 14.6 16.4 31.4 15.1 12.7 9.8 21.9 15.1 18.9 12.3 18.7 15.4 20.1 24.1 26.6 23.6 16.9 19.4 19.7 14.9 10.5 5.7 19.0 11.9 16.9 18.5 15.6 14.6 16.7 19.6 16.1 12.2 11.9 10.6 12.3 11.2 6.2 12.2 5.7 25.7 12.4 13.1 13.1 5.9 15.7 15.7 15.7 23.1 13.1 13.9 13.2 11.5 15.3 17.2 18.8 26.0 5.7 22.3 28.7 14.6 6.4 17.7 16.2 11.6 22.6 6.9 20.0 16.2 10.9 12.1 16.1 10.8 13.4 9.8 15.0 20.4 20.5 21.8 11.7 11.3 17.5 13.5 19.4 27.7 22.5 16.9 23.6 16.3 14.8 17.0 24.1 17.7 15.6 13.7 21.0 19.7 19.3 9.0 19.4 14.7 26.6 18.8 14.9 35.1 28.0 25.4 27.3 27.5 28.4 28.7 23.2 22.7 21.9 SNRPG Sm-G ENSG00000143977 "Small nuclear ribonucleoprotein polypeptide G" P62308 2 70281362-70293771 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA064152, HPA067814" Supported Approved Nucleoplasm Nucleoplasm "HPA064152: , HPA067814: " "unprognostic (6.42e-2)" "unprognostic (7.89e-2)" "unprognostic (6.10e-2)" "unprognostic (5.42e-2)" "unprognostic (1.29e-1)" "unprognostic (1.11e-3)" "unprognostic (1.75e-3)" "unprognostic (2.28e-2)" "unprognostic (3.60e-3)" "unprognostic (6.19e-2)" "unprognostic (1.00e-2)" "unprognostic (9.14e-2)" "prognostic unfavourable (1.08e-6)" "unprognostic (4.37e-2)" "unprognostic (1.33e-1)" "unprognostic (8.96e-2)" "unprognostic (1.41e-2)" 24.8 40.2 22.8 36.4 26.4 40.3 34.8 16.7 23.1 21.1 34.3 14.3 29.0 25.5 25.4 42.8 40.3 19.5 28.5 33.6 24.0 18.6 35.2 38.9 25.5 36.3 30.5 25.0 22.7 37.7 10.0 29.5 36.1 27.4 22.8 32.8 16.7 38.9 33.2 57.3 17.6 26.0 24.6 34.0 33.8 26.1 33.9 27.9 33.8 28.8 42.2 36.6 22.1 47.3 51.2 69.6 43.1 55.0 33.2 57.2 63.6 48.3 50.7 52.3 30.2 18.8 20.3 46.9 31.8 28.6 41.9 39.1 87.4 32.3 43.4 24.1 24.7 32.1 51.4 43.8 45.1 40.2 50.3 57.7 34.6 107.9 25.1 72.6 41.3 18.0 24.8 39.4 39.3 42.1 76.8 32.1 33.0 57.5 62.9 116.6 56.3 42.3 42.9 64.4 51.0 59.8 45.1 30.1 26.8 29.4 25.3 35.1 25.4 59.3 28.9 30.1 57.8 31.5 63.3 25.1 26.1 88.8 27.1 62.4 32.6 31.0 43.8 43.1 40.4 55.0 40.7 51.2 56.0 46.3 51.0 40.9 45.6 53.7 21.9 33.2 54.9 69.6 57.2 63.6 22.8 26.4 16.7 23.1 24.0 18.6 30.5 25.0 27.4 27.9 SNRPN "HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN" ENSG00000128739 "Small nuclear ribonucleoprotein polypeptide N" P63162 15 24823637-24978723 "Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 122.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, HPA067842" Approved Approved Nucleoplasm Nucleoplasm "HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (9.91e-2)" "unprognostic (1.03e-3)" "unprognostic (2.79e-1)" "unprognostic (1.66e-2)" "unprognostic (3.71e-2)" "unprognostic (2.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.72e-2)" "unprognostic (9.44e-3)" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (6.59e-2)" "prognostic favourable (8.93e-8)" "unprognostic (4.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (6.74e-2)" 7.9 35.1 62.2 7.8 73.4 5.6 13.0 65.6 74.7 21.4 9.4 18.4 14.2 6.5 11.6 64.8 8.0 22.8 25.9 84.7 55.9 68.3 35.8 12.4 13.0 14.9 51.3 47.4 28.4 20.3 49.8 42.8 6.5 51.6 33.0 6.4 17.3 22.4 29.1 34.9 6.3 7.9 10.9 31.9 13.3 10.3 9.6 21.3 9.9 55.5 6.8 14.1 12.9 7.8 48.6 71.0 23.6 9.6 36.3 73.7 67.3 0.1 22.3 40.9 28.0 24.2 11.0 0.1 7.3 15.2 4.9 9.0 20.6 10.6 0.0 14.6 17.8 4.2 0.0 21.7 2.8 12.2 0.0 13.5 14.3 22.2 28.7 16.1 12.2 20.8 9.3 10.7 12.7 14.6 3.6 0.0 27.9 0.0 32.2 0.2 122.2 9.5 16.8 15.4 0.0 26.4 33.6 24.2 23.2 0.1 0.5 26.1 14.4 41.4 9.7 12.3 12.6 0.0 4.4 34.5 18.5 21.1 10.4 11.0 9.2 23.6 9.3 13.7 44.6 9.5 49.9 48.6 55.2 50.6 8.7 45.1 73.7 60.6 2.5 36.3 9.6 71.0 55.4 67.3 62.2 73.4 65.6 74.7 55.9 68.3 51.3 47.4 51.6 21.3 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: " "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.6 1.2 0.0 2.6 0.0 0.0 14.9 0.0 1.0 0.0 0.0 0.1 4.6 6.0 10.7 0.0 0.4 3.4 0.9 0.0 8.2 3.2 0.6 0.1 9.0 0.0 12.7 2.3 0.1 1.4 0.0 1.1 0.2 0.3 0.0 0.0 2.4 5.3 13.4 3.9 1.3 0.0 0.0 0.3 26.6 2.9 5.8 1.8 2.9 2.2 15.5 3.9 18.2 0.0 0.0 3.2 0.0 3.4 4.6 3.7 4.0 0.1 21.8 75.8 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;thyroid gland: 41.1" "Cell line enriched" "Detected in some" 4 "Daudi: 19.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 6.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 9 "B-cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038470: AB_10673174" "prognostic favourable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favourable (2.19e-4)" "unprognostic (1.74e-2)" 1.1 1.5 11.9 7.6 8.9 10.2 1.2 3.4 16.5 0.7 1.1 23.2 11.8 1.5 1.2 3.5 0.9 0.8 1.3 7.9 13.4 9.0 1.1 1.9 4.7 11.4 13.7 8.1 1.3 1.6 0.4 2.2 1.0 12.3 3.0 0.7 0.0 3.6 8.4 0.7 2.0 2.2 0.9 17.0 6.1 2.1 1.0 6.6 1.6 41.1 0.0 13.3 2.1 0.3 11.5 1.2 0.0 0.2 0.1 0.1 1.6 0.2 0.4 0.9 0.8 0.1 0.0 0.7 0.8 0.0 0.0 0.2 0.4 0.9 19.5 0.5 0.1 0.4 1.7 0.0 0.0 0.1 2.3 0.3 2.2 2.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 3.3 0.0 1.1 0.2 0.0 1.3 0.3 4.0 0.3 1.2 0.8 0.8 4.5 0.9 0.2 0.7 0.0 1.9 0.0 0.0 1.1 1.4 0.2 0.5 4.2 1.7 4.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.2 11.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.6 11.9 8.9 3.4 9.3 13.4 9.0 13.7 8.1 12.3 6.6 SNX27 "KIAA0488, MGC20471, MY014" ENSG00000143376 "Sorting nexin family member 27" Q96L92 1 151612006-151699091 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045816 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045816: " "unprognostic (3.35e-1)" "unprognostic (4.76e-1)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (2.79e-2)" "unprognostic (3.42e-1)" "unprognostic (2.41e-2)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (5.92e-2)" "unprognostic (1.63e-1)" "unprognostic (5.45e-2)" "unprognostic (2.81e-1)" "unprognostic (4.15e-1)" "unprognostic (7.30e-2)" "unprognostic (1.04e-1)" 10.9 12.5 21.5 12.5 28.6 13.4 12.6 25.0 27.7 14.8 15.9 23.4 13.5 9.1 12.1 16.2 12.1 13.9 11.5 12.1 23.0 21.3 24.2 12.8 13.6 10.4 23.7 19.2 17.2 10.0 26.0 14.8 17.5 20.3 14.8 13.0 13.1 9.7 20.6 25.6 16.0 10.1 21.3 23.1 17.0 11.2 12.8 18.7 8.8 12.8 7.7 10.8 17.4 21.7 2.5 8.4 20.3 18.6 1.7 3.6 7.3 5.8 8.7 9.3 11.7 14.7 10.9 20.7 3.2 6.6 5.6 6.0 7.1 7.8 5.6 6.9 5.1 7.3 11.9 6.4 7.1 7.9 4.5 8.9 5.1 7.9 9.8 10.6 6.1 8.6 4.8 6.4 7.4 6.3 5.4 34.5 7.3 10.5 6.3 7.3 16.4 5.6 6.6 9.0 7.2 8.7 8.9 9.3 8.0 8.5 15.9 6.1 10.2 9.0 8.3 8.0 5.4 8.3 6.6 7.2 7.3 11.3 9.5 6.9 8.9 9.5 18.6 2.6 2.6 16.1 3.6 1.8 3.2 2.3 8.4 2.5 3.1 2.5 20.3 1.7 16.9 2.1 2.5 7.3 21.5 28.6 25.0 24.6 23.0 21.3 23.7 19.2 20.3 18.7 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.7 6.5 5.1 8.2 7.5 5.5 5.2 10.8 4.4 4.2 13.3 1.4 10.0 4.4 13.3 7.2 7.9 3.0 6.8 3.2 3.7 3.0 3.4 5.4 5.9 3.1 5.5 6.1 4.3 6.7 5.0 3.7 4.8 5.7 5.9 4.2 2.0 3.6 7.2 4.0 4.3 15.2 2.5 8.5 10.5 9.7 3.1 6.7 9.3 12.9 6.9 5.5 4.2 6.5 7.0 19.1 4.4 14.9 13.7 4.8 8.4 2.9 12.7 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572882-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0" "Cell line enriched" "Detected in single" 50 "RT4: 41.9" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "thalamus: 2.9" "Group enriched" "Detected in some" 4 "basal ganglia: 0.8;olfactory region: 3.1" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: " "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favourable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.0 0.6 0.1 0.7 0.1 0.4 0.6 2.3 1.7 0.3 0.3 0.1 0.2 0.3 0.2 6.2 0.3 0.9 1.8 0.8 0.7 0.3 0.4 0.3 0.3 0.9 0.3 0.3 0.2 0.1 0.2 0.1 0.6 13.8 0.1 0.4 1.4 0.1 1.0 0.5 0.1 7.4 0.8 0.1 0.6 3.3 0.5 0.1 0.4 2.6 21.4 25.4 16.0 1.1 0.3 3.0 0.5 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 2.5 0.5 0.2 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.5 0.1 0.3 3.0 1.6 0.0 0.3 0.0 0.0 0.6 0.7 0.6 0.3 0.8 0.7 0.9 0.3 0.6 0.5 SOBP FLJ10159 ENSG00000112320 "Sine oculis binding protein homolog" A7XYQ1 6 107489958-107660167 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 10.8;AN3-CA: 14.0;ASC diff: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 3.0;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 14 "B-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029242 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA029242: AB_10603340" "unprognostic (7.11e-2)" "unprognostic (1.35e-3)" "unprognostic (9.01e-2)" "unprognostic (2.04e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (3.80e-2)" "unprognostic (5.63e-2)" "unprognostic (9.84e-2)" "unprognostic (5.35e-3)" "prognostic favourable (1.55e-5)" "unprognostic (6.64e-2)" "unprognostic (2.00e-3)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (1.95e-3)" 7.6 12.0 19.3 4.4 15.6 1.3 3.6 15.1 30.2 12.7 12.8 11.0 2.5 3.7 9.0 5.5 5.6 6.2 7.6 17.0 18.0 12.4 5.8 3.6 5.0 2.9 12.5 14.9 21.6 3.9 10.9 12.0 6.1 9.6 13.0 4.2 7.4 21.1 7.0 22.1 1.5 3.4 14.3 9.6 4.7 5.6 9.1 11.1 1.0 6.1 4.1 3.3 14.8 8.0 4.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 10.8 14.0 13.2 5.1 1.2 0.0 0.0 0.3 0.6 0.0 0.0 5.7 0.4 0.0 0.0 7.2 0.2 0.2 9.1 6.8 0.7 0.0 6.7 1.7 2.9 0.6 5.3 0.0 5.2 0.0 4.3 0.0 0.3 0.0 2.8 1.3 0.3 2.5 0.9 3.2 1.3 0.0 0.0 0.2 3.5 5.8 1.3 0.0 0.1 0.4 2.0 0.1 3.4 1.2 5.9 0.5 2.7 0.5 3.7 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.2 0.0 4.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 19.3 15.6 15.1 20.6 18.0 12.4 12.5 14.9 9.6 11.1 SOCS4 SOCS7 ENSG00000180008 "Suppressor of cytokine signaling 4" Q8WXH5 14 55027230-55049488 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013478, HPA057961" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB013478: , HPA057961: " "unprognostic (7.18e-3)" "unprognostic (1.49e-1)" "unprognostic (9.74e-3)" "unprognostic (4.57e-2)" "unprognostic (3.36e-3)" "unprognostic (3.82e-3)" "unprognostic (3.69e-3)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (4.56e-2)" "unprognostic (7.61e-2)" "unprognostic (4.35e-3)" "unprognostic (1.13e-1)" 14.5 11.1 12.5 16.0 21.2 12.7 12.2 12.6 19.1 11.4 12.0 14.0 8.7 11.1 13.6 9.3 13.2 13.9 15.0 13.9 15.5 10.9 17.6 10.6 16.7 18.0 22.6 10.5 12.6 10.2 12.8 18.5 12.4 17.0 11.7 12.8 7.2 11.9 10.3 12.3 10.5 13.2 17.5 29.6 16.4 15.1 9.5 19.6 16.2 15.3 6.5 16.0 16.1 18.9 3.8 4.1 4.5 5.8 6.0 4.9 2.0 10.7 9.3 12.7 14.8 8.4 9.7 10.1 12.6 9.3 8.0 13.2 7.6 11.6 16.2 8.9 9.4 15.1 17.2 10.2 18.8 16.6 7.0 9.6 12.1 4.5 8.6 11.0 17.0 7.7 10.6 14.4 10.6 14.4 5.7 16.3 14.6 10.7 16.4 8.0 10.0 10.1 15.2 19.8 6.2 11.4 11.9 16.9 14.5 12.7 7.7 12.0 10.7 8.1 14.7 20.6 20.9 10.1 10.7 5.9 6.2 15.7 13.3 8.9 15.8 1.7 4.2 4.5 3.2 4.9 4.9 3.0 4.0 3.0 3.1 3.8 2.2 2.4 2.6 6.0 5.8 4.1 3.6 2.0 12.5 21.2 12.6 19.1 15.5 10.9 22.6 10.5 17.0 19.6 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46763129 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 44.9;fHDF/TERT166: 43.7;U-138 MG: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavourable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavourable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.2 10.1 16.9 5.6 24.9 6.2 21.3 26.4 14.9 13.6 9.4 6.3 7.6 4.8 14.0 8.8 8.2 9.6 11.2 11.2 11.9 8.1 9.1 6.3 10.1 9.9 9.1 10.8 23.8 6.0 14.8 9.0 6.9 11.8 9.9 6.5 5.8 9.3 13.0 8.8 6.9 6.8 13.6 10.8 8.1 7.2 9.5 8.8 10.9 9.8 5.0 6.1 9.4 9.0 4.8 1.3 6.3 3.7 2.3 3.3 1.6 5.1 3.9 3.4 5.0 11.0 15.9 4.2 24.2 44.9 11.9 7.0 3.7 2.5 2.6 4.7 43.7 2.5 3.7 3.8 15.2 2.6 3.4 4.1 3.7 4.4 6.8 2.4 4.6 12.6 5.8 10.1 4.0 4.0 3.6 2.9 7.5 1.8 2.1 3.9 3.8 3.2 2.7 5.8 3.3 4.8 3.9 2.7 7.4 5.9 3.9 4.6 1.6 3.4 4.5 29.7 6.6 9.8 4.7 3.6 2.2 2.2 13.5 4.7 9.2 1.2 1.1 6.3 2.4 1.0 3.0 4.5 1.5 1.6 1.2 4.8 2.7 3.3 1.1 2.3 3.7 1.3 2.5 1.6 16.9 24.9 26.4 14.9 11.9 8.1 9.1 10.8 11.8 8.8 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Cell line enhanced" "Detected in some" "AF22: 7.4;SCLC-21H: 23.9;SH-SY5Y: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA035388: , HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.4 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.3 0.2 0.3 0.4 0.2 0.1 0.0 0.8 0.0 0.6 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.6 0.0 0.0 0.3 0.2 0.5 0.5 4.8 0.0 3.3 0.8 0.4 1.8 0.0 0.1 0.0 23.9 13.7 0.0 0.0 0.1 0.0 0.3 0.2 5.9 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.8 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.5;HaCaT: 16.3;HMC-1: 12.3;RPMI-8226: 7.2;SiHa: 11.7;THP-1: 6.9;U-937: 7.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA061916: " "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavourable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.5 0.0 6.5 4.1 16.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.2 0.1 0.0 12.3 0.2 3.6 5.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.7 0.0 1.3 7.2 0.2 0.0 0.7 0.6 11.7 0.0 0.0 0.0 6.9 0.0 4.2 1.2 0.0 0.1 0.0 0.0 0.0 1.4 7.1 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 SOS2 ENSG00000100485 "SOS Ras/Rho guanine nucleotide exchange factor 2" Q07890 14 50117120-50231558 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004577, HPA047368, HPA052689" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "CAB004577: AB_628270, HPA047368: , HPA052689: " "unprognostic (7.99e-2)" "unprognostic (6.17e-2)" "unprognostic (7.80e-2)" "unprognostic (4.93e-2)" "unprognostic (2.81e-2)" "unprognostic (7.64e-2)" "unprognostic (1.56e-1)" "unprognostic (3.08e-1)" "unprognostic (2.01e-1)" "unprognostic (3.88e-1)" "unprognostic (9.99e-2)" "unprognostic (8.21e-2)" "prognostic favourable (8.48e-8)" "unprognostic (2.47e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (6.57e-2)" 16.0 12.9 16.9 10.5 17.8 25.2 13.4 15.8 14.5 12.9 20.1 19.8 23.4 15.5 14.9 17.3 12.7 11.2 11.4 15.3 17.7 13.4 18.4 9.4 12.5 15.6 19.9 9.8 11.8 11.6 38.6 20.5 30.1 15.1 13.0 13.0 11.1 14.3 14.7 37.1 13.0 26.7 18.3 23.1 17.0 12.1 19.2 16.8 14.7 18.7 14.6 10.3 15.3 15.0 1.2 2.1 8.5 2.8 2.4 1.8 0.6 9.5 7.1 14.4 9.6 11.1 12.1 6.8 8.6 9.5 6.5 8.2 3.1 12.7 10.0 7.8 10.9 8.8 7.7 6.5 11.7 16.8 2.8 10.1 5.5 5.3 12.2 11.8 10.8 12.5 16.1 6.1 14.2 14.0 7.7 25.3 15.6 7.9 9.7 9.4 4.4 6.2 10.6 20.0 7.5 10.6 9.1 10.4 12.2 9.5 11.4 11.2 12.6 14.5 15.3 18.0 11.8 8.1 5.6 17.8 19.3 12.5 4.7 6.6 10.6 8.5 1.8 4.1 1.8 1.4 1.5 0.9 1.1 1.3 1.2 1.2 1.3 1.2 7.2 2.4 2.8 2.1 0.1 0.6 16.9 17.8 15.8 14.5 17.7 13.4 19.9 9.8 15.1 16.8 SOX17 ENSG00000164736 "SRY-box 17" Q9H6I2 8 54457935-54460888 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "EFO-21: 49.1" "Group enriched" "Detected in many" 12 "endometrial cancer: 122.8;ovarian cancer: 96.2;testis cancer: 25.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025594, HPA068399" Enhanced Approved Nucleoplasm Nucleoplasm "CAB025594: , HPA068399: " "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (1.76e-3)" "prognostic favourable (2.76e-4)" "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (3.34e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (7.90e-2)" "unprognostic (3.62e-2)" "unprognostic (1.18e-1)" "unprognostic (4.98e-2)" "unprognostic (7.28e-3)" "unprognostic (1.12e-1)" "unprognostic (3.76e-1)" "unprognostic (1.88e-1)" 26.7 2.0 1.2 9.1 1.8 0.6 31.3 0.6 2.9 25.7 7.9 1.5 1.0 1.4 23.9 7.1 11.6 23.1 20.2 20.6 1.5 1.3 3.0 2.2 8.7 1.5 2.0 1.0 13.0 1.5 1.7 1.5 9.9 2.3 7.6 1.6 3.6 2.4 3.0 13.3 3.1 3.3 5.9 1.8 15.7 3.7 5.8 0.4 0.8 3.6 6.2 1.3 12.3 5.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.6 2.9 1.5 1.3 2.0 1.0 2.3 0.4 SOX18 ENSG00000203883 "SRY-box 18" P35713 20 64047582-64049641 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 53.3" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.2;NB-4: 25.0;REH: 5.9;TIME: 6.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073703 Approved Nucleoplasm Nucleoplasm "HPA073703: " "unprognostic (2.51e-1)" "unprognostic (3.23e-1)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.07e-1)" "unprognostic (2.88e-2)" "unprognostic (2.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.62e-1)" "unprognostic (3.45e-2)" "unprognostic (1.33e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-3)" "unprognostic (9.63e-3)" "unprognostic (1.41e-1)" "unprognostic (2.46e-1)" "unprognostic (5.40e-2)" 53.3 6.2 3.1 9.9 5.0 1.8 27.5 2.5 5.2 18.3 9.4 3.1 4.3 7.4 26.0 10.0 16.4 15.0 15.8 29.7 3.2 3.1 10.1 6.8 29.3 17.7 4.8 2.3 11.2 3.6 4.6 3.2 12.4 6.1 12.3 2.7 13.1 8.1 5.8 20.3 7.9 7.2 7.0 3.4 13.7 7.2 6.9 1.2 2.9 13.8 20.5 5.8 8.4 18.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.1 0.2 0.0 0.0 0.3 0.7 0.0 2.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.2 2.6 0.0 0.0 0.5 0.0 25.0 0.1 0.2 5.9 0.0 0.4 0.0 1.0 0.4 0.4 0.2 0.0 0.3 0.4 1.2 6.9 0.1 1.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 2.5 5.2 3.2 3.1 4.8 2.3 6.1 1.2 SOX21 SOX25 ENSG00000125285 "SRY-box 21" Q9Y651 13 94709622-94712399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;skin 1: 18.3;stomach 1: 38.7" "Group enriched" "Detected in some" 4 "AF22: 41.6;NTERA-2: 11.2" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048337, HPA064084" Approved Approved Nucleoplasm Nucleoplasm "HPA048337: , HPA064084: " "unprognostic (3.33e-1)" "prognostic favourable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favourable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.6 0.6 11.0 0.7 10.1 0.6 1.5 2.5 13.2 0.7 0.6 7.5 0.0 0.6 0.7 0.6 8.3 0.7 0.7 0.6 10.9 5.5 0.6 0.6 0.8 0.6 6.0 8.2 0.6 0.6 0.6 0.1 0.6 5.8 1.2 0.6 0.0 1.7 0.6 0.7 18.3 0.6 0.7 6.1 0.6 38.7 0.8 9.8 0.0 0.7 1.0 4.3 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 6.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.1 2.5 12.3 10.9 5.5 6.0 8.2 5.8 9.8 SP140L ENSG00000185404 "SP140 nuclear body protein like" Q9H930 2 230327184-230403732 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA055864 Uncertain Approved Nucleoplasm Nucleoplasm "HPA055864: " "unprognostic (1.44e-2)" "unprognostic (8.91e-2)" "unprognostic (4.44e-2)" "unprognostic (9.70e-3)" "unprognostic (2.07e-1)" "unprognostic (1.42e-2)" "unprognostic (1.22e-3)" "unprognostic (1.77e-1)" "unprognostic (3.87e-1)" "unprognostic (2.31e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-1)" "prognostic unfavourable (5.09e-10)" "unprognostic (9.15e-2)" "unprognostic (7.81e-2)" "unprognostic (9.49e-2)" "unprognostic (2.00e-3)" 11.0 10.5 2.2 24.3 4.6 9.6 9.3 1.0 2.8 11.2 10.0 4.3 8.7 8.5 12.5 12.0 8.4 7.7 9.7 6.0 3.3 2.2 7.7 14.5 12.3 19.3 4.8 1.4 12.3 5.1 1.9 6.1 10.8 4.8 9.1 7.5 5.1 16.0 12.5 5.4 3.5 16.2 9.4 6.7 25.0 6.8 2.8 4.3 15.7 6.3 6.4 22.7 10.5 16.0 21.0 5.1 11.2 7.1 14.5 13.4 6.0 7.7 1.4 1.8 5.6 9.7 10.6 10.2 11.4 13.2 9.6 15.3 0.8 8.9 5.8 12.0 8.9 1.4 0.0 8.3 15.8 15.3 0.0 10.4 6.1 5.7 18.0 8.5 11.9 8.7 4.5 13.9 9.3 14.0 2.5 5.5 17.3 4.2 12.6 11.9 6.4 4.0 4.4 17.0 4.6 8.7 9.7 0.3 1.7 2.7 5.7 6.4 8.5 9.1 15.3 8.6 6.3 4.8 8.7 8.2 5.0 8.4 11.3 8.7 14.9 11.2 4.9 2.4 10.4 6.5 12.5 16.9 9.5 8.3 5.1 21.0 13.4 12.0 5.0 14.5 7.1 2.1 5.8 6.0 2.2 4.6 1.0 2.8 3.3 2.2 4.8 1.4 4.8 4.3 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715351-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "Hep G2: 50.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Low region specificity" "Detected in many" HPA074123 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA074123: " "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 8.7 1.8 0.5 2.5 0.6 0.1 7.4 1.6 1.0 11.4 3.9 1.4 3.2 3.1 7.2 3.0 1.9 3.0 5.1 0.8 0.6 1.4 0.8 5.9 4.6 3.1 0.2 0.8 1.5 0.5 0.1 0.1 2.1 0.4 7.2 1.0 3.8 2.1 0.9 0.7 6.6 3.1 3.1 0.1 0.2 7.3 2.4 0.0 0.2 0.1 0.8 6.5 3.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 1.4 0.1 0.1 0.0 50.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.6 1.0 0.6 1.4 0.2 0.8 0.4 0.0 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782283-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 14.3" "Cell line enhanced" "Detected in some" "HEK 293: 4.2;HUVEC TERT2: 5.8;NTERA-2: 12.0;PC-3: 20.2" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "basal ganglia: 15.7;olfactory region: 66.8" "Region enriched" "Detected in some" 11 "olfactory region: 72.4" HPA054006 Uncertain Approved Nucleoplasm Nucleoplasm "HPA054006: " "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.1 0.1 2.3 0.1 2.8 0.1 0.2 0.1 3.2 0.3 0.3 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.5 0.3 0.1 0.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.2 0.7 14.3 0.1 0.0 0.1 0.1 0.1 2.4 0.8 0.1 0.2 0.2 0.3 0.5 0.7 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 4.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 0.7 12.0 20.2 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 0.1 3.2 2.4 0.5 0.1 1.7 0.7 0.7 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 216 "testis: 21.5" "Group enriched" "Detected in some" 10 "A-431: 5.0;U-2 OS: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046423: , HPA073647: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 9.6 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN2 "CT11.7, SPANX-N2" ENSG00000268988 "SPANX family member N2" Q5MJ10 X 143711955-143721423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA045652: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 28.4" "Cell line enriched" "Detected in some" 5 "U-2 OS: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA045652: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAST "ADPSP, FSP2, KIAA1083, SPG4" ENSG00000021574 Spastin Q9UBP0 2 32063547-32157637 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis" "Allosteric enzyme, Developmental protein, Isomerase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017311 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA017311: AB_1857415" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (5.33e-2)" "unprognostic (3.90e-2)" "unprognostic (3.75e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (1.62e-4)" "unprognostic (3.26e-2)" "unprognostic (2.35e-2)" "unprognostic (7.39e-2)" "unprognostic (5.98e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (4.15e-4)" "unprognostic (5.71e-2)" "unprognostic (3.04e-1)" "unprognostic (1.53e-2)" "unprognostic (1.13e-1)" 12.7 9.6 18.4 14.8 16.4 13.4 9.8 21.1 21.9 14.7 12.7 15.1 12.5 11.5 12.3 8.7 11.1 10.4 10.2 6.2 20.2 18.5 9.4 14.6 9.7 18.9 20.6 10.0 15.1 10.9 11.8 12.3 11.5 17.5 10.3 12.0 6.8 9.3 13.7 15.4 11.5 17.6 11.6 27.0 15.5 9.7 14.4 14.6 21.5 13.4 6.2 13.8 11.3 10.1 5.0 7.1 9.5 9.0 6.6 7.6 4.3 10.6 7.7 12.6 12.4 8.0 9.4 11.4 5.9 8.7 6.2 5.6 10.4 9.3 18.6 5.5 8.2 7.6 12.4 6.0 7.7 12.5 7.5 20.5 4.2 12.7 7.3 14.2 14.4 5.2 7.9 7.9 7.6 13.7 16.6 6.3 6.8 4.5 22.8 12.0 13.1 4.5 12.1 17.8 12.1 8.4 6.6 18.0 19.3 10.0 8.5 9.8 5.5 9.8 11.8 6.9 10.6 6.1 6.9 9.5 17.7 15.1 7.5 12.3 8.2 3.4 6.3 6.7 3.6 9.0 5.2 5.0 5.8 5.6 7.1 3.9 5.9 6.0 9.5 6.6 6.3 3.2 7.6 4.3 18.4 16.4 21.1 15.8 20.2 18.5 20.6 10.0 17.5 14.6 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.8;RH-30: 3.5;RPTEC TERT1: 2.2;U-2 OS: 2.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.4 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.5 0.5 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.7 0.0 0.0 1.3 0.2 0.5 0.0 0.1 2.8 0.0 0.7 0.2 0.1 0.0 0.0 1.7 1.7 0.0 3.5 0.1 2.2 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.9 0.1 2.3 0.4 0.3 0.0 0.3 1.1 0.7 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 SPATA17 IQCH ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.5 0.6 1.4 0.3 5.2 2.4 0.9 0.5 1.2 1.0 0.5 2.7 2.9 0.6 0.7 9.7 0.5 6.8 0.8 1.1 2.3 2.2 2.8 0.4 3.0 0.3 0.8 1.6 3.3 0.6 3.0 10.8 0.4 11.1 0.7 0.3 1.2 0.6 1.2 2.9 1.0 0.7 0.2 0.7 0.4 0.6 48.0 1.4 0.0 3.1 0.3 0.2 0.5 0.5 1.3 0.6 2.3 0.6 0.6 1.0 0.1 0.6 1.2 1.2 1.2 0.3 2.0 0.9 0.4 0.7 0.6 0.3 0.8 3.2 0.6 1.0 0.4 2.2 0.8 1.1 0.7 0.6 1.2 0.5 1.5 0.7 0.6 0.3 0.5 0.7 2.3 1.2 1.2 0.1 0.7 1.3 0.6 2.5 0.4 1.0 2.3 1.2 0.4 0.4 0.4 2.3 0.9 4.7 1.8 0.7 0.7 0.6 1.4 0.6 0.6 0.8 0.6 0.9 0.5 1.2 0.7 0.3 1.9 0.5 1.0 2.3 0.5 0.5 0.9 0.5 0.8 0.7 0.7 0.7 0.3 1.3 0.9 1.0 1.5 0.6 0.6 0.6 0.3 0.1 1.4 5.2 0.5 1.2 2.3 2.2 0.8 1.6 11.1 1.4 SPATA2 "KIAA0757, PD1, PPP1R145, tamo" ENSG00000158480 "Spermatogenesis associated 2" Q9UM82 20 49903391-49915508 "Predicted intracellular proteins" Necrosis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048581, HPA052224" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA048581: , HPA052224: " "unprognostic (4.02e-2)" "unprognostic (5.98e-2)" "unprognostic (8.26e-2)" "prognostic unfavourable (1.87e-4)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (3.25e-3)" "unprognostic (8.77e-2)" "prognostic favourable (9.08e-4)" "unprognostic (8.33e-2)" "unprognostic (6.45e-3)" "unprognostic (5.99e-2)" "unprognostic (4.89e-2)" "unprognostic (9.57e-2)" "unprognostic (4.38e-1)" "prognostic unfavourable (4.53e-4)" "unprognostic (2.52e-1)" 4.6 6.2 15.3 5.4 19.3 15.4 5.7 16.6 25.7 5.8 10.5 12.8 4.1 11.7 5.4 6.0 5.7 7.1 5.5 5.5 15.2 11.4 5.8 5.4 5.4 5.1 14.4 15.4 6.0 11.9 7.6 6.9 5.5 10.6 8.1 9.8 5.9 8.8 6.6 12.9 5.1 11.2 5.0 19.9 15.6 8.7 18.5 10.2 4.6 11.0 4.0 5.5 5.2 3.6 4.9 3.3 6.1 3.5 3.4 4.8 2.3 5.4 6.8 4.6 4.1 5.3 3.8 7.6 3.5 5.2 12.3 5.2 21.1 4.4 4.2 7.5 3.5 10.1 3.4 5.8 6.5 5.8 3.3 2.2 4.0 13.7 5.0 5.9 9.0 3.8 7.1 6.3 4.0 2.6 7.5 4.8 2.9 11.6 6.0 15.1 6.9 8.2 4.6 5.0 4.4 4.0 4.4 4.4 4.7 7.1 21.6 5.5 5.2 5.2 3.7 8.8 7.3 7.3 4.9 11.9 9.1 4.5 6.9 3.1 3.9 0.3 3.5 3.3 3.7 2.5 3.5 3.6 3.4 4.5 3.3 4.9 4.5 4.8 6.1 3.4 1.3 1.6 3.8 2.3 15.3 19.3 16.6 25.7 15.2 11.4 14.4 15.4 10.6 10.2 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 26.7;MCF7: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favourable (9.69e-5)" 9.7 29.0 14.9 15.2 13.1 4.6 8.2 17.7 22.8 11.7 13.4 11.4 16.8 9.8 16.0 21.1 10.7 13.5 25.4 36.3 9.8 14.3 15.7 13.1 11.2 8.7 15.0 18.3 20.4 22.4 11.9 10.4 6.9 13.3 15.4 5.8 29.0 18.9 15.0 17.9 8.7 9.9 12.7 13.0 14.1 22.8 62.7 6.8 2.5 22.3 8.5 9.9 13.1 7.9 3.2 8.9 1.1 4.7 9.3 2.6 2.9 3.4 15.7 0.9 10.3 2.4 7.4 2.9 5.8 6.7 2.7 2.2 11.7 5.0 3.7 14.1 4.1 2.6 0.5 2.8 1.4 4.9 2.2 2.5 3.4 26.7 10.9 0.9 7.3 11.7 3.8 1.5 4.3 3.6 0.3 6.8 2.5 26.3 0.0 0.9 1.1 6.9 1.5 2.5 1.0 13.5 16.7 1.8 4.2 5.1 3.9 6.2 7.4 0.4 7.9 2.7 8.8 1.6 1.1 13.0 3.9 0.0 5.8 0.5 2.8 0.0 4.5 1.1 2.0 4.7 2.6 3.2 1.5 1.5 8.9 2.2 2.0 2.2 0.3 9.3 4.0 2.0 0.8 2.9 14.9 13.1 17.7 22.8 9.8 14.3 15.0 18.3 13.3 6.8 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 23.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.2 4.2 1.4 6.9 1.1 1.2 8.1 3.6 1.7 1.7 1.1 7.8 4.5 1.8 4.9 1.1 9.1 1.3 2.0 0.3 1.7 14.8 1.2 1.4 10.6 3.8 0.9 3.7 1.2 2.5 2.7 0.8 1.8 5.4 1.2 1.2 23.8 3.1 5.6 4.2 5.6 6.7 0.7 5.1 2.4 1.8 8.1 5.3 3.8 3.9 4.5 10.1 4.0 4.7 1.7 6.3 0.3 1.7 3.1 1.9 1.6 5.2 2.9 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: " "unprognostic (1.05e-2)" "prognostic favourable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.1 9.7 12.1 4.3 3.2 2.8 4.2 6.9 2.8 10.0 4.3 9.1 8.5 1.0 3.7 4.6 13.7 5.3 3.7 7.6 2.0 7.5 1.7 11.8 13.4 1.4 2.1 4.1 2.9 4.4 6.9 3.0 2.2 10.8 1.4 6.5 11.9 6.4 5.5 6.6 7.4 13.0 6.7 3.4 5.9 3.5 11.3 6.2 15.3 2.8 3.7 12.5 2.9 2.1 7.7 9.7 6.4 5.5 3.5 5.2 4.1 7.5 12.2 2.7 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402331-45421419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavourable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 9.0 8.7 10.7 12.3 10.7 11.1 9.5 21.3 8.2 10.3 9.9 10.0 10.2 12.1 9.8 8.4 17.5 8.8 8.3 9.6 9.6 5.9 10.8 14.8 11.2 14.1 13.5 5.8 12.9 12.0 7.6 7.6 10.6 8.9 9.9 10.2 7.2 9.4 12.8 15.9 16.1 13.2 9.4 7.1 8.6 8.2 12.1 12.0 9.9 11.2 12.3 10.9 10.2 11.9 3.6 3.3 4.8 6.4 3.3 4.7 0.7 7.2 5.6 7.5 5.5 6.2 6.1 9.1 6.5 5.9 7.0 6.9 12.7 4.7 5.3 7.2 4.2 16.7 11.1 8.1 7.9 7.2 6.2 6.9 8.9 9.9 7.0 9.2 3.0 5.0 9.3 5.8 7.7 5.6 11.1 8.6 7.9 4.8 6.3 17.7 5.3 7.2 7.1 10.5 4.9 8.8 7.2 10.3 5.2 5.3 11.7 5.8 10.3 16.9 3.4 3.5 5.2 21.0 13.7 7.3 14.5 8.2 8.9 15.2 6.2 0.1 2.8 4.8 4.1 2.6 1.5 1.9 2.8 4.7 3.3 3.6 2.9 3.0 4.2 3.3 6.4 2.5 2.6 0.7 10.7 10.7 21.3 8.2 9.6 5.9 13.5 5.8 8.9 12.0 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295372-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.8" "Cell line enhanced" "Detected in many" "AN3-CA: 10.4;ASC TERT1: 17.6;HSkMC: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: " "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.8 8.9 6.2 3.0 12.9 1.5 8.4 2.4 8.9 7.5 5.0 12.9 10.1 3.3 6.9 7.9 4.1 16.2 5.9 4.7 7.8 5.6 6.9 2.4 7.5 7.0 14.9 3.9 9.0 5.2 12.8 21.5 5.3 8.5 6.4 4.6 6.6 6.9 12.2 3.8 5.0 3.7 8.3 10.0 4.1 7.3 61.8 13.4 1.1 10.3 2.4 2.2 6.5 12.2 0.2 1.7 5.2 8.2 0.3 0.6 0.7 0.1 0.9 9.4 10.4 8.8 17.6 1.3 1.0 3.9 0.8 0.7 0.1 0.7 0.0 0.6 1.7 0.2 0.8 2.3 0.7 0.7 1.3 0.1 0.4 0.4 1.8 0.0 0.7 12.5 1.8 1.5 0.5 3.7 0.1 0.0 3.9 0.3 0.1 0.1 4.0 1.0 2.9 0.0 0.9 5.8 1.6 2.3 5.2 3.8 0.4 9.0 2.3 0.5 1.1 1.4 1.4 2.2 1.5 0.0 0.0 0.0 5.8 0.1 6.2 0.0 1.8 5.2 0.1 4.3 0.0 0.2 0.4 0.0 1.7 0.1 0.6 0.5 0.3 0.3 8.2 0.8 0.0 0.7 6.2 12.9 2.4 8.9 7.8 5.6 14.9 3.9 8.5 13.4 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favourable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favourable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.4 5.1 7.1 8.5 16.0 5.2 3.9 8.7 4.9 3.2 0.9 4.2 1.5 2.3 5.2 2.2 2.4 3.7 4.6 2.6 1.7 0.1 1.7 1.2 12.6 3.6 0.3 7.6 6.1 2.0 3.7 8.9 1.2 2.5 4.4 2.6 1.6 3.3 0.6 4.3 3.7 5.3 0.8 7.8 1.4 3.0 4.6 4.9 6.7 4.0 5.7 3.8 4.6 3.0 3.9 5.0 2.1 2.5 1.2 0.5 6.0 1.1 2.5 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342660-44377167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 9.0;testis: 33.5" "Cell line enriched" "Detected in single" 67 "SK-MEL-30: 12.9" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030897, HPA049722" Approved Approved Nucleoplasm Nucleoplasm "HPA030897: , HPA049722: " "unprognostic (2.30e-3)" 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.0 0.0 0.1 4.8 0.1 9.0 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.0 0.4 0.0 1.6 0.0 0.2 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.4 0.7 0.7 0.4 0.0 3.5 0.1 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979031 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm 220000 Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 21.8 32.8 29.1 25.8 29.2 13.4 28.7 20.0 26.8 36.5 30.4 26.8 49.5 23.2 32.3 61.6 23.3 25.8 21.4 25.2 29.8 27.5 30.0 46.5 24.0 25.3 33.4 33.5 24.0 75.5 41.6 26.7 28.5 32.9 29.2 31.1 18.6 55.9 34.9 26.4 17.2 24.0 24.8 33.4 30.1 26.5 24.2 27.6 20.3 43.9 14.9 38.7 23.8 21.4 78.2 89.7 86.4 45.9 47.9 65.4 71.8 22.7 26.9 35.8 32.1 31.6 21.3 19.6 32.7 32.0 30.2 26.5 52.7 51.7 37.1 41.5 27.6 42.0 31.0 24.0 37.7 30.6 22.7 37.6 32.7 43.5 36.0 39.8 26.5 18.9 31.2 25.4 41.8 28.9 43.2 96.8 27.3 34.7 28.4 25.5 22.0 25.6 35.4 55.2 84.1 34.7 38.1 29.1 29.3 32.6 44.0 107.2 42.5 30.6 23.2 34.4 21.4 35.7 28.9 41.4 41.8 68.8 14.1 28.3 34.8 86.4 45.9 41.3 58.3 44.4 65.4 78.2 54.0 55.9 43.4 62.1 41.4 49.6 29.6 47.9 38.2 89.7 50.9 71.8 29.1 29.2 20.0 26.8 29.8 27.5 33.4 33.5 32.9 27.6 SPIN2A "DXF34, SPIN2, TDRD25" ENSG00000147059 "Spindlin family member 2A" Q99865 X 57134530-57137625 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 5.7;HSkMC: 7.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm Nucleoplasm "HPA000162: AB_1080079, HPA069835: " "unprognostic (3.18e-1)" "unprognostic (1.72e-2)" "unprognostic (7.32e-2)" "unprognostic (1.10e-4)" "unprognostic (1.02e-1)" "unprognostic (2.61e-3)" "unprognostic (1.55e-1)" "unprognostic (4.00e-2)" "unprognostic (1.12e-1)" "unprognostic (4.35e-2)" "unprognostic (8.01e-2)" "unprognostic (1.48e-1)" "unprognostic (7.95e-5)" "unprognostic (3.63e-2)" "unprognostic (8.61e-2)" "unprognostic (2.75e-1)" "unprognostic (5.07e-3)" 1.8 1.4 1.8 2.3 1.6 0.2 1.7 5.0 2.9 2.4 1.5 1.9 2.1 0.7 1.0 1.4 1.7 0.9 1.9 1.9 1.7 1.1 1.5 3.2 1.2 3.2 1.4 1.6 2.7 1.2 2.1 2.0 2.1 1.7 0.5 3.5 1.5 2.2 1.2 2.7 1.9 0.8 2.5 2.1 1.5 2.7 1.4 0.5 0.0 0.8 0.0 0.8 0.2 0.9 1.8 4.9 0.9 0.9 0.9 1.3 1.8 0.7 0.4 0.8 0.8 1.5 0.4 0.8 3.1 1.2 1.1 1.0 0.4 0.6 0.7 0.7 5.7 0.9 1.7 0.8 1.0 7.1 0.8 0.3 0.3 0.5 0.7 2.4 1.0 1.2 0.5 2.3 1.8 0.8 0.9 1.2 0.7 0.8 0.9 3.2 0.9 0.9 0.5 0.2 0.8 0.9 0.7 2.5 1.1 1.1 0.5 2.3 0.3 0.3 0.7 2.0 0.9 0.0 0.8 0.0 0.5 0.3 0.8 1.4 0.3 0.5 0.0 0.4 0.7 0.1 0.0 0.0 0.3 0.5 0.7 0.2 SPIN2B "SPIN-2, TDRD26" ENSG00000186787 "Spindlin family member 2B" Q9BPZ2 X 57118551-57121546 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA000162, HPA069835" Uncertain Approved Nucleoplasm Nucleoplasm "HPA000162: AB_1080079, HPA069835: " "unprognostic (3.21e-2)" "unprognostic (7.92e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (8.28e-2)" "unprognostic (2.30e-2)" "unprognostic (8.42e-4)" "unprognostic (1.73e-3)" "unprognostic (2.24e-2)" "prognostic favourable (3.43e-4)" "prognostic favourable (3.39e-4)" "unprognostic (9.04e-3)" "prognostic favourable (1.78e-5)" "unprognostic (3.41e-2)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.26e-3)" 8.9 11.8 14.6 11.1 19.4 5.6 16.1 17.0 24.3 13.0 13.9 8.5 9.9 6.4 12.3 16.2 8.5 9.8 12.0 11.5 14.4 17.3 11.1 8.4 9.3 13.1 15.7 15.8 12.2 9.6 11.6 14.3 9.1 14.4 15.9 16.6 8.2 10.6 15.3 12.0 12.1 9.0 18.2 15.1 12.4 11.1 6.3 13.4 8.8 12.5 6.6 11.9 10.9 14.2 10.8 9.4 1.2 6.1 11.3 13.1 8.3 11.7 8.8 10.6 8.0 10.9 12.3 7.1 7.9 5.1 10.3 6.8 11.4 9.8 2.5 13.3 7.3 1.8 12.3 4.0 10.7 4.6 14.6 7.1 25.9 15.0 8.9 6.0 5.6 10.3 7.7 6.6 6.9 8.0 8.6 8.3 10.7 16.7 8.7 10.9 10.3 9.9 8.5 13.8 10.7 10.9 5.5 7.2 7.5 13.8 3.4 6.9 7.7 4.2 8.1 8.7 8.4 14.9 4.7 8.4 5.7 7.3 6.8 11.7 4.9 1.2 5.3 0.6 9.0 6.1 13.0 10.8 11.4 12.3 6.5 8.5 13.1 10.5 0.3 11.3 5.5 9.4 13.1 8.3 14.6 19.4 17.0 24.3 14.4 17.3 15.7 15.8 14.4 13.4 SPIN3 TDRD27 ENSG00000204271 "Spindlin family member 3" Q5JUX0 X 56818298-56995827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000727 Uncertain Approved Nucleoplasm Nucleoplasm "HPA000727: AB_2196121" "unprognostic (3.12e-3)" "unprognostic (2.32e-1)" "unprognostic (7.45e-3)" "prognostic unfavourable (3.49e-4)" "unprognostic (1.20e-2)" "unprognostic (1.67e-2)" "unprognostic (6.85e-4)" "prognostic favourable (6.79e-4)" "unprognostic (1.70e-2)" "unprognostic (1.30e-1)" "unprognostic (2.48e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-2)" "unprognostic (6.53e-2)" "unprognostic (8.51e-2)" "unprognostic (1.98e-2)" "prognostic favourable (6.30e-4)" 5.7 7.6 10.5 4.8 10.7 0.4 9.4 28.6 14.2 7.8 4.6 7.3 9.2 4.8 10.4 8.3 4.5 7.4 5.5 3.8 9.2 6.6 5.3 5.0 5.4 6.7 6.6 10.3 11.3 10.2 4.4 12.4 4.1 9.6 10.4 7.0 6.5 7.5 7.5 4.2 4.7 6.6 7.6 5.0 6.1 7.5 4.3 8.3 0.3 6.0 1.4 6.9 8.2 6.2 2.7 1.6 3.3 1.5 4.7 4.5 2.2 4.2 6.3 3.6 0.0 6.9 6.2 2.8 3.7 1.9 2.5 2.9 3.7 5.5 0.0 2.6 3.1 5.1 5.6 2.2 3.2 0.0 1.3 0.5 16.8 2.5 3.8 0.0 4.8 5.3 4.7 2.7 4.3 1.6 2.6 8.4 4.4 2.7 0.0 3.4 7.3 6.0 0.0 3.0 1.7 3.4 5.0 7.2 5.0 3.9 3.9 4.0 9.6 1.0 1.1 4.3 6.7 7.2 2.0 3.5 2.4 0.0 4.2 0.0 3.3 3.3 1.0 1.9 0.2 1.5 1.7 2.7 3.9 1.6 1.6 0.9 4.5 1.1 0.0 4.7 0.1 0.2 1.0 2.2 10.5 10.7 28.6 13.4 9.2 6.6 6.6 10.3 9.6 8.3 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Cell line enriched" "Detected in some" 20 "HeLa: 99.6" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 99.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor, Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3" "Cell line enriched" "Detected in some" 6 "HMC-1: 61.9" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.1" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Low region specificity" "Detected in many" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favourable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 0.2 0.4 0.2 24.3 0.3 0.0 0.2 0.2 0.2 0.2 69.3 0.2 0.2 28.8 0.2 0.2 0.3 0.2 35.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.4 0.2 0.2 0.3 110.5 2.5 0.2 0.2 0.3 0.2 120.9 4.6 0.2 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 3.4 0.2 0.0 0.0 5.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 10.0 0.4 0.0 0.0 61.9 0.0 0.0 0.0 0.1 0.0 1.3 0.1 0.0 1.3 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.5 5.2 1.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 5.1 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Cell line enhanced" "Detected in many" "EFO-21: 18.2;U-266/84: 19.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 10.9 2.0 2.8 3.0 0.4 1.0 2.4 3.0 0.1 0.2 0.5 4.5 8.4 3.2 18.2 0.2 2.3 0.9 0.6 0.8 4.6 2.2 6.3 6.8 2.0 0.2 2.2 2.6 0.1 0.6 0.3 0.1 0.0 3.8 14.1 0.4 9.4 2.2 3.3 11.2 4.4 2.9 2.8 3.5 1.4 9.0 5.1 5.8 2.9 6.4 1.9 10.4 2.1 6.9 3.3 10.6 3.2 3.4 8.9 19.3 3.2 2.7 1.9 4.5 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell line enhanced" "Detected in many" "BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: " "prognostic unfavourable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favourable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 18.8 0.1 0.0 0.1 0.0 0.0 51.3 0.3 0.4 0.6 0.3 30.0 31.5 0.0 22.5 0.0 58.6 4.8 28.2 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 14.9 0.0 41.7 0.6 2.6 2.3 0.4 0.1 0.0 14.6 0.1 2.5 5.8 2.7 1.9 0.0 3.7 28.4 47.5 12.6 0.6 1.4 88.0 2.3 42.0 2.4 0.0 0.0 0.3 0.1 0.0 0.1 3.5 0.1 0.1 2.4 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell line enhanced" "Detected in many" "BEWO: 14.5;T-47d: 15.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: , HPA049415: " "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavourable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.3 6.8 4.3 3.6 1.2 0.8 14.5 2.3 1.3 3.2 1.3 2.6 7.2 4.5 1.0 0.6 7.2 1.9 0.2 1.0 1.8 8.3 0.9 5.6 6.9 1.1 0.3 1.5 1.5 1.7 1.0 0.8 0.1 6.9 1.3 0.9 10.1 0.1 1.5 4.7 4.2 3.4 1.5 1.0 1.6 6.9 11.3 5.8 9.4 4.1 4.1 15.5 2.4 0.3 1.9 4.1 2.6 1.9 0.6 2.9 0.4 2.9 1.6 3.9 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: , HPA031715: " "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favourable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.6 0.3 0.0 0.0 0.2 1.5 0.5 13.9 18.6 13.5 9.0 0.2 0.6 0.1 1.9 15.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.8 0.2 19.3 0.6 9.1 0.2 0.2 7.9 0.0 0.1 0.0 0.2 0.3 0.0 1.4 0.0 0.0 32.6 0.0 0.0 0.3 0.0 0.9 8.0 0.0 16.9 14.2 1.4 9.2 5.2 0.0 0.1 0.0 32.1 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962689-14267884 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.2" "Group enriched" "Detected in some" 35 "EFO-21: 41.0;RPTEC TERT1: 115.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 199.1" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 74 "T-cells: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" 11500000 27000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: " "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favourable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavourable (1.88e-4)" 16.8 5.1 8.3 5.2 12.5 0.0 3.3 4.8 10.7 15.7 9.7 7.6 0.0 9.6 12.0 4.6 5.3 20.3 40.2 4.9 7.2 5.4 0.1 8.1 0.7 5.1 8.8 12.0 0.8 0.0 2.0 12.3 7.5 7.2 15.0 8.5 0.9 2.5 0.0 1.6 12.4 15.7 3.2 1.8 3.9 0.8 5.7 0.0 0.8 0.6 0.0 15.6 9.9 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 115.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.3 0.0 1.3 0.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887360-72892158 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 61.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9" "Group enriched" "Detected in many" 13 "dendritic cells: 9.9;monocytes: 9.3" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol 52000 "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 13.3 22.6 6.3 6.1 8.2 0.0 36.2 2.0 6.4 6.0 17.1 3.1 8.9 11.4 5.7 19.1 13.4 13.2 11.4 16.1 6.4 6.0 20.3 43.5 7.2 5.3 7.9 5.0 8.7 61.7 16.7 5.5 3.9 7.9 17.3 16.2 4.5 20.9 8.8 16.0 3.3 15.1 9.5 4.9 4.7 15.4 4.9 7.2 1.0 31.7 6.2 3.6 9.5 41.4 0.0 9.9 0.7 9.3 0.0 0.4 2.5 13.9 39.2 0.2 6.1 16.1 5.8 9.8 6.6 9.6 4.9 4.6 24.9 14.5 10.2 7.9 7.8 13.2 17.5 10.5 4.1 2.9 13.6 15.3 9.7 25.5 6.0 2.4 4.2 5.2 11.8 5.4 6.1 12.9 15.7 2.0 6.4 29.4 0.9 9.1 3.3 37.5 0.0 25.5 6.0 26.0 21.9 2.4 4.6 12.1 27.3 8.9 12.3 2.9 15.8 5.4 13.2 9.4 11.5 2.2 4.9 0.7 7.7 5.2 9.3 0.0 9.3 0.7 0.4 2.6 0.4 0.0 0.2 0.1 9.9 0.0 0.2 0.4 0.0 0.0 1.0 0.9 0.0 2.5 6.3 8.2 2.0 6.4 6.4 6.0 7.9 5.0 7.9 7.2 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell line enhanced" "Detected in many" "AF22: 29.6;AN3-CA: 59.8;ASC diff: 24.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: , HPA070554: " "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.8 0.5 29.6 59.8 24.3 16.5 1.9 0.1 1.5 0.1 0.6 1.8 3.1 0.0 13.3 0.8 0.3 0.7 1.4 0.2 0.0 3.0 0.6 0.0 9.2 6.9 4.1 0.0 6.7 0.7 0.2 0.6 2.5 0.5 0.5 1.4 0.2 4.8 10.3 7.1 9.8 2.1 3.2 0.0 4.0 4.3 4.5 3.8 0.0 6.0 5.7 0.6 0.0 6.1 0.3 0.0 0.1 0.8 0.3 0.0 0.0 0.4 0.8 0.9 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Actin filaments, Cytosol" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favourable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 16.8 15.7 30.4 10.1 51.9 3.3 11.6 27.1 59.3 15.3 11.4 14.9 10.6 10.8 14.1 21.7 15.9 26.8 11.7 23.1 28.3 27.0 11.3 8.0 13.1 8.8 21.5 34.9 26.4 20.4 26.5 20.3 8.0 34.2 18.3 10.0 15.6 23.3 25.1 7.4 13.0 9.8 18.3 14.0 9.8 13.4 4.9 12.2 3.7 20.2 6.6 11.4 12.4 11.4 9.4 9.4 26.7 18.4 9.7 21.0 15.6 12.4 19.4 2.5 5.1 20.7 10.3 3.3 19.2 9.9 7.2 4.6 3.2 10.5 8.0 15.9 23.4 11.6 3.3 14.5 4.8 8.7 5.1 5.1 11.8 7.3 15.6 9.6 9.1 9.3 23.0 10.3 15.9 14.9 4.4 20.4 12.6 26.9 6.8 5.0 1.4 13.7 3.0 4.3 16.5 9.2 10.0 4.3 4.2 16.5 15.3 7.8 14.3 7.5 20.6 8.3 8.4 18.6 13.0 11.5 10.2 2.3 24.3 8.5 10.0 15.5 9.8 26.7 21.0 17.5 20.1 9.4 14.5 16.9 9.4 7.5 12.5 14.6 15.5 9.7 18.4 4.5 8.0 15.6 30.4 51.9 27.1 59.3 28.3 27.0 21.5 34.9 34.2 12.2 SPRYD4 DKFZp686N0877 ENSG00000176422 "SPRY domain containing 4" Q8WW59 12 56468567-56479707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 58.4" "Cell line enhanced" "Detected in all" "Karpas-707: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053469 Uncertain Approved Nucleoplasm Nucleoplasm "HPA053469: " "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.00e-2)" "prognostic unfavourable (8.85e-5)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (3.06e-3)" "prognostic favourable (4.52e-4)" "unprognostic (5.59e-3)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (9.98e-2)" "unprognostic (1.27e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-1)" "unprognostic (3.44e-1)" "unprognostic (1.14e-1)" 3.8 9.6 3.3 6.0 4.6 4.4 6.2 4.2 6.1 3.8 5.1 6.0 6.7 4.2 4.5 6.3 7.1 3.8 7.4 7.2 3.6 3.6 12.0 58.4 3.1 3.5 4.4 4.3 4.9 12.3 5.0 7.0 4.3 3.7 5.2 6.5 5.8 8.2 6.3 10.5 4.6 6.4 4.3 3.3 4.8 5.0 2.6 3.3 3.8 7.6 7.3 6.1 5.2 4.1 4.6 5.0 3.8 3.8 4.8 3.2 2.5 2.7 3.7 3.2 2.5 2.8 1.8 4.3 2.3 2.3 4.8 2.9 3.4 4.9 3.4 3.1 2.9 4.8 2.7 3.9 3.0 1.7 5.6 5.0 3.8 5.0 2.7 3.4 5.0 4.0 2.6 3.5 2.9 4.9 2.7 14.9 4.0 4.5 1.6 2.4 2.1 4.2 2.0 2.4 7.1 5.1 3.5 3.2 1.5 4.4 5.3 3.4 9.0 1.0 2.3 2.1 3.9 3.0 1.8 2.5 1.4 1.2 1.7 2.9 2.6 3.8 3.8 2.0 3.0 3.0 3.2 3.8 2.8 3.0 3.3 4.6 3.2 3.2 3.8 4.8 3.2 5.0 1.2 2.5 3.3 4.6 4.2 6.1 3.6 3.6 4.4 4.3 3.7 3.3 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051402-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 22.0" "Cell line enhanced" "Detected in some" "AF22: 15.9;NTERA-2: 4.5;RH-30: 5.4;SH-SY5Y: 4.5;U-2 OS: 3.7" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062793 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA062793: " "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favourable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.8 0.9 1.0 0.2 1.5 0.2 0.2 0.2 2.0 0.1 0.3 0.7 0.0 0.2 0.1 0.3 0.2 0.1 0.2 2.2 1.1 1.1 0.4 0.3 1.3 3.2 1.5 0.6 0.1 22.0 0.1 4.6 0.2 1.2 0.2 0.1 0.0 0.1 0.1 1.7 0.2 0.2 0.2 1.9 2.5 0.1 3.6 0.2 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.9 0.3 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.9 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 4.5 0.0 0.0 5.4 0.8 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.3 0.4 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.5 0.2 1.2 1.1 1.1 1.5 0.6 1.2 0.2 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA054481: " "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 1.9 0.4 0.0 0.0 0.0 0.0 0.4 2.3 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.0 3.5 5.0 0.0 1.3 0.0 0.0 0.2 0.8 0.5 0.0 1.1 0.0 0.0 7.9 4.8 0.1 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;breast: 14.7" "Group enriched" "Detected in some" 12 "Hep G2: 9.0;SK-BR-3: 16.1;T-47d: 5.1" "Cancer enhanced" "Detected in some" "breast cancer: 7.7;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.3" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favourable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.9 1.1 12.8 1.2 19.9 2.2 14.7 7.5 19.3 6.6 0.8 3.5 0.0 1.3 3.8 1.2 1.1 0.8 1.1 1.5 14.1 6.4 2.7 0.9 0.9 1.3 12.8 7.2 1.1 1.1 0.6 0.3 1.0 22.0 2.5 0.8 0.0 8.6 0.8 2.2 2.2 0.9 0.6 7.8 1.1 1.4 1.1 16.6 0.0 3.8 0.0 0.7 1.2 0.3 0.8 0.5 5.3 0.4 1.0 0.6 0.1 0.3 0.1 0.4 0.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.7 9.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.5 0.3 0.4 0.1 0.2 0.2 0.3 0.2 0.0 0.1 0.5 0.8 0.3 16.1 0.3 5.1 0.4 0.2 0.6 0.4 0.4 0.1 0.3 0.6 0.3 0.2 0.3 0.7 2.0 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.1 0.8 0.6 0.6 5.3 1.0 0.3 0.5 0.2 0.1 12.8 19.9 7.5 19.3 14.1 6.4 12.8 7.2 22.0 16.6 SREK1IP1 "FLJ36754, P18SRP, SFRS12IP1" ENSG00000153006 "SREK1 interacting protein 1" Q8N9Q2 5 64718144-64768685 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045677, HPA062853" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045677: AB_10964635, HPA062853: " "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.22e-1)" "prognostic unfavourable (9.03e-4)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (8.67e-2)" "unprognostic (1.20e-2)" "prognostic unfavourable (9.68e-4)" "unprognostic (2.67e-1)" "unprognostic (8.39e-2)" "unprognostic (3.85e-2)" "unprognostic (1.99e-1)" 16.3 12.1 12.2 10.9 16.5 8.3 13.8 13.9 12.8 17.0 16.1 4.1 10.8 8.6 12.5 12.4 25.3 10.8 11.6 13.1 12.3 10.7 18.0 13.1 13.2 12.1 10.6 9.5 14.6 11.7 10.8 20.5 20.2 11.9 15.5 10.4 4.7 10.3 15.0 15.7 18.7 15.2 12.6 15.5 19.0 10.9 11.7 11.5 19.2 13.9 17.9 12.3 24.1 14.6 4.0 8.2 3.8 4.1 4.1 4.7 2.1 6.9 3.5 9.1 7.0 8.2 13.6 5.5 10.6 8.5 7.3 9.7 6.6 7.7 7.2 10.9 8.5 4.6 8.3 16.0 12.8 8.6 10.1 7.9 6.6 5.9 8.5 8.4 8.0 8.9 15.2 10.1 13.2 10.7 7.0 4.5 8.6 2.5 15.1 8.6 4.7 4.9 7.2 7.5 11.6 12.4 5.6 4.0 5.9 6.7 4.8 10.1 6.1 16.4 10.8 5.3 3.2 6.4 11.0 6.6 11.3 6.5 10.2 13.3 7.2 3.8 4.1 1.7 4.5 3.0 4.7 3.9 4.6 4.2 3.4 4.0 4.5 4.7 1.6 4.1 1.9 8.2 4.0 2.1 12.2 16.5 13.9 12.8 12.3 10.7 10.6 9.5 11.9 11.5 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavourable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavourable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 3.5 2.4 2.2 3.3 0.7 4.3 1.3 0.0 0.0 1.4 2.0 1.2 1.7 1.5 0.5 0.7 0.5 2.4 1.9 3.1 0.5 7.4 3.4 0.1 0.1 0.0 0.9 0.0 8.5 0.0 2.3 4.2 0.6 1.0 0.0 1.8 1.1 4.8 12.7 14.1 9.9 1.4 3.0 2.2 19.0 12.8 43.6 11.1 20.7 18.7 17.1 16.4 12.3 14.4 15.8 8.7 14.6 7.4 9.5 18.2 15.5 12.9 10.9 14.5 9.2 10.5 15.3 23.0 13.1 8.6 10.5 17.2 17.0 9.4 18.5 12.9 24.9 12.6 24.3 9.1 13.2 8.3 9.3 14.0 14.8 19.0 17.8 17.6 6.2 3.5 14.5 6.6 14.0 10.5 20.5 13.0 18.7 24.7 14.2 17.2 17.4 15.1 16.1 14.4 7.0 17.1 14.7 34.4 0.6 9.3 0.5 2.6 9.4 1.0 2.2 2.1 2.6 6.3 4.8 0.8 1.8 14.1 1.4 9.9 12.7 3.0 2.2 SRM "SPS1, SRML1" ENSG00000116649 "Spermidine synthase" P19623 1 11054584-11060024 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 107.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015746 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA015746: AB_1857472" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (2.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.97e-1)" "prognostic unfavourable (2.25e-5)" "unprognostic (2.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-2)" "unprognostic (3.01e-1)" "unprognostic (3.45e-1)" "prognostic unfavourable (3.80e-8)" "unprognostic (1.74e-2)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (2.98e-2)" 26.7 17.7 20.3 29.0 35.4 15.2 16.9 10.2 30.8 14.3 13.3 14.0 11.5 10.8 18.8 9.8 17.7 15.8 14.2 24.9 19.6 16.9 13.9 45.3 14.0 31.0 15.3 15.0 22.8 107.4 8.0 14.5 14.8 15.6 13.1 11.7 15.0 36.0 17.6 43.6 18.2 9.8 22.9 11.7 21.1 14.5 14.4 14.1 17.9 11.9 21.2 20.8 20.2 19.8 10.7 10.2 0.3 6.0 5.0 10.3 2.0 24.9 36.3 12.1 40.4 24.1 26.1 19.0 38.8 19.9 55.5 29.8 44.7 15.1 48.2 22.9 33.6 19.6 38.6 31.2 18.4 23.7 58.3 30.4 40.2 50.4 35.5 50.9 27.9 26.2 22.6 53.7 47.1 23.4 49.4 40.9 26.9 54.7 43.4 44.5 26.3 70.4 32.7 12.5 78.7 19.7 9.9 23.3 22.3 20.0 43.3 30.3 15.1 25.9 19.4 36.2 28.5 62.7 43.5 33.0 33.2 72.2 25.2 68.5 41.7 0.0 5.4 0.3 7.0 6.0 10.3 10.7 7.1 9.1 6.4 9.3 8.4 9.7 0.2 5.0 3.1 10.2 7.5 2.0 20.3 35.4 10.2 30.8 19.6 16.9 15.3 15.0 15.6 14.1 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035739-40039188 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli 400000 Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favourable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 63.0 81.2 100.0 46.0 102.8 85.9 75.4 65.4 91.3 87.8 62.6 67.9 54.7 50.7 83.0 115.7 75.6 87.8 64.2 114.2 80.7 95.4 107.2 79.6 52.2 60.8 103.5 86.3 99.1 59.1 69.6 82.3 68.8 84.3 84.1 65.0 61.0 71.3 66.4 107.5 44.4 65.7 67.2 86.5 67.5 56.0 43.4 68.9 58.7 98.9 56.6 65.0 80.9 72.7 78.7 151.5 111.2 69.3 63.6 96.4 135.1 24.7 31.1 75.4 56.3 56.5 51.3 36.8 45.7 48.5 39.7 40.8 55.9 21.2 20.8 47.6 55.4 40.2 59.9 47.5 37.6 49.7 42.8 49.7 99.3 65.4 43.3 44.2 40.6 53.2 54.4 32.8 40.3 66.6 51.9 38.3 63.4 37.6 65.2 52.1 41.1 56.4 44.8 34.4 35.0 85.5 74.0 55.0 49.0 46.1 45.8 29.9 62.9 82.0 57.3 46.2 31.4 43.5 33.3 31.2 87.0 51.6 44.9 48.2 42.8 76.2 69.3 111.2 68.5 62.5 66.4 78.7 77.7 76.3 74.5 66.1 75.4 72.8 60.7 63.6 56.5 151.5 96.4 135.1 100.0 102.8 65.4 91.3 80.7 95.4 103.5 86.3 84.3 68.9 SRSF1 "ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a" ENSG00000136450 "Serine and arginine rich splicing factor 1" Q07955 17 58003360-58007346 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013073, HPA061301" Supported Approved Nucleoplasm 1100000 Nucleoplasm "CAB013073: AB_2533079, HPA061301: " "unprognostic (9.86e-2)" "prognostic favourable (7.00e-4)" "prognostic favourable (4.56e-5)" "unprognostic (8.11e-2)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "prognostic unfavourable (1.64e-6)" "unprognostic (8.28e-2)" "unprognostic (2.60e-3)" "unprognostic (3.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.48e-2)" "prognostic unfavourable (2.95e-5)" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (1.59e-2)" 27.0 30.0 25.4 41.0 31.7 19.1 29.9 58.3 32.9 43.8 41.1 26.3 41.7 32.2 44.9 29.3 28.6 43.2 30.2 24.0 23.9 15.8 29.0 30.9 31.4 47.1 34.6 21.6 73.1 28.5 40.8 52.3 28.5 30.1 44.9 32.4 28.7 32.9 31.7 40.7 24.7 38.9 42.2 27.4 38.4 29.2 26.0 32.1 57.0 44.7 30.7 50.7 32.1 44.1 19.8 41.8 16.5 36.1 24.8 23.2 22.3 52.2 46.8 56.4 34.1 15.7 15.9 39.6 48.8 24.6 50.2 45.5 54.5 40.9 89.5 29.9 31.7 42.2 65.0 51.9 54.3 53.0 44.9 71.2 56.5 51.2 20.2 70.4 38.6 15.4 19.4 47.2 33.4 32.4 77.1 31.0 33.6 42.5 83.6 41.9 55.9 42.3 81.8 55.5 49.5 31.3 44.1 46.6 44.0 39.2 28.6 26.2 40.5 41.2 42.1 36.4 43.2 27.1 59.3 27.5 53.9 86.0 36.0 60.5 45.4 9.8 27.3 16.5 23.2 36.1 23.1 19.8 17.8 21.8 41.8 14.6 19.5 19.5 12.7 24.8 23.8 21.3 19.2 22.3 25.4 31.7 58.3 32.9 23.9 15.8 34.6 21.6 30.1 32.1 SS18 "SSXT, SYT" ENSG00000141380 "SS18, nBAF chromatin remodeling complex subunit" Q15532 18 26016253-26091217 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055741, HPA059539" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA055741: , HPA059539: " "unprognostic (2.03e-2)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (1.95e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "unprognostic (4.59e-2)" "unprognostic (1.53e-2)" "unprognostic (1.63e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (2.47e-1)" "prognostic favourable (4.86e-4)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (1.40e-2)" "unprognostic (1.30e-1)" 26.1 40.5 18.7 30.4 26.4 15.5 26.6 17.6 20.2 24.8 21.4 31.8 32.1 14.0 31.7 32.7 29.8 27.2 23.4 22.4 21.6 16.1 30.0 30.9 21.9 25.8 32.6 16.3 39.4 20.6 39.4 41.8 43.2 25.3 28.6 18.7 26.1 26.0 33.5 10.3 31.3 22.6 31.0 23.7 24.7 22.5 28.3 32.6 27.8 35.6 24.7 35.2 25.5 25.9 15.9 13.1 19.9 17.1 20.7 17.6 13.1 19.0 13.8 33.9 16.6 27.0 24.5 17.1 23.4 21.3 20.7 19.8 9.0 15.8 33.2 18.7 27.4 24.9 18.4 22.7 25.6 21.2 8.8 16.4 20.3 14.6 21.4 25.2 25.5 31.4 26.8 26.0 28.5 15.5 12.0 17.1 28.6 19.1 10.3 14.6 6.4 13.4 12.0 26.4 15.9 21.9 22.5 14.5 21.9 35.8 16.6 10.1 16.9 14.9 17.7 43.6 8.7 10.0 22.9 30.8 20.6 24.0 20.4 17.5 23.1 19.9 11.7 16.5 15.1 17.1 17.6 15.9 14.6 15.7 13.1 13.0 15.5 17.4 5.6 20.7 16.7 7.4 15.7 13.1 18.7 26.4 17.6 20.2 21.6 16.1 32.6 16.3 25.3 32.6 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: " "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favourable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 15.8 7.3 14.6 13.2 18.8 15.3 9.1 10.3 11.8 15.4 17.4 13.9 14.5 21.7 9.5 7.0 8.9 17.5 14.4 17.0 10.8 20.4 23.5 14.2 23.3 13.6 30.7 18.6 12.0 9.3 12.4 11.6 16.8 21.2 32.7 12.4 15.0 21.5 38.1 23.1 17.9 11.4 10.7 30.1 17.0 20.0 8.2 11.8 8.7 13.7 13.9 18.0 28.7 9.8 9.1 14.8 21.7 18.7 23.8 37.6 36.8 13.3 33.7 8.6 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 SSB "La, La/SSB, LARP3" ENSG00000138385 "Sjogren syndrome antigen B" P05455 2 169791933-169812064 "Predicted intracellular proteins" RNA-binding "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004643, HPA017287" Supported Approved Nucleoplasm Nucleoplasm "CAB004643: AB_425691, HPA017287: AB_1852672" "unprognostic (5.58e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "unprognostic (9.05e-3)" "unprognostic (6.60e-2)" "prognostic unfavourable (5.99e-4)" "prognostic unfavourable (8.30e-8)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (9.81e-3)" "unprognostic (3.24e-3)" "unprognostic (2.57e-1)" "prognostic unfavourable (6.17e-6)" "unprognostic (9.92e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-3)" "unprognostic (2.38e-2)" 52.4 38.5 39.7 35.1 41.8 43.8 38.2 45.8 48.4 37.8 32.7 18.9 24.2 23.7 34.7 42.4 35.8 31.7 28.9 32.7 37.2 42.9 54.0 44.9 27.0 41.3 36.0 34.3 46.5 21.8 40.3 76.9 39.8 51.1 44.5 28.9 19.8 23.5 35.0 44.6 22.4 30.7 38.2 42.4 45.6 26.6 19.4 35.7 35.9 48.1 30.0 38.1 49.3 29.1 32.4 21.0 22.4 33.2 32.3 38.5 22.5 30.2 17.9 38.8 28.8 42.0 39.1 48.4 37.3 24.9 35.1 32.7 54.0 33.3 68.1 42.7 24.4 32.6 52.2 32.6 48.2 36.9 42.8 81.5 22.6 51.9 37.6 65.4 30.6 30.0 31.4 44.5 26.6 38.9 94.7 15.9 73.4 23.9 43.3 68.7 62.4 18.4 43.0 41.3 49.1 44.4 33.6 37.1 28.3 29.6 22.1 41.2 25.4 47.3 35.0 25.7 30.5 25.8 35.9 18.6 35.7 58.1 25.3 61.8 27.8 22.4 16.9 19.8 26.9 27.8 38.5 32.4 38.2 33.9 19.6 27.1 34.9 36.8 2.7 32.3 33.2 21.0 33.9 22.5 39.7 41.8 45.8 48.4 37.2 42.9 36.0 34.3 51.1 35.7 SSC5D "FLJ35258, S5D-SRCRB" ENSG00000179954 "Scavenger receptor cysteine rich family member with 5 domains" A1L4H1 19 55488404-55519098 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 19.2;BJ: 18.2;fHDF/TERT166: 18.4;U-87 MG: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042008, HPA053316" Approved Approved Nucleoplasm,Cytosol "Secreted in other tissues" 44000000 "Nucleoplasm, Cytosol" "HPA042008: AB_10804124, HPA053316: " "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.28e-2)" "unprognostic (4.55e-2)" "unprognostic (6.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.34e-3)" "unprognostic (1.40e-1)" "unprognostic (6.20e-3)" "prognostic unfavourable (4.26e-8)" "unprognostic (7.73e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-2)" "unprognostic (2.21e-3)" 10.7 2.1 3.3 4.9 1.8 0.1 8.1 3.5 1.9 33.0 18.4 1.6 6.3 2.1 33.1 15.2 9.8 11.0 30.9 10.6 1.4 0.6 2.5 1.8 5.8 1.2 1.2 1.6 17.0 1.8 0.3 13.4 2.5 3.0 6.8 3.2 4.7 1.9 15.7 4.7 3.8 5.8 23.8 3.2 7.3 6.9 5.7 1.4 0.5 2.4 4.2 1.6 19.3 10.9 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.3 19.2 0.0 18.2 4.1 2.6 3.0 0.2 0.0 0.7 0.2 18.4 0.0 0.0 0.0 1.4 0.0 0.1 3.2 0.8 0.0 3.7 0.1 5.7 9.0 0.0 3.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.9 0.1 2.0 0.0 2.0 0.2 0.2 0.0 0.3 0.2 0.7 7.3 0.8 1.0 0.7 2.9 0.2 0.0 0.1 19.6 0.2 4.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 1.8 3.5 1.9 1.4 0.6 1.2 1.6 3.0 1.4 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: , HPA039989: " "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavourable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favourable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavourable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.1 8.1 23.6 4.0 20.6 17.1 6.7 28.7 27.9 10.1 13.4 8.3 18.7 0.3 9.3 20.2 14.0 5.7 13.8 19.6 7.4 6.4 16.3 34.7 6.7 15.2 8.3 15.3 10.1 20.3 17.4 23.7 52.8 7.3 9.0 28.1 8.1 7.3 11.7 1.6 19.1 5.5 9.5 5.6 28.6 4.9 4.1 3.6 16.8 6.0 25.7 4.3 18.3 21.0 24.0 11.6 8.6 14.9 6.2 2.7 6.5 11.2 5.0 17.8 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 SSPN "KRAG, SPN1, SPN2" ENSG00000123096 Sarcospan Q14714 12 26121991-26299290 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.6;ASC TERT1: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "memory B-cell: 29.7" "Lineage enriched" "Detected in many" 21 "B-cells: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066432 Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA066432: " "unprognostic (4.82e-2)" "unprognostic (1.63e-1)" "unprognostic (2.03e-1)" "unprognostic (6.49e-2)" "unprognostic (2.04e-1)" "unprognostic (2.45e-1)" "unprognostic (6.11e-2)" "unprognostic (1.44e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" "unprognostic (1.37e-2)" "prognostic unfavourable (2.77e-5)" "unprognostic (2.64e-3)" "unprognostic (3.86e-2)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" 12.5 6.8 13.9 6.6 12.6 0.1 11.5 16.5 11.4 24.9 12.7 11.1 4.1 2.7 14.6 10.3 11.4 15.0 14.3 26.2 21.0 6.1 3.8 1.4 5.4 4.5 17.2 8.7 21.5 4.7 2.9 4.8 2.5 20.9 14.5 7.3 7.8 6.8 21.1 38.7 3.6 6.3 20.1 20.4 4.9 6.7 5.8 19.0 3.2 10.0 15.4 6.5 18.2 10.8 29.7 0.0 1.4 0.0 0.0 0.2 0.3 0.6 1.1 3.1 0.0 20.6 11.9 0.2 6.1 8.5 0.8 2.4 0.0 7.5 0.0 1.3 8.3 2.4 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 7.4 0.7 2.7 0.6 0.3 0.0 0.1 6.4 1.4 0.4 1.8 6.9 2.0 0.2 8.5 2.3 1.9 6.3 0.3 6.0 2.3 0.4 5.9 0.6 0.3 2.2 2.9 1.5 2.9 1.5 0.2 0.8 0.1 4.5 0.0 7.4 0.0 0.0 1.2 0.0 0.0 0.2 29.7 0.0 0.0 0.0 6.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 13.9 12.6 16.5 11.4 21.0 6.1 17.2 8.7 20.9 19.0 SSRP1 FACT80 ENSG00000149136 "Structure specific recognition protein 1" Q08945 11 57325985-57335877 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002697 Approved Approved Nucleoplasm,Cytosol 8300 Cytosol Nucleoplasm "HPA002697: AB_1857509" "unprognostic (1.67e-1)" "unprognostic (3.21e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-1)" "unprognostic (2.84e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (4.03e-7)" "unprognostic (3.22e-2)" "unprognostic (1.96e-1)" "unprognostic (1.49e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (1.06e-1)" "prognostic unfavourable (5.63e-4)" "unprognostic (5.92e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.52e-2)" 25.3 23.2 23.5 37.7 25.1 32.0 38.4 28.5 27.6 27.2 30.5 19.4 28.8 23.0 34.9 28.2 34.6 34.4 33.1 28.4 22.7 20.3 22.6 27.8 26.5 33.7 21.6 20.7 41.8 39.3 39.7 31.2 34.8 22.0 26.6 33.0 17.2 32.8 27.5 47.7 32.9 26.2 28.9 17.1 28.3 29.3 28.3 25.2 44.0 45.9 37.0 42.5 28.7 51.7 10.2 10.3 4.5 5.2 6.9 12.0 4.7 57.1 55.2 52.4 38.3 16.5 18.5 25.6 31.5 30.4 55.0 39.5 37.9 42.7 69.5 33.7 27.6 44.2 83.1 49.0 69.5 48.4 46.6 44.3 40.7 40.7 26.1 73.4 33.3 18.5 30.0 56.5 78.8 35.9 60.2 35.2 37.4 38.7 74.3 65.0 68.8 34.0 62.8 88.6 67.5 25.7 41.3 54.9 46.5 44.6 38.3 46.4 46.4 29.0 27.0 37.6 49.7 50.6 53.8 41.1 40.6 71.8 31.8 41.5 49.5 0.8 4.3 4.5 9.4 5.2 9.1 8.7 8.1 10.2 6.1 10.2 8.9 12.0 1.2 6.9 5.0 10.3 9.6 4.7 23.5 25.1 28.5 27.6 22.7 20.3 21.6 20.7 22.0 25.2 SSU72 HSPC182 ENSG00000160075 "SSU72 homolog, RNA polymerase II CTD phosphatase" Q9NP77 1 1541673-1574869 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069290, HPA070604" Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA069290: , HPA070604: " "unprognostic (3.33e-2)" "unprognostic (2.79e-2)" "unprognostic (6.37e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "unprognostic (9.84e-2)" "unprognostic (2.40e-3)" "unprognostic (2.43e-2)" "unprognostic (3.23e-1)" "unprognostic (3.23e-1)" "unprognostic (6.75e-2)" "unprognostic (1.36e-1)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "unprognostic (8.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.06e-1)" 44.1 32.5 48.0 33.6 51.5 29.3 73.9 42.3 51.5 37.2 40.1 25.4 39.3 41.3 32.6 51.8 45.7 46.2 35.3 44.4 40.7 42.5 38.0 50.9 37.5 49.0 39.4 39.0 38.0 61.8 33.9 39.9 35.8 36.9 33.9 35.9 34.1 54.2 35.8 107.1 36.9 40.8 35.4 35.0 41.7 38.5 28.0 28.4 37.0 50.9 45.3 36.3 30.8 42.2 35.5 30.1 62.0 28.8 20.7 46.5 28.1 40.6 26.0 18.8 29.0 32.5 31.3 19.3 35.3 27.6 30.9 32.2 24.4 47.2 41.4 19.4 27.8 31.8 30.3 29.1 30.2 34.4 35.9 25.9 22.9 38.6 36.7 32.8 22.7 27.9 24.6 33.1 31.6 28.9 44.8 32.0 24.4 36.2 37.5 52.7 32.9 39.6 29.9 30.4 57.8 33.8 12.5 34.8 23.9 23.9 61.5 104.3 32.0 28.6 21.9 29.8 18.9 33.5 30.3 39.1 46.9 51.6 31.2 52.3 14.4 37.1 28.3 53.6 25.9 28.8 31.9 35.5 34.4 30.7 30.1 33.1 42.2 34.1 62.0 20.7 25.4 19.0 46.5 28.1 48.0 51.5 42.3 51.5 40.7 42.5 39.4 39.0 36.9 28.4 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255317-48267444 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 12.6" "Cell line enhanced" "Detected in some" "Daudi: 28.1;Karpas-707: 40.8;U-2197: 9.5" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 40.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.5 0.0 0.0 2.0 0.0 2.3 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 24.1" "Cell line enhanced" "Detected in some" "PC-3: 3.1;U-2197: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045683, CAB046020" Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB046020: AB_2194010, HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.6 0.1 0.6 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 13.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HMC-1: 5.3;PC-3: 5.1;T-47d: 2.2;U-2197: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.5 0.1 0.0 0.0 0.2 5.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 2.2 0.0 1.0 0.0 0.5 3.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346428-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Cell line enriched" "Detected in some" 4 "Karpas-707: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.5 0.2 0.2 0.0 0.0 1.6 0.2 0.8 0.3 0.1 0.2 0.8 0.3 0.4 0.0 0.9 0.4 0.4 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Group enriched" "Detected in some" 10 "BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Group enriched" "Detected in some" 10 "BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196763 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3;thyroid gland: 2.9" "Cell line enriched" "Detected in some" 4 "BEWO: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.4 0.0 0.1 0.1 0.4 1.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.0 0.5 0.2 0.1 0.8 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.1 1.6 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.8 0.0 4.3 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.5 0.2 0.9 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.6 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.4 0.3 0.4 0.1 0.5 0.1 0.4 0.9 0.6 0.0 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644090-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 7.9;RT4: 4.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045683: " "unprognostic (1.29e-1)" 0.1 0.2 0.2 0.4 0.1 0.7 0.1 0.1 1.0 0.1 0.2 0.6 0.2 0.0 1.5 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.5 0.3 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.1 1.5 0.1 0.0 0.1 0.6 0.4 1.0 0.4 0.0 0.2 0.1 0.0 0.2 1.0 0.7 0.3 0.4 0.0 0.4 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.1 0.5 0.3 1.7 0.7 0.3 0.0 0.0 7.9 0.0 0.2 0.2 0.0 0.1 0.2 1.4 0.1 1.0 0.7 0.2 0.0 0.0 0.4 0.5 0.0 0.0 4.2 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.3 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.5 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.3 0.7 0.1 0.0 0.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell line enhanced" "Detected in some" "CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047014 Approved Nucleoplasm,Vesicles 220000 "Nucleoplasm, Vesicles" "HPA047014: " "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favourable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.2 0.0 0.0 0.1 0.0 0.0 14.3 0.0 0.0 0.0 0.0 35.7 72.1 26.0 2.7 0.0 50.5 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.2 0.1 0.0 0.0 47.3 4.7 21.5 2.9 0.0 0.2 33.4 0.0 50.5 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.4 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 ST5 "DENND2B, HTS1, p126" ENSG00000166444 "Suppression of tumorigenicity 5" P78524 11 8693351-8910951 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046796 Approved Approved Nucleoplasm Nucleoplasm "HPA046796: " "unprognostic (1.88e-3)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (1.88e-2)" "unprognostic (4.17e-2)" "unprognostic (2.46e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-1)" "unprognostic (1.72e-1)" "unprognostic (5.56e-2)" "unprognostic (3.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" 9.6 25.4 9.5 14.9 11.9 1.3 11.0 16.3 13.2 45.1 29.3 14.1 20.4 11.9 71.3 22.2 27.0 41.1 22.4 13.9 8.5 7.5 10.8 10.4 11.0 5.9 7.9 9.7 49.5 14.4 6.5 14.8 19.2 11.6 24.5 11.7 28.9 21.0 28.3 8.4 8.4 17.8 51.4 8.5 22.8 22.4 34.5 8.6 4.5 15.8 9.2 8.6 26.5 19.7 1.3 1.6 1.0 5.9 0.0 0.2 0.6 12.4 1.8 20.6 3.4 6.8 7.2 0.9 11.3 36.6 10.9 10.1 2.5 13.5 0.4 6.7 20.3 12.6 3.8 16.3 4.3 1.7 5.0 0.0 6.4 8.6 10.4 0.0 0.1 24.5 4.6 6.2 8.3 2.1 2.6 1.1 17.6 1.3 0.7 0.5 3.0 3.0 0.4 12.4 0.7 15.2 9.1 3.9 12.2 9.7 12.7 7.8 2.1 0.4 5.7 5.9 10.0 19.2 8.8 3.0 5.7 0.1 9.8 0.0 11.9 0.0 0.1 0.0 0.1 0.8 0.0 1.3 0.0 0.0 1.6 1.2 0.1 0.1 1.0 0.0 5.9 0.0 0.2 0.6 9.5 11.9 16.3 13.2 8.5 7.5 7.9 9.7 11.6 8.6 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell line enhanced" "Detected in some" "A549: 5.7;NTERA-2: 4.9;PC-3: 6.5;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.2 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 6.5 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;HaCaT: 6.8;HEL: 10.9;K-562: 32.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favourable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.1 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 6.1 0.0 6.8 0.0 1.8 0.0 0.0 0.0 10.9 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell line enhanced" "Detected in many" "HDLM-2: 34.9;RPMI-8226: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavourable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavourable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavourable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.1 5.4 1.4 6.9 9.7 7.4 1.0 5.5 6.1 5.6 3.3 3.0 5.8 20.1 8.4 6.8 7.7 2.8 5.8 0.9 34.9 2.4 6.4 17.2 11.4 11.9 0.5 6.7 9.1 6.2 5.0 4.5 14.9 4.6 13.5 2.7 1.4 1.2 0.7 1.6 13.3 6.0 3.6 49.4 5.7 0.1 11.8 2.6 8.0 17.3 1.0 3.5 4.1 10.6 4.6 5.3 14.3 8.6 21.9 11.3 6.3 9.2 2.8 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.1;NB-4: 45.7;TIME: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavourable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavourable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 STAM2 Hbp ENSG00000115145 "Signal transducing adaptor molecule 2" O75886 2 152116801-152175992 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035528, HPA035529" Enhanced Supported Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA035528: AB_10601606, HPA035529: AB_10672868" "unprognostic (1.53e-1)" "unprognostic (1.79e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (5.16e-2)" "unprognostic (2.76e-2)" "unprognostic (3.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-1)" "unprognostic (7.92e-2)" "unprognostic (1.11e-2)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" 17.8 19.1 17.2 12.4 19.9 4.9 21.3 16.1 19.5 19.6 16.7 17.6 17.2 15.1 18.5 16.0 17.8 21.6 15.6 16.1 15.3 15.4 24.6 17.8 17.6 13.0 19.9 14.4 20.6 20.5 23.1 34.0 16.7 20.4 22.1 18.4 14.5 19.5 19.3 14.3 17.6 19.6 19.8 20.0 14.0 18.8 24.3 21.2 16.0 23.8 13.2 14.7 19.5 16.6 2.3 3.3 14.0 6.5 2.5 2.2 1.7 5.4 5.2 4.9 5.9 12.9 15.4 5.3 11.3 13.0 7.3 9.3 5.2 5.2 7.1 9.0 16.0 5.5 5.4 10.4 11.8 8.7 4.3 5.1 3.7 7.8 14.8 7.4 10.0 11.8 10.0 13.6 18.4 7.8 3.3 5.0 14.9 5.3 3.9 5.8 3.0 7.6 3.2 6.0 3.8 11.4 9.3 2.6 4.0 6.2 5.6 9.3 7.5 6.9 10.2 16.3 5.3 12.8 6.8 4.2 4.3 4.6 12.4 6.0 8.9 14.0 3.5 4.4 1.9 4.7 1.8 1.7 2.0 2.0 2.7 2.3 1.7 2.1 8.8 2.5 6.5 3.3 2.2 1.7 17.2 19.9 16.1 19.5 15.3 15.4 19.9 14.4 20.4 21.2 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042073-172188386 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell line enhanced" "Detected in all" "WM-115: 51.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 27.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" 24000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: " "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favourable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavourable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 4.7 2.6 25.8 4.4 38.3 13.5 27.5 3.0 3.6 5.0 4.8 3.4 4.7 4.4 4.4 3.6 4.2 11.0 9.0 2.4 2.5 5.3 4.5 15.4 40.9 5.4 1.9 3.5 4.1 2.5 3.7 16.2 4.5 4.3 4.0 5.6 7.8 2.5 3.1 9.0 12.2 5.7 4.6 33.0 6.2 13.1 3.5 20.6 4.6 3.1 23.7 9.5 11.3 5.0 10.3 22.3 30.8 7.4 18.0 15.6 7.7 7.2 4.5 6.7 5.2 6.5 11.5 10.1 8.4 7.3 6.8 3.7 10.2 9.3 5.4 12.4 9.0 2.0 12.3 4.8 12.2 3.3 11.2 3.0 2.1 7.5 11.3 13.3 6.4 2.6 9.9 8.3 6.3 1.0 13.1 5.1 12.4 8.1 25.5 1.8 5.7 13.4 3.5 6.2 3.0 9.8 3.0 3.7 5.8 8.1 27.6 2.9 24.0 8.7 8.2 4.1 5.7 5.4 11.1 16.3 5.9 10.8 17.5 51.5 7.1 10.8 10.0 18.0 21.4 13.3 5.0 9.4 12.8 10.3 4.4 5.6 9.6 22.3 7.4 30.8 3.2 12.2 15.6 2.6 4.4 27.5 3.0 2.4 2.5 5.4 1.9 4.5 3.5 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell line enhanced" "Detected in many" "Daudi: 14.1;HEK 293: 12.0;Karpas-707: 13.2;SCLC-21H: 14.8;U-251 MG: 14.9;U-266/84: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: " "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favourable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.8 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.2 0.0 14.1 7.4 0.3 0.0 4.3 1.3 3.7 0.0 12.0 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 0.3 0.0 13.2 0.1 0.0 0.3 0.0 7.0 0.0 5.3 1.3 8.9 3.8 0.0 14.8 3.9 0.0 0.0 0.1 0.0 0.8 0.0 0.0 6.7 0.1 14.9 3.1 12.5 0.2 4.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 STPG1 "C1orf201, FLJ33340, MAPO2" ENSG00000001460 "Sperm tail PG-rich repeat containing 1" Q5TH74 1 24356999-24416934 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024301 Approved Nucleoplasm Nucleoplasm "HPA024301: AB_1845634" "unprognostic (2.63e-2)" "unprognostic (3.35e-1)" "unprognostic (1.36e-2)" "prognostic favourable (1.33e-4)" "unprognostic (6.06e-4)" "unprognostic (5.14e-2)" "unprognostic (2.91e-3)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-2)" "prognostic favourable (2.31e-4)" "unprognostic (9.14e-2)" "unprognostic (3.93e-2)" "unprognostic (5.21e-2)" "unprognostic (1.42e-1)" 5.5 4.3 6.0 2.6 12.8 1.5 4.2 13.6 23.3 4.7 7.9 12.0 2.4 4.4 4.8 7.1 4.9 20.8 4.2 4.0 6.7 8.7 5.9 1.9 6.2 2.5 6.5 8.0 5.6 4.8 13.0 9.2 1.6 14.2 5.8 6.9 9.9 3.5 4.6 1.5 4.3 5.5 6.4 6.1 2.1 5.1 29.2 7.9 2.5 5.9 1.2 3.4 4.5 3.9 5.2 2.7 1.1 1.4 0.0 4.3 1.9 5.9 3.4 0.5 6.5 4.7 6.8 3.5 8.7 8.3 8.3 8.7 1.5 8.8 0.7 5.9 9.0 2.4 5.6 6.1 9.6 6.9 5.5 1.0 1.9 1.6 9.7 2.9 1.5 4.0 12.3 12.0 15.9 6.5 2.1 0.0 6.2 2.1 0.0 2.4 5.3 5.9 1.6 0.0 0.2 11.0 1.9 5.3 3.6 4.7 1.8 13.4 4.7 5.2 4.4 3.0 3.5 1.1 2.5 3.8 3.6 2.1 3.3 0.3 4.8 0.0 0.1 1.1 1.5 1.4 0.2 5.2 1.2 4.3 0.6 3.4 1.4 1.7 0.1 0.0 0.2 2.7 2.5 1.9 6.0 12.8 13.6 23.3 6.7 8.7 6.5 8.0 14.2 7.9 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Cell line enhanced" "Detected in some" "Karpas-707: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047366: , HPA052691: " "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.2 0.4 0.0 0.2 0.7 0.5 0.4 0.4 0.4 0.0 0.2 0.0 0.6 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.9 0.1 0.3 0.1 6.5 0.8 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 STRN "PPP2R6A, STRN1" ENSG00000115808 Striatin O43815 2 36843640-36966472 "Cancer-related genes, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017286 Approved Approved Nucleoplasm,Cytosol 11000 Cytosol Nucleoplasm "HPA017286: AB_1857618" "unprognostic (1.65e-1)" "unprognostic (1.65e-1)" "unprognostic (3.57e-3)" "unprognostic (2.23e-2)" "unprognostic (3.25e-1)" "unprognostic (1.53e-1)" "unprognostic (1.63e-3)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.77e-3)" "unprognostic (1.33e-1)" "prognostic favourable (2.27e-4)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (2.11e-1)" "unprognostic (3.43e-2)" 11.8 8.1 11.4 11.0 22.1 17.4 13.3 16.4 14.2 11.2 14.0 10.9 8.9 10.1 8.6 7.1 25.9 6.8 8.4 25.7 16.2 10.2 11.6 10.2 10.3 9.6 16.9 9.4 9.9 7.1 11.3 6.3 12.6 10.5 8.1 13.7 5.6 16.2 6.9 16.0 16.1 13.2 11.1 34.3 10.9 11.4 9.8 14.8 18.6 8.1 15.5 16.7 11.3 14.4 1.5 0.8 3.7 1.5 0.5 2.1 0.4 23.0 11.7 15.6 6.6 8.6 12.0 15.7 9.3 8.8 9.1 8.4 11.9 7.5 15.3 7.5 11.8 11.0 13.1 10.3 11.3 17.3 10.1 24.8 10.3 6.1 8.2 14.9 13.9 7.2 9.0 14.5 11.5 11.6 18.5 12.2 11.2 6.6 14.7 6.5 12.5 5.9 9.6 24.7 6.7 7.5 19.1 2.9 9.5 14.0 10.8 8.8 7.7 5.8 15.4 16.4 16.5 10.1 12.2 12.3 18.6 13.5 8.3 14.9 11.3 3.4 0.8 1.4 2.1 1.5 0.7 1.5 1.5 1.3 0.4 0.9 0.8 0.9 3.7 0.5 1.4 0.8 0.3 0.4 11.4 22.1 16.4 13.0 16.2 10.2 16.9 9.4 10.5 14.8 STRN3 "PPP2R6B, S/G2NA, SG2NA" ENSG00000196792 "Striatin 3" Q13033 14 30893799-31026401 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003392, HPA004636, CAB069925" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" 15000 Cytosol "Nucleoplasm, Actin filaments" "CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940" "unprognostic (4.08e-1)" "unprognostic (8.66e-2)" "unprognostic (8.08e-2)" "unprognostic (4.22e-2)" "unprognostic (3.06e-2)" "unprognostic (7.74e-3)" "unprognostic (3.37e-2)" "unprognostic (2.83e-1)" "unprognostic (3.05e-1)" "unprognostic (9.53e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "prognostic favourable (9.66e-4)" "unprognostic (8.74e-2)" "unprognostic (7.85e-2)" "unprognostic (4.83e-2)" "unprognostic (1.01e-2)" 18.5 14.3 15.9 12.1 16.2 10.9 13.5 23.4 17.7 15.8 17.4 11.5 16.5 8.8 14.7 14.8 16.5 10.8 14.0 21.5 14.4 12.1 15.2 22.7 11.6 7.2 12.9 10.1 12.6 13.1 18.0 20.2 14.1 13.9 16.2 14.0 11.4 12.6 17.2 52.0 12.6 11.3 22.0 11.8 11.9 12.9 22.4 14.6 9.3 14.9 13.5 9.7 25.1 20.5 7.0 10.5 8.5 7.9 7.4 10.0 2.4 17.7 15.3 17.1 12.3 14.6 11.1 14.2 16.9 12.5 14.2 14.4 20.4 12.0 10.3 12.4 12.3 9.8 19.0 10.8 21.1 8.9 6.4 10.2 10.5 39.4 15.8 8.7 11.4 11.7 11.4 11.3 13.8 11.4 12.3 9.8 13.7 12.1 11.3 8.5 8.4 14.2 8.3 20.1 2.7 21.3 25.5 10.8 8.9 18.8 13.8 9.2 15.8 7.5 13.7 14.0 12.5 8.8 6.7 9.3 10.7 10.2 6.9 6.4 11.1 6.3 7.1 8.3 6.8 7.9 8.9 7.0 8.5 7.7 5.8 6.9 8.6 10.0 8.5 7.4 6.2 10.5 6.4 2.4 15.9 16.2 23.4 17.7 14.4 12.1 12.9 10.1 13.9 14.6 STX2 "EPIM, EPM, STX2A, STX2B, STX2C" ENSG00000111450 "Syntaxin 2" P32856 12 130789600-130839266 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038189, HPA069176, CAB079007" Uncertain Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB079007: , HPA038189: , HPA069176: " "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (3.38e-2)" "unprognostic (9.85e-2)" "unprognostic (2.11e-2)" "unprognostic (4.16e-2)" "unprognostic (2.83e-1)" "unprognostic (7.62e-2)" "unprognostic (1.30e-2)" "unprognostic (5.69e-2)" "prognostic unfavourable (5.15e-5)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.63e-2)" "unprognostic (3.41e-3)" 15.9 14.5 16.0 15.4 13.4 8.8 27.0 12.5 18.7 13.1 18.8 15.3 8.8 6.1 18.1 15.4 9.6 19.4 14.5 16.4 15.5 11.4 12.2 12.0 18.3 11.9 12.7 12.4 16.0 10.7 11.9 16.3 18.0 17.9 10.2 10.2 9.8 5.2 15.7 6.3 6.1 10.7 23.5 24.8 12.3 11.7 23.2 12.3 9.7 12.6 6.9 9.4 13.5 22.2 2.6 1.6 4.6 2.4 1.4 3.1 0.9 4.7 9.5 13.8 10.7 12.8 29.1 1.4 20.1 16.2 24.9 16.5 2.6 3.3 6.1 3.2 22.0 1.3 12.6 3.3 25.9 9.2 4.3 3.2 8.3 7.4 13.8 4.7 8.0 10.8 4.1 12.1 9.7 12.2 12.7 5.7 21.2 2.8 6.6 4.8 9.2 13.1 7.0 9.0 3.2 13.7 1.0 13.2 12.9 10.2 0.9 8.5 3.2 3.0 16.4 14.3 10.1 15.7 8.8 4.2 3.3 4.0 16.5 5.2 11.2 4.6 2.2 2.8 2.4 2.4 2.4 2.6 2.7 2.7 1.5 1.7 2.9 3.1 3.0 1.4 1.2 1.6 1.9 0.9 16.0 13.4 12.5 18.7 15.5 11.4 12.7 12.4 17.9 12.3 STX3 STX3A ENSG00000166900 "Syntaxin 3" Q13277 11 59713456-59805882 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 14.3;eosinophil: 28.1;neutrophil: 25.7" "Lineage enriched" "Detected in many" 10 "granulocytes: 28.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002191, HPA069176" Approved Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA002191: AB_1080165, HPA069176: " "unprognostic (2.24e-2)" "unprognostic (1.97e-2)" "unprognostic (7.96e-3)" "unprognostic (1.02e-1)" "unprognostic (2.84e-2)" "unprognostic (2.36e-3)" "prognostic unfavourable (8.41e-7)" "unprognostic (1.64e-1)" "unprognostic (3.00e-1)" "unprognostic (7.71e-3)" "unprognostic (2.07e-2)" "unprognostic (5.55e-2)" "prognostic favourable (1.14e-6)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" "unprognostic (4.02e-2)" "unprognostic (1.17e-2)" 10.8 16.3 5.3 14.1 8.3 23.4 22.6 11.5 10.7 10.7 19.9 4.9 27.8 23.8 14.2 16.4 12.8 6.8 21.1 9.4 6.2 6.0 25.0 6.4 26.5 15.1 8.7 10.2 12.0 14.8 16.7 21.2 33.6 6.8 12.6 22.9 54.7 16.0 19.8 7.3 11.4 19.7 11.4 7.2 14.5 19.5 11.4 6.2 2.1 12.8 9.3 6.4 11.4 12.2 0.9 2.7 28.1 2.5 0.2 1.4 0.9 12.0 7.1 0.2 3.4 6.2 3.6 9.8 6.5 11.1 15.0 18.6 32.3 11.4 3.4 12.5 4.7 13.6 18.8 6.7 18.4 3.0 4.0 3.7 5.0 10.0 16.6 12.5 36.5 6.6 14.5 11.6 14.1 11.9 32.4 7.1 6.5 7.0 0.1 9.2 18.4 5.9 4.3 12.5 5.6 28.2 28.7 8.2 12.7 2.8 14.3 49.2 15.7 8.6 16.7 6.5 14.2 8.9 5.6 8.4 14.6 6.9 9.0 8.2 8.6 14.3 2.5 28.1 1.0 0.7 1.1 0.3 1.4 0.6 2.7 0.9 1.3 0.4 25.7 0.2 0.4 0.4 0.0 0.9 5.3 8.3 11.5 10.7 6.2 6.0 8.7 10.2 6.8 6.2 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806897-62832088 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 21.3 20.0 17.5 16.2 17.0 28.3 22.6 33.0 24.2 26.9 19.6 17.6 40.9 17.2 21.6 36.4 22.3 23.7 20.1 17.7 17.6 15.7 22.3 42.6 21.0 17.7 18.6 16.7 29.3 33.7 22.8 20.2 37.4 17.4 27.9 18.2 20.6 47.3 32.2 17.1 26.4 23.0 19.2 16.0 24.0 22.1 16.1 19.7 29.1 33.7 16.4 29.0 22.5 22.3 9.4 10.0 24.9 10.4 9.5 9.7 4.7 17.3 11.1 14.9 13.2 20.5 22.7 13.8 17.1 24.1 28.9 23.4 8.3 17.2 11.1 16.0 24.3 18.2 12.9 16.2 21.4 25.8 12.3 9.6 14.9 16.9 24.8 11.4 14.8 18.7 18.5 25.7 31.2 14.0 8.7 30.9 15.3 20.9 15.4 18.5 5.0 16.4 15.9 14.4 29.5 13.0 9.2 11.2 9.5 13.8 21.9 26.1 24.2 15.4 15.0 21.1 11.1 24.2 10.9 28.3 15.9 11.7 16.9 8.0 12.8 8.2 8.8 24.9 8.5 10.4 7.4 8.7 6.7 8.2 8.1 9.4 6.4 6.2 14.0 9.5 9.1 10.0 9.7 4.7 17.5 17.0 33.0 24.2 17.6 15.7 18.6 16.7 17.4 19.7 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.1;SK-MEL-30: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavourable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.47e-4)" "prognostic unfavourable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favourable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.0 8.5 8.2 9.2 18.6 16.0 7.4 14.3 7.3 8.6 7.6 0.4 4.8 4.0 8.0 9.3 1.4 7.2 8.8 10.6 9.2 4.8 5.4 23.1 1.5 9.4 0.5 4.7 12.1 4.9 22.6 11.0 10.2 5.4 6.2 14.5 7.5 3.8 1.7 7.0 11.8 2.3 3.9 9.7 7.1 0.2 47.1 22.9 24.1 11.9 40.8 1.8 1.7 15.2 9.8 5.0 19.2 5.3 13.4 22.1 5.4 19.2 5.8 9.0 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 STXBP3 UNC-18C ENSG00000116266 "Syntaxin binding protein 3" O00186 1 108746674-108809526 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027225 Approved Approved Nucleoplasm,Cytosol 160000 Nucleoplasm Cytosol "HPA027225: AB_1857627" "unprognostic (3.14e-3)" "unprognostic (4.33e-2)" "unprognostic (7.18e-3)" "unprognostic (4.88e-2)" "unprognostic (6.54e-2)" "unprognostic (9.78e-3)" "unprognostic (2.00e-3)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "unprognostic (6.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.25e-2)" "unprognostic (1.65e-1)" "unprognostic (8.08e-2)" "unprognostic (1.08e-1)" "unprognostic (4.55e-2)" 18.3 18.4 29.8 18.7 42.1 15.2 20.9 21.9 27.1 19.4 20.5 26.3 15.6 18.7 20.3 19.9 18.8 16.0 20.8 14.3 30.4 22.1 30.2 17.8 16.8 18.2 48.0 28.0 16.2 20.5 31.9 18.0 20.3 31.4 18.1 21.9 9.8 17.5 21.3 15.4 19.7 23.8 18.4 56.6 19.8 18.0 11.3 42.5 20.0 27.8 14.6 17.8 20.2 18.3 5.9 8.3 26.2 11.6 8.7 10.2 5.9 21.9 8.7 15.0 7.9 18.3 17.8 21.2 20.4 18.9 13.8 14.1 8.0 8.9 19.5 13.9 16.5 13.2 10.1 12.0 19.4 21.7 14.0 16.1 11.9 10.4 14.5 25.1 27.7 13.8 17.1 15.4 16.9 17.0 11.9 19.3 19.1 14.9 15.8 20.2 16.0 13.8 13.3 21.9 10.7 22.4 18.4 9.0 8.3 25.1 24.3 29.7 9.7 23.9 19.1 18.1 10.6 25.0 17.5 12.9 11.2 16.2 32.5 19.3 27.4 26.2 8.8 20.8 7.8 10.6 9.9 5.9 9.2 7.8 8.3 5.4 7.9 7.5 24.3 8.7 11.6 3.9 10.2 5.9 29.8 42.1 21.9 27.1 30.4 22.1 48.0 28.0 31.4 42.5 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.2;HDLM-2: 10.8;HMC-1: 11.9;HUVEC TERT2: 16.4;TIME: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040468: , HPA048569: " "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 2.9 0.1 0.0 0.4 0.0 0.0 0.9 4.8 0.5 2.2 2.1 1.6 18.2 0.2 3.1 1.2 0.8 0.9 5.0 4.8 10.8 0.3 0.7 1.3 0.1 0.0 1.4 11.9 0.2 0.2 3.4 0.2 16.4 0.2 0.2 5.2 1.7 0.1 0.8 2.7 1.3 0.0 1.4 0.2 1.6 9.4 0.6 0.0 2.7 2.9 0.0 2.3 0.3 15.2 0.6 2.5 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 STYX ENSG00000198252 "Serine/threonine/tyrosine interacting protein" Q8WUJ0 14 52730180-52774998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040290 Uncertain Approved Nucleoplasm Nucleoplasm "HPA040290: AB_10963686" "unprognostic (5.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.22e-1)" "unprognostic (9.56e-2)" "unprognostic (2.43e-1)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.37e-1)" "unprognostic (3.00e-3)" "unprognostic (1.91e-2)" "unprognostic (3.21e-2)" "unprognostic (2.26e-1)" "unprognostic (1.57e-3)" "unprognostic (6.89e-2)" "unprognostic (6.82e-2)" "unprognostic (2.48e-2)" "unprognostic (6.84e-3)" 12.2 6.4 7.6 14.8 8.3 6.4 19.6 9.9 7.4 9.7 10.1 8.5 8.2 7.1 10.8 6.4 13.2 8.1 9.6 11.5 7.2 5.4 7.5 32.2 12.6 23.5 10.2 5.8 9.7 11.8 7.0 9.4 11.6 7.2 9.9 8.4 7.1 10.2 11.5 26.6 10.9 9.0 15.5 10.0 11.7 11.2 13.9 8.6 16.7 7.7 12.2 14.9 13.4 10.7 7.1 5.4 6.6 6.8 5.4 13.4 6.3 10.3 5.7 7.9 9.4 13.5 19.4 15.1 12.5 9.3 9.2 9.3 8.2 7.6 12.9 10.7 11.7 8.2 9.8 10.2 16.3 11.4 3.7 6.6 6.4 10.9 11.2 10.4 8.7 13.9 12.4 12.0 12.6 16.6 7.8 12.5 12.6 14.3 11.6 6.9 9.5 11.8 9.9 10.7 7.6 11.9 11.9 1.8 5.3 12.8 8.6 8.2 21.0 10.6 15.2 16.1 10.3 17.4 7.7 4.6 6.2 8.0 5.2 7.0 13.6 6.6 5.0 4.0 6.8 6.8 9.0 7.1 11.2 9.1 5.4 4.8 13.4 9.9 2.6 5.4 6.1 4.1 12.2 6.3 7.6 8.3 9.9 7.4 7.2 5.4 10.2 5.8 7.2 8.6 SUGT1 SGT1 ENSG00000165416 "SGT1 homolog, MIS12 kinetochore complex assembly cochaperone" Q9Y2Z0 13 52652709-52700909 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015942, HPA043949" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB015942: , HPA043949: " "unprognostic (3.66e-2)" "unprognostic (3.98e-2)" "unprognostic (3.57e-1)" "unprognostic (1.22e-1)" "unprognostic (3.77e-2)" "prognostic unfavourable (8.69e-4)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (3.76e-1)" "unprognostic (1.96e-3)" "unprognostic (9.51e-2)" "unprognostic (1.12e-1)" "unprognostic (6.83e-2)" "unprognostic (2.82e-3)" "unprognostic (9.05e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-1)" 22.7 29.9 40.0 23.1 44.8 26.2 27.9 39.7 42.7 17.9 24.0 23.0 14.9 25.8 19.4 20.6 27.1 19.2 18.9 33.8 34.0 28.8 30.8 34.3 19.8 23.5 35.9 28.9 20.8 28.6 14.0 39.8 24.4 36.0 18.1 26.5 14.2 22.5 16.8 26.1 23.1 24.8 21.4 31.1 21.3 23.1 31.2 43.5 15.2 21.6 19.5 27.4 21.8 48.3 17.5 23.4 29.0 19.1 17.5 25.3 13.6 15.2 16.7 24.8 18.8 24.6 20.1 23.8 33.7 22.3 21.1 16.9 36.4 38.5 33.6 9.6 20.8 26.5 30.5 19.3 31.1 27.8 12.7 31.2 21.9 27.5 17.9 24.2 23.5 13.9 17.6 21.8 16.6 35.3 29.1 11.1 32.2 10.8 22.5 44.5 29.0 16.1 26.0 14.4 14.5 36.6 17.2 8.2 10.5 17.4 14.3 15.8 14.7 23.1 25.3 17.7 20.7 20.3 28.7 8.7 12.3 30.0 10.6 19.5 25.3 29.0 16.8 26.8 14.9 19.1 14.6 17.5 19.4 20.0 18.6 16.3 14.9 16.5 2.3 17.5 18.2 23.4 25.3 13.6 40.0 44.8 39.7 42.7 34.0 28.8 35.9 28.9 36.0 43.5 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721162-69787961 "Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 137.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 47.5;TIME: 15.4;U-2197: 13.7" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA002107: " "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 1.2 0.6 0.9 9.3 1.8 1.3 1.1 0.5 1.5 1.1 38.6 0.5 0.7 31.8 0.8 0.6 1.0 1.5 1.2 1.2 0.9 0.9 1.1 24.8 2.4 12.9 1.2 0.7 0.7 0.5 0.0 0.4 0.6 2.0 0.6 20.3 1.3 0.6 0.2 0.4 0.4 137.6 1.4 3.6 13.3 13.9 0.5 0.7 2.0 0.6 0.3 2.0 0.7 1.2 0.2 1.8 21.9 3.2 1.8 3.6 1.6 0.3 0.2 0.3 0.4 0.8 0.9 0.6 0.4 0.2 0.1 0.1 0.3 0.3 0.5 0.3 0.4 0.5 0.0 0.1 0.3 0.6 0.4 0.5 0.4 0.2 1.2 0.6 0.7 5.5 0.0 0.1 0.2 47.5 0.2 1.1 0.4 0.3 0.3 0.5 0.4 0.2 0.2 1.6 0.3 0.1 0.8 0.7 0.4 0.2 0.2 0.2 0.7 0.3 15.4 0.4 0.8 13.7 0.3 0.8 0.4 0.2 0.2 1.4 0.6 5.8 3.2 0.8 0.7 1.9 0.2 0.1 1.1 0.3 1.8 0.2 3.6 1.7 21.9 1.8 2.2 0.2 0.5 1.6 0.9 1.8 0.5 1.5 0.9 0.9 1.2 0.7 2.0 0.7 SUMO2 "SMT3B, SMT3H2" ENSG00000188612 "Small ubiquitin-like modifier 2" P61956 17 75165586-75182983 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037314, HPA042123, HPA048064" Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "CAB037314: AB_796170, HPA042123: , HPA048064: " "unprognostic (6.49e-2)" "unprognostic (1.01e-2)" "unprognostic (4.23e-2)" "prognostic unfavourable (1.88e-5)" "unprognostic (1.32e-1)" "unprognostic (1.23e-3)" "prognostic unfavourable (2.12e-4)" "unprognostic (9.80e-2)" "unprognostic (6.02e-3)" "unprognostic (2.58e-3)" "unprognostic (5.07e-2)" "unprognostic (2.29e-2)" "prognostic unfavourable (5.23e-6)" "unprognostic (2.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.14e-2)" "unprognostic (4.89e-3)" 69.0 70.0 77.8 62.6 70.9 63.5 62.6 105.3 73.1 75.4 55.4 50.4 44.5 52.3 69.5 55.7 77.2 58.8 64.3 51.7 68.2 59.4 67.8 60.9 58.0 63.4 57.5 48.3 81.0 62.3 27.9 51.0 60.4 41.5 65.6 48.8 49.7 54.7 53.8 66.9 51.0 53.9 69.9 59.0 69.2 65.8 59.7 44.8 92.6 65.5 50.7 72.1 80.3 61.6 90.7 107.4 130.6 89.3 73.9 119.0 122.6 80.0 33.1 117.4 60.1 34.5 33.3 55.2 63.4 31.1 43.9 40.8 37.8 44.2 70.1 45.5 36.2 39.2 52.7 39.1 51.9 40.5 80.0 70.2 33.4 64.8 22.6 92.0 63.2 33.6 22.3 39.0 21.4 45.2 57.7 57.4 32.3 34.6 140.2 79.6 71.5 50.0 98.0 111.9 58.5 43.9 67.6 72.2 84.5 76.9 64.0 50.9 69.2 72.6 50.7 64.0 66.5 48.7 101.8 40.4 36.5 107.4 40.3 55.1 51.1 113.4 76.1 130.6 73.2 84.7 75.9 90.7 92.3 84.5 78.8 77.6 85.6 83.0 68.0 73.9 89.3 107.4 119.0 122.6 77.8 70.9 105.3 73.1 68.2 59.4 57.5 48.3 41.5 44.8 SUMO4 "dJ281H8.4, IDDM5, SMT3H4" ENSG00000177688 "Small ubiquitin-like modifier 4" Q6EEV6 6 149400227-149401292 "Predicted intracellular proteins" "Ubl conjugation pathway" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 2.9;HeLa: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042123, HPA048064" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA042123: , HPA048064: " "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-1)" "unprognostic (7.75e-2)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-2)" "unprognostic (2.44e-11)" "unprognostic (4.94e-3)" "unprognostic (5.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" 1.5 0.8 0.7 1.9 1.7 3.6 2.7 5.1 6.5 2.1 1.1 1.2 1.4 1.6 3.0 3.2 1.7 0.7 1.5 3.6 1.0 0.8 2.3 6.6 2.8 3.9 0.7 1.7 2.9 2.2 1.2 2.6 1.8 2.8 3.1 1.7 1.7 2.5 1.1 2.3 1.3 1.4 1.9 1.9 2.2 1.5 2.0 0.2 1.4 2.1 0.7 1.8 1.4 3.5 1.9 0.7 5.6 1.1 3.2 2.6 0.5 0.2 0.0 0.2 0.2 0.4 0.0 0.5 0.8 0.2 0.3 0.3 0.3 0.3 1.5 0.3 0.0 0.3 0.0 0.6 0.4 2.9 0.3 0.2 4.1 0.3 0.3 0.2 0.3 0.3 0.2 0.5 1.0 0.0 0.6 1.2 0.2 0.0 0.5 0.6 0.5 0.3 0.4 0.6 0.5 0.0 1.4 0.9 0.2 0.5 0.0 0.0 0.0 1.7 1.4 0.8 0.7 0.6 0.4 0.6 0.1 0.1 0.5 0.6 0.0 0.3 0.5 0.9 1.3 0.6 0.7 1.1 2.6 1.9 0.7 1.9 1.7 2.4 5.6 3.2 1.1 0.5 2.5 0.5 0.7 1.7 5.1 6.5 1.0 0.8 0.7 1.7 2.8 0.2 SUPT4H1 "Spt4, SPT4H, Supt4a, SUPT4H" ENSG00000213246 "SPT4 homolog, DSIF elongation factor subunit" P63272 17 58345175-58353093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059748 Approved Nucleoplasm Nucleoplasm "HPA059748: " "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.43e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-2)" "prognostic unfavourable (7.69e-5)" "unprognostic (6.71e-2)" "unprognostic (7.05e-2)" "unprognostic (2.37e-3)" "unprognostic (1.57e-2)" "unprognostic (9.52e-2)" "unprognostic (1.28e-2)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (2.54e-1)" 33.3 41.5 34.2 29.8 32.0 67.5 37.4 36.0 53.3 35.1 34.9 29.4 23.9 24.3 36.4 32.0 36.2 31.3 27.5 31.7 29.3 26.7 43.1 52.5 29.7 44.5 30.0 27.3 34.8 34.4 25.5 23.1 41.7 33.5 33.0 32.0 33.0 33.5 31.6 37.4 33.7 36.7 30.3 27.9 41.5 30.5 35.1 20.5 44.1 46.2 37.4 35.9 33.4 29.6 17.8 33.2 73.0 41.4 11.9 21.1 41.7 20.3 38.2 19.9 14.1 21.1 18.4 26.0 22.2 22.5 31.3 30.4 11.4 19.7 21.4 39.0 32.7 12.3 26.3 26.7 38.2 34.5 28.8 32.1 22.1 46.0 20.3 40.6 23.5 25.8 23.8 22.8 21.5 25.2 34.0 25.1 25.1 30.4 42.7 28.6 17.1 32.2 32.7 27.7 21.2 25.9 22.1 17.5 31.4 11.8 10.4 22.3 28.2 32.3 19.6 27.0 23.0 13.9 27.3 36.5 79.8 29.5 22.3 13.9 18.2 38.3 39.0 46.3 17.4 41.4 17.0 17.8 16.7 18.1 33.2 14.7 13.5 16.3 73.0 11.9 40.4 18.3 21.1 41.7 34.2 32.0 36.0 53.3 29.3 26.7 30.0 27.3 33.5 20.5 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone" Q7KZ85 17 28662091-28702684 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: " "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavourable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favourable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 27.6 30.0 30.0 24.1 32.8 56.3 25.6 31.9 35.7 28.0 30.1 28.5 23.2 19.9 38.6 28.4 24.4 24.1 25.0 23.8 25.7 22.0 24.1 32.6 26.3 26.0 25.7 32.8 33.1 28.8 40.7 34.5 31.9 24.3 26.9 21.8 33.2 28.2 29.2 50.1 38.6 28.7 40.0 29.8 33.1 28.5 23.4 29.0 27.2 27.6 18.4 29.4 30.7 27.1 5.7 8.2 14.4 6.1 5.4 5.6 3.4 17.7 37.2 18.7 21.3 22.8 15.3 14.4 24.4 26.1 28.8 25.9 34.5 7.9 18.9 12.8 24.3 21.2 27.3 17.7 29.9 35.1 24.3 26.4 30.0 21.3 19.1 27.6 29.5 21.0 10.7 30.6 20.4 18.9 25.8 22.4 20.5 21.2 27.3 11.8 14.5 12.1 14.0 34.4 15.4 14.2 35.2 14.3 18.9 28.6 45.2 15.5 27.7 19.6 29.7 22.8 18.8 21.6 31.0 28.5 21.8 27.7 25.7 12.5 18.8 14.4 5.9 5.4 5.2 3.9 5.5 5.6 4.3 5.6 4.8 5.7 4.4 3.8 9.0 5.4 6.1 8.2 3.8 3.4 30.0 32.8 31.9 35.7 25.7 22.0 25.7 32.8 24.3 29.0 SUPT7L "KIAA0764, SPT7L, STAF65, STAF65gamma" ENSG00000119760 "SPT7 like, STAGA complex gamma subunit" O94864 2 27650812-27663840 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039565, HPA063643" Uncertain Approved Nucleoplasm Nucleoplasm "HPA039565: AB_10795109, HPA063643: " "unprognostic (1.10e-1)" "unprognostic (1.15e-1)" "unprognostic (3.07e-2)" "prognostic unfavourable (2.28e-4)" "unprognostic (7.54e-2)" "unprognostic (3.70e-1)" "prognostic unfavourable (4.46e-7)" "unprognostic (5.15e-2)" "unprognostic (1.43e-3)" "unprognostic (2.27e-2)" "unprognostic (1.97e-3)" "unprognostic (9.75e-3)" "prognostic unfavourable (1.53e-4)" "unprognostic (2.26e-1)" "unprognostic (4.86e-1)" "unprognostic (3.79e-1)" "unprognostic (5.23e-3)" 24.5 27.5 23.5 23.3 39.7 33.9 25.3 38.6 47.6 22.4 21.8 35.6 21.4 25.0 31.4 29.3 20.5 27.3 22.9 31.0 26.6 28.0 25.1 28.5 23.9 27.6 25.8 27.2 33.4 23.9 33.2 39.3 29.6 36.7 26.7 29.0 28.8 19.3 26.0 26.1 18.7 24.8 31.7 23.2 32.5 22.9 19.5 25.9 34.7 29.7 18.4 26.0 21.8 23.1 12.5 17.3 20.2 13.0 18.2 18.1 10.9 18.3 16.0 23.5 18.1 21.5 17.7 28.1 17.9 17.4 16.3 17.6 20.5 20.8 16.1 19.0 18.9 20.1 21.0 19.9 16.0 18.4 20.3 21.9 22.6 23.2 28.2 17.6 21.5 24.7 25.1 24.0 25.4 21.0 24.6 19.4 21.1 12.5 15.2 29.0 15.6 14.1 14.7 25.1 20.4 20.9 17.3 18.7 24.3 16.1 16.8 29.5 11.6 15.4 16.1 22.7 16.8 11.4 17.0 35.0 25.4 33.4 17.6 22.0 15.4 20.2 12.4 10.7 16.4 13.0 18.1 9.2 12.8 16.6 17.3 12.5 15.6 14.7 3.3 18.2 11.1 11.6 14.1 10.9 23.5 39.7 38.6 47.6 26.6 28.0 25.8 27.2 36.7 25.9 SURF6 "FLJ30322, RRP14" ENSG00000148296 "Surfeit 6" O75683 9 133328774-133336398 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023608, HPA074622" Approved Enhanced Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA023608: AB_1857671, HPA074622: " "unprognostic (5.27e-3)" "unprognostic (8.67e-3)" "unprognostic (5.41e-3)" "unprognostic (3.69e-2)" "unprognostic (2.61e-1)" "unprognostic (3.20e-1)" "unprognostic (1.26e-3)" "unprognostic (3.60e-2)" "unprognostic (1.18e-1)" "unprognostic (9.37e-2)" "unprognostic (6.18e-3)" "unprognostic (9.32e-3)" "prognostic favourable (7.31e-5)" "unprognostic (1.50e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (2.66e-1)" 14.8 16.8 19.9 15.0 22.7 16.2 15.7 16.4 25.8 13.9 16.2 14.0 11.9 21.7 18.6 10.9 17.4 18.5 15.9 13.9 19.1 17.9 14.5 16.2 12.6 17.6 19.6 22.9 27.4 23.1 16.5 11.8 12.5 24.6 15.8 13.1 11.6 18.3 19.5 47.3 17.8 22.3 18.0 23.6 18.8 13.6 16.5 19.8 8.6 14.4 11.1 13.5 15.3 19.1 7.7 8.9 3.9 4.7 4.6 8.5 3.6 4.1 6.6 5.1 7.6 3.2 2.9 8.4 6.7 3.9 6.0 3.7 10.3 7.2 12.2 5.2 3.7 12.7 6.5 7.0 2.2 8.1 7.4 8.4 7.5 6.1 5.8 14.1 7.3 4.2 6.3 6.3 5.8 3.1 18.2 6.6 5.3 10.9 11.4 11.6 14.8 11.9 12.1 7.1 12.3 5.2 4.0 10.7 9.1 6.5 10.8 5.8 9.4 8.0 6.3 13.7 7.2 6.9 9.0 4.9 6.9 15.8 5.1 9.7 8.0 3.9 4.7 1.9 6.8 4.4 7.0 7.1 6.2 6.1 4.9 7.7 8.5 7.0 1.3 4.6 3.7 8.9 5.0 3.6 19.9 22.7 16.4 25.8 19.1 17.9 19.6 22.9 24.6 19.8 SUSD1 DKFZP761E1824 ENSG00000106868 "Sushi domain containing 1" Q6UWL2 9 112040785-112175408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.9;HEL: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 24.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048554 Approved Approved Nucleoplasm "Intracellular and membrane" 530000 Nucleoplasm "HPA048554: " "unprognostic (2.25e-1)" "unprognostic (4.02e-2)" "unprognostic (1.42e-2)" "unprognostic (1.62e-1)" "unprognostic (9.29e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.73e-2)" "unprognostic (1.23e-2)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "prognostic favourable (3.63e-6)" "unprognostic (2.14e-3)" "unprognostic (8.38e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" 9.6 13.9 9.1 9.7 13.9 14.1 8.4 3.1 15.3 7.6 10.2 2.7 11.6 8.6 5.7 9.8 4.8 6.7 7.6 11.2 6.1 16.4 15.5 4.4 11.5 15.7 8.3 8.2 3.3 8.1 9.4 8.2 23.3 7.4 5.8 11.4 8.1 10.7 12.8 2.9 3.6 9.9 9.3 5.1 14.5 12.2 5.8 3.5 9.6 5.6 1.4 6.6 13.1 4.6 0.2 24.9 5.8 2.7 1.7 1.6 1.1 1.3 8.6 6.1 0.0 4.5 3.0 19.7 5.5 7.3 7.7 10.0 17.0 11.5 0.1 6.2 9.5 3.9 2.2 1.0 5.8 22.9 1.8 25.8 6.3 11.5 5.5 6.7 8.3 3.7 0.8 4.3 0.1 18.0 14.0 1.1 4.8 1.6 0.9 4.2 2.0 1.4 5.7 1.4 0.0 1.8 4.5 2.2 5.2 3.0 0.6 0.0 1.0 7.4 13.6 0.1 2.9 0.8 0.0 0.3 0.3 0.5 5.4 2.7 1.7 3.5 1.4 5.8 1.6 1.6 0.5 0.1 0.4 1.1 1.0 0.2 0.2 1.2 0.5 1.7 2.7 24.9 0.1 1.1 9.1 13.9 3.1 15.3 6.1 16.4 8.3 8.2 7.4 3.5 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085138 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.8;testis: 64.8" "Cell line enhanced" "Detected in some" "Daudi: 50.6;MCF7: 12.3;NB-4: 25.8;RPMI-8226: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042310 Uncertain Approved Nucleoplasm Nucleoplasm "HPA042310: AB_10796902" "prognostic favourable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 3.2 1.0 3.3 16.9 3.2 18.7 8.0 1.2 3.2 8.3 3.3 8.5 0.6 2.2 11.6 12.8 1.9 18.2 1.9 1.0 2.4 2.7 18.5 13.9 3.8 25.8 4.0 2.3 20.9 0.8 0.2 3.2 1.4 3.7 1.8 0.9 3.0 7.5 1.5 0.4 1.6 9.7 3.0 5.4 20.2 1.9 64.8 3.1 13.9 2.5 0.8 19.9 3.0 3.7 20.4 9.2 16.7 3.9 2.2 52.8 17.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 1.1 0.4 50.6 0.2 0.2 0.1 0.8 0.0 0.0 4.4 0.0 6.9 0.0 0.7 3.4 0.0 1.6 3.5 0.2 0.0 0.0 0.0 2.0 11.2 0.0 12.3 0.0 25.8 0.6 1.5 2.1 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.7 11.6 0.1 0.0 0.0 0.0 0.0 2.3 1.2 3.1 0.0 0.0 0.1 0.1 3.9 16.7 5.7 3.4 6.4 20.4 30.1 10.5 9.2 14.4 52.8 21.3 1.3 2.2 0.6 0.8 39.8 17.0 3.3 3.2 1.2 3.2 2.4 2.7 4.0 2.3 3.7 3.1 SUSD6 KIAA0247 ENSG00000100647 "Sushi domain containing 6" Q92537 14 69611596-69715142 "Predicted membrane proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030464 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA030464: AB_10601128" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "unprognostic (1.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.46e-2)" "unprognostic (2.17e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-1)" "unprognostic (3.66e-3)" "unprognostic (1.10e-2)" "unprognostic (6.70e-2)" "prognostic favourable (2.16e-4)" "unprognostic (1.10e-2)" "unprognostic (5.35e-2)" "unprognostic (1.30e-2)" "unprognostic (2.34e-1)" 25.4 17.4 9.2 26.0 11.9 40.2 19.5 36.4 12.3 12.1 25.0 15.5 14.8 17.2 13.0 31.0 27.0 16.1 19.6 13.2 11.4 8.4 16.7 11.6 30.9 25.3 15.1 8.2 13.4 20.9 13.7 14.6 14.1 13.9 16.0 13.4 14.6 26.6 17.5 10.6 22.5 36.7 14.0 14.1 30.9 17.3 9.1 12.9 12.7 23.4 14.8 27.4 16.4 15.3 4.1 5.3 23.1 9.1 2.9 4.2 5.0 10.6 2.8 4.0 3.7 8.3 6.1 7.4 6.1 12.8 3.5 3.4 3.3 9.5 12.6 6.9 7.6 15.0 2.3 12.5 3.3 21.5 1.7 10.2 2.2 5.4 13.4 1.6 26.5 9.8 12.4 5.8 10.9 7.1 3.1 11.2 4.8 5.2 2.4 4.4 0.8 2.9 4.2 3.5 5.0 6.7 5.5 1.7 2.7 5.0 14.6 2.2 5.9 4.6 10.9 8.1 4.8 5.1 2.4 7.8 1.7 8.9 5.2 5.7 4.2 8.9 7.5 8.3 4.1 7.3 4.2 3.9 3.6 2.5 5.3 4.1 3.5 2.5 23.1 2.9 9.1 3.0 3.2 5.0 9.2 11.9 36.4 12.3 11.4 8.4 15.1 8.2 13.9 12.9 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favourable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.4 5.0 33.1 11.9 13.4 21.4 16.0 9.0 7.4 12.3 12.7 9.3 8.4 11.4 9.9 12.1 7.3 5.8 9.7 16.6 20.2 10.0 22.9 5.0 18.3 10.8 17.1 15.0 13.4 15.5 6.9 7.1 12.4 17.8 6.1 15.7 4.9 17.1 20.5 18.1 6.1 12.5 25.2 8.0 13.0 11.5 19.8 17.7 10.8 6.3 12.9 4.9 48.5 9.5 10.9 12.3 8.7 14.6 5.9 7.3 8.2 7.0 11.7 10.3 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.7;Karpas-707: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: " "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.3 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.7 0.4 3.2 0.0 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 3.9 0.0 1.6 2.3 2.0 0.3 1.4 0.0 0.0 7.3 0.4 3.3 0.0 0.0 0.3 0.0 0.0 0.0 3.8 1.2 2.6 0.8 2.3 0.0 2.2 1.4 2.1 1.7 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell line enhanced" "Detected in many" "U-138 MG: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavourable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.0 6.3 3.4 8.8 7.7 7.2 2.7 17.2 12.7 17.0 14.4 1.4 2.4 0.0 11.4 17.3 2.6 2.6 3.0 9.5 0.1 3.0 0.6 11.7 2.7 14.7 0.0 0.0 12.5 2.2 10.1 4.6 3.1 0.0 0.0 12.6 2.0 0.0 0.0 5.6 6.5 0.0 8.5 0.0 4.2 0.5 0.1 6.8 9.6 5.9 11.5 0.7 0.4 6.5 40.8 12.4 18.6 18.5 0.0 0.1 0.0 11.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" 3 12004402-12191400 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 20 "brain: 72.5" "Cell line enhanced" "Detected in some" "HAP1: 3.4;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.1;SCLC-21H: 4.1;SH-SY5Y: 16.2" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm Nucleoplasm "CAB079005: , HPA037012: " "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 3.7 2.7 28.2 0.7 23.3 0.5 1.4 9.2 72.5 1.0 0.8 0.2 0.0 0.8 1.2 1.2 0.5 0.8 0.7 0.7 15.4 1.4 0.4 0.8 0.5 0.0 33.4 1.5 0.5 1.8 0.0 2.3 15.3 0.7 0.9 0.0 0.9 0.6 0.9 0.9 1.2 1.9 2.2 0.8 1.2 2.4 1.6 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 3.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 5.1 0.4 0.0 0.0 0.0 0.0 0.2 4.1 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33457541 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell line enhanced" "Detected in many" "AF22: 20.7;HMC-1: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.9" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favourable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavourable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 4.5 5.0 29.7 11.9 28.6 6.2 4.3 27.2 33.7 7.8 5.9 5.5 2.4 6.0 13.0 5.3 4.2 11.9 6.1 4.4 37.9 7.6 4.0 2.2 5.9 10.3 4.1 38.9 12.8 3.5 10.0 26.1 6.2 7.9 6.3 4.7 3.2 3.7 7.1 2.3 6.2 5.7 11.1 8.7 9.7 4.9 8.7 9.3 8.9 5.6 0.2 7.0 6.9 6.4 1.5 0.1 0.1 0.2 0.0 1.9 0.0 2.0 0.9 20.7 7.7 4.3 4.5 2.6 5.0 3.2 2.8 2.2 8.6 0.8 5.8 1.3 2.4 3.0 2.6 2.9 2.0 3.3 1.6 14.5 2.3 0.5 2.9 2.2 17.0 3.1 0.9 5.2 2.5 2.0 4.5 2.7 2.0 4.3 3.5 3.4 10.4 2.2 13.6 0.5 2.4 2.1 1.5 5.0 4.0 1.9 3.6 1.6 7.9 2.1 0.6 5.9 5.8 2.3 0.9 3.2 1.1 4.3 3.4 2.6 1.4 0.0 0.2 0.1 0.3 0.0 0.8 0.1 1.9 0.9 0.0 1.5 0.9 0.2 0.1 0.0 0.1 0.1 0.1 0.0 29.7 28.6 27.2 33.7 37.9 7.6 4.1 38.9 7.9 9.3 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favourable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavourable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.5 2.8 5.1 5.6 8.9 7.2 10.3 11.5 6.6 7.0 5.9 6.3 2.6 2.0 3.9 6.9 5.2 9.1 6.7 8.4 6.5 8.7 13.8 9.0 3.5 4.8 5.7 12.3 4.0 5.0 12.2 6.2 10.9 10.3 11.9 9.0 5.6 5.3 4.7 3.6 6.3 5.8 11.1 7.2 7.4 4.0 5.8 4.5 14.1 9.0 5.5 7.8 7.4 12.1 10.9 5.4 8.7 6.3 6.2 7.2 4.3 8.2 10.8 8.6 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell line enhanced" "Detected in many" "BEWO: 25.8;EFO-21: 21.3;HUVEC TERT2: 20.9;TIME: 50.7;U-87 MG: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: " "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavourable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.1 1.0 0.9 25.8 3.9 5.4 1.3 1.1 6.0 2.8 0.0 21.3 5.6 2.5 0.0 3.8 0.5 0.0 0.0 0.0 10.4 1.3 5.8 0.0 0.2 1.1 6.2 1.5 1.1 20.9 0.0 0.0 1.2 0.4 0.0 0.1 0.8 3.3 0.1 0.2 0.0 1.0 0.5 2.4 11.5 5.6 6.2 0.2 0.4 1.8 50.7 5.1 15.9 0.1 1.0 0.2 0.0 0.3 44.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 SYT17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268334 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2" "Cell line enhanced" "Detected in some" "BEWO: 10.2;CAPAN-2: 19.9;Daudi: 8.7;MCF7: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4" "Group enriched" "Detected in many" 8 "B-cells: 14.7;monocytes: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042059: " "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 3.8 5.2 16.5 1.4 9.2 0.4 4.7 1.0 25.2 3.5 2.4 6.1 1.2 4.3 1.2 3.1 4.0 2.5 1.3 1.3 15.5 16.5 3.8 12.1 7.8 3.2 13.9 10.2 0.8 2.5 21.3 13.4 3.9 7.5 9.7 3.0 7.6 1.5 3.8 0.4 9.9 2.1 1.0 5.5 1.4 4.3 0.6 7.4 0.0 7.1 0.8 4.7 4.2 3.8 14.7 1.6 0.4 13.4 0.0 0.0 0.6 0.0 7.3 0.1 0.0 0.2 0.5 10.2 0.0 0.0 0.0 0.0 0.3 19.9 8.7 2.4 0.0 3.5 0.5 0.3 0.0 0.0 1.4 0.0 7.3 0.1 0.0 0.0 0.0 0.7 1.8 0.1 0.0 0.3 0.0 0.0 0.0 15.0 0.0 0.0 0.8 4.1 0.0 0.8 0.6 2.5 4.4 1.5 0.9 2.8 7.9 0.4 7.8 1.8 0.0 0.0 5.2 0.1 0.0 1.4 0.0 8.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 4.1 0.0 5.1 0.0 0.0 1.6 14.7 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.6 16.5 9.2 1.0 22.9 15.5 16.5 13.9 10.2 7.5 7.4 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell line enhanced" "Detected in some" "CACO-2: 6.8;MCF7: 6.3;SK-MEL-30: 16.4;U-2 OS: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 6.8 1.6 0.0 0.0 0.6 0.7 0.0 0.0 0.1 0.0 0.7 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.1 0.1 0.2 0.3 6.3 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.4 3.6 0.1 0.3 1.4 16.4 0.0 0.0 0.0 0.2 5.5 0.0 3.6 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 SZRD1 "C1orf144, DKFZp566C0424" ENSG00000055070 "SUZ RNA binding domain containing 1" Q7Z422 1 16352575-16398145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024221 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA024221: AB_10603450" "unprognostic (3.52e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (5.98e-6)" "unprognostic (2.53e-1)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "unprognostic (7.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" "unprognostic (7.60e-2)" 34.9 30.7 23.1 25.0 26.3 37.5 33.1 17.1 20.6 30.7 29.0 20.8 15.4 23.0 38.5 23.2 33.7 26.5 30.5 37.0 23.5 14.3 39.8 41.4 26.2 27.2 27.4 11.8 36.3 25.1 32.2 16.8 46.4 22.4 24.8 20.9 27.9 20.8 23.7 55.2 24.9 39.3 31.3 20.9 40.6 27.1 18.3 25.0 32.1 35.0 27.6 33.6 34.3 35.1 30.4 19.2 34.3 36.7 20.0 25.5 29.6 37.4 28.8 39.9 27.6 34.1 39.4 13.2 38.4 50.0 45.7 35.6 28.8 33.4 32.9 43.1 51.2 20.7 35.7 42.3 33.9 56.6 30.9 37.7 31.0 22.6 30.8 36.6 37.2 39.7 35.5 49.8 33.4 39.5 33.7 31.0 41.7 36.4 35.7 27.9 27.8 33.0 36.6 42.1 38.6 31.0 17.6 31.6 33.0 33.6 21.7 48.6 22.5 24.2 44.0 31.2 36.5 48.6 38.1 17.2 18.9 39.6 34.8 50.1 41.2 15.0 24.3 34.3 24.5 33.2 24.2 28.3 21.2 22.8 19.2 30.4 19.6 21.1 27.1 20.0 36.7 14.9 25.5 29.6 23.1 26.3 17.1 20.6 23.5 14.3 27.4 11.8 22.4 25.0 SZT2 "C1orf84, FLJ10387, FLJ34502, KIAA0467, RP11-506B15.1, SZT2A, SZT2B" ENSG00000198198 "SZT2, KICSTOR complex subunit" Q5T011 1 43389882-43454247 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029012 Approved Approved "Nucleoplasm,Vesicles,Actin filaments" "Nucleoplasm, Vesicles, Actin filaments" "HPA029012: AB_10600817" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.14e-1)" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "prognostic favourable (1.47e-7)" "prognostic unfavourable (2.53e-4)" "prognostic favourable (6.20e-4)" "unprognostic (1.54e-1)" "unprognostic (1.81e-2)" "unprognostic (5.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (1.84e-3)" "unprognostic (8.28e-2)" "unprognostic (7.19e-2)" "unprognostic (2.61e-2)" 10.0 8.4 9.0 15.9 12.8 13.5 10.3 16.1 12.9 10.2 10.2 21.7 12.8 8.8 13.7 8.3 9.4 11.3 8.2 8.6 8.7 6.8 7.9 6.1 10.3 11.1 12.4 9.1 14.9 10.8 23.6 16.1 8.1 10.9 10.9 8.9 13.5 11.4 11.6 10.9 17.4 11.6 12.1 9.9 11.0 10.0 12.2 11.1 13.9 16.3 5.9 12.6 12.3 9.6 1.8 3.0 4.9 1.8 1.3 3.0 1.2 6.2 5.9 5.9 5.3 15.2 9.1 8.3 4.8 6.9 6.7 6.6 2.0 7.7 5.8 6.4 8.5 7.6 5.0 8.9 5.1 7.4 4.9 10.5 11.2 3.6 6.0 8.4 8.6 8.1 7.1 11.0 10.2 7.3 4.7 9.2 5.0 3.1 5.7 2.9 4.9 6.4 7.3 6.4 7.8 4.2 7.9 5.7 5.3 9.6 8.9 6.6 5.3 12.9 9.5 7.3 9.2 10.1 8.4 9.6 3.8 4.7 7.6 5.8 5.3 3.8 1.8 4.9 1.5 1.5 3.0 1.4 0.8 0.8 1.5 1.8 1.7 1.3 3.7 1.3 1.7 3.0 1.7 1.2 9.0 12.8 16.1 12.9 8.7 6.8 12.4 9.1 10.9 11.1 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843354-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favourable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavourable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favourable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 13.4 11.7 10.2 10.7 11.1 7.8 12.1 14.0 12.7 12.3 7.4 8.4 15.9 7.1 19.2 14.5 16.5 13.6 9.7 8.5 9.3 11.7 17.9 9.9 11.5 13.9 9.2 9.5 12.7 8.9 22.6 19.5 20.2 10.7 12.6 8.1 11.6 10.1 20.1 7.2 11.3 7.5 11.1 8.5 13.9 8.4 17.1 9.2 23.3 14.9 10.9 15.8 9.9 14.4 9.8 11.3 4.9 13.1 8.5 12.9 4.6 12.0 12.0 16.7 5.1 8.4 12.9 26.9 13.2 13.2 14.4 12.5 11.1 9.8 14.2 7.0 10.7 6.9 14.5 16.3 16.1 13.8 15.8 15.3 5.1 14.9 10.9 12.0 17.1 10.1 9.6 10.6 15.7 21.6 10.2 15.1 14.5 8.0 9.0 10.2 20.1 8.8 5.4 14.1 4.4 14.7 10.8 7.1 18.2 11.4 15.3 11.6 5.3 9.6 10.0 17.4 20.5 17.0 18.2 7.4 8.8 20.2 10.5 13.9 14.9 2.6 8.4 4.9 11.5 13.1 10.9 9.5 9.5 12.9 11.3 9.8 6.3 9.4 0.4 8.5 10.0 9.4 9.4 4.6 10.2 11.1 14.0 12.7 9.3 11.7 9.2 9.5 10.7 9.2 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 36.1" "Cell line enriched" "Detected in some" 17 "SiHa: 35.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.6" "Low region specificity" "Detected in all" HPA001879 Approved Approved Nucleoplasm Nucleoplasm "HPA001879: AB_1857751" "unprognostic (1.70e-2)" "prognostic favourable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.0 1.4 0.1 1.7 0.2 0.1 0.1 0.6 1.6 0.5 0.2 0.1 0.0 0.7 3.5 0.1 0.0 0.1 0.1 0.8 0.2 0.3 0.5 0.1 0.1 0.1 0.8 0.1 0.1 2.5 0.2 0.4 0.3 1.8 0.0 0.4 0.1 1.8 0.1 0.6 0.3 0.1 0.4 0.1 0.1 36.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.6 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.6 0.0 0.1 0.2 0.1 1.7 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 35.2 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.7 0.1 0.6 0.8 0.2 0.1 0.8 0.3 0.1 TAF9B "DN-7, DN7, TAF9L, TAFII31L, TFIID-31" ENSG00000187325 "TATA-box binding protein associated factor 9b" Q9HBM6 X 78129748-78139706 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045275, HPA058961" Approved Approved Nucleoplasm Nucleoplasm "HPA045275: AB_10962831, HPA058961: " "unprognostic (3.62e-3)" "prognostic favourable (5.40e-5)" "unprognostic (1.91e-1)" "unprognostic (1.78e-1)" "unprognostic (4.20e-2)" "unprognostic (6.43e-2)" "unprognostic (1.02e-1)" "unprognostic (5.67e-2)" "unprognostic (3.46e-2)" "unprognostic (2.37e-3)" "unprognostic (5.68e-2)" "unprognostic (9.56e-2)" "unprognostic (8.42e-3)" "unprognostic (8.71e-2)" "unprognostic (9.34e-3)" "unprognostic (9.47e-2)" "unprognostic (2.62e-1)" 15.5 12.4 25.6 10.3 23.5 10.7 16.6 20.1 27.5 21.5 15.5 20.2 9.9 6.9 24.8 15.6 20.2 17.4 14.2 23.6 21.6 23.0 19.2 14.4 11.5 11.0 21.2 22.1 17.7 11.6 24.4 19.6 13.6 21.3 21.5 10.9 12.9 10.5 19.2 20.7 12.8 9.3 31.9 23.9 10.6 14.0 10.7 19.2 15.9 20.0 11.3 10.9 22.4 12.4 4.5 4.9 1.4 3.3 10.3 13.3 7.2 10.6 9.3 23.0 10.1 9.0 9.2 3.4 9.6 8.9 15.6 8.7 12.9 18.6 12.3 13.8 10.4 8.5 34.3 7.9 16.3 19.1 11.9 6.7 13.2 11.8 9.0 10.5 7.5 11.8 4.2 17.1 11.8 9.4 13.7 26.6 13.8 16.3 16.5 8.2 27.0 17.5 14.4 30.0 11.3 10.6 21.8 14.6 14.5 26.7 11.6 10.3 18.8 7.6 9.9 12.1 18.5 13.2 11.5 11.5 23.1 9.1 21.0 21.3 17.0 0.6 3.1 0.9 5.5 3.3 10.2 4.5 12.5 9.5 4.0 4.4 12.8 9.4 1.4 10.3 2.4 4.9 13.3 7.2 25.6 23.5 20.1 27.5 21.6 23.0 21.2 22.1 21.3 19.2 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747329-765024 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 148.6;neutrophil: 204.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol 39000000 Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavourable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 39.0 24.2 26.6 34.8 31.3 117.4 44.2 20.6 38.3 27.7 28.5 51.2 18.8 34.2 20.4 20.7 90.0 23.2 33.2 37.5 29.2 23.6 45.8 48.4 37.9 60.0 46.5 26.6 23.4 31.9 14.6 15.8 34.3 30.7 28.3 23.7 15.5 38.3 19.5 31.2 38.4 29.4 40.4 47.5 45.6 35.8 14.8 33.0 34.1 42.2 82.4 43.1 51.4 37.5 8.5 36.1 204.6 60.8 5.9 10.4 45.3 41.9 53.1 15.4 29.1 31.9 18.6 45.4 31.9 41.1 31.6 26.1 22.6 91.6 23.4 43.4 41.8 45.4 24.3 34.4 16.5 30.6 49.3 40.5 20.6 78.8 34.1 64.7 60.5 15.2 27.8 21.2 17.2 43.4 52.5 39.2 29.3 40.1 37.6 76.8 24.2 43.1 31.4 18.1 83.9 57.4 24.5 38.0 13.3 29.7 61.5 30.9 29.2 49.3 57.6 14.5 13.6 11.4 29.9 16.6 16.1 27.8 32.1 56.6 58.4 64.7 60.8 148.6 5.6 23.2 6.1 8.5 7.5 6.8 36.1 6.8 6.1 5.7 204.6 5.9 23.2 14.8 10.4 45.3 26.6 31.3 20.6 38.3 29.2 23.6 46.5 26.6 30.7 33.0 TARS2 "FLJ12528, TARSL1" ENSG00000143374 "Threonyl-tRNA synthetase 2, mitochondrial" Q9BW92 1 150487364-150507609 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028626 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Cytosol" "Intermediate filaments" "HPA028626: AB_10601719" "unprognostic (2.48e-1)" "unprognostic (7.75e-2)" "unprognostic (6.68e-2)" "unprognostic (3.75e-3)" "unprognostic (2.03e-1)" "unprognostic (1.62e-1)" "unprognostic (4.93e-2)" "unprognostic (2.14e-1)" "unprognostic (9.35e-2)" "unprognostic (4.26e-2)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (9.23e-2)" "unprognostic (9.29e-3)" "unprognostic (4.19e-2)" "unprognostic (1.14e-2)" "unprognostic (5.55e-2)" 10.7 21.1 16.5 10.5 17.8 9.2 11.3 17.5 21.4 10.2 10.9 14.8 12.9 9.4 10.5 14.7 15.7 13.0 11.8 20.9 18.1 12.3 15.6 26.8 9.1 14.0 15.0 19.7 13.3 11.5 20.4 12.2 9.4 16.5 9.8 12.5 13.3 11.3 10.9 36.0 13.3 10.5 10.9 13.8 15.1 12.4 10.7 16.6 10.6 12.3 12.2 15.7 12.5 10.8 21.5 17.4 20.4 18.6 21.5 20.9 12.2 17.0 14.3 9.7 14.5 10.9 10.0 18.4 8.3 9.1 16.5 16.7 11.6 16.0 24.8 18.4 6.2 17.8 23.4 19.3 12.7 14.9 20.3 11.7 13.5 11.7 10.8 16.1 18.0 8.8 16.2 12.5 17.1 10.6 20.3 17.4 11.5 20.7 13.6 13.2 11.9 21.3 14.1 12.3 30.6 11.2 8.1 13.7 16.0 12.6 27.9 19.6 22.5 25.3 6.2 9.7 10.3 7.9 14.0 16.8 19.8 18.7 14.4 18.8 9.3 15.1 11.0 20.4 15.7 18.3 15.6 21.5 15.4 15.5 17.4 18.6 15.1 15.8 1.7 21.5 18.6 11.7 20.9 12.2 16.5 17.8 17.5 21.4 18.1 12.3 15.0 19.7 16.5 16.6 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Cell line enhanced" "Detected in many" "hTCEpi: 10.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.0 0.4 1.1 0.9 0.2 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.4 1.2 2.8 1.0 2.6 0.3 0.1 1.7 0.6 3.9 1.3 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.2 0.3 0.4 0.2 0.1 0.4 0.3 0.9 0.6 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816626 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favourable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 14.8 14.4 10.9 24.7 11.9 11.0 12.5 22.9 7.6 8.8 16.6 6.8 7.0 8.5 15.2 8.3 8.7 8.3 20.7 13.7 15.2 18.3 11.1 8.5 16.2 14.5 18.9 10.1 11.3 12.8 11.9 8.0 22.1 8.0 8.6 11.4 9.4 8.2 29.4 7.4 8.1 11.6 15.5 11.5 11.9 10.5 12.0 11.3 13.1 8.3 10.8 10.6 6.5 15.6 30.1 23.8 24.1 5.3 6.9 8.7 6.6 6.7 5.9 8.6 9.4 14.2 13.5 7.4 8.0 5.9 7.4 1.7 9.5 14.8 7.0 6.3 4.3 7.2 10.0 6.5 9.0 9.2 7.5 5.6 3.2 11.0 17.8 9.3 11.3 7.2 8.0 20.0 8.5 14.5 12.3 6.5 3.1 15.2 5.9 7.8 4.3 8.8 11.1 26.4 6.2 3.4 12.5 10.7 8.1 13.9 16.3 14.8 11.0 5.8 4.5 6.0 9.4 7.2 11.1 17.0 24.5 11.7 14.2 6.8 8.5 15.6 23.8 5.5 23.7 4.9 15.6 6.9 6.6 18.4 12.7 5.5 6.6 17.5 5.3 24.1 30.1 6.4 8.7 14.4 24.7 12.5 22.9 13.7 15.2 14.5 18.9 22.1 12.0 TAX1BP1 "CALCOCO3, TXBP151" ENSG00000106052 "Tax1 binding protein 1" Q86VP1 7 27739331-27844564 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024432 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA024432: AB_1857783" "unprognostic (1.38e-2)" "unprognostic (5.52e-2)" "unprognostic (3.55e-2)" "unprognostic (2.71e-2)" "unprognostic (2.55e-1)" "unprognostic (9.83e-3)" "unprognostic (1.81e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (6.72e-2)" "prognostic unfavourable (1.06e-4)" "unprognostic (3.69e-1)" "prognostic favourable (2.80e-6)" "unprognostic (1.76e-1)" "unprognostic (4.76e-2)" "unprognostic (1.21e-1)" "unprognostic (3.03e-1)" 28.5 63.0 31.1 19.5 49.8 34.9 30.7 33.5 48.4 33.8 33.4 16.1 26.7 23.7 27.4 35.5 46.6 30.7 28.2 47.4 30.8 31.9 51.0 35.3 28.7 23.0 41.0 34.8 32.0 29.7 46.3 69.4 65.8 54.1 36.4 31.1 18.7 32.3 32.6 50.3 23.5 41.0 48.8 41.7 34.5 30.3 30.3 35.2 34.2 44.5 27.0 24.6 51.3 29.0 21.1 17.5 59.7 31.3 17.3 33.0 22.5 40.0 22.2 22.8 21.5 36.1 26.4 15.5 30.0 36.9 22.5 28.3 17.9 32.7 8.5 28.3 43.7 28.6 21.3 19.6 35.3 16.0 11.0 23.1 23.9 35.7 34.1 33.6 27.5 22.3 40.8 26.1 30.1 24.2 25.7 26.3 45.4 14.7 14.7 33.3 25.6 20.9 12.3 24.5 17.4 31.8 45.4 15.1 24.6 42.0 55.0 62.5 25.6 50.8 26.0 21.3 33.3 26.4 19.7 48.4 33.5 16.0 24.9 64.0 48.7 37.4 24.2 59.7 21.8 29.3 26.3 21.1 25.9 25.3 17.5 17.9 24.0 24.0 48.9 17.3 31.3 16.2 33.0 22.5 31.1 49.8 33.5 48.4 30.8 31.9 41.0 34.8 54.1 35.2 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favourable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 6.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 TBC1D14 KIAA1322 ENSG00000132405 "TBC1 domain family member 14" Q9P2M4 4 6909242-7033118 "Plasma proteins, Predicted intracellular proteins" Autophagy "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036930, HPA067398" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "HPA036930: AB_10670155, HPA067398: " "unprognostic (3.05e-2)" "unprognostic (7.48e-3)" "unprognostic (4.80e-3)" "unprognostic (8.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.78e-3)" "unprognostic (9.63e-2)" "unprognostic (5.25e-2)" "unprognostic (9.71e-2)" "unprognostic (7.65e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" "prognostic favourable (5.28e-10)" "unprognostic (1.56e-1)" "unprognostic (3.50e-1)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" 20.0 31.2 31.9 24.4 33.8 10.6 22.0 18.1 32.8 16.0 20.2 22.5 17.0 17.3 16.2 21.9 24.3 18.8 15.0 22.9 28.6 27.5 32.1 21.6 20.7 48.4 28.8 20.5 23.3 19.3 23.6 20.7 18.0 29.0 19.6 20.7 26.1 23.2 16.7 35.1 37.3 20.0 17.8 37.3 26.2 35.8 22.4 29.3 24.0 14.9 17.9 19.9 16.7 15.4 5.3 7.5 26.4 8.2 5.5 8.9 6.0 10.3 11.3 12.7 14.2 10.6 8.9 7.7 8.3 9.1 7.8 6.7 11.7 21.7 16.7 4.9 9.9 7.5 21.3 19.1 9.6 4.6 6.9 27.9 7.4 12.2 7.3 12.6 62.9 6.8 27.1 7.4 12.2 7.3 26.4 6.0 9.4 6.7 19.3 12.8 17.2 12.7 24.3 16.8 18.0 11.6 7.3 19.5 13.9 6.9 7.5 25.6 10.4 12.0 7.3 8.6 6.5 7.5 12.2 11.6 26.8 17.1 8.1 16.2 8.3 1.7 8.2 3.5 5.9 5.3 8.9 5.2 6.4 6.3 6.9 5.3 4.9 4.5 26.4 5.5 2.4 7.5 7.5 6.0 31.9 33.8 18.1 28.0 28.6 27.5 28.8 20.5 29.0 29.3 TBC1D19 FLJ11082 ENSG00000109680 "TBC1 domain family member 19" Q8N5T2 4 26576437-26755351 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039592 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA039592: AB_10671043" "unprognostic (2.64e-2)" "unprognostic (2.71e-2)" "unprognostic (2.94e-1)" "unprognostic (8.65e-2)" "unprognostic (1.03e-1)" "unprognostic (1.57e-1)" "unprognostic (2.86e-1)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.90e-1)" "unprognostic (3.29e-2)" "unprognostic (4.28e-2)" "prognostic favourable (1.21e-7)" "unprognostic (1.04e-1)" "unprognostic (1.53e-2)" "prognostic unfavourable (4.06e-4)" "unprognostic (3.51e-1)" 6.1 13.9 8.6 5.4 10.2 2.8 6.8 11.5 11.2 11.8 8.8 8.7 7.7 3.1 22.4 11.0 4.8 11.9 11.8 10.7 6.6 9.0 24.9 4.6 6.6 3.5 9.3 7.7 13.9 7.7 21.9 23.4 6.1 14.8 8.7 5.1 8.4 5.8 10.4 5.7 4.2 3.8 13.5 8.6 4.4 6.9 10.0 7.1 33.3 12.1 2.9 4.2 8.3 7.0 4.1 2.4 2.3 0.9 6.6 8.7 1.8 1.3 1.2 4.6 2.8 6.7 10.4 1.4 5.8 4.5 2.7 2.9 2.1 3.3 3.2 5.2 8.2 0.6 2.5 3.2 2.6 0.9 1.3 0.7 3.7 0.6 3.5 1.6 0.7 5.0 2.5 5.3 3.0 3.7 2.5 0.0 40.3 0.0 3.3 1.8 2.0 4.9 2.4 4.7 0.3 10.4 1.3 4.6 1.9 2.8 0.6 2.8 1.1 0.7 3.3 3.4 1.0 2.6 1.4 0.8 1.7 1.4 12.0 0.9 3.5 1.6 0.9 2.3 8.1 0.9 8.7 3.2 6.2 8.3 1.4 4.1 4.9 5.1 0.1 6.6 0.8 2.4 3.0 1.8 8.6 10.2 11.5 11.2 6.6 9.0 9.3 7.7 14.8 7.1 TBC1D2 "Armus, PARIS1, TBC1D2A" ENSG00000095383 "TBC1 domain family member 2" Q9BYX2 9 98198999-98255721 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 27.2;HaCaT: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 18.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030871 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA030871: AB_10670046" "unprognostic (2.32e-2)" "unprognostic (1.11e-1)" "unprognostic (1.06e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-2)" "prognostic unfavourable (2.77e-4)" "unprognostic (1.86e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (9.21e-3)" "unprognostic (6.40e-3)" "unprognostic (2.30e-1)" "unprognostic (6.07e-2)" "unprognostic (4.32e-1)" "prognostic unfavourable (5.62e-4)" "unprognostic (1.30e-2)" "unprognostic (4.30e-1)" 13.1 4.1 6.6 7.0 15.6 14.5 7.6 7.7 7.6 7.8 12.0 17.8 6.0 15.5 4.4 4.3 25.3 4.4 5.3 2.2 9.5 7.4 4.6 12.6 27.4 4.5 15.2 5.3 4.3 3.0 4.5 3.1 11.9 9.0 8.1 5.9 6.2 10.1 8.8 3.3 18.8 15.2 5.7 14.3 6.7 5.1 3.1 12.2 4.7 7.1 14.7 16.8 14.7 11.6 0.9 7.0 8.1 18.4 0.7 3.9 6.4 27.2 4.0 0.1 0.9 3.1 6.0 9.0 12.1 6.7 8.8 7.4 2.5 12.0 0.4 9.2 7.0 35.9 0.2 13.4 3.1 0.9 0.5 0.2 13.9 1.9 14.4 0.6 1.0 8.3 22.2 8.8 22.0 3.1 0.8 0.3 7.0 3.5 0.1 1.6 0.5 2.3 0.4 1.7 0.0 13.4 17.0 0.3 0.5 4.1 9.0 1.2 2.9 0.9 18.8 10.8 3.2 1.7 4.8 0.6 0.5 0.2 10.9 1.0 1.1 1.1 18.4 5.5 1.9 10.8 1.3 0.9 2.8 1.6 7.0 0.6 1.2 1.4 8.1 0.7 8.0 0.9 3.9 6.4 6.6 15.6 7.7 7.6 9.5 7.4 15.2 5.3 9.0 12.2 TBC1D22A C22orf4 ENSG00000054611 "TBC1 domain family member 22A" Q8WUA7 22 46762617-47175699 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001173 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA001173: AB_1080212" "unprognostic (1.62e-1)" "unprognostic (5.90e-3)" "unprognostic (1.10e-1)" "unprognostic (4.79e-3)" "unprognostic (3.65e-2)" "unprognostic (7.07e-2)" "prognostic unfavourable (2.42e-4)" "unprognostic (5.95e-2)" "unprognostic (8.17e-2)" "prognostic unfavourable (6.94e-4)" "unprognostic (1.69e-1)" "unprognostic (9.17e-2)" "unprognostic (4.68e-2)" "unprognostic (4.93e-2)" "unprognostic (4.14e-1)" "unprognostic (1.09e-1)" "unprognostic (2.39e-1)" 18.1 17.6 18.3 36.5 16.0 14.0 16.4 10.8 18.5 14.6 23.1 22.4 16.5 22.8 20.6 17.8 24.8 19.6 22.1 15.1 16.1 15.4 18.1 14.8 18.5 26.6 17.3 17.0 16.1 20.5 18.8 15.9 23.2 16.9 12.5 15.3 17.0 23.5 15.5 23.7 22.6 26.3 13.0 18.4 27.2 22.8 14.2 18.2 21.1 17.8 16.5 36.3 16.5 17.3 11.7 10.8 13.2 15.0 4.4 8.6 5.6 13.2 9.2 5.9 7.1 8.6 12.1 7.2 9.1 12.4 10.4 11.3 10.4 10.4 11.6 10.2 13.8 14.7 5.0 14.2 7.3 5.0 14.1 6.6 8.1 19.9 13.2 14.3 5.3 14.1 16.7 7.1 10.0 17.0 4.2 12.5 9.4 6.8 6.3 7.4 5.8 10.5 8.2 6.9 12.5 12.0 6.9 4.8 9.0 8.3 3.2 14.1 7.6 9.5 13.7 8.0 11.5 8.4 5.7 8.4 2.6 7.4 19.8 7.4 4.9 2.1 9.0 5.3 5.9 13.0 5.7 10.8 5.5 5.5 10.8 11.7 3.6 4.0 13.2 4.4 15.0 5.3 8.6 5.6 18.3 16.0 10.8 18.5 16.1 15.4 17.3 17.0 16.9 18.2 TBC1D9 "GRAMD9, KIAA0882, MDR1" ENSG00000109436 "TBC1 domain family member 9" Q6ZT07 4 140620765-140756120 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 7 "breast cancer: 85.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.0" "Group enriched" "Detected in many" 38 "B-cells: 9.0;dendritic cells: 4.6;monocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000262, HPA006503" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA000262: , HPA006503: " "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.22e-2)" "unprognostic (9.17e-2)" "unprognostic (2.11e-3)" "unprognostic (2.64e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-3)" "unprognostic (6.77e-2)" "prognostic favourable (1.61e-6)" "unprognostic (2.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.72e-2)" "unprognostic (2.16e-2)" 15.9 6.2 8.1 9.2 10.0 1.0 33.6 37.6 13.7 9.2 6.7 3.8 32.1 5.2 5.5 6.4 5.9 6.7 9.4 5.7 7.5 13.9 10.7 8.0 10.4 9.6 9.6 8.2 10.9 6.0 9.9 5.7 13.1 11.0 9.8 4.3 10.6 7.3 27.4 1.7 2.8 9.9 5.0 5.3 20.4 10.0 2.9 3.8 1.6 4.3 3.0 12.2 11.1 8.9 9.0 4.6 0.1 2.4 0.1 0.0 0.9 0.4 6.3 5.9 5.1 14.5 13.7 12.1 8.1 8.8 5.9 7.6 1.3 5.6 0.0 5.2 10.6 1.2 7.4 5.8 5.6 0.0 4.1 3.6 4.6 5.4 5.3 0.4 0.5 11.3 9.7 5.1 20.6 16.3 0.0 0.0 5.5 6.3 0.8 0.0 0.9 5.6 3.9 9.7 9.3 6.7 11.7 8.7 6.2 8.4 14.9 5.5 3.5 0.2 25.3 15.7 4.7 10.1 6.9 0.0 0.0 0.0 9.5 0.7 8.5 0.0 2.4 0.0 0.0 1.9 0.0 9.0 0.0 0.0 4.0 4.0 0.0 0.0 0.1 0.1 0.7 4.6 0.0 0.9 8.1 10.0 37.6 13.7 7.5 13.9 9.6 8.2 11.0 3.8 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907859 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavourable (3.99e-4)" "unprognostic (8.22e-2)" 30.4 28.7 31.2 14.3 29.8 17.0 21.2 27.0 37.9 21.7 17.8 36.7 20.6 16.4 18.9 24.5 21.7 20.7 19.0 15.2 31.4 26.6 20.7 22.4 18.3 16.8 34.9 23.3 24.8 24.6 22.7 13.3 14.8 29.0 18.2 14.5 17.5 25.6 21.9 20.3 24.0 18.9 19.1 42.3 18.0 16.1 12.2 24.1 12.0 23.3 12.5 17.2 17.4 19.7 5.4 9.4 5.0 8.1 3.7 5.5 4.9 10.6 16.4 7.4 17.3 22.9 14.7 17.4 12.9 13.3 13.0 13.0 11.0 10.7 7.3 16.0 15.6 10.2 8.9 30.1 6.0 24.2 10.0 6.5 12.0 7.3 12.3 8.6 22.7 16.9 13.1 10.2 7.3 14.3 4.3 8.5 11.6 26.5 5.5 7.1 5.2 9.3 9.6 5.7 7.1 12.2 17.3 10.7 7.9 12.2 14.6 14.8 11.5 13.9 14.5 19.0 8.5 9.0 11.4 4.4 5.7 5.7 18.0 11.0 13.4 4.5 5.9 5.0 5.5 8.1 4.5 5.4 4.0 4.7 7.8 5.1 3.9 3.1 0.8 3.7 7.9 9.4 3.4 4.9 31.2 29.8 27.0 37.9 31.4 26.6 34.9 23.3 29.0 24.1 TBCK "HSPC302, MGC16169" ENSG00000145348 "TBC1 domain containing kinase" Q8TEA7 4 106041599-106321495 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.6;HBF TERT88: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039951, HPA051611" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA039951: AB_10795300, HPA051611: " "unprognostic (1.65e-1)" "unprognostic (2.60e-2)" "unprognostic (8.47e-2)" "unprognostic (1.12e-1)" "unprognostic (8.06e-2)" "unprognostic (1.13e-3)" "unprognostic (1.55e-1)" "unprognostic (3.81e-1)" "unprognostic (8.68e-2)" "unprognostic (1.85e-1)" "unprognostic (3.67e-2)" "unprognostic (1.80e-1)" "prognostic favourable (3.20e-4)" "unprognostic (8.17e-3)" "unprognostic (1.69e-1)" "unprognostic (1.12e-1)" "unprognostic (2.29e-1)" 12.8 19.0 14.2 7.6 15.2 3.4 10.0 16.3 15.2 13.5 8.3 10.0 11.0 4.4 10.9 14.9 10.6 13.0 13.2 9.3 12.1 11.1 17.8 10.5 9.6 6.9 15.0 8.5 17.5 8.2 12.6 24.2 13.7 12.1 11.9 9.1 9.0 9.1 14.6 4.2 8.5 7.2 13.3 10.3 8.5 8.1 12.0 13.8 18.5 13.9 4.6 8.9 14.5 10.7 10.7 6.3 11.9 6.8 5.9 8.4 4.2 0.9 2.5 5.1 1.9 19.2 12.0 0.9 3.8 6.2 24.8 43.6 4.4 3.8 1.7 5.8 13.0 2.2 3.4 4.7 29.8 2.3 1.0 5.3 2.0 4.6 5.0 2.2 3.1 11.2 3.9 2.3 3.9 6.4 4.1 2.1 7.5 3.3 2.8 2.0 1.2 1.7 2.1 3.2 3.5 6.5 4.4 2.7 2.2 3.4 2.4 3.3 3.3 4.8 3.7 4.4 2.2 1.0 1.9 1.0 2.8 3.7 6.0 3.2 2.3 11.9 6.4 6.3 6.2 6.8 7.2 6.2 6.8 8.4 6.3 10.7 7.4 6.7 0.5 5.9 4.6 6.1 6.7 4.2 14.2 15.2 16.3 15.2 12.1 11.1 15.0 8.5 12.1 13.8 TBKBP1 "KIAA0775, ProSAPiP2" ENSG00000198933 "TBK1 binding protein 1" A7MCY6 17 47694081-47712050 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.7;NK-cells: 2.2;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062347, HPA064856" Approved Approved Nucleoplasm Nucleoplasm "HPA062347: , HPA064856: " "unprognostic (2.14e-3)" "unprognostic (1.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.92e-2)" "unprognostic (2.39e-1)" "unprognostic (3.09e-2)" "unprognostic (3.72e-1)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "prognostic favourable (8.14e-6)" "unprognostic (5.83e-2)" "unprognostic (1.14e-1)" "unprognostic (3.03e-1)" "unprognostic (4.22e-1)" "unprognostic (1.56e-1)" "prognostic favourable (1.59e-5)" 12.6 7.8 16.1 8.7 8.4 5.6 6.0 13.5 20.1 11.2 7.3 3.9 5.4 3.1 9.7 5.9 10.9 6.7 7.8 12.2 16.3 14.6 6.3 3.2 7.8 5.3 11.2 15.2 17.9 15.0 9.2 6.4 9.2 8.0 7.4 2.4 12.2 18.2 9.8 30.1 4.6 3.6 12.1 4.2 11.0 5.4 8.5 2.8 2.8 9.1 6.5 6.7 8.0 9.6 0.6 0.5 5.7 0.5 2.2 2.8 0.3 0.2 5.1 9.5 10.1 4.9 5.0 6.2 5.2 5.5 2.5 3.0 31.9 0.8 0.1 5.2 6.4 0.5 7.4 1.3 1.5 6.2 16.9 13.5 4.5 5.3 11.4 2.5 3.0 10.1 3.4 0.6 0.9 9.0 11.6 0.0 1.4 1.3 1.6 12.6 13.3 3.6 6.0 3.0 5.3 3.2 0.4 8.3 15.5 2.5 0.6 2.6 5.7 5.8 10.3 8.0 9.4 9.6 0.6 3.5 0.3 6.2 4.7 4.9 2.0 0.0 0.5 0.9 2.8 0.2 1.5 0.0 0.7 2.0 0.5 0.6 0.3 1.0 5.7 2.2 0.0 0.5 0.5 0.3 16.1 8.4 13.5 17.9 16.3 14.6 11.2 15.2 8.0 2.8 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 17.3" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: " "prognostic unfavourable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favourable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favourable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 6.5 7.1 10.1 6.0 12.3 4.5 8.1 3.3 8.1 21.4 7.9 13.2 18.0 2.1 33.0 26.4 8.3 12.4 6.7 5.2 8.6 9.0 12.5 11.0 5.2 9.5 7.6 6.0 13.8 11.3 21.0 24.3 14.5 7.5 24.7 4.1 9.8 5.5 33.0 4.9 5.8 4.2 22.4 9.0 5.7 7.0 9.9 8.5 14.7 9.4 3.4 7.1 15.3 24.5 3.2 3.1 17.3 4.2 0.3 3.1 1.7 0.0 13.5 8.6 23.0 8.0 8.4 8.5 5.2 11.6 10.0 10.5 10.1 9.3 14.4 0.3 10.3 3.1 18.8 4.1 14.7 5.9 9.3 9.0 16.5 11.9 11.4 3.2 32.5 7.5 4.7 10.4 5.5 9.2 15.8 25.1 5.7 11.4 7.8 12.2 17.1 14.6 17.6 6.8 17.6 13.6 7.7 11.1 5.0 12.5 3.1 7.5 6.1 7.1 13.3 3.5 8.7 0.3 2.0 15.3 11.9 11.4 12.9 7.9 3.3 4.4 4.2 4.9 2.1 2.6 1.7 2.0 1.6 1.9 3.1 3.2 3.1 2.8 17.3 0.3 1.7 0.3 2.5 1.7 10.1 12.3 3.3 8.1 8.6 9.0 7.6 6.0 7.5 8.5 TBL1XR1 "C21, DC42, FLJ12894, IRA1, TBLR1" ENSG00000177565 "Transducin beta like 1 X-linked receptor 1" Q9BZK7 3 177019340-177228000 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Repressor" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019182 Supported Approved Nucleoplasm Nucleoplasm "HPA019182: AB_1857800" "unprognostic (4.11e-2)" "unprognostic (3.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.27e-3)" "prognostic favourable (5.16e-5)" "unprognostic (4.44e-2)" "prognostic unfavourable (1.08e-7)" "unprognostic (3.75e-1)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (3.13e-3)" "unprognostic (2.50e-1)" "prognostic unfavourable (4.25e-5)" "unprognostic (5.83e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" 20.7 26.0 27.4 24.3 26.8 27.3 20.3 27.5 28.1 28.9 29.9 22.6 15.4 24.0 23.9 20.5 23.8 21.9 22.7 30.3 26.2 20.7 19.9 21.8 30.8 27.8 21.4 25.9 26.5 19.9 30.6 11.3 24.0 19.7 24.4 23.2 24.7 21.3 17.7 21.1 17.8 24.3 21.9 19.6 24.7 21.3 17.4 22.3 28.4 45.6 14.9 32.1 29.1 25.5 7.4 13.3 12.9 4.6 6.8 8.3 4.1 23.4 12.0 15.6 8.8 13.3 14.5 9.3 7.4 11.5 6.4 8.9 13.8 19.4 24.0 35.1 10.6 14.5 11.7 15.5 13.0 25.2 3.7 13.5 20.6 8.2 11.4 21.4 8.0 21.3 8.0 9.5 23.6 10.0 10.1 42.6 8.3 8.4 20.0 2.9 9.9 8.2 11.5 19.9 25.6 5.8 33.2 5.6 9.0 10.0 7.9 9.3 28.6 16.4 15.3 10.6 8.9 5.9 16.0 23.3 29.8 69.5 7.1 16.0 12.0 11.4 3.0 3.8 5.8 4.6 5.1 7.3 5.7 6.6 4.0 7.4 5.0 6.4 12.9 6.8 3.9 13.3 8.3 4.1 27.4 26.8 27.5 28.1 26.2 20.7 21.4 25.9 19.7 22.3 TBX15 TBX14 ENSG00000092607 "T-box 15" Q96SF7 1 118883046-118989556 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.3;skeletal muscle: 84.9;tongue: 37.5" "Cell line enhanced" "Detected in some" "ASC diff: 27.7;ASC TERT1: 11.7;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;fHDF/TERT166: 14.1;HSkMC: 19.9;RH-30: 14.9;U-2197: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052245, HPA053713" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA052245: , HPA053713: " "unprognostic (1.94e-1)" "unprognostic (2.75e-3)" "unprognostic (1.92e-2)" "unprognostic (3.94e-2)" "unprognostic (5.72e-3)" "unprognostic (7.79e-2)" "unprognostic (5.82e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-3)" "unprognostic (1.39e-1)" "unprognostic (3.81e-3)" "unprognostic (5.03e-2)" "prognostic unfavourable (5.57e-8)" "unprognostic (2.63e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-3)" "unprognostic (2.31e-1)" 18.1 0.1 0.2 0.1 0.5 0.1 12.5 0.4 0.8 0.1 0.1 0.2 0.0 0.0 0.1 2.1 1.2 0.1 0.3 1.2 0.5 0.0 0.1 23.3 0.2 1.3 0.2 0.2 0.1 0.1 0.2 0.5 0.1 2.1 0.7 0.0 0.2 2.8 0.1 84.9 3.6 0.1 0.2 0.6 0.0 0.1 0.4 0.4 0.0 1.9 37.5 2.4 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 27.7 11.7 0.0 2.4 3.2 6.3 10.6 0.0 0.0 0.0 1.3 14.1 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 19.9 0.1 0.1 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.1 1.2 0.1 0.0 14.9 0.2 1.5 0.7 0.3 0.0 0.8 0.0 0.3 0.0 0.3 0.0 3.4 2.1 14.0 0.1 0.2 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.8 0.5 0.0 0.2 0.2 2.1 0.4 TBX2 ENSG00000121068 "T-box 2" Q13207 17 61399896-61409466 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 47.6;MCF7: 27.9;SH-SY5Y: 22.2;SK-MEL-30: 15.1;WM-115: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008586, CAB013636" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB013636: , HPA008586: AB_1080222" "unprognostic (6.18e-2)" "unprognostic (8.51e-2)" "unprognostic (4.50e-1)" "unprognostic (2.09e-1)" "unprognostic (1.36e-1)" "unprognostic (8.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (9.29e-2)" "unprognostic (2.10e-2)" "unprognostic (2.10e-1)" "unprognostic (2.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" "unprognostic (6.34e-3)" 11.5 3.4 2.0 2.9 3.1 0.4 9.9 1.3 2.3 14.8 4.4 1.9 30.4 4.9 12.2 37.0 5.9 11.3 16.8 6.8 1.8 1.8 28.9 4.6 35.7 1.3 3.6 1.5 8.3 1.8 1.8 3.7 30.4 3.6 15.1 2.2 33.7 2.2 38.1 5.8 2.9 5.5 16.4 1.7 8.8 8.1 9.6 1.5 0.0 8.6 5.0 1.8 19.5 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 47.6 1.5 1.7 5.8 7.3 7.7 0.4 0.1 1.3 0.1 0.0 0.6 1.2 0.0 0.8 0.0 0.1 0.0 2.8 0.8 0.0 2.3 5.3 0.1 0.7 3.0 0.1 8.7 0.5 0.0 0.1 0.0 0.5 27.9 0.0 0.1 0.0 3.3 0.0 1.9 0.2 0.0 11.3 0.1 22.2 0.0 0.0 15.1 0.6 0.9 0.0 1.1 0.0 2.7 1.6 0.0 0.1 0.0 6.6 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 1.3 2.3 1.8 1.8 3.6 1.5 3.6 1.5 TBX5 HOS ENSG00000089225 "T-box 5" Q99593 12 114353931-114408442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.5;lung: 14.0;placenta: 19.7" "Cell line enhanced" "Detected in some" "BJ: 12.8;BJ hTERT+: 28.6;BJ hTERT+ SV40 Large T+: 6.6;BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HAP1: 11.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hippocampal formation: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm Nucleoplasm "HPA008786: AB_10601720, HPA064683: " "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 2.2 0.1 0.1 0.0 0.1 0.0 3.8 0.8 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 6.4 0.1 0.0 44.5 2.2 0.1 0.1 0.1 14.0 1.6 0.1 0.1 0.1 0.1 0.0 0.1 19.7 0.5 5.4 0.0 1.4 0.1 0.0 0.1 0.5 0.1 6.6 0.2 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 6.5 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.8 28.6 6.6 8.1 0.0 0.0 0.0 0.0 0.7 0.0 11.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 2.2 0.1 0.1 0.1 0.5 0.0 TBX6 ENSG00000149922 "T-box 6" O95947 16 30085793-30091887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8" "Cell line enhanced" "Detected in many" "RT4: 10.0;U-266/70: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm Nucleoplasm "HPA062498: " "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.2 1.4 1.4 1.0 1.5 0.6 0.9 0.9 1.5 2.7 1.2 0.9 0.9 1.8 0.9 1.0 22.8 1.6 1.3 0.9 1.5 1.0 1.8 1.2 1.2 1.2 1.7 0.9 1.9 19.8 3.2 2.3 0.9 2.1 3.2 0.3 2.3 3.9 2.2 2.8 5.0 1.7 0.9 1.5 1.8 7.8 2.4 1.2 1.6 2.3 5.1 16.3 5.5 8.6 4.4 1.3 3.3 2.6 1.3 1.9 1.1 0.9 1.1 0.6 1.2 1.5 0.8 0.8 0.3 0.2 0.0 0.2 1.3 4.3 1.9 2.3 0.2 1.3 0.5 0.9 0.0 1.4 0.8 1.2 1.7 1.0 1.1 0.2 2.6 0.3 1.2 0.3 0.5 0.6 0.1 4.3 0.1 3.7 0.7 0.5 0.9 0.9 2.8 0.1 3.2 0.0 10.0 1.4 2.1 0.2 0.9 1.2 1.8 1.7 0.5 1.2 0.7 0.6 0.0 10.5 2.4 0.3 1.2 1.8 0.4 3.1 2.6 0.8 1.8 2.3 1.2 1.3 0.9 1.3 1.3 4.4 1.9 1.7 3.3 1.3 0.8 1.1 1.8 1.1 1.4 1.5 0.9 1.4 1.5 1.0 1.7 0.9 2.1 1.2 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779751-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 100.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.1;MCF7: 9.2;RT4: 21.0;SK-BR-3: 25.4;T-47d: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "MAIT T-cell: 32.2" "Group enriched" "Detected in many" 46 "NK-cells: 12.9;T-cells: 32.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavourable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favourable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 6.6 1.5 0.9 15.8 0.9 1.9 12.3 0.4 1.9 8.9 10.2 0.6 16.7 5.4 7.6 7.0 11.6 5.4 24.9 4.7 0.9 1.0 3.7 6.8 13.5 11.3 0.8 0.5 5.5 100.1 12.4 8.4 13.1 1.6 9.3 7.0 6.6 29.8 20.1 2.1 6.9 11.7 3.2 1.1 12.3 10.8 4.9 0.1 8.7 10.3 5.8 27.9 8.3 9.5 0.2 0.0 0.4 0.0 12.9 32.2 7.7 5.1 0.8 0.0 0.0 1.0 0.0 7.2 0.0 0.1 0.0 0.0 3.7 11.1 3.4 0.2 0.0 0.6 5.1 5.2 0.0 0.0 2.7 0.0 1.3 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.2 0.0 0.1 2.7 0.0 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.5 21.0 3.9 0.0 0.4 25.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.7 0.0 32.2 0.2 16.2 18.6 0.0 0.1 13.3 11.0 0.4 12.9 0.0 0.0 5.2 7.7 0.9 0.9 0.4 1.9 0.9 1.0 0.8 0.5 1.6 0.1 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23381061-23424740 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 114.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.1;Hep G2: 33.5;SiHa: 11.1;T-47d: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3" "Lineage enriched" "Detected in many" 5 "T-cells: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: " "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favourable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 5.4 17.8 2.5 10.7 1.9 0.1 3.6 1.5 1.5 9.1 12.2 2.2 12.0 4.6 3.8 14.5 12.0 6.2 13.0 20.3 2.4 0.8 12.1 38.0 6.0 1.3 1.2 2.3 19.8 60.4 4.5 3.3 2.5 2.2 16.7 12.5 8.7 32.7 15.9 114.0 8.9 11.9 13.7 2.0 1.6 11.5 2.6 1.3 0.5 8.6 58.3 16.0 8.4 6.9 0.0 2.8 0.0 0.7 0.2 14.3 2.5 0.0 0.1 0.3 0.3 1.7 10.1 5.6 3.9 2.6 2.1 1.2 2.5 0.3 0.1 0.4 4.9 5.5 0.4 0.0 1.8 0.0 0.0 0.0 4.2 33.5 1.2 0.5 0.0 6.6 1.8 1.8 0.0 0.2 0.0 0.0 0.7 0.9 0.2 3.6 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 11.1 0.5 0.4 17.7 1.6 0.2 0.0 0.1 0.4 0.0 0.3 2.9 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.5 0.7 0.5 0.0 8.5 1.2 2.8 0.0 14.3 6.3 0.0 0.2 0.2 0.9 0.7 2.5 2.5 1.9 1.5 1.5 2.4 0.8 1.2 2.3 2.2 1.3 TCEAL8 "MGC45400, WEX3" ENSG00000180964 "Transcription elongation factor A like 8" Q8IYN2 X 103252995-103255203 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059115 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059115: " "unprognostic (1.51e-2)" "unprognostic (4.56e-2)" "unprognostic (9.24e-2)" "unprognostic (7.13e-3)" "unprognostic (1.03e-1)" "prognostic unfavourable (8.53e-6)" "unprognostic (3.71e-3)" "unprognostic (1.88e-2)" "unprognostic (5.52e-2)" "unprognostic (4.80e-3)" "unprognostic (4.03e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (3.26e-2)" "unprognostic (7.22e-2)" "unprognostic (9.12e-2)" "unprognostic (9.32e-2)" 24.6 30.9 37.3 16.8 32.5 12.4 30.0 34.5 38.5 34.8 25.1 25.6 25.8 14.9 29.6 67.9 26.7 22.7 27.9 43.9 33.4 32.4 33.9 20.2 20.8 20.6 34.5 25.8 36.7 25.0 32.2 64.5 32.9 39.4 31.6 24.7 26.0 29.7 28.6 8.8 19.8 19.9 31.1 34.6 24.3 21.5 21.0 22.5 30.7 35.2 18.8 20.9 31.7 22.4 17.5 28.7 16.3 9.4 33.3 30.3 15.2 9.8 5.1 23.7 11.3 35.0 59.2 11.4 20.3 31.7 18.3 29.9 4.0 20.4 4.8 13.6 24.2 6.7 4.0 24.5 24.4 0.1 12.7 22.2 7.0 6.1 21.9 22.2 22.9 40.3 14.8 16.4 0.0 26.2 27.2 5.3 46.1 0.0 18.5 9.3 26.4 10.8 7.6 31.6 1.5 26.3 7.6 12.6 16.6 11.2 4.0 26.3 7.2 7.8 16.5 11.9 15.2 35.2 6.8 5.3 8.8 0.2 19.1 12.3 18.9 16.3 9.4 5.5 19.7 8.2 23.5 17.5 23.9 21.2 16.9 14.8 26.5 22.8 0.9 33.3 6.2 28.7 30.3 15.2 37.3 32.5 34.5 38.5 33.4 32.4 34.5 25.8 39.4 22.5 TCEAL9 "DKFZp313K1940, WBP5, WEX6" ENSG00000185222 "Transcription elongation factor A like 9" Q9UHQ7 X 103356489-103358462 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 18.6" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011790 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA011790: AB_2214932" "unprognostic (1.26e-1)" "unprognostic (9.24e-2)" "unprognostic (3.35e-2)" "unprognostic (1.67e-3)" "unprognostic (5.52e-2)" "unprognostic (1.00e-3)" "unprognostic (1.31e-3)" "unprognostic (5.85e-2)" "unprognostic (7.64e-2)" "unprognostic (7.50e-3)" "unprognostic (1.59e-2)" "unprognostic (4.32e-2)" "unprognostic (1.10e-3)" "unprognostic (4.33e-3)" "unprognostic (1.26e-1)" "unprognostic (3.28e-2)" "unprognostic (2.58e-2)" 28.2 61.0 17.9 14.7 20.9 3.7 42.1 20.7 24.0 30.8 20.6 10.9 35.0 7.6 32.3 59.6 21.4 20.1 25.6 29.4 19.5 20.5 38.8 12.6 25.9 9.5 23.7 15.0 93.4 15.7 19.6 54.5 67.1 40.3 27.6 17.7 15.2 15.7 45.4 7.8 12.1 11.7 30.2 44.1 26.4 23.1 27.5 23.6 5.4 58.6 18.5 7.6 35.5 75.7 1.8 18.6 0.9 1.3 1.1 3.5 1.3 17.8 8.8 27.9 14.2 60.6 59.0 20.9 37.6 50.4 26.7 43.7 16.9 19.0 0.0 55.8 30.7 10.8 4.8 23.9 36.0 0.0 10.4 18.3 21.5 10.8 41.7 0.0 0.0 40.4 23.3 35.6 35.7 44.3 16.1 1.3 63.3 0.0 8.9 0.1 17.3 16.9 0.0 55.8 0.0 32.2 33.2 12.6 15.2 23.6 0.7 24.5 3.8 1.0 36.1 23.9 10.4 71.7 10.4 0.0 1.0 0.1 57.9 0.0 18.9 0.9 1.3 0.0 0.2 0.7 0.0 1.8 1.5 0.5 1.0 1.0 3.5 2.9 0.0 1.1 0.1 18.6 0.9 1.3 17.9 20.9 20.7 24.0 19.5 20.5 23.7 15.0 40.3 23.6 TCEANC2 "C1orf83, FLJ32112" ENSG00000116205 "Transcription elongation factor A N-terminal and central domain containing 2" Q96MN5 1 54053587-54112519 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046918 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA046918: " "unprognostic (2.80e-1)" "unprognostic (6.19e-2)" "unprognostic (6.56e-3)" "unprognostic (2.34e-1)" "unprognostic (5.12e-3)" "unprognostic (1.35e-3)" "unprognostic (1.73e-5)" "unprognostic (8.64e-2)" "unprognostic (7.93e-3)" "unprognostic (6.59e-2)" "unprognostic (3.55e-1)" "unprognostic (3.52e-2)" "unprognostic (9.63e-2)" "unprognostic (2.26e-3)" "unprognostic (8.57e-2)" "unprognostic (7.51e-3)" "unprognostic (2.08e-1)" 5.9 5.9 7.9 7.6 11.1 6.5 5.9 3.0 7.9 6.1 5.4 13.4 6.6 6.8 5.3 6.2 7.9 5.2 4.4 4.4 8.3 6.4 7.2 4.7 4.8 9.4 10.2 4.5 4.3 6.4 6.6 6.2 6.0 8.8 5.1 8.1 6.5 5.5 4.1 9.4 6.8 6.4 6.3 14.1 8.2 5.2 15.4 8.8 15.7 5.7 3.0 10.8 7.3 5.1 7.8 7.6 10.1 8.9 10.2 6.3 3.8 5.1 2.3 5.9 4.9 4.0 6.3 5.7 5.6 4.3 6.3 5.6 1.4 3.3 4.6 4.9 2.4 5.2 7.8 4.3 8.0 10.2 4.2 6.8 5.5 2.7 2.5 5.0 6.9 4.7 3.7 5.5 3.2 8.0 6.7 4.3 5.2 1.9 10.0 3.7 13.6 3.9 10.0 10.8 6.7 2.3 3.1 5.1 5.4 3.6 5.6 6.7 5.5 9.4 4.2 5.7 3.6 5.5 6.8 9.9 14.3 6.4 4.8 6.9 7.1 5.9 7.3 10.1 4.7 8.9 4.6 7.3 5.4 5.8 7.6 7.8 6.3 6.2 9.4 10.2 6.5 6.9 4.1 3.8 7.9 11.1 3.0 7.9 8.3 6.4 10.2 4.5 8.8 8.8 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950250-113167678 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 12.1;non-classical monocyte: 33.1" "Lineage enriched" "Detected in many" 13 "monocytes: 33.1" "Group enriched" "Detected in many" 8 "midbrain: 84.5;thalamus: 98.3" "Group enriched" "Detected in all" 5 "midbrain: 190.1;pons and medulla: 104.8;thalamus: 169.1" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 27.4 10.3 8.7 18.7 10.0 7.3 46.4 5.4 10.3 27.4 34.2 15.4 28.1 21.0 26.6 14.9 12.6 18.2 15.3 13.5 8.1 17.9 10.2 22.9 26.9 13.9 8.5 9.0 25.6 13.9 16.5 17.9 24.0 10.2 14.4 23.7 13.9 14.9 52.8 13.7 17.6 40.4 18.0 13.9 27.3 24.0 10.6 10.1 6.6 14.3 9.3 7.0 21.5 16.3 0.0 1.7 2.5 33.1 0.0 0.6 1.1 7.0 18.5 20.3 19.6 10.6 7.1 24.2 5.0 9.8 3.5 4.3 12.2 21.5 0.0 5.7 9.4 5.0 6.9 8.7 4.5 0.8 6.4 5.0 12.3 11.3 11.3 1.9 1.8 12.5 3.2 5.5 9.3 5.9 5.1 0.3 4.1 13.8 3.1 1.2 14.6 10.7 8.9 14.9 3.2 7.6 9.9 0.4 6.2 7.6 7.6 8.1 4.9 1.0 13.6 3.3 9.6 8.4 10.3 1.3 0.1 0.1 3.3 4.2 7.4 0.1 1.8 0.1 0.6 12.1 0.4 0.0 0.1 0.5 1.7 0.0 0.1 0.3 2.5 0.0 33.1 0.0 0.0 1.1 8.7 10.0 5.4 10.3 8.1 17.9 8.5 9.0 10.2 10.1 TCIM "C8orf4, hTC-1, TC-1, TC1" ENSG00000176907 "Transcriptional and immune response regulator" Q9NR00 8 40153455-40155308 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 14.4;AF22: 40.9;BJ: 15.4;BJ hTERT+: 40.4;EFO-21: 26.8;HeLa: 25.7;RPTEC TERT1: 20.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027188 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA027188: AB_10601150" "unprognostic (8.88e-2)" "unprognostic (2.76e-2)" "unprognostic (7.89e-3)" "unprognostic (7.95e-2)" "unprognostic (7.33e-3)" "unprognostic (1.87e-3)" "unprognostic (2.11e-1)" "unprognostic (2.32e-1)" "unprognostic (2.93e-2)" "unprognostic (8.15e-2)" "unprognostic (6.23e-2)" "unprognostic (8.19e-2)" "unprognostic (2.54e-2)" "unprognostic (5.32e-3)" "unprognostic (1.39e-1)" "unprognostic (9.13e-3)" "unprognostic (4.48e-2)" 23.5 5.9 1.8 23.2 4.5 0.0 16.0 0.6 5.9 32.1 24.1 1.0 15.6 6.0 14.3 20.3 22.2 4.3 22.1 38.3 2.0 1.7 44.5 54.7 96.5 5.0 2.7 4.3 11.9 24.4 28.9 6.2 50.2 2.3 29.6 15.2 7.9 89.9 16.3 20.2 4.0 21.2 72.4 4.3 26.7 10.7 4.9 1.4 1.3 15.8 14.4 4.8 35.8 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 40.9 0.0 0.0 0.0 0.0 15.4 40.4 0.0 0.2 0.2 0.0 0.0 26.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.7 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 12.9 0.0 0.3 0.1 0.2 0.3 0.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 4.5 0.6 5.9 2.0 1.7 2.7 4.3 2.3 1.4 TCTN1 "FLJ21127, JBTS13, TECT1" ENSG00000204852 "Tectonic family member 1" Q2MV58 12 110614027-110649430 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039687, HPA040036" Approved Approved "Nucleoplasm,Actin filaments" "Intracellular and membrane" "Nucleoplasm, Actin filaments" "HPA039687: AB_10795293, HPA040036: AB_10794759" "unprognostic (2.54e-1)" "unprognostic (7.22e-3)" "unprognostic (2.28e-1)" "prognostic favourable (1.13e-5)" "unprognostic (2.89e-2)" "unprognostic (6.53e-2)" "unprognostic (2.11e-1)" "unprognostic (3.05e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (9.60e-2)" "unprognostic (9.97e-2)" "unprognostic (2.15e-2)" "unprognostic (8.41e-2)" "unprognostic (1.24e-1)" "unprognostic (4.27e-2)" 8.0 12.4 11.2 5.1 13.8 3.0 8.9 5.6 10.1 17.7 5.4 12.3 20.6 4.1 10.3 28.7 5.4 35.4 12.3 14.4 11.0 13.0 16.1 7.2 11.6 5.5 11.0 5.3 15.5 9.1 24.1 32.9 8.4 22.1 14.5 4.0 16.3 10.2 20.6 8.0 5.3 4.1 10.3 8.9 6.0 7.2 24.7 8.0 4.4 25.5 3.9 5.2 8.8 12.2 13.7 5.0 8.4 3.5 1.1 2.9 1.9 7.4 9.5 6.7 18.4 19.2 16.8 3.4 5.4 11.0 5.0 4.3 2.1 2.3 1.5 4.7 13.2 5.3 3.9 4.1 3.6 3.2 6.2 0.4 3.9 4.6 9.1 0.8 0.8 10.5 6.2 6.5 8.0 3.6 5.2 3.2 6.1 10.9 0.6 2.6 3.3 12.8 1.9 3.5 10.7 15.2 1.8 5.7 7.6 9.3 2.2 4.5 15.5 8.6 4.0 8.6 2.2 3.0 4.6 3.1 1.5 2.0 8.5 0.8 6.8 0.3 2.4 0.4 1.3 3.5 2.9 6.3 1.9 2.7 3.7 13.7 2.9 2.4 8.4 1.1 2.0 5.0 0.6 1.9 11.2 13.8 5.6 10.1 11.0 13.0 11.0 5.3 22.1 8.0 TDRD7 PCTAIRE2BP ENSG00000196116 "Tudor domain containing 7" Q8NHU6 9 97411950-97496125 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" RNA-binding "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.0;THP-1: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB020800, HPA022250, HPA024529" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" "Cytoplasmic bodies" Nucleoplasm "CAB020800: , HPA022250: , HPA024529: AB_1857869" "unprognostic (8.22e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-3)" "unprognostic (1.03e-1)" "unprognostic (2.88e-1)" "unprognostic (3.07e-1)" "prognostic unfavourable (5.91e-4)" "unprognostic (2.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.06e-1)" "unprognostic (2.74e-2)" "prognostic favourable (4.76e-5)" "unprognostic (4.03e-2)" "unprognostic (2.90e-1)" "unprognostic (1.17e-2)" "unprognostic (2.67e-1)" 9.5 7.1 10.6 9.1 11.5 8.9 7.7 7.1 10.2 8.8 12.8 8.9 3.7 14.0 9.8 6.0 10.5 8.2 9.2 5.7 8.6 6.6 6.4 7.3 9.8 7.0 10.2 8.8 8.3 9.7 12.5 9.3 7.9 11.6 7.1 12.7 19.0 8.8 7.0 5.1 6.1 16.5 9.6 12.6 8.8 7.6 31.1 9.8 9.3 7.3 4.7 7.3 12.1 8.6 4.3 4.6 9.8 6.1 1.6 2.9 1.8 8.0 5.6 0.0 1.9 4.3 5.7 4.8 5.1 12.9 17.6 19.8 7.2 6.8 0.5 2.5 7.2 6.2 4.7 2.6 4.7 26.0 4.0 3.6 2.8 5.2 4.0 8.2 8.9 1.9 5.2 5.8 0.6 7.6 2.0 0.4 4.6 4.8 4.0 4.0 0.8 3.0 1.8 2.9 0.1 4.3 5.4 0.9 2.3 7.1 3.2 19.4 1.9 25.8 7.7 2.2 2.2 5.6 3.9 2.7 3.1 0.5 5.2 4.5 5.7 2.4 3.1 9.8 1.7 6.1 2.4 4.3 2.4 1.8 4.6 3.4 1.8 2.9 5.7 1.6 5.8 0.9 1.6 1.8 10.6 11.5 7.1 10.2 8.6 6.6 10.2 8.8 11.6 9.8 TECPR2 KIAA0329 ENSG00000196663 "Tectonin beta-propeller repeat containing 2" O15040 14 102362963-102502481 "Disease related genes, Predicted intracellular proteins" Autophagy "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000658 Enhanced Approved Nucleoplasm Nucleoplasm "HPA000658: AB_1079191" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.77e-2)" "unprognostic (2.62e-1)" "unprognostic (4.46e-1)" "unprognostic (1.63e-3)" "prognostic unfavourable (5.66e-5)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (1.64e-1)" "unprognostic (5.76e-3)" "unprognostic (3.78e-2)" "prognostic favourable (6.53e-9)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "unprognostic (1.91e-1)" "unprognostic (1.56e-3)" 8.5 7.0 15.4 8.4 19.3 8.3 7.4 13.5 23.3 10.0 8.5 28.3 6.3 6.2 9.6 11.3 8.2 10.7 7.4 11.0 15.9 12.1 7.0 4.6 7.1 6.8 23.6 14.3 10.2 6.9 17.5 8.4 9.1 14.4 9.8 5.5 12.0 15.2 12.5 12.4 6.2 5.6 13.9 16.3 6.6 6.5 16.9 17.3 7.6 8.7 2.6 4.7 9.1 5.6 0.3 0.3 10.5 0.7 0.2 0.5 0.6 3.8 7.8 7.6 6.2 15.7 11.9 4.2 8.7 10.1 8.7 7.4 1.6 2.8 2.9 5.4 9.0 7.0 5.2 6.5 7.4 10.5 3.5 3.4 4.2 3.3 7.4 1.9 3.3 7.8 5.8 7.9 5.3 8.6 1.7 6.6 8.1 7.3 1.6 2.0 2.9 8.2 4.1 5.3 0.9 4.4 6.4 6.0 5.6 7.5 1.9 4.8 8.9 2.6 8.8 6.8 1.7 18.1 3.6 6.8 4.0 0.6 6.6 5.0 7.0 0.5 0.7 1.1 0.4 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.5 0.2 10.5 0.2 0.1 0.2 0.5 0.6 15.4 19.3 13.5 23.3 15.9 12.1 23.6 14.3 14.4 17.3 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: , HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavourable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 2.0 10.5 8.5 13.6 10.8 5.2 5.1 10.3 3.3 7.6 10.7 2.0 9.4 5.5 5.0 5.2 4.0 5.5 3.4 10.3 7.4 2.9 4.0 6.2 8.8 7.9 4.6 2.7 6.4 2.5 4.5 7.9 7.1 3.7 3.2 3.9 5.8 4.6 3.9 10.1 8.3 2.1 7.4 5.9 10.6 9.1 9.5 16.0 5.1 7.1 11.8 6.1 3.5 0.8 5.7 1.4 2.2 0.1 3.7 0.7 7.9 18.3 4.3 6.5 0.4 0.7 11.8 6.3 2.5 7.6 7.3 6.6 15.0 12.0 13.3 1.0 21.1 1.5 6.8 1.5 14.1 7.5 3.1 10.1 6.4 0.3 6.1 8.9 0.1 2.2 5.1 1.6 3.0 5.0 15.1 1.2 30.5 12.5 13.8 5.7 19.5 10.3 6.8 8.3 2.1 6.8 12.5 7.3 6.5 7.7 4.6 12.3 6.0 3.7 5.3 9.1 16.3 10.4 8.8 3.7 7.2 6.8 6.9 8.6 0.0 1.2 1.4 1.5 2.2 1.0 0.3 2.2 3.7 1.7 0.8 1.4 0.4 0.4 0.1 2.0 5.7 1.6 0.7 10.5 13.6 5.1 10.3 10.3 7.4 7.9 4.6 7.1 9.5 TEDC2 "C16orf59, FLJ13909" ENSG00000162062 "Tubulin epsilon and delta complex 2" Q7L2K0 16 2460080-2464963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3;testis: 12.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051394, HPA055389" Approved Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA051394: , HPA055389: " "unprognostic (3.23e-1)" "unprognostic (1.03e-2)" "unprognostic (2.14e-2)" "unprognostic (7.46e-3)" "unprognostic (1.27e-1)" "unprognostic (1.38e-3)" "prognostic unfavourable (2.43e-5)" "prognostic unfavourable (7.58e-4)" "unprognostic (4.04e-3)" "unprognostic (8.85e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (1.16e-4)" "unprognostic (1.28e-3)" "unprognostic (1.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.03e-1)" 0.8 1.8 2.3 6.2 4.1 9.3 1.1 2.8 4.6 1.2 2.6 0.8 0.0 4.3 1.2 1.4 4.5 1.2 1.4 1.3 2.3 2.7 2.2 1.7 1.0 5.6 2.1 1.9 1.0 1.9 0.3 2.4 3.8 2.0 1.3 2.2 1.0 1.3 0.8 1.0 2.6 3.8 1.1 1.4 2.5 2.2 12.5 0.8 15.3 0.9 4.2 3.9 0.6 2.2 1.2 1.4 0.0 1.0 0.0 2.1 0.7 5.2 16.6 9.5 11.1 0.1 0.6 9.6 4.2 2.5 6.8 6.6 11.4 4.3 7.3 6.9 1.7 8.1 6.9 4.2 1.6 8.1 9.2 6.5 11.7 11.7 0.2 6.3 8.9 0.6 0.5 6.0 1.6 3.1 11.2 2.8 2.3 10.0 11.1 11.8 21.1 6.0 27.1 8.2 16.4 1.4 2.2 9.0 14.8 4.8 5.1 3.6 7.6 7.4 1.1 7.2 10.5 6.9 9.4 6.2 10.1 14.6 3.7 6.4 9.8 0.0 0.0 0.0 0.1 0.1 0.0 0.6 2.1 0.0 0.3 1.2 0.7 1.3 0.0 0.0 1.0 1.4 1.9 0.7 2.3 4.1 2.8 4.6 2.3 2.7 2.1 1.9 2.0 0.8 TENM3 "KIAA1455, ODZ3, Ten-M3" ENSG00000218336 "Teneurin transmembrane protein 3" Q9P273 4 182143987-182803024 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" Microphthalmia "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 24.0;BEWO: 23.0;HDLM-2: 31.2;T-47d: 30.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA047043 Approved Approved Nucleoplasm Nucleoplasm "HPA047043: " "unprognostic (5.79e-2)" "unprognostic (3.01e-2)" "unprognostic (6.62e-2)" "unprognostic (4.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (8.28e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (2.31e-2)" "unprognostic (4.85e-2)" "unprognostic (2.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (8.59e-2)" "unprognostic (1.07e-2)" "unprognostic (5.25e-4)" 9.5 10.8 11.3 3.7 12.5 1.0 9.3 8.5 17.8 3.9 8.5 1.5 5.7 2.4 6.4 2.6 2.4 2.9 5.3 3.5 11.8 9.4 2.7 1.4 2.4 2.3 3.5 15.4 8.4 3.2 17.0 15.0 24.5 5.4 8.3 2.5 6.4 2.0 8.0 4.3 1.4 2.5 5.2 6.1 4.8 2.2 4.7 2.3 0.8 12.3 1.8 3.0 3.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 24.0 0.1 4.9 8.8 23.0 2.8 0.9 2.5 2.2 11.9 6.2 0.0 0.3 18.5 1.2 5.7 1.2 2.5 31.2 9.5 0.0 0.0 0.0 0.4 0.0 0.0 11.6 0.4 7.8 5.5 3.4 0.0 0.1 3.8 0.8 0.0 0.0 7.7 1.0 0.0 6.2 0.0 0.0 0.0 9.9 9.2 1.4 0.1 0.0 30.9 1.2 7.5 19.7 14.2 0.0 13.9 0.0 0.0 0.0 10.3 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.5 8.5 17.8 11.8 9.4 3.5 15.4 5.4 2.3 TET2 "FLJ20032, KIAA1546" ENSG00000168769 "Tet methylcytosine dioxygenase 2" Q6N021 4 105145875-105279816 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.0" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043135 Supported Approved Nucleoplasm Nucleoplasm "HPA043135: AB_10794177" "unprognostic (6.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.69e-2)" "unprognostic (9.42e-2)" "unprognostic (4.15e-2)" "unprognostic (5.88e-2)" "unprognostic (6.12e-2)" "unprognostic (1.19e-3)" "unprognostic (1.15e-2)" "unprognostic (1.57e-2)" "unprognostic (5.77e-2)" "unprognostic (7.29e-2)" "unprognostic (2.70e-3)" "unprognostic (6.10e-2)" "unprognostic (1.89e-1)" "unprognostic (9.15e-2)" "unprognostic (7.84e-2)" 9.9 6.1 8.7 11.9 11.4 26.3 8.0 4.1 10.0 9.6 7.4 10.1 5.8 8.2 10.1 7.4 16.2 9.2 6.6 6.8 9.0 4.2 6.7 5.5 9.9 9.8 13.7 5.7 8.5 7.0 7.4 29.0 12.4 9.1 6.5 8.0 4.7 13.5 8.2 9.8 16.0 10.2 7.8 15.5 12.9 6.8 3.2 14.6 9.3 7.2 6.9 8.7 9.8 12.3 2.8 5.1 29.0 7.0 2.6 2.1 1.4 4.7 3.1 10.4 10.6 1.9 4.3 4.3 3.4 4.6 4.9 4.8 3.1 6.4 0.5 3.9 4.3 4.6 10.1 6.0 5.6 6.2 2.7 6.6 5.9 1.1 5.3 15.1 11.1 3.6 8.1 4.7 6.1 6.5 7.1 12.5 4.2 3.6 2.5 4.1 2.3 1.9 7.8 5.2 0.9 4.5 10.0 7.4 6.1 3.8 9.8 0.6 4.4 10.9 8.4 7.5 6.8 2.1 5.8 8.4 6.0 6.3 4.6 3.7 7.3 10.8 7.0 7.2 2.1 5.5 0.8 2.6 1.2 1.2 5.1 2.8 1.0 1.6 29.0 2.6 6.4 4.5 1.5 1.4 8.7 11.4 4.1 10.0 9.0 4.2 13.7 5.7 9.1 14.6 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA050845: " "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.1 5.4 10.4 6.3 0.9 1.0 19.1 1.3 1.7 2.5 1.9 11.6 5.8 10.3 2.5 1.7 6.6 9.2 3.6 2.6 4.4 3.6 13.2 4.5 3.9 3.8 13.8 8.2 1.5 9.7 3.0 7.2 3.7 9.0 3.4 1.4 10.2 6.8 9.0 5.8 1.9 10.3 6.5 3.6 2.7 11.5 13.0 11.1 2.8 7.4 3.5 4.7 11.2 4.7 2.6 11.2 1.2 4.6 3.0 1.3 9.0 1.7 9.7 3.4 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Cell line enhanced" "Detected in some" "HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036800 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 8.7 1.1 0.0 1.1 3.1 19.7 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.1 0.1 0.1 3.7 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 TEX2 "HT008, KIAA1738, TMEM96" ENSG00000136478 "Testis expressed 2" Q8IWB9 17 64147227-64263301 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "plasmacytoid DC: 18.1" "Lineage enriched" "Detected in many" 7 "dendritic cells: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020648, HPA057116" Approved Approved Nucleoplasm Nucleoplasm "HPA020648: AB_1857908, HPA057116: " "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "prognostic favourable (3.90e-6)" "unprognostic (1.69e-2)" "unprognostic (3.84e-2)" "unprognostic (8.34e-2)" "unprognostic (6.97e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-2)" "unprognostic (1.11e-1)" "unprognostic (7.97e-2)" "unprognostic (7.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.53e-3)" "unprognostic (5.59e-3)" 11.7 18.1 22.3 5.0 25.1 11.8 14.3 18.9 22.5 14.0 8.8 22.9 4.2 7.3 10.8 8.7 12.6 10.2 15.8 19.2 23.0 20.1 14.6 23.4 10.7 4.1 29.0 13.8 12.0 21.1 27.2 10.7 8.7 20.5 12.3 10.0 46.2 17.7 13.2 28.1 11.1 7.2 10.8 26.3 8.7 9.1 35.7 17.2 4.9 29.3 10.9 4.9 8.1 8.2 0.6 18.1 0.7 2.6 2.6 1.6 1.4 13.0 6.3 4.0 8.1 19.4 11.5 4.8 18.2 20.7 16.6 11.5 5.9 3.2 4.6 4.7 23.1 6.5 7.1 22.1 18.9 6.7 4.9 31.2 4.4 11.1 7.2 9.0 5.2 8.4 12.3 11.3 23.2 8.0 8.5 5.7 12.3 14.7 8.2 4.1 2.3 11.4 5.1 36.3 6.6 9.6 6.2 6.2 10.1 9.1 23.3 10.0 11.0 7.8 9.3 15.5 9.1 11.9 10.5 6.0 8.1 3.0 6.2 8.6 14.0 0.0 2.6 0.7 1.4 0.8 1.6 0.3 1.5 1.6 2.5 0.6 1.6 1.5 0.3 2.6 1.5 18.1 1.0 1.4 22.3 25.1 18.9 22.3 23.0 20.1 29.0 13.8 20.5 17.2 TEX261 "MGC32043, TEG-261" ENSG00000144043 "Testis expressed 261" Q6UWH6 2 70985938-70994945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA016631 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA016631: AB_2240434" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (2.42e-1)" "prognostic unfavourable (6.17e-4)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "prognostic unfavourable (4.23e-4)" "unprognostic (5.52e-3)" "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.70e-3)" "unprognostic (3.36e-1)" "unprognostic (5.59e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.99e-1)" 22.9 27.1 14.5 11.1 15.4 9.3 22.2 13.4 21.4 19.9 15.9 21.6 20.9 13.8 17.3 27.2 17.3 20.9 21.2 21.6 14.4 12.0 25.1 36.9 19.8 16.1 17.0 10.9 23.7 50.8 36.1 20.1 19.3 15.0 18.9 18.9 28.7 22.3 21.0 33.5 12.9 23.6 19.6 17.4 16.0 18.4 23.8 15.3 15.5 31.7 14.3 16.3 14.9 13.9 3.8 4.4 12.0 5.3 3.4 6.7 2.8 19.9 18.9 13.3 16.8 40.6 20.7 15.0 23.1 22.1 27.0 17.1 22.2 16.6 16.3 8.8 40.6 15.1 25.2 27.6 39.3 12.3 21.0 19.5 9.8 23.4 23.9 22.7 16.4 18.6 18.5 25.9 17.7 27.4 24.2 10.9 31.5 15.7 19.5 12.6 8.8 22.4 13.9 41.1 14.0 19.6 17.5 21.8 11.5 24.0 24.0 15.1 15.6 13.5 21.9 33.2 28.8 17.7 30.7 8.5 7.5 19.4 29.0 30.0 27.8 12.0 5.3 10.0 5.1 5.3 4.3 2.6 5.4 6.7 4.0 3.8 6.2 4.9 4.0 3.4 5.2 4.4 4.3 2.8 14.5 15.4 13.4 21.4 14.4 12.0 17.0 10.9 15.0 15.3 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847613 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 65.5" "Group enriched" "Detected in some" 4 "AF22: 31.7;SH-SY5Y: 59.0" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in some" 41 "cerebellum: 4.7;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 11.2" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm Nucleoplasm "HPA034683: AB_10670966, HPA062942: " "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.2 3.0 0.0 0.0 0.0 0.0 9.4 4.7 0.0 0.2 0.2 0.0 8.8 0.0 0.0 65.5 5.8 0.0 0.0 0.1 0.0 0.1 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 6.3 0.1 0.0 12.2 7.0 0.6 0.0 6.3 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 59.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 6.3 0.0 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" 21 42311667-42315651 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 230.9;thyroid gland: 258.3" "Cell line enhanced" "Detected in some" "MCF7: 32.1;SCLC-21H: 9.8;T-47d: 15.0;TIME: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "eosinophil: 9.5" "Lineage enriched" "Detected in single" 63 "granulocytes: 9.5" "Region enriched" "Detected in single" 20 "cerebellum: 1.7" "Region enriched" "Detected in single" 8 "olfactory region: 1.0" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" 2090000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: " "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favourable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 2.2 1.2 0.2 16.8 0.2 0.0 4.3 0.2 0.2 45.1 66.3 0.2 0.5 40.8 2.8 1.2 5.1 8.0 230.9 0.7 0.2 0.3 1.0 0.6 12.6 0.6 0.4 0.2 2.0 4.8 0.0 0.5 0.5 0.2 3.6 63.3 0.3 54.8 0.7 0.6 1.6 70.6 1.5 0.5 5.0 1.1 0.4 0.2 0.3 258.3 14.4 72.6 1.1 1.6 0.0 0.0 9.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 32.1 0.0 0.5 0.1 4.8 0.0 3.6 0.4 0.0 0.0 9.8 0.1 0.0 1.0 0.0 15.0 0.0 41.7 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 TFIP11 "DKFZP434B194, Spp382, TIP39" ENSG00000100109 "Tuftelin interacting protein 11" Q9UBB9 22 26491225-26512505 "Plasma proteins, Predicted intracellular proteins" "Biomineralization, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027085 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA027085: AB_1857964" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (4.87e-2)" "unprognostic (9.14e-2)" "unprognostic (3.24e-2)" "unprognostic (3.86e-2)" "unprognostic (6.28e-2)" "unprognostic (2.63e-1)" "unprognostic (1.76e-1)" "unprognostic (3.01e-1)" "unprognostic (4.38e-2)" "unprognostic (2.34e-1)" "unprognostic (2.96e-3)" "unprognostic (1.46e-2)" "unprognostic (9.24e-2)" "unprognostic (1.18e-1)" "unprognostic (2.62e-1)" 11.8 13.5 12.7 12.7 13.8 43.9 10.9 13.8 15.4 9.4 9.5 13.1 8.9 9.9 11.8 8.9 14.5 10.7 10.3 11.8 13.2 9.6 12.3 24.7 11.0 17.7 15.5 12.0 10.3 16.3 11.1 12.0 11.5 12.2 10.5 9.8 11.9 10.9 8.7 34.2 16.3 12.7 10.2 10.6 17.8 11.1 40.6 12.3 23.8 15.4 11.0 19.0 11.1 11.5 23.8 15.5 35.4 23.8 19.6 25.5 17.8 10.9 12.9 11.2 12.6 18.0 10.9 11.3 13.5 17.2 21.1 20.0 9.8 8.0 21.4 8.4 16.7 16.3 16.0 13.0 15.7 15.6 15.2 13.1 8.3 9.9 16.5 30.4 16.9 13.9 17.6 20.0 15.8 16.1 17.7 20.5 14.1 13.4 13.8 16.7 10.8 10.8 21.0 17.3 18.9 12.2 11.1 8.5 12.3 16.1 11.6 15.8 9.4 14.5 15.8 17.8 29.2 11.2 12.3 15.1 19.3 42.4 14.1 12.3 13.2 35.4 16.9 28.6 23.8 18.2 22.1 22.9 21.1 22.2 15.5 23.8 20.2 18.4 26.8 19.6 23.8 9.7 25.5 17.8 12.7 13.8 13.8 15.4 13.2 9.6 15.5 12.0 12.2 12.3 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.2 3.0 5.1 4.6 7.6 6.1 6.4 6.6 6.4 6.3 6.1 8.4 7.1 11.2 6.7 4.6 4.6 9.0 5.2 6.5 8.9 3.6 9.0 3.6 7.8 9.6 30.8 6.2 7.1 4.2 3.5 10.1 5.8 8.8 3.9 5.6 4.4 8.4 15.9 6.7 3.9 7.2 5.2 6.6 7.9 3.2 7.3 4.0 5.0 10.5 18.6 4.7 16.7 5.3 2.5 6.6 3.9 5.5 8.9 4.8 41.2 6.9 11.4 6.8 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 TGIF2LX ENSG00000153779 "TGFB induced factor homeobox 2 like, X-linked" Q8IUE1 X 89921882-89922883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 13.3" "Group enriched" "Detected in some" 11 "SH-SY5Y: 10.0;U-2 OS: 11.7;U-266/84: 18.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA034543 Supported Approved Nucleoplasm Nucleoplasm "HPA034543: AB_10603037" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 11.7 0.3 0.0 1.0 18.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892785 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 6 "monocytes: 7.3" HPA041416 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA041416: AB_10795592" "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favourable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 3.3 4.6 7.5 2.5 10.9 0.3 3.9 13.4 16.0 4.8 4.1 9.9 0.8 4.3 4.2 4.0 3.9 6.3 3.0 9.4 7.8 10.3 5.8 3.7 3.6 1.8 9.5 6.5 7.8 3.7 8.7 4.6 3.6 11.7 5.7 3.8 7.0 3.7 6.5 3.8 2.4 2.4 4.1 11.6 1.8 5.1 6.2 7.6 0.2 7.0 1.8 1.6 5.5 3.8 0.6 1.1 0.0 7.3 0.8 0.4 0.2 4.6 8.2 5.2 6.8 2.7 3.2 0.1 9.1 4.0 7.9 9.3 1.2 6.4 0.0 5.7 2.4 7.2 11.1 2.1 7.0 0.0 5.7 1.7 4.6 0.5 1.4 0.4 3.4 1.1 3.4 4.3 4.2 3.7 0.5 0.0 5.1 3.6 0.0 1.6 7.7 3.2 0.0 6.6 0.2 3.1 3.9 5.6 6.0 6.2 2.7 3.9 3.1 3.8 2.9 5.6 3.7 27.3 6.3 2.3 2.6 0.0 3.3 0.6 7.7 0.0 0.6 0.0 0.1 0.9 0.1 0.6 0.4 0.0 1.1 0.3 0.0 0.3 0.0 0.8 7.3 0.0 0.3 0.2 7.5 10.9 13.4 16.0 7.8 10.3 9.5 6.5 11.7 7.6 THAP12 "DAP4, P52rIPK, PRKRIR, THAP0" ENSG00000137492 "THAP domain containing 12" O43422 11 76349956-76380971 "Plasma proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008758 Approved Approved Nucleoplasm Nucleoplasm "HPA008758: AB_1855714" "unprognostic (2.79e-1)" "unprognostic (9.79e-2)" "unprognostic (1.16e-3)" "unprognostic (6.47e-2)" "unprognostic (8.85e-3)" "unprognostic (1.23e-1)" "unprognostic (4.03e-3)" "unprognostic (1.08e-1)" "unprognostic (6.68e-3)" "unprognostic (1.48e-1)" "unprognostic (1.57e-2)" "unprognostic (2.65e-2)" "unprognostic (7.98e-2)" "unprognostic (2.06e-1)" "unprognostic (3.95e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-2)" 17.0 15.4 19.4 15.5 16.9 17.1 26.4 28.8 15.5 14.6 14.5 7.1 7.2 11.9 17.9 13.7 12.5 14.9 10.2 20.6 13.6 11.2 17.0 25.3 13.2 18.5 11.7 8.7 15.2 32.3 10.4 16.2 20.1 14.2 12.8 16.3 8.2 12.4 12.6 20.6 9.3 14.5 13.8 12.7 21.9 13.8 14.4 13.4 43.2 16.3 11.6 17.2 11.9 23.3 5.1 2.9 2.0 2.1 7.5 7.7 2.4 10.6 8.5 16.3 9.2 11.2 16.0 9.9 11.0 11.5 14.0 12.4 17.1 11.5 29.1 17.0 10.5 10.6 20.0 13.1 22.5 21.8 6.3 20.8 6.1 7.9 12.4 26.2 10.3 11.4 17.4 12.4 23.3 12.0 24.0 16.5 12.5 11.5 22.6 14.8 6.7 9.4 17.0 37.4 30.1 8.1 11.3 16.0 10.6 10.7 12.0 5.8 12.0 10.4 10.7 16.8 27.5 34.0 9.6 14.7 15.5 70.6 4.0 14.7 9.0 1.1 2.1 2.0 6.6 2.1 7.7 4.9 6.9 7.2 2.9 5.1 5.1 6.6 0.6 7.5 2.0 1.3 6.3 2.4 19.4 16.9 28.8 15.5 13.6 11.2 11.7 8.7 14.2 13.4 THAP2 DKFZP564I0422 ENSG00000173451 "THAP domain containing 2" Q9H0W7 12 71663009-71680639 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039790 Approved Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA039790: AB_10795157" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" "unprognostic (5.55e-2)" "unprognostic (2.90e-2)" "unprognostic (1.80e-2)" "unprognostic (1.51e-4)" "unprognostic (1.24e-4)" "unprognostic (7.00e-2)" "unprognostic (1.02e-1)" "unprognostic (7.20e-2)" "unprognostic (3.73e-3)" "unprognostic (6.83e-2)" "unprognostic (3.13e-2)" "unprognostic (7.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.38e-1)" "unprognostic (4.80e-2)" 19.8 31.3 10.9 9.9 13.3 14.2 6.1 24.1 14.1 7.7 6.4 7.3 6.2 6.6 7.1 20.0 10.0 6.9 10.2 7.9 11.6 8.1 6.7 5.9 6.8 7.9 16.3 10.4 9.9 6.1 5.5 20.6 7.9 12.6 8.4 6.8 2.5 5.4 5.5 5.7 6.5 6.3 5.3 18.2 7.4 8.2 21.0 16.0 7.0 8.0 4.2 7.7 7.8 11.6 6.5 3.8 2.8 4.1 8.4 11.4 3.1 3.8 4.9 11.5 8.7 8.6 7.1 5.7 6.1 5.5 5.9 5.0 4.7 5.0 2.6 4.2 4.0 6.9 11.0 3.4 7.7 11.3 6.0 7.5 8.3 7.7 7.6 4.5 3.5 5.3 14.7 5.7 12.4 9.1 5.5 5.6 7.8 1.2 3.7 4.5 5.7 8.1 5.3 3.8 12.9 6.8 6.0 8.0 12.7 6.4 3.9 5.3 7.2 4.7 4.0 6.1 2.9 5.2 4.0 7.1 8.8 6.1 3.5 5.3 3.7 2.0 2.8 2.8 5.0 3.9 8.2 5.7 7.0 4.8 3.8 6.5 11.4 7.6 2.5 8.4 4.1 1.9 6.8 3.1 10.9 13.3 24.1 14.1 11.6 8.1 16.3 10.4 12.6 16.0 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: " "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavourable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.8 9.3 8.5 12.3 14.1 12.7 8.2 8.9 11.7 23.8 14.9 12.5 6.2 8.7 12.0 9.8 7.8 13.5 7.9 8.3 15.0 22.1 10.0 12.5 11.1 17.7 7.1 10.4 11.9 10.2 14.9 13.2 10.2 10.1 11.2 8.7 6.8 12.2 16.0 7.3 15.8 11.8 10.3 12.5 10.6 2.3 11.2 12.7 10.9 15.0 20.6 9.6 12.8 9.2 12.6 7.6 8.6 13.8 12.7 13.5 11.4 10.7 15.2 7.1 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 THAP4 CGI-36 ENSG00000176946 "THAP domain containing 4" Q8WY91 2 241584405-241637449 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044982, HPA053448" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA044982: AB_10959786, HPA053448: " "unprognostic (3.17e-2)" "unprognostic (1.70e-2)" "unprognostic (6.56e-2)" "unprognostic (1.36e-2)" "unprognostic (8.35e-2)" "unprognostic (7.23e-2)" "unprognostic (1.16e-3)" "unprognostic (3.61e-2)" "unprognostic (7.56e-2)" "unprognostic (2.18e-1)" "unprognostic (3.24e-1)" "unprognostic (2.21e-1)" "prognostic favourable (1.46e-4)" "unprognostic (2.57e-1)" "unprognostic (1.78e-1)" "unprognostic (5.06e-1)" "unprognostic (1.07e-1)" 11.9 11.5 19.3 13.0 22.5 13.3 26.3 13.8 27.5 12.8 21.3 13.5 10.8 23.7 12.7 19.1 23.6 15.3 16.9 52.4 15.4 18.1 38.2 25.1 13.6 11.9 18.3 11.7 16.7 25.0 30.9 15.0 11.2 15.6 17.1 15.4 12.5 19.7 17.4 55.8 18.5 20.4 13.7 11.3 10.3 18.5 22.7 11.4 16.0 19.0 26.1 15.7 19.4 18.3 14.3 13.9 22.9 12.7 12.5 30.2 9.8 15.1 19.1 11.5 21.3 15.5 16.2 18.1 10.0 15.4 17.2 15.3 17.3 14.2 13.6 5.9 17.8 17.6 23.1 25.5 6.5 10.2 27.1 13.9 13.1 49.2 20.7 16.5 9.8 16.7 20.2 18.4 25.5 15.8 23.8 4.7 13.2 29.7 16.8 40.2 19.8 16.2 19.3 16.1 18.2 35.7 20.2 27.4 18.0 8.4 27.5 22.8 13.7 19.4 13.8 18.4 12.8 17.4 20.3 11.1 6.5 14.0 14.1 14.1 14.0 15.4 9.3 22.9 17.5 10.8 18.5 13.8 19.4 16.2 9.7 14.3 18.7 14.9 6.5 12.5 12.7 13.9 30.2 9.8 19.3 22.5 13.8 27.5 15.4 18.1 18.3 11.7 15.6 11.4 THAP5 DKFZp313O1132 ENSG00000177683 "THAP domain containing 5" Q7Z6K1 7 108554543-108569750 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043170, HPA051488" Approved Approved Nucleoplasm Nucleoplasm "HPA043170: AB_10964500, HPA051488: " "unprognostic (2.53e-2)" "unprognostic (1.91e-1)" "unprognostic (2.88e-1)" "unprognostic (2.05e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (1.79e-1)" "unprognostic (5.84e-2)" "unprognostic (3.33e-2)" "unprognostic (3.94e-1)" "unprognostic (3.67e-2)" "unprognostic (3.20e-1)" "prognostic favourable (8.99e-4)" "unprognostic (6.00e-2)" "unprognostic (3.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.79e-2)" 12.8 16.9 17.8 13.2 18.9 5.3 16.2 22.9 22.3 16.4 11.3 11.1 16.1 12.1 16.3 16.5 10.0 12.9 9.9 16.5 18.0 17.6 20.4 25.8 12.7 16.1 24.5 18.7 22.5 16.0 22.7 29.4 14.8 20.2 16.8 10.6 8.1 11.5 24.3 19.6 10.3 11.9 12.3 22.3 14.7 12.4 28.9 22.0 19.4 27.9 9.4 16.0 16.7 15.1 16.8 10.5 21.2 11.4 8.9 15.5 6.2 9.1 7.1 9.1 20.6 5.9 8.5 4.8 8.4 9.6 9.4 10.0 3.5 7.7 11.1 15.1 5.8 3.9 9.4 6.5 12.2 14.2 7.2 8.3 7.4 3.3 12.7 14.8 11.0 5.2 12.9 5.7 13.7 5.7 12.9 24.1 9.5 9.1 22.4 6.5 10.7 7.0 7.0 13.0 25.8 5.7 5.3 10.7 18.9 12.1 14.3 16.5 6.0 5.6 5.6 17.8 9.8 13.9 10.3 28.0 24.0 20.5 9.9 9.1 16.0 12.4 6.8 10.7 10.0 8.2 13.3 14.6 11.7 9.5 6.1 16.8 15.5 12.9 21.2 8.9 11.4 10.5 8.8 6.2 17.8 18.9 22.9 22.3 18.0 17.6 24.5 18.7 20.2 22.0 THAP6 MGC30052 ENSG00000174796 "THAP domain containing 6" Q8TBB0 4 75513946-75550473 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035767 Uncertain Approved Nucleoplasm,Centrosome Centrosome Nucleoplasm "HPA035767: AB_10696510" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.52e-1)" "unprognostic (6.89e-2)" "unprognostic (8.96e-2)" "unprognostic (3.37e-3)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "unprognostic (1.06e-1)" "unprognostic (9.93e-3)" "unprognostic (1.08e-1)" "unprognostic (3.47e-2)" "unprognostic (8.54e-2)" "unprognostic (2.38e-2)" 15.7 14.9 11.5 18.7 17.6 14.4 18.6 21.2 17.0 18.4 17.0 24.4 16.5 14.9 20.2 23.8 15.5 15.6 13.5 17.2 12.0 11.9 17.8 21.9 13.1 17.9 21.9 14.0 19.3 14.9 19.9 30.9 24.3 17.8 18.3 14.5 17.3 17.0 13.3 20.3 20.8 21.1 18.8 19.2 17.8 13.1 26.5 21.3 18.0 20.4 16.9 15.2 16.5 14.3 10.7 7.1 18.5 8.7 6.8 13.6 6.5 6.8 4.9 10.9 7.6 12.4 12.3 6.2 16.4 8.4 8.6 8.9 6.2 17.1 10.0 8.4 5.3 7.3 9.8 7.8 10.5 11.3 6.8 7.2 8.0 7.9 17.2 9.7 8.2 10.3 13.6 9.8 15.1 4.6 12.4 20.5 9.0 8.0 8.7 6.6 6.2 5.1 8.5 12.0 6.8 8.0 5.8 8.4 8.6 7.7 10.5 9.1 11.4 8.1 5.6 14.7 9.7 16.9 8.4 18.4 9.0 9.4 10.2 7.8 12.3 14.6 8.7 12.2 9.8 7.5 13.0 8.9 11.9 9.2 7.1 10.7 13.6 10.4 18.5 6.8 8.0 5.9 13.0 6.5 11.5 17.6 21.2 16.5 12.0 11.9 21.9 14.0 17.8 21.3 THAP7 MGC10963 ENSG00000184436 "THAP domain containing 7" Q9BT49 22 20999104-21002196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 49.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003083 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA003083: AB_1080264" "unprognostic (6.48e-2)" "unprognostic (2.13e-3)" "unprognostic (3.28e-1)" "unprognostic (4.89e-3)" "unprognostic (1.92e-2)" "unprognostic (1.82e-3)" "unprognostic (5.56e-2)" "unprognostic (1.40e-2)" "unprognostic (2.82e-1)" "unprognostic (2.74e-3)" "unprognostic (1.27e-3)" "unprognostic (2.23e-2)" "unprognostic (9.15e-2)" "unprognostic (2.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.72e-2)" "unprognostic (3.51e-3)" 11.2 17.1 12.0 10.5 11.5 9.7 11.5 14.8 24.1 16.6 15.0 14.0 19.8 15.6 14.3 11.7 11.6 13.6 16.6 12.5 11.3 11.4 13.1 22.5 11.1 14.8 12.0 11.5 20.2 20.5 11.7 26.8 12.4 11.4 18.8 5.8 18.7 30.2 19.8 44.5 15.0 14.4 12.2 8.9 16.2 15.3 28.6 11.7 12.3 22.1 14.6 14.2 13.0 12.0 23.9 15.7 4.3 11.6 11.0 24.7 12.4 10.4 11.8 3.2 5.4 2.8 3.5 7.1 6.0 5.3 7.3 6.9 6.0 6.1 8.8 5.7 3.4 7.2 2.7 5.5 1.1 8.3 17.4 10.3 9.0 7.0 8.8 9.9 6.4 3.3 6.9 6.4 5.9 3.8 49.2 9.0 4.0 13.4 10.5 6.6 4.6 11.9 8.8 6.4 4.7 3.8 5.4 7.2 6.0 6.9 8.9 9.3 10.2 6.7 2.4 12.0 9.5 7.1 6.0 13.2 7.4 6.7 12.9 6.3 10.3 1.0 11.5 4.3 14.3 11.6 19.0 23.9 17.6 14.8 10.7 18.4 24.7 19.7 1.0 11.0 11.4 15.7 14.5 12.4 12.0 11.5 14.8 24.1 11.3 11.4 12.0 11.5 11.4 11.7 THBD CD141 ENSG00000178726 Thrombomodulin P07204 20 23045633-23049741 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation, Hemolytic uremic syndrome, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;CAPAN-2: 20.0;EFO-21: 17.5;HaCaT: 16.8;hTCEpi: 22.2;THP-1: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002425, HPA002982" Supported Approved Nucleoplasm,Cytosol 690000 "Nucleoplasm, Cytosol" "CAB002425: AB_563497, HPA002982: AB_1078444" "unprognostic (1.96e-1)" "unprognostic (2.93e-3)" "unprognostic (8.70e-2)" "unprognostic (3.00e-2)" "unprognostic (3.07e-2)" "unprognostic (1.88e-1)" "unprognostic (7.81e-3)" "unprognostic (4.70e-2)" "unprognostic (1.38e-1)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.33e-2)" "unprognostic (2.23e-2)" "unprognostic (7.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.58e-3)" "unprognostic (9.71e-2)" 27.0 6.3 1.4 10.5 6.7 6.9 11.8 1.2 2.7 13.2 14.4 1.4 4.3 2.9 9.7 11.5 21.7 15.8 18.2 24.3 5.0 1.5 7.0 10.0 61.9 26.8 2.5 0.1 10.2 7.2 10.0 10.9 16.4 6.2 6.1 3.3 8.8 6.0 4.2 55.5 32.4 14.1 8.5 7.7 44.4 14.4 15.8 2.4 2.1 18.3 32.2 10.4 14.2 10.4 0.0 7.8 17.7 6.2 1.5 0.0 1.1 5.6 5.0 0.1 0.0 12.9 0.7 0.1 0.1 0.0 0.0 0.0 0.0 20.0 0.0 17.5 1.7 16.8 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.0 0.1 0.6 22.2 0.3 1.4 5.6 2.1 0.0 0.5 0.4 0.0 2.1 0.0 0.8 0.0 0.0 2.4 0.1 8.2 0.3 0.0 4.7 0.6 8.7 0.0 12.5 11.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 1.0 2.9 0.4 0.0 2.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 17.7 1.5 5.8 7.8 0.0 1.1 1.4 6.7 1.2 2.7 5.0 1.5 2.5 0.1 6.2 2.4 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0" "Cell line enhanced" "Detected in many" "Karpas-707: 47.2;U-266/70: 36.7;U-937: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 13.4 5.2 4.3 27.2 7.2 72.3 5.8 0.9 4.6 3.6 7.2 10.7 0.3 4.1 3.0 6.6 4.6 5.4 9.5 6.5 7.1 4.6 5.9 7.5 22.1 39.0 11.5 2.7 3.8 2.7 1.0 2.7 7.1 7.8 2.8 4.2 6.0 6.0 1.8 2.3 2.3 12.7 6.0 16.4 73.0 4.8 9.9 6.7 12.5 5.3 1.1 25.2 7.8 3.3 6.5 43.6 72.0 62.6 8.5 11.3 40.5 3.1 0.1 1.2 0.2 4.0 5.6 0.5 0.6 6.9 10.1 14.3 0.4 0.8 4.4 0.4 2.2 0.4 1.8 0.4 1.6 0.6 0.4 6.2 0.1 0.9 8.0 7.6 10.1 2.8 0.1 5.2 0.0 3.8 8.6 47.2 0.7 2.1 0.3 6.7 4.1 0.7 1.3 4.5 7.7 3.0 0.1 0.0 1.8 0.0 0.2 8.8 0.1 6.8 2.4 0.6 0.0 1.9 0.1 36.7 2.1 0.3 11.4 21.4 0.1 4.4 54.1 47.1 11.3 62.6 10.3 6.5 8.2 9.1 43.6 2.9 7.1 7.3 72.0 8.5 60.9 17.7 7.9 40.5 4.3 7.2 0.9 4.6 7.1 4.6 11.5 2.7 7.8 6.7 THOC2 "CXorf3, dJ506G2.1, MRX12, MRX35, THO2" ENSG00000125676 "THO complex 2" Q8NI27 X 123600561-123733056 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047921 Supported Approved Nucleoplasm Nucleoplasm "HPA047921: AB_10960388" "unprognostic (2.12e-2)" "unprognostic (5.64e-2)" "unprognostic (3.49e-1)" "unprognostic (3.74e-2)" "unprognostic (2.22e-2)" "unprognostic (3.08e-1)" "prognostic unfavourable (5.77e-5)" "unprognostic (1.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (6.29e-2)" "unprognostic (4.27e-3)" "unprognostic (6.43e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" 25.9 22.7 25.2 23.3 28.2 21.6 26.6 36.0 29.8 30.1 22.5 17.8 24.8 22.5 27.4 39.8 24.7 21.6 19.9 17.7 25.2 19.2 28.0 20.3 24.0 29.4 28.9 21.9 30.1 23.6 28.3 45.4 22.8 24.9 26.3 23.4 17.2 18.9 24.6 20.6 29.0 31.1 27.0 31.7 27.4 20.0 15.2 29.7 45.3 26.2 20.7 26.3 27.0 21.2 13.5 15.2 9.7 12.7 11.7 16.0 8.2 21.1 17.7 22.8 24.5 16.8 16.1 12.2 14.5 14.3 16.0 21.5 12.4 21.8 21.7 16.7 15.8 16.2 27.5 10.8 27.3 20.7 24.9 30.4 24.9 16.8 15.6 35.1 21.8 31.9 13.6 18.3 21.2 14.8 45.4 19.8 16.2 22.3 30.2 34.5 12.6 17.6 30.8 14.2 17.9 25.1 24.0 17.6 15.6 40.6 11.2 13.5 11.2 21.6 15.2 14.5 7.5 20.6 24.3 13.7 20.1 18.7 12.9 31.5 15.8 9.6 9.2 9.7 13.4 12.4 15.6 12.3 14.6 14.4 8.9 13.5 16.0 15.4 5.6 11.7 12.7 15.2 11.1 8.2 25.2 28.2 36.0 29.8 25.2 19.2 28.9 21.9 24.9 29.7 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009" Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 2.3 3.5 8.5 2.3 5.8 8.3 6.0 12.5 6.4 4.7 7.3 3.0 3.4 20.0 21.5 4.0 1.6 1.7 8.5 3.2 4.4 6.0 2.8 7.3 2.6 5.3 3.4 0.4 3.7 4.5 3.8 5.9 5.5 4.1 2.6 7.2 4.1 3.0 2.0 4.3 4.5 11.9 5.1 12.5 5.1 7.6 24.0 13.9 4.7 10.5 12.6 41.4 19.2 22.1 12.4 13.1 28.9 12.7 11.4 48.2 13.4 12.5 29.6 34.4 17.5 18.2 28.9 19.4 7.7 19.1 20.0 57.0 31.4 19.8 29.2 15.6 12.3 19.0 4.2 25.5 14.0 9.6 24.3 25.4 12.9 16.2 23.6 13.1 18.7 26.7 17.1 15.6 11.3 45.4 29.9 16.7 30.1 21.1 16.6 25.5 14.8 27.7 13.6 13.7 15.5 23.4 12.4 10.2 11.7 15.7 23.9 6.6 11.5 17.3 7.6 24.8 7.9 4.4 9.0 4.7 13.7 10.5 16.5 16.5 28.3 16.8 13.9 24.0 34.9 21.9 1.3 12.6 9.4 12.9 41.4 19.2 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6" "Cell line enriched" "Detected in some" 13 "ASC diff: 41.5" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Cell type enhanced" "Detected in some" "NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavourable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favourable (3.28e-4)" "unprognostic (1.69e-3)" 62.0 1.6 0.0 18.3 0.0 0.0 22.7 1.0 0.0 0.0 12.2 0.0 2.8 0.0 0.1 1.2 0.1 0.3 16.5 11.7 0.0 0.0 2.1 92.5 0.0 2.9 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 45.6 2.0 9.3 7.2 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.6 4.3 0.3 5.7 0.3 0.5 0.1 0.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.5 0.1 0.5 0.2 1.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 8 "Daudi: 10.1;SCLC-21H: 21.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051416: , HPA056745: " "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.1 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell line enhanced" "Detected in many" "ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" 9800000 Nucleoplasm "Plasma membrane" "CAB068243: , CAB068244: , HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavourable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.3 0.0 52.6 38.1 0.0 82.2 92.1 29.5 32.7 0.0 0.0 0.0 0.0 144.0 0.0 0.4 0.1 22.6 7.0 0.0 4.4 1.5 0.0 16.3 0.0 0.0 28.2 0.0 37.4 1.3 0.0 0.0 0.0 22.7 0.0 0.0 0.0 19.7 0.1 0.0 5.8 0.0 0.0 0.0 2.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 42.4 14.1 12.2 12.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 TIAL1 TIAR ENSG00000151923 "TIA1 cytotoxic granule associated RNA binding protein like 1" Q01085 10 119571802-119597029 "Predicted intracellular proteins" Apoptosis RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060962 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA060962: " "unprognostic (1.61e-2)" "unprognostic (9.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.76e-1)" "unprognostic (5.33e-2)" "unprognostic (3.91e-2)" "prognostic unfavourable (7.81e-6)" "unprognostic (5.54e-2)" "unprognostic (9.21e-2)" "unprognostic (3.89e-3)" "unprognostic (3.74e-1)" "unprognostic (1.32e-3)" "unprognostic (6.48e-3)" "unprognostic (6.35e-2)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (2.26e-2)" 30.0 29.6 31.4 29.4 44.4 39.2 46.6 72.8 47.3 27.7 27.3 26.7 26.9 23.8 35.0 37.9 43.9 27.1 27.9 30.1 32.5 20.4 25.7 35.3 30.2 39.5 48.2 25.0 34.6 35.5 40.2 30.7 33.2 33.6 27.7 34.3 20.3 33.6 32.0 51.5 31.7 32.5 30.3 39.3 33.3 32.5 28.1 47.8 38.0 33.3 23.6 40.9 29.5 45.8 5.7 6.6 4.9 5.9 7.8 8.6 2.6 35.7 23.7 40.5 44.2 24.5 33.7 27.0 31.9 40.3 39.1 37.6 28.2 43.2 35.6 19.7 29.0 33.9 39.7 25.9 51.1 34.8 17.7 26.8 26.2 29.4 29.3 40.4 32.8 28.8 31.9 31.0 52.2 38.1 26.7 38.2 36.3 30.9 35.5 37.3 20.3 19.8 30.6 31.8 23.6 32.4 20.3 14.5 17.2 21.5 20.7 28.4 21.4 24.1 26.4 24.8 21.0 20.3 33.6 25.1 31.5 28.7 23.4 38.5 18.1 3.7 4.5 3.9 7.2 3.6 7.3 5.4 7.4 6.7 4.6 5.7 7.9 8.3 4.9 7.8 5.9 6.6 8.6 2.6 31.4 44.4 72.8 47.3 32.5 20.4 48.2 25.0 33.6 47.8 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 45.1;U-698: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 6.8 1.7 2.6 4.3 3.2 2.6 5.2 5.5 10.4 3.5 6.0 0.9 6.2 21.1 4.5 2.1 2.0 3.5 4.2 7.4 17.1 2.1 2.1 4.2 1.9 2.1 6.6 2.9 3.5 2.3 3.7 4.1 5.5 2.1 45.1 4.6 3.4 11.6 3.6 0.5 2.2 20.1 6.5 14.0 7.7 4.7 6.0 6.2 4.4 9.3 2.1 4.0 9.5 4.1 5.5 6.6 4.6 4.3 28.2 25.9 38.9 5.2 4.4 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232547968-232550592 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA041717: " "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 3.9 5.9 13.3 9.2 15.3 19.4 8.9 10.1 11.7 5.4 5.1 10.7 2.0 5.9 8.5 10.1 5.6 7.4 6.9 4.9 13.8 8.2 10.1 5.0 6.9 12.5 9.1 8.0 13.2 5.8 6.3 21.2 6.5 8.6 8.3 6.7 8.3 7.3 7.9 7.5 13.6 6.8 4.3 8.8 11.1 8.1 9.7 10.8 14.2 9.6 4.8 10.6 5.5 5.9 7.1 3.8 7.0 4.8 4.5 9.8 1.9 6.9 5.2 11.3 16.7 4.2 5.5 8.5 5.0 2.8 6.1 6.9 6.5 7.8 11.5 3.8 3.7 6.6 9.3 2.8 9.4 7.0 8.1 10.2 15.2 7.4 2.6 8.5 6.8 6.1 2.7 6.4 4.0 3.8 8.0 12.2 5.3 10.4 10.5 17.3 6.7 6.3 9.7 10.1 5.2 3.6 8.2 13.5 13.5 5.4 4.8 5.2 7.1 8.3 6.5 10.2 10.4 6.4 5.1 10.8 7.5 10.7 5.9 8.6 6.3 4.0 4.8 5.3 6.7 4.3 6.1 4.9 6.5 4.3 3.4 7.1 9.8 7.7 7.0 4.5 4.8 3.8 4.5 1.9 13.3 15.3 10.1 11.7 13.8 8.2 9.1 8.0 8.6 10.8 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040016 Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.3 2.6 2.2 5.9 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.0 0.3 1.0 1.0 0.2 1.4 2.2 0.1 0.2 1.7 2.3 0.4 1.3 4.6 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.3 1.4 3.0 0.0 3.4 2.8 1.9 1.3 1.1 4.1 1.0 4.0 0.1 1.3 6.6 4.2 1.7 2.6 1.0 4.2 1.4 0.0 0.2 1.1 1.5 1.0 6.3 4.0 1.3 0.1 1.8 0.6 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779764 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.1;testis: 11.8" "Cell line enhanced" "Detected in some" "Karpas-707: 4.5;U-266/70: 6.6;U-266/84: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035649 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA035649: AB_10670956" "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.7 1.0 2.2 0.7 8.6 0.2 2.1 3.5 3.6 2.5 0.8 2.1 3.9 1.1 2.0 4.2 0.6 5.5 0.8 1.0 4.8 2.1 2.0 0.6 3.5 0.5 1.6 3.2 1.7 0.9 5.4 14.1 0.5 5.8 1.3 0.9 5.4 2.0 1.1 1.2 1.3 0.8 0.9 2.7 0.8 1.0 11.8 1.3 0.3 2.1 0.6 0.5 1.0 0.8 0.4 0.0 1.6 1.1 2.1 1.3 0.0 0.6 0.5 2.9 1.2 0.2 0.4 0.3 0.1 0.7 0.3 0.6 0.5 1.3 1.0 0.1 0.1 0.5 1.1 0.5 0.5 1.0 0.2 1.5 0.7 0.3 0.2 0.6 0.3 0.1 0.5 0.5 0.3 0.1 0.4 4.5 0.3 0.3 2.8 0.3 1.3 0.4 0.5 0.6 0.0 2.0 0.1 1.4 1.6 0.2 0.3 2.8 0.7 0.2 0.0 0.4 0.6 0.5 0.6 6.6 12.9 0.6 1.0 1.5 2.1 0.0 0.3 0.8 0.0 1.1 0.2 0.0 0.3 1.3 0.0 0.4 0.1 0.4 1.6 2.1 0.2 0.0 0.0 0.0 2.2 8.6 3.5 3.6 4.8 2.1 1.6 3.2 5.8 1.3 TIGD6 DKFZp761E2110 ENSG00000164296 "Tigger transposable element derived 6" Q17RP2 5 149993118-150001167 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA044599 Uncertain Approved "Nucleoplasm,Vesicles,Actin filaments" Nucleoplasm "Vesicles, Actin filaments" "HPA044599: AB_10961286" "unprognostic (1.06e-1)" "unprognostic (3.25e-1)" "prognostic favourable (5.35e-4)" "unprognostic (1.94e-2)" "unprognostic (8.18e-2)" "unprognostic (3.00e-2)" "unprognostic (1.30e-3)" "unprognostic (7.48e-2)" "unprognostic (5.96e-2)" "unprognostic (3.85e-2)" "prognostic favourable (5.88e-4)" "unprognostic (1.94e-3)" "unprognostic (1.85e-3)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.33e-3)" "unprognostic (1.18e-1)" 6.9 10.5 5.9 3.9 10.7 2.8 9.9 9.3 9.4 5.8 6.1 10.0 8.9 4.7 6.5 11.1 5.0 6.9 5.1 4.5 6.4 4.7 7.7 7.0 5.3 3.9 7.3 7.1 8.6 6.8 28.0 10.5 5.5 7.1 8.8 5.7 6.4 8.1 12.6 3.8 7.2 5.2 5.9 7.6 5.8 6.1 9.8 8.0 6.1 6.5 3.6 4.3 6.2 6.1 3.5 3.3 2.1 4.0 6.3 8.0 2.6 2.3 6.2 4.2 9.1 12.1 10.0 6.6 6.6 7.0 5.2 5.2 4.0 4.1 1.1 5.9 7.7 4.1 3.7 4.8 6.1 4.9 3.1 1.9 3.2 2.1 10.8 2.7 5.0 10.3 9.2 6.7 8.8 4.0 2.6 5.3 6.3 5.4 3.6 1.2 1.7 5.3 4.1 4.8 2.9 4.9 3.3 3.3 4.2 4.6 7.5 9.3 8.3 4.8 5.3 4.2 3.3 4.6 4.8 3.9 1.5 3.0 6.7 3.0 6.5 0.2 4.0 2.1 2.8 3.9 2.5 2.7 3.8 2.8 3.3 3.5 8.0 5.1 0.0 6.3 2.2 2.2 3.7 2.6 5.9 10.7 9.3 9.4 6.4 4.7 7.3 7.1 7.1 8.0 TIMM29 C19orf52 ENSG00000142444 "Translocase of inner mitochondrial membrane 29" Q9BSF4 19 10928733-10933535 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041858 Approved Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA041858: AB_10963429" "unprognostic (8.45e-2)" "prognostic favourable (9.93e-5)" "unprognostic (8.99e-2)" "unprognostic (5.21e-2)" "unprognostic (9.31e-2)" "unprognostic (8.10e-2)" "unprognostic (2.82e-3)" "unprognostic (1.42e-2)" "unprognostic (1.81e-1)" "unprognostic (5.92e-2)" "unprognostic (5.26e-3)" "unprognostic (1.80e-1)" "unprognostic (3.79e-3)" "prognostic favourable (7.03e-7)" "unprognostic (1.10e-1)" "unprognostic (2.35e-1)" "unprognostic (7.26e-3)" 13.4 11.4 13.8 11.0 18.0 18.4 8.0 19.9 16.4 8.5 9.9 10.3 7.6 17.5 11.3 7.1 13.8 8.6 9.4 12.5 15.1 8.9 10.5 13.5 8.1 11.6 13.5 9.3 8.3 17.1 7.0 10.8 12.2 11.9 9.9 5.1 11.3 16.8 9.5 30.9 12.1 12.4 10.3 8.3 11.7 15.0 11.3 13.2 12.0 9.2 8.9 9.7 10.1 10.6 13.6 10.3 8.7 8.7 10.9 12.0 3.2 10.7 3.9 3.0 5.2 2.6 2.6 8.8 7.4 3.7 5.3 4.9 7.0 3.5 9.0 13.2 3.3 10.0 1.6 4.4 0.9 10.8 13.0 10.5 4.0 4.7 4.2 7.4 8.0 2.2 4.2 3.7 1.5 3.2 11.3 7.6 2.0 8.7 8.5 14.5 11.2 17.2 11.6 4.4 11.0 2.2 4.1 8.0 8.3 8.6 4.5 8.7 6.5 8.1 5.4 8.6 5.2 11.0 11.3 26.5 25.8 9.7 5.4 9.5 7.1 3.5 7.9 8.7 5.6 8.7 8.8 13.6 10.8 12.0 5.6 10.6 10.1 8.5 1.7 10.9 6.7 10.3 11.0 3.2 13.8 18.0 19.9 16.4 15.1 8.9 13.5 9.3 11.9 13.2 TIRAP "Mal, wyatt" ENSG00000150455 "TIR domain containing adaptor protein" P58753 11 126283065-126298845 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054431 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA054431: " "unprognostic (9.30e-3)" "unprognostic (7.39e-2)" "unprognostic (1.21e-1)" "prognostic favourable (1.24e-4)" "unprognostic (2.73e-2)" "unprognostic (5.77e-2)" "unprognostic (1.27e-1)" "unprognostic (6.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.28e-1)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (3.34e-3)" "unprognostic (4.29e-3)" "unprognostic (3.62e-2)" "unprognostic (3.47e-1)" "unprognostic (2.57e-1)" 8.8 10.4 5.2 11.9 5.4 3.9 16.8 7.2 8.0 11.9 18.9 4.6 13.2 11.6 11.1 11.1 9.7 8.7 14.2 11.6 4.4 6.5 9.2 14.8 16.8 17.6 6.5 5.8 13.4 18.7 14.0 8.8 9.2 5.1 11.1 8.9 10.5 15.3 21.1 10.5 8.4 17.3 13.6 4.7 13.4 8.7 3.5 2.4 3.3 8.0 6.4 9.8 11.8 7.3 6.5 8.7 8.8 10.5 4.4 8.3 6.2 1.9 6.3 3.4 5.6 5.8 8.1 4.1 5.1 8.4 3.6 3.4 9.8 7.5 5.0 8.9 5.3 5.6 3.5 4.0 1.4 13.3 3.3 13.6 3.5 6.2 4.6 8.3 7.3 6.1 5.6 6.8 4.8 5.9 3.6 11.7 4.1 3.5 0.2 1.3 1.6 5.7 1.7 1.0 4.7 2.8 6.9 4.1 5.3 6.1 6.0 4.2 16.5 4.3 5.8 2.0 1.9 4.1 3.8 3.3 4.7 3.7 3.1 6.7 6.3 7.7 10.5 4.9 7.7 8.7 7.4 4.3 6.1 8.3 8.7 6.5 5.0 4.9 8.8 4.4 5.7 5.9 6.1 6.2 5.2 5.4 7.2 8.0 4.4 6.5 6.5 5.8 5.1 2.4 TJP2 "DFNA51, X104, ZO-2, ZO2" ENSG00000119139 "Tight junction protein 2" Q9UDY2 9 69121264-69255208 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.0" "Lineage enriched" "Detected in single" 8 "monocytes: 4.0" "HPA001813, CAB009228, HPA070714" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions" 790000 "Plasma membrane, Cell Junctions" Nucleoplasm "CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: " "unprognostic (1.30e-1)" "unprognostic (7.69e-2)" "unprognostic (1.23e-3)" "unprognostic (7.68e-2)" "unprognostic (2.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.82e-2)" "unprognostic (3.30e-2)" "unprognostic (2.93e-3)" "unprognostic (3.60e-1)" "prognostic favourable (1.78e-14)" "unprognostic (3.29e-2)" "unprognostic (6.42e-2)" "unprognostic (8.15e-3)" "unprognostic (5.85e-2)" 25.2 9.5 23.7 8.0 29.7 5.7 20.7 35.6 24.9 9.0 20.0 50.3 20.6 27.2 11.9 7.3 28.9 12.6 13.2 19.8 35.1 12.7 23.3 34.5 23.9 5.8 39.7 20.5 20.9 13.2 43.2 3.6 18.0 32.0 13.5 16.7 19.1 18.0 23.1 8.3 18.6 25.7 15.3 39.7 3.5 30.4 17.8 41.1 11.1 22.5 9.0 10.8 26.5 26.6 0.0 0.2 0.4 4.0 0.0 0.5 0.5 53.2 1.7 4.2 4.7 20.1 19.7 23.2 8.1 5.9 12.9 7.0 6.4 19.4 7.6 8.1 4.5 32.7 6.9 17.0 14.7 27.2 5.0 7.4 4.6 32.8 5.6 3.0 14.0 15.3 12.3 10.1 6.0 27.1 4.4 5.2 6.7 7.4 1.1 0.4 10.4 11.6 3.9 6.1 0.8 33.3 35.5 1.9 3.3 2.9 20.7 0.6 6.7 1.6 38.8 9.7 10.5 7.5 8.2 5.3 1.1 0.1 11.1 4.3 3.5 0.0 0.7 0.0 0.0 1.5 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.4 0.0 4.0 0.1 0.5 0.5 23.7 29.7 35.6 17.5 35.1 12.7 39.7 20.5 32.0 41.1 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333210-61353295 "Enzymes, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.2;liver: 42.8" "Cell line enhanced" "Detected in all" "Hep G2: 39.8;RPMI-8226: 42.0;T-47d: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol 4800000 "Nucleoplasm, Cytosol" "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favourable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favourable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 3.1 34.7 3.6 6.1 5.3 5.3 4.6 3.7 7.3 3.4 43.4 7.6 8.0 69.5 4.6 7.8 6.2 5.9 8.8 2.8 3.1 2.6 17.4 42.8 3.5 5.2 3.3 5.3 4.5 9.8 3.0 5.5 3.9 4.4 5.0 2.3 7.3 7.2 7.1 4.6 6.1 90.2 2.6 3.1 5.4 5.7 17.1 3.4 5.5 6.4 6.3 6.7 5.4 3.9 9.7 18.4 5.4 11.4 5.3 10.9 7.8 6.0 15.3 2.7 9.3 3.4 3.7 7.6 3.5 3.8 3.3 2.1 6.9 14.6 7.5 12.4 2.5 8.5 5.0 6.6 1.1 12.9 6.7 4.6 8.1 39.8 5.8 3.9 7.8 5.8 4.5 3.1 11.0 3.3 8.1 14.5 2.4 27.4 3.4 3.6 7.4 10.5 6.1 4.2 42.0 5.3 10.7 10.4 9.3 6.5 11.4 5.9 42.0 2.8 3.9 6.6 6.9 5.2 2.1 26.9 22.2 6.7 6.8 3.6 6.0 2.3 11.4 5.4 6.7 6.8 8.6 9.7 7.8 6.5 18.4 9.7 5.6 5.9 0.9 5.3 5.3 9.0 10.9 7.8 3.6 5.3 3.7 7.3 3.1 2.6 3.3 5.3 4.4 3.4 TLNRD1 "MESDC1, MGC99595" ENSG00000140406 "Talin rod domain containing 1" Q9H1K6 15 81000944-81005788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 25.5;SK-MEL-30: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071716 Approved "Nucleoplasm,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "HPA071716: " "unprognostic (1.32e-2)" "unprognostic (5.30e-2)" "unprognostic (9.29e-2)" "unprognostic (5.37e-3)" "unprognostic (9.10e-3)" "unprognostic (1.24e-2)" "unprognostic (1.61e-2)" "prognostic unfavourable (1.47e-5)" "unprognostic (1.68e-2)" "unprognostic (6.82e-2)" "unprognostic (1.81e-1)" "unprognostic (3.24e-1)" "prognostic unfavourable (1.87e-7)" "unprognostic (1.91e-1)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "unprognostic (3.82e-3)" 24.4 13.1 5.8 11.8 19.2 13.7 11.1 18.5 12.6 8.2 12.0 7.0 10.3 8.8 9.7 8.2 9.6 8.7 14.4 10.0 5.9 6.0 9.2 10.1 17.9 12.5 5.8 4.6 6.5 11.9 4.4 7.3 10.7 5.9 7.2 7.4 10.8 7.5 6.6 5.6 4.5 10.1 6.2 8.2 21.4 15.7 2.8 4.6 15.0 6.5 11.0 10.4 7.8 8.7 3.0 2.2 2.0 1.9 4.7 2.9 1.2 6.0 2.0 5.3 3.8 2.4 1.4 8.8 5.6 1.6 3.5 2.6 3.4 5.6 6.6 7.8 1.4 7.8 3.2 1.7 2.0 25.5 9.5 13.0 1.1 3.7 1.8 4.5 9.4 1.4 2.4 2.2 2.1 5.2 7.3 16.5 2.3 3.0 7.1 5.3 8.4 2.8 9.2 5.4 14.9 2.2 6.2 8.3 7.1 3.1 3.4 24.7 3.1 4.0 6.2 4.1 12.8 5.6 8.3 11.5 11.3 7.0 2.7 6.6 4.2 2.0 1.3 1.4 2.7 1.9 2.0 3.0 2.9 2.8 0.9 2.3 1.5 2.1 2.0 4.7 1.6 2.2 1.2 1.2 5.8 19.2 18.5 12.6 5.9 6.0 5.8 4.6 5.9 4.6 TLR5 "FLJ10052, MGC126430, MGC126431, SLEB1, TIL3" ENSG00000187554 "Toll like receptor 5" O60602 1 223109406-223143282 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.4;HaCaT: 6.7;SK-BR-3: 4.3;T-47d: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 17.0;intermediate monocyte: 15.7;myeloid DC: 12.8;neutrophil: 13.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 10 "dendritic cells: 12.8;granulocytes: 13.4;monocytes: 17.0" "Low region specificity" "Detected in many" CAB009013 Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB009013: AB_2240732" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-2)" "unprognostic (3.81e-2)" "unprognostic (3.09e-2)" "unprognostic (6.83e-2)" "unprognostic (1.49e-2)" "unprognostic (2.71e-1)" "unprognostic (4.23e-3)" "unprognostic (1.46e-1)" "unprognostic (3.69e-2)" "prognostic unfavourable (4.95e-4)" "unprognostic (1.06e-3)" "unprognostic (5.60e-2)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" 3.8 2.4 5.3 4.8 7.3 0.4 9.7 0.8 5.3 7.1 2.7 3.4 1.7 1.7 2.4 6.2 9.0 5.6 4.8 5.8 5.0 2.6 4.6 2.2 6.5 12.5 7.0 0.8 22.5 5.3 6.6 6.3 3.5 6.8 6.2 2.3 3.2 12.6 2.9 1.4 3.7 2.3 3.7 12.8 6.7 4.5 2.3 8.1 1.2 4.3 3.5 5.7 5.9 7.8 0.1 12.8 13.4 17.0 0.2 1.4 5.7 4.4 0.4 0.7 0.4 0.3 0.0 0.6 0.2 0.0 0.1 0.1 0.0 1.3 0.0 0.9 0.4 6.7 0.1 0.5 0.4 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.1 1.9 0.2 0.9 0.0 0.0 0.6 1.0 0.3 2.5 0.0 0.1 0.0 0.2 2.1 0.8 1.8 0.4 1.3 4.3 0.1 4.8 0.0 0.0 0.1 0.1 0.0 1.2 0.2 0.0 0.2 0.0 0.7 0.5 0.0 17.0 0.2 0.1 15.7 0.2 0.1 0.9 0.2 12.8 0.0 1.4 0.4 13.4 0.2 6.3 0.2 0.6 5.7 5.3 7.3 0.8 5.3 5.0 2.6 7.0 0.8 6.8 8.1 TLX2 "Enx, HOX11L1, NCX, Tlx2" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.0;brain: 4.3;retina: 3.8" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 37.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040969, HPA062254" Uncertain Approved Nucleoplasm Nucleoplasm "HPA040969: AB_10794431, HPA062254: " "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.1 8.0 1.7 1.7 4.0 0.2 0.1 0.8 4.3 0.1 2.7 0.0 0.0 1.9 0.1 0.1 0.5 0.1 0.6 0.1 0.4 0.7 0.1 0.1 0.1 0.5 0.8 0.0 0.1 0.6 0.5 0.0 0.2 3.5 0.1 0.7 3.8 0.1 0.1 0.1 0.4 2.5 0.2 0.3 0.2 0.9 3.3 0.6 2.5 0.1 0.0 0.3 2.1 0.4 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 1.8 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 0.8 4.3 0.4 0.7 0.8 0.0 3.5 0.6 TM2D2 BLP1 ENSG00000169490 "TM2 domain containing 2" Q9BX73 8 38988808-38996824 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047152, HPA050547" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Nucleoplasm, Vesicles, Plasma membrane" "HPA047152: , HPA050547: AB_2681168" "prognostic unfavourable (7.49e-4)" "unprognostic (1.49e-1)" "prognostic favourable (1.71e-4)" "unprognostic (2.55e-2)" "unprognostic (7.02e-2)" "unprognostic (2.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (3.69e-2)" "unprognostic (2.43e-3)" "unprognostic (4.58e-2)" "unprognostic (1.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-2)" "unprognostic (8.61e-2)" 21.6 26.2 19.9 14.9 24.3 11.3 24.5 18.8 29.6 21.0 15.3 18.4 25.4 17.5 20.1 27.6 17.2 17.9 22.9 19.4 18.7 20.4 32.6 29.0 21.1 18.1 20.5 17.3 23.3 26.8 25.9 17.5 32.6 25.7 22.8 16.6 22.9 18.8 23.4 14.6 18.5 20.7 17.7 16.4 24.3 19.2 26.1 13.9 11.1 39.7 14.9 14.9 16.7 19.5 14.4 33.5 27.2 18.8 17.4 22.8 19.2 13.9 22.5 10.6 14.5 24.7 16.6 14.5 29.7 18.3 22.5 20.5 17.1 12.1 4.9 23.4 21.9 15.2 11.1 17.9 24.6 5.8 8.6 11.2 13.3 18.5 21.8 3.3 14.6 20.1 17.7 17.7 8.6 28.9 12.3 14.6 30.0 8.6 8.1 11.3 13.3 9.0 7.0 13.6 8.2 25.7 11.1 3.5 6.9 11.3 8.0 14.6 19.5 7.0 25.9 18.3 13.7 26.6 14.9 10.3 22.5 8.6 13.9 7.6 12.7 27.2 16.2 14.5 18.0 18.8 19.6 14.3 21.2 19.6 17.0 14.4 20.2 19.6 4.5 17.4 15.6 33.5 22.8 19.2 19.9 24.3 18.8 29.6 18.7 20.4 20.5 17.3 25.7 13.9 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA054064: " "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 17.8 25.1 32.8 14.1 33.1 15.4 26.0 30.7 46.7 24.9 16.9 21.3 15.3 15.2 26.3 29.1 15.3 22.5 18.7 28.3 35.3 49.8 20.6 32.8 17.5 23.0 28.2 35.8 37.6 28.2 23.5 25.7 19.6 26.8 21.5 15.6 19.1 20.9 24.0 22.6 16.8 15.0 20.7 22.7 17.0 15.8 20.6 19.1 16.0 29.1 14.2 19.2 19.2 16.1 21.4 14.3 38.4 20.2 24.1 24.1 18.0 8.7 21.8 11.7 21.1 33.6 25.1 14.3 11.6 19.2 13.8 15.5 11.7 25.0 14.3 16.1 15.7 20.6 18.2 15.0 11.0 13.6 40.0 21.4 18.9 19.8 22.2 16.6 25.6 20.7 30.4 8.3 17.3 19.0 17.5 21.7 21.7 17.7 12.1 17.6 18.0 7.3 14.8 14.8 22.2 27.9 23.2 15.8 14.4 16.0 17.0 23.1 16.1 22.0 15.1 14.6 15.0 9.7 12.7 20.6 30.4 15.5 12.4 20.9 12.0 14.8 20.2 38.4 21.7 19.9 24.1 15.5 17.9 16.5 14.3 21.4 23.9 22.1 34.4 24.1 15.0 12.1 18.0 18.0 32.8 33.1 30.7 46.7 35.3 49.8 28.2 35.8 26.8 19.1 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA047397: " "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favourable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 63.8 46.4 75.3 53.9 62.5 61.0 51.9 52.9 41.7 50.7 50.4 37.7 46.4 41.8 37.8 46.0 25.0 65.6 59.6 56.7 51.4 55.9 78.8 100.0 96.0 48.6 89.4 52.9 55.8 64.1 47.8 46.7 64.0 42.1 44.8 72.3 66.2 104.0 121.7 100.3 74.9 29.8 47.2 70.8 87.1 86.6 24.8 63.0 59.5 43.6 79.5 42.0 132.9 47.8 43.0 77.4 66.5 103.1 74.7 110.1 100.8 55.2 86.5 44.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.6 6.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.2 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 1.4 1.7 0.0 0.0 1.4 0.1 0.1 0.4 0.1 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 TMCO6 "FLJ39769, PRO1580" ENSG00000113119 "Transmembrane and coiled-coil domains 6" Q96DC7 5 140639427-140645408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037473, HPA037474" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA037473: AB_10671049, HPA037474: AB_10671050" "unprognostic (1.03e-1)" "unprognostic (3.40e-1)" "unprognostic (3.95e-2)" "unprognostic (1.38e-2)" "unprognostic (6.10e-3)" "unprognostic (1.31e-2)" "unprognostic (1.65e-1)" "unprognostic (2.11e-1)" "unprognostic (4.89e-2)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (6.24e-2)" "prognostic unfavourable (6.37e-4)" "unprognostic (7.21e-2)" "unprognostic (1.77e-1)" "unprognostic (1.96e-2)" "unprognostic (1.20e-2)" 9.0 15.9 4.0 10.2 6.0 4.9 9.1 9.9 7.9 10.0 10.3 9.6 5.8 5.6 9.6 8.0 9.6 11.8 9.0 5.2 4.4 5.2 6.1 21.4 5.8 9.9 6.1 5.8 13.2 9.9 6.1 7.2 10.5 6.0 7.5 4.3 6.0 16.9 5.9 5.4 7.4 8.5 5.6 6.6 12.0 6.7 19.0 5.2 14.7 8.4 5.5 11.4 7.7 7.7 9.1 7.6 13.4 10.2 4.3 11.3 4.8 3.0 5.9 3.9 5.8 3.9 4.1 14.7 2.4 2.7 3.0 3.2 9.0 5.5 12.0 6.4 1.8 6.0 3.1 6.6 1.4 4.3 11.1 9.2 2.6 6.3 5.4 5.2 3.5 6.8 1.5 3.7 6.0 7.0 3.7 4.0 3.6 5.8 12.0 11.9 4.5 9.2 10.2 8.3 12.1 3.5 2.7 6.9 2.9 6.9 13.0 6.1 10.5 6.1 3.3 0.1 2.9 1.1 0.9 7.0 4.1 5.5 1.9 8.2 3.6 10.6 7.3 5.8 6.1 9.9 6.8 9.1 8.1 6.2 7.6 6.4 11.3 4.8 13.4 4.3 10.2 2.1 8.7 4.8 4.0 6.0 9.9 7.9 4.4 5.2 6.1 5.8 6.0 5.2 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039739 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039739: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favourable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavourable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favourable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.6 23.7 8.5 7.0 20.3 19.6 8.5 10.1 15.4 20.1 19.2 17.6 25.3 10.9 2.8 10.4 14.9 9.8 17.6 15.4 11.8 19.8 8.2 19.0 35.6 17.5 13.1 14.3 17.5 20.1 14.2 20.2 17.5 16.8 21.5 12.5 12.9 14.1 15.1 4.0 26.8 12.3 18.4 19.8 16.7 7.9 11.1 8.8 6.5 0.2 24.1 11.7 25.3 10.5 18.5 12.4 8.0 19.8 22.4 15.4 5.0 19.4 12.5 16.4 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776483-74839779 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavourable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favourable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 11.5 15.5 10.6 11.6 12.1 15.4 7.7 10.5 13.9 8.1 7.9 19.1 9.5 7.6 7.4 8.9 9.3 6.8 9.6 9.0 11.4 8.2 10.9 19.9 14.7 19.0 17.3 9.1 9.4 18.7 21.0 14.7 12.5 13.1 8.0 6.7 10.0 15.1 9.1 7.5 9.7 7.7 9.4 18.5 10.4 8.3 17.4 14.2 7.5 11.7 6.5 10.2 10.6 6.1 4.9 8.8 5.7 7.7 3.9 7.9 5.0 6.2 15.4 8.3 9.3 11.7 7.3 4.9 10.8 11.0 13.9 15.5 12.6 6.8 3.3 3.5 12.3 7.1 8.3 6.0 7.4 2.4 11.7 8.3 6.3 8.7 8.6 13.6 7.7 5.8 6.7 14.1 3.1 9.9 4.8 5.2 9.4 6.0 8.1 5.5 4.5 12.4 5.1 13.1 5.5 6.2 5.5 7.0 9.2 6.0 7.8 8.0 10.0 21.1 7.8 29.4 7.5 11.1 14.0 3.6 3.1 3.8 11.3 14.2 11.1 2.2 7.7 5.7 7.9 6.5 4.0 4.9 7.6 7.2 8.3 1.6 6.3 4.4 3.6 3.9 6.6 8.8 7.5 5.0 10.6 12.1 10.5 13.9 11.4 8.2 17.3 9.1 13.1 14.2 TMEM116 FLJ90167 ENSG00000198270 "Transmembrane protein 116" Q8NCL8 12 111931282-112013185 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in all" 4 "T-cells: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040720 Approved Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA040720: AB_10795623" "unprognostic (8.91e-2)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.71e-1)" "unprognostic (5.48e-2)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (6.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.34e-1)" "unprognostic (3.27e-3)" "unprognostic (9.12e-2)" "prognostic favourable (1.08e-4)" "unprognostic (2.41e-1)" "unprognostic (1.33e-1)" "unprognostic (2.85e-2)" "unprognostic (3.19e-3)" 3.7 10.7 4.4 3.0 8.4 1.0 10.2 6.7 6.6 5.3 4.1 11.2 9.1 9.5 3.9 6.4 4.9 4.2 5.8 20.2 5.3 3.7 26.8 10.0 7.2 3.7 8.7 5.5 4.7 4.1 31.2 9.6 2.7 14.0 4.5 3.4 5.9 12.5 7.0 5.0 11.8 9.0 5.1 8.2 3.9 8.7 20.8 7.3 6.0 6.6 3.6 5.6 8.6 4.5 2.5 3.0 3.0 3.3 1.5 14.9 3.4 4.1 4.4 6.2 6.9 6.2 4.9 4.2 3.4 5.5 4.5 4.9 3.3 3.5 4.8 2.2 2.5 4.3 3.4 3.6 3.9 11.6 2.8 3.1 4.2 4.1 9.9 1.2 0.5 6.0 6.3 5.7 10.0 1.5 5.9 3.9 4.5 6.2 1.8 9.8 7.7 2.9 4.9 2.5 8.3 14.0 23.6 5.9 3.9 3.7 3.2 5.7 11.8 16.3 1.1 4.2 1.3 3.8 1.5 4.7 8.1 4.6 5.9 3.8 5.9 0.8 1.8 3.0 6.5 3.3 5.2 2.1 14.9 12.1 2.1 2.5 7.9 8.6 0.3 1.5 2.4 3.0 13.5 3.4 4.4 8.4 6.7 6.6 5.3 3.7 8.7 5.5 14.0 7.3 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Cell line enhanced" "Detected in some" "AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: " "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8 3.1 2.2 0.1 0.2 3.0 0.0 0.3 0.1 14.7 2.2 0.0 0.0 0.3 0.0 11.8 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 9.8 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 TMEM126A "DKFZp586C1924, OPA7" ENSG00000171202 "Transmembrane protein 126A" Q9H061 11 85647967-85656547 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046648 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA046648: " "unprognostic (3.79e-2)" "unprognostic (4.75e-3)" "unprognostic (2.08e-3)" "unprognostic (1.08e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (8.60e-5)" "unprognostic (8.25e-2)" "unprognostic (6.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.02e-2)" "unprognostic (6.93e-2)" "unprognostic (1.25e-1)" "unprognostic (1.87e-2)" "unprognostic (2.70e-1)" "unprognostic (6.94e-2)" "unprognostic (2.17e-1)" 18.3 17.4 24.9 15.9 23.3 23.7 20.0 13.2 30.0 13.9 16.2 9.5 15.6 19.8 13.2 20.6 17.2 12.5 16.0 44.4 20.9 20.7 22.0 28.5 12.6 15.0 21.8 22.9 13.7 27.7 13.1 19.9 14.1 19.9 14.0 18.3 8.9 25.2 15.7 49.5 12.2 15.1 16.5 18.0 14.1 19.1 21.4 18.8 10.5 16.5 36.4 15.6 14.0 18.7 14.5 19.1 6.3 15.3 8.4 16.5 11.1 15.9 20.1 18.1 12.5 24.4 24.6 14.8 19.0 20.7 28.6 28.3 24.8 25.8 9.2 22.7 22.9 17.6 18.6 20.1 26.5 23.4 10.4 25.3 24.0 27.0 30.7 31.8 21.4 21.2 24.7 25.3 27.0 26.0 17.8 15.2 31.7 21.2 17.2 40.6 18.5 23.0 17.6 18.2 29.8 20.0 21.1 13.0 13.2 17.2 27.2 15.8 33.7 21.9 15.4 27.8 19.8 52.0 21.8 10.2 17.8 24.2 14.6 22.9 32.9 2.9 13.4 6.3 12.5 15.3 16.5 14.5 16.4 14.6 19.1 13.2 15.6 15.4 1.2 8.4 13.1 14.4 14.1 11.1 24.9 23.3 13.2 30.0 20.9 20.7 21.8 22.9 19.9 18.8 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 30.9" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: " "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 TMEM14A "C6orf73, PTD011" ENSG00000096092 "Transmembrane protein 14A" Q9Y6G1 6 52671109-52686588 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072536 Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA072536: " "unprognostic (6.75e-2)" "unprognostic (3.65e-2)" "unprognostic (2.04e-1)" "unprognostic (8.10e-3)" "unprognostic (3.55e-2)" "unprognostic (1.06e-1)" "unprognostic (8.05e-2)" "unprognostic (4.10e-2)" "unprognostic (1.45e-1)" "unprognostic (2.56e-3)" "unprognostic (8.88e-2)" "unprognostic (1.17e-1)" "unprognostic (3.52e-2)" "unprognostic (9.60e-2)" "unprognostic (5.44e-2)" "unprognostic (3.37e-1)" "unprognostic (2.64e-1)" 8.7 24.4 26.7 6.2 32.0 4.3 12.9 25.7 40.0 13.9 12.5 13.5 5.8 18.9 14.3 19.3 18.0 16.3 12.6 8.1 25.5 40.7 25.8 52.7 9.0 8.8 28.3 22.6 21.0 23.8 9.2 12.9 7.9 31.7 19.0 13.3 25.7 9.6 11.7 2.0 6.8 17.4 13.4 29.1 6.5 20.3 8.4 10.7 5.8 14.6 11.1 11.6 14.1 11.6 22.3 14.3 6.4 0.2 4.0 25.7 11.9 68.3 10.4 7.7 21.8 21.2 16.3 6.5 13.8 19.0 12.8 19.9 15.8 17.7 8.4 15.5 17.4 26.2 17.1 23.2 21.6 33.8 14.0 12.4 17.0 25.9 6.9 6.3 15.5 14.6 16.3 14.0 3.1 17.3 2.6 24.0 15.2 13.9 12.3 7.2 4.5 18.1 9.7 11.0 6.6 24.8 13.2 40.2 19.5 15.4 12.4 25.7 19.1 12.2 12.6 17.8 23.9 6.9 22.2 11.6 9.8 12.6 25.0 4.0 14.1 6.4 0.2 6.4 16.4 0.0 10.6 22.3 21.2 17.2 7.8 13.2 16.4 17.5 0.9 4.0 0.0 14.3 25.7 11.9 26.7 32.0 25.7 40.0 25.5 40.7 28.3 22.6 31.7 10.7 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.3;HMC-1: 28.0;Karpas-707: 21.8;U-266/70: 27.3;U-937: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA019184: , HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.0 0.0 0.1 0.0 0.2 3.5 5.5 3.0 11.3 3.3 6.4 0.1 1.6 12.4 1.3 2.8 8.8 0.0 24.3 6.2 0.0 0.0 0.6 0.1 0.0 3.6 9.5 28.0 3.3 11.7 10.7 9.3 8.3 0.0 21.8 0.2 0.8 3.7 2.9 0.6 2.9 0.4 0.0 0.0 19.2 7.4 0.0 0.5 0.7 2.4 0.4 0.3 6.7 3.3 0.4 2.0 0.3 4.2 27.3 9.2 6.8 4.6 21.7 2.5 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;LHCN-M2: 6.7;RPTEC TERT1: 12.2;SCLC-21H: 10.5;SH-SY5Y: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Nucleoplasm, Cytosol" Centrosome "HPA062462: , HPA062797: , HPA070657: , HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.3 0.2 0.9 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.4 0.1 6.1 0.3 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 0.0 0.0 0.4 6.7 0.7 0.2 0.3 4.3 0.1 1.5 2.4 0.2 12.2 0.0 10.5 15.1 0.2 0.2 6.0 0.4 1.1 0.1 0.2 0.4 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.5 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057160: " "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favourable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.0 3.5 4.8 16.7 8.8 8.1 8.1 5.9 5.0 7.4 2.8 13.2 2.5 5.1 8.5 5.5 3.2 6.4 2.2 6.2 7.4 5.1 8.8 2.8 9.7 2.7 9.6 12.4 7.8 4.4 3.0 3.1 5.2 20.7 4.3 10.8 6.8 11.1 2.2 17.0 4.8 2.1 7.1 4.7 3.1 9.5 8.4 5.7 3.6 5.4 15.8 7.4 4.0 9.2 2.1 10.6 6.2 14.1 3.7 4.8 8.9 5.9 7.4 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Group enriched" "Detected in some" 17 "HSkMC: 117.6;THP-1: 37.5" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: " "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 117.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 37.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 TMEM177 MGC10993 ENSG00000144120 "Transmembrane protein 177" Q53S58 2 119679167-119686507 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036689, HPA053816" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA036689: , HPA053816: " "unprognostic (1.24e-1)" "unprognostic (2.65e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (9.81e-3)" "unprognostic (2.05e-3)" "unprognostic (3.17e-2)" "unprognostic (8.05e-2)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.07e-1)" "unprognostic (4.90e-1)" "unprognostic (6.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" 3.5 9.5 10.0 6.0 11.4 1.3 8.8 10.4 16.9 6.7 13.5 9.0 6.1 20.1 8.1 11.9 6.7 13.5 9.4 9.2 9.5 8.7 15.2 27.9 4.6 7.6 7.6 9.8 10.5 10.4 7.7 19.2 4.1 6.6 7.2 11.7 7.3 9.1 9.0 13.5 8.3 16.5 8.1 6.6 5.1 7.7 9.0 8.8 6.7 7.3 4.9 6.4 6.3 5.7 7.4 4.9 2.1 2.3 5.7 15.9 5.3 11.0 9.8 8.6 8.3 2.4 2.3 4.4 4.1 5.2 12.3 9.4 24.6 6.2 18.3 10.3 3.6 6.7 13.9 14.2 7.1 8.6 25.8 9.4 5.8 27.2 5.2 5.9 7.0 6.4 10.2 9.7 6.4 7.8 14.5 2.4 6.6 9.1 10.3 11.7 22.0 14.9 9.4 8.4 10.8 12.2 5.8 17.1 10.0 5.6 11.6 12.8 8.8 10.2 6.3 6.1 14.9 4.6 8.1 2.5 1.8 11.2 2.3 7.4 10.9 0.0 2.3 2.1 7.7 1.9 7.8 6.0 6.6 7.6 4.3 7.4 15.9 9.8 0.7 5.7 1.1 4.9 6.2 5.3 10.0 11.4 10.4 16.9 9.5 8.7 7.6 9.8 6.6 8.8 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell line enriched" "Detected in some" 5 "AF22: 55.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA052128: " "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.0 0.0 0.6 0.0 0.0 0.4 0.1 10.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA045861 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA045861: " "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.4 1.1 1.2 1.0 1.3 0.3 1.1 1.7 1.8 1.4 1.0 0.5 1.5 1.0 0.6 2.3 1.8 1.1 0.8 40.3 1.2 1.9 1.4 1.7 0.6 0.8 1.2 0.5 1.0 1.1 1.5 6.8 0.8 2.8 1.9 1.0 0.9 3.8 1.2 53.9 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.4 1.8 2.0 37.8 4.0 1.2 0.7 4.4 3.1 0.3 0.3 2.4 4.1 1.1 4.8 2.8 2.1 6.5 2.7 2.6 7.6 2.6 2.3 2.7 3.8 9.0 6.8 4.0 9.1 0.9 2.8 2.3 3.7 5.6 9.0 1.8 6.0 1.3 5.7 3.1 5.4 4.8 3.3 6.7 4.2 3.8 0.3 4.2 1.6 2.7 3.5 2.9 5.2 3.6 2.9 3.1 5.5 3.8 3.7 4.2 5.4 1.9 3.5 3.9 8.5 3.2 2.9 0.2 4.3 3.1 3.3 3.3 3.9 9.9 3.3 4.4 9.0 6.4 0.0 0.0 0.3 3.9 0.3 3.2 4.4 2.8 2.2 1.3 1.9 3.8 4.1 0.1 2.4 0.3 3.1 0.8 1.1 1.2 1.3 1.7 1.8 1.2 1.9 1.2 0.5 2.8 0.4 TMEM183A C1orf37 ENSG00000163444 "Transmembrane protein 183A" Q8IXX5 1 203007386-203024848 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072607 Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA072607: " "unprognostic (2.94e-3)" "unprognostic (1.60e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (3.41e-2)" "unprognostic (5.99e-2)" "prognostic unfavourable (2.62e-4)" "unprognostic (6.46e-2)" "unprognostic (3.21e-2)" "unprognostic (4.82e-3)" "unprognostic (5.28e-2)" "unprognostic (7.84e-2)" "unprognostic (4.83e-2)" "unprognostic (6.01e-3)" "unprognostic (9.55e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" 12.2 12.6 22.4 13.5 20.8 50.1 17.2 31.9 30.4 14.4 21.1 12.4 6.7 20.0 13.6 15.2 19.3 12.0 15.0 11.5 19.8 21.0 16.0 21.1 13.4 20.2 19.3 14.8 15.0 29.9 12.0 8.2 10.9 20.8 15.0 23.6 11.1 22.2 13.6 8.8 16.1 18.8 17.6 12.4 14.5 15.8 27.7 12.3 23.3 20.5 14.8 17.7 15.3 20.7 17.4 27.2 35.6 24.4 26.4 23.7 24.3 12.7 12.4 15.9 26.1 21.1 15.9 26.3 12.8 12.7 14.9 13.1 15.0 13.5 31.8 9.3 16.5 16.1 21.3 18.0 12.4 10.3 25.9 15.7 14.5 16.5 15.3 28.1 13.8 15.5 20.0 12.2 24.8 18.7 32.2 11.6 13.8 28.4 22.9 28.9 43.7 19.8 17.7 27.2 25.6 23.0 12.5 20.5 25.7 19.2 32.0 18.4 22.9 22.2 13.8 10.1 14.1 17.2 14.0 11.8 18.9 24.7 11.1 21.9 10.6 21.1 24.4 35.6 18.1 20.4 17.9 16.6 20.5 20.5 27.2 17.4 23.7 19.3 21.3 26.4 18.5 19.5 21.2 24.3 22.4 20.8 31.9 30.4 19.8 21.0 19.3 14.8 20.8 12.3 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell line enhanced" "Detected in many" "MCF7: 14.9;RT4: 16.9;SCLC-21H: 17.4;SK-BR-3: 27.0;T-47d: 23.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053790, HPA071312" Uncertain Approved Nucleoplasm Nucleoplasm "HPA053790: , HPA071312: " "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavourable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavourable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.5 6.4 0.0 0.0 0.0 0.0 2.1 0.3 0.1 0.4 0.0 8.7 11.4 0.2 3.4 0.1 7.4 0.0 4.3 0.1 0.1 0.2 0.0 5.9 4.0 0.1 0.0 0.0 0.0 4.2 0.1 3.8 0.0 0.1 0.0 0.0 14.9 0.0 0.0 0.3 8.4 0.2 0.0 4.6 3.3 16.9 17.4 0.0 2.8 27.0 0.0 23.9 0.0 0.0 0.0 3.6 4.5 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.0 14.9 8.8 6.9 17.6 14.2 20.4 18.5 26.3 15.2 13.5 10.9 7.9 3.2 14.5 27.5 21.1 7.9 18.2 10.3 11.6 14.2 6.4 10.9 9.0 18.5 5.0 9.0 11.8 16.1 17.8 20.0 18.9 4.1 11.4 13.2 9.7 3.2 4.3 7.1 13.7 5.5 7.9 3.2 11.2 18.9 19.2 3.4 13.9 20.3 9.8 11.1 3.7 27.9 15.5 15.9 13.6 11.2 23.9 58.9 2.6 22.5 3.7 13.3 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054013: " "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavourable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favourable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.1 14.3 18.2 13.9 24.9 24.3 11.9 17.1 20.1 12.8 14.8 11.8 17.5 8.5 8.6 13.3 11.0 14.7 13.1 14.1 18.9 8.5 11.0 11.1 8.5 19.2 14.6 16.4 18.1 17.7 14.0 14.7 16.4 14.0 24.0 17.8 13.7 12.7 5.3 11.7 8.4 12.7 6.3 14.7 14.2 17.1 14.2 18.3 9.3 14.6 14.9 14.5 9.2 16.1 16.2 8.8 13.2 10.9 26.3 34.4 11.4 19.0 8.8 17.5 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 TMEM192 FLJ38482 ENSG00000170088 "Transmembrane protein 192" Q8IY95 4 165070608-165208549 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014717, HPA024110" Enhanced Supported Nucleoplasm,Endosomes,Lysosomes "Endosomes, Lysosomes" Nucleoplasm "HPA014717: AB_1844373, HPA024110: AB_2204898" "prognostic unfavourable (9.52e-4)" "unprognostic (5.38e-3)" "unprognostic (9.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.55e-2)" "unprognostic (2.91e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (3.10e-1)" "unprognostic (3.27e-2)" "unprognostic (5.06e-2)" "prognostic favourable (2.33e-14)" "unprognostic (2.09e-2)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (9.30e-2)" 12.6 14.4 11.3 7.4 13.6 5.3 12.1 12.0 11.9 11.6 9.7 10.5 6.2 8.3 9.7 10.0 7.8 10.1 8.9 10.4 9.9 9.4 40.7 37.7 9.1 8.5 13.0 10.6 21.8 21.3 20.3 14.2 9.3 13.1 19.4 11.7 24.7 11.3 7.8 19.0 7.4 8.2 8.6 13.3 10.8 10.5 8.6 11.3 3.1 22.9 5.2 6.6 12.1 7.3 18.2 12.0 3.4 12.5 13.4 12.8 7.7 6.2 9.5 3.4 8.7 9.0 3.2 8.0 9.5 14.1 10.0 11.2 5.5 10.3 13.8 5.7 6.1 5.6 12.8 9.8 11.6 8.9 6.6 7.6 7.1 6.2 23.0 18.8 10.3 11.6 20.9 8.9 18.3 8.1 13.0 23.2 12.2 13.6 3.2 5.6 7.1 8.1 7.4 3.0 12.5 8.1 9.2 7.3 7.7 14.9 23.7 15.1 11.5 8.7 6.1 4.4 5.4 13.8 10.8 22.8 30.2 19.2 10.6 10.4 17.5 2.0 12.5 3.4 9.7 10.9 12.8 18.2 7.5 9.9 11.6 15.2 8.3 10.0 1.4 13.4 5.8 12.0 6.0 7.7 11.3 13.6 12.0 11.9 9.9 9.4 13.0 10.6 13.1 11.3 TMEM205 "MBC3205, UNQ501" ENSG00000105518 "Transmembrane protein 205" Q6UW68 19 11342776-11346518 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041504 Approved Approved "Nucleoplasm,Nuclear membrane,Endoplasmic reticulum" "Endoplasmic reticulum" "Nucleoplasm, Nuclear membrane" "HPA041504: AB_10795595" "unprognostic (2.54e-2)" "unprognostic (2.60e-2)" "unprognostic (7.19e-2)" "unprognostic (1.57e-2)" "unprognostic (6.83e-2)" "unprognostic (1.80e-1)" "unprognostic (5.04e-3)" "unprognostic (3.77e-2)" "unprognostic (1.01e-2)" "unprognostic (5.56e-3)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" "unprognostic (8.10e-2)" "unprognostic (5.78e-2)" "unprognostic (8.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.45e-1)" 15.8 40.5 25.7 10.6 29.4 14.5 19.3 16.2 36.3 30.3 19.2 19.8 34.6 18.7 15.5 29.7 14.6 25.9 27.8 31.7 24.5 23.6 36.1 90.8 19.4 22.9 25.2 21.9 21.7 50.5 52.4 21.7 17.5 20.6 24.3 11.3 31.8 28.6 28.4 30.0 15.0 18.2 16.9 21.4 14.2 17.2 23.1 13.2 11.1 46.6 15.4 13.3 21.3 13.1 21.9 43.1 11.0 71.0 10.4 14.8 32.1 19.0 47.2 5.8 19.8 11.6 14.0 11.0 7.2 16.8 15.9 12.4 14.3 6.1 17.1 44.1 14.6 19.5 8.4 21.8 10.7 20.0 8.0 4.5 16.4 23.5 29.3 7.7 14.6 13.2 22.3 10.2 17.1 19.1 13.7 73.2 9.8 48.1 11.5 21.4 10.4 36.2 10.9 9.0 45.1 38.6 34.5 10.5 16.0 7.6 31.5 17.6 27.4 22.4 11.2 20.0 7.6 21.8 16.1 43.6 43.5 10.1 19.3 34.5 15.3 5.2 71.0 7.1 14.6 29.8 14.8 21.9 12.2 12.8 43.1 18.4 9.8 11.8 11.0 10.4 17.5 31.0 14.6 32.1 25.7 29.4 16.2 36.3 24.5 23.6 25.2 21.9 20.6 13.2 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.1 12.9 7.7 10.6 6.2 7.1 10.6 8.2 7.1 9.2 7.7 11.3 18.6 11.4 20.1 5.8 23.1 9.3 10.1 5.3 18.0 17.5 8.4 14.6 13.4 11.5 10.3 10.0 7.7 10.2 6.0 7.6 7.0 12.8 8.5 6.8 22.0 10.3 23.0 15.3 15.7 12.9 9.4 25.3 14.2 9.7 13.3 17.6 8.5 17.4 21.5 26.0 9.7 7.4 11.1 13.4 10.1 9.7 17.6 14.0 13.0 13.1 9.3 11.5 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 TMEM233 IFITMD2 ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593459-119643066 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 88.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.3;RH-30: 6.0;U-2197: 9.0;U-87 MG: 36.2" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.6 0.3 0.8 0.0 0.4 0.0 0.6 0.1 8.8 0.2 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.2 1.0 0.7 0.2 0.5 0.5 0.3 0.6 0.2 0.1 1.4 0.6 0.1 1.7 0.4 0.0 0.4 0.4 0.1 0.7 0.5 0.3 88.0 0.1 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.1 11.1 5.2 0.3 0.4 1.8 0.3 0.3 0.7 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 11.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.7 0.6 0.1 0.3 0.1 0.1 0.8 0.4 0.1 1.5 0.2 0.5 0.1 1.4 0.4 0.0 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA029105: , HPA072613: " "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.1 6.9 11.6 8.9 14.3 18.0 17.7 7.0 5.1 5.1 5.2 5.2 22.3 5.5 11.9 8.9 7.6 4.7 5.7 5.4 9.0 8.3 1.4 2.2 7.2 6.5 6.8 7.3 11.6 26.4 4.5 3.9 4.5 4.0 12.0 5.1 14.6 5.5 5.0 6.3 22.6 6.8 1.4 4.7 7.0 6.0 4.1 6.7 6.5 16.1 6.9 22.9 4.5 6.5 4.0 6.9 6.8 3.9 8.3 11.7 0.4 10.1 6.9 3.3 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 TMEM255B "FAM70B, MGC20579" ENSG00000184497 "Transmembrane protein 255B" Q8WV15 13 113759240-113816995 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 15.5;HUVEC TERT2: 20.1;PC-3: 20.4;RPMI-8226: 13.0;TIME: 18.8;U-87 MG: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 7 "granulocytes: 17.0;monocytes: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA043334 Approved Approved Nucleoplasm Nucleoplasm "HPA043334: AB_10795982" "unprognostic (2.20e-1)" "unprognostic (2.57e-3)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (4.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.99e-1)" "unprognostic (4.49e-3)" "unprognostic (3.00e-2)" "unprognostic (9.39e-2)" "prognostic unfavourable (4.12e-5)" "unprognostic (4.65e-2)" "unprognostic (1.84e-1)" "unprognostic (4.00e-1)" "unprognostic (2.83e-1)" 18.5 6.6 3.9 7.1 4.5 1.5 11.8 2.0 4.7 11.1 3.9 2.3 4.3 3.5 10.1 5.3 3.9 6.6 7.5 7.3 6.5 3.7 9.0 6.6 11.7 7.9 5.4 2.1 4.6 4.7 3.1 8.0 2.4 6.1 8.8 3.2 3.3 3.8 5.1 4.6 6.0 4.5 10.4 4.9 9.5 4.4 4.6 4.0 0.1 12.4 2.4 3.7 8.1 29.9 1.5 1.3 17.0 4.8 0.0 0.0 1.0 5.2 0.0 0.3 0.0 1.4 0.0 0.0 2.5 5.6 2.9 1.8 0.2 0.1 0.1 0.0 3.9 0.7 0.5 0.3 1.2 0.0 0.6 0.1 0.1 0.0 0.9 1.4 15.5 1.0 1.3 6.2 2.4 20.1 0.0 0.1 6.2 0.1 0.7 0.4 0.6 20.4 0.9 0.4 13.0 2.8 0.2 1.2 2.8 0.1 0.7 0.0 0.3 4.1 18.8 0.8 5.7 0.3 0.8 0.0 0.0 1.0 21.5 1.4 0.1 17.0 4.8 0.6 0.0 4.5 0.0 0.8 0.0 0.0 1.3 1.5 0.0 0.0 2.2 0.0 3.2 0.0 0.0 1.0 3.9 4.5 2.0 4.7 6.5 3.7 5.4 2.1 6.1 4.0 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favourable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.3 5.2 4.0 8.5 14.3 11.8 7.9 7.9 8.8 5.2 6.2 2.4 5.5 6.0 7.8 5.9 8.6 9.3 5.7 8.2 7.4 4.7 3.9 2.4 3.2 10.1 5.4 9.3 14.5 10.4 2.9 10.1 6.8 4.7 6.5 6.8 4.9 2.8 2.0 3.7 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.4 5.2 8.2 8.4 9.5 10.6 4.0 7.9 3.9 3.9 3.1 3.5 6.6 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 TMEM267 "C5orf28, FLJ21657" ENSG00000151881 "Transmembrane protein 267" Q0VDI3 5 43444252-43483893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059946 Approved Nucleoplasm Nucleoplasm "HPA059946: " "unprognostic (8.20e-2)" "unprognostic (2.02e-2)" "unprognostic (7.60e-2)" "unprognostic (8.11e-3)" "unprognostic (1.57e-1)" "unprognostic (2.05e-1)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.82e-2)" "unprognostic (4.77e-3)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.25e-1)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-2)" "unprognostic (4.40e-3)" 9.9 8.1 9.0 7.8 9.4 3.9 14.2 13.8 12.5 11.7 7.7 5.7 6.8 7.1 11.1 11.7 9.4 8.9 7.5 8.3 6.3 8.5 12.1 7.1 8.1 9.0 9.9 11.2 10.9 17.3 9.9 23.0 6.3 11.6 9.6 9.7 8.9 12.3 9.9 7.1 9.8 8.6 9.2 9.4 9.5 9.1 7.9 7.9 6.1 36.8 7.6 8.8 10.4 9.0 11.6 9.7 9.0 11.6 13.7 18.0 11.0 9.9 9.2 4.9 11.0 9.4 18.8 5.7 14.3 8.9 7.8 5.7 4.0 21.5 11.1 19.8 14.6 8.4 4.7 6.5 11.3 13.3 7.7 6.4 19.8 4.4 17.1 13.1 9.4 15.4 18.6 11.6 16.6 8.7 8.4 20.7 17.0 8.6 7.2 7.7 2.2 9.1 4.9 12.3 13.5 9.7 10.2 6.9 4.9 28.7 16.4 14.0 23.9 9.5 11.2 12.7 10.3 7.8 7.1 8.9 12.7 10.9 9.5 19.0 11.1 9.0 8.6 3.1 12.3 10.0 18.0 11.6 16.4 13.0 9.7 9.6 16.9 14.0 1.6 13.7 11.6 7.5 13.0 11.0 9.0 9.4 13.8 12.5 6.3 8.5 9.9 11.2 11.6 7.9 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 42.3;CAPAN-2: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA051024: " "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 23.1 20.6 6.4 10.7 8.0 5.3 24.4 5.7 7.9 23.7 13.8 9.3 12.6 7.4 22.3 19.0 15.2 19.7 26.1 17.6 6.4 5.8 27.5 24.4 25.3 28.0 9.9 7.6 20.0 20.5 9.2 14.6 29.5 9.6 29.6 12.6 26.6 14.2 17.4 10.5 7.2 16.0 18.3 10.2 19.0 12.9 21.4 7.8 17.9 48.7 9.8 18.4 22.0 19.1 24.9 37.3 29.4 26.8 36.4 53.1 38.4 9.0 6.9 1.7 2.7 42.3 25.1 3.4 9.9 16.5 7.1 9.6 6.8 40.0 4.6 15.3 10.1 9.8 3.0 8.4 5.8 17.0 4.6 9.6 3.6 8.0 23.3 6.4 10.1 24.9 7.9 6.3 13.4 13.7 6.2 13.2 12.3 5.5 4.7 6.4 7.5 4.9 6.3 13.6 1.4 18.9 8.9 4.2 1.4 15.0 0.2 13.2 3.7 9.7 14.0 9.5 8.8 8.3 5.6 7.6 4.3 3.1 9.5 10.4 7.9 29.4 24.5 25.4 47.3 26.8 50.7 24.9 52.3 51.9 16.8 21.0 46.1 46.3 7.6 36.4 21.9 37.3 53.1 38.4 6.4 8.0 5.7 7.9 6.4 5.8 9.9 7.6 9.6 7.8 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Group enriched" "Detected in some" 5 "EFO-21: 13.1;Hep G2: 34.4;RPTEC TERT1: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: " "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.4 0.3 0.1 2.1 0.2 0.5 0.1 0.0 0.0 0.0 5.3 3.0 0.0 13.1 1.6 0.8 1.4 0.0 0.0 0.0 1.3 0.4 2.0 34.4 2.9 0.0 0.0 4.8 0.0 0.0 0.0 2.8 0.1 5.2 0.0 0.3 0.0 0.3 2.5 0.1 0.0 0.0 4.5 28.8 2.3 0.4 0.2 0.1 1.4 0.0 0.6 0.8 1.8 0.0 5.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661127-16690029 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 158.8" "Cell line enhanced" "Detected in many" "Daudi: 12.1;U-266/70: 12.2;U-698: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favourable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavourable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favourable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 1.3 1.6 3.6 1.1 7.9 2.3 1.2 5.1 12.2 1.3 1.4 2.1 3.1 1.3 1.1 6.6 3.5 1.8 1.0 5.4 3.0 3.8 2.0 2.7 2.1 1.3 5.2 3.7 1.2 1.3 1.7 2.2 0.9 4.8 2.9 1.5 8.3 2.7 2.4 158.8 1.0 1.1 1.1 1.9 1.0 5.3 1.6 1.4 0.0 1.8 30.1 1.9 1.1 0.4 3.9 0.5 20.3 2.9 2.1 0.5 0.6 3.0 0.6 0.8 4.7 2.6 0.3 0.4 1.1 0.6 0.7 1.5 0.9 4.4 12.1 1.9 0.2 2.5 6.2 1.3 0.7 0.8 1.8 0.0 1.8 1.0 0.7 0.1 0.2 1.1 4.8 0.9 0.5 0.3 0.1 1.1 0.5 4.6 0.1 1.2 1.2 7.2 6.3 1.1 3.2 4.6 2.3 7.8 5.4 3.3 0.4 1.5 2.3 1.0 0.0 0.9 2.3 2.9 0.5 12.2 8.8 20.3 1.1 7.2 0.9 20.3 2.9 8.2 0.0 1.1 0.0 2.8 0.4 0.0 0.2 3.9 0.1 0.1 1.6 2.1 0.7 0.5 0.5 0.6 3.6 7.9 5.1 12.2 3.0 3.8 5.2 3.7 4.8 1.4 TMEM39A FLJ10902 ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119429500-119468830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 13.7 12.7 5.6 13.0 8.8 9.3 13.2 10.5 6.4 18.3 8.7 10.4 27.0 9.6 20.8 18.3 10.9 13.5 13.4 14.4 5.1 3.8 9.7 16.7 15.2 11.0 8.9 2.4 17.6 37.5 8.3 47.9 19.5 7.6 13.9 9.5 12.1 30.2 30.0 8.7 10.7 10.6 9.6 8.4 11.8 11.5 15.4 8.0 11.3 17.4 9.5 19.2 11.9 13.0 8.6 18.1 11.5 11.2 11.9 13.8 9.2 15.7 7.9 14.1 10.0 28.2 26.4 14.9 15.6 26.8 16.9 23.6 13.9 12.1 6.6 14.8 14.4 16.4 14.6 6.2 18.7 6.5 5.6 8.1 6.0 14.1 19.0 15.0 12.2 16.0 10.3 12.3 30.0 11.2 8.0 19.1 9.4 7.3 7.9 5.5 13.6 15.8 8.6 7.4 14.2 4.9 6.1 6.1 8.6 14.7 8.5 21.1 8.1 14.1 9.6 10.5 10.0 7.3 9.8 22.0 6.2 15.7 15.7 10.9 14.9 11.5 11.2 8.0 13.5 6.2 13.8 8.5 8.4 11.3 13.2 8.6 7.0 7.1 4.7 11.9 4.8 18.1 9.8 9.2 5.6 8.8 10.5 6.4 5.1 3.8 8.9 2.4 7.6 8.0 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: , HPA059790: " "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavourable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.6 7.5 5.0 6.2 8.0 8.6 14.8 8.0 7.0 10.1 7.4 19.5 8.2 6.4 15.3 7.4 14.4 13.8 8.5 10.2 10.7 12.7 11.1 4.5 19.6 8.9 12.0 6.3 8.0 12.8 9.1 10.5 7.7 19.7 16.0 6.4 8.0 7.3 6.9 8.3 11.9 7.4 7.7 11.7 8.7 15.2 5.1 6.5 6.9 17.7 12.1 21.1 9.4 5.6 6.0 7.5 12.5 16.6 23.7 36.0 12.9 9.1 7.2 7.2 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815819-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.6" "Cell line enhanced" "Detected in some" "CACO-2: 14.5;Hep G2: 14.8;PC-3: 18.7;RT4: 49.6;T-47d: 14.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1" "Group enriched" "Detected in many" 12 "granulocytes: 13.1;T-cells: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.2 0.2 0.6 9.0 0.9 0.0 4.0 0.3 0.7 6.6 50.3 0.5 1.7 40.4 1.2 4.1 29.5 6.5 9.3 0.4 1.2 0.6 9.6 13.2 4.5 1.9 0.4 0.7 1.4 3.1 0.0 2.9 1.2 2.3 4.0 29.0 0.3 7.3 2.4 0.2 10.9 106.6 1.5 0.5 0.6 7.4 0.7 0.2 0.5 9.1 21.9 19.9 9.4 10.9 0.6 0.4 13.1 0.6 0.7 4.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 14.5 6.3 0.1 2.7 0.0 8.4 0.0 0.0 0.0 0.0 0.2 0.1 0.8 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.5 0.0 18.7 0.1 0.0 0.9 8.0 49.6 1.5 0.2 0.0 4.1 0.0 14.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.1 0.3 0.2 0.3 0.2 3.6 0.9 0.0 0.6 4.3 0.7 13.1 0.7 0.2 0.4 0.6 1.3 0.6 0.9 0.3 0.7 1.2 0.6 0.4 0.7 2.3 0.2 TMEM51 "C1orf72, FLJ10199" ENSG00000171729 "Transmembrane protein 51" Q9NW97 1 15152532-15220480 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "classical monocyte: 1.8;intermediate monocyte: 2.3;myeloid DC: 1.7;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 23 "dendritic cells: 1.7;monocytes: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014547, HPA019441" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA014547: AB_1858121, HPA019441: AB_2670142" "unprognostic (1.21e-1)" "unprognostic (1.84e-1)" "unprognostic (8.74e-2)" "unprognostic (1.89e-2)" "unprognostic (3.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.47e-2)" "unprognostic (7.81e-3)" "unprognostic (7.84e-2)" "unprognostic (1.39e-1)" "unprognostic (3.00e-2)" "unprognostic (8.91e-2)" "prognostic favourable (8.16e-8)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (5.58e-2)" "unprognostic (1.67e-3)" 4.6 14.1 4.7 7.7 4.4 0.4 7.0 14.2 5.1 9.7 22.4 4.5 14.3 15.9 5.3 7.6 12.0 7.2 25.3 3.7 5.0 2.2 23.5 3.9 10.4 7.4 4.1 3.4 15.4 36.7 14.5 5.2 7.5 4.2 12.3 7.8 16.1 7.5 15.5 1.2 5.3 22.9 8.9 5.7 7.1 18.9 3.4 3.9 2.0 3.8 12.3 8.4 18.5 22.2 0.0 1.7 0.0 2.8 0.0 0.0 0.3 18.9 10.1 5.8 1.4 1.0 2.2 0.0 2.2 9.2 6.8 9.2 13.3 21.4 0.0 7.2 1.4 18.4 2.0 7.1 3.9 0.0 5.1 0.4 0.5 13.2 8.5 0.0 18.6 0.7 6.4 8.8 9.7 6.2 2.9 0.0 3.4 6.5 0.0 0.0 1.0 3.9 2.6 3.7 3.3 17.2 19.7 0.9 17.3 1.8 7.5 18.2 1.0 2.0 4.3 7.1 6.2 3.1 6.8 0.2 0.2 0.0 7.0 0.2 8.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 4.7 4.4 14.2 5.1 5.0 2.2 4.1 3.4 4.2 3.9 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell line enhanced" "Detected in some" "AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010661, HPA070701" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA010661: AB_1078338, HPA070701: " "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavourable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favourable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.3 24.7 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 0.0 0.0 0.1 0.5 0.8 0.1 0.0 1.8 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.0 1.4 0.0 0.0 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185146 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: , HPA062359: " "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favourable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 11.6 8.6 7.6 9.5 12.0 9.6 28.6 21.1 13.9 10.4 15.5 15.1 9.8 15.5 9.9 15.4 10.7 9.4 14.0 7.3 7.8 9.8 9.5 12.3 13.0 10.5 10.2 8.2 6.1 12.0 16.5 10.8 12.3 12.7 8.6 17.6 11.9 16.9 9.2 14.5 8.5 17.3 11.0 11.9 9.6 12.0 3.1 7.8 4.6 10.5 8.9 13.7 13.2 9.0 2.5 4.6 2.6 1.8 3.8 5.0 0.9 7.4 4.0 1.8 3.5 2.2 3.0 19.3 7.2 9.1 12.9 17.9 6.4 14.8 7.6 4.2 6.8 14.4 7.7 5.7 4.7 8.9 3.4 6.2 8.9 4.7 5.0 6.4 5.6 2.1 6.8 5.6 3.9 7.0 5.4 6.6 1.4 1.7 0.0 1.5 0.6 1.7 3.8 2.0 4.0 6.8 9.5 11.7 5.0 5.7 14.2 3.4 7.6 6.5 4.1 6.4 2.6 4.5 11.6 5.5 33.2 5.4 5.9 7.1 5.5 1.5 1.8 2.6 2.4 0.8 2.9 1.9 3.2 2.7 2.0 2.5 1.9 2.6 0.5 3.8 1.0 4.6 5.0 0.9 7.6 12.0 21.1 13.9 7.8 9.8 10.2 8.2 12.7 7.8 TMEM65 ENSG00000164983 "Transmembrane protein 65" Q6PI78 8 124306189-124372692 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025020 Uncertain Approved Nucleoplasm Nucleoplasm "HPA025020: AB_2205178" "prognostic unfavourable (2.17e-4)" "unprognostic (3.52e-2)" "unprognostic (2.97e-2)" "prognostic unfavourable (1.05e-4)" "unprognostic (1.24e-1)" "unprognostic (7.74e-2)" "prognostic unfavourable (2.56e-4)" "unprognostic (2.26e-2)" "unprognostic (1.84e-1)" "unprognostic (4.71e-2)" "unprognostic (7.95e-2)" "unprognostic (8.26e-2)" "unprognostic (5.67e-2)" "unprognostic (8.25e-2)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (3.78e-1)" 6.8 5.7 16.2 7.8 10.7 5.3 8.5 13.2 19.3 8.2 9.5 9.3 2.9 23.9 8.3 4.2 12.0 5.1 8.0 28.5 11.9 15.2 8.1 4.7 6.1 6.9 11.6 12.5 7.5 8.9 18.4 5.3 5.7 11.9 5.1 7.7 4.5 13.1 4.1 19.8 16.0 10.1 6.4 13.1 7.5 4.9 3.8 10.5 7.6 9.0 12.9 7.3 5.7 9.7 1.6 1.2 2.4 0.7 2.4 1.7 0.4 4.9 3.5 7.4 2.6 2.3 4.2 0.6 2.9 2.9 4.5 5.3 0.5 2.0 4.7 2.9 5.1 2.3 3.8 2.7 5.5 14.6 3.8 3.2 3.0 1.0 6.4 2.1 3.2 3.0 5.3 6.6 5.3 10.2 1.4 4.0 5.5 3.8 1.5 0.8 1.9 4.9 0.9 7.0 2.8 4.8 2.2 6.0 3.6 10.7 27.5 4.9 2.4 2.7 6.6 3.9 9.3 12.8 4.9 2.8 2.0 1.9 5.5 15.7 5.5 2.4 0.7 1.4 1.3 0.6 1.5 1.6 1.6 1.6 0.5 1.3 1.4 1.1 2.3 2.4 0.6 1.2 1.7 0.4 16.2 10.7 13.2 19.3 11.9 15.2 11.6 12.5 11.9 10.5 TMEM69 "C1orf154, FLJ21029" ENSG00000159596 "Transmembrane protein 69" Q5SWH9 1 45687214-45694443 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026993 Approved Approved Nucleoplasm Nucleoplasm "HPA026993: AB_10601824" "prognostic favourable (2.24e-4)" "unprognostic (2.47e-1)" "unprognostic (5.25e-2)" "unprognostic (1.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.01e-1)" "prognostic unfavourable (3.66e-8)" "unprognostic (4.05e-2)" "unprognostic (1.59e-3)" "unprognostic (5.17e-2)" "unprognostic (3.98e-3)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (1.49e-2)" "unprognostic (1.96e-1)" "unprognostic (4.41e-3)" "unprognostic (3.65e-2)" 6.0 9.0 7.0 5.8 11.0 2.6 12.2 6.8 13.8 5.3 7.5 7.3 2.9 8.3 5.6 9.9 12.1 6.0 5.6 11.6 6.3 6.2 8.4 7.6 8.3 8.8 6.9 5.0 8.9 7.8 10.7 5.5 6.8 10.8 7.0 8.4 4.7 7.9 5.7 8.2 7.7 8.2 6.2 9.1 7.8 5.7 12.1 9.4 10.1 7.5 8.8 9.3 8.4 11.1 8.7 10.9 5.4 15.6 4.6 8.2 6.1 12.9 3.2 9.0 7.3 6.9 8.9 22.1 8.5 10.0 14.3 14.0 8.9 6.8 15.7 5.9 8.1 17.6 7.2 19.3 14.8 10.9 8.4 32.1 7.9 9.6 12.3 15.3 15.8 10.3 20.1 13.2 8.4 11.8 19.2 10.9 9.0 4.7 8.4 11.0 21.3 8.7 13.3 8.2 15.9 15.2 13.7 10.4 9.4 8.9 24.2 14.5 12.6 15.7 8.8 6.6 11.4 14.5 10.2 8.7 10.8 12.1 9.2 11.6 9.7 5.0 12.2 5.0 5.1 12.7 6.4 8.7 7.2 5.7 10.9 8.3 8.2 6.3 5.4 4.6 15.6 6.8 6.8 6.1 7.0 11.0 6.8 13.8 6.3 6.2 6.9 5.0 10.8 9.4 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;Hep G2: 9.7;K-562: 16.4;Karpas-707: 7.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favourable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 4.8 2.7 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.7 0.7 0.1 0.9 0.0 0.3 3.6 0.5 0.1 0.0 4.6 1.1 0.0 9.7 0.0 0.0 1.3 0.0 1.0 0.0 0.2 0.1 16.4 7.4 0.0 0.1 0.1 0.1 3.3 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 3.2 0.1 0.1 3.2 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 TMEM86A FLJ90119 ENSG00000151117 "Transmembrane protein 86A" Q8N2M4 11 18693122-18704785 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.5" "Group enriched" "Detected in many" 12 "dendritic cells: 6.5;monocytes: 3.7;T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057119 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA057119: " "unprognostic (1.25e-1)" "unprognostic (1.09e-3)" "unprognostic (8.08e-3)" "unprognostic (1.89e-1)" "unprognostic (2.53e-1)" "unprognostic (1.10e-1)" "unprognostic (4.05e-2)" "unprognostic (2.94e-1)" "unprognostic (3.73e-1)" "unprognostic (1.74e-1)" "unprognostic (8.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "unprognostic (7.92e-2)" "unprognostic (4.20e-1)" "unprognostic (3.24e-1)" 6.9 4.9 4.7 3.6 5.7 0.7 5.6 3.4 9.7 3.8 3.3 7.0 1.2 2.5 4.0 3.8 3.9 4.4 6.6 8.1 6.9 3.7 15.3 6.7 5.7 11.1 6.7 3.2 12.3 8.2 7.0 3.9 7.1 5.0 2.9 3.2 16.7 4.6 2.7 4.7 24.4 3.2 3.4 7.2 9.2 3.3 4.1 3.7 5.3 3.7 3.9 4.2 5.2 5.4 0.2 6.5 0.3 3.7 0.2 1.7 1.4 0.0 0.2 0.7 3.4 3.0 0.0 0.1 0.7 0.5 0.6 0.5 0.0 0.4 0.0 1.3 0.6 0.3 0.2 0.1 0.4 0.2 1.9 0.2 0.1 0.0 2.4 0.0 3.0 4.2 1.3 0.1 0.2 1.8 0.6 0.0 1.4 1.7 0.0 0.0 0.2 1.7 0.0 5.5 0.0 18.8 4.0 1.0 1.4 1.0 3.5 1.4 4.2 0.4 2.0 0.5 0.3 0.2 0.1 3.4 2.7 0.0 1.2 0.0 1.2 0.0 3.7 0.3 0.4 2.8 1.0 0.0 0.4 0.9 6.5 0.2 1.0 1.7 0.0 0.2 0.9 3.8 1.0 1.4 4.7 5.7 3.4 9.7 6.9 3.7 6.7 3.2 5.0 3.7 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751561-51816368 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.8" "Group enriched" "Detected in all" 4 "granulocytes: 12.8;monocytes: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favourable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.9 6.3 25.4 6.1 29.6 1.6 5.1 22.0 68.6 7.0 6.1 9.1 4.6 3.1 6.0 4.4 4.9 6.0 5.2 4.9 21.6 18.1 3.5 2.2 4.5 4.9 16.9 22.6 6.5 3.1 6.7 4.4 3.0 29.5 3.7 5.1 2.9 3.8 9.6 2.7 4.6 4.7 6.7 11.4 4.5 3.7 3.1 9.6 1.2 4.3 0.2 4.7 4.7 4.6 2.5 1.6 12.8 8.8 1.3 2.2 1.1 0.8 0.5 1.7 4.0 8.2 8.8 0.3 4.5 1.5 3.4 3.7 0.0 0.4 3.6 0.1 3.5 2.3 7.1 4.0 1.1 0.0 3.5 0.0 0.7 0.0 1.4 1.4 0.2 5.1 5.4 0.5 1.0 0.7 0.0 0.1 4.2 0.6 2.9 0.5 1.1 0.8 2.2 1.0 0.1 0.5 1.2 26.3 6.4 4.2 0.0 1.2 1.0 0.2 1.6 9.3 0.7 5.8 3.2 0.0 0.0 0.0 2.9 9.7 4.2 0.1 5.9 7.8 2.2 2.3 1.0 2.5 1.3 1.0 1.6 1.8 1.7 0.7 12.8 1.3 8.8 1.2 0.4 1.1 25.4 29.6 22.0 38.3 21.6 18.1 16.9 22.6 29.5 9.6 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33096801 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "BEWO: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 6.3 5.4 3.7 6.8 5.2 20.3 6.8 5.3 7.4 4.5 6.9 4.1 7.4 6.4 6.5 12.0 7.0 5.4 9.9 4.4 3.6 3.7 13.9 13.1 9.3 9.6 3.5 3.0 5.7 9.7 12.1 5.2 8.4 4.9 4.6 6.5 9.0 7.7 6.5 3.8 10.3 11.0 4.6 3.8 7.2 6.8 3.2 2.3 2.4 9.5 2.2 7.2 5.3 5.0 0.8 2.2 4.2 5.5 0.1 1.4 0.9 1.2 1.7 1.0 1.5 1.2 1.0 25.0 0.5 0.9 1.5 0.9 2.4 3.4 0.7 1.1 1.5 1.3 1.6 1.4 2.4 3.7 0.6 3.0 1.6 1.8 0.8 2.6 4.4 1.1 1.1 1.9 1.3 1.7 2.2 2.6 1.1 1.1 1.0 1.2 0.9 1.0 1.2 0.5 1.6 1.4 1.7 0.2 0.6 0.8 2.4 0.6 1.3 3.7 2.4 2.2 2.8 1.2 2.3 2.1 1.3 0.4 2.8 2.0 1.5 0.0 2.3 0.7 0.4 5.5 1.4 0.8 0.5 0.1 2.2 0.3 0.0 0.0 4.2 0.1 2.3 0.4 0.5 0.9 3.7 5.2 5.3 7.4 3.6 3.7 3.5 3.0 4.9 2.3 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavourable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 44.9 0.0 1.7 0.0 19.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 31.5 39.3 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell line enhanced" "Detected in some" "AF22: 4.4;CAPAN-2: 7.1;WM-115: 5.8" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.4 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.4 0.4 0.3 0.5 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.6 1.2 0.8 0.8 0.5 0.9 0.0 0.8 1.2 0.5 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.5 0.6 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033806 Approved Approved Nucleoplasm,Vesicles,Cytosol 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavourable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 141.5 118.6 233.1 367.2 285.8 313.3 0.5 75.1 196.5 58.3 100.5 24.4 119.2 33.9 72.6 227.8 62.4 34.5 50.3 78.5 198.2 1.9 42.2 70.3 0.3 66.6 164.9 350.9 145.8 72.2 69.0 60.4 350.3 5.3 0.5 206.3 50.4 196.0 357.9 83.8 81.8 151.1 82.5 138.5 347.1 41.5 24.8 10.5 108.8 5.1 13.8 136.7 167.5 281.7 85.2 42.2 482.6 74.5 110.6 80.3 65.8 130.3 68.4 61.3 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 TMTC1 "ARG99, FLJ31400, FLJ41625, OLF" ENSG00000133687 "Transmembrane and tetratricopeptide repeat containing 1" Q8IUR5 12 29500840-29784759 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 28.6;HSkMC: 19.4;hTERT-HME1: 35.0;LHCN-M2: 19.5;RH-30: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016720 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA016720: AB_1858155" "unprognostic (1.67e-1)" "unprognostic (6.35e-3)" "unprognostic (1.18e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (1.63e-3)" "unprognostic (4.53e-2)" "unprognostic (3.88e-2)" "unprognostic (8.36e-2)" "unprognostic (1.77e-1)" "unprognostic (8.90e-3)" "unprognostic (3.08e-3)" "unprognostic (1.21e-1)" "prognostic unfavourable (5.49e-4)" "unprognostic (5.89e-3)" "unprognostic (6.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.51e-3)" 29.3 12.8 12.9 4.6 30.8 0.5 25.8 2.2 9.0 11.4 8.4 2.9 4.3 3.0 7.4 2.9 6.1 12.6 6.2 15.7 15.2 8.1 13.1 2.4 6.7 2.4 5.4 7.8 8.7 2.9 10.0 18.7 2.7 9.1 6.4 5.4 7.1 3.7 8.3 13.7 2.9 4.6 12.7 4.9 34.1 7.4 2.8 6.2 0.8 3.7 4.4 2.0 8.9 10.5 0.1 0.1 0.4 2.3 0.1 0.1 0.3 0.0 0.0 5.1 0.0 16.3 10.9 0.0 5.3 10.9 1.4 1.1 0.0 0.0 0.0 2.7 3.3 0.0 0.1 0.1 0.0 0.1 1.5 0.0 15.3 0.2 28.6 0.6 0.0 19.4 1.9 13.5 35.0 0.7 0.0 0.7 19.5 0.0 0.0 0.0 3.9 7.0 0.0 40.9 0.7 0.0 0.1 0.4 0.4 0.6 0.0 1.3 0.0 0.2 2.1 1.3 0.8 0.7 4.2 7.1 0.0 0.0 9.3 0.0 0.1 0.2 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 2.3 0.1 0.0 0.3 12.9 30.8 2.2 7.6 15.2 8.1 5.4 7.8 9.1 6.2 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712600-57740973 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: " "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (3.64e-4)" "prognostic unfavourable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favourable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavourable (3.37e-4)" 29.5 40.5 33.6 21.0 39.0 13.7 30.8 26.5 60.5 28.0 40.6 50.7 29.0 33.3 22.5 36.7 32.7 25.5 20.0 33.0 32.6 32.1 47.4 71.7 24.4 22.1 40.4 30.4 25.9 40.6 49.8 25.8 26.2 45.3 31.1 49.3 38.4 27.9 34.4 21.9 21.9 34.0 26.1 42.3 25.4 29.9 19.1 31.3 24.0 34.4 25.8 27.0 22.2 22.6 17.7 23.1 17.9 37.5 16.5 21.8 18.8 28.8 33.9 19.5 35.0 36.4 19.5 21.4 34.9 27.1 34.4 29.2 32.2 49.8 27.1 39.0 28.0 53.4 49.4 27.9 36.5 19.4 21.5 26.1 27.4 32.2 30.1 36.5 36.1 23.9 40.9 38.0 60.6 19.5 44.9 32.0 38.3 14.8 21.5 41.6 37.8 46.5 29.3 24.5 57.4 42.8 32.6 22.3 31.9 26.8 62.6 38.7 55.9 24.2 16.3 32.5 21.2 43.2 36.0 31.5 61.5 27.4 36.5 26.0 48.1 15.9 19.6 17.9 17.1 33.1 21.6 17.7 17.3 20.0 19.0 15.3 21.8 21.8 5.2 16.5 37.5 23.1 14.3 18.8 33.6 39.0 26.5 60.5 32.6 32.1 40.4 30.4 45.3 31.3 TNFAIP2 "B94, EXOC3L3" ENSG00000185215 "TNF alpha induced protein 2" Q03169 14 103123442-103137439 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "RT4: 126.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 25.9" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004598, HPA030624" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "Nucleoplasm, Nuclear membrane" "CAB004598: AB_628370, HPA030624: " "unprognostic (5.01e-3)" "unprognostic (4.93e-2)" "unprognostic (1.56e-3)" "unprognostic (8.02e-3)" "unprognostic (3.39e-2)" "unprognostic (2.98e-2)" "unprognostic (5.52e-3)" "unprognostic (5.97e-2)" "unprognostic (1.94e-1)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (4.10e-4)" "prognostic favourable (2.79e-5)" "unprognostic (1.75e-2)" "unprognostic (3.83e-2)" "prognostic favourable (7.17e-5)" 27.3 17.0 3.8 58.2 5.7 20.1 19.3 2.5 3.6 23.5 12.9 2.8 4.7 8.1 16.7 18.7 35.5 14.3 30.9 12.7 2.9 3.6 18.8 13.6 32.0 17.9 4.6 3.0 9.7 9.0 17.4 3.5 33.0 6.1 21.7 6.1 16.3 25.1 7.1 12.5 13.2 11.3 28.0 3.8 35.9 8.3 13.0 2.9 11.0 8.5 31.4 48.6 39.8 16.3 0.1 5.0 25.9 9.8 0.1 0.1 1.9 5.4 26.9 0.1 0.1 1.7 7.7 9.0 1.6 6.9 4.3 1.5 0.2 24.4 0.0 20.1 7.8 17.4 1.9 0.0 2.1 0.9 0.1 2.4 18.8 0.1 3.3 1.2 3.4 2.9 0.2 1.4 0.0 2.2 2.4 5.9 0.6 0.5 0.0 1.9 1.6 2.2 1.0 3.1 3.9 13.8 126.5 0.2 0.3 24.7 8.6 0.3 13.9 8.0 4.6 0.9 2.3 5.0 5.0 5.3 0.3 0.1 6.5 5.5 2.6 2.5 8.8 4.6 0.0 9.8 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 25.9 0.1 6.9 0.2 0.0 1.9 3.8 5.7 2.5 3.6 2.9 3.6 4.6 3.0 6.1 2.9 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.0;smooth muscle: 47.0" "Cell line enhanced" "Detected in some" "ASC diff: 12.6;ASC TERT1: 32.2;HUVEC TERT2: 27.5;LHCN-M2: 25.8;TIME: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA077484: " "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavourable (3.51e-4)" 4.6 2.4 11.8 4.1 3.8 0.8 10.5 0.6 5.8 9.8 4.1 1.8 2.8 1.2 47.0 9.9 11.5 20.9 3.7 5.5 11.4 3.1 1.9 1.5 6.6 5.4 1.9 5.6 17.5 1.6 0.6 1.8 1.4 3.3 6.6 5.0 0.6 1.9 3.5 2.1 10.7 3.2 47.0 1.5 14.7 2.9 3.4 1.1 0.0 2.5 4.7 2.4 12.3 18.8 1.4 1.0 3.7 1.5 1.7 0.8 0.3 0.0 0.1 0.0 0.0 12.6 32.2 0.1 0.1 0.0 0.3 0.5 0.0 0.3 0.0 0.6 1.7 0.0 0.4 0.3 0.1 0.0 0.3 0.0 0.9 2.0 3.3 0.1 0.7 11.8 2.5 2.4 9.3 27.5 0.0 0.0 25.8 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 36.8 2.9 0.2 9.4 0.7 0.1 0.0 0.0 6.0 0.0 0.0 2.8 1.5 0.7 0.5 0.7 0.6 0.8 0.6 0.5 0.3 1.4 0.6 0.8 3.7 1.7 1.0 1.0 0.4 0.3 11.8 3.8 0.6 5.8 11.4 3.1 1.9 5.6 3.3 1.1 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.1;BJ hTERT+: 26.3;fHDF/TERT166: 20.0;Hep G2: 27.3;SK-MEL-30: 45.6;WM-115: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favourable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favourable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.1 0.0 1.6 16.1 1.1 1.2 26.3 0.6 0.9 7.6 0.0 0.0 0.0 20.0 0.0 1.0 0.9 1.2 0.0 0.9 0.2 0.8 27.3 0.7 0.0 0.3 7.7 0.2 7.6 0.1 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.7 1.6 0.0 4.5 0.0 2.7 0.1 10.5 1.8 0.0 0.0 45.6 0.0 0.1 0.0 3.8 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.4 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell line enhanced" "Detected in many" "HDLM-2: 19.7;NB-4: 7.8;RPMI-8226: 19.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavourable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favourable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavourable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.5 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.2 2.1 0.0 2.9 0.0 3.1 0.4 3.6 0.0 19.7 1.4 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.1 3.1 0.0 0.0 0.0 1.6 0.0 7.8 1.0 5.3 0.6 0.2 19.3 0.8 0.5 3.8 5.2 0.0 1.9 0.1 1.6 2.1 1.6 1.0 1.5 0.0 1.5 0.0 3.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell line enhanced" "Detected in some" "HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" 1112540 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: " "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.7 1.4 0.0 0.0 11.5 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.6 0.0 14.5 0.0 0.8 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 14.2 0.1 0.0 0.0 0.7 0.0 1.1 0.0 6.6 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183734-173207313 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.5;testis: 14.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 18.3;HHSteC: 7.9;HUVEC TERT2: 35.9;LHCN-M2: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA059579 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA059579: " "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 2.1 4.0 1.7 8.2 2.3 0.9 3.7 4.5 3.4 1.7 1.8 1.0 0.8 0.3 1.5 1.5 1.6 1.4 2.1 2.1 3.0 2.0 1.5 1.6 2.5 11.5 1.9 0.8 2.7 2.1 1.0 3.3 1.2 1.2 2.8 2.5 1.0 0.8 1.0 0.8 0.3 2.5 1.6 1.9 9.7 1.4 14.4 1.2 9.3 0.8 0.8 3.7 1.6 1.6 1.3 2.6 1.7 0.2 3.4 1.2 6.5 0.0 0.0 0.2 0.5 1.2 6.5 0.0 1.8 0.4 0.1 0.1 0.0 0.0 0.0 0.3 18.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 7.9 0.1 0.0 2.8 0.1 0.9 0.1 35.9 0.0 0.2 29.9 0.0 0.3 0.1 0.1 0.3 0.8 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.1 3.3 1.9 0.0 0.2 0.3 1.1 0.1 0.8 1.1 0.7 0.9 0.8 1.3 1.2 1.1 1.7 3.4 0.1 2.6 0.9 6.5 1.7 2.3 4.5 3.4 3.0 2.0 1.9 0.8 1.2 1.2 TNKS "PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555914-9782346 "Enzymes, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 9.1 13.4 17.8 8.7 19.6 14.6 14.0 26.5 22.3 18.1 8.9 17.0 12.5 8.5 14.9 25.3 7.7 11.9 8.9 9.5 18.6 17.9 9.0 9.1 10.3 12.9 28.7 17.2 19.2 10.2 23.9 20.0 11.0 20.1 11.5 10.0 10.9 9.4 11.7 22.1 15.6 9.8 11.0 21.0 8.7 10.1 26.3 21.8 15.6 13.7 4.4 11.7 10.8 13.6 6.8 3.6 7.4 2.8 2.9 4.8 1.2 6.0 8.0 20.5 12.3 12.9 17.4 7.6 9.3 10.6 7.6 8.6 4.7 4.8 12.9 3.9 9.1 6.4 11.6 8.7 11.0 3.3 6.0 9.1 7.3 10.7 11.7 4.7 5.6 12.3 10.6 7.9 15.6 10.2 8.5 13.9 14.0 3.9 11.7 7.1 13.3 4.7 9.5 12.6 3.7 9.1 12.3 20.8 15.3 7.3 7.0 13.2 4.7 7.0 13.7 12.5 7.7 8.5 6.9 4.8 7.8 9.2 13.5 6.6 12.0 4.8 2.3 1.8 4.4 2.2 2.4 4.2 3.5 4.2 2.8 6.8 4.2 4.8 7.4 2.9 2.8 3.6 1.7 1.2 17.8 19.6 26.5 22.3 18.6 17.9 28.7 17.2 20.1 21.8 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451102-52454070 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 431.6;skeletal muscle: 765.7" "Cell line enhanced" "Detected in some" "CACO-2: 23.8;EFO-21: 23.9;HeLa: 15.7;Hep G2: 15.9;HSkMC: 24.8;U-2 OS: 36.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Lineage enriched" "Detected in single" 7 "T-cells: 4.0" "Region enriched" "Detected in many" 4 "cerebral cortex: 88.3" "Region enriched" "Detected in single" 7 "midbrain: 8.5" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" 260000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 2.0 0.3 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 17.8 12.8 0.1 0.0 431.6 0.1 0.1 0.6 0.1 2.6 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.2 0.5 5.5 0.1 0.7 10.4 0.0 765.7 0.4 0.1 0.1 0.7 0.1 0.1 0.7 0.0 0.0 3.0 86.9 8.7 0.4 0.2 0.2 0.6 0.0 0.0 0.0 4.0 0.5 0.2 1.8 1.3 0.2 0.0 0.2 2.9 0.1 0.1 0.1 0.1 23.8 11.9 0.2 23.9 3.4 0.1 0.0 0.1 0.0 0.4 0.5 0.1 15.7 15.9 0.1 0.1 0.0 24.8 0.4 0.0 0.2 0.0 0.0 1.8 0.7 0.0 0.0 0.2 0.1 0.2 0.0 1.0 0.8 1.1 4.5 0.0 0.0 0.1 2.4 0.0 9.6 0.2 0.0 0.0 36.7 0.3 0.0 1.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 4.0 0.2 0.9 0.5 0.0 0.1 1.4 0.5 0.0 0.0 0.0 0.6 2.5 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.0 TNNC2 ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "FDA approved drug targets, Predicted intracellular proteins" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 851.6" "Group enriched" "Detected in some" 7 "Hep G2: 9.7;HSkMC: 15.3;SCLC-21H: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 6.0" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles 63000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: " "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 12.0 0.2 0.1 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 2.7 4.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.0 7.8 0.1 851.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 169.1 6.6 0.1 0.1 6.0 0.8 2.4 1.1 0.3 4.1 11.9 0.1 0.0 0.2 0.5 1.7 1.2 1.7 0.2 0.4 0.0 0.1 0.2 1.1 0.4 1.2 1.0 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.9 9.7 0.4 0.3 0.2 15.3 0.2 0.1 0.7 0.0 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.6 0.2 0.6 0.2 0.3 0.0 11.5 0.5 1.7 0.1 0.4 1.3 0.4 0.5 0.3 0.4 0.9 0.2 1.5 0.4 0.3 1.6 0.1 0.2 0.0 0.7 1.4 0.2 1.1 0.7 6.0 1.5 0.2 0.3 3.8 0.0 0.3 2.4 0.3 0.8 0.8 4.1 11.9 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell line enhanced" "Detected in many" "HMC-1: 119.1;RH-30: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in many" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: " "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavourable (4.66e-4)" "prognostic unfavourable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavourable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.3 14.3 0.1 3.1 0.0 0.2 4.7 1.1 4.2 1.6 4.7 5.2 16.2 0.3 9.5 0.4 12.4 3.4 10.6 1.3 1.6 27.0 4.6 1.5 0.9 0.5 0.3 119.1 5.3 17.2 0.4 18.3 0.0 23.1 22.6 1.5 23.2 0.4 0.0 3.0 28.4 15.5 89.7 2.9 3.7 0.8 0.9 7.0 1.5 0.2 7.8 14.8 14.2 0.5 23.6 35.1 0.9 1.7 0.1 0.9 1.1 24.8 3.6 7.1 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: " "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favourable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 21.7 19.8 37.1 16.0 35.7 17.8 13.5 33.1 44.7 17.9 13.9 23.2 12.7 13.4 20.7 20.9 22.9 22.4 15.9 20.0 31.1 24.9 14.3 10.1 13.7 16.6 24.8 36.6 32.9 16.0 26.6 19.1 16.1 22.2 16.8 15.9 18.2 15.1 20.0 15.2 36.6 12.5 23.3 25.2 15.3 12.9 24.1 20.9 14.9 17.8 9.9 17.8 18.9 14.7 1.6 4.3 2.6 1.2 0.4 3.3 0.7 17.4 13.3 20.6 26.3 12.5 16.6 13.4 20.2 13.4 29.3 20.7 18.2 9.5 11.9 15.8 17.0 23.4 36.5 20.0 16.4 14.7 29.2 18.3 21.0 22.1 14.2 32.3 17.7 14.8 15.8 19.4 20.7 13.7 28.5 11.4 16.2 30.3 27.0 22.3 23.9 40.4 26.1 16.1 21.8 17.4 12.8 50.5 25.1 16.4 20.9 10.0 14.6 11.5 13.7 45.0 11.9 24.0 29.6 22.7 21.8 20.3 13.4 29.4 15.9 0.6 0.9 0.3 2.1 0.8 3.0 1.5 1.5 1.7 1.2 1.6 2.7 3.3 2.6 0.4 1.2 4.3 0.5 0.7 37.1 35.7 33.1 42.1 31.1 24.9 24.8 36.6 22.2 20.9 TNRC6C "FLJ20015, KIAA1582" ENSG00000078687 "Trinucleotide repeat containing 6C" Q9HCJ0 17 77959240-78108835 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 12.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022007, HPA062051" Uncertain Approved Nucleoplasm Nucleoplasm "HPA022007: , HPA062051: " "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-3)" "unprognostic (2.66e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (2.89e-3)" "unprognostic (2.59e-1)" "unprognostic (7.83e-2)" "prognostic favourable (6.56e-5)" "unprognostic (1.36e-1)" "unprognostic (1.17e-2)" "unprognostic (1.07e-1)" "unprognostic (1.84e-1)" "unprognostic (3.04e-1)" "unprognostic (5.70e-2)" 5.5 3.6 8.9 7.4 15.1 3.6 5.1 13.3 13.8 6.0 3.8 14.5 4.4 2.3 6.9 7.6 3.1 6.9 4.7 6.9 8.5 7.6 3.3 3.4 4.2 7.5 13.3 6.3 9.1 4.4 6.1 7.6 1.9 12.2 6.1 3.0 10.9 6.0 4.9 11.1 3.3 3.8 5.6 7.5 6.0 3.6 13.2 14.3 3.4 4.1 6.1 5.5 3.6 4.1 1.1 0.7 12.9 0.3 3.1 2.7 0.5 3.1 3.0 5.4 5.8 2.3 1.8 0.0 4.7 3.9 3.4 2.8 3.1 0.9 0.0 2.0 3.6 0.3 3.9 0.1 2.1 2.5 4.1 11.0 1.0 3.4 2.1 2.6 5.6 1.5 1.5 1.3 3.2 7.1 2.1 5.6 3.5 4.2 24.8 1.4 2.8 2.2 3.3 10.8 2.0 0.8 4.5 6.6 12.3 5.6 7.3 2.6 5.6 3.9 5.2 7.5 2.5 3.8 5.8 4.2 0.7 3.2 2.1 4.0 5.4 12.9 0.3 1.3 1.9 0.2 2.2 1.0 2.1 2.0 0.2 1.1 2.3 2.7 1.2 3.1 0.3 0.7 0.9 0.5 8.9 15.1 13.3 12.5 8.5 7.6 13.3 6.3 12.2 14.3 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA047839: " "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (5.04e-5)" "prognostic unfavourable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 14.3 68.4 10.5 10.4 15.7 19.6 29.5 11.3 13.4 20.9 24.2 23.6 24.2 16.9 7.9 12.9 30.2 17.4 42.7 21.7 12.0 11.8 22.5 57.5 17.7 7.5 12.0 10.2 21.5 74.4 30.2 20.0 5.6 13.9 24.5 18.3 36.5 32.4 56.0 60.4 44.7 26.3 23.7 11.9 6.1 28.8 9.0 13.1 8.9 30.3 31.0 13.8 38.8 22.9 7.8 21.3 63.0 25.1 4.8 51.2 25.2 10.9 22.5 7.3 3.0 13.8 6.9 5.6 8.2 20.4 5.4 6.6 9.0 14.1 10.0 15.8 11.2 15.6 4.9 13.9 5.6 5.0 7.2 1.2 26.4 14.9 19.3 5.1 4.9 14.7 17.3 6.2 31.9 2.5 4.1 8.8 11.3 29.8 3.9 4.8 2.6 8.6 3.5 9.3 11.9 21.1 22.8 4.3 10.5 14.0 41.7 4.9 65.7 6.8 3.4 6.2 4.4 6.8 3.9 13.4 14.0 4.7 5.0 2.6 2.3 63.0 10.5 49.9 46.6 18.6 51.2 7.8 43.4 36.4 21.3 6.2 38.4 46.2 23.6 4.8 25.1 6.9 35.9 25.2 10.5 15.7 11.3 13.4 12.0 11.8 12.0 10.2 13.9 13.1 TOGARAM1 "crescerin, Crescerin-1, FAM179B, KIAA0423" ENSG00000198718 "TOG array regulator of axonemal microtubules 1" Q9Y4F4 14 44962208-45074431 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050849, HPA053559" Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA050849: , HPA053559: " "unprognostic (2.91e-1)" "unprognostic (4.07e-2)" "unprognostic (2.04e-2)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (2.67e-2)" "unprognostic (2.69e-1)" "unprognostic (1.21e-1)" "unprognostic (5.63e-2)" "unprognostic (6.49e-2)" "prognostic favourable (8.38e-4)" "unprognostic (1.62e-1)" "unprognostic (2.15e-1)" "unprognostic (3.02e-2)" "unprognostic (1.60e-1)" 6.9 11.6 13.6 7.0 17.5 6.0 9.0 16.3 34.4 12.3 6.7 10.0 9.8 4.8 10.3 9.9 8.1 17.5 8.3 13.7 14.5 10.5 14.0 8.0 12.9 8.4 13.1 17.0 13.9 11.1 15.5 20.1 9.9 11.0 9.9 6.6 6.8 7.8 11.5 19.1 6.5 5.9 9.2 13.0 7.1 6.4 9.3 12.5 9.1 15.4 5.2 6.7 8.6 6.7 1.7 1.8 6.9 1.0 1.9 1.4 0.8 3.0 5.1 5.0 1.3 11.3 13.5 3.5 4.3 9.7 8.5 10.2 2.0 3.4 2.9 5.0 7.1 5.9 8.9 2.8 9.5 2.6 3.2 2.3 2.7 2.5 8.3 4.1 2.6 7.7 5.2 4.6 8.3 6.7 1.7 3.5 8.7 4.7 5.4 2.3 1.7 3.9 2.7 12.1 2.0 8.1 10.9 5.1 2.0 5.1 7.9 7.8 5.8 3.4 5.0 5.8 4.5 7.4 3.2 3.5 2.4 3.3 3.3 0.8 4.8 6.9 1.0 2.2 1.1 0.9 1.3 1.0 1.4 1.1 1.3 1.7 1.4 0.9 0.1 1.9 0.9 1.8 1.4 0.8 13.6 17.5 16.3 34.4 14.5 10.5 13.1 17.0 11.0 12.5 TOP3B ENSG00000100038 "DNA topoisomerase III beta" O95985 22 21957025-21982816 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 48.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072114 Approved Nucleoplasm Nucleoplasm "HPA072114: " "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (3.37e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (3.93e-1)" "unprognostic (2.15e-2)" "unprognostic (2.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-2)" "unprognostic (1.96e-2)" "unprognostic (1.69e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-2)" "unprognostic (1.11e-4)" 10.4 11.7 12.1 16.1 17.4 20.8 10.9 17.2 17.1 12.5 11.0 16.9 14.9 15.4 16.1 11.0 14.2 11.0 11.2 10.1 12.7 5.5 13.4 15.3 12.7 17.0 18.7 6.5 20.2 12.1 13.5 21.0 12.1 16.2 15.6 14.9 14.1 13.3 13.3 13.4 17.5 16.1 14.5 17.4 23.6 11.8 11.1 16.9 13.1 14.2 5.7 18.9 10.5 14.3 9.0 8.8 2.7 6.8 6.1 9.3 5.2 9.5 9.1 18.7 7.4 6.9 5.8 11.7 6.4 7.9 14.7 13.1 9.9 4.1 13.1 4.8 6.6 17.5 8.4 11.2 11.9 6.7 20.2 10.3 11.8 10.2 9.4 14.0 6.8 2.8 17.3 12.1 5.9 12.2 48.2 7.2 6.9 9.7 8.8 10.9 7.7 8.8 13.8 12.4 2.0 7.3 12.8 12.2 8.9 7.8 6.9 5.9 5.4 9.0 8.9 6.1 12.7 5.7 7.7 10.6 8.6 12.4 4.7 8.6 6.2 2.5 6.7 2.7 9.3 6.8 6.5 7.5 5.8 6.5 7.4 9.0 5.9 5.7 2.3 6.1 3.8 8.8 6.7 5.2 12.1 17.4 17.2 17.1 12.7 5.5 18.7 6.5 16.2 16.9 TOR4A "C9orf167, FLJ20245" ENSG00000198113 "Torsin family 4 member A" Q9NXH8 9 137277749-137282641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044913 Enhanced Approved Nucleoplasm 1500000 Nucleoplasm "HPA044913: AB_10965030" "unprognostic (1.95e-1)" "unprognostic (1.51e-2)" "prognostic unfavourable (6.48e-4)" "unprognostic (1.99e-1)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "prognostic unfavourable (3.44e-4)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (2.24e-1)" "unprognostic (5.20e-2)" "unprognostic (2.00e-3)" "unprognostic (4.39e-3)" "unprognostic (7.93e-3)" "unprognostic (2.56e-1)" 8.7 3.0 1.6 9.1 3.1 3.2 3.8 0.6 1.7 6.0 12.9 2.8 7.6 12.5 5.0 4.7 8.4 4.6 23.2 12.4 1.5 1.3 8.0 6.6 14.8 7.5 2.8 1.1 9.4 4.0 0.4 2.1 4.9 2.3 3.4 5.8 5.5 1.8 9.7 1.8 2.0 14.5 1.9 2.4 19.4 15.6 1.9 2.0 2.9 5.0 1.4 13.3 4.5 3.9 0.9 1.6 3.7 3.5 0.7 0.7 0.9 7.8 10.4 0.0 0.3 0.1 0.8 0.8 13.2 9.1 6.1 3.2 1.3 15.0 0.8 18.6 4.7 16.5 0.0 4.3 2.1 0.6 0.7 8.7 7.2 7.0 13.2 3.8 22.6 0.4 4.6 1.2 2.4 8.2 13.0 1.0 1.0 0.8 0.0 10.4 1.3 11.7 2.1 2.9 5.3 7.3 0.0 0.4 0.1 9.5 0.1 0.2 0.8 11.8 20.2 0.3 7.3 1.4 2.2 0.1 0.5 5.0 2.3 3.5 2.9 1.6 2.3 3.7 0.5 2.1 0.6 0.7 0.4 0.1 1.6 0.9 0.0 0.1 1.4 0.7 3.5 0.2 0.7 0.9 1.6 3.1 0.6 1.7 1.5 1.3 2.8 1.1 2.3 2.0 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805418-59119208 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 88.8" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 9.8;MOLT-4: 53.9;SH-SY5Y: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 21.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: " "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favourable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavourable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 1.3 1.2 10.5 15.7 6.3 2.8 1.5 1.9 15.6 2.1 13.4 1.5 1.2 10.0 1.5 1.1 3.7 1.1 5.0 0.9 6.3 9.8 3.2 1.7 4.9 17.7 4.8 12.0 6.6 2.4 2.9 3.7 1.5 2.2 2.4 9.3 2.6 1.8 1.3 0.5 1.0 10.7 2.8 2.3 5.7 10.0 6.5 2.5 88.8 1.5 0.8 19.4 2.6 2.3 3.4 0.8 10.2 0.1 10.4 21.0 3.1 0.3 0.0 6.0 0.0 0.6 1.4 0.0 1.2 2.8 0.7 0.1 0.0 0.0 0.0 0.0 5.4 0.4 1.4 0.0 0.1 0.2 0.5 0.0 1.1 0.0 5.0 1.0 0.2 0.7 0.2 0.9 1.1 9.8 0.0 0.0 0.4 0.0 53.9 0.0 1.0 0.1 1.1 4.1 0.0 0.1 0.1 5.5 16.9 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.7 4.9 1.6 0.0 0.0 3.7 0.2 0.0 1.0 10.2 0.1 1.8 7.5 0.0 3.4 3.4 5.5 11.3 0.8 0.6 2.1 6.3 0.2 10.4 0.0 0.0 21.0 3.1 10.5 6.3 1.9 15.6 6.3 9.8 4.8 12.0 2.2 2.5 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favourable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 12.9 13.8 11.5 10.9 16.7 16.1 15.4 12.6 24.9 26.9 26.0 13.3 15.8 7.9 8.9 20.7 15.8 18.8 19.4 34.5 13.9 7.6 8.8 9.4 18.4 21.7 16.2 14.5 20.9 20.1 21.0 20.3 19.0 10.8 13.6 19.1 11.1 16.0 9.0 6.5 21.8 14.4 11.9 9.1 12.5 16.5 10.7 10.9 12.4 13.3 10.9 12.6 6.2 12.4 13.6 12.9 12.2 11.0 17.9 19.4 17.7 6.6 7.9 14.4 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 TPBG "5T4, 5T4-AG" ENSG00000146242 "Trophoblast glycoprotein" Q13641 6 82363206-82370828 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTCEpi: 30.0;hTEC/SVTERT24-B: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010554 Enhanced Approved Nucleoplasm 330000 Nucleoplasm "HPA010554: AB_1858206" "unprognostic (3.03e-1)" "unprognostic (1.46e-2)" "prognostic unfavourable (6.68e-4)" "unprognostic (1.06e-1)" "unprognostic (4.52e-3)" "unprognostic (7.47e-3)" "unprognostic (8.55e-2)" "unprognostic (3.55e-3)" "unprognostic (8.39e-2)" "unprognostic (3.42e-2)" "unprognostic (8.02e-2)" "unprognostic (4.94e-1)" "unprognostic (3.77e-1)" "unprognostic (7.46e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-1)" "unprognostic (5.57e-2)" 10.2 2.9 0.4 4.8 15.7 1.2 10.2 0.0 8.8 22.0 4.6 1.9 12.1 4.2 12.6 4.6 35.2 8.4 9.3 5.3 0.7 2.0 6.6 1.7 4.1 3.0 4.3 1.4 5.8 4.8 4.1 11.2 16.9 17.6 14.1 4.6 5.1 11.5 9.4 2.6 12.6 4.9 16.2 4.5 5.7 6.2 3.3 7.9 4.2 13.0 6.8 4.5 22.9 25.5 0.0 0.0 0.0 0.1 0.0 3.2 0.0 4.4 6.7 2.4 5.0 8.9 12.9 4.2 21.0 24.5 4.2 5.8 0.7 6.3 0.0 2.2 11.5 8.7 2.8 11.6 4.5 0.0 3.5 2.5 3.2 0.2 7.3 0.2 2.1 8.2 30.0 27.4 10.2 1.0 0.4 0.0 1.1 9.2 0.0 0.0 2.9 5.3 0.0 4.7 0.0 6.2 6.3 1.2 3.8 4.6 6.7 0.0 11.2 0.8 3.1 3.7 3.6 7.8 4.5 0.0 0.0 0.0 17.9 0.3 3.8 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.0 8.8 0.7 2.0 4.3 1.4 17.6 7.9 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.8;skeletal muscle: 211.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles 270000000 Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavourable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 20.2 41.2 41.2 24.3 46.9 27.4 83.4 93.2 196.1 27.1 39.1 12.8 18.6 40.1 17.2 22.6 51.0 22.1 33.3 94.9 36.7 33.1 43.1 40.8 48.8 140.2 34.0 34.6 19.9 87.0 32.1 16.8 27.1 70.7 19.0 43.5 21.1 26.0 28.7 211.0 25.8 37.8 29.4 20.8 20.1 21.6 15.7 19.4 14.2 20.2 38.4 38.0 23.0 28.0 55.4 170.3 145.5 148.2 81.2 67.1 234.8 119.2 106.9 56.6 87.6 55.5 58.6 100.1 86.3 95.3 163.1 197.9 110.3 65.6 70.0 17.4 85.1 59.4 134.6 144.2 181.0 92.3 100.3 90.7 78.3 72.7 41.4 103.2 74.5 63.6 60.2 125.8 108.4 99.1 46.9 26.9 125.2 87.8 54.2 87.2 139.7 68.1 31.9 93.2 71.8 102.1 85.1 40.3 67.1 75.3 78.4 41.8 17.9 77.6 61.2 87.5 75.0 56.6 126.5 52.6 21.6 104.6 175.6 64.2 62.7 87.7 146.1 145.5 56.1 148.2 57.0 55.4 56.5 54.5 170.3 44.3 39.9 49.3 61.1 81.2 127.8 30.7 67.1 234.8 41.2 46.9 93.2 196.1 36.7 33.1 34.0 34.6 70.7 19.4 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185915-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favourable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavourable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 8.9 10.3 8.3 28.8 13.4 45.5 12.0 15.3 11.4 10.6 14.7 7.4 19.9 15.9 9.3 15.6 19.9 9.2 18.1 10.0 9.0 4.9 13.4 20.0 13.1 25.6 12.4 6.1 10.2 42.9 5.9 12.0 9.6 9.5 14.8 6.0 8.4 24.6 19.5 14.0 13.0 18.3 9.3 9.6 19.5 16.5 9.7 11.8 21.0 13.2 13.2 33.1 11.5 13.1 6.9 33.0 23.0 14.2 14.7 13.6 9.2 22.4 14.9 5.4 8.8 2.9 3.4 13.5 7.8 5.1 6.6 5.6 9.4 10.8 13.9 7.7 3.6 14.1 6.9 13.8 1.3 9.7 32.2 8.0 23.0 15.9 11.6 16.2 16.0 5.5 8.5 4.8 6.5 6.4 9.8 22.8 2.8 24.8 11.2 18.4 7.9 14.2 31.4 7.3 29.3 5.0 21.8 6.3 10.6 6.7 24.3 11.1 10.4 16.4 7.1 5.5 13.7 7.1 8.7 27.8 4.9 16.6 6.8 11.3 8.6 7.0 14.2 23.0 10.9 12.5 10.2 6.9 9.8 9.8 15.4 3.6 6.7 7.7 19.5 14.7 7.6 33.0 13.6 9.2 8.3 13.4 15.3 11.4 9.0 4.9 12.4 6.1 9.5 11.8 TRAF1 EBI6 ENSG00000056558 "TNF receptor associated factor 1" Q13077 9 120902393-120929173 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HDLM-2: 35.1;WM-115: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;T-cells: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001852, CAB009593" Enhanced Approved Nucleoplasm Nucleoplasm "CAB009593: , HPA001852: AB_1080344" "unprognostic (1.45e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-3)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.02e-2)" "unprognostic (1.39e-1)" "prognostic favourable (2.19e-5)" "unprognostic (3.23e-1)" "prognostic unfavourable (4.42e-5)" "unprognostic (1.85e-3)" "unprognostic (5.70e-3)" "unprognostic (2.64e-1)" "unprognostic (9.87e-3)" 5.4 8.6 9.5 21.6 20.5 8.7 5.7 4.7 13.7 5.3 6.5 17.5 9.2 4.3 6.6 7.4 5.2 6.7 8.6 7.5 11.4 5.5 7.8 4.9 7.4 33.1 14.8 11.2 10.9 3.9 5.3 11.0 3.6 12.5 10.0 5.0 9.4 10.3 7.2 2.4 8.2 8.9 7.8 7.6 15.5 6.6 3.1 19.1 3.5 7.9 2.2 24.0 9.0 10.0 0.2 2.8 0.0 0.4 1.4 11.1 2.0 1.2 0.8 0.1 0.0 1.4 3.6 0.0 0.3 1.9 0.5 1.0 0.1 0.6 2.4 0.4 0.4 0.5 0.2 0.1 0.7 35.1 0.0 0.2 0.8 0.1 1.0 0.1 2.8 1.7 1.9 2.3 1.7 0.3 0.0 4.8 0.3 0.1 0.0 1.0 0.4 0.1 0.5 0.6 4.8 0.2 0.1 0.4 0.0 0.3 0.1 0.1 0.3 0.4 0.3 0.4 0.3 1.9 6.2 3.7 1.3 1.2 1.2 0.2 44.4 0.0 0.3 0.0 3.6 0.4 6.4 0.2 8.8 7.4 0.4 0.2 2.7 4.0 0.0 1.4 0.3 2.8 11.1 2.0 9.5 20.5 4.7 13.7 11.4 5.5 14.8 11.2 12.5 19.1 TRAFD1 FLN29 ENSG00000135148 "TRAF-type zinc finger domain containing 1" O14545 12 112125501-112153609 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039254, HPA039266" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039254: AB_10805358, HPA039266: AB_10795142" "unprognostic (7.80e-2)" "prognostic favourable (5.73e-4)" "unprognostic (6.12e-2)" "unprognostic (1.44e-1)" "unprognostic (9.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavourable (4.87e-4)" "unprognostic (1.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavourable (9.26e-6)" "unprognostic (1.07e-1)" "unprognostic (6.15e-2)" "unprognostic (3.33e-3)" "prognostic favourable (3.92e-5)" 15.1 13.1 11.0 21.9 19.2 20.5 16.6 11.9 19.8 15.6 31.6 42.1 15.2 12.7 15.1 12.8 26.0 12.8 14.0 16.9 12.2 10.8 12.7 12.5 21.2 25.5 26.2 10.7 15.3 10.2 15.3 14.9 15.5 22.2 18.5 16.8 22.7 16.4 16.7 10.3 28.1 16.0 20.5 25.0 25.0 15.2 30.9 23.4 28.2 13.0 13.0 29.7 25.6 17.4 13.2 11.4 59.1 21.4 14.8 13.8 19.3 10.6 12.1 19.6 18.2 13.3 12.8 10.1 12.1 17.7 17.3 13.7 12.9 9.7 12.1 10.5 12.8 21.6 19.0 11.9 11.6 21.1 18.1 19.6 17.1 7.0 23.2 12.1 30.7 16.4 20.3 12.3 16.8 15.1 21.9 7.5 10.9 17.9 13.3 16.7 16.0 14.3 19.0 12.0 20.4 11.2 40.1 16.6 12.8 25.3 25.0 6.7 16.2 16.9 9.6 7.9 5.7 7.7 6.4 18.3 16.1 13.0 8.4 9.6 8.5 59.1 21.4 48.3 10.7 19.4 7.3 13.2 10.5 9.6 11.4 12.2 9.7 8.9 42.8 14.8 20.0 7.5 13.8 19.3 11.0 19.2 11.9 19.8 12.2 10.8 26.2 10.7 22.2 23.4 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225889 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 71.9;skeletal muscle: 101.1" "Cell line enhanced" "Detected in all" "RT4: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: " "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favourable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 11.3 5.9 14.7 8.3 15.7 7.6 8.6 20.5 20.1 7.1 23.5 15.4 4.2 15.5 6.1 8.0 14.9 9.6 21.9 71.9 15.1 12.4 9.5 7.7 11.0 9.8 14.3 15.6 4.1 6.5 16.8 11.0 9.7 16.2 7.8 11.9 23.8 22.9 7.7 101.1 21.6 23.7 7.9 11.7 12.2 26.9 7.0 10.6 4.9 14.4 31.9 14.2 19.1 10.5 7.1 4.8 1.6 4.3 1.7 1.8 1.1 7.4 6.5 12.9 5.6 9.0 8.9 17.0 10.1 11.4 6.6 7.2 4.3 10.6 14.6 5.3 24.9 3.6 8.9 23.1 7.2 13.2 6.4 10.0 6.6 11.9 4.5 11.4 8.0 7.5 10.0 14.5 13.4 13.2 5.1 11.7 8.3 3.1 1.2 6.0 5.6 5.0 5.3 4.8 12.2 9.1 56.2 8.3 9.8 3.8 5.6 5.4 5.0 9.7 13.5 5.7 6.8 34.3 5.8 8.7 7.4 13.2 6.3 10.0 5.5 1.6 2.5 1.0 1.2 4.3 1.1 5.0 1.8 1.5 2.8 7.1 0.8 1.8 1.1 1.7 2.4 4.8 0.8 1.1 14.7 15.7 20.5 20.1 15.1 12.4 14.3 15.6 16.2 10.6 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: " "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favourable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.8 5.6 3.7 13.7 25.5 36.8 4.0 14.2 12.5 10.4 12.2 8.2 3.6 2.5 5.8 19.6 3.9 7.8 4.4 17.9 7.2 4.2 5.6 10.2 6.1 14.1 4.3 6.8 19.7 4.4 10.9 8.8 15.2 4.4 10.9 22.1 5.6 3.4 2.6 4.1 11.3 4.4 9.2 3.9 8.9 5.5 6.9 9.0 7.7 6.2 23.9 4.4 4.6 17.7 16.8 6.3 11.5 8.8 6.0 10.3 3.1 14.2 6.9 8.6 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826820-36945098 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.3" "Cell line enhanced" "Detected in many" "Daudi: 38.1;HMC-1: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 42.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 42.3" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavourable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 4.1 3.6 4.5 10.4 11.2 6.9 4.7 21.5 12.0 8.5 14.2 1.7 3.1 8.6 12.3 4.5 3.1 19.3 7.3 4.1 3.3 3.9 3.2 7.9 6.2 13.9 2.9 6.6 9.0 2.8 5.0 3.8 3.7 6.0 7.9 10.9 4.4 4.9 5.0 2.6 2.9 23.1 10.5 3.2 9.9 6.0 2.9 1.7 15.1 5.8 1.1 16.2 9.8 6.0 5.2 0.5 42.3 1.3 2.8 5.7 0.9 0.7 0.9 0.2 0.0 2.4 9.5 0.0 0.7 5.0 2.3 4.4 0.0 3.9 38.1 1.5 2.8 0.2 0.1 0.5 0.4 1.9 0.0 6.2 2.5 0.0 3.1 1.7 15.3 3.1 1.9 1.7 0.1 2.8 4.9 5.5 1.6 0.0 4.8 0.7 0.2 1.0 1.3 0.1 0.7 0.7 1.7 0.3 0.0 3.8 1.0 0.3 0.6 2.1 1.9 1.8 0.7 0.1 0.6 5.4 1.1 8.4 0.3 1.3 0.2 2.5 0.6 3.9 5.6 0.9 4.2 4.0 4.8 5.7 0.5 5.2 4.4 4.2 42.3 2.8 1.3 0.0 4.0 0.9 4.5 11.2 21.5 12.0 3.3 3.9 2.9 6.6 6.0 1.7 TRAPPC13 "C5orf44, FLJ13611, FLJ26957, MGC48585" ENSG00000113597 "Trafficking protein particle complex 13" A5PLN9 5 65624716-65666233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037777 Approved Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA037777: AB_10672464" "unprognostic (3.66e-2)" "unprognostic (3.27e-1)" "unprognostic (1.54e-2)" "unprognostic (7.22e-2)" "unprognostic (4.79e-2)" "unprognostic (1.16e-2)" "unprognostic (2.55e-2)" "unprognostic (2.49e-2)" "unprognostic (5.70e-2)" "unprognostic (5.75e-2)" "unprognostic (3.49e-2)" "unprognostic (1.92e-1)" "prognostic favourable (8.66e-4)" "unprognostic (2.89e-1)" "unprognostic (2.58e-2)" "unprognostic (2.53e-2)" "unprognostic (6.25e-2)" 10.4 12.9 16.1 10.3 22.5 7.5 14.0 14.5 22.7 12.1 11.3 12.8 10.2 9.8 11.9 10.4 13.4 9.7 9.8 17.7 17.1 17.7 21.6 16.9 11.0 10.2 17.3 14.2 10.1 8.2 20.6 22.4 11.8 19.5 20.6 14.3 10.5 9.9 12.4 15.2 8.0 13.3 13.9 18.9 10.7 11.0 10.6 15.1 18.0 18.7 11.7 10.8 11.5 9.9 6.6 10.1 14.7 13.7 9.1 13.1 9.8 12.9 8.8 13.9 25.0 10.8 13.8 13.4 15.4 14.0 19.1 21.0 7.5 18.3 13.2 17.0 12.4 12.0 15.7 16.0 22.6 9.2 11.6 8.5 10.9 6.9 14.7 10.3 12.8 9.8 12.7 14.8 19.1 16.8 10.1 12.6 16.8 13.7 17.1 4.0 6.4 4.8 15.0 17.5 15.4 13.9 14.8 17.6 12.6 18.8 11.4 14.1 16.5 13.5 11.5 6.7 9.4 14.9 15.5 8.3 16.2 21.1 14.2 18.6 12.8 14.7 9.4 3.8 10.1 10.1 13.1 6.6 9.9 8.4 10.1 5.4 9.9 9.9 3.6 9.1 13.7 7.6 10.4 9.8 16.1 22.5 14.5 22.7 17.1 17.7 17.3 14.2 19.5 15.1 TRAPPC2 "hYP38334, MIP-2A, SEDL, SEDT, TRS20, ZNF547L" ENSG00000196459 "Trafficking protein particle complex 2" "P0DI81, P0DI82" X 13712244-13734635 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB004665, HPA063308" Approved Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "CAB004665: AB_425678, HPA063308: " "unprognostic (1.97e-1)" "prognostic favourable (8.09e-4)" "unprognostic (2.13e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "unprognostic (2.70e-2)" "unprognostic (1.04e-2)" "unprognostic (2.08e-3)" "unprognostic (1.76e-2)" "prognostic favourable (6.35e-4)" "unprognostic (3.50e-2)" "unprognostic (8.24e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (2.36e-1)" "prognostic favourable (7.89e-5)" 6.5 6.4 15.6 9.5 13.7 9.5 9.4 24.1 16.1 10.5 9.4 10.1 8.8 8.2 16.4 8.7 8.5 9.4 7.6 6.4 14.4 14.2 10.1 10.1 7.8 16.1 10.4 13.0 11.7 11.2 8.9 19.5 7.2 11.5 8.9 9.1 10.2 8.1 8.3 4.9 10.3 8.8 16.0 11.5 11.1 10.7 4.3 11.1 4.3 8.8 4.2 16.4 8.1 9.4 11.2 10.7 13.7 6.6 18.5 16.1 9.0 6.7 5.2 8.0 20.6 6.2 4.8 3.3 6.3 5.4 5.0 5.4 4.4 8.3 11.4 10.2 5.2 8.9 10.7 9.0 6.9 11.5 15.9 8.5 12.3 3.5 4.7 11.6 16.4 6.2 5.1 10.7 14.7 4.4 10.7 19.6 5.1 11.1 11.4 15.4 7.7 9.4 11.3 10.7 11.1 7.9 5.0 8.6 11.4 11.6 9.3 8.0 11.6 7.7 5.8 5.1 4.6 9.1 4.0 10.2 9.9 14.3 4.7 8.3 5.2 13.7 4.9 8.6 16.1 6.6 16.0 11.2 12.8 15.8 4.3 11.1 10.8 15.5 10.0 18.5 5.4 10.7 15.3 9.0 15.6 13.7 24.1 16.1 14.4 14.2 10.4 13.0 11.5 11.1 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363511-57365353 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: " "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favourable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 14.6 23.3 13.4 9.9 17.1 11.6 17.2 23.8 16.7 11.5 12.5 6.7 12.1 7.0 12.2 15.1 15.4 11.4 13.7 26.5 18.0 14.0 12.9 14.5 12.4 15.0 11.6 14.5 15.8 9.7 12.2 16.4 16.9 18.1 14.3 7.9 9.0 11.4 10.4 28.8 11.5 8.6 12.7 15.1 14.3 10.2 31.2 9.6 12.7 17.6 16.8 13.7 15.4 9.5 26.7 21.5 32.2 13.2 22.8 15.5 13.4 9.1 7.6 10.3 6.6 9.6 10.9 9.5 6.2 14.5 9.5 28.9 3.6 7.1 7.0 8.9 8.4 3.3 5.2 10.4 10.3 3.4 36.2 7.4 12.3 8.0 10.1 7.7 11.4 11.7 13.1 7.6 5.2 7.0 2.2 0.1 11.2 2.6 11.4 6.8 3.5 14.9 5.7 9.8 10.5 10.7 14.4 11.0 8.5 6.5 6.7 5.7 10.5 10.0 7.5 8.8 7.8 4.4 10.3 11.4 14.4 14.1 12.7 4.8 9.0 32.2 13.2 16.3 7.5 11.6 14.7 25.0 15.5 12.3 14.8 26.7 15.0 12.0 15.3 22.8 10.3 21.5 13.4 13.4 13.4 17.1 23.8 16.7 18.0 14.0 11.6 14.5 18.1 9.6 TRAPPC9 "IKBKBBP, KIAA1882, MRT13, NIBP, T1, TRS120" ENSG00000167632 "Trafficking protein particle complex 9" Q96Q05 8 139730343-140458579 "Disease related genes, Predicted intracellular proteins" Differentiation "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026579 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA026579: AB_1854459" "unprognostic (1.82e-2)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.14e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.76e-2)" "unprognostic (2.31e-1)" "prognostic favourable (5.11e-6)" "unprognostic (2.09e-1)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.62e-1)" 9.7 12.0 13.0 14.7 17.9 13.8 8.3 18.3 22.0 11.3 10.3 17.2 12.5 11.3 11.4 9.8 12.1 17.4 12.8 14.7 13.0 13.7 12.2 10.0 9.5 10.6 14.5 11.7 11.5 15.4 42.0 28.2 14.1 15.1 10.4 9.0 17.2 12.7 12.7 38.3 8.8 12.7 10.5 13.2 10.5 11.1 7.9 9.1 24.8 14.2 10.0 15.3 10.1 8.3 6.3 6.3 14.2 5.0 7.5 7.1 4.6 6.9 12.4 5.7 15.3 12.1 7.2 3.8 4.4 7.5 2.5 4.0 4.5 8.2 8.4 10.7 8.9 8.9 7.5 7.1 2.6 12.2 4.6 13.4 7.3 4.4 8.5 3.4 10.8 6.9 6.8 1.9 6.3 9.8 4.8 7.4 4.0 19.2 20.4 4.3 1.7 10.9 8.8 2.1 13.8 8.4 8.5 14.2 8.0 7.3 3.5 7.6 11.2 4.9 5.7 3.4 6.1 8.0 3.5 10.5 7.7 5.8 7.2 7.3 5.5 14.2 4.9 4.0 6.5 5.0 7.1 4.5 4.5 5.1 5.1 6.3 4.7 5.5 7.8 7.5 4.7 6.3 3.3 4.6 13.0 17.9 18.3 22.0 13.0 13.7 14.5 11.7 15.1 9.1 TRDMT1 "DNMT2, RNMT1" ENSG00000107614 "TRNA aspartic acid methyltransferase 1" O14717 10 17142254-17202054 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009468, HPA036945, HPA036946" Approved Approved Nucleoplasm,Nucleoli,Centrosome Nucleoli "Nucleoplasm, Centrosome" "CAB009468: AB_2208432, HPA036945: , HPA036946: " "unprognostic (4.55e-1)" "unprognostic (3.22e-2)" "unprognostic (4.49e-6)" "unprognostic (7.07e-2)" "unprognostic (3.87e-3)" "unprognostic (1.33e-1)" "unprognostic (3.27e-4)" "unprognostic (3.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (3.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (2.64e-2)" 6.1 4.4 4.4 8.5 7.7 4.0 6.3 14.0 6.2 5.3 3.8 4.2 4.7 4.1 7.5 14.4 3.9 6.8 5.1 5.0 4.9 4.5 6.7 2.7 5.3 5.3 4.3 2.9 9.6 5.0 12.8 12.6 5.1 6.2 5.0 3.6 8.0 5.6 3.8 4.3 4.4 5.0 5.4 5.1 5.9 4.2 4.2 6.1 19.9 11.5 3.3 5.7 4.0 5.2 6.1 10.5 5.2 4.4 3.5 8.0 3.6 5.1 2.5 10.0 2.6 3.8 2.2 0.0 4.4 3.2 4.7 5.5 4.2 4.3 3.5 0.6 5.0 2.6 6.7 4.2 5.4 7.4 4.3 5.2 3.8 2.5 3.4 3.4 3.9 3.0 2.6 3.2 2.3 6.1 6.5 3.9 7.7 1.6 17.0 0.8 6.3 2.9 3.7 7.8 2.2 2.5 2.8 2.7 3.4 0.0 1.9 3.4 4.8 3.1 3.6 3.4 7.2 6.3 5.1 5.0 4.7 8.9 4.3 4.8 3.4 5.2 4.4 2.4 3.9 2.5 7.2 5.4 6.6 4.9 5.5 6.1 8.0 5.8 2.8 3.5 1.4 10.5 2.2 3.6 4.4 7.7 14.0 6.2 4.9 4.5 4.3 2.9 6.2 6.1 TRIAP1 "HSPC132, MDM35, P53CSV, WF-1" ENSG00000170855 "TP53 regulated inhibitor of apoptosis 1" O43715 12 120443961-120446412 "Predicted intracellular proteins, Transporters" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053640 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA053640: " "unprognostic (8.74e-3)" "unprognostic (9.44e-2)" "unprognostic (5.24e-2)" "unprognostic (4.06e-2)" "unprognostic (3.07e-1)" "unprognostic (1.40e-1)" "unprognostic (1.19e-2)" "unprognostic (3.31e-2)" "prognostic unfavourable (2.22e-4)" "unprognostic (9.87e-3)" "unprognostic (4.39e-2)" "unprognostic (9.93e-2)" "prognostic unfavourable (8.77e-4)" "unprognostic (8.81e-2)" "unprognostic (2.00e-1)" "unprognostic (6.44e-2)" "unprognostic (4.97e-2)" 11.7 16.8 10.6 12.5 13.1 14.6 20.6 9.1 12.4 9.4 12.5 8.0 12.0 10.0 9.9 11.6 15.4 9.3 12.7 17.3 13.6 8.3 12.5 34.5 14.2 13.6 15.5 11.9 7.7 36.5 5.7 8.6 17.8 13.5 12.4 17.0 6.8 19.3 8.6 29.1 16.8 12.1 11.1 10.4 12.3 12.3 11.2 11.6 11.7 11.2 21.5 13.9 12.0 10.0 17.4 28.2 9.0 24.8 22.2 25.5 19.6 15.8 21.7 20.0 13.6 17.4 26.9 47.8 20.9 14.9 18.6 15.4 18.1 8.9 31.4 17.8 17.0 10.9 23.1 34.4 19.7 13.9 25.9 19.1 15.2 47.5 26.0 32.0 14.8 27.8 43.5 18.2 26.1 38.3 30.5 8.2 27.0 19.9 24.0 43.2 28.5 17.7 20.0 18.8 32.6 23.8 17.8 19.7 12.9 24.0 8.3 17.7 27.6 18.8 21.7 12.0 18.1 12.0 12.6 21.0 33.2 33.7 18.4 24.8 20.8 9.0 22.0 8.0 20.7 24.8 24.9 17.4 20.3 19.7 28.2 15.8 25.5 22.0 1.9 22.2 16.5 25.4 17.6 19.6 10.6 13.1 9.1 12.4 13.6 8.3 15.5 11.9 13.5 11.6 TRIB2 "GS3955, TRB2" ENSG00000071575 "Tribbles pseudokinase 2" Q92519 2 12716889-12742734 "Enzymes, Predicted membrane proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 40.2;HEL: 39.4;K-562: 53.6;SK-MEL-30: 39.1;WM-115: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 24.8" "Group enriched" "Detected in many" 9 "B-cells: 7.1;NK-cells: 9.5;T-cells: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001305 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001305: AB_1080371" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (4.31e-3)" "unprognostic (1.86e-3)" "unprognostic (6.68e-3)" "unprognostic (3.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.80e-2)" "unprognostic (3.32e-2)" "unprognostic (2.52e-3)" "unprognostic (1.67e-2)" "unprognostic (1.08e-3)" "unprognostic (1.30e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-2)" "unprognostic (2.13e-2)" 19.6 30.9 13.2 17.7 13.3 7.0 23.2 23.2 23.0 10.8 12.3 10.5 6.7 8.7 23.0 22.6 8.1 11.6 14.5 18.2 15.0 10.8 24.8 10.6 18.9 33.0 13.4 16.2 52.3 14.4 6.6 11.3 23.0 15.5 16.3 6.9 35.7 9.9 13.6 6.9 8.2 11.9 17.6 10.4 38.9 19.5 13.9 10.1 37.3 12.1 6.2 33.4 21.9 23.2 7.1 0.6 1.5 0.1 9.5 24.8 4.5 0.0 0.0 30.6 40.2 11.0 10.2 0.0 1.7 1.6 1.0 1.7 0.1 3.3 3.4 1.2 3.6 0.5 2.2 3.4 0.9 3.8 6.3 39.4 0.1 0.5 13.7 2.2 15.1 9.4 3.5 4.4 1.2 4.8 53.6 0.0 1.7 0.3 5.0 9.4 14.5 3.9 0.0 10.2 1.4 7.0 5.0 26.4 12.6 0.2 1.6 39.1 0.0 0.2 3.0 14.6 7.3 0.1 3.8 0.0 0.0 4.9 7.8 7.7 53.8 0.8 0.1 1.5 7.3 0.0 8.8 5.3 14.4 7.7 0.6 7.1 8.5 5.2 0.3 9.5 0.1 0.0 24.8 4.5 13.2 13.3 23.2 23.0 15.0 10.8 13.4 16.2 15.5 10.1 TRIM14 KIAA0129 ENSG00000106785 "Tripartite motif containing 14" Q14142 9 98069275-98119212 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053217 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA053217: " "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (1.82e-1)" "unprognostic (3.64e-1)" "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-1)" "unprognostic (9.80e-2)" "unprognostic (9.00e-2)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (6.63e-2)" "unprognostic (8.61e-3)" "unprognostic (3.55e-3)" "unprognostic (4.57e-2)" 9.2 3.3 6.4 20.2 7.6 6.4 6.2 1.4 5.4 5.2 15.4 4.2 1.1 18.1 3.8 4.9 16.8 3.8 10.8 4.1 5.9 4.4 13.4 19.8 14.3 24.4 5.2 3.5 4.5 3.9 15.0 5.0 5.7 5.6 8.2 10.7 4.7 7.7 3.5 1.0 6.0 31.8 5.3 5.8 30.4 7.0 6.2 5.7 35.2 3.2 3.7 19.5 8.9 7.4 4.4 8.0 2.4 27.7 6.2 11.5 7.5 10.2 5.3 0.2 4.8 0.0 1.7 3.6 6.0 11.8 33.8 29.2 10.2 6.2 13.7 5.0 6.6 11.8 10.4 6.9 10.4 17.4 8.5 4.0 8.5 10.0 7.4 21.4 4.5 1.0 3.4 4.9 6.4 4.2 15.8 6.5 3.0 13.3 16.8 6.8 6.0 16.7 10.8 0.6 6.9 2.7 6.4 1.7 1.4 8.6 18.2 5.8 4.8 12.4 2.9 1.4 3.6 0.5 8.3 2.8 3.3 4.6 3.9 16.9 4.7 0.4 7.4 1.0 8.1 14.5 8.9 4.4 9.3 8.4 7.9 3.3 7.4 6.2 2.4 6.2 27.7 8.0 11.5 7.5 6.4 7.6 1.4 5.4 5.9 4.4 5.2 3.5 5.6 5.7 TRIM21 "RNF81, Ro/SSA, RO52, SSA1" ENSG00000132109 "Tripartite motif containing 21" P19474 11 4384897-4393696 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004566, HPA005673" Approved Approved Nucleoplasm Nucleoplasm "CAB004566: AB_628286, HPA005673: AB_1080090" "prognostic favourable (4.83e-5)" "unprognostic (4.55e-2)" "unprognostic (3.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.87e-4)" "unprognostic (1.20e-1)" "unprognostic (5.04e-2)" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (3.31e-1)" "unprognostic (1.82e-2)" "unprognostic (6.27e-2)" "unprognostic (4.69e-2)" "prognostic favourable (2.26e-6)" "unprognostic (9.12e-3)" 18.2 12.1 4.9 13.7 6.5 15.0 9.8 2.5 6.4 15.0 11.7 6.4 6.0 12.5 11.6 10.3 14.6 10.4 10.8 8.5 5.0 5.3 12.9 14.9 14.6 21.4 6.8 4.0 17.4 10.7 4.3 9.9 19.9 8.6 18.0 12.0 8.5 11.9 8.6 4.5 6.9 21.8 12.0 4.7 28.3 13.5 6.0 4.7 21.5 19.1 6.8 17.0 11.6 13.5 10.9 22.0 72.4 27.5 14.5 19.5 28.6 5.9 7.0 3.5 3.3 7.3 11.0 4.9 7.6 14.4 30.2 33.5 3.2 17.2 9.1 3.5 11.2 8.5 6.2 11.6 9.4 15.2 6.9 14.0 4.0 2.8 16.2 16.5 13.9 10.7 7.0 6.1 4.2 18.4 4.4 10.0 10.0 5.2 8.6 12.1 3.0 3.6 6.1 4.6 5.0 11.9 5.5 0.0 1.5 6.2 7.0 8.4 2.4 11.3 16.5 7.4 5.8 3.8 2.8 5.3 4.1 5.8 6.6 13.1 5.2 18.8 26.9 60.1 19.3 27.5 16.8 10.5 16.6 17.1 22.0 10.9 14.9 15.7 72.4 14.5 24.4 7.4 19.5 28.6 4.9 6.5 2.5 6.4 5.0 5.3 6.8 4.0 8.6 4.7 TRIM27 "RFP, RNF76" ENSG00000204713 "Tripartite motif containing 27" P14373 6 28903002-28923989 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048684, HPA053408" Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA048684: , HPA053408: " "unprognostic (1.57e-1)" "unprognostic (1.48e-2)" "unprognostic (2.36e-1)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (2.56e-1)" "unprognostic (2.00e-3)" "unprognostic (1.17e-2)" "unprognostic (1.01e-2)" "unprognostic (1.12e-3)" "unprognostic (4.76e-3)" "unprognostic (1.16e-2)" "prognostic unfavourable (3.50e-6)" "unprognostic (1.27e-1)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "prognostic favourable (2.71e-4)" 11.5 10.6 8.8 25.5 9.7 7.9 9.3 10.1 12.2 11.2 10.2 8.7 20.2 23.8 12.1 13.2 7.8 12.1 11.4 8.1 8.2 9.6 10.1 22.5 10.4 17.4 12.6 8.3 14.7 31.0 7.4 13.9 13.7 10.6 13.7 4.6 7.7 17.0 25.2 12.2 9.7 19.4 9.2 8.4 18.6 18.5 9.2 9.2 16.7 12.5 7.9 12.1 9.9 11.8 12.5 12.5 13.8 13.9 11.2 15.9 13.8 3.3 2.3 0.9 6.0 0.8 1.7 0.6 4.6 1.1 1.4 1.7 1.7 1.4 7.7 7.9 1.3 7.4 1.1 2.7 0.1 3.0 12.9 10.8 0.5 2.3 1.3 4.5 1.7 1.3 1.6 1.2 0.5 1.2 10.5 3.3 0.4 1.3 6.3 2.4 0.0 7.3 9.0 6.9 14.2 1.1 1.1 3.2 12.9 5.5 3.4 7.3 3.3 3.5 3.9 3.4 7.1 6.2 2.7 12.0 14.4 12.0 1.8 11.5 5.2 12.6 13.8 8.8 12.7 13.9 15.9 12.5 12.6 14.4 12.5 10.5 11.8 12.1 13.8 11.2 12.1 9.8 10.4 13.8 8.8 9.7 10.1 12.2 8.2 9.6 12.6 8.3 10.6 9.2 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392777-114511160 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 48.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favourable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favourable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 15.2 12.8 16.9 18.4 19.9 27.1 17.1 38.3 21.8 16.9 14.3 11.0 21.9 10.9 19.8 38.3 16.4 15.0 15.6 10.8 18.1 12.5 17.3 15.0 14.3 15.2 12.1 18.0 19.8 15.7 21.8 22.4 27.2 15.2 16.5 13.0 10.7 16.4 19.1 14.3 19.5 14.8 20.2 12.9 14.9 14.1 29.0 16.3 20.5 17.9 9.8 16.6 17.9 28.7 3.4 4.0 12.2 2.8 4.7 4.4 1.0 12.9 7.0 13.2 9.9 5.6 5.9 22.5 6.6 7.0 9.2 9.8 7.9 5.5 13.8 6.8 7.7 7.5 12.0 7.7 12.7 10.4 7.1 13.3 9.2 9.1 6.2 16.8 11.1 5.6 5.7 10.9 11.2 7.7 16.6 9.8 8.8 48.5 16.9 7.1 17.8 7.1 14.6 20.2 4.5 6.6 20.4 9.2 9.7 12.5 15.1 11.9 6.9 9.2 8.6 6.4 10.5 14.8 9.2 6.9 6.4 14.5 9.1 9.8 18.2 12.2 1.6 7.4 3.5 1.8 3.1 3.4 3.7 3.7 2.0 2.2 2.9 4.4 4.8 4.7 2.8 4.0 2.0 1.0 16.9 19.9 38.3 21.8 18.1 12.5 12.1 18.0 15.2 16.3 TRIM35 "HLS5, KIAA1098, MAIR" ENSG00000104228 "Tripartite motif containing 35" Q9UPQ4 8 27284887-27311319 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019647 Approved Approved Nucleoplasm Nucleoplasm "HPA019647: AB_1858291" "unprognostic (7.67e-3)" "unprognostic (6.53e-2)" "unprognostic (1.61e-2)" "unprognostic (9.64e-3)" "unprognostic (9.35e-2)" "prognostic favourable (1.38e-4)" "unprognostic (8.79e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (2.30e-1)" "unprognostic (1.12e-1)" "unprognostic (4.86e-2)" "prognostic favourable (5.59e-7)" "unprognostic (1.74e-2)" "unprognostic (1.69e-1)" "unprognostic (3.99e-2)" "unprognostic (1.92e-1)" 10.6 7.2 5.7 8.1 8.9 8.6 17.7 5.7 12.9 8.2 7.9 8.7 17.3 7.2 10.2 6.6 11.7 8.2 6.3 6.9 10.9 5.9 11.3 14.6 8.4 12.7 7.3 7.3 8.7 11.6 6.8 5.1 7.1 7.0 8.3 5.4 5.4 23.4 27.7 5.8 32.7 7.3 9.7 12.6 7.8 6.8 10.4 6.6 10.2 6.1 7.4 9.0 8.6 10.8 5.2 5.9 8.7 3.0 7.8 12.8 4.8 8.8 6.4 3.7 4.8 37.4 9.3 8.6 5.4 4.3 5.0 5.4 9.1 1.8 7.9 5.6 5.9 8.9 5.3 10.4 3.8 4.4 4.0 7.7 5.0 7.7 9.7 4.2 6.7 13.5 23.7 7.1 14.1 4.9 5.4 8.8 4.0 4.6 14.0 5.8 6.5 5.2 7.1 4.8 6.8 3.4 6.9 6.4 6.1 4.5 4.3 7.4 2.7 6.8 5.8 4.6 9.6 14.4 5.2 4.0 4.2 5.8 6.6 6.2 4.4 8.7 2.8 3.4 8.6 2.7 9.7 5.2 11.2 9.5 3.5 3.7 7.7 11.3 1.1 7.8 3.0 5.9 12.8 4.8 5.7 8.9 5.7 12.9 10.9 5.9 7.3 7.3 7.0 6.6 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 88.8" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 7.5;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 43 "dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061321 Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA061321: " "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 1.0 1.4 6.8 1.4 7.6 0.8 3.2 0.6 11.7 1.4 4.8 7.7 0.0 8.2 1.1 1.0 0.8 1.9 1.0 0.7 10.1 7.2 0.9 0.9 1.6 0.8 7.1 8.6 3.5 1.5 0.7 8.2 1.3 18.3 5.7 4.8 5.1 1.0 1.0 0.7 1.0 7.9 1.1 8.7 0.9 2.0 88.8 4.7 0.0 0.8 0.0 0.9 0.8 1.0 0.1 7.5 4.2 7.7 0.0 0.0 0.8 2.4 0.7 1.2 6.2 0.1 0.1 1.5 0.5 2.1 1.1 1.3 0.9 1.2 0.0 1.0 0.1 0.6 5.8 1.1 0.8 0.4 1.9 4.3 2.5 1.2 0.2 4.2 3.6 0.1 1.1 0.5 1.5 0.0 0.1 5.9 1.7 3.3 1.1 3.8 4.9 2.8 0.9 17.8 1.4 0.6 0.0 19.9 14.5 3.8 0.4 2.3 4.2 5.3 0.5 1.7 1.3 1.3 1.9 0.9 0.5 0.0 1.9 2.4 0.8 0.0 1.7 4.2 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.3 0.0 7.7 1.6 0.0 0.8 6.8 7.6 0.6 11.7 10.1 7.2 7.1 8.6 18.3 4.7 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085439-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavourable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favourable (2.13e-4)" 14.3 12.0 6.2 15.7 9.3 4.7 24.5 3.2 11.1 14.9 15.0 6.8 22.3 9.7 14.3 13.1 12.9 12.8 13.7 8.7 7.5 5.2 10.8 10.4 23.7 11.7 15.8 5.2 17.3 10.8 10.7 15.2 14.0 8.8 12.5 8.3 7.5 12.2 22.1 8.7 13.2 12.8 15.2 8.5 17.2 10.3 5.6 12.0 9.7 14.0 9.1 12.0 13.6 22.0 3.3 2.1 7.4 2.4 7.7 3.6 1.0 9.9 12.5 5.4 6.9 12.5 13.0 6.5 8.3 7.4 13.5 12.6 5.9 14.5 11.8 9.0 6.9 11.5 2.2 7.6 9.1 11.8 3.5 7.4 15.7 4.4 11.2 13.1 16.9 8.2 11.1 8.8 14.4 7.1 12.9 15.0 9.3 13.6 11.0 14.6 5.4 10.4 10.2 8.8 7.7 7.1 10.4 0.3 0.2 9.2 25.8 7.0 5.9 8.6 13.4 19.0 16.9 14.2 8.9 7.4 7.4 9.3 9.4 10.7 14.8 2.5 2.4 2.1 3.6 1.5 2.6 2.0 2.7 2.3 0.8 3.3 2.6 3.4 7.4 7.7 2.1 2.1 1.1 1.0 6.2 9.3 3.2 11.1 7.5 5.2 15.8 5.2 8.8 12.0 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell line enhanced" "Detected in many" "HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 2.9 0.0 0.3 0.5 0.5 0.1 1.4 0.0 0.5 1.2 0.2 8.0 0.4 4.3 1.7 11.2 3.2 9.2 0.1 23.8 1.3 0.5 7.8 0.1 1.6 0.0 1.3 0.1 7.1 0.2 4.6 2.6 0.3 1.3 0.2 0.8 0.3 0.2 0.0 13.2 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.1 4.0 0.7 0.2 10.8 0.1 2.4 0.4 4.2 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214021-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 71.6;tongue: 37.7" "Cell line enhanced" "Detected in some" "HL-60: 4.7;LHCN-M2: 8.7;RH-30: 22.6;U-266/70: 14.1" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 12 "cerebellum: 3.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA054909: " "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 2.3 0.1 0.1 0.1 0.2 0.3 0.1 3.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 5.5 1.8 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.0 71.6 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 37.7 1.9 0.0 0.0 2.0 1.9 4.9 1.3 2.1 1.3 0.4 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.6 0.3 0.2 4.7 0.2 1.0 0.1 0.0 0.1 0.0 0.3 0.5 8.7 0.2 0.1 0.4 0.2 0.3 0.3 22.6 3.0 0.0 0.3 1.9 0.2 0.2 0.3 0.1 0.2 1.9 0.1 0.2 0.3 0.2 0.1 14.1 1.2 0.2 0.2 0.3 0.2 4.5 1.3 1.5 1.1 1.2 1.0 1.3 1.0 0.9 0.8 2.0 1.3 1.3 4.9 2.1 1.2 1.9 0.8 0.4 0.1 0.2 3.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751526 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 19.4" "Lineage enriched" "Detected in many" 12 "dendritic cells: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles 15000 Vesicles Nucleoplasm "HPA041934: , HPA072625: , HPA073886: " "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavourable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favourable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavourable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 19.7 10.7 6.0 9.2 7.2 2.3 16.8 3.7 5.4 25.6 19.1 4.5 20.6 9.7 17.8 16.7 44.8 12.0 17.6 18.1 6.5 1.9 14.0 4.5 19.5 5.4 6.7 3.5 22.4 12.9 7.0 4.8 25.4 7.0 19.2 6.6 20.2 16.1 18.3 103.7 10.4 10.1 20.9 6.7 7.1 11.3 8.7 5.4 2.8 31.7 21.6 21.7 24.3 26.5 1.5 19.4 0.1 0.7 1.6 0.9 0.4 26.6 16.2 5.7 8.6 22.4 23.5 20.5 17.2 19.9 19.7 17.3 21.9 15.4 0.5 23.4 14.5 19.9 12.8 25.1 11.8 16.8 5.1 8.7 15.3 16.7 18.4 0.4 2.7 27.1 17.1 17.5 13.5 20.2 12.7 7.3 14.4 9.0 2.3 6.0 12.1 13.8 3.9 11.7 7.8 16.6 13.3 0.0 6.6 22.7 10.2 6.4 10.7 4.7 39.4 13.3 23.9 34.7 18.1 7.7 4.2 2.6 21.5 2.5 8.7 0.0 0.7 0.0 0.5 0.1 0.7 1.2 0.2 0.9 3.8 1.5 0.3 0.2 0.1 1.6 0.1 19.4 0.0 0.4 6.0 7.2 3.7 5.4 6.5 1.9 6.7 3.5 7.0 5.4 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: " "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favourable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 13.0 15.0 10.5 10.8 12.5 7.7 12.1 18.5 14.1 17.4 13.0 8.8 15.2 11.1 13.3 12.7 14.7 11.4 11.2 12.9 9.2 6.7 15.5 16.1 10.6 9.4 12.2 11.1 16.0 27.1 27.1 34.9 24.4 15.2 14.5 11.0 9.4 15.1 15.3 24.0 12.4 15.9 11.2 10.7 15.2 16.2 14.0 13.5 16.4 18.4 11.1 11.9 15.8 12.5 20.0 12.7 17.0 13.0 12.1 14.1 3.9 12.4 12.6 8.2 8.6 14.5 22.5 12.5 19.8 15.2 9.8 11.3 7.6 20.3 8.7 14.6 17.4 16.4 10.8 9.6 21.5 13.2 3.3 9.8 11.4 7.2 11.1 11.5 9.8 8.6 11.8 17.3 14.9 15.6 6.4 10.1 15.3 17.4 6.5 2.8 3.7 9.0 8.1 15.7 4.3 8.8 20.4 6.0 5.4 16.0 9.4 6.1 20.5 5.8 20.6 11.4 8.1 11.9 8.9 9.0 13.8 7.8 13.4 6.5 14.3 8.2 8.8 17.0 13.3 8.0 12.8 11.8 14.1 12.1 6.9 20.0 13.5 14.1 8.7 12.1 13.0 12.7 12.2 3.9 10.5 12.5 18.5 14.1 9.2 6.7 12.2 11.1 15.2 13.5 TRIP13 16E1BP ENSG00000071539 "Thyroid hormone receptor interactor 13" Q15645 5 892643-919357 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.4;testis: 52.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005727, HPA053093" Enhanced Approved Nucleoplasm Nucleoplasm "HPA005727: AB_10603220, HPA053093: " "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (8.59e-2)" "prognostic unfavourable (3.93e-4)" "unprognostic (2.34e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (1.30e-6)" "unprognostic (4.44e-3)" "unprognostic (1.73e-3)" "prognostic favourable (1.39e-4)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.99e-1)" "unprognostic (1.31e-1)" "unprognostic (3.34e-1)" 1.5 0.9 1.7 8.6 1.2 3.4 1.7 0.6 1.6 1.6 2.7 0.4 1.4 2.4 1.6 1.9 5.3 4.9 2.4 1.2 1.4 1.7 1.3 0.8 1.5 4.7 0.6 0.6 2.1 1.0 0.0 1.9 2.8 1.0 1.0 4.5 0.4 1.3 1.0 0.6 1.4 2.5 2.5 0.7 3.8 1.4 52.9 0.3 16.4 0.5 8.8 6.3 1.1 1.8 2.7 2.3 0.0 0.3 3.3 4.8 0.9 19.3 22.5 14.6 20.6 1.3 3.3 15.3 20.5 10.3 32.6 30.6 21.1 13.4 17.5 14.7 12.1 14.2 30.9 14.6 40.7 26.1 24.1 12.2 42.2 15.3 0.3 19.8 7.3 1.4 1.0 27.1 11.9 15.9 17.9 15.5 22.2 13.2 19.2 16.4 16.0 19.6 11.5 27.1 32.6 8.7 10.4 14.5 14.9 31.1 11.3 6.0 21.7 9.3 8.1 17.4 21.6 14.1 22.8 9.1 19.9 19.0 10.3 22.7 18.9 0.0 0.1 0.0 1.0 0.1 0.5 2.7 1.4 1.9 0.3 2.1 0.6 0.2 0.0 3.3 0.3 2.3 4.8 0.9 1.7 1.2 0.6 1.6 1.4 1.7 0.6 0.6 1.0 0.3 TRIR "C19orf43, fSAP18, MGC2803, TERCIR" ENSG00000123144 "Telomerase RNA component interacting RNase" Q9BQ61 19 12730640-12734775 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059965 Approved Approved Nucleoplasm Nucleoplasm "HPA059965: " "unprognostic (5.57e-2)" "unprognostic (2.73e-3)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (3.17e-3)" "unprognostic (1.93e-2)" "unprognostic (1.74e-1)" "unprognostic (9.33e-3)" "unprognostic (2.43e-3)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (4.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.63e-3)" "unprognostic (1.02e-2)" 58.6 48.6 51.6 64.7 48.9 62.7 53.7 46.3 51.2 61.9 66.0 33.6 45.5 46.8 49.7 68.4 60.0 37.8 59.2 51.5 45.8 41.4 49.1 97.1 45.4 51.8 47.1 39.3 62.3 53.8 31.4 40.2 62.1 31.3 60.4 40.4 36.7 55.6 48.0 77.3 42.5 55.6 47.6 45.1 65.1 48.4 45.8 32.6 87.1 59.5 39.0 59.1 62.2 80.7 24.7 13.6 33.8 10.9 10.6 16.1 5.6 43.9 23.7 29.8 22.0 24.1 25.7 28.8 37.5 23.1 28.8 28.2 31.4 15.4 35.0 49.2 22.2 30.4 29.8 23.7 23.4 39.7 57.5 23.3 27.1 50.9 23.4 33.6 44.4 26.0 29.3 21.9 17.5 27.3 32.3 14.6 26.6 95.1 55.7 79.3 33.9 67.7 48.5 23.4 34.9 33.7 30.1 33.9 45.2 25.6 26.4 42.1 22.9 51.9 28.1 34.7 27.9 54.0 47.9 48.9 52.5 39.0 29.4 41.1 24.3 8.0 10.9 33.8 11.4 9.3 13.3 24.7 14.8 14.6 9.7 17.5 14.0 12.5 21.0 10.6 8.7 13.6 16.1 5.6 51.6 48.9 46.3 51.2 45.8 41.4 47.1 39.3 31.3 32.6 TRIT1 "FLJ20061, IPT" ENSG00000043514 "TRNA isopentenyltransferase 1" Q9H3H1 1 39841022-39883511 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024174 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024174: AB_1858346" "unprognostic (4.61e-2)" "unprognostic (1.77e-1)" "unprognostic (8.38e-3)" "prognostic unfavourable (8.80e-4)" "unprognostic (4.00e-2)" "unprognostic (8.55e-2)" "prognostic unfavourable (5.34e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-3)" "unprognostic (3.18e-2)" "unprognostic (3.54e-1)" "unprognostic (6.68e-3)" "prognostic unfavourable (7.08e-8)" "unprognostic (6.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (6.90e-2)" 9.5 10.3 12.9 10.4 19.1 8.0 19.8 25.8 18.4 15.1 13.4 15.9 22.7 11.4 19.3 21.3 19.8 18.4 9.1 15.9 12.5 12.0 14.6 13.2 11.9 14.8 13.9 10.4 16.7 27.7 14.1 26.7 17.6 14.4 21.4 15.8 13.5 15.1 23.9 10.1 22.9 11.7 18.0 9.8 14.0 12.9 17.3 17.9 15.4 19.2 9.4 14.7 17.2 17.5 3.9 13.4 0.9 6.6 2.4 5.2 2.8 14.5 6.7 14.6 14.9 7.3 11.0 22.0 9.7 13.0 15.6 17.6 12.9 19.2 8.4 12.8 8.2 14.8 21.0 16.7 21.9 10.3 10.6 18.0 15.6 8.0 16.9 17.5 9.9 9.3 15.1 19.5 19.3 12.5 24.4 10.2 9.7 7.1 13.3 18.8 19.6 6.1 14.2 18.3 19.3 14.8 18.7 16.6 11.1 13.9 9.5 10.6 10.5 30.0 8.9 10.4 12.8 18.0 16.0 13.8 10.8 17.1 13.2 17.9 9.0 0.0 6.6 0.9 2.7 4.9 5.2 3.9 2.6 2.9 13.4 3.2 3.4 3.5 0.1 2.4 5.8 11.6 2.7 2.8 12.9 19.1 25.8 18.4 12.5 12.0 13.9 10.4 14.4 17.9 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922570 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm Nucleoplasm "HPA021281: , HPA052197: " "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favourable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 12.2 15.9 13.6 22.5 14.2 20.4 19.3 15.9 14.9 13.5 10.0 19.2 14.9 9.4 15.1 17.3 12.9 15.0 10.6 9.1 13.0 12.3 13.9 17.6 17.9 23.0 14.2 16.3 13.9 13.7 15.7 26.7 10.4 13.3 14.0 11.6 13.4 19.7 11.7 14.1 15.0 14.8 10.1 15.0 20.8 12.8 18.2 14.2 22.8 26.1 10.3 19.1 11.9 10.7 15.8 13.4 28.8 13.7 11.9 25.8 12.0 15.1 9.7 5.2 6.4 6.6 5.5 9.1 7.8 8.9 12.3 9.3 13.4 11.0 9.6 5.4 7.5 14.4 8.5 6.2 9.7 11.3 6.9 7.6 11.7 11.9 13.8 14.8 12.9 9.6 13.8 6.7 5.8 5.4 12.3 12.2 8.5 22.0 6.3 10.4 7.3 11.0 7.7 11.6 6.9 11.6 12.4 9.4 8.3 5.9 12.3 12.6 5.4 8.3 8.2 6.9 6.9 14.2 11.7 13.5 9.6 4.9 7.2 7.8 6.0 20.1 12.8 28.8 12.9 13.7 15.9 11.9 19.8 15.5 13.4 15.8 25.8 17.9 20.9 11.9 9.1 7.8 20.2 12.0 13.6 14.2 15.9 14.9 13.0 12.3 14.2 16.3 13.3 14.2 TRMT1 "FLJ20244, TRM1" ENSG00000104907 "TRNA methyltransferase 1" Q9NXH9 19 13104902-13117567 "Enzymes, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041130, HPA041380" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041130: AB_10803995, HPA041380: AB_10793873" "unprognostic (2.10e-2)" "unprognostic (2.40e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-2)" "unprognostic (5.54e-2)" "unprognostic (1.08e-3)" "unprognostic (2.19e-2)" "unprognostic (1.59e-1)" "unprognostic (7.62e-2)" "unprognostic (1.91e-2)" "unprognostic (8.74e-3)" "prognostic unfavourable (9.87e-7)" "unprognostic (1.19e-3)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-2)" 15.5 15.0 19.1 19.8 23.5 23.1 16.6 19.5 22.6 15.0 16.3 17.3 15.5 14.9 19.2 19.0 17.6 19.6 19.4 13.2 15.7 13.4 14.4 17.3 13.5 26.8 22.1 14.7 29.1 23.8 16.3 14.4 14.4 21.9 18.1 14.5 10.9 14.9 15.6 21.4 22.1 16.1 16.5 12.4 25.0 16.3 16.8 20.1 12.2 15.6 12.1 19.6 17.3 18.8 11.2 14.9 3.1 15.7 4.3 10.2 8.5 15.3 10.4 11.3 19.1 11.5 14.7 16.2 17.3 8.7 19.1 16.6 11.1 12.7 19.3 22.7 9.3 14.3 18.8 15.2 8.9 12.6 26.3 15.3 26.7 18.6 20.8 30.7 18.1 20.8 20.5 19.9 18.7 14.0 33.2 6.2 11.8 17.0 12.4 33.2 26.7 24.4 21.0 14.5 26.6 11.9 15.7 26.8 12.2 10.8 22.5 18.0 8.7 17.2 15.6 27.6 10.7 16.6 30.3 10.7 20.7 17.8 12.9 32.5 14.3 1.2 15.7 0.5 8.1 11.9 7.7 10.4 8.6 7.7 14.9 11.2 10.2 7.7 3.1 4.3 7.5 8.8 5.6 8.5 19.1 23.5 19.5 22.6 15.7 13.4 22.1 14.7 21.9 20.1 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favourable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favourable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 7.4 10.3 9.9 10.9 10.3 10.1 9.8 13.7 12.3 10.6 11.8 12.7 12.8 8.3 17.3 9.5 10.4 9.6 10.6 7.0 9.9 9.2 8.2 8.0 8.6 13.1 16.4 9.8 15.4 10.5 9.0 13.8 7.4 10.0 14.8 7.1 12.1 10.3 12.1 7.8 20.4 9.7 11.8 12.7 12.1 10.8 5.0 10.4 10.0 12.4 5.6 13.6 14.8 10.1 9.2 4.6 6.6 5.3 4.6 7.6 2.7 5.4 6.4 8.3 7.3 5.1 4.1 3.9 5.4 3.8 5.4 4.7 3.9 4.8 10.0 4.0 4.0 6.3 3.9 6.4 5.0 4.3 6.9 8.8 15.7 4.0 9.3 8.9 6.3 4.7 6.7 4.7 9.2 5.5 7.0 4.4 4.1 3.8 9.2 7.1 7.4 7.9 9.3 2.9 5.2 5.2 5.0 11.3 10.8 4.3 5.4 4.7 5.9 6.6 5.5 4.3 6.1 6.8 4.6 5.0 6.9 8.0 2.5 7.2 8.6 6.6 5.3 2.8 6.7 4.6 7.6 6.6 6.0 6.3 2.5 9.2 7.3 6.7 5.4 4.6 3.2 4.6 3.9 2.7 9.9 10.3 13.7 12.3 9.9 9.2 16.4 9.8 10.0 10.4 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64318084 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavourable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavourable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 44.2 77.0 41.9 40.9 37.6 48.3 57.9 30.9 48.5 52.8 39.2 33.5 38.4 25.9 50.9 58.6 54.2 68.1 49.4 47.4 37.4 51.8 47.4 68.6 41.7 58.2 42.8 34.3 81.9 53.4 36.3 54.0 54.5 35.1 55.7 26.9 50.0 44.5 50.5 53.6 38.6 28.6 50.3 38.7 52.7 35.6 54.6 31.0 64.7 85.5 55.2 57.3 56.2 62.8 132.1 97.2 92.4 58.5 53.2 98.2 112.6 54.2 79.7 26.7 40.8 25.7 21.1 27.8 24.5 24.5 24.9 19.9 40.8 53.4 38.4 79.1 20.4 46.0 40.2 44.6 19.1 47.9 45.1 42.8 72.0 95.9 28.7 34.3 30.0 25.2 45.5 22.4 42.5 25.2 35.9 52.8 23.2 144.7 51.5 69.9 74.4 69.8 31.1 29.9 57.3 28.8 57.0 17.8 83.9 33.9 42.2 73.9 68.1 32.8 23.8 31.8 40.3 55.1 48.1 43.9 71.9 63.9 43.4 35.6 33.8 92.4 58.5 81.7 67.6 47.2 69.2 132.1 88.5 74.6 59.3 112.8 98.2 85.3 69.7 53.2 42.3 97.2 77.4 112.6 41.9 37.6 30.9 48.5 37.4 51.8 42.8 34.3 35.1 31.0 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavourable (2.99e-5)" "prognostic unfavourable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavourable (9.25e-4)" "unprognostic (1.04e-2)" 10.8 11.6 16.7 8.4 20.9 4.1 15.0 13.8 18.3 11.8 9.5 8.0 6.8 7.5 11.9 10.7 9.6 13.2 8.6 9.9 19.4 9.9 12.9 9.8 9.8 11.8 13.6 14.3 8.8 10.1 14.7 17.7 8.9 14.7 12.0 11.2 7.8 12.0 11.0 18.0 9.9 9.6 14.3 12.9 11.0 10.6 11.7 13.4 9.1 14.9 12.0 10.7 10.2 8.5 5.8 5.0 6.3 6.1 5.1 7.6 4.4 7.4 6.5 5.4 4.2 10.3 5.3 1.3 4.7 5.5 7.0 6.0 3.9 5.2 7.6 6.5 4.8 5.2 7.7 7.7 8.3 7.5 5.8 7.3 6.2 1.3 8.1 0.0 5.9 6.5 10.4 6.8 8.7 5.8 10.2 5.3 4.3 37.1 8.5 3.1 0.0 6.0 2.7 3.6 5.0 6.4 8.1 9.2 7.3 6.9 26.1 9.7 7.4 3.1 4.6 4.8 12.7 3.6 5.3 5.5 7.7 2.9 4.4 2.6 3.9 0.5 6.1 6.3 4.5 4.9 5.6 4.0 6.1 4.6 5.0 5.8 7.6 7.4 2.4 5.1 5.5 1.5 3.7 4.4 16.7 20.9 13.8 18.3 19.4 9.9 13.6 14.3 14.7 13.4 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150497 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavourable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavourable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 13.0 12.2 13.9 21.7 24.1 5.9 18.3 26.5 22.5 17.4 13.1 18.2 24.2 13.6 17.4 15.4 13.7 13.9 9.6 12.0 14.4 9.0 12.1 13.0 9.6 20.9 23.1 12.8 21.4 18.1 23.8 26.8 13.2 15.6 14.9 14.4 10.8 14.3 17.4 16.9 17.9 14.2 14.3 19.4 16.5 12.6 11.1 25.8 17.8 16.5 12.0 17.6 13.9 15.8 15.1 9.6 2.2 4.5 5.4 13.6 3.9 10.6 6.2 10.5 7.3 5.7 11.2 11.5 11.3 4.5 8.6 7.2 7.4 4.4 17.6 14.1 9.0 9.7 19.3 8.7 15.0 17.7 15.3 10.5 13.8 7.1 10.3 18.1 9.9 7.8 10.0 16.3 21.5 7.8 22.0 11.4 8.6 4.0 14.8 9.6 14.6 12.6 15.9 15.9 9.6 7.1 8.5 6.9 11.5 10.4 10.0 13.3 5.9 16.1 8.1 11.5 7.7 9.6 15.0 14.6 11.8 20.9 13.0 14.6 4.4 0.1 4.5 2.2 8.5 4.4 10.4 14.8 9.0 8.3 5.2 15.1 13.6 11.1 1.9 5.4 3.5 9.6 6.2 3.9 13.9 24.1 26.5 22.5 14.4 9.0 23.1 12.8 15.6 25.8 TRMT1L C1orf25 ENSG00000121486 "TRNA methyltransferase 1 like" Q7Z2T5 1 185118098-185157072 "Predicted intracellular proteins" "Behavior, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026728 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA026728: AB_1845641" "unprognostic (1.07e-2)" "unprognostic (1.31e-1)" "unprognostic (8.55e-3)" "unprognostic (2.96e-1)" "unprognostic (1.46e-2)" "unprognostic (8.95e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-2)" "unprognostic (2.32e-1)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (8.75e-2)" "unprognostic (1.16e-2)" "unprognostic (7.44e-2)" "unprognostic (9.45e-2)" "unprognostic (7.87e-2)" "unprognostic (2.26e-1)" 7.6 12.9 9.4 10.1 12.8 5.9 8.9 14.2 11.3 10.5 10.0 9.6 9.6 9.6 9.3 11.3 10.5 12.6 8.2 13.2 10.3 10.6 15.3 16.0 10.3 11.1 11.2 9.1 13.7 8.3 18.0 26.9 9.7 11.9 11.7 8.5 5.2 7.6 10.0 27.4 5.5 8.7 8.5 12.4 12.8 8.4 29.4 12.8 16.5 12.4 7.6 13.0 11.8 12.2 16.2 12.1 19.0 15.8 11.0 12.7 8.1 8.0 14.8 10.2 7.6 15.1 13.9 14.5 7.8 7.0 10.7 11.2 13.4 15.5 8.8 19.5 5.3 10.4 17.1 10.2 10.5 10.4 7.4 8.4 11.2 13.6 10.5 12.4 14.0 6.7 13.9 10.9 11.0 11.7 22.0 12.1 12.7 6.8 9.4 7.2 16.9 3.1 11.1 14.7 14.0 10.3 8.9 9.1 8.1 15.2 14.8 10.5 15.1 7.0 11.2 9.8 7.8 6.7 10.4 19.5 26.1 14.0 6.4 11.0 9.4 16.8 9.8 19.0 7.4 13.4 7.9 11.7 9.7 8.9 12.1 16.2 12.2 9.5 11.1 11.0 15.8 5.1 12.7 8.1 9.4 12.8 14.2 11.3 10.3 10.6 11.2 9.1 11.9 12.8 TRMT2A HTF9C ENSG00000099899 "TRNA methyltransferase 2 homolog A" Q8IZ69 22 20111866-20117392 "Plasma proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001077 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA001077: AB_1079092" "unprognostic (5.01e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (9.70e-2)" "unprognostic (1.17e-1)" "unprognostic (8.05e-3)" "unprognostic (2.19e-3)" "unprognostic (5.93e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (2.99e-8)" "unprognostic (4.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.80e-1)" "unprognostic (1.14e-3)" 14.3 22.5 12.6 18.8 13.6 14.3 13.4 16.3 19.7 13.9 16.6 17.4 15.4 18.2 13.1 15.6 16.1 15.3 17.1 12.8 13.1 11.4 13.2 22.8 11.1 22.8 12.4 14.4 15.2 23.6 10.8 18.5 15.8 11.2 16.8 6.1 14.2 36.5 16.1 14.8 18.4 16.2 12.4 12.7 23.2 16.7 16.9 13.4 26.8 15.6 12.7 18.3 13.1 11.0 9.7 14.0 7.0 14.9 9.5 15.2 11.5 6.3 7.4 2.8 4.6 2.9 2.1 9.8 5.7 2.9 4.6 4.1 8.7 5.5 8.8 4.9 2.6 10.0 2.1 3.2 0.6 9.1 24.0 10.1 9.8 7.9 7.9 15.8 10.2 3.8 4.3 4.8 1.8 4.7 37.9 6.1 3.1 10.1 8.9 10.0 5.4 9.4 10.4 4.9 3.6 2.6 7.2 7.6 5.8 3.5 9.1 9.1 6.3 13.5 4.4 5.6 7.5 4.3 4.9 21.9 9.7 6.7 7.5 6.7 5.6 6.6 11.5 7.0 10.5 14.9 15.2 9.7 10.9 12.1 14.0 6.8 12.2 11.5 1.5 9.5 12.0 12.4 8.5 11.5 12.6 13.6 16.3 19.7 13.1 11.4 12.4 14.4 11.2 13.4 TRMT2B "CXorf34, FLJ12687" ENSG00000188917 "TRNA methyltransferase 2 homolog B" Q96GJ1 X 101009346-101052116 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003745, HPA035120, HPA040814" Uncertain Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA003745: , HPA035120: AB_10601702, HPA040814: " "prognostic unfavourable (1.58e-5)" "unprognostic (6.72e-3)" "unprognostic (3.28e-1)" "unprognostic (1.54e-2)" "unprognostic (4.44e-1)" "unprognostic (8.74e-2)" "unprognostic (3.52e-2)" "unprognostic (8.16e-3)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-2)" "prognostic favourable (2.30e-7)" "unprognostic (4.58e-2)" "unprognostic (4.82e-1)" "unprognostic (5.03e-2)" "unprognostic (1.60e-2)" 7.6 10.4 6.9 8.9 10.3 9.1 8.5 7.0 14.2 9.6 11.4 6.9 10.7 8.1 8.1 8.6 12.9 7.4 7.3 13.0 10.7 6.6 12.3 9.5 9.4 12.6 9.5 6.6 11.3 10.4 18.5 17.6 5.9 10.7 10.1 12.6 13.4 15.3 10.4 17.6 9.5 13.5 7.9 8.4 16.6 11.4 4.0 7.9 18.2 12.8 5.3 17.7 9.9 9.5 16.5 8.1 14.8 8.2 14.4 19.2 11.5 15.6 13.6 2.8 6.4 6.4 3.4 8.6 8.1 11.0 9.2 13.7 14.6 12.5 13.9 16.3 7.5 9.8 12.5 11.3 11.5 12.0 7.9 8.8 11.2 6.9 5.7 15.6 14.4 4.3 6.7 13.2 6.1 17.6 9.0 13.3 8.4 15.8 19.4 8.3 3.8 10.1 15.9 13.4 13.3 6.7 9.3 4.1 5.4 13.9 10.1 8.1 6.6 7.5 10.3 11.6 7.0 10.8 7.2 8.5 12.7 13.0 9.0 18.0 8.9 9.6 8.2 14.8 13.8 6.5 14.6 14.9 16.1 13.3 7.4 16.5 19.2 16.1 4.8 14.4 7.0 8.1 13.0 11.5 6.9 10.3 7.0 14.2 10.7 6.6 9.5 6.6 10.7 7.9 TRMT44 "C4orf23, FLJ35725, METTL19, TRM44" ENSG00000155275 "TRNA methyltransferase 44 homolog" Q8IYL2 4 8436140-8493531 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045461 Uncertain Approved Nucleoplasm Nucleoplasm "HPA045461: AB_10961276" "unprognostic (1.50e-1)" "unprognostic (1.65e-3)" "unprognostic (3.47e-1)" "unprognostic (1.01e-2)" "unprognostic (2.06e-1)" "unprognostic (1.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.78e-2)" "unprognostic (3.46e-1)" "unprognostic (8.13e-2)" "unprognostic (3.44e-3)" "unprognostic (2.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (6.76e-2)" "unprognostic (8.34e-3)" 11.5 7.6 13.3 7.3 17.5 13.1 15.4 20.3 16.2 10.1 9.2 14.1 10.1 7.1 16.3 10.7 13.6 12.3 8.6 9.8 12.1 6.3 7.1 8.9 8.8 9.8 12.2 14.7 17.1 9.7 11.3 10.9 10.2 8.7 10.8 7.2 9.4 12.4 8.7 11.5 17.2 7.6 9.7 6.7 8.1 11.3 15.8 13.8 7.8 9.9 9.0 10.7 10.8 11.4 2.1 2.1 0.4 2.1 0.8 3.0 0.5 5.5 5.8 7.3 8.6 7.8 7.6 15.9 6.6 4.7 8.8 7.9 7.1 7.9 7.6 3.2 2.6 4.3 10.6 6.5 7.7 3.8 5.2 7.1 9.1 5.6 6.7 12.2 5.9 4.6 8.9 6.7 7.3 9.3 10.8 8.2 5.5 3.6 10.1 8.9 8.3 8.8 7.5 7.8 4.8 7.5 6.7 8.0 5.5 4.3 3.9 5.8 3.5 4.7 5.5 5.4 3.0 5.0 10.1 9.6 6.0 7.0 5.9 11.4 5.2 0.4 1.2 0.1 2.3 1.2 1.6 0.8 2.1 2.5 2.1 2.1 3.0 0.9 0.2 0.8 2.1 1.7 0.2 0.5 13.3 17.5 20.3 16.2 12.1 6.3 12.2 14.7 8.7 13.8 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971451-60981358 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 15.8 10.1 7.9 13.8 12.1 5.4 12.9 9.3 11.8 10.9 8.6 5.7 11.9 7.5 12.0 10.9 11.1 10.0 6.7 6.8 7.7 7.1 12.5 13.9 6.6 7.3 6.7 8.3 17.1 11.1 15.9 13.1 10.8 9.0 10.6 8.1 4.8 11.5 9.9 14.8 9.7 7.4 9.2 6.3 8.6 8.1 24.9 5.9 12.4 10.4 12.1 7.2 13.3 9.0 7.2 7.4 0.9 7.5 2.0 6.0 3.7 28.3 7.3 10.7 14.9 9.4 14.2 11.7 10.7 8.2 11.5 9.1 5.3 17.0 14.6 11.9 7.7 13.1 13.4 15.4 15.1 14.4 6.8 10.7 4.9 5.9 15.4 18.9 6.0 11.2 15.0 10.4 15.4 10.0 13.9 5.2 16.8 10.7 9.7 9.5 9.8 12.0 3.1 24.8 12.3 9.7 9.6 13.1 13.0 11.9 11.9 9.4 19.9 11.4 9.4 13.3 16.1 9.4 10.1 3.2 6.0 6.9 9.3 4.1 12.4 0.1 4.6 0.9 3.5 7.5 5.0 7.2 5.2 5.2 4.2 4.9 5.6 5.1 0.4 2.0 7.5 7.4 6.0 3.7 7.9 12.1 9.3 11.8 7.7 7.1 6.7 8.3 9.0 5.9 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell line enhanced" "Detected in some" "AF22: 7.0;BJ: 10.0;fHDF/TERT166: 13.4;RPTEC TERT1: 4.7;SCLC-21H: 5.1;U-266/84: 4.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favourable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.0 0.0 0.0 0.0 1.7 10.0 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.4 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.5 0.0 0.1 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.0 1.1 0.1 0.1 4.7 0.2 5.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.9 1.0 0.1 0.4 4.8 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 TRMU "FLJ10140, MTO2, TRMT" ENSG00000100416 "TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA000824: , HPA035273: AB_10602901, HPA043300: " "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavourable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favourable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavourable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 8.5 16.1 11.5 9.9 16.0 6.4 7.5 17.8 16.0 9.7 8.7 11.5 10.2 10.9 12.1 18.0 10.9 6.2 7.3 16.8 11.3 11.9 20.5 18.8 7.1 10.2 15.7 11.8 8.0 22.7 20.0 13.6 9.7 11.2 8.7 10.2 9.0 12.5 15.5 17.8 9.8 7.6 9.4 11.4 8.7 9.2 8.3 13.9 6.5 9.6 8.3 9.8 7.1 9.1 6.2 7.6 3.9 9.6 7.5 11.3 6.3 10.8 9.9 4.3 9.6 8.0 5.7 10.7 11.3 8.0 16.1 12.5 14.0 2.7 7.1 8.0 10.1 9.7 18.1 10.1 13.8 4.6 24.4 8.4 15.2 16.5 6.9 16.1 5.8 5.4 11.4 16.6 5.3 10.3 11.7 1.7 9.7 11.4 6.2 13.2 16.1 17.5 7.4 9.2 13.1 8.0 7.5 10.2 12.3 10.0 11.8 18.9 6.7 6.7 7.5 7.2 12.8 10.1 12.6 4.2 4.5 7.6 10.1 11.7 14.4 0.0 6.8 3.9 11.1 9.4 9.4 5.7 9.4 10.0 7.6 6.2 8.6 8.0 1.4 7.5 9.6 6.0 11.3 6.3 11.5 16.0 17.8 16.0 11.3 11.9 15.7 11.8 11.2 13.9 TRNAU1AP "FLJ20503, SECP43, TRSPAP1" ENSG00000180098 "TRNA selenocysteine 1 associated protein 1" Q9NX07 1 28553085-28578545 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032068, HPA032069" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA032068: , HPA032069: AB_10603998" "unprognostic (4.06e-2)" "unprognostic (1.62e-2)" "unprognostic (3.28e-2)" "prognostic favourable (2.22e-4)" "unprognostic (4.93e-2)" "unprognostic (2.28e-2)" "prognostic unfavourable (8.64e-5)" "unprognostic (5.79e-3)" "unprognostic (9.48e-3)" "unprognostic (2.24e-2)" "unprognostic (1.37e-1)" "unprognostic (2.28e-3)" "prognostic unfavourable (1.16e-5)" "unprognostic (1.84e-1)" "unprognostic (2.72e-1)" "prognostic favourable (9.45e-4)" "unprognostic (2.76e-1)" 11.4 10.5 12.6 11.3 14.7 9.3 13.4 19.6 14.1 12.4 10.9 15.4 12.0 7.0 11.7 14.8 10.8 13.2 8.7 12.3 11.7 12.1 11.4 8.7 13.2 15.7 19.3 13.3 12.8 11.6 14.0 9.2 10.8 13.6 10.3 11.6 10.7 10.5 14.0 7.9 17.3 9.4 14.0 12.8 11.1 10.2 7.2 17.1 15.4 8.4 9.0 16.9 12.9 9.5 4.8 4.3 9.1 5.9 12.9 7.5 2.7 4.4 2.7 7.9 5.3 7.2 13.8 3.7 6.1 12.3 11.2 10.1 4.1 7.0 6.8 2.4 6.6 3.4 8.5 9.6 11.3 6.0 9.7 5.1 9.4 2.8 6.7 3.9 4.4 14.8 8.4 8.7 6.9 15.8 5.9 5.6 10.9 3.0 6.6 4.6 5.5 5.9 4.9 5.5 4.8 12.2 4.6 4.6 6.0 7.2 6.4 6.6 7.0 4.8 4.5 3.0 2.8 4.6 5.4 7.3 9.2 4.2 7.1 8.6 8.2 6.9 3.5 9.1 5.7 5.9 6.0 4.8 6.2 7.2 4.3 4.7 7.5 4.8 2.2 12.9 3.5 2.8 4.0 2.7 12.6 14.7 19.6 14.1 11.7 12.1 19.3 13.3 13.6 17.1 TRO "KIAA1114, MAGE-D3, MAGED3" ENSG00000067445 Trophinin Q12816 X 54920462-54931431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.1" "Cell line enhanced" "Detected in many" "AF22: 20.9;HEK 293: 12.9;HSkMC: 13.1;SCLC-21H: 14.0;SH-SY5Y: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053358 Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA053358: " "unprognostic (6.18e-2)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (9.09e-3)" "unprognostic (2.72e-1)" "unprognostic (5.66e-2)" "unprognostic (1.46e-1)" "unprognostic (4.67e-2)" "unprognostic (3.18e-1)" "prognostic favourable (1.93e-4)" "unprognostic (1.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.67e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (6.86e-2)" 4.5 4.2 21.7 2.1 15.5 1.6 3.7 11.3 23.8 8.0 2.5 7.9 1.4 1.7 16.3 8.6 2.4 7.1 5.6 2.9 17.9 15.6 5.3 13.2 2.5 2.3 10.5 13.2 21.7 5.7 7.6 20.2 5.5 22.3 7.4 3.2 5.0 1.5 6.9 32.1 1.5 1.8 10.9 8.9 1.4 2.0 3.6 14.2 4.2 9.2 0.1 2.4 3.6 5.0 0.7 2.6 0.0 0.2 5.2 1.2 0.4 0.0 0.2 20.9 0.0 4.1 5.7 0.0 1.1 7.2 1.1 0.4 0.0 0.0 0.0 3.0 7.5 0.1 0.1 0.3 0.6 0.0 12.9 9.6 0.0 0.8 1.5 0.0 0.1 13.1 0.0 6.7 0.0 0.5 0.0 0.1 7.7 0.0 0.1 0.0 10.7 0.0 6.1 9.1 0.1 2.0 0.1 14.0 18.8 0.0 0.3 1.8 0.0 1.2 0.0 8.8 9.2 0.1 1.1 3.3 0.4 0.0 1.3 0.0 7.6 0.0 0.0 0.0 1.2 0.0 0.7 0.7 0.1 0.4 0.0 0.5 0.3 0.7 0.0 5.2 0.2 2.6 0.0 0.4 21.7 15.5 11.3 23.8 17.9 15.6 10.5 13.2 22.3 14.2 TROVE2 "Ro60, SSA2" ENSG00000116747 "TROVE domain family member 2" P10155 1 193059422-193091777 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002835, HPA005142" Uncertain Approved Nucleoplasm,Cytosol 28000 Cytosol Nucleoplasm "HPA002835: AB_1857490, HPA005142: " "unprognostic (1.91e-2)" "unprognostic (5.11e-2)" "unprognostic (3.94e-3)" "unprognostic (7.34e-2)" "unprognostic (2.34e-2)" "unprognostic (1.41e-1)" "unprognostic (3.62e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-2)" "unprognostic (1.16e-2)" "unprognostic (8.45e-3)" "unprognostic (1.52e-1)" "unprognostic (1.05e-3)" "unprognostic (6.32e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (3.31e-4)" "unprognostic (5.62e-2)" 21.2 13.7 13.3 11.4 16.2 29.7 18.5 13.7 16.5 16.9 12.3 13.2 11.7 8.4 15.3 10.9 16.8 11.3 10.9 18.0 13.9 7.7 14.3 13.6 15.0 13.0 19.6 11.8 19.8 12.1 16.8 13.0 13.6 15.1 17.3 9.4 11.4 14.8 14.7 23.4 16.5 11.6 22.7 20.4 14.7 10.9 24.3 17.0 15.1 14.9 8.7 12.9 19.9 19.8 19.1 13.9 38.3 14.6 19.6 24.3 14.5 8.8 15.9 18.4 17.1 15.9 14.7 11.2 13.5 12.6 9.5 12.7 8.1 12.1 18.4 12.5 15.1 13.7 14.4 10.3 16.7 22.7 11.0 22.2 15.2 10.8 14.6 25.8 16.3 13.7 12.2 17.3 19.3 15.3 24.1 24.7 16.2 14.5 15.4 6.8 13.8 5.2 12.9 15.8 20.9 9.2 18.4 6.5 12.9 16.6 20.2 17.4 16.7 8.9 20.4 18.0 6.6 16.9 17.2 14.5 14.8 17.4 9.7 12.9 27.7 38.3 13.9 17.4 24.3 13.1 23.4 19.1 17.9 20.3 13.9 17.2 19.0 21.2 22.7 19.6 14.6 12.2 17.9 14.5 13.3 16.2 13.7 16.0 13.9 7.7 19.6 11.8 15.1 17.0 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 32.5;SK-BR-3: 21.4" "Cancer enhanced" "Detected in all" "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" 6500 "Nucleoplasm, Plasma membrane" "HPA041169: " "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favourable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favourable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 6.7 3.8 3.5 13.7 3.7 4.3 8.5 3.0 6.8 8.2 25.2 4.5 8.6 20.6 7.9 9.1 7.7 5.4 24.8 9.3 2.7 2.2 14.2 23.6 9.4 3.5 2.6 5.7 2.7 17.4 3.4 3.3 5.0 6.9 20.2 11.4 10.6 16.2 13.2 16.4 16.1 26.8 9.4 2.5 3.4 18.3 4.2 2.2 0.4 10.1 11.5 6.8 9.9 8.6 1.1 5.4 4.9 6.8 1.0 0.7 2.1 6.0 4.5 1.1 5.1 3.8 3.6 3.6 5.1 3.0 1.4 1.9 3.3 9.5 0.2 1.3 3.4 8.0 0.7 1.5 0.6 0.1 1.6 1.0 1.9 2.0 3.4 0.1 6.6 4.3 7.0 2.6 1.2 2.4 2.4 1.2 3.5 9.1 0.4 0.5 0.6 6.9 2.2 1.0 0.3 2.4 32.5 0.4 1.1 2.1 21.4 1.1 11.6 2.0 6.1 7.6 4.3 4.2 0.1 2.2 2.2 0.2 4.3 4.0 2.8 2.7 6.8 1.1 0.6 4.0 0.5 0.8 0.5 0.4 5.4 1.1 0.6 0.7 4.9 1.0 1.5 4.9 0.3 2.1 3.5 3.7 3.0 6.8 2.7 2.2 2.6 5.7 6.9 2.2 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 262.0" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "basophil: 12.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.0" "Low region specificity" "Detected in all" HPA029897 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 262.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.0 2.1 12.0 0.6 2.3 2.1 0.4 3.4 4.6 2.0 2.3 1.5 2.8 3.8 1.6 1.0 2.3 2.5 4.2 2.4 5.0 2.7 1.0 3.9 3.9 0.5 2.1 2.9 8.5 3.4 6.8 4.5 1.0 3.1 3.0 1.0 6.6 2.3 3.0 0.7 9.3 3.2 0.4 5.8 3.0 1.8 6.4 5.6 3.5 0.8 4.9 5.8 2.1 3.1 1.7 2.4 6.5 2.6 3.5 3.3 1.7 1.4 2.4 1.2 2.3 5.8 9.3 7.5 0.9 1.7 1.3 12.0 0.5 0.1 1.5 0.3 0.7 1.7 1.1 1.3 0.3 2.0 2.1 1.8 0.2 2.3 0.6 2.1 1.2 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.1 TSC22D1 "MGC17597, TGFB1I4, TSC22" ENSG00000102804 "TSC22 domain family member 1" Q15714 13 44432143-44577147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.7" "Group enriched" "Detected in all" 5 "dendritic cells: 8.9;granulocytes: 17.7;NK-cells: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077414 Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA077414: " "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (5.22e-2)" "unprognostic (4.78e-3)" "unprognostic (6.30e-2)" "unprognostic (2.04e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (7.97e-4)" "unprognostic (4.24e-2)" "unprognostic (9.08e-2)" "prognostic favourable (4.54e-4)" "unprognostic (8.14e-2)" "unprognostic (6.52e-2)" "unprognostic (1.83e-2)" "unprognostic (4.48e-2)" 43.1 38.6 71.6 23.7 82.3 6.6 56.6 32.6 94.8 73.7 49.9 27.9 14.1 27.3 68.3 62.5 46.4 67.6 49.7 54.1 64.2 63.9 46.3 36.7 37.7 14.1 71.2 49.2 63.7 15.5 44.7 36.4 40.8 54.6 72.6 47.7 56.6 31.0 39.5 49.6 20.4 48.6 64.4 46.0 11.1 36.7 27.9 38.6 31.7 38.2 24.3 17.4 39.7 31.6 1.1 8.9 17.7 2.3 7.9 2.5 24.6 5.3 17.1 16.7 6.8 10.7 13.3 19.4 5.9 24.5 6.5 6.9 19.1 19.1 8.9 12.5 14.2 13.6 7.2 48.4 9.1 1.7 5.6 61.0 31.2 5.8 9.9 3.5 7.8 19.9 21.1 17.3 42.4 14.6 1.6 0.0 12.2 5.4 11.0 2.8 11.8 16.0 7.9 3.3 2.6 12.9 8.9 8.7 11.8 16.3 16.2 4.7 7.9 4.9 12.7 7.3 6.7 15.0 8.7 0.1 1.6 2.8 18.4 2.9 16.8 17.7 1.0 2.7 2.5 0.9 2.4 0.7 0.8 1.1 0.9 1.1 0.9 1.3 4.8 7.9 2.3 8.9 1.5 24.6 71.6 82.3 32.6 94.8 64.2 63.9 71.2 49.2 54.6 38.6 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavourable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favourable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavourable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 14.2 17.5 20.6 13.2 22.1 16.2 17.3 14.0 34.0 16.4 16.8 25.4 7.8 11.2 16.7 24.5 12.7 13.9 12.3 17.2 22.1 19.0 12.8 14.2 15.9 16.3 27.6 16.6 15.0 19.2 13.0 13.4 16.0 20.7 16.3 11.8 13.2 13.9 14.5 31.8 13.7 10.3 15.0 34.5 13.4 13.9 12.4 24.2 20.8 19.4 15.4 15.2 13.7 12.5 14.0 20.2 15.9 14.2 28.2 21.9 17.6 22.5 7.5 9.8 12.1 8.2 7.8 28.0 10.8 19.5 16.4 16.2 7.1 9.9 14.7 11.9 12.1 10.4 10.6 9.1 16.8 21.5 6.8 6.7 5.7 9.3 15.1 26.2 9.4 5.3 17.7 7.2 15.0 9.1 14.8 41.2 14.5 10.9 26.1 13.3 21.0 8.6 16.5 16.4 31.0 10.4 7.6 10.2 15.1 14.1 11.3 27.3 14.3 16.5 4.6 10.9 24.6 7.4 17.3 56.0 38.3 22.4 10.4 14.7 23.7 15.9 9.8 13.5 20.4 14.2 17.6 14.0 19.3 20.9 20.2 10.4 15.0 20.4 1.8 28.2 13.0 18.1 21.9 17.6 20.6 22.1 14.0 34.0 22.1 19.0 27.6 16.6 20.7 24.2 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782589-57808071 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 153.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favourable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 14.5 46.2 16.6 14.7 21.5 15.3 18.5 18.2 24.3 12.7 18.8 13.3 17.6 17.8 11.6 13.7 16.1 12.4 10.3 27.7 14.6 15.6 27.0 30.2 10.1 14.6 15.4 20.8 10.3 19.6 17.0 13.1 11.6 17.8 11.7 18.3 11.1 13.5 14.1 33.5 14.7 13.4 17.7 11.6 12.5 14.0 23.2 13.6 11.3 15.4 26.9 13.4 14.4 13.0 18.5 18.7 9.0 16.8 20.0 23.5 16.0 8.2 9.6 5.8 8.6 5.4 5.4 8.4 6.9 6.2 11.3 7.9 11.2 10.9 20.7 13.3 6.1 9.8 9.7 10.0 8.6 8.4 11.8 12.6 8.1 9.8 8.2 16.0 7.6 6.2 10.2 8.6 4.9 7.0 16.2 11.2 8.5 9.5 9.5 17.4 8.8 12.8 11.6 153.6 18.5 10.7 9.4 12.5 7.7 7.4 13.1 12.6 22.7 11.7 5.1 6.2 8.7 9.0 7.4 8.3 17.0 16.1 8.7 9.7 7.3 3.7 14.8 9.0 18.6 13.8 23.5 18.5 20.9 18.4 18.7 16.4 21.2 21.7 4.2 20.0 16.8 14.7 18.1 16.0 16.6 21.5 18.2 24.3 14.6 15.6 15.4 20.8 17.8 13.6 TSHZ1 "NY-CO-33, SDCCAG33, TSH1" ENSG00000179981 "Teashirt zinc finger homeobox 1" Q6ZSZ6 18 75210755-75289950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in many" 5 "olfactory region: 81.2" "Low region specificity" "Detected in all" HPA006982 Approved Approved Nucleoplasm Nucleoplasm "HPA006982: AB_1079886" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (4.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (1.24e-1)" "unprognostic (4.12e-2)" "unprognostic (9.05e-2)" "unprognostic (5.64e-2)" "unprognostic (1.69e-1)" "unprognostic (3.43e-3)" "unprognostic (1.26e-1)" "unprognostic (8.00e-2)" "prognostic unfavourable (1.71e-5)" "unprognostic (3.42e-3)" 16.2 9.4 13.8 10.3 16.8 3.6 25.6 25.9 23.2 20.9 22.4 8.5 9.3 15.3 13.1 11.3 11.7 19.0 11.9 13.6 11.9 9.2 13.9 9.3 9.3 10.0 9.9 7.7 41.6 8.9 12.6 18.5 32.1 12.7 10.8 10.8 13.7 13.3 13.6 9.4 12.0 17.5 13.5 19.0 10.2 11.5 8.7 7.9 14.3 9.7 5.2 6.2 14.7 19.9 1.2 1.7 1.2 1.2 3.2 5.1 1.4 3.2 4.0 1.4 8.0 12.3 5.9 1.3 15.1 14.3 2.5 4.8 2.0 8.1 6.6 1.9 13.7 3.0 1.8 4.3 0.9 27.5 14.9 5.1 9.2 2.6 3.2 12.0 6.0 5.9 4.6 2.1 4.1 6.5 2.8 12.0 4.1 3.2 8.6 6.8 0.5 4.9 7.9 4.2 7.9 4.8 2.4 10.2 7.8 4.2 5.5 4.1 1.3 6.3 4.8 5.6 3.8 3.8 2.4 3.9 9.4 5.4 5.4 10.2 5.1 0.0 1.2 1.2 4.8 0.5 3.4 1.0 2.4 4.2 1.7 1.2 3.7 5.1 0.8 3.2 0.5 1.7 1.0 1.4 13.8 16.8 25.9 23.2 11.9 9.2 9.9 7.7 12.7 7.9 TSHZ2 "C20orf17, OVC10-2, TSH2, ZABC2, ZNF218" ENSG00000182463 "Teashirt zinc finger homeobox 2" Q9NRE2 20 52972407-53495330 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 19.4;ASC diff: 8.5;HeLa: 17.0;SiHa: 11.0;U-2197: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in many" 4 "T-cells: 6.1" "Low region specificity" "Detected in many" HPA038123 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA038123: AB_10670657" "unprognostic (9.24e-3)" "unprognostic (1.58e-1)" "unprognostic (9.35e-2)" "unprognostic (1.13e-1)" "unprognostic (1.21e-4)" "unprognostic (3.30e-1)" "unprognostic (4.30e-1)" "unprognostic (1.28e-1)" "unprognostic (2.16e-1)" "unprognostic (3.23e-2)" "unprognostic (3.33e-1)" "unprognostic (3.14e-2)" "unprognostic (9.88e-8)" "unprognostic (6.26e-2)" "unprognostic (3.81e-2)" "unprognostic (3.37e-7)" "unprognostic (2.97e-3)" 16.2 12.3 2.8 5.7 3.5 0.2 10.3 1.0 9.8 12.9 7.4 1.8 27.7 2.0 11.8 15.9 7.6 7.3 11.4 3.9 4.8 3.5 2.7 11.1 3.0 3.6 3.5 5.8 17.2 3.4 2.1 2.6 1.2 4.6 7.6 1.9 0.1 11.2 35.8 3.9 4.9 3.1 8.3 14.3 4.4 4.4 9.6 2.5 0.0 5.0 5.8 3.0 9.0 16.5 0.9 0.3 1.3 0.1 0.2 6.1 1.0 0.0 0.0 1.3 19.4 8.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.6 1.0 0.0 17.0 0.0 0.2 0.0 0.4 3.1 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 10.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.8 4.1 0.2 0.0 0.9 6.1 0.4 1.3 0.2 0.1 0.3 4.3 1.0 2.8 3.5 1.0 9.8 4.8 3.5 3.5 5.8 4.6 2.5 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798154 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.8" "Cell line enhanced" "Detected in many" "A549: 42.5;ASC diff: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted - unknown location" 2100000 Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favourable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavourable (2.87e-4)" "prognostic favourable (1.66e-4)" "prognostic unfavourable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 33.1 2.8 1.0 3.6 1.4 0.6 26.9 1.5 2.0 38.8 16.1 1.8 6.4 11.5 13.2 25.5 17.8 15.3 8.6 9.3 1.2 0.3 31.8 86.8 5.1 3.7 1.7 1.3 27.8 12.2 2.6 4.3 43.0 3.4 15.7 4.5 48.5 9.3 10.8 7.0 15.0 21.4 13.0 0.8 3.0 8.7 9.0 0.8 1.5 12.2 16.0 12.4 18.2 27.9 1.8 0.7 2.1 0.4 0.7 1.3 0.2 0.8 42.5 4.7 4.6 72.7 9.3 8.7 1.4 8.0 3.1 3.0 5.5 11.7 0.1 8.3 5.3 17.0 2.7 10.4 1.0 8.7 1.4 2.0 11.0 15.2 13.7 0.7 3.2 9.5 11.5 5.6 4.6 3.9 4.6 0.3 2.9 19.6 0.1 1.5 6.2 1.8 1.4 4.5 6.7 7.4 7.4 4.3 7.1 8.1 6.4 3.8 8.5 0.6 1.2 8.9 7.1 21.7 3.4 0.3 0.1 0.3 4.2 2.2 1.6 1.8 0.4 0.5 0.9 0.2 0.4 1.8 0.8 0.7 0.4 1.8 0.9 1.3 2.1 0.7 0.4 0.7 0.8 0.2 1.0 1.4 1.5 2.0 1.2 0.3 1.7 1.3 3.4 0.8 TSNARE1 FLJ31164 ENSG00000171045 "T-SNARE domain containing 1" Q96NA8 8 142212080-142403240 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA015890, HPA074249" Approved Approved Nucleoplasm Nucleoplasm "HPA015890: AB_1858402, HPA074249: " "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.94e-3)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (1.09e-2)" "unprognostic (1.48e-2)" "unprognostic (3.72e-3)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (6.87e-3)" "unprognostic (1.66e-1)" "unprognostic (6.26e-2)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "prognostic favourable (7.33e-4)" 9.0 8.4 14.3 10.1 14.3 5.3 9.0 14.4 18.4 11.2 8.9 15.6 7.4 15.2 12.6 10.5 7.4 13.2 8.2 7.2 8.6 8.0 8.6 6.6 9.2 8.2 12.7 12.9 17.9 24.3 9.0 9.8 4.8 11.6 10.5 4.3 10.5 17.1 11.5 11.7 31.9 16.5 7.4 8.4 13.2 11.3 8.9 14.3 6.3 12.3 6.5 9.7 9.3 8.8 1.2 1.5 3.9 5.0 1.2 2.3 1.4 5.1 5.0 3.3 4.1 2.7 2.4 10.5 1.5 2.5 1.5 1.6 1.5 5.5 2.7 8.3 1.2 4.5 1.5 5.3 0.6 3.0 4.7 3.0 1.2 5.5 7.0 7.2 7.5 4.7 4.9 0.0 3.5 1.6 6.1 0.3 1.1 6.7 5.9 6.5 3.3 12.0 0.0 1.8 4.6 2.9 6.3 13.8 8.4 6.8 5.7 10.0 3.7 6.5 4.1 2.4 6.7 4.6 3.2 0.4 2.1 4.2 4.5 19.0 2.5 3.9 1.3 0.3 2.3 5.0 1.6 0.8 1.3 0.6 1.5 1.2 0.5 0.9 0.1 1.2 3.5 0.0 1.5 1.4 14.3 14.3 14.4 18.4 8.6 8.0 12.7 12.9 11.6 14.3 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2;testis: 40.6" "Cell line enhanced" "Detected in many" "AN3-CA: 6.9;SiHa: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA053516 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053516: " "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favourable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.9 1.9 4.8 1.1 9.2 0.6 0.9 2.0 3.9 1.3 0.9 3.3 1.9 0.5 1.8 3.6 0.7 14.2 1.2 0.7 3.8 3.3 1.6 0.8 2.1 0.7 1.2 3.7 2.5 2.2 2.9 6.9 0.7 6.3 1.0 0.7 1.0 1.0 2.0 0.5 0.8 0.6 1.2 0.9 0.8 1.2 40.6 2.5 0.0 1.1 0.0 0.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.4 1.1 0.4 2.5 6.9 3.5 0.9 0.9 0.0 1.6 0.5 2.4 0.7 0.8 1.0 1.0 0.2 1.3 1.0 1.1 1.5 0.3 0.9 0.0 0.8 0.1 1.1 1.6 0.2 0.8 0.9 3.5 0.5 0.0 0.5 0.3 0.0 0.0 0.3 0.6 0.7 0.4 1.7 0.7 0.1 3.5 0.6 2.0 2.1 4.4 0.1 0.4 1.8 0.1 0.8 0.4 0.1 0.3 0.2 1.2 2.1 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.8 9.2 2.0 3.9 3.8 3.3 1.2 3.7 6.3 2.5 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185958 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.0;testis: 119.0" "Cell line enhanced" "Detected in some" "A-431: 21.2;CAPAN-2: 36.7;HaCaT: 25.6;hTCEpi: 29.8;RPTEC TERT1: 107.6;RT4: 51.6" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 90 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA011909 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favourable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.7 0.6 1.7 4.8 2.4 0.0 1.5 11.4 3.5 9.0 59.9 1.8 1.5 2.2 1.8 4.6 1.9 13.9 2.6 2.6 2.2 0.0 46.0 1.9 5.7 2.1 2.4 1.7 1.5 1.5 15.4 3.3 1.5 2.1 22.7 70.0 3.3 16.1 7.8 1.5 0.1 18.3 1.9 1.8 1.6 24.6 119.0 1.9 1.6 13.9 1.8 1.9 21.0 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 21.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 36.7 0.0 6.9 0.0 25.6 0.0 18.8 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 29.8 0.1 10.6 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.2 107.6 51.6 0.3 0.0 0.0 2.2 0.1 1.5 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 1.7 2.4 11.4 3.5 2.2 0.0 2.4 1.7 2.1 1.9 TSPAN13 "NET-6, TM4SF13" ENSG00000106537 "Tetraspanin 13" O95857 7 16753535-16784536 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 36.2;SK-BR-3: 52.4;T-47d: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 24.7;plasmacytoid DC: 51.3" "Group enriched" "Detected in many" 41 "B-cells: 24.7;dendritic cells: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007426 Uncertain Approved Nucleoplasm Nucleoplasm "HPA007426: AB_10603137" "unprognostic (3.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (3.56e-5)" "unprognostic (2.63e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (5.69e-2)" "unprognostic (6.63e-2)" "prognostic favourable (2.20e-4)" "unprognostic (1.50e-1)" "unprognostic (3.07e-1)" "prognostic unfavourable (2.43e-4)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" 20.8 24.2 17.7 7.6 24.9 6.2 25.6 10.7 33.0 18.6 23.6 3.0 21.0 25.2 5.9 12.3 8.8 5.7 16.0 6.8 14.5 21.7 3.3 22.2 53.4 14.8 12.0 15.9 2.1 55.2 4.6 48.0 19.0 14.0 15.1 29.1 8.5 49.1 19.2 4.1 4.7 27.8 5.9 3.6 12.9 31.3 3.1 3.4 3.6 13.0 7.1 18.5 12.1 10.6 24.7 51.3 0.9 0.0 0.8 0.0 1.2 7.5 6.2 8.0 8.4 1.0 0.0 2.2 16.3 2.6 0.4 0.8 22.0 11.7 0.2 4.1 5.8 11.8 9.2 13.6 3.6 0.2 9.9 3.2 2.6 2.3 2.2 0.3 0.6 0.9 5.9 0.8 1.0 4.9 10.5 0.0 0.4 21.6 0.4 0.4 5.6 7.7 8.7 0.0 7.8 25.4 14.4 36.2 5.4 2.9 52.4 0.7 98.0 0.8 0.4 0.2 2.9 0.2 5.3 4.8 0.1 0.1 7.5 0.1 11.4 0.1 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 24.7 0.0 0.0 0.9 0.8 0.0 51.3 0.0 1.2 17.7 24.9 10.7 33.0 14.5 21.7 12.0 15.9 14.0 3.4 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451473-69507669 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 34.8;EFO-21: 48.5;MCF7: 36.6;PC-3: 60.3;SK-BR-3: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 17.4" "Lineage enriched" "Detected in many" 6 "T-cells: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044657 Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA044657: AB_10967927" "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavourable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavourable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 34.2 3.1 11.5 9.7 22.7 0.9 24.9 40.4 17.0 8.9 30.4 49.2 12.5 24.0 15.1 8.4 7.1 16.2 17.1 8.3 18.0 9.2 10.2 3.0 20.4 4.9 33.1 11.2 3.0 10.8 1.4 3.3 17.7 16.8 17.6 24.9 5.4 16.8 17.0 9.9 4.6 21.5 23.0 43.0 13.5 46.4 4.0 28.3 0.8 6.7 2.7 4.8 22.6 6.8 0.0 2.7 0.0 0.0 0.1 17.4 0.5 11.1 23.1 0.4 0.0 0.5 0.0 2.7 0.0 0.4 0.6 1.5 9.9 34.8 0.0 48.5 0.5 22.7 1.6 2.5 0.7 9.1 4.6 0.6 0.7 2.2 0.2 0.0 0.4 0.5 0.7 0.3 0.3 8.9 0.2 0.0 0.2 36.6 0.1 0.2 0.6 60.3 0.8 0.4 0.4 6.7 20.6 7.9 3.0 0.1 30.6 3.8 13.4 0.5 7.7 0.0 0.1 0.0 3.8 0.2 1.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 17.4 0.0 2.7 2.5 2.7 0.0 0.9 0.2 0.0 0.1 0.0 0.2 0.9 0.5 11.5 22.7 40.4 17.0 18.0 9.2 33.1 11.2 16.8 28.3 TSPAN17 "FBX23, FBXO23, TM4SF17" ENSG00000048140 "Tetraspanin 17" Q96FV3 5 176647387-176659054 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030447 Approved Nucleoplasm Nucleoplasm "HPA030447: " "unprognostic (1.70e-2)" "unprognostic (7.92e-2)" "unprognostic (2.91e-1)" "unprognostic (3.47e-2)" "unprognostic (3.97e-2)" "unprognostic (3.71e-3)" "unprognostic (1.21e-3)" "unprognostic (3.82e-1)" "unprognostic (2.30e-1)" "unprognostic (3.60e-1)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.41e-2)" "unprognostic (7.11e-3)" "unprognostic (2.32e-1)" "unprognostic (4.50e-1)" "unprognostic (1.46e-1)" 11.1 29.3 18.7 12.8 12.6 39.1 14.7 18.3 20.9 8.7 14.7 7.1 12.4 13.1 9.0 10.5 16.6 11.2 16.8 16.5 13.3 10.4 16.4 15.0 13.5 19.8 9.2 9.2 8.6 30.5 12.3 19.5 10.3 10.4 12.4 11.8 9.1 11.7 15.8 30.2 11.2 14.6 11.7 6.6 15.7 15.3 18.4 11.2 3.4 11.9 13.7 15.8 14.5 9.4 2.6 3.1 0.8 4.9 3.7 9.3 3.4 16.2 16.5 11.1 20.1 15.4 13.3 17.3 12.2 18.0 18.1 18.1 5.0 18.8 7.3 22.4 21.1 12.4 5.5 28.5 11.1 53.7 11.5 2.8 7.2 5.9 14.0 5.9 10.2 15.7 16.1 14.4 8.8 24.8 13.7 7.9 18.3 26.8 1.2 2.6 8.9 18.2 6.2 9.4 4.0 17.0 12.0 16.8 11.9 13.3 15.5 16.5 12.7 7.5 19.2 19.8 20.6 14.8 15.3 4.5 5.8 3.1 21.5 12.6 11.5 0.0 3.1 0.8 5.4 3.1 4.3 1.6 4.1 8.8 3.1 2.6 2.9 3.9 0.5 3.7 4.9 0.8 9.3 3.4 18.7 12.6 18.3 20.9 13.3 10.4 9.2 9.2 10.4 11.2 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7" "Group enriched" "Detected in all" 5 "B-cells: 69.7;dendritic cells: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 64.0 31.4 71.6 16.9 66.5 6.0 43.3 36.8 67.5 31.4 75.3 49.4 74.2 70.6 28.4 95.9 16.8 53.8 39.4 24.6 58.1 63.7 44.9 17.8 41.9 22.9 64.4 45.8 33.0 31.6 53.6 44.0 23.1 54.1 21.3 82.7 44.3 30.8 60.9 79.3 16.3 71.2 27.6 49.2 19.1 46.1 21.3 40.4 14.2 43.0 24.7 25.4 23.2 15.2 69.7 46.7 1.5 10.8 8.3 6.9 12.1 21.0 57.5 47.8 30.1 84.0 51.7 15.8 33.8 36.8 41.7 45.6 35.0 44.1 20.7 50.3 34.8 47.9 45.3 23.1 31.4 23.2 68.7 14.8 44.1 33.1 40.8 19.0 10.9 48.7 28.0 23.0 20.5 50.9 15.6 18.3 40.7 8.0 16.8 18.1 33.8 25.6 21.2 59.4 21.8 68.5 12.0 43.4 48.0 23.1 19.6 62.8 21.0 36.1 48.2 38.7 15.1 23.3 47.2 40.3 54.8 11.0 34.3 28.5 22.0 0.8 7.5 1.5 5.1 9.9 5.4 69.4 2.6 3.7 14.8 69.7 6.9 6.3 0.7 8.3 10.8 46.7 0.6 12.1 71.6 66.5 36.8 64.2 58.1 63.7 64.4 45.8 54.1 40.4 TSPAN31 SAS ENSG00000135452 "Tetraspanin 31" Q12999 12 57738013-57750211 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 59.0" "Cancer enhanced" "Detected in all" "glioma: 54.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030758, HPA057489" Approved Approved "Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA030758: , HPA057489: " "unprognostic (2.66e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (8.96e-3)" "prognostic unfavourable (1.09e-4)" "unprognostic (4.31e-3)" "unprognostic (1.19e-1)" "unprognostic (6.51e-3)" "unprognostic (5.31e-2)" "unprognostic (2.68e-1)" "unprognostic (2.79e-1)" "prognostic favourable (9.91e-5)" "unprognostic (1.68e-1)" "unprognostic (1.59e-1)" "unprognostic (6.32e-2)" "unprognostic (1.58e-1)" 27.0 26.4 19.4 18.2 22.5 5.4 21.8 14.3 20.5 21.9 20.1 30.5 23.0 16.3 23.1 37.6 21.3 27.7 23.3 23.3 19.1 17.8 32.1 29.2 20.7 14.5 20.3 16.0 32.0 32.1 31.4 22.7 31.5 19.4 23.3 19.0 32.1 24.6 22.0 19.8 15.2 24.0 17.5 24.3 23.1 18.2 11.4 17.1 14.6 42.4 16.5 20.7 20.2 16.8 17.6 35.4 18.6 24.8 23.7 22.0 18.8 3.5 8.7 8.9 2.2 20.7 13.6 5.8 5.6 7.5 3.0 3.0 6.0 19.2 3.2 12.6 13.0 7.4 2.3 12.0 4.3 8.5 6.3 4.4 7.2 2.5 20.4 4.3 7.6 12.0 14.2 5.9 12.5 8.0 3.1 9.4 9.8 7.2 3.3 2.5 1.9 2.8 4.2 59.0 8.4 12.5 7.3 3.1 7.6 6.1 8.9 4.4 16.8 6.8 10.9 4.9 4.1 2.6 3.0 11.7 2.6 1.5 13.3 2.9 7.4 18.6 15.7 11.1 22.0 15.7 21.3 17.6 17.8 18.9 15.6 16.8 17.8 16.7 5.3 23.7 24.8 35.4 12.1 18.8 19.4 22.5 14.3 18.5 19.1 17.8 20.3 16.0 19.4 17.1 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Group enriched" "Detected in some" 8 "HEL: 15.4;HL-60: 6.7;NB-4: 5.6;THP-1: 5.9;U-937: 9.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.4 0.0 0.1 0.7 6.7 1.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.4 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 TSPAN8 "CO-029, TM4SF3" ENSG00000127324 "Tetraspanin 8" P19075 12 71125085-71441898 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 235.3" "Cell line enhanced" "Detected in some" "CACO-2: 14.9;HeLa: 18.0;PC-3: 57.3;RPTEC TERT1: 11.0;RT4: 13.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 283.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB026009, HPA044337" Enhanced Approved Nucleoplasm Nucleoplasm "CAB026009: , HPA044337: " "unprognostic (1.64e-1)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "unprognostic (6.40e-2)" "unprognostic (6.81e-2)" "unprognostic (7.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.01e-3)" "unprognostic (2.93e-1)" "prognostic unfavourable (9.66e-5)" "unprognostic (1.88e-2)" "unprognostic (1.00e-1)" "unprognostic (2.97e-2)" "prognostic favourable (7.36e-5)" 1.9 0.8 0.7 24.1 2.3 0.0 1.1 0.6 1.3 2.0 139.5 2.8 1.5 83.2 1.2 1.5 1.1 1.3 30.8 1.0 0.7 0.7 7.6 3.7 5.1 1.0 4.7 1.0 6.9 9.9 0.0 0.8 0.7 3.5 14.2 79.5 2.6 11.7 1.0 12.5 2.4 235.3 3.4 9.7 0.6 55.5 1.6 2.7 0.6 1.8 3.1 5.0 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.2 0.9 0.0 0.0 0.0 0.0 14.9 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 18.0 1.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 57.3 0.0 0.0 1.5 11.0 13.2 1.3 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.6 1.3 0.7 0.7 4.7 1.0 3.5 2.7 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell line enhanced" "Detected in many" "RH-30: 62.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavourable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 5.9 5.0 4.9 4.6 13.9 6.7 20.3 4.3 5.7 8.1 3.1 0.2 6.7 3.9 0.9 2.3 2.5 2.6 1.0 2.6 9.1 2.7 5.7 13.3 0.0 0.7 5.9 2.1 8.9 4.2 14.8 0.2 0.2 3.8 5.2 0.0 0.2 8.3 1.8 2.7 62.6 0.8 18.1 1.5 10.5 7.1 4.4 11.3 4.3 3.9 0.0 8.7 2.4 7.2 3.8 6.3 0.0 0.0 0.0 6.0 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Cell line enriched" "Detected in single" 131 "K-562: 13.1" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034699: , HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 TSR2 "DT1P1A10, RP1-112K5.2, WGG1" ENSG00000158526 "TSR2, ribosome maturation factor" Q969E8 X 54440401-54445487 "Disease related genes, Predicted intracellular proteins" "rRNA processing" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030514 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions,Cytosol" "Nucleoplasm, Nucleoli" "Cell Junctions, Cytosol" "HPA030514: AB_10603457" "unprognostic (1.05e-1)" "unprognostic (1.80e-2)" "unprognostic (1.77e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-2)" "unprognostic (5.91e-2)" "unprognostic (7.15e-3)" "unprognostic (8.29e-2)" "unprognostic (4.39e-1)" "unprognostic (1.31e-1)" "unprognostic (2.94e-2)" "unprognostic (6.19e-2)" "prognostic favourable (1.21e-6)" "unprognostic (2.27e-1)" "unprognostic (1.13e-1)" "unprognostic (7.93e-3)" "unprognostic (1.80e-3)" 20.8 25.0 52.9 13.8 53.1 15.3 19.2 27.6 44.3 18.2 17.2 30.8 16.9 13.9 18.4 33.9 16.2 21.1 14.8 22.2 45.3 46.2 26.5 23.7 17.5 14.9 53.8 34.4 22.9 17.2 30.7 19.0 19.8 31.0 20.8 20.6 19.0 16.6 25.4 35.5 17.2 14.7 19.7 54.3 18.1 16.5 8.4 27.5 10.2 23.9 10.8 22.0 17.7 16.8 39.6 15.4 28.7 21.2 24.7 41.4 21.1 20.4 26.2 19.2 17.4 17.3 12.5 17.1 20.3 16.5 18.9 16.3 24.7 22.4 22.4 14.1 17.7 21.2 46.9 28.1 25.3 29.1 23.2 18.2 19.6 19.2 10.7 31.5 19.1 11.6 15.4 26.4 27.3 13.2 18.5 16.8 19.2 37.5 24.0 24.8 30.5 29.8 21.6 35.7 18.9 20.1 18.2 24.2 16.8 38.6 19.3 21.5 39.3 11.0 17.9 13.9 24.5 29.2 17.3 18.0 27.1 26.8 20.5 25.1 20.8 24.5 15.3 28.7 35.1 20.5 28.8 38.7 33.3 31.8 13.9 39.6 41.4 31.7 9.4 24.7 21.2 15.4 35.5 21.1 52.9 53.1 27.6 44.3 45.3 46.2 53.8 34.4 31.0 27.5 TSSC4 ENSG00000184281 "Tumor suppressing subtransferable candidate 4" Q9Y5U2 11 2400488-2403878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041801, HPA058763" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA041801: AB_10793934, HPA058763: " "unprognostic (1.98e-1)" "unprognostic (9.22e-2)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" "unprognostic (8.13e-2)" "prognostic unfavourable (9.91e-4)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "unprognostic (1.13e-1)" "unprognostic (3.29e-2)" "unprognostic (2.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (6.50e-2)" "unprognostic (1.32e-2)" "unprognostic (7.38e-2)" 25.6 11.7 12.1 13.9 12.5 33.0 13.2 10.7 20.9 17.5 21.5 12.7 10.9 15.9 20.6 13.3 16.7 16.4 15.1 23.2 11.9 11.0 14.1 19.4 13.8 16.8 15.2 12.7 17.7 20.9 10.3 14.7 19.8 11.2 18.2 5.6 13.1 20.2 19.0 32.5 16.2 16.1 19.0 10.5 18.5 14.0 29.1 10.7 21.7 22.7 25.2 14.7 20.2 36.2 54.0 44.9 55.3 44.7 43.0 49.0 37.3 19.5 24.6 8.0 12.8 6.8 5.0 15.5 13.4 9.3 16.3 11.3 18.1 25.4 14.3 11.9 10.6 19.5 9.3 15.5 3.1 16.3 25.6 8.3 13.0 18.4 18.7 14.2 17.5 12.0 22.4 10.4 10.0 11.3 18.8 16.0 7.7 25.3 16.9 25.9 23.4 28.9 19.3 7.2 12.7 8.2 16.5 21.0 21.4 11.4 25.9 15.6 13.6 16.8 14.8 21.7 11.2 20.1 15.5 32.4 27.8 12.0 18.6 14.6 22.5 55.3 44.7 43.8 46.1 38.2 49.0 43.5 45.9 47.2 44.9 54.0 41.4 39.0 43.2 43.0 40.1 43.3 47.8 37.3 12.1 12.5 10.7 20.9 11.9 11.0 15.2 12.7 11.2 10.7 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: " "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.6 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 0.0 3.1 5.8 0.0 0.6 1.4 1.5 1.5 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 TSTA3 "FX, P35B, SDR4E1" ENSG00000104522 "Tissue specific transplantation antigen P35B" Q13630 8 143612618-143618048 "Enzymes, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol 600000 Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favourable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 9.4 12.0 7.0 9.5 10.1 16.3 10.2 6.1 13.8 8.6 18.7 8.4 16.6 24.8 8.4 9.9 28.0 7.7 23.7 15.7 8.1 7.8 11.7 40.0 8.9 16.5 6.8 8.1 9.7 60.1 6.4 14.2 21.9 12.2 13.9 14.9 9.5 35.4 14.2 16.8 28.4 20.2 6.9 4.7 11.3 35.5 24.6 5.6 14.7 13.0 17.8 24.8 9.8 10.4 18.7 25.6 17.7 21.0 28.1 26.9 20.5 17.5 12.8 6.5 19.3 5.4 5.2 12.0 14.6 14.3 10.4 7.8 15.7 18.8 7.7 14.3 10.3 12.6 9.7 19.8 4.7 19.9 14.1 11.4 22.7 18.1 11.1 7.6 13.0 6.5 10.2 7.0 25.0 16.8 12.6 11.2 7.8 53.3 9.9 11.5 8.8 17.6 11.3 4.9 23.7 20.9 17.6 13.3 10.4 10.0 19.7 14.6 25.0 11.1 14.1 6.9 27.4 8.2 14.0 8.4 6.0 5.6 10.6 17.4 10.3 10.5 15.9 17.7 21.0 21.0 21.2 16.1 22.7 22.6 18.0 18.7 16.9 18.7 16.3 28.1 16.3 25.6 26.9 20.5 7.0 10.1 6.1 13.8 8.1 7.8 6.8 8.1 12.2 5.6 TSTD2 "C9orf97, PP4189" ENSG00000136925 "Thiosulfate sulfurtransferase like domain containing 2" Q5T7W7 9 97600080-97633575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022537, HPA024241, HPA064304" Uncertain Approved Nucleoplasm Nucleoplasm "HPA022537: AB_1845850, HPA024241: AB_1845851, HPA064304: " "unprognostic (7.24e-2)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (1.39e-2)" "unprognostic (1.38e-1)" "unprognostic (7.07e-2)" "unprognostic (1.10e-1)" "unprognostic (1.23e-3)" "unprognostic (9.67e-2)" "unprognostic (1.51e-1)" "prognostic favourable (5.75e-4)" "unprognostic (2.21e-2)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" 11.9 11.8 11.9 7.4 11.6 3.3 12.1 18.9 15.1 14.2 12.4 14.9 10.6 6.9 14.8 10.6 10.0 12.7 11.0 14.9 9.8 8.4 12.8 14.4 11.0 8.9 12.4 9.5 17.2 15.7 19.8 17.0 13.9 12.5 12.2 11.3 11.1 10.2 13.1 21.1 9.2 9.7 14.4 13.8 8.7 11.2 11.6 12.4 10.6 16.2 12.1 12.0 14.4 9.7 6.2 6.5 5.2 7.0 11.2 10.4 5.3 10.8 8.5 13.7 8.8 9.2 7.7 12.0 7.1 8.8 9.8 10.3 8.4 3.6 11.3 3.5 9.0 14.9 12.2 6.9 11.1 7.5 5.5 7.7 9.8 6.3 10.8 11.4 10.2 10.2 11.9 9.5 16.9 7.5 13.8 8.5 8.4 5.2 13.5 5.6 11.2 8.3 11.2 20.2 5.9 6.7 5.0 9.9 7.7 9.1 6.4 8.3 4.9 6.4 7.8 8.5 8.2 10.0 8.0 12.2 16.0 5.8 7.1 5.7 6.1 4.3 3.9 5.2 6.4 7.0 10.4 5.8 6.4 7.7 6.5 6.2 7.2 6.9 1.6 11.2 5.2 2.9 3.6 5.3 11.9 11.6 18.9 15.1 9.8 8.4 12.4 9.5 12.5 12.4 TTC12 "FLJ13859, FLJ20535, TPARM" ENSG00000149292 "Tetratricopeptide repeat domain 12" Q9H892 11 113314529-113383544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.8" "Cell line enhanced" "Detected in many" "SiHa: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038542, HPA038543, HPA061364" Enhanced Approved Nucleoplasm Nucleoplasm "HPA038542: , HPA038543: AB_10674686, HPA061364: " "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "prognostic favourable (3.14e-4)" "prognostic favourable (2.48e-5)" "unprognostic (2.11e-2)" "unprognostic (3.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.33e-3)" "unprognostic (7.67e-2)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (5.46e-2)" "prognostic favourable (5.95e-5)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.26e-1)" "unprognostic (1.35e-2)" 3.1 6.1 3.8 8.8 5.2 1.3 8.1 3.1 4.4 9.0 4.7 7.3 16.3 2.8 10.8 14.9 4.3 13.1 6.8 5.4 3.5 4.5 7.2 4.4 4.9 9.8 3.9 2.1 6.9 5.1 17.5 25.7 3.4 5.7 9.8 5.1 10.0 9.5 13.1 3.5 4.7 4.2 11.5 4.0 4.2 4.6 44.8 4.7 2.5 12.1 5.9 8.4 7.2 4.6 6.4 4.0 3.1 1.8 2.9 5.7 2.2 3.8 2.4 6.0 6.3 4.4 5.5 3.5 3.5 6.7 4.8 4.6 2.9 10.7 2.1 5.3 0.1 8.4 0.0 17.1 7.2 2.3 2.7 0.8 7.8 4.4 8.8 0.0 1.4 5.9 6.7 0.0 10.5 3.4 3.5 1.4 8.6 4.9 0.0 0.7 3.8 4.5 0.0 1.0 3.6 8.8 2.9 5.2 7.1 18.4 6.7 3.5 11.7 2.4 1.2 0.8 4.2 3.7 6.1 1.3 2.0 0.1 4.0 0.4 0.0 0.0 1.8 3.0 3.5 1.8 5.4 4.5 4.7 3.8 4.0 6.4 5.7 5.0 3.1 2.9 1.8 3.3 1.8 2.2 3.8 5.2 3.1 4.4 3.5 4.5 3.9 2.1 5.7 4.7 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm Nucleoplasm "HPA018022: AB_2211524, HPA051558: " "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favourable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favourable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavourable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 10.5 7.1 8.9 16.6 26.7 13.1 9.6 11.2 12.4 7.3 13.6 12.5 8.6 10.5 9.3 9.2 8.5 9.2 8.9 7.0 9.9 7.9 6.9 9.0 12.2 23.4 13.3 9.3 8.2 13.7 13.5 15.5 9.9 12.6 8.1 21.6 7.9 9.6 9.5 15.6 12.8 15.6 8.4 14.7 21.3 15.6 3.9 13.7 18.4 9.8 6.2 18.9 8.0 9.1 4.2 10.8 7.6 7.7 11.9 10.0 5.1 7.9 8.2 8.0 15.7 7.5 4.9 16.6 11.7 9.3 6.6 7.5 11.9 8.8 14.8 10.8 7.0 12.9 5.3 4.3 4.4 16.5 16.2 4.4 8.7 8.1 8.0 9.0 4.1 4.3 7.7 6.2 5.8 11.6 4.7 8.6 6.0 4.1 4.8 8.6 9.1 10.2 7.7 11.6 20.5 6.9 5.5 11.1 9.6 8.9 9.3 15.6 9.8 11.8 5.9 7.8 1.1 10.5 20.7 10.7 17.5 4.5 7.7 5.7 12.7 7.6 7.6 6.8 10.0 5.8 6.8 4.2 7.0 8.2 10.8 3.9 5.7 6.8 2.9 11.9 7.7 7.4 5.4 5.1 8.9 26.7 11.2 12.4 9.9 7.9 13.3 9.3 12.6 13.7 TTC24 ENSG00000187862 "Tetratricopeptide repeat domain 24" A2A3L6 1 156579727-156586770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 13.3;lymphoid tissue: 8.4" "Cell line enhanced" "Detected in some" "MOLT-4: 4.1;REH: 15.5;U-698: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" HPA029799 Approved Nucleoplasm Nucleoplasm "HPA029799: AB_10601684" "unprognostic (2.43e-3)" "unprognostic (5.61e-5)" "unprognostic (5.86e-2)" "unprognostic (1.39e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-6)" "unprognostic (6.26e-2)" "unprognostic (1.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (4.42e-1)" "unprognostic (7.96e-2)" "unprognostic (4.87e-9)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-2)" "unprognostic (9.76e-4)" 0.2 0.0 0.2 2.7 0.3 2.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 8.4 0.2 0.2 0.2 0.2 0.0 3.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.6 0.0 2.6 0.2 0.2 5.1 0.4 0.2 0.2 1.4 0.2 0.2 7.5 0.2 0.2 2.2 13.3 0.3 0.0 3.8 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 1.1 0.1 2.2 0.2 1.9 0.3 3.8 0.0 13.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: " "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.4 7.6 35.7 6.7 34.5 50.2 12.4 23.6 29.4 10.7 14.5 10.1 10.8 18.5 8.2 39.5 7.0 10.7 14.5 15.1 19.6 7.7 37.4 11.5 13.1 12.6 20.8 12.1 25.9 9.0 10.8 9.7 15.8 22.5 21.8 20.0 16.6 20.2 5.4 10.1 13.0 27.1 17.1 9.7 12.4 16.6 27.3 20.8 29.3 16.8 15.2 19.0 8.2 20.5 15.3 6.1 18.7 8.8 21.9 15.7 18.5 25.2 20.9 11.5 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 TTC30A "FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612992-177618966 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA051714: , HPA052100: , HPA052487: " "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.7 4.1 3.8 1.5 7.1 0.4 5.6 2.2 7.1 4.2 3.4 5.9 7.8 2.2 5.0 10.9 2.4 8.4 4.8 4.4 3.7 4.2 6.9 4.6 3.7 1.4 3.6 6.6 5.5 4.4 11.6 8.1 1.9 4.8 3.9 3.3 5.0 8.1 4.0 3.5 1.9 2.5 3.6 3.0 1.7 3.6 24.5 2.1 2.6 9.6 4.6 1.7 3.1 1.7 0.5 1.6 1.9 1.6 0.2 2.7 1.0 5.7 3.3 3.3 0.0 6.8 5.6 2.4 2.8 8.1 5.0 5.3 1.0 4.2 1.3 5.5 4.9 4.8 2.2 6.2 5.5 0.4 1.8 1.1 1.6 1.4 2.7 1.4 1.3 3.4 4.1 2.8 1.1 2.3 0.8 0.5 3.5 2.9 4.4 2.6 1.8 1.2 2.9 8.8 0.6 6.3 1.5 10.9 7.2 2.5 5.0 3.0 2.8 1.4 2.1 3.1 1.9 3.4 2.3 2.3 2.1 0.4 7.8 0.1 3.0 0.0 1.3 1.9 0.4 1.6 0.1 0.4 0.1 0.4 1.6 0.5 2.7 1.2 0.7 0.2 1.3 0.6 1.0 1.0 3.8 7.1 2.2 7.1 3.7 4.2 3.6 6.6 4.8 2.1 TTC30B "fleer, FLJ30990, IFT70B" ENSG00000196659 "Tetratricopeptide repeat domain 30B" Q8N4P2 2 177548998-177553014 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA051714: , HPA052100: , HPA052487: " "unprognostic (5.76e-2)" "unprognostic (5.29e-2)" "unprognostic (2.15e-2)" "unprognostic (9.10e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.89e-2)" "unprognostic (3.26e-1)" "unprognostic (5.45e-2)" "unprognostic (2.75e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (5.27e-2)" "unprognostic (9.77e-2)" "unprognostic (9.61e-2)" "unprognostic (9.25e-3)" "unprognostic (1.65e-1)" 2.4 4.6 4.4 1.9 4.9 0.7 10.5 3.2 5.1 4.8 4.0 7.7 3.8 3.1 4.9 8.9 3.7 13.2 4.5 2.3 3.9 3.8 10.8 4.3 5.5 2.5 3.1 1.5 6.0 5.2 8.0 7.0 3.3 3.4 3.5 3.7 4.5 4.4 4.2 1.2 3.0 3.7 3.1 5.2 3.1 4.7 11.5 2.9 7.7 10.4 1.6 2.8 3.3 2.2 3.2 3.9 6.5 3.4 1.9 2.2 1.6 2.8 4.2 5.7 1.1 5.1 5.9 3.8 1.7 5.3 4.7 5.0 2.4 7.1 1.1 4.7 3.2 7.0 6.8 7.2 4.5 1.6 3.4 2.0 2.7 2.1 4.2 2.5 3.5 4.9 6.8 4.6 3.5 3.7 2.6 1.0 2.7 4.8 5.0 3.9 2.6 1.1 3.9 4.9 1.1 7.0 3.1 13.8 7.8 2.1 4.9 3.3 5.0 4.8 3.2 2.6 1.4 3.3 1.5 2.6 2.9 0.3 5.9 1.0 4.3 6.5 3.4 2.8 1.7 3.3 1.1 1.4 1.2 1.8 3.9 3.2 2.2 2.2 2.0 1.9 2.2 2.8 1.0 1.6 4.4 4.9 3.2 5.1 3.9 3.8 3.1 1.5 3.4 2.9 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavourable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favourable (2.49e-4)" 9.2 8.9 7.4 12.3 11.7 11.5 8.6 13.8 9.3 9.0 15.7 8.6 5.3 10.5 11.6 9.4 8.7 7.9 14.5 7.4 8.9 3.7 9.9 23.6 8.2 10.4 10.4 7.7 9.7 13.4 13.2 10.0 13.7 8.3 8.0 9.5 10.5 8.1 7.5 6.5 11.1 16.2 9.3 7.0 13.6 11.6 8.6 12.2 11.5 7.7 9.7 11.5 10.6 8.5 9.3 9.7 8.1 10.2 7.5 9.0 7.8 10.9 10.0 6.5 3.4 3.8 11.2 7.6 6.1 8.5 11.1 7.7 8.4 8.2 15.5 4.9 4.8 8.0 6.0 6.6 5.5 17.0 6.2 16.5 8.9 14.5 7.4 6.7 10.9 8.1 8.9 9.5 5.9 7.5 11.0 6.6 6.9 10.2 9.9 3.9 4.0 4.9 9.8 17.1 7.3 6.1 8.1 3.2 12.0 5.7 9.0 6.2 6.7 3.8 13.8 7.6 12.8 4.7 9.0 9.7 7.8 10.1 9.5 7.7 7.1 6.4 10.2 8.1 8.4 10.2 9.0 9.3 6.5 8.0 9.7 7.3 6.3 6.8 1.4 7.5 10.2 5.7 8.3 7.8 7.4 11.7 13.8 9.3 8.9 3.7 10.4 7.7 8.3 12.2 TTC32 ENSG00000183891 "Tetratricopeptide repeat domain 32" Q5I0X7 2 19896643-19901986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036024 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA036024: AB_10673493" "unprognostic (2.77e-3)" "unprognostic (5.44e-2)" "unprognostic (8.85e-2)" "unprognostic (8.80e-3)" "unprognostic (1.08e-1)" "unprognostic (2.62e-1)" "unprognostic (5.25e-2)" "prognostic favourable (9.44e-4)" "unprognostic (4.46e-2)" "unprognostic (1.48e-2)" "unprognostic (4.92e-3)" "unprognostic (6.22e-2)" "prognostic unfavourable (5.45e-6)" "unprognostic (1.21e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-2)" "unprognostic (2.27e-2)" 11.8 8.9 12.8 10.8 24.7 30.1 17.4 24.1 18.9 10.8 11.0 17.5 11.9 11.5 13.6 28.5 7.8 11.8 11.8 7.3 14.9 11.8 9.4 12.6 10.1 13.7 29.6 9.2 16.9 8.7 13.4 17.0 8.2 16.9 16.6 10.4 14.5 11.4 13.1 19.6 14.2 12.1 9.4 18.4 13.9 10.6 12.9 23.6 15.5 13.7 12.9 9.5 11.9 11.7 9.3 5.4 21.6 5.9 4.5 12.8 3.8 14.2 9.1 8.2 6.0 3.8 8.2 1.6 3.1 5.2 5.2 3.4 4.6 16.6 9.0 1.8 3.3 9.1 3.8 10.2 3.4 13.2 15.7 9.2 12.1 8.2 8.1 9.0 16.7 7.8 6.2 5.7 13.9 4.8 17.1 18.6 4.3 4.4 6.4 13.4 6.4 16.1 7.7 5.6 15.1 14.4 5.6 13.6 12.7 10.7 5.7 11.4 7.8 3.5 3.4 7.3 8.1 7.6 4.2 18.8 17.1 15.2 11.9 8.8 4.2 6.1 5.9 16.5 5.9 4.3 6.7 8.8 9.2 6.1 5.4 9.3 12.8 9.7 21.6 4.5 4.8 3.8 10.9 3.8 12.8 24.7 24.1 18.9 14.9 11.8 29.6 9.2 16.9 23.6 TTC33 OSRF ENSG00000113638 "Tetratricopeptide repeat domain 33" Q6PID6 5 40512333-40755975 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038252, HPA038253" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA038252: AB_10674551, HPA038253: AB_10671739" "unprognostic (2.86e-1)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (3.41e-3)" "unprognostic (1.04e-3)" "unprognostic (3.01e-2)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.60e-1)" "prognostic favourable (1.83e-4)" "unprognostic (8.50e-2)" "unprognostic (1.29e-1)" "unprognostic (2.04e-2)" "unprognostic (4.28e-3)" 11.0 11.8 13.5 6.9 27.7 1.5 11.0 20.4 20.1 11.7 9.9 6.4 8.1 8.2 12.3 7.8 9.1 10.1 9.0 13.4 11.5 12.1 14.7 15.0 9.0 8.9 8.8 19.4 15.2 8.6 15.6 15.1 9.0 13.1 11.5 9.2 7.3 9.3 10.6 24.2 6.4 9.1 10.5 9.5 8.4 8.7 9.0 9.8 14.3 12.8 5.5 9.2 10.8 9.0 7.2 5.3 15.9 10.8 7.8 10.0 8.2 5.1 4.5 8.8 11.3 6.2 8.9 4.1 7.1 7.5 7.8 8.0 2.3 5.4 16.3 4.3 5.3 2.8 8.5 3.8 12.9 18.4 6.4 3.6 15.4 6.4 6.3 9.2 5.2 5.3 7.2 7.3 7.5 10.8 8.3 12.6 9.4 1.3 16.1 8.9 2.7 4.5 15.7 17.6 9.1 8.3 3.2 6.4 7.3 17.8 8.7 9.5 6.9 10.4 7.4 9.4 8.5 5.9 5.8 10.3 11.1 8.9 6.3 12.3 7.4 15.9 6.1 11.1 8.1 9.0 8.7 7.2 8.5 7.5 5.3 6.9 10.0 8.0 9.0 7.8 10.8 3.9 9.0 8.2 13.5 27.7 20.4 20.1 11.5 12.1 8.8 19.4 13.1 9.8 TTC39C "C18orf17, FLJ33761, HsT2697" ENSG00000168234 "Tetratricopeptide repeat domain 39C" Q8N584 18 23992773-24135610 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 92.2" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065705, HPA065713" Approved Approved Nucleoplasm Nucleoplasm "HPA065705: , HPA065713: " "prognostic favourable (1.48e-4)" "unprognostic (6.37e-2)" "unprognostic (3.66e-1)" "unprognostic (9.97e-2)" "unprognostic (4.37e-2)" "unprognostic (2.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (2.60e-5)" "unprognostic (2.32e-1)" "unprognostic (3.51e-1)" "unprognostic (8.94e-3)" "unprognostic (4.48e-3)" 9.0 14.2 6.2 12.0 4.9 17.7 10.9 5.1 12.2 8.7 6.3 2.4 1.5 5.1 9.8 6.5 9.4 9.0 17.2 3.9 5.3 2.7 3.3 92.2 7.1 14.1 2.2 6.7 5.9 9.8 1.3 13.4 1.5 6.2 9.7 4.6 20.8 11.8 3.9 4.7 24.2 6.2 5.3 2.2 6.7 6.1 14.3 1.0 12.0 3.7 5.7 20.9 8.3 9.3 5.2 8.8 0.5 1.9 5.7 35.5 4.2 6.5 4.9 3.3 2.2 20.8 22.0 11.9 9.4 21.5 7.5 7.7 0.6 3.6 10.8 9.3 16.4 8.2 6.4 8.2 6.0 16.0 6.6 3.1 23.5 12.1 4.0 16.9 8.3 17.7 11.1 4.3 6.1 0.5 0.1 0.1 4.8 5.1 2.7 5.1 8.1 12.6 15.5 5.0 4.1 7.8 10.0 8.7 6.9 18.1 6.1 5.7 4.8 6.2 4.2 6.6 4.9 5.0 4.7 0.2 0.0 15.7 8.8 17.7 4.5 0.5 1.9 0.0 11.2 1.9 28.8 5.2 24.9 14.0 2.5 3.3 10.7 9.0 0.5 5.7 1.5 8.8 35.5 4.2 6.2 4.9 5.1 12.2 5.3 2.7 2.2 6.7 6.2 1.0 TTC9C MGC29649 ENSG00000162222 "Tetratricopeptide repeat domain 9C" Q8N5M4 11 62728069-62740293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055169 Approved Approved Nucleoplasm Nucleoplasm "HPA055169: " "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (2.71e-2)" "unprognostic (7.23e-3)" "unprognostic (2.17e-1)" "unprognostic (6.56e-3)" "unprognostic (1.86e-3)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" "unprognostic (6.90e-3)" "unprognostic (1.33e-3)" "unprognostic (1.57e-1)" "prognostic unfavourable (4.67e-7)" "prognostic favourable (4.15e-5)" "unprognostic (7.49e-2)" "unprognostic (3.55e-2)" "unprognostic (1.53e-2)" 17.1 19.0 23.4 20.9 24.2 6.5 18.4 26.2 29.3 19.1 19.3 15.8 21.2 25.0 22.9 21.6 18.0 22.6 18.7 13.2 21.5 22.6 20.9 17.2 16.4 28.2 20.4 20.0 32.9 22.3 12.3 18.3 23.1 22.3 18.5 18.8 16.7 21.6 20.0 21.1 24.4 18.2 19.0 17.0 23.2 18.4 17.0 17.5 31.1 24.3 13.3 27.9 21.3 18.0 25.2 20.2 31.0 23.9 16.8 22.7 14.0 19.8 17.2 14.4 14.0 19.7 23.9 10.6 20.4 21.0 25.2 20.8 15.2 19.8 15.1 39.0 14.3 18.1 21.2 6.4 19.6 39.3 10.5 16.6 25.0 18.2 22.6 11.2 18.6 15.8 13.6 20.4 20.7 18.4 12.1 15.3 23.9 14.6 17.7 23.8 12.2 13.6 14.1 18.2 22.8 15.9 7.9 12.6 10.3 17.6 15.6 24.7 20.5 10.8 15.9 25.8 15.0 28.4 14.6 16.1 24.1 16.7 14.1 8.6 13.4 31.0 23.9 23.1 14.4 21.3 11.0 25.2 15.4 14.2 20.2 22.6 15.4 13.9 15.3 16.8 13.8 20.2 22.7 14.0 23.4 24.2 26.2 29.3 21.5 22.6 20.4 20.0 22.3 17.5 TTI1 "KIAA0406, smg-10" ENSG00000101407 "TELO2 interacting protein 1" O43156 20 37983007-38033468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034230, HPA068338" Uncertain Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "CAB034230: AB_1564322, HPA068338: " "unprognostic (7.14e-3)" "unprognostic (3.15e-1)" "unprognostic (6.61e-2)" "prognostic unfavourable (3.30e-5)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "prognostic unfavourable (2.40e-7)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.49e-2)" "unprognostic (2.36e-1)" "unprognostic (9.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.80e-2)" "unprognostic (7.56e-3)" "unprognostic (1.34e-1)" 9.2 14.2 16.6 10.5 16.2 9.5 11.1 15.5 16.3 10.8 9.8 16.0 9.2 7.4 12.7 12.7 10.2 12.8 7.3 11.3 10.2 9.0 10.7 15.2 9.6 13.4 14.9 12.9 15.4 24.5 16.6 22.8 13.2 15.6 12.8 13.5 13.9 11.7 14.9 22.0 10.4 9.8 13.8 15.8 12.5 11.3 13.0 14.1 17.6 15.4 4.9 15.3 13.7 10.0 10.2 12.9 17.0 11.6 10.3 13.9 9.1 9.6 14.4 16.0 6.0 6.5 9.2 17.2 11.1 6.5 16.5 14.1 33.6 12.7 16.0 11.5 6.2 15.5 17.9 23.1 16.3 6.4 7.0 21.9 14.3 17.2 7.4 17.5 10.3 7.0 15.3 16.4 10.0 12.2 23.0 11.0 12.4 10.0 23.6 12.2 15.7 15.2 15.5 25.8 18.7 6.3 10.4 14.6 13.0 16.9 30.0 3.8 17.0 8.5 8.0 22.3 14.8 11.8 11.2 9.6 8.3 18.1 13.0 11.6 11.4 12.9 9.8 17.0 11.9 11.6 13.4 10.2 9.3 11.7 12.9 9.7 13.9 11.1 6.2 10.3 6.9 6.3 11.7 9.1 16.6 16.2 15.5 16.3 10.2 9.0 14.9 12.9 15.6 14.1 TTL MGC46235 ENSG00000114999 "Tubulin tyrosine ligase" Q8NG68 2 112482154-112541739 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066819 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA066819: " "unprognostic (1.05e-2)" "unprognostic (3.90e-3)" "unprognostic (2.25e-1)" "unprognostic (3.95e-3)" "unprognostic (9.75e-2)" "unprognostic (1.81e-2)" "prognostic unfavourable (5.65e-4)" "unprognostic (2.95e-1)" "unprognostic (3.65e-1)" "unprognostic (2.10e-1)" "unprognostic (5.48e-2)" "unprognostic (7.19e-2)" "unprognostic (6.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.45e-1)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" 4.4 4.0 9.9 4.2 11.9 7.1 11.3 5.0 12.5 3.3 4.1 9.2 2.5 3.1 4.6 4.2 5.2 3.2 4.9 10.3 9.4 6.5 3.9 3.3 5.9 4.4 8.1 5.3 3.2 3.8 4.1 2.4 5.3 5.9 3.2 3.9 2.6 3.0 3.7 13.1 6.0 3.2 5.8 5.4 4.0 3.2 3.0 6.5 5.1 4.2 5.2 3.8 4.8 2.9 1.8 1.2 2.7 1.3 1.0 1.3 0.5 3.7 2.8 3.6 8.1 4.4 6.2 1.4 6.4 5.3 6.8 5.9 3.5 1.3 3.5 3.6 5.5 2.6 6.3 3.3 8.3 2.4 3.6 2.9 4.0 4.4 1.9 4.1 1.5 2.8 2.3 9.9 5.3 5.8 4.8 2.8 5.3 1.9 3.5 2.3 3.1 5.8 3.8 4.1 1.9 2.1 2.9 7.7 5.4 5.0 1.7 8.9 1.7 2.4 5.7 8.1 5.9 6.3 4.7 1.5 3.1 2.9 9.0 3.1 3.4 2.7 1.3 1.0 1.3 0.8 1.1 0.8 1.0 1.0 0.4 1.8 0.9 1.1 2.4 1.0 1.1 1.2 0.8 0.5 9.9 11.9 5.0 12.5 9.4 6.5 8.1 5.3 5.9 6.5 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278630-133312337 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.3 26.7 16.7 17.3 25.6 29.4 21.4 28.6 33.4 20.3 19.3 22.5 25.2 19.2 23.2 18.9 19.8 35.1 21.7 18.6 21.9 17.2 24.4 22.2 22.8 27.7 16.3 26.5 28.3 30.9 31.9 23.0 17.0 22.3 20.8 16.0 19.0 26.8 22.3 30.4 24.1 19.7 17.6 16.7 25.6 20.1 33.5 15.4 25.6 23.0 18.3 19.5 19.3 18.2 6.1 14.3 17.3 11.9 12.1 10.4 8.7 18.2 25.4 9.4 9.5 10.0 10.9 12.0 14.3 23.3 17.7 17.9 26.4 12.8 13.8 8.1 16.3 12.3 12.5 11.7 7.8 12.9 24.0 8.8 12.5 14.5 12.6 18.8 16.3 11.3 10.3 16.4 20.4 11.6 10.7 11.2 14.2 25.0 10.3 20.9 8.2 20.2 8.2 10.9 6.0 11.6 9.5 6.4 12.7 10.2 11.5 11.5 8.3 9.7 14.0 8.6 7.8 11.3 12.7 11.2 7.6 16.1 34.7 8.5 5.5 5.0 11.9 11.9 7.6 11.2 8.5 6.0 7.6 8.0 14.3 6.1 8.7 9.0 17.3 12.1 11.8 6.5 10.4 8.7 16.7 25.6 28.6 33.4 21.9 17.2 16.3 26.5 22.3 15.4 TUSC1 "CCDC89B, TSG-9" ENSG00000198680 "Tumor suppressor candidate 1" Q2TAM9 9 25676389-25678440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051426 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA051426: " "unprognostic (9.84e-2)" "unprognostic (3.56e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.78e-1)" "unprognostic (4.79e-3)" "unprognostic (1.72e-2)" "unprognostic (5.71e-2)" "unprognostic (1.85e-3)" "unprognostic (9.14e-3)" "unprognostic (1.03e-2)" "unprognostic (1.89e-3)" "unprognostic (2.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" 19.8 13.1 10.9 6.2 12.2 3.6 13.8 9.9 17.4 15.3 13.2 10.7 9.7 11.3 17.6 14.0 9.3 15.0 11.0 11.0 10.4 10.5 13.8 12.2 9.3 4.3 12.3 11.3 16.5 10.3 9.6 9.1 17.9 10.4 15.8 8.4 10.2 14.9 14.2 15.6 14.8 11.9 12.1 8.6 7.5 11.8 32.0 11.9 2.9 20.0 11.4 6.7 11.0 14.9 0.6 1.8 0.0 0.8 0.0 0.1 0.0 6.5 1.4 1.4 0.0 4.9 4.1 0.0 5.0 0.0 1.9 2.3 0.1 2.3 0.0 1.5 5.9 0.0 3.5 6.3 1.2 0.0 7.0 25.4 7.5 0.0 2.4 0.0 0.0 4.9 8.9 2.1 5.0 2.1 0.0 0.0 2.2 3.3 0.0 0.1 1.2 6.5 0.0 0.9 0.1 2.6 3.1 0.5 11.5 6.2 5.2 5.1 4.6 7.1 4.4 0.0 9.4 0.1 0.0 0.0 0.0 0.0 6.1 1.7 6.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.8 1.8 0.0 0.0 10.9 12.2 9.9 17.4 10.4 10.5 12.3 11.3 10.4 11.9 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179686-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: " "prognostic favourable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favourable (5.53e-4)" "prognostic unfavourable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favourable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavourable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 22.5 29.4 20.2 19.4 27.5 14.0 17.9 23.2 26.4 20.3 23.7 17.0 23.4 16.6 30.4 24.7 24.2 25.0 24.6 16.4 18.5 13.9 20.9 44.8 19.0 19.9 25.6 13.4 26.5 23.6 31.5 35.9 19.3 21.8 24.6 18.5 20.8 23.9 23.3 16.5 31.0 18.9 28.3 19.9 23.5 21.2 38.4 22.9 17.0 22.8 18.8 26.0 19.3 23.5 8.0 14.3 8.4 12.2 14.2 13.9 9.0 19.7 16.9 17.7 19.8 22.9 30.3 14.3 28.3 22.5 27.4 26.3 18.8 21.5 22.6 11.5 27.4 22.4 24.0 18.6 25.0 25.8 18.6 35.7 24.6 24.6 24.4 25.9 28.4 30.3 25.0 28.9 13.7 21.6 14.5 23.4 22.3 10.9 18.9 16.7 25.7 15.6 22.3 26.8 19.9 18.7 25.2 18.5 19.1 29.3 18.6 30.0 17.2 15.8 22.4 29.0 25.1 38.2 36.0 35.0 27.0 20.5 30.0 35.4 26.7 8.4 9.0 4.5 13.9 9.7 11.9 7.3 9.6 10.3 6.9 8.0 8.4 9.1 1.3 14.2 12.2 14.3 7.0 9.0 20.2 27.5 23.2 26.4 18.5 13.9 25.6 13.4 21.8 22.9 TXNL4A "DIB1, DIM1, HsT161, SNRNP15, TXNL4, U5-15kD" ENSG00000141759 "Thioredoxin like 4A" P83876 18 79970811-80033949 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing" Deafness "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041324 Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA041324: " "unprognostic (7.56e-2)" "unprognostic (1.06e-3)" "unprognostic (5.94e-2)" "unprognostic (2.67e-2)" "unprognostic (6.99e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (3.38e-4)" "unprognostic (1.45e-1)" "unprognostic (9.39e-2)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (4.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 28.2 35.8 57.2 27.7 43.9 36.7 30.2 21.7 43.4 22.0 29.4 30.7 22.9 23.9 15.8 38.9 26.5 21.0 21.8 33.5 47.9 42.7 29.0 42.5 18.4 35.1 52.6 25.4 14.1 64.9 22.1 38.4 23.2 32.7 21.1 25.2 24.0 46.8 20.5 35.5 26.6 25.1 19.0 37.7 26.9 23.2 41.6 20.8 40.2 28.8 26.8 32.2 23.5 16.9 12.7 25.0 8.4 9.6 11.3 12.7 4.4 21.5 29.0 25.9 24.6 21.2 22.4 23.0 23.5 19.0 31.9 29.0 27.0 15.4 26.3 8.8 22.4 18.4 31.1 27.3 21.1 30.7 39.5 18.9 44.1 63.4 27.1 54.0 30.9 20.8 24.2 22.7 29.1 30.0 16.5 38.4 22.2 39.0 38.3 36.6 20.2 63.0 23.4 17.3 54.2 31.3 34.2 39.7 28.9 11.6 34.6 42.8 17.0 32.2 14.1 28.2 34.6 12.8 28.6 17.1 64.0 43.2 26.4 41.1 25.8 8.4 8.4 6.8 12.2 9.6 8.4 12.3 10.0 9.6 11.4 12.7 10.2 11.9 6.8 11.3 9.5 25.0 12.7 4.4 57.2 43.9 21.7 43.4 47.9 42.7 52.6 25.4 32.7 20.8 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013568: , HPA014118: , HPA015535: AB_1856487, HPA043136: , HPA047029: , HPA047052: , HPA052097: " "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavourable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 15.4 19.1 10.2 12.3 15.4 11.9 15.1 14.9 15.3 18.8 12.9 21.2 18.2 14.1 22.7 15.3 12.0 15.5 10.8 12.9 10.8 9.8 15.2 17.7 11.1 15.5 14.1 10.8 19.4 23.9 22.9 28.0 13.2 14.5 14.9 16.5 17.8 15.3 14.7 26.2 14.4 12.8 14.0 13.9 15.1 12.6 13.7 13.4 19.7 19.0 13.6 23.3 15.3 15.2 9.6 8.3 3.6 9.1 11.2 11.8 5.3 10.5 13.5 8.3 17.1 12.4 8.6 9.6 11.3 8.6 9.0 8.4 15.4 13.8 18.4 17.4 10.4 12.5 17.1 13.9 13.0 14.4 13.1 7.9 11.2 10.4 12.3 18.3 10.6 8.8 14.1 12.1 18.7 8.1 20.9 11.1 10.2 10.4 11.5 15.3 14.5 12.1 13.1 11.6 23.1 12.2 10.7 12.7 12.6 13.6 26.4 11.3 18.0 13.0 9.5 10.3 7.4 8.2 15.4 11.2 15.8 22.2 8.4 17.2 14.2 2.0 7.0 3.6 8.6 7.8 11.7 8.5 9.4 9.8 8.3 9.6 11.5 11.8 2.0 11.2 9.1 6.6 6.8 5.3 10.2 15.4 14.9 15.3 10.8 9.8 14.1 10.8 14.5 13.4 TYW1B "LINC00069, MGC87315, NCRNA00069, RSAFD2" ENSG00000277149 "TRNA-yW synthesizing protein 1 homolog B" 7 72558744-72828198 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA013568: , HPA014118: , HPA043136: , HPA047029: , HPA047052: , HPA052097: " "unprognostic (2.61e-1)" "unprognostic (3.54e-1)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (1.91e-2)" "unprognostic (6.22e-3)" "unprognostic (3.88e-2)" "unprognostic (1.64e-2)" "unprognostic (1.19e-2)" "unprognostic (8.96e-3)" "unprognostic (5.78e-2)" "unprognostic (2.90e-2)" "unprognostic (4.33e-4)" "unprognostic (1.02e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" 2.7 1.6 1.8 4.5 3.8 4.4 4.2 6.0 3.3 5.6 2.9 5.8 7.4 1.5 6.0 5.2 3.4 4.1 1.5 2.3 1.9 3.1 7.9 2.9 2.4 3.9 1.7 10.1 5.7 2.0 11.6 3.0 3.4 4.1 4.4 4.7 4.1 5.9 4.4 2.5 2.9 3.6 4.7 3.0 3.1 7.2 3.8 6.0 5.9 1.8 6.0 3.1 1.1 7.5 5.4 5.7 3.5 2.4 3.0 0.9 2.3 2.4 1.0 2.0 1.6 0.5 1.1 1.2 0.5 1.0 1.1 7.9 4.1 7.2 0.7 0.8 1.1 1.9 0.8 1.3 7.7 2.3 0.7 1.2 4.6 0.8 7.3 2.0 3.7 0.6 1.3 0.8 0.7 9.8 7.6 1.0 0.9 2.3 3.7 1.8 4.5 1.4 5.4 2.6 1.1 0.8 1.8 0.9 1.5 8.2 4.3 2.1 2.6 3.1 1.8 4.3 9.5 1.4 6.6 8.0 8.2 0.5 2.0 9.5 4.0 3.5 5.7 3.0 1.8 2.8 7.5 2.0 1.8 1.4 5.2 2.3 2.7 4.3 2.4 1.7 5.4 2.0 0.9 U2AF1L4 "MGC33901, U2AF1L3, U2af26" ENSG00000161265 "U2 small nuclear RNA auxiliary factor 1 like 4" Q8WU68 19 35742464-35745445 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA052083, HPA061644" Supported Approved Nucleoplasm Nucleoplasm "HPA052083: , HPA061644: " "prognostic favourable (2.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" "unprognostic (1.31e-2)" "unprognostic (2.35e-1)" "prognostic favourable (2.58e-5)" "unprognostic (3.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.67e-2)" "prognostic favourable (8.58e-5)" "unprognostic (8.44e-2)" "prognostic unfavourable (9.73e-5)" "unprognostic (1.06e-1)" "unprognostic (7.21e-2)" "unprognostic (1.92e-1)" "prognostic favourable (7.05e-4)" 5.3 9.7 12.1 4.5 15.0 4.6 4.5 9.3 12.5 4.8 5.7 8.7 8.0 2.7 5.7 6.0 4.9 6.1 5.1 24.3 11.1 10.2 7.0 4.4 4.7 2.8 9.5 10.3 10.7 4.7 11.7 6.6 5.8 8.7 6.7 2.8 10.9 2.5 9.1 19.8 3.4 5.8 6.8 8.5 5.0 4.1 10.7 6.0 2.7 7.4 4.3 5.3 4.2 3.1 9.2 8.4 2.2 3.2 0.8 9.9 5.2 3.7 13.6 1.8 3.1 0.0 1.7 3.1 3.4 3.5 8.7 8.6 5.4 3.1 1.5 6.7 7.7 1.9 6.8 5.3 5.4 10.4 1.0 1.7 3.3 5.8 10.8 2.5 5.6 2.0 2.3 3.6 2.1 1.6 4.1 4.6 5.4 7.9 7.6 2.6 3.0 2.4 1.9 3.2 0.0 1.9 0.6 4.5 4.5 5.0 3.3 0.9 3.8 5.0 2.9 5.4 2.4 1.2 5.5 5.5 6.3 3.5 3.6 5.6 6.5 0.0 2.1 1.5 3.1 3.2 3.0 9.2 6.0 5.9 2.0 6.9 9.0 8.6 2.2 0.8 2.4 8.4 9.9 5.2 12.1 15.0 9.3 12.3 11.1 10.2 9.5 10.3 8.7 6.0 UAP1 "AgX, AGX1, SPAG2" ENSG00000117143 "UDP-N-acetylglucosamine pyrophosphorylase 1" Q16222 1 162561506-162599842 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 105.7;U-251 MG: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014659 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" 19000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA014659: AB_1857409" "unprognostic (2.32e-2)" "unprognostic (2.45e-1)" "unprognostic (2.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.71e-2)" "unprognostic (1.46e-2)" "unprognostic (1.37e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (1.29e-3)" "unprognostic (4.96e-2)" "prognostic unfavourable (5.12e-5)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "unprognostic (3.51e-1)" "unprognostic (3.45e-2)" 38.4 18.5 7.0 17.4 9.8 17.2 24.8 9.0 13.4 16.1 26.9 5.7 45.7 17.2 10.9 19.4 23.6 15.7 18.3 22.5 7.7 7.8 11.0 67.1 16.0 7.4 6.6 8.9 20.4 31.4 5.1 16.0 21.5 9.1 13.9 26.9 7.8 43.9 62.5 19.4 12.4 33.4 28.8 7.1 8.1 23.0 37.7 3.7 5.6 12.4 13.5 15.3 24.4 16.7 8.3 5.6 8.1 1.6 6.2 16.1 4.8 29.9 2.1 6.0 4.8 29.2 23.4 4.1 44.1 16.2 34.0 27.8 5.7 14.1 1.1 9.9 33.8 5.2 6.7 12.8 56.1 4.7 10.1 5.3 6.9 11.1 13.7 9.0 3.6 10.8 6.1 37.3 105.7 20.8 29.9 12.4 45.4 5.5 5.2 5.8 4.4 9.8 4.7 11.7 14.6 5.3 3.5 6.4 6.7 19.2 12.0 10.2 5.9 10.3 35.3 17.2 15.8 43.2 68.8 20.8 7.3 9.9 9.8 4.2 10.8 1.0 1.6 8.1 13.0 1.6 16.1 8.3 7.9 13.3 3.4 6.5 7.6 9.5 1.6 6.2 0.8 5.6 3.9 4.8 7.0 9.8 9.0 13.4 7.7 7.8 6.6 8.9 9.1 3.7 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" 9600 "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: , HPA065335: " "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavourable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 19.1 25.3 29.7 22.2 31.0 53.7 26.8 30.9 31.4 20.3 19.7 31.3 15.9 16.1 22.8 25.4 25.4 19.5 18.4 38.2 23.8 22.7 24.7 17.6 19.3 28.7 37.5 21.2 20.4 15.1 17.9 28.0 27.8 40.8 22.6 22.6 21.8 28.0 20.4 25.0 27.6 21.9 24.0 30.2 27.8 17.3 13.5 31.9 28.4 18.2 17.2 31.0 22.9 20.4 18.9 22.3 35.6 27.8 20.2 22.2 26.0 26.8 11.4 28.1 17.1 26.3 34.9 21.7 24.1 27.3 26.3 26.5 14.1 19.0 20.5 7.0 25.9 15.5 21.6 27.6 30.0 37.3 13.7 27.7 21.5 14.2 20.3 27.1 23.3 27.4 18.5 24.8 20.8 33.8 11.4 17.6 34.6 9.6 17.8 18.3 24.9 9.8 13.9 20.8 18.8 41.9 34.4 12.1 16.9 25.4 18.5 20.6 12.6 26.7 25.6 20.0 17.6 25.9 33.4 20.2 32.3 24.4 20.5 30.2 25.4 34.7 25.4 35.6 14.3 27.8 16.1 18.9 18.9 17.6 22.3 16.0 17.9 18.0 24.4 20.2 27.7 11.4 22.2 26.0 29.7 31.0 30.9 31.4 23.8 22.7 37.5 21.2 40.8 31.9 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: , HPA049132: , HPA056624: " "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 84.7 73.8 71.1 76.4 76.5 167.0 101.5 32.8 71.1 83.2 73.0 48.7 67.8 47.7 79.0 93.2 102.7 78.8 82.0 85.9 58.2 50.2 74.1 135.5 67.7 182.7 64.0 59.0 150.3 225.2 56.5 62.8 71.6 55.5 75.8 74.0 51.6 96.0 75.2 191.4 104.6 68.0 91.9 72.0 101.1 75.5 89.5 52.1 121.2 97.6 131.7 145.1 99.9 161.7 200.5 157.0 75.1 132.4 109.7 205.0 246.6 104.6 83.7 62.9 104.8 163.3 155.4 155.9 80.9 112.4 134.4 107.3 151.5 98.2 151.9 83.7 133.3 71.0 121.5 143.8 127.2 40.7 189.8 83.1 130.1 170.8 119.0 180.2 106.5 179.8 196.8 92.1 134.0 134.6 131.4 210.6 114.6 175.3 143.9 161.7 140.7 181.3 119.1 62.8 173.8 129.5 159.2 82.0 99.2 58.7 142.4 140.2 63.1 233.3 99.9 67.5 56.4 142.0 142.9 129.7 172.1 150.3 91.8 204.8 91.3 50.7 132.4 69.8 119.4 107.2 162.2 200.5 178.5 142.6 147.6 199.1 205.0 165.6 75.1 109.7 96.1 157.0 138.5 246.6 71.1 76.5 32.8 71.1 58.2 50.2 64.0 59.0 55.5 52.1 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805207-49813946 "Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 22.3;HEL: 20.8;HMC-1: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol 1400000 "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: " "prognostic favourable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavourable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favourable (1.48e-4)" 11.3 12.1 6.8 22.0 7.5 16.0 11.5 2.0 6.7 10.8 12.7 14.4 25.4 19.6 17.2 31.6 17.7 12.9 33.1 9.1 6.7 3.9 15.9 11.9 18.8 28.2 6.0 6.2 19.1 9.5 1.4 8.4 8.9 9.4 18.5 12.1 14.2 24.5 34.2 3.3 9.0 25.5 11.3 7.7 35.9 13.2 3.4 5.9 20.4 17.8 18.4 23.5 12.6 13.1 12.4 14.3 24.8 21.7 11.1 11.8 13.0 4.3 0.0 0.3 0.1 12.0 12.7 1.3 2.3 10.4 16.7 22.3 0.0 9.1 0.1 1.8 8.5 2.4 0.0 4.1 1.4 11.1 0.0 20.8 0.2 1.3 8.9 1.9 40.6 19.5 0.2 6.5 0.4 8.3 0.0 1.3 3.8 0.1 4.2 5.1 0.0 0.4 5.4 0.4 0.7 3.4 8.4 0.0 0.3 2.8 4.1 1.4 0.4 13.8 3.7 3.3 0.4 1.4 0.9 0.0 0.0 0.1 9.1 7.4 0.7 13.9 14.7 24.8 11.8 21.7 10.3 12.3 10.8 10.5 14.3 12.4 9.9 8.9 4.6 11.1 17.2 5.2 10.6 13.0 6.8 7.5 2.0 6.7 6.7 3.9 6.0 6.2 9.4 5.9 UBALD1 FAM100A ENSG00000153443 "UBA like domain containing 1" Q8TB05 16 4608883-4615027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066771 Approved Approved "Nucleoplasm,Cell Junctions,Cytosol" "Nucleoplasm, Cytosol" "Cell Junctions" "HPA066771: " "unprognostic (7.09e-2)" "unprognostic (2.21e-2)" "unprognostic (1.55e-1)" "unprognostic (7.67e-3)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.54e-1)" "unprognostic (4.37e-3)" "unprognostic (2.63e-3)" "unprognostic (8.06e-2)" "unprognostic (1.95e-3)" "unprognostic (2.35e-1)" "unprognostic (3.99e-2)" "unprognostic (6.20e-2)" "unprognostic (1.35e-2)" 23.0 16.7 20.5 17.9 25.0 37.5 11.9 32.4 39.2 12.1 19.3 15.1 11.7 23.7 20.4 11.0 15.0 13.9 12.4 14.8 20.9 14.2 19.6 32.9 15.7 13.8 12.0 22.2 14.8 27.2 9.0 12.1 27.9 16.9 18.9 5.3 13.6 19.4 18.1 38.3 16.7 19.5 14.2 11.5 23.9 25.9 13.2 13.0 9.9 17.3 11.3 11.6 17.8 12.8 1.9 2.8 11.3 4.5 1.5 2.6 1.5 5.4 15.7 3.7 5.9 2.5 3.3 16.8 8.2 3.4 3.2 4.6 7.7 6.4 8.1 9.2 2.5 15.0 2.4 8.4 0.9 17.0 23.9 7.6 16.4 11.9 5.2 4.7 13.0 4.6 6.3 4.9 2.4 3.4 11.4 8.5 1.2 26.8 7.8 25.7 14.0 13.9 11.3 4.6 26.2 2.8 7.9 10.9 10.0 9.7 15.0 12.9 9.6 7.7 10.0 6.5 7.3 25.8 5.3 16.6 13.3 9.1 2.6 6.4 3.3 1.3 2.3 11.3 2.5 3.5 1.6 1.9 2.0 2.6 2.8 1.8 2.1 2.2 3.9 1.5 4.5 1.8 2.4 1.5 20.5 25.0 32.4 39.2 20.9 14.2 12.0 22.2 16.9 13.0 UBE2E1 UbcH6 ENSG00000170142 "Ubiquitin conjugating enzyme E2 E1" P51965 3 23805903-23891316 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030445, CAB073413" Approved Approved Nucleoplasm Nucleoplasm "CAB073413: , HPA030445: AB_10669599" "unprognostic (7.50e-2)" "unprognostic (2.78e-2)" "unprognostic (7.91e-3)" "unprognostic (7.13e-2)" "unprognostic (6.74e-3)" "unprognostic (1.74e-1)" "prognostic unfavourable (9.97e-7)" "unprognostic (3.69e-2)" "unprognostic (3.53e-2)" "unprognostic (1.34e-2)" "unprognostic (5.36e-3)" "unprognostic (2.70e-2)" "unprognostic (2.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.94e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" 32.0 28.1 50.8 34.7 44.4 56.1 52.6 38.7 43.4 41.9 40.6 32.4 27.5 23.9 35.3 35.6 57.9 29.5 29.9 58.5 47.3 43.2 33.6 34.0 34.9 44.9 52.0 36.9 36.5 32.0 41.6 22.5 44.5 38.1 38.5 37.8 23.2 30.3 36.4 52.2 33.3 25.8 44.1 55.6 36.3 29.9 24.3 43.3 33.8 41.4 38.0 47.3 52.2 46.3 6.7 7.6 6.8 9.1 7.0 7.2 4.1 33.3 21.0 33.2 16.5 20.3 29.6 29.0 25.3 39.3 28.4 38.1 15.8 37.0 29.5 21.4 24.3 10.8 39.1 31.2 37.3 35.7 43.7 40.8 15.8 19.3 29.2 40.2 21.8 27.9 29.5 36.2 48.7 45.1 28.5 33.0 22.7 17.2 28.2 43.7 48.7 53.9 31.4 14.5 85.0 44.2 23.8 9.6 34.5 22.6 21.0 36.4 23.6 53.2 29.3 20.9 25.9 15.4 18.7 27.5 16.3 58.5 22.5 38.6 16.1 2.4 8.4 6.8 4.5 9.1 6.5 6.5 5.4 3.8 7.3 6.7 7.2 4.3 3.3 7.0 5.8 7.6 3.9 4.1 50.8 44.4 38.7 43.4 47.3 43.2 52.0 36.9 38.1 43.3 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 15.2;intermediate monocyte: 17.8;memory B-cell: 12.3;myeloid DC: 20.9;naive B-cell: 14.8;non-classical monocyte: 18.3;plasmacytoid DC: 27.1" "Group enriched" "Detected in many" 6 "B-cells: 14.8;dendritic cells: 27.1;monocytes: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 22.7 11.4 19.2 12.0 23.3 7.6 15.9 18.8 32.7 22.4 14.5 20.8 7.5 5.9 17.7 31.9 19.7 12.0 18.5 23.4 21.3 21.8 19.1 15.8 16.7 17.7 14.1 19.7 19.0 9.8 15.5 14.4 9.0 20.9 18.2 6.4 8.4 11.2 17.0 32.0 14.8 7.2 22.4 17.6 15.9 11.1 17.8 13.3 14.8 16.8 11.1 14.5 17.0 16.2 14.8 27.1 0.4 18.3 0.8 3.6 5.2 16.7 6.0 16.0 0.3 14.2 15.9 14.5 10.6 18.1 10.0 14.1 1.7 13.8 14.6 7.3 9.3 1.6 11.6 16.5 12.9 0.1 11.6 0.0 7.2 2.0 10.2 0.0 11.7 12.5 17.4 14.3 24.2 9.6 0.8 15.6 9.0 2.6 7.6 3.3 11.3 8.8 16.0 6.2 16.7 9.7 0.4 4.1 8.5 11.7 6.9 0.2 14.7 9.7 8.3 9.9 14.0 6.6 12.0 15.0 4.9 21.5 9.3 6.6 2.7 0.0 15.2 0.0 0.2 17.8 0.3 12.3 0.5 0.2 20.9 14.8 3.6 1.3 0.4 0.8 18.3 27.1 0.2 5.2 19.2 23.3 18.8 32.7 21.3 21.8 14.1 19.7 20.9 13.3 UBE2G1 "UBC7, UBE2G" ENSG00000132388 "Ubiquitin conjugating enzyme E2 G1" P62253 17 4269259-4366628 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045681, HPA050551" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA045681: , HPA050551: " "unprognostic (1.57e-3)" "unprognostic (1.94e-1)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "unprognostic (5.16e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (5.13e-2)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (3.97e-2)" "unprognostic (6.50e-2)" 10.8 11.1 12.6 17.8 13.5 14.3 11.2 11.6 15.3 13.0 19.4 17.8 8.9 11.9 13.3 8.5 27.4 9.2 9.7 26.9 13.5 11.2 14.6 17.7 8.9 18.7 15.2 9.7 9.1 17.1 12.0 6.0 11.4 14.5 14.0 13.3 8.8 11.9 12.0 95.6 14.1 16.6 14.6 19.4 15.0 11.9 11.8 13.6 21.3 12.5 20.7 23.3 17.7 16.5 23.7 13.1 24.4 11.5 20.5 20.6 13.1 21.2 23.0 21.5 15.7 17.6 18.7 30.7 20.7 16.7 19.8 17.4 15.8 10.9 33.3 21.8 20.3 23.0 26.7 19.2 31.9 17.5 21.8 12.4 12.2 18.0 17.3 18.0 23.6 15.9 28.8 18.7 27.3 26.4 21.8 36.1 16.2 9.5 22.9 16.6 23.7 12.0 29.8 11.4 30.4 23.0 14.0 9.3 17.4 19.5 17.0 16.1 16.7 11.8 19.8 19.9 15.2 23.2 23.1 14.0 16.4 47.1 15.3 16.9 15.2 8.1 10.3 24.4 15.4 10.8 20.6 23.7 20.1 20.1 13.1 15.5 20.2 20.5 18.6 20.5 11.5 9.6 18.3 13.1 12.6 13.5 11.6 15.3 13.5 11.2 15.2 9.7 14.5 13.6 UBE2L3 UBCH7 ENSG00000185651 "Ubiquitin conjugating enzyme E2 L3" P68036 22 21549447-21624034 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA045609, HPA062415" Approved Approved Nucleoplasm,Cytosol 8800000 "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: " "unprognostic (4.90e-2)" "unprognostic (3.05e-1)" "unprognostic (1.92e-2)" "unprognostic (1.07e-2)" "unprognostic (2.74e-2)" "unprognostic (9.99e-3)" "prognostic unfavourable (1.29e-4)" "unprognostic (3.28e-2)" "unprognostic (3.65e-2)" "prognostic favourable (3.82e-6)" "unprognostic (3.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.18e-2)" "unprognostic (4.66e-2)" "unprognostic (5.09e-2)" "unprognostic (2.77e-1)" "unprognostic (3.15e-3)" 27.8 34.9 34.8 23.5 29.6 31.3 24.9 25.5 36.9 25.9 27.7 38.4 22.8 26.4 25.6 29.2 38.0 26.9 23.0 33.0 30.7 30.8 27.4 36.0 23.5 32.5 34.3 33.1 24.3 23.9 24.3 21.7 30.1 36.9 27.5 31.7 29.3 30.6 26.7 43.5 23.9 34.4 33.1 36.2 28.5 25.1 35.7 22.6 25.3 25.0 32.4 33.9 28.4 22.2 34.7 49.9 46.1 45.8 34.6 46.9 54.9 24.4 14.1 20.7 16.1 22.6 20.2 11.9 20.6 23.6 26.6 25.3 16.0 11.8 23.1 10.4 27.3 21.0 27.5 22.4 26.5 23.0 29.7 26.7 13.8 19.1 15.1 38.1 19.3 17.8 19.6 19.2 14.0 29.8 107.9 12.4 28.6 18.0 19.8 27.6 15.2 14.9 16.2 31.1 6.3 24.9 19.7 18.6 13.8 16.4 20.7 18.9 12.9 21.1 21.3 18.8 24.2 15.9 21.0 12.1 19.5 21.1 25.5 17.7 17.8 30.8 40.4 46.1 41.4 45.8 38.8 34.7 39.6 44.2 49.9 31.2 34.5 41.6 34.2 34.6 37.6 48.4 46.9 54.9 34.8 29.6 25.5 36.9 30.7 30.8 34.3 33.1 36.9 22.6 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558960 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Nucleoplasm "Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 18.1 26.0 51.8 16.3 38.9 32.1 13.6 28.4 52.4 15.2 20.4 17.0 20.5 17.8 17.3 19.6 24.9 19.3 17.4 43.2 35.1 33.9 19.6 19.1 16.5 18.1 32.1 30.5 19.4 20.2 25.9 22.8 32.0 26.4 18.4 16.7 15.0 20.9 22.6 61.9 19.2 15.9 19.2 19.8 18.5 17.9 31.8 16.1 32.7 22.2 21.2 19.9 18.2 23.5 3.8 7.6 10.9 4.3 1.8 3.8 2.1 21.1 38.6 19.6 18.6 10.5 12.5 14.3 22.1 19.5 16.0 13.8 23.3 16.5 22.3 16.7 15.6 13.9 21.7 21.8 12.0 25.3 131.9 32.4 24.8 15.1 25.6 29.3 25.7 13.3 17.1 24.4 29.0 19.2 15.7 28.2 21.2 21.7 23.3 26.6 12.4 33.8 21.8 16.3 28.6 18.4 26.7 34.4 28.2 19.1 23.4 20.6 14.1 26.9 14.4 50.2 10.2 15.7 39.1 34.1 51.6 23.9 31.9 26.0 32.7 6.8 4.3 4.1 3.5 2.8 2.7 3.4 3.8 3.7 3.1 3.8 3.7 2.5 10.9 1.8 2.7 7.6 3.1 2.1 51.8 38.9 28.4 52.4 35.1 33.9 32.1 30.5 26.4 16.1 UBE2Q1 "NICE-5, PRO3094, UBE2Q" ENSG00000160714 "Ubiquitin conjugating enzyme E2 Q1" Q7Z7E8 1 154548577-154559028 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063368 Approved Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA063368: " "unprognostic (3.88e-1)" "unprognostic (2.13e-1)" "unprognostic (4.44e-3)" "unprognostic (3.64e-3)" "unprognostic (5.32e-3)" "unprognostic (6.10e-3)" "prognostic unfavourable (8.74e-4)" "unprognostic (2.92e-1)" "unprognostic (2.07e-1)" "unprognostic (9.92e-3)" "unprognostic (3.79e-2)" "unprognostic (1.46e-1)" "prognostic unfavourable (4.84e-7)" "unprognostic (2.20e-1)" "unprognostic (4.46e-1)" "prognostic favourable (1.86e-5)" "unprognostic (1.04e-2)" 17.3 18.7 26.5 16.2 29.4 24.2 19.4 26.4 29.0 20.0 21.2 18.7 8.2 16.2 18.3 25.4 20.9 21.8 18.2 17.6 24.5 25.8 25.7 27.4 23.0 26.3 22.8 21.0 21.7 27.2 21.4 29.3 24.5 27.2 21.4 25.7 18.5 19.0 19.8 19.1 21.6 21.4 21.9 19.1 26.0 20.5 30.0 22.0 25.1 21.0 14.0 29.9 19.3 18.5 3.2 5.1 8.1 3.1 4.7 6.2 1.6 18.0 15.7 22.2 16.9 22.8 23.6 19.2 17.9 27.4 23.2 18.8 17.6 19.4 22.3 25.9 25.0 15.8 26.1 20.8 20.0 22.4 16.5 17.7 14.0 17.0 28.8 28.7 28.5 22.7 27.6 18.7 21.7 29.7 14.8 27.7 29.5 28.0 17.5 21.1 30.3 26.7 20.2 15.5 23.4 25.4 19.3 22.6 31.6 18.2 34.3 29.4 20.9 43.8 20.6 15.0 16.8 17.7 19.1 33.8 25.0 29.5 16.8 20.3 22.7 8.1 2.8 5.6 4.8 3.1 4.3 3.0 4.5 5.9 2.5 3.2 5.0 5.7 4.4 4.7 2.6 5.1 6.2 1.6 26.5 29.4 26.4 29.0 24.5 25.8 22.8 21.0 27.2 22.0 UBE2R2 "CDC34B, FLJ20419, MGC10481, UBC3B" ENSG00000107341 "Ubiquitin conjugating enzyme E2 R2" Q712K3 9 33817567-33920404 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 21.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061000 Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA061000: " "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (7.08e-2)" "unprognostic (1.53e-1)" "unprognostic (6.55e-2)" "unprognostic (5.15e-2)" "prognostic unfavourable (4.37e-4)" "unprognostic (1.82e-3)" "unprognostic (4.61e-3)" "unprognostic (3.05e-3)" "unprognostic (2.22e-2)" "unprognostic (4.19e-1)" "unprognostic (2.01e-2)" "unprognostic (4.18e-2)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (1.43e-1)" 26.1 19.7 29.4 19.7 26.8 13.9 39.3 23.7 32.3 25.6 24.1 27.9 16.3 28.0 26.1 18.4 25.3 22.3 21.8 29.2 25.5 20.3 22.1 34.5 23.0 27.1 30.5 23.2 29.8 44.5 15.7 13.9 24.6 21.6 21.0 21.4 19.3 18.7 20.8 56.1 28.1 25.7 28.5 24.2 21.6 20.8 34.5 29.6 36.7 19.5 22.5 25.7 35.8 30.5 3.3 4.2 21.9 11.6 5.0 2.1 2.4 16.3 18.0 34.6 15.0 19.1 31.2 10.6 14.6 20.3 17.1 17.1 14.4 12.3 14.0 6.0 20.3 7.3 18.1 16.6 18.8 23.0 9.6 12.0 19.8 18.3 27.2 14.3 13.1 26.4 24.7 14.0 26.5 28.7 11.3 15.1 16.9 9.5 26.9 37.6 19.7 14.9 25.0 10.5 7.2 18.1 12.4 16.2 19.5 17.0 15.2 10.9 13.4 17.4 21.4 16.5 15.0 11.4 13.5 9.6 9.0 19.5 15.8 8.3 35.5 12.4 7.5 4.1 2.0 7.5 1.3 3.1 1.9 1.6 4.2 3.3 1.9 1.7 21.9 5.0 11.6 2.6 2.1 2.4 29.4 26.8 23.7 32.3 25.5 20.3 30.5 23.2 21.6 29.6 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: " "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavourable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavourable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavourable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 59.4 32.2 28.3 22.6 1.8 2.6 5.0 48.4 14.7 29.9 27.3 21.8 21.3 57.9 20.1 12.1 17.5 28.4 12.6 13.3 45.3 94.2 34.6 18.5 7.0 5.4 41.3 33.7 2.8 3.5 22.0 21.3 11.7 34.3 40.6 18.7 15.7 56.0 21.5 71.1 54.7 49.3 21.8 20.8 8.0 12.7 72.0 39.0 61.7 15.3 27.4 10.9 22.5 17.9 18.1 51.3 15.3 115.2 32.7 78.5 67.9 18.9 29.3 65.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavourable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favourable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavourable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 1.9 4.2 9.6 8.5 12.2 20.8 3.9 4.4 13.5 3.5 11.2 0.7 17.2 7.5 4.3 4.1 10.3 2.9 3.0 8.8 8.8 11.2 4.5 2.8 3.1 15.2 8.7 8.2 1.3 0.9 2.4 3.1 8.7 8.2 2.2 13.9 1.9 2.8 7.0 13.1 4.5 6.9 8.1 3.4 6.7 4.0 16.0 1.8 46.8 2.6 12.8 15.3 6.3 4.5 9.0 3.6 1.7 8.6 1.1 11.1 2.9 30.3 29.0 43.2 20.4 4.0 7.4 24.7 33.2 18.6 38.0 26.8 20.6 37.3 35.4 13.2 12.1 24.8 39.9 19.5 34.3 32.1 22.8 21.6 15.8 23.5 1.8 25.9 26.4 2.6 4.7 29.9 12.4 22.0 27.3 29.3 29.7 28.3 46.3 33.0 16.7 14.8 35.9 46.0 30.8 14.5 14.6 34.0 34.7 23.2 28.6 11.1 30.1 16.4 10.8 17.1 27.4 29.9 39.4 14.9 29.0 45.1 17.0 27.0 35.5 0.0 0.8 1.7 3.7 2.4 2.8 9.0 5.0 3.9 1.7 6.3 7.3 8.0 0.0 1.1 8.6 3.6 11.1 2.9 9.6 12.2 4.4 13.5 8.8 11.2 8.7 8.2 8.2 1.8 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 19.3 19.4 20.3 23.1 25.0 17.8 20.2 30.0 25.1 21.7 19.9 14.3 19.8 14.1 21.0 22.1 19.8 18.5 17.2 24.0 22.2 20.8 20.2 24.6 19.7 23.1 19.1 19.5 23.0 17.2 26.1 24.6 20.1 20.9 20.6 17.9 13.3 19.3 21.5 70.2 18.4 18.8 21.2 19.9 18.8 16.9 26.4 16.4 36.4 25.0 26.6 19.5 19.9 26.6 15.6 11.9 11.6 14.8 21.1 16.0 5.7 19.3 10.9 27.6 16.4 16.1 19.2 13.6 29.8 18.7 21.1 19.2 25.3 9.7 34.7 22.6 22.2 17.9 34.9 21.0 25.8 17.9 11.7 28.8 18.4 14.9 24.2 34.7 21.3 22.6 19.8 19.9 25.5 16.5 29.0 24.8 33.1 10.5 28.7 10.1 17.9 15.9 29.5 41.2 15.3 19.1 30.4 28.3 21.4 24.1 26.2 34.2 21.4 19.6 21.2 37.0 30.6 17.7 21.7 28.4 33.5 46.8 21.2 18.9 19.2 8.6 8.7 11.6 13.3 7.6 15.2 12.0 14.0 15.9 11.9 15.6 16.0 14.2 2.0 21.1 14.8 11.1 10.1 5.7 20.3 25.0 30.0 25.1 22.2 20.8 19.1 19.5 20.9 16.4 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138913-157269372 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" Mitochondria "Nucleoplasm, Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favourable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 24.7 21.0 14.0 17.9 23.1 12.4 19.8 25.5 29.9 21.3 23.4 17.2 15.3 17.4 28.8 16.8 26.8 18.8 24.8 31.8 14.4 13.8 21.2 30.5 16.7 16.7 14.5 15.1 20.7 22.1 29.6 20.3 21.3 22.3 19.0 21.0 20.2 31.7 21.5 51.2 21.2 23.9 25.7 16.1 20.5 21.8 35.9 11.1 20.3 15.6 24.5 24.4 23.1 19.1 2.5 4.0 2.1 4.6 3.7 6.6 2.9 22.5 17.9 11.5 23.0 20.7 21.8 12.8 25.0 21.6 21.1 21.4 16.1 18.9 12.2 22.3 27.5 14.4 17.9 23.1 25.2 22.2 16.4 12.4 12.6 11.6 20.7 18.6 18.3 19.3 21.3 23.4 19.5 24.6 18.1 13.7 29.8 19.7 18.2 11.8 18.3 21.7 10.5 13.0 25.1 21.9 24.9 18.5 19.1 24.6 21.2 18.3 10.9 13.1 22.0 26.7 5.7 65.4 31.0 13.7 13.8 12.3 30.6 27.8 30.5 0.5 3.5 2.1 4.8 4.6 6.6 2.5 5.2 5.2 4.0 2.5 4.9 5.9 1.3 3.7 4.5 3.6 5.2 2.9 14.0 23.1 25.5 29.9 14.4 13.8 14.5 15.1 22.3 11.1 UBFD1 "FLJ38870, FLJ42145, UBPH" ENSG00000103353 "Ubiquitin family domain containing 1" O14562 16 23557362-23574389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051746 Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA051746: " "unprognostic (2.70e-2)" "unprognostic (1.84e-1)" "unprognostic (9.45e-3)" "unprognostic (2.31e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (2.86e-3)" "unprognostic (1.63e-1)" "unprognostic (2.17e-1)" "unprognostic (3.86e-1)" "unprognostic (8.28e-2)" "unprognostic (8.06e-2)" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "unprognostic (3.13e-1)" "unprognostic (1.46e-1)" 10.2 16.2 11.9 8.9 13.0 7.1 10.0 23.1 19.5 11.7 9.2 9.4 15.2 6.1 16.4 14.9 9.6 13.9 11.8 21.2 11.3 17.6 12.3 15.4 7.6 8.7 13.0 11.8 14.5 17.5 28.5 17.2 16.5 13.6 12.5 9.4 12.3 12.3 12.6 52.8 7.6 7.0 14.6 7.4 9.1 8.1 27.6 7.0 16.2 16.4 11.1 11.7 10.9 12.9 2.8 4.1 1.0 1.9 3.0 4.0 1.1 6.4 14.6 20.8 15.0 24.0 29.8 19.5 20.0 16.4 15.9 15.0 11.1 11.1 14.3 31.2 24.4 8.9 32.8 13.3 20.6 23.7 19.3 7.4 13.2 24.1 12.8 7.8 14.4 21.2 10.0 15.5 14.6 15.4 18.8 7.9 17.5 13.4 11.1 14.1 49.7 6.5 20.3 12.8 11.8 14.9 5.5 20.7 19.0 6.6 12.9 11.7 17.7 11.5 16.2 9.0 10.4 9.6 10.4 11.9 11.9 8.7 16.4 9.3 13.6 0.0 1.3 1.0 4.0 1.9 2.3 1.6 2.8 3.9 3.0 2.8 1.7 2.3 0.0 3.0 1.0 4.1 2.3 1.1 11.9 13.0 23.1 19.5 11.3 17.6 13.0 11.8 13.6 7.0 UBL7 "BMSC-UbP, MGC14421" ENSG00000138629 "Ubiquitin like 7" Q96S82 15 74445977-74461182 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040423, HPA041897" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040423: AB_10673442, HPA041897: " "unprognostic (4.21e-2)" "prognostic favourable (6.37e-5)" "unprognostic (2.93e-3)" "unprognostic (5.56e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "unprognostic (3.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (6.71e-2)" "unprognostic (5.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-3)" "unprognostic (8.94e-3)" "unprognostic (7.05e-2)" "unprognostic (2.75e-1)" "unprognostic (3.43e-2)" 14.4 18.0 30.0 16.6 31.8 16.4 17.0 20.8 58.4 20.7 19.4 22.7 15.2 18.2 17.9 19.6 18.4 22.0 15.9 27.6 29.0 21.1 18.6 17.2 16.4 23.1 26.8 26.1 18.4 21.4 30.2 14.3 18.9 33.0 17.5 20.7 15.0 19.8 21.4 45.5 23.0 16.1 23.0 28.3 22.5 18.5 34.8 16.1 36.9 28.2 18.6 34.9 17.7 14.4 26.6 75.5 32.8 28.7 25.8 31.6 23.1 11.5 12.6 20.5 27.5 21.5 28.3 13.8 18.7 23.0 24.6 30.5 15.3 16.8 16.9 20.2 23.0 18.8 57.0 25.4 23.5 22.3 34.8 22.1 21.0 27.5 20.7 13.7 19.1 21.6 23.1 20.4 28.2 20.4 18.9 25.4 24.9 15.8 16.9 21.3 49.0 15.4 18.3 16.1 37.7 21.1 13.5 20.2 40.0 18.3 17.3 25.0 18.3 22.9 11.9 22.8 13.5 11.4 23.2 25.6 48.7 18.8 14.8 25.0 19.6 13.6 26.2 28.5 18.8 28.7 17.9 26.6 18.9 19.5 35.1 26.4 18.5 21.8 32.8 25.8 25.7 75.5 31.6 23.1 30.0 31.8 20.8 58.4 29.0 21.1 26.8 26.1 33.0 16.1 UBOX5 "KIAA0860, RNF37, Ubce7ip5, UIP5" ENSG00000185019 "U-box domain containing 5" O94941 20 3107573-3160196 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028871 Approved Approved Nucleoplasm Nucleoplasm "HPA028871: AB_10603140" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "prognostic favourable (4.52e-5)" "unprognostic (2.58e-2)" "unprognostic (1.02e-1)" "unprognostic (3.11e-2)" "unprognostic (1.61e-1)" "prognostic favourable (1.80e-5)" "unprognostic (4.02e-2)" "unprognostic (9.71e-3)" "unprognostic (3.33e-1)" "unprognostic (5.58e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-2)" 10.1 9.9 9.6 10.0 13.0 17.7 15.4 14.9 16.3 11.6 12.7 12.3 9.0 8.6 14.1 8.8 11.2 13.9 8.8 10.8 10.0 9.1 13.7 12.2 10.1 19.6 10.0 10.2 15.2 17.8 12.8 11.6 11.1 11.9 11.8 8.8 9.5 13.2 13.6 34.1 16.3 10.7 12.2 7.9 10.4 10.8 15.1 9.3 14.9 10.4 11.1 11.5 12.8 9.7 8.7 7.0 11.4 7.0 7.5 8.4 5.5 6.2 6.4 5.1 3.3 6.7 3.7 2.7 5.3 4.8 6.4 6.4 6.0 5.4 4.7 2.0 4.4 8.7 3.4 7.9 3.9 1.4 2.9 8.2 1.9 5.5 5.4 3.4 3.3 4.8 5.9 5.2 6.5 4.1 6.7 4.7 3.7 4.2 7.0 5.2 4.0 3.9 4.7 6.4 3.4 4.0 6.4 6.3 6.0 3.3 19.6 4.1 8.4 2.6 4.6 4.3 2.8 4.7 4.3 6.2 9.1 4.2 2.4 3.6 3.1 11.1 7.0 11.4 7.1 7.0 7.3 8.7 8.0 5.8 7.0 6.8 8.4 8.1 11.4 7.5 5.9 5.6 7.6 5.5 9.6 13.0 14.9 16.3 10.0 9.1 10.0 10.2 11.9 9.3 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038838 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA038838: AB_10673120" "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 16.7 13.2 13.7 18.3 16.7 28.4 18.8 21.8 18.1 18.2 16.2 14.8 10.5 11.3 21.0 12.9 10.8 15.9 14.2 19.7 10.0 15.4 14.4 10.6 16.6 14.9 11.8 10.5 16.3 16.4 26.3 25.6 16.2 18.9 15.3 12.9 12.5 11.8 16.8 23.6 11.0 14.4 18.2 12.1 14.7 13.8 13.7 14.7 23.2 18.8 9.7 14.3 17.3 19.7 4.6 5.0 5.5 4.2 6.2 7.2 1.8 4.9 7.2 8.3 6.7 13.2 10.2 7.9 12.1 13.4 10.7 13.9 9.1 3.9 5.8 7.2 12.4 8.6 11.9 10.6 12.8 11.9 5.8 22.9 14.4 4.4 9.2 16.1 11.0 11.0 6.0 13.1 10.7 12.0 13.0 8.8 13.3 2.8 8.7 4.8 4.7 7.4 11.4 11.4 5.0 10.8 11.7 8.4 7.5 15.9 8.4 5.6 8.1 8.4 16.5 13.2 8.2 11.7 12.2 10.4 17.6 16.7 9.0 10.2 11.9 4.4 3.0 5.2 5.7 4.2 6.5 4.1 5.9 6.9 2.9 4.6 5.9 7.2 5.5 6.2 3.4 5.0 4.1 1.8 13.7 16.7 21.8 18.1 10.0 15.4 11.8 10.5 18.9 14.7 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564062-42693504 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favourable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 19.8 18.8 14.4 21.8 16.7 22.1 18.6 26.6 20.4 17.2 19.3 17.8 17.8 20.1 29.5 16.8 16.2 15.6 16.2 16.8 13.8 13.2 17.8 24.0 19.3 18.0 16.7 12.9 20.8 24.6 28.0 26.3 16.3 17.2 16.5 20.1 15.8 18.3 15.6 33.5 18.0 24.6 19.9 15.9 21.3 18.2 9.2 17.2 26.1 20.1 14.9 17.7 18.9 29.8 3.6 3.5 25.2 5.7 3.9 4.4 1.9 15.7 8.0 9.3 14.6 19.2 18.5 12.6 12.2 13.2 10.8 11.3 11.5 6.5 10.9 9.7 13.1 16.0 13.4 10.4 13.8 14.6 9.4 17.2 11.9 14.9 15.6 16.6 11.9 13.0 11.4 10.7 11.8 12.2 20.1 13.8 10.4 12.8 13.0 14.7 8.5 7.8 11.6 13.9 16.2 12.4 13.8 11.1 8.8 12.3 11.9 11.9 11.6 16.1 17.6 9.9 7.7 12.0 8.8 12.8 11.3 16.8 5.2 12.5 6.0 10.4 4.6 9.2 4.4 4.8 3.7 3.4 2.9 3.4 3.5 3.6 3.0 3.3 25.2 3.9 5.7 2.6 3.3 1.9 14.4 16.7 26.6 20.4 13.8 13.2 16.7 12.9 17.2 17.2 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.8 7.5 8.0 10.6 16.0 12.7 6.8 16.0 9.3 9.3 7.5 11.5 5.6 10.0 13.9 12.4 11.7 9.5 8.1 11.6 10.4 8.2 36.6 8.0 12.2 8.0 12.1 11.9 7.6 7.6 12.1 8.1 9.1 19.0 10.9 15.7 8.3 7.8 5.9 6.3 6.3 7.5 13.2 10.6 6.7 12.5 15.8 8.6 11.2 10.4 6.5 6.8 6.8 11.5 14.0 5.7 10.9 10.0 8.9 6.9 9.2 11.5 7.1 7.7 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 UBR7 C14orf130 ENSG00000012963 "Ubiquitin protein ligase E3 component n-recognin 7 (putative)" Q8N806 14 93207056-93229215 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000861 Approved Approved Nucleoplasm Nucleoplasm "HPA000861: AB_1078321" "unprognostic (9.60e-2)" "unprognostic (5.12e-3)" "unprognostic (1.11e-1)" "unprognostic (9.20e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "prognostic unfavourable (8.12e-5)" "unprognostic (1.14e-1)" "unprognostic (9.83e-2)" "unprognostic (1.04e-2)" "unprognostic (4.30e-2)" "unprognostic (5.94e-2)" "prognostic favourable (9.76e-5)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" 14.1 12.3 16.4 12.5 22.9 17.0 17.5 20.0 25.8 17.1 15.7 17.7 11.3 11.1 14.9 13.4 14.8 13.7 11.9 19.0 14.2 12.8 15.3 13.2 11.9 18.0 14.0 17.1 17.0 20.4 28.2 11.5 11.4 13.3 13.9 17.1 13.6 13.7 14.9 19.9 15.2 12.7 14.1 16.9 13.8 14.1 21.1 14.3 31.9 15.4 12.9 23.3 13.4 13.3 18.1 10.7 15.8 9.5 11.5 16.5 8.2 6.4 8.7 13.3 11.1 6.3 6.7 4.7 13.7 9.7 15.2 11.6 6.3 7.4 15.4 11.5 6.9 7.8 14.3 7.7 15.7 11.9 7.7 11.1 9.3 6.0 2.9 16.2 12.5 4.0 5.4 8.4 5.3 8.5 10.3 15.5 14.5 18.9 26.3 8.9 6.1 15.7 20.3 23.9 8.4 5.1 10.6 16.8 12.0 9.8 8.2 4.0 14.9 11.2 6.5 11.2 6.1 9.6 14.1 17.9 27.4 15.8 9.8 12.6 9.5 15.8 7.3 11.8 12.7 9.1 13.3 18.1 11.4 11.7 7.8 14.8 10.0 10.6 11.5 11.5 9.5 10.7 16.5 8.2 16.4 22.9 20.0 25.8 14.2 12.8 14.0 17.1 13.3 14.3 UBXN1 "2B28, LOC51035, SAKS1, UBXD10" ENSG00000162191 "UBX domain protein 1" Q04323 11 62676498-62679117 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012669 Approved Approved Nucleoplasm 12000 Nucleoplasm "HPA012669: AB_1853149" "unprognostic (1.76e-3)" "unprognostic (8.72e-3)" "unprognostic (3.67e-3)" "unprognostic (2.94e-2)" "unprognostic (9.39e-2)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-1)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (3.52e-2)" "unprognostic (1.43e-1)" "unprognostic (3.34e-3)" "unprognostic (2.42e-1)" 40.4 37.8 33.1 33.8 35.1 27.6 44.1 27.7 37.8 36.0 36.6 36.3 32.3 36.1 38.0 33.7 36.7 37.8 42.3 38.2 30.8 27.2 30.4 26.1 27.3 46.9 33.7 28.5 62.3 41.7 31.4 25.0 29.3 27.2 37.6 19.5 26.6 29.5 32.1 115.3 42.8 31.2 51.5 36.6 37.9 35.0 35.8 29.0 58.9 56.6 40.9 41.2 43.5 67.2 84.1 54.9 27.8 64.2 44.6 85.4 77.8 19.5 31.5 23.7 33.0 33.0 35.5 21.7 17.2 31.7 32.9 22.4 22.4 25.3 31.2 31.8 22.9 27.9 18.9 29.3 15.3 28.0 24.3 21.8 28.0 30.2 64.8 34.3 24.1 45.9 45.7 28.9 44.7 30.5 33.6 20.1 20.5 43.8 25.9 63.3 1.2 21.8 19.6 25.9 30.5 26.4 19.8 23.6 40.9 16.4 25.2 74.4 35.0 42.6 30.0 26.8 20.1 27.1 19.4 25.8 19.5 27.9 30.9 14.7 24.2 21.0 51.1 24.4 46.3 53.1 58.9 83.4 70.6 54.2 54.9 84.1 85.4 62.3 27.8 44.6 64.2 43.7 84.9 77.8 33.1 35.1 27.7 37.8 30.8 27.2 33.7 28.5 27.2 29.0 UBXN2B p37 ENSG00000215114 "UBX domain protein 2B" Q14CS0 8 58411264-58451501 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.6" "Group enriched" "Detected in all" 5 "granulocytes: 27.6;monocytes: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045278 Uncertain Approved Nucleoplasm Nucleoplasm "HPA045278: AB_10963578" "unprognostic (1.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (2.15e-3)" "unprognostic (1.63e-1)" "unprognostic (2.22e-1)" "unprognostic (2.46e-1)" "unprognostic (8.71e-2)" "unprognostic (3.36e-1)" "unprognostic (5.97e-2)" "unprognostic (1.58e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-3)" "unprognostic (1.26e-1)" "unprognostic (8.22e-2)" "unprognostic (2.00e-1)" "unprognostic (1.42e-2)" 9.6 11.7 20.2 14.1 18.8 17.8 13.9 27.2 25.4 8.9 11.1 9.8 7.4 9.3 10.4 14.0 8.4 10.9 10.7 12.0 25.5 13.3 19.6 22.7 12.1 11.6 16.0 20.0 12.0 11.4 22.0 11.7 9.1 14.7 12.3 11.6 6.7 15.0 11.2 12.1 7.8 9.3 14.4 19.7 14.9 10.8 11.1 16.9 11.7 17.7 6.5 11.2 11.4 13.1 2.3 3.6 27.6 7.3 3.0 3.2 3.0 7.4 15.2 11.3 13.8 2.0 1.4 8.4 4.4 8.1 5.8 7.3 5.7 16.4 9.0 9.7 5.4 7.5 16.5 7.9 7.8 8.2 8.4 10.4 13.7 7.8 8.6 9.2 10.1 3.7 12.7 3.1 12.8 6.7 7.6 15.8 4.9 7.3 16.3 10.2 16.0 3.1 9.8 5.4 8.0 17.7 11.0 4.9 17.1 7.6 8.2 12.8 16.2 11.4 1.5 5.3 11.4 9.2 9.4 8.3 9.6 12.5 14.0 8.8 6.1 7.0 7.1 12.3 2.8 6.9 3.1 2.3 2.7 2.4 3.6 2.1 3.1 2.9 27.6 3.0 7.3 2.0 3.2 3.0 20.2 18.8 27.2 25.4 25.5 13.3 16.0 20.0 14.7 16.9 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell line enhanced" "Detected in many" "EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavourable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavourable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 55.0 11.4 0.0 1.5 1.9 0.0 57.6 29.7 20.4 20.6 11.1 0.0 0.0 97.1 29.3 0.1 21.0 0.0 8.3 0.1 8.6 0.0 0.3 0.0 44.0 0.0 0.0 10.6 0.2 16.3 0.0 0.1 0.0 0.2 10.8 0.0 0.0 0.9 32.9 62.2 0.0 24.4 0.0 30.8 0.0 96.9 60.9 0.3 0.2 0.1 0.0 0.4 0.3 1.3 0.4 0.0 88.7 45.5 85.5 0.2 94.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 UCHL3 ENSG00000118939 "Ubiquitin C-terminal hydrolase L3" P15374 13 75549480-75606020 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019678, CAB037139, CAB037208" Approved Supported Nucleoplasm,Cytosol 490000 "Nucleoplasm, Cytosol" "CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583" "unprognostic (4.16e-1)" "unprognostic (3.84e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (5.15e-2)" "unprognostic (6.46e-3)" "prognostic unfavourable (6.41e-4)" "unprognostic (1.19e-1)" "unprognostic (5.59e-2)" "unprognostic (9.71e-2)" "unprognostic (1.24e-1)" "unprognostic (7.09e-2)" "unprognostic (4.47e-2)" "unprognostic (3.97e-1)" "unprognostic (2.76e-2)" "unprognostic (8.84e-2)" "unprognostic (3.26e-2)" 13.7 39.1 23.6 11.9 37.6 17.4 21.4 17.5 18.7 10.6 21.2 11.4 12.8 12.8 9.0 40.5 37.7 8.1 12.4 15.5 20.6 12.6 20.7 36.8 10.3 12.2 18.2 13.5 7.7 20.8 9.5 28.9 26.3 14.7 12.4 25.0 6.1 24.0 14.9 31.7 28.8 15.0 16.9 13.3 15.3 14.5 24.6 18.6 18.9 28.1 29.8 20.2 16.0 16.2 17.4 46.0 15.8 43.5 20.5 23.4 17.3 53.2 8.9 7.8 5.4 14.6 17.4 22.5 20.2 20.0 26.3 29.5 49.3 25.9 27.6 14.6 21.2 29.4 18.2 49.0 40.0 14.7 15.9 17.4 14.8 31.5 21.1 41.5 13.1 15.5 34.1 20.5 33.1 25.6 19.0 7.9 39.5 19.2 16.8 27.2 11.6 26.9 13.5 12.6 18.1 30.9 21.7 23.5 6.9 11.5 22.4 9.3 12.9 11.8 19.8 11.5 13.7 12.2 26.9 11.1 12.3 32.1 23.2 45.0 8.2 15.6 24.1 15.8 10.9 43.5 14.2 17.4 19.9 15.5 33.6 16.0 19.8 18.3 5.4 20.5 36.2 46.0 23.4 17.3 23.6 37.6 17.5 18.7 20.6 12.6 18.2 13.5 14.7 18.6 UCK1 "FLJ12255, URK1" ENSG00000130717 "Uridine-cytidine kinase 1" Q9HA47 9 131523801-131531268 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050969 Approved Approved Nucleoplasm Nucleoplasm "HPA050969: " "unprognostic (2.20e-1)" "prognostic favourable (3.19e-4)" "unprognostic (1.16e-2)" "unprognostic (1.74e-3)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.54e-1)" "prognostic favourable (2.21e-7)" "unprognostic (5.11e-2)" "unprognostic (3.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.07e-1)" 13.2 15.9 21.7 13.7 22.5 13.7 15.6 29.9 23.2 15.0 15.6 17.3 20.8 11.4 12.2 19.3 14.5 17.6 16.5 21.0 19.6 18.4 18.3 26.7 12.7 12.9 20.4 19.1 21.3 24.0 17.6 14.4 16.4 14.8 14.9 9.2 17.6 24.1 18.3 30.0 12.0 12.2 14.8 19.9 12.1 13.4 15.7 15.6 12.5 18.5 10.8 11.5 13.6 9.4 7.9 6.6 9.4 7.8 6.8 13.5 6.1 6.9 15.4 17.9 22.9 12.7 9.1 15.2 11.3 16.8 19.6 15.0 15.3 6.4 7.6 6.8 13.5 13.6 16.6 14.5 8.5 13.9 15.5 7.1 23.2 9.6 18.2 11.6 10.5 10.2 13.6 15.8 11.5 12.0 8.9 5.8 14.4 27.7 15.8 5.9 21.2 15.4 15.2 27.7 12.7 12.6 6.6 24.2 15.2 16.3 12.5 17.6 24.4 6.9 8.8 21.8 11.1 13.5 11.0 12.0 15.3 9.6 10.8 8.1 15.1 2.3 6.2 9.4 8.5 7.8 11.3 7.9 10.1 7.6 5.7 7.9 13.5 6.8 4.1 6.8 2.7 6.6 12.3 6.1 21.7 22.5 29.9 23.2 19.6 18.4 20.4 19.1 14.8 15.6 UCK2 UMPK ENSG00000143179 "Uridine-cytidine kinase 2" Q9BZX2 1 165827531-165911618 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057128 Approved Nucleoplasm Nucleoplasm "HPA057128: " "unprognostic (5.37e-2)" "unprognostic (1.75e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" "unprognostic (4.54e-2)" "unprognostic (6.83e-3)" "prognostic unfavourable (9.22e-8)" "prognostic unfavourable (4.98e-4)" "prognostic unfavourable (6.70e-4)" "unprognostic (3.04e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "prognostic unfavourable (5.12e-13)" "unprognostic (2.49e-3)" "unprognostic (1.14e-1)" "unprognostic (2.01e-3)" "unprognostic (1.83e-1)" 12.5 7.1 6.5 11.1 8.6 11.6 17.5 16.9 9.6 9.3 18.4 8.9 11.0 15.3 10.1 15.3 20.5 8.8 9.0 9.6 6.4 6.6 6.6 14.6 11.1 10.3 10.5 6.6 7.5 17.6 7.9 9.4 65.8 11.2 8.1 19.9 5.0 16.1 9.9 20.9 15.0 24.8 10.0 8.2 7.7 13.2 7.2 7.9 13.1 6.4 12.4 12.3 9.0 11.1 3.4 14.7 0.8 5.6 3.4 3.9 2.0 25.2 26.3 14.2 12.7 7.3 12.2 23.1 27.9 20.6 29.8 34.0 25.0 27.8 12.5 19.9 17.3 20.8 26.6 32.8 26.7 22.9 22.5 14.5 22.6 25.6 18.2 28.3 11.1 11.5 16.9 56.2 35.1 19.6 38.3 18.0 26.7 18.3 25.1 18.2 38.9 25.5 11.5 15.6 42.5 13.8 16.5 21.4 25.3 19.9 39.4 19.3 24.3 27.0 20.4 16.7 23.3 18.9 29.5 24.2 36.0 46.3 14.4 18.8 12.7 0.8 5.6 0.1 1.8 3.7 3.9 3.4 1.7 2.4 14.7 3.4 0.0 1.4 0.2 3.4 3.2 14.0 2.2 2.0 6.5 8.6 16.9 9.6 6.4 6.6 10.5 6.6 11.2 7.9 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Cell line enriched" "Detected in many" 4 "HDLM-2: 17.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "CAB010771: AB_261839, HPA072225: " "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.0 2.0 1.7 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.0 0.3 0.4 2.2 0.8 0.4 0.8 17.8 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.6 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.4 1.6 4.2 0.6 1.1 0.6 1.2 1.2 0.5 0.9 0.7 0.2 1.1 0.4 0.3 1.4 0.6 1.2 1.6 1.7 0.8 0.3 1.1 0.6 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 UEVLD "Attp, UEV3" ENSG00000151116 "UEV and lactate/malate dehyrogenase domains" Q8IX04 11 18529609-18588747 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047134 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA047134: AB_10960698" "unprognostic (1.05e-1)" "unprognostic (6.76e-2)" "prognostic favourable (7.07e-4)" "unprognostic (5.94e-3)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.38e-3)" "unprognostic (9.08e-3)" "unprognostic (9.81e-2)" "unprognostic (2.87e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (1.61e-3)" "unprognostic (2.65e-1)" "unprognostic (3.22e-1)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 17.3 15.0 13.3 11.6 12.9 5.5 20.8 9.7 13.3 17.1 18.2 16.4 12.9 15.1 15.0 16.3 17.8 12.6 13.0 13.2 13.1 12.1 21.8 17.2 13.3 12.3 15.6 10.9 13.8 11.8 19.1 14.2 16.2 15.5 17.9 20.0 11.4 14.8 13.9 20.4 20.2 15.9 18.3 23.0 12.5 13.4 10.0 15.0 14.3 15.2 11.8 11.5 16.5 13.5 5.2 7.1 11.1 8.5 8.7 7.6 3.8 9.1 11.0 5.2 5.0 17.1 15.3 5.1 10.0 14.1 13.3 12.8 4.6 2.6 2.8 5.6 11.7 14.2 4.7 10.2 15.2 8.3 6.2 4.0 5.2 5.0 7.6 6.3 6.2 10.5 11.0 6.4 9.2 12.3 3.0 2.8 16.9 6.9 0.2 2.1 1.4 11.4 1.0 12.2 3.5 16.0 14.5 2.2 4.7 11.0 14.1 8.7 11.2 3.8 9.2 12.3 6.5 20.3 9.8 0.6 6.2 0.6 10.6 5.0 12.5 6.9 8.3 5.0 7.6 8.5 7.1 4.5 5.5 6.1 5.5 5.2 3.6 4.7 11.1 8.7 6.6 7.1 3.8 3.8 13.3 12.9 9.7 13.3 13.1 12.1 15.6 10.9 15.5 15.0 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.4 22.9 19.6 29.6 16.1 11.3 15.1 26.0 26.0 36.0 33.4 25.4 13.7 22.0 20.3 21.8 27.3 22.9 22.8 31.5 40.5 24.2 23.2 16.2 20.0 15.3 36.8 31.7 10.4 23.5 30.7 15.1 28.9 130.1 42.5 21.9 45.7 23.6 22.5 14.0 19.5 28.7 46.3 8.5 22.1 29.7 16.1 18.1 20.4 22.2 20.4 13.3 17.7 31.3 30.5 41.4 25.3 27.9 18.2 36.1 28.7 25.6 18.8 27.7 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 UFSP2 "C4orf20, FLJ11200" ENSG00000109775 "UFM1 specific peptidase 2" Q9NUQ7 4 185399540-185425985 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039985, HPA043298" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039985: AB_10794206, HPA043298: AB_10795037" "unprognostic (8.87e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (3.63e-2)" "unprognostic (3.19e-2)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (2.56e-1)" "prognostic favourable (1.07e-8)" "unprognostic (1.92e-1)" "unprognostic (8.12e-2)" "unprognostic (9.36e-3)" "unprognostic (6.70e-3)" 15.8 20.3 12.5 10.3 14.9 4.1 18.7 11.3 20.3 17.3 17.4 16.3 17.0 11.0 19.4 17.4 20.1 17.3 13.5 24.2 11.4 11.7 28.1 19.2 13.2 11.6 14.6 11.3 30.5 20.1 18.3 22.8 12.3 17.0 18.4 12.6 13.7 14.4 20.3 40.8 16.6 13.6 16.9 20.2 14.2 17.3 23.7 14.6 15.8 23.5 19.2 12.2 20.8 13.3 15.6 13.0 5.5 7.9 13.9 17.9 8.2 12.0 7.4 20.8 15.0 18.8 19.6 11.5 12.5 12.7 15.0 14.2 12.4 15.5 12.2 5.8 15.1 9.6 16.1 20.3 15.6 13.0 9.4 6.4 7.2 11.2 20.8 9.7 8.0 11.5 15.9 13.1 13.6 24.0 16.3 24.6 19.4 7.3 13.0 7.3 5.4 10.7 12.9 8.2 14.6 14.4 7.0 12.4 11.6 7.8 12.7 15.2 9.8 6.9 13.9 6.3 11.1 4.3 9.7 22.4 8.6 5.8 20.3 6.1 15.9 5.5 7.9 5.4 16.3 6.8 17.1 15.6 16.5 17.6 9.8 11.0 17.8 17.9 0.4 13.9 6.6 13.0 14.0 8.2 12.5 14.9 11.3 20.3 11.4 11.7 14.6 11.3 17.0 14.6 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favourable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.3 14.4 13.8 9.3 47.2 61.2 58.0 35.4 29.0 19.1 22.8 36.9 23.3 28.7 10.7 38.0 12.0 16.7 22.2 31.0 19.2 7.1 18.2 10.2 25.2 22.5 16.0 16.1 40.1 40.7 17.9 18.5 26.5 9.1 11.7 79.6 10.8 21.7 15.1 33.1 10.1 17.8 27.4 16.6 33.8 16.0 7.3 6.0 28.3 36.4 13.4 10.4 11.4 36.1 20.0 31.6 29.7 18.6 20.9 9.4 36.4 24.0 25.1 61.0 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;T-47d: 5.7;THP-1: 12.9" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: " "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 5.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 4.0 0.0 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavourable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 7.6 9.3 7.6 7.6 8.2 18.7 6.7 18.5 10.9 4.8 5.9 7.1 4.7 5.1 5.5 4.4 6.0 5.3 4.5 13.7 6.1 5.8 6.1 10.9 8.0 6.9 5.5 6.8 6.6 13.1 15.1 9.5 8.1 7.7 6.0 6.3 6.8 8.6 5.1 22.2 4.9 5.5 6.4 7.6 6.8 7.2 22.5 5.5 8.5 9.4 3.2 6.8 5.9 10.8 1.5 1.2 1.1 4.5 1.4 1.3 0.8 8.3 6.0 5.4 17.4 2.8 2.1 9.7 4.9 3.3 4.8 6.8 11.9 2.2 12.6 5.4 5.1 6.4 19.5 2.8 6.6 6.5 6.3 11.2 5.8 9.9 11.6 10.1 7.0 4.7 8.2 3.8 8.2 6.0 18.7 5.0 2.1 8.0 7.8 6.6 2.4 4.2 4.7 8.6 7.6 6.5 7.8 6.5 6.6 12.4 6.5 16.6 12.4 13.3 3.7 2.4 8.8 3.7 5.4 7.5 11.7 8.1 1.3 14.2 5.9 0.5 1.2 1.1 1.3 1.7 1.3 1.3 1.2 1.3 1.2 1.5 0.6 1.0 0.7 1.4 4.5 0.5 0.4 0.8 7.6 8.2 18.5 10.9 6.1 5.8 5.5 6.8 7.7 5.5 UHRF1BP1L KIAA0701 ENSG00000111647 "UHRF1 binding protein 1 like" A0JNW5 12 100028455-100142848 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039671, HPA075150" Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA039671: AB_10794201, HPA075150: " "unprognostic (4.80e-2)" "unprognostic (3.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.14e-1)" "unprognostic (8.96e-2)" "unprognostic (7.36e-2)" "unprognostic (8.10e-2)" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (5.43e-2)" "unprognostic (1.88e-2)" "unprognostic (2.53e-1)" "unprognostic (2.94e-3)" "unprognostic (6.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.28e-2)" 14.9 13.9 15.9 11.4 19.9 31.9 10.8 16.9 26.0 9.5 10.0 8.7 5.3 9.9 9.3 8.8 10.2 8.0 10.6 10.4 18.0 13.7 14.7 28.0 10.6 9.7 14.8 12.0 11.1 4.7 21.5 15.3 13.7 22.6 11.1 9.6 6.9 8.7 11.2 26.2 8.4 11.1 11.2 13.7 11.8 9.0 15.2 9.8 10.0 13.0 8.1 8.1 16.7 8.4 3.8 8.4 22.9 8.4 3.7 3.7 3.4 11.3 12.4 6.9 7.1 10.7 15.2 13.8 17.7 17.9 14.4 10.5 9.1 3.9 9.8 4.6 18.1 4.4 12.9 6.0 14.0 26.1 6.3 6.6 9.9 10.6 9.9 12.3 10.8 8.6 5.1 17.2 12.0 10.0 5.2 10.3 14.0 6.3 7.9 10.7 11.9 11.3 9.0 12.3 9.7 7.3 20.1 11.8 7.3 13.5 15.5 5.2 13.9 14.2 7.9 15.9 8.5 13.7 12.4 12.2 20.8 13.8 8.0 9.4 9.6 12.5 7.6 4.9 2.6 8.4 3.7 3.8 2.9 2.9 8.4 3.4 2.5 3.0 22.9 3.7 6.8 5.1 3.2 3.4 15.9 19.9 16.9 26.0 18.0 13.7 14.8 12.0 22.6 9.8 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 4.3 4.8 5.1 4.7 8.3 10.3 4.2 4.3 5.4 11.9 2.8 5.9 6.0 2.1 10.7 10.9 2.8 12.3 3.1 13.1 5.2 3.0 5.4 3.4 5.5 4.2 3.1 4.2 4.5 3.6 13.5 19.7 9.0 5.8 4.4 2.8 6.7 4.2 4.5 1.4 3.5 3.3 5.1 5.7 4.4 3.4 27.5 3.4 6.3 7.1 1.7 8.4 4.0 6.0 6.4 5.1 10.7 6.3 2.6 10.3 5.2 7.2 1.7 2.6 3.0 1.1 1.7 4.5 2.5 2.6 3.0 2.6 0.9 2.1 8.4 1.4 5.7 3.7 3.2 1.9 2.8 1.1 0.9 1.6 5.3 2.8 3.9 5.5 1.7 1.6 2.2 14.7 3.0 2.1 1.8 7.0 2.2 5.8 6.9 4.4 3.2 3.0 1.5 8.4 3.7 6.4 7.0 1.3 9.7 2.5 1.2 2.0 2.9 1.8 6.1 1.9 2.2 13.0 2.0 4.2 7.9 3.5 10.8 5.8 2.3 5.7 5.8 5.8 8.0 6.3 6.5 5.6 8.6 7.2 5.1 6.4 6.5 9.2 10.7 2.6 3.2 4.6 10.3 5.2 5.1 8.3 4.3 5.4 5.2 3.0 3.1 4.2 5.8 3.4 UMAD1 "RPA3-AS1, RPA3OS" ENSG00000219545 "UBAP1-MVB12-associated (UMA) domain containing 1" 7 7640711-7968020 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044806 Approved Approved Nucleoplasm Nucleoplasm "HPA044806: AB_10961141" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" "unprognostic (9.08e-3)" "unprognostic (9.24e-2)" "unprognostic (6.86e-3)" "unprognostic (4.87e-1)" "unprognostic (2.56e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "prognostic favourable (1.73e-8)" "unprognostic (6.66e-3)" "unprognostic (8.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.58e-1)" 4.1 8.7 7.0 6.5 8.5 3.8 6.7 6.8 8.8 4.2 6.1 5.3 9.6 7.6 6.2 7.8 4.2 5.0 5.1 6.6 5.5 8.7 7.0 6.6 6.9 7.5 8.3 7.2 18.7 12.5 17.0 4.2 8.1 10.0 5.8 6.1 11.4 11.9 3.5 2.6 8.1 6.3 7.3 5.1 11.6 2.4 6.3 8.6 12.9 3.5 6.3 7.1 8.4 17.0 9.7 27.4 13.0 10.1 22.0 10.9 14.8 11.0 5.7 6.6 8.2 9.7 6.5 9.2 10.7 7.2 11.1 4.6 11.1 8.1 9.7 5.7 9.7 6.5 9.2 9.1 6.1 5.0 4.4 8.4 5.4 9.2 8.1 10.4 9.1 11.7 10.5 8.1 4.4 9.0 25.1 9.6 12.1 7.3 4.4 10.2 9.2 8.2 13.4 12.9 13.3 6.8 2.3 9.4 12.9 16.7 13.0 13.0 10.0 4.8 7.5 17.5 14.6 9.3 18.1 19.8 9.3 16.8 11.7 22.9 22.8 9.7 24.6 12.1 12.4 15.0 17.0 17.3 15.1 8.1 16.2 20.5 15.3 27.4 10.1 13.0 9.7 22.0 10.9 UNC13B "hmunc13, UNC13, Unc13h2" ENSG00000198722 "Unc-13 homolog B" O14795 9 35161992-35405338 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024493, HPA062300" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles,Intermediate filaments" Vesicles "Nucleoplasm, Golgi apparatus, Intermediate filaments" "HPA024493: AB_1858618, HPA062300: " "unprognostic (9.73e-3)" "unprognostic (2.33e-1)" "prognostic favourable (4.96e-4)" "unprognostic (6.56e-2)" "unprognostic (9.93e-2)" "prognostic favourable (8.51e-5)" "unprognostic (7.64e-2)" "prognostic favourable (6.59e-5)" "unprognostic (3.80e-1)" "unprognostic (1.64e-1)" "prognostic favourable (3.71e-4)" "unprognostic (1.74e-1)" "prognostic favourable (4.34e-11)" "unprognostic (2.40e-1)" "unprognostic (1.89e-1)" "unprognostic (1.48e-1)" "unprognostic (2.80e-2)" 11.9 12.1 9.3 9.0 18.3 1.4 10.4 16.6 18.8 12.2 21.4 10.1 35.0 11.5 10.6 8.4 14.9 11.1 14.6 11.1 9.2 7.1 22.1 21.5 37.6 2.2 9.5 9.5 7.9 28.7 21.7 13.7 6.3 10.1 20.5 25.1 27.2 20.7 33.6 21.1 14.6 13.0 12.2 9.4 5.0 15.8 16.2 9.1 0.8 12.5 11.6 5.8 8.6 10.4 0.9 1.9 0.0 0.4 0.0 0.3 0.4 5.4 7.3 8.1 13.0 15.7 8.8 6.9 8.9 4.1 6.6 9.0 6.0 2.5 0.0 4.1 11.6 2.6 20.4 10.4 8.5 0.0 6.5 3.3 20.7 7.7 7.6 1.2 3.8 6.9 8.2 10.5 10.9 21.4 7.4 4.7 7.8 4.2 1.1 0.1 7.3 7.7 0.0 5.0 1.9 9.1 7.1 8.7 9.2 6.3 3.9 6.5 6.7 4.2 19.6 4.6 4.3 7.1 6.8 7.4 8.8 0.0 5.0 10.4 4.6 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.3 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 9.3 18.3 16.6 18.8 9.2 7.1 9.5 9.5 10.1 9.1 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Group enriched" "Detected in some" 5 "REH: 8.3;SCLC-21H: 6.1;SH-SY5Y: 3.9;U-937: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA071881: " "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 8.3 0.0 0.0 0.2 0.2 6.1 3.9 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991104-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6" "Group enriched" "Detected in many" 4 "CAPAN-2: 30.6;RPMI-8226: 85.2;SK-BR-3: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm Nucleoplasm "HPA038716: , HPA038717: AB_10674836, HPA042803: " "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavourable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 8.0 2.7 5.7 9.7 7.4 9.2 5.0 6.2 7.0 4.7 11.9 5.3 6.9 11.8 2.3 5.7 5.5 4.1 13.9 4.6 8.7 6.0 5.9 7.1 13.4 20.8 3.6 0.4 3.0 5.2 0.8 3.3 6.7 2.7 5.3 1.2 5.0 12.3 9.0 6.1 3.7 16.9 2.7 3.5 28.6 10.7 4.1 2.2 2.6 5.3 2.4 13.3 5.9 2.8 2.5 13.6 5.7 6.6 1.8 0.2 0.9 4.4 8.0 0.6 3.3 1.8 0.6 7.0 2.0 1.8 3.1 2.9 0.6 30.6 9.8 7.7 0.9 10.7 0.2 1.6 0.1 3.4 2.3 0.9 2.5 1.4 2.7 6.9 5.5 1.5 1.8 0.9 0.3 0.6 0.7 4.6 0.4 4.3 0.0 5.5 1.5 4.3 5.8 0.0 85.2 2.8 2.5 0.9 1.4 3.3 22.9 4.4 8.5 9.1 2.1 2.1 3.0 3.0 0.2 3.3 4.3 1.6 3.9 7.2 2.5 0.1 3.6 5.7 0.1 6.6 0.2 2.4 0.2 0.2 4.7 2.5 0.0 0.0 3.1 1.8 6.6 13.6 0.0 0.9 5.7 7.4 6.2 7.0 8.7 6.0 3.6 0.4 2.7 2.2 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Cell line enriched" "Detected in some" 20 "NB-4: 46.1" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 9 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm Nucleoplasm "HPA063294: " "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 UPF3A "HUPF3A, RENT3A, UPF3" ENSG00000169062 "UPF3A, regulator of nonsense mediated mRNA decay" Q9H1J1 13 114281584-114305817 "Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018325, HPA061316" Approved Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA018325: AB_1858638, HPA061316: " "unprognostic (9.08e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-2)" "unprognostic (1.16e-2)" "unprognostic (6.48e-2)" "unprognostic (1.98e-1)" "unprognostic (9.80e-3)" "unprognostic (1.44e-1)" "prognostic favourable (7.09e-5)" "unprognostic (1.39e-3)" "unprognostic (1.52e-2)" "unprognostic (2.34e-2)" "unprognostic (9.21e-3)" "unprognostic (1.76e-1)" "prognostic favourable (3.71e-4)" 11.3 16.3 16.9 10.9 20.2 11.9 10.9 32.8 21.9 10.4 9.9 18.6 13.0 13.8 13.1 12.3 10.1 13.2 9.2 7.1 16.1 14.9 11.0 7.5 9.2 12.0 20.2 16.0 12.7 15.4 8.1 12.8 8.5 17.2 12.1 8.7 10.0 11.9 16.1 16.1 11.9 11.9 10.2 23.6 11.8 11.2 34.5 16.7 10.7 24.0 7.4 7.9 11.2 9.3 11.7 15.6 4.1 5.5 11.1 9.5 4.3 23.0 6.8 15.1 13.5 7.2 12.7 9.7 17.9 12.9 11.5 12.9 10.3 8.2 22.7 5.2 8.2 12.5 7.4 5.9 14.5 16.6 14.6 19.5 19.4 11.3 12.6 33.9 8.8 8.5 12.3 7.7 9.0 9.1 11.9 10.6 11.4 7.0 13.8 9.1 20.1 6.8 18.0 8.5 13.2 10.2 7.4 17.2 19.0 14.2 22.0 12.8 16.3 30.4 11.6 12.2 20.5 6.6 11.1 23.1 16.0 31.4 22.5 19.5 10.0 1.9 5.5 4.1 6.8 4.4 5.3 11.7 7.1 7.0 6.0 9.1 7.4 6.7 0.8 11.1 5.1 15.6 9.5 4.3 16.9 20.2 32.8 21.9 16.1 14.9 20.2 16.0 17.2 16.7 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;REH: 1.5" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 2.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.1 1.2 1.3 1.5 0.3 0.0 0.3 0.6 0.7 0.4 0.5 0.5 0.0 0.8 0.2 0.0 0.2 0.3 0.0 0.0 1.3 0.1 0.4 0.4 1.3 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.8 9.9 11.2 10.3 11.4 12.5 1.6 13.0 14.1 23.3 16.2 32.1 13.5 21.8 24.6 8.1 18.1 19.7 22.5 17.7 6.5 7.8 29.3 13.2 25.7 7.2 17.5 8.7 12.2 23.0 12.4 15.6 7.9 12.6 7.2 16.2 8.9 20.0 6.3 9.4 20.4 11.0 17.5 12.0 21.4 7.7 15.8 10.6 11.0 53.0 11.4 7.9 11.2 7.4 15.9 10.1 8.3 11.8 11.2 12.1 9.1 28.4 10.2 12.8 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA046851: " "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavourable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 11.8 24.1 3.5 5.5 2.2 2.2 3.0 4.7 1.6 3.6 3.5 14.1 10.4 7.7 9.8 1.6 11.8 3.4 5.5 1.1 3.9 12.5 4.4 12.7 9.0 3.0 7.0 3.5 2.1 4.7 3.1 3.6 2.7 9.3 5.6 1.9 36.3 6.8 17.3 3.9 13.7 7.9 5.4 13.7 2.7 5.9 7.2 7.3 5.2 19.1 7.0 18.2 6.6 3.5 7.8 9.1 8.1 10.5 8.7 4.7 7.9 6.4 6.1 5.6 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 URM1 "C9orf74, MGC2668" ENSG00000167118 "Ubiquitin related modifier 1" Q9BTM9 9 128371319-128392016 "Predicted intracellular proteins" "tRNA processing, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053645, HPA065160" Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA053645: , HPA065160: " "unprognostic (7.42e-2)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic unfavourable (6.91e-4)" "unprognostic (3.04e-2)" "unprognostic (9.19e-2)" "unprognostic (5.61e-3)" "unprognostic (2.39e-2)" "unprognostic (2.36e-1)" "prognostic favourable (7.43e-6)" "unprognostic (1.77e-3)" "unprognostic (1.93e-1)" "unprognostic (2.47e-1)" "unprognostic (6.17e-2)" 27.2 28.9 25.4 22.4 25.5 31.3 23.2 19.4 40.9 23.4 26.3 36.0 19.7 30.9 25.0 24.4 26.5 26.9 22.9 32.3 25.0 21.4 25.5 39.1 20.8 28.5 29.2 22.9 23.4 53.2 21.2 19.6 28.6 32.0 23.7 25.2 22.2 29.2 23.9 34.9 24.4 36.6 26.4 31.8 30.6 25.6 19.2 21.4 34.9 28.0 29.7 28.8 23.0 20.5 12.4 16.7 10.2 17.7 11.3 15.5 11.5 9.4 18.5 16.7 11.3 17.0 16.8 15.2 8.7 15.4 22.3 15.4 14.6 15.2 19.0 7.4 19.8 31.7 21.2 19.7 11.3 13.4 14.7 16.0 22.3 17.2 16.6 19.4 16.1 21.8 17.5 17.5 15.0 27.1 21.5 13.5 15.9 21.2 27.6 28.5 21.0 22.2 22.6 21.6 23.9 18.1 8.4 15.0 19.9 16.5 28.0 21.2 26.9 16.1 15.3 16.5 15.7 16.4 15.0 13.0 23.9 19.5 17.3 16.8 20.4 5.6 14.3 10.2 15.5 17.7 13.1 12.3 13.5 14.2 16.7 12.4 13.5 14.4 3.7 11.3 16.1 12.4 14.9 11.5 25.4 25.5 19.4 40.9 25.0 21.4 29.2 22.9 32.0 21.4 UROS ENSG00000188690 "Uroporphyrinogen III synthase" P10746 10 125784980-125823248 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044038 Approved Approved Nucleoplasm,Cytosol 15000 Nucleoplasm Cytosol "HPA044038: AB_10966692" "unprognostic (8.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.77e-1)" "unprognostic (7.19e-2)" "unprognostic (1.90e-1)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (5.82e-2)" "unprognostic (1.27e-1)" "unprognostic (4.35e-3)" "unprognostic (4.23e-3)" "unprognostic (2.00e-2)" "prognostic unfavourable (6.27e-4)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (3.93e-1)" 13.8 16.1 48.6 9.0 46.6 33.2 13.9 12.8 35.3 8.9 11.4 15.7 12.8 13.2 9.3 41.2 10.5 11.3 11.5 31.4 36.9 20.4 22.6 25.5 10.0 16.8 22.7 23.4 14.5 14.1 14.4 12.0 7.9 20.0 12.9 12.4 14.0 18.1 14.0 45.6 9.8 12.0 13.0 12.5 11.7 12.5 13.8 13.8 10.8 16.4 14.4 12.7 9.4 6.3 17.3 27.1 2.4 15.6 24.7 21.3 17.8 17.4 18.9 13.8 30.7 18.5 18.8 18.6 22.6 39.1 15.9 15.9 8.2 21.3 24.4 10.6 28.0 10.0 8.0 16.1 15.0 30.1 15.2 51.8 10.7 13.5 26.1 21.8 12.2 23.5 9.2 11.1 29.8 14.5 8.9 23.2 26.5 20.8 19.1 24.6 15.0 19.8 13.5 15.3 14.5 20.8 10.9 10.8 18.6 22.6 17.4 30.7 15.6 20.8 14.4 21.1 7.9 16.2 19.1 21.4 15.5 16.6 29.4 8.9 10.0 2.4 15.6 2.2 16.1 15.4 18.5 15.7 16.0 20.4 27.1 17.3 21.3 16.3 1.2 24.7 14.6 12.9 14.2 17.8 48.6 46.6 12.8 35.3 36.9 20.4 22.7 23.4 20.0 13.8 USP12 USP12L1 ENSG00000152484 "Ubiquitin specific peptidase 12" O75317 13 27066142-27171896 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, HPA059492" Uncertain Approved Nucleoplasm Nucleoplasm "HPA007288: AB_1080531, HPA059492: " "unprognostic (6.72e-3)" "unprognostic (2.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" "unprognostic (5.85e-2)" "unprognostic (1.79e-1)" "unprognostic (3.39e-1)" "unprognostic (8.38e-2)" "unprognostic (8.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.91e-1)" "unprognostic (6.77e-2)" "unprognostic (1.73e-1)" 15.7 10.4 18.3 23.3 17.8 46.0 15.6 16.6 18.3 12.1 30.6 16.1 8.8 13.0 15.3 11.6 23.5 9.5 14.5 11.3 19.3 15.9 18.3 27.9 19.9 19.6 20.5 7.5 12.0 13.4 10.7 16.2 14.8 12.4 17.5 19.1 10.1 8.9 9.5 9.8 17.3 33.0 43.8 18.5 16.5 14.7 11.0 13.1 8.4 12.0 6.6 18.5 42.8 24.2 4.6 3.0 5.3 2.1 2.3 3.6 1.2 12.0 7.6 14.6 7.5 9.8 12.5 5.2 17.0 12.0 9.5 7.1 13.7 19.0 17.2 8.6 13.4 7.5 9.5 9.9 20.3 27.7 8.2 26.6 9.9 9.6 12.3 15.3 18.7 7.8 14.5 10.7 12.3 21.8 8.8 8.4 19.6 7.0 9.4 20.5 10.4 13.5 10.8 18.6 4.0 18.7 8.6 16.1 9.7 14.6 12.3 13.8 5.8 15.0 25.7 9.9 9.6 21.2 15.4 6.4 7.1 12.3 16.7 9.2 11.0 0.0 1.2 5.3 1.5 1.3 2.5 3.2 2.4 2.0 1.6 4.6 1.6 1.7 1.2 2.3 2.1 3.0 3.6 1.2 18.3 17.8 16.6 15.5 19.3 15.9 20.5 7.5 12.4 13.1 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179652755-179789401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 34.8;skeletal muscle: 90.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "MAIT T-cell: 15.4" "Lineage enriched" "Detected in many" 8 "T-cells: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavourable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavourable (3.06e-4)" 6.4 7.5 2.0 2.3 2.8 0.8 3.5 2.9 4.1 2.7 2.1 4.6 1.5 0.7 3.2 3.8 2.6 2.5 2.5 34.8 2.0 2.3 2.3 3.4 6.0 2.5 2.1 2.1 7.2 3.0 3.3 9.8 1.9 3.0 3.0 1.8 3.1 3.3 2.1 90.3 1.8 1.7 3.7 2.5 1.6 1.6 5.6 1.3 1.7 5.5 17.1 3.2 2.6 1.9 2.0 1.9 0.0 0.4 0.0 15.4 0.7 12.3 5.3 10.1 7.7 4.6 6.4 4.9 7.3 8.4 10.8 9.1 7.8 4.4 15.3 8.2 8.8 0.9 11.3 4.4 12.9 36.2 4.8 4.0 8.0 7.3 3.3 11.2 0.0 6.8 1.6 8.4 10.7 8.6 1.9 19.8 8.9 8.1 6.8 2.0 7.8 4.8 11.7 10.0 12.5 7.3 3.5 5.7 7.4 7.0 9.4 4.2 16.2 8.1 9.3 13.0 10.4 11.1 28.1 9.6 8.0 31.4 6.0 7.6 12.1 0.0 0.2 0.0 1.3 0.4 15.4 2.0 1.3 2.9 1.5 0.6 1.0 1.0 0.0 0.0 0.4 1.9 0.6 0.7 2.0 2.8 2.9 4.1 2.0 2.3 2.1 2.1 3.0 1.3 USP16 Ubp-M ENSG00000156256 "Ubiquitin specific peptidase 16" Q9Y5T5 21 29024629-29054488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021140 Supported Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA021140: AB_1858668" "unprognostic (6.06e-2)" "unprognostic (3.14e-1)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (5.92e-2)" "unprognostic (5.79e-3)" "unprognostic (1.92e-1)" "unprognostic (8.99e-2)" "unprognostic (5.78e-2)" "unprognostic (7.40e-2)" "unprognostic (8.73e-2)" "unprognostic (8.65e-2)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-1)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" 25.4 21.7 24.4 27.4 24.2 20.4 22.8 32.4 23.1 24.2 24.3 13.5 23.6 20.4 22.6 28.2 27.1 19.4 17.0 23.8 23.8 22.6 28.4 34.0 16.8 20.7 25.8 19.5 27.3 23.6 31.6 41.6 45.9 25.3 26.0 22.3 13.3 20.6 28.8 35.8 16.1 33.2 26.2 28.6 29.1 20.8 20.1 25.3 37.6 28.4 25.6 25.5 30.8 17.1 30.9 23.5 21.2 20.5 19.9 26.2 10.1 21.8 8.7 13.9 12.5 9.9 16.3 13.1 21.3 14.2 14.8 14.1 10.9 14.2 22.3 6.5 20.4 10.0 17.2 15.5 19.4 21.3 18.3 29.7 10.6 12.1 14.7 29.1 16.5 13.9 16.4 19.3 17.8 14.2 24.4 39.4 17.1 10.0 17.9 10.6 14.8 11.3 12.0 34.3 25.5 12.2 15.8 15.1 16.1 13.8 22.1 18.7 15.2 20.0 14.2 17.3 21.6 15.9 21.9 33.7 46.2 23.4 18.1 21.2 17.2 21.2 16.2 20.9 25.4 16.1 19.8 26.4 23.9 22.8 14.9 30.9 26.2 24.8 15.5 19.9 20.5 23.5 24.5 10.1 24.4 24.2 32.4 23.1 23.8 22.6 25.8 19.5 25.3 25.3 USP20 KIAA1003 ENSG00000136878 "Ubiquitin specific peptidase 20" Q9Y2K6 9 129834698-129881838 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 30.4;MOLT-4: 27.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006287, HPA007008" Uncertain Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA006287: AB_1080510, HPA007008: " "unprognostic (2.64e-2)" "prognostic favourable (8.01e-4)" "prognostic unfavourable (2.48e-4)" "prognostic favourable (4.01e-4)" "unprognostic (4.69e-1)" "unprognostic (1.89e-2)" "unprognostic (2.25e-1)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (7.89e-2)" "prognostic favourable (1.54e-7)" "unprognostic (2.09e-1)" "prognostic favourable (5.65e-5)" "unprognostic (1.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.19e-2)" "unprognostic (1.24e-2)" 7.8 13.2 10.5 15.2 14.6 24.4 8.5 23.0 19.6 13.2 12.1 12.7 10.2 9.7 13.3 6.2 9.3 11.6 12.5 8.8 10.5 13.7 8.0 7.3 9.1 19.6 9.6 16.1 16.8 12.9 11.5 19.0 8.0 11.9 14.9 6.1 10.8 13.7 17.2 10.2 14.0 11.8 20.0 8.8 14.6 10.2 14.0 8.8 51.5 19.3 4.2 15.3 15.6 10.0 3.8 2.4 4.8 1.7 9.0 10.7 5.4 3.0 2.9 5.2 7.0 6.8 5.8 7.4 4.9 4.1 3.7 2.6 2.4 3.3 4.1 4.2 4.7 7.6 3.1 3.5 1.5 22.2 4.1 7.6 8.0 1.6 4.8 7.1 5.7 5.1 5.1 4.9 3.7 4.0 30.4 5.1 2.2 8.0 27.8 16.9 4.1 7.0 4.7 5.8 7.0 2.9 3.3 1.1 5.8 5.7 7.2 4.6 7.5 10.0 5.9 4.1 1.9 5.5 3.2 5.1 7.4 2.9 8.2 9.4 3.8 1.0 1.7 4.8 8.6 1.4 9.3 3.7 8.8 8.3 2.4 3.8 10.4 8.9 2.8 9.0 1.3 2.1 10.7 5.4 10.5 14.6 23.0 19.6 10.5 13.7 9.6 16.1 11.9 8.8 USP27X USP27 ENSG00000273820 "Ubiquitin specific peptidase 27, X-linked" A6NNY8 X 49879948-49882565 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077264 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA077264: " "unprognostic (4.12e-2)" "unprognostic (9.58e-3)" "unprognostic (2.29e-1)" "unprognostic (4.66e-2)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (6.14e-4)" "unprognostic (3.10e-3)" "unprognostic (3.91e-2)" "unprognostic (1.31e-2)" "prognostic favourable (9.31e-4)" "unprognostic (5.37e-2)" "unprognostic (7.45e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.58e-1)" 1.8 3.3 1.8 5.9 2.9 0.3 7.7 1.7 7.4 3.9 5.9 4.8 2.2 1.1 12.7 4.1 3.1 4.7 3.8 3.9 2.2 3.5 3.5 6.1 1.9 1.3 3.2 8.8 3.2 4.1 0.8 15.5 2.8 4.1 1.7 4.1 5.2 3.9 7.5 2.6 4.7 3.9 1.3 2.0 1.9 3.8 1.9 2.8 3.2 3.6 2.2 3.7 3.1 1.7 1.0 0.7 0.7 0.3 1.3 0.4 2.1 5.6 6.5 7.5 6.2 5.0 5.4 2.4 4.1 2.8 2.3 10.0 2.5 1.4 2.3 6.4 3.6 9.3 6.2 4.1 2.9 4.3 2.3 1.6 9.2 4.2 0.7 5.1 7.0 4.2 4.0 4.0 3.9 4.6 2.4 4.5 5.3 3.5 2.0 7.0 3.9 3.7 5.6 0.5 4.6 2.1 1.7 4.9 4.8 4.5 5.8 5.2 1.7 2.9 3.3 6.4 5.7 0.9 2.2 0.5 1.0 3.8 2.0 3.6 0.7 0.4 0.1 0.6 0.4 0.8 0.6 0.5 0.3 1.0 1.7 0.8 0.6 0.7 0.3 0.7 0.4 1.3 0.4 USP33 "KIAA1097, VDU1" ENSG00000077254 "Ubiquitin specific peptidase 33" Q8TEY7 1 77695987-77759852 "Enzymes, Predicted intracellular proteins" "Endocytosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005719 Uncertain Supported "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA005719: AB_10601708" "unprognostic (2.31e-3)" "unprognostic (2.73e-2)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (9.19e-3)" "unprognostic (1.88e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.59e-1)" "unprognostic (5.36e-3)" "unprognostic (4.89e-2)" "unprognostic (5.76e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" 30.8 27.1 28.1 18.8 32.1 24.6 28.6 55.3 37.5 21.6 20.4 20.6 18.5 20.2 23.3 23.0 17.8 19.2 21.7 17.0 30.7 30.6 26.0 20.3 21.0 20.7 26.0 25.4 25.3 17.0 28.8 23.4 34.6 38.7 24.6 21.0 21.4 19.5 19.8 16.3 19.4 23.8 19.8 21.4 22.3 19.5 19.9 21.6 27.8 25.1 12.9 20.3 21.0 20.0 15.7 12.2 33.2 18.4 12.3 17.8 10.6 16.3 7.5 25.9 17.9 37.3 32.6 22.3 17.9 17.1 21.9 24.6 9.9 14.1 12.2 17.0 17.4 12.9 18.8 12.3 26.8 11.2 14.7 43.1 18.3 8.6 23.2 14.7 10.9 24.0 9.7 21.1 15.5 19.4 16.8 10.7 16.4 6.3 13.2 14.7 25.0 14.8 12.8 27.3 8.6 20.6 16.8 21.8 16.8 12.5 16.7 25.0 9.3 16.0 16.2 20.2 14.4 20.3 16.9 8.7 11.1 11.9 15.3 17.4 10.2 33.2 15.4 20.0 15.1 15.0 15.3 13.4 14.7 15.2 11.5 15.7 17.8 15.6 20.9 12.3 18.4 12.2 13.2 10.6 28.1 32.1 55.3 37.5 30.7 30.6 26.0 25.4 38.7 21.6 USP34 "KIAA0570, KIAA0729" ENSG00000115464 "Ubiquitin specific peptidase 34" Q70CQ2 2 61187463-61470769 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025815, HPA070764" Uncertain Approved Nucleoplasm Nucleoplasm "HPA025815: AB_1858681, HPA070764: " "unprognostic (4.04e-2)" "unprognostic (8.21e-3)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (8.91e-2)" "unprognostic (4.62e-2)" "unprognostic (9.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (6.34e-2)" "unprognostic (7.01e-2)" 17.2 19.6 31.8 37.2 25.6 24.8 28.3 77.1 35.5 22.5 22.7 14.4 31.1 11.4 22.2 44.5 18.6 17.5 20.0 16.9 30.5 24.0 20.5 21.5 29.7 34.2 22.0 21.2 24.7 17.2 33.5 40.3 13.4 22.0 22.7 21.5 21.2 16.9 45.2 27.0 31.6 21.0 22.7 20.8 24.8 19.3 26.4 25.3 21.7 23.2 13.9 33.5 19.1 16.7 6.0 5.8 3.4 4.6 5.2 7.5 2.3 16.6 11.9 15.5 16.0 29.5 19.8 13.0 10.3 14.5 9.2 8.8 16.7 6.4 39.5 10.9 22.1 9.1 12.2 13.5 17.2 14.1 9.6 23.9 11.6 26.8 24.8 17.7 15.2 21.6 17.5 16.7 25.1 19.3 16.3 12.8 20.4 15.6 11.6 25.8 10.5 9.4 12.5 18.9 10.5 27.1 20.4 12.8 13.7 16.2 12.0 17.7 6.3 12.9 17.2 14.6 19.4 8.6 13.4 14.9 7.3 41.5 13.7 16.5 12.5 3.4 2.0 2.8 7.5 2.2 6.7 5.1 5.1 5.5 1.8 6.0 5.8 7.5 3.4 5.2 4.6 5.8 4.5 2.3 31.8 25.6 77.1 35.5 30.5 24.0 22.0 21.2 22.0 25.3 USP35 KIAA1372 ENSG00000118369 "Ubiquitin specific peptidase 35" Q9P2H5 11 78188812-78214711 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 32.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055213, HPA058592" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA055213: , HPA058592: " "unprognostic (6.69e-2)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (6.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.08e-2)" "unprognostic (2.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.57e-2)" "unprognostic (3.84e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (1.29e-3)" "unprognostic (2.93e-1)" "unprognostic (1.31e-1)" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" 4.9 17.1 5.1 5.4 9.3 3.8 5.2 10.4 15.0 6.4 5.8 8.0 6.3 5.5 6.8 5.4 5.6 5.4 5.6 8.7 6.1 6.7 5.0 13.8 5.6 4.8 6.7 8.8 6.6 6.4 32.4 12.0 7.1 15.0 5.0 3.4 7.7 4.0 5.6 5.6 3.2 5.3 7.8 4.5 4.6 3.9 5.3 4.0 1.9 7.7 2.9 4.1 5.2 6.6 0.0 0.1 3.4 0.6 0.1 0.3 0.2 2.1 3.3 5.7 6.0 9.8 9.0 3.9 4.9 5.8 5.8 4.1 8.3 4.6 1.7 5.1 9.2 5.7 3.8 7.6 3.4 12.2 2.0 2.8 8.6 4.8 7.6 1.8 8.3 7.6 5.1 12.1 3.5 7.1 3.9 4.2 4.5 1.9 4.6 7.2 1.7 5.3 2.8 5.3 2.1 4.6 3.9 2.8 5.4 3.8 5.0 1.8 4.2 1.5 8.6 10.7 6.1 12.6 2.6 5.7 1.9 2.6 3.2 1.9 6.2 0.0 0.2 3.4 0.1 0.6 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.2 5.1 9.3 10.4 15.0 6.1 6.7 6.7 8.8 15.0 4.0 USP37 KIAA1594 ENSG00000135913 "Ubiquitin specific peptidase 37" Q86T82 2 218450251-218568361 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045160 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA045160: AB_10795620" "unprognostic (7.00e-2)" "unprognostic (2.29e-1)" "unprognostic (8.83e-2)" "unprognostic (9.19e-4)" "unprognostic (1.83e-1)" "prognostic favourable (2.85e-4)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.66e-3)" "unprognostic (1.17e-1)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (3.82e-2)" "unprognostic (3.26e-1)" "unprognostic (2.87e-1)" "unprognostic (6.69e-2)" "unprognostic (6.41e-3)" 10.4 8.4 9.2 9.7 10.5 19.2 9.0 16.2 10.0 8.3 6.6 10.4 8.0 5.8 9.6 15.8 8.2 7.8 7.0 6.9 7.4 5.5 6.1 7.4 8.1 10.5 8.7 7.8 15.3 6.9 10.7 17.1 8.5 8.7 7.3 7.0 7.4 9.7 9.6 11.1 9.9 7.2 8.1 10.2 7.0 6.6 22.2 10.5 13.4 9.8 5.4 9.4 10.5 9.1 7.4 6.1 7.4 4.8 5.9 9.0 2.5 7.3 5.4 11.4 8.8 3.0 3.7 9.7 5.6 4.1 9.9 11.1 10.2 5.9 6.7 6.2 4.4 7.1 12.5 6.3 10.9 9.2 6.6 18.2 10.9 6.7 3.4 11.8 9.1 2.0 3.8 10.3 7.5 4.2 13.1 13.0 6.2 5.5 15.2 8.1 9.8 4.7 12.3 17.1 6.2 3.4 8.8 12.5 6.8 9.0 4.5 5.7 5.2 8.4 5.3 11.1 9.8 6.2 7.4 8.9 7.8 13.8 6.0 8.8 7.5 6.5 4.2 7.4 7.0 4.8 7.3 5.4 5.8 5.9 4.4 7.4 9.0 5.7 3.5 5.9 4.4 6.1 7.3 2.5 9.2 10.5 16.2 10.0 7.4 5.5 8.7 7.8 8.7 10.5 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Cell line enhanced" "Detected in all" "U-266/84: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Nucleoplasm "Centrosome, Cytosol" "HPA036990: , HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favourable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.7 4.5 4.0 6.8 5.2 5.2 2.9 7.6 7.4 7.0 6.0 12.9 7.0 5.9 5.4 6.4 3.8 9.3 7.5 5.8 14.4 6.0 5.4 5.3 2.7 7.2 10.9 5.4 6.3 6.9 7.2 5.8 7.0 11.7 18.5 4.7 7.5 14.2 2.0 3.6 8.7 9.4 5.9 5.6 4.5 5.5 8.1 7.3 5.9 10.3 6.6 6.3 4.1 8.3 6.5 5.3 5.6 7.9 20.7 35.1 10.7 6.6 8.4 5.4 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 USP42 FLJ12697 ENSG00000106346 "Ubiquitin specific peptidase 42" Q9H9J4 7 6104884-6161564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064800 Approved Nucleoplasm Nucleoplasm "HPA064800: " "unprognostic (1.48e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (1.19e-2)" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (2.82e-1)" "unprognostic (6.21e-3)" "unprognostic (2.47e-2)" "unprognostic (3.17e-3)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.66e-1)" 6.7 5.6 5.7 5.7 9.5 19.8 7.2 14.1 10.6 8.5 7.4 10.4 5.5 8.1 14.1 7.0 6.9 8.1 6.5 5.4 5.8 6.0 7.4 7.1 7.3 6.5 6.7 4.9 10.6 11.7 10.5 10.9 8.2 6.2 7.4 6.5 8.9 6.6 6.3 7.4 9.2 9.2 8.7 9.9 7.8 6.7 25.2 8.1 14.3 7.7 6.2 8.3 7.6 6.9 1.9 2.2 3.3 2.4 1.9 4.3 0.8 8.3 6.2 11.3 11.0 6.5 5.0 7.7 4.5 5.8 5.4 5.3 4.4 4.4 9.9 3.0 5.6 7.8 9.4 5.0 5.8 2.4 7.3 4.6 5.3 4.5 5.5 10.6 5.3 5.8 5.9 5.7 7.4 6.5 17.6 6.7 3.5 7.4 6.4 12.0 12.7 4.8 12.2 8.8 6.8 5.0 4.4 8.6 15.3 5.8 12.0 3.6 5.5 5.5 5.5 4.8 17.8 6.0 5.4 6.0 5.0 8.6 4.0 6.5 9.4 2.3 1.1 3.3 2.1 2.4 3.0 1.9 2.6 1.3 1.1 1.1 1.7 4.3 1.4 1.9 1.2 2.2 1.8 0.8 5.7 9.5 14.1 10.6 5.8 6.0 6.7 4.9 6.2 8.1 USP45 MGC14793 ENSG00000123552 "Ubiquitin specific peptidase 45" Q70EL2 6 99432379-99521728 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029602, HPA029604" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA029602: AB_10600418, HPA029604: AB_10602283" "unprognostic (7.81e-3)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (6.62e-2)" "unprognostic (1.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.15e-2)" "unprognostic (1.01e-1)" "unprognostic (2.77e-2)" "unprognostic (8.65e-2)" "unprognostic (2.95e-3)" "unprognostic (1.10e-1)" "unprognostic (3.43e-3)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" "unprognostic (1.43e-1)" "unprognostic (6.91e-2)" 9.8 9.1 8.5 10.2 12.2 7.2 9.0 28.4 11.6 9.0 9.7 8.6 8.9 13.7 15.7 9.6 10.0 8.1 11.9 11.5 7.7 8.5 12.2 9.0 7.1 12.7 9.8 8.0 10.7 9.6 10.2 21.7 9.6 15.0 9.9 13.1 7.9 9.8 8.4 14.6 11.8 12.4 10.8 10.6 9.9 8.9 5.7 9.4 7.1 10.7 10.4 9.5 8.8 15.0 8.6 5.1 3.7 2.5 2.6 6.2 1.4 4.1 3.0 5.9 8.3 10.9 10.4 6.2 7.2 8.1 7.6 10.8 6.1 4.6 11.1 5.4 7.3 5.6 9.0 7.2 10.5 8.7 8.6 10.8 5.9 4.8 8.4 10.0 6.2 11.1 5.7 6.8 11.6 11.2 26.0 11.0 7.1 3.9 3.2 9.5 9.5 6.4 4.7 4.4 6.2 10.5 4.9 8.3 6.8 5.1 6.8 5.3 3.6 4.9 11.2 4.2 5.3 6.1 11.0 4.7 4.3 20.3 7.2 9.5 7.4 3.7 2.0 0.6 4.9 1.3 6.2 7.4 4.2 5.6 3.5 8.6 3.0 2.9 0.5 2.6 2.5 5.1 3.5 1.4 8.5 12.2 28.4 11.6 7.7 8.5 9.8 8.0 15.0 9.4 USP5 IsoT ENSG00000111667 "Ubiquitin specific peptidase 5" P45974 12 6852128-6866632 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006756 Uncertain Approved Nucleoplasm,Cytosol 820000 "Nucleoplasm, Cytosol" "HPA006756: AB_1080534" "unprognostic (2.19e-1)" "unprognostic (5.83e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-1)" "unprognostic (7.60e-2)" "unprognostic (2.21e-2)" "unprognostic (4.02e-2)" "unprognostic (3.93e-2)" "unprognostic (2.57e-1)" "unprognostic (4.71e-2)" "unprognostic (8.90e-3)" "unprognostic (4.69e-2)" "unprognostic (1.17e-2)" "unprognostic (2.65e-2)" "unprognostic (3.56e-1)" "unprognostic (3.23e-1)" "unprognostic (2.02e-3)" 18.6 28.7 23.1 17.8 32.6 13.6 12.9 24.6 50.9 15.9 21.5 26.8 13.8 17.6 22.3 12.8 27.7 19.1 14.7 22.4 23.9 28.6 14.9 24.8 14.4 18.6 23.6 33.2 14.4 13.2 29.7 19.6 21.7 36.8 19.5 16.1 11.6 14.1 22.7 41.2 33.5 18.1 25.3 23.6 14.1 15.9 30.9 18.7 22.8 19.2 20.4 19.9 21.3 16.0 10.8 18.6 5.3 16.6 10.8 17.1 16.6 25.3 39.7 26.7 30.2 18.2 16.8 34.1 27.6 21.2 33.0 24.1 37.5 25.2 30.7 14.5 28.6 22.4 29.3 27.4 21.2 57.5 24.8 28.1 31.9 20.3 14.2 25.4 29.6 16.9 15.9 28.5 19.8 28.2 24.1 12.3 27.2 27.8 38.1 12.6 52.0 16.8 30.0 34.8 21.2 18.8 24.7 14.7 29.7 18.8 28.7 12.0 11.5 20.8 27.3 28.0 33.9 21.3 34.3 14.9 34.2 46.7 31.2 16.2 27.2 2.3 12.3 5.3 17.1 16.6 16.1 10.8 15.2 14.4 18.6 10.0 14.6 14.8 0.9 10.8 14.7 13.6 12.9 16.6 23.1 32.6 24.6 50.9 23.9 28.6 23.6 33.2 36.8 18.7 USP53 KIAA1350 ENSG00000145390 "Ubiquitin specific peptidase 53" Q70EK8 4 119212587-119295517 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 82.1;SK-MEL-30: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035844, HPA035845" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA035844: AB_10669532, HPA035845: " "unprognostic (9.33e-2)" "unprognostic (1.49e-2)" "prognostic favourable (3.15e-6)" "unprognostic (4.37e-3)" "unprognostic (4.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "prognostic unfavourable (7.54e-6)" "prognostic favourable (3.58e-8)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" 26.7 11.9 4.6 11.2 7.9 0.7 20.7 10.9 6.2 16.5 15.0 2.9 27.4 4.5 11.6 16.1 17.9 24.7 8.2 18.6 6.4 5.3 20.2 6.6 26.1 8.7 8.8 4.0 11.4 19.3 6.2 33.9 10.4 13.4 10.7 13.1 17.2 17.7 25.8 33.7 11.3 11.2 9.0 15.5 14.1 13.6 10.2 4.9 4.8 10.7 15.6 8.0 20.5 27.0 1.9 0.8 3.1 0.0 2.2 5.1 0.9 2.7 1.6 0.6 0.0 15.7 15.8 3.4 17.6 82.1 1.6 2.1 1.8 2.6 11.3 0.6 5.2 1.3 1.3 1.3 4.1 1.4 1.1 0.7 1.2 0.6 12.3 0.9 0.1 5.2 3.8 5.5 8.0 7.4 1.7 0.4 2.1 0.6 0.6 1.2 1.7 0.9 0.2 2.9 2.2 4.1 1.7 0.9 0.7 0.9 6.9 25.4 1.7 0.6 8.0 0.5 1.8 6.6 1.5 0.8 1.2 1.9 8.0 0.4 2.0 3.1 0.0 0.2 1.3 0.0 1.4 1.7 2.6 2.0 0.4 1.9 5.1 2.7 0.6 2.2 0.0 0.8 2.2 0.9 4.6 7.9 10.9 6.2 6.4 5.3 8.8 4.0 13.4 4.9 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11, small subunit processome component" Q9Y3A2 1 38009258-38024824 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavourable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 11.3 12.4 9.1 9.6 8.4 9.3 9.7 7.5 11.3 10.6 12.1 6.0 6.9 7.3 11.4 9.1 13.8 9.8 8.6 11.5 12.9 9.5 9.1 13.1 7.4 8.6 9.3 8.7 10.7 11.5 6.6 10.2 11.4 11.2 12.9 8.7 6.7 10.0 8.8 74.7 9.4 7.6 19.7 10.9 10.2 10.4 9.3 5.7 10.5 8.1 26.1 10.6 22.6 10.9 12.9 18.7 9.6 22.5 21.9 17.7 12.3 14.8 9.0 15.7 15.3 11.8 16.2 14.4 16.9 16.1 22.9 21.0 13.2 18.6 24.8 15.9 13.6 12.9 17.8 14.8 28.6 18.6 16.4 28.9 12.1 11.5 16.0 28.7 19.0 14.9 9.6 25.2 22.0 18.2 32.9 13.5 25.8 10.5 22.2 29.7 38.3 12.0 19.8 33.7 23.0 15.0 14.5 20.8 17.3 14.7 12.8 27.0 11.7 17.7 13.4 15.6 18.9 17.0 31.9 12.8 25.2 20.9 21.0 31.6 19.2 8.4 18.9 9.6 16.9 20.5 17.7 10.5 13.5 14.0 18.7 12.9 12.4 15.0 5.7 21.9 22.5 18.0 15.6 12.3 9.1 8.4 7.5 11.3 12.9 9.5 9.3 8.7 11.2 5.7 UTRN "DMDL, DRP, DRP1" ENSG00000152818 Utrophin P46939 6 144285701-144853034 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 57.2;TIME: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016348, HPA018894" Enhanced Supported "Nucleoplasm,Plasma membrane" 6000000 "Nucleoplasm, Plasma membrane" "CAB016348: AB_628424, HPA018894: AB_10600839" "unprognostic (3.47e-2)" "unprognostic (2.82e-1)" "unprognostic (2.32e-1)" "unprognostic (6.87e-3)" "unprognostic (1.75e-1)" "unprognostic (3.30e-2)" "unprognostic (3.99e-3)" "unprognostic (2.44e-1)" "unprognostic (9.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.10e-2)" "prognostic favourable (7.61e-5)" "unprognostic (6.32e-2)" "unprognostic (2.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 34.5 14.1 11.6 34.5 23.5 22.9 25.4 3.1 11.3 32.6 15.3 6.8 21.9 7.7 28.8 21.5 17.7 21.4 15.8 13.8 9.2 12.8 15.5 11.8 35.2 30.9 12.7 8.8 22.7 23.8 53.1 13.0 21.1 16.0 23.4 15.2 17.3 18.4 24.8 11.7 16.7 14.8 19.8 16.6 45.8 13.3 45.0 8.5 27.4 32.4 20.0 25.7 20.7 23.4 11.7 15.0 10.6 48.0 10.3 12.6 3.7 6.8 5.8 10.3 13.3 17.9 16.5 6.2 10.1 9.8 8.2 12.1 22.1 2.5 2.1 8.9 22.7 4.0 57.2 8.5 11.9 22.8 6.6 8.1 6.3 13.1 7.1 9.0 0.1 9.5 1.8 12.2 6.4 40.8 0.5 6.0 11.5 4.5 7.1 3.9 4.1 6.2 6.5 18.6 0.1 9.5 0.1 13.1 0.2 15.7 2.2 6.2 8.7 12.3 52.5 7.9 9.9 4.0 9.6 4.6 6.2 0.3 4.8 5.5 12.9 9.8 12.3 6.6 12.6 36.3 9.0 7.4 8.0 10.2 5.1 11.7 7.0 7.3 10.6 10.3 48.0 15.0 6.4 3.7 11.6 23.5 3.1 11.3 9.2 12.8 12.7 8.8 16.0 8.5 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell line enhanced" "Detected in many" "HEL: 14.7;U-266/84: 11.3;U-698: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA000568, HPA001165" Supported Approved Nucleoplasm,Nucleoli "Intracellular and membrane" Nucleoplasm Nucleoli "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.5 3.3 5.6 3.7 5.6 0.0 0.0 8.9 0.0 3.7 0.0 0.0 0.0 5.2 4.9 0.0 14.7 0.1 0.0 4.9 0.0 0.0 5.9 5.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 5.0 0.1 0.0 0.0 0.0 2.3 3.9 4.0 6.0 3.7 0.0 0.0 0.0 10.5 0.0 3.2 4.3 6.5 0.0 0.0 2.3 10.0 11.3 14.7 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 UVSSA KIAA1530 ENSG00000163945 "UV stimulated scaffold protein A" "Q2YD98, Q8N1N5" 4 1347266-1395992 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050824, HPA053496" Approved Approved Nucleoplasm Nucleoplasm "HPA050824: , HPA053496: " "unprognostic (6.40e-3)" "unprognostic (4.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-2)" "unprognostic (1.67e-1)" "unprognostic (3.85e-4)" "unprognostic (1.89e-1)" "unprognostic (4.80e-2)" "unprognostic (1.38e-1)" "unprognostic (4.88e-2)" "unprognostic (2.12e-3)" "unprognostic (3.92e-3)" "prognostic unfavourable (1.90e-4)" "unprognostic (2.76e-3)" "unprognostic (5.19e-2)" "unprognostic (1.02e-2)" "prognostic favourable (6.87e-4)" 6.5 7.1 5.7 8.0 10.8 11.8 8.1 7.2 7.1 6.1 7.6 10.6 10.9 9.7 10.0 11.4 6.8 10.7 5.5 4.8 8.0 3.4 5.8 6.3 9.4 7.6 7.8 4.3 9.5 13.4 6.7 19.0 9.4 7.0 6.7 5.6 9.6 11.1 6.7 8.7 19.6 8.7 7.2 8.4 9.9 8.9 22.2 7.6 7.1 11.5 3.1 7.3 9.3 7.0 1.5 2.4 3.6 2.1 8.2 1.6 1.5 4.2 6.7 6.2 6.5 9.6 9.6 5.8 3.8 3.0 3.1 2.5 4.5 7.2 2.5 7.4 3.2 4.5 3.6 4.5 2.5 4.4 2.1 6.3 8.5 6.9 2.6 3.9 8.4 2.9 8.6 3.3 3.8 5.0 6.4 8.8 3.7 3.1 6.2 9.0 6.6 6.0 5.6 3.1 3.7 2.6 5.8 4.7 6.2 2.7 3.4 4.7 9.0 2.2 10.6 11.7 2.9 4.4 6.3 15.5 8.9 5.7 8.9 4.8 7.2 0.2 1.8 1.7 1.6 1.1 1.0 1.2 1.3 1.5 2.4 1.5 1.3 0.9 3.6 8.2 2.1 1.4 0.6 1.5 5.7 10.8 7.2 7.1 8.0 3.4 7.8 4.3 7.0 7.6 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 33.7;HUVEC TERT2: 63.0;LHCN-M2: 74.0;TIME: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.0 28.1 0.4 17.0 27.0 16.7 18.5 6.7 2.6 0.0 0.4 29.4 0.1 0.0 0.4 7.4 24.0 0.5 0.3 0.4 9.3 33.7 0.7 0.1 19.4 1.6 7.0 0.2 63.0 0.0 0.0 74.0 2.4 10.4 2.3 0.0 0.1 15.6 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.8 0.1 0.5 0.8 43.0 0.4 1.2 1.3 0.0 0.0 0.5 0.4 19.7 0.9 11.4 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Cell line enhanced" "Detected in many" "HL-60: 80.6;NB-4: 125.9;U-937: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Supported "Nucleoplasm,Golgi apparatus" 210000 "Nucleoplasm, Golgi apparatus" "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favourable (8.07e-9)" "prognostic favourable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.4 3.0 0.2 0.2 0.2 0.1 23.5 0.0 0.0 0.0 0.0 17.5 21.6 5.2 17.1 0.1 16.7 0.2 42.1 0.0 21.4 16.3 27.1 10.4 19.8 0.3 80.6 28.1 0.2 29.9 0.0 7.0 5.4 19.3 1.1 9.6 33.0 0.0 125.9 0.3 2.5 0.5 0.8 35.4 48.8 35.4 0.8 0.3 11.5 61.0 1.8 22.3 62.6 10.8 0.0 1.5 0.3 0.2 0.3 13.2 30.8 0.3 83.6 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 12 "U-2197: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: " "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.7 3.1 1.1 5.2 5.1 1.6 2.6 0.3 0.5 0.0 1.9 3.4 0.0 0.0 0.1 0.2 1.1 0.1 0.1 1.4 1.6 9.9 0.0 0.0 3.2 0.0 3.9 0.1 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.9 2.4 4.1 0.0 0.9 0.2 0.0 4.8 1.2 123.8 0.6 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Group enriched" "Detected in some" 7 "A-431: 7.5;WM-115: 5.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favourable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.2 0.0 2.5 9.3 0.0 11.0 24.3 3.2 4.8 0.3 1.7 0.0 4.3 11.8 0.0 0.1 0.2 18.2 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 13.9 2.8 64.8 0.6 0.0 8.8 0.2 0.0 0.0 1.7 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 18.8 0.0 38.5 13.0 0.4 4.5 15.0 0.0 0.0 0.0 10.4 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 VGLL4 KIAA0121 ENSG00000144560 "Vestigial like family member 4" Q14135 3 11556070-11771350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038225, HPA038614" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA038225: AB_10674549, HPA038614: " "unprognostic (1.21e-2)" "unprognostic (4.68e-3)" "unprognostic (3.29e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.24e-2)" "unprognostic (2.73e-1)" "unprognostic (1.66e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (1.86e-1)" "prognostic favourable (1.32e-5)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (9.42e-2)" "unprognostic (1.26e-1)" 22.3 29.3 26.6 20.7 25.1 10.5 28.2 18.0 23.8 32.3 18.6 22.8 17.8 18.9 35.6 23.3 23.6 36.0 28.9 20.7 23.3 13.2 22.5 10.6 20.4 15.2 22.4 14.9 65.4 18.4 27.2 19.6 19.9 19.7 21.8 14.7 28.8 28.7 23.5 13.8 24.2 18.6 24.7 28.2 15.8 18.6 25.4 23.3 30.0 37.5 21.3 19.9 23.4 30.3 5.6 5.3 16.2 5.8 6.3 11.3 5.8 10.5 7.1 20.4 6.2 25.9 14.1 38.3 7.0 14.5 6.2 6.1 6.0 10.5 14.3 16.2 11.1 7.1 9.3 11.7 4.4 8.7 14.2 15.3 7.1 10.0 20.2 12.0 10.1 17.5 24.3 8.4 10.8 23.1 5.5 2.5 9.6 9.0 14.2 13.8 12.6 12.6 18.4 13.8 18.7 14.2 15.2 9.0 25.8 8.0 8.6 17.9 8.4 11.9 12.1 16.9 8.2 10.9 17.7 3.9 11.1 31.4 18.5 20.6 32.6 16.2 4.4 1.0 11.3 2.5 7.3 5.6 6.2 9.2 5.3 4.0 8.5 8.9 2.6 6.3 5.8 4.5 3.1 5.8 26.6 25.1 18.0 23.8 23.3 13.2 22.4 14.9 19.7 23.3 VPS13D "FLJ10619, KIAA0453" ENSG00000048707 "Vacuolar protein sorting 13 homolog D" Q5THJ4 1 12230032-12512047 "Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027332, HPA051621" Uncertain Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA027332: , HPA051621: " "unprognostic (2.97e-1)" "unprognostic (8.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.75e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-3)" "unprognostic (3.33e-1)" "unprognostic (2.00e-2)" "unprognostic (1.57e-1)" "unprognostic (7.77e-2)" "prognostic favourable (7.42e-12)" "unprognostic (5.13e-1)" "unprognostic (1.72e-1)" "unprognostic (4.04e-2)" "unprognostic (8.31e-2)" 11.7 9.8 16.6 8.5 16.4 8.0 16.6 18.5 19.7 19.9 12.5 17.0 11.7 6.9 12.8 15.3 16.1 10.8 10.2 15.8 15.7 13.2 15.4 11.0 12.3 9.9 16.5 13.8 15.9 11.9 28.1 14.1 9.2 13.3 18.6 11.3 14.0 15.1 16.8 30.3 39.2 9.7 17.3 14.8 10.2 12.8 11.6 13.6 8.6 21.7 11.3 14.4 10.8 17.9 4.1 3.9 6.0 1.9 1.7 3.6 0.9 8.0 4.6 5.2 4.0 14.0 11.2 2.4 4.0 6.9 6.8 6.5 3.1 5.7 7.6 5.0 11.2 7.4 9.1 7.7 9.5 4.1 3.0 6.5 7.2 2.5 5.9 9.4 3.4 9.4 11.0 8.7 8.5 10.7 13.3 3.9 6.2 3.7 5.5 3.7 2.1 5.9 4.8 6.3 2.2 4.8 4.8 2.5 3.5 11.5 8.5 8.1 7.3 3.1 11.6 4.2 4.4 10.9 3.2 3.5 2.8 12.0 4.8 6.7 6.4 6.0 1.9 1.4 3.3 1.9 3.5 2.5 3.6 2.3 1.5 4.1 3.2 2.5 2.6 1.7 1.4 3.9 1.7 0.9 16.6 16.4 18.5 19.7 15.7 13.2 16.5 13.8 13.3 13.6 VPS33A ENSG00000139719 "VPS33A, CORVET/HOPS core subunit" Q96AX1 12 122229564-122266521 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038701 Approved Nucleoplasm Nucleoplasm "HPA038701: AB_10673473" "unprognostic (3.98e-2)" "unprognostic (2.90e-2)" "unprognostic (4.07e-2)" "unprognostic (4.61e-3)" "unprognostic (2.00e-1)" "unprognostic (2.14e-1)" "prognostic unfavourable (9.11e-5)" "unprognostic (2.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (1.25e-1)" "prognostic unfavourable (5.29e-4)" "unprognostic (4.63e-2)" "unprognostic (7.65e-2)" "prognostic favourable (2.41e-4)" "unprognostic (1.09e-2)" 10.4 15.2 13.4 13.6 17.3 12.6 12.7 17.3 19.9 9.6 13.7 14.2 10.5 11.7 11.7 16.8 10.5 12.8 10.4 9.5 13.6 14.4 12.6 12.5 10.8 14.9 13.7 16.8 12.9 11.4 14.7 19.3 17.3 16.8 10.8 11.7 13.0 11.5 14.5 17.1 14.3 11.8 13.6 13.4 16.6 11.2 16.3 9.9 16.1 10.4 9.1 15.8 11.3 11.6 11.6 11.7 21.3 13.7 13.1 17.4 9.6 7.7 10.4 10.6 4.2 8.2 6.3 12.3 7.1 7.8 12.5 7.9 16.9 4.0 8.7 6.1 4.8 6.7 19.1 7.5 10.9 11.7 10.3 8.9 7.1 14.7 10.6 12.1 9.7 7.0 6.4 8.9 7.1 8.2 19.9 4.5 8.1 8.8 5.8 12.4 15.4 11.2 10.2 9.8 10.3 5.3 8.2 7.8 11.8 14.9 4.5 13.8 19.3 8.2 5.3 5.7 9.0 10.7 6.6 14.1 30.5 13.6 9.0 7.8 7.7 21.3 11.2 17.9 11.8 12.2 10.6 11.6 13.4 12.5 11.7 9.2 9.6 11.1 9.5 13.1 13.7 7.4 17.4 9.6 13.4 17.3 17.3 19.9 13.6 14.4 13.7 16.8 16.8 9.9 VPS37C FLJ20847 ENSG00000167987 "VPS37C, ESCRT-I subunit" A5D8V6 11 61130256-61161617 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavourable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favourable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 12.8 12.7 15.6 13.8 14.5 9.8 13.9 10.0 17.4 15.4 18.4 16.0 17.3 19.1 16.1 15.0 20.9 14.5 14.3 15.0 15.5 9.2 15.4 12.1 13.9 8.0 12.5 10.2 16.3 22.6 14.7 19.8 19.5 13.4 19.5 12.5 18.2 29.1 18.2 20.6 24.1 26.4 16.7 13.6 13.0 23.7 18.6 15.3 5.9 14.0 14.9 14.4 17.3 14.6 1.1 1.9 6.8 4.5 0.4 0.8 1.0 17.1 7.0 8.9 8.2 4.3 9.2 19.6 8.8 23.4 13.2 8.9 8.1 7.9 4.5 12.3 11.8 9.5 8.0 9.3 6.8 9.8 6.1 5.9 4.8 8.8 13.9 4.5 7.0 8.0 14.3 10.9 13.8 8.5 15.1 7.3 8.6 20.9 0.9 6.6 10.6 10.0 1.6 4.0 10.7 10.0 9.3 5.4 13.3 8.9 26.8 13.9 25.7 11.0 6.4 12.8 9.3 12.6 10.7 3.6 4.9 3.8 11.3 5.5 8.3 0.8 2.5 2.8 0.6 4.5 0.8 1.1 0.4 0.7 1.9 1.1 0.5 0.3 6.8 0.4 4.1 0.3 0.3 1.0 15.6 14.5 10.0 17.4 15.5 9.2 12.5 10.2 13.4 15.3 VPS54 "HCC8, PPP1R164" ENSG00000143952 "VPS54, GARP complex subunit" Q9P1Q0 2 63892146-64019072 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055894, HPA067981, HPA070582" Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA055894: , HPA067981: , HPA070582: " "unprognostic (1.35e-1)" "unprognostic (3.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.46e-1)" "unprognostic (3.37e-1)" "unprognostic (9.47e-3)" "prognostic unfavourable (2.47e-4)" "unprognostic (1.16e-1)" "unprognostic (4.62e-2)" "unprognostic (1.82e-1)" "prognostic favourable (2.03e-4)" "unprognostic (3.20e-1)" "unprognostic (8.38e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (1.57e-1)" "unprognostic (4.91e-2)" 15.5 14.2 10.1 11.1 13.2 12.6 14.3 22.1 12.9 18.6 17.1 11.4 17.3 12.9 16.3 14.4 13.3 14.4 13.7 12.5 11.3 8.5 15.8 15.5 15.2 9.6 14.3 10.6 18.0 21.0 34.2 32.1 13.0 12.1 17.3 13.5 14.3 31.9 19.4 12.2 13.1 16.9 17.5 10.4 13.3 13.7 12.2 12.5 18.3 17.5 11.3 11.3 13.5 26.2 3.1 2.8 4.1 3.2 3.0 4.3 1.0 16.5 9.2 16.9 13.1 12.4 13.1 12.3 10.8 16.2 11.5 11.4 16.7 10.8 11.6 8.1 14.2 7.7 16.6 9.7 20.3 16.4 11.0 11.0 7.1 28.2 11.6 7.5 4.7 12.1 14.7 8.1 17.7 17.2 12.0 9.8 14.4 7.3 7.6 7.3 10.1 6.6 7.7 16.5 6.5 12.6 9.7 9.7 14.5 9.3 12.0 12.3 8.6 14.6 12.3 14.8 11.8 8.9 17.5 22.5 6.2 14.8 10.8 14.9 12.4 4.1 3.2 1.3 2.1 3.2 2.6 2.4 2.1 2.5 1.8 3.1 2.8 2.2 3.0 3.0 2.5 2.8 4.3 1.0 10.1 13.2 22.1 12.9 11.3 8.5 14.3 10.6 12.1 12.5 VPS9D1 "ATP-BL, C16orf7" ENSG00000075399 "VPS9 domain containing 1" Q9Y2B5 16 89707134-89720986 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 13 "neutrophil: 16.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007847, HPA023620" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA007847: AB_1845582, HPA023620: AB_1845583" "unprognostic (7.08e-2)" "unprognostic (8.63e-2)" "unprognostic (6.26e-3)" "unprognostic (1.63e-3)" "unprognostic (5.67e-2)" "unprognostic (2.29e-3)" "unprognostic (5.03e-2)" "unprognostic (8.72e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (8.23e-3)" "unprognostic (1.37e-1)" "prognostic favourable (2.91e-5)" "unprognostic (4.06e-2)" "unprognostic (3.55e-1)" "unprognostic (2.25e-1)" "unprognostic (3.13e-3)" 8.6 15.4 16.1 19.2 17.9 14.2 5.3 22.7 30.6 6.7 7.1 13.3 8.8 16.6 7.1 7.2 17.0 7.0 9.3 11.0 17.2 16.3 11.7 15.0 8.2 10.4 12.6 24.1 6.4 12.2 16.5 17.6 6.8 17.6 7.9 4.9 10.2 15.3 8.4 12.8 12.6 13.0 6.2 9.3 15.7 10.3 13.5 10.6 1.7 9.3 7.5 7.7 8.5 7.6 0.2 0.2 16.6 0.6 0.1 0.4 0.1 4.5 6.9 7.7 8.2 7.8 7.7 6.5 8.5 8.7 7.3 3.6 6.0 10.2 4.7 5.5 9.2 10.5 0.6 4.8 2.1 4.2 11.8 3.3 5.9 7.2 5.9 1.9 8.1 8.4 4.4 8.8 2.0 5.0 8.4 2.9 4.8 20.6 3.5 7.3 2.9 7.9 8.8 6.4 2.8 5.8 7.2 6.5 6.9 10.8 4.1 8.6 18.2 8.2 7.9 9.6 12.1 7.7 5.0 13.4 4.2 4.1 13.9 5.1 7.9 1.2 0.6 0.3 0.2 0.4 0.0 0.2 0.1 0.1 0.2 0.2 0.4 0.2 16.6 0.1 0.2 0.0 0.2 0.1 16.1 17.9 22.7 30.6 17.2 16.3 12.6 24.1 17.6 10.6 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8" "Cell line enriched" "Detected in some" 9 "NTERA-2: 33.0" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 2.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.6 0.0 4.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.5 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.2 0.2 5.8 0.0 0.0 0.1 0.0 1.9 0.1 0.1 0.8 1.2 1.4 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.8 0.3 0.4 1.4 0.8 0.5 1.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Group enriched" "Detected in some" 5 "Hep G2: 7.0;T-47d: 12.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm Nucleoplasm "HPA060453: , HPA066745: " "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavourable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.4 0.1 0.6 0.6 0.1 0.3 0.1 0.1 0.0 0.2 0.4 1.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.8 0.8 0.2 0.2 7.0 0.0 0.0 1.2 0.0 0.8 0.2 0.0 0.0 0.6 2.0 0.0 0.6 0.0 0.1 0.9 0.7 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.0 12.8 0.0 0.1 0.0 0.2 1.1 0.0 1.7 1.1 0.1 0.8 0.2 0.4 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747472-124752238 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.2;stomach 1: 105.5" "Cell line enriched" "Detected in some" 4 "RT4: 38.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm 81000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 1.3 0.1 0.3 11.2 0.4 0.2 3.3 0.3 0.5 5.2 23.5 0.7 0.3 0.7 1.0 0.8 8.6 2.9 38.2 0.6 0.3 0.2 1.6 0.7 25.3 0.3 0.3 0.3 2.2 0.4 0.0 0.3 0.7 0.5 18.5 24.3 0.4 12.4 0.8 0.3 0.3 2.0 3.5 0.3 0.3 105.5 1.2 0.3 0.3 28.9 3.1 5.3 26.0 14.7 0.3 1.4 0.6 3.8 0.8 2.1 2.7 0.2 0.1 2.7 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.8 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 9.0 0.0 4.3 0.4 0.2 1.7 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.0 0.9 0.0 0.0 0.3 2.1 0.2 2.0 0.0 0.0 38.5 0.1 0.5 0.0 2.6 0.0 0.2 1.3 2.3 1.0 0.6 0.2 0.4 0.1 0.0 0.0 0.3 0.9 0.5 0.0 3.8 0.0 0.0 0.6 1.6 0.0 1.8 0.3 1.4 0.3 2.0 1.6 0.6 0.8 0.5 0.0 2.1 2.7 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.3 0.5 0.3 VSIR "B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747559-71773498 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 111.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.0;HaCaT: 19.7;HMC-1: 33.0;U-937: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 111.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm 360000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavourable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 20.8 5.7 13.3 23.4 14.8 55.3 30.4 3.4 10.2 10.7 12.9 10.5 5.4 16.6 14.7 8.8 13.7 15.0 10.8 13.6 13.0 9.8 5.8 4.1 20.1 60.0 12.4 7.2 17.5 4.4 2.4 3.8 48.2 11.8 11.0 7.1 8.1 8.6 8.7 4.7 9.1 16.3 12.7 11.1 55.1 10.2 6.4 11.8 4.6 7.7 10.1 17.6 14.1 24.8 1.9 24.4 111.3 44.9 5.8 11.7 40.1 3.2 6.4 0.0 0.1 3.5 2.9 3.1 1.2 7.8 1.5 2.6 2.6 26.0 0.2 1.6 11.0 19.7 0.0 0.7 0.4 0.1 0.0 4.3 1.3 0.2 4.8 0.7 33.0 2.4 0.7 0.2 0.1 0.5 0.1 2.4 0.9 0.1 0.7 5.4 0.0 1.2 0.0 0.3 1.5 0.0 1.5 0.0 0.1 1.6 1.2 1.2 0.1 9.3 1.7 0.0 0.0 5.3 0.0 1.8 0.9 0.0 0.1 28.8 0.1 22.0 42.3 81.0 8.9 40.5 11.7 1.8 8.9 8.4 24.4 1.9 8.3 8.3 111.3 5.8 44.9 6.4 8.8 40.1 13.3 14.8 3.4 10.2 13.0 9.8 12.4 7.2 11.8 11.8 VSTM4 "C10orf72, FLJ31737" ENSG00000165633 "V-set and transmembrane domain containing 4" Q8IW00 10 49014245-49115509 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 6.8;RH-30: 7.8;SH-SY5Y: 6.7;U-138 MG: 8.9;U-2197: 20.0;U-87 MG: 9.8" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 22.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017279 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" "Nucleoplasm, Vesicles" "HPA017279: AB_10959519" "unprognostic (8.46e-2)" "unprognostic (5.41e-1)" "unprognostic (1.89e-1)" "unprognostic (2.07e-1)" "unprognostic (1.80e-1)" "unprognostic (2.84e-2)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" "unprognostic (1.93e-2)" "unprognostic (2.81e-2)" "unprognostic (3.03e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (4.25e-4)" 13.0 31.6 7.2 3.4 6.7 0.4 10.5 3.3 7.1 18.2 6.2 9.3 3.1 2.0 13.2 5.9 6.1 6.5 11.7 10.3 7.2 4.4 9.3 3.0 8.9 7.0 8.9 5.4 27.2 1.3 22.8 4.6 7.7 10.1 11.2 4.4 15.1 2.8 9.2 3.8 4.2 4.1 12.5 7.9 2.8 5.4 7.8 6.0 2.9 20.8 6.9 3.4 9.4 8.6 1.8 0.9 2.7 0.9 1.7 0.7 0.2 0.0 0.1 2.6 0.1 1.1 0.6 0.1 2.1 3.4 0.8 0.2 0.1 0.1 0.1 0.1 4.9 0.1 0.1 0.0 0.3 2.6 1.1 0.1 0.0 0.1 0.1 0.1 0.0 4.1 0.0 3.5 0.0 0.0 6.8 0.1 0.6 0.1 0.0 0.1 0.5 0.0 0.0 7.8 4.0 0.0 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.2 0.0 8.9 1.1 20.0 0.1 0.0 5.3 0.0 9.8 0.1 0.1 1.9 0.9 0.4 0.6 0.3 0.5 0.8 0.4 0.3 0.2 1.8 0.7 0.6 2.7 1.7 0.5 0.9 0.3 0.2 7.2 6.7 3.3 7.1 7.2 4.4 8.9 5.4 10.1 6.0 VTA1 "C6orf55, HSPC228, My012" ENSG00000009844 "Vesicle trafficking 1" Q9NP79 6 142147162-142224689 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030968, HPA030969" Approved Supported Nucleoplasm,Vesicles,Cytosol 22000 "Nucleoplasm, Vesicles, Cytosol" "HPA030968: AB_10602585, HPA030969: AB_2673679" "prognostic unfavourable (7.02e-4)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.17e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" "prognostic unfavourable (6.58e-6)" "unprognostic (2.83e-2)" "unprognostic (3.61e-1)" "unprognostic (5.18e-2)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (3.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.96e-1)" "unprognostic (3.24e-1)" 18.8 19.5 20.5 15.5 28.2 17.2 20.6 25.0 39.3 17.2 22.0 18.5 9.6 24.2 16.0 17.1 31.4 17.9 14.9 21.2 19.8 20.3 24.9 29.9 13.5 19.3 20.1 20.7 15.3 15.6 16.3 21.7 30.5 30.7 16.8 26.3 11.2 19.4 13.5 48.6 20.9 32.7 17.0 24.0 20.8 14.6 12.9 18.2 33.6 18.0 24.3 24.0 18.4 19.7 29.0 30.9 58.6 38.1 30.9 30.1 36.1 18.1 15.6 25.5 39.0 22.5 24.8 17.6 41.1 24.6 37.7 36.1 26.3 14.2 29.6 27.9 36.8 23.2 27.1 28.1 52.3 20.0 23.8 32.1 16.7 31.4 16.6 49.7 18.6 20.4 32.9 37.6 24.4 24.1 29.7 14.9 31.5 26.4 32.2 25.9 19.1 17.9 29.7 20.4 18.0 29.0 20.1 26.7 20.8 23.1 17.8 20.6 19.3 33.9 17.4 17.0 23.7 28.4 29.5 14.7 25.4 33.7 11.1 27.8 25.8 58.6 31.0 49.5 23.5 38.1 30.1 29.0 26.8 27.4 30.9 26.6 29.8 29.9 19.1 30.9 37.4 19.0 25.7 36.1 20.5 28.2 25.0 39.3 19.8 20.3 20.1 20.7 30.7 18.2 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 24.4;testis: 51.9" "Cell line enhanced" "Detected in single" "U-138 MG: 1.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA036700: , HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 1.0 0.2 1.7 0.0 0.0 0.0 0.2 1.1 0.2 2.0 0.0 0.0 0.5 4.3 0.0 24.4 0.5 0.4 1.7 1.6 0.0 0.0 4.0 0.0 0.1 0.1 2.3 0.0 0.0 1.1 0.1 3.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 51.9 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.1 1.7 1.6 0.1 0.1 3.2 0.3 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 35.9;brain: 10.1;pancreas: 11.0" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 26.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: , HPA061412: " "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.4 35.9 9.2 0.4 4.8 0.2 0.4 9.8 10.1 0.5 2.5 0.4 0.4 1.7 0.4 0.4 0.4 1.2 0.4 0.4 9.5 3.3 0.4 0.4 2.4 0.4 1.9 0.4 3.7 11.0 1.6 3.4 0.4 0.4 0.9 0.4 0.4 0.5 2.4 0.4 0.1 2.4 0.4 0.4 0.4 2.8 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 26.5 1.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.7 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 4.8 9.8 10.1 9.5 3.3 1.9 0.4 0.4 0.4 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell line enhanced" "Detected in many" "K-562: 10.6;NTERA-2: 5.3;SCLC-21H: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" Cytosol Nucleoplasm "HPA026619: , HPA036044: " "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.7 0.0 2.0 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.4 2.1 1.9 0.6 3.9 2.2 3.5 4.7 0.0 0.0 1.0 2.3 0.1 0.3 0.0 1.2 0.8 10.6 0.0 0.0 1.2 0.0 0.0 5.3 0.6 0.0 0.0 1.6 0.0 1.3 8.5 1.3 0.0 1.7 0.0 0.0 1.1 0.1 0.0 1.0 0.0 0.8 3.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743970-102816267 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favourable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favourable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 23.8 23.0 11.5 12.9 13.7 2.3 14.2 9.5 14.2 19.0 14.5 12.2 13.3 9.0 18.9 14.9 13.1 18.9 15.3 23.6 11.9 8.9 11.6 21.3 13.3 11.5 14.9 8.0 23.6 9.3 12.5 13.5 14.1 17.5 15.2 9.2 20.2 21.8 14.9 77.3 20.1 12.3 16.3 15.0 12.5 15.0 11.0 10.1 23.2 26.1 35.5 11.1 17.6 11.4 6.1 8.2 14.7 16.7 12.4 8.7 8.9 10.1 13.2 7.3 12.2 24.3 19.7 14.9 10.4 28.2 10.4 13.1 8.9 15.9 8.8 14.1 15.9 11.3 5.3 9.0 7.9 8.8 5.6 17.8 6.0 6.4 15.7 8.5 21.2 21.3 16.1 13.3 10.3 20.2 8.6 11.0 17.7 13.3 10.2 9.5 5.5 6.4 20.6 19.1 5.6 9.2 10.0 1.7 7.0 5.7 5.8 11.7 23.6 9.5 15.0 10.0 10.4 11.2 9.2 20.5 10.7 6.5 14.1 16.4 4.4 6.6 11.8 14.7 8.7 13.7 6.9 6.1 7.4 8.4 8.2 6.0 6.8 7.2 14.4 12.4 16.7 5.2 7.5 8.9 11.5 13.7 9.5 14.2 11.9 8.9 14.9 8.0 17.5 10.1 WBP2 "GRAMD6, WBP-2" ENSG00000132471 "WW domain binding protein 2" Q969T9 17 75845699-75856507 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065682, HPA068819" Approved Approved Nucleoplasm,Cytosol 870000 "Nucleoplasm, Cytosol" "HPA065682: , HPA068819: " "unprognostic (1.74e-1)" "unprognostic (1.71e-2)" "unprognostic (3.17e-2)" "unprognostic (2.85e-1)" "unprognostic (8.39e-2)" "unprognostic (7.12e-2)" "unprognostic (8.89e-2)" "unprognostic (3.09e-1)" "unprognostic (2.68e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-3)" "unprognostic (6.18e-2)" "unprognostic (2.21e-1)" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "unprognostic (2.13e-2)" "unprognostic (1.76e-1)" 37.4 50.4 59.5 22.8 79.8 29.9 22.6 62.5 119.3 24.3 20.4 75.2 15.0 27.0 22.9 19.7 25.7 36.6 26.4 51.6 58.7 56.4 32.0 48.7 31.9 22.3 62.1 56.2 41.8 35.7 36.8 24.5 23.0 110.8 32.2 17.2 40.3 55.5 33.6 47.1 28.2 25.9 23.0 55.6 30.5 27.4 28.5 44.3 10.6 26.8 15.7 21.5 24.5 18.3 14.9 11.1 63.5 25.5 11.2 15.1 16.8 26.5 30.9 11.7 13.8 24.0 24.0 15.3 8.6 27.2 19.9 24.8 15.4 27.2 13.8 22.1 12.2 16.0 12.2 26.1 18.4 10.1 23.5 25.4 18.8 24.9 49.5 10.4 43.5 26.5 25.0 23.5 33.1 38.6 17.0 41.8 16.0 27.1 21.6 21.6 9.9 20.5 14.9 23.3 25.6 29.0 16.5 19.6 30.6 15.1 26.3 41.9 35.4 26.2 22.1 20.4 18.0 19.7 13.6 38.7 27.7 10.3 57.1 9.8 14.4 42.8 16.7 56.0 11.6 20.5 12.9 14.9 13.0 11.7 11.1 12.0 12.6 10.3 63.5 11.2 25.5 8.6 15.1 16.8 59.5 79.8 62.5 119.3 58.7 56.4 62.1 56.2 110.8 44.3 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.7;lymphoid tissue: 31.2" "Cell line enhanced" "Detected in some" "Daudi: 29.4;HDLM-2: 26.9;HL-60: 10.2;THP-1: 9.1;U-698: 12.5;U-937: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7" "Group enriched" "Detected in many" 7 "B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 2.7 1.5 3.6 31.2 5.4 8.6 1.5 0.9 2.7 1.2 1.6 5.2 0.0 1.1 1.2 1.5 1.5 1.5 2.6 1.4 3.1 1.9 1.7 1.2 9.4 20.8 5.3 0.6 1.1 1.1 0.2 1.1 0.8 3.7 1.2 1.5 1.2 5.7 0.4 0.9 2.0 10.2 1.3 7.3 19.1 1.6 1.5 4.4 4.1 1.6 0.9 26.6 3.0 1.2 12.5 19.7 6.2 1.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 3.1 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 12.1 0.0 0.0 1.7 0.0 0.0 1.6 0.0 8.9 0.0 0.1 6.7 12.5 0.0 0.0 6.2 0.0 0.8 19.7 0.0 0.6 3.6 5.4 0.9 2.7 3.1 1.9 5.3 0.6 3.7 4.4 WDR19 "DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp" ENSG00000157796 "WD repeat domain 19" Q8NEZ3 4 39182404-39285810 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 41.1" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;ASC TERT1: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039616, HPA058847" Approved Approved Nucleoplasm Nucleoplasm "HPA039616: AB_10796331, HPA058847: " "unprognostic (1.80e-1)" "unprognostic (9.32e-2)" "unprognostic (6.40e-2)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (1.26e-3)" "prognostic unfavourable (4.43e-4)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "prognostic favourable (2.70e-4)" "prognostic unfavourable (8.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (5.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.56e-2)" 8.5 7.6 8.1 4.8 12.9 3.4 9.2 21.0 14.5 13.2 7.8 5.7 7.8 1.9 15.5 11.2 5.4 20.9 8.6 5.1 11.7 4.1 8.6 7.0 8.6 4.4 6.0 11.0 19.0 6.6 10.1 41.1 6.3 14.6 8.1 4.3 6.9 7.6 8.2 3.1 6.0 5.7 9.5 9.7 4.3 8.0 12.7 7.3 6.8 17.1 3.8 5.0 9.9 8.9 3.9 1.1 1.5 2.0 2.3 2.4 0.8 3.2 2.3 5.5 6.5 25.2 28.3 2.5 4.2 9.7 4.5 5.9 1.4 3.6 5.2 2.1 4.1 1.9 5.4 2.8 5.0 0.3 3.9 1.0 4.3 2.6 7.9 5.1 1.3 17.2 6.1 6.0 3.8 5.4 4.6 5.3 5.4 1.1 3.5 3.6 1.8 2.6 4.3 5.6 2.3 3.6 1.3 6.0 5.6 4.2 1.3 2.8 2.8 1.9 3.9 4.4 2.9 9.6 4.2 3.9 3.5 3.7 6.5 1.5 1.9 0.7 1.2 0.9 1.7 2.0 1.3 3.4 2.1 2.4 1.1 3.9 2.1 2.1 1.5 2.3 1.7 0.7 1.4 0.8 8.1 12.9 21.0 14.5 11.7 4.1 6.0 11.0 14.6 7.3 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavourable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.2 12.8 18.8 13.1 21.7 17.3 16.2 19.5 23.3 15.1 12.6 17.7 9.4 9.4 13.3 13.3 20.6 17.5 12.2 16.9 18.8 17.5 15.8 14.8 14.0 13.9 21.4 20.0 9.4 21.3 14.4 15.8 11.4 28.9 12.0 13.8 11.5 13.7 12.0 19.7 12.8 11.2 19.2 23.3 12.5 11.5 26.6 19.8 8.1 23.1 12.9 16.6 13.5 13.6 8.9 24.8 24.0 18.1 15.8 5.7 7.3 6.7 11.6 16.4 23.9 17.1 24.4 12.9 21.5 23.3 10.2 18.9 10.6 11.4 20.5 9.9 20.3 8.8 12.3 29.4 11.0 24.7 14.1 8.2 13.6 9.1 26.2 17.3 20.4 15.5 37.9 11.5 25.2 16.3 8.1 22.4 16.5 14.5 9.1 11.1 6.1 4.6 21.9 22.4 14.4 11.1 5.7 9.6 11.8 18.4 11.6 17.9 11.5 21.7 14.2 13.8 11.2 7.6 15.7 20.4 16.5 36.7 18.9 7.8 23.0 11.4 14.0 24.0 5.7 16.3 5.5 8.9 3.4 5.1 24.8 5.4 2.3 4.2 6.8 15.8 18.1 11.1 2.6 7.3 18.8 21.7 19.5 23.3 18.8 17.5 21.4 20.0 28.9 19.8 WDR45B "WDR45L, WIPI3" ENSG00000141580 "WD repeat domain 45B" Q5MNZ6 17 82614562-82648553 "Predicted intracellular proteins" Autophagy "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017886 Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Nucleoplasm, Golgi apparatus" Cytosol "HPA017886: AB_1858810" "unprognostic (1.91e-1)" "unprognostic (7.77e-2)" "unprognostic (5.13e-2)" "unprognostic (3.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.88e-2)" "prognostic unfavourable (2.98e-5)" "unprognostic (1.23e-1)" "unprognostic (6.38e-2)" "unprognostic (1.22e-2)" "unprognostic (4.41e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-2)" "unprognostic (9.93e-3)" "unprognostic (8.89e-2)" "unprognostic (4.27e-2)" "unprognostic (1.02e-1)" 25.4 31.0 37.1 17.2 39.0 38.7 38.9 30.3 38.1 27.4 23.5 35.3 19.9 21.8 25.6 24.9 39.9 32.7 29.5 29.4 36.6 29.2 26.6 22.9 23.5 26.6 38.2 28.5 32.8 35.6 29.9 24.2 19.6 39.2 26.6 21.2 18.8 32.6 23.8 20.9 28.4 25.0 29.3 53.3 19.3 29.5 47.7 39.1 6.8 26.5 23.3 23.5 23.3 24.8 10.0 15.6 22.1 19.3 8.9 12.6 11.9 28.7 19.8 16.7 15.2 15.5 14.4 19.9 21.5 24.3 35.3 30.3 23.6 15.4 8.3 13.5 19.2 16.0 16.0 18.3 32.5 5.2 31.9 16.8 11.3 18.3 20.4 13.2 12.9 15.5 19.3 18.8 17.7 28.4 12.5 7.8 19.6 18.5 9.4 9.1 21.3 26.4 10.3 30.1 8.5 19.1 28.9 21.8 32.1 21.3 21.8 25.1 25.9 10.1 19.3 36.7 28.8 25.8 38.4 20.1 8.6 12.2 23.8 13.4 26.8 16.5 19.3 22.1 12.3 19.2 12.6 10.0 9.7 10.4 15.6 9.9 8.7 7.9 16.2 8.9 14.8 8.0 7.6 11.9 37.1 39.0 30.3 38.1 36.6 29.2 38.2 28.5 39.2 39.1 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favourable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.1 7.2 17.7 5.1 24.0 10.1 6.4 19.9 42.6 8.0 5.6 9.5 3.4 3.7 9.4 5.8 13.7 8.4 7.1 7.5 20.1 20.6 7.5 3.6 6.7 5.0 14.8 21.0 7.6 5.6 10.4 4.4 6.3 24.8 7.3 5.4 5.8 4.7 7.2 14.2 20.3 4.1 9.8 12.7 5.3 5.6 19.9 11.3 5.5 6.1 4.8 7.0 6.8 6.3 3.5 5.6 18.8 5.0 2.2 4.6 2.0 10.6 3.2 6.2 7.8 12.4 10.9 3.4 12.2 7.5 8.2 9.2 3.2 1.6 4.8 6.6 11.6 12.0 8.8 5.3 10.8 8.9 4.9 4.0 7.2 3.5 7.1 6.2 6.0 6.7 8.9 12.7 6.2 9.6 2.4 6.8 13.8 6.3 6.0 4.9 2.6 6.5 8.5 15.9 2.6 13.6 9.2 11.1 10.1 10.7 5.7 8.5 2.6 6.4 16.4 10.9 5.0 19.0 10.0 4.4 3.6 3.9 12.7 6.2 16.2 11.4 4.7 5.8 3.2 5.0 2.8 2.0 2.9 3.4 5.1 3.5 2.6 2.2 18.8 2.2 4.5 5.6 4.6 2.0 17.7 24.0 19.9 32.4 20.1 20.6 14.8 21.0 24.8 11.3 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Cell line enhanced" "Detected in some" "AF22: 3.3;NTERA-2: 3.7;THP-1: 16.7;U-937: 8.8" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: " "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.8 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 WDR7 "KIAA0541, TRAG" ENSG00000091157 "WD repeat domain 7" Q9Y4E6 18 56651343-57036606 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042074, HPA051057" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA042074: , HPA051057: " "unprognostic (1.03e-1)" "unprognostic (1.32e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "unprognostic (7.70e-2)" "unprognostic (9.21e-2)" "unprognostic (2.00e-2)" "unprognostic (5.05e-2)" "prognostic favourable (1.13e-5)" "unprognostic (4.80e-2)" "unprognostic (4.52e-3)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" 8.0 11.3 14.2 7.9 21.2 9.1 6.8 16.7 34.0 7.5 7.7 11.9 6.1 6.0 7.1 8.1 6.6 6.4 7.7 8.8 17.3 17.9 7.9 10.4 7.2 9.5 14.4 16.4 6.6 6.2 15.6 19.0 6.9 21.1 11.1 7.4 7.9 6.1 8.8 10.5 5.7 6.1 8.3 12.5 8.3 6.9 6.2 12.1 13.2 13.1 4.0 8.2 7.4 6.3 4.5 6.3 9.2 8.7 7.4 9.0 3.2 3.8 6.5 7.5 4.1 11.8 6.9 1.9 7.7 6.6 6.4 7.6 2.6 2.4 10.7 3.1 6.9 4.2 7.5 6.1 8.0 12.4 4.6 10.1 5.3 2.3 7.1 15.2 12.9 5.8 5.1 8.5 5.7 7.9 4.8 14.9 7.8 3.8 10.5 4.5 3.2 4.3 4.7 5.7 5.2 4.9 7.0 9.7 4.8 5.5 2.7 3.6 4.1 4.3 6.9 9.1 4.6 2.7 4.1 15.0 11.1 11.8 7.5 7.7 6.1 7.2 5.0 9.2 6.6 7.6 8.2 4.4 7.5 6.7 6.3 4.5 7.9 7.2 4.6 7.4 8.7 3.0 9.0 3.2 14.2 21.2 16.7 23.7 17.3 17.9 14.4 16.4 21.1 12.1 WDR74 FLJ10439 ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 14.2 13.2 12.6 19.7 13.8 77.4 14.2 14.6 21.5 12.5 12.5 10.9 8.7 10.8 14.1 10.2 16.1 15.1 12.8 12.6 12.2 11.9 15.5 19.7 10.0 18.1 15.4 16.5 17.4 20.6 9.4 8.0 11.9 13.6 12.5 11.2 8.0 16.5 9.8 42.1 19.8 10.6 11.5 9.5 18.0 13.4 23.5 16.6 16.0 20.0 19.1 16.0 12.4 14.0 39.1 44.8 15.9 34.8 26.8 16.7 11.9 16.2 19.5 7.7 12.7 6.3 8.7 23.7 9.1 9.9 19.9 13.3 28.6 19.9 28.6 26.0 7.5 21.7 23.5 18.2 15.6 18.2 17.3 14.4 21.6 24.7 18.6 28.6 9.5 8.4 20.5 12.6 42.2 9.7 31.4 8.5 9.0 31.2 27.3 45.5 31.2 26.1 27.9 13.1 49.8 14.1 9.3 17.1 19.2 10.5 21.8 29.4 15.3 22.1 6.9 11.6 14.0 26.1 22.9 21.2 29.4 34.7 12.9 17.5 15.1 8.7 34.8 3.2 11.7 16.9 14.7 18.6 12.1 11.0 29.2 39.1 16.7 14.8 15.9 26.8 11.3 44.8 13.7 11.9 12.6 13.8 14.6 21.5 12.2 11.9 15.4 16.5 13.6 16.6 WDR75 "FLJ12519, NET16, UTP17" ENSG00000115368 "WD repeat domain 75" Q8IWA0 2 189441433-189475565 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038199 Approved Approved Nucleoplasm Nucleoplasm "HPA038199: AB_10674548" "unprognostic (1.23e-1)" "unprognostic (7.34e-2)" "unprognostic (3.31e-1)" "unprognostic (1.54e-1)" "unprognostic (4.22e-2)" "unprognostic (1.29e-2)" "prognostic unfavourable (6.50e-8)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" "unprognostic (1.93e-2)" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (3.15e-11)" "unprognostic (1.34e-1)" "unprognostic (7.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-2)" 24.8 23.8 15.4 20.7 20.4 17.7 25.5 25.5 25.6 26.8 16.4 16.1 18.4 15.1 25.5 27.3 20.1 21.7 15.6 14.9 16.5 17.0 21.6 18.5 13.7 25.2 20.0 17.5 28.9 22.4 19.0 21.7 17.5 20.7 18.5 19.5 13.9 15.4 14.5 16.7 22.6 17.4 20.9 23.6 24.1 17.6 18.2 24.2 28.9 15.5 25.3 24.0 24.8 19.2 8.1 9.9 3.3 7.8 7.8 13.7 5.6 13.1 12.7 16.0 20.1 17.7 18.7 20.1 28.1 12.4 30.7 23.9 26.8 14.4 28.9 15.9 8.5 18.8 30.8 18.1 30.2 19.0 14.4 38.7 23.2 19.7 16.7 41.8 18.9 15.5 15.3 22.0 31.0 20.1 37.6 16.5 20.4 14.2 19.4 27.9 38.9 35.0 18.4 26.3 22.6 15.0 16.5 15.8 16.1 17.9 16.1 14.0 14.9 17.6 19.2 18.1 20.1 14.1 20.4 18.2 29.3 35.4 13.0 19.0 15.3 1.3 5.2 3.3 8.0 7.8 13.7 8.1 8.2 10.5 9.9 6.8 10.8 9.5 0.0 7.8 5.0 5.4 10.4 5.6 15.4 20.4 25.5 25.6 16.5 17.0 20.0 17.5 20.7 24.2 WDR81 "CAMRQ2, FLJ33817, PPP1R166, SORF-2" ENSG00000167716 "WD repeat domain 81" Q562E7 17 1716523-1738599 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023044 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA023044: AB_1858822" "unprognostic (1.00e-1)" "unprognostic (4.67e-2)" "unprognostic (6.63e-2)" "unprognostic (4.90e-3)" "unprognostic (6.10e-2)" "unprognostic (7.75e-3)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (3.06e-2)" "unprognostic (1.60e-2)" "prognostic favourable (3.30e-4)" "unprognostic (3.26e-1)" "unprognostic (8.72e-2)" "unprognostic (2.25e-1)" "unprognostic (8.43e-2)" "unprognostic (7.99e-2)" "unprognostic (3.90e-2)" 12.7 12.2 8.9 12.1 8.4 10.7 22.9 7.0 11.7 12.6 9.1 10.5 26.4 11.3 14.9 11.6 7.4 12.8 9.3 9.0 8.4 4.3 9.6 22.7 17.2 21.4 9.2 4.4 18.5 8.3 3.5 9.9 8.9 8.5 11.9 4.6 10.6 10.1 21.8 13.1 16.7 12.7 11.6 5.0 19.0 8.4 6.3 8.2 17.3 8.1 5.2 10.3 11.6 16.2 2.8 6.9 5.1 5.0 4.2 3.0 1.9 0.5 10.6 1.4 7.2 10.4 5.7 7.9 0.6 0.1 0.4 0.0 1.3 4.0 4.1 5.7 4.3 10.1 5.2 7.1 0.3 7.8 11.2 0.1 7.3 4.8 17.8 3.3 6.5 14.3 7.3 5.1 3.1 4.0 0.3 5.3 5.9 5.1 1.1 5.7 3.3 7.5 5.4 2.5 5.6 2.9 1.5 2.1 4.6 3.8 3.3 12.4 4.8 5.0 5.9 4.1 4.9 6.6 5.4 0.4 0.9 2.4 6.4 5.4 2.9 0.0 3.1 5.1 2.6 5.0 3.0 2.8 2.7 2.6 3.8 2.3 1.8 2.4 0.6 4.2 4.3 6.9 2.4 1.9 8.9 8.4 7.0 11.7 8.4 4.3 9.2 4.4 8.5 8.2 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666800-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved Nucleoplasm,Vesicles,Centrosome Vesicles "Nucleoplasm, Centrosome" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favourable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favourable (3.12e-4)" 6.4 7.8 10.2 6.2 9.1 8.8 6.5 17.2 14.5 7.1 5.2 9.1 2.3 4.9 5.8 6.1 5.9 11.3 5.2 9.2 8.5 8.9 8.1 5.9 6.0 8.3 12.4 11.6 9.2 11.6 9.4 6.7 4.9 9.1 6.9 2.6 7.7 14.6 6.9 4.6 11.3 6.3 3.8 7.0 7.4 7.1 9.2 10.6 11.7 9.2 2.6 5.8 6.0 5.7 8.8 19.4 5.4 11.1 17.6 11.3 8.6 5.0 8.4 4.8 6.6 9.5 3.5 3.9 4.8 4.5 5.8 6.1 9.8 4.4 7.6 7.0 4.3 5.7 5.6 7.4 1.1 7.7 12.3 6.0 5.6 6.1 7.5 8.3 7.1 6.5 6.0 4.7 3.8 5.8 5.3 0.8 2.6 19.1 12.1 6.8 3.8 14.6 8.6 6.2 7.1 5.5 5.9 10.0 6.7 5.2 7.1 4.2 4.0 8.2 3.1 6.5 2.0 5.1 5.0 19.4 13.0 3.4 10.2 6.4 4.2 4.5 11.1 4.6 9.2 9.6 10.7 8.1 8.9 8.6 11.1 8.8 8.7 11.3 5.4 17.6 4.7 19.4 9.8 8.6 10.2 9.1 17.2 14.5 8.5 8.9 12.4 11.6 9.1 10.6 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 25.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: " "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.3 0.5 0.4 1.1 0.6 1.0 0.3 0.7 1.4 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.7 0.2 0.6 1.2 0.4 0.4 0.3 0.3 0.3 1.6 0.3 0.3 1.0 1.0 0.0 0.5 0.3 0.3 0.3 0.0 0.3 1.1 0.3 0.3 0.9 0.9 0.3 0.3 0.6 0.3 25.2 0.3 0.3 1.4 0.3 0.3 0.3 0.3 1.2 0.6 0.6 1.3 2.9 1.4 0.3 1.1 2.3 1.5 2.8 0.8 0.0 2.1 0.9 0.0 0.2 0.0 1.1 2.2 2.8 1.4 0.0 0.8 0.0 0.3 0.0 5.7 0.8 2.6 1.8 0.5 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 1.8 2.9 0.0 3.3 1.1 1.2 1.1 0.9 2.1 0.8 0.5 0.0 1.3 4.1 4.1 2.8 1.3 0.6 3.5 2.1 1.5 0.7 2.2 1.2 0.4 2.7 1.8 1.6 0.5 4.4 1.2 0.0 0.4 0.4 1.4 1.3 1.3 0.0 1.2 1.0 0.3 1.2 0.8 0.7 0.6 2.9 0.6 0.6 0.2 0.3 0.4 0.6 0.7 0.8 0.4 0.4 0.3 0.3 0.3 0.3 WDR92 "FLJ31741, Monad" ENSG00000243667 "WD repeat domain 92" Q96MX6 2 68122936-68157560 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035335, HPA035336" Approved Approved Nucleoplasm Nucleoplasm "HPA035335: AB_10959456, HPA035336: AB_10964348" "unprognostic (3.55e-2)" "unprognostic (3.42e-3)" "unprognostic (6.80e-2)" "unprognostic (1.69e-2)" "unprognostic (1.31e-1)" "unprognostic (3.20e-2)" "unprognostic (3.76e-3)" "unprognostic (2.51e-2)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.61e-1)" "unprognostic (3.56e-3)" "unprognostic (9.86e-2)" "unprognostic (7.23e-2)" "unprognostic (4.07e-1)" "unprognostic (3.15e-2)" 9.5 12.4 16.6 12.8 26.5 5.2 12.3 19.8 17.3 9.2 10.0 12.3 6.5 9.2 11.1 23.7 10.5 16.2 7.8 12.7 12.2 10.7 8.7 9.8 8.3 12.9 8.7 7.9 11.3 13.5 15.8 17.1 8.2 15.0 12.2 11.9 10.9 10.8 12.4 15.4 14.9 8.6 16.2 9.5 11.1 9.2 12.8 12.3 10.2 12.9 12.2 12.1 10.1 10.2 8.8 7.9 1.9 4.1 9.0 8.5 4.8 14.1 10.1 11.4 11.7 13.1 13.7 10.2 12.9 8.9 11.1 11.6 7.9 12.1 17.6 4.6 8.8 14.4 11.8 7.9 14.3 11.6 14.3 16.9 12.5 7.9 6.6 18.8 5.1 8.5 10.3 9.2 8.1 10.8 12.8 10.7 12.4 8.9 12.3 16.4 12.0 12.1 14.7 15.8 13.7 11.2 8.1 12.7 10.7 8.5 14.9 11.2 11.6 11.8 13.5 17.7 8.0 11.4 11.2 7.4 10.9 11.5 18.5 18.5 9.1 0.7 3.9 1.9 5.7 4.1 7.7 8.8 6.1 6.3 4.6 8.5 8.0 8.5 1.6 9.0 2.7 7.9 5.9 4.8 16.6 26.5 19.8 17.3 12.2 10.7 8.7 7.9 15.0 12.3 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: " "unprognostic (1.37e-2)" "prognostic favourable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.6 4.9 4.5 7.1 8.2 9.5 15.3 5.2 10.2 9.5 16.7 10.7 10.8 8.8 5.5 7.8 4.0 12.6 4.7 13.4 3.4 10.5 9.1 5.7 10.7 10.0 7.7 12.6 5.5 17.6 11.6 9.6 7.8 12.0 6.7 8.9 6.8 5.5 14.2 6.1 10.7 8.7 6.6 4.8 10.9 9.5 8.4 5.5 5.4 7.0 12.0 5.4 13.5 3.2 6.7 5.0 9.4 4.9 3.4 5.7 8.1 11.9 9.6 4.2 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 WIPI1 "ATG18, ATG18A, FLJ10055, WIPI49" ENSG00000070540 "WD repeat domain, phosphoinositide interacting 1" Q5MNZ9 17 68420948-68457513 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 51.5;ASC TERT1: 39.4;HHSteC: 49.6;HSkMC: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 25.0;eosinophil: 53.0" "Lineage enriched" "Detected in all" 9 "granulocytes: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007493, CAB037230" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "CAB037230: AB_1841265, HPA007493: AB_1848642" "unprognostic (2.83e-2)" "unprognostic (7.85e-2)" "unprognostic (1.05e-3)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-2)" "unprognostic (3.97e-3)" "unprognostic (1.78e-2)" "prognostic favourable (3.11e-4)" "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (3.06e-1)" "unprognostic (6.32e-3)" "unprognostic (6.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (1.89e-3)" 18.4 11.0 6.0 6.5 10.0 10.5 19.6 7.6 9.6 16.1 15.9 7.8 39.7 5.7 9.0 12.9 8.1 6.7 10.7 34.8 5.3 3.7 20.2 11.5 14.4 12.2 8.5 5.3 6.9 23.9 10.0 10.2 33.5 9.4 8.4 17.9 11.5 30.2 19.3 49.3 11.8 7.7 10.0 7.5 8.9 14.5 4.6 6.5 1.6 10.0 25.2 9.8 10.3 10.3 1.1 2.2 53.0 5.7 2.5 3.1 3.3 1.0 2.1 1.9 2.8 51.5 39.4 10.4 7.5 36.1 3.0 9.8 1.6 1.6 0.5 3.4 16.1 0.8 0.7 4.8 5.4 0.9 0.9 7.4 0.7 9.2 49.6 0.5 10.8 41.4 8.9 12.0 16.5 13.6 0.4 18.8 9.1 6.4 0.1 1.4 0.3 3.2 0.1 6.6 7.3 4.6 3.7 0.5 2.5 1.7 23.6 38.3 12.2 2.1 12.9 15.0 2.2 6.9 1.8 16.5 18.6 2.2 22.6 3.6 6.6 25.0 4.6 53.0 3.1 5.5 1.4 1.1 0.8 3.0 2.2 0.4 0.0 1.5 9.7 2.5 5.7 1.5 0.6 3.3 6.0 10.0 7.6 9.6 5.3 3.7 8.5 5.3 9.4 6.5 WIPI2 "ATG18B, ATG21, CGI-50, DKFZP434J154, DKFZp686P02188, FLJ12979, FLJ14217, FLJ42984" ENSG00000157954 "WD repeat domain, phosphoinositide interacting 2" Q9Y4P8 7 5190188-5233826 "Predicted intracellular proteins" Autophagy "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019852, HPA021488" Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA019852: AB_1846589, HPA021488: AB_1846591" "unprognostic (5.79e-2)" "unprognostic (1.47e-1)" "unprognostic (2.57e-2)" "prognostic unfavourable (7.69e-5)" "unprognostic (1.96e-3)" "unprognostic (9.27e-3)" "unprognostic (4.60e-3)" "unprognostic (4.96e-2)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "prognostic favourable (9.78e-4)" "unprognostic (1.20e-1)" "prognostic favourable (2.05e-6)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (7.41e-2)" "unprognostic (6.98e-2)" 24.5 23.6 33.9 17.8 34.7 32.7 21.9 30.6 47.4 20.6 21.7 27.8 17.4 20.3 24.4 23.1 25.4 25.3 20.5 30.5 27.9 27.2 23.5 27.5 21.9 22.3 26.0 31.2 25.0 30.8 28.7 23.2 27.0 26.1 25.0 17.2 25.0 34.7 25.5 28.3 31.8 18.2 22.9 25.6 22.0 23.0 49.3 26.0 26.6 24.1 15.9 23.4 22.9 20.5 6.1 6.9 13.0 6.3 2.6 9.2 2.2 27.0 17.3 16.9 28.9 26.1 27.5 26.1 24.2 27.8 25.8 27.4 16.7 25.2 19.3 18.6 30.2 19.9 17.1 19.7 20.2 9.9 26.6 13.2 17.5 18.4 25.9 20.7 14.5 28.8 23.7 29.3 16.3 35.8 37.3 17.5 23.3 28.1 15.7 35.9 35.2 25.5 25.9 24.2 31.8 17.0 13.2 21.2 31.9 17.7 30.5 21.0 18.7 39.5 28.4 16.5 34.7 27.5 18.0 31.6 29.4 22.1 26.9 24.0 24.3 0.3 4.9 13.0 5.1 6.3 3.1 5.6 6.7 9.1 4.5 6.1 8.5 5.4 9.9 2.6 4.2 6.9 9.2 2.2 33.9 34.7 30.6 47.4 27.9 27.2 26.0 31.2 26.1 26.0 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 66.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 6.8;HSkMC: 12.9;TIME: 5.2" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" Vesicles Nucleoplasm "HPA047274: , HPA066368: " "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 3.4 1.9 1.7 3.4 4.6 0.2 2.1 2.6 2.9 9.2 12.0 0.8 3.7 3.9 7.5 5.4 7.6 4.4 8.0 3.6 1.6 1.7 1.8 0.5 5.2 0.9 2.0 2.4 28.7 2.0 1.2 1.9 6.0 1.5 7.3 6.8 66.7 1.7 18.3 1.3 13.4 9.1 12.9 3.0 1.2 4.4 16.2 0.8 0.5 1.4 5.6 1.9 10.3 8.5 2.3 1.2 1.7 0.7 0.8 1.2 0.1 0.7 0.4 3.4 0.8 3.4 6.8 0.6 1.4 1.5 0.4 0.6 0.3 0.7 1.8 0.3 1.6 2.1 1.1 0.5 0.3 0.1 0.7 0.2 1.1 0.5 2.9 0.2 0.8 12.9 1.2 0.6 0.2 1.7 0.2 0.3 0.4 0.5 0.1 0.2 0.6 0.5 0.1 0.5 0.0 2.3 0.4 0.5 0.5 1.3 0.2 1.1 0.1 0.4 5.2 0.5 2.0 1.2 0.4 0.2 0.1 0.0 1.4 0.2 1.3 0.9 0.7 1.0 0.9 0.3 0.8 1.4 1.2 1.0 0.3 2.3 0.4 0.7 1.7 0.8 0.5 1.2 0.4 0.1 1.7 4.6 2.6 2.9 1.6 1.7 2.0 2.4 1.5 0.8 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: " "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavourable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favourable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 6.9 6.9 8.1 10.3 8.0 13.3 6.8 11.8 10.7 7.4 7.2 10.6 6.8 6.8 8.4 8.4 7.9 25.6 7.7 6.8 7.5 6.6 9.4 6.6 8.7 12.7 7.9 5.8 7.8 12.0 6.1 7.6 8.1 7.8 5.3 7.3 7.8 6.6 6.6 9.8 8.1 7.7 7.8 5.4 12.5 7.2 11.4 8.3 22.8 7.6 6.6 12.8 7.5 6.2 4.7 6.6 20.0 5.8 4.2 8.5 3.5 11.0 20.8 15.0 15.0 4.5 4.2 8.8 7.2 7.7 23.6 22.1 12.1 6.9 13.4 7.6 6.4 12.4 17.2 12.7 18.3 8.0 22.3 6.1 13.8 10.1 4.1 4.7 8.0 3.3 5.0 20.8 4.8 15.3 5.8 4.4 9.4 10.1 13.7 11.5 8.0 10.4 18.1 9.9 7.8 8.7 4.0 6.9 10.5 11.4 6.1 6.0 8.3 5.0 5.3 9.4 10.0 0.0 18.6 3.5 8.8 7.0 8.5 8.1 11.4 20.0 5.2 4.6 5.4 5.8 6.3 3.3 4.2 6.0 4.7 4.7 3.8 4.4 2.7 4.2 2.3 6.6 8.5 3.5 8.1 8.0 11.8 10.7 7.5 6.6 7.9 5.8 7.8 8.3 WRNIP1 "bA420G6.2, FLJ22526, WHIP" ENSG00000124535 "Werner helicase interacting protein 1" Q96S55 6 2765414-2786952 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031752, HPA031753" Enhanced Approved Nucleoplasm Nucleoplasm "HPA031752: AB_10603004, HPA031753: AB_2674028" "unprognostic (5.52e-2)" "unprognostic (5.95e-2)" "unprognostic (6.83e-3)" "unprognostic (8.35e-3)" "unprognostic (7.66e-2)" "unprognostic (7.10e-2)" "unprognostic (5.63e-3)" "unprognostic (3.40e-2)" "unprognostic (1.39e-2)" "unprognostic (1.73e-2)" "unprognostic (1.81e-1)" "unprognostic (6.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.37e-1)" "unprognostic (2.61e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" 15.4 23.1 29.9 19.8 32.1 31.2 22.4 42.5 33.5 22.2 21.9 23.3 25.7 17.7 19.8 29.7 32.8 28.0 24.7 28.8 30.9 30.1 23.3 25.8 21.2 23.4 27.4 26.2 23.2 37.4 39.2 31.2 32.3 21.3 22.5 22.6 23.9 34.6 22.0 29.0 27.8 19.6 18.5 20.2 20.7 19.3 24.6 24.2 34.1 31.6 36.0 25.3 18.8 29.2 3.4 4.2 9.1 2.8 3.7 6.5 2.3 31.0 15.6 15.9 26.1 16.9 14.6 21.2 14.3 20.1 26.3 26.3 24.6 14.5 27.9 38.9 18.4 24.2 26.0 28.7 25.8 27.8 28.6 29.1 17.7 38.4 19.3 18.3 20.2 14.8 23.5 24.1 26.3 33.2 22.2 10.1 19.1 30.3 27.0 33.2 13.6 19.4 21.6 23.3 28.2 27.9 19.2 48.1 13.7 16.8 17.2 33.2 22.1 20.6 18.0 19.8 14.9 17.1 34.4 13.0 22.7 21.6 7.7 19.9 26.7 9.1 2.6 3.4 6.5 2.8 2.1 3.4 4.7 4.8 2.1 2.4 5.5 5.2 1.1 3.7 1.4 4.2 6.5 2.3 29.9 32.1 42.5 33.5 30.9 30.1 27.4 26.2 21.3 24.2 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.3;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 5.4 0.1 0.0 0.0 7.3 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 13.3 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 32.7;BJ hTERT+ SV40 Large T+ RasG12V: 33.8;HHSteC: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: " "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavourable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 1.9 0.1 0.2 0.5 2.7 6.2 0.2 2.5 10.3 32.7 33.8 0.2 2.9 0.5 0.8 3.8 1.2 0.0 0.5 3.7 4.4 0.1 0.7 0.3 0.4 15.0 0.4 3.1 2.8 0.0 4.3 0.1 2.7 0.2 10.6 1.0 0.1 2.2 8.7 0.2 0.8 4.2 0.1 0.2 0.0 1.8 0.2 0.2 1.2 0.2 5.5 0.3 12.0 0.3 0.4 0.3 0.9 0.1 1.5 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495676-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 28.7" "Cell line enhanced" "Detected in some" "HMC-1: 73.0;NB-4: 71.1;THP-1: 73.0;U-2 OS: 53.3;U-266/70: 34.8;U-266/84: 94.4;U-937: 58.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046363 Approved Nucleoplasm Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.1 0.2 5.0 73.0 0.0 0.0 53.3 0.0 10.2 34.8 94.4 0.1 0.0 58.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XAGE1B CT12.1b ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 28.8" "Cell line enhanced" "Detected in some" "HMC-1: 76.7;NB-4: 74.6;THP-1: 72.5;U-2 OS: 55.6;U-266/70: 34.9;U-266/84: 95.3;U-937: 59.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" HPA046363 Approved Nucleoplasm Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 76.7 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.1 74.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.2 0.3 5.2 72.5 0.0 0.0 55.6 0.0 10.3 34.9 95.3 0.1 0.0 59.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell line enriched" "Detected in single" 34 "U-2 OS: 22.2" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA052507: , HPA055941: " "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 95.0;skeletal muscle: 219.0" "Group enriched" "Detected in some" 5 "HSkMC: 9.1;LHCN-M2: 2.3;RH-30: 6.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.7 1.9 0.0 0.4 95.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.3 1.1 0.0 0.0 1.3 0.0 219.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 4.9 18.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.1 9.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell line enhanced" "Detected in many" "HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 8.2 0.1 0.0 1.5 8.8 0.0 0.0 0.0 2.4 24.7 1.4 0.0 0.0 12.7 2.0 0.0 0.4 0.0 0.0 0.0 15.9 6.3 0.0 0.9 0.1 11.7 3.1 3.2 0.0 0.0 11.2 0.0 0.6 2.3 0.0 0.4 0.8 0.0 1.2 3.1 0.0 0.0 0.4 0.0 1.3 5.4 8.9 0.0 0.1 6.8 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 XPA "XP1, XPAC" ENSG00000136936 "XPA, DNA damage recognition and repair factor" P23025 9 97674909-97697357 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000155, HPA056856" Supported Approved "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "CAB000155: , HPA056856: " "unprognostic (8.76e-2)" "unprognostic (1.05e-3)" "unprognostic (1.60e-1)" "unprognostic (2.30e-2)" "unprognostic (4.17e-1)" "unprognostic (1.84e-1)" "unprognostic (5.26e-2)" "unprognostic (2.38e-1)" "unprognostic (3.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.97e-3)" "unprognostic (9.55e-3)" "prognostic favourable (4.28e-5)" "unprognostic (2.19e-2)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (1.17e-1)" 18.7 17.5 20.1 17.1 21.0 10.6 17.4 26.8 20.8 20.3 25.2 17.2 11.7 20.6 25.5 15.4 18.9 15.0 19.5 12.9 17.2 15.3 24.9 24.2 14.8 16.7 18.6 17.5 17.2 14.5 23.0 23.1 12.8 17.7 20.3 13.6 16.4 16.1 21.7 43.3 16.3 22.2 27.5 17.1 16.2 25.1 6.4 15.8 15.7 31.5 11.9 21.6 22.0 16.4 22.2 23.4 12.7 15.8 19.7 21.6 11.3 23.4 5.5 8.2 10.1 10.1 9.8 5.7 6.4 10.1 11.7 7.9 14.3 19.7 13.2 6.2 7.0 11.8 6.5 7.7 9.9 9.0 13.1 10.4 12.0 7.9 11.0 12.2 12.6 8.5 8.4 5.4 5.6 13.0 14.3 10.4 6.4 7.3 15.9 14.8 5.6 9.2 16.3 17.6 11.2 18.6 9.2 11.6 11.6 9.1 7.1 8.3 10.2 7.5 8.1 4.1 10.2 16.2 13.8 18.4 14.7 8.3 10.2 8.8 8.0 6.0 13.3 12.7 16.2 13.1 18.7 19.5 17.7 15.6 13.5 22.2 21.6 18.6 1.5 19.7 15.8 23.4 18.3 11.3 20.1 21.0 26.8 20.8 17.2 15.3 18.6 17.5 17.7 15.8 XPO6 "FLJ22519, KIAA0370, RANBP20" ENSG00000169180 "Exportin 6" Q96QU8 16 28097979-28211920 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "neutrophil: 56.4" "Lineage enriched" "Detected in all" 9 "granulocytes: 56.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038246 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Nucleoplasm, Nucleoli" "Plasma membrane, Cytosol" "HPA038246: AB_10674550" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "unprognostic (1.07e-1)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "prognostic unfavourable (3.68e-4)" "unprognostic (2.22e-1)" "unprognostic (1.41e-1)" "unprognostic (1.31e-2)" "unprognostic (4.48e-1)" "unprognostic (1.40e-1)" "unprognostic (1.01e-3)" "unprognostic (2.10e-1)" "unprognostic (5.36e-2)" "unprognostic (8.50e-2)" "prognostic unfavourable (8.80e-4)" 18.4 14.1 24.3 32.0 25.0 47.9 17.7 16.0 30.6 12.4 17.7 30.4 9.9 13.4 13.5 12.0 16.8 14.1 14.9 9.6 27.5 23.9 13.3 19.1 20.6 54.6 25.6 16.9 15.3 13.2 22.0 18.0 25.9 21.7 14.1 17.0 16.3 19.4 13.1 8.3 18.8 18.3 16.3 23.8 50.4 14.8 28.9 19.8 37.1 18.0 7.8 31.8 17.2 13.2 5.2 2.6 56.4 4.4 2.7 6.5 2.0 28.4 20.4 18.0 19.3 12.5 19.9 20.7 35.2 31.9 41.3 41.8 28.6 20.4 20.2 30.4 32.0 18.6 42.7 27.0 50.2 45.5 26.5 22.1 28.8 31.8 29.6 30.8 24.9 15.6 20.1 36.6 36.3 23.7 40.2 10.2 27.9 31.9 37.0 36.8 30.5 19.5 34.8 21.4 33.5 15.3 14.5 35.2 19.1 17.4 29.1 15.4 20.9 20.4 25.1 34.9 23.4 29.7 29.3 23.9 30.2 30.0 26.6 32.2 29.4 4.7 2.7 8.4 4.1 3.0 4.4 5.2 4.7 4.4 2.0 3.9 5.2 6.5 56.4 2.7 4.4 2.6 3.8 2.0 24.3 25.0 16.0 30.6 27.5 23.9 25.6 16.9 21.7 19.8 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644779-152676165 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.7;testis: 11.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA065153: " "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 1.3 1.3 3.4 4.5 2.0 5.4 2.4 4.4 2.6 1.6 1.5 2.5 0.6 1.1 1.9 2.2 2.6 1.3 0.6 2.5 3.3 1.1 1.1 1.3 1.4 3.0 1.9 1.9 2.0 1.2 0.4 1.3 7.2 2.7 1.5 2.9 0.6 1.5 1.3 1.1 1.6 1.9 1.3 1.8 1.8 1.5 11.7 2.2 12.7 1.2 1.1 3.6 1.3 1.6 1.8 1.0 3.1 1.1 1.1 1.6 0.6 7.4 4.5 6.6 7.1 0.8 0.7 7.6 5.4 1.9 4.7 4.6 5.6 6.5 10.6 4.2 2.1 5.4 5.3 4.4 8.5 5.0 5.5 7.6 6.0 3.1 0.3 11.3 3.7 0.5 0.4 7.6 2.0 1.6 15.7 9.1 2.7 5.2 10.4 2.7 8.7 4.0 8.4 8.8 5.9 1.4 4.9 6.3 6.0 6.0 2.6 1.1 2.2 2.4 3.1 6.2 2.8 5.8 9.9 3.3 6.4 9.3 3.3 6.1 8.1 2.0 0.9 1.5 1.6 0.6 1.1 1.3 1.3 1.1 0.3 1.8 1.6 0.8 3.1 1.1 1.1 1.0 1.5 0.6 3.4 2.0 4.4 2.6 3.3 1.1 1.9 1.9 2.7 2.2 YBEY C21orf57 ENSG00000182362 "YbeY metallopeptidase (putative)" P58557 21 46286337-46297751 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016593, HPA018162" Uncertain Approved Nucleoplasm Nucleoplasm "HPA016593: AB_1845698, HPA018162: AB_1845699" "prognostic favourable (5.54e-4)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (7.24e-3)" "unprognostic (4.81e-1)" "unprognostic (2.78e-2)" "unprognostic (7.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-3)" "unprognostic (2.95e-1)" "unprognostic (1.51e-2)" "unprognostic (7.50e-2)" "unprognostic (7.48e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-3)" 7.0 8.3 9.5 8.9 10.3 4.1 10.9 8.9 12.1 7.6 11.1 11.6 10.1 8.9 6.6 12.0 5.9 8.2 6.8 8.1 9.0 9.1 8.8 11.0 10.1 10.9 11.4 10.5 8.2 11.3 10.1 10.0 4.7 9.2 10.4 9.7 7.3 10.5 9.6 11.5 9.4 12.4 6.3 13.6 7.0 6.8 58.3 8.5 6.8 7.5 12.7 10.6 6.3 6.4 21.8 16.0 14.8 7.8 12.7 16.8 6.8 9.9 8.8 7.5 9.1 5.7 22.0 7.3 6.8 10.3 6.8 8.3 4.6 1.7 12.7 6.0 7.0 3.3 3.2 3.1 6.2 12.0 12.6 3.6 5.7 1.8 16.5 4.1 0.4 15.2 13.6 5.3 11.2 4.4 8.7 15.3 7.9 8.4 8.0 5.4 21.9 9.1 16.9 3.5 24.4 13.8 4.6 5.5 9.7 9.3 4.2 18.3 2.1 3.6 5.3 6.5 2.4 5.2 4.4 19.1 33.8 21.9 11.9 4.5 3.9 14.8 6.1 4.6 9.6 6.8 9.3 21.8 11.6 11.7 6.9 15.5 11.4 13.0 2.1 12.7 7.8 16.0 16.8 6.8 9.5 10.3 8.9 12.1 9.0 9.1 11.4 10.5 9.2 8.5 YDJC ENSG00000161179 "YdjC chitooligosaccharide deacetylase homolog" A8MPS7 22 21628089-21630064 "Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061005 Approved Nucleoplasm Nucleoplasm "HPA061005: " "unprognostic (5.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.96e-1)" "unprognostic (2.29e-1)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" "prognostic unfavourable (9.84e-4)" "unprognostic (9.35e-2)" "unprognostic (7.08e-2)" "unprognostic (8.09e-3)" "unprognostic (1.24e-1)" "unprognostic (9.86e-2)" "unprognostic (4.90e-3)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (9.60e-2)" "prognostic favourable (8.98e-5)" 5.0 6.5 8.1 12.4 6.9 4.0 4.9 5.8 12.3 9.4 9.8 6.0 6.9 10.3 5.4 5.8 9.4 8.3 7.0 3.5 8.6 5.7 12.4 10.2 5.3 13.3 5.9 3.8 7.9 19.2 9.2 4.4 7.3 5.8 7.1 6.2 4.3 8.2 6.1 4.6 8.1 11.8 4.5 5.9 10.2 7.4 4.2 3.8 10.3 14.6 7.5 13.8 7.1 5.5 20.4 18.1 11.6 15.4 21.4 16.0 11.7 3.8 0.9 0.1 0.3 1.2 0.9 4.3 1.6 1.0 0.9 1.7 0.3 1.4 3.8 6.3 0.0 3.4 1.2 2.9 1.5 3.2 12.8 5.4 0.7 4.7 1.6 9.5 4.0 1.4 5.8 0.8 7.4 2.8 39.2 0.7 0.7 4.0 3.5 13.5 1.5 7.2 2.4 0.0 3.7 7.0 2.0 5.0 3.2 1.6 2.5 3.4 3.4 4.5 2.3 0.4 4.8 1.0 2.2 7.3 4.2 3.4 0.4 2.9 0.8 7.6 15.4 11.6 11.1 13.6 11.2 18.1 15.8 12.1 18.1 20.4 13.8 12.6 5.6 21.4 9.7 12.3 16.0 11.7 8.1 6.9 5.8 12.3 8.6 5.7 5.9 3.8 5.8 3.8 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697818-183812625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavourable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavourable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 11.1 8.5 17.9 18.9 21.0 20.4 13.1 27.2 22.7 13.7 12.8 17.9 4.9 9.0 16.0 8.5 13.1 17.5 10.9 10.7 15.5 14.9 10.5 5.9 16.1 19.1 14.1 17.8 25.8 8.9 18.1 20.2 17.9 14.9 14.2 11.6 12.8 12.5 12.9 8.4 13.6 10.7 19.6 16.2 13.6 9.8 13.0 15.0 21.7 16.2 5.1 18.5 15.0 14.3 2.6 2.8 10.5 8.0 1.5 2.7 2.3 19.1 5.8 17.1 7.6 8.4 12.4 18.9 11.4 8.9 17.0 20.0 14.2 6.9 17.6 21.2 10.0 12.3 16.5 10.9 17.5 14.3 9.8 17.7 6.2 6.9 12.9 13.2 10.3 8.5 8.6 12.2 14.8 17.2 7.0 14.9 12.7 5.2 19.0 10.2 15.3 11.5 27.0 16.1 21.1 6.8 8.5 16.6 11.8 8.5 29.0 15.1 14.4 9.1 14.5 15.7 11.5 7.9 12.7 14.2 11.1 29.9 12.2 13.2 11.1 0.1 6.0 1.6 2.7 2.5 1.9 2.6 2.3 1.9 2.0 1.8 1.9 2.1 10.5 1.5 8.0 2.8 0.9 2.3 17.9 21.0 27.2 22.7 15.5 14.9 14.1 17.8 14.9 15.0 YEATS4 "GAS41, NuBI-1, YAF9" ENSG00000127337 "YEATS domain containing 4" O95619 12 69359703-69390796 "Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072532 Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA072532: " "unprognostic (7.23e-2)" "unprognostic (8.50e-3)" "unprognostic (2.05e-3)" "unprognostic (8.07e-3)" "unprognostic (1.64e-1)" "unprognostic (1.06e-1)" "prognostic unfavourable (3.52e-6)" "unprognostic (1.77e-2)" "unprognostic (3.03e-3)" "unprognostic (1.80e-2)" "unprognostic (6.15e-2)" "unprognostic (2.13e-1)" "unprognostic (7.19e-2)" "unprognostic (8.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" 10.0 13.4 10.7 12.9 11.7 33.1 15.6 21.2 16.0 9.4 10.3 8.2 5.6 11.4 10.6 13.6 12.7 10.8 7.3 10.2 10.2 11.4 13.0 12.6 8.8 17.6 13.8 8.1 10.7 19.2 6.0 14.7 9.2 11.5 9.6 12.1 12.1 12.1 9.0 12.5 9.5 11.2 9.7 11.7 12.1 10.3 51.6 10.9 22.6 12.2 13.4 16.7 10.1 9.8 13.5 10.7 14.7 15.1 12.8 23.1 13.0 17.2 8.8 17.4 10.8 4.1 6.6 13.9 10.4 11.2 18.5 15.5 10.2 5.1 35.1 10.2 5.6 13.4 13.8 10.6 18.2 17.1 15.1 20.1 7.1 12.4 5.7 29.1 17.8 4.8 13.6 9.8 14.7 10.5 17.0 42.9 9.0 8.6 41.0 31.9 24.3 12.2 21.8 16.4 17.1 10.4 15.7 19.3 13.2 10.8 10.5 17.0 20.1 17.3 6.2 7.6 7.7 21.1 12.6 11.4 13.9 38.3 8.2 14.0 13.3 5.2 7.8 14.7 13.5 11.0 15.1 13.2 18.9 14.1 10.7 13.5 23.1 19.5 4.0 12.8 15.1 8.9 18.3 13.0 10.7 11.7 21.2 16.0 10.2 11.4 13.8 8.1 11.5 10.9 YIPF1 "DJ167A19.1, FinGER1" ENSG00000058799 "Yip1 domain family member 1" Q9Y548 1 53851719-53889834 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014716 Approved Approved Nucleoplasm Nucleoplasm "HPA014716: AB_1847686" "unprognostic (4.94e-2)" "unprognostic (4.50e-1)" "unprognostic (6.37e-2)" "unprognostic (2.06e-2)" "unprognostic (3.93e-2)" "unprognostic (1.35e-1)" "prognostic unfavourable (1.34e-4)" "unprognostic (1.96e-1)" "unprognostic (6.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.76e-1)" "unprognostic (1.24e-2)" "unprognostic (7.75e-3)" "unprognostic (2.38e-1)" "unprognostic (5.39e-3)" "unprognostic (6.35e-1)" 10.1 15.6 12.8 9.1 13.9 8.0 18.2 6.9 12.8 11.2 12.1 8.8 11.5 11.0 6.6 12.2 14.0 10.2 10.8 13.4 10.6 12.1 16.1 31.8 11.9 14.1 12.4 9.1 11.8 13.7 7.2 15.5 15.4 14.4 17.8 14.4 10.2 17.1 14.3 18.7 13.9 10.6 9.4 10.6 13.3 13.0 10.8 11.1 10.3 33.5 9.8 15.7 12.9 16.2 8.1 11.4 26.7 14.5 6.9 16.0 10.2 7.2 4.4 7.0 4.9 8.2 9.3 6.2 5.2 8.2 9.7 12.7 5.0 2.1 2.4 8.9 6.2 8.7 9.2 11.5 10.0 18.4 7.3 6.1 4.9 7.5 11.3 6.7 5.7 9.3 10.9 7.7 9.3 10.4 6.3 7.0 9.4 6.2 6.7 9.7 5.1 7.3 4.3 6.6 10.3 8.2 3.7 3.1 3.9 4.9 9.4 24.0 14.5 7.5 4.6 4.0 4.1 7.0 4.5 14.1 16.0 4.5 6.0 5.5 3.5 12.5 12.5 13.2 8.5 11.3 8.0 8.1 7.3 8.5 11.4 7.7 7.1 6.7 26.7 6.9 14.5 7.8 16.0 10.2 12.8 13.9 6.9 12.8 10.6 12.1 12.4 9.1 14.4 11.1 YIPF3 "C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1" ENSG00000137207 "Yip1 domain family member 3" Q9GZM5 6 43511827-43516990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014859, HPA063699" Supported Enhanced "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA014859: AB_1845729, HPA063699: " "unprognostic (2.82e-2)" "unprognostic (1.29e-1)" "unprognostic (2.29e-2)" "unprognostic (4.71e-2)" "unprognostic (1.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (3.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.70e-3)" "unprognostic (1.70e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.94e-2)" "unprognostic (3.55e-1)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" 26.8 51.0 26.1 20.3 36.8 19.3 28.1 24.2 48.9 33.5 30.4 38.1 40.3 31.9 31.2 50.5 31.9 34.4 39.9 30.9 26.2 25.5 44.2 62.0 30.0 21.1 26.1 21.4 34.0 73.7 47.0 38.9 59.3 29.7 36.0 29.9 36.8 75.4 31.8 30.6 26.9 38.4 27.4 28.1 28.0 38.8 27.8 22.6 27.9 51.2 31.3 32.9 32.8 26.5 11.7 18.5 74.3 19.7 14.6 18.3 16.0 23.0 16.2 24.0 46.4 54.0 43.8 14.5 27.9 43.3 23.1 29.3 19.4 16.9 9.5 22.3 51.2 23.3 17.6 27.2 14.7 17.3 25.2 14.8 23.9 36.8 42.0 15.7 22.3 43.6 35.5 19.6 19.5 34.8 16.0 21.9 27.5 35.4 11.9 20.0 12.4 18.1 10.5 11.1 24.9 41.2 24.6 19.4 27.8 12.7 16.8 29.4 27.7 32.9 33.0 26.3 13.9 14.4 19.2 25.9 20.7 18.8 18.7 13.5 17.7 26.2 19.7 28.3 15.3 18.5 13.3 11.7 13.8 13.5 18.5 11.7 11.3 12.6 74.3 14.6 18.4 17.0 18.3 16.0 26.1 36.8 24.2 48.9 26.2 25.5 26.1 21.4 29.7 22.6 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158159-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: , HPA073622: " "prognostic unfavourable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.12e-5)" "prognostic unfavourable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 26.6 26.6 18.4 14.7 21.2 15.8 22.5 19.2 22.6 23.9 22.2 17.2 22.5 26.5 25.7 22.0 27.2 18.9 19.0 18.3 15.1 18.5 23.0 27.8 20.4 21.0 16.2 20.5 19.6 41.7 21.5 45.3 37.1 21.8 16.8 23.4 18.9 32.7 18.3 11.9 24.5 30.5 25.2 19.7 18.8 23.8 20.7 16.2 14.0 20.2 21.2 20.1 24.1 19.9 22.3 27.2 28.8 28.1 23.7 36.7 23.4 11.4 7.7 10.0 7.9 24.0 26.0 9.1 39.2 26.6 17.7 28.6 12.2 12.1 6.3 18.9 42.5 10.6 9.5 19.2 23.9 8.8 8.3 4.6 13.4 12.4 19.4 10.3 7.7 19.6 18.0 15.8 13.0 16.7 4.9 10.6 23.8 6.0 5.0 5.9 6.4 8.4 5.4 14.9 10.4 11.0 10.2 6.8 8.4 13.6 7.3 17.4 15.2 6.8 64.4 20.9 10.1 20.1 15.4 9.7 15.9 8.0 19.9 9.9 15.1 25.6 21.0 28.8 30.3 28.1 34.3 22.3 31.0 33.6 25.0 21.5 32.8 30.8 15.6 23.7 25.4 27.2 36.7 23.4 18.4 21.2 19.2 22.6 15.1 18.5 16.2 20.5 21.8 16.2 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 164.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA042809: " "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 29.6 32.5 39.0 20.1 38.2 164.9 32.9 34.2 52.9 31.2 34.6 20.7 38.2 19.4 28.7 40.9 35.1 25.6 30.8 26.1 38.1 39.5 40.5 29.8 31.9 30.5 35.3 32.5 30.0 23.4 24.6 26.0 48.1 36.4 33.8 22.2 33.1 28.7 47.6 27.7 26.1 29.1 36.8 30.6 29.6 27.2 31.4 18.3 34.2 39.0 20.6 28.2 40.1 25.2 21.3 35.0 72.4 31.9 12.5 21.6 30.9 10.0 5.5 12.1 5.9 34.3 33.3 10.3 14.2 44.0 8.3 12.8 4.5 10.4 5.9 9.7 28.6 5.4 2.8 14.5 11.7 26.2 5.4 3.1 2.5 7.3 29.3 1.0 7.3 34.3 29.5 15.6 20.1 15.6 4.3 10.6 22.2 5.2 3.2 7.2 6.7 6.6 1.9 16.3 5.6 27.6 19.5 4.9 14.9 7.2 7.0 17.6 7.8 5.8 20.4 22.4 8.6 6.1 3.9 25.3 9.9 7.9 16.0 2.8 9.0 41.7 19.6 43.1 13.6 21.8 13.5 21.3 16.6 15.9 18.2 17.4 16.0 14.1 72.4 12.5 31.9 35.0 21.6 30.9 39.0 38.2 34.2 52.9 38.1 39.5 35.3 32.5 36.4 18.3 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350089 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favourable (7.29e-5)" 22.1 16.6 25.1 28.8 33.2 101.8 24.3 38.4 25.8 30.3 20.8 24.4 24.0 16.7 29.2 25.1 25.4 20.2 17.6 18.5 23.5 19.6 19.8 19.5 21.1 26.8 26.1 23.4 39.7 24.2 27.6 32.4 33.2 22.8 25.2 21.3 13.8 22.7 30.2 32.9 26.1 21.2 27.6 25.4 23.6 20.6 17.7 35.1 30.2 23.8 20.2 26.7 34.8 30.3 18.0 15.1 41.6 9.3 7.5 11.1 3.2 17.4 10.5 21.5 12.9 12.9 11.3 17.8 19.2 12.2 12.1 12.7 12.9 16.1 28.6 15.8 9.8 13.2 20.1 16.9 19.7 21.2 12.2 21.8 15.0 14.3 13.3 23.0 16.9 10.6 18.4 10.8 25.9 13.0 20.6 16.8 17.6 13.3 26.8 20.8 16.1 10.4 23.5 24.3 12.7 18.9 20.3 18.6 14.6 16.8 18.2 13.9 14.2 16.1 13.8 13.9 14.7 9.5 12.7 17.6 11.8 29.9 9.4 15.0 12.7 20.2 8.3 14.7 9.9 5.0 7.7 12.7 8.0 7.9 4.6 18.0 11.1 9.2 41.6 7.5 9.3 15.1 7.3 3.2 25.1 33.2 38.4 25.8 23.5 19.6 26.1 23.4 22.8 35.1 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513683-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: " "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favourable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 15.2 16.3 12.4 18.5 16.8 12.8 15.3 25.2 26.1 16.5 12.7 11.7 9.0 13.6 17.7 14.6 16.1 14.2 12.2 13.0 10.4 10.5 14.3 18.3 12.4 18.7 12.8 10.2 19.9 14.7 35.5 26.2 10.3 18.6 12.8 15.3 14.9 15.5 13.3 18.5 16.5 16.5 13.2 13.7 19.3 13.4 20.5 13.3 19.7 16.2 15.4 18.4 14.7 14.8 9.5 5.5 4.2 4.9 5.7 5.7 1.7 11.1 10.0 13.1 22.0 7.3 9.7 14.3 8.6 9.6 11.1 17.3 7.0 6.3 20.3 6.2 7.2 10.9 15.7 19.3 14.5 8.7 14.2 11.0 18.0 9.4 10.8 8.8 9.8 7.9 7.5 6.9 12.8 15.3 10.8 9.4 9.7 3.7 12.1 6.3 6.0 6.6 5.1 11.3 15.7 9.2 14.8 10.5 8.8 11.6 8.5 8.8 11.9 7.9 13.3 17.0 5.9 8.7 11.7 9.6 12.0 12.7 9.8 10.1 7.2 0.0 4.3 4.2 4.5 2.8 5.3 9.5 5.3 4.8 3.6 8.1 5.7 4.7 1.8 5.7 4.9 5.5 3.7 1.7 12.4 16.8 25.2 26.1 10.4 10.5 12.8 10.2 18.6 13.3 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported Nucleoplasm,Nucleoli,Cytosol 160000000 Cytosol "Nucleoplasm, Nucleoli" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavourable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavourable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.1 46.7 41.4 52.5 42.4 24.5 18.7 43.2 21.4 26.8 29.2 29.3 40.0 52.4 14.9 38.3 34.8 51.8 47.7 37.8 35.5 22.6 49.6 32.0 32.5 38.7 60.5 48.6 26.8 45.8 31.3 64.9 42.6 68.1 59.3 40.0 35.0 43.2 44.7 45.9 32.8 50.7 41.9 57.9 42.1 25.4 22.2 61.7 47.9 61.4 30.6 42.7 36.7 44.9 52.4 30.5 46.4 57.7 19.7 36.9 80.7 47.1 57.3 55.8 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Cell line enhanced" "Detected in some" "HEL: 4.0;K-562: 15.9;MOLT-4: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA047397: " "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 ZADH2 MGC45594 ENSG00000180011 "Zinc binding alcohol dehydrogenase domain containing 2" Q8N4Q0 18 75195108-75209348 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021468, HPA053646" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" Nucleoplasm "Golgi apparatus, Vesicles" "HPA021468: AB_1858932, HPA053646: " "unprognostic (3.22e-2)" "unprognostic (1.03e-2)" "unprognostic (7.14e-2)" "unprognostic (1.13e-1)" "unprognostic (4.79e-1)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (1.49e-1)" "unprognostic (3.62e-3)" "unprognostic (1.42e-1)" "unprognostic (3.05e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.02e-6)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (1.94e-4)" "unprognostic (2.23e-1)" 14.1 12.1 15.6 12.5 22.5 12.7 28.1 19.1 24.1 15.5 18.9 10.8 13.6 13.7 12.8 19.0 18.1 13.5 15.7 24.4 17.4 11.3 18.0 23.4 13.3 12.7 12.9 18.4 19.6 19.5 22.4 20.5 26.2 19.3 13.8 21.4 13.5 16.3 14.1 34.5 15.8 24.0 16.9 12.1 15.0 15.5 7.1 11.2 11.2 20.7 15.5 14.5 17.4 15.5 2.7 3.3 12.1 5.2 2.5 4.8 2.3 9.3 6.2 6.6 13.5 10.3 13.4 7.3 16.9 19.7 6.7 8.4 3.8 13.3 6.5 2.7 16.7 12.7 8.2 14.3 4.7 40.6 12.0 14.7 13.7 7.3 7.4 24.7 15.0 14.8 14.3 5.3 12.3 13.7 7.9 24.1 12.7 10.9 6.2 12.2 1.7 14.2 13.3 10.6 21.5 13.0 15.8 12.3 10.1 9.4 9.7 10.7 9.7 12.3 12.1 13.1 10.1 4.1 5.3 3.9 17.1 4.5 8.7 21.5 10.6 1.9 5.0 12.1 4.8 4.2 3.8 2.7 4.1 4.5 3.3 2.5 2.3 3.5 2.7 2.5 5.2 2.5 4.4 2.3 15.6 22.5 19.1 24.1 17.4 11.3 12.9 18.4 19.3 11.2 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087323 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.6;MOLT-4: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA055995: " "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favourable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 14.4 5.2 8.0 3.0 16.6 3.4 13.0 6.7 10.8 10.5 6.9 20.5 6.4 5.7 15.8 12.7 3.8 10.6 5.3 6.5 9.5 6.2 18.0 16.2 7.3 3.3 22.7 7.2 12.2 10.9 13.9 9.0 3.6 9.5 7.8 6.5 8.3 8.3 10.3 3.7 3.9 5.0 13.0 10.5 5.0 8.7 4.0 13.7 5.2 16.4 1.6 2.8 5.4 5.8 0.2 1.8 0.3 1.1 0.1 0.8 0.2 3.3 2.7 3.6 19.6 15.0 1.0 0.2 1.1 3.3 1.7 4.6 5.8 1.6 0.0 7.3 2.2 0.4 1.9 1.2 1.5 1.1 3.6 2.6 5.9 6.6 9.0 3.5 1.0 16.8 4.5 0.8 3.4 5.5 0.0 7.3 1.0 3.3 18.5 0.5 2.3 1.6 7.7 6.8 1.0 8.1 1.2 3.9 8.3 3.9 3.3 5.6 4.9 2.4 2.2 1.5 3.0 3.4 4.5 5.3 5.0 7.5 2.4 6.7 3.5 0.0 1.1 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.9 0.2 0.8 0.8 0.3 0.1 0.1 1.8 0.0 0.2 8.0 16.6 6.7 10.8 9.5 6.2 22.7 7.2 9.5 13.7 ZBED5 Buster1 ENSG00000236287 "Zinc finger BED-type containing 5" Q49AG3 11 10812074-10858796 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048472, HPA050994" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA048472: , HPA050994: " "unprognostic (7.74e-2)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (4.72e-2)" "unprognostic (3.40e-1)" "unprognostic (9.05e-2)" "prognostic unfavourable (2.19e-5)" "unprognostic (5.69e-2)" "unprognostic (4.61e-2)" "unprognostic (2.23e-2)" "unprognostic (2.25e-2)" "unprognostic (3.27e-2)" "unprognostic (8.77e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic favourable (3.87e-4)" 21.6 18.5 20.4 32.6 21.6 21.5 27.5 43.2 30.2 35.6 24.7 22.0 17.2 18.4 34.7 27.6 22.5 30.8 19.8 32.7 21.3 13.1 24.0 13.0 24.5 38.1 24.0 23.4 40.2 24.4 42.0 44.6 20.9 27.1 30.1 22.7 16.3 24.9 19.1 32.6 36.8 29.4 22.4 30.5 35.6 22.2 17.2 25.3 45.0 34.9 17.7 32.3 30.0 26.4 18.4 12.4 5.8 8.4 13.4 14.5 6.2 19.7 16.0 27.9 18.2 15.2 24.0 14.4 16.2 16.9 11.1 11.0 11.4 43.2 22.0 12.3 12.0 24.6 17.4 16.8 15.1 21.1 15.7 5.6 33.6 7.0 12.5 18.0 7.6 16.1 24.8 8.3 18.5 13.7 14.7 24.9 15.9 10.0 17.5 19.5 15.1 21.3 26.6 15.5 11.6 13.1 27.9 13.8 24.6 16.8 21.7 12.9 20.5 10.2 13.5 24.0 17.3 15.9 11.3 12.2 15.1 17.3 20.7 12.7 18.1 0.7 6.7 5.8 9.3 7.3 12.0 16.7 11.1 11.7 9.6 18.4 14.5 14.0 5.6 13.4 8.4 12.4 9.4 6.2 20.4 21.6 43.2 30.2 21.3 13.1 24.0 23.4 27.1 25.3 ZBED6 ENSG00000257315 "Zinc finger BED-type containing 6" P86452 1 203795714-203854999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "HPA026439, HPA028490, HPA028526, HPA068807" Approved Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533, HPA068807: " "unprognostic (1.79e-1)" "unprognostic (4.96e-3)" "unprognostic (4.81e-2)" "unprognostic (2.73e-1)" "unprognostic (6.94e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" "unprognostic (1.24e-2)" "unprognostic (2.28e-3)" "unprognostic (7.54e-3)" "unprognostic (1.56e-1)" "unprognostic (4.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (4.15e-3)" "unprognostic (1.47e-2)" 9.1 10.1 7.8 4.9 6.3 4.3 21.8 13.3 7.3 12.1 8.4 6.8 6.2 8.4 12.2 4.7 8.7 7.4 8.1 6.8 8.6 2.4 8.3 9.9 8.9 6.7 9.6 4.1 12.0 10.0 10.1 18.9 13.3 7.7 7.6 5.4 4.0 11.0 7.4 11.7 10.6 10.8 6.3 8.5 8.8 7.6 18.6 7.6 9.7 11.9 5.5 6.9 9.0 19.8 0.7 1.5 0.4 0.5 1.8 0.8 0.1 3.8 5.2 8.5 3.9 10.7 19.1 3.9 4.6 13.8 4.4 5.6 1.2 4.1 2.7 1.1 10.3 5.4 2.8 5.1 7.7 5.9 2.1 5.6 5.2 1.4 4.9 3.4 3.5 9.8 3.4 5.0 5.5 13.5 5.9 10.0 9.8 2.3 2.7 3.3 2.2 2.2 1.8 7.2 2.5 3.9 5.3 1.8 9.8 6.1 9.0 2.4 10.5 5.1 15.8 7.7 6.1 2.9 3.3 4.0 1.4 1.0 7.1 2.3 6.3 0.0 0.5 0.2 0.8 0.2 0.1 0.7 0.3 0.6 0.4 0.2 0.1 0.6 0.4 1.8 0.2 1.5 0.3 0.1 7.8 6.3 13.3 7.3 8.6 2.4 9.6 4.1 7.7 7.6 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Cell line enhanced" "Detected in many" "EFO-21: 7.7;hTCEpi: 7.0;K-562: 12.3;U-266/84: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.8 0.0 0.0 0.0 2.2 0.4 0.0 0.4 1.1 0.0 1.2 0.0 7.7 0.1 1.0 0.0 2.1 0.4 0.0 5.1 0.4 1.2 1.8 1.2 0.0 0.0 1.1 7.0 0.1 3.5 0.0 12.3 0.0 0.1 1.3 0.0 0.1 1.8 0.9 0.6 0.8 0.1 2.0 2.1 2.0 4.8 0.0 1.9 0.0 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 5.9 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 ZBTB12 "C6orf46, D6S59E, G10, NG35" ENSG00000204366 "Zinc finger and BTB domain containing 12" Q9Y330 6 31899607-31901992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047161 Approved Approved Nucleoplasm Nucleoplasm "HPA047161: " "unprognostic (2.05e-1)" "unprognostic (3.15e-2)" "unprognostic (3.77e-1)" "unprognostic (2.93e-1)" "unprognostic (1.24e-1)" "unprognostic (8.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.55e-1)" "unprognostic (5.22e-2)" "unprognostic (8.16e-2)" "unprognostic (2.58e-1)" "unprognostic (5.41e-2)" "prognostic unfavourable (1.52e-4)" "unprognostic (1.87e-1)" "unprognostic (2.11e-1)" "unprognostic (6.39e-2)" "unprognostic (8.98e-3)" 2.2 3.2 5.0 3.4 4.6 1.8 3.0 4.5 5.5 5.3 2.7 7.4 5.7 4.8 5.7 2.3 2.9 5.3 2.6 2.8 5.5 3.6 1.6 1.4 2.2 2.5 8.6 2.9 7.4 2.2 2.5 2.1 2.3 4.0 6.5 1.2 3.2 4.5 2.4 3.3 1.8 3.7 7.3 4.7 3.2 3.3 2.4 9.9 3.5 6.5 1.8 1.6 4.4 6.7 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.6 6.1 5.3 1.2 1.4 0.5 1.1 1.1 2.2 1.6 2.0 2.9 2.6 2.5 1.3 0.7 3.0 2.1 0.9 6.9 8.3 2.2 0.0 4.1 2.2 8.6 4.1 1.2 0.7 0.9 1.7 0.1 2.5 1.5 1.3 2.8 4.4 6.2 6.3 1.0 9.7 1.3 0.0 1.3 1.6 3.3 11.2 1.1 0.6 3.1 0.0 2.6 0.9 3.3 1.1 1.5 0.1 2.2 8.1 2.7 1.5 0.9 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.6 4.5 5.1 5.5 3.6 8.6 2.9 4.0 9.9 ZBTB22 "BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A" ENSG00000236104 "Zinc finger and BTB domain containing 22" O15209 6 33314406-33317942 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043848 Approved Nucleoplasm Nucleoplasm "HPA043848: AB_10961146" "unprognostic (1.32e-1)" "unprognostic (2.87e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (2.82e-1)" "unprognostic (1.31e-1)" "unprognostic (1.55e-2)" "unprognostic (2.06e-1)" "unprognostic (6.88e-2)" "unprognostic (4.98e-2)" "unprognostic (1.81e-1)" "unprognostic (6.54e-3)" "unprognostic (1.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.66e-2)" "unprognostic (9.32e-3)" 7.0 15.4 9.5 5.7 11.0 4.9 8.3 9.0 18.1 11.0 8.0 9.4 6.4 12.0 12.5 20.9 11.6 9.9 11.0 10.1 11.6 7.2 8.8 6.8 10.6 12.4 7.4 14.9 14.8 20.3 37.6 8.2 15.9 8.7 9.2 9.7 8.8 8.8 11.3 7.8 13.1 10.1 11.0 7.7 10.7 8.5 7.5 6.4 7.2 14.9 3.0 8.9 9.9 9.7 1.8 1.8 3.3 1.7 0.6 3.2 0.8 0.2 0.3 7.2 3.7 7.2 3.8 4.3 5.4 8.8 7.2 6.3 0.1 3.3 2.0 4.1 11.7 0.5 0.3 3.9 4.5 7.3 4.4 6.3 5.6 2.4 0.0 2.0 3.0 12.7 12.9 0.2 3.3 0.6 1.3 8.2 3.1 4.6 3.7 6.5 0.0 1.5 0.4 0.0 4.4 5.3 0.3 7.9 0.4 0.6 0.3 3.3 0.6 0.3 10.4 3.5 4.8 0.1 0.1 3.5 3.8 2.2 5.6 1.9 5.0 2.0 0.8 3.3 1.3 1.7 0.4 1.8 1.6 1.0 1.1 1.6 3.2 0.8 1.5 0.6 0.7 1.8 0.4 0.8 9.5 11.0 9.0 18.1 11.6 7.2 7.4 14.9 8.7 6.4 ZBTB24 "BIF1, KIAA0441, PATZ2, ZNF450" ENSG00000112365 "Zinc finger and BTB domain containing 24" O43167 6 109462594-109483237 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017872, HPA049003" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Centrosome" Nucleoplasm "Cytokinetic bridge, Centrosome" "HPA017872: , HPA049003: " "unprognostic (8.15e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" "unprognostic (4.80e-2)" "unprognostic (1.98e-2)" "prognostic unfavourable (3.15e-4)" "unprognostic (4.53e-2)" "unprognostic (5.09e-2)" "unprognostic (3.31e-2)" "unprognostic (1.22e-3)" "unprognostic (1.37e-1)" "unprognostic (1.75e-3)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (2.60e-1)" "unprognostic (6.77e-2)" 9.6 7.1 6.6 13.8 13.7 16.6 10.1 12.7 11.5 9.5 7.5 11.4 6.8 7.6 9.8 7.5 8.4 8.4 6.4 5.5 7.0 6.8 9.1 6.6 8.5 16.9 11.5 8.8 8.3 8.2 19.1 10.0 12.4 8.8 8.8 8.5 9.6 9.8 9.1 9.7 12.2 11.1 8.5 7.7 13.7 8.6 9.0 12.1 17.4 10.8 5.2 17.1 10.0 10.2 5.7 2.2 1.7 1.5 2.4 5.3 1.0 3.8 4.0 3.7 9.2 6.0 6.1 6.1 4.5 6.2 5.7 6.5 5.6 3.0 16.6 5.9 5.6 5.1 9.3 7.0 8.6 10.3 9.2 13.4 5.4 4.2 4.4 10.9 6.9 6.1 5.8 5.7 10.0 4.6 11.2 9.4 5.8 6.6 15.6 7.4 9.2 4.5 9.8 5.2 6.9 6.9 6.7 6.3 5.5 5.7 6.1 14.2 4.2 11.9 4.6 4.6 4.6 3.8 9.6 4.6 3.5 17.1 6.0 8.7 7.6 0.1 1.2 1.7 1.5 1.1 0.9 5.7 3.0 1.8 1.4 5.6 3.9 2.2 0.8 2.4 1.5 2.2 5.3 1.0 6.6 13.7 12.7 11.5 7.0 6.8 11.5 8.8 8.8 12.1 ZBTB37 "MGC2629, ZNF908" ENSG00000185278 "Zinc finger and BTB domain containing 37" Q5TC79 1 173868082-173903549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023438 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA023438: AB_1858954" "unprognostic (1.18e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" "unprognostic (5.46e-2)" "unprognostic (2.66e-4)" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (9.86e-2)" "unprognostic (2.41e-1)" "unprognostic (3.72e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (4.03e-3)" "unprognostic (1.96e-2)" 6.4 4.0 6.9 6.5 9.8 11.1 5.8 6.4 7.9 5.3 4.0 11.2 3.7 4.0 9.1 5.5 3.4 4.6 4.7 5.6 7.2 3.7 5.3 4.8 6.0 7.7 9.9 5.2 7.6 4.5 6.8 9.2 4.7 7.8 5.3 3.9 10.6 4.6 4.9 4.0 7.0 5.2 6.8 9.5 7.9 5.1 18.4 8.8 7.7 6.1 2.8 6.3 4.8 5.5 1.8 2.4 6.0 1.0 2.3 2.8 0.8 2.4 3.7 5.6 2.4 3.4 2.8 6.2 2.2 1.6 4.0 2.9 4.6 3.1 6.6 4.6 3.4 3.1 4.7 2.4 3.3 3.6 3.0 9.0 3.9 2.2 2.0 5.3 5.7 2.5 1.7 6.0 4.0 2.0 8.0 4.4 4.2 1.8 3.6 1.4 5.3 0.8 2.4 4.9 2.2 2.2 6.0 4.2 5.2 3.1 4.3 4.3 6.2 5.5 3.6 5.2 5.6 2.6 3.5 8.0 5.9 10.5 3.5 3.0 3.1 0.4 1.0 3.4 2.8 1.0 1.2 0.7 1.3 2.0 0.6 1.8 0.7 1.8 6.0 2.3 1.0 2.4 1.0 0.8 6.9 9.8 6.4 7.9 7.2 3.7 9.9 5.2 7.8 8.8 ZBTB40 "KIAA0478, ZNF923" ENSG00000184677 "Zinc finger and BTB domain containing 40" Q9NUA8 1 22451851-22531157 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042386 Approved Nucleoplasm Nucleoplasm "HPA042386: AB_10794649" "unprognostic (2.78e-1)" "unprognostic (3.39e-1)" "unprognostic (2.29e-1)" "unprognostic (5.17e-2)" "unprognostic (6.91e-2)" "prognostic favourable (2.01e-4)" "prognostic unfavourable (7.78e-8)" "unprognostic (8.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.44e-2)" "prognostic favourable (4.12e-5)" "unprognostic (1.52e-1)" "unprognostic (6.74e-2)" "unprognostic (1.98e-2)" "unprognostic (9.51e-2)" "unprognostic (6.66e-2)" "unprognostic (3.34e-2)" 14.1 21.0 8.3 13.5 12.3 11.2 10.8 18.0 12.6 13.9 11.7 14.1 10.9 10.6 21.5 10.5 8.8 13.1 11.9 8.4 9.6 6.4 11.7 8.2 11.5 17.8 12.9 7.3 15.3 15.5 19.0 31.6 8.5 11.6 13.6 11.6 13.5 14.6 10.6 12.7 11.5 18.1 14.4 12.8 23.2 12.5 9.2 13.0 16.6 14.4 6.8 19.5 12.9 14.8 2.5 1.7 1.6 2.1 7.6 3.0 0.8 6.8 7.9 13.1 13.8 9.8 8.2 11.8 6.0 6.6 9.3 10.1 7.1 8.5 8.1 7.2 7.2 9.0 13.3 6.4 11.1 10.7 11.1 17.2 14.9 8.4 8.5 10.0 16.7 6.9 9.6 12.3 9.5 8.0 18.2 0.1 7.6 5.1 6.8 12.8 7.9 6.6 11.6 10.2 9.1 4.6 7.5 11.0 9.1 11.4 8.4 4.9 15.9 8.5 9.8 11.4 9.5 11.8 6.0 5.6 7.4 8.2 6.9 12.6 8.2 1.6 1.0 0.6 2.4 2.1 3.0 1.8 1.9 2.0 1.7 2.5 1.9 2.3 0.4 7.6 1.0 1.1 2.7 0.8 8.3 12.3 18.0 12.6 9.6 6.4 12.9 7.3 11.6 13.0 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153680-197200542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: , HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavourable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 2.6 3.8 4.1 1.8 4.0 0.2 5.9 10.8 5.0 4.5 2.2 2.1 3.2 3.8 2.4 2.8 3.2 2.3 4.0 4.7 4.3 3.3 2.3 2.4 4.2 5.9 2.9 5.6 3.8 2.2 3.3 2.5 2.9 2.6 3.3 2.4 1.8 2.2 4.8 3.0 3.2 2.6 6.4 2.2 3.1 2.1 1.5 1.4 1.7 0.7 1.8 2.2 0.7 7.2 4.1 5.5 4.4 8.7 13.2 4.4 4.4 7.3 4.7 4.4 2.6 6.1 2.7 6.4 10.0 6.0 3.8 3.8 7.4 2.3 2.2 2.2 5.5 2.4 7.7 4.3 2.1 5.4 10.1 4.7 8.2 3.1 5.0 3.3 11.9 3.5 3.2 2.4 2.1 1.5 2.2 7.6 4.8 5.7 4.1 7.8 6.9 7.9 13.9 8.3 10.6 3.3 5.2 9.2 5.4 7.2 5.7 3.7 1.9 2.9 4.3 1.6 12.7 1.7 0.7 0.4 1.2 0.4 2.2 1.5 1.6 1.6 1.4 1.4 2.2 2.0 0.0 1.8 0.6 0.7 1.0 0.7 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favourable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 6.6 6.2 7.8 4.9 12.1 51.7 6.6 10.6 13.6 5.8 5.6 9.5 3.0 5.6 6.6 5.2 10.3 5.3 5.9 9.5 7.9 5.7 5.1 9.0 9.3 6.0 8.6 7.1 7.1 5.9 9.6 9.3 8.2 8.1 5.1 6.6 7.5 7.4 4.4 34.7 14.6 6.7 6.0 8.5 5.7 7.4 15.7 9.3 5.3 6.2 7.1 10.1 5.5 7.0 6.1 5.2 10.6 6.3 9.0 10.7 4.3 4.5 3.5 6.4 5.9 5.4 7.8 6.7 6.4 6.0 4.8 4.3 8.5 3.2 6.3 3.1 6.1 13.3 5.6 6.0 6.0 6.0 3.7 4.4 10.4 3.6 7.3 6.1 8.4 9.5 15.2 7.8 19.5 3.7 7.5 14.8 7.1 4.9 5.3 3.9 5.8 6.0 4.6 20.7 5.2 5.3 5.3 5.7 5.3 6.6 6.2 5.7 5.8 3.9 3.5 5.8 5.6 6.5 5.2 15.9 11.3 2.5 7.2 5.2 4.7 10.6 6.3 5.3 10.7 6.3 10.2 6.1 5.8 6.2 5.2 5.1 6.4 7.3 3.5 9.0 4.8 2.8 8.2 4.3 7.8 12.1 10.6 13.6 7.9 5.7 8.6 7.1 8.1 9.3 ZBTB44 "BTBD15, HSPC063, ZNF851" ENSG00000196323 "Zinc finger and BTB domain containing 44" Q8NCP5 11 130226677-130314686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052589 Approved Approved Nucleoplasm Nucleoplasm "HPA052589: " "unprognostic (4.04e-2)" "unprognostic (1.33e-1)" "unprognostic (8.03e-2)" "unprognostic (7.60e-2)" "unprognostic (4.13e-2)" "unprognostic (5.63e-2)" "unprognostic (2.19e-1)" "unprognostic (2.47e-2)" "unprognostic (1.93e-2)" "unprognostic (3.56e-2)" "unprognostic (1.38e-3)" "unprognostic (3.34e-1)" "unprognostic (8.45e-3)" "unprognostic (6.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.78e-2)" 14.6 14.1 27.8 10.6 22.3 10.6 21.2 42.4 29.0 13.5 12.1 11.8 22.0 9.2 13.1 18.4 13.7 15.4 9.6 13.6 25.4 9.4 27.4 14.7 15.2 15.3 17.4 17.4 18.4 13.7 24.2 14.7 12.9 16.9 12.5 10.6 8.5 16.7 19.2 38.8 15.6 12.4 10.2 11.8 14.1 11.8 34.2 21.8 28.2 14.6 8.4 16.3 16.5 28.6 3.5 4.1 5.8 2.2 3.7 5.8 1.1 6.5 4.4 6.6 6.4 9.5 9.1 7.5 4.2 6.6 3.4 4.4 7.2 20.6 22.1 20.9 6.4 7.0 9.3 8.1 6.0 17.8 5.6 31.6 4.9 4.6 5.3 16.6 24.3 5.9 9.4 6.1 13.3 5.4 9.4 32.7 4.1 4.7 14.7 10.8 6.1 7.3 10.3 6.0 7.4 9.8 5.7 14.0 6.1 12.5 7.7 3.2 14.7 12.5 6.2 7.8 6.9 3.8 4.5 6.1 8.8 18.8 1.9 20.6 6.5 2.2 1.8 2.3 5.8 2.2 3.7 3.0 3.4 3.4 2.1 3.5 2.8 3.3 5.8 3.7 1.6 4.1 3.9 1.1 27.8 22.3 42.4 29.0 25.4 9.4 17.4 17.4 16.9 21.8 ZBTB46 "BTBD4, BZEL, FLJ13502, RINZF, ZNF340" ENSG00000130584 "Zinc finger and BTB domain containing 46" Q86UZ6 20 63743666-63831244 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 3.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013997 Uncertain Approved Nucleoplasm Nucleoplasm "HPA013997: AB_1858961" "unprognostic (1.11e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.13e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (9.33e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-1)" "unprognostic (1.38e-1)" "prognostic favourable (2.17e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (3.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.70e-2)" "unprognostic (2.12e-1)" 9.2 4.6 6.3 3.8 4.3 2.3 6.0 24.2 6.1 8.1 1.9 2.6 3.2 2.2 9.9 8.0 2.3 6.7 4.4 10.1 4.3 3.8 7.3 3.6 6.4 5.7 4.3 3.0 12.4 6.2 3.4 8.8 7.1 5.3 3.8 1.3 9.4 5.1 6.6 7.3 2.9 3.0 3.3 2.5 14.8 2.4 3.5 2.7 1.8 8.5 4.4 2.0 4.0 10.7 0.2 3.4 0.3 0.6 0.7 0.7 0.2 2.5 2.4 8.5 2.7 0.4 0.9 4.6 1.2 2.8 0.5 0.3 5.8 6.5 0.4 9.0 0.1 2.4 0.5 0.1 0.4 0.9 2.3 0.5 2.4 5.3 2.0 0.8 1.5 0.5 0.1 0.1 0.0 0.8 3.2 0.8 1.6 6.1 0.4 11.6 1.5 5.3 3.1 4.1 3.5 0.5 1.6 8.5 2.6 2.0 5.1 0.7 6.3 7.9 0.7 7.2 4.0 3.4 1.4 1.7 4.8 0.7 1.3 1.6 1.3 0.0 0.4 0.2 0.6 0.6 0.3 0.2 0.4 0.6 3.4 0.0 0.4 0.4 0.3 0.7 0.2 0.1 0.7 0.2 6.3 4.3 24.2 6.1 4.3 3.8 4.3 3.0 5.3 2.7 ZBTB47 "DKFZp434N0615, KIAA1190, ZNF651" ENSG00000114853 "Zinc finger and BTB domain containing 47" Q9UFB7 3 42653684-42665854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.1;skeletal muscle: 33.1" "Cell line enhanced" "Detected in many" "ASC diff: 33.5;fHDF/TERT166: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074057 Enhanced Approved Nucleoplasm Nucleoplasm "HPA074057: " "unprognostic (1.03e-1)" "unprognostic (1.15e-2)" "unprognostic (8.23e-2)" "unprognostic (3.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" "unprognostic (2.74e-1)" "unprognostic (2.00e-2)" "unprognostic (4.86e-2)" "unprognostic (8.99e-2)" "prognostic favourable (7.96e-5)" "unprognostic (5.77e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (7.10e-2)" 5.8 3.3 11.4 3.1 18.0 0.5 2.8 3.3 11.3 4.8 4.4 15.7 0.7 1.1 5.4 1.5 4.4 3.1 4.4 28.1 16.1 4.7 1.2 2.0 2.6 2.1 8.6 9.1 5.0 4.5 2.7 3.0 2.1 6.3 4.8 1.0 2.9 7.6 6.2 33.1 2.8 1.4 5.8 12.8 1.7 3.0 3.1 16.7 0.7 5.2 4.2 1.6 3.7 3.3 0.0 0.9 2.8 1.6 0.3 0.3 0.4 3.6 3.2 2.0 1.3 33.5 13.0 0.7 8.7 7.5 3.8 2.8 0.7 1.5 0.0 3.6 17.7 0.9 0.5 3.3 0.8 0.0 4.3 2.2 9.4 0.8 10.3 0.0 3.0 13.9 6.1 4.9 4.2 4.2 2.0 2.6 7.6 0.9 0.1 0.2 1.1 2.1 2.6 3.9 1.0 2.1 0.8 2.2 3.7 4.0 0.7 3.2 4.6 4.8 9.4 8.0 4.6 7.7 3.4 0.1 0.0 0.0 7.3 2.6 2.3 0.0 1.6 0.1 0.3 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 2.8 0.3 0.9 0.0 0.0 0.4 11.4 18.0 3.3 9.3 16.1 4.7 8.6 9.1 6.3 16.7 ZBTB48 "HKR3, TZAP, ZNF855" ENSG00000204859 "Zinc finger and BTB domain containing 48" P10074 1 6580001-6589280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030417 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA030417: AB_10603145" "unprognostic (6.66e-2)" "prognostic favourable (1.04e-4)" "unprognostic (7.15e-3)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (8.15e-3)" "unprognostic (6.43e-2)" "unprognostic (1.70e-1)" "prognostic favourable (5.19e-6)" "unprognostic (7.73e-2)" "unprognostic (1.82e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-2)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" 10.8 12.0 9.6 15.1 12.6 13.3 12.3 11.1 16.3 13.5 12.2 12.7 21.4 11.7 13.2 15.1 12.7 14.2 17.6 9.6 8.9 7.5 12.9 21.6 14.3 17.1 7.0 11.3 19.9 15.8 17.1 14.0 10.7 11.4 17.2 13.2 16.9 12.6 11.7 10.9 14.4 17.2 11.3 8.8 17.1 12.9 28.2 10.3 19.9 18.4 7.4 15.9 13.0 14.4 7.5 7.8 26.7 6.8 6.6 6.4 5.3 3.8 4.7 7.5 10.9 8.3 6.4 3.9 3.9 4.7 7.6 8.2 4.8 8.9 12.8 7.0 3.4 7.3 11.3 7.8 6.1 13.0 10.7 10.4 13.6 4.7 9.9 16.7 28.2 6.4 6.1 7.3 11.8 5.5 10.2 8.4 5.6 7.4 8.2 12.0 5.6 8.2 9.3 7.0 14.1 6.8 3.6 14.6 6.7 5.9 13.5 9.0 7.8 13.4 6.1 5.2 3.4 5.6 4.9 9.2 7.9 19.8 4.8 13.4 3.0 10.9 6.8 26.7 6.0 4.2 6.0 6.5 4.7 5.7 7.8 7.5 6.4 5.5 10.0 6.6 6.6 5.0 3.8 5.3 9.6 12.6 11.1 16.3 8.9 7.5 7.0 11.3 11.4 10.3 ZBTB49 "FLJ38559, ZNF509" ENSG00000168826 "Zinc finger and BTB domain containing 49" Q6ZSB9 4 4290251-4321786 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024450 Approved Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA024450: AB_1859311" "unprognostic (4.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.30e-1)" "unprognostic (2.49e-2)" "unprognostic (2.54e-1)" "prognostic favourable (5.24e-4)" "unprognostic (3.56e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.11e-1)" "prognostic favourable (1.76e-4)" "unprognostic (5.54e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "prognostic favourable (2.88e-5)" 7.3 5.4 5.0 6.0 9.0 11.8 6.8 9.2 8.7 7.2 6.2 9.9 3.4 4.5 9.5 7.0 5.6 6.3 5.3 6.2 6.1 5.1 4.7 5.9 6.5 7.5 6.8 5.3 10.6 7.7 6.0 13.3 5.6 8.9 7.9 4.4 7.1 10.0 6.5 10.1 4.8 6.3 6.5 6.1 9.2 6.0 10.3 6.7 6.7 8.1 5.0 8.5 7.8 5.8 2.9 1.9 12.1 2.7 3.2 6.4 1.8 2.1 3.5 4.3 7.2 5.8 6.1 5.1 2.6 5.1 5.7 4.4 3.0 4.0 7.4 2.7 2.9 3.6 7.5 4.3 5.9 2.4 2.9 8.6 2.3 4.2 4.9 5.2 3.2 3.9 3.6 5.2 3.4 5.7 4.4 4.0 5.3 3.4 10.3 10.2 7.3 4.7 6.2 5.6 4.6 2.3 3.7 5.2 5.0 5.7 2.2 5.7 3.1 5.1 5.5 5.2 2.3 3.4 5.5 4.9 4.8 6.3 3.7 4.4 5.0 3.7 2.6 12.1 6.4 2.7 5.0 2.2 3.6 6.0 1.9 2.9 4.1 4.7 6.2 3.2 2.2 0.4 3.2 1.8 5.0 9.0 9.2 8.7 6.1 5.1 6.8 5.3 8.9 6.7 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438114-37465399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: " "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 7.9 9.2 6.7 10.8 9.5 16.0 10.6 12.8 11.2 10.6 10.0 15.9 7.0 8.7 11.8 11.5 24.6 8.8 7.7 8.4 8.7 5.9 11.0 17.2 11.3 11.7 14.0 6.9 12.5 12.4 11.4 7.9 11.8 9.9 11.3 8.4 9.8 11.9 16.5 7.4 16.6 11.1 7.6 10.4 10.8 10.1 20.4 11.7 15.2 14.8 7.8 17.8 9.5 12.7 2.7 2.6 0.4 1.2 1.1 3.2 1.2 6.5 7.5 19.6 12.1 5.0 3.5 8.4 5.4 4.2 6.7 5.5 5.6 4.8 13.3 5.9 4.0 8.0 12.7 4.5 5.1 9.8 6.6 4.9 19.4 6.5 4.9 6.0 4.3 3.4 11.4 3.3 7.1 7.4 11.5 11.4 4.9 4.1 12.6 4.4 4.9 3.9 11.5 9.4 5.0 6.4 5.9 9.0 16.2 5.3 8.5 4.2 13.7 5.9 5.0 4.7 13.1 2.7 5.1 6.1 6.7 11.7 4.3 5.2 4.9 0.4 1.2 0.2 2.2 0.9 2.6 2.7 1.9 1.9 2.6 2.7 2.9 3.2 0.1 1.1 0.1 0.8 1.5 1.2 6.7 9.5 12.8 11.2 8.7 5.9 14.0 6.9 9.9 11.7 ZBTB7A "DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A" ENSG00000178951 "Zinc finger and BTB domain containing 7A" O95365 19 4044364-4066945 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037214, CAB037285, HPA046387" Supported Approved Nucleoplasm Nucleoplasm "CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: " "unprognostic (8.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.02e-1)" "prognostic favourable (6.50e-6)" "unprognostic (7.54e-2)" "unprognostic (3.65e-3)" "unprognostic (3.71e-2)" "unprognostic (1.12e-1)" "unprognostic (1.56e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (2.99e-4)" "unprognostic (3.75e-1)" "prognostic favourable (1.34e-6)" "prognostic favourable (1.79e-4)" "unprognostic (2.01e-1)" "unprognostic (4.25e-1)" "unprognostic (1.36e-2)" 19.6 13.6 18.1 14.3 19.5 17.5 13.6 26.3 26.6 15.2 23.3 14.3 16.0 27.1 16.7 10.6 29.8 12.6 21.1 11.1 20.6 10.4 11.6 12.2 13.7 14.2 13.2 11.6 12.0 12.1 16.2 11.4 12.9 16.8 14.2 11.6 12.4 16.3 14.0 32.0 21.9 22.7 14.2 10.2 19.5 29.2 5.6 13.2 12.4 10.6 15.8 20.5 17.7 16.0 2.9 2.2 4.9 3.7 2.8 2.2 0.5 17.4 8.6 1.5 5.5 12.3 12.7 6.1 12.6 8.0 3.7 3.9 3.1 7.7 8.1 8.5 9.6 15.5 2.0 6.3 3.3 15.0 8.5 4.9 6.1 4.2 8.4 7.0 17.2 6.9 10.6 5.2 5.2 4.2 9.3 7.6 4.2 12.2 8.3 4.9 3.8 10.9 6.3 4.6 8.2 5.8 7.6 6.7 5.0 7.9 17.9 7.6 10.1 12.2 12.5 13.9 6.5 18.6 16.2 15.4 6.5 4.7 17.4 7.3 8.8 1.6 2.8 0.8 2.2 3.7 1.8 2.9 1.3 1.7 0.8 1.9 1.0 2.0 4.9 2.8 2.9 2.2 0.9 0.5 18.1 19.5 26.3 26.6 20.6 10.4 13.2 11.6 16.8 13.2 ZBTB9 "MGC23166, ZNF919" ENSG00000213588 "Zinc finger and BTB domain containing 9" Q96C00 6 33453970-33457548 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 11.4;U-698: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036767, HPA058171" Uncertain Approved "Nucleoplasm,Nuclear membrane" Nucleoplasm "Nuclear membrane" "HPA036767: AB_10696787, HPA058171: " "unprognostic (1.79e-2)" "unprognostic (1.46e-1)" "unprognostic (6.86e-2)" "unprognostic (2.89e-1)" "unprognostic (2.18e-1)" "unprognostic (9.16e-2)" "unprognostic (1.85e-4)" "unprognostic (4.20e-1)" "unprognostic (2.73e-1)" "unprognostic (2.13e-1)" "unprognostic (1.70e-2)" "unprognostic (4.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.95e-1)" 4.5 7.1 5.5 5.4 5.9 4.4 3.3 4.9 7.4 5.4 4.4 6.4 2.4 6.6 4.5 8.7 5.4 4.8 4.2 4.4 5.9 5.1 7.7 5.4 3.7 6.6 4.4 4.5 10.6 11.3 8.5 17.3 4.5 4.2 5.9 7.1 4.6 6.3 3.9 5.7 5.0 3.9 3.8 3.5 5.4 3.7 12.7 3.8 9.7 6.8 4.0 13.7 7.8 4.3 0.8 2.6 8.5 2.2 1.9 4.3 1.0 0.2 0.1 5.1 0.8 2.6 0.2 11.4 0.1 0.2 0.0 0.0 1.8 0.0 1.8 1.7 0.1 0.0 4.9 2.0 0.7 2.0 0.0 6.8 0.0 0.0 0.0 2.5 6.7 0.2 0.2 3.0 3.0 0.0 2.7 0.6 2.2 0.6 0.4 0.0 3.2 0.4 3.4 3.1 2.3 2.7 2.3 0.6 0.4 3.4 0.2 1.1 0.5 0.4 1.6 0.3 0.1 1.0 1.2 0.0 1.9 12.9 0.2 2.2 0.0 8.5 1.5 0.5 3.9 1.5 1.9 0.3 1.9 4.3 2.6 0.8 3.6 3.2 1.4 1.9 2.2 0.3 3.2 1.0 5.5 5.9 4.9 7.4 5.9 5.1 4.4 4.5 4.2 3.8 ZC3H3 "KIAA0150, ZC3HDC3" ENSG00000014164 "Zinc finger CCCH-type containing 3" Q8IXZ2 8 143437655-143541453 "Predicted intracellular proteins" "mRNA transport, Transport" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023658, HPA050577" Uncertain Approved Nucleoplasm Nucleoplasm "HPA023658: AB_1858973, HPA050577: " "unprognostic (1.15e-1)" "unprognostic (7.74e-2)" "unprognostic (1.87e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.66e-1)" "prognostic unfavourable (4.06e-4)" "unprognostic (2.18e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (3.32e-1)" "prognostic unfavourable (4.38e-7)" "unprognostic (3.59e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "unprognostic (2.18e-1)" 11.9 7.9 9.9 10.1 11.1 28.0 9.1 17.3 16.6 6.3 7.5 11.9 9.8 20.8 9.4 4.4 9.2 7.6 7.1 6.0 7.9 4.5 12.6 26.9 9.3 8.5 7.3 8.7 8.6 10.1 5.7 6.4 8.8 8.5 7.9 3.6 9.1 12.0 7.7 15.1 10.9 16.5 10.0 5.0 13.4 11.8 23.2 7.4 13.8 9.4 7.0 9.1 8.0 7.7 5.2 5.3 13.4 8.1 2.9 9.2 6.7 7.5 11.3 3.5 8.6 2.2 2.6 10.1 4.3 3.1 5.6 4.6 6.0 7.1 5.5 8.0 3.6 8.8 2.9 4.5 1.2 11.8 10.1 6.9 6.9 9.5 5.5 3.4 6.2 5.9 4.3 4.6 3.3 4.1 11.4 10.1 2.3 19.7 16.1 6.4 6.5 18.4 9.3 2.8 17.1 4.0 4.6 9.2 6.1 8.6 7.5 4.7 12.1 6.3 5.6 4.9 15.1 10.8 7.6 9.3 6.1 4.7 6.4 8.1 5.4 9.1 6.3 8.6 6.2 8.1 7.3 5.2 7.1 7.5 5.3 4.7 9.2 7.3 13.4 2.9 5.0 4.5 5.1 6.7 9.9 11.1 17.3 16.6 7.9 4.5 7.3 8.7 8.5 7.4 ZC3H6 "FLJ41410, FLJ45877, KIAA2035, ZC3HDC6" ENSG00000188177 "Zinc finger CCCH-type containing 6" P61129 2 112275594-112340063 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036019, HPA036020, HPA076065" Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA036019: AB_10673228, HPA036020: , HPA076065: " "unprognostic (1.05e-2)" "unprognostic (3.01e-1)" "unprognostic (2.77e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-3)" "unprognostic (1.83e-1)" "unprognostic (3.99e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.68e-1)" "unprognostic (4.41e-2)" "unprognostic (6.42e-3)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" 10.9 8.8 8.1 6.2 18.9 5.8 11.2 16.6 14.3 10.9 8.1 11.4 7.7 5.3 9.1 11.9 6.7 10.3 6.5 9.4 8.9 7.4 7.6 6.4 7.4 8.9 15.6 10.5 20.5 7.1 13.8 18.3 7.0 11.1 9.8 6.2 8.6 8.2 8.0 16.4 14.3 7.5 10.5 11.5 10.0 6.9 9.4 13.1 12.4 12.5 5.2 8.6 13.4 8.6 5.5 2.9 3.9 3.4 1.8 4.5 1.1 1.7 0.8 4.0 3.7 3.5 7.0 1.2 2.0 3.1 1.2 2.6 0.4 2.4 2.9 1.5 1.1 1.1 1.1 0.5 1.7 3.2 0.4 0.5 0.9 0.1 3.3 0.9 0.8 2.7 5.4 1.4 9.1 1.9 0.7 4.9 2.8 1.6 1.6 1.2 2.5 0.9 1.1 0.2 2.5 1.7 0.3 2.8 3.9 1.9 1.1 2.0 1.2 1.1 3.0 2.0 0.3 2.2 0.9 5.2 1.5 2.5 3.7 1.9 4.9 1.5 1.8 2.3 2.9 1.3 3.2 3.7 3.9 3.0 1.6 5.5 4.5 3.7 3.9 1.8 3.4 2.9 3.2 1.1 8.1 18.9 16.6 14.3 8.9 7.4 15.6 10.5 11.1 13.1 ZCCHC10 FLJ20094 ENSG00000155329 "Zinc finger CCHC-type containing 10" Q8TBK6 5 132996985-133026604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038944 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA038944: AB_10673601" "unprognostic (1.09e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-2)" "unprognostic (2.30e-2)" "unprognostic (4.77e-1)" "unprognostic (1.90e-3)" "unprognostic (1.23e-3)" "unprognostic (8.80e-2)" "unprognostic (1.89e-3)" "unprognostic (1.69e-1)" "unprognostic (2.03e-1)" "unprognostic (8.30e-3)" "unprognostic (1.36e-2)" "unprognostic (1.27e-1)" "unprognostic (8.85e-2)" "unprognostic (1.62e-1)" "unprognostic (8.89e-3)" 18.6 17.3 14.5 18.2 14.1 30.6 16.4 18.1 20.6 17.4 24.1 10.5 15.4 18.3 18.7 15.4 26.9 14.9 14.2 17.3 13.7 12.4 19.6 23.5 21.0 26.0 11.9 15.2 17.3 17.7 9.8 27.4 23.0 15.3 16.1 22.1 10.0 17.9 16.8 31.5 14.0 21.7 14.0 17.5 23.6 17.8 20.3 14.1 25.6 13.9 22.4 26.5 17.8 17.3 48.1 27.2 16.5 28.0 22.9 27.7 18.8 11.7 12.3 16.3 13.5 8.2 7.4 21.4 12.4 9.7 15.9 18.5 31.0 14.7 32.8 19.1 8.3 15.0 19.9 15.9 17.3 19.3 26.4 19.0 15.1 23.0 12.1 16.3 22.3 6.7 18.3 9.7 15.8 15.7 20.5 18.2 12.0 15.4 25.4 18.9 17.7 12.9 22.9 19.3 14.3 14.6 17.0 12.8 10.8 19.9 8.1 22.9 18.0 21.2 16.0 13.7 16.2 8.9 17.9 15.4 24.4 46.1 11.1 29.2 16.1 16.5 28.0 16.4 19.7 25.3 20.6 39.7 24.1 23.5 27.2 48.1 21.2 21.8 14.6 22.9 25.3 24.0 27.7 18.8 14.5 14.1 18.1 20.6 13.7 12.4 11.9 15.2 15.3 14.1 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 5.8 5.1 4.4 8.7 13.5 5.8 8.4 3.4 5.1 8.1 8.1 2.7 3.6 16.6 4.5 5.6 10.0 14.2 7.5 3.4 11.4 6.7 4.4 11.8 18.6 4.6 8.3 6.4 5.7 9.7 5.1 9.6 15.2 4.6 5.6 2.6 4.8 5.4 3.5 2.8 5.1 7.2 4.7 0.1 5.6 6.0 5.6 3.5 5.7 12.8 5.0 4.5 6.6 6.4 8.0 5.5 3.1 4.8 2.2 4.2 7.1 6.0 3.5 2.9 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell line enhanced" "Detected in many" "ASC diff: 42.7;ASC TERT1: 36.7;BJ hTERT+: 28.0;HSkMC: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavourable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavourable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 27.9 9.0 30.9 9.5 54.4 1.8 9.8 11.1 36.0 22.9 19.8 56.8 4.2 4.6 18.0 6.9 10.3 15.5 16.8 19.1 30.6 19.7 3.5 13.5 10.2 4.8 56.7 23.5 20.1 4.0 3.9 3.0 11.4 36.2 14.5 6.8 4.5 6.2 20.7 34.8 5.0 5.4 25.6 36.8 7.0 9.0 6.6 51.9 0.0 6.0 2.5 3.2 14.9 7.3 0.0 3.4 0.6 2.4 0.7 0.9 0.5 0.9 0.9 3.2 2.7 42.7 36.7 0.7 7.4 28.0 4.4 5.1 0.8 0.0 0.0 4.0 14.8 0.0 0.5 0.1 3.7 1.8 1.9 0.3 2.2 0.9 11.1 1.1 0.6 38.1 0.4 3.9 1.0 0.9 1.4 1.6 3.7 0.3 0.0 4.4 0.7 9.2 0.1 3.8 0.6 0.5 1.2 0.1 4.0 2.3 0.3 9.2 1.1 2.1 0.6 4.2 3.9 11.5 2.5 2.8 1.8 0.0 8.7 1.4 15.0 0.0 2.4 0.6 0.9 1.1 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.2 0.6 0.7 0.1 3.4 0.4 0.5 30.9 54.4 11.1 36.0 30.6 19.7 56.7 23.5 36.2 51.9 ZCCHC6 "FLJ13409, KIAA1711, PAPD6, TUT7" ENSG00000083223 "Zinc finger CCHC-type containing 6" Q5VYS8 9 86287733-86354454 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Group enriched" "Detected in all" 5 "granulocytes: 42.1;monocytes: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020615, HPA020620" Approved Supported Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA020615: AB_1858983, HPA020620: AB_1858984" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.64e-1)" "unprognostic (1.26e-2)" "unprognostic (3.66e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-2)" "unprognostic (2.49e-2)" "unprognostic (4.43e-2)" "unprognostic (6.51e-2)" "unprognostic (1.91e-2)" "unprognostic (3.07e-1)" "unprognostic (5.79e-3)" "unprognostic (1.59e-2)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (1.40e-1)" 11.2 9.3 7.7 22.6 11.2 17.0 17.3 9.7 13.7 10.8 13.5 5.6 12.8 9.4 8.6 8.1 23.1 8.3 10.3 10.1 9.4 5.2 7.4 33.1 16.3 19.5 9.8 5.1 9.0 12.9 9.2 18.6 33.3 9.0 19.3 10.8 4.5 14.0 13.6 12.5 30.9 15.6 9.7 13.6 22.2 11.7 10.3 10.7 23.3 8.7 15.2 16.9 13.7 14.3 4.4 4.3 42.1 15.7 4.5 5.7 2.9 9.8 10.7 6.4 9.2 16.3 24.8 7.8 13.5 13.2 6.0 7.0 4.8 8.8 14.1 12.3 8.9 17.5 7.5 7.6 8.9 16.5 4.0 10.1 11.3 9.0 13.9 11.5 14.8 16.4 16.0 9.5 11.3 10.0 9.5 15.3 16.6 10.6 9.6 7.0 5.2 7.2 4.9 11.1 6.5 10.6 19.4 4.6 3.7 8.2 10.9 4.7 4.1 5.2 15.4 5.7 6.9 10.1 9.2 17.7 13.7 10.5 13.6 6.9 7.5 11.5 7.1 7.1 5.7 9.1 4.9 4.4 3.2 4.1 4.3 4.4 3.7 4.0 42.1 4.5 15.7 2.0 3.0 2.9 7.7 11.2 9.7 13.7 9.4 5.2 9.8 5.1 9.0 10.7 ZDBF2 "FLJ45338, KIAA1571, Slx9" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell line enhanced" "Detected in many" "BEWO: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039121: , HPA050311: " "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 4.4 12.0 8.6 3.5 26.9 2.2 4.2 14.7 12.7 5.4 3.7 2.1 5.1 2.0 7.2 6.1 3.1 5.1 4.4 4.5 8.9 8.3 4.9 3.6 3.2 3.8 3.7 10.8 14.8 8.3 5.6 20.9 7.5 9.0 4.7 2.6 3.8 3.7 5.3 5.4 3.9 3.0 5.1 4.0 4.2 3.4 5.4 3.1 2.5 6.5 2.9 3.3 3.7 3.5 0.7 0.5 0.3 0.0 0.3 1.4 0.2 1.9 0.3 6.6 1.2 2.2 1.9 9.3 1.9 2.2 0.9 1.4 1.0 1.5 0.1 0.9 2.3 0.5 4.2 1.4 1.7 2.3 3.9 0.0 3.7 0.2 2.9 2.0 4.2 2.0 2.4 1.6 3.9 2.4 0.3 2.6 2.8 0.3 0.5 0.0 8.9 1.9 0.0 6.9 0.0 1.1 1.0 3.4 8.2 3.3 0.0 2.7 0.2 0.0 3.6 0.8 3.2 0.7 1.5 6.0 1.5 0.3 4.6 0.0 2.2 0.3 0.0 0.0 0.3 0.0 0.9 0.5 1.0 0.6 0.0 0.7 1.1 0.7 0.0 0.3 0.0 0.5 1.4 0.2 8.6 26.9 14.7 12.7 8.9 8.3 3.7 10.8 9.0 3.1 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Cell line enhanced" "Detected in many" "MCF7: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA059339: " "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.1 38.8 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.0 6.7 31.8 16.4 9.9 8.6 6.8 37.5 3.5 18.1 1.0 18.2 9.3 5.2 29.5 13.9 10.3 8.7 24.1 5.6 12.6 8.2 3.1 7.4 5.2 25.2 1.9 54.5 11.9 17.4 7.2 32.1 5.4 5.8 28.4 7.6 13.3 11.6 8.4 12.4 17.2 4.8 26.5 9.3 7.4 0.0 10.5 7.1 12.2 16.3 28.8 4.4 16.8 10.0 11.0 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type containing 23" Q8IYP9 3 113947901-113965401 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favourable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavourable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 0.8 6.3 2.1 5.9 0.4 1.9 2.7 10.4 1.4 7.7 0.9 2.2 6.0 1.5 1.6 1.7 2.1 1.8 1.3 8.9 1.9 4.7 3.2 2.4 2.7 0.9 4.7 1.1 4.4 8.2 3.5 0.4 1.4 1.8 9.9 1.2 4.9 1.4 1.2 2.9 5.4 0.7 0.9 1.9 5.0 25.8 0.6 0.8 5.5 0.9 2.8 1.7 1.5 2.7 1.1 0.5 0.0 0.0 0.5 0.1 13.3 3.4 0.4 7.9 1.2 0.2 11.6 5.3 1.6 1.0 1.6 5.5 9.0 6.1 4.7 3.0 8.8 10.1 1.4 1.7 3.6 4.6 5.7 4.9 3.4 0.4 6.3 5.3 0.2 1.7 0.2 0.7 0.9 0.0 3.6 0.1 7.7 5.2 0.4 2.4 3.8 0.9 4.6 5.1 5.6 6.6 13.9 3.5 4.1 13.7 2.6 8.2 2.1 0.2 3.8 7.7 0.8 2.3 4.1 5.3 9.9 3.3 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.0 1.7 0.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 6.3 5.9 2.7 10.4 8.9 1.9 0.9 4.7 1.4 0.6 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavourable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 27.9 31.1 12.2 12.4 27.0 20.8 23.0 26.3 31.6 22.1 16.5 18.8 34.5 18.9 34.2 31.1 39.6 19.0 31.2 19.7 23.2 8.6 16.0 14.3 16.7 30.3 30.0 27.2 29.3 28.2 32.6 33.1 24.8 21.1 23.9 27.8 16.8 16.9 8.4 14.8 18.7 16.8 24.7 23.3 25.2 41.6 8.9 11.4 24.5 27.7 25.7 29.7 17.2 29.1 28.6 14.9 30.0 18.3 17.4 21.5 16.3 21.3 15.5 24.8 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 ZDHHC7 "DHHC7, FLJ10792, FLJ20279, SERZ-B, SERZ1, ZNF370" ENSG00000153786 "Zinc finger DHHC-type containing 7" Q9NXF8 16 84974181-85011535 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019215, HPA059642" Uncertain Supported "Nucleoplasm,Golgi apparatus" "Golgi apparatus" Nucleoplasm "HPA019215: , HPA059642: " "unprognostic (9.77e-2)" "unprognostic (2.12e-1)" "unprognostic (6.70e-2)" "unprognostic (1.09e-1)" "unprognostic (2.31e-1)" "unprognostic (8.76e-2)" "prognostic unfavourable (4.20e-4)" "unprognostic (1.41e-2)" "unprognostic (5.78e-2)" "unprognostic (2.21e-2)" "unprognostic (7.79e-3)" "unprognostic (8.04e-2)" "prognostic favourable (1.12e-5)" "unprognostic (1.67e-1)" "unprognostic (1.36e-2)" "unprognostic (2.45e-1)" "unprognostic (5.42e-2)" 23.4 20.9 17.7 25.4 14.7 40.3 45.8 17.8 20.0 23.7 26.8 15.5 15.6 19.7 27.7 18.6 20.4 19.2 29.1 24.9 13.0 11.6 23.4 21.3 31.3 36.3 15.5 14.5 21.8 30.0 31.1 15.2 25.1 14.8 24.1 24.3 18.1 18.7 18.4 36.5 23.1 25.5 31.1 14.9 27.1 32.3 18.6 13.9 16.1 19.9 25.8 18.8 27.7 28.9 2.0 6.9 8.5 10.6 1.5 3.0 3.5 20.0 17.7 9.4 11.2 41.6 31.4 12.9 18.6 36.1 29.3 14.6 18.6 23.6 9.2 10.9 30.0 21.2 12.0 24.5 37.0 5.3 9.6 7.2 7.5 21.1 17.4 12.5 7.0 25.9 28.2 23.9 13.8 15.0 21.4 3.2 18.5 24.0 8.5 12.0 14.5 12.9 10.6 8.6 5.0 28.8 26.5 8.0 10.1 24.0 13.5 11.6 25.5 7.6 21.9 17.7 13.5 16.7 10.8 11.1 15.3 20.9 16.8 9.4 14.0 6.7 10.6 8.5 2.5 8.8 3.0 1.6 2.4 2.0 6.9 2.0 1.8 2.6 7.1 1.5 7.2 4.7 0.6 3.5 17.7 14.7 17.8 20.0 13.0 11.6 15.5 14.5 14.8 13.9 ZDHHC8 "KIAA1292, ZNF378" ENSG00000099904 "Zinc finger DHHC-type containing 8" Q9ULC8 22 20129456-20148007 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003422 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA003422: AB_1080640" "unprognostic (1.00e-2)" "prognostic unfavourable (9.68e-4)" "unprognostic (3.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-1)" "unprognostic (8.02e-2)" "unprognostic (5.14e-2)" "unprognostic (1.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.43e-3)" "unprognostic (9.34e-3)" "unprognostic (3.20e-1)" "prognostic unfavourable (4.04e-4)" "unprognostic (1.11e-1)" "unprognostic (1.02e-1)" "unprognostic (9.88e-2)" "unprognostic (9.57e-2)" 20.7 19.2 25.7 16.9 23.0 9.2 23.4 24.4 35.3 14.3 9.9 14.0 17.3 11.6 16.0 10.9 13.9 13.6 14.4 16.0 18.7 10.6 15.2 16.5 14.6 15.4 17.7 17.6 18.0 23.9 17.4 21.0 16.4 19.0 13.4 7.0 17.5 20.4 16.6 20.5 22.2 11.2 13.0 10.4 19.8 15.9 8.4 18.6 8.9 18.5 7.9 11.1 12.9 14.5 2.0 4.1 4.0 1.5 1.3 2.5 0.5 11.3 7.3 11.6 15.3 17.1 10.2 10.5 21.5 14.7 14.6 13.1 3.8 5.9 0.0 8.9 17.8 15.6 6.1 16.4 7.2 16.4 23.3 5.5 19.1 8.7 14.1 0.0 7.7 17.8 11.1 11.2 9.5 16.3 38.0 9.0 12.9 5.6 6.7 14.9 5.9 11.6 14.4 10.2 4.1 6.3 13.9 18.7 9.5 8.7 4.2 10.2 0.3 7.8 18.6 33.2 24.3 18.6 9.5 13.0 4.2 4.3 9.7 7.2 9.7 4.0 1.2 0.3 2.5 1.5 1.3 0.8 0.7 1.2 0.4 2.0 1.3 1.8 0.0 1.3 0.8 4.1 2.0 0.5 25.7 23.0 24.4 35.3 18.7 10.6 17.7 17.6 19.0 18.6 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell line enhanced" "Detected in many" "HEL: 38.4;THP-1: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.1 0.0 26.4 13.5 0.0 9.1 9.2 10.2 9.9 0.0 0.2 1.6 0.0 9.8 0.1 3.7 0.0 12.8 9.4 2.6 38.4 1.6 0.0 5.9 6.6 30.5 11.0 0.2 12.6 6.1 7.7 10.7 1.1 12.0 0.0 0.0 20.1 3.2 0.5 11.3 15.2 0.0 0.1 0.2 0.1 5.8 1.1 0.0 23.9 0.0 45.7 11.9 11.7 0.2 22.8 2.8 12.5 0.0 1.9 17.6 19.9 31.6 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA035159: , HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favourable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 13.4 12.9 16.4 14.6 16.9 23.8 13.5 22.3 24.6 14.8 30.0 20.2 15.9 30.5 15.3 14.2 22.2 13.1 22.2 11.6 16.2 13.3 20.0 28.5 15.2 27.3 18.8 17.9 14.1 29.1 18.6 18.0 22.2 15.6 14.7 18.5 11.3 17.3 14.2 15.9 23.4 34.7 24.5 17.5 22.6 21.8 9.5 13.9 23.0 30.0 12.9 19.3 14.7 16.6 29.1 20.5 36.6 27.8 30.7 32.5 25.4 10.4 7.1 8.2 11.5 8.7 9.2 11.4 10.6 12.5 15.3 15.2 16.0 9.0 8.5 11.3 18.1 7.2 7.6 13.5 12.2 13.1 11.8 19.4 11.8 13.8 17.9 10.3 22.5 7.6 29.7 15.1 36.0 10.2 11.3 24.2 14.9 18.1 17.0 21.7 4.2 8.2 10.6 4.9 14.6 14.5 8.9 17.9 8.1 5.1 8.7 11.8 7.4 21.9 10.8 15.5 14.5 17.8 15.1 10.0 3.2 15.3 15.2 20.5 12.0 17.7 21.7 28.6 32.1 27.8 28.0 25.4 29.3 31.3 16.4 29.1 26.7 32.5 36.6 30.7 21.9 20.5 30.2 25.4 16.4 16.9 22.3 24.6 16.2 13.3 18.8 17.9 15.6 13.9 ZFAND3 "FLJ13222, TEX27" ENSG00000156639 "Zinc finger AN1-type containing 3" Q9H8U3 6 37819499-38154624 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016755 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA016755: AB_1859011" "unprognostic (3.32e-1)" "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" "unprognostic (2.89e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (1.07e-1)" "unprognostic (1.36e-2)" "unprognostic (9.30e-2)" "unprognostic (1.48e-2)" "unprognostic (9.60e-3)" "unprognostic (1.01e-1)" "unprognostic (2.94e-1)" "unprognostic (7.41e-2)" "unprognostic (4.33e-1)" 26.7 27.5 31.0 26.0 31.1 23.9 37.6 26.2 31.4 28.6 27.0 26.6 26.0 24.5 25.9 31.2 22.2 21.4 33.5 30.5 29.9 24.1 31.6 35.6 24.8 26.1 30.4 22.2 23.9 26.1 33.9 31.6 31.4 24.2 23.7 20.2 24.3 20.3 31.0 77.9 19.4 26.9 35.4 33.4 21.9 25.1 60.5 27.3 26.4 32.1 19.7 19.3 30.7 34.0 3.0 4.4 9.2 2.8 2.9 2.6 1.4 17.0 10.6 36.7 26.0 22.2 23.1 12.7 28.6 33.3 25.8 27.6 20.7 10.1 7.1 22.0 30.4 11.8 14.0 21.1 35.5 27.1 8.9 21.5 5.5 19.8 52.1 8.9 18.8 29.0 27.8 27.2 46.3 22.2 10.2 15.1 19.5 14.8 14.0 7.5 10.8 11.1 14.8 14.8 8.6 24.5 29.2 22.7 20.0 16.0 14.1 49.2 21.6 18.9 24.3 27.2 20.7 14.5 17.8 14.8 13.4 21.6 10.2 14.1 28.0 0.7 2.7 8.8 2.6 2.8 1.8 1.9 1.9 2.0 1.3 3.0 1.7 2.6 9.2 2.9 2.1 4.4 2.4 1.4 31.0 31.1 26.2 31.4 29.9 24.1 30.4 22.2 24.2 27.3 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351425-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Cell line enhanced" "Detected in all" "HDLM-2: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018129 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA018129: AB_1859012" "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favourable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 82.5 57.6 26.9 15.5 35.2 36.6 57.1 31.7 34.3 28.6 23.1 20.3 31.4 10.8 25.7 35.5 29.0 27.4 28.7 33.0 24.3 22.6 32.6 56.5 31.6 23.6 24.3 21.1 59.3 20.9 17.0 45.4 22.4 25.1 24.0 15.1 22.4 17.2 52.7 207.5 17.6 15.8 28.4 25.9 24.1 23.2 26.7 21.7 14.6 23.1 29.5 16.5 39.2 29.3 7.0 13.6 15.4 32.1 8.6 6.8 7.8 21.8 22.4 26.4 11.7 34.3 16.3 20.0 25.9 36.1 13.9 10.9 2.7 20.7 12.2 15.7 40.5 24.5 60.9 10.1 20.9 82.5 9.4 9.6 12.9 13.7 25.3 13.8 14.3 21.4 18.8 14.6 16.3 24.7 9.2 16.2 16.4 5.8 18.0 7.8 34.2 15.6 14.1 13.7 12.9 45.5 21.3 19.4 17.3 16.4 18.0 21.1 8.0 12.1 18.8 11.6 14.3 20.5 17.7 23.3 20.3 6.4 15.6 9.4 28.8 15.1 13.6 15.4 5.2 21.6 5.7 7.0 6.8 6.6 13.6 6.2 6.3 5.6 12.2 8.6 32.1 2.9 4.8 7.8 26.9 35.2 31.7 34.3 24.3 22.6 24.3 21.1 25.1 21.7 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 68.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in single" 25 "dendritic cells: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA020989: , HPA063592: " "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 4.5 2.9 4.2 3.5 4.2 1.7 5.0 6.8 4.5 3.0 7.8 2.6 2.8 3.2 5.0 3.1 4.2 3.3 2.4 3.8 3.0 1.7 12.4 2.8 4.1 4.5 2.5 2.8 3.3 3.3 3.7 4.6 68.8 2.9 3.9 2.6 4.3 3.7 4.2 8.5 3.4 3.8 3.9 2.0 4.4 3.6 3.5 3.0 4.8 3.3 2.8 4.0 6.0 5.3 0.6 22.1 0.8 0.5 0.0 0.5 0.5 5.7 9.0 3.3 4.1 6.4 6.4 2.8 6.2 5.5 5.7 5.7 6.1 7.2 6.4 5.4 6.4 4.4 6.5 7.8 7.4 5.3 8.7 12.0 9.1 4.6 5.0 6.6 5.9 5.4 4.0 6.3 8.2 6.9 4.5 12.0 4.8 7.4 6.9 0.8 4.5 5.9 4.3 4.3 2.7 5.4 8.5 3.7 3.1 6.3 4.9 5.2 4.0 6.3 7.6 3.3 5.0 4.7 7.0 4.3 5.8 6.4 4.3 4.9 6.4 0.7 0.3 0.8 0.3 0.5 0.3 0.6 0.2 0.5 0.3 0.6 0.4 0.2 0.7 0.0 0.3 22.1 0.1 0.5 4.2 4.2 6.8 4.5 3.0 1.7 2.5 2.8 2.9 3.0 ZFC3H1 "CCDC131, CSRC2, KIAA0546, MGC23401, PSRC2" ENSG00000133858 "Zinc finger C3H1-type containing" O60293 12 71609472-71667725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007072, HPA007151" Enhanced Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA007072: AB_1846134, HPA007151: AB_1846133" "unprognostic (3.90e-3)" "unprognostic (3.69e-1)" "unprognostic (2.78e-1)" "unprognostic (2.15e-2)" "unprognostic (9.44e-2)" "unprognostic (6.14e-2)" "prognostic unfavourable (3.63e-4)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (6.56e-2)" "unprognostic (3.80e-2)" "unprognostic (2.53e-3)" "prognostic unfavourable (1.48e-5)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" 12.1 12.8 17.6 19.1 17.4 22.7 12.9 35.3 23.8 15.4 16.9 6.7 14.6 8.0 13.7 17.3 15.1 12.8 12.7 12.1 14.6 7.7 10.7 8.0 16.4 19.1 14.8 12.3 17.1 11.6 17.6 17.6 14.6 14.9 12.6 13.2 6.7 12.0 14.2 11.6 12.2 15.2 12.4 14.7 15.9 13.5 17.5 17.6 16.8 13.5 8.4 17.1 15.7 20.8 14.8 12.7 29.7 10.3 4.2 7.2 1.1 10.5 10.7 7.7 5.3 10.7 19.1 4.6 8.2 13.2 13.0 12.9 9.8 5.8 13.6 4.7 10.1 11.3 10.9 4.8 17.4 13.7 8.0 13.2 16.5 4.6 6.0 14.4 6.5 10.7 10.4 9.2 3.9 13.0 12.2 6.0 11.9 3.2 10.2 5.0 7.7 6.2 8.8 9.4 10.4 9.8 7.8 5.3 4.8 8.3 5.3 5.4 14.2 9.5 9.9 7.3 5.0 4.2 4.1 10.5 6.3 10.5 8.6 10.1 5.1 20.7 10.3 12.1 7.2 4.8 5.5 9.2 6.2 4.6 3.9 14.8 5.8 4.9 29.7 4.2 8.7 12.7 4.9 1.1 17.6 17.4 35.3 23.8 14.6 7.7 14.8 12.3 14.9 17.6 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell line enhanced" "Detected in many" "AN3-CA: 8.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.3 4.2 8.4 2.9 0.4 0.3 1.2 0.4 0.6 2.1 0.5 0.4 0.4 0.5 0.1 0.1 2.2 0.3 0.9 3.7 1.3 4.3 0.0 1.0 0.5 0.7 3.0 0.6 0.2 0.9 0.3 0.6 0.6 0.7 0.1 1.4 0.5 0.5 5.1 1.2 2.3 0.1 0.0 2.3 2.0 4.6 3.0 0.7 1.1 0.3 1.7 1.1 0.1 0.0 2.1 1.3 0.5 0.5 1.7 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 ZFHX4 "FLJ20980, ZFH4" ENSG00000091656 "Zinc finger homeobox 4" Q86UP3 8 76681219-76867285 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.1" "Cell line enhanced" "Detected in many" "HSkMC: 12.9;TIME: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023837 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA023837: AB_1859013" "unprognostic (2.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.63e-3)" "unprognostic (6.14e-8)" "unprognostic (3.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.79e-2)" "unprognostic (9.15e-4)" "unprognostic (3.18e-2)" "unprognostic (1.17e-3)" "unprognostic (6.20e-7)" "unprognostic (3.50e-3)" "unprognostic (2.51e-1)" "unprognostic (4.50e-4)" "unprognostic (5.89e-4)" 4.9 8.8 6.2 2.1 10.7 0.8 5.8 1.4 8.5 6.3 5.1 7.7 14.1 1.0 2.2 8.9 1.7 2.0 2.9 1.5 7.2 4.3 1.6 7.3 1.1 1.5 8.3 4.3 5.5 1.5 1.2 13.7 1.1 5.9 3.2 2.0 8.0 1.6 29.1 6.5 1.4 1.3 11.8 11.6 1.2 2.0 15.6 9.8 0.0 1.2 2.4 1.0 7.8 5.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 2.4 0.0 4.8 6.3 0.0 2.0 2.9 2.4 2.5 0.0 0.0 0.0 3.9 3.4 0.2 4.8 0.6 4.4 0.0 7.1 0.1 0.0 0.0 1.3 0.0 0.3 12.9 0.2 6.2 2.5 0.4 0.0 0.2 4.7 0.0 0.0 0.0 0.4 4.1 0.0 4.3 0.0 3.8 0.0 0.0 4.5 0.0 0.5 0.0 0.6 0.0 28.1 2.4 3.7 7.1 4.7 7.2 0.7 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 10.7 1.4 8.5 7.2 4.3 8.3 4.3 5.9 9.8 ZFP1 "FLJ34243, ZNF475" ENSG00000184517 "ZFP1 zinc finger protein" Q6P2D0 16 75148492-75172236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044916, HPA062910" Uncertain Approved Nucleoplasm Nucleoplasm "HPA044916: , HPA062910: " "unprognostic (1.39e-2)" "unprognostic (1.84e-1)" "unprognostic (1.36e-2)" "unprognostic (1.38e-1)" "prognostic favourable (4.24e-5)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (2.99e-1)" "unprognostic (1.50e-1)" "unprognostic (4.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.13e-2)" "unprognostic (1.24e-3)" "prognostic unfavourable (9.80e-4)" "unprognostic (5.55e-1)" "unprognostic (6.64e-2)" "unprognostic (2.08e-1)" 6.0 5.9 13.7 4.6 14.8 4.1 7.4 14.8 19.0 8.6 6.6 8.9 5.9 4.2 9.1 5.6 5.2 7.1 6.6 7.1 12.8 9.9 7.8 23.2 6.1 6.7 10.2 10.0 11.4 4.9 11.9 7.1 7.1 12.8 6.7 5.0 5.0 3.6 7.8 7.4 4.8 4.0 9.5 10.7 5.1 4.5 7.6 9.4 18.1 11.6 3.7 7.4 6.8 5.0 3.6 1.9 3.0 3.2 4.4 4.7 2.2 2.5 5.3 7.4 6.7 4.2 5.6 3.0 3.1 3.6 6.9 8.4 4.3 1.9 10.7 3.5 2.5 3.2 6.8 4.4 7.7 5.6 4.3 3.8 2.0 3.1 3.8 3.7 12.4 3.9 4.4 4.9 6.4 4.5 4.6 2.3 5.0 9.6 12.9 3.5 2.3 2.1 12.1 3.3 3.4 2.9 2.1 7.6 6.0 7.8 2.2 2.8 4.9 3.0 3.1 6.3 6.6 2.9 3.4 9.4 8.9 23.7 3.0 5.2 4.6 3.0 1.7 0.7 4.3 3.2 4.6 3.4 2.9 4.7 1.9 3.6 3.9 4.1 0.1 4.4 1.4 0.8 4.4 2.2 13.7 14.8 14.8 19.0 12.8 9.9 10.2 10.0 12.8 9.4 ZFP28 "KIAA1431, mkr5" ENSG00000196867 "ZFP28 zinc finger protein" Q8NHY6 19 56538948-56556810 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028879 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA028879: AB_10603841" "unprognostic (5.02e-3)" "unprognostic (3.67e-3)" "unprognostic (1.78e-1)" "unprognostic (1.90e-1)" "unprognostic (1.89e-1)" "unprognostic (4.24e-3)" "unprognostic (1.73e-1)" "unprognostic (7.00e-2)" "unprognostic (4.26e-3)" "unprognostic (3.16e-2)" "unprognostic (3.32e-4)" "unprognostic (1.15e-3)" "unprognostic (2.36e-5)" "unprognostic (6.77e-3)" "unprognostic (1.53e-1)" "unprognostic (1.07e-1)" "unprognostic (1.34e-1)" 3.1 3.6 4.9 1.4 4.1 0.4 3.7 6.1 7.0 3.4 2.5 1.1 5.6 4.2 2.3 3.1 3.2 3.6 5.4 5.7 3.1 0.1 3.5 1.6 5.0 10.1 2.5 6.1 4.0 2.9 4.3 1.6 2.3 4.0 1.9 2.7 1.2 4.4 5.5 2.8 2.1 5.1 4.0 1.8 2.8 2.5 3.1 1.5 3.9 0.5 2.4 3.7 0.9 0.0 1.7 8.0 2.4 2.7 2.6 4.1 5.2 5.0 4.2 6.9 0.0 1.1 0.0 2.6 6.2 0.2 3.9 1.7 6.4 0.0 6.8 5.3 0.2 0.0 7.8 0.2 6.1 7.2 2.2 6.3 0.1 0.8 1.0 0.1 5.4 0.0 2.6 0.9 3.7 1.7 4.1 10.4 0.0 5.6 3.3 0.0 7.3 0.0 0.3 1.2 3.1 5.3 1.9 3.9 4.3 0.4 6.3 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.5 3.9 0.5 0.3 2.6 1.9 2.6 1.8 1.1 3.1 2.1 1.6 0.5 2.4 0.4 1.5 3.7 0.9 ZFP3 "FLJ30726, ZNF752" ENSG00000180787 "ZFP3 zinc finger protein" Q96NJ6 17 5078248-5096374 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.4;SH-SY5Y: 7.6;SiHa: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053085, HPA057290" Approved Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA053085: , HPA057290: " "unprognostic (3.71e-2)" "prognostic favourable (5.68e-4)" "unprognostic (1.45e-1)" "unprognostic (4.88e-2)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (3.05e-1)" "prognostic favourable (1.38e-4)" "unprognostic (5.42e-2)" "unprognostic (3.33e-1)" "prognostic favourable (1.07e-4)" "unprognostic (4.89e-2)" "prognostic favourable (7.69e-7)" "unprognostic (8.30e-2)" "unprognostic (1.16e-1)" "unprognostic (6.32e-2)" "unprognostic (3.29e-3)" 4.9 6.3 11.0 10.0 10.4 1.9 8.9 19.6 14.7 6.8 8.9 11.9 9.6 13.0 6.9 6.9 6.7 11.2 6.3 12.4 9.8 7.6 10.2 3.3 7.3 9.2 7.9 8.3 9.9 11.3 16.6 10.8 5.2 11.4 7.9 10.9 7.4 10.7 15.4 33.3 6.7 11.3 6.3 8.5 10.2 8.3 9.9 11.8 10.6 11.1 3.5 11.2 6.6 5.7 5.4 1.4 1.4 2.2 1.9 4.3 1.6 0.0 1.3 0.3 0.0 1.2 0.6 0.0 2.8 0.0 2.1 2.5 5.5 2.5 0.0 4.0 2.7 5.6 0.0 0.0 1.2 0.0 0.1 0.2 2.0 0.0 3.9 0.0 7.4 1.9 0.0 1.5 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.2 0.3 0.5 0.0 0.8 1.8 3.4 3.4 3.5 7.6 6.9 5.7 3.6 3.4 5.4 0.0 0.0 1.1 2.0 4.0 0.1 0.2 0.0 0.0 0.0 3.2 0.0 2.0 1.4 2.8 2.2 1.7 2.1 1.6 2.5 1.4 5.4 4.3 3.0 0.2 1.9 1.9 0.9 1.6 1.6 11.0 10.4 19.6 14.7 9.8 7.6 7.9 8.3 11.4 11.8 ZFP37 ZNF906 ENSG00000136866 "ZFP37 zinc finger protein" Q9Y6Q3 9 113038380-113056759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049112 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049112: " "unprognostic (3.18e-1)" "unprognostic (9.57e-2)" "unprognostic (5.62e-2)" "unprognostic (3.54e-3)" "prognostic favourable (1.96e-4)" "unprognostic (7.84e-2)" "unprognostic (8.09e-2)" "unprognostic (2.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.53e-2)" "unprognostic (2.51e-2)" "unprognostic (1.38e-3)" "unprognostic (4.22e-2)" "unprognostic (9.46e-2)" "unprognostic (3.67e-1)" "unprognostic (4.86e-1)" "unprognostic (2.07e-1)" 3.8 4.4 4.9 3.1 19.2 0.9 6.7 10.9 9.9 6.5 3.6 5.3 4.0 2.1 10.5 5.8 3.2 6.3 3.5 3.7 10.5 5.6 5.8 1.7 3.2 2.8 6.7 10.6 17.0 3.2 4.3 8.5 3.2 10.7 6.3 2.9 2.8 3.2 4.8 3.2 3.2 2.5 6.2 9.1 4.7 3.0 5.1 5.9 0.4 6.9 2.4 3.2 4.3 5.6 2.3 0.9 0.2 0.4 1.3 5.6 0.7 0.6 1.8 7.6 6.4 4.3 8.2 3.9 2.4 3.5 2.7 2.2 0.0 1.8 4.3 1.9 2.5 1.6 0.0 0.9 4.2 5.3 0.9 0.2 3.8 1.9 2.3 0.0 0.9 2.3 0.8 3.1 6.2 1.5 0.4 3.8 5.5 0.0 0.0 0.0 7.8 0.0 0.0 10.6 0.6 2.0 0.0 6.5 6.1 7.4 1.6 1.4 6.3 0.0 0.6 6.2 2.7 7.3 3.6 1.5 2.8 0.0 4.8 0.1 3.8 0.2 0.1 0.1 2.5 0.4 1.9 2.3 2.2 2.2 0.9 1.1 1.8 2.5 0.2 1.3 0.0 0.1 5.6 0.7 4.9 19.2 10.9 9.9 10.5 5.6 6.7 10.6 10.7 5.9 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" 8 143246821-143262705 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: " "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavourable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 7.8 6.6 10.3 6.5 9.0 4.1 5.6 12.6 13.7 8.0 8.8 10.7 6.5 9.4 12.5 6.8 5.7 9.2 5.6 6.3 10.8 14.3 6.5 5.8 6.3 6.7 10.7 7.4 13.1 9.1 11.4 10.2 3.5 9.6 7.7 4.5 8.9 12.6 9.1 8.1 12.1 9.1 7.3 7.4 8.5 7.2 10.6 8.6 4.6 8.0 4.6 6.7 6.7 10.0 0.9 3.7 0.1 0.9 0.7 2.2 0.8 7.1 11.3 4.9 6.6 5.7 4.5 5.8 4.3 2.3 8.5 5.8 5.6 5.9 3.9 6.4 5.6 5.8 5.4 5.6 4.2 6.2 6.5 5.0 5.5 4.3 8.0 1.9 3.1 4.7 8.0 5.4 8.1 3.9 10.5 3.9 4.0 12.7 5.2 2.1 7.3 11.3 2.8 4.0 1.4 3.7 6.4 6.3 8.7 12.1 3.3 6.4 8.5 3.9 4.1 6.4 11.5 5.0 6.8 6.3 4.7 1.9 5.7 4.8 8.4 0.0 0.6 0.1 1.3 0.9 2.2 0.4 1.1 0.9 0.5 0.9 1.9 1.2 0.0 0.7 0.1 3.7 0.9 0.8 10.3 9.0 12.6 13.7 10.8 14.3 10.7 7.4 9.6 8.6 ZFP62 "FLJ34231, ZET, ZNF755" ENSG00000196670 "ZFP62 zinc finger protein" Q8NB50 5 180847611-180861285 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048629 Approved Approved "Nucleoplasm,Actin filaments" "Nucleoplasm, Actin filaments" "HPA048629: " "unprognostic (2.77e-2)" "unprognostic (1.77e-1)" "unprognostic (9.18e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (1.89e-2)" "unprognostic (9.49e-2)" "unprognostic (7.11e-3)" "unprognostic (7.29e-2)" "unprognostic (3.44e-2)" "unprognostic (1.05e-2)" "unprognostic (2.14e-1)" "unprognostic (4.34e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-2)" "unprognostic (2.29e-3)" 10.9 8.6 17.2 16.0 20.2 4.0 14.4 19.9 16.5 14.3 14.5 11.9 15.1 13.7 15.6 16.4 15.1 16.8 13.2 9.7 17.6 9.5 11.9 8.3 10.4 17.7 18.3 12.8 22.5 15.2 18.9 16.3 10.1 16.4 15.1 18.4 10.1 15.6 18.5 14.5 16.0 15.5 18.8 15.7 13.4 16.3 8.8 22.1 26.9 25.4 10.5 20.0 16.0 14.8 7.0 3.8 7.7 4.9 4.8 10.3 4.2 7.7 5.8 12.6 16.2 9.2 8.2 15.5 8.0 6.0 6.6 9.3 14.1 19.5 19.2 12.9 3.6 11.6 6.0 14.2 10.0 32.7 11.0 10.8 15.6 4.7 6.3 9.8 6.5 6.4 11.4 6.8 11.7 5.9 8.9 10.6 9.0 18.3 14.1 5.4 8.8 14.2 12.6 12.9 10.7 5.5 14.1 16.5 11.5 11.7 8.8 8.6 13.5 8.8 8.4 10.2 8.9 4.9 8.0 11.2 12.8 9.6 8.4 13.2 7.9 7.7 3.2 3.9 4.0 4.3 7.8 6.9 5.5 5.8 3.4 7.0 10.3 8.6 1.5 4.8 4.9 3.8 5.6 4.2 17.2 20.2 19.9 16.5 17.6 9.5 18.3 12.8 16.4 22.1 ZFP64 "dJ548G19.1, dJ831D17.1, FLJ10734, FLJ12628, ZNF338" ENSG00000020256 "ZFP64 zinc finger protein" "Q9NPA5, Q9NTW7" 20 52051663-52204308 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035112, HPA058387" Uncertain Approved Nucleoplasm Nucleoplasm "HPA035112: AB_10672859, HPA058387: " "unprognostic (3.86e-2)" "unprognostic (8.84e-2)" "unprognostic (2.34e-1)" "unprognostic (4.61e-3)" "unprognostic (9.22e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (9.86e-7)" "unprognostic (4.68e-2)" "unprognostic (5.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (1.35e-3)" "unprognostic (2.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" 9.4 12.1 11.5 10.6 14.5 9.7 10.1 11.6 18.7 12.7 13.2 14.5 12.6 13.3 14.4 9.7 16.3 13.9 15.0 9.4 10.5 10.3 10.9 11.8 9.1 12.1 10.2 11.9 16.7 10.9 14.8 11.5 8.8 11.6 16.5 11.5 15.1 13.7 12.3 9.4 22.3 13.0 11.0 11.1 11.6 11.9 12.8 9.2 22.9 14.3 12.5 16.7 13.6 13.6 8.6 6.7 12.4 6.6 7.8 7.8 4.3 19.3 10.9 8.5 20.2 4.3 7.8 12.2 6.6 9.9 14.7 12.4 10.3 8.0 8.5 13.3 11.9 26.2 6.9 14.9 9.2 3.5 21.2 5.1 19.5 11.1 11.8 5.7 3.9 6.8 22.8 7.4 8.6 10.1 6.1 11.2 3.7 8.1 7.8 4.9 8.5 8.3 8.7 4.4 8.5 7.0 7.8 8.7 10.2 12.9 16.4 12.5 10.9 6.9 6.6 10.4 15.4 11.3 4.2 12.0 10.8 6.9 10.1 5.8 6.9 7.4 5.4 12.4 7.8 3.1 5.7 8.6 5.9 6.1 6.7 6.0 6.8 6.4 3.2 7.8 6.6 6.5 5.3 4.3 11.5 14.5 11.6 18.7 10.5 10.3 10.2 11.9 11.6 9.2 ZFP69 "FLJ16030, ZFP69A, ZKSCAN23A, ZNF642, ZSCAN54A" ENSG00000187815 "ZFP69 zinc finger protein" Q49AA0 1 40477215-40496343 "Predicted intracellular proteins, Transcription factors" "Lipid metabolism, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "THP-1: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027808, HPA054942" Uncertain Approved Nucleoplasm Nucleoplasm "HPA027808: AB_10601031, HPA054942: " "unprognostic (1.07e-2)" "unprognostic (6.00e-2)" "unprognostic (7.58e-3)" "unprognostic (4.15e-2)" "unprognostic (1.52e-1)" "prognostic favourable (9.31e-4)" "unprognostic (7.21e-3)" "unprognostic (1.72e-1)" "unprognostic (8.40e-3)" "unprognostic (6.34e-3)" "unprognostic (2.31e-1)" "unprognostic (4.46e-2)" "prognostic unfavourable (5.00e-6)" "unprognostic (1.05e-1)" "unprognostic (3.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.81e-1)" 5.1 3.4 8.3 5.8 8.5 4.1 5.1 6.8 5.8 4.7 5.3 7.5 5.1 4.4 5.6 5.6 4.4 5.2 8.9 7.3 6.7 5.6 3.7 4.7 5.6 6.3 9.0 2.4 6.8 6.7 8.1 3.1 5.3 8.6 5.6 4.9 3.9 4.9 6.0 1.2 6.7 4.9 9.7 8.7 6.9 4.8 8.4 8.4 9.4 5.2 2.9 6.8 6.1 14.3 1.1 0.6 0.1 0.5 4.8 2.0 0.6 3.2 0.0 2.0 2.6 2.5 2.5 3.3 1.8 2.1 2.8 3.2 1.7 2.6 5.8 2.3 2.8 2.6 3.7 1.5 3.2 5.3 2.5 4.4 3.0 2.9 1.9 0.1 4.7 2.6 3.9 1.8 2.8 1.6 2.5 0.0 1.6 1.7 4.4 5.5 3.7 0.0 2.4 7.0 2.7 1.5 2.5 2.5 4.1 3.0 2.8 5.0 0.0 35.6 0.7 1.3 2.6 3.6 0.2 0.1 4.5 3.7 2.3 0.9 3.4 0.0 0.5 0.1 1.6 0.2 2.0 1.1 1.2 1.9 0.6 0.6 0.6 2.0 0.1 4.8 0.4 0.0 0.6 0.6 8.3 8.5 6.8 5.8 6.7 5.6 9.0 2.4 8.6 8.4 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 1.6 1.7 7.8 4.6 11.1 1.1 2.8 8.2 12.8 3.1 2.5 1.8 0.1 2.6 4.3 2.4 2.2 1.6 3.3 1.8 6.3 4.9 1.6 2.4 1.6 3.7 3.6 5.8 2.0 3.5 3.2 3.6 1.1 4.7 2.0 3.1 1.2 1.9 1.8 1.2 1.4 1.8 3.0 3.2 2.3 2.5 4.0 3.8 5.0 2.7 0.9 5.5 3.8 1.7 2.1 1.2 0.9 2.1 1.3 4.1 1.0 3.3 1.3 5.6 13.9 2.1 5.7 1.6 3.2 3.1 1.4 2.8 1.6 2.2 6.3 3.1 2.8 1.2 2.9 2.8 3.2 5.5 1.2 2.6 3.2 4.7 1.5 0.4 4.2 1.3 4.7 5.1 6.8 2.0 6.8 6.3 4.4 2.3 8.4 0.6 7.7 1.4 4.8 5.6 3.0 2.9 3.2 7.7 8.0 5.1 4.4 2.1 2.3 7.3 4.3 4.7 10.0 4.3 4.6 9.8 9.3 13.7 6.3 0.9 4.9 0.0 0.3 0.9 2.6 2.1 3.5 2.0 1.8 1.4 1.2 2.1 3.4 3.0 0.2 1.3 0.7 0.5 4.1 1.0 7.8 11.1 8.2 12.8 6.3 4.9 3.6 5.8 4.7 3.8 ZFP82 "KIAA1948, MGC45380, ZNF545" ENSG00000181007 "ZFP82 zinc finger protein" Q8N141 19 36383120-36418656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051669, HPA060470" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Cytosol" "Nuclear membrane" "HPA051669: , HPA060470: " "unprognostic (1.52e-1)" "unprognostic (2.38e-2)" "unprognostic (6.03e-2)" "unprognostic (4.14e-4)" "unprognostic (9.63e-2)" "unprognostic (9.17e-4)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (2.61e-3)" "unprognostic (4.91e-1)" "unprognostic (3.69e-2)" "unprognostic (6.00e-2)" "unprognostic (3.21e-2)" "unprognostic (3.81e-2)" "unprognostic (3.05e-1)" 4.3 5.0 9.8 8.8 9.3 1.5 8.7 15.0 13.9 9.9 5.2 5.3 2.4 2.4 9.1 12.4 2.7 9.0 5.4 7.3 8.5 9.7 5.5 1.8 4.9 7.8 8.3 6.3 13.8 2.7 8.0 10.1 7.0 8.3 7.4 3.3 3.6 4.1 6.8 2.1 2.2 3.6 7.8 6.8 6.3 3.1 6.4 8.7 9.3 10.8 1.6 8.6 5.8 6.9 9.6 3.1 1.1 1.1 4.7 9.2 2.9 0.0 2.6 8.4 8.8 2.9 3.8 2.8 3.4 4.3 7.0 9.1 1.6 1.2 7.4 5.8 4.1 0.2 0.0 0.9 8.9 6.9 4.2 6.6 1.9 2.1 6.7 0.0 5.8 5.8 1.3 5.0 1.5 3.2 0.0 0.0 6.8 0.0 11.5 0.0 7.9 1.5 9.7 5.8 2.2 3.5 4.2 0.1 8.7 0.0 0.5 5.5 1.6 5.1 0.4 2.5 4.4 4.5 5.8 5.1 3.5 11.4 0.0 0.0 5.4 0.0 0.9 1.1 6.0 1.1 6.0 9.6 5.9 6.8 2.7 9.0 9.2 8.1 0.1 4.7 1.1 3.1 3.6 2.9 9.8 9.3 15.0 13.9 8.5 9.7 8.3 6.3 8.3 8.7 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell line enhanced" "Detected in many" "HEL: 14.3;K-562: 21.2" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA046603: " "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favourable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.8 2.1 4.5 0.4 0.1 9.2 3.0 0.4 1.0 0.3 9.1 1.1 4.4 2.3 0.4 7.1 0.1 2.5 0.2 3.4 1.9 14.3 5.6 7.9 1.7 0.8 4.8 1.0 1.6 1.0 0.3 1.0 21.2 0.3 0.8 5.4 5.0 5.2 1.4 2.5 1.4 1.0 2.1 1.0 3.6 6.0 9.9 3.7 0.2 2.9 2.3 2.3 3.6 3.8 2.5 1.7 0.6 1.0 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 ZFR "SPG71, ZFR1" ENSG00000056097 "Zinc finger RNA binding protein" Q96KR1 5 32354350-32444761 "Predicted intracellular proteins" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016666 Supported Approved Nucleoplasm Nucleoplasm "HPA016666: AB_1859060" "unprognostic (7.45e-3)" "unprognostic (8.46e-2)" "unprognostic (4.07e-3)" "unprognostic (4.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.76e-2)" "prognostic unfavourable (4.75e-4)" "unprognostic (1.38e-1)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (1.58e-1)" "unprognostic (3.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.47e-2)" "unprognostic (5.46e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" 22.5 24.2 36.0 16.9 42.8 21.7 22.1 37.3 40.7 23.6 19.4 29.9 11.7 15.0 23.9 18.7 21.8 23.9 19.6 27.6 36.2 27.6 25.1 20.2 15.8 19.8 32.1 28.3 33.5 21.2 33.0 26.5 28.7 29.4 22.6 19.0 16.1 21.1 21.9 37.4 15.1 20.3 22.9 36.3 17.4 16.9 23.6 38.6 20.0 28.6 11.3 20.7 24.1 23.5 14.6 14.2 23.4 20.0 18.7 15.9 10.5 16.1 24.0 28.2 17.5 31.2 23.0 24.7 25.0 21.2 26.5 19.1 23.9 14.4 23.7 16.3 24.3 12.6 36.6 17.7 37.4 22.3 20.5 29.0 25.9 23.5 27.4 29.7 24.0 21.7 22.2 28.0 51.5 19.9 29.0 20.1 27.1 12.2 25.9 12.5 20.7 18.1 21.2 38.0 13.0 19.8 26.7 15.8 16.7 37.1 21.7 22.3 13.4 36.8 22.5 26.4 24.8 19.4 20.8 10.0 17.5 26.8 19.5 24.0 31.9 23.4 12.7 15.7 13.8 20.0 15.9 14.6 13.3 14.0 14.2 11.6 12.9 12.9 8.2 18.7 19.2 7.7 12.2 10.5 36.0 42.8 37.3 35.7 36.2 27.6 32.1 28.3 29.4 38.6 ZFX ZNF926 ENSG00000005889 "Zinc finger protein, X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: " "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 20.3 8.8 10.8 8.2 11.7 25.9 23.5 22.1 12.6 18.5 12.2 7.2 8.4 6.6 18.5 11.0 10.6 15.8 7.2 17.8 10.1 6.6 16.6 11.3 9.7 12.7 13.1 9.6 20.2 11.8 20.2 17.9 23.2 10.4 16.4 6.5 7.0 9.4 13.1 24.1 8.9 11.8 15.7 11.3 12.4 10.1 5.4 14.7 16.4 13.9 8.9 10.6 12.5 25.3 11.9 9.6 16.6 10.3 9.9 10.7 7.0 8.0 10.9 11.3 13.1 15.3 10.7 5.9 7.6 7.2 8.8 9.2 6.7 6.0 9.3 10.3 11.7 10.3 12.9 14.1 11.8 9.0 16.0 8.2 33.8 3.9 6.4 10.8 14.5 9.3 4.5 17.1 22.3 11.0 9.7 10.1 6.3 4.4 7.7 8.0 6.5 8.4 10.6 9.0 8.0 5.2 13.0 6.0 9.0 23.0 9.2 7.4 5.8 5.7 10.8 7.8 4.6 10.8 5.3 5.7 7.5 9.3 6.1 4.6 9.0 11.2 8.7 13.5 10.6 10.3 10.7 8.4 9.9 10.6 9.6 11.9 9.9 9.4 16.6 9.9 9.4 6.9 5.7 7.0 10.8 11.7 22.1 12.6 10.1 6.6 13.1 9.6 10.4 14.7 ZFY ZNF911 ENSG00000067646 "Zinc finger protein, Y-linked" P08048 Y 2935281-2982506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA001748, HPA071863" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA071863: " "unprognostic (1.07e-1)" "unprognostic (7.43e-2)" "prognostic favourable (3.58e-5)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-1)" "unprognostic (8.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.91e-1)" "unprognostic (2.54e-2)" 4.1 2.9 2.8 6.8 4.3 9.6 3.4 6.8 5.3 0.0 5.4 2.8 14.1 3.2 0.0 9.1 7.2 0.0 7.0 6.1 3.0 3.0 2.7 13.1 10.1 10.9 2.6 0.0 0.0 10.0 0.1 3.3 5.8 4.5 10.6 8.0 3.5 15.8 10.2 7.0 2.9 6.3 5.8 3.3 9.1 4.7 10.5 0.0 12.6 7.2 5.7 5.8 6.1 0.0 5.8 5.9 4.7 4.7 6.2 7.0 2.7 0.0 3.5 0.0 0.0 0.0 0.0 6.4 9.0 8.7 7.7 7.5 0.0 0.0 6.9 0.0 9.3 0.0 0.0 0.0 10.3 10.4 0.0 12.7 0.1 4.6 6.8 0.0 0.0 7.5 6.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 5.2 0.0 2.8 0.0 0.0 5.6 2.6 5.2 11.7 6.1 0.0 0.0 0.0 9.0 0.0 4.1 7.8 7.5 0.0 0.0 4.5 4.9 0.0 11.6 1.0 0.0 0.0 0.0 4.7 4.7 5.0 3.9 7.0 4.3 5.5 2.8 5.9 5.8 6.3 3.0 3.2 6.2 3.3 4.3 3.1 2.7 2.8 4.3 6.8 5.3 3.0 3.0 2.6 0.0 4.5 0.0 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell line enhanced" "Detected in many" "HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: " "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favourable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.1 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.6 0.0 1.9 3.2 3.8 1.2 0.3 0.6 9.5 1.3 0.2 4.2 0.3 4.3 0.7 11.0 3.0 0.6 1.1 0.1 3.0 1.8 8.1 0.9 2.2 0.1 11.9 0.1 8.1 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 2.4 0.3 0.5 1.7 0.0 5.4 0.1 12.6 9.1 0.1 5.3 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell line enhanced" "Detected in some" "MCF7: 18.8;SK-BR-3: 17.4;T-47d: 15.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favourable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.8 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.0 1.5 0.0 3.1 0.0 0.0 0.0 6.3 1.8 1.6 1.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 2.6 0.2 18.8 0.0 0.3 0.1 3.6 0.0 0.0 5.9 0.1 4.4 0.0 0.0 0.0 17.4 0.0 15.9 0.0 2.2 0.0 0.4 1.3 0.0 0.0 0.3 0.2 0.2 4.5 0.2 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZGLP1 "GATAD3, GLP-1, GLP1" ENSG00000220201 "Zinc finger, GATA-like protein 1" P0C6A0 19 10304803-10309880 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 26.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049855 Uncertain Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA049855: " "unprognostic (1.73e-2)" "unprognostic (3.43e-3)" "unprognostic (1.42e-3)" "unprognostic (1.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-4)" "unprognostic (1.18e-1)" "unprognostic (1.34e-2)" "unprognostic (3.04e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-4)" "unprognostic (2.82e-2)" "unprognostic (6.57e-7)" "unprognostic (6.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.57e-1)" "unprognostic (2.57e-4)" 0.5 0.9 2.5 2.0 6.5 0.9 1.0 8.0 5.4 1.4 0.9 2.2 2.1 0.7 0.6 2.6 1.8 0.6 2.9 3.4 2.4 3.0 1.0 3.6 1.0 3.9 3.1 1.9 4.8 2.0 3.4 0.3 5.1 2.5 1.4 4.8 1.6 0.2 0.9 2.6 1.4 3.7 5.3 1.4 1.2 0.9 0.3 0.3 0.1 0.3 0.0 1.0 0.1 0.4 1.0 1.4 0.5 0.9 0.4 3.5 0.8 0.2 0.7 1.5 1.0 0.3 1.5 0.7 0.2 1.4 1.0 0.3 0.2 1.3 4.5 1.4 1.3 0.5 0.6 0.0 0.4 0.8 2.1 0.7 0.4 0.2 1.4 1.0 0.9 1.5 0.1 26.0 2.2 1.6 1.4 0.6 0.6 0.6 0.6 1.2 1.4 0.3 0.3 1.2 2.0 0.4 0.5 2.0 2.4 2.0 0.2 5.1 6.0 0.6 0.4 6.6 0.9 0.0 0.3 0.0 1.0 0.1 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Cell line enhanced" "Detected in some" "AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030194: " "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.2 0.0 5.2 2.1 3.9 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.0 0.4 5.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 2.5 0.0 0.0 0.0 1.3 0.0 4.3 1.9 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.1 6.7 17.8 19.5 18.4 22.5 6.7 10.2 12.5 6.1 6.2 4.0 8.7 10.3 13.1 11.4 7.6 10.2 8.8 11.8 9.9 6.2 8.3 8.2 10.4 10.4 15.9 10.0 15.0 14.2 8.3 27.8 13.5 19.2 9.0 12.1 12.1 15.1 9.5 7.2 8.4 8.9 9.1 9.2 10.3 14.4 20.8 24.8 15.9 20.9 18.0 10.6 10.6 20.2 13.5 13.2 15.6 10.3 10.5 18.2 10.7 9.2 11.4 17.6 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 ZKSCAN2 "FLJ23199, ZNF694, ZSCAN34" ENSG00000155592 "Zinc finger with KRAB and SCAN domains 2" Q63HK3 16 25236001-25257931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049141 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus" "HPA049141: " "unprognostic (2.71e-1)" "unprognostic (4.99e-2)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.03e-1)" "unprognostic (1.65e-1)" "unprognostic (1.26e-1)" "unprognostic (5.14e-2)" "unprognostic (1.01e-1)" "unprognostic (9.14e-2)" "unprognostic (8.28e-4)" "unprognostic (2.63e-1)" "prognostic favourable (1.70e-6)" "unprognostic (2.33e-1)" "unprognostic (2.29e-1)" "unprognostic (1.97e-1)" "unprognostic (4.03e-2)" 3.4 4.0 5.9 2.6 5.8 4.5 4.8 6.2 7.6 6.1 3.7 7.3 3.5 2.0 6.4 4.4 2.2 4.9 2.9 5.0 5.3 6.5 4.4 4.5 3.4 5.6 5.2 5.1 10.5 3.3 11.8 8.0 4.7 5.4 4.7 3.0 5.5 4.0 5.0 7.5 2.0 3.0 5.2 5.1 3.3 3.1 12.7 4.6 6.7 5.8 4.4 3.2 4.1 3.0 0.7 1.6 0.9 0.6 2.0 1.4 0.5 2.3 2.3 10.5 6.5 4.2 4.0 4.2 2.5 3.8 3.7 3.7 5.9 1.7 7.6 2.8 2.9 1.7 6.9 3.4 4.6 4.1 4.8 4.5 4.1 9.1 5.6 3.5 2.3 5.4 4.1 3.6 6.1 2.9 8.0 3.7 3.5 2.4 8.8 3.8 5.7 2.2 10.5 7.7 1.6 3.1 3.3 8.3 8.3 3.1 2.8 2.8 3.4 5.9 2.9 6.2 4.1 2.4 3.9 5.1 4.2 9.1 2.1 2.9 3.6 0.0 0.6 0.9 0.7 0.4 1.0 0.5 1.1 0.8 0.8 0.7 1.1 1.4 0.0 2.0 0.5 1.6 0.2 0.5 5.9 5.8 6.2 7.6 5.3 6.5 5.2 5.1 5.4 4.6 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141910-28159472 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavourable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 16.5 12.1 13.4 10.3 15.6 17.7 16.1 27.7 16.5 17.7 16.3 20.8 12.5 9.2 21.8 19.9 10.0 17.2 11.0 10.7 13.5 9.3 11.2 10.9 14.1 13.9 18.4 13.3 25.0 15.4 21.9 22.6 12.8 14.0 15.1 11.9 17.2 13.9 17.2 12.0 11.5 15.9 18.3 18.2 14.4 14.1 12.8 18.2 18.1 17.1 8.8 14.5 16.7 12.4 3.8 1.9 4.1 4.2 3.0 3.1 1.3 5.9 3.7 18.2 17.9 11.7 10.9 5.8 6.7 12.2 8.6 10.9 4.1 3.5 13.0 10.9 6.4 5.1 11.5 4.4 12.8 7.0 9.8 11.8 7.2 9.5 10.7 14.4 8.8 11.5 7.7 9.0 13.7 8.8 17.9 4.9 9.1 3.0 10.0 12.8 6.8 4.3 10.8 11.4 10.2 6.4 7.3 13.7 17.3 7.9 3.7 8.6 4.2 8.1 7.4 13.1 7.5 4.3 8.9 12.0 8.5 10.7 3.7 10.2 6.9 4.1 1.3 1.3 2.7 3.3 3.1 1.5 1.7 1.2 1.0 3.8 2.8 2.3 0.5 3.0 4.2 1.9 1.6 1.3 13.4 15.6 27.7 16.5 13.5 9.3 18.4 13.3 14.0 18.2 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932031 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 38.7" "Cell line enhanced" "Detected in some" "Karpas-707: 12.4;U-266/70: 6.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favourable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.1 13.0 11.4 9.9 12.4 10.0 9.9 7.1 12.8 5.0 4.9 16.5 7.0 4.0 7.4 38.7 3.0 7.3 7.2 7.6 11.1 9.6 9.6 6.5 10.8 10.9 10.2 11.4 11.9 7.3 14.5 31.4 2.3 9.2 9.3 3.4 13.6 7.9 14.2 5.1 4.3 5.4 8.3 12.0 10.7 4.1 5.9 11.3 7.0 18.8 3.2 7.5 3.3 3.7 3.7 3.2 2.6 1.1 0.6 1.6 0.6 0.4 0.0 1.4 1.5 0.0 0.0 0.2 0.6 0.1 0.0 0.7 0.0 1.8 2.7 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.3 1.1 0.0 12.4 0.9 0.0 0.1 0.2 1.9 0.2 2.1 0.0 0.1 3.3 0.0 0.6 1.7 1.0 0.0 0.1 2.1 3.0 3.0 0.9 0.0 0.0 0.1 6.2 0.4 0.0 0.6 2.9 0.9 2.6 1.1 1.7 0.9 0.4 1.6 2.0 1.3 1.4 0.2 3.7 1.6 1.4 0.8 0.6 0.7 3.2 0.6 0.6 11.4 12.4 7.1 12.8 11.1 9.6 10.2 11.4 9.2 11.3 ZMAT2 "FLJ31121, hSNU23, Snu23" ENSG00000146007 "Zinc finger matrin-type 2" Q96NC0 5 140698680-140706676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036518 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA036518: AB_10671960" "unprognostic (4.00e-1)" "unprognostic (2.43e-3)" "prognostic favourable (7.96e-4)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "unprognostic (1.60e-3)" "unprognostic (1.25e-3)" "unprognostic (2.16e-1)" "unprognostic (2.35e-1)" "unprognostic (3.38e-3)" "unprognostic (6.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.60e-3)" "unprognostic (2.54e-1)" "unprognostic (2.72e-2)" "unprognostic (2.91e-3)" "unprognostic (2.84e-2)" 25.3 25.1 36.7 19.9 50.4 32.1 31.9 31.2 52.4 23.6 26.7 16.0 24.9 17.7 27.7 29.1 29.7 27.1 17.6 18.1 60.2 27.6 31.2 29.4 21.3 25.3 28.4 53.8 26.5 17.6 36.5 21.9 24.1 33.6 22.7 30.0 13.9 24.6 26.5 102.9 25.1 19.9 25.2 36.1 26.2 24.7 15.2 19.8 24.4 23.7 29.8 33.9 20.9 30.7 12.3 11.8 42.5 15.1 11.2 17.1 11.5 22.2 37.5 24.4 41.5 40.0 26.9 32.8 23.3 25.5 32.4 35.4 57.4 37.3 25.1 37.8 39.8 21.4 34.5 46.5 41.3 27.4 30.7 20.3 45.4 39.8 25.4 47.3 27.0 30.9 35.9 33.3 39.1 27.3 22.6 28.0 29.8 34.2 38.2 33.2 18.1 24.1 26.8 28.8 27.3 28.4 32.6 29.0 22.2 32.8 32.9 34.2 45.1 41.7 22.6 28.5 15.4 14.7 35.5 18.3 37.1 28.4 30.4 33.1 21.6 20.9 15.1 23.6 13.4 12.3 17.1 12.3 14.8 13.7 10.9 12.0 14.0 14.7 42.5 11.2 12.0 11.8 13.9 11.5 36.7 50.4 31.2 52.4 60.2 27.6 28.4 53.8 33.6 19.8 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.5;brain: 21.6;thyroid gland: 29.1" "Group enriched" "Detected in some" 5 "AF22: 20.6;U-2197: 12.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "NK-cell: 11.5" "Lineage enriched" "Detected in single" 115 "NK-cells: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA069813: , HPA071585: " "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (3.51e-4)" "unprognostic (4.79e-3)" 0.8 2.0 4.4 0.9 15.3 0.8 0.9 0.6 20.4 3.3 1.0 0.9 0.0 0.7 1.4 1.0 0.7 0.9 1.0 1.5 6.1 4.0 1.2 0.7 0.8 0.9 3.3 7.8 1.6 0.7 0.7 5.3 1.0 21.6 1.6 1.2 1.4 0.8 1.5 0.7 0.7 0.8 0.8 1.0 1.3 1.0 2.9 3.9 0.0 29.1 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 1.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.0 0.0 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 4.4 15.3 0.6 20.4 6.1 4.0 3.3 7.8 21.6 3.9 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79069035-79316528 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045144 Approved Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA045144: AB_10962360" "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favourable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 24.7 21.1 15.9 15.8 18.9 20.0 24.1 43.7 35.7 41.5 21.3 23.8 26.0 16.5 42.4 18.0 28.1 22.2 35.5 25.1 19.0 17.1 17.4 13.9 23.5 13.7 22.2 15.7 44.3 20.2 14.6 12.7 18.7 22.1 21.9 13.0 33.3 24.6 26.9 38.0 24.5 21.2 25.6 16.4 36.2 21.4 8.4 21.5 16.0 33.3 22.4 16.5 25.6 30.1 1.0 4.6 5.7 6.1 5.4 2.3 1.8 7.1 9.0 17.1 7.3 17.9 5.1 6.0 6.9 12.5 4.9 2.8 2.6 3.3 3.7 5.6 16.1 10.2 2.8 5.1 2.6 8.0 1.5 13.1 3.4 7.8 12.6 7.2 27.8 6.7 5.7 7.0 5.0 7.8 5.0 19.6 4.1 13.6 7.2 11.3 5.0 13.8 32.2 3.2 3.7 3.6 6.1 17.9 26.2 4.5 55.0 14.2 17.6 7.1 10.9 18.6 7.6 9.3 8.8 3.6 6.3 0.0 24.4 13.0 3.5 1.8 3.7 2.7 2.3 6.1 1.6 1.0 1.6 1.2 4.6 0.4 0.6 1.2 5.7 5.4 5.1 4.5 1.6 1.8 15.9 18.9 43.7 19.1 19.0 17.1 22.2 15.7 22.1 21.5 ZMYM2 "FIM, MYM, RAMP, ZNF198" ENSG00000121741 "Zinc finger MYM-type containing 2" Q9UBW7 13 19958670-20091829 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031765 Approved Approved "Nucleoplasm,Endoplasmic reticulum" "Nucleoplasm, Endoplasmic reticulum" "HPA031765: AB_10601927" "unprognostic (2.96e-1)" "unprognostic (3.42e-3)" "unprognostic (1.85e-1)" "unprognostic (1.69e-1)" "unprognostic (7.71e-2)" "unprognostic (2.33e-1)" "unprognostic (2.66e-3)" "unprognostic (1.16e-1)" "unprognostic (6.78e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (2.80e-2)" "unprognostic (6.65e-3)" "unprognostic (2.05e-1)" "unprognostic (8.74e-2)" "unprognostic (1.06e-1)" "prognostic favourable (6.07e-4)" 15.0 17.3 15.9 18.1 23.3 22.2 16.1 23.9 26.8 18.3 16.8 14.0 13.7 13.3 20.0 14.0 18.5 16.1 15.7 17.1 14.4 12.0 17.3 13.7 15.4 14.2 12.9 20.2 21.7 16.2 17.1 32.1 14.0 23.2 19.4 13.8 13.8 18.2 17.6 19.7 18.3 14.5 15.3 16.2 16.3 16.0 44.5 16.5 38.0 24.3 10.4 19.7 19.5 17.2 5.5 6.3 7.4 5.9 5.4 7.9 3.5 6.3 5.7 22.0 9.5 9.7 10.5 10.5 6.6 10.6 8.6 10.3 8.8 13.1 15.2 6.1 9.3 10.2 16.2 7.1 11.7 6.1 4.6 26.9 8.6 4.4 9.8 22.7 8.2 10.3 13.3 6.8 7.1 14.6 10.2 10.8 11.8 9.0 21.9 6.4 20.4 3.6 24.5 24.0 7.1 6.7 9.3 25.8 25.7 12.8 9.2 12.0 12.2 16.2 8.5 4.3 6.8 5.2 3.5 8.6 6.7 15.7 3.6 5.3 10.2 0.2 5.2 4.0 5.5 5.9 6.7 5.5 7.5 5.6 6.1 4.5 7.9 6.9 7.4 5.4 4.9 6.3 5.4 3.5 15.9 23.3 23.9 26.8 14.4 12.0 12.9 20.2 23.2 16.5 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA051301: , HPA054802: " "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.7 10.4 31.9 16.1 9.3 20.3 11.8 15.2 23.0 18.6 24.3 11.2 12.8 23.8 9.4 19.0 8.3 22.1 11.2 26.9 13.4 15.3 29.0 12.1 9.5 17.0 24.8 13.2 15.3 10.1 18.0 17.1 20.6 31.6 6.5 22.5 7.7 21.0 13.8 26.6 9.9 23.6 20.5 11.5 13.3 16.9 18.4 17.9 18.3 13.4 20.8 10.9 18.9 24.8 17.3 18.0 7.6 16.3 7.2 13.3 18.3 12.5 19.0 16.5 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 ZMYM5 "MYM, ZNF198L1, ZNF237" ENSG00000132950 "Zinc finger MYM-type containing 5" Q9UJ78 13 19823482-19863636 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA015544, HPA020879" Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015544: , HPA020879: " "unprognostic (4.14e-1)" "unprognostic (3.05e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (9.35e-2)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 10.2 10.6 7.4 10.5 8.6 11.4 10.7 18.2 11.9 9.7 8.5 6.0 6.2 6.9 9.3 10.6 12.4 8.5 10.9 9.0 8.5 5.6 7.6 7.8 8.9 10.6 13.7 5.5 11.0 8.2 6.4 18.6 8.1 9.2 9.7 7.5 7.6 9.5 9.4 9.5 8.7 10.7 9.7 13.2 9.6 8.1 25.2 10.6 22.1 10.8 7.5 12.3 10.9 10.9 12.8 9.9 15.6 8.7 9.3 13.1 5.4 6.5 3.4 8.0 6.2 5.7 9.0 2.9 6.4 9.9 10.1 8.6 8.2 13.0 9.0 6.7 9.2 6.2 5.8 7.4 11.9 7.2 4.6 16.9 6.1 5.6 17.6 12.4 9.1 11.0 9.0 5.5 10.5 10.4 6.8 7.9 9.6 16.1 9.0 12.4 4.2 5.2 10.1 10.0 3.6 8.6 7.3 7.3 7.0 7.9 6.8 20.6 10.2 10.6 8.3 5.7 4.1 7.5 4.4 12.9 5.7 13.5 5.5 5.3 9.0 15.6 7.0 9.9 11.7 6.3 12.4 12.8 13.1 11.2 7.0 11.1 10.4 11.1 13.7 9.3 8.7 9.9 10.5 5.4 7.4 8.6 18.2 11.9 8.5 5.6 13.7 5.5 9.2 10.6 ZMYM6 "Buster2, MYM, ZBED7, ZNF198L4, ZNF258" ENSG00000163867 "Zinc finger MYM-type containing 6" O95789 1 34986165-35031968 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA011004, HPA071865" Approved Approved Nucleoplasm Nucleoplasm "HPA011004: AB_1859075, HPA071865: " "prognostic favourable (1.30e-5)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (3.06e-2)" "unprognostic (3.92e-2)" "unprognostic (2.11e-6)" "unprognostic (1.77e-3)" "unprognostic (4.83e-3)" "unprognostic (3.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.70e-2)" "unprognostic (9.29e-2)" "unprognostic (7.15e-2)" "unprognostic (2.28e-1)" "unprognostic (1.72e-1)" "unprognostic (4.84e-3)" 12.8 14.7 9.4 13.3 15.9 21.3 11.6 16.3 16.0 10.7 10.9 14.6 9.8 11.0 13.3 13.6 12.8 11.7 10.7 10.8 8.6 8.3 11.7 9.7 12.2 14.9 13.8 10.2 15.9 11.5 13.7 33.7 7.9 17.0 11.0 12.9 12.5 12.9 11.0 8.0 13.6 15.3 11.9 16.7 20.1 11.6 14.9 10.1 16.2 15.4 8.4 14.7 12.5 11.2 10.1 12.3 9.0 9.3 6.5 9.3 4.3 9.3 5.1 9.3 8.9 10.7 13.5 5.8 7.8 11.7 9.4 10.3 4.0 10.3 12.9 8.4 11.5 9.2 10.3 8.3 11.5 8.9 6.1 11.3 7.3 5.4 9.4 15.7 13.4 11.3 11.9 10.4 8.7 10.5 17.5 14.2 9.4 3.0 7.2 10.7 9.4 8.2 10.3 12.3 7.3 7.7 7.3 9.7 9.1 9.1 8.6 10.6 5.7 8.7 10.7 11.8 8.7 12.3 11.5 8.7 13.3 9.5 11.9 15.2 9.4 4.6 9.3 9.0 9.3 7.5 8.1 8.1 6.4 5.3 8.3 10.1 9.1 6.1 4.9 6.5 9.1 12.3 6.8 4.3 9.4 15.9 16.3 16.0 8.6 8.3 13.8 10.2 17.0 10.1 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 9.9 0.0 11.1 4.7 6.0 4.0 3.6 5.0 3.4 3.6 2.2 0.0 5.6 4.0 1.6 6.3 3.3 3.7 0.0 5.8 7.3 9.3 3.7 3.3 4.4 2.5 4.9 3.1 5.4 6.0 4.0 5.2 0.0 5.9 1.1 10.6 9.4 10.2 4.1 8.8 6.3 4.9 3.9 7.2 10.0 6.3 8.0 1.1 3.3 6.2 4.3 3.9 3.7 3.4 3.4 3.3 0.2 0.0 11.6 1.1 1.6 3.3 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA054267: " "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.1 8.2 14.4 15.9 36.4 32.1 8.8 11.5 11.0 10.1 10.8 19.3 4.1 9.5 10.3 14.1 16.2 14.9 11.8 15.5 15.4 7.2 18.2 19.2 6.9 10.5 21.8 10.9 24.1 7.9 15.3 17.1 16.2 21.6 1.3 16.4 5.6 8.3 5.3 6.1 8.4 8.0 26.2 5.2 5.3 16.0 9.2 4.9 23.3 11.0 13.0 10.1 14.2 24.4 10.9 16.8 14.4 16.8 7.9 15.2 35.6 9.7 17.4 18.8 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 ZNF114 MGC17986 ENSG00000178150 "Zinc finger protein 114" Q8NC26 19 48270102-48287608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 11.5" "Cell line enhanced" "Detected in many" "BEWO: 16.7;Hep G2: 19.6;NTERA-2: 10.2;REH: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA025019, HPA029553" Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA025019: AB_1859080, HPA029553: AB_10603005" "unprognostic (1.82e-1)" "unprognostic (1.88e-1)" "unprognostic (5.41e-2)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "prognostic unfavourable (3.29e-4)" "unprognostic (2.67e-1)" "unprognostic (3.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (4.56e-3)" "unprognostic (5.21e-2)" "unprognostic (1.13e-7)" "unprognostic (9.74e-2)" "unprognostic (2.78e-1)" "unprognostic (9.15e-2)" "unprognostic (1.63e-1)" 1.5 1.0 3.7 2.2 2.7 2.1 1.2 1.2 3.3 2.3 0.6 2.1 1.0 0.9 2.4 2.4 1.3 1.9 1.5 1.7 3.7 4.6 1.6 0.5 1.4 1.9 2.6 0.8 1.2 5.3 4.2 1.6 7.5 2.1 3.1 0.4 2.5 3.7 1.3 3.7 3.7 0.7 1.4 3.5 1.6 0.7 1.6 1.7 1.0 11.5 0.5 1.1 1.3 5.7 2.6 3.5 5.4 0.7 2.0 0.6 0.4 2.7 4.2 5.1 0.5 0.3 0.0 16.7 0.5 0.0 1.5 2.1 1.5 4.3 0.1 4.9 0.3 5.5 7.0 0.3 1.8 0.0 0.4 0.6 1.3 19.6 1.6 2.6 0.5 0.3 0.5 0.8 0.1 0.3 0.7 0.4 0.3 7.9 0.2 8.3 10.2 0.9 10.4 0.0 0.3 0.2 2.3 2.0 2.4 2.7 0.0 2.9 1.1 4.9 0.7 0.8 1.7 1.5 0.5 0.4 0.1 0.1 0.2 1.4 0.8 3.3 0.7 0.9 0.5 0.6 0.3 0.9 0.6 0.4 1.7 2.6 0.5 0.4 5.4 2.0 0.7 3.5 0.2 0.4 3.7 2.7 1.2 3.3 3.7 4.6 2.6 0.8 2.1 1.7 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome "Nucleoplasm, Centrosome" Nucleoli "HPA054961: " "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favourable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavourable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.6 4.9 5.9 12.3 2.7 3.3 9.1 2.6 2.4 4.0 5.0 8.5 3.4 8.7 7.6 2.1 7.6 12.1 7.0 5.6 4.2 19.6 27.2 12.2 7.6 3.4 13.4 13.6 4.5 6.2 3.9 10.3 2.9 9.7 14.8 2.9 6.4 9.9 30.9 14.6 8.6 6.4 8.1 6.0 3.8 32.5 10.6 5.4 5.2 5.2 3.0 4.2 4.3 4.2 12.7 7.1 4.3 6.8 15.7 8.6 10.3 3.4 7.9 4.3 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.7;salivary gland: 23.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favourable (1.03e-4)" 1.9 1.1 1.2 1.9 1.0 2.8 2.1 1.9 1.4 1.6 3.9 3.5 4.1 2.3 1.7 1.7 1.8 1.5 1.5 1.7 3.4 1.9 2.8 3.0 1.8 3.1 3.9 0.5 0.8 2.2 2.3 4.0 23.4 1.2 1.1 2.2 4.2 1.8 2.1 5.2 2.6 2.8 2.4 3.4 3.1 1.8 10.6 12.6 10.0 14.7 9.9 12.3 6.3 3.6 2.7 7.8 10.3 2.9 1.8 19.7 3.7 2.2 4.0 4.0 4.1 3.3 7.3 4.5 3.0 3.9 9.3 3.0 5.7 0.4 2.6 6.4 3.3 8.8 2.9 11.4 7.4 2.3 2.4 3.9 3.8 5.7 9.0 5.1 4.9 3.1 11.8 7.4 20.2 6.4 12.4 6.3 5.2 3.8 10.9 12.2 12.4 5.5 4.3 3.7 3.2 18.3 6.4 3.0 4.5 3.3 6.7 4.5 5.4 10.8 1.2 11.7 6.2 6.2 8.8 10.0 7.0 9.9 10.1 10.6 9.1 8.5 12.6 6.7 12.3 11.8 2.0 9.9 14.7 9.9 6.7 6.3 ZNF133 "pHZ-13, pHZ-66, ZNF150" ENSG00000125846 "Zinc finger protein 133" P52736 20 18288283-18316996 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001493 Supported Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA001493: AB_1080666" "unprognostic (9.09e-3)" "unprognostic (3.24e-1)" "unprognostic (8.27e-3)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" "unprognostic (1.54e-2)" "prognostic unfavourable (4.46e-6)" "unprognostic (6.01e-3)" "unprognostic (8.60e-2)" "unprognostic (4.17e-1)" "unprognostic (1.04e-3)" "unprognostic (7.36e-2)" "prognostic unfavourable (2.20e-5)" "unprognostic (5.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (1.52e-1)" 10.0 10.1 12.4 11.4 15.9 5.6 20.8 25.4 18.4 13.9 11.6 14.4 12.6 7.7 18.2 24.9 13.2 14.2 11.2 10.6 12.0 12.0 12.1 9.6 10.6 7.4 10.3 12.1 19.5 12.5 17.9 24.7 12.5 14.1 14.9 10.2 9.2 13.6 13.9 17.2 22.2 8.1 15.7 12.1 12.5 9.9 8.9 13.2 7.1 14.7 9.3 9.5 10.0 12.1 5.4 5.4 3.4 4.5 10.7 8.7 3.5 6.8 7.6 6.0 8.6 14.7 10.2 12.7 6.5 9.6 8.3 12.1 6.0 8.2 1.8 3.9 7.7 15.2 5.7 17.0 7.9 1.9 4.0 4.7 6.4 13.3 11.1 4.0 0.7 9.9 11.7 6.9 20.4 8.0 5.5 2.0 7.1 6.9 4.9 6.5 4.9 7.6 4.3 8.2 4.4 8.1 4.7 8.5 8.7 5.0 13.6 9.3 5.2 10.9 5.6 8.9 4.3 6.2 6.4 6.6 6.6 0.6 2.7 2.7 5.0 1.2 4.3 3.4 8.7 3.0 5.8 4.7 7.4 5.9 5.4 5.4 5.8 6.8 1.5 10.7 4.5 2.8 5.5 3.5 12.4 15.9 25.4 18.4 12.0 12.0 10.3 12.1 14.1 13.2 ZNF134 pHZ-15 ENSG00000213762 "Zinc finger protein 134" P52741 19 57614233-57624723 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009064 Supported Approved Nucleoplasm Nucleoplasm "HPA009064: AB_1080668" "unprognostic (3.60e-2)" "prognostic unfavourable (1.03e-4)" "unprognostic (1.88e-1)" "unprognostic (4.29e-2)" "unprognostic (9.62e-2)" "prognostic unfavourable (5.21e-4)" "unprognostic (6.34e-2)" "unprognostic (1.35e-1)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (3.39e-2)" "unprognostic (1.17e-2)" "prognostic favourable (2.61e-4)" "unprognostic (1.56e-2)" "unprognostic (3.40e-1)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" 10.8 12.6 12.7 9.4 17.7 18.9 13.7 26.2 14.6 11.3 12.4 10.6 10.9 6.4 13.9 11.6 11.5 12.2 9.5 11.5 11.3 9.3 10.6 8.8 10.6 12.2 10.9 13.4 14.5 8.7 24.4 18.9 14.1 13.7 13.8 8.5 12.1 12.1 16.0 13.5 15.3 10.8 14.6 10.0 13.1 10.8 14.2 9.9 17.1 15.3 8.4 14.9 15.9 9.7 10.2 5.1 8.0 4.6 12.9 9.8 5.8 1.6 4.4 10.5 5.7 4.7 6.4 5.3 5.0 7.4 6.6 3.4 1.4 1.9 3.2 3.2 5.6 1.4 4.8 8.3 11.5 0.0 22.2 10.4 4.4 4.0 6.9 6.8 7.7 8.5 8.4 5.0 11.4 4.4 1.3 3.8 9.9 2.4 13.4 2.9 14.7 9.4 7.9 15.5 5.1 5.0 14.2 8.4 9.9 7.4 3.3 4.9 4.6 5.5 5.7 10.0 4.3 2.3 5.9 10.4 13.8 4.9 5.3 1.2 6.6 1.9 4.6 8.0 7.3 3.3 9.8 10.2 7.7 7.9 5.1 9.5 9.0 9.0 3.8 12.9 3.5 3.8 4.7 5.8 12.7 17.7 26.2 14.6 11.3 9.3 10.9 13.4 13.7 9.9 ZNF14 "GIOT-4, KOX6" ENSG00000105708 "Zinc finger protein 14" P17017 19 19710471-19733097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA049863 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA049863: " "unprognostic (1.04e-1)" "unprognostic (9.86e-2)" "unprognostic (6.22e-2)" "unprognostic (1.61e-2)" "unprognostic (6.08e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favourable (7.96e-4)" "unprognostic (1.84e-3)" "unprognostic (1.04e-2)" "unprognostic (5.51e-3)" "unprognostic (1.55e-2)" "prognostic favourable (8.09e-6)" "unprognostic (1.83e-2)" "unprognostic (1.61e-1)" "unprognostic (5.17e-2)" "unprognostic (9.05e-3)" 7.4 5.3 7.9 8.7 10.5 11.9 12.8 23.3 10.3 11.3 7.0 8.1 6.6 3.9 9.4 9.6 5.7 9.3 6.0 6.6 8.1 7.6 8.4 1.7 4.9 10.5 12.2 6.0 15.7 7.5 12.7 10.7 8.8 9.4 12.3 5.1 6.5 7.1 9.9 3.4 7.2 7.2 8.9 9.0 9.4 7.0 6.2 10.7 7.1 13.8 3.1 10.9 9.8 7.7 10.3 3.0 11.4 3.6 6.5 18.4 6.3 3.5 3.5 6.0 7.8 4.0 4.4 7.2 3.7 5.0 5.4 5.9 3.3 2.7 9.4 6.1 3.8 3.5 6.2 3.6 6.8 2.3 7.2 4.4 2.7 4.5 4.9 0.1 6.8 4.4 3.9 3.8 3.3 3.4 5.1 4.5 5.3 5.8 7.9 5.1 7.8 10.3 4.2 9.8 4.5 3.9 7.1 6.0 4.3 0.1 4.2 5.7 5.9 9.1 2.1 4.8 1.3 5.5 4.7 3.5 4.2 8.3 0.3 4.9 2.8 11.4 1.8 6.1 9.6 3.1 15.1 10.3 13.1 12.0 2.6 8.2 18.4 14.5 4.1 6.5 3.6 3.0 8.4 6.3 7.9 10.5 23.3 10.3 8.1 7.6 12.2 6.0 9.4 10.7 ZNF142 "KIAA0236, pHZ-49" ENSG00000115568 "Zinc finger protein 142" P52746 2 218637916-218659655 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049594 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA049594: " "unprognostic (2.17e-1)" "unprognostic (4.43e-1)" "unprognostic (8.20e-3)" "unprognostic (9.08e-2)" "unprognostic (3.54e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (1.35e-5)" "unprognostic (2.94e-1)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" "unprognostic (9.63e-3)" "unprognostic (4.77e-2)" "unprognostic (1.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.77e-2)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" 10.4 10.4 16.7 13.6 18.2 23.6 10.9 22.8 21.0 11.8 12.5 18.2 8.4 8.2 14.4 7.7 13.6 12.6 12.3 12.5 17.0 11.7 11.2 7.7 11.3 15.0 14.3 15.0 12.9 14.7 19.8 15.5 9.0 12.5 12.7 10.0 10.2 11.7 15.5 18.7 18.7 12.2 14.4 12.6 14.4 12.7 12.3 15.7 16.3 13.2 7.9 14.3 14.9 11.7 4.4 3.5 3.1 3.1 1.7 4.5 2.0 6.0 10.4 8.3 11.4 7.8 6.6 9.1 7.1 4.1 10.0 7.2 20.2 4.7 8.7 6.6 6.1 11.3 16.6 9.8 6.5 10.6 14.2 11.1 20.5 10.7 5.0 15.6 11.8 4.5 8.9 11.9 10.6 7.9 17.8 16.6 5.5 14.0 11.9 8.9 10.7 9.6 18.1 4.5 8.3 5.9 12.2 13.9 10.5 5.3 11.8 4.0 6.5 5.5 9.0 10.5 10.9 7.4 10.4 10.3 6.1 14.7 6.0 7.3 9.8 2.3 3.1 3.1 4.5 0.7 2.3 4.4 3.2 2.4 2.7 2.2 4.0 2.4 1.9 1.7 0.5 3.5 4.0 2.0 16.7 18.2 22.8 21.0 17.0 11.7 14.3 15.0 12.5 15.7 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA074818" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" Nucleoplasm "Nuclear bodies, Vesicles" "HPA003263: AB_1080672, HPA074818: " "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavourable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 22.7 9.8 11.6 13.6 11.7 20.9 16.4 25.4 11.8 16.8 14.7 11.0 12.8 11.8 20.8 19.5 14.7 13.4 10.7 13.2 11.9 10.8 11.9 12.1 14.0 18.0 12.6 8.7 18.8 10.7 10.3 24.0 15.7 11.4 17.4 12.9 11.7 14.9 13.0 27.0 12.8 13.5 16.1 15.2 18.7 11.6 20.4 13.8 27.4 18.8 10.4 17.3 25.0 21.8 13.0 12.0 31.2 15.6 10.2 17.0 10.5 15.0 14.6 18.5 12.1 15.1 14.1 16.7 16.7 13.6 12.9 14.2 20.5 18.8 14.9 7.8 13.6 17.2 17.8 13.3 19.5 14.9 21.6 14.1 21.6 14.2 12.5 19.5 14.2 12.3 16.0 17.5 15.5 12.8 15.1 18.3 14.1 13.0 17.8 8.0 20.6 15.4 16.3 16.8 9.2 11.4 18.5 12.7 12.4 18.5 12.6 10.9 11.7 10.9 12.4 17.2 12.2 11.9 14.7 9.1 15.5 25.5 10.9 11.2 9.7 20.6 14.2 31.2 17.0 13.9 15.3 13.0 15.2 13.8 12.0 11.2 14.2 12.2 25.7 10.2 15.6 5.8 16.6 10.5 11.6 11.7 25.4 11.8 11.9 10.8 12.6 8.7 11.4 13.8 ZNF154 pHZ-92 ENSG00000179909 "Zinc finger protein 154" Q13106 19 57697367-57709194 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.0;HSkMC: 5.1;MOLT-4: 7.2;NTERA-2: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA076284 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA076284: " "unprognostic (3.32e-2)" "unprognostic (3.43e-1)" "unprognostic (1.26e-2)" "unprognostic (1.33e-1)" "unprognostic (5.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.25e-1)" "unprognostic (1.41e-2)" "unprognostic (1.27e-3)" "unprognostic (1.57e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.20e-3)" "unprognostic (9.39e-2)" "unprognostic (3.35e-1)" "unprognostic (8.38e-3)" "unprognostic (1.11e-1)" 2.8 5.9 7.9 5.7 10.2 2.5 4.3 17.9 9.3 3.1 5.7 2.6 9.9 2.2 2.8 3.6 4.4 3.1 4.1 5.6 7.8 3.1 3.8 1.8 3.6 8.8 2.2 6.4 3.4 3.4 11.9 11.5 6.0 5.1 4.5 2.8 7.3 5.0 12.6 3.1 2.0 5.4 5.6 3.6 8.4 3.2 2.3 3.9 11.4 10.5 0.6 8.3 6.6 2.1 3.1 1.5 5.1 0.3 2.7 3.2 0.8 0.2 0.4 9.0 0.3 0.0 0.0 0.6 1.3 0.0 0.0 0.1 0.2 0.4 0.5 0.2 2.2 0.3 0.0 0.0 0.3 0.3 0.7 0.3 1.3 0.2 3.2 0.5 0.9 5.1 0.0 0.6 0.0 0.1 0.4 0.7 2.0 0.2 7.2 0.4 5.0 0.2 0.3 0.9 0.2 0.1 1.2 0.5 0.3 0.4 0.3 0.1 0.4 0.6 0.2 0.2 0.5 0.2 0.4 0.9 0.3 0.5 0.1 0.3 0.2 1.8 0.3 5.1 1.1 0.1 3.2 1.3 0.6 1.5 0.3 3.1 1.0 1.4 1.9 2.7 0.2 1.5 0.1 0.8 7.9 10.2 17.9 9.3 7.8 3.1 2.2 6.4 5.1 3.9 ZNF155 pHZ-96 ENSG00000204920 "Zinc finger protein 155" Q12901 19 43967862-43998325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003220 Uncertain Approved Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA003220: AB_1080675" "unprognostic (2.71e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" "unprognostic (1.99e-1)" "unprognostic (7.98e-3)" "unprognostic (4.36e-2)" "unprognostic (2.98e-1)" "unprognostic (1.90e-1)" "unprognostic (3.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (6.57e-2)" 9.9 9.7 6.1 5.2 9.4 4.2 9.4 16.0 11.1 10.1 7.6 11.7 9.6 5.4 12.8 12.0 7.0 7.7 6.2 9.7 7.2 7.5 8.9 10.6 7.4 8.0 6.8 5.4 10.6 5.7 15.8 13.0 7.1 9.4 9.9 8.0 7.7 10.0 8.1 6.2 8.8 10.8 10.1 9.4 11.5 8.3 5.2 7.4 10.1 13.3 8.5 8.9 13.1 6.4 6.2 5.1 11.8 3.5 6.4 9.3 4.9 4.5 3.8 9.7 8.8 5.4 6.2 2.8 3.7 3.5 2.7 3.8 2.5 2.3 0.0 4.8 5.8 3.5 3.2 8.0 4.4 5.0 8.0 9.5 8.1 2.7 5.5 3.0 5.6 8.8 6.4 5.4 8.0 6.1 0.1 0.1 7.1 4.0 4.3 3.5 5.9 3.4 0.0 10.3 3.4 7.1 14.8 6.5 8.7 9.2 0.5 3.6 6.2 8.4 4.5 5.9 8.7 3.8 5.4 10.8 7.7 0.0 5.0 0.7 5.4 10.3 3.4 11.8 8.5 3.5 8.4 5.3 6.1 9.3 5.1 6.2 7.4 6.8 3.0 6.4 2.7 3.0 5.2 4.9 6.1 9.4 16.0 11.1 7.2 7.5 6.8 5.4 9.4 7.4 ZNF18 "HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38" ENSG00000154957 "Zinc finger protein 18" P17022 17 11977439-11997510 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006144 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA006144: AB_1080683" "unprognostic (2.99e-3)" "prognostic favourable (6.32e-4)" "unprognostic (2.32e-1)" "unprognostic (2.50e-2)" "unprognostic (4.91e-2)" "unprognostic (2.72e-3)" "unprognostic (2.28e-2)" "unprognostic (5.93e-3)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "prognostic favourable (5.12e-6)" "unprognostic (2.28e-1)" "prognostic unfavourable (3.06e-6)" "unprognostic (1.52e-2)" "unprognostic (9.31e-2)" "unprognostic (3.34e-2)" "unprognostic (3.53e-3)" 8.3 6.8 8.2 7.0 13.9 15.7 9.6 9.4 15.5 8.5 7.2 13.2 3.5 6.4 14.1 9.5 8.8 7.5 7.2 7.3 9.0 8.7 6.5 13.2 6.2 10.5 9.9 9.8 10.4 7.8 8.4 11.8 5.1 14.5 9.8 9.2 12.5 9.0 7.1 8.2 12.8 8.2 7.8 10.8 12.3 6.2 15.5 9.2 15.6 8.4 14.3 10.2 7.7 7.6 9.1 8.8 19.6 7.6 7.0 11.2 5.6 3.1 6.6 7.0 10.5 13.3 11.8 3.7 4.6 8.1 6.0 6.5 3.0 5.4 10.8 6.9 5.0 6.6 5.8 7.2 6.6 8.1 4.9 6.4 6.7 4.2 9.4 3.7 8.6 9.7 11.8 4.6 8.4 9.1 3.7 5.1 8.2 3.3 11.8 7.2 5.2 3.0 9.9 7.1 4.8 8.7 3.9 2.7 5.9 7.8 3.9 6.1 5.5 3.4 7.1 7.2 3.6 3.2 3.5 5.7 4.1 5.3 8.3 8.3 8.4 10.6 5.9 6.6 11.0 5.8 10.2 9.1 10.2 10.3 5.8 8.2 11.0 11.2 19.6 7.0 7.6 8.8 10.6 5.6 8.2 13.9 9.4 15.5 9.0 8.7 9.9 9.8 14.5 9.2 ZNF180 HHZ168 ENSG00000167384 "Zinc finger protein 180" Q9UJW8 19 44474428-44500524 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028979, HPA028980" Uncertain Approved Nucleoplasm Nucleoplasm "HPA028979: AB_10600328, HPA028980: AB_10611524" "unprognostic (2.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.34e-3)" "unprognostic (1.37e-2)" "unprognostic (1.82e-1)" "unprognostic (7.13e-3)" "unprognostic (1.73e-1)" "unprognostic (2.16e-2)" "unprognostic (4.09e-3)" "unprognostic (1.33e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-2)" "unprognostic (6.49e-2)" "unprognostic (2.21e-1)" "unprognostic (2.02e-2)" "unprognostic (3.38e-3)" 8.2 8.6 7.3 10.0 9.1 6.7 10.5 13.4 8.7 10.3 7.7 7.1 10.4 8.8 11.1 6.3 7.5 9.7 8.0 5.9 6.8 5.6 9.4 9.5 7.0 10.7 6.9 5.1 11.9 8.0 16.4 13.7 7.5 8.7 12.3 8.7 6.7 7.4 11.6 6.0 8.8 10.7 7.7 6.6 12.8 7.7 8.1 8.3 17.7 11.2 7.2 8.6 8.2 8.7 6.0 3.8 6.5 3.4 3.6 9.6 3.0 8.1 2.3 10.1 7.0 2.1 4.1 6.8 4.2 4.3 6.7 8.1 4.4 1.6 1.0 5.2 5.7 2.1 5.8 9.9 8.4 8.4 4.3 10.0 2.7 2.9 2.2 12.4 6.0 4.4 3.9 4.6 5.6 4.9 4.9 6.9 5.3 1.6 6.3 4.1 6.1 4.6 4.4 5.2 5.4 6.7 14.7 8.5 6.7 7.9 7.2 4.4 4.3 10.3 3.9 12.2 5.3 1.4 6.7 1.9 5.6 3.8 4.0 5.4 6.0 5.8 3.4 6.5 3.5 2.4 4.6 5.4 4.5 5.5 3.8 6.0 5.8 5.4 2.9 3.6 2.7 1.8 9.6 3.0 7.3 9.1 13.4 8.7 6.8 5.6 6.9 5.1 8.7 8.3 ZNF181 "HHZ181, MGC44316" ENSG00000197841 "Zinc finger protein 181" Q2M3W8 19 34734155-34745378 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA043701, HPA062305" Uncertain Approved Nucleoplasm Nucleoplasm "HPA043701: AB_10960859, HPA062305: " "unprognostic (2.00e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-4)" "unprognostic (1.06e-1)" "unprognostic (4.83e-3)" "unprognostic (5.60e-2)" "unprognostic (2.28e-2)" "prognostic unfavourable (2.60e-4)" "unprognostic (1.01e-1)" "prognostic favourable (1.05e-4)" "unprognostic (1.06e-1)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (9.34e-2)" "prognostic favourable (5.45e-4)" 8.5 12.1 13.4 7.2 14.2 3.9 13.0 20.8 15.1 11.1 12.0 9.4 12.7 11.7 11.6 8.1 8.3 11.4 8.9 17.0 12.4 10.1 11.2 17.2 9.7 8.3 17.4 11.2 22.8 15.7 16.3 19.3 6.7 13.7 12.2 8.9 6.9 9.3 13.9 25.5 5.7 13.6 10.6 14.6 11.2 9.8 8.3 15.8 11.0 13.1 10.1 10.7 11.8 9.3 12.0 5.8 5.4 12.1 8.4 16.1 5.6 3.6 6.2 7.4 9.6 12.0 9.4 2.2 4.4 8.0 5.0 5.8 4.2 3.9 5.8 12.8 7.0 3.5 5.0 5.0 3.8 12.0 5.1 10.9 7.5 5.9 14.2 6.5 3.8 7.4 8.1 3.5 6.9 4.7 8.7 0.2 9.9 2.6 12.4 4.3 4.7 5.0 8.5 9.0 7.3 6.8 4.4 5.0 9.4 9.9 2.7 10.0 5.7 10.0 6.6 12.8 6.4 3.1 4.8 9.0 13.1 4.8 5.1 1.6 6.5 2.6 3.6 5.4 7.5 5.0 7.7 7.5 10.2 10.2 5.1 12.0 16.1 11.4 0.7 8.4 12.1 5.8 6.2 5.6 13.4 14.2 20.8 15.1 12.4 10.1 17.4 11.2 13.7 15.8 ZNF182 "HHZ150, KOX14, Zfp182, ZNF21" ENSG00000147118 "Zinc finger protein 182" P17025 X 47974851-48003978 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059574 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059574: " "unprognostic (1.86e-1)" "unprognostic (9.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (2.51e-3)" "prognostic unfavourable (3.73e-4)" "unprognostic (1.88e-3)" "unprognostic (6.88e-2)" "unprognostic (8.81e-2)" "unprognostic (3.53e-3)" "unprognostic (2.42e-2)" "prognostic unfavourable (2.42e-5)" "unprognostic (1.01e-1)" "unprognostic (9.49e-2)" "unprognostic (8.59e-2)" "prognostic favourable (1.55e-7)" 6.8 6.9 10.2 7.3 15.2 8.7 8.8 22.1 12.9 8.3 6.5 7.1 5.4 5.7 8.1 9.7 4.7 7.6 6.5 5.0 9.1 6.4 7.7 7.3 7.0 11.9 10.2 7.1 9.9 9.4 11.0 16.9 6.7 9.9 8.4 7.1 4.7 6.1 7.7 4.2 7.3 7.9 6.1 7.7 12.6 7.3 5.8 12.9 16.1 13.2 3.5 12.1 7.0 8.7 7.9 4.3 7.4 8.5 4.9 9.0 4.4 3.7 5.0 6.4 6.1 3.7 4.1 2.5 4.8 5.7 7.1 8.5 3.9 5.1 9.7 3.6 3.1 4.7 10.4 2.8 8.6 6.8 6.1 4.9 6.4 4.9 4.6 8.9 7.9 3.5 6.0 5.9 7.2 4.2 4.1 7.3 6.5 2.8 6.9 16.0 10.0 5.9 5.9 12.0 10.6 6.2 2.6 5.9 8.1 7.9 2.6 4.5 6.4 7.8 4.2 5.7 6.2 8.0 4.0 9.6 7.8 7.6 3.9 7.7 3.7 3.1 3.4 7.0 6.2 3.4 7.0 7.9 5.6 5.7 4.3 5.6 9.0 7.5 7.4 4.9 8.5 3.2 5.2 4.4 10.2 15.2 22.1 12.9 9.1 6.4 10.2 7.1 9.9 12.9 ZNF195 ENSG00000005801 "Zinc finger protein 195" O14628 11 3339261-3379222 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA030605 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030605: AB_10602686" "unprognostic (2.30e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.67e-1)" "unprognostic (5.40e-2)" "unprognostic (4.02e-2)" "prognostic unfavourable (3.53e-5)" "unprognostic (3.10e-2)" "unprognostic (1.39e-2)" "unprognostic (5.94e-2)" "unprognostic (3.14e-1)" "prognostic unfavourable (4.24e-4)" "prognostic unfavourable (7.89e-5)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.54e-2)" "prognostic favourable (4.79e-7)" 12.2 11.3 14.0 13.2 18.8 15.0 20.9 28.0 22.7 13.4 15.4 19.6 10.8 13.5 13.4 25.3 10.8 12.6 11.1 9.6 15.2 16.9 16.4 14.6 12.7 16.5 16.9 10.5 10.6 16.0 8.8 20.8 9.9 22.5 16.4 19.4 9.3 13.2 9.7 13.0 13.5 14.0 11.3 15.4 19.5 13.3 6.9 20.0 25.8 15.9 8.6 15.9 13.1 12.9 13.6 12.2 9.9 9.2 13.0 19.1 8.2 7.9 8.7 15.0 18.2 5.3 6.6 22.0 8.2 7.0 8.7 11.0 9.1 14.9 13.0 5.1 5.4 11.2 16.6 9.9 12.7 6.3 13.9 9.7 8.6 9.1 6.8 15.9 14.4 8.3 9.6 7.2 12.3 10.9 16.9 8.5 9.5 6.4 18.8 12.6 34.9 8.8 16.6 9.2 6.6 13.8 18.8 25.1 24.9 9.0 11.3 7.4 5.6 14.2 7.7 4.2 8.0 7.4 7.2 7.7 10.9 20.6 4.2 11.8 7.3 1.9 8.4 9.9 12.0 9.2 15.2 13.6 14.8 14.6 12.2 12.7 14.0 15.6 1.4 13.0 7.7 10.7 19.1 8.2 14.0 18.8 28.0 22.7 15.2 16.9 16.9 10.5 22.5 20.0 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 8.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm Nucleoplasm "HPA054567: " "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavourable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 9.9 9.9 14.0 12.4 16.1 4.2 12.7 23.7 15.4 13.5 10.9 8.6 18.3 8.9 13.6 13.4 8.3 11.0 9.2 9.8 13.2 12.4 10.2 12.8 9.4 9.7 15.0 14.0 18.4 10.2 17.8 23.5 11.1 16.0 13.7 11.1 9.2 9.0 19.8 18.2 10.8 8.8 17.6 18.3 10.1 9.2 10.1 16.2 11.8 15.9 8.9 9.6 12.0 15.7 2.7 3.2 0.9 8.4 2.5 1.7 0.7 3.0 1.4 13.8 4.5 7.8 8.5 0.4 6.1 7.8 5.3 5.8 2.9 2.6 3.0 3.7 5.1 2.1 7.0 5.3 6.0 0.7 1.7 12.5 5.2 2.1 7.5 10.1 3.2 8.9 8.0 5.7 9.7 3.8 7.8 5.0 8.6 0.7 5.7 6.6 9.1 4.4 1.9 10.0 3.6 5.6 3.7 5.9 10.0 5.7 2.7 8.3 7.7 8.6 4.3 5.9 4.3 8.3 5.1 6.4 7.4 1.9 4.6 3.1 5.8 0.6 1.4 0.9 1.5 0.6 1.5 1.1 1.4 1.4 1.9 2.7 1.7 1.0 0.9 2.5 8.4 3.2 1.5 0.7 14.0 16.1 23.7 14.7 13.2 12.4 15.0 14.0 16.0 16.2 ZNF2 "A1-5, Zfp661, ZNF661" ENSG00000275111 "Zinc finger protein 2" Q9BSG1 2 95165432-95184317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041358 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA041358: AB_10795539" "unprognostic (1.18e-1)" "unprognostic (6.41e-3)" "unprognostic (5.81e-2)" "unprognostic (9.29e-2)" "unprognostic (4.47e-2)" "unprognostic (6.03e-2)" "unprognostic (1.13e-3)" "prognostic favourable (4.69e-5)" "unprognostic (1.47e-2)" "unprognostic (1.78e-1)" "unprognostic (2.37e-2)" "unprognostic (2.63e-2)" "unprognostic (2.66e-3)" "unprognostic (2.57e-2)" "unprognostic (6.78e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" 5.1 4.1 5.2 3.2 6.3 0.7 4.0 6.4 6.1 5.3 2.6 6.4 2.5 3.3 5.4 5.7 3.5 4.8 2.3 4.6 5.1 4.2 2.7 3.5 4.3 5.3 5.0 6.5 2.8 6.5 7.1 3.1 5.2 4.8 2.5 4.9 3.7 5.5 4.2 4.7 2.2 4.1 6.1 4.3 3.5 4.3 5.9 4.3 5.0 4.5 5.0 4.3 4.0 7.2 5.0 15.1 6.2 4.2 8.6 4.5 5.3 5.2 6.4 10.7 9.5 7.5 4.2 6.0 7.9 8.2 10.9 5.6 3.7 3.4 4.3 5.7 4.5 6.8 4.5 8.7 7.5 5.9 7.9 4.2 6.9 7.8 4.1 5.2 6.4 6.4 7.5 11.7 7.1 5.3 2.8 8.5 4.9 5.8 5.7 2.8 7.2 5.6 11.1 4.4 4.7 3.2 5.4 7.4 5.6 8.1 6.8 5.0 6.2 5.8 10.0 5.8 7.9 5.0 4.9 4.3 4.2 6.7 5.4 7.6 5.9 4.4 15.1 8.6 6.2 6.2 7.2 7.0 7.5 5.0 6.9 8.5 8.6 3.6 4.2 4.7 4.1 7.6 4.5 ZNF20 KOX13 ENSG00000132010 "Zinc finger protein 20" P17024 19 12092843-12140407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.5" "Low lineage specificity" "Detected in all" HPA020887 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA020887: AB_2218842" "unprognostic (1.77e-2)" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-3)" "unprognostic (4.00e-2)" "unprognostic (1.08e-4)" "unprognostic (1.69e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (7.01e-2)" "unprognostic (9.23e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.21e-3)" 3.3 4.0 2.7 3.5 4.0 4.9 6.3 3.5 3.7 7.3 4.4 2.3 9.5 1.8 6.3 7.8 4.5 10.3 2.7 2.5 3.0 2.8 5.6 2.6 3.6 4.3 2.8 1.3 6.6 6.1 4.0 9.5 3.8 4.0 9.1 4.4 2.7 4.6 4.0 1.9 6.2 7.5 3.9 2.9 6.0 4.4 14.8 3.8 8.9 9.3 3.9 3.9 5.3 4.5 2.3 2.2 18.5 2.2 6.0 3.3 1.0 3.3 0.1 4.6 9.6 2.1 3.5 3.5 2.9 5.3 2.7 3.8 1.0 1.8 3.1 3.3 3.4 2.1 2.5 2.1 2.8 2.5 0.7 1.3 3.5 1.6 1.2 0.1 3.0 2.9 4.6 1.1 1.6 1.6 2.0 0.5 5.7 1.3 4.0 3.6 7.8 2.6 3.0 2.6 1.7 3.4 7.3 2.0 4.6 2.7 1.9 3.9 3.6 5.2 0.0 6.4 2.2 6.3 2.0 5.2 2.9 3.1 0.4 0.0 2.5 9.7 2.2 5.1 1.5 1.1 1.5 1.5 1.3 1.5 1.2 2.3 1.4 1.2 18.5 6.0 2.0 2.2 3.3 1.0 2.7 4.0 3.5 3.7 3.0 2.8 2.8 1.3 4.0 3.8 ZNF205 "Zfp13, ZNF210" ENSG00000122386 "Zinc finger protein 205" O95201 16 3112560-3120517 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001791 Uncertain Approved Nucleoplasm Nucleoplasm "HPA001791: AB_1080688" "unprognostic (8.46e-2)" "unprognostic (1.57e-1)" "unprognostic (1.94e-2)" "unprognostic (5.72e-2)" "unprognostic (3.51e-1)" "unprognostic (2.28e-2)" "unprognostic (1.98e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.71e-2)" "unprognostic (7.26e-2)" "unprognostic (6.17e-2)" "unprognostic (4.15e-2)" "unprognostic (3.46e-2)" "unprognostic (8.41e-2)" "unprognostic (9.43e-2)" "unprognostic (9.19e-3)" 10.7 10.6 11.4 7.0 13.6 3.5 9.8 16.4 16.8 11.8 11.1 14.2 17.2 13.9 13.0 9.3 10.6 14.2 14.9 12.9 11.5 10.1 13.6 12.4 10.3 5.3 13.0 12.1 17.2 18.3 16.5 10.9 11.0 12.0 12.9 6.1 10.2 15.4 14.8 30.6 19.0 11.1 9.7 9.0 9.0 11.5 5.6 14.3 1.4 14.4 9.0 4.6 8.2 12.4 0.6 0.3 1.5 0.5 2.7 2.4 0.6 7.5 9.1 8.7 14.0 3.4 4.6 12.0 6.3 6.6 8.3 10.3 4.9 7.2 0.3 8.3 3.9 11.7 7.7 6.5 4.0 2.0 15.3 3.2 12.7 6.1 7.8 0.3 1.8 5.1 10.3 8.0 5.4 9.5 6.7 5.8 4.1 12.7 0.1 0.3 9.2 7.5 0.4 10.9 6.9 4.9 4.3 12.4 10.8 6.6 14.2 9.2 10.0 2.7 5.5 8.4 9.7 8.1 9.0 0.1 5.7 0.3 3.7 0.4 7.0 0.0 0.5 1.5 2.1 0.4 1.8 0.4 0.7 1.9 0.3 0.6 1.8 2.4 0.2 2.7 0.0 0.2 1.1 0.6 11.4 13.6 16.4 16.8 11.5 10.1 13.0 12.1 12.0 14.3 ZNF213 "CR53, ZKSCAN21, ZSCAN53" ENSG00000085644 "Zinc finger protein 213" O14771 16 3129777-3142805 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035000, HPA056750" Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA035000: AB_10669997, HPA056750: " "unprognostic (1.94e-1)" "unprognostic (1.62e-2)" "unprognostic (3.25e-1)" "unprognostic (1.87e-2)" "unprognostic (1.31e-2)" "unprognostic (4.05e-3)" "prognostic unfavourable (6.74e-4)" "unprognostic (4.72e-2)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-1)" "unprognostic (4.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.57e-1)" 5.7 8.2 9.0 6.0 10.3 6.0 5.7 10.8 16.7 5.0 6.2 14.6 4.7 9.3 7.5 5.1 8.4 6.8 6.0 9.1 9.5 7.7 4.4 2.4 6.3 8.8 7.1 9.3 10.3 12.1 8.7 7.3 4.1 9.1 6.5 2.5 6.8 17.4 5.9 11.1 16.9 11.2 6.8 7.6 7.5 6.9 20.1 8.0 7.5 9.2 4.7 5.4 7.1 5.8 4.8 3.2 3.5 2.5 4.0 4.7 1.8 3.3 10.6 4.7 11.2 4.6 3.8 5.9 6.2 2.5 3.3 3.8 3.4 7.0 4.1 6.1 4.0 8.2 2.2 6.8 1.3 8.5 8.2 2.9 11.7 6.6 8.8 7.0 7.6 3.7 8.5 4.6 1.7 2.4 7.4 9.2 2.1 14.5 6.5 8.6 8.1 8.1 8.8 5.5 7.5 2.6 2.3 9.8 8.5 9.3 5.6 4.4 7.3 12.1 6.0 6.7 6.1 7.5 4.3 5.2 4.8 6.3 2.7 9.3 5.1 0.0 1.6 3.4 3.7 2.5 3.2 2.7 3.6 2.4 1.6 4.8 4.7 3.4 3.5 4.0 1.9 3.2 2.0 1.8 9.0 10.3 10.8 16.7 9.5 7.7 7.1 9.3 9.1 8.0 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.6" "Cell line enhanced" "Detected in many" "U-698: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: " "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 1.2 1.4 1.5 9.0 1.8 1.4 2.7 0.7 4.0 1.9 4.2 0.3 0.9 4.6 2.3 5.2 2.8 1.4 1.1 1.4 1.2 2.2 2.9 1.6 1.5 6.7 0.7 1.4 1.9 10.4 0.0 0.8 0.7 1.9 2.7 5.5 1.2 4.2 2.0 0.9 1.6 5.5 0.9 1.1 4.8 1.6 6.1 0.0 6.5 2.7 2.1 11.6 3.3 2.2 2.5 2.9 4.0 1.8 1.5 1.4 0.8 2.6 1.2 1.7 0.6 1.3 1.6 5.7 6.1 5.2 3.2 6.3 0.2 0.1 8.5 2.0 3.2 3.0 5.0 6.0 6.0 0.0 6.9 0.1 0.8 0.1 1.2 5.3 0.4 2.8 2.9 0.1 6.5 5.0 10.0 3.0 1.3 0.1 0.2 0.2 8.4 1.7 0.2 0.1 1.0 0.2 4.7 0.1 0.2 0.0 2.1 0.2 0.2 2.1 2.4 2.0 5.7 2.3 0.1 0.4 0.1 17.8 4.5 0.3 1.7 4.0 1.8 0.6 0.8 1.0 0.3 2.5 0.6 1.4 1.7 2.5 1.4 0.8 2.7 1.5 0.5 2.9 0.7 0.8 1.5 1.8 0.7 4.0 1.2 2.2 0.7 1.4 1.9 0.0 ZNF222 ENSG00000159885 "Zinc finger protein 222" Q9UK12 19 44025342-44033112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004086 Approved Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA004086: AB_2273259" "unprognostic (1.91e-3)" "unprognostic (3.41e-2)" "unprognostic (8.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (7.45e-2)" "unprognostic (1.75e-3)" "unprognostic (6.75e-2)" "unprognostic (1.58e-2)" "unprognostic (7.58e-2)" "prognostic favourable (5.56e-7)" "unprognostic (2.19e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-1)" "unprognostic (8.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-3)" 4.8 7.7 8.1 5.1 9.1 8.0 8.3 18.3 12.6 6.2 4.4 7.5 5.3 2.9 5.1 7.3 3.5 5.5 6.4 7.5 11.5 8.2 5.9 5.1 5.7 7.2 8.8 7.8 8.9 5.4 6.6 12.7 5.4 10.7 6.6 5.0 5.7 6.9 6.4 3.7 4.5 5.0 6.0 9.3 8.8 5.5 15.4 11.1 10.3 7.6 5.0 7.3 8.5 6.6 7.6 4.0 8.9 3.6 6.1 9.7 4.0 3.9 4.6 7.8 7.1 6.0 6.1 0.4 4.2 7.5 4.9 7.7 2.4 2.5 1.3 6.5 4.6 1.3 5.4 4.0 6.3 5.7 5.9 6.4 5.8 3.7 7.6 0.2 5.9 4.6 5.4 4.1 7.0 4.6 1.2 2.7 6.1 0.5 4.4 2.6 4.7 2.2 0.1 8.3 2.1 4.1 12.3 4.2 9.6 6.8 1.3 5.7 1.7 6.3 3.4 5.5 5.3 3.2 5.2 11.2 9.1 0.1 2.9 0.1 6.0 8.9 3.6 7.0 9.2 2.3 7.7 7.4 8.7 8.9 3.6 7.6 9.7 7.3 7.5 6.1 2.8 4.0 6.0 4.0 8.1 9.1 18.3 12.6 11.5 8.2 8.8 7.8 10.7 11.1 ZNF223 ENSG00000178386 "Zinc finger protein 223" Q9UK11 19 44051367-44067991 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 21.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA067823 Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA067823: " "unprognostic (6.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.42e-1)" "unprognostic (8.36e-2)" "unprognostic (1.29e-2)" "unprognostic (1.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (1.85e-1)" "unprognostic (6.32e-2)" "unprognostic (4.33e-1)" "unprognostic (4.95e-2)" "unprognostic (3.67e-1)" "unprognostic (2.58e-4)" 6.5 8.0 6.6 5.9 14.7 3.2 10.1 19.8 17.3 7.6 8.0 9.6 6.0 7.1 7.7 11.3 6.5 7.5 9.5 8.8 9.4 8.5 7.5 4.7 7.0 6.0 6.7 7.4 7.7 6.2 10.8 9.8 9.7 15.3 12.3 10.7 7.1 7.7 9.4 3.5 8.8 9.2 7.8 5.7 8.6 8.8 6.2 7.9 6.7 11.7 4.6 7.6 9.0 6.2 4.4 7.7 11.6 7.1 6.6 9.3 2.6 2.5 1.4 5.4 1.3 3.6 4.6 0.1 3.9 4.2 3.5 5.1 2.6 4.3 0.0 3.7 3.0 2.4 0.0 4.4 3.7 0.0 4.1 5.1 3.9 3.4 2.7 0.2 0.1 4.4 3.5 2.9 2.8 3.9 0.2 0.0 3.8 2.0 0.0 1.8 4.0 1.9 0.0 2.2 1.2 4.1 21.4 3.4 8.1 6.7 0.9 2.7 3.8 4.7 3.9 3.3 3.1 1.7 1.4 2.6 4.3 0.0 1.4 0.0 3.2 11.6 5.8 8.7 2.8 7.1 4.3 3.6 4.7 2.4 6.4 4.4 9.3 4.0 0.5 6.6 2.9 7.7 4.0 2.6 6.6 14.7 19.8 17.3 9.4 8.5 6.7 7.4 15.3 7.9 ZNF225 ENSG00000256294 "Zinc finger protein 225" Q9UK10 19 44112181-44134816 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA073778 Approved Nucleoplasm Nucleoplasm "HPA073778: " "unprognostic (1.52e-1)" "unprognostic (8.99e-2)" "unprognostic (1.36e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-2)" "unprognostic (9.03e-2)" "unprognostic (7.54e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (7.18e-3)" "unprognostic (5.67e-2)" "unprognostic (7.54e-2)" "unprognostic (1.84e-1)" "unprognostic (6.60e-2)" "unprognostic (5.90e-2)" "unprognostic (3.17e-4)" 6.0 8.3 8.7 4.9 8.5 4.1 16.0 15.8 8.8 8.4 5.6 10.8 9.9 4.7 7.9 5.1 5.8 6.4 5.5 5.9 7.6 5.1 6.0 6.3 5.3 7.3 10.2 6.0 10.3 6.2 7.9 11.0 6.2 8.7 6.9 4.8 7.4 6.2 7.1 4.6 6.0 6.1 6.5 7.3 8.2 5.5 21.4 9.9 11.8 7.8 2.0 7.1 6.5 6.0 6.7 6.4 11.4 6.7 6.0 7.6 3.3 2.6 4.3 5.6 6.5 8.4 7.5 1.3 4.3 6.5 5.1 6.6 2.6 1.6 1.1 3.3 4.6 2.2 5.1 3.2 4.5 2.5 4.9 7.6 5.4 2.4 4.9 4.7 7.3 7.0 3.8 4.5 7.4 4.9 2.2 1.4 4.3 0.8 3.3 3.3 5.0 4.4 2.8 7.7 2.5 5.0 5.2 3.4 5.9 7.8 18.7 2.2 2.0 8.0 5.0 4.7 4.9 2.3 2.9 6.2 3.6 0.8 2.2 2.8 4.2 11.4 4.7 7.4 5.3 6.7 5.2 5.0 4.1 4.0 6.4 6.7 7.6 5.5 1.2 6.0 2.7 2.8 5.3 3.3 8.7 8.5 15.8 8.8 7.6 5.1 10.2 6.0 8.7 9.9 ZNF233 FLJ38032 ENSG00000159915 "Zinc finger protein 233" A6NK53 19 44259880-44275317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell line enhanced" "Detected in many" "U-266/70: 10.6;U-266/84: 9.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA020975 Uncertain Approved Nucleoplasm Nucleoplasm "HPA020975: AB_1859145" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-1)" "unprognostic (1.60e-1)" "unprognostic (3.72e-2)" "unprognostic (7.37e-3)" "unprognostic (2.77e-2)" "unprognostic (9.07e-3)" "unprognostic (1.48e-1)" "unprognostic (4.20e-3)" "unprognostic (1.65e-1)" "unprognostic (6.28e-3)" "unprognostic (6.88e-2)" "unprognostic (3.47e-2)" "unprognostic (2.71e-4)" "unprognostic (1.55e-1)" 0.6 2.3 4.4 2.1 6.3 3.9 2.5 10.9 8.5 1.3 4.3 0.8 0.2 1.9 0.9 2.8 1.4 2.2 1.8 4.8 4.1 5.0 2.1 0.8 1.2 2.3 3.3 6.1 1.2 1.6 3.1 11.2 2.2 6.2 4.8 2.2 2.1 1.6 2.3 2.5 3.8 1.8 1.6 3.4 2.2 2.1 25.2 2.4 3.3 3.5 2.7 1.0 1.6 0.8 4.7 3.9 3.3 1.2 3.4 2.2 0.5 0.7 2.7 3.0 3.0 3.1 0.6 1.3 1.2 0.8 1.0 1.8 2.8 3.3 1.2 2.9 0.8 1.3 0.1 0.7 1.1 0.6 3.8 1.9 3.5 2.8 2.2 1.2 1.3 0.7 0.5 0.7 1.9 1.3 1.3 5.8 0.2 1.6 0.9 1.0 3.2 0.8 2.0 0.4 2.4 0.7 2.4 4.2 6.4 1.2 0.8 2.0 5.0 1.5 0.8 1.3 0.8 0.8 0.8 10.6 9.9 2.2 4.4 1.2 1.4 3.3 1.0 0.9 1.6 1.1 1.5 2.7 1.4 1.1 0.5 4.7 2.0 2.2 2.4 3.4 1.2 3.9 2.1 0.5 4.4 6.3 10.9 8.5 4.1 5.0 3.3 6.1 6.2 2.4 ZNF235 "ANF270, HZF6, ZFP93, ZNF270" ENSG00000159917 "Zinc finger protein 235" Q14590 19 44228729-44305046 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045582 Uncertain Approved Nucleoplasm Nucleoplasm "HPA045582: AB_10963792" "unprognostic (2.11e-2)" "unprognostic (1.67e-1)" "unprognostic (1.11e-2)" "unprognostic (9.91e-3)" "unprognostic (2.04e-2)" "unprognostic (1.23e-4)" "unprognostic (4.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (3.37e-1)" "unprognostic (1.46e-5)" "unprognostic (1.20e-2)" "unprognostic (1.36e-1)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-3)" "unprognostic (3.38e-2)" 5.6 4.8 8.1 6.6 10.4 1.8 8.1 13.9 10.3 6.1 7.7 10.7 10.1 5.0 13.2 6.5 5.2 7.1 4.9 6.9 7.8 7.5 6.7 5.5 6.6 7.4 8.5 4.1 8.1 6.2 10.1 9.0 7.3 9.4 7.7 6.0 6.9 5.8 8.2 6.5 4.4 6.4 6.9 7.1 8.2 5.3 6.8 8.5 10.7 9.1 2.9 9.3 6.2 5.9 10.9 8.3 14.5 3.7 5.6 7.5 2.4 1.9 3.2 6.3 6.3 4.7 2.8 2.4 1.2 3.7 2.3 2.7 2.0 3.5 3.3 3.2 2.4 1.7 5.5 2.6 2.8 0.0 6.8 7.2 4.8 2.9 3.9 4.0 4.3 2.8 3.5 2.6 3.1 3.7 1.6 0.0 2.5 1.6 6.6 0.8 7.5 2.0 3.2 6.0 2.9 4.5 5.0 4.6 12.8 3.4 4.1 3.0 3.1 4.9 4.4 2.1 2.9 0.6 1.4 7.7 7.7 2.4 1.8 1.1 3.4 14.5 3.7 3.6 6.8 3.0 4.7 6.9 5.1 5.8 2.7 10.9 7.5 6.5 2.0 5.6 2.9 8.3 3.7 2.4 8.1 10.4 13.9 10.3 7.8 7.5 8.5 4.1 9.4 8.5 ZNF236 ENSG00000130856 "Zinc finger protein 236" Q9UL36 18 76822607-76970727 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008600 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA008600: AB_1080696" "unprognostic (1.38e-1)" "unprognostic (7.24e-2)" "unprognostic (3.13e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (9.88e-3)" "unprognostic (5.51e-2)" "unprognostic (1.77e-1)" "unprognostic (2.83e-3)" "unprognostic (2.43e-1)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "unprognostic (2.95e-2)" "unprognostic (9.40e-2)" "unprognostic (1.74e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" 5.7 5.2 7.0 9.1 11.2 10.8 10.0 15.3 11.0 7.2 5.8 7.3 6.7 5.0 7.6 7.1 5.6 7.6 6.3 5.1 8.3 5.7 4.7 4.3 6.4 6.2 8.3 3.5 11.3 7.1 12.2 8.9 5.6 7.3 6.2 4.1 5.4 6.6 12.6 5.7 9.9 5.5 5.8 6.5 5.5 5.8 16.6 10.6 10.4 6.5 1.9 10.0 6.2 12.7 9.0 4.6 5.9 3.4 3.0 5.4 1.2 4.3 5.8 8.2 6.0 6.3 6.1 3.7 3.4 4.7 5.4 4.3 4.1 4.1 6.2 1.7 4.4 8.0 5.7 4.8 4.6 6.5 5.7 5.9 6.7 4.8 3.9 9.4 6.8 6.0 5.2 5.1 7.9 5.4 5.6 5.2 5.4 4.1 11.4 5.2 4.5 4.6 7.3 8.5 4.1 4.0 6.8 4.7 4.9 6.1 3.7 4.2 4.4 6.6 5.6 9.3 3.7 2.5 5.0 3.5 4.9 8.0 6.2 5.2 6.9 1.1 3.4 5.9 5.4 2.9 5.2 9.0 4.0 3.7 2.2 8.1 4.6 4.8 3.7 3.0 2.7 4.6 3.9 1.2 7.0 11.2 15.3 11.0 8.3 5.7 8.3 3.5 7.3 10.6 ZNF239 "HOK-2, MOK2" ENSG00000196793 "Zinc finger protein 239" Q16600 10 43556344-43574618 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 17.7;T-47d: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 4.2;T-cells: 8.8" "Low region specificity" "Detected in all" "HPA030843, HPA046679" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA030843: , HPA046679: AB_10960498" "unprognostic (1.74e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.45e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-7)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.90e-3)" "unprognostic (4.13e-2)" "unprognostic (5.59e-3)" "prognostic unfavourable (4.70e-7)" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" 5.0 5.0 8.8 5.6 9.3 0.9 10.4 5.7 8.2 6.8 5.3 5.2 2.1 2.9 8.8 4.5 2.5 8.7 3.5 4.1 6.5 5.1 4.6 2.6 2.7 5.3 5.3 8.5 8.1 8.7 9.9 8.6 2.0 7.2 10.6 5.8 1.7 6.2 9.4 4.9 1.3 3.3 9.8 3.7 2.7 4.7 14.5 6.8 1.6 6.5 1.4 5.1 6.1 10.4 4.2 0.1 0.0 0.0 0.5 8.8 1.9 0.0 3.0 3.6 3.5 5.1 3.9 0.0 6.4 0.7 7.8 6.9 7.8 7.0 0.0 2.4 3.5 0.2 0.0 0.3 9.9 0.1 5.2 0.0 5.2 0.0 4.0 0.0 2.3 4.3 0.1 6.1 0.0 0.2 10.1 0.0 6.4 3.3 1.0 1.0 17.7 3.6 0.0 0.0 0.2 6.5 2.7 6.9 9.3 2.9 0.1 0.4 13.9 4.3 0.8 0.0 8.0 0.2 8.1 0.8 6.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.1 0.0 5.0 3.6 4.8 3.2 0.1 4.2 8.8 5.2 0.0 0.5 0.0 0.0 2.5 1.9 8.8 9.3 5.7 8.2 6.5 5.1 5.3 8.5 7.2 6.8 ZNF248 bA162G10.3 ENSG00000198105 "Zinc finger protein 248" Q8NDW4 10 37776526-37858106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018237, HPA018287, HPA018455" Uncertain Approved Nucleoplasm Nucleoplasm "HPA018237: , HPA018287: , HPA018455: " "unprognostic (6.25e-3)" "unprognostic (1.16e-2)" "unprognostic (3.75e-2)" "unprognostic (3.15e-2)" "unprognostic (3.20e-2)" "unprognostic (6.51e-3)" "unprognostic (2.50e-4)" "prognostic favourable (1.04e-4)" "unprognostic (6.37e-3)" "unprognostic (2.05e-2)" "prognostic favourable (1.22e-4)" "prognostic unfavourable (6.71e-4)" "prognostic unfavourable (2.25e-4)" "unprognostic (2.70e-1)" "unprognostic (1.62e-1)" "unprognostic (9.51e-2)" "unprognostic (8.68e-3)" 5.1 7.7 11.0 6.4 18.3 0.7 8.2 29.8 16.2 11.7 14.0 9.5 11.4 5.7 16.1 15.5 6.1 12.6 7.0 8.0 11.5 10.3 6.3 4.9 6.4 6.3 11.2 12.7 14.1 5.8 17.7 23.8 6.7 11.4 13.5 9.6 8.4 7.4 18.1 7.9 7.4 6.8 12.3 7.7 7.4 6.7 7.0 13.3 3.1 14.2 4.6 6.7 8.0 8.9 6.7 3.8 1.4 1.8 4.0 8.9 3.0 5.3 4.6 1.0 12.8 9.3 7.8 5.6 5.5 2.8 5.8 6.3 5.5 6.8 7.1 4.9 3.9 6.9 7.3 3.9 5.0 12.4 8.2 8.9 9.4 6.7 4.6 7.3 6.0 3.1 7.5 3.0 2.5 5.3 3.8 5.1 8.5 2.6 7.3 4.7 3.9 24.6 6.8 12.9 5.0 7.1 2.7 5.3 10.3 4.8 2.6 3.2 7.0 2.1 5.1 5.2 5.6 4.2 3.4 8.1 8.5 6.0 7.1 9.7 2.5 1.1 1.8 1.4 5.7 1.2 6.2 5.8 5.1 4.8 3.8 6.7 8.9 7.6 0.2 4.0 1.6 3.5 2.6 3.0 11.0 18.3 29.8 16.2 11.5 10.3 11.2 12.7 11.4 13.3 ZNF25 "FLJ31890, KOX19, Zfp9" ENSG00000175395 "Zinc finger protein 25" P17030 10 37949572-37976633 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030190 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA030190: AB_10602687" "unprognostic (9.42e-2)" "unprognostic (6.18e-2)" "unprognostic (5.64e-2)" "unprognostic (2.93e-1)" "unprognostic (4.67e-2)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (3.85e-3)" "unprognostic (1.15e-1)" "unprognostic (5.32e-2)" "unprognostic (1.40e-3)" "unprognostic (1.45e-1)" "unprognostic (2.01e-3)" "unprognostic (1.21e-2)" "unprognostic (1.29e-1)" "unprognostic (9.30e-3)" "unprognostic (2.61e-1)" 9.7 12.1 17.0 4.0 21.7 2.7 8.7 23.2 27.6 10.9 8.1 7.3 3.4 2.7 11.3 7.5 6.5 7.3 7.1 11.1 13.3 16.7 6.8 3.5 6.9 4.9 12.7 23.7 13.1 4.0 7.1 10.7 5.4 16.0 8.9 5.4 5.1 4.5 11.0 22.9 5.1 3.7 11.6 9.5 7.1 4.4 5.2 11.6 1.2 6.3 5.7 4.9 8.4 5.4 2.3 3.4 6.0 8.5 1.8 3.7 2.2 1.6 3.0 3.3 6.8 12.7 9.7 0.6 3.6 5.0 2.9 4.4 0.5 2.3 3.0 1.1 6.4 0.4 0.9 1.5 4.7 7.1 1.6 4.9 0.0 1.0 8.1 3.2 3.2 6.9 6.8 3.2 3.7 4.9 0.4 2.3 6.9 0.9 1.1 2.5 0.6 2.2 1.2 3.8 0.6 3.4 0.6 1.2 7.8 1.2 0.2 4.6 3.0 5.2 7.0 4.5 0.8 7.3 2.2 2.9 1.4 1.3 8.5 6.3 2.9 2.3 2.8 6.0 3.1 4.7 3.4 2.0 2.7 2.6 3.4 2.3 3.7 3.0 0.5 1.8 8.5 0.5 2.2 2.2 17.0 21.7 23.2 27.6 13.3 16.7 12.7 23.7 16.0 11.6 ZNF251 ENSG00000198169 "Zinc finger protein 251" Q9BRH9 8 144720907-144756417 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018290 Approved Approved Nucleoplasm Nucleoplasm "HPA018290: AB_1859153" "unprognostic (1.16e-3)" "unprognostic (1.50e-1)" "unprognostic (1.47e-1)" "unprognostic (1.77e-1)" "unprognostic (6.87e-2)" "unprognostic (1.20e-1)" "unprognostic (4.26e-3)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (2.30e-1)" "unprognostic (5.75e-2)" "unprognostic (2.07e-1)" "prognostic unfavourable (1.42e-9)" "unprognostic (5.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-1)" "unprognostic (2.33e-3)" 10.1 6.7 14.1 8.6 11.8 4.0 10.5 26.0 12.5 13.1 9.9 12.0 8.5 8.7 14.3 25.9 6.4 11.3 11.2 7.9 10.2 9.2 9.8 6.6 8.4 10.8 10.5 9.6 13.8 9.0 17.6 15.1 10.2 10.0 11.8 12.0 9.8 12.0 14.2 11.5 8.8 9.6 11.1 8.7 11.4 10.8 12.0 12.8 9.9 19.6 6.1 10.0 9.5 10.4 2.6 2.4 2.3 0.9 2.7 3.7 1.5 5.1 1.9 11.5 4.3 5.6 8.8 1.2 6.8 4.0 3.7 7.1 1.1 5.3 5.9 4.9 5.4 7.8 3.4 3.7 7.1 3.6 3.4 6.3 16.4 1.3 4.8 1.0 3.4 7.9 4.8 2.8 3.7 3.2 4.3 1.7 2.5 0.4 5.8 0.6 4.9 0.0 8.4 1.6 2.5 1.1 2.3 5.7 4.5 5.8 1.8 4.6 4.3 1.9 1.7 5.1 10.7 6.7 4.6 3.9 1.0 6.6 4.4 2.0 2.7 0.0 0.2 2.3 1.8 0.6 3.3 1.4 2.8 3.0 2.4 2.6 3.7 1.2 0.1 2.7 0.9 1.4 2.5 1.5 14.1 11.8 26.0 12.5 10.2 9.2 10.5 9.6 10.0 12.8 ZNF263 "FPM315, ZKSCAN12, ZSCAN44" ENSG00000006194 "Zinc finger protein 263" O14978 16 3263800-3301401 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035085, HPA035086" Approved Supported "Nucleoplasm,Mitotic spindle,Cytosol" Cytosol "Nucleoplasm, Mitotic spindle" "HPA035085: AB_10671099, HPA035086: AB_10603244" "unprognostic (2.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (3.33e-1)" "unprognostic (2.25e-1)" "unprognostic (6.42e-2)" "unprognostic (7.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (6.39e-2)" "unprognostic (2.30e-3)" "unprognostic (2.98e-3)" "unprognostic (5.10e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (2.66e-1)" 28.3 17.8 21.5 16.9 25.7 15.0 23.3 26.4 23.5 21.9 19.2 18.1 14.0 13.8 30.4 23.4 15.4 24.2 17.6 14.6 15.7 14.2 16.9 17.1 18.5 20.4 20.3 18.1 30.7 23.0 36.4 24.8 20.1 16.8 21.8 16.8 20.2 19.5 21.1 15.8 22.7 18.2 18.6 14.0 23.6 20.5 17.3 16.5 18.9 20.1 14.5 28.8 20.2 27.6 6.6 5.5 9.6 5.0 6.7 9.2 3.3 8.4 11.0 13.2 19.1 10.5 13.9 17.1 11.7 18.0 14.1 15.3 12.0 13.4 31.3 12.2 15.0 10.8 17.8 11.9 14.2 17.2 17.8 14.2 14.7 11.5 12.3 21.0 17.5 16.0 24.9 12.8 18.8 12.0 16.0 21.4 11.5 11.7 19.3 16.2 24.5 9.5 31.5 13.3 24.6 9.8 8.5 19.1 20.0 12.8 13.9 14.2 15.3 25.2 12.4 14.9 14.4 11.0 10.9 22.9 24.2 37.8 5.8 10.6 10.5 2.1 3.9 9.6 6.0 4.2 6.9 4.5 7.3 8.0 5.5 6.6 9.2 6.8 5.0 6.7 5.0 4.6 4.9 3.3 21.5 25.7 26.4 23.5 15.7 14.2 20.3 18.1 16.8 16.5 ZNF264 KIAA0412 ENSG00000083844 "Zinc finger protein 264" O43296 19 57191500-57222846 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046330 Approved Nucleoplasm Nucleoplasm "HPA046330: " "unprognostic (2.19e-1)" "unprognostic (2.33e-1)" "unprognostic (9.26e-2)" "unprognostic (1.08e-3)" "unprognostic (3.60e-1)" "unprognostic (1.25e-2)" "unprognostic (1.23e-1)" "unprognostic (2.75e-1)" "unprognostic (9.92e-2)" "unprognostic (2.70e-1)" "unprognostic (2.19e-3)" "unprognostic (5.96e-2)" "unprognostic (2.16e-2)" "unprognostic (4.39e-2)" "unprognostic (2.04e-1)" "unprognostic (3.36e-1)" "unprognostic (1.65e-2)" 10.4 10.7 8.1 10.2 12.4 12.1 14.5 15.0 11.2 12.2 8.2 10.9 17.6 8.0 13.2 10.1 11.3 12.2 8.9 7.2 8.3 5.2 10.5 11.6 14.2 13.5 12.4 10.2 15.6 21.2 14.7 13.7 11.3 10.0 10.5 8.0 9.6 12.8 13.5 8.3 11.6 12.9 10.6 9.0 17.3 13.4 15.9 11.1 16.3 13.1 10.4 11.6 11.3 10.6 6.6 3.3 7.1 2.8 4.1 6.6 2.0 7.0 5.0 5.7 4.5 4.1 5.8 2.4 4.1 6.4 5.7 10.3 3.5 5.7 2.3 2.9 5.7 7.5 0.0 5.6 8.3 0.1 20.7 9.4 7.8 2.7 4.9 1.8 8.9 6.0 3.1 7.0 16.5 5.4 0.1 0.2 5.1 0.0 7.7 2.3 3.7 12.6 2.9 7.4 7.6 4.6 9.8 6.5 4.3 8.3 2.6 3.3 4.6 4.5 7.9 7.6 6.6 2.3 5.9 10.2 12.0 7.1 5.7 0.1 3.1 1.5 1.8 7.1 3.6 2.7 2.5 6.6 5.1 3.5 2.3 3.8 6.6 6.3 1.7 4.1 2.8 3.3 3.6 2.0 8.1 12.4 15.0 11.2 8.3 5.2 12.4 10.2 10.0 11.1 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412598-9435578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: , HPA054110: " "unprognostic (2.50e-2)" "prognostic favourable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favourable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favourable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favourable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavourable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favourable (9.15e-5)" 14.7 12.1 11.0 21.5 12.5 12.8 17.6 19.0 10.0 21.8 15.7 13.1 9.6 8.6 17.2 55.8 12.7 14.6 12.8 11.7 8.2 5.4 10.9 10.4 15.8 21.0 14.5 4.9 18.9 11.2 12.5 19.8 13.0 11.4 23.8 15.7 14.4 14.4 13.5 9.3 19.1 20.8 17.0 10.9 31.3 13.5 13.0 11.4 34.6 20.8 7.3 23.4 14.4 14.2 6.9 3.8 5.6 5.5 12.6 13.0 5.1 10.6 2.7 7.9 15.1 5.7 11.1 6.4 11.8 10.0 9.8 16.3 5.7 4.6 11.9 7.6 5.8 4.0 10.0 6.3 11.7 3.3 16.5 16.3 14.6 8.3 5.1 9.3 10.1 10.5 8.7 5.3 8.2 7.8 8.5 0.1 9.0 1.0 13.6 45.8 8.3 9.0 6.1 8.2 8.3 7.6 13.3 6.8 10.7 5.4 6.4 6.6 4.7 7.2 7.1 9.1 3.5 13.7 6.0 19.5 25.8 14.2 2.8 8.9 6.8 4.8 4.1 5.6 13.0 4.8 8.5 6.0 7.2 9.2 3.3 6.9 10.6 10.2 3.6 12.6 5.5 3.8 8.7 5.1 11.0 12.5 19.0 10.0 8.2 5.4 14.5 4.9 11.4 11.4 ZNF267 HZF2 ENSG00000185947 "Zinc finger protein 267" Q14586 16 31873758-31917357 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003866 Approved Approved Nucleoplasm Nucleoplasm "HPA003866: AB_1080698" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (4.84e-2)" "unprognostic (6.24e-2)" "unprognostic (5.60e-3)" "unprognostic (8.64e-2)" "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" "unprognostic (3.60e-2)" "unprognostic (2.75e-2)" "prognostic unfavourable (1.58e-6)" "unprognostic (2.34e-1)" "unprognostic (3.34e-2)" "unprognostic (3.95e-1)" "unprognostic (8.21e-2)" 19.3 5.1 5.4 21.3 7.2 23.8 9.9 8.2 7.5 10.7 9.8 3.9 1.3 7.3 7.3 7.8 14.6 6.4 10.6 6.6 5.4 5.3 9.2 6.8 21.7 20.4 7.0 5.1 8.2 6.1 7.5 7.1 10.5 7.7 8.6 7.7 3.4 10.3 4.3 10.8 5.7 11.2 6.3 11.1 31.1 6.8 9.6 8.0 20.0 7.9 11.0 18.4 12.3 8.7 9.6 8.3 34.8 11.5 6.9 8.9 5.0 5.1 5.2 5.4 4.2 3.8 4.6 16.4 4.2 7.0 5.9 8.9 10.3 8.2 8.9 7.7 3.3 6.6 8.7 6.7 11.3 13.5 7.3 9.2 3.2 9.4 3.5 9.9 21.9 6.4 4.7 8.3 6.1 8.2 14.9 21.9 8.0 7.0 6.7 6.6 5.0 3.2 6.7 15.1 8.0 6.7 22.6 1.7 2.7 6.5 5.7 6.0 3.4 13.9 10.1 5.8 5.1 5.0 7.0 12.5 6.8 9.3 7.6 8.1 3.5 13.8 10.8 14.4 5.8 10.8 8.5 9.6 7.7 5.8 8.3 6.8 6.0 7.2 34.8 6.9 11.5 4.9 8.9 5.0 5.4 7.2 8.2 7.5 5.4 5.3 7.0 5.1 7.7 8.0 ZNF273 HZF9 ENSG00000198039 "Zinc finger protein 273" Q14593 7 64870172-64930966 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA077549 Approved Nucleoplasm Nucleoplasm "HPA077549: " "unprognostic (7.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.80e-2)" "unprognostic (5.87e-4)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-2)" "unprognostic (1.65e-2)" "unprognostic (2.02e-5)" "unprognostic (2.54e-1)" "unprognostic (5.76e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (1.04e-2)" "unprognostic (3.14e-1)" "unprognostic (9.48e-2)" "unprognostic (1.85e-2)" 2.8 1.5 1.9 1.7 4.1 5.5 4.8 8.6 3.7 3.5 1.5 2.1 1.0 1.4 2.6 0.7 2.9 3.4 0.9 1.7 2.7 1.6 1.7 1.8 1.8 5.0 4.4 2.6 3.7 1.7 0.9 2.8 2.1 5.2 1.9 1.9 0.0 1.8 1.7 1.9 12.1 1.6 1.4 2.6 3.8 1.7 9.2 5.1 11.5 5.8 4.2 3.5 2.2 1.8 3.2 1.8 5.0 0.7 0.7 2.5 1.0 2.2 1.7 3.7 5.4 0.5 1.3 3.1 1.0 0.7 1.6 2.9 2.6 2.1 6.1 3.3 0.4 0.7 7.4 1.4 1.2 3.0 2.7 3.2 0.9 0.8 0.3 3.2 2.1 0.8 0.9 2.6 2.4 1.5 8.6 2.3 1.8 2.1 6.7 3.2 7.4 2.6 7.1 5.8 3.7 0.8 1.3 3.4 3.6 2.9 1.4 1.7 2.7 4.4 0.7 1.9 1.9 1.3 2.2 2.3 3.0 9.0 0.5 3.1 1.3 5.0 0.6 3.1 1.0 0.7 1.9 3.2 2.1 1.4 1.7 2.4 1.7 2.5 1.0 0.7 0.5 1.8 2.2 1.0 1.9 4.1 8.6 3.7 2.7 1.6 4.4 2.6 5.2 5.1 ZNF276 "CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477" ENSG00000158805 "Zinc finger protein 276" Q8N554 16 89720400-89740903 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021309, HPA022255" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "HPA021309: AB_1859024, HPA022255: AB_1859025" "unprognostic (1.45e-2)" "unprognostic (7.05e-2)" "unprognostic (1.17e-2)" "unprognostic (8.25e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (1.92e-1)" "unprognostic (7.85e-2)" "unprognostic (1.59e-2)" "unprognostic (1.36e-3)" "prognostic unfavourable (3.37e-4)" "unprognostic (2.65e-2)" "unprognostic (4.14e-1)" "unprognostic (1.26e-1)" "unprognostic (1.62e-3)" 9.7 9.8 9.0 18.6 13.1 25.5 7.9 20.2 12.3 10.8 11.1 30.6 9.4 16.0 9.0 8.4 14.5 11.4 9.5 6.7 9.8 7.3 8.4 10.1 9.6 21.7 21.3 11.2 13.5 10.9 11.0 11.6 7.4 12.6 10.2 8.8 8.1 11.3 11.4 11.4 18.5 15.3 6.8 9.9 22.2 12.2 6.4 18.4 11.1 10.1 8.1 15.1 9.5 10.3 2.9 2.0 4.5 1.9 5.0 10.1 2.4 5.0 4.2 3.4 8.9 2.8 3.9 6.1 3.4 2.1 3.2 1.2 5.4 5.3 6.6 4.4 3.6 9.2 4.3 3.8 2.3 4.1 23.2 5.9 7.9 2.1 5.4 5.7 7.8 5.3 5.1 4.3 3.5 4.8 10.8 5.7 1.4 7.0 7.3 13.1 2.5 9.5 11.7 3.8 4.4 4.0 2.9 9.3 7.8 7.5 6.8 4.2 9.2 8.3 5.4 5.3 7.2 4.1 2.9 20.5 6.6 3.5 4.2 9.5 5.2 4.3 1.7 2.8 10.1 1.9 4.8 2.0 5.5 7.6 1.8 2.9 5.6 7.2 4.5 5.0 1.2 2.0 4.0 2.4 9.0 13.1 20.2 11.3 9.8 7.3 21.3 11.2 12.6 18.4 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206588-112343096 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favourable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.2 14.8 11.2 12.9 16.2 10.9 20.1 9.3 13.8 13.6 13.9 8.4 8.8 13.7 14.7 8.8 18.4 12.6 14.3 14.4 11.8 9.1 22.7 30.0 19.2 14.3 11.3 11.9 15.4 23.5 13.5 16.4 8.1 11.6 17.1 14.2 5.5 14.9 12.9 12.7 17.7 13.4 15.9 16.1 13.7 14.6 10.2 14.1 23.9 22.4 11.1 15.6 26.6 13.6 13.3 10.4 9.5 14.3 12.4 17.2 9.1 5.8 6.1 8.2 10.2 13.6 37.8 6.4 5.8 12.7 4.8 10.4 5.6 9.3 13.2 11.5 6.2 4.9 5.1 10.0 11.5 7.0 7.9 5.3 6.0 12.5 13.3 10.3 7.8 21.8 18.0 9.3 12.3 16.8 9.4 14.1 9.1 9.5 14.3 19.9 4.9 6.3 8.0 9.7 13.7 14.3 6.8 6.3 12.6 7.1 13.6 14.0 5.5 11.0 10.4 6.7 4.1 17.6 5.5 10.3 8.4 13.1 5.7 10.1 7.6 7.1 11.6 9.5 11.2 14.3 15.9 13.3 15.2 17.2 10.4 11.2 16.3 13.5 9.3 12.4 11.6 10.1 17.0 9.1 11.2 16.2 9.3 13.8 11.8 9.1 11.3 11.9 11.6 14.1 ZNF280A "3'OY11.1, SUHW1, ZNF280, ZNF636" ENSG00000169548 "Zinc finger protein 280A" P59817 22 22513736-22520270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.6;epididymis: 5.6;retina: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 3.0;K-562: 12.7;SK-MEL-30: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044475 Approved Nucleoplasm Nucleoplasm "HPA044475: AB_10960420" "unprognostic (7.53e-2)" "unprognostic (3.76e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (3.29e-1)" "unprognostic (4.65e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.1 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.5 0.3 0.5 0.2 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 ZNF280B "5'OY11.1, SUHW2, ZNF279, ZNF632" ENSG00000275004 "Zinc finger protein 280B" Q86YH2 22 22484421-22509154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.4;testis: 19.2" "Cell line enhanced" "Detected in many" "K-562: 12.9;U-2 OS: 6.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059519 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059519: " "unprognostic (7.32e-2)" "unprognostic (2.99e-2)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (2.65e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-2)" "unprognostic (2.85e-3)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" "unprognostic (3.34e-2)" "unprognostic (4.80e-1)" "unprognostic (2.44e-2)" "unprognostic (5.34e-2)" 0.3 2.1 4.3 0.9 5.5 0.6 0.5 3.9 6.8 0.7 0.5 1.6 0.0 0.4 1.5 1.3 0.5 1.2 0.6 0.8 1.8 0.5 0.3 0.5 1.2 1.7 3.2 2.5 0.7 2.0 5.6 0.5 6.6 1.3 0.7 3.5 0.5 1.4 0.8 0.6 0.6 1.1 2.2 1.1 0.6 19.2 1.2 0.0 2.3 0.0 1.2 0.6 0.0 3.3 3.1 12.4 6.4 6.8 5.4 2.0 0.0 1.8 2.1 0.0 0.0 0.0 2.8 0.4 0.0 0.0 0.0 1.1 0.8 2.0 2.0 0.0 0.0 1.7 0.2 0.0 0.0 3.4 2.3 0.4 2.6 1.6 1.6 2.9 0.8 0.0 1.7 0.0 1.8 12.9 0.8 0.7 0.0 2.0 1.1 1.6 0.4 1.6 0.0 0.2 0.6 0.0 1.2 1.5 0.0 0.0 0.7 0.0 1.4 0.8 3.3 6.8 0.7 0.0 1.2 1.2 1.1 2.0 1.4 0.1 12.4 2.3 3.8 2.9 3.3 5.4 3.1 3.6 3.1 2.0 3.3 4.5 4.9 5.9 6.8 6.4 3.1 3.5 2.0 ZNF280C "FLJ20095, SUHW3, ZNF633" ENSG00000056277 "Zinc finger protein 280C" Q8ND82 X 130202711-130268899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051494, HPA055788" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA051494: , HPA055788: " "unprognostic (2.97e-1)" "unprognostic (2.02e-1)" "unprognostic (3.97e-1)" "unprognostic (5.69e-3)" "unprognostic (2.98e-2)" "unprognostic (8.52e-2)" "unprognostic (1.16e-6)" "unprognostic (1.96e-2)" "unprognostic (3.33e-2)" "unprognostic (9.77e-2)" "unprognostic (1.06e-2)" "unprognostic (3.69e-2)" "unprognostic (3.27e-8)" "unprognostic (1.71e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (6.85e-2)" 5.4 4.5 3.9 7.1 6.8 6.2 4.9 5.6 6.8 7.6 4.4 5.4 2.9 3.7 10.6 13.3 4.6 5.0 5.1 3.3 3.8 4.2 4.0 4.1 4.1 5.7 4.2 4.2 6.8 4.6 4.9 12.5 4.8 5.8 5.5 4.0 5.1 4.1 3.8 4.5 4.5 4.4 5.0 5.8 6.0 3.8 21.5 2.8 8.2 4.9 3.6 6.8 4.9 5.4 4.0 2.3 2.7 2.9 4.5 4.9 1.1 3.4 4.3 11.5 10.3 3.5 4.8 4.3 3.2 4.3 3.5 5.3 2.6 5.5 8.1 13.0 2.3 3.4 7.9 2.6 6.2 7.1 2.2 3.5 3.3 1.9 2.8 11.3 3.3 3.5 1.2 4.9 5.2 3.9 1.7 5.0 4.0 4.3 6.1 4.6 6.7 3.6 8.5 3.9 3.1 3.6 5.5 5.6 7.7 3.1 1.8 3.7 2.0 3.9 3.9 3.9 3.2 6.3 8.5 2.1 1.3 4.6 3.6 10.3 3.5 2.7 1.4 1.5 3.0 2.2 4.9 4.0 3.8 3.5 1.9 3.2 2.7 3.7 0.8 4.5 2.9 2.3 4.8 1.1 3.9 6.8 5.6 6.8 3.8 4.2 4.2 4.2 5.8 2.8 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630181-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 16.5 15.7 10.5 9.2 13.3 22.8 16.5 23.0 18.8 21.1 14.3 14.2 12.6 8.1 21.2 9.0 12.0 18.2 9.9 11.4 10.3 7.0 11.0 14.0 11.4 9.8 11.3 14.9 27.2 16.9 14.4 28.0 12.2 16.9 18.1 12.4 8.5 18.8 11.7 22.0 9.8 11.2 24.8 16.3 11.1 14.6 8.4 14.5 46.3 13.6 8.4 10.0 23.6 19.6 6.1 5.9 10.0 4.1 3.0 4.3 1.8 8.7 5.0 9.2 14.1 9.3 13.1 6.8 13.5 9.6 5.7 6.5 3.5 9.1 14.8 5.7 9.5 6.5 4.6 3.6 6.8 7.5 2.7 1.5 8.2 5.4 9.3 13.2 4.5 8.5 4.9 3.9 5.5 12.3 7.6 17.2 8.6 6.2 8.8 1.5 0.0 4.0 2.8 15.2 10.5 6.6 10.2 7.4 13.5 11.3 7.0 4.3 7.7 12.3 10.8 8.3 12.6 7.6 10.8 9.0 13.5 0.0 9.3 19.7 8.9 10.0 4.1 5.4 3.6 3.7 3.6 6.1 3.4 3.1 5.9 5.5 3.5 4.3 0.6 3.0 3.2 5.9 3.0 1.8 10.5 13.3 23.0 18.8 10.3 7.0 11.3 14.9 16.9 14.5 ZNF282 HUB1 ENSG00000170265 "Zinc finger protein 282" Q9UDV7 7 149195485-149226248 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024374 Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA024374: AB_1851322" "unprognostic (1.79e-1)" "unprognostic (6.97e-2)" "unprognostic (1.19e-3)" "unprognostic (5.23e-3)" "unprognostic (3.11e-2)" "unprognostic (3.70e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (2.73e-1)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (7.88e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" 13.6 11.7 12.6 12.7 11.5 17.5 13.1 20.7 18.1 19.1 16.1 16.6 16.8 17.7 17.9 14.1 17.9 17.2 18.1 12.5 10.2 8.4 12.4 14.4 12.3 11.2 10.8 11.8 18.5 26.6 12.2 12.3 24.9 10.8 21.4 7.8 13.3 17.8 15.8 20.7 19.5 14.5 15.1 8.9 15.2 14.6 6.4 12.9 14.2 14.1 16.3 12.7 17.0 13.8 3.9 2.4 3.5 1.8 1.8 3.4 1.0 11.5 11.5 6.8 16.2 6.0 7.1 10.0 10.6 7.8 9.4 9.4 10.5 12.7 11.7 16.0 6.6 12.9 7.9 10.1 3.6 17.6 28.1 9.8 7.5 8.8 8.9 12.3 11.1 8.1 13.7 9.0 9.9 9.7 18.8 9.2 5.0 13.6 25.8 18.2 21.9 14.5 16.9 6.6 16.2 5.1 11.2 15.4 14.8 11.7 14.2 9.7 9.1 12.0 12.1 13.4 3.0 16.0 15.3 13.3 7.9 8.7 11.2 10.7 11.4 0.0 1.8 3.5 2.1 1.5 2.3 0.9 2.7 2.1 1.0 3.9 1.4 1.8 1.8 1.8 1.7 2.4 3.4 1.0 12.6 11.5 20.7 18.1 10.2 8.4 10.8 11.8 10.8 12.9 ZNF283 ENSG00000167637 "Zinc finger protein 283" Q8N7M2 19 43827292-43852017 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072977 Approved Nucleoplasm Nucleoplasm "HPA072977: " "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-2)" "unprognostic (1.54e-1)" "unprognostic (5.42e-2)" "unprognostic (1.05e-3)" "unprognostic (6.49e-2)" "unprognostic (8.47e-2)" "unprognostic (3.08e-2)" "unprognostic (3.84e-1)" "unprognostic (1.16e-2)" "unprognostic (8.18e-3)" "unprognostic (4.93e-2)" "unprognostic (1.92e-1)" "unprognostic (6.88e-2)" "unprognostic (1.26e-1)" "unprognostic (4.63e-2)" 5.4 6.5 9.1 4.5 12.3 2.6 10.6 18.7 12.7 6.7 6.4 9.1 6.7 6.5 11.5 9.2 7.1 9.0 6.4 10.9 11.8 8.2 6.6 4.6 5.2 6.4 14.7 11.9 11.3 5.8 12.1 17.6 6.6 11.1 9.2 8.5 6.9 7.4 6.4 6.0 8.9 6.9 7.6 15.0 7.2 7.8 3.6 15.7 6.4 10.5 5.1 6.5 6.5 7.6 5.3 4.6 11.9 4.2 7.0 5.1 2.2 6.4 4.7 4.7 9.1 4.4 7.9 4.1 3.7 4.8 4.4 6.2 3.9 3.3 0.1 2.9 6.2 6.0 6.1 4.7 7.1 1.5 7.7 5.6 8.1 2.7 3.1 3.2 4.1 5.9 6.0 5.5 6.8 3.7 6.3 1.8 5.8 3.2 1.8 2.7 4.4 2.8 0.0 3.4 1.6 3.9 8.6 5.5 7.7 7.4 5.1 3.2 2.8 5.9 4.0 6.6 22.1 3.4 4.6 4.9 4.7 0.4 2.8 0.4 4.5 6.7 4.2 3.9 4.3 3.1 5.0 4.5 4.2 2.7 3.0 5.3 5.1 3.5 11.9 7.0 2.9 4.6 4.3 2.2 9.1 12.3 18.7 12.7 11.8 8.2 14.7 11.9 11.1 15.7 ZNF292 "bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16" ENSG00000188994 "Zinc finger protein 292" O60281 6 87152833-87264196 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032154, HPA050618" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA032154: AB_10601930, HPA050618: " "unprognostic (6.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-2)" "unprognostic (2.07e-2)" "unprognostic (2.08e-3)" "unprognostic (2.28e-2)" "unprognostic (2.81e-2)" "unprognostic (4.03e-2)" "unprognostic (8.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.06e-2)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.02e-1)" "unprognostic (7.36e-2)" 11.8 10.2 15.2 16.7 16.8 31.1 14.5 31.1 19.7 15.0 13.9 10.3 11.4 11.2 16.4 15.1 11.1 11.1 9.8 11.6 13.6 9.0 9.8 10.8 9.7 14.8 18.2 9.8 20.6 12.5 14.6 20.7 12.3 15.3 14.0 10.2 12.0 15.0 11.2 9.3 14.0 15.7 12.3 18.6 12.2 11.6 8.7 19.6 25.6 14.1 5.7 16.5 22.6 22.9 16.7 10.4 35.8 7.6 4.3 8.3 3.0 6.2 3.7 12.6 11.1 7.3 6.6 13.2 4.9 6.3 5.8 8.1 6.3 4.4 9.7 7.2 6.4 6.5 7.8 7.4 12.7 21.9 5.9 13.1 4.8 5.1 5.4 10.4 6.0 6.5 7.3 5.7 7.5 5.3 9.5 15.0 6.3 3.5 6.0 9.4 6.3 3.4 12.7 12.6 3.7 5.2 13.6 9.4 13.3 6.2 4.2 4.7 4.2 12.6 6.0 7.8 5.5 5.7 7.7 13.9 9.0 6.6 8.6 9.1 5.6 18.0 7.6 7.9 6.9 2.2 6.5 16.6 7.4 7.5 3.2 16.7 8.3 7.1 35.8 4.3 2.3 10.4 7.1 3.0 15.2 16.8 31.1 19.7 13.6 9.0 18.2 9.8 15.3 19.6 ZNF296 ZNF342 ENSG00000170684 "Zinc finger protein 296" Q8WUU4 19 45071500-45076588 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.8;lymphoid tissue: 26.2" "Cell line enhanced" "Detected in many" "Daudi: 16.3;SK-BR-3: 11.0;U-698: 19.1" "Cancer enhanced" "Detected in all" "testis cancer: 19.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046940, HPA049576" Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA046940: , HPA049576: " "unprognostic (1.32e-1)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.24e-4)" "unprognostic (3.83e-3)" "unprognostic (1.67e-2)" "unprognostic (9.70e-2)" "unprognostic (9.55e-2)" "unprognostic (3.20e-3)" "unprognostic (1.12e-1)" "unprognostic (2.67e-5)" "unprognostic (7.14e-3)" "unprognostic (1.52e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-3)" 1.4 0.8 2.4 22.8 3.4 10.5 7.3 6.6 1.4 3.0 7.1 0.4 3.2 6.4 1.0 1.2 11.3 1.4 4.0 1.4 2.0 1.7 1.4 1.0 3.4 15.9 1.1 0.1 0.6 2.7 0.3 3.5 0.7 0.8 2.4 1.0 0.8 13.8 3.4 0.8 6.2 10.1 0.6 1.3 16.9 5.5 2.6 0.6 4.3 1.7 9.5 26.2 2.0 2.7 29.8 26.7 14.7 6.2 14.7 3.5 2.6 3.0 2.1 0.0 0.4 0.0 0.2 1.7 0.5 0.0 0.2 0.2 3.4 1.2 16.3 1.9 0.1 5.7 0.8 1.3 0.0 3.4 4.3 4.8 0.9 3.3 0.9 2.7 5.1 0.7 0.6 0.7 0.0 0.4 3.4 5.8 0.0 4.6 0.2 4.5 1.9 4.3 9.1 0.0 9.8 0.4 1.1 3.1 0.3 2.0 11.0 0.1 2.4 5.4 1.1 0.0 1.7 0.1 0.0 6.0 6.0 19.1 0.1 3.4 0.1 14.7 3.6 5.7 3.0 6.2 3.5 29.8 1.6 3.3 8.8 22.4 0.7 1.7 1.8 14.7 5.8 26.7 1.4 2.6 2.4 3.4 6.6 1.4 2.0 1.7 1.1 0.1 0.8 0.6 ZNF3 "A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113" ENSG00000166526 "Zinc finger protein 3" P17036 7 100064033-100082548 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003719 Supported Supported Approved Nucleoplasm Nucleoplasm "HPA003719: AB_1080701" "unprognostic (5.92e-2)" "unprognostic (3.82e-2)" "unprognostic (1.00e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (2.76e-2)" "unprognostic (1.10e-1)" "prognostic favourable (5.73e-4)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.65e-1)" "unprognostic (2.50e-3)" "unprognostic (7.54e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-3)" "unprognostic (1.24e-1)" "unprognostic (3.41e-2)" "prognostic favourable (2.20e-4)" 16.1 12.8 12.8 9.8 16.8 20.7 19.2 18.3 22.6 18.6 16.4 39.5 16.6 19.3 23.9 20.5 15.2 33.9 11.6 11.5 14.8 11.2 15.0 19.3 11.7 11.1 20.8 11.1 22.5 18.9 17.9 17.8 13.3 21.1 15.6 17.8 19.7 16.4 16.3 18.9 15.4 22.1 14.6 18.0 15.6 16.0 11.8 21.9 21.4 17.6 11.1 16.6 16.7 15.5 16.2 11.2 17.9 12.2 17.3 17.2 9.4 6.1 6.9 19.0 27.1 9.6 7.5 11.1 7.8 8.9 12.0 10.2 8.6 9.2 8.8 14.3 7.5 8.4 14.0 8.5 9.8 9.7 11.8 7.2 8.9 11.6 11.4 12.8 6.7 9.3 10.7 8.0 18.7 10.6 19.9 14.0 10.8 16.5 30.0 12.8 26.1 12.6 12.8 15.3 21.9 10.7 12.1 21.3 29.6 9.2 27.4 12.1 8.1 13.0 8.1 14.9 10.7 10.6 10.1 18.9 21.3 17.6 7.5 11.5 13.9 12.3 9.8 17.9 14.2 9.6 17.2 13.3 12.5 14.9 9.9 16.2 14.2 15.5 4.1 17.3 12.2 11.2 11.5 9.4 12.8 16.8 18.3 22.6 14.8 11.2 20.8 11.1 21.1 21.9 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favourable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.7 8.2 3.5 8.8 6.4 4.1 0.1 3.6 2.6 3.4 3.7 5.8 1.2 0.0 4.8 2.3 2.3 10.1 5.2 4.2 0.0 4.8 2.7 4.5 4.4 3.2 3.6 2.5 3.5 4.6 3.4 4.5 5.2 8.8 0.0 5.3 2.8 2.6 1.6 4.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.7 0.0 0.1 3.4 3.3 1.0 3.8 7.1 3.7 2.6 4.9 2.4 11.6 1.0 1.4 0.0 4.1 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 ZNF319 "KIAA1388, Zfp319" ENSG00000166188 "Zinc finger protein 319" Q9P2F9 16 57994668-58000453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052584 Uncertain Approved Nucleoplasm Nucleoplasm "HPA052584: " "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (3.82e-1)" "unprognostic (2.13e-1)" "prognostic unfavourable (1.90e-4)" "unprognostic (7.63e-2)" "unprognostic (1.15e-1)" "unprognostic (4.87e-2)" "prognostic favourable (5.87e-5)" "unprognostic (8.69e-2)" "unprognostic (3.72e-3)" "unprognostic (4.49e-1)" "unprognostic (1.82e-1)" "unprognostic (3.53e-2)" "unprognostic (5.80e-2)" 8.0 8.4 7.6 7.5 7.7 21.3 7.1 11.2 15.0 11.0 8.0 10.6 5.1 6.7 12.0 8.0 6.1 9.7 10.6 6.7 7.3 8.2 7.8 5.7 8.5 10.4 7.1 6.2 13.7 10.6 17.1 7.0 9.4 9.4 8.7 4.3 11.2 8.6 10.8 8.9 6.9 6.6 8.8 6.4 13.9 6.5 6.1 6.0 16.9 19.8 5.6 10.2 11.2 6.2 1.6 2.9 7.4 2.6 1.8 5.3 2.5 4.8 13.3 6.6 8.8 6.1 7.4 5.6 7.0 6.9 6.8 3.3 5.2 2.9 8.2 12.8 6.7 5.4 5.4 7.5 4.2 3.6 5.2 3.0 5.7 6.2 12.1 3.9 10.5 10.9 8.8 5.4 11.8 4.3 6.5 1.3 5.6 4.3 7.6 6.8 3.6 13.3 13.5 4.4 8.1 4.4 12.6 4.7 5.0 11.6 4.4 4.4 1.6 5.9 8.2 5.4 3.2 2.7 5.3 7.5 3.1 6.4 4.0 4.1 5.7 0.0 2.6 7.4 5.3 1.9 3.6 1.6 2.8 3.7 2.9 1.6 1.9 3.0 4.8 1.8 1.5 1.1 2.3 2.5 7.6 7.7 11.2 15.0 7.3 8.2 7.1 6.2 9.4 6.0 ZNF32 KOX30 ENSG00000169740 "Zinc finger protein 32" P17041 10 43643859-43648856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" "Nuclear bodies" Nucleoplasm "HPA039148: " "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavourable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favourable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 14.4 16.2 24.4 12.4 23.6 4.4 29.2 21.1 20.1 20.2 20.4 19.0 18.0 7.9 21.9 37.7 12.6 20.7 14.7 26.1 22.2 20.8 22.1 17.7 13.7 12.2 27.7 17.7 28.7 26.0 18.7 20.3 10.3 22.5 22.5 15.1 14.7 18.5 25.4 45.7 14.4 11.0 23.4 19.8 14.2 14.5 8.6 25.8 15.4 25.8 14.5 15.4 17.9 25.4 14.2 11.2 8.5 6.9 23.0 21.7 10.3 9.8 8.8 13.3 20.1 24.6 26.6 4.3 8.8 26.8 16.6 15.0 5.9 5.1 0.0 15.7 18.8 5.9 8.5 8.6 12.2 10.8 9.4 2.6 5.5 6.8 23.1 0.2 8.1 27.2 19.9 10.2 12.5 12.5 7.6 0.0 20.8 9.0 9.8 9.0 10.3 4.6 15.2 15.0 2.2 16.6 3.9 17.1 15.2 7.3 5.4 13.8 20.1 9.2 5.3 9.3 11.3 6.7 2.1 5.9 15.5 0.0 3.3 6.3 8.6 4.1 6.9 8.5 19.3 6.1 19.1 13.3 15.5 21.4 11.2 14.2 20.0 21.7 0.6 23.0 5.4 9.5 10.8 10.3 24.4 23.6 21.1 20.1 22.2 20.8 27.7 17.7 22.5 25.8 ZNF324 "ZF5128, ZNF324A" ENSG00000083812 "Zinc finger protein 324" O75467 19 58467045-58475436 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA039774 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nucleoplasm, Nuclear membrane, Cytosol" "HPA039774: AB_10673149" "unprognostic (8.60e-2)" "unprognostic (7.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.12e-3)" "unprognostic (3.69e-3)" "unprognostic (2.36e-2)" "unprognostic (5.09e-3)" "unprognostic (2.84e-1)" "unprognostic (1.57e-1)" "prognostic favourable (4.74e-5)" "unprognostic (6.39e-2)" "prognostic favourable (1.34e-7)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "prognostic unfavourable (6.99e-4)" "unprognostic (3.56e-1)" 7.7 8.0 8.9 11.5 10.8 12.6 7.4 15.8 14.0 9.8 8.8 11.9 10.2 8.5 12.0 9.1 12.7 10.5 9.2 7.6 9.9 9.3 6.5 10.5 7.7 10.5 10.4 11.5 14.6 15.0 10.2 12.7 7.1 7.1 10.6 6.0 7.2 11.2 13.3 5.8 11.9 7.3 8.2 9.3 8.3 8.6 8.0 9.7 16.8 11.9 8.1 10.7 9.3 7.2 6.4 6.4 13.1 5.0 6.0 11.8 3.4 4.0 5.1 3.5 5.3 4.0 3.5 3.8 3.3 4.1 3.3 3.0 4.5 2.0 6.3 3.1 2.7 5.1 4.5 4.5 1.6 5.5 34.8 4.4 3.9 2.1 3.2 7.3 5.2 2.6 5.6 4.7 2.2 2.3 6.2 4.1 3.6 3.3 6.5 4.0 2.8 7.8 7.0 4.4 4.0 2.4 8.2 7.1 5.6 3.6 5.8 2.5 2.9 5.3 4.1 10.0 2.2 3.5 5.6 6.0 6.0 3.2 5.0 3.6 3.1 2.3 4.7 7.2 9.5 5.0 10.7 5.3 7.6 10.5 3.2 6.4 11.8 8.9 13.1 6.0 3.9 6.4 7.2 3.4 8.9 10.8 15.8 14.0 9.9 9.3 10.4 11.5 7.1 9.7 ZNF329 FLJ12586 ENSG00000181894 "Zinc finger protein 329" Q86UD4 19 58126252-58155110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044373 Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "HPA044373: AB_10966569" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (6.01e-2)" "unprognostic (2.58e-1)" "unprognostic (6.53e-3)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-3)" "prognostic favourable (8.58e-9)" "unprognostic (9.23e-2)" "unprognostic (1.37e-2)" "unprognostic (1.78e-2)" "unprognostic (2.52e-1)" 7.1 7.2 9.2 5.2 11.7 10.3 11.7 15.9 14.7 10.8 6.9 8.1 5.7 3.5 10.6 10.7 5.6 10.5 7.0 6.7 9.2 10.0 11.8 8.0 6.9 6.8 8.5 6.7 11.2 5.4 20.4 10.7 7.9 10.6 10.1 6.1 9.7 7.1 9.1 2.7 7.2 5.9 9.6 6.5 8.2 6.1 23.7 7.6 8.6 11.3 3.5 8.0 8.7 15.1 8.0 5.0 6.4 1.7 5.3 7.6 2.2 3.2 1.7 7.6 13.2 6.2 6.4 0.1 4.2 8.9 4.6 3.5 1.4 2.5 2.0 2.3 7.5 1.1 1.3 5.8 5.6 1.5 10.3 6.6 2.3 2.4 6.0 3.9 6.4 6.6 6.2 4.5 9.2 5.9 1.6 8.8 6.5 1.1 6.7 2.4 5.7 5.6 3.7 7.5 2.0 4.9 6.5 5.1 4.8 6.7 0.8 3.3 7.6 2.2 3.6 12.0 3.3 1.1 0.0 5.2 15.3 4.8 2.6 0.1 6.9 4.8 1.6 6.4 2.5 1.7 4.4 5.8 4.8 4.3 2.1 8.0 7.6 4.6 4.9 5.3 1.1 5.0 2.1 2.2 9.2 11.7 15.9 14.7 9.2 10.0 8.5 6.7 10.6 7.6 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53520981-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 66.4;ovary: 86.4" "Cell line enhanced" "Detected in many" "HEK 293: 36.6;RT4: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm Nucleoplasm "HPA063157: " "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavourable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavourable (7.43e-4)" "unprognostic (6.74e-2)" 19.1 66.4 6.8 9.0 8.2 18.6 10.5 11.4 9.5 9.4 5.3 8.4 8.9 2.1 9.5 11.6 4.9 19.5 23.8 15.5 5.1 7.7 6.6 6.1 15.6 4.0 6.8 5.5 86.4 9.9 11.3 29.0 23.3 7.2 10.2 4.2 9.9 4.7 31.5 6.3 5.2 4.8 8.5 9.1 4.5 6.3 8.1 6.0 3.8 7.8 4.4 4.8 25.7 9.2 8.1 4.1 6.5 7.4 4.6 14.7 5.2 0.1 5.1 10.3 11.9 8.0 6.0 17.3 7.4 6.5 5.6 10.3 5.5 2.6 4.1 1.9 4.3 3.0 7.5 5.5 10.1 0.0 36.6 5.2 8.7 3.4 5.9 3.2 7.2 6.0 3.6 6.2 3.0 2.5 0.2 1.6 5.5 3.6 7.3 6.8 4.6 7.7 9.0 6.5 4.2 3.4 28.0 7.4 7.5 3.5 9.7 2.4 1.7 2.9 2.6 7.9 7.0 4.6 4.8 20.4 13.3 7.8 0.1 0.4 6.2 0.5 4.9 6.5 8.7 3.8 13.4 8.1 9.4 8.8 3.6 8.1 14.7 9.7 0.7 4.6 7.4 4.1 9.4 5.2 6.8 8.2 11.4 9.5 5.1 7.7 6.8 5.5 7.2 6.0 ZNF333 KIAA1806 ENSG00000160961 "Zinc finger protein 333" Q96JL9 19 14689801-14733746 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043973, HPA054680" Uncertain Approved Nucleoplasm Nucleoplasm "HPA043973: AB_10961277, HPA054680: " "unprognostic (8.16e-2)" "unprognostic (2.80e-4)" "unprognostic (5.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-2)" "unprognostic (1.45e-3)" "unprognostic (2.98e-2)" "unprognostic (2.17e-3)" "unprognostic (2.12e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-3)" "unprognostic (3.46e-2)" "unprognostic (1.32e-5)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.62e-1)" "unprognostic (7.06e-3)" 10.7 8.1 8.8 7.8 11.3 12.2 9.4 16.2 12.1 11.4 9.9 14.3 7.0 4.5 16.5 11.0 5.3 10.8 6.6 6.3 8.6 6.9 5.8 4.9 8.7 7.3 16.8 9.8 15.3 9.1 8.2 7.5 7.4 10.3 8.8 5.9 10.3 5.7 8.5 14.5 7.7 6.5 11.6 9.6 13.0 6.7 8.8 12.8 6.7 6.9 4.3 6.6 9.5 8.8 2.7 4.9 7.9 5.0 13.5 5.4 2.4 1.5 0.9 5.7 7.7 8.3 7.8 2.2 3.5 4.8 3.0 4.4 0.4 1.4 2.4 3.9 4.5 1.4 2.0 1.4 4.6 5.5 1.5 9.8 2.1 2.4 6.8 3.9 5.6 7.1 3.8 2.8 8.0 4.4 2.0 4.7 3.8 0.8 2.5 9.4 2.3 1.7 3.6 3.2 2.3 3.0 2.0 3.1 6.1 3.1 0.4 5.6 1.5 6.6 7.1 5.2 2.4 8.3 3.6 2.2 1.0 2.4 5.4 6.8 6.1 7.9 4.0 6.0 4.0 5.0 5.4 2.6 3.6 3.0 4.9 2.7 4.1 3.6 7.0 13.5 4.3 2.4 3.0 2.4 8.8 11.3 16.2 12.1 8.6 6.9 16.8 9.8 10.3 12.8 ZNF334 bA179N14.1 ENSG00000198185 "Zinc finger protein 334" Q9HCZ1 20 46499630-46513559 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.9;BEWO: 16.2;NTERA-2: 8.7;SCLC-21H: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "NK-cell: 2.7;plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 5 "dendritic cells: 3.6;NK-cells: 2.7" "Low region specificity" "Detected in all" HPA050022 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA050022: " "unprognostic (3.04e-2)" "unprognostic (1.28e-2)" "unprognostic (3.68e-1)" "unprognostic (2.74e-4)" "unprognostic (9.08e-2)" "unprognostic (5.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (3.62e-2)" "unprognostic (8.25e-2)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.55e-3)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "unprognostic (1.71e-3)" 3.1 7.3 11.1 2.2 14.3 1.9 9.5 18.2 12.0 6.4 2.6 8.1 11.5 2.9 9.2 13.4 2.4 12.1 5.8 2.1 9.8 7.8 6.8 4.1 4.7 2.1 5.8 6.9 22.5 7.5 2.9 20.4 7.0 11.5 12.8 3.5 7.0 6.8 10.0 1.5 3.0 3.8 4.9 7.6 3.1 7.0 8.3 8.8 2.7 10.8 1.7 1.8 5.2 4.5 0.4 3.6 0.2 0.5 2.7 0.1 0.1 0.0 0.0 12.9 0.1 0.9 0.1 16.2 1.1 0.1 1.0 0.1 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.2 0.5 0.0 2.7 4.1 0.1 4.6 3.5 0.1 0.0 4.2 0.0 1.1 0.0 0.1 2.7 0.0 0.1 0.0 0.0 7.3 8.7 1.1 0.0 0.0 0.0 3.5 3.1 10.8 6.1 0.0 0.3 0.2 0.0 3.6 0.0 0.1 5.9 0.1 0.0 1.0 5.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.1 2.7 0.0 3.6 0.0 0.1 11.1 14.3 18.2 12.0 9.8 7.8 5.8 6.9 11.5 8.8 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: " "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favourable (3.93e-4)" "prognostic unfavourable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 4.5 4.3 7.3 6.9 10.4 7.7 5.1 10.4 9.1 6.5 4.9 7.2 2.1 5.8 6.5 3.5 6.7 5.4 5.2 4.5 6.8 3.1 3.1 3.6 4.7 5.5 8.8 6.3 5.5 5.4 4.0 5.2 5.4 4.9 4.9 4.9 3.7 5.7 6.9 7.2 8.2 5.0 4.9 4.2 5.8 4.5 7.4 6.9 4.9 4.9 2.9 4.7 6.5 5.5 2.6 1.5 5.9 2.4 2.2 2.4 1.4 1.8 8.1 3.0 4.0 2.9 2.1 11.0 2.8 1.7 2.7 1.3 6.1 5.2 3.7 3.7 1.9 3.5 2.7 4.8 0.9 3.6 2.7 4.2 3.3 2.8 1.0 2.4 4.6 2.0 2.9 2.1 1.2 2.7 2.2 1.5 2.3 3.7 2.2 1.0 2.5 4.2 2.5 1.3 1.8 1.5 6.2 2.1 1.9 8.1 5.4 1.0 6.2 2.1 2.1 3.5 1.2 0.8 2.2 1.2 1.6 2.9 4.3 1.6 2.6 3.5 1.9 5.9 1.9 2.4 1.6 2.6 1.2 1.3 1.5 2.5 1.1 2.4 3.8 2.2 1.5 1.1 1.0 1.4 7.3 10.4 10.4 9.1 6.8 3.1 8.8 6.3 4.9 6.9 ZNF343 MGC10715 ENSG00000088876 "Zinc finger protein 343" Q6P1L6 20 2481817-2524702 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA030587, HPA052438" Approved Approved Nucleoplasm Nucleoplasm "HPA030587: AB_10603246, HPA052438: " "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-3)" "unprognostic (3.83e-1)" "unprognostic (1.28e-1)" "prognostic unfavourable (1.38e-6)" "unprognostic (9.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-1)" "unprognostic (4.88e-1)" "unprognostic (5.60e-2)" "prognostic unfavourable (4.53e-5)" "unprognostic (1.65e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-2)" "unprognostic (9.53e-2)" 11.6 8.6 10.4 8.0 11.9 3.9 12.4 20.6 15.0 10.6 12.3 10.7 8.5 5.1 13.9 18.0 8.9 10.6 8.1 7.8 10.0 7.1 9.3 8.0 9.4 9.9 9.1 7.6 12.7 12.8 17.2 10.9 9.4 10.4 10.2 10.1 9.0 8.7 10.4 13.8 11.3 7.5 13.0 9.1 8.2 8.9 7.5 9.5 5.4 11.4 6.6 9.8 11.3 12.9 8.9 5.3 4.5 3.9 1.8 7.6 3.0 9.4 10.2 6.9 7.6 8.0 8.3 2.4 6.6 7.4 8.2 8.5 5.3 5.6 12.2 2.5 6.6 9.0 10.6 12.1 10.6 3.2 5.2 7.9 4.5 10.5 7.1 4.7 2.9 7.5 12.1 9.9 15.9 8.1 10.1 6.2 7.8 3.3 10.1 3.1 7.0 10.9 8.3 9.3 7.2 4.1 2.5 8.0 12.8 8.3 13.7 7.8 4.8 4.0 5.2 11.3 5.2 8.2 7.5 12.7 20.1 6.3 3.0 6.5 6.6 0.6 3.9 4.5 5.1 3.8 5.4 7.0 6.3 4.4 3.9 8.9 5.8 7.6 3.3 1.8 3.4 5.3 5.7 3.0 10.4 11.9 20.6 15.0 10.0 7.1 9.1 7.6 10.4 9.5 ZNF35 "HF.10, HF10, Zfp105" ENSG00000169981 "Zinc finger protein 35" P13682 3 44648727-44660791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051859, HPA054738" Uncertain Approved Nucleoplasm Nucleoplasm "HPA051859: AB_2681642, HPA054738: AB_2682588" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (8.91e-3)" "unprognostic (9.91e-2)" "unprognostic (6.68e-2)" "unprognostic (1.48e-1)" "unprognostic (2.01e-2)" "unprognostic (4.54e-2)" "unprognostic (1.47e-2)" "unprognostic (1.69e-2)" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (8.64e-2)" "unprognostic (1.60e-3)" "unprognostic (3.30e-1)" 8.8 5.9 8.3 6.2 10.4 6.2 8.2 8.7 11.5 8.1 8.3 8.4 7.2 5.2 10.8 11.0 8.8 6.4 6.8 7.9 7.3 6.3 10.2 4.5 7.1 5.3 8.2 7.0 6.4 6.3 8.4 15.3 5.9 10.8 8.7 6.6 7.7 7.2 8.8 8.1 7.9 7.6 12.0 8.5 11.9 7.4 17.7 7.5 3.9 7.9 8.4 8.8 8.3 7.0 4.0 3.9 1.5 4.0 4.6 2.4 1.9 3.0 2.3 6.2 8.0 4.1 3.2 1.2 3.8 5.3 6.7 6.4 4.2 1.4 2.7 1.7 5.2 2.2 0.3 5.5 7.0 0.0 2.2 8.9 4.3 0.2 3.7 8.8 6.9 3.4 4.3 6.0 5.4 5.4 5.9 2.6 7.3 2.0 0.2 2.9 13.8 6.6 0.1 6.6 4.7 3.5 8.8 3.5 8.9 4.8 3.0 0.8 8.0 5.5 5.5 7.2 5.3 3.9 7.6 7.2 10.9 1.5 6.2 4.3 5.5 0.0 3.8 1.5 2.2 4.0 1.4 3.6 0.6 2.4 3.9 4.0 1.1 1.2 0.2 4.6 3.7 1.6 0.2 1.9 8.3 10.4 8.7 11.5 7.3 6.3 8.2 7.0 10.8 7.5 ZNF354B "FLJ25008, KID2" ENSG00000178338 "Zinc finger protein 354B" Q96LW1 5 178859953-178888122 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029056 Approved Approved Nucleoplasm Nucleoplasm "HPA029056: AB_10603006" "unprognostic (2.15e-1)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (4.19e-2)" "unprognostic (5.24e-1)" "prognostic favourable (9.52e-4)" "unprognostic (2.88e-4)" "unprognostic (6.72e-2)" "unprognostic (1.26e-3)" "unprognostic (1.11e-3)" "unprognostic (6.22e-2)" "unprognostic (1.80e-2)" "prognostic unfavourable (1.30e-5)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.32e-2)" "unprognostic (3.15e-3)" 14.2 8.8 13.1 9.4 15.3 5.4 15.0 22.8 13.3 14.5 11.7 8.1 9.3 8.9 14.2 10.0 8.6 10.7 9.2 7.3 13.7 5.6 10.0 7.4 9.8 10.3 15.8 7.7 13.0 13.0 15.8 20.4 28.6 11.2 13.3 8.1 4.7 10.7 11.7 12.9 10.7 9.8 9.7 11.6 12.4 10.1 7.3 16.3 12.8 15.5 8.3 9.5 11.6 11.9 8.1 3.8 2.6 3.3 2.2 5.9 1.6 4.4 3.5 6.5 14.7 6.4 6.3 16.6 5.5 5.0 5.4 6.2 4.3 7.8 0.0 6.0 4.9 9.1 8.2 9.1 6.6 0.0 6.7 5.1 11.4 3.2 5.6 0.1 3.6 5.7 5.6 4.4 6.8 4.8 4.1 0.0 5.8 4.9 8.0 11.4 3.4 4.7 7.7 3.5 4.8 4.6 5.3 7.3 7.6 6.7 5.9 4.3 5.2 8.8 5.5 9.5 8.5 3.4 4.0 3.2 4.6 0.2 0.6 0.0 4.9 2.6 3.3 1.3 5.9 1.9 5.4 4.8 4.2 3.3 2.8 8.1 5.1 5.1 0.9 2.2 2.2 3.8 3.5 1.6 13.1 15.3 22.8 13.3 13.7 5.6 15.8 7.7 11.2 16.3 ZNF358 "FLJ10390, ZFEND" ENSG00000198816 "Zinc finger protein 358" Q9NW07 19 7515292-7521026 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030887, HPA063624" Approved Approved Nucleoplasm Nucleoplasm "HPA030887: AB_10602688, HPA063624: " "unprognostic (1.32e-2)" "unprognostic (3.40e-1)" "unprognostic (1.34e-2)" "unprognostic (1.59e-2)" "unprognostic (9.89e-3)" "unprognostic (7.82e-2)" "unprognostic (7.40e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (6.52e-2)" "prognostic favourable (2.50e-4)" "unprognostic (4.30e-1)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.00e-1)" "unprognostic (9.72e-2)" "unprognostic (3.60e-2)" 23.7 21.1 33.6 7.9 26.1 2.1 31.6 21.4 54.7 30.1 26.1 20.2 17.5 19.2 22.4 19.5 18.0 27.9 20.9 36.4 29.1 22.5 17.4 17.9 14.4 6.8 24.9 20.2 46.1 25.0 21.1 17.7 12.2 15.0 23.1 12.6 19.1 32.3 30.8 95.9 11.7 18.0 24.9 16.8 13.8 18.3 8.5 18.3 4.4 27.3 13.5 7.7 24.7 24.3 2.6 1.4 4.6 1.8 0.7 2.4 0.7 10.3 7.0 13.2 21.0 28.5 31.7 11.4 3.9 25.8 18.0 15.9 3.0 7.4 0.0 15.4 21.1 4.1 5.4 10.1 5.8 0.0 11.7 2.0 8.7 4.2 31.3 0.3 0.1 27.5 19.1 8.5 7.4 18.9 5.2 0.0 15.9 5.1 0.0 7.5 13.6 12.5 11.5 7.1 1.1 9.4 4.5 14.7 29.4 4.9 4.1 14.1 3.1 5.5 8.8 11.6 8.5 17.2 5.9 14.1 7.6 0.0 10.7 0.0 16.0 4.6 1.7 1.1 1.8 1.8 1.3 0.4 0.6 1.0 0.9 2.6 1.4 2.4 0.0 0.7 0.4 1.4 0.0 0.7 33.6 26.1 21.4 54.7 29.1 22.5 24.9 20.2 15.0 18.3 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256545-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA059239: " "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 21.6 14.0 18.1 12.0 17.2 8.9 21.7 24.5 30.5 18.6 17.3 13.8 9.6 11.0 23.7 23.8 14.2 20.1 20.7 28.0 15.4 13.8 16.8 8.8 18.7 26.3 12.8 15.6 23.3 19.9 16.4 19.1 17.9 12.3 20.4 8.8 27.4 22.8 21.7 26.1 23.5 11.6 28.1 13.1 22.6 14.0 8.5 10.3 17.9 17.4 14.1 15.3 20.1 15.4 6.0 8.3 6.0 4.6 4.2 4.7 2.5 3.3 5.4 23.4 9.3 6.2 4.3 15.4 4.6 5.5 5.8 6.1 5.5 11.3 1.7 10.2 5.8 11.1 5.4 2.6 2.4 9.9 4.9 8.4 3.2 6.7 5.5 4.0 6.9 9.3 6.5 2.5 2.2 7.8 0.9 2.9 4.4 8.0 12.9 6.6 13.9 5.1 21.0 5.6 0.7 4.6 5.3 8.3 25.1 13.2 4.2 20.7 4.0 10.3 11.3 3.5 4.7 8.2 3.0 8.8 8.1 1.8 2.8 3.6 10.2 3.8 4.6 6.0 4.7 4.1 3.4 3.0 3.5 4.1 3.3 6.0 3.1 2.9 3.5 4.2 4.5 8.3 2.6 2.5 18.1 17.2 24.5 30.5 15.4 13.8 12.8 15.6 12.3 10.3 ZNF384 "CAGH1A, CIZ, NMP4, NP, TNRC1" ENSG00000126746 "Zinc finger protein 384" Q8TF68 12 6666477-6689572 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004051 Supported Approved Nucleoplasm Nucleoplasm "HPA004051: AB_1859228" "unprognostic (1.90e-1)" "unprognostic (5.11e-3)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (3.04e-2)" "unprognostic (1.87e-2)" "unprognostic (9.94e-2)" "unprognostic (1.35e-2)" "unprognostic (2.57e-2)" "unprognostic (3.51e-2)" "unprognostic (4.25e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.22e-1)" "unprognostic (2.06e-1)" "unprognostic (8.13e-2)" 20.5 22.8 18.9 30.9 19.9 33.4 22.1 36.1 23.0 23.2 23.3 19.5 16.8 22.1 29.8 17.6 21.1 24.2 25.3 16.1 16.0 10.8 20.7 19.9 19.7 21.9 19.7 17.7 31.3 25.8 25.8 20.5 23.9 14.8 22.7 21.4 18.6 22.4 20.6 22.7 24.1 29.4 24.8 14.2 33.6 21.3 20.5 18.7 39.7 27.0 17.5 29.7 25.2 28.9 10.2 11.1 14.2 13.3 15.6 17.3 7.3 10.6 20.5 25.3 16.9 17.9 12.7 34.0 15.5 14.5 15.0 16.1 22.5 22.9 25.3 5.9 17.4 14.5 18.6 14.2 17.2 45.6 16.9 28.9 27.2 11.7 12.6 27.4 21.4 13.9 13.8 18.5 28.9 13.0 15.0 8.7 16.4 16.6 24.6 17.6 48.9 9.0 24.5 27.1 9.7 13.3 28.8 7.9 25.6 16.0 21.5 13.8 5.6 22.7 16.0 16.5 23.2 12.9 18.2 12.2 11.6 46.1 16.3 9.9 18.7 3.3 8.0 14.2 17.3 9.7 13.8 10.2 11.0 13.6 11.1 8.8 10.8 12.1 14.2 15.6 13.3 7.4 13.2 7.3 18.9 19.9 36.1 23.0 16.0 10.8 19.7 17.7 14.8 18.7 ZNF385A "DKFZp586G1122, Hzf, ZFP385, ZNF385" ENSG00000161642 "Zinc finger protein 385A" Q96PM9 12 54369133-54391298 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation, Translation regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 81.6" "Cell line enhanced" "Detected in many" "HaCaT: 28.8;HBEC3-KT: 27.4;HEL: 34.4;hTCEpi: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 10 "dendritic cells: 16.6;monocytes: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039799 Supported Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "HPA039799: AB_10795117" "unprognostic (8.56e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (5.20e-4)" "unprognostic (6.70e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-3)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "prognostic unfavourable (9.75e-5)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (2.43e-1)" "unprognostic (6.07e-3)" 23.7 4.3 23.6 16.3 27.3 16.8 7.9 13.2 32.5 7.9 5.7 12.8 2.3 4.8 3.2 10.7 28.1 6.2 8.9 4.3 18.4 22.6 2.3 3.8 11.6 8.9 31.8 15.4 2.0 2.0 13.8 8.5 12.6 19.4 10.3 5.4 35.5 8.9 10.1 5.9 81.6 5.7 8.7 16.4 13.9 4.4 2.1 16.1 5.5 18.1 21.9 21.9 25.8 14.9 0.8 16.6 1.6 16.8 0.0 0.2 6.6 0.8 3.4 5.2 6.5 6.0 4.0 14.3 0.6 2.6 2.7 2.3 6.9 2.5 1.9 2.3 1.4 28.8 1.9 27.4 0.9 1.8 2.7 34.4 2.2 1.3 2.7 0.5 24.1 3.5 30.9 3.0 7.7 1.6 16.5 0.1 1.2 15.3 1.6 4.9 2.9 2.7 6.1 0.4 6.7 2.1 22.5 2.3 10.4 0.2 19.5 1.4 23.0 14.4 1.7 1.5 3.4 1.7 1.7 0.5 0.1 1.6 6.1 1.6 3.8 1.6 15.3 0.0 0.0 16.8 0.0 0.6 0.0 0.0 16.6 0.8 0.0 0.2 1.2 0.0 11.9 1.6 0.0 6.6 23.6 27.3 13.2 32.5 18.4 22.6 31.8 15.4 19.4 16.1 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favourable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favourable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favourable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.7 7.7 5.2 10.9 8.1 5.6 10.3 6.6 8.8 7.7 7.5 8.1 8.5 9.2 9.5 6.8 7.5 7.0 8.4 7.6 6.7 9.2 9.1 9.1 8.9 6.5 12.9 15.9 7.3 7.3 7.5 8.0 8.7 13.0 18.5 7.0 14.5 13.3 21.2 11.6 9.2 7.6 5.7 16.1 8.3 11.1 6.2 12.9 7.7 18.7 12.4 4.8 16.1 9.1 9.3 9.4 13.4 8.2 15.2 15.9 15.0 6.6 13.1 9.8 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 ZNF395 "DKFZp434K1210, HDBP2, PBF, PRF-1" ENSG00000186918 "Zinc finger protein 395" Q9H8N7 8 28345585-28402701 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049382, HPA076275" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA049382: , HPA076275: " "unprognostic (1.28e-1)" "unprognostic (3.02e-1)" "unprognostic (1.95e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-2)" "unprognostic (4.51e-2)" "prognostic unfavourable (1.66e-4)" "unprognostic (9.35e-3)" "unprognostic (8.90e-2)" "unprognostic (2.15e-2)" "unprognostic (7.08e-2)" "unprognostic (2.25e-2)" "prognostic unfavourable (5.71e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-1)" "unprognostic (2.46e-2)" "unprognostic (7.42e-2)" 17.4 10.7 10.0 13.3 10.9 18.6 19.0 7.4 10.1 16.8 22.5 9.7 13.4 12.1 12.0 11.9 27.2 16.9 14.1 15.0 10.4 5.4 13.1 19.5 11.3 18.0 9.0 6.8 33.8 27.8 9.8 9.5 19.6 7.6 22.1 8.3 13.7 21.7 11.1 13.8 23.2 16.3 13.8 8.8 11.9 14.2 12.3 10.8 9.6 18.2 10.2 25.3 27.5 27.6 13.7 6.4 10.6 4.2 3.3 7.2 2.1 48.7 7.0 6.7 18.4 5.1 7.5 19.3 6.0 10.5 4.8 11.5 11.1 8.6 23.3 20.7 9.3 10.6 6.0 14.7 9.5 3.8 4.7 5.8 1.4 2.2 5.3 2.3 2.5 13.0 20.3 0.8 12.7 2.5 5.9 5.2 6.7 8.3 10.9 7.5 10.4 8.2 10.7 7.2 7.7 11.2 9.7 18.5 19.2 1.5 3.7 9.6 7.3 5.8 0.7 10.3 12.5 5.5 2.5 6.4 3.3 15.3 27.1 4.8 9.0 6.7 4.2 10.6 4.8 0.8 4.6 10.0 5.6 5.6 1.6 13.7 7.2 4.9 1.8 3.3 0.6 6.4 2.1 2.1 10.0 10.9 7.4 10.1 10.4 5.4 9.0 6.8 7.6 10.8 ZNF398 "KIAA1339, P51, P71, ZER6" ENSG00000197024 "Zinc finger protein 398" Q8TD17 7 149126416-149182802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NTERA-2: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071533 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA071533: " "unprognostic (4.11e-1)" "unprognostic (8.56e-2)" "unprognostic (3.90e-2)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (6.65e-3)" "unprognostic (2.94e-3)" "unprognostic (2.27e-2)" "unprognostic (3.64e-3)" "unprognostic (1.43e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (1.45e-1)" "unprognostic (3.97e-2)" "unprognostic (9.27e-2)" "unprognostic (9.17e-2)" "unprognostic (1.89e-1)" 8.9 8.1 12.7 10.2 12.5 15.6 10.6 25.9 16.0 11.7 10.7 10.2 10.5 8.8 9.8 10.2 14.3 10.4 8.6 9.3 10.9 9.0 9.3 10.7 9.2 10.0 10.7 11.4 11.1 13.4 14.7 20.9 8.6 9.8 12.7 8.6 8.5 11.2 12.5 10.0 17.2 9.5 9.7 9.8 12.6 11.1 18.1 12.6 13.0 8.7 7.4 12.3 9.9 11.1 2.9 1.6 6.1 2.0 1.9 3.8 1.2 7.4 6.3 4.9 9.5 7.4 5.2 6.3 4.6 5.9 5.3 5.8 5.3 3.6 8.8 5.3 7.7 6.3 8.4 5.8 3.7 5.8 11.7 5.8 5.0 3.5 5.1 6.5 6.1 5.9 8.5 5.7 6.1 3.5 9.0 3.2 5.6 9.5 9.6 6.7 35.3 6.7 7.5 5.6 6.6 3.9 12.6 7.4 8.1 6.4 7.8 3.8 4.9 7.3 4.7 5.4 1.5 9.6 5.6 10.1 4.8 6.7 7.4 5.4 5.2 5.1 1.6 6.1 3.1 2.0 3.7 2.9 2.1 3.4 1.5 2.5 3.3 3.8 3.1 1.9 1.7 1.6 3.0 1.2 12.7 12.5 25.9 16.0 10.9 9.0 10.7 11.4 9.8 12.6 ZNF407 "FLJ13839, FLJ20307, KIAA1703" ENSG00000215421 "Zinc finger protein 407" Q9C0G0 18 74597870-75065671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028255, HPA041673" Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA028255: AB_10603466, HPA041673: " "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (2.48e-1)" "unprognostic (8.62e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-2)" "unprognostic (1.76e-2)" "unprognostic (4.31e-1)" "unprognostic (1.19e-3)" "unprognostic (4.04e-4)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "prognostic favourable (9.79e-5)" "unprognostic (8.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" 7.7 6.3 8.5 11.7 11.4 12.0 7.6 15.5 10.5 11.8 9.4 5.3 5.8 5.8 11.7 5.2 7.3 9.4 5.5 8.1 7.3 5.2 6.6 6.0 7.4 7.9 7.8 5.7 12.8 6.0 14.9 13.2 10.8 9.0 7.6 6.0 5.9 8.4 7.7 13.3 7.7 10.3 8.7 7.5 11.2 7.5 10.0 7.7 18.1 9.4 8.2 7.6 9.9 9.2 2.4 3.6 6.0 2.6 3.0 3.1 0.9 4.6 4.9 5.5 5.1 4.1 6.0 3.9 6.2 5.4 4.6 5.0 2.0 2.7 6.7 1.8 8.7 5.5 5.2 6.7 6.9 11.1 3.2 8.6 6.6 3.8 3.7 12.9 7.5 5.5 3.1 7.4 6.4 6.9 4.8 9.9 7.0 3.6 6.3 1.8 3.2 4.4 6.5 7.2 5.3 3.3 8.7 5.3 5.0 5.8 3.7 4.4 4.2 5.5 9.6 10.4 4.4 2.8 4.9 3.5 7.2 7.1 3.8 5.6 6.1 4.0 1.9 2.3 3.1 2.6 2.9 2.1 2.3 1.7 0.7 2.4 2.6 3.1 6.0 3.0 1.6 3.6 0.6 0.9 8.5 11.4 15.5 10.5 7.3 5.2 7.8 5.7 9.0 7.7 ZNF41 "MGC8941, MRX89" ENSG00000147124 "Zinc finger protein 41" P51814 X 47445879-47482946 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069102 Supported Approved Nucleoplasm Nucleoplasm "HPA069102: " "unprognostic (9.63e-2)" "unprognostic (1.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.72e-2)" "unprognostic (6.87e-2)" "prognostic favourable (8.32e-4)" "unprognostic (3.72e-1)" "unprognostic (5.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.17e-2)" "unprognostic (1.51e-1)" "unprognostic (4.23e-2)" "prognostic favourable (6.95e-4)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" 8.8 8.0 8.5 11.8 12.2 2.4 10.2 15.2 12.1 10.6 9.5 8.4 8.6 6.8 8.6 9.4 8.3 7.2 9.8 15.2 8.9 7.9 8.8 8.8 8.8 9.4 8.9 8.6 8.8 10.1 20.0 13.8 7.9 9.3 9.3 11.5 7.1 11.0 8.4 26.7 7.6 9.1 9.8 7.9 10.7 8.5 4.3 11.1 12.8 11.5 9.2 11.5 9.7 8.5 6.9 6.5 4.8 6.2 5.6 7.9 4.0 5.9 6.5 5.4 13.7 6.6 7.4 3.7 8.2 6.8 7.1 8.2 3.7 6.5 8.5 4.5 10.7 9.4 12.1 5.6 8.9 13.4 4.6 2.0 9.0 2.3 4.6 8.4 7.7 5.4 7.2 8.1 10.6 6.4 6.1 9.3 8.9 8.8 8.7 4.6 9.1 10.2 8.2 7.0 8.7 5.4 10.1 7.5 7.6 12.0 9.5 4.7 9.8 4.7 9.6 7.6 5.9 15.2 5.8 6.8 9.1 9.2 6.5 17.0 8.0 1.4 4.7 4.8 6.5 6.2 7.9 4.9 5.9 7.2 6.5 6.9 6.7 6.1 1.1 5.6 3.0 4.3 4.8 4.0 8.5 12.2 15.2 12.1 8.9 7.9 8.9 8.6 9.3 11.1 ZNF414 "MGC15716, Zfp414" ENSG00000133250 "Zinc finger protein 414" Q96IQ9 19 8509678-8514164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053769 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA053769: " "unprognostic (7.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.26e-3)" "prognostic favourable (4.17e-4)" "unprognostic (1.45e-1)" "prognostic favourable (1.67e-6)" "unprognostic (1.21e-1)" "unprognostic (2.32e-1)" "unprognostic (6.42e-2)" "unprognostic (7.29e-2)" "prognostic favourable (4.59e-4)" "unprognostic (1.08e-1)" "unprognostic (2.07e-2)" "unprognostic (3.84e-1)" "unprognostic (1.94e-1)" "unprognostic (1.91e-1)" "prognostic favourable (8.71e-4)" 16.6 16.2 14.3 13.6 22.7 20.8 10.6 17.6 28.6 13.2 10.9 22.4 5.6 21.4 16.6 10.0 11.6 11.6 9.7 9.9 14.1 11.4 12.0 13.1 10.7 15.8 15.5 14.8 16.7 13.7 9.2 15.3 14.0 17.3 15.8 4.6 13.4 20.5 14.1 23.6 25.5 16.6 7.7 12.5 22.8 19.1 13.6 20.3 19.9 15.7 6.1 13.5 11.8 12.3 3.0 3.4 5.4 2.1 2.5 2.7 1.2 5.4 4.7 2.6 4.1 0.7 1.6 5.7 4.1 1.6 2.7 2.5 4.1 2.7 7.5 12.0 1.3 7.6 0.8 3.4 0.4 6.7 18.9 4.7 4.3 4.9 3.7 4.1 6.4 3.0 2.5 2.2 0.8 1.1 6.2 11.1 1.7 6.7 9.2 23.9 7.7 13.4 10.8 1.3 7.5 1.9 4.5 8.9 13.9 4.5 3.5 3.7 6.6 4.8 4.3 8.0 4.1 11.6 5.3 16.2 6.7 5.9 6.4 3.5 4.3 3.0 1.6 0.8 1.8 1.4 1.0 2.5 2.7 2.7 1.6 3.0 2.6 2.6 5.4 2.5 2.1 3.4 1.4 1.2 14.3 22.7 17.6 28.6 14.1 11.4 15.5 14.8 17.3 20.3 ZNF420 FLJ32191 ENSG00000197050 "Zinc finger protein 420" Q8TAQ5 19 37007857-37130314 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA059675 Approved Approved Nucleoplasm Nucleoplasm "HPA059675: " "unprognostic (1.00e-2)" "unprognostic (5.00e-2)" "unprognostic (2.30e-2)" "unprognostic (5.40e-3)" "prognostic favourable (3.57e-5)" "unprognostic (7.94e-2)" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.14e-3)" "unprognostic (1.64e-1)" "unprognostic (5.24e-2)" "unprognostic (7.59e-2)" "prognostic favourable (1.83e-4)" "unprognostic (2.42e-1)" "unprognostic (7.23e-2)" "unprognostic (7.35e-3)" "unprognostic (1.63e-2)" 6.0 7.4 9.3 6.6 12.6 2.2 9.7 21.2 12.1 9.2 6.6 6.1 5.8 4.2 8.6 6.9 5.8 9.7 4.9 5.7 10.6 7.9 7.4 5.5 4.7 7.6 12.5 7.7 14.8 5.3 12.5 16.0 5.6 10.0 7.6 4.5 4.6 5.6 7.3 8.4 6.2 4.9 9.7 8.7 7.0 5.3 15.5 10.6 9.3 12.3 3.1 7.9 5.8 8.6 10.7 4.8 5.8 3.4 11.1 11.8 5.1 0.0 6.8 6.4 6.6 5.9 3.9 3.5 4.0 4.2 4.8 7.3 1.4 1.4 3.3 8.5 2.7 1.2 6.3 2.0 5.5 10.6 5.2 7.1 4.1 2.6 6.1 5.8 3.3 4.0 4.6 4.9 3.5 2.7 4.0 0.3 5.4 2.3 10.0 2.3 7.3 4.0 5.7 13.3 6.8 2.6 4.4 9.0 10.3 6.1 2.4 3.3 4.0 5.1 2.9 4.9 7.8 4.5 4.8 9.9 12.3 8.0 0.0 1.2 4.3 1.8 2.5 5.8 9.0 3.4 9.7 8.7 10.1 9.4 4.8 10.7 10.5 11.3 0.4 11.1 3.3 2.5 11.8 5.1 9.3 12.6 21.2 12.1 10.6 7.9 12.5 7.7 10.0 10.6 ZNF426 MGC2663 ENSG00000130818 "Zinc finger protein 426" Q9BUY5 19 9523224-9538645 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029342 Approved Approved Nucleoplasm Nucleoplasm "HPA029342: AB_10603007" "unprognostic (3.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (6.62e-2)" "prognostic favourable (3.74e-4)" "unprognostic (4.34e-2)" "unprognostic (1.77e-2)" "unprognostic (4.75e-3)" "unprognostic (1.05e-3)" "unprognostic (8.89e-3)" "unprognostic (7.41e-3)" "prognostic favourable (2.57e-6)" "unprognostic (1.05e-1)" "unprognostic (3.17e-2)" "unprognostic (2.49e-1)" "prognostic favourable (1.81e-4)" 8.0 7.0 6.5 5.0 8.9 6.7 9.3 13.5 8.8 10.9 7.8 7.5 7.2 3.9 10.3 7.2 28.2 8.5 5.9 7.1 8.0 4.5 6.6 3.1 6.8 7.2 6.4 5.4 12.8 5.8 9.1 7.9 7.3 7.0 8.4 5.4 7.8 8.8 7.7 6.7 6.6 5.6 10.5 8.0 5.9 6.7 7.9 7.3 9.9 9.1 6.7 7.4 11.1 11.9 8.8 4.4 9.8 6.7 8.7 12.7 3.9 4.4 1.5 9.1 9.6 6.1 8.1 5.1 5.7 8.6 7.6 9.4 2.0 2.1 4.4 4.6 5.5 3.8 9.4 6.7 11.5 2.1 7.2 18.5 7.5 3.4 5.6 0.6 6.0 10.3 5.8 8.5 12.3 8.2 7.3 0.5 7.3 0.4 10.5 9.0 11.4 3.5 5.7 11.3 4.6 4.2 11.6 5.2 6.9 9.6 3.5 7.8 4.8 4.3 6.6 10.8 6.3 4.8 6.0 5.3 7.3 3.8 1.6 0.3 7.7 9.8 3.9 6.9 11.2 5.6 9.9 8.6 8.7 10.9 4.4 8.8 12.7 11.9 8.3 8.7 6.7 4.1 8.1 3.9 6.5 8.9 13.5 8.8 8.0 4.5 6.4 5.4 7.0 7.3 ZNF429 ENSG00000197013 "Zinc finger protein 429" Q86V71 19 21496682-21556270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA004139 Approved Nucleoplasm Nucleoplasm "HPA004139: " "unprognostic (1.06e-1)" "unprognostic (1.88e-1)" "unprognostic (2.77e-1)" "unprognostic (1.75e-2)" "unprognostic (1.45e-2)" "unprognostic (3.13e-1)" "unprognostic (3.39e-2)" "unprognostic (1.95e-2)" "unprognostic (2.19e-1)" "prognostic favourable (1.96e-8)" "prognostic favourable (7.30e-4)" "unprognostic (5.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.48e-1)" 6.3 14.3 12.0 4.8 13.1 4.3 11.2 15.3 14.2 10.2 6.7 12.3 10.3 5.4 7.5 12.4 6.2 10.8 5.6 4.9 9.6 7.6 11.3 11.1 6.4 9.0 12.6 8.6 14.3 14.3 17.7 24.1 7.4 12.3 8.7 8.9 8.4 9.3 8.2 5.2 11.0 6.2 5.7 9.1 10.6 8.4 11.3 12.9 7.5 16.6 5.1 7.5 7.8 7.5 7.2 2.7 10.4 2.4 9.2 9.5 2.8 0.3 0.9 5.4 6.3 3.7 3.8 4.8 2.7 2.1 3.9 6.0 0.6 3.4 4.6 7.8 1.8 1.5 3.1 1.2 7.7 1.3 3.7 0.9 0.7 1.7 2.0 4.8 1.9 3.4 1.9 2.3 0.8 0.2 7.4 1.0 6.1 3.3 11.3 3.0 5.4 1.7 5.1 3.0 1.9 4.3 5.3 8.8 3.6 0.2 0.2 1.9 6.3 3.0 0.7 0.5 1.2 4.4 2.1 0.7 3.7 6.1 0.3 0.4 1.7 10.0 1.8 8.4 4.9 2.2 5.3 7.2 6.8 6.5 1.6 6.4 9.5 8.6 10.4 9.2 2.4 2.7 4.1 2.8 12.0 13.1 15.3 14.2 9.6 7.6 12.6 8.6 12.3 12.9 ZNF44 "KOX7, ZNF504, ZNF55, ZNF58" ENSG00000197857 "Zinc finger protein 44" P15621 19 12224686-12294887 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003146 Supported Approved Nucleoplasm,Microtubules,Cytosol Nucleoplasm "Microtubules, Cytosol" "HPA003146: AB_1080723" "unprognostic (1.51e-1)" "unprognostic (2.47e-3)" "unprognostic (7.07e-2)" "unprognostic (4.60e-2)" "unprognostic (9.63e-2)" "prognostic favourable (8.74e-4)" "unprognostic (8.39e-2)" "prognostic favourable (7.54e-4)" "unprognostic (5.65e-3)" "unprognostic (9.17e-2)" "unprognostic (1.75e-3)" "unprognostic (3.56e-3)" "unprognostic (7.30e-3)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (5.69e-2)" "prognostic favourable (9.21e-6)" 10.5 8.4 9.6 7.3 13.1 20.2 13.6 19.3 9.8 9.8 11.6 7.9 20.8 8.2 9.6 13.2 10.3 9.5 8.1 7.0 8.5 4.6 11.7 15.2 9.6 9.6 12.2 6.9 15.9 11.1 8.7 12.1 7.0 9.4 11.1 13.0 9.1 9.2 18.1 17.3 15.4 11.1 14.1 11.6 13.9 9.6 13.8 12.8 6.5 11.3 6.5 10.5 10.7 10.8 4.7 3.1 15.1 3.0 11.5 9.5 3.5 3.5 1.0 2.7 4.8 2.7 2.7 11.8 5.2 2.3 8.2 7.3 4.8 2.0 3.6 6.4 4.9 3.8 3.5 3.6 7.1 0.0 3.2 3.4 4.7 12.7 3.8 0.0 9.2 2.9 5.6 5.0 6.5 3.2 2.2 0.7 5.2 3.7 5.2 5.9 2.7 6.1 3.5 6.1 4.4 4.9 8.5 3.1 3.7 6.5 2.5 1.6 5.4 5.7 3.7 9.9 2.6 9.6 4.4 7.6 9.5 3.4 0.2 3.1 2.9 9.8 1.6 15.1 8.0 3.0 9.4 4.7 8.6 8.6 1.4 3.2 9.5 9.2 5.3 11.5 3.0 3.1 5.7 3.5 9.6 13.1 19.3 9.8 8.5 4.6 12.2 6.9 9.4 12.8 ZNF440 FLJ37933 ENSG00000171295 "Zinc finger protein 440" Q8IYI8 19 11814284-11835201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 12.1" "Low lineage specificity" "Detected in all" HPA047845 Approved Approved Nucleoplasm Nucleoplasm "HPA047845: " "unprognostic (2.48e-1)" "unprognostic (8.96e-3)" "unprognostic (1.34e-1)" "unprognostic (4.40e-2)" "unprognostic (2.45e-3)" "unprognostic (1.24e-3)" "unprognostic (1.03e-1)" "unprognostic (3.13e-2)" "unprognostic (9.05e-2)" "unprognostic (4.64e-3)" "unprognostic (1.33e-1)" "prognostic unfavourable (3.57e-4)" "prognostic favourable (1.18e-4)" "unprognostic (9.81e-3)" "unprognostic (2.22e-1)" "unprognostic (3.80e-2)" "prognostic favourable (9.88e-4)" 8.5 6.3 5.2 6.4 7.7 7.8 9.5 12.7 9.1 10.1 13.0 4.5 9.2 7.5 11.0 8.6 15.2 19.6 6.0 4.9 10.4 4.4 9.1 5.8 10.7 5.9 5.2 5.7 10.7 8.5 19.2 9.5 21.2 11.1 12.4 15.2 5.4 11.0 10.6 5.4 20.4 11.7 6.0 7.9 7.2 11.4 9.0 6.1 6.6 8.7 9.2 7.0 19.1 10.7 1.8 2.4 12.1 3.6 3.8 2.4 1.0 5.0 0.0 5.8 7.1 4.4 4.0 15.4 3.6 2.9 4.4 3.8 5.4 4.5 2.8 3.5 3.3 6.4 2.9 6.9 6.1 0.2 2.0 4.0 3.2 4.3 2.2 0.0 9.2 2.2 4.7 2.7 0.8 2.4 14.9 0.3 5.0 2.1 3.5 5.2 4.4 4.6 3.0 7.6 1.2 3.2 19.8 3.3 2.7 5.6 2.3 4.0 10.1 7.7 2.6 10.0 2.1 7.3 3.2 5.4 3.9 3.8 4.7 2.6 3.6 12.1 1.9 2.4 1.7 1.2 2.0 1.4 2.1 1.9 2.4 1.8 1.5 2.4 3.6 3.8 3.6 1.5 2.4 1.0 5.2 7.7 12.7 9.1 10.4 4.4 5.2 5.7 11.1 6.1 ZNF443 ZK1 ENSG00000180855 "Zinc finger protein 443" Q9Y2A4 19 12429707-12441112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: " "unprognostic (5.64e-3)" "unprognostic (1.51e-2)" "unprognostic (7.98e-2)" "unprognostic (1.45e-2)" "unprognostic (1.92e-1)" "unprognostic (7.38e-3)" "unprognostic (3.42e-1)" "unprognostic (1.64e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-2)" "unprognostic (7.10e-2)" "unprognostic (2.92e-2)" "prognostic favourable (2.74e-7)" "unprognostic (3.85e-3)" "unprognostic (2.16e-1)" "unprognostic (2.19e-2)" "prognostic favourable (3.91e-4)" 5.5 3.4 5.5 9.5 6.9 1.0 8.5 13.6 5.9 7.6 7.2 2.0 21.4 4.0 6.6 6.3 4.9 5.2 4.2 3.3 4.3 4.5 10.6 5.8 4.7 3.2 4.2 3.0 4.9 5.9 9.3 4.1 6.3 5.0 7.0 6.7 1.9 5.7 12.9 1.9 7.3 8.9 3.6 5.9 3.6 4.7 3.4 4.1 16.9 4.8 3.7 4.3 7.9 9.6 4.0 2.2 4.8 1.2 3.1 7.1 2.0 3.3 1.4 5.9 5.2 1.7 1.5 8.1 2.4 1.8 3.2 3.1 3.2 0.9 3.8 4.3 1.9 2.0 3.8 2.4 2.8 0.0 2.1 1.6 1.8 7.3 0.4 3.6 4.5 1.4 1.5 1.6 0.7 1.9 2.7 0.0 3.5 3.9 13.6 5.0 5.0 5.1 1.5 6.1 4.6 3.9 12.1 2.8 4.6 4.0 2.2 0.5 0.1 4.6 1.2 6.5 2.7 3.6 2.3 2.4 3.6 2.5 0.9 3.8 1.4 4.8 1.2 1.6 2.1 0.6 7.1 4.0 4.5 4.3 2.2 3.2 4.0 2.7 0.7 3.1 0.3 1.1 3.3 2.0 5.5 6.9 13.6 5.9 4.3 4.5 4.2 3.0 5.0 4.1 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431720-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 6.8 6.4 8.3 6.4 10.9 4.5 7.5 16.5 10.9 8.6 7.1 11.7 8.0 5.1 13.6 7.7 5.2 8.3 6.1 6.3 7.7 7.0 6.3 7.5 6.7 6.6 11.3 10.5 13.0 7.6 16.1 13.9 7.1 7.9 8.6 6.6 9.9 8.1 8.2 11.2 8.2 5.7 12.3 6.6 7.0 7.3 6.5 8.9 14.2 6.9 4.8 8.1 6.7 8.2 1.1 1.1 4.1 2.5 1.9 1.5 0.5 2.5 2.9 9.1 7.1 5.1 5.2 4.1 3.5 2.9 5.3 5.3 4.4 2.2 4.5 2.2 3.5 2.1 6.1 2.3 6.4 4.9 2.3 8.3 5.9 4.3 3.2 10.4 7.0 3.6 3.0 5.9 3.7 3.7 6.4 3.4 4.2 1.6 9.9 7.1 6.1 2.6 4.4 5.7 2.2 2.8 5.2 4.5 5.6 5.4 2.8 1.4 5.2 4.6 4.4 7.5 6.6 4.5 4.4 2.7 2.0 3.8 2.7 5.2 4.5 2.7 1.3 2.3 1.2 0.8 1.1 0.7 0.9 0.9 0.9 1.1 1.5 1.1 4.1 1.9 2.5 1.1 0.4 0.5 8.3 10.9 16.5 10.9 7.7 7.0 11.3 10.5 7.9 8.9 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363152 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 13.7 15.8 5.3 6.7 10.4 1.9 11.6 7.5 10.8 10.1 7.2 6.0 4.8 5.0 14.0 10.9 7.5 6.0 8.6 8.3 5.0 6.1 6.1 5.0 7.3 5.8 6.3 9.6 9.7 16.1 12.5 9.8 11.0 12.2 9.6 5.5 6.6 8.6 7.5 7.6 5.8 5.3 12.4 5.0 9.5 7.6 4.8 4.7 5.3 10.6 4.6 6.4 12.1 8.9 1.5 2.6 3.6 6.6 5.6 5.7 2.2 2.8 4.2 8.5 7.0 7.8 15.6 4.2 5.6 4.3 3.6 8.8 1.4 3.9 1.7 7.3 4.4 3.3 6.0 2.5 5.8 2.4 5.0 2.4 4.1 2.1 5.9 1.9 3.6 5.9 7.5 3.0 9.0 6.8 2.3 2.0 10.2 1.6 2.4 2.1 2.9 4.6 2.0 5.7 2.7 5.3 1.7 2.0 5.1 1.3 4.1 4.2 3.0 2.1 6.6 8.3 3.1 5.6 4.9 1.6 1.9 1.4 3.3 3.2 5.3 1.7 2.7 3.6 3.0 3.4 5.7 1.5 2.7 4.1 2.6 1.1 2.6 2.6 0.6 5.6 6.6 1.5 2.4 2.2 5.3 10.4 7.5 10.8 5.0 6.1 6.3 9.6 12.2 4.7 ZNF451 "COASTER, dJ417I1.1, KIAA0576, KIAA1702" ENSG00000112200 "Zinc finger protein 451" Q9Y4E5 6 57086844-57170307 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028838 Approved Nucleoplasm Nucleoplasm "HPA028838: AB_10603330" "unprognostic (5.95e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (1.81e-1)" "unprognostic (9.00e-3)" "unprognostic (1.06e-2)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "unprognostic (1.38e-2)" "unprognostic (1.27e-3)" "unprognostic (9.09e-2)" "unprognostic (6.42e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (2.50e-1)" "unprognostic (2.13e-3)" "unprognostic (6.17e-2)" 13.2 17.8 14.2 10.8 30.9 61.8 14.4 23.3 21.2 13.8 12.8 15.5 11.6 8.8 14.9 16.1 11.7 12.0 11.2 11.2 15.4 13.0 11.9 13.3 13.5 15.2 20.5 13.9 14.3 11.9 14.5 27.6 18.0 20.3 14.9 10.8 8.8 11.3 11.8 11.2 12.3 12.0 18.9 21.1 15.5 12.9 27.5 21.0 16.5 16.6 7.8 14.1 14.9 12.9 14.2 14.2 19.3 10.0 7.7 12.3 6.8 9.2 5.0 12.7 7.8 12.2 15.7 12.2 10.2 12.9 12.5 13.6 11.5 4.6 10.1 6.8 11.3 8.8 12.5 11.4 20.3 8.2 8.8 26.3 9.2 10.7 9.3 14.6 11.4 11.1 11.7 13.8 17.4 12.2 35.1 9.8 10.7 6.7 18.2 12.7 6.9 5.6 12.5 16.2 9.5 8.3 15.8 15.1 10.1 11.2 7.4 12.1 8.9 14.1 8.0 12.6 13.0 16.2 12.0 9.6 16.0 20.7 11.0 18.1 6.2 19.3 10.0 9.7 10.8 8.3 10.6 9.6 9.3 6.4 10.6 14.2 12.3 9.4 5.0 7.7 8.5 14.2 7.2 6.8 14.2 30.9 23.3 21.2 15.4 13.0 20.5 13.9 20.3 21.0 ZNF460 "HZF8, ZNF272" ENSG00000197714 "Zinc finger protein 460" Q14592 19 57280051-57293569 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA053004, HPA066506" Uncertain Approved Nucleoplasm Nucleoplasm "HPA053004: , HPA066506: " "unprognostic (2.57e-1)" "unprognostic (1.72e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-2)" "unprognostic (1.58e-2)" "unprognostic (3.20e-1)" "unprognostic (8.04e-2)" "unprognostic (2.52e-1)" "unprognostic (2.19e-1)" "unprognostic (2.86e-1)" "unprognostic (2.89e-2)" "unprognostic (1.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (2.08e-2)" "unprognostic (4.10e-2)" 9.5 23.2 7.7 6.2 12.0 24.7 9.2 9.4 10.1 6.8 5.6 12.7 7.5 3.6 6.5 5.4 7.7 5.7 6.5 8.7 7.4 5.0 7.0 8.5 7.9 5.5 14.6 7.0 13.2 6.5 10.3 13.0 8.0 8.6 7.0 4.8 6.4 8.3 7.3 8.7 9.6 5.1 7.4 10.8 7.8 5.9 9.6 10.7 5.9 8.3 6.7 8.6 5.9 7.5 5.4 0.4 3.4 2.8 2.0 3.6 1.6 1.5 2.3 1.9 2.6 1.9 1.7 4.9 1.0 1.5 1.2 3.6 2.9 0.9 2.3 1.1 1.3 1.1 2.5 1.3 2.1 1.7 4.9 2.2 1.7 1.5 2.2 3.8 2.5 0.9 2.3 3.2 3.7 0.7 2.1 17.0 1.4 1.2 2.3 0.6 2.6 2.3 1.7 2.7 1.1 0.7 3.0 2.4 1.2 2.6 1.4 1.6 1.2 2.7 1.1 3.6 4.2 0.5 2.1 7.4 3.1 3.9 1.3 1.5 1.1 0.0 1.2 2.6 2.2 2.8 2.3 2.3 1.7 1.2 0.4 5.4 3.6 1.5 3.4 2.0 1.9 0.2 2.7 1.6 7.7 12.0 9.4 10.1 7.4 5.0 14.6 7.0 8.6 10.7 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.8 5.3 4.0 5.1 2.8 6.2 2.4 3.1 3.5 4.8 6.8 0.9 1.3 0.4 6.6 4.3 0.5 2.8 3.4 5.2 5.4 3.9 4.6 0.7 1.9 4.5 3.9 5.5 3.9 6.2 1.5 4.3 3.0 0.2 0.4 4.8 3.1 6.0 1.0 2.2 2.0 0.4 3.8 0.9 1.5 6.6 4.6 6.6 0.2 2.3 4.1 2.4 1.5 3.0 2.9 3.8 1.9 3.7 8.7 12.8 1.6 0.0 0.7 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 ZNF462 "DKFZP762N2316, KIAA1803, Zfp462" ENSG00000148143 "Zinc finger protein 462" Q96JM2 9 106863097-107013634 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022283 Uncertain Approved Nucleoplasm Nucleoplasm "HPA022283: AB_2220602" "unprognostic (4.22e-2)" "unprognostic (3.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.25e-2)" "unprognostic (1.99e-1)" "unprognostic (2.28e-1)" "unprognostic (2.04e-2)" "unprognostic (2.01e-1)" "unprognostic (3.62e-2)" "unprognostic (1.84e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "prognostic favourable (6.19e-4)" "unprognostic (2.96e-2)" "unprognostic (1.68e-1)" "unprognostic (9.00e-2)" "unprognostic (1.33e-2)" 4.8 11.9 10.4 5.0 11.0 0.8 6.4 25.4 9.5 10.4 6.5 13.2 7.7 2.3 13.3 5.1 10.7 9.1 6.0 8.6 10.6 6.6 5.6 2.9 5.3 1.8 8.1 7.8 11.5 2.1 18.1 10.0 5.6 10.0 11.4 6.4 8.1 12.6 11.9 22.1 11.2 3.3 10.8 9.7 4.8 3.3 9.1 9.8 1.5 11.7 5.4 2.5 5.6 9.3 0.4 0.5 1.1 0.6 1.8 1.7 0.3 3.2 7.6 15.1 10.3 5.1 3.8 2.2 2.0 2.9 2.0 2.2 9.3 3.3 0.0 5.7 2.1 5.1 9.8 9.0 2.5 0.1 1.3 0.0 2.5 0.0 2.0 1.6 0.3 3.5 4.1 4.5 12.4 1.0 0.0 4.2 5.5 5.7 1.8 0.1 11.6 7.4 0.0 10.2 0.2 5.8 2.8 7.0 7.9 3.8 0.1 3.3 7.8 0.0 1.0 2.6 8.9 5.9 6.3 0.0 0.1 0.1 4.3 0.2 9.3 1.1 0.2 0.3 0.7 0.4 1.2 0.3 0.7 0.3 0.3 0.4 1.7 0.5 0.7 1.8 0.6 0.5 0.3 0.3 10.4 11.0 25.4 7.7 10.6 6.6 8.1 7.8 10.0 9.8 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.0 5.0 6.6 4.2 3.4 4.2 0.0 3.3 5.4 6.0 6.5 1.6 3.1 3.5 3.0 2.7 6.7 4.8 5.0 6.3 5.6 2.1 3.0 4.0 3.3 5.3 2.5 5.5 4.7 3.8 6.5 6.9 5.1 3.2 14.2 6.4 4.1 3.6 1.1 5.4 2.5 3.0 8.0 2.6 3.2 4.6 4.6 4.1 5.9 1.7 3.3 0.4 2.0 5.5 5.4 5.1 2.8 2.4 5.4 2.7 2.1 3.5 2.0 4.2 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.9 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.2 0.7 4.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.6 2.0 4.5 1.9 2.8 7.2 3.4 6.0 4.6 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 2.5 2.0 1.0 2.4 8.3 2.6 2.8 1.9 3.4 2.0 2.2 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 ZNF497 FLJ44773 ENSG00000174586 "Zinc finger protein 497" Q6ZNH5 19 58354357-58362848 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA047872 Uncertain Approved "Nucleoplasm,Cell Junctions" Nucleoplasm "Cell Junctions" "HPA047872: " "unprognostic (8.24e-2)" "unprognostic (1.12e-1)" "unprognostic (2.17e-1)" "unprognostic (1.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.42e-2)" "unprognostic (2.30e-2)" "unprognostic (8.53e-2)" "unprognostic (9.45e-2)" "unprognostic (9.29e-2)" "unprognostic (4.16e-3)" "unprognostic (7.03e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "unprognostic (4.58e-2)" "unprognostic (7.28e-2)" "unprognostic (1.24e-1)" 0.8 2.3 3.3 2.8 5.5 2.3 5.0 7.5 6.2 3.3 1.7 3.1 3.0 2.0 4.1 3.7 3.6 9.1 3.1 2.0 7.2 3.3 3.7 5.0 3.2 3.8 2.0 4.5 4.5 6.0 3.8 5.9 1.8 5.8 3.2 1.2 1.4 7.7 1.9 0.8 4.6 3.1 0.6 3.5 3.6 2.8 2.3 0.6 2.5 4.9 2.0 1.5 1.4 2.1 4.7 4.8 2.3 2.8 2.1 4.8 1.9 1.6 5.8 5.2 5.1 0.2 0.1 7.0 3.1 0.0 0.0 0.0 0.4 1.9 3.4 1.7 0.0 0.8 0.6 0.4 0.0 3.6 17.4 3.1 1.6 1.0 0.3 1.2 8.1 0.4 0.8 0.1 0.6 0.0 2.5 0.5 0.1 6.0 4.2 4.3 3.2 1.8 10.6 3.9 1.8 0.5 1.4 4.1 5.8 1.7 5.2 2.8 7.1 3.5 0.5 5.8 3.1 0.5 1.0 7.6 9.1 3.0 1.6 3.5 3.1 2.3 2.8 0.9 2.4 1.1 2.6 3.8 2.8 2.9 2.7 4.7 2.9 4.8 1.0 2.1 0.9 4.8 3.1 1.9 3.3 5.5 7.5 4.2 7.2 3.3 2.0 4.5 5.8 0.6 ZNF503 "FLJ45745, MGC2555, Nlz2" ENSG00000165655 "Zinc finger protein 503" Q96F45 10 75397830-75401906 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.2;PC-3: 49.5;U-87 MG: 15.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.6;myeloid DC: 1.4" "Group enriched" "Detected in many" 16 "dendritic cells: 1.4;monocytes: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026848 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA026848: AB_10610704" "unprognostic (1.18e-1)" "unprognostic (8.56e-2)" "unprognostic (8.63e-3)" "unprognostic (7.41e-2)" "unprognostic (2.82e-1)" "unprognostic (3.57e-2)" "unprognostic (9.63e-2)" "unprognostic (7.42e-2)" "unprognostic (3.42e-2)" "unprognostic (3.22e-1)" "unprognostic (6.53e-2)" "prognostic unfavourable (3.50e-4)" "prognostic favourable (1.97e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" 9.4 23.1 2.3 6.2 7.2 2.2 14.1 0.8 4.7 47.8 10.2 3.0 20.8 9.0 28.1 15.1 27.8 14.1 15.3 5.8 3.4 3.0 22.1 5.7 16.5 2.6 4.8 1.5 38.1 19.4 4.0 3.0 4.8 7.5 21.3 2.5 18.5 6.4 50.7 2.9 3.2 6.6 10.1 8.0 7.6 9.4 7.3 2.9 0.5 7.7 8.5 3.7 14.4 25.0 0.0 1.4 0.0 1.6 0.0 0.0 0.1 1.7 1.6 0.3 2.1 3.6 2.4 0.5 1.5 0.9 0.6 0.5 2.4 6.8 0.0 4.5 1.5 3.1 0.2 1.6 0.4 0.0 38.2 0.0 4.1 7.9 2.9 1.9 4.3 6.5 1.6 1.2 0.7 0.1 0.0 0.0 0.8 0.8 0.0 6.0 0.0 49.5 0.0 1.9 0.0 0.9 1.3 1.4 1.7 2.8 0.2 8.2 0.3 1.3 1.2 5.0 5.6 10.3 4.2 0.0 0.0 0.0 15.4 8.8 3.9 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.3 7.2 0.8 3.6 3.4 3.0 4.8 1.5 7.5 2.9 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96755865-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA049139: " "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favourable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 9.1 9.2 10.9 6.5 15.7 5.7 12.7 23.0 13.9 14.4 8.8 6.3 11.6 4.6 11.5 8.1 7.9 10.7 6.5 7.4 11.5 10.3 8.9 8.5 8.4 11.4 8.6 12.3 14.9 10.7 13.5 19.8 6.9 10.1 12.6 9.3 5.2 7.5 11.2 9.2 6.2 6.8 11.3 9.2 10.1 6.8 8.2 9.1 14.9 11.2 4.3 13.3 13.9 10.7 5.9 1.3 3.8 2.9 6.4 7.7 2.1 5.0 5.2 11.4 8.5 9.7 9.1 5.9 5.7 11.4 9.6 8.5 4.8 3.8 6.6 3.0 6.0 11.1 3.3 5.3 8.6 10.7 5.4 9.4 9.6 2.4 5.8 3.6 6.2 7.9 7.2 8.2 10.3 9.2 9.5 6.5 9.4 4.6 10.4 4.7 8.1 5.2 6.8 18.6 3.2 5.0 4.9 11.8 9.5 11.1 5.2 5.6 3.8 6.8 8.1 6.2 5.9 6.9 6.6 11.3 11.9 4.9 3.5 2.5 6.2 2.3 1.2 3.8 3.8 1.9 7.7 3.6 5.0 3.0 1.0 5.9 5.7 5.2 0.4 6.4 2.9 1.3 7.1 2.1 10.9 15.7 23.0 13.9 11.5 10.3 8.6 12.3 10.1 9.1 ZNF512 KIAA1805 ENSG00000243943 "Zinc finger protein 512" Q96ME7 2 27582969-27623215 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031430 Approved Approved Nucleoplasm Nucleoplasm "HPA031430: AB_10603844" "prognostic favourable (9.79e-4)" "unprognostic (4.19e-2)" "unprognostic (1.87e-2)" "prognostic unfavourable (5.10e-4)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (7.75e-3)" "prognostic favourable (5.08e-9)" "unprognostic (6.08e-2)" "unprognostic (2.33e-1)" "prognostic favourable (5.19e-4)" "unprognostic (1.10e-2)" "unprognostic (8.09e-3)" "unprognostic (4.44e-2)" "unprognostic (1.85e-1)" "unprognostic (5.66e-2)" "unprognostic (5.60e-3)" 11.0 12.8 12.0 13.3 19.9 5.2 15.6 18.5 22.4 18.1 14.8 20.4 12.1 7.4 23.7 14.7 9.9 20.8 12.3 12.0 11.0 14.3 12.1 6.7 12.9 14.5 12.1 15.4 33.7 8.1 28.0 27.6 12.1 18.8 17.8 11.7 18.7 11.3 19.1 7.2 6.8 12.5 17.4 14.2 15.0 11.0 12.0 11.6 21.3 19.6 6.6 15.8 17.2 14.0 9.6 6.3 14.6 5.2 17.0 14.6 8.5 11.4 10.1 21.1 9.3 10.5 11.9 0.0 5.7 8.1 10.8 12.8 7.8 7.2 10.0 6.4 6.5 3.9 18.6 5.3 11.5 9.2 14.9 21.0 8.2 11.8 8.1 13.6 9.5 10.8 5.9 8.4 2.4 17.1 18.1 7.3 15.8 1.4 1.4 10.4 14.6 0.0 22.8 29.7 8.6 7.7 3.2 20.6 20.5 5.4 3.4 15.9 4.2 7.8 14.0 3.8 9.3 3.9 7.4 7.4 5.2 17.3 5.7 17.0 7.8 14.6 4.2 7.3 8.7 5.2 11.7 9.6 10.9 12.4 6.3 8.0 14.6 12.2 1.2 17.0 4.1 4.5 7.5 8.5 12.0 19.9 18.5 22.4 11.0 14.3 12.1 15.4 18.8 11.6 ZNF512B "GM632, MGC149845, MGC149846" ENSG00000196700 "Zinc finger protein 512B" Q96KM6 20 63956702-63969865 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006688 Approved Approved Nucleoplasm Nucleoplasm "HPA006688: AB_10963053" "unprognostic (7.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-3)" "unprognostic (7.19e-3)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (5.30e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-1)" "unprognostic (6.99e-3)" "unprognostic (5.03e-3)" "unprognostic (2.12e-1)" "unprognostic (7.72e-2)" "unprognostic (5.52e-2)" "unprognostic (1.95e-3)" "unprognostic (3.72e-2)" 7.5 8.2 11.0 6.3 13.3 6.2 5.6 14.3 16.7 7.4 3.6 9.9 6.1 5.3 9.3 9.0 10.1 8.5 7.5 8.3 11.0 8.5 9.6 18.5 7.1 7.0 8.8 10.5 11.3 14.4 13.6 10.3 10.4 8.4 8.5 1.7 9.9 15.5 10.5 11.2 14.3 5.8 7.8 6.4 9.3 8.5 8.8 6.5 6.2 10.7 5.8 8.8 6.2 6.7 0.6 0.4 0.0 0.1 1.4 1.1 0.3 5.3 9.1 10.3 10.9 4.6 3.4 9.4 7.8 6.2 23.6 7.7 17.8 9.1 3.5 19.3 6.8 6.9 7.7 11.6 5.7 5.8 11.1 8.7 12.8 16.9 7.3 4.7 10.5 7.1 9.6 8.1 4.7 7.3 12.1 5.4 4.6 12.9 22.8 10.2 7.1 12.0 10.5 0.9 10.7 4.2 9.1 15.1 8.8 6.4 10.7 5.2 22.5 11.4 10.1 22.7 3.5 5.7 6.7 13.1 6.2 9.9 8.1 0.0 9.6 0.0 0.1 0.0 1.1 0.0 0.1 0.1 1.0 0.1 0.4 0.6 1.1 1.0 0.0 1.4 0.0 0.4 0.0 0.3 11.0 13.3 14.3 16.7 11.0 8.5 8.8 10.5 8.4 6.5 ZNF514 FLJ14457 ENSG00000144026 "Zinc finger protein 514" Q96K75 2 95147330-95165413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028974 Approved Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA028974: AB_10603845" "unprognostic (8.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (4.68e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" "unprognostic (5.17e-2)" "unprognostic (1.80e-3)" "unprognostic (4.33e-2)" "unprognostic (1.91e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-2)" 7.1 7.6 7.8 5.1 16.4 1.7 12.7 14.9 12.9 10.4 10.5 15.7 12.0 9.4 15.0 27.1 8.1 11.5 6.7 8.4 14.2 8.4 9.8 5.0 8.4 7.0 17.0 9.9 20.6 9.6 12.5 23.5 7.9 11.5 12.1 9.6 10.1 11.5 11.6 12.0 11.6 9.4 10.6 12.5 8.9 10.0 19.8 18.0 14.0 15.2 10.3 7.8 8.9 10.9 7.7 5.2 10.4 5.3 6.4 11.3 5.5 14.6 5.2 13.7 9.1 10.3 13.7 10.5 5.8 6.2 9.3 10.0 7.6 5.5 2.3 2.9 6.2 8.9 7.2 5.4 10.7 4.8 9.6 2.7 6.9 6.2 4.3 1.5 7.4 8.3 16.4 5.9 4.2 4.6 7.5 2.7 7.3 7.0 3.9 7.4 4.6 5.1 7.1 4.8 5.2 6.3 6.2 12.8 9.3 6.1 3.0 6.2 5.6 5.4 4.8 6.7 9.2 2.2 4.7 7.8 5.7 3.8 7.4 3.1 4.4 10.4 5.3 9.9 5.1 2.6 6.1 7.3 6.8 4.8 5.2 7.7 11.3 9.2 1.5 6.4 3.0 4.1 7.1 5.5 7.8 16.4 14.9 12.9 14.2 8.4 17.0 9.9 11.5 18.0 ZNF516 "HsT287, KIAA0222" ENSG00000101493 "Zinc finger protein 516" Q92618 18 76358190-76495190 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015792 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA015792: AB_1859314" "prognostic favourable (7.09e-4)" "unprognostic (7.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.22e-3)" "unprognostic (3.33e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (2.79e-4)" "unprognostic (2.63e-3)" "unprognostic (3.14e-1)" "unprognostic (3.29e-2)" "prognostic favourable (7.96e-4)" "unprognostic (5.87e-2)" "prognostic favourable (1.21e-4)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" "unprognostic (1.71e-1)" "unprognostic (2.02e-1)" 4.2 5.4 8.3 5.7 9.9 15.1 4.7 2.0 4.8 20.8 5.9 4.5 18.6 4.1 25.2 8.0 6.3 15.8 3.9 3.5 5.1 2.9 3.4 5.1 5.0 4.2 4.7 3.9 17.0 4.6 8.7 10.8 2.6 6.4 7.3 1.8 13.1 6.4 13.3 8.6 6.3 4.1 9.1 3.3 6.3 4.5 18.6 4.6 3.0 4.8 4.0 4.9 8.0 10.9 0.4 1.6 12.2 2.2 1.0 0.6 0.4 1.4 1.7 12.2 16.0 3.6 5.4 1.5 9.2 7.7 2.0 3.7 3.4 5.6 7.9 1.9 9.8 3.3 6.6 8.8 1.4 0.0 5.2 0.7 0.0 7.4 8.9 5.2 5.3 10.2 4.0 4.2 4.4 2.2 0.0 0.0 2.0 3.2 0.1 9.3 6.1 0.4 3.4 1.2 4.1 3.2 6.9 12.2 7.6 0.1 0.0 9.9 2.0 21.2 1.5 4.6 8.0 0.1 0.9 0.0 0.2 6.1 2.7 3.7 11.8 2.7 2.2 3.0 0.1 1.5 0.6 0.1 0.2 0.1 1.6 0.4 0.6 0.3 12.2 1.0 1.6 1.0 0.0 0.4 8.3 9.9 2.0 4.8 5.1 2.9 4.7 3.9 6.4 4.6 ZNF517 ENSG00000197363 "Zinc finger protein 517" Q6ZMY9 8 144798876-144811169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA055337 Approved Nucleoplasm Nucleoplasm "HPA055337: " "unprognostic (9.54e-3)" "unprognostic (4.72e-2)" "unprognostic (3.20e-2)" "unprognostic (3.06e-2)" "unprognostic (1.81e-1)" "unprognostic (1.55e-2)" "unprognostic (2.22e-2)" "unprognostic (3.13e-1)" "unprognostic (4.83e-2)" "unprognostic (9.64e-2)" "prognostic favourable (1.66e-4)" "unprognostic (1.83e-1)" "unprognostic (4.23e-2)" "unprognostic (2.75e-1)" "unprognostic (2.40e-1)" "unprognostic (1.38e-1)" "unprognostic (9.57e-2)" 2.9 6.5 5.3 3.1 4.5 1.5 8.5 7.3 8.6 3.3 3.0 2.7 5.3 3.6 5.6 3.1 3.2 4.1 3.2 5.8 6.8 3.2 3.9 3.2 4.6 6.5 5.6 6.1 7.5 3.8 4.5 3.9 4.4 4.2 3.7 0.5 5.4 6.9 1.9 9.6 10.5 4.5 1.4 4.1 4.3 3.6 3.6 4.4 3.0 4.1 1.4 1.4 4.1 2.8 4.1 1.1 0.5 2.4 1.4 2.2 1.2 2.0 3.8 6.4 6.2 1.0 1.9 3.4 1.8 0.5 0.4 0.3 1.3 2.3 1.1 4.5 0.6 2.1 0.2 0.7 0.9 4.5 1.7 2.6 2.0 13.7 2.4 0.6 2.7 1.4 1.6 0.3 1.3 1.4 3.0 1.8 1.1 3.3 2.6 1.6 4.5 4.3 3.8 1.9 0.9 0.6 2.5 2.8 8.2 5.2 2.1 1.9 5.3 2.4 1.8 4.4 6.7 2.2 1.8 2.9 0.5 0.8 4.7 1.1 3.5 0.4 1.2 0.0 1.8 2.4 1.5 4.1 1.7 1.2 1.1 0.7 1.4 1.2 0.5 1.4 1.4 0.5 2.2 1.2 5.3 4.5 7.3 8.6 6.8 3.2 5.6 6.1 4.2 4.4 ZNF518A "KIAA0335, ZNF518" ENSG00000177853 "Zinc finger protein 518A" Q6AHZ1 10 96129715-96205288 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029049 Approved Nucleoplasm Nucleoplasm "HPA029049: " "unprognostic (1.48e-1)" "unprognostic (5.24e-2)" "unprognostic (1.70e-2)" "unprognostic (4.66e-2)" "unprognostic (7.61e-2)" "unprognostic (3.38e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.73e-2)" "unprognostic (6.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" "unprognostic (8.38e-3)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (3.09e-2)" "unprognostic (1.16e-3)" 3.5 2.8 4.8 4.6 5.9 6.1 6.9 7.1 5.6 5.7 6.4 6.5 5.9 4.4 6.0 7.7 3.8 4.0 4.4 2.8 4.1 6.1 4.0 4.2 4.9 8.1 4.5 7.3 4.8 5.0 15.1 5.8 7.7 5.6 6.6 4.6 3.4 4.2 2.2 5.3 8.7 5.6 7.1 5.0 6.1 15.0 5.5 12.2 7.3 3.9 5.4 4.0 4.2 4.4 4.8 11.0 7.9 3.9 5.6 2.3 2.8 6.4 7.3 0.0 3.7 4.2 8.8 3.0 1.7 3.3 3.4 6.0 6.9 10.5 2.9 1.9 4.1 8.2 2.9 3.0 4.8 4.4 15.7 2.2 9.8 3.2 16.9 9.5 2.7 7.1 3.5 5.6 3.9 13.3 7.1 3.2 2.8 9.9 10.3 11.1 0.4 11.3 8.3 4.2 3.9 5.8 2.1 5.1 4.2 4.0 3.1 4.8 10.9 2.5 1.6 6.1 2.1 3.3 6.5 16.4 6.1 1.1 13.0 1.6 11.0 4.5 5.4 3.2 4.8 5.1 4.4 3.9 3.2 2.8 4.1 5.6 3.8 4.5 3.9 7.9 4.8 4.0 2.3 ZNF518B KIAA1729 ENSG00000178163 "Zinc finger protein 518B" Q9C0D4 4 10439874-10457410 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031215, HPA031216" Approved Approved Nucleoplasm Nucleoplasm "HPA031215: AB_10600200, HPA031216: AB_10601449" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-1)" "unprognostic (7.74e-3)" "unprognostic (2.11e-1)" "unprognostic (7.99e-2)" "unprognostic (1.01e-1)" "unprognostic (4.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.07e-1)" "unprognostic (2.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (1.27e-1)" "unprognostic (5.44e-2)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" 11.2 9.6 9.4 10.5 12.2 6.1 12.9 16.0 13.2 11.4 10.3 6.0 9.6 6.4 10.4 11.4 7.7 8.3 7.8 11.0 9.3 9.9 6.2 4.2 7.5 12.6 7.5 7.6 15.8 5.7 10.5 12.7 13.1 8.3 12.7 5.4 9.3 12.1 13.5 12.1 6.5 11.4 10.0 6.4 11.1 7.9 15.1 4.7 19.5 14.1 7.3 14.8 10.7 11.5 9.5 4.5 11.8 5.3 6.8 4.8 2.3 4.9 3.4 13.2 3.8 1.7 2.6 0.0 5.8 1.4 3.6 4.3 0.0 0.0 0.0 5.9 8.4 0.1 3.0 6.4 8.1 0.0 5.5 16.0 0.0 0.0 7.7 0.0 7.1 7.5 3.8 5.7 0.0 12.2 17.2 0.0 2.9 0.0 10.8 0.4 12.9 7.7 9.4 5.6 1.8 0.1 7.0 9.9 2.9 2.7 0.0 1.8 2.1 4.3 9.2 0.0 12.1 0.0 5.4 6.8 5.0 9.4 0.7 0.9 0.7 2.8 2.5 11.8 2.9 2.6 3.8 9.5 4.6 3.3 4.5 5.2 4.8 4.4 6.5 6.8 5.3 1.5 3.4 2.3 9.4 12.2 16.0 13.2 9.3 9.9 7.5 7.6 8.3 4.7 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061926-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.1" "Cell line enhanced" "Detected in many" "AF22: 31.4;fHDF/TERT166: 14.7;HUVEC TERT2: 21.5;THP-1: 17.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 69.1" "Group enriched" "Detected in some" 5 "basophil: 8.8;plasmacytoid DC: 9.8" "Group enriched" "Detected in many" 5 "dendritic cells: 9.8;granulocytes: 8.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 105.4" "HPA023056, HPA023849" Enhanced Approved Nucleoplasm Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 9.2 11.3 5.2 2.8 7.0 1.9 9.1 69.1 11.5 11.0 3.4 9.1 4.7 1.7 19.8 5.9 3.8 9.0 10.0 7.0 5.8 5.1 3.1 1.2 6.4 4.0 8.4 2.8 20.5 1.4 1.4 16.8 8.0 12.2 4.4 3.5 6.7 8.7 3.0 3.8 4.6 3.2 13.3 12.2 18.5 2.4 3.4 8.9 0.5 5.3 6.9 2.6 7.4 5.4 0.0 9.8 8.8 0.1 1.7 0.0 0.1 0.0 0.0 31.4 0.0 5.0 8.8 0.1 4.5 6.6 1.6 1.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.0 1.3 0.0 1.8 6.2 0.3 0.2 0.9 0.0 9.4 10.9 0.0 0.1 0.0 21.5 0.1 0.0 2.8 0.0 4.0 0.0 2.1 0.0 0.0 7.1 0.5 0.0 0.0 4.1 2.6 0.4 0.0 0.0 0.0 17.5 12.2 12.5 1.0 3.6 0.6 0.0 0.0 0.1 4.7 0.0 10.2 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 9.8 0.0 0.1 5.2 7.0 69.1 4.3 5.8 5.1 8.4 2.8 12.2 8.9 ZNF524 MGC23143 ENSG00000171443 "Zinc finger protein 524" Q96C55 19 55600022-55603138 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050981 Uncertain Approved Nucleoplasm Nucleoplasm "HPA050981: AB_2681298" "unprognostic (6.69e-2)" "unprognostic (1.23e-2)" "unprognostic (5.70e-2)" "unprognostic (4.27e-3)" "unprognostic (2.88e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.99e-1)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (2.13e-1)" "unprognostic (8.26e-2)" "unprognostic (1.02e-2)" "unprognostic (3.84e-1)" "unprognostic (1.59e-2)" "prognostic favourable (4.98e-8)" 10.4 7.9 7.9 9.9 8.2 9.4 36.6 6.9 10.3 7.1 10.9 5.5 15.8 15.8 7.9 13.6 12.8 8.7 16.2 9.6 7.5 4.4 8.4 10.8 10.5 14.1 12.2 4.8 7.1 31.4 5.4 7.8 5.4 7.5 10.6 4.5 4.5 22.9 13.8 32.1 13.8 12.3 6.4 8.1 11.8 13.3 4.0 9.5 7.9 12.9 12.1 5.9 8.4 16.5 13.2 16.5 16.4 21.2 10.1 19.1 12.4 8.7 8.7 1.3 6.0 4.0 8.5 9.9 5.7 3.4 3.6 3.6 2.6 10.1 4.4 3.3 3.1 7.0 0.8 4.3 0.5 13.1 22.1 5.3 4.8 4.5 9.9 3.4 6.9 7.0 10.2 3.0 3.1 6.7 4.9 9.1 1.9 5.1 3.3 7.4 1.5 9.9 4.4 3.0 13.2 4.7 5.0 6.2 3.9 5.6 8.0 6.2 3.7 11.5 5.7 3.1 5.3 5.9 7.3 4.0 4.7 2.0 8.5 8.9 4.1 11.5 21.2 16.4 12.7 18.3 11.7 11.6 13.2 12.2 16.5 13.2 15.8 8.6 13.4 10.1 12.1 5.1 19.1 12.4 7.9 8.2 6.9 10.3 7.5 4.4 12.2 4.8 7.5 9.5 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220271-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: , HPA056609: " "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 10.1 7.0 5.9 12.3 9.1 8.5 8.5 14.5 10.0 10.6 8.5 8.6 9.2 8.3 12.2 6.4 8.4 9.3 5.0 6.8 7.5 4.3 7.0 7.6 7.3 9.1 8.7 6.6 12.0 9.0 10.1 11.7 8.6 6.2 9.9 5.6 7.5 11.1 9.1 11.7 13.0 10.1 6.3 4.6 9.1 7.9 11.6 8.1 13.8 7.6 6.1 11.5 9.0 10.3 6.9 6.1 2.5 7.1 4.5 10.7 4.3 7.0 23.1 6.8 6.1 7.9 7.6 5.9 8.3 7.8 8.8 9.7 12.1 5.2 11.6 6.1 8.8 5.3 7.2 9.0 5.6 6.8 8.7 11.6 10.8 11.6 7.3 7.3 7.5 7.5 7.3 8.8 9.2 5.5 11.0 7.4 5.6 9.9 7.3 4.8 4.5 8.3 8.6 8.3 5.2 4.0 13.0 7.0 6.2 9.5 9.6 6.9 3.9 13.2 7.3 10.9 7.5 4.6 10.4 9.0 5.2 8.0 7.3 7.2 9.0 2.5 5.1 1.9 7.0 5.4 10.7 6.9 5.5 6.3 4.2 6.7 6.7 8.3 1.2 4.5 7.1 6.1 5.4 4.3 5.9 9.1 14.5 10.0 7.5 4.3 8.7 6.6 6.2 8.1 ZNF529 KIAA1615 ENSG00000186020 "Zinc finger protein 529" Q6P280 19 36534774-36605276 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA031311 Uncertain Approved Nucleoplasm Nucleoplasm "HPA031311: AB_10604158" "unprognostic (2.19e-2)" "unprognostic (4.89e-2)" "unprognostic (8.51e-2)" "unprognostic (7.94e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-3)" "unprognostic (8.67e-2)" "unprognostic (1.30e-2)" "unprognostic (3.84e-3)" "unprognostic (7.10e-2)" "unprognostic (1.05e-3)" "unprognostic (6.61e-3)" "unprognostic (3.37e-2)" "unprognostic (1.45e-2)" "unprognostic (1.00e-1)" "unprognostic (9.64e-2)" "prognostic favourable (1.39e-5)" 9.0 11.8 13.8 11.6 22.4 15.9 12.4 22.6 18.3 9.5 7.6 16.0 8.1 6.5 14.4 12.7 6.2 13.3 8.5 11.7 13.4 12.2 7.1 8.1 9.2 13.4 20.4 16.5 15.5 6.1 17.0 17.2 10.3 16.0 10.5 7.1 9.0 6.9 8.1 8.5 13.7 8.0 10.2 16.9 11.4 7.1 16.7 18.4 15.3 12.2 3.7 12.4 7.4 8.6 5.3 2.7 6.3 2.1 3.9 6.3 2.4 3.7 7.6 10.6 12.2 6.3 7.6 4.7 5.6 3.5 3.7 7.9 3.8 2.9 9.1 7.7 5.2 1.6 8.5 3.3 6.5 12.9 9.4 11.7 5.1 2.6 7.2 8.9 7.0 8.5 5.5 4.6 7.5 3.0 5.2 0.7 7.5 1.2 9.4 3.4 7.6 2.8 2.8 7.6 4.8 3.3 8.4 5.2 10.6 7.4 3.1 2.8 3.6 6.5 5.6 8.0 5.2 5.1 6.9 12.5 6.2 8.8 0.2 3.0 5.2 6.3 2.1 2.6 4.4 1.4 6.3 5.3 5.0 4.9 2.2 4.9 5.7 4.5 1.0 3.9 1.4 2.7 5.6 2.4 13.8 22.4 22.6 18.3 13.4 12.2 20.4 16.5 16.0 18.4 ZNF532 FLJ10697 ENSG00000074657 "Zinc finger protein 532" Q9HCE3 18 58862600-58986480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015322 Approved Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA015322: AB_2304947" "unprognostic (3.43e-1)" "unprognostic (4.36e-2)" "unprognostic (1.41e-3)" "prognostic unfavourable (6.46e-5)" "unprognostic (4.24e-1)" "unprognostic (5.84e-2)" "unprognostic (1.50e-3)" "unprognostic (7.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.09e-3)" "unprognostic (1.90e-1)" "unprognostic (7.60e-3)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "unprognostic (5.53e-2)" "prognostic unfavourable (5.76e-4)" 12.3 7.0 14.3 8.0 17.1 0.6 11.4 44.6 22.5 17.5 12.3 23.7 11.6 3.7 35.5 11.2 12.3 15.0 13.1 18.6 14.7 11.9 7.2 2.3 10.4 7.8 14.2 13.4 29.6 4.2 14.5 18.2 13.7 15.0 27.1 7.2 14.5 7.8 19.6 29.5 8.8 6.1 22.5 18.9 8.5 7.1 12.5 17.2 2.5 13.6 7.0 8.9 13.0 19.8 6.7 1.4 0.0 2.2 0.4 1.0 0.7 7.0 9.9 41.2 21.7 6.8 15.1 2.1 13.1 12.1 8.9 8.1 3.5 7.7 8.6 10.0 15.9 11.7 0.3 9.5 8.9 6.3 8.6 0.0 14.9 0.2 9.0 0.0 0.0 11.8 18.6 9.3 17.1 10.0 0.1 10.9 10.5 0.0 0.0 0.1 21.8 6.4 0.2 10.6 1.4 6.2 0.9 9.3 24.8 8.5 0.9 14.4 10.4 5.8 7.4 24.3 18.2 0.2 10.3 0.1 7.1 2.4 8.7 0.0 18.7 0.0 0.4 0.0 1.0 2.2 0.3 6.7 0.5 0.5 1.4 3.6 0.1 0.3 0.0 0.4 0.3 0.2 0.0 0.7 14.3 17.1 44.6 21.4 14.7 11.9 14.2 13.4 15.0 17.2 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA077341: " "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 8.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 23.8 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.8 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.7" "Group enriched" "Detected in some" 5 "HEL: 3.1;SiHa: 10.0;U-87 MG: 3.5" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA058541: , HPA076453: " "unprognostic (4.49e-2)" "prognostic favourable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.2 2.6 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.5 0.0 17.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.5 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.2 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 ZNF543 DKFZp434H055 ENSG00000178229 "Zinc finger protein 543" Q08ER8 19 57320509-57330776 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046330 Approved Nucleoplasm Nucleoplasm "HPA046330: " "unprognostic (9.20e-2)" "unprognostic (8.89e-2)" "unprognostic (2.60e-2)" "unprognostic (1.51e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-1)" "unprognostic (2.45e-2)" "unprognostic (9.86e-2)" "unprognostic (1.01e-1)" "unprognostic (6.55e-2)" "unprognostic (2.44e-2)" "unprognostic (7.47e-2)" "prognostic favourable (2.03e-5)" "unprognostic (1.94e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-1)" "unprognostic (2.84e-2)" 6.2 6.0 6.6 4.0 10.1 5.0 8.0 18.1 10.3 5.7 5.3 7.4 7.1 2.3 6.5 5.4 7.7 6.9 4.7 5.2 7.0 4.0 5.1 3.9 5.1 6.5 8.4 5.8 14.8 5.7 10.0 10.8 8.1 7.2 6.4 3.5 7.5 6.8 7.3 6.7 8.9 4.8 6.2 7.7 7.2 4.9 11.0 8.0 15.8 7.9 2.4 8.0 6.5 5.1 6.4 3.6 7.3 3.5 5.2 5.6 3.5 3.3 4.5 4.2 6.6 3.7 3.3 5.1 2.0 3.6 3.8 6.8 1.4 2.0 5.4 2.8 2.7 1.9 3.6 3.7 5.0 2.4 9.7 5.2 4.7 4.1 4.1 5.0 3.5 3.6 3.9 3.0 6.3 2.9 2.8 1.0 2.8 0.4 5.8 1.6 3.8 3.5 5.5 6.4 5.7 2.5 8.2 7.8 5.5 5.7 2.3 3.9 2.8 4.7 2.8 5.6 4.0 1.1 3.7 8.1 5.3 6.2 2.7 2.3 2.9 2.2 3.4 7.3 3.8 3.2 4.9 6.0 4.1 5.6 3.6 6.4 5.0 4.9 3.6 5.2 3.5 2.4 2.1 3.5 6.6 10.1 18.1 10.3 7.0 4.0 8.4 5.8 7.2 8.0 ZNF544 AF020591 ENSG00000198131 "Zinc finger protein 544" Q6NX49 19 58228594-58277495 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002732 Approved Approved Nucleoplasm Nucleoplasm "HPA002732: AB_1080735" "unprognostic (5.28e-2)" "unprognostic (9.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.24e-2)" "unprognostic (4.32e-2)" "unprognostic (1.54e-1)" "prognostic unfavourable (1.04e-5)" "unprognostic (3.61e-3)" "prognostic unfavourable (3.65e-5)" "unprognostic (4.94e-2)" "unprognostic (2.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (2.49e-1)" 7.0 10.2 14.0 12.7 12.9 6.8 12.8 20.6 14.4 11.7 8.0 10.7 5.4 4.3 18.3 31.2 10.8 20.1 9.4 13.9 12.0 12.2 10.2 7.3 7.2 9.7 12.6 13.7 12.6 12.1 22.8 19.1 9.9 11.1 10.1 8.5 16.2 8.7 9.6 3.7 11.7 7.4 10.4 13.0 10.2 8.8 19.6 12.0 13.9 16.5 8.9 12.0 10.4 7.9 11.7 8.4 12.5 3.8 14.4 11.1 5.4 15.3 6.0 4.2 4.6 4.5 7.6 10.2 7.3 3.4 14.0 9.8 5.2 6.7 20.5 3.6 8.7 5.3 5.0 16.1 19.6 9.5 51.7 15.6 12.1 2.5 12.4 9.4 12.6 5.2 23.9 9.5 26.5 12.2 8.8 0.0 8.1 4.9 19.7 6.5 9.6 2.9 6.8 4.7 15.8 9.5 24.3 22.8 0.0 8.8 4.5 3.2 6.5 6.8 10.2 2.6 9.1 2.6 8.3 17.9 34.9 0.0 0.0 0.0 6.4 2.3 2.3 12.5 7.6 3.8 7.0 9.3 6.8 9.6 5.3 11.7 8.3 11.1 2.8 14.4 0.9 8.4 5.5 5.4 14.0 12.9 20.6 14.4 12.0 12.2 12.6 13.7 11.1 12.0 ZNF546 "MGC43537, ZNF49" ENSG00000187187 "Zinc finger protein 546" Q86UE3 19 39984134-40021041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA030838 Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030838: AB_10603332" "unprognostic (4.38e-6)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "unprognostic (1.69e-2)" "unprognostic (6.10e-2)" "unprognostic (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (1.73e-2)" "unprognostic (8.20e-3)" "unprognostic (4.99e-2)" "unprognostic (2.03e-3)" "unprognostic (2.70e-1)" "unprognostic (5.69e-3)" "unprognostic (2.23e-1)" "unprognostic (6.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.58e-5)" 4.1 5.1 5.0 3.7 7.1 2.5 4.7 7.9 6.6 4.2 3.6 7.6 7.3 2.0 6.3 3.8 2.8 5.7 2.9 4.9 4.7 3.8 4.8 5.5 3.2 3.8 7.9 4.4 7.3 3.7 6.5 8.5 3.1 6.8 4.6 2.7 5.2 2.9 6.1 5.6 3.8 3.4 5.3 8.3 5.4 3.1 20.8 7.9 6.6 6.0 2.8 4.4 3.6 3.3 2.7 2.8 2.6 2.4 2.5 4.7 1.2 0.2 4.6 2.0 2.6 4.7 3.4 0.3 1.8 2.8 2.2 3.0 0.2 0.6 2.5 2.1 1.6 0.2 1.0 0.3 3.3 2.6 3.3 3.2 3.2 1.7 2.5 3.2 2.2 2.7 2.0 1.3 3.5 2.8 4.0 6.1 2.3 0.6 1.5 0.7 0.7 0.5 1.8 1.7 1.2 1.1 0.4 1.4 1.5 1.0 0.2 1.8 0.9 1.4 1.1 0.7 1.5 0.3 1.4 4.6 4.4 0.5 1.7 1.3 1.4 1.6 1.5 2.6 3.7 2.4 2.5 2.7 2.4 2.2 2.8 2.4 4.7 4.1 1.1 2.5 1.2 0.7 3.0 1.2 5.0 7.1 7.9 6.6 4.7 3.8 7.9 4.4 6.8 7.9 ZNF548 FLJ32932 ENSG00000188785 "Zinc finger protein 548" Q8NEK5 19 57389850-57402992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA066042 Uncertain Approved Nucleoplasm Nucleoplasm "HPA066042: " "prognostic favourable (7.85e-4)" "unprognostic (4.61e-2)" "unprognostic (5.53e-2)" "unprognostic (8.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.05e-3)" "unprognostic (1.61e-2)" "unprognostic (6.77e-2)" "unprognostic (3.01e-2)" "unprognostic (1.59e-2)" "unprognostic (4.66e-2)" "unprognostic (2.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (5.85e-2)" 18.6 9.2 11.0 17.0 18.1 26.8 17.5 27.5 16.3 9.7 13.1 13.2 7.4 7.5 14.3 12.7 11.0 14.3 13.4 16.0 9.2 7.0 9.6 9.5 16.1 24.0 12.9 10.7 18.6 8.1 14.5 14.0 10.6 11.5 13.1 10.3 14.1 10.5 10.1 13.5 12.8 19.6 16.1 9.1 23.6 10.6 9.8 10.4 13.5 14.6 9.8 20.4 12.2 11.5 10.2 4.9 3.4 3.3 7.3 9.7 3.8 5.5 5.1 9.9 7.0 5.3 5.7 1.9 4.4 6.9 6.8 13.0 1.1 14.3 5.5 2.9 4.4 2.3 4.1 5.2 7.5 2.8 13.1 5.9 32.7 6.4 4.1 6.4 11.9 6.6 7.2 6.6 10.3 3.4 0.3 0.0 5.9 1.5 10.1 2.2 2.7 5.6 11.6 10.8 7.9 3.9 10.0 5.9 7.1 6.1 2.6 3.2 5.9 5.5 5.3 8.0 7.5 2.6 7.2 13.8 9.1 8.3 5.6 3.4 8.0 2.2 2.4 3.4 6.8 2.6 9.7 6.6 6.3 8.4 4.9 10.2 9.1 9.5 2.1 7.3 3.3 4.1 9.3 3.8 11.0 18.1 27.5 16.3 9.2 7.0 12.9 10.7 11.5 10.4 ZNF549 FLJ34917 ENSG00000121406 "Zinc finger protein 549" Q6P9A3 19 57527325-57557542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 16.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 13.4" "Group enriched" "Detected in all" 4 "B-cells: 4.7;NK-cells: 13.4;T-cells: 5.8" HPA039511 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA039511: AB_10671998" "unprognostic (6.27e-2)" "unprognostic (9.03e-3)" "unprognostic (2.02e-2)" "unprognostic (1.20e-2)" "unprognostic (4.28e-2)" "unprognostic (2.80e-1)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (7.07e-2)" "unprognostic (4.01e-4)" "unprognostic (4.03e-3)" "unprognostic (2.51e-8)" "unprognostic (2.88e-2)" "unprognostic (9.92e-2)" "unprognostic (9.89e-3)" "unprognostic (9.11e-3)" 4.7 6.2 7.3 11.8 11.0 5.9 9.3 18.8 10.3 5.2 5.8 8.0 4.0 3.6 7.2 7.7 3.9 8.0 6.9 5.4 9.0 6.2 5.6 2.6 7.6 8.8 9.5 7.0 11.2 4.5 12.5 13.8 6.9 7.0 8.3 4.4 6.5 5.6 6.7 5.4 7.3 6.1 7.3 10.6 9.9 5.2 7.2 8.5 11.2 9.1 3.0 9.7 6.5 11.6 4.7 1.8 1.8 1.2 13.4 5.8 2.1 1.3 1.8 7.2 6.0 2.2 1.8 1.7 3.4 4.1 3.3 16.3 1.9 1.3 2.0 2.4 3.1 0.8 2.3 4.9 5.5 0.2 13.4 9.1 1.4 2.7 3.1 7.5 6.4 3.2 3.8 3.4 4.7 2.1 0.1 0.3 6.0 0.8 8.4 3.2 6.2 4.8 6.0 6.0 4.1 1.3 3.5 3.0 5.3 0.1 0.5 3.9 4.1 5.9 1.7 6.4 4.4 0.3 4.9 3.4 9.9 6.3 1.1 2.6 5.8 0.7 1.0 1.8 3.0 0.8 4.1 2.7 4.1 4.6 1.8 4.7 5.8 3.7 0.8 13.4 1.2 1.6 2.4 2.1 7.3 11.0 18.8 10.3 9.0 6.2 9.5 7.0 7.0 8.5 ZNF551 DKFZp686H1038 ENSG00000204519 "Zinc finger protein 551" Q7Z340 19 57681969-57717301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038187 Approved "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA038187: " "unprognostic (1.96e-1)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (6.24e-3)" "unprognostic (1.30e-1)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "prognostic unfavourable (7.68e-5)" "unprognostic (2.92e-1)" "unprognostic (5.89e-2)" "unprognostic (4.83e-3)" "prognostic favourable (1.32e-4)" "unprognostic (4.70e-2)" "unprognostic (2.73e-1)" "unprognostic (1.26e-2)" "unprognostic (1.54e-1)" 6.6 5.6 4.4 8.3 6.9 12.8 7.9 17.3 5.2 5.2 5.1 6.8 8.6 4.2 6.3 5.9 5.3 5.9 6.1 4.9 4.9 4.6 5.1 3.2 3.8 10.8 3.8 3.3 6.8 10.7 6.1 11.3 5.3 4.9 6.0 5.1 6.4 6.0 5.8 8.8 7.3 5.6 6.8 4.0 8.2 5.1 18.1 5.7 13.0 11.1 5.2 10.3 6.4 6.0 6.6 4.7 2.1 3.1 4.7 8.1 3.8 2.6 5.8 7.2 5.2 1.4 1.7 7.6 3.1 2.2 4.4 2.0 4.9 2.6 4.7 2.0 2.3 3.0 4.8 7.2 6.9 0.0 21.0 8.4 0.2 2.1 1.3 5.9 7.6 3.0 2.7 4.5 4.1 1.8 5.7 0.0 3.9 2.5 12.1 2.3 15.1 9.4 7.7 12.5 6.3 1.7 15.0 7.0 5.8 4.7 3.0 2.5 3.8 7.8 2.2 5.1 5.3 1.7 5.8 5.2 11.1 10.8 0.9 2.9 4.8 1.9 2.1 2.1 3.3 3.1 6.2 6.6 4.9 5.2 4.7 5.5 8.1 7.3 1.1 4.7 1.6 3.8 3.9 3.8 4.4 6.9 17.3 5.2 4.9 4.6 3.8 3.3 4.9 5.7 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.6;brain: 22.3;ovary: 11.3" "Cell line enhanced" "Detected in some" "CACO-2: 7.1;HBEC3-KT: 7.6;Hep G2: 11.8;RH-30: 17.6;THP-1: 6.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 22.3" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 14.6" HPA060593 Approved Nucleoplasm Nucleoplasm "HPA060593: " "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.3 0.2 0.5 0.3 0.5 1.0 0.5 22.3 0.5 0.7 0.3 0.0 1.7 0.1 1.6 0.7 3.1 4.2 0.8 0.2 0.4 0.3 2.6 0.1 0.4 0.3 0.4 0.1 11.3 2.6 0.4 1.6 0.8 1.3 0.4 0.1 0.1 1.0 0.1 4.5 0.7 0.2 0.3 0.5 0.3 0.3 3.5 0.0 0.6 0.2 8.7 0.9 0.2 0.2 0.4 14.6 1.2 0.2 0.6 0.2 0.1 1.8 0.3 0.0 3.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 7.1 0.1 2.3 1.2 0.1 0.1 0.0 7.6 0.0 0.1 0.0 0.1 3.1 11.8 0.1 0.2 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.2 0.0 0.1 0.0 17.6 1.5 0.0 0.3 0.1 2.9 0.0 0.3 0.0 3.6 6.4 0.0 0.1 0.1 4.6 0.1 2.1 3.8 0.1 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.6 0.1 14.6 0.1 0.1 0.5 0.5 22.3 0.5 0.4 0.3 0.4 0.1 1.3 0.0 ZNF557 MGC4054 ENSG00000130544 "Zinc finger protein 557" Q8N988 19 7069444-7087968 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003151, HPA029291" Uncertain Approved "Nucleoplasm,Intermediate filaments,Cytosol" "Nucleoplasm, Intermediate filaments" Cytosol "HPA003151: AB_1859344, HPA029291: AB_10602357" "unprognostic (1.05e-1)" "unprognostic (2.96e-3)" "unprognostic (5.29e-2)" "prognostic favourable (5.70e-4)" "unprognostic (2.56e-2)" "prognostic favourable (3.67e-6)" "unprognostic (1.32e-1)" "prognostic favourable (2.62e-4)" "unprognostic (2.51e-2)" "unprognostic (2.51e-2)" "prognostic favourable (1.51e-4)" "unprognostic (2.28e-1)" "unprognostic (2.24e-2)" "unprognostic (1.52e-3)" "unprognostic (4.71e-2)" "unprognostic (6.18e-2)" "unprognostic (2.81e-3)" 6.8 9.2 7.2 8.1 9.4 13.1 8.5 12.4 9.9 7.0 6.5 11.1 7.2 5.1 9.5 7.7 8.7 8.5 6.0 5.5 5.9 5.6 6.9 10.3 6.8 9.7 7.6 8.1 9.8 9.0 7.0 12.9 6.7 9.2 7.5 6.4 7.2 9.2 10.5 5.3 7.2 7.6 7.6 6.7 11.7 8.0 8.4 9.8 21.7 9.0 4.0 11.3 7.0 7.1 10.7 11.1 9.3 6.7 13.7 11.5 4.0 3.6 4.4 4.0 8.2 6.3 4.6 3.3 3.8 4.9 5.1 6.8 5.0 2.5 7.0 6.8 4.7 4.9 7.9 5.1 4.8 9.0 4.8 10.1 7.8 2.6 4.4 10.1 10.8 6.1 5.9 5.5 7.5 4.7 4.1 12.6 7.4 5.3 7.8 3.1 3.9 6.2 5.5 6.0 4.2 3.2 9.4 4.7 5.8 5.7 4.2 4.4 3.5 6.2 6.9 4.4 3.2 8.5 4.1 12.0 9.2 6.7 4.8 5.4 3.4 9.3 6.7 8.6 9.5 5.5 10.6 7.6 10.3 8.6 7.2 10.7 11.5 9.6 7.4 13.7 5.2 11.1 9.3 4.0 7.2 9.4 12.4 9.9 5.9 5.6 7.6 8.1 9.2 9.8 ZNF561 MGC45408 ENSG00000171469 "Zinc finger protein 561" Q8N587 19 9604680-9621399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm Nucleoplasm "HPA055332: , HPA062397: " "unprognostic (6.68e-2)" "unprognostic (1.26e-1)" "unprognostic (6.86e-3)" "unprognostic (3.43e-2)" "unprognostic (1.18e-2)" "unprognostic (3.63e-3)" "unprognostic (9.92e-2)" "unprognostic (2.53e-2)" "unprognostic (9.54e-2)" "prognostic favourable (1.31e-4)" "unprognostic (9.21e-2)" "unprognostic (3.34e-2)" "prognostic favourable (1.16e-4)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (3.27e-3)" "unprognostic (2.85e-3)" 11.7 11.7 7.5 9.1 8.8 7.7 14.6 11.2 8.2 14.5 11.5 10.4 21.9 6.6 18.6 14.9 21.5 16.3 11.1 9.1 7.0 6.4 11.3 10.7 10.8 13.4 9.6 6.2 18.1 16.9 13.1 18.3 8.8 7.4 19.2 11.4 9.6 13.3 15.9 10.3 15.7 10.6 22.2 8.5 10.4 11.6 7.7 11.7 16.4 20.6 11.7 12.2 26.1 14.3 7.2 6.6 9.3 8.5 2.7 10.9 5.7 7.6 3.0 17.1 13.3 14.8 17.7 15.3 10.0 13.4 12.5 14.3 5.6 3.4 6.8 7.4 10.0 4.3 11.5 19.2 13.2 9.5 12.1 8.7 6.4 9.7 8.6 11.3 8.7 11.3 30.3 9.4 12.2 15.7 9.9 9.2 15.7 3.6 4.8 11.9 14.1 9.6 5.7 8.5 7.4 11.4 28.2 11.0 11.0 0.2 6.2 7.9 7.9 7.6 4.9 13.7 4.8 9.6 9.7 11.3 15.7 9.4 6.7 2.9 9.2 5.0 8.5 9.3 8.5 8.2 10.9 4.8 6.6 7.6 6.6 7.2 9.6 7.2 5.5 2.7 4.2 5.9 6.3 5.7 7.5 8.8 11.2 8.2 7.0 6.4 9.6 6.2 7.4 11.7 ZNF562 FLJ20079 ENSG00000171466 "Zinc finger protein 562" Q6V9R5 19 9641808-9675086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA055332, HPA062397" Uncertain Approved Nucleoplasm Nucleoplasm "HPA055332: , HPA062397: " "unprognostic (2.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.85e-3)" "unprognostic (1.62e-1)" "unprognostic (2.02e-2)" "prognostic favourable (4.17e-4)" "unprognostic (4.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.88e-2)" "unprognostic (2.96e-3)" "unprognostic (1.81e-1)" "unprognostic (4.07e-2)" "unprognostic (1.81e-2)" "unprognostic (1.62e-3)" "unprognostic (9.44e-2)" "unprognostic (3.82e-2)" "unprognostic (1.13e-3)" 12.3 11.2 13.9 11.3 15.8 11.6 21.4 20.5 15.2 11.8 15.0 13.5 20.9 9.8 14.6 10.9 26.1 12.0 12.1 11.4 13.4 10.9 11.1 12.2 12.9 10.2 14.9 11.9 13.7 15.5 13.8 22.6 11.1 14.3 13.1 15.0 9.0 15.7 23.4 7.0 12.9 10.6 15.1 16.1 14.0 11.5 6.3 16.8 10.9 11.8 9.4 13.3 16.6 14.5 6.4 8.5 5.5 9.6 6.5 7.9 2.6 8.2 6.5 9.5 17.5 5.7 4.6 0.5 7.8 6.0 8.6 8.9 4.8 4.5 7.4 8.0 6.2 6.3 11.5 9.6 11.3 8.6 9.0 27.1 6.6 5.0 5.7 9.9 20.2 8.1 7.0 10.9 18.2 9.1 13.1 13.2 8.1 4.1 9.8 2.9 12.1 4.6 3.9 10.4 3.8 4.0 21.7 10.4 6.7 12.5 5.1 6.2 7.3 8.4 8.5 16.2 5.5 7.4 10.4 11.6 25.4 12.4 2.2 0.6 7.9 4.1 6.2 5.5 7.0 9.6 7.9 6.3 5.6 4.3 8.5 6.4 5.8 7.1 2.4 6.5 9.2 5.1 4.0 2.6 13.9 15.8 20.5 15.2 13.4 10.9 14.9 11.9 14.3 16.8 ZNF565 FLJ36991 ENSG00000196357 "Zinc finger protein 565" Q8N9K5 19 36182060-36246257 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044123 Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA044123: AB_10794395" "unprognostic (1.51e-1)" "unprognostic (3.77e-2)" "unprognostic (6.80e-2)" "unprognostic (7.46e-3)" "unprognostic (6.08e-3)" "unprognostic (7.97e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.90e-2)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-3)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (3.35e-2)" "unprognostic (1.55e-3)" "unprognostic (1.93e-4)" 5.9 5.7 12.1 4.2 11.6 7.1 7.1 10.4 12.8 5.7 5.2 16.8 4.8 4.4 7.1 6.5 5.2 6.7 4.8 5.3 8.0 7.7 5.5 6.2 4.6 4.4 17.3 10.1 11.1 5.7 4.9 7.5 4.6 12.1 7.0 5.8 4.1 8.0 5.6 7.8 6.6 4.1 6.2 17.3 4.5 6.1 13.5 14.9 2.3 6.8 3.5 5.7 6.6 8.4 2.1 3.6 13.8 3.7 3.1 4.5 2.3 3.8 5.5 6.6 4.6 10.4 6.9 1.8 3.8 6.3 4.6 7.9 3.2 3.4 2.9 5.0 4.9 2.3 3.3 2.8 7.3 5.0 1.5 5.3 4.7 4.2 4.4 3.5 3.7 8.1 8.0 3.0 8.0 5.5 3.5 3.6 5.6 4.9 4.2 0.9 2.6 2.6 3.6 3.9 2.9 4.6 5.2 5.3 5.5 3.1 3.6 3.5 2.5 3.8 4.5 6.6 3.8 4.8 5.5 1.1 1.8 1.9 6.3 2.9 3.2 13.8 3.1 4.8 3.5 3.2 3.8 2.1 4.0 3.4 3.6 2.1 4.5 3.5 1.5 3.1 3.7 1.9 2.0 2.3 12.1 11.6 10.4 12.8 8.0 7.7 17.3 10.1 12.1 14.9 ZNF566 "FLJ14779, MGC12515" ENSG00000186017 "Zinc finger protein 566" Q969W8 19 36445119-36489902 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023456 Uncertain Approved Nucleoplasm Nucleoplasm "HPA023456: AB_2221143" "unprognostic (1.68e-1)" "unprognostic (6.34e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (1.86e-4)" "unprognostic (3.89e-3)" "unprognostic (5.71e-4)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (1.92e-2)" "unprognostic (7.56e-2)" "unprognostic (8.19e-4)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (9.48e-2)" "unprognostic (3.00e-1)" "unprognostic (5.47e-3)" 8.2 8.2 10.4 7.2 11.4 5.9 9.0 22.7 14.2 8.7 7.0 9.4 5.8 6.7 12.1 10.3 6.1 9.7 6.2 8.1 10.9 11.7 8.8 8.4 7.9 9.1 11.6 11.8 14.3 6.3 10.4 14.0 5.5 12.7 8.1 5.9 11.6 6.3 7.2 7.3 8.5 6.4 9.1 10.7 7.6 6.0 5.1 13.8 5.1 10.3 5.3 8.9 8.4 6.1 8.1 2.8 5.6 1.6 4.6 8.6 3.2 3.5 8.5 9.9 10.9 7.5 7.6 6.9 6.9 5.8 8.7 9.2 3.5 1.5 6.7 7.5 4.4 2.5 8.9 2.5 10.1 10.8 6.7 6.8 5.9 3.1 5.5 7.2 8.1 6.5 3.6 4.6 7.3 3.3 9.8 0.2 5.9 5.6 9.4 3.7 11.9 3.7 6.2 7.9 4.5 2.6 6.8 9.3 14.0 8.3 4.8 6.5 4.2 9.9 3.7 7.6 10.4 3.2 6.5 2.8 7.6 9.2 0.4 4.8 9.9 5.6 1.5 1.9 5.3 1.4 8.6 8.1 6.5 6.5 2.8 6.1 7.9 8.0 1.4 4.6 1.6 2.0 6.7 3.2 10.4 11.4 22.7 14.2 10.9 11.7 11.6 11.8 12.7 13.8 ZNF567 MGC45586 ENSG00000189042 "Zinc finger protein 567" Q8N184 19 36687612-36727701 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023937 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA023937: AB_1859351" "unprognostic (4.39e-3)" "unprognostic (2.26e-1)" "unprognostic (1.76e-1)" "unprognostic (1.03e-2)" "unprognostic (2.36e-2)" "unprognostic (6.57e-2)" "unprognostic (2.40e-2)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (1.54e-1)" "unprognostic (9.93e-2)" "unprognostic (1.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (7.24e-2)" "unprognostic (9.03e-2)" 5.9 7.0 6.3 6.7 6.9 5.0 10.2 12.2 10.2 8.0 6.3 4.7 6.6 3.8 9.2 7.5 7.8 7.0 5.5 5.3 7.7 6.0 6.0 7.7 5.8 8.6 7.1 2.3 8.4 4.9 10.4 15.8 13.0 8.0 9.3 5.0 5.1 7.3 12.1 7.4 5.6 5.5 9.7 9.1 7.2 5.5 14.2 9.6 9.0 8.3 3.3 8.2 6.6 7.5 8.8 3.9 7.0 2.3 7.9 8.2 3.0 6.7 5.3 9.8 8.7 5.6 5.5 9.3 5.0 7.7 5.7 9.2 3.0 2.4 4.3 6.1 4.5 1.8 9.0 5.2 7.8 8.4 4.6 8.1 5.9 2.9 5.2 10.2 6.2 8.6 6.3 5.4 10.6 6.6 3.1 2.3 6.8 4.2 13.1 3.9 9.4 4.3 6.5 13.5 6.1 3.7 10.4 7.3 7.9 9.3 4.6 4.9 5.9 6.9 4.1 7.6 7.7 3.8 5.6 8.8 7.3 14.3 0.0 4.1 6.6 5.7 2.3 7.0 7.7 2.0 6.3 7.3 8.2 7.1 3.9 8.8 8.2 8.2 1.3 7.9 2.0 2.7 6.6 3.0 6.3 6.9 12.2 10.2 7.7 6.0 7.1 2.3 8.0 9.6 ZNF568 DKFZp686B0797 ENSG00000198453 "Zinc finger protein 568" Q3ZCX4 19 36916329-36998700 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024541, HPA052061" Uncertain Approved Nucleoplasm Nucleoplasm "HPA024541: , HPA052061: " "unprognostic (3.62e-2)" "unprognostic (2.73e-1)" "unprognostic (9.97e-2)" "unprognostic (1.99e-3)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (8.64e-2)" "unprognostic (2.65e-2)" "unprognostic (5.83e-5)" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (2.05e-5)" "unprognostic (2.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.06e-3)" "unprognostic (9.98e-3)" 6.9 11.3 11.8 5.6 14.7 5.9 9.2 30.4 13.4 11.3 7.3 10.5 6.3 4.5 12.3 8.1 5.9 10.3 5.6 8.9 11.5 13.0 7.8 5.5 6.9 6.5 15.0 9.8 16.3 6.8 14.4 24.6 8.4 13.7 8.5 5.0 8.1 8.6 9.0 8.5 6.8 5.2 10.6 13.0 9.3 7.0 9.5 16.3 6.4 13.2 7.6 7.0 7.6 7.3 8.7 3.0 12.8 2.3 7.1 10.1 3.1 0.2 4.4 7.3 2.4 6.8 7.6 2.3 6.1 6.1 5.2 7.0 0.2 2.6 0.3 7.3 7.6 1.2 0.1 3.5 5.3 1.0 5.3 2.3 0.6 0.8 8.7 0.2 5.9 9.9 4.2 5.1 0.1 2.6 0.4 0.9 7.5 0.3 1.6 1.2 5.9 0.3 0.6 5.3 2.3 4.9 9.7 7.2 9.2 0.3 0.2 5.4 5.9 1.0 5.1 3.6 10.1 5.7 4.1 8.6 10.5 5.3 0.2 0.2 11.2 12.8 1.9 6.5 8.4 1.5 7.6 8.7 7.9 7.0 3.0 7.6 10.1 8.0 1.6 7.1 2.3 2.9 6.7 3.1 11.8 14.7 30.4 13.4 11.5 13.0 15.0 9.8 13.7 16.3 ZNF569 "FLJ32053, ZAP1" ENSG00000196437 "Zinc finger protein 569" Q5MCW4 19 37411155-37469275 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA052994 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA052994: " "unprognostic (1.40e-1)" "unprognostic (3.37e-1)" "unprognostic (4.95e-2)" "unprognostic (2.18e-2)" "unprognostic (5.44e-2)" "unprognostic (4.79e-2)" "unprognostic (2.95e-2)" "unprognostic (4.00e-1)" "unprognostic (5.08e-2)" "unprognostic (6.50e-3)" "unprognostic (4.01e-3)" "unprognostic (9.41e-2)" "unprognostic (9.70e-2)" "unprognostic (3.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" 5.8 7.8 10.9 6.1 11.1 7.7 6.6 20.9 10.6 6.9 5.0 6.4 3.8 3.2 7.2 9.5 4.4 6.5 4.5 7.7 8.0 11.2 6.9 6.0 4.6 7.2 8.6 8.7 10.9 3.7 8.8 18.5 5.5 10.6 6.6 3.5 5.2 4.5 5.6 7.2 6.5 4.1 6.3 10.2 6.2 4.2 20.1 11.3 9.6 10.5 3.8 5.9 6.4 4.7 7.2 3.2 7.1 4.0 6.2 11.3 3.2 2.8 5.8 6.6 11.0 5.5 4.9 3.2 5.1 3.1 5.7 6.1 1.9 1.2 3.3 7.5 3.8 1.0 7.3 2.0 6.0 7.6 4.4 8.6 1.4 3.2 3.3 1.6 3.5 3.4 1.3 5.7 0.1 4.5 2.8 0.6 7.9 1.7 10.9 3.7 7.8 4.1 7.0 8.4 3.5 4.0 2.7 5.7 8.9 0.2 1.3 2.9 4.9 6.9 4.4 4.4 9.1 3.4 8.3 9.4 16.0 13.1 0.3 3.6 7.0 4.9 2.6 7.1 8.7 3.3 7.7 6.1 7.8 8.1 2.8 7.2 11.3 8.9 2.7 6.2 4.0 3.2 7.8 3.2 10.9 11.1 20.9 10.6 8.0 11.2 8.6 8.7 10.6 11.3 ZNF570 FLJ30791 ENSG00000171827 "Zinc finger protein 570" Q96NI8 19 37467585-37488652 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028881 Uncertain Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA028881: AB_10603938" "unprognostic (2.93e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-2)" "unprognostic (1.24e-1)" "unprognostic (1.70e-2)" "unprognostic (1.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.23e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (6.54e-2)" "unprognostic (4.59e-2)" "prognostic favourable (4.06e-5)" "unprognostic (5.30e-2)" "unprognostic (2.85e-2)" "unprognostic (3.12e-2)" "unprognostic (2.20e-3)" 7.4 5.8 7.6 3.7 8.8 4.3 6.7 8.2 9.8 6.1 4.7 6.7 3.0 4.4 7.1 4.9 5.2 4.9 5.0 5.4 6.6 5.7 6.7 4.0 4.6 5.6 9.3 6.2 8.3 4.5 13.6 8.0 4.8 8.3 6.8 2.9 4.5 5.0 5.3 4.9 4.1 4.0 5.4 9.0 6.9 4.7 14.7 10.0 7.2 7.5 4.9 5.4 5.7 7.8 3.7 2.0 3.9 3.3 4.7 5.6 2.3 1.9 2.7 3.6 10.7 4.9 6.2 1.8 3.8 2.0 3.6 4.9 0.0 0.8 0.5 5.2 2.8 0.4 3.1 2.3 4.4 2.1 2.2 2.5 0.3 1.2 3.4 0.2 5.5 5.3 2.2 2.4 0.1 3.6 0.4 0.2 3.8 0.8 6.0 1.9 2.4 1.1 1.1 3.8 2.0 3.0 3.0 3.3 6.9 0.0 0.1 1.2 2.2 2.8 1.8 1.4 2.8 2.4 2.7 6.1 5.2 2.8 0.0 0.3 2.9 1.4 1.9 2.3 3.6 3.3 2.9 3.6 5.6 2.4 1.9 3.7 5.0 5.0 3.9 4.7 1.4 2.0 3.4 2.3 7.6 8.8 8.2 9.8 6.6 5.7 9.3 6.2 8.3 10.0 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.7 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.2 6.3 5.7 1.3 2.4 0.8 5.3 1.7 9.5 2.1 15.8 3.5 4.8 3.0 5.0 9.0 11.6 13.6 9.5 6.4 2.1 3.2 9.7 1.3 0.8 3.0 3.9 3.2 6.9 7.7 15.8 13.2 0.5 0.8 6.5 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 ZNF575 FLJ32567 ENSG00000176472 "Zinc finger protein 575" Q86XF7 19 43525497-43536130 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 11.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051865 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA051865: " "unprognostic (1.77e-3)" "unprognostic (2.73e-2)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (8.56e-2)" "unprognostic (6.53e-4)" "unprognostic (1.23e-1)" "unprognostic (2.37e-1)" "unprognostic (2.36e-2)" "unprognostic (2.21e-1)" "unprognostic (3.87e-5)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (7.83e-2)" "unprognostic (2.75e-1)" 8.8 3.9 10.5 3.8 10.0 2.5 3.2 12.3 13.5 4.9 13.8 6.8 2.9 5.6 4.7 4.0 2.4 3.6 4.6 3.6 6.6 4.2 3.9 3.2 3.6 3.9 5.4 6.2 6.3 2.3 3.0 5.2 2.0 6.7 5.5 7.1 5.1 5.0 4.1 12.9 4.8 6.4 3.4 6.0 5.8 4.7 1.9 6.5 2.4 3.3 2.3 4.2 3.5 3.7 3.0 1.9 0.8 0.9 7.0 4.4 1.3 2.9 2.6 0.6 0.8 4.0 3.3 0.2 1.9 1.2 0.7 1.0 0.6 1.1 0.6 1.3 1.4 1.6 0.1 0.3 0.3 4.1 0.5 2.2 0.9 0.5 0.9 0.9 2.7 1.9 1.1 1.0 0.2 0.6 0.8 4.1 1.2 1.9 11.6 0.3 0.2 1.3 6.3 0.0 1.5 0.7 1.7 0.6 1.0 1.5 1.9 1.9 0.5 1.0 2.0 3.7 2.5 0.8 1.4 2.2 3.1 1.7 2.3 2.6 3.8 0.1 0.9 0.6 3.0 0.5 1.2 1.5 2.8 2.9 1.3 3.0 4.4 3.2 0.8 7.0 0.3 1.9 2.3 1.3 10.5 10.0 12.3 13.5 6.6 4.2 5.4 6.2 6.7 6.5 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA050064: " "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 11.8 14.4 14.5 11.4 18.7 5.2 11.3 28.0 19.4 11.2 11.5 15.3 11.4 16.0 12.7 9.0 15.0 14.2 13.4 16.0 13.3 13.7 12.1 23.5 8.7 12.5 15.7 16.8 17.9 14.7 11.4 16.4 10.2 16.5 16.9 8.5 9.5 17.7 12.9 21.0 11.3 15.1 9.8 13.4 10.3 11.9 13.2 13.3 13.3 13.9 8.4 10.2 16.1 10.5 22.3 22.2 13.9 13.6 15.7 17.7 10.3 15.6 18.3 6.8 8.6 9.1 8.2 6.1 13.1 8.7 13.2 14.8 8.9 12.0 10.3 14.9 9.8 6.4 9.7 9.2 3.6 11.2 16.6 7.6 12.7 11.0 7.6 10.1 14.2 7.0 11.7 11.5 4.7 9.4 9.4 13.4 10.0 15.4 14.1 4.5 4.7 15.6 12.0 6.0 10.1 7.8 14.1 12.6 7.9 8.6 17.4 6.6 8.2 11.7 9.7 17.7 9.9 7.9 19.1 7.1 7.9 7.0 15.3 11.8 15.2 9.3 13.6 13.9 15.9 12.6 14.3 22.3 16.0 13.5 13.9 16.7 17.7 14.0 7.3 15.7 12.5 22.2 15.9 10.3 14.5 18.7 28.0 19.4 13.3 13.7 15.7 16.8 16.5 13.3 ZNF579 FLJ35453 ENSG00000218891 "Zinc finger protein 579" Q8NAF0 19 55576770-55580845 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062812 Approved Approved Nucleoplasm Nucleoplasm "HPA062812: " "unprognostic (1.76e-2)" "unprognostic (1.43e-2)" "unprognostic (4.09e-2)" "unprognostic (9.08e-2)" "unprognostic (2.87e-1)" "unprognostic (5.95e-2)" "unprognostic (4.79e-2)" "unprognostic (2.87e-2)" "unprognostic (5.39e-2)" "unprognostic (1.71e-1)" "unprognostic (5.85e-3)" "unprognostic (1.68e-2)" "prognostic unfavourable (1.00e-5)" "unprognostic (5.27e-2)" "unprognostic (3.46e-1)" "unprognostic (1.57e-1)" "unprognostic (4.08e-3)" 9.6 7.0 9.0 5.9 11.2 7.5 8.8 27.5 19.5 10.3 8.5 13.4 10.9 8.3 12.6 13.7 8.2 13.6 14.5 10.2 7.8 8.9 11.3 8.6 10.4 8.2 8.0 6.3 13.4 12.4 6.8 10.3 5.2 9.7 10.4 5.3 10.6 9.8 10.6 33.0 11.8 6.5 8.2 7.1 8.2 17.6 5.7 7.6 8.5 14.6 8.3 6.6 10.9 9.8 1.9 1.8 0.9 1.7 0.6 1.3 0.2 5.1 10.4 5.7 5.8 9.4 6.5 7.3 10.2 2.7 5.6 6.1 3.5 6.3 8.5 4.1 6.0 5.0 3.3 5.5 5.8 1.5 28.6 5.1 17.8 6.4 9.5 3.1 4.5 16.3 6.3 4.3 4.4 3.1 10.2 2.9 11.0 6.6 4.4 4.2 5.1 16.5 7.9 5.3 3.4 7.5 9.6 6.9 10.1 6.8 5.3 4.7 2.7 4.3 6.9 7.4 7.2 2.3 6.1 7.7 6.4 4.6 3.9 5.0 3.6 0.5 1.7 0.2 0.8 0.6 0.4 0.4 0.3 0.9 1.8 1.9 1.3 0.5 0.9 0.6 0.5 1.8 0.8 0.2 9.0 11.2 27.5 19.5 7.8 8.9 8.0 6.3 9.7 7.6 ZNF580 ENSG00000213015 "Zinc finger protein 580" Q9UK33 19 55635016-55643469 "Predicted intracellular proteins, Transcription factors" "Chemotaxis, Inflammatory response, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEK 293: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054058 Approved Approved Nucleoplasm Nucleoplasm "HPA054058: AB_2682360" "unprognostic (1.36e-2)" "unprognostic (5.13e-3)" "unprognostic (2.47e-3)" "unprognostic (3.80e-2)" "unprognostic (1.72e-3)" "unprognostic (1.15e-1)" "prognostic unfavourable (5.63e-4)" "unprognostic (3.54e-2)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "prognostic favourable (2.36e-5)" "unprognostic (1.47e-1)" "prognostic unfavourable (5.79e-6)" "unprognostic (1.43e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-1)" "unprognostic (3.46e-3)" 32.8 23.6 24.5 25.5 23.4 17.2 19.1 28.7 28.2 23.4 25.2 23.1 36.4 19.8 32.2 39.5 18.2 25.8 25.5 17.2 23.1 21.7 23.3 8.7 17.1 24.2 19.1 22.0 33.0 24.1 37.8 38.2 13.7 19.9 31.3 16.2 23.0 31.7 34.2 20.9 19.4 20.0 32.4 17.3 30.1 24.9 10.7 20.9 23.0 35.4 10.8 21.6 25.8 21.1 12.8 4.1 10.5 9.2 2.9 3.3 1.5 4.6 8.8 8.0 5.2 8.9 5.0 3.1 6.3 7.5 9.8 12.3 1.5 4.5 3.4 1.8 9.1 3.9 5.3 5.7 7.6 10.7 76.7 6.2 8.3 4.1 11.9 3.0 14.3 10.8 6.0 4.7 9.1 6.7 6.2 9.4 8.1 1.4 13.8 4.5 4.2 11.3 12.5 2.8 14.0 11.1 5.5 8.9 11.0 4.4 4.4 5.7 3.8 3.2 8.4 5.4 8.1 3.7 3.4 19.0 5.1 8.3 3.0 4.8 5.1 4.4 3.4 10.5 1.2 4.8 1.3 8.2 2.7 2.7 3.6 12.8 3.3 2.8 6.2 2.9 9.2 4.1 2.1 1.5 24.5 23.4 28.7 28.2 23.1 21.7 19.1 22.0 19.9 20.9 ZNF582 FLJ30927 ENSG00000018869 "Zinc finger protein 582" Q96NG8 19 56375846-56393545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028858 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA028858: AB_10603247" "unprognostic (1.19e-3)" "unprognostic (9.86e-4)" "unprognostic (3.88e-1)" "unprognostic (3.46e-2)" "unprognostic (4.08e-3)" "unprognostic (1.04e-2)" "unprognostic (2.12e-2)" "unprognostic (6.05e-2)" "unprognostic (3.10e-2)" "unprognostic (4.12e-2)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (2.02e-7)" "unprognostic (3.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.54e-2)" "unprognostic (5.00e-3)" 4.8 8.7 7.7 4.7 8.9 2.7 6.3 9.4 9.0 4.7 4.9 7.8 3.6 2.3 7.9 13.5 4.8 6.1 6.4 8.0 8.2 7.1 5.9 4.8 5.2 8.0 9.6 3.9 10.2 4.0 7.5 11.4 5.4 8.9 8.4 2.7 4.4 4.1 5.5 3.5 5.6 3.3 5.5 7.7 7.2 3.4 8.9 13.1 7.8 13.8 2.2 3.7 5.4 5.9 5.9 3.4 5.9 3.3 11.0 6.5 2.8 0.0 1.0 5.9 1.2 1.5 1.5 0.0 2.4 2.5 1.6 1.2 0.0 0.3 0.0 1.6 1.3 0.0 0.7 0.3 1.2 0.0 23.8 5.7 0.0 0.4 2.5 1.5 4.6 5.3 1.3 1.0 0.0 0.9 1.3 0.0 0.9 0.0 3.3 3.6 3.3 0.0 1.5 2.0 2.1 1.3 3.3 0.0 3.9 0.0 0.8 0.0 2.7 3.1 1.0 3.1 6.3 0.8 3.2 5.1 5.5 3.6 0.2 0.3 1.7 4.3 2.2 5.9 4.4 3.3 6.5 5.9 5.2 4.4 3.3 4.3 3.8 4.8 0.5 11.0 2.4 3.4 1.6 2.8 7.7 8.9 9.4 9.0 8.2 7.1 9.6 3.9 8.9 13.1 ZNF585B "FLJ14928, SZFP41" ENSG00000245680 "Zinc finger protein 585B" Q52M93 19 37181579-37218153 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA075556 Approved "Nucleoplasm,Cytoplasmic bodies" "Nucleoplasm, Cytoplasmic bodies" "HPA075556: " "unprognostic (9.53e-3)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.30e-2)" "unprognostic (9.52e-2)" "unprognostic (2.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.13e-1)" "unprognostic (3.11e-2)" "unprognostic (5.01e-2)" "unprognostic (3.56e-2)" "unprognostic (2.58e-1)" "unprognostic (3.26e-2)" "unprognostic (4.59e-2)" "unprognostic (2.79e-1)" "unprognostic (6.41e-2)" "unprognostic (4.18e-3)" 6.6 8.3 11.2 5.8 13.4 2.6 9.3 17.9 12.9 10.0 8.1 8.7 11.4 5.6 11.6 15.2 5.8 8.8 7.5 7.2 9.8 10.0 8.7 5.2 6.2 7.3 14.1 9.8 15.0 6.2 23.4 22.6 8.0 10.1 8.9 7.2 8.3 6.3 11.6 5.0 6.3 7.2 10.1 12.3 9.7 7.6 9.2 12.4 9.5 13.1 5.6 9.1 9.3 7.2 6.5 1.9 3.7 4.2 2.9 7.1 2.9 2.4 4.1 3.7 7.4 6.2 9.8 2.0 3.2 5.1 5.8 8.8 2.2 3.0 0.1 6.8 4.1 0.7 0.1 4.9 7.3 4.8 1.9 3.2 5.4 1.2 6.0 0.3 6.7 7.6 3.0 6.6 3.5 2.4 0.0 0.2 3.4 1.5 5.5 2.1 4.2 1.1 0.2 2.1 0.1 3.1 9.9 6.6 4.3 0.0 0.3 1.4 2.8 3.4 2.0 0.6 1.4 4.9 3.8 5.7 7.4 6.8 0.3 0.1 6.4 3.3 1.6 3.7 5.0 3.1 6.3 6.5 3.6 4.4 1.9 4.9 5.2 7.1 2.5 2.9 4.2 1.7 3.5 2.9 11.2 13.4 17.9 12.9 9.8 10.0 14.1 9.8 10.1 12.4 ZNF592 "CAMOS, KIAA0211, SCAR5" ENSG00000166716 "Zinc finger protein 592" Q92610 15 84748635-84806432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020332, HPA021600" Approved Approved Nucleoplasm Nucleoplasm "HPA020332: AB_1859365, HPA021600: AB_1859364" "unprognostic (2.83e-1)" "unprognostic (1.90e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (7.63e-2)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (5.04e-1)" "unprognostic (7.98e-2)" "unprognostic (2.84e-1)" "unprognostic (4.80e-3)" "unprognostic (3.64e-1)" "unprognostic (6.62e-2)" "unprognostic (3.90e-1)" "unprognostic (2.62e-1)" 16.8 15.0 19.0 19.8 20.0 20.5 22.5 20.4 20.6 17.3 16.4 22.7 16.6 17.0 21.5 17.8 12.9 19.0 14.7 16.4 18.6 13.4 15.7 17.5 15.8 21.0 22.5 12.0 26.9 23.5 23.3 18.4 13.0 16.8 15.2 15.9 16.1 14.9 15.8 31.3 21.2 17.9 17.7 19.1 20.0 13.8 17.8 21.0 23.9 16.7 15.9 19.7 14.7 21.3 3.7 3.4 6.6 3.5 2.3 3.3 1.7 7.1 12.2 11.3 6.3 12.7 8.5 12.5 5.0 7.2 8.4 6.7 11.5 8.5 10.4 6.6 11.3 13.3 17.3 7.2 6.0 8.3 10.4 12.1 12.1 10.2 7.8 9.8 9.6 9.3 10.3 6.5 10.9 7.3 11.9 6.6 8.8 11.1 6.5 12.0 10.2 4.8 9.6 10.1 9.1 8.9 14.6 10.3 11.1 11.6 10.4 8.3 5.8 20.9 10.3 12.5 7.3 6.9 9.6 7.6 8.1 11.3 7.9 14.5 7.2 0.0 3.1 2.2 3.3 3.5 1.3 3.7 2.1 3.1 3.4 3.7 2.8 2.4 6.6 2.3 3.2 2.7 1.8 1.7 19.0 20.0 20.4 20.6 18.6 13.4 22.5 12.0 16.8 21.0 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432422-3443542 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.3" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 6.7 6.7 4.5 4.6 8.5 5.0 5.9 5.2 8.7 4.7 4.2 7.3 2.4 3.8 5.6 6.8 4.0 5.9 6.0 5.4 4.8 4.4 5.2 5.4 7.4 6.1 4.5 4.5 7.2 5.2 4.5 7.7 7.9 8.9 4.8 3.2 5.8 4.6 4.9 3.6 4.4 5.1 4.1 4.6 5.4 4.8 13.2 5.4 5.4 6.4 2.6 5.6 5.7 4.6 1.4 1.1 11.3 2.2 0.9 2.2 0.8 0.0 1.8 2.2 5.3 1.7 2.6 8.6 2.5 3.1 2.5 3.1 0.0 3.3 4.3 2.5 2.9 1.4 5.1 2.3 3.2 2.6 2.0 7.5 4.8 3.1 2.5 4.4 4.5 3.3 3.6 2.8 3.1 6.8 1.6 2.9 2.8 1.4 3.1 4.6 7.3 0.0 2.0 6.6 3.0 2.0 7.0 2.9 4.1 5.1 2.6 1.9 2.2 6.7 4.4 4.1 2.1 0.0 2.4 3.8 4.0 0.5 0.0 2.5 2.5 3.8 1.1 11.3 1.3 2.2 2.2 1.4 1.0 1.1 1.1 1.1 1.9 1.4 0.3 0.9 1.0 0.5 1.6 0.8 4.5 8.5 5.2 8.7 4.8 4.4 4.5 4.5 8.9 5.4 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758076-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 5.9 8.1 10.0 5.2 12.5 2.4 8.5 16.8 8.0 10.1 6.5 11.7 5.8 4.5 12.2 21.4 4.4 14.1 6.5 5.8 10.3 6.8 9.7 4.9 6.0 5.7 10.5 5.7 11.4 5.7 14.3 13.2 6.0 8.1 10.4 5.5 11.6 7.4 9.5 5.5 8.0 5.4 7.1 8.1 6.5 5.9 19.9 11.2 10.4 13.2 6.0 6.2 6.4 7.2 4.3 3.8 6.4 4.8 5.7 6.7 2.9 5.3 2.7 5.9 5.5 6.6 8.9 3.2 2.0 5.5 4.9 5.8 2.3 3.6 0.6 5.7 3.7 2.8 3.9 2.5 6.1 0.6 4.9 4.1 5.4 6.6 5.0 0.9 4.7 8.0 3.7 2.2 2.3 5.6 6.9 0.5 7.6 2.1 10.3 4.3 2.6 0.2 5.6 5.6 3.3 6.1 1.3 7.1 10.1 6.6 1.2 3.9 3.5 0.5 3.0 4.9 5.5 3.6 2.1 6.2 6.7 0.5 3.0 0.1 4.6 3.1 1.1 6.4 6.1 2.5 4.0 2.0 6.5 3.5 1.7 4.3 6.7 5.9 0.6 5.7 4.8 3.8 4.9 2.9 10.0 12.5 16.8 8.0 10.3 6.8 10.5 5.7 8.1 11.2 ZNF605 ENSG00000196458 "Zinc finger protein 605" Q86T29 12 132918308-132956306 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061970, HPA062655" Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA061970: , HPA062655: " "unprognostic (2.38e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-2)" "unprognostic (6.38e-2)" "unprognostic (3.83e-2)" "unprognostic (1.16e-6)" "unprognostic (3.62e-1)" "unprognostic (1.15e-1)" "unprognostic (4.03e-1)" "unprognostic (2.13e-2)" "unprognostic (1.10e-2)" "unprognostic (2.89e-1)" "unprognostic (6.58e-2)" "unprognostic (1.10e-1)" "unprognostic (7.53e-2)" "unprognostic (9.06e-3)" 5.5 8.2 10.9 7.6 9.9 3.2 12.2 19.0 12.8 10.1 8.3 8.4 9.5 6.7 10.2 13.1 7.3 9.3 6.6 9.9 10.8 7.9 9.9 8.1 7.6 8.0 7.8 8.2 13.3 8.2 16.9 12.9 10.2 8.1 10.7 6.9 9.9 8.8 9.6 14.6 11.5 8.3 8.2 7.4 7.4 8.7 4.8 9.1 8.5 15.5 6.1 7.5 8.5 9.9 2.6 1.4 1.9 1.2 1.7 3.0 0.8 4.5 3.7 9.5 9.0 5.2 10.9 7.1 6.2 3.6 2.9 2.0 0.6 0.6 1.9 3.4 5.3 2.5 4.1 1.5 3.6 1.5 7.1 8.7 2.9 2.9 4.0 3.6 9.6 6.9 6.9 2.0 4.4 2.2 1.3 0.1 7.2 1.3 4.7 5.1 7.3 5.1 4.4 6.2 1.3 4.9 7.8 6.1 7.0 2.8 1.7 4.3 10.3 10.5 4.3 3.6 5.8 5.3 2.5 0.0 0.0 1.5 0.1 3.0 2.1 1.6 1.2 1.3 1.6 0.8 0.9 2.6 1.4 1.7 0.9 2.2 3.0 1.9 1.9 1.7 0.9 1.4 0.4 0.8 10.9 9.9 19.0 12.8 10.8 7.9 7.8 8.2 8.1 9.1 ZNF607 "FLJ14802, MGC13071" ENSG00000198182 "Zinc finger protein 607" Q96SK3 19 37696363-37719790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA049465, HPA055018" Uncertain Approved Nucleoplasm Nucleoplasm "HPA049465: , HPA055018: " "unprognostic (6.70e-2)" "unprognostic (8.00e-2)" "unprognostic (1.77e-3)" "unprognostic (2.69e-3)" "unprognostic (1.58e-1)" "unprognostic (9.23e-2)" "unprognostic (9.86e-3)" "unprognostic (2.15e-1)" "unprognostic (4.86e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-3)" "unprognostic (1.68e-1)" "unprognostic (6.43e-3)" "unprognostic (3.86e-1)" "unprognostic (4.30e-2)" "unprognostic (5.03e-2)" "prognostic favourable (5.23e-5)" 3.1 5.4 8.1 4.2 9.0 1.4 7.7 14.9 9.4 5.9 4.9 9.8 4.6 3.9 9.0 8.0 5.6 10.8 4.2 5.6 7.0 6.6 5.9 1.6 4.7 5.6 12.3 7.2 12.2 5.0 14.0 12.3 6.1 9.3 7.2 4.9 6.7 4.4 6.2 4.4 7.9 4.6 8.4 11.3 5.5 5.5 13.9 8.7 7.3 9.1 2.4 7.2 5.5 6.0 5.7 3.0 2.8 0.4 3.8 5.3 1.5 5.0 5.2 8.2 8.6 4.5 5.2 5.8 3.7 3.6 3.4 6.1 7.9 2.8 7.0 5.5 3.9 2.5 8.0 2.8 5.2 3.6 8.2 3.4 4.4 4.3 3.6 0.1 2.2 3.4 5.4 4.2 3.9 1.8 7.1 0.0 3.7 4.3 6.8 3.8 9.7 2.1 3.3 12.7 1.9 3.6 6.6 2.3 7.4 0.2 2.2 0.7 5.8 0.5 0.4 2.6 1.8 3.0 4.2 7.1 7.8 10.0 0.1 0.0 3.2 0.0 0.4 2.8 2.7 0.3 1.7 5.7 4.2 5.3 1.5 4.2 3.6 4.4 0.0 3.8 0.4 3.0 1.5 1.5 8.1 9.0 14.9 9.4 7.0 6.6 12.3 7.2 9.3 8.7 ZNF608 "DKFZp434M098, KIAA1281, NY-REN-36" ENSG00000168916 "Zinc finger protein 608" Q9ULD9 5 124636913-124748807 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 24.8;AN3-CA: 15.8;REH: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.2;naive B-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005545, HPA076984" Approved Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA005545: AB_1080742, HPA076984: " "unprognostic (3.82e-2)" "unprognostic (2.50e-2)" "unprognostic (1.92e-1)" "prognostic unfavourable (5.47e-4)" "unprognostic (3.75e-1)" "unprognostic (2.26e-1)" "unprognostic (3.04e-2)" "unprognostic (5.02e-2)" "unprognostic (7.52e-2)" "unprognostic (5.24e-2)" "unprognostic (3.67e-1)" "unprognostic (2.69e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (6.36e-2)" "unprognostic (2.80e-1)" "unprognostic (3.02e-1)" "unprognostic (9.56e-2)" 8.5 14.7 17.0 7.5 17.2 2.0 10.1 25.5 16.5 11.5 10.4 28.3 2.8 15.7 7.5 7.1 5.4 13.6 10.1 12.5 19.7 8.8 8.2 3.9 15.3 10.8 21.8 10.7 9.6 12.0 9.1 11.6 4.5 18.0 8.5 10.7 14.1 8.3 7.1 8.9 4.8 9.1 6.4 22.9 3.9 9.8 13.0 24.5 4.6 13.4 3.3 11.0 6.6 6.6 3.1 1.1 5.2 0.0 0.0 0.0 0.0 0.1 0.4 24.8 15.8 3.7 6.1 0.0 0.0 0.6 0.1 1.5 2.6 7.4 8.1 8.3 0.0 0.3 1.6 1.5 0.1 0.0 3.9 0.0 0.0 0.1 5.7 0.0 0.7 6.1 4.5 0.7 0.7 5.3 0.7 0.1 1.3 0.0 0.0 0.0 10.5 0.3 43.1 2.1 0.0 3.5 0.3 3.7 13.1 0.0 0.3 5.6 1.4 0.7 1.4 5.0 9.6 0.1 1.5 3.9 3.9 14.6 1.3 0.2 7.1 5.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 3.1 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 17.0 17.2 25.5 14.3 19.7 8.8 21.8 10.7 18.0 24.5 ZNF610 FLJ36040 ENSG00000167554 "Zinc finger protein 610" Q8N9Z0 19 52336245-52367778 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA055771, HPA078134" Enhanced Approved Nucleoplasm Nucleoplasm "HPA055771: , HPA078134: " "unprognostic (1.13e-1)" "unprognostic (5.48e-3)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (3.65e-2)" "unprognostic (1.27e-1)" "unprognostic (3.34e-1)" "unprognostic (2.84e-1)" "unprognostic (1.83e-1)" "prognostic favourable (3.38e-4)" "unprognostic (5.54e-2)" "unprognostic (1.14e-2)" "prognostic favourable (1.05e-7)" "unprognostic (2.46e-2)" "unprognostic (1.11e-2)" "unprognostic (1.88e-2)" "unprognostic (5.73e-3)" 2.3 4.8 7.9 2.1 11.9 0.8 5.5 11.0 9.7 5.5 3.0 6.9 3.3 1.5 5.1 11.7 2.1 7.4 4.3 4.2 7.6 7.7 5.9 1.0 3.3 2.6 7.5 7.2 14.3 2.9 7.5 6.8 4.5 10.0 7.6 2.9 5.7 2.2 4.1 1.9 1.6 1.8 4.4 8.5 4.1 2.7 18.1 7.3 3.6 7.7 0.2 2.1 3.6 2.4 3.6 1.5 4.0 0.5 2.5 4.8 1.6 0.2 0.0 6.2 5.1 4.1 3.5 4.7 1.9 3.4 1.1 3.4 0.0 0.4 0.5 3.8 0.8 0.2 0.0 0.0 2.8 0.1 3.0 0.1 0.3 0.2 4.9 0.0 1.5 4.7 0.1 1.2 0.2 3.5 0.3 0.2 5.6 1.3 3.2 0.9 5.8 0.4 2.3 4.7 0.6 2.2 4.4 7.7 4.4 0.1 0.5 1.9 3.7 2.7 2.8 0.3 2.0 0.1 2.3 0.2 12.1 0.0 0.0 0.1 2.4 4.0 0.5 1.1 2.9 0.1 4.4 2.5 2.4 2.3 1.4 3.6 4.8 2.0 1.4 2.5 0.1 1.5 3.2 1.6 7.9 11.9 11.0 9.7 7.6 7.7 7.5 7.2 10.0 7.3 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 25.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favourable (1.92e-6)" 4.7 5.3 7.1 3.9 7.4 1.6 9.5 14.2 7.4 5.3 6.5 5.2 1.9 2.8 5.5 5.3 4.7 4.3 3.7 4.3 9.7 4.7 8.7 4.0 4.9 6.3 7.2 4.9 6.5 3.4 7.4 7.0 8.2 8.8 25.4 6.7 5.4 4.5 5.6 3.9 4.5 4.9 5.8 7.5 6.7 4.2 3.5 7.0 9.0 7.3 2.6 5.2 5.8 4.1 10.1 9.6 14.1 11.3 9.5 14.3 7.0 3.1 4.2 6.9 6.9 6.0 6.9 1.7 5.3 8.5 7.1 9.2 1.4 3.7 2.6 2.8 6.6 3.6 6.7 6.6 7.7 0.1 8.6 5.5 3.0 3.9 6.1 0.3 7.9 5.1 7.6 6.7 5.5 7.6 2.5 0.0 7.1 0.6 9.2 4.1 4.9 5.9 5.0 7.3 2.8 6.9 10.8 4.6 4.5 8.5 6.3 5.0 6.6 6.8 4.8 3.1 5.9 2.4 5.6 6.0 0.0 5.1 0.2 0.0 9.3 7.7 7.4 14.1 10.4 7.5 9.3 7.6 11.1 12.1 9.6 10.1 11.2 14.3 7.6 9.5 11.3 4.8 10.0 7.0 7.1 7.4 14.2 7.4 9.7 4.7 7.2 4.9 8.8 7.0 ZNF614 FLJ21941 ENSG00000142556 "Zinc finger protein 614" Q8N883 19 52012765-52030240 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021197 Uncertain Approved Nucleoplasm,Vesicles,Cytosol Nucleoplasm "Vesicles, Cytosol" "HPA021197: AB_1859380" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (3.24e-2)" "unprognostic (1.30e-1)" "unprognostic (7.67e-3)" "unprognostic (2.68e-1)" "unprognostic (4.74e-3)" "unprognostic (5.07e-3)" "unprognostic (1.09e-1)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.74e-2)" "unprognostic (1.66e-2)" "unprognostic (3.06e-2)" "unprognostic (1.57e-1)" "unprognostic (2.30e-1)" "unprognostic (7.15e-3)" 7.7 7.1 9.9 5.6 9.4 10.1 10.1 15.6 12.5 9.2 7.3 6.6 5.8 4.5 9.5 7.3 6.3 8.8 6.0 7.0 7.9 8.5 6.9 4.7 6.3 8.2 9.3 7.1 14.0 5.1 6.5 13.7 14.2 9.7 16.4 5.5 5.5 5.4 8.9 11.1 7.6 6.3 8.9 13.5 9.7 5.8 13.8 10.7 18.2 14.3 5.1 7.5 8.5 9.6 6.0 5.5 4.3 5.9 9.6 8.1 3.2 3.8 2.8 7.3 9.5 5.2 5.9 1.0 5.1 3.7 4.8 5.9 3.7 2.2 9.6 2.9 4.4 1.7 10.8 6.9 7.2 2.6 15.4 14.5 5.2 7.3 4.3 3.0 7.4 4.5 3.8 4.9 6.9 5.6 7.7 2.2 6.4 1.5 12.4 6.0 8.4 5.2 8.3 14.1 7.9 4.9 9.8 9.8 5.9 3.1 3.9 3.2 5.2 7.6 5.7 4.8 6.6 2.7 6.1 4.4 6.8 14.8 4.5 4.2 6.2 4.3 4.3 3.0 6.5 5.9 7.8 6.0 5.7 6.1 5.5 6.0 8.1 5.3 3.3 9.6 4.5 3.1 5.9 3.2 9.9 9.4 15.6 12.5 7.9 8.5 9.3 7.1 9.7 10.7 ZNF618 "KIAA1952, NEDD10" ENSG00000157657 "Zinc finger protein 618" Q5T7W0 9 113876282-114056591 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023116, HPA061732" Uncertain Approved Nucleoplasm Nucleoplasm "HPA023116: AB_10964204, HPA061732: " "unprognostic (1.92e-1)" "unprognostic (3.22e-2)" "unprognostic (2.29e-2)" "unprognostic (4.17e-3)" "prognostic unfavourable (6.34e-4)" "unprognostic (3.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.61e-1)" "unprognostic (6.43e-2)" "unprognostic (2.38e-2)" "unprognostic (1.56e-2)" "unprognostic (8.24e-2)" "prognostic favourable (5.22e-7)" "unprognostic (4.57e-2)" "unprognostic (2.79e-1)" "unprognostic (1.04e-1)" "unprognostic (3.51e-2)" 5.2 7.5 5.0 8.1 5.2 3.4 6.1 19.2 5.0 9.3 3.6 5.4 4.0 3.3 11.5 7.3 3.5 8.4 12.1 3.1 4.3 3.8 13.3 8.2 5.2 3.0 2.8 3.3 15.0 13.3 15.8 11.6 3.2 4.8 5.9 2.5 14.5 6.0 4.8 3.1 3.4 2.6 6.9 2.7 5.4 6.4 5.6 2.4 5.6 10.9 2.6 3.0 4.3 6.6 1.3 4.3 4.0 0.9 2.8 0.9 0.9 4.3 13.4 20.1 8.7 4.9 5.7 1.0 2.9 4.7 5.8 5.2 0.1 3.1 2.4 2.8 4.9 0.1 10.0 5.0 2.3 0.0 4.0 0.0 1.0 0.0 3.6 2.5 4.5 5.5 2.0 6.1 1.4 14.6 0.0 0.0 2.6 7.1 0.1 3.3 10.0 3.0 18.6 11.7 0.0 6.2 4.8 6.2 14.8 8.2 5.2 5.3 0.4 5.2 11.8 7.8 6.2 4.3 3.4 0.0 0.0 0.0 0.6 3.9 5.4 4.0 0.9 0.6 0.9 0.5 0.3 0.0 0.1 0.8 3.4 1.3 0.7 0.5 0.0 2.8 0.7 4.3 0.0 0.9 5.0 5.2 19.2 5.0 4.3 3.8 2.8 3.3 4.8 2.4 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40490236 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 8.8 7.6 6.3 9.2 9.5 9.0 9.2 7.9 8.7 7.0 6.7 13.3 8.4 7.3 9.3 6.6 6.4 8.4 8.9 6.9 7.8 5.8 7.1 8.1 9.6 18.0 12.7 9.2 9.4 12.3 14.0 6.6 6.3 7.3 7.0 8.2 9.7 8.6 10.4 8.5 7.3 7.5 7.6 9.6 9.0 7.3 3.8 9.3 6.0 10.2 5.0 9.4 8.0 6.8 4.1 4.5 5.1 4.5 5.2 5.1 2.7 2.7 4.0 4.7 4.1 6.8 7.2 1.7 3.6 4.4 7.0 6.9 1.2 3.9 0.3 2.2 3.4 3.0 4.3 7.4 7.6 4.7 1.6 8.2 3.2 1.9 7.2 5.8 7.4 5.8 5.6 7.1 10.5 6.4 5.4 3.9 4.3 3.4 0.1 2.6 2.5 3.6 1.6 4.8 4.5 2.9 6.3 3.0 3.1 4.0 5.9 3.2 4.8 3.8 4.9 5.1 3.9 2.8 4.1 2.2 2.8 0.3 3.1 3.6 5.3 2.8 3.2 5.1 3.0 4.5 3.3 3.3 3.0 3.8 4.5 4.1 3.1 3.9 3.8 5.2 4.3 2.8 5.1 2.7 6.3 9.5 7.9 8.7 7.8 5.8 12.7 9.2 7.3 9.3 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636013-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 13.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 9.4 8.7 10.4 10.2 14.1 5.3 11.3 18.2 16.7 14.5 10.7 12.2 10.3 12.1 15.0 11.2 10.3 10.8 10.5 10.0 9.6 9.1 8.1 8.6 10.1 10.9 8.8 14.5 17.7 10.4 9.5 9.9 8.6 11.9 12.4 9.8 8.5 12.0 8.5 11.7 14.0 12.0 12.0 8.3 10.7 8.6 11.2 10.2 12.3 12.6 6.5 11.4 11.7 12.5 2.9 1.3 13.5 3.6 2.0 3.3 1.1 3.3 4.8 3.8 6.0 4.0 6.6 3.4 1.9 3.8 4.0 0.7 3.0 5.8 1.3 2.7 7.0 2.3 5.7 1.8 3.7 5.4 2.2 7.8 7.6 1.7 3.3 1.3 2.2 3.5 4.5 2.1 10.7 3.5 7.6 5.3 4.7 8.8 7.7 1.9 4.4 17.2 4.4 1.8 8.3 3.1 2.8 5.8 7.4 19.0 4.2 5.1 6.5 4.9 1.0 7.2 1.1 1.1 1.9 1.5 1.7 4.4 3.3 2.3 4.2 13.5 1.0 3.5 2.6 1.3 1.4 2.7 1.7 1.3 1.3 2.9 3.3 2.5 1.8 2.0 3.6 1.2 1.8 1.1 10.4 14.1 18.2 16.7 9.6 9.1 8.8 14.5 11.9 10.2 ZNF625 ENSG00000257591 "Zinc finger protein 625" Q96I27 19 12142090-12156729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA074014 Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA074014: " "unprognostic (7.88e-3)" "unprognostic (6.74e-2)" "unprognostic (9.56e-2)" "unprognostic (8.75e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-3)" "unprognostic (4.72e-2)" "unprognostic (3.31e-2)" "unprognostic (6.23e-2)" "unprognostic (2.73e-1)" "unprognostic (5.49e-2)" "unprognostic (3.70e-2)" "unprognostic (8.29e-2)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.62e-1)" 4.9 5.2 6.7 3.4 5.4 3.8 8.5 11.2 8.3 7.2 5.1 5.6 7.5 2.8 8.3 10.6 4.7 6.0 4.7 3.7 6.0 8.8 6.0 2.8 4.8 5.2 6.6 5.5 13.1 5.4 6.9 9.4 6.4 6.4 7.3 3.5 7.5 4.0 7.1 2.0 7.3 3.3 6.6 4.7 5.8 3.8 4.6 2.9 1.0 8.7 3.2 3.9 7.3 7.2 1.4 0.4 1.3 0.5 2.9 2.1 0.7 0.7 0.0 6.5 10.8 2.8 2.0 1.1 2.8 3.5 4.0 4.5 0.1 0.2 0.0 5.0 2.1 0.7 0.0 3.5 3.8 0.0 2.0 2.9 0.0 2.9 1.3 0.2 4.1 1.7 1.4 3.3 2.1 3.1 0.0 0.0 6.0 2.1 0.1 1.3 7.8 3.9 0.2 5.8 0.0 3.4 8.7 4.4 3.0 0.0 0.1 2.2 4.7 0.2 2.4 9.3 4.2 6.9 3.6 7.1 5.6 0.0 2.2 0.0 3.3 0.7 0.4 0.2 0.7 0.5 0.9 0.5 1.0 1.2 0.4 1.4 1.5 1.2 1.3 2.9 0.1 0.3 2.1 0.7 6.7 5.4 11.2 6.8 6.0 8.8 6.6 5.5 6.4 2.9 ZNF626 ENSG00000188171 "Zinc finger protein 626" Q68DY1 19 20620061-20661596 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA045631 Uncertain Approved "Nucleoplasm,Nuclear membrane,Vesicles" "Nuclear membrane, Vesicles" Nucleoplasm "HPA045631: " "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-2)" "unprognostic (2.18e-2)" "unprognostic (6.24e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-2)" "unprognostic (6.51e-3)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (5.10e-2)" "unprognostic (1.73e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (2.31e-1)" 8.1 13.9 10.2 6.0 15.6 4.1 18.5 15.2 14.8 11.2 8.3 12.0 21.6 2.4 13.0 9.5 8.0 14.0 10.7 10.8 10.1 10.1 12.7 6.5 7.2 12.4 10.9 11.1 29.2 9.6 36.3 14.8 8.3 11.0 12.8 4.4 13.6 8.9 23.9 7.3 10.8 6.0 11.9 12.1 7.8 9.1 5.8 11.9 13.6 26.9 4.9 10.7 21.3 9.7 11.4 4.2 11.6 4.3 9.1 8.6 4.2 0.1 0.0 4.3 0.7 5.3 6.9 0.5 4.9 0.5 7.0 6.2 0.2 0.2 0.7 2.5 6.0 0.8 0.0 0.2 8.9 0.0 0.2 0.0 0.1 1.7 9.4 0.1 0.1 12.8 2.2 4.1 2.2 3.3 3.0 0.5 7.3 0.1 0.8 1.1 9.3 2.2 4.3 3.2 1.6 7.0 5.3 1.5 8.3 0.2 0.5 4.4 10.3 0.4 0.0 3.2 0.2 12.7 0.5 6.9 13.8 6.2 0.1 0.1 0.5 0.8 1.1 6.0 7.6 1.0 7.3 7.9 8.0 8.6 3.2 11.4 7.7 6.6 11.6 9.1 4.3 4.2 3.7 4.2 10.2 15.6 15.2 14.8 10.1 10.1 10.9 11.1 11.0 11.9 ZNF627 FLJ90365 ENSG00000198551 "Zinc finger protein 627" Q7L945 19 11559374-11619135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA049770, HPA073463" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA049770: , HPA073463: " "unprognostic (1.81e-1)" "unprognostic (9.89e-2)" "unprognostic (1.64e-2)" "unprognostic (3.14e-2)" "unprognostic (7.89e-3)" "prognostic favourable (8.12e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.83e-3)" "unprognostic (3.17e-2)" "unprognostic (2.03e-1)" "unprognostic (1.67e-2)" "prognostic favourable (6.93e-7)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-1)" "unprognostic (6.39e-3)" 10.3 8.4 9.9 10.1 11.1 10.5 17.5 15.6 12.8 13.8 9.2 11.1 15.4 8.1 16.7 14.6 7.9 19.4 10.1 8.4 9.2 10.0 15.4 11.0 9.6 10.3 12.3 10.0 20.9 19.7 9.3 17.8 9.8 10.3 13.4 11.0 12.5 11.6 14.8 7.7 10.1 8.5 14.1 9.6 9.9 9.2 12.1 11.8 17.4 19.9 7.8 11.3 11.9 13.8 10.2 8.0 13.4 5.6 7.9 8.9 4.8 4.7 3.9 12.8 15.7 5.8 6.1 7.2 7.1 8.4 8.1 8.2 3.3 3.3 3.5 7.1 5.5 4.3 5.1 6.9 9.1 6.3 2.3 10.0 2.5 6.3 11.0 5.6 5.8 7.3 9.9 5.5 12.2 8.9 9.4 5.1 10.6 9.9 9.0 5.7 9.4 8.6 10.0 9.7 4.8 9.2 7.5 17.8 12.8 9.3 5.2 9.8 9.2 16.0 7.8 8.7 4.0 4.9 4.9 7.3 7.0 3.9 4.0 9.3 7.1 13.4 4.9 7.8 5.4 5.6 6.4 10.2 6.6 6.6 8.0 6.9 8.9 7.9 2.6 7.9 5.3 3.1 3.6 4.8 9.9 11.1 15.6 12.8 9.2 10.0 12.3 10.0 10.3 11.8 ZNF628 "ZEC, Zfp628" ENSG00000197483 "Zinc finger protein 628" Q5EBL2 19 55476332-55484487 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044451 Uncertain Approved Nucleoplasm Nucleoplasm "HPA044451: AB_10962507" "unprognostic (8.70e-2)" "unprognostic (5.08e-1)" "unprognostic (8.30e-2)" "unprognostic (1.81e-1)" "unprognostic (4.65e-2)" "unprognostic (2.35e-2)" "unprognostic (2.13e-2)" "unprognostic (5.19e-2)" "unprognostic (3.10e-1)" "unprognostic (7.15e-2)" "unprognostic (4.58e-3)" "unprognostic (3.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (4.88e-3)" 6.8 4.7 3.6 6.0 5.0 9.8 5.0 4.1 10.5 5.5 5.8 5.2 5.6 8.4 6.9 4.7 5.0 5.7 4.8 4.3 2.4 2.4 5.4 10.0 5.5 5.4 1.9 4.9 7.6 6.8 2.8 5.9 6.9 4.6 6.2 2.0 5.4 5.7 5.0 15.0 7.3 7.0 4.9 2.0 7.2 8.0 20.8 2.1 12.1 5.0 5.0 7.5 6.2 4.4 0.6 1.0 0.5 2.3 0.4 1.0 0.3 6.7 4.2 1.0 2.9 0.5 1.3 8.1 4.6 0.9 1.6 1.3 2.6 2.9 6.3 4.5 0.8 3.9 0.5 2.7 0.2 6.4 15.8 4.3 3.8 2.3 1.8 3.4 11.3 1.0 1.8 1.2 0.7 1.2 6.5 3.4 0.6 4.5 4.8 2.3 4.4 8.3 9.1 1.6 5.9 1.4 4.2 5.2 5.7 3.4 4.0 5.8 3.9 5.3 2.9 3.0 4.4 3.0 4.8 8.0 6.8 4.8 3.9 2.5 2.9 0.0 0.7 0.5 0.7 0.2 0.5 0.6 1.0 0.6 0.7 0.2 0.3 0.4 0.5 0.4 2.3 1.0 0.0 0.3 3.6 5.0 4.1 10.5 2.4 2.4 1.9 4.9 4.6 2.1 ZNF630 "BC037316, dJ54B20.2, FLJ20573, MGC138344" ENSG00000221994 "Zinc finger protein 630" Q2M218 X 47983356-48071658 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001053, HPA068130" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA001053: , HPA068130: " "unprognostic (1.03e-1)" "unprognostic (2.73e-1)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (8.09e-2)" "unprognostic (5.86e-3)" "unprognostic (5.83e-2)" "unprognostic (9.06e-3)" "unprognostic (8.68e-2)" "unprognostic (5.83e-2)" "unprognostic (2.14e-2)" "unprognostic (7.92e-2)" "unprognostic (6.07e-3)" "unprognostic (5.92e-2)" "unprognostic (1.31e-1)" "unprognostic (3.27e-1)" "unprognostic (7.51e-5)" 4.0 5.2 5.3 6.4 9.0 2.1 6.7 8.8 8.5 7.0 5.4 5.9 11.3 3.5 6.3 7.5 5.0 4.8 5.8 5.9 6.0 4.6 5.2 3.0 5.0 5.4 12.3 5.8 11.2 8.3 11.9 10.1 4.9 8.8 8.4 6.2 6.4 6.1 6.9 2.3 4.0 4.2 7.5 7.3 4.8 6.8 1.8 10.1 1.0 9.3 1.5 3.6 8.4 13.7 2.6 3.8 5.8 1.9 1.5 2.8 2.0 1.4 1.1 0.3 0.0 0.1 0.1 0.0 1.9 0.6 1.0 0.9 3.3 5.4 0.1 1.0 2.0 2.3 0.0 1.0 1.3 0.0 0.0 0.0 1.4 0.0 1.4 0.0 0.0 1.3 5.7 3.2 0.0 1.0 0.0 5.4 3.6 5.7 0.0 0.0 2.1 1.6 0.7 1.3 0.0 2.5 3.0 3.2 2.6 7.1 4.8 2.1 5.7 1.4 1.2 0.0 2.6 2.5 0.0 0.0 4.7 0.0 0.0 0.1 4.5 5.8 1.9 4.8 2.2 1.0 2.4 2.6 2.0 2.0 3.8 1.8 2.5 2.8 2.1 1.5 0.6 0.9 1.1 2.0 5.3 9.0 8.8 8.5 6.0 4.6 12.3 5.8 8.8 10.1 ZNF646 KIAA0296 ENSG00000167395 "Zinc finger protein 646" O15015 16 31074422-31084196 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042364, HPA066468" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA042364: AB_10794796, HPA066468: " "unprognostic (1.61e-2)" "unprognostic (2.18e-1)" "unprognostic (8.08e-2)" "unprognostic (1.18e-2)" "unprognostic (4.66e-1)" "unprognostic (6.20e-3)" "prognostic unfavourable (1.28e-6)" "unprognostic (3.23e-2)" "unprognostic (4.21e-2)" "unprognostic (6.96e-2)" "unprognostic (1.16e-2)" "unprognostic (9.83e-2)" "unprognostic (2.07e-2)" "unprognostic (2.65e-1)" "unprognostic (1.93e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" 9.8 6.4 5.9 10.4 7.6 13.4 7.3 12.2 7.8 10.2 6.8 10.4 8.2 10.6 9.8 6.8 7.5 8.6 7.6 5.9 6.8 5.5 6.9 6.1 13.5 11.3 10.6 5.6 10.3 8.2 10.1 9.4 8.0 7.2 7.9 4.9 5.8 9.8 14.2 12.4 10.6 9.6 6.5 7.4 12.9 9.1 36.1 9.2 24.7 7.7 5.2 11.5 7.8 10.8 4.0 5.2 19.8 3.7 3.4 4.3 1.5 6.1 12.9 8.5 6.6 6.1 4.8 11.2 6.8 7.2 8.2 7.6 9.4 5.9 12.1 10.9 5.8 8.3 7.0 7.4 3.2 13.8 6.6 8.9 11.5 7.8 6.3 11.5 14.0 6.1 6.8 8.8 5.1 4.9 14.1 7.1 6.2 9.8 12.7 7.9 11.5 6.7 20.4 16.6 12.1 2.6 5.9 12.4 12.5 7.8 8.3 4.1 6.9 10.1 9.9 10.4 5.9 6.9 6.3 11.9 10.9 12.3 9.4 12.5 8.1 5.9 3.7 9.4 4.3 3.3 2.2 3.3 2.0 1.7 3.5 4.0 2.2 2.5 19.8 3.4 2.1 5.2 2.0 1.5 5.9 7.6 12.2 7.8 6.8 5.5 10.6 5.6 7.2 9.2 ZNF652 KIAA0924 ENSG00000198740 "Zinc finger protein 652" Q9Y2D9 17 49289206-49362473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044408 Uncertain Approved Nucleoplasm Nucleoplasm "HPA044408: " "unprognostic (1.33e-2)" "unprognostic (5.54e-2)" "unprognostic (1.15e-1)" "prognostic favourable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (7.31e-3)" "unprognostic (2.34e-1)" "unprognostic (4.52e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-1)" "unprognostic (4.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.30e-2)" 6.4 6.2 8.5 6.3 23.7 9.7 16.0 8.4 14.5 7.0 8.5 17.1 8.2 5.2 6.8 4.6 5.6 5.5 6.4 5.4 9.6 5.6 5.9 8.0 7.3 6.1 28.3 6.5 7.6 7.4 10.0 7.6 6.5 13.0 6.8 6.4 6.0 12.6 8.2 19.9 11.0 7.0 7.9 15.6 8.6 7.8 9.9 23.4 5.1 8.2 1.5 6.6 8.0 6.7 2.7 2.3 6.2 2.1 1.4 1.8 0.6 4.7 4.0 3.4 4.6 3.4 2.3 4.7 1.9 3.1 2.6 2.7 7.0 3.1 10.4 5.7 3.9 3.3 3.7 3.8 4.0 4.3 3.1 4.3 5.6 3.9 1.5 3.6 6.4 2.7 2.2 2.2 3.8 2.6 3.7 9.7 2.1 6.3 5.0 1.1 3.9 2.8 3.9 8.3 4.2 1.9 7.0 7.0 4.6 3.5 3.4 4.2 7.3 4.2 4.5 7.1 6.3 3.2 2.8 11.1 9.0 8.2 3.6 2.6 2.7 3.0 1.6 2.4 1.5 0.8 1.8 1.3 1.1 1.5 1.2 2.7 1.0 1.1 6.2 1.4 2.1 2.3 0.6 0.6 8.5 23.7 8.4 14.5 9.6 5.6 28.3 6.5 13.0 23.4 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" Q8IZM8 3 88059274-88144665 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: , HPA049262: , HPA077939: " "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavourable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 18.2 8.9 10.9 13.2 11.6 15.1 12.6 18.6 13.3 13.5 11.8 9.8 13.5 9.7 14.0 12.1 14.4 9.5 10.8 10.4 11.3 8.5 11.0 15.4 11.8 12.3 13.9 10.3 14.7 9.5 12.8 21.8 11.9 11.1 12.8 9.8 10.7 12.5 10.2 13.9 14.9 13.4 13.1 15.8 10.1 10.0 12.3 14.8 22.2 13.4 9.4 12.0 16.6 14.6 2.6 2.3 10.0 2.0 6.5 4.0 1.7 4.6 1.9 3.4 4.7 7.5 6.2 3.0 6.1 5.6 4.1 5.9 2.9 2.8 7.4 4.3 5.3 3.1 3.6 5.7 8.3 4.5 2.0 4.6 2.6 2.1 5.6 5.2 5.2 6.1 5.7 4.6 5.5 5.6 3.1 6.0 9.3 3.6 5.2 4.8 1.8 3.2 3.6 2.3 3.5 4.0 6.1 2.5 2.2 4.5 3.6 11.7 4.9 4.1 6.3 9.2 6.1 34.5 4.4 6.9 4.7 5.2 7.5 5.0 5.9 10.0 1.9 2.7 2.9 2.0 3.3 1.8 3.2 4.0 2.3 2.6 3.9 2.6 2.7 6.5 1.4 1.1 2.2 1.7 10.9 11.6 18.6 13.3 11.3 8.5 13.9 10.3 11.1 14.8 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "neutrophil: 20.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.9" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm Nucleoplasm "HPA047730: , HPA048668: " "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 0.5 0.8 0.1 0.0 2.8 1.4 1.6 0.6 0.3 1.5 0.8 1.4 1.8 0.1 1.8 1.5 0.5 0.9 0.5 3.5 1.1 2.4 0.1 1.8 0.7 1.6 1.4 1.9 4.5 0.0 0.9 1.1 0.6 1.2 2.1 0.9 0.9 1.3 0.4 20.9 0.5 1.8 1.4 0.1 2.7 4.7 4.6 8.7 4.7 5.7 3.5 2.2 4.0 3.0 3.4 0.4 2.1 6.4 2.4 2.1 7.5 3.7 4.3 3.3 0.2 2.3 1.0 3.9 1.0 5.2 3.9 2.3 4.5 9.7 2.9 4.3 5.9 1.2 1.3 3.9 1.6 3.2 2.0 3.9 8.1 0.3 7.4 2.3 3.3 7.2 6.7 4.0 3.4 1.9 3.4 2.7 10.2 1.3 3.9 5.1 3.5 2.6 0.8 3.7 1.5 1.8 1.4 4.1 0.5 0.5 1.5 0.6 0.4 0.1 0.6 0.9 0.8 0.2 1.3 1.4 0.7 20.9 1.8 0.4 0.4 0.5 0.1 ZNF664 "DKFZp761B128, ZFOC1, ZNF176" ENSG00000179195 "Zinc finger protein 664" Q8N3J9 12 123971845-124015439 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047846 Approved Nucleoplasm Nucleoplasm "HPA047846: " "unprognostic (4.16e-2)" "unprognostic (1.32e-1)" "unprognostic (5.75e-3)" "unprognostic (1.90e-2)" "unprognostic (8.12e-2)" "unprognostic (3.79e-1)" "unprognostic (2.49e-3)" "unprognostic (3.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (1.85e-2)" "unprognostic (1.85e-2)" 22.9 15.0 38.3 11.3 34.5 5.3 29.4 26.9 24.8 23.0 25.5 34.2 26.0 36.6 18.9 35.3 14.4 27.3 16.1 22.4 39.2 30.7 29.3 21.0 20.6 10.4 46.7 20.1 15.2 28.2 72.1 33.4 17.0 28.7 21.1 28.3 22.2 31.2 21.1 21.3 8.9 39.8 14.6 61.8 11.1 20.1 12.0 30.0 10.1 43.9 11.0 13.2 15.3 17.5 2.4 1.0 0.5 0.6 1.7 4.3 1.7 24.7 17.4 27.9 29.1 21.9 16.7 23.8 14.6 19.8 15.1 12.4 21.5 13.7 24.4 17.8 19.7 21.9 39.8 17.9 28.1 20.6 28.8 37.9 22.8 18.2 26.4 22.9 20.9 10.6 40.2 15.7 25.9 24.1 23.2 10.4 13.4 19.0 22.5 10.4 26.1 37.9 19.7 27.2 14.8 32.9 40.9 58.0 42.1 25.1 26.8 24.5 47.7 12.2 15.6 13.1 21.3 18.5 15.0 14.3 17.8 19.3 22.8 16.1 20.2 0.2 0.6 0.5 2.8 0.3 4.3 1.9 2.2 2.4 1.0 2.4 2.7 2.2 0.3 1.7 0.0 0.8 3.8 1.7 38.3 34.5 26.9 24.8 39.2 30.7 46.7 20.1 28.7 30.0 ZNF667 FLJ14011 ENSG00000198046 "Zinc finger protein 667" Q5HYK9 19 56439325-56478065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 9.3;HEL: 10.8;U-138 MG: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030731, HPA046673" Uncertain Approved Nucleoplasm Nucleoplasm "HPA030731: , HPA046673: " "unprognostic (6.10e-2)" "unprognostic (7.87e-3)" "unprognostic (2.91e-2)" "unprognostic (4.81e-2)" "unprognostic (6.38e-2)" "unprognostic (2.26e-3)" "unprognostic (8.55e-2)" "unprognostic (5.37e-2)" "unprognostic (1.05e-1)" "unprognostic (5.67e-2)" "unprognostic (3.77e-4)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (8.34e-3)" "unprognostic (3.54e-2)" "unprognostic (7.62e-2)" "unprognostic (1.55e-2)" 2.4 7.7 8.0 1.7 18.2 6.2 6.8 12.1 16.1 4.7 2.6 5.3 1.8 1.6 6.4 11.6 2.4 6.3 4.3 4.0 10.2 9.9 4.1 1.3 2.1 2.4 6.5 8.3 11.1 3.5 6.1 18.9 3.0 9.7 5.6 0.9 3.2 4.5 4.5 2.0 2.9 1.1 5.6 6.6 2.4 1.8 5.9 5.3 2.9 12.6 0.6 1.8 3.7 4.2 6.2 2.2 0.4 0.0 4.5 3.7 0.6 0.1 0.2 9.3 0.1 0.0 0.0 0.2 3.9 3.0 3.6 2.9 0.2 0.1 0.5 5.5 1.4 0.1 0.0 0.1 5.5 0.0 2.1 10.8 0.1 0.2 2.8 6.3 4.9 6.0 0.1 0.7 0.0 0.0 0.0 0.3 2.8 0.2 0.1 0.2 6.8 1.8 0.0 3.5 7.4 3.6 0.6 0.3 5.4 0.2 0.1 0.0 2.5 0.0 0.0 13.6 3.7 0.2 6.9 0.2 5.8 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 1.2 0.4 0.3 0.3 6.2 1.5 3.7 0.4 4.5 0.0 2.2 0.0 0.6 8.0 18.2 12.1 14.4 10.2 9.9 6.5 8.3 9.7 5.3 ZNF668 FLJ13479 ENSG00000167394 "Zinc finger protein 668" Q96K58 16 31060843-31074320 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043048 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA043048: AB_10962503" "unprognostic (2.71e-2)" "unprognostic (4.95e-2)" "unprognostic (6.42e-2)" "unprognostic (1.48e-1)" "unprognostic (3.27e-1)" "unprognostic (7.20e-3)" "unprognostic (6.73e-5)" "unprognostic (4.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (7.71e-3)" "prognostic unfavourable (6.24e-4)" "unprognostic (1.72e-3)" "unprognostic (2.00e-1)" "unprognostic (2.23e-1)" "unprognostic (4.83e-3)" "unprognostic (7.25e-2)" 7.1 8.2 8.2 8.9 10.0 18.5 5.9 11.1 15.4 8.3 10.2 6.6 5.1 11.8 9.4 5.6 8.0 6.1 9.6 5.1 8.6 7.4 5.9 6.9 7.3 8.6 7.6 5.2 5.7 10.6 4.6 6.7 10.1 9.2 8.1 4.2 4.9 7.2 7.6 12.6 9.0 10.3 9.5 6.5 8.6 8.8 10.0 6.1 16.9 5.4 8.8 7.5 6.6 6.5 5.6 7.3 8.6 4.8 8.4 13.9 5.4 3.7 12.7 2.8 7.0 3.0 3.1 9.8 10.5 7.7 5.2 4.4 5.7 5.1 5.9 8.4 6.1 6.7 1.9 5.6 1.3 7.5 8.3 3.6 7.9 9.2 3.7 5.7 9.1 3.8 2.3 9.1 1.8 3.8 6.8 3.8 9.5 12.5 12.1 12.4 10.2 10.7 16.1 21.4 8.6 2.8 8.2 10.0 11.7 6.6 9.4 3.2 7.1 8.4 6.4 13.1 5.5 9.9 4.5 6.3 10.2 8.4 8.7 6.0 8.5 7.6 4.8 8.6 13.9 4.7 9.2 5.6 4.1 8.4 7.3 4.4 4.5 5.6 1.7 8.4 3.8 3.9 4.3 5.4 8.2 10.0 11.1 15.4 8.6 7.4 7.6 5.2 9.2 6.1 ZNF670 MGC12466 ENSG00000277462 "Zinc finger protein 670" Q9BS34 1 247036784-247078755 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003142 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA003142: AB_1859404" "unprognostic (2.11e-1)" "unprognostic (8.04e-3)" "unprognostic (2.05e-3)" "unprognostic (9.98e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-1)" "unprognostic (1.26e-2)" "unprognostic (1.50e-2)" "unprognostic (1.63e-2)" "unprognostic (3.23e-2)" "unprognostic (9.88e-2)" "unprognostic (5.21e-3)" "unprognostic (2.19e-2)" "unprognostic (1.23e-1)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "unprognostic (1.39e-2)" 3.5 2.2 3.1 2.9 5.5 0.7 6.2 12.0 6.1 4.1 2.6 3.2 0.0 2.8 5.7 3.4 1.9 3.7 3.8 2.5 4.5 3.9 3.0 4.0 3.4 1.8 1.3 5.5 2.8 3.1 1.3 1.4 4.0 3.4 3.5 2.5 1.9 3.1 1.6 2.6 2.4 4.3 2.9 3.1 3.3 4.8 2.7 5.4 3.7 3.0 4.7 4.2 1.0 6.6 4.1 1.7 2.3 2.8 6.5 2.3 3.7 2.7 7.7 9.5 1.9 3.4 17.9 4.9 3.3 5.8 5.8 3.2 4.0 6.1 8.1 3.0 3.2 8.5 3.8 11.0 4.6 1.0 5.4 1.8 4.8 1.7 6.8 3.3 1.9 3.9 3.8 7.3 3.7 7.8 2.7 5.8 1.5 7.9 3.3 14.4 4.8 8.2 9.6 5.8 3.5 8.3 8.9 8.1 6.8 2.7 3.8 2.8 14.2 2.3 3.5 4.1 2.6 5.4 5.2 9.8 12.5 1.3 4.9 4.5 0.0 2.0 1.7 4.4 2.3 2.3 6.6 4.1 4.6 4.1 5.9 6.5 4.9 0.2 2.8 1.4 2.3 3.0 2.3 ZNF671 FLJ23506 ENSG00000083814 "Zinc finger protein 671" Q8TAW3 19 57719751-57727624 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046099, HPA056043" Uncertain Approved Nucleoplasm Nucleoplasm "HPA046099: AB_10962484, HPA056043: " "prognostic favourable (2.20e-4)" "unprognostic (4.16e-3)" "unprognostic (6.02e-2)" "unprognostic (5.91e-3)" "unprognostic (8.76e-2)" "unprognostic (3.97e-3)" "unprognostic (6.12e-2)" "unprognostic (5.56e-3)" "unprognostic (8.26e-3)" "unprognostic (2.04e-1)" "prognostic favourable (3.57e-4)" "unprognostic (2.14e-1)" "unprognostic (1.92e-3)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (4.22e-1)" 3.3 7.9 9.1 6.3 10.1 5.6 6.6 28.5 10.4 5.4 6.7 4.5 4.5 2.7 3.3 8.4 3.2 6.9 4.2 8.1 9.0 6.7 6.2 3.3 5.6 13.2 8.0 7.5 5.4 4.1 16.1 11.3 5.9 7.9 6.6 3.7 7.8 4.5 9.4 10.3 3.2 7.1 6.6 9.0 15.1 3.8 7.1 8.9 15.6 10.4 1.1 12.1 6.2 2.5 22.2 11.0 13.7 10.0 13.9 19.4 10.9 0.1 0.2 2.5 0.0 0.4 0.1 0.0 2.7 1.6 5.4 1.9 0.3 0.4 5.5 0.9 3.9 0.1 2.1 2.2 6.3 6.0 4.0 0.1 0.9 0.0 4.7 0.0 8.1 7.0 1.6 3.4 1.9 0.8 0.8 2.8 4.8 0.1 10.5 0.1 3.5 5.6 4.1 7.5 3.3 2.0 0.2 0.2 0.0 0.0 0.1 3.6 1.6 7.7 0.0 0.6 2.9 0.0 2.1 5.0 0.1 3.0 0.6 1.3 1.8 12.1 7.6 13.7 6.4 7.0 16.7 17.2 13.3 11.0 11.0 22.2 19.4 15.5 5.6 13.9 10.0 10.0 13.1 10.9 9.1 10.1 28.5 10.4 9.0 6.7 8.0 7.5 7.9 8.9 ZNF674 "MRX92, ZNF673B" ENSG00000251192 "Zinc finger protein 674" Q2M3X9 X 46497727-46545457 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031026, HPA065295" Uncertain Approved Nucleoplasm Nucleoplasm "HPA031026: AB_10602690, HPA065295: " "unprognostic (6.11e-4)" "unprognostic (1.97e-2)" "unprognostic (2.16e-1)" "unprognostic (9.30e-2)" "unprognostic (1.54e-2)" "unprognostic (3.39e-2)" "unprognostic (6.41e-5)" "unprognostic (2.74e-4)" "unprognostic (5.68e-2)" "unprognostic (2.43e-2)" "unprognostic (2.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (3.25e-4)" "unprognostic (8.45e-4)" 6.7 5.1 5.7 4.0 10.1 3.8 5.5 12.6 9.8 4.7 4.5 6.8 1.9 4.2 6.3 6.5 4.1 3.7 4.9 4.9 5.7 6.3 5.6 8.1 4.3 5.1 6.4 5.8 7.2 7.4 4.8 11.2 4.5 9.6 8.2 5.1 6.8 4.5 5.7 5.0 5.4 4.6 6.9 6.8 5.8 3.9 3.7 7.0 6.0 6.9 1.8 4.6 4.5 5.1 2.3 2.5 5.8 3.5 1.9 2.7 2.1 2.7 3.6 3.6 4.5 3.3 3.2 3.5 3.0 4.1 3.9 4.2 2.4 2.3 3.0 1.9 5.0 2.7 4.8 3.6 4.3 2.6 3.0 1.4 3.9 2.0 4.4 3.3 5.6 3.1 5.8 2.9 9.5 3.1 1.6 4.7 3.5 1.8 3.3 1.5 5.8 3.4 1.6 6.0 3.5 2.6 1.1 1.4 3.0 4.6 1.5 9.4 3.8 2.4 2.7 5.0 5.7 3.0 2.8 5.5 4.8 1.3 2.1 1.7 5.0 2.5 2.2 2.9 1.9 3.5 2.0 2.3 2.7 1.5 2.1 1.4 2.2 2.3 5.8 1.9 0.8 2.5 2.2 2.1 5.7 10.1 12.6 9.8 5.7 6.3 6.4 5.8 9.6 7.0 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.5" "Cell line enhanced" "Detected in many" "NTERA-2: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA023106 Approved Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.1 7.3 5.9 4.3 8.3 4.2 9.3 13.0 7.3 7.4 7.0 13.9 1.3 2.9 12.3 5.7 4.6 9.7 6.2 9.4 5.3 4.3 6.3 2.3 6.8 7.3 9.9 4.8 14.3 4.4 9.1 9.9 7.5 6.6 8.9 3.4 7.6 7.4 6.2 3.9 7.5 3.9 8.1 10.5 7.0 5.7 40.5 8.7 6.7 10.1 5.2 5.0 8.2 6.6 17.4 14.5 10.1 2.8 10.3 15.4 4.1 0.2 0.2 11.8 0.4 4.0 6.2 2.1 7.7 5.9 8.0 7.2 0.0 0.5 0.1 5.8 6.7 0.7 0.0 6.0 2.3 0.2 4.2 0.3 0.5 0.2 10.0 0.1 7.9 10.7 0.0 7.6 0.1 3.5 0.1 0.5 5.3 0.2 6.4 0.2 20.3 2.7 0.1 0.0 0.2 2.3 3.1 0.2 11.2 0.2 2.9 0.2 0.4 0.3 2.2 12.6 0.3 0.2 5.0 0.3 0.1 0.2 0.2 0.3 0.1 10.1 2.2 6.4 5.1 2.8 7.3 9.6 7.2 5.6 6.1 17.4 15.4 10.0 2.6 10.3 1.8 14.5 4.5 4.1 5.9 8.3 13.0 7.0 5.3 4.3 9.9 4.8 6.6 8.7 ZNF680 FLJ90430 ENSG00000173041 "Zinc finger protein 680" Q8NEM1 7 64519884-64563106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003173 Approved Nucleoplasm Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.65e-1)" "unprognostic (3.21e-2)" "unprognostic (6.88e-2)" "unprognostic (7.41e-2)" "unprognostic (1.52e-3)" "unprognostic (3.62e-2)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (1.07e-2)" "unprognostic (1.20e-1)" "unprognostic (2.46e-1)" "unprognostic (5.72e-2)" "unprognostic (1.35e-1)" "unprognostic (8.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (8.05e-3)" 6.4 15.8 18.7 4.2 24.4 2.6 15.4 37.0 23.7 7.7 4.4 7.1 3.3 3.4 5.9 7.0 4.4 6.2 6.2 12.1 20.0 10.8 9.8 21.6 5.7 6.9 23.4 14.6 13.1 5.8 4.0 10.0 5.3 19.9 12.0 6.2 3.9 5.4 6.8 11.6 6.6 3.9 7.1 25.9 7.3 7.0 4.7 24.4 5.4 28.5 6.6 6.0 6.8 5.2 4.3 1.7 4.2 1.3 8.3 4.4 1.7 3.7 2.2 8.9 10.7 4.4 5.0 5.7 3.1 2.6 5.6 7.0 3.0 7.4 7.2 7.7 2.9 2.6 7.2 3.3 9.2 1.3 5.2 5.5 4.4 2.8 2.0 7.2 5.0 3.3 4.1 5.0 5.6 5.2 9.8 0.0 7.7 2.9 11.1 11.6 10.5 2.7 8.8 9.1 21.6 7.8 12.4 7.2 9.9 9.3 8.8 3.2 8.9 3.2 2.8 6.8 3.4 3.2 5.3 6.4 8.2 20.4 0.3 6.7 5.9 4.2 1.0 1.1 3.0 1.3 2.5 4.3 4.1 3.5 1.7 3.4 4.4 4.0 0.5 8.3 1.1 1.4 1.2 1.7 18.7 24.4 37.0 23.7 20.0 10.8 23.4 14.6 19.9 24.4 ZNF684 MGC27466 ENSG00000117010 "Zinc finger protein 684" Q5T5D7 1 40531561-40548169 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059153 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA059153: " "unprognostic (4.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-4)" "unprognostic (2.29e-2)" "unprognostic (2.96e-2)" "unprognostic (3.67e-4)" "unprognostic (8.49e-2)" "unprognostic (2.26e-3)" "unprognostic (2.10e-2)" "unprognostic (7.00e-2)" "unprognostic (4.14e-3)" "unprognostic (3.96e-2)" "prognostic favourable (4.89e-10)" "unprognostic (4.76e-3)" "unprognostic (7.11e-2)" "unprognostic (5.98e-2)" "unprognostic (1.52e-2)" 3.6 6.4 4.1 2.9 8.9 8.2 4.2 5.8 7.4 3.6 3.8 2.3 5.4 3.2 3.6 4.3 3.2 3.1 3.4 10.6 4.4 3.3 18.3 20.8 3.4 4.4 9.8 3.6 3.8 5.4 2.5 4.6 2.1 5.4 5.1 4.8 1.6 3.5 4.1 4.4 4.1 3.4 3.2 5.9 5.1 4.2 4.3 7.8 6.4 5.6 4.1 3.5 3.1 2.7 6.0 3.9 7.0 7.7 3.5 5.9 2.4 2.1 0.7 2.7 3.7 2.5 3.7 1.6 2.0 1.9 2.3 4.0 1.3 2.8 3.7 1.6 1.2 2.7 2.7 1.9 3.8 3.2 4.6 4.0 2.5 3.5 1.3 4.3 4.4 2.5 0.8 2.9 1.1 3.6 2.1 5.5 3.4 0.6 6.3 5.0 6.7 2.3 2.9 8.2 2.6 3.6 1.9 2.0 3.5 3.6 3.6 4.0 1.5 27.5 2.1 2.4 5.1 2.3 3.9 4.7 3.3 4.3 2.1 4.6 3.7 7.0 4.0 1.9 5.9 7.7 3.2 6.0 4.2 3.6 2.4 3.5 2.8 5.5 2.3 3.5 4.1 3.9 4.7 2.4 4.1 8.9 5.8 7.4 4.4 3.3 9.8 3.6 5.4 7.8 ZNF688 ENSG00000229809 "Zinc finger protein 688" P0C7X2 16 30569346-30572734 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048922 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" Nucleoplasm "Plasma membrane, Cell Junctions" "HPA048922: AB_2680557" "prognostic favourable (5.90e-4)" "prognostic favourable (7.74e-4)" "unprognostic (1.68e-1)" "prognostic favourable (4.58e-5)" "unprognostic (1.37e-1)" "unprognostic (1.76e-2)" "unprognostic (4.01e-1)" "prognostic favourable (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "prognostic favourable (6.61e-4)" "unprognostic (7.75e-2)" "unprognostic (5.14e-2)" "unprognostic (7.08e-2)" "unprognostic (2.48e-1)" "unprognostic (4.12e-2)" "unprognostic (4.03e-2)" 10.7 11.9 14.2 11.8 11.8 13.7 8.0 13.8 16.7 8.8 15.3 15.5 12.1 20.5 11.5 9.6 12.0 13.5 14.5 17.2 13.1 10.6 11.2 12.4 10.3 19.9 12.1 11.5 12.9 14.7 8.4 14.0 7.8 11.2 11.8 9.0 11.0 13.8 10.1 32.5 9.5 14.4 14.2 11.0 13.9 13.0 24.6 8.3 21.6 13.7 8.3 10.0 10.4 13.3 6.1 5.4 12.6 5.4 15.1 6.8 2.8 7.6 5.8 5.9 6.2 11.3 2.9 2.5 4.4 6.1 3.7 2.9 1.8 11.7 4.1 8.9 5.5 5.7 1.6 2.8 4.1 12.0 3.6 2.8 2.3 1.4 3.0 3.8 12.5 5.8 6.2 4.0 4.8 3.7 2.9 9.5 4.2 4.6 10.9 4.3 2.1 1.9 9.3 2.4 6.0 6.5 2.5 8.5 9.4 1.5 11.6 9.8 12.7 6.4 2.9 3.2 3.5 3.8 3.4 13.5 9.4 4.3 9.9 3.3 5.5 12.6 3.9 8.3 4.8 3.9 5.8 5.5 5.6 5.4 3.9 6.1 4.8 4.4 6.0 15.1 5.4 5.4 6.8 2.8 14.2 11.8 13.8 16.7 13.1 10.6 12.1 11.5 11.2 8.3 ZNF689 FLJ90415 ENSG00000156853 "Zinc finger protein 689" Q96CS4 16 30602558-30624012 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054095, HPA055385" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoplasm, Nucleoli fibrillar center" "HPA054095: , HPA055385: " "unprognostic (5.62e-2)" "unprognostic (2.36e-2)" "unprognostic (2.77e-3)" "unprognostic (2.73e-2)" "unprognostic (7.73e-2)" "unprognostic (3.74e-2)" "unprognostic (1.57e-1)" "unprognostic (8.38e-2)" "unprognostic (5.83e-3)" "unprognostic (2.26e-1)" "prognostic favourable (9.89e-4)" "unprognostic (3.21e-1)" "unprognostic (1.58e-3)" "unprognostic (3.93e-2)" "unprognostic (5.23e-1)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" 5.9 5.7 5.6 4.7 7.5 7.8 15.0 7.5 10.7 7.4 6.2 8.6 5.4 6.7 8.5 4.1 3.7 6.4 6.1 5.2 4.7 4.5 5.2 6.3 4.9 5.2 8.0 4.9 8.0 7.2 11.8 7.7 4.6 4.8 6.1 4.6 7.7 4.8 7.1 6.7 3.8 6.7 6.0 4.8 7.3 5.7 28.2 8.2 11.4 6.7 4.3 6.5 6.8 4.6 4.4 9.6 2.7 10.5 9.3 6.0 4.4 3.4 6.2 8.7 9.1 3.8 3.7 4.3 4.3 6.4 7.1 6.9 7.3 2.7 10.0 6.8 3.8 2.7 10.9 4.7 5.7 8.2 18.5 8.5 5.4 11.1 4.0 8.3 6.5 3.5 4.5 4.8 4.9 5.0 10.0 5.8 4.5 5.2 15.3 7.9 9.9 6.4 19.4 8.4 9.0 3.0 3.5 11.0 6.6 3.1 5.8 4.9 6.0 7.3 3.9 9.3 3.9 4.5 5.9 10.8 12.4 12.1 3.4 9.2 8.9 0.2 6.8 2.7 5.9 10.0 4.3 4.4 5.0 6.0 9.6 3.7 4.5 4.2 0.4 9.3 10.5 3.6 4.7 4.4 5.6 7.5 7.5 10.7 4.7 4.5 8.0 4.9 4.8 8.2 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA062527: " "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavourable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favourable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.4 13.1 10.8 11.8 9.1 1.7 5.5 6.7 9.0 9.0 4.5 6.8 11.3 8.6 5.1 8.1 12.5 7.2 7.8 20.2 12.7 11.8 17.6 8.1 8.8 4.5 2.5 7.8 8.9 11.2 9.3 9.1 11.4 4.9 8.7 3.6 13.4 6.0 19.5 4.8 9.2 16.4 7.7 8.3 4.4 9.4 9.3 5.6 10.2 9.4 5.6 15.5 4.7 9.0 9.5 5.0 5.9 11.9 9.4 3.3 6.3 5.5 7.5 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143298061 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA057855: , HPA072473: " "unprognostic (3.23e-2)" "prognostic unfavourable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavourable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favourable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 8.5 6.9 10.3 8.1 10.6 6.3 6.9 13.9 13.7 5.6 5.4 9.8 5.4 13.5 8.8 4.8 5.0 6.6 7.1 5.2 10.4 10.3 7.2 8.1 7.6 8.6 12.6 7.2 9.8 13.7 8.6 6.7 5.5 10.6 7.5 4.1 7.2 11.9 5.1 7.7 13.3 8.0 10.7 8.9 8.3 6.5 6.9 12.8 6.5 7.5 3.0 6.6 7.2 5.2 6.4 6.4 2.3 3.3 5.3 7.5 3.3 6.2 5.8 5.6 6.7 2.4 1.6 12.2 4.9 1.6 3.5 2.1 3.3 4.9 0.4 6.9 1.7 4.4 6.5 2.7 3.1 7.0 14.2 8.4 5.5 5.0 2.4 3.3 10.7 1.4 4.4 2.3 4.9 1.7 17.3 3.8 2.1 12.5 3.6 6.9 8.0 14.9 7.7 3.5 6.2 1.9 4.5 9.6 13.4 7.5 4.9 6.1 7.9 6.1 3.5 4.8 11.1 4.3 8.7 8.0 5.4 7.8 3.3 6.9 5.6 1.1 3.3 2.3 5.3 1.9 5.8 4.2 4.0 5.9 3.7 6.4 7.5 6.2 1.4 5.3 2.9 6.4 1.3 3.3 10.3 10.6 13.9 13.5 10.4 10.3 12.6 7.2 10.6 12.8 ZNF697 MGC45731 ENSG00000143067 "Zinc finger protein 697" Q5TEC3 1 119619422-119647773 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 24.3;WM-115: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049933 Uncertain Approved Nucleoplasm Nucleoplasm "HPA049933: " "unprognostic (2.57e-1)" "unprognostic (7.02e-3)" "unprognostic (4.32e-2)" "unprognostic (2.45e-2)" "unprognostic (3.38e-1)" "unprognostic (9.79e-3)" "unprognostic (1.20e-3)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (1.45e-1)" "unprognostic (5.09e-2)" "unprognostic (1.14e-1)" "prognostic favourable (6.20e-5)" "unprognostic (1.19e-2)" "unprognostic (6.48e-2)" "unprognostic (3.53e-2)" "unprognostic (3.36e-1)" 6.1 4.1 4.5 1.7 5.2 1.0 5.0 1.6 6.9 2.0 2.8 0.7 3.5 2.1 3.1 3.4 1.2 2.0 2.0 6.3 1.8 1.2 11.1 5.3 6.5 0.6 2.1 6.6 3.3 7.3 4.2 6.4 9.7 3.8 6.2 1.9 1.0 10.8 1.3 2.9 2.3 1.9 4.4 1.5 2.3 2.5 5.0 1.2 0.5 4.6 2.2 0.7 2.4 1.5 0.0 0.6 0.3 1.5 0.0 0.1 0.3 1.1 0.6 2.9 1.0 3.9 4.4 4.0 5.2 7.3 3.1 2.8 1.8 0.2 0.0 1.7 2.9 1.2 2.2 5.1 7.3 0.0 2.3 1.9 1.1 3.4 7.6 1.2 1.3 7.3 1.5 6.8 14.8 6.0 1.7 0.2 1.3 0.9 0.0 0.9 15.6 1.7 0.0 7.1 0.1 1.4 2.6 0.6 4.1 1.1 1.3 24.3 0.6 1.8 13.8 5.1 6.4 3.6 9.0 0.7 1.1 0.0 7.2 1.3 25.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 4.5 5.2 1.6 6.9 1.8 1.2 2.1 6.6 3.8 1.2 ZNF701 FLJ10891 ENSG00000167562 "Zinc finger protein 701" Q9NV72 19 52555457-52587174 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 23.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA005532 Uncertain Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA005532: AB_1080746" "unprognostic (1.21e-1)" "unprognostic (4.98e-3)" "unprognostic (5.58e-2)" "unprognostic (3.40e-1)" "unprognostic (7.74e-2)" "unprognostic (1.13e-2)" "unprognostic (8.86e-2)" "unprognostic (4.67e-2)" "unprognostic (5.46e-4)" "unprognostic (3.75e-1)" "unprognostic (2.86e-1)" "unprognostic (1.16e-2)" "unprognostic (8.17e-3)" "unprognostic (8.64e-2)" "unprognostic (2.54e-1)" "unprognostic (2.79e-1)" "prognostic favourable (4.89e-5)" 10.0 7.8 9.5 13.5 13.8 11.0 9.9 12.1 8.6 8.8 12.1 7.0 9.2 6.1 8.9 9.8 8.1 9.5 6.2 6.7 9.0 4.6 11.5 3.8 7.1 9.1 11.9 2.7 10.0 7.2 9.6 11.7 22.4 10.3 10.2 9.0 3.6 9.4 8.8 6.4 9.1 10.5 6.0 14.5 11.4 7.8 7.3 12.5 28.0 12.1 4.1 8.8 10.1 11.6 8.1 5.9 19.9 8.8 11.5 8.8 6.0 1.7 0.3 4.0 7.3 4.1 5.3 7.4 4.7 4.8 6.4 6.7 3.7 4.3 8.2 2.5 3.6 2.8 1.8 5.2 7.1 0.3 5.4 2.4 6.7 1.0 4.8 0.3 11.5 5.9 3.8 4.9 8.3 6.1 10.5 1.2 5.5 1.5 8.5 4.0 4.0 6.1 8.5 5.3 3.7 5.0 23.1 4.0 4.6 3.1 7.7 2.4 10.0 5.2 5.3 5.1 2.5 2.4 8.3 1.0 5.4 11.1 0.2 9.1 8.1 15.3 8.1 15.5 8.7 8.8 7.3 7.9 6.9 7.4 5.9 8.1 8.2 8.8 19.9 11.5 6.5 5.7 8.0 6.0 9.5 13.8 12.1 8.6 9.0 4.6 11.9 2.7 10.3 12.5 ZNF704 "FLJ16218, Gig1" ENSG00000164684 "Zinc finger protein 704" Q6ZNC4 8 80628451-80874781 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 30.0;RH-30: 19.4;SH-SY5Y: 24.8;SK-BR-3: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.6" "Lineage enriched" "Detected in single" 5 "monocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024285, HPA024302" Uncertain Approved Nucleoplasm Nucleoplasm "HPA024285: AB_2219847, HPA024302: AB_1859427" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.27e-1)" "unprognostic (3.39e-3)" "unprognostic (6.86e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (1.34e-1)" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (1.26e-1)" "prognostic favourable (4.02e-4)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.90e-2)" 9.7 5.6 10.4 5.5 12.5 0.9 15.9 25.4 11.6 20.2 7.3 11.9 7.2 2.9 19.2 7.6 3.2 13.7 8.5 11.7 9.5 6.3 9.5 3.9 9.4 1.5 11.8 6.1 20.8 19.5 22.7 2.9 5.1 10.5 10.6 6.3 6.9 13.6 13.3 5.9 5.2 4.8 7.5 9.2 3.2 5.8 7.3 14.6 12.0 6.2 5.9 1.3 8.6 13.9 0.0 0.0 0.3 1.6 0.2 0.1 0.0 0.0 1.1 4.8 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.5 0.8 0.0 1.9 0.0 30.0 0.4 0.8 0.0 0.0 5.0 1.7 2.2 4.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 2.0 0.0 0.1 0.0 3.1 4.4 0.0 0.4 0.4 3.1 19.4 0.0 0.0 10.4 6.1 24.8 0.9 30.4 9.0 4.8 0.6 0.1 0.0 5.1 0.1 1.0 0.0 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.6 0.0 0.0 0.0 10.4 12.5 25.4 11.6 9.5 6.3 11.8 6.1 10.5 14.6 ZNF707 ENSG00000181135 "Zinc finger protein 707" Q96C28 8 143684452-143713898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044991 Approved Approved Nucleoplasm Nucleoplasm "HPA044991: AB_10961134" "unprognostic (5.12e-2)" "unprognostic (5.65e-2)" "unprognostic (3.86e-2)" "prognostic unfavourable (6.79e-4)" "unprognostic (1.73e-1)" "unprognostic (5.91e-2)" "unprognostic (2.94e-2)" "unprognostic (1.65e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-1)" "unprognostic (6.98e-2)" "unprognostic (5.07e-2)" "unprognostic (2.30e-2)" "unprognostic (1.14e-2)" "unprognostic (5.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.08e-2)" 5.4 5.4 6.6 6.2 7.5 5.7 6.0 6.6 8.0 5.5 5.1 7.0 10.4 6.2 6.1 7.1 6.3 6.2 5.8 3.9 6.6 3.4 6.1 5.5 7.7 9.4 10.3 5.1 5.7 8.3 9.2 7.9 4.7 5.5 7.0 3.6 6.5 7.5 6.7 3.8 13.0 8.0 6.7 6.5 13.2 5.8 11.0 7.3 7.7 8.8 5.0 7.8 6.9 5.8 1.1 1.4 1.7 1.0 4.2 2.4 1.0 3.7 3.8 4.1 5.1 4.1 3.5 5.7 3.9 3.2 4.9 2.9 2.8 5.3 3.6 5.0 2.1 4.2 4.4 4.5 3.0 5.5 2.0 7.4 9.5 4.3 3.5 2.2 4.1 3.9 5.7 6.1 4.7 3.6 4.2 2.7 1.4 7.6 5.4 2.9 0.1 9.5 4.9 2.8 3.7 3.1 4.0 3.8 4.6 8.5 5.8 3.5 6.9 4.6 6.6 3.1 9.8 3.8 4.8 4.3 2.6 1.3 4.5 4.4 2.8 1.0 1.0 1.5 2.4 0.7 1.7 1.1 1.3 2.1 0.7 1.0 1.3 1.9 1.7 4.2 0.7 1.4 1.7 1.0 6.6 7.5 6.6 8.0 6.6 3.4 10.3 5.1 5.5 7.3 ZNF709 FLJ38281 ENSG00000242852 "Zinc finger protein 709" Q8N972 19 12461184-12513854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA045573, HPA053153" Uncertain Approved Nucleoplasm Nucleoplasm "HPA045573: , HPA053153: " "unprognostic (2.27e-1)" "unprognostic (7.40e-4)" "unprognostic (3.53e-2)" "unprognostic (3.01e-2)" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (4.19e-3)" "unprognostic (2.58e-4)" "unprognostic (6.76e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-3)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" "unprognostic (1.71e-1)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (8.53e-5)" 3.4 3.0 7.8 4.8 8.4 2.0 5.1 12.7 7.3 5.0 2.7 3.2 5.6 0.7 5.5 5.3 2.4 6.6 2.4 3.6 6.2 5.4 5.4 2.0 3.0 2.7 3.8 4.6 8.4 4.1 6.2 8.0 3.5 4.9 5.7 2.1 3.3 3.4 4.5 2.5 2.8 2.7 5.1 5.5 4.0 2.6 26.6 5.0 7.2 8.5 0.0 4.0 4.1 4.5 2.0 1.3 3.5 1.1 5.5 4.4 1.0 1.8 0.0 6.2 7.6 1.2 1.8 1.0 1.8 2.1 2.1 2.2 1.7 0.2 1.8 1.2 2.0 1.3 3.4 1.3 2.3 0.3 0.9 1.6 1.1 1.2 2.5 0.4 2.7 1.0 0.6 1.2 0.0 1.4 1.0 0.2 2.6 3.5 3.9 2.2 2.1 2.0 2.1 6.0 5.6 2.1 3.0 2.8 3.9 0.0 0.3 0.8 1.5 1.0 0.0 3.3 0.6 1.4 1.3 3.3 4.8 2.6 0.0 0.0 1.5 3.5 0.4 0.1 2.0 0.1 3.1 1.7 3.3 2.1 0.9 2.0 4.4 3.1 0.1 5.5 1.1 1.3 1.8 1.0 7.8 8.4 12.7 7.3 6.2 5.4 3.8 4.6 4.9 5.0 ZNF71 "Cos26, EZFIT" ENSG00000197951 "Zinc finger protein 71" Q9NQZ8 19 56595264-56626481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018124 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA018124: AB_1848339" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" "unprognostic (7.72e-2)" "unprognostic (5.03e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.39e-1)" "unprognostic (1.12e-3)" "unprognostic (1.90e-3)" "unprognostic (3.91e-2)" "unprognostic (4.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "unprognostic (6.97e-3)" 11.8 6.4 12.9 6.9 8.7 3.5 11.7 12.0 12.5 7.9 9.9 10.2 6.5 6.7 12.3 6.6 8.6 8.7 7.0 10.5 9.3 8.0 6.4 3.4 9.6 10.6 7.7 10.2 12.3 8.8 7.6 8.5 8.0 9.3 8.7 5.0 6.4 8.9 10.5 10.6 7.4 6.0 16.6 8.5 10.2 7.0 8.7 8.2 9.8 7.5 5.9 6.2 10.0 10.7 7.0 4.9 6.8 4.2 9.0 8.3 4.2 3.4 6.6 9.7 8.0 4.0 3.6 6.2 4.0 3.7 2.7 3.9 1.2 1.0 2.9 3.6 3.3 1.2 2.1 3.0 2.4 0.0 20.0 4.4 0.9 2.6 3.4 5.5 4.3 4.1 3.2 2.8 1.8 4.4 2.5 0.0 3.0 0.0 11.2 2.0 7.5 6.5 4.1 6.0 2.4 1.9 3.9 8.6 10.4 2.7 3.7 4.0 2.1 5.6 5.8 9.3 5.2 2.2 6.3 2.8 3.5 4.4 3.1 3.2 2.5 2.9 3.2 6.8 7.7 2.0 8.3 6.5 6.4 7.3 4.9 7.0 7.2 7.4 1.3 9.0 4.2 3.7 6.6 4.2 12.9 8.7 12.0 12.5 9.3 8.0 7.7 10.2 9.3 8.2 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001392-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 79.6" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria Mitochondria Nucleoplasm "HPA030226: , HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 2.6 2.1 5.6 8.7 6.7 4.3 3.2 2.9 5.0 3.1 4.3 6.6 1.7 5.3 3.3 4.1 9.5 2.9 4.8 5.9 3.9 3.5 2.7 3.4 6.4 7.9 4.0 4.1 3.4 79.6 1.5 2.5 3.2 5.0 4.2 4.0 3.5 5.2 2.6 18.3 6.7 4.5 4.3 6.3 8.6 5.9 2.4 4.1 11.7 3.5 5.2 7.0 4.4 4.9 0.3 2.3 3.0 7.9 0.4 0.8 0.9 5.7 6.8 13.1 4.9 1.8 2.6 6.8 6.0 5.6 4.4 5.7 4.8 5.3 5.9 2.8 5.8 4.0 3.3 8.6 2.5 3.7 6.1 10.7 2.7 8.1 3.7 3.1 16.7 4.4 4.7 9.5 5.2 7.6 3.6 4.0 1.7 14.8 6.9 8.6 10.2 4.4 8.5 2.9 6.4 1.8 7.2 12.0 8.1 8.0 29.0 4.1 6.3 10.7 10.8 9.2 4.5 2.7 4.7 3.3 1.6 5.7 7.0 9.2 4.7 0.0 2.6 1.8 0.4 5.7 0.3 0.2 0.2 0.3 1.9 0.3 0.8 0.8 3.0 0.4 7.9 2.3 0.7 0.9 5.6 6.7 2.9 4.3 3.9 3.5 4.0 4.1 5.0 4.1 ZNF711 "CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6" ENSG00000147180 "Zinc finger protein 711" Q9Y462 X 85244032-85273362 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell line enhanced" "Detected in many" "AF22: 16.5;AN3-CA: 12.9;HAP1: 23.9;HEK 293: 22.0;Karpas-707: 14.7;MOLT-4: 12.8;RH-30: 20.1;SH-SY5Y: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6;naive B-cell: 3.6" "Group enriched" "Detected in many" 7 "B-cells: 3.6;T-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030654 Enhanced Approved Nucleoplasm Nucleoplasm "HPA030654: AB_10670561" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.07e-2)" "unprognostic (5.51e-3)" "unprognostic (1.75e-2)" "unprognostic (9.11e-3)" "unprognostic (7.40e-3)" "unprognostic (1.37e-2)" "unprognostic (2.96e-1)" "unprognostic (2.50e-3)" "unprognostic (3.25e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (6.62e-3)" 1.4 13.6 11.6 2.1 11.9 5.8 5.4 10.8 19.2 5.9 2.4 4.4 0.0 3.0 8.9 2.9 2.1 4.7 4.0 3.8 11.1 8.3 5.1 0.7 1.9 2.2 6.5 8.1 9.3 4.3 1.5 16.0 7.1 12.6 4.1 1.9 3.3 4.0 2.8 1.6 11.2 4.2 3.4 9.8 4.5 2.8 38.6 9.5 14.4 4.2 1.6 2.5 3.0 2.5 3.6 0.2 0.0 0.0 0.3 1.3 0.3 0.0 1.5 16.5 12.9 0.0 0.0 1.2 0.2 0.0 0.0 0.0 3.4 1.4 0.0 0.5 0.2 0.3 23.9 0.0 0.0 0.0 22.0 7.6 0.4 0.9 0.6 0.0 0.2 1.5 0.1 0.0 3.1 0.1 2.3 14.7 2.9 0.8 12.8 0.0 8.0 0.3 0.0 20.1 0.0 0.0 1.1 4.8 12.5 0.0 0.4 0.0 2.1 2.1 0.0 0.0 5.4 0.0 0.0 5.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.1 0.4 0.1 3.6 1.3 0.8 0.0 0.3 0.0 0.2 0.0 0.3 11.6 11.9 10.8 15.1 11.1 8.3 6.5 8.1 12.6 9.5 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75709643-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 37.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 8.1 8.6 11.9 7.2 14.4 4.6 11.2 12.1 12.4 7.7 6.7 11.7 7.3 6.9 11.0 24.6 7.7 11.3 8.1 8.2 10.9 8.3 13.4 10.5 6.8 6.2 16.2 7.1 12.6 12.7 14.7 22.8 7.3 12.6 9.4 8.9 10.8 9.9 9.6 6.1 13.7 7.3 10.9 15.6 10.1 10.1 11.2 13.6 8.4 16.2 5.3 8.4 8.6 7.8 9.5 6.2 6.8 5.3 4.0 10.2 3.2 7.2 4.6 4.4 2.7 4.8 6.8 2.6 2.5 4.8 3.0 3.9 6.2 6.2 3.9 4.2 4.5 3.7 7.0 5.2 2.8 0.4 6.7 7.6 7.0 0.7 9.4 0.3 6.8 6.6 4.3 7.4 11.2 0.6 37.8 9.3 4.0 2.4 0.8 10.1 5.0 8.2 5.7 4.3 21.4 4.9 3.5 3.6 17.1 2.1 4.3 9.1 15.0 3.5 0.9 7.8 10.6 6.4 1.0 11.2 13.7 4.6 4.2 0.8 4.7 1.5 4.0 6.8 3.6 5.3 1.8 7.6 5.1 3.4 4.1 9.5 10.2 6.2 1.0 4.0 4.9 6.2 1.9 3.2 11.9 14.4 12.1 12.4 10.9 8.3 16.2 7.1 12.6 13.6 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041570 Uncertain Approved Nucleoplasm,Cytosol Cytosol Nucleoplasm "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 15.1 15.8 11.1 13.7 11.8 9.9 12.7 16.8 17.6 14.3 12.4 11.3 17.7 7.2 11.7 17.4 16.4 12.8 10.3 10.1 11.1 15.1 14.2 11.6 10.7 17.5 15.5 11.0 9.6 12.9 13.4 24.5 19.4 15.5 14.5 14.0 11.4 13.9 17.7 10.3 17.3 10.1 13.2 14.3 18.4 14.1 13.7 15.9 16.6 19.2 11.0 18.1 14.6 11.6 14.4 8.9 23.0 5.5 12.8 14.2 5.0 10.2 7.2 9.0 7.9 7.9 12.0 8.7 11.0 7.2 5.4 7.2 5.2 11.0 5.0 19.4 3.7 7.2 8.8 4.2 8.0 22.2 4.6 2.7 3.9 14.8 11.8 5.9 15.3 8.1 11.8 3.7 5.4 10.1 9.2 6.6 5.8 16.6 6.0 7.8 8.8 5.7 11.4 4.0 7.8 6.1 6.5 4.1 6.1 11.1 5.0 9.8 9.6 11.7 6.5 3.9 3.1 7.8 3.3 11.0 12.0 14.3 3.5 9.1 6.1 13.9 4.8 23.0 14.2 5.4 10.6 13.7 10.0 12.7 5.2 14.4 9.3 11.7 6.3 12.8 5.5 8.9 12.2 5.0 11.1 11.8 16.8 17.6 11.1 15.1 15.5 11.0 15.5 15.9 ZNF740 Zfp740 ENSG00000139651 "Zinc finger protein 740" Q8NDX6 12 53180700-53195141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035691 Approved Approved Nucleoplasm Nucleoplasm "HPA035691: AB_10669777" "unprognostic (2.31e-1)" "unprognostic (3.40e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" "unprognostic (2.86e-2)" "unprognostic (3.20e-2)" "unprognostic (4.19e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (4.55e-4)" "unprognostic (4.88e-2)" "unprognostic (2.36e-3)" "unprognostic (7.92e-2)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.30e-2)" 12.5 13.9 12.5 13.6 14.9 6.5 14.0 23.8 17.6 13.8 13.1 13.8 18.1 11.1 17.2 15.7 13.2 16.3 11.1 8.0 17.2 10.1 12.9 11.4 11.6 18.1 16.5 11.8 18.3 16.3 21.2 13.2 11.5 13.0 14.2 12.2 11.8 13.8 16.0 10.1 13.6 14.7 12.6 10.5 18.1 12.4 7.1 13.8 19.0 15.9 7.4 20.1 11.9 16.9 1.7 1.6 2.9 0.8 4.6 2.0 0.7 4.7 6.4 11.4 7.4 11.6 8.6 4.3 5.0 9.5 8.1 7.1 5.4 7.7 11.1 7.6 5.7 7.8 8.3 5.9 8.3 8.3 8.9 12.3 8.6 4.8 8.5 11.1 7.7 10.9 11.9 6.5 9.8 6.6 8.1 22.4 4.2 5.5 8.8 6.0 5.6 7.8 9.0 8.8 17.9 4.6 6.7 8.9 9.8 8.6 7.2 8.5 10.4 11.6 5.9 4.3 6.0 4.8 3.6 11.0 4.7 6.1 6.6 6.3 5.3 2.9 0.8 1.4 1.6 0.4 1.1 1.6 1.4 2.0 0.7 1.7 1.9 1.9 0.2 4.6 0.4 1.6 1.7 0.7 12.5 14.9 23.8 17.6 17.2 10.1 16.5 11.8 13.0 13.8 ZNF749 FLJ16360 ENSG00000186230 "Zinc finger protein 749" O43361 19 57435329-57445485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042082, HPA042091, HPA056001" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA042082: AB_10796572, HPA042091: AB_10793874, HPA056001: " "unprognostic (2.54e-1)" "unprognostic (1.55e-1)" "unprognostic (6.67e-2)" "unprognostic (9.92e-2)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.87e-1)" "unprognostic (8.23e-2)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (9.27e-3)" "unprognostic (2.76e-2)" "unprognostic (3.05e-5)" "unprognostic (1.35e-1)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-1)" 5.8 5.6 7.2 7.6 8.0 5.0 8.4 12.4 10.7 6.3 8.1 5.2 7.5 6.6 6.3 5.1 7.4 7.9 8.3 5.1 6.4 6.0 5.3 12.4 5.4 7.5 9.0 7.7 8.2 7.0 11.4 7.2 6.3 6.0 6.2 4.5 8.5 12.8 10.8 6.2 9.7 7.1 5.9 5.3 6.7 5.5 6.2 6.8 7.8 6.7 12.1 8.0 6.0 6.1 2.9 3.2 0.2 2.7 1.9 4.1 2.8 2.6 6.2 5.6 5.6 1.5 1.4 2.3 1.6 1.3 2.7 5.0 2.6 1.9 5.2 1.4 1.6 2.0 5.3 4.2 4.1 2.3 23.1 4.7 6.6 2.9 1.7 5.1 3.1 1.8 4.7 3.5 7.5 1.5 4.4 6.1 2.0 1.1 6.3 1.8 5.3 8.7 6.6 8.0 3.8 1.3 6.4 5.5 4.5 3.1 1.9 1.2 2.7 1.6 1.6 5.1 3.7 1.5 4.6 4.7 6.1 5.4 2.8 2.2 3.0 0.1 1.2 0.2 2.1 2.7 3.4 2.7 3.5 3.1 3.2 2.9 4.1 3.0 0.2 1.9 1.2 1.6 2.6 2.8 7.2 8.0 12.4 10.7 6.4 6.0 9.0 7.7 6.0 6.8 ZNF75A FLJ31529 ENSG00000162086 "Zinc finger protein 75a" Q96N20 16 3305406-3318852 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA001665 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA001665: AB_1080751" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (1.64e-1)" "unprognostic (7.79e-3)" "unprognostic (6.32e-2)" "unprognostic (4.45e-1)" "unprognostic (2.67e-2)" "unprognostic (5.93e-2)" "unprognostic (4.66e-3)" "unprognostic (2.75e-3)" "unprognostic (6.79e-3)" "unprognostic (4.71e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-2)" "unprognostic (8.97e-3)" 10.0 11.4 13.6 14.8 15.7 9.0 15.0 19.6 15.4 10.6 10.1 17.2 14.4 8.0 12.4 26.1 9.5 14.1 9.0 9.0 13.2 12.2 12.7 16.2 10.4 18.1 12.8 14.4 19.3 13.6 32.1 23.5 12.7 17.7 16.2 15.1 10.1 10.6 15.4 10.4 13.8 12.8 10.8 10.3 15.6 10.1 13.5 15.9 15.8 17.9 7.7 18.0 10.2 8.6 25.2 13.8 15.2 9.1 17.8 23.0 3.3 4.5 6.7 12.6 6.4 6.0 5.5 10.7 7.3 3.0 6.9 8.2 0.1 5.9 7.3 5.0 5.3 3.4 7.5 4.4 10.4 3.0 10.1 15.5 7.8 0.6 4.3 9.9 15.7 7.4 4.6 7.2 5.4 6.2 8.7 12.0 9.6 6.2 15.0 6.8 19.5 4.7 31.3 6.2 8.7 7.4 7.4 11.4 8.1 11.4 4.6 4.5 14.8 12.6 7.2 5.1 12.9 4.9 5.8 8.3 7.3 20.9 1.7 11.2 7.8 13.3 6.7 15.2 13.0 6.2 16.0 16.8 14.8 13.3 5.2 25.2 23.0 17.2 4.8 17.8 9.1 13.8 11.9 3.3 13.6 15.7 19.6 15.4 13.2 12.2 12.8 14.4 17.7 15.9 ZNF75D "D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28" ENSG00000186376 "Zinc finger protein 75D" P51815 X 135248920-135344087 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004705 Supported Approved "Nucleoplasm,Golgi apparatus" "Nucleoplasm, Golgi apparatus" "HPA004705: AB_1080749" "unprognostic (1.56e-3)" "unprognostic (7.96e-3)" "unprognostic (3.07e-1)" "unprognostic (5.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.00e-2)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (9.17e-2)" "unprognostic (1.81e-1)" "unprognostic (1.15e-2)" "unprognostic (2.13e-2)" "prognostic favourable (1.31e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "prognostic favourable (7.42e-5)" 8.4 18.8 8.2 14.6 9.7 9.2 9.9 11.4 10.5 11.8 10.6 9.2 10.4 6.9 10.7 12.8 7.6 9.8 7.9 7.6 5.6 7.7 10.6 13.4 9.7 11.2 6.2 7.7 10.1 12.9 12.6 14.7 8.0 9.2 15.0 8.4 7.5 10.0 11.8 6.6 9.9 10.6 7.5 5.9 18.6 9.7 3.4 6.7 16.6 13.2 9.3 13.3 8.0 8.6 3.7 1.8 4.1 2.1 5.2 6.5 2.9 3.4 4.6 5.0 8.0 8.5 10.4 7.6 5.9 8.0 4.8 10.3 2.8 4.4 3.6 8.7 5.0 4.8 16.3 2.6 4.6 3.5 4.3 2.5 8.3 3.6 3.7 4.2 7.2 5.1 6.4 3.0 3.7 4.9 2.1 5.8 4.2 8.3 5.1 7.7 2.4 6.2 4.9 5.0 3.2 5.4 4.8 1.7 5.7 3.3 5.7 0.9 2.0 6.1 5.1 4.6 1.1 7.7 5.5 2.9 4.1 2.7 2.9 4.7 2.9 4.1 2.1 3.7 4.9 1.5 4.5 2.9 5.2 5.6 1.8 3.7 6.5 5.9 2.6 5.2 1.5 1.6 6.3 2.9 8.2 9.7 11.4 10.5 5.6 7.7 6.2 7.7 9.2 6.7 ZNF76 "D6S229E, Zfp523, ZNF523" ENSG00000065029 "Zinc finger protein 76" P36508 6 35258909-35295985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030090, HPA030091" Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA030090: AB_10603334, HPA030091: AB_10602593" "unprognostic (8.29e-3)" "unprognostic (3.61e-2)" "unprognostic (7.71e-2)" "unprognostic (8.70e-3)" "unprognostic (2.76e-1)" "unprognostic (6.51e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.23e-2)" "prognostic favourable (1.18e-4)" "prognostic favourable (5.09e-4)" "unprognostic (3.66e-3)" "unprognostic (1.20e-3)" "unprognostic (5.31e-3)" "unprognostic (1.14e-1)" "unprognostic (3.76e-1)" "unprognostic (1.20e-3)" 9.2 20.0 16.0 14.6 18.4 8.5 11.3 27.2 17.8 11.4 11.5 18.1 14.5 11.9 12.5 18.5 10.4 13.7 12.7 20.8 14.8 9.6 14.1 13.0 10.6 15.0 15.3 12.3 19.5 13.9 19.5 31.4 19.7 16.9 15.6 10.2 21.8 16.0 16.6 45.1 10.5 13.1 10.6 13.6 18.3 12.2 19.9 16.4 12.6 24.0 10.3 14.6 12.4 11.0 10.5 7.4 5.4 9.3 9.3 16.0 8.8 6.6 6.1 13.5 14.9 5.7 8.8 9.7 5.7 9.7 9.7 7.7 4.5 8.9 14.4 8.5 8.6 3.8 11.3 8.7 5.7 21.5 17.0 13.8 9.3 7.2 11.4 7.0 8.2 10.7 5.5 11.2 10.5 8.8 10.2 15.3 8.7 14.5 11.6 8.1 6.6 5.9 11.3 7.0 13.3 8.7 9.3 21.1 7.8 7.0 8.9 17.2 13.4 22.6 6.7 6.8 5.9 4.6 8.2 15.4 10.7 13.5 5.9 11.0 17.9 3.8 6.6 5.4 16.0 8.6 12.7 10.0 11.7 11.3 7.4 10.5 12.5 13.0 2.0 9.3 9.3 3.7 9.0 8.8 16.0 18.4 27.2 17.8 14.8 9.6 15.3 12.3 16.9 16.4 ZNF768 FLJ23436 ENSG00000169957 "Zinc finger protein 768" Q9H5H4 16 30524001-30526821 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024630, HPA066512" Supported Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA024630: AB_1859446, HPA066512: " "unprognostic (2.33e-1)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" "unprognostic (1.73e-1)" "unprognostic (7.94e-3)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (3.26e-2)" "unprognostic (2.74e-1)" "prognostic favourable (9.30e-6)" "unprognostic (4.49e-2)" "unprognostic (1.94e-1)" "unprognostic (3.13e-1)" "prognostic favourable (6.46e-4)" 11.7 9.2 12.7 12.0 15.6 8.0 17.8 11.1 12.2 11.4 26.0 13.9 11.5 20.4 13.1 7.4 12.6 13.1 11.2 26.2 11.1 9.3 18.9 14.4 8.6 4.7 13.5 6.0 15.9 14.3 25.4 11.5 10.1 11.5 14.2 12.1 13.9 17.5 16.0 56.6 11.2 31.6 16.0 12.8 13.1 11.7 14.0 14.4 3.8 10.1 14.2 7.8 14.1 24.5 3.7 1.8 3.1 1.9 1.8 0.5 0.6 10.0 12.6 14.3 13.9 7.0 8.1 11.3 7.6 8.6 12.7 11.1 8.0 14.0 6.3 11.8 5.3 13.4 9.5 9.1 7.6 14.2 20.1 14.9 8.4 11.1 17.6 9.9 47.2 7.1 20.3 9.7 12.6 8.4 17.3 10.8 6.5 27.7 3.6 23.9 13.4 10.4 18.8 9.5 15.6 9.3 5.2 17.0 18.8 4.3 23.1 29.0 22.8 24.9 5.6 13.4 10.2 7.5 8.4 16.0 11.7 7.8 11.2 15.5 13.4 0.2 1.4 3.1 0.1 1.9 0.4 3.7 0.5 0.2 1.8 1.4 0.4 0.1 1.7 1.8 0.3 1.7 0.1 0.6 12.7 15.6 11.1 12.2 11.1 9.3 13.5 6.0 11.5 14.4 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favourable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favourable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favourable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 6.3 6.6 6.6 5.4 8.9 5.6 13.2 18.2 9.8 8.4 6.1 8.4 9.9 4.1 8.5 8.5 7.5 7.3 4.2 7.4 5.9 5.8 6.4 6.3 12.7 6.6 7.0 7.8 9.7 8.2 8.2 8.2 8.2 6.5 6.9 6.4 8.9 11.4 6.7 6.1 8.3 6.1 8.7 5.5 6.8 8.1 8.3 4.3 9.6 8.8 4.0 9.3 6.4 6.7 5.5 3.7 1.3 3.1 3.9 6.2 3.3 4.7 2.2 10.8 6.3 2.3 3.0 4.9 2.9 4.3 5.8 6.9 7.3 1.9 5.3 2.4 3.2 3.8 7.0 4.7 9.8 0.4 5.2 6.4 3.4 8.1 5.7 0.2 5.3 4.6 6.5 4.5 6.7 8.0 8.4 0.0 3.9 5.2 7.8 4.6 2.4 3.1 8.9 8.3 3.7 4.6 7.4 4.4 8.3 4.4 4.2 5.0 4.0 11.1 3.8 2.4 3.1 6.8 5.2 5.5 5.3 2.5 6.2 0.1 4.4 0.0 2.7 1.3 5.5 2.6 6.2 5.5 5.8 5.9 3.7 5.3 4.5 6.2 0.2 3.9 3.1 3.0 2.8 3.3 6.6 8.9 18.2 9.8 5.9 5.8 7.0 7.8 6.5 4.3 ZNF773 "MGC4728, ZNF419B" ENSG00000152439 "Zinc finger protein 773" Q6PK81 19 57499915-57518404 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003152 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Nucleoplasm "Nucleoli fibrillar center" "HPA003152: AB_1080716" "unprognostic (6.53e-2)" "unprognostic (3.79e-3)" "unprognostic (2.09e-1)" "unprognostic (1.29e-1)" "unprognostic (6.06e-2)" "unprognostic (2.07e-1)" "unprognostic (3.21e-2)" "unprognostic (5.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (9.50e-4)" "unprognostic (2.97e-2)" "unprognostic (3.56e-4)" "unprognostic (1.54e-1)" "unprognostic (2.69e-2)" "unprognostic (1.14e-1)" "unprognostic (3.71e-3)" 9.0 10.3 7.3 7.0 10.8 10.7 12.5 15.4 11.3 6.0 7.7 6.0 11.2 8.2 8.4 11.4 6.8 8.7 8.4 7.3 7.2 6.9 8.2 4.9 8.1 16.1 8.6 7.8 12.1 5.6 16.0 14.6 8.7 8.2 9.7 7.1 9.6 9.0 8.1 17.8 10.7 7.9 8.8 9.7 11.3 6.9 8.8 4.7 12.7 12.3 6.2 10.4 9.2 9.6 14.8 6.9 16.2 4.8 8.9 17.2 5.8 1.8 3.2 5.5 7.2 4.0 4.9 0.3 5.3 8.0 4.7 19.6 3.3 2.6 3.4 2.9 3.5 1.4 2.7 5.6 7.0 0.1 17.1 5.8 0.4 1.9 7.6 4.4 4.7 11.2 8.0 3.4 13.6 3.3 0.2 0.6 6.0 0.4 8.2 3.1 5.7 9.5 4.5 8.8 5.3 3.3 6.4 5.9 7.2 0.9 2.5 6.1 4.1 8.1 2.8 7.5 3.4 1.9 5.6 8.7 8.9 5.6 2.8 4.3 6.7 16.2 4.8 7.6 8.4 3.6 13.6 11.8 10.4 9.0 6.4 14.8 17.2 13.8 2.2 8.9 3.1 6.9 7.2 5.8 7.3 10.8 15.4 11.3 7.2 6.9 8.6 7.8 8.2 4.7 ZNF776 FLJ38288 ENSG00000152443 "Zinc finger protein 776" Q68DI1 19 57746796-57758159 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA046653, HPA068553" Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA046653: AB_10961126, HPA068553: " "unprognostic (6.73e-2)" "prognostic unfavourable (9.74e-4)" "unprognostic (3.99e-2)" "unprognostic (3.26e-1)" "unprognostic (6.35e-2)" "unprognostic (2.73e-2)" "unprognostic (1.62e-1)" "unprognostic (2.69e-2)" "unprognostic (2.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (7.45e-3)" "unprognostic (1.71e-3)" "unprognostic (2.11e-1)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (6.86e-2)" 5.8 9.8 14.0 10.8 15.9 19.4 12.2 34.9 15.2 9.4 8.6 7.9 17.3 8.4 8.2 29.9 7.8 10.3 6.9 9.8 11.0 9.5 10.7 9.5 8.6 11.0 10.7 8.9 12.4 7.1 17.0 18.8 10.2 12.8 11.9 9.3 9.6 10.8 13.4 11.4 8.6 8.7 7.3 9.6 11.6 10.0 8.7 15.0 19.3 14.5 6.0 10.7 10.7 8.0 4.2 2.5 11.1 2.4 7.5 4.3 2.1 4.6 3.9 12.5 8.3 2.1 6.4 5.4 3.7 6.5 6.5 4.3 2.3 5.0 5.2 3.4 3.3 3.0 6.5 6.4 10.4 4.9 23.8 7.1 9.2 2.6 4.7 3.9 5.7 7.3 5.4 4.3 4.7 5.0 4.7 3.8 8.4 2.0 12.8 3.7 7.3 8.2 8.3 9.5 5.9 4.8 14.7 14.3 10.3 6.8 5.7 4.0 5.8 5.6 4.5 7.0 3.8 0.6 5.5 10.6 11.8 8.7 4.2 3.7 5.7 7.9 2.4 11.1 1.8 1.7 3.9 3.5 2.8 3.4 2.2 4.2 4.3 3.2 6.2 7.5 2.1 2.5 2.3 2.1 14.0 15.9 34.9 15.2 11.0 9.5 10.7 8.9 12.8 15.0 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461123 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 65.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 5.0 4.3 5.5 4.1 8.8 6.9 4.9 7.1 9.3 5.2 5.2 5.4 3.5 4.5 7.3 3.5 4.1 6.5 3.5 4.7 5.3 5.1 3.8 4.4 4.4 4.7 4.3 5.3 9.1 6.6 6.6 5.9 65.7 6.6 5.8 3.3 5.0 7.3 5.8 10.6 7.3 4.4 5.4 6.2 6.0 4.9 4.2 3.5 3.5 5.2 4.8 3.9 6.2 5.0 0.4 0.2 0.6 0.3 0.1 1.5 0.1 10.1 12.6 8.6 12.3 6.3 5.2 11.0 6.6 7.0 9.0 7.8 7.8 6.5 6.5 13.4 7.4 6.8 8.3 10.0 4.9 10.5 12.6 6.4 3.6 7.8 10.9 8.9 9.3 6.1 11.5 7.3 10.6 4.8 20.4 0.0 5.1 13.1 18.9 12.3 10.3 7.4 15.6 4.3 13.6 5.5 8.0 9.3 13.1 11.4 11.7 11.0 5.5 15.0 7.5 7.6 3.0 14.9 10.7 6.2 5.4 3.0 5.7 6.2 9.6 0.0 0.3 0.0 0.5 0.3 0.1 0.3 0.4 0.4 0.0 0.4 0.1 1.5 0.6 0.1 0.1 0.2 0.0 0.1 5.5 8.8 7.1 9.3 5.3 5.1 4.3 5.3 6.6 3.5 ZNF780A ZNF780 ENSG00000197782 "Zinc finger protein 780A" O75290 19 40069152-40090938 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (1.92e-1)" "unprognostic (9.25e-2)" "unprognostic (7.38e-2)" "unprognostic (2.27e-2)" "unprognostic (1.53e-2)" "unprognostic (8.95e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (1.46e-2)" "unprognostic (1.19e-2)" "unprognostic (2.17e-1)" "unprognostic (4.47e-3)" "unprognostic (1.13e-1)" "unprognostic (9.49e-2)" "unprognostic (4.91e-2)" "prognostic favourable (9.30e-4)" 6.9 9.2 11.1 8.6 8.5 4.1 7.7 12.8 10.8 8.7 6.6 5.8 13.9 5.7 8.2 10.8 10.4 7.8 7.8 6.7 7.1 6.1 7.9 11.8 7.0 11.3 10.5 8.9 8.6 11.0 15.8 14.1 7.0 6.8 7.9 6.0 6.8 10.0 11.4 4.5 8.0 9.1 6.0 10.4 12.0 8.2 7.9 9.7 7.8 11.2 5.3 11.3 8.8 7.9 3.9 4.6 8.4 7.7 3.3 5.9 2.5 4.8 9.2 6.0 5.6 5.5 5.0 4.3 5.6 4.5 4.6 7.1 6.0 3.3 4.3 3.7 2.7 4.1 3.8 3.2 5.1 7.4 5.2 6.8 7.6 5.7 4.9 7.0 5.6 5.2 3.6 4.7 3.9 4.7 7.6 7.3 3.9 2.8 2.8 2.4 4.8 2.9 2.3 10.6 2.5 3.8 10.0 3.7 7.1 8.4 3.2 3.7 4.0 8.5 3.5 5.7 7.6 5.1 4.5 7.2 6.3 4.3 3.6 4.9 3.8 2.7 5.4 8.4 3.9 4.9 5.1 3.7 4.2 3.5 4.6 3.9 5.9 5.1 4.7 3.3 7.7 3.6 4.5 2.5 11.1 8.5 12.8 10.8 7.1 6.1 10.5 8.9 6.8 9.7 ZNF780B ZNF779 ENSG00000128000 "Zinc finger protein 780B" Q9Y6R6 19 40028260-40056209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA003311 Uncertain Approved Nucleoplasm,Centrosome Nucleoplasm Centrosome "HPA003311: AB_1080757" "unprognostic (3.28e-1)" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (3.56e-3)" "unprognostic (5.54e-2)" "unprognostic (1.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.76e-2)" "unprognostic (1.24e-2)" "unprognostic (4.59e-3)" "unprognostic (1.83e-3)" "unprognostic (1.33e-2)" "unprognostic (4.89e-3)" "unprognostic (4.71e-2)" "unprognostic (1.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-3)" 6.3 8.2 12.4 9.8 18.8 3.3 10.3 22.2 14.0 8.2 8.5 8.2 11.6 5.7 10.8 12.3 5.5 10.0 6.6 12.5 9.4 7.2 9.4 6.7 5.9 9.7 8.1 10.8 16.6 8.1 10.5 24.7 7.1 11.6 9.7 7.6 9.3 7.9 10.5 6.9 7.1 7.6 9.7 7.8 9.2 7.2 5.0 11.4 8.7 14.0 6.4 9.8 9.1 8.2 4.2 5.9 1.5 3.2 2.3 5.1 1.3 2.6 3.4 5.8 4.0 3.5 2.3 0.0 3.0 2.2 3.3 4.4 6.2 2.4 6.4 2.8 3.1 1.5 4.8 1.9 4.0 5.4 2.4 5.0 6.1 3.9 2.4 7.4 4.2 3.4 1.2 4.6 2.9 3.1 5.2 8.7 3.4 1.2 2.4 1.2 5.7 3.6 3.5 10.2 2.2 1.9 14.2 6.4 6.8 5.3 2.3 1.9 2.7 3.2 5.6 3.3 8.1 5.7 4.6 6.6 8.5 5.0 3.0 3.9 2.7 0.1 3.2 1.5 2.8 2.8 2.9 2.5 3.4 3.3 2.4 4.2 5.1 4.2 0.6 2.3 1.8 5.9 1.9 1.3 12.4 18.8 22.2 14.0 9.4 7.2 8.1 10.8 11.6 11.4 ZNF781 FLJ37549 ENSG00000196381 "Zinc finger protein 781" Q8N8C0 19 37667751-37692322 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 4.7;ASC diff: 4.7;HSkMC: 4.6;SH-SY5Y: 4.6;U-266/84: 5.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 11 "B-cells: 1.0;T-cells: 3.2" HPA062512 Uncertain Approved Nucleoplasm Nucleoplasm "HPA062512: " "unprognostic (3.01e-1)" "unprognostic (8.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.86e-2)" "unprognostic (1.90e-2)" "unprognostic (5.82e-2)" "unprognostic (1.76e-3)" "unprognostic (2.68e-2)" "unprognostic (1.58e-1)" "unprognostic (1.86e-1)" "unprognostic (1.84e-3)" "unprognostic (1.67e-1)" "unprognostic (1.23e-2)" "unprognostic (2.11e-2)" "unprognostic (8.12e-2)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" 4.9 5.3 5.7 4.6 12.9 0.5 2.9 15.8 13.6 4.3 4.5 3.8 1.9 1.6 7.3 4.8 2.2 4.8 3.1 6.5 5.8 5.8 2.6 1.3 3.7 3.5 6.1 6.8 9.8 1.3 4.8 7.4 5.0 7.6 4.5 3.1 3.8 1.5 5.2 1.5 2.0 2.4 8.5 9.6 5.0 2.2 4.8 5.5 0.6 5.3 1.3 2.5 4.7 5.4 1.0 0.1 0.1 0.2 0.0 3.2 0.7 0.0 0.0 1.9 4.7 4.7 1.0 1.0 1.7 0.0 1.7 1.2 0.2 0.0 0.2 0.0 1.1 0.0 0.1 0.0 1.9 0.0 0.1 0.1 0.0 2.0 2.3 0.0 0.1 4.6 0.0 1.3 0.1 0.4 0.9 0.0 0.0 0.0 1.1 1.0 0.5 0.0 0.0 3.3 0.0 0.7 1.2 0.0 4.6 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.0 1.0 1.5 5.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.1 0.4 1.8 2.5 0.1 1.0 2.6 3.2 0.1 0.0 0.0 0.1 0.8 0.7 5.7 12.9 15.8 13.6 5.8 5.8 6.1 6.8 7.6 5.5 ZNF782 FLJ16636 ENSG00000196597 "Zinc finger protein 782" Q6ZMW2 9 96816472-96875623 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011013 Approved Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA011013: AB_1080758" "unprognostic (5.51e-2)" "unprognostic (5.29e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.48e-2)" "unprognostic (2.82e-2)" "unprognostic (9.89e-3)" "unprognostic (2.38e-2)" "unprognostic (3.04e-2)" "unprognostic (4.68e-3)" "unprognostic (3.63e-3)" "unprognostic (4.84e-2)" "unprognostic (3.55e-1)" "unprognostic (4.95e-1)" "unprognostic (2.61e-2)" "unprognostic (4.39e-2)" 5.3 4.2 7.4 7.4 8.4 2.5 7.6 19.8 8.0 7.5 5.3 6.9 5.9 6.1 7.9 8.5 5.2 5.5 5.8 4.0 6.8 4.5 7.1 5.5 4.4 5.9 5.9 4.8 9.3 12.7 11.8 15.1 4.9 7.7 7.5 6.9 5.4 8.0 7.3 9.2 8.6 7.1 5.3 6.5 6.4 6.6 13.9 8.3 6.0 8.8 2.5 7.4 5.6 10.8 2.3 0.2 0.7 0.5 1.0 2.2 0.4 2.9 2.3 5.8 8.9 1.6 2.2 4.0 2.8 2.8 4.5 3.4 2.7 3.0 5.7 3.7 2.0 4.1 5.1 1.8 4.5 5.7 2.2 5.2 4.7 2.7 1.7 7.2 3.7 1.3 3.8 3.7 1.9 1.5 7.0 5.8 2.7 4.9 7.6 3.5 4.3 5.1 6.8 7.1 1.9 3.1 1.9 5.9 4.5 3.8 2.3 3.0 4.3 4.2 3.3 6.0 3.5 6.0 3.1 5.5 3.9 2.7 2.4 1.8 4.3 0.0 0.5 0.2 1.1 0.5 2.2 2.0 1.0 0.0 0.2 2.3 0.9 0.7 0.7 1.0 0.2 0.2 0.6 0.4 7.4 8.4 19.8 8.0 6.8 4.5 5.9 4.8 7.7 8.3 ZNF784 MGC75238 ENSG00000179922 "Zinc finger protein 784" Q8NCA9 19 55620742-55624601 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 39.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059676 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059676: " "unprognostic (4.67e-2)" "unprognostic (8.13e-2)" "unprognostic (4.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-1)" "unprognostic (9.44e-2)" "unprognostic (4.74e-1)" "unprognostic (1.26e-1)" "unprognostic (9.11e-3)" "unprognostic (4.86e-2)" "unprognostic (3.48e-3)" "unprognostic (3.87e-1)" "unprognostic (7.93e-2)" "unprognostic (5.10e-2)" "prognostic favourable (1.02e-4)" 5.9 5.6 2.9 7.4 3.2 5.7 4.9 5.2 5.0 7.5 9.3 3.3 4.1 8.6 7.9 8.0 4.9 6.7 7.0 9.1 2.8 2.3 5.8 7.3 10.4 3.5 2.7 3.2 9.7 15.0 6.0 5.5 4.9 3.9 7.9 3.8 5.8 5.9 5.8 39.1 4.9 11.2 10.4 2.6 6.5 5.8 3.6 2.6 3.2 7.3 16.1 6.1 6.7 4.5 1.4 1.6 2.9 2.0 1.4 1.3 0.6 4.5 6.3 6.0 3.2 2.3 3.1 5.7 4.7 3.0 2.7 3.7 3.2 5.0 5.4 4.2 3.3 2.5 1.7 4.1 1.9 3.0 16.8 5.1 4.9 4.0 4.6 4.1 5.4 4.2 4.5 2.3 2.9 1.8 5.9 5.7 4.1 4.3 3.2 4.7 5.8 14.0 6.1 4.1 6.0 5.0 11.5 6.7 9.0 7.8 3.7 2.1 3.9 7.4 5.4 3.2 3.0 1.9 3.8 6.5 2.7 3.1 4.8 3.1 2.6 0.0 2.0 2.9 0.8 1.8 0.6 1.0 0.8 0.8 1.6 1.4 0.8 1.3 1.1 1.4 1.5 1.2 0.1 0.6 2.9 3.2 5.2 5.0 2.8 2.3 2.7 3.2 3.9 2.6 ZNF785 FLJ32130 ENSG00000197162 "Zinc finger protein 785" A8K8V0 16 30573740-30585771 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA030510 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA030510: " "unprognostic (2.85e-2)" "unprognostic (1.29e-1)" "unprognostic (8.25e-2)" "unprognostic (2.47e-1)" "unprognostic (2.35e-1)" "unprognostic (4.15e-2)" "unprognostic (2.54e-4)" "prognostic favourable (8.99e-4)" "unprognostic (1.55e-1)" "unprognostic (2.08e-1)" "prognostic favourable (2.03e-5)" "unprognostic (3.37e-2)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (3.13e-2)" "unprognostic (1.74e-1)" "unprognostic (1.54e-2)" 5.9 8.7 15.8 7.9 13.6 4.8 8.3 26.8 16.6 10.9 7.7 14.7 8.7 14.2 12.4 9.8 6.9 10.2 8.3 6.2 12.6 7.6 7.8 6.1 6.5 8.7 15.7 12.2 14.7 9.1 11.9 12.7 6.1 11.8 10.8 8.2 10.8 10.5 9.5 9.2 12.6 10.7 7.5 9.5 9.5 12.4 3.9 19.2 8.8 9.9 4.3 8.8 10.4 9.6 5.1 5.4 4.9 5.1 3.3 3.5 1.0 4.9 0.4 4.8 6.4 6.0 6.8 1.5 4.3 3.9 4.5 3.4 6.6 7.9 5.1 5.1 4.1 7.0 0.1 2.8 2.6 3.4 1.3 6.2 13.7 1.5 4.4 0.5 10.7 4.4 6.1 3.0 2.8 4.7 5.8 6.4 4.1 8.5 6.1 5.8 2.8 2.8 16.2 5.5 2.5 4.2 5.1 13.3 9.4 3.5 4.4 2.6 5.6 5.3 7.0 1.8 4.8 4.0 0.3 0.9 2.6 2.1 5.7 3.8 7.2 4.7 2.6 1.0 2.3 1.6 2.5 5.1 2.8 1.9 1.9 3.1 3.5 2.7 4.9 3.3 5.1 5.4 3.3 1.0 15.8 13.6 26.8 16.6 12.6 7.6 15.7 12.2 11.8 19.2 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069643-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles" "Nuclear speckles" Nucleoplasm "HPA021518: , HPA053459: " "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavourable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favourable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 3.9 4.3 8.7 6.1 9.6 3.3 5.1 10.4 15.2 6.0 5.1 4.2 6.4 4.6 6.9 6.1 6.8 6.7 4.8 3.2 6.4 6.1 4.5 5.4 7.3 8.2 4.8 5.8 8.3 6.0 7.6 8.5 3.8 4.0 6.8 3.4 5.4 5.3 5.8 4.1 13.0 5.1 6.6 3.4 7.7 5.1 2.9 4.2 8.4 6.1 5.8 6.5 6.2 6.1 7.2 4.5 2.9 5.0 8.4 12.1 5.3 4.4 8.0 6.4 10.8 3.9 1.6 9.2 2.7 2.9 3.1 2.4 4.2 4.2 6.3 6.6 1.9 5.1 3.9 3.7 2.0 6.8 6.0 3.1 4.7 5.3 3.3 6.1 4.2 2.3 4.2 3.8 2.7 2.8 5.5 3.6 2.8 13.8 10.3 10.4 11.8 6.1 7.7 3.2 4.1 2.5 6.2 7.7 12.1 6.7 6.4 5.0 4.1 2.9 3.6 3.6 2.1 6.2 3.9 13.2 9.7 3.5 6.0 3.9 4.0 1.7 3.7 2.9 12.1 5.0 9.8 7.2 8.5 10.7 4.5 7.1 11.3 9.5 1.1 8.4 3.9 3.9 5.1 5.3 8.7 9.6 10.4 15.2 6.4 6.1 4.8 5.8 4.0 4.2 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 11.8 11.7 3.8 8.0 1.1 2.4 10.0 6.2 2.4 4.2 4.8 6.9 7.4 8.5 0.4 2.6 9.4 2.4 5.0 1.9 11.2 43.4 13.5 5.9 10.4 6.2 12.9 11.9 3.2 4.9 3.5 6.1 3.1 16.1 9.6 2.4 7.5 8.0 16.3 12.1 22.2 10.0 5.6 10.8 4.3 7.9 14.7 14.3 6.5 12.8 11.4 7.9 18.4 6.6 16.0 11.4 6.7 16.9 20.4 14.9 8.2 9.2 8.7 7.4 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 ZNF79 pT7 ENSG00000196152 "Zinc finger protein 79" Q15937 9 127424374-127445372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028977 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA028977: AB_10602359" "unprognostic (4.56e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "prognostic favourable (6.83e-5)" "unprognostic (2.84e-2)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "prognostic favourable (5.96e-4)" "unprognostic (3.41e-1)" "unprognostic (1.13e-2)" "prognostic favourable (5.42e-5)" "unprognostic (4.53e-3)" "prognostic favourable (6.04e-7)" "unprognostic (6.09e-3)" "unprognostic (5.01e-1)" "unprognostic (5.23e-2)" "unprognostic (1.32e-1)" 9.9 11.0 7.6 6.7 7.8 6.7 8.1 18.3 8.5 9.2 9.6 10.3 6.9 5.6 12.9 10.4 7.0 9.4 5.6 6.8 6.8 5.3 6.8 9.5 6.8 8.3 7.5 5.2 9.1 9.5 13.2 11.8 8.1 8.4 11.2 8.2 10.7 12.2 8.3 13.2 8.7 7.7 8.3 6.1 10.2 8.8 21.1 8.6 12.8 8.5 4.8 10.5 13.3 9.9 8.5 7.5 7.4 6.0 9.4 11.8 4.9 2.2 4.5 6.0 3.6 6.8 4.0 16.9 5.6 6.8 6.7 7.7 4.8 2.1 4.8 2.3 4.1 7.0 4.5 6.8 5.3 4.8 2.9 3.3 7.3 5.3 8.0 7.8 5.3 4.0 7.7 8.3 6.7 6.9 5.6 7.2 6.3 4.9 6.1 2.9 4.8 5.8 5.1 8.4 6.8 2.8 3.3 6.9 4.6 10.6 5.5 3.2 7.2 4.5 4.8 4.3 3.9 4.2 4.3 9.8 20.8 6.2 5.5 2.4 7.1 3.3 4.9 7.4 9.3 6.0 10.6 7.4 6.4 11.8 7.0 8.5 8.4 9.1 6.5 9.4 4.0 7.5 7.9 4.9 7.6 7.8 18.3 8.5 6.8 5.3 7.5 5.2 8.4 8.6 ZNF791 FLJ90396 ENSG00000173875 "Zinc finger protein 791" Q3KP31 19 12610918-12633840 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021537 Uncertain Approved Nucleoplasm Nucleoplasm "HPA021537: " "unprognostic (1.95e-1)" "unprognostic (4.88e-3)" "unprognostic (1.73e-2)" "unprognostic (7.58e-2)" "unprognostic (2.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.86e-2)" "prognostic favourable (9.07e-4)" "unprognostic (1.88e-2)" "unprognostic (1.59e-2)" "unprognostic (3.38e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" "prognostic favourable (1.39e-5)" 16.7 12.0 11.9 18.0 15.4 22.5 18.6 30.3 17.1 20.0 15.0 12.7 14.1 10.9 16.6 16.3 14.0 15.4 10.1 13.0 11.5 10.9 13.4 11.9 17.0 15.8 14.7 12.5 21.5 15.3 20.2 32.1 13.4 15.5 16.6 13.4 11.8 15.5 18.2 15.9 17.1 15.3 17.9 16.0 16.6 13.8 7.0 13.8 14.4 25.4 8.9 19.6 23.7 18.1 11.6 10.5 9.7 3.8 10.9 8.3 2.6 6.9 3.8 7.5 7.4 9.3 12.0 6.5 9.0 9.9 6.7 8.2 4.8 4.2 1.6 8.7 9.3 6.6 7.3 8.5 11.2 4.7 7.6 6.9 9.5 6.7 7.6 8.9 7.7 10.3 9.7 8.0 13.0 7.0 7.9 11.2 8.3 11.1 5.5 3.4 8.5 11.7 4.0 12.3 5.7 6.7 13.4 8.3 10.0 8.0 6.5 8.5 6.5 7.7 8.7 13.5 5.7 11.7 7.2 16.8 20.0 4.9 9.2 7.0 7.9 9.7 3.3 5.2 7.0 2.1 7.2 7.4 6.3 8.0 3.0 11.6 7.4 8.3 5.6 10.9 3.8 10.5 5.4 2.6 11.9 15.4 30.3 17.1 11.5 10.9 14.7 12.5 15.5 13.8 ZNF792 FLJ38451 ENSG00000180884 "Zinc finger protein 792" Q3KQV3 19 34956354-34964049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 12.0;HMC-1: 15.9;HUVEC TERT2: 10.7;SH-SY5Y: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035157, HPA035158" Supported Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA035157: , HPA035158: AB_10603010" "unprognostic (1.31e-1)" "unprognostic (7.31e-2)" "prognostic favourable (2.72e-4)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (7.91e-2)" "unprognostic (2.41e-5)" "unprognostic (2.49e-2)" "unprognostic (4.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.88e-1)" "unprognostic (2.48e-1)" "unprognostic (6.02e-2)" "unprognostic (2.77e-3)" 9.4 3.9 3.6 7.3 5.8 2.3 8.9 11.6 5.4 6.1 6.1 5.9 8.9 4.3 6.3 4.3 3.1 5.8 7.9 4.1 2.3 2.0 4.5 3.7 9.4 8.3 2.2 2.0 5.2 5.0 6.9 3.4 7.1 3.8 8.8 5.1 5.7 5.7 4.9 3.1 4.0 6.0 5.6 2.8 8.6 5.1 3.7 2.1 12.0 5.4 3.4 5.8 7.3 4.0 1.8 1.1 6.9 0.7 4.4 5.5 2.2 1.0 3.6 1.7 2.7 1.8 1.4 0.0 1.0 1.9 1.3 1.6 1.4 1.7 1.5 3.3 1.4 0.7 2.5 1.9 2.0 4.4 0.5 12.0 1.1 2.8 1.3 1.0 15.9 1.6 0.6 1.0 0.5 10.7 3.2 0.0 2.1 0.8 4.1 1.1 1.3 0.8 2.8 0.0 0.2 1.0 3.3 0.9 10.2 1.0 1.0 1.3 1.2 3.3 4.3 1.9 2.4 0.8 1.1 0.3 0.9 0.9 2.0 0.2 0.8 6.9 0.7 6.1 3.1 0.7 4.1 1.8 4.9 4.3 1.1 1.7 5.5 4.6 0.2 4.4 0.5 0.1 4.6 2.2 3.6 5.8 11.6 5.4 2.3 2.0 2.2 2.0 3.8 2.1 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RT4: 9.7;U-266/70: 16.9;U-266/84: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.4 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 0.4 0.3 2.8 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.5 0.6 0.1 0.1 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.3 0.1 0.1 0.6 2.8 9.7 3.1 6.7 0.2 0.2 0.0 6.4 0.3 0.4 0.1 1.8 0.2 3.2 16.9 11.3 0.2 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6 ZNF799 "HIT-40, MGC71805, ZNF842" ENSG00000196466 "Zinc finger protein 799" Q96GE5 19 12390016-12401271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA003150, HPA018683" Approved Approved "Nucleoplasm,Centriolar satellite" Nucleoplasm "Centriolar satellite" "HPA003150: AB_1080725, HPA018683: " "unprognostic (2.96e-1)" "unprognostic (1.10e-1)" "unprognostic (8.84e-2)" "prognostic favourable (2.39e-4)" "unprognostic (3.63e-2)" "unprognostic (5.18e-3)" "unprognostic (3.02e-1)" "unprognostic (8.83e-3)" "unprognostic (4.47e-5)" "unprognostic (1.45e-1)" "unprognostic (5.56e-3)" "unprognostic (6.55e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.04e-1)" "unprognostic (8.91e-3)" "unprognostic (1.23e-3)" 7.9 7.2 6.1 11.9 5.5 3.2 10.1 7.7 8.0 12.6 8.2 4.6 12.9 4.7 6.9 5.8 7.6 9.3 4.9 4.1 6.6 4.3 7.8 8.3 6.6 5.3 6.3 1.8 10.8 10.7 7.6 2.8 10.5 6.3 8.4 6.2 3.3 6.2 6.8 5.5 5.6 6.1 5.6 5.0 7.4 4.5 5.8 6.7 9.1 7.5 6.4 5.2 7.1 6.5 7.5 4.6 4.6 4.3 4.5 10.3 3.9 3.7 2.9 4.1 9.2 2.1 2.0 8.0 2.1 2.8 5.1 4.9 5.9 1.5 4.9 3.7 2.4 3.1 3.1 3.6 4.9 0.1 3.1 3.7 2.4 9.6 0.7 2.9 7.0 2.5 2.2 3.6 2.9 2.4 3.9 0.0 3.3 5.2 6.1 4.1 2.0 8.1 0.7 5.9 4.9 5.1 9.3 2.9 3.0 4.2 0.9 1.1 4.1 5.3 2.3 5.4 3.0 6.2 2.3 3.4 5.4 3.8 0.8 3.0 2.2 4.4 4.1 4.6 6.9 4.3 8.3 7.5 6.5 10.3 3.4 6.7 6.5 5.0 4.3 4.5 2.6 4.6 6.9 3.9 6.1 5.5 7.7 8.0 6.6 4.3 6.3 1.8 6.3 6.7 ZNF8 "HF.18, Zfp128" ENSG00000278129 "Zinc finger protein 8" P17098 19 58278951-58302805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034797, HPA034798" Uncertain Approved "Nucleoplasm,Nuclear bodies" "Nucleoplasm, Nuclear bodies" "HPA034797: AB_10696364, HPA034798: AB_10602785" "unprognostic (1.41e-1)" "unprognostic (7.27e-2)" "unprognostic (6.66e-2)" "unprognostic (3.03e-2)" "unprognostic (1.52e-2)" "unprognostic (4.16e-3)" "unprognostic (1.09e-2)" "unprognostic (9.20e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (4.98e-2)" "unprognostic (7.16e-3)" "unprognostic (8.56e-2)" "unprognostic (7.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.28e-2)" 2.7 3.1 4.6 2.7 5.5 7.7 4.3 6.4 7.5 3.4 2.6 6.1 2.7 3.0 4.9 4.0 2.8 3.5 2.8 3.7 4.7 3.4 2.2 3.4 3.4 4.1 3.3 3.8 3.1 7.5 4.3 3.8 4.1 3.3 3.1 4.4 3.0 3.7 2.1 6.6 2.2 3.9 4.6 4.5 3.6 3.5 4.3 9.2 3.9 1.5 3.5 3.0 3.9 2.3 1.6 4.7 2.4 1.9 1.9 1.9 2.2 3.2 4.8 8.6 3.0 2.7 3.9 1.1 1.8 1.2 1.4 3.5 1.6 2.7 1.4 1.9 2.1 3.5 3.8 1.5 2.1 13.9 5.4 6.1 2.9 2.7 1.8 4.4 4.8 2.3 2.0 3.9 2.1 2.8 1.2 2.4 2.4 4.1 2.5 4.2 2.2 4.7 4.4 1.9 2.2 7.7 8.1 4.4 3.3 2.4 1.0 2.3 3.4 3.0 8.6 2.2 1.3 2.2 4.3 3.4 3.5 1.5 0.1 2.2 3.6 2.4 1.6 1.6 1.3 1.9 1.5 1.4 1.2 1.6 2.3 1.5 1.7 4.7 1.9 1.0 1.4 0.7 1.9 ZNF805 ENSG00000204524 "Zinc finger protein 805" Q5CZA5 19 57240685-57255135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046330, HPA058895" Uncertain Approved Nucleoplasm Nucleoplasm "HPA046330: , HPA058895: " "unprognostic (2.18e-1)" "unprognostic (1.10e-1)" "unprognostic (8.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.22e-1)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.20e-1)" "unprognostic (1.95e-1)" "unprognostic (1.58e-2)" "unprognostic (3.51e-1)" "unprognostic (3.68e-2)" "unprognostic (7.16e-3)" "unprognostic (1.64e-1)" 8.4 8.8 3.6 5.5 7.2 18.5 9.6 4.8 9.4 6.6 6.1 8.3 5.8 3.9 9.1 6.4 6.6 6.0 5.9 6.3 3.4 3.5 5.4 6.2 6.8 5.1 6.4 5.2 10.2 7.2 9.8 9.0 7.5 5.8 6.2 5.7 6.8 7.9 5.8 9.0 7.7 6.3 7.2 5.2 7.2 6.1 8.6 5.9 9.2 6.7 2.4 7.4 7.1 11.6 3.9 2.1 5.3 1.8 5.6 4.9 2.4 2.3 3.6 3.6 4.7 6.5 4.8 4.5 2.3 5.3 3.9 7.7 3.1 2.1 4.5 1.8 5.5 1.4 3.9 3.8 7.0 2.4 9.8 4.6 3.0 3.0 5.8 4.2 4.6 6.0 4.8 5.1 8.9 3.6 1.7 6.1 2.7 1.6 5.0 1.4 3.0 4.1 2.5 7.6 3.9 2.5 7.7 3.8 3.8 6.1 3.5 3.6 2.4 4.1 4.0 5.7 3.9 2.6 2.6 6.1 4.2 4.4 3.6 2.3 3.1 0.0 1.8 5.3 3.8 0.5 4.9 3.9 3.3 4.8 2.1 1.7 3.3 3.1 2.0 5.6 0.9 1.5 3.6 2.4 3.6 7.2 4.8 9.4 3.4 3.5 6.4 5.2 5.8 5.9 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;testis: 23.7" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 11.5" "Group enriched" "Detected in many" 8 "B-cells: 11.5;T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: " "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favourable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favourable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favourable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 4.2 6.3 3.7 7.5 3.1 4.8 26.9 13.4 4.3 3.8 5.1 2.3 2.1 5.8 11.1 2.5 3.5 3.9 2.9 5.7 7.6 5.9 2.6 3.4 6.0 5.2 6.0 7.3 2.4 5.6 9.2 2.5 7.1 4.4 5.0 5.2 5.2 5.1 4.0 6.0 4.3 3.0 4.8 3.7 3.3 23.7 3.4 2.2 6.1 0.7 7.3 2.4 4.0 11.5 0.9 0.4 0.5 1.0 5.1 0.7 1.1 0.9 13.8 6.7 2.8 3.6 2.4 1.4 3.1 3.1 4.9 1.9 0.8 2.6 2.4 2.7 1.9 4.6 2.0 3.8 3.9 5.2 0.5 1.0 0.7 1.7 0.9 3.0 3.1 3.5 2.1 1.3 2.3 1.6 1.9 3.3 3.3 1.4 0.9 5.5 0.6 6.0 2.9 4.5 3.5 0.4 13.9 6.6 1.8 1.2 1.5 4.7 3.0 4.6 3.3 3.4 1.2 0.9 4.7 2.3 10.5 1.1 2.6 3.1 0.0 0.5 0.4 2.2 0.0 1.9 9.3 2.3 1.6 0.9 11.5 1.4 0.5 0.4 1.0 0.5 0.0 5.1 0.7 6.3 7.5 26.9 13.4 5.7 7.6 5.2 6.0 7.1 3.4 ZNF827 ENSG00000151612 "Zinc finger protein 827" Q17R98 4 145757627-145938635 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 23.1;WM-115: 35.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021166 Uncertain Approved Nucleoplasm Nucleoplasm "HPA021166: " "unprognostic (2.75e-2)" "unprognostic (3.46e-3)" "unprognostic (2.79e-1)" "unprognostic (3.64e-1)" "unprognostic (3.90e-2)" "unprognostic (2.40e-2)" "unprognostic (3.77e-1)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.90e-2)" "unprognostic (7.64e-2)" "unprognostic (3.47e-1)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (7.85e-2)" "unprognostic (4.03e-2)" "unprognostic (1.88e-2)" 3.8 9.5 8.2 9.6 15.6 3.9 6.5 37.3 12.3 6.0 7.1 8.1 7.7 8.1 10.7 6.5 3.8 8.3 6.3 7.0 5.9 5.8 6.3 1.1 4.7 6.4 5.8 8.2 11.0 4.3 14.9 28.3 2.2 7.4 26.3 6.4 4.3 28.1 9.3 24.9 3.4 10.0 11.4 13.0 5.5 6.3 4.5 9.5 14.0 10.9 3.3 7.7 10.2 5.0 1.9 2.6 5.4 0.0 12.3 3.4 1.2 2.7 4.3 7.9 5.1 3.4 3.8 0.0 4.5 4.3 3.5 2.7 2.2 7.1 0.7 1.6 8.2 1.7 4.5 3.4 3.7 5.5 2.2 2.2 4.2 2.4 3.7 1.6 0.0 5.2 3.1 2.7 7.8 6.2 0.4 4.3 3.0 0.0 2.3 0.1 3.8 5.7 7.1 4.1 1.4 3.7 4.0 7.2 6.6 3.9 6.8 10.2 3.0 0.1 23.1 9.4 7.6 0.6 5.2 3.0 0.2 3.0 3.0 8.9 35.7 5.4 0.0 0.0 3.3 0.0 0.9 1.5 1.2 3.1 0.0 1.9 2.1 3.4 0.0 12.3 0.0 2.6 0.1 1.2 8.2 15.6 37.3 12.3 5.9 5.8 5.8 8.2 7.4 9.5 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.1" "Cell line enhanced" "Detected in many" "U-266/84: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA073073 Approved "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA073073: " "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 2.6 2.8 4.9 2.4 5.9 1.9 4.3 8.0 4.8 2.9 2.6 2.3 5.0 1.7 3.6 2.0 2.2 3.1 1.8 2.4 3.3 2.5 2.6 1.8 2.2 2.8 6.4 2.9 5.3 2.1 3.8 3.4 3.6 3.3 3.6 1.6 1.6 2.6 3.0 1.9 3.5 2.1 4.8 4.4 2.8 2.3 20.1 5.1 3.4 5.2 1.0 2.9 3.1 4.7 3.3 1.4 4.2 0.8 2.1 4.9 1.0 0.0 1.2 3.3 0.1 1.8 2.8 1.4 3.7 2.1 4.6 7.0 0.1 0.6 0.1 4.3 2.3 0.7 0.0 2.6 5.4 0.0 5.2 1.8 0.1 0.1 1.8 0.0 5.2 2.8 2.6 5.0 0.0 0.5 0.0 0.1 4.9 0.8 0.7 0.8 5.5 0.0 0.0 4.4 1.6 1.2 5.4 3.7 5.5 0.1 0.0 3.1 3.4 0.3 1.4 2.9 3.9 3.7 3.9 9.6 14.7 6.2 0.0 0.0 6.8 4.2 0.6 2.9 3.2 0.7 4.2 2.2 3.2 4.9 1.0 3.3 4.1 4.2 1.3 2.1 0.8 1.4 3.2 1.0 4.9 5.9 8.0 4.8 3.3 2.5 6.4 2.9 3.3 5.1 ZNF83 "FLJ11015, HPF1, ZNF816B" ENSG00000167766 "Zinc finger protein 83" P51522 19 52594060-52690496 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA025970 Approved Approved Nucleoplasm Nucleoplasm "HPA025970: AB_1859463" "unprognostic (6.38e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-2)" "unprognostic (1.78e-1)" "unprognostic (1.18e-1)" "prognostic favourable (3.83e-4)" "unprognostic (3.38e-3)" "unprognostic (3.67e-1)" "prognostic unfavourable (9.20e-4)" "prognostic favourable (9.06e-4)" "unprognostic (6.08e-2)" "unprognostic (3.85e-3)" "prognostic unfavourable (3.13e-5)" "unprognostic (2.81e-2)" "unprognostic (1.14e-1)" "unprognostic (3.33e-1)" "prognostic favourable (6.92e-6)" 13.1 19.0 14.5 16.2 66.8 14.6 22.3 42.6 20.2 21.6 16.4 11.7 41.4 8.4 23.3 54.0 11.4 27.2 16.0 11.1 17.2 11.5 26.0 4.0 12.9 18.5 25.7 12.5 34.5 11.8 22.3 29.4 44.2 21.9 25.5 14.0 11.0 11.8 32.6 5.8 16.2 12.3 21.0 20.4 19.0 14.7 9.8 24.4 16.9 24.3 8.1 15.9 15.9 34.3 9.9 4.3 8.5 4.9 12.8 9.3 3.7 9.2 0.5 13.2 9.5 11.8 24.0 7.4 14.2 9.9 8.6 11.7 3.6 8.0 9.6 7.5 9.6 4.1 7.9 9.4 12.1 1.3 9.1 8.1 8.2 4.5 9.7 5.6 11.3 19.3 12.0 7.2 36.1 9.7 8.9 7.9 14.2 6.2 8.0 9.8 3.7 9.0 8.0 11.3 6.4 22.1 18.5 7.6 6.2 9.1 9.0 3.5 9.6 6.0 13.2 8.7 5.4 4.4 14.6 0.9 8.4 13.2 0.5 6.1 6.9 4.4 3.6 8.5 7.6 3.9 7.8 6.9 8.9 9.3 4.3 9.9 7.6 8.7 3.3 12.8 4.9 2.9 4.3 3.7 14.5 66.8 42.6 20.2 17.2 11.5 25.7 12.5 21.9 24.4 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favourable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favourable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 8.9 9.9 10.9 10.6 14.1 11.3 15.7 11.6 16.9 11.1 10.2 14.4 9.0 8.1 15.3 11.2 8.4 19.7 7.8 8.4 11.1 10.1 9.7 13.0 6.8 11.0 8.8 13.4 12.9 15.6 14.3 13.2 9.0 8.9 10.1 9.5 13.0 11.9 13.4 18.6 21.6 10.3 10.6 8.3 15.2 8.7 39.7 7.8 11.3 12.9 8.8 11.8 7.8 9.5 1.9 2.1 3.5 1.9 0.3 2.6 0.4 8.6 7.9 10.3 18.6 4.8 8.2 17.7 6.8 5.6 8.5 7.0 3.0 7.4 9.0 5.6 4.6 8.5 6.7 17.1 6.6 12.0 12.7 6.2 7.2 5.0 4.3 5.8 5.5 6.5 12.9 16.5 15.4 11.3 13.2 11.8 11.9 16.1 8.8 9.4 13.8 8.0 19.2 6.3 5.6 7.6 7.1 5.6 17.5 5.6 7.2 6.0 16.2 9.6 4.4 5.5 5.0 7.6 6.0 11.7 8.4 10.3 4.3 7.0 9.0 0.0 0.7 2.3 2.4 1.9 2.6 1.9 1.6 1.5 1.3 1.4 2.6 2.2 3.5 0.3 0.4 2.1 2.1 0.4 10.9 14.1 11.6 16.9 11.1 10.1 8.8 13.4 8.9 7.8 ZNF850 ZNF850P ENSG00000267041 "Zinc finger protein 850" A8MQ14 19 36714383-36772825 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 17.9" "Cell line enhanced" "Detected in many" "HEL: 14.7;NTERA-2: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA029299 Uncertain Approved Nucleoplasm Nucleoplasm "HPA029299: " "unprognostic (1.35e-2)" "unprognostic (5.54e-2)" "unprognostic (3.85e-2)" "unprognostic (1.38e-3)" "unprognostic (7.78e-2)" "unprognostic (6.63e-2)" "unprognostic (1.65e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-2)" "unprognostic (1.25e-1)" "unprognostic (3.00e-2)" "unprognostic (5.56e-2)" "unprognostic (4.11e-3)" "unprognostic (1.77e-1)" "unprognostic (7.49e-2)" "unprognostic (4.49e-2)" "unprognostic (7.37e-3)" 4.0 3.4 2.6 3.0 4.2 11.5 3.3 8.7 3.1 5.1 2.4 3.4 1.6 1.9 5.6 2.6 2.8 2.9 3.2 4.6 2.5 1.7 2.0 2.8 3.0 4.0 5.9 0.7 5.9 4.1 3.2 6.4 17.9 3.2 3.4 2.9 3.0 2.3 2.2 1.9 3.2 2.9 2.3 3.5 3.6 2.7 6.7 3.8 7.0 2.6 1.0 2.9 5.0 4.4 6.8 3.5 6.0 3.8 3.8 6.0 5.1 0.3 1.7 3.7 5.8 0.8 0.3 7.1 2.4 1.3 1.4 2.1 1.3 0.4 1.2 5.1 0.4 0.8 2.6 0.5 2.7 0.6 2.1 14.7 0.2 1.1 1.0 1.8 8.3 1.1 0.1 2.4 0.0 1.3 3.8 0.8 3.7 0.8 2.6 1.8 10.8 1.0 1.6 7.3 0.9 0.6 7.3 2.5 4.0 3.8 0.2 0.6 1.5 3.3 2.9 3.7 5.8 2.1 3.6 1.5 2.6 3.2 0.0 0.8 5.7 4.2 3.4 2.4 3.9 3.6 5.0 6.8 4.8 3.2 3.2 5.4 5.7 6.0 6.0 3.8 3.8 3.5 3.2 5.1 2.6 4.2 8.7 3.1 2.5 1.7 5.9 0.7 3.2 3.8 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell line enriched" "Detected in many" 4 "BEWO: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" HPA063386 Uncertain Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA063386: " "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.6 0.0 1.6 0.0 0.0 31.3 0.2 0.1 0.2 0.2 2.0 2.4 2.2 2.3 0.0 1.9 0.7 3.0 0.2 0.0 0.3 0.0 3.1 1.0 0.0 0.0 0.0 0.1 1.3 0.2 6.0 0.6 0.0 0.0 0.2 1.7 0.0 0.0 0.8 3.3 0.0 0.0 0.1 7.1 0.8 0.2 0.0 0.5 3.7 0.0 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.5 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605405-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA068079: " "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 12.1 7.5 8.3 11.0 10.5 11.1 8.2 12.3 15.1 8.0 10.0 9.7 6.6 11.0 11.5 6.8 6.2 8.7 7.0 12.2 7.3 5.8 8.3 6.7 8.7 13.3 7.4 8.5 10.3 11.2 9.9 9.5 6.1 7.4 9.9 4.8 8.1 12.1 7.7 56.2 11.1 10.4 7.4 7.3 16.0 12.2 4.7 7.9 14.0 9.5 8.0 9.1 9.3 9.9 1.2 0.5 1.4 0.1 0.1 0.6 0.1 6.3 5.2 2.3 3.7 2.5 1.9 6.2 4.6 2.6 2.5 2.4 1.7 4.2 7.5 5.4 3.3 5.3 1.4 2.8 1.0 7.3 17.4 4.2 3.2 2.2 3.9 4.8 8.4 2.9 4.4 3.0 1.8 1.7 8.1 5.1 1.6 3.0 7.6 5.2 5.2 9.2 11.9 3.6 4.6 2.9 4.4 5.4 8.8 6.3 3.9 3.8 3.1 7.6 5.0 3.8 9.2 3.5 5.7 10.7 9.3 3.9 4.7 3.8 6.1 0.0 0.0 1.4 0.3 0.1 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.6 0.8 0.1 0.1 0.5 0.0 0.1 8.3 10.5 12.3 15.1 7.3 5.8 7.4 8.5 7.4 7.9 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 6.4" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli Nucleoplasm Nucleoli "HPA052735: " "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 1.1 1.4 0.4 1.5 3.1 5.8 0.8 2.5 2.4 1.5 1.2 0.4 0.0 0.6 1.8 1.2 1.4 1.2 1.4 0.7 1.9 0.5 7.7 2.5 1.5 1.4 4.4 0.3 2.4 5.0 0.8 2.4 5.1 7.4 1.4 1.2 0.4 3.2 0.3 0.5 1.0 1.3 1.4 1.9 1.3 1.2 4.6 2.2 1.7 1.4 0.0 1.3 1.2 1.7 0.3 0.1 0.5 0.0 1.5 0.5 0.1 3.1 0.0 1.7 6.4 0.1 0.0 3.8 1.0 0.5 1.3 1.7 2.5 0.4 1.4 1.5 0.4 0.8 0.6 0.9 1.2 0.0 0.9 1.8 0.0 3.5 0.0 1.2 3.4 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.3 0.0 2.9 1.7 3.6 0.5 2.5 3.4 0.0 2.2 2.3 1.8 0.4 0.0 0.1 0.3 3.3 3.9 0.0 1.9 1.4 1.5 1.8 1.3 3.8 0.3 0.0 0.6 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.5 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.4 3.1 2.5 2.4 1.9 0.5 4.4 0.3 7.4 2.2 ZNF879 DKFZp686E2433 ENSG00000234284 "Zinc finger protein 879" B4DU55 5 179023752-179035064 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.3;BEWO: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068608 Uncertain Approved Nucleoplasm Nucleoplasm "HPA068608: " "unprognostic (3.20e-2)" "unprognostic (5.24e-3)" "unprognostic (7.33e-2)" "unprognostic (1.49e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-3)" "unprognostic (5.83e-2)" "unprognostic (8.80e-3)" "unprognostic (3.19e-3)" "unprognostic (6.04e-2)" "unprognostic (5.69e-4)" "unprognostic (1.07e-1)" "unprognostic (4.61e-2)" "unprognostic (2.10e-1)" "unprognostic (3.79e-1)" "unprognostic (4.72e-2)" "unprognostic (5.17e-3)" 5.9 4.0 5.5 5.3 7.2 1.9 6.6 13.5 8.0 6.1 5.8 6.3 4.9 2.9 7.3 5.5 5.0 6.2 4.0 6.3 7.4 4.7 5.9 3.6 4.7 7.2 7.0 5.7 10.2 4.9 8.4 7.6 6.7 6.1 7.7 3.0 4.4 5.2 8.1 7.9 8.2 5.2 5.6 6.9 7.1 4.6 14.5 10.7 12.1 9.1 2.5 7.9 6.2 5.0 5.4 4.4 13.1 4.9 6.0 9.1 3.7 0.0 4.1 3.7 11.3 3.5 2.7 12.3 2.0 2.9 4.9 6.1 3.8 2.0 3.0 2.9 1.9 1.7 0.0 2.3 3.9 0.0 0.3 0.0 2.5 0.7 5.8 0.0 5.7 2.7 2.2 2.7 1.4 1.7 0.6 0.0 4.0 2.0 3.4 1.2 4.1 1.0 3.1 1.3 0.4 3.6 3.3 1.6 3.7 3.9 0.6 5.3 5.5 3.4 1.5 2.3 4.2 2.6 0.5 0.0 0.0 4.6 0.0 0.0 3.0 13.1 4.9 4.7 6.3 4.1 6.5 5.2 5.8 5.3 4.4 5.4 9.1 7.1 0.1 6.0 3.9 2.8 6.7 3.7 5.5 7.2 13.5 8.0 7.4 4.7 7.0 5.7 6.1 10.7 ZNF891 ENSG00000214029 "Zinc finger protein 891" A8MT65 12 133106817-133130473 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040301 Uncertain Approved Nucleoplasm,Vesicles Nucleoplasm Vesicles "HPA040301: AB_10795380" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" "unprognostic (3.29e-1)" "unprognostic (3.72e-1)" "unprognostic (7.51e-3)" "unprognostic (5.98e-3)" "unprognostic (1.94e-2)" "unprognostic (7.90e-2)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (1.60e-2)" "unprognostic (6.09e-2)" "unprognostic (5.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (2.07e-3)" "unprognostic (6.68e-2)" 3.6 5.3 7.0 4.0 9.3 4.2 5.4 13.2 7.2 4.6 4.4 3.6 2.6 3.4 5.5 4.6 2.9 4.0 2.9 3.5 7.9 3.3 3.4 2.9 2.9 4.3 7.8 2.7 6.4 3.8 4.9 8.8 3.0 6.6 3.8 3.5 2.3 4.5 4.0 4.3 6.9 3.3 4.5 7.0 4.5 4.0 14.0 8.9 4.2 5.6 2.9 3.8 4.3 4.5 2.9 1.6 2.3 1.2 2.4 2.7 0.7 1.5 1.7 4.6 0.3 1.9 2.2 3.0 0.8 0.9 1.2 1.0 1.3 0.7 0.3 1.3 1.0 2.1 2.4 1.2 1.3 0.1 2.3 3.8 5.0 1.7 0.9 3.4 2.7 1.6 1.2 1.8 1.6 1.0 2.3 0.8 1.5 1.0 3.8 4.1 2.9 1.9 3.5 2.6 1.5 0.9 2.7 4.6 2.9 3.0 1.1 1.0 3.1 1.4 1.8 2.4 2.4 2.0 1.3 0.5 0.2 3.1 0.6 1.3 1.8 2.0 1.2 1.4 1.8 0.7 1.6 1.9 1.7 1.7 0.6 2.9 2.7 2.3 2.3 2.4 0.8 1.6 1.1 0.7 7.0 9.3 13.2 7.2 7.9 3.3 7.8 2.7 6.6 8.9 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.3;seminal vesicle: 36.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.7;HBF TERT88: 6.5;NTERA-2: 16.5;U-2197: 6.9" "Cancer enhanced" "Detected in many" "testis cancer: 10.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 1.5 1.0 1.1 3.6 2.5 1.6 1.8 6.9 1.1 3.0 1.7 1.2 20.3 0.5 3.3 2.7 2.1 2.8 1.0 1.4 0.8 0.6 1.7 0.7 2.4 3.0 2.1 0.3 4.7 3.4 12.7 1.4 3.8 1.7 4.1 2.1 3.2 1.2 36.4 1.2 2.8 2.3 3.3 1.6 2.3 2.7 1.6 2.2 4.1 10.3 0.7 2.9 4.9 2.9 0.5 0.4 1.8 0.2 0.3 0.9 0.2 0.0 0.0 3.9 9.7 0.0 0.0 0.0 1.0 0.4 3.8 4.5 3.3 2.3 1.4 1.8 0.7 1.0 0.0 0.6 6.5 0.0 0.9 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 3.6 0.0 0.0 0.3 0.0 0.0 0.1 2.0 5.5 16.5 0.0 0.0 3.5 0.2 2.0 3.4 0.0 3.5 0.0 1.2 0.2 1.9 0.0 0.0 1.0 0.0 6.9 3.8 0.0 1.5 0.0 0.0 0.0 1.5 0.8 0.2 0.3 0.1 0.0 0.9 0.2 0.2 0.4 0.4 0.5 0.3 0.1 1.8 0.3 0.0 0.2 0.7 0.2 1.1 2.5 6.9 1.1 0.8 0.6 2.1 0.3 1.7 2.2 ZNF92 "HPF12, TF12" ENSG00000146757 "Zinc finger protein 92" Q03936 7 65373799-65401135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003173 Approved Nucleoplasm Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "unprognostic (8.53e-2)" "unprognostic (1.97e-1)" "prognostic unfavourable (6.56e-4)" "unprognostic (5.48e-3)" "unprognostic (1.30e-2)" "unprognostic (3.86e-2)" "unprognostic (5.83e-2)" "unprognostic (1.40e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-3)" 6.7 9.3 9.6 13.7 13.0 20.8 16.3 24.4 11.9 8.3 6.2 5.0 6.1 6.1 5.7 7.2 11.2 5.4 6.3 4.6 9.6 8.9 7.9 5.6 5.7 14.8 12.1 8.6 8.8 6.9 7.7 13.4 5.7 12.6 6.6 7.0 2.5 6.9 6.6 4.7 4.9 10.1 3.9 18.5 14.8 7.6 7.6 15.7 26.0 9.4 5.1 14.0 8.3 5.7 10.7 2.3 5.6 2.7 9.4 6.0 2.2 4.4 3.0 13.5 13.4 3.5 4.2 6.4 3.7 2.8 4.1 6.0 5.6 6.7 17.5 7.3 2.1 4.5 10.5 2.5 6.8 6.5 7.0 7.8 1.6 5.5 1.2 9.4 7.5 3.5 2.2 3.8 2.9 5.1 10.1 7.2 5.9 1.3 13.8 10.7 18.2 4.2 12.6 7.9 5.9 4.5 9.1 11.5 8.8 5.7 9.0 4.2 6.4 12.9 3.7 4.8 4.4 2.9 5.3 4.6 4.0 25.4 3.2 7.6 4.3 5.6 1.6 4.0 2.7 2.1 5.7 10.7 4.2 4.1 2.3 9.2 5.1 5.2 1.3 9.4 2.7 2.2 6.0 2.2 9.6 13.0 24.4 11.9 9.6 8.9 12.1 8.6 12.6 15.7 ZNHIT1 "CG1I, H_DJ0747G18.14, ZNFN4A1" ENSG00000106400 "Zinc finger HIT-type containing 1" O43257 7 101217668-101224190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019043 Uncertain Approved Nucleoplasm Nucleoplasm "HPA019043: AB_1859481" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.52e-3)" "unprognostic (1.24e-1)" "unprognostic (4.26e-2)" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (3.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-2)" "unprognostic (1.05e-2)" "unprognostic (2.02e-2)" "unprognostic (2.10e-3)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (3.36e-1)" "unprognostic (7.24e-3)" 24.6 21.0 29.4 18.7 26.9 18.3 23.6 11.7 20.8 21.1 24.5 16.6 29.4 24.5 15.0 29.4 21.1 23.2 29.8 26.9 24.7 19.4 27.7 77.2 14.1 18.5 27.9 17.2 13.2 34.7 17.2 17.3 19.9 18.7 17.4 16.2 12.0 29.3 29.9 32.7 16.2 23.4 15.0 28.0 18.4 22.7 13.1 17.6 21.0 27.3 24.0 14.1 14.7 20.9 27.9 42.8 45.5 47.1 22.4 39.7 45.9 13.8 14.3 9.4 18.1 17.5 22.5 9.2 17.2 16.9 16.9 16.8 14.2 16.1 9.9 23.0 18.7 11.8 8.5 23.8 7.3 10.3 33.0 5.4 12.5 17.0 22.3 11.0 11.7 21.0 29.0 14.9 7.3 24.6 17.0 16.5 14.3 41.3 18.1 59.7 18.0 36.1 9.6 7.4 30.5 22.6 6.6 11.6 26.4 12.9 23.5 28.3 6.0 13.5 18.7 15.8 13.9 27.4 12.1 13.4 16.8 11.9 15.3 19.4 21.2 42.0 47.1 45.5 27.4 42.5 28.9 27.4 30.5 27.5 40.6 27.9 24.7 26.5 39.1 22.4 40.8 42.8 39.7 45.9 29.4 26.9 11.7 20.8 24.7 19.4 27.9 17.2 18.7 17.6 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.2" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" Nucleoplasm "HPA077519: " "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.2 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 ZSCAN16 "dJ265C24.3, FLJ22191, ZNF392, ZNF435" ENSG00000196812 "Zinc finger and SCAN domain containing 16" Q9H4T2 6 28124560-28130082 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007290 Supported Approved Nucleoplasm Nucleoplasm "HPA007290: AB_1080721" "unprognostic (1.50e-1)" "prognostic favourable (5.73e-4)" "unprognostic (3.29e-2)" "unprognostic (8.93e-2)" "unprognostic (3.05e-3)" "unprognostic (1.00e-2)" "unprognostic (3.07e-2)" "prognostic favourable (3.19e-4)" "unprognostic (1.23e-2)" "prognostic favourable (1.14e-5)" "unprognostic (2.50e-1)" "unprognostic (1.98e-1)" "unprognostic (2.50e-1)" "unprognostic (1.55e-2)" "unprognostic (2.14e-1)" "unprognostic (3.37e-3)" "prognostic favourable (3.41e-5)" 5.3 6.7 7.6 7.8 8.9 3.5 9.3 26.4 7.7 5.4 9.0 5.5 12.7 11.0 6.0 9.6 6.1 5.4 6.3 3.7 6.9 5.4 9.5 6.9 6.2 11.3 8.0 5.9 4.6 8.3 11.2 11.9 2.8 7.8 7.5 12.0 4.3 10.4 9.9 5.1 8.8 13.0 6.2 10.1 13.4 9.1 3.2 9.3 11.7 7.5 4.2 11.2 7.2 5.4 10.0 11.0 30.5 6.3 9.9 10.7 4.8 0.0 7.1 9.2 6.7 2.6 0.6 7.5 2.4 5.3 6.5 7.1 4.9 4.6 7.0 6.7 2.2 5.5 6.3 3.5 6.1 10.1 8.8 7.3 5.7 6.9 4.1 5.3 6.2 0.8 6.0 5.4 3.0 11.9 1.0 6.0 1.7 7.8 0.0 8.5 1.9 4.3 8.7 7.0 9.6 7.6 10.1 12.5 13.7 1.2 7.6 8.5 10.0 2.6 3.7 2.4 5.6 3.6 6.3 3.1 9.6 1.9 1.1 2.7 1.3 30.5 4.9 5.4 8.1 6.3 10.7 10.0 7.2 6.2 5.0 8.1 8.8 7.1 8.9 9.9 6.1 11.0 7.7 4.8 7.6 8.9 26.4 7.7 6.9 5.4 8.0 5.9 7.8 9.3 ZSCAN18 "FLJ12895, ZNF447" ENSG00000121413 "Zinc finger and SCAN domain containing 18" Q8TBC5 19 58083838-58118427 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 48.6;SCLC-21H: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA024318 Supported Approved Nucleoplasm Nucleoplasm "HPA024318: AB_1859494" "unprognostic (1.85e-2)" "unprognostic (3.48e-2)" "unprognostic (7.07e-2)" "unprognostic (6.45e-3)" "unprognostic (1.28e-1)" "unprognostic (1.22e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (2.24e-1)" "unprognostic (8.27e-2)" "unprognostic (2.59e-3)" "unprognostic (1.59e-1)" "prognostic favourable (3.95e-7)" "unprognostic (3.68e-2)" "unprognostic (7.23e-2)" "unprognostic (3.70e-1)" "unprognostic (9.04e-2)" 18.1 18.1 26.7 10.4 34.3 5.3 11.8 27.9 47.7 20.5 17.1 20.8 16.0 8.7 26.2 20.3 13.4 33.9 18.6 28.9 27.0 33.7 19.3 7.3 15.0 12.2 23.7 31.1 31.8 16.8 23.7 28.0 15.1 21.1 21.1 6.0 17.7 18.2 27.5 15.9 9.9 10.0 29.0 20.7 17.0 12.9 20.0 18.3 7.4 28.9 8.7 6.1 15.9 14.6 4.6 2.3 3.9 0.8 2.2 2.4 0.7 0.0 0.4 5.1 13.1 0.6 0.8 12.6 3.3 0.1 4.2 0.7 0.0 3.1 1.2 7.5 4.5 0.0 0.4 2.5 4.5 0.0 48.6 0.0 0.0 0.0 9.0 0.0 9.8 7.8 0.1 3.2 0.0 0.2 0.0 0.6 6.4 0.0 6.7 2.5 8.3 0.0 8.0 0.0 0.6 4.1 10.0 23.3 5.6 0.0 0.2 0.0 15.2 0.0 0.0 0.2 6.0 5.7 0.0 5.8 16.7 0.0 0.0 0.0 3.9 2.0 0.5 3.5 0.4 0.3 2.1 1.7 1.7 1.8 0.9 4.6 2.4 2.2 3.9 2.2 0.8 2.3 0.1 0.7 26.7 34.3 27.9 31.4 27.0 33.7 23.7 31.1 21.1 18.3 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favourable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favourable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favourable (4.16e-5)" 9.8 7.6 5.2 7.2 7.4 9.7 15.0 5.9 6.3 7.3 6.2 5.8 9.0 4.1 9.5 8.4 3.4 5.3 8.2 8.2 4.8 4.7 9.1 10.1 4.5 8.0 6.2 5.0 10.2 36.9 6.9 6.3 2.8 5.1 7.1 4.3 6.7 12.4 5.1 9.5 3.4 5.5 9.0 5.1 8.1 8.5 12.0 6.0 24.4 6.3 3.9 6.9 6.5 9.7 7.1 10.5 10.0 12.2 9.0 12.1 6.4 1.7 9.8 7.7 12.7 4.5 3.0 6.7 1.9 5.3 4.1 5.5 7.5 4.0 3.6 5.4 3.0 4.3 6.5 3.7 3.6 7.4 10.0 4.6 5.7 15.8 3.9 2.9 3.7 4.5 4.5 5.2 5.0 12.1 6.1 2.9 4.9 4.8 13.4 6.8 14.1 5.8 14.0 4.4 6.8 4.3 12.5 10.8 19.1 5.9 3.3 9.1 6.8 8.2 7.9 5.0 9.6 2.4 2.4 5.0 6.6 12.1 3.3 6.8 3.1 10.0 9.6 8.3 10.9 10.5 5.4 7.1 9.2 8.2 10.5 7.1 7.6 8.2 5.4 9.0 12.2 10.2 12.1 6.4 5.2 7.4 5.9 6.3 4.8 4.7 6.2 5.0 5.1 6.0 ZSCAN20 "KOX29, ZNF31, ZNF360" ENSG00000121903 "Zinc finger and SCAN domain containing 20" P17040 1 33472645-33496507 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017933 Uncertain Approved Nucleoplasm Nucleoplasm "HPA017933: AB_1859028" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-3)" "unprognostic (9.28e-2)" "unprognostic (3.03e-3)" "unprognostic (1.77e-6)" "unprognostic (3.13e-1)" "unprognostic (6.94e-2)" "unprognostic (4.05e-2)" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (2.92e-2)" "unprognostic (4.43e-2)" "unprognostic (1.74e-2)" 3.8 4.2 4.7 2.5 7.1 1.0 4.4 6.1 8.2 4.4 4.1 7.7 4.5 8.4 7.4 3.2 3.6 4.4 3.6 6.1 4.3 2.9 3.9 3.0 3.2 2.1 4.3 5.7 7.8 4.0 11.2 8.6 4.0 5.7 4.2 4.4 5.1 5.0 5.5 3.4 2.9 6.6 5.9 4.2 3.1 4.3 6.1 7.6 3.9 4.4 2.7 3.2 4.9 8.5 0.8 1.7 0.7 2.2 1.0 3.0 0.6 3.8 2.8 6.6 4.6 5.3 5.4 4.4 4.8 4.8 6.4 5.2 2.9 4.9 2.8 2.6 5.0 4.8 5.5 2.5 6.7 0.0 6.2 5.8 6.3 2.5 5.1 3.2 2.1 3.8 4.6 6.8 5.6 5.0 3.8 3.6 5.7 1.3 2.5 2.0 5.5 1.6 2.8 7.7 1.1 3.5 3.3 2.6 3.8 3.6 4.0 5.1 2.7 3.6 4.5 5.6 4.0 5.1 6.7 4.9 3.1 1.3 5.9 1.0 3.7 0.2 2.2 0.0 1.3 1.0 2.1 0.3 0.4 0.9 1.7 0.8 1.9 3.0 0.7 1.0 1.0 1.2 0.8 0.6 4.7 7.1 6.1 8.2 4.3 2.9 4.3 5.7 5.7 7.6 ZSCAN25 "FLJ32468, ZNF498" ENSG00000197037 "Zinc finger and SCAN domain containing 25" Q6NSZ9 7 99616946-99632407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055127, HPA057173" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" "Nucleoli fibrillar center" Nucleoplasm "HPA055127: , HPA057173: " "unprognostic (2.21e-3)" "unprognostic (3.96e-2)" "unprognostic (4.45e-1)" "unprognostic (3.92e-2)" "unprognostic (5.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (1.57e-3)" "unprognostic (3.97e-2)" "unprognostic (8.44e-2)" "unprognostic (3.82e-3)" "unprognostic (9.98e-2)" "unprognostic (1.10e-2)" "unprognostic (5.21e-2)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (7.19e-3)" 10.8 10.0 11.4 12.2 12.5 12.3 14.5 18.5 14.6 11.3 11.0 13.1 16.9 7.4 14.5 11.7 12.7 12.4 9.6 7.7 9.4 6.9 9.4 9.1 10.0 16.4 10.3 12.2 18.5 12.3 15.0 12.3 9.4 9.2 12.7 8.6 10.3 15.4 13.9 9.7 15.6 10.8 12.6 8.7 13.6 10.3 15.7 11.0 14.9 11.2 8.7 11.8 11.7 11.4 3.3 3.0 5.5 4.2 4.2 9.0 4.7 5.7 2.7 7.9 9.0 3.5 2.7 7.8 6.4 5.4 7.3 7.6 7.1 4.8 8.1 7.4 5.2 7.5 8.5 7.3 9.2 4.5 7.2 5.4 4.5 6.1 6.0 12.4 4.9 4.2 9.3 5.8 6.2 4.6 15.1 6.6 5.1 6.3 17.9 17.3 14.5 6.2 7.5 8.1 8.6 3.1 7.8 5.4 13.3 8.4 12.7 9.0 3.5 8.6 3.3 11.5 9.2 6.6 10.6 5.9 9.3 13.9 6.1 7.8 16.8 5.5 3.8 4.8 7.4 4.2 9.0 3.3 5.1 6.9 3.0 2.9 8.7 8.4 4.6 4.2 3.7 2.4 7.2 4.7 11.4 12.5 18.5 14.6 9.4 6.9 10.3 12.2 9.2 11.0 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 8.3 8.9 13.5 14.2 14.2 6.6 9.4 15.9 15.2 11.0 9.8 12.1 9.3 11.8 12.6 12.5 11.0 9.6 11.9 7.2 14.7 8.0 8.1 10.3 9.2 13.2 19.1 12.0 10.7 15.4 12.5 13.9 13.0 15.4 9.7 10.5 7.9 11.2 9.5 13.6 7.7 13.0 9.0 13.3 11.9 11.8 20.9 15.0 16.8 11.1 9.4 13.7 11.0 12.5 2.1 1.0 6.9 1.0 2.3 1.9 0.6 7.4 8.2 19.4 11.9 6.8 7.2 10.5 5.9 9.2 10.5 11.0 12.7 5.4 7.3 9.9 7.2 22.2 14.2 7.2 9.5 19.0 7.8 16.2 12.3 9.9 7.6 11.0 14.2 6.3 12.8 7.1 10.1 5.3 15.0 9.0 8.4 4.7 10.5 9.1 9.7 6.3 16.5 10.8 9.0 6.1 9.1 13.9 15.0 9.1 15.0 6.9 10.5 17.2 5.9 12.4 9.8 9.3 10.6 17.4 23.9 14.2 7.2 10.9 9.3 1.1 0.7 6.9 1.2 1.0 1.0 2.1 1.2 0.8 1.0 1.6 0.6 1.7 1.8 2.3 0.8 0.9 1.9 0.6 13.5 14.2 15.9 15.2 14.7 8.0 19.1 12.0 15.4 15.0 ZSCAN30 "ZNF397OS, ZNF917" ENSG00000186814 "Zinc finger and SCAN domain containing 30" Q86W11 18 35251058-35290245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007289 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007289: AB_1079726" "unprognostic (6.02e-3)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (8.94e-2)" "unprognostic (3.56e-3)" "unprognostic (7.02e-3)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (3.05e-3)" "unprognostic (2.78e-3)" "unprognostic (8.27e-3)" "unprognostic (1.15e-1)" "unprognostic (8.44e-3)" "unprognostic (8.75e-2)" "unprognostic (1.36e-1)" 9.4 14.4 11.8 9.2 19.1 7.9 12.2 23.0 19.9 9.4 8.9 20.9 9.8 10.1 14.2 13.9 6.7 10.3 10.4 16.4 12.2 10.6 12.1 8.7 10.3 12.4 11.8 12.8 10.7 9.7 19.8 27.3 9.6 14.7 11.1 8.4 12.8 9.2 9.4 15.4 11.7 12.8 9.4 15.0 12.1 10.0 10.5 15.0 13.0 15.2 6.8 9.4 8.6 8.2 7.7 5.4 4.8 1.9 4.0 5.6 2.5 4.4 1.2 10.1 13.3 6.8 13.5 6.9 8.6 11.6 5.0 9.9 3.6 5.5 8.0 5.7 9.1 3.1 4.7 9.0 13.7 8.1 2.7 5.2 5.7 2.5 7.1 4.4 5.2 8.7 7.1 13.5 11.5 9.2 8.4 9.6 13.1 2.0 6.4 7.4 6.5 4.2 9.5 3.4 5.8 7.6 3.0 14.2 7.4 8.5 2.7 3.6 4.2 5.9 11.4 18.1 3.9 2.8 3.4 17.1 7.3 7.1 13.7 4.9 10.2 2.4 1.3 4.4 4.6 1.6 3.0 5.3 4.2 2.7 2.2 7.7 5.0 5.6 4.8 4.0 1.9 5.4 3.7 2.5 11.8 19.1 23.0 19.9 12.2 10.6 11.8 12.8 14.7 15.0 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 21.3;TIME: 16.0;U-2 OS: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 13.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.4" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favourable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.2 4.0 11.3 2.2 12.1 3.5 11.2 36.4 27.6 8.0 9.9 3.6 5.9 3.2 16.3 8.4 9.9 6.8 15.5 6.4 8.0 3.8 5.2 4.5 8.7 1.9 16.7 5.6 17.7 8.1 4.8 8.3 2.3 14.9 7.1 5.1 3.5 6.5 8.3 7.0 11.0 3.5 10.7 21.9 2.1 13.3 18.4 11.8 0.6 21.0 5.6 3.1 7.3 6.9 1.5 2.0 13.4 0.3 1.4 1.5 0.3 1.0 1.4 2.2 10.1 0.3 0.5 3.2 0.4 0.6 0.5 0.4 1.2 15.3 0.2 21.3 0.7 3.2 1.1 0.9 0.3 1.8 0.9 3.5 7.9 2.3 0.9 7.1 4.4 0.3 8.5 0.6 0.9 14.6 3.8 2.7 2.2 1.4 1.2 1.7 0.7 6.3 3.1 2.0 1.8 1.5 1.2 7.1 2.0 13.6 8.8 2.0 4.4 2.4 16.0 3.3 26.0 0.7 1.1 1.1 1.6 0.2 0.4 3.4 0.7 13.4 0.3 0.6 1.5 0.2 1.3 1.5 1.2 1.2 0.3 1.3 1.0 1.5 0.3 1.4 0.3 2.0 0.2 0.3 11.3 12.1 36.4 27.6 8.0 3.8 16.7 5.6 14.9 11.8 ZSCAN32 "FLJ20417, ZNF434" ENSG00000140987 "Zinc finger and SCAN domain containing 32" Q9NX65 16 3382081-3401065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA005758 Uncertain Approved Nucleoplasm Nucleoplasm "HPA005758: AB_1080720" "unprognostic (5.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-2)" "unprognostic (6.04e-2)" "unprognostic (2.84e-2)" "unprognostic (2.38e-3)" "unprognostic (7.72e-2)" "unprognostic (9.40e-2)" "unprognostic (2.19e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-3)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (1.18e-3)" "unprognostic (9.71e-2)" 7.4 10.0 12.0 11.1 19.7 4.7 9.2 12.0 11.9 9.5 9.0 12.5 5.5 11.6 10.8 7.2 7.5 10.6 9.9 8.0 11.5 10.3 9.3 8.3 9.2 11.2 19.3 7.3 12.4 9.8 14.3 13.2 8.0 14.1 9.5 9.0 8.3 7.2 11.7 5.6 8.3 12.4 9.1 14.1 10.1 8.7 11.1 16.1 13.9 10.9 5.9 13.7 8.9 7.0 8.2 5.1 6.9 12.2 16.3 10.4 6.0 4.8 7.5 10.9 13.0 8.7 8.8 7.8 6.2 10.8 8.8 8.3 3.6 6.8 15.7 6.5 8.7 4.3 8.7 8.9 10.0 10.0 6.3 14.1 6.5 5.5 11.2 9.4 10.2 8.6 14.7 8.1 14.8 8.1 13.2 5.7 11.5 5.4 12.4 6.4 11.3 4.3 13.2 11.8 13.5 7.6 5.2 8.8 6.8 11.6 7.7 5.1 8.3 11.3 10.7 6.5 6.9 5.8 7.1 10.1 11.4 19.4 2.4 7.6 10.7 4.9 4.9 6.9 10.4 4.3 8.8 8.2 7.2 6.6 4.6 7.4 9.8 8.8 6.0 16.3 12.2 5.1 9.4 6.0 12.0 19.7 12.0 11.9 11.5 10.3 19.3 7.3 14.1 16.1 ZSCAN9 "PRD51, ZNF193" ENSG00000137185 "Zinc finger and SCAN domain containing 9" O15535 6 28224886-28233482 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054512, HPA059951" Uncertain Approved Nucleoplasm Nucleoplasm "HPA054512: , HPA059951: " "unprognostic (1.67e-1)" "unprognostic (5.32e-2)" "unprognostic (2.68e-1)" "unprognostic (2.04e-1)" "unprognostic (1.32e-2)" "unprognostic (5.24e-3)" "prognostic unfavourable (3.49e-4)" "unprognostic (5.69e-2)" "unprognostic (4.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.55e-2)" "unprognostic (6.14e-3)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.74e-2)" "unprognostic (1.51e-2)" "unprognostic (2.51e-1)" "prognostic favourable (1.16e-5)" 12.2 11.0 7.9 12.7 11.9 10.1 16.1 21.2 13.1 17.2 12.7 14.8 13.0 10.2 22.7 15.9 10.4 11.4 14.2 10.2 8.2 9.6 13.0 9.3 10.6 10.5 10.2 7.1 16.0 12.5 13.6 22.4 12.6 11.2 15.8 17.4 12.9 12.3 14.6 8.9 6.9 14.5 17.9 11.9 16.8 11.7 20.1 13.5 4.1 14.5 7.4 11.1 12.2 16.7 5.7 5.6 5.6 4.0 13.0 4.4 2.6 6.9 4.6 16.3 19.3 6.4 6.9 6.0 8.4 7.1 8.1 9.3 4.3 3.5 0.0 12.8 5.4 4.8 7.9 7.7 9.5 4.5 6.7 10.6 9.3 8.0 8.1 12.3 8.7 5.8 12.2 6.9 10.7 10.5 15.6 5.8 12.0 4.0 0.0 20.3 6.0 5.4 6.4 11.4 7.1 10.3 9.7 14.2 19.5 7.4 5.7 10.1 6.9 8.5 8.8 17.0 11.7 3.9 14.5 13.2 13.3 2.8 3.5 15.3 9.6 4.8 4.0 5.6 4.4 2.0 3.4 5.7 1.5 3.2 5.6 5.2 0.5 0.9 1.6 13.0 0.9 2.9 1.1 2.6 7.9 11.9 21.2 13.1 8.2 9.6 10.2 7.1 11.2 13.5 ZSWIM9 "C19orf68, LOC374920" ENSG00000185453 "Zinc finger SWIM-type containing 9" Q86XI8 19 48170692-48197620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061028 Uncertain Approved Nucleoplasm Nucleoplasm "HPA061028: " "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (5.79e-3)" "unprognostic (1.65e-1)" "unprognostic (8.49e-3)" "unprognostic (1.65e-2)" "prognostic unfavourable (2.35e-5)" "unprognostic (1.26e-1)" "unprognostic (2.93e-1)" "unprognostic (6.96e-2)" "unprognostic (3.19e-3)" "unprognostic (2.20e-2)" "prognostic favourable (2.44e-4)" "unprognostic (3.59e-1)" "unprognostic (2.64e-1)" "unprognostic (7.07e-2)" "unprognostic (1.03e-1)" 6.8 3.9 11.6 4.2 15.5 4.3 9.8 5.7 10.0 6.0 4.4 8.1 4.5 4.6 9.6 2.0 6.5 4.2 5.5 5.1 10.1 10.2 4.5 3.3 3.8 4.7 9.9 4.8 8.1 5.0 6.2 2.8 3.6 6.6 4.7 2.8 3.9 5.9 5.6 16.2 5.3 5.0 11.1 7.6 5.4 4.2 3.2 6.0 1.2 5.2 1.5 4.2 6.1 8.6 1.2 0.4 0.5 0.4 0.2 1.6 0.1 9.2 10.4 6.2 4.6 4.0 2.3 5.6 7.2 3.8 3.3 3.9 1.7 3.0 7.4 3.4 3.3 7.7 2.0 4.4 3.7 11.2 7.7 4.7 6.6 4.2 4.4 4.2 4.0 2.4 3.5 4.9 5.9 3.4 1.1 4.1 2.1 4.9 4.6 17.9 3.9 6.6 8.6 5.5 2.0 2.3 7.6 4.3 5.3 10.0 3.2 4.7 4.3 6.5 8.5 4.0 7.3 3.3 7.7 6.7 6.7 4.6 2.3 6.1 5.1 0.1 0.4 0.1 0.9 0.4 0.2 1.2 0.4 1.6 0.3 0.4 1.0 0.6 0.5 0.2 0.4 0.4 0.0 0.1 11.6 15.5 5.7 9.6 10.1 10.2 9.9 4.8 6.6 6.0 ZUFSP "C6orf113, dJ412I7.3" ENSG00000153975 "Zinc finger with UFM1 specific peptidase domain" Q96AP4 6 116635618-116668794 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044426 Uncertain Approved Nucleoplasm,Cytosol Nucleoplasm Cytosol "HPA044426: AB_10960887" "unprognostic (2.28e-3)" "unprognostic (2.45e-3)" "unprognostic (3.91e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (3.27e-1)" "unprognostic (5.88e-2)" "unprognostic (2.83e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (1.90e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (7.33e-2)" "unprognostic (7.92e-3)" 8.0 8.4 8.8 9.7 14.1 19.0 9.7 18.8 14.4 7.2 10.3 7.3 5.1 16.5 7.3 7.3 11.0 6.7 9.0 5.4 10.5 8.7 9.3 11.9 10.2 12.8 14.3 8.0 5.6 9.7 6.0 18.1 8.5 11.3 8.6 9.8 5.2 8.2 7.3 6.2 10.3 13.5 6.8 10.5 12.3 8.4 9.5 11.5 15.4 7.6 7.5 13.9 8.9 8.2 11.1 11.1 17.3 11.5 9.2 12.6 7.1 4.4 4.4 10.4 18.7 6.0 8.0 7.5 10.0 9.5 10.0 11.9 7.4 5.2 16.2 8.3 6.2 7.5 11.7 6.9 13.4 9.5 12.1 12.3 6.3 13.5 9.3 14.6 15.2 7.0 11.7 7.8 13.9 8.7 22.0 8.5 13.0 7.0 7.3 11.2 7.4 4.8 9.7 8.7 6.8 10.9 4.7 8.7 9.8 6.9 6.1 6.1 3.7 11.4 6.9 6.3 4.3 3.6 8.7 7.7 9.9 16.4 5.7 8.9 9.2 17.3 8.5 8.4 8.4 9.9 9.7 11.1 9.3 9.5 11.1 10.3 10.7 7.8 3.3 9.2 11.5 7.9 12.6 7.1 8.8 14.1 18.8 14.4 10.5 8.7 14.3 8.0 11.3 11.5 ZXDA ZNF896 ENSG00000198205 "Zinc finger, X-linked, duplicated A" P98168 X 57906708-57910820 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA043789 Approved Approved Nucleoplasm Nucleoplasm "HPA043789: " "unprognostic (1.53e-1)" "unprognostic (3.71e-1)" "unprognostic (1.01e-1)" "unprognostic (3.61e-3)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-1)" "unprognostic (4.22e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.85e-3)" "unprognostic (6.50e-2)" "prognostic favourable (8.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.94e-1)" "unprognostic (1.15e-1)" "unprognostic (3.27e-2)" 3.5 2.5 1.9 1.4 2.4 3.1 3.5 2.8 2.9 3.3 2.2 1.1 3.6 2.1 1.5 4.3 2.1 2.4 1.9 2.2 2.3 1.6 2.0 3.1 1.6 6.3 3.3 3.7 2.4 0.7 3.3 1.4 2.6 2.9 3.4 2.9 2.4 2.6 1.9 3.5 2.8 0.5 3.6 2.8 2.9 2.4 0.9 0.4 0.0 0.2 1.7 2.3 0.2 2.8 2.5 0.8 3.0 3.0 4.5 2.0 1.6 3.0 2.2 2.5 0.5 2.2 6.2 4.2 4.2 2.6 3.0 3.9 1.9 5.0 4.6 0.8 2.3 0.0 5.1 0.0 0.3 3.6 6.7 3.2 6.5 3.6 0.9 0.2 4.1 2.1 3.1 1.1 3.3 2.3 3.2 2.3 1.9 1.7 2.4 0.4 2.8 3.6 2.4 2.4 3.5 2.2 3.0 3.7 8.2 1.1 1.8 0.0 0.0 3.3 2.5 2.6 2.2 0.0 0.2 0.0 2.3 0.2 0.8 0.2 0.6 1.0 0.2 0.9 1.5 0.2 0.0 1.7 0.2 0.4 1.3 0.2 ZXDB ZNF905 ENSG00000198455 "Zinc finger, X-linked, duplicated B" P98169 X 57591652-57597545 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 24.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA043789 Approved Approved Nucleoplasm Nucleoplasm "HPA043789: " "unprognostic (1.87e-1)" "unprognostic (3.22e-1)" "unprognostic (1.88e-1)" "unprognostic (8.61e-3)" "unprognostic (4.29e-2)" "unprognostic (2.80e-1)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (4.36e-1)" "unprognostic (9.04e-2)" "unprognostic (6.73e-2)" "unprognostic (2.16e-2)" "unprognostic (1.17e-3)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (4.02e-3)" "unprognostic (2.87e-3)" 2.6 2.1 2.4 1.9 3.0 5.1 3.4 6.3 3.4 3.5 2.5 1.6 4.0 2.0 2.1 4.1 2.8 2.3 2.4 3.2 2.4 11.2 2.3 2.9 2.3 4.5 4.3 5.3 1.9 1.4 3.6 2.5 2.8 3.1 3.6 3.9 2.9 4.2 2.4 2.9 3.2 0.5 3.8 2.9 4.1 2.3 1.3 1.3 0.0 0.6 0.5 2.4 0.3 3.6 4.4 2.8 3.8 4.9 4.8 3.9 2.6 3.3 2.1 2.3 1.8 2.7 3.2 3.9 4.7 4.2 8.1 13.9 4.2 7.8 4.4 1.7 5.7 4.9 6.3 2.9 2.0 4.2 24.2 5.5 15.0 6.5 1.9 3.4 5.8 2.6 2.6 2.4 11.4 5.5 3.3 10.4 1.8 2.9 5.8 2.4 4.5 5.3 3.9 4.0 4.0 3.3 5.6 4.7 9.3 4.0 2.6 0.0 1.4 4.4 3.3 2.6 2.1 0.0 0.3 0.0 1.5 0.5 1.3 1.3 1.1 2.4 0.4 1.2 2.1 1.1 0.0 0.5 0.6 1.3 0.9 0.3 ZYG11A ZYG11 ENSG00000203995 "Zyg-11 family member A, cell cycle regulator" Q6WRX3 1 52842511-52894998 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.2;thyroid gland: 8.1" "Cell line enhanced" "Detected in many" "HeLa: 10.5;hTEC/SVTERT24-B: 10.1;K-562: 9.7;SiHa: 10.2" "Cancer enriched" "Detected in many" 7 "testis cancer: 11.1" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030378, HPA030379" Uncertain Approved Nucleoplasm Nucleoplasm "HPA030378: AB_10604159, HPA030379: " "unprognostic (7.94e-2)" "unprognostic (6.71e-3)" "unprognostic (1.04e-2)" "unprognostic (4.06e-3)" "unprognostic (1.59e-2)" "unprognostic (1.00e-4)" "unprognostic (1.87e-1)" "unprognostic (2.34e-1)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "unprognostic (4.01e-2)" "unprognostic (1.01e-1)" "unprognostic (6.15e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" 0.3 0.1 0.2 3.0 0.2 0.4 1.4 0.7 0.1 0.6 0.2 0.1 0.8 0.4 0.1 3.0 1.7 0.1 0.4 0.9 0.1 0.3 6.4 3.1 0.1 1.0 0.1 0.0 0.6 0.3 0.6 0.5 1.0 2.2 1.7 0.2 1.0 0.5 0.0 0.3 0.6 0.3 0.5 1.3 0.3 0.1 21.2 0.0 0.9 8.1 1.3 5.6 0.5 1.1 1.0 0.8 3.1 0.6 0.9 0.7 0.2 0.0 1.9 0.3 0.0 0.0 0.0 4.4 1.2 1.3 5.6 4.6 0.1 0.1 0.0 2.9 1.7 0.1 3.8 0.1 6.7 0.3 7.2 0.0 10.5 0.0 2.7 0.0 0.8 0.0 0.3 10.1 0.1 1.3 9.7 5.4 0.2 5.2 0.0 5.2 1.4 0.9 0.0 1.2 4.6 3.5 0.2 1.4 2.2 10.2 0.5 0.0 5.7 2.9 0.1 0.0 0.1 0.0 0.0 2.7 4.5 0.1 0.0 0.1 0.8 1.8 0.6 0.8 0.5 0.3 0.3 0.7 0.5 0.5 0.1 1.0 0.6 0.7 3.1 0.9 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.1 0.1 0.3 0.1 0.0 2.2 0.0 ZZEF1 "FLJ10821, KIAA0399, ZZZ4" ENSG00000074755 "Zinc finger ZZ-type and EF-hand domain containing 1" O43149 17 4004445-4143020 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031778, HPA031790" Uncertain Approved Nucleoplasm,Mitochondria Nucleoplasm Mitochondria "HPA031778: AB_10599831, HPA031790: AB_10600999" "unprognostic (4.48e-2)" "unprognostic (7.59e-2)" "unprognostic (6.75e-2)" "unprognostic (2.39e-2)" "unprognostic (1.43e-1)" "prognostic favourable (1.02e-4)" "unprognostic (2.80e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (2.21e-2)" "prognostic favourable (6.08e-4)" "unprognostic (1.54e-1)" "unprognostic (1.38e-3)" "unprognostic (6.09e-3)" "unprognostic (1.80e-1)" "unprognostic (9.43e-2)" "unprognostic (6.46e-2)" 11.3 11.7 8.0 13.5 10.2 21.1 10.5 14.4 14.3 11.3 23.8 17.5 9.2 17.7 11.6 11.0 12.8 9.9 11.1 10.7 7.7 7.7 8.8 9.6 12.1 15.6 8.3 8.4 12.0 15.3 18.0 12.6 13.1 11.3 11.4 17.3 17.6 10.1 11.8 37.7 13.9 42.4 10.9 7.5 16.1 12.8 8.1 9.7 22.5 12.1 6.5 14.2 12.4 9.8 1.5 1.8 3.8 3.4 1.1 4.2 1.5 10.3 16.2 5.9 8.0 14.8 8.4 7.0 9.0 11.5 10.6 10.3 8.0 3.6 9.9 6.1 12.1 11.9 11.8 6.2 10.8 11.5 12.3 9.4 13.1 5.2 10.1 8.0 18.9 10.8 8.4 10.4 12.3 13.6 6.9 10.1 6.6 7.1 9.9 4.7 3.5 6.3 11.1 7.2 4.2 6.0 10.7 4.6 6.8 10.2 6.4 8.8 6.3 6.1 16.0 9.4 4.7 11.6 11.8 4.5 2.3 5.1 9.3 7.2 8.6 2.8 2.3 2.3 3.2 3.2 4.2 1.5 2.2 2.0 1.8 1.3 1.5 2.5 3.8 1.1 3.4 1.7 1.4 1.5 8.0 10.2 14.4 14.3 7.7 7.7 8.3 8.4 11.3 9.7